id	name	formula	rt	pubchem.cid	pubchem.smiles.isomeric	pubchem.smiles.canonical	pubchem.inchi	pubchem.inchikey	id.chebi	id.hmdb	id.lipidmaps	id.kegg	comment
0391_000000	DTXSID40865579	C12H24NO4+	1.3323	6426852		CC(C)CC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C12H23NO4/c1-9(2)6-12(16)17-10(7-11(14)15)8-13(3,4)5/h9-10H,6-8H2,1-5H3/p+1	IGQBPDJNUXPEMT-UHFFFAOYSA-O					compound annotation
0391_000001	ticlopidine	C14H14ClNS	2.1063	5472		Clc1ccccc1CN1CCc2c(ccs2)C1	InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2	PHWBOXQYWZNQIN-UHFFFAOYSA-N					compound annotation
0391_000002	AMG-337	C23H22FN7O3	2.551	44181686	C[C@H](C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=C(C4=O)C=C(C=N5)OCCOC	COCCOc1cc2c(ccn(C(C)c3nnc4c(F)cc(-c5cn(C)nc5)cn34)c2=O)nc1	InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1	DWHXUGDWKAIASB-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_000004	CINPA1	C23H29N3O3	2.8247	969470		CCOC(=O)Nc1cc2c(cc1)CCc1ccccc1N2C(=O)CN(CC)CC	InChI=1S/C23H29N3O3/c1-4-25(5-2)16-22(27)26-20-10-8-7-9-17(20)11-12-18-13-14-19(15-21(18)26)24-23(28)29-6-3/h7-10,13-15H,4-6,11-12,16H2,1-3H3,(H,24,28)	AYQBYSPEGRYKFA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000006	Seletalisib	C23H14ClF3N6O	3.0545	56928390	C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])[C@H](C(F)(F)F)NC4=NC=NC5=C4N=CC=C5	[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2C(Nc2ncnc3c2nccc3)C(F)(F)F)c1	InChI=1S/C23H14ClF3N6O/c24-16-6-1-4-13-10-15(18(31-19(13)16)14-5-3-9-33(34)11-14)21(23(25,26)27)32-22-20-17(29-12-30-22)7-2-8-28-20/h1-12,21H,(H,29,30,32)/t21-/m1/s1	LNLJHGXOFYUARS-OAQYLSRUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000008	Seletalisib	C23H14ClF3N6O	3.2697	56928390	C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])[C@H](C(F)(F)F)NC4=NC=NC5=C4N=CC=C5	[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2C(Nc2ncnc3c2nccc3)C(F)(F)F)c1	InChI=1S/C23H14ClF3N6O/c24-16-6-1-4-13-10-15(18(31-19(13)16)14-5-3-9-33(34)11-14)21(23(25,26)27)32-22-20-17(29-12-30-22)7-2-8-28-20/h1-12,21H,(H,29,30,32)/t21-/m1/s1	LNLJHGXOFYUARS-OAQYLSRUSA-N					doublet; compound annotation
0391_000009	SR-59230A free base	C21H27NO2	3.3656	5311452	CCC1=CC=CC=C1OC[C@H](CN[C@H]2CCCC3=CC=CC=C23)O	CCc1ccccc1OCC(O)CNC1CCCc2ccccc21	InChI=1S/C21H27NO2/c1-2-16-8-4-6-13-21(16)24-15-18(23)14-22-20-12-7-10-17-9-3-5-11-19(17)20/h3-6,8-9,11,13,18,20,22-23H,2,7,10,12,14-15H2,1H3/t18-,20-/m0/s1	VFDHMSXXELYMRW-ICSRJNTNSA-N					doublet; compound annotation
0391_000010	1002789-86-7	C17H14N6O4	3.7089	7593228		Nc1nc(Nc2ccccc2)nc(COC(=O)c2ccc([N+](=O)[O-])cc2)n1	InChI=1S/C17H14N6O4/c18-16-20-14(21-17(22-16)19-12-4-2-1-3-5-12)10-27-15(24)11-6-8-13(9-7-11)23(25)26/h1-9H,10H2,(H3,18,19,20,21,22)	RRRDZFQRNJTKHL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000012	Erismodegib	C26H26F3N3O3	4.0408	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; compound annotation
0391_000013	Erismodegib	C26H26F3N3O3	4.5152	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; removed another duplicate entry; compound annotation
0391_000015	MJN110	C22H21Cl2N3O4	5.0713	71722059		O=C(ON1C(=O)CCC1=O)N1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1	InChI=1S/C22H21Cl2N3O4/c23-17-5-1-15(2-6-17)21(16-3-7-18(24)8-4-16)25-11-13-26(14-12-25)22(30)31-27-19(28)9-10-20(27)29/h1-8,21H,9-14H2	BEADRWVIFHOSGN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000017	Dabuzalgron	C12H16ClN3O3S	1.1097	216249		Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O	InChI=1S/C12H16ClN3O3S/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18/h3-4,16H,5-7H2,1-2H3,(H,14,15)	FOYWMEJSRSBQGB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000019	RMC-4550	C21H26Cl2N4O2	2.6452	134183206	C[C@H]1[C@H](C2(CCN(CC2)C3=NC(=C(N=C3CO)C4=C(C(=CC=C4)Cl)Cl)C)CO1)N	Cc1c(-c2c(Cl)c(Cl)ccc2)nc(CO)c(N2CCC3(CC2)COC(C)C3N)n1	InChI=1S/C21H26Cl2N4O2/c1-12-18(14-4-3-5-15(22)17(14)23)26-16(10-28)20(25-12)27-8-6-21(7-9-27)11-29-13(2)19(21)24/h3-5,13,19,28H,6-11,24H2,1-2H3/t13-,19+/m0/s1	IKUYEYLZXGGCRD-ORAYPTAESA-N					doublet; compound annotation
0391_000020	RMC-4550	C21H26Cl2N4O2	3.0234	134183206	C[C@H]1[C@H](C2(CCN(CC2)C3=NC(=C(N=C3CO)C4=C(C(=CC=C4)Cl)Cl)C)CO1)N	Cc1c(-c2c(Cl)c(Cl)ccc2)nc(CO)c(N2CCC3(CC2)COC(C)C3N)n1	InChI=1S/C21H26Cl2N4O2/c1-12-18(14-4-3-5-15(22)17(14)23)26-16(10-28)20(25-12)27-8-6-21(7-9-27)11-29-13(2)19(21)24/h3-5,13,19,28H,6-11,24H2,1-2H3/t13-,19+/m0/s1	IKUYEYLZXGGCRD-ORAYPTAESA-N					doublet; compound annotation
0391_000021	PFI-2	C23H25F4N3O3S	3.0234	71300326	C1CCN(C1)C(=O)[C@@H](CC2=CC(=CC=C2)C(F)(F)F)NS(=O)(=O)C3=CC4=C(CNCC4)C(=C3)F	O=C(C(Cc1cc(C(F)(F)F)ccc1)NS(=O)(=O)c1cc2c(CNCC2)c(F)c1)N1CCCC1	InChI=1S/C23H25F4N3O3S/c24-20-13-18(12-16-6-7-28-14-19(16)20)34(32,33)29-21(22(31)30-8-1-2-9-30)11-15-4-3-5-17(10-15)23(25,26)27/h3-5,10,12-13,21,28-29H,1-2,6-9,11,14H2/t21-/m1/s1	JCKGSPAAPQRPBW-OAQYLSRUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000023	PFI-2	C23H25F4N3O3S	3.0917	71300326	C1CCN(C1)C(=O)[C@@H](CC2=CC(=CC=C2)C(F)(F)F)NS(=O)(=O)C3=CC4=C(CNCC4)C(=C3)F	O=C(C(Cc1cc(C(F)(F)F)ccc1)NS(=O)(=O)c1cc2c(CNCC2)c(F)c1)N1CCCC1	InChI=1S/C23H25F4N3O3S/c24-20-13-18(12-16-6-7-28-14-19(16)20)34(32,33)29-21(22(31)30-8-1-2-9-30)11-15-4-3-5-17(10-15)23(25,26)27/h3-5,10,12-13,21,28-29H,1-2,6-9,11,14H2/t21-/m1/s1	JCKGSPAAPQRPBW-OAQYLSRUSA-N					doublet; compound annotation
0391_000024	2084867-65-0	C15H13N3OS2	3.7086	124081114		O=C(NCCc1nccs1)c1cnc2c(S)cccc2c1	InChI=1S/C15H13N3OS2/c19-15(17-5-4-13-16-6-7-21-13)11-8-10-2-1-3-12(20)14(10)18-9-11/h1-3,6-9,20H,4-5H2,(H,17,19)	MYNGHZGMRXNEEH-UHFFFAOYSA-N					compound annotation
0391_000025	INH14	C15H16N2O	4.1538	295048		CCc1ccc(NC(=O)Nc2ccccc2)cc1	InChI=1S/C15H16N2O/c1-2-12-8-10-14(11-9-12)17-15(18)16-13-6-4-3-5-7-13/h3-11H,2H2,1H3,(H2,16,17,18)	CPCZNJSFVOOZOG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000028	INT-777	C27H46O5	4.1989	45483949	CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3C[C@@H]([C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)C[C@H](C)C(=O)O)C)O)C)O	CCC1C(O)C2C(CC(O)C3(C)C(C(C)CC(C)C(=O)O)CCC23)C2(C)CCC(O)CC12	InChI=1S/C27H46O5/c1-6-17-20-12-16(28)9-10-26(20,4)21-13-22(29)27(5)18(14(2)11-15(3)25(31)32)7-8-19(27)23(21)24(17)30/h14-24,28-30H,6-13H2,1-5H3,(H,31,32)/t14-,15+,16-,17-,18-,19+,20+,21+,22+,23+,24-,26+,27-/m1/s1	NPBCMXATLRCCLF-IRRLEISYSA-N					compound annotation
0391_000029	CGK733	C23H18Cl3FN4O3S	5.0084	6605258		O=C(NC(NC(=S)Nc1cc([N+](=O)[O-])c(F)cc1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1	InChI=1S/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35)	HLCDNLNLQNYZTK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000031	Closantel	C22H14Cl2I2N2O2	6.4009	42574		Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1c(O)c(I)cc(I)c1	InChI=1S/C22H14Cl2I2N2O2/c1-11-6-15(17(10-27)12-2-4-13(23)5-3-12)18(24)9-20(11)28-22(30)16-7-14(25)8-19(26)21(16)29/h2-9,17,29H,1H3,(H,28,30)	JMPFSEBWVLAJKM-UHFFFAOYSA-N					doublet; compound annotation
0391_000032	Closantel	C22H14Cl2I2N2O2	6.4046	42574		Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1c(O)c(I)cc(I)c1	InChI=1S/C22H14Cl2I2N2O2/c1-11-6-15(17(10-27)12-2-4-13(23)5-3-12)18(24)9-20(11)28-22(30)16-7-14(25)8-19(26)21(16)29/h2-9,17,29H,1H3,(H,28,30)	JMPFSEBWVLAJKM-UHFFFAOYSA-N					doublet; compound annotation
0391_000033	A2AR-agonist-1	C20H22N6O4	2.1432	219015	C1=CC=C2C(=C1)C(=CN2)CCNC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O	OCC1OC(n2cnc3c(NCCc4c[nH]c5ccccc45)ncnc32)C(O)C1O	InChI=1S/C20H22N6O4/c27-8-14-16(28)17(29)20(30-14)26-10-25-15-18(23-9-24-19(15)26)21-6-5-11-7-22-13-4-2-1-3-12(11)13/h1-4,7,9-10,14,16-17,20,22,27-29H,5-6,8H2,(H,21,23,24)/t14-,16-,17-,20-/m1/s1	QGCNEMXXKWZPHR-WVSUBDOOSA-N					compound annotation
0391_000034	cbl0137	C21H24N2O2	2.2681	44519124		CC(=O)c1cc2c(cc1)n(CCNC(C)C)c1c2cc(C(C)=O)cc1	InChI=1S/C21H24N2O2/c1-13(2)22-9-10-23-20-7-5-16(14(3)24)11-18(20)19-12-17(15(4)25)6-8-21(19)23/h5-8,11-13,22H,9-10H2,1-4H3	JKCSODVERGVDLT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000036	Birinapant	C42H56F2N8O6	2.7466	49836020	CC[C@@H](C(=O)N1C[C@H](C[C@H]1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)C[C@@H]6C[C@@H](CN6C(=O)[C@H](CC)NC(=O)[C@H](C)NC)O)O)NC(=O)[C@H](C)NC	CCC(NC(=O)C(C)NC)C(=O)N1CC(O)CC1Cc1c(-c2c(CC3CC(O)CN3C(=O)C(CC)NC(=O)C(C)NC)c3ccc(F)cc3[nH]2)[nH]c2c1ccc(F)c2	InChI=1S/C42H56F2N8O6/c1-7-33(49-39(55)21(3)45-5)41(57)51-19-27(53)15-25(51)17-31-29-11-9-23(43)13-35(29)47-37(31)38-32(30-12-10-24(44)14-36(30)48-38)18-26-16-28(54)20-52(26)42(58)34(8-2)50-40(56)22(4)46-6/h9-14,21-22,25-28,33-34,45-48,53-54H,7-8,15-20H2,1-6H3,(H,49,55)(H,50,56)/t21-,22-,25-,26-,27-,28-,33-,34-/m0/s1	PKWRMUKBEYJEIX-DXXQBUJASA-N					removed another duplicate entry; compound annotation
0391_000038	BBT594	C28H30F3N7O3	2.8537	59596344		CC(=O)Nc1cc(Oc2cc3c(cc2)N(C(=O)Nc2cc(C(F)(F)F)c(CN4CCN(C)CC4)cc2)CC3)ncn1	InChI=1S/C28H30F3N7O3/c1-18(39)34-25-15-26(33-17-32-25)41-22-5-6-24-19(13-22)7-8-38(24)27(40)35-21-4-3-20(23(14-21)28(29,30)31)16-37-11-9-36(2)10-12-37/h3-6,13-15,17H,7-12,16H2,1-2H3,(H,35,40)(H,32,33,34,39)	VQLNKQZLPGLOSI-UHFFFAOYSA-N					compound annotation
0391_000039	Nintedanib	C31H33N5O4	2.996	135423438		COC(=O)c1cc2c(cc1)c(C(=Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)c(O)[nH]2	InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3	CPMDPSXJELVGJG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000041	SZL P1-41	C24H24N2O3S	3.3318	1286902		CCc1cc2c(occ(-c3nc4ccccc4s3)c2=O)c(CN2CCCCC2)c1O	InChI=1S/C24H24N2O3S/c1-2-15-12-16-22(28)18(24-25-19-8-4-5-9-20(19)30-24)14-29-23(16)17(21(15)27)13-26-10-6-3-7-11-26/h4-5,8-9,12,14,27H,2-3,6-7,10-11,13H2,1H3	JKIXLEKBXHMXTN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000043	Alda-1	C15H11Cl2NO3	3.5358	831629		O=C(NCc1cc2c(cc1)OCO2)c1c(Cl)cccc1Cl	InChI=1S/C15H11Cl2NO3/c16-10-2-1-3-11(17)14(10)15(19)18-7-9-4-5-12-13(6-9)21-8-20-12/h1-6H,7-8H2,(H,18,19)	NMKJFZCBCIUYHI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000046	1351635-67-0	C25H24N6O3	3.5673	89455219	C=CC(=O)N1CCC[C@@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	C=CC(=O)N1CCCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O3/c1-2-21(32)29-14-6-7-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-10-12-20(13-11-17)34-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m0/s1	KSUDUUBCXJUFRL-SFHVURJKSA-N					doublet; compound annotation
0391_000047	1351635-67-0	C25H24N6O3	3.5705	89455219	C=CC(=O)N1CCC[C@@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	C=CC(=O)N1CCCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O3/c1-2-21(32)29-14-6-7-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-10-12-20(13-11-17)34-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m0/s1	KSUDUUBCXJUFRL-SFHVURJKSA-N					doublet; compound annotation
0391_000048	Revizinone	C26H29N5O3	3.6679	135544124	CN(C1CCCCC1)C(=O)CO/N=C(\C2=CC=CC=C2)/C3=CC4=C(C=C3)N=C5NC(=O)CN5C4	CN(C(=O)CON=C(c1ccccc1)c1cc2c(cc1)NC1=NC(=O)CN1C2)C1CCCCC1	InChI=1S/C26H29N5O3/c1-30(21-10-6-3-7-11-21)24(33)17-34-29-25(18-8-4-2-5-9-18)19-12-13-22-20(14-19)15-31-16-23(32)28-26(31)27-22/h2,4-5,8-9,12-14,21H,3,6-7,10-11,15-17H2,1H3,(H,27,28,32)/b29-25+	VHDUUXNHZLBGHQ-XLVZBRSZSA-N					compound annotation
0391_000049	DMAPT	C17H27NO3	1.8914	129395999	C/C/1=C/CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)[C@H](C(=O)O3)CN(C)C)C	CC1=CCCC2(C)OC2C2OC(=O)C(CN(C)C)C2CC1	InChI=1S/C17H27NO3/c1-11-6-5-9-17(2)15(21-17)14-12(8-7-11)13(10-18(3)4)16(19)20-14/h6,12-15H,5,7-10H2,1-4H3/b11-6-/t12-,13+,14-,15+,17+/m0/s1	UJNSFDHVIBGEJZ-CMRIBGNTSA-N					doublet; removed another duplicate entry; compound annotation
0391_000051	MS436	C18H17N5O3S	2.6106	135566899		Cc1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O	InChI=1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)	DZTGIRNXWSZBIM-UHFFFAOYSA-N					doublet; compound annotation
0391_000052	CAL-130	C23H22N8O	2.691	71576676	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)[C@H](C)NC4=NC(=NC5=C4NC=N5)N	Cc1ccccc1-n1c(C(C)Nc2nc(N)nc3c2[nH]cn3)nc2cccc(C)c2c1=O	InChI=1S/C23H22N8O/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30)/t14-/m0/s1	PUYVJBBSBPUKBT-AWEZNQCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_000054	LY2090314	C28H25FN6O3	2.7033	10029385		O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2CCN(C(=O)N3CCCCC3)Cc3c2c1cc(F)c3	InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37)	HRJWTAWVFDCTGO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000056	CAL-130	C23H22N8O	2.7954	71576676	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)[C@H](C)NC4=NC(=NC5=C4NC=N5)N	Cc1ccccc1-n1c(C(C)Nc2nc(N)nc3c2[nH]cn3)nc2cccc(C)c2c1=O	InChI=1S/C23H22N8O/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30)/t14-/m0/s1	PUYVJBBSBPUKBT-AWEZNQCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_000058	MS436	C18H17N5O3S	2.9997	135566899		Cc1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)c(N)cc1O	InChI=1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)	DZTGIRNXWSZBIM-UHFFFAOYSA-N					doublet; compound annotation
0391_000059	LY2090314	C28H25FN6O3	3.4609	10029385		O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2CCN(C(=O)N3CCCCC3)Cc3c2c1cc(F)c3	InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37)	HRJWTAWVFDCTGO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000061	DMAPT	C17H27NO3	3.609	129395999	C/C/1=C/CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)[C@H](C(=O)O3)CN(C)C)C	CC1=CCCC2(C)OC2C2OC(=O)C(CN(C)C)C2CC1	InChI=1S/C17H27NO3/c1-11-6-5-9-17(2)15(21-17)14-12(8-7-11)13(10-18(3)4)16(19)20-14/h6,12-15H,5,7-10H2,1-4H3/b11-6-/t12-,13+,14-,15+,17+/m0/s1	UJNSFDHVIBGEJZ-CMRIBGNTSA-N					doublet; compound annotation
0391_000062	CAL-130	C23H22N8O	3.6797	71576676	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)[C@H](C)NC4=NC(=NC5=C4NC=N5)N	Cc1ccccc1-n1c(C(C)Nc2nc(N)nc3c2[nH]cn3)nc2cccc(C)c2c1=O	InChI=1S/C23H22N8O/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30)/t14-/m0/s1	PUYVJBBSBPUKBT-AWEZNQCLSA-N					doublet; compound annotation
0391_000063	bumetanide	C17H20N2O5S	3.7812	2471		CCCCNc1c(Oc2ccccc2)c(S(N)(=O)=O)cc(C(=O)O)c1	InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)	MAEIEVLCKWDQJH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000065	bumetanide	C17H20N2O5S	3.7842	2471		CCCCNc1c(Oc2ccccc2)c(S(N)(=O)=O)cc(C(=O)O)c1	InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)	MAEIEVLCKWDQJH-UHFFFAOYSA-N					doublet; compound annotation
0391_000066	CAL-130	C23H22N8O	3.8358	71576676	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)[C@H](C)NC4=NC(=NC5=C4NC=N5)N	Cc1ccccc1-n1c(C(C)Nc2nc(N)nc3c2[nH]cn3)nc2cccc(C)c2c1=O	InChI=1S/C23H22N8O/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30)/t14-/m0/s1	PUYVJBBSBPUKBT-AWEZNQCLSA-N					doublet; compound annotation
0391_000067	CAL-130	C23H22N8O	3.8913	71576676	CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)[C@H](C)NC4=NC(=NC5=C4NC=N5)N	Cc1ccccc1-n1c(C(C)Nc2nc(N)nc3c2[nH]cn3)nc2cccc(C)c2c1=O	InChI=1S/C23H22N8O/c1-12-7-4-5-10-16(12)31-21(28-15-9-6-8-13(2)17(15)22(31)32)14(3)27-20-18-19(26-11-25-18)29-23(24)30-20/h4-11,14H,1-3H3,(H4,24,25,26,27,29,30)/t14-/m0/s1	PUYVJBBSBPUKBT-AWEZNQCLSA-N					doublet; compound annotation
0391_000068	EL-102	C19H16N2O3S2	4.4118	62705067		COc1ccc(S(=O)(=O)Nc2c(C)ccc(-c3csc(C#N)c3)c2)cc1	InChI=1S/C19H16N2O3S2/c1-13-3-4-14(15-9-17(11-20)25-12-15)10-19(13)21-26(22,23)18-7-5-16(24-2)6-8-18/h3-10,12,21H,1-2H3	STJKZARVVAISJM-UHFFFAOYSA-N					compound annotation
0391_000069	SH-4-54	C29H27F5N2O5S	5.855	72188643		CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F	InChI=1S/C29H27F5N2O5S/c1-35(42(40,41)28-26(33)24(31)23(30)25(32)27(28)34)16-22(37)36(21-13-11-20(12-14-21)29(38)39)15-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h7-14,18H,2-6,15-16H2,1H3,(H,38,39)	VFPYGNNOSJWBHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000071	N6-Cyclohexyladenosine	C16H23N5O4	1.9618	9841284	C1CCC(CC1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NC4CCCCC4)ncnc32)C(O)C1O	InChI=1S/C16H23N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h7-10,12-13,16,22-24H,1-6H2,(H,17,18,20)/t10-,12-,13-,16-/m1/s1	SZBULDQSDUXAPJ-XNIJJKJLSA-N					doublet; compound annotation
0391_000072	N6-Cyclohexyladenosine	C16H23N5O4	1.9645	9841284	C1CCC(CC1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NC4CCCCC4)ncnc32)C(O)C1O	InChI=1S/C16H23N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h7-10,12-13,16,22-24H,1-6H2,(H,17,18,20)/t10-,12-,13-,16-/m1/s1	SZBULDQSDUXAPJ-XNIJJKJLSA-N					doublet; compound annotation
0391_000073	Olmesartan	C24H26N6O3	2.3526	158781		CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)	VTRAEEWXHOVJFV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000075	TASOSARTAN	C23H21N7O	2.5452	60919		Cc1nc(C)c2CCC(=O)N(Cc3ccc(-c4ccccc4-c4n[nH]nn4)cc3)c2n1	InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)	ADXGNEYLLLSOAR-UHFFFAOYSA-N					doublet; compound annotation
0391_000076	TASOSARTAN	C23H21N7O	2.5479	60919		Cc1nc(C)c2CCC(=O)N(Cc3ccc(-c4ccccc4-c4n[nH]nn4)cc3)c2n1	InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)	ADXGNEYLLLSOAR-UHFFFAOYSA-N					doublet; compound annotation
0391_000077	GSK2256294A	C21H24F3N7O	2.7446	59448236	CC1=NC(=NC(=N1)N[C@H]2CCC[C@H](C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F)NC	CNc1nc(NC2CCCC(C(=O)NCc3c(C(F)(F)F)cc(C#N)cc3)C2)nc(C)n1	InChI=1S/C21H24F3N7O/c1-12-28-19(26-2)31-20(29-12)30-16-5-3-4-14(9-16)18(32)27-11-15-7-6-13(10-25)8-17(15)21(22,23)24/h6-8,14,16H,3-5,9,11H2,1-2H3,(H,27,32)(H2,26,28,29,30,31)/t14-,16+/m1/s1	LQHDJQIMETZMPH-ZBFHGGJFSA-N					compound annotation
0391_000078	5-(N,N-Hexamethylene)amiloride	C12H18ClN7O	2.9149	1794		NC(N)=NC(=O)c1c(N)nc(N2CCCCCC2)c(Cl)n1	InChI=1S/C12H18ClN7O/c13-8-10(20-5-3-1-2-4-6-20)18-9(14)7(17-8)11(21)19-12(15)16/h1-6H2,(H2,14,18)(H4,15,16,19,21)	RQQJJXVETXFINY-UHFFFAOYSA-N					compound annotation
0391_000079	Sitravatinib	C33H29F2N5O4S	3.3028	25212148		COCCNCc1cnc(-c2cc3nccc(Oc4c(F)cc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4)c3s2)cc1	InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)	WLAVZAAODLTUSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000081	Cyproconazole	C15H18ClN3O	3.3321	86132		CC(C1CC1)C(O)(Cn1cncn1)c1ccc(Cl)cc1	InChI=1S/C15H18ClN3O/c1-11(12-2-3-12)15(20,8-19-10-17-9-18-19)13-4-6-14(16)7-5-13/h4-7,9-12,20H,2-3,8H2,1H3	UFNOUKDBUJZYDE-UHFFFAOYSA-N					doublet; compound annotation
0391_000082	ABT-737	C42H45ClN6O5S2	3.4681	11228183	CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]	CN(C)CCC(CSc1ccccc1)Nc1c([N+](=O)[O-])cc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1	InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1	HPLNQCPCUACXLM-PGUFJCEWSA-N					compound annotation
0391_000083	Cyproconazole	C15H18ClN3O	3.9261	86132		CC(C1CC1)C(O)(Cn1cncn1)c1ccc(Cl)cc1	InChI=1S/C15H18ClN3O/c1-11(12-2-3-12)15(20,8-19-10-17-9-18-19)13-4-6-14(16)7-5-13/h4-7,9-12,20H,2-3,8H2,1H3	UFNOUKDBUJZYDE-UHFFFAOYSA-N					doublet; compound annotation
0391_000084	Cyproconazole	C15H18ClN3O	3.9609	86132		CC(C1CC1)C(O)(Cn1cncn1)c1ccc(Cl)cc1	InChI=1S/C15H18ClN3O/c1-11(12-2-3-12)15(20,8-19-10-17-9-18-19)13-4-6-14(16)7-5-13/h4-7,9-12,20H,2-3,8H2,1H3	UFNOUKDBUJZYDE-UHFFFAOYSA-N					doublet; compound annotation
0391_000085	Gentian violet cation	C25H30N3+	4.1518	3468		CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1	InChI=1S/C25H30N3/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6/h7-18H,1-6H3/q+1	LGLFFNDHMLKUMI-UHFFFAOYSA-N					compound annotation
0391_000086	Marinopyrrole A	C22H12Cl4N2O4	5.6392	24797083		O=C(c1ccccc1O)c1c(-n2c(C(=O)c3ccccc3O)cc(Cl)c2Cl)c(Cl)c(Cl)[nH]1	InChI=1S/C22H12Cl4N2O4/c23-12-9-13(19(31)10-5-1-3-7-14(10)29)28(22(12)26)18-16(24)21(25)27-17(18)20(32)11-6-2-4-8-15(11)30/h1-9,27,29-30H	QYPJBTMRYKRTFG-UHFFFAOYSA-N					compound annotation
0391_000087	Alagebrium	C13H14NOS+	1.5998	216305		Cc1c(C)[n+](CC(=O)c2ccccc2)cs1	InChI=1S/C13H14NOS/c1-10-11(2)16-9-14(10)8-13(15)12-6-4-3-5-7-12/h3-7,9H,8H2,1-2H3/q+1	LYLFQLCLUXOFOL-UHFFFAOYSA-N					compound annotation
0391_000088	Fostemsavir	C25H26N7O8P	2.0241	11319217		COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O	InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)	SWMDAPWAQQTBOG-UHFFFAOYSA-N					doublet; compound annotation
0391_000089	Fostemsavir	C25H26N7O8P	2.0275	11319217		COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O	InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)	SWMDAPWAQQTBOG-UHFFFAOYSA-N					doublet; compound annotation
0391_000090	Bikinin	C9H9BrN2O3	2.2322	647833		O=C(O)CCC(=O)Nc1ncc(Br)cc1	InChI=1S/C9H9BrN2O3/c10-6-1-2-7(11-5-6)12-8(13)3-4-9(14)15/h1-2,5H,3-4H2,(H,14,15)(H,11,12,13)	XFYYQDHEDOXWGA-UHFFFAOYSA-N					compound annotation
0391_000091	JNJ-38877618	C20H12F2N6	2.2454	57654476		FC(F)(c1cc2c(cc1)nccc2)c1nnc2ccc(-c3ccncc3)nn12	InChI=1S/C20H12F2N6/c21-20(22,15-3-4-16-14(12-15)2-1-9-24-16)19-26-25-18-6-5-17(27-28(18)19)13-7-10-23-11-8-13/h1-12H	KOAWAWHSMVKCON-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000093	TMC353121	C32H42N6O3	2.2681	11249932		Cc1cc(NCc2cc3c(cc2)nc(NCCCN2CCOCC2)n3Cc2c(O)ccc(C)n2)c(CCCO)cc1	InChI=1S/C32H42N6O3/c1-23-6-9-26(5-3-16-39)28(19-23)34-21-25-8-10-27-30(20-25)38(22-29-31(40)11-7-24(2)35-29)32(36-27)33-12-4-13-37-14-17-41-18-15-37/h6-11,19-20,34,39-40H,3-5,12-18,21-22H2,1-2H3,(H,33,36)	DKORMNNYNRPTBJ-UHFFFAOYSA-N					compound annotation
0391_000094	848193-69-1	C13H13ClN2O	3.5505	707032	C1C[C@H](C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N	NC(=O)C1CCCc2c1[nH]c1c2cc(Cl)cc1	InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)/t9-/m1/s1	FUZYTVDVLBBXDL-SECBINFHSA-N					removed another duplicate entry; compound annotation
0391_000096	Ibrolipim	C19H20BrN2O4P	3.7588	131601		CCOP(=O)(Cc1ccc(C(=O)Nc2c(C#N)cc(Br)cc2)cc1)OCC	InChI=1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23)	KPRTURMJVWXURQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000098	BMS-833923	C30H27N5O	3.7759	57662985		CNCc1cc(NC(=O)c2ccc(Nc3nc4ccccc4c(-c4ccccc4)n3)cc2)c(C)cc1	InChI=1S/C30H27N5O/c1-20-12-13-21(19-31-2)18-27(20)33-29(36)23-14-16-24(17-15-23)32-30-34-26-11-7-6-10-25(26)28(35-30)22-8-4-3-5-9-22/h3-18,31H,19H2,1-2H3,(H,33,36)(H,32,34,35)	KLRRGBHZCJLIEL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000100	Sitaxsentan	C18H15ClN2O6S2	4.0311	216235		Cc1cc2c(cc1CC(=O)c1c(S(=O)(=O)Nc3c(Cl)c(C)no3)ccs1)OCO2	InChI=1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3	PHWXUGHIIBDVKD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000103	KK8645V7LE	C22H20F5N3O3	4.0995	49867930	CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3NC1=O	CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)NC1C(=O)Nc2ccccc2-c2ccccc21	InChI=1S/C22H20F5N3O3/c1-20(2,18(32)28-11-21(23,24)22(25,26)27)19(33)30-16-14-9-4-3-7-12(14)13-8-5-6-10-15(13)29-17(16)31/h3-10,16H,11H2,1-2H3,(H,28,32)(H,29,31)(H,30,33)/t16-/m0/s1	OJPLJFIFUQPSJR-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_000105	Hexaminolevulinate	C11H21NO3	2.5607	6433083		CCCCCCOC(=O)CCC(=O)CN	InChI=1S/C11H21NO3/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12/h2-9,12H2,1H3	RYQOILLJDKPETL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000107	Bromosporine	C17H20N6O4S	3.069	72943187		CCOC(=O)Nc1cc(-c2cc(NS(C)(=O)=O)c(C)cc2)nn2c(C)nnc12	InChI=1S/C17H20N6O4S/c1-5-27-17(24)18-15-9-14(21-23-11(3)19-20-16(15)23)12-7-6-10(2)13(8-12)22-28(4,25)26/h6-9,22H,5H2,1-4H3,(H,18,24)	UYBRROMMFMPJAN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000109	1228690-36-5	C27H24N2O5	4.2925	46213949	CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)O	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)OC(C)c1ccccc1	InChI=1S/C27H24N2O5/c1-17-25(28-27(32)33-18(2)20-6-4-3-5-7-20)26(34-29-17)23-14-12-22(13-15-23)21-10-8-19(9-11-21)16-24(30)31/h3-15,18H,16H2,1-2H3,(H,28,32)(H,30,31)/t18-/m1/s1	LNDDRUPAICPXIN-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_000111	Empesertib	C29H26FN5O4S	4.4006	71599640	C[C@H](C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3	COc1c(Nc2nn3cc(-c4ccc(NC(=O)C(C)c5ccc(F)cc5)cc4)ccc3n2)ccc(S(C)(=O)=O)c1	InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1	NRJKIOCCERLIDG-GOSISDBHSA-N					doublet; compound annotation
0391_000112	Empesertib	C29H26FN5O4S	4.4033	71599640	C[C@H](C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3	COc1c(Nc2nn3cc(-c4ccc(NC(=O)C(C)c5ccc(F)cc5)cc4)ccc3n2)ccc(S(C)(=O)=O)c1	InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1	NRJKIOCCERLIDG-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_000114	Elafibranor	C22H24O4S	4.5208	9864881	CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)/C=C/C(=O)C2=CC=C(C=C2)SC	CSc1ccc(C(=O)C=Cc2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1	InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+	AFLFKFHDSCQHOL-IZZDOVSWSA-N					doublet; removed another duplicate entry; compound annotation
0391_000116	BTdCPU	C13H8Cl2N4OS	4.6996	49787174		O=C(Nc1cc(Cl)c(Cl)cc1)Nc1cc2c(cc1)nns2	InChI=1S/C13H8Cl2N4OS/c14-9-3-1-7(5-10(9)15)16-13(20)17-8-2-4-11-12(6-8)21-19-18-11/h1-6H,(H2,16,17,20)	NUUSUAWULNXMGF-UHFFFAOYSA-N					doublet; compound annotation
0391_000117	BTdCPU	C13H8Cl2N4OS	4.7026	49787174		O=C(Nc1cc(Cl)c(Cl)cc1)Nc1cc2c(cc1)nns2	InChI=1S/C13H8Cl2N4OS/c14-9-3-1-7(5-10(9)15)16-13(20)17-8-2-4-11-12(6-8)21-19-18-11/h1-6H,(H2,16,17,20)	NUUSUAWULNXMGF-UHFFFAOYSA-N					doublet; compound annotation
0391_000118	Sal003	C18H15Cl4N3OS	4.718	5717737	C1=CC=C(C=C1)/C=C/C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=C(C=C2)Cl	O=C(C=Cc1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl	InChI=1S/C18H15Cl4N3OS/c19-13-7-9-14(10-8-13)23-17(27)25-16(18(20,21)22)24-15(26)11-6-12-4-2-1-3-5-12/h1-11,16H,(H,24,26)(H2,23,25,27)/b11-6+	TVNBASWNLOIQML-IZZDOVSWSA-N					doublet; compound annotation
0391_000119	Elafibranor	C22H24O4S	4.7231	9864881	CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)/C=C/C(=O)C2=CC=C(C=C2)SC	CSc1ccc(C(=O)C=Cc2cc(C)c(OC(C)(C)C(=O)O)c(C)c2)cc1	InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+	AFLFKFHDSCQHOL-IZZDOVSWSA-N					doublet; compound annotation
0391_000120	Sal003	C18H15Cl4N3OS	4.7694	5717737	C1=CC=C(C=C1)/C=C/C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=C(C=C2)Cl	O=C(C=Cc1ccccc1)NC(NC(=S)Nc1ccc(Cl)cc1)C(Cl)(Cl)Cl	InChI=1S/C18H15Cl4N3OS/c19-13-7-9-14(10-8-13)23-17(27)25-16(18(20,21)22)24-15(26)11-6-12-4-2-1-3-5-12/h1-11,16H,(H,24,26)(H2,23,25,27)/b11-6+	TVNBASWNLOIQML-IZZDOVSWSA-N					doublet; removed another duplicate entry; compound annotation
0391_000122	Antitumor Compound 1	C18H10F6N4S	4.9575	73427118		FC(F)(F)c1ccc(Nc2nc(-c3c(C(F)(F)F)nc4ccccn34)cs2)cc1	InChI=1S/C18H10F6N4S/c19-17(20,21)10-4-6-11(7-5-10)25-16-26-12(9-29-16)14-15(18(22,23)24)27-13-3-1-2-8-28(13)14/h1-9H,(H,25,26)	KYPPJHVEENIEGO-UHFFFAOYSA-N					compound annotation
0391_000123	P7C3-A20	C22H19Br2FN2O	6.1964	46853447		COc1cccc(NCC(F)Cn2c3ccc(Br)cc3c3c2ccc(Br)c3)c1	InChI=1S/C22H19Br2FN2O/c1-28-18-4-2-3-17(11-18)26-12-16(25)13-27-21-7-5-14(23)9-19(21)20-10-15(24)6-8-22(20)27/h2-11,16,26H,12-13H2,1H3	XNLTWMQBJFWQOU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000125	BX-912	C20H23BrN8O	1.5628	11754511		O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1	InChI=1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28)	DMMILYKXNCVKOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000126	BX-912	C20H23BrN8O	1.5661	11754511		O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1	InChI=1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28)	DMMILYKXNCVKOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000127	Liproxstatin-1	C19H21ClN4	1.6267	135735917		Clc1cccc(CNC2=Nc3ccccc3NC23CCNCC3)c1	InChI=1S/C19H21ClN4/c20-15-5-3-4-14(12-15)13-22-18-19(8-10-21-11-9-19)24-17-7-2-1-6-16(17)23-18/h1-7,12,21,24H,8-11,13H2,(H,22,23)	YAFQFNOUYXZVPZ-UHFFFAOYSA-N					compound annotation
0391_000128	895158-95-9	C16H11FN6O	1.9634	400169		O=C(NNc1nc2c(ccc(F)c2)n2cccc12)c1nccnc1	InChI=1S/C16H11FN6O/c17-10-3-4-13-11(8-10)20-15(14-2-1-7-23(13)14)21-22-16(24)12-9-18-5-6-19-12/h1-9H,(H,20,21)(H,22,24)	UEADAWQSJOWXBK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000130	EHop-016	C25H30N6O	2.2089	51031035		CCn1c2ccccc2c2c1ccc(Nc1nc(NCCCN3CCOCC3)ncc1)c2	InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4,6-10,12,18H,2,5,11,13-17H2,1H3,(H2,26,27,28,29)	AFTZZRFCMOAFCR-UHFFFAOYSA-N					doublet; compound annotation
0391_000131	Tandutinib	C31H42N6O4	2.2681	3038522		COc1c(OCCCN2CCCCC2)cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2c1	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	UXXQOJXBIDBUAC-UHFFFAOYSA-N					doublet; compound annotation
0391_000132	EHop-016	C25H30N6O	2.3343	51031035		CCn1c2ccccc2c2c1ccc(Nc1nc(NCCCN3CCOCC3)ncc1)c2	InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4,6-10,12,18H,2,5,11,13-17H2,1H3,(H2,26,27,28,29)	AFTZZRFCMOAFCR-UHFFFAOYSA-N					doublet; compound annotation
0391_000133	ERK5-IN-2	C17H11BrFN3O2	2.4356	118959080		O=C(Nc1cnccc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1	InChI=1S/C17H11BrFN3O2/c18-12-4-1-5-13(19)15(12)16(23)10-7-14(21-8-10)17(24)22-11-3-2-6-20-9-11/h1-9,21H,(H,22,24)	ATKCERYALDNMPL-UHFFFAOYSA-N					compound annotation
0391_000134	EHop-016	C25H30N6O	2.6172	51031035		CCn1c2ccccc2c2c1ccc(Nc1nc(NCCCN3CCOCC3)ncc1)c2	InChI=1S/C25H30N6O/c1-2-31-22-7-4-3-6-20(22)21-18-19(8-9-23(21)31)28-24-10-12-27-25(29-24)26-11-5-13-30-14-16-32-17-15-30/h3-4,6-10,12,18H,2,5,11,13-17H2,1H3,(H2,26,27,28,29)	AFTZZRFCMOAFCR-UHFFFAOYSA-N					doublet; compound annotation
0391_000135	1378524-41-4	C27H35FN2O4	3.0722	59052285	C/C(=C\C1=CC=CC=C1F)/CN(CCC2CCCN2C)C(=O)C3=CC(=C(C(=C3)OC)OC)OC	COc1cc(C(=O)N(CCC2CCCN2C)CC(C)=Cc2ccccc2F)cc(OC)c1OC	InChI=1S/C27H35FN2O4/c1-19(15-20-9-6-7-11-23(20)28)18-30(14-12-22-10-8-13-29(22)2)27(31)21-16-24(32-3)26(34-5)25(17-21)33-4/h6-7,9,11,15-17,22H,8,10,12-14,18H2,1-5H3/b19-15+	JVRRRKAXHMGUHZ-XDJHFCHBSA-N					doublet; compound annotation
0391_000136	1378524-41-4	C27H35FN2O4	3.1867	59052285	C/C(=C\C1=CC=CC=C1F)/CN(CCC2CCCN2C)C(=O)C3=CC(=C(C(=C3)OC)OC)OC	COc1cc(C(=O)N(CCC2CCCN2C)CC(C)=Cc2ccccc2F)cc(OC)c1OC	InChI=1S/C27H35FN2O4/c1-19(15-20-9-6-7-11-23(20)28)18-30(14-12-22-10-8-13-29(22)2)27(31)21-16-24(32-3)26(34-5)25(17-21)33-4/h6-7,9,11,15-17,22H,8,10,12-14,18H2,1-5H3/b19-15+	JVRRRKAXHMGUHZ-XDJHFCHBSA-N					doublet; compound annotation
0391_000137	895158-95-9	C16H11FN6O	3.3375	400169		O=C(NNc1nc2c(ccc(F)c2)n2cccc12)c1nccnc1	InChI=1S/C16H11FN6O/c17-10-3-4-13-11(8-10)20-15(14-2-1-7-23(13)14)21-22-16(24)12-9-18-5-6-19-12/h1-9H,(H,20,21)(H,22,24)	UEADAWQSJOWXBK-UHFFFAOYSA-N					doublet; compound annotation
0391_000138	ML228	C27H21N5	3.9325	46742353		c1ccc(-c2ccc(CNc3nc(-c4ccccn4)nnc3-c3ccccc3)cc2)cc1	InChI=1S/C27H21N5/c1-3-9-21(10-4-1)22-16-14-20(15-17-22)19-29-27-25(23-11-5-2-6-12-23)31-32-26(30-27)24-13-7-8-18-28-24/h1-18H,19H2,(H,29,30,32)	QNRODODTMXCRKU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000140	895158-95-9	C16H11FN6O	4.5482	400169		O=C(NNc1nc2c(ccc(F)c2)n2cccc12)c1nccnc1	InChI=1S/C16H11FN6O/c17-10-3-4-13-11(8-10)20-15(14-2-1-7-23(13)14)21-22-16(24)12-9-18-5-6-19-12/h1-9H,(H,20,21)(H,22,24)	UEADAWQSJOWXBK-UHFFFAOYSA-N					doublet; compound annotation
0391_000141	Zatolmilast	C21H15ClF3NO2	5.3225	90111638		O=C(O)Cc1ccc(Cc2cc(-c3cc(Cl)ccc3)nc(C(F)(F)F)c2)cc1	InChI=1S/C21H15ClF3NO2/c22-17-3-1-2-16(12-17)18-9-15(10-19(26-18)21(23,24)25)8-13-4-6-14(7-5-13)11-20(27)28/h1-7,9-10,12H,8,11H2,(H,27,28)	LTSUMTMGJHPGFX-UHFFFAOYSA-N					compound annotation
0391_000142	Brevianamide F	C16H17N3O2	2.0187	181567	C1C[C@H]2C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43	O=C1NC(Cc2c[nH]c3ccccc23)C(=O)N2CCCC12	InChI=1S/C16H17N3O2/c20-15-14-6-3-7-19(14)16(21)13(18-15)8-10-9-17-12-5-2-1-4-11(10)12/h1-2,4-5,9,13-14,17H,3,6-8H2,(H,18,20)/t13-,14-/m0/s1	RYFZBPVMVYTEKZ-KBPBESRZSA-N					compound annotation
0391_000143	Fostemsavir	C25H26N7O8P	2.0258	11319217		COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O	InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)	SWMDAPWAQQTBOG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000145	CH5132799	C15H19N7O3S	2.2153	49784945		CS(=O)(=O)N1CCc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc21	InChI=1S/C15H19N7O3S/c1-26(23,24)22-3-2-11-12(10-8-17-14(16)18-9-10)19-15(20-13(11)22)21-4-6-25-7-5-21/h8-9H,2-7H2,1H3,(H2,16,17,18)	JEGHXKRHKHPBJD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000147	PF-04691502	C22H27N5O4	2.2707	25033539		COc1ncc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cc1	InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)	XDLYKKIQACFMJG-UHFFFAOYSA-N					doublet; compound annotation
0391_000148	PF-04691502	C22H27N5O4	2.3409	25033539		COc1ncc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cc1	InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)	XDLYKKIQACFMJG-UHFFFAOYSA-N					doublet; compound annotation
0391_000149	PF-04691502	C22H27N5O4	2.6141	25033539		COc1ncc(-c2cc3c(C)nc(N)nc3n(C3CCC(OCCO)CC3)c2=O)cc1	InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)	XDLYKKIQACFMJG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000152	ALK inhibitor 1	C23H28BrN7O3S	2.6739	24857689		CNS(=O)(=O)c1ccccc1Nc1nc(Nc2c(OC)cc(N3CCN(C)CC3)cc2)ncc1Br	InChI=1S/C23H28BrN7O3S/c1-25-35(32,33)21-7-5-4-6-19(21)27-22-17(24)15-26-23(29-22)28-18-9-8-16(14-20(18)34-3)31-12-10-30(2)11-13-31/h4-9,14-15,25H,10-13H2,1-3H3,(H2,26,27,28,29)	FTSDLONCFCQDGA-UHFFFAOYSA-N					doublet; compound annotation
0391_000153	ALK inhibitor 1	C23H28BrN7O3S	2.6789	24857689		CNS(=O)(=O)c1ccccc1Nc1nc(Nc2c(OC)cc(N3CCN(C)CC3)cc2)ncc1Br	InChI=1S/C23H28BrN7O3S/c1-25-35(32,33)21-7-5-4-6-19(21)27-22-17(24)15-26-23(29-22)28-18-9-8-16(14-20(18)34-3)31-12-10-30(2)11-13-31/h4-9,14-15,25H,10-13H2,1-3H3,(H2,26,27,28,29)	FTSDLONCFCQDGA-UHFFFAOYSA-N					doublet; compound annotation
0391_000154	IPSU	C23H27N5O2	2.8543	56970858		COc1nc(N2CCC3(CCCN(Cc4c[nH]c5ccccc45)C3=O)CC2)ncc1	InChI=1S/C23H27N5O2/c1-30-20-7-11-24-22(26-20)27-13-9-23(10-14-27)8-4-12-28(21(23)29)16-17-15-25-19-6-3-2-5-18(17)19/h2-3,5-7,11,15,25H,4,8-10,12-14,16H2,1H3	PCMHOSYCWRRHTG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000156	TG003	C13H15NO2S	3.1938	1893668	CCN\1C2=C(C=CC(=C2)OC)S/C1=C\C(=O)C	CCN1C(=CC(C)=O)Sc2c1cc(OC)cc2	InChI=1S/C13H15NO2S/c1-4-14-11-8-10(16-3)5-6-12(11)17-13(14)7-9(2)15/h5-8H,4H2,1-3H3/b13-7-	BGVLELSCIHASRV-QPEQYQDCSA-N					compound annotation
0391_000157	4egi-1	C18H12Cl2N4O4S	4.9379	6911989	C1=CC=C(C(=C1)C/C(=N/NC2=NC(=CS2)C3=CC(=C(C=C3)Cl)Cl)/C(=O)O)[N+](=O)[O-]	O=C(O)C(Cc1ccccc1[N+](=O)[O-])=NNc1nc(-c2cc(Cl)c(Cl)cc2)cs1	InChI=1S/C18H12Cl2N4O4S/c19-12-6-5-10(7-13(12)20)15-9-29-18(21-15)23-22-14(17(25)26)8-11-3-1-2-4-16(11)24(27)28/h1-7,9H,8H2,(H,21,23)(H,25,26)/b22-14-	KFRKRECSIYXARE-HMAPJEAMSA-N					doublet; compound annotation
0391_000158	CCT007093	C15H12OS2	4.9945	2314623	C1/C(=C\C2=CC=CS2)/C(=O)/C(=C/C3=CC=CS3)/C1	O=C1C(=Cc2cccs2)CCC1=Cc1cccs1	InChI=1S/C15H12OS2/c16-15-11(9-13-3-1-7-17-13)5-6-12(15)10-14-4-2-8-18-14/h1-4,7-10H,5-6H2/b11-9+,12-10+	KPFZCKDPBMGECB-WGDLNXRISA-N					doublet; compound annotation
0391_000159	CCT007093	C15H12OS2	5.1217	2314623	C1/C(=C\C2=CC=CS2)/C(=O)/C(=C/C3=CC=CS3)/C1	O=C1C(=Cc2cccs2)CCC1=Cc1cccs1	InChI=1S/C15H12OS2/c16-15-11(9-13-3-1-7-17-13)5-6-12(15)10-14-4-2-8-18-14/h1-4,7-10H,5-6H2/b11-9+,12-10+	KPFZCKDPBMGECB-WGDLNXRISA-N					doublet; compound annotation
0391_000160	4egi-1	C18H12Cl2N4O4S	5.4372	6911989	C1=CC=C(C(=C1)C/C(=N/NC2=NC(=CS2)C3=CC(=C(C=C3)Cl)Cl)/C(=O)O)[N+](=O)[O-]	O=C(O)C(Cc1ccccc1[N+](=O)[O-])=NNc1nc(-c2cc(Cl)c(Cl)cc2)cs1	InChI=1S/C18H12Cl2N4O4S/c19-12-6-5-10(7-13(12)20)15-9-29-18(21-15)23-22-14(17(25)26)8-11-3-1-2-4-16(11)24(27)28/h1-7,9H,8H2,(H,21,23)(H,25,26)/b22-14-	KFRKRECSIYXARE-HMAPJEAMSA-N					doublet; compound annotation
0391_000161	o6-benzylguanine	C12H11N5O	1.8033	4578		Nc1nc2c([nH]cn2)c(OCc2ccccc2)n1	InChI=1S/C12H11N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,13,14,15,16,17)	KRWMERLEINMZFT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000163	CEP-33779	C24H26N6O2S	1.8719	57336812		CN1CCN(c2cccc(Nc3nn4cccc(-c5ccc(S(C)(=O)=O)cc5)c4n3)c2)CC1	InChI=1S/C24H26N6O2S/c1-28-13-15-29(16-14-28)20-6-3-5-19(17-20)25-24-26-23-22(7-4-12-30(23)27-24)18-8-10-21(11-9-18)33(2,31)32/h3-12,17H,13-16H2,1-2H3,(H,25,27)	RFZKSQIFOZZIAQ-UHFFFAOYSA-N					doublet; compound annotation
0391_000164	CDK4/6-IN-2	C27H32F2N8	2.1252	91820696		CCN1CCN(Cc2cnc(Nc3ncc(F)c(-c4cc5c(nc(C)n5C(C)C)c(F)c4)c3)nc2)CC1	InChI=1S/C27H32F2N8/c1-5-35-6-8-36(9-7-35)16-19-13-31-27(32-14-19)34-25-12-21(23(29)15-30-25)20-10-22(28)26-24(11-20)37(17(2)3)18(4)33-26/h10-15,17H,5-9,16H2,1-4H3,(H,30,31,32,34)	CMOYPFUEZDEQEH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000166	LY 344864 racemate	C21H22FN3O	2.2605	18971832		CN(C)C1CCc2c(C1)c1c(ccc(NC(=O)c3ccc(F)cc3)c1)[nH]2	InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26)	GKWHICIUSVVNGX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000168	CEP-33779	C24H26N6O2S	2.4481	57336812		CN1CCN(c2cccc(Nc3nn4cccc(-c5ccc(S(C)(=O)=O)cc5)c4n3)c2)CC1	InChI=1S/C24H26N6O2S/c1-28-13-15-29(16-14-28)20-6-3-5-19(17-20)25-24-26-23-22(7-4-12-30(23)27-24)18-8-10-21(11-9-18)33(2,31)32/h3-12,17H,13-16H2,1-2H3,(H,25,27)	RFZKSQIFOZZIAQ-UHFFFAOYSA-N					doublet; compound annotation
0391_000169	CEP-33779	C24H26N6O2S	2.4513	57336812		CN1CCN(c2cccc(Nc3nn4cccc(-c5ccc(S(C)(=O)=O)cc5)c4n3)c2)CC1	InChI=1S/C24H26N6O2S/c1-28-13-15-29(16-14-28)20-6-3-5-19(17-20)25-24-26-23-22(7-4-12-30(23)27-24)18-8-10-21(11-9-18)33(2,31)32/h3-12,17H,13-16H2,1-2H3,(H,25,27)	RFZKSQIFOZZIAQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000171	851723-84-7	C21H17FN2O2	2.6855	11462174		Cc1c(Cc2nc3ccccc3cc2)c2c(ccc(F)c2)n1CC(=O)O	InChI=1S/C21H17FN2O2/c1-13-17(11-16-8-6-14-4-2-3-5-19(14)23-16)18-10-15(22)7-9-20(18)24(13)12-21(25)26/h2-10H,11-12H2,1H3,(H,25,26)	FATGTHLOZSXOBC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000173	300816-15-3	C25H27N3O3	2.95	9953769		Cc1cc2c(cc1)NC(=O)OC21CCN(CCc2c(C)oc(-c3ccccc3)n2)CC1	InChI=1S/C25H27N3O3/c1-17-8-9-22-20(16-17)25(31-24(29)27-22)11-14-28(15-12-25)13-10-21-18(2)30-23(26-21)19-6-4-3-5-7-19/h3-9,16H,10-15H2,1-2H3,(H,27,29)	ODNICNWASXKNNQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000175	IOX2	C19H16N2O5	4.1652	54685215		O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O	InChI=1S/C19H16N2O5/c22-15(23)10-20-18(25)16-17(24)13-8-4-5-9-14(13)21(19(16)26)11-12-6-2-1-3-7-12/h1-9,24H,10-11H2,(H,20,25)(H,22,23)	CAOSCCRYLYQBES-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000177	tizanidine	C9H8ClN5S	0.9297	5487		Clc1c(NC2=NCCN2)c2nsnc2cc1	InChI=1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13)	XFYDIVBRZNQMJC-UHFFFAOYSA-N					compound annotation
0391_000178	1,10-phenanthroline	C12H8N2	1.0346	1318		c1cc2c(nc1)c1c(cccn1)cc2	InChI=1S/C12H8N2/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1/h1-8H	DGEZNRSVGBDHLK-UHFFFAOYSA-N					doublet; compound annotation
0391_000179	1,10-phenanthroline	C12H8N2	1.0375	1318		c1cc2c(nc1)c1c(cccn1)cc2	InChI=1S/C12H8N2/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1/h1-8H	DGEZNRSVGBDHLK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000181	Ailanthone	C20H24O7	1.4885	72965	CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@]([C@@H](C(=C)[C@@H]4CC(=O)O3)O)(OC5)O)C)O	C=C1C(O)C2(O)OCC34C(CC5C(C)=CC(=O)C(O)C5(C)C23)OC(=O)CC14	InChI=1S/C20H24O7/c1-8-4-12(21)16(24)18(3)10(8)5-13-19-7-26-20(25,17(18)19)15(23)9(2)11(19)6-14(22)27-13/h4,10-11,13,15-17,23-25H,2,5-7H2,1,3H3/t10-,11-,13+,15+,16+,17+,18+,19+,20-/m0/s1	WBBVXGHSWZIJST-RLQYZCPESA-N					removed another duplicate entry; compound annotation
0391_000183	mafenide	C7H10N2O2S	1.897	3998		NCc1ccc(S(N)(=O)=O)cc1	InChI=1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)	TYMRLRRVMHJFTF-UHFFFAOYSA-N					compound annotation
0391_000184	5041-82-7	C22H22O12	2.0803	5318645	COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1c(O)ccc(-c2c(OC3OC(CO)C(O)C(O)C3O)c(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C22H22O12/c1-31-12-4-8(2-3-10(12)25)20-21(17(28)15-11(26)5-9(24)6-13(15)32-20)34-22-19(30)18(29)16(27)14(7-23)33-22/h2-6,14,16,18-19,22-27,29-30H,7H2,1H3/t14-,16-,18+,19-,22+/m1/s1	CQLRUIIRRZYHHS-LFXZADKFSA-N					removed another duplicate entry; compound annotation
0391_000186	Levobupivacaine	C18H28N2O	2.372	92253	CCCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)/t16-/m0/s1	LEBVLXFERQHONN-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_000188	Genkwanin	C16H12O5	3.7609	5281617		COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1	InChI=1S/C16H12O5/c1-20-11-6-12(18)16-13(19)8-14(21-15(16)7-11)9-2-4-10(17)5-3-9/h2-8,17-18H,1H3	JPMYFOBNRRGFNO-UHFFFAOYSA-N					doublet; compound annotation
0391_000189	Genkwanin	C16H12O5	3.7639	5281617		COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1	InChI=1S/C16H12O5/c1-20-11-6-12(18)16-13(19)8-14(21-15(16)7-11)9-2-4-10(17)5-3-9/h2-8,17-18H,1H3	JPMYFOBNRRGFNO-UHFFFAOYSA-N					doublet; compound annotation
0391_000190	OTILONIUM	C29H43N2O4+	4.5815	72093		CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1	InChI=1S/C29H42N2O4/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3/h12-13,15-20H,5-11,14,21-23H2,1-4H3/p+1	NQHNLNLJPDMBFN-UHFFFAOYSA-O					compound annotation
0391_000191	934162-61-5	C18H17FN4O	1.5719	16666333	C1C[C@H](NC1)C2=CC(=C(C=C2)C3=NC4=C(C=CC=C4N3)C(=O)N)F	NC(=O)c1c2nc(-c3c(F)cc(C4CCCN4)cc3)[nH]c2ccc1	InChI=1S/C18H17FN4O/c19-13-9-10(14-5-2-8-21-14)6-7-11(13)18-22-15-4-1-3-12(17(20)24)16(15)23-18/h1,3-4,6-7,9,14,21H,2,5,8H2,(H2,20,24)(H,22,23)/t14-/m0/s1	AHIVQGOUBLVTCB-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_000193	SKL2001	C14H14N4O3	1.703	16003447		O=C(NCCCn1ccnc1)c1noc(-c2ccco2)c1	InChI=1S/C14H14N4O3/c19-14(16-4-2-6-18-7-5-15-10-18)11-9-13(21-17-11)12-3-1-8-20-12/h1,3,5,7-10H,2,4,6H2,(H,16,19)	PQXINDBPUDNMPE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000195	YKL-5-124	C28H33N7O3	2.4362	121443990	CC1(C2=C(CN1C(=O)N[C@H](CN(C)C)C3=CC=CC=C3)C(=NN2)NC(=O)C4=CC=C(C=C4)NC(=O)C=C)C	C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)NC(CN(C)C)c2ccccc2)C3(C)C)cc1	InChI=1S/C28H33N7O3/c1-6-23(36)29-20-14-12-19(13-15-20)26(37)31-25-21-16-35(28(2,3)24(21)32-33-25)27(38)30-22(17-34(4)5)18-10-8-7-9-11-18/h6-15,22H,1,16-17H2,2-5H3,(H,29,36)(H,30,38)(H2,31,32,33,37)/t22-/m1/s1	KPABJHHKKJIDGX-JOCHJYFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_000197	YKL-5-124	C28H33N7O3	2.6031	121443990	CC1(C2=C(CN1C(=O)N[C@H](CN(C)C)C3=CC=CC=C3)C(=NN2)NC(=O)C4=CC=C(C=C4)NC(=O)C=C)C	C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)NC(CN(C)C)c2ccccc2)C3(C)C)cc1	InChI=1S/C28H33N7O3/c1-6-23(36)29-20-14-12-19(13-15-20)26(37)31-25-21-16-35(28(2,3)24(21)32-33-25)27(38)30-22(17-34(4)5)18-10-8-7-9-11-18/h6-15,22H,1,16-17H2,2-5H3,(H,29,36)(H,30,38)(H2,31,32,33,37)/t22-/m1/s1	KPABJHHKKJIDGX-JOCHJYFZSA-N					doublet; compound annotation
0391_000198	Ruboxistaurin	C28H28N4O3	2.6569	153999	CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O	CN(C)CC1CCn2cc(C3=C(C(=O)NC3=O)c3cn(CCO1)c1ccccc31)c1ccccc12	InChI=1S/C28H28N4O3/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34)/t18-/m0/s1	ZCBUQCWBWNUWSU-SFHVURJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_000200	Ruboxistaurin	C28H28N4O3	2.6598	153999	CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O	CN(C)CC1CCn2cc(C3=C(C(=O)NC3=O)c3cn(CCO1)c1ccccc31)c1ccccc12	InChI=1S/C28H28N4O3/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34)/t18-/m0/s1	ZCBUQCWBWNUWSU-SFHVURJKSA-N					doublet; compound annotation
0391_000201	YKL-5-124	C28H33N7O3	2.7297	121443990	CC1(C2=C(CN1C(=O)N[C@H](CN(C)C)C3=CC=CC=C3)C(=NN2)NC(=O)C4=CC=C(C=C4)NC(=O)C=C)C	C=CC(=O)Nc1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)NC(CN(C)C)c2ccccc2)C3(C)C)cc1	InChI=1S/C28H33N7O3/c1-6-23(36)29-20-14-12-19(13-15-20)26(37)31-25-21-16-35(28(2,3)24(21)32-33-25)27(38)30-22(17-34(4)5)18-10-8-7-9-11-18/h6-15,22H,1,16-17H2,2-5H3,(H,29,36)(H,30,38)(H2,31,32,33,37)/t22-/m1/s1	KPABJHHKKJIDGX-JOCHJYFZSA-N					doublet; compound annotation
0391_000202	440122-66-7	C13H8BrNO3	3.359	135418373		Oc1ccc(-c2nc3c(o2)c(Br)cc(O)c3)cc1	InChI=1S/C13H8BrNO3/c14-10-5-9(17)6-11-12(10)18-13(15-11)7-1-3-8(16)4-2-7/h1-6,16-17H	BAAILVWEAXFTSF-UHFFFAOYSA-N					compound annotation
0391_000203	NQ301	C18H12ClNO3	3.9132	781109		CC(=O)c1ccc(NC2=C(Cl)C(=O)c3ccccc3C2=O)cc1	InChI=1S/C18H12ClNO3/c1-10(21)11-6-8-12(9-7-11)20-16-15(19)17(22)13-4-2-3-5-14(13)18(16)23/h2-9,20H,1H3	LSQZKIQSQHZVQS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000205	148451-96-1	C22H18F6N2O3	4.6778	132837	CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F	CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1	InChI=1S/C22H18F6N2O3/c1-12(31)30-19(8-14-10-29-18-5-3-2-4-17(14)18)20(32)33-11-13-6-15(21(23,24)25)9-16(7-13)22(26,27)28/h2-7,9-10,19,29H,8,11H2,1H3,(H,30,31)/t19-/m0/s1	BYYQYXVAWXAYQC-IBGZPJMESA-N					compound annotation
0391_000206	Nrf2-IN-1	C21H22ClN3O2	5.1482	76900951		CC(C)(C)c1ccc(Cn2nc(-c3ccc(Cl)cc3)cc2C(=O)NO)cc1	InChI=1S/C21H22ClN3O2/c1-21(2,3)16-8-4-14(5-9-16)13-25-19(20(26)24-27)12-18(23-25)15-6-10-17(22)11-7-15/h4-12,27H,13H2,1-3H3,(H,24,26)	ZFDMUUNGVLREEC-UHFFFAOYSA-N					compound annotation
0391_000207	1,1'-diheptyl-4,4'-bipyridinium	C24H38N2+2	2.6028	80263		CCCCCCC[n+]1ccc(-c2cc[n+](CCCCCCC)cc2)cc1	InChI=1S/C24H38N2/c1-3-5-7-9-11-17-25-19-13-23(14-20-25)24-15-21-26(22-16-24)18-12-10-8-6-4-2/h13-16,19-22H,3-12,17-18H2,1-2H3/q+2	XJGZGUSMZSXHJI-UHFFFAOYSA-N					compound annotation
0391_000208	IFN alpha-IFNAR-IN-1	C18H17NS	3.0941	826634		CNCc1ccccc1Sc1cccc2ccccc12	InChI=1S/C18H17NS/c1-19-13-15-8-3-5-11-17(15)20-18-12-6-9-14-7-2-4-10-16(14)18/h2-12,19H,13H2,1H3	OHDXDNUPVVYWOV-UHFFFAOYSA-N					compound annotation
0391_000209	GSK-7975A	C18H12F5N3O2	3.7072	59547990		O=C(Nc1nn(Cc2c(C(F)(F)F)cc(O)cc2)cc1)c1c(F)cccc1F	InChI=1S/C18H12F5N3O2/c19-13-2-1-3-14(20)16(13)17(28)24-15-6-7-26(25-15)9-10-4-5-11(27)8-12(10)18(21,22)23/h1-8,27H,9H2,(H,24,25,28)	CPYTVBALBFSXSH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000211	NBI-74330	C32H27F4N5O3	3.746	45784923	CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F	CCOc1ccc(-n2c(C(C)N(Cc3cnccc3)C(=O)Cc3cc(C(F)(F)F)c(F)cc3)nc3c(cccn3)c2=O)cc1	InChI=1S/C32H27F4N5O3/c1-3-44-24-11-9-23(10-12-24)41-30(39-29-25(31(41)43)7-5-15-38-29)20(2)40(19-22-6-4-14-37-18-22)28(42)17-21-8-13-27(33)26(16-21)32(34,35)36/h4-16,18,20H,3,17,19H2,1-2H3/t20-/m1/s1	XMRGQUDUVGRCBS-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_000213	GSK-7975A	C18H12F5N3O2	3.7693	59547990		O=C(Nc1nn(Cc2c(C(F)(F)F)cc(O)cc2)cc1)c1c(F)cccc1F	InChI=1S/C18H12F5N3O2/c19-13-2-1-3-14(20)16(13)17(28)24-15-6-7-26(25-15)9-10-4-5-11(27)8-12(10)18(21,22)23/h1-8,27H,9H2,(H,24,25,28)	CPYTVBALBFSXSH-UHFFFAOYSA-N					doublet; compound annotation
0391_000214	IRAK inhibitor 4	C33H35F3N6O3	3.8684	24797387		CC(C)CCNC(=O)c1cc2c(cc1)n(C1CCC(O)CC1)c(Nc1n[nH]c3c1cc(-c1ccccc1OC(F)(F)F)cc3)n2	InChI=1S/C33H35F3N6O3/c1-19(2)15-16-37-31(44)21-8-14-28-27(18-21)38-32(42(28)22-9-11-23(43)12-10-22)39-30-25-17-20(7-13-26(25)40-41-30)24-5-3-4-6-29(24)45-33(34,35)36/h3-8,13-14,17-19,22-23,43H,9-12,15-16H2,1-2H3,(H,37,44)(H2,38,39,40,41)	QZMAOGLWCNTFCG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000216	NMS-873	C27H28N4O3S2	4.1056	71521142		Cc1c(-c2ccc(S(C)(=O)=O)cc2)ccc(OCc2nnc(SC3CCCC3)n2-c2cnccc2)c1	InChI=1S/C27H28N4O3S2/c1-19-16-22(11-14-25(19)20-9-12-24(13-10-20)36(2,32)33)34-18-26-29-30-27(35-23-7-3-4-8-23)31(26)21-6-5-15-28-17-21/h5-6,9-17,23H,3-4,7-8,18H2,1-2H3	UJGTUKMAJVCBIS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000218	S1P1 Agonist III	C21H16F3N3O3	4.2262	54764919		COc1c(C(=O)NC(=O)Nc2cc(C(F)(F)F)c(-c3ccccc3)cc2)cncc1	InChI=1S/C21H16F3N3O3/c1-30-18-9-10-25-12-16(18)19(28)27-20(29)26-14-7-8-15(13-5-3-2-4-6-13)17(11-14)21(22,23)24/h2-12H,1H3,(H2,26,27,28,29)	MLDQTQOMWDNTNN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000220	856243-80-6	C19H18BrN3O	4.5804	11222830	CCC[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CCCC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C19H18BrN3O/c1-2-7-17(14-8-4-3-5-9-14)23-19(24)15(13-21)12-16-10-6-11-18(20)22-16/h3-6,8-12,17H,2,7H2,1H3,(H,23,24)/b15-12+/t17-/m0/s1	LIDOPKHSVQTSJY-VMEIHUARSA-N					doublet; compound annotation
0391_000221	856243-80-6	C19H18BrN3O	4.6343	11222830	CCC[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CCCC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C19H18BrN3O/c1-2-7-17(14-8-4-3-5-9-14)23-19(24)15(13-21)12-16-10-6-11-18(20)22-16/h3-6,8-12,17H,2,7H2,1H3,(H,23,24)/b15-12+/t17-/m0/s1	LIDOPKHSVQTSJY-VMEIHUARSA-N					doublet; removed another duplicate entry; compound annotation
0391_000223	PHT-7.3	C24H23N3O3S	4.7127	76287542		Cc1ccc(-c2csc(Cn3nc(CC4OCCCO4)c4ccccc4c3=O)n2)cc1	InChI=1S/C24H23N3O3S/c1-16-7-9-17(10-8-16)21-15-31-22(25-21)14-27-24(28)19-6-3-2-5-18(19)20(26-27)13-23-29-11-4-12-30-23/h2-3,5-10,15,23H,4,11-14H2,1H3	AFPMVLVIYVAFSP-UHFFFAOYSA-N					doublet; compound annotation
0391_000224	PHT-7.3	C24H23N3O3S	4.7165	76287542		Cc1ccc(-c2csc(Cn3nc(CC4OCCCO4)c4ccccc4c3=O)n2)cc1	InChI=1S/C24H23N3O3S/c1-16-7-9-17(10-8-16)21-15-31-22(25-21)14-27-24(28)19-6-3-2-5-18(19)20(26-27)13-23-29-11-4-12-30-23/h2-3,5-10,15,23H,4,11-14H2,1H3	AFPMVLVIYVAFSP-UHFFFAOYSA-N					doublet; compound annotation
0391_000225	856243-80-6	C19H18BrN3O	4.8244	11222830	CCC[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CCCC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C19H18BrN3O/c1-2-7-17(14-8-4-3-5-9-14)23-19(24)15(13-21)12-16-10-6-11-18(20)22-16/h3-6,8-12,17H,2,7H2,1H3,(H,23,24)/b15-12+/t17-/m0/s1	LIDOPKHSVQTSJY-VMEIHUARSA-N					doublet; removed another duplicate entry; compound annotation
0391_000227	NBI-74330	C32H27F4N5O3	7.162	45784923	CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F	CCOc1ccc(-n2c(C(C)N(Cc3cnccc3)C(=O)Cc3cc(C(F)(F)F)c(F)cc3)nc3c(cccn3)c2=O)cc1	InChI=1S/C32H27F4N5O3/c1-3-44-24-11-9-23(10-12-24)41-30(39-29-25(31(41)43)7-5-15-38-29)20(2)40(19-22-6-4-14-37-18-22)28(42)17-21-8-13-27(33)26(16-21)32(34,35)36/h4-16,18,20H,3,17,19H2,1-2H3/t20-/m1/s1	XMRGQUDUVGRCBS-HXUWFJFHSA-N					doublet; compound annotation
0391_000228	CCT128930	C18H20ClN5	1.6663	17751819		NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3c2cc[nH]3)CC1	InChI=1S/C18H20ClN5/c19-14-3-1-13(2-4-14)11-18(20)6-9-24(10-7-18)17-15-5-8-21-16(15)22-12-23-17/h1-5,8,12H,6-7,9-11,20H2,(H,21,22,23)	RZIDZIGAXXNODG-UHFFFAOYSA-N					compound annotation
0391_000229	IRAK inhibitor 2	C17H14N4O2	2.1457	135900142		Oc1ccc(-c2cnc3ccc(NCc4ccco4)nn23)cc1	InChI=1S/C17H14N4O2/c22-13-5-3-12(4-6-13)15-11-19-17-8-7-16(20-21(15)17)18-10-14-2-1-9-23-14/h1-9,11,22H,10H2,(H,18,20)	OPKXXSDVMPBIOF-UHFFFAOYSA-N					compound annotation
0391_000230	ABT-751	C18H17N3O4S	2.1714	3035714		COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1	InChI=1S/C18H17N3O4S/c1-25-15-8-10-16(11-9-15)26(23,24)21-17-3-2-12-19-18(17)20-13-4-6-14(22)7-5-13/h2-12,21-22H,1H3,(H,19,20)	URCVCIZFVQDVPM-UHFFFAOYSA-N					compound annotation
0391_000231	MPI-0479605	C22H29N7O	2.8942	46909588		Cc1c(Nc2nc3c([nH]cn3)c(NC3CCCCC3)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H29N7O/c1-15-13-17(29-9-11-30-12-10-29)7-8-18(15)26-22-27-20-19(23-14-24-20)21(28-22)25-16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H3,23,24,25,26,27,28)	OVJBNYKNHXJGSA-UHFFFAOYSA-N					doublet; compound annotation
0391_000232	MPI-0479605	C22H29N7O	2.897	46909588		Cc1c(Nc2nc3c([nH]cn3)c(NC3CCCCC3)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H29N7O/c1-15-13-17(29-9-11-30-12-10-29)7-8-18(15)26-22-27-20-19(23-14-24-20)21(28-22)25-16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H3,23,24,25,26,27,28)	OVJBNYKNHXJGSA-UHFFFAOYSA-N					doublet; compound annotation
0391_000233	PF-06380101	C39H62N6O6S	3.1855	71569947	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)C(C)(C)N	CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(Cc1ccccc1)c1nccs1)OC)N(C)C(=O)C(NC(=O)C(C)(C)N)C(C)C	InChI=1S/C39H62N6O6S/c1-11-25(4)33(44(8)37(48)32(24(2)3)43-38(49)39(6,7)40)30(50-9)23-31(46)45-20-15-18-29(45)34(51-10)26(5)35(47)42-28(36-41-19-21-52-36)22-27-16-13-12-14-17-27/h12-14,16-17,19,21,24-26,28-30,32-34H,11,15,18,20,22-23,40H2,1-10H3,(H,42,47)(H,43,49)/t25-,26+,28-,29-,30+,32-,33-,34+/m0/s1	QAAFNSMAIAVCHE-BZLYQNAUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000235	PF-06380101	C39H62N6O6S	3.3701	71569947	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)C(C)(C)N	CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(Cc1ccccc1)c1nccs1)OC)N(C)C(=O)C(NC(=O)C(C)(C)N)C(C)C	InChI=1S/C39H62N6O6S/c1-11-25(4)33(44(8)37(48)32(24(2)3)43-38(49)39(6,7)40)30(50-9)23-31(46)45-20-15-18-29(45)34(51-10)26(5)35(47)42-28(36-41-19-21-52-36)22-27-16-13-12-14-17-27/h12-14,16-17,19,21,24-26,28-30,32-34H,11,15,18,20,22-23,40H2,1-10H3,(H,42,47)(H,43,49)/t25-,26+,28-,29-,30+,32-,33-,34+/m0/s1	QAAFNSMAIAVCHE-BZLYQNAUSA-N					doublet; compound annotation
0391_000236	1260907-17-2	C22H22ClN5O2	3.3728	46943432	CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C	CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(ccc(OC)c2)-n2c(C)nnc12	InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1	AAAQFGUYHFJNHI-SFHVURJKSA-N					doublet; compound annotation
0391_000237	1260907-17-2	C22H22ClN5O2	3.3776	46943432	CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C	CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(ccc(OC)c2)-n2c(C)nnc12	InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1	AAAQFGUYHFJNHI-SFHVURJKSA-N					doublet; compound annotation
0391_000238	PH-797804	C22H19BrF2N2O3	3.6923	22049997		CNC(=O)c1cc(-n2c(C)cc(OCc3c(F)cc(F)cc3)c(Br)c2=O)c(C)cc1	InChI=1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28)	KCAJXIDMCNPGHZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000240	WP1066	C17H14BrN3O	3.9213	11210478	C[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1	VFUAJMPDXIRPKO-LQELWAHVSA-N					doublet; compound annotation
0391_000241	WP1066	C17H14BrN3O	3.9722	11210478	C[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1	VFUAJMPDXIRPKO-LQELWAHVSA-N					doublet; compound annotation
0391_000242	WP1066	C17H14BrN3O	4.0286	11210478	C[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1	VFUAJMPDXIRPKO-LQELWAHVSA-N					doublet; removed another duplicate entry; compound annotation
0391_000244	WP1066	C17H14BrN3O	4.2112	11210478	C[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N	CC(NC(=O)C(C#N)=Cc1nc(Br)ccc1)c1ccccc1	InChI=1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1	VFUAJMPDXIRPKO-LQELWAHVSA-N					doublet; removed another duplicate entry; compound annotation
0391_000246	alpha-Naphthoflavone	C19H12O2	4.6157	11790		O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12	InChI=1S/C19H12O2/c20-17-12-18(14-7-2-1-3-8-14)21-19-15-9-5-4-6-13(15)10-11-16(17)19/h1-12H	VFMMPHCGEFXGIP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000248	alpha-Naphthoflavone	C19H12O2	4.619	11790		O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12	InChI=1S/C19H12O2/c20-17-12-18(14-7-2-1-3-8-14)21-19-15-9-5-4-6-13(15)10-11-16(17)19/h1-12H	VFMMPHCGEFXGIP-UHFFFAOYSA-N					doublet; compound annotation
0391_000249	690206-97-4	C16H13ClFN3O2	2.5395	5329006		COc1c(OC)cc2c(Nc3c(F)cc(Cl)cc3)ncnc2c1	InChI=1S/C16H13ClFN3O2/c1-22-14-6-10-13(7-15(14)23-2)19-8-20-16(10)21-12-4-3-9(17)5-11(12)18/h3-8H,1-2H3,(H,19,20,21)	YHUIUSRCUKUUQA-UHFFFAOYSA-N					compound annotation
0391_000250	TAS4464	C21H23FN6O6S	2.5926	124121703	CCOC1=C(C(=CC=C1)F)C#CC2=CN(C3=NC=NC(=C23)N)[C@H]4[C@@H]([C@@H]([C@H](O4)CNS(=O)(=O)N)O)O	CCOc1c(C#Cc2cn(C3OC(CNS(N)(=O)=O)C(O)C3O)c3ncnc(N)c23)c(F)ccc1	InChI=1S/C21H23FN6O6S/c1-2-33-14-5-3-4-13(22)12(14)7-6-11-9-28(20-16(11)19(23)25-10-26-20)21-18(30)17(29)15(34-21)8-27-35(24,31)32/h3-5,9-10,15,17-18,21,27,29-30H,2,8H2,1H3,(H2,23,25,26)(H2,24,31,32)/t15-,17-,18-,21-/m1/s1	TZTRUHFXPVXWRD-QTQZEZTPSA-N					doublet; removed another duplicate entry; compound annotation
0391_000252	PK68	C22H24N4O3S	3.2389	134203923		CC(=O)Nc1nc2c(cc(-c3cc(NC(=O)OC4CCCCC4)c(C)nc3)cc2)s1	InChI=1S/C22H24N4O3S/c1-13-19(26-22(28)29-17-6-4-3-5-7-17)10-16(12-23-13)15-8-9-18-20(11-15)30-21(25-18)24-14(2)27/h8-12,17H,3-7H2,1-2H3,(H,26,28)(H,24,25,27)	DRCNWQYEKZTTEW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000254	Agomelatine	C15H17NO2	3.2687	82148		COc1cc2c(cccc2CCNC(C)=O)cc1	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	YJYPHIXNFHFHND-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000256	methiothepin	C20H24N2S2	3.5099	4106		CSc1cc2c(cc1)Sc1ccccc1CC2N1CCN(C)CC1	InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3	RLJFTICUTYVZDG-UHFFFAOYSA-N					compound annotation
0391_000257	172889-26-8	C16H19N5	3.5765	1400		Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1	InChI=1S/C16H19N5/c1-10-5-7-11(8-6-10)13-12-14(17)18-9-19-15(12)21(20-13)16(2,3)4/h5-9H,1-4H3,(H2,17,18,19)	ZVPDNRVYHLRXLX-UHFFFAOYSA-N					compound annotation
0391_000258	CCT196969	C27H24FN7O3	3.9316	42628843		CC(C)(C)c1nn(-c2ccccc2)c(NC(=O)Nc2c(F)cc(Oc3c4ncc(=O)[nH]c4ncc3)cc2)c1	InChI=1S/C27H24FN7O3/c1-27(2,3)21-14-22(35(34-21)16-7-5-4-6-8-16)32-26(37)31-19-10-9-17(13-18(19)28)38-20-11-12-29-25-24(20)30-15-23(36)33-25/h4-15H,1-3H3,(H,29,33,36)(H2,31,32,37)	KYYKGSDLXXKQCR-UHFFFAOYSA-N					compound annotation
0391_000259	Emapunil	C23H23N5O2	4.215	6433109		CCN(Cc1ccccc1)C(=O)Cn1c(=O)n(C)c2cnc(-c3ccccc3)nc21	InChI=1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3	NBMBIEOUVBHEBM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000261	terutroban	C20H22ClNO4S	4.2432	9938840	CC1=C(C2=C(C[C@@H](CC2)NS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1)CCC(=O)O	Cc1c(CCC(=O)O)c2c(cc1)CC(NS(=O)(=O)c1ccc(Cl)cc1)CC2	InChI=1S/C20H22ClNO4S/c1-13-2-3-14-12-16(6-9-19(14)18(13)10-11-20(23)24)22-27(25,26)17-7-4-15(21)5-8-17/h2-5,7-8,16,22H,6,9-12H2,1H3,(H,23,24)/t16-/m1/s1	HWEOXFSBSQIWSY-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_000263	Ketone Ester	C8H16O4	1.2497	44631890	C[C@H](CCOC(=O)C[C@@H](C)O)O	CC(O)CCOC(=O)CC(C)O	InChI=1S/C8H16O4/c1-6(9)3-4-12-8(11)5-7(2)10/h6-7,9-10H,3-5H2,1-2H3/t6-,7-/m1/s1	AOWPVIWVMWUSBD-RNFRBKRXSA-N					doublet; compound annotation
0391_000264	Ketone Ester	C8H16O4	1.3444	44631890	C[C@H](CCOC(=O)C[C@@H](C)O)O	CC(O)CCOC(=O)CC(C)O	InChI=1S/C8H16O4/c1-6(9)3-4-12-8(11)5-7(2)10/h6-7,9-10H,3-5H2,1-2H3/t6-,7-/m1/s1	AOWPVIWVMWUSBD-RNFRBKRXSA-N					doublet; compound annotation
0391_000265	ONO-8590580	C21H21FN6	1.5298	118278442		Cc1c(F)c(Nc2ncc(-c3cn(C)cn3)cc2)cc2c1ncn2CC1CC1	InChI=1S/C21H21FN6/c1-13-20(22)16(7-18-21(13)25-12-28(18)9-14-3-4-14)26-19-6-5-15(8-23-19)17-10-27(2)11-24-17/h5-8,10-12,14H,3-4,9H2,1-2H3,(H,23,26)	INGJMHPGMVUEKY-UHFFFAOYSA-N					doublet; compound annotation
0391_000266	ONO-8590580	C21H21FN6	1.533	118278442		Cc1c(F)c(Nc2ncc(-c3cn(C)cn3)cc2)cc2c1ncn2CC1CC1	InChI=1S/C21H21FN6/c1-13-20(22)16(7-18-21(13)25-12-28(18)9-14-3-4-14)26-19-6-5-15(8-23-19)17-10-27(2)11-24-17/h5-8,10-12,14H,3-4,9H2,1-2H3,(H,23,26)	INGJMHPGMVUEKY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000268	MEK inhibitor	C26H26N4O2	2.2228	135742497		CNC(=O)c1cc2c(cc1)c(C(=Nc1cccc(CN(C)C)c1)c1ccccc1)c(O)[nH]2	InChI=1S/C26H26N4O2/c1-27-25(31)19-12-13-21-22(15-19)29-26(32)23(21)24(18-9-5-4-6-10-18)28-20-11-7-8-17(14-20)16-30(2)3/h4-15,29,32H,16H2,1-3H3,(H,27,31)	UPICVLXBXZXYIE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000270	NG25	C29H30F3N5O2	2.8647	53340664		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(Oc4c5cc[nH]c5ncc4)c(C)cc3)cc2)CC1	InChI=1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38)	SMPGEBOIKULBCT-UHFFFAOYSA-N					compound annotation
0391_000271	scriptaid	C18H18N2O4	2.8959	5186		O=C(CCCCCN1C(=O)c2cccc3cccc(c23)C1=O)NO	InChI=1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9,24H,1-3,10-11H2,(H,19,21)	JTDYUFSDZATMKU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000273	OXYPHENISATIN ACETATE	C24H19NO5	4.0699	8269		CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1	InChI=1S/C24H19NO5/c1-15(26)29-19-11-7-17(8-12-19)24(18-9-13-20(14-10-18)30-16(2)27)21-5-3-4-6-22(21)25-23(24)28/h3-14H,1-2H3,(H,25,28)	PHPUXYRXPHEJDF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000275	BMS-986205	C24H24ClFN2O	4.2032	121328278	C[C@H](C1CCC(CC1)C2=C3C=C(C=CC3=NC=C2)F)C(=O)NC4=CC=C(C=C4)Cl	CC(C(=O)Nc1ccc(Cl)cc1)C1CCC(c2ccnc3ccc(F)cc23)CC1	InChI=1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1	KRTIYQIPSAGSBP-KLAILNCOSA-N					compound annotation
0391_000276	DOTAP	C42H80NO4+	7.2251	6437371	CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC	CCCCCCCCC=CCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC	InChI=1S/C42H80NO4/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-41(44)46-39-40(38-43(3,4)5)47-42(45)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h20-23,40H,6-19,24-39H2,1-5H3/q+1/b22-20-,23-21-	KWVJHCQQUFDPLU-YEUCEMRASA-N					compound annotation
0391_000277	RR6	C16H23NO4	2.4948	54754611	CC(C)(CO)[C@H](C(=O)NCCC(=O)CC1=CC=CC=C1)O	CC(C)(CO)C(O)C(=O)NCCC(=O)Cc1ccccc1	InChI=1S/C16H23NO4/c1-16(2,11-18)14(20)15(21)17-9-8-13(19)10-12-6-4-3-5-7-12/h3-7,14,18,20H,8-11H2,1-2H3,(H,17,21)/t14-/m0/s1	PTVUGLNOPRZQEY-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_000279	SPHINX31	C27H24F3N5O2	2.5066	91972002		O=C(Nc1cc(C(F)(F)F)ccc1N1CCN(Cc2ccccn2)CC1)c1ccc(-c2ccncc2)o1	InChI=1S/C27H24F3N5O2/c28-27(29,30)20-4-5-23(35-15-13-34(14-16-35)18-21-3-1-2-10-32-21)22(17-20)33-26(36)25-7-6-24(37-25)19-8-11-31-12-9-19/h1-12,17H,13-16,18H2,(H,33,36)	VURLRACCOCGFDB-UHFFFAOYSA-N					doublet; compound annotation
0391_000280	SPHINX31	C27H24F3N5O2	2.5114	91972002		O=C(Nc1cc(C(F)(F)F)ccc1N1CCN(Cc2ccccn2)CC1)c1ccc(-c2ccncc2)o1	InChI=1S/C27H24F3N5O2/c28-27(29,30)20-4-5-23(35-15-13-34(14-16-35)18-21-3-1-2-10-32-21)22(17-20)33-26(36)25-7-6-24(37-25)19-8-11-31-12-9-19/h1-12,17H,13-16,18H2,(H,33,36)	VURLRACCOCGFDB-UHFFFAOYSA-N					doublet; compound annotation
0391_000281	164658-13-3	C18H18ClN5O	2.7562	644215		OCCCNc1nccc(-c2nc(Nc3cc(Cl)ccc3)ncc2)c1	InChI=1S/C18H18ClN5O/c19-14-3-1-4-15(12-14)23-18-22-9-6-16(24-18)13-5-8-21-17(11-13)20-7-2-10-25/h1,3-6,8-9,11-12,25H,2,7,10H2,(H,20,21)(H,22,23,24)	IYNDTACKOAXKBJ-UHFFFAOYSA-N					compound annotation
0391_000282	488793-85-7	C27H20N4O2	2.8623	1386351		O=C(Nc1ccccc1)c1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1	InChI=1S/C27H20N4O2/c32-22-16-12-18(13-17-22)25-23-8-4-5-9-24(23)26(31-30-25)28-21-14-10-19(11-15-21)27(33)29-20-6-2-1-3-7-20/h1-17,32H,(H,28,31)(H,29,33)	UPKNGUQNXSMHBE-UHFFFAOYSA-N					doublet; compound annotation
0391_000283	488793-85-7	C27H20N4O2	2.8655	1386351		O=C(Nc1ccccc1)c1ccc(Nc2nnc(-c3ccc(O)cc3)c3ccccc23)cc1	InChI=1S/C27H20N4O2/c32-22-16-12-18(13-17-22)25-23-8-4-5-9-24(23)26(31-30-25)28-21-14-10-19(11-15-21)27(33)29-20-6-2-1-3-7-20/h1-17,32H,(H,28,31)(H,29,33)	UPKNGUQNXSMHBE-UHFFFAOYSA-N					doublet; compound annotation
0391_000284	BIBF0775	C31H34N4O2	2.8703	135837779		CCN(C)C(=O)c1cc2c(cc1)c(C(=Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)c(O)[nH]2	InChI=1S/C31H34N4O2/c1-3-34(2)31(37)24-14-17-26-27(20-24)33-30(36)28(26)29(23-10-6-4-7-11-23)32-25-15-12-22(13-16-25)21-35-18-8-5-9-19-35/h4,6-7,10-17,20,33,36H,3,5,8-9,18-19,21H2,1-2H3	JGQSLTZPBLZNBX-UHFFFAOYSA-N					compound annotation
0391_000285	tolterodine	C22H31NO	3.0732	443879	CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2	Cc1cc(C(CCN(C(C)C)C(C)C)c2ccccc2)c(O)cc1	InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1	OOGJQPCLVADCPB-HXUWFJFHSA-N					doublet; compound annotation
0391_000286	THPP-1	C23H21ClN6O3	3.9137	49821991		COCCOc1nc(-c2cnc(Cl)cc2)nc2c1CN(C(=O)c1c3ccccn3cn1)CC2	InChI=1S/C23H21ClN6O3/c1-32-10-11-33-22-16-13-29(23(31)20-18-4-2-3-8-30(18)14-26-20)9-7-17(16)27-21(28-22)15-5-6-19(24)25-12-15/h2-6,8,12,14H,7,9-11,13H2,1H3	JBHLOPKIPKTRSU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000288	Mirk-IN-1	C23H17Cl2N5O4	3.9695	57523919		COc1ncc2cc(C(=O)Nc3c(Cl)ccc(C(=O)NCc4cc(Cl)ccc4)c3)c(=O)[nH]c2n1	InChI=1S/C23H17Cl2N5O4/c1-34-23-27-11-14-8-16(22(33)29-19(14)30-23)21(32)28-18-9-13(5-6-17(18)25)20(31)26-10-12-3-2-4-15(24)7-12/h2-9,11H,10H2,1H3,(H,26,31)(H,28,32)(H,27,29,30,33)	CQKBSRPVZZLCJE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000290	I-191	C23H26FN5O2	4.5476	117977934		CC(C)(C)c1cc(-c2ccc(F)cc2)nn2cc(C(=O)N3CCNC(=O)C3(C)C)nc12	InChI=1S/C23H26FN5O2/c1-22(2,3)16-12-17(14-6-8-15(24)9-7-14)27-29-13-18(26-19(16)29)20(30)28-11-10-25-21(31)23(28,4)5/h6-9,12-13H,10-11H2,1-5H3,(H,25,31)	DTASTQAQBOZSRR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000292	cc-223	C21H27N5O3	2.1673	58298316		COC1CCC(N2C(=O)CNc3ncc(-c4cnc(C(C)(C)O)cc4)nc32)CC1	InChI=1S/C21H27N5O3/c1-21(2,28)17-9-4-13(10-22-17)16-11-23-19-20(25-16)26(18(27)12-24-19)14-5-7-15(29-3)8-6-14/h4,9-11,14-15,28H,5-8,12H2,1-3H3,(H,23,24)	UFKLYTOEMRFKAD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000294	butein	C15H12O5	2.1722	5281222	C1=CC(=C(C=C1/C=C/C(=O)C2=C(C=C(C=C2)O)O)O)O	O=C(C=Cc1cc(O)c(O)cc1)c1c(O)cc(O)cc1	InChI=1S/C15H12O5/c16-10-3-4-11(14(19)8-10)12(17)5-1-9-2-6-13(18)15(20)7-9/h1-8,16,18-20H/b5-1+	AYMYWHCQALZEGT-ORCRQEGFSA-N					compound annotation
0391_000295	CNX-2006	C26H27F4N7O2	2.3536	56968072		C=CC(=O)Nc1cccc(Nc2nc(Nc3c(OC)cc(NC4CN(CCF)C4)cc3)ncc2C(F)(F)F)c1	InChI=1S/C26H27F4N7O2/c1-3-23(38)33-16-5-4-6-17(11-16)34-24-20(26(28,29)30)13-31-25(36-24)35-21-8-7-18(12-22(21)39-2)32-19-14-37(15-19)10-9-27/h3-8,11-13,19,32H,1,9-10,14-15H2,2H3,(H,33,38)(H2,31,34,35,36)	BFSRTTWIPACGMI-UHFFFAOYSA-N					doublet; compound annotation
0391_000296	CNX-2006	C26H27F4N7O2	2.4784	56968072		C=CC(=O)Nc1cccc(Nc2nc(Nc3c(OC)cc(NC4CN(CCF)C4)cc3)ncc2C(F)(F)F)c1	InChI=1S/C26H27F4N7O2/c1-3-23(38)33-16-5-4-6-17(11-16)34-24-20(26(28,29)30)13-31-25(36-24)35-21-8-7-18(12-22(21)39-2)32-19-14-37(15-19)10-9-27/h3-8,11-13,19,32H,1,9-10,14-15H2,2H3,(H,33,38)(H2,31,34,35,36)	BFSRTTWIPACGMI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000299	tirofiban	C22H36N2O5S	2.6685	40466968	CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CC[NH2+]CC2)C(=O)[O-]	CCCCS(=O)(=O)NC(Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O	InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1	COKMIXFXJJXBQG-NRFANRHFSA-N					compound annotation
0391_000300	PND-1186	C25H26F3N5O3	2.7899	25073775		CNC(=O)c1ccccc1Nc1cc(Nc2c(OC)cc(N3CCOCC3)cc2)ncc1C(F)(F)F	InChI=1S/C25H26F3N5O3/c1-29-24(34)17-5-3-4-6-19(17)31-21-14-23(30-15-18(21)25(26,27)28)32-20-8-7-16(13-22(20)35-2)33-9-11-36-12-10-33/h3-8,13-15H,9-12H2,1-2H3,(H,29,34)(H2,30,31,32)	IGUBBWJDMLCRIK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000302	Zenidolol	C17H27NO2	2.9518	104824	CC1=C2CCCC2=C(C=C1)OC[C@@H]([C@@H](C)NC(C)C)O	Cc1c2CCCc2c(OCC(O)C(C)NC(C)C)cc1	InChI=1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3/t13-,16+/m1/s1	VFIDUCMKNJIJTO-CJNGLKHVSA-N					compound annotation
0391_000303	Udenafil	C25H36N6O4S	2.9793	135413547		CCCOc1c(-c2nc(=O)c3c([nH]2)c(CCC)nn3C)cc(S(=O)(=O)NCCC2CCCN2C)cc1	InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)	IYFNEFQTYQPVOC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000305	Retapamulin	C30H47NO4S	3.1494	6918462	C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C	C=CC1(C)CC(OC(=O)CSC2CC3CCC(C2)N3C)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22?,24-,26+,27+,28-,29+,30+/m1/s1	STZYTFJPGGDRJD-FJJJPKKESA-N					compound annotation
0391_000306	CPDA	C20H15ClF2N2O2	4.0902	71089297		O=C(Cc1c(F)cccc1F)Nc1nccc(OCc2ccc(Cl)cc2)c1	InChI=1S/C20H15ClF2N2O2/c21-14-6-4-13(5-7-14)12-27-15-8-9-24-19(10-15)25-20(26)11-16-17(22)2-1-3-18(16)23/h1-10H,11-12H2,(H,24,25,26)	GISJHCLTIVIGLX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000308	8-Bromotheophylline	C7H7BrN4O2	1.4649	11808		Cn1c(=O)c2c(nc(Br)[nH]2)n(C)c1=O	InChI=1S/C7H7BrN4O2/c1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h1-2H3,(H,9,10)	SKTFQHRVFFOHTQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000310	EPZ011989	C35H51N5O4	1.8022	73670548		CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCC(N(C)CCOC)CC1	InChI=1S/C35H51N5O4/c1-7-40(30-12-10-29(11-13-30)38(5)15-18-43-6)33-23-28(9-8-14-39-16-19-44-20-17-39)22-31(27(33)4)34(41)36-24-32-25(2)21-26(3)37-35(32)42/h21-23,29-30H,7,10-20,24H2,1-6H3,(H,36,41)(H,37,42)	XQFINGFCBFHOPE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000312	Ombrabulin	C21H26N2O6	2.6462	6918405	COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)NC(=O)[C@H](CO)N	COc1c(NC(=O)C(N)CO)cc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1	IXWNTLSTOZFSCM-YVACAVLKSA-N					doublet; compound annotation
0391_000313	Ombrabulin	C21H26N2O6	2.7229	6918405	COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)NC(=O)[C@H](CO)N	COc1c(NC(=O)C(N)CO)cc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1	IXWNTLSTOZFSCM-YVACAVLKSA-N					doublet; compound annotation
0391_000314	Ombrabulin	C21H26N2O6	2.7261	6918405	COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)NC(=O)[C@H](CO)N	COc1c(NC(=O)C(N)CO)cc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1	IXWNTLSTOZFSCM-YVACAVLKSA-N					doublet; removed another duplicate entry; compound annotation
0391_000316	Nexturastat A	C19H23N3O3	3.1985	71462653		CCCCN(Cc1ccc(C(=O)NO)cc1)C(=O)Nc1ccccc1	InChI=1S/C19H23N3O3/c1-2-3-13-22(19(24)20-17-7-5-4-6-8-17)14-15-9-11-16(12-10-15)18(23)21-25/h4-12,25H,2-3,13-14H2,1H3,(H,20,24)(H,21,23)	JZWXMCPARMXZQV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000319	Nodinitib-1	C14H13N3O2S	3.2864	1088438		Cc1ccc(S(=O)(=O)n2c(N)nc3ccccc32)cc1	InChI=1S/C14H13N3O2S/c1-10-6-8-11(9-7-10)20(18,19)17-13-5-3-2-4-12(13)16-14(17)15/h2-9H,1H3,(H2,15,16)	SRFABRWQVPCPRG-UHFFFAOYSA-N					compound annotation
0391_000320	Belizatinib	C33H44FN5O3	3.3333	57345941		CC(C)NC(=O)C1CCC(n2c(NC(=O)c3ccc(F)cc3)nc3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1	InChI=1S/C33H44FN5O3/c1-21(2)35-30(40)24-8-12-27(13-9-24)39-29-19-22(20-38-17-15-25(16-18-38)33(3,4)42)5-14-28(29)36-32(39)37-31(41)23-6-10-26(34)11-7-23/h5-7,10-11,14,19,21,24-25,27,42H,8-9,12-13,15-18,20H2,1-4H3,(H,35,40)(H,36,37,41)	WSTUJEXAPHIEIM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000322	Pifithrin-Beta	C16H16N2S	3.6963	443278		Cc1ccc(-c2cn3c4c(CCCC4)sc3n2)cc1	InChI=1S/C16H16N2S/c1-11-6-8-12(9-7-11)13-10-18-14-4-2-3-5-15(14)19-16(18)17-13/h6-10H,2-5H2,1H3	IMUKUMUNZJILCG-UHFFFAOYSA-N					compound annotation
0391_000323	RO8994	C31H31Cl2FN4O4	4.2356	53238217	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3=C(C=C(C=C3)C(=O)N)OC)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	COc1c(NC(=O)C2NC(CC(C)(C)C)C3(C(=O)Nc4cc(Cl)ccc43)C2c2c(F)c(Cl)ccc2)ccc(C(N)=O)c1	InChI=1S/C31H31Cl2FN4O4/c1-30(2,3)14-23-31(18-10-9-16(32)13-21(18)37-29(31)41)24(17-6-5-7-19(33)25(17)34)26(38-23)28(40)36-20-11-8-15(27(35)39)12-22(20)42-4/h5-13,23-24,26,38H,14H2,1-4H3,(H2,35,39)(H,36,40)(H,37,41)/t23-,24-,26+,31+/m0/s1	MURAVORBGFDSMA-ISKXDESKSA-N					doublet; compound annotation
0391_000324	RO8994	C31H31Cl2FN4O4	4.4922	53238217	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3=C(C=C(C=C3)C(=O)N)OC)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	COc1c(NC(=O)C2NC(CC(C)(C)C)C3(C(=O)Nc4cc(Cl)ccc43)C2c2c(F)c(Cl)ccc2)ccc(C(N)=O)c1	InChI=1S/C31H31Cl2FN4O4/c1-30(2,3)14-23-31(18-10-9-16(32)13-21(18)37-29(31)41)24(17-6-5-7-19(33)25(17)34)26(38-23)28(40)36-20-11-8-15(27(35)39)12-22(20)42-4/h5-13,23-24,26,38H,14H2,1-4H3,(H2,35,39)(H,36,40)(H,37,41)/t23-,24-,26+,31+/m0/s1	MURAVORBGFDSMA-ISKXDESKSA-N					doublet; compound annotation
0391_000325	RO8994	C31H31Cl2FN4O4	4.6511	53238217	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3=C(C=C(C=C3)C(=O)N)OC)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	COc1c(NC(=O)C2NC(CC(C)(C)C)C3(C(=O)Nc4cc(Cl)ccc43)C2c2c(F)c(Cl)ccc2)ccc(C(N)=O)c1	InChI=1S/C31H31Cl2FN4O4/c1-30(2,3)14-23-31(18-10-9-16(32)13-21(18)37-29(31)41)24(17-6-5-7-19(33)25(17)34)26(38-23)28(40)36-20-11-8-15(27(35)39)12-22(20)42-4/h5-13,23-24,26,38H,14H2,1-4H3,(H2,35,39)(H,36,40)(H,37,41)/t23-,24-,26+,31+/m0/s1	MURAVORBGFDSMA-ISKXDESKSA-N					doublet; removed another duplicate entry; compound annotation
0391_000327	Bithionoloxide	C12H6Cl4O3S	4.7407	68939		[O-][S+](c1cc(Cl)cc(Cl)c1O)c1cc(Cl)cc(Cl)c1O	InChI=1S/C12H6Cl4O3S/c13-5-1-7(15)11(17)9(3-5)20(19)10-4-6(14)2-8(16)12(10)18/h1-4,17-18H	RPAJWWXZIQJVJF-UHFFFAOYSA-N					compound annotation
0391_000328	RO8994	C31H31Cl2FN4O4	4.7601	53238217	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3=C(C=C(C=C3)C(=O)N)OC)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	COc1c(NC(=O)C2NC(CC(C)(C)C)C3(C(=O)Nc4cc(Cl)ccc43)C2c2c(F)c(Cl)ccc2)ccc(C(N)=O)c1	InChI=1S/C31H31Cl2FN4O4/c1-30(2,3)14-23-31(18-10-9-16(32)13-21(18)37-29(31)41)24(17-6-5-7-19(33)25(17)34)26(38-23)28(40)36-20-11-8-15(27(35)39)12-22(20)42-4/h5-13,23-24,26,38H,14H2,1-4H3,(H2,35,39)(H,36,40)(H,37,41)/t23-,24-,26+,31+/m0/s1	MURAVORBGFDSMA-ISKXDESKSA-N					doublet; compound annotation
0391_000329	871361-88-5	C18H16N2O	0.8835	6018993	C1C/C(=C\C2=CC=NC=C2)/C(=O)/C(=C/C3=CC=NC=C3)/C1	O=C1C(=Cc2ccncc2)CCCC1=Cc1ccncc1	InChI=1S/C18H16N2O/c21-18-16(12-14-4-8-19-9-5-14)2-1-3-17(18)13-15-6-10-20-11-7-15/h4-13H,1-3H2/b16-12+,17-13+	CYVVJSKZRBZHAV-UNZYHPAISA-N					doublet; compound annotation
0391_000330	Etiracetam	C8H14N2O2	0.9955	59708		CCC(C(N)=O)N1CCCC1=O	InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)	HPHUVLMMVZITSG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000332	871361-88-5	C18H16N2O	1.0458	6018993	C1C/C(=C\C2=CC=NC=C2)/C(=O)/C(=C/C3=CC=NC=C3)/C1	O=C1C(=Cc2ccncc2)CCCC1=Cc1ccncc1	InChI=1S/C18H16N2O/c21-18-16(12-14-4-8-19-9-5-14)2-1-3-17(18)13-15-6-10-20-11-7-15/h4-13H,1-3H2/b16-12+,17-13+	CYVVJSKZRBZHAV-UNZYHPAISA-N					doublet; removed another duplicate entry; compound annotation
0391_000334	1059070-10-8	C19H28N8O2	1.7578	25071151		CCCCNc1nc(N)c2[nH]c(=O)n(Cc3cnc(OCCN(C)C)cc3)c2n1	InChI=1S/C19H28N8O2/c1-4-5-8-21-18-24-16(20)15-17(25-18)27(19(28)23-15)12-13-6-7-14(22-11-13)29-10-9-26(2)3/h6-7,11H,4-5,8-10,12H2,1-3H3,(H,23,28)(H3,20,21,24,25)	SSZHESNDOMBSRV-UHFFFAOYSA-N					compound annotation
0391_000335	345987-15-7	C20H16N6S	1.9736	10109823		N#CC(c1nc(NCCc2cnccc2)ncc1)c1nc2ccccc2s1	InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)	RCYPVQCPYKNSTG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000337	345987-15-7	C20H16N6S	2.4123	10109823		N#CC(c1nc(NCCc2cnccc2)ncc1)c1nc2ccccc2s1	InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)	RCYPVQCPYKNSTG-UHFFFAOYSA-N					doublet; compound annotation
0391_000338	345987-15-7	C20H16N6S	2.6304	10109823		N#CC(c1nc(NCCc2cnccc2)ncc1)c1nc2ccccc2s1	InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)	RCYPVQCPYKNSTG-UHFFFAOYSA-N					doublet; compound annotation
0391_000339	GSK503	C31H38N6O2	2.7104	67469117		Cc1cc(C)c(CNC(=O)c2c3c(C)cn(C(C)C)c3cc(-c3cnc(N4CCN(C)CC4)cc3)c2)c(=O)[nH]1	InChI=1S/C31H38N6O2/c1-19(2)37-18-21(4)29-25(30(38)33-17-26-20(3)13-22(5)34-31(26)39)14-24(15-27(29)37)23-7-8-28(32-16-23)36-11-9-35(6)10-12-36/h7-8,13-16,18-19H,9-12,17H2,1-6H3,(H,33,38)(H,34,39)	HRDQQHUKUIKFHT-UHFFFAOYSA-N					compound annotation
0391_000340	345987-15-7	C20H16N6S	2.7385	10109823		N#CC(c1nc(NCCc2cnccc2)ncc1)c1nc2ccccc2s1	InChI=1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26)	RCYPVQCPYKNSTG-UHFFFAOYSA-N					doublet; compound annotation
0391_000341	Bafetinib	C30H31F3N8O	2.7762	11387605	CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CC[C@@H](C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5	Cc1c(Nc2nccc(-c3cncnc3)n2)cc(NC(=O)c2cc(C(F)(F)F)c(CN3CCC(N(C)C)C3)cc2)cc1	InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1	ZGBAJMQHJDFTQJ-DEOSSOPVSA-N					removed another duplicate entry; compound annotation
0391_000343	NSC117079	C20H15N3O7S2	3.2847	272572		Nc1c(S(=O)(=O)O)cc(Nc2cc(S(N)(=O)=O)ccc2)c2c1C(=O)c1ccccc1C2=O	InChI=1S/C20H15N3O7S2/c21-18-15(32(28,29)30)9-14(23-10-4-3-5-11(8-10)31(22,26)27)16-17(18)20(25)13-7-2-1-6-12(13)19(16)24/h1-9,23H,21H2,(H2,22,26,27)(H,28,29,30)	LHSBZAWDPSTOEY-UHFFFAOYSA-N					compound annotation
0391_000344	Vadimezan	C17H14O4	3.4667	123964		Cc1c(C)c2c(cc1)c(=O)c1cccc(CC(=O)O)c1o2	InChI=1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19)	XGOYIMQSIKSOBS-UHFFFAOYSA-N					compound annotation
0391_000345	BMS 299897	C24H21ClF3NO4S	4.9632	11249248	C[C@H](C1=C(C=C(C=C1)F)CCCC(=O)O)N(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl	CC(c1c(CCCC(=O)O)cc(F)cc1)N(c1c(F)ccc(F)c1)S(=O)(=O)c1ccc(Cl)cc1	InChI=1S/C24H21ClF3NO4S/c1-15(21-11-7-18(26)13-16(21)3-2-4-24(30)31)29(23-14-19(27)8-12-22(23)28)34(32,33)20-9-5-17(25)6-10-20/h5-15H,2-4H2,1H3,(H,30,31)/t15-/m1/s1	IZAOBRWCUGOKNH-OAHLLOKOSA-N					compound annotation
0391_000346	APNEA	C18H22N6O4	0.9209	9952135	C1=CC(=CC=C1CCNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	Nc1ccc(CCNc2c3ncn(C4OC(CO)C(O)C4O)c3ncn2)cc1	InChI=1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22)/t12-,14-,15-,18-/m1/s1	XTPOZVLRZZIEBW-SCFUHWHPSA-N					removed another duplicate entry; compound annotation
0391_000348	XMD-17-51	C21H24N8O	1.9099	90431752		CN1C(=O)c2ccccc2N(C)c2nc(Nc3cn(C4CCNCC4)nc3)ncc21	InChI=1S/C21H24N8O/c1-27-17-6-4-3-5-16(17)20(30)28(2)18-12-23-21(26-19(18)27)25-14-11-24-29(13-14)15-7-9-22-10-8-15/h3-6,11-13,15,22H,7-10H2,1-2H3,(H,23,25,26)	LKOFXMLMYKWELM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000350	SP-420	C16H21NO6S	2.9905	135511704	C[C@@]1(CSC(=N1)C2=C(C=C(C=C2)OCCOCCOC)O)C(=O)O	COCCOCCOc1cc(O)c(C2=NC(C)(C(=O)O)CS2)cc1	InChI=1S/C16H21NO6S/c1-16(15(19)20)10-24-14(17-16)12-4-3-11(9-13(12)18)23-8-7-22-6-5-21-2/h3-4,9,18H,5-8,10H2,1-2H3,(H,19,20)/t16-/m1/s1	YASYAEVZKXPYIZ-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_000352	Etifoxine	C17H17ClN2O	3.1299	135413553		CCNC1=Nc2c(cc(Cl)cc2)C(C)(c2ccccc2)O1	InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)	IBYCYJFUEJQSMK-UHFFFAOYSA-N					doublet; compound annotation
0391_000353	Mevociclib	C31H35ClN8O2	3.2026	118426108	C[C@@]1(CCC[C@H](C1)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)NC(=O)C5=NC=C(C=C5)NC(=O)/C=C/CN(C)C	CN(C)CC=CC(=O)Nc1cnc(C(=O)NC2(C)CCCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1	InChI=1S/C31H35ClN8O2/c1-31(39-29(42)26-13-12-21(17-33-26)36-27(41)11-7-15-40(2)3)14-6-8-20(16-31)37-30-35-19-24(32)28(38-30)23-18-34-25-10-5-4-9-22(23)25/h4-5,7,9-13,17-20,34H,6,8,14-16H2,1-3H3,(H,36,41)(H,39,42)(H,35,37,38)/b11-7+/t20-,31+/m1/s1	SCJNYBYSTCRPAO-LXBQGUBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_000355	Mevociclib	C31H35ClN8O2	3.2508	118426108	C[C@@]1(CCC[C@H](C1)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)NC(=O)C5=NC=C(C=C5)NC(=O)/C=C/CN(C)C	CN(C)CC=CC(=O)Nc1cnc(C(=O)NC2(C)CCCC(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1	InChI=1S/C31H35ClN8O2/c1-31(39-29(42)26-13-12-21(17-33-26)36-27(41)11-7-15-40(2)3)14-6-8-20(16-31)37-30-35-19-24(32)28(38-30)23-18-34-25-10-5-4-9-22(23)25/h4-5,7,9-13,17-20,34H,6,8,14-16H2,1-3H3,(H,36,41)(H,39,42)(H,35,37,38)/b11-7+/t20-,31+/m1/s1	SCJNYBYSTCRPAO-LXBQGUBHSA-N					doublet; compound annotation
0391_000356	Qstatin	C7H5BrN2O2S2	3.6989	3237735		O=S(=O)(c1ccc(Br)s1)n1cccn1	InChI=1S/C7H5BrN2O2S2/c8-6-2-3-7(13-6)14(11,12)10-5-1-4-9-10/h1-5H	MLRBBGFHILYDBK-UHFFFAOYSA-N					compound annotation
0391_000357	Etifoxine	C17H17ClN2O	3.6989	135413553		CCNC1=Nc2c(cc(Cl)cc2)C(C)(c2ccccc2)O1	InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)	IBYCYJFUEJQSMK-UHFFFAOYSA-N					doublet; compound annotation
0391_000358	313254-51-2	C23H19N3O3S2	3.9227	998021		O=C(Nc1ccc(S(=O)(=O)Nc2nccs2)cc1)C(c1ccccc1)c1ccccc1	InChI=1S/C23H19N3O3S2/c27-22(21(17-7-3-1-4-8-17)18-9-5-2-6-10-18)25-19-11-13-20(14-12-19)31(28,29)26-23-24-15-16-30-23/h1-16,21H,(H,24,26)(H,25,27)	URSQNPPONHUJDL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000360	75629-57-1	C16H12ClNO	4.3514	872445		O=Cc1cn(Cc2ccc(Cl)cc2)c2ccccc12	InChI=1S/C16H12ClNO/c17-14-7-5-12(6-8-14)9-18-10-13(11-19)15-3-1-2-4-16(15)18/h1-8,10-11H,9H2	ZDRQMXCSSAPUMM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000362	Mofegiline	C11H13F2N	1.9747	6437850	C1=CC(=CC=C1CC/C(=C\F)/CN)F	NCC(=CF)CCc1ccc(F)cc1	InChI=1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+	VXLBSYHAEKDUSU-JXMROGBWSA-N					doublet; compound annotation
0391_000363	Mofegiline	C11H13F2N	2.2087	6437850	C1=CC(=CC=C1CC/C(=C\F)/CN)F	NCC(=CF)CCc1ccc(F)cc1	InChI=1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+	VXLBSYHAEKDUSU-JXMROGBWSA-N					doublet; compound annotation
0391_000364	ILORASERTIB	C25H21FN6O2S	2.8899	46207586		Nc1ncc(-c2cn(CCO)nc2)c2c1c(-c1ccc(NC(=O)Nc3cc(F)ccc3)cc1)cs2	InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)	WPHKIQPVPYJNAX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000367	SN 2	C17H21NO	2.9573	11834987		Cc1cc(C)c(C2=NOC3C4CCC(C4)C23)c(C)c1	InChI=1S/C17H21NO/c1-9-6-10(2)14(11(3)7-9)16-15-12-4-5-13(8-12)17(15)19-18-16/h6-7,12-13,15,17H,4-5,8H2,1-3H3	WKLZNTYMDOPBSE-UHFFFAOYSA-N					doublet; compound annotation
0391_000368	Atomoxetine	C17H21NO	2.9573	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	CNCCC(Oc1ccccc1C)c1ccccc1	InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1	VHGCDTVCOLNTBX-QGZVFWFLSA-N					doublet; compound annotation
0391_000369	BV-6	C70H96N10O8	3.6813	23657864	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)NCCCCCCNC(=O)[C@H](C(C5=CC=CC=C5)C6=CC=CC=C6)NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NCCCCCCNC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)NC)C1CCCCC1)C(c1ccccc1)c1ccccc1)C(c1ccccc1)c1ccccc1)C1CCCCC1	InChI=1S/C70H96N10O8/c1-47(71-3)63(81)75-59(53-37-21-11-22-38-53)69(87)79-45-27-41-55(79)65(83)77-61(57(49-29-13-7-14-30-49)50-31-15-8-16-32-50)67(85)73-43-25-5-6-26-44-74-68(86)62(58(51-33-17-9-18-34-51)52-35-19-10-20-36-52)78-66(84)56-42-28-46-80(56)70(88)60(54-39-23-12-24-40-54)76-64(82)48(2)72-4/h7-10,13-20,29-36,47-48,53-62,71-72H,5-6,11-12,21-28,37-46H2,1-4H3,(H,73,85)(H,74,86)(H,75,81)(H,76,82)(H,77,83)(H,78,84)/t47-,48-,55-,56-,59-,60-,61-,62-/m0/s1	DPXJXGNXKOVBJV-YLOPQIBLSA-N					compound annotation
0391_000370	PLX7904	C24H22F2N6O3S	3.7875	90116945		CCN(C)S(=O)(=O)Nc1c(F)c(C(=O)c2c[nH]c3c2cc(-c2cnc(C4CC4)nc2)cn3)c(F)cc1	InChI=1S/C24H22F2N6O3S/c1-3-32(2)36(34,35)31-19-7-6-18(25)20(21(19)26)22(33)17-12-30-24-16(17)8-14(9-29-24)15-10-27-23(28-11-15)13-4-5-13/h6-13,31H,3-5H2,1-2H3,(H,29,30)	DKNZQPXIIHLUHU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000372	NU6300	C20H23N5O3S	3.9341	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000374	NU6300	C20H23N5O3S	4.7395	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000375	NU6300	C20H23N5O3S	4.8921	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000376	SN 2	C17H21NO	5.1389	11834987		Cc1cc(C)c(C2=NOC3C4CCC(C4)C23)c(C)c1	InChI=1S/C17H21NO/c1-9-6-10(2)14(11(3)7-9)16-15-12-4-5-13(8-12)17(15)19-18-16/h6-7,12-13,15,17H,4-5,8H2,1-3H3	WKLZNTYMDOPBSE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000377	Atomoxetine	C17H21NO	5.1389	54841	CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2	CNCCC(Oc1ccccc1C)c1ccccc1	InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1	VHGCDTVCOLNTBX-QGZVFWFLSA-N					doublet; removed another duplicate entry; compound annotation
0391_000380	NU6300	C20H23N5O3S	5.217	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000381	NU6300	C20H23N5O3S	5.3364	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000382	NU6300	C20H23N5O3S	5.5346	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000383	AGN 195183	C22H22ClF2NO4	5.7303	9867758		CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl	InChI=1S/C22H22ClF2NO4/c1-21(2)5-6-22(3,4)16-12(21)9-11(18(27)17(16)23)19(28)26-10-7-13(24)15(20(29)30)14(25)8-10/h7-9,27H,5-6H2,1-4H3,(H,26,28)(H,29,30)	PNAWUIKCVQSLFG-UHFFFAOYSA-N					compound annotation
0391_000384	NU6300	C20H23N5O3S	5.7726	118704754		C=CS(=O)(=O)c1ccc(Nc2nc3c([nH]cn3)c(OCC3CCCCC3)n2)cc1	InChI=1S/C20H23N5O3S/c1-2-29(26,27)16-10-8-15(9-11-16)23-20-24-18-17(21-13-22-18)19(25-20)28-12-14-6-4-3-5-7-14/h2,8-11,13-14H,1,3-7,12H2,(H2,21,22,23,24,25)	KGWSQGUVJUGIPF-UHFFFAOYSA-N					doublet; compound annotation
0391_000385	PLX7904	C24H22F2N6O3S	6.4862	90116945		CCN(C)S(=O)(=O)Nc1c(F)c(C(=O)c2c[nH]c3c2cc(-c2cnc(C4CC4)nc2)cn3)c(F)cc1	InChI=1S/C24H22F2N6O3S/c1-3-32(2)36(34,35)31-19-7-6-18(25)20(21(19)26)22(33)17-12-30-24-16(17)8-14(9-29-24)15-10-27-23(28-11-15)13-4-5-13/h6-13,31H,3-5H2,1-2H3,(H,29,30)	DKNZQPXIIHLUHU-UHFFFAOYSA-N					doublet; compound annotation
0391_000386	891494-63-6	C15H18BrN7	1.8004	46239015	CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)[C@@H]4CCCNC4	Cn1cc(-c2c3nc(C4CCCNC4)c(Br)c(N)n3nc2)cn1	InChI=1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,18H,2-5,17H2,1H3/t9-/m1/s1	GMIZZEXBPRLVIV-SECBINFHSA-N					compound annotation
0391_000387	1373215-15-6	C25H29FN4O5	1.9177	67475270	CNC(=O)O[C@H]1COC2=C([C@@H]1NC(=O)C3=CC=C(C=C3)F)C=C(C=C2)N4CCN(CC4)C5COC5	CNC(=O)OC1COc2c(cc(N3CCN(C4COC4)CC3)cc2)C1NC(=O)c1ccc(F)cc1	InChI=1S/C25H29FN4O5/c1-27-25(32)35-22-15-34-21-7-6-18(29-8-10-30(11-9-29)19-13-33-14-19)12-20(21)23(22)28-24(31)16-2-4-17(26)5-3-16/h2-7,12,19,22-23H,8-11,13-15H2,1H3,(H,27,32)(H,28,31)/t22-,23-/m0/s1	NDEBZCZEAVMSQF-GOTSBHOMSA-N					doublet; compound annotation
0391_000388	1373215-15-6	C25H29FN4O5	2.0137	67475270	CNC(=O)O[C@H]1COC2=C([C@@H]1NC(=O)C3=CC=C(C=C3)F)C=C(C=C2)N4CCN(CC4)C5COC5	CNC(=O)OC1COc2c(cc(N3CCN(C4COC4)CC3)cc2)C1NC(=O)c1ccc(F)cc1	InChI=1S/C25H29FN4O5/c1-27-25(32)35-22-15-34-21-7-6-18(29-8-10-30(11-9-29)19-13-33-14-19)12-20(21)23(22)28-24(31)16-2-4-17(26)5-3-16/h2-7,12,19,22-23H,8-11,13-15H2,1H3,(H,27,32)(H,28,31)/t22-,23-/m0/s1	NDEBZCZEAVMSQF-GOTSBHOMSA-N					doublet; removed another duplicate entry; compound annotation
0391_000391	KPLH1130	C15H13N3O3	2.1715	135487465		Cc1ccc(-n2c(-c3c(O)cc(O)cc3)n[nH]c2=O)cc1	InChI=1S/C15H13N3O3/c1-9-2-4-10(5-3-9)18-14(16-17-15(18)21)12-7-6-11(19)8-13(12)20/h2-8,19-20H,1H3,(H,17,21)	UUTBMTOBGXJTLN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000393	MK2-IN-1	C27H25ClN4O2	2.3027	53475321		O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1	InChI=1S/C27H25ClN4O2/c28-21-6-4-20(5-7-21)25-12-13-26(34-25)27(33)32(19-22-3-1-2-14-30-22)24-10-8-23(9-11-24)31-17-15-29-16-18-31/h1-14,29H,15-19H2	LIPNXDIBECKOMJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000394	MK2-IN-1	C27H25ClN4O2	2.692	53475321		O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1	InChI=1S/C27H25ClN4O2/c28-21-6-4-20(5-7-21)25-12-13-26(34-25)27(33)32(19-22-3-1-2-14-30-22)24-10-8-23(9-11-24)31-17-15-29-16-18-31/h1-14,29H,15-19H2	LIPNXDIBECKOMJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000395	MK2-IN-1	C27H25ClN4O2	2.6985	53475321		O=C(c1ccc(-c2ccc(Cl)cc2)o1)N(Cc1ccccn1)c1ccc(N2CCNCC2)cc1	InChI=1S/C27H25ClN4O2/c28-21-6-4-20(5-7-21)25-12-13-26(34-25)27(33)32(19-22-3-1-2-14-30-22)24-10-8-23(9-11-24)31-17-15-29-16-18-31/h1-14,29H,15-19H2	LIPNXDIBECKOMJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000397	BRL 15572	C25H27ClN2O	3.518	3654103		OC(CN1CCN(c2cc(Cl)ccc2)CC1)C(c1ccccc1)c1ccccc1	InChI=1S/C25H27ClN2O/c26-22-12-7-13-23(18-22)28-16-14-27(15-17-28)19-24(29)25(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-13,18,24-25,29H,14-17,19H2	QJHCTHPYUOXOGM-UHFFFAOYSA-N					compound annotation
0391_000398	Sotagliflozin	C21H25ClO5S	4.0554	24831714	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C3OC(SC)C(O)C(O)C3O)c2)cc1	InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1	QKDRXGFQVGOQKS-CRSSMBPESA-N					removed another duplicate entry; compound annotation
0391_000400	DMAT	C9H7Br4N3	4.0987	5326976		CN(C)c1nc2c([nH]1)c(Br)c(Br)c(Br)c2Br	InChI=1S/C9H7Br4N3/c1-16(2)9-14-7-5(12)3(10)4(11)6(13)8(7)15-9/h1-2H3,(H,14,15)	SLPJGDQJLTYWCI-UHFFFAOYSA-N					compound annotation
0391_000401	XY101	C25H20F7NO4S	4.5019	138105957		CCS(=O)(=O)c1ccc(CC(=O)Nc2ccc(-c3c(F)cc(C(O)(C(F)(F)F)C(F)(F)F)cc3)cc2)cc1	InChI=1S/C25H20F7NO4S/c1-2-38(36,37)19-10-3-15(4-11-19)13-22(34)33-18-8-5-16(6-9-18)20-12-7-17(14-21(20)26)23(35,24(27,28)29)25(30,31)32/h3-12,14,35H,2,13H2,1H3,(H,33,34)	AUIAOCHKUNGZHV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000404	GW7647	C29H46N2O3S	6.302	3392731		CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O	InChI=1S/C29H46N2O3S/c1-29(2,27(32)33)35-26-18-16-24(17-19-26)20-22-31(28(34)30-25-14-7-4-8-15-25)21-10-9-13-23-11-5-3-6-12-23/h16-19,23,25H,3-15,20-22H2,1-2H3,(H,30,34)(H,32,33)	PKNYXWMTHFMHKD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000406	GW7647	C29H46N2O3S	7.3378	3392731		CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(=O)O	InChI=1S/C29H46N2O3S/c1-29(2,27(32)33)35-26-18-16-24(17-19-26)20-22-31(28(34)30-25-14-7-4-8-15-25)21-10-9-13-23-11-5-3-6-12-23/h16-19,23,25H,3-15,20-22H2,1-2H3,(H,30,34)(H,32,33)	PKNYXWMTHFMHKD-UHFFFAOYSA-N					doublet; compound annotation
0391_000407	Radafaxine	C13H18ClNO2	1.9245	9795056	C[C@H]1[C@@](OCC(N1)(C)C)(C2=CC(=CC=C2)Cl)O	CC1NC(C)(C)COC1(O)c1cc(Cl)ccc1	InChI=1S/C13H18ClNO2/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3/t9-,13+/m0/s1	RCOBKSKAZMVBHT-TVQRCGJNSA-N					compound annotation
0391_000408	183499-57-2	C22H20ClN5O	2.559	216454		N#Cc1ccc(Cn2cncc2CN2CCN(c3cc(Cl)ccc3)C(=O)C2)cc1	InChI=1S/C22H20ClN5O/c23-19-2-1-3-20(10-19)28-9-8-26(15-22(28)29)14-21-12-25-16-27(21)13-18-6-4-17(11-24)5-7-18/h1-7,10,12,16H,8-9,13-15H2	JNUGFGAVPBYSHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000410	AZD3514	C25H32F3N7O2	2.5828	46893585		CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1	InChI=1S/C25H32F3N7O2/c1-18(36)33-14-12-32(13-15-33)16-17-37-21-4-2-19(3-5-21)20-8-10-34(11-9-20)23-7-6-22-29-30-24(25(26,27)28)35(22)31-23/h2-5,20H,6-17H2,1H3	JMEYDSHPKCSIJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000412	Nepafenac	C15H14N2O2	2.966	151075		NC(=O)Cc1c(N)c(C(=O)c2ccccc2)ccc1	InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)	QEFAQIPZVLVERP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000414	CHEMBL1628668	C30H36N2O2	4.1239	5311122		COc1cc2c(cc1)CCCC2C(=O)N(Cc1ccc(N(C)C)cc1)c1ccc(C(C)C)cc1	InChI=1S/C30H36N2O2/c1-21(2)23-11-16-26(17-12-23)32(20-22-9-14-25(15-10-22)31(3)4)30(33)28-8-6-7-24-13-18-27(34-5)19-29(24)28/h9-19,21,28H,6-8,20H2,1-5H3	DVYASSBBADJRAS-UHFFFAOYSA-N					doublet; compound annotation
0391_000415	ABX-1431	C20H22F9N3O2	4.4635	71657619		O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1	InChI=1S/C20H22F9N3O2/c21-18(22,23)14-4-3-13(15(11-14)31-5-1-2-6-31)12-30-7-9-32(10-8-30)17(33)34-16(19(24,25)26)20(27,28)29/h3-4,11,16H,1-2,5-10,12H2	SQZJGTOZFRNWCX-UHFFFAOYSA-N					compound annotation
0391_000416	CHEMBL1628668	C30H36N2O2	5.6026	5311122		COc1cc2c(cc1)CCCC2C(=O)N(Cc1ccc(N(C)C)cc1)c1ccc(C(C)C)cc1	InChI=1S/C30H36N2O2/c1-21(2)23-11-16-26(17-12-23)32(20-22-9-14-25(15-10-22)31(3)4)30(33)28-8-6-7-24-13-18-27(34-5)19-29(24)28/h9-19,21,28H,6-8,20H2,1-5H3	DVYASSBBADJRAS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000418	BAM7	C21H19N5O2S	5.8724	3101542		CCOc1ccccc1N=Nc1c(C)[nH]n(-c2nc(-c3ccccc3)cs2)c1=O	InChI=1S/C21H19N5O2S/c1-3-28-18-12-8-7-11-16(18)23-24-19-14(2)25-26(20(19)27)21-22-17(13-29-21)15-9-5-4-6-10-15/h4-13,25H,3H2,1-2H3	WRLVHADVOGFZOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_000419	BAM7	C21H19N5O2S	5.88	3101542		CCOc1ccccc1N=Nc1c(C)[nH]n(-c2nc(-c3ccccc3)cs2)c1=O	InChI=1S/C21H19N5O2S/c1-3-28-18-12-8-7-11-16(18)23-24-19-14(2)25-26(20(19)27)21-22-17(13-29-21)15-9-5-4-6-10-15/h4-13,25H,3H2,1-2H3	WRLVHADVOGFZOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_000420	Gefitinib	C22H24ClFN4O3	1.8972	123631		COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1	InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)	XGALLCVXEZPNRQ-UHFFFAOYSA-N					doublet; compound annotation
0391_000421	DEL-22379	C26H28N4O3	2.1008	11224574	COC1=CC2=C(C=C1)NC=C2/C=C\3/C4=C(C=CC(=C4)NC(=O)CCN5CCCCC5)NC3=O	COc1cc2c(cc1)[nH]cc2C=C1C(=O)Nc2ccc(NC(=O)CCN3CCCCC3)cc12	InChI=1S/C26H28N4O3/c1-33-19-6-8-23-20(15-19)17(16-27-23)13-22-21-14-18(5-7-24(21)29-26(22)32)28-25(31)9-12-30-10-3-2-4-11-30/h5-8,13-16,27H,2-4,9-12H2,1H3,(H,28,31)(H,29,32)/b22-13-	INQUULPXCZAKMS-XKZIYDEJSA-N					doublet; compound annotation
0391_000422	DEL-22379	C26H28N4O3	2.2227	11224574	COC1=CC2=C(C=C1)NC=C2/C=C\3/C4=C(C=CC(=C4)NC(=O)CCN5CCCCC5)NC3=O	COc1cc2c(cc1)[nH]cc2C=C1C(=O)Nc2ccc(NC(=O)CCN3CCCCC3)cc12	InChI=1S/C26H28N4O3/c1-33-19-6-8-23-20(15-19)17(16-27-23)13-22-21-14-18(5-7-24(21)29-26(22)32)28-25(31)9-12-30-10-3-2-4-11-30/h5-8,13-16,27H,2-4,9-12H2,1H3,(H,28,31)(H,29,32)/b22-13-	INQUULPXCZAKMS-XKZIYDEJSA-N					doublet; removed another duplicate entry; compound annotation
0391_000425	c-Fms-IN-1	C22H27N5O2	2.3059	11502871		CN1CCN(c2cc(N3CCCCC3)c(NC(=O)c3ccc(C#N)o3)cc2)CC1	InChI=1S/C22H27N5O2/c1-25-11-13-26(14-12-25)17-5-7-19(20(15-17)27-9-3-2-4-10-27)24-22(28)21-8-6-18(16-23)29-21/h5-8,15H,2-4,9-14H2,1H3,(H,24,28)	UUPPIQKPNBIUKY-UHFFFAOYSA-N					doublet; compound annotation
0391_000426	DEL-22379	C26H28N4O3	2.3417	11224574	COC1=CC2=C(C=C1)NC=C2/C=C\3/C4=C(C=CC(=C4)NC(=O)CCN5CCCCC5)NC3=O	COc1cc2c(cc1)[nH]cc2C=C1C(=O)Nc2ccc(NC(=O)CCN3CCCCC3)cc12	InChI=1S/C26H28N4O3/c1-33-19-6-8-23-20(15-19)17(16-27-23)13-22-21-14-18(5-7-24(21)29-26(22)32)28-25(31)9-12-30-10-3-2-4-11-30/h5-8,13-16,27H,2-4,9-12H2,1H3,(H,28,31)(H,29,32)/b22-13-	INQUULPXCZAKMS-XKZIYDEJSA-N					doublet; removed another duplicate entry; compound annotation
0391_000429	riviciclib	C21H20ClNO5	2.6239	23643976	CN1CC[C@H]([C@@H]1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2ccccc2Cl)cc3=O)C1CO	InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3/t12-,14+/m1/s1	QLUYMIVVAYRECT-OCCSQVGLSA-N					compound annotation
0391_000430	c-Fms-IN-1	C22H27N5O2	2.7569	11502871		CN1CCN(c2cc(N3CCCCC3)c(NC(=O)c3ccc(C#N)o3)cc2)CC1	InChI=1S/C22H27N5O2/c1-25-11-13-26(14-12-25)17-5-7-19(20(15-17)27-9-3-2-4-10-27)24-22(28)21-8-6-18(16-23)29-21/h5-8,15H,2-4,9-14H2,1H3,(H,24,28)	UUPPIQKPNBIUKY-UHFFFAOYSA-N					doublet; compound annotation
0391_000431	c-Fms-IN-1	C22H27N5O2	2.7597	11502871		CN1CCN(c2cc(N3CCCCC3)c(NC(=O)c3ccc(C#N)o3)cc2)CC1	InChI=1S/C22H27N5O2/c1-25-11-13-26(14-12-25)17-5-7-19(20(15-17)27-9-3-2-4-10-27)24-22(28)21-8-6-18(16-23)29-21/h5-8,15H,2-4,9-14H2,1H3,(H,24,28)	UUPPIQKPNBIUKY-UHFFFAOYSA-N					doublet; compound annotation
0391_000432	furosemide	C12H11ClN2O5S	2.8735	3440		NS(=O)(=O)c1c(Cl)cc(NCc2ccco2)c(C(=O)O)c1	InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)	ZZUFCTLCJUWOSV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000434	DEL-22379	C26H28N4O3	2.8799	11224574	COC1=CC2=C(C=C1)NC=C2/C=C\3/C4=C(C=CC(=C4)NC(=O)CCN5CCCCC5)NC3=O	COc1cc2c(cc1)[nH]cc2C=C1C(=O)Nc2ccc(NC(=O)CCN3CCCCC3)cc12	InChI=1S/C26H28N4O3/c1-33-19-6-8-23-20(15-19)17(16-27-23)13-22-21-14-18(5-7-24(21)29-26(22)32)28-25(31)9-12-30-10-3-2-4-11-30/h5-8,13-16,27H,2-4,9-12H2,1H3,(H,28,31)(H,29,32)/b22-13-	INQUULPXCZAKMS-XKZIYDEJSA-N					doublet; compound annotation
0391_000435	Uprosertib	C18H16Cl2F2N4O2	2.8861	51042438	CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)oc(C(=O)NC(CN)Cc2cc(F)c(F)cc2)c1	InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1	AXTAPYRUEKNRBA-JTQLQIEISA-N					doublet; compound annotation
0391_000436	c-Fms-IN-1	C22H27N5O2	2.9071	11502871		CN1CCN(c2cc(N3CCCCC3)c(NC(=O)c3ccc(C#N)o3)cc2)CC1	InChI=1S/C22H27N5O2/c1-25-11-13-26(14-12-25)17-5-7-19(20(15-17)27-9-3-2-4-10-27)24-22(28)21-8-6-18(16-23)29-21/h5-8,15H,2-4,9-14H2,1H3,(H,24,28)	UUPPIQKPNBIUKY-UHFFFAOYSA-N					doublet; compound annotation
0391_000437	Uprosertib	C18H16Cl2F2N4O2	2.9995	51042438	CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)oc(C(=O)NC(CN)Cc2cc(F)c(F)cc2)c1	InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1	AXTAPYRUEKNRBA-JTQLQIEISA-N					doublet; compound annotation
0391_000438	VER-49009	C19H18ClN3O4	3.2017	4369536		CCNC(=O)c1c(-c2ccc(OC)cc2)c(-c2cc(Cl)c(O)cc2O)n[nH]1	InChI=1S/C19H18ClN3O4/c1-3-21-19(26)18-16(10-4-6-11(27-2)7-5-10)17(22-23-18)12-8-13(20)15(25)9-14(12)24/h4-9,24-25H,3H2,1-2H3,(H,21,26)(H,22,23)	HUNAOTXNHVALTN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000440	221243-82-9	C19H19N5	3.7603	4877		CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21	InChI=1S/C19H19N5/c1-19(2,3)24-18-15(17(20)21-11-22-18)16(23-24)14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H2,20,21,22)	XSHQBIXMLULFEV-UHFFFAOYSA-N					doublet; compound annotation
0391_000441	ETIMIZOL	C9H14N4O2	1.5916	6168		CCn1cnc(C(=O)NC)c1C(=O)NC	InChI=1S/C9H14N4O2/c1-4-13-5-12-6(8(14)10-2)7(13)9(15)11-3/h5H,4H2,1-3H3,(H,10,14)(H,11,15)	RYRFAMRQBZNEPX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000443	quercetin 3-O-glucuronide	C21H18O13	1.8405	5274585	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O	O=C(O)C1OC(Oc2c(-c3cc(O)c(O)cc3)oc3cc(O)cc(O)c3c2=O)C(O)C(O)C1O	InChI=1S/C21H18O13/c22-7-4-10(25)12-11(5-7)32-17(6-1-2-8(23)9(24)3-6)18(13(12)26)33-21-16(29)14(27)15(28)19(34-21)20(30)31/h1-5,14-16,19,21-25,27-29H,(H,30,31)/t14-,15-,16+,19-,21+/m0/s1	DUBCCGAQYVUYEU-ZUGPOPFOSA-N					compound annotation
0391_000444	Flumatinib	C29H29F3N8O	1.9921	46848036		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cn1	InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)	BJCJYEYYYGBROF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000446	Verubecestat	C17H17F2N5O3S	2.3588	51352361	C[C@]1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F	CN1C(N)=NC(C)(c2c(F)ccc(NC(=O)c3ncc(F)cc3)c2)CS1(=O)=O	InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1	YHYKUSGACIYRML-KRWDZBQOSA-N					doublet; compound annotation
0391_000447	Verubecestat	C17H17F2N5O3S	2.3636	51352361	C[C@]1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F	CN1C(N)=NC(C)(c2c(F)ccc(NC(=O)c3ncc(F)cc3)c2)CS1(=O)=O	InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1	YHYKUSGACIYRML-KRWDZBQOSA-N					doublet; compound annotation
0391_000448	Flumatinib	C29H29F3N8O	2.3781	46848036		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cn1	InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)	BJCJYEYYYGBROF-UHFFFAOYSA-N					doublet; compound annotation
0391_000449	ACTB-1003	C27H26F5N7O3	3.3849	23653175		COCc1c(CN2CCOCC2)n2ncnc(N)c2c1-c1cc(F)c(NC(=O)Nc2c(F)ccc(C(F)(F)F)c2)cc1	InChI=1S/C27H26F5N7O3/c1-41-13-17-22(12-38-6-8-42-9-7-38)39-24(25(33)34-14-35-39)23(17)15-2-5-20(19(29)10-15)36-26(40)37-21-11-16(27(30,31)32)3-4-18(21)28/h2-5,10-11,14H,6-9,12-13H2,1H3,(H2,33,34,35)(H2,36,37,40)	GZPJCJKUZPUFAL-UHFFFAOYSA-N					compound annotation
0391_000450	Tegobuvir	C25H14F7N5	3.4965	23649154		Fc1ccccc1-c1nc2cn(Cc3nnc(-c4c(C(F)(F)F)cc(C(F)(F)F)cc4)cc3)ccc-2n1	InChI=1S/C25H14F7N5/c26-19-4-2-1-3-17(19)23-33-21-9-10-37(13-22(21)34-23)12-15-6-8-20(36-35-15)16-7-5-14(24(27,28)29)11-18(16)25(30,31)32/h1-11,13H,12H2	XBEQSQDCBSKCHJ-UHFFFAOYSA-N					compound annotation
0391_000451	WIKI4	C29H23N5O3S	3.826	2984337		COc1ccc(-n2c(SCCCN3C(=O)c4cccc5c4c(ccc5)C3=O)nnc2-c2ccncc2)cc1	InChI=1S/C29H23N5O3S/c1-37-22-11-9-21(10-12-22)34-26(20-13-15-30-16-14-20)31-32-29(34)38-18-4-17-33-27(35)23-7-2-5-19-6-3-8-24(25(19)23)28(33)36/h2-3,5-16H,4,17-18H2,1H3	RNUXIZKXJOGYQP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000453	AVE 0991	C29H32N4O5S2	5.1808	9851724		CCNC(=O)NS(=O)(=O)c1c(-c2ccc(Cn3c(-c4ccccc4)nc(OC)c3C=O)cc2)cc(CC(C)C)s1	InChI=1S/C29H32N4O5S2/c1-5-30-29(35)32-40(36,37)28-24(16-23(39-28)15-19(2)3)21-13-11-20(12-14-21)17-33-25(18-34)27(38-4)31-26(33)22-9-7-6-8-10-22/h6-14,16,18-19H,5,15,17H2,1-4H3,(H2,30,32,35)	QTOZBSNPDCWHPV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000455	JNJ-42165279	C18H17ClF2N4O3	2.0953	54576693		O=C(Nc1c(Cl)ccnc1)N1CCN(Cc2cc3c(cc2)OC(F)(F)O3)CC1	InChI=1S/C18H17ClF2N4O3/c19-13-3-4-22-10-14(13)23-17(26)25-7-5-24(6-8-25)11-12-1-2-15-16(9-12)28-18(20,21)27-15/h1-4,9-10H,5-8,11H2,(H,23,26)	YWGYNGCRVZLMCS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000457	G-5555	C25H25ClN6O3	2.3485	91664373		CNc1ncc2cc(-c3c(Cl)cc(-c4cccc(C)n4)cc3)c(=O)n(CC3OCC(N)CO3)c2n1	InChI=1S/C25H25ClN6O3/c1-14-4-3-5-21(30-14)15-6-7-18(20(26)9-15)19-8-16-10-29-25(28-2)31-23(16)32(24(19)33)11-22-34-12-17(27)13-35-22/h3-10,17,22H,11-13,27H2,1-2H3,(H,28,29,31)	ZBCMHWUFWQFPLV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000459	Ca2+ channel agonist 1	C19H26N6O	2.8471	69472592	CCCN1C=NC2=C(N=C(N=C21)N[C@H](CC)CO)NCC3=CC=CC=C3	CCCn1cnc2c(NCc3ccccc3)nc(NC(CC)CO)nc21	InChI=1S/C19H26N6O/c1-3-10-25-13-21-16-17(20-11-14-8-6-5-7-9-14)23-19(24-18(16)25)22-15(4-2)12-26/h5-9,13,15,26H,3-4,10-12H2,1-2H3,(H2,20,22,23,24)/t15-/m1/s1	LKXPLOHGQSEPEM-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_000462	amlodipine	C20H25ClN2O5	3.1537	2162		CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl	InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3	HTIQEAQVCYTUBX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000464	Telcagepant	C26H27F5N6O3	3.844	11319053	C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5	O=C(NC1CCC(c2c(F)c(F)ccc2)CN(CC(F)(F)F)C1=O)N1CCC(n2c(=O)[nH]c3c2cccn3)CC1	InChI=1S/C26H27F5N6O3/c27-18-4-1-3-17(21(18)28)15-6-7-19(23(38)36(13-15)14-26(29,30)31)33-24(39)35-11-8-16(9-12-35)37-20-5-2-10-32-22(20)34-25(37)40/h1-5,10,15-16,19H,6-9,11-14H2,(H,33,39)(H,32,34,40)/t15-,19-/m1/s1	CGDZXLJGHVKVIE-DNVCBOLYSA-N					removed another duplicate entry; compound annotation
0391_000466	(S,S)-Valifenalate	C19H27ClN2O5	4.037	23377346	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C	COC(=O)CC(NC(=O)C(NC(=O)OC(C)C)C(C)C)c1ccc(Cl)cc1	InChI=1S/C19H27ClN2O5/c1-11(2)17(22-19(25)27-12(3)4)18(24)21-15(10-16(23)26-5)13-6-8-14(20)9-7-13/h6-9,11-12,15,17H,10H2,1-5H3,(H,21,24)(H,22,25)/t15-,17-/m0/s1	DBXFMOWZRXXBRN-RDJZCZTQSA-N					doublet; removed another duplicate entry; compound annotation
0391_000468	(S,S)-Valifenalate	C19H27ClN2O5	4.0917	23377346	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C	COC(=O)CC(NC(=O)C(NC(=O)OC(C)C)C(C)C)c1ccc(Cl)cc1	InChI=1S/C19H27ClN2O5/c1-11(2)17(22-19(25)27-12(3)4)18(24)21-15(10-16(23)26-5)13-6-8-14(20)9-7-13/h6-9,11-12,15,17H,10H2,1-5H3,(H,21,24)(H,22,25)/t15-,17-/m0/s1	DBXFMOWZRXXBRN-RDJZCZTQSA-N					doublet; removed another duplicate entry; compound annotation
0391_000470	Avobenzone	C20H22O3	5.0587	51040		COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1	InChI=1S/C20H22O3/c1-20(2,3)16-9-5-14(6-10-16)18(21)13-19(22)15-7-11-17(23-4)12-8-15/h5-12H,13H2,1-4H3	XNEFYCZVKIDDMS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000472	Avobenzone	C20H22O3	6.1781	51040		COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1	InChI=1S/C20H22O3/c1-20(2,3)16-9-5-14(6-10-16)18(21)13-19(22)15-7-11-17(23-4)12-8-15/h5-12H,13H2,1-4H3	XNEFYCZVKIDDMS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000474	azathioprine	C9H7N7O2S	1.2736	2265		Cn1cnc([N+](=O)[O-])c1Sc1ncnc2c1[nH]cn2	InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)	LMEKQMALGUDUQG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000476	triamcinolone	C21H27FO6	1.9795	31307	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F	InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1	GFNANZIMVAIWHM-OBYCQNJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_000478	triamcinolone	C21H27FO6	2.2656	31307	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O	CC12C=CC(=O)C=C1CCC1C3CC(O)C(O)(C(=O)CO)C3(C)CC(O)C12F	InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1	GFNANZIMVAIWHM-OBYCQNJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_000480	Fenebrutinib	C37H44N8O4	2.8399	86567195	C[C@H]1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8	CC1CN(C2COC2)CCN1c1cnc(Nc2cc(-c3c(CO)c(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)ncc3)cn(C)c2=O)cc1	InChI=1S/C37H44N8O4/c1-23-18-42(27-21-49-22-27)9-10-43(23)26-5-6-33(39-17-26)40-30-13-25(19-41(4)35(30)47)28-7-8-38-34(29(28)20-46)45-12-11-44-31(36(45)48)14-24-15-37(2,3)16-32(24)44/h5-8,13-14,17,19,23,27,46H,9-12,15-16,18,20-22H2,1-4H3,(H,39,40)/t23-/m0/s1	WNEODWDFDXWOLU-QHCPKHFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_000482	Fenebrutinib	C37H44N8O4	2.8427	86567195	C[C@H]1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8	CC1CN(C2COC2)CCN1c1cnc(Nc2cc(-c3c(CO)c(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)ncc3)cn(C)c2=O)cc1	InChI=1S/C37H44N8O4/c1-23-18-42(27-21-49-22-27)9-10-43(23)26-5-6-33(39-17-26)40-30-13-25(19-41(4)35(30)47)28-7-8-38-34(29(28)20-46)45-12-11-44-31(36(45)48)14-24-15-37(2,3)16-32(24)44/h5-8,13-14,17,19,23,27,46H,9-12,15-16,18,20-22H2,1-4H3,(H,39,40)/t23-/m0/s1	WNEODWDFDXWOLU-QHCPKHFHSA-N					doublet; compound annotation
0391_000483	JNJ-18038683 free base	C20H20ClN3	3.0669	11151899		Clc1ccc(-c2nn(Cc3ccccc3)c3c2CCNCC3)cc1	InChI=1S/C20H20ClN3/c21-17-8-6-16(7-9-17)20-18-10-12-22-13-11-19(18)24(23-20)14-15-4-2-1-3-5-15/h1-9,22H,10-14H2	UKJPMZGILXATGT-UHFFFAOYSA-N					compound annotation
0391_000484	1802326-66-4	C17H17ClN2O2	3.5076	2548547	C[C@@H](C1=CC=CC=C1)NC(=O)CNC(=O)C2=CC(=CC=C2)Cl	CC(NC(=O)CNC(=O)c1cc(Cl)ccc1)c1ccccc1	InChI=1S/C17H17ClN2O2/c1-12(13-6-3-2-4-7-13)20-16(21)11-19-17(22)14-8-5-9-15(18)10-14/h2-10,12H,11H2,1H3,(H,19,22)(H,20,21)/t12-/m0/s1	MWDVCHRYCKXEBY-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_000486	tioconazole	C16H13Cl3N2OS	3.7	5482		Clc1cc(Cl)c(C(Cn2ccnc2)OCc2c(Cl)scc2)cc1	InChI=1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2	QXHHHPZILQDDPS-UHFFFAOYSA-N					compound annotation
0391_000487	AZD-5069	C18H22F2N4O5S2	3.7389	56645576	C[C@H]([C@H](CO)O)OC1=NC(=NC(=C1)NS(=O)(=O)N2CCC2)SCC3=C(C(=CC=C3)F)F	CC(Oc1nc(SCc2c(F)c(F)ccc2)nc(NS(=O)(=O)N2CCC2)c1)C(O)CO	InChI=1S/C18H22F2N4O5S2/c1-11(14(26)9-25)29-16-8-15(23-31(27,28)24-6-3-7-24)21-18(22-16)30-10-12-4-2-5-13(19)17(12)20/h2,4-5,8,11,14,25-26H,3,6-7,9-10H2,1H3,(H,21,22,23)/t11-,14+/m1/s1	QZECRCLSIGFCIO-RISCZKNCSA-N					removed another duplicate entry; compound annotation
0391_000489	3PO	C13H10N2O	0.7958	5720233	C1=CC(=CN=C1)/C=C/C(=O)C2=CC=NC=C2	O=C(C=Cc1cnccc1)c1ccncc1	InChI=1S/C13H10N2O/c16-13(12-5-8-14-9-6-12)4-3-11-2-1-7-15-10-11/h1-10H/b4-3+	UOWGYMNWMDNSTL-ONEGZZNKSA-N					doublet; compound annotation
0391_000490	3PO	C13H10N2O	1.1804	5720233	C1=CC(=CN=C1)/C=C/C(=O)C2=CC=NC=C2	O=C(C=Cc1cnccc1)c1ccncc1	InChI=1S/C13H10N2O/c16-13(12-5-8-14-9-6-12)4-3-11-2-1-7-15-10-11/h1-10H/b4-3+	UOWGYMNWMDNSTL-ONEGZZNKSA-N					doublet; removed another duplicate entry; compound annotation
0391_000492	MPO-IN-28	C11H13N5O	2.0152	2835211		COc1cc2nc(N=C(N)N)nc(C)c2cc1	InChI=1S/C11H13N5O/c1-6-8-4-3-7(17-2)5-9(8)15-11(14-6)16-10(12)13/h3-5H,1-2H3,(H4,12,13,14,15,16)	ZJBMSSBTCGJZEE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000494	FIIN-2	C35H38N8O4	2.7644	91825767		C=CC(=O)Nc1ccc(CN2C(=O)N(c3cc(OC)cc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1	InChI=1S/C35H38N8O4/c1-5-32(44)37-26-8-6-24(7-9-26)22-43-33-25(23-42(35(43)45)29-18-30(46-3)20-31(19-29)47-4)21-36-34(39-33)38-27-10-12-28(13-11-27)41-16-14-40(2)15-17-41/h5-13,18-21H,1,14-17,22-23H2,2-4H3,(H,37,44)(H,36,38,39)	DVBPRWJMHURKHP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000497	losartan	C22H23ClN6O	3.2667	3961		CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)	PSIFNNKUMBGKDQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000499	USP7-IN-1	C23H24ClN3O3	3.6289	71278663		O=C(CCc1ccccc1)N1CCC(O)(Cn2cnc3c(ccc(Cl)c3)c2=O)CC1	InChI=1S/C23H24ClN3O3/c24-18-7-8-19-20(14-18)25-16-27(22(19)29)15-23(30)10-12-26(13-11-23)21(28)9-6-17-4-2-1-3-5-17/h1-5,7-8,14,16,30H,6,9-13,15H2	CITWIBXKKHFDFM-UHFFFAOYSA-N					doublet; compound annotation
0391_000500	USP7-IN-1	C23H24ClN3O3	3.6322	71278663		O=C(CCc1ccccc1)N1CCC(O)(Cn2cnc3c(ccc(Cl)c3)c2=O)CC1	InChI=1S/C23H24ClN3O3/c24-18-7-8-19-20(14-18)25-16-27(22(19)29)15-23(30)10-12-26(13-11-23)21(28)9-6-17-4-2-1-3-5-17/h1-5,7-8,14,16,30H,6,9-13,15H2	CITWIBXKKHFDFM-UHFFFAOYSA-N					doublet; compound annotation
0391_000501	Remodelin	C15H14N4S	4.3925	44442376		N#Cc1ccc(-c2csc(NN=C3CCCC3)n2)cc1	InChI=1S/C15H14N4S/c16-9-11-5-7-12(8-6-11)14-10-20-15(17-14)19-18-13-3-1-2-4-13/h5-8,10H,1-4H2,(H,17,19)	XAEJIFARBQJLML-UHFFFAOYSA-N					compound annotation
0391_000502	ZLN024	C13H13BrN2OS	4.8233	1825716		Cc1cc(Br)c(OCCSc2ncccn2)cc1	InChI=1S/C13H13BrN2OS/c1-10-3-4-12(11(14)9-10)17-7-8-18-13-15-5-2-6-16-13/h2-6,9H,7-8H2,1H3	KWJRSHZSULRJHE-UHFFFAOYSA-N					compound annotation
0391_000503	tolfenpyrad	C21H22ClN3O2	5.3499	10110536		CCc1nn(C)c(C(=O)NCc2ccc(Oc3ccc(C)cc3)cc2)c1Cl	InChI=1S/C21H22ClN3O2/c1-4-18-19(22)20(25(3)24-18)21(26)23-13-15-7-11-17(12-8-15)27-16-9-5-14(2)6-10-16/h5-12H,4,13H2,1-3H3,(H,23,26)	WPALTCMYPARVNV-UHFFFAOYSA-N					compound annotation
0391_000504	salinomycin	C42H70O11	5.8493	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_000505	salinomycin	C42H70O11	6.7091	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_000506	salinomycin	C42H70O11	6.791	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_000507	salinomycin	C42H70O11	7.016	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_000508	Eltoprazine	C12H16N2O2	1.3447	65853		c1cc(N2CCNCC2)c2OCCOc2c1	InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2	WVLHGCRWEHCIOT-UHFFFAOYSA-N					doublet; compound annotation
0391_000509	Eltoprazine	C12H16N2O2	1.3474	65853		c1cc(N2CCNCC2)c2OCCOc2c1	InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2	WVLHGCRWEHCIOT-UHFFFAOYSA-N					doublet; compound annotation
0391_000510	2206736-04-9	C33H39N7O2	2.0412	134326084	CC1=C2C(=CC=C1)C=CC=C2N3CCC4=C(C3)N=C(N=C4N5CCN([C@H](C5)CC#N)C(=O)C=C)OC[C@@H]6CCCN6C	C=CC(=O)N1CCN(c2nc(OCC3CCCN3C)nc3c2CCN(c2cccc4cccc(C)c24)C3)CC1CC#N	InChI=1S/C33H39N7O2/c1-4-30(41)40-19-18-39(20-25(40)13-15-34)32-27-14-17-38(29-12-6-10-24-9-5-8-23(2)31(24)29)21-28(27)35-33(36-32)42-22-26-11-7-16-37(26)3/h4-6,8-10,12,25-26H,1,7,11,13-14,16-22H2,2-3H3/t25-,26-/m0/s1	YRYQLVCTQFBRLD-UIOOFZCWSA-N					doublet; compound annotation
0391_000511	AWZ1066S	C19H19F3N6O	2.4049	135240137	C[C@H]1COCCN1C2=NC3=C(C=CC=N3)C(=N2)NCC4=C(N=CC=C4)C(F)(F)F	CC1COCCN1c1nc2c(cccn2)c(NCc2c(C(F)(F)F)nccc2)n1	InChI=1S/C19H19F3N6O/c1-12-11-29-9-8-28(12)18-26-16-14(5-3-7-24-16)17(27-18)25-10-13-4-2-6-23-15(13)19(20,21)22/h2-7,12H,8-11H2,1H3,(H,24,25,26,27)/t12-/m0/s1	IZFVCNUAPFSNCO-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_000513	Carbetocin	C45H69N11O12S	2.9141	16681432	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)OC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	CCC(C)C1NC(=O)C(Cc2ccc(OC)cc2)NC(=O)CCCSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O	InChI=1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1	NSTRIRCPWQHTIA-DTRKZRJBSA-N					removed another duplicate entry; compound annotation
0391_000515	APY0201	C23H23N7O	3.1308	56927660	CC1=CC(=CC=C1)/C=N/NC2=NC3=CC(=NN3C(=C2)N4CCOCC4)C5=CC=NC=C5	Cc1cc(C=NNc2nc3cc(-c4ccncc4)nn3c(N3CCOCC3)c2)ccc1	InChI=1S/C23H23N7O/c1-17-3-2-4-18(13-17)16-25-27-21-15-23(29-9-11-31-12-10-29)30-22(26-21)14-20(28-30)19-5-7-24-8-6-19/h2-8,13-16H,9-12H2,1H3,(H,26,27)/b25-16+	RFZQYGBLRIKROZ-PCLIKHOPSA-N					removed another duplicate entry; compound annotation
0391_000517	1316214-52-4	C24H27N5O3	3.308	53340666		O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2)nc1)NO	InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)	QGZYDVAGYRLSKP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000520	2206736-04-9	C33H39N7O2	3.5081	134326084	CC1=C2C(=CC=C1)C=CC=C2N3CCC4=C(C3)N=C(N=C4N5CCN([C@H](C5)CC#N)C(=O)C=C)OC[C@@H]6CCCN6C	C=CC(=O)N1CCN(c2nc(OCC3CCCN3C)nc3c2CCN(c2cccc4cccc(C)c24)C3)CC1CC#N	InChI=1S/C33H39N7O2/c1-4-30(41)40-19-18-39(20-25(40)13-15-34)32-27-14-17-38(29-12-6-10-24-9-5-8-23(2)31(24)29)21-28(27)35-33(36-32)42-22-26-11-7-16-37(26)3/h4-6,8-10,12,25-26H,1,7,11,13-14,16-22H2,2-3H3/t25-,26-/m0/s1	YRYQLVCTQFBRLD-UIOOFZCWSA-N					doublet; removed another duplicate entry; compound annotation
0391_000522	BAMB-4	C15H12N2O2	3.8423	8087347		Cc1ccc(C(=O)Nc2noc3ccccc23)cc1	InChI=1S/C15H12N2O2/c1-10-6-8-11(9-7-10)15(18)16-14-12-4-2-3-5-13(12)19-17-14/h2-9H,1H3,(H,16,17,18)	IEPCQLHHUYRTEY-UHFFFAOYSA-N					doublet; compound annotation
0391_000523	BAMB-4	C15H12N2O2	3.8457	8087347		Cc1ccc(C(=O)Nc2noc3ccccc23)cc1	InChI=1S/C15H12N2O2/c1-10-6-8-11(9-7-10)15(18)16-14-12-4-2-3-5-13(12)19-17-14/h2-9H,1H3,(H,16,17,18)	IEPCQLHHUYRTEY-UHFFFAOYSA-N					doublet; compound annotation
0391_000524	MLT-748	C19H19Cl2N9O3	4.1744	129072285	C[C@H]([C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC(=O)NC3=CC(=C(N=C3)N4N=CC=N4)Cl)OC)OC	COC(C)C(OC)c1c(NC(=O)Nc2cc(Cl)c(-n3nccn3)nc2)cnc2cc(Cl)nn12	InChI=1S/C19H19Cl2N9O3/c1-10(32-2)17(33-3)16-13(9-22-15-7-14(21)28-29(15)16)27-19(31)26-11-6-12(20)18(23-8-11)30-24-4-5-25-30/h4-10,17H,1-3H3,(H2,26,27,31)/t10-,17+/m1/s1	XKQLNDPUQSZBJW-QGHHPUGFSA-N					removed another duplicate entry; compound annotation
0391_000526	BAMB-4	C15H12N2O2	5.4322	8087347		Cc1ccc(C(=O)Nc2noc3ccccc23)cc1	InChI=1S/C15H12N2O2/c1-10-6-8-11(9-7-10)15(18)16-14-12-4-2-3-5-13(12)19-17-14/h2-9H,1H3,(H,16,17,18)	IEPCQLHHUYRTEY-UHFFFAOYSA-N					doublet; compound annotation
0391_000527	Genipin	C11H14O5	1.7384	442424	COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O	COC(=O)C1=COC(O)C2C(CO)=CCC12	InChI=1S/C11H14O5/c1-15-10(13)8-5-16-11(14)9-6(4-12)2-3-7(8)9/h2,5,7,9,11-12,14H,3-4H2,1H3/t7-,9-,11-/m1/s1	AZKVWQKMDGGDSV-BCMRRPTOSA-N					compound annotation
0391_000528	CaMKII-IN-1	C29H30ClN5O2S	3.3909	50898538		Cc1c(S(=O)(=O)Nc2nc(NCCc3ccccc3)nc3c2CN(Cc2ccccc2)CC3)cccc1Cl	InChI=1S/C29H30ClN5O2S/c1-21-25(30)13-8-14-27(21)38(36,37)34-28-24-20-35(19-23-11-6-3-7-12-23)18-16-26(24)32-29(33-28)31-17-15-22-9-4-2-5-10-22/h2-14H,15-20H2,1H3,(H2,31,32,33,34)	LGUUETDTMQTHML-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000530	MDL 28170	C22H26N2O4	3.5092	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; removed another duplicate entry; compound annotation
0391_000532	MDL 28170	C22H26N2O4	3.6208	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000533	MDL 28170	C22H26N2O4	3.8805	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000534	MDL 28170	C22H26N2O4	3.8839	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000535	MDL 28170	C22H26N2O4	3.9477	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000536	N-Benzyl-p-toluenesulfonamide	C14H15NO2S	3.9806	95801		Cc1ccc(S(=O)(=O)NCc2ccccc2)cc1	InChI=1S/C14H15NO2S/c1-12-7-9-14(10-8-12)18(16,17)15-11-13-5-3-2-4-6-13/h2-10,15H,11H2,1H3	WTHKAJZQYNKTCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000537	N-Benzyl-p-toluenesulfonamide	C14H15NO2S	3.9838	95801		Cc1ccc(S(=O)(=O)NCc2ccccc2)cc1	InChI=1S/C14H15NO2S/c1-12-7-9-14(10-8-12)18(16,17)15-11-13-5-3-2-4-6-13/h2-10,15H,11H2,1H3	WTHKAJZQYNKTCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000538	MDL 28170	C22H26N2O4	3.9926	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000539	MDL 28170	C22H26N2O4	3.9961	72430	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)Cc1ccccc1	InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1	NGBKFLTYGSREKK-PMACEKPBSA-N					doublet; compound annotation
0391_000540	Valifenalate	C19H27ClN2O5	4.0369	11338509	CC(C)[C@@H](C(=O)NC(CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C	COC(=O)CC(NC(=O)C(NC(=O)OC(C)C)C(C)C)c1ccc(Cl)cc1	InChI=1S/C19H27ClN2O5/c1-11(2)17(22-19(25)27-12(3)4)18(24)21-15(10-16(23)26-5)13-6-8-14(20)9-7-13/h6-9,11-12,15,17H,10H2,1-5H3,(H,21,24)(H,22,25)/t15?,17-/m0/s1	DBXFMOWZRXXBRN-LWKPJOBUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000542	Valifenalate	C19H27ClN2O5	4.0944	11338509	CC(C)[C@@H](C(=O)NC(CC(=O)OC)C1=CC=C(C=C1)Cl)NC(=O)OC(C)C	COC(=O)CC(NC(=O)C(NC(=O)OC(C)C)C(C)C)c1ccc(Cl)cc1	InChI=1S/C19H27ClN2O5/c1-11(2)17(22-19(25)27-12(3)4)18(24)21-15(10-16(23)26-5)13-6-8-14(20)9-7-13/h6-9,11-12,15,17H,10H2,1-5H3,(H,21,24)(H,22,25)/t15?,17-/m0/s1	DBXFMOWZRXXBRN-LWKPJOBUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000544	Ipfencarbazone	C18H14Cl2F2N4O2	4.8606	15457339		CC(C)N(C(=O)n1cnn(-c2c(Cl)cc(Cl)cc2)c1=O)c1c(F)cc(F)cc1	InChI=1S/C18H14Cl2F2N4O2/c1-10(2)25(16-6-4-12(21)8-14(16)22)17(27)24-9-23-26(18(24)28)15-5-3-11(19)7-13(15)20/h3-10H,1-2H3	DHYXNIKICPUXJI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000546	AK-7	C19H21BrN2O3S	5.031	1328033		O=C(Nc1cc(Br)ccc1)c1cc(S(=O)(=O)N2CCCCCC2)ccc1	InChI=1S/C19H21BrN2O3S/c20-16-8-6-9-17(14-16)21-19(23)15-7-5-10-18(13-15)26(24,25)22-11-3-1-2-4-12-22/h5-10,13-14H,1-4,11-12H2,(H,21,23)	IYAYHZZWYNXHEQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000549	Novaluron	C17H9ClF8N2O4	5.2708	93541		O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)OC(F)(F)F)cc1	InChI=1S/C17H9ClF8N2O4/c18-8-6-7(4-5-11(8)31-16(22,23)14(21)32-17(24,25)26)27-15(30)28-13(29)12-9(19)2-1-3-10(12)20/h1-6,14H,(H2,27,28,29,30)	NJPPVKZQTLUDBO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000551	Ximelagatran	C24H35N5O5	1.4818	9574101	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N	CCOC(=O)CNC(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=NO)cc1)C1CCCCC1	InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1	ZXIBCJHYVWYIKI-PZJWPPBQSA-N					doublet; compound annotation
0391_000552	Ximelagatran	C24H35N5O5	1.5686	9574101	CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N	CCOC(=O)CNC(C(=O)N1CCC1C(=O)NCc1ccc(C(N)=NO)cc1)C1CCCCC1	InChI=1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1	ZXIBCJHYVWYIKI-PZJWPPBQSA-N					doublet; removed another duplicate entry; compound annotation
0391_000554	Ipatasertib	C24H32ClN5O2	1.8935	24788740	C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O	CC(C)NCC(C(=O)N1CCN(c2ncnc3c2C(C)CC3O)CC1)c1ccc(Cl)cc1	InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1	GRZXWCHAXNAUHY-NSISKUIASA-N					doublet; compound annotation
0391_000555	GNE-6776	C20H20N4O2	1.9591	122531750		CCc1c(-c2ccc(O)cc2)c(N)ncc1-c1cnc(C(=O)NC)cc1	InChI=1S/C20H20N4O2/c1-3-15-16(13-6-9-17(23-10-13)20(26)22-2)11-24-19(21)18(15)12-4-7-14(25)8-5-12/h4-11,25H,3H2,1-2H3,(H2,21,24)(H,22,26)	UCYSSYGGXOFJKK-UHFFFAOYSA-N					doublet; compound annotation
0391_000556	GNE-6776	C20H20N4O2	1.9618	122531750		CCc1c(-c2ccc(O)cc2)c(N)ncc1-c1cnc(C(=O)NC)cc1	InChI=1S/C20H20N4O2/c1-3-15-16(13-6-9-17(23-10-13)20(26)22-2)11-24-19(21)18(15)12-4-7-14(25)8-5-12/h4-11,25H,3H2,1-2H3,(H2,21,24)(H,22,26)	UCYSSYGGXOFJKK-UHFFFAOYSA-N					doublet; compound annotation
0391_000557	1018927-63-3	C17H19N7O5S3	2.1735	44631827	C1=CC2=NSN=C2C(=C1)S(=O)(=O)NC3=C(SC=C3)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O	NC(N)=NCCCC(NC(=O)c1c(NS(=O)(=O)c2cccc3nsnc23)ccs1)C(=O)O	InChI=1S/C17H19N7O5S3/c18-17(19)20-7-2-4-11(16(26)27)21-15(25)14-10(6-8-30-14)24-32(28,29)12-5-1-3-9-13(12)23-31-22-9/h1,3,5-6,8,11,24H,2,4,7H2,(H,21,25)(H,26,27)(H4,18,19,20)/t11-/m0/s1	ZWWMEDURALZMEV-NSHDSACASA-N					doublet; compound annotation
0391_000558	1018927-63-3	C17H19N7O5S3	2.1763	44631827	C1=CC2=NSN=C2C(=C1)S(=O)(=O)NC3=C(SC=C3)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O	NC(N)=NCCCC(NC(=O)c1c(NS(=O)(=O)c2cccc3nsnc23)ccs1)C(=O)O	InChI=1S/C17H19N7O5S3/c18-17(19)20-7-2-4-11(16(26)27)21-15(25)14-10(6-8-30-14)24-32(28,29)12-5-1-3-9-13(12)23-31-22-9/h1,3,5-6,8,11,24H,2,4,7H2,(H,21,25)(H,26,27)(H4,18,19,20)/t11-/m0/s1	ZWWMEDURALZMEV-NSHDSACASA-N					doublet; compound annotation
0391_000559	Buparlisib	C18H21F3N6O2	2.2202	16654980		Nc1ncc(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)c1	InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)	CWHUFRVAEUJCEF-UHFFFAOYSA-N					doublet; compound annotation
0391_000560	4-Hydroxychalcone	C15H12O2	3.6343	5282361	C1=CC=C(C=C1)C(=O)/C=C/C2=CC=C(C=C2)O	O=C(C=Cc1ccc(O)cc1)c1ccccc1	InChI=1S/C15H12O2/c16-14-9-6-12(7-10-14)8-11-15(17)13-4-2-1-3-5-13/h1-11,16H/b11-8+	PWWCDTYUYPOAIU-DHZHZOJOSA-N					removed another duplicate entry; compound annotation
0391_000562	Pefloxacin	C17H20FN3O3	1.5334	6919009		CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21	InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)	FHFYDNQZQSQIAI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000564	Acetosyringone	C10H12O4	1.9008	17198		COc1cc(C(C)=O)cc(OC)c1O	InChI=1S/C10H12O4/c1-6(11)7-4-8(13-2)10(12)9(5-7)14-3/h4-5,12H,1-3H3	OJOBTAOGJIWAGB-UHFFFAOYSA-N					compound annotation
0391_000565	Dimethylfraxetin	C12H12O5	2.6043	3083928		COc1c(OC)c(OC)c2oc(=O)ccc2c1	InChI=1S/C12H12O5/c1-14-8-6-7-4-5-9(13)17-10(7)12(16-3)11(8)15-2/h4-6H,1-3H3	RAYQKHLZHPFYEJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000568	bufalin	C24H34O4	3.5216	9547215	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O	CC12CCC(O)CC1CCC1C2CCC2(C)C(c3coc(=O)cc3)CCC12O	InChI=1S/C24H34O4/c1-22-10-7-17(25)13-16(22)4-5-20-19(22)8-11-23(2)18(9-12-24(20,23)27)15-3-6-21(26)28-14-15/h3,6,14,16-20,25,27H,4-5,7-13H2,1-2H3/t16-,17+,18-,19+,20-,22+,23-,24+/m1/s1	QEEBRPGZBVVINN-BMPKRDENSA-N					removed another duplicate entry; compound annotation
0391_000570	BRUCEANTIN	C28H36O11	3.5955	5281304	CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)/C=C(\C)/C(C)C)(OC5)C(=O)OC)O)O)C)O	COC(=O)C12OCC34C(CC5C(C)=C(O)C(=O)CC5(C)C3C(O)C1O)OC(=O)C(OC(=O)C=C(C)C(C)C)C24	InChI=1S/C28H36O11/c1-11(2)12(3)7-17(30)39-20-22-27-10-37-28(22,25(35)36-6)23(33)19(32)21(27)26(5)9-15(29)18(31)13(4)14(26)8-16(27)38-24(20)34/h7,11,14,16,19-23,31-33H,8-10H2,1-6H3/b12-7+/t14-,16+,19+,20+,21+,22+,23-,26-,27+,28-/m0/s1	IRQXZTBHNKVIRL-GOTQHHPNSA-N					removed another duplicate entry; compound annotation
0391_000572	Dimethylfraxetin	C12H12O5	4.3196	3083928		COc1c(OC)c(OC)c2oc(=O)ccc2c1	InChI=1S/C12H12O5/c1-14-8-6-7-4-5-9(13)17-10(7)12(16-3)11(8)15-2/h4-6H,1-3H3	RAYQKHLZHPFYEJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000573	trapidil	C10H15N5	1.5365	5531		CCN(CC)c1cc(C)nc2ncnn12	InChI=1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-10-11-7-12-15(9)10/h6-7H,4-5H2,1-3H3	GSNOZLZNQMLSKJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000575	ETHACRIDINE	C15H15N3O	2.1877	2017		CCOc1cc2c(N)c3c(cc(N)cc3)nc2cc1	InChI=1S/C15H15N3O/c1-2-19-10-4-6-13-12(8-10)15(17)11-5-3-9(16)7-14(11)18-13/h3-8H,2,16H2,1H3,(H2,17,18)	CIKWKGFPFXJVGW-UHFFFAOYSA-N					doublet; compound annotation
0391_000576	Olopatadine	C21H23NO3	2.6368	25271818	C[NH+](C)CC/C=C\1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)[O-]	CN(C)CCC=C1c2ccccc2COc2c1cc(CC(=O)O)cc2	InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-	JBIMVDZLSHOPLA-LSCVHKIXSA-N					compound annotation
0391_000577	bentiromide	C23H20N2O5	2.8767	6957673	C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)C(=O)O	O=C(O)c1ccc(NC(=O)C(Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1	InChI=1S/C23H20N2O5/c26-19-12-6-15(7-13-19)14-20(25-21(27)16-4-2-1-3-5-16)22(28)24-18-10-8-17(9-11-18)23(29)30/h1-13,20,26H,14H2,(H,24,28)(H,25,27)(H,29,30)/t20-/m0/s1	SPPTWHFVYKCNNK-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_000579	phenolphthalein	C20H14O4	3.1231	4764		O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc12	InChI=1S/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22H	KJFMBFZCATUALV-UHFFFAOYSA-N					compound annotation
0391_000580	Erythrosin B	C20H8I4O5	4.6522	3259		O=C1OC2(c3ccccc13)c1cc(I)c(O)c(I)c1Oc1c(I)c(O)c(I)cc12	InChI=1S/C20H8I4O5/c21-11-5-9-17(13(23)15(11)25)28-18-10(6-12(22)16(26)14(18)24)20(9)8-4-2-1-3-7(8)19(27)29-20/h1-6,25-26H	OALHHIHQOFIMEF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000582	Solvent blue 35	C22H26N2O2	6.5943	3766139		CCCCNc1c2C(=O)c3ccccc3C(=O)c2c(NCCCC)cc1	InChI=1S/C22H26N2O2/c1-3-5-13-23-17-11-12-18(24-14-6-4-2)20-19(17)21(25)15-9-7-8-10-16(15)22(20)26/h7-12,23-24H,3-6,13-14H2,1-2H3	OCQDPIXQTSYZJL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000584	NEOSTIGMINE	C12H19N2O2+	0.9976	4456		CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1	InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1	ALWKGYPQUAPLQC-UHFFFAOYSA-N					doublet; compound annotation
0391_000585	Rimeporide	C11H15N3O5S2	1.3023	9799487		Cc1cc(S(C)(=O)=O)c(S(C)(=O)=O)cc1C(=O)N=C(N)N	InChI=1S/C11H15N3O5S2/c1-6-4-8(20(2,16)17)9(21(3,18)19)5-7(6)10(15)14-11(12)13/h4-5H,1-3H3,(H4,12,13,14,15)	GROMEQPXDKRRIE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000587	Sulfaclozine	C10H9ClN4O2S	2.4172	66890		Nc1ccc(S(=O)(=O)Nc2cncc(Cl)n2)cc1	InChI=1S/C10H9ClN4O2S/c11-9-5-13-6-10(14-9)15-18(16,17)8-3-1-7(12)2-4-8/h1-6H,12H2,(H,14,15)	QKLPUVXBJHRFQZ-UHFFFAOYSA-N					compound annotation
0391_000588	nu2058	C12H17N5O	2.448	4564		Nc1nc2c([nH]cn2)c(OCC2CCCCC2)n1	InChI=1S/C12H17N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h7-8H,1-6H2,(H3,13,14,15,16,17)	MWGXGTJJAOZBNW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000590	MI-136	C23H21F3N6S	2.794	86297077		N#Cc1cc2c(ccc(CN3CCC(Nc4c5cc(CC(F)(F)F)sc5ncn4)CC3)c2)[nH]1	InChI=1S/C23H21F3N6S/c24-23(25,26)10-18-9-19-21(28-13-29-22(19)33-18)31-16-3-5-32(6-4-16)12-14-1-2-20-15(7-14)8-17(11-27)30-20/h1-2,7-9,13,16,30H,3-6,10,12H2,(H,28,29,31)	PSOJDGBGVBEYJX-UHFFFAOYSA-N					compound annotation
0391_000591	procyclidine	C19H29NO	2.9644	4919		OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1	InChI=1S/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2	WYDUSKDSKCASEF-UHFFFAOYSA-N					compound annotation
0391_000592	Hypaconitine	C33H45NO10	3.154	441737	CC(=O)O[C@@]12[C@@H]3[C@@H](C[C@@]([C@@H]3OC(=O)C4=CC=CC=C4)([C@H]([C@@H]1O)OC)O)[C@]56[C@H](CC[C@@]7([C@H]5[C@H]([C@H]2C6N(C7)C)OC)COC)OC	COCC12CCC(OC)C34C5CC6(O)C(OC)C(O)C(OC(C)=O)(C5C6OC(=O)c5ccccc5)C(C(OC)C13)C4N(C)C2	InChI=1S/C33H45NO10/c1-17(35)44-33-21-19(14-31(38,28(42-6)26(33)36)27(21)43-29(37)18-10-8-7-9-11-18)32-20(40-4)12-13-30(16-39-3)15-34(2)25(32)22(33)23(41-5)24(30)32/h7-11,19-28,36,38H,12-16H2,1-6H3/t19-,20+,21-,22+,23+,24-,25?,26+,27-,28+,30+,31-,32+,33-/m1/s1	FIDOCHXHMJHKRW-VHQVDBNASA-N					compound annotation
0391_000593	Ansofaxine	C24H31NO3	3.5994	15983287		Cc1ccc(C(=O)Oc2ccc(C(CN(C)C)C3(O)CCCCC3)cc2)cc1	InChI=1S/C24H31NO3/c1-18-7-9-20(10-8-18)23(26)28-21-13-11-19(12-14-21)22(17-25(2)3)24(27)15-5-4-6-16-24/h7-14,22,27H,4-6,15-17H2,1-3H3	QKYBZJLEMOZFFU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000595	Phorbol 12,13-dibutyrate	C28H40O8	4.516	37783	CCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)CCC)O)C	CCCC(=O)OC1C(C)C2(O)C(C=C(CO)CC3(O)C(=O)C(C)=CC32)C2C(C)(C)C12OC(=O)CCC	InChI=1S/C28H40O8/c1-7-9-20(30)35-24-16(4)27(34)18(22-25(5,6)28(22,24)36-21(31)10-8-2)12-17(14-29)13-26(33)19(27)11-15(3)23(26)32/h11-12,16,18-19,22,24,29,33-34H,7-10,13-14H2,1-6H3/t16-,18+,19-,22-,24-,26-,27-,28-/m1/s1	BQJRUJTZSGYBEZ-YVQNUNKESA-N					compound annotation
0391_000596	CHELIDONINE	C20H19NO5	2.0888	197810	CN1CC2=C(C=CC3=C2OCO3)[C@@H]4[C@H]1C5=CC6=C(C=C5C[C@@H]4O)OCO6	CN1Cc2c(ccc3c2OCO3)C2C(O)Cc3cc4c(cc3C21)OCO4	InChI=1S/C20H19NO5/c1-21-7-13-11(2-3-15-20(13)26-9-23-15)18-14(22)4-10-5-16-17(25-8-24-16)6-12(10)19(18)21/h2-3,5-6,14,18-19,22H,4,7-9H2,1H3/t14-,18-,19+/m0/s1	GHKISGDRQRSCII-ZOCIIQOWSA-N					doublet; compound annotation
0391_000597	CHELIDONINE	C20H19NO5	2.1777	197810	CN1CC2=C(C=CC3=C2OCO3)[C@@H]4[C@H]1C5=CC6=C(C=C5C[C@@H]4O)OCO6	CN1Cc2c(ccc3c2OCO3)C2C(O)Cc3cc4c(cc3C21)OCO4	InChI=1S/C20H19NO5/c1-21-7-13-11(2-3-15-20(13)26-9-23-15)18-14(22)4-10-5-16-17(25-8-24-16)6-12(10)19(18)21/h2-3,5-6,14,18-19,22H,4,7-9H2,1H3/t14-,18-,19+/m0/s1	GHKISGDRQRSCII-ZOCIIQOWSA-N					doublet; compound annotation
0391_000598	Tilmicosin	C46H80N2O13	2.5025	5282521	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CCN3C[C@@H](C[C@@H](C3)C)C)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(O)C(N(C)C)C2O)C(CCN2CC(C)CC(C)C2)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H80N2O13/c1-13-36-33(24-57-46-44(56-12)43(55-11)40(53)31(8)59-46)19-25(2)14-15-34(49)28(5)20-32(16-17-48-22-26(3)18-27(4)23-48)42(29(6)35(50)21-37(51)60-36)61-45-41(54)38(47(9)10)39(52)30(7)58-45/h14-15,19,26-33,35-36,38-46,50,52-54H,13,16-18,20-24H2,1-12H3/b15-14+,25-19+/t26-,27+,28-,29+,30-,31-,32+,33-,35-,36-,38+,39-,40-,41-,42-,43-,44-,45+,46-/m1/s1	JTSDBFGMPLKDCD-XVFHVFLVSA-N					doublet; compound annotation
0391_000599	Tilmicosin	C46H80N2O13	2.5426	5282521	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CCN3C[C@@H](C[C@@H](C3)C)C)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(O)C(N(C)C)C2O)C(CCN2CC(C)CC(C)C2)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H80N2O13/c1-13-36-33(24-57-46-44(56-12)43(55-11)40(53)31(8)59-46)19-25(2)14-15-34(49)28(5)20-32(16-17-48-22-26(3)18-27(4)23-48)42(29(6)35(50)21-37(51)60-36)61-45-41(54)38(47(9)10)39(52)30(7)58-45/h14-15,19,26-33,35-36,38-46,50,52-54H,13,16-18,20-24H2,1-12H3/b15-14+,25-19+/t26-,27+,28-,29+,30-,31-,32+,33-,35-,36-,38+,39-,40-,41-,42-,43-,44-,45+,46-/m1/s1	JTSDBFGMPLKDCD-XVFHVFLVSA-N					doublet; compound annotation
0391_000600	Pramocaine	C17H27NO3	2.9792	4886		CCCCOc1ccc(OCCCN2CCOCC2)cc1	InChI=1S/C17H27NO3/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18/h5-8H,2-4,9-15H2,1H3	DQKXQSGTHWVTAD-UHFFFAOYSA-N					compound annotation
0391_000601	proscillaridin	C30H42O8	3.2081	5284613	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)O	CC1OC(OC2C=C3CCC4C(CCC5(C)C(c6coc(=O)cc6)CCC45O)C3(C)CC2)C(O)C(O)C1O	InChI=1S/C30H42O8/c1-16-24(32)25(33)26(34)27(37-16)38-19-8-11-28(2)18(14-19)5-6-22-21(28)9-12-29(3)20(10-13-30(22,29)35)17-4-7-23(31)36-15-17/h4,7,14-16,19-22,24-27,32-35H,5-6,8-13H2,1-3H3/t16-,19-,20+,21-,22+,24-,25+,26+,27-,28-,29+,30-/m0/s1	MYEJFUXQJGHEQK-ALRJYLEOSA-N					removed another duplicate entry; compound annotation
0391_000603	IODIPAMIDE	C20H14I6N2O6	3.2081	3739		O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I	InChI=1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34)	FFINMCNLQNTKLU-UHFFFAOYSA-N					compound annotation
0391_000604	NIFURSOL	C12H7N5O9	3.2954	9570327	C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O	O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1c(O)c([N+](=O)[O-])cc([N+](=O)[O-])c1	InChI=1S/C12H7N5O9/c18-11-8(3-6(15(20)21)4-9(11)16(22)23)12(19)14-13-5-7-1-2-10(26-7)17(24)25/h1-5,18H,(H,14,19)/b13-5+	XXUXXCZCUGIGPP-WLRTZDKTSA-N					compound annotation
0391_000605	fendiline	C23H25N	3.4794	3336		CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1	InChI=1S/C23H25N/c1-19(20-11-5-2-6-12-20)24-18-17-23(21-13-7-3-8-14-21)22-15-9-4-10-16-22/h2-16,19,23-24H,17-18H2,1H3	NMKSAYKQLCHXDK-UHFFFAOYSA-N					compound annotation
0391_000606	11beta-Hydroxyprogesterone	C21H30O3	3.7358	101788	CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C	CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C	InChI=1S/C21H30O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h10,15-19,24H,4-9,11H2,1-3H3/t15-,16+,17-,18-,19+,20-,21+/m0/s1	BFZHCUBIASXHPK-ATWVFEABSA-N					removed another duplicate entry; compound annotation
0391_000608	Atglistatin	C17H21N3O	1.7442	71699712		CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1	InChI=1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)	AWOPBSAJHCUSAS-UHFFFAOYSA-N					doublet; compound annotation
0391_000609	LY2119620	C19H24ClN5O3S	2.0589	57664406		Cc1c2c(N)c(C(=O)NC3CC3)sc2nc(OCC(=O)N2CCN(C)CC2)c1Cl	InChI=1S/C19H24ClN5O3S/c1-10-13-15(21)16(17(27)22-11-3-4-11)29-19(13)23-18(14(10)20)28-9-12(26)25-7-5-24(2)6-8-25/h11H,3-9,21H2,1-2H3,(H,22,27)	TYTGOXSAAQWLPJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000611	Atglistatin	C17H21N3O	2.3174	71699712		CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1	InChI=1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)	AWOPBSAJHCUSAS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000613	Atglistatin	C17H21N3O	2.3224	71699712		CN(C)C(=O)Nc1cccc(-c2ccc(N(C)C)cc2)c1	InChI=1S/C17H21N3O/c1-19(2)16-10-8-13(9-11-16)14-6-5-7-15(12-14)18-17(21)20(3)4/h5-12H,1-4H3,(H,18,21)	AWOPBSAJHCUSAS-UHFFFAOYSA-N					doublet; compound annotation
0391_000614	BX517	C15H14N4O2	2.5202	11161844	C/C(=C/1\C2=C(C=CC(=C2)NC(=O)N)NC1=O)/C3=CC=CN3	CC(=C1C(=O)Nc2ccc(NC(N)=O)cc12)c1ccc[nH]1	InChI=1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8-	DFURSNCTQGJRRX-JYRVWZFOSA-N					doublet; removed another duplicate entry; compound annotation
0391_000616	BX517	C15H14N4O2	2.5239	11161844	C/C(=C/1\C2=C(C=CC(=C2)NC(=O)N)NC1=O)/C3=CC=CN3	CC(=C1C(=O)Nc2ccc(NC(N)=O)cc12)c1ccc[nH]1	InChI=1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8-	DFURSNCTQGJRRX-JYRVWZFOSA-N					doublet; compound annotation
0391_000617	Benzoylhypaconine	C31H43NO9	2.5996	78358535	CN1C[C@@]2(CCC(C34[C@@H]2C(C(C31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6OC(=O)C7=CC=CC=C7)([C@H]([C@@H]5O)OC)O)O)OC)OC)COC	COCC12CCC(OC)C34C5CC6(O)C(OC)C(O)C(O)(C5C6OC(=O)c5ccccc5)C(C(OC)C13)C4N(C)C2	InChI=1S/C31H43NO9/c1-32-14-28(15-37-2)12-11-18(38-3)30-17-13-29(35)25(41-27(34)16-9-7-6-8-10-16)19(17)31(36,24(33)26(29)40-5)20(23(30)32)21(39-4)22(28)30/h6-10,17-26,33,35-36H,11-15H2,1-5H3/t17-,18?,19-,20?,21?,22-,23?,24+,25-,26+,28+,29-,30?,31-/m1/s1	MDFCJNFOINXVSU-JSRYRGFVSA-N					compound annotation
0391_000618	587850-67-7	C14H16N2O2S	3.1954	833539		Nc1ccc(S(=O)(=O)NCCc2ccccc2)cc1	InChI=1S/C14H16N2O2S/c15-13-6-8-14(9-7-13)19(17,18)16-11-10-12-4-2-1-3-5-12/h1-9,16H,10-11,15H2	BYWZPUPRVIECEC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000620	Rutaecarpine	C18H13N3O	3.9917	65752		O=c1c2ccccc2nc2-c3c(CCn21)c1ccccc1[nH]3	InChI=1S/C18H13N3O/c22-18-13-6-2-4-8-15(13)20-17-16-12(9-10-21(17)18)11-5-1-3-7-14(11)19-16/h1-8,19H,9-10H2	ACVGWSKVRYFWRP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000622	gambogic acid	C38H44O8	6.5952	9852185	CC(=CCC[C@@]1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)O)O)C)C	CC(C)=CCCC1(C)C=Cc2c(O1)c(CC=C(C)C)c1OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c1c2O	InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43)/b22-13-/t23-,27+,36-,37+,38-/m1/s1	GEZHEQNLKAOMCA-RRZNCOCZSA-N					doublet; compound annotation
0391_000623	gambogic acid	C38H44O8	6.6736	9852185	CC(=CCC[C@@]1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)O)O)C)C	CC(C)=CCCC1(C)C=Cc2c(O1)c(CC=C(C)C)c1OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c1c2O	InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43)/b22-13-/t23-,27+,36-,37+,38-/m1/s1	GEZHEQNLKAOMCA-RRZNCOCZSA-N					doublet; compound annotation
0391_000624	gambogic acid	C38H44O8	6.8101	9852185	CC(=CCC[C@@]1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)O)O)C)C	CC(C)=CCCC1(C)C=Cc2c(O1)c(CC=C(C)C)c1OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c1c2O	InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43)/b22-13-/t23-,27+,36-,37+,38-/m1/s1	GEZHEQNLKAOMCA-RRZNCOCZSA-N					doublet; compound annotation
0391_000625	gambogic acid	C38H44O8	6.8138	9852185	CC(=CCC[C@@]1(C=CC2=C(C3=C(C(=C2O1)CC=C(C)C)O[C@@]45[C@H]6C[C@@H](C=C4C3=O)C(=O)[C@@]5(OC6(C)C)C/C=C(/C)\C(=O)O)O)C)C	CC(C)=CCCC1(C)C=Cc2c(O1)c(CC=C(C)C)c1OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c1c2O	InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43)/b22-13-/t23-,27+,36-,37+,38-/m1/s1	GEZHEQNLKAOMCA-RRZNCOCZSA-N					doublet; compound annotation
0391_000626	Nirogacestat	C27H41F2N5O	1.999	46224413	CCC[C@@H](C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)N[C@H]2CCC3=C(C2)C(=CC(=C3)F)F	CCCC(NC1CCc2c(C1)c(F)cc(F)c2)C(=O)Nc1cn(C(C)(C)CNCC(C)(C)C)cn1	InChI=1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1	VFCRKLWBYMDAED-REWPJTCUSA-N					removed another duplicate entry; compound annotation
0391_000628	Targapremir-210	C32H36N10O2	2.0568	44221088		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2cc(OCCCC(=O)NCCCN=[N+]=[N-])ccc2)[nH]4)[nH]3)CC1	InChI=1S/C32H36N10O2/c1-41-14-16-42(17-15-41)24-9-11-27-29(21-24)39-32(37-27)23-8-10-26-28(20-23)38-31(36-26)22-5-2-6-25(19-22)44-18-3-7-30(43)34-12-4-13-35-40-33/h2,5-6,8-11,19-21H,3-4,7,12-18H2,1H3,(H,34,43)(H,36,38)(H,37,39)	PAYVJEWMAWLKAP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000630	Neohesperidin	C28H34O15	2.2356	442439	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)CO)O)O)O)O)O	COc1c(O)cc(C2CC(=O)c3c(O)cc(OC4OC(CO)C(O)C(O)C4OC4OC(C)C(O)C(O)C4O)cc3O2)cc1	InChI=1S/C28H34O15/c1-10-21(33)23(35)25(37)27(39-10)43-26-24(36)22(34)19(9-29)42-28(26)40-12-6-14(31)20-15(32)8-17(41-18(20)7-12)11-3-4-16(38-2)13(30)5-11/h3-7,10,17,19,21-31,33-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1	ARGKVCXINMKCAZ-UZRWAPQLSA-N					removed another duplicate entry; compound annotation
0391_000632	FLUOCINOLONE ACETONIDE	C24H30F2O6	3.2997	6215	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O	CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1	FEBLZLNTKCEFIT-VSXGLTOVSA-N					removed another duplicate entry; compound annotation
0391_000634	Ginkgetin	C32H22O10	4.1477	5271805		COc1cc(O)c2c(=O)cc(-c3cc(-c4c(O)cc(O)c5c4oc(-c4ccc(O)cc4)cc5=O)c(OC)cc3)oc2c1	InChI=1S/C32H22O10/c1-39-18-10-20(34)30-23(37)13-27(41-28(30)11-18)16-5-8-25(40-2)19(9-16)29-21(35)12-22(36)31-24(38)14-26(42-32(29)31)15-3-6-17(33)7-4-15/h3-14,33-36H,1-2H3	AIFCFBUSLAEIBR-UHFFFAOYSA-N					compound annotation
0391_000635	FLI-06	C25H30N2O5	4.9434	3103157		CC1=C(C(=O)OC2CCCCC2)C(c2ccc([N+](=O)[O-])cc2)C2=C(CC(C)(C)CC2=O)N1	InChI=1S/C25H30N2O5/c1-15-21(24(29)32-18-7-5-4-6-8-18)22(16-9-11-17(12-10-16)27(30)31)23-19(26-15)13-25(2,3)14-20(23)28/h9-12,18,22,26H,4-8,13-14H2,1-3H3	SWWVFYHSSOWZMF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000637	cetrimonium	C19H42N+	5.2851	2681		CCCCCCCCCCCCCCCC[N+](C)(C)C	InChI=1S/C19H42N/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4/h5-19H2,1-4H3/q+1	RLGQACBPNDBWTB-UHFFFAOYSA-N					compound annotation
0391_000638	Schisandrin B	C23H28O6	5.5888	108130		COc1c(OC)c(OC)c2c(c1)CC(C)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C23H28O6/c1-12-7-14-9-16(24-3)20(25-4)22(26-5)18(14)19-15(8-13(12)2)10-17-21(23(19)27-6)29-11-28-17/h9-10,12-13H,7-8,11H2,1-6H3	RTZKSTLPRTWFEV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000640	Schisandrin B	C23H28O6	5.6506	108130		COc1c(OC)c(OC)c2c(c1)CC(C)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C23H28O6/c1-12-7-14-9-16(24-3)20(25-4)22(26-5)18(14)19-15(8-13(12)2)10-17-21(23(19)27-6)29-11-28-17/h9-10,12-13H,7-8,11H2,1-6H3	RTZKSTLPRTWFEV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000643	SCHEMBL245816	C12H19NO4S	1.2533	4312242		CCN(CCCS(=O)(=O)O)c1cc(OC)ccc1	InChI=1S/C12H19NO4S/c1-3-13(8-5-9-18(14,15)16)11-6-4-7-12(10-11)17-2/h4,6-7,10H,3,5,8-9H2,1-2H3,(H,14,15,16)	STBWJPWQQLXSCK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000645	LDN-212854	C25H22N6	1.7023	60182388		c1cc2ncccc2c(-c2c3ncc(-c4ccc(N5CCNCC5)cc4)cn3nc2)c1	InChI=1S/C25H22N6/c1-3-21(22-4-2-10-27-24(22)5-1)23-16-29-31-17-19(15-28-25(23)31)18-6-8-20(9-7-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2	BBDGBGOVJPEFBT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000647	DY131	C18H21N3O2	2.101	5497124	CCN(CC)C1=CC=C(C=C1)/C=N/NC(=O)C2=CC=C(C=C2)O	CCN(CC)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1	InChI=1S/C18H21N3O2/c1-3-21(4-2)16-9-5-14(6-10-16)13-19-20-18(23)15-7-11-17(22)12-8-15/h5-13,22H,3-4H2,1-2H3,(H,20,23)/b19-13+	WLKOCYWYAWBGKY-CPNJWEJPSA-N					removed another duplicate entry; compound annotation
0391_000650	ABTS	C18H18N4O6S4	2.101	6301202	CCN1/C(=N\N=C/2\SC3=C(N2CC)C=CC(=C3)S(=O)(=O)O)/SC4=C1C=CC(=C4)S(=O)(=O)O	CCn1c(=NN=c2sc3c(ccc(S(=O)(=O)O)c3)n2CC)sc2c1ccc(S(=O)(=O)O)c2	InChI=1S/C18H18N4O6S4/c1-3-21-13-7-5-11(31(23,24)25)9-15(13)29-17(21)19-20-18-22(4-2)14-8-6-12(32(26,27)28)10-16(14)30-18/h5-10H,3-4H2,1-2H3,(H,23,24,25)(H,26,27,28)/b19-17+,20-18+	ZTOJFFHGPLIVKC-XPWSMXQVSA-N					compound annotation
0391_000651	nutlin-3B	C30H30Cl2N4O4	2.9524	16755649	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m1/s1	BDUHCSBCVGXTJM-IZLXSDGUSA-N					doublet; compound annotation
0391_000652	nutlin-3B	C30H30Cl2N4O4	3.1819	16755649	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m1/s1	BDUHCSBCVGXTJM-IZLXSDGUSA-N					doublet; compound annotation
0391_000653	Flupentixol	C23H25F3N2OS	3.3627	5281881	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO	OCCN1CCN(CCC=C2c3ccccc3Sc3c2cc(C(F)(F)F)cc3)CC1	InChI=1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5-	NJMYODHXAKYRHW-DVZOWYKESA-N					doublet; compound annotation
0391_000654	CW069	C23H21IN2O3	3.4501	73427517	C1=CC=C(C=C1)C[C@@H](C(=O)NC2=C(C=C(C=C2)I)C(=O)O)NCC3=CC=CC=C3	O=C(O)c1c(NC(=O)C(Cc2ccccc2)NCc2ccccc2)ccc(I)c1	InChI=1S/C23H21IN2O3/c24-18-11-12-20(19(14-18)23(28)29)26-22(27)21(13-16-7-3-1-4-8-16)25-15-17-9-5-2-6-10-17/h1-12,14,21,25H,13,15H2,(H,26,27)(H,28,29)/t21-/m0/s1	IRDIXDXDSUBHIU-NRFANRHFSA-N					compound annotation
0391_000655	Flupentixol	C23H25F3N2OS	3.5141	5281881	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO	OCCN1CCN(CCC=C2c3ccccc3Sc3c2cc(C(F)(F)F)cc3)CC1	InChI=1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5-	NJMYODHXAKYRHW-DVZOWYKESA-N					doublet; compound annotation
0391_000656	nutlin-3B	C30H30Cl2N4O4	3.6469	16755649	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m1/s1	BDUHCSBCVGXTJM-IZLXSDGUSA-N					doublet; compound annotation
0391_000657	nutlin-3B	C30H30Cl2N4O4	3.7995	16755649	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@@H]([C@@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m1/s1	BDUHCSBCVGXTJM-IZLXSDGUSA-N					doublet; compound annotation
0391_000658	LOXIGLUMIDE	C21H30Cl2N2O5	4.3958	60182		CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C21H30Cl2N2O5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18H,3-6,9-13H2,1-2H3,(H,24,28)(H,26,27)	QNQZBKQEIFTHFZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000660	Sudan III	C22H16N4O	6.6966	62331		Oc1c(N=Nc2ccc(N=Nc3ccccc3)cc2)c2ccccc2cc1	InChI=1S/C22H16N4O/c27-21-15-10-16-6-4-5-9-20(16)22(21)26-25-19-13-11-18(12-14-19)24-23-17-7-2-1-3-8-17/h1-15,27H	FHNINJWBTRXEBC-UHFFFAOYSA-N					compound annotation
0391_000661	pantothenic acid	C9H17NO5	0.6337	6613	CC(C)(CO)[C@H](C(=O)NCCC(=O)O)O	CC(C)(CO)C(O)C(=O)NCCC(=O)O	InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1	GHOKWGTUZJEAQD-ZETCQYMHSA-N					doublet; compound annotation
0391_000662	pantothenic acid	C9H17NO5	0.6373	6613	CC(C)(CO)[C@H](C(=O)NCCC(=O)O)O	CC(C)(CO)C(O)C(=O)NCCC(=O)O	InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1	GHOKWGTUZJEAQD-ZETCQYMHSA-N					doublet; compound annotation
0391_000663	Bruceine D	C20H26O9	1.3045	441788	CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@]4([C@H](C(=O)O3)O)O)(OC5)C)O)O)C)O	CC1=CC(=O)C(O)C2(C)C1CC1OC(=O)C(O)C3(O)C4(C)OCC13C2C(O)C4O	InChI=1S/C20H26O9/c1-7-4-9(21)13(23)17(2)8(7)5-10-19-6-28-18(3,14(24)11(22)12(17)19)20(19,27)15(25)16(26)29-10/h4,8,10-15,22-25,27H,5-6H2,1-3H3/t8-,10+,11+,12+,13+,14-,15-,17-,18+,19+,20+/m0/s1	JBDMZGKDLMGOFR-KQSRGDCESA-N					removed another duplicate entry; compound annotation
0391_000665	ambroxol	C13H18Br2N2O	2.0844	2132		Nc1c(CNC2CCC(O)CC2)cc(Br)cc1Br	InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2	JBDGDEWWOUBZPM-UHFFFAOYSA-N					compound annotation
0391_000666	INCB 3284	C26H31F3N4O4	2.3353	11527661	COC1=NC=C(C=C1)C2(CCC(CC2)N3CC[C@H](C3)NC(=O)CNC(=O)C4=CC(=CC=C4)C(F)(F)F)O	COc1ncc(C2(O)CCC(N3CCC(NC(=O)CNC(=O)c4cc(C(F)(F)F)ccc4)C3)CC2)cc1	InChI=1S/C26H31F3N4O4/c1-37-23-6-5-19(14-30-23)25(36)10-7-21(8-11-25)33-12-9-20(16-33)32-22(34)15-31-24(35)17-3-2-4-18(13-17)26(27,28)29/h2-6,13-14,20-21,36H,7-12,15-16H2,1H3,(H,31,35)(H,32,34)/t20-,21?,25?/m1/s1	NXZNYBUBXWWKCP-JMOWIOHXSA-N					doublet; compound annotation
0391_000667	INCB 3284	C26H31F3N4O4	2.338	11527661	COC1=NC=C(C=C1)C2(CCC(CC2)N3CC[C@H](C3)NC(=O)CNC(=O)C4=CC(=CC=C4)C(F)(F)F)O	COc1ncc(C2(O)CCC(N3CCC(NC(=O)CNC(=O)c4cc(C(F)(F)F)ccc4)C3)CC2)cc1	InChI=1S/C26H31F3N4O4/c1-37-23-6-5-19(14-30-23)25(36)10-7-21(8-11-25)33-12-9-20(16-33)32-22(34)15-31-24(35)17-3-2-4-18(13-17)26(27,28)29/h2-6,13-14,20-21,36H,7-12,15-16H2,1H3,(H,31,35)(H,32,34)/t20-,21?,25?/m1/s1	NXZNYBUBXWWKCP-JMOWIOHXSA-N					doublet; compound annotation
0391_000668	thioflavin T cation	C17H19N2S+	2.6734	16954		Cc1cc2c(cc1)[n+](C)c(-c1ccc(N(C)C)cc1)s2	InChI=1S/C17H19N2S/c1-12-5-10-15-16(11-12)20-17(19(15)4)13-6-8-14(9-7-13)18(2)3/h5-11H,1-4H3/q+1	FXEKRIDRIFBJOR-UHFFFAOYSA-N					doublet; compound annotation
0391_000669	thioflavin T cation	C17H19N2S+	2.789	16954		Cc1cc2c(cc1)[n+](C)c(-c1ccc(N(C)C)cc1)s2	InChI=1S/C17H19N2S/c1-12-5-10-15-16(11-12)20-17(19(15)4)13-6-8-14(9-7-13)18(2)3/h5-11H,1-4H3/q+1	FXEKRIDRIFBJOR-UHFFFAOYSA-N					doublet; compound annotation
0391_000670	NVP-HSP990	C20H18FN5O2	3.0596	46216556	CC1=C2C(=NC(=N1)N)C[C@@H](NC2=O)C3=C(C=C(C=C3)F)C4=NC(=CC=C4)OC	COc1cccc(-c2cc(F)ccc2C2Cc3nc(N)nc(C)c3C(=O)N2)n1	InChI=1S/C20H18FN5O2/c1-10-18-16(26-20(22)23-10)9-15(25-19(18)27)12-7-6-11(21)8-13(12)14-4-3-5-17(24-14)28-2/h3-8,15H,9H2,1-2H3,(H,25,27)(H2,22,23,26)/t15-/m1/s1	WSMQUUGTQYPVPD-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_000672	fluorescein	C20H12O5	3.1911	16850		O=C1OC2(c3ccc(O)cc3Oc3c2ccc(O)c3)c2ccccc12	InChI=1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H	GNBHRKFJIUUOQI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000675	D-64131	C16H13NO2	4.1871	3921152		COc1cc2c(cc1)[nH]c(C(=O)c1ccccc1)c2	InChI=1S/C16H13NO2/c1-19-13-7-8-14-12(9-13)10-15(17-14)16(18)11-5-3-2-4-6-11/h2-10,17H,1H3	ICMIJSRDISNKOC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000677	CEP-32496	C24H22F3N5O5	4.3339	56846693		COc1c(OC)cc2c(Oc3cccc(NC(=O)Nc4noc(C(C)(C)C(F)(F)F)c4)c3)ncnc2c1	InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)	DKNUPRMJNUQNHR-UHFFFAOYSA-N					doublet; compound annotation
0391_000678	CEP-32496	C24H22F3N5O5	4.3389	56846693		COc1c(OC)cc2c(Oc3cccc(NC(=O)Nc4noc(C(C)(C)C(F)(F)F)c4)c3)ncnc2c1	InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)	DKNUPRMJNUQNHR-UHFFFAOYSA-N					doublet; compound annotation
0391_000679	Fmoc-N-Me-Leu-OH	C22H25NO4	4.9279	7015835	CC(C)C[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13	CC(C)CC(C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21	InChI=1S/C22H25NO4/c1-14(2)12-20(21(24)25)23(3)22(26)27-13-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h4-11,14,19-20H,12-13H2,1-3H3,(H,24,25)/t20-/m0/s1	BUJQSIPFDWLNDC-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_000681	140651-18-9	C9H10N6O	1.2556	135398514		Nc1n[nH]c(N)c1N=Nc1ccc(O)cc1	InChI=1S/C9H10N6O/c10-8-7(9(11)15-14-8)13-12-5-1-3-6(16)4-2-5/h1-4,16H,(H5,10,11,14,15)	AYZRKFOEZQBUEA-UHFFFAOYSA-N					compound annotation
0391_000682	Rilmenidine	C10H16N2O	1.5641	68712		C1COC(NC(C2CC2)C2CC2)=N1	InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12)	CQXADFVORZEARL-UHFFFAOYSA-N					doublet; compound annotation
0391_000683	Wander	C26H23ClN6O2	1.6315	65558		O=C(Nc1ccc(C2=NCCN2)cc1)c1cc(Cl)c(C(=O)Nc2ccc(C3=NCCN3)cc2)cc1	InChI=1S/C26H23ClN6O2/c27-22-15-18(25(34)32-19-6-1-16(2-7-19)23-28-11-12-29-23)5-10-21(22)26(35)33-20-8-3-17(4-9-20)24-30-13-14-31-24/h1-10,15H,11-14H2,(H,28,29)(H,30,31)(H,32,34)(H,33,35)	UJQGBYRKCZQJJS-UHFFFAOYSA-N					compound annotation
0391_000684	152121-30-7	C20H14FN3O	1.9971	5169		Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C20H14FN3O/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(25)8-4-15/h1-12,25H,(H,23,24)	QHKYPYXTTXKZST-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000686	MCHr1 antagonist 2	C23H21FN2O5	2.2905	11464405		O=C(NC1CCN(Cc2cc3c(cc2)OCO3)CC1)c1cc(=O)c2c(ccc(F)c2)o1	InChI=1S/C23H21FN2O5/c24-15-2-4-19-17(10-15)18(27)11-22(31-19)23(28)25-16-5-7-26(8-6-16)12-14-1-3-20-21(9-14)30-13-29-20/h1-4,9-11,16H,5-8,12-13H2,(H,25,28)	HHCYCBKPWYJVEB-UHFFFAOYSA-N					compound annotation
0391_000687	SAR-020106	C19H19ClN6O	3.0241	44203948	C[C@H](CN(C)C)OC1=NC(=CN=C1C#N)NC2=NC=C3C(=C2)C=CC=C3Cl	CC(CN(C)C)Oc1nc(Nc2ncc3c(Cl)cccc3c2)cnc1C#N	InChI=1S/C19H19ClN6O/c1-12(11-26(2)3)27-19-16(8-21)22-10-18(25-19)24-17-7-13-5-4-6-15(20)14(13)9-23-17/h4-7,9-10,12H,11H2,1-3H3,(H,23,24,25)/t12-/m1/s1	SRBJWIBAMIKCMV-GFCCVEGCSA-N					compound annotation
0391_000688	Ticagrelor	C23H28F2N6O4S	4.207	9871419	CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F	CCCSc1nc(NC2CC2c2cc(F)c(F)cc2)c2nnn(C3CC(OCCO)C(O)C3O)c2n1	InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1	OEKWJQXRCDYSHL-FNOIDJSQSA-N					doublet; compound annotation
0391_000689	Ticagrelor	C23H28F2N6O4S	4.21	9871419	CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F	CCCSc1nc(NC2CC2c2cc(F)c(F)cc2)c2nnn(C3CC(OCCO)C(O)C3O)c2n1	InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1	OEKWJQXRCDYSHL-FNOIDJSQSA-N					doublet; compound annotation
0391_000690	847728-01-2	C22H17ClFNO4	4.362	11524454	C[C@@H](C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(C=CC(=C2)Cl)OC3=CC=C(C=C3)F	CC(NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1	InChI=1S/C22H17ClFNO4/c1-13(14-2-4-15(5-3-14)22(27)28)25-21(26)19-12-16(23)6-11-20(19)29-18-9-7-17(24)8-10-18/h2-13H,1H3,(H,25,26)(H,27,28)/t13-/m0/s1	MWBNCZHVEXULBD-ZDUSSCGKSA-N					compound annotation
0391_000691	AK-1	C19H21N3O5S	4.635	1341463		O=C(Nc1cc([N+](=O)[O-])ccc1)c1cc(S(=O)(=O)N2CCCCCC2)ccc1	InChI=1S/C19H21N3O5S/c23-19(20-16-8-6-9-17(14-16)22(24)25)15-7-5-10-18(13-15)28(26,27)21-11-3-1-2-4-12-21/h5-10,13-14H,1-4,11-12H2,(H,20,23)	HAYBKCHPEBZNGW-UHFFFAOYSA-N					doublet; compound annotation
0391_000692	AK-1	C19H21N3O5S	4.638	1341463		O=C(Nc1cc([N+](=O)[O-])ccc1)c1cc(S(=O)(=O)N2CCCCCC2)ccc1	InChI=1S/C19H21N3O5S/c23-19(20-16-8-6-9-17(14-16)22(24)25)15-7-5-10-18(13-15)28(26,27)21-11-3-1-2-4-12-21/h5-10,13-14H,1-4,11-12H2,(H,20,23)	HAYBKCHPEBZNGW-UHFFFAOYSA-N					doublet; compound annotation
0391_000693	kynurenic acid	C10H7NO3	1.0932	3845		O=C(O)c1cc(=O)c2ccccc2[nH]1	InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	HCZHHEIFKROPDY-UHFFFAOYSA-N					doublet; compound annotation
0391_000694	AZD1480	C14H14ClFN8	1.7246	16659841	CC1=CC(=NN1)NC2=NC(=NC=C2Cl)N[C@@H](C)C3=NC=C(C=N3)F	Cc1cc(Nc2nc(NC(C)c3ncc(F)cn3)ncc2Cl)n[nH]1	InChI=1S/C14H14ClFN8/c1-7-3-11(24-23-7)21-13-10(15)6-19-14(22-13)20-8(2)12-17-4-9(16)5-18-12/h3-6,8H,1-2H3,(H3,19,20,21,22,23,24)/t8-/m0/s1	PDOQBOJDRPLBQU-QMMMGPOBSA-N					removed another duplicate entry; compound annotation
0391_000696	XMD16-5	C23H24N6O2	2.0013	57340666		CN1c2ccccc2C(=O)Nc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21	InChI=1S/C23H24N6O2/c1-28-20-5-3-2-4-18(20)22(31)26-19-14-24-23(27-21(19)28)25-15-6-8-16(9-7-15)29-12-10-17(30)11-13-29/h2-9,14,17,30H,10-13H2,1H3,(H,26,31)(H,24,25,27)	AGLKBEPKKDHHKY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000698	Y-26763	C14H16N2O4	2.4644	121878	CC(=O)N([C@H]1[C@@H](C(OC2=C1C=C(C=C2)C#N)(C)C)O)O	CC(=O)N(O)C1c2c(ccc(C#N)c2)OC(C)(C)C1O	InChI=1S/C14H16N2O4/c1-8(17)16(19)12-10-6-9(7-15)4-5-11(10)20-14(2,3)13(12)18/h4-6,12-13,18-19H,1-3H3/t12-,13+/m1/s1	IWTCFIIOUXJOOV-OLZOCXBDSA-N					compound annotation
0391_000699	abt-702	C22H19BrN6O	2.7343	1973		Nc1c2c(-c3cc(Br)ccc3)cc(-c3cnc(N4CCOCC4)cc3)nc2ncn1	InChI=1S/C22H19BrN6O/c23-16-3-1-2-14(10-16)17-11-18(28-22-20(17)21(24)26-13-27-22)15-4-5-19(25-12-15)29-6-8-30-9-7-29/h1-5,10-13H,6-9H2,(H2,24,26,27,28)	RQCXKDWOCUJWQZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000701	209808-01-5	C23H28N2O	2.8749	9841259		CCN(CC)C(=O)c1ccc(C(=C2CCNCC2)c2ccccc2)cc1	InChI=1S/C23H28N2O/c1-3-25(4-2)23(26)21-12-10-19(11-13-21)22(18-8-6-5-7-9-18)20-14-16-24-17-15-20/h5-13,24H,3-4,14-17H2,1-2H3	SMUGAZNLKPFBSB-UHFFFAOYSA-N					doublet; compound annotation
0391_000702	209808-01-5	C23H28N2O	2.8776	9841259		CCN(CC)C(=O)c1ccc(C(=C2CCNCC2)c2ccccc2)cc1	InChI=1S/C23H28N2O/c1-3-25(4-2)23(26)21-12-10-19(11-13-21)22(18-8-6-5-7-9-18)20-14-16-24-17-15-20/h5-13,24H,3-4,14-17H2,1-2H3	SMUGAZNLKPFBSB-UHFFFAOYSA-N					doublet; compound annotation
0391_000703	GSK2982772	C20H19N5O3	3.2811	77108121	CN1C2=CC=CC=C2OC[C@@H](C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4	CN1C(=O)C(NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21	InChI=1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(23-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24)/t14-/m0/s1	LYPAFUINURXJSG-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_000705	Btk inhibitor 2	C24H25N5O3	3.6982	75204377	C=CC(=O)N1CCC[C@H](C1)N2C(=C(C(=N2)C3=CC=C(C=C3)OC4=CC=CC=C4)C(=O)N)N	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c2N)C1	InChI=1S/C24H25N5O3/c1-2-20(30)28-14-6-7-17(15-28)29-23(25)21(24(26)31)22(27-29)16-10-12-19(13-11-16)32-18-8-4-3-5-9-18/h2-5,8-13,17H,1,6-7,14-15,25H2,(H2,26,31)/t17-/m1/s1	WTLRSSATGYETCG-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_000707	80306-38-3	C15H12ClNO	5.5037	44250175		Cc1ccc(C2=Nc3c(cc(Cl)cc3)OC2)cc1	InChI=1S/C15H12ClNO/c1-10-2-4-11(5-3-10)14-9-18-15-8-12(16)6-7-13(15)17-14/h2-8H,9H2,1H3	MVOZLTFXYGHZPM-UHFFFAOYSA-N					compound annotation
0391_000708	Gefapixant	C14H19N5O4S	1.6671	24764487		COc1c(S(N)(=O)=O)cc(Oc2cnc(N)nc2N)c(C(C)C)c1	InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)	HLWURFKMDLAKOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000710	Ivacaftor	C24H28N2O3	2.4009	16220172		CC(C)(C)c1c(O)cc(NC(=O)c2c[nH]c3ccccc3c2=O)c(C(C)(C)C)c1	InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)	PURKAOJPTOLRMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000711	ADL5859	C24H28N2O3	2.4009	11417954		CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c23)cc1	InChI=1S/C24H28N2O3/c1-3-26(4-2)23(28)18-10-8-17(9-11-18)19-16-24(12-14-25-15-13-24)29-21-7-5-6-20(27)22(19)21/h5-11,16,25,27H,3-4,12-15H2,1-2H3	OPIKUXLJQFYMSC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000714	Fostamatinib	C23H26FN6O9P	2.4529	11671467		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4COP(=O)(O)O)n2)cc(OC)c1OC	InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)	GKDRMWXFWHEQQT-UHFFFAOYSA-N					doublet; compound annotation
0391_000715	133229-23-9	C19H24Cl2N2O4S	2.8466	2129		CN(CCc1cc(Cl)c(Cl)cc1)CC(O)COc1ccc(NS(C)(=O)=O)cc1	InChI=1S/C19H24Cl2N2O4S/c1-23(10-9-14-3-8-18(20)19(21)11-14)12-16(24)13-27-17-6-4-15(5-7-17)22-28(2,25)26/h3-8,11,16,22,24H,9-10,12-13H2,1-2H3	BQBSHJUQVIWEFM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000717	CCT251236	C32H32N4O5	2.8864	117996749		Cc1c(NC(=O)c2cc3c(cc2)nc(OCCN2CCCC2)cc3)cc(NC(=O)c2cc3c(cc2)OCCO3)cc1	InChI=1S/C32H32N4O5/c1-21-4-8-25(33-31(37)24-6-10-28-29(19-24)40-17-16-39-28)20-27(21)35-32(38)23-5-9-26-22(18-23)7-11-30(34-26)41-15-14-36-12-2-3-13-36/h4-11,18-20H,2-3,12-17H2,1H3,(H,33,37)(H,35,38)	KLHOCHQJHXNKAS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000719	PE859	C28H24N4O2	3.1517	66571561	COC1=C(C=CC(=C1)OCC2=CC=CC=N2)/C=C/C3=CC(=NN3)/C=C/C4=CC5=C(C=C4)C=CN5	COc1c(C=Cc2cc(C=Cc3cc4c(cc[nH]4)cc3)n[nH]2)ccc(OCc2ccccn2)c1	InChI=1S/C28H24N4O2/c1-33-28-18-26(34-19-25-4-2-3-14-29-25)12-9-22(28)8-11-24-17-23(31-32-24)10-6-20-5-7-21-13-15-30-27(21)16-20/h2-18,30H,19H2,1H3,(H,31,32)/b10-6+,11-8+	AMBZHNVCLPHAKA-NSJFVGFPSA-N					compound annotation
0391_000720	Ivacaftor	C24H28N2O3	4.971	16220172		CC(C)(C)c1c(O)cc(NC(=O)c2c[nH]c3ccccc3c2=O)c(C(C)(C)C)c1	InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)	PURKAOJPTOLRMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000721	ADL5859	C24H28N2O3	4.971	11417954		CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c23)cc1	InChI=1S/C24H28N2O3/c1-3-26(4-2)23(28)18-10-8-17(9-11-18)19-16-24(12-14-25-15-13-24)29-21-7-5-6-20(27)22(19)21/h5-11,16,25,27H,3-4,12-15H2,1-2H3	OPIKUXLJQFYMSC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000724	AZD1080	C19H18N4O2	1.3653	135564570		N#Cc1cc2c(cc1)[nH]c(O)c2-c1ncc(CN2CCOCC2)cc1	InChI=1S/C19H18N4O2/c20-10-13-1-3-16-15(9-13)18(19(24)22-16)17-4-2-14(11-21-17)12-23-5-7-25-8-6-23/h1-4,9,11,22,24H,5-8,12H2	BLTVBQXJFVRPFK-UHFFFAOYSA-N					compound annotation
0391_000725	Cgs 21680	C23H29N7O6	1.9062	3086599	CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O	CCNC(=O)C1OC(n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc32)C(O)C1O	InChI=1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1	PAOANWZGLPPROA-RQXXJAGISA-N					removed another duplicate entry; compound annotation
0391_000727	dihexa	C27H44N4O5	3.0657	129010512	CCCCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCCCCCC(=O)N	CCCCCC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(C(=O)NCCCCCC(N)=O)C(C)CC	InChI=1S/C27H44N4O5/c1-4-6-8-12-24(34)30-22(18-20-13-15-21(32)16-14-20)26(35)31-25(19(3)5-2)27(36)29-17-10-7-9-11-23(28)33/h13-16,19,22,25,32H,4-12,17-18H2,1-3H3,(H2,28,33)(H,29,36)(H,30,34)(H,31,35)/t19-,22-,25-/m0/s1	XEUVNVNAVKZSPT-JTJYXVOQSA-N					removed another duplicate entry; compound annotation
0391_000729	Purvalanol B	C20H25ClN6O3	3.2514	448991	CC(C)[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=C(C=C3)C(=O)O)Cl	CC(C)C(CO)Nc1nc(Nc2cc(Cl)c(C(=O)O)cc2)c2ncn(C(C)C)c2n1	InChI=1S/C20H25ClN6O3/c1-10(2)15(8-28)24-20-25-17(16-18(26-20)27(9-22-16)11(3)4)23-12-5-6-13(19(29)30)14(21)7-12/h5-7,9-11,15,28H,8H2,1-4H3,(H,29,30)(H2,23,24,25,26)/t15-/m0/s1	ZKDXRFMOHZVXSG-HNNXBMFYSA-N					compound annotation
0391_000730	518058-84-9	C16H13FN2O2	3.2672	21014417		O=C(NCc1cc(O)ccc1)c1cc2c(ccc(F)c2)[nH]1	InChI=1S/C16H13FN2O2/c17-12-4-5-14-11(7-12)8-15(19-14)16(21)18-9-10-2-1-3-13(20)6-10/h1-8,19-20H,9H2,(H,18,21)	TUIHIKXCMCXXJG-UHFFFAOYSA-N					compound annotation
0391_000731	kn-92	C24H25ClN2O3S	3.6433	5353702	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2NS(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)Nc2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C24H25ClN2O3S/c1-27(17-5-6-19-9-11-21(25)12-10-19)18-20-7-3-4-8-24(20)26-31(28,29)23-15-13-22(30-2)14-16-23/h3-16,26H,17-18H2,1-2H3/b6-5+	RUAOVVIUGUOYHA-AATRIKPKSA-N					doublet; compound annotation
0391_000732	Mitiglinide	C19H25NO3	3.9468	121891	C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)O	O=C(O)C(CC(=O)N1CC2CCCCC2C1)Cc1ccccc1	InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1	WPGGHFDDFPHPOB-BBWFWOEESA-N					removed another duplicate entry; compound annotation
0391_000734	Nestoron	C23H30O4	4.2075	108059	CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)OC(=O)C	C=C1CC2C3CCC4=CC(=O)CCC4C3CCC2(C)C1(OC(C)=O)C(C)=O	InChI=1S/C23H30O4/c1-13-11-21-20-7-5-16-12-17(26)6-8-18(16)19(20)9-10-22(21,4)23(13,14(2)24)27-15(3)25/h12,18-21H,1,5-11H2,2-4H3/t18-,19+,20+,21-,22-,23-/m0/s1	CKFBRGLGTWAVLG-GOMYTPFNSA-N					compound annotation
0391_000735	iohexol	C19H26I3N3O9	0.4934	3730		CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	InChI=1S/C19H26I3N3O9/c1-8(29)25(4-11(32)7-28)17-15(21)12(18(33)23-2-9(30)5-26)14(20)13(16(17)22)19(34)24-3-10(31)6-27/h9-11,26-28,30-32H,2-7H2,1H3,(H,23,33)(H,24,34)	NTHXOOBQLCIOLC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000737	Almotriptan	C17H25N3O2S	1.7922	123606		CN(C)CCc1c[nH]c2c1cc(CS(=O)(=O)N1CCCC1)cc2	InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3	WKEMJKQOLOHJLZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000739	RUCAPARIB	C19H18FN3O	1.8116	9931954		CNCc1ccc(-c2c3CCNC(=O)c4c3c(cc(F)c4)[nH]2)cc1	InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)	HMABYWSNWIZPAG-UHFFFAOYSA-N					doublet; compound annotation
0391_000740	RUCAPARIB	C19H18FN3O	1.8164	9931954		CNCc1ccc(-c2c3CCNC(=O)c4c3c(cc(F)c4)[nH]2)cc1	InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)	HMABYWSNWIZPAG-UHFFFAOYSA-N					doublet; compound annotation
0391_000741	betaxolol	C18H29NO3	2.636	2369		CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3	NWIUTZDMDHAVTP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000743	adiphenine	C20H25NO2	2.9804	2031		CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1	InChI=1S/C20H25NO2/c1-3-21(4-2)15-16-23-20(22)19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,19H,3-4,15-16H2,1-2H3	JGOAIQNSOGZNBX-UHFFFAOYSA-N					compound annotation
0391_000744	Mecarbinate	C13H15NO3	3.0186	616236		CCOC(=O)c1c(C)n(C)c2c1cc(O)cc2	InChI=1S/C13H15NO3/c1-4-17-13(16)12-8(2)14(3)11-6-5-9(15)7-10(11)12/h5-7,15H,4H2,1-3H3	YTBNTDMBGXAOCG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000746	METHYLPREDNISOLONE HEMISUCCINATE	C26H34O8	3.1116	16923	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O	CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12	InChI=1S/C26H34O8/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31)/t14-,16-,17-,19-,23+,24-,25-,26-/m0/s1	IMBXEJJVJRTNOW-XYMSELFBSA-N					doublet; compound annotation
0391_000747	bisacodyl	C22H19NO4	3.2715	2391		CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1	InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3	KHOITXIGCFIULA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000749	bisacodyl	C22H19NO4	3.3985	2391		CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1	InChI=1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3	KHOITXIGCFIULA-UHFFFAOYSA-N					doublet; compound annotation
0391_000750	METHYLPREDNISOLONE HEMISUCCINATE	C26H34O8	3.4045	16923	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O	CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12	InChI=1S/C26H34O8/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31)/t14-,16-,17-,19-,23+,24-,25-,26-/m0/s1	IMBXEJJVJRTNOW-XYMSELFBSA-N					doublet; removed another duplicate entry; compound annotation
0391_000752	Pyriproxyfen	C20H19NO3	5.4415	91753		CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1	InChI=1S/C20H19NO3/c1-16(23-20-9-5-6-14-21-20)15-22-17-10-12-19(13-11-17)24-18-7-3-2-4-8-18/h2-14,16H,15H2,1H3	NHDHVHZZCFYRSB-UHFFFAOYSA-N					doublet; compound annotation
0391_000753	Pyriproxyfen	C20H19NO3	5.5252	91753		CC(COc1ccc(Oc2ccccc2)cc1)Oc1ccccn1	InChI=1S/C20H19NO3/c1-16(23-20-9-5-6-14-21-20)15-22-17-10-12-19(13-11-17)24-18-7-3-2-4-8-18/h2-14,16H,15H2,1H3	NHDHVHZZCFYRSB-UHFFFAOYSA-N					doublet; compound annotation
0391_000754	Isomangiferin	C19H18O11	1.4456	5318597	C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=CC(=C3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c2cc(O)c(O)cc2oc2c1c(O)cc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C19H18O11/c20-4-11-15(26)16(27)17(28)19(30-11)13-9(24)2-8(23)12-14(25)5-1-6(21)7(22)3-10(5)29-18(12)13/h1-3,11,15-17,19-24,26-28H,4H2/t11-,15-,16+,17-,19+/m1/s1	CDYBOKJASDEORM-HBVDJMOISA-N					compound annotation
0391_000755	VS-5584	C17H22N8O	1.6401	46912230		Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C	InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)	QYBGBLQCOOISAR-UHFFFAOYSA-N					doublet; compound annotation
0391_000756	VS-5584	C17H22N8O	2.751	46912230		Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C	InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)	QYBGBLQCOOISAR-UHFFFAOYSA-N					doublet; compound annotation
0391_000757	VS-5584	C17H22N8O	2.8817	46912230		Cc1nc2c(-c3cnc(N)nc3)nc(N3CCOCC3)nc2n1C(C)C	InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)	QYBGBLQCOOISAR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000759	Angelicin	C11H6O3	2.9468	10658		O=c1ccc2c(o1)c1c(cc2)occ1	InChI=1S/C11H6O3/c12-10-4-2-7-1-3-9-8(5-6-13-9)11(7)14-10/h1-6H	XDROKJSWHURZGO-UHFFFAOYSA-N					compound annotation
0391_000760	Solcitinib	C22H23N5O2	3.0212	44603362		CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1	InChI=1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28)	MPYACSQFXVMWNO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000762	AFN-1252	C22H21N3O3	3.2293	10407120	CC1=C(OC2=CC=CC=C12)CN(C)C(=O)/C=C/C3=CC4=C(NC(=O)CC4)N=C3	Cc1c(CN(C)C(=O)C=Cc2cc3c(nc2)NC(=O)CC3)oc2ccccc12	InChI=1S/C22H21N3O3/c1-14-17-5-3-4-6-18(17)28-19(14)13-25(2)21(27)10-7-15-11-16-8-9-20(26)24-22(16)23-12-15/h3-7,10-12H,8-9,13H2,1-2H3,(H,23,24,26)/b10-7+	QXTWSUQCXCWEHF-JXMROGBWSA-N					doublet; compound annotation
0391_000763	AFN-1252	C22H21N3O3	3.5685	10407120	CC1=C(OC2=CC=CC=C12)CN(C)C(=O)/C=C/C3=CC4=C(NC(=O)CC4)N=C3	Cc1c(CN(C)C(=O)C=Cc2cc3c(nc2)NC(=O)CC3)oc2ccccc12	InChI=1S/C22H21N3O3/c1-14-17-5-3-4-6-18(17)28-19(14)13-25(2)21(27)10-7-15-11-16-8-9-20(26)24-22(16)23-12-15/h3-7,10-12H,8-9,13H2,1-2H3,(H,23,24,26)/b10-7+	QXTWSUQCXCWEHF-JXMROGBWSA-N					doublet; removed another duplicate entry; compound annotation
0391_000765	Auglurant	C16H12FN5O2	3.6417	60168069		Cc1cc(Oc2cncnc2)cc(C(=O)Nc2ncc(F)cc2)n1	InChI=1S/C16H12FN5O2/c1-10-4-12(24-13-7-18-9-19-8-13)5-14(21-10)16(23)22-15-3-2-11(17)6-20-15/h2-9H,1H3,(H,20,22,23)	RBAHIIPVJVMACF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000767	MA-0204	C25H27F3N2O4	3.6708	126752361	CC1=CN=C(N1CC2=CC=CC=C2OCCC[C@@H](C)CC(=O)O)C3=CC=C(C=C3)OC(F)(F)F	Cc1cnc(-c2ccc(OC(F)(F)F)cc2)n1Cc1ccccc1OCCCC(C)CC(=O)O	InChI=1S/C25H27F3N2O4/c1-17(14-23(31)32)6-5-13-33-22-8-4-3-7-20(22)16-30-18(2)15-29-24(30)19-9-11-21(12-10-19)34-25(26,27)28/h3-4,7-12,15,17H,5-6,13-14,16H2,1-2H3,(H,31,32)/t17-/m1/s1	GYNMVDMBFKGCCR-QGZVFWFLSA-N					compound annotation
0391_000768	Galangin	C15H10O5	3.7985	5281616		O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O5/c16-9-6-10(17)12-11(7-9)20-15(14(19)13(12)18)8-4-2-1-3-5-8/h1-7,16-17,19H	VCCRNZQBSJXYJD-UHFFFAOYSA-N					compound annotation
0391_000769	Gomisin J	C22H28O6	4.096	3001686	C[C@@H]1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3C[C@@H]1C)O)OC)OC)OC)OC)O	COc1c(O)cc2CC(C)C(C)Cc3cc(O)c(OC)c(OC)c3-c2c1OC	InChI=1S/C22H28O6/c1-11-7-13-9-15(23)19(25-3)21(27-5)17(13)18-14(8-12(11)2)10-16(24)20(26-4)22(18)28-6/h9-12,23-24H,7-8H2,1-6H3/t11-,12+	PICOUNAPKDEPCA-TXEJJXNPSA-N					removed another duplicate entry; compound annotation
0391_000771	Neochlorogenic acid	C16H18O9	0.8578	5280633	C1[C@H]([C@@H]([C@@H](C[C@]1(C(=O)O)O)OC(=O)/C=C/C2=CC(=C(C=C2)O)O)O)O	O=C(C=Cc1cc(O)c(O)cc1)OC1CC(O)(C(=O)O)CC(O)C1O	InChI=1S/C16H18O9/c17-9-3-1-8(5-10(9)18)2-4-13(20)25-12-7-16(24,15(22)23)6-11(19)14(12)21/h1-5,11-12,14,17-19,21,24H,6-7H2,(H,22,23)/b4-2+/t11-,12-,14+,16-/m1/s1	CWVRJTMFETXNAD-NXLLHMKUSA-N					removed another duplicate entry; compound annotation
0391_000773	ORNIPRESSIN	C45H63N13O12S2	1.3615	14257660	C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N	NCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O	InChI=1S/C45H63N13O12S2/c46-16-4-8-28(39(64)51-21-37(50)62)53-44(69)34-9-5-17-58(34)45(70)33-23-72-71-22-27(47)38(63)54-30(19-25-10-12-26(59)13-11-25)42(67)55-31(18-24-6-2-1-3-7-24)41(66)52-29(14-15-35(48)60)40(65)56-32(20-36(49)61)43(68)57-33/h1-3,6-7,10-13,27-34,59H,4-5,8-9,14-23,46-47H2,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,69)(H,54,63)(H,55,67)(H,56,65)(H,57,68)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1	MUNMIGOEDGHVLE-LGYYRGKSSA-N					compound annotation
0391_000774	Isoliensinine	C37H42N2O6	1.7457	5274591	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)O)O)OC	COc1ccc(CC2c3cc(Oc4c(O)ccc(CC5c6cc(O)c(OC)cc6CCN5C)c4)c(OC)cc3CCN2C)cc1	InChI=1S/C37H42N2O6/c1-38-15-13-26-20-36(44-5)37(22-29(26)30(38)16-23-6-9-27(42-3)10-7-23)45-35-18-24(8-11-32(35)40)17-31-28-21-33(41)34(43-4)19-25(28)12-14-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	AJPXZTKPPINUKN-FIRIVFDPSA-N					doublet; compound annotation
0391_000775	MET-enkephalin	C27H35N5O7S	1.9201	443363	CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N	CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(=O)O	InChI=1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1	YFGBQHOOROIVKG-FKBYEOEOSA-N					removed another duplicate entry; compound annotation
0391_000777	Isoliensinine	C37H42N2O6	1.9201	5274591	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)O)O)OC	COc1ccc(CC2c3cc(Oc4c(O)ccc(CC5c6cc(O)c(OC)cc6CCN5C)c4)c(OC)cc3CCN2C)cc1	InChI=1S/C37H42N2O6/c1-38-15-13-26-20-36(44-5)37(22-29(26)30(38)16-23-6-9-27(42-3)10-7-23)45-35-18-24(8-11-32(35)40)17-31-28-21-33(41)34(43-4)19-25(28)12-14-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	AJPXZTKPPINUKN-FIRIVFDPSA-N					doublet; compound annotation
0391_000778	Isoliensinine	C37H42N2O6	2.1611	5274591	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)O)O)OC	COc1ccc(CC2c3cc(Oc4c(O)ccc(CC5c6cc(O)c(OC)cc6CCN5C)c4)c(OC)cc3CCN2C)cc1	InChI=1S/C37H42N2O6/c1-38-15-13-26-20-36(44-5)37(22-29(26)30(38)16-23-6-9-27(42-3)10-7-23)45-35-18-24(8-11-32(35)40)17-31-28-21-33(41)34(43-4)19-25(28)12-14-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	AJPXZTKPPINUKN-FIRIVFDPSA-N					doublet; compound annotation
0391_000779	Isocorynoxeine	C22H26N2O4	2.2067	3037448	CO/C=C(\[C@H]1C[C@H]2[C@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	C=CC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1	MUVGVMUWMAGNSY-VKCGGMIFSA-N					doublet; compound annotation
0391_000780	Isocorynoxeine	C22H26N2O4	2.3229	3037448	CO/C=C(\[C@H]1C[C@H]2[C@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	C=CC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1	MUVGVMUWMAGNSY-VKCGGMIFSA-N					doublet; removed another duplicate entry; compound annotation
0391_000782	Vapreotide	C57H70N12O9S2	2.509	71306		CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccccc2)CSSCC(C(=O)NC(Cc2c[nH]c3ccccc23)C(N)=O)NC1=O	InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)	SWXOGPJRIDTIRL-UHFFFAOYSA-N					compound annotation
0391_000783	Isosilybin	C25H22O10	2.9595	21723007	COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=CC(=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O	COc1c(O)ccc(C2Oc3c(cc(C4Oc5cc(O)cc(O)c5C(=O)C4O)cc3)OC2CO)c1	InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-18-7-12(3-5-16(18)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20?,23-,24?,25+/m0/s1	FDQAOULAVFHKBX-DBMPWETRSA-N					removed another duplicate entry; compound annotation
0391_000785	zaltoprofen	C17H14O3S	4.0856	5720		CC(C(=O)O)c1cc2c(cc1)Sc1ccccc1C(=O)C2	InChI=1S/C17H14O3S/c1-10(17(19)20)11-6-7-15-12(8-11)9-14(18)13-4-2-3-5-16(13)21-15/h2-8,10H,9H2,1H3,(H,19,20)	MUXFZBHBYYYLTH-UHFFFAOYSA-N					compound annotation
0391_000786	methimazole	C4H6N2S	0.4621	1349907		Cn1ccnc1S	InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)	PMRYVIKBURPHAH-UHFFFAOYSA-N					compound annotation
0391_000787	Procodazole	C10H10N2O2	0.5955	4739544		O=C(O)CCc1nc2ccccc2[nH]1	InChI=1S/C10H10N2O2/c13-10(14)6-5-9-11-7-3-1-2-4-8(7)12-9/h1-4H,5-6H2,(H,11,12)(H,13,14)	XYWJNTOURDMTPI-UHFFFAOYSA-N					compound annotation
0391_000788	MS023	C17H25N3O	1.6819	92136227		CC(C)Oc1ccc(-c2c[nH]cc2CN(C)CCN)cc1	InChI=1S/C17H25N3O/c1-13(2)21-16-6-4-14(5-7-16)17-11-19-10-15(17)12-20(3)9-8-18/h4-7,10-11,13,19H,8-9,12,18H2,1-3H3	FMTVWAGUJRUAKE-UHFFFAOYSA-N					compound annotation
0391_000789	Tiamulin (fumarate)	C28H47NO4S	2.5742	86280313	CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C	C=CC1(C)CC(OC(=O)CSCCN(CC)CC)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27-,28+/m1/s1	UURAUHCOJAIIRQ-KWVPEQCVSA-N					doublet; compound annotation
0391_000790	betaxolol	C18H29NO3	2.6355	2369		CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3	NWIUTZDMDHAVTP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000792	dihydroergotamine	C33H37N5O5	2.7077	10531	C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C	CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3c4c(c[nH]c4ccc3)CC21	InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1	LUZRJRNZXALNLM-JGRZULCMSA-N					doublet; compound annotation
0391_000793	dihydroergotamine	C33H37N5O5	2.7104	10531	C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C	CN1CC(C(=O)NC2(C)OC3(O)C4CCCN4C(=O)C(Cc4ccccc4)N3C2=O)CC2c3c4c(c[nH]c4ccc3)CC21	InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1	LUZRJRNZXALNLM-JGRZULCMSA-N					doublet; compound annotation
0391_000794	flavoxate	C24H25NO4	2.7756	3354		Cc1c(-c2ccccc2)oc2c(cccc2C(=O)OCCN2CCCCC2)c1=O	InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3	SPIUTQOUKAMGCX-UHFFFAOYSA-N					compound annotation
0391_000795	Tiamulin (fumarate)	C28H47NO4S	2.9495	86280313	CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C	C=CC1(C)CC(OC(=O)CSCCN(CC)CC)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27-,28+/m1/s1	UURAUHCOJAIIRQ-KWVPEQCVSA-N					doublet; compound annotation
0391_000796	Tiamulin (fumarate)	C28H47NO4S	3.1265	86280313	CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C	C=CC1(C)CC(OC(=O)CSCCN(CC)CC)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27-,28+/m1/s1	UURAUHCOJAIIRQ-KWVPEQCVSA-N					doublet; compound annotation
0391_000797	Tiamulin (fumarate)	C28H47NO4S	3.1953	86280313	CCN(CC)CCSCC(=O)O[C@@H]1C[C@@]([C@H]([C@@H]([C@@]23CC[C@H]([C@]1([C@@H]2C(=O)CC3)C)C)C)O)(C)C=C	C=CC1(C)CC(OC(=O)CSCCN(CC)CC)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C28H47NO4S/c1-8-26(6)17-22(33-23(31)18-34-16-15-29(9-2)10-3)27(7)19(4)11-13-28(20(5)25(26)32)14-12-21(30)24(27)28/h8,19-20,22,24-25,32H,1,9-18H2,2-7H3/t19-,20+,22-,24+,25+,26-,27-,28+/m1/s1	UURAUHCOJAIIRQ-KWVPEQCVSA-N					doublet; compound annotation
0391_000798	irbesartan	C25H28N6O	3.2045	3749		CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)	YOSHYTLCDANDAN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000800	Pepstatin A	C34H63N5O9	3.5706	5478883	C[C@@H](C(=O)N[C@@H](CC(C)C)[C@H](CC(=O)O)O)NC(=O)C[C@@H]([C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C)O	CC(C)CC(=O)NC(C(=O)NC(C(=O)NC(CC(C)C)C(O)CC(=O)NC(C)C(=O)NC(CC(C)C)C(O)CC(=O)O)C(C)C)C(C)C	InChI=1S/C34H63N5O9/c1-17(2)12-23(37-33(47)31(21(9)10)39-34(48)30(20(7)8)38-27(42)14-19(5)6)25(40)15-28(43)35-22(11)32(46)36-24(13-18(3)4)26(41)16-29(44)45/h17-26,30-31,40-41H,12-16H2,1-11H3,(H,35,43)(H,36,46)(H,37,47)(H,38,42)(H,39,48)(H,44,45)/t22-,23-,24-,25-,26-,30-,31-/m0/s1	FAXGPCHRFPCXOO-LXTPJMTPSA-N					removed another duplicate entry; compound annotation
0391_000802	irbesartan	C25H28N6O	3.8048	3749		CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)	YOSHYTLCDANDAN-UHFFFAOYSA-N					doublet; compound annotation
0391_000803	Napropamide	C17H21NO2	4.1237	27189		CCN(CC)C(=O)C(C)Oc1cccc2ccccc12	InChI=1S/C17H21NO2/c1-4-18(5-2)17(19)13(3)20-16-12-8-10-14-9-6-7-11-15(14)16/h6-13H,4-5H2,1-3H3	WXZVAROIGSFCFJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000804	Napropamide	C17H21NO2	4.2743	27189		CCN(CC)C(=O)C(C)Oc1cccc2ccccc12	InChI=1S/C17H21NO2/c1-4-18(5-2)17(19)13(3)20-16-12-8-10-14-9-6-7-11-15(14)16/h6-13H,4-5H2,1-3H3	WXZVAROIGSFCFJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000805	Napropamide	C17H21NO2	4.2792	27189		CCN(CC)C(=O)C(C)Oc1cccc2ccccc12	InChI=1S/C17H21NO2/c1-4-18(5-2)17(19)13(3)20-16-12-8-10-14-9-6-7-11-15(14)16/h6-13H,4-5H2,1-3H3	WXZVAROIGSFCFJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000806	DANEGAPTIDE	C14H17N3O4	0.9603	16656685	C1[C@H](CN([C@@H]1C(=O)O)C(=O)CN)NC(=O)C2=CC=CC=C2	NCC(=O)N1CC(NC(=O)c2ccccc2)CC1C(=O)O	InChI=1S/C14H17N3O4/c15-7-12(18)17-8-10(6-11(17)14(20)21)16-13(19)9-4-2-1-3-5-9/h1-5,10-11H,6-8,15H2,(H,16,19)(H,20,21)/t10-,11+/m1/s1	BIZKIHUJGMSVFD-MNOVXSKESA-N					compound annotation
0391_000807	Isochlorogenic acid C	C25H24O12	2.1464	6474309	C1[C@H]([C@@H]([C@@H](C[C@]1(C(=O)O)O)OC(=O)/C=C/C2=CC(=C(C=C2)O)O)OC(=O)/C=C/C3=CC(=C(C=C3)O)O)O	O=C(C=Cc1cc(O)c(O)cc1)OC1CC(O)(C(=O)O)CC(O)C1OC(=O)C=Cc1cc(O)c(O)cc1	InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(35,24(33)34)11-19(30)23(20)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23+,25-/m1/s1	UFCLZKMFXSILNL-RVXRWRFUSA-N					removed another duplicate entry; compound annotation
0391_000809	XMU-MP-1	C17H16N6O3S2	2.779	121499143		CN1C(=O)c2c(ccs2)N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21	InChI=1S/C17H16N6O3S2/c1-22-12-7-8-27-14(12)16(24)23(2)13-9-19-17(21-15(13)22)20-10-3-5-11(6-4-10)28(18,25)26/h3-9H,1-2H3,(H2,18,25,26)(H,19,20,21)	YRDHKIFCGOZTGD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000811	1093058-52-6	C13H15BrN2	2.8344	57775660		Brc1ccc(CCCCn2ccnc2)cc1	InChI=1S/C13H15BrN2/c14-13-6-4-12(5-7-13)3-1-2-9-16-10-8-15-11-16/h4-8,10-11H,1-3,9H2	FZNINMHMRBYDPR-UHFFFAOYSA-N					doublet; compound annotation
0391_000812	Licogliflozin	C23H28O7	3.1533	52913524	CCC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4	CCc1c(Cc2cc3c(cc2)OCCO3)cc(C2OC(CO)C(O)C(O)C2O)cc1	InChI=1S/C23H28O7/c1-2-14-4-5-15(23-22(27)21(26)20(25)19(12-24)30-23)11-16(14)9-13-3-6-17-18(10-13)29-8-7-28-17/h3-6,10-11,19-27H,2,7-9,12H2,1H3/t19-,20-,21+,22-,23+/m1/s1	XFJAMQQAAMJFGB-ZQGJOIPISA-N					removed another duplicate entry; compound annotation
0391_000814	TES-991	C17H11N7OS2	3.258	137142884		N#Cc1c(-c2cccs2)[nH]c(SCc2cc(-c3n[nH]nn3)ccc2)nc1=O	InChI=1S/C17H11N7OS2/c18-8-12-14(13-5-2-6-26-13)19-17(20-16(12)25)27-9-10-3-1-4-11(7-10)15-21-23-24-22-15/h1-7H,9H2,(H,19,20,25)(H,21,22,23,24)	VCDQAPTULMMFKX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000816	Ganetespib	C20H20N4O3	3.2617	135564985		CC(C)c1c(O)cc(O)c(-c2n[nH]c(=O)n2-c2cc3c(cc2)n(C)cc3)c1	InChI=1S/C20H20N4O3/c1-11(2)14-9-15(18(26)10-17(14)25)19-21-22-20(27)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25-26H,1-3H3,(H,22,27)	RVAQIUULWULRNW-UHFFFAOYSA-N					compound annotation
0391_000817	JNJ-632	C18H19FN2O4S	3.5432	73389570	CC1=C(C=CC(=C1)NC(=O)C2=CC(=CC=C2)S(=O)(=O)N[C@H]3CCOC3)F	Cc1c(F)ccc(NC(=O)c2cc(S(=O)(=O)NC3CCOC3)ccc2)c1	InChI=1S/C18H19FN2O4S/c1-12-9-14(5-6-17(12)19)20-18(22)13-3-2-4-16(10-13)26(23,24)21-15-7-8-25-11-15/h2-6,9-10,15,21H,7-8,11H2,1H3,(H,20,22)/t15-/m0/s1	JIZGLOVJKCSHTH-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_000820	6-Carboxyfluorescein diacetate	C25H16O9	3.8488	151095		CC(=O)Oc1cc2c(cc1)C1(OC(=O)c3ccc(C(=O)O)cc31)c1c(cc(OC(C)=O)cc1)O2	InChI=1S/C25H16O9/c1-12(26)31-15-4-7-18-21(10-15)33-22-11-16(32-13(2)27)5-8-19(22)25(18)20-9-14(23(28)29)3-6-17(20)24(30)34-25/h3-11H,1-2H3,(H,28,29)	QMOGCCYGOPYYNT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000822	OXFBD04	C17H16N2O3	1.4704	145925690		Cc1noc(C)c1-c1cc(C(O)c2cnccc2)cc(O)c1	InChI=1S/C17H16N2O3/c1-10-16(11(2)22-19-10)13-6-14(8-15(20)7-13)17(21)12-4-3-5-18-9-12/h3-9,17,20-21H,1-2H3	RFDVEAHRRMEOHK-UHFFFAOYSA-N					compound annotation
0391_000823	LY2444296	C24H22F2N2O2	2.5205	56655502	C1C[C@H](N(C1)CC2=CC=C(C=C2)OC3=C(C=C(C=C3)C(=O)N)F)C4=CC(=CC=C4)F	NC(=O)c1cc(F)c(Oc2ccc(CN3CCCC3c3cc(F)ccc3)cc2)cc1	InChI=1S/C24H22F2N2O2/c25-19-4-1-3-17(13-19)22-5-2-12-28(22)15-16-6-9-20(10-7-16)30-23-11-8-18(24(27)29)14-21(23)26/h1,3-4,6-11,13-14,22H,2,5,12,15H2,(H2,27,29)/t22-/m0/s1	WHHMECUDUQRPJT-QFIPXVFZSA-N					compound annotation
0391_000824	694433-59-5	C20H21N3O2	2.6198	9858940		Cc1nc(-c2c(-c3cc4c(cc3)OCO4)nc(C(C)(C)C)[nH]2)ccc1	InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)	WGZOTBUYUFBEPZ-UHFFFAOYSA-N					compound annotation
0391_000825	MMP-9-IN-1	C16H17F2N3O3S	3.3913	135415473		CCCc1cc(=O)nc(SCC(=O)Nc2ccc(OC(F)F)cc2)[nH]1	InChI=1S/C16H17F2N3O3S/c1-2-3-11-8-13(22)21-16(20-11)25-9-14(23)19-10-4-6-12(7-5-10)24-15(17)18/h4-8,15H,2-3,9H2,1H3,(H,19,23)(H,20,21,22)	OLTRRVUORWPRGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000827	Taladegib	C26H24F4N6O	3.6136	49848070		CN(C(=O)c1c(C(F)(F)F)cc(F)cc1)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1	InChI=1S/C26H24F4N6O/c1-34(25(37)20-8-7-16(27)15-21(20)26(28,29)30)17-10-13-36(14-11-17)24-19-6-4-3-5-18(19)23(32-33-24)22-9-12-31-35(22)2/h3-9,12,15,17H,10-11,13-14H2,1-2H3	SZBGQDXLNMELTB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000829	EXEMESTANE	C20H24O2	3.8646	60198	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C	C=C1CC2C(CCC3(C)C(=O)CCC23)C2(C)C=CC(=O)C=C12	InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1	BFYIZQONLCFLEV-DAELLWKTSA-N					compound annotation
0391_000830	5-iodo-Indirubin-3'-monoxime	C16H10IN3O2	3.9108	403176		O=Nc1c(-c2c(O)[nH]c3c2cc(I)cc3)[nH]c2ccccc12	InChI=1S/C16H10IN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18-19,21H	WCCYEJYTLNWYCC-UHFFFAOYSA-N					doublet; compound annotation
0391_000831	MK-5108	C22H21ClFN3O3S	4.0825	24748204		O=C(O)C1(Cc2nc(Nc3nccs3)ccc2)CCC(Oc2c(F)c(Cl)ccc2)CC1	InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27)	LCVIRAZGMYMNNT-UHFFFAOYSA-N					compound annotation
0391_000832	5-iodo-Indirubin-3'-monoxime	C16H10IN3O2	4.2214	403176		O=Nc1c(-c2c(O)[nH]c3c2cc(I)cc3)[nH]c2ccccc12	InChI=1S/C16H10IN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18-19,21H	WCCYEJYTLNWYCC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000834	SAFit2	C46H62N2O10	4.5074	86277887	COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC	COc1c(OC)cc(CCC(OC(=O)C2CCCCN2C(=O)C(c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cc(OCCN3CCOCC3)ccc2)cc1	InChI=1S/C46H62N2O10/c1-51-39-20-18-32(28-40(39)52-2)17-19-38(34-14-11-15-36(29-34)57-27-24-47-22-25-56-26-23-47)58-46(50)37-16-9-10-21-48(37)45(49)43(33-12-7-6-8-13-33)35-30-41(53-3)44(55-5)42(31-35)54-4/h11,14-15,18,20,28-31,33,37-38,43H,6-10,12-13,16-17,19,21-27H2,1-5H3/t37-,38+,43-/m0/s1	ZDBWLRLGUBSLPG-FDHYQTMZSA-N					doublet; compound annotation
0391_000835	SAFit2	C46H62N2O10	4.515	86277887	COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC	COc1c(OC)cc(CCC(OC(=O)C2CCCCN2C(=O)C(c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cc(OCCN3CCOCC3)ccc2)cc1	InChI=1S/C46H62N2O10/c1-51-39-20-18-32(28-40(39)52-2)17-19-38(34-14-11-15-36(29-34)57-27-24-47-22-25-56-26-23-47)58-46(50)37-16-9-10-21-48(37)45(49)43(33-12-7-6-8-13-33)35-30-41(53-3)44(55-5)42(31-35)54-4/h11,14-15,18,20,28-31,33,37-38,43H,6-10,12-13,16-17,19,21-27H2,1-5H3/t37-,38+,43-/m0/s1	ZDBWLRLGUBSLPG-FDHYQTMZSA-N					doublet; compound annotation
0391_000836	WHI-P154	C16H14BrN3O3	2.1286	3795		COc1c(OC)cc2c(Nc3cc(Br)c(O)cc3)ncnc2c1	InChI=1S/C16H14BrN3O3/c1-22-14-6-10-12(7-15(14)23-2)18-8-19-16(10)20-9-3-4-13(21)11(17)5-9/h3-8,21H,1-2H3,(H,18,19,20)	CBIAKDAYHRWZCU-UHFFFAOYSA-N					doublet; compound annotation
0391_000837	Tinoridine	C17H20N2O2S	2.2985	5480		CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2	InChI=1S/C17H20N2O2S/c1-2-21-17(20)15-13-8-9-19(11-14(13)22-16(15)18)10-12-6-4-3-5-7-12/h3-7H,2,8-11,18H2,1H3	PFENFDGYVLAFBR-UHFFFAOYSA-N					compound annotation
0391_000838	2244989-34-0	C24H26F2N6O	2.5621	137319851	C[C@@H](C1=CN=CC(=N1)N2CCN(CC2)C3=CC=CC=N3)NC(=O)CCC4=CC(=C(C=C4)F)F	CC(NC(=O)CCc1cc(F)c(F)cc1)c1cncc(N2CCN(c3ccccn3)CC2)n1	InChI=1S/C24H26F2N6O/c1-17(29-24(33)8-6-18-5-7-19(25)20(26)14-18)21-15-27-16-23(30-21)32-12-10-31(11-13-32)22-4-2-3-9-28-22/h2-5,7,9,14-17H,6,8,10-13H2,1H3,(H,29,33)/t17-/m0/s1	WQYZERNSONBUCW-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_000840	HTH-01-015	C26H28N8O	2.5709	78357766		Cc1c2c(nc(Nc3cn(C4CCNCC4)nc3)n1)N(C)c1cc3ccccc3cc1C(=O)N2C	InChI=1S/C26H28N8O/c1-16-23-24(31-26(29-16)30-19-14-28-34(15-19)20-8-10-27-11-9-20)32(2)22-13-18-7-5-4-6-17(18)12-21(22)25(35)33(23)3/h4-7,12-15,20,27H,8-11H2,1-3H3,(H,29,30,31)	CHSDJDLAKKAWCI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000842	WHI-P154	C16H14BrN3O3	2.9304	3795		COc1c(OC)cc2c(Nc3cc(Br)c(O)cc3)ncnc2c1	InChI=1S/C16H14BrN3O3/c1-22-14-6-10-12(7-15(14)23-2)18-8-19-16(10)20-9-3-4-13(21)11(17)5-9/h3-8,21H,1-2H3,(H,18,19,20)	CBIAKDAYHRWZCU-UHFFFAOYSA-N					doublet; compound annotation
0391_000843	FRAX486	C25H23Cl2FN6O	3.0424	68060125		CCn1c(=O)c(-c2c(Cl)cc(Cl)cc2)cc2cnc(Nc3cc(F)c(N4CCNCC4)cc3)nc21	InChI=1S/C25H23Cl2FN6O/c1-2-34-23-15(11-19(24(34)35)18-5-3-16(26)12-20(18)27)14-30-25(32-23)31-17-4-6-22(21(28)13-17)33-9-7-29-8-10-33/h3-6,11-14,29H,2,7-10H2,1H3,(H,30,31,32)	DHKFOIHIUYFSOF-UHFFFAOYSA-N					doublet; compound annotation
0391_000844	GSK2593074A	C27H23N5OS	3.176	53466951		Cn1cc(-c2cnc(N)c3c2scc3-c2cc3c(cc2)N(C(=O)Cc2ccccc2)CC3)cn1	InChI=1S/C27H23N5OS/c1-31-15-20(13-30-31)21-14-29-27(28)25-22(16-34-26(21)25)18-7-8-23-19(12-18)9-10-32(23)24(33)11-17-5-3-2-4-6-17/h2-8,12-16H,9-11H2,1H3,(H2,28,29)	LIGGMBSSOOVGAE-UHFFFAOYSA-N					compound annotation
0391_000845	FRAX486	C25H23Cl2FN6O	3.63	68060125		CCn1c(=O)c(-c2c(Cl)cc(Cl)cc2)cc2cnc(Nc3cc(F)c(N4CCNCC4)cc3)nc21	InChI=1S/C25H23Cl2FN6O/c1-2-34-23-15(11-19(24(34)35)18-5-3-16(26)12-20(18)27)14-30-25(32-23)31-17-4-6-22(21(28)13-17)33-9-7-29-8-10-33/h3-6,11-14,29H,2,7-10H2,1H3,(H,30,31,32)	DHKFOIHIUYFSOF-UHFFFAOYSA-N					doublet; compound annotation
0391_000846	FRAX486	C25H23Cl2FN6O	3.6332	68060125		CCn1c(=O)c(-c2c(Cl)cc(Cl)cc2)cc2cnc(Nc3cc(F)c(N4CCNCC4)cc3)nc21	InChI=1S/C25H23Cl2FN6O/c1-2-34-23-15(11-19(24(34)35)18-5-3-16(26)12-20(18)27)14-30-25(32-23)31-17-4-6-22(21(28)13-17)33-9-7-29-8-10-33/h3-6,11-14,29H,2,7-10H2,1H3,(H,30,31,32)	DHKFOIHIUYFSOF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000848	Imrecoxib	C21H23NO3S	3.7131	11682175		CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O	InChI=1S/C21H23NO3S/c1-4-13-22-14-19(16-9-11-18(12-10-16)26(3,24)25)20(21(22)23)17-7-5-15(2)6-8-17/h5-12H,4,13-14H2,1-3H3	AXMZZGKKZDJGAZ-UHFFFAOYSA-N					doublet; compound annotation
0391_000849	Imrecoxib	C21H23NO3S	3.7179	11682175		CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O	InChI=1S/C21H23NO3S/c1-4-13-22-14-19(16-9-11-18(12-10-16)26(3,24)25)20(21(22)23)17-7-5-15(2)6-8-17/h5-12H,4,13-14H2,1-3H3	AXMZZGKKZDJGAZ-UHFFFAOYSA-N					doublet; compound annotation
0391_000850	Imrecoxib	C21H23NO3S	3.8821	11682175		CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O	InChI=1S/C21H23NO3S/c1-4-13-22-14-19(16-9-11-18(12-10-16)26(3,24)25)20(21(22)23)17-7-5-15(2)6-8-17/h5-12H,4,13-14H2,1-3H3	AXMZZGKKZDJGAZ-UHFFFAOYSA-N					doublet; compound annotation
0391_000851	2262452-06-0	C19H12Cl2N4O3	3.9359	135397653		Cc1c(C2OC(=O)c3ccccc32)c(=O)n(-c2nc3c(ccc(Cl)c3Cl)[nH]2)[nH]1	InChI=1S/C19H12Cl2N4O3/c1-8-13(16-9-4-2-3-5-10(9)18(27)28-16)17(26)25(24-8)19-22-12-7-6-11(20)14(21)15(12)23-19/h2-7,16,24H,1H3,(H,22,23)	IAWZUQAOMURCLV-UHFFFAOYSA-N					compound annotation
0391_000852	IRAK4-IN-4	C22H16N2O2	4.2352	145712357		Cc1cc2nc(-c3ccccc3)c(C(=O)C(=O)c3ccccc3)n2cc1	InChI=1S/C22H16N2O2/c1-15-12-13-24-18(14-15)23-19(16-8-4-2-5-9-16)20(24)22(26)21(25)17-10-6-3-7-11-17/h2-14H,1H3	AHNNWZOVCRQAAH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000854	LJH685	C22H21F2N3O	1.2774	73010393		CN1CCN(c2ccc(-c3ccncc3-c3cc(F)c(O)c(F)c3)cc2)CC1	InChI=1S/C22H21F2N3O/c1-26-8-10-27(11-9-26)17-4-2-15(3-5-17)18-6-7-25-14-19(18)16-12-20(23)22(28)21(24)13-16/h2-7,12-14,28H,8-11H2,1H3	IKUFKDGKRLMXEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000856	HPOB	C17H18N2O4	1.9572	71532921		O=C(NO)c1ccc(CC(=O)N(CCO)c2ccccc2)cc1	InChI=1S/C17H18N2O4/c20-11-10-19(15-4-2-1-3-5-15)16(21)12-13-6-8-14(9-7-13)17(22)18-23/h1-9,20,23H,10-12H2,(H,18,22)	RFAZNTABYJYOAR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000858	GDC-0927	C28H28FNO4	2.8058	87055263	CC1=C([C@@H](OC2=C1C=C(C=C2)O)C3=CC=C(C=C3)OCCN4CC(C4)CF)C5=CC(=CC=C5)O	CC1=C(c2cc(O)ccc2)C(c2ccc(OCCN3CC(CF)C3)cc2)Oc2c1cc(O)cc2	InChI=1S/C28H28FNO4/c1-18-25-14-23(32)7-10-26(25)34-28(27(18)21-3-2-4-22(31)13-21)20-5-8-24(9-6-20)33-12-11-30-16-19(15-29)17-30/h2-10,13-14,19,28,31-32H,11-12,15-17H2,1H3/t28-/m0/s1	KJAAPZIFCQQQKX-NDEPHWFRSA-N					doublet; compound annotation
0391_000859	GDC-0927	C28H28FNO4	2.8558	87055263	CC1=C([C@@H](OC2=C1C=C(C=C2)O)C3=CC=C(C=C3)OCCN4CC(C4)CF)C5=CC(=CC=C5)O	CC1=C(c2cc(O)ccc2)C(c2ccc(OCCN3CC(CF)C3)cc2)Oc2c1cc(O)cc2	InChI=1S/C28H28FNO4/c1-18-25-14-23(32)7-10-26(25)34-28(27(18)21-3-2-4-22(31)13-21)20-5-8-24(9-6-20)33-12-11-30-16-19(15-29)17-30/h2-10,13-14,19,28,31-32H,11-12,15-17H2,1H3/t28-/m0/s1	KJAAPZIFCQQQKX-NDEPHWFRSA-N					doublet; removed another duplicate entry; compound annotation
0391_000861	GDC-0927	C28H28FNO4	2.8586	87055263	CC1=C([C@@H](OC2=C1C=C(C=C2)O)C3=CC=C(C=C3)OCCN4CC(C4)CF)C5=CC(=CC=C5)O	CC1=C(c2cc(O)ccc2)C(c2ccc(OCCN3CC(CF)C3)cc2)Oc2c1cc(O)cc2	InChI=1S/C28H28FNO4/c1-18-25-14-23(32)7-10-26(25)34-28(27(18)21-3-2-4-22(31)13-21)20-5-8-24(9-6-20)33-12-11-30-16-19(15-29)17-30/h2-10,13-14,19,28,31-32H,11-12,15-17H2,1H3/t28-/m0/s1	KJAAPZIFCQQQKX-NDEPHWFRSA-N					doublet; compound annotation
0391_000862	EMIXUSTAT	C16H25NO2	3.1448	25221720	C1CCC(CC1)COC2=CC=CC(=C2)[C@@H](CCN)O	NCCC(O)c1cc(OCC2CCCCC2)ccc1	InChI=1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2/t16-/m1/s1	WJIGGYYSZBWCGC-MRXNPFEDSA-N					doublet; compound annotation
0391_000863	JNJ-61432059	C25H22FN5O2	3.1525	122656119		O=C1Cc2c(ccc(-c3c4ccnc(N5CCC(O)CC5)n4nc3-c3ccc(F)cc3)c2)N1	InChI=1S/C25H22FN5O2/c26-18-4-1-15(2-5-18)24-23(16-3-6-20-17(13-16)14-22(33)28-20)21-7-10-27-25(31(21)29-24)30-11-8-19(32)9-12-30/h1-7,10,13,19,32H,8-9,11-12,14H2,(H,28,33)	UWIJVELUZWBFEU-UHFFFAOYSA-N					doublet; compound annotation
0391_000864	JNJ-61432059	C25H22FN5O2	3.1573	122656119		O=C1Cc2c(ccc(-c3c4ccnc(N5CCC(O)CC5)n4nc3-c3ccc(F)cc3)c2)N1	InChI=1S/C25H22FN5O2/c26-18-4-1-15(2-5-18)24-23(16-3-6-20-17(13-16)14-22(33)28-20)21-7-10-27-25(31(21)29-24)30-11-8-19(32)9-12-30/h1-7,10,13,19,32H,8-9,11-12,14H2,(H,28,33)	UWIJVELUZWBFEU-UHFFFAOYSA-N					doublet; compound annotation
0391_000865	SRT3190	C18H23F2N5O4S2	3.4418	59149652	C[C@@H]([C@H](CO)O)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)F)F)NS(=O)(=O)N3CCC3	CC(Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2c(F)c(F)ccc2)n1)C(O)CO	InChI=1S/C18H23F2N5O4S2/c1-11(14(27)9-26)21-15-8-16(24-31(28,29)25-6-3-7-25)23-18(22-15)30-10-12-4-2-5-13(19)17(12)20/h2,4-5,8,11,14,26-27H,3,6-7,9-10H2,1H3,(H2,21,22,23,24)/t11-,14-/m0/s1	QVKPEMXUBULFBM-FZMZJTMJSA-N					removed another duplicate entry; compound annotation
0391_000867	A-1155463	C35H32FN5O4S2	3.7192	59447577		CN(C)CC#Cc1cc(F)c(OCCCc2c(C(=O)O)nc(N3CCc4c(C3)c(C(=O)Nc3nc5ccccc5s3)ccc4)s2)cc1	InChI=1S/C35H32FN5O4S2/c1-40(2)17-6-8-22-14-15-28(26(36)20-22)45-19-7-13-30-31(33(43)44)38-35(47-30)41-18-16-23-9-5-10-24(25(23)21-41)32(42)39-34-37-27-11-3-4-12-29(27)46-34/h3-5,9-12,14-15,20H,7,13,16-19,21H2,1-2H3,(H,43,44)(H,37,39,42)	SOYCFODXNRVBTI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000869	TY-52156	C18H19Cl2N3O	4.0404	16046248		CC(C)(C)C(=O)C(=Nc1ccc(Cl)cc1)NNc1ccc(Cl)cc1	InChI=1S/C18H19Cl2N3O/c1-18(2,3)16(24)17(21-14-8-4-12(19)5-9-14)23-22-15-10-6-13(20)7-11-15/h4-11,22H,1-3H3,(H,21,23)	XONRRGIRSGNWFP-UHFFFAOYSA-N					doublet; compound annotation
0391_000870	RS-1	C20H16Br2N2O3S	4.8763	1039737		O=C(Nc1ccc(Br)cc1)c1cc(S(=O)(=O)NCc2ccccc2)c(Br)cc1	InChI=1S/C20H16Br2N2O3S/c21-16-7-9-17(10-8-16)24-20(25)15-6-11-18(22)19(12-15)28(26,27)23-13-14-4-2-1-3-5-14/h1-12,23H,13H2,(H,24,25)	SWKAVEUTKGKHSR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000872	TY-52156	C18H19Cl2N3O	5.5046	16046248		CC(C)(C)C(=O)C(=Nc1ccc(Cl)cc1)NNc1ccc(Cl)cc1	InChI=1S/C18H19Cl2N3O/c1-18(2,3)16(24)17(21-14-8-4-12(19)5-9-14)23-22-15-10-6-13(20)7-11-15/h4-11,22H,1-3H3,(H,21,23)	XONRRGIRSGNWFP-UHFFFAOYSA-N					doublet; compound annotation
0391_000873	TY-52156	C18H19Cl2N3O	6.2118	16046248		CC(C)(C)C(=O)C(=Nc1ccc(Cl)cc1)NNc1ccc(Cl)cc1	InChI=1S/C18H19Cl2N3O/c1-18(2,3)16(24)17(21-14-8-4-12(19)5-9-14)23-22-15-10-6-13(20)7-11-15/h4-11,22H,1-3H3,(H,21,23)	XONRRGIRSGNWFP-UHFFFAOYSA-N					doublet; compound annotation
0391_000874	SCHEMBL3622084	C22H16FN5O2	0.8254	11316552		O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2CCNCc3cc(F)cc1c32	InChI=1S/C22H16FN5O2/c23-13-7-12-9-24-4-6-27-11-15(14(8-13)20(12)27)18-19(22(30)26-21(18)29)16-10-25-17-3-1-2-5-28(16)17/h1-3,5,7-8,10-11,24H,4,6,9H2,(H,26,29,30)	VCNHSKHGFXUGRH-UHFFFAOYSA-N					compound annotation
0391_000875	Nomifensine	C16H18N2	2.0993	4528		CN1Cc2c(cccc2N)C(c2ccccc2)C1	InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3	XXPANQJNYNUNES-UHFFFAOYSA-N					doublet; compound annotation
0391_000876	UK-371804	C14H16ClN5O4S	2.2507	9952109		CC(C)(NS(=O)(=O)c1cc2c(cc1)c(Cl)cnc2N=C(N)N)C(=O)O	InChI=1S/C14H16ClN5O4S/c1-14(2,12(21)22)20-25(23,24)7-3-4-8-9(5-7)11(19-13(16)17)18-6-10(8)15/h3-6,20H,1-2H3,(H,21,22)(H4,16,17,18,19)	XSDAXWRCPTYNOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000878	ETHAMIVAN	C12H17NO3	2.3091	9363		CCN(CC)C(=O)c1cc(OC)c(O)cc1	InChI=1S/C12H17NO3/c1-4-13(5-2)12(15)9-6-7-10(14)11(8-9)16-3/h6-8,14H,4-5H2,1-3H3	BQJODPIMMWWMFC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000880	Limaprost	C22H36O5	3.7523	6438378	CCCC[C@H](C)C[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCC/C=C/C(=O)O)O)O	CCCCC(C)CC(O)C=CC1C(O)CC(=O)C1CCCCC=CC(=O)O	InChI=1S/C22H36O5/c1-3-4-9-16(2)14-17(23)12-13-19-18(20(24)15-21(19)25)10-7-5-6-8-11-22(26)27/h8,11-13,16-19,21,23,25H,3-7,9-10,14-15H2,1-2H3,(H,26,27)/b11-8+,13-12+/t16-,17+,18+,19+,21+/m0/s1	OJZYRQPMEIEQFC-UAWLTFRCSA-N					compound annotation
0391_000881	IDF-11774	C23H32N2O2	3.8084	71542096		CN1CCN(C(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)CC1	InChI=1S/C23H32N2O2/c1-24-6-8-25(9-7-24)22(26)16-27-21-4-2-20(3-5-21)23-13-17-10-18(14-23)12-19(11-17)15-23/h2-5,17-19H,6-16H2,1H3	QGBBBLPWBSWERZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000883	1135695-98-5	C26H25F2N3O6	4.1973	24794416	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C=CC=C1F)F)NC(=O)C2=NC3=CC=CC=C3C=C2	CC(C)C(NC(=O)c1nc2ccccc2cc1)C(=O)NC(CC(=O)O)C(=O)COc1c(F)cccc1F	InChI=1S/C26H25F2N3O6/c1-14(2)23(31-25(35)19-11-10-15-6-3-4-9-18(15)29-19)26(36)30-20(12-22(33)34)21(32)13-37-24-16(27)7-5-8-17(24)28/h3-11,14,20,23H,12-13H2,1-2H3,(H,30,36)(H,31,35)(H,33,34)/t20-,23-/m0/s1	OOBJCYKITXPCNS-REWPJTCUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000885	1135695-98-5	C26H25F2N3O6	4.2421	24794416	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C=CC=C1F)F)NC(=O)C2=NC3=CC=CC=C3C=C2	CC(C)C(NC(=O)c1nc2ccccc2cc1)C(=O)NC(CC(=O)O)C(=O)COc1c(F)cccc1F	InChI=1S/C26H25F2N3O6/c1-14(2)23(31-25(35)19-11-10-15-6-3-4-9-18(15)29-19)26(36)30-20(12-22(33)34)21(32)13-37-24-16(27)7-5-8-17(24)28/h3-11,14,20,23H,12-13H2,1-2H3,(H,30,36)(H,31,35)(H,33,34)/t20-,23-/m0/s1	OOBJCYKITXPCNS-REWPJTCUSA-N					doublet; removed another duplicate entry; compound annotation
0391_000887	maropitant	C32H40N2O	4.3891	204108	CC(C)(C)C1=CC(=C(C=C1)OC)CN[C@@H]2[C@@H](N3CCC2CC3)C(C4=CC=CC=C4)C5=CC=CC=C5	COc1c(CNC2C3CCN(CC3)C2C(c2ccccc2)c2ccccc2)cc(C(C)(C)C)cc1	InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3/t30-,31-/m0/s1	OMPCVMLFFSQFIX-CONSDPRKSA-N					compound annotation
0391_000888	YH239-EE	C25H27Cl2N3O4	4.8493	56943013		CCOC(=O)c1c(C(C(=O)NC(C)(C)C)N(C=O)Cc2ccc(Cl)cc2)c2c(cc(Cl)cc2)[nH]1	InChI=1S/C25H27Cl2N3O4/c1-5-34-24(33)21-20(18-11-10-17(27)12-19(18)28-21)22(23(32)29-25(2,3)4)30(14-31)13-15-6-8-16(26)9-7-15/h6-12,14,22,28H,5,13H2,1-4H3,(H,29,32)	OTUBDDRFPQLPKD-UHFFFAOYSA-N					doublet; compound annotation
0391_000889	YH239-EE	C25H27Cl2N3O4	4.8543	56943013		CCOC(=O)c1c(C(C(=O)NC(C)(C)C)N(C=O)Cc2ccc(Cl)cc2)c2c(cc(Cl)cc2)[nH]1	InChI=1S/C25H27Cl2N3O4/c1-5-34-24(33)21-20(18-11-10-17(27)12-19(18)28-21)22(23(32)29-25(2,3)4)30(14-31)13-15-6-8-16(26)9-7-15/h6-12,14,22,28H,5,13H2,1-4H3,(H,29,32)	OTUBDDRFPQLPKD-UHFFFAOYSA-N					doublet; compound annotation
0391_000890	13-cis-N-[4-(Ethoxycarbonyl)phenyl]retinamide	C29H37NO3	6.8531	72950958	CCOC(=O)C1=CC=C(C=C1)NC(=O)/C=C(/C)\C=C\C=C(/C)\C=C\C2=C(CCCC2(C)C)C	CCOC(=O)c1ccc(NC(=O)C=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)cc1	InChI=1S/C29H37NO3/c1-7-33-28(32)24-14-16-25(17-15-24)30-27(31)20-22(3)11-8-10-21(2)13-18-26-23(4)12-9-19-29(26,5)6/h8,10-11,13-18,20H,7,9,12,19H2,1-6H3,(H,30,31)/b11-8+,18-13+,21-10+,22-20-	VRSMJNVXOITYPE-XWJHKTRCSA-N					doublet; compound annotation
0391_000891	13-cis-N-[4-(Ethoxycarbonyl)phenyl]retinamide	C29H37NO3	6.8988	72950958	CCOC(=O)C1=CC=C(C=C1)NC(=O)/C=C(/C)\C=C\C=C(/C)\C=C\C2=C(CCCC2(C)C)C	CCOC(=O)c1ccc(NC(=O)C=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)cc1	InChI=1S/C29H37NO3/c1-7-33-28(32)24-14-16-25(17-15-24)30-27(31)20-22(3)11-8-10-21(2)13-18-26-23(4)12-9-19-29(26,5)6/h8,10-11,13-18,20H,7,9,12,19H2,1-6H3,(H,30,31)/b11-8+,18-13+,21-10+,22-20-	VRSMJNVXOITYPE-XWJHKTRCSA-N					doublet; compound annotation
0391_000892	13-cis-N-[4-(Ethoxycarbonyl)phenyl]retinamide	C29H37NO3	7.0529	72950958	CCOC(=O)C1=CC=C(C=C1)NC(=O)/C=C(/C)\C=C\C=C(/C)\C=C\C2=C(CCCC2(C)C)C	CCOC(=O)c1ccc(NC(=O)C=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)cc1	InChI=1S/C29H37NO3/c1-7-33-28(32)24-14-16-25(17-15-24)30-27(31)20-22(3)11-8-10-21(2)13-18-26-23(4)12-9-19-29(26,5)6/h8,10-11,13-18,20H,7,9,12,19H2,1-6H3,(H,30,31)/b11-8+,18-13+,21-10+,22-20-	VRSMJNVXOITYPE-XWJHKTRCSA-N					doublet; compound annotation
0391_000893	RUCAPARIB	C19H18FN3O	1.8082	9931954		CNCc1ccc(-c2c3CCNC(=O)c4c3c(cc(F)c4)[nH]2)cc1	InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)	HMABYWSNWIZPAG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000895	Borussertib	C36H32N6O3	2.4389	122668091		C=CC(=O)Nc1cc2c(cc1)[nH]c(=O)n2C1CCN(Cc2ccc(-c3nc4c(cc3-c3ccccc3)c(=O)[nH]cc4)cc2)CC1	InChI=1S/C36H32N6O3/c1-2-33(43)38-26-12-13-31-32(20-26)42(36(45)40-31)27-15-18-41(19-16-27)22-23-8-10-25(11-9-23)34-28(24-6-4-3-5-7-24)21-29-30(39-34)14-17-37-35(29)44/h2-14,17,20-21,27H,1,15-16,18-19,22H2,(H,37,44)(H,38,43)(H,40,45)	HXBRBOYWXDLHDC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000897	741713-40-6	C18H21F2N5O4S	2.8091	6918852		COc1c(C(=O)c2cnc(NC3CCN(S(C)(=O)=O)CC3)nc2N)c(F)c(F)cc1	InChI=1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24)	JRNJNYBQQYBCLE-UHFFFAOYSA-N					compound annotation
0391_000898	ML604440	C17H24BF3N2O4	2.855	57655545	B([C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)C1=CC=CC=C1C(F)(F)F)(O)O	CC(C)CC(NC(=O)C(C)(C)NC(=O)c1ccccc1C(F)(F)F)B(O)O	InChI=1S/C17H24BF3N2O4/c1-10(2)9-13(18(26)27)22-15(25)16(3,4)23-14(24)11-7-5-6-8-12(11)17(19,20)21/h5-8,10,13,26-27H,9H2,1-4H3,(H,22,25)(H,23,24)/t13-/m0/s1	IRZZVDHGNHGNAI-ZDUSSCGKSA-N					compound annotation
0391_000899	AZD8186	C24H25F2N3O4	3.3699	52913813	C[C@H](C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F	CC(Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c1oc(N1CCOCC1)cc2=O	InChI=1S/C24H25F2N3O4/c1-14(27-18-11-16(25)10-17(26)12-18)19-8-15(24(31)28(2)3)9-20-21(30)13-22(33-23(19)20)29-4-6-32-7-5-29/h8-14,27H,4-7H2,1-3H3/t14-/m1/s1	LMJFJIDLEAWOQJ-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_000901	CCB02	C14H9N3O	3.4129	129216797		COc1c(C#N)c2nc3ccccc3cc2cn1	InChI=1S/C14H9N3O/c1-18-14-11(7-15)13-10(8-16-14)6-9-4-2-3-5-12(9)17-13/h2-6,8H,1H3	QNJYUHRGCPRPQS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000903	BETP	C20H17F3N2O2S	4.7699	49868481		CC[S+]([O-])c1nc(-c2cccc(OCc3ccccc3)c2)cc(C(F)(F)F)n1	InChI=1S/C20H17F3N2O2S/c1-2-28(26)19-24-17(12-18(25-19)20(21,22)23)15-9-6-10-16(11-15)27-13-14-7-4-3-5-8-14/h3-12H,2,13H2,1H3	NTDFYGSSDDMNHI-UHFFFAOYSA-N					doublet; compound annotation
0391_000904	BETP	C20H17F3N2O2S	4.7744	49868481		CC[S+]([O-])c1nc(-c2cccc(OCc3ccccc3)c2)cc(C(F)(F)F)n1	InChI=1S/C20H17F3N2O2S/c1-2-28(26)19-24-17(12-18(25-19)20(21,22)23)15-9-6-10-16(11-15)27-13-14-7-4-3-5-8-14/h3-12H,2,13H2,1H3	NTDFYGSSDDMNHI-UHFFFAOYSA-N					doublet; compound annotation
0391_000905	1218942-37-0	C21H19ClN4O2	5.1807	58496428		CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1	InChI=1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3	RGYQPQARIQKJKH-UHFFFAOYSA-N					doublet; compound annotation
0391_000906	1218942-37-0	C21H19ClN4O2	6.7104	58496428		CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1	InChI=1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3	RGYQPQARIQKJKH-UHFFFAOYSA-N					doublet; compound annotation
0391_000907	Flumatinib	C29H29F3N8O	1.9945	46848036		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cn1	InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)	BJCJYEYYYGBROF-UHFFFAOYSA-N					doublet; compound annotation
0391_000908	Flumatinib	C29H29F3N8O	1.9973	46848036		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cn1	InChI=1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38)	BJCJYEYYYGBROF-UHFFFAOYSA-N					doublet; compound annotation
0391_000909	BMS-813160	C25H40N8O2	2.1741	51039119	CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N2CC[C@@H](C2=O)NC3=NC=NC4=CC(=NN43)C(C)(C)C)NC(C)(C)C	CC(=O)NC1CC(NC(C)(C)C)CCC1N1CCC(Nc2ncnc3cc(C(C)(C)C)nn23)C1=O	InChI=1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1	CMVHFGNTABZQJU-HCXYKTFWSA-N					removed another duplicate entry; compound annotation
0391_000911	Foliglurax	C23H23N3O3S	2.6935	135565465	C1COCCN1CCCC2=CC\3=C(C=C2)OC(=C/C3=N\O)C4=NC=C5C=CSC5=C4	ON=c1cc(-c2ncc3ccsc3c2)oc2c1cc(CCCN1CCOCC1)cc2	InChI=1S/C23H23N3O3S/c27-25-19-13-22(20-14-23-17(15-24-20)5-11-30-23)29-21-4-3-16(12-18(19)21)2-1-6-26-7-9-28-10-8-26/h3-5,11-15,27H,1-2,6-10H2/b25-19+	ZTEDNASHAWNBKQ-NCELDCMTSA-N					doublet; compound annotation
0391_000912	Foliglurax	C23H23N3O3S	2.8635	135565465	C1COCCN1CCCC2=CC\3=C(C=C2)OC(=C/C3=N\O)C4=NC=C5C=CSC5=C4	ON=c1cc(-c2ncc3ccsc3c2)oc2c1cc(CCCN1CCOCC1)cc2	InChI=1S/C23H23N3O3S/c27-25-19-13-22(20-14-23-17(15-24-20)5-11-30-23)29-21-4-3-16(12-18(19)21)2-1-6-26-7-9-28-10-8-26/h3-5,11-15,27H,1-2,6-10H2/b25-19+	ZTEDNASHAWNBKQ-NCELDCMTSA-N					doublet; compound annotation
0391_000913	761437-28-9	C23H25ClN6O3	3.008	9934347		CNC(=O)c1ccccc1Nc1nc(Nc2c(OC)cc(N3CCOCC3)cc2)ncc1Cl	InChI=1S/C23H25ClN6O3/c1-25-22(31)16-5-3-4-6-18(16)27-21-17(24)14-26-23(29-21)28-19-8-7-15(13-20(19)32-2)30-9-11-33-12-10-30/h3-8,13-14H,9-12H2,1-2H3,(H,25,31)(H2,26,27,28,29)	UYJNQQDJUOUFQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000914	Mibefradil	C29H38FN3O3	3.0356	60663	CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F	COCC(=O)OC1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2c(ccc(F)c2)C1C(C)C	InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1	HBNPJJILLOYFJU-VMPREFPWSA-N					removed another duplicate entry; compound annotation
0391_000916	Foliglurax	C23H23N3O3S	3.6703	135565465	C1COCCN1CCCC2=CC\3=C(C=C2)OC(=C/C3=N\O)C4=NC=C5C=CSC5=C4	ON=c1cc(-c2ncc3ccsc3c2)oc2c1cc(CCCN1CCOCC1)cc2	InChI=1S/C23H23N3O3S/c27-25-19-13-22(20-14-23-17(15-24-20)5-11-30-23)29-21-4-3-16(12-18(19)21)2-1-6-26-7-9-28-10-8-26/h3-5,11-15,27H,1-2,6-10H2/b25-19+	ZTEDNASHAWNBKQ-NCELDCMTSA-N					doublet; compound annotation
0391_000917	DMX-5804	C21H19N3O3	3.7165	137334091		COCCOc1ccc(-c2cn(-c3ccccc3)c3c2c(=O)[nH]cn3)cc1	InChI=1S/C21H19N3O3/c1-26-11-12-27-17-9-7-15(8-10-17)18-13-24(16-5-3-2-4-6-16)20-19(18)21(25)23-14-22-20/h2-10,13-14H,11-12H2,1H3,(H,22,23,25)	FUSHFOGORKZNNQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000920	761437-28-9	C23H25ClN6O3	3.935	9934347		CNC(=O)c1ccccc1Nc1nc(Nc2c(OC)cc(N3CCOCC3)cc2)ncc1Cl	InChI=1S/C23H25ClN6O3/c1-25-22(31)16-5-3-4-6-18(16)27-21-17(24)14-26-23(29-21)28-19-8-7-15(13-20(19)32-2)30-9-11-33-12-10-30/h3-8,13-14H,9-12H2,1-2H3,(H,25,31)(H2,26,27,28,29)	UYJNQQDJUOUFQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_000921	SB-674042	C24H21FN4O2S	4.084	10204153	CC1=NC(=C(S1)C2=CC=CC=C2F)C(=O)N3CCC[C@H]3CC4=NN=C(O4)C5=CC=CC=C5	Cc1nc(C(=O)N2CCCC2Cc2nnc(-c3ccccc3)o2)c(-c2ccccc2F)s1	InChI=1S/C24H21FN4O2S/c1-15-26-21(22(32-15)18-11-5-6-12-19(18)25)24(30)29-13-7-10-17(29)14-20-27-28-23(31-20)16-8-3-2-4-9-16/h2-6,8-9,11-12,17H,7,10,13-14H2,1H3/t17-/m0/s1	HYBZWVLPALMACV-KRWDZBQOSA-N					doublet; compound annotation
0391_000922	SB-674042	C24H21FN4O2S	4.2249	10204153	CC1=NC(=C(S1)C2=CC=CC=C2F)C(=O)N3CCC[C@H]3CC4=NN=C(O4)C5=CC=CC=C5	Cc1nc(C(=O)N2CCCC2Cc2nnc(-c3ccccc3)o2)c(-c2ccccc2F)s1	InChI=1S/C24H21FN4O2S/c1-15-26-21(22(32-15)18-11-5-6-12-19(18)25)24(30)29-13-7-10-17(29)14-20-27-28-23(31-20)16-8-3-2-4-9-16/h2-6,8-9,11-12,17H,7,10,13-14H2,1H3/t17-/m0/s1	HYBZWVLPALMACV-KRWDZBQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_000924	LTI-291	C20H30N4O2	4.7272	121327414		CCCCCOC1CCC(NC(=O)c2c3nc(C)cc(C)n3nc2)CC1	InChI=1S/C20H30N4O2/c1-4-5-6-11-26-17-9-7-16(8-10-17)23-20(25)18-13-21-24-15(3)12-14(2)22-19(18)24/h12-13,16-17H,4-11H2,1-3H3,(H,23,25)	HZILSILAELSWKN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000926	N-Acetylprocainamide	C15H23N3O2	0.9707	4342		CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1	InChI=1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19)	KEECCEWTUVWFCV-UHFFFAOYSA-N					compound annotation
0391_000927	METAXALONE	C12H15NO3	3.2162	15459		Cc1cc(C)cc(OCC2CNC(=O)O2)c1	InChI=1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14)	IMWZZHHPURKASS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000930	ASP-9521	C19H26N2O3	3.3432	25210792		COc1cc2c(cc1)[nH]c(C(=O)N1CCC(CC(C)(C)O)CC1)c2	InChI=1S/C19H26N2O3/c1-19(2,23)12-13-6-8-21(9-7-13)18(22)17-11-14-10-15(24-3)4-5-16(14)20-17/h4-5,10-11,13,20,23H,6-9,12H2,1-3H3	OXSCPDKUZWPWFR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000933	LDC7559	C20H19N3O3	3.5509	138319675		COc1ccccc1-c1nn2Cc3c(cc(NC(C)=O)cc3)OCc2c1	InChI=1S/C20H19N3O3/c1-13(24)21-15-8-7-14-11-23-16(12-26-20(14)9-15)10-18(22-23)17-5-3-4-6-19(17)25-2/h3-10H,11-12H2,1-2H3,(H,21,24)	IFOIINXSFCQLOV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000935	LRRK2 inhibitor 1	C20H23N5O4	3.6316	118286428		CCOc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)cc2)nc2c1cc[nH]2	InChI=1S/C20H23N5O4/c1-3-29-18-14-6-7-21-17(14)23-20(24-18)22-15-5-4-13(12-16(15)27-2)19(26)25-8-10-28-11-9-25/h4-7,12H,3,8-11H2,1-2H3,(H2,21,22,23,24)	OTTOCUYGSZUQOI-UHFFFAOYSA-N					compound annotation
0391_000936	YQ128	C27H29ClN2O4S2	5.0859	139600339		C#CCNS(=O)(=O)c1ccc(CCN(Cc2c(OCCC)ccc(Cl)c2)C(=O)Cc2cscc2)cc1	InChI=1S/C27H29ClN2O4S2/c1-3-13-29-36(32,33)25-8-5-21(6-9-25)11-14-30(27(31)17-22-12-16-35-20-22)19-23-18-24(28)7-10-26(23)34-15-4-2/h1,5-10,12,16,18,20,29H,4,11,13-15,17,19H2,2H3	SFPYRFRNYALLHS-UHFFFAOYSA-N					doublet; compound annotation
0391_000937	YQ128	C27H29ClN2O4S2	5.0892	139600339		C#CCNS(=O)(=O)c1ccc(CCN(Cc2c(OCCC)ccc(Cl)c2)C(=O)Cc2cscc2)cc1	InChI=1S/C27H29ClN2O4S2/c1-3-13-29-36(32,33)25-8-5-21(6-9-25)11-14-30(27(31)17-22-12-16-35-20-22)19-23-18-24(28)7-10-26(23)34-15-4-2/h1,5-10,12,16,18,20,29H,4,11,13-15,17,19H2,2H3	SFPYRFRNYALLHS-UHFFFAOYSA-N					doublet; compound annotation
0391_000938	Fluxametamide	C20H16Cl2F3N3O3	5.5588	136412260	CC1=C(C=CC(=C1)C2=NOC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)N/C=N/OC	CONC=NC(=O)c1c(C)cc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)cc1	InChI=1S/C20H16Cl2F3N3O3/c1-11-5-12(3-4-16(11)18(29)26-10-27-30-2)17-9-19(31-28-17,20(23,24)25)13-6-14(21)8-15(22)7-13/h3-8,10H,9H2,1-2H3,(H,26,27,29)	BPFUIWLQXNPZHI-UHFFFAOYSA-N					doublet; compound annotation
0391_000939	Fluxametamide	C20H16Cl2F3N3O3	5.6393	136412260	CC1=C(C=CC(=C1)C2=NOC(C2)(C3=CC(=CC(=C3)Cl)Cl)C(F)(F)F)C(=O)N/C=N/OC	CONC=NC(=O)c1c(C)cc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)cc1	InChI=1S/C20H16Cl2F3N3O3/c1-11-5-12(3-4-16(11)18(29)26-10-27-30-2)17-9-19(31-28-17,20(23,24)25)13-6-14(21)8-15(22)7-13/h3-8,10H,9H2,1-2H3,(H,26,27,29)	BPFUIWLQXNPZHI-UHFFFAOYSA-N					doublet; compound annotation
0391_000940	313516-66-4	C12H8ClN3O3	1.7481	2777391		O=C(Nc1ccncc1)c1c(Cl)ccc([N+](=O)[O-])c1	InChI=1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17)	FRPJSHKMZHWJBE-UHFFFAOYSA-N					compound annotation
0391_000941	DTXSID401044300	C29H35N2O2P+	2.2419	73504625		CC1(C)CC(NC(=O)C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)CC(C)(C)N1[O]	InChI=1S/C29H34N2O2P/c1-28(2)20-23(21-29(3,4)31(28)33)30-27(32)22-34(24-14-8-5-9-15-24,25-16-10-6-11-17-25)26-18-12-7-13-19-26/h5-19,23H,20-22H2,1-4H3/p+1	OVDPLBMWAOKARA-UHFFFAOYSA-O					doublet; compound annotation
0391_000942	DTXSID401044300	C29H35N2O2P+	3.0742	73504625		CC1(C)CC(NC(=O)C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)CC(C)(C)N1[O]	InChI=1S/C29H34N2O2P/c1-28(2)20-23(21-29(3,4)31(28)33)30-27(32)22-34(24-14-8-5-9-15-24,25-16-10-6-11-17-25)26-18-12-7-13-19-26/h5-19,23H,20-22H2,1-4H3/p+1	OVDPLBMWAOKARA-UHFFFAOYSA-O					doublet; compound annotation
0391_000943	CDK9-IN-1	C26H21N5O4S	3.3012	66577006		Cc1c(NS(C)(=O)=O)cc(Nc2ncnc(-c3cc(N4C(=O)c5ccccc5C4=O)ccc3)c2)cc1	InChI=1S/C26H21N5O4S/c1-16-10-11-18(13-22(16)30-36(2,34)35)29-24-14-23(27-15-28-24)17-6-5-7-19(12-17)31-25(32)20-8-3-4-9-21(20)26(31)33/h3-15,30H,1-2H3,(H,27,28,29)	CKUFOBCNTCLXJP-UHFFFAOYSA-N					compound annotation
0391_000944	DMH-1	C24H20N4O	3.539	50997747		CC(C)Oc1ccc(-c2cn3ncc(-c4ccnc5ccccc45)c3nc2)cc1	InChI=1S/C24H20N4O/c1-16(2)29-19-9-7-17(8-10-19)18-13-26-24-22(14-27-28(24)15-18)20-11-12-25-23-6-4-3-5-21(20)23/h3-16H,1-2H3	JMIFGARJSWXZSH-UHFFFAOYSA-N					compound annotation
0391_000945	325457-89-4	C12H7ClF2N2O	3.5809	9903497		O=C(Nc1cnc(Cl)cc1)c1cc(F)c(F)cc1	InChI=1S/C12H7ClF2N2O/c13-11-4-2-8(6-16-11)17-12(18)7-1-3-9(14)10(15)5-7/h1-6H,(H,17,18)	GDGUOCFTHNGPBK-UHFFFAOYSA-N					compound annotation
0391_000946	TVB-2640	C27H29N5O	3.8339	66548316		Cc1nc(-c2cc(C(=O)N3CCC(c4ccc(C#N)cc4)CC3)c(C)cc2C2CCC2)n[nH]1	InChI=1S/C27H29N5O/c1-17-14-24(22-4-3-5-22)25(26-29-18(2)30-31-26)15-23(17)27(33)32-12-10-21(11-13-32)20-8-6-19(16-28)7-9-20/h6-9,14-15,21-22H,3-5,10-13H2,1-2H3,(H,29,30,31)	BBGOSBDSLYHMRA-UHFFFAOYSA-N					compound annotation
0391_000947	DT-061	C25H23F3N2O5S	5.4541	91885558	C1C[C@H]([C@@H]([C@H](C1)N2C3=CC=CC=C3OC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F	O=S(=O)(NC1CCCC(N2c3ccccc3Oc3ccccc32)C1O)c1ccc(OC(F)(F)F)cc1	InChI=1S/C25H23F3N2O5S/c26-25(27,28)35-16-12-14-17(15-13-16)36(32,33)29-18-6-5-9-21(24(18)31)30-19-7-1-3-10-22(19)34-23-11-4-2-8-20(23)30/h1-4,7-8,10-15,18,21,24,29,31H,5-6,9H2/t18-,21+,24+/m1/s1	WGKGADVPRVLHHZ-ZHRMCQFGSA-N					doublet; compound annotation
0391_000948	DT-061	C25H23F3N2O5S	5.4575	91885558	C1C[C@H]([C@@H]([C@H](C1)N2C3=CC=CC=C3OC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F	O=S(=O)(NC1CCCC(N2c3ccccc3Oc3ccccc32)C1O)c1ccc(OC(F)(F)F)cc1	InChI=1S/C25H23F3N2O5S/c26-25(27,28)35-16-12-14-17(15-13-16)36(32,33)29-18-6-5-9-21(24(18)31)30-19-7-1-3-10-22(19)34-23-11-4-2-8-20(23)30/h1-4,7-8,10-15,18,21,24,29,31H,5-6,9H2/t18-,21+,24+/m1/s1	WGKGADVPRVLHHZ-ZHRMCQFGSA-N					doublet; compound annotation
0391_000949	DK419	C16H8ClF6N3O	5.5538	44536362		O=C(Nc1ccc(C(F)(F)F)cc1)c1c2nc(C(F)(F)F)[nH]c2cc(Cl)c1	InChI=1S/C16H8ClF6N3O/c17-8-5-10(12-11(6-8)25-14(26-12)16(21,22)23)13(27)24-9-3-1-7(2-4-9)15(18,19)20/h1-6H,(H,24,27)(H,25,26)	MWNNIGRGNSXNEA-UHFFFAOYSA-N					compound annotation
0391_000950	Sumanirole	C11H13N3O	0.5185	9818479	CN[C@@H]1CC2=C3C(=CC=C2)NC(=O)N3C1	CNC1Cc2c3c(ccc2)[nH]c(=O)n3C1	InChI=1S/C11H13N3O/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9/h2-4,8,12H,5-6H2,1H3,(H,13,15)/t8-/m1/s1	RKZSNTNMEFVBDT-MRVPVSSYSA-N					removed another duplicate entry; compound annotation
0391_000952	Protionamide	C9H12N2S	1.1995	666418		CCCc1nccc(C(=N)S)c1	InChI=1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H,2-3H2,1H3,(H2,10,12)	VRDIULHPQTYCLN-UHFFFAOYSA-N					compound annotation
0391_000953	CHEMBL2030550	C20H20BrN3	1.454	57342889	CN1CCN(CC1)C2=CC=C(C=C2)/C=C(\C#N)/C3=CC=CC=C3Br	CN1CCN(c2ccc(C=C(C#N)c3ccccc3Br)cc2)CC1	InChI=1S/C20H20BrN3/c1-23-10-12-24(13-11-23)18-8-6-16(7-9-18)14-17(15-22)19-4-2-3-5-20(19)21/h2-9,14H,10-13H2,1H3/b17-14+	ZJMDTBBCNMGFMS-SAPNQHFASA-N					doublet; compound annotation
0391_000954	(+)-Bicuculline	C20H17NO6	1.8487	10237	CN1CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3	CN1CCc2cc3c(cc2C1C1OC(=O)c2c4OCOc4ccc21)OCO3	InChI=1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1	IYGYMKDQCDOMRE-ZWKOTPCHSA-N					removed another duplicate entry; compound annotation
0391_000956	Buparlisib	C18H21F3N6O2	2.2194	16654980		Nc1ncc(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)c1	InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)	CWHUFRVAEUJCEF-UHFFFAOYSA-N					doublet; compound annotation
0391_000957	miransertib	C27H24N6	2.3944	53262401		Nc1c(-c2nc3ccc(-c4ccccc4)nc3n2-c2ccc(C3(N)CCC3)cc2)cccn1	InChI=1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30)	HNFMVVHMKGFCMB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000960	chemerin C-terminal peptide	C54H66N10O13	2.4581	11332190	C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CC=C(C=C5)O)N	CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)O	InChI=1S/C54H66N10O13/c1-32(47(69)60-41(28-34-14-7-3-8-15-34)51(73)63-43(31-65)54(76)77)58-50(72)40(27-33-12-5-2-6-13-33)61-49(71)39(23-24-45(56)67)59-46(68)30-57-52(74)44-18-11-25-64(44)53(75)42(29-35-16-9-4-10-17-35)62-48(70)38(55)26-36-19-21-37(66)22-20-36/h2-10,12-17,19-22,32,38-44,65-66H,11,18,23-31,55H2,1H3,(H2,56,67)(H,57,74)(H,58,72)(H,59,68)(H,60,69)(H,61,71)(H,62,70)(H,63,73)(H,76,77)/t32-,38-,39-,40-,41-,42-,43-,44-/m0/s1	QLVGSBXIQFERFK-NBBYSTNSSA-N					doublet; compound annotation
0391_000961	chemerin C-terminal peptide	C54H66N10O13	2.4631	11332190	C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CC=C(C=C5)O)N	CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C1CCCN1C(=O)C(Cc1ccccc1)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)O	InChI=1S/C54H66N10O13/c1-32(47(69)60-41(28-34-14-7-3-8-15-34)51(73)63-43(31-65)54(76)77)58-50(72)40(27-33-12-5-2-6-13-33)61-49(71)39(23-24-45(56)67)59-46(68)30-57-52(74)44-18-11-25-64(44)53(75)42(29-35-16-9-4-10-17-35)62-48(70)38(55)26-36-19-21-37(66)22-20-36/h2-10,12-17,19-22,32,38-44,65-66H,11,18,23-31,55H2,1H3,(H2,56,67)(H,57,74)(H,58,72)(H,59,68)(H,60,69)(H,61,71)(H,62,70)(H,63,73)(H,76,77)/t32-,38-,39-,40-,41-,42-,43-,44-/m0/s1	QLVGSBXIQFERFK-NBBYSTNSSA-N					doublet; compound annotation
0391_000962	CHEMBL2030550	C20H20BrN3	2.9593	57342889	CN1CCN(CC1)C2=CC=C(C=C2)/C=C(\C#N)/C3=CC=CC=C3Br	CN1CCN(c2ccc(C=C(C#N)c3ccccc3Br)cc2)CC1	InChI=1S/C20H20BrN3/c1-23-10-12-24(13-11-23)18-8-6-16(7-9-18)14-17(15-22)19-4-2-3-5-20(19)21/h2-9,14H,10-13H2,1H3/b17-14+	ZJMDTBBCNMGFMS-SAPNQHFASA-N					doublet; compound annotation
0391_000963	CHEMBL2030550	C20H20BrN3	3.2762	57342889	CN1CCN(CC1)C2=CC=C(C=C2)/C=C(\C#N)/C3=CC=CC=C3Br	CN1CCN(c2ccc(C=C(C#N)c3ccccc3Br)cc2)CC1	InChI=1S/C20H20BrN3/c1-23-10-12-24(13-11-23)18-8-6-16(7-9-18)14-17(15-22)19-4-2-3-5-20(19)21/h2-9,14H,10-13H2,1H3/b17-14+	ZJMDTBBCNMGFMS-SAPNQHFASA-N					doublet; compound annotation
0391_000964	CHEMBL2030550	C20H20BrN3	3.2794	57342889	CN1CCN(CC1)C2=CC=C(C=C2)/C=C(\C#N)/C3=CC=CC=C3Br	CN1CCN(c2ccc(C=C(C#N)c3ccccc3Br)cc2)CC1	InChI=1S/C20H20BrN3/c1-23-10-12-24(13-11-23)18-8-6-16(7-9-18)14-17(15-22)19-4-2-3-5-20(19)21/h2-9,14H,10-13H2,1H3/b17-14+	ZJMDTBBCNMGFMS-SAPNQHFASA-N					doublet; compound annotation
0391_000965	KS176	C22H19N3O5	3.954	49779726		O=C(Nc1ccccc1C(=O)Nc1ccc(CCO)cc1)c1ccc([N+](=O)[O-])cc1	InChI=1S/C22H19N3O5/c26-14-13-15-5-9-17(10-6-15)23-22(28)19-3-1-2-4-20(19)24-21(27)16-7-11-18(12-8-16)25(29)30/h1-12,26H,13-14H2,(H,23,28)(H,24,27)	LTWQQWSXYYXVGA-UHFFFAOYSA-N					compound annotation
0391_000966	nbqx	C12H8N4O6S	1.1981	3272524		NS(=O)(=O)c1cccc2c3[nH]c(=O)c(=O)[nH]c3cc([N+](=O)[O-])c12	InChI=1S/C12H8N4O6S/c13-23(21,22)8-3-1-2-5-9(8)7(16(19)20)4-6-10(5)15-12(18)11(17)14-6/h1-4H,(H,14,17)(H,15,18)(H2,13,21,22)	UQNAFPHGVPVTAL-UHFFFAOYSA-N					compound annotation
0391_000967	Vanin-1-IN-1	C18H22N6O2	1.8065	134177597		O=C(c1cnc(NCc2nccnc2)nc1)N1CCC2(CCOCC2)C1	InChI=1S/C18H22N6O2/c25-16(24-6-1-18(13-24)2-7-26-8-3-18)14-9-21-17(22-10-14)23-12-15-11-19-4-5-20-15/h4-5,9-11H,1-3,6-8,12-13H2,(H,21,22,23)	VGRLXWFIXGZRMS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000969	GDC-0349	C24H32N6O3	2.1566	59239165	CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOC[C@@H]5C	CCNC(=O)Nc1ccc(-c2nc3c(CCN(C4COC4)C3)c(N3CCOCC3C)n2)cc1	InChI=1S/C24H32N6O3/c1-3-25-24(31)26-18-6-4-17(5-7-18)22-27-21-12-29(19-14-33-15-19)9-8-20(21)23(28-22)30-10-11-32-13-16(30)2/h4-7,16,19H,3,8-15H2,1-2H3,(H2,25,26,31)/t16-/m0/s1	RGJOJUGRHPQXGF-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_000971	2059904-66-2	C18H18Cl2N2O	2.8705	137541784		CN1CCc2ccccc2C1CNC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C18H18Cl2N2O/c1-22-9-8-12-4-2-3-5-14(12)17(22)11-21-18(23)13-6-7-15(19)16(20)10-13/h2-7,10,17H,8-9,11H2,1H3,(H,21,23)	LIYLICKKTYEDQP-UHFFFAOYSA-N					compound annotation
0391_000972	918348-67-1	C28H29ClN2O3S	3.0237	59251511		CC(C)(O)c1cn(-c2ccc(-c3cc(S(C)(=O)=O)ccc3)cc2)c(C(C)(C)c2ccccc2Cl)n1	InChI=1S/C28H29ClN2O3S/c1-27(2,23-11-6-7-12-24(23)29)26-30-25(28(3,4)32)18-31(26)21-15-13-19(14-16-21)20-9-8-10-22(17-20)35(5,33)34/h6-18,32H,1-5H3	JLPURTXCSILYLW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000974	Silmitasertib	C19H12ClN3O2	3.5991	24748573		O=C(O)c1cc2c(cc1)c1c(ccnc1)c(Nc1cc(Cl)ccc1)n2	InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)	MUOKSQABCJCOPU-UHFFFAOYSA-N					doublet; compound annotation
0391_000975	98791-67-4	C16H15F3N2O4	4.0211	6604881	CC1=C([C@H](C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC	COC(=O)C1=C(C)NC(C)=C([N+](=O)[O-])C1c1ccccc1C(F)(F)F	InChI=1S/C16H15F3N2O4/c1-8-12(15(22)25-3)13(14(21(23)24)9(2)20-8)10-6-4-5-7-11(10)16(17,18)19/h4-7,13,20H,1-3H3/t13-/m1/s1	ZFLWDHHVRRZMEI-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_000976	98625-26-4	C16H15F3N2O4	4.0211	6603728	CC1=C([C@@H](C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC	COC(=O)C1=C(C)NC(C)=C([N+](=O)[O-])C1c1ccccc1C(F)(F)F	InChI=1S/C16H15F3N2O4/c1-8-12(15(22)25-3)13(14(21(23)24)9(2)20-8)10-6-4-5-7-11(10)16(17,18)19/h4-7,13,20H,1-3H3/t13-/m0/s1	ZFLWDHHVRRZMEI-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_000979	LDC000067	C18H18N4O3S	1.9218	25104564		COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1	InChI=1S/C18H18N4O3S/c1-25-17-8-3-2-7-15(17)16-10-18(21-12-20-16)22-14-6-4-5-13(9-14)11-26(19,23)24/h2-10,12H,11H2,1H3,(H2,19,23,24)(H,20,21,22)	GGQCIOOSELPMBB-UHFFFAOYSA-N					doublet; compound annotation
0391_000980	LDC000067	C18H18N4O3S	1.9245	25104564		COc1ccccc1-c1cc(Nc2cccc(CS(N)(=O)=O)c2)ncn1	InChI=1S/C18H18N4O3S/c1-25-17-8-3-2-7-15(17)16-10-18(21-12-20-16)22-14-6-4-5-13(9-14)11-26(19,23)24/h2-10,12H,11H2,1H3,(H2,19,23,24)(H,20,21,22)	GGQCIOOSELPMBB-UHFFFAOYSA-N					doublet; compound annotation
0391_000981	36417-86-4	C17H17NO3	2.2361	5372945	C1=CC(=CC=C1CCNC(=O)/C=C/C2=CC=C(C=C2)O)O	O=C(C=Cc1ccc(O)cc1)NCCc1ccc(O)cc1	InChI=1S/C17H17NO3/c19-15-6-1-13(2-7-15)5-10-17(21)18-12-11-14-3-8-16(20)9-4-14/h1-10,19-20H,11-12H2,(H,18,21)/b10-5+	RXGUTQNKCXHALN-BJMVGYQFSA-N					doublet; removed another duplicate entry; compound annotation
0391_000983	36417-86-4	C17H17NO3	2.3668	5372945	C1=CC(=CC=C1CCNC(=O)/C=C/C2=CC=C(C=C2)O)O	O=C(C=Cc1ccc(O)cc1)NCCc1ccc(O)cc1	InChI=1S/C17H17NO3/c19-15-6-1-13(2-7-15)5-10-17(21)18-12-11-14-3-8-16(20)9-4-14/h1-10,19-20H,11-12H2,(H,18,21)/b10-5+	RXGUTQNKCXHALN-BJMVGYQFSA-N					doublet; removed another duplicate entry; compound annotation
0391_000985	Epimedin A	C39H50O20	2.4669	13916051	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3OC3OC(CO)C(O)C(O)C3O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C39H50O20/c1-14(2)5-10-18-20(54-37-31(50)28(47)25(44)21(12-40)55-37)11-19(42)23-27(46)35(33(57-34(18)23)16-6-8-17(52-4)9-7-16)58-39-36(30(49)24(43)15(3)53-39)59-38-32(51)29(48)26(45)22(13-41)56-38/h5-9,11,15,21-22,24-26,28-32,36-45,47-51H,10,12-13H2,1-4H3/t15-,21+,22+,24-,25+,26+,28-,29-,30+,31+,32+,36+,37+,38-,39-/m0/s1	SVXJDTNFJXKATR-BTXBWYRTSA-N					doublet; compound annotation
0391_000986	Epimedin A	C39H50O20	2.6437	13916051	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3OC3OC(CO)C(O)C(O)C3O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C39H50O20/c1-14(2)5-10-18-20(54-37-31(50)28(47)25(44)21(12-40)55-37)11-19(42)23-27(46)35(33(57-34(18)23)16-6-8-17(52-4)9-7-16)58-39-36(30(49)24(43)15(3)53-39)59-38-32(51)29(48)26(45)22(13-41)56-38/h5-9,11,15,21-22,24-26,28-32,36-45,47-51H,10,12-13H2,1-4H3/t15-,21+,22+,24-,25+,26+,28-,29-,30+,31+,32+,36+,37+,38-,39-/m0/s1	SVXJDTNFJXKATR-BTXBWYRTSA-N					doublet; removed another duplicate entry; compound annotation
0391_000988	Epimedin C	C39H50O19	2.7211	5748394	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)C6=CC=C(C=C6)OC)C)O)O)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C39H50O19/c1-14(2)6-11-19-21(54-38-32(50)29(47)26(44)22(13-40)55-38)12-20(41)23-27(45)35(33(56-34(19)23)17-7-9-18(51-5)10-8-17)57-39-36(30(48)25(43)16(4)53-39)58-37-31(49)28(46)24(42)15(3)52-37/h6-10,12,15-16,22,24-26,28-32,36-44,46-50H,11,13H2,1-5H3/t15-,16-,22+,24-,25-,26+,28+,29-,30+,31+,32+,36+,37-,38+,39-/m0/s1	ULZLIYVOYYQJRO-JIYCBSMMSA-N					removed another duplicate entry; compound annotation
0391_000990	18378-20-6	C13H10N4O3	3.8428	87615		O=[N+]([O-])c1ccc(NCc2ccccc2)c2nonc12	InChI=1S/C13H10N4O3/c18-17(19)11-7-6-10(12-13(11)16-20-15-12)14-8-9-4-2-1-3-5-9/h1-7,14H,8H2	GZFKJMWBKTUNJS-UHFFFAOYSA-N					doublet; compound annotation
0391_000991	18378-20-6	C13H10N4O3	3.8495	87615		O=[N+]([O-])c1ccc(NCc2ccccc2)c2nonc12	InChI=1S/C13H10N4O3/c18-17(19)11-7-6-10(12-13(11)16-20-15-12)14-8-9-4-2-1-3-5-9/h1-7,14H,8H2	GZFKJMWBKTUNJS-UHFFFAOYSA-N					doublet; compound annotation
0391_000992	Aprocitentan	C16H14Br2N6O4S	3.9369	25099191		NS(=O)(=O)Nc1c(-c2ccc(Br)cc2)c(OCCOc2ncc(Br)cn2)ncn1	InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24)	DKULOVKANLVDEA-UHFFFAOYSA-N					compound annotation
0391_000993	Bevirimat	C36H56O6	6.2377	457928	CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O	C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC43C)C12	InChI=1S/C36H56O6/c1-21(2)22-12-17-36(30(40)41)19-18-34(8)23(28(22)36)10-11-25-33(7)15-14-26(42-27(37)20-31(3,4)29(38)39)32(5,6)24(33)13-16-35(25,34)9/h22-26,28H,1,10-20H2,2-9H3,(H,38,39)(H,40,41)/t22-,23+,24-,25+,26-,28+,33-,34+,35+,36-/m0/s1	YJEJKUQEXFSVCJ-WRFMNRASSA-N					compound annotation
0391_000994	288150-92-5	C19H18F2N4O	1.6201	4331799		Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26)	JTARFZSNUAGHRB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_000996	BEBT-908	C23H25N9O3S	2.0083	59474330		CNc1ncc(-c2nc3c(sc(CN(C)c4ncc(C(=O)NO)cn4)c3)c(N3CCOCC3)n2)cc1	InChI=1S/C23H25N9O3S/c1-24-18-4-3-14(10-25-18)20-28-17-9-16(36-19(17)21(29-20)32-5-7-35-8-6-32)13-31(2)23-26-11-15(12-27-23)22(33)30-34/h3-4,9-12,34H,5-8,13H2,1-2H3,(H,24,25)(H,30,33)	TWJZFXHSPBBPNI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_000998	GSK1070916	C30H33N7O	2.1847	46885626		CCn1cc(-c2c3cc(-c4cccc(CN(C)C)c4)[nH]c3ncc2)c(-c2ccc(NC(=O)N(C)C)cc2)n1	InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)	QTBWCSQGBMPECM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001001	Oxfendazole	C15H13N3O3S	2.1897	40854		COC(=O)Nc1nc2ccc([S+]([O-])c3ccccc3)cc2[nH]1	InChI=1S/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)	BEZZFPOZAYTVHN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001003	Zaurategrast	C26H25BrN4O3	2.3883	10186367	C1CCC2(CC1)C(=C(C2=O)Br)N[C@@H](CC3=CC=C(C=C3)NC4=NC=CC5=C4C=NC=C5)C(=O)O	O=C(O)C(Cc1ccc(Nc2nccc3c2cncc3)cc1)NC1=C(Br)C(=O)C12CCCCC2	InChI=1S/C26H25BrN4O3/c27-21-22(26(23(21)32)10-2-1-3-11-26)31-20(25(33)34)14-16-4-6-18(7-5-16)30-24-19-15-28-12-8-17(19)9-13-29-24/h4-9,12-13,15,20,31H,1-3,10-11,14H2,(H,29,30)(H,33,34)/t20-/m0/s1	KYHVWHYLKOHLKA-FQEVSTJZSA-N					doublet; compound annotation
0391_001004	Zaurategrast	C26H25BrN4O3	2.3911	10186367	C1CCC2(CC1)C(=C(C2=O)Br)N[C@@H](CC3=CC=C(C=C3)NC4=NC=CC5=C4C=NC=C5)C(=O)O	O=C(O)C(Cc1ccc(Nc2nccc3c2cncc3)cc1)NC1=C(Br)C(=O)C12CCCCC2	InChI=1S/C26H25BrN4O3/c27-21-22(26(23(21)32)10-2-1-3-11-26)31-20(25(33)34)14-16-4-6-18(7-5-16)30-24-19-15-28-12-8-17(19)9-13-29-24/h4-9,12-13,15,20,31H,1-3,10-11,14H2,(H,29,30)(H,33,34)/t20-/m0/s1	KYHVWHYLKOHLKA-FQEVSTJZSA-N					doublet; compound annotation
0391_001005	SGC-GAK-1	C18H17BrN2O3	2.5134	134812846		COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC	InChI=1S/C18H17BrN2O3/c1-22-16-9-12(10-17(23-2)18(16)24-3)21-15-6-7-20-14-5-4-11(19)8-13(14)15/h4-10H,1-3H3,(H,20,21)	AUOSKLDNVNGKRR-UHFFFAOYSA-N					compound annotation
0391_001006	MKC3946	C21H20N2O3S	2.7455	59599728		CN1CCN(C(=O)c2ccc(-c3cc4c(cc3)c(C=O)c(O)cc4)s2)CC1	InChI=1S/C21H20N2O3S/c1-22-8-10-23(11-9-22)21(26)20-7-6-19(27-20)15-2-4-16-14(12-15)3-5-18(25)17(16)13-24/h2-7,12-13,25H,8-11H2,1H3	IVQVBMWPWPTSNO-UHFFFAOYSA-N					compound annotation
0391_001007	(-)-Epigallocatechin	C15H14O7	1.0434	72277	C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O	Oc1cc(O)c2CC(O)C(c3cc(O)c(O)c(O)c3)Oc2c1	InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1	XMOCLSLCDHWDHP-IUODEOHRSA-N					compound annotation
0391_001008	TRV-120027	C43H67N13O10	1.2957	3082475	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC	CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)CNC)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(C)C(=O)O	InChI=1S/C43H67N13O10/c1-7-24(4)35(40(63)53-31(19-27-20-47-22-49-27)41(64)56-17-9-11-32(56)38(61)50-25(5)42(65)66)55-37(60)30(18-26-12-14-28(57)15-13-26)52-39(62)34(23(2)3)54-36(59)29(51-33(58)21-46-6)10-8-16-48-43(44)45/h12-15,20,22-25,29-32,34-35,46,57H,7-11,16-19,21H2,1-6H3,(H,47,49)(H,50,61)(H,51,58)(H,52,62)(H,53,63)(H,54,59)(H,55,60)(H,65,66)(H4,44,45,48)/t24-,25+,29-,30-,31-,32-,34-,35-/m0/s1	XIEWFECSPPTVQN-KMIMAYJXSA-N					compound annotation
0391_001009	Nialamide	C16H18N4O2	1.5468	4472		O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)	NOIIUHRQUVNIDD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001011	SORIVUDINE	C11H13BrN2O6	1.6004	5282192	C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)/C=C/Br	O=c1[nH]c(=O)n(C2OC(CO)C(O)C2O)cc1C=CBr	InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1	GCQYYIHYQMVWLT-HQNLTJAPSA-N					compound annotation
0391_001012	Nialamide	C16H18N4O2	2.1365	4472		O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)	NOIIUHRQUVNIDD-UHFFFAOYSA-N					doublet; compound annotation
0391_001013	Rhapontigenin	C15H14O4	2.553	5320954	COC1=C(C=C(C=C1)/C=C/C2=CC(=CC(=C2)O)O)O	COc1c(O)cc(C=Cc2cc(O)cc(O)c2)cc1	InChI=1S/C15H14O4/c1-19-15-5-4-10(8-14(15)18)2-3-11-6-12(16)9-13(17)7-11/h2-9,16-18H,1H3/b3-2+	PHMHDRYYFAYWEG-NSCUHMNNSA-N					removed another duplicate entry; compound annotation
0391_001015	Nialamide	C16H18N4O2	2.7035	4472		O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1	InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)	NOIIUHRQUVNIDD-UHFFFAOYSA-N					doublet; compound annotation
0391_001016	Taltobulin	C27H43N3O4	2.9372	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; removed another duplicate entry; compound annotation
0391_001018	Taltobulin	C27H43N3O4	2.9835	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_001019	Asperosaponin VI	C47H76O18	2.9835	14284436	C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)C)(C)CO)O[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O	CC1(C)CCC2(C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(CO)C5CCC43C)C2C1	InChI=1S/C47H76O18/c1-42(2)13-15-47(41(59)65-40-37(58)34(55)32(53)26(63-40)20-61-38-36(57)33(54)31(52)25(18-48)62-38)16-14-45(5)22(23(47)17-42)7-8-28-43(3)11-10-29(64-39-35(56)30(51)24(50)19-60-39)44(4,21-49)27(43)9-12-46(28,45)6/h7,23-40,48-58H,8-21H2,1-6H3/t23-,24-,25+,26+,27+,28+,29-,30-,31+,32+,33-,34-,35+,36+,37+,38+,39-,40-,43-,44-,45+,46+,47-/m0/s1	CCRXMHCQWYVXTE-HMRSNRLKSA-N					doublet; compound annotation
0391_001020	Asperosaponin VI	C47H76O18	2.9863	14284436	C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)C)(C)CO)O[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O	CC1(C)CCC2(C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(CO)C5CCC43C)C2C1	InChI=1S/C47H76O18/c1-42(2)13-15-47(41(59)65-40-37(58)34(55)32(53)26(63-40)20-61-38-36(57)33(54)31(52)25(18-48)62-38)16-14-45(5)22(23(47)17-42)7-8-28-43(3)11-10-29(64-39-35(56)30(51)24(50)19-60-39)44(4,21-49)27(43)9-12-46(28,45)6/h7,23-40,48-58H,8-21H2,1-6H3/t23-,24-,25+,26+,27+,28+,29-,30-,31+,32+,33-,34-,35+,36+,37+,38+,39-,40-,43-,44-,45+,46+,47-/m0/s1	CCRXMHCQWYVXTE-HMRSNRLKSA-N					doublet; compound annotation
0391_001021	Taltobulin	C27H43N3O4	3.1072	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_001022	Taltobulin	C27H43N3O4	3.1807	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_001023	Taltobulin	C27H43N3O4	3.2353	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; removed another duplicate entry; compound annotation
0391_001025	Taltobulin	C27H43N3O4	3.5068	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_001026	malotilate	C12H16O4S2	4.651	4006		CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1	InChI=1S/C12H16O4S2/c1-7(2)15-10(13)9(11(14)16-8(3)4)12-17-5-6-18-12/h5-8H,1-4H3	YPIQVCUJEKAZCP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001028	HYDROCORTISONE CYPIONATE	C29H42O6	5.0918	223253	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC5CCCC5)O)C)O	CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC1CCCC1	InChI=1S/C29H42O6/c1-27-13-11-20(30)15-19(27)8-9-21-22-12-14-29(34,28(22,2)16-23(31)26(21)27)24(32)17-35-25(33)10-7-18-5-3-4-6-18/h15,18,21-23,26,31,34H,3-14,16-17H2,1-2H3/t21-,22-,23-,26+,27-,28-,29-/m0/s1	DLVOSEUFIRPIRM-KAQKJVHQSA-N					removed another duplicate entry; compound annotation
0391_001030	GDC-0879	C19H18N4O2	1.5291	11717001	C1C/C(=N\O)/C2=C1C=C(C=C2)C3=CN(N=C3C4=CC=NC=C4)CCO	OCCn1cc(-c2cc3c(cc2)C(=NO)CC3)c(-c2ccncc2)n1	InChI=1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18+	DEZZLWQELQORIU-RELWKKBWSA-N					doublet; compound annotation
0391_001031	GDC-0879	C19H18N4O2	1.6428	11717001	C1C/C(=N\O)/C2=C1C=C(C=C2)C3=CN(N=C3C4=CC=NC=C4)CCO	OCCn1cc(-c2cc3c(cc2)C(=NO)CC3)c(-c2ccncc2)n1	InChI=1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18+	DEZZLWQELQORIU-RELWKKBWSA-N					doublet; compound annotation
0391_001032	Crenolanib	C26H29N5O2	1.8289	10366136		CC1(COc2cc3c(cc2)n(-c2nc4c(cccc4N4CCC(N)CC4)cc2)cn3)COC1	InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3	DYNHJHQFHQTFTP-UHFFFAOYSA-N					doublet; compound annotation
0391_001033	Crenolanib	C26H29N5O2	2.5416	10366136		CC1(COc2cc3c(cc2)n(-c2nc4c(cccc4N4CCC(N)CC4)cc2)cn3)COC1	InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3	DYNHJHQFHQTFTP-UHFFFAOYSA-N					doublet; compound annotation
0391_001034	Crenolanib	C26H29N5O2	2.5448	10366136		CC1(COc2cc3c(cc2)n(-c2nc4c(cccc4N4CCC(N)CC4)cc2)cn3)COC1	InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3	DYNHJHQFHQTFTP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001036	LY-310,762	C24H27FN2O2	2.9716	4282258		CC1(C)C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc21	InChI=1S/C24H27FN2O2/c1-24(2)20-5-3-4-6-21(20)27(23(24)29)16-15-26-13-11-18(12-14-26)22(28)17-7-9-19(25)10-8-17/h3-10,18H,11-16H2,1-2H3	KDXISMANFPJVJY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001038	Defactinib	C20H21F3N8O3S	3.0534	25117126		CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1	InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)	FWLMVFUGMHIOAA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001040	COH29	C22H16N2O5S	3.4236	44253415		O=C(Nc1nc(-c2cc(O)c(O)cc2)c(-c2ccccc2)s1)c1cc(O)c(O)cc1	InChI=1S/C22H16N2O5S/c25-15-8-6-13(10-17(15)27)19-20(12-4-2-1-3-5-12)30-22(23-19)24-21(29)14-7-9-16(26)18(28)11-14/h1-11,25-28H,(H,23,24,29)	LGGDLPSXAGQFSG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001042	RGFP966	C21H19FN4O	3.7405	56650312	C1=CC=C(C=C1)/C=C/CN2C=C(C=N2)/C=C/C(=O)NC3=C(C=C(C=C3)F)N	Nc1c(NC(=O)C=Cc2cn(CC=Cc3ccccc3)nc2)ccc(F)c1	InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)/b7-4+,11-8+	BLVQHYHDYFTPDV-VCABWLAWSA-N					removed another duplicate entry; compound annotation
0391_001044	ML281	C22H19N3O2S	4.4098	53377448		CC(C)c1cc(-c2nc3ccccc3[nH]c2=O)c(NC(=O)c2cccs2)cc1	InChI=1S/C22H19N3O2S/c1-13(2)14-9-10-16(24-21(26)19-8-5-11-28-19)15(12-14)20-22(27)25-18-7-4-3-6-17(18)23-20/h3-13H,1-2H3,(H,24,26)(H,25,27)	HWOYIOLMBQSTQS-UHFFFAOYSA-N					doublet; compound annotation
0391_001045	ML281	C22H19N3O2S	4.526	53377448		CC(C)c1cc(-c2nc3ccccc3[nH]c2=O)c(NC(=O)c2cccs2)cc1	InChI=1S/C22H19N3O2S/c1-13(2)14-9-10-16(24-21(26)19-8-5-11-28-19)15(12-14)20-22(27)25-18-7-4-3-6-17(18)23-20/h3-13H,1-2H3,(H,24,26)(H,25,27)	HWOYIOLMBQSTQS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001047	BTSA1	C21H14N6OS2	5.4843	3857348		O=c1c(N=Nc2nccs2)c(-c2ccccc2)[nH]n1-c1nc(-c2ccccc2)cs1	InChI=1S/C21H14N6OS2/c28-19-18(24-25-20-22-11-12-29-20)17(15-9-5-2-6-10-15)26-27(19)21-23-16(13-30-21)14-7-3-1-4-8-14/h1-13,26H	CTRCXGFSYFTJIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001049	Adomeglivant	C32H36F3NO4	6.1259	91933867	CC1=CC(=CC(=C1C2=CC=C(C=C2)C(C)(C)C)C)O[C@@H](CCC(F)(F)F)C3=CC=C(C=C3)C(=O)NCCC(=O)O	Cc1cc(OC(CCC(F)(F)F)c2ccc(C(=O)NCCC(=O)O)cc2)cc(C)c1-c1ccc(C(C)(C)C)cc1	InChI=1S/C32H36F3NO4/c1-20-18-26(19-21(2)29(20)23-10-12-25(13-11-23)31(3,4)5)40-27(14-16-32(33,34)35)22-6-8-24(9-7-22)30(39)36-17-15-28(37)38/h6-13,18-19,27H,14-17H2,1-5H3,(H,36,39)(H,37,38)/t27-/m0/s1	FASLTMSUPQDLIB-MHZLTWQESA-N					removed another duplicate entry; compound annotation
0391_001052	AM-1638	C33H35FO4	6.169	57706778	CC1(CCC=C1C2=C(C=CC(=C2)COC3=CC=CC(=C3)[C@@H](CC(=O)O)C4CC4)C5=C(C=CC(=C5)OC)F)C	COc1cc(-c2ccc(COc3cccc(C(CC(=O)O)C4CC4)c3)cc2C2=CCCC2(C)C)c(F)cc1	InChI=1S/C33H35FO4/c1-33(2)15-5-8-30(33)28-16-21(9-13-26(28)29-18-24(37-3)12-14-31(29)34)20-38-25-7-4-6-23(17-25)27(19-32(35)36)22-10-11-22/h4,6-9,12-14,16-18,22,27H,5,10-11,15,19-20H2,1-3H3,(H,35,36)/t27-/m0/s1	CHEANNSDVJOIBS-MHZLTWQESA-N					doublet; removed another duplicate entry; compound annotation
0391_001054	AM-1638	C33H35FO4	6.1723	57706778	CC1(CCC=C1C2=C(C=CC(=C2)COC3=CC=CC(=C3)[C@@H](CC(=O)O)C4CC4)C5=C(C=CC(=C5)OC)F)C	COc1cc(-c2ccc(COc3cccc(C(CC(=O)O)C4CC4)c3)cc2C2=CCCC2(C)C)c(F)cc1	InChI=1S/C33H35FO4/c1-33(2)15-5-8-30(33)28-16-21(9-13-26(28)29-18-24(37-3)12-14-31(29)34)20-38-25-7-4-6-23(17-25)27(19-32(35)36)22-10-11-22/h4,6-9,12-14,16-18,22,27H,5,10-11,15,19-20H2,1-3H3,(H,35,36)/t27-/m0/s1	CHEANNSDVJOIBS-MHZLTWQESA-N					doublet; compound annotation
0391_001055	Adelmidrol	C13H26N2O4	1.1986	176874		O=C(CCCCCCCC(=O)NCCO)NCCO	InChI=1S/C13H26N2O4/c16-10-8-14-12(18)6-4-2-1-3-5-7-13(19)15-9-11-17/h16-17H,1-11H2,(H,14,18)(H,15,19)	PAHZPHDAJQIETD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001057	1245-13-2	C20H12N2O4	3.2203	71068		O=C(O)c1cc(-c2nc3ccccc3c(C(=O)O)c2)nc2ccccc12	InChI=1S/C20H12N2O4/c23-19(24)13-9-17(21-15-7-3-1-5-11(13)15)18-10-14(20(25)26)12-6-2-4-8-16(12)22-18/h1-10H,(H,23,24)(H,25,26)	AFYNADDZULBEJA-UHFFFAOYSA-N					compound annotation
0391_001058	Dimethylcurcumin	C23H24O6	3.8386	6477182	COC1=C(C=C(C=C1)/C=C/C(=C/C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)/O)OC	COc1c(OC)cc(C=CC(=O)C=C(O)C=Cc2cc(OC)c(OC)cc2)cc1	InChI=1S/C23H24O6/c1-26-20-11-7-16(13-22(20)28-3)5-9-18(24)15-19(25)10-6-17-8-12-21(27-2)23(14-17)29-4/h5-15,24H,1-4H3/b9-5+,10-6+,18-15-	ZMGUKFHHNQMKJI-CIOHCNBKSA-N					doublet; removed another duplicate entry; compound annotation
0391_001060	OSMI-4	C27H26ClN3O7S2	3.8448	137319721	CCOC(=O)CN(CC1=CC=CS1)C(=O)[C@@H](C2=CC=CC=C2OC)NS(=O)(=O)C3=C(C=C4C(=C3)C=CC(=O)N4)Cl	CCOC(=O)CN(Cc1cccs1)C(=O)C(NS(=O)(=O)c1c(Cl)cc2[nH]c(=O)ccc2c1)c1ccccc1OC	InChI=1S/C27H26ClN3O7S2/c1-3-38-25(33)16-31(15-18-7-6-12-39-18)27(34)26(19-8-4-5-9-22(19)37-2)30-40(35,36)23-13-17-10-11-24(32)29-21(17)14-20(23)28/h4-14,26,30H,3,15-16H2,1-2H3,(H,29,32)/t26-/m1/s1	STPSLAZMEWZDAJ-AREMUKBSSA-N					doublet; compound annotation
0391_001061	OSMI-4	C27H26ClN3O7S2	3.8481	137319721	CCOC(=O)CN(CC1=CC=CS1)C(=O)[C@@H](C2=CC=CC=C2OC)NS(=O)(=O)C3=C(C=C4C(=C3)C=CC(=O)N4)Cl	CCOC(=O)CN(Cc1cccs1)C(=O)C(NS(=O)(=O)c1c(Cl)cc2[nH]c(=O)ccc2c1)c1ccccc1OC	InChI=1S/C27H26ClN3O7S2/c1-3-38-25(33)16-31(15-18-7-6-12-39-18)27(34)26(19-8-4-5-9-22(19)37-2)30-40(35,36)23-13-17-10-11-24(32)29-21(17)14-20(23)28/h4-14,26,30H,3,15-16H2,1-2H3,(H,29,32)/t26-/m1/s1	STPSLAZMEWZDAJ-AREMUKBSSA-N					doublet; compound annotation
0391_001062	Diacetazotol	C18H19N3O2	3.8787	6751		CC(=O)N(C(C)=O)c1c(C)cc(N=Nc2ccccc2C)cc1	InChI=1S/C18H19N3O2/c1-12-7-5-6-8-17(12)20-19-16-9-10-18(13(2)11-16)21(14(3)22)15(4)23/h5-11H,1-4H3	YIEDSISPYKQADU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001064	GGTI298	C27H33N3O3S	3.9181	9811606	CC(C)C[C@@H](C(=O)OC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC3=CC=CC=C32	COC(=O)C(CC(C)C)NC(=O)c1c(-c2cccc3ccccc23)cc(NCC(N)CS)cc1	InChI=1S/C27H33N3O3S/c1-17(2)13-25(27(32)33-3)30-26(31)23-12-11-20(29-15-19(28)16-34)14-24(23)22-10-6-8-18-7-4-5-9-21(18)22/h4-12,14,17,19,25,29,34H,13,15-16,28H2,1-3H3,(H,30,31)/t19-,25+/m1/s1	XVWPFYDMUFBHBF-CLOONOSVSA-N					doublet; compound annotation
0391_001065	5128-44-9	C17H14O5	4.607	5281601		COc1ccc(-c2cc(=O)c3c(O)cc(OC)cc3o2)cc1	InChI=1S/C17H14O5/c1-20-11-5-3-10(4-6-11)15-9-14(19)17-13(18)7-12(21-2)8-16(17)22-15/h3-9,18H,1-2H3	LZERJKGWTQYMBB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001067	Dimethylcurcumin	C23H24O6	4.8327	6477182	COC1=C(C=C(C=C1)/C=C/C(=C/C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)/O)OC	COc1c(OC)cc(C=CC(=O)C=C(O)C=Cc2cc(OC)c(OC)cc2)cc1	InChI=1S/C23H24O6/c1-26-20-11-7-16(13-22(20)28-3)5-9-18(24)15-19(25)10-6-17-8-12-21(27-2)23(14-17)29-4/h5-15,24H,1-4H3/b9-5+,10-6+,18-15-	ZMGUKFHHNQMKJI-CIOHCNBKSA-N					doublet; compound annotation
0391_001068	Diacetazotol	C18H19N3O2	4.9738	6751		CC(=O)N(C(C)=O)c1c(C)cc(N=Nc2ccccc2C)cc1	InChI=1S/C18H19N3O2/c1-12-7-5-6-8-17(12)20-19-16-9-10-18(13(2)11-16)21(14(3)22)15(4)23/h5-11H,1-4H3	YIEDSISPYKQADU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001071	AM251	C22H21Cl2IN4O	5.6516	2125		Cc1c(-c2ccc(I)cc2)n(-c2c(Cl)cc(Cl)cc2)nc1C(=O)NN1CCCCC1	InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	BUZAJRPLUGXRAB-UHFFFAOYSA-N					doublet; compound annotation
0391_001072	AM251	C22H21Cl2IN4O	5.6561	2125		Cc1c(-c2ccc(I)cc2)n(-c2c(Cl)cc(Cl)cc2)nc1C(=O)NN1CCCCC1	InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	BUZAJRPLUGXRAB-UHFFFAOYSA-N					doublet; compound annotation
0391_001073	Trilaciclib	C24H30N8O	1.5295	68029831		CN1CCN(c2cnc(Nc3ncc4cc5C(=O)NCC6(CCCCC6)n5c4n3)cc2)CC1	InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29)	PDGKHKMBHVFCMG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001075	ABT-046	C20H22N4O2	2.4431	56933229		Nc1c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)cnc2ccnn12	InChI=1S/C20H22N4O2/c21-20-17(12-22-18-9-10-23-24(18)20)16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-19(25)26/h5-10,12-14H,1-4,11,21H2,(H,25,26)	BWUXSHHOKODNAK-UHFFFAOYSA-N					compound annotation
0391_001076	chroman 1	C24H28N4O4	2.4939	66577033	CN(C)CCOC1=C(C=CC(=C1)C2=CNN=C2)NC(=O)[C@H]3CC4=C(C=CC(=C4)OC)OC3	COc1cc2c(cc1)OCC(C(=O)Nc1c(OCCN(C)C)cc(-c3c[nH]nc3)cc1)C2	InChI=1S/C24H28N4O4/c1-28(2)8-9-31-23-12-16(19-13-25-26-14-19)4-6-21(23)27-24(29)18-10-17-11-20(30-3)5-7-22(17)32-15-18/h4-7,11-14,18H,8-10,15H2,1-3H3,(H,25,26)(H,27,29)/t18-/m0/s1	ROFMCPHQNWGXGE-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_001078	Encenicline	C16H17ClN2OS	2.704	46196517	C1CN2CCC1[C@H](C2)NC(=O)C3=CC4=C(S3)C(=CC=C4)Cl	O=C(NC1CN2CCC1CC2)c1cc2c(s1)c(Cl)ccc2	InChI=1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3,8,10,13H,4-7,9H2,(H,18,20)/t13-/m0/s1	SSRDSYXGYPJKRR-ZDUSSCGKSA-N					compound annotation
0391_001079	EMD638683	C18H18F2N2O4	2.8871	44182398		CCc1c(C(=O)NNC(=O)C(O)c2cc(F)cc(F)c2)ccc(O)c1C	InChI=1S/C18H18F2N2O4/c1-3-13-9(2)15(23)5-4-14(13)17(25)21-22-18(26)16(24)10-6-11(19)8-12(20)7-10/h4-8,16,23-24H,3H2,1-2H3,(H,21,25)(H,22,26)	SSNAPUUWBPZGOY-UHFFFAOYSA-N					compound annotation
0391_001080	Picropodophyllin	C22H22O8	3.1275	72435	COC1=CC(=CC(=C1OC)OC)[C@H]2[C@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O	COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1OC	InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1	YJGVMLPVUAXIQN-HAEOHBJNSA-N					removed another duplicate entry; compound annotation
0391_001082	Cebranopadol	C24H27FN2O	3.1684	11848225		CN(C)C1(c2ccccc2)CCC2(CC1)OCCc1c2[nH]c2c1cc(F)cc2	InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3	CSMVOZKEWSOFER-UHFFFAOYSA-N					doublet; compound annotation
0391_001083	Avosentan	C23H21N5O5S	3.2747	9912992		COc1ccccc1Oc1c(OC)nc(-c2ccncc2)nc1NS(=O)(=O)c1ncc(C)cc1	InChI=1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28)	YBWLTKFZAOSWSM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001085	NNC-55-0396 Free base	C30H38FN3O2	3.4189	9957280	CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)C5CC5)C=C(C=C2)F	CC(C)C1c2c(cc(F)cc2)CCC1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1	InChI=1S/C30H38FN3O2/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33)/t28-,30-/m0/s1	VHHVPDKNKPNKHY-JDXGNMNLSA-N					doublet; compound annotation
0391_001086	NNC-55-0396 Free base	C30H38FN3O2	3.4216	9957280	CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)C5CC5)C=C(C=C2)F	CC(C)C1c2c(cc(F)cc2)CCC1(CCN(C)CCCc1nc2ccccc2[nH]1)OC(=O)C1CC1	InChI=1S/C30H38FN3O2/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33)/t28-,30-/m0/s1	VHHVPDKNKPNKHY-JDXGNMNLSA-N					doublet; compound annotation
0391_001087	Cebranopadol	C24H27FN2O	3.5061	11848225		CN(C)C1(c2ccccc2)CCC2(CC1)OCCc1c2[nH]c2c1cc(F)cc2	InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3	CSMVOZKEWSOFER-UHFFFAOYSA-N					doublet; compound annotation
0391_001088	Hordenine	C10H15NO	0.4565	68313		CN(C)CCc1ccc(O)cc1	InChI=1S/C10H15NO/c1-11(2)8-7-9-3-5-10(12)6-4-9/h3-6,12H,7-8H2,1-2H3	KUBCEEMXQZUPDQ-UHFFFAOYSA-N					compound annotation
0391_001089	ozagrel	C13H12N2O2	0.8996	5282440	C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O	O=C(O)C=Cc1ccc(Cn2ccnc2)cc1	InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+	SHZKQBHERIJWAO-AATRIKPKSA-N					doublet; compound annotation
0391_001090	2-Chloroadenosine	C10H12ClN5O4	1.0117	8974	C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)N	Nc1c2ncn(C3OC(CO)C(O)C3O)c2nc(Cl)n1	InChI=1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1	BIXYYZIIJIXVFW-UUOKFMHZSA-N					doublet; compound annotation
0391_001091	2-Chloroadenosine	C10H12ClN5O4	1.0152	8974	C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)Cl)N	Nc1c2ncn(C3OC(CO)C(O)C3O)c2nc(Cl)n1	InChI=1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1	BIXYYZIIJIXVFW-UUOKFMHZSA-N					doublet; compound annotation
0391_001092	Leucocrystal Violet	C25H31N3	1.737	69048		CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1	InChI=1S/C25H31N3/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6/h7-18,25H,1-6H3	OAZWDJGLIYNYMU-UHFFFAOYSA-N					doublet; compound annotation
0391_001093	Daurisoline	C37H42N2O6	1.7973	51106	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)O)O)OC)OC	COc1c(O)cc2c(c1)CCN(C)C2Cc1cc(Oc2ccc(CC3c4cc(OC)c(OC)cc4CCN3C)cc2)c(O)cc1	InChI=1S/C37H42N2O6/c1-38-15-13-26-20-36(43-4)37(44-5)22-29(26)30(38)16-23-6-9-27(10-7-23)45-35-18-24(8-11-32(35)40)17-31-28-21-33(41)34(42-3)19-25(28)12-14-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	BURJAQFYNVMZDV-FIRIVFDPSA-N					compound annotation
0391_001094	lappaconitine	C32H44N2O8	2.1489	115161	CCN1C[C@@]2(CC[C@@H](C34[C@@H]2CC(C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C	CCN1CC2(OC(=O)c3ccccc3NC(C)=O)CCC(OC)C34C1C(CC23)C1(O)CC(OC)C2CC4C1(O)C2OC	InChI=1S/C32H44N2O8/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35)/t19-,20?,22+,23-,24+,25+,26?,27+,29-,30+,31?,32+/m1/s1	NWBWCXBPKTTZNQ-KZWQFSGXSA-N					doublet; compound annotation
0391_001095	Leucocrystal Violet	C25H31N3	2.1826	69048		CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2ccc(N(C)C)cc2)cc1	InChI=1S/C25H31N3/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6/h7-18,25H,1-6H3	OAZWDJGLIYNYMU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001097	lappaconitine	C32H44N2O8	2.3034	115161	CCN1C[C@@]2(CC[C@@H](C34[C@@H]2CC(C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C	CCN1CC2(OC(=O)c3ccccc3NC(C)=O)CCC(OC)C34C1C(CC23)C1(O)CC(OC)C2CC4C1(O)C2OC	InChI=1S/C32H44N2O8/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35)/t19-,20?,22+,23-,24+,25+,26?,27+,29-,30+,31?,32+/m1/s1	NWBWCXBPKTTZNQ-KZWQFSGXSA-N					doublet; removed another duplicate entry; compound annotation
0391_001099	Tozasertib	C23H28N8OS	2.3551	5494449		Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)	GCIKSSRWRFVXBI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001101	alpha-Hederin	C41H66O12	4.1682	73296	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@]4([C@H]([C@]3(C)CO)CC[C@@]5([C@@H]4CC=C6[C@]5(CC[C@@]7([C@H]6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)O)O	CC1OC(OC2C(OC3CCC4(C)C(CCC5(C)C4CC=C4C6CC(C)(C)CCC6(C(=O)O)CCC45C)C3(C)CO)OCC(O)C2O)C(O)C(O)C1O	InChI=1S/C41H66O12/c1-21-28(44)30(46)31(47)33(51-21)53-32-29(45)24(43)19-50-34(32)52-27-11-12-37(4)25(38(27,5)20-42)10-13-40(7)26(37)9-8-22-23-18-36(2,3)14-16-41(23,35(48)49)17-15-39(22,40)6/h8,21,23-34,42-47H,9-20H2,1-7H3,(H,48,49)/t21-,23-,24-,25+,26+,27-,28-,29-,30+,31+,32+,33-,34-,37-,38-,39+,40+,41-/m0/s1	KEOITPILCOILGM-LLJOFIFVSA-N					removed another duplicate entry; compound annotation
0391_001103	sofalcone	C27H30O6	5.4248	5282219	CC(=CCOC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C	CC(C)=CCOc1ccc(C=CC(=O)c2c(OCC(=O)O)cc(OCC=C(C)C)cc2)cc1	InChI=1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+	GFWRVVCDTLRWPK-KPKJPENVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001105	sofalcone	C27H30O6	5.4913	5282219	CC(=CCOC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C	CC(C)=CCOc1ccc(C=CC(=O)c2c(OCC(=O)O)cc(OCC=C(C)C)cc2)cc1	InChI=1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+	GFWRVVCDTLRWPK-KPKJPENVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001107	PF-670462 free base	C19H20FN5	2.3405	11681588		Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1	InChI=1S/C19H20FN5/c20-14-8-6-13(7-9-14)17-18(16-10-11-22-19(21)24-16)25(12-23-17)15-4-2-1-3-5-15/h6-12,15H,1-5H2,(H2,21,22,24)	WUDBUIUHVNECTM-UHFFFAOYSA-N					compound annotation
0391_001108	Benorilate	C17H15NO5	3.211	21102		CC(=O)Nc1ccc(OC(=O)c2ccccc2OC(C)=O)cc1	InChI=1S/C17H15NO5/c1-11(19)18-13-7-9-14(10-8-13)23-17(21)15-5-3-4-6-16(15)22-12(2)20/h3-10H,1-2H3,(H,18,19)	FEJKLNWAOXSSNR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001110	1959551-27-9	C24H23F4N7O3	3.6461	121457109	C1CN(CCC1(CN2C=NC3=C(C2=O)C=NN3C4=CC=C(C=C4)F)O)C(=O)C[C@H](C(F)F)N5C=CC(=N5)F	O=C(CC(C(F)F)n1ccc(F)n1)N1CCC(O)(Cn2cnc3c(cnn3-c3ccc(F)cc3)c2=O)CC1	InChI=1S/C24H23F4N7O3/c25-15-1-3-16(4-2-15)35-22-17(12-30-35)23(37)33(14-29-22)13-24(38)6-9-32(10-7-24)20(36)11-18(21(27)28)34-8-5-19(26)31-34/h1-5,8,12,14,18,21,38H,6-7,9-11,13H2/t18-/m1/s1	BLSNYSFLZAWBIV-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_001112	Methyl cholate	C25H42O5	4.5186	10960835	C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C	COC(=O)CCC(C)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C25H42O5/c1-14(5-8-22(29)30-4)17-6-7-18-23-19(13-21(28)25(17,18)3)24(2)10-9-16(26)11-15(24)12-20(23)27/h14-21,23,26-28H,5-13H2,1-4H3/t14-,15+,16-,17-,18+,19+,20-,21+,23+,24+,25-/m1/s1	DLYVTEULDNMQAR-SRNOMOOLSA-N					doublet; compound annotation
0391_001113	Methyl cholate	C25H42O5	4.5216	10960835	C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C	COC(=O)CCC(C)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C25H42O5/c1-14(5-8-22(29)30-4)17-6-7-18-23-19(13-21(28)25(17,18)3)24(2)10-9-16(26)11-15(24)12-20(23)27/h14-21,23,26-28H,5-13H2,1-4H3/t14-,15+,16-,17-,18+,19+,20-,21+,23+,24+,25-/m1/s1	DLYVTEULDNMQAR-SRNOMOOLSA-N					doublet; compound annotation
0391_001114	CAY10650	C28H25NO6	4.6703	45102612		CC(C)C(=O)c1cn(CC(=O)COc2ccc(Oc3ccccc3)cc2)c2c1cc(C(=O)O)cc2	InChI=1S/C28H25NO6/c1-18(2)27(31)25-16-29(26-13-8-19(28(32)33)14-24(25)26)15-20(30)17-34-21-9-11-23(12-10-21)35-22-6-4-3-5-7-22/h3-14,16,18H,15,17H2,1-2H3,(H,32,33)	HTOJZPHWNDZOPQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001116	312917-14-9	C20H16N2OS	5.1778	766949		N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2	InChI=1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23)	WQGDQGAFSDMBLA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001119	PHORBOL	C20H28O6	1.0316	442070	C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)O)O	CC1=CC2C(O)(CC(CO)=CC3C4C(C)(C)C4(O)C(O)C(C)C32O)C1=O	InChI=1S/C20H28O6/c1-9-5-13-18(24,15(9)22)7-11(8-21)6-12-14-17(3,4)20(14,26)16(23)10(2)19(12,13)25/h5-6,10,12-14,16,21,23-26H,7-8H2,1-4H3/t10-,12+,13-,14-,16-,18-,19-,20-/m1/s1	QGVLYPPODPLXMB-UBTYZVCOSA-N					compound annotation
0391_001120	Scoparone	C11H10O4	2.2674	8417		COc1c(OC)cc2oc(=O)ccc2c1	InChI=1S/C11H10O4/c1-13-9-5-7-3-4-11(12)15-8(7)6-10(9)14-2/h3-6H,1-2H3	GUAFOGOEJLSQBT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001122	Catharanthine	C21H24N2O2	2.4989	5458190	CCC1=C[C@H]2C[C@]3([C@@H]1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC	CCC1=CC2CN3CCc4c([nH]c5ccccc45)C(C(=O)OC)(C2)C13	InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3/t13-,19+,21-/m0/s1	CMKFQVZJOWHHDV-NQZBTDCJSA-N					doublet; compound annotation
0391_001123	Catharanthine	C21H24N2O2	2.5022	5458190	CCC1=C[C@H]2C[C@]3([C@@H]1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC	CCC1=CC2CN3CCc4c([nH]c5ccccc45)C(C(=O)OC)(C2)C13	InChI=1S/C21H24N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,10,13,19,22H,3,8-9,11-12H2,1-2H3/t13-,19+,21-/m0/s1	CMKFQVZJOWHHDV-NQZBTDCJSA-N					doublet; compound annotation
0391_001124	4'-Demethylpodophyllotoxin	C21H20O8	2.6606	122667	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O	COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1O	InChI=1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15)23)17-10-5-13-14(29-8-28-13)6-11(10)19(22)12-7-27-21(24)18(12)17/h3-6,12,17-19,22-23H,7-8H2,1-2H3/t12-,17+,18-,19-/m0/s1	YVCVYCSAAZQOJI-BTINSWFASA-N					removed another duplicate entry; compound annotation
0391_001126	AP-III-a4	C31H43FN8O3	3.1074	24012277		NCCOCCOCCNC(=O)Cc1ccc(Nc2nc(NCc3ccc(F)cc3)nc(NCC3CCCCC3)n2)cc1	InChI=1S/C31H43FN8O3/c32-26-10-6-25(7-11-26)22-36-30-38-29(35-21-24-4-2-1-3-5-24)39-31(40-30)37-27-12-8-23(9-13-27)20-28(41)34-15-17-43-19-18-42-16-14-33/h6-13,24H,1-5,14-22,33H2,(H,34,41)(H3,35,36,37,38,39,40)	MOVYITHKOHMLHC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001128	AP-III-a4	C31H43FN8O3	3.2489	24012277		NCCOCCOCCNC(=O)Cc1ccc(Nc2nc(NCc3ccc(F)cc3)nc(NCC3CCCCC3)n2)cc1	InChI=1S/C31H43FN8O3/c32-26-10-6-25(7-11-26)22-36-30-38-29(35-21-24-4-2-1-3-5-24)39-31(40-30)37-27-12-8-23(9-13-27)20-28(41)34-15-17-43-19-18-42-16-14-33/h6-13,24H,1-5,14-22,33H2,(H,34,41)(H3,35,36,37,38,39,40)	MOVYITHKOHMLHC-UHFFFAOYSA-N					doublet; compound annotation
0391_001129	CHEMBL4563700	C17H18F3N7O2	3.2521	137049058		Cc1c(C(=O)N2CCN(CC(F)(F)F)CC2)cnn1-c1nc(=O)c2cccn2[nH]1	InChI=1S/C17H18F3N7O2/c1-11-12(15(29)25-7-5-24(6-8-25)10-17(18,19)20)9-21-27(11)16-22-14(28)13-3-2-4-26(13)23-16/h2-4,9H,5-8,10H2,1H3,(H,22,23,28)	GPMQVMCLRRPIIE-UHFFFAOYSA-N					compound annotation
0391_001130	Mdivi-1	C15H10Cl2N2O2S	4.1287	3825829		COc1c(Cl)cc(Cl)c(-n2c(=S)[nH]c3ccccc3c2=O)c1	InChI=1S/C15H10Cl2N2O2S/c1-21-13-7-12(9(16)6-10(13)17)19-14(20)8-4-2-3-5-11(8)18-15(19)22/h2-7H,1H3,(H,18,22)	NZJKEVWTYMOYOR-UHFFFAOYSA-N					compound annotation
0391_001131	Ipatasertib	C24H32ClN5O2	1.8955	24788740	C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O	CC(C)NCC(C(=O)N1CCN(c2ncnc3c2C(C)CC3O)CC1)c1ccc(Cl)cc1	InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1	GRZXWCHAXNAUHY-NSISKUIASA-N					doublet; compound annotation
0391_001132	CA-074	C18H29N3O6	2.2951	9821383	CCCNC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)O	CCCNC(=O)C1OC1C(=O)NC(C(=O)N1CCCC1C(=O)O)C(C)CC	InChI=1S/C18H29N3O6/c1-4-8-19-15(22)13-14(27-13)16(23)20-12(10(3)5-2)17(24)21-9-6-7-11(21)18(25)26/h10-14H,4-9H2,1-3H3,(H,19,22)(H,20,23)(H,25,26)/t10-,11-,12-,13-,14-/m0/s1	ZEZGJKSEBRELAS-PEDHHIEDSA-N					removed another duplicate entry; compound annotation
0391_001134	Asenapine	C17H16ClNO	2.7613	163091	CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24	CN1CC2c3ccccc3Oc3c(cc(Cl)cc3)C2C1	InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m1/s1	VSWBSWWIRNCQIJ-HUUCEWRRSA-N					doublet; compound annotation
0391_001135	Asenapine	C17H16ClNO	2.8515	163091	CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24	CN1CC2c3ccccc3Oc3c(cc(Cl)cc3)C2C1	InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m1/s1	VSWBSWWIRNCQIJ-HUUCEWRRSA-N					doublet; compound annotation
0391_001136	FTI-277	C22H29N3O3S2	3.1443	3005532	COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2	COC(=O)C(CCSC)NC(=O)c1c(-c2ccccc2)cc(NCC(N)CS)cc1	InChI=1S/C22H29N3O3S2/c1-28-22(27)20(10-11-30-2)25-21(26)18-9-8-17(24-13-16(23)14-29)12-19(18)15-6-4-3-5-7-15/h3-9,12,16,20,24,29H,10-11,13-14,23H2,1-2H3,(H,25,26)/t16-,20+/m1/s1	GKFPROVOIQKYTO-UZLBHIALSA-N					compound annotation
0391_001137	kn-93	C26H29ClN2O4S	3.2083	5312122	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCO)S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C26H29ClN2O4S/c1-28(17-5-6-21-9-11-23(27)12-10-21)20-22-7-3-4-8-26(22)29(18-19-30)34(31,32)25-15-13-24(33-2)14-16-25/h3-16,30H,17-20H2,1-2H3/b6-5+	LLLQTDSSHZREGW-AATRIKPKSA-N					doublet; compound annotation
0391_001138	Tubeimoside I	C63H98O29	3.2083	6110917		CC1OC2OC3C(OCC(O)C3O)OC(=O)C34CCC(C)(C)CC3C3=CCC5C6(C)CC(O)C(OC7OC(CO)C(O)C(O)C7OC7OCC(OC(=O)CC(C)(O)CC(=O)OC1C(OC1OCC(O)C(O)C1O)C2O)C(O)C7O)C(C)(CO)C6CCC5(C)C3(C)CC4	InChI=1S/C63H98O29/c1-26-46-47(88-51-43(76)38(71)30(67)22-81-51)45(78)53(84-26)90-48-39(72)31(68)23-82-54(48)92-56(79)63-15-13-57(2,3)17-28(63)27-9-10-35-59(5)18-29(66)50(60(6,25-65)34(59)11-12-62(35,8)61(27,7)14-16-63)91-55-49(42(75)40(73)32(21-64)86-55)89-52-44(77)41(74)33(24-83-52)85-36(69)19-58(4,80)20-37(70)87-46/h9,26,28-35,38-55,64-68,71-78,80H,10-25H2,1-8H3	MCPFEAJYKIXPQF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001140	DDX3-IN-1	C17H17N5O	3.3056	122455312		Cc1cn(-c2ccc(NC(=O)Nc3ccccc3C)cc2)nn1	InChI=1S/C17H17N5O/c1-12-5-3-4-6-16(12)19-17(23)18-14-7-9-15(10-8-14)22-11-13(2)20-21-22/h3-11H,1-2H3,(H2,18,19,23)	YIIUGRJFJAHCFZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001142	DDX3-IN-1	C17H17N5O	3.5103	122455312		Cc1cn(-c2ccc(NC(=O)Nc3ccccc3C)cc2)nn1	InChI=1S/C17H17N5O/c1-12-5-3-4-6-16(12)19-17(23)18-14-7-9-15(10-8-14)22-11-13(2)20-21-22/h3-11H,1-2H3,(H2,18,19,23)	YIIUGRJFJAHCFZ-UHFFFAOYSA-N					doublet; compound annotation
0391_001143	kn-93	C26H29ClN2O4S	3.7647	5312122	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCO)S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C26H29ClN2O4S/c1-28(17-5-6-21-9-11-23(27)12-10-21)20-22-7-3-4-8-26(22)29(18-19-30)34(31,32)25-15-13-24(33-2)14-16-25/h3-16,30H,17-20H2,1-2H3/b6-5+	LLLQTDSSHZREGW-AATRIKPKSA-N					doublet; compound annotation
0391_001144	TAK-285	C26H25ClF3N5O3	3.7918	11620908		CC(C)(O)CC(=O)NCCn1ccc2c1c(Nc1cc(Cl)c(Oc3cccc(C(F)(F)F)c3)cc1)ncn2	InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)	ZYQXEVJIFYIBHZ-UHFFFAOYSA-N					compound annotation
0391_001145	1118807-13-8	C18H17ClN2O3S	4.4281	8582409		COc1c(OC)cc(CCC(=O)Nc2nc3c(cc(Cl)cc3)s2)cc1	InChI=1S/C18H17ClN2O3S/c1-23-14-7-3-11(9-15(14)24-2)4-8-17(22)21-18-20-13-6-5-12(19)10-16(13)25-18/h3,5-7,9-10H,4,8H2,1-2H3,(H,20,21,22)	LXFKEVQQSKQXPR-UHFFFAOYSA-N					doublet; compound annotation
0391_001146	1118807-13-8	C18H17ClN2O3S	4.4314	8582409		COc1c(OC)cc(CCC(=O)Nc2nc3c(cc(Cl)cc3)s2)cc1	InChI=1S/C18H17ClN2O3S/c1-23-14-7-3-11(9-15(14)24-2)4-8-17(22)21-18-20-13-6-5-12(19)10-16(13)25-18/h3,5-7,9-10H,4,8H2,1-2H3,(H,20,21,22)	LXFKEVQQSKQXPR-UHFFFAOYSA-N					doublet; compound annotation
0391_001147	FIBOFLAPON	C38H43N3O4S	4.6251	44473151		CCOc1ncc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ncc(C)cc5)ccc43)cc2)cc1	InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)	DFQGDHBGRSTTHX-UHFFFAOYSA-N					doublet; compound annotation
0391_001148	FIBOFLAPON	C38H43N3O4S	5.4409	44473151		CCOc1ncc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ncc(C)cc5)ccc43)cc2)cc1	InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)	DFQGDHBGRSTTHX-UHFFFAOYSA-N					doublet; compound annotation
0391_001149	23583-48-4	C10H11BrN5O6P	0.5391	32014	C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3Br)N)O)OP(=O)(O1)O	Nc1c2nc(Br)n(C3OC4COP(=O)(O)OC4C3O)c2ncn1	InChI=1S/C10H11BrN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1	DVKQVRZMKBDMDH-UUOKFMHZSA-N					compound annotation
0391_001150	Cardiogenol C	C13H16N4O2	1.5457	11345983		COc1ccc(Nc2nccc(NCCO)n2)cc1	InChI=1S/C13H16N4O2/c1-19-11-4-2-10(3-5-11)16-13-15-7-6-12(17-13)14-8-9-18/h2-7,18H,8-9H2,1H3,(H2,14,15,16,17)	LKBSMPFEKIBRGC-UHFFFAOYSA-N					compound annotation
0391_001151	Moracin M	C14H10O4	2.4606	185848		Oc1cc(-c2cc3c(cc(O)cc3)o2)cc(O)c1	InChI=1S/C14H10O4/c15-10-2-1-8-5-13(18-14(8)7-10)9-3-11(16)6-12(17)4-9/h1-7,15-17H	LHPRYOJTASOZGJ-UHFFFAOYSA-N					compound annotation
0391_001152	PF-06928215	C20H20N4O4	3.1184	137300622	C1CC[C@@H]([C@@H](C1)C(=O)O)NC(=O)C2=CNN3C2=NC(=CC3=O)C4=CC=CC=C4	O=C(NC1CCCCC1C(=O)O)c1c[nH]n2c(=O)cc(-c3ccccc3)nc12	InChI=1S/C20H20N4O4/c25-17-10-16(12-6-2-1-3-7-12)22-18-14(11-21-24(17)18)19(26)23-15-9-5-4-8-13(15)20(27)28/h1-3,6-7,10-11,13,15,21H,4-5,8-9H2,(H,23,26)(H,27,28)/t13-,15+/m1/s1	WGQGCLHXUPGUSZ-HIFRSBDPSA-N					removed another duplicate entry; compound annotation
0391_001154	PROTAC BET degrader-2	C41H42N10O6	3.6208	137319718		CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCc2c3CN(C4CCC(=O)NC4=O)C(=O)c3ccc2)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C41H42N10O6/c1-5-51-32(18-28(48-51)23-11-12-23)44-37-35-25-17-31(56-4)26(34-20(2)49-57-21(34)3)16-29(25)43-36(35)46-38(47-37)40(54)42-15-7-9-22-8-6-10-24-27(22)19-50(41(24)55)30-13-14-33(52)45-39(30)53/h6,8,10,16-18,23,30H,5,7,9,11-15,19H2,1-4H3,(H,42,54)(H,45,52,53)(H2,43,44,46,47)	LKCUEUQTTCOYPW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001156	Flavokawain b	C17H16O4	3.8508	5356121	COC1=CC(=C(C(=C1)OC)C(=O)/C=C/C2=CC=CC=C2)O	COc1cc(O)c(C(=O)C=Cc2ccccc2)c(OC)c1	InChI=1S/C17H16O4/c1-20-13-10-15(19)17(16(11-13)21-2)14(18)9-8-12-6-4-3-5-7-12/h3-11,19H,1-2H3/b9-8+	QKQLSQLKXBHUSO-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001158	333745-53-2	C22H19ClN2O6S	4.4934	1000980		COc1c(N(CC(=O)Nc2cc3c(cc2)OCO3)S(=O)(=O)c2ccccc2)cc(Cl)cc1	InChI=1S/C22H19ClN2O6S/c1-29-19-9-7-15(23)11-18(19)25(32(27,28)17-5-3-2-4-6-17)13-22(26)24-16-8-10-20-21(12-16)31-14-30-20/h2-12H,13-14H2,1H3,(H,24,26)	ZGYSGIYKAVUVOR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001161	CYTOSPORONE B	C18H26O5	4.5452	10687292		CCCCCCCC(=O)c1c(CC(=O)OCC)cc(O)cc1O	InChI=1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3	UVVWQQKSNZLUQA-UHFFFAOYSA-N					doublet; compound annotation
0391_001162	333745-53-2	C22H19ClN2O6S	4.5681	1000980		COc1c(N(CC(=O)Nc2cc3c(cc2)OCO3)S(=O)(=O)c2ccccc2)cc(Cl)cc1	InChI=1S/C22H19ClN2O6S/c1-29-19-9-7-15(23)11-18(19)25(32(27,28)17-5-3-2-4-6-17)13-22(26)24-16-8-10-20-21(12-16)31-14-30-20/h2-12H,13-14H2,1H3,(H,24,26)	ZGYSGIYKAVUVOR-UHFFFAOYSA-N					doublet; compound annotation
0391_001163	prednisolone tebutate	C27H38O6	4.5738	93055	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=C[C@]34C)O	CC(C)(C)CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C	InChI=1S/C27H38O6/c1-24(2,3)14-22(31)33-15-21(30)27(32)11-9-19-18-7-6-16-12-17(28)8-10-25(16,4)23(18)20(29)13-26(19,27)5/h8,10,12,18-20,23,29,32H,6-7,9,11,13-15H2,1-5H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1	HUMXXHTVHHLNRO-KAJVQRHHSA-N					removed another duplicate entry; compound annotation
0391_001165	CYTOSPORONE B	C18H26O5	4.5882	10687292		CCCCCCCC(=O)c1c(CC(=O)OCC)cc(O)cc1O	InChI=1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3	UVVWQQKSNZLUQA-UHFFFAOYSA-N					doublet; compound annotation
0391_001166	CYTOSPORONE B	C18H26O5	4.6516	10687292		CCCCCCCC(=O)c1c(CC(=O)OCC)cc(O)cc1O	InChI=1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3	UVVWQQKSNZLUQA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001168	Flavokawain b	C17H16O4	4.7685	5356121	COC1=CC(=C(C(=C1)OC)C(=O)/C=C/C2=CC=CC=C2)O	COc1cc(O)c(C(=O)C=Cc2ccccc2)c(OC)c1	InChI=1S/C17H16O4/c1-20-13-10-15(19)17(16(11-13)21-2)14(18)9-8-12-6-4-3-5-7-12/h3-11,19H,1-2H3/b9-8+	QKQLSQLKXBHUSO-CMDGGOBGSA-N					doublet; compound annotation
0391_001169	Flavokawain b	C17H16O4	5.1012	5356121	COC1=CC(=C(C(=C1)OC)C(=O)/C=C/C2=CC=CC=C2)O	COc1cc(O)c(C(=O)C=Cc2ccccc2)c(OC)c1	InChI=1S/C17H16O4/c1-20-13-10-15(19)17(16(11-13)21-2)14(18)9-8-12-6-4-3-5-7-12/h3-11,19H,1-2H3/b9-8+	QKQLSQLKXBHUSO-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001171	Nilotinib	C28H22F3N7O	2.9341	644241		Cc1cn(-c2cc(C(F)(F)F)cc(NC(=O)c3cc(Nc4nccc(-c5cnccc5)n4)c(C)cc3)c2)cn1	InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)	HHZIURLSWUIHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_001172	Nilotinib	C28H22F3N7O	2.9369	644241		Cc1cn(-c2cc(C(F)(F)F)cc(NC(=O)c3cc(Nc4nccc(-c5cnccc5)n4)c(C)cc3)c2)cn1	InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)	HHZIURLSWUIHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_001173	GDC-0152	C25H34N6O3S	3.0612	46940575	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=NS3)C4=CC=CC=C4)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1c(-c2ccccc2)nns1)C1CCCCC1	InChI=1S/C25H34N6O3S/c1-16(26-2)22(32)27-21(18-12-7-4-8-13-18)25(34)31-15-9-14-19(31)23(33)28-24-20(29-30-35-24)17-10-5-3-6-11-17/h3,5-6,10-11,16,18-19,21,26H,4,7-9,12-15H2,1-2H3,(H,27,32)(H,28,33)/t16-,19-,21-/m0/s1	WZRFLSDVFPIXOV-LRQRDZAKSA-N					removed another duplicate entry; compound annotation
0391_001175	TP-10	C26H19F3N4O	3.277	11648276		FC(F)(F)Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C26H19F3N4O/c27-26(28,29)17-33-15-23(18-11-13-30-14-12-18)25(32-33)20-6-9-22(10-7-20)34-16-21-8-5-19-3-1-2-4-24(19)31-21/h1-15H,16-17H2	NOIXNOMHHWGUTG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001177	B-Raf IN 1	C29H24F3N5O	3.6496	24884503		CN(C)Cc1ccc(-c2c3nccc(-c4cc(NC(=O)c5cc(C(F)(F)F)ccc5)ccc4)n3nc2)cc1	InChI=1S/C29H24F3N5O/c1-36(2)18-19-9-11-20(12-10-19)25-17-34-37-26(13-14-33-27(25)37)21-5-4-8-24(16-21)35-28(38)22-6-3-7-23(15-22)29(30,31)32/h3-17H,18H2,1-2H3,(H,35,38)	AIWJVLQNYNCDSL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001179	mhy1485	C17H21N7O4	4.0312	2834965		O=[N+]([O-])c1ccc(Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc1	InChI=1S/C17H21N7O4/c25-24(26)14-3-1-13(2-4-14)18-15-19-16(22-5-9-27-10-6-22)21-17(20-15)23-7-11-28-12-8-23/h1-4H,5-12H2,(H,18,19,20,21)	MSSXBKQZZINCRI-UHFFFAOYSA-N					compound annotation
0391_001180	Azelnidipine	C33H34N4O6	4.0586	65948		CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1	InChI=1S/C33H34N4O6/c1-20(2)42-32(38)27-21(3)35-31(34)29(28(27)24-15-10-16-25(17-24)37(40)41)33(39)43-26-18-36(19-26)30(22-11-6-4-7-12-22)23-13-8-5-9-14-23/h4-17,20,26,28,30,35H,18-19,34H2,1-3H3	ZKFQEACEUNWPMT-UHFFFAOYSA-N					doublet; compound annotation
0391_001181	Azelnidipine	C33H34N4O6	4.2075	65948		CC1=C(C(=O)OC(C)C)C(c2cc([N+](=O)[O-])ccc2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1	InChI=1S/C33H34N4O6/c1-20(2)42-32(38)27-21(3)35-31(34)29(28(27)24-15-10-16-25(17-24)37(40)41)33(39)43-26-18-36(19-26)30(22-11-6-4-7-12-22)23-13-8-5-9-14-23/h4-17,20,26,28,30,35H,18-19,34H2,1-3H3	ZKFQEACEUNWPMT-UHFFFAOYSA-N					doublet; compound annotation
0391_001182	Fulvestrant	C32H47F5O3S	5.1142	104741	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F	CC12CCC3c4ccc(O)cc4CC(CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)C3C1CCC2O	InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1	VWUXBMIQPBEWFH-WCCTWKNTSA-N					removed another duplicate entry; compound annotation
0391_001185	103733-65-9	C10H11NO2	0.626	712398	C1[C@@H](NCC2=CC=CC=C21)C(=O)O	O=C(O)C1Cc2ccccc2CN1	InChI=1S/C10H11NO2/c12-10(13)9-5-7-3-1-2-4-8(7)6-11-9/h1-4,9,11H,5-6H2,(H,12,13)/t9-/m1/s1	BWKMGYQJPOAASG-SECBINFHSA-N					compound annotation
0391_001186	PF-06282999	C13H12ClN3O3S	2.1224	71571306		COc1c(-c2cc(=O)[nH]c(=S)n2CC(N)=O)cc(Cl)cc1	InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)	ICYNYWFGIDGBRD-UHFFFAOYSA-N					compound annotation
0391_001187	1210608-43-7	C24H23F3N4O	2.5455	44814409	C[C@H]1C[C@H](C[C@H](C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F	CC1CC(N)CC(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2)C1	InChI=1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1	VRQXRVAKPDCRCI-ZNMIVQPWSA-N					doublet; compound annotation
0391_001188	1210608-43-7	C24H23F3N4O	2.5503	44814409	C[C@H]1C[C@H](C[C@H](C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F	CC1CC(N)CC(c2ccncc2NC(=O)c2nc(-c3c(F)cccc3F)c(F)cc2)C1	InChI=1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1	VRQXRVAKPDCRCI-ZNMIVQPWSA-N					doublet; compound annotation
0391_001189	ETC-159	C19H17N7O3	2.7298	86280523		Cn1c(=O)c2c(ncn2CC(=O)Nc2nnc(-c3ccccc3)cc2)n(C)c1=O	InChI=1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27)	QTRXIFVSTWXRJJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001191	Cot inhibitor-1	C27H27Cl2FN8	2.9394	11584834		N#Cc1cnc2c(Cl)cc(NCc3cn(CCN4CCCCCC4)nn3)cc2c1Nc1cc(Cl)c(F)cc1	InChI=1S/C27H27Cl2FN8/c28-23-12-19(5-6-25(23)30)34-26-18(14-31)15-33-27-22(26)11-20(13-24(27)29)32-16-21-17-38(36-35-21)10-9-37-7-3-1-2-4-8-37/h5-6,11-13,15,17,32H,1-4,7-10,16H2,(H,33,34)	ZWFKJFUFYPOTKL-UHFFFAOYSA-N					doublet; compound annotation
0391_001192	SAR405838	C29H34Cl2FN3O3	3.5104	53476877	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1	IDKAKZRYYDCJDU-AEPXTFJPSA-N					doublet; compound annotation
0391_001193	SAR405838	C29H34Cl2FN3O3	3.6382	53476877	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1	IDKAKZRYYDCJDU-AEPXTFJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_001195	SAR405838	C29H34Cl2FN3O3	3.8042	53476877	CC(C)(C)C[C@H]1[C@@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1	IDKAKZRYYDCJDU-AEPXTFJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_001197	Orexin 2 Receptor Agonist	C32H34N4O5S	3.807	91810287		COc1c(S(=O)(=O)Nc2cccc(NCCNC(=O)c3cccc(C)c3)c2)cc(-c2cc(C(=O)N(C)C)ccc2)cc1	InChI=1S/C32H34N4O5S/c1-22-8-5-10-25(18-22)31(37)34-17-16-33-27-12-7-13-28(21-27)35-42(39,40)30-20-24(14-15-29(30)41-4)23-9-6-11-26(19-23)32(38)36(2)3/h5-15,18-21,33,35H,16-17H2,1-4H3,(H,34,37)	RHLMXWCISNJNDH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001199	Adjudin	C15H12Cl2N4O	3.8366	9819086		NNC(=O)c1nn(Cc2c(Cl)cc(Cl)cc2)c2ccccc12	InChI=1S/C15H12Cl2N4O/c16-10-6-5-9(12(17)7-10)8-21-13-4-2-1-3-11(13)14(20-21)15(22)19-18/h1-7H,8,18H2,(H,19,22)	VENCPJAAXKBIJD-UHFFFAOYSA-N					compound annotation
0391_001200	Cot inhibitor-1	C27H27Cl2FN8	3.9193	11584834		N#Cc1cnc2c(Cl)cc(NCc3cn(CCN4CCCCCC4)nn3)cc2c1Nc1cc(Cl)c(F)cc1	InChI=1S/C27H27Cl2FN8/c28-23-12-19(5-6-25(23)30)34-26-18(14-31)15-33-27-22(26)11-20(13-24(27)29)32-16-21-17-38(36-35-21)10-9-37-7-3-1-2-4-8-37/h5-6,11-13,15,17,32H,1-4,7-10,16H2,(H,33,34)	ZWFKJFUFYPOTKL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001202	Tezacaftor	C26H27F3N2O6	4.2428	46199646	CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F	CC(C)(CO)c1cc2cc(NC(=O)C3(c4cc5c(cc4)OC(F)(F)O5)CC3)c(F)cc2n1CC(O)CO	InChI=1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1	MJUVRTYWUMPBTR-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_001205	Cot inhibitor-1	C27H27Cl2FN8	4.3233	11584834		N#Cc1cnc2c(Cl)cc(NCc3cn(CCN4CCCCCC4)nn3)cc2c1Nc1cc(Cl)c(F)cc1	InChI=1S/C27H27Cl2FN8/c28-23-12-19(5-6-25(23)30)34-26-18(14-31)15-33-27-22(26)11-20(13-24(27)29)32-16-21-17-38(36-35-21)10-9-37-7-3-1-2-4-8-37/h5-6,11-13,15,17,32H,1-4,7-10,16H2,(H,33,34)	ZWFKJFUFYPOTKL-UHFFFAOYSA-N					doublet; compound annotation
0391_001206	FIBOFLAPON	C38H43N3O4S	5.4248	44473151		CCOc1ncc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ncc(C)cc5)ccc43)cc2)cc1	InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)	DFQGDHBGRSTTHX-UHFFFAOYSA-N					doublet; compound annotation
0391_001207	FIBOFLAPON	C38H43N3O4S	5.4407	44473151		CCOc1ncc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ncc(C)cc5)ccc43)cc2)cc1	InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)	DFQGDHBGRSTTHX-UHFFFAOYSA-N					doublet; compound annotation
0391_001208	1876467-74-1	C20H21N7O	2.2356	118869362	C[C@@H]1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C	CC1COCCN1c1nc2c(ccnc2-c2ccn[nH]2)c(-c2ccnn2C)c1	InChI=1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1	YBXRSCXGRPSTMW-CYBMUJFWSA-N					compound annotation
0391_001209	Benzoylaconine	C32H45NO10	2.4963	20055771	CCN1C[C@@]2([C@@H](C[C@@H]([C@@]34[C@@H]2[C@H]([C@@H](C31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6OC(=O)C7=CC=CC=C7)([C@H]([C@@H]5O)OC)O)O)OC)OC)O)COC	CCN1CC2(COC)C(O)CC(OC)C34C5CC6(O)C(OC)C(O)C(O)(C5C6OC(=O)c5ccccc5)C(C(OC)C23)C14	InChI=1S/C32H45NO10/c1-6-33-14-29(15-39-2)18(34)12-19(40-3)31-17-13-30(37)26(43-28(36)16-10-8-7-9-11-16)20(17)32(38,25(35)27(30)42-5)21(24(31)33)22(41-4)23(29)31/h7-11,17-27,34-35,37-38H,6,12-15H2,1-5H3/t17-,18-,19+,20-,21+,22+,23-,24?,25+,26-,27+,29+,30-,31+,32-/m1/s1	DHJXZSFKLJCHLH-KYSNEVMMSA-N					compound annotation
0391_001210	ARS-1620	C21H17ClF2N4O2	3.0153	137003167		C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1	InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2	ZRPZPNYZFSJUPA-UHFFFAOYSA-N					doublet; compound annotation
0391_001211	6-METHOXYNICOTINAMIDE	C7H8N2O2	1.0947	250810		COc1ncc(C(N)=O)cc1	InChI=1S/C7H8N2O2/c1-11-6-3-2-5(4-9-6)7(8)10/h2-4H,1H3,(H2,8,10)	KXDSMFBEVSJYRF-UHFFFAOYSA-N					compound annotation
0391_001212	Ganfeborole	C10H13BClNO4	1.3756	133080621	B1(C2=C(C=CC(=C2[C@H](O1)CN)Cl)OCCO)O	NCC1OB(O)c2c(OCCO)ccc(Cl)c21	InChI=1S/C10H13BClNO4/c12-6-1-2-7(16-4-3-14)10-9(6)8(5-13)17-11(10)15/h1-2,8,14-15H,3-5,13H2/t8-/m1/s1	DJUOWOXTPXUHDQ-MRVPVSSYSA-N					compound annotation
0391_001213	CC-90003	C22H21F3N6O2	3.384	90331177		C=CC(=O)Nc1c(Nc2nc(Nc3cc(OC)ncc3C)ncc2C(F)(F)F)ccc(C)c1	InChI=1S/C22H21F3N6O2/c1-5-18(32)28-17-8-12(2)6-7-15(17)29-20-14(22(23,24)25)11-27-21(31-20)30-16-9-19(33-4)26-10-13(16)3/h5-11H,1H2,2-4H3,(H,28,32)(H2,26,27,29,30,31)	ILUKRINUNLAVMH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001215	Acoziborole	C17H14BF4NO3	3.7639	44178354		CC1(C)OB(O)c2c1ccc(NC(=O)c1c(C(F)(F)F)cc(F)cc1)c2	InChI=1S/C17H14BF4NO3/c1-16(2)12-6-4-10(8-14(12)18(25)26-16)23-15(24)11-5-3-9(19)7-13(11)17(20,21)22/h3-8,25H,1-2H3,(H,23,24)	PTYGDEXEGLDNAZ-UHFFFAOYSA-N					compound annotation
0391_001216	GLP-1 receptor agonist 2	C30H31ClFN5O4	3.9813	134611104	C[C@H]1CN(CCN1CC2=NC3=C(N2C[C@@H]4CCO4)C=C(C=C3)C(=O)O)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)Cl)F	CC1CN(c2nc(OCc3c(F)cc(Cl)cc3)ccc2)CCN1Cc1nc2c(cc(C(=O)O)cc2)n1CC1CCO1	InChI=1S/C30H31ClFN5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1	IGXAOFNNKAUXCJ-CVDCTZTESA-N					compound annotation
0391_001217	oxybenzone	C14H12O3	4.4848	4632		COc1cc(O)c(C(=O)c2ccccc2)cc1	InChI=1S/C14H12O3/c1-17-11-7-8-12(13(15)9-11)14(16)10-5-3-2-4-6-10/h2-9,15H,1H3	DXGLGDHPHMLXJC-UHFFFAOYSA-N					compound annotation
0391_001218	Duocarmycin TM	C25H23ClN2O5	4.6747	394851	COC1=C(C(=C2C(=C1)C=C(N2)C(=O)N3C[C@H](C4=C3C=C(C5=CC=CC=C54)O)CCl)OC)OC	COc1c(OC)c(OC)c2[nH]c(C(=O)N3CC(CCl)c4c3cc(O)c3ccccc43)cc2c1	InChI=1S/C25H23ClN2O5/c1-31-20-9-13-8-17(27-22(13)24(33-3)23(20)32-2)25(30)28-12-14(11-26)21-16-7-5-4-6-15(16)19(29)10-18(21)28/h4-10,14,27,29H,11-12H2,1-3H3/t14-/m1/s1	NRHDGIYFJJUFKN-CQSZACIVSA-N					compound annotation
0391_001219	199433-58-4	C16H16N4O	0.8613	9810884	C[C@H](C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N	CC(N)c1ccc(C(=O)Nc2c3cc[nH]c3ncc2)cc1	InChI=1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1	JTVBXQAYBIJXRP-SNVBAGLBSA-N					doublet; compound annotation
0391_001220	6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide	C16H21N5O2	1.1789	135413504		C=CCN1CCCC1CNC(=O)c1cc2n[nH]nc2cc1OC	InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)	KSEYRUGYKHXGFW-UHFFFAOYSA-N					compound annotation
0391_001221	SCHEMBL10654942	C15H20ClN3O2	1.9237	9819591		CCN(CC)CCNC(=O)c1c(OC)cc(Cl)c(C#N)c1	InChI=1S/C15H20ClN3O2/c1-4-19(5-2)7-6-18-15(20)12-8-11(10-17)13(16)9-14(12)21-3/h8-9H,4-7H2,1-3H3,(H,18,20)	JEMKCYHUYUPGFN-UHFFFAOYSA-N					compound annotation
0391_001222	BTTAA	C19H30N10O2	2.0843	56655929		CC(C)(C)n1cc(CN(Cc2cn(CC(=O)O)nn2)Cc2cn(C(C)(C)C)nn2)nn1	InChI=1S/C19H30N10O2/c1-18(2,3)28-11-15(21-24-28)8-26(7-14-10-27(23-20-14)13-17(30)31)9-16-12-29(25-22-16)19(4,5)6/h10-12H,7-9,13H2,1-6H3,(H,30,31)	MGQYHUDOWOGSQI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001224	NIFURATEL	C10H11N3O5S	2.7401	6433427	CSCC1CN(C(=O)O1)/N=C/C2=CC=C(O2)[N+](=O)[O-]	CSCC1CN(N=Cc2ccc([N+](=O)[O-])o2)C(=O)O1	InChI=1S/C10H11N3O5S/c1-19-6-8-5-12(10(14)18-8)11-4-7-2-3-9(17-7)13(15)16/h2-4,8H,5-6H2,1H3/b11-4+	SRQKTCXJCCHINN-NYYWCZLTSA-N					removed another duplicate entry; compound annotation
0391_001226	SF2523	C19H17NO5S	3.1375	44180156		O=c1cc(N2CCOCC2)oc2c1scc2-c1cc2c(cc1)OCCO2	InChI=1S/C19H17NO5S/c21-14-10-17(20-3-5-22-6-4-20)25-18-13(11-26-19(14)18)12-1-2-15-16(9-12)24-8-7-23-15/h1-2,9-11H,3-8H2	BYTKNUOMWLJVNQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001228	SGC2085	C19H24N2O2	3.3975	121231417	CC1=CC(=CC(=C1)OC2=C(C=C(C=C2)CNC(=O)[C@H](C)N)C)C	Cc1cc(C)cc(Oc2c(C)cc(CNC(=O)C(C)N)cc2)c1	InChI=1S/C19H24N2O2/c1-12-7-13(2)9-17(8-12)23-18-6-5-16(10-14(18)3)11-21-19(22)15(4)20/h5-10,15H,11,20H2,1-4H3,(H,21,22)/t15-/m0/s1	GLFOFXKMALJTCZ-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_001230	8-Nitrotryptanthrin	C15H7N3O4	3.5918	478573		O=C1c2c(ccc([N+](=O)[O-])c2)-n2c1nc1ccccc1c2=O	InChI=1S/C15H7N3O4/c19-13-10-7-8(18(21)22)5-6-12(10)17-14(13)16-11-4-2-1-3-9(11)15(17)20/h1-7H	UFMQJYHLIUACCG-UHFFFAOYSA-N					compound annotation
0391_001231	ML335	C15H14Cl2N2O3S	3.7093	1243054		CS(=O)(=O)Nc1ccc(C(=O)NCc2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C15H14Cl2N2O3S/c1-23(21,22)19-13-6-3-10(4-7-13)15(20)18-9-11-2-5-12(16)8-14(11)17/h2-8,19H,9H2,1H3,(H,18,20)	RDFIQTZRJRVFHK-UHFFFAOYSA-N					compound annotation
0391_001232	199433-58-4	C16H16N4O	4.3184	9810884	C[C@H](C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N	CC(N)c1ccc(C(=O)Nc2c3cc[nH]c3ncc2)cc1	InChI=1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1	JTVBXQAYBIJXRP-SNVBAGLBSA-N					doublet; compound annotation
0391_001233	cl-82198	C17H22N2O3	1.811	2777		O=C(NCCCCN1CCOCC1)c1cc2ccccc2o1	InChI=1S/C17H22N2O3/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19/h1-2,5-6,13H,3-4,7-12H2,(H,18,20)	KUJQEQAVMNFFAO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001235	Naloxegol	C34H53NO11	2.0895	56959087	COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O	C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5	InChI=1S/C34H53NO11/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2/h3-5,28-29,32,36-37H,1,6-25H2,2H3/t28-,29+,32-,33-,34+/m0/s1	XNKCCCKFOQNXKV-ZRSCBOBOSA-N					removed another duplicate entry; compound annotation
0391_001237	NVS-PAK1-1	C23H25ClF3N5O	2.9718	137125241	CC(C)NC(=O)N1CC[C@@H](C1)N=C2C3=C(C=CC(=C3)Cl)N(C4=C(N2)C=C(C=C4)F)CC(F)F	CC(C)NC(=O)N1CCC(NC2=Nc3c(ccc(F)c3)N(CC(F)F)c3c2cc(Cl)cc3)C1	InChI=1S/C23H25ClF3N5O/c1-13(2)28-23(33)31-8-7-16(11-31)29-22-17-9-14(24)3-5-19(17)32(12-21(26)27)20-6-4-15(25)10-18(20)30-22/h3-6,9-10,13,16,21H,7-8,11-12H2,1-2H3,(H,28,33)(H,29,30)/t16-/m0/s1	OINGHOPGNMYCAB-INIZCTEOSA-N					doublet; compound annotation
0391_001238	NVS-PAK1-1	C23H25ClF3N5O	3.021	137125241	CC(C)NC(=O)N1CC[C@@H](C1)N=C2C3=C(C=CC(=C3)Cl)N(C4=C(N2)C=C(C=C4)F)CC(F)F	CC(C)NC(=O)N1CCC(NC2=Nc3c(ccc(F)c3)N(CC(F)F)c3c2cc(Cl)cc3)C1	InChI=1S/C23H25ClF3N5O/c1-13(2)28-23(33)31-8-7-16(11-31)29-22-17-9-14(24)3-5-19(17)32(12-21(26)27)20-6-4-15(25)10-18(20)30-22/h3-6,9-10,13,16,21H,7-8,11-12H2,1-2H3,(H,28,33)(H,29,30)/t16-/m0/s1	OINGHOPGNMYCAB-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_001240	TP-3654	C22H25F3N4O	3.3372	66598080		CC(C)(O)C1CCC(Nc2nn3c(-c4cc(C(F)(F)F)ccc4)cnc3cc2)CC1	InChI=1S/C22H25F3N4O/c1-21(2,30)15-6-8-17(9-7-15)27-19-10-11-20-26-13-18(29(20)28-19)14-4-3-5-16(12-14)22(23,24)25/h3-5,10-13,15,17,30H,6-9H2,1-2H3,(H,27,28)	XRNVABDYQLHODA-UHFFFAOYSA-N					compound annotation
0391_001241	KDM5-IN-1	C17H20N6O	3.3781	118908379		CC(C)c1c(-c2cn(C(C)(C)C)nc2)nc2c(C#N)c[nH]n2c1=O	InChI=1S/C17H20N6O/c1-10(2)13-14(12-8-19-22(9-12)17(3,4)5)21-15-11(6-18)7-20-23(15)16(13)24/h7-10,20H,1-5H3	YQCOPPONWZNBQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001243	NOD-IN-1	C18H17NO4S	5.0496	14783456		CCOC(=O)c1cc2ccccc2n1S(=O)(=O)c1ccc(C)cc1	InChI=1S/C18H17NO4S/c1-3-23-18(20)17-12-14-6-4-5-7-16(14)19(17)24(21,22)15-10-8-13(2)9-11-15/h4-12H,3H2,1-2H3	OJMOGUKIYRAILM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001245	Octocrylene	C24H27NO2	6.3283	22571		CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1	InChI=1S/C24H27NO2/c1-3-5-12-19(4-2)18-27-24(26)22(17-25)23(20-13-8-6-9-14-20)21-15-10-7-11-16-21/h6-11,13-16,19H,3-5,12,18H2,1-2H3	FMJSMJQBSVNSBF-UHFFFAOYSA-N					compound annotation
0391_001246	etretinate	C23H30O3	6.5706	5282375	CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C	CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)c(C)c(OC)cc1C	InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	HQMNCQVAMBCHCO-DJRRULDNSA-N					doublet; removed another duplicate entry; compound annotation
0391_001248	etretinate	C23H30O3	6.7092	5282375	CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C	CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)c(C)c(OC)cc1C	InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	HQMNCQVAMBCHCO-DJRRULDNSA-N					doublet; compound annotation
0391_001249	etretinate	C23H30O3	6.7169	5282375	CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C	CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)c(C)c(OC)cc1C	InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	HQMNCQVAMBCHCO-DJRRULDNSA-N					doublet; compound annotation
0391_001250	etretinate	C23H30O3	6.776	5282375	CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C	CCOC(=O)C=C(C)C=CC=C(C)C=Cc1c(C)c(C)c(OC)cc1C	InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+	HQMNCQVAMBCHCO-DJRRULDNSA-N					doublet; compound annotation
0391_001251	Pamiparib	C16H15FN4O	1.5974	135565554	C[C@]12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F	CC12CCCN1CC1=NNC(=O)c3c4c1c2[nH]c4cc(F)c3	InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1	DENYZIUJOTUUNY-MRXNPFEDSA-N					doublet; compound annotation
0391_001252	Pamiparib	C16H15FN4O	1.6001	135565554	C[C@]12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F	CC12CCCN1CC1=NNC(=O)c3c4c1c2[nH]c4cc(F)c3	InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1	DENYZIUJOTUUNY-MRXNPFEDSA-N					doublet; compound annotation
0391_001253	Azasetron	C17H20ClN3O3	1.8005	2264		CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21	InChI=1S/C17H20ClN3O3/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23)	WUKZPHOXUVCQOR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001255	Clomethiazole	C6H8ClNS	2.1583	10783		Cc1c(CCCl)scn1	InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3	PCLITLDOTJTVDJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001256	mk-1064	C24H20ClN5O3	3.0123	44633765		COc1c(OC)nc(CNC(=O)c2cc(-c3cc(Cl)cnc3)cnc2-c2ccccn2)cc1	InChI=1S/C24H20ClN5O3/c1-32-21-7-6-18(30-24(21)33-2)14-29-23(31)19-10-16(15-9-17(25)13-26-11-15)12-28-22(19)20-5-3-4-8-27-20/h3-13H,14H2,1-2H3,(H,29,31)	CKTWQGHVNRYNCM-UHFFFAOYSA-N					doublet; compound annotation
0391_001257	mk-1064	C24H20ClN5O3	3.0156	44633765		COc1c(OC)nc(CNC(=O)c2cc(-c3cc(Cl)cnc3)cnc2-c2ccccn2)cc1	InChI=1S/C24H20ClN5O3/c1-32-21-7-6-18(30-24(21)33-2)14-29-23(31)19-10-16(15-9-17(25)13-26-11-15)12-28-22(19)20-5-3-4-8-27-20/h3-13H,14H2,1-2H3,(H,29,31)	CKTWQGHVNRYNCM-UHFFFAOYSA-N					doublet; compound annotation
0391_001258	VERAPAMIL	C27H38N2O4	3.1569	2520		COc1c(OC)cc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)cc2)C(C)C)cc1	InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3	SGTNSNPWRIOYBX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001260	Valdecoxib	C16H14N2O3S	3.4279	119607		Cc1c(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccccc2)no1	InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)	LNPDTQAFDNKSHK-UHFFFAOYSA-N					compound annotation
0391_001261	Hexaconazole	C14H17Cl2N3O	3.8541	66461		CCCCC(O)(Cn1cncn1)c1c(Cl)cc(Cl)cc1	InChI=1S/C14H17Cl2N3O/c1-2-3-6-14(20,8-19-10-17-9-18-19)12-5-4-11(15)7-13(12)16/h4-5,7,9-10,20H,2-3,6,8H2,1H3	STMIIPIFODONDC-UHFFFAOYSA-N					doublet; compound annotation
0391_001262	Hexaconazole	C14H17Cl2N3O	4.4339	66461		CCCCC(O)(Cn1cncn1)c1c(Cl)cc(Cl)cc1	InChI=1S/C14H17Cl2N3O/c1-2-3-6-14(20,8-19-10-17-9-18-19)12-5-4-11(15)7-13(12)16/h4-5,7,9-10,20H,2-3,6,8H2,1H3	STMIIPIFODONDC-UHFFFAOYSA-N					doublet; compound annotation
0391_001263	spirodiclofen	C21H24Cl2O4	6.1505	177863		CCC(C)(C)C(=O)OC1=C(c2c(Cl)cc(Cl)cc2)C(=O)OC12CCCCC2	InChI=1S/C21H24Cl2O4/c1-4-20(2,3)19(25)26-17-16(14-9-8-13(22)12-15(14)23)18(24)27-21(17)10-6-5-7-11-21/h8-9,12H,4-7,10-11H2,1-3H3	DTDSAWVUFPGDMX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001265	n6-ethyladenosine	C12H17N5O4	0.7544	15160100	CCNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	CCNc1c2ncn(C3OC(CO)C(O)C3O)c2ncn1	InChI=1S/C12H17N5O4/c1-2-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20)8(19)6(3-18)21-12/h4-6,8-9,12,18-20H,2-3H2,1H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1	SHXVYOLWYFZWKE-WOUKDFQISA-N					compound annotation
0391_001266	vactosertib	C22H18FN7	2.3668	54766013		Cc1nc(-c2c(-c3cn4ncnc4cc3)nc(CNc3ccccc3F)[nH]2)ccc1	InChI=1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29)	FJCDSQATIJKQKA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001270	Yunaconitine	C35H49NO11	3.1726	155569		CCN1CC2(COC)C(O)CC(OC)C34C5CC6(O)C(OC)CC(OC(C)=O)(C5C6OC(=O)c5ccc(OC)cc5)C(C(OC)C23)C14	InChI=1S/C35H49NO11/c1-8-36-16-32(17-41-3)22(38)13-23(43-5)35-21-14-33(40)24(44-6)15-34(47-18(2)37,26(29(35)36)27(45-7)28(32)35)25(21)30(33)46-31(39)19-9-11-20(42-4)12-10-19/h9-12,21-30,38,40H,8,13-17H2,1-7H3	LLEMSCWAKNQHHA-UHFFFAOYSA-N					compound annotation
0391_001271	GNE-7915	C19H21F4N5O3	3.5356	58539171		CCNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)c(F)c2)ncc1C(F)(F)F	InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)	XCFLWTZSJYBCPF-UHFFFAOYSA-N					doublet; compound annotation
0391_001272	GNE-7915	C19H21F4N5O3	3.5411	58539171		CCNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)c(F)c2)ncc1C(F)(F)F	InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)	XCFLWTZSJYBCPF-UHFFFAOYSA-N					doublet; compound annotation
0391_001273	Fexaramine	C32H36N2O3	3.8795	5326713	CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)/C=C/C(=O)OC)C(=O)C4CCCCC4	COC(=O)C=Cc1cc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)ccc1	InChI=1S/C32H36N2O3/c1-33(2)29-19-17-27(18-20-29)26-15-12-25(13-16-26)23-34(32(36)28-9-5-4-6-10-28)30-11-7-8-24(22-30)14-21-31(35)37-3/h7-8,11-22,28H,4-6,9-10,23H2,1-3H3/b21-14+	VLQTUNDJHLEFEQ-KGENOOAVSA-N					doublet; compound annotation
0391_001274	Neoseptin 3	C29H34N2O4	4.6166	77461013	CC(C)(C)OC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)C2=CC(=C(C=C2)N)CCC3=CC=C(C=C3)O	CC(C)(C)OC(=O)C(CCc1ccccc1)NC(=O)c1cc(CCc2ccc(O)cc2)c(N)cc1	InChI=1S/C29H34N2O4/c1-29(2,3)35-28(34)26(18-12-20-7-5-4-6-8-20)31-27(33)23-14-17-25(30)22(19-23)13-9-21-10-15-24(32)16-11-21/h4-8,10-11,14-17,19,26,32H,9,12-13,18,30H2,1-3H3,(H,31,33)/t26-/m0/s1	OACODUCFPHHCIH-SANMLTNESA-N					removed another duplicate entry; compound annotation
0391_001276	DAA-1106	C23H22FNO4	4.7342	10430788		COc1cc(CN(C(C)=O)c2cc(F)ccc2Oc2ccccc2)c(OC)cc1	InChI=1S/C23H22FNO4/c1-16(26)25(15-17-13-20(27-2)10-12-22(17)28-3)21-14-18(24)9-11-23(21)29-19-7-5-4-6-8-19/h4-14H,15H2,1-3H3	DCRZYADKQRHHSF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001279	Fexaramine	C32H36N2O3	5.4805	5326713	CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)/C=C/C(=O)OC)C(=O)C4CCCCC4	COC(=O)C=Cc1cc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)ccc1	InChI=1S/C32H36N2O3/c1-33(2)29-19-17-27(18-20-29)26-15-12-25(13-16-26)23-34(32(36)28-9-5-4-6-10-28)30-11-7-8-24(22-30)14-21-31(35)37-3/h7-8,11-22,28H,4-6,9-10,23H2,1-3H3/b21-14+	VLQTUNDJHLEFEQ-KGENOOAVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001282	Tebipenem	C16H21N3O4S2	1.1714	9800194	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O	CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CN(C4=NCCS4)C3)C(C)C12	InChI=1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1	GXXLUDOKHXEFBQ-YJFSRANCSA-N					doublet; compound annotation
0391_001283	Tebipenem	C16H21N3O4S2	1.5131	9800194	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O	CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CN(C4=NCCS4)C3)C(C)C12	InChI=1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1	GXXLUDOKHXEFBQ-YJFSRANCSA-N					doublet; compound annotation
0391_001284	HDAC-IN-4	C24H29N5O	1.6387	16225380		Cc1nn(C)cc1CN1CCC(c2ccc(C(=O)Nc3ccccc3N)cc2)CC1	InChI=1S/C24H29N5O/c1-17-21(15-28(2)27-17)16-29-13-11-19(12-14-29)18-7-9-20(10-8-18)24(30)26-23-6-4-3-5-22(23)25/h3-10,15,19H,11-14,16,25H2,1-2H3,(H,26,30)	JHDZMASHNBKTPS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001286	Tebipenem	C16H21N3O4S2	1.6518	9800194	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O	CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CN(C4=NCCS4)C3)C(C)C12	InChI=1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1	GXXLUDOKHXEFBQ-YJFSRANCSA-N					doublet; compound annotation
0391_001287	AZD5153	C25H33N7O3	2.2226	118693659	C[C@@H]1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C	COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)C5C)cc4)CC3)nn12	InChI=1S/C25H33N7O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23/h4-9,18,20H,10-17H2,1-3H3/t18-/m1/s1	RSMYFSPOTCDHHJ-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_001289	isopropamide	C23H33N2O+	2.4801	3775		CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C	InChI=1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1	JTPUMZTWMWIVPA-UHFFFAOYSA-O					compound annotation
0391_001290	CPI-637	C22H22N6O	2.9612	121271792	C[C@@H]1CC(=O)NC2=CC=CC(=C2N1)C3=CC4=C(C=C3)N(N=C4C5=CN(N=C5)C)C	CC1CC(=O)Nc2cccc(-c3cc4c(cc3)n(C)nc4-c3cn(C)nc3)c2N1	InChI=1S/C22H22N6O/c1-13-9-20(29)25-18-6-4-5-16(22(18)24-13)14-7-8-19-17(10-14)21(26-28(19)3)15-11-23-27(2)12-15/h4-8,10-13,24H,9H2,1-3H3,(H,25,29)/t13-/m1/s1	BFTKDWYIRJGJCA-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_001293	PF-06726304	C22H21Cl2N3O3	3.5156	86723730		Cc1cc(C)c(CN2CCc3c(Cl)cc(-c4c(C)onc4C)c(Cl)c3C2=O)c(=O)[nH]1	InChI=1S/C22H21Cl2N3O3/c1-10-7-11(2)25-21(28)16(10)9-27-6-5-14-17(23)8-15(20(24)19(14)22(27)29)18-12(3)26-30-13(18)4/h7-8H,5-6,9H2,1-4H3,(H,25,28)	PDKDOPJQPKXNCT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001295	TGX-221	C21H24N4O2	3.7452	9907093		Cc1cn2c(=O)cc(N3CCOCC3)nc2c(C(C)Nc2ccccc2)c1	InChI=1S/C21H24N4O2/c1-15-12-18(16(2)22-17-6-4-3-5-7-17)21-23-19(13-20(26)25(21)14-15)24-8-10-27-11-9-24/h3-7,12-14,16,22H,8-11H2,1-2H3	CPRAGQJXBLMUEL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001298	GNE-140 (racemate)	C25H23ClN2O3S2	3.8219	118384725		O=C1CC(c2ccc(N3CCOCC3)cc2)(c2cscc2)NC(=O)C1Sc1ccccc1Cl	InChI=1S/C25H23ClN2O3S2/c26-20-3-1-2-4-22(20)33-23-21(29)15-25(27-24(23)30,18-9-14-32-16-18)17-5-7-19(8-6-17)28-10-12-31-13-11-28/h1-9,14,16,23H,10-13,15H2,(H,27,30)	GLDDJXYFHWRGPI-UHFFFAOYSA-N					doublet; compound annotation
0391_001299	GNE-140 (racemate)	C25H23ClN2O3S2	3.8249	118384725		O=C1CC(c2ccc(N3CCOCC3)cc2)(c2cscc2)NC(=O)C1Sc1ccccc1Cl	InChI=1S/C25H23ClN2O3S2/c26-20-3-1-2-4-22(20)33-23-21(29)15-25(27-24(23)30,18-9-14-32-16-18)17-5-7-19(8-6-17)28-10-12-31-13-11-28/h1-9,14,16,23H,10-13,15H2,(H,27,30)	GLDDJXYFHWRGPI-UHFFFAOYSA-N					doublet; compound annotation
0391_001300	959122-11-3	C26H24N2O4	4.167	24768261	C1C[C@H]([C@@H](C1)C(=O)O)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4	O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1	InChI=1S/C26H24N2O4/c29-24(22-7-4-8-23(22)25(30)31)19-11-9-17(10-12-19)18-13-15-21(16-14-18)28-26(32)27-20-5-2-1-3-6-20/h1-3,5-6,9-16,22-23H,4,7-8H2,(H,30,31)(H2,27,28,32)/t22-,23-/m1/s1	BOZRFEQDOFSZBV-DHIUTWEWSA-N					doublet; compound annotation
0391_001301	959122-11-3	C26H24N2O4	4.2872	24768261	C1C[C@H]([C@@H](C1)C(=O)O)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4	O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1	InChI=1S/C26H24N2O4/c29-24(22-7-4-8-23(22)25(30)31)19-11-9-17(10-12-19)18-13-15-21(16-14-18)28-26(32)27-20-5-2-1-3-6-20/h1-3,5-6,9-16,22-23H,4,7-8H2,(H,30,31)(H2,27,28,32)/t22-,23-/m1/s1	BOZRFEQDOFSZBV-DHIUTWEWSA-N					doublet; compound annotation
0391_001302	959122-11-3	C26H24N2O4	4.2901	24768261	C1C[C@H]([C@@H](C1)C(=O)O)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4	O=C(Nc1ccccc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)cc2)cc1	InChI=1S/C26H24N2O4/c29-24(22-7-4-8-23(22)25(30)31)19-11-9-17(10-12-19)18-13-15-21(16-14-18)28-26(32)27-20-5-2-1-3-6-20/h1-3,5-6,9-16,22-23H,4,7-8H2,(H,30,31)(H2,27,28,32)/t22-,23-/m1/s1	BOZRFEQDOFSZBV-DHIUTWEWSA-N					doublet; compound annotation
0391_001303	Vorapaxar	C29H33FN2O4	4.3813	10077130	CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C	CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=Cc1ncc(-c2cc(F)ccc2)cc1	InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1	ZBGXUVOIWDMMJE-QHNZEKIYSA-N					removed another duplicate entry; compound annotation
0391_001305	Avadomide	C14H14N4O3	1.3709	24967599		Cc1nc2cccc(N)c2c(=O)n1C1CCC(=O)NC1=O	InChI=1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20)	RSNPAKAFCAAMBH-UHFFFAOYSA-N					compound annotation
0391_001306	1335210-23-5	C13H17NO8	2.428	53469000		COC(=O)c1c(OC)c(=O)c(C(=O)O)cn1CC(OC)OC	InChI=1S/C13H17NO8/c1-19-8(20-2)6-14-5-7(12(16)17)10(15)11(21-3)9(14)13(18)22-4/h5,8H,6H2,1-4H3,(H,16,17)	XAXGEECGULRZGN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001308	537034-15-4	C19H23N3O2	2.5677	9543539		Nc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1	InChI=1S/C19H23N3O2/c20-16-11-7-8-12-17(16)22-19(24)14-6-2-5-13-18(23)21-15-9-3-1-4-10-15/h1,3-4,7-12H,2,5-6,13-14,20H2,(H,21,23)(H,22,24)	ZAIULUYKQLVQFH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001310	537034-15-4	C19H23N3O2	2.5711	9543539		Nc1ccccc1NC(=O)CCCCCC(=O)Nc1ccccc1	InChI=1S/C19H23N3O2/c20-16-11-7-8-12-17(16)22-19(24)14-6-2-5-13-18(23)21-15-9-3-1-4-10-15/h1,3-4,7-12H,2,5-6,13-14,20H2,(H,21,23)(H,22,24)	ZAIULUYKQLVQFH-UHFFFAOYSA-N					doublet; compound annotation
0391_001311	STF-62247	C15H13N3S	2.6542	704473		Cc1cc(Nc2nc(-c3ccncc3)cs2)ccc1	InChI=1S/C15H13N3S/c1-11-3-2-4-13(9-11)17-15-18-14(10-19-15)12-5-7-16-8-6-12/h2-10H,1H3,(H,17,18)	KATNUHQNJGNLPW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001313	Lanabecestat	C26H28N4O	2.8481	67979346	CC#CC1=CC(=CN=C1)C2=CC3=C(CC4([C@]35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2	CC#Cc1cc(-c2cc3c(cc2)CC2(CCC(OC)CC2)C32N=C(C)C(N)=N2)cnc1	InChI=1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22?,25?,26-/m0/s1	WKDNQONLGXOZRG-BOPKNSRXSA-N					doublet; compound annotation
0391_001314	Lanabecestat	C26H28N4O	3.0267	67979346	CC#CC1=CC(=CN=C1)C2=CC3=C(CC4([C@]35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2	CC#Cc1cc(-c2cc3c(cc2)CC2(CCC(OC)CC2)C32N=C(C)C(N)=N2)cnc1	InChI=1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22?,25?,26-/m0/s1	WKDNQONLGXOZRG-BOPKNSRXSA-N					doublet; compound annotation
0391_001315	Remetinostat	C16H21NO6	3.0563	24875489		COC(=O)c1ccc(OC(=O)CCCCCCC(=O)NO)cc1	InChI=1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18)	XDZAHHULFQIBFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001317	Rimacalib	C22H23FN4O2	3.4495	40486337	C[C@@H](C1=CC(=C(C=C1)C2=CC=CC=C2)F)C3=NOC(=C3)N=C(N)N4CCOCC4	CC(c1cc(F)c(-c2ccccc2)cc1)c1noc(N=C(N)N2CCOCC2)c1	InChI=1S/C22H23FN4O2/c1-15(17-7-8-18(19(23)13-17)16-5-3-2-4-6-16)20-14-21(29-26-20)25-22(24)27-9-11-28-12-10-27/h2-8,13-15H,9-12H2,1H3,(H2,24,25)/t15-/m0/s1	MYTIJGWONQOOLC-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_001320	BAPTA-AM	C34H40N2O18	4.5833	2293		CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccccc1OCCOc1ccccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O	InChI=1S/C34H40N2O18/c1-23(37)47-19-51-31(41)15-35(16-32(42)52-20-48-24(2)38)27-9-5-7-11-29(27)45-13-14-46-30-12-8-6-10-28(30)36(17-33(43)53-21-49-25(3)39)18-34(44)54-22-50-26(4)40/h5-12H,13-22H2,1-4H3	YJIYWYAMZFVECX-UHFFFAOYSA-N					doublet; compound annotation
0391_001321	BAPTA-AM	C34H40N2O18	4.5881	2293		CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)c1ccccc1OCCOc1ccccc1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O	InChI=1S/C34H40N2O18/c1-23(37)47-19-51-31(41)15-35(16-32(42)52-20-48-24(2)38)27-9-5-7-11-29(27)45-13-14-46-30-12-8-6-10-28(30)36(17-33(43)53-21-49-25(3)39)18-34(44)54-22-50-26(4)40/h5-12H,13-22H2,1-4H3	YJIYWYAMZFVECX-UHFFFAOYSA-N					doublet; compound annotation
0391_001322	tucidinostat	C22H19FN4O2	1.9154	12136798	C1=CC(=CN=C1)/C=C/C(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N	Nc1c(NC(=O)c2ccc(CNC(=O)C=Cc3cnccc3)cc2)ccc(F)c1	InChI=1S/C22H19FN4O2/c23-18-8-9-20(19(24)12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)/b10-5+	SZMJVTADHFNAIS-BJMVGYQFSA-N					compound annotation
0391_001323	Vecuronium	C34H57N2O4+	2.1815	39765	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C	CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1	InChI=1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1	BGSZAXLLHYERSY-XQIGCQGXSA-N					compound annotation
0391_001324	153436-54-5	C16H14BrN3O2	2.6775	4705		COc1c(OC)cc2c(Nc3cc(Br)ccc3)ncnc2c1	InChI=1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)	LSPANGZZENHZNJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001325	40172-65-4	C11H8N2S	2.6918	94880		Nc1nc2c(ccc3ccccc32)s1	InChI=1S/C11H8N2S/c12-11-13-10-8-4-2-1-3-7(8)5-6-9(10)14-11/h1-6H,(H2,12,13)	FECQXVPRUCCUIL-UHFFFAOYSA-N					compound annotation
0391_001326	REBASTINIB	C30H28FN7O3	3.8591	25066467		CNC(=O)c1nccc(Oc2cc(F)c(NC(=O)Nc3cc(C(C)(C)C)nn3-c3cc4c(cc3)nccc4)cc2)c1	InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)	WVXNSAVVKYZVOE-UHFFFAOYSA-N					doublet; compound annotation
0391_001327	REBASTINIB	C30H28FN7O3	3.8623	25066467		CNC(=O)c1nccc(Oc2cc(F)c(NC(=O)Nc3cc(C(C)(C)C)nn3-c3cc4c(cc3)nccc4)cc2)c1	InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)	WVXNSAVVKYZVOE-UHFFFAOYSA-N					doublet; compound annotation
0391_001328	PF-04457845	C23H20F3N5O2	4.3435	24771824		O=C(Nc1nnccc1)N1CCC(=Cc2cc(Oc3ncc(C(F)(F)F)cc3)ccc2)CC1	InChI=1S/C23H20F3N5O2/c24-23(25,26)18-6-7-21(27-15-18)33-19-4-1-3-17(14-19)13-16-8-11-31(12-9-16)22(32)29-20-5-2-10-28-30-20/h1-7,10,13-15H,8-9,11-12H2,(H,29,30,32)	BATCTBJIJJEPHM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001330	AM679	C40H44N4O5S	5.5655	44627267	CC(=O)N1[C@@H](CC2=CC=CC=C21)COC3=CC4=C(C=C3)N(C(=C4SC(C)(C)C)CC(C)(C)C(=O)O)CC5=CC=C(C=C5)C6=NC=C(C=N6)OC	COc1cnc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4c3ccc(OCC3Cc5ccccc5N3C(C)=O)c4)cc2)nc1	InChI=1S/C40H44N4O5S/c1-25(45)44-29(18-28-10-8-9-11-33(28)44)24-49-30-16-17-34-32(19-30)36(50-39(2,3)4)35(20-40(5,6)38(46)47)43(34)23-26-12-14-27(15-13-26)37-41-21-31(48-7)22-42-37/h8-17,19,21-22,29H,18,20,23-24H2,1-7H3,(H,46,47)/t29-/m0/s1	VYXWHVDEWWHDLH-LJAQVGFWSA-N					removed another duplicate entry; compound annotation
0391_001332	9-propenyladenine	C8H9N5	1.0266	71812668	C/C=C/N1C=NC2=C(N=CN=C21)N	CC=Cn1cnc2c(N)ncnc21	InChI=1S/C8H9N5/c1-2-3-13-5-12-6-7(9)10-4-11-8(6)13/h2-5H,1H3,(H2,9,10,11)/b3-2+	ACWCANXGLNLMJB-NSCUHMNNSA-N					compound annotation
0391_001333	ritodrine	C17H21NO3	1.219	688570	C[C@H]([C@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O	CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1	InChI=1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13/h2-9,12,17-21H,10-11H2,1H3/t12-,17-/m1/s1	IOVGROKTTNBUGK-SJKOYZFVSA-N					compound annotation
0391_001334	Proflavine	C13H11N3	1.6572	7099		Nc1cc2c(cc1)cc1ccc(N)cc1n2	InChI=1S/C13H11N3/c14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10/h1-7H,14-15H2	WDVSHHCDHLJJJR-UHFFFAOYSA-N					compound annotation
0391_001335	GSK2256098	C20H23ClN6O2	2.335	46214930		CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl	InChI=1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24)	BVAHPPKGOOJSPU-UHFFFAOYSA-N					doublet; compound annotation
0391_001336	GSK2256098	C20H23ClN6O2	3.2814	46214930		CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl	InChI=1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24)	BVAHPPKGOOJSPU-UHFFFAOYSA-N					doublet; compound annotation
0391_001337	IDH-305	C23H22F4N6O2	3.4148	90415637	CC1=CC(=NC=C1C2=CC(=NC=C2)C(F)(F)F)[C@H](C)NC3=NC=CC(=N3)N4[C@H](COC4=O)[C@H](C)F	Cc1cc(C(C)Nc2nccc(N3C(=O)OCC3C(C)F)n2)ncc1-c1cc(C(F)(F)F)ncc1	InChI=1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14-,18+/m0/s1	DCGDPJCUIKLTDU-SUNYJGFJSA-N					doublet; removed another duplicate entry; compound annotation
0391_001339	GSK2256098	C20H23ClN6O2	3.565	46214930		CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl	InChI=1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24)	BVAHPPKGOOJSPU-UHFFFAOYSA-N					doublet; compound annotation
0391_001340	IDH-305	C23H22F4N6O2	3.565	90415637	CC1=CC(=NC=C1C2=CC(=NC=C2)C(F)(F)F)[C@H](C)NC3=NC=CC(=N3)N4[C@H](COC4=O)[C@H](C)F	Cc1cc(C(C)Nc2nccc(N3C(=O)OCC3C(C)F)n2)ncc1-c1cc(C(F)(F)F)ncc1	InChI=1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14-,18+/m0/s1	DCGDPJCUIKLTDU-SUNYJGFJSA-N					doublet; compound annotation
0391_001341	FMK 9a	C23H21FN2O3	3.6562	127020966	C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)CF)NC(=O)C2=CC=CC3=CC=CC=C32	O=C(CF)CNC(=O)C(Cc1ccccc1)NC(=O)c1cccc2ccccc12	InChI=1S/C23H21FN2O3/c24-14-18(27)15-25-23(29)21(13-16-7-2-1-3-8-16)26-22(28)20-12-6-10-17-9-4-5-11-19(17)20/h1-12,21H,13-15H2,(H,25,29)(H,26,28)/t21-/m0/s1	VMVOHHPQIAPYHG-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_001343	FLLL32	C28H32O6	4.7231	68019246	COC1=C(C=C(C=C1)/C=C/C(=O)C2(CCCCC2)C(=O)/C=C/C3=CC(=C(C=C3)OC)OC)OC	COc1c(OC)cc(C=CC(=O)C2(C(=O)C=Cc3cc(OC)c(OC)cc3)CCCCC2)cc1	InChI=1S/C28H32O6/c1-31-22-12-8-20(18-24(22)33-3)10-14-26(29)28(16-6-5-7-17-28)27(30)15-11-21-9-13-23(32-2)25(19-21)34-4/h8-15,18-19H,5-7,16-17H2,1-4H3/b14-10+,15-11+	NQDROBVIYYEMDQ-WFYKWJGLSA-N					removed another duplicate entry; compound annotation
0391_001345	POLIUMOSIDE	C35H46O19	1.9153	10373017	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC(=C(C=C3)O)O)O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)OC(=O)/C=C/C5=CC(=C(C=C5)O)O)O)O)O	CC1OC(OCC2OC(OCCc3cc(O)c(O)cc3)C(O)C(OC3OC(C)C(O)C(O)C3O)C2OC(=O)C=Cc2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C35H46O19/c1-14-24(41)26(43)28(45)33(50-14)49-13-22-31(53-23(40)8-5-16-3-6-18(36)20(38)11-16)32(54-35-29(46)27(44)25(42)15(2)51-35)30(47)34(52-22)48-10-9-17-4-7-19(37)21(39)12-17/h3-8,11-12,14-15,22,24-39,41-47H,9-10,13H2,1-2H3/b8-5+/t14-,15-,22+,24-,25-,26+,27+,28+,29+,30+,31+,32+,33+,34+,35-/m0/s1	YMWRMAOPKNYHMZ-LLVTZOIGSA-N					compound annotation
0391_001346	Phlorizin	C21H24O10	2.267	6072	C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O	O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1	IOUVKUPGCMBWBT-QNDFHXLGSA-N					compound annotation
0391_001347	Pacritinib	C28H32N4O3	3.029	46216796	C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2	C1=CCOCc2cc(ccc2OCCN2CCCC2)Nc2nc(ccn2)-c2cc(ccc2)COC1	InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+	HWXVIOGONBBTBY-ONEGZZNKSA-N					doublet; compound annotation
0391_001348	Pacritinib	C28H32N4O3	3.0318	46216796	C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2	C1=CCOCc2cc(ccc2OCCN2CCCC2)Nc2nc(ccn2)-c2cc(ccc2)COC1	InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+	HWXVIOGONBBTBY-ONEGZZNKSA-N					doublet; compound annotation
0391_001349	indoprofen	C17H15NO3	3.2001	3718		CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1	InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)	RJMIEHBSYVWVIN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001351	Withaferin A	C28H38O6	3.2927	265237	CC1=C(C(=O)O[C@H](C1)[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C[C@@H]5[C@]6([C@@]4(C(=O)C=C[C@@H]6O)C)O5)C)CO	CC1=C(CO)C(=O)OC(C(C)C2CCC3C4CC5OC56C(O)C=CC(=O)C6(C)C4CCC23C)C1	InChI=1S/C28H38O6/c1-14-11-21(33-25(32)17(14)13-29)15(2)18-5-6-19-16-12-24-28(34-24)23(31)8-7-22(30)27(28,4)20(16)9-10-26(18,19)3/h7-8,15-16,18-21,23-24,29,31H,5-6,9-13H2,1-4H3/t15-,16-,18+,19-,20-,21+,23-,24+,26+,27-,28+/m0/s1	DBRXOUCRJQVYJQ-CKNDUULBSA-N					removed another duplicate entry; compound annotation
0391_001353	HY-N1479	C29H44O6	4.0887	138911406	C[C@@]12CC[C@@H]3[C@@]([C@H]1CCC4=C2CC[C@]5([C@H]4CC(CC5)(C)C)C(=O)O)(C[C@@H]([C@@H]([C@@]3(C)C(=O)O)O)O)C	CC1(C)CCC2(C(=O)O)CCC3=C(CCC4C3(C)CCC3C4(C)CC(O)C(O)C3(C)C(=O)O)C2C1	InChI=1S/C29H44O6/c1-25(2)12-13-29(24(34)35)11-8-17-16(18(29)14-25)6-7-20-26(17,3)10-9-21-27(20,4)15-19(30)22(31)28(21,5)23(32)33/h18-22,30-31H,6-15H2,1-5H3,(H,32,33)(H,34,35)/t18-,19-,20-,21+,22-,26-,27+,28-,29-/m0/s1	VZRKWGPIZJDNHC-ZLBVQBNPSA-N					compound annotation
0391_001354	Anagliptin	C19H25N7O2	1.4835	44513473	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	Cc1nn2cc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cnc2c1	InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1	LDXYBEHACFJIEL-HNNXBMFYSA-N					doublet; compound annotation
0391_001355	Anagliptin	C19H25N7O2	1.5325	44513473	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	Cc1nn2cc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cnc2c1	InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1	LDXYBEHACFJIEL-HNNXBMFYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001357	Anagliptin	C19H25N7O2	1.6264	44513473	CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N	Cc1nn2cc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cnc2c1	InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1	LDXYBEHACFJIEL-HNNXBMFYSA-N					doublet; compound annotation
0391_001358	Etomidate	C14H16N2O2	2.7861	667484	CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2	CCOC(=O)c1cncn1C(C)c1ccccc1	InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1	NPUKDXXFDDZOKR-LLVKDONJSA-N					doublet; compound annotation
0391_001359	EMPA	C23H26N4O4S	2.8559	9981404		CCN(Cc1cnccc1)C(=O)CN(c1cnc(OC)cc1)S(=O)(=O)c1ccccc1C	InChI=1S/C23H26N4O4S/c1-4-26(16-19-9-7-13-24-14-19)23(28)17-27(20-11-12-22(31-3)25-15-20)32(29,30)21-10-6-5-8-18(21)2/h5-15H,4,16-17H2,1-3H3	KJPHTXTWFHVJIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001361	flumethasone	C22H28F2O5	3.0702	16490	C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F	CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1	WXURHACBFYSXBI-GQKYHHCASA-N					compound annotation
0391_001362	Tadalafil	C22H19N3O4	3.3247	110635	CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2cc3c(cc2)OCO3)C1=O	InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1	WOXKDUGGOYFFRN-IIBYNOLFSA-N					removed another duplicate entry; compound annotation
0391_001364	1161205-04-4	C13H11ClN2O2	4.017	44191096		COc1c(Cl)ccc(NC(=O)c2ccccn2)c1	InChI=1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8H,1H3,(H,16,17)	ARYUXFNGXHNNDM-UHFFFAOYSA-N					compound annotation
0391_001365	Travoprost	C26H35F3O6	4.5817	5282226	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O	CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(O)COc1cccc(C(F)(F)F)c1	InChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1	MKPLKVHSHYCHOC-AHTXBMBWSA-N					removed another duplicate entry; compound annotation
0391_001367	Aleglitazar	C24H23NO5S	4.7585	10274777	CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=C4C=CSC4=C(C=C3)C[C@@H](C(=O)O)OC	COC(Cc1c2sccc2c(OCCc2c(C)oc(-c3ccccc3)n2)cc1)C(=O)O	InChI=1S/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1	DAYKLWSKQJBGCS-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_001369	1246525-60-9	C17H10F9NO2	4.8249	17980288		O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccc(C(F)(F)F)cc1	InChI=1S/C17H10F9NO2/c18-15(19,20)11-3-1-9(2-4-11)13(28)27-12-7-5-10(6-8-12)14(29,16(21,22)23)17(24,25)26/h1-8,29H,(H,27,28)	DUXWIYXHHGNUJU-UHFFFAOYSA-N					compound annotation
0391_001370	Pibenzimol	C25H24N6O	1.3399	2392		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2ccc(O)cc2)[nH]4)[nH]3)CC1	InChI=1S/C25H24N6O/c1-30-10-12-31(13-11-30)18-5-9-21-23(15-18)29-25(27-21)17-4-8-20-22(14-17)28-24(26-20)16-2-6-19(32)7-3-16/h2-9,14-15,32H,10-13H2,1H3,(H,26,28)(H,27,29)	INAAIJLSXJJHOZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001372	927871-76-9	C11H15NOS	1.6052	24763624		COc1cc2c(cc1)SCCN(C)C2	InChI=1S/C11H15NOS/c1-12-5-6-14-11-4-3-10(13-2)7-9(11)8-12/h3-4,7H,5-6,8H2,1-2H3	BGVCEGVSQDOGSB-UHFFFAOYSA-N					doublet; compound annotation
0391_001373	Sapitinib	C23H25ClFN5O3	1.8014	11488320		CNC(=O)CN1CCC(Oc2c(OC)cc3ncnc(Nc4c(F)c(Cl)ccc4)c3c2)CC1	InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)	DFJSJLGUIXFDJP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001375	LY2886721	C18H16F2N4O2S	2.1405	49837968	C1[C@H]2CSC(=N[C@]2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)F)F)N	NC1=NC2(c3c(F)ccc(NC(=O)c4ncc(F)cc4)c3)COCC2CS1	InChI=1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1	NIDRNVHMMDAAIK-YPMLDQLKSA-N					removed another duplicate entry; compound annotation
0391_001377	MTEP	C11H8N2S	2.2708	9794218		Cc1nc(C#Cc2cnccc2)cs1	InChI=1S/C11H8N2S/c1-9-13-11(8-14-9)5-4-10-3-2-6-12-7-10/h2-3,6-8H,1H3	NRBNGHCYDWUVLC-UHFFFAOYSA-N					compound annotation
0391_001378	LolCDE-IN-1	C21H16FN3O	2.7046	118720981		Fc1ccc(COc2cccc(-c3c(-c4ccncc4)cn[nH]3)c2)cc1	InChI=1S/C21H16FN3O/c22-18-6-4-15(5-7-18)14-26-19-3-1-2-17(12-19)21-20(13-24-25-21)16-8-10-23-11-9-16/h1-13H,14H2,(H,24,25)	DNZHPYAAJMOOPF-UHFFFAOYSA-N					compound annotation
0391_001379	AZD2461	C22H22FN3O3	2.8427	44199317		COC1CCN(C(=O)c2c(F)ccc(Cc3n[nH]c(=O)c4ccccc34)c2)CC1	InChI=1S/C22H22FN3O3/c1-29-15-8-10-26(11-9-15)22(28)18-12-14(6-7-19(18)23)13-20-16-4-2-3-5-17(16)21(27)25-24-20/h2-7,12,15H,8-11,13H2,1H3,(H,25,27)	HYNBNUYQTQIHJK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001381	870061-27-1	C19H14Cl2N6O	4.2307	53325875		Clc1cccc(-n2nnnc2NCc2ccccc2Oc2ccccn2)c1Cl	InChI=1S/C19H14Cl2N6O/c20-14-7-5-8-15(18(14)21)27-19(24-25-26-27)23-12-13-6-1-2-9-16(13)28-17-10-3-4-11-22-17/h1-11H,12H2,(H,23,24,26)	GMVNBKZQJFRFAR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001383	Dofetilide	C19H27N3O5S2	1.6433	71329		CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1	InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3	IXTMWRCNAAVVAI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001385	CWHM-1008	C22H26F3N3O	2.223	138319676	C[C@@H](C1=CC=C(C=C1)N(C)C)NC(=O)[C@H]2CNC[C@@H]2C3=CC=C(C=C3)C(F)(F)F	CC(NC(=O)C1CNCC1c1ccc(C(F)(F)F)cc1)c1ccc(N(C)C)cc1	InChI=1S/C22H26F3N3O/c1-14(15-6-10-18(11-7-15)28(2)3)27-21(29)20-13-26-12-19(20)16-4-8-17(9-5-16)22(23,24)25/h4-11,14,19-20,26H,12-13H2,1-3H3,(H,27,29)/t14-,19+,20-/m0/s1	BNAUPWAOLQXQJZ-KPOBHBOGSA-N					removed another duplicate entry; compound annotation
0391_001388	Seltorexant	C21H22FN7O	2.3249	67116280		Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1	InChI=1S/C21H22FN7O/c1-13-8-14(2)26-21(25-13)28-11-15-9-27(10-16(15)12-28)20(30)19-17(22)4-3-5-18(19)29-23-6-7-24-29/h3-8,15-16H,9-12H2,1-2H3	SQOCEMCKYDVLMM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001390	186953-56-0	C20H20N4O3	2.4272	459963		CON=C(N)c1ccc(-c2ccc(-c3ccc(C(N)=NOC)cc3)o2)cc1	InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)	UKOQVLAXCBRRGH-UHFFFAOYSA-N					doublet; compound annotation
0391_001391	1802632-22-9	C24H33NO4S	2.5648	118278088		CC(C)(C)Oc1c(O)ccc(CCC(C)(C)N2Cc3c(cc(S(C)(=O)=O)cc3)C2)c1	InChI=1S/C24H33NO4S/c1-23(2,3)29-22-13-17(7-10-21(22)26)11-12-24(4,5)25-15-18-8-9-20(30(6,27)28)14-19(18)16-25/h7-10,13-14,26H,11-12,15-16H2,1-6H3	ISQAPFMBJFZOLG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001393	ZLN005	C17H18N2	2.8881	899323		CC(C)(C)c1ccc(-c2nc3ccccc3[nH]2)cc1	InChI=1S/C17H18N2/c1-17(2,3)13-10-8-12(9-11-13)16-18-14-6-4-5-7-15(14)19-16/h4-11H,1-3H3,(H,18,19)	LQUNNCQSFFKSSK-UHFFFAOYSA-N					doublet; compound annotation
0391_001394	186953-56-0	C20H20N4O3	3.0066	459963		CON=C(N)c1ccc(-c2ccc(-c3ccc(C(N)=NOC)cc3)o2)cc1	InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)	UKOQVLAXCBRRGH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001396	AZD-0364	C24H24F2N8O2	3.3034	129116690	CC1=CN=C(N=C1C2=CN3C[C@@H](N(C(=O)C3=N2)CC4=CC(=C(C=C4)F)F)COC)NC5=CC=NN5C	COCC1Cn2cc(-c3nc(Nc4ccnn4C)ncc3C)nc2C(=O)N1Cc1cc(F)c(F)cc1	InChI=1S/C24H24F2N8O2/c1-14-9-27-24(30-20-6-7-28-32(20)2)31-21(14)19-12-33-11-16(13-36-3)34(23(35)22(33)29-19)10-15-4-5-17(25)18(26)8-15/h4-9,12,16H,10-11,13H2,1-3H3,(H,27,30,31)/t16-/m1/s1	HVIGNZUDBVLTLU-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_001398	Siremadlin	C26H24Cl2N6O4	4.0296	71678098	CC(C)N1C2=C(C(=O)N([C@H]2C3=CC=C(C=C3)Cl)C4=CC(=CN(C4=O)C)Cl)N=C1C5=CN=C(N=C5OC)OC	COc1ncc(-c2nc3c(C(c4ccc(Cl)cc4)N(c4cc(Cl)cn(C)c4=O)C3=O)n2C(C)C)c(OC)n1	InChI=1S/C26H24Cl2N6O4/c1-13(2)33-21-19(30-22(33)17-11-29-26(38-5)31-23(17)37-4)25(36)34(18-10-16(28)12-32(3)24(18)35)20(21)14-6-8-15(27)9-7-14/h6-13,20H,1-5H3/t20-/m0/s1	AGBSXNCBIWWLHD-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_001400	TRIAMCINOLONE HEXACETONIDE	C30H41FO7	5.2788	21826	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)COC(=O)CC(C)(C)C)CCC5=CC(=O)C=C[C@@]53C)F)O	CC(C)(C)CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C	InChI=1S/C30H41FO7/c1-25(2,3)15-24(35)36-16-22(34)30-23(37-26(4,5)38-30)13-20-19-9-8-17-12-18(32)10-11-27(17,6)29(19,31)21(33)14-28(20,30)7/h10-12,19-21,23,33H,8-9,13-16H2,1-7H3/t19-,20-,21-,23+,27-,28-,29-,30+/m0/s1	TZIZWYVVGLXXFV-FLRHRWPCSA-N					doublet; compound annotation
0391_001401	TRIAMCINOLONE HEXACETONIDE	C30H41FO7	5.2816	21826	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)COC(=O)CC(C)(C)C)CCC5=CC(=O)C=C[C@@]53C)F)O	CC(C)(C)CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C	InChI=1S/C30H41FO7/c1-25(2,3)15-24(35)36-16-22(34)30-23(37-26(4,5)38-30)13-20-19-9-8-17-12-18(32)10-11-27(17,6)29(19,31)21(33)14-28(20,30)7/h10-12,19-21,23,33H,8-9,13-16H2,1-7H3/t19-,20-,21-,23+,27-,28-,29-,30+/m0/s1	TZIZWYVVGLXXFV-FLRHRWPCSA-N					doublet; compound annotation
0391_001402	ZLN005	C17H18N2	7.0541	899323		CC(C)(C)c1ccc(-c2nc3ccccc3[nH]2)cc1	InChI=1S/C17H18N2/c1-17(2,3)13-10-8-12(9-11-13)16-18-14-6-4-5-7-15(14)19-16/h4-11H,1-3H3,(H,18,19)	LQUNNCQSFFKSSK-UHFFFAOYSA-N					doublet; compound annotation
0391_001403	Thiochrome	C12H14N4OS	0.4954	66706		CC1=C(CCO)SC2=Nc3nc(C)ncc3CN21	InChI=1S/C12H14N4OS/c1-7-10(3-4-17)18-12-15-11-9(6-16(7)12)5-13-8(2)14-11/h5,17H,3-4,6H2,1-2H3	GTQXMAIXVFLYKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001405	hycanthone	C20H24N2O2S	2.4439	3634		CCN(CC)CCNc1c2c(=O)c3ccccc3sc2c(CO)cc1	InChI=1S/C20H24N2O2S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20/h5-10,21,23H,3-4,11-13H2,1-2H3	MFZWMTSUNYWVBU-UHFFFAOYSA-N					compound annotation
0391_001406	Z-Gly-Gly-Arg-AMC	C28H33N7O7	2.5124	21155421	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)CNC(=O)OCC3=CC=CC=C3	Cc1cc(=O)oc2c1ccc(NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)CNC(=O)OCc1ccccc1)c2	InChI=1S/C28H33N7O7/c1-17-12-25(38)42-22-13-19(9-10-20(17)22)34-26(39)21(8-5-11-31-27(29)30)35-24(37)15-32-23(36)14-33-28(40)41-16-18-6-3-2-4-7-18/h2-4,6-7,9-10,12-13,21H,5,8,11,14-16H2,1H3,(H,32,36)(H,33,40)(H,34,39)(H,35,37)(H4,29,30,31)/t21-/m0/s1	SXTGIAYWYXVNLT-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_001408	HYDROXYHEXAMIDE	C15H22N2O4S	3.0484	18497		CC(O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	InChI=1S/C15H22N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-11,13,18H,2-6H2,1H3,(H2,16,17,19)	VQDAEOYLIBGCHE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001410	Bimatoprost	C25H37NO4	3.174	5311027	CCNC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](CCC2=CC=CC=C2)O)O)O	CCNC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(O)CCc1ccccc1	InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1	AQOKCDNYWBIDND-FTOWTWDKSA-N					removed another duplicate entry; compound annotation
0391_001412	SRT2183	C27H24N4O2S	3.474	24180126	C1CN(C[C@@H]1O)CC2=CSC3=NC(=CN23)C4=CC=CC=C4NC(=O)C5=CC6=CC=CC=C6C=C5	O=C(Nc1ccccc1-c1cn2c(CN3CCC(O)C3)csc2n1)c1cc2ccccc2cc1	InChI=1S/C27H24N4O2S/c32-22-11-12-30(15-22)14-21-17-34-27-29-25(16-31(21)27)23-7-3-4-8-24(23)28-26(33)20-10-9-18-5-1-2-6-19(18)13-20/h1-10,13,16-17,22,32H,11-12,14-15H2,(H,28,33)/t22-/m1/s1	MUFSINOSQBMSLE-JOCHJYFZSA-N					removed another duplicate entry; compound annotation
0391_001414	INDIRUBIN-3'-MONOXIME	C16H11N3O2	3.5387	3707		O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12	InChI=1S/C16H11N3O2/c20-16-13(9-5-1-3-7-11(9)18-16)15-14(19-21)10-6-2-4-8-12(10)17-15/h1-8,17-18,20H	FQCPPVRJPILDIK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001416	Atractylenolide II	C15H20O2	4.6031	14448070	CC1=C2C[C@H]3C(=C)CCC[C@@]3(C[C@@H]2OC1=O)C	C=C1CCCC2(C)CC3OC(=O)C(C)=C3CC12	InChI=1S/C15H20O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h12-13H,1,4-8H2,2-3H3/t12-,13-,15+/m0/s1	OQYBLUDOOFOBPO-KCQAQPDRSA-N					compound annotation
0391_001417	LJI308	C21H18F2N2O2	1.2956	118704762		Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F	InChI=1S/C21H18F2N2O2/c22-19-11-15(12-20(23)21(19)26)18-13-24-6-5-17(18)14-1-3-16(4-2-14)25-7-9-27-10-8-25/h1-6,11-13,26H,7-10H2	YUYJEQHNWKQNBT-UHFFFAOYSA-N					doublet; compound annotation
0391_001418	2-BENZOXAZOLINONE	C7H5NO2	1.8307	6043		O=c1[nH]c2ccccc2o1	InChI=1S/C7H5NO2/c9-7-8-5-3-1-2-4-6(5)10-7/h1-4H,(H,8,9)	ASSKVPFEZFQQNQ-UHFFFAOYSA-N					compound annotation
0391_001419	878663-43-5	C38H63N9O9	2.0305	91379699	CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)C	CCC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(NC(C)=O)C(C)C)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCCN)C(N)=O)C(C)C	InChI=1S/C38H63N9O9/c1-8-22(6)32(47-34(52)27(16-17-29(40)50)44-36(54)30(20(2)3)42-23(7)48)38(56)46-31(21(4)5)37(55)45-28(19-24-12-14-25(49)15-13-24)35(53)43-26(33(41)51)11-9-10-18-39/h12-15,20-22,26-28,30-32,49H,8-11,16-19,39H2,1-7H3,(H2,40,50)(H2,41,51)(H,42,48)(H,43,53)(H,44,54)(H,45,55)(H,46,56)(H,47,52)/t22-,26-,27-,28-,30-,31-,32-/m0/s1	MJXAAZHAGTZEDV-RULZGXMMSA-N					doublet; compound annotation
0391_001420	878663-43-5	C38H63N9O9	2.0332	91379699	CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)C	CCC(C)C(NC(=O)C(CCC(N)=O)NC(=O)C(NC(C)=O)C(C)C)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCCN)C(N)=O)C(C)C	InChI=1S/C38H63N9O9/c1-8-22(6)32(47-34(52)27(16-17-29(40)50)44-36(54)30(20(2)3)42-23(7)48)38(56)46-31(21(4)5)37(55)45-28(19-24-12-14-25(49)15-13-24)35(53)43-26(33(41)51)11-9-10-18-39/h12-15,20-22,26-28,30-32,49H,8-11,16-19,39H2,1-7H3,(H2,40,50)(H2,41,51)(H,42,48)(H,43,53)(H,44,54)(H,45,55)(H,46,56)(H,47,52)/t22-,26-,27-,28-,30-,31-,32-/m0/s1	MJXAAZHAGTZEDV-RULZGXMMSA-N					doublet; compound annotation
0391_001421	Lanreotide	C54H69N11O10S2	2.3105	6918011	C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O	CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2cc3ccccc3cc2)CSSCC(C(=O)NC(C(N)=O)C(C)O)NC1=O	InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)/t30-,38-,40+,41+,42-,43+,44+,45+,46+/m1/s1	PUDHBTGHUJUUFI-SCTWWAJVSA-N					compound annotation
0391_001422	ML167	C19H17N3O3	2.359	44968231		Cc1ccc(CNc2ncnc3c2cc(-c2ccc(CO)o2)cc3)o1	InChI=1S/C19H17N3O3/c1-12-2-4-14(24-12)9-20-19-16-8-13(3-6-17(16)21-11-22-19)18-7-5-15(10-23)25-18/h2-8,11,23H,9-10H2,1H3,(H,20,21,22)	ROCFOIBAEVAOLQ-UHFFFAOYSA-N					compound annotation
0391_001423	LJI308	C21H18F2N2O2	2.4044	118704762		Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F	InChI=1S/C21H18F2N2O2/c22-19-11-15(12-20(23)21(19)26)18-13-24-6-5-17(18)14-1-3-16(4-2-14)25-7-9-27-10-8-25/h1-6,11-13,26H,7-10H2	YUYJEQHNWKQNBT-UHFFFAOYSA-N					doublet; compound annotation
0391_001424	LJI308	C21H18F2N2O2	2.4071	118704762		Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F	InChI=1S/C21H18F2N2O2/c22-19-11-15(12-20(23)21(19)26)18-13-24-6-5-17(18)14-1-3-16(4-2-14)25-7-9-27-10-8-25/h1-6,11-13,26H,7-10H2	YUYJEQHNWKQNBT-UHFFFAOYSA-N					doublet; compound annotation
0391_001425	Arctiin	C27H34O11	2.5768	100528	COC1=C(C=C(C=C1)C[C@H]2COC(=O)[C@@H]2CC3=CC(=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC)OC	COc1c(OC)cc(CC2COC(=O)C2Cc2cc(OC)c(OC3OC(CO)C(O)C(O)C3O)cc2)cc1	InChI=1S/C27H34O11/c1-33-18-6-4-14(10-20(18)34-2)8-16-13-36-26(32)17(16)9-15-5-7-19(21(11-15)35-3)37-27-25(31)24(30)23(29)22(12-28)38-27/h4-7,10-11,16-17,22-25,27-31H,8-9,12-13H2,1-3H3/t16-,17+,22+,23+,24-,25+,27+/m0/s1	XOJVHLIYNSOZOO-SWOBOCGESA-N					compound annotation
0391_001426	LJI308	C21H18F2N2O2	2.9567	118704762		Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F	InChI=1S/C21H18F2N2O2/c22-19-11-15(12-20(23)21(19)26)18-13-24-6-5-17(18)14-1-3-16(4-2-14)25-7-9-27-10-8-25/h1-6,11-13,26H,7-10H2	YUYJEQHNWKQNBT-UHFFFAOYSA-N					doublet; compound annotation
0391_001427	MSC2530818	C18H17ClN4O	3.2063	118879529	CC1=C2C=C(C=NC2=NN1)C(=O)N3CCC[C@H]3C4=CC=C(C=C4)Cl	Cc1c2cc(C(=O)N3CCCC3c3ccc(Cl)cc3)cnc2n[nH]1	InChI=1S/C18H17ClN4O/c1-11-15-9-13(10-20-17(15)22-21-11)18(24)23-8-2-3-16(23)12-4-6-14(19)7-5-12/h4-7,9-10,16H,2-3,8H2,1H3,(H,20,21,22)/t16-/m0/s1	ODRITQGYYWHQGM-INIZCTEOSA-N					doublet; compound annotation
0391_001428	FIIN-3	C34H36Cl2N8O4	3.2406	73707531		C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2ncnc(Nc3ccc(N4CCN(C)CC4)cc3)c2)cc1	InChI=1S/C34H36Cl2N8O4/c1-5-30(45)40-24-8-6-22(7-9-24)20-44(34(46)41-33-31(35)26(47-3)18-27(48-4)32(33)36)29-19-28(37-21-38-29)39-23-10-12-25(13-11-23)43-16-14-42(2)15-17-43/h5-13,18-19,21H,1,14-17,20H2,2-4H3,(H,40,45)(H,41,46)(H,37,38,39)	SFLKJNSBBVSPFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001430	MSC2530818	C18H17ClN4O	3.3575	118879529	CC1=C2C=C(C=NC2=NN1)C(=O)N3CCC[C@H]3C4=CC=C(C=C4)Cl	Cc1c2cc(C(=O)N3CCCC3c3ccc(Cl)cc3)cnc2n[nH]1	InChI=1S/C18H17ClN4O/c1-11-15-9-13(10-20-17(15)22-21-11)18(24)23-8-2-3-16(23)12-4-6-14(19)7-5-12/h4-7,9-10,16H,2-3,8H2,1H3,(H,20,21,22)/t16-/m0/s1	ODRITQGYYWHQGM-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_001432	1028327-66-3	C15H19N5	0.4703	25129523		CN1CCN(c2nc(N)nc(-c3ccccc3)c2)CC1	InChI=1S/C15H19N5/c1-19-7-9-20(10-8-19)14-11-13(17-15(16)18-14)12-5-3-2-4-6-12/h2-6,11H,7-10H2,1H3,(H2,16,17,18)	NIJGWJIOMPHDBP-UHFFFAOYSA-N					compound annotation
0391_001433	EPZ004777	C28H41N7O4	1.8137	56962336	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2ccc3c(N)ncnc32)C(O)C1O	InChI=1S/C28H41N7O4/c1-17(2)34(13-6-12-30-27(38)33-19-9-7-18(8-10-19)28(3,4)5)15-21-22(36)23(37)26(39-21)35-14-11-20-24(29)31-16-32-25(20)35/h7-11,14,16-17,21-23,26,36-37H,6,12-13,15H2,1-5H3,(H2,29,31,32)(H2,30,33,38)/t21-,22-,23-,26-/m1/s1	WXRGFPHDRFQODR-ICLZECGLSA-N					doublet; compound annotation
0391_001434	EPZ004777	C28H41N7O4	2.259	56962336	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2ccc3c(N)ncnc32)C(O)C1O	InChI=1S/C28H41N7O4/c1-17(2)34(13-6-12-30-27(38)33-19-9-7-18(8-10-19)28(3,4)5)15-21-22(36)23(37)26(39-21)35-14-11-20-24(29)31-16-32-25(20)35/h7-11,14,16-17,21-23,26,36-37H,6,12-13,15H2,1-5H3,(H2,29,31,32)(H2,30,33,38)/t21-,22-,23-,26-/m1/s1	WXRGFPHDRFQODR-ICLZECGLSA-N					doublet; removed another duplicate entry; compound annotation
0391_001436	Cgp 52432	C15H24Cl2NO4P	2.4395	132252		CCOC(OCC)P(=O)(O)CCCNCc1cc(Cl)c(Cl)cc1	InChI=1S/C15H24Cl2NO4P/c1-3-21-15(22-4-2)23(19,20)9-5-8-18-11-12-6-7-13(16)14(17)10-12/h6-7,10,15,18H,3-5,8-9,11H2,1-2H3,(H,19,20)	GJZVQXWEIYRHBE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001438	77307-50-7	C25H24O12	3.2029	10459196	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C	CC(=O)OC1C(C)OC(Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C(O)C1OC(C)=O	InChI=1S/C25H24O12/c1-10-21(34-11(2)26)24(35-12(3)27)20(32)25(33-10)37-23-19(31)18-16(30)8-15(29)9-17(18)36-22(23)13-4-6-14(28)7-5-13/h4-10,20-21,24-25,28-30,32H,1-3H3/t10-,20+,21-,24-,25-/m0/s1	SXOZSDJHGMAEGZ-IGKKHSBFSA-N					doublet; removed another duplicate entry; compound annotation
0391_001440	77307-50-7	C25H24O12	3.327	10459196	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C	CC(=O)OC1C(C)OC(Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)C(O)C1OC(C)=O	InChI=1S/C25H24O12/c1-10-21(34-11(2)26)24(35-12(3)27)20(32)25(33-10)37-23-19(31)18-16(30)8-15(29)9-17(18)36-22(23)13-4-6-14(28)7-5-13/h4-10,20-21,24-25,28-30,32H,1-3H3/t10-,20+,21-,24-,25-/m0/s1	SXOZSDJHGMAEGZ-IGKKHSBFSA-N					doublet; removed another duplicate entry; compound annotation
0391_001442	Cgs 15943	C13H8ClN5O	3.6121	2690		Nc1nc2c(cc(Cl)cc2)c2nc(-c3ccco3)nn12	InChI=1S/C13H8ClN5O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,(H2,15,16)	MSJODEOZODDVGW-UHFFFAOYSA-N					compound annotation
0391_001443	477775-14-7	C23H29N3O4S2	3.8634	9804984		CCCCOC(=O)NS(=O)(=O)c1c(-c2ccc(Cn3ccnc3)cc2)cc(CC(C)C)s1	InChI=1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27)	XTEOJPUYZWEXFI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001445	HSF1A	C21H19N3O2S2	4.8953	44472508		CCc1ccc(S(=O)(=O)Nc2cc(-c3cccs3)nn2-c2ccccc2)cc1	InChI=1S/C21H19N3O2S2/c1-2-16-10-12-18(13-11-16)28(25,26)23-21-15-19(20-9-6-14-27-20)22-24(21)17-7-4-3-5-8-17/h3-15,23H,2H2,1H3	KJTITGSAONQVPY-UHFFFAOYSA-N					doublet; compound annotation
0391_001446	HSF1A	C21H19N3O2S2	4.9616	44472508		CCc1ccc(S(=O)(=O)Nc2cc(-c3cccs3)nn2-c2ccccc2)cc1	InChI=1S/C21H19N3O2S2/c1-2-16-10-12-18(13-11-16)28(25,26)23-21-15-19(20-9-6-14-27-20)22-24(21)17-7-4-3-5-8-17/h3-15,23H,2H2,1H3	KJTITGSAONQVPY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001448	892711-75-0	C20H20N2O2	5.4573	16016585		Cc1nc2c(cccc2NC(=O)c2ccc(OC(C)C)cc2)cc1	InChI=1S/C20H20N2O2/c1-13(2)24-17-11-9-16(10-12-17)20(23)22-18-6-4-5-15-8-7-14(3)21-19(15)18/h4-13H,1-3H3,(H,22,23)	GVGVYDCVFBGALZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001450	892711-75-0	C20H20N2O2	5.6107	16016585		Cc1nc2c(cccc2NC(=O)c2ccc(OC(C)C)cc2)cc1	InChI=1S/C20H20N2O2/c1-13(2)24-17-11-9-16(10-12-17)20(23)22-18-6-4-5-15-8-7-14(3)21-19(15)18/h4-13H,1-3H3,(H,22,23)	GVGVYDCVFBGALZ-UHFFFAOYSA-N					doublet; compound annotation
0391_001451	Benzoyleneurea	C8H6N2O2	1.2367	64048		O=c1[nH]c(=O)c2ccccc2[nH]1	InChI=1S/C8H6N2O2/c11-7-5-3-1-2-4-6(5)9-8(12)10-7/h1-4H,(H2,9,10,11,12)	SDQJTWBNWQABLE-UHFFFAOYSA-N					compound annotation
0391_001452	Desvenlafaxine	C16H25NO2	1.6765	125017		CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3	KYYIDSXMWOZKMP-UHFFFAOYSA-N					doublet; compound annotation
0391_001453	29741-09-1	C21H18O11	2.125	5319484	C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O	O=C(O)C1OC(Oc2cc(O)c3c(=O)cc(-c4ccc(O)cc4)oc3c2)C(O)C(O)C1O	InChI=1S/C21H18O11/c22-9-3-1-8(2-4-9)13-7-12(24)15-11(23)5-10(6-14(15)31-13)30-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21-23,25-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1	JBFOLLJCGUCDQP-ZFORQUDYSA-N					compound annotation
0391_001454	AB928	C23H22N8O	3.2024	135242184		Cc1c(C#N)cccc1-c1cc(-c2cn(Cc3nc(C(C)(C)O)ccc3)nn2)nc(N)n1	InChI=1S/C23H22N8O/c1-14-15(11-24)6-4-8-17(14)18-10-19(28-22(25)27-18)20-13-31(30-29-20)12-16-7-5-9-21(26-16)23(2,3)32/h4-10,13,32H,12H2,1-3H3,(H2,25,27,28)	BUXIAWLTBSXYSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001456	Glycoursodeoxycholic acid	C26H43NO5	3.3566	12310288	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21+,24+,25+,26-/m1/s1	GHCZAUBVMUEKKP-XROMFQGDSA-N					removed another duplicate entry; compound annotation
0391_001458	1429617-90-2	C30H29F3N6O	3.7784	71550931		CCc1c(C#Cc2cn3nccc3nc2)cc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1	InChI=1S/C30H29F3N6O/c1-3-23-6-7-25(16-24(23)5-4-21-18-34-28-8-9-35-39(28)20-21)29(40)36-27-15-22(14-26(17-27)30(31,32)33)19-38-12-10-37(2)11-13-38/h6-9,14-18,20H,3,10-13,19H2,1-2H3,(H,36,40)	DDLPXZXBWGJRGK-UHFFFAOYSA-N					compound annotation
0391_001459	CP-809101	C15H17ClN4O	2.6911	9901086		Clc1cccc(COc2nc(N3CCNCC3)cnc2)c1	InChI=1S/C15H17ClN4O/c16-13-3-1-2-12(8-13)11-21-15-10-18-9-14(19-15)20-6-4-17-5-7-20/h1-3,8-10,17H,4-7,11H2	PCWGGOVOEWHPMG-UHFFFAOYSA-N					compound annotation
0391_001460	mifepristone	C29H35NO2	2.7741	55245	CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	VKHAHZOOUSRJNA-GCNJZUOMSA-N					doublet; compound annotation
0391_001461	824983-91-7	C15H12N2O5S	2.8881	11652865		O=c1c2c(ccs2)n(CC2COc3ccccc3O2)c(=O)n1O	InChI=1S/C15H12N2O5S/c18-14-13-10(5-6-23-13)16(15(19)17(14)20)7-9-8-21-11-3-1-2-4-12(11)22-9/h1-6,9,20H,7-8H2	MXQGCMQXTPTJJT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001463	mifepristone	C29H35NO2	3.0683	55245	CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	VKHAHZOOUSRJNA-GCNJZUOMSA-N					doublet; compound annotation
0391_001464	mifepristone	C29H35NO2	3.071	55245	CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1	VKHAHZOOUSRJNA-GCNJZUOMSA-N					doublet; removed another duplicate entry; compound annotation
0391_001466	1-(pyridin-3-yl)pyrrolidin-3-amine	C9H13N3	3.2627	17928441		NC1CCN(c2cnccc2)C1	InChI=1S/C9H13N3/c10-8-3-5-12(7-8)9-2-1-4-11-6-9/h1-2,4,6,8H,3,5,7,10H2	LVGMMVAWLISWJD-UHFFFAOYSA-N					compound annotation
0391_001467	SB 242084	C21H19ClN4O2	3.5804	3644637		Cc1cc2c(cc1Cl)N(C(=O)Nc1cnc(Oc3c(C)nccc3)cc1)CC2	InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27)	GIUZEIJUFOPTMR-UHFFFAOYSA-N					doublet; compound annotation
0391_001468	G007-LK	C25H16ClN7O3S	3.6185	67960134	CS(=O)(=O)C1=CN=C(C=C1)C2=NN=C(N2C3=CC=CC=C3Cl)/C=C/C4=NN=C(O4)C5=CC=C(C=C5)C#N	CS(=O)(=O)c1cnc(-c2nnc(C=Cc3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)cc1	InChI=1S/C25H16ClN7O3S/c1-37(34,35)18-10-11-20(28-15-18)24-31-29-22(33(24)21-5-3-2-4-19(21)26)12-13-23-30-32-25(36-23)17-8-6-16(14-27)7-9-17/h2-13,15H,1H3/b13-12+	HIWVLHPKZNBSBE-OUKQBFOZSA-N					doublet; compound annotation
0391_001469	Elagolix	C32H30F5N3O5	3.6644	11250647	CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F	COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(CC(NCCCC(=O)O)c3ccccc3)c2=O)c1F	InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1	HEAUOKZIVMZVQL-VWLOTQADSA-N					doublet; removed another duplicate entry; compound annotation
0391_001471	SB 242084	C21H19ClN4O2	3.8323	3644637		Cc1cc2c(cc1Cl)N(C(=O)Nc1cnc(Oc3c(C)nccc3)cc1)CC2	InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27)	GIUZEIJUFOPTMR-UHFFFAOYSA-N					doublet; compound annotation
0391_001472	G007-LK	C25H16ClN7O3S	3.8379	67960134	CS(=O)(=O)C1=CN=C(C=C1)C2=NN=C(N2C3=CC=CC=C3Cl)/C=C/C4=NN=C(O4)C5=CC=C(C=C5)C#N	CS(=O)(=O)c1cnc(-c2nnc(C=Cc3nnc(-c4ccc(C#N)cc4)o3)n2-c2ccccc2Cl)cc1	InChI=1S/C25H16ClN7O3S/c1-37(34,35)18-10-11-20(28-15-18)24-31-29-22(33(24)21-5-3-2-4-19(21)26)12-13-23-30-32-25(36-23)17-8-6-16(14-27)7-9-17/h2-13,15H,1H3/b13-12+	HIWVLHPKZNBSBE-OUKQBFOZSA-N					doublet; removed another duplicate entry; compound annotation
0391_001474	Protein kinase inhibitors 1	C18H17N5O3S	1.2155	132274054	C1CN(CCN1)C2=NC=C(C=C2)C3=CC(=CNC3=O)/C=C/4\C(=O)NC(=O)S4	O=C1NC(=O)C(=Cc2c[nH]c(=O)c(-c3cnc(N4CCNCC4)cc3)c2)S1	InChI=1S/C18H17N5O3S/c24-16-13(7-11(9-21-16)8-14-17(25)22-18(26)27-14)12-1-2-15(20-10-12)23-5-3-19-4-6-23/h1-2,7-10,19H,3-6H2,(H,21,24)(H,22,25,26)/b14-8+	YHUKWWWCNSTFHL-RIYZIHGNSA-N					doublet; compound annotation
0391_001475	Protein kinase inhibitors 1	C18H17N5O3S	1.3136	132274054	C1CN(CCN1)C2=NC=C(C=C2)C3=CC(=CNC3=O)/C=C/4\C(=O)NC(=O)S4	O=C1NC(=O)C(=Cc2c[nH]c(=O)c(-c3cnc(N4CCNCC4)cc3)c2)S1	InChI=1S/C18H17N5O3S/c24-16-13(7-11(9-21-16)8-14-17(25)22-18(26)27-14)12-1-2-15(20-10-12)23-5-3-19-4-6-23/h1-2,7-10,19H,3-6H2,(H,21,24)(H,22,25,26)/b14-8+	YHUKWWWCNSTFHL-RIYZIHGNSA-N					doublet; compound annotation
0391_001476	Liensinine	C37H42N2O6	1.6361	160644	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)O)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC	COc1c(OC)cc2c(c1)CCN(C)C2Cc1cc(Oc2c(OC)cc3CCN(C)C(Cc4ccc(O)cc4)c3c2)c(O)cc1	InChI=1S/C37H42N2O6/c1-38-14-13-26-20-35(43-4)37(22-29(26)30(38)16-23-6-9-27(40)10-7-23)45-33-18-24(8-11-32(33)41)17-31-28-21-36(44-5)34(42-3)19-25(28)12-15-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	XCUCMLUTCAKSOZ-FIRIVFDPSA-N					doublet; compound annotation
0391_001477	BRD 4354	C21H23ClN4O	1.8136	3516032		CCN1CCN(C(c2cnccc2)c2cc(Cl)c3cccnc3c2O)CC1	InChI=1S/C21H23ClN4O/c1-2-25-9-11-26(12-10-25)20(15-5-3-7-23-14-15)17-13-18(22)16-6-4-8-24-19(16)21(17)27/h3-8,13-14,20,27H,2,9-12H2,1H3	XAFSFXYJOJWLJD-UHFFFAOYSA-N					compound annotation
0391_001478	CTX1	C14H10N4	1.9545	435038		N#Cc1c2ccc(N)cc2nc2c1ccc(N)c2	InChI=1S/C14H10N4/c15-7-12-10-3-1-8(16)5-13(10)18-14-6-9(17)2-4-11(12)14/h1-6H,16-17H2	PUMGFEMNXBLDKD-UHFFFAOYSA-N					compound annotation
0391_001479	Complanatuside	C28H32O16	2.2536	5492406	COC1=CC(=C2C(=C1)OC(=C(C2=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O	COc1cc(O)c2c(=O)c(OC3OC(CO)C(O)C(O)C3O)c(-c3ccc(OC4OC(CO)C(O)C(O)C4O)cc3)oc2c1	InChI=1S/C28H32O16/c1-39-12-6-13(31)17-14(7-12)41-25(26(20(17)34)44-28-24(38)22(36)19(33)16(9-30)43-28)10-2-4-11(5-3-10)40-27-23(37)21(35)18(32)15(8-29)42-27/h2-7,15-16,18-19,21-24,27-33,35-38H,8-9H2,1H3/t15-,16-,18-,19-,21+,22+,23-,24-,27-,28+/m1/s1	KKPKUPKKMALLKG-QDYVESOYSA-N					removed another duplicate entry; compound annotation
0391_001481	9-Methoxycanthin-6-one	C15H10N2O2	2.9822	9881423		COc1cc2c(cc1)c1c3c(ncc1)ccc(=O)n23	InChI=1S/C15H10N2O2/c1-19-9-2-3-10-11-6-7-16-12-4-5-14(18)17(15(11)12)13(10)8-9/h2-8H,1H3	OWCRARVHWCCRAG-UHFFFAOYSA-N					compound annotation
0391_001482	TC13172	C17H16N4O5S	3.0832	134691750		Cn1c(=O)c2c(nc(S(C)(=O)=O)n2C)n(CC#Cc2cc(O)ccc2)c1=O	InChI=1S/C17H16N4O5S/c1-19-13-14(18-16(19)27(3,25)26)21(17(24)20(2)15(13)23)9-5-7-11-6-4-8-12(22)10-11/h4,6,8,10,22H,9H2,1-3H3	ZTQLCNOQWGSELY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001484	1181083-81-7	C19H21FN4O3S	3.6442	44188755	C1CCN(NC1)C2=NC(=O)/C(=C/C3=C(C=C(C=C3)F)OC(=O)N4CCCC4)/S2	O=C1N=C(N2CCCCN2)SC1=Cc1ccc(F)cc1OC(=O)N1CCCC1	InChI=1S/C19H21FN4O3S/c20-14-6-5-13(15(12-14)27-19(26)23-8-3-4-9-23)11-16-17(25)22-18(28-16)24-10-2-1-7-21-24/h5-6,11-12,21H,1-4,7-10H2/b16-11-	DIXMMXNNKLCLOM-WJDWOHSUSA-N					doublet; removed another duplicate entry; compound annotation
0391_001486	1181083-81-7	C19H21FN4O3S	3.8092	44188755	C1CCN(NC1)C2=NC(=O)/C(=C/C3=C(C=C(C=C3)F)OC(=O)N4CCCC4)/S2	O=C1N=C(N2CCCCN2)SC1=Cc1ccc(F)cc1OC(=O)N1CCCC1	InChI=1S/C19H21FN4O3S/c20-14-6-5-13(15(12-14)27-19(26)23-8-3-4-9-23)11-16-17(25)22-18(28-16)24-10-2-1-7-21-24/h5-6,11-12,21H,1-4,7-10H2/b16-11-	DIXMMXNNKLCLOM-WJDWOHSUSA-N					doublet; removed another duplicate entry; compound annotation
0391_001488	1892576-58-7	C26H26F3N5O2	3.894	118977746		CC(C)C(=O)N1CCC(c2cn(C)c3ncc(NC(=O)c4cccc(C#N)c4)c(C(F)(F)F)c23)CC1	InChI=1S/C26H26F3N5O2/c1-15(2)25(36)34-9-7-17(8-10-34)19-14-33(3)23-21(19)22(26(27,28)29)20(13-31-23)32-24(35)18-6-4-5-16(11-18)12-30/h4-6,11,13-15,17H,7-10H2,1-3H3,(H,32,35)	BIHPJIJLDNUDGH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001490	AZD5991	C35H34ClN5O3S2	5.2026	131634760		Cc1c2c(nn1C)CSCc1nn(C)c(c1)CSc1cc3ccccc3c(c1)OCCCc1c(C(=O)O)n(C)c3c1ccc(Cl)c-23	InChI=1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43)	KBQCEQAXHPIRTF-UHFFFAOYSA-N					doublet; compound annotation
0391_001491	AZD5991	C35H34ClN5O3S2	5.296	131634760		Cc1c2c(nn1C)CSCc1nn(C)c(c1)CSc1cc3ccccc3c(c1)OCCCc1c(C(=O)O)n(C)c3c1ccc(Cl)c-23	InChI=1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43)	KBQCEQAXHPIRTF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001493	Resminostat	C16H19N3O4S	1.571	11609955	CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)/C=C/C(=O)NO	CN(C)Cc1ccc(S(=O)(=O)n2ccc(C=CC(=O)NO)c2)cc1	InChI=1S/C16H19N3O4S/c1-18(2)11-13-3-6-15(7-4-13)24(22,23)19-10-9-14(12-19)5-8-16(20)17-21/h3-10,12,21H,11H2,1-2H3,(H,17,20)/b8-5+	FECGNJPYVFEKOD-VMPITWQZSA-N					removed another duplicate entry; compound annotation
0391_001495	Tabersonine	C21H24N2O2	2.6023	20485	CC[C@]12CC(=C3[C@@]4([C@H]1N(CC4)CC=C2)C5=CC=CC=C5N3)C(=O)OC	CCC12C=CCN3CCC4(C(=C(C(=O)OC)C1)Nc1ccccc14)C32	InChI=1S/C21H24N2O2/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2/h4-9,19,22H,3,10-13H2,1-2H3/t19-,20-,21-/m0/s1	FNGGIPWAZSFKCN-ACRUOGEOSA-N					compound annotation
0391_001496	6-Hydroxyflavone	C15H10O3	3.3295	72279		O=c1cc(-c2ccccc2)oc2c1cc(O)cc2	InChI=1S/C15H10O3/c16-11-6-7-14-12(8-11)13(17)9-15(18-14)10-4-2-1-3-5-10/h1-9,16H	GPZYYYGYCRFPBU-UHFFFAOYSA-N					compound annotation
0391_001497	Glycocholic acid	C26H43NO6	3.3673	10140	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1	RFDAIACWWDREDC-FRVQLJSFSA-N					removed another duplicate entry; compound annotation
0391_001499	ORM-10962	C27H29N3O4	3.4403	69016811		O=C(CN1CCC(O)CC1)Nc1cnc(Oc2cc3c(cc2)OC(c2ccccc2)CC3)cc1	InChI=1S/C27H29N3O4/c31-22-12-14-30(15-13-22)18-26(32)29-21-7-11-27(28-17-21)33-23-8-10-25-20(16-23)6-9-24(34-25)19-4-2-1-3-5-19/h1-5,7-8,10-11,16-17,22,24,31H,6,9,12-15,18H2,(H,29,32)	UPGUBLDTYLMRHO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001501	339068-25-6	C12H18N2O	3.6735	2727594		CCCCc1cc(C)c(N=CNO)cc1	InChI=1S/C12H18N2O/c1-3-4-5-11-6-7-12(10(2)8-11)13-9-14-15/h6-9,15H,3-5H2,1-2H3,(H,13,14)	LYNOGBKNFIHKLE-UHFFFAOYSA-N					doublet; compound annotation
0391_001502	ML355	C21H19N3O4S2	3.7498	70701426		COc1cccc(CNc2ccc(S(=O)(=O)Nc3nc4ccccc4s3)cc2)c1O	InChI=1S/C21H19N3O4S2/c1-28-18-7-4-5-14(20(18)25)13-22-15-9-11-16(12-10-15)30(26,27)24-21-23-17-6-2-3-8-19(17)29-21/h2-12,22,25H,13H2,1H3,(H,23,24)	OWHBVKBNNRYMIN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001504	339068-25-6	C12H18N2O	3.8044	2727594		CCCCc1cc(C)c(N=CNO)cc1	InChI=1S/C12H18N2O/c1-3-4-5-11-6-7-12(10(2)8-11)13-9-14-15/h6-9,15H,3-5H2,1-2H3,(H,13,14)	LYNOGBKNFIHKLE-UHFFFAOYSA-N					doublet; compound annotation
0391_001505	69227-93-6	C24H46O11	4.1482	114880	CCCCCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O	CCCCCCCCCCCCOC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O	InChI=1S/C24H46O11/c1-2-3-4-5-6-7-8-9-10-11-12-32-23-21(31)19(29)22(16(14-26)34-23)35-24-20(30)18(28)17(27)15(13-25)33-24/h15-31H,2-14H2,1H3/t15-,16-,17-,18+,19-,20-,21-,22-,23-,24-/m1/s1	NLEBIOOXCVAHBD-QKMCSOCLSA-N					doublet; compound annotation
0391_001506	69227-93-6	C24H46O11	4.2556	114880	CCCCCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O	CCCCCCCCCCCCOC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O	InChI=1S/C24H46O11/c1-2-3-4-5-6-7-8-9-10-11-12-32-23-21(31)19(29)22(16(14-26)34-23)35-24-20(30)18(28)17(27)15(13-25)33-24/h15-31H,2-14H2,1H3/t15-,16-,17-,18+,19-,20-,21-,22-,23-,24-/m1/s1	NLEBIOOXCVAHBD-QKMCSOCLSA-N					doublet; compound annotation
0391_001507	idebenone	C19H30O5	4.6249	3686		COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O	InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3	JGPMMRGNQUBGND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001509	EHP-101	C28H35NO3	6.8733	118465221	CCCCCC1=C(C(=C(C(=O)C1=O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O)NCC3=CC=CC=C3	C=C(C)C1CCC(C)=CC1C1=C(O)C(NCc2ccccc2)=C(CCCCC)C(=O)C1=O	InChI=1S/C28H35NO3/c1-5-6-8-13-22-25(29-17-20-11-9-7-10-12-20)27(31)24(28(32)26(22)30)23-16-19(4)14-15-21(23)18(2)3/h7,9-12,16,21,23,29,31H,2,5-6,8,13-15,17H2,1,3-4H3/t21-,23+/m0/s1	CGGGAXJIRQSRPH-JTHBVZDNSA-N					compound annotation
0391_001510	398473-34-2	C20H32N2O	0.917	2766326		c1c(CN2CCCCC2)ccc(OCCCN2CCCCC2)c1	InChI=1S/C20H32N2O/c1-3-12-21(13-4-1)16-7-17-23-20-10-8-19(9-11-20)18-22-14-5-2-6-15-22/h8-11H,1-7,12-18H2	PTKHFRNHJULJKT-UHFFFAOYSA-N					compound annotation
0391_001511	PI-3065	C27H31FN6OS	2.0325	24937012		Fc1c(-c2nc3c(sc(CN4CCN(CC5CC5)CC4)c3)c(N3CCOCC3)n2)c2c(cc1)[nH]cc2	InChI=1S/C27H31FN6OS/c28-21-3-4-22-20(5-6-29-22)24(21)26-30-23-15-19(17-33-9-7-32(8-10-33)16-18-1-2-18)36-25(23)27(31-26)34-11-13-35-14-12-34/h3-6,15,18,29H,1-2,7-14,16-17H2	YDNOHCOYQVZOMC-UHFFFAOYSA-N					compound annotation
0391_001512	GNE-9605	C17H20ClF4N7O	2.1739	76328936	CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4)Cl	CNc1nc(Nc2c(Cl)n(C3CCN(C4COC4)CC3F)nc2)ncc1C(F)(F)F	InChI=1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1	PUXPEQJKNAWNQA-AAEUAGOBSA-N					doublet; compound annotation
0391_001513	s130	C24H25N3O2	2.2141	44128205		CCN(CC)CCCNC(=O)c1cnc2C(=O)c3ccccc3-c3c2c1ccc3	InChI=1S/C24H25N3O2/c1-3-27(4-2)14-8-13-25-24(29)20-15-26-22-21-17(11-7-12-18(20)21)16-9-5-6-10-19(16)23(22)28/h5-7,9-12,15H,3-4,8,13-14H2,1-2H3,(H,25,29)	DZUCZYXRADUTMW-UHFFFAOYSA-N					compound annotation
0391_001514	MPEP	C14H11N	3.0858	3025961		Cc1nc(C#Cc2ccccc2)ccc1	InChI=1S/C14H11N/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13/h2-9H,1H3	NEWKHUASLBMWRE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001516	GNE-9605	C17H20ClF4N7O	3.6465	76328936	CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4)Cl	CNc1nc(Nc2c(Cl)n(C3CCN(C4COC4)CC3F)nc2)ncc1C(F)(F)F	InChI=1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1	PUXPEQJKNAWNQA-AAEUAGOBSA-N					doublet; compound annotation
0391_001517	mTOR inhibitor-1	C16H15BrN2O3	3.8318	135418721	CC1=C(C=C(C=C1)C(=O)N/N=C(\C)/C2=C(C=C(C=C2)O)O)Br	CC(=NNC(=O)c1cc(Br)c(C)cc1)c1c(O)cc(O)cc1	InChI=1S/C16H15BrN2O3/c1-9-3-4-11(7-14(9)17)16(22)19-18-10(2)13-6-5-12(20)8-15(13)21/h3-8,20-21H,1-2H3,(H,19,22)/b18-10+	NKMSVTGHOVMMHV-VCHYOVAHSA-N					compound annotation
0391_001518	GNE-9605	C17H20ClF4N7O	4.6643	76328936	CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)[C@H]3CCN(C[C@@H]3F)C4COC4)Cl	CNc1nc(Nc2c(Cl)n(C3CCN(C4COC4)CC3F)nc2)ncc1C(F)(F)F	InChI=1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1	PUXPEQJKNAWNQA-AAEUAGOBSA-N					doublet; compound annotation
0391_001519	3-Mercaptopicolinic acid	C6H5NO2S	1.8747	119070		O=C(O)c1c(S)cccn1	InChI=1S/C6H5NO2S/c8-6(9)5-4(10)2-1-3-7-5/h1-3,10H,(H,8,9)	ZYFDNIOIEFZULT-UHFFFAOYSA-N					compound annotation
0391_001520	Anamorelin	C31H42N6O3	1.968	9828911	CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@](C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N	CN(C)N(C)C(=O)C1(Cc2ccccc2)CCCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1	InChI=1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1	VQPFSIRUEPQQPP-MXBOTTGLSA-N					doublet; compound annotation
0391_001521	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	2.178	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001522	364042-47-7	C29H34N6O	2.1926	6539952		CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1	InChI=1S/C29H34N6O/c1-33-15-17-34(18-16-33)22-9-11-23(12-10-22)35-19-26(27-28(30)31-20-32-29(27)35)21-7-13-25(14-8-21)36-24-5-3-2-4-6-24/h2-8,13-14,19-20,22-23H,9-12,15-18H2,1H3,(H2,30,31,32)	FDVSOQRNTAPCHB-UHFFFAOYSA-N					compound annotation
0391_001523	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	2.3944	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001524	54827-17-7	C16H20N2	2.3944	41206		Cc1c(N)c(C)cc(-c2cc(C)c(N)c(C)c2)c1	InChI=1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3	UAIUNKRWKOVEES-UHFFFAOYSA-N					doublet; compound annotation
0391_001525	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	2.3978	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001526	591778-68-6	C30H35N3O3	2.6737	449097	C1C[C@H](CN(C1)C2CCN(CC2)C(=O)C3=C4C=CC=CC4=CC5=CC=CC=C53)C(=O)N6CCOCC6	O=C(c1c2ccccc2cc2ccccc12)N1CCC(N2CCCC(C(=O)N3CCOCC3)C2)CC1	InChI=1S/C30H35N3O3/c34-29(32-16-18-36-19-17-32)24-8-5-13-33(21-24)25-11-14-31(15-12-25)30(35)28-26-9-3-1-6-22(26)20-23-7-2-4-10-27(23)28/h1-4,6-7,9-10,20,24-25H,5,8,11-19,21H2/t24-/m1/s1	LDQKDRLEMKIYMC-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_001528	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	3.0946	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001529	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	3.0979	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001530	54827-17-7	C16H20N2	3.0979	41206		Cc1c(N)c(C)cc(-c2cc(C)c(N)c(C)c2)c1	InChI=1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3	UAIUNKRWKOVEES-UHFFFAOYSA-N					doublet; compound annotation
0391_001531	Anamorelin	C31H42N6O3	3.3579	9828911	CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@](C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N	CN(C)N(C)C(=O)C1(Cc2ccccc2)CCCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1	InChI=1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1	VQPFSIRUEPQQPP-MXBOTTGLSA-N					doublet; removed another duplicate entry; compound annotation
0391_001533	Telotristat	C25H22ClF3N6O3	3.675	25025298	CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)[C@H](C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	Cc1nn(-c2cc(Cl)ccc2C(Oc2nc(N)nc(-c3ccc(CC(N)C(=O)O)cc3)c2)C(F)(F)F)cc1	InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1	NCLGDOBQAWBXRA-PGRDOPGGSA-N					doublet; compound annotation
0391_001534	54827-17-7	C16H20N2	3.7668	41206		Cc1c(N)c(C)cc(-c2cc(C)c(N)c(C)c2)c1	InChI=1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3	UAIUNKRWKOVEES-UHFFFAOYSA-N					doublet; compound annotation
0391_001535	1-Methyl-2-[(E)-4-(dimethylamino)styryl]pyridinium	C16H19N2+	3.7668	5463011	C[N+]1=CC=CC=C1/C=C/C2=CC=C(C=C2)N(C)C	CN(C)c1ccc(C=Cc2cccc[n+]2C)cc1	InChI=1S/C16H19N2/c1-17(2)15-10-7-14(8-11-15)9-12-16-6-4-5-13-18(16)3/h4-13H,1-3H3/q+1	HJWUQHBYOGZTTM-UHFFFAOYSA-N					doublet; compound annotation
0391_001536	Telotristat	C25H22ClF3N6O3	4.3011	25025298	CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)[C@H](C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	Cc1nn(-c2cc(Cl)ccc2C(Oc2nc(N)nc(-c3ccc(CC(N)C(=O)O)cc3)c2)C(F)(F)F)cc1	InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1	NCLGDOBQAWBXRA-PGRDOPGGSA-N					doublet; compound annotation
0391_001537	733750-99-7	C21H24FN7O5S	4.5152	24939268		CC(C)c1noc(C2CCN(c3ncnc(Nc4c(F)cc(S(C)(=O)=O)cc4)c3[N+](=O)[O-])CC2)n1	InChI=1S/C21H24FN7O5S/c1-12(2)18-26-21(34-27-18)13-6-8-28(9-7-13)20-17(29(30)31)19(23-11-24-20)25-16-5-4-14(10-15(16)22)35(3,32)33/h4-5,10-13H,6-9H2,1-3H3,(H,23,24,25)	DGBKNTVAKIFYNU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001539	Fluticasone furoate	C27H29F3O6S	4.6489	9854489	C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F	CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)SCF	InChI=1S/C27H29F3O6S/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1	XTULMSXFIHGYFS-VLSRWLAYSA-N					removed another duplicate entry; compound annotation
0391_001541	142344-87-4	C16H21N5O4	0.5619	164444	C1=CC=C(C=C1)CNC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC(=C3N)C(=O)N)O)O	NC(=O)c1c(N)n(C2OC(CNCc3ccccc3)C(O)C2O)cn1	InChI=1S/C16H21N5O4/c17-14-11(15(18)24)20-8-21(14)16-13(23)12(22)10(25-16)7-19-6-9-4-2-1-3-5-9/h1-5,8,10,12-13,16,19,22-23H,6-7,17H2,(H2,18,24)/t10-,12-,13-,16-/m1/s1	LECUGLHMNZTZQB-XNIJJKJLSA-N					doublet; compound annotation
0391_001542	142344-87-4	C16H21N5O4	0.5655	164444	C1=CC=C(C=C1)CNC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC(=C3N)C(=O)N)O)O	NC(=O)c1c(N)n(C2OC(CNCc3ccccc3)C(O)C2O)cn1	InChI=1S/C16H21N5O4/c17-14-11(15(18)24)20-8-21(14)16-13(23)12(22)10(25-16)7-19-6-9-4-2-1-3-5-9/h1-5,8,10,12-13,16,19,22-23H,6-7,17H2,(H2,18,24)/t10-,12-,13-,16-/m1/s1	LECUGLHMNZTZQB-XNIJJKJLSA-N					doublet; compound annotation
0391_001543	Endomorphin 2	C32H37N5O5	2.3376	5311081	C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N	NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(N)Cc1ccc(O)cc1	InChI=1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1	XIJHWXXXIMEHKW-LJWNLINESA-N					removed another duplicate entry; compound annotation
0391_001545	EF-5	C8H7F5N4O3	2.3419	389053		O=C(Cn1ccnc1[N+](=O)[O-])NCC(F)(F)C(F)(F)F	InChI=1S/C8H7F5N4O3/c9-7(10,8(11,12)13)4-15-5(18)3-16-2-1-14-6(16)17(19)20/h1-2H,3-4H2,(H,15,18)	JGGDSDPOPRWSCX-UHFFFAOYSA-N					compound annotation
0391_001546	Periplocin	C36H56O13	2.715	14463159	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C6=CC(=O)OC6)C)C)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O	COC1CC(OC2CCC3(C)C4CCC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)OC(C)C1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C36H56O13/c1-18-31(49-32-30(41)29(40)28(39)25(16-37)48-32)24(44-4)14-27(46-18)47-20-5-9-33(2)22-6-10-34(3)21(19-13-26(38)45-17-19)8-12-36(34,43)23(22)7-11-35(33,42)15-20/h13,18,20-25,27-32,37,39-43H,5-12,14-17H2,1-4H3/t18-,20+,21-,22+,23-,24+,25-,27+,28-,29+,30-,31-,32+,33-,34-,35+,36+/m1/s1	KWBPKUMWVXUSCA-AXQDKOMKSA-N					compound annotation
0391_001547	CCK-B Receptor Antagonist 1	C28H30N6O3	2.8238	21842392		CNc1cc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)ccc1	InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)	YDZYKNJZCVIKPP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001549	CCK-B Receptor Antagonist 1	C28H30N6O3	3.8454	21842392		CNc1cc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)ccc1	InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)	YDZYKNJZCVIKPP-UHFFFAOYSA-N					doublet; compound annotation
0391_001550	deprodone propionate	C24H32O5	3.8742	443972	CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)C	CCC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C	InChI=1S/C24H32O5/c1-5-20(28)29-24(14(2)25)11-9-18-17-7-6-15-12-16(26)8-10-22(15,3)21(17)19(27)13-23(18,24)4/h8,10,12,17-19,21,27H,5-7,9,11,13H2,1-4H3/t17-,18-,19-,21+,22-,23-,24-/m0/s1	DRSFVGQMPYTGJY-GNSLJVCWSA-N					removed another duplicate entry; compound annotation
0391_001552	CCK-B Receptor Antagonist 1	C28H30N6O3	3.9606	21842392		CNc1cc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)ccc1	InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)	YDZYKNJZCVIKPP-UHFFFAOYSA-N					doublet; compound annotation
0391_001553	3BDO	C18H17NO5	4.3049	16216349		O=C1OC(COc2ccccc2[N+](=O)[O-])CC1Cc1ccccc1	InChI=1S/C18H17NO5/c20-18-14(10-13-6-2-1-3-7-13)11-15(24-18)12-23-17-9-5-4-8-16(17)19(21)22/h1-9,14-15H,10-12H2	AXPZIVKEZRHGAS-UHFFFAOYSA-N					doublet; compound annotation
0391_001554	3BDO	C18H17NO5	4.3078	16216349		O=C1OC(COc2ccccc2[N+](=O)[O-])CC1Cc1ccccc1	InChI=1S/C18H17NO5/c20-18-14(10-13-6-2-1-3-7-13)11-15(24-18)12-23-17-9-5-4-8-16(17)19(21)22/h1-9,14-15H,10-12H2	AXPZIVKEZRHGAS-UHFFFAOYSA-N					doublet; compound annotation
0391_001555	SCHEMBL424527	C16H24NO5+	1.4132	89287		COc1cc(C=CC(=O)OCC[N+](C)(C)C)cc(OC)c1O	InChI=1S/C16H23NO5/c1-17(2,3)8-9-22-15(18)7-6-12-10-13(20-4)16(19)14(11-12)21-5/h6-7,10-11H,8-9H2,1-5H3/p+1	HUJXHFRXWWGYQH-UHFFFAOYSA-O					doublet; compound annotation
0391_001556	AZD3759	C22H23ClFN5O3	1.7294	78209992	C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C	COc1c(OC(=O)N2CCN(C)CC2C)cc2c(Nc3c(F)c(Cl)ccc3)ncnc2c1	InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1	MXDSJQHFFDGFDK-CYBMUJFWSA-N					doublet; compound annotation
0391_001557	AZD3759	C22H23ClFN5O3	1.8666	78209992	C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C	COc1c(OC(=O)N2CCN(C)CC2C)cc2c(Nc3c(F)c(Cl)ccc3)ncnc2c1	InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1	MXDSJQHFFDGFDK-CYBMUJFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_001559	NBD-556	C17H24ClN3O2	2.5796	1570601		CC1(C)CC(NC(=O)C(=O)Nc2ccc(Cl)cc2)CC(C)(C)N1	InChI=1S/C17H24ClN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23)	ZKXLQCIOURANAD-UHFFFAOYSA-N					compound annotation
0391_001560	GSK256066	C27H26N4O5S	2.6139	9827968		COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1	InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)	JFHROPTYMMSOLG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001562	GSK256066	C27H26N4O5S	2.7318	9827968		COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1	InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)	JFHROPTYMMSOLG-UHFFFAOYSA-N					doublet; compound annotation
0391_001563	6,2'-Dihydroxyflavone	C15H10O4	2.9044	688661		O=c1cc(-c2ccccc2O)oc2c1cc(O)cc2	InChI=1S/C15H10O4/c16-9-5-6-14-11(7-9)13(18)8-15(19-14)10-3-1-2-4-12(10)17/h1-8,16-17H	YCGXYGWBHFKQHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001565	GSK256066	C27H26N4O5S	2.9074	9827968		COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1	InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)	JFHROPTYMMSOLG-UHFFFAOYSA-N					doublet; compound annotation
0391_001566	ETOMOXIR	C17H23ClO4	5.5773	9840324	CCOC(=O)[C@]1(CO1)CCCCCCOC2=CC=C(C=C2)Cl	CCOC(=O)C1(CCCCCCOc2ccc(Cl)cc2)CO1	InChI=1S/C17H23ClO4/c1-2-20-16(19)17(13-22-17)11-5-3-4-6-12-21-15-9-7-14(18)8-10-15/h7-10H,2-6,11-13H2,1H3/t17-/m1/s1	DZLOHEOHWICNIL-QGZVFWFLSA-N					compound annotation
0391_001567	AMD-070	C21H27N5	0.7185	11256587	C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3	NCCCCN(Cc1nc2ccccc2[nH]1)C1CCCc2c1nccc2	InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1	WVLHHLRVNDMIAR-IBGZPJMESA-N					doublet; compound annotation
0391_001568	AMD-070	C21H27N5	0.7234	11256587	C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3	NCCCCN(Cc1nc2ccccc2[nH]1)C1CCCc2c1nccc2	InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1	WVLHHLRVNDMIAR-IBGZPJMESA-N					doublet; compound annotation
0391_001569	AT9283	C19H23N7O2	1.4055	135398495		O=C(Nc1c(-c2nc3c(cc(CN4CCOCC4)cc3)[nH]2)[nH]nc1)NC1CC1	InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)	LOLPPWBBNUVNQZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001571	Alogliptin	C18H21N5O2	1.6745	11450633	CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O	InChI=1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1	ZSBOMTDTBDDKMP-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_001573	INCB3344	C29H34F3N3O6	2.8303	10008367	CCO[C@H]1CN(C[C@@H]1NC(=O)CNC(=O)C2=CC(=CC=C2)C(F)(F)F)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O	CCOC1CN(C2CCC(O)(c3cc4c(cc3)OCO4)CC2)CC1NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1	InChI=1S/C29H34F3N3O6/c1-2-39-25-16-35(21-8-10-28(38,11-9-21)19-6-7-23-24(13-19)41-17-40-23)15-22(25)34-26(36)14-33-27(37)18-4-3-5-20(12-18)29(30,31)32/h3-7,12-13,21-22,25,38H,2,8-11,14-17H2,1H3,(H,33,37)(H,34,36)/t21?,22-,25-,28?/m0/s1	MZEOSVPWMSEFPW-XYCDVDSTSA-N					doublet; removed another duplicate entry; compound annotation
0391_001575	Darifenacin	C28H30N2O2	3.0288	444031	C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5	NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2cc3c(cc2)OCC3)C1	InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1	HXGBXQDTNZMWGS-RUZDIDTESA-N					doublet; compound annotation
0391_001576	dyclonine	C18H27NO2	3.0745	3180		CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1	InChI=1S/C18H27NO2/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4-6-13-19/h7-10H,2-6,11-15H2,1H3	BZEWSEKUUPWQDQ-UHFFFAOYSA-N					compound annotation
0391_001577	425671-29-0	C23H27N3O4	3.7453	135449333		Cc1ccc(Cn2[nH]c(CCCc3ccc(OC(C)(C)C(=O)O)cc3)nc2=O)cc1	InChI=1S/C23H27N3O4/c1-16-7-9-18(10-8-16)15-26-22(29)24-20(25-26)6-4-5-17-11-13-19(14-12-17)30-23(2,3)21(27)28/h7-14H,4-6,15H2,1-3H3,(H,27,28)(H,24,25,29)	PNHFDVSKDSLUFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001579	N-desmethyl enzalutamide	C20H14F4N4O2S	3.9313	70678916		CC1(C)C(=O)N(c2cc(C(F)(F)F)c(C#N)cc2)C(=S)N1c1cc(F)c(C(N)=O)cc1	InChI=1S/C20H14F4N4O2S/c1-19(2)17(30)27(11-4-3-10(9-25)14(7-11)20(22,23)24)18(31)28(19)12-5-6-13(16(26)29)15(21)8-12/h3-8H,1-2H3,(H2,26,29)	JSFOGZGIBIQRPU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001581	Bosentan	C27H29N5O6S	4.228	104865		COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)c1ccc(C(C)(C)C)cc1	InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	GJPICJJJRGTNOD-UHFFFAOYSA-N					doublet; compound annotation
0391_001582	Bosentan	C27H29N5O6S	4.2307	104865		COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)c1ccc(C(C)(C)C)cc1	InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	GJPICJJJRGTNOD-UHFFFAOYSA-N					doublet; compound annotation
0391_001583	DMOG	C6H9NO5	0.6087	560326		COC(=O)CNC(=O)C(=O)OC	InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9)	BNJOZDZCRHCODO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001585	Tenofovir disoproxil	C19H30N5O10P	2.7909	5481350	C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C	CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C	InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1	JFVZFKDSXNQEJW-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001587	HS-173	C21H18N4O4S	3.2724	52936849		CCOC(=O)c1cnc2ccc(-c3cc(NS(=O)(=O)c4ccccc4)cnc3)cn12	InChI=1S/C21H18N4O4S/c1-2-29-21(26)19-13-23-20-9-8-15(14-25(19)20)16-10-17(12-22-11-16)24-30(27,28)18-6-4-3-5-7-18/h3-14,24H,2H2,1H3	SEKOTFCHZNXZMM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001589	(R)-Filanesib	C20H22F2N4O2S	3.364	46189838	CN(C(=O)N1[C@@](SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC	CON(C)C(=O)N1N=C(c2c(F)ccc(F)c2)SC1(CCCN)c1ccccc1	InChI=1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m1/s1	LLXISKGBWFTGEI-HXUWFJFHSA-N					removed another duplicate entry; compound annotation
0391_001591	tranilast	C18H17NO5	3.6292	5282230	COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC	COc1c(OC)cc(C=CC(=O)Nc2ccccc2C(=O)O)cc1	InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+	NZHGWWWHIYHZNX-CSKARUKUSA-N					doublet; removed another duplicate entry; compound annotation
0391_001593	HS-173	C21H18N4O4S	3.7185	52936849		CCOC(=O)c1cnc2ccc(-c3cc(NS(=O)(=O)c4ccccc4)cnc3)cn12	InChI=1S/C21H18N4O4S/c1-2-29-21(26)19-13-23-20-9-8-15(14-25(19)20)16-10-17(12-22-11-16)24-30(27,28)18-6-4-3-5-7-18/h3-14,24H,2H2,1H3	SEKOTFCHZNXZMM-UHFFFAOYSA-N					doublet; compound annotation
0391_001594	Pseudolaric acid B	C23H28O8	3.7185	6475943	C/C(=C\C=C\[C@@]1([C@@H]2CC[C@@]3([C@@]2(CCC(=CC3)C(=O)OC)OC(=O)C)C(=O)O1)C)/C(=O)O	COC(=O)C1=CCC23CCC(C(C)(C=CC=C(C)C(=O)O)OC2=O)C3(OC(C)=O)CC1	InChI=1S/C23H28O8/c1-14(18(25)26)6-5-10-21(3)17-9-12-22(20(28)31-21)11-7-16(19(27)29-4)8-13-23(17,22)30-15(2)24/h5-7,10,17H,8-9,11-13H2,1-4H3,(H,25,26)/b10-5+,14-6+/t17-,21+,22+,23-/m0/s1	VDGOFNMYZYBUDT-YDRCMHEVSA-N					doublet; compound annotation
0391_001595	7-methoxyisoflavone	C16H12O3	4.055	638006		COc1cc2c(cc1)c(=O)c(-c1ccccc1)co2	InChI=1S/C16H12O3/c1-18-12-7-8-13-15(9-12)19-10-14(16(13)17)11-5-3-2-4-6-11/h2-10H,1H3	IECSQLKWZBEUGA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001597	Pseudolaric acid B	C23H28O8	4.32	6475943	C/C(=C\C=C\[C@@]1([C@@H]2CC[C@@]3([C@@]2(CCC(=CC3)C(=O)OC)OC(=O)C)C(=O)O1)C)/C(=O)O	COC(=O)C1=CCC23CCC(C(C)(C=CC=C(C)C(=O)O)OC2=O)C3(OC(C)=O)CC1	InChI=1S/C23H28O8/c1-14(18(25)26)6-5-10-21(3)17-9-12-22(20(28)31-21)11-7-16(19(27)29-4)8-13-23(17,22)30-15(2)24/h5-7,10,17H,8-9,11-13H2,1-4H3,(H,25,26)/b10-5+,14-6+/t17-,21+,22+,23-/m0/s1	VDGOFNMYZYBUDT-YDRCMHEVSA-N					doublet; compound annotation
0391_001598	890842-28-1	C25H22N2O2	4.4472	25022668		O=C(O)c1c(C2CCCC2)cc(-c2c[nH]c3c2cc(-c2ccccc2)cn3)cc1	InChI=1S/C25H22N2O2/c28-25(29)20-11-10-18(12-21(20)17-8-4-5-9-17)23-15-27-24-22(23)13-19(14-26-24)16-6-2-1-3-7-16/h1-3,6-7,10-15,17H,4-5,8-9H2,(H,26,27)(H,28,29)	WVSBGSNVCDAMCF-UHFFFAOYSA-N					compound annotation
0391_001599	Targocil	C21H22ClN5O4S	4.8649	44547009		CCN(CC)c1nc2c(S(=O)(=O)c3ccc(Cl)cc3)nnn2c2cc(OC)c(OC)cc12	InChI=1S/C21H22ClN5O4S/c1-5-26(6-2)19-15-11-17(30-3)18(31-4)12-16(15)27-20(23-19)21(24-25-27)32(28,29)14-9-7-13(22)8-10-14/h7-12H,5-6H2,1-4H3	TYNZGYMGTTUYKZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001601	4-Methylumbelliferyl phosphate	C10H9O6P	1.1351	65118		Cc1cc(=O)oc2c1ccc(OP(=O)(O)O)c2	InChI=1S/C10H9O6P/c1-6-4-10(11)15-9-5-7(2-3-8(6)9)16-17(12,13)14/h2-5H,1H3,(H2,12,13,14)	BCHIXGBGRHLSBE-UHFFFAOYSA-N					compound annotation
0391_001602	4-Hydroxymephenytoin	C12H14N2O3	1.8593	119507		CCC1(c2ccc(O)cc2)NC(=O)N(C)C1=O	InChI=1S/C12H14N2O3/c1-3-12(8-4-6-9(15)7-5-8)10(16)14(2)11(17)13-12/h4-7,15H,3H2,1-2H3,(H,13,17)	OQPLORUDZLXXPD-UHFFFAOYSA-N					compound annotation
0391_001603	Acotiamide	C21H30N4O5S	2.6083	5282338		COc1c(OC)cc(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)c(O)c1	InChI=1S/C21H30N4O5S/c1-12(2)25(13(3)4)8-7-22-20(28)15-11-31-21(23-15)24-19(27)14-9-17(29-5)18(30-6)10-16(14)26/h9-13,26H,7-8H2,1-6H3,(H,22,28)(H,23,24,27)	TWHZNAUBXFZMCA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001605	propafenone	C21H27NO3	3.0995	4932		CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1	InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3	JWHAUXFOSRPERK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001607	Sagittatoside A	C33H40O15	3.5757	13916054	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C(=CC(=C3C2=O)O)O)CC=C(C)C)C4=CC=C(C=C4)OC)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3OC3OC(CO)C(O)C(O)C3O)c(=O)c3c(O)cc(O)c(CC=C(C)C)c3o2)cc1	InChI=1S/C33H40O15/c1-13(2)5-10-17-18(35)11-19(36)21-24(39)30(28(46-29(17)21)15-6-8-16(43-4)9-7-15)47-33-31(26(41)22(37)14(3)44-33)48-32-27(42)25(40)23(38)20(12-34)45-32/h5-9,11,14,20,22-23,25-27,31-38,40-42H,10,12H2,1-4H3/t14-,20+,22-,23+,25-,26+,27+,31+,32-,33-/m0/s1	COHHGQPQHHUMDG-WVQJJEIESA-N					removed another duplicate entry; compound annotation
0391_001609	EPIBRASSINOLIDE	C28H48O6	4.0035	443055	C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2COC(=O)[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C)C)[C@H]([C@@H]([C@H](C)C(C)C)O)O	CC(C)C(C)C(O)C(O)C(C)C1CCC2C3COC(=O)C4CC(O)C(O)CC4(C)C3CCC12C	InChI=1S/C28H48O6/c1-14(2)15(3)24(31)25(32)16(4)18-7-8-19-17-13-34-26(33)21-11-22(29)23(30)12-28(21,6)20(17)9-10-27(18,19)5/h14-25,29-32H,7-13H2,1-6H3/t15-,16+,17+,18-,19+,20+,21-,22+,23-,24-,25-,27-,28-/m1/s1	IXVMHGVQKLDRKH-QHBHMFGVSA-N					doublet; compound annotation
0391_001610	EPIBRASSINOLIDE	C28H48O6	4.0065	443055	C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2COC(=O)[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C)C)[C@H]([C@@H]([C@H](C)C(C)C)O)O	CC(C)C(C)C(O)C(O)C(C)C1CCC2C3COC(=O)C4CC(O)C(O)CC4(C)C3CCC12C	InChI=1S/C28H48O6/c1-14(2)15(3)24(31)25(32)16(4)18-7-8-19-17-13-34-26(33)21-11-22(29)23(30)12-28(21,6)20(17)9-10-27(18,19)5/h14-25,29-32H,7-13H2,1-6H3/t15-,16+,17+,18-,19+,20+,21-,22+,23-,24-,25-,27-,28-/m1/s1	IXVMHGVQKLDRKH-QHBHMFGVSA-N					doublet; compound annotation
0391_001611	UNBS5162	C17H18N4O3	1.4501	16048966		CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(c23)C1=O	InChI=1S/C17H18N4O3/c1-20(2)6-7-21-15(22)12-5-3-4-10-8-11(19-17(18)24)9-13(14(10)12)16(21)23/h3-5,8-9H,6-7H2,1-2H3,(H3,18,19,24)	WCKZRLOUKYFJDY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001613	Tefinostat	C28H37N3O5	2.7891	15940949	C1CCC(C1)OC(=O)[C@H](C2=CC=CC=C2)NCC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO	O=C(CCCCCCC(=O)Nc1ccc(CNC(C(=O)OC2CCCC2)c2ccccc2)cc1)NO	InChI=1S/C28H37N3O5/c32-25(14-6-1-2-7-15-26(33)31-35)30-23-18-16-21(17-19-23)20-29-27(22-10-4-3-5-11-22)28(34)36-24-12-8-9-13-24/h3-5,10-11,16-19,24,27,29,35H,1-2,6-9,12-15,20H2,(H,30,32)(H,31,33)/t27-/m0/s1	GLNWREBYRLDPQP-MHZLTWQESA-N					doublet; removed another duplicate entry; compound annotation
0391_001615	Tefinostat	C28H37N3O5	2.7924	15940949	C1CCC(C1)OC(=O)[C@H](C2=CC=CC=C2)NCC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO	O=C(CCCCCCC(=O)Nc1ccc(CNC(C(=O)OC2CCCC2)c2ccccc2)cc1)NO	InChI=1S/C28H37N3O5/c32-25(14-6-1-2-7-15-26(33)31-35)30-23-18-16-21(17-19-23)20-29-27(22-10-4-3-5-11-22)28(34)36-24-12-8-9-13-24/h3-5,10-11,16-19,24,27,29,35H,1-2,6-9,12-15,20H2,(H,30,32)(H,31,33)/t27-/m0/s1	GLNWREBYRLDPQP-MHZLTWQESA-N					doublet; compound annotation
0391_001616	199596-05-9	C17H13ClN4	2.9581	6519698	C1=CC=C(C=C1)/C(=N\NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17+	YHHFKWKMXWRVTJ-OQKWZONESA-N					doublet; removed another duplicate entry; compound annotation
0391_001618	SB-399885	C18H21Cl2N3O4S	3.1607	6918649		COc1c(N2CCNCC2)cc(S(=O)(=O)Nc2c(OC)c(Cl)cc(Cl)c2)cc1	InChI=1S/C18H21Cl2N3O4S/c1-26-17-4-3-13(11-16(17)23-7-5-21-6-8-23)28(24,25)22-15-10-12(19)9-14(20)18(15)27-2/h3-4,9-11,21-22H,5-8H2,1-2H3	ATKZKAYWARYLBW-UHFFFAOYSA-N					compound annotation
0391_001619	Darolutamide	C19H19ClN6O2	3.1685	67171867	C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O	CC(Cn1ccc(-c2cc(Cl)c(C#N)cc2)n1)NC(=O)c1n[nH]c(C(C)O)c1	InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1	BLIJXOOIHRSQRB-PXYINDEMSA-N					removed another duplicate entry; compound annotation
0391_001621	Dapagliflozin	C21H25ClO6	3.4162	9887712	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C3OC(CO)C(O)C(O)C3O)c2)cc1	InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	JVHXJTBJCFBINQ-ADAARDCZSA-N					doublet; removed another duplicate entry; compound annotation
0391_001623	Pirinixic acid	C14H14ClN3O2S	3.9975	5694		Cc1c(C)c(Nc2cc(Cl)nc(SCC(=O)O)n2)ccc1	InChI=1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h3-6H,7H2,1-2H3,(H,19,20)(H,16,17,18)	SZRPDCCEHVWOJX-UHFFFAOYSA-N					compound annotation
0391_001624	Narlaprevir	C36H61N5O7S	4.3293	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001626	Narlaprevir	C36H61N5O7S	4.625	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; compound annotation
0391_001627	Narlaprevir	C36H61N5O7S	4.6287	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; compound annotation
0391_001628	Narlaprevir	C36H61N5O7S	4.8614	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001630	Narlaprevir	C36H61N5O7S	4.9387	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001632	199596-05-9	C17H13ClN4	5.261	6519698	C1=CC=C(C=C1)/C(=N\NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17+	YHHFKWKMXWRVTJ-OQKWZONESA-N					doublet; removed another duplicate entry; compound annotation
0391_001634	GW0742	C21H17F4NO3S2	5.4707	9934458		Cc1c(OCC(=O)O)ccc(SCc2c(C)nc(-c3cc(F)c(C(F)(F)F)cc3)s2)c1	InChI=1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28)	HWVNEWGKWRGSRK-UHFFFAOYSA-N					compound annotation
0391_001635	Narlaprevir	C36H61N5O7S	6.3674	11857239	CCCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C	CCCCC(NC(=O)C1C2C(CN1C(=O)C(NC(=O)NC1(CS(=O)(=O)C(C)(C)C)CCCCC1)C(C)(C)C)C2(C)C)C(=O)C(=O)NC1CC1	InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1	RICZEKWVNZFTNZ-LFGITCQGSA-N					doublet; compound annotation
0391_001636	24769-58-2	C16H21N5O5	0.4674	10428784	C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)O	O=C1CCC(C(=O)NC(Cc2cnc[nH]2)C(=O)N2CCCC2C(=O)O)N1	InChI=1S/C16H21N5O5/c22-13-4-3-10(19-13)14(23)20-11(6-9-7-17-8-18-9)15(24)21-5-1-2-12(21)16(25)26/h7-8,10-12H,1-6H2,(H,17,18)(H,19,22)(H,20,23)(H,25,26)/t10-,11-,12-/m0/s1	ITYONPBTNRIEBA-SRVKXCTJSA-N					doublet; compound annotation
0391_001637	24769-58-2	C16H21N5O5	0.4705	10428784	C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)O	O=C1CCC(C(=O)NC(Cc2cnc[nH]2)C(=O)N2CCCC2C(=O)O)N1	InChI=1S/C16H21N5O5/c22-13-4-3-10(19-13)14(23)20-11(6-9-7-17-8-18-9)15(24)21-5-1-2-12(21)16(25)26/h7-8,10-12H,1-6H2,(H,17,18)(H,19,22)(H,20,23)(H,25,26)/t10-,11-,12-/m0/s1	ITYONPBTNRIEBA-SRVKXCTJSA-N					doublet; compound annotation
0391_001638	picolinohydrazide	C6H7N3O	0.4772	255881		NNC(=O)c1ccccn1	InChI=1S/C6H7N3O/c7-9-6(10)5-3-1-2-4-8-5/h1-4H,7H2,(H,9,10)	BAQLNPIEFOYKNB-UHFFFAOYSA-N					compound annotation
0391_001639	sulpiride	C15H23N3O4S	0.8835	5355		CCN1CCCC1CNC(=O)c1c(OC)ccc(S(N)(=O)=O)c1	InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)	BGRJTUBHPOOWDU-UHFFFAOYSA-N					compound annotation
0391_001640	JAK3-IN-1	C26H30ClN7O2	1.7624	92042864		C=CC(=O)Nc1cccc(CNc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)c1	InChI=1S/C26H30ClN7O2/c1-4-24(35)30-19-7-5-6-18(14-19)16-28-25-21(27)17-29-26(32-25)31-22-9-8-20(15-23(22)36-3)34-12-10-33(2)11-13-34/h4-9,14-15,17H,1,10-13,16H2,2-3H3,(H,30,35)(H2,28,29,31,32)	UGXCBYVBIJACEK-UHFFFAOYSA-N					doublet; compound annotation
0391_001641	JAK3-IN-1	C26H30ClN7O2	1.7673	92042864		C=CC(=O)Nc1cccc(CNc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)c1	InChI=1S/C26H30ClN7O2/c1-4-24(35)30-19-7-5-6-18(14-19)16-28-25-21(27)17-29-26(32-25)31-22-9-8-20(15-23(22)36-3)34-12-10-33(2)11-13-34/h4-9,14-15,17H,1,10-13,16H2,2-3H3,(H,30,35)(H2,28,29,31,32)	UGXCBYVBIJACEK-UHFFFAOYSA-N					doublet; compound annotation
0391_001642	Telocinobufagin	C24H34O5	3.0977	259991	C[C@]12CC[C@@H](C[C@]1(CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)O	CC12CCC(O)CC1(O)CCC1C2CCC2(C)C(c3coc(=O)cc3)CCC12O	InChI=1S/C24H34O5/c1-21-9-5-16(25)13-23(21,27)11-7-19-18(21)6-10-22(2)17(8-12-24(19,22)28)15-3-4-20(26)29-14-15/h3-4,14,16-19,25,27-28H,5-13H2,1-2H3/t16-,17+,18-,19+,21+,22+,23-,24-/m0/s1	PBSOJKPTQWWJJD-ZBDZJSKLSA-N					removed another duplicate entry; compound annotation
0391_001644	CY2	C25H27N2O4+	3.5494	121596145	CCN\1C2=CC=CC=C2O/C1=C\C=C\C3=[N+](C4=CC=CC=C4O3)CCCCCC(=O)O	CCN1C(=CC=Cc2[n+](CCCCCC(=O)O)c3ccccc3o2)Oc2ccccc21	InChI=1S/C25H26N2O4/c1-2-26-19-11-5-7-13-21(19)30-23(26)15-10-16-24-27(18-9-3-4-17-25(28)29)20-12-6-8-14-22(20)31-24/h5-8,10-16H,2-4,9,17-18H2,1H3/p+1	WORLWSFCGZCFSW-UHFFFAOYSA-O					compound annotation
0391_001645	1363281-27-9	C20H17FN2O3	3.9499	56846694		O=C(c1ccc(F)cc1)N1CCc2c(C1)oc(COc1ccccc1)n2	InChI=1S/C20H17FN2O3/c21-15-8-6-14(7-9-15)20(24)23-11-10-17-18(12-23)26-19(22-17)13-25-16-4-2-1-3-5-16/h1-9H,10-13H2	QUZLMKNNIUSREV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001647	SPR741	C44H73N13O13	1.4991	53323381	C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC2=CC=CC=C2)CCN)NC(=O)[C@@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)C)O	CC(=O)NC(C(=O)NC(CO)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O	InChI=1S/C44H73N13O13/c1-22(2)19-31-40(66)52-27(11-15-45)36(62)51-29(13-17-47)39(65)57-34(23(3)59)43(69)48-18-14-30(53-42(68)33(21-58)56-44(70)35(24(4)60)49-25(5)61)38(64)50-28(12-16-46)37(63)55-32(41(67)54-31)20-26-9-7-6-8-10-26/h6-10,22-24,27-35,58-60H,11-21,45-47H2,1-5H3,(H,48,69)(H,49,61)(H,50,64)(H,51,62)(H,52,66)(H,53,68)(H,54,67)(H,55,63)(H,56,70)(H,57,65)/t23-,24-,27+,28+,29+,30+,31+,32-,33-,34+,35+/m1/s1	JBFNEVNUGGFPBQ-DDMCRLCFSA-N					compound annotation
0391_001648	MELPERONE	C16H22FNO	2.2195	15387		CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1	InChI=1S/C16H22FNO/c1-13-8-11-18(12-9-13)10-2-3-16(19)14-4-6-15(17)7-5-14/h4-7,13H,2-3,8-12H2,1H3	DKMFBWQBDIGMHM-UHFFFAOYSA-N					compound annotation
0391_001649	Tomatine	C50H83NO21	2.5303	28523	C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CCC5CC(OC6OC(CO)C(OC7OC(CO)C(O)C(OC8OCC(O)C(O)C8O)C7OC7OC(CO)C(O)C(O)C7O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C50H83NO21/c1-20-7-12-50(51-15-20)21(2)32-28(72-50)14-26-24-6-5-22-13-23(8-10-48(22,3)25(24)9-11-49(26,32)4)65-45-40(63)37(60)41(31(18-54)68-45)69-47-43(71-46-39(62)36(59)34(57)29(16-52)66-46)42(35(58)30(17-53)67-47)70-44-38(61)33(56)27(55)19-64-44/h20-47,51-63H,5-19H2,1-4H3/t20-,21-,22-,23-,24+,25-,26-,27+,28-,29+,30+,31+,32-,33-,34+,35+,36-,37+,38+,39+,40+,41-,42-,43+,44-,45+,46-,47-,48-,49-,50-/m0/s1	REJLGAUYTKNVJM-SGXCCWNXSA-N					compound annotation
0391_001650	Epimedin B	C38H48O19	2.6802	5748393	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3OC3OCC(O)C(O)C3O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C38H48O19/c1-14(2)5-10-18-21(53-37-31(49)28(46)26(44)22(12-39)54-37)11-19(40)23-27(45)34(32(55-33(18)23)16-6-8-17(50-4)9-7-16)56-38-35(29(47)24(42)15(3)52-38)57-36-30(48)25(43)20(41)13-51-36/h5-9,11,15,20,22,24-26,28-31,35-44,46-49H,10,12-13H2,1-4H3/t15-,20+,22+,24-,25-,26+,28-,29+,30+,31+,35+,36-,37+,38-/m0/s1	OCZZCFAOOWZSRX-LRHLXKJSSA-N					removed another duplicate entry; compound annotation
0391_001652	Boc-Leu-Gly-Arg-AMC	C29H43N7O7	3.011	53765602	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C	Cc1cc(=O)oc2c1ccc(NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CC(C)C)NC(=O)OC(C)(C)C)c2	InChI=1S/C29H43N7O7/c1-16(2)12-21(36-28(41)43-29(4,5)6)25(39)33-15-23(37)35-20(8-7-11-32-27(30)31)26(40)34-18-9-10-19-17(3)13-24(38)42-22(19)14-18/h9-10,13-14,16,20-21H,7-8,11-12,15H2,1-6H3,(H,33,39)(H,34,40)(H,35,37)(H,36,41)(H4,30,31,32)/t20-,21-/m0/s1	DLAQYOHJZUTWDJ-SFTDATJTSA-N					doublet; compound annotation
0391_001653	Boc-Leu-Gly-Arg-AMC	C29H43N7O7	3.064	53765602	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C	Cc1cc(=O)oc2c1ccc(NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CC(C)C)NC(=O)OC(C)(C)C)c2	InChI=1S/C29H43N7O7/c1-16(2)12-21(36-28(41)43-29(4,5)6)25(39)33-15-23(37)35-20(8-7-11-32-27(30)31)26(40)34-18-9-10-19-17(3)13-24(38)42-22(19)14-18/h9-10,13-14,16,20-21H,7-8,11-12,15H2,1-6H3,(H,33,39)(H,34,40)(H,35,37)(H,36,41)(H4,30,31,32)/t20-,21-/m0/s1	DLAQYOHJZUTWDJ-SFTDATJTSA-N					doublet; removed another duplicate entry; compound annotation
0391_001655	Sakuranetin	C16H14O5	3.7157	73571	COC1=CC(=C2C(=O)C[C@H](OC2=C1)C3=CC=C(C=C3)O)O	COc1cc(O)c2C(=O)CC(c3ccc(O)cc3)Oc2c1	InChI=1S/C16H14O5/c1-20-11-6-12(18)16-13(19)8-14(21-15(16)7-11)9-2-4-10(17)5-3-9/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1	DJOJDHGQRNZXQQ-AWEZNQCLSA-N					compound annotation
0391_001656	7-Epitaxol	C47H51NO14	4.6176	184492	CC1=C2[C@H](C(=O)[C@@]3([C@@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32+,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	RCINICONZNJXQF-LYTKHFMESA-N					doublet; compound annotation
0391_001657	7-Epitaxol	C47H51NO14	4.6205	184492	CC1=C2[C@H](C(=O)[C@@]3([C@@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32+,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	RCINICONZNJXQF-LYTKHFMESA-N					doublet; compound annotation
0391_001658	Fmoc-N-Me-Ile-OH	C22H25NO4	4.892	15433034	CC[C@H](C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13	CCC(C)C(C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21	InChI=1S/C22H25NO4/c1-4-14(2)20(21(24)25)23(3)22(26)27-13-19-17-11-7-5-9-15(17)16-10-6-8-12-18(16)19/h5-12,14,19-20H,4,13H2,1-3H3,(H,24,25)/t14-,20-/m0/s1	IQIOLCJHRZWOLS-XOBRGWDASA-N					removed another duplicate entry; compound annotation
0391_001660	Bergamottin	C21H22O4	5.8215	5471349	CC(=CCC/C(=C/COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)/C)C	CC(C)=CCCC(C)=CCOc1c2ccc(=O)oc2cc2c1cco2	InChI=1S/C21H22O4/c1-14(2)5-4-6-15(3)9-11-24-21-16-7-8-20(22)25-19(16)13-18-17(21)10-12-23-18/h5,7-10,12-13H,4,6,11H2,1-3H3/b15-9+	DBMJZOMNXBSRED-OQLLNIDSSA-N					compound annotation
0391_001661	dapi	C16H15N5	1.028	2954		N=C(N)c1ccc(-c2cc3c(cc(C(=N)N)cc3)[nH]2)cc1	InChI=1S/C16H15N5/c17-15(18)10-3-1-9(2-4-10)13-7-11-5-6-12(16(19)20)8-14(11)21-13/h1-8,21H,(H3,17,18)(H3,19,20)	FWBHETKCLVMNFS-UHFFFAOYSA-N					doublet; compound annotation
0391_001662	dapi	C16H15N5	1.3802	2954		N=C(N)c1ccc(-c2cc3c(cc(C(=N)N)cc3)[nH]2)cc1	InChI=1S/C16H15N5/c17-15(18)10-3-1-9(2-4-10)13-7-11-5-6-12(16(19)20)8-14(11)21-13/h1-8,21H,(H3,17,18)(H3,19,20)	FWBHETKCLVMNFS-UHFFFAOYSA-N					doublet; compound annotation
0391_001663	aspartame	C14H18N2O5	1.6105	6992066	COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)[O-])[NH3+]	COC(=O)C(Cc1ccccc1)NC(=O)C(N)CC(=O)O	InChI=1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1	IAOZJIPTCAWIRG-QWRGUYRKSA-N					compound annotation
0391_001664	Ribocil-C	C21H21N7OS	2.0585	136981150	C1C[C@@H](CN(C1)CC2=CN(C=N2)C3=NC=CC=N3)C4=NC(=CC(=O)N4)C5=CC=CS5	O=c1cc(-c2cccs2)[nH]c(C2CCCN(Cc3cn(-c4ncccn4)cn3)C2)n1	InChI=1S/C21H21N7OS/c29-19-10-17(18-5-2-9-30-18)25-20(26-19)15-4-1-8-27(11-15)12-16-13-28(14-24-16)21-22-6-3-7-23-21/h2-3,5-7,9-10,13-15H,1,4,8,11-12H2,(H,25,26,29)/t15-/m0/s1	UVDVCDUBJWYRJW-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_001666	146368-13-0	C31H38N2O8S2	2.0819	126969904		CCN1C(=CC=CC2=[N+](CCCCCC(=O)O)c3c(cc(S(=O)(=O)O)cc3)C2(C)C)C(C)(C)c2c1ccc(S(=O)(=O)[O-])c2	InChI=1S/C31H38N2O8S2/c1-6-32-25-16-14-21(42(36,37)38)19-23(25)30(2,3)27(32)11-10-12-28-31(4,5)24-20-22(43(39,40)41)15-17-26(24)33(28)18-9-7-8-13-29(34)35/h10-12,14-17,19-20H,6-9,13,18H2,1-5H3,(H2-,34,35,36,37,38,39,40,41)	YDNYBBRGPORVRT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001668	dapi	C16H15N5	2.4556	2954		N=C(N)c1ccc(-c2cc3c(cc(C(=N)N)cc3)[nH]2)cc1	InChI=1S/C16H15N5/c17-15(18)10-3-1-9(2-4-10)13-7-11-5-6-12(16(19)20)8-14(11)21-13/h1-8,21H,(H3,17,18)(H3,19,20)	FWBHETKCLVMNFS-UHFFFAOYSA-N					doublet; compound annotation
0391_001669	loxapine	C18H18ClN3O	2.8747	3964		CN1CCN(C2=Nc3ccccc3Oc3c2cc(Cl)cc3)CC1	InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	XJGVXQDUIWGIRW-UHFFFAOYSA-N					doublet; compound annotation
0391_001670	NQDI-1	C19H13NO4	3.446	5522952		CCOC(=O)c1c2-c3ccccc3C(=O)c3c2c(ccc3)nc1O	InChI=1S/C19H13NO4/c1-2-24-19(23)16-15-10-6-3-4-7-11(10)17(21)12-8-5-9-13(14(12)15)20-18(16)22/h3-9H,2H2,1H3,(H,20,22)	UFJGFNHRMPMALC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001672	50995-74-9	C14H15NO4	3.5259	659294		CCN(CC)c1cc2c(cc1)cc(C(=O)O)c(=O)o2	InChI=1S/C14H15NO4/c1-3-15(4-2)10-6-5-9-7-11(13(16)17)14(18)19-12(9)8-10/h5-8H,3-4H2,1-2H3,(H,16,17)	WHCPTFFIERCDSB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001675	artemisone	C19H31NO6S	4.5124	11531457	C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)N5CCS(=O)(=O)CC5)C	CC1CCC2C(C)C(N3CCS(=O)(=O)CC3)OC3OC4(C)CCC1C32OO4	InChI=1S/C19H31NO6S/c1-12-4-5-15-13(2)16(20-8-10-27(21,22)11-9-20)23-17-19(15)14(12)6-7-18(3,24-17)25-26-19/h12-17H,4-11H2,1-3H3/t12-,13-,14+,15+,16-,17-,18-,19-/m1/s1	FDMUNKXWYMSZIR-NQWKWHCYSA-N					removed another duplicate entry; compound annotation
0391_001677	2-iminobiotin	C10H17N3O2S	1.1893	128878	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)O)N=C(N2)N	NC1=NC2C(CSC2CCCCC(=O)O)N1	InChI=1S/C10H17N3O2S/c11-10-12-6-5-16-7(9(6)13-10)3-1-2-4-8(14)15/h6-7,9H,1-5H2,(H,14,15)(H3,11,12,13)/t6-,7-,9-/m0/s1	WWVANQJRLPIHNS-ZKWXMUAHSA-N					compound annotation
0391_001678	6-Carboxyfluorescein	C21H12O7	2.5926	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; compound annotation
0391_001679	6-Carboxyfluorescein	C21H12O7	2.5953	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; compound annotation
0391_001680	6-Carboxyfluorescein	C21H12O7	2.6358	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001682	ROQUINIMEX	C18H16N2O3	2.8163	54676478		CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1	InChI=1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3	SGOOQMRIPALTEL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001684	AST-1306	C24H18ClFN4O2	3.6245	24739943		C=CC(=O)Nc1cc2c(cc1)ncnc2Nc1cc(Cl)c(OCc2cc(F)ccc2)cc1	InChI=1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30)	MVZGYPSXNDCANY-UHFFFAOYSA-N					compound annotation
0391_001685	PF-06471553	C23H25N5O4S	3.689	122189255		COc1cccc(CC(=O)N2Cc3c(cc(S(=O)(=O)Nc4nn(C5CCC5)nc4)cc3)C2)c1	InChI=1S/C23H25N5O4S/c1-32-20-7-2-4-16(10-20)11-23(29)27-14-17-8-9-21(12-18(17)15-27)33(30,31)26-22-13-24-28(25-22)19-5-3-6-19/h2,4,7-10,12-13,19H,3,5-6,11,14-15H2,1H3,(H,25,26)	GRXCLNMCJWKTAT-UHFFFAOYSA-N					doublet; compound annotation
0391_001686	ODM-203	C26H21F2N5O2S	3.7305	71554322		Cn1cc(-c2cc3c(cc2)n(-c2cc(-c4c(F)cc(F)cc4)cc(NS(=O)(=O)C4CC4)c2)cn3)cn1	InChI=1S/C26H21F2N5O2S/c1-32-14-18(13-30-32)16-2-7-26-25(10-16)29-15-33(26)21-9-17(23-6-3-19(27)11-24(23)28)8-20(12-21)31-36(34,35)22-4-5-22/h2-3,6-15,22,31H,4-5H2,1H3	ZJFCBQXPTQSTCZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001688	PF-06471553	C23H25N5O4S	3.8121	122189255		COc1cccc(CC(=O)N2Cc3c(cc(S(=O)(=O)Nc4nn(C5CCC5)nc4)cc3)C2)c1	InChI=1S/C23H25N5O4S/c1-32-20-7-2-4-16(10-20)11-23(29)27-14-17-8-9-21(12-18(17)15-27)33(30,31)26-22-13-24-28(25-22)19-5-3-6-19/h2,4,7-10,12-13,19H,3,5-6,11,14-15H2,1H3,(H,25,26)	GRXCLNMCJWKTAT-UHFFFAOYSA-N					doublet; compound annotation
0391_001689	PF-06471553	C23H25N5O4S	3.817	122189255		COc1cccc(CC(=O)N2Cc3c(cc(S(=O)(=O)Nc4nn(C5CCC5)nc4)cc3)C2)c1	InChI=1S/C23H25N5O4S/c1-32-20-7-2-4-16(10-20)11-23(29)27-14-17-8-9-21(12-18(17)15-27)33(30,31)26-22-13-24-28(25-22)19-5-3-6-19/h2,4,7-10,12-13,19H,3,5-6,11,14-15H2,1H3,(H,25,26)	GRXCLNMCJWKTAT-UHFFFAOYSA-N					doublet; compound annotation
0391_001690	Clascoterone	C24H34O5	3.8954	11750009	CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO	CCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1	GPNHMOZDMYNCPO-PDUMRIMRSA-N					doublet; removed another duplicate entry; compound annotation
0391_001692	Clascoterone	C24H34O5	4.3895	11750009	CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO	CCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1	GPNHMOZDMYNCPO-PDUMRIMRSA-N					doublet; compound annotation
0391_001693	Biotin-PEG3-Amine	C18H34N4O5S	1.2203	50896259	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCOCCN)NC(=O)N2	NCCOCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C18H34N4O5S/c19-5-7-25-9-11-27-12-10-26-8-6-20-16(23)4-2-1-3-15-17-14(13-28-15)21-18(24)22-17/h14-15,17H,1-13,19H2,(H,20,23)(H2,21,22,24)/t14-,15-,17-/m0/s1	KIJSBKNJFAUJFV-ZOBUZTSGSA-N					doublet; compound annotation
0391_001694	Biotin-PEG3-Amine	C18H34N4O5S	1.2235	50896259	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCOCCN)NC(=O)N2	NCCOCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C18H34N4O5S/c19-5-7-25-9-11-27-12-10-26-8-6-20-16(23)4-2-1-3-15-17-14(13-28-15)21-18(24)22-17/h14-15,17H,1-13,19H2,(H,20,23)(H2,21,22,24)/t14-,15-,17-/m0/s1	KIJSBKNJFAUJFV-ZOBUZTSGSA-N					doublet; compound annotation
0391_001695	IBMX	C10H14N4O2	2.0568	3758		CC(C)Cn1c(=O)n(C)c(=O)c2c1nc[nH]2	InChI=1S/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12)	APIXJSLKIYYUKG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001697	ONC212	C24H23F3N4O	2.4379	124085867		O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1ccc(C(F)(F)F)cc1	InChI=1S/C24H23F3N4O/c25-24(26,27)19-8-6-18(7-9-19)15-31-22(32)20-16-29(14-17-4-2-1-3-5-17)12-10-21(20)30-13-11-28-23(30)31/h1-9H,10-16H2	DFULPGUTXZTYKA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001699	Defactinib	C20H21F3N8O3S	3.0507	25117126		CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1	InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)	FWLMVFUGMHIOAA-UHFFFAOYSA-N					doublet; compound annotation
0391_001700	Defactinib	C20H21F3N8O3S	3.0556	25117126		CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1	InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)	FWLMVFUGMHIOAA-UHFFFAOYSA-N					doublet; compound annotation
0391_001701	FRAX597	C29H28ClN7OS	3.0691	70934541		CCn1c(=O)c(-c2c(Cl)cc(-c3cncs3)cc2)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21	InChI=1S/C29H28ClN7OS/c1-3-37-27-20(14-24(28(37)38)23-9-4-19(15-25(23)30)26-17-31-18-39-26)16-32-29(34-27)33-21-5-7-22(8-6-21)36-12-10-35(2)11-13-36/h4-9,14-18H,3,10-13H2,1-2H3,(H,32,33,34)	DHUJCQOUWQMVCG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001703	XMD17-109	C36H46N8O3	3.119	71604307		CCOc1c(Nc2ncc3c(n2)N(C2CCCC2)c2ccccc2C(=O)N3C)ccc(C(=O)N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C36H46N8O3/c1-4-47-32-23-25(34(45)43-17-15-26(16-18-43)42-21-19-40(2)20-22-42)13-14-29(32)38-36-37-24-31-33(39-36)44(27-9-5-6-10-27)30-12-8-7-11-28(30)35(46)41(31)3/h7-8,11-14,23-24,26-27H,4-6,9-10,15-22H2,1-3H3,(H,37,38,39)	XVBGRTMNFNMINE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001705	FRAX597	C29H28ClN7OS	3.1568	70934541		CCn1c(=O)c(-c2c(Cl)cc(-c3cncs3)cc2)cc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21	InChI=1S/C29H28ClN7OS/c1-3-37-27-20(14-24(28(37)38)23-9-4-19(15-25(23)30)26-17-31-18-39-26)16-32-29(34-27)33-21-5-7-22(8-6-21)36-12-10-35(2)11-13-36/h4-9,14-18H,3,10-13H2,1-2H3,(H,32,33,34)	DHUJCQOUWQMVCG-UHFFFAOYSA-N					doublet; compound annotation
0391_001706	2185859-59-8	C20H27F2N5O4S	3.2825	134253135	C[C@@]1(CCC[C@@H]1N2C3=NC(=NC=C3C=C(C2=O)C(F)F)NC4CCN(CC4)S(=O)(=O)C)O	CC1(O)CCCC1n1c(=O)c(C(F)F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21	InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m0/s1	QIEKHLDZKRQLLN-YWZLYKJASA-N					removed another duplicate entry; compound annotation
0391_001708	JW 642	C21H20F6N2O3	3.9523	71656520		O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2cc(Oc3ccccc3)ccc2)CC1	InChI=1S/C21H20F6N2O3/c22-20(23,24)18(21(25,26)27)32-19(30)29-11-9-28(10-12-29)14-15-5-4-8-17(13-15)31-16-6-2-1-3-7-16/h1-8,13,18H,9-12,14H2	AVSCNEOUWSVZEY-UHFFFAOYSA-N					doublet; compound annotation
0391_001709	JW 642	C21H20F6N2O3	4.0345	71656520		O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2cc(Oc3ccccc3)ccc2)CC1	InChI=1S/C21H20F6N2O3/c22-20(23,24)18(21(25,26)27)32-19(30)29-11-9-28(10-12-29)14-15-5-4-8-17(13-15)31-16-6-2-1-3-7-16/h1-8,13,18H,9-12,14H2	AVSCNEOUWSVZEY-UHFFFAOYSA-N					doublet; compound annotation
0391_001710	Pracinostat	C20H30N4O2	0.9285	49855250	CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)/C=C/C(=O)NO	CCCCc1nc2c(ccc(C=CC(=O)NO)c2)n1CCN(CC)CC	InChI=1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+	JHDKZFFAIZKUCU-ZRDIBKRKSA-N					compound annotation
0391_001711	nifenazone	C17H16N4O2	1.4211	4487		Cc1c(NC(=O)c2cnccc2)c(=O)n(-c2ccccc2)n1C	InChI=1S/C17H16N4O2/c1-12-15(19-16(22)13-7-6-10-18-11-13)17(23)21(20(12)2)14-8-4-3-5-9-14/h3-11H,1-2H3,(H,19,22)	BRZANEXCSZCZCI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001713	Glycyl-N-(4-nitrophenyl)-L-prolinamide	C13H16N4O4	1.7106	7275806	C1C[C@H](N(C1)C(=O)CN)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-]	NCC(=O)N1CCCC1C(=O)Nc1ccc([N+](=O)[O-])cc1	InChI=1S/C13H16N4O4/c14-8-12(18)16-7-1-2-11(16)13(19)15-9-3-5-10(6-4-9)17(20)21/h3-6,11H,1-2,7-8,14H2,(H,15,19)/t11-/m0/s1	NCOCKEVUJUIWRX-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_001715	1439934-41-4	C22H24ClN7O	1.9842	71558939		CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1Cl	InChI=1S/C22H24ClN7O/c1-24-21(31)17-4-2-3-5-19(17)28-20-18(23)14-26-22(29-20)27-15-6-8-16(9-7-15)30-12-10-25-11-13-30/h2-9,14,25H,10-13H2,1H3,(H,24,31)(H2,26,27,28,29)	FCLOIQHNUARDSR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001718	AZD-26	C22H21N3O	2.154	56953649		NC(=O)c1cnc(-c2ccc(C3(N)CCC3)cc2)c(-c2ccccc2)c1	InChI=1S/C22H21N3O/c23-21(26)17-13-19(15-5-2-1-3-6-15)20(25-14-17)16-7-9-18(10-8-16)22(24)11-4-12-22/h1-3,5-10,13-14H,4,11-12,24H2,(H2,23,26)	GIRZDHCBMNHMEH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001720	Glasdegib	C21H22N6O	2.2871	25166913	CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N	CN1CCC(NC(=O)Nc2ccc(C#N)cc2)CC1c1nc2ccccc2[nH]1	InChI=1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28)/t16-,19-/m1/s1	SFNSLLSYNZWZQG-VQIMIIECSA-N					removed another duplicate entry; compound annotation
0391_001722	Chitinase-IN-2	C20H21N5O2S	2.3237	86223064		Cc1nnc(CNCCN2C(=O)c3cccc4c(N(C)C)ccc(c34)C2=O)s1	InChI=1S/C20H21N5O2S/c1-12-22-23-17(28-12)11-21-9-10-25-19(26)14-6-4-5-13-16(24(2)3)8-7-15(18(13)14)20(25)27/h4-8,21H,9-11H2,1-3H3	MZVBLDCRQKXSHR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001724	1439934-41-4	C22H24ClN7O	2.3547	71558939		CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1Cl	InChI=1S/C22H24ClN7O/c1-24-21(31)17-4-2-3-5-19(17)28-20-18(23)14-26-22(29-20)27-15-6-8-16(9-7-15)30-12-10-25-11-13-30/h2-9,14,25H,10-13H2,1H3,(H,24,31)(H2,26,27,28,29)	FCLOIQHNUARDSR-UHFFFAOYSA-N					doublet; compound annotation
0391_001725	1572414-83-5	C23H24N6	2.887	60167849		Cc1cnc(-c2ccccc2C(C)C)nc1NCc1ccc(-n2ccnn2)cc1	InChI=1S/C23H24N6/c1-16(2)20-6-4-5-7-21(20)23-24-14-17(3)22(27-23)25-15-18-8-10-19(11-9-18)29-13-12-26-28-29/h4-14,16H,15H2,1-3H3,(H,24,25,27)	VUIRVWPJNKZOSS-UHFFFAOYSA-N					compound annotation
0391_001726	SMAP-2	C27H27F3N2O4S	5.4845	91885560	C1C[C@@H]([C@H]([C@@H](C1)N2C3=CC=CC=C3CCC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F	O=S(=O)(NC1CCCC(N2c3ccccc3CCc3ccccc32)C1O)c1ccc(OC(F)(F)F)cc1	InChI=1S/C27H27F3N2O4S/c28-27(29,30)36-20-14-16-21(17-15-20)37(34,35)31-22-8-5-11-25(26(22)33)32-23-9-3-1-6-18(23)12-13-19-7-2-4-10-24(19)32/h1-4,6-7,9-10,14-17,22,25-26,31,33H,5,8,11-13H2/t22-,25+,26+/m0/s1	SDVKTCLBCCAFIS-HDYLNDSGSA-N					doublet; compound annotation
0391_001727	SMAP-2	C27H27F3N2O4S	5.8441	91885560	C1C[C@@H]([C@H]([C@@H](C1)N2C3=CC=CC=C3CCC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F	O=S(=O)(NC1CCCC(N2c3ccccc3CCc3ccccc32)C1O)c1ccc(OC(F)(F)F)cc1	InChI=1S/C27H27F3N2O4S/c28-27(29,30)36-20-14-16-21(17-15-20)37(34,35)31-22-8-5-11-25(26(22)33)32-23-9-3-1-6-18(23)12-13-19-7-2-4-10-24(19)32/h1-4,6-7,9-10,14-17,22,25-26,31,33H,5,8,11-13H2/t22-,25+,26+/m0/s1	SDVKTCLBCCAFIS-HDYLNDSGSA-N					doublet; removed another duplicate entry; compound annotation
0391_001730	HOE 32021	C26H26N6O	1.6805	10071840		COc1ccc(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)cc1	InChI=1S/C26H26N6O/c1-31-11-13-32(14-12-31)19-6-10-22-24(16-19)30-26(28-22)18-5-9-21-23(15-18)29-25(27-21)17-3-7-20(33-2)8-4-17/h3-10,15-16H,11-14H2,1-2H3,(H,27,29)(H,28,30)	ZEEIKPHYGCYRRH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001732	Thiazovivin	C15H13N5OS	2.2851	46209426		O=C(NCc1ccccc1)c1csc(Nc2ncncc2)n1	InChI=1S/C15H13N5OS/c21-14(17-8-11-4-2-1-3-5-11)12-9-22-15(19-12)20-13-6-7-16-10-18-13/h1-7,9-10H,8H2,(H,17,21)(H,16,18,19,20)	DOBKQCZBPPCLEG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001734	DCZ0415	C23H20N2O2	2.5162	145925662		O=C1C2C3C=CC(C4CC34)C2C(=O)N1c1ccc(Cc2ccncc2)cc1	InChI=1S/C23H20N2O2/c26-22-20-16-5-6-17(19-12-18(16)19)21(20)23(27)25(22)15-3-1-13(2-4-15)11-14-7-9-24-10-8-14/h1-10,16-21H,11-12H2	LOXMLWHUIONWMI-UHFFFAOYSA-N					compound annotation
0391_001735	roniciclib	C18H21F3N4O3S	2.8739	45380979	C[C@H]([C@@H](C)OC1=NC(=NC=C1C(F)(F)F)NC2=CC=C(C=C2)S(=N)(=O)C3CC3)O	CC(O)C(C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F	InChI=1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1	UELYDGOOJPRWGF-MFOHZAOFSA-N					doublet; compound annotation
0391_001736	832115-62-5	C11H10N2O2S	3.1816	19582717		O=C(NC1CC1)c1noc(-c2cccs2)c1	InChI=1S/C11H10N2O2S/c14-11(12-7-3-4-7)8-6-9(15-13-8)10-2-1-5-16-10/h1-2,5-7H,3-4H2,(H,12,14)	SYENTKHGMVKGAQ-UHFFFAOYSA-N					compound annotation
0391_001737	GSK269962A	C29H30N8O5	3.1816	16095342		CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21	InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)	YOVNFNXUCOWYSG-UHFFFAOYSA-N					doublet; compound annotation
0391_001738	GSK269962A	C29H30N8O5	3.1865	16095342		CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21	InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)	YOVNFNXUCOWYSG-UHFFFAOYSA-N					doublet; compound annotation
0391_001739	roniciclib	C18H21F3N4O3S	3.2011	45380979	C[C@H]([C@@H](C)OC1=NC(=NC=C1C(F)(F)F)NC2=CC=C(C=C2)S(=N)(=O)C3CC3)O	CC(O)C(C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F	InChI=1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1	UELYDGOOJPRWGF-MFOHZAOFSA-N					doublet; compound annotation
0391_001740	roniciclib	C18H21F3N4O3S	3.2059	45380979	C[C@H]([C@@H](C)OC1=NC(=NC=C1C(F)(F)F)NC2=CC=C(C=C2)S(=N)(=O)C3CC3)O	CC(O)C(C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F	InChI=1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1	UELYDGOOJPRWGF-MFOHZAOFSA-N					doublet; compound annotation
0391_001741	848141-11-7	C25H22F3N5O4S	3.5618	46861623		Cc1c(-c2ccnn2C)cc(C(=O)NCc2ncc(S(C)(=O)=O)cc2)c(=O)n1-c1cccc(C(F)(F)F)c1	InChI=1S/C25H22F3N5O4S/c1-15-20(22-9-10-31-32(22)2)12-21(23(34)30-13-17-7-8-19(14-29-17)38(3,36)37)24(35)33(15)18-6-4-5-16(11-18)25(26,27)28/h4-12,14H,13H2,1-3H3,(H,30,34)	QNQZWEGMKJBHEM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001743	HDAC8-IN-1	C22H19NO3	4.2715	70676597	COC1=CC(=C(C=C1)/C=C/C(=O)NO)C2=CC=C(C=C2)C3=CC=CC=C3	COc1cc(-c2ccc(-c3ccccc3)cc2)c(C=CC(=O)NO)cc1	InChI=1S/C22H19NO3/c1-26-20-13-11-19(12-14-22(24)23-25)21(15-20)18-9-7-17(8-10-18)16-5-3-2-4-6-16/h2-15,25H,1H3,(H,23,24)/b14-12+	ASHPRZYGCOMVHO-WYMLVPIESA-N					compound annotation
0391_001744	AM-211	C27H27F3N2O4	4.4677	44158492		CCN(Cc1cc(C(F)(F)F)ccc1-c1c(OC)ccc(CC(=O)O)c1)C(=O)NCc1ccccc1	InChI=1S/C27H27F3N2O4/c1-3-32(26(35)31-16-18-7-5-4-6-8-18)17-20-15-21(27(28,29)30)10-11-22(20)23-13-19(14-25(33)34)9-12-24(23)36-2/h4-13,15H,3,14,16-17H2,1-2H3,(H,31,35)(H,33,34)	OPXIRFWNLBDKQB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001746	GSK2194069	C25H24N4O3	3.5068	67376285	C1CN(C[C@@H]1CC2=NNC(=O)N2C3=CC=C(C=C3)C4=CC5=C(C=C4)OC=C5)C(=O)C6CC6	O=C(C1CC1)N1CCC(Cc2n[nH]c(=O)n2-c2ccc(-c3cc4c(cc3)occ4)cc2)C1	InChI=1S/C25H24N4O3/c30-24(18-1-2-18)28-11-9-16(15-28)13-23-26-27-25(31)29(23)21-6-3-17(4-7-21)19-5-8-22-20(14-19)10-12-32-22/h3-8,10,12,14,16,18H,1-2,9,11,13,15H2,(H,27,31)/t16-/m0/s1	AQTPWCUIYUOEMG-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_001748	209984-57-6	C26H23F2N3O4	3.5776	10435235	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C4=CC(=CC(=C4)F)F)O	CC(NC(=O)C(O)c1cc(F)cc(F)c1)C(=O)NC1C(=O)N(C)c2ccccc2-c2ccccc21	InChI=1S/C26H23F2N3O4/c1-14(29-25(34)23(32)15-11-16(27)13-17(28)12-15)24(33)30-22-20-9-4-3-7-18(20)19-8-5-6-10-21(19)31(2)26(22)35/h3-14,22-23,32H,1-2H3,(H,29,34)(H,30,33)/t14-,22-,23-/m0/s1	ULSSJYNJIZWPSB-CVRXJBIPSA-N					doublet; removed another duplicate entry; compound annotation
0391_001750	WRG-28	C21H18N2O5S	3.6353	139035038		CCNS(=O)(=O)c1ccc(COc2cc3c(cc2)nc2ccc(=O)cc-2o3)cc1	InChI=1S/C21H18N2O5S/c1-2-22-29(25,26)17-7-3-14(4-8-17)13-27-16-6-10-19-21(12-16)28-20-11-15(24)5-9-18(20)23-19/h3-12,22H,2,13H2,1H3	AARVTLIQNGAELZ-UHFFFAOYSA-N					compound annotation
0391_001751	209984-57-6	C26H23F2N3O4	3.8699	10435235	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)[C@H](C4=CC(=CC(=C4)F)F)O	CC(NC(=O)C(O)c1cc(F)cc(F)c1)C(=O)NC1C(=O)N(C)c2ccccc2-c2ccccc21	InChI=1S/C26H23F2N3O4/c1-14(29-25(34)23(32)15-11-16(27)13-17(28)12-15)24(33)30-22-20-9-4-3-7-18(20)19-8-5-6-10-21(19)31(2)26(22)35/h3-14,22-23,32H,1-2H3,(H,29,34)(H,30,33)/t14-,22-,23-/m0/s1	ULSSJYNJIZWPSB-CVRXJBIPSA-N					doublet; removed another duplicate entry; compound annotation
0391_001753	BAY-85-8501	C22H17F3N4O3S	4.202	66601502	CC1=C([C@H](N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N	CC1=C(C#N)C(c2c(S(C)(=O)=O)cc(C#N)cc2)N(C)C(=O)N1c1cccc(C(F)(F)F)c1	InChI=1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m1/s1	YAJWYFPMASPAMM-HXUWFJFHSA-N					doublet; compound annotation
0391_001754	(R)-BAY-85-8501	C22H17F3N4O3S	4.202	137704648	CC1=C([C@@H](N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N	CC1=C(C#N)C(c2c(S(C)(=O)=O)cc(C#N)cc2)N(C)C(=O)N1c1cccc(C(F)(F)F)c1	InChI=1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m0/s1	YAJWYFPMASPAMM-FQEVSTJZSA-N					doublet; compound annotation
0391_001755	BAY-85-8501	C22H17F3N4O3S	4.2072	66601502	CC1=C([C@H](N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N	CC1=C(C#N)C(c2c(S(C)(=O)=O)cc(C#N)cc2)N(C)C(=O)N1c1cccc(C(F)(F)F)c1	InChI=1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m1/s1	YAJWYFPMASPAMM-HXUWFJFHSA-N					doublet; compound annotation
0391_001756	(R)-BAY-85-8501	C22H17F3N4O3S	4.2072	137704648	CC1=C([C@@H](N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N	CC1=C(C#N)C(c2c(S(C)(=O)=O)cc(C#N)cc2)N(C)C(=O)N1c1cccc(C(F)(F)F)c1	InChI=1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m0/s1	YAJWYFPMASPAMM-FQEVSTJZSA-N					doublet; compound annotation
0391_001757	glucagon receptor antagonists-4	C26H28F3N3O4	4.9456	60151939	CCC[C@@H](C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC(=C(C(=C2)C)N3C=C(C=N3)C(F)(F)F)C	CCCC(Oc1cc(C)c(-n2cc(C(F)(F)F)cn2)c(C)c1)c1ccc(C(=O)NCCC(=O)O)cc1	InChI=1S/C26H28F3N3O4/c1-4-5-22(18-6-8-19(9-7-18)25(35)30-11-10-23(33)34)36-21-12-16(2)24(17(3)13-21)32-15-20(14-31-32)26(27,28)29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1	IBDYYOQKQCCSDP-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_001759	COH000	C25H25NO5	5.1649	60156415	CC1=CC=C(C=C1)C[C@H]([C@]23C=C[C@H](O2)C(=C3C(=O)OC)C(=O)OC)NC4=CC=CC=C4	COC(=O)C1=C(C(=O)OC)C2(C(Cc3ccc(C)cc3)Nc3ccccc3)C=CC1O2	InChI=1S/C25H25NO5/c1-16-9-11-17(12-10-16)15-20(26-18-7-5-4-6-8-18)25-14-13-19(31-25)21(23(27)29-2)22(25)24(28)30-3/h4-14,19-20,26H,15H2,1-3H3/t19-,20+,25-/m0/s1	UFPINDDCTUCUSA-DFIYOIEZSA-N					doublet; compound annotation
0391_001760	COH000	C25H25NO5	5.1756	60156415	CC1=CC=C(C=C1)C[C@H]([C@]23C=C[C@H](O2)C(=C3C(=O)OC)C(=O)OC)NC4=CC=CC=C4	COC(=O)C1=C(C(=O)OC)C2(C(Cc3ccc(C)cc3)Nc3ccccc3)C=CC1O2	InChI=1S/C25H25NO5/c1-16-9-11-17(12-10-16)15-20(26-18-7-5-4-6-8-18)25-14-13-19(31-25)21(23(27)29-2)22(25)24(28)30-3/h4-14,19-20,26H,15H2,1-3H3/t19-,20+,25-/m0/s1	UFPINDDCTUCUSA-DFIYOIEZSA-N					doublet; compound annotation
0391_001761	COH000	C25H25NO5	5.2633	60156415	CC1=CC=C(C=C1)C[C@H]([C@]23C=C[C@H](O2)C(=C3C(=O)OC)C(=O)OC)NC4=CC=CC=C4	COC(=O)C1=C(C(=O)OC)C2(C(Cc3ccc(C)cc3)Nc3ccccc3)C=CC1O2	InChI=1S/C25H25NO5/c1-16-9-11-17(12-10-16)15-20(26-18-7-5-4-6-8-18)25-14-13-19(31-25)21(23(27)29-2)22(25)24(28)30-3/h4-14,19-20,26H,15H2,1-3H3/t19-,20+,25-/m0/s1	UFPINDDCTUCUSA-DFIYOIEZSA-N					doublet; removed another duplicate entry; compound annotation
0391_001763	COH000	C25H25NO5	6.3245	60156415	CC1=CC=C(C=C1)C[C@H]([C@]23C=C[C@H](O2)C(=C3C(=O)OC)C(=O)OC)NC4=CC=CC=C4	COC(=O)C1=C(C(=O)OC)C2(C(Cc3ccc(C)cc3)Nc3ccccc3)C=CC1O2	InChI=1S/C25H25NO5/c1-16-9-11-17(12-10-16)15-20(26-18-7-5-4-6-8-18)25-14-13-19(31-25)21(23(27)29-2)22(25)24(28)30-3/h4-14,19-20,26H,15H2,1-3H3/t19-,20+,25-/m0/s1	UFPINDDCTUCUSA-DFIYOIEZSA-N					doublet; compound annotation
0391_001764	662164-09-2	C20H23N5	1.598	2950121		CC(Nc1nc(N2CCNCC2)nc2ccccc12)c1ccccc1	InChI=1S/C20H23N5/c1-15(16-7-3-2-4-8-16)22-19-17-9-5-6-10-18(17)23-20(24-19)25-13-11-21-12-14-25/h2-10,15,21H,11-14H2,1H3,(H,22,23,24)	LOGWGZNWEWFTJV-UHFFFAOYSA-N					compound annotation
0391_001765	BAY-850	C38H44ClN5O3	2.1987	129196931	CC1=CC=C(C=C1)[C@@H](C)NCC2=CC=C(O2)C3=CC(=C(C=C3OC)Cl)C(=O)N[C@H](CC4=CC=C(C=C4)C#N)CNC5CCC(CC5)N	COc1cc(Cl)c(C(=O)NC(CNC2CCC(N)CC2)Cc2ccc(C#N)cc2)cc1-c1ccc(CNC(C)c2ccc(C)cc2)o1	InChI=1S/C38H44ClN5O3/c1-24-4-10-28(11-5-24)25(2)42-23-32-16-17-36(47-32)34-19-33(35(39)20-37(34)46-3)38(45)44-31(18-26-6-8-27(21-40)9-7-26)22-43-30-14-12-29(41)13-15-30/h4-11,16-17,19-20,25,29-31,42-43H,12-15,18,22-23,41H2,1-3H3,(H,44,45)/t25-,29?,30?,31-/m1/s1	BSISGUIVBKDTQO-JLXKDNNHSA-N					removed another duplicate entry; compound annotation
0391_001767	1214265-56-1	C24H25ClN6O2	2.4614	44607360		C=CC(=O)Nc1cc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C24H25ClN6O2/c1-3-22(32)27-18-5-4-6-20(15-18)33-23-21(25)16-26-24(29-23)28-17-7-9-19(10-8-17)31-13-11-30(2)12-14-31/h3-10,15-16H,1,11-14H2,2H3,(H,27,32)(H,26,28,29)	APHGZZPEOCCYNO-UHFFFAOYSA-N					doublet; compound annotation
0391_001768	Flavopiridol	C21H20ClNO5	2.6598	5287969	CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2ccccc2Cl)cc3=O)C(O)C1	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	BIIVYFLTOXDAOV-YVEFUNNKSA-N					doublet; compound annotation
0391_001769	1214265-56-1	C24H25ClN6O2	2.9028	44607360		C=CC(=O)Nc1cc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C24H25ClN6O2/c1-3-22(32)27-18-5-4-6-20(15-18)33-23-21(25)16-26-24(29-23)28-17-7-9-19(10-8-17)31-13-11-30(2)12-14-31/h3-10,15-16H,1,11-14H2,2H3,(H,27,32)(H,26,28,29)	APHGZZPEOCCYNO-UHFFFAOYSA-N					doublet; compound annotation
0391_001770	1214265-56-1	C24H25ClN6O2	2.9514	44607360		C=CC(=O)Nc1cc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C24H25ClN6O2/c1-3-22(32)27-18-5-4-6-20(15-18)33-23-21(25)16-26-24(29-23)28-17-7-9-19(10-8-17)31-13-11-30(2)12-14-31/h3-10,15-16H,1,11-14H2,2H3,(H,27,32)(H,26,28,29)	APHGZZPEOCCYNO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001773	Trofosfamide	C9H18Cl3N2O2P	3.3366	65702		O=P1(N(CCCl)CCCl)OCCCN1CCCl	InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2	UMKFEPPTGMDVMI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001775	IOX4	C15H16N6O3	3.569	24812792		CC(C)(C)OC(=O)c1cnc(-n2[nH]cc(-n3ccnn3)c2=O)cc1	InChI=1S/C15H16N6O3/c1-15(2,3)24-14(23)10-4-5-12(16-8-10)21-13(22)11(9-18-21)20-7-6-17-19-20/h4-9,18H,1-3H3	HWQQDVNGHZIALS-UHFFFAOYSA-N					compound annotation
0391_001776	NVP-BHG712	C26H20F3N7O	3.8534	16747388		Cc1c(Nc2c3cnn(C)c3nc(-c3cnccc3)n2)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C26H20F3N7O/c1-15-8-9-16(25(37)32-19-7-3-6-18(12-19)26(27,28)29)11-21(15)33-23-20-14-31-36(2)24(20)35-22(34-23)17-5-4-10-30-13-17/h3-14H,1-2H3,(H,32,37)(H,33,34,35)	ZCCPLJOKGAACRT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001778	1268524-71-5	C23H25ClN4O2S	4.972	49871818	CC1=C(SC2=C1C(=N[C@@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)OC(C)(C)C)N=C2c1ccc(Cl)cc1	InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m1/s1	DNVXATUJJDPFDM-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_001780	Tetradecyl nicotinate	C20H33NO2	7.2564	531641		CCCCCCCCCCCCCCOC(=O)c1cnccc1	InChI=1S/C20H33NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-23-20(22)19-15-14-16-21-18-19/h14-16,18H,2-13,17H2,1H3	TVGLGJWCZSCAEM-UHFFFAOYSA-N					compound annotation
0391_001781	Tubastatin A	C20H21N3O2	1.7825	49850262		CN1CCc2c(C1)c1ccccc1n2Cc1ccc(C(=O)NO)cc1	InChI=1S/C20H21N3O2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25/h2-9,25H,10-13H2,1H3,(H,21,24)	GOVYBPLHWIEHEJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001782	182563-08-2	C21H22FN3O	2.2446	5311258		CN1CCC(c2c[nH]c3c2cc(NC(=O)c2ccc(F)cc2)cc3)CC1	InChI=1S/C21H22FN3O/c1-25-10-8-14(9-11-25)19-13-23-20-7-6-17(12-18(19)20)24-21(26)15-2-4-16(22)5-3-15/h2-7,12-14,23H,8-11H2,1H3,(H,24,26)	MDMJLMDBRQXOOI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001784	Pritelivir	C18H18N4O3S2	2.3005	491941		Cc1c(S(N)(=O)=O)sc(N(C)C(=O)Cc2ccc(-c3ccccn3)cc2)n1	InChI=1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25)	IVZKZONQVYTCKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001786	Axitinib	C22H18N4OS	2.3357	6450551	CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4	CNC(=O)c1ccccc1Sc1cc2c(cc1)c(C=Cc1ccccn1)n[nH]2	InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+	RITAVMQDGBJQJZ-FMIVXFBMSA-N					doublet; removed another duplicate entry; compound annotation
0391_001788	Axitinib	C22H18N4OS	2.3833	6450551	CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4	CNC(=O)c1ccccc1Sc1cc2c(cc1)c(C=Cc1ccccn1)n[nH]2	InChI=1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+	RITAVMQDGBJQJZ-FMIVXFBMSA-N					doublet; compound annotation
0391_001789	Ralfinamide	C17H19FN2O2	2.4252	5745207	C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F	CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	BHJIBOFHEFDSAU-LBPRGKRZSA-N					doublet; compound annotation
0391_001790	Ralfinamide	C17H19FN2O2	2.4302	5745207	C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F	CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	BHJIBOFHEFDSAU-LBPRGKRZSA-N					doublet; compound annotation
0391_001791	182563-08-2	C21H22FN3O	3.3505	5311258		CN1CCC(c2c[nH]c3c2cc(NC(=O)c2ccc(F)cc2)cc3)CC1	InChI=1S/C21H22FN3O/c1-25-10-8-14(9-11-25)19-13-23-20-7-6-17(12-18(19)20)24-21(26)15-2-4-16(22)5-3-15/h2-7,12-14,23H,8-11H2,1H3,(H,24,26)	MDMJLMDBRQXOOI-UHFFFAOYSA-N					doublet; compound annotation
0391_001792	Delanzomib	C21H28BN3O5	3.3505	24800541	B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O	CC(C)CC(NC(=O)C(NC(=O)c1cccc(-c2ccccc2)n1)C(C)O)B(O)O	InChI=1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14-,18+,19+/m1/s1	SJFBTAPEPRWNKH-CCKFTAQKSA-N					compound annotation
0391_001793	AS1842856	C18H22FN3O3	4.2914	72193864		CCn1cc(C(=O)O)c(=O)c2c1cc(NC1CCCCC1)c(F)c2N	InChI=1S/C18H22FN3O3/c1-2-22-9-11(18(24)25)17(23)14-13(22)8-12(15(19)16(14)20)21-10-6-4-3-5-7-10/h8-10,21H,2-7,20H2,1H3,(H,24,25)	MOMCHYGXXYBDCD-UHFFFAOYSA-N					doublet; compound annotation
0391_001794	AS1842856	C18H22FN3O3	4.2946	72193864		CCn1cc(C(=O)O)c(=O)c2c1cc(NC1CCCCC1)c(F)c2N	InChI=1S/C18H22FN3O3/c1-2-22-9-11(18(24)25)17(23)14-13(22)8-12(15(19)16(14)20)21-10-6-4-3-5-7-10/h8-10,21H,2-7,20H2,1H3,(H,24,25)	MOMCHYGXXYBDCD-UHFFFAOYSA-N					doublet; compound annotation
0391_001795	D-I03	C23H36N6S	0.6374	24761372		CCN(CC)CCNC(=S)Nc1cc2c(cc1)nc(N1CCN(CC)CC1)cc2C	InChI=1S/C23H36N6S/c1-5-27(6-2)11-10-24-23(30)25-19-8-9-21-20(17-19)18(4)16-22(26-21)29-14-12-28(7-3)13-15-29/h8-9,16-17H,5-7,10-15H2,1-4H3,(H2,24,25,30)	UXDGHRWOHOPKIL-UHFFFAOYSA-N					doublet; compound annotation
0391_001796	D-I03	C23H36N6S	0.9443	24761372		CCN(CC)CCNC(=S)Nc1cc2c(cc1)nc(N1CCN(CC)CC1)cc2C	InChI=1S/C23H36N6S/c1-5-27(6-2)11-10-24-23(30)25-19-8-9-21-20(17-19)18(4)16-22(26-21)29-14-12-28(7-3)13-15-29/h8-9,16-17H,5-7,10-15H2,1-4H3,(H2,24,25,30)	UXDGHRWOHOPKIL-UHFFFAOYSA-N					doublet; compound annotation
0391_001797	PF-562271	C21H20F3N7O3S	2.408	11713159		CN(c1c(CNc2nc(Nc3cc4c(cc3)NC(=O)C4)ncc2C(F)(F)F)cccn1)S(C)(=O)=O	InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)	MZDKLVOWGIOKTN-UHFFFAOYSA-N					doublet; compound annotation
0391_001798	PF-562271	C21H20F3N7O3S	2.4107	11713159		CN(c1c(CNc2nc(Nc3cc4c(cc3)NC(=O)C4)ncc2C(F)(F)F)cccn1)S(C)(=O)=O	InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)	MZDKLVOWGIOKTN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001800	TA-02	C20H13F2N3	2.4992	91691130		Fc1ccc(-c2c(-c3ccncc3)[nH]c(-c3ccccc3F)n2)cc1	InChI=1S/C20H13F2N3/c21-15-7-5-13(6-8-15)18-19(14-9-11-23-12-10-14)25-20(24-18)16-3-1-2-4-17(16)22/h1-12H,(H,24,25)	QIFJOFNVIVQRNJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001801	TA-02	C20H13F2N3	2.5432	91691130		Fc1ccc(-c2c(-c3ccncc3)[nH]c(-c3ccccc3F)n2)cc1	InChI=1S/C20H13F2N3/c21-15-7-5-13(6-8-15)18-19(14-9-11-23-12-10-14)25-20(24-18)16-3-1-2-4-17(16)22/h1-12H,(H,24,25)	QIFJOFNVIVQRNJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001802	Halopemide	C21H22ClFN4O2	2.5432	65490		O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1	InChI=1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)	NBHPRWLFLUBAIE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001804	Mps1-IN-1	C28H33N5O4S	2.6025	25195352		COc1c(Nc2nc3c(cc[nH]3)c(Nc3ccccc3S(=O)(=O)C(C)C)c2)ccc(N2CCC(O)CC2)c1	InChI=1S/C28H33N5O4S/c1-18(2)38(35,36)26-7-5-4-6-23(26)30-24-17-27(32-28-21(24)10-13-29-28)31-22-9-8-19(16-25(22)37-3)33-14-11-20(34)12-15-33/h4-10,13,16-18,20,34H,11-12,14-15H2,1-3H3,(H3,29,30,31,32)	NMJMRSQTDLRCRQ-UHFFFAOYSA-N					compound annotation
0391_001805	SAR405	C19H21ClF3N5O2	3.2372	72709209	C[C@@H]1COCCN1C2=CC(=O)N3CC[C@H](N(C3=N2)CC4=CC(=CN=C4)Cl)C(F)(F)F	CC1COCCN1c1cc(=O)n2CCC(C(F)(F)F)N(Cc3cc(Cl)cnc3)c2n1	InChI=1S/C19H21ClF3N5O2/c1-12-11-30-5-4-26(12)16-7-17(29)27-3-2-15(19(21,22)23)28(18(27)25-16)10-13-6-14(20)9-24-8-13/h6-9,12,15H,2-5,10-11H2,1H3/t12-,15+/m1/s1	SPDQRCUBFSRAFI-DOMZBBRYSA-N					removed another duplicate entry; compound annotation
0391_001807	TBA-354	C19H15F3N4O5	4.0376	49836057	C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CN=C(C=C3)C4=CC=C(C=C4)OC(F)(F)F	O=[N+]([O-])c1cn2CC(OCc3cnc(-c4ccc(OC(F)(F)F)cc4)cc3)COc2n1	InChI=1S/C19H15F3N4O5/c20-19(21,22)31-14-4-2-13(3-5-14)16-6-1-12(7-23-16)10-29-15-8-25-9-17(26(27)28)24-18(25)30-11-15/h1-7,9,15H,8,10-11H2/t15-/m0/s1	ZXSGSFMORAILEY-HNNXBMFYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001809	Ferrostatin-1	C15H22N2O2	4.0802	4068248		CCOC(=O)c1cc(N)c(NC2CCCCC2)cc1	InChI=1S/C15H22N2O2/c1-2-19-15(18)11-8-9-14(13(16)10-11)17-12-6-4-3-5-7-12/h8-10,12,17H,2-7,16H2,1H3	UJHBVMHOBZBWMX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001811	TBA-354	C19H15F3N4O5	4.2748	49836057	C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CN=C(C=C3)C4=CC=C(C=C4)OC(F)(F)F	O=[N+]([O-])c1cn2CC(OCc3cnc(-c4ccc(OC(F)(F)F)cc4)cc3)COc2n1	InChI=1S/C19H15F3N4O5/c20-19(21,22)31-14-4-2-13(3-5-14)16-6-1-12(7-23-16)10-29-15-8-25-9-17(26(27)28)24-18(25)30-11-15/h1-7,9,15H,8,10-11H2/t15-/m0/s1	ZXSGSFMORAILEY-HNNXBMFYSA-N					doublet; compound annotation
0391_001812	WJ460	C27H28N2O3S	4.4342	134820567		COc1ccccc1N1C(=O)CSC1c1cc(C(=O)NCCCCc2ccccc2)ccc1	InChI=1S/C27H28N2O3S/c1-32-24-16-6-5-15-23(24)29-25(30)19-33-27(29)22-14-9-13-21(18-22)26(31)28-17-8-7-12-20-10-3-2-4-11-20/h2-6,9-11,13-16,18,27H,7-8,12,17,19H2,1H3,(H,28,31)	BOSNKHFAOWELSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001814	307986-98-7	C29H31N7O4S	4.4765	23549991		CS(=O)(=O)c1cccc(NC(=O)N(Cc2ccc(C(=O)Nc3n[nH]nn3)cc2)c2ccc(C3CCCCC3)cc2)c1	InChI=1S/C29H31N7O4S/c1-41(39,40)26-9-5-8-24(18-26)30-29(38)36(25-16-14-22(15-17-25)21-6-3-2-4-7-21)19-20-10-12-23(13-11-20)27(37)31-28-32-34-35-33-28/h5,8-18,21H,2-4,6-7,19H2,1H3,(H,30,38)(H2,31,32,33,34,35,37)	PPTKULJUDJWTSA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001816	Palosuran	C25H30N4O2	1.5071	10173280		Cc1nc2ccccc2c(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c1	InChI=1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30)	WYJCYXOCHXWTHG-UHFFFAOYSA-N					doublet; compound annotation
0391_001817	GK921	C21H20N4O	2.2686	56682080		C(#Cc1nc2c(cccn2)nc1OCCN1CCCC1)c1ccccc1	InChI=1S/C21H20N4O/c1-2-7-17(8-3-1)10-11-19-21(26-16-15-25-13-4-5-14-25)24-18-9-6-12-22-20(18)23-19/h1-3,6-9,12H,4-5,13-16H2	MNYJJHBAEYKXEG-UHFFFAOYSA-N					doublet; compound annotation
0391_001818	GK921	C21H20N4O	2.2719	56682080		C(#Cc1nc2c(cccn2)nc1OCCN1CCCC1)c1ccccc1	InChI=1S/C21H20N4O/c1-2-7-17(8-3-1)10-11-19-21(26-16-15-25-13-4-5-14-25)24-18-9-6-12-22-20(18)23-19/h1-3,6-9,12H,4-5,13-16H2	MNYJJHBAEYKXEG-UHFFFAOYSA-N					doublet; compound annotation
0391_001819	Palosuran	C25H30N4O2	2.47	10173280		Cc1nc2ccccc2c(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c1	InChI=1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30)	WYJCYXOCHXWTHG-UHFFFAOYSA-N					doublet; compound annotation
0391_001820	ML216	C15H9F4N5OS	3.3978	49852229		O=C(Nc1cc(C(F)(F)F)c(F)cc1)Nc1nnc(-c2ccncc2)s1	InChI=1S/C15H9F4N5OS/c16-11-2-1-9(7-10(11)15(17,18)19)21-13(25)22-14-24-23-12(26-14)8-3-5-20-6-4-8/h1-7H,(H2,21,22,24,25)	WMCOYUSJXXCHFH-UHFFFAOYSA-N					compound annotation
0391_001821	Nelonemdaz	C15H8F7NO3	4.3051	9951955		O=C(O)c1c(O)ccc(NCc2c(F)c(F)c(C(F)(F)F)c(F)c2F)c1	InChI=1S/C15H8F7NO3/c16-10-7(11(17)13(19)9(12(10)18)15(20,21)22)4-23-5-1-2-8(24)6(3-5)14(25)26/h1-3,23-24H,4H2,(H,25,26)	HABROHXUHNHQMY-UHFFFAOYSA-N					doublet; compound annotation
0391_001822	AMG-517	C20H13F3N4O2S	4.352	16007367		CC(=O)Nc1nc2c(Oc3ncnc(-c4ccc(C(F)(F)F)cc4)c3)cccc2s1	InChI=1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28)	YUTIXVXZQIQWGY-UHFFFAOYSA-N					doublet; compound annotation
0391_001823	BMS-687453	C22H21ClN2O6	4.5966	16725047		COC(=O)N(CC(=O)O)Cc1cc(OCc2c(C)oc(-c3ccc(Cl)cc3)n2)ccc1	InChI=1S/C22H21ClN2O6/c1-14-19(24-21(31-14)16-6-8-17(23)9-7-16)13-30-18-5-3-4-15(10-18)11-25(12-20(26)27)22(28)29-2/h3-10H,11-13H2,1-2H3,(H,26,27)	UJIBXDMNCMEJAY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001825	AMG-517	C20H13F3N4O2S	4.7146	16007367		CC(=O)Nc1nc2c(Oc3ncnc(-c4ccc(C(F)(F)F)cc4)c3)cccc2s1	InChI=1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28)	YUTIXVXZQIQWGY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001827	875787-07-8	C21H12ClF5N2	5.9105	16734800		Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2c(Cl)cc(F)cc2)cc1	InChI=1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2	KYWWJENKIMRJBI-UHFFFAOYSA-N					compound annotation
0391_001828	Nicaraven	C15H16N4O2	0.8009	71234		CC(CNC(=O)c1cnccc1)NC(=O)c1cnccc1	InChI=1S/C15H16N4O2/c1-11(19-15(21)13-5-3-7-17-10-13)8-18-14(20)12-4-2-6-16-9-12/h2-7,9-11H,8H2,1H3,(H,18,20)(H,19,21)	KTXBOOWDLPUROC-UHFFFAOYSA-N					doublet; compound annotation
0391_001829	Didesethyl Chloroquine	C14H18ClN3	1.0185	122672		CC(CCCN)Nc1c2ccc(Cl)cc2ncc1	InChI=1S/C14H18ClN3/c1-10(3-2-7-16)18-13-6-8-17-14-9-11(15)4-5-12(13)14/h4-6,8-10H,2-3,7,16H2,1H3,(H,17,18)	GYEDIFVVTRKXHP-UHFFFAOYSA-N					compound annotation
0391_001830	NSC 663284	C15H16ClN3O3	1.0333	379077		O=C1C(Cl)=C(NCCN2CCOCC2)C(=O)c2c1cccn2	InChI=1S/C15H16ClN3O3/c16-11-13(18-4-5-19-6-8-22-9-7-19)15(21)12-10(14(11)20)2-1-3-17-12/h1-3,18H,4-9H2	BMKPVDQDJQWBPD-UHFFFAOYSA-N					compound annotation
0391_001831	Nicaraven	C15H16N4O2	1.6351	71234		CC(CNC(=O)c1cnccc1)NC(=O)c1cnccc1	InChI=1S/C15H16N4O2/c1-11(19-15(21)13-5-3-7-17-10-13)8-18-14(20)12-4-2-6-16-9-12/h2-7,9-11H,8H2,1H3,(H,18,20)(H,19,21)	KTXBOOWDLPUROC-UHFFFAOYSA-N					doublet; compound annotation
0391_001832	Nicaraven	C15H16N4O2	1.945	71234		CC(CNC(=O)c1cnccc1)NC(=O)c1cnccc1	InChI=1S/C15H16N4O2/c1-11(19-15(21)13-5-3-7-17-10-13)8-18-14(20)12-4-2-6-16-9-12/h2-7,9-11H,8H2,1H3,(H,18,20)(H,19,21)	KTXBOOWDLPUROC-UHFFFAOYSA-N					doublet; compound annotation
0391_001833	UNC0379	C23H35N5O2	1.945	78357767		COc1c(OC)cc2c(NCCCCCN3CCCC3)nc(N3CCCC3)nc2c1	InChI=1S/C23H35N5O2/c1-29-20-16-18-19(17-21(20)30-2)25-23(28-14-8-9-15-28)26-22(18)24-10-4-3-5-11-27-12-6-7-13-27/h16-17H,3-15H2,1-2H3,(H,24,25,26)	WEXCGGWTIDNVNT-UHFFFAOYSA-N					compound annotation
0391_001834	331771-20-1	C29H31N5O4	1.983	9914412		COc1c(OCCCN2CCOCC2)cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2c1	InChI=1S/C29H31N5O4/c1-36-26-18-24-25(19-27(26)38-15-5-12-34-13-16-37-17-14-34)30-20-31-28(24)32-22-8-10-23(11-9-22)33-29(35)21-6-3-2-4-7-21/h2-4,6-11,18-20H,5,12-17H2,1H3,(H,33,35)(H,30,31,32)	OGNYUTNQZVRGMN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001836	PQR620	C21H25F2N7O2	2.9493	122412735	C1C[C@H]2COC[C@@H]1N2C3=NC(=NC(=N3)C4=CN=C(C=C4C(F)F)N)N5[C@@H]6CC[C@H]5COC6	Nc1ncc(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)c(C(F)F)c1	InChI=1S/C21H25F2N7O2/c22-18(23)15-5-17(24)25-6-16(15)19-26-20(29-11-1-2-12(29)8-31-7-11)28-21(27-19)30-13-3-4-14(30)10-32-9-13/h5-6,11-14,18H,1-4,7-10H2,(H2,24,25)/t11-,12+,13-,14+	UGDKPWVVBKHRDK-KPWCQOOUSA-N					doublet; compound annotation
0391_001837	PQR620	C21H25F2N7O2	3.1685	122412735	C1C[C@H]2COC[C@@H]1N2C3=NC(=NC(=N3)C4=CN=C(C=C4C(F)F)N)N5[C@@H]6CC[C@H]5COC6	Nc1ncc(-c2nc(N3C4CCC3COC4)nc(N3C4CCC3COC4)n2)c(C(F)F)c1	InChI=1S/C21H25F2N7O2/c22-18(23)15-5-17(24)25-6-16(15)19-26-20(29-11-1-2-12(29)8-31-7-11)28-21(27-19)30-13-3-4-14(30)10-32-9-13/h5-6,11-14,18H,1-4,7-10H2,(H2,24,25)/t11-,12+,13-,14+	UGDKPWVVBKHRDK-KPWCQOOUSA-N					doublet; compound annotation
0391_001838	HUHS015	C19H18N4O	4.423	71696702		Cc1cc2c(cc1)nc(-n1[nH]c(C)c(Cc3ccccc3)c1=O)[nH]2	InChI=1S/C19H18N4O/c1-12-8-9-16-17(10-12)21-19(20-16)23-18(24)15(13(2)22-23)11-14-6-4-3-5-7-14/h3-10,22H,11H2,1-2H3,(H,20,21)	IQOKQFQFGHZHJT-UHFFFAOYSA-N					doublet; compound annotation
0391_001839	HUHS015	C19H18N4O	4.4793	71696702		Cc1cc2c(cc1)nc(-n1[nH]c(C)c(Cc3ccccc3)c1=O)[nH]2	InChI=1S/C19H18N4O/c1-12-8-9-16-17(10-12)21-19(20-16)23-18(24)15(13(2)22-23)11-14-6-4-3-5-7-14/h3-10,22H,11H2,1-2H3,(H,20,21)	IQOKQFQFGHZHJT-UHFFFAOYSA-N					doublet; compound annotation
0391_001840	m-Tyramine	C8H11NO	0.4658	11492		NCCc1cc(O)ccc1	InChI=1S/C8H11NO/c9-5-4-7-2-1-3-8(10)6-7/h1-3,6,10H,4-5,9H2	GHFGJTVYMNRGBY-UHFFFAOYSA-N					compound annotation
0391_001841	ST-836	C23H34N4OS	1.9021	42602909		CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(C1)scn2	InChI=1S/C23H34N4OS/c1-3-10-26(19-8-9-20-23(17-19)29-18-24-20)14-11-25-12-15-27(16-13-25)21-6-4-5-7-22(21)28-2/h4-7,18-19H,3,8-17H2,1-2H3	RSWFSOOHVWOZQI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001843	DIZOCILPINE	C16H15N	2.0001	180081	C[C@@]12C3=CC=CC=C3C[C@@H](N1)C4=CC=CC=C24	CC12NC(Cc3ccccc31)c1ccccc12	InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15-,16+/m1/s1	LBOJYSIDWZQNJS-CVEARBPZSA-N					compound annotation
0391_001844	DHED	C18H24O3	2.4901	11851170	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)C=C[C@]34O	CC12CCC3C(CCC4=CC(=O)C=CC43O)C1CCC2O	InChI=1S/C18H24O3/c1-17-8-7-15-13(14(17)4-5-16(17)20)3-2-11-10-12(19)6-9-18(11,15)21/h6,9-10,13-16,20-21H,2-5,7-8H2,1H3/t13-,14-,15-,16-,17-,18+/m0/s1	UIKDFTLKOKNUJP-UGDFAFBOSA-N					compound annotation
0391_001845	Capromorelin	C28H35N5O4	2.7311	216208	CC(C)(C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)[C@@]3(C2)CC4=CC=CC=C4)C)N	CN1N=C2CCN(C(=O)C(COCc3ccccc3)NC(=O)C(C)(C)N)CC2(Cc2ccccc2)C1=O	InChI=1S/C28H35N5O4/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20/h4-13,22H,14-19,29H2,1-3H3,(H,30,35)/t22-,28-/m1/s1	KVLLHLWBPNCVNR-SKCUWOTOSA-N					doublet; removed another duplicate entry; compound annotation
0391_001847	Capromorelin	C28H35N5O4	2.8924	216208	CC(C)(C(=O)N[C@H](COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)[C@@]3(C2)CC4=CC=CC=C4)C)N	CN1N=C2CCN(C(=O)C(COCc3ccccc3)NC(=O)C(C)(C)N)CC2(Cc2ccccc2)C1=O	InChI=1S/C28H35N5O4/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20/h4-13,22H,14-19,29H2,1-3H3,(H,30,35)/t22-,28-/m1/s1	KVLLHLWBPNCVNR-SKCUWOTOSA-N					doublet; compound annotation
0391_001848	PCI-34051	C17H16N2O3	3.1594	24753719		COc1ccc(Cn2ccc3c2cc(C(=O)NO)cc3)cc1	InChI=1S/C17H16N2O3/c1-22-15-6-2-12(3-7-15)11-19-9-8-13-4-5-14(10-16(13)19)17(20)18-21/h2-10,21H,11H2,1H3,(H,18,20)	AJRGHIGYPXNABY-UHFFFAOYSA-N					compound annotation
0391_001849	1808714-73-9	C19H14F2N4O2	3.3623	99640033		C=CC(=O)Nc1c(F)ccc(NC(=O)c2cn(-c3ccccc3F)nc2)c1	InChI=1S/C19H14F2N4O2/c1-2-18(26)24-16-9-13(7-8-14(16)20)23-19(27)12-10-22-25(11-12)17-6-4-3-5-15(17)21/h2-11H,1H2,(H,23,27)(H,24,26)	SUSXQEYPNDORDQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001851	Tonabersat	C20H19ClFNO4	3.3623	6918324	CC(=O)C1=CC2=C(C=C1)OC([C@H]([C@H]2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C	CC(=O)c1cc2c(cc1)OC(C)(C)C(O)C2NC(=O)c1cc(Cl)c(F)cc1	InChI=1S/C20H19ClFNO4/c1-10(24)11-5-7-16-13(8-11)17(18(25)20(2,3)27-16)23-19(26)12-4-6-15(22)14(21)9-12/h4-9,17-18,25H,1-3H3,(H,23,26)/t17-,18-/m0/s1	XLIIRNOPGJTBJD-ROUUACIJSA-N					doublet; compound annotation
0391_001852	Tonabersat	C20H19ClFNO4	3.6616	6918324	CC(=O)C1=CC2=C(C=C1)OC([C@H]([C@H]2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C	CC(=O)c1cc2c(cc1)OC(C)(C)C(O)C2NC(=O)c1cc(Cl)c(F)cc1	InChI=1S/C20H19ClFNO4/c1-10(24)11-5-7-16-13(8-11)17(18(25)20(2,3)27-16)23-19(26)12-4-6-15(22)14(21)9-12/h4-9,17-18,25H,1-3H3,(H,23,26)/t17-,18-/m0/s1	XLIIRNOPGJTBJD-ROUUACIJSA-N					doublet; removed another duplicate entry; compound annotation
0391_001854	reparixin	C14H21NO3S	4.2641	9838712	C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)NS(=O)(=O)C	CC(C)Cc1ccc(C(C)C(=O)NS(C)(=O)=O)cc1	InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1	KQDRVXQXKZXMHP-LLVKDONJSA-N					doublet; compound annotation
0391_001855	dexamethasone palmitate	C38H59FO6	7.4626	63044	CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O	CCCCCCCCCCCCCCCC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C38H59FO6/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-34(43)45-26-33(42)38(44)27(2)23-31-30-20-19-28-24-29(40)21-22-35(28,3)37(30,39)32(41)25-36(31,38)4/h21-22,24,27,30-32,41,44H,5-20,23,25-26H2,1-4H3/t27-,30+,31+,32+,35+,36+,37+,38+/m1/s1	WDPYZTKOEFDTCU-WDJQFAPHSA-N					removed another duplicate entry; compound annotation
0391_001857	kinetin	C10H9N5O	1.2004	3830		c1coc(CNc2ncnc3c2[nH]cn3)c1	InChI=1S/C10H9N5O/c1-2-7(16-3-1)4-11-9-8-10(13-5-12-8)15-6-14-9/h1-3,5-6H,4H2,(H2,11,12,13,14,15)	QANMHLXAZMSUEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001859	Rhodionin	C21H20O11	2.4079	21626477	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(C3=C(C(=C2)O)C(=O)C(=C(O3)C4=CC=C(C=C4)O)O)O)O)O)O	CC1OC(Oc2c(O)c3c(c(O)c2)c(=O)c(O)c(-c2ccc(O)cc2)o3)C(O)C(O)C1O	InChI=1S/C21H20O11/c1-7-13(24)16(27)18(29)21(30-7)31-11-6-10(23)12-15(26)17(28)19(32-20(12)14(11)25)8-2-4-9(22)5-3-8/h2-7,13,16,18,21-25,27-29H,1H3/t7-,13-,16+,18+,21-/m0/s1	CIAXXTSXVCLEJK-JOEVVYSCSA-N					compound annotation
0391_001860	Nigakinone	C15H10N2O3	2.5938	5320161		COc1c(O)c(=O)n2c3ccccc3c3c2c1ncc3	InChI=1S/C15H10N2O3/c1-20-14-11-12-9(6-7-16-11)8-4-2-3-5-10(8)17(12)15(19)13(14)18/h2-7,18H,1H3	PGFKZUOYIFDMQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001861	Nigakinone	C15H10N2O3	2.5967	5320161		COc1c(O)c(=O)n2c3ccccc3c3c2c1ncc3	InChI=1S/C15H10N2O3/c1-20-14-11-12-9(6-7-16-11)8-4-2-3-5-10(8)17(12)15(19)13(14)18/h2-7,18H,1H3	PGFKZUOYIFDMQJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001863	Radioprotectin-1	C23H19ClN2O6S	3.3106	77461257		O=C(O)c1c(S(=O)(=O)NCCCCN2C(=O)c3cccc4c3c(ccc4)C2=O)ccc(Cl)c1	InChI=1S/C23H19ClN2O6S/c24-15-9-10-19(18(13-15)23(29)30)33(31,32)25-11-1-2-12-26-21(27)16-7-3-5-14-6-4-8-17(20(14)16)22(26)28/h3-10,13,25H,1-2,11-12H2,(H,29,30)	OVJUYQCJIFWMBI-UHFFFAOYSA-N					doublet; compound annotation
0391_001864	clopidogrel thiolactone	C16H16ClNO3S	4.0898	56848893	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3C(=CC(=O)S3)C2	COC(=O)C(c1ccccc1Cl)N1CCC2SC(=O)C=C2C1	InChI=1S/C16H16ClNO3S/c1-21-16(20)15(11-4-2-3-5-12(11)17)18-7-6-13-10(9-18)8-14(19)22-13/h2-5,8,13,15H,6-7,9H2,1H3/t13?,15-/m0/s1	JBSAZVIMJUOBNB-WUJWULDRSA-N					doublet; compound annotation
0391_001865	clopidogrel thiolactone	C16H16ClNO3S	4.1527	56848893	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3C(=CC(=O)S3)C2	COC(=O)C(c1ccccc1Cl)N1CCC2SC(=O)C=C2C1	InChI=1S/C16H16ClNO3S/c1-21-16(20)15(11-4-2-3-5-12(11)17)18-7-6-13-10(9-18)8-14(19)22-13/h2-5,8,13,15H,6-7,9H2,1H3/t13?,15-/m0/s1	JBSAZVIMJUOBNB-WUJWULDRSA-N					doublet; compound annotation
0391_001866	Radioprotectin-1	C23H19ClN2O6S	4.2226	77461257		O=C(O)c1c(S(=O)(=O)NCCCCN2C(=O)c3cccc4c3c(ccc4)C2=O)ccc(Cl)c1	InChI=1S/C23H19ClN2O6S/c24-15-9-10-19(18(13-15)23(29)30)33(31,32)25-11-1-2-12-26-21(27)16-7-3-5-14-6-4-8-17(20(14)16)22(26)28/h3-10,13,25H,1-2,11-12H2,(H,29,30)	OVJUYQCJIFWMBI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001868	1443460-91-0	C48H73ClN2O6	4.8844	71580991	CC(C)C1=C2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC[C@]2(CC1=O)[C@H](CN(CCN(C)C)CC6=CC=C(C=C6)Cl)O)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C	CC(C)C1=C2C3CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC4(C)C3(C)CCC2(C(O)CN(CCN(C)C)Cc2ccc(Cl)cc2)CC1=O	InChI=1S/C48H73ClN2O6/c1-30(2)40-34(52)26-48(37(53)29-51(25-24-50(10)11)28-31-12-14-32(49)15-13-31)23-22-46(8)33(41(40)48)16-17-36-45(7)20-19-38(57-39(54)27-43(3,4)42(55)56)44(5,6)35(45)18-21-47(36,46)9/h12-15,30,33,35-38,53H,16-29H2,1-11H3,(H,55,56)/t33-,35+,36-,37+,38+,45+,46-,47-,48+/m1/s1	MEOWKUXNVNJAMY-PZFKGGKESA-N					compound annotation
0391_001869	PF-04217903	C19H16N8O	1.6937	17754438		OCCn1cc(-c2cnc3nnn(Cc4cc5c(cc4)nccc5)c3n2)cn1	InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2	PDMUGYOXRHVNMO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001871	1184136-10-4	C16H21BrN2O	1.7862	61041645		O=C(c1cc(Br)ccc1)N1CCC(N2CCCC2)CC1	InChI=1S/C16H21BrN2O/c17-14-5-3-4-13(12-14)16(20)19-10-6-15(7-11-19)18-8-1-2-9-18/h3-5,12,15H,1-2,6-11H2	OWGLFIKZKQOYHZ-UHFFFAOYSA-N					compound annotation
0391_001872	575474-82-7	C16H13FN4O2	1.9053	9904854		Oc1cccc(Nc2ncc(F)c(Nc3cc(O)ccc3)n2)c1	InChI=1S/C16H13FN4O2/c17-14-9-18-16(20-11-4-2-6-13(23)8-11)21-15(14)19-10-3-1-5-12(22)7-10/h1-9,22-23H,(H2,18,19,20,21)	TVKGTSHBQZEFEE-UHFFFAOYSA-N					compound annotation
0391_001873	CDK9-IN-2	C23H25ClFN5	2.7601	49855228		NC1CCC(Nc2ncc(Cl)c(-c3nc(NCc4cc(F)ccc4)ccc3)c2)CC1	InChI=1S/C23H25ClFN5/c24-20-14-28-23(29-18-9-7-17(26)8-10-18)12-19(20)21-5-2-6-22(30-21)27-13-15-3-1-4-16(25)11-15/h1-6,11-12,14,17-18H,7-10,13,26H2,(H,27,30)(H,28,29)	XKHXPTSUVPZYDW-UHFFFAOYSA-N					compound annotation
0391_001874	Ulipristal acetate	C30H37NO4	2.8258	130904	CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1	OOLLAFOLCSJHRE-ZHAKMVSLSA-N					doublet; compound annotation
0391_001875	SNS-314	C18H15ClN6OS2	2.9042	24995524		O=C(Nc1cc(Cl)ccc1)Nc1ncc(CCNc2ncnc3c2scc3)s1	InChI=1S/C18H15ClN6OS2/c19-11-2-1-3-12(8-11)24-17(26)25-18-21-9-13(28-18)4-6-20-16-15-14(5-7-27-15)22-10-23-16/h1-3,5,7-10H,4,6H2,(H,20,22,23)(H2,21,24,25,26)	FAYAUAZLLLJJGH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001877	NVP-BGJ398	C26H31Cl2N7O3	2.9709	53235510		CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1	InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H,32,36)(H,29,30,31)	QADPYRIHXKWUSV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001879	Ulipristal acetate	C30H37NO4	3.3736	130904	CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1	OOLLAFOLCSJHRE-ZHAKMVSLSA-N					doublet; compound annotation
0391_001880	Ulipristal acetate	C30H37NO4	3.3768	130904	CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1	OOLLAFOLCSJHRE-ZHAKMVSLSA-N					doublet; compound annotation
0391_001881	LY2874455	C21H19Cl2N5O2	3.5609	46944259	C[C@H](C1=C(C=NC=C1Cl)Cl)OC2=CC3=C(C=C2)NN=C3/C=C/C4=CN(N=C4)CCO	CC(Oc1cc2c(cc1)[nH]nc2C=Cc1cn(CCO)nc1)c1c(Cl)cncc1Cl	InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+/t13-/m1/s1	GKJCVYLDJWTWQU-CXLRFSCWSA-N					doublet; compound annotation
0391_001882	LY2874455	C21H19Cl2N5O2	3.7845	46944259	C[C@H](C1=C(C=NC=C1Cl)Cl)OC2=CC3=C(C=C2)NN=C3/C=C/C4=CN(N=C4)CCO	CC(Oc1cc2c(cc1)[nH]nc2C=Cc1cn(CCO)nc1)c1c(Cl)cncc1Cl	InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+/t13-/m1/s1	GKJCVYLDJWTWQU-CXLRFSCWSA-N					doublet; compound annotation
0391_001883	Arglabin	C15H18O3	3.9165	5574924	CC1=CC[C@@]23[C@H]1[C@@H]4[C@@H](CC[C@@]2(O3)C)C(=C)C(=O)O4	C=C1C(=O)OC2C1CCC1(C)OC13CC=C(C)C23	InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11+,12-,14-,15+/m0/s1	UVJYAKBJSGRTHA-CUZKYEQNSA-N					compound annotation
0391_001884	montelukast	C35H36ClNO3S	5.469	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	CC(C)(O)c1ccccc1CCC(SCC1(CC(=O)O)CC1)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1	UCHDWCPVSPXUMX-TZIWLTJVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001886	montelukast	C35H36ClNO3S	5.6895	5281040	CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O	CC(C)(O)c1ccccc1CCC(SCC1(CC(=O)O)CC1)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1	UCHDWCPVSPXUMX-TZIWLTJVSA-N					doublet; removed another duplicate entry; compound annotation
0391_001888	53602-84-9	C12H13N3O7	0.4903	104545	C1=CC(=C(C=C1NC(=O)CC[C@@H](C(=O)O)N)C(=O)O)[N+](=O)[O-]	NC(CCC(=O)Nc1cc(C(=O)O)c([N+](=O)[O-])cc1)C(=O)O	InChI=1S/C12H13N3O7/c13-8(12(19)20)2-4-10(16)14-6-1-3-9(15(21)22)7(5-6)11(17)18/h1,3,5,8H,2,4,13H2,(H,14,16)(H,17,18)(H,19,20)/t8-/m0/s1	AHFFWTMLFDZSOF-QMMMGPOBSA-N					compound annotation
0391_001889	Gepotidacin	C24H28N6O3	0.9414	25101874	C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)C[C@@H]4CN5C(=O)C=CC6=C5N4C(=O)C=N6	O=c1ccc2c3n1CC(CN1CCC(NCc4ncc5OCCCc5c4)CC1)n3c(=O)cn2	InChI=1S/C24H28N6O3/c31-22-4-3-20-24-29(22)15-19(30(24)23(32)13-27-20)14-28-7-5-17(6-8-28)25-11-18-10-16-2-1-9-33-21(16)12-26-18/h3-4,10,12-13,17,19,25H,1-2,5-9,11,14-15H2/t19-/m1/s1	PZFAZQUREQIODZ-LJQANCHMSA-N					removed another duplicate entry; compound annotation
0391_001891	LY2584702	C21H19F4N7	2.3626	25118925		Cn1cc(-c2cc(C(F)(F)F)c(F)cc2)nc1C1CCN(c2ncnc3c2cn[nH]3)CC1	InChI=1S/C21H19F4N7/c1-31-10-17(13-2-3-16(22)15(8-13)21(23,24)25)29-19(31)12-4-6-32(7-5-12)20-14-9-28-30-18(14)26-11-27-20/h2-3,8-12H,4-7H2,1H3,(H,26,27,28,30)	FYXRSVDHGLUMHB-UHFFFAOYSA-N					compound annotation
0391_001892	bisindolylmaleimide i	C25H24N4O2	2.5525	2396		CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21	InChI=1S/C25H24N4O2/c1-28(2)12-7-13-29-15-19(17-9-4-6-11-21(17)29)23-22(24(30)27-25(23)31)18-14-26-20-10-5-3-8-16(18)20/h3-6,8-11,14-15,26H,7,12-13H2,1-2H3,(H,27,30,31)	QMGUOJYZJKLOLH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001895	1307245-86-8	C22H23ClF2N4O2S	2.9532	52914971		Cc1nn(-c2c(CO)cccn2)cc1CN1CCC2(CC1)OCC(F)(F)c1c2sc(Cl)c1	InChI=1S/C22H23ClF2N4O2S/c1-14-16(11-29(27-14)20-15(12-30)3-2-6-26-20)10-28-7-4-21(5-8-28)19-17(9-18(23)32-19)22(24,25)13-31-21/h2-3,6,9,11,30H,4-5,7-8,10,12-13H2,1H3	NKQHBJNRBKHUQR-UHFFFAOYSA-N					compound annotation
0391_001896	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.0227	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; compound annotation
0391_001897	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.0598	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_001899	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.0625	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; compound annotation
0391_001900	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.3056	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; compound annotation
0391_001901	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.4138	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_001903	Pilaralisib	C25H25ClN6O4S	3.7253	56599306		COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c(Cl)cc1	InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)	QINPEPAQOBZPOF-UHFFFAOYSA-N					doublet; compound annotation
0391_001904	Pilaralisib	C25H25ClN6O4S	3.7302	56599306		COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c(Cl)cc1	InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)	QINPEPAQOBZPOF-UHFFFAOYSA-N					doublet; compound annotation
0391_001905	HDACs/mTOR Inhibitor 1	C28H38N8O5	3.8752	137628684	C[C@@H]1CN(CCO1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(C=NN4CCCCCCC(=O)NO)C(=N3)N5CCOCC5	CC1CN(C(=O)Nc2ccc(-c3nc4c(cnn4CCCCCCC(=O)NO)c(N4CCOCC4)n3)cc2)CCO1	InChI=1S/C28H38N8O5/c1-20-19-35(14-17-41-20)28(38)30-22-9-7-21(8-10-22)25-31-26(34-12-15-40-16-13-34)23-18-29-36(27(23)32-25)11-5-3-2-4-6-24(37)33-39/h7-10,18,20,39H,2-6,11-17,19H2,1H3,(H,30,38)(H,33,37)/t20-/m1/s1	YPXRCUVTZDXVHY-HXUWFJFHSA-N					doublet; compound annotation
0391_001906	Closantel	C22H14Cl2I2N2O2	6.3996	42574		Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1c(O)c(I)cc(I)c1	InChI=1S/C22H14Cl2I2N2O2/c1-11-6-15(17(10-27)12-2-4-13(23)5-3-12)18(24)9-20(11)28-22(30)16-7-14(25)8-19(26)21(16)29/h2-9,17,29H,1H3,(H,28,30)	JMPFSEBWVLAJKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001908	Cetaben	C23H39NO2	7.3216	47263		CCCCCCCCCCCCCCCCNc1ccc(C(=O)O)cc1	InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20-24-22-18-16-21(17-19-22)23(25)26/h16-19,24H,2-15,20H2,1H3,(H,25,26)	QXWKHSSBFQDQPR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001910	863329-66-2	C10H13FN2O5	0.5043	11311503	C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)O)F	CC1(F)C(O)C(CO)OC1n1ccc(=O)[nH]c1=O	InChI=1S/C10H13FN2O5/c1-10(11)7(16)5(4-14)18-8(10)13-3-2-6(15)12-9(13)17/h2-3,5,7-8,14,16H,4H2,1H3,(H,12,15,17)/t5-,7-,8-,10-/m1/s1	ARKKGZQTGXJVKW-VPCXQMTMSA-N					compound annotation
0391_001911	2328073-61-4	C21H31N5O2	1.5385	138911316		COc1c(OC)cc2c(NC3CCN(C(C)C)CC3)nc(NC3CC3)nc2c1	InChI=1S/C21H31N5O2/c1-13(2)26-9-7-15(8-10-26)22-20-16-11-18(27-3)19(28-4)12-17(16)24-21(25-20)23-14-5-6-14/h11-15H,5-10H2,1-4H3,(H2,22,23,24,25)	AMAQJTHMSLYMFT-UHFFFAOYSA-N					compound annotation
0391_001912	ortho-iodoHoechst 33258	C25H23IN6	1.8417	10324821		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2ccccc2I)[nH]4)[nH]3)CC1	InChI=1S/C25H23IN6/c1-31-10-12-32(13-11-31)17-7-9-21-23(15-17)29-24(27-21)16-6-8-20-22(14-16)30-25(28-20)18-4-2-3-5-19(18)26/h2-9,14-15H,10-13H2,1H3,(H,27,29)(H,28,30)	UOHARKYRPCGBEI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001914	CBP/p300-IN-3	C24H29N7O	2.1714	138466007		CCN(CC)c1ncc(-c2nc3cc(C(=O)NC)ccc3n2Cc2nn(CC)cc2)cc1	InChI=1S/C24H29N7O/c1-5-29(6-2)22-11-9-18(15-26-22)23-27-20-14-17(24(32)25-4)8-10-21(20)31(23)16-19-12-13-30(7-3)28-19/h8-15H,5-7,16H2,1-4H3,(H,25,32)	LYVJDLHFTGYNAV-UHFFFAOYSA-N					doublet; compound annotation
0391_001915	MK-3697	C23H21N5O3S	2.3361	46190695		COc1c(OC)nc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2nccs2)cc1	InChI=1S/C23H21N5O3S/c1-14-8-15(11-24-10-14)19-9-17(18(13-26-19)23-25-6-7-32-23)21(29)27-12-16-4-5-20(30-2)22(28-16)31-3/h4-11,13H,12H2,1-3H3,(H,27,29)	VSOUDUXMPUHJEU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001917	CBP/p300-IN-3	C24H29N7O	2.3762	138466007		CCN(CC)c1ncc(-c2nc3cc(C(=O)NC)ccc3n2Cc2nn(CC)cc2)cc1	InChI=1S/C24H29N7O/c1-5-29(6-2)22-11-9-18(15-26-22)23-27-20-14-17(24(32)25-4)8-10-21(20)31(23)16-19-12-13-30(7-3)28-19/h8-15H,5-7,16H2,1-4H3,(H,25,32)	LYVJDLHFTGYNAV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001920	NVP-LCQ195	C17H19Cl2N5O4S	3.1384	11655534		CS(=O)(=O)N1CCC(NC(=O)c2c(NC(=O)c3c(Cl)cccc3Cl)cn[nH]2)CC1	InChI=1S/C17H19Cl2N5O4S/c1-29(27,28)24-7-5-10(6-8-24)21-17(26)15-13(9-20-23-15)22-16(25)14-11(18)3-2-4-12(14)19/h2-4,9-10H,5-8H2,1H3,(H,20,23)(H,21,26)(H,22,25)	CCUXEBOOTMDSAM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001922	c-Kit-IN-3	C26H20ClF3N2O4	3.8151	139030518		COc1cc2nccc(Oc3ccc(NC(=O)Cc4cc(C(F)(F)F)c(Cl)cc4)cc3)c2cc1OC	InChI=1S/C26H20ClF3N2O4/c1-34-23-13-18-21(14-24(23)35-2)31-10-9-22(18)36-17-6-4-16(5-7-17)32-25(33)12-15-3-8-20(27)19(11-15)26(28,29)30/h3-11,13-14H,12H2,1-2H3,(H,32,33)	YOHLRCOPRAVUCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_001923	GLPG1205	C22H22N2O4	3.8986	71616860	C1CC1C#CC2=CC3=C(C=C2)C4=CC(=NC(=O)N4CC3)OC[C@@H]5COCCO5	O=c1nc(OCC2COCCO2)cc2-c3c(cc(C#CC4CC4)cc3)CCn21	InChI=1S/C22H22N2O4/c25-22-23-21(28-14-18-13-26-9-10-27-18)12-20-19-6-5-16(4-3-15-1-2-15)11-17(19)7-8-24(20)22/h5-6,11-12,15,18H,1-2,7-10,13-14H2/t18-/m0/s1	IRBAWVGZNJIROV-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_001925	Resorufin	C12H7NO3	2.1187	69462		O=c1ccc2nc3c(cc(O)cc3)oc-2c1	InChI=1S/C12H7NO3/c14-7-1-3-9-11(5-7)16-12-6-8(15)2-4-10(12)13-9/h1-6,14H	HSSLDCABUXLXKM-UHFFFAOYSA-N					compound annotation
0391_001926	Atipamezole	C14H16N2	2.3293	71310		CCC1(c2cnc[nH]2)Cc2ccccc2C1	InChI=1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16)	HSWPZIDYAHLZDD-UHFFFAOYSA-N					doublet; compound annotation
0391_001927	E-7386	C39H48FN9O4	2.4662	91810345	CCN1CCN(CC1)C2CN(C2)C3=CC=CC(=N3)CN4C[C@H]5N([C@H](C4=O)CC6=C(C=C(C=C6)O)F)C(=O)CN(N5C(=O)NCC7=CC=CC=C7)CC=C	C=CCN1CC(=O)N2C(Cc3c(F)cc(O)cc3)C(=O)N(Cc3nc(N4CC(N5CCN(CC)CC5)C4)ccc3)CC2N1C(=O)NCc1ccccc1	InChI=1S/C39H48FN9O4/c1-3-15-47-27-37(51)48-34(20-29-13-14-32(50)21-33(29)40)38(52)46(26-36(48)49(47)39(53)41-22-28-9-6-5-7-10-28)23-30-11-8-12-35(42-30)45-24-31(25-45)44-18-16-43(4-2)17-19-44/h3,5-14,21,31,34,36,50H,1,4,15-20,22-27H2,2H3,(H,41,53)/t34-,36-/m0/s1	ZGNKNLOBYFTGRG-GIWKVKTRSA-N					removed another duplicate entry; compound annotation
0391_001929	Sulfatinib	C24H28N6O3S	2.5871	52920501		Cc1cc2c(ccc(Oc3nc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)ncc3)c2)[nH]1	InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)	TTZSNFLLYPYKIL-UHFFFAOYSA-N					doublet; compound annotation
0391_001930	Lodenafil	C23H32N6O5S	2.7201	135452901		CCCc1nn(C)c2c1[nH]c(-c1c(OCC)ccc(S(=O)(=O)N3CCN(CCO)CC3)c1)nc2=O	InChI=1S/C23H32N6O5S/c1-4-6-18-20-21(27(3)26-18)23(31)25-22(24-20)17-15-16(7-8-19(17)34-5-2)35(32,33)29-11-9-28(10-12-29)13-14-30/h7-8,15,30H,4-6,9-14H2,1-3H3,(H,24,25,31)	NEYKRKVLEWKOBI-UHFFFAOYSA-N					doublet; compound annotation
0391_001931	Lodenafil	C23H32N6O5S	2.7229	135452901		CCCc1nn(C)c2c1[nH]c(-c1c(OCC)ccc(S(=O)(=O)N3CCN(CCO)CC3)c1)nc2=O	InChI=1S/C23H32N6O5S/c1-4-6-18-20-21(27(3)26-18)23(31)25-22(24-20)17-15-16(7-8-19(17)34-5-2)35(32,33)29-11-9-28(10-12-29)13-14-30/h7-8,15,30H,4-6,9-14H2,1-3H3,(H,24,25,31)	NEYKRKVLEWKOBI-UHFFFAOYSA-N					doublet; compound annotation
0391_001932	Sulfatinib	C24H28N6O3S	2.771	52920501		Cc1cc2c(ccc(Oc3nc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)ncc3)c2)[nH]1	InChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)	TTZSNFLLYPYKIL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001934	1292310-49-6	C26H27N5O3	2.9636	51049969		N#Cc1c(OC2CCOCC2)ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)c1	InChI=1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30)	BWABTWGSXHTHCG-UHFFFAOYSA-N					doublet; compound annotation
0391_001935	PF-06873600	C20H27F2N5O4S	3.2817	134247638	C[C@]1(CCC[C@H]1N2C3=NC(=NC=C3C=C(C2=O)C(F)F)NC4CCN(CC4)S(=O)(=O)C)O	CC1(O)CCCC1n1c(=O)c(C(F)F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21	InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m1/s1	QIEKHLDZKRQLLN-FOIQADDNSA-N					removed another duplicate entry; compound annotation
0391_001937	1292310-49-6	C26H27N5O3	3.6165	51049969		N#Cc1c(OC2CCOCC2)ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)c1	InChI=1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30)	BWABTWGSXHTHCG-UHFFFAOYSA-N					doublet; compound annotation
0391_001938	GSK0660	C19H18N2O5S2	4.3222	46233311		COC(=O)c1c(S(=O)(=O)Nc2c(OC)cc(Nc3ccccc3)cc2)ccs1	InChI=1S/C19H18N2O5S2/c1-25-16-12-14(20-13-6-4-3-5-7-13)8-9-15(16)21-28(23,24)17-10-11-27-18(17)19(22)26-2/h3-12,20-21H,1-2H3	NDFKBGWLUHKMFY-UHFFFAOYSA-N					doublet; compound annotation
0391_001939	GSK0660	C19H18N2O5S2	4.4965	46233311		COC(=O)c1c(S(=O)(=O)Nc2c(OC)cc(Nc3ccccc3)cc2)ccs1	InChI=1S/C19H18N2O5S2/c1-25-16-12-14(20-13-6-4-3-5-7-13)8-9-15(16)21-28(23,24)17-10-11-27-18(17)19(22)26-2/h3-12,20-21H,1-2H3	NDFKBGWLUHKMFY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_001941	ML277	C23H25N3O4S2	5.057	53347902	CC1=CC=C(C=C1)S(=O)(=O)N2CCCC[C@@H]2C(=O)NC3=NC(=CS3)C4=CC=C(C=C4)OC	COc1ccc(-c2csc(NC(=O)C3CCCCN3S(=O)(=O)c3ccc(C)cc3)n2)cc1	InChI=1S/C23H25N3O4S2/c1-16-6-12-19(13-7-16)32(28,29)26-14-4-3-5-21(26)22(27)25-23-24-20(15-31-23)17-8-10-18(30-2)11-9-17/h6-13,15,21H,3-5,14H2,1-2H3,(H,24,25,27)/t21-/m1/s1	OXQNLLVUVDAEHC-OAQYLSRUSA-N					removed another duplicate entry; compound annotation
0391_001943	Zotarolimus	C52H79N5O12	5.7093	9876378	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)N5C=NN=N5)C)/C)O)OC)C)C)/C)OC	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(n3cnnn3)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-30-53-54-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1	CGTADGCBEXYWNE-JUKNQOCSSA-N					compound annotation
0391_001944	2-furoyl-LIGRLO-amide	C36H63N11O8	2.2772	10395438	CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)C1=CC=CO1	CCC(C)C(NC(=O)C(CC(C)C)NC(=O)c1ccco1)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(CCCN)C(N)=O	InChI=1S/C36H63N11O8/c1-7-22(6)29(47-33(52)26(18-21(4)5)46-34(53)27-13-10-16-55-27)35(54)42-19-28(48)43-24(12-9-15-41-36(39)40)31(50)45-25(17-20(2)3)32(51)44-23(30(38)49)11-8-14-37/h10,13,16,20-26,29H,7-9,11-12,14-15,17-19,37H2,1-6H3,(H2,38,49)(H,42,54)(H,43,48)(H,44,51)(H,45,50)(H,46,53)(H,47,52)(H4,39,40,41)/t22-,23-,24-,25-,26-,29-/m0/s1	OSKIRYSKGDEIOG-WTWMNNMUSA-N					removed another duplicate entry; compound annotation
0391_001946	Ac-Leu-Arg-AMC	C24H34N6O5	2.3942	134611626	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)Nc1cc2c(cc1)c(C)cc(=O)o2	InChI=1S/C24H34N6O5/c1-13(2)10-19(28-15(4)31)23(34)30-18(6-5-9-27-24(25)26)22(33)29-16-7-8-17-14(3)11-21(32)35-20(17)12-16/h7-8,11-13,18-19H,5-6,9-10H2,1-4H3,(H,28,31)(H,29,33)(H,30,34)(H4,25,26,27)/t18-,19-/m0/s1	YAPHUDCEMGABMM-OALUTQOASA-N					doublet; removed another duplicate entry; compound annotation
0391_001948	Ac-Leu-Arg-AMC	C24H34N6O5	2.5827	134611626	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)Nc1cc2c(cc1)c(C)cc(=O)o2	InChI=1S/C24H34N6O5/c1-13(2)10-19(28-15(4)31)23(34)30-18(6-5-9-27-24(25)26)22(33)29-16-7-8-17-14(3)11-21(32)35-20(17)12-16/h7-8,11-13,18-19H,5-6,9-10H2,1-4H3,(H,28,31)(H,29,33)(H,30,34)(H4,25,26,27)/t18-,19-/m0/s1	YAPHUDCEMGABMM-OALUTQOASA-N					doublet; compound annotation
0391_001949	VERATRAMINE	C27H39NO2	2.6282	6070	C[C@H]1C[C@H]([C@@H](NC1)[C@@H](C)C2=C(C3=C(C=C2)[C@@H]4CC=C5C[C@H](CC[C@@]5([C@H]4C3)C)O)C)O	Cc1c(C(C)C2NCC(C)CC2O)ccc2c1CC1C2CC=C2CC(O)CCC21C	InChI=1S/C27H39NO2/c1-15-11-25(30)26(28-14-15)17(3)20-7-8-21-22-6-5-18-12-19(29)9-10-27(18,4)24(22)13-23(21)16(20)2/h5,7-8,15,17,19,22,24-26,28-30H,6,9-14H2,1-4H3/t15-,17-,19-,22-,24-,25+,26-,27-/m0/s1	MALFODICFSIXPO-KFKQDBFTSA-N					compound annotation
0391_001950	CYN 154806	C56H68N12O14S2	2.6344	16133842	C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@H](CC5=CC=C(C=C5)[N+](=O)[O-])NC(=O)C)C(=O)N[C@H](CC6=CC=C(C=C6)O)C(=O)N)O	CC(=O)NC(Cc1ccc([N+](=O)[O-])cc1)C(=O)NC1CSSCC(C(=O)NC(Cc2ccc(O)cc2)C(N)=O)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC1=O	InChI=1S/C56H68N12O14S2/c1-30(69)48-56(80)66-47(54(78)62-42(49(58)73)23-33-12-18-37(71)19-13-33)29-84-83-28-46(65-51(75)43(60-31(2)70)24-32-10-16-36(17-11-32)68(81)82)55(79)63-44(25-34-14-20-38(72)21-15-34)52(76)64-45(26-35-27-59-40-8-4-3-7-39(35)40)53(77)61-41(50(74)67-48)9-5-6-22-57/h3-4,7-8,10-21,27,30,41-48,59,69,71-72H,5-6,9,22-26,28-29,57H2,1-2H3,(H2,58,73)(H,60,70)(H,61,77)(H,62,78)(H,63,79)(H,64,76)(H,65,75)(H,66,80)(H,67,74)/t30-,41+,42-,43+,44+,45-,46-,47+,48+/m1/s1	RDTVTSXTFYXNSG-HDNDNHAUSA-N					compound annotation
0391_001951	acetazolamide	C4H6N4O3S2	0.9021	1986		CC(=O)Nc1nnc(S(N)(=O)=O)s1	InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)	BZKPWHYZMXOIDC-UHFFFAOYSA-N					compound annotation
0391_001952	ceftizoxime	C13H13N5O5S2	1.1148	6533629	CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=CCSC12)c1csc(N)n1	InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1	NNULBSISHYWZJU-LLKWHZGFSA-N					doublet; compound annotation
0391_001953	ceftizoxime	C13H13N5O5S2	1.2849	6533629	CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=CCSC12)c1csc(N)n1	InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1	NNULBSISHYWZJU-LLKWHZGFSA-N					doublet; removed another duplicate entry; compound annotation
0391_001955	3-Hydroxy-4-methoxybenzaldehyde	C8H8O3	1.6175	12127		COc1c(O)cc(C=O)cc1	InChI=1S/C8H8O3/c1-11-8-3-2-6(5-9)4-7(8)10/h2-5,10H,1H3	JVTZFYYHCGSXJV-UHFFFAOYSA-N					compound annotation
0391_001956	Vitexin	C21H20O10	1.8142	5280441	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2c1c(O)cc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C21H20O10/c22-7-14-17(27)18(28)19(29)21(31-14)16-11(25)5-10(24)15-12(26)6-13(30-20(15)16)8-1-3-9(23)4-2-8/h1-6,14,17-19,21-25,27-29H,7H2/t14-,17-,18+,19-,21+/m1/s1	SGEWCQFRYRRZDC-VPRICQMDSA-N					compound annotation
0391_001957	AZ5104	C27H31N7O2	1.9808	71496460		C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C27H31N7O2/c1-6-26(35)30-22-15-23(25(36-5)16-24(22)34(4)14-13-33(2)3)32-27-28-12-11-21(31-27)19-17-29-20-10-8-7-9-18(19)20/h6-12,15-17,29H,1,13-14H2,2-5H3,(H,30,35)(H,28,31,32)	IQNVEOMHJHBNHC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001959	AT7519	C16H17Cl2N5O2	1.9926	11338033		O=C(NC1CCNCC1)c1c(NC(=O)c2c(Cl)cccc2Cl)cn[nH]1	InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)	OVPNQJVDAFNBDN-UHFFFAOYSA-N					doublet; compound annotation
0391_001960	dolasetron	C19H20N2O3	2.0179	3033818	C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54	O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12	InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14?	UKTAZPQNNNJVKR-AKJUYKBHSA-N					doublet; compound annotation
0391_001961	Baohuoside I	C27H30O10	3.8726	5488822	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C(=CC(=C3C2=O)O)O)CC=C(C)C)C4=CC=C(C=C4)OC)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3O)c(=O)c3c(O)cc(O)c(CC=C(C)C)c3o2)cc1	InChI=1S/C27H30O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h5-9,11,13,20,22-23,27-30,32-33H,10H2,1-4H3/t13-,20-,22+,23+,27-/m0/s1	NGMYNFJANBHLKA-LVKFHIPRSA-N					compound annotation
0391_001962	His-[D-2-ME-Trp]-Ala	C21H26N6O4	1.3016	134691700	CC1=C(C2=CC=CC=C2N1)C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N	Cc1c(CC(NC(=O)C(N)Cc2cnc[nH]2)C(=O)NC(C)C(=O)O)c2ccccc2[nH]1	InChI=1S/C21H26N6O4/c1-11-15(14-5-3-4-6-17(14)25-11)8-18(20(29)26-12(2)21(30)31)27-19(28)16(22)7-13-9-23-10-24-13/h3-6,9-10,12,16,18,25H,7-8,22H2,1-2H3,(H,23,24)(H,26,29)(H,27,28)(H,30,31)/t12-,16-,18-/m0/s1	GYFZFNBHWAGTMO-IWEFOYFVSA-N					compound annotation
0391_001963	Nefiracetam	C14H18N2O2	2.0949	71157		Cc1c(NC(=O)CN2CCCC2=O)c(C)ccc1	InChI=1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17)	NGHTXZCKLWZPGK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001965	139180-30-6	C16H15N7O2	2.3301	176407		Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N					doublet; compound annotation
0391_001966	139180-30-6	C16H15N7O2	2.3328	176407		Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12	InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)	PWTBZOIUWZOPFT-UHFFFAOYSA-N					doublet; compound annotation
0391_001967	5-Phenylpenta-2,4-dienoic acid	C11H10O2	3.3851	1549512	C1=CC=C(C=C1)/C=C/C=C/C(=O)O	O=C(O)C=CC=Cc1ccccc1	InChI=1S/C11H10O2/c12-11(13)9-5-4-8-10-6-2-1-3-7-10/h1-9H,(H,12,13)/b8-4+,9-5+	FEIQOMCWGDNMHM-KBXRYBNXSA-N					compound annotation
0391_001968	ORM-15341	C19H17ClN6O2	3.4308	52919826	C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C	CC(=O)c1n[nH]c(C(=O)NC(C)Cn2ccc(-c3cc(Cl)c(C#N)cc3)n2)c1	InChI=1S/C19H17ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-/m0/s1	GMBPVBVTPBWIKC-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_001970	tolfenamic acid	C14H12ClNO2	4.8593	610479		Cc1c(Nc2ccccc2C(=O)O)cccc1Cl	InChI=1S/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18)	YEZNLOUZAIOMLT-UHFFFAOYSA-N					compound annotation
0391_001971	Nicodicosapent	C28H39N3O2	5.2416	50991753	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCNC(=O)C1=CN=CC=C1	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)NCCNC(=O)c1cnccc1	InChI=1S/C28H39N3O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-27(32)30-23-24-31-28(33)26-20-19-22-29-25-26/h3-4,6-7,9-10,12-13,15-16,19-20,22,25H,2,5,8,11,14,17-18,21,23-24H2,1H3,(H,30,32)(H,31,33)/b4-3-,7-6-,10-9-,13-12-,16-15-	YYQALOWPCKMFDQ-JLNKQSITSA-N					removed another duplicate entry; compound annotation
0391_001973	Matrine	C15H24N2O	0.516	91466	C1C[C@@H]2[C@H]3CCCN4[C@H]3[C@@H](CCC4)CN2C(=O)C1	O=C1CCCC2C3CCCN4CCCC(CN12)C34	InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12+,13+,15-/m0/s1	ZSBXGIUJOOQZMP-JLNYLFASSA-N					removed another duplicate entry; compound annotation
0391_001975	Morroniside	C17H26O11	1.1958	11228693	C[C@H]1[C@@H]2[C@H](C[C@@H](O1)O)C(=CO[C@H]2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)OC	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C(C)OC(O)CC12	InChI=1S/C17H26O11/c1-6-11-7(3-10(19)26-6)8(15(23)24-2)5-25-16(11)28-17-14(22)13(21)12(20)9(4-18)27-17/h5-7,9-14,16-22H,3-4H2,1-2H3/t6-,7+,9+,10+,11+,12+,13-,14+,16-,17-/m0/s1	YTZSBJLNMIQROD-SFBCHFHNSA-N					compound annotation
0391_001976	Corynoxine	C22H28N2O4	2.3192	10475115	CC[C@@H]1CN2CC[C@@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22+/m1/s1	DAXYUDFNWXHGBE-NRAMRBJXSA-N					doublet; compound annotation
0391_001977	Corynoxine	C22H28N2O4	2.3247	10475115	CC[C@@H]1CN2CC[C@@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22+/m1/s1	DAXYUDFNWXHGBE-NRAMRBJXSA-N					doublet; compound annotation
0391_001978	Ononin	C22H22O9	2.4236	442813	COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COc1ccc(-c2coc3c(ccc(OC4OC(CO)C(O)C(O)C4O)c3)c2=O)cc1	InChI=1S/C22H22O9/c1-28-12-4-2-11(3-5-12)15-10-29-16-8-13(6-7-14(16)18(15)24)30-22-21(27)20(26)19(25)17(9-23)31-22/h2-8,10,17,19-23,25-27H,9H2,1H3/t17-,19-,20+,21-,22-/m1/s1	MGJLSBDCWOSMHL-MIUGBVLSSA-N					removed another duplicate entry; compound annotation
0391_001980	Corynoxine	C22H28N2O4	2.5274	10475115	CC[C@@H]1CN2CC[C@@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22+/m1/s1	DAXYUDFNWXHGBE-NRAMRBJXSA-N					doublet; compound annotation
0391_001981	JH-II-127	C19H21ClN6O3	2.5565	112499966		CNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)cc2)nc2c1c(Cl)c[nH]2	InChI=1S/C19H21ClN6O3/c1-21-16-15-12(20)10-22-17(15)25-19(24-16)23-13-4-3-11(9-14(13)28-2)18(27)26-5-7-29-8-6-26/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24,25)	HUEKBQXFNHWTQQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001983	Avanafil	C23H26ClN7O3	2.7159	9869929	COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl	COc1c(Cl)cc(CNc2nc(N3CCCC3CO)ncc2C(=O)NCc2ncccn2)cc1	InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1	WEAJZXNPAWBCOA-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_001985	834903-43-4	C25H19N3O4	3.2398	16020046		Cc1ccc(-c2n[nH]c3c2C(c2cc(O)ccc2)N(c2ccc(C(=O)O)cc2)C3=O)cc1	InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32)	VGUQVYZXABOXCX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_001988	Isosakuranetin	C16H14O5	3.7308	160481	COC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O	COc1ccc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1	InChI=1S/C16H14O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1	HMUJXQRRKBLVOO-AWEZNQCLSA-N					compound annotation
0391_001989	CCG215022	C26H22FN7O3	1.3638	118888941		CC1=C(C(=O)Nc2cc3c(cc2)[nH]nc3)C(c2cc(C(=O)NCc3ccccn3)c(F)cc2)NC(=O)N1	InChI=1S/C26H22FN7O3/c1-14-22(25(36)32-17-6-8-21-16(10-17)12-30-34-21)23(33-26(37)31-14)15-5-7-20(27)19(11-15)24(35)29-13-18-4-2-3-9-28-18/h2-12,23H,13H2,1H3,(H,29,35)(H,30,34)(H,32,36)(H2,31,33,37)	BLMBNKDQXGINRE-UHFFFAOYSA-N					doublet; compound annotation
0391_001990	CCG215022	C26H22FN7O3	1.3671	118888941		CC1=C(C(=O)Nc2cc3c(cc2)[nH]nc3)C(c2cc(C(=O)NCc3ccccn3)c(F)cc2)NC(=O)N1	InChI=1S/C26H22FN7O3/c1-14-22(25(36)32-17-6-8-21-16(10-17)12-30-34-21)23(33-26(37)31-14)15-5-7-20(27)19(11-15)24(35)29-13-18-4-2-3-9-28-18/h2-12,23H,13H2,1H3,(H,29,35)(H,30,34)(H,32,36)(H2,31,33,37)	BLMBNKDQXGINRE-UHFFFAOYSA-N					doublet; compound annotation
0391_001991	Ligustroflavone	C33H40O18	1.9644	10417462	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)C(OC3OC(C)C(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C33H40O18/c1-11-22(37)25(40)28(43)31(46-11)45-10-20-24(39)27(42)30(51-32-29(44)26(41)23(38)12(2)47-32)33(50-20)48-15-7-16(35)21-17(36)9-18(49-19(21)8-15)13-3-5-14(34)6-4-13/h3-9,11-12,20,22-35,37-44H,10H2,1-2H3/t11-,12-,20+,22-,23-,24+,25+,26+,27-,28+,29+,30+,31+,32-,33+/m0/s1	NULBHTHMVOCGOE-ZBCCAYPVSA-N					removed another duplicate entry; compound annotation
0391_001993	GSK180736A	C19H16FN5O2	2.031	11233873		CC1=C(C(=O)Nc2cc3c(cc2)[nH]nc3)C(c2ccc(F)cc2)NC(=O)N1	InChI=1S/C19H16FN5O2/c1-10-16(17(24-19(27)22-10)11-2-4-13(20)5-3-11)18(26)23-14-6-7-15-12(8-14)9-21-25-15/h2-9,17H,1H3,(H,21,25)(H,23,26)(H2,22,24,27)	HEAIGWIZTYAQTC-UHFFFAOYSA-N					compound annotation
0391_001994	6''-O-ACETYLGLYCITIN	C24H24O11	2.2233	10228095	CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=C(C=C3C(=C2)OC=C(C3=O)C4=CC=C(C=C4)O)OC)O)O)O	COc1c(OC2OC(COC(C)=O)C(O)C(O)C2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1	InChI=1S/C24H24O11/c1-11(25)32-10-19-21(28)22(29)23(30)24(35-19)34-18-8-16-14(7-17(18)31-2)20(27)15(9-33-16)12-3-5-13(26)6-4-12/h3-9,19,21-24,26,28-30H,10H2,1-2H3/t19-,21-,22+,23-,24-/m1/s1	DUBPGEJGGVZKDD-PFKOEMKTSA-N					removed another duplicate entry; compound annotation
0391_001996	893990-34-6	C16H14N4OS2	3.6459	7211972		Cc1csc(NC(=O)CSc2nnc(-c3ccccc3)cc2)n1	InChI=1S/C16H14N4OS2/c1-11-9-23-16(17-11)18-14(21)10-22-15-8-7-13(19-20-15)12-5-3-2-4-6-12/h2-9H,10H2,1H3,(H,17,18,21)	WJRWSLORVIHRNX-UHFFFAOYSA-N					doublet; compound annotation
0391_001997	893990-34-6	C16H14N4OS2	3.6488	7211972		Cc1csc(NC(=O)CSc2nnc(-c3ccccc3)cc2)n1	InChI=1S/C16H14N4OS2/c1-11-9-23-16(17-11)18-14(21)10-22-15-8-7-13(19-20-15)12-5-3-2-4-6-12/h2-9H,10H2,1H3,(H,17,18,21)	WJRWSLORVIHRNX-UHFFFAOYSA-N					doublet; compound annotation
0391_001998	Isoginkgetin	C32H22O10	4.1534	5318569		COc1ccc(-c2cc(=O)c3c(o2)c(-c2c(OC)ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)c2)c(O)cc3O)cc1	InChI=1S/C32H22O10/c1-39-18-6-3-15(4-7-18)26-14-24(38)31-22(36)12-21(35)29(32(31)42-26)19-9-16(5-8-25(19)40-2)27-13-23(37)30-20(34)10-17(33)11-28(30)41-27/h3-14,33-36H,1-2H3	HUOOMAOYXQFIDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_001999	Corylin	C20H16O4	4.218	5316097		CC1(C)C=Cc2c(ccc(-c3coc4c(ccc(O)c4)c3=O)c2)O1	InChI=1S/C20H16O4/c1-20(2)8-7-13-9-12(3-6-17(13)24-20)16-11-23-18-10-14(21)4-5-15(18)19(16)22/h3-11,21H,1-2H3	PWAACAMQKVIVPZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002000	Corylin	C20H16O4	4.2213	5316097		CC1(C)C=Cc2c(ccc(-c3coc4c(ccc(O)c4)c3=O)c2)O1	InChI=1S/C20H16O4/c1-20(2)8-7-13-9-12(3-6-17(13)24-20)16-11-23-18-10-14(21)4-5-15(18)19(16)22/h3-11,21H,1-2H3	PWAACAMQKVIVPZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002002	Isoginkgetin	C32H22O10	4.2258	5318569		COc1ccc(-c2cc(=O)c3c(o2)c(-c2c(OC)ccc(-c4cc(=O)c5c(O)cc(O)cc5o4)c2)c(O)cc3O)cc1	InChI=1S/C32H22O10/c1-39-18-6-3-15(4-7-18)26-14-24(38)31-22(36)12-21(35)29(32(31)42-26)19-9-16(5-8-25(19)40-2)27-13-23(37)30-20(34)10-17(33)11-28(30)41-27/h3-14,33-36H,1-2H3	HUOOMAOYXQFIDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002003	BMS-3	C17H12Cl2F2N4OS	4.2939	73265272		O=C(Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1)C1CC1	InChI=1S/C17H12Cl2F2N4OS/c18-9-2-1-3-10(19)14(9)25-12(6-11(24-25)15(20)21)13-7-22-17(27-13)23-16(26)8-4-5-8/h1-3,6-8,15H,4-5H2,(H,22,23,26)	YBGGBHCJSAEIAS-UHFFFAOYSA-N					compound annotation
0391_002004	Decursin	C19H20O5	4.5402	442126	CC(=CC(=O)O[C@H]1CC2=C(C=C3C(=C2)C=CC(=O)O3)OC1(C)C)C	CC(C)=CC(=O)OC1Cc2c(cc3oc(=O)ccc3c2)OC1(C)C	InChI=1S/C19H20O5/c1-11(2)7-18(21)23-16-9-13-8-12-5-6-17(20)22-14(12)10-15(13)24-19(16,3)4/h5-8,10,16H,9H2,1-4H3/t16-/m0/s1	CUKSFECWKQBVED-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_002006	fenspiride	C15H20N2O2	1.2503	3344		O=C1NCC2(CCN(CCc3ccccc3)CC2)O1	InChI=1S/C15H20N2O2/c18-14-16-12-15(19-14)7-10-17(11-8-15)9-6-13-4-2-1-3-5-13/h1-5H,6-12H2,(H,16,18)	FVNFBBAOMBJTST-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002008	Rhodamine 110	C20H14N2O3	2.2883	65204		N=c1ccc2c(-c3ccccc3C(=O)O)c3c(cc(N)cc3)oc-2c1	InChI=1S/C20H14N2O3/c21-11-5-7-15-17(9-11)25-18-10-12(22)6-8-16(18)19(15)13-3-1-2-4-14(13)20(23)24/h1-10,21H,22H2,(H,23,24)	UPZKDDJKJWYWHQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002010	821794-90-5	C18H19ClN4O2	2.7553	16663089		Cc1ccc(-c2c(C(=O)CCl)n(CCCO)c3ncnc(N)c23)cc1	InChI=1S/C18H19ClN4O2/c1-11-3-5-12(6-4-11)14-15-17(20)21-10-22-18(15)23(7-2-8-24)16(14)13(25)9-19/h3-6,10,24H,2,7-9H2,1H3,(H2,20,21,22)	PELFTNQHGSITLB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002012	CPA inhibitor	C18H19NO4	3.2415	44374998		O=C(O)C(Cc1ccccc1)CN(O)C(=O)Cc1ccccc1	InChI=1S/C18H19NO4/c20-17(12-15-9-5-2-6-10-15)19(23)13-16(18(21)22)11-14-7-3-1-4-8-14/h1-10,16,23H,11-13H2,(H,21,22)	PONANXDRJJIGPG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002014	Lasofoxifene	C28H31NO2	3.5142	216416	C1CCN(C1)CCOC2=CC=C(C=C2)[C@H]3[C@H](CCC4=C3C=CC(=C4)O)C5=CC=CC=C5	Oc1cc2c(cc1)C(c1ccc(OCCN3CCCC3)cc1)C(c1ccccc1)CC2	InChI=1S/C28H31NO2/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2/t26-,28+/m1/s1	GXESHMAMLJKROZ-IAPPQJPRSA-N					compound annotation
0391_002015	SCHEMBL10293765	C33H31N2O5+	3.7307	4097104		O=C(O)c1cc(C(=O)O)c(C2=c3cc4CCC[N+]5=c4c(c3Oc3c2cc2CCCN4CCCc3c24)CCC5)cc1	InChI=1S/C33H30N2O5/c36-32(37)20-9-10-21(24(17-20)33(38)39)27-25-15-18-5-1-11-34-13-3-7-22(28(18)34)30(25)40-31-23-8-4-14-35-12-2-6-19(29(23)35)16-26(27)31/h9-10,15-17H,1-8,11-14H2,(H-,36,37,38,39)/p+1	UNGMOMJDNDFGJG-UHFFFAOYSA-O					compound annotation
0391_002016	Galeterone	C26H32N2O	3.8151	11188409	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4N5C=NC6=CC=CC=C65)C)O	CC12CCC(O)CC1=CCC1C2CCC2(C)C(n3cnc4ccccc43)=CCC12	InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1	PAFKTGFSEFKSQG-PAASFTFBSA-N					compound annotation
0391_002017	Pyridoxal isonicotinoyl hydrazone	C14H14N4O3	1.1543	135409539	CC1=NC=C(C(=C1O)/C=N/NC(=O)C2=CC=NC=C2)CO	Cc1ncc(CO)c(C=NNC(=O)c2ccncc2)c1O	InChI=1S/C14H14N4O3/c1-9-13(20)12(11(8-19)6-16-9)7-17-18-14(21)10-2-4-15-5-3-10/h2-7,19-20H,8H2,1H3,(H,18,21)/b17-7+	BQYIXOPJPLGCRZ-REZTVBANSA-N					removed another duplicate entry; compound annotation
0391_002019	LMK-235	C15H22N2O4	2.5033	71520717		Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1	InChI=1S/C15H22N2O4/c1-11-8-12(2)10-13(9-11)15(19)17-21-7-5-3-4-6-14(18)16-20/h8-10,20H,3-7H2,1-2H3,(H,16,18)(H,17,19)	VRYZCEONIWEUAV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002021	LMK-235	C15H22N2O4	2.5063	71520717		Cc1cc(C)cc(C(=O)NOCCCCCC(=O)NO)c1	InChI=1S/C15H22N2O4/c1-11-8-12(2)10-13(9-11)15(19)17-21-7-5-3-4-6-14(18)16-20/h8-10,20H,3-7H2,1-2H3,(H,16,18)(H,17,19)	VRYZCEONIWEUAV-UHFFFAOYSA-N					doublet; compound annotation
0391_002022	Mifobate	C11H17ClO7P2	2.8276	60910		COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC	InChI=1S/C11H17ClO7P2/c1-15-20(13,16-2)11(19-21(14,17-3)18-4)9-5-7-10(12)8-6-9/h5-8,11H,1-4H3	VQHUQHAPWMNBLP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002024	ML401	C20H20BrClN2O	3.0915	73169083	C1CN(CCN1CC2=CC=C(C=C2)Cl)C(=O)/C=C/C3=CC=C(C=C3)Br	O=C(C=Cc1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2)CC1	InChI=1S/C20H20BrClN2O/c21-18-6-1-16(2-7-18)5-10-20(25)24-13-11-23(12-14-24)15-17-3-8-19(22)9-4-17/h1-10H,11-15H2/b10-5+	NXTNVQJKGHAGAX-BJMVGYQFSA-N					doublet; compound annotation
0391_002025	EHT-1864	C25H27F3N2O4S	3.1665	9938203		O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12	InChI=1S/C25H27F3N2O4S/c26-25(27,28)18-4-5-20-21(14-18)29-7-6-24(20)35-13-3-1-2-10-33-23-17-34-19(15-22(23)31)16-30-8-11-32-12-9-30/h4-7,14-15,17H,1-3,8-13,16H2	MIDUFIRTIFUTQA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002027	EHT-1864	C25H27F3N2O4S	3.2517	9938203		O=c1cc(CN2CCOCC2)occ1OCCCCCSc1ccnc2cc(C(F)(F)F)ccc12	InChI=1S/C25H27F3N2O4S/c26-25(27,28)18-4-5-20-21(14-18)29-7-6-24(20)35-13-3-1-2-10-33-23-17-34-19(15-22(23)31)16-30-8-11-32-12-9-30/h4-7,14-15,17H,1-3,8-13,16H2	MIDUFIRTIFUTQA-UHFFFAOYSA-N					doublet; compound annotation
0391_002028	ML401	C20H20BrClN2O	3.2545	73169083	C1CN(CCN1CC2=CC=C(C=C2)Cl)C(=O)/C=C/C3=CC=C(C=C3)Br	O=C(C=Cc1ccc(Br)cc1)N1CCN(Cc2ccc(Cl)cc2)CC1	InChI=1S/C20H20BrClN2O/c21-18-6-1-16(2-7-18)5-10-20(25)24-13-11-23(12-14-24)15-17-3-8-19(22)9-4-17/h1-10H,11-15H2/b10-5+	NXTNVQJKGHAGAX-BJMVGYQFSA-N					doublet; compound annotation
0391_002029	Filanesib	C20H22F2N4O2S	3.3622	44224257	CN(C(=O)N1[C@](SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC	CON(C)C(=O)N1N=C(c2c(F)ccc(F)c2)SC1(CCCN)c1ccccc1	InChI=1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m0/s1	LLXISKGBWFTGEI-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_002031	ILK-IN-2	C30H30F3N5O	3.4802	118986645		CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)nn1-c1ccc(N2CCNCC2)cc1	InChI=1S/C30H30F3N5O/c1-34-29(39)15-14-27-20-28(36-38(27)26-12-10-25(11-13-26)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-13,20,35H,14-19H2,1H3,(H,34,39)	AJLOJUFSIDSBNN-UHFFFAOYSA-N					doublet; compound annotation
0391_002032	ILK-IN-2	C30H30F3N5O	3.4878	118986645		CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)nn1-c1ccc(N2CCNCC2)cc1	InChI=1S/C30H30F3N5O/c1-34-29(39)15-14-27-20-28(36-38(27)26-12-10-25(11-13-26)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-13,20,35H,14-19H2,1H3,(H,34,39)	AJLOJUFSIDSBNN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002034	49843-98-3	C13H13ClN2O	3.5477	5113032		NC(=O)C1CCCc2c1[nH]c1c2cc(Cl)cc1	InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)	FUZYTVDVLBBXDL-UHFFFAOYSA-N					compound annotation
0391_002035	614726-85-1	C17H12Cl3N3O	4.8875	66844170		Cc1c(-c2ccc(Cl)cc2)n(-c2c(Cl)cc(Cl)cc2)nc1C(N)=O	InChI=1S/C17H12Cl3N3O/c1-9-15(17(21)24)22-23(14-7-6-12(19)8-13(14)20)16(9)10-2-4-11(18)5-3-10/h2-8H,1H3,(H2,21,24)	BBUKVPCUOHFAQN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002037	Cephalotaxine	C18H21NO4	0.8935	65305	COC1=C[C@]23CCCN2CCC4=CC5=C(C=C4[C@@H]3[C@@H]1O)OCO5	COC1=CC23CCCN2CCc2cc4c(cc2C3C1O)OCO4	InChI=1S/C18H21NO4/c1-21-15-9-18-4-2-5-19(18)6-3-11-7-13-14(23-10-22-13)8-12(11)16(18)17(15)20/h7-9,16-17,20H,2-6,10H2,1H3/t16-,17-,18+/m1/s1	YMNCVRSYJBNGLD-KURKYZTESA-N					compound annotation
0391_002038	SLIGRL-NH2	C29H56N10O7	1.797	9831050	CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N	CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(N)CO)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(N)=O	InChI=1S/C29H56N10O7/c1-7-17(6)23(39-27(45)21(12-16(4)5)38-25(43)18(30)14-40)28(46)35-13-22(41)36-19(9-8-10-34-29(32)33)26(44)37-20(24(31)42)11-15(2)3/h15-21,23,40H,7-14,30H2,1-6H3,(H2,31,42)(H,35,46)(H,36,41)(H,37,44)(H,38,43)(H,39,45)(H4,32,33,34)/t17-,18-,19-,20-,21-,23-/m0/s1	SGPMJRPYYIJZPC-JYAZKYGWSA-N					removed another duplicate entry; compound annotation
0391_002040	Jaceosidin	C17H14O7	3.0166	5379096		COc1c(O)ccc(-c2cc(=O)c3c(cc(O)c(OC)c3O)o2)c1	InChI=1S/C17H14O7/c1-22-13-5-8(3-4-9(13)18)12-6-10(19)15-14(24-12)7-11(20)17(23-2)16(15)21/h3-7,18,20-21H,1-2H3	GLAAQZFBFGEBPS-UHFFFAOYSA-N					doublet; compound annotation
0391_002041	Jaceosidin	C17H14O7	3.0195	5379096		COc1c(O)ccc(-c2cc(=O)c3c(cc(O)c(OC)c3O)o2)c1	InChI=1S/C17H14O7/c1-22-13-5-8(3-4-9(13)18)12-6-10(19)15-14(24-12)7-11(20)17(23-2)16(15)21/h3-7,18,20-21H,1-2H3	GLAAQZFBFGEBPS-UHFFFAOYSA-N					doublet; compound annotation
0391_002042	MICHELIOLIDE	C15H20O3	3.5027	442279	CC1=C2CC[C@@]([C@@H]2[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)(C)O	C=C1C(=O)OC2C1CCC(C)=C1CCC(C)(O)C12	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)14(16)18-13(11)12-10(8)6-7-15(12,3)17/h11-13,17H,2,4-7H2,1,3H3/t11-,12-,13-,15+/m0/s1	RDJAFOWISVMOJY-PWNZVWSESA-N					doublet; removed another duplicate entry; compound annotation
0391_002044	1369489-71-3	C22H18F5N3O4	3.8914	56944705	C[C@@H](C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(N(N=C2C(F)F)C)OC3=CC=CC(=C3)C(F)(F)F	CC(NC(=O)c1c(Oc2cccc(C(F)(F)F)c2)n(C)nc1C(F)F)c1ccc(C(=O)O)cc1	InChI=1S/C22H18F5N3O4/c1-11(12-6-8-13(9-7-12)21(32)33)28-19(31)16-17(18(23)24)29-30(2)20(16)34-15-5-3-4-14(10-15)22(25,26)27/h3-11,18H,1-2H3,(H,28,31)(H,32,33)/t11-/m0/s1	MKLKAQMPKHNQPR-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002046	Pterostilbene	C16H16O3	4.1128	5281727	COC1=CC(=CC(=C1)/C=C/C2=CC=C(C=C2)O)OC	COc1cc(OC)cc(C=Cc2ccc(O)cc2)c1	InChI=1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+	VLEUZFDZJKSGMX-ONEGZZNKSA-N					removed another duplicate entry; compound annotation
0391_002048	Isoastragaloside I	C45H72O16	4.2663	60148697	CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1O)OC(=O)C)O[C@H]2CC[C@]34C[C@]35CC[C@@]6([C@H]([C@H](C[C@]6([C@@H]5C[C@@H]([C@H]4C2(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C	CC(=O)OC1COC(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)C(OC(C)=O)C1O	InChI=1S/C45H72O16/c1-21(47)56-26-19-55-38(34(31(26)51)57-22(2)48)60-28-11-13-45-20-44(45)15-14-41(7)35(43(9)12-10-29(61-43)40(5,6)54)23(49)17-42(41,8)27(44)16-24(36(45)39(28,3)4)58-37-33(53)32(52)30(50)25(18-46)59-37/h23-38,46,49-54H,10-20H2,1-9H3/t23-,24-,25+,26+,27-,28-,29-,30+,31-,32-,33+,34+,35-,36-,37+,38-,41+,42-,43+,44-,45+/m0/s1	HVPKALQHGQMJER-XOUPSZAESA-N					removed another duplicate entry; compound annotation
0391_002050	Gomisin G	C30H32O9	4.6369	14992067	C[C@H]1CC2=CC(=C(C(=C2C3=C(C4=C(C=C3[C@@H]([C@@]1(C)O)OC(=O)C5=CC=CC=C5)OCO4)OC)OC)OC)OC	COc1c(OC)c(OC)c2c(c1)CC(C)C(C)(O)C(OC(=O)c1ccccc1)c1cc3c(OCO3)c(OC)c1-2	InChI=1S/C30H32O9/c1-16-12-18-13-20(33-3)24(34-4)26(35-5)22(18)23-19(14-21-25(27(23)36-6)38-15-37-21)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1	OFDWKHIQKPKRKY-DSASHONVSA-N					doublet; compound annotation
0391_002051	Gomisin G	C30H32O9	4.645	14992067	C[C@H]1CC2=CC(=C(C(=C2C3=C(C4=C(C=C3[C@@H]([C@@]1(C)O)OC(=O)C5=CC=CC=C5)OCO4)OC)OC)OC)OC	COc1c(OC)c(OC)c2c(c1)CC(C)C(C)(O)C(OC(=O)c1ccccc1)c1cc3c(OCO3)c(OC)c1-2	InChI=1S/C30H32O9/c1-16-12-18-13-20(33-3)24(34-4)26(35-5)22(18)23-19(14-21-25(27(23)36-6)38-15-37-21)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1	OFDWKHIQKPKRKY-DSASHONVSA-N					doublet; compound annotation
0391_002052	MICHELIOLIDE	C15H20O3	6.9589	442279	CC1=C2CC[C@@]([C@@H]2[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)(C)O	C=C1C(=O)OC2C1CCC(C)=C1CCC(C)(O)C12	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)14(16)18-13(11)12-10(8)6-7-15(12,3)17/h11-13,17H,2,4-7H2,1,3H3/t11-,12-,13-,15+/m0/s1	RDJAFOWISVMOJY-PWNZVWSESA-N					doublet; compound annotation
0391_002053	MICHELIOLIDE	C15H20O3	7.05	442279	CC1=C2CC[C@@]([C@@H]2[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)(C)O	C=C1C(=O)OC2C1CCC(C)=C1CCC(C)(O)C12	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)14(16)18-13(11)12-10(8)6-7-15(12,3)17/h11-13,17H,2,4-7H2,1,3H3/t11-,12-,13-,15+/m0/s1	RDJAFOWISVMOJY-PWNZVWSESA-N					doublet; compound annotation
0391_002054	Sophoricoside	C21H20O10	2.0719	5321398	C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	O=c1c(-c2ccc(OC3OC(CO)C(O)C(O)C3O)cc2)coc2cc(O)cc(O)c12	InChI=1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-11-3-1-9(2-4-11)12-8-29-14-6-10(23)5-13(24)16(14)17(12)25/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1	ISQRJFLLIDGZEP-CMWLGVBASA-N					removed another duplicate entry; compound annotation
0391_002056	Digoxigenin	C23H34O5	2.0957	15478	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O)O	CC12CCC(O)CC1CCC1C2CC(O)C2(C)C(C3=CC(=O)OC3)CCC12O	InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1	SHIBSTMRCDJXLN-KCZCNTNESA-N					removed another duplicate entry; compound annotation
0391_002058	4'-Hydroxypropiophenone	C9H10O2	2.2936	6271		CCC(=O)c1ccc(O)cc1	InChI=1S/C9H10O2/c1-2-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3	RARSHUDCJQSEFJ-UHFFFAOYSA-N					compound annotation
0391_002059	1-Azakenpaullone	C15H10BrN3O	3.2771	6538897		O=C1Cc2c([nH]c3c2cc(Br)cc3)-c2c(cccn2)N1	InChI=1S/C15H10BrN3O/c16-8-3-4-11-9(6-8)10-7-13(20)18-12-2-1-5-17-15(12)14(10)19-11/h1-6,19H,7H2,(H,18,20)	NTSBZVCEIVPKBJ-UHFFFAOYSA-N					doublet; compound annotation
0391_002060	Alizarin	C14H8O4	3.4033	6293		O=C1c2ccccc2C(=O)c2c1ccc(O)c2O	InChI=1S/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18H	RGCKGOZRHPZPFP-UHFFFAOYSA-N					compound annotation
0391_002061	1-Azakenpaullone	C15H10BrN3O	3.5235	6538897		O=C1Cc2c([nH]c3c2cc(Br)cc3)-c2c(cccn2)N1	InChI=1S/C15H10BrN3O/c16-8-3-4-11-9(6-8)10-7-13(20)18-12-2-1-5-17-15(12)14(10)19-11/h1-6,19H,7H2,(H,18,20)	NTSBZVCEIVPKBJ-UHFFFAOYSA-N					doublet; compound annotation
0391_002062	Cinacalcet	C22H22F3N	3.7394	156419	C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F	CC(NCCCc1cc(C(F)(F)F)ccc1)c1cccc2ccccc12	InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1	VDHAWDNDOKGFTD-MRXNPFEDSA-N					doublet; compound annotation
0391_002063	Enzalutamide	C21H16F4N4O2S	4.1022	15951529		CNC(=O)c1c(F)cc(N2C(=S)N(c3cc(C(F)(F)F)c(C#N)cc3)C(=O)C2(C)C)cc1	InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)	WXCXUHSOUPDCQV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002065	alisol A 24-acetate	C32H52O6	4.8502	76336194	C[C@H](C[C@@H]([C@H](C(C)(C)O)OC(=O)C)O)C1=C2C[C@@H]([C@H]3[C@]4(CCC(=O)C([C@@H]4CC[C@@]3([C@]2(CC1)C)C)(C)C)C)O	CC(=O)OC(C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1)C(C)(C)O	InChI=1S/C32H52O6/c1-18(16-23(35)27(29(5,6)37)38-19(2)33)20-10-14-31(8)21(20)17-22(34)26-30(7)13-12-25(36)28(3,4)24(30)11-15-32(26,31)9/h18,22-24,26-27,34-35,37H,10-17H2,1-9H3/t18-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1	WXHUQVMHWUQNTG-JSWHPQHOSA-N					doublet; compound annotation
0391_002066	alisol A 24-acetate	C32H52O6	5.1322	76336194	C[C@H](C[C@@H]([C@H](C(C)(C)O)OC(=O)C)O)C1=C2C[C@@H]([C@H]3[C@]4(CCC(=O)C([C@@H]4CC[C@@]3([C@]2(CC1)C)C)(C)C)C)O	CC(=O)OC(C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1)C(C)(C)O	InChI=1S/C32H52O6/c1-18(16-23(35)27(29(5,6)37)38-19(2)33)20-10-14-31(8)21(20)17-22(34)26-30(7)13-12-25(36)28(3,4)24(30)11-15-32(26,31)9/h18,22-24,26-27,34-35,37H,10-17H2,1-9H3/t18-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1	WXHUQVMHWUQNTG-JSWHPQHOSA-N					doublet; compound annotation
0391_002067	heptaminol	C8H19NO	0.5974	3590		CC(N)CCCC(C)(C)O	InChI=1S/C8H19NO/c1-7(9)5-4-6-8(2,3)10/h7,10H,4-6,9H2,1-3H3	LREQLEBVOXIEOM-UHFFFAOYSA-N					compound annotation
0391_002068	6160-80-1	C16H16O9	1.449	91553	CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O	Cc1cc(=O)oc2c1ccc(OC1OC(C(=O)O)C(O)C(O)C1O)c2	InChI=1S/C16H16O9/c1-6-4-10(17)24-9-5-7(2-3-8(6)9)23-16-13(20)11(18)12(19)14(25-16)15(21)22/h2-5,11-14,16,18-20H,1H3,(H,21,22)/t11-,12-,13+,14-,16+/m0/s1	ARQXEQLMMNGFDU-JHZZJYKESA-N					removed another duplicate entry; compound annotation
0391_002070	beclomethasone	C22H29ClO5	3.1428	20469	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H29ClO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	NBMKJKDGKREAPL-DVTGEIKXSA-N					compound annotation
0391_002071	metergoline	C25H29N3O2	3.1846	28693	CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5	CN1CC(CNC(=O)OCc2ccccc2)CC2c3c4c(cn(C)c4ccc3)CC21	InChI=1S/C25H29N3O2/c1-27-14-18(13-26-25(29)30-16-17-7-4-3-5-8-17)11-21-20-9-6-10-22-24(20)19(12-23(21)27)15-28(22)2/h3-10,15,18,21,23H,11-14,16H2,1-2H3,(H,26,29)/t18-,21+,23+/m0/s1	WZHJKEUHNJHDLS-QTGUNEKASA-N					compound annotation
0391_002072	TMRM	C25H25N2O3+	3.4701	5009757		COC(=O)c1ccccc1-c1c2ccc(=[N+](C)C)cc-2oc2c1ccc(N(C)C)c2	InChI=1S/C25H25N2O3/c1-26(2)16-10-12-20-22(14-16)30-23-15-17(27(3)4)11-13-21(23)24(20)18-8-6-7-9-19(18)25(28)29-5/h6-15H,1-5H3/q+1	WAWRKBQQBUDAMY-UHFFFAOYSA-N					compound annotation
0391_002073	Altiratinib	C26H21F3N4O4	4.2647	54576299		O=C(Nc1nccc(Oc2c(F)cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)c(F)c2)c1)C1CC1	InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)	GNNDEPIMDAZHRQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002075	4091-99-0	C24H16Cl2O7	4.8545	77718		CC(=O)Oc1c(Cl)cc2c(c1)Oc1cc(OC(C)=O)c(Cl)cc1C2c1ccccc1C(=O)O	InChI=1S/C24H16Cl2O7/c1-11(27)31-21-9-19-15(7-17(21)25)23(13-5-3-4-6-14(13)24(29)30)16-8-18(26)22(32-12(2)28)10-20(16)33-19/h3-10,23H,1-2H3,(H,29,30)	PXEZTIWVRVSYOK-UHFFFAOYSA-N					compound annotation
0391_002076	HYDROXYPROGESTERONE CAPROATE	C27H40O4	5.5761	169870	CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C	CCCCCC(=O)OC1(C(C)=O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C27H40O4/c1-5-6-7-8-24(30)31-27(18(2)28)16-13-23-21-10-9-19-17-20(29)11-14-25(19,3)22(21)12-15-26(23,27)4/h17,21-23H,5-16H2,1-4H3/t21-,22+,23+,25+,26+,27+/m1/s1	DOMWKUIIPQCAJU-LJHIYBGHSA-N					removed another duplicate entry; compound annotation
0391_002078	Fraxetin	C10H8O5	1.352	5273569		COc1c(O)c(O)c2oc(=O)ccc2c1	InChI=1S/C10H8O5/c1-14-6-4-5-2-3-7(11)15-10(5)9(13)8(6)12/h2-4,12-13H,1H3	HAVWRBANWNTOJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002079	Fraxin	C16H18O10	1.352	5273568	COC1=C(C(=C2C(=C1)C=CC(=O)O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O	COc1c(O)c(OC2OC(CO)C(O)C(O)C2O)c2oc(=O)ccc2c1	InChI=1S/C16H18O10/c1-23-7-4-6-2-3-9(18)25-14(6)15(11(7)20)26-16-13(22)12(21)10(19)8(5-17)24-16/h2-4,8,10,12-13,16-17,19-22H,5H2,1H3/t8-,10-,12+,13-,16+/m1/s1	CRSFLLTWRCYNNX-QBNNUVSCSA-N					compound annotation
0391_002080	Fraxetin	C10H8O5	1.5429	5273569		COc1c(O)c(O)c2oc(=O)ccc2c1	InChI=1S/C10H8O5/c1-14-6-4-5-2-3-7(11)15-10(5)9(13)8(6)12/h2-4,12-13H,1H3	HAVWRBANWNTOJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002081	Sucralose	C12H19Cl3O8	1.5465	71485	C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CCl)O)O)CCl)O)O)Cl)O	OCC1OC(OC2(CCl)OC(CCl)C(O)C2O)C(O)C(O)C1Cl	InChI=1S/C12H19Cl3O8/c13-1-4-7(17)10(20)12(3-14,22-4)23-11-9(19)8(18)6(15)5(2-16)21-11/h4-11,16-20H,1-3H2/t4-,5-,6+,7-,8+,9-,10+,11-,12+/m1/s1	BAQAVOSOZGMPRM-QBMZZYIRSA-N					compound annotation
0391_002082	Genistin	C21H20O10	1.9219	5281377	C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1c(-c2ccc(O)cc2)coc2cc(OC3OC(CO)C(O)C(O)C3O)cc(O)c12	InChI=1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-11-5-13(24)16-14(6-11)29-8-12(17(16)25)9-1-3-10(23)4-2-9/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1	ZCOLJUOHXJRHDI-CMWLGVBASA-N					compound annotation
0391_002083	77128-73-5	C25H23NO4	4.7903	978356	CN([C@@H](CC1=CC=CC=C1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24	CN(C(=O)OCC1c2ccccc2-c2ccccc21)C(Cc1ccccc1)C(=O)O	InChI=1S/C25H23NO4/c1-26(23(24(27)28)15-17-9-3-2-4-10-17)25(29)30-16-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h2-14,22-23H,15-16H2,1H3,(H,27,28)/t23-/m0/s1	GBROUWPNYVBLFO-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_002085	Schisanhenol	C23H30O6	4.9753	73057	C[C@H]1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3C[C@H]1C)OC)OC)OC)O)OC)OC	COc1c(OC)c(O)c2c(c1)CC(C)C(C)Cc1cc(OC)c(OC)c(OC)c1-2	InChI=1S/C23H30O6/c1-12-8-14-10-16(25-3)21(27-5)20(24)18(14)19-15(9-13(12)2)11-17(26-4)22(28-6)23(19)29-7/h10-13,24H,8-9H2,1-7H3/t12-,13+/m0/s1	FYSHYFPJBONYCQ-QWHCGFSZSA-N					removed another duplicate entry; compound annotation
0391_002088	5784-74-7	C12H17NO2	1.0706	10302		COc1c(OC)cc2c(c1)CCNC2C	InChI=1S/C12H17NO2/c1-8-10-7-12(15-3)11(14-2)6-9(10)4-5-13-8/h6-8,13H,4-5H2,1-3H3	HMYJLVDKPJHJCF-UHFFFAOYSA-N					compound annotation
0391_002089	Sultopride	C17H26N2O4S	1.4396	5357		CCN1CCCC1CNC(=O)c1c(OC)ccc(S(=O)(=O)CC)c1	InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)	UNRHXEPDKXPRTM-UHFFFAOYSA-N					compound annotation
0391_002090	Tepilamide fumarate	C11H17NO5	2.417	46179632	CCN(CC)C(=O)COC(=O)/C=C/C(=O)OC	CCN(CC)C(=O)COC(=O)C=CC(=O)OC	InChI=1S/C11H17NO5/c1-4-12(5-2)9(13)8-17-11(15)7-6-10(14)16-3/h6-7H,4-5,8H2,1-3H3/b7-6+	AKUGRXRLHCCENI-VOTSOKGWSA-N					removed another duplicate entry; compound annotation
0391_002092	Belvarafenib	C23H16ClFN6OS	2.6782	89655386		Cc1c(NC(=O)c2csc3c2ncnc3N)c2c(cc1)c(Nc1c(F)c(Cl)ccc1)ncc2	InChI=1S/C23H16ClFN6OS/c1-11-5-6-13-12(7-8-27-22(13)30-16-4-2-3-15(24)17(16)25)18(11)31-23(32)14-9-33-20-19(14)28-10-29-21(20)26/h2-10H,1H3,(H,27,30)(H,31,32)(H2,26,28,29)	KVCQTKNUUQOELD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002094	otenabant	C25H25Cl2N7O	3.1591	10052040		CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1	InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35)	UNAZAADNBYXMIV-UHFFFAOYSA-N					doublet; compound annotation
0391_002095	otenabant	C25H25Cl2N7O	3.1624	10052040		CCNC1(C(N)=O)CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1	InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35)	UNAZAADNBYXMIV-UHFFFAOYSA-N					doublet; compound annotation
0391_002096	1855871-76-9	C34H38N2O4	3.7346	127035871	CC1=CC(=CC=C1)COC2=CC=CC=C2CN(CC[C@@H](C(=O)O)N)CC3=CC=CC=C3OCC4=CC=CC(=C4)C	Cc1cc(COc2ccccc2CN(CCC(N)C(=O)O)Cc2ccccc2OCc2cccc(C)c2)ccc1	InChI=1S/C34H38N2O4/c1-25-9-7-11-27(19-25)23-39-32-15-5-3-13-29(32)21-36(18-17-31(35)34(37)38)22-30-14-4-6-16-33(30)40-24-28-12-8-10-26(2)20-28/h3-16,19-20,31H,17-18,21-24,35H2,1-2H3,(H,37,38)/t31-/m0/s1	YGKNVAAMULVFNN-HKBQPEDESA-N					doublet; compound annotation
0391_002097	1855871-76-9	C34H38N2O4	3.7662	127035871	CC1=CC(=CC=C1)COC2=CC=CC=C2CN(CC[C@@H](C(=O)O)N)CC3=CC=CC=C3OCC4=CC=CC(=C4)C	Cc1cc(COc2ccccc2CN(CCC(N)C(=O)O)Cc2ccccc2OCc2cccc(C)c2)ccc1	InChI=1S/C34H38N2O4/c1-25-9-7-11-27(19-25)23-39-32-15-5-3-13-29(32)21-36(18-17-31(35)34(37)38)22-30-14-4-6-16-33(30)40-24-28-12-8-10-26(2)20-28/h3-16,19-20,31H,17-18,21-24,35H2,1-2H3,(H,37,38)/t31-/m0/s1	YGKNVAAMULVFNN-HKBQPEDESA-N					doublet; removed another duplicate entry; compound annotation
0391_002099	SMS2-IN-2	C19H13ClFN3O2	3.8246	134813905		Fc1cc(COc2cccc3c2c(Nc2cnccc2)no3)c(Cl)cc1	InChI=1S/C19H13ClFN3O2/c20-15-7-6-13(21)9-12(15)11-25-16-4-1-5-17-18(16)19(24-26-17)23-14-3-2-8-22-10-14/h1-10H,11H2,(H,23,24)	VZWFUUUUCXTDJT-UHFFFAOYSA-N					compound annotation
0391_002100	AMG-333	C20H12F5N3O4	4.4952	71144018	C1=CC(=C(N=C1)[C@H](C2=CC(=C(C=C2)OC(F)(F)F)F)NC(=O)C3=NC=C(C=C3)C(=O)O)F	O=C(O)c1cnc(C(=O)NC(c2cc(F)c(OC(F)(F)F)cc2)c2c(F)cccn2)cc1	InChI=1S/C20H12F5N3O4/c21-12-2-1-7-26-17(12)16(10-4-6-15(13(22)8-10)32-20(23,24)25)28-18(29)14-5-3-11(9-27-14)19(30)31/h1-9,16H,(H,28,29)(H,30,31)/t16-/m0/s1	QEBYISWYMFIXOZ-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_002102	Rovazolac	C21H19F3N2O4S	4.6726	89792952		CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cc(S(C)(=O)=O)ccc2)cc1	InChI=1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3	ZUMNJDGBYXHASJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002104	1800405-30-4	C14H12N2O2	1.6584	91820639		CC(C)c1nc2c([nH]1)C(=O)C(=O)c1ccccc1-2	InChI=1S/C14H12N2O2/c1-7(2)14-15-10-8-5-3-4-6-9(8)12(17)13(18)11(10)16-14/h3-7H,1-2H3,(H,15,16)	AJFWITSBVLLDCC-UHFFFAOYSA-N					doublet; compound annotation
0391_002105	1800405-30-4	C14H12N2O2	1.6619	91820639		CC(C)c1nc2c([nH]1)C(=O)C(=O)c1ccccc1-2	InChI=1S/C14H12N2O2/c1-7(2)14-15-10-8-5-3-4-6-9(8)12(17)13(18)11(10)16-14/h3-7H,1-2H3,(H,15,16)	AJFWITSBVLLDCC-UHFFFAOYSA-N					doublet; compound annotation
0391_002106	1800405-30-4	C14H12N2O2	2.5722	91820639		CC(C)c1nc2c([nH]1)C(=O)C(=O)c1ccccc1-2	InChI=1S/C14H12N2O2/c1-7(2)14-15-10-8-5-3-4-6-9(8)12(17)13(18)11(10)16-14/h3-7H,1-2H3,(H,15,16)	AJFWITSBVLLDCC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002108	Dienogest	C20H25NO2	3.1083	68861	C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O	CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(O)CC#N	InChI=1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1	AZFLJNIPTRTECV-FUMNGEBKSA-N					removed another duplicate entry; compound annotation
0391_002110	2-[[3-Ethyl-4-oxo-5-[3-methylbenzothiazole-2(3H)-ylidene]thiazolidine]-2-ylidenemethyl]-1-ethylpyridinium	C21H22N3OS2+	3.178	3037934	CCN1C(=CC2=CC=CC=[N+]2CC)S/C(=C/3\N(C4=CC=CC=C4S3)C)/C1=O	CCn1c(=Cc2cccc[n+]2CC)sc(=C2Sc3ccccc3N2C)c1=O	InChI=1S/C21H22N3OS2/c1-4-23-13-9-8-10-15(23)14-18-24(5-2)20(25)19(27-18)21-22(3)16-11-6-7-12-17(16)26-21/h6-14H,4-5H2,1-3H3/q+1/b21-19+	QLYHOWIZHHZGPV-XUTLUUPISA-N					compound annotation
0391_002111	ABMA	C18H24BrNO	3.214	2853512		COc1c(CNC23CC4CC(CC(C4)C2)C3)cc(Br)cc1	InChI=1S/C18H24BrNO/c1-21-17-3-2-16(19)7-15(17)11-20-18-8-12-4-13(9-18)6-14(5-12)10-18/h2-3,7,12-14,20H,4-6,8-11H2,1H3	UCAHJECAHMOSHI-UHFFFAOYSA-N					compound annotation
0391_002112	NAPROXEN	C14H14O3	3.606	156391	C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O	COc1cc2c(cc1)cc(C(C)C(=O)O)cc2	InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1	CMWTZPSULFXXJA-VIFPVBQESA-N					compound annotation
0391_002113	RO4987655	C20H19F3IN3O5	3.983	11548630		O=C(NOCCO)c1c(Nc2c(F)cc(I)cc2)c(F)c(F)c(CN2OCCCC2=O)c1	InChI=1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30)	FIMYFEGKMOCQKT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002115	leflunomide	C12H9F3N2O2	4.046	3899		Cc1c(C(=O)Nc2ccc(C(F)(F)F)cc2)cno1	InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)	VHOGYURTWQBHIL-UHFFFAOYSA-N					compound annotation
0391_002116	glimepiride	C24H34N4O5S	4.4755	3476		CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O	InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)	WIGIZIANZCJQQY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002118	P7C3-OMe	C22H20Br2N2O2	5.7218	3103961		COc1cccc(NCC(O)Cn2c3ccc(Br)cc3c3c2ccc(Br)c3)c1	InChI=1S/C22H20Br2N2O2/c1-28-18-4-2-3-16(11-18)25-12-17(27)13-26-21-7-5-14(23)9-19(21)20-10-15(24)6-8-22(20)26/h2-11,17,25,27H,12-13H2,1H3	LEICNUMXFWNCSJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002120	phenylbutazone	C19H20N2O2	1.8532	4781		CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O	InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3	VYMDGNCVAMGZFE-UHFFFAOYSA-N					compound annotation
0391_002121	lanraplenib	C23H25N9O	1.8532	118161062		Nc1nc(-c2cn3ccnc3c(Nc3ccc(N4CCN(C5COC5)CC4)cc3)n2)cnc1	InChI=1S/C23H25N9O/c24-21-12-25-11-19(28-21)20-13-32-6-5-26-23(32)22(29-20)27-16-1-3-17(4-2-16)30-7-9-31(10-8-30)18-14-33-15-18/h1-6,11-13,18H,7-10,14-15H2,(H2,24,28)(H,27,29)	XCIGZBVOUQVIPI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002123	957054-30-7	C23H27N7O3S2	2.4028	17755052		CS(=O)(=O)N1CCN(Cc2cc3c(s2)c(N2CCOCC2)nc(-c2c4cn[nH]c4ccc2)n3)CC1	InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)	LHNIIDJUOCFXAP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002125	Nemorexant	C23H23ClN6O2	3.0234	91801202	CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl	COc1ccc(-n2nccn2)c(C(=O)N2CCCC2(C)c2nc3c(ccc(Cl)c3C)[nH]2)c1	InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1	NBGABHGMJVIVBW-QHCPKHFHSA-N					doublet; compound annotation
0391_002126	CF53	C24H25N7O2	3.0952	118340554		COc1c(-c2c(C)onc2C)cc2[nH]c3c(c(Nc4cc(C5CC5)nn4C)nc(C)n3)c2c1	InChI=1S/C24H25N7O2/c1-11-21(12(2)33-30-11)16-8-18-15(9-19(16)32-5)22-23(27-18)25-13(3)26-24(22)28-20-10-17(14-6-7-14)29-31(20)4/h8-10,14H,6-7H2,1-5H3,(H2,25,26,27,28)	JIYPVUCBRQNICX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002128	H3B-6545	C30H29F4N5O2	3.211	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002129	H3B-6545	C30H29F4N5O2	3.2586	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002130	H3B-6545	C30H29F4N5O2	3.3039	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002131	Nemorexant	C23H23ClN6O2	3.3419	91801202	CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl	COc1ccc(-n2nccn2)c(C(=O)N2CCCC2(C)c2nc3c(ccc(Cl)c3C)[nH]2)c1	InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1	NBGABHGMJVIVBW-QHCPKHFHSA-N					doublet; compound annotation
0391_002132	Nemorexant	C23H23ClN6O2	3.3458	91801202	CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl	COc1ccc(-n2nccn2)c(C(=O)N2CCCC2(C)c2nc3c(ccc(Cl)c3C)[nH]2)c1	InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1	NBGABHGMJVIVBW-QHCPKHFHSA-N					doublet; compound annotation
0391_002133	H3B-6545	C30H29F4N5O2	3.4819	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002134	H3B-6545	C30H29F4N5O2	3.5363	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; removed another duplicate entry; compound annotation
0391_002136	H3B-6545	C30H29F4N5O2	3.6511	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002137	Tubulin inhibitor 1	C21H24N2O4	4.2513	137319628		CCOc1ccc(-c2cn(C)nc2-c2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C21H24N2O4/c1-6-27-16-9-7-14(8-10-16)17-13-23(2)22-20(17)15-11-18(24-3)21(26-5)19(12-15)25-4/h7-13H,6H2,1-5H3	YWYCRTNRTJCKHS-UHFFFAOYSA-N					doublet; compound annotation
0391_002138	Tubulin inhibitor 1	C21H24N2O4	4.2561	137319628		CCOc1ccc(-c2cn(C)nc2-c2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C21H24N2O4/c1-6-27-16-9-7-14(8-10-16)17-13-23(2)22-20(17)15-11-18(24-3)21(26-5)19(12-15)25-4/h7-13H,6H2,1-5H3	YWYCRTNRTJCKHS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002140	H3B-6545	C30H29F4N5O2	4.7482	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002141	79558-09-1	C22H26O7	4.8234	6603901		CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O	InChI=1S/C22H26O7/c1-3-5-19-20(11-10-18(15(2)23)22(19)26)28-13-4-12-27-16-6-8-17(9-7-16)29-14-21(24)25/h6-11,26H,3-5,12-14H2,1-2H3,(H,24,25)	HBBVCKCCQCQCTJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002143	H3B-6545	C30H29F4N5O2	4.8487	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002144	H3B-6545	C30H29F4N5O2	4.8876	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; compound annotation
0391_002145	Tyrphostin AG 879	C18H24N2OS	4.9643	135419190	CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)/C=C(\C#N)/C(=S)N	CC(C)(C)c1cc(C=C(C#N)C(N)=S)cc(C(C)(C)C)c1O	InChI=1S/C18H24N2OS/c1-17(2,3)13-8-11(7-12(10-19)16(20)22)9-14(15(13)21)18(4,5)6/h7-9,21H,1-6H3,(H2,20,22)/b12-7+	XRZYELWZLNAXGE-KPKJPENVSA-N					compound annotation
0391_002146	PAT-505	C23H18ClF2N3O2S	4.9754	118094189		CCn1cc(-n2c(C3CC3)c(Sc3cccc(C(=O)O)c3F)c3ccc(Cl)c(F)c32)cn1	InChI=1S/C23H18ClF2N3O2S/c1-2-28-11-13(10-27-28)29-20(12-6-7-12)22(15-8-9-16(24)19(26)21(15)29)32-17-5-3-4-14(18(17)25)23(30)31/h3-5,8-12H,2,6-7H2,1H3,(H,30,31)	BQMMCRXYIIKAOB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002148	FN-1501	C22H25N9O	1.1762	72195175		CN1CCN(Cc2ccc(NC(=O)c3c(Nc4ncnc5c4cc[nH]5)cn[nH]3)cc2)CC1	InChI=1S/C22H25N9O/c1-30-8-10-31(11-9-30)13-15-2-4-16(5-3-15)27-22(32)19-18(12-26-29-19)28-21-17-6-7-23-20(17)24-14-25-21/h2-7,12,14H,8-11,13H2,1H3,(H,26,29)(H,27,32)(H2,23,24,25,28)	VXLAKHWYGRKCGI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002150	2165340-32-7	C17H15NO2	2.3062	135567383		COc1ccc2c(-c3cc(C)c(O)cc3)ccnc2c1	InChI=1S/C17H15NO2/c1-11-9-12(3-6-17(11)19)14-7-8-18-16-10-13(20-2)4-5-15(14)16/h3-10,19H,1-2H3	HNYBTVKYLVLWCB-UHFFFAOYSA-N					doublet; compound annotation
0391_002151	MK-7622	C25H25N3O2	2.5303	46207733	CC1=NC=C(C=C1)CC2=CC3=C(C4=CC=CC=C42)N=CN(C3=O)[C@H]5CCCC[C@@H]5O	Cc1ncc(Cc2cc3c(ncn(C4CCCCC4O)c3=O)c3ccccc23)cc1	InChI=1S/C25H25N3O2/c1-16-10-11-17(14-26-16)12-18-13-21-24(20-7-3-2-6-19(18)20)27-15-28(25(21)30)22-8-4-5-9-23(22)29/h2-3,6-7,10-11,13-15,22-23,29H,4-5,8-9,12H2,1H3/t22-,23-/m0/s1	JUVQLZBJFOGEEO-GOTSBHOMSA-N					removed another duplicate entry; compound annotation
0391_002153	CA-5f	C24H24N2O3	2.6763	57341148	CN1C/C(=C\C2=CC(=C(C=C2)OC)OC)/C(=O)/C(=C/C3=CNC4=CC=CC=C43)/C1	COc1c(OC)cc(C=C2CN(C)CC(=Cc3c[nH]c4ccccc34)C2=O)cc1	InChI=1S/C24H24N2O3/c1-26-14-18(10-16-8-9-22(28-2)23(11-16)29-3)24(27)19(15-26)12-17-13-25-21-7-5-4-6-20(17)21/h4-13,25H,14-15H2,1-3H3/b18-10+,19-12+	JYOLPDWVAMBMQN-UBIAKTOFSA-N					doublet; compound annotation
0391_002154	CA-5f	C24H24N2O3	2.8627	57341148	CN1C/C(=C\C2=CC(=C(C=C2)OC)OC)/C(=O)/C(=C/C3=CNC4=CC=CC=C43)/C1	COc1c(OC)cc(C=C2CN(C)CC(=Cc3c[nH]c4ccccc34)C2=O)cc1	InChI=1S/C24H24N2O3/c1-26-14-18(10-16-8-9-22(28-2)23(11-16)29-3)24(27)19(15-26)12-17-13-25-21-7-5-4-6-20(17)21/h4-13,25H,14-15H2,1-3H3/b18-10+,19-12+	JYOLPDWVAMBMQN-UBIAKTOFSA-N					doublet; compound annotation
0391_002155	2165340-32-7	C17H15NO2	2.8661	135567383		COc1ccc2c(-c3cc(C)c(O)cc3)ccnc2c1	InChI=1S/C17H15NO2/c1-11-9-12(3-6-17(11)19)14-7-8-18-16-10-13(20-2)4-5-15(14)16/h3-10,19H,1-2H3	HNYBTVKYLVLWCB-UHFFFAOYSA-N					doublet; compound annotation
0391_002156	CA-5f	C24H24N2O3	2.8661	57341148	CN1C/C(=C\C2=CC(=C(C=C2)OC)OC)/C(=O)/C(=C/C3=CNC4=CC=CC=C43)/C1	COc1c(OC)cc(C=C2CN(C)CC(=Cc3c[nH]c4ccccc34)C2=O)cc1	InChI=1S/C24H24N2O3/c1-26-14-18(10-16-8-9-22(28-2)23(11-16)29-3)24(27)19(15-26)12-17-13-25-21-7-5-4-6-20(17)21/h4-13,25H,14-15H2,1-3H3/b18-10+,19-12+	JYOLPDWVAMBMQN-UBIAKTOFSA-N					doublet; compound annotation
0391_002157	HAMNO	C17H13NO2	2.8806	85895		Oc1ccccc1N=Cc1c(O)ccc2ccccc12	InChI=1S/C17H13NO2/c19-16-10-9-12-5-1-2-6-13(12)14(16)11-18-15-7-3-4-8-17(15)20/h1-11,19-20H	FMIVOPRNBGRDKP-UHFFFAOYSA-N					doublet; compound annotation
0391_002158	Olutasidenib	C18H15ClN4O2	3.4281	118955396	C[C@@H](C1=CC2=C(C=CC(=C2)Cl)NC1=O)NC3=CC=C(N(C3=O)C)C#N	CC(Nc1ccc(C#N)n(C)c1=O)c1cc2c(ccc(Cl)c2)[nH]c1=O	InChI=1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1	NEQYWYXGTJDAKR-JTQLQIEISA-N					removed another duplicate entry; compound annotation
0391_002160	6266-66-6	C18H15NO3	3.5697	235453		O=C(CC(C(=O)O)c1c[nH]c2ccccc12)c1ccccc1	InChI=1S/C18H15NO3/c20-17(12-6-2-1-3-7-12)10-14(18(21)22)15-11-19-16-9-5-4-8-13(15)16/h1-9,11,14,19H,10H2,(H,21,22)	SJVMWLJNHPHNPT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002162	HAMNO	C17H13NO2	3.8335	85895		Oc1ccccc1N=Cc1c(O)ccc2ccccc12	InChI=1S/C17H13NO2/c19-16-10-9-12-5-1-2-6-13(12)14(16)11-18-15-7-3-4-8-17(15)20/h1-11,19-20H	FMIVOPRNBGRDKP-UHFFFAOYSA-N					doublet; compound annotation
0391_002163	capsazepine	C19H21ClN2O2S	3.9073	2733484		Oc1c(O)cc2CN(C(S)=NCCc3ccc(Cl)cc3)CCCc2c1	InChI=1S/C19H21ClN2O2S/c20-16-5-3-13(4-6-16)7-8-21-19(25)22-9-1-2-14-10-17(23)18(24)11-15(14)12-22/h3-6,10-11,23-24H,1-2,7-9,12H2,(H,21,25)	DRCMAZOSEIMCHM-UHFFFAOYSA-N					compound annotation
0391_002164	MC3482	C33H38N4O8	4.0265	134694957	C1=CC=C(C=C1)COC(=O)N[C@@H](CCCCNC(=O)CC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)C(=O)NC3=CC=CC=C3	O=C(CCC(NC(=O)OCc1ccccc1)C(=O)O)NCCCCC(NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1	InChI=1S/C33H38N4O8/c38-29(20-19-28(31(40)41)37-33(43)45-23-25-14-6-2-7-15-25)34-21-11-10-18-27(30(39)35-26-16-8-3-9-17-26)36-32(42)44-22-24-12-4-1-5-13-24/h1-9,12-17,27-28H,10-11,18-23H2,(H,34,38)(H,35,39)(H,36,42)(H,37,43)(H,40,41)/t27-,28-/m0/s1	LDCYHYVNYRUUOL-NSOVKSMOSA-N					removed another duplicate entry; compound annotation
0391_002166	NXT629	C35H39N5O3S	5.2156	71721539		CCn1c(CCCc2ccc(-c3ncc(NS(=O)(=O)c4ccccc4)cc3)cc2)nn(Cc2ccc(C(C)(C)C)cc2)c1=O	InChI=1S/C35H39N5O3S/c1-5-39-33(37-40(34(39)41)25-27-16-20-29(21-17-27)35(2,3)4)13-9-10-26-14-18-28(19-15-26)32-23-22-30(24-36-32)38-44(42,43)31-11-7-6-8-12-31/h6-8,11-12,14-24,38H,5,9-10,13,25H2,1-4H3	IRSFLNXJVJKMDT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002168	PS-1145	C17H11ClN4O	1.9179	9949093		O=C(Nc1cc(Cl)cc2c1[nH]c1c2ccnc1)c1cnccc1	InChI=1S/C17H11ClN4O/c18-11-6-13-12-3-5-20-9-15(12)21-16(13)14(7-11)22-17(23)10-2-1-4-19-8-10/h1-9,21H,(H,22,23)	JZRMBDHPALEPDM-UHFFFAOYSA-N					compound annotation
0391_002169	Edonerpic	C16H21NO2S	2.4824	9901946		OC1CN(CCCOCCc2cc3c(cc2)scc3)C1	InChI=1S/C16H21NO2S/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2	HQNACSFBDBYLJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002170	sulfadimethoxine	C12H14N4O4S	2.4915	5323		COc1nc(OC)nc(NS(=O)(=O)c2ccc(N)cc2)c1	InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	ZZORFUFYDOWNEF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002172	Edonerpic	C16H21NO2S	2.522	9901946		OC1CN(CCCOCCc2cc3c(cc2)scc3)C1	InChI=1S/C16H21NO2S/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2	HQNACSFBDBYLJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002173	Edonerpic	C16H21NO2S	2.5991	9901946		OC1CN(CCCOCCc2cc3c(cc2)scc3)C1	InChI=1S/C16H21NO2S/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2	HQNACSFBDBYLJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002174	Edonerpic	C16H21NO2S	2.8098	9901946		OC1CN(CCCOCCc2cc3c(cc2)scc3)C1	InChI=1S/C16H21NO2S/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2	HQNACSFBDBYLJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002175	138847-85-5	C19H27NO3	2.9638	126402		O=C(OCCN1CCOCC1)C1(c2ccccc2)CCCCC1	InChI=1S/C19H27NO3/c21-18(23-16-13-20-11-14-22-15-12-20)19(9-5-2-6-10-19)17-7-3-1-4-8-17/h1,3-4,7-8H,2,5-6,9-16H2	RQHKZUBCUZVZEF-UHFFFAOYSA-N					compound annotation
0391_002176	Edonerpic	C16H21NO2S	3.2833	9901946		OC1CN(CCCOCCc2cc3c(cc2)scc3)C1	InChI=1S/C16H21NO2S/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2	HQNACSFBDBYLJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002177	GSK2606414	C24H20F3N5O	3.4252	53469448		Cn1cc(-c2cc3c(cc2)N(C(=O)Cc2cc(C(F)(F)F)ccc2)CC3)c2c(N)ncnc21	InChI=1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30)	SIXVRXARNAVBTC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002179	WZB117	C20H13FO6	3.9447	46830365		O=C(Oc1cccc(F)c1OC(=O)c1cc(O)ccc1)c1cc(O)ccc1	InChI=1S/C20H13FO6/c21-16-8-3-9-17(26-19(24)12-4-1-6-14(22)10-12)18(16)27-20(25)13-5-2-7-15(23)11-13/h1-11,22-23H	FRSWCCBXIHFKKY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002181	sulfadimethoxine	C12H14N4O4S	4.3164	5323		COc1nc(OC)nc(NS(=O)(=O)c2ccc(N)cc2)c1	InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	ZZORFUFYDOWNEF-UHFFFAOYSA-N					doublet; compound annotation
0391_002182	Ezutromid	C19H15NO3S	4.6924	25109292		CCS(=O)(=O)c1cc2c(cc1)oc(-c1cc3ccccc3cc1)n2	InChI=1S/C19H15NO3S/c1-2-24(21,22)16-9-10-18-17(12-16)20-19(23-18)15-8-7-13-5-3-4-6-14(13)11-15/h3-12H,2H2,1H3	KSGCNXAZROJSNW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002184	Ezutromid	C19H15NO3S	4.6954	25109292		CCS(=O)(=O)c1cc2c(cc1)oc(-c1cc3ccccc3cc1)n2	InChI=1S/C19H15NO3S/c1-2-24(21,22)16-9-10-18-17(12-16)20-19(23-18)15-8-7-13-5-3-4-6-14(13)11-15/h3-12H,2H2,1H3	KSGCNXAZROJSNW-UHFFFAOYSA-N					doublet; compound annotation
0391_002185	Oteseconazole	C23H16F7N5O2	4.7974	77050711	C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F	OC(Cn1cnnn1)(c1c(F)cc(F)cc1)C(F)(F)c1ncc(-c2ccc(OCC(F)(F)F)cc2)cc1	InChI=1S/C23H16F7N5O2/c24-16-4-7-18(19(25)9-16)21(36,11-35-13-32-33-34-35)23(29,30)20-8-3-15(10-31-20)14-1-5-17(6-2-14)37-12-22(26,27)28/h1-10,13,36H,11-12H2/t21-/m0/s1	IDUYJRXRDSPPRC-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_002187	1229652-21-4	C24H19BFNO5S	4.9465	46911532	B(C1=CC(=CC=C1)COC2=CC=C(C=C2)/C=C\3/C(=O)N(C(=O)S3)CC4=CC=C(C=C4)F)(O)O	O=C1SC(=Cc2ccc(OCc3cccc(B(O)O)c3)cc2)C(=O)N1Cc1ccc(F)cc1	InChI=1S/C24H19BFNO5S/c26-20-8-4-17(5-9-20)14-27-23(28)22(33-24(27)29)13-16-6-10-21(11-7-16)32-15-18-2-1-3-19(12-18)25(30)31/h1-13,30-31H,14-15H2/b22-13-	VTNKMYWFWQTEHE-XKZIYDEJSA-N					compound annotation
0391_002188	Otamixaban	C25H26N4O4	1.773	5496659	C[C@H]([C@@H](CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-]	COC(=O)C(Cc1cc(C(=N)N)ccc1)C(C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1	InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1	PFGVNLZDWRZPJW-OPAMFIHVSA-N					removed another duplicate entry; compound annotation
0391_002190	pranoprofen	C15H13NO3	2.3709	4888		CC(C(=O)O)c1cc2c(cc1)Oc1c(cccn1)C2	InChI=1S/C15H13NO3/c1-9(15(17)18)10-4-5-13-12(7-10)8-11-3-2-6-16-14(11)19-13/h2-7,9H,8H2,1H3,(H,17,18)	TVQZAMVBTVNYLA-UHFFFAOYSA-N					doublet; compound annotation
0391_002191	6-Carboxyfluorescein	C21H12O7	2.601	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; compound annotation
0391_002192	600734-02-9	C22H25N3O4	2.6135	135454904	C1C[C@H](CNC1)C2=CC(=NC3=C2COC(=O)N3)C4=C(C=CC=C4OCC5CC5)O	O=C1Nc2c(CO1)c(C1CCCNC1)cc(-c1c(O)cccc1OCC1CC1)n2	InChI=1S/C22H25N3O4/c26-18-4-1-5-19(28-11-13-6-7-13)20(18)17-9-15(14-3-2-8-23-10-14)16-12-29-22(27)25-21(16)24-17/h1,4-5,9,13-14,23,26H,2-3,6-8,10-12H2,(H,24,25,27)/t14-/m1/s1	IGJVFGZEWDGDOO-CQSZACIVSA-N					compound annotation
0391_002193	6-Carboxyfluorescein	C21H12O7	2.6366	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; compound annotation
0391_002194	6-Carboxyfluorescein	C21H12O7	2.6417	76806		O=C(O)c1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-14-17(8-11)27-18-9-12(23)3-6-15(18)21(14)16-7-10(19(24)25)1-4-13(16)20(26)28-21/h1-9,22-23H,(H,24,25)	BZTDTCNHAFUJOG-UHFFFAOYSA-N					doublet; compound annotation
0391_002195	chlormezanone	C11H12ClNO3S	2.6765	2717		CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1	InChI=1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3	WEQAYVWKMWHEJO-UHFFFAOYSA-N					compound annotation
0391_002196	pranoprofen	C15H13NO3	2.7013	4888		CC(C(=O)O)c1cc2c(cc1)Oc1c(cccn1)C2	InChI=1S/C15H13NO3/c1-9(15(17)18)10-4-5-13-12(7-10)8-11-3-2-6-16-14(11)19-13/h2-7,9H,8H2,1H3,(H,17,18)	TVQZAMVBTVNYLA-UHFFFAOYSA-N					doublet; compound annotation
0391_002197	pranoprofen	C15H13NO3	2.8305	4888		CC(C(=O)O)c1cc2c(cc1)Oc1c(cccn1)C2	InChI=1S/C15H13NO3/c1-9(15(17)18)10-4-5-13-12(7-10)8-11-3-2-6-16-14(11)19-13/h2-7,9H,8H2,1H3,(H,17,18)	TVQZAMVBTVNYLA-UHFFFAOYSA-N					doublet; compound annotation
0391_002198	Dapoxetine	C21H23NO	3.3007	71353	CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3	CN(C)C(CCOc1cccc2ccccc12)c1ccccc1	InChI=1S/C21H23NO/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21/h3-14,20H,15-16H2,1-2H3/t20-/m0/s1	USRHYDPUVLEVMC-FQEVSTJZSA-N					compound annotation
0391_002199	Laropiprant	C21H19ClFNO4S	4.5747	9867642	CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F	CS(=O)(=O)c1cc(F)cc2c1n(Cc1ccc(Cl)cc1)c1c2CCC1CC(=O)O	InChI=1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1	NXFFJDQHYLNEJK-CYBMUJFWSA-N					compound annotation
0391_002200	antipyrine	C11H12N2O	1.6928	2206		Cc1cc(=O)n(-c2ccccc2)n1C	InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3	VEQOALNAAJBPNY-UHFFFAOYSA-N					doublet; compound annotation
0391_002201	antipyrine	C11H12N2O	1.6977	2206		Cc1cc(=O)n(-c2ccccc2)n1C	InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3	VEQOALNAAJBPNY-UHFFFAOYSA-N					doublet; compound annotation
0391_002202	altretamine	C9H18N6	1.9385	2123		CN(C)c1nc(N(C)C)nc(N(C)C)n1	InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3	UUVWYPNAQBNQJQ-UHFFFAOYSA-N					compound annotation
0391_002203	Isoacteoside	C29H36O15	2.0233	6476333	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@H](O[C@H]([C@@H]2O)OCCC3=CC(=C(C=C3)O)O)COC(=O)/C=C/C4=CC(=C(C=C4)O)O)O)O)O)O	CC1OC(OC2C(O)C(COC(=O)C=Cc3cc(O)c(O)cc3)OC(OCCc3cc(O)c(O)cc3)C2O)C(O)C(O)C1O	InChI=1S/C29H36O15/c1-13-22(35)24(37)25(38)29(42-13)44-27-23(36)20(12-41-21(34)7-4-14-2-5-16(30)18(32)10-14)43-28(26(27)39)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27-,28+,29-/m0/s1	FNMHEHXNBNCPCI-QEOJJFGVSA-N					removed another duplicate entry; compound annotation
0391_002205	Talazoparib	C19H14F2N6O	2.6876	135565082	CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F	Cn1ncnc1C1c2n[nH]c(=O)c3c2c(cc(F)c3)NC1c1ccc(F)cc1	InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	HWGQMRYQVZSGDQ-HZPDHXFCSA-N					doublet; compound annotation
0391_002206	Talazoparib	C19H14F2N6O	2.6904	135565082	CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F	Cn1ncnc1C1c2n[nH]c(=O)c3c2c(cc(F)c3)NC1c1ccc(F)cc1	InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	HWGQMRYQVZSGDQ-HZPDHXFCSA-N					doublet; compound annotation
0391_002207	1071992-99-8	C32H43N5O4	2.921	25022340	C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC(C)C)NC	CNC(C)C(=O)NC1CN(C(=O)CC(C)C)CCC2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O	InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1	LSXUTRRVVSPWDZ-MKKUMYSQSA-N					doublet; compound annotation
0391_002208	Diosmetin	C16H12O6	2.9703	5281612		COc1c(O)cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3	MBNGWHIJMBWFHU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002210	ZM323881	C22H18FN3O2	3.0821	16759369		Cc1cc(F)c(Nc2ncnc3c2ccc(OCc2ccccc2)c3)cc1O	InChI=1S/C22H18FN3O2/c1-14-9-18(23)20(11-21(14)27)26-22-17-8-7-16(10-19(17)24-13-25-22)28-12-15-5-3-2-4-6-15/h2-11,13,27H,12H2,1H3,(H,24,25,26)	NVBNDZZLJRYRPD-UHFFFAOYSA-N					compound annotation
0391_002211	1071992-99-8	C32H43N5O4	3.2374	25022340	C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC(C)C)NC	CNC(C)C(=O)NC1CN(C(=O)CC(C)C)CCC2CCC(C(=O)NC(c3ccccc3)c3ccccc3)N2C1=O	InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1	LSXUTRRVVSPWDZ-MKKUMYSQSA-N					doublet; removed another duplicate entry; compound annotation
0391_002213	fenbendazole	C15H13N3O2S	3.3101	3334		COC(=O)Nc1nc2c(cc(Sc3ccccc3)cc2)[nH]1	InChI=1S/C15H13N3O2S/c1-20-15(19)18-14-16-12-8-7-11(9-13(12)17-14)21-10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)	HDDSHPAODJUKPD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002215	kn-93	C26H29ClN2O4S	3.7654	5312122	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCO)S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C26H29ClN2O4S/c1-28(17-5-6-21-9-11-23(27)12-10-21)20-22-7-3-4-8-26(22)29(18-19-30)34(31,32)25-15-13-24(33-2)14-16-25/h3-16,30H,17-20H2,1-2H3/b6-5+	LLLQTDSSHZREGW-AATRIKPKSA-N					doublet; compound annotation
0391_002216	Alantolactone	C15H20O2	4.7777	72724	C[C@H]1CCC[C@]2(C1=C[C@H]3[C@@H](C2)OC(=O)C3=C)C	C=C1C(=O)OC2CC3(C)CCCC(C)C3=CC12	InChI=1S/C15H20O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h7,9,11,13H,2,4-6,8H2,1,3H3/t9-,11+,13+,15+/m0/s1	PXOYOCNNSUAQNS-AGNJHWRGSA-N					compound annotation
0391_002217	GELSEMINE	C20H22N2O2	1.3227	5390854	CN1C[C@]2([C@@H]3C[C@@H]4[C@]5([C@H]2[C@H]1[C@H]3CO4)C6=CC=CC=C6NC5=O)C=C	C=CC12CN(C)C3C4COC(CC41)C1(C(=O)Nc4ccccc41)C32	InChI=1S/C20H22N2O2/c1-3-19-10-22(2)16-11-9-24-15(8-13(11)19)20(17(16)19)12-6-4-5-7-14(12)21-18(20)23/h3-7,11,13,15-17H,1,8-10H2,2H3,(H,21,23)/t11-,13+,15+,16+,17-,19-,20-/m0/s1	NFYYATWFXNPTRM-QJICHLCESA-N					compound annotation
0391_002218	LLY-283	C17H18N4O4	1.3558	122669401	C1=CC=C(C=C1)[C@H]([C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O)O	Nc1c2ccn(C3OC(C(O)c4ccccc4)C(O)C3O)c2ncn1	InChI=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)11(22)9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12+,13-,14-,17-/m1/s1	WWOOWAHTEXIWBO-QFRSUPTLSA-N					removed another duplicate entry; compound annotation
0391_002220	INDOTECAN	C26H26N2O7	2.7173	11533060		COc1c(OC)cc2c(=O)n(CCCN3CCOCC3)c3c(C(=O)c4cc5c(cc4-3)OCO5)c2c1	InChI=1S/C26H26N2O7/c1-31-19-10-15-18(13-20(19)32-2)26(30)28(5-3-4-27-6-8-33-9-7-27)24-16-11-21-22(35-14-34-21)12-17(16)25(29)23(15)24/h10-13H,3-9,14H2,1-2H3	FMFIFGLHVOZDEL-UHFFFAOYSA-N					compound annotation
0391_002221	CCT241736	C22H23Cl2N7	2.7298	71454279		Cc1nn(C)cc1-c1nc2ncc(Cl)c(N3CCN(Cc4ccc(Cl)cc4)CC3)c2[nH]1	InChI=1S/C22H23Cl2N7/c1-14-17(13-29(2)28-14)21-26-19-20(18(24)11-25-22(19)27-21)31-9-7-30(8-10-31)12-15-3-5-16(23)6-4-15/h3-6,11,13H,7-10,12H2,1-2H3,(H,25,26,27)	AKJBLKUZXRMECW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002223	192321-23-6	C26H29N5O2S	3.3287	5312114		Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12	InChI=1S/C26H29N5O2S/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31)	UULIGRNKXHCLQN-UHFFFAOYSA-N					compound annotation
0391_002224	tolbutamide	C12H18N2O3S	3.4027	5505		CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1	InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)	JLRGJRBPOGGCBT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002226	CG-806	C26H19F4N5O2	3.5669	66981446		Cc1cnc(-c2ccc(-c3c(F)cc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c3c2C(=O)NC3)[nH]1	InChI=1S/C26H19F4N5O2/c1-13-11-31-23(33-13)19-8-7-17(20-12-32-24(36)22(19)20)18-6-5-16(10-21(18)27)35-25(37)34-15-4-2-3-14(9-15)26(28,29)30/h2-11H,12H2,1H3,(H,31,33)(H,32,36)(H2,34,35,37)	BOLRZWTVMUHQQU-UHFFFAOYSA-N					compound annotation
0391_002227	SU 3327	C5H3N5O2S3	2.2052	11837140		Nc1nnc(Sc2ncc([N+](=O)[O-])s2)s1	InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)	NQQBNZBOOHHVQP-UHFFFAOYSA-N					compound annotation
0391_002228	TWS119	C18H14N4O2	2.5077	9549289		Nc1cccc(-c2cc3c(ncnc3Oc3cccc(O)c3)[nH]2)c1	InChI=1S/C18H14N4O2/c19-12-4-1-3-11(7-12)16-9-15-17(22-16)20-10-21-18(15)24-14-6-2-5-13(23)8-14/h1-10,23H,19H2,(H,20,21,22)	VPVLEBIVXZSOMQ-UHFFFAOYSA-N					compound annotation
0391_002229	SAR7334	C21H22ClN3O	2.7756	53378752	C1C[C@H](CN(C1)[C@@H]2CC3=CC=CC=C3[C@H]2OC4=C(C=C(C=C4)C#N)Cl)N	N#Cc1cc(Cl)c(OC2c3ccccc3CC2N2CCCC(N)C2)cc1	InChI=1S/C21H22ClN3O/c22-18-10-14(12-23)7-8-20(18)26-21-17-6-2-1-4-15(17)11-19(21)25-9-3-5-16(24)13-25/h1-2,4,6-8,10,16,19,21H,3,5,9,11,13,24H2/t16-,19-,21-/m1/s1	RLKRLNQEXBPQGQ-OZOXKJRCSA-N					doublet; removed another duplicate entry; compound annotation
0391_002231	H3B-5942	C31H34N4O2	3.4534	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002232	H3B-5942	C31H34N4O2	3.5366	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; removed another duplicate entry; compound annotation
0391_002234	H3B-5942	C31H34N4O2	3.6644	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002235	Cilofexor	C28H22Cl3N3O5	3.7091	71228883		O=C(O)c1cc(N2CC(O)(c3c(Cl)cc(OCc4c(C5CC5)onc4-c4c(Cl)cccc4Cl)cc3)C2)ncc1	InChI=1S/C28H22Cl3N3O5/c29-20-2-1-3-21(30)24(20)25-18(26(39-33-25)15-4-5-15)12-38-17-6-7-19(22(31)11-17)28(37)13-34(14-28)23-10-16(27(35)36)8-9-32-23/h1-3,6-11,15,37H,4-5,12-14H2,(H,35,36)	KZSKGLFYQAYZCO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002237	H3B-5942	C31H34N4O2	3.9566	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002238	6508-43-6	C23H26O4	4.0006	3765615		CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1	InChI=1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3	XQDXIHYKAGHZRX-UHFFFAOYSA-N					doublet; compound annotation
0391_002239	6508-43-6	C23H26O4	4.0039	3765615		CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1	InChI=1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3	XQDXIHYKAGHZRX-UHFFFAOYSA-N					doublet; compound annotation
0391_002240	UCPH-101	C27H22N2O3	4.4935	25223366		COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1	InChI=1S/C27H22N2O3/c1-31-19-11-9-17(10-12-19)25-22(15-28)27(29)32-24-14-18(13-23(30)26(24)25)21-8-4-6-16-5-2-3-7-20(16)21/h2-12,18,25H,13-14,29H2,1H3	YBMGNDPBARCLFT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002242	TTA-Q6	C20H15ClF3N3O	4.5603	46927979	C1CC1[C@@]2(C3=C(C=CC(=C3)Cl)NC(=O)N2CC(F)(F)F)C4=CC=C(C=C4)C#N	N#Cc1ccc(C2(C3CC3)c3cc(Cl)ccc3NC(=O)N2CC(F)(F)F)cc1	InChI=1S/C20H15ClF3N3O/c21-15-7-8-17-16(9-15)20(14-5-6-14,13-3-1-12(10-25)2-4-13)27(18(28)26-17)11-19(22,23)24/h1-4,7-9,14H,5-6,11H2,(H,26,28)/t20-/m1/s1	OVRNWJYZCIAMGV-HXUWFJFHSA-N					compound annotation
0391_002243	UCPH-101	C27H22N2O3	4.5683	25223366		COc1ccc(C2C(C#N)=C(N)OC3=C2C(=O)CC(c2cccc4ccccc24)C3)cc1	InChI=1S/C27H22N2O3/c1-31-19-11-9-17(10-12-19)25-22(15-28)27(29)32-24-14-18(13-23(30)26(24)25)21-8-4-6-16-5-2-3-7-20(16)21/h2-12,18,25H,13-14,29H2,1H3	YBMGNDPBARCLFT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002246	6508-43-6	C23H26O4	4.6321	3765615		CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1	InChI=1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3	XQDXIHYKAGHZRX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002248	H3B-5942	C31H34N4O2	4.7446	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002249	H3B-5942	C31H34N4O2	4.8058	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002250	6508-43-6	C23H26O4	4.8595	3765615		CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1	InChI=1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3	XQDXIHYKAGHZRX-UHFFFAOYSA-N					doublet; compound annotation
0391_002251	6508-43-6	C23H26O4	4.9505	3765615		CC1(C)CC(=O)C(C2C3=C(CC(C)(C)CC3=O)Oc3ccccc32)C(=O)C1	InChI=1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3	XQDXIHYKAGHZRX-UHFFFAOYSA-N					doublet; compound annotation
0391_002252	H3B-5942	C31H34N4O2	4.9617	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002253	H3B-5942	C31H34N4O2	5.0362	124091011	CC/C(=C(/C1=CC=C(C=C1)OCCNC/C=C/C(=O)N(C)C)\C2=CC3=C(C=C2)NN=C3)/C4=CC=CC=C4	CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1cc2c(cc1)[nH]nc2)c1ccccc1	InChI=1S/C31H34N4O2/c1-4-28(23-9-6-5-7-10-23)31(25-14-17-29-26(21-25)22-33-34-29)24-12-15-27(16-13-24)37-20-19-32-18-8-11-30(36)35(2)3/h5-17,21-22,32H,4,18-20H2,1-3H3,(H,33,34)/b11-8+,31-28+	BYAUIDXIQATDBT-GIHLFXONSA-N					doublet; compound annotation
0391_002254	CHLOROPROCAINE	C13H19ClN2O2	1.378	8612		CCN(CC)CCOC(=O)c1c(Cl)cc(N)cc1	InChI=1S/C13H19ClN2O2/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14/h5-6,9H,3-4,7-8,15H2,1-2H3	VDANGULDQQJODZ-UHFFFAOYSA-N					compound annotation
0391_002255	benfluorex	C19H20F3NO2	3.2913	2318		CC(Cc1cc(C(F)(F)F)ccc1)NCCOC(=O)c1ccccc1	InChI=1S/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16/h2-9,13-14,23H,10-12H2,1H3	CJAVTWRYCDNHSM-UHFFFAOYSA-N					compound annotation
0391_002256	Sinensetin	C20H20O7	3.4279	145659		COc1c(OC)cc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1	InChI=1S/C20H20O7/c1-22-13-7-6-11(8-15(13)23-2)14-9-12(21)18-16(27-14)10-17(24-3)19(25-4)20(18)26-5/h6-10H,1-5H3	LKMNXYDUQXAUCZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002258	Corosolic acid	C30H48O4	3.6472	6918774	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C)C5CCC43C)C2C1C	InChI=1S/C30H48O4/c1-17-10-13-30(25(33)34)15-14-28(6)19(23(30)18(17)2)8-9-22-27(5)16-20(31)24(32)26(3,4)21(27)11-12-29(22,28)7/h8,17-18,20-24,31-32H,9-16H2,1-7H3,(H,33,34)/t17-,18+,20-,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1	HFGSQOYIOKBQOW-ZSDYHTTISA-N					doublet; compound annotation
0391_002259	Astragaloside II	C43H70O15	3.6472	13996693	CC(=O)O[C@@H]1[C@H]([C@@H](CO[C@H]1O[C@H]2CC[C@]34C[C@]35CC[C@@]6([C@H]([C@H](C[C@]6([C@@H]5C[C@@H]([C@H]4C2(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C)O)O	CC(=O)OC1C(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)OCC(O)C1O	InChI=1S/C43H70O15/c1-20(45)54-32-28(48)22(47)18-53-36(32)57-26-10-12-43-19-42(43)14-13-39(6)33(41(8)11-9-27(58-41)38(4,5)52)21(46)16-40(39,7)25(42)15-23(34(43)37(26,2)3)55-35-31(51)30(50)29(49)24(17-44)56-35/h21-36,44,46-52H,9-19H2,1-8H3/t21-,22+,23-,24+,25-,26-,27-,28-,29+,30-,31+,32+,33-,34-,35+,36-,39+,40-,41+,42-,43+/m0/s1	AYWNHWGQTMCQIV-PENCHUSISA-N					doublet; compound annotation
0391_002260	Astragaloside II	C43H70O15	3.6502	13996693	CC(=O)O[C@@H]1[C@H]([C@@H](CO[C@H]1O[C@H]2CC[C@]34C[C@]35CC[C@@]6([C@H]([C@H](C[C@]6([C@@H]5C[C@@H]([C@H]4C2(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C)O)O	CC(=O)OC1C(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)OCC(O)C1O	InChI=1S/C43H70O15/c1-20(45)54-32-28(48)22(47)18-53-36(32)57-26-10-12-43-19-42(43)14-13-39(6)33(41(8)11-9-27(58-41)38(4,5)52)21(46)16-40(39,7)25(42)15-23(34(43)37(26,2)3)55-35-31(51)30(50)29(49)24(17-44)56-35/h21-36,44,46-52H,9-19H2,1-8H3/t21-,22+,23-,24+,25-,26-,27-,28-,29+,30-,31+,32+,33-,34-,35+,36-,39+,40-,41+,42-,43+/m0/s1	AYWNHWGQTMCQIV-PENCHUSISA-N					doublet; compound annotation
0391_002261	Fluorescein diacetate	C24H16O7	4.2152	65047		CC(=O)Oc1cc2c(cc1)C1(OC(=O)c3ccccc31)c1c(cc(OC(C)=O)cc1)O2	InChI=1S/C24H16O7/c1-13(25)28-15-7-9-19-21(11-15)30-22-12-16(29-14(2)26)8-10-20(22)24(19)18-6-4-3-5-17(18)23(27)31-24/h3-12H,1-2H3	CHADEQDQBURGHL-UHFFFAOYSA-N					doublet; compound annotation
0391_002262	Fluorescein diacetate	C24H16O7	4.3692	65047		CC(=O)Oc1cc2c(cc1)C1(OC(=O)c3ccccc31)c1c(cc(OC(C)=O)cc1)O2	InChI=1S/C24H16O7/c1-13(25)28-15-7-9-19-21(11-15)30-22-12-16(29-14(2)26)8-10-20(22)24(19)18-6-4-3-5-17(18)23(27)31-24/h3-12H,1-2H3	CHADEQDQBURGHL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002264	Nile red	C20H18N2O2	5.1205	65182		CCN(CC)c1cc2c(cc1)nc1-c(cc(=O)c3ccccc13)o2	InChI=1S/C20H18N2O2/c1-3-22(4-2)13-9-10-16-18(11-13)24-19-12-17(23)14-7-5-6-8-15(14)20(19)21-16/h5-12H,3-4H2,1-2H3	VOFUROIFQGPCGE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002266	Nile red	C20H18N2O2	5.1329	65182		CCN(CC)c1cc2c(cc1)nc1-c(cc(=O)c3ccccc13)o2	InChI=1S/C20H18N2O2/c1-3-22(4-2)13-9-10-16-18(11-13)24-19-12-17(23)14-7-5-6-8-15(14)20(19)21-16/h5-12H,3-4H2,1-2H3	VOFUROIFQGPCGE-UHFFFAOYSA-N					doublet; compound annotation
0391_002267	Corosolic acid	C30H48O4	5.141	6918774	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C)C5CCC43C)C2C1C	InChI=1S/C30H48O4/c1-17-10-13-30(25(33)34)15-14-28(6)19(23(30)18(17)2)8-9-22-27(5)16-20(31)24(32)26(3,4)21(27)11-12-29(22,28)7/h8,17-18,20-24,31-32H,9-16H2,1-7H3,(H,33,34)/t17-,18+,20-,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1	HFGSQOYIOKBQOW-ZSDYHTTISA-N					doublet; removed another duplicate entry; compound annotation
0391_002269	SCHEMBL179816	C29H37N2O2+	5.3799	6367922	CCCCCCN\1C2=CC=CC=C2O/C1=C\C=C\C3=[N+](C4=CC=CC=C4O3)CCCCCC	CCCCCCN1C(=CC=Cc2[n+](CCCCCC)c3ccccc3o2)Oc2ccccc21	InChI=1S/C29H37N2O2/c1-3-5-7-13-22-30-24-16-9-11-18-26(24)32-28(30)20-15-21-29-31(23-14-8-6-4-2)25-17-10-12-19-27(25)33-29/h9-12,15-21H,3-8,13-14,22-23H2,1-2H3/q+1	GKLGUKVTTNJEBK-UHFFFAOYSA-N					compound annotation
0391_002270	tropicamide	C17H20N2O2	1.5601	5593		CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	InChI=1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3	BGDKAVGWHJFAGW-UHFFFAOYSA-N					doublet; compound annotation
0391_002271	tropicamide	C17H20N2O2	1.5633	5593		CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1	InChI=1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3	BGDKAVGWHJFAGW-UHFFFAOYSA-N					doublet; compound annotation
0391_002272	Alibendol	C13H17NO4	2.584	71916		C=CCc1cc(C(=O)NCCO)c(O)c(OC)c1	InChI=1S/C13H17NO4/c1-3-4-9-7-10(13(17)14-5-6-15)12(16)11(8-9)18-2/h3,7-8,15-16H,1,4-6H2,2H3,(H,14,17)	UMJHTFHIQDEGKB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002275	NAN-190	C23H27N3O3	2.635	4431		COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1	InChI=1S/C23H27N3O3/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28/h2-5,8-11H,6-7,12-17H2,1H3	SJDOMIRMMUGQQK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002278	FGH10019	C18H19N3O2S2	2.7441	25012898		CCCc1nccc(-c2nc(-c3ccc(NS(C)(=O)=O)cc3)cs2)c1	InChI=1S/C18H19N3O2S2/c1-3-4-16-11-14(9-10-19-16)18-20-17(12-24-18)13-5-7-15(8-6-13)21-25(2,22)23/h5-12,21H,3-4H2,1-2H3	OWAXXHRQPWGNTG-UHFFFAOYSA-N					compound annotation
0391_002279	Alofanib	C19H15N3O6S	2.8838	86280646		Cc1cc([N+](=O)[O-])c(NS(=O)(=O)c2cccc(C(=O)O)c2)cc1-c1cnccc1	InChI=1S/C19H15N3O6S/c1-12-8-18(22(25)26)17(10-16(12)14-5-3-7-20-11-14)21-29(27,28)15-6-2-4-13(9-15)19(23)24/h2-11,21H,1H3,(H,23,24)	QUQGQIASFYWKAB-UHFFFAOYSA-N					compound annotation
0391_002280	ONO-7475	C32H26N4O6	3.1563	90645873		COc1cc2nccc(Oc3cnc(NC(=O)c4cc5c(CCCC5=O)n(-c5ccccc5)c4=O)cc3)c2cc1OC	InChI=1S/C32H26N4O6/c1-40-28-16-21-24(17-29(28)41-2)33-14-13-27(21)42-20-11-12-30(34-18-20)35-31(38)23-15-22-25(9-6-10-26(22)37)36(32(23)39)19-7-4-3-5-8-19/h3-5,7-8,11-18H,6,9-10H2,1-2H3,(H,34,35,38)	WHMMKPWGWNYYFE-UHFFFAOYSA-N					doublet; compound annotation
0391_002281	ONO-7475	C32H26N4O6	3.1596	90645873		COc1cc2nccc(Oc3cnc(NC(=O)c4cc5c(CCCC5=O)n(-c5ccccc5)c4=O)cc3)c2cc1OC	InChI=1S/C32H26N4O6/c1-40-28-16-21-24(17-29(28)41-2)33-14-13-27(21)42-20-11-12-30(34-18-20)35-31(38)23-15-22-25(9-6-10-26(22)37)36(32(23)39)19-7-4-3-5-8-19/h3-5,7-8,11-18H,6,9-10H2,1-2H3,(H,34,35,38)	WHMMKPWGWNYYFE-UHFFFAOYSA-N					doublet; compound annotation
0391_002282	VU6012962	C21H19F3N4O4	4.709	137321168		COc1c(OCC2CC2)ccc(C(=O)Nc2cc(OC(F)(F)F)ccc2-n2cncn2)c1	InChI=1S/C21H19F3N4O4/c1-30-19-8-14(4-7-18(19)31-10-13-2-3-13)20(29)27-16-9-15(32-21(22,23)24)5-6-17(16)28-12-25-11-26-28/h4-9,11-13H,2-3,10H2,1H3,(H,27,29)	IQNLJJLZIVCGFI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002284	SR9009	C20H24ClN3O4S	5.4537	57394020		CCOC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1	InChI=1S/C20H24ClN3O4S/c1-2-28-20(25)23-10-9-16(13-23)12-22(11-15-3-5-17(21)6-4-15)14-18-7-8-19(29-18)24(26)27/h3-8,16H,2,9-14H2,1H3	MMJJNHOIVCGAAP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002286	Cenerimod	C25H31N3O5	6.0037	49871973	CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OC[C@H](CO)O	CCc1c(OCC(O)CO)c(C)cc(-c2noc(-c3cc(C4CCCC4)nc(OC)c3)n2)c1	InChI=1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1	KJKKMMMRWISKRF-FQEVSTJZSA-N					doublet; compound annotation
0391_002287	Cenerimod	C25H31N3O5	6.1148	49871973	CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OC[C@H](CO)O	CCc1c(OCC(O)CO)c(C)cc(-c2noc(-c3cc(C4CCCC4)nc(OC)c3)n2)c1	InChI=1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1	KJKKMMMRWISKRF-FQEVSTJZSA-N					doublet; compound annotation
0391_002288	1-methoxy-5-methylphenazin-5-ium	C14H13N2O+	1.0271	127833		COc1cccc2[n+](C)c3ccccc3nc12	InChI=1S/C14H13N2O/c1-16-11-7-4-3-6-10(11)15-14-12(16)8-5-9-13(14)17-2/h3-9H,1-2H3/q+1	NIKBRKQHDZFDIQ-UHFFFAOYSA-N					compound annotation
0391_002289	Sesamoside	C17H24O12	1.0352	3082856	C[C@@]12[C@H]3[C@@H](OC=C([C@]3([C@@H]([C@@H]1O2)O)O)C(=O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C3(C)OC3C(O)C12O	InChI=1S/C17H24O12/c1-16-10-15(28-14-9(21)8(20)7(19)6(3-18)27-14)26-4-5(13(23)25-2)17(10,24)11(22)12(16)29-16/h4,6-12,14-15,18-22,24H,3H2,1-2H3/t6-,7-,8+,9-,10-,11-,12+,14+,15+,16-,17+/m1/s1	XZVXEPPPQBLGMQ-HISQCTEXSA-N					compound annotation
0391_002290	BG45	C11H10N4O	1.4329	16773791		Nc1ccccc1NC(=O)c1nccnc1	InChI=1S/C11H10N4O/c12-8-3-1-2-4-9(8)15-11(16)10-7-13-5-6-14-10/h1-7H,12H2,(H,15,16)	LMWPVSNHKACEKW-UHFFFAOYSA-N					doublet; compound annotation
0391_002291	BG45	C11H10N4O	1.4362	16773791		Nc1ccccc1NC(=O)c1nccnc1	InChI=1S/C11H10N4O/c12-8-3-1-2-4-9(8)15-11(16)10-7-13-5-6-14-10/h1-7H,12H2,(H,15,16)	LMWPVSNHKACEKW-UHFFFAOYSA-N					doublet; compound annotation
0391_002292	troxipide	C15H22N2O4	1.5134	5597		COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC	InChI=1S/C15H22N2O4/c1-19-12-7-10(8-13(20-2)14(12)21-3)15(18)17-11-5-4-6-16-9-11/h7-8,11,16H,4-6,9H2,1-3H3,(H,17,18)	YSIITVVESCNIPR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002294	Astragalin	C21H20O11	2.0323	5282102	C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O11/c22-7-13-15(26)17(28)18(29)21(31-13)32-20-16(27)14-11(25)5-10(24)6-12(14)30-19(20)8-1-3-9(23)4-2-8/h1-6,13,15,17-18,21-26,28-29H,7H2/t13-,15-,17+,18-,21+/m1/s1	JPUKWEQWGBDDQB-QSOFNFLRSA-N					doublet; compound annotation
0391_002295	Astragalin	C21H20O11	2.0353	5282102	C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O11/c22-7-13-15(26)17(28)18(29)21(31-13)32-20-16(27)14-11(25)5-10(24)6-12(14)30-19(20)8-1-3-9(23)4-2-8/h1-6,13,15,17-18,21-26,28-29H,7H2/t13-,15-,17+,18-,21+/m1/s1	JPUKWEQWGBDDQB-QSOFNFLRSA-N					doublet; compound annotation
0391_002296	Picroside I	C24H28O11	2.2878	6440892	C1=CC=C(C=C1)/C=C/C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4[C@@H](C=CO3)[C@@H]([C@H]5[C@@]4(O5)CO)O)O)O)O	O=C(C=Cc1ccccc1)OCC1OC(OC2OC=CC3C(O)C4OC4(CO)C23)C(O)C(O)C1O	InChI=1S/C24H28O11/c25-11-24-16-13(17(27)21(24)35-24)8-9-31-22(16)34-23-20(30)19(29)18(28)14(33-23)10-32-15(26)7-6-12-4-2-1-3-5-12/h1-9,13-14,16-23,25,27-30H,10-11H2/b7-6+/t13-,14-,16-,17+,18-,19+,20-,21+,22+,23+,24-/m1/s1	XZGPUOQGERGURE-LUVHZPKESA-N					removed another duplicate entry; compound annotation
0391_002298	Cardamonin	C16H14O4	3.0716	641785	COC1=CC(=CC(=C1C(=O)/C=C/C2=CC=CC=C2)O)O	COc1cc(O)cc(O)c1C(=O)C=Cc1ccccc1	InChI=1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+	NYSZJNUIVUBQMM-BQYQJAHWSA-N					doublet; removed another duplicate entry; compound annotation
0391_002300	reserpine	C33H40N2O9	3.3321	5770	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	COC(=O)C1C2CC3c4c(CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC)c1c(cc(OC)cc1)[nH]4	InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	QEVHRUUCFGRFIF-MDEJGZGSSA-N					doublet; compound annotation
0391_002301	reserpine	C33H40N2O9	3.3353	5770	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	COC(=O)C1C2CC3c4c(CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC)c1c(cc(OC)cc1)[nH]4	InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	QEVHRUUCFGRFIF-MDEJGZGSSA-N					doublet; compound annotation
0391_002302	Astragaloside IV	C41H68O14	3.4057	13943297	C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O	CC(C)(O)C1CCC(C)(C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C5C(C)(C)C(OC6OCC(O)C(O)C6O)CCC56CC46CCC23C)O1	InChI=1S/C41H68O14/c1-35(2)24(54-33-29(48)26(45)20(44)17-51-33)9-11-41-18-40(41)13-12-37(5)31(39(7)10-8-25(55-39)36(3,4)50)19(43)15-38(37,6)23(40)14-21(32(35)41)52-34-30(49)28(47)27(46)22(16-42)53-34/h19-34,42-50H,8-18H2,1-7H3/t19-,20+,21-,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34+,37+,38-,39+,40-,41+/m0/s1	QMNWISYXSJWHRY-YLNUDOOFSA-N					removed another duplicate entry; compound annotation
0391_002304	troxipide	C15H22N2O4	3.6456	5597		COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC	InChI=1S/C15H22N2O4/c1-19-12-7-10(8-13(20-2)14(12)21-3)15(18)17-11-5-4-6-16-9-11/h7-8,11,16H,4-6,9H2,1-3H3,(H,17,18)	YSIITVVESCNIPR-UHFFFAOYSA-N					doublet; compound annotation
0391_002305	Ramatroban	C21H21FN2O4S	4.0278	123879	C1CC2=C(C[C@@H]1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O	O=C(O)CCn1c2c(CC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccccc21	InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1	LDXDSHIEDAPSSA-OAHLLOKOSA-N					compound annotation
0391_002306	Cardamonin	C16H14O4	4.2896	641785	COC1=CC(=CC(=C1C(=O)/C=C/C2=CC=CC=C2)O)O	COc1cc(O)cc(O)c1C(=O)C=Cc1ccccc1	InChI=1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+	NYSZJNUIVUBQMM-BQYQJAHWSA-N					doublet; compound annotation
0391_002307	BENZYDAMINE	C19H23N3O	2.219	12555		CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3	CNBGNNVCVSKAQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002308	Cot inhibitor-2	C26H25Cl2FN8	2.7593	44143370		CCN1CCC(n2cc(CNc3cc4c(Nc5cc(Cl)c(F)cc5)c(C#N)cnc4c(Cl)c3)nn2)CC1	InChI=1S/C26H25Cl2FN8/c1-2-36-7-5-20(6-8-36)37-15-19(34-35-37)14-31-18-9-21-25(33-17-3-4-24(29)22(27)10-17)16(12-30)13-32-26(21)23(28)11-18/h3-4,9-11,13,15,20,31H,2,5-8,14H2,1H3,(H,32,33)	PHNZIIMWDVXPGG-UHFFFAOYSA-N					compound annotation
0391_002309	701232-20-4	C22H26N4O3	2.8023	9865421		CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1	InChI=1S/C22H26N4O3/c1-22(2)19(26-18-20(23)24-12-25-21(18)29-22)16-9-7-15(8-10-16)14-5-3-13(4-6-14)11-17(27)28/h7-10,12-14H,3-6,11H2,1-2H3,(H,27,28)(H2,23,24,25)	FUIYMYNYUHVDPT-UHFFFAOYSA-N					doublet; compound annotation
0391_002310	EMD638683 (S-Form)	C18H18F2N2O4	2.8879	66577017	CCC1=C(C=CC(=C1C)O)C(=O)NNC(=O)[C@H](C2=CC(=CC(=C2)F)F)O	CCc1c(C(=O)NNC(=O)C(O)c2cc(F)cc(F)c2)ccc(O)c1C	InChI=1S/C18H18F2N2O4/c1-3-13-9(2)15(23)5-4-14(13)17(25)21-22-18(26)16(24)10-6-11(19)8-12(20)7-10/h4-8,16,23-24H,3H2,1-2H3,(H,21,25)(H,22,26)/t16-/m0/s1	SSNAPUUWBPZGOY-INIZCTEOSA-N					compound annotation
0391_002311	1184940-47-3	C18H18F2N2O4	2.8879	66577016	CCC1=C(C=CC(=C1C)O)C(=O)NNC(=O)[C@@H](C2=CC(=CC(=C2)F)F)O	CCc1c(C(=O)NNC(=O)C(O)c2cc(F)cc(F)c2)ccc(O)c1C	InChI=1S/C18H18F2N2O4/c1-3-13-9(2)15(23)5-4-14(13)17(25)21-22-18(26)16(24)10-6-11(19)8-12(20)7-10/h4-8,16,23-24H,3H2,1-2H3,(H,21,25)(H,22,26)/t16-/m1/s1	SSNAPUUWBPZGOY-MRXNPFEDSA-N					compound annotation
0391_002312	BENZYDAMINE	C19H23N3O	2.9584	12555		CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12	InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3	CNBGNNVCVSKAQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002313	701232-20-4	C22H26N4O3	3.2959	9865421		CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C2CCC(CC(=O)O)CC2)cc1	InChI=1S/C22H26N4O3/c1-22(2)19(26-18-20(23)24-12-25-21(18)29-22)16-9-7-15(8-10-16)14-5-3-13(4-6-14)11-17(27)28/h7-10,12-14H,3-6,11H2,1-2H3,(H,27,28)(H2,23,24,25)	FUIYMYNYUHVDPT-UHFFFAOYSA-N					doublet; compound annotation
0391_002314	Zucapsaicin	C18H27NO3	4.0707	1548942	CC(C)/C=C\CCCCC(=O)NCC1=CC(=C(C=C1)O)OC	COc1c(O)ccc(CNC(=O)CCCCC=CC(C)C)c1	InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6-	YKPUWZUDDOIDPM-VURMDHGXSA-N					doublet; compound annotation
0391_002315	Zucapsaicin	C18H27NO3	4.0737	1548942	CC(C)/C=C\CCCCC(=O)NCC1=CC(=C(C=C1)O)OC	COc1c(O)ccc(CNC(=O)CCCCC=CC(C)C)c1	InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6-	YKPUWZUDDOIDPM-VURMDHGXSA-N					doublet; compound annotation
0391_002316	inauhzin	C25H19N5OS2	4.8678	5494506		CCC(Sc1nc2c(nn1)c1ccccc1[nH]2)C(=O)N1c2ccccc2Sc2ccccc21	InChI=1S/C25H19N5OS2/c1-2-19(33-25-27-23-22(28-29-25)15-9-3-4-10-16(15)26-23)24(31)30-17-11-5-7-13-20(17)32-21-14-8-6-12-18(21)30/h3-14,19H,2H2,1H3,(H,26,27,29)	VHUOXERIKQWIJE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002318	Surfactin	C53H93N7O13	6.9451	443592	CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)CC(C)C)CC(C)C)CC(=O)O)C(C)C)CC(C)C)CC(C)C)CCC(=O)O	CC(C)CCCCCCCCCC1CC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1	InChI=1S/C53H93N7O13/c1-30(2)20-18-16-14-13-15-17-19-21-36-28-43(61)54-37(22-23-44(62)63)47(66)55-38(24-31(3)4)48(67)57-40(26-33(7)8)51(70)60-46(35(11)12)52(71)58-41(29-45(64)65)50(69)56-39(25-32(5)6)49(68)59-42(27-34(9)10)53(72)73-36/h30-42,46H,13-29H2,1-12H3,(H,54,61)(H,55,66)(H,56,69)(H,57,67)(H,58,71)(H,59,68)(H,60,70)(H,62,63)(H,64,65)/t36-,37+,38+,39-,40-,41+,42+,46+/m1/s1	NJGWOFRZMQRKHT-WGVNQGGSSA-N					doublet; removed another duplicate entry; compound annotation
0391_002320	Surfactin	C53H93N7O13	7.1445	443592	CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)CC(C)C)CC(C)C)CC(=O)O)C(C)C)CC(C)C)CC(C)C)CCC(=O)O	CC(C)CCCCCCCCCC1CC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1	InChI=1S/C53H93N7O13/c1-30(2)20-18-16-14-13-15-17-19-21-36-28-43(61)54-37(22-23-44(62)63)47(66)55-38(24-31(3)4)48(67)57-40(26-33(7)8)51(70)60-46(35(11)12)52(71)58-41(29-45(64)65)50(69)56-39(25-32(5)6)49(68)59-42(27-34(9)10)53(72)73-36/h30-42,46H,13-29H2,1-12H3,(H,54,61)(H,55,66)(H,56,69)(H,57,67)(H,58,71)(H,59,68)(H,60,70)(H,62,63)(H,64,65)/t36-,37+,38+,39-,40-,41+,42+,46+/m1/s1	NJGWOFRZMQRKHT-WGVNQGGSSA-N					doublet; removed another duplicate entry; compound annotation
0391_002322	198474-05-4	C12H9FN2O2	2.2793	23063810		O=C1CC(c2c[nH]c3c2cc(F)cc3)C(=O)N1	InChI=1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17)	MXKLDYKORJEOPR-UHFFFAOYSA-N					compound annotation
0391_002323	Aticaprant	C26H27FN2O2	2.9921	44129648	CC1=CC(=CC(=C1)[C@@H]2CCCN2CC3=CC=C(C=C3)OC4=C(C=C(C=C4)C(=O)N)F)C	Cc1cc(C)cc(C2CCCN2Cc2ccc(Oc3c(F)cc(C(N)=O)cc3)cc2)c1	InChI=1S/C26H27FN2O2/c1-17-12-18(2)14-21(13-17)24-4-3-11-29(24)16-19-5-8-22(9-6-19)31-25-10-7-20(26(28)30)15-23(25)27/h5-10,12-15,24H,3-4,11,16H2,1-2H3,(H2,28,30)/t24-/m0/s1	ZHPMYDSXGRRERG-DEOSSOPVSA-N					compound annotation
0391_002324	ABT-239	C22H22N2O	3.0229	9818903	C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C4=CC=C(C=C4)C#N	CC1CCCN1CCc1cc2c(ccc(-c3ccc(C#N)cc3)c2)o1	InChI=1S/C22H22N2O/c1-16-3-2-11-24(16)12-10-21-14-20-13-19(8-9-22(20)25-21)18-6-4-17(15-23)5-7-18/h4-9,13-14,16H,2-3,10-12H2,1H3/t16-/m1/s1	KFHYZKCRXNRKRC-MRXNPFEDSA-N					compound annotation
0391_002325	RIPA-56	C13H19NO2	3.5147	121439991		CCC(C)(C)C(=O)N(O)Cc1ccccc1	InChI=1S/C13H19NO2/c1-4-13(2,3)12(15)14(16)10-11-8-6-5-7-9-11/h5-9,16H,4,10H2,1-3H3	AVYVHIKSFXVDBG-UHFFFAOYSA-N					compound annotation
0391_002326	Resmetirom	C17H12Cl2N6O4	4.0055	15981237		CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O	InChI=1S/C17H12Cl2N6O4/c1-7(2)9-5-13(22-23-15(9)26)29-14-10(18)3-8(4-11(14)19)25-17(28)21-16(27)12(6-20)24-25/h3-5,7H,1-2H3,(H,23,26)(H,21,27,28)	FDBYIYFVSAHJLY-UHFFFAOYSA-N					compound annotation
0391_002327	557782-81-7	C21H20N2O3S	4.3721	1138914		COc1c(OC)cc(CC(=O)Nc2nc3c(CCc4ccccc4-3)s2)cc1	InChI=1S/C21H20N2O3S/c1-25-16-9-7-13(11-17(16)26-2)12-19(24)22-21-23-20-15-6-4-3-5-14(15)8-10-18(20)27-21/h3-7,9,11H,8,10,12H2,1-2H3,(H,22,23,24)	DQNMDJGZWFZNHS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002329	LTURM34	C24H18N2O3S	4.4549	122705987		O=c1nc(N2CCOCC2)oc2c1cccc2-c1cccc2c1sc1ccccc12	InChI=1S/C24H18N2O3S/c27-23-19-9-3-6-16(21(19)29-24(25-23)26-11-13-28-14-12-26)18-8-4-7-17-15-5-1-2-10-20(15)30-22(17)18/h1-10H,11-14H2	SMMSWOMXOZLOPI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002331	NPPB	C16H16N2O4	4.5592	4549		O=C(O)c1c(NCCCc2ccccc2)ccc([N+](=O)[O-])c1	InChI=1S/C16H16N2O4/c19-16(20)14-11-13(18(21)22)8-9-15(14)17-10-4-7-12-5-2-1-3-6-12/h1-3,5-6,8-9,11,17H,4,7,10H2,(H,19,20)	WBSMIPAMAXNXFS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002333	Lumacaftor	C24H18F2N2O5	4.8476	16678941		Cc1c(-c2cc(C(=O)O)ccc2)nc(NC(=O)C2(c3cc4c(cc3)OC(F)(F)O4)CC2)cc1	InChI=1S/C24H18F2N2O5/c1-13-5-8-19(27-20(13)14-3-2-4-15(11-14)21(29)30)28-22(31)23(9-10-23)16-6-7-17-18(12-16)33-24(25,26)32-17/h2-8,11-12H,9-10H2,1H3,(H,29,30)(H,27,28,31)	UFSKUSARDNFIRC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002335	CDDO-EA	C33H46N2O3	5.0652	44159258	CCNC(=O)[C@@]12CC[C@@]3([C@@H]([C@@H]1CC(CC2)(C)C)C(=O)C=C4[C@]3(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)C	CCNC(=O)C12CCC(C)(C)CC1C1C(=O)C=C3C4(C)C=C(C#N)C(=O)C(C)(C)C4CCC3(C)C1(C)CC2	InChI=1S/C33H46N2O3/c1-9-35-27(38)33-14-12-28(2,3)18-21(33)25-22(36)16-24-30(6)17-20(19-34)26(37)29(4,5)23(30)10-11-31(24,7)32(25,8)13-15-33/h16-17,21,23,25H,9-15,18H2,1-8H3,(H,35,38)/t21-,23-,25-,30-,31+,32+,33-/m0/s1	RZRQJICXYQPEQJ-YKEYHJQHSA-N					removed another duplicate entry; compound annotation
0391_002337	(4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-ol	C14H19NO3	1.1832	5311346	CCCN1CCO[C@H]2[C@H]1COC3=C2C=C(C=C3)O	CCCN1CCOC2c3c(ccc(O)c3)OCC21	InChI=1S/C14H19NO3/c1-2-5-15-6-7-17-14-11-8-10(16)3-4-13(11)18-9-12(14)15/h3-4,8,12,14,16H,2,5-7,9H2,1H3/t12-,14-/m1/s1	YOILXOMTHPUMRG-TZMCWYRMSA-N					compound annotation
0391_002338	A-366	C19H27N3O2	1.2279	76285486		COc1c(OCCCN2CCCC2)cc2N=C(N)C3(CCC3)c2c1	InChI=1S/C19H27N3O2/c1-23-16-12-14-15(21-18(20)19(14)6-4-7-19)13-17(16)24-11-5-10-22-8-2-3-9-22/h12-13H,2-11H2,1H3,(H2,20,21)	BKCDJTRMYWSXMC-UHFFFAOYSA-N					compound annotation
0391_002339	ENMD-2076	C21H25N7	1.7435	16041424	CC1=CC(=NN1)NC2=CC(=NC(=N2)/C=C/C3=CC=CC=C3)N4CCN(CC4)C	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	BLQYVHBZHAISJM-CMDGGOBGSA-N					doublet; compound annotation
0391_002340	UNC2881	C25H33N7O2	1.8243	71721525		CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(NC2CCC(O)CC2)n1	InChI=1S/C25H33N7O2/c1-2-3-12-27-25-29-16-22(23(31-25)30-19-6-10-21(33)11-7-19)24(34)28-15-18-4-8-20(9-5-18)32-14-13-26-17-32/h4-5,8-9,13-14,16-17,19,21,33H,2-3,6-7,10-12,15H2,1H3,(H,28,34)(H2,27,29,30,31)	NPVXOWLPOFYACO-UHFFFAOYSA-N					doublet; compound annotation
0391_002341	ENMD-2076	C21H25N7	2.048	16041424	CC1=CC(=NN1)NC2=CC(=NC(=N2)/C=C/C3=CC=CC=C3)N4CCN(CC4)C	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	BLQYVHBZHAISJM-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002343	UNC2881	C25H33N7O2	2.0709	71721525		CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(NC2CCC(O)CC2)n1	InChI=1S/C25H33N7O2/c1-2-3-12-27-25-29-16-22(23(31-25)30-19-6-10-21(33)11-7-19)24(34)28-15-18-4-8-20(9-5-18)32-14-13-26-17-32/h4-5,8-9,13-14,16-17,19,21,33H,2-3,6-7,10-12,15H2,1H3,(H,28,34)(H2,27,29,30,31)	NPVXOWLPOFYACO-UHFFFAOYSA-N					doublet; compound annotation
0391_002344	evofosfamide	C9H16Br2N5O4P	2.6093	11984561		Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]	InChI=1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19)	UGJWRPJDTDGERK-UHFFFAOYSA-N					compound annotation
0391_002345	GSK2200150A	C20H23NO3S	2.6776	70689288		c1cc2c(CCOC23CCN(Cc2cc4c(cc2)OCCO4)CC3)s1	InChI=1S/C20H23NO3S/c1-2-17-18(23-11-10-22-17)13-15(1)14-21-7-5-20(6-8-21)16-4-12-25-19(16)3-9-24-20/h1-2,4,12-13H,3,5-11,14H2	NCRPMBWORFWNGT-UHFFFAOYSA-N					doublet; compound annotation
0391_002346	GSK2200150A	C20H23NO3S	2.7399	70689288		c1cc2c(CCOC23CCN(Cc2cc4c(cc2)OCCO4)CC3)s1	InChI=1S/C20H23NO3S/c1-2-17-18(23-11-10-22-17)13-15(1)14-21-7-5-20(6-8-21)16-4-12-25-19(16)3-9-24-20/h1-2,4,12-13H,3,5-11,14H2	NCRPMBWORFWNGT-UHFFFAOYSA-N					doublet; compound annotation
0391_002347	HMN-176	C20H18N2O4S	2.7971	12134997	COC1=CC=C(C=C1)S(=O)(=O)/N=C/2\C=CC=C\C2=C/C=C3C=CN(C=C3)O	COc1ccc(S(=O)(=O)N=C2C=CC=CC2=CC=C2C=CN(O)C=C2)cc1	InChI=1S/C20H18N2O4S/c1-26-18-8-10-19(11-9-18)27(24,25)21-20-5-3-2-4-17(20)7-6-16-12-14-22(23)15-13-16/h2-15,23H,1H3/b17-7+,21-20+	MYEJOKLXXLVMPR-STNHEDLKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002349	HMN-176	C20H18N2O4S	2.9664	12134997	COC1=CC=C(C=C1)S(=O)(=O)/N=C/2\C=CC=C\C2=C/C=C3C=CN(C=C3)O	COc1ccc(S(=O)(=O)N=C2C=CC=CC2=CC=C2C=CN(O)C=C2)cc1	InChI=1S/C20H18N2O4S/c1-26-18-8-10-19(11-9-18)27(24,25)21-20-5-3-2-4-17(20)7-6-16-12-14-22(23)15-13-16/h2-15,23H,1H3/b17-7+,21-20+	MYEJOKLXXLVMPR-STNHEDLKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002351	AZD4573	C22H28ClN5O2	3.3817	124155204	CC(=O)N[C@@H]1CCC[C@@H](C1)C(=O)NC2=NC=C(C(=C2)C3=C4CC(CN4N=C3)(C)C)Cl	CC(=O)NC1CCCC(C(=O)Nc2ncc(Cl)c(-c3c4CC(C)(C)Cn4nc3)c2)C1	InChI=1S/C22H28ClN5O2/c1-13(29)26-15-6-4-5-14(7-15)21(30)27-20-8-16(18(23)11-24-20)17-10-25-28-12-22(2,3)9-19(17)28/h8,10-11,14-15H,4-7,9,12H2,1-3H3,(H,26,29)(H,24,27,30)/t14-,15+/m0/s1	AVIWDYSJSPOOAR-LSDHHAIUSA-N					removed another duplicate entry; compound annotation
0391_002353	CDC25B-IN-1	C20H19NO3	5.2189	138911333		CCOC(=O)c1cc(Nc2cc(OC)cc3ccccc23)ccc1	InChI=1S/C20H19NO3/c1-3-24-20(22)15-8-6-9-16(11-15)21-19-13-17(23-2)12-14-7-4-5-10-18(14)19/h4-13,21H,3H2,1-2H3	UCMCQFKDMRVNDS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002355	SIB-1553A	C13H19NOS	1.5769	5310968		CN1CCCC1CCSc1ccc(O)cc1	InChI=1S/C13H19NOS/c1-14-9-2-3-11(14)8-10-16-13-6-4-12(15)5-7-13/h4-7,11,15H,2-3,8-10H2,1H3	NVZGJSVPOOILDI-UHFFFAOYSA-N					compound annotation
0391_002356	Interferon receptor agonist	C12H22N4O2	2.1511	134395184	CCCC[C@H](CO)NC1=NC(=NC=C1OC)NC	CCCCC(CO)Nc1nc(NC)ncc1OC	InChI=1S/C12H22N4O2/c1-4-5-6-9(8-17)15-11-10(18-3)7-14-12(13-2)16-11/h7,9,17H,4-6,8H2,1-3H3,(H2,13,14,15,16)/t9-/m1/s1	MRKKUGDWODATMF-SECBINFHSA-N					compound annotation
0391_002357	Valemetostat	C26H34ClN3O4	2.5194	126481870	CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)O[C@@](O3)(C)C4CCC(CC4)N(C)C)Cl)C	Cc1cc(C)c(CNC(=O)c2cc(Cl)c3OC(C)(C4CCC(N(C)C)CC4)Oc3c2C)c(=O)[nH]1	InChI=1S/C26H34ClN3O4/c1-14-11-15(2)29-25(32)20(14)13-28-24(31)19-12-21(27)23-22(16(19)3)33-26(4,34-23)17-7-9-18(10-8-17)30(5)6/h11-12,17-18H,7-10,13H2,1-6H3,(H,28,31)(H,29,32)/t17?,18?,26-/m1/s1	SSDRNUPMYCFXGM-ZZHSESOFSA-N					removed another duplicate entry; compound annotation
0391_002359	Arctigenin	C21H24O6	3.326	64981	COC1=C(C=C(C=C1)C[C@H]2COC(=O)[C@@H]2CC3=CC(=C(C=C3)O)OC)OC	COc1c(O)ccc(CC2C(=O)OCC2Cc2cc(OC)c(OC)cc2)c1	InChI=1S/C21H24O6/c1-24-18-7-5-13(11-20(18)26-3)8-15-12-27-21(23)16(15)9-14-4-6-17(22)19(10-14)25-2/h4-7,10-11,15-16,22H,8-9,12H2,1-3H3/t15-,16+/m0/s1	NQWVSMVXKMHKTF-JKSUJKDBSA-N					doublet; removed another duplicate entry; compound annotation
0391_002361	Arctigenin	C21H24O6	3.3293	64981	COC1=C(C=C(C=C1)C[C@H]2COC(=O)[C@@H]2CC3=CC(=C(C=C3)O)OC)OC	COc1c(O)ccc(CC2C(=O)OCC2Cc2cc(OC)c(OC)cc2)c1	InChI=1S/C21H24O6/c1-24-18-7-5-13(11-20(18)26-3)8-15-12-27-21(23)16(15)9-14-4-6-17(22)19(10-14)25-2/h4-7,10-11,15-16,22H,8-9,12H2,1-3H3/t15-,16+/m0/s1	NQWVSMVXKMHKTF-JKSUJKDBSA-N					doublet; compound annotation
0391_002362	BAY-2402234	C21H18ClF5N4O4	3.8827	134470179	CCN1C(=NN(C1=O)C2=C(C=C(C(=C2)O[C@@H](C)C(F)(F)F)C(=O)NC3=C(C=CC=C3Cl)F)F)CO	CCn1c(CO)nn(-c2c(F)cc(C(=O)Nc3c(F)cccc3Cl)c(OC(C)C(F)(F)F)c2)c1=O	InChI=1S/C21H18ClF5N4O4/c1-3-30-17(9-32)29-31(20(30)34)15-8-16(35-10(2)21(25,26)27)11(7-14(15)24)19(33)28-18-12(22)5-4-6-13(18)23/h4-8,10,32H,3,9H2,1-2H3,(H,28,33)/t10-/m0/s1	KNVJMHHAXCPZHF-JTQLQIEISA-N					doublet; compound annotation
0391_002363	BAY-2402234	C21H18ClF5N4O4	3.8875	134470179	CCN1C(=NN(C1=O)C2=C(C=C(C(=C2)O[C@@H](C)C(F)(F)F)C(=O)NC3=C(C=CC=C3Cl)F)F)CO	CCn1c(CO)nn(-c2c(F)cc(C(=O)Nc3c(F)cccc3Cl)c(OC(C)C(F)(F)F)c2)c1=O	InChI=1S/C21H18ClF5N4O4/c1-3-30-17(9-32)29-31(20(30)34)15-8-16(35-10(2)21(25,26)27)11(7-14(15)24)19(33)28-18-12(22)5-4-6-13(18)23/h4-8,10,32H,3,9H2,1-2H3,(H,28,33)/t10-/m0/s1	KNVJMHHAXCPZHF-JTQLQIEISA-N					doublet; compound annotation
0391_002364	MK-4074	C33H31N3O6	4.2387	24964679		COc1cc(C(=O)N2CCC3(CC2)CC(=O)c2c(ccc(-c4cc(C(=O)O)cnc4)c2)O3)cc2c1c(C)cn2C1CC1	InChI=1S/C33H31N3O6/c1-19-18-36(24-4-5-24)26-13-21(14-29(41-2)30(19)26)31(38)35-9-7-33(8-10-35)15-27(37)25-12-20(3-6-28(25)42-33)22-11-23(32(39)40)17-34-16-22/h3,6,11-14,16-18,24H,4-5,7-10,15H2,1-2H3,(H,39,40)	WDBNGXLHMZSUEI-UHFFFAOYSA-N					compound annotation
0391_002365	4-Octyl Itaconate	C13H22O4	4.6932	14239884		C=C(CC(=O)OCCCCCCCC)C(=O)O	InChI=1S/C13H22O4/c1-3-4-5-6-7-8-9-17-12(14)10-11(2)13(15)16/h2-10H2,1H3,(H,15,16)	KBASUIDPDITQHT-UHFFFAOYSA-N					compound annotation
0391_002366	Alisol B 23-acetate	C32H50O5	4.8509	14036811	C[C@H](C[C@@H]([C@@H]1C(O1)(C)C)OC(=O)C)C2=C3C[C@@H]([C@H]4[C@]5(CCC(=O)C([C@@H]5CC[C@@]4([C@]3(CC2)C)C)(C)C)C)O	CC(=O)OC(CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1)C1OC1(C)C	InChI=1S/C32H50O5/c1-18(16-23(36-19(2)33)27-29(5,6)37-27)20-10-14-31(8)21(20)17-22(34)26-30(7)13-12-25(35)28(3,4)24(30)11-15-32(26,31)9/h18,22-24,26-27,34H,10-17H2,1-9H3/t18-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1	NLOAQXKIIGTTRE-JSWHPQHOSA-N					doublet; compound annotation
0391_002367	Alisol B 23-acetate	C32H50O5	5.9168	14036811	C[C@H](C[C@@H]([C@@H]1C(O1)(C)C)OC(=O)C)C2=C3C[C@@H]([C@H]4[C@]5(CCC(=O)C([C@@H]5CC[C@@]4([C@]3(CC2)C)C)(C)C)C)O	CC(=O)OC(CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1)C1OC1(C)C	InChI=1S/C32H50O5/c1-18(16-23(36-19(2)33)27-29(5,6)37-27)20-10-14-31(8)21(20)17-22(34)26-30(7)13-12-25(35)28(3,4)24(30)11-15-32(26,31)9/h18,22-24,26-27,34H,10-17H2,1-9H3/t18-,22+,23+,24+,26+,27-,30+,31+,32+/m1/s1	NLOAQXKIIGTTRE-JSWHPQHOSA-N					doublet; removed another duplicate entry; compound annotation
0391_002369	Naspm	C22H34N4O	0.6518	129695		NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12	InChI=1S/C22H34N4O/c23-12-6-15-24-13-3-4-14-25-16-7-17-26-22(27)18-20-10-5-9-19-8-1-2-11-21(19)20/h1-2,5,8-11,24-25H,3-4,6-7,12-18,23H2,(H,26,27)	ZUINPPQIQARTKX-UHFFFAOYSA-N					doublet; compound annotation
0391_002370	Naspm	C22H34N4O	1.0341	129695		NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12	InChI=1S/C22H34N4O/c23-12-6-15-24-13-3-4-14-25-16-7-17-26-22(27)18-20-10-5-9-19-8-1-2-11-21(19)20/h1-2,5,8-11,24-25H,3-4,6-7,12-18,23H2,(H,26,27)	ZUINPPQIQARTKX-UHFFFAOYSA-N					doublet; compound annotation
0391_002371	Naspm	C22H34N4O	1.0374	129695		NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12	InChI=1S/C22H34N4O/c23-12-6-15-24-13-3-4-14-25-16-7-17-26-22(27)18-20-10-5-9-19-8-1-2-11-21(19)20/h1-2,5,8-11,24-25H,3-4,6-7,12-18,23H2,(H,26,27)	ZUINPPQIQARTKX-UHFFFAOYSA-N					doublet; compound annotation
0391_002372	UNC2250	C24H36N6O2	1.7257	73211763		CCCCNc1ncc(-c2ncc(CN3CCOCC3)cc2)c(NC2CCC(O)CC2)n1	InChI=1S/C24H36N6O2/c1-2-3-10-25-24-27-16-21(23(29-24)28-19-5-7-20(31)8-6-19)22-9-4-18(15-26-22)17-30-11-13-32-14-12-30/h4,9,15-16,19-20,31H,2-3,5-8,10-14,17H2,1H3,(H2,25,27,28,29)	HSYSSKFCQHXOBP-UHFFFAOYSA-N					compound annotation
0391_002373	890819-86-0	C23H22N2O4S2	2.4585	16193817		COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1	InChI=1S/C23H22N2O4S2/c1-29-18-8-6-17(7-9-18)24-10-12-25(13-11-24)23(26)20-14-16-15-31(27,28)21-5-3-2-4-19(21)22(16)30-20/h2-9,14H,10-13,15H2,1H3	YVIJPELUPZUEJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002374	bpr1j-097	C27H28N6O3S	2.6203	56673651		CN1CCN(c2ccc(C(=O)Nc3n[nH]c(-c4cc(NS(=O)(=O)c5ccccc5)ccc4)c3)cc2)CC1	InChI=1S/C27H28N6O3S/c1-32-14-16-33(17-15-32)23-12-10-20(11-13-23)27(34)28-26-19-25(29-30-26)21-6-5-7-22(18-21)31-37(35,36)24-8-3-2-4-9-24/h2-13,18-19,31H,14-17H2,1H3,(H2,28,29,30,34)	RRKKHABFIOHAOI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002376	Isavuconazonium	C35H35F2N8O5S+	3.0572	6918606	C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O	CNCC(=O)OCc1c(N(C)C(=O)OC(C)[n+]2cn(CC(O)(c3c(F)ccc(F)c3)C(C)c3nc(-c4ccc(C#N)cc4)cs3)nc2)nccc1	InChI=1S/C35H35F2N8O5S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3/q+1/t22-,23?,35+/m0/s1	RSWOJTICKMKTER-QXLBVTBOSA-N					compound annotation
0391_002377	Mutant EGFR inhibitor	C27H30ClN7O2	3.0821	78357783		C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C27H30ClN7O2/c1-6-25(36)31-21-13-22(24(37-5)14-23(21)35(4)12-11-34(2)3)32-27-30-16-19(28)26(33-27)18-15-29-20-10-8-7-9-17(18)20/h6-10,13-16,29H,1,11-12H2,2-5H3,(H,31,36)(H,30,32,33)	SUPQPCQJBYPRPC-UHFFFAOYSA-N					doublet; compound annotation
0391_002378	Mutant EGFR inhibitor	C27H30ClN7O2	3.0859	78357783		C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C27H30ClN7O2/c1-6-25(36)31-21-13-22(24(37-5)14-23(21)35(4)12-11-34(2)3)32-27-30-16-19(28)26(33-27)18-15-29-20-10-8-7-9-17(18)20/h6-10,13-16,29H,1,11-12H2,2-5H3,(H,31,36)(H,30,32,33)	SUPQPCQJBYPRPC-UHFFFAOYSA-N					doublet; compound annotation
0391_002379	PLX51107	C26H22N4O3	3.4825	90448953	CC1=C(C(=NO1)C)C2=CC3=C(C(=CN3[C@@H](C)C4=CC=CC=N4)C5=CC=C(C=C5)C(=O)O)N=C2	Cc1noc(C)c1-c1cc2c(nc1)c(-c1ccc(C(=O)O)cc1)cn2C(C)c1ccccn1	InChI=1S/C26H22N4O3/c1-15-24(17(3)33-29-15)20-12-23-25(28-13-20)21(18-7-9-19(10-8-18)26(31)32)14-30(23)16(2)22-6-4-5-11-27-22/h4-14,16H,1-3H3,(H,31,32)/t16-/m0/s1	AMSUHYUVOVCWTP-INIZCTEOSA-N					compound annotation
0391_002380	890819-86-0	C23H22N2O4S2	3.7127	16193817		COc1ccc(N2CCN(C(=O)c3cc4c(s3)-c3ccccc3S(=O)(=O)C4)CC2)cc1	InChI=1S/C23H22N2O4S2/c1-29-18-8-6-17(7-9-18)24-10-12-25(13-11-24)23(26)20-14-16-15-31(27,28)21-5-3-2-4-19(21)22(16)30-20/h2-9,14H,10-13,15H2,1H3	YVIJPELUPZUEJX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002383	(1R,2R)-2-PCCA	C30H37N3O	4.0437	58466521	CCCC1=CC=C(C=C1)C2=CC=C(C=C2)N(C[C@H]([C@@H](C)CC)N)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4	CCCc1ccc(-c2ccc(N(CC(N)C(C)CC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C30H37N3O/c1-4-8-22-10-12-23(13-11-22)24-14-16-25(17-15-24)33(20-28(31)21(3)5-2)30(34)27-19-26(27)29-9-6-7-18-32-29/h6-7,9-18,21,26-28H,4-5,8,19-20,31H2,1-3H3/t21-,26+,27+,28+/m0/s1	OBGKRTYDTRUMGO-RFNYNIMXSA-N					doublet; compound annotation
0391_002384	(1R,2R)-2-PCCA	C30H37N3O	4.1255	58466521	CCCC1=CC=C(C=C1)C2=CC=C(C=C2)N(C[C@H]([C@@H](C)CC)N)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4	CCCc1ccc(-c2ccc(N(CC(N)C(C)CC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C30H37N3O/c1-4-8-22-10-12-23(13-11-22)24-14-16-25(17-15-24)33(20-28(31)21(3)5-2)30(34)27-19-26(27)29-9-6-7-18-32-29/h6-7,9-18,21,26-28H,4-5,8,19-20,31H2,1-3H3/t21-,26+,27+,28+/m0/s1	OBGKRTYDTRUMGO-RFNYNIMXSA-N					doublet; compound annotation
0391_002385	SR-31747 free base	C23H34ClN	4.6016	6913112	CCN(C/C=C\C1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3	CCN(CC=Cc1cc(Cl)c(C2CCCCC2)cc1)C1CCCCC1	InChI=1S/C23H34ClN/c1-2-25(21-13-7-4-8-14-21)17-9-10-19-15-16-22(23(24)18-19)20-11-5-3-6-12-20/h9-10,15-16,18,20-21H,2-8,11-14,17H2,1H3/b10-9-	MYKJVLTXPNIGOV-KTKRTIGZSA-N					compound annotation
0391_002386	lanraplenib	C23H25N9O	1.8542	118161062		Nc1nc(-c2cn3ccnc3c(Nc3ccc(N4CCN(C5COC5)CC4)cc3)n2)cnc1	InChI=1S/C23H25N9O/c24-21-12-25-11-19(28-21)20-13-32-6-5-26-23(32)22(29-20)27-16-1-3-17(4-2-16)30-7-9-31(10-8-30)18-14-33-15-18/h1-6,11-13,18H,7-10,14-15H2,(H2,24,28)(H,27,29)	XCIGZBVOUQVIPI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002388	desformylflustrabromine	C16H21BrN2	2.7182	637026		C=CC(C)(C)c1c(CCNC)c2c(cc(Br)cc2)[nH]1	InChI=1S/C16H21BrN2/c1-5-16(2,3)15-13(8-9-18-4)12-7-6-11(17)10-14(12)19-15/h5-7,10,18-19H,1,8-9H2,2-4H3	GQHSCJUTJKLZPX-UHFFFAOYSA-N					doublet; compound annotation
0391_002389	desformylflustrabromine	C16H21BrN2	2.8843	637026		C=CC(C)(C)c1c(CCNC)c2c(cc(Br)cc2)[nH]1	InChI=1S/C16H21BrN2/c1-5-16(2,3)15-13(8-9-18-4)12-7-6-11(17)10-14(12)19-15/h5-7,10,18-19H,1,8-9H2,2-4H3	GQHSCJUTJKLZPX-UHFFFAOYSA-N					doublet; compound annotation
0391_002390	desformylflustrabromine	C16H21BrN2	2.9399	637026		C=CC(C)(C)c1c(CCNC)c2c(cc(Br)cc2)[nH]1	InChI=1S/C16H21BrN2/c1-5-16(2,3)15-13(8-9-18-4)12-7-6-11(17)10-14(12)19-15/h5-7,10,18-19H,1,8-9H2,2-4H3	GQHSCJUTJKLZPX-UHFFFAOYSA-N					doublet; compound annotation
0391_002391	desformylflustrabromine	C16H21BrN2	3.0603	637026		C=CC(C)(C)c1c(CCNC)c2c(cc(Br)cc2)[nH]1	InChI=1S/C16H21BrN2/c1-5-16(2,3)15-13(8-9-18-4)12-7-6-11(17)10-14(12)19-15/h5-7,10,18-19H,1,8-9H2,2-4H3	GQHSCJUTJKLZPX-UHFFFAOYSA-N					doublet; compound annotation
0391_002392	PKC-theta inhibitor	C20H25F3N6O3	3.2466	10253430		NCC1CCC(CNc2nc(NCc3ccccc3OC(F)(F)F)ncc2[N+](=O)[O-])CC1	InChI=1S/C20H25F3N6O3/c21-20(22,23)32-17-4-2-1-3-15(17)11-26-19-27-12-16(29(30)31)18(28-19)25-10-14-7-5-13(9-24)6-8-14/h1-4,12-14H,5-11,24H2,(H2,25,26,27,28)	HKOWATVSFKRXRW-UHFFFAOYSA-N					doublet; compound annotation
0391_002393	PKC-theta inhibitor	C20H25F3N6O3	3.2552	10253430		NCC1CCC(CNc2nc(NCc3ccccc3OC(F)(F)F)ncc2[N+](=O)[O-])CC1	InChI=1S/C20H25F3N6O3/c21-20(22,23)32-17-4-2-1-3-15(17)11-26-19-27-12-16(29(30)31)18(28-19)25-10-14-7-5-13(9-24)6-8-14/h1-4,12-14H,5-11,24H2,(H2,25,26,27,28)	HKOWATVSFKRXRW-UHFFFAOYSA-N					doublet; compound annotation
0391_002394	CCR6 inhibitor 1	C24H23F3N4O3S	3.4967	134817249		NC(=O)c1nccc(-c2ccc(S(=O)(=O)C3CCC(Nc4ncc(C(F)(F)F)cc4)CC3)cc2)c1	InChI=1S/C24H23F3N4O3S/c25-24(26,27)17-3-10-22(30-14-17)31-18-4-8-20(9-5-18)35(33,34)19-6-1-15(2-7-19)16-11-12-29-21(13-16)23(28)32/h1-3,6-7,10-14,18,20H,4-5,8-9H2,(H2,28,32)(H,30,31)	CNOZLNNAVQPFBD-UHFFFAOYSA-N					compound annotation
0391_002395	1855871-76-9	C34H38N2O4	3.7661	127035871	CC1=CC(=CC=C1)COC2=CC=CC=C2CN(CC[C@@H](C(=O)O)N)CC3=CC=CC=C3OCC4=CC=CC(=C4)C	Cc1cc(COc2ccccc2CN(CCC(N)C(=O)O)Cc2ccccc2OCc2cccc(C)c2)ccc1	InChI=1S/C34H38N2O4/c1-25-9-7-11-27(19-25)23-39-32-15-5-3-13-29(32)21-36(18-17-31(35)34(37)38)22-30-14-4-6-16-33(30)40-24-28-12-8-10-26(2)20-28/h3-16,19-20,31H,17-18,21-24,35H2,1-2H3,(H,37,38)/t31-/m0/s1	YGKNVAAMULVFNN-HKBQPEDESA-N					doublet; removed another duplicate entry; compound annotation
0391_002397	Nidufexor	C27H22ClN3O4	4.7917	118063735		Cn1nc(C(=O)N(Cc2ccccc2)Cc2ccc(C(=O)O)cc2)c2c1-c1c(ccc(Cl)c1)OC2	InChI=1S/C27H22ClN3O4/c1-30-25-21-13-20(28)11-12-23(21)35-16-22(25)24(29-30)26(32)31(14-17-5-3-2-4-6-17)15-18-7-9-19(10-8-18)27(33)34/h2-13H,14-16H2,1H3,(H,33,34)	JYTIXGYXBIBOMN-UHFFFAOYSA-N					compound annotation
0391_002398	VU 0365114	C22H14F3NO3	5.3558	45281794		O=C1C(=O)N(Cc2ccc(-c3ccccc3)cc2)c2ccc(OC(F)(F)F)cc12	InChI=1S/C22H14F3NO3/c23-22(24,25)29-17-10-11-19-18(12-17)20(27)21(28)26(19)13-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-12H,13H2	SPBGRXOPAXZSER-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002400	CDDO-dhTFEA	C33H45F3N2O3	5.4736	66775163	C[C@@]12CC[C@@H]3[C@@]([C@H]1CC(=O)[C@H]4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)NCC(F)(F)F)C)(C=C(C(=O)C3(C)C)C#N)C	CC1(C)CCC2(C(=O)NCC(F)(F)F)CCC3(C)C(C(=O)CC4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C33H45F3N2O3/c1-27(2)10-12-32(26(41)38-18-33(34,35)36)13-11-31(7)24(20(32)16-27)21(39)14-23-29(5)15-19(17-37)25(40)28(3,4)22(29)8-9-30(23,31)6/h15,20,22-24H,8-14,16,18H2,1-7H3,(H,38,41)/t20-,22-,23+,24-,29-,30+,31+,32-/m0/s1	RMYWYZJDSBWZHH-BFGQVZSYSA-N					doublet; compound annotation
0391_002401	CDDO-dhTFEA	C33H45F3N2O3	5.4767	66775163	C[C@@]12CC[C@@H]3[C@@]([C@H]1CC(=O)[C@H]4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)NCC(F)(F)F)C)(C=C(C(=O)C3(C)C)C#N)C	CC1(C)CCC2(C(=O)NCC(F)(F)F)CCC3(C)C(C(=O)CC4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C33H45F3N2O3/c1-27(2)10-12-32(26(41)38-18-33(34,35)36)13-11-31(7)24(20(32)16-27)21(39)14-23-29(5)15-19(17-37)25(40)28(3,4)22(29)8-9-30(23,31)6/h15,20,22-24H,8-14,16,18H2,1-7H3,(H,38,41)/t20-,22-,23+,24-,29-,30+,31+,32-/m0/s1	RMYWYZJDSBWZHH-BFGQVZSYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002403	Parimifasor	C18H11Cl2F4N5O	6.058	135565102		O=C(N=C(Nc1cc(F)cc(Cl)c1)Nc1n[nH]c(C(F)(F)F)c1)c1cc(Cl)ccc1	InChI=1S/C18H11Cl2F4N5O/c19-10-3-1-2-9(4-10)16(30)27-17(25-13-6-11(20)5-12(21)7-13)26-15-8-14(28-29-15)18(22,23)24/h1-8H,(H3,25,26,27,28,29,30)	GPLAWHGEODGIAW-UHFFFAOYSA-N					compound annotation
0391_002404	283167-06-6	C14H17FN2O2	2.101	9816738		CC(=O)N1CCC(NC(=O)c2ccc(F)cc2)CC1	InChI=1S/C14H17FN2O2/c1-10(18)17-8-6-13(7-9-17)16-14(19)11-2-4-12(15)5-3-11/h2-5,13H,6-9H2,1H3,(H,16,19)	VBHVOHJOTMCSBQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002406	Serdemetan	C21H20N4	2.3392	11609586		c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1	InChI=1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25)	CEGSUKYESLWKJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002407	Serdemetan	C21H20N4	2.6177	11609586		c1ccc2c(CCNc3ccc(Nc4ccncc4)cc3)c[nH]c2c1	InChI=1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25)	CEGSUKYESLWKJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002408	BAY 41-2272	C20H17FN6	2.8352	9798973		Nc1nc(-c2nn(Cc3ccccc3F)c3c2cccn3)ncc1C1CC1	InChI=1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6,9-10,12H,7-8,11H2,(H2,22,24,25)	ATOAHNRJAXSBOR-UHFFFAOYSA-N					doublet; compound annotation
0391_002409	BAY 41-2272	C20H17FN6	2.8386	9798973		Nc1nc(-c2nn(Cc3ccccc3F)c3c2cccn3)ncc1C1CC1	InChI=1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6,9-10,12H,7-8,11H2,(H2,22,24,25)	ATOAHNRJAXSBOR-UHFFFAOYSA-N					doublet; compound annotation
0391_002410	Roxadustat	C19H16N2O5	3.1742	11256664		Cc1c2cc(Oc3ccccc3)ccc2c(O)c(C(=O)NCC(=O)O)n1	InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)	YOZBGTLTNGAVFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002411	Roxadustat	C19H16N2O5	3.1775	11256664		Cc1c2cc(Oc3ccccc3)ccc2c(O)c(C(=O)NCC(=O)O)n1	InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)	YOZBGTLTNGAVFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002412	213261-59-7	C14H12O3S2	3.2341	374536		OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1	InChI=1S/C14H12O3S2/c15-7-9-1-5-13(18-9)11-3-4-12(17-11)14-6-2-10(8-16)19-14/h1-6,15-16H,7-8H2	KZENBFUSKMWCJF-UHFFFAOYSA-N					compound annotation
0391_002413	DJ001	C15H12N2O3	4.4383	44161060	C1=CC=C(C=C1)C(=O)/C=C\NC2=CC(=CC=C2)[N+](=O)[O-]	O=C(C=CNc1cc([N+](=O)[O-])ccc1)c1ccccc1	InChI=1S/C15H12N2O3/c18-15(12-5-2-1-3-6-12)9-10-16-13-7-4-8-14(11-13)17(19)20/h1-11,16H/b10-9-	OVTJWWUGQKIRCL-KTKRTIGZSA-N					compound annotation
0391_002414	Roxadustat	C19H16N2O5	4.4442	11256664		Cc1c2cc(Oc3ccccc3)ccc2c(O)c(C(=O)NCC(=O)O)n1	InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)	YOZBGTLTNGAVFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002415	Roxadustat	C19H16N2O5	4.4491	11256664		Cc1c2cc(Oc3ccccc3)ccc2c(O)c(C(=O)NCC(=O)O)n1	InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)	YOZBGTLTNGAVFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002416	KN-62	C38H35N5O6S2	4.4685	5312126	CN([C@@H](CC1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C(=O)N4CCN(CC4)C5=CC=CC=C5)S(=O)(=O)C6=CC=CC7=C6C=CN=C7	CN(C(Cc1ccc(OS(=O)(=O)c2cccc3c2ccnc3)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2c1ccnc2	InChI=1S/C38H35N5O6S2/c1-41(50(45,46)36-11-5-7-29-26-39-19-17-33(29)36)35(38(44)43-23-21-42(22-24-43)31-9-3-2-4-10-31)25-28-13-15-32(16-14-28)49-51(47,48)37-12-6-8-30-27-40-20-18-34(30)37/h2-20,26-27,35H,21-25H2,1H3/t35-/m0/s1	RJVLFQBBRSMWHX-DHUJRADRSA-N					removed another duplicate entry; compound annotation
0391_002418	MRS-1191	C31H27NO4	5.4948	393594		CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1C#Cc1ccccc1	InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3	SNVFDPHQAOXWJZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002419	MRS-1191	C31H27NO4	5.5592	393594		CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1C#Cc1ccccc1	InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3	SNVFDPHQAOXWJZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002421	MRS-1191	C31H27NO4	5.7112	393594		CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1C#Cc1ccccc1	InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3	SNVFDPHQAOXWJZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002422	MRS-1191	C31H27NO4	5.8246	393594		CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1C#Cc1ccccc1	InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3	SNVFDPHQAOXWJZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002423	MRS-1191	C31H27NO4	6.0739	393594		CCOC(=O)C1=C(C)NC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1C#Cc1ccccc1	InChI=1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3	SNVFDPHQAOXWJZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002424	SAR407899	C14H16N2O2	0.9066	15604510		O=c1[nH]ccc2c1ccc(OC1CCNCC1)c2	InChI=1S/C14H16N2O2/c17-14-13-2-1-12(9-10(13)3-8-16-14)18-11-4-6-15-7-5-11/h1-3,8-9,11,15H,4-7H2,(H,16,17)	IPEXHQGMTHOKQV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002426	23554-98-5	C26H26N6	1.8375	10070883		Cc1ccc(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)cc1	InChI=1S/C26H26N6/c1-17-3-5-18(6-4-17)25-27-21-9-7-19(15-23(21)29-25)26-28-22-10-8-20(16-24(22)30-26)32-13-11-31(2)12-14-32/h3-10,15-16H,11-14H2,1-2H3,(H,27,29)(H,28,30)	SISCTNULNFGYKU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002428	23554-98-5	C26H26N6	1.9892	10070883		Cc1ccc(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)cc1	InChI=1S/C26H26N6/c1-17-3-5-18(6-4-17)25-27-21-9-7-19(15-23(21)29-25)26-28-22-10-8-20(16-24(22)30-26)32-13-11-31(2)12-14-32/h3-10,15-16H,11-14H2,1-2H3,(H,27,29)(H,28,30)	SISCTNULNFGYKU-UHFFFAOYSA-N					doublet; compound annotation
0391_002429	CA-4948	C21H19N7O3	1.9942	118224238		Nc1ncc(-c2nc(C(=O)Nc3cc4c(nc3)nc(N3CCOCC3)o4)ccc2)cc1	InChI=1S/C21H19N7O3/c22-18-5-4-13(11-23-18)15-2-1-3-16(26-15)20(29)25-14-10-17-19(24-12-14)27-21(31-17)28-6-8-30-9-7-28/h1-5,10-12H,6-9H2,(H2,22,23)(H,25,29)	RWIMETUXCNDSLE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002432	meta-iodoHoechst 33258	C25H23IN6	2.2417	449492		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2cc(I)ccc2)[nH]4)[nH]3)CC1	InChI=1S/C25H23IN6/c1-31-9-11-32(12-10-31)19-6-8-21-23(15-19)30-25(28-21)17-5-7-20-22(14-17)29-24(27-20)16-3-2-4-18(26)13-16/h2-8,13-15H,9-12H2,1H3,(H,27,29)(H,28,30)	ZEXOKHKEQNNOBG-UHFFFAOYSA-N					compound annotation
0391_002433	SGC0946	C28H40BrN7O4	2.6357	56962337	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2cc(Br)c3c(N)ncnc32)C(O)C1O	InChI=1S/C28H40BrN7O4/c1-16(2)35(12-6-11-31-27(39)34-18-9-7-17(8-10-18)28(3,4)5)14-20-22(37)23(38)26(40-20)36-13-19(29)21-24(30)32-15-33-25(21)36/h7-10,13,15-16,20,22-23,26,37-38H,6,11-12,14H2,1-5H3,(H2,30,32,33)(H2,31,34,39)/t20-,22-,23-,26-/m1/s1	IQCKJUKAQJINMK-HUBRGWSESA-N					doublet; compound annotation
0391_002434	SGC0946	C28H40BrN7O4	2.6909	56962337	CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O	CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)CC1OC(n2cc(Br)c3c(N)ncnc32)C(O)C1O	InChI=1S/C28H40BrN7O4/c1-16(2)35(12-6-11-31-27(39)34-18-9-7-17(8-10-18)28(3,4)5)14-20-22(37)23(38)26(40-20)36-13-19(29)21-24(30)32-15-33-25(21)36/h7-10,13,15-16,20,22-23,26,37-38H,6,11-12,14H2,1-5H3,(H2,30,32,33)(H2,31,34,39)/t20-,22-,23-,26-/m1/s1	IQCKJUKAQJINMK-HUBRGWSESA-N					doublet; compound annotation
0391_002435	PAC-1	C23H28N4O2	3.1483	135421197	C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O	C=CCc1c(O)c(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)ccc1	InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+	YQNRVGJCPCNMKT-LFVJCYFKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002437	209984-56-5	C26H23F2N3O3	3.6514	11454028	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)CC4=CC(=CC(=C4)F)F	CC(NC(=O)Cc1cc(F)cc(F)c1)C(=O)NC1C(=O)N(C)c2ccccc2-c2ccccc21	InChI=1S/C26H23F2N3O3/c1-15(29-23(32)13-16-11-17(27)14-18(28)12-16)25(33)30-24-21-9-4-3-7-19(21)20-8-5-6-10-22(20)31(2)26(24)34/h3-12,14-15,24H,13H2,1-2H3,(H,29,32)(H,30,33)/t15-,24-/m0/s1	QSHGISMANBKLQL-OWJWWREXSA-N					doublet; removed another duplicate entry; compound annotation
0391_002439	209984-56-5	C26H23F2N3O3	4.0797	11454028	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=CC=CC=C3N(C1=O)C)NC(=O)CC4=CC(=CC(=C4)F)F	CC(NC(=O)Cc1cc(F)cc(F)c1)C(=O)NC1C(=O)N(C)c2ccccc2-c2ccccc21	InChI=1S/C26H23F2N3O3/c1-15(29-23(32)13-16-11-17(27)14-18(28)12-16)25(33)30-24-21-9-4-3-7-19(21)20-8-5-6-10-22(20)31(2)26(24)34/h3-12,14-15,24H,13H2,1-2H3,(H,29,32)(H,30,33)/t15-,24-/m0/s1	QSHGISMANBKLQL-OWJWWREXSA-N					doublet; removed another duplicate entry; compound annotation
0391_002441	PAC-1	C23H28N4O2	4.1016	135421197	C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O	C=CCc1c(O)c(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)ccc1	InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+	YQNRVGJCPCNMKT-LFVJCYFKSA-N					doublet; compound annotation
0391_002442	PAC-1	C23H28N4O2	4.321	135421197	C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O	C=CCc1c(O)c(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)ccc1	InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+	YQNRVGJCPCNMKT-LFVJCYFKSA-N					doublet; compound annotation
0391_002443	PAC-1	C23H28N4O2	4.3992	135421197	C=CCC1=C(C(=CC=C1)/C=N/NC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O	C=CCc1c(O)c(C=NNC(=O)CN2CCN(Cc3ccccc3)CC2)ccc1	InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+	YQNRVGJCPCNMKT-LFVJCYFKSA-N					doublet; compound annotation
0391_002444	Idasanutlin	C31H29Cl2F2N3O4	5.8362	53358942	CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F	COc1c(NC(=O)C2NC(CC(C)(C)C)C(C#N)(c3c(F)cc(Cl)cc3)C2c2c(F)c(Cl)ccc2)ccc(C(=O)O)c1	InChI=1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1	TVTXCJFHQKSQQM-LJQIRTBHSA-N					compound annotation
0391_002445	GENZ-644282	C22H21N3O5	1.6763	10294813		CNCCn1c(=O)c2cc(OC)c(OC)cc2c2c1c1cc3c(cc1nc2)OCO3	InChI=1S/C22H21N3O5/c1-23-4-5-25-21-14-8-19-20(30-11-29-19)9-16(14)24-10-15(21)12-6-17(27-2)18(28-3)7-13(12)22(25)26/h6-10,23H,4-5,11H2,1-3H3	BAORCAMWLWRZQG-UHFFFAOYSA-N					compound annotation
0391_002446	Theliatinib	C25H26N6O2	1.693	54759275	CN1CC[C@H]2[C@@H]1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC	C#Cc1cc(Nc2ncnc3cc(OC)c(NC(=O)N4CC5CCN(C)C5C4)cc23)ccc1	InChI=1S/C25H26N6O2/c1-4-16-6-5-7-18(10-16)28-24-19-11-21(23(33-3)12-20(19)26-15-27-24)29-25(32)31-13-17-8-9-30(2)22(17)14-31/h1,5-7,10-12,15,17,22H,8-9,13-14H2,2-3H3,(H,29,32)(H,26,27,28)/t17-,22+/m1/s1	FSXCKIBROURMFT-VGSWGCGISA-N					removed another duplicate entry; compound annotation
0391_002448	AMITIFADINE	C11H11Cl2N	2.48	11658655	C1[C@H]2[C@@]1(CNC2)C3=CC(=C(C=C3)Cl)Cl	Clc1c(Cl)cc(C23CNCC2C3)cc1	InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m1/s1	BSMNRYCSBFHEMQ-KCJUWKMLSA-N					compound annotation
0391_002449	870483-87-7	C20H22N4O3	2.6698	11617559		COc1ccc(COc2c(OC)cc(Cc3cnc(N)nc3N)cc2)cc1	InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)	MYQAUKPBNJWPIE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002451	870483-87-7	C20H22N4O3	2.7896	11617559		COc1ccc(COc2c(OC)cc(Cc3cnc(N)nc3N)cc2)cc1	InChI=1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24)	MYQAUKPBNJWPIE-UHFFFAOYSA-N					doublet; compound annotation
0391_002452	SBI-553	C26H31FN4O2	2.8245	118610427		COc1ccccc1C1CCN(c2nc(C3(F)CC3)nc3c2cc(N(C)CCO)cc3)CC1	InChI=1S/C26H31FN4O2/c1-30(15-16-32)19-7-8-22-21(17-19)24(29-25(28-22)26(27)11-12-26)31-13-9-18(10-14-31)20-5-3-4-6-23(20)33-2/h3-8,17-18,32H,9-16H2,1-2H3	BLWXTJQMEBQCIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002453	455264-30-9	C28H29BrN4O3	3.2906	23394557	CCOC(=O)[C@H](CC1=CC=C(C=C1)NC2=NC=CC3=C2C=NC=C3)NC4=C(C(=O)C45CCCCC5)Br	CCOC(=O)C(Cc1ccc(Nc2nccc3c2cncc3)cc1)NC1=C(Br)C(=O)C12CCCCC2	InChI=1S/C28H29BrN4O3/c1-2-36-27(35)22(33-24-23(29)25(34)28(24)12-4-3-5-13-28)16-18-6-8-20(9-7-18)32-26-21-17-30-14-10-19(21)11-15-31-26/h6-11,14-15,17,22,33H,2-5,12-13,16H2,1H3,(H,31,32)/t22-/m0/s1	QCYAXXZCQKMTMO-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_002455	SBI-553	C26H31FN4O2	3.6762	118610427		COc1ccccc1C1CCN(c2nc(C3(F)CC3)nc3c2cc(N(C)CCO)cc3)CC1	InChI=1S/C26H31FN4O2/c1-30(15-16-32)19-7-8-22-21(17-19)24(29-25(28-22)26(27)11-12-26)31-13-9-18(10-14-31)20-5-3-4-6-23(20)33-2/h3-8,17-18,32H,9-16H2,1-2H3	BLWXTJQMEBQCIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002456	RU-SKI 43	C22H30N2O2S	3.704	46006640		CCC(C)CNCC(=O)N1CCc2c(ccs2)C1COc1cccc(C)c1	InChI=1S/C22H30N2O2S/c1-4-16(2)13-23-14-22(25)24-10-8-21-19(9-11-27-21)20(24)15-26-18-7-5-6-17(3)12-18/h5-7,9,11-12,16,20,23H,4,8,10,13-15H2,1-3H3	AEENEMOEBJOKGN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002458	4GF4A623RF	C18H17F2N3O2	4.159	5329775		CCCCOc1c2cn[nH]c2ncc1C(=O)c1c(F)cc(C)cc1F	InChI=1S/C18H17F2N3O2/c1-3-4-5-25-17-11(8-21-18-12(17)9-22-23-18)16(24)15-13(19)6-10(2)7-14(15)20/h6-9H,3-5H2,1-2H3,(H,21,22,23)	SCFMWQIQBVZOQR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002460	Cycloastragenol	C30H50O5	4.209	13943286	C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O)(C)C)O	CC(C)(O)C1CCC(C)(C2C(O)CC3(C)C4CC(O)C5C(C)(C)C(O)CCC56CC46CCC23C)O1	InChI=1S/C30H50O5/c1-24(2)20(33)8-11-30-16-29(30)13-12-26(5)23(28(7)10-9-21(35-28)25(3,4)34)18(32)15-27(26,6)19(29)14-17(31)22(24)30/h17-23,31-34H,8-16H2,1-7H3/t17-,18-,19-,20-,21-,22-,23-,26+,27-,28+,29-,30+/m0/s1	WENNXORDXYGDTP-UOUCMYEWSA-N					doublet; removed another duplicate entry; compound annotation
0391_002462	4GF4A623RF	C18H17F2N3O2	5.5012	5329775		CCCCOc1c2cn[nH]c2ncc1C(=O)c1c(F)cc(C)cc1F	InChI=1S/C18H17F2N3O2/c1-3-4-5-25-17-11(8-21-18-12(17)9-22-23-18)16(24)15-13(19)6-10(2)7-14(15)20/h6-9H,3-5H2,1-2H3,(H,21,22,23)	SCFMWQIQBVZOQR-UHFFFAOYSA-N					doublet; compound annotation
0391_002463	DIAVERIDINE	C13H16N4O2	1.2767	21453		COc1c(OC)cc(Cc2cnc(N)nc2N)cc1	InChI=1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17)	LDBTVAXGKYIFHO-UHFFFAOYSA-N					compound annotation
0391_002464	R-IMPP	C24H27N3O2	2.6555	122198706	COC1=CC=C(C=C1)CCC(=O)N([C@@H]2CCCNC2)C3=NC=CC4=CC=CC=C43	COc1ccc(CCC(=O)N(c2nccc3ccccc23)C2CCCNC2)cc1	InChI=1S/C24H27N3O2/c1-29-21-11-8-18(9-12-21)10-13-23(28)27(20-6-4-15-25-17-20)24-22-7-3-2-5-19(22)14-16-26-24/h2-3,5,7-9,11-12,14,16,20,25H,4,6,10,13,15,17H2,1H3/t20-/m1/s1	OKTGXQMSOIQCTJ-HXUWFJFHSA-N					doublet; compound annotation
0391_002465	R-IMPP	C24H27N3O2	2.6582	122198706	COC1=CC=C(C=C1)CCC(=O)N([C@@H]2CCCNC2)C3=NC=CC4=CC=CC=C43	COc1ccc(CCC(=O)N(c2nccc3ccccc23)C2CCCNC2)cc1	InChI=1S/C24H27N3O2/c1-29-21-11-8-18(9-12-21)10-13-23(28)27(20-6-4-15-25-17-20)24-22-7-3-2-5-19(22)14-16-26-24/h2-3,5,7-9,11-12,14,16,20,25H,4,6,10,13,15,17H2,1H3/t20-/m1/s1	OKTGXQMSOIQCTJ-HXUWFJFHSA-N					doublet; compound annotation
0391_002466	R-IMPP	C24H27N3O2	2.7297	122198706	COC1=CC=C(C=C1)CCC(=O)N([C@@H]2CCCNC2)C3=NC=CC4=CC=CC=C43	COc1ccc(CCC(=O)N(c2nccc3ccccc23)C2CCCNC2)cc1	InChI=1S/C24H27N3O2/c1-29-21-11-8-18(9-12-21)10-13-23(28)27(20-6-4-15-25-17-20)24-22-7-3-2-5-19(22)14-16-26-24/h2-3,5,7-9,11-12,14,16,20,25H,4,6,10,13,15,17H2,1H3/t20-/m1/s1	OKTGXQMSOIQCTJ-HXUWFJFHSA-N					doublet; compound annotation
0391_002467	R-IMPP	C24H27N3O2	2.8677	122198706	COC1=CC=C(C=C1)CCC(=O)N([C@@H]2CCCNC2)C3=NC=CC4=CC=CC=C43	COc1ccc(CCC(=O)N(c2nccc3ccccc23)C2CCCNC2)cc1	InChI=1S/C24H27N3O2/c1-29-21-11-8-18(9-12-21)10-13-23(28)27(20-6-4-15-25-17-20)24-22-7-3-2-5-19(22)14-16-26-24/h2-3,5,7-9,11-12,14,16,20,25H,4,6,10,13,15,17H2,1H3/t20-/m1/s1	OKTGXQMSOIQCTJ-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_002469	Diclofensine	C17H17Cl2NO	3.0872	68871		COc1cc2c(cc1)C(c1cc(Cl)c(Cl)cc1)CN(C)C2	InChI=1S/C17H17Cl2NO/c1-20-9-12-7-13(21-2)4-5-14(12)15(10-20)11-3-6-16(18)17(19)8-11/h3-8,15H,9-10H2,1-2H3	ZJDCGVDEEHWEIG-UHFFFAOYSA-N					doublet; compound annotation
0391_002470	rolipram	C16H21NO3	3.1461	5092		COc1c(OC2CCCC2)cc(C2CNC(=O)C2)cc1	InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)	HJORMJIFDVBMOB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002472	rolipram	C16H21NO3	3.1491	5092		COc1c(OC2CCCC2)cc(C2CNC(=O)C2)cc1	InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)	HJORMJIFDVBMOB-UHFFFAOYSA-N					doublet; compound annotation
0391_002473	XL888	C29H37N5O3	3.1832	57748689	CC[C@@H](C)NC1=C(C=C(C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C)C(=O)N	CCC(C)Nc1c(C(N)=O)cc(C)c(C(=O)NC2CC3CCC(C2)N3c2ncc(C(=O)C3CC3)cc2)c1	InChI=1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20?,21?,22?/m1/s1	LHGWWAFKVCIILM-LAQKFSSHSA-N					removed another duplicate entry; compound annotation
0391_002476	Diclofensine	C17H17Cl2NO	3.2133	68871		COc1cc2c(cc1)C(c1cc(Cl)c(Cl)cc1)CN(C)C2	InChI=1S/C17H17Cl2NO/c1-20-9-12-7-13(21-2)4-5-14(12)15(10-20)11-3-6-16(18)17(19)8-11/h3-8,15H,9-10H2,1-2H3	ZJDCGVDEEHWEIG-UHFFFAOYSA-N					doublet; compound annotation
0391_002477	PLpro inhibitor	C22H22N2O2	3.6486	44235889	CC1=C(C=C(C=C1)NC(=O)C)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32	CC(=O)Nc1cc(C(=O)NC(C)c2cccc3ccccc23)c(C)cc1	InChI=1S/C22H22N2O2/c1-14-11-12-18(24-16(3)25)13-21(14)22(26)23-15(2)19-10-6-8-17-7-4-5-9-20(17)19/h4-13,15H,1-3H3,(H,23,26)(H,24,25)/t15-/m1/s1	KGPYBLOBHQLIET-OAHLLOKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_002479	R-IMPP	C24H27N3O2	3.6486	122198706	COC1=CC=C(C=C1)CCC(=O)N([C@@H]2CCCNC2)C3=NC=CC4=CC=CC=C43	COc1ccc(CCC(=O)N(c2nccc3ccccc23)C2CCCNC2)cc1	InChI=1S/C24H27N3O2/c1-29-21-11-8-18(9-12-21)10-13-23(28)27(20-6-4-15-25-17-20)24-22-7-3-2-5-19(22)14-16-26-24/h2-3,5,7-9,11-12,14,16,20,25H,4,6,10,13,15,17H2,1H3/t20-/m1/s1	OKTGXQMSOIQCTJ-HXUWFJFHSA-N					doublet; compound annotation
0391_002480	PURPURIN	C14H8O5	3.8006	6683		O=C1c2ccccc2C(=O)c2c1c(O)cc(O)c2O	InChI=1S/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19H	BBNQQADTFFCFGB-UHFFFAOYSA-N					compound annotation
0391_002481	DUBs-IN-2	C15H9N5O	4.7016	16065491	CCO/N=C/1\C2=CC=CC=C2C3=NC(=C(N=C31)C#N)C#N	CCON=C1c2ccccc2-c2nc(C#N)c(C#N)nc12	InChI=1S/C15H9N5O/c1-2-21-20-14-10-6-4-3-5-9(10)13-15(14)19-12(8-17)11(7-16)18-13/h3-6H,2H2,1H3/b20-14+	VKVAJBRQGBRHIK-XSFVSMFZSA-N					compound annotation
0391_002482	PLpro inhibitor	C22H22N2O2	7.382	44235889	CC1=C(C=C(C=C1)NC(=O)C)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32	CC(=O)Nc1cc(C(=O)NC(C)c2cccc3ccccc23)c(C)cc1	InChI=1S/C22H22N2O2/c1-14-11-12-18(24-16(3)25)13-21(14)22(26)23-15(2)19-10-6-8-17-7-4-5-9-20(17)19/h4-13,15H,1-3H3,(H,23,26)(H,24,25)/t15-/m1/s1	KGPYBLOBHQLIET-OAHLLOKOSA-N					doublet; compound annotation
0391_002483	NECA	C12H16N6O4	0.6918	448222	CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	CCNC(=O)C1OC(n2cnc3c(N)ncnc32)C(O)C1O	InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1	JADDQZYHOWSFJD-FLNNQWSLSA-N					removed another duplicate entry; compound annotation
0391_002485	MELK-8a	C25H32N6O	0.9617	119058124		CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1	InChI=1S/C25H32N6O/c1-29-12-14-30(15-13-29)22-2-4-23(5-3-22)31-18-21(16-28-31)24-8-11-27-17-25(24)32-19-20-6-9-26-10-7-20/h2-5,8,11,16-18,20,26H,6-7,9-10,12-15,19H2,1H3	BLFBSGVUERKSST-UHFFFAOYSA-N					compound annotation
0391_002486	EDOXABAN	C24H30ClN7O4S	2.0971	10280735	CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C	CN1CCc2c(C1)sc(C(=O)NC1CC(C(=O)N(C)C)CCC1NC(=O)C(=O)Nc1ncc(Cl)cc1)n2	InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1	HGVDHZBSSITLCT-JLJPHGGASA-N					doublet; removed another duplicate entry; compound annotation
0391_002488	PF-562271	C21H20F3N7O3S	2.3984	11713159		CN(c1c(CNc2nc(Nc3cc4c(cc3)NC(=O)C4)ncc2C(F)(F)F)cccn1)S(C)(=O)=O	InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)	MZDKLVOWGIOKTN-UHFFFAOYSA-N					doublet; compound annotation
0391_002489	PF-562271	C21H20F3N7O3S	2.405	11713159		CN(c1c(CNc2nc(Nc3cc4c(cc3)NC(=O)C4)ncc2C(F)(F)F)cccn1)S(C)(=O)=O	InChI=1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30)	MZDKLVOWGIOKTN-UHFFFAOYSA-N					doublet; compound annotation
0391_002490	Landiolol	C25H39N3O8	2.4088	114905	CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C	CC1(C)OCC(COC(=O)CCc2ccc(OCC(O)CNCCNC(=O)N3CCOCC3)cc2)O1	InChI=1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31)/t20-,22+/m0/s1	WMDSZGFJQKSLLH-RBBKRZOGSA-N					removed another duplicate entry; compound annotation
0391_002492	Omipalisib	C25H17F2N5O3S	3.3114	25167777		COc1c(NS(=O)(=O)c2c(F)cc(F)cc2)cc(-c2cc3c(-c4cnncc4)ccnc3cc2)cn1	InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3	CGBJSGAELGCMKE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002494	Tyrphostin AG1433	C16H14N2O2	3.3409	2050		Cc1cc2ncc(-c3cc(O)c(O)cc3)nc2cc1C	InChI=1S/C16H14N2O2/c1-9-5-12-13(6-10(9)2)18-14(8-17-12)11-3-4-15(19)16(20)7-11/h3-8,19-20H,1-2H3	SMKFYHOKXJUJOT-UHFFFAOYSA-N					compound annotation
0391_002495	LC3-mHTT-IN-AN1	C15H9Br2NO3	3.57	1759437	C1=CC2=C(C=C1Br)/C(=C/C3=CC(=C(C(=C3)Br)O)O)/C(=O)N2	O=C1Nc2c(cc(Br)cc2)C1=Cc1cc(O)c(O)c(Br)c1	InChI=1S/C15H9Br2NO3/c16-8-1-2-12-9(6-8)10(15(21)18-12)3-7-4-11(17)14(20)13(19)5-7/h1-6,19-20H,(H,18,21)/b10-3-	GPKLWRHHVIBYEO-KMKOMSMNSA-N					doublet; compound annotation
0391_002496	LC3-mHTT-IN-AN1	C15H9Br2NO3	4.1493	1759437	C1=CC2=C(C=C1Br)/C(=C/C3=CC(=C(C(=C3)Br)O)O)/C(=O)N2	O=C1Nc2c(cc(Br)cc2)C1=Cc1cc(O)c(O)c(Br)c1	InChI=1S/C15H9Br2NO3/c16-8-1-2-12-9(6-8)10(15(21)18-12)3-7-4-11(17)14(20)13(19)5-7/h1-6,19-20H,(H,18,21)/b10-3-	GPKLWRHHVIBYEO-KMKOMSMNSA-N					doublet; compound annotation
0391_002497	GSK682753A	C23H21Cl3N2O3	4.8824	126843232	C1CN(CCC12CN(C(=O)O2)CC3=CC(=C(C=C3)Cl)Cl)C(=O)/C=C/C4=CC=C(C=C4)Cl	O=C(C=Cc1ccc(Cl)cc1)N1CCC2(CC1)CN(Cc1cc(Cl)c(Cl)cc1)C(=O)O2	InChI=1S/C23H21Cl3N2O3/c24-18-5-1-16(2-6-18)4-8-21(29)27-11-9-23(10-12-27)15-28(22(30)31-23)14-17-3-7-19(25)20(26)13-17/h1-8,13H,9-12,14-15H2/b8-4+	RDDLWMWIRXGSJM-XBXARRHUSA-N					removed another duplicate entry; compound annotation
0391_002499	Amonafide	C16H17N3O2	1.5356	50515		CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O	InChI=1S/C16H17N3O2/c1-18(2)6-7-19-15(20)12-5-3-4-10-8-11(17)9-13(14(10)12)16(19)21/h3-5,8-9H,6-7,17H2,1-2H3	UPALIKSFLSVKIS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002501	Mutant IDH1 inhibitor	C25H34N6O3	1.7732	71542482	C[C@@H](C1=CC=C(C=C1)CN2CCN(CC2)C(=O)C)NC3=NC=CC(=N3)N4[C@H](COC4=O)C(C)C	CC(=O)N1CCN(Cc2ccc(C(C)Nc3nccc(N4C(=O)OCC4C(C)C)n3)cc2)CC1	InChI=1S/C25H34N6O3/c1-17(2)22-16-34-25(33)31(22)23-9-10-26-24(28-23)27-18(3)21-7-5-20(6-8-21)15-29-11-13-30(14-12-29)19(4)32/h5-10,17-18,22H,11-16H2,1-4H3,(H,26,27,28)/t18-,22+/m0/s1	BEWLUEOYYPKPQL-PGRDOPGGSA-N					doublet; compound annotation
0391_002502	Mutant IDH1 inhibitor	C25H34N6O3	1.778	71542482	C[C@@H](C1=CC=C(C=C1)CN2CCN(CC2)C(=O)C)NC3=NC=CC(=N3)N4[C@H](COC4=O)C(C)C	CC(=O)N1CCN(Cc2ccc(C(C)Nc3nccc(N4C(=O)OCC4C(C)C)n3)cc2)CC1	InChI=1S/C25H34N6O3/c1-17(2)22-16-34-25(33)31(22)23-9-10-26-24(28-23)27-18(3)21-7-5-20(6-8-21)15-29-11-13-30(14-12-29)19(4)32/h5-10,17-18,22H,11-16H2,1-4H3,(H,26,27,28)/t18-,22+/m0/s1	BEWLUEOYYPKPQL-PGRDOPGGSA-N					doublet; compound annotation
0391_002503	trimetrexate	C19H23N5O3	1.9522	5583		COc1cc(NCc2c(C)c3c(cc2)nc(N)nc3N)cc(OC)c1OC	InChI=1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24)	NOYPYLRCIDNJJB-UHFFFAOYSA-N					doublet; compound annotation
0391_002504	trimetrexate	C19H23N5O3	1.9557	5583		COc1cc(NCc2c(C)c3c(cc2)nc(N)nc3N)cc(OC)c1OC	InChI=1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24)	NOYPYLRCIDNJJB-UHFFFAOYSA-N					doublet; compound annotation
0391_002505	Mutant IDH1 inhibitor	C25H34N6O3	1.9591	71542482	C[C@@H](C1=CC=C(C=C1)CN2CCN(CC2)C(=O)C)NC3=NC=CC(=N3)N4[C@H](COC4=O)C(C)C	CC(=O)N1CCN(Cc2ccc(C(C)Nc3nccc(N4C(=O)OCC4C(C)C)n3)cc2)CC1	InChI=1S/C25H34N6O3/c1-17(2)22-16-34-25(33)31(22)23-9-10-26-24(28-23)27-18(3)21-7-5-20(6-8-21)15-29-11-13-30(14-12-29)19(4)32/h5-10,17-18,22H,11-16H2,1-4H3,(H,26,27,28)/t18-,22+/m0/s1	BEWLUEOYYPKPQL-PGRDOPGGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002507	Ro-3306	C18H13N3OS2	2.3502	135400873	C1=CC2=C(C=CC(=C2)/C=C\3/C(=O)NC(=NCC4=CC=CS4)S3)N=C1	O=C1N=C(NCc2cccs2)SC1=Cc1cc2c(cc1)nccc2	InChI=1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)/b16-10-	XOLMRFUGOINFDQ-YBEGLDIGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002509	TH588	C13H12Cl2N4	2.5205	73389731		Nc1nc(-c2c(Cl)c(Cl)ccc2)cc(NC2CC2)n1	InChI=1S/C13H12Cl2N4/c14-9-3-1-2-8(12(9)15)10-6-11(17-7-4-5-7)19-13(16)18-10/h1-3,6-7H,4-5H2,(H3,16,17,18,19)	PNMYJIOQIAEYQL-UHFFFAOYSA-N					compound annotation
0391_002510	Ro-3306	C18H13N3OS2	2.6116	135400873	C1=CC2=C(C=CC(=C2)/C=C\3/C(=O)NC(=NCC4=CC=CS4)S3)N=C1	O=C1N=C(NCc2cccs2)SC1=Cc1cc2c(cc1)nccc2	InChI=1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)/b16-10-	XOLMRFUGOINFDQ-YBEGLDIGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002512	VX-702	C19H12F4N4O2	2.6444	10341154		NC(=O)c1c(-c2c(F)cc(F)cc2)nc(N(C(N)=O)c2c(F)cccc2F)cc1	InChI=1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29)	FYSRKRZDBHOFAY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002514	Vps34-IN-1	C21H24ClN7O	3.6016	57404276		CC(C)(O)CNc1ncc(-c2nc(Nc3cc(Cl)ncc3)ncc2)c(CC2CC2)n1	InChI=1S/C21H24ClN7O/c1-21(2,30)12-26-19-25-11-15(17(29-19)9-13-3-4-13)16-6-8-24-20(28-16)27-14-5-7-23-18(22)10-14/h5-8,10-11,13,30H,3-4,9,12H2,1-2H3,(H,25,26,29)(H,23,24,27,28)	AWNXKZVIZARMME-UHFFFAOYSA-N					compound annotation
0391_002515	5'-fluoroindirubinoxime	C16H10FN3O2	3.8144	135398503		O=Nc1c(-c2c(O)[nH]c3c2cc(F)cc3)[nH]c2ccccc12	InChI=1S/C16H10FN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18-19,21H	LAPHNLUPQPQSKF-UHFFFAOYSA-N					doublet; compound annotation
0391_002516	5'-fluoroindirubinoxime	C16H10FN3O2	3.8181	135398503		O=Nc1c(-c2c(O)[nH]c3c2cc(F)cc3)[nH]c2ccccc12	InChI=1S/C16H10FN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18-19,21H	LAPHNLUPQPQSKF-UHFFFAOYSA-N					doublet; compound annotation
0391_002517	GSK-5498A	C18H11F6N3O	4.1561	46945384		O=C(Nc1nn(Cc2c(C(F)(F)F)cccc2F)cc1)c1c(F)cccc1F	InChI=1S/C18H11F6N3O/c19-12-4-1-3-11(18(22,23)24)10(12)9-27-8-7-15(26-27)25-17(28)16-13(20)5-2-6-14(16)21/h1-8H,9H2,(H,25,26,28)	AUBGZAJDHUHMAE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002519	Cintirorgon	C27H23F6NO6S	5.5554	124126348	CC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O	CC(C)(CC1CN(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2c(ccc(-c3cc(OC(F)F)cc(F)c3)c2)O1)C(=O)O	InChI=1S/C27H23F6NO6S/c1-26(2,24(35)36)13-20-14-34(41(37,38)21-5-3-4-17(11-21)27(31,32)33)22-10-15(6-7-23(22)39-20)16-8-18(28)12-19(9-16)40-25(29)30/h3-12,20,25H,13-14H2,1-2H3,(H,35,36)/t20-/m0/s1	GULSIMHVQYBADX-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_002521	CBB1007	C27H34N8O4	0.5222	72199289		COC(=O)c1cc(CN2CCN(C(=N)N)CC2)cc(C(=O)N2CCN(C(=O)c3ccc(C(=N)N)cc3)CC2)c1	InChI=1S/C27H34N8O4/c1-39-26(38)22-15-18(17-32-6-8-35(9-7-32)27(30)31)14-21(16-22)25(37)34-12-10-33(11-13-34)24(36)20-4-2-19(3-5-20)23(28)29/h2-5,14-16H,6-13,17H2,1H3,(H3,28,29)(H3,30,31)	IBVRETRIDAQSEM-UHFFFAOYSA-N					compound annotation
0391_002522	IRAK inhibitor 1	C17H19N5	0.8374	44449078		c1cc(-c2cnc3ccccn23)nc(NC2CCNCC2)c1	InChI=1S/C17H19N5/c1-2-11-22-15(12-19-17(22)6-1)14-4-3-5-16(21-14)20-13-7-9-18-10-8-13/h1-6,11-13,18H,7-10H2,(H,20,21)	HUYUPQNBDBTPQQ-UHFFFAOYSA-N					compound annotation
0391_002523	Verubulin	C17H17N3O	2.5759	11414799		COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1	InChI=1S/C17H17N3O/c1-12-18-16-7-5-4-6-15(16)17(19-12)20(2)13-8-10-14(21-3)11-9-13/h4-11H,1-3H3	SNHCRNMVYDHVDT-UHFFFAOYSA-N					compound annotation
0391_002524	911417-87-3	C26H24N6O2	2.6249	11950170		CC(C)NC(=O)COc1cccc(-c2nc3ccccc3c(Nc3cc4c(cc3)[nH]nc4)n2)c1	InChI=1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31)	GKHIVNAUVKXIIY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002526	S516	C21H19N5O4S	2.8346	46929538		COc1cc(C(=O)c2ccc(-c3csc(N)n3)cc2-n2cncn2)cc(OC)c1OC	InChI=1S/C21H19N5O4S/c1-28-17-7-13(8-18(29-2)20(17)30-3)19(27)14-5-4-12(15-9-31-21(22)25-15)6-16(14)26-11-23-10-24-26/h4-11H,1-3H3,(H2,22,25)	OJZSPKKXYGZDRQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002528	7758-73-8	C15H10O4	2.927	5398649		O=c1cc(-c2ccccc2)c2c(O)cc(O)cc2o1	InChI=1S/C15H10O4/c16-10-6-12(17)15-11(9-4-2-1-3-5-9)8-14(18)19-13(15)7-10/h1-8,16-17H	HUQKUJNSVHEHIH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002530	HPGDS inhibitor 2	C20H24F2N2O3	3.2572	129247606		CC(C)(O)C1CCC(NC(=O)c2cnc3cc(OC(F)F)ccc3c2)CC1	InChI=1S/C20H24F2N2O3/c1-20(2,26)14-4-6-15(7-5-14)24-18(25)13-9-12-3-8-16(27-19(21)22)10-17(12)23-11-13/h3,8-11,14-15,19,26H,4-7H2,1-2H3,(H,24,25)	YRWMWDLEUYLURJ-UHFFFAOYSA-N					compound annotation
0391_002531	1166227-08-2	C17H23N5O2S2	3.5656	42636535	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CSC(=N3)C(C)(C)C	Cc1c(-c2csc(C(C)(C)C)n2)sc(NC(=O)N2CCCC2C(N)=O)n1	InChI=1S/C17H23N5O2S2/c1-9-12(10-8-25-14(20-10)17(2,3)4)26-15(19-9)21-16(24)22-7-5-6-11(22)13(18)23/h8,11H,5-7H2,1-4H3,(H2,18,23)(H,19,21,24)/t11-/m0/s1	HBPXWEPKNBHKAX-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002533	Glutaminase C-IN-1	C27H27BrN2O	4.379	3099980		CN(C)c1c(Br)cc(C2Nc3c(C4=C2C(=O)CC(C)(C)C4)c2ccccc2cc3)cc1	InChI=1S/C27H27BrN2O/c1-27(2)14-19-24-18-8-6-5-7-16(18)9-11-21(24)29-26(25(19)23(31)15-27)17-10-12-22(30(3)4)20(28)13-17/h5-13,26,29H,14-15H2,1-4H3	NVFRRJQWRZFDLM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002535	L-ANAP	C15H16N2O3	1.6212	72695021	CC(=O)C1=CC2=C(C=C1)C=C(C=C2)NC[C@@H](C(=O)O)N	CC(=O)c1cc2c(cc1)cc(NCC(N)C(=O)O)cc2	InChI=1S/C15H16N2O3/c1-9(18)10-2-3-12-7-13(5-4-11(12)6-10)17-8-14(16)15(19)20/h2-7,14,17H,8,16H2,1H3,(H,19,20)/t14-/m0/s1	XKZCXMNMUMGDJG-AWEZNQCLSA-N					compound annotation
0391_002536	Pemigatinib	C24H27F2N5O4	2.2998	86705695		CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21	InChI=1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28)	HCDMJFOHIXMBOV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002538	Ethanol, 2-[2-[4-[(3-phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]-	C21H28N2O3	2.4942	11688990		OCCOCCN1CCN(Cc2cc(Oc3ccccc3)ccc2)CC1	InChI=1S/C21H28N2O3/c24-14-16-25-15-13-22-9-11-23(12-10-22)18-19-5-4-8-21(17-19)26-20-6-2-1-3-7-20/h1-8,17,24H,9-16,18H2	SHDFUNGIHDOLQM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002540	1610358-53-6	C19H18F2N4O2S	2.5521	74767009		COc1c(-c2cc(Nc3nccc(CS(C)(=N)=O)c3)ncc2F)ccc(F)c1	InChI=1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25)	YZCUMZWULWOUMD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002544	BAY-1816032	C27H24F2N6O4	3.2841	118958833		COc1c(Nc2nc(-c3nn(Cc4c(F)cc(OCCO)cc4F)c4ccccc34)ncc2OC)ccnc1	InChI=1S/C27H24F2N6O4/c1-37-23-13-30-8-7-21(23)32-26-24(38-2)14-31-27(33-26)25-17-5-3-4-6-22(17)35(34-25)15-18-19(28)11-16(12-20(18)29)39-10-9-36/h3-8,11-14,36H,9-10,15H2,1-2H3,(H,30,31,32,33)	QVOGVAVHOLLLAZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002546	VEGF Receptor 2 Kinase Inhibitor I	C18H18N2O3	3.7783	6419834	CCOC(=O)C1=C(NC(=C1C)/C=C\2/C3=CC=CC=C3NC2=O)C	CCOC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccccc23)c1C	InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9-	PMUJUSJUVIXDQC-LCYFTJDESA-N					doublet; removed another duplicate entry; compound annotation
0391_002548	Inobrodib	C30H32F2N4O3	3.8444	134457551	CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)[C@@H]4CCCC(=O)N4C5=CC(=C(C=C5)F)F)C6CCC(CC6)OC	COC1CCC(n2c(C3CCCC(=O)N3c3cc(F)c(F)cc3)nc3c2ccc(-c2c(C)onc2C)c3)CC1	InChI=1S/C30H32F2N4O3/c1-17-29(18(2)39-34-17)19-7-14-26-25(15-19)33-30(36(26)20-8-11-22(38-3)12-9-20)27-5-4-6-28(37)35(27)21-10-13-23(31)24(32)16-21/h7,10,13-16,20,22,27H,4-6,8-9,11-12H2,1-3H3/t20?,22?,27-/m0/s1	SKDNDJWEBPQKCS-RIQBOWGZSA-N					removed another duplicate entry; compound annotation
0391_002550	LY2955303	C36H42N4O3	4.1554	71552369		CN1CCN(C(=O)c2ccc(-n3nc(-c4ccc(C(=O)O)cc4)cc3-c3cc(C(C)(C)C)cc(C(C)(C)C)c3)cc2)CC1	InChI=1S/C36H42N4O3/c1-35(2,3)28-20-27(21-29(22-28)36(4,5)6)32-23-31(24-8-10-26(11-9-24)34(42)43)37-40(32)30-14-12-25(13-15-30)33(41)39-18-16-38(7)17-19-39/h8-15,20-23H,16-19H2,1-7H3,(H,42,43)	YVXYHNKIOFSFMZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002552	VEGF Receptor 2 Kinase Inhibitor I	C18H18N2O3	4.7863	6419834	CCOC(=O)C1=C(NC(=C1C)/C=C\2/C3=CC=CC=C3NC2=O)C	CCOC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccccc23)c1C	InChI=1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9-	PMUJUSJUVIXDQC-LCYFTJDESA-N					doublet; removed another duplicate entry; compound annotation
0391_002554	A-395	C26H35FN4O2S	2.2746	123132213	CN(C)[C@H]1CN(C[C@@H]1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F	CN(C)C1CN(C2CCc3c2c(F)ccc3)CC1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1	InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1	REVJNSVNICWODC-KIDMSAQOSA-N					doublet; compound annotation
0391_002555	A-395	C26H35FN4O2S	2.3223	123132213	CN(C)[C@H]1CN(C[C@@H]1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F	CN(C)C1CN(C2CCc3c2c(F)ccc3)CC1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1	InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1	REVJNSVNICWODC-KIDMSAQOSA-N					doublet; compound annotation
0391_002556	A-395	C26H35FN4O2S	2.4624	123132213	CN(C)[C@H]1CN(C[C@@H]1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F	CN(C)C1CN(C2CCc3c2c(F)ccc3)CC1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1	InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1	REVJNSVNICWODC-KIDMSAQOSA-N					doublet; compound annotation
0391_002557	A-395	C26H35FN4O2S	2.4657	123132213	CN(C)[C@H]1CN(C[C@@H]1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F	CN(C)C1CN(C2CCc3c2c(F)ccc3)CC1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1	InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1	REVJNSVNICWODC-KIDMSAQOSA-N					doublet; compound annotation
0391_002558	A-395	C26H35FN4O2S	2.5497	123132213	CN(C)[C@H]1CN(C[C@@H]1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F	CN(C)C1CN(C2CCc3c2c(F)ccc3)CC1c1ccc(N2CCN(S(C)(=O)=O)CC2)cc1	InChI=1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1	REVJNSVNICWODC-KIDMSAQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_002560	2098836-54-3	C23H30N4O4S2	2.6631	124201834	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)S)NC(=O)C)O	CC(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2c(C)ncs2)cc1)C(C)(C)S	InChI=1S/C23H30N4O4S2/c1-13-19(33-12-25-13)16-7-5-15(6-8-16)10-24-21(30)18-9-17(29)11-27(18)22(31)20(23(3,4)32)26-14(2)28/h5-8,12,17-18,20,29,32H,9-11H2,1-4H3,(H,24,30)(H,26,28)/t17-,18+,20-/m1/s1	MTXNPMAFURZVJC-WSTZPKSXSA-N					doublet; compound annotation
0391_002561	2098836-54-3	C23H30N4O4S2	2.6687	124201834	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)S)NC(=O)C)O	CC(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2c(C)ncs2)cc1)C(C)(C)S	InChI=1S/C23H30N4O4S2/c1-13-19(33-12-25-13)16-7-5-15(6-8-16)10-24-21(30)18-9-17(29)11-27(18)22(31)20(23(3,4)32)26-14(2)28/h5-8,12,17-18,20,29,32H,9-11H2,1-4H3,(H,24,30)(H,26,28)/t17-,18+,20-/m1/s1	MTXNPMAFURZVJC-WSTZPKSXSA-N					doublet; compound annotation
0391_002562	SB290157	C22H28N4O4	2.787	5311120	C1=CC=C(C=C1)C(COCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C2=CC=CC=C2	NC(N)=NCCCC(NC(=O)COCC(c1ccccc1)c1ccccc1)C(=O)O	InChI=1S/C22H28N4O4/c23-22(24)25-13-7-12-19(21(28)29)26-20(27)15-30-14-18(16-8-3-1-4-9-16)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,27)(H,28,29)(H4,23,24,25)/t19-/m0/s1	RRKKJYBCPXAJAO-IBGZPJMESA-N					doublet; compound annotation
0391_002563	SB290157	C22H28N4O4	2.7897	5311120	C1=CC=C(C=C1)C(COCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C2=CC=CC=C2	NC(N)=NCCCC(NC(=O)COCC(c1ccccc1)c1ccccc1)C(=O)O	InChI=1S/C22H28N4O4/c23-22(24)25-13-7-12-19(21(28)29)26-20(27)15-30-14-18(16-8-3-1-4-9-16)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,27)(H,28,29)(H4,23,24,25)/t19-/m0/s1	RRKKJYBCPXAJAO-IBGZPJMESA-N					doublet; compound annotation
0391_002564	GNE-317	C19H22N6O3S	2.8587	70676303		COC1(c2c(C)c3c(s2)c(N2CCOCC2)nc(-c2cnc(N)nc2)n3)COC1	InChI=1S/C19H22N6O3S/c1-11-13-14(29-15(11)19(26-2)9-28-10-19)17(25-3-5-27-6-4-25)24-16(23-13)12-7-21-18(20)22-8-12/h7-8H,3-6,9-10H2,1-2H3,(H2,20,21,22)	XOZLHJMDLKDZAL-UHFFFAOYSA-N					compound annotation
0391_002565	cmpd101	C24H21F3N6O	3.0136	11677079		Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1	InChI=1S/C24H21F3N6O/c1-33-21(31-32-22(33)16-9-11-28-12-10-16)15-29-19-7-4-6-17(13-19)23(34)30-14-18-5-2-3-8-20(18)24(25,26)27/h2-13,29H,14-15H2,1H3,(H,30,34)	WFOVEDJTASPCIR-UHFFFAOYSA-N					doublet; compound annotation
0391_002566	cmpd101	C24H21F3N6O	3.0185	11677079		Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1	InChI=1S/C24H21F3N6O/c1-33-21(31-32-22(33)16-9-11-28-12-10-16)15-29-19-7-4-6-17(13-19)23(34)30-14-18-5-2-3-8-20(18)24(25,26)27/h2-13,29H,14-15H2,1H3,(H,30,34)	WFOVEDJTASPCIR-UHFFFAOYSA-N					doublet; compound annotation
0391_002567	Repotrectinib	C18H18FN5O2	3.1543	135565923	C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C	CC1CNC(=O)c2c3nc(ccn3nc2)NC(C)c2c(ccc(F)c2)O1	InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1	FIKPXCOQUIZNHB-WDEREUQCSA-N					doublet; compound annotation
0391_002568	Repotrectinib	C18H18FN5O2	3.1575	135565923	C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C	CC1CNC(=O)c2c3nc(ccn3nc2)NC(C)c2c(ccc(F)c2)O1	InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1	FIKPXCOQUIZNHB-WDEREUQCSA-N					doublet; compound annotation
0391_002569	SSR128129E free acid	C18H16N2O4	3.3748	11347895		COc1c2ccccn2c(C(=O)c2cc(C(=O)O)c(N)cc2)c1C	InChI=1S/C18H16N2O4/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23/h3-9H,19H2,1-2H3,(H,22,23)	SNMCWIDCSPHZRD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002571	Ledipasvir	C49H54F2N8O6	3.439	67505836	CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CC2(CC2)CC1c1ncc(-c2cc3c(cc2)-c2c(cc(-c4cc5c(cc4)nc(C4C6CCC(C6)N4C(=O)C(NC(=O)OC)C(C)C)[nH]5)cc2)C3(F)F)[nH]1)C(C)C	InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1	VRTWBAAJJOHBQU-KMWAZVGDSA-N					doublet; compound annotation
0391_002572	Ledipasvir	C49H54F2N8O6	3.4418	67505836	CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CC2(CC2)CC1c1ncc(-c2cc3c(cc2)-c2c(cc(-c4cc5c(cc4)nc(C4C6CCC(C6)N4C(=O)C(NC(=O)OC)C(C)C)[nH]5)cc2)C3(F)F)[nH]1)C(C)C	InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1	VRTWBAAJJOHBQU-KMWAZVGDSA-N					doublet; compound annotation
0391_002573	JNJ-42041935	C12H6ClF3N4O3	3.8136	45102710		O=C(O)c1cn(-c2nc3cc(OC(F)(F)F)c(Cl)cc3[nH]2)nc1	InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14,15)16)19-11(18-7)20-4-5(3-17-20)10(21)22/h1-4H,(H,18,19)(H,21,22)	FXHHASJVTYRJHH-UHFFFAOYSA-N					doublet; compound annotation
0391_002574	JNJ-42041935	C12H6ClF3N4O3	3.8168	45102710		O=C(O)c1cn(-c2nc3cc(OC(F)(F)F)c(Cl)cc3[nH]2)nc1	InChI=1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14,15)16)19-11(18-7)20-4-5(3-17-20)10(21)22/h1-4H,(H,18,19)(H,21,22)	FXHHASJVTYRJHH-UHFFFAOYSA-N					doublet; compound annotation
0391_002575	HTS01037	C14H11NO5S2	3.93	5714537	COC(=O)C1=C(C=C(S1)C2=CC=CS2)NC(=O)/C=C/C(=O)O	COC(=O)c1c(NC(=O)C=CC(=O)O)cc(-c2cccs2)s1	InChI=1S/C14H11NO5S2/c1-20-14(19)13-8(15-11(16)4-5-12(17)18)7-10(22-13)9-3-2-6-21-9/h2-7H,1H3,(H,15,16)(H,17,18)/b5-4+	GJODSFZNKNHKML-SNAWJCMRSA-N					doublet; removed another duplicate entry; compound annotation
0391_002578	HTS01037	C14H11NO5S2	4.1889	5714537	COC(=O)C1=C(C=C(S1)C2=CC=CS2)NC(=O)/C=C/C(=O)O	COC(=O)c1c(NC(=O)C=CC(=O)O)cc(-c2cccs2)s1	InChI=1S/C14H11NO5S2/c1-20-14(19)13-8(15-11(16)4-5-12(17)18)7-10(22-13)9-3-2-6-21-9/h2-7H,1H3,(H,15,16)(H,17,18)/b5-4+	GJODSFZNKNHKML-SNAWJCMRSA-N					doublet; compound annotation
0391_002579	PJ34	C17H17N3O2	1.4049	4858		CN(C)CC(=O)Nc1cc2c(cc1)[nH]c(=O)c1ccccc12	InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22)	UYJZZVDLGDDTCL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002581	Chloramben	C7H5Cl2NO2	2.1105	8630		Nc1cc(Cl)cc(C(=O)O)c1Cl	InChI=1S/C7H5Cl2NO2/c8-3-1-4(7(11)12)6(9)5(10)2-3/h1-2H,10H2,(H,11,12)	HSSBORCLYSCBJR-UHFFFAOYSA-N					compound annotation
0391_002582	Zatebradine	C26H36N2O5	2.2779	65637		COc1c(OC)cc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1	InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3	KEDQCFRVSHYKLR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002584	Apratastat	C17H22N2O6S2	2.46	11452716	CC1([C@@H](N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C	CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)C1C(=O)NO	InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1	MAVDNGWEBZTACC-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_002586	RAF265	C24H16F6N6O	3.9546	11656518		Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2c1ccc(Oc1cc(-c3ncc(C(F)(F)F)[nH]3)ncc1)c2	InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)	YABJJWZLRMPFSI-UHFFFAOYSA-N					compound annotation
0391_002587	Kif15-IN-1	C20H22N4O5S	4.2341	60076300	CCOC(=O)C1=C(N=C(S1)NC(=O)[C@H](C(C)C)N2C(=O)C3=CC=CC=C3NC2=O)C	CCOC(=O)c1c(C)nc(NC(=O)C(C(C)C)n2c(=O)[nH]c3ccccc3c2=O)s1	InChI=1S/C20H22N4O5S/c1-5-29-18(27)15-11(4)21-19(30-15)23-16(25)14(10(2)3)24-17(26)12-8-6-7-9-13(12)22-20(24)28/h6-10,14H,5H2,1-4H3,(H,22,28)(H,21,23,25)/t14-/m0/s1	CTQQKICGMSZCJL-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_002589	Mavacoxib	C16H11F4N3O2S	4.298	9843089		NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(F)cc2)cc1	InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)	TTZNQDOUNXBMJV-UHFFFAOYSA-N					compound annotation
0391_002590	SX-682	C19H14BF4N3O4S	4.42	90467234		O=C(Nc1ccc(F)cc1)c1cnc(SCc2c(B(O)O)ccc(OC(F)(F)F)c2)nc1	InChI=1S/C19H14BF4N3O4S/c21-13-1-3-14(4-2-13)27-17(28)12-8-25-18(26-9-12)32-10-11-7-15(31-19(22,23)24)5-6-16(11)20(29)30/h1-9,29-30H,10H2,(H,27,28)	SDUDZBCEHIZMFZ-UHFFFAOYSA-N					compound annotation
0391_002591	Boldenone Cypionate	C27H38O3	6.5156	71314193	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=CC(=O)C=C[C@]35C	CC12C=CC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12	InChI=1S/C27H38O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h13,15,17-18,21-24H,3-12,14,16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1	QPMSXPMLTYTHGM-ZLQWOROUSA-N					removed another duplicate entry; compound annotation
0391_002594	BAY-985	C27H30F3N9O	1.6299	145925685	C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F	CC(c1cc(Nc2nc3c(cc(-c4cc(N(C)C)ncn4)cc3)[nH]2)ncc1)N1CCN(C(=O)CC(F)(F)F)CC1	InChI=1S/C27H30F3N9O/c1-17(38-8-10-39(11-9-38)25(40)15-27(28,29)30)18-6-7-31-23(13-18)36-26-34-20-5-4-19(12-22(20)35-26)21-14-24(37(2)3)33-16-32-21/h4-7,12-14,16-17H,8-11,15H2,1-3H3,(H2,31,34,35,36)/t17-/m1/s1	HZRJHVDNTDBTOZ-QGZVFWFLSA-N					doublet; compound annotation
0391_002595	BAY-985	C27H30F3N9O	1.6337	145925685	C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F	CC(c1cc(Nc2nc3c(cc(-c4cc(N(C)C)ncn4)cc3)[nH]2)ncc1)N1CCN(C(=O)CC(F)(F)F)CC1	InChI=1S/C27H30F3N9O/c1-17(38-8-10-39(11-9-38)25(40)15-27(28,29)30)18-6-7-31-23(13-18)36-26-34-20-5-4-19(12-22(20)35-26)21-14-24(37(2)3)33-16-32-21/h4-7,12-14,16-17H,8-11,15H2,1-3H3,(H2,31,34,35,36)/t17-/m1/s1	HZRJHVDNTDBTOZ-QGZVFWFLSA-N					doublet; compound annotation
0391_002596	PF-04979064	C24H26N6O3	1.7408	46866705	CC1=NC=C(C=C1)C2=NC3=C4C(=CN=C3C=C2)N(C(=O)N4C5CCN(CC5)C(=O)[C@H](C)O)C	Cc1ncc(-c2nc3c4c(cnc3cc2)n(C)c(=O)n4C2CCN(C(=O)C(C)O)CC2)cc1	InChI=1S/C24H26N6O3/c1-14-4-5-16(12-25-14)18-6-7-19-21(27-18)22-20(13-26-19)28(3)24(33)30(22)17-8-10-29(11-9-17)23(32)15(2)31/h4-7,12-13,15,17,31H,8-11H2,1-3H3/t15-/m0/s1	GACQNUHFDBEIQH-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_002598	OTS514	C21H20N2O2S	2.0007	67448836	CC1=CC(=C(C2=C1NC(=O)C3=C2C=CS3)C4=CC=C(C=C4)[C@@H](C)CN)O	Cc1cc(O)c(-c2ccc(C(C)CN)cc2)c2c1[nH]c(=O)c1c2ccs1	InChI=1S/C21H20N2O2S/c1-11-9-16(24)17(14-5-3-13(4-6-14)12(2)10-22)18-15-7-8-26-20(15)21(25)23-19(11)18/h3-9,12,24H,10,22H2,1-2H3,(H,23,25)/t12-/m0/s1	OETLNMOJNONWOY-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_002600	Coluracetam	C19H23N3O3	2.4989	214346		Cc1c(C)c2c(NC(=O)CN3CCCC3=O)c3c(CCCC3)nc2o1	InChI=1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)	PSPGQHXMUKWNDI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002602	Empagliflozin	C23H27ClO7	3.0663	11949646	C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl	OCC1OC(c2cc(Cc3ccc(OC4CCOC4)cc3)c(Cl)cc2)C(O)C(O)C1O	InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1	OBWASQILIWPZMG-QZMOQZSNSA-N					removed another duplicate entry; compound annotation
0391_002604	Amcasertib	C31H33N5O2S	3.3469	25190990	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc23)c1C	InChI=1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b24-17-	QDWKGEFGLQMDAM-ULJHMMPZSA-N					doublet; compound annotation
0391_002605	SIS3 free base	C28H27N3O3	3.7854	10138988	CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5	COc1c(OC)cc2CN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4c3cccn4)CCc2c1	InChI=1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+	IJYPHMXWKKKHGT-VAWYXSNFSA-N					doublet; removed another duplicate entry; compound annotation
0391_002607	SIS3 free base	C28H27N3O3	3.7883	10138988	CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5	COc1c(OC)cc2CN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4c3cccn4)CCc2c1	InChI=1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+	IJYPHMXWKKKHGT-VAWYXSNFSA-N					doublet; compound annotation
0391_002608	Amcasertib	C31H33N5O2S	3.7995	25190990	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc23)c1C	InChI=1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b24-17-	QDWKGEFGLQMDAM-ULJHMMPZSA-N					doublet; compound annotation
0391_002609	SIS3 free base	C28H27N3O3	3.9323	10138988	CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5	COc1c(OC)cc2CN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4c3cccn4)CCc2c1	InChI=1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+	IJYPHMXWKKKHGT-VAWYXSNFSA-N					doublet; compound annotation
0391_002610	Amcasertib	C31H33N5O2S	3.9947	25190990	CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc23)c1C	InChI=1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b24-17-	QDWKGEFGLQMDAM-ULJHMMPZSA-N					doublet; compound annotation
0391_002611	Ro 48-8071	C23H27BrFNO2	4.0113	1949		C=CCN(C)CCCCCCOc1cc(F)c(C(=O)c2ccc(Br)cc2)cc1	InChI=1S/C23H27BrFNO2/c1-3-14-26(2)15-6-4-5-7-16-28-20-12-13-21(22(25)17-20)23(27)18-8-10-19(24)11-9-18/h3,8-13,17H,1,4-7,14-16H2,2H3	CMYCCJYVZIMDFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002612	MK-4101	C24H24F5N5O	4.1141	16222379		Cn1c(-c2ccccc2C(F)(F)F)nnc1C12CCC(c3noc(C4CC(F)(F)C4)n3)(CC1)CC2	InChI=1S/C24H24F5N5O/c1-34-17(15-4-2-3-5-16(15)24(27,28)29)31-32-20(34)22-9-6-21(7-10-22,8-11-22)19-30-18(35-33-19)14-12-23(25,26)13-14/h2-5,14H,6-13H2,1H3	HKJOIWLYDJCTQR-UHFFFAOYSA-N					doublet; compound annotation
0391_002613	MK-4101	C24H24F5N5O	4.123	16222379		Cn1c(-c2ccccc2C(F)(F)F)nnc1C12CCC(c3noc(C4CC(F)(F)C4)n3)(CC1)CC2	InChI=1S/C24H24F5N5O/c1-34-17(15-4-2-3-5-16(15)24(27,28)29)31-32-20(34)22-9-6-21(7-10-22,8-11-22)19-30-18(35-33-19)14-12-23(25,26)13-14/h2-5,14H,6-13H2,1H3	HKJOIWLYDJCTQR-UHFFFAOYSA-N					doublet; compound annotation
0391_002614	SIS3 free base	C28H27N3O3	4.2675	10138988	CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5	COc1c(OC)cc2CN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4c3cccn4)CCc2c1	InChI=1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+	IJYPHMXWKKKHGT-VAWYXSNFSA-N					doublet; removed another duplicate entry; compound annotation
0391_002616	SIS3 free base	C28H27N3O3	4.4032	10138988	CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5	COc1c(OC)cc2CN(C(=O)C=Cc3c(-c4ccccc4)n(C)c4c3cccn4)CCc2c1	InChI=1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+	IJYPHMXWKKKHGT-VAWYXSNFSA-N					doublet; compound annotation
0391_002617	Ro 48-8071	C23H27BrFNO2	4.4702	1949		C=CCN(C)CCCCCCOc1cc(F)c(C(=O)c2ccc(Br)cc2)cc1	InChI=1S/C23H27BrFNO2/c1-3-14-26(2)15-6-4-5-7-16-28-20-12-13-21(22(25)17-20)23(27)18-8-10-19(24)11-9-18/h3,8-13,17H,1,4-7,14-16H2,2H3	CMYCCJYVZIMDFU-UHFFFAOYSA-N					doublet; compound annotation
0391_002618	Olprinone	C14H10N4O	0.463	4593		Cc1c(-c2cn3ccnc3cc2)cc(C#N)c(=O)[nH]1	InChI=1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19)	JPAWFIIYTJQOKW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002620	Omecamtiv mecarbil	C20H24FN5O3	0.9705	11689883		COC(=O)N1CCN(Cc2c(F)c(NC(=O)Nc3cnc(C)cc3)ccc2)CC1	InChI=1S/C20H24FN5O3/c1-14-6-7-16(12-22-14)23-19(27)24-17-5-3-4-15(18(17)21)13-25-8-10-26(11-9-25)20(28)29-2/h3-7,12H,8-11,13H2,1-2H3,(H2,23,24,27)	RFUBTTPMWSKEIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002622	Vernakalant	C20H31NO4	2.2693	9930049	COC1=C(C=C(C=C1)CCO[C@@H]2CCCC[C@H]2N3CC[C@H](C3)O)OC	COc1c(OC)cc(CCOC2CCCCC2N2CCC(O)C2)cc1	InChI=1S/C20H31NO4/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3/t16-,17-,18-/m1/s1	VBHQKCBVWWUUKN-KZNAEPCWSA-N					compound annotation
0391_002623	letrozole	C17H11N5	3.0356	3902		N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1	InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H	HPJKCIUCZWXJDR-UHFFFAOYSA-N					compound annotation
0391_002624	GSK1059865	C20H23BrFN3O2	4.0602	44463491	C[C@H]1CC[C@H](N(C1)C(=O)C2=C(C(=CC=C2)F)OC)CNC3=NC=C(C=C3)Br	COc1c(C(=O)N2CC(C)CCC2CNc2ncc(Br)cc2)cccc1F	InChI=1S/C20H23BrFN3O2/c1-13-6-8-15(11-24-18-9-7-14(21)10-23-18)25(12-13)20(26)16-4-3-5-17(22)19(16)27-2/h3-5,7,9-10,13,15H,6,8,11-12H2,1-2H3,(H,23,24)/t13-,15-/m0/s1	TWCRHJLMMAYSTE-ZFWWWQNUSA-N					doublet; compound annotation
0391_002625	GSK1059865	C20H23BrFN3O2	4.0634	44463491	C[C@H]1CC[C@H](N(C1)C(=O)C2=C(C(=CC=C2)F)OC)CNC3=NC=C(C=C3)Br	COc1c(C(=O)N2CC(C)CCC2CNc2ncc(Br)cc2)cccc1F	InChI=1S/C20H23BrFN3O2/c1-13-6-8-15(11-24-18-9-7-14(21)10-23-18)25(12-13)20(26)16-4-3-5-17(22)19(16)27-2/h3-5,7,9-10,13,15H,6,8,11-12H2,1-2H3,(H,23,24)/t13-,15-/m0/s1	TWCRHJLMMAYSTE-ZFWWWQNUSA-N					doublet; compound annotation
0391_002626	GSK963	C14H18N2O	4.0988	122703613	CC(C)(C)C(=O)N1[C@@H](CC=N1)C2=CC=CC=C2	CC(C)(C)C(=O)N1N=CCC1c1ccccc1	InChI=1S/C14H18N2O/c1-14(2,3)13(17)16-12(9-10-15-16)11-7-5-4-6-8-11/h4-8,10,12H,9H2,1-3H3/t12-/m0/s1	NJQVSLWJBLPTMD-LBPRGKRZSA-N					doublet; compound annotation
0391_002627	GSK963	C14H18N2O	4.1017	122703613	CC(C)(C)C(=O)N1[C@@H](CC=N1)C2=CC=CC=C2	CC(C)(C)C(=O)N1N=CCC1c1ccccc1	InChI=1S/C14H18N2O/c1-14(2,3)13(17)16-12(9-10-15-16)11-7-5-4-6-8-11/h4-8,10,12H,9H2,1-3H3/t12-/m0/s1	NJQVSLWJBLPTMD-LBPRGKRZSA-N					doublet; compound annotation
0391_002628	Fmoc-N-Me-Ala-OH	C19H19NO4	4.1139	688634	C[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13	CC(C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21	InChI=1S/C19H19NO4/c1-12(18(21)22)20(2)19(23)24-11-17-15-9-5-3-7-13(15)14-8-4-6-10-16(14)17/h3-10,12,17H,11H2,1-2H3,(H,21,22)/t12-/m0/s1	JOFHWKQIQLPZTC-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_002630	VX-11e	C24H20Cl2FN5O2	4.3466	11634725	CC1=CN=C(N=C1C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)NC4=C(C=C(C=C4)F)Cl	Cc1cnc(Nc2c(Cl)cc(F)cc2)nc1-c1c[nH]c(C(=O)NC(CO)c2cc(Cl)ccc2)c1	InChI=1S/C24H20Cl2FN5O2/c1-13-10-29-24(31-19-6-5-17(27)9-18(19)26)32-22(13)15-8-20(28-11-15)23(34)30-21(12-33)14-3-2-4-16(25)7-14/h2-11,21,28,33H,12H2,1H3,(H,30,34)(H,29,31,32)/t21-/m1/s1	WUTVMXLIGHTZJC-OAQYLSRUSA-N					compound annotation
0391_002631	LUMINOL	C8H7N3O2	1.1425	10638		Nc1cccc2c1c(=O)[nH][nH]c2=O	InChI=1S/C8H7N3O2/c9-5-3-1-2-4-6(5)8(13)11-10-7(4)12/h1-3H,9H2,(H,10,12)(H,11,13)	HWYHZTIRURJOHG-UHFFFAOYSA-N					compound annotation
0391_002632	36783-03-6	C12H19NO3S	1.3367	169814		CCN(CCCS(=O)(=O)O)c1cccc(C)c1	InChI=1S/C12H19NO3S/c1-3-13(8-5-9-17(14,15)16)12-7-4-6-11(2)10-12/h4,6-7,10H,3,5,8-9H2,1-2H3,(H,14,15,16)	IBSUMVZKDLDAEK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002634	Radiprodil	C21H20FN3O4	2.5448	10200813		O=C(Nc1cc2c(cc1)[nH]c(=O)o2)C(=O)N1CCC(Cc2ccc(F)cc2)CC1	InChI=1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28)	GKGRZLGAQZPEHO-UHFFFAOYSA-N					doublet; compound annotation
0391_002635	Befiradol	C20H22ClF2N3O	2.548	9865384		Cc1cnc(CNCC2(F)CCN(C(=O)c3cc(Cl)c(F)cc3)CC2)cc1	InChI=1S/C20H22ClF2N3O/c1-14-2-4-16(25-11-14)12-24-13-20(23)6-8-26(9-7-20)19(27)15-3-5-18(22)17(21)10-15/h2-5,10-11,24H,6-9,12-13H2,1H3	PKZXLMVXBZICTF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002637	Adoprazine	C24H24FN3O2	2.7445	9887537		Fc1ccc(-c2cncc(CN3CCN(c4c5OCCOc5ccc4)CC3)c2)cc1	InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2	IUVSEUFHPNITEQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002638	Adoprazine	C24H24FN3O2	2.7494	9887537		Fc1ccc(-c2cncc(CN3CCN(c4c5OCCOc5ccc4)CC3)c2)cc1	InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2	IUVSEUFHPNITEQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002639	TAK-960	C27H34F3N7O3	2.9439	53357478		COc1c(Nc2ncc3c(n2)N(C2CCCC2)CC(F)(F)C(=O)N3C)cc(F)c(C(=O)NC2CCN(C)CC2)c1	InChI=1S/C27H34F3N7O3/c1-35-10-8-16(9-11-35)32-24(38)18-12-22(40-3)20(13-19(18)28)33-26-31-14-21-23(34-26)37(17-6-4-5-7-17)15-27(29,30)25(39)36(21)2/h12-14,16-17H,4-11,15H2,1-3H3,(H,32,38)(H,31,33,34)	GWRSATNRNFYMDI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002641	Radiprodil	C21H20FN3O4	3.7886	10200813		O=C(Nc1cc2c(cc1)[nH]c(=O)o2)C(=O)N1CCC(Cc2ccc(F)cc2)CC1	InChI=1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28)	GKGRZLGAQZPEHO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002643	666260-75-9	C18H17Cl2F3N4O2	4.3779	10253143		O=C(NCC1CCOCC1)c1cnc(Nc2c(Cl)cc(Cl)cc2)nc1C(F)(F)F	InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)	TWQYWUXBZHPIIV-UHFFFAOYSA-N					compound annotation
0391_002644	PETCM	C8H8Cl3NO	1.4338	224859		OC(Cc1ccncc1)C(Cl)(Cl)Cl	InChI=1S/C8H8Cl3NO/c9-8(10,11)7(13)5-6-1-3-12-4-2-6/h1-4,7,13H,5H2	NGTDJJKTGRNNAU-UHFFFAOYSA-N					compound annotation
0391_002645	NUCC-390	C23H33N5O	1.7245	45159110		CCCn1nc(C(=O)N2CCCCC2)c2c1CCC(NCCc1ccncc1)C2	InChI=1S/C23H33N5O/c1-2-14-28-21-7-6-19(25-13-10-18-8-11-24-12-9-18)17-20(21)22(26-28)23(29)27-15-4-3-5-16-27/h8-9,11-12,19,25H,2-7,10,13-17H2,1H3	QUEIKILOAGDRRO-UHFFFAOYSA-N					doublet; compound annotation
0391_002646	NUCC-390	C23H33N5O	1.7273	45159110		CCCn1nc(C(=O)N2CCCCC2)c2c1CCC(NCCc1ccncc1)C2	InChI=1S/C23H33N5O/c1-2-14-28-21-7-6-19(25-13-10-18-8-11-24-12-9-18)17-20(21)22(26-28)23(29)27-15-4-3-5-16-27/h8-9,11-12,19,25H,2-7,10,13-17H2,1H3	QUEIKILOAGDRRO-UHFFFAOYSA-N					doublet; compound annotation
0391_002647	SM 16	C25H26N4O3	2.3455	10387982		Cc1nc(-c2c(-c3cc4c(cc3)OCO4)nc(C34CCC(C(N)=O)(CC3)CC4)[nH]2)ccc1	InChI=1S/C25H26N4O3/c1-15-3-2-4-17(27-15)21-20(16-5-6-18-19(13-16)32-14-31-18)28-23(29-21)25-10-7-24(8-11-25,9-12-25)22(26)30/h2-6,13H,7-12,14H2,1H3,(H2,26,30)(H,28,29)	JUHTXZGCTPDXRU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002649	221529-58-4	C19H23N3O	3.229	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002650	945966-46-1	C17H17FN2O4S	3.4825	24744336		CC1(C)Oc2c(ccc(NS(C)(=O)=O)c2)N(c2ccc(F)cc2)C1=O	InChI=1S/C17H17FN2O4S/c1-17(2)16(21)20(13-7-4-11(18)5-8-13)14-9-6-12(10-15(14)24-17)19-25(3,22)23/h4-10,19H,1-3H3	AZNHWXAFPBYFGH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002652	221529-58-4	C19H23N3O	3.5972	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002653	221529-58-4	C19H23N3O	3.6005	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002654	221529-58-4	C19H23N3O	3.6871	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002655	221529-58-4	C19H23N3O	3.69	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002656	221529-58-4	C19H23N3O	3.8875	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002657	221529-58-4	C19H23N3O	3.9307	9839644		CC(C)Oc1ccc(Cc2ccc(NC3=NCCN3)cc2)cc1	InChI=1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22)	GYYRMJMXXLJZAB-UHFFFAOYSA-N					doublet; compound annotation
0391_002658	Auxinole	C20H19NO3	4.1499	13077496		Cc1cc(C)c(C(=O)CC(C(=O)O)c2c[nH]c3ccccc23)cc1	InChI=1S/C20H19NO3/c1-12-7-8-14(13(2)9-12)19(22)10-16(20(23)24)17-11-21-18-6-4-3-5-15(17)18/h3-9,11,16,21H,10H2,1-2H3,(H,23,24)	HGUYAIJBXSQXGV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002660	RGX-104	C34H33ClF3NO3	6.0387	10218693	C[C@H](CCOC1=CC=CC(=C1)CC(=O)O)N(CC2=C(C(=CC=C2)C(F)(F)F)Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4	CC(CCOc1cccc(CC(=O)O)c1)N(Cc1c(Cl)c(C(F)(F)F)ccc1)CC(c1ccccc1)c1ccccc1	InChI=1S/C34H33ClF3NO3/c1-24(18-19-42-29-16-8-10-25(20-29)21-32(40)41)39(22-28-15-9-17-31(33(28)35)34(36,37)38)23-30(26-11-4-2-5-12-26)27-13-6-3-7-14-27/h2-17,20,24,30H,18-19,21-23H2,1H3,(H,40,41)/t24-/m1/s1	ZLJZDYOBXVOTSA-XMMPIXPASA-N					doublet; compound annotation
0391_002661	Rolziracetam	C7H9NO2	0.5894	71893		O=C1CCC2CCC(=O)N12	InChI=1S/C7H9NO2/c9-6-3-1-5-2-4-7(10)8(5)6/h5H,1-4H2	IEZDOKQWPWZVQF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002663	Caracemide	C6H11N3O4	0.8419	54747		CNC(=O)ON(C(C)=O)C(=O)NC	InChI=1S/C6H11N3O4/c1-4(10)9(5(11)7-2)13-6(12)8-3/h1-3H3,(H,7,11)(H,8,12)	JURAJLFHWXNPHG-UHFFFAOYSA-N					compound annotation
0391_002664	AQ-13 free base	C16H22ClN3	0.8601	3805581		CCN(CC)CCCNc1c2ccc(Cl)cc2ncc1	InChI=1S/C16H22ClN3/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19)	NCPLTAGJJVCHOW-UHFFFAOYSA-N					compound annotation
0391_002665	SHP099	C16H19Cl2N5	2.3211	118238298		CC1(N)CCN(c2cnc(-c3c(Cl)c(Cl)ccc3)c(N)n2)CC1	InChI=1S/C16H19Cl2N5/c1-16(20)5-7-23(8-6-16)12-9-21-14(15(19)22-12)10-3-2-4-11(17)13(10)18/h2-4,9H,5-8,20H2,1H3,(H2,19,22)	YGUFCDOEKKVKJK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002667	Luminespib	C26H31N3O5	2.44	135539077		CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1	InChI=1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,30-31H,4,9-12,15H2,1-3H3,(H,27,32)	NDAZATDQFDPQBD-UHFFFAOYSA-N					doublet; compound annotation
0391_002668	658084-23-2	C28H30ClN5O4S	2.6045	9549297	CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)/C=C\3/C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O	Cc1c(C(=O)N2CCN(C)CC2)c(C)c(C=C2C(=O)Nc3ccc(S(=O)(=O)N(C)c4cc(Cl)ccc4)cc23)[nH]1	InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30H,10-13H2,1-4H3,(H,31,35)/b23-16-	FPYJSJDOHRDAMT-KQWNVCNZSA-N					doublet; removed another duplicate entry; compound annotation
0391_002670	Luminespib	C26H31N3O5	2.6194	135539077		CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1	InChI=1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,30-31H,4,9-12,15H2,1-3H3,(H,27,32)	NDAZATDQFDPQBD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002672	Ravoxertinib	C21H18ClFN6O2	3.1315	71727581	CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)[C@H](CO)C4=CC(=C(C=C4)Cl)F	Cn1nccc1Nc1nccc(-c2cc(=O)n(C(CO)c3cc(F)c(Cl)cc3)cc2)n1	InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1	RZUOCXOYPYGSKL-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_002674	658084-23-2	C28H30ClN5O4S	3.2231	9549297	CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)/C=C\3/C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O	Cc1c(C(=O)N2CCN(C)CC2)c(C)c(C=C2C(=O)Nc3ccc(S(=O)(=O)N(C)c4cc(Cl)ccc4)cc23)[nH]1	InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30H,10-13H2,1-4H3,(H,31,35)/b23-16-	FPYJSJDOHRDAMT-KQWNVCNZSA-N					doublet; removed another duplicate entry; compound annotation
0391_002676	SB 242084	C21H19ClN4O2	3.5812	3644637		Cc1cc2c(cc1Cl)N(C(=O)Nc1cnc(Oc3c(C)nccc3)cc1)CC2	InChI=1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27)	GIUZEIJUFOPTMR-UHFFFAOYSA-N					doublet; compound annotation
0391_002677	Ravoxertinib	C21H18ClFN6O2	3.6382	71727581	CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)[C@H](CO)C4=CC(=C(C=C4)Cl)F	Cn1nccc1Nc1nccc(-c2cc(=O)n(C(CO)c3cc(F)c(Cl)cc3)cc2)n1	InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1	RZUOCXOYPYGSKL-GOSISDBHSA-N					doublet; compound annotation
0391_002678	TAK-715	C24H21N3OS	5.155	9952773		CCc1nc(-c2cccc(C)c2)c(-c2cc(NC(=O)c3ccccc3)ncc2)s1	InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)	HEKAIDKUDLCBRU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002680	Savolitinib	C17H15N9	1.5612	68289010	C[C@@H](C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C	CC(c1cn2ccnc2cc1)n1nnc2ncc(-c3cn(C)nc3)nc21	InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1	XYDNMOZJKOGZLS-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002682	GNE-493	C17H20N6O2S	1.9481	25242324		CC(C)(O)c1cc2c(s1)c(N1CCOCC1)nc(-c1cnc(N)nc1)n2	InChI=1S/C17H20N6O2S/c1-17(2,24)12-7-11-13(26-12)15(23-3-5-25-6-4-23)22-14(21-11)10-8-19-16(18)20-9-10/h7-9,24H,3-6H2,1-2H3,(H2,18,19,20)	LEXMMFPAPDGYGZ-UHFFFAOYSA-N					compound annotation
0391_002683	alvespimycin	C32H48N4O8	2.7298	5288674	C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)/C)OC)OC(=O)N)\C)C)O)OC	COC1C=CC=C(C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(CC(C)CC(OC)C(O)C(C)C=C(C)C1OC(N)=O)C2=O	InChI=1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10+,21-16+/t18-,20+,25+,26+,28-,30+/m1/s1	KUFRQPKVAWMTJO-LMZWQJSESA-N					removed another duplicate entry; compound annotation
0391_002685	Glumetinib	C21H17N9O2S	2.9072	117797905		Cn1cc(-c2cc3c(cnn3S(=O)(=O)c3cnc4ccc(-c5cn(C)nc5)cn34)nc2)cn1	InChI=1S/C21H17N9O2S/c1-27-11-16(7-24-27)14-3-4-20-23-10-21(29(20)13-14)33(31,32)30-19-5-15(6-22-18(19)9-26-30)17-8-25-28(2)12-17/h3-13H,1-2H3	RYBLECYFLJXEJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002686	Glumetinib	C21H17N9O2S	2.9105	117797905		Cn1cc(-c2cc3c(cnn3S(=O)(=O)c3cnc4ccc(-c5cn(C)nc5)cn34)nc2)cn1	InChI=1S/C21H17N9O2S/c1-27-11-16(7-24-27)14-3-4-20-23-10-21(29(20)13-14)33(31,32)30-19-5-15(6-22-18(19)9-26-30)17-8-25-28(2)12-17/h3-13H,1-2H3	RYBLECYFLJXEJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002687	Skp2 Inhibitor C1	C18H13BrN2O4S2	3.3366	5733396	C1=CC(=CN=C1)CN2C(=O)/C(=C/C3=C(C=CC(=C3)Br)OCC(=O)O)/SC2=S	O=C(O)COc1c(C=C2SC(=S)N(Cc3cnccc3)C2=O)cc(Br)cc1	InChI=1S/C18H13BrN2O4S2/c19-13-3-4-14(25-10-16(22)23)12(6-13)7-15-17(24)21(18(26)27-15)9-11-2-1-5-20-8-11/h1-8H,9-10H2,(H,22,23)/b15-7-	IYCJJVVXEHZJHE-CHHVJCJISA-N					doublet; compound annotation
0391_002688	Skp2 Inhibitor C1	C18H13BrN2O4S2	3.7723	5733396	C1=CC(=CN=C1)CN2C(=O)/C(=C/C3=C(C=CC(=C3)Br)OCC(=O)O)/SC2=S	O=C(O)COc1c(C=C2SC(=S)N(Cc3cnccc3)C2=O)cc(Br)cc1	InChI=1S/C18H13BrN2O4S2/c19-13-3-4-14(25-10-16(22)23)12(6-13)7-15-17(24)21(18(26)27-15)9-11-2-1-5-20-8-11/h1-8H,9-10H2,(H,22,23)/b15-7-	IYCJJVVXEHZJHE-CHHVJCJISA-N					doublet; compound annotation
0391_002689	391210-10-9	C16H14F3IN2O4	3.8195	9826528	C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O	O=C(NOCC(O)CO)c1c(Nc2c(F)cc(I)cc2)c(F)c(F)cc1	InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1	SUDAHWBOROXANE-SECBINFHSA-N					removed another duplicate entry; compound annotation
0391_002691	Tubacin	C41H43N3O7S	4.6939	6675804	C1[C@@H](O[C@@H](O[C@@H]1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6	O=C(CCCCCCC(=O)Nc1ccc(C2OC(CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)CC(c3ccc(CO)cc3)O2)cc1)NO	InChI=1S/C41H43N3O7S/c45-26-28-17-19-29(20-18-28)35-25-34(27-52-41-43-38(30-11-5-3-6-12-30)39(51-41)31-13-7-4-8-14-31)49-40(50-35)32-21-23-33(24-22-32)42-36(46)15-9-1-2-10-16-37(47)44-48/h3-8,11-14,17-24,34-35,40,45,48H,1-2,9-10,15-16,25-27H2,(H,42,46)(H,44,47)/t34-,35+,40+/m1/s1	BHUZLJOUHMBZQY-YXQOSMAKSA-N					doublet; compound annotation
0391_002692	6-Shogaol	C17H24O3	4.7064	5281794	CCCCC/C=C/C(=O)CCC1=CC(=C(C=C1)O)OC	CCCCCC=CC(=O)CCc1cc(OC)c(O)cc1	InChI=1S/C17H24O3/c1-3-4-5-6-7-8-15(18)11-9-14-10-12-16(19)17(13-14)20-2/h7-8,10,12-13,19H,3-6,9,11H2,1-2H3/b8-7+	OQWKEEOHDMUXEO-BQYQJAHWSA-N					compound annotation
0391_002693	Tubacin	C41H43N3O7S	4.7699	6675804	C1[C@@H](O[C@@H](O[C@@H]1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6	O=C(CCCCCCC(=O)Nc1ccc(C2OC(CSc3nc(-c4ccccc4)c(-c4ccccc4)o3)CC(c3ccc(CO)cc3)O2)cc1)NO	InChI=1S/C41H43N3O7S/c45-26-28-17-19-29(20-18-28)35-25-34(27-52-41-43-38(30-11-5-3-6-12-30)39(51-41)31-13-7-4-8-14-31)49-40(50-35)32-21-23-33(24-22-32)42-36(46)15-9-1-2-10-16-37(47)44-48/h3-8,11-14,17-24,34-35,40,45,48H,1-2,9-10,15-16,25-27H2,(H,42,46)(H,44,47)/t34-,35+,40+/m1/s1	BHUZLJOUHMBZQY-YXQOSMAKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002696	AG14361	C19H20N4O	0.97	9840076		CN(C)Cc1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1	InChI=1S/C19H20N4O/c1-22(2)12-13-6-8-14(9-7-13)18-21-16-5-3-4-15-17(16)23(18)11-10-20-19(15)24/h3-9H,10-12H2,1-2H3,(H,20,24)	SEKJSSBJKFLZIT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002698	PF-06446846	C22H20ClN7O	2.4109	86271238	C1C[C@H](CNC1)N(C2=C(C=CC=N2)Cl)C(=O)C3=CC=C(C=C3)N4C5=C(C=CC=N5)N=N4	O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1c(Cl)cccn1)C1CCCNC1	InChI=1S/C22H20ClN7O/c23-18-5-2-12-25-20(18)29(17-4-1-11-24-14-17)22(31)15-7-9-16(10-8-15)30-21-19(27-28-30)6-3-13-26-21/h2-3,5-10,12-13,17,24H,1,4,11,14H2/t17-/m1/s1	FDTXHWQFIXYHCL-QGZVFWFLSA-N					doublet; compound annotation
0391_002699	PF-06446846	C22H20ClN7O	2.4137	86271238	C1C[C@H](CNC1)N(C2=C(C=CC=N2)Cl)C(=O)C3=CC=C(C=C3)N4C5=C(C=CC=N5)N=N4	O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1c(Cl)cccn1)C1CCCNC1	InChI=1S/C22H20ClN7O/c23-18-5-2-12-25-20(18)29(17-4-1-11-24-14-17)22(31)15-7-9-16(10-8-15)30-21-19(27-28-30)6-3-13-26-21/h2-3,5-10,12-13,17,24H,1,4,11,14H2/t17-/m1/s1	FDTXHWQFIXYHCL-QGZVFWFLSA-N					doublet; compound annotation
0391_002700	133550-30-8	C17H14N2O3	2.7009	5328779	C1=CC=C(C=C1)CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)NCc1ccccc1	InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+	TUCIOBMMDDOEMM-RIYZIHGNSA-N					doublet; compound annotation
0391_002701	315703-52-7	C19H18N4OS	2.9822	1069686		CCOc1ccc(Nc2nc(-c3c(C)nc4ccccn34)cs2)cc1	InChI=1S/C19H18N4OS/c1-3-24-15-9-7-14(8-10-15)21-19-22-16(12-25-19)18-13(2)20-17-6-4-5-11-23(17)18/h4-12H,3H2,1-2H3,(H,21,22)	ROYXIPOUVGDTAO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002703	PF-4800567	C17H18ClN5O2	3.1226	53472153		Nc1c2c(COc3cc(Cl)ccc3)nn(C3CCOCC3)c2ncn1	InChI=1S/C17H18ClN5O2/c18-11-2-1-3-13(8-11)25-9-14-15-16(19)20-10-21-17(15)23(22-14)12-4-6-24-7-5-12/h1-3,8,10,12H,4-7,9H2,(H2,19,20,21)	AUMDBEHGJRZSOO-UHFFFAOYSA-N					compound annotation
0391_002704	133550-30-8	C17H14N2O3	3.1351	5328779	C1=CC=C(C=C1)CNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)NCc1ccccc1	InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+	TUCIOBMMDDOEMM-RIYZIHGNSA-N					doublet; compound annotation
0391_002705	CCR7 Ligand 1	C22H29N5O5S	3.512	136165388	CC1=C(C(=C(C=C1)NC2=NS(=O)(=O)NC2=N[C@@H](C3=CC=C(O3)C)C(C)(C)C)O)C(=O)N(C)C	Cc1ccc(C(N=C2NS(=O)(=O)N=C2Nc2c(O)c(C(=O)N(C)C)c(C)cc2)C(C)(C)C)o1	InChI=1S/C22H29N5O5S/c1-12-8-10-14(17(28)16(12)21(29)27(6)7)23-19-20(26-33(30,31)25-19)24-18(22(3,4)5)15-11-9-13(2)32-15/h8-11,18,28H,1-7H3,(H,23,25)(H,24,26)/t18-/m0/s1	MAYXLCLBDVEYAL-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_002707	106392-48-7	C16H20N2O2	3.5475	6439072	CC(C)C1=CC(=CC(=C1O)C(C)C)/C=C(\C#N)/C(=O)N	CC(C)c1cc(C=C(C#N)C(N)=O)cc(C(C)C)c1O	InChI=1S/C16H20N2O2/c1-9(2)13-6-11(5-12(8-17)16(18)20)7-14(10(3)4)15(13)19/h5-7,9-10,19H,1-4H3,(H2,18,20)/b12-5+	HMLQHJRJKQDTKW-LFYBBSHMSA-N					removed another duplicate entry; compound annotation
0391_002710	WIN 55212-2	C27H26N2O3	4.0352	5311501	CC1=C(C2=C3N1[C@@H](COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65	Cc1c(C(=O)c2cccc3ccccc23)c2c3c(ccc2)OCC(CN2CCOCC2)n13	InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1	HQVHOQAKMCMIIM-HXUWFJFHSA-N					removed another duplicate entry; compound annotation
0391_002712	Abrocitinib	C14H21N5O2S	1.5832	78323835		CCCS(=O)(=O)NC1CC(N(C)c2ncnc3c2cc[nH]3)C1	InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)	IUEWXNHSKRWHDY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002714	Ilaprazole	C19H18N4O2S	1.7486	214351		COc1ccnc(C[S+]([O-])c2nc3ccc(-n4cccc4)cc3[nH]2)c1C	InChI=1S/C19H18N4O2S/c1-13-17(20-8-7-18(13)25-2)12-26(24)19-21-15-6-5-14(11-16(15)22-19)23-9-3-4-10-23/h3-11H,12H2,1-2H3,(H,21,22)	HRRXCXABAPSOCP-UHFFFAOYSA-N					doublet; compound annotation
0391_002715	722544-51-6	C26H30FN7O3	1.757	16007391		CCN(CCO)CCCOc1cc2c(cc1)c(Nc1n[nH]c(CC(=O)Nc3cc(F)ccc3)c1)ncn2	InChI=1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33)	QYZOGCMHVIGURT-UHFFFAOYSA-N					doublet; compound annotation
0391_002716	722544-51-6	C26H30FN7O3	1.762	16007391		CCN(CCO)CCCOc1cc2c(cc1)c(Nc1n[nH]c(CC(=O)Nc3cc(F)ccc3)c1)ncn2	InChI=1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33)	QYZOGCMHVIGURT-UHFFFAOYSA-N					doublet; compound annotation
0391_002717	Ilaprazole	C19H18N4O2S	1.908	214351		COc1ccnc(C[S+]([O-])c2nc3ccc(-n4cccc4)cc3[nH]2)c1C	InChI=1S/C19H18N4O2S/c1-13-17(20-8-7-18(13)25-2)12-26(24)19-21-15-6-5-14(11-16(15)22-19)23-9-3-4-10-23/h3-11H,12H2,1-2H3,(H,21,22)	HRRXCXABAPSOCP-UHFFFAOYSA-N					doublet; compound annotation
0391_002718	TH287	C11H10Cl2N4	2.0582	73441664		CNc1nc(N)nc(-c2c(Cl)c(Cl)ccc2)c1	InChI=1S/C11H10Cl2N4/c1-15-9-5-8(16-11(14)17-9)6-3-2-4-7(12)10(6)13/h2-5H,1H3,(H3,14,15,16,17)	URWCXPXBBITYLR-UHFFFAOYSA-N					compound annotation
0391_002719	303727-31-3	C20H14ClN3O	2.4951	9950176		Oc1c(Cl)ccc(-c2c(-c3ccncc3)[nH]c(-c3ccccc3)n2)c1	InChI=1S/C20H14ClN3O/c21-16-7-6-15(12-17(16)25)19-18(13-8-10-22-11-9-13)23-20(24-19)14-4-2-1-3-5-14/h1-12,25H,(H,23,24)	WXJLXRNWMLWVFB-UHFFFAOYSA-N					doublet; compound annotation
0391_002720	PRN1371	C26H30Cl2N6O4	2.6553	118295624		C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1	InChI=1S/C26H30Cl2N6O4/c1-5-20(35)33-11-9-32(10-12-33)7-6-8-34-24-16(15-30-26(29-2)31-24)13-17(25(34)36)21-22(27)18(37-3)14-19(38-4)23(21)28/h5,13-15H,1,6-12H2,2-4H3,(H,29,30,31)	PUIXMSRTTHLNKI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002722	303727-31-3	C20H14ClN3O	2.9203	9950176		Oc1c(Cl)ccc(-c2c(-c3ccncc3)[nH]c(-c3ccccc3)n2)c1	InChI=1S/C20H14ClN3O/c21-16-7-6-15(12-17(16)25)19-18(13-8-10-22-11-9-13)23-20(24-19)14-4-2-1-3-5-14/h1-12,25H,(H,23,24)	WXJLXRNWMLWVFB-UHFFFAOYSA-N					doublet; compound annotation
0391_002723	AZD3965	C21H24F3N5O5S	3.0381	10369242	CC1=C(C(=NN1)C(F)(F)F)CC2=C(C3=C(S2)N(C(=O)N(C3=O)C)C(C)C)C(=O)N4C[C@](CO4)(C)O	Cc1c(Cc2c(C(=O)N3CC(C)(O)CO3)c3c(s2)n(C(C)C)c(=O)n(C)c3=O)c(C(F)(F)F)n[nH]1	InChI=1S/C21H24F3N5O5S/c1-9(2)29-18-14(16(30)27(5)19(29)32)13(17(31)28-7-20(4,33)8-34-28)12(35-18)6-11-10(3)25-26-15(11)21(22,23)24/h9,33H,6-8H2,1-5H3,(H,25,26)/t20-/m0/s1	PRNXOFBDXNTIFG-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_002725	Sortin1	C26H19NO6	3.3307	2888976		COC(=O)C1=C(C)NC2=C(C(=O)c3ccccc23)C1c1ccc(-c2ccc(C(=O)O)cc2)o1	InChI=1S/C26H19NO6/c1-13-20(26(31)32-2)21(22-23(27-13)16-5-3-4-6-17(16)24(22)28)19-12-11-18(33-19)14-7-9-15(10-8-14)25(29)30/h3-12,21,27H,1-2H3,(H,29,30)	QKEXVHYWWUXESV-UHFFFAOYSA-N					doublet; compound annotation
0391_002726	4-Hydroxytamoxifen	C26H29NO2	3.5627	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_002727	4-Hydroxytamoxifen	C26H29NO2	3.6262	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_002728	Sortin1	C26H19NO6	3.7761	2888976		COC(=O)C1=C(C)NC2=C(C(=O)c3ccccc23)C1c1ccc(-c2ccc(C(=O)O)cc2)o1	InChI=1S/C26H19NO6/c1-13-20(26(31)32-2)21(22-23(27-13)16-5-3-4-6-17(16)24(22)28)19-12-11-18(33-19)14-7-9-15(10-8-14)25(29)30/h3-12,21,27H,1-2H3,(H,29,30)	QKEXVHYWWUXESV-UHFFFAOYSA-N					doublet; compound annotation
0391_002729	4-Hydroxytamoxifen	C26H29NO2	3.8418	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_002730	IRAK inhibitor 6	C20H20N4O3S	2.0841	44449392		COc1c(NC(=O)c2csc(-c3cnccc3)n2)ccc(N2CCOCC2)c1	InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25)	JQSRUVXPODZKAF-UHFFFAOYSA-N					doublet; compound annotation
0391_002731	IRAK inhibitor 3	C21H21N5O4S	2.1218	25103689		COc1c(OC)cc(-c2cnc3ccc(NCc4ccc(S(N)(=O)=O)cc4)nn23)cc1	InChI=1S/C21H21N5O4S/c1-29-18-8-5-15(11-19(18)30-2)17-13-24-21-10-9-20(25-26(17)21)23-12-14-3-6-16(7-4-14)31(22,27)28/h3-11,13H,12H2,1-2H3,(H,23,25)(H2,22,27,28)	UPFVAHVWLNBVSG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002734	SBI-425	C13H12ClN3O4S	2.4269	89768286		COc1c(S(=O)(=O)Nc2cncc(C(N)=O)c2)cc(Cl)cc1	InChI=1S/C13H12ClN3O4S/c1-21-11-3-2-9(14)5-12(11)22(19,20)17-10-4-8(13(15)18)6-16-7-10/h2-7,17H,1H3,(H2,15,18)	SBAITEDLNTYIOE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002736	Tesevatinib	C24H25Cl2FN4O2	2.5588	10458325	CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC	COc1c(OCC2CC3CN(C)CC3C2)cc2ncnc(Nc3c(F)c(Cl)c(Cl)cc3)c2c1	InChI=1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+	HVXKQKFEHMGHSL-GOOCMWNKSA-N					compound annotation
0391_002737	IRAK inhibitor 6	C20H20N4O3S	3.1873	44449392		COc1c(NC(=O)c2csc(-c3cnccc3)n2)ccc(N2CCOCC2)c1	InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25)	JQSRUVXPODZKAF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002739	IRAK inhibitor 6	C20H20N4O3S	3.1906	44449392		COc1c(NC(=O)c2csc(-c3cnccc3)n2)ccc(N2CCOCC2)c1	InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25)	JQSRUVXPODZKAF-UHFFFAOYSA-N					doublet; compound annotation
0391_002740	Z-DEVD-FMK	C30H41FN4O12	3.1906	16760394	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CCC(=O)OC)NC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1	COC(=O)CCC(NC(=O)C(CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CC(=O)OC)C(=O)CF)C(C)C	InChI=1S/C30H41FN4O12/c1-17(2)26(29(42)33-20(22(36)15-31)13-24(38)45-4)35-27(40)19(11-12-23(37)44-3)32-28(41)21(14-25(39)46-5)34-30(43)47-16-18-9-7-6-8-10-18/h6-10,17,19-21,26H,11-16H2,1-5H3,(H,32,41)(H,33,42)(H,34,43)(H,35,40)/t19-,20-,21-,26-/m0/s1	GBJVAVGBSGRRKN-JYEBCORGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002742	Z-DEVD-FMK	C30H41FN4O12	3.6281	16760394	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CCC(=O)OC)NC(=O)[C@H](CC(=O)OC)NC(=O)OCC1=CC=CC=C1	COC(=O)CCC(NC(=O)C(CC(=O)OC)NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NC(CC(=O)OC)C(=O)CF)C(C)C	InChI=1S/C30H41FN4O12/c1-17(2)26(29(42)33-20(22(36)15-31)13-24(38)45-4)35-27(40)19(11-12-23(37)44-3)32-28(41)21(14-25(39)46-5)34-30(43)47-16-18-9-7-6-8-10-18/h6-10,17,19-21,26H,11-16H2,1-5H3,(H,32,41)(H,33,42)(H,34,43)(H,35,40)/t19-,20-,21-,26-/m0/s1	GBJVAVGBSGRRKN-JYEBCORGSA-N					doublet; removed another duplicate entry; compound annotation
0391_002744	MF63	C23H11ClN4	4.6298	16070041		N#Cc1cccc(C#N)c1-c1nc2c([nH]1)c1c(cc(Cl)cc1)c1ccccc12	InChI=1S/C23H11ClN4/c24-15-8-9-18-19(10-15)16-6-1-2-7-17(16)21-22(18)28-23(27-21)20-13(11-25)4-3-5-14(20)12-26/h1-10H,(H,27,28)	BVFLHOOKHPFDCT-UHFFFAOYSA-N					doublet; compound annotation
0391_002745	MF63	C23H11ClN4	4.633	16070041		N#Cc1cccc(C#N)c1-c1nc2c([nH]1)c1c(cc(Cl)cc1)c1ccccc12	InChI=1S/C23H11ClN4/c24-15-8-9-18-19(10-15)16-6-1-2-7-17(16)21-22(18)28-23(27-21)20-13(11-25)4-3-5-14(20)12-26/h1-10H,(H,27,28)	BVFLHOOKHPFDCT-UHFFFAOYSA-N					doublet; compound annotation
0391_002746	BL-918	C23H15F8N3OS	5.3924	146014432	C1=CC=C(C=C1)[C@H](C(=O)NC2=C(C=C(C=C2)F)F)NC(=S)NC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F	O=C(Nc1c(F)cc(F)cc1)C(NC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1	InChI=1S/C23H15F8N3OS/c24-15-6-7-18(17(25)11-15)33-20(35)19(12-4-2-1-3-5-12)34-21(36)32-16-9-13(22(26,27)28)8-14(10-16)23(29,30)31/h1-11,19H,(H,33,35)(H2,32,34,36)/t19-/m1/s1	BDBWQANRZRCMMD-LJQANCHMSA-N					compound annotation
0391_002747	(Rac)-BL-918	C23H15F8N3OS	5.3924	138377593		O=C(Nc1c(F)cc(F)cc1)C(NC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1	InChI=1S/C23H15F8N3OS/c24-15-6-7-18(17(25)11-15)33-20(35)19(12-4-2-1-3-5-12)34-21(36)32-16-9-13(22(26,27)28)8-14(10-16)23(29,30)31/h1-11,19H,(H,33,35)(H2,32,34,36)	BDBWQANRZRCMMD-UHFFFAOYSA-N					compound annotation
0391_002748	100874-08-6	C14H10BrNOS	5.4699	731364		Brc1ccc(CSc2nc3ccccc3o2)cc1	InChI=1S/C14H10BrNOS/c15-11-7-5-10(6-8-11)9-18-14-16-12-3-1-2-4-13(12)17-14/h1-8H,9H2	JDVOIBFEFVKUPL-UHFFFAOYSA-N					compound annotation
0391_002749	53527-42-7	C21H18O12	2.2156	10253785	C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O	O=C(O)C1OC(Oc2c(O)ccc(-c3cc(=O)c4c(O)cc(O)cc4o3)c2)C(O)C(O)C1O	InChI=1S/C21H18O12/c22-8-4-10(24)15-11(25)6-12(31-14(15)5-8)7-1-2-9(23)13(3-7)32-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6,16-19,21-24,26-28H,(H,29,30)/t16-,17-,18+,19-,21+/m0/s1	JDOFZOKGCYYUER-ZFORQUDYSA-N					removed another duplicate entry; compound annotation
0391_002751	Alicapistat	C25H27N3O4	2.7924	67095330	C1CC(=O)N([C@H]1C(=O)NC(CC2=CC=CC=C2)C(=O)C(=O)NC3CC3)CC4=CC=CC=C4	O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)C1CCC(=O)N1Cc1ccccc1	InChI=1S/C25H27N3O4/c29-22-14-13-21(28(22)16-18-9-5-2-6-10-18)24(31)27-20(15-17-7-3-1-4-8-17)23(30)25(32)26-19-11-12-19/h1-10,19-21H,11-16H2,(H,26,32)(H,27,31)/t20?,21-/m1/s1	MMLDHJRGTZHNHV-BPGUCPLFSA-N					doublet; compound annotation
0391_002752	Alicapistat	C25H27N3O4	3.1946	67095330	C1CC(=O)N([C@H]1C(=O)NC(CC2=CC=CC=C2)C(=O)C(=O)NC3CC3)CC4=CC=CC=C4	O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)C1CCC(=O)N1Cc1ccccc1	InChI=1S/C25H27N3O4/c29-22-14-13-21(28(22)16-18-9-5-2-6-10-18)24(31)27-20(15-17-7-3-1-4-8-17)23(30)25(32)26-19-11-12-19/h1-10,19-21H,11-16H2,(H,26,32)(H,27,31)/t20?,21-/m1/s1	MMLDHJRGTZHNHV-BPGUCPLFSA-N					doublet; compound annotation
0391_002753	Alicapistat	C25H27N3O4	3.3889	67095330	C1CC(=O)N([C@H]1C(=O)NC(CC2=CC=CC=C2)C(=O)C(=O)NC3CC3)CC4=CC=CC=C4	O=C(NC1CC1)C(=O)C(Cc1ccccc1)NC(=O)C1CCC(=O)N1Cc1ccccc1	InChI=1S/C25H27N3O4/c29-22-14-13-21(28(22)16-18-9-5-2-6-10-18)24(31)27-20(15-17-7-3-1-4-8-17)23(30)25(32)26-19-11-12-19/h1-10,19-21H,11-16H2,(H,26,32)(H,27,31)/t20?,21-/m1/s1	MMLDHJRGTZHNHV-BPGUCPLFSA-N					doublet; removed another duplicate entry; compound annotation
0391_002755	AS-252424	C14H8FNO4S	3.5198	11630874	C1=CC(=C(C=C1F)O)C2=CC=C(O2)/C=C\3/C(=O)NC(=O)S3	O=C1NC(=O)C(=Cc2ccc(-c3c(O)cc(F)cc3)o2)S1	InChI=1S/C14H8FNO4S/c15-7-1-3-9(10(17)5-7)11-4-2-8(20-11)6-12-13(18)16-14(19)21-12/h1-6,17H,(H,16,18,19)/b12-6-	OYYVWNDMOQPMGE-SDQBBNPISA-N					removed another duplicate entry; compound annotation
0391_002757	289483-69-8	C17H12N4O2S	3.5641	196970		Cc1c2c(C#N)c[nH]c2c(NS(=O)(=O)c2cccc(C#N)c2)cc1	InChI=1S/C17H12N4O2S/c1-11-5-6-15(17-16(11)13(9-19)10-20-17)21-24(22,23)14-4-2-3-12(7-14)8-18/h2-7,10,20-21H,1H3	LWGUASZLXHYWIV-UHFFFAOYSA-N					compound annotation
0391_002758	MC180295	C17H18N4O3S	4.0045	137333456	C1C[C@H]2C[C@@H]1C[C@@H]2NC3=NC(=C(S3)C(=O)C4=CC=CC=C4[N+](=O)[O-])N	Nc1c(C(=O)c2ccccc2[N+](=O)[O-])sc(NC2CC3CCC2C3)n1	InChI=1S/C17H18N4O3S/c18-16-15(14(22)11-3-1-2-4-13(11)21(23)24)25-17(20-16)19-12-8-9-5-6-10(12)7-9/h1-4,9-10,12H,5-8,18H2,(H,19,20)/t9-,10+,12+/m1/s1	JRNXAQINDCOHGS-SCVCMEIPSA-N					removed another duplicate entry; compound annotation
0391_002760	hDHODH-IN-3	C18H19BrN4O2	5.2723	118430627		CCOc1nn(-c2ncc(CC)cn2)c(C)c1Oc1ccccc1Br	InChI=1S/C18H19BrN4O2/c1-4-13-10-20-18(21-11-13)23-12(3)16(17(22-23)24-5-2)25-15-9-7-6-8-14(15)19/h6-11H,4-5H2,1-3H3	SNDPFEDGFPXNIX-UHFFFAOYSA-N					doublet; compound annotation
0391_002761	hDHODH-IN-3	C18H19BrN4O2	5.2762	118430627		CCOc1nn(-c2ncc(CC)cn2)c(C)c1Oc1ccccc1Br	InChI=1S/C18H19BrN4O2/c1-4-13-10-20-18(21-11-13)23-12(3)16(17(22-23)24-5-2)25-15-9-7-6-8-14(15)19/h6-11H,4-5H2,1-3H3	SNDPFEDGFPXNIX-UHFFFAOYSA-N					doublet; compound annotation
0391_002762	K-80003	C22H21FO2	5.5669	46224594	CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)C(C)C)C=CC(=C2)F)CC(=O)O	CC1=C(CC(=O)O)c2c(ccc(F)c2)C1=Cc1ccc(C(C)C)cc1	InChI=1S/C22H21FO2/c1-13(2)16-6-4-15(5-7-16)10-19-14(3)20(12-22(24)25)21-11-17(23)8-9-18(19)21/h4-11,13H,12H2,1-3H3,(H,24,25)/b19-10-	QCXBVGNDRYQVJO-GRSHGNNSSA-N					compound annotation
0391_002763	CHR-6494	C16H16N6	1.1315	70679308		CCCNc1nn2c(-c3cc4c(cc3)[nH]nc4)cnc2cc1	InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)	CZZCAOGIEGXMBZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002764	ETP-46321	C20H27N9O3S	1.5633	46927938		CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1	InChI=1S/C20H27N9O3S/c1-33(30,31)29-4-2-26(3-5-29)12-16-13-28-14-17(15-10-22-20(21)23-11-15)25-19(18(28)24-16)27-6-8-32-9-7-27/h10-11,13-14H,2-9,12H2,1H3,(H2,21,22,23)	OHKDVDMWRKFZRB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002766	Dacinostat	C22H25N3O3	1.6791	6445533	C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)/C=C/C(=O)NO	O=C(C=Cc1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO	InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+	BWDQBBCUWLSASG-MDZDMXLPSA-N					doublet; compound annotation
0391_002767	Dacinostat	C22H25N3O3	1.6821	6445533	C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)/C=C/C(=O)NO	O=C(C=Cc1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1)NO	InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+	BWDQBBCUWLSASG-MDZDMXLPSA-N					doublet; compound annotation
0391_002768	CHR-6494	C16H16N6	2.1128	70679308		CCCNc1nn2c(-c3cc4c(cc3)[nH]nc4)cnc2cc1	InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)	CZZCAOGIEGXMBZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002769	CHR-6494	C16H16N6	2.116	70679308		CCCNc1nn2c(-c3cc4c(cc3)[nH]nc4)cnc2cc1	InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)	CZZCAOGIEGXMBZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002770	Ro3280	C27H35F2N7O3	2.6769	25015677		COc1c(Nc2ncc3c(n2)N(C2CCCC2)CC(F)(F)C(=O)N3C)ccc(C(=O)NC2CCN(C)CC2)c1	InChI=1S/C27H35F2N7O3/c1-34-12-10-18(11-13-34)31-24(37)17-8-9-20(22(14-17)39-3)32-26-30-15-21-23(33-26)36(19-6-4-5-7-19)16-27(28,29)25(38)35(21)2/h8-9,14-15,18-19H,4-7,10-13,16H2,1-3H3,(H,31,37)(H,30,32,33)	DJNZZLZKAXGMMC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002772	CHR-6494	C16H16N6	2.7207	70679308		CCCNc1nn2c(-c3cc4c(cc3)[nH]nc4)cnc2cc1	InChI=1S/C16H16N6/c1-2-7-17-15-5-6-16-18-10-14(22(16)21-15)11-3-4-13-12(8-11)9-19-20-13/h3-6,8-10H,2,7H2,1H3,(H,17,21)(H,19,20)	CZZCAOGIEGXMBZ-UHFFFAOYSA-N					doublet; compound annotation
0391_002773	Selitrectinib	C20H21FN6O	2.8012	129103609	C[C@@H]1CCC2=C(C=C(C=N2)F)[C@H]3CCCN3C4=NC5=C(C=NN5C=C4)C(=O)N1	CC1CCc2c(cc(F)cn2)C2CCCN2c2nc3c(cnn3cc2)C(=O)N1	InChI=1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1	OEBIHOVSAMBXIB-SJKOYZFVSA-N					doublet; removed another duplicate entry; compound annotation
0391_002775	Selitrectinib	C20H21FN6O	2.9953	129103609	C[C@@H]1CCC2=C(C=C(C=N2)F)[C@H]3CCCN3C4=NC5=C(C=NN5C=C4)C(=O)N1	CC1CCc2c(cc(F)cn2)C2CCCN2c2nc3c(cnn3cc2)C(=O)N1	InChI=1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1	OEBIHOVSAMBXIB-SJKOYZFVSA-N					doublet; compound annotation
0391_002776	Opc 21268	C26H31N3O4	3.2072	114904		CC(=O)NCCCOc1ccc(C(=O)N2CCC(N3C(=O)CCc4ccccc43)CC2)cc1	InChI=1S/C26H31N3O4/c1-19(30)27-15-4-18-33-23-10-7-21(8-11-23)26(32)28-16-13-22(14-17-28)29-24-6-3-2-5-20(24)9-12-25(29)31/h2-3,5-8,10-11,22H,4,9,12-18H2,1H3,(H,27,30)	KSNUCNRMDYJBKT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002778	Ro3280	C27H35F2N7O3	3.3834	25015677		COc1c(Nc2ncc3c(n2)N(C2CCCC2)CC(F)(F)C(=O)N3C)ccc(C(=O)NC2CCN(C)CC2)c1	InChI=1S/C27H35F2N7O3/c1-34-12-10-18(11-13-34)31-24(37)17-8-9-20(22(14-17)39-3)32-26-30-15-21-23(33-26)36(19-6-4-5-7-19)16-27(28,29)25(38)35(21)2/h8-9,14-15,18-19H,4-7,10-13,16H2,1-3H3,(H,31,37)(H,30,32,33)	DJNZZLZKAXGMMC-UHFFFAOYSA-N					doublet; compound annotation
0391_002779	sjb2-043	C17H9NO3	4.3497	509070		O=C1c2ccccc2C(=O)c2c1nc(-c1ccccc1)o2	InChI=1S/C17H9NO3/c19-14-11-8-4-5-9-12(11)15(20)16-13(14)18-17(21-16)10-6-2-1-3-7-10/h1-9H	CMYQQADDUUDCCA-UHFFFAOYSA-N					compound annotation
0391_002780	Roblitinib	C25H30N8O4	1.6587	118036971		COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N	InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36)	BHKDKKZMPODMIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002781	Banoxantrone	C22H28N4O6	1.8827	9955116		C[N+](C)([O-])CCNc1c2C(=O)c3c(O)ccc(O)c3C(=O)c2c(NCC[N+](C)(C)[O-])cc1	InChI=1S/C22H28N4O6/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30/h5-8,23-24,27-28H,9-12H2,1-4H3	YZBAXVICWUUHGG-UHFFFAOYSA-N					compound annotation
0391_002782	hVEGF-IN-1	C34H43N7O2	1.8904	131704486		CCN(CC)CCOc1ccc(Nc2nc(-c3ccccc3NC(=O)CCN3CCN(C)CC3)nc3ccccc23)cc1	InChI=1S/C34H43N7O2/c1-4-40(5-2)24-25-43-27-16-14-26(15-17-27)35-33-29-11-7-9-13-31(29)37-34(38-33)28-10-6-8-12-30(28)36-32(42)18-19-41-22-20-39(3)21-23-41/h6-17H,4-5,18-25H2,1-3H3,(H,36,42)(H,35,37,38)	VIBJAHJNWHZSJP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002784	Roblitinib	C25H30N8O4	1.9769	118036971		COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N	InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36)	BHKDKKZMPODMIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002785	TLK117	C23H27N3O6S	2.6895	444051	C1=CC=C(C=C1)CSC[C@@H](C(=O)N[C@H](C2=CC=CC=C2)C(=O)O)NC(=O)CC[C@@H](C(=O)O)N	NC(CCC(=O)NC(CSCc1ccccc1)C(=O)NC(C(=O)O)c1ccccc1)C(=O)O	InChI=1S/C23H27N3O6S/c24-17(22(29)30)11-12-19(27)25-18(14-33-13-15-7-3-1-4-8-15)21(28)26-20(23(31)32)16-9-5-2-6-10-16/h1-10,17-18,20H,11-14,24H2,(H,25,27)(H,26,28)(H,29,30)(H,31,32)/t17-,18-,20+/m0/s1	ZPSKWMFLCHMEOY-CMKODMSKSA-N					removed another duplicate entry; compound annotation
0391_002787	PP121	C17H17N7	2.7259	24905142		Nc1c2c(-c3cnc4[nH]ccc4c3)nn(C3CCCC3)c2ncn1	InChI=1S/C17H17N7/c18-15-13-14(11-7-10-5-6-19-16(10)20-8-11)23-24(12-3-1-2-4-12)17(13)22-9-21-15/h5-9,12H,1-4H2,(H,19,20)(H2,18,21,22)	NVRXTLZYXZNATH-UHFFFAOYSA-N					compound annotation
0391_002788	hVEGF-IN-1	C34H43N7O2	2.7259	131704486		CCN(CC)CCOc1ccc(Nc2nc(-c3ccccc3NC(=O)CCN3CCN(C)CC3)nc3ccccc23)cc1	InChI=1S/C34H43N7O2/c1-4-40(5-2)24-25-43-27-16-14-26(15-17-27)35-33-29-11-7-9-13-31(29)37-34(38-33)28-10-6-8-12-30(28)36-32(42)18-19-41-22-20-39(3)21-23-41/h6-17H,4-5,18-25H2,1-3H3,(H,36,42)(H,35,37,38)	VIBJAHJNWHZSJP-UHFFFAOYSA-N					doublet; compound annotation
0391_002789	Necrostatin 2 racemate	C13H12ClN3O2	2.8005	643953		CN1C(=O)NC(Cc2c[nH]c3c2cccc3Cl)C1=O	InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)	WIKGAEMMNQTUGL-UHFFFAOYSA-N					compound annotation
0391_002790	finasteride	C23H36N2O2	3.7522	57363	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C	CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C	InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1	DBEPLOCGEIEOCV-WSBQPABSSA-N					removed another duplicate entry; compound annotation
0391_002792	1809885-32-2	C18H23F4N3O3	4.1572	91933845	CC[C@H](C)C(=O)N1CCC(CC1)NC(=O)NC2=CC(=C(C=C2)OC(F)(F)F)F	CCC(C)C(=O)N1CCC(NC(=O)Nc2cc(F)c(OC(F)(F)F)cc2)CC1	InChI=1S/C18H23F4N3O3/c1-3-11(2)16(26)25-8-6-12(7-9-25)23-17(27)24-13-4-5-15(14(19)10-13)28-18(20,21)22/h4-5,10-12H,3,6-9H2,1-2H3,(H2,23,24,27)/t11-/m0/s1	LHRXHTKENPCGSZ-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002794	Odanacatib	C25H27F4N3O3S	4.1861	10152654	CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F	CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1	InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1	FWIVDMJALNEADT-SFTDATJTSA-N					doublet; compound annotation
0391_002795	Odanacatib	C25H27F4N3O3S	4.1894	10152654	CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F	CC(C)(F)CC(NC(c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1	InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1	FWIVDMJALNEADT-SFTDATJTSA-N					doublet; compound annotation
0391_002796	141400-58-0	C7H12N2S2	1.4365	219104		CCC(C)SSc1ncc[nH]1	InChI=1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9)	BPBPYQWMFCTCNG-UHFFFAOYSA-N					compound annotation
0391_002797	Vatalanib	C20H15ClN4	1.5106	151194		Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	YCOYDOIWSSHVCK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002799	Facinicline	C15H18N4O	1.5296	9970357	C1CN2CCC1[C@@H](C2)NC(=O)C3=NNC4=CC=CC=C43	O=C(NC1CN2CCC1CC2)c1n[nH]c2ccccc12	InChI=1S/C15H18N4O/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18)/t13-/m1/s1	TXCYUSKWBHUVEP-CYBMUJFWSA-N					doublet; compound annotation
0391_002800	Facinicline	C15H18N4O	1.5325	9970357	C1CN2CCC1[C@@H](C2)NC(=O)C3=NNC4=CC=CC=C43	O=C(NC1CN2CCC1CC2)c1n[nH]c2ccccc12	InChI=1S/C15H18N4O/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18)/t13-/m1/s1	TXCYUSKWBHUVEP-CYBMUJFWSA-N					doublet; compound annotation
0391_002801	ellipticine	C17H14N2	2.4654	3213		Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12	InChI=1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3	CTSPAMFJBXKSOY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002803	Vatalanib	C20H15ClN4	2.487	151194		Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)	YCOYDOIWSSHVCK-UHFFFAOYSA-N					doublet; compound annotation
0391_002804	LY2828360	C22H27ClN6O	2.6693	46833780		Cc1nc2c(nc(-c3ccccc3Cl)n2C2CCOCC2)c(N2CCN(C)CC2)n1	InChI=1S/C22H27ClN6O/c1-15-24-21(28-11-9-27(2)10-12-28)19-22(25-15)29(16-7-13-30-14-8-16)20(26-19)17-5-3-4-6-18(17)23/h3-6,16H,7-14H2,1-2H3	UCMNDPDJRSEZPL-UHFFFAOYSA-N					compound annotation
0391_002805	196868-63-0	C18H16ClN3O2	3.1467	9549305		COc1c(NC(=O)Nc2cc(C)nc3ccccc23)cc(Cl)cc1	InChI=1S/C18H16ClN3O2/c1-11-9-15(13-5-3-4-6-14(13)20-11)21-18(23)22-16-10-12(19)7-8-17(16)24-2/h3-10H,1-2H3,(H2,20,21,22,23)	YBLWOZUPHDKFOT-UHFFFAOYSA-N					compound annotation
0391_002806	QNZ46	C24H17N3O6	3.886	46861929	COC1=CC2=C(C=C1)N=C(N(C2=O)C3=CC=C(C=C3)C(=O)O)/C=C/C4=CC(=CC=C4)[N+](=O)[O-]	COc1cc2c(cc1)nc(C=Cc1cc([N+](=O)[O-])ccc1)n(-c1ccc(C(=O)O)cc1)c2=O	InChI=1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14H,1H3,(H,29,30)/b12-5+	GNLVJIICVWDSNI-LFYBBSHMSA-N					doublet; compound annotation
0391_002807	QNZ46	C24H17N3O6	4.2213	46861929	COC1=CC2=C(C=C1)N=C(N(C2=O)C3=CC=C(C=C3)C(=O)O)/C=C/C4=CC(=CC=C4)[N+](=O)[O-]	COc1cc2c(cc1)nc(C=Cc1cc([N+](=O)[O-])ccc1)n(-c1ccc(C(=O)O)cc1)c2=O	InChI=1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14H,1H3,(H,29,30)/b12-5+	GNLVJIICVWDSNI-LFYBBSHMSA-N					doublet; compound annotation
0391_002808	AZD5363	C21H25ClN6O2	1.699	25227436	C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4	NC1(C(=O)NC(CCO)c2ccc(Cl)cc2)CCN(c2ncnc3c2cc[nH]3)CC1	InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1	JDUBGYFRJFOXQC-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_002810	Riociguat	C20H19FN8O2	2.7014	11304743		COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3c2cccn3)nc1N	InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26)	WXXSNCNJFUAIDG-UHFFFAOYSA-N					doublet; compound annotation
0391_002811	Riociguat	C20H19FN8O2	2.7046	11304743		COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3c2cccn3)nc1N	InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26)	WXXSNCNJFUAIDG-UHFFFAOYSA-N					doublet; compound annotation
0391_002812	CCT241533	C23H27FN4O4	2.7686	135564841	CC(C)([C@@H]1CNC[C@H]1NC2=NC(=NC3=CC(=C(C=C32)OC)OC)C4=C(C=CC(=C4)F)O)O	COc1c(OC)cc2c(NC3CNCC3C(C)(C)O)nc(-c3c(O)ccc(F)c3)nc2c1	InChI=1S/C23H27FN4O4/c1-23(2,30)15-10-25-11-17(15)27-21-13-8-19(31-3)20(32-4)9-16(13)26-22(28-21)14-7-12(24)5-6-18(14)29/h5-9,15,17,25,29-30H,10-11H2,1-4H3,(H,26,27,28)/t15-,17-/m1/s1	HZASIAXCPXTISQ-NVXWUHKLSA-N					doublet; removed another duplicate entry; compound annotation
0391_002814	CCT241533	C23H27FN4O4	2.7714	135564841	CC(C)([C@@H]1CNC[C@H]1NC2=NC(=NC3=CC(=C(C=C32)OC)OC)C4=C(C=CC(=C4)F)O)O	COc1c(OC)cc2c(NC3CNCC3C(C)(C)O)nc(-c3c(O)ccc(F)c3)nc2c1	InChI=1S/C23H27FN4O4/c1-23(2,30)15-10-25-11-17(15)27-21-13-8-19(31-3)20(32-4)9-16(13)26-22(28-21)14-7-12(24)5-6-18(14)29/h5-9,15,17,25,29-30H,10-11H2,1-4H3,(H,26,27,28)/t15-,17-/m1/s1	HZASIAXCPXTISQ-NVXWUHKLSA-N					doublet; compound annotation
0391_002815	Monomethyl auristatin E	C39H67N5O7	2.8825	11542188	CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC	CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C)C(O)c1ccccc1)OC)N(C)C(=O)C(NC(=O)C(NC)C(C)C)C(C)C	InChI=1S/C39H67N5O7/c1-13-25(6)34(43(10)39(49)33(24(4)5)42-38(48)32(40-9)23(2)3)30(50-11)22-31(45)44-21-17-20-29(44)36(51-12)26(7)37(47)41-27(8)35(46)28-18-15-14-16-19-28/h14-16,18-19,23-27,29-30,32-36,40,46H,13,17,20-22H2,1-12H3,(H,41,47)(H,42,48)/t25-,26+,27+,29-,30+,32-,33-,34-,35+,36+/m0/s1	DASWEROEPLKSEI-UIJRFTGLSA-N					removed another duplicate entry; compound annotation
0391_002817	Firocoxib	C17H20O5S	3.6694	208910		CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(S(C)(=O)=O)cc1	InChI=1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3	FULAPETWGIGNMT-UHFFFAOYSA-N					compound annotation
0391_002818	(+)-JQ1 PA	C22H20ClN5OS	3.7612	134821687	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCC#C)C4=CC=C(C=C4)Cl)C	C#CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc12	InChI=1S/C22H20ClN5OS/c1-5-10-24-18(29)11-17-21-27-26-14(4)28(21)22-19(12(2)13(3)30-22)20(25-17)15-6-8-16(23)9-7-15/h1,6-9,17H,10-11H2,2-4H3,(H,24,29)/t17-/m0/s1	ZLSCJWMPQYKVKU-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_002820	Lomitapide	C39H37F6N3O2	4.1212	9853053		O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1	InChI=1S/C39H37F6N3O2/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49)	MBBCVAKAJPKAKM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002822	Apoptozole	C33H25F6N3O3	4.7411	24894064		COc1ccc(-c2c(-c3ccc(OC)cc3)n(Cc3ccc(C(N)=O)cc3)c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)cc1	InChI=1S/C33H25F6N3O3/c1-44-26-11-7-20(8-12-26)28-29(21-9-13-27(45-2)14-10-21)42(18-19-3-5-22(6-4-19)30(40)43)31(41-28)23-15-24(32(34,35)36)17-25(16-23)33(37,38)39/h3-17H,18H2,1-2H3,(H2,40,43)	ZIMMTPFXOMAJTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002823	Apoptozole	C33H25F6N3O3	4.785	24894064		COc1ccc(-c2c(-c3ccc(OC)cc3)n(Cc3ccc(C(N)=O)cc3)c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)cc1	InChI=1S/C33H25F6N3O3/c1-44-26-11-7-20(8-12-26)28-29(21-9-13-27(45-2)14-10-21)42(18-19-3-5-22(6-4-19)30(40)43)31(41-28)23-15-24(32(34,35)36)17-25(16-23)33(37,38)39/h3-17H,18H2,1-2H3,(H2,40,43)	ZIMMTPFXOMAJTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002824	Apoptozole	C33H25F6N3O3	4.7985	24894064		COc1ccc(-c2c(-c3ccc(OC)cc3)n(Cc3ccc(C(N)=O)cc3)c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)cc1	InChI=1S/C33H25F6N3O3/c1-44-26-11-7-20(8-12-26)28-29(21-9-13-27(45-2)14-10-21)42(18-19-3-5-22(6-4-19)30(40)43)31(41-28)23-15-24(32(34,35)36)17-25(16-23)33(37,38)39/h3-17H,18H2,1-2H3,(H2,40,43)	ZIMMTPFXOMAJTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002825	Zuranolone	C25H35N3O2	4.8733	86294073	C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O	CC1(O)CCC2C(CCC3C2CCC2(C)C(C(=O)Cn4cc(C#N)cn4)CCC32)C1	InChI=1S/C25H35N3O2/c1-24(30)9-7-18-17(11-24)3-4-20-19(18)8-10-25(2)21(20)5-6-22(25)23(29)15-28-14-16(12-26)13-27-28/h13-14,17-22,30H,3-11,15H2,1-2H3/t17-,18+,19-,20-,21+,22-,24-,25+/m1/s1	HARRKNSQXBRBGZ-GVKWWOCJSA-N					compound annotation
0391_002826	Apoptozole	C33H25F6N3O3	5.4349	24894064		COc1ccc(-c2c(-c3ccc(OC)cc3)n(Cc3ccc(C(N)=O)cc3)c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)cc1	InChI=1S/C33H25F6N3O3/c1-44-26-11-7-20(8-12-26)28-29(21-9-13-27(45-2)14-10-21)42(18-19-3-5-22(6-4-19)30(40)43)31(41-28)23-15-24(32(34,35)36)17-25(16-23)33(37,38)39/h3-17H,18H2,1-2H3,(H2,40,43)	ZIMMTPFXOMAJTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002827	Apoptozole	C33H25F6N3O3	5.6263	24894064		COc1ccc(-c2c(-c3ccc(OC)cc3)n(Cc3ccc(C(N)=O)cc3)c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)n2)cc1	InChI=1S/C33H25F6N3O3/c1-44-26-11-7-20(8-12-26)28-29(21-9-13-27(45-2)14-10-21)42(18-19-3-5-22(6-4-19)30(40)43)31(41-28)23-15-24(32(34,35)36)17-25(16-23)33(37,38)39/h3-17H,18H2,1-2H3,(H2,40,43)	ZIMMTPFXOMAJTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_002828	CC-401	C22H24N6O	1.9059	10430360		c1cc(-c2n[nH]c3c2cc(-c2ncn[nH]2)cc3)cc(OCCN2CCCCC2)c1	InChI=1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27)	XDJCLCLBSGGNKS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002830	UCB9608	C20H26N8O2	2.107	76282073	C[C@H]1CN(CCN1C2=NC(=NC3=C2C=NN3C)N)C(=O)NC4=C(C=C(C=C4)OC)C	COc1cc(C)c(NC(=O)N2CCN(c3nc(N)nc4c3cnn4C)C(C)C2)cc1	InChI=1S/C20H26N8O2/c1-12-9-14(30-4)5-6-16(12)23-20(29)27-7-8-28(13(2)11-27)18-15-10-22-26(3)17(15)24-19(21)25-18/h5-6,9-10,13H,7-8,11H2,1-4H3,(H,23,29)(H2,21,24,25)/t13-/m0/s1	WRONAJQPZWDYAR-ZDUSSCGKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002832	rosiptor	C20H35NO2	2.1298	76965484	C[C@@]1(CC[C@@H](C[C@@H]1CO)O)[C@H]2CC[C@]3([C@H]([C@@H]2CN)CCC3=C)C	C=C1CCC2C(CN)C(C3(C)CCC(O)CC3CO)CCC12C	InChI=1S/C20H35NO2/c1-13-4-5-17-16(11-21)18(7-9-19(13,17)2)20(3)8-6-15(23)10-14(20)12-22/h14-18,22-23H,1,4-12,21H2,2-3H3/t14-,15+,16+,17+,18+,19-,20+/m1/s1	MDEJTPWQNNMAQF-BVMLLJBZSA-N					compound annotation
0391_002833	PDGFRalpha kinase inhibitor 1	C34H34N8O2	2.1756	129318936		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cnccc3)cc2)cc1	InChI=1S/C34H34N8O2/c1-24-8-13-29(20-31(24)40-34-37-17-14-30(39-34)27-6-4-15-35-21-27)38-32(43)26-11-9-25(10-12-26)23-42(19-18-41(2)3)33(44)28-7-5-16-36-22-28/h4-17,20-22H,18-19,23H2,1-3H3,(H,38,43)(H,37,39,40)	NWVOHJOHQOHBMB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002835	UCB9608	C20H26N8O2	2.4096	76282073	C[C@H]1CN(CCN1C2=NC(=NC3=C2C=NN3C)N)C(=O)NC4=C(C=C(C=C4)OC)C	COc1cc(C)c(NC(=O)N2CCN(c3nc(N)nc4c3cnn4C)C(C)C2)cc1	InChI=1S/C20H26N8O2/c1-12-9-14(30-4)5-6-16(12)23-20(29)27-7-8-28(13(2)11-27)18-15-10-22-26(3)17(15)24-19(21)25-18/h5-6,9-10,13H,7-8,11H2,1-4H3,(H,23,29)(H2,21,24,25)/t13-/m0/s1	WRONAJQPZWDYAR-ZDUSSCGKSA-N					doublet; compound annotation
0391_002836	Taminadenant	C10H8BrN7	2.4556	53466958		Nc1c(Br)c(-n2cccn2)nc(-n2cccn2)n1	InChI=1S/C10H8BrN7/c11-7-8(12)15-10(18-6-2-4-14-18)16-9(7)17-5-1-3-13-17/h1-6H,(H2,12,15,16)	ATFXVNUWQOXRRU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002838	1644342-14-2	C21H23BrN6O5S	2.8732	86566743	C1[C@H](C[C@@H]([C@H]1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br	NS(=O)(=O)OCC1CC(Nc2ncncc2C(=O)c2nn(Cc3cc(Br)ccc3)cc2)CC1O	InChI=1S/C21H23BrN6O5S/c22-15-3-1-2-13(6-15)10-28-5-4-18(27-28)20(30)17-9-24-12-25-21(17)26-16-7-14(19(29)8-16)11-33-34(23,31)32/h1-6,9,12,14,16,19,29H,7-8,10-11H2,(H2,23,31,32)(H,24,25,26)/t14-,16-,19+/m1/s1	PZCKLTWSXFDLLP-OGWOLHLISA-N					doublet; compound annotation
0391_002839	1644342-14-2	C21H23BrN6O5S	2.9114	86566743	C1[C@H](C[C@@H]([C@H]1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br	NS(=O)(=O)OCC1CC(Nc2ncncc2C(=O)c2nn(Cc3cc(Br)ccc3)cc2)CC1O	InChI=1S/C21H23BrN6O5S/c22-15-3-1-2-13(6-15)10-28-5-4-18(27-28)20(30)17-9-24-12-25-21(17)26-16-7-14(19(29)8-16)11-33-34(23,31)32/h1-6,9,12,14,16,19,29H,7-8,10-11H2,(H2,23,31,32)(H,24,25,26)/t14-,16-,19+/m1/s1	PZCKLTWSXFDLLP-OGWOLHLISA-N					doublet; removed another duplicate entry; compound annotation
0391_002841	GLP-26	C19H17F2N3O3	3.552	130408536		C#CCNC(=O)C(=O)c1c(C)n(C)c(C(=O)Nc2cc(F)c(F)cc2)c1C	InChI=1S/C19H17F2N3O3/c1-5-8-22-19(27)17(25)15-10(2)16(24(4)11(15)3)18(26)23-12-6-7-13(20)14(21)9-12/h1,6-7,9H,8H2,2-4H3,(H,22,27)(H,23,26)	SQOFSIXYJGPNKV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002843	NGP555	C23H23FN4S	3.9249	46853593		CCc1cc(Nc2nc(-c3cc(F)c(-n4cnc(C)c4)cc3)cs2)c(C)cc1C	InChI=1S/C23H23FN4S/c1-5-17-10-20(15(3)8-14(17)2)26-23-27-21(12-29-23)18-6-7-22(19(24)9-18)28-11-16(4)25-13-28/h6-13H,5H2,1-4H3,(H,26,27)	WDEKUGNKKOGFOA-UHFFFAOYSA-N					doublet; compound annotation
0391_002844	GLP-26	C19H17F2N3O3	3.9739	130408536		C#CCNC(=O)C(=O)c1c(C)n(C)c(C(=O)Nc2cc(F)c(F)cc2)c1C	InChI=1S/C19H17F2N3O3/c1-5-8-22-19(27)17(25)15-10(2)16(24(4)11(15)3)18(26)23-12-6-7-13(20)14(21)9-12/h1,6-7,9H,8H2,2-4H3,(H,22,27)(H,23,26)	SQOFSIXYJGPNKV-UHFFFAOYSA-N					doublet; compound annotation
0391_002845	NGP555	C23H23FN4S	4.0784	46853593		CCc1cc(Nc2nc(-c3cc(F)c(-n4cnc(C)c4)cc3)cs2)c(C)cc1C	InChI=1S/C23H23FN4S/c1-5-17-10-20(15(3)8-14(17)2)26-23-27-21(12-29-23)18-6-7-22(19(24)9-18)28-11-16(4)25-13-28/h6-13H,5H2,1-4H3,(H,26,27)	WDEKUGNKKOGFOA-UHFFFAOYSA-N					doublet; compound annotation
0391_002846	Desisobutyrylciclesonide	C28H38O6	4.4528	6918281	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(O[C@@H](O4)C5CCCCC5)C(=O)CO)CCC6=CC(=O)C=C[C@]36C)O	CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CC1OC(C3CCCCC3)OC12C(=O)CO	InChI=1S/C28H38O6/c1-26-11-10-18(30)12-17(26)8-9-19-20-13-23-28(22(32)15-29,27(20,2)14-21(31)24(19)26)34-25(33-23)16-6-4-3-5-7-16/h10-12,16,19-21,23-25,29,31H,3-9,13-15H2,1-2H3/t19-,20-,21-,23+,24+,25+,26-,27-,28+/m0/s1	OXPLANUPKBHPMS-ZXBNPROVSA-N					removed another duplicate entry; compound annotation
0391_002848	NGP555	C23H23FN4S	4.7804	46853593		CCc1cc(Nc2nc(-c3cc(F)c(-n4cnc(C)c4)cc3)cs2)c(C)cc1C	InChI=1S/C23H23FN4S/c1-5-17-10-20(15(3)8-14(17)2)26-23-27-21(12-29-23)18-6-7-22(19(24)9-18)28-11-16(4)25-13-28/h6-13H,5H2,1-4H3,(H,26,27)	WDEKUGNKKOGFOA-UHFFFAOYSA-N					doublet; compound annotation
0391_002849	RGX-104	C34H33ClF3NO3	6.039	10218693	C[C@H](CCOC1=CC=CC(=C1)CC(=O)O)N(CC2=C(C(=CC=C2)C(F)(F)F)Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4	CC(CCOc1cccc(CC(=O)O)c1)N(Cc1c(Cl)c(C(F)(F)F)ccc1)CC(c1ccccc1)c1ccccc1	InChI=1S/C34H33ClF3NO3/c1-24(18-19-42-29-16-8-10-25(20-29)21-32(40)41)39(22-28-15-9-17-31(33(28)35)34(36,37)38)23-30(26-11-4-2-5-12-26)27-13-6-3-7-14-27/h2-17,20,24,30H,18-19,21-23H2,1H3,(H,40,41)/t24-/m1/s1	ZLJZDYOBXVOTSA-XMMPIXPASA-N					doublet; compound annotation
0391_002850	17318-31-9	C9H11N5O	0.6653	5270		Nc1c2ncn(C3CCCO3)c2ncn1	InChI=1S/C9H11N5O/c10-8-7-9(12-4-11-8)14(5-13-7)6-2-1-3-15-6/h4-6H,1-3H2,(H2,10,11,12)	UKHMZCMKHPHFOT-UHFFFAOYSA-N					compound annotation
0391_002851	FGFR4-IN-1	C24H27N7O5	2.1862	118036840		COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N	InChI=1S/C24H27N7O5/c1-35-7-4-26-19-10-21(27-12-18(19)11-25)29-24(34)31-5-2-3-16-9-17(20(14-32)28-23(16)31)13-30-6-8-36-15-22(30)33/h9-10,12,14H,2-8,13,15H2,1H3,(H2,26,27,29,34)	ZTYSXMGILYNNJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002852	FGFR4-IN-1	C24H27N7O5	2.5268	118036840		COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCOCC4=O)c(C=O)nc32)ncc1C#N	InChI=1S/C24H27N7O5/c1-35-7-4-26-19-10-21(27-12-18(19)11-25)29-24(34)31-5-2-3-16-9-17(20(14-32)28-23(16)31)13-30-6-8-36-15-22(30)33/h9-10,12,14H,2-8,13,15H2,1H3,(H2,26,27,29,34)	ZTYSXMGILYNNJX-UHFFFAOYSA-N					doublet; compound annotation
0391_002853	(S)-Tedizolid	C17H15FN6O3	2.557	71576658	CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@H](OC4=O)CO)F	Cn1nnc(-c2ncc(-c3c(F)cc(N4CC(CO)OC4=O)cc3)cc2)n1	InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m0/s1	XFALPSLJIHVRKE-LBPRGKRZSA-N					doublet; compound annotation
0391_002854	(S)-Tedizolid	C17H15FN6O3	2.5603	71576658	CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@H](OC4=O)CO)F	Cn1nnc(-c2ncc(-c3c(F)cc(N4CC(CO)OC4=O)cc3)cc2)n1	InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m0/s1	XFALPSLJIHVRKE-LBPRGKRZSA-N					doublet; compound annotation
0391_002855	Glyoxalase I inhibitor free base	C21H29BrN4O8S	2.8717	66577014	CCOC(=O)CNC(=O)[C@H](CSC(=O)N(C1=CC=C(C=C1)Br)O)NC(=O)CC[C@@H](C(=O)OCC)N	CCOC(=O)CNC(=O)C(CSC(=O)N(O)c1ccc(Br)cc1)NC(=O)CCC(N)C(=O)OCC	InChI=1S/C21H29BrN4O8S/c1-3-33-18(28)11-24-19(29)16(25-17(27)10-9-15(23)20(30)34-4-2)12-35-21(31)26(32)14-7-5-13(22)6-8-14/h5-8,15-16,32H,3-4,9-12,23H2,1-2H3,(H,24,29)(H,25,27)/t15-,16-/m0/s1	PYPKSBBTQSNXLR-HOTGVXAUSA-N					doublet; removed another duplicate entry; compound annotation
0391_002857	ML348	C18H17ClF3N3O3	3.6649	3238952		O=C(CN1CCN(C(=O)c2ccco2)CC1)Nc1c(Cl)ccc(C(F)(F)F)c1	InChI=1S/C18H17ClF3N3O3/c19-13-4-3-12(18(20,21)22)10-14(13)23-16(26)11-24-5-7-25(8-6-24)17(27)15-2-1-9-28-15/h1-4,9-10H,5-8,11H2,(H,23,26)	OXKNHBBDOIMFFQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002859	Refametinib	C19H20F3IN2O5S	4.4272	44182295	COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F	COc1cc(F)c(F)c(Nc2c(F)cc(I)cc2)c1NS(=O)(=O)C1(CC(O)CO)CC1	InChI=1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1	RDSACQWTXKSHJT-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002862	BL-1249	C17H17N5	5.0526	16078951		c1ccc(-c2n[nH]nn2)c(Nc2cccc3c2CCCC3)c1	InChI=1S/C17H17N5/c1-2-8-13-12(6-1)7-5-11-15(13)18-16-10-4-3-9-14(16)17-19-21-22-20-17/h3-5,7,9-11,18H,1-2,6,8H2,(H,19,20,21,22)	YYNRZIFBTOUICE-UHFFFAOYSA-N					doublet; compound annotation
0391_002863	BL-1249	C17H17N5	5.0556	16078951		c1ccc(-c2n[nH]nn2)c(Nc2cccc3c2CCCC3)c1	InChI=1S/C17H17N5/c1-2-8-13-12(6-1)7-5-11-15(13)18-16-10-4-3-9-14(16)17-19-21-22-20-17/h3-5,7,9-11,18H,1-2,6,8H2,(H,19,20,21,22)	YYNRZIFBTOUICE-UHFFFAOYSA-N					doublet; compound annotation
0391_002864	TPO agonist 1	C25H22N8O2	5.4709	135451068		Cc1c(C)cc(-n2[nH]c(C)c(N=Nc3cccc(-c4cc(-c5n[nH]nn5)ccc4)c3O)c2=O)cc1	InChI=1S/C25H22N8O2/c1-14-10-11-19(12-15(14)2)33-25(35)22(16(3)30-33)27-26-21-9-5-8-20(23(21)34)17-6-4-7-18(13-17)24-28-31-32-29-24/h4-13,30,34H,1-3H3,(H,28,29,31,32)	YLSNQYHZCMCURB-UHFFFAOYSA-N					compound annotation
0391_002865	937174-76-0	C21H27N7O3	2.2385	16725726	CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N	CCn1c(-c2nonc2N)nc2c1c(OCC1CCCNC1)cnc2C#CC(C)(C)O	InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1	KGPGFQWBCSZGEL-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_002867	go 6983	C26H26N4O3	2.5176	3499		COc1cc2c(cc1)n(CCCN(C)C)cc2C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O	InChI=1S/C26H26N4O3/c1-29(2)11-6-12-30-15-20(18-13-16(33-3)9-10-22(18)30)24-23(25(31)28-26(24)32)19-14-27-21-8-5-4-7-17(19)21/h4-5,7-10,13-15,27H,6,11-12H2,1-3H3,(H,28,31,32)	LLJJDLHGZUOMQP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002869	go 6983	C26H26N4O3	2.5209	3499		COc1cc2c(cc1)n(CCCN(C)C)cc2C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O	InChI=1S/C26H26N4O3/c1-29(2)11-6-12-30-15-20(18-13-16(33-3)9-10-22(18)30)24-23(25(31)28-26(24)32)19-14-27-21-8-5-4-7-17(19)21/h4-5,7-10,13-15,27H,6,11-12H2,1-3H3,(H,28,31,32)	LLJJDLHGZUOMQP-UHFFFAOYSA-N					doublet; compound annotation
0391_002870	chromafenozide	C24H30N2O3	3.0816	10157484		Cc1cc(C)cc(C(=O)N(NC(=O)c2c(C)c3c(cc2)OCCC3)C(C)(C)C)c1	InChI=1S/C24H30N2O3/c1-15-12-16(2)14-18(13-15)23(28)26(24(4,5)6)25-22(27)20-9-10-21-19(17(20)3)8-7-11-29-21/h9-10,12-14H,7-8,11H2,1-6H3,(H,25,27)	HPNSNYBUADCFDR-UHFFFAOYSA-N					doublet; compound annotation
0391_002871	CPI-360	C25H31N3O4	3.0816	73442743	CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)[C@H](C)C4CCOCC4)C)OC	COc1c(CNC(=O)c2c(C)n(C(C)C3CCOCC3)c3ccccc23)c(=O)[nH]c(C)c1	InChI=1S/C25H31N3O4/c1-15-13-22(31-4)20(24(29)27-15)14-26-25(30)23-17(3)28(21-8-6-5-7-19(21)23)16(2)18-9-11-32-12-10-18/h5-8,13,16,18H,9-12,14H2,1-4H3,(H,26,30)(H,27,29)/t16-/m1/s1	PFPSFENQCNMITC-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_002873	215923-54-9	C14H17NO3	3.0912	2890		O=C(c1cc2c(cc1)OCCO2)N1CCCCC1	InChI=1S/C14H17NO3/c16-14(15-6-2-1-3-7-15)11-4-5-12-13(10-11)18-9-8-17-12/h4-5,10H,1-3,6-9H2	LJUNPHMOGNFFOS-UHFFFAOYSA-N					doublet; compound annotation
0391_002874	215923-54-9	C14H17NO3	3.0958	2890		O=C(c1cc2c(cc1)OCCO2)N1CCCCC1	InChI=1S/C14H17NO3/c16-14(15-6-2-1-3-7-15)11-4-5-12-13(10-11)18-9-8-17-12/h4-5,10H,1-3,6-9H2	LJUNPHMOGNFFOS-UHFFFAOYSA-N					doublet; compound annotation
0391_002875	SGK1-IN-1	C17H12ClFN6O2S	3.2344	71506845		Nc1c2ncc(-c3ccc(NS(=O)(=O)c4c(F)ccc(Cl)c4)cc3)nc2n[nH]1	InChI=1S/C17H12ClFN6O2S/c18-10-3-6-12(19)14(7-10)28(26,27)25-11-4-1-9(2-5-11)13-8-21-15-16(20)23-24-17(15)22-13/h1-8,25H,(H3,20,22,23,24)	DDKHTWASHUKHLD-UHFFFAOYSA-N					compound annotation
0391_002876	Cyhalofop	C16H12FNO4	3.7536	15118048	C[C@H](C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)C#N)F	CC(Oc1ccc(Oc2c(F)cc(C#N)cc2)cc1)C(=O)O	InChI=1S/C16H12FNO4/c1-10(16(19)20)21-12-3-5-13(6-4-12)22-15-7-2-11(9-18)8-14(15)17/h2-8,10H,1H3,(H,19,20)/t10-/m1/s1	ROBSGBGTWRRYSK-SNVBAGLBSA-N					compound annotation
0391_002877	Asapiprant	C24H27N3O7S	4.1414	59232326		CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3cc(OCC(=O)O)c(-c4ncco4)cc3)CC2)cc1	InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29)	ZMZNWNTZRWXTJU-UHFFFAOYSA-N					doublet; compound annotation
0391_002878	Asapiprant	C24H27N3O7S	4.1463	59232326		CC(C)Oc1ccc(S(=O)(=O)N2CCN(c3cc(OCC(=O)O)c(-c4ncco4)cc3)CC2)cc1	InChI=1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29)	ZMZNWNTZRWXTJU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002880	chromafenozide	C24H30N2O3	4.4662	10157484		Cc1cc(C)cc(C(=O)N(NC(=O)c2c(C)c3c(cc2)OCCC3)C(C)(C)C)c1	InChI=1S/C24H30N2O3/c1-15-12-16(2)14-18(13-15)23(28)26(24(4,5)6)25-22(27)20-9-10-21-19(17(20)3)8-7-11-29-21/h9-10,12-14H,7-8,11H2,1-6H3,(H,25,27)	HPNSNYBUADCFDR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002882	Tanespimycin	C31H43N3O8	4.5286	6505803	C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC	C=CCNC1=C2CC(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O	InChI=1S/C31H43N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,36H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1	AYUNIORJHRXIBJ-TXHRRWQRSA-N					compound annotation
0391_002883	1254205-52-1	C21H13ClF6N2O5S	5.2581	49783953		O=C(O)c1ccc(S(=O)(=O)N(Cc2ccc(OC(F)(F)F)cc2)c2c(Cl)cc(C(F)(F)F)cn2)cc1	InChI=1S/C21H13ClF6N2O5S/c22-17-9-14(20(23,24)25)10-29-18(17)30(11-12-1-5-15(6-2-12)35-21(26,27)28)36(33,34)16-7-3-13(4-8-16)19(31)32/h1-10H,11H2,(H,31,32)	IJGQFZYYEHCCIZ-UHFFFAOYSA-N					compound annotation
0391_002884	golidocitinib	C25H31N9O2	1.4556	126715380	C[C@H](C(=O)NC1=CC=CC2=C1NC=C2C3=NC(=NC=C3)NC4=CN(N=C4OC)C)N5CCN(CC5)C	COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c2cccc3NC(=O)C(C)N2CCN(C)CC2)n1	InChI=1S/C25H31N9O2/c1-16(34-12-10-32(2)11-13-34)23(35)28-20-7-5-6-17-18(14-27-22(17)20)19-8-9-26-25(29-19)30-21-15-33(3)31-24(21)36-4/h5-9,14-16,27H,10-13H2,1-4H3,(H,28,35)(H,26,29,30)/t16-/m1/s1	CVCVOSPZEVINRM-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_002887	152121-47-6	C21H16FN3OS	1.9291	176155		C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25)	CDMGBJANTYXAIV-UHFFFAOYSA-N					doublet; compound annotation
0391_002888	BIX02188	C25H24N4O2	2.0437	135398492		CN(C)Cc1cc(N=C(c2ccccc2)c2c(O)[nH]c3c2ccc(C(N)=O)c3)ccc1	InChI=1S/C25H24N4O2/c1-29(2)15-16-7-6-10-19(13-16)27-23(17-8-4-3-5-9-17)22-20-12-11-18(24(26)30)14-21(20)28-25(22)31/h3-14,28,31H,15H2,1-2H3,(H2,26,30)	WGPXKFOFEXJMBD-UHFFFAOYSA-N					compound annotation
0391_002889	Saracatinib	C27H32ClN5O5	2.111	10302451		CN1CCN(CCOc2cc3c(c(OC4CCOCC4)c2)c(Nc2c(Cl)ccc4c2OCO4)ncn3)CC1	InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)	OUKYUETWWIPKQR-UHFFFAOYSA-N					compound annotation
0391_002890	methoxy-PEPy	C13H10N2O	2.4498	10081842		COc1cncc(C#Cc2ccccn2)c1	InChI=1S/C13H10N2O/c1-16-13-8-11(9-14-10-13)5-6-12-4-2-3-7-15-12/h2-4,7-10H,1H3	VRTFKUFTEWQHDD-UHFFFAOYSA-N					compound annotation
0391_002891	hesperadin	C29H32N4O3S	2.4592	135421442		CCS(=O)(=O)Nc1cc2c(cc1)[nH]c(O)c2C(=Nc1ccc(CN2CCCCC2)cc1)c1ccccc1	InChI=1S/C29H32N4O3S/c1-2-37(35,36)32-24-15-16-26-25(19-24)27(29(34)31-26)28(22-9-5-3-6-10-22)30-23-13-11-21(12-14-23)20-33-17-7-4-8-18-33/h3,5-6,9-16,19,31-32,34H,2,4,7-8,17-18,20H2,1H3	HYHIYZMIFPJROG-UHFFFAOYSA-N					compound annotation
0391_002892	AT7867	C20H20ClN3	2.5357	11175137		Clc1ccc(C2(c3ccc(-c4c[nH]nc4)cc3)CCNCC2)cc1	InChI=1S/C20H20ClN3/c21-19-7-5-18(6-8-19)20(9-11-22-12-10-20)17-3-1-15(2-4-17)16-13-23-24-14-16/h1-8,13-14,22H,9-12H2,(H,23,24)	LZMOSYUFVYJEPY-UHFFFAOYSA-N					doublet; compound annotation
0391_002893	GV-58	C18H26N6OS	3.0258	71463101	CCCN1C=NC2=C(N=C(N=C21)N[C@H](CC)CO)NCC3=CC=C(S3)C	CCCn1cnc2c(NCc3ccc(C)s3)nc(NC(CC)CO)nc21	InChI=1S/C18H26N6OS/c1-4-8-24-11-20-15-16(19-9-14-7-6-12(3)26-14)22-18(23-17(15)24)21-13(5-2)10-25/h6-7,11,13,25H,4-5,8-10H2,1-3H3,(H2,19,21,22,23)/t13-/m1/s1	DPTXJOUVBMUSGY-CYBMUJFWSA-N					doublet; compound annotation
0391_002894	GV-58	C18H26N6OS	3.0356	71463101	CCCN1C=NC2=C(N=C(N=C21)N[C@H](CC)CO)NCC3=CC=C(S3)C	CCCn1cnc2c(NCc3ccc(C)s3)nc(NC(CC)CO)nc21	InChI=1S/C18H26N6OS/c1-4-8-24-11-20-15-16(19-9-14-7-6-12(3)26-14)22-18(23-17(15)24)21-13(5-2)10-25/h6-7,11,13,25H,4-5,8-10H2,1-3H3,(H2,19,21,22,23)/t13-/m1/s1	DPTXJOUVBMUSGY-CYBMUJFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_002896	1005883-72-6	C20H20N4O3	3.7334	51116434		CCOC(=O)c1ccc(NC(=O)NCc2ccc(-n3cccn3)cc2)cc1	InChI=1S/C20H20N4O3/c1-2-27-19(25)16-6-8-17(9-7-16)23-20(26)21-14-15-4-10-18(11-5-15)24-13-3-12-22-24/h3-13H,2,14H2,1H3,(H2,21,23,26)	KQUKHINHCUELQL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002898	3-Methyltoxoflavin	C8H9N5O2	0.6957	460747		Cc1nn(C)c2nc(=O)n(C)c(=O)c-2n1	InChI=1S/C8H9N5O2/c1-4-9-5-6(13(3)11-4)10-8(15)12(2)7(5)14/h1-3H3	CPXHNWKHOFNPDO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002900	CORIN	C26H28N4O2	2.0488	134828251	C1[C@H]([C@@H]1N)C2=CC=C(C=C2)NC(=O)CCCC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N	Nc1ccccc1NC(=O)c1ccc(CCCC(=O)Nc2ccc(C3CC3N)cc2)cc1	InChI=1S/C26H28N4O2/c27-22-5-1-2-6-24(22)30-26(32)19-10-8-17(9-11-19)4-3-7-25(31)29-20-14-12-18(13-15-20)21-16-23(21)28/h1-2,5-6,8-15,21,23H,3-4,7,16,27-28H2,(H,29,31)(H,30,32)/t21-,23+/m0/s1	TYTLARZOLKJSJU-JTHBVZDNSA-N					removed another duplicate entry; compound annotation
0391_002902	linezolid	C16H20FN3O4	2.0936	441401	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	CC(=O)NCC1CN(c2cc(F)c(N3CCOCC3)cc2)C(=O)O1	InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1	TYZROVQLWOKYKF-ZDUSSCGKSA-N					doublet; removed another duplicate entry; compound annotation
0391_002904	linezolid	C16H20FN3O4	2.0985	441401	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F	CC(=O)NCC1CN(c2cc(F)c(N3CCOCC3)cc2)C(=O)O1	InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1	TYZROVQLWOKYKF-ZDUSSCGKSA-N					doublet; compound annotation
0391_002905	2285330-15-4	C17H20BNO5	2.3141	138319683	B([C@H](CC1=COC2=CC=CC=C21)NC(=O)[C@@H]3C[C@H]4CC[C@@H]3O4)(O)O	O=C(NC(Cc1coc2ccccc12)B(O)O)C1CC2CCC1O2	InChI=1S/C17H20BNO5/c20-17(13-8-11-5-6-15(13)24-11)19-16(18(21)22)7-10-9-23-14-4-2-1-3-12(10)14/h1-4,9,11,13,15-16,21-22H,5-8H2,(H,19,20)/t11-,13-,15+,16+/m1/s1	RFQDLTYXNINJON-OYNZBZHQSA-N					compound annotation
0391_002906	IB-MECA	C18H19IN6O4	3.0802	123683	CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O	CNC(=O)C1OC(n2cnc3c(NCc4cc(I)ccc4)ncnc32)C(O)C1O	InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1	HUJXGQILHAUCCV-MOROJQBDSA-N					removed another duplicate entry; compound annotation
0391_002908	841290-80-0	C22H23FN6O5	3.1502	11213558		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4)n2)cc(OC)c1OC	InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)	NHHQJBCNYHBUSI-UHFFFAOYSA-N					doublet; compound annotation
0391_002909	L-888607	C19H15ClFNO2S	5.1858	44403763	C1CN2C3=C(C=CC(=C3)F)C(=C2[C@@H]1CC(=O)O)SC4=CC=C(C=C4)Cl	O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c2cc(F)cc1	InChI=1S/C19H15ClFNO2S/c20-12-1-4-14(5-2-12)25-19-15-6-3-13(21)10-16(15)22-8-7-11(18(19)22)9-17(23)24/h1-6,10-11H,7-9H2,(H,23,24)/t11-/m0/s1	GSBAVONRPNJJOH-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_002911	916603-07-1	C17H16FN5	1.5772	15980598		NCc1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1	InChI=1S/C17H16FN5/c18-15-11-20-17(22-14-8-6-12(10-19)7-9-14)23-16(15)21-13-4-2-1-3-5-13/h1-9,11H,10,19H2,(H2,20,21,22,23)	UKOHFWNBTUJMMN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002913	BMS-690514	C19H24N6O2	1.6818	11349170	COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N	COc1cccc(Nc2ncnn3ccc(CN4CCC(N)C(O)C4)c23)c1	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	CSGQVNMSRKWUSH-IAGOWNOFSA-N					doublet; compound annotation
0391_002914	LMPTP inhibitor 1	C28H36N4O	1.7773	121284761		CCN(CC)C(=O)c1ccc(-c2nc3ccccc3c(NCCCN3CCCCC3)c2)cc1	InChI=1S/C28H36N4O/c1-3-32(4-2)28(33)23-15-13-22(14-16-23)26-21-27(24-11-6-7-12-25(24)30-26)29-17-10-20-31-18-8-5-9-19-31/h6-7,11-16,21H,3-5,8-10,17-20H2,1-2H3,(H,29,30)	XISMYRQHGUUMGY-UHFFFAOYSA-N					compound annotation
0391_002915	BMS-690514	C19H24N6O2	1.9274	11349170	COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N	COc1cccc(Nc2ncnn3ccc(CN4CCC(N)C(O)C4)c23)c1	InChI=1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1	CSGQVNMSRKWUSH-IAGOWNOFSA-N					doublet; compound annotation
0391_002916	GSK1838705A	C27H29FN8O3	2.3164	25182616		CNC(=O)c1c(Nc2nc(Nc3c(OC)cc4CCN(C(=O)CN(C)C)c4c3)nc3c2cc[nH]3)cccc1F	InChI=1S/C27H29FN8O3/c1-29-26(38)23-17(28)6-5-7-18(23)31-25-16-8-10-30-24(16)33-27(34-25)32-19-13-20-15(12-21(19)39-4)9-11-36(20)22(37)14-35(2)3/h5-8,10,12-13H,9,11,14H2,1-4H3,(H,29,38)(H3,30,31,32,33,34)	HZTYDQRUAWIZRE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002919	TAK-063	C23H17FN6O2	3.4451	46848915		COc1cn(-c2c(F)cc(-n3cccn3)cc2)nc(-c2ccnn2-c2ccccc2)c1=O	InChI=1S/C23H17FN6O2/c1-32-21-15-29(19-9-8-17(14-18(19)24)28-13-5-11-25-28)27-22(23(21)31)20-10-12-26-30(20)16-6-3-2-4-7-16/h2-15H,1H3	KVHRYLNQDWXAGI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002921	TAK-063	C23H17FN6O2	3.7293	46848915		COc1cn(-c2c(F)cc(-n3cccn3)cc2)nc(-c2ccnn2-c2ccccc2)c1=O	InChI=1S/C23H17FN6O2/c1-32-21-15-29(19-9-8-17(14-18(19)24)28-13-5-11-25-28)27-22(23(21)31)20-10-12-26-30(20)16-6-3-2-4-7-16/h2-15H,1H3	KVHRYLNQDWXAGI-UHFFFAOYSA-N					doublet; compound annotation
0391_002922	TH-237A	C18H17F2NO3	4.0921	16722711	C1C2(CO[C@H](N2[C@H](O1)C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)CO	OCC12COC(c3ccc(F)cc3)N1C(c1ccc(F)cc1)OC2	InChI=1S/C18H17F2NO3/c19-14-5-1-12(2-6-14)16-21-17(13-3-7-15(20)8-4-13)24-11-18(21,9-22)10-23-16/h1-8,16-17,22H,9-11H2/t16-,17+,18?	AEZQGSQEXPUADE-JWTNVVGKSA-N					compound annotation
0391_002923	UKI-1	C32H47N5O5S	4.132	9895193	CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C	CCOC(=O)N1CCN(C(=O)C(Cc2cc(C(=N)N)ccc2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1	InChI=1S/C32H47N5O5S/c1-8-42-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34)35-43(40,41)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35H,8,12-15,17H2,1-7H3,(H3,33,34)/t28-/m0/s1	ISJSHQTWOHGCMM-NDEPHWFRSA-N					removed another duplicate entry; compound annotation
0391_002925	Pyributicarb	C18H22N2O2S	5.682	93486		COc1cccc(N(C)C(=S)Oc2cccc(C(C)(C)C)c2)n1	InChI=1S/C18H22N2O2S/c1-18(2,3)13-8-6-9-14(12-13)22-17(23)20(4)15-10-7-11-16(19-15)21-5/h6-12H,1-5H3	VTRWMTJQBQJKQH-UHFFFAOYSA-N					compound annotation
0391_002926	SHP099	C16H19Cl2N5	2.3242	118238298		CC1(N)CCN(c2cnc(-c3c(Cl)c(Cl)ccc3)c(N)n2)CC1	InChI=1S/C16H19Cl2N5/c1-16(20)5-7-23(8-6-16)12-9-21-14(15(19)22-12)10-3-2-4-11(17)13(10)18/h2-4,9H,5-8,20H2,1H3,(H2,19,22)	YGUFCDOEKKVKJK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002928	IQ-1S	C15H9N3O	3.3033	619002		O=Nc1c2[nH]c3ccccc3nc-2c2ccccc12	InChI=1S/C15H9N3O/c19-18-14-10-6-2-1-5-9(10)13-15(14)17-12-8-4-3-7-11(12)16-13/h1-8,17H	YSYIWCNPSZNNKW-UHFFFAOYSA-N					doublet; compound annotation
0391_002929	Nevanimibe	C27H39N3O	3.4753	131679		CC(C)c1c(NC(=O)NCC2(c3ccc(N(C)C)cc3)CCCC2)c(C(C)C)ccc1	InChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31)	PKKNCEXEVUFFFI-UHFFFAOYSA-N					doublet; compound annotation
0391_002930	IQ-1S	C15H9N3O	3.4836	619002		O=Nc1c2[nH]c3ccccc3nc-2c2ccccc12	InChI=1S/C15H9N3O/c19-18-14-10-6-2-1-5-9(10)13-15(14)17-12-8-4-3-7-11(12)16-13/h1-8,17H	YSYIWCNPSZNNKW-UHFFFAOYSA-N					doublet; compound annotation
0391_002931	PHCCC	C17H14N2O3	3.7683	5866327	C1C\2C1(OC3=CC=CC=C3/C2=N/O)C(=O)NC4=CC=CC=C4	O=C(Nc1ccccc1)C12CC1C(=NO)c1ccccc1O2	InChI=1S/C17H14N2O3/c20-16(18-11-6-2-1-3-7-11)17-10-13(17)15(19-21)12-8-4-5-9-14(12)22-17/h1-9,13,21H,10H2,(H,18,20)/b19-15-	FPXPIEZPAXSELW-CYVLTUHYSA-N					compound annotation
0391_002932	Nevanimibe	C27H39N3O	4.429	131679		CC(C)c1c(NC(=O)NCC2(c3ccc(N(C)C)cc3)CCCC2)c(C(C)C)ccc1	InChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31)	PKKNCEXEVUFFFI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002934	DIHYDROMUNDULETONE	C25H28O6	4.9426	3492326		COc1c(CC(=O)c2c(O)cc3OC(C)(C)C(O)Cc3c2)ccc2c1C=CC(C)(C)O2	InChI=1S/C25H28O6/c1-24(2)9-8-16-20(30-24)7-6-14(23(16)29-5)11-18(26)17-10-15-12-22(28)25(3,4)31-21(15)13-19(17)27/h6-10,13,22,27-28H,11-12H2,1-5H3	RMVZECFNOTWEKD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002936	956958-53-5	C21H16N6O2S2	5.2975	1893730		Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2cc3nsnc3cc2)cc1	InChI=1S/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27)	MQMKRQLTIWPEDM-UHFFFAOYSA-N					compound annotation
0391_002937	Quiflapon	C34H35ClN2O3S	6.0044	60923		CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2c1cc(OCc1nc3ccccc3cc1)cc2	InChI=1S/C34H35ClN2O3S/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39/h6-18H,19-21H2,1-5H3,(H,38,39)	NZOONKHCNQFYCI-UHFFFAOYSA-N					doublet; compound annotation
0391_002938	Etoricoxib	C18H15ClN2O2S	2.3042	123619		Cc1ncc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cc1	InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3	MNJVRJDLRVPLFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002940	Levetimide	C23H26N2O2	2.3341	30844	C1CN(CCC1[C@]2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4	O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1	InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m0/s1	LQQIVYSCPWCSSD-QHCPKHFHSA-N					compound annotation
0391_002941	1022150-12-4	C22H22N6O	2.6687	58223272	C1C[C@H](CNC1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N	Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCNC3)c2ncn1	InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)/t16-/m1/s1	GPSQYTDPBDNDGI-MRXNPFEDSA-N					doublet; compound annotation
0391_002942	CHIR-124	C23H22ClN5O	2.7155	135399748	C1CN2CCC1[C@@H](C2)NC3=C(C(=O)NC4=C3C=C(C=C4)Cl)C5=NC6=CC=CC=C6N5	O=c1[nH]c2c(cc(Cl)cc2)c(NC2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1	InChI=1S/C23H22ClN5O/c24-14-5-6-16-15(11-14)21(25-19-12-29-9-7-13(19)8-10-29)20(23(30)28-16)22-26-17-3-1-2-4-18(17)27-22/h1-6,11,13,19H,7-10,12H2,(H,26,27)(H2,25,28,30)/t19-/m1/s1	MOVBBVMDHIRCTG-LJQANCHMSA-N					compound annotation
0391_002943	PEPA	C16H16F2N2O4S2	3.2269	6603828		NC(=O)COc1c(F)cc(SCCNS(=O)(=O)c2ccccc2)cc1F	InChI=1S/C16H16F2N2O4S2/c17-13-8-11(9-14(18)16(13)24-10-15(19)21)25-7-6-20-26(22,23)12-4-2-1-3-5-12/h1-5,8-9,20H,6-7,10H2,(H2,19,21)	GTACSIONMHMRPD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002946	CPI-203	C19H18ClN5OS	3.3197	71291068	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(N)=O)N=C2c1ccc(Cl)cc1	InChI=1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1	QECMENZMDBOLDR-AWEZNQCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_002948	CPI-203	C19H18ClN5OS	3.4065	71291068	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(N)=O)N=C2c1ccc(Cl)cc1	InChI=1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1	QECMENZMDBOLDR-AWEZNQCLSA-N					doublet; compound annotation
0391_002949	Sacubitril	C24H29NO5	4.1879	9811834	CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O	CCOC(=O)C(C)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O	InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21+/m1/s1	PYNXFZCZUAOOQC-UTKZUKDTSA-N					doublet; removed another duplicate entry; compound annotation
0391_002951	dapt	C23H26F2N2O4	4.3949	5311272	C[C@@H](C(=O)N[C@@H](C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F	CC(NC(=O)Cc1cc(F)cc(F)c1)C(=O)NC(C(=O)OC(C)(C)C)c1ccccc1	InChI=1S/C23H26F2N2O4/c1-14(26-19(28)12-15-10-17(24)13-18(25)11-15)21(29)27-20(16-8-6-5-7-9-16)22(30)31-23(2,3)4/h5-11,13-14,20H,12H2,1-4H3,(H,26,28)(H,27,29)/t14-,20-/m0/s1	DWJXYEABWRJFSP-XOBRGWDASA-N					doublet; compound annotation
0391_002952	dapt	C23H26F2N2O4	4.3995	5311272	C[C@@H](C(=O)N[C@@H](C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F	CC(NC(=O)Cc1cc(F)cc(F)c1)C(=O)NC(C(=O)OC(C)(C)C)c1ccccc1	InChI=1S/C23H26F2N2O4/c1-14(26-19(28)12-15-10-17(24)13-18(25)11-15)21(29)27-20(16-8-6-5-7-9-16)22(30)31-23(2,3)4/h5-11,13-14,20H,12H2,1-4H3,(H,26,28)(H,27,29)/t14-,20-/m0/s1	DWJXYEABWRJFSP-XOBRGWDASA-N					doublet; compound annotation
0391_002953	Grazoprevir	C38H50N6O9S	5.5468	44603531	CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1	C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3c(cc(OC)cc3)nc1O2)C(=O)NS(=O)(=O)C1CC1	InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	OBMNJSNZOWALQB-NCQNOWPTSA-N					doublet; removed another duplicate entry; compound annotation
0391_002955	ROCK inhibitor-2	C21H20N2O2	2.4471	51003130	C[C@H](C1=CC(=CC=C1)OC)NC(=O)C2=CC=C(C=C2)C3=CC=NC=C3	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1	InChI=1S/C21H20N2O2/c1-15(19-4-3-5-20(14-19)25-2)23-21(24)18-8-6-16(7-9-18)17-10-12-22-13-11-17/h3-15H,1-2H3,(H,23,24)/t15-/m1/s1	JRVSFZKYQCETAH-OAHLLOKOSA-N					doublet; compound annotation
0391_002956	ROCK inhibitor-2	C21H20N2O2	2.4498	51003130	C[C@H](C1=CC(=CC=C1)OC)NC(=O)C2=CC=C(C=C2)C3=CC=NC=C3	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1	InChI=1S/C21H20N2O2/c1-15(19-4-3-5-20(14-19)25-2)23-21(24)18-8-6-16(7-9-18)17-10-12-22-13-11-17/h3-15H,1-2H3,(H,23,24)/t15-/m1/s1	JRVSFZKYQCETAH-OAHLLOKOSA-N					doublet; compound annotation
0391_002957	CUDC-101	C24H26N4O4	2.5876	24756910		C#Cc1cc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)ccc1	InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)	PLIVFNIUGLLCEK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002960	2-(2-aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide	C15H13Cl2N3O4	3.1381	71527596		NCCOc1c(C(=O)Nc2c(Cl)cc([N+](=O)[O-])cc2)cc(Cl)cc1	InChI=1S/C15H13Cl2N3O4/c16-9-1-4-14(24-6-5-18)11(7-9)15(21)19-13-3-2-10(20(22)23)8-12(13)17/h1-4,7-8H,5-6,18H2,(H,19,21)	DIMJVBOEXNWPOG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002962	NVP-BHG712 isomer	C26H20F3N7O	3.3232	117602383		Cc1c(Nc2nc(-c3cnccc3)nc3nn(C)cc23)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C26H20F3N7O/c1-15-8-9-16(25(37)31-19-7-3-6-18(12-19)26(27,28)29)11-21(15)32-23-20-14-36(2)35-24(20)34-22(33-23)17-5-4-10-30-13-17/h3-14H,1-2H3,(H,31,37)(H,32,33,34,35)	MWKSRKSEWLRPBL-UHFFFAOYSA-N					doublet; compound annotation
0391_002963	NVP-BHG712 isomer	C26H20F3N7O	3.3259	117602383		Cc1c(Nc2nc(-c3cnccc3)nc3nn(C)cc23)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C26H20F3N7O/c1-15-8-9-16(25(37)31-19-7-3-6-18(12-19)26(27,28)29)11-21(15)32-23-20-14-36(2)35-24(20)34-22(33-23)17-5-4-10-30-13-17/h3-14H,1-2H3,(H,31,37)(H,32,33,34,35)	MWKSRKSEWLRPBL-UHFFFAOYSA-N					doublet; compound annotation
0391_002964	1380392-05-1	C25H26ClN3O	3.3738	57382073		O=c1c2cccn2c2ccccc2n1CCCN1CCC(c2ccc(Cl)cc2)CC1	InChI=1S/C25H26ClN3O/c26-21-10-8-19(9-11-21)20-12-17-27(18-13-20)14-4-16-29-23-6-2-1-5-22(23)28-15-3-7-24(28)25(29)30/h1-3,5-11,15,20H,4,12-14,16-18H2	WOSMCMULWWHMIV-UHFFFAOYSA-N					compound annotation
0391_002965	GLPG2451	C16H16F3N3O5S	3.6881	124106089	C[C@@H](CNC(=O)C1=C(C=C(C=N1)S(=O)(=O)C2=CC=C(C=C2)OC(F)(F)F)N)O	CC(O)CNC(=O)c1c(N)cc(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cn1	InChI=1S/C16H16F3N3O5S/c1-9(23)7-22-15(24)14-13(20)6-12(8-21-14)28(25,26)11-4-2-10(3-5-11)27-16(17,18)19/h2-6,8-9,23H,7,20H2,1H3,(H,22,24)/t9-/m0/s1	UMOGNCVNHXWFIX-VIFPVBQESA-N					doublet; removed another duplicate entry; compound annotation
0391_002967	284028-89-3	C14H11F3N2OS	3.7009	135418940		O=c1nc(-c2ccc(C(F)(F)F)cc2)[nH]c2c1CSCC2	InChI=1S/C14H11F3N2OS/c15-14(16,17)9-3-1-8(2-4-9)12-18-11-5-6-21-7-10(11)13(20)19-12/h1-4H,5-7H2,(H,18,19,20)	KLGQSVMIPOVQAX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002969	RIPK1-IN-7	C25H22F3N5O2	3.7308	137321158		CCn1cc(-c2cc3c(cc2)N(C(=O)Cc2cc(OC(F)(F)F)ccc2)CC3)c2c(N)ncnc21	InChI=1S/C25H22F3N5O2/c1-2-32-13-19(22-23(29)30-14-31-24(22)32)16-6-7-20-17(12-16)8-9-33(20)21(34)11-15-4-3-5-18(10-15)35-25(26,27)28/h3-7,10,12-14H,2,8-9,11H2,1H3,(H2,29,30,31)	APPXQUDJLJXULP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002971	GLPG2451	C16H16F3N3O5S	3.7505	124106089	C[C@@H](CNC(=O)C1=C(C=C(C=N1)S(=O)(=O)C2=CC=C(C=C2)OC(F)(F)F)N)O	CC(O)CNC(=O)c1c(N)cc(S(=O)(=O)c2ccc(OC(F)(F)F)cc2)cn1	InChI=1S/C16H16F3N3O5S/c1-9(23)7-22-15(24)14-13(20)6-12(8-21-14)28(25,26)11-4-2-10(3-5-11)27-16(17,18)19/h2-6,8-9,23H,7,20H2,1H3,(H,22,24)/t9-/m0/s1	UMOGNCVNHXWFIX-VIFPVBQESA-N					doublet; compound annotation
0391_002972	CUDC-101	C24H26N4O4	4.21	24756910		C#Cc1cc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)ccc1	InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)	PLIVFNIUGLLCEK-UHFFFAOYSA-N					doublet; compound annotation
0391_002973	DGAT1-IN-1	C30H28F3N3O4	4.7576	71696573		O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)cc5)nc4cc3)cc2)CC1	InChI=1S/C30H28F3N3O4/c31-30(32,33)40-25-12-3-20(4-13-25)16-34-29(39)26-18-36-17-24(11-14-27(36)35-26)23-9-7-22(8-10-23)21-5-1-19(2-6-21)15-28(37)38/h3-4,7-14,17-19,21H,1-2,5-6,15-16H2,(H,34,39)(H,37,38)	KFGSQOIWOCDWAS-UHFFFAOYSA-N					doublet; compound annotation
0391_002974	DGAT1-IN-1	C30H28F3N3O4	4.7604	71696573		O=C(O)CC1CCC(c2ccc(-c3cn4cc(C(=O)NCc5ccc(OC(F)(F)F)cc5)nc4cc3)cc2)CC1	InChI=1S/C30H28F3N3O4/c31-30(32,33)40-25-12-3-20(4-13-25)16-34-29(39)26-18-36-17-24(11-14-27(36)35-26)23-9-7-22(8-10-23)21-5-1-19(2-6-21)15-28(37)38/h3-4,7-14,17-19,21H,1-2,5-6,15-16H2,(H,34,39)(H,37,38)	KFGSQOIWOCDWAS-UHFFFAOYSA-N					doublet; compound annotation
0391_002975	110683-10-8	C21H23NO3	5.5083	5353376	CCCCCC1=CC=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O	CCCCCc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1	InChI=1S/C21H23NO3/c1-2-3-4-7-16-10-12-17(13-11-16)14-15-20(23)22-19-9-6-5-8-18(19)21(24)25/h5-6,8-15H,2-4,7H2,1H3,(H,22,23)(H,24,25)/b15-14+	GAMRBCZMOOMBSQ-CCEZHUSRSA-N					removed another duplicate entry; compound annotation
0391_002977	(+)-DHMEQ	C13H11NO5	1.9025	53310057	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@H]3[C@@H]([C@@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m1/s1	IUOMATKBBPCLFR-GRYCIOLGSA-N					doublet; compound annotation
0391_002978	Exatecan	C24H22FN3O4	2.0138	151115	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4c5c(c(C)c(F)c4)CCC(N)c5c3Cn1c2=O	InChI=1S/C24H22FN3O4/c1-3-24(31)14-6-18-21-12(8-28(18)22(29)13(14)9-32-23(24)30)19-16(26)5-4-11-10(2)15(25)7-17(27-21)20(11)19/h6-7,16,31H,3-5,8-9,26H2,1-2H3/t16-,24-/m0/s1	ZVYVPGLRVWUPMP-FYSMJZIKSA-N					doublet; compound annotation
0391_002979	(+)-DHMEQ	C13H11NO5	2.1195	53310057	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@H]3[C@@H]([C@@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m1/s1	IUOMATKBBPCLFR-GRYCIOLGSA-N					doublet; compound annotation
0391_002980	Exatecan	C24H22FN3O4	2.2943	151115	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C5[C@H](CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4c5c(c(C)c(F)c4)CCC(N)c5c3Cn1c2=O	InChI=1S/C24H22FN3O4/c1-3-24(31)14-6-18-21-12(8-28(18)22(29)13(14)9-32-23(24)30)19-16(26)5-4-11-10(2)15(25)7-17(27-21)20(11)19/h6-7,16,31H,3-5,8-9,26H2,1-2H3/t16-,24-/m0/s1	ZVYVPGLRVWUPMP-FYSMJZIKSA-N					doublet; compound annotation
0391_002981	Dovitinib	C21H21FN6O	2.3093	135398510		CN1CCN(c2cc3c(cc2)nc(-c2c(N)c4c(cccc4F)[nH]c2=O)[nH]3)CC1	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	PIQCTGMSNWUMAF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_002983	(+)-DHMEQ	C13H11NO5	2.4216	53310057	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@H]3[C@@H]([C@@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m1/s1	IUOMATKBBPCLFR-GRYCIOLGSA-N					doublet; compound annotation
0391_002984	ML329	C16H12N2O4S	2.9165	12387471		NS(=O)(=O)c1ccc(NC2=CC(=O)c3ccccc3C2=O)cc1	InChI=1S/C16H12N2O4S/c17-23(21,22)11-7-5-10(6-8-11)18-14-9-15(19)12-3-1-2-4-13(12)16(14)20/h1-9,18H,(H2,17,21,22)	CSYFFQVEQXEIAB-UHFFFAOYSA-N					compound annotation
0391_002985	252003-65-9	C20H24BrF2N5O3S	3.2773	9811611		NC(=O)c1c(NC(=O)NCCCCN2CCCC2)snc1OCc1c(F)cc(Br)cc1F	InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)	HXHAJRMTJXHJJZ-UHFFFAOYSA-N					compound annotation
0391_002986	LY2608204	C28H37N3O3S3	3.9082	46832368	C1CCC(CC1)[C@@H]2C[C@@]2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6	O=C(Nc1ncc(SCCN2CCCC2)s1)C1(c2ccc(S(=O)(=O)C3CC3)cc2)CC1C1CCCCC1	InChI=1S/C28H37N3O3S3/c32-26(30-27-29-19-25(36-27)35-17-16-31-14-4-5-15-31)28(18-24(28)20-6-2-1-3-7-20)21-8-10-22(11-9-21)37(33,34)23-12-13-23/h8-11,19-20,23-24H,1-7,12-18H2,(H,29,30,32)/t24-,28-/m0/s1	QIIVJLHCZUTGSD-CUBQBAPOSA-N					compound annotation
0391_002987	hDHODH-IN-1	C17H14N2O2	4.2864	54727972	C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C2=CC=CC=C2)/O	CC(O)=C(C#N)C(=O)Nc1ccc(-c2ccccc2)cc1	InChI=1S/C17H14N2O2/c1-12(20)16(11-18)17(21)19-15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-10,20H,1H3,(H,19,21)/b16-12-	MUVPBAIVOHJDOC-VBKFSLOCSA-N					removed another duplicate entry; compound annotation
0391_002989	Talarozole	C21H23N5S	4.7667	9799888		CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1	InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)	SNFYYXUGUBUECJ-UHFFFAOYSA-N					compound annotation
0391_002990	Jaspamycin	C12H12N4O5	0.6666	136670059	C1=C(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CNC2=O)C#N	N#Cc1cn(C2OC(CO)C(O)C2O)c2c1c(=O)nc[nH]2	InChI=1S/C12H12N4O5/c13-1-5-2-16(10-7(5)11(20)15-4-14-10)12-9(19)8(18)6(3-17)21-12/h2,4,6,8-9,12,17-19H,3H2,(H,14,15,20)/t6-,8-,9-,12-/m1/s1	SKDKFLFSBDYEDO-WOUKDFQISA-N					removed another duplicate entry; compound annotation
0391_002992	KDM5-C70	C17H28N4O3	0.7584	90094283		CCOC(=O)c1cc(CNCC(=O)N(CC)CCN(C)C)ncc1	InChI=1S/C17H28N4O3/c1-5-21(10-9-20(3)4)16(22)13-18-12-15-11-14(7-8-19-15)17(23)24-6-2/h7-8,11,18H,5-6,9-10,12-13H2,1-4H3	WCILOMUUNVPIKQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_002994	1621175-65-2	C18H19ClN6O2S	2.5278	91826086		CNc1nc(-c2ccccn2)cc(NCc2c(Cl)cc(NS(C)(=O)=O)cc2)n1	InChI=1S/C18H19ClN6O2S/c1-20-18-23-16(15-5-3-4-8-21-15)10-17(24-18)22-11-12-6-7-13(9-14(12)19)25-28(2,26)27/h3-10,25H,11H2,1-2H3,(H2,20,22,23,24)	DRSZMILOMUPIBJ-UHFFFAOYSA-N					compound annotation
0391_002995	HMN-214	C22H20N2O5S	2.5909	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_002996	MK-3207	C31H29F2N5O3	2.6378	25019940	C1CCC2(C1)C(=O)N([C@@H](CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(C[C@@]6(C5)C7=C(NC6=O)N=CC=C7)C=C4	O=C(CN1C(=O)C2(CCCC2)NCC1c1cc(F)cc(F)c1)Nc1cc2c(cc1)CC1(C2)C(=O)Nc2c1cccn2	InChI=1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1	AZAANWYREOQRFB-SETSBSEESA-N					doublet; removed another duplicate entry; compound annotation
0391_002998	HMN-214	C22H20N2O5S	2.6795	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_002999	HMN-214	C22H20N2O5S	2.758	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003000	HMN-214	C22H20N2O5S	3.0175	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003001	HMN-214	C22H20N2O5S	3.0224	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003002	HMN-214	C22H20N2O5S	3.0952	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; removed another duplicate entry; compound annotation
0391_003004	HMN-214	C22H20N2O5S	3.2244	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003005	HMN-214	C22H20N2O5S	3.3928	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003006	MRTX849	C32H35ClFN7O2	3.6548	138611145	CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F	C=C(F)C(=O)N1CCN(c2nc(OCC3CCCN3C)nc3c2CCN(c2cccc4c2c(Cl)ccc4)C3)CC1CC#N	InChI=1S/C32H35ClFN7O2/c1-21(34)31(42)41-17-16-40(18-23(41)11-13-35)30-25-12-15-39(28-10-4-7-22-6-3-9-26(33)29(22)28)19-27(25)36-32(37-30)43-20-24-8-5-14-38(24)2/h3-4,6-7,9-10,23-24H,1,5,8,11-12,14-20H2,2H3/t23-,24-/m0/s1	PEMUGDMSUDYLHU-ZEQRLZLVSA-N					removed another duplicate entry; compound annotation
0391_003008	HMN-214	C22H20N2O5S	3.7152	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003009	HMN-214	C22H20N2O5S	3.7863	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; removed another duplicate entry; compound annotation
0391_003011	HMN-214	C22H20N2O5S	3.858	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; removed another duplicate entry; compound annotation
0391_003013	HMN-214	C22H20N2O5S	3.9729	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003014	HMN-214	C22H20N2O5S	3.9763	9888590	CC(=O)N(C1=CC=CC=C1/C=C/C2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2C=Cc2cc[n+]([O-])cc2)cc1	InChI=1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+	OCKHRKSTDPOHEN-BQYQJAHWSA-N					doublet; compound annotation
0391_003015	GSK962	C14H18N2O	4.0992	122703688	CC(C)(C)C(=O)N1[C@H](CC=N1)C2=CC=CC=C2	CC(C)(C)C(=O)N1N=CCC1c1ccccc1	InChI=1S/C14H18N2O/c1-14(2,3)13(17)16-12(9-10-15-16)11-7-5-4-6-8-11/h4-8,10,12H,9H2,1-3H3/t12-/m1/s1	NJQVSLWJBLPTMD-GFCCVEGCSA-N					removed another duplicate entry; compound annotation
0391_003017	SJA710-6	C22H20BrFN4	4.3619	71466685		CCCn1c(-c2ccc(Br)cc2)nc2c1nc(NCc1ccc(F)cc1)cc2	InChI=1S/C22H20BrFN4/c1-2-13-28-21(16-5-7-17(23)8-6-16)26-19-11-12-20(27-22(19)28)25-14-15-3-9-18(24)10-4-15/h3-12H,2,13-14H2,1H3,(H,25,27)	RPNQWWSSADJSGS-UHFFFAOYSA-N					compound annotation
0391_003018	Dooku1	C13H9Cl2N3OS	4.5477	137321150		Clc1cccc(Cl)c1CSc1nnc(-c2ccc[nH]2)o1	InChI=1S/C13H9Cl2N3OS/c14-9-3-1-4-10(15)8(9)7-20-13-18-17-12(19-13)11-5-2-6-16-11/h1-6,16H,7H2	MNPOBXLPCWFONX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003020	Dizocilpine, (-)-	C16H15N	2.0009	6337640	C[C@]12C3=CC=CC=C3C[C@H](N1)C4=CC=CC=C24	CC12NC(Cc3ccccc31)c1ccccc12	InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15-,16+/m0/s1	LBOJYSIDWZQNJS-JKSUJKDBSA-N					compound annotation
0391_003021	Icotinib	C22H21N3O4	2.4039	22024915		C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1	InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)	QQLKULDARVNMAL-UHFFFAOYSA-N					doublet; compound annotation
0391_003022	Icotinib	C22H21N3O4	2.4066	22024915		C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1	InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)	QQLKULDARVNMAL-UHFFFAOYSA-N					doublet; compound annotation
0391_003023	4712-12-3	C17H14O6	3.3799	5351234		COc1c(OC)cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C17H14O6/c1-21-13-4-3-9(5-15(13)22-2)14-8-12(20)17-11(19)6-10(18)7-16(17)23-14/h3-8,18-19H,1-2H3	AOLOMULCAJQEIG-UHFFFAOYSA-N					doublet; compound annotation
0391_003024	4712-12-3	C17H14O6	3.3833	5351234		COc1c(OC)cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C17H14O6/c1-21-13-4-3-9(5-15(13)22-2)14-8-12(20)17-11(19)6-10(18)7-16(17)23-14/h3-8,18-19H,1-2H3	AOLOMULCAJQEIG-UHFFFAOYSA-N					doublet; compound annotation
0391_003025	NFAT Transcription Factor Regulator	C17H10F6N4O2	4.294	9931706		O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2OC(F)F)cc1)c1c(F)cncc1	InChI=1S/C17H10F6N4O2/c18-12-8-24-6-5-11(12)15(28)25-9-1-3-10(4-2-9)27-14(29-16(19)20)7-13(26-27)17(21,22)23/h1-8,16H,(H,25,28)	XGCRLPUGFWHAGJ-UHFFFAOYSA-N					compound annotation
0391_003026	AZILSARTAN MEDOXOMIL	C30H24N4O8	4.3111	135409642		CCOc1nc2cccc(C(=O)OCc3c(C)oc(=O)o3)c2n1Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1	InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36)	QJFSABGVXDWMIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003028	VU 0357121	C17H17F2NO2	4.7902	2296132		CCCCOc1ccc(C(=O)Nc2c(F)cc(F)cc2)cc1	InChI=1S/C17H17F2NO2/c1-2-3-10-22-14-7-4-12(5-8-14)17(21)20-16-9-6-13(18)11-15(16)19/h4-9,11H,2-3,10H2,1H3,(H,20,21)	AHCYOTLTLQTPSU-UHFFFAOYSA-N					compound annotation
0391_003029	PR-619	C7H5N5S2	1.3329	2817763		N#CSc1c(N)nc(N)c(SC#N)c1	InChI=1S/C7H5N5S2/c8-2-13-4-1-5(14-3-9)7(11)12-6(4)10/h1H,(H4,10,11,12)	ZXOBLNBVNROVLC-UHFFFAOYSA-N					doublet; compound annotation
0391_003030	PR-619	C7H5N5S2	2.1511	2817763		N#CSc1c(N)nc(N)c(SC#N)c1	InChI=1S/C7H5N5S2/c8-2-13-4-1-5(14-3-9)7(11)12-6(4)10/h1H,(H4,10,11,12)	ZXOBLNBVNROVLC-UHFFFAOYSA-N					doublet; compound annotation
0391_003031	314245-33-5	C18H21FN2O	2.7288	675434		Cc1cc(C(=O)CN2CCCC2)c(C)n1-c1ccc(F)cc1	InChI=1S/C18H21FN2O/c1-13-11-17(18(22)12-20-9-3-4-10-20)14(2)21(13)16-7-5-15(19)6-8-16/h5-8,11H,3-4,9-10,12H2,1-2H3	JUWDSDKJBMFLHE-UHFFFAOYSA-N					compound annotation
0391_003032	Necrostatin-1	C13H13N3OS	2.8918	2828334		CN1C(=O)C(Cc2c[nH]c3ccccc23)N=C1S	InChI=1S/C13H13N3OS/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)	TXUWMXQFNYDOEZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003033	(R)-Equol	C15H14O3	2.9107	6950272	C1[C@@H](COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O	Oc1ccc(C2COc3c(ccc(O)c3)C2)cc1	InChI=1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m0/s1	ADFCQWZHKCXPAJ-LBPRGKRZSA-N					compound annotation
0391_003034	Necrostatin-1	C13H13N3OS	2.9484	2828334		CN1C(=O)C(Cc2c[nH]c3ccccc23)N=C1S	InChI=1S/C13H13N3OS/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)	TXUWMXQFNYDOEZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003035	Olorinab	C18H23N5O3	2.9484	60164925	CC(C)(C)[C@@H](CO)NC(=O)C1=NN(C2=C1C[C@H]3[C@@H]2C3)C4=NC=C[N+](=C4)[O-]	CC(C)(C)C(CO)NC(=O)c1nn(-c2ncc[n+]([O-])c2)c2c1CC1CC21	InChI=1S/C18H23N5O3/c1-18(2,3)13(9-24)20-17(25)15-12-7-10-6-11(10)16(12)23(21-15)14-8-22(26)5-4-19-14/h4-5,8,10-11,13,24H,6-7,9H2,1-3H3,(H,20,25)/t10-,11-,13+/m0/s1	ACSQLTBPYZSGBA-GMXVVIOVSA-N					removed another duplicate entry; compound annotation
0391_003037	ML367	C19H12F2N4	3.1356	921541		Fc1c(F)cc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1	InChI=1S/C19H12F2N4/c20-15-6-5-13(11-16(15)21)23-19-14-3-1-2-4-17(14)24-18(25-19)12-7-9-22-10-8-12/h1-11H,(H,23,24,25)	LBPYNNJXARHGAG-UHFFFAOYSA-N					doublet; compound annotation
0391_003038	ML367	C19H12F2N4	3.3103	921541		Fc1c(F)cc(Nc2nc(-c3ccncc3)nc3ccccc23)cc1	InChI=1S/C19H12F2N4/c20-15-6-5-13(11-16(15)21)23-19-14-3-1-2-4-17(14)24-18(25-19)12-7-9-22-10-8-12/h1-11H,(H,23,24,25)	LBPYNNJXARHGAG-UHFFFAOYSA-N					doublet; compound annotation
0391_003039	GLPG1837	C16H20N4O3S	3.3103	117857370		CC1(C)Cc2c(sc(NC(=O)c3ccn[nH]3)c2C(N)=O)C(C)(C)O1	InChI=1S/C16H20N4O3S/c1-15(2)7-8-10(12(17)21)14(24-11(8)16(3,4)23-15)19-13(22)9-5-6-18-20-9/h5-6H,7H2,1-4H3,(H2,17,21)(H,18,20)(H,19,22)	GHTGYZMBQPXTCQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003042	alexidine	C26H56N10	3.7703	2090		CCCCC(CC)CN=C(N)NC(N)=NCCCCCCN=C(N)NC(N)=NCC(CC)CCCC	InChI=1S/C26H56N10/c1-5-9-15-21(7-3)19-33-25(29)35-23(27)31-17-13-11-12-14-18-32-24(28)36-26(30)34-20-22(8-4)16-10-6-2/h21-22H,5-20H2,1-4H3,(H5,27,29,31,33,35)(H5,28,30,32,34,36)	LFVVNPBBFUSSHL-UHFFFAOYSA-N					compound annotation
0391_003043	2,2,5,7,8-Pentamethyl-6-chromanol	C14H20O2	4.6119	99479		Cc1c(C)c2c(CCC(C)(C)O2)c(C)c1O	InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3	SEBPXHSZHLFWRL-UHFFFAOYSA-N					doublet; compound annotation
0391_003044	2,2,5,7,8-Pentamethyl-6-chromanol	C14H20O2	4.8112	99479		Cc1c(C)c2c(CCC(C)(C)O2)c(C)c1O	InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3	SEBPXHSZHLFWRL-UHFFFAOYSA-N					doublet; compound annotation
0391_003045	2,2,5,7,8-Pentamethyl-6-chromanol	C14H20O2	5.0396	99479		Cc1c(C)c2c(CCC(C)(C)O2)c(C)c1O	InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3	SEBPXHSZHLFWRL-UHFFFAOYSA-N					doublet; compound annotation
0391_003046	Zatebradine	C26H36N2O5	2.2763	65637		COc1c(OC)cc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1	InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3	KEDQCFRVSHYKLR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003048	Zoxazolamine	C7H5ClN2O	2.3296	6103		Nc1nc2c(ccc(Cl)c2)o1	InChI=1S/C7H5ClN2O/c8-4-1-2-6-5(3-4)10-7(9)11-6/h1-3H,(H2,9,10)	YGCODSQDUUUKIV-UHFFFAOYSA-N					compound annotation
0391_003049	Bentiamine	C26H26N4O4S	2.4067	3036235	CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C	CC(=C(CCOC(=O)c1ccccc1)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C26H26N4O4S/c1-18(30(17-31)16-22-15-28-19(2)29-24(22)27)23(35-26(33)21-11-7-4-8-12-21)13-14-34-25(32)20-9-5-3-6-10-20/h3-12,15,17H,13-14,16H2,1-2H3,(H2,27,28,29)/b23-18-	AZJUFRDUYTYIHV-NKFKGCMQSA-N					doublet; compound annotation
0391_003050	Zatebradine	C26H36N2O5	2.633	65637		COc1c(OC)cc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1	InChI=1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3	KEDQCFRVSHYKLR-UHFFFAOYSA-N					doublet; compound annotation
0391_003051	raloxifene	C28H27NO4S	2.7007	5035		O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2c1ccc(O)c2	InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2	GZUITABIAKMVPG-UHFFFAOYSA-N					doublet; compound annotation
0391_003052	raloxifene	C28H27NO4S	2.7088	5035		O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2c1ccc(O)c2	InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2	GZUITABIAKMVPG-UHFFFAOYSA-N					doublet; compound annotation
0391_003053	Bentiamine	C26H26N4O4S	2.8178	3036235	CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C	CC(=C(CCOC(=O)c1ccccc1)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C26H26N4O4S/c1-18(30(17-31)16-22-15-28-19(2)29-24(22)27)23(35-26(33)21-11-7-4-8-12-21)13-14-34-25(32)20-9-5-3-6-10-20/h3-12,15,17H,13-14,16H2,1-2H3,(H2,27,28,29)/b23-18-	AZJUFRDUYTYIHV-NKFKGCMQSA-N					doublet; compound annotation
0391_003054	Ravoxertinib	C21H18ClFN6O2	3.13	71727581	CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)[C@H](CO)C4=CC(=C(C=C4)Cl)F	Cn1nccc1Nc1nccc(-c2cc(=O)n(C(CO)c3cc(F)c(Cl)cc3)cc2)n1	InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1	RZUOCXOYPYGSKL-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_003056	raloxifene	C28H27NO4S	3.1509	5035		O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2c1ccc(O)c2	InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2	GZUITABIAKMVPG-UHFFFAOYSA-N					doublet; compound annotation
0391_003057	Bentiamine	C26H26N4O4S	3.2226	3036235	CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOC(=O)C2=CC=CC=C2)\SC(=O)C3=CC=CC=C3)/C	CC(=C(CCOC(=O)c1ccccc1)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C26H26N4O4S/c1-18(30(17-31)16-22-15-28-19(2)29-24(22)27)23(35-26(33)21-11-7-4-8-12-21)13-14-34-25(32)20-9-5-3-6-10-20/h3-12,15,17H,13-14,16H2,1-2H3,(H2,27,28,29)/b23-18-	AZJUFRDUYTYIHV-NKFKGCMQSA-N					doublet; removed another duplicate entry; compound annotation
0391_003059	OLEANDRIN	C32H48O9	3.7841	11541511	C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O	COC1CC(OC2CCC3(C)C(CCC4C3CCC3(C)C(C5=CC(=O)OC5)C(OC(C)=O)CC43O)C2)OC(C)C1O	InChI=1S/C32H48O9/c1-17-29(35)24(37-5)14-27(39-17)41-21-8-10-30(3)20(13-21)6-7-23-22(30)9-11-31(4)28(19-12-26(34)38-16-19)25(40-18(2)33)15-32(23,31)36/h12,17,20-25,27-29,35-36H,6-11,13-16H2,1-5H3/t17-,20+,21-,22-,23+,24-,25-,27-,28-,29-,30-,31+,32-/m0/s1	JLPDBLFIVFSOCC-XYXFTTADSA-N					removed another duplicate entry; compound annotation
0391_003061	Tiratricol	C14H9I3O4	4.1925	5803		O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)cc2)c(I)c1	InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)	UOWZUVNAGUAEQC-UHFFFAOYSA-N					compound annotation
0391_003062	amcinonide	C28H35FO7	4.5111	443958	CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3CCC5=CC(=O)C=C[C@@]54C)F)O)C)OC6(O2)CCCC6	CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC12C	InChI=1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1	ILKJAFIWWBXGDU-MOGDOJJUSA-N					removed another duplicate entry; compound annotation
0391_003064	DprE1-IN-2	C19H24N6O2	1.441	90467014		Cc1cc2c(nc1)c(C(=O)NCCO)cn2Cc1c(C)c(N(C)C)ncn1	InChI=1S/C19H24N6O2/c1-12-7-16-17(21-8-12)14(19(27)20-5-6-26)9-25(16)10-15-13(2)18(24(3)4)23-11-22-15/h7-9,11,26H,5-6,10H2,1-4H3,(H,20,27)	BLNAAWXUNQHVNT-UHFFFAOYSA-N					doublet; compound annotation
0391_003065	DprE1-IN-2	C19H24N6O2	1.4443	90467014		Cc1cc2c(nc1)c(C(=O)NCCO)cn2Cc1c(C)c(N(C)C)ncn1	InChI=1S/C19H24N6O2/c1-12-7-16-17(21-8-12)14(19(27)20-5-6-26)9-25(16)10-15-13(2)18(24(3)4)23-11-22-15/h7-9,11,26H,5-6,10H2,1-4H3,(H,20,27)	BLNAAWXUNQHVNT-UHFFFAOYSA-N					doublet; compound annotation
0391_003066	IDE1	C15H18N2O5	2.3414	23749403	C1=CC=C(C(=C1)/C=N/NC(=O)CCCCCC(=O)O)C(=O)O	O=C(O)CCCCCC(=O)NN=Cc1ccccc1C(=O)O	InChI=1S/C15H18N2O5/c18-13(8-2-1-3-9-14(19)20)17-16-10-11-6-4-5-7-12(11)15(21)22/h4-7,10H,1-3,8-9H2,(H,17,18)(H,19,20)(H,21,22)/b16-10+	ABKJCDILEUEJSH-MHWRWJLKSA-N					compound annotation
0391_003067	DEFLAZACORT	C25H31NO6	2.5761	189821	CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C	CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C	InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1	FBHSPRKOSMHSIF-GRMWVWQJSA-N					doublet; compound annotation
0391_003068	Valecobulin	C26H28N6O5S	2.7134	44243402	CC(C)[C@@H](C(=O)NC1=NC(=CS1)C2=CC(=C(C=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC)N4C=NC=N4)N	COc1cc(C(=O)c2ccc(-c3csc(NC(=O)C(N)C(C)C)n3)cc2-n2cncn2)cc(OC)c1OC	InChI=1S/C26H28N6O5S/c1-14(2)22(27)25(34)31-26-30-18(11-38-26)15-6-7-17(19(8-15)32-13-28-12-29-32)23(33)16-9-20(35-3)24(37-5)21(10-16)36-4/h6-14,22H,27H2,1-5H3,(H,30,31,34)/t22-/m0/s1	UKKRUIXIDCWALA-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_003070	887686-02-4	C19H14N2O6	2.7287	6496840		O=C(Nc1cc(C(=O)O)c(O)cc1)c1cc(NC(=O)c2ccco2)ccc1	InChI=1S/C19H14N2O6/c22-15-7-6-13(10-14(15)19(25)26)20-17(23)11-3-1-4-12(9-11)21-18(24)16-5-2-8-27-16/h1-10,22H,(H,20,23)(H,21,24)(H,25,26)	HTJWLEGCECXGSQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003072	EED226	C17H15N5O3S	2.8009	123132228		CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1	InChI=1S/C17H15N5O3S/c1-26(23,24)14-6-4-12(5-7-14)15-10-19-17(22-11-20-21-16(15)22)18-9-13-3-2-8-25-13/h2-8,10-11H,9H2,1H3,(H,18,19)	DYIRSNMPIZZNBK-UHFFFAOYSA-N					doublet; compound annotation
0391_003073	EED226	C17H15N5O3S	2.8038	123132228		CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1	InChI=1S/C17H15N5O3S/c1-26(23,24)14-6-4-12(5-7-14)15-10-19-17(22-11-20-21-16(15)22)18-9-13-3-2-8-25-13/h2-8,10-11H,9H2,1H3,(H,18,19)	DYIRSNMPIZZNBK-UHFFFAOYSA-N					doublet; compound annotation
0391_003074	DEFLAZACORT	C25H31NO6	3.4596	189821	CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C	CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C	InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1	FBHSPRKOSMHSIF-GRMWVWQJSA-N					doublet; compound annotation
0391_003075	DEFLAZACORT	C25H31NO6	3.4625	189821	CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C	CC(=O)OCC(=O)C12N=C(C)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C	InChI=1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1	FBHSPRKOSMHSIF-GRMWVWQJSA-N					doublet; compound annotation
0391_003076	WYC-209	C20H20N2O3S	3.6485	130417665		CCOC(=O)c1cnc(C#Cc2ccc3c(c2)C(C)(C)CC[S+]3[O-])nc1	InChI=1S/C20H20N2O3S/c1-4-25-19(23)15-12-21-18(22-13-15)8-6-14-5-7-17-16(11-14)20(2,3)9-10-26(17)24/h5,7,11-13H,4,9-10H2,1-3H3	LLMDAYVUHYVJSS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003078	SYP-5	C18H16O3S	5.0146	123131800	CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)/C=C/C3=CC=CS3)C	CC1(C)C=Cc2c(ccc(C(=O)C=Cc3cccs3)c2O)O1	InChI=1S/C18H16O3S/c1-18(2)10-9-14-16(21-18)8-6-13(17(14)20)15(19)7-5-12-4-3-11-22-12/h3-11,20H,1-2H3/b7-5+	OMVURDVBYIJCOI-FNORWQNLSA-N					doublet; compound annotation
0391_003079	CCG-1423	C18H13ClF6N2O3	5.3005	2726015		CC(ONC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc(Cl)cc1	InChI=1S/C18H13ClF6N2O3/c1-9(15(28)26-14-4-2-13(19)3-5-14)30-27-16(29)10-6-11(17(20,21)22)8-12(7-10)18(23,24)25/h2-9H,1H3,(H,26,28)(H,27,29)	DSMXVSGJIDFLKP-UHFFFAOYSA-N					compound annotation
0391_003080	SYP-5	C18H16O3S	5.9134	123131800	CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)/C=C/C3=CC=CS3)C	CC1(C)C=Cc2c(ccc(C(=O)C=Cc3cccs3)c2O)O1	InChI=1S/C18H16O3S/c1-18(2)10-9-14-16(21-18)8-6-13(17(14)20)15(19)7-5-12-4-3-11-22-12/h3-11,20H,1-2H3/b7-5+	OMVURDVBYIJCOI-FNORWQNLSA-N					doublet; compound annotation
0391_003081	152121-47-6	C21H16FN3OS	1.9274	176155		C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25)	CDMGBJANTYXAIV-UHFFFAOYSA-N					doublet; compound annotation
0391_003082	Necrostatin 2 S enantiomer	C13H12ClN3O2	2.8002	44404825	CN1C(=O)[C@@H](NC1=O)CC2=CNC3=C2C=CC=C3Cl	CN1C(=O)NC(Cc2c[nH]c3c2cccc3Cl)C1=O	InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)/t10-/m0/s1	WIKGAEMMNQTUGL-JTQLQIEISA-N					compound annotation
0391_003083	BAY 73-6691	C15H12ClF3N4O	3.8051	135541419	C[C@H](CC1=NC2=C(C=NN2C3=CC=CC=C3Cl)C(=O)N1)C(F)(F)F	CC(Cc1nc2c(cnn2-c2ccccc2Cl)c(=O)[nH]1)C(F)(F)F	InChI=1S/C15H12ClF3N4O/c1-8(15(17,18)19)6-12-21-13-9(14(24)22-12)7-20-23(13)11-5-3-2-4-10(11)16/h2-5,7-8H,6H2,1H3,(H,21,22,24)/t8-/m1/s1	FFPXPXOAFQCNBS-MRVPVSSYSA-N					compound annotation
0391_003084	136831-49-7	C14H8Cl2N2	4.1765	5353928	C1=CC(=CN=C1)/C(=C\C2=CC(=CC(=C2)Cl)Cl)/C#N	N#CC(=Cc1cc(Cl)cc(Cl)c1)c1cnccc1	InChI=1S/C14H8Cl2N2/c15-13-5-10(6-14(16)7-13)4-12(8-17)11-2-1-3-18-9-11/h1-7,9H/b12-4-	TYXIVBJQPBWBHO-QCDXTXTGSA-N					doublet; compound annotation
0391_003085	2304947-71-3	C19H18BrIN4O2	4.1952	137321164		O=C(Nc1ccc(I)cc1)N1CCC(n2c(=O)[nH]c3c(Br)cccc32)CC1	InChI=1S/C19H18BrIN4O2/c20-15-2-1-3-16-17(15)23-19(27)25(16)14-8-10-24(11-9-14)18(26)22-13-6-4-12(21)5-7-13/h1-7,14H,8-11H2,(H,22,26)(H,23,27)	FZLKVWWPFOLPKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003087	136831-49-7	C14H8Cl2N2	4.4243	5353928	C1=CC(=CN=C1)/C(=C\C2=CC(=CC(=C2)Cl)Cl)/C#N	N#CC(=Cc1cc(Cl)cc(Cl)c1)c1cnccc1	InChI=1S/C14H8Cl2N2/c15-13-5-10(6-14(16)7-13)4-12(8-17)11-2-1-3-18-9-11/h1-7,9H/b12-4-	TYXIVBJQPBWBHO-QCDXTXTGSA-N					doublet; compound annotation
0391_003088	BECLOMETHASONE DIPROPIONATE	C28H37ClO7	4.8567	21700	CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C	InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	KUVIULQEHSCUHY-XYWKZLDCSA-N					doublet; compound annotation
0391_003089	BECLOMETHASONE DIPROPIONATE	C28H37ClO7	4.8608	21700	CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C	InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	KUVIULQEHSCUHY-XYWKZLDCSA-N					doublet; compound annotation
0391_003090	Pimecrolimus	C43H68ClNO11	5.6277	6509979	CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C	CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(Cl)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC	InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1	KASDHRXLYQOAKZ-XDSKOBMDSA-N					doublet; compound annotation
0391_003091	Pimecrolimus	C43H68ClNO11	6.0624	6509979	CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C	CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(Cl)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC	InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1	KASDHRXLYQOAKZ-XDSKOBMDSA-N					doublet; compound annotation
0391_003092	Pimecrolimus	C43H68ClNO11	6.3051	6509979	CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C	CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(Cl)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC	InChI=1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1	KASDHRXLYQOAKZ-XDSKOBMDSA-N					doublet; compound annotation
0391_003093	LY2795050	C23H22ClN3O2	1.8985	56851583	C1C[C@H](N(C1)CC2=CC=C(C=C2)OC3=C(C=C(C=C3)C(=O)N)Cl)C4=CN=CC=C4	NC(=O)c1cc(Cl)c(Oc2ccc(CN3CCCC3c3cnccc3)cc2)cc1	InChI=1S/C23H22ClN3O2/c24-20-13-17(23(25)28)7-10-22(20)29-19-8-5-16(6-9-19)15-27-12-2-4-21(27)18-3-1-11-26-14-18/h1,3,5-11,13-14,21H,2,4,12,15H2,(H2,25,28)/t21-/m0/s1	LOOCZNLSXJHWTG-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_003095	451492-95-8	C27H28ClFN6O	2.2917	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003096	Thalidomide, propargyl	C16H12N2O5	2.3947	132118478		C#CCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C16H12N2O5/c1-2-8-23-11-5-3-4-9-13(11)16(22)18(15(9)21)10-6-7-12(19)17-14(10)20/h1,3-5,10H,6-8H2,(H,17,19,20)	NOGQTNDSZFYNTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003098	451492-95-8	C27H28ClFN6O	2.6721	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003100	oxamflatin	C17H14N2O4S	2.9703	5353852	C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)C#C/C=C/C(=O)NO	O=C(C=CC#Cc1cc(NS(=O)(=O)c2ccccc2)ccc1)NO	InChI=1S/C17H14N2O4S/c20-17(18-21)12-5-4-7-14-8-6-9-15(13-14)19-24(22,23)16-10-2-1-3-11-16/h1-3,5-6,8-13,19,21H,(H,18,20)/b12-5+	QRPSQQUYPMFERG-LFYBBSHMSA-N					compound annotation
0391_003101	451492-95-8	C27H28ClFN6O	2.9703	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003102	azosemide	C12H11ClN6O2S2	3.359	2273		NS(=O)(=O)c1c(Cl)cc(NCc2cccs2)c(-c2n[nH]nn2)c1	InChI=1S/C12H11ClN6O2S2/c13-9-5-10(15-6-7-2-1-3-22-7)8(12-16-18-19-17-12)4-11(9)23(14,20)21/h1-5,15H,6H2,(H2,14,20,21)(H,16,17,18,19)	HMEDEBAJARCKCT-UHFFFAOYSA-N					compound annotation
0391_003103	451492-95-8	C27H28ClFN6O	3.5761	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003104	AMG 487	C32H28F3N5O4	3.5761	24957182	CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC=C(C=C5)OC(F)(F)F	CCOc1ccc(-n2c(C(C)N(Cc3cnccc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3c(cccn3)c2=O)cc1	InChI=1S/C32H28F3N5O4/c1-3-43-25-14-10-24(11-15-25)40-30(38-29-27(31(40)42)7-5-17-37-29)21(2)39(20-23-6-4-16-36-19-23)28(41)18-22-8-12-26(13-9-22)44-32(33,34)35/h4-17,19,21H,3,18,20H2,1-2H3/t21-/m1/s1	WQTKNBPCJKRYPA-OAQYLSRUSA-N					doublet; compound annotation
0391_003105	NIBR189	C21H21BrN2O3	3.7323	36295259	COC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC=C(C=C3)Br	COc1ccc(C(=O)N2CCN(C(=O)C=Cc3ccc(Br)cc3)CC2)cc1	InChI=1S/C21H21BrN2O3/c1-27-19-9-5-17(6-10-19)21(26)24-14-12-23(13-15-24)20(25)11-4-16-2-7-18(22)8-3-16/h2-11H,12-15H2,1H3/b11-4+	OFHXXBRBGWUOHR-NYYWCZLTSA-N					doublet; compound annotation
0391_003106	AMG 487	C32H28F3N5O4	3.783	24957182	CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC=C(C=C5)OC(F)(F)F	CCOc1ccc(-n2c(C(C)N(Cc3cnccc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3c(cccn3)c2=O)cc1	InChI=1S/C32H28F3N5O4/c1-3-43-25-14-10-24(11-15-25)40-30(38-29-27(31(40)42)7-5-17-37-29)21(2)39(20-23-6-4-16-36-19-23)28(41)18-22-8-12-26(13-9-22)44-32(33,34)35/h4-17,19,21H,3,18,20H2,1-2H3/t21-/m1/s1	WQTKNBPCJKRYPA-OAQYLSRUSA-N					doublet; removed another duplicate entry; compound annotation
0391_003108	NIBR189	C21H21BrN2O3	3.9778	36295259	COC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)/C=C/C3=CC=C(C=C3)Br	COc1ccc(C(=O)N2CCN(C(=O)C=Cc3ccc(Br)cc3)CC2)cc1	InChI=1S/C21H21BrN2O3/c1-27-19-9-5-17(6-10-19)21(26)24-14-12-23(13-15-24)20(25)11-4-16-2-7-18(22)8-3-16/h2-11H,12-15H2,1H3/b11-4+	OFHXXBRBGWUOHR-NYYWCZLTSA-N					doublet; removed another duplicate entry; compound annotation
0391_003110	AMG 487	C32H28F3N5O4	4.2786	24957182	CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC=C(C=C5)OC(F)(F)F	CCOc1ccc(-n2c(C(C)N(Cc3cnccc3)C(=O)Cc3ccc(OC(F)(F)F)cc3)nc3c(cccn3)c2=O)cc1	InChI=1S/C32H28F3N5O4/c1-3-43-25-14-10-24(11-15-25)40-30(38-29-27(31(40)42)7-5-17-37-29)21(2)39(20-23-6-4-16-36-19-23)28(41)18-22-8-12-26(13-9-22)44-32(33,34)35/h4-17,19,21H,3,18,20H2,1-2H3/t21-/m1/s1	WQTKNBPCJKRYPA-OAQYLSRUSA-N					doublet; compound annotation
0391_003111	MK-2894	C25H22F3NO3S	4.6403	24952929		Cc1c(Cc2ccc(C(F)(F)F)cc2)c(C(=O)NC2(c3ccc(C(=O)O)cc3)CC2)c(C)s1	InChI=1S/C25H22F3NO3S/c1-14-20(13-16-3-7-19(8-4-16)25(26,27)28)21(15(2)33-14)22(30)29-24(11-12-24)18-9-5-17(6-10-18)23(31)32/h3-10H,11-13H2,1-2H3,(H,29,30)(H,31,32)	QJZQFVRFJCGDKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003113	Motesanib	C22H23N5O	1.6623	11667893		CC1(C)CNc2c1ccc(NC(=O)c1cccnc1NCc1ccncc1)c2	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	RAHBGWKEPAQNFF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003116	JWG-071	C34H44N8O3	2.818	131842089		CCC(C)N1c2ccccc2C(=O)N(C)c2cnc(Nc3c(OC)cc(C(=O)N4CCC(N5CCN(C)CC5)CC4)cc3)nc21	InChI=1S/C34H44N8O3/c1-6-23(2)42-28-10-8-7-9-26(28)33(44)39(4)29-22-35-34(37-31(29)42)36-27-12-11-24(21-30(27)45-5)32(43)41-15-13-25(14-16-41)40-19-17-38(3)18-20-40/h7-12,21-23,25H,6,13-20H2,1-5H3,(H,35,36,37)	ACWOMSOYIIVIRV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003118	Nesolicaftor	C18H18N4O4	2.9027	121439966	C[C@H](C1=NN=C(O1)C2CC(C2)NC(=O)C3=CC(=NO3)C4=CC=CC=C4)O	CC(O)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1	InChI=1S/C18H18N4O4/c1-10(23)17-20-21-18(25-17)12-7-13(8-12)19-16(24)15-9-14(22-26-15)11-5-3-2-4-6-11/h2-6,9-10,12-13,23H,7-8H2,1H3,(H,19,24)/t10-,12?,13?/m1/s1	XPEHHUISIBFLHX-QFWMXSHPSA-N					removed another duplicate entry; compound annotation
0391_003120	1144068-46-1	C27H33N7O4	3.5124	25260757		CNC(=O)Nc1ccc(-c2nc3c(cnn3C3CCC4(CC3)OCCO4)c(N3CC4CCC(C3)O4)n2)cc1	InChI=1S/C27H33N7O4/c1-28-26(35)30-18-4-2-17(3-5-18)23-31-24(33-15-20-6-7-21(16-33)38-20)22-14-29-34(25(22)32-23)19-8-10-27(11-9-19)36-12-13-37-27/h2-5,14,19-21H,6-13,15-16H2,1H3,(H2,28,30,35)	QLHHRYZMBGPBJG-UHFFFAOYSA-N					doublet; compound annotation
0391_003121	1144068-46-1	C27H33N7O4	3.5173	25260757		CNC(=O)Nc1ccc(-c2nc3c(cnn3C3CCC4(CC3)OCCO4)c(N3CC4CCC(C3)O4)n2)cc1	InChI=1S/C27H33N7O4/c1-28-26(35)30-18-4-2-17(3-5-18)23-31-24(33-15-20-6-7-21(16-33)38-20)22-14-29-34(25(22)32-23)19-8-10-27(11-9-19)36-12-13-37-27/h2-5,14,19-21H,6-13,15-16H2,1H3,(H2,28,30,35)	QLHHRYZMBGPBJG-UHFFFAOYSA-N					doublet; compound annotation
0391_003122	Gemcabene	C16H30O5	3.8942	157692		CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O	InChI=1S/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20)	SDMBRCRVFFHJKR-UHFFFAOYSA-N					doublet; compound annotation
0391_003123	ICG-001	C33H32N4O4	3.9126	11238147	C1CN([C@H]2CN(C(=O)[C@@H](N2C1=O)CC3=CC=C(C=C3)O)CC4=CC=CC5=CC=CC=C54)C(=O)NCC6=CC=CC=C6	O=C1C(Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)C2CN1Cc1cccc2ccccc12	InChI=1S/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30+/m0/s1	HQWTUOLCGKIECB-XZWHSSHBSA-N					removed another duplicate entry; compound annotation
0391_003125	GeA-69	C20H16N2O	4.204	135397654		CC(=O)Nc1ccccc1-c1cccc2c1[nH]c1ccccc12	InChI=1S/C20H16N2O/c1-13(23)21-18-11-4-2-7-14(18)16-9-6-10-17-15-8-3-5-12-19(15)22-20(16)17/h2-12,22H,1H3,(H,21,23)	LDPDVNYCIOHPGF-UHFFFAOYSA-N					doublet; compound annotation
0391_003126	GeA-69	C20H16N2O	4.2069	135397654		CC(=O)Nc1ccccc1-c1cccc2c1[nH]c1ccccc12	InChI=1S/C20H16N2O/c1-13(23)21-18-11-4-2-7-14(18)16-9-6-10-17-15-8-3-5-12-19(15)22-20(16)17/h2-12,22H,1H3,(H,21,23)	LDPDVNYCIOHPGF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003128	Cyclopyrimorate	C19H20ClN3O4	4.4117	23013854		Cc1c(Oc2nnc(Cl)cc2OC(=O)N2CCOCC2)c(C2CC2)ccc1	InChI=1S/C19H20ClN3O4/c1-12-3-2-4-14(13-5-6-13)17(12)27-18-15(11-16(20)21-22-18)26-19(24)23-7-9-25-10-8-23/h2-4,11,13H,5-10H2,1H3	BXIGJZDQFDFASM-UHFFFAOYSA-N					doublet; compound annotation
0391_003129	Cyclopyrimorate	C19H20ClN3O4	4.4162	23013854		Cc1c(Oc2nnc(Cl)cc2OC(=O)N2CCOCC2)c(C2CC2)ccc1	InChI=1S/C19H20ClN3O4/c1-12-3-2-4-14(13-5-6-13)17(12)27-18-15(11-16(20)21-22-18)26-19(24)23-7-9-25-10-8-23/h2-4,11,13H,5-10H2,1H3	BXIGJZDQFDFASM-UHFFFAOYSA-N					doublet; compound annotation
0391_003130	1110873-99-8	C21H19F3N4O4S	4.4659	40135492		Cc1noc(CSc2ccccc2C(=O)NCCNc2c([N+](=O)[O-])cc(C(F)(F)F)cc2)c1	InChI=1S/C21H19F3N4O4S/c1-13-10-15(32-27-13)12-33-19-5-3-2-4-16(19)20(29)26-9-8-25-17-7-6-14(21(22,23)24)11-18(17)28(30)31/h2-7,10-11,25H,8-9,12H2,1H3,(H,26,29)	BPHPWPNHNGXNPR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003132	Capadenoson	C25H18ClN5O2S2	4.7868	9936489		N#Cc1c(-c2ccc(OCCO)cc2)c(C#N)c(SCc2csc(-c3ccc(Cl)cc3)n2)nc1N	InChI=1S/C25H18ClN5O2S2/c26-17-5-1-16(2-6-17)24-30-18(13-34-24)14-35-25-21(12-28)22(20(11-27)23(29)31-25)15-3-7-19(8-4-15)33-10-9-32/h1-8,13,32H,9-10,14H2,(H2,29,31)	CITWCLNVRIKQAF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003134	MW-150	C24H23N5	2.0239	86270361		CN1CCN(c2nnc(-c3cc4ccccc4cc3)c(-c3ccncc3)c2)CC1	InChI=1S/C24H23N5/c1-28-12-14-29(15-13-28)23-17-22(19-8-10-25-11-9-19)24(27-26-23)21-7-6-18-4-2-3-5-20(18)16-21/h2-11,16-17H,12-15H2,1H3	CIIVUDIZZJLXCN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003136	BMS-852927	C29H28Cl2F2N2O4S	3.0787	49787490		CC(C)(O)c1cn(-c2c(F)cc(-c3cc(F)c(CO)c(S(C)(=O)=O)c3)cc2)c(C(C)(C)c2c(Cl)cccc2Cl)n1	InChI=1S/C29H28Cl2F2N2O4S/c1-28(2,26-19(30)7-6-8-20(26)31)27-34-25(29(3,4)37)14-35(27)23-10-9-16(11-22(23)33)17-12-21(32)18(15-36)24(13-17)40(5,38)39/h6-14,36-37H,15H2,1-5H3	HNAJDMYOTDNOBK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003138	GNF351	C24H25N7	3.1521	46216378		Cc1cc(-c2nc(NCCc3c[nH]c4ccccc34)c3ncn(C(C)C)c3n2)cnc1	InChI=1S/C24H25N7/c1-15(2)31-14-28-21-23(26-9-8-17-13-27-20-7-5-4-6-19(17)20)29-22(30-24(21)31)18-10-16(3)11-25-12-18/h4-7,10-15,27H,8-9H2,1-3H3,(H,26,29,30)	ABXIUYMKZDZUDC-UHFFFAOYSA-N					compound annotation
0391_003139	473727-83-2	C21H23N3O5	3.1999	9865554	CC[C@H](C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C	CCC(Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1	InChI=1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1	RXIUEIPPLAFSDF-CYBMUJFWSA-N					compound annotation
0391_003140	AZD4635	C15H11ClFN5	3.3892	86676119		Cc1cc(-c2nnc(N)nc2-c2ccc(F)cc2)cc(Cl)n1	InChI=1S/C15H11ClFN5/c1-8-6-10(7-12(16)19-8)14-13(20-15(18)22-21-14)9-2-4-11(17)5-3-9/h2-7H,1H3,(H2,18,20,22)	NCWQLHHDGDXIJN-UHFFFAOYSA-N					compound annotation
0391_003141	SUCROSE OCTAACETATE	C28H38O19	3.7596	31340	CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C	CC(=O)OCC1OC(OC2(COC(C)=O)OC(COC(C)=O)C(OC(C)=O)C2OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O	InChI=1S/C28H38O19/c1-12(29)37-9-20-22(40-15(4)32)24(42-17(6)34)25(43-18(7)35)27(45-20)47-28(11-39-14(3)31)26(44-19(8)36)23(41-16(5)33)21(46-28)10-38-13(2)30/h20-27H,9-11H2,1-8H3/t20-,21-,22-,23-,24+,25-,26+,27-,28+/m1/s1	ZIJKGAXBCRWEOL-SAXBRCJISA-N					compound annotation
0391_003142	CDK9-PROTAC	C33H35N5O7	3.977	132472236		O=C1CCC(N2C(=O)c3c(C2=O)c(OCCCCCOc2ccc(CC(=O)Nc4n[nH]c(C5CCC5)c4)cc2)ccc3)C(=O)N1	InChI=1S/C33H35N5O7/c39-28-15-14-25(31(41)35-28)38-32(42)23-8-5-9-26(30(23)33(38)43)45-17-3-1-2-16-44-22-12-10-20(11-13-22)18-29(40)34-27-19-24(36-37-27)21-6-4-7-21/h5,8-13,19,21,25H,1-4,6-7,14-18H2,(H,35,39,41)(H2,34,36,37,40)	WCEHIDWONYOKOJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003144	Bamaquimast	C16H21N3O3	4.2437	184838		CCCn1c(=O)c(CCCOC(=O)NC)nc2ccccc21	InChI=1S/C16H21N3O3/c1-3-10-19-14-9-5-4-7-12(14)18-13(15(19)20)8-6-11-22-16(21)17-2/h4-5,7,9H,3,6,8,10-11H2,1-2H3,(H,17,21)	HNQSZPBGDAJIJO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003146	CGI-1746	C34H37N5O4	4.4115	24857323		Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C(=O)N4CCOCC4)cc3)n2)cccc1NC(=O)c1ccc(C(C)(C)C)cc1	InChI=1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-13-25(14-10-23)34(2,3)4)29-21-38(5)33(42)30(36-29)35-26-15-11-24(12-16-26)32(41)39-17-19-43-20-18-39/h6-16,21H,17-20H2,1-5H3,(H,35,36)(H,37,40)	JIFCFQDXHMUPGP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003148	Vasicine	C11H12N2O	0.739	667496	C1CN2CC3=CC=CC=C3N=C2[C@H]1O	OC1CCN2Cc3ccccc3N=C12	InChI=1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2/t10-/m0/s1	YIICVSCAKJMMDJ-JTQLQIEISA-N					compound annotation
0391_003149	Picosulfate	C18H15NO8S2	0.9377	5243		O=S(=O)(O)Oc1ccc(C(c2ccc(OS(=O)(=O)O)cc2)c2ccccn2)cc1	InChI=1S/C18H15NO8S2/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25/h1-12,18H,(H,20,21,22)(H,23,24,25)	UJIDKYTZIQTXPM-UHFFFAOYSA-N					compound annotation
0391_003150	7-Amino-4-methylcoumarin	C10H9NO2	1.9941	92249		Cc1cc(=O)oc2c1ccc(N)c2	InChI=1S/C10H9NO2/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5H,11H2,1H3	GLNDAGDHSLMOKX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003153	diazoxide	C8H7ClN2O2S	2.1025	3019		CC1=NS(=O)(=O)c2c(ccc(Cl)c2)N1	InChI=1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11)	GDLBFKVLRPITMI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003155	7-Methoxy-4-methylcoumarin	C11H10O3	2.9892	390807		COc1cc2c(cc1)c(C)cc(=O)o2	InChI=1S/C11H10O3/c1-7-5-11(12)14-10-6-8(13-2)3-4-9(7)10/h3-6H,1-2H3	UDFPKNSWSYBIHO-UHFFFAOYSA-N					doublet; compound annotation
0391_003156	7-Methoxy-4-methylcoumarin	C11H10O3	2.9925	390807		COc1cc2c(cc1)c(C)cc(=O)o2	InChI=1S/C11H10O3/c1-7-5-11(12)14-10-6-8(13-2)3-4-9(7)10/h3-6H,1-2H3	UDFPKNSWSYBIHO-UHFFFAOYSA-N					doublet; compound annotation
0391_003157	Forchlorfenuron	C12H10ClN3O	3.2196	93379		O=C(Nc1ccccc1)Nc1cc(Cl)ncc1	InChI=1S/C12H10ClN3O/c13-11-8-10(6-7-14-11)16-12(17)15-9-4-2-1-3-5-9/h1-8H,(H2,14,15,16,17)	GPXLRLUVLMHHIK-UHFFFAOYSA-N					compound annotation
0391_003158	fenbufen	C16H14O3	3.7633	3335		O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1	InChI=1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19)	ZPAKPRAICRBAOD-UHFFFAOYSA-N					compound annotation
0391_003159	cephalothin	C16H16N2O6S2	2.5192	6024	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O	CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)Cc3cccs3)C2SC1	InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1	XIURVHNZVLADCM-IUODEOHRSA-N					doublet; compound annotation
0391_003160	cephalothin	C16H16N2O6S2	2.563	6024	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O	CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)Cc3cccs3)C2SC1	InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1	XIURVHNZVLADCM-IUODEOHRSA-N					doublet; compound annotation
0391_003161	GJ103	C16H14N4O3S	2.6276	71748051		COc1cccc(-n2c(SCC(=O)O)nnc2-c2ccccn2)c1	InChI=1S/C16H14N4O3S/c1-23-12-6-4-5-11(9-12)20-15(13-7-2-3-8-17-13)18-19-16(20)24-10-14(21)22/h2-9H,10H2,1H3,(H,21,22)	GBVQSAZHPCDBDY-UHFFFAOYSA-N					doublet; compound annotation
0391_003162	GJ103	C16H14N4O3S	2.6303	71748051		COc1cccc(-n2c(SCC(=O)O)nnc2-c2ccccn2)c1	InChI=1S/C16H14N4O3S/c1-23-12-6-4-5-11(9-12)20-15(13-7-2-3-8-17-13)18-19-16(20)24-10-14(21)22/h2-9H,10H2,1H3,(H,21,22)	GBVQSAZHPCDBDY-UHFFFAOYSA-N					doublet; compound annotation
0391_003163	Oxybuprocaine	C17H28N2O3	2.6331	4633		CCCCOc1c(N)ccc(C(=O)OCCN(CC)CC)c1	InChI=1S/C17H28N2O3/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3/h8-9,13H,4-7,10-12,18H2,1-3H3	CMHHMUWAYWTMGS-UHFFFAOYSA-N					compound annotation
0391_003164	Doramapimod	C31H37N5O3	3.4449	156422		Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1	InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)	MVCOAUNKQVWQHZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003166	Boc-Met-Leu-Phe-OH	C25H39N3O6S	4.1192	14655143	CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)NC(=O)OC(C)(C)C	CSCCC(NC(=O)OC(C)(C)C)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C25H39N3O6S/c1-16(2)14-19(22(30)27-20(23(31)32)15-17-10-8-7-9-11-17)26-21(29)18(12-13-35-6)28-24(33)34-25(3,4)5/h7-11,16,18-20H,12-15H2,1-6H3,(H,26,29)(H,27,30)(H,28,33)(H,31,32)/t18-,19-,20-/m0/s1	GYBXWOPENJVQKE-UFYCRDLUSA-N					removed another duplicate entry; compound annotation
0391_003168	MYCLOBUTANIL	C15H17ClN4	4.1521	6336		CCCCC(C#N)(Cn1cncn1)c1ccc(Cl)cc1	InChI=1S/C15H17ClN4/c1-2-3-8-15(9-17,10-20-12-18-11-19-20)13-4-6-14(16)7-5-13/h4-7,11-12H,2-3,8,10H2,1H3	HZJKXKUJVSEEFU-UHFFFAOYSA-N					compound annotation
0391_003169	FIN56	C25H31N3O5S2	4.8794	118986699		O=S(=O)(NC1CCCCC1)c1cc2c(cc1)-c1c(cc(S(=O)(=O)NC3CCCCC3)cc1)C2=NO	InChI=1S/C25H31N3O5S2/c29-26-25-23-15-19(34(30,31)27-17-7-3-1-4-8-17)11-13-21(23)22-14-12-20(16-24(22)25)35(32,33)28-18-9-5-2-6-10-18/h11-18,27-29H,1-10H2	JLCFMMIWBSZOIS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003172	5-Bromo-4'-chlorosalicylanilide	C13H9BrClNO2	4.9629	77254		O=C(Nc1ccc(Cl)cc1)c1c(O)ccc(Br)c1	InChI=1S/C13H9BrClNO2/c14-8-1-6-12(17)11(7-8)13(18)16-10-4-2-9(15)3-5-10/h1-7,17H,(H,16,18)	QBSGXIBYUQJHMJ-UHFFFAOYSA-N					compound annotation
0391_003173	Triclocarban	C13H9Cl3N2O	5.0046	7547		O=C(Nc1ccc(Cl)cc1)Nc1cc(Cl)c(Cl)cc1	InChI=1S/C13H9Cl3N2O/c14-8-1-3-9(4-2-8)17-13(19)18-10-5-6-11(15)12(16)7-10/h1-7H,(H2,17,18,19)	ICUTUKXCWQYESQ-UHFFFAOYSA-N					compound annotation
0391_003174	phosalone	C12H15ClNO4PS2	5.1143	4793		CCOP(=S)(OCC)SCn1c(=O)oc2c1ccc(Cl)c2	InChI=1S/C12H15ClNO4PS2/c1-3-16-19(20,17-4-2)21-8-14-10-6-5-9(13)7-11(10)18-12(14)15/h5-7H,3-4,8H2,1-2H3	IOUNQDKNJZEDEP-UHFFFAOYSA-N					doublet; compound annotation
0391_003175	phosalone	C12H15ClNO4PS2	5.1198	4793		CCOP(=S)(OCC)SCn1c(=O)oc2c1ccc(Cl)c2	InChI=1S/C12H15ClNO4PS2/c1-3-16-19(20,17-4-2)21-8-14-10-6-5-9(13)7-11(10)18-12(14)15/h5-7H,3-4,8H2,1-2H3	IOUNQDKNJZEDEP-UHFFFAOYSA-N					doublet; compound annotation
0391_003176	Oxypaeoniflorin	C23H28O12	1.1846	21631105	C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)C5=CC=C(C=C5)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O	CC12CC3(O)OC(O1)C1(COC(=O)c4ccc(O)cc4)C3CC21OC1OC(CO)C(O)C(O)C1O	InChI=1S/C23H28O12/c1-20-8-22(30)13-6-23(20,33-18-16(28)15(27)14(26)12(7-24)32-18)21(13,19(34-20)35-22)9-31-17(29)10-2-4-11(25)5-3-10/h2-5,12-16,18-19,24-28,30H,6-9H2,1H3/t12-,13-,14-,15+,16-,18+,19-,20+,21+,22-,23+/m1/s1	FCHVXNVDFYXLIL-WRJNSLSBSA-N					compound annotation
0391_003177	Isoorientin	C21H20O11	1.6172	114776	C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O	O=c1cc(-c2cc(O)c(O)cc2)oc2c1c(O)c(C1OC(CO)C(O)C(O)C1O)c(O)c2	InChI=1S/C21H20O11/c22-6-14-17(27)19(29)20(30)21(32-14)16-11(26)5-13-15(18(16)28)10(25)4-12(31-13)7-1-2-8(23)9(24)3-7/h1-5,14,17,19-24,26-30H,6H2/t14-,17-,19+,20-,21+/m1/s1	ODBRNZZJSYPIDI-VJXVFPJBSA-N					removed another duplicate entry; compound annotation
0391_003179	57420-46-9	C19H28O12	1.7843	162823	CC(=O)O[C@]1(C[C@H]([C@H]2[C@@H]1[C@@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)C	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C1C(O)CC2(C)OC(C)=O	InChI=1S/C19H28O12/c1-7(21)31-19(2)4-9(22)11-8(16(26)27-3)6-28-17(12(11)19)30-18-15(25)14(24)13(23)10(5-20)29-18/h6,9-15,17-18,20,22-25H,4-5H2,1-3H3/t9-,10-,11+,12-,13-,14+,15-,17+,18+,19+/m1/s1	ARFRZOLTIRQFCI-NGQYDJQZSA-N					compound annotation
0391_003180	Neoandrographolide	C26H40O8	3.1994	9848024	C[C@]1(CCC[C@@]2([C@@H]1CCC(=C)[C@H]2CCC3=CCOC3=O)C)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	C=C1CCC2C(C)(COC3OC(CO)C(O)C(O)C3O)CCCC2(C)C1CCC1=CCOC1=O	InChI=1S/C26H40O8/c1-15-5-8-19-25(2,14-33-24-22(30)21(29)20(28)18(13-27)34-24)10-4-11-26(19,3)17(15)7-6-16-9-12-32-23(16)31/h9,17-22,24,27-30H,1,4-8,10-14H2,2-3H3/t17-,18-,19-,20-,21+,22-,24-,25+,26+/m1/s1	YGCYRQKJYWQXHG-RDNQFMDVSA-N					compound annotation
0391_003181	Eupatilin	C18H16O7	3.4582	5273755		COc1c(OC)cc(-c2cc(=O)c3c(cc(O)c(OC)c3O)o2)cc1	InChI=1S/C18H16O7/c1-22-12-5-4-9(6-14(12)23-2)13-7-10(19)16-15(25-13)8-11(20)18(24-3)17(16)21/h4-8,20-21H,1-3H3	DRRWBCNQOKKKOL-UHFFFAOYSA-N					doublet; compound annotation
0391_003182	Eupatilin	C18H16O7	3.4615	5273755		COc1c(OC)cc(-c2cc(=O)c3c(cc(O)c(OC)c3O)o2)cc1	InChI=1S/C18H16O7/c1-22-12-5-4-9(6-14(12)23-2)13-7-10(19)16-15(25-13)8-11(20)18(24-3)17(16)21/h4-8,20-21H,1-3H3	DRRWBCNQOKKKOL-UHFFFAOYSA-N					doublet; compound annotation
0391_003183	Nardosinone	C15H22O3	3.9658	168136	C[C@@H]1CCC=C2[C@]1([C@H]3[C@@H](CC2=O)OOC3(C)C)C	CC1CCC=C2C(=O)CC3OOC(C)(C)C3C21C	InChI=1S/C15H22O3/c1-9-6-5-7-10-11(16)8-12-13(15(9,10)4)14(2,3)18-17-12/h7,9,12-13H,5-6,8H2,1-4H3/t9-,12-,13+,15+/m1/s1	KXGHHSIMRWPVQM-JWFUOXDNSA-N					compound annotation
0391_003184	Aceclofenac	C16H13Cl2NO4	4.3501	71771		O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl	InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)	MNIPYSSQXLZQLJ-UHFFFAOYSA-N					compound annotation
0391_003185	Bromothymol blue	C27H28Br2O5S	4.6034	6450		Cc1c(C2(c3c(C)c(Br)c(O)c(C(C)C)c3)OS(=O)(=O)c3ccccc32)cc(C(C)C)c(O)c1Br	InChI=1S/C27H28Br2O5S/c1-13(2)17-11-20(15(5)23(28)25(17)30)27(19-9-7-8-10-22(19)35(32,33)34-27)21-12-18(14(3)4)26(31)24(29)16(21)6/h7-14,30-31H,1-6H3	NUHCTOLBWMJMLX-UHFFFAOYSA-N					doublet; compound annotation
0391_003186	Bromothymol blue	C27H28Br2O5S	4.9456	6450		Cc1c(C2(c3c(C)c(Br)c(O)c(C(C)C)c3)OS(=O)(=O)c3ccccc32)cc(C(C)C)c(O)c1Br	InChI=1S/C27H28Br2O5S/c1-13(2)17-11-20(15(5)23(28)25(17)30)27(19-9-7-8-10-22(19)35(32,33)34-27)21-12-18(14(3)4)26(31)24(29)16(21)6/h7-14,30-31H,1-6H3	NUHCTOLBWMJMLX-UHFFFAOYSA-N					doublet; compound annotation
0391_003187	PIK-III	C17H17N7	1.7054	67983123		Nc1ncc(-c2nc(Nc3ccncc3)ncc2)c(CC2CC2)n1	InChI=1S/C17H17N7/c18-16-21-10-13(15(23-16)9-11-1-2-11)14-5-8-20-17(24-14)22-12-3-6-19-7-4-12/h3-8,10-11H,1-2,9H2,(H2,18,21,23)(H,19,20,22,24)	XXSDLQLNIVFIJI-UHFFFAOYSA-N					compound annotation
0391_003188	Dofequidar	C30H31N3O3	2.2886	213040		O=C(C(c1ccccc1)c1ccccc1)N1CCN(CC(O)COc2cccc3c2cccn3)CC1	InChI=1S/C30H31N3O3/c34-25(22-36-28-15-7-14-27-26(28)13-8-16-31-27)21-32-17-19-33(20-18-32)30(35)29(23-9-3-1-4-10-23)24-11-5-2-6-12-24/h1-16,25,29,34H,17-22H2	KLWUUPVJTLHYIM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003190	36840-10-5	C20H16N2O6	2.5196	1105689	C1=CC(=CC=C1C2=CC=C(C=C2)NC(=O)/C=C/C(=O)O)NC(=O)/C=C/C(=O)O	O=C(O)C=CC(=O)Nc1ccc(-c2ccc(NC(=O)C=CC(=O)O)cc2)cc1	InChI=1S/C20H16N2O6/c23-17(9-11-19(25)26)21-15-5-1-13(2-6-15)14-3-7-16(8-4-14)22-18(24)10-12-20(27)28/h1-12H,(H,21,23)(H,22,24)(H,25,26)(H,27,28)/b11-9+,12-10+	FTLRWRKPUWMOMS-WGDLNXRISA-N					compound annotation
0391_003191	2-D08	C15H10O5	2.5227	22507438		O=c1cc(-c2c(O)c(O)c(O)cc2)oc2ccccc12	InChI=1S/C15H10O5/c16-10-6-5-9(14(18)15(10)19)13-7-11(17)8-3-1-2-4-12(8)20-13/h1-7,16,18-19H	JJAXTFSPCLZPIW-UHFFFAOYSA-N					compound annotation
0391_003192	Cyantraniliprole	C19H14BrClN6O2	3.4109	11578610		CNC(=O)c1c(NC(=O)c2cc(Br)nn2-c2c(Cl)cccn2)c(C)cc(C#N)c1	InChI=1S/C19H14BrClN6O2/c1-10-6-11(9-22)7-12(18(28)23-2)16(10)25-19(29)14-8-15(20)26-27(14)17-13(21)4-3-5-24-17/h3-8H,1-2H3,(H,23,28)(H,25,29)	DVBUIBGJRQBEDP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003194	WEHI-539	C31H29N5O3S2	3.5731	71297207	C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)/C(=N/NC5=NC6=CC=CC=C6S5)/C1	NCc1ccc(OCCCc2c(C(=O)O)nc(-c3cc4c(cc3)CCCC4=NNc3nc4ccccc4s3)s2)cc1	InChI=1S/C31H29N5O3S2/c32-18-19-10-14-22(15-11-19)39-16-4-9-27-28(30(37)38)34-29(40-27)21-13-12-20-5-3-7-24(23(20)17-21)35-36-31-33-25-6-1-2-8-26(25)41-31/h1-2,6,8,10-15,17H,3-5,7,9,16,18,32H2,(H,33,36)(H,37,38)/b35-24+	JKMWZKPAXZBYEH-JWHWKPFMSA-N					doublet; compound annotation
0391_003195	WEHI-539	C31H29N5O3S2	3.5764	71297207	C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)/C(=N/NC5=NC6=CC=CC=C6S5)/C1	NCc1ccc(OCCCc2c(C(=O)O)nc(-c3cc4c(cc3)CCCC4=NNc3nc4ccccc4s3)s2)cc1	InChI=1S/C31H29N5O3S2/c32-18-19-10-14-22(15-11-19)39-16-4-9-27-28(30(37)38)34-29(40-27)21-13-12-20-5-3-7-24(23(20)17-21)35-36-31-33-25-6-1-2-8-26(25)41-31/h1-2,6,8,10-15,17H,3-5,7,9,16,18,32H2,(H,33,36)(H,37,38)/b35-24+	JKMWZKPAXZBYEH-JWHWKPFMSA-N					doublet; compound annotation
0391_003196	MM-102	C35H49F2N7O4	3.9593	54766613	CCC(CC)(C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC1(CCCC1)C(=O)NC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)NC(=O)C(C)C	CCC(CC)(NC(=O)C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC1(C(=O)NC(c2ccc(F)cc2)c2ccc(F)cc2)CCCC1	InChI=1S/C35H49F2N7O4/c1-5-34(6-2,43-29(45)22(3)4)31(47)41-27(10-9-21-40-33(38)39)30(46)44-35(19-7-8-20-35)32(48)42-28(23-11-15-25(36)16-12-23)24-13-17-26(37)18-14-24/h11-18,22,27-28H,5-10,19-21H2,1-4H3,(H,41,47)(H,42,48)(H,43,45)(H,44,46)(H4,38,39,40)/t27-/m0/s1	RZKSQRIPRKWVBU-MHZLTWQESA-N					doublet; compound annotation
0391_003197	MM-102	C35H49F2N7O4	3.9621	54766613	CCC(CC)(C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC1(CCCC1)C(=O)NC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)NC(=O)C(C)C	CCC(CC)(NC(=O)C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC1(C(=O)NC(c2ccc(F)cc2)c2ccc(F)cc2)CCCC1	InChI=1S/C35H49F2N7O4/c1-5-34(6-2,43-29(45)22(3)4)31(47)41-27(10-9-21-40-33(38)39)30(46)44-35(19-7-8-20-35)32(48)42-28(23-11-15-25(36)16-12-23)24-13-17-26(37)18-14-24/h11-18,22,27-28H,5-10,19-21H2,1-4H3,(H,41,47)(H,42,48)(H,43,45)(H,44,46)(H4,38,39,40)/t27-/m0/s1	RZKSQRIPRKWVBU-MHZLTWQESA-N					doublet; compound annotation
0391_003198	S26131	C31H34N2O4	4.4432	9870523		CC(=O)NCCc1cccc2c1cc(OCCCOc1cc3c(cccc3CCNC(C)=O)cc1)cc2	InChI=1S/C31H34N2O4/c1-22(34)32-16-14-26-8-3-6-24-10-12-28(20-30(24)26)36-18-5-19-37-29-13-11-25-7-4-9-27(31(25)21-29)15-17-33-23(2)35/h3-4,6-13,20-21H,5,14-19H2,1-2H3,(H,32,34)(H,33,35)	NSXBZYDTTKLTOH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003200	71203-35-5	C22H21N3O3S	4.5536	2950007		COc1ccc(C2CC(c3ccccc3)=NN2c2ccc(S(N)(=O)=O)cc2)cc1	InChI=1S/C22H21N3O3S/c1-28-19-11-7-17(8-12-19)22-15-21(16-5-3-2-4-6-16)24-25(22)18-9-13-20(14-10-18)29(23,26)27/h2-14,22H,15H2,1H3,(H2,23,26,27)	QBNZBMVRFYREHK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003202	Tubastatin A	C20H21N3O2	1.7864	49850262		CN1CCc2c(C1)c1ccccc1n2Cc1ccc(C(=O)NO)cc1	InChI=1S/C20H21N3O2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25/h2-9,25H,10-13H2,1H3,(H,21,24)	GOVYBPLHWIEHEJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003203	Btk inhibitor 1	C22H22N6O	1.7864	67095487		Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCNC3)c2ncn1	InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)	GPSQYTDPBDNDGI-UHFFFAOYSA-N					doublet; compound annotation
0391_003204	Rhosin	C20H18N6O	2.0397	9552914	C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)N/N=C/C3=CC4=NC=CN=C4C=C3)N	NC(Cc1c[nH]c2ccccc12)C(=O)NN=Cc1cc2nccnc2cc1	InChI=1S/C20H18N6O/c21-16(10-14-12-24-17-4-2-1-3-15(14)17)20(27)26-25-11-13-5-6-18-19(9-13)23-8-7-22-18/h1-9,11-12,16,24H,10,21H2,(H,26,27)/b25-11+/t16-/m1/s1	FGYHLIHEFHCMPP-FVWOBLMASA-N					doublet; compound annotation
0391_003205	Rhosin	C20H18N6O	2.0459	9552914	C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)N/N=C/C3=CC4=NC=CN=C4C=C3)N	NC(Cc1c[nH]c2ccccc12)C(=O)NN=Cc1cc2nccnc2cc1	InChI=1S/C20H18N6O/c21-16(10-14-12-24-17-4-2-1-3-15(14)17)20(27)26-25-11-13-5-6-18-19(9-13)23-8-7-22-18/h1-9,11-12,16,24H,10,21H2,(H,26,27)/b25-11+/t16-/m1/s1	FGYHLIHEFHCMPP-FVWOBLMASA-N					doublet; compound annotation
0391_003206	BS-181	C22H32N6	2.3546	49867929		CC(C)c1c2nc(NCCCCCCN)cc(NCc3ccccc3)n2nc1	InChI=1S/C22H32N6/c1-17(2)19-16-26-28-21(25-15-18-10-6-5-7-11-18)14-20(27-22(19)28)24-13-9-4-3-8-12-23/h5-7,10-11,14,16-17,25H,3-4,8-9,12-13,15,23H2,1-2H3,(H,24,27)	DNYBIOICMDTDAP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003208	Btk inhibitor 1	C22H22N6O	2.669	67095487		Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCNC3)c2ncn1	InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)	GPSQYTDPBDNDGI-UHFFFAOYSA-N					doublet; compound annotation
0391_003209	HhAntag	C24H23ClN4O3	2.7384	9911630		COc1cc(C(=O)Nc2cc(-c3nc4c(cc(N(C)C)cc4)[nH]3)c(Cl)cc2)cc(OC)c1	InChI=1S/C24H23ClN4O3/c1-29(2)16-6-8-21-22(12-16)28-23(27-21)19-11-15(5-7-20(19)25)26-24(30)14-9-17(31-3)13-18(10-14)32-4/h5-13H,1-4H3,(H,26,30)(H,27,28)	UBHJFPVTEATUFS-UHFFFAOYSA-N					doublet; compound annotation
0391_003210	Telomerase-IN-2	C34H39N3O9	2.8871	76285870		COc1cc2c(c(OC)c1)c(=O)c(OCCCCN1CCN(C(=O)c3ccncc3)CC1)c(-c1cc(OC)c(OC)c(OC)c1)o2	InChI=1S/C34H39N3O9/c1-40-24-20-25(41-2)29-26(21-24)46-31(23-18-27(42-3)32(44-5)28(19-23)43-4)33(30(29)38)45-17-7-6-12-36-13-15-37(16-14-36)34(39)22-8-10-35-11-9-22/h8-11,18-21H,6-7,12-17H2,1-5H3	HDOUAPSDPPFIGT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003212	HhAntag	C24H23ClN4O3	2.9564	9911630		COc1cc(C(=O)Nc2cc(-c3nc4c(cc(N(C)C)cc4)[nH]3)c(Cl)cc2)cc(OC)c1	InChI=1S/C24H23ClN4O3/c1-29(2)16-6-8-21-22(12-16)28-23(27-21)19-11-15(5-7-20(19)25)26-24(30)14-9-17(31-3)13-18(10-14)32-4/h5-13H,1-4H3,(H,26,30)(H,27,28)	UBHJFPVTEATUFS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003215	Dynasore	C18H14N2O4	3.1416	135533054	C1=CC=C2C=C(C(=CC2=C1)C(=O)N/N=C/C3=CC(=C(C=C3)O)O)O	O=C(NN=Cc1cc(O)c(O)cc1)c1cc2ccccc2cc1O	InChI=1S/C18H14N2O4/c21-15-6-5-11(7-17(15)23)10-19-20-18(24)14-8-12-3-1-2-4-13(12)9-16(14)22/h1-10,21-23H,(H,20,24)/b19-10+	SYNDQCRDGGCQRZ-VXLYETTFSA-N					removed another duplicate entry; compound annotation
0391_003217	GCN2-IN-6	C19H12Cl2F2N4O3S	3.6197	137347437		Nc1ncc(C#Cc2c(F)ccc(NS(=O)(=O)c3cc(Cl)cc(CO)c3Cl)c2F)cn1	InChI=1S/C19H12Cl2F2N4O3S/c20-12-5-11(9-28)17(21)16(6-12)31(29,30)27-15-4-3-14(22)13(18(15)23)2-1-10-7-25-19(24)26-8-10/h3-8,27-28H,9H2,(H2,24,25,26)	VJXAWOQPYMAEFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003218	GCN2-IN-6	C19H12Cl2F2N4O3S	3.6775	137347437		Nc1ncc(C#Cc2c(F)ccc(NS(=O)(=O)c3cc(Cl)cc(CO)c3Cl)c2F)cn1	InChI=1S/C19H12Cl2F2N4O3S/c20-12-5-11(9-28)17(21)16(6-12)31(29,30)27-15-4-3-14(22)13(18(15)23)2-1-10-7-25-19(24)26-8-10/h3-8,27-28H,9H2,(H2,24,25,26)	VJXAWOQPYMAEFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003219	1433286-57-7	C33H30ClN3O5	3.9617	71566397		NCCCOc1cc2ccccc2cc1C(=O)NCCOc1cc2ccccc2cc1C(=O)Nc1c(O)cc(Cl)cc1	InChI=1S/C33H30ClN3O5/c34-25-10-11-28(29(38)20-25)37-33(40)27-17-22-7-2-4-9-24(22)19-31(27)42-15-13-36-32(39)26-16-21-6-1-3-8-23(21)18-30(26)41-14-5-12-35/h1-4,6-11,16-20,38H,5,12-15,35H2,(H,36,39)(H,37,40)	AZHZVCGYOUJGQE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003221	Grazoprevir	C38H50N6O9S	5.5504	44603531	CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1	C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3c(cc(OC)cc3)nc1O2)C(=O)NS(=O)(=O)C1CC1	InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	OBMNJSNZOWALQB-NCQNOWPTSA-N					doublet; removed another duplicate entry; compound annotation
0391_003223	DS18561882	C28H31F3N4O6S	2.5496	139486677	C[C@H]1CN(CCN1C)C2=C(C3=C(C=C2)C4=C(CN(CC4)C(=O)C5=CC(=C(C=C5)NS(=O)(=O)C)OC(F)(F)F)C(=O)O3)C	Cc1c(N2CCN(C)C(C)C2)ccc2c1oc(=O)c1c2CCN(C(=O)c2cc(OC(F)(F)F)c(NS(C)(=O)=O)cc2)C1	InChI=1S/C28H31F3N4O6S/c1-16-14-34(12-11-33(16)3)23-8-6-20-19-9-10-35(15-21(19)27(37)40-25(20)17(23)2)26(36)18-5-7-22(32-42(4,38)39)24(13-18)41-28(29,30)31/h5-8,13,16,32H,9-12,14-15H2,1-4H3/t16-/m0/s1	OQKAKSSZSQPTDZ-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_003225	1022150-12-4	C22H22N6O	2.6024	58223272	C1C[C@H](CNC1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N	Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCNC3)c2ncn1	InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)/t16-/m1/s1	GPSQYTDPBDNDGI-MRXNPFEDSA-N					doublet; compound annotation
0391_003226	1022150-12-4	C22H22N6O	2.67	58223272	C1C[C@H](CNC1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N	Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCNC3)c2ncn1	InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26)/t16-/m1/s1	GPSQYTDPBDNDGI-MRXNPFEDSA-N					doublet; compound annotation
0391_003227	GANDOTINIB	C23H25ClFN7O	2.9791	46213929		Cc1cc(Nc2nn3c(Cc4c(F)cc(Cl)cc4)c(C)nc3c(CN3CCOCC3)c2)n[nH]1	InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)	SQSZANZGUXWJEA-UHFFFAOYSA-N					compound annotation
0391_003228	LY3009120	C23H29FN6O	3.1109	71721540		CNc1nc2nc(C)c(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)cc2cn1	InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)	HHCBMISMPSAZBF-UHFFFAOYSA-N					doublet; compound annotation
0391_003229	LY3009120	C23H29FN6O	3.2515	71721540		CNc1nc2nc(C)c(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)cc2cn1	InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)	HHCBMISMPSAZBF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003231	Amuvatinib	C23H21N5O3S	3.7323	11282283		S=C(NCc1cc2c(cc1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1	InChI=1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32)	FOFDIMHVKGYHRU-UHFFFAOYSA-N					compound annotation
0391_003232	LX-1031	C28H25F3N4O4	3.7544	23633604	COC1=CC=CC(=C1)C2=CC=C(C=C2)[C@H](C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	COc1cccc(-c2ccc(C(Oc3nc(N)nc(-c4ccc(CC(N)C(=O)O)cc4)c3)C(F)(F)F)cc2)c1	InChI=1S/C28H25F3N4O4/c1-38-21-4-2-3-20(14-21)17-9-11-19(12-10-17)25(28(29,30)31)39-24-15-23(34-27(33)35-24)18-7-5-16(6-8-18)13-22(32)26(36)37/h2-12,14-15,22,25H,13,32H2,1H3,(H,36,37)(H2,33,34,35)/t22-,25+/m0/s1	XNMUICFMGGQSMZ-WIOPSUGQSA-N					doublet; compound annotation
0391_003233	TP0463518	C20H18ClN3O6	4.0227	73052863		O=C(O)CNC(=O)C1=C(O)CCN(Cc2cnc(Oc3ccc(Cl)cc3)cc2)C1=O	InChI=1S/C20H18ClN3O6/c21-13-2-4-14(5-3-13)30-16-6-1-12(9-22-16)11-24-8-7-15(25)18(20(24)29)19(28)23-10-17(26)27/h1-6,9,25H,7-8,10-11H2,(H,23,28)(H,26,27)	HMMHKGLPKAQOOH-UHFFFAOYSA-N					compound annotation
0391_003234	LX-1031	C28H25F3N4O4	4.3065	23633604	COC1=CC=CC(=C1)C2=CC=C(C=C2)[C@H](C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	COc1cccc(-c2ccc(C(Oc3nc(N)nc(-c4ccc(CC(N)C(=O)O)cc4)c3)C(F)(F)F)cc2)c1	InChI=1S/C28H25F3N4O4/c1-38-21-4-2-3-20(14-21)17-9-11-19(12-10-17)25(28(29,30)31)39-24-15-23(34-27(33)35-24)18-7-5-16(6-8-18)13-22(32)26(36)37/h2-12,14-15,22,25H,13,32H2,1H3,(H,36,37)(H2,33,34,35)/t22-,25+/m0/s1	XNMUICFMGGQSMZ-WIOPSUGQSA-N					doublet; compound annotation
0391_003235	LY3009120	C23H29FN6O	4.5122	71721540		CNc1nc2nc(C)c(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)cc2cn1	InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)	HHCBMISMPSAZBF-UHFFFAOYSA-N					doublet; compound annotation
0391_003236	2250091-96-2	C48H54Cl2N10O2S2	5.307	137349088	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCCCCCCCCNC(=O)C[C@H]4C5=NN=C(N5C6=C(C(=C(S6)C)C)C(=N4)C7=CC=C(C=C7)Cl)C)C8=CC=C(C=C8)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)NCCCCCCCCCCNC(=O)CC1N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc13)N=C2c1ccc(Cl)cc1	InChI=1S/C48H54Cl2N10O2S2/c1-27-29(3)63-47-41(27)43(33-15-19-35(49)20-16-33)53-37(45-57-55-31(5)59(45)47)25-39(61)51-23-13-11-9-7-8-10-12-14-24-52-40(62)26-38-46-58-56-32(6)60(46)48-42(28(2)30(4)64-48)44(54-38)34-17-21-36(50)22-18-34/h15-22,37-38H,7-14,23-26H2,1-6H3,(H,51,61)(H,52,62)/t37-,38-/m0/s1	VFGPQYYCEGAFLY-UWXQCODUSA-N					removed another duplicate entry; compound annotation
0391_003238	Eltrombopag	C25H22N4O4	5.657	135449332		Cc1c(C)cc(-n2[nH]c(C)c(N=Nc3cccc(-c4cc(C(=O)O)ccc4)c3O)c2=O)cc1	InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33)	SVOQIEJWJCQGDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003239	Eltrombopag	C25H22N4O4	5.6616	135449332		Cc1c(C)cc(-n2[nH]c(C)c(N=Nc3cccc(-c4cc(C(=O)O)ccc4)c3O)c2=O)cc1	InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33)	SVOQIEJWJCQGDQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003241	(E)-LHF-535	C27H28N2O2	2.248	89761388	CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C/C4=CC=C(C=C4)C(C)(C)O	CC(C)Oc1ccc(-n2cnc3c2ccc(C=Cc2ccc(C(C)(C)O)cc2)c3)cc1	InChI=1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5+	DBNZTRPIBJSUIX-AATRIKPKSA-N					doublet; compound annotation
0391_003242	VTP50469	C32H47FN6O4S	2.2509	132212900		CC(C)N(C(=O)c1c(Oc2cncnc2N2CC3(CCN(CC4CCC(NS(C)(=O)=O)CC4)CC3)C2)ccc(F)c1)C(C)C	InChI=1S/C32H47FN6O4S/c1-22(2)39(23(3)4)31(40)27-16-25(33)8-11-28(27)43-29-17-34-21-35-30(29)38-19-32(20-38)12-14-37(15-13-32)18-24-6-9-26(10-7-24)36-44(5,41)42/h8,11,16-17,21-24,26,36H,6-7,9-10,12-15,18-20H2,1-5H3	ADHHOUXZPBYYSU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003244	ALK2-IN-2	C28H27N5O2S	2.5318	138454752		CC(c1ccc(-c2cn3ncc(-c4ccc(S(N)(=O)=O)c5ccccc45)c3nc2)cc1)N1CCCC1	InChI=1S/C28H27N5O2S/c1-19(32-14-4-5-15-32)20-8-10-21(11-9-20)22-16-30-28-26(17-31-33(28)18-22)24-12-13-27(36(29,34)35)25-7-3-2-6-23(24)25/h2-3,6-13,16-19H,4-5,14-15H2,1H3,(H2,29,34,35)	IPESYYFOXATSFJ-UHFFFAOYSA-N					compound annotation
0391_003245	Almonertinib	C30H35N7O2	2.7452	121280087		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)	DOEOECWDNSEFDN-UHFFFAOYSA-N					doublet; compound annotation
0391_003246	Mivebresib	C22H19F2N3O4S	3.5635	71600087		CCS(=O)(=O)Nc1cc(-c2cn(C)c(=O)c3c2cc[nH]3)c(Oc2c(F)cc(F)cc2)cc1	InChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6-4-13(23)10-18(20)24)16(11-14)17-12-27(2)22(28)21-15(17)8-9-25-21/h4-12,25-26H,3H2,1-2H3	RDONXGFGWSSFMY-UHFFFAOYSA-N					compound annotation
0391_003247	PLX5622	C21H19F2N5O	3.5781	52936034		COc1c(CNc2nc(F)c(Cc3c[nH]c4c3cc(C)cn4)cc2)cc(F)cn1	InChI=1S/C21H19F2N5O/c1-12-5-17-14(9-26-20(17)25-8-12)6-13-3-4-18(28-19(13)23)24-10-15-7-16(22)11-27-21(15)29-2/h3-5,7-9,11H,6,10H2,1-2H3,(H,24,28)(H,25,26)	NSMOZFXKTHCPTQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003249	1598426-03-9	C16H17N3O2	3.9353	118000986		CCOC(=O)c1cnc(NC2(c3ccccc3)CC2)nc1	InChI=1S/C16H17N3O2/c1-2-21-14(20)12-10-17-15(18-11-12)19-16(8-9-16)13-6-4-3-5-7-13/h3-7,10-11H,2,8-9H2,1H3,(H,17,18,19)	CTTSUGRYXUPYIO-UHFFFAOYSA-N					compound annotation
0391_003250	S63845	C39H37ClF4N6O6S	3.9958	122197581	CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)O[C@H](CC5=CC=CC=C5OCC6=CC=NN6CC(F)(F)F)C(=O)O)C7=CC=C(O7)F	Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(OC(Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl	InChI=1S/C39H37ClF4N6O6S/c1-23-26(7-8-28(34(23)40)53-18-17-49-15-13-48(2)14-16-49)32-33-36(45-22-46-37(33)57-35(32)29-9-10-31(41)55-29)56-30(38(51)52)19-24-5-3-4-6-27(24)54-20-25-11-12-47-50(25)21-39(42,43)44/h3-12,22,30H,13-21H2,1-2H3,(H,51,52)/t30-/m1/s1	ZFBHXVOCZBPADE-SSEXGKCCSA-N					doublet; compound annotation
0391_003251	S63845	C39H37ClF4N6O6S	4.2475	122197581	CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)O[C@H](CC5=CC=CC=C5OCC6=CC=NN6CC(F)(F)F)C(=O)O)C7=CC=C(O7)F	Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(OC(Cc4ccccc4OCc4ccnn4CC(F)(F)F)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl	InChI=1S/C39H37ClF4N6O6S/c1-23-26(7-8-28(34(23)40)53-18-17-49-15-13-48(2)14-16-49)32-33-36(45-22-46-37(33)57-35(32)29-9-10-31(41)55-29)56-30(38(51)52)19-24-5-3-4-6-27(24)54-20-25-11-12-47-50(25)21-39(42,43)44/h3-12,22,30H,13-21H2,1-2H3,(H,51,52)/t30-/m1/s1	ZFBHXVOCZBPADE-SSEXGKCCSA-N					doublet; removed another duplicate entry; compound annotation
0391_003253	(E)-LHF-535	C27H28N2O2	4.3337	89761388	CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C/C4=CC=C(C=C4)C(C)(C)O	CC(C)Oc1ccc(-n2cnc3c2ccc(C=Cc2ccc(C(C)(C)O)cc2)c3)cc1	InChI=1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5+	DBNZTRPIBJSUIX-AATRIKPKSA-N					doublet; compound annotation
0391_003254	(E)-LHF-535	C27H28N2O2	4.413	89761388	CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C/C4=CC=C(C=C4)C(C)(C)O	CC(C)Oc1ccc(-n2cnc3c2ccc(C=Cc2ccc(C(C)(C)O)cc2)c3)cc1	InChI=1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5+	DBNZTRPIBJSUIX-AATRIKPKSA-N					doublet; compound annotation
0391_003255	Varenicline	C13H13N3	1.0488	170361		c1cnc2cc3c(cc2n1)C1CNCC3C1	InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2	JQSHBVHOMNKWFT-UHFFFAOYSA-N					doublet; compound annotation
0391_003256	Varenicline	C13H13N3	1.6441	170361		c1cnc2cc3c(cc2n1)C1CNCC3C1	InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2	JQSHBVHOMNKWFT-UHFFFAOYSA-N					doublet; compound annotation
0391_003257	1627696-51-8	C16H12FN5O	2.0406	81689696	C[C@@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F	CC1(c2ncncc2F)NC(=O)c2cc(-c3c[nH]nc3)ccc21	InChI=1S/C16H12FN5O/c1-16(14-13(17)7-18-8-19-14)12-3-2-9(10-5-20-21-6-10)4-11(12)15(23)22-16/h2-8H,1H3,(H,20,21)(H,22,23)/t16-/m1/s1	KNLVLWZENYQYRT-MRXNPFEDSA-N					doublet; compound annotation
0391_003258	1627696-51-8	C16H12FN5O	2.0439	81689696	C[C@@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F	CC1(c2ncncc2F)NC(=O)c2cc(-c3c[nH]nc3)ccc21	InChI=1S/C16H12FN5O/c1-16(14-13(17)7-18-8-19-14)12-3-2-9(10-5-20-21-6-10)4-11(12)15(23)22-16/h2-8H,1H3,(H,20,21)(H,22,23)/t16-/m1/s1	KNLVLWZENYQYRT-MRXNPFEDSA-N					doublet; compound annotation
0391_003259	TCS-OX2-29	C23H31N3O3	2.1164	10408514	CC(C)(C)[C@@H](C(=O)N1CCC2=CC(=C(C=C2C1)OC)OC)NCC3=CC=NC=C3	COc1c(OC)cc2CN(C(=O)C(NCc3ccncc3)C(C)(C)C)CCc2c1	InChI=1S/C23H31N3O3/c1-23(2,3)21(25-14-16-6-9-24-10-7-16)22(27)26-11-8-17-12-19(28-4)20(29-5)13-18(17)15-26/h6-7,9-10,12-13,21,25H,8,11,14-15H2,1-5H3/t21-/m1/s1	COFVZFLCAOUMJT-OAQYLSRUSA-N					doublet; compound annotation
0391_003260	TCS-OX2-29	C23H31N3O3	2.2171	10408514	CC(C)(C)[C@@H](C(=O)N1CCC2=CC(=C(C=C2C1)OC)OC)NCC3=CC=NC=C3	COc1c(OC)cc2CN(C(=O)C(NCc3ccncc3)C(C)(C)C)CCc2c1	InChI=1S/C23H31N3O3/c1-23(2,3)21(25-14-16-6-9-24-10-7-16)22(27)26-11-8-17-12-19(28-4)20(29-5)13-18(17)15-26/h6-7,9-10,12-13,21,25H,8,11,14-15H2,1-5H3/t21-/m1/s1	COFVZFLCAOUMJT-OAQYLSRUSA-N					doublet; removed another duplicate entry; compound annotation
0391_003262	849234-64-6	C19H17N3O2S	3.0691	6918878		CC(=O)Nc1ccc(C(=O)Nc2c(N)ccc(-c3cccs3)c2)cc1	InChI=1S/C19H17N3O2S/c1-12(23)21-15-7-4-13(5-8-15)19(24)22-17-11-14(6-9-16(17)20)18-3-2-10-25-18/h2-11H,20H2,1H3,(H,21,23)(H,22,24)	ABZSPJVXTTUFAA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003264	849234-64-6	C19H17N3O2S	3.0725	6918878		CC(=O)Nc1ccc(C(=O)Nc2c(N)ccc(-c3cccs3)c2)cc1	InChI=1S/C19H17N3O2S/c1-12(23)21-15-7-4-13(5-8-15)19(24)22-17-11-14(6-9-16(17)20)18-3-2-10-25-18/h2-11H,20H2,1H3,(H,21,23)(H,22,24)	ABZSPJVXTTUFAA-UHFFFAOYSA-N					doublet; compound annotation
0391_003265	APS-2-79	C23H21N3O3	3.1993	121499159		COc1c(OC)cc2c(Nc3c(C)cc(Oc4ccccc4)cc3)ncnc2c1	InChI=1S/C23H21N3O3/c1-15-11-17(29-16-7-5-4-6-8-16)9-10-19(15)26-23-18-12-21(27-2)22(28-3)13-20(18)24-14-25-23/h4-14H,1-3H3,(H,24,25,26)	PEKZLFZZBGBOPJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003266	APS-2-79	C23H21N3O3	3.282	121499159		COc1c(OC)cc2c(Nc3c(C)cc(Oc4ccccc4)cc3)ncnc2c1	InChI=1S/C23H21N3O3/c1-15-11-17(29-16-7-5-4-6-8-16)9-10-19(15)26-23-18-12-21(27-2)22(28-3)13-20(18)24-14-25-23/h4-14H,1-3H3,(H,24,25,26)	PEKZLFZZBGBOPJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003267	DDR1-IN-1	C30H31F3N4O3	3.3393	72836888		CCN1CCN(Cc2c(C(F)(F)F)cc(C(=O)Nc3cc(Oc4cc5c(cc4)NC(=O)C5)c(C)cc3)cc2)CC1	InChI=1S/C30H31F3N4O3/c1-3-36-10-12-37(13-11-36)18-21-6-5-20(15-25(21)30(31,32)33)29(39)34-23-7-4-19(2)27(17-23)40-24-8-9-26-22(14-24)16-28(38)35-26/h4-9,14-15,17H,3,10-13,16,18H2,1-2H3,(H,34,39)(H,35,38)	AOZPVMOOEJAZGK-UHFFFAOYSA-N					doublet; compound annotation
0391_003268	DDR1-IN-1	C30H31F3N4O3	3.7752	72836888		CCN1CCN(Cc2c(C(F)(F)F)cc(C(=O)Nc3cc(Oc4cc5c(cc4)NC(=O)C5)c(C)cc3)cc2)CC1	InChI=1S/C30H31F3N4O3/c1-3-36-10-12-37(13-11-36)18-21-6-5-20(15-25(21)30(31,32)33)29(39)34-23-7-4-19(2)27(17-23)40-24-8-9-26-22(14-24)16-28(38)35-26/h4-9,14-15,17H,3,10-13,16,18H2,1-2H3,(H,34,39)(H,35,38)	AOZPVMOOEJAZGK-UHFFFAOYSA-N					doublet; compound annotation
0391_003269	gamma-secretase modulator 1	C24H24N4OS	3.8851	42647277		COc1c(-n2cnc(C)c2)ccc(Nc2nc3c(CCCC3c3ccccc3)s2)c1	InChI=1S/C24H24N4OS/c1-16-14-28(15-25-16)20-12-11-18(13-21(20)29-2)26-24-27-23-19(9-6-10-22(23)30-24)17-7-4-3-5-8-17/h3-5,7-8,11-15,19H,6,9-10H2,1-2H3,(H,26,27)	VFSGAZRYSCNFDF-UHFFFAOYSA-N					doublet; compound annotation
0391_003270	gamma-secretase modulator 1	C24H24N4OS	3.8896	42647277		COc1c(-n2cnc(C)c2)ccc(Nc2nc3c(CCCC3c3ccccc3)s2)c1	InChI=1S/C24H24N4OS/c1-16-14-28(15-25-16)20-12-11-18(13-21(20)29-2)26-24-27-23-19(9-6-10-22(23)30-24)17-7-4-3-5-8-17/h3-5,7-8,11-15,19H,6,9-10H2,1-2H3,(H,26,27)	VFSGAZRYSCNFDF-UHFFFAOYSA-N					doublet; compound annotation
0391_003271	(1R,2R)-2-PCCA	C30H37N3O	4.0378	58466521	CCCC1=CC=C(C=C1)C2=CC=C(C=C2)N(C[C@H]([C@@H](C)CC)N)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4	CCCc1ccc(-c2ccc(N(CC(N)C(C)CC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C30H37N3O/c1-4-8-22-10-12-23(13-11-22)24-14-16-25(17-15-24)33(20-28(31)21(3)5-2)30(34)27-19-26(27)29-9-6-7-18-32-29/h6-7,9-18,21,26-28H,4-5,8,19-20,31H2,1-3H3/t21-,26+,27+,28+/m0/s1	OBGKRTYDTRUMGO-RFNYNIMXSA-N					doublet; removed another duplicate entry; compound annotation
0391_003273	CBP/EP300-IN-1	C23H23FN2O5	4.9841	137628649		COc1cc2c(cc1)n(C(C)=O)cc2C(=O)Nc1c(F)ccc(C(=O)OC(C)(C)C)c1	InChI=1S/C23H23FN2O5/c1-13(27)26-12-17(16-11-15(30-5)7-9-20(16)26)21(28)25-19-10-14(6-8-18(19)24)22(29)31-23(2,3)4/h6-12H,1-5H3,(H,25,28)	BNTANBUTBDVIHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003276	(1R,2R)-2-PCCA	C30H37N3O	5.1696	58466521	CCCC1=CC=C(C=C1)C2=CC=C(C=C2)N(C[C@H]([C@@H](C)CC)N)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4	CCCc1ccc(-c2ccc(N(CC(N)C(C)CC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C30H37N3O/c1-4-8-22-10-12-23(13-11-22)24-14-16-25(17-15-24)33(20-28(31)21(3)5-2)30(34)27-19-26(27)29-9-6-7-18-32-29/h6-7,9-18,21,26-28H,4-5,8,19-20,31H2,1-3H3/t21-,26+,27+,28+/m0/s1	OBGKRTYDTRUMGO-RFNYNIMXSA-N					doublet; removed another duplicate entry; compound annotation
0391_003278	SUN11602	C26H37N5O2	0.8192	22245705		Cc1c(C)c(NCC(=O)N(C)C2CCN(Cc3ccc(C(N)=O)cc3)CC2)c(C)c(C)c1N	InChI=1S/C26H37N5O2/c1-16-18(3)25(19(4)17(2)24(16)27)29-14-23(32)30(5)22-10-12-31(13-11-22)15-20-6-8-21(9-7-20)26(28)33/h6-9,22,29H,10-15,27H2,1-5H3,(H2,28,33)	KCODNOOPOPTZMO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003281	Bentamapimod	C25H23N5O2S	2.1505	10195250		N#CC(c1nc(OCc2ccc(CN3CCOCC3)cc2)ncc1)c1nc2ccccc2s1	InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2	XCPPIJCBCWUBNT-UHFFFAOYSA-N					doublet; compound annotation
0391_003282	1610358-53-6	C19H18F2N4O2S	2.5568	74767009		COc1c(-c2cc(Nc3nccc(CS(C)(=N)=O)c3)ncc2F)ccc(F)c1	InChI=1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25)	YZCUMZWULWOUMD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003284	MK-3207	C31H29F2N5O3	2.6388	25019940	C1CCC2(C1)C(=O)N([C@@H](CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(C[C@@]6(C5)C7=C(NC6=O)N=CC=C7)C=C4	O=C(CN1C(=O)C2(CCCC2)NCC1c1cc(F)cc(F)c1)Nc1cc2c(cc1)CC1(C2)C(=O)Nc2c1cccn2	InChI=1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1	AZAANWYREOQRFB-SETSBSEESA-N					doublet; removed another duplicate entry; compound annotation
0391_003286	Bentamapimod	C25H23N5O2S	2.6984	10195250		N#CC(c1nc(OCc2ccc(CN3CCOCC3)cc2)ncc1)c1nc2ccccc2s1	InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2	XCPPIJCBCWUBNT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003289	BAY-545	C18H22F3N3O4S	3.0403	118016229		CCn1c(=O)c2c(sc(C(=O)N3CCC(O)CC3)c2C)n(CCC(F)(F)F)c1=O	InChI=1S/C18H22F3N3O4S/c1-3-23-14(26)12-10(2)13(15(27)22-7-4-11(25)5-8-22)29-16(12)24(17(23)28)9-6-18(19,20)21/h11,25H,3-9H2,1-2H3	NTYVAKNEYLJAPT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003291	3,4'-DIHYDROXYFLAVONE	C15H10O4	3.2258	688715		O=c1c(O)c(-c2ccc(O)cc2)oc2ccccc12	InChI=1S/C15H10O4/c16-10-7-5-9(6-8-10)15-14(18)13(17)11-3-1-2-4-12(11)19-15/h1-8,16,18H	GPGOCTLAUAHUQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003293	Bentamapimod	C25H23N5O2S	3.3351	10195250		N#CC(c1nc(OCc2ccc(CN3CCOCC3)cc2)ncc1)c1nc2ccccc2s1	InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2	XCPPIJCBCWUBNT-UHFFFAOYSA-N					doublet; compound annotation
0391_003294	BAY-545	C18H22F3N3O4S	3.438	118016229		CCn1c(=O)c2c(sc(C(=O)N3CCC(O)CC3)c2C)n(CCC(F)(F)F)c1=O	InChI=1S/C18H22F3N3O4S/c1-3-23-14(26)12-10(2)13(15(27)22-7-4-11(25)5-8-22)29-16(12)24(17(23)28)9-6-18(19,20)21/h11,25H,3-9H2,1-2H3	NTYVAKNEYLJAPT-UHFFFAOYSA-N					doublet; compound annotation
0391_003295	VE-821	C18H16N4O3S	3.7926	51000408		CS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3ccccc3)n2)cc1	InChI=1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23)	DUIHHZKTCSNTGM-UHFFFAOYSA-N					compound annotation
0391_003296	FASN-IN-1	C18H25N3O3S2	4.6163	118356203	CC[C@H](C)C(=O)NC1=NC(=CS1)C2=CC=C(C=C2)S(=O)(=O)N(CC)CC	CCC(C)C(=O)Nc1nc(-c2ccc(S(=O)(=O)N(CC)CC)cc2)cs1	InChI=1S/C18H25N3O3S2/c1-5-13(4)17(22)20-18-19-16(12-25-18)14-8-10-15(11-9-14)26(23,24)21(6-2)7-3/h8-13H,5-7H2,1-4H3,(H,19,20,22)/t13-/m0/s1	IXMQVFSSASHOGM-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_003298	Nmi 8739	C30H41NO3	5.9097	6443994	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCC1=CC(=C(C=C1)O)O	CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCc1cc(O)c(O)cc1	InChI=1S/C30H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-30(34)31-25-24-27-22-23-28(32)29(33)26-27/h3-4,6-7,9-10,12-13,15-16,18-19,22-23,26,32-33H,2,5,8,11,14,17,20-21,24-25H2,1H3,(H,31,34)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-	HXJMZRVSTICUKC-KUBAVDMBSA-N					removed another duplicate entry; compound annotation
0391_003300	Metrizoic acid	C12H11I3N2O4	0.8527	2528		CC(=O)Nc1c(I)c(N(C)C(C)=O)c(I)c(C(=O)O)c1I	InChI=1S/C12H11I3N2O4/c1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19/h1-3H3,(H,16,18)(H,20,21)	GGGDNPWHMNJRFN-UHFFFAOYSA-N					doublet; compound annotation
0391_003301	Metrizoic acid	C12H11I3N2O4	1.0706	2528		CC(=O)Nc1c(I)c(N(C)C(C)=O)c(I)c(C(=O)O)c1I	InChI=1S/C12H11I3N2O4/c1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19/h1-3H3,(H,16,18)(H,20,21)	GGGDNPWHMNJRFN-UHFFFAOYSA-N					doublet; compound annotation
0391_003302	RV01	C17H13NO2	1.6976	56837609	C1=CC=C2C(=C1)C(=CC=N2)/C=C/C3=CC(=CC(=C3)O)O	Oc1cc(C=Cc2ccnc3ccccc23)cc(O)c1	InChI=1S/C17H13NO2/c19-14-9-12(10-15(20)11-14)5-6-13-7-8-18-17-4-2-1-3-16(13)17/h1-11,19-20H/b6-5+	YRSOXYVELWTHAE-AATRIKPKSA-N					doublet; removed another duplicate entry; compound annotation
0391_003304	RV01	C17H13NO2	1.8113	56837609	C1=CC=C2C(=C1)C(=CC=N2)/C=C/C3=CC(=CC(=C3)O)O	Oc1cc(C=Cc2ccnc3ccccc23)cc(O)c1	InChI=1S/C17H13NO2/c19-14-9-12(10-15(20)11-14)5-6-13-7-8-18-17-4-2-1-3-16(13)17/h1-11,19-20H/b6-5+	YRSOXYVELWTHAE-AATRIKPKSA-N					doublet; compound annotation
0391_003305	pyrilamine	C17H23N3O	1.9837	4992		COc1ccc(CN(CCN(C)C)c2ccccn2)cc1	InChI=1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3	YECBIJXISLIIDS-UHFFFAOYSA-N					compound annotation
0391_003306	792173-99-0	C17H13N5O2	2.0089	6604926		Cc1nc2c(cc(NC(=O)Nc3ccnc4cccnc34)cc2)o1	InChI=1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23)	AKMNUCBQGHFICM-UHFFFAOYSA-N					compound annotation
0391_003307	HSP70-IN-1	C24H28N6O2S	2.1514	66973893		CN1CCN(c2ncc(Sc3cccc(NC(=O)CN)c3)c(OCc3ccccc3)n2)CC1	InChI=1S/C24H28N6O2S/c1-29-10-12-30(13-11-29)24-26-16-21(23(28-24)32-17-18-6-3-2-4-7-18)33-20-9-5-8-19(14-20)27-22(31)15-25/h2-9,14,16H,10-13,15,17,25H2,1H3,(H,27,31)	LBJCUDZMNPAWPX-UHFFFAOYSA-N					doublet; compound annotation
0391_003308	BI-1347	C22H20N4O	2.1889	132180482		CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1	InChI=1S/C22H20N4O/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21/h3-14H,15H2,1-2H3	WULUGQONDYDNKY-UHFFFAOYSA-N					doublet; compound annotation
0391_003309	BI-1347	C22H20N4O	2.1921	132180482		CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1	InChI=1S/C22H20N4O/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21/h3-14H,15H2,1-2H3	WULUGQONDYDNKY-UHFFFAOYSA-N					doublet; compound annotation
0391_003310	HSP70-IN-1	C24H28N6O2S	2.2223	66973893		CN1CCN(c2ncc(Sc3cccc(NC(=O)CN)c3)c(OCc3ccccc3)n2)CC1	InChI=1S/C24H28N6O2S/c1-29-10-12-30(13-11-29)24-26-16-21(23(28-24)32-17-18-6-3-2-4-7-18)33-20-9-5-8-19(14-20)27-22(31)15-25/h2-9,14,16H,10-13,15,17,25H2,1H3,(H,27,31)	LBJCUDZMNPAWPX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003312	Pimasertib	C15H15FIN3O3	2.469	44187362	C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NC[C@@H](CO)O	O=C(NCC(O)CO)c1c(Nc2c(F)cc(I)cc2)cncc1	InChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1	VIUAUNHCRHHYNE-JTQLQIEISA-N					removed another duplicate entry; compound annotation
0391_003314	LY3200882	C24H29N5O3	2.5657	121249291		CC(C)(O)c1nccc(Nc2nccc(Oc3cn(C4CC4)nc3C3CCOCC3)c2)c1	InChI=1S/C24H29N5O3/c1-24(2,30)21-13-17(5-9-25-21)27-22-14-19(6-10-26-22)32-20-15-29(18-3-4-18)28-23(20)16-7-11-31-12-8-16/h5-6,9-10,13-16,18,30H,3-4,7-8,11-12H2,1-2H3,(H,25,26,27)	PNPFMWIDAKQFPY-UHFFFAOYSA-N					compound annotation
0391_003315	1233231-30-5	C20H20F3N5O2	3.4009	129080919	C[C@@H](C(=O)N)NCC1=NC2=C(N1C3CCC3)N=C(C=C2)OC4=CC(=C(C(=C4)F)F)F	CC(NCc1nc2c(nc(Oc3cc(F)c(F)c(F)c3)cc2)n1C1CCC1)C(N)=O	InChI=1S/C20H20F3N5O2/c1-10(19(24)29)25-9-16-26-15-5-6-17(27-20(15)28(16)11-3-2-4-11)30-12-7-13(21)18(23)14(22)8-12/h5-8,10-11,25H,2-4,9H2,1H3,(H2,24,29)/t10-/m0/s1	HHXCJIMPEJSJTG-JTQLQIEISA-N					removed another duplicate entry; compound annotation
0391_003317	Pempidine	C10H21N	0.8461	6603		CN1C(C)(C)CCCC1(C)C	InChI=1S/C10H21N/c1-9(2)7-6-8-10(3,4)11(9)5/h6-8H2,1-5H3	XULIXFLCVXWHRF-UHFFFAOYSA-N					compound annotation
0391_003318	4-Aminosalicylic acid	C7H7NO3	0.9322	4649		Nc1cc(O)c(C(=O)O)cc1	InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)	WUBBRNOQWQTFEX-UHFFFAOYSA-N					doublet; compound annotation
0391_003319	nemiralisib	C26H28N6O	2.3558	49784002		CC(C)N1CCN(Cc2cnc(-c3c4cn[nH]c4cc(-c4c5cc[nH]c5ccc4)c3)o2)CC1	InChI=1S/C26H28N6O/c1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24/h3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30)	MCIDWGZGWVSZMK-UHFFFAOYSA-N					compound annotation
0391_003320	Rhodamine 123 free base	C21H16N2O3	2.5619	65218		COC(=O)c1ccccc1-c1c2ccc(=N)cc-2oc2c1ccc(N)c2	InChI=1S/C21H16N2O3/c1-25-21(24)15-5-3-2-4-14(15)20-16-8-6-12(22)10-18(16)26-19-11-13(23)7-9-17(19)20/h2-11,22H,23H2,1H3	FCGVBHISQBBIQF-UHFFFAOYSA-N					compound annotation
0391_003321	SCH 58261	C18H15N7O	3.5333	176408		Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12	InChI=1S/C18H15N7O/c19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14/h1-7,10-11H,8-9H2,(H2,19,22)	UTLPKQYUXOEJIL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003323	GSK1016790A	C28H32Cl2N4O6S2	4.4965	23630211	CC(C)C[C@@H](C(=O)N1CCN(CC1)C(=O)[C@H](CO)NS(=O)(=O)C2=C(C=C(C=C2)Cl)Cl)NC(=O)C3=CC4=CC=CC=C4S3	CC(C)CC(NC(=O)c1cc2ccccc2s1)C(=O)N1CCN(C(=O)C(CO)NS(=O)(=O)c2c(Cl)cc(Cl)cc2)CC1	InChI=1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1	IVYQPSHHYIAUFO-VXKWHMMOSA-N					removed another duplicate entry; compound annotation
0391_003325	369-07-3	C12H15NO8	1.1647	96647	C1=CC=C(C(=C1)[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	O=[N+]([O-])c1ccccc1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C12H15NO8/c14-5-8-9(15)10(16)11(17)12(21-8)20-7-4-2-1-3-6(7)13(18)19/h1-4,8-12,14-17H,5H2/t8-,9+,10+,11-,12-/m1/s1	KUWPCJHYPSUOFW-YBXAARCKSA-N					compound annotation
0391_003326	Gabazine	C15H17N3O3	1.9627	107896		COc1ccc(-c2nn(CCCC(=O)O)c(=N)cc2)cc1	InChI=1S/C15H17N3O3/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20/h4-9,16H,2-3,10H2,1H3,(H,19,20)	ACVGNKYJVGNLIL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003328	(Rac)-WAY-161503	C11H11Cl2N3O	1.9818	3906894		O=C1Nc2cc(Cl)c(Cl)cc2N2CCNCC12	InChI=1S/C11H11Cl2N3O/c12-6-3-8-9(4-7(6)13)16-2-1-14-5-10(16)11(17)15-8/h3-4,10,14H,1-2,5H2,(H,15,17)	PHGWDAICBXUJDU-UHFFFAOYSA-N					compound annotation
0391_003329	256925-03-8	C23H24ClN3O2	3.1051	9822799		CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2c(Cl)ccc([N+](=O)[O-])c2)cc1	InChI=1S/C23H24ClN3O2/c1-25(2)18-9-5-16(6-10-18)23(17-7-11-19(12-8-17)26(3)4)21-15-20(27(28)29)13-14-22(21)24/h5-15,23H,1-4H3	IPICUXHYPAMJNC-UHFFFAOYSA-N					doublet; compound annotation
0391_003330	BI-6C9	C23H25N3O4S2	3.5188	11547341		COc1ccc(S(=O)(=O)NCCCC(=O)Nc2ccc(Sc3ccc(N)cc3)cc2)cc1	InChI=1S/C23H25N3O4S2/c1-30-19-8-14-22(15-9-19)32(28,29)25-16-2-3-23(27)26-18-6-12-21(13-7-18)31-20-10-4-17(24)5-11-20/h4-15,25H,2-3,16,24H2,1H3,(H,26,27)	LCFUJBSKPDPGKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003333	447410-57-3	C21H28N2O8S2	3.6644	1520267		COc1c(OC)cc(S(=O)(=O)N2CCCN(S(=O)(=O)c3cc(OC)c(OC)cc3)CC2)cc1	InChI=1S/C21H28N2O8S2/c1-28-18-8-6-16(14-20(18)30-3)32(24,25)22-10-5-11-23(13-12-22)33(26,27)17-7-9-19(29-2)21(15-17)31-4/h6-9,14-15H,5,10-13H2,1-4H3	GJUFPAZNBPFNRI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003335	447410-57-3	C21H28N2O8S2	3.6941	1520267		COc1c(OC)cc(S(=O)(=O)N2CCCN(S(=O)(=O)c3cc(OC)c(OC)cc3)CC2)cc1	InChI=1S/C21H28N2O8S2/c1-28-18-8-6-16(14-20(18)30-3)32(24,25)22-10-5-11-23(13-12-22)33(26,27)17-7-9-19(29-2)21(15-17)31-4/h6-9,14-15H,5,10-13H2,1-4H3	GJUFPAZNBPFNRI-UHFFFAOYSA-N					doublet; compound annotation
0391_003336	256925-03-8	C23H24ClN3O2	4.782	9822799		CN(C)c1ccc(C(c2ccc(N(C)C)cc2)c2c(Cl)ccc([N+](=O)[O-])c2)cc1	InChI=1S/C23H24ClN3O2/c1-25(2)18-9-5-16(6-10-18)23(17-7-11-19(12-8-17)26(3)4)21-15-20(27(28)29)13-14-22(21)24/h5-15,23H,1-4H3	IPICUXHYPAMJNC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003338	LH846	C16H13ClN2OS	4.8057	851474		Cc1cc2c(cc1Cl)nc(NC(=O)Cc1ccccc1)s2	InChI=1S/C16H13ClN2OS/c1-10-7-14-13(9-12(10)17)18-16(21-14)19-15(20)8-11-5-3-2-4-6-11/h2-7,9H,8H2,1H3,(H,18,19,20)	DYHAMRNAHTWYKY-UHFFFAOYSA-N					doublet; compound annotation
0391_003339	LH846	C16H13ClN2OS	4.8087	851474		Cc1cc2c(cc1Cl)nc(NC(=O)Cc1ccccc1)s2	InChI=1S/C16H13ClN2OS/c1-10-7-14-13(9-12(10)17)18-16(21-14)19-15(20)8-11-5-3-2-4-6-11/h2-7,9H,8H2,1H3,(H,18,19,20)	DYHAMRNAHTWYKY-UHFFFAOYSA-N					doublet; compound annotation
0391_003340	CDDO-Im	C34H43N3O3	4.9181	9958995	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)N6C=CN=C6	CC1(C)CCC2(C(=O)n3ccnc3)CCC3(C)C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C34H43N3O3/c1-29(2)10-12-34(28(40)37-15-14-36-20-37)13-11-33(7)26(22(34)18-29)23(38)16-25-31(5)17-21(19-35)27(39)30(3,4)24(31)8-9-32(25,33)6/h14-17,20,22,24,26H,8-13,18H2,1-7H3/t22-,24-,26-,31-,32+,33+,34-/m0/s1	ITFBYYCNYVFPKD-FMIDTUQUSA-N					compound annotation
0391_003341	5-Iodotubercidin	C11H13IN4O4	0.6748	97297	C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)I	Nc1c2c(I)cn(C3OC(CO)C(O)C3O)c2ncn1	InChI=1S/C11H13IN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1	WHSIXKUPQCKWBY-IOSLPCCCSA-N					compound annotation
0391_003342	BMS-378806	C22H22N4O4	2.2906	5495818	C[C@@H]1CN(CCN1C(=O)C(=O)C2=CNC3=NC=CC(=C23)OC)C(=O)C4=CC=CC=C4	COc1c2-c(ncc2C(=O)C(=O)N2CCN(C(=O)c3ccccc3)CC2C)[nH]cc1	InChI=1S/C22H22N4O4/c1-14-13-25(21(28)15-6-4-3-5-7-15)10-11-26(14)22(29)19(27)16-12-24-20-18(16)17(30-2)8-9-23-20/h3-9,12,14H,10-11,13H2,1-2H3,(H,23,24)/t14-/m1/s1	OKGPFTLYBPQBIX-CQSZACIVSA-N					doublet; compound annotation
0391_003343	BMS-378806	C22H22N4O4	2.2938	5495818	C[C@@H]1CN(CCN1C(=O)C(=O)C2=CNC3=NC=CC(=C23)OC)C(=O)C4=CC=CC=C4	COc1c2-c(ncc2C(=O)C(=O)N2CCN(C(=O)c3ccccc3)CC2C)[nH]cc1	InChI=1S/C22H22N4O4/c1-14-13-25(21(28)15-6-4-3-5-7-15)10-11-26(14)22(29)19(27)16-12-24-20-18(16)17(30-2)8-9-23-20/h3-9,12,14H,10-11,13H2,1-2H3,(H,23,24)/t14-/m1/s1	OKGPFTLYBPQBIX-CQSZACIVSA-N					doublet; compound annotation
0391_003344	B-Raf inhibitor 1	C26H19ClN8	2.5011	44223999		Cc1c(Nc2ncccc2-c2c3[nH]cnc3ncn2)c2c(cc1)c(Nc1ccc(Cl)cc1)ncc2	InChI=1S/C26H19ClN8/c1-15-4-9-19-18(10-12-29-24(19)34-17-7-5-16(27)6-8-17)21(15)35-25-20(3-2-11-28-25)22-23-26(32-13-30-22)33-14-31-23/h2-14H,1H3,(H,28,35)(H,29,34)(H,30,31,32,33)	KKVYYGGCHJGEFJ-UHFFFAOYSA-N					compound annotation
0391_003345	Clorgiline	C13H15Cl2NO	2.7943	4380		C#CCN(C)CCCOc1c(Cl)cc(Cl)cc1	InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3	BTFHLQRNAMSNLC-UHFFFAOYSA-N					compound annotation
0391_003346	Sograzepide	C28H30N6O3	2.8202	9870520	CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)NC)C4=CC=CC=N4	CNc1cc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)ccc1	InChI=1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)/t25-/m0/s1	YDZYKNJZCVIKPP-VWLOTQADSA-N					removed another duplicate entry; compound annotation
0391_003348	carbamimidothioic acid 2-[4-[(4-nitrophenyl)methoxy]phenyl]ethyl ester	C16H17N3O3S	3.0042	4534086		N=C(N)SCCc1ccc(OCc2ccc([N+](=O)[O-])cc2)cc1	InChI=1S/C16H17N3O3S/c17-16(18)23-10-9-12-3-7-15(8-4-12)22-11-13-1-5-14(6-2-13)19(20)21/h1-8H,9-11H2,(H3,17,18)	UMJUNUMSJDTYTM-UHFFFAOYSA-N					compound annotation
0391_003349	BI-671800	C25H26F3N5O3	3.293	45270144		CN(C)c1c(CC(=O)O)c(N(C)C)nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)n1	InChI=1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35)	XEOSTBFUCNZKGS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003351	Darusentan	C22H22N2O6	4.4862	177236	COC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)OC	COc1cc(OC)nc(OC(C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1	InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1	FEJVSJIALLTFRP-LJQANCHMSA-N					removed another duplicate entry; compound annotation
0391_003353	Macitentan	C19H20Br2N6O4S	4.7927	16004692		CCCNS(=O)(=O)Nc1c(-c2ccc(Br)cc2)c(OCCOc2ncc(Br)cn2)ncn1	InChI=1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27)	JGCMEBMXRHSZKX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003355	F1063-0967	C24H24N2O5S2	5.1366	5895168	CC1=CC=C(C=C1)/C=C\2/C(=O)N(C(=S)S2)CCCCCC(=O)NC3=CC(=C(C=C3)C(=O)O)O	Cc1ccc(C=C2SC(=S)N(CCCCCC(=O)Nc3cc(O)c(C(=O)O)cc3)C2=O)cc1	InChI=1S/C24H24N2O5S2/c1-15-6-8-16(9-7-15)13-20-22(29)26(24(32)33-20)12-4-2-3-5-21(28)25-17-10-11-18(23(30)31)19(27)14-17/h6-11,13-14,27H,2-5,12H2,1H3,(H,25,28)(H,30,31)/b20-13-	RNICWTYEMLCCAS-MOSHPQCFSA-N					doublet; removed another duplicate entry; compound annotation
0391_003357	F1063-0967	C24H24N2O5S2	5.3001	5895168	CC1=CC=C(C=C1)/C=C\2/C(=O)N(C(=S)S2)CCCCCC(=O)NC3=CC(=C(C=C3)C(=O)O)O	Cc1ccc(C=C2SC(=S)N(CCCCCC(=O)Nc3cc(O)c(C(=O)O)cc3)C2=O)cc1	InChI=1S/C24H24N2O5S2/c1-15-6-8-16(9-7-15)13-20-22(29)26(24(32)33-20)12-4-2-3-5-21(28)25-17-10-11-18(23(30)31)19(27)14-17/h6-11,13-14,27H,2-5,12H2,1H3,(H,25,28)(H,30,31)/b20-13-	RNICWTYEMLCCAS-MOSHPQCFSA-N					doublet; removed another duplicate entry; compound annotation
0391_003359	XL388	C23H22FN3O4S	2.1719	59604787		Cc1c(C(=O)N2CCOc3c(cc(-c4cnc(N)cc4)cc3)C2)ccc(S(C)(=O)=O)c1F	InChI=1S/C23H22FN3O4S/c1-14-18(5-7-20(22(14)24)32(2,29)30)23(28)27-9-10-31-19-6-3-15(11-17(19)13-27)16-4-8-21(25)26-12-16/h3-8,11-12H,9-10,13H2,1-2H3,(H2,25,26)	LNFBAYSBVQBKFR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003361	Vipadenant	C16H15N7O	2.1777	21874557		Cc1c(N)ccc(Cn2nnc3c(-c4ccco4)nc(N)nc32)c1	InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)	HQSBCDPYXDGTCL-UHFFFAOYSA-N					doublet; compound annotation
0391_003362	193551-21-2	C20H21FN4O2	2.2169	5166		COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1	InChI=1S/C20H21FN4O2/c1-27-20-22-11-10-17(24-20)19-18(13-2-4-14(21)5-3-13)23-12-25(19)15-6-8-16(26)9-7-15/h2-5,10-12,15-16,26H,6-9H2,1H3	ZQUSFAUAYSEREK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003364	astemizole	C28H31FN4O	2.3784	2247		COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1	InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)	GXDALQBWZGODGZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003365	astemizole	C28H31FN4O	2.3816	2247		COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1	InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)	GXDALQBWZGODGZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003366	Vipadenant	C16H15N7O	2.7901	21874557		Cc1c(N)ccc(Cn2nnc3c(-c4ccco4)nc(N)nc32)c1	InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)	HQSBCDPYXDGTCL-UHFFFAOYSA-N					doublet; compound annotation
0391_003367	1384424-80-9	C17H13F3N4O2	2.8592	49830684		COc1cc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2cc1	InChI=1S/C17H13F3N4O2/c1-26-10-5-6-11-12(7-8-21-13(11)9-10)22-16(25)24-15-4-2-3-14(23-15)17(18,19)20/h2-9H,1H3,(H2,21,22,23,24,25)	VQPBIJGXSXEOCU-UHFFFAOYSA-N					compound annotation
0391_003368	LEXITHROMYCIN	C38H70N2O13	3.1853	6532846	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOC)C(C)C(O)C1(C)O	InChI=1S/C38H70N2O13/c1-15-26-38(10,46)31(42)21(4)28(39-48-14)19(2)17-36(8,45)33(53-35-29(41)25(40(11)12)16-20(3)49-35)22(5)30(23(6)34(44)51-26)52-27-18-37(9,47-13)32(43)24(7)50-27/h19-27,29-33,35,41-43,45-46H,15-18H2,1-14H3/b39-28+/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	HPZGUSZNXKOMCQ-SQYJNGITSA-N					doublet; removed another duplicate entry; compound annotation
0391_003370	LEXITHROMYCIN	C38H70N2O13	3.3839	6532846	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOC)C(C)C(O)C1(C)O	InChI=1S/C38H70N2O13/c1-15-26-38(10,46)31(42)21(4)28(39-48-14)19(2)17-36(8,45)33(53-35-29(41)25(40(11)12)16-20(3)49-35)22(5)30(23(6)34(44)51-26)52-27-18-37(9,47-13)32(43)24(7)50-27/h19-27,29-33,35,41-43,45-46H,15-18H2,1-14H3/b39-28+/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	HPZGUSZNXKOMCQ-SQYJNGITSA-N					doublet; removed another duplicate entry; compound annotation
0391_003372	LEXITHROMYCIN	C38H70N2O13	3.7711	6532846	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOC)C(C)C(O)C1(C)O	InChI=1S/C38H70N2O13/c1-15-26-38(10,46)31(42)21(4)28(39-48-14)19(2)17-36(8,45)33(53-35-29(41)25(40(11)12)16-20(3)49-35)22(5)30(23(6)34(44)51-26)52-27-18-37(9,47-13)32(43)24(7)50-27/h19-27,29-33,35,41-43,45-46H,15-18H2,1-14H3/b39-28+/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	HPZGUSZNXKOMCQ-SQYJNGITSA-N					doublet; compound annotation
0391_003373	Mapracorat	C25H26F4N2O2	3.7994	24795088	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1	VJGFOYBQOIPQFY-XMMPIXPASA-N					doublet; compound annotation
0391_003374	Ponesimod	C23H25ClN2O4S	4.2985	11363176	CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C	CCCN=C1SC(=Cc2cc(Cl)c(OCC(O)CO)cc2)C(=O)N1c1ccccc1C	InChI=1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23?/t17-/m1/s1	LPAUOXUZGSBGDU-ULCCENQXSA-N					doublet; compound annotation
0391_003375	Ponesimod	C23H25ClN2O4S	4.3817	11363176	CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C	CCCN=C1SC(=Cc2cc(Cl)c(OCC(O)CO)cc2)C(=O)N1c1ccccc1C	InChI=1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23?/t17-/m1/s1	LPAUOXUZGSBGDU-ULCCENQXSA-N					doublet; compound annotation
0391_003376	Ponesimod	C23H25ClN2O4S	5.0676	11363176	CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C	CCCN=C1SC(=Cc2cc(Cl)c(OCC(O)CO)cc2)C(=O)N1c1ccccc1C	InChI=1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23?/t17-/m1/s1	LPAUOXUZGSBGDU-ULCCENQXSA-N					doublet; compound annotation
0391_003377	Mapracorat	C25H26F4N2O2	5.5699	24795088	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1	VJGFOYBQOIPQFY-XMMPIXPASA-N					doublet; compound annotation
0391_003378	BPTU	C23H22F3N3O3	5.7787	11510579		CC(C)(C)c1ccccc1Oc1ncccc1NC(=O)Nc1ccc(OC(F)(F)F)cc1	InChI=1S/C23H22F3N3O3/c1-22(2,3)17-7-4-5-9-19(17)31-20-18(8-6-14-27-20)29-21(30)28-15-10-12-16(13-11-15)32-23(24,25)26/h4-14H,1-3H3,(H2,28,29,30)	AHFLGPTXSIRAQK-UHFFFAOYSA-N					compound annotation
0391_003379	Triciribine	C13H16N6O4	0.7048	65399	CN1C2=NC=NC3=C2C(=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(=N1)N	CN1N=C(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23	InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8-,9-,13-/m1/s1	HOGVTUZUJGHKPL-HTVVRFAVSA-N					compound annotation
0391_003380	NVP-BVU972	C20H16N6	1.4163	44206063		Cn1cc(-c2nn3c(Cc4cc5c(cc4)nccc5)cnc3cc2)cn1	InChI=1S/C20H16N6/c1-25-13-16(11-23-25)19-6-7-20-22-12-17(26(20)24-19)10-14-4-5-18-15(9-14)3-2-8-21-18/h2-9,11-13H,10H2,1H3	RNCNPRCUHHDYPC-UHFFFAOYSA-N					compound annotation
0391_003381	CC-90009	C22H18ClF2N3O4	3.346	118647211		O=C1CCC(N2Cc3c(ccc(CNC(=O)C(F)(F)c4ccc(Cl)cc4)c3)C2=O)C(=O)N1	InChI=1S/C22H18ClF2N3O4/c23-15-4-2-14(3-5-15)22(24,25)21(32)26-10-12-1-6-16-13(9-12)11-28(20(16)31)17-7-8-18(29)27-19(17)30/h1-6,9,17H,7-8,10-11H2,(H,26,32)(H,27,29,30)	PWBHUSLMHZLGRN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003383	p38 MAPK-IN-1	C21H14F2N2O	3.4261	24899733		Cc1ccccc1-c1[n+]([O-])ccc2c(-c3c(F)cc(F)cc3)ccnc12	InChI=1S/C21H14F2N2O/c1-13-4-2-3-5-15(13)21-20-18(9-11-25(21)26)16(8-10-24-20)17-7-6-14(22)12-19(17)23/h2-12H,1H3	BSZQSLWNMVTKJT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003385	p38 MAPK-IN-1	C21H14F2N2O	3.6365	24899733		Cc1ccccc1-c1[n+]([O-])ccc2c(-c3c(F)cc(F)cc3)ccnc12	InChI=1S/C21H14F2N2O/c1-13-4-2-3-5-15(13)21-20-18(9-11-25(21)26)16(8-10-24-20)17-7-6-14(22)12-19(17)23/h2-12H,1H3	BSZQSLWNMVTKJT-UHFFFAOYSA-N					doublet; compound annotation
0391_003386	BNC105	C20H20O7	3.6444	24786555		COc1cc(C(=O)c2c(C)oc3c2ccc(OC)c3O)cc(OC)c1OC	InChI=1S/C20H20O7/c1-10-16(12-6-7-13(23-2)18(22)19(12)27-10)17(21)11-8-14(24-3)20(26-5)15(9-11)25-4/h6-9,22H,1-5H3	RADMJHVVIZTENA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003388	AZD8797	C19H25N5OS2	3.6714	11965767	C[C@@H](C1=CC=CC=C1)SC2=NC3=C(C(=N2)N[C@H](CC(C)C)CO)SC(=N3)N	CC(C)CC(CO)Nc1nc(SC(C)c2ccccc2)nc2c1sc(N)n2	InChI=1S/C19H25N5OS2/c1-11(2)9-14(10-25)21-16-15-17(22-18(20)27-15)24-19(23-16)26-12(3)13-7-5-4-6-8-13/h4-8,11-12,14,25H,9-10H2,1-3H3,(H3,20,21,22,23,24)/t12-,14+/m0/s1	ZMQSLMZOWVGBSM-GXTWGEPZSA-N					removed another duplicate entry; compound annotation
0391_003390	BML-190	C23H23ClN2O4	4.2907	2415		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)N1CCOCC1	InChI=1S/C23H23ClN2O4/c1-15-19(14-22(27)25-9-11-30-12-10-25)20-13-18(29-2)7-8-21(20)26(15)23(28)16-3-5-17(24)6-4-16/h3-8,13H,9-12,14H2,1-2H3	BJSDNVVWJYDOLK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003392	BML-190	C23H23ClN2O4	4.2957	2415		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)N1CCOCC1	InChI=1S/C23H23ClN2O4/c1-15-19(14-22(27)25-9-11-30-12-10-25)20-13-18(29-2)7-8-21(20)26(15)23(28)16-3-5-17(24)6-4-16/h3-8,13H,9-12,14H2,1-2H3	BJSDNVVWJYDOLK-UHFFFAOYSA-N					doublet; compound annotation
0391_003393	TMP920	C29H30N2O3	4.9331	71493659		Cc1cc(C)c(C(NC(=O)Cc2ccc(OCc3c(C)onc3C)cc2)c2ccccc2)cc1	InChI=1S/C29H30N2O3/c1-19-10-15-26(20(2)16-19)29(24-8-6-5-7-9-24)30-28(32)17-23-11-13-25(14-12-23)33-18-27-21(3)31-34-22(27)4/h5-16,29H,17-18H2,1-4H3,(H,30,32)	SHMBIDOWYJZWLB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003395	4egi-1	C18H12Cl2N4O4S	4.9379	5717952	C1=CC=C(C(=C1)C/C(=N\NC2=NC(=CS2)C3=CC(=C(C=C3)Cl)Cl)/C(=O)O)[N+](=O)[O-]	O=C(O)C(Cc1ccccc1[N+](=O)[O-])=NNc1nc(-c2cc(Cl)c(Cl)cc2)cs1	InChI=1S/C18H12Cl2N4O4S/c19-12-6-5-10(7-13(12)20)15-9-29-18(21-15)23-22-14(17(25)26)8-11-3-1-2-4-16(11)24(27)28/h1-7,9H,8H2,(H,21,23)(H,25,26)/b22-14+	KFRKRECSIYXARE-HYARGMPZSA-N					doublet; compound annotation
0391_003396	4egi-1	C18H12Cl2N4O4S	5.4445	5717952	C1=CC=C(C(=C1)C/C(=N\NC2=NC(=CS2)C3=CC(=C(C=C3)Cl)Cl)/C(=O)O)[N+](=O)[O-]	O=C(O)C(Cc1ccccc1[N+](=O)[O-])=NNc1nc(-c2cc(Cl)c(Cl)cc2)cs1	InChI=1S/C18H12Cl2N4O4S/c19-12-6-5-10(7-13(12)20)15-9-29-18(21-15)23-22-14(17(25)26)8-11-3-1-2-4-16(11)24(27)28/h1-7,9H,8H2,(H,21,23)(H,25,26)/b22-14+	KFRKRECSIYXARE-HYARGMPZSA-N					doublet; compound annotation
0391_003397	GSK3326595	C24H32N6O3	1.5897	90241742	CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NC[C@@H](CN3CCC4=CC=CC=C4C3)O	CC(=O)N1CCC(Nc2ncnc(C(=O)NCC(O)CN3CCc4ccccc4C3)c2)CC1	InChI=1S/C24H32N6O3/c1-17(31)30-10-7-20(8-11-30)28-23-12-22(26-16-27-23)24(33)25-13-21(32)15-29-9-6-18-4-2-3-5-19(18)14-29/h2-5,12,16,20-21,32H,6-11,13-15H2,1H3,(H,25,33)(H,26,27,28)/t21-/m0/s1	JLCCNYVTIWRPIZ-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_003399	853299-07-7	C24H26F3N7O2	2.0603	11260561		CN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)Nc3ccc(Oc4nc(N)ncc4)cc3)cc2)CC1	InChI=1S/C24H26F3N7O2/c1-33-10-12-34(13-11-33)15-16-2-3-18(14-20(16)24(25,26)27)31-23(35)30-17-4-6-19(7-5-17)36-21-8-9-29-22(28)32-21/h2-9,14H,10-13,15H2,1H3,(H2,28,29,32)(H2,30,31,35)	PWDLXPJQFNVTNL-UHFFFAOYSA-N					compound annotation
0391_003400	1093058-52-6	C13H15BrN2	2.6562	57775660		Brc1ccc(CCCCn2ccnc2)cc1	InChI=1S/C13H15BrN2/c14-13-6-4-12(5-7-13)3-1-2-9-16-10-8-15-11-16/h4-8,10-11H,1-3,9H2	FZNINMHMRBYDPR-UHFFFAOYSA-N					doublet; compound annotation
0391_003401	1093058-52-6	C13H15BrN2	2.8285	57775660		Brc1ccc(CCCCn2ccnc2)cc1	InChI=1S/C13H15BrN2/c14-13-6-4-12(5-7-13)3-1-2-9-16-10-8-15-11-16/h4-8,10-11H,1-3,9H2	FZNINMHMRBYDPR-UHFFFAOYSA-N					doublet; compound annotation
0391_003402	1093058-52-6	C13H15BrN2	2.9959	57775660		Brc1ccc(CCCCn2ccnc2)cc1	InChI=1S/C13H15BrN2/c14-13-6-4-12(5-7-13)3-1-2-9-16-10-8-15-11-16/h4-8,10-11H,1-3,9H2	FZNINMHMRBYDPR-UHFFFAOYSA-N					doublet; compound annotation
0391_003403	Afuresertib	C18H17Cl2FN4OS	3.0715	46843057	CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)sc(C(=O)NC(CN)Cc2cc(F)ccc2)c1	InChI=1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1	AFJRDFWMXUECEW-LBPRGKRZSA-N					doublet; compound annotation
0391_003404	Afuresertib	C18H17Cl2FN4OS	3.1361	46843057	CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)sc(C(=O)NC(CN)Cc2cc(F)ccc2)c1	InChI=1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1	AFJRDFWMXUECEW-LBPRGKRZSA-N					doublet; removed another duplicate entry; compound annotation
0391_003406	ACY-1083	C17H18F2N4O2	3.2487	91844718		O=C(NO)c1cnc(NC2(c3ccccc3)CCC(F)(F)CC2)nc1	InChI=1S/C17H18F2N4O2/c18-17(19)8-6-16(7-9-17,13-4-2-1-3-5-13)22-15-20-10-12(11-21-15)14(24)23-25/h1-5,10-11,25H,6-9H2,(H,23,24)(H,20,21,22)	MRWCVKLVSWYIFO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003408	ML-030	C20H20N4O4S	3.345	17757146		COc1cc(-c2nnc3SCC(c4cc(OC)c(OC)cc4)=Nn32)c(OC)cc1	InChI=1S/C20H20N4O4S/c1-25-13-6-8-16(26-2)14(10-13)19-21-22-20-24(19)23-15(11-29-20)12-5-7-17(27-3)18(9-12)28-4/h5-10H,11H2,1-4H3	DZAUSKKPHXFGNN-UHFFFAOYSA-N					doublet; compound annotation
0391_003409	ML-030	C20H20N4O4S	3.3499	17757146		COc1cc(-c2nnc3SCC(c4cc(OC)c(OC)cc4)=Nn32)c(OC)cc1	InChI=1S/C20H20N4O4S/c1-25-13-6-8-16(26-2)14(10-13)19-21-22-20-24(19)23-15(11-29-20)12-5-7-17(27-3)18(9-12)28-4/h5-10H,11H2,1-4H3	DZAUSKKPHXFGNN-UHFFFAOYSA-N					doublet; compound annotation
0391_003410	CK1-IN-1	C24H15F2N3	3.3673	118303686		Fc1ccc(-c2c(-c3ccncc3)[nH]c(-c3c(F)c4ccccc4cc3)n2)cc1	InChI=1S/C24H15F2N3/c25-18-8-5-16(6-9-18)22-23(17-11-13-27-14-12-17)29-24(28-22)20-10-7-15-3-1-2-4-19(15)21(20)26/h1-14H,(H,28,29)	PUQAFIILJICJRR-UHFFFAOYSA-N					compound annotation
0391_003411	PIK-294	C28H23N7O2	3.3902	24905149		Cc1ccccc1-n1c(Cn2nc(-c3cc(O)ccc3)c3c(N)ncnc32)nc2cccc(C)c2c1=O	InChI=1S/C28H23N7O2/c1-16-7-3-4-12-21(16)35-22(32-20-11-5-8-17(2)23(20)28(35)37)14-34-27-24(26(29)30-15-31-27)25(33-34)18-9-6-10-19(36)13-18/h3-13,15,36H,14H2,1-2H3,(H2,29,30,31)	WFSLJOPRIJSOJR-UHFFFAOYSA-N					doublet; compound annotation
0391_003412	PIK-294	C28H23N7O2	3.3952	24905149		Cc1ccccc1-n1c(Cn2nc(-c3cc(O)ccc3)c3c(N)ncnc32)nc2cccc(C)c2c1=O	InChI=1S/C28H23N7O2/c1-16-7-3-4-12-21(16)35-22(32-20-11-5-8-17(2)23(20)28(35)37)14-34-27-24(26(29)30-15-31-27)25(33-34)18-9-6-10-19(36)13-18/h3-13,15,36H,14H2,1-2H3,(H2,29,30,31)	WFSLJOPRIJSOJR-UHFFFAOYSA-N					doublet; compound annotation
0391_003413	Ravuconazole	C22H17F2N5OS	4.5143	467825	C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)O	CC(c1nc(-c2ccc(C#N)cc2)cs1)C(O)(Cn1cncn1)c1c(F)cc(F)cc1	InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1	OPAHEYNNJWPQPX-RCDICMHDSA-N					compound annotation
0391_003414	ETOFYLLINE	C9H12N4O3	1.0822	1892		Cn1c(=O)c2c(ncn2CCO)n(C)c1=O	InChI=1S/C9H12N4O3/c1-11-7-6(8(15)12(2)9(11)16)13(3-4-14)5-10-7/h5,14H,3-4H2,1-2H3	NWPRCRWQMGIBOT-UHFFFAOYSA-N					compound annotation
0391_003415	sulfathiazole	C9H9N3O2S2	1.1808	5340		Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12)	JNMRHUJNCSQMMB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003417	Epiberberine	C20H18NO4+	2.2194	160876		COc1c(OC)cc2c(c1)CC[n+]1c-2cc2ccc3c(OCO3)c2c1	InChI=1S/C20H18NO4/c1-22-18-8-13-5-6-21-10-15-12(3-4-17-20(15)25-11-24-17)7-16(21)14(13)9-19(18)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1	FPJQGFLUORYYPE-UHFFFAOYSA-N					doublet; compound annotation
0391_003418	Cinchophen	C16H11NO2	3.0569	8593		O=C(O)c1cc(-c2ccccc2)nc2ccccc12	InChI=1S/C16H11NO2/c18-16(19)13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,(H,18,19)	YTRMTPPVNRALON-UHFFFAOYSA-N					doublet; compound annotation
0391_003419	Cinchophen	C16H11NO2	3.0602	8593		O=C(O)c1cc(-c2ccccc2)nc2ccccc12	InChI=1S/C16H11NO2/c18-16(19)13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,(H,18,19)	YTRMTPPVNRALON-UHFFFAOYSA-N					doublet; compound annotation
0391_003420	SCHEMBL18872260	C33H31N2O5+	3.4048	2762613		O=C(O)c1cc(C2=c3cc4CCC[N+]5=c4c(c3Oc3c2cc2CCCN4CCCc3c24)CCC5)c(C(=O)O)cc1	InChI=1S/C33H30N2O5/c36-32(37)20-9-10-21(33(38)39)24(17-20)27-25-15-18-5-1-11-34-13-3-7-22(28(18)34)30(25)40-31-23-8-4-14-35-12-2-6-19(29(23)35)16-26(27)31/h9-10,15-17H,1-8,11-14H2,(H-,36,37,38,39)/p+1	WQZIDRAQTRIQDX-UHFFFAOYSA-O					doublet; compound annotation
0391_003421	SCHEMBL18872260	C33H31N2O5+	3.731	2762613		O=C(O)c1cc(C2=c3cc4CCC[N+]5=c4c(c3Oc3c2cc2CCCN4CCCc3c24)CCC5)c(C(=O)O)cc1	InChI=1S/C33H30N2O5/c36-32(37)20-9-10-21(33(38)39)24(17-20)27-25-15-18-5-1-11-34-13-3-7-22(28(18)34)30(25)40-31-23-8-4-14-35-12-2-6-19(29(23)35)16-26(27)31/h9-10,15-17H,1-8,11-14H2,(H-,36,37,38,39)/p+1	WQZIDRAQTRIQDX-UHFFFAOYSA-O					doublet; compound annotation
0391_003422	AS2863619 (free base)	C16H12N8O	0.4793	139600292		Cc1nc2c(cc(-n3c(-c4nonc4N)nc4cnccc43)cc2)[nH]1	InChI=1S/C16H12N8O/c1-8-19-10-3-2-9(6-11(10)20-8)24-13-4-5-18-7-12(13)21-16(24)14-15(17)23-25-22-14/h2-7H,1H3,(H2,17,23)(H,19,20)	OORKHRHPVSWORX-UHFFFAOYSA-N					doublet; compound annotation
0391_003423	1243244-14-5	C23H20N6O	1.8704	46926973		Cc1nccc(-c2ncc(CC(=O)Nc3ncc(-c4nccnc4)cc3)cc2C)c1	InChI=1S/C23H20N6O/c1-15-9-17(12-28-23(15)18-5-6-25-16(2)10-18)11-22(30)29-21-4-3-19(13-27-21)20-14-24-7-8-26-20/h3-10,12-14H,11H2,1-2H3,(H,27,29,30)	XXYGTCZJJLTAGH-UHFFFAOYSA-N					compound annotation
0391_003424	GNE 2861	C22H26N6O2	2.7795	68181954		COCCNc1nc2c(cc(C#CC3(O)CCCCC3)cc2)n1-c1nc(N)ncc1	InChI=1S/C22H26N6O2/c1-30-14-13-25-21-26-17-6-5-16(7-11-22(29)9-3-2-4-10-22)15-18(17)28(21)19-8-12-24-20(23)27-19/h5-6,8,12,15,29H,2-4,9-10,13-14H2,1H3,(H,25,26)(H2,23,24,27)	RZXMIHOUHYSGJO-UHFFFAOYSA-N					doublet; compound annotation
0391_003425	GNE 2861	C22H26N6O2	2.7829	68181954		COCCNc1nc2c(cc(C#CC3(O)CCCCC3)cc2)n1-c1nc(N)ncc1	InChI=1S/C22H26N6O2/c1-30-14-13-25-21-26-17-6-5-16(7-11-22(29)9-3-2-4-10-22)15-18(17)28(21)19-8-12-24-20(23)27-19/h5-6,8,12,15,29H,2-4,9-10,13-14H2,1H3,(H,25,26)(H2,23,24,27)	RZXMIHOUHYSGJO-UHFFFAOYSA-N					doublet; compound annotation
0391_003426	Poziotinib	C23H21Cl2FN4O3	3.0737	25127713		C=CC(=O)N1CCC(Oc2c(OC)cc3ncnc(Nc4c(F)c(Cl)c(Cl)cc4)c3c2)CC1	InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)	LPFWVDIFUFFKJU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003428	Droxinostat	C11H14ClNO3	3.189	568416		Cc1c(OCCCC(=O)NO)ccc(Cl)c1	InChI=1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5,7,15H,2-3,6H2,1H3,(H,13,14)	JHSXDAWGLCZYSM-UHFFFAOYSA-N					compound annotation
0391_003429	Icilin	C16H13N3O4	3.2759	161930		O=C1NC(c2cc([N+](=O)[O-])ccc2)=CCN1c1ccccc1O	InChI=1S/C16H13N3O4/c20-15-7-2-1-6-14(15)18-9-8-13(17-16(18)21)11-4-3-5-12(10-11)19(22)23/h1-8,10,20H,9H2,(H,17,21)	RCEFMOGVOYEGJN-UHFFFAOYSA-N					compound annotation
0391_003430	664993-53-7	C25H26N2O5	3.2901	2946601		COc1ccc(C2(CNC(=O)c3ccc(NC(=O)c4ccco4)cc3)CCOCC2)cc1	InChI=1S/C25H26N2O5/c1-30-21-10-6-19(7-11-21)25(12-15-31-16-13-25)17-26-23(28)18-4-8-20(9-5-18)27-24(29)22-3-2-14-32-22/h2-11,14H,12-13,15-17H2,1H3,(H,26,28)(H,27,29)	ZJZWZIXSGNFWQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003431	664993-53-7	C25H26N2O5	3.2929	2946601		COc1ccc(C2(CNC(=O)c3ccc(NC(=O)c4ccco4)cc3)CCOCC2)cc1	InChI=1S/C25H26N2O5/c1-30-21-10-6-19(7-11-21)25(12-15-31-16-13-25)17-26-23(28)18-4-8-20(9-5-18)27-24(29)22-3-2-14-32-22/h2-11,14H,12-13,15-17H2,1H3,(H,26,28)(H,27,29)	ZJZWZIXSGNFWQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003432	329221-38-7	C13H16N2O2S	3.2979	673481		NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2	InChI=1S/C13H16N2O2S/c14-11(16)10-8-3-1-2-4-9(8)18-13(10)15-12(17)7-5-6-7/h7H,1-6H2,(H2,14,16)(H,15,17)	VATFNEMGBRWLHI-UHFFFAOYSA-N					doublet; compound annotation
0391_003433	329221-38-7	C13H16N2O2S	3.3029	673481		NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2	InChI=1S/C13H16N2O2S/c14-11(16)10-8-3-1-2-4-9(8)18-13(10)15-12(17)7-5-6-7/h7H,1-6H2,(H2,14,16)(H,15,17)	VATFNEMGBRWLHI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003435	BMS-707035	C17H19FN4O5S	3.4502	54682040		Cn1c(N2CCCCS2(=O)=O)nc(C(=O)NCc2ccc(F)cc2)c(O)c1=O	InChI=1S/C17H19FN4O5S/c1-21-16(25)14(23)13(15(24)19-10-11-4-6-12(18)7-5-11)20-17(21)22-8-2-3-9-28(22,26)27/h4-7,23H,2-3,8-10H2,1H3,(H,19,24)	VNIWZCGZPBJWBI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003437	Poziotinib	C23H21Cl2FN4O3	3.5003	25127713		C=CC(=O)N1CCC(Oc2c(OC)cc3ncnc(Nc4c(F)c(Cl)c(Cl)cc4)c3c2)CC1	InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)	LPFWVDIFUFFKJU-UHFFFAOYSA-N					doublet; compound annotation
0391_003438	SR-4370	C17H18F2N2O	3.8992	118418385		CCCCNNC(=O)c1ccc(-c2c(F)c(F)ccc2)cc1	InChI=1S/C17H18F2N2O/c1-2-3-11-20-21-17(22)13-9-7-12(8-10-13)14-5-4-6-15(18)16(14)19/h4-10,20H,2-3,11H2,1H3,(H,21,22)	OSQKWTZHYXRTBG-UHFFFAOYSA-N					doublet; compound annotation
0391_003439	SR-4370	C17H18F2N2O	3.902	118418385		CCCCNNC(=O)c1ccc(-c2c(F)c(F)ccc2)cc1	InChI=1S/C17H18F2N2O/c1-2-3-11-20-21-17(22)13-9-7-12(8-10-13)14-5-4-6-15(18)16(14)19/h4-10,20H,2-3,11H2,1H3,(H,21,22)	OSQKWTZHYXRTBG-UHFFFAOYSA-N					doublet; compound annotation
0391_003440	Nebracetam	C12H16N2O	1.0896	65926		NCC1CC(=O)N(Cc2ccccc2)C1	InChI=1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2	LCAFGJGYCUMTGS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003442	Ropanicant	C11H13ClN2O	1.1789	146026959	C1[C@H]2C[C@H]2N[C@@H]1COC3=CN=C(C=C3)Cl	Clc1ncc(OCC2CC3CC3N2)cc1	InChI=1S/C11H13ClN2O/c12-11-2-1-9(5-13-11)15-6-8-3-7-4-10(7)14-8/h1-2,5,7-8,10,14H,3-4,6H2/t7-,8-,10+/m0/s1	PYSCVJMLJRHJGJ-OYNCUSHFSA-N					compound annotation
0391_003443	264218-23-7	C16H10ClN3O5	2.0906	4210951		O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cc(Cl)c(O)cc1	InChI=1S/C16H10ClN3O5/c17-10-7-8(5-6-12(10)21)18-14-13(15(22)19-16(14)23)9-3-1-2-4-11(9)20(24)25/h1-7,21H,(H2,18,19,22,23)	PQCXVIPXISBFPN-UHFFFAOYSA-N					doublet; compound annotation
0391_003444	264218-23-7	C16H10ClN3O5	2.0937	4210951		O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cc(Cl)c(O)cc1	InChI=1S/C16H10ClN3O5/c17-10-7-8(5-6-12(10)21)18-14-13(15(22)19-16(14)23)9-3-1-2-4-11(9)20(24)25/h1-7,21H,(H2,18,19,22,23)	PQCXVIPXISBFPN-UHFFFAOYSA-N					doublet; compound annotation
0391_003445	ent-Rotigotine	C19H25NOS	2.6446	57537		CCCN(CCc1cccs1)C1CCc2c(cccc2O)C1	InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3	KFQYTPMOWPVWEJ-UHFFFAOYSA-N					compound annotation
0391_003446	NS309	C8H4Cl2N2O2	3.0288	135502903		O=Nc1c(O)[nH]c2c1ccc(Cl)c2Cl	InChI=1S/C8H4Cl2N2O2/c9-4-2-1-3-6(5(4)10)11-8(13)7(3)12-14/h1-2,11,13H	ROBYKNONIPZMTK-UHFFFAOYSA-N					compound annotation
0391_003447	ML-109	C31H29N3O5	4.5289	25246343		COc1c(COc2ccc(NC(C)=O)cc2)cc(C2Nc3c(C(=O)N2Cc2ccccc2)c(O)ccc3)cc1	InChI=1S/C31H29N3O5/c1-20(35)32-24-12-14-25(15-13-24)39-19-23-17-22(11-16-28(23)38-2)30-33-26-9-6-10-27(36)29(26)31(37)34(30)18-21-7-4-3-5-8-21/h3-17,30,33,36H,18-19H2,1-2H3,(H,32,35)	JRVXFGNCHKHBPA-UHFFFAOYSA-N					doublet; compound annotation
0391_003448	ML-109	C31H29N3O5	4.5322	25246343		COc1c(COc2ccc(NC(C)=O)cc2)cc(C2Nc3c(C(=O)N2Cc2ccccc2)c(O)ccc3)cc1	InChI=1S/C31H29N3O5/c1-20(35)32-24-12-14-25(15-13-24)39-19-23-17-22(11-16-28(23)38-2)30-33-26-9-6-10-27(36)29(26)31(37)34(30)18-21-7-4-3-5-8-21/h3-17,30,33,36H,18-19H2,1-2H3,(H,32,35)	JRVXFGNCHKHBPA-UHFFFAOYSA-N					doublet; compound annotation
0391_003449	CCG-222740	C23H19ClF2N2O3	4.8433	121317937		O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1	InChI=1S/C23H19ClF2N2O3/c24-18-6-8-19(9-7-18)27-21(29)17-12-23(25,26)14-28(13-17)22(30)16-4-1-3-15(11-16)20-5-2-10-31-20/h1-11,17H,12-14H2,(H,27,29)	PMTPYUTZAJWGPE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003452	CPPHA	C22H15ClN2O4	4.8773	9931205		O=C(Nc1ccc(Cl)cc1CN1C(=O)c2ccccc2C1=O)c1ccccc1O	InChI=1S/C22H15ClN2O4/c23-14-9-10-18(24-20(27)17-7-3-4-8-19(17)26)13(11-14)12-25-21(28)15-5-1-2-6-16(15)22(25)29/h1-11,26H,12H2,(H,24,27)	UFOUABRZSDGGAZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003454	4871-40-3	C8H9N3O3S	1.7246	2807216		NNC(=O)CSc1ccccc1[N+](=O)[O-]	InChI=1S/C8H9N3O3S/c9-10-8(12)5-15-7-4-2-1-3-6(7)11(13)14/h1-4H,5,9H2,(H,10,12)	CZXFCCXLFQCYBK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003456	Garenoxacin	C23H20F2N2O4	2.3463	124093	C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F	CC1NCc2c1ccc(-c1c(OC(F)F)c3c(cc1)c(=O)c(C(=O)O)cn3C1CC1)c2	InChI=1S/C23H20F2N2O4/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30)/t11-/m1/s1	NJDRXTDGYFKORP-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_003458	1245792-51-1	C22H23NO	2.8912	6419844	C1CCC(CC1)NC\2C3=CC=CC=C3C(=O)/C2=C/C4=CC=CC=C4	O=C1C(=Cc2ccccc2)C(NC2CCCCC2)c2ccccc12	InChI=1S/C22H23NO/c24-22-19-14-8-7-13-18(19)21(23-17-11-5-2-6-12-17)20(22)15-16-9-3-1-4-10-16/h1,3-4,7-10,13-15,17,21,23H,2,5-6,11-12H2/b20-15+	XJDKPLZUXCIMIS-HMMYKYKNSA-N					doublet; compound annotation
0391_003459	1245792-51-1	C22H23NO	3.0577	6419844	C1CCC(CC1)NC\2C3=CC=CC=C3C(=O)/C2=C/C4=CC=CC=C4	O=C1C(=Cc2ccccc2)C(NC2CCCCC2)c2ccccc12	InChI=1S/C22H23NO/c24-22-19-14-8-7-13-18(19)21(23-17-11-5-2-6-12-17)20(22)15-16-9-3-1-4-10-16/h1,3-4,7-10,13-15,17,21,23H,2,5-6,11-12H2/b20-15+	XJDKPLZUXCIMIS-HMMYKYKNSA-N					doublet; compound annotation
0391_003460	Icaridin	C12H23NO3	3.378	125098		CCC(C)OC(=O)N1CCCCC1CCO	InChI=1S/C12H23NO3/c1-3-10(2)16-12(15)13-8-5-4-6-11(13)7-9-14/h10-11,14H,3-9H2,1-2H3	QLHULAHOXSSASE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003462	Helioxanthin derivative 5-4-2	C20H13NO5	3.4526	5273792		O=C1NCc2c1cc1ccc3c(OCO3)c1c2-c1cc2c(cc1)OCO2	InChI=1S/C20H13NO5/c22-20-12-5-10-2-4-15-19(26-9-24-15)18(10)17(13(12)7-21-20)11-1-3-14-16(6-11)25-8-23-14/h1-6H,7-9H2,(H,21,22)	UVKXTQRJKHBAMT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003465	AER-271	C15H9ClF6NO5P	3.8722	10412080		O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1c(OP(=O)(O)O)ccc(Cl)c1	InChI=1S/C15H9ClF6NO5P/c16-9-1-2-12(28-29(25,26)27)11(6-9)13(24)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6H,(H,23,24)(H2,25,26,27)	WSHXPHFIHYXZKC-UHFFFAOYSA-N					compound annotation
0391_003466	TTP 22	C16H14N2O2S2	4.1793	1536915		Cc1ccc(-c2csc3c2c(SCCC(=O)O)ncn3)cc1	InChI=1S/C16H14N2O2S2/c1-10-2-4-11(5-3-10)12-8-22-16-14(12)15(17-9-18-16)21-7-6-13(19)20/h2-5,8-9H,6-7H2,1H3,(H,19,20)	RAOULLCLLOGTDA-UHFFFAOYSA-N					compound annotation
0391_003467	SRPKIN-1	C27H21FN2O3S	5.3494	135324340		CCc1cc2c(cc1-c1cc(S(=O)(=O)F)ccc1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C27H21FN2O3S/c1-4-16-12-21-22(13-20(16)17-6-5-7-18(11-17)34(28,32)33)27(2,3)26-24(25(21)31)19-9-8-15(14-29)10-23(19)30-26/h5-13,30H,4H2,1-3H3	TWKWEBMGDALHPN-UHFFFAOYSA-N					doublet; compound annotation
0391_003468	SRPKIN-1	C27H21FN2O3S	5.4346	135324340		CCc1cc2c(cc1-c1cc(S(=O)(=O)F)ccc1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C27H21FN2O3S/c1-4-16-12-21-22(13-20(16)17-6-5-7-18(11-17)34(28,32)33)27(2,3)26-24(25(21)31)19-9-8-15(14-29)10-23(19)30-26/h5-13,30H,4H2,1-3H3	TWKWEBMGDALHPN-UHFFFAOYSA-N					doublet; compound annotation
0391_003469	SRPKIN-1	C27H21FN2O3S	5.4374	135324340		CCc1cc2c(cc1-c1cc(S(=O)(=O)F)ccc1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C27H21FN2O3S/c1-4-16-12-21-22(13-20(16)17-6-5-7-18(11-17)34(28,32)33)27(2,3)26-24(25(21)31)19-9-8-15(14-29)10-23(19)30-26/h5-13,30H,4H2,1-3H3	TWKWEBMGDALHPN-UHFFFAOYSA-N					doublet; compound annotation
0391_003470	1507370-20-8	C26H26N4	1.4222	72201045		c1ccc(-c2ccc(CNCCNCc3ccc(-c4ccccn4)cc3)cc2)nc1	InChI=1S/C26H26N4/c1-3-15-29-25(5-1)23-11-7-21(8-12-23)19-27-17-18-28-20-22-9-13-24(14-10-22)26-6-2-4-16-30-26/h1-16,27-28H,17-20H2	IXEPQJQQSLMESJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003471	PF-04447943	C20H25N7O2	1.4222	135564558	C[C@@H]1CN(C[C@H]1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=NC=CC=N5	CC1CN(Cc2ncccn2)CC1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	InChI=1S/C20H25N7O2/c1-13-10-26(12-17-21-5-2-6-22-17)11-16(13)18-24-19-15(20(28)25-18)9-23-27(19)14-3-7-29-8-4-14/h2,5-6,9,13-14,16H,3-4,7-8,10-12H2,1H3,(H,24,25,28)/t13-,16-/m1/s1	IWXUVYOOUMLUTQ-CZUORRHYSA-N					removed another duplicate entry; compound annotation
0391_003473	783348-36-7	C19H15ClN4O2	1.6212	9929127		COc1c(Cl)cc2c(c1NC(=O)c1c(C)nccc1)[nH]c1c2ccnc1	InChI=1S/C19H15ClN4O2/c1-10-11(4-3-6-22-10)19(25)24-17-16-13(8-14(20)18(17)26-2)12-5-7-21-9-15(12)23-16/h3-9,23H,1-2H3,(H,24,25)	ZNOLRTPMNMPLHY-UHFFFAOYSA-N					compound annotation
0391_003474	1507370-20-8	C26H26N4	1.6212	72201045		c1ccc(-c2ccc(CNCCNCc3ccc(-c4ccccn4)cc3)cc2)nc1	InChI=1S/C26H26N4/c1-3-15-29-25(5-1)23-11-7-21(8-12-23)19-27-17-18-28-20-22-9-13-24(14-10-22)26-6-2-4-16-30-26/h1-16,27-28H,17-20H2	IXEPQJQQSLMESJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003475	OTSSP167	C25H28Cl2N4O2	1.9844	135398499		CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1NC1CCC(CN(C)C)CC1	InChI=1S/C25H28Cl2N4O2/c1-14(32)18-12-28-22-9-8-21(16-10-19(26)25(33)20(27)11-16)30-24(22)23(18)29-17-6-4-15(5-7-17)13-31(2)3/h8-12,15,17,33H,4-7,13H2,1-3H3,(H,28,29)	DKZYXHCYPUVGAF-UHFFFAOYSA-N					compound annotation
0391_003476	2271122-53-1	C23H22F2N2O4	3.4591	69496820	CC[C@H](C(=O)O)OC1=C(C=C(C(=N1)OC2=CC(=CC(=C2)C3=CC=CC(=C3)CN)C)F)F	CCC(Oc1c(F)cc(F)c(Oc2cc(C)cc(-c3cccc(CN)c3)c2)n1)C(=O)O	InChI=1S/C23H22F2N2O4/c1-3-20(23(28)29)31-22-19(25)11-18(24)21(27-22)30-17-8-13(2)7-16(10-17)15-6-4-5-14(9-15)12-26/h4-11,20H,3,12,26H2,1-2H3,(H,28,29)/t20-/m1/s1	CVNXUNVHFJANHX-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_003478	LP-935509	C20H24N6O3	4.1227	86697436		COc1c(-c2c3nc(N4CCN(C(=O)OC(C)C)CC4)ccn3nc2)cccn1	InChI=1S/C20H24N6O3/c1-14(2)29-20(27)25-11-9-24(10-12-25)17-6-8-26-18(23-17)16(13-22-26)15-5-4-7-21-19(15)28-3/h4-8,13-14H,9-12H2,1-3H3	GOOYSJIWTIHOGW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003481	LP-935509	C20H24N6O3	4.3202	86697436		COc1c(-c2c3nc(N4CCN(C(=O)OC(C)C)CC4)ccn3nc2)cccn1	InChI=1S/C20H24N6O3/c1-14(2)29-20(27)25-11-9-24(10-12-25)17-6-8-26-18(23-17)16(13-22-26)15-5-4-7-21-19(15)28-3/h4-8,13-14H,9-12H2,1-3H3	GOOYSJIWTIHOGW-UHFFFAOYSA-N					doublet; compound annotation
0391_003482	2271122-53-1	C23H22F2N2O4	4.3236	69496820	CC[C@H](C(=O)O)OC1=C(C=C(C(=N1)OC2=CC(=CC(=C2)C3=CC=CC(=C3)CN)C)F)F	CCC(Oc1c(F)cc(F)c(Oc2cc(C)cc(-c3cccc(CN)c3)c2)n1)C(=O)O	InChI=1S/C23H22F2N2O4/c1-3-20(23(28)29)31-22-19(25)11-18(24)21(27-22)30-17-8-13(2)7-16(10-17)15-6-4-5-14(9-15)12-26/h4-11,20H,3,12,26H2,1-2H3,(H,28,29)/t20-/m1/s1	CVNXUNVHFJANHX-HXUWFJFHSA-N					doublet; compound annotation
0391_003483	CPI-613	C22H28O2S2	5.3409	24770514		O=C(O)CCCCC(CCSCc1ccccc1)SCc1ccccc1	InChI=1S/C22H28O2S2/c23-22(24)14-8-7-13-21(26-18-20-11-5-2-6-12-20)15-16-25-17-19-9-3-1-4-10-19/h1-6,9-12,21H,7-8,13-18H2,(H,23,24)	ZYRLHJIMTROTBO-UHFFFAOYSA-N					compound annotation
0391_003484	Tylosin	C46H77NO17	2.7866	5280440	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1	WBPYTXDJUQJLPQ-VMXQISHHSA-N					doublet; compound annotation
0391_003485	diphenylpyraline	C19H23NO	2.9443	3103		CN1CCC(OC(c2ccccc2)c2ccccc2)CC1	InChI=1S/C19H23NO/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-19H,12-15H2,1H3	OWQUZNMMYNAXSL-UHFFFAOYSA-N					doublet; compound annotation
0391_003486	Tylosin	C46H77NO17	2.9889	5280440	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1	WBPYTXDJUQJLPQ-VMXQISHHSA-N					doublet; removed another duplicate entry; compound annotation
0391_003488	sulfanitran	C14H13N3O5S	3.0655	5334		CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1	InChI=1S/C14H13N3O5S/c1-10(18)15-11-4-8-14(9-5-11)23(21,22)16-12-2-6-13(7-3-12)17(19)20/h2-9,16H,1H3,(H,15,18)	GWBPFRGXNGPPMF-UHFFFAOYSA-N					compound annotation
0391_003489	BMS-536924	C25H26ClN5O3	3.072	135440466	CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N5CCOCC5	Cc1cc(N2CCOCC2)cc2c1nc(-c1c(NCC(O)c3cc(Cl)ccc3)cc[nH]c1=O)[nH]2	InChI=1S/C25H26ClN5O3/c1-15-11-18(31-7-9-34-10-8-31)13-20-23(15)30-24(29-20)22-19(5-6-27-25(22)33)28-14-21(32)16-3-2-4-17(26)12-16/h2-6,11-13,21,32H,7-10,14H2,1H3,(H,29,30)(H2,27,28,33)/t21-/m1/s1	ZWVZORIKUNOTCS-OAQYLSRUSA-N					compound annotation
0391_003490	Tylosin	C46H77NO17	3.0769	5280440	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1	WBPYTXDJUQJLPQ-VMXQISHHSA-N					doublet; compound annotation
0391_003491	Jujuboside A	C58H94O26	3.2719	51346169	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@@]4([C@H]5CC[C@@H]6[C@H]7[C@@](C[C@@H](O[C@@]78C[C@]6([C@@]5(CC[C@H]4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O)O	CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OCC(O)C(OC7OC(COC8OC(CO)C(O)C(O)C8O)C(O)C(O)C7OC7OCC(O)C(O)C7O)C6OC6OC(C)C(O)C(O)C6O)C(C)(C)C5CCC4(C)C34COC2(C4)O1	InChI=1S/C58H94O26/c1-23(2)15-25-16-56(8,72)47-26-9-10-32-54(6)13-12-33(53(4,5)31(54)11-14-55(32,7)57(26)21-58(47,84-25)76-22-57)80-51-46(83-50-43(71)38(66)34(62)24(3)77-50)44(28(61)19-74-51)81-52-45(82-49-41(69)35(63)27(60)18-73-49)40(68)37(65)30(79-52)20-75-48-42(70)39(67)36(64)29(17-59)78-48/h15,24-52,59-72H,9-14,16-22H2,1-8H3/t24-,25-,26+,27+,28-,29+,30+,31-,32+,33-,34-,35-,36+,37+,38+,39-,40-,41+,42+,43+,44-,45+,46+,47-,48+,49-,50-,51-,52-,54-,55+,56-,57-,58-/m0/s1	KVKRFLVYJLIZFD-OQVAHBRNSA-N					compound annotation
0391_003492	Almorexant	C29H31F3N2O3	3.7506	23727689	CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC	CNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1CCc1ccc(C(F)(F)F)cc1	InChI=1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1	DKMACHNQISHMDN-RPLLCQBOSA-N					doublet; compound annotation
0391_003493	Almorexant	C29H31F3N2O3	3.7545	23727689	CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC	CNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1CCc1ccc(C(F)(F)F)cc1	InChI=1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1	DKMACHNQISHMDN-RPLLCQBOSA-N					doublet; compound annotation
0391_003494	103141-09-9	C16H15N3O	4.393	128268		COc1ccc(Nc2nn(-c3ccccc3)cc2)cc1	InChI=1S/C16H15N3O/c1-20-15-9-7-13(8-10-15)17-16-11-12-19(18-16)14-5-3-2-4-6-14/h2-12H,1H3,(H,17,18)	WKLGNFJHVJIZPK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003496	103141-09-9	C16H15N3O	4.5891	128268		COc1ccc(Nc2nn(-c3ccccc3)cc2)cc1	InChI=1S/C16H15N3O/c1-20-15-9-7-13(8-10-15)17-16-11-12-19(18-16)14-5-3-2-4-6-14/h2-12H,1H3,(H,17,18)	WKLGNFJHVJIZPK-UHFFFAOYSA-N					doublet; compound annotation
0391_003497	Artemisinic acid	C15H22O2	4.9526	10922465	C[C@@H]1CC[C@H]([C@@H]2[C@H]1CCC(=C2)C)C(=C)C(=O)O	C=C(C(=O)O)C1CCC(C)C2CCC(C)=CC12	InChI=1S/C15H22O2/c1-9-4-6-12-10(2)5-7-13(14(12)8-9)11(3)15(16)17/h8,10,12-14H,3-7H2,1-2H3,(H,16,17)/t10-,12+,13+,14+/m1/s1	PLQMEXSCSAIXGB-SAXRGWBVSA-N					compound annotation
0391_003498	BI-2852	C31H28N6O2	1.6772	138756246	CN1C=C(N=C1)CN2C=CC3=C2C=C(C=C3)CNCC4=C(C5=CC=CC=C5N4)[C@@H]6C7=C(C=CC(=C7)O)C(=O)N6	Cn1cnc(Cn2ccc3c2cc(CNCc2c(C4NC(=O)c5ccc(O)cc54)c4ccccc4[nH]2)cc3)c1	InChI=1S/C31H28N6O2/c1-36-16-21(33-18-36)17-37-11-10-20-7-6-19(12-28(20)37)14-32-15-27-29(24-4-2-3-5-26(24)34-27)30-25-13-22(38)8-9-23(25)31(39)35-30/h2-13,16,18,30,32,34,38H,14-15,17H2,1H3,(H,35,39)/t30-/m0/s1	JYEQLXOWWLNVDX-PMERELPUSA-N					removed another duplicate entry; compound annotation
0391_003500	LX7101	C23H29N7O3	1.8643	56962369		Cc1c[nH]c2c1c(N1CCC(CN)(C(=O)Nc3cc(OC(=O)N(C)C)ccc3)CC1)ncn2	InChI=1S/C23H29N7O3/c1-15-12-25-19-18(15)20(27-14-26-19)30-9-7-23(13-24,8-10-30)21(31)28-16-5-4-6-17(11-16)33-22(32)29(2)3/h4-6,11-12,14H,7-10,13,24H2,1-3H3,(H,28,31)(H,25,26,27)	PWPNYABQEOGNNC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003502	Ulipristal	C28H35NO3	2.3345	13559281	CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C28H35NO3/c1-17(30)28(32)14-13-25-23-11-7-19-15-21(31)10-12-22(19)26(23)24(16-27(25,28)2)18-5-8-20(9-6-18)29(3)4/h5-6,8-9,15,23-25,32H,7,10-14,16H2,1-4H3/t23-,24+,25-,27-,28-/m0/s1	HKDLNTKNLJPAIY-WKWWZUSTSA-N					doublet; compound annotation
0391_003503	Ulipristal	C28H35NO3	2.7987	13559281	CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O	CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C	InChI=1S/C28H35NO3/c1-17(30)28(32)14-13-25-23-11-7-19-15-21(31)10-12-22(19)26(23)24(16-27(25,28)2)18-5-8-20(9-6-18)29(3)4/h5-6,8-9,15,23-25,32H,7,10-14,16H2,1-4H3/t23-,24+,25-,27-,28-/m0/s1	HKDLNTKNLJPAIY-WKWWZUSTSA-N					doublet; removed another duplicate entry; compound annotation
0391_003506	122555-91-3	C26H50N4O6	2.8678	11237632		CC(C)(C)OC(=O)CN1CCNCCN(CC(=O)OC(C)(C)C)CCN(CC(=O)OC(C)(C)C)CC1	InChI=1S/C26H50N4O6/c1-24(2,3)34-21(31)18-28-12-10-27-11-13-29(19-22(32)35-25(4,5)6)15-17-30(16-14-28)20-23(33)36-26(7,8)9/h27H,10-20H2,1-9H3	NMHVTLJFPDOJOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003508	LDC4297	C23H28N8O	3.1784	78161839		CC(C)c1c2nc(OC3CCCNC3)nc(NCc3ccccc3-n3cccn3)n2nc1	InChI=1S/C23H28N8O/c1-16(2)19-15-27-31-21(19)28-23(32-18-8-5-10-24-14-18)29-22(31)25-13-17-7-3-4-9-20(17)30-12-6-11-26-30/h3-4,6-7,9,11-12,15-16,18,24H,5,8,10,13-14H2,1-2H3,(H,25,28,29)	LSGRZENCFIIHNV-UHFFFAOYSA-N					doublet; compound annotation
0391_003509	LDC4297	C23H28N8O	3.1833	78161839		CC(C)c1c2nc(OC3CCCNC3)nc(NCc3ccccc3-n3cccn3)n2nc1	InChI=1S/C23H28N8O/c1-16(2)19-15-27-31-21(19)28-23(32-18-8-5-10-24-14-18)29-22(31)25-13-17-7-3-4-9-20(17)30-12-6-11-26-30/h3-4,6-7,9,11-12,15-16,18,24H,5,8,10,13-14H2,1-2H3,(H,25,28,29)	LSGRZENCFIIHNV-UHFFFAOYSA-N					doublet; compound annotation
0391_003510	SP2509	C19H20ClN3O5S	3.2831	135743577	C/C(=N\NC(=O)C1=CC(=CC=C1)S(=O)(=O)N2CCOCC2)/C3=C(C=CC(=C3)Cl)O	CC(=NNC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1)c1c(O)ccc(Cl)c1	InChI=1S/C19H20ClN3O5S/c1-13(17-12-15(20)5-6-18(17)24)21-22-19(25)14-3-2-4-16(11-14)29(26,27)23-7-9-28-10-8-23/h2-6,11-12,24H,7-10H2,1H3,(H,22,25)/b21-13+	NKUDGJUBIVEDTF-FYJGNVAPSA-N					doublet; compound annotation
0391_003511	LDC4297	C23H28N8O	3.8853	78161839		CC(C)c1c2nc(OC3CCCNC3)nc(NCc3ccccc3-n3cccn3)n2nc1	InChI=1S/C23H28N8O/c1-16(2)19-15-27-31-21(19)28-23(32-18-8-5-10-24-14-18)29-22(31)25-13-17-7-3-4-9-20(17)30-12-6-11-26-30/h3-4,6-7,9,11-12,15-16,18,24H,5,8,10,13-14H2,1-2H3,(H,25,28,29)	LSGRZENCFIIHNV-UHFFFAOYSA-N					doublet; compound annotation
0391_003512	SP2509	C19H20ClN3O5S	4.1367	135743577	C/C(=N\NC(=O)C1=CC(=CC=C1)S(=O)(=O)N2CCOCC2)/C3=C(C=CC(=C3)Cl)O	CC(=NNC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1)c1c(O)ccc(Cl)c1	InChI=1S/C19H20ClN3O5S/c1-13(17-12-15(20)5-6-18(17)24)21-22-19(25)14-3-2-4-16(11-14)29(26,27)23-7-9-28-10-8-23/h2-6,11-12,24H,7-10H2,1H3,(H,22,25)/b21-13+	NKUDGJUBIVEDTF-FYJGNVAPSA-N					doublet; removed another duplicate entry; compound annotation
0391_003514	LDC4297	C23H28N8O	4.3207	78161839		CC(C)c1c2nc(OC3CCCNC3)nc(NCc3ccccc3-n3cccn3)n2nc1	InChI=1S/C23H28N8O/c1-16(2)19-15-27-31-21(19)28-23(32-18-8-5-10-24-14-18)29-22(31)25-13-17-7-3-4-9-20(17)30-12-6-11-26-30/h3-4,6-7,9,11-12,15-16,18,24H,5,8,10,13-14H2,1-2H3,(H,25,28,29)	LSGRZENCFIIHNV-UHFFFAOYSA-N					doublet; compound annotation
0391_003515	NDI-091143	C20H14ClF2NO5S	4.7112	137796782		COC(=O)c1cc(S(=O)(=O)Nc2c(F)cc(F)c(-c3ccccc3)c2)c(O)c(Cl)c1	InChI=1S/C20H14ClF2NO5S/c1-29-20(26)12-7-14(21)19(25)18(8-12)30(27,28)24-17-9-13(15(22)10-16(17)23)11-5-3-2-4-6-11/h2-10,24-25H,1H3	YSTSHUWHIDBZAK-UHFFFAOYSA-N					compound annotation
0391_003516	AGI-6780	C21H18F3N3O3S2	4.7224	71299339		O=C(Nc1cccc(C(F)(F)F)c1)Nc1cc(S(=O)(=O)NC2CC2)ccc1-c1cscc1	InChI=1S/C21H18F3N3O3S2/c22-21(23,24)14-2-1-3-16(10-14)25-20(28)26-19-11-17(32(29,30)27-15-4-5-15)6-7-18(19)13-8-9-31-12-13/h1-3,6-12,15,27H,4-5H2,(H2,25,26,28)	CCAWRGNYALGPQH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003518	Eprinex	C49H73NO14	5.4562	6450531	C[C@H]1/C=C\C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(\[C@H]1O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@H]([C@@H]([C@@H](O6)C)NC(=O)C)OC)OC)/C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C(C)C)C)O	COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C(C)C)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1NC(C)=O	InChI=1S/C49H73NO14/c1-25(2)43-28(5)17-18-48(64-43)23-35-20-34(63-48)16-15-27(4)44(26(3)13-12-14-33-24-57-46-42(52)29(6)19-36(47(53)60-35)49(33,46)54)61-40-22-38(56-11)45(31(8)59-40)62-39-21-37(55-10)41(30(7)58-39)50-32(9)51/h12-15,17-19,25-26,28,30-31,34-46,52,54H,16,20-24H2,1-11H3,(H,50,51)/b13-12-,27-15-,33-14-/t26-,28-,30-,31-,34+,35-,36-,37+,38-,39-,40-,41+,42+,43+,44-,45+,46+,48+,49+/m0/s1	WPNHOHPRXXCPRA-TVXIRPTOSA-N					compound annotation
0391_003519	CGP 57380	C11H9FN6	1.5543	11644425		Nc1ncnc2n[nH]c(Nc3ccc(F)cc3)c12	InChI=1S/C11H9FN6/c12-6-1-3-7(4-2-6)16-11-8-9(13)14-5-15-10(8)17-18-11/h1-5H,(H4,13,14,15,16,17,18)	UQPMANVRZYYQMD-UHFFFAOYSA-N					doublet; compound annotation
0391_003520	CGP 57380	C11H9FN6	1.5572	11644425		Nc1ncnc2n[nH]c(Nc3ccc(F)cc3)c12	InChI=1S/C11H9FN6/c12-6-1-3-7(4-2-6)16-11-8-9(13)14-5-15-10(8)17-18-11/h1-5H,(H4,13,14,15,16,17,18)	UQPMANVRZYYQMD-UHFFFAOYSA-N					doublet; compound annotation
0391_003521	Secoisolariciresinol diglucoside	C32H46O16	1.7355	9917980	COC1=C(C=CC(=C1)C[C@@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@H](CC3=CC(=C(C=C3)O)OC)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1c(O)ccc(CC(COC2OC(CO)C(O)C(O)C2O)C(COC2OC(CO)C(O)C(O)C2O)Cc2cc(OC)c(O)cc2)c1	InChI=1S/C32H46O16/c1-43-21-9-15(3-5-19(21)35)7-17(13-45-31-29(41)27(39)25(37)23(11-33)47-31)18(8-16-4-6-20(36)22(10-16)44-2)14-46-32-30(42)28(40)26(38)24(12-34)48-32/h3-6,9-10,17-18,23-42H,7-8,11-14H2,1-2H3/t17-,18-,23+,24+,25+,26+,27-,28-,29+,30+,31+,32+/m0/s1	SBVBJPHMDABKJV-PGCJWIIOSA-N					doublet; removed another duplicate entry; compound annotation
0391_003524	Acetovanillone	C9H10O3	1.8255	2214		COc1c(O)ccc(C(C)=O)c1	InChI=1S/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H3	DFYRUELUNQRZTB-UHFFFAOYSA-N					doublet; compound annotation
0391_003525	PP242	C16H16N6O	2.1563	135565635		CC(C)n1nc(-c2cc3c(ccc(O)c3)[nH]2)c2c(N)ncnc21	InChI=1S/C16H16N6O/c1-8(2)22-16-13(15(17)18-7-19-16)14(21-22)12-6-9-5-10(23)3-4-11(9)20-12/h3-8,20,23H,1-2H3,(H2,17,18,19)	MFAQYJIYDMLAIM-UHFFFAOYSA-N					compound annotation
0391_003526	Arenobufagin	C24H32O6	2.5726	12305198	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2[C@@H](C(=O)[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)O	CC12CCC(O)CC1CCC1C2C(O)C(=O)C2(C)C(c3coc(=O)cc3)CCC12O	InChI=1S/C24H32O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,19-20,25,27,29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,19-,20+,22+,23+,24+/m1/s1	JGDCRWYOMWSTFC-AZGSIFHYSA-N					doublet; compound annotation
0391_003527	Arenobufagin	C24H32O6	2.5755	12305198	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2[C@@H](C(=O)[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)O	CC12CCC(O)CC1CCC1C2C(O)C(=O)C2(C)C(c3coc(=O)cc3)CCC12O	InChI=1S/C24H32O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,19-20,25,27,29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,19-,20+,22+,23+,24+/m1/s1	JGDCRWYOMWSTFC-AZGSIFHYSA-N					doublet; compound annotation
0391_003528	Octahydrocurcumin	C21H28O6	2.6537	11068834		COc1c(O)ccc(CCC(O)CC(O)CCc2cc(OC)c(O)cc2)c1	InChI=1S/C21H28O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16-17,22-25H,3-4,7-8,13H2,1-2H3	OELMAFBLFOKZJD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003530	Octahydrocurcumin	C21H28O6	2.6893	11068834		COc1c(O)ccc(CCC(O)CC(O)CCc2cc(OC)c(O)cc2)c1	InChI=1S/C21H28O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16-17,22-25H,3-4,7-8,13H2,1-2H3	OELMAFBLFOKZJD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003533	A-967079	C12H14FNO	3.9105	60150207	CC/C(=N/O)/C(=C/C1=CC=C(C=C1)F)/C	CCC(=NO)C(C)=Cc1ccc(F)cc1	InChI=1S/C12H14FNO/c1-3-12(14-15)9(2)8-10-4-6-11(13)7-5-10/h4-8,15H,3H2,1-2H3/b9-8+,14-12-	HKROEBDHHKMNBZ-BYKJOZEVSA-N					doublet; compound annotation
0391_003534	A-967079	C12H14FNO	3.9841	60150207	CC/C(=N/O)/C(=C/C1=CC=C(C=C1)F)/C	CCC(=NO)C(C)=Cc1ccc(F)cc1	InChI=1S/C12H14FNO/c1-3-12(14-15)9(2)8-10-4-6-11(13)7-5-10/h4-8,15H,3H2,1-2H3/b9-8+,14-12-	HKROEBDHHKMNBZ-BYKJOZEVSA-N					doublet; compound annotation
0391_003535	Acetovanillone	C9H10O3	4.286	2214		COc1c(O)ccc(C(C)=O)c1	InChI=1S/C9H10O3/c1-6(10)7-3-4-8(11)9(5-7)12-2/h3-5,11H,1-2H3	DFYRUELUNQRZTB-UHFFFAOYSA-N					doublet; compound annotation
0391_003536	A-967079	C12H14FNO	4.289	60150207	CC/C(=N/O)/C(=C/C1=CC=C(C=C1)F)/C	CCC(=NO)C(C)=Cc1ccc(F)cc1	InChI=1S/C12H14FNO/c1-3-12(14-15)9(2)8-10-4-6-11(13)7-5-10/h4-8,15H,3H2,1-2H3/b9-8+,14-12-	HKROEBDHHKMNBZ-BYKJOZEVSA-N					doublet; compound annotation
0391_003537	GSK-2018682	C22H21ClN4O4	5.6888	24988201		CC(C)Oc1c(Cl)cc(-c2nc(-c3c4ccn(CCCC(=O)O)c4ccc3)no2)cn1	InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29)	NFIGDBFIDKDNIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003539	Polidocanol	C30H62O10	5.8666	656641		CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO	InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3	ONJQDTZCDSESIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003541	10-Deacetylbaccatin III	C29H36O10	2.693	154272	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O	CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(O)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C	InChI=1S/C29H36O10/c1-14-17(31)12-29(36)24(38-25(35)16-9-7-6-8-10-16)22-27(5,23(34)21(33)20(14)26(29,3)4)18(32)11-19-28(22,13-37-19)39-15(2)30/h6-10,17-19,21-22,24,31-33,36H,11-13H2,1-5H3/t17-,18-,19+,21+,22-,24-,27+,28-,29+/m0/s1	YWLXLRUDGLRYDR-ZHPRIASZSA-N					removed another duplicate entry; compound annotation
0391_003543	28755-03-5	C10H8ClNO	2.7609	152961		O=C(CCl)c1c[nH]c2ccccc12	InChI=1S/C10H8ClNO/c11-5-10(13)8-6-12-9-4-2-1-3-7(8)9/h1-4,6,12H,5H2	LLZQFAXTCYDVTR-UHFFFAOYSA-N					compound annotation
0391_003544	Homocarbonyltopsentin	C21H14N4O3	2.8315	11326167		O=C(c1cnc(C(=O)c2c[nH]c3c2ccc(O)c3)[nH]1)c1c[nH]c2ccccc12	InChI=1S/C21H14N4O3/c26-11-5-6-13-15(9-23-17(13)7-11)20(28)21-24-10-18(25-21)19(27)14-8-22-16-4-2-1-3-12(14)16/h1-10,22-23,26H,(H,24,25)	DRCVQVIMGSWRLN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003546	AZ304	C27H25N5O2	2.9668	16202218		COc1cc2c(cc1)c(Nc1c(C)ccc(NC(=O)c3cc(C(C)(C)C#N)ccc3)c1)ncn2	InChI=1S/C27H25N5O2/c1-17-8-9-20(31-26(33)18-6-5-7-19(12-18)27(2,3)15-28)13-23(17)32-25-22-11-10-21(34-4)14-24(22)29-16-30-25/h5-14,16H,1-4H3,(H,31,33)(H,29,30,32)	NGWQZRWVYYFTHC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003548	Ibiglustat	C20H24FN3O2S	3.0042	60199242	CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4	CC(C)(NC(=O)OC1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	InChI=1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1	YFHRCLAKZBDRHN-MRXNPFEDSA-N					doublet; compound annotation
0391_003549	Ibiglustat	C20H24FN3O2S	3.007	60199242	CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4	CC(C)(NC(=O)OC1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	InChI=1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1	YFHRCLAKZBDRHN-MRXNPFEDSA-N					doublet; compound annotation
0391_003550	(R)-NVS-ZP7-4	C28H28FN5OS	3.3132	145712359	C1CN(CCC12C3=CC=CC=C3NC(=O)N2)C[C@@H](CC4=CC=CC=C4)NC5=NC6=C(S5)C=C(C=C6)F	O=C1Nc2ccccc2C2(CCN(CC(Cc3ccccc3)Nc3nc4c(cc(F)cc4)s3)CC2)N1	InChI=1S/C28H28FN5OS/c29-20-10-11-24-25(17-20)36-27(32-24)30-21(16-19-6-2-1-3-7-19)18-34-14-12-28(13-15-34)22-8-4-5-9-23(22)31-26(35)33-28/h1-11,17,21H,12-16,18H2,(H,30,32)(H2,31,33,35)/t21-/m1/s1	FZOFDZMKSAUTHT-OAQYLSRUSA-N					doublet; compound annotation
0391_003551	(R)-NVS-ZP7-4	C28H28FN5OS	3.3164	145712359	C1CN(CCC12C3=CC=CC=C3NC(=O)N2)C[C@@H](CC4=CC=CC=C4)NC5=NC6=C(S5)C=C(C=C6)F	O=C1Nc2ccccc2C2(CCN(CC(Cc3ccccc3)Nc3nc4c(cc(F)cc4)s3)CC2)N1	InChI=1S/C28H28FN5OS/c29-20-10-11-24-25(17-20)36-27(32-24)30-21(16-19-6-2-1-3-7-19)18-34-14-12-28(13-15-34)22-8-4-5-9-23(22)31-26(35)33-28/h1-11,17,21H,12-16,18H2,(H,30,32)(H2,31,33,35)/t21-/m1/s1	FZOFDZMKSAUTHT-OAQYLSRUSA-N					doublet; compound annotation
0391_003552	SYM2206	C20H22N4O3	3.4318	5039877		CCCNC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C1C)OCO3	InChI=1S/C20H22N4O3/c1-3-8-22-20(25)24-12(2)15-9-17-18(27-11-26-17)10-16(15)19(23-24)13-4-6-14(21)7-5-13/h4-7,9-10,12H,3,8,11,21H2,1-2H3,(H,22,25)	OFUDZKKOKPGXOH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003555	Ibiglustat	C20H24FN3O2S	3.4318	60199242	CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4	CC(C)(NC(=O)OC1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	InChI=1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1	YFHRCLAKZBDRHN-MRXNPFEDSA-N					doublet; compound annotation
0391_003556	1155877-97-6	C21H19ClN2O2	4.582	57703712		COc1c(-c2cc(Cl)ccc2)cc(Cc2ccc(NC(N)=O)cc2)cc1	InChI=1S/C21H19ClN2O2/c1-26-20-10-7-15(12-19(20)16-3-2-4-17(22)13-16)11-14-5-8-18(9-6-14)24-21(23)25/h2-10,12-13H,11H2,1H3,(H3,23,24,25)	RJJLUTWHJUDZFP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003559	JD-5037	C27H27Cl2N5O3S	5.013	66553204	CC(C)[C@@H](C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2C[C@@H](C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4	CC(C)C(N=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O	InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1	GTCSIQFTNPTSLO-RPWUZVMVSA-N					doublet; compound annotation
0391_003560	JD-5037	C27H27Cl2N5O3S	5.062	66553204	CC(C)[C@@H](C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2C[C@@H](C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4	CC(C)C(N=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CC(c2ccccc2)C(c2ccc(Cl)cc2)=N1)C(N)=O	InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1	GTCSIQFTNPTSLO-RPWUZVMVSA-N					doublet; removed another duplicate entry; compound annotation
0391_003562	Tecadenoson	C14H19N5O5	1.1269	158795	C1COC[C@@H]1NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NC4CCOC4)ncnc32)C(O)C1O	InChI=1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1	OESBDSFYJMDRJY-BAYCTPFLSA-N					removed another duplicate entry; compound annotation
0391_003564	4-Bromolevamisole	C11H11BrN2S	1.8988	688042	C1CSC2=N[C@H](CN21)C3=CC=C(C=C3)Br	Brc1ccc(C2CN3CCSC3=N2)cc1	InChI=1S/C11H11BrN2S/c12-9-3-1-8(2-4-9)10-7-14-5-6-15-11(14)13-10/h1-4,10H,5-7H2/t10-/m1/s1	HTHGAIADRJRJOY-SNVBAGLBSA-N					compound annotation
0391_003565	Mutant IDH1-IN-2	C24H31F2N5O2	2.184	71515481	C[C@@H](C1=CC=C(C=C1)CN2CCC(CC2)(F)F)NC3=NC=CC(=N3)N4[C@H](COC4=O)C(C)C	CC(Nc1nccc(N2C(=O)OCC2C(C)C)n1)c1ccc(CN2CCC(F)(F)CC2)cc1	InChI=1S/C24H31F2N5O2/c1-16(2)20-15-33-23(32)31(20)21-8-11-27-22(29-21)28-17(3)19-6-4-18(5-7-19)14-30-12-9-24(25,26)10-13-30/h4-8,11,16-17,20H,9-10,12-15H2,1-3H3,(H,27,28,29)/t17-,20+/m0/s1	OCZCXJFDMAWAIM-FXAWDEMLSA-N					doublet; compound annotation
0391_003566	RGB-286638 free base	C29H35N7O4	2.322	11285002		COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c-4cccc3NC(=O)NN3CCOCC3)cc2)CC1	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	XLSYZSRXVVCHLS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003568	Mutant IDH1-IN-2	C24H31F2N5O2	2.3444	71515481	C[C@@H](C1=CC=C(C=C1)CN2CCC(CC2)(F)F)NC3=NC=CC(=N3)N4[C@H](COC4=O)C(C)C	CC(Nc1nccc(N2C(=O)OCC2C(C)C)n1)c1ccc(CN2CCC(F)(F)CC2)cc1	InChI=1S/C24H31F2N5O2/c1-16(2)20-15-33-23(32)31(20)21-8-11-27-22(29-21)28-17(3)19-6-4-18(5-7-19)14-30-12-9-24(25,26)10-13-30/h4-8,11,16-17,20H,9-10,12-15H2,1-3H3,(H,27,28,29)/t17-,20+/m0/s1	OCZCXJFDMAWAIM-FXAWDEMLSA-N					doublet; compound annotation
0391_003569	G150	C18H16Cl2N4O2	2.3721	138393372		Nc1ncc(-c2cc(Cl)c(Cl)c3c2c2c(CCN(C(=O)CO)C2)[nH]3)cc1	InChI=1S/C18H16Cl2N4O2/c19-12-5-10(9-1-2-14(21)22-6-9)16-11-7-24(15(26)8-25)4-3-13(11)23-18(16)17(12)20/h1-2,5-6,23,25H,3-4,7-8H2,(H2,21,22)	VVUOUIPXYFIWLE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003571	CHIR-98014	C20H17Cl2N9O2	2.6278	53396311		Nc1c([N+](=O)[O-])ccc(NCCNc2ncc(-n3ccnc3)c(-c3c(Cl)cc(Cl)cc3)n2)n1	InChI=1S/C20H17Cl2N9O2/c21-12-1-2-13(14(22)9-12)18-16(30-8-7-24-11-30)10-27-20(29-18)26-6-5-25-17-4-3-15(31(32)33)19(23)28-17/h1-4,7-11H,5-6H2,(H3,23,25,28)(H,26,27,29)	MDZCSIDIPDZWKL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003573	kn-92	C24H25ClN2O3S	3.6386	5353702	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2NS(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)Nc2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C24H25ClN2O3S/c1-27(17-5-6-19-9-11-21(25)12-10-19)18-20-7-3-4-8-24(20)26-31(28,29)23-15-13-22(30-2)14-16-23/h3-16,26H,17-18H2,1-2H3/b6-5+	RUAOVVIUGUOYHA-AATRIKPKSA-N					doublet; compound annotation
0391_003574	Merestinib	C30H22F2N6O3	4.0585	44603533		Cc1ccc(C(=O)Nc2cc(F)c(Oc3cc4c(cc3-c3c[nH]nc3)n(C)nc4)cc2)c(=O)n1-c1ccc(F)cc1	InChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)	QHADVLVFMKEIIP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003580	Olodanrigan	C32H29NO5	4.9781	9937291	COC1=C(C2=C(CN([C@@H](C2)C(=O)O)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4)C=C1)OCC5=CC=CC=C5	COc1c(OCc2ccccc2)c2c(cc1)CN(C(=O)C(c1ccccc1)c1ccccc1)C(C(=O)O)C2	InChI=1S/C32H29NO5/c1-37-28-18-17-25-20-33(31(34)29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)27(32(35)36)19-26(25)30(28)38-21-22-11-5-2-6-12-22/h2-18,27,29H,19-21H2,1H3,(H,35,36)/t27-/m0/s1	GHBCIXGRCZIPNQ-MHZLTWQESA-N					removed another duplicate entry; compound annotation
0391_003582	G-5555	C25H25ClN6O3	2.342	91664373		CNc1ncc2cc(-c3c(Cl)cc(-c4cccc(C)n4)cc3)c(=O)n(CC3OCC(N)CO3)c2n1	InChI=1S/C25H25ClN6O3/c1-14-4-3-5-21(30-14)15-6-7-18(20(26)9-15)19-8-16-10-29-25(28-2)31-23(16)32(24(19)33)11-22-34-12-17(27)13-35-22/h3-10,17,22H,11-13,27H2,1-2H3,(H,28,29,31)	ZBCMHWUFWQFPLV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003584	2,3-Dimethoxybenzaldehyde	C9H10O3	2.7365	66581		COc1cccc(C=O)c1OC	InChI=1S/C9H10O3/c1-11-8-5-3-4-7(6-10)9(8)12-2/h3-6H,1-2H3	JIVGSHFYXPRRSZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003585	2,3-Dimethoxybenzaldehyde	C9H10O3	3.1761	66581		COc1cccc(C=O)c1OC	InChI=1S/C9H10O3/c1-11-8-5-3-4-7(6-10)9(8)12-2/h3-6H,1-2H3	JIVGSHFYXPRRSZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003586	Tirasemtiv	C12H14N4O	3.3142	23729157		C#Cc1cnc2[nH]c(=O)n(C(CC)CC)c2n1	InChI=1S/C12H14N4O/c1-4-8-7-13-10-11(14-8)16(12(17)15-10)9(5-2)6-3/h1,7,9H,5-6H2,2-3H3,(H,13,15,17)	RSQGZEAXODVTOL-UHFFFAOYSA-N					compound annotation
0391_003587	PKR-IN-2	C24H28N4O4S	3.3602	86295470		CC(C)CC1(O)CCN(C(=O)c2ccc(NS(=O)(=O)c3cccc4nccnc34)cc2)CC1	InChI=1S/C24H28N4O4S/c1-17(2)16-24(30)10-14-28(15-11-24)23(29)18-6-8-19(9-7-18)27-33(31,32)21-5-3-4-20-22(21)26-13-12-25-20/h3-9,12-13,17,27,30H,10-11,14-16H2,1-2H3	JTGUGSWLWPKCGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003589	glesatinib	C31H27F2N5O3S2	3.5094	25181472		COCCNCc1cnc(-c2cc3nccc(Oc4c(F)cc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4)c3s2)cc1	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	YRCHYHRCBXNYNU-UHFFFAOYSA-N					doublet; compound annotation
0391_003590	glesatinib	C31H27F2N5O3S2	3.5122	25181472		COCCNCc1cnc(-c2cc3nccc(Oc4c(F)cc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4)c3s2)cc1	InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)	YRCHYHRCBXNYNU-UHFFFAOYSA-N					doublet; compound annotation
0391_003591	GSK-4716	C17H18N2O2	3.6067	5399376	CC(C)C1=CC=C(C=C1)/C=N\NC(=O)C2=CC=C(C=C2)O	CC(C)c1ccc(C=NNC(=O)c2ccc(O)cc2)cc1	InChI=1S/C17H18N2O2/c1-12(2)14-5-3-13(4-6-14)11-18-19-17(21)15-7-9-16(20)10-8-15/h3-12,20H,1-2H3,(H,19,21)/b18-11-	IKPPIUNQWSRCOZ-WQRHYEAKSA-N					removed another duplicate entry; compound annotation
0391_003593	2,3-Dimethoxybenzaldehyde	C9H10O3	4.2813	66581		COc1cccc(C=O)c1OC	InChI=1S/C9H10O3/c1-11-8-5-3-4-7(6-10)9(8)12-2/h3-6H,1-2H3	JIVGSHFYXPRRSZ-UHFFFAOYSA-N					doublet; compound annotation
0391_003594	522650-83-5	C22H23N5O2S	4.8476	3152990		CCC(Sc1nc2c(nn1)c1ccccc1n2CC)C(=O)Nc1ccccc1OC	InChI=1S/C22H23N5O2S/c1-4-18(21(28)23-15-11-7-9-13-17(15)29-3)30-22-24-20-19(25-26-22)14-10-6-8-12-16(14)27(20)5-2/h6-13,18H,4-5H2,1-3H3,(H,23,28)	PEVRGVRHMMZNGI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003596	RKI-1447	C16H14N4O2S	1.7772	60138149		O=C(NCc1cc(O)ccc1)Nc1nc(-c2ccncc2)cs1	InChI=1S/C16H14N4O2S/c21-13-3-1-2-11(8-13)9-18-15(22)20-16-19-14(10-23-16)12-4-6-17-7-5-12/h1-8,10,21H,9H2,(H2,18,19,20,22)	GDVRVPIXWXOKQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003598	MLN0905	C24H25F3N6S	2.1935	46235922		Cc1c(Nc2ncc3CC(=S)Nc4c(ccc(C(F)(F)F)c4)-c3n2)cc(CCCN(C)C)cn1	InChI=1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32)	CODBZFJPKJDNDT-UHFFFAOYSA-N					doublet; compound annotation
0391_003599	MLN0905	C24H25F3N6S	2.5535	46235922		Cc1c(Nc2ncc3CC(=S)Nc4c(ccc(C(F)(F)F)c4)-c3n2)cc(CCCN(C)C)cn1	InChI=1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32)	CODBZFJPKJDNDT-UHFFFAOYSA-N					doublet; compound annotation
0391_003600	Reversine	C21H27N7O	2.7705	210332		c1nc2c([nH]1)c(NC1CCCCC1)nc(Nc1ccc(N3CCOCC3)cc1)n2	InChI=1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27)	ZFLJHSQHILSNCM-UHFFFAOYSA-N					doublet; compound annotation
0391_003601	Reversine	C21H27N7O	2.7737	210332		c1nc2c([nH]1)c(NC1CCCCC1)nc(Nc1ccc(N3CCOCC3)cc1)n2	InChI=1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27)	ZFLJHSQHILSNCM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003603	1438638-83-5	C24H23N5O3S2	4.3575	71566783		COCCOc1cnc(Sc2cc(C)c(-c3csc(NC(=O)c4ccncc4)n3)c(C)c2)cn1	InChI=1S/C24H23N5O3S2/c1-15-10-18(34-21-13-26-20(12-27-21)32-9-8-31-3)11-16(2)22(15)19-14-33-24(28-19)29-23(30)17-4-6-25-7-5-17/h4-7,10-14H,8-9H2,1-3H3,(H,28,29,30)	ICECVTFTHRPNOE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003605	GS967	C14H7F6N3O	4.4727	58118983		FC(F)(F)Oc1ccc(-c2cn3c(C(F)(F)F)nnc3cc2)cc1	InChI=1S/C14H7F6N3O/c15-13(16,17)12-22-21-11-6-3-9(7-23(11)12)8-1-4-10(5-2-8)24-14(18,19)20/h1-7H	FEVBKJITJDHASC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003607	1161002-05-6	C19H16BrNO2	5.6632	7433743	C1C=C[C@@H]2[C@H]1[C@@H](NC3=CC=CC=C23)C4=CC5=C(C=C4Br)OCO5	Brc1cc2c(cc1C1Nc3ccccc3C3C=CCC31)OCO2	InChI=1S/C19H16BrNO2/c20-15-9-18-17(22-10-23-18)8-14(15)19-13-6-3-5-11(13)12-4-1-2-7-16(12)21-19/h1-5,7-9,11,13,19,21H,6,10H2/t11-,13-,19+/m0/s1	YOLTZIVRJAPVPH-MJLGCCKJSA-N					doublet; compound annotation
0391_003608	1161002-05-6	C19H16BrNO2	5.8325	7433743	C1C=C[C@@H]2[C@H]1[C@@H](NC3=CC=CC=C23)C4=CC5=C(C=C4Br)OCO5	Brc1cc2c(cc1C1Nc3ccccc3C3C=CCC31)OCO2	InChI=1S/C19H16BrNO2/c20-15-9-18-17(22-10-23-18)8-14(15)19-13-6-3-5-11(13)12-4-1-2-7-16(12)21-19/h1-5,7-9,11,13,19,21H,6,10H2/t11-,13-,19+/m0/s1	YOLTZIVRJAPVPH-MJLGCCKJSA-N					doublet; compound annotation
0391_003609	1161002-05-6	C19H16BrNO2	5.8369	7433743	C1C=C[C@@H]2[C@H]1[C@@H](NC3=CC=CC=C23)C4=CC5=C(C=C4Br)OCO5	Brc1cc2c(cc1C1Nc3ccccc3C3C=CCC31)OCO2	InChI=1S/C19H16BrNO2/c20-15-9-18-17(22-10-23-18)8-14(15)19-13-6-3-5-11(13)12-4-1-2-7-16(12)21-19/h1-5,7-9,11,13,19,21H,6,10H2/t11-,13-,19+/m0/s1	YOLTZIVRJAPVPH-MJLGCCKJSA-N					doublet; compound annotation
0391_003610	1846570-40-8	C29H40N4O3	1.4014	118613729		COc1c(OCCCN2CCCC2)cc2nc(-c3ccc(C)o3)cc(NCC3CCN(C)CC3)c2c1	InChI=1S/C29H40N4O3/c1-21-7-8-27(36-21)26-18-24(30-20-22-9-14-32(2)15-10-22)23-17-28(34-3)29(19-25(23)31-26)35-16-6-13-33-11-4-5-12-33/h7-8,17-19,22H,4-6,9-16,20H2,1-3H3,(H,30,31)	VMMRDFLDWHFNOX-UHFFFAOYSA-N					compound annotation
0391_003611	Centanafadine	C15H15N	2.4253	16095349	C1[C@H]2[C@@]1(CNC2)C3=CC4=CC=CC=C4C=C3	c1ccc2cc(C34CNCC3C4)ccc2c1	InChI=1S/C15H15N/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15/h1-7,14,16H,8-10H2/t14-,15+/m1/s1	HKHCSWPSUSWGLI-CABCVRRESA-N					compound annotation
0391_003612	1365267-27-1	C25H25Cl2FN6O3	2.7853	56960447	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC(=NN=C2N)C(=O)NC3=CC=C(C=C3)C(=O)N4CCN(CC4)C	CC(Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl	InChI=1S/C25H25Cl2FN6O3/c1-14(21-17(26)7-8-18(28)22(21)27)37-20-13-19(31-32-23(20)29)24(35)30-16-5-3-15(4-6-16)25(36)34-11-9-33(2)10-12-34/h3-8,13-14H,9-12H2,1-2H3,(H2,29,32)(H,30,35)/t14-/m1/s1	ONPGOSVDVDPBCY-CQSZACIVSA-N					doublet; compound annotation
0391_003613	1365267-27-1	C25H25Cl2FN6O3	2.7886	56960447	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC(=NN=C2N)C(=O)NC3=CC=C(C=C3)C(=O)N4CCN(CC4)C	CC(Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl	InChI=1S/C25H25Cl2FN6O3/c1-14(21-17(26)7-8-18(28)22(21)27)37-20-13-19(31-32-23(20)29)24(35)30-16-5-3-15(4-6-16)25(36)34-11-9-33(2)10-12-34/h3-8,13-14H,9-12H2,1-2H3,(H2,29,32)(H,30,35)/t14-/m1/s1	ONPGOSVDVDPBCY-CQSZACIVSA-N					doublet; compound annotation
0391_003614	Tauroursodeoxycholic acid	C26H45NO6S	3.017	9848818	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1	BHTRKEVKTKCXOH-LBSADWJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_003616	Zuclopenthixol	C22H25ClN2OS	3.2619	5311507	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	OCCN1CCN(CCC=C2c3ccccc3Sc3c2cc(Cl)cc3)CC1	InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-	WFPIAZLQTJBIFN-DVZOWYKESA-N					doublet; compound annotation
0391_003617	Zuclopenthixol	C22H25ClN2OS	3.3056	5311507	C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO	OCCN1CCN(CCC=C2c3ccccc3Sc3c2cc(Cl)cc3)CC1	InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-	WFPIAZLQTJBIFN-DVZOWYKESA-N					doublet; removed another duplicate entry; compound annotation
0391_003619	Flucloxacillin	C19H17ClFN3O5S	3.6182	21319	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Cc1c(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c(-c2c(F)cccc2Cl)no1	InChI=1S/C19H17ClFN3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1	UIOFUWFRIANQPC-JKIFEVAISA-N					removed another duplicate entry; compound annotation
0391_003621	Deferasirox	C21H15N3O4	4.2573	214348		O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1	InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)	BOFQWVMAQOTZIW-UHFFFAOYSA-N					doublet; compound annotation
0391_003622	S-Metolachlor	C15H22ClNO2	4.4225	11140605	CCC1=CC=CC(=C1N([C@@H](C)COC)C(=O)CCl)C	CCc1cccc(C)c1N(C(=O)CCl)C(C)COC	InChI=1S/C15H22ClNO2/c1-5-13-8-6-7-11(2)15(13)17(14(18)9-16)12(3)10-19-4/h6-8,12H,5,9-10H2,1-4H3/t12-/m0/s1	WVQBLGZPHOPPFO-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_003624	Gemilukast	C36H37F2NO5	6.2017	46830962		Cc1c(CCCCOc2ccc(C#Cc3c4c(c(F)cc3)c(CCCC(=O)O)c(C)n4CCCC(=O)O)cc2)cccc1F	InChI=1S/C36H37F2NO5/c1-24-27(9-5-11-31(24)37)8-3-4-23-44-29-19-15-26(16-20-29)14-17-28-18-21-32(38)35-30(10-6-12-33(40)41)25(2)39(36(28)35)22-7-13-34(42)43/h5,9,11,15-16,18-21H,3-4,6-8,10,12-13,22-23H2,1-2H3,(H,40,41)(H,42,43)	SILHYVDKGHXGBL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003627	ROSOXACIN	C17H14N2O3	1.6434	287180		CCn1cc(C(=O)O)c(=O)c2c1cc(-c1ccncc1)cc2	InChI=1S/C17H14N2O3/c1-2-19-10-14(17(21)22)16(20)13-4-3-12(9-15(13)19)11-5-7-18-8-6-11/h3-10H,2H2,1H3,(H,21,22)	XBPZXDSZHPDXQU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003629	INH154	C22H24N4OS	2.3771	91669222		Cc1cc(N2CCCCC2)cc(C)c1-c1csc(NC(=O)c2ccncc2)n1	InChI=1S/C22H24N4OS/c1-15-12-18(26-10-4-3-5-11-26)13-16(2)20(15)19-14-28-22(24-19)25-21(27)17-6-8-23-9-7-17/h6-9,12-14H,3-5,10-11H2,1-2H3,(H,24,25,27)	BBVORAZSFSZSKG-UHFFFAOYSA-N					doublet; compound annotation
0391_003630	INH154	C22H24N4OS	2.5114	91669222		Cc1cc(N2CCCCC2)cc(C)c1-c1csc(NC(=O)c2ccncc2)n1	InChI=1S/C22H24N4OS/c1-15-12-18(26-10-4-3-5-11-26)13-16(2)20(15)19-14-28-22(24-19)25-21(27)17-6-8-23-9-7-17/h6-9,12-14H,3-5,10-11H2,1-2H3,(H,24,25,27)	BBVORAZSFSZSKG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003632	INH154	C22H24N4OS	2.5147	91669222		Cc1cc(N2CCCCC2)cc(C)c1-c1csc(NC(=O)c2ccncc2)n1	InChI=1S/C22H24N4OS/c1-15-12-18(26-10-4-3-5-11-26)13-16(2)20(15)19-14-28-22(24-19)25-21(27)17-6-8-23-9-7-17/h6-9,12-14H,3-5,10-11H2,1-2H3,(H,24,25,27)	BBVORAZSFSZSKG-UHFFFAOYSA-N					doublet; compound annotation
0391_003633	K-Ras-IN-1	C11H13NOS	2.6913	551134		Oc1ccccc1C(=S)N1CCCC1	InChI=1S/C11H13NOS/c13-10-6-2-1-5-9(10)11(14)12-7-3-4-8-12/h1-2,5-6,13H,3-4,7-8H2	QIKLOVZAPGSYNO-UHFFFAOYSA-N					compound annotation
0391_003634	LLY-507	C36H42N6O	2.7559	91623361		Cc1cn(CCN2CCN(c3ccccc3-c3cc(C(=O)NCCCN4CCCC4)cc(C#N)c3)CC2)c2ccccc12	InChI=1S/C36H42N6O/c1-28-27-42(34-11-4-2-9-32(28)34)22-19-40-17-20-41(21-18-40)35-12-5-3-10-33(35)30-23-29(26-37)24-31(25-30)36(43)38-13-8-16-39-14-6-7-15-39/h2-5,9-12,23-25,27H,6-8,13-22H2,1H3,(H,38,43)	PNYRDVBFYVDJJI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003636	Apabetalone	C20H22N2O5	2.7608	135564749		COc1cc2c(c(OC)c1)c(=O)nc(-c1cc(C)c(OCCO)c(C)c1)[nH]2	InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)	NETXMUIMUZJUTB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003638	roscovitine	C19H26N6O	2.8155	160355	CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_003640	roscovitine	C19H26N6O	2.8187	160355	CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1	BTIHMVBBUGXLCJ-OAHLLOKOSA-N					doublet; compound annotation
0391_003641	Dafadine-A	C23H25N3O3	3.0798	24790866		Cc1c(OCc2cc(C(=O)N3CCC(c4ccncc4)CC3)no2)c(C)ccc1	InChI=1S/C23H25N3O3/c1-16-4-3-5-17(2)22(16)28-15-20-14-21(25-29-20)23(27)26-12-8-19(9-13-26)18-6-10-24-11-7-18/h3-7,10-11,14,19H,8-9,12-13,15H2,1-2H3	WNSNPYIHDMIFOO-UHFFFAOYSA-N					doublet; compound annotation
0391_003642	187389-52-2	C22H30FN3O7	3.0798	5497174	C[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1	COC(=O)CC(NC(=O)C(C)NC(=O)C(NC(=O)OCc1ccccc1)C(C)C)C(=O)CF	InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9,13-14,16,19H,10-12H2,1-4H3,(H,24,30)(H,25,29)(H,26,31)/t14-,16-,19-/m0/s1	MIFGOLAMNLSLGH-QOKNQOGYSA-N					doublet; compound annotation
0391_003643	Dafadine-A	C23H25N3O3	3.083	24790866		Cc1c(OCc2cc(C(=O)N3CCC(c4ccncc4)CC3)no2)c(C)ccc1	InChI=1S/C23H25N3O3/c1-16-4-3-5-17(2)22(16)28-15-20-14-21(25-29-20)23(27)26-12-8-19(9-13-26)18-6-10-24-11-7-18/h3-7,10-11,14,19H,8-9,12-13,15H2,1-2H3	WNSNPYIHDMIFOO-UHFFFAOYSA-N					doublet; compound annotation
0391_003644	Etifoxine hydrochloride	C17H17ClN2O	3.1306	135413553		CCNC1=Nc2c(cc(Cl)cc2)C(C)(c2ccccc2)O1	InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)	IBYCYJFUEJQSMK-UHFFFAOYSA-N					doublet; compound annotation
0391_003645	187389-52-2	C22H30FN3O7	3.3986	5497174	C[C@@H](C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1	COC(=O)CC(NC(=O)C(C)NC(=O)C(NC(=O)OCc1ccccc1)C(C)C)C(=O)CF	InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9,13-14,16,19H,10-12H2,1-4H3,(H,24,30)(H,25,29)(H,26,31)/t14-,16-,19-/m0/s1	MIFGOLAMNLSLGH-QOKNQOGYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003647	Voxelotor	C19H19N3O3	3.9113	71602803		CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O	InChI=1S/C19H19N3O3/c1-13(2)22-16(8-10-21-22)19-14(5-4-9-20-19)12-25-18-7-3-6-17(24)15(18)11-23/h3-11,13,24H,12H2,1-2H3	FWCVZAQENIZVMY-UHFFFAOYSA-N					compound annotation
0391_003648	Etifoxine hydrochloride	C17H17ClN2O	4.4443	135413553		CCNC1=Nc2c(cc(Cl)cc2)C(C)(c2ccccc2)O1	InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)	IBYCYJFUEJQSMK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003650	Entinostat	C21H20N4O3	1.5312	4261		Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cnccc2)cc1	InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)	INVTYAOGFAGBOE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003652	Marimastat	C15H29N3O5	2.0718	119031	CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C	CNC(=O)C(NC(=O)C(CC(C)C)C(O)C(=O)NO)C(C)(C)C	InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1	OCSMOTCMPXTDND-OUAUKWLOSA-N					removed another duplicate entry; compound annotation
0391_003654	Mocetinostat	C23H20N6O	2.0718	9865515		Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cnccc3)n2)cc1	InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)	HRNLUBSXIHFDHP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003656	NMS-859	C15H12ClN3O3S	2.805	71607189		O=C(CCl)Nc1cccc(NC2=NS(=O)(=O)c3ccccc23)c1	InChI=1S/C15H12ClN3O3S/c16-9-14(20)17-10-4-3-5-11(8-10)18-15-12-6-1-2-7-13(12)23(21,22)19-15/h1-8H,9H2,(H,17,20)(H,18,19)	JWMFLBAPPIWNGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003658	TAK-071	C24H24FN3O3	3.6025	92042879	CC1=C(C2=C(C=C1CC3=CC=C(C=C3)N4C=CC=N4)C(=O)N(C2)[C@H]5COCC[C@@H]5O)F	Cc1c(F)c2c(cc1Cc1ccc(-n3cccn3)cc1)C(=O)N(C1COCCC1O)C2	InChI=1S/C24H24FN3O3/c1-15-17(11-16-3-5-18(6-4-16)28-9-2-8-26-28)12-19-20(23(15)25)13-27(24(19)30)21-14-31-10-7-22(21)29/h2-6,8-9,12,21-22,29H,7,10-11,13-14H2,1H3/t21-,22-/m0/s1	WFSARWQASFQZMG-VXKWHMMOSA-N					removed another duplicate entry; compound annotation
0391_003660	birabresib	C25H22ClN5O2S	3.8246	9936746	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)Nc1ccc(O)cc1)N=C2c1ccc(Cl)cc1	InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11,20,32H,12H2,1-3H3,(H,27,33)/t20-/m0/s1	GNMUEVRJHCWKTO-FQEVSTJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_003662	Purmorphamine	C31H32N6O2	3.9765	5284329		c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1	InChI=1S/C31H32N6O2/c1-2-9-25(10-3-1)37-21-32-28-29(33-23-13-15-24(16-14-23)36-17-19-38-20-18-36)34-31(35-30(28)37)39-27-12-6-8-22-7-4-5-11-26(22)27/h4-8,11-16,21,25H,1-3,9-10,17-20H2,(H,33,34,35)	FYBHCRQFSFYWPY-UHFFFAOYSA-N					doublet; compound annotation
0391_003663	75450-34-9	C15H11Cl2NOS	4.3688	2688		O=C1CSC(c2ccccc2Cl)c2c(ccc(Cl)c2)N1	InChI=1S/C15H11Cl2NOS/c16-9-5-6-13-11(7-9)15(20-8-14(19)18-13)10-3-1-2-4-12(10)17/h1-7,15H,8H2,(H,18,19)	KQEPIRKXSUIUTH-UHFFFAOYSA-N					compound annotation
0391_003664	birabresib	C25H22ClN5O2S	4.8255	9936746	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)Nc1ccc(O)cc1)N=C2c1ccc(Cl)cc1	InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11,20,32H,12H2,1-3H3,(H,27,33)/t20-/m0/s1	GNMUEVRJHCWKTO-FQEVSTJZSA-N					doublet; compound annotation
0391_003665	LV-320	C29H26ClNO2S2	5.1813	134817239	C1=CC=C(C=C1)CCSC(C2=CC=C(C=C2)/C=C/C3=C4C=CC(=CC4=NC=C3)Cl)SCCC(=O)O	O=C(O)CCSC(SCCc1ccccc1)c1ccc(C=Cc2ccnc3cc(Cl)ccc23)cc1	InChI=1S/C29H26ClNO2S2/c30-25-12-13-26-23(14-17-31-27(26)20-25)9-6-22-7-10-24(11-8-22)29(35-19-16-28(32)33)34-18-15-21-4-2-1-3-5-21/h1-14,17,20,29H,15-16,18-19H2,(H,32,33)/b9-6+	PHENTWJNXGESKT-RMKNXTFCSA-N					doublet; compound annotation
0391_003666	Purmorphamine	C31H32N6O2	5.2278	5284329		c1ccc2c(Oc3nc(Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4n3)cccc2c1	InChI=1S/C31H32N6O2/c1-2-9-25(10-3-1)37-21-32-28-29(33-23-13-15-24(16-14-23)36-17-19-38-20-18-36)34-31(35-30(28)37)39-27-12-6-8-22-7-4-5-11-26(22)27/h4-8,11-16,21,25H,1-3,9-10,17-20H2,(H,33,34,35)	FYBHCRQFSFYWPY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003669	LV-320	C29H26ClNO2S2	5.365	134817239	C1=CC=C(C=C1)CCSC(C2=CC=C(C=C2)/C=C/C3=C4C=CC(=CC4=NC=C3)Cl)SCCC(=O)O	O=C(O)CCSC(SCCc1ccccc1)c1ccc(C=Cc2ccnc3cc(Cl)ccc23)cc1	InChI=1S/C29H26ClNO2S2/c30-25-12-13-26-23(14-17-31-27(26)20-25)9-6-22-7-10-24(11-8-22)29(35-19-16-28(32)33)34-18-15-21-4-2-1-3-5-21/h1-14,17,20,29H,15-16,18-19H2,(H,32,33)/b9-6+	PHENTWJNXGESKT-RMKNXTFCSA-N					doublet; compound annotation
0391_003670	ISO-1	C12H13NO4	2.2144	4633677		COC(=O)CC1CC(c2ccc(O)cc2)=NO1	InChI=1S/C12H13NO4/c1-16-12(15)7-10-6-11(13-17-10)8-2-4-9(14)5-3-8/h2-5,10,14H,6-7H2,1H3	AIXMJTYHQHQJLU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003672	PU-WS13	C17H20Cl2N6S	2.3103	71660551		CC(C)NCCCn1c(Sc2cc(Cl)cc(Cl)c2)nc2c(N)ncnc21	InChI=1S/C17H20Cl2N6S/c1-10(2)21-4-3-5-25-16-14(15(20)22-9-23-16)24-17(25)26-13-7-11(18)6-12(19)8-13/h6-10,21H,3-5H2,1-2H3,(H2,20,22,23)	JYSLFQTWNRYWJT-UHFFFAOYSA-N					doublet; compound annotation
0391_003673	PU-WS13	C17H20Cl2N6S	2.4088	71660551		CC(C)NCCCn1c(Sc2cc(Cl)cc(Cl)c2)nc2c(N)ncnc21	InChI=1S/C17H20Cl2N6S/c1-10(2)21-4-3-5-25-16-14(15(20)22-9-23-16)24-17(25)26-13-7-11(18)6-12(19)8-13/h6-10,21H,3-5H2,1-2H3,(H2,20,22,23)	JYSLFQTWNRYWJT-UHFFFAOYSA-N					doublet; compound annotation
0391_003674	Clozapine N-oxide	C18H19ClN4O	2.5008	135445691		C[N+]1([O-])CCN(C2=Nc3c(ccc(Cl)c3)Nc3ccccc23)CC1	InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3	OGUCZBIQSYYWEF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003676	ML346	C14H12N2O4	2.8006	767276	COC1=CC=C(C=C1)/C=C/C=C2C(=O)NC(=O)NC2=O	COc1ccc(C=CC=C2C(=O)NC(=O)NC2=O)cc1	InChI=1S/C14H12N2O4/c1-20-10-7-5-9(6-8-10)3-2-4-11-12(17)15-14(19)16-13(11)18/h2-8H,1H3,(H2,15,16,17,18,19)/b3-2+	IXYLVJHFJKDHRM-NSCUHMNNSA-N					compound annotation
0391_003677	Fevipiprant	C19H17F3N2O4S	3.4548	23582412		Cc1c(CC(=O)O)c2c(nccc2)n1Cc1c(C(F)(F)F)cc(S(C)(=O)=O)cc1	InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)	GFPPXZDRVCSVNR-UHFFFAOYSA-N					compound annotation
0391_003678	Centrinone	C26H25F2N7O6S2	4.0956	91801159		COc1c(Nc2n[nH]c(C)c2)nc(Sc2c(F)cc(S(=O)(=O)Cc3c(F)c([N+](=O)[O-])ccc3)cc2)nc1N1CCOCC1	InChI=1S/C26H25F2N7O6S2/c1-15-12-21(33-32-15)29-24-23(40-2)25(34-8-10-41-11-9-34)31-26(30-24)42-20-7-6-17(13-18(20)27)43(38,39)14-16-4-3-5-19(22(16)28)35(36)37/h3-7,12-13H,8-11,14H2,1-2H3,(H2,29,30,31,32,33)	HHJSKDRCUMVWKF-UHFFFAOYSA-N					doublet; compound annotation
0391_003679	MK-7246	C21H21FN2O4S	4.1444	45268455	CN([C@@H]1CCC2=C(C3=CC=CC=C3N2C1)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F	CN(C1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1	InChI=1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-21(25)26)17-4-2-3-5-19(17)24(20)13-15/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1	JTCAGRAKUAAYDY-OAHLLOKOSA-N					compound annotation
0391_003680	Centrinone	C26H25F2N7O6S2	4.2092	91801159		COc1c(Nc2n[nH]c(C)c2)nc(Sc2c(F)cc(S(=O)(=O)Cc3c(F)c([N+](=O)[O-])ccc3)cc2)nc1N1CCOCC1	InChI=1S/C26H25F2N7O6S2/c1-15-12-21(33-32-15)29-24-23(40-2)25(34-8-10-41-11-9-34)31-26(30-24)42-20-7-6-17(13-18(20)27)43(38,39)14-16-4-3-5-19(22(16)28)35(36)37/h3-7,12-13H,8-11,14H2,1-2H3,(H2,29,30,31,32,33)	HHJSKDRCUMVWKF-UHFFFAOYSA-N					doublet; compound annotation
0391_003681	Centrinone	C26H25F2N7O6S2	4.212	91801159		COc1c(Nc2n[nH]c(C)c2)nc(Sc2c(F)cc(S(=O)(=O)Cc3c(F)c([N+](=O)[O-])ccc3)cc2)nc1N1CCOCC1	InChI=1S/C26H25F2N7O6S2/c1-15-12-21(33-32-15)29-24-23(40-2)25(34-8-10-41-11-9-34)31-26(30-24)42-20-7-6-17(13-18(20)27)43(38,39)14-16-4-3-5-19(22(16)28)35(36)37/h3-7,12-13H,8-11,14H2,1-2H3,(H2,29,30,31,32,33)	HHJSKDRCUMVWKF-UHFFFAOYSA-N					doublet; compound annotation
0391_003682	Centrinone-B	C27H27F2N7O5S2	4.8451	118704753		COc1c(Nc2n[nH]c(C)c2)nc(Sc2c(F)cc(S(=O)(=O)Cc3c(F)c([N+](=O)[O-])ccc3)cc2)nc1N1CCCCC1	InChI=1S/C27H27F2N7O5S2/c1-16-13-22(34-33-16)30-25-24(41-2)26(35-11-4-3-5-12-35)32-27(31-25)42-21-10-9-18(14-19(21)28)43(39,40)15-17-7-6-8-20(23(17)29)36(37)38/h6-10,13-14H,3-5,11-12,15H2,1-2H3,(H2,30,31,32,33,34)	UPZNTUYHCRQOIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_003683	Centrinone-B	C27H27F2N7O5S2	4.9321	118704753		COc1c(Nc2n[nH]c(C)c2)nc(Sc2c(F)cc(S(=O)(=O)Cc3c(F)c([N+](=O)[O-])ccc3)cc2)nc1N1CCCCC1	InChI=1S/C27H27F2N7O5S2/c1-16-13-22(34-33-16)30-25-24(41-2)26(35-11-4-3-5-12-35)32-27(31-25)42-21-10-9-18(14-19(21)28)43(39,40)15-17-7-6-8-20(23(17)29)36(37)38/h6-10,13-14H,3-5,11-12,15H2,1-2H3,(H2,30,31,32,33,34)	UPZNTUYHCRQOIQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003685	NEOSTIGMINE	C12H19N2O2+	1.0047	4456		CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1	InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1	ALWKGYPQUAPLQC-UHFFFAOYSA-N					doublet; compound annotation
0391_003686	2-Aminobenzenesulfonamide	C6H8N2O2S	1.122	72894		Nc1ccccc1S(N)(=O)=O	InChI=1S/C6H8N2O2S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)	YAZSBRQTAHVVGE-UHFFFAOYSA-N					compound annotation
0391_003687	tryptamine	C10H12N2	1.1764	1150		NCCc1c[nH]c2ccccc12	InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2	APJYDQYYACXCRM-UHFFFAOYSA-N					compound annotation
0391_003688	HOMATROPINE	C16H21NO3	1.2839	5282593	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O	CN1C2CCC1CC(OC(=O)C(O)c1ccccc1)C2	InChI=1S/C16H21NO3/c1-17-12-7-8-13(17)10-14(9-12)20-16(19)15(18)11-5-3-2-4-6-11/h2-6,12-15,18H,7-10H2,1H3/t12-,13+,14?,15?	ZTVIKZXZYLEVOL-DGKWVBSXSA-N					compound annotation
0391_003689	Tacrine	C13H14N2	1.5767	1935		Nc1c2CCCCc2nc2ccccc12	InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)	YLJREFDVOIBQDA-UHFFFAOYSA-N					doublet; compound annotation
0391_003690	3-Cyano-7-ethoxycoumarin	C12H9NO3	3.3927	164045		CCOc1cc2c(cc1)cc(C#N)c(=O)o2	InChI=1S/C12H9NO3/c1-2-15-10-4-3-8-5-9(7-13)12(14)16-11(8)6-10/h3-6H,2H2,1H3	YAFGHMIAFYQSCF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003692	fenoterol	C17H21NO4	1.11	3343		CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1	InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3	LSLYOANBFKQKPT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003694	glafenine	C19H17ClN2O4	1.8009	3474		O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12	InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)	GWOFUCIGLDBNKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003696	glafenine	C19H17ClN2O4	1.8705	3474		O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12	InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)	GWOFUCIGLDBNKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003698	alosetron	C17H18N4O	1.9523	2099		Cc1c(CN2CCc3c(C2=O)c2ccccc2n3C)nc[nH]1	InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)	JSWZEAMFRNKZNL-UHFFFAOYSA-N					doublet; compound annotation
0391_003699	alosetron	C17H18N4O	1.955	2099		Cc1c(CN2CCc3c(C2=O)c2ccccc2n3C)nc[nH]1	InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)	JSWZEAMFRNKZNL-UHFFFAOYSA-N					doublet; compound annotation
0391_003700	cefoxitin	C16H17N3O7S2	1.9883	441199	CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3	COC1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CSC21	InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N					doublet; compound annotation
0391_003701	cefoxitin	C16H17N3O7S2	2.1672	441199	CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3	COC1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CSC21	InChI=1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N					doublet; compound annotation
0391_003702	201943-63-7	C20H19NO5	2.2035	9819927	C1[C@@H]([C@H]1[C@@](CC2C3=CC=CC=C3OC4=CC=CC=C24)(C(=O)O)N)C(=O)O	NC(CC1c2ccccc2Oc2ccccc21)(C(=O)O)C1CC1C(=O)O	InChI=1S/C20H19NO5/c21-20(19(24)25,15-9-13(15)18(22)23)10-14-11-5-1-3-7-16(11)26-17-8-4-2-6-12(14)17/h1-8,13-15H,9-10,21H2,(H,22,23)(H,24,25)/t13-,15-,20-/m0/s1	VLZBRVJVCCNPRJ-KPHUOKFYSA-N					compound annotation
0391_003703	Oxibendazole	C12H15N3O3	2.2318	4622		CCCOc1cc2c(cc1)nc(NC(=O)OC)[nH]2	InChI=1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)	RAOCRURYZCVHMG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003705	glafenine	C19H17ClN2O4	2.5162	3474		O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12	InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)	GWOFUCIGLDBNKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003707	163521-19-5	C26H26N4O3	2.5681	11201569		N#Cc1cc2c(cc1)[nH]cc2CCCCN1CCN(c2cc3c(cc2)oc(C(=O)O)c3)CC1	InChI=1S/C26H26N4O3/c27-16-18-4-6-23-22(13-18)19(17-28-23)3-1-2-8-29-9-11-30(12-10-29)21-5-7-24-20(14-21)15-25(33-24)26(31)32/h4-7,13-15,17,28H,1-3,8-12H2,(H,31,32)	RSXUEYFLDNUILS-UHFFFAOYSA-N					compound annotation
0391_003708	glafenine	C19H17ClN2O4	2.9085	3474		O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12	InChI=1S/C19H17ClN2O4/c20-12-5-6-14-17(7-8-21-18(14)9-12)22-16-4-2-1-3-15(16)19(25)26-11-13(24)10-23/h1-9,13,23-24H,10-11H2,(H,21,22)	GWOFUCIGLDBNKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003710	DEXKETOPROFEN	C16H14O3	3.5859	667550	C[C@@H](C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O	CC(C(=O)O)c1cc(C(=O)c2ccccc2)ccc1	InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m0/s1	DKYWVDODHFEZIM-NSHDSACASA-N					compound annotation
0391_003711	Mulberroside A	C26H32O14	1.1317	6443484	C1=CC(=C(C=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)/C=C/C3=CC(=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	OCC1OC(Oc2cc(C=Cc3c(O)cc(OC4OC(CO)C(O)C(O)C4O)cc3)cc(O)c2)C(O)C(O)C1O	InChI=1S/C26H32O14/c27-9-17-19(31)21(33)23(35)25(39-17)37-14-4-3-12(16(30)8-14)2-1-11-5-13(29)7-15(6-11)38-26-24(36)22(34)20(32)18(10-28)40-26/h1-8,17-36H,9-10H2/b2-1+/t17-,18-,19-,20-,21+,22+,23-,24-,25-,26-/m1/s1	HPSWAEGGWLOOKT-VUNDNAJOSA-N					doublet; removed another duplicate entry; compound annotation
0391_003713	Mulberroside A	C26H32O14	1.4667	6443484	C1=CC(=C(C=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)/C=C/C3=CC(=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	OCC1OC(Oc2cc(C=Cc3c(O)cc(OC4OC(CO)C(O)C(O)C4O)cc3)cc(O)c2)C(O)C(O)C1O	InChI=1S/C26H32O14/c27-9-17-19(31)21(33)23(35)25(39-17)37-14-4-3-12(16(30)8-14)2-1-11-5-13(29)7-15(6-11)38-26-24(36)22(34)20(32)18(10-28)40-26/h1-8,17-36H,9-10H2/b2-1+/t17-,18-,19-,20-,21+,22+,23-,24-,25-,26-/m1/s1	HPSWAEGGWLOOKT-VUNDNAJOSA-N					doublet; compound annotation
0391_003714	Enrofloxacin	C19H22FN3O3	1.6991	71188		CCN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2)CC1	InChI=1S/C19H22FN3O3/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12/h9-12H,2-8H2,1H3,(H,25,26)	SPFYMRJSYKOXGV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003716	Bendazol	C14H12N2	1.7866	12132		c1ccc(Cc2nc3ccccc3[nH]2)cc1	InChI=1S/C14H12N2/c1-2-6-11(7-3-1)10-14-15-12-8-4-5-9-13(12)16-14/h1-9H,10H2,(H,15,16)	YTLQFZVCLXFFRK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003718	Cimifugin	C16H18O6	1.9686	441960	CC(C)([C@@H]1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)CO)O	COc1c2c(=O)cc(CO)oc2cc2c1CC(C(C)(C)O)O2	InChI=1S/C16H18O6/c1-16(2,19)13-5-9-11(22-13)6-12-14(15(9)20-3)10(18)4-8(7-17)21-12/h4,6,13,17,19H,5,7H2,1-3H3/t13-/m0/s1	ATDBDSBKYKMRGZ-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_003720	UFIPRAZOLE	C17H19N3O2S	2.2724	155794		COc1cc2c(cc1)nc(SCc1ncc(C)c(OC)c1C)[nH]2	InChI=1S/C17H19N3O2S/c1-10-8-18-15(11(2)16(10)22-4)9-23-17-19-13-6-5-12(21-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)	XURCIPRUUASYLR-UHFFFAOYSA-N					doublet; compound annotation
0391_003721	UFIPRAZOLE	C17H19N3O2S	2.2757	155794		COc1cc2c(cc1)nc(SCc1ncc(C)c(OC)c1C)[nH]2	InChI=1S/C17H19N3O2S/c1-10-8-18-15(11(2)16(10)22-4)9-23-17-19-13-6-5-12(21-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)	XURCIPRUUASYLR-UHFFFAOYSA-N					doublet; compound annotation
0391_003722	Climbazole	C15H17ClN2O2	3.0912	37907		CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	InChI=1S/C15H17ClN2O2/c1-15(2,3)13(19)14(18-9-8-17-10-18)20-12-6-4-11(16)5-7-12/h4-10,14H,1-3H3	OWEGWHBOCFMBLP-UHFFFAOYSA-N					doublet; compound annotation
0391_003723	Climbazole	C15H17ClN2O2	3.1277	37907		CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1	InChI=1S/C15H17ClN2O2/c1-15(2,3)13(19)14(18-9-8-17-10-18)20-12-6-4-11(16)5-7-12/h4-10,14H,1-3H3	OWEGWHBOCFMBLP-UHFFFAOYSA-N					doublet; compound annotation
0391_003724	608141-44-2	C22H24N2O7S	3.4396	9912092	CCOC1=C(C=CC(=C1)[C@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC	CCOc1c(OC)ccc(C(CS(C)(=O)=O)N2C(=O)c3c(C2=O)c(NC(C)=O)ccc3)c1	InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m0/s1	IMOZEMNVLZVGJZ-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_003727	Furaltadone	C13H16N4O6	0.9362	9553856	C1COCCN1CC2CN(C(=O)O2)/N=C/C3=CC=C(O3)[N+](=O)[O-]	O=C1OC(CN2CCOCC2)CN1N=Cc1ccc([N+](=O)[O-])o1	InChI=1S/C13H16N4O6/c18-13-16(14-7-10-1-2-12(22-10)17(19)20)9-11(23-13)8-15-3-5-21-6-4-15/h1-2,7,11H,3-6,8-9H2/b14-7+	YVQVOQKFMFRVGR-VGOFMYFVSA-N					removed another duplicate entry; compound annotation
0391_003729	Sulbutiamine	C32H46N8O6S2	2.2402	20055424	CC1=NC=C(C(=N1)N)CN(/C(=C(\SS/C(=C(\N(C=O)CC2=CN=C(N=C2N)C)/C)/CCOC(=O)C(C)C)/CCOC(=O)C(C)C)/C)C=O	CC(=C(CCOC(=O)C(C)C)SSC(CCOC(=O)C(C)C)=C(C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)/b27-21-,28-22-	CKHJPWQVLKHBIH-ZDSKVHJSSA-N					doublet; compound annotation
0391_003730	Sulbutiamine	C32H46N8O6S2	2.2451	20055424	CC1=NC=C(C(=N1)N)CN(/C(=C(\SS/C(=C(\N(C=O)CC2=CN=C(N=C2N)C)/C)/CCOC(=O)C(C)C)/CCOC(=O)C(C)C)/C)C=O	CC(=C(CCOC(=O)C(C)C)SSC(CCOC(=O)C(C)C)=C(C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)/b27-21-,28-22-	CKHJPWQVLKHBIH-ZDSKVHJSSA-N					doublet; compound annotation
0391_003731	Apronal	C9H16N2O2	2.6642	10715		C=CCC(C(=O)NC(N)=O)C(C)C	InChI=1S/C9H16N2O2/c1-4-5-7(6(2)3)8(12)11-9(10)13/h4,6-7H,1,5H2,2-3H3,(H3,10,11,12,13)	KSUUMAWCGDNLFK-UHFFFAOYSA-N					compound annotation
0391_003732	Oxyphenisatin	C20H15NO3	2.8492	31315		O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1	InChI=1S/C20H15NO3/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)17-3-1-2-4-18(17)21-19(20)24/h1-12,22-23H,(H,21,24)	SJDACOMXKWHBOW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003735	Oxyphenisatin	C20H15NO3	3.2905	31315		O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1	InChI=1S/C20H15NO3/c22-15-9-5-13(6-10-15)20(14-7-11-16(23)12-8-14)17-3-1-2-4-18(17)21-19(20)24/h1-12,22-23H,(H,21,24)	SJDACOMXKWHBOW-UHFFFAOYSA-N					doublet; compound annotation
0391_003736	CHEMBL3781349	C25H33N5O	1.5933	91827690		CC1CN(CC2CCN(Cc3ccccc3)CC2)C(=O)N(c2cccc(C(=N)N)c2)C1	InChI=1S/C25H33N5O/c1-19-15-29(25(31)30(16-19)23-9-5-8-22(14-23)24(26)27)18-21-10-12-28(13-11-21)17-20-6-3-2-4-7-20/h2-9,14,19,21H,10-13,15-18H2,1H3,(H3,26,27)	HGBLIBDRBSWLRN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003738	Cenisertib	C24H30FN7O	1.6751	11569967	CC1=C(C=CC(=C1)NC2=NC=C(C(=N2)N[C@@H]3[C@@H]4C[C@H]([C@@H]3C(=O)N)C=C4)F)N5CCN(CC5)C	Cc1c(N2CCN(C)CC2)ccc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)c1	InChI=1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)/t15-,16+,20+,21-/m1/s1	KSOVGRCOLZZTPF-QMKUDKLTSA-N					doublet; compound annotation
0391_003739	Cenisertib	C24H30FN7O	1.6778	11569967	CC1=C(C=CC(=C1)NC2=NC=C(C(=N2)N[C@@H]3[C@@H]4C[C@H]([C@@H]3C(=O)N)C=C4)F)N5CCN(CC5)C	Cc1c(N2CCN(C)CC2)ccc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)c1	InChI=1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)/t15-,16+,20+,21-/m1/s1	KSOVGRCOLZZTPF-QMKUDKLTSA-N					doublet; removed another duplicate entry; compound annotation
0391_003741	891494-64-7	C15H18BrN7	1.8017	46239014	CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)[C@H]4CCCNC4	Cn1cc(-c2c3nc(C4CCCNC4)c(Br)c(N)n3nc2)cn1	InChI=1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,18H,2-5,17H2,1H3/t9-/m0/s1	GMIZZEXBPRLVIV-VIFPVBQESA-N					compound annotation
0391_003742	Domatinostat	C23H21N5O3S	2.6428	15985904	CN1C=C(C=N1)C2=CC=C(C=C2)S(=O)(=O)N3C=CC(=C3)/C=C/C(=O)NC4=CC=CC=C4N	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(C=CC(=O)Nc4ccccc4N)c3)cc2)cn1	InChI=1S/C23H21N5O3S/c1-27-16-19(14-25-27)18-7-9-20(10-8-18)32(30,31)28-13-12-17(15-28)6-11-23(29)26-22-5-3-2-4-21(22)24/h2-16H,24H2,1H3,(H,26,29)/b11-6+	PRXXYMVLYKJITB-IZZDOVSWSA-N					doublet; compound annotation
0391_003743	186452-09-5	C20H28N2O4	2.7021	445501	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)OCCCC2=CN=CC=C2	CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)OCCCc1cnccc1	InChI=1S/C20H28N2O4/c1-4-20(2,3)17(23)18(24)22-12-6-10-16(22)19(25)26-13-7-9-15-8-5-11-21-14-15/h5,8,11,14,16H,4,6-7,9-10,12-13H2,1-3H3/t16-/m0/s1	OQAHHWOPVDDWHD-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_003745	LIT-001 (free base)	C28H33N7O2S	2.9093	145711714	CC1=C(C=CC(=C1)C(=O)N2CC3=C(NC4=CC=CC=C42)N(N=C3)C)CNC(=O)N5CCC[C@H]5C(=S)N(C)C	Cc1c(CNC(=O)N2CCCC2C(=S)N(C)C)ccc(C(=O)N2Cc3c(Nc4ccccc42)n(C)nc3)c1	InChI=1S/C28H33N7O2S/c1-18-14-19(11-12-20(18)15-29-28(37)34-13-7-10-24(34)27(38)32(2)3)26(36)35-17-21-16-30-33(4)25(21)31-22-8-5-6-9-23(22)35/h5-6,8-9,11-12,14,16,24,31H,7,10,13,15,17H2,1-4H3,(H,29,37)/t24-/m0/s1	AOPORIRPXVMWSL-DEOSSOPVSA-N					removed another duplicate entry; compound annotation
0391_003748	Domatinostat	C23H21N5O3S	3.3177	15985904	CN1C=C(C=N1)C2=CC=C(C=C2)S(=O)(=O)N3C=CC(=C3)/C=C/C(=O)NC4=CC=CC=C4N	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(C=CC(=O)Nc4ccccc4N)c3)cc2)cn1	InChI=1S/C23H21N5O3S/c1-27-16-19(14-25-27)18-7-9-20(10-8-18)32(30,31)28-13-12-17(15-28)6-11-23(29)26-22-5-3-2-4-21(22)24/h2-16H,24H2,1H3,(H,26,29)/b11-6+	PRXXYMVLYKJITB-IZZDOVSWSA-N					doublet; compound annotation
0391_003749	Domatinostat	C23H21N5O3S	3.321	15985904	CN1C=C(C=N1)C2=CC=C(C=C2)S(=O)(=O)N3C=CC(=C3)/C=C/C(=O)NC4=CC=CC=C4N	Cn1cc(-c2ccc(S(=O)(=O)n3ccc(C=CC(=O)Nc4ccccc4N)c3)cc2)cn1	InChI=1S/C23H21N5O3S/c1-27-16-19(14-25-27)18-7-9-20(10-8-18)32(30,31)28-13-12-17(15-28)6-11-23(29)26-22-5-3-2-4-21(22)24/h2-16H,24H2,1H3,(H,26,29)/b11-6+	PRXXYMVLYKJITB-IZZDOVSWSA-N					doublet; compound annotation
0391_003750	FGTI-2734	C26H31FN6O2S	3.6394	49783195		Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1c(F)cc(C#N)cc1	InChI=1S/C26H31FN6O2S/c1-31-20-29-17-23(31)19-32(25-11-10-22(16-28)15-24(25)27)13-14-33(18-21-7-3-2-4-8-21)36(34,35)26-9-5-6-12-30-26/h5-6,9-12,15,17,20-21H,2-4,7-8,13-14,18-19H2,1H3	BXNRVJLIEMQDOL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003752	Seviteronel	C18H17F4N3O3	4.1158	78357816	CC(C)[C@](C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O	CC(C)C(O)(c1cc2cc(OC(F)F)c(OC(F)F)cc2cc1)c1n[nH]nc1	InChI=1S/C18H17F4N3O3/c1-9(2)18(26,15-8-23-25-24-15)12-4-3-10-6-13(27-16(19)20)14(28-17(21)22)7-11(10)5-12/h3-9,16-17,26H,1-2H3,(H,23,24,25)/t18-/m0/s1	ZBRAJOQFSNYJMF-SFHVURJKSA-N					compound annotation
0391_003753	MK-8245	C17H16BrFN6O4	4.2633	24988881		O=C(O)Cn1nnc(-c2cc(N3CCC(Oc4c(Br)ccc(F)c4)CC3)no2)n1	InChI=1S/C17H16BrFN6O4/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27/h1-2,7-8,11H,3-6,9H2,(H,26,27)	UJEAABFSXKCSGI-UHFFFAOYSA-N					compound annotation
0391_003754	SKI II	C15H11ClN2OS	4.2956	753704		Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1	InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18)	ZFGXZJKLOFCECI-UHFFFAOYSA-N					doublet; compound annotation
0391_003755	SKI II	C15H11ClN2OS	5.1952	753704		Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1	InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18)	ZFGXZJKLOFCECI-UHFFFAOYSA-N					doublet; compound annotation
0391_003756	SKI II	C15H11ClN2OS	5.5349	753704		Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1	InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18)	ZFGXZJKLOFCECI-UHFFFAOYSA-N					doublet; compound annotation
0391_003757	DETOMIDINE	C12H14N2	2.0181	56032		Cc1c(C)c(Cc2cnc[nH]2)ccc1	InChI=1S/C12H14N2/c1-9-4-3-5-11(10(9)2)6-12-7-13-8-14-12/h3-5,7-8H,6H2,1-2H3,(H,13,14)	RHDJRPPFURBGLQ-UHFFFAOYSA-N					compound annotation
0391_003758	2158197-70-5	C24H24N4O	2.3196	134817449		Cc1ccc(Oc2ccnc3cc(-c4cn(C5CCNCC5)nc4)ccc23)cc1	InChI=1S/C24H24N4O/c1-17-2-5-21(6-3-17)29-24-10-13-26-23-14-18(4-7-22(23)24)19-15-27-28(16-19)20-8-11-25-12-9-20/h2-7,10,13-16,20,25H,8-9,11-12H2,1H3	VPVLPCIBKVWFDT-UHFFFAOYSA-N					compound annotation
0391_003759	pravastatin	C23H36O7	2.9565	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21	InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1	TUZYXOIXSAXUGO-PZAWKZKUSA-N					doublet; compound annotation
0391_003760	pravastatin	C23H36O7	3.116	54687	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O	CCC(C)C(=O)OC1CC(O)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21	InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1	TUZYXOIXSAXUGO-PZAWKZKUSA-N					doublet; compound annotation
0391_003761	duloxetine	C18H19NOS	3.1373	60835	CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32	CNCCC(Oc1cccc2ccccc12)c1cccs1	InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1	ZEUITGRIYCTCEM-KRWDZBQOSA-N					compound annotation
0391_003762	glipizide	C21H27N5O4S	3.4155	3478		Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1	InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)	ZJJXGWJIGJFDTL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003764	PCI-33380	C46H52BF2N11O3	3.8227	168008660	[B-]1(N2C(=CC(=C2C=C3[N+]1=C(C=C3)CCC(=O)NCCN4CCN(CC4)C/C=C/C(=O)N5CCCC(C5)N6C7=NC=NC(=C7C(=N6)C8=CC=C(C=C8)OC9=CC=CC=C9)N)C)C)(F)F	Cc1c2C=C3C=CC(CCC(=O)NCCN4CCN(CC=CC(=O)N5CCCC(n6nc(-c7ccc(Oc8ccccc8)cc7)c7c(N)ncnc76)C5)CC4)=[N+]3[B-](F)(F)n2c(C)c1	InChI=1S/C46H52BF2N11O3/c1-32-28-33(2)58-40(32)29-36-15-14-35(59(36)47(58,48)49)16-19-41(61)51-20-23-56-26-24-55(25-27-56)21-7-11-42(62)57-22-6-8-37(30-57)60-46-43(45(50)52-31-53-46)44(54-60)34-12-17-39(18-13-34)63-38-9-4-3-5-10-38/h3-5,7,9-15,17-18,28-29,31,37H,6,8,16,19-27,30H2,1-2H3,(H,51,61)(H2,50,52,53)/b11-7+	YUGFMNZIROEBNV-YRNVUSSQSA-N					doublet; compound annotation
0391_003765	PCI-33380	C46H52BF2N11O3	3.8255	168008660	[B-]1(N2C(=CC(=C2C=C3[N+]1=C(C=C3)CCC(=O)NCCN4CCN(CC4)C/C=C/C(=O)N5CCCC(C5)N6C7=NC=NC(=C7C(=N6)C8=CC=C(C=C8)OC9=CC=CC=C9)N)C)C)(F)F	Cc1c2C=C3C=CC(CCC(=O)NCCN4CCN(CC=CC(=O)N5CCCC(n6nc(-c7ccc(Oc8ccccc8)cc7)c7c(N)ncnc76)C5)CC4)=[N+]3[B-](F)(F)n2c(C)c1	InChI=1S/C46H52BF2N11O3/c1-32-28-33(2)58-40(32)29-36-15-14-35(59(36)47(58,48)49)16-19-41(61)51-20-23-56-26-24-55(25-27-56)21-7-11-42(62)57-22-6-8-37(30-57)60-46-43(45(50)52-31-53-46)44(54-60)34-12-17-39(18-13-34)63-38-9-4-3-5-10-38/h3-5,7,9-15,17-18,28-29,31,37H,6,8,16,19-27,30H2,1-2H3,(H,51,61)(H2,50,52,53)/b11-7+	YUGFMNZIROEBNV-YRNVUSSQSA-N					doublet; compound annotation
0391_003766	dydrogesterone	C21H28O2	4.2448	9051	CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C	CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1	JGMOKGBVKVMRFX-HQZYFCCVSA-N					compound annotation
0391_003767	Ro 67-7476	C17H18FNO2S	4.7138	32681978	CC1=CC=C(C=C1)S(=O)(=O)N2CCC[C@H]2C3=CC=C(C=C3)F	Cc1ccc(S(=O)(=O)N2CCCC2c2ccc(F)cc2)cc1	InChI=1S/C17H18FNO2S/c1-13-4-10-16(11-5-13)22(20,21)19-12-2-3-17(19)14-6-8-15(18)9-7-14/h4-11,17H,2-3,12H2,1H3/t17-/m0/s1	DAEHFYNGSSBGSS-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_003769	Sapanisertib	C15H15N7O	1.9306	45375953		CC(C)n1nc(-c2cc3c(cc2)oc(N)n3)c2c(N)ncnc21	InChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19)	GYLDXIAOMVERTK-UHFFFAOYSA-N					compound annotation
0391_003770	CP-724714	C27H27N5O3	1.9306	9874913	CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C	COCC(=O)NCC=Cc1cc2c(cc1)ncnc2Nc1cc(C)c(Oc2cnc(C)cc2)cc1	InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+	LLVZBTWPGQVVLW-SNAWJCMRSA-N					doublet; removed another duplicate entry; compound annotation
0391_003772	208260-29-1	C23H23N3O3	1.9811	5730		Cc1c(NC(=O)c2ccc(O)cc2)cc(NC(=O)c2cc(N(C)C)ccc2)cc1	InChI=1S/C23H23N3O3/c1-15-7-10-18(24-23(29)17-5-4-6-19(13-17)26(2)3)14-21(15)25-22(28)16-8-11-20(27)12-9-16/h4-14,27H,1-3H3,(H,24,29)(H,25,28)	PYEFPDQFAZNXLI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003774	CP-724714	C27H27N5O3	2.0528	9874913	CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C	COCC(=O)NCC=Cc1cc2c(cc1)ncnc2Nc1cc(C)c(Oc2cnc(C)cc2)cc1	InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+	LLVZBTWPGQVVLW-SNAWJCMRSA-N					doublet; compound annotation
0391_003775	CP-724714	C27H27N5O3	2.0558	9874913	CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C	COCC(=O)NCC=Cc1cc2c(cc1)ncnc2Nc1cc(C)c(Oc2cnc(C)cc2)cc1	InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+	LLVZBTWPGQVVLW-SNAWJCMRSA-N					doublet; compound annotation
0391_003776	208260-29-1	C23H23N3O3	2.8089	5730		Cc1c(NC(=O)c2ccc(O)cc2)cc(NC(=O)c2cc(N(C)C)ccc2)cc1	InChI=1S/C23H23N3O3/c1-15-7-10-18(24-23(29)17-5-4-6-19(13-17)26(2)3)14-21(15)25-22(28)16-8-11-20(27)12-9-16/h4-14,27H,1-3H3,(H,24,29)(H,25,28)	PYEFPDQFAZNXLI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003779	409351-28-6	C18H19N3O2S	3.5457	864492		COc1ccc(CNC(=O)c2c(N)c3c(nc(C)cc3C)s2)cc1	InChI=1S/C18H19N3O2S/c1-10-8-11(2)21-18-14(10)15(19)16(24-18)17(22)20-9-12-4-6-13(23-3)7-5-12/h4-8H,9,19H2,1-3H3,(H,20,22)	MDNWGCQSCGNTKH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003781	1335106-03-0	C15H13F6N3O4S2	3.6391	44241473		CC(=O)Nc1nc(C)c(S(=O)(=O)Nc2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2)s1	InChI=1S/C15H13F6N3O4S2/c1-7-11(29-12(22-7)23-8(2)25)30(27,28)24-10-5-3-9(4-6-10)13(26,14(16,17)18)15(19,20)21/h3-6,24,26H,1-2H3,(H,22,23,25)	OZBSSKGBKHOLGA-UHFFFAOYSA-N					compound annotation
0391_003782	NVP-CGM097	C38H47ClN4O4	3.8394	53240420	CC(C)OC1=C(C=C2CC(=O)N([C@H](C2=C1)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)N(C)CC5CCC(CC5)N6CCN(C(=O)C6)C)OC	COc1c(OC(C)C)cc2c(c1)CC(=O)N(c1ccc(N(C)CC3CCC(N4CCN(C)C(=O)C4)CC3)cc1)C2c1ccc(Cl)cc1	InChI=1S/C38H47ClN4O4/c1-25(2)47-35-22-33-28(20-34(35)46-5)21-36(44)43(38(33)27-8-10-29(39)11-9-27)32-16-14-30(15-17-32)41(4)23-26-6-12-31(13-7-26)42-19-18-40(3)37(45)24-42/h8-11,14-17,20,22,25-26,31,38H,6-7,12-13,18-19,21,23-24H2,1-5H3/t26?,31?,38-/m0/s1	CLRSLRWKONPSRQ-CPOWQTMSSA-N					doublet; removed another duplicate entry; compound annotation
0391_003785	diclofenac	C14H11Cl2NO2	4.3091	3033		O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	DCOPUUMXTXDBNB-UHFFFAOYSA-N					doublet; compound annotation
0391_003786	174635-69-9	C26H24N2O	4.3762	6604009	CC[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)C	CCC(NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	InChI=1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1	MQNYRKWJSMQECI-QFIPXVFZSA-N					doublet; compound annotation
0391_003787	174635-69-9	C26H24N2O	4.3817	6604009	CC[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)C	CCC(NC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12)c1ccccc1	InChI=1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1	MQNYRKWJSMQECI-QFIPXVFZSA-N					doublet; compound annotation
0391_003788	Evacetrapib	C31H36F6N6O2	6.3051	49836058	CC1=CC(=C2C(=C1)[C@H](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C	Cc1cc(C)c2c(c1)C(N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nn(C)nn1)CCCN2CC1CCC(C(=O)O)CC1	InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20?,22?,26-/m0/s1	IHIUGIVXARLYHP-UXNJHFGPSA-N					compound annotation
0391_003789	azd7507	C23H27FN6O3	1.499	25001557		COc1c(N2CCN(CCO)CC2)cc2c(Nc3c(F)cc(C)cc3)c(C(N)=O)nnc2c1	InChI=1S/C23H27FN6O3/c1-14-3-4-17(16(24)11-14)26-21-15-12-19(30-7-5-29(6-8-30)9-10-31)20(33-2)13-18(15)27-28-22(21)23(25)32/h3-4,11-13,31H,5-10H2,1-2H3,(H2,25,32)(H,26,27)	CPDGCAFPSYOTGO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003791	Erismodegib	C26H26F3N3O3	1.9411	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; compound annotation
0391_003792	Erismodegib	C26H26F3N3O3	2.4204	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; compound annotation
0391_003793	PF-06650833	C18H20FN3O4	2.6423	118414016	CC[C@H]1[C@H](NC(=O)[C@H]1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N	CCC1C(COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)C1F	InChI=1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1	JKDGKIBAOAFRPJ-ZBINZKHDSA-N					removed another duplicate entry; compound annotation
0391_003795	RPR-260243	C28H25F3N2O4	3.1245	11466357	COC1=CC2=C(C=CN=C2C=C1)C(=O)CC[C@@H]3CCN(C[C@@H]3C(=O)O)CC#CC4=C(C(=CC(=C4)F)F)F	COc1cc2c(C(=O)CCC3CCN(CC#Cc4c(F)c(F)cc(F)c4)CC3C(=O)O)ccnc2cc1	InChI=1S/C28H25F3N2O4/c1-37-20-5-6-25-22(15-20)21(8-10-32-25)26(34)7-4-17-9-12-33(16-23(17)28(35)36)11-2-3-18-13-19(29)14-24(30)27(18)31/h5-6,8,10,13-15,17,23H,4,7,9,11-12,16H2,1H3,(H,35,36)/t17-,23+/m1/s1	VWNMWKSURFWKAL-HXOBKFHXSA-N					removed another duplicate entry; compound annotation
0391_003797	Eleclazine	C21H16F3N3O3	4.3359	71183216		O=C1c2c(ccc(-c3ccc(OC(F)(F)F)cc3)c2)OCCN1Cc1ncccn1	InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2	YNUAEEJQYHYLMS-UHFFFAOYSA-N					doublet; compound annotation
0391_003798	Eleclazine	C21H16F3N3O3	4.3401	71183216		O=C1c2c(ccc(-c3ccc(OC(F)(F)F)cc3)c2)OCCN1Cc1ncccn1	InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2	YNUAEEJQYHYLMS-UHFFFAOYSA-N					doublet; compound annotation
0391_003799	Erismodegib	C26H26F3N3O3	4.5113	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; compound annotation
0391_003800	Erismodegib	C26H26F3N3O3	4.5145	24775005	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F	Cc1c(-c2ccc(OC(F)(F)F)cc2)cccc1C(=O)Nc1cnc(N2CC(C)OC(C)C2)cc1	InChI=1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+	VZZJRYRQSPEMTK-CALCHBBNSA-N					doublet; compound annotation
0391_003801	KC7f2	C16H16Cl4N2O4S4	5.0427	16047442		O=S(=O)(NCCSSCCNS(=O)(=O)c1c(Cl)ccc(Cl)c1)c1c(Cl)ccc(Cl)c1	InChI=1S/C16H16Cl4N2O4S4/c17-11-1-3-13(19)15(9-11)29(23,24)21-5-7-27-28-8-6-22-30(25,26)16-10-12(18)2-4-14(16)20/h1-4,9-10,21-22H,5-8H2	REQLACDIZMLXIC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003804	Visudyne	C41H42N4O8	5.9641	5362420	CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C	C=Cc1c(C)c2cc3nc(cc4c(C)c(CCC(=O)OC)c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)[nH]4)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC	InChI=1S/C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/t38-,41+/m0/s1	YTZALCGQUPRCGW-ZSFNYQMMSA-N					doublet; removed another duplicate entry; compound annotation
0391_003806	Visudyne	C41H42N4O8	6.1295	5362420	CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C	C=Cc1c(C)c2cc3nc(cc4c(C)c(CCC(=O)OC)c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)[nH]4)C1(C)C3=CC=C(C(=O)OC)C1C(=O)OC	InChI=1S/C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/t38-,41+/m0/s1	YTZALCGQUPRCGW-ZSFNYQMMSA-N					doublet; removed another duplicate entry; compound annotation
0391_003808	Doramectin	C50H74O14	6.3153	9832750	C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C8CCCCC8)C)O	COC1CC(OC2C(C)OC(OC3C(C)=CCC4CC(CC5(C=CC(C)C(C6CCCCC6)O5)O4)OC(=O)C4C=C(C)C(O)C5OCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O	InChI=1S/C50H74O14/c1-27-13-12-16-34-26-57-47-42(51)30(4)21-37(50(34,47)54)48(53)60-36-22-35(63-49(25-36)20-19-29(3)45(64-49)33-14-10-9-11-15-33)18-17-28(2)44(27)61-41-24-39(56-8)46(32(6)59-41)62-40-23-38(55-7)43(52)31(5)58-40/h12-13,16-17,19-21,27,29,31-33,35-47,51-52,54H,9-11,14-15,18,22-26H2,1-8H3/b13-12+,28-17+,34-16+/t27-,29-,31-,32-,35+,36-,37-,38-,39-,40-,41-,42+,43-,44-,45-,46-,47+,49+,50+/m0/s1	QLFZZSKTJWDQOS-YDBLARSUSA-N					removed another duplicate entry; compound annotation
0391_003810	5025-82-1	C6H9NO3S	0.6596	98928		CC(=O)N1CSCC1C(=O)O	InChI=1S/C6H9NO3S/c1-4(8)7-3-11-2-5(7)6(9)10/h5H,2-3H2,1H3,(H,9,10)	WXTBYSIPOKXCPM-UHFFFAOYSA-N					compound annotation
0391_003811	MOZ-IN-2	C17H13FN4O3S	2.3523	131750228		O=C(NNS(=O)(=O)c1ccccc1)c1c(F)ccc(-c2cnncc2)c1	InChI=1S/C17H13FN4O3S/c18-16-7-6-12(13-8-9-19-20-11-13)10-15(16)17(23)21-22-26(24,25)14-4-2-1-3-5-14/h1-11,22H,(H,21,23)	WYMCVPPNOFFNGE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003813	Pimodivir	C20H19F2N5O2	2.9888	67286591	C1CC2CCC1[C@@H]([C@H]2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O	O=C(O)C1C2CCC(CC2)C1Nc1nc(-c2c[nH]c3c2cc(F)cn3)ncc1F	InChI=1S/C20H19F2N5O2/c21-11-5-12-13(7-24-17(12)23-6-11)18-25-8-14(22)19(27-18)26-16-10-3-1-9(2-4-10)15(16)20(28)29/h5-10,15-16H,1-4H2,(H,23,24)(H,28,29)(H,25,26,27)/t9?,10?,15-,16-/m0/s1	JGPXDNKSIXAZEQ-SBBZOCNPSA-N					compound annotation
0391_003814	Sulcotrione	C14H13ClO5S	3.0314	91760		CS(=O)(=O)c1cc(Cl)c(C(=O)C2C(=O)CCCC2=O)cc1	InChI=1S/C14H13ClO5S/c1-21(19,20)8-5-6-9(10(15)7-8)14(18)13-11(16)3-2-4-12(13)17/h5-7,13H,2-4H2,1H3	PQTBTIFWAXVEPB-UHFFFAOYSA-N					compound annotation
0391_003815	WAY-100635	C25H34N4O2	3.1949	5684		COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1	InChI=1S/C25H34N4O2/c1-31-23-12-6-5-11-22(23)28-18-15-27(16-19-28)17-20-29(24-13-7-8-14-26-24)25(30)21-9-3-2-4-10-21/h5-8,11-14,21H,2-4,9-10,15-20H2,1H3	SBPRIAGPYFYCRT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003817	SSTR5 antagonist 1	C28H34FN3O5	3.4139	90423921		CCOc1cc(CN2CC3(CC(N4CCC(C(=O)O)CC4)=NO3)C2)cc(OCC)c1-c1ccc(F)cc1	InChI=1S/C28H34FN3O5/c1-3-35-23-13-19(14-24(36-4-2)26(23)20-5-7-22(29)8-6-20)16-31-17-28(18-31)15-25(30-37-28)32-11-9-21(10-12-32)27(33)34/h5-8,13-14,21H,3-4,9-12,15-18H2,1-2H3,(H,33,34)	UQRAIIGEZLINAT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003819	A2A receptor antagonist 1	C16H12FN5O	3.4309	9879687		Nc1nc(-c2ccco2)c2cnn(Cc3ccccc3F)c2n1	InChI=1S/C16H12FN5O/c17-12-5-2-1-4-10(12)9-22-15-11(8-19-22)14(20-16(18)21-15)13-6-3-7-23-13/h1-8H,9H2,(H2,18,20,21)	JEEJMSUHUZNTCD-UHFFFAOYSA-N					compound annotation
0391_003820	AZD6482	C22H24N4O4	3.5304	44137675	CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4	Cc1cn2c(=O)cc(N3CCOCC3)nc2c(C(C)Nc2ccccc2C(=O)O)c1	InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1	IRTDIKMSKMREGO-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_003823	KX2-391	C26H29N3O3	1.8752	23635314		O=C(Cc1ncc(-c2ccc(OCCN3CCOCC3)cc2)cc1)NCc1ccccc1	InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30)	HUNGUWOZPQBXGX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003827	Ulixertinib	C21H22Cl2N4O2	2.8316	11719003	CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl	CC(C)Nc1ncc(Cl)c(-c2c[nH]c(C(=O)NC(CO)c3cc(Cl)ccc3)c2)c1	InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1	KSERXGMCDHOLSS-LJQANCHMSA-N					doublet; compound annotation
0391_003828	PBTZ169	C20H23F3N4O3S	3.1026	57331386		O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c1cc(C(F)(F)F)cc2[N+](=O)[O-]	InChI=1S/C20H23F3N4O3S/c21-20(22,23)14-10-15-17(16(11-14)27(29)30)31-19(24-18(15)28)26-8-6-25(7-9-26)12-13-4-2-1-3-5-13/h10-11,13H,1-9,12H2	BJDZBXGJNBMCAV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003830	amibegron	C22H26ClNO4	3.1055	3035442	CCOC(=O)COC1=CC2=C(CC[C@@H](C2)NC[C@@H](C3=CC(=CC=C3)Cl)O)C=C1	CCOC(=O)COc1cc2c(cc1)CCC(NCC(O)c1cc(Cl)ccc1)C2	InChI=1S/C22H26ClNO4/c1-2-27-22(26)14-28-20-9-7-15-6-8-19(11-17(15)12-20)24-13-21(25)16-4-3-5-18(23)10-16/h3-5,7,9-10,12,19,21,24-25H,2,6,8,11,13-14H2,1H3/t19-,21-/m0/s1	RDJQCOBTKKAQAH-FPOVZHCZSA-N					doublet; compound annotation
0391_003831	amibegron	C22H26ClNO4	3.1765	3035442	CCOC(=O)COC1=CC2=C(CC[C@@H](C2)NC[C@@H](C3=CC(=CC=C3)Cl)O)C=C1	CCOC(=O)COc1cc2c(cc1)CCC(NCC(O)c1cc(Cl)ccc1)C2	InChI=1S/C22H26ClNO4/c1-2-27-22(26)14-28-20-9-7-15-6-8-19(11-17(15)12-20)24-13-21(25)16-4-3-5-18(23)10-16/h3-5,7,9-10,12,19,21,24-25H,2,6,8,11,13-14H2,1H3/t19-,21-/m0/s1	RDJQCOBTKKAQAH-FPOVZHCZSA-N					doublet; removed another duplicate entry; compound annotation
0391_003833	Brivanib alaninate	C22H24FN5O4	3.2389	11154925	CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C	Cc1cc2c(ccc(Oc3ncnn4cc(OCC(C)OC(=O)C(C)N)c(C)c34)c2F)[nH]1	InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1	LTEJRLHKIYCEOX-OCCSQVGLSA-N					doublet; removed another duplicate entry; compound annotation
0391_003835	Brivanib alaninate	C22H24FN5O4	3.3258	11154925	CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C	Cc1cc2c(ccc(Oc3ncnn4cc(OCC(C)OC(=O)C(C)N)c(C)c34)c2F)[nH]1	InChI=1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1	LTEJRLHKIYCEOX-OCCSQVGLSA-N					doublet; compound annotation
0391_003836	bepridil	C24H34N2O	4.0425	2351		CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3	UIEATEWHFDRYRU-UHFFFAOYSA-N					doublet; compound annotation
0391_003837	CU-CPT22	C19H22O7	5.1379	71503400		CCCCCCOC(=O)c1cc(=O)c(O)c2c(O)c(O)c(OC)cc2c1	InChI=1S/C19H22O7/c1-3-4-5-6-7-26-19(24)12-8-11-10-14(25-2)17(22)18(23)15(11)16(21)13(20)9-12/h8-10,22-23H,3-7H2,1-2H3,(H,20,21)	UBQFTTUFRSSOHE-UHFFFAOYSA-N					compound annotation
0391_003838	Varenicline	C13H13N3	1.0563	170361		c1cnc2cc3c(cc2n1)C1CNCC3C1	InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2	JQSHBVHOMNKWFT-UHFFFAOYSA-N					doublet; compound annotation
0391_003839	H-VAL-PHE-OH	C14H20N2O3	1.3623	6993120	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N	CC(C)C(N)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C14H20N2O3/c1-9(2)12(15)13(17)16-11(14(18)19)8-10-6-4-3-5-7-10/h3-7,9,11-12H,8,15H2,1-2H3,(H,16,17)(H,18,19)/t11-,12-/m0/s1	GJNDXQBALKCYSZ-RYUDHWBXSA-N					removed another duplicate entry; compound annotation
0391_003841	451492-95-8	C27H28ClFN6O	2.294	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003842	NVP-TNKS656	C27H34N4O5	2.3081	136237316		COc1ccc(C(=O)C2CCN(CC(=O)N(Cc3nc(=O)c4c(CCOC4)[nH]3)CC3CC3)CC2)cc1	InChI=1S/C27H34N4O5/c1-35-21-6-4-19(5-7-21)26(33)20-8-11-30(12-9-20)16-25(32)31(14-18-2-3-18)15-24-28-23-10-13-36-17-22(23)27(34)29-24/h4-7,18,20H,2-3,8-17H2,1H3,(H,28,29,34)	DYGBNAYFDZEYBA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003844	M2698	C21H19ClF3N5O	2.4864	89808643	C1CN(C1)C[C@H](C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N	NC(=O)c1cccc2c1ncnc2NC(CN1CCC1)c1cc(C(F)(F)F)c(Cl)cc1	InChI=1S/C21H19ClF3N5O/c22-16-6-5-12(9-15(16)21(23,24)25)17(10-30-7-2-8-30)29-20-14-4-1-3-13(19(26)31)18(14)27-11-28-20/h1,3-6,9,11,17H,2,7-8,10H2,(H2,26,31)(H,27,28,29)/t17-/m1/s1	HXAUJHZZPCBFPN-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_003846	451492-95-8	C27H28ClFN6O	2.6729	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003847	451492-95-8	C27H28ClFN6O	2.6761	9806229		C=CC(=O)Nc1cc2c(cc1C#CC(C)(C)N1CCN(C)CC1)ncnc2Nc1cc(Cl)c(F)cc1	InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)	ZAJXXUDARPGGOC-UHFFFAOYSA-N					doublet; compound annotation
0391_003848	Talazoparib	C19H14F2N6O	2.6895	135565082	CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F	Cn1ncnc1C1c2n[nH]c(=O)c3c2c(cc(F)c3)NC1c1ccc(F)cc1	InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1	HWGQMRYQVZSGDQ-HZPDHXFCSA-N					doublet; compound annotation
0391_003849	Faropenem daloxate	C17H19NO8S	3.0139	6918218	CC1=C(OC(=O)O1)COC(=O)C2=C(S[C@H]3N2C(=O)[C@@H]3[C@@H](C)O)[C@H]4CCCO4	Cc1c(COC(=O)C2=C(C3CCCO3)SC3C(C(C)O)C(=O)N23)oc(=O)o1	InChI=1S/C17H19NO8S/c1-7(19)11-14(20)18-12(13(27-15(11)18)9-4-3-5-23-9)16(21)24-6-10-8(2)25-17(22)26-10/h7,9,11,15,19H,3-6H2,1-2H3/t7-,9-,11+,15-/m1/s1	JQBKWZPHJOEQAO-DVPVEWDBSA-N					compound annotation
0391_003850	SHA 68	C26H24FN3O3	4.2562	11374217		O=C(NCc1ccc(F)cc1)N1CCN2C(=O)OC(c3ccccc3)(c3ccccc3)C2C1	InChI=1S/C26H24FN3O3/c27-22-13-11-19(12-14-22)17-28-24(31)29-15-16-30-23(18-29)26(33-25(30)32,20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-14,23H,15-18H2,(H,28,31)	SFRQIPRTNYHJHP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003852	Regorafenib	C21H15ClF4N4O3	4.7209	11167602		CNC(=O)c1nccc(Oc2cc(F)c(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3)cc2)c1	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	FNHKPVJBJVTLMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003854	AUDA	C23H40N2O3	4.995	10069117		O=C(O)CCCCCCCCCCCNC(=O)NC12CC3CC(CC(C3)C1)C2	InChI=1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28)	XLGSEOAVLVTJDH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003856	pinometostat	C30H42N8O3	1.8276	57345410	CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C	CC(C)N(CC1OC(n2cnc3c(N)ncnc32)C(O)C1O)C1CC(CCc2nc3c(cc(C(C)(C)C)cc3)[nH]2)C1	InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17?,19?,22-,25-,26-,29-/m1/s1	LXFOLMYKSYSZQS-XKHGBIBOSA-N					removed another duplicate entry; compound annotation
0391_003858	4'-Demethylepipodophyllotoxin	C21H20O8	2.462	122797	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O	COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1O	InChI=1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15)23)17-10-5-13-14(29-8-28-13)6-11(10)19(22)12-7-27-21(24)18(12)17/h3-6,12,17-19,22-23H,7-8H2,1-2H3/t12-,17+,18-,19+/m0/s1	YVCVYCSAAZQOJI-JHQYFNNDSA-N					removed another duplicate entry; compound annotation
0391_003861	AZD1208	C21H21N3O2S	2.9148	58423153	C1C[C@H](CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)/C=C\4/C(=O)NC(=O)S4)N	NC1CCCN(c2c(C=C3SC(=O)NC3=O)cccc2-c2ccccc2)C1	InChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1	MCUJKPPARUPFJM-UWCCDQBKSA-N					doublet; compound annotation
0391_003862	Lotamilast	C26H24N4O5	3.1467	24864553		CNc1nc2cc(OC)c(OC)cc2c(-c2cc(NC(=O)c3ccc(C(=O)OC)cc3)ccc2)n1	InChI=1S/C26H24N4O5/c1-27-26-29-20-14-22(34-3)21(33-2)13-19(20)23(30-26)17-6-5-7-18(12-17)28-24(31)15-8-10-16(11-9-15)25(32)35-4/h5-14H,1-4H3,(H,28,31)(H,27,29,30)	BBTFKAOFCSOZMB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003864	Lotamilast	C26H24N4O5	3.1516	24864553		CNc1nc2cc(OC)c(OC)cc2c(-c2cc(NC(=O)c3ccc(C(=O)OC)cc3)ccc2)n1	InChI=1S/C26H24N4O5/c1-27-26-29-20-14-22(34-3)21(33-2)13-19(20)23(30-26)17-6-5-7-18(12-17)28-24(31)15-8-10-16(11-9-15)25(32)35-4/h5-14H,1-4H3,(H,28,31)(H,27,29,30)	BBTFKAOFCSOZMB-UHFFFAOYSA-N					doublet; compound annotation
0391_003865	AZD1208	C21H21N3O2S	3.2384	58423153	C1C[C@H](CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)/C=C\4/C(=O)NC(=O)S4)N	NC1CCCN(c2c(C=C3SC(=O)NC3=O)cccc2-c2ccccc2)C1	InChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1	MCUJKPPARUPFJM-UWCCDQBKSA-N					doublet; compound annotation
0391_003866	894002-50-7	C17H15N3S	4.6344	7207425		Cc1ccccc1CSc1nnc(-c2ccccn2)cc1	InChI=1S/C17H15N3S/c1-13-6-2-3-7-14(13)12-21-17-10-9-16(19-20-17)15-8-4-5-11-18-15/h2-11H,12H2,1H3	DUUQLWDHNYFUPP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003868	AMG 9810	C21H23NO3	4.7965	680502	CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3	CC(C)(C)c1ccc(C=CC(=O)Nc2cc3c(cc2)OCCO3)cc1	InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+	GZTFUVZVLYUPRG-IZZDOVSWSA-N					doublet; compound annotation
0391_003869	AMZ30	C19H12FN3O6S2	4.8499	44607965	C1=CC(=CC(=C1)S(=O)(=O)N2C=CC=C2/C=C(\C#N)/S(=O)(=O)C3=CC=C(C=C3)F)[N+](=O)[O-]	N#CC(=Cc1cccn1S(=O)(=O)c1cccc([N+](=O)[O-])c1)S(=O)(=O)c1ccc(F)cc1	InChI=1S/C19H12FN3O6S2/c20-14-6-8-17(9-7-14)30(26,27)19(13-21)11-15-4-2-10-22(15)31(28,29)18-5-1-3-16(12-18)23(24)25/h1-12H/b19-11+	GUCUORSUHTZMBW-YBFXNURJSA-N					removed another duplicate entry; compound annotation
0391_003871	AMG 9810	C21H23NO3	4.9067	680502	CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3	CC(C)(C)c1ccc(C=CC(=O)Nc2cc3c(cc2)OCCO3)cc1	InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+	GZTFUVZVLYUPRG-IZZDOVSWSA-N					doublet; compound annotation
0391_003872	AMG 9810	C21H23NO3	4.91	680502	CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3	CC(C)(C)c1ccc(C=CC(=O)Nc2cc3c(cc2)OCCO3)cc1	InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+	GZTFUVZVLYUPRG-IZZDOVSWSA-N					doublet; removed another duplicate entry; compound annotation
0391_003874	AMG 9810	C21H23NO3	5.0275	680502	CC(C)(C)C1=CC=C(C=C1)/C=C/C(=O)NC2=CC3=C(C=C2)OCCO3	CC(C)(C)c1ccc(C=CC(=O)Nc2cc3c(cc2)OCCO3)cc1	InChI=1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+	GZTFUVZVLYUPRG-IZZDOVSWSA-N					doublet; compound annotation
0391_003875	Pico145	C23H20ClF3N4O5	5.0335	85473438		Cn1c(=O)n(CCCO)c(=O)c2c1nc(Oc1cc(OC(F)(F)F)ccc1)n2Cc1ccc(Cl)cc1	InChI=1S/C23H20ClF3N4O5/c1-29-19-18(20(33)30(22(29)34)10-3-11-32)31(13-14-6-8-15(24)9-7-14)21(28-19)35-16-4-2-5-17(12-16)36-23(25,26)27/h2,4-9,12,32H,3,10-11,13H2,1H3	PRJHEJGMSOBHTO-UHFFFAOYSA-N					doublet; compound annotation
0391_003876	Pico145	C23H20ClF3N4O5	5.0363	85473438		Cn1c(=O)n(CCCO)c(=O)c2c1nc(Oc1cc(OC(F)(F)F)ccc1)n2Cc1ccc(Cl)cc1	InChI=1S/C23H20ClF3N4O5/c1-29-19-18(20(33)30(22(29)34)10-3-11-32)31(13-14-6-8-15(24)9-7-14)21(28-19)35-16-4-2-5-17(12-16)36-23(25,26)27/h2,4-9,12,32H,3,10-11,13H2,1H3	PRJHEJGMSOBHTO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003878	OMARIGLIPTIN	C17H20F2N4O3S	1.581	46209133	CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N	CS(=O)(=O)n1cc2CN(C3COC(c4c(F)ccc(F)c4)C(N)C3)Cc2n1	InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1	MKMPWKUAHLTIBJ-ISTRZQFTSA-N					removed another duplicate entry; compound annotation
0391_003880	Cerdulatinib	C20H27N7O3S	1.6955	44595079		CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1	InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)	BGLPECHZZQDNCD-UHFFFAOYSA-N					doublet; compound annotation
0391_003881	XMD8-87	C24H27N7O2	2.1745	53322923		COc1c(Nc2ncc3NC(=O)c4ccccc4N(C)c3n2)ccc(N2CCN(C)CC2)c1	InChI=1S/C24H27N7O2/c1-29-10-12-31(13-11-29)16-8-9-18(21(14-16)33-3)27-24-25-15-19-22(28-24)30(2)20-7-5-4-6-17(20)23(32)26-19/h4-9,14-15H,10-13H2,1-3H3,(H,26,32)(H,25,27,28)	LGLHCXISMKHLIK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003883	Cerdulatinib	C20H27N7O3S	2.4741	44595079		CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1	InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)	BGLPECHZZQDNCD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003885	Cerdulatinib	C20H27N7O3S	2.477	44595079		CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1	InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)	BGLPECHZZQDNCD-UHFFFAOYSA-N					doublet; compound annotation
0391_003886	HG-14-10-04	C29H34ClN7O	2.6138	56655374		COc1c(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C29H34ClN7O/c1-35-13-15-37(16-14-35)20-9-11-36(12-10-20)21-7-8-26(27(17-21)38-2)33-29-32-19-24(30)28(34-29)23-18-31-25-6-4-3-5-22(23)25/h3-8,17-20,31H,9-16H2,1-2H3,(H,32,33,34)	HRYNCLKDKCPYBF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003888	h-89	C20H20BrN3O2S	2.7295	449241	C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNC/C=C/C3=CC=C(C=C3)Br	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2c1ccnc2	InChI=1S/C20H20BrN3O2S/c21-18-8-6-16(7-9-18)3-2-11-22-13-14-24-27(25,26)20-5-1-4-17-15-23-12-10-19(17)20/h1-10,12,15,22,24H,11,13-14H2/b3-2+	ZKZXNDJNWUTGDK-NSCUHMNNSA-N					compound annotation
0391_003889	Vericiguat	C19H16F2N8O2	2.8127	54674461		COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3c2cc(F)cn3)nc1N	InChI=1S/C19H16F2N8O2/c1-31-19(30)25-14-15(22)26-17(27-16(14)23)13-11-6-10(20)7-24-18(11)29(28-13)8-9-4-2-3-5-12(9)21/h2-7H,8H2,1H3,(H,25,30)(H4,22,23,26,27)	QZFHIXARHDBPBY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003891	VER-50589	C19H17ClN2O5	3.4249	135446210		CCNC(=O)c1noc(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1	InChI=1S/C19H17ClN2O5/c1-3-21-19(25)17-16(10-4-6-11(26-2)7-5-10)18(27-22-17)12-8-13(20)15(24)9-14(12)23/h4-9,23-24H,3H2,1-2H3,(H,21,25)	JXPCDMPJCKNLBY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003893	905586-69-8	C18H16F2N6	3.8747	25099184	CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F	Cc1cc(Nc2c(F)cc(C#N)c(NC(C)c3ccc(F)cc3)n2)n[nH]1	InChI=1S/C18H16F2N6/c1-10-7-16(26-25-10)23-18-15(20)8-13(9-21)17(24-18)22-11(2)12-3-5-14(19)6-4-12/h3-8,11H,1-2H3,(H3,22,23,24,25,26)/t11-/m0/s1	SUNXHXDJOIXABJ-NSHDSACASA-N					compound annotation
0391_003894	P7C3	C21H18Br2N2O	5.7904	2836187		OC(CNc1ccccc1)Cn1c2ccc(Br)cc2c2c1ccc(Br)c2	InChI=1S/C21H18Br2N2O/c22-14-6-8-20-18(10-14)19-11-15(23)7-9-21(19)25(20)13-17(26)12-24-16-4-2-1-3-5-16/h1-11,17,24,26H,12-13H2	FZHHRERIIVOATI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003896	PKI-166	C20H18N4O	2.5856	6918403	C[C@H](C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O	CC(Nc1ncnc2c1cc(-c1ccc(O)cc1)[nH]2)c1ccccc1	InChI=1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1	XRYJULCDUUATMC-CYBMUJFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_003898	PROTO-1	C17H19ClN4O2S	2.6114	1069493		CCN1CCc2c(C1)sc(NC(=O)Nc1ccc(Cl)cc1)c2C(N)=O	InChI=1S/C17H19ClN4O2S/c1-2-22-8-7-12-13(9-22)25-16(14(12)15(19)23)21-17(24)20-11-5-3-10(18)4-6-11/h3-6H,2,7-9H2,1H3,(H2,19,23)(H2,20,21,24)	QBLKUVUKIZEWAL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003900	JQ-35, (S)-	C27H34ClN7OS	2.6526	54670351	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCN4CCN(CC4)C)C5=CC=C(C=C5)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)NCCCN1CCN(C)CC1)N=C2c1ccc(Cl)cc1	InChI=1S/C27H34ClN7OS/c1-17-18(2)37-27-24(17)25(20-6-8-21(28)9-7-20)30-22(26-32-31-19(3)35(26)27)16-23(36)29-10-5-11-34-14-12-33(4)13-15-34/h6-9,22H,5,10-16H2,1-4H3,(H,29,36)/t22-/m0/s1	PKQXLRYFPSZKDU-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_003902	Pexidartinib	C20H15ClF3N5	2.8711	25151352		FC(F)(F)c1ncc(CNc2ncc(Cc3c[nH]c4c3cc(Cl)cn4)cc2)cc1	InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)	JGWRKYUXBBNENE-UHFFFAOYSA-N					doublet; compound annotation
0391_003903	Ibiglustat	C20H24FN3O2S	3.0003	60199242	CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4	CC(C)(NC(=O)OC1CN2CCC1CC2)c1csc(-c2ccc(F)cc2)n1	InChI=1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1	YFHRCLAKZBDRHN-MRXNPFEDSA-N					doublet; removed another duplicate entry; compound annotation
0391_003905	PROTO-1	C17H19ClN4O2S	3.2469	1069493		CCN1CCc2c(C1)sc(NC(=O)Nc1ccc(Cl)cc1)c2C(N)=O	InChI=1S/C17H19ClN4O2S/c1-2-22-8-7-12-13(9-22)25-16(14(12)15(19)23)21-17(24)20-11-5-3-10(18)4-6-11/h3-6H,2,7-9H2,1H3,(H2,19,23)(H2,20,21,24)	QBLKUVUKIZEWAL-UHFFFAOYSA-N					doublet; compound annotation
0391_003906	Linerixibat	C28H38N2O7S	3.7028	53492727	CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC	CCCCC1(CC)CS(=O)(=O)c2c(cc(OC)c(CNC(CC(=O)O)CC(=O)O)c2)C(c2ccccc2)N1	InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1	CZGVOBIGEBDYTP-VSGBNLITSA-N					doublet; removed another duplicate entry; compound annotation
0391_003908	Linerixibat	C28H38N2O7S	3.7716	53492727	CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC	CCCCC1(CC)CS(=O)(=O)c2c(cc(OC)c(CNC(CC(=O)O)CC(=O)O)c2)C(c2ccccc2)N1	InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1	CZGVOBIGEBDYTP-VSGBNLITSA-N					doublet; compound annotation
0391_003909	PKI-166	C20H18N4O	3.8933	6918403	C[C@H](C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O	CC(Nc1ncnc2c1cc(-c1ccc(O)cc1)[nH]2)c1ccccc1	InChI=1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1	XRYJULCDUUATMC-CYBMUJFWSA-N					doublet; compound annotation
0391_003910	Setipiprant	C24H19FN2O3	3.9107	49843471		O=C(O)Cn1c2c(CN(C(=O)c3cccc4ccccc34)CC2)c2c1ccc(F)c2	InChI=1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29)	IHAXLPDVOWLUOS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003913	Enasidenib	C19H17F6N7O	3.9796	89683805		CC(C)(O)CNc1nc(Nc2cc(C(F)(F)F)ncc2)nc(-c2nc(C(F)(F)F)ccc2)n1	InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)	DYLUUSLLRIQKOE-UHFFFAOYSA-N					doublet; compound annotation
0391_003914	Enasidenib	C19H17F6N7O	3.9826	89683805		CC(C)(O)CNc1nc(Nc2cc(C(F)(F)F)ncc2)nc(-c2nc(C(F)(F)F)ccc2)n1	InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)	DYLUUSLLRIQKOE-UHFFFAOYSA-N					doublet; compound annotation
0391_003915	iCRT 14	C21H17N3O2S	4.2218	5967294	CC1=CC(=C(N1C2=CN=CC=C2)C)/C=C\3/C(=O)N(C(=O)S3)C4=CC=CC=C4	Cc1cc(C=C2SC(=O)N(c3ccccc3)C2=O)c(C)n1-c1cnccc1	InChI=1S/C21H17N3O2S/c1-14-11-16(15(2)23(14)18-9-6-10-22-13-18)12-19-20(25)24(21(26)27-19)17-7-4-3-5-8-17/h3-13H,1-2H3/b19-12-	NCSHZXNGQYSKLR-UNOMPAQXSA-N					doublet; compound annotation
0391_003916	iCRT 14	C21H17N3O2S	4.2809	5967294	CC1=CC(=C(N1C2=CN=CC=C2)C)/C=C\3/C(=O)N(C(=O)S3)C4=CC=CC=C4	Cc1cc(C=C2SC(=O)N(c3ccccc3)C2=O)c(C)n1-c1cnccc1	InChI=1S/C21H17N3O2S/c1-14-11-16(15(2)23(14)18-9-6-10-22-13-18)12-19-20(25)24(21(26)27-19)17-7-4-3-5-8-17/h3-13H,1-2H3/b19-12-	NCSHZXNGQYSKLR-UNOMPAQXSA-N					doublet; compound annotation
0391_003917	SJ-172550	C22H21ClN2O5	5.2711	1317464	CCOC1=C(C(=CC(=C1)/C=C/2\C(=NN(C2=O)C3=CC=CC=C3)C)Cl)OCC(=O)OC	CCOc1c(OCC(=O)OC)c(Cl)cc(C=C2C(=O)N(c3ccccc3)N=C2C)c1	InChI=1S/C22H21ClN2O5/c1-4-29-19-12-15(11-18(23)21(19)30-13-20(26)28-3)10-17-14(2)24-25(22(17)27)16-8-6-5-7-9-16/h5-12H,4,13H2,1-3H3/b17-10+	RKKFQJXGAQWHBZ-LICLKQGHSA-N					doublet; compound annotation
0391_003918	SJ-172550	C22H21ClN2O5	5.5119	1317464	CCOC1=C(C(=CC(=C1)/C=C/2\C(=NN(C2=O)C3=CC=CC=C3)C)Cl)OCC(=O)OC	CCOc1c(OCC(=O)OC)c(Cl)cc(C=C2C(=O)N(c3ccccc3)N=C2C)c1	InChI=1S/C22H21ClN2O5/c1-4-29-19-12-15(11-18(23)21(19)30-13-20(26)28-3)10-17-14(2)24-25(22(17)27)16-8-6-5-7-9-16/h5-12H,4,13H2,1-3H3/b17-10+	RKKFQJXGAQWHBZ-LICLKQGHSA-N					doublet; removed another duplicate entry; compound annotation
0391_003921	PRT062607	C19H23N9O	2.2413	44462758	C1CC[C@H]([C@H](C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N	NC(=O)c1cnc(NC2CCCCC2N)nc1Nc1cc(-n2nccn2)ccc1	InChI=1S/C19H23N9O/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27)/t15-,16+/m0/s1	TXGKRVFSSHPBAJ-JKSUJKDBSA-N					doublet; removed another duplicate entry; compound annotation
0391_003923	Grapiprant	C26H29N5O3S	2.6133	11677589		CCc1nc2c(cc(C)nc2C)n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1	InChI=1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32)	HZVLFTCYCLXTGV-UHFFFAOYSA-N					doublet; compound annotation
0391_003924	Grapiprant	C26H29N5O3S	2.6862	11677589		CCc1nc2c(cc(C)nc2C)n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1	InChI=1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32)	HZVLFTCYCLXTGV-UHFFFAOYSA-N					doublet; compound annotation
0391_003925	zardaverine	C12H10F2N2O3	2.8034	5723		COc1c(OC(F)F)ccc(-c2n[nH]c(=O)cc2)c1	InChI=1S/C12H10F2N2O3/c1-18-10-6-7(2-4-9(10)19-12(13)14)8-3-5-11(17)16-15-8/h2-6,12H,1H3,(H,16,17)	HJMQDJPMQIHLPB-UHFFFAOYSA-N					compound annotation
0391_003926	(R)-(-)-Rolipram	C16H21NO3	3.1442	448055	COC1=C(C=C(C=C1)[C@H]2CC(=O)NC2)OC3CCCC3	COc1c(OC2CCCC2)cc(C2CNC(=O)C2)cc1	InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m0/s1	HJORMJIFDVBMOB-LBPRGKRZSA-N					doublet; removed another duplicate entry; compound annotation
0391_003928	(R)-(-)-Rolipram	C16H21NO3	3.147	448055	COC1=C(C=C(C=C1)[C@H]2CC(=O)NC2)OC3CCCC3	COc1c(OC2CCCC2)cc(C2CNC(=O)C2)cc1	InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m0/s1	HJORMJIFDVBMOB-LBPRGKRZSA-N					doublet; compound annotation
0391_003929	USP25/28 inhibitor AZ1	C17H16BrF4NO2	3.321	135397656		OCCNCc1c(OCc2cc(C(F)(F)F)c(F)cc2)ccc(Br)c1	InChI=1S/C17H16BrF4NO2/c18-13-2-4-16(12(8-13)9-23-5-6-24)25-10-11-1-3-15(19)14(7-11)17(20,21)22/h1-4,7-8,23-24H,5-6,9-10H2	ITHSFXDGKQYOED-UHFFFAOYSA-N					compound annotation
0391_003930	Ertugliflozin	C22H25ClO7	3.4992	44814423	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C34OCC(CO)(O3)C(O)C(O)C4O)c2)cc1	InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	MCIACXAZCBVDEE-CUUWFGFTSA-N					doublet; removed another duplicate entry; compound annotation
0391_003932	Ertugliflozin	C22H25ClO7	3.5045	44814423	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C34OCC(CO)(O3)C(O)C(O)C4O)c2)cc1	InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	MCIACXAZCBVDEE-CUUWFGFTSA-N					doublet; compound annotation
0391_003933	CTEP	C19H13ClF3N3O	3.7879	11646823		Cc1nc(C#Cc2cc(Cl)ncc2)c(C)n1-c1ccc(OC(F)(F)F)cc1	InChI=1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3	GOHCTCOGYKAJLZ-UHFFFAOYSA-N					compound annotation
0391_003934	salubrinal	C21H17Cl3N4OS	4.6012	5717801	C1=CC=C(C=C1)/C=C/C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3	O=C(C=Cc1ccccc1)NC(NC(=S)Nc1cccc2c1nccc2)C(Cl)(Cl)Cl	InChI=1S/C21H17Cl3N4OS/c22-21(23,24)19(27-17(29)12-11-14-6-2-1-3-7-14)28-20(30)26-16-10-4-8-15-9-5-13-25-18(15)16/h1-13,19H,(H,27,29)(H2,26,28,30)/b12-11+	LCOIAYJMPKXARU-VAWYXSNFSA-N					removed another duplicate entry; compound annotation
0391_003936	FENRETINIDE	C26H33NO2	6.0048	5288209	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+	AKJHMTWEGVYYSE-FXILSDISSA-N					doublet; removed another duplicate entry; compound annotation
0391_003938	FENRETINIDE	C26H33NO2	6.0781	5288209	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+	AKJHMTWEGVYYSE-FXILSDISSA-N					doublet; compound annotation
0391_003939	gossypol	C30H30O8	6.0781	3503		Cc1cc2c(c(O)c1-c1c(O)c3c(cc1C)c(C(C)C)c(O)c(O)c3C=O)c(C=O)c(O)c(O)c2C(C)C	InChI=1S/C30H30O8/c1-11(2)19-15-7-13(5)21(27(35)23(15)17(9-31)25(33)29(19)37)22-14(6)8-16-20(12(3)4)30(38)26(34)18(10-32)24(16)28(22)36/h7-12,33-38H,1-6H3	QBKSWRVVCFFDOT-UHFFFAOYSA-N					compound annotation
0391_003940	FENRETINIDE	C26H33NO2	6.1554	5288209	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+	AKJHMTWEGVYYSE-FXILSDISSA-N					doublet; compound annotation
0391_003941	PRT062607	C19H23N9O	6.1554	44462758	C1CC[C@H]([C@H](C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N	NC(=O)c1cnc(NC2CCCCC2N)nc1Nc1cc(-n2nccn2)ccc1	InChI=1S/C19H23N9O/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27)/t15-,16+/m0/s1	TXGKRVFSSHPBAJ-JKSUJKDBSA-N					doublet; compound annotation
0391_003942	FENRETINIDE	C26H33NO2	6.2069	5288209	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+	AKJHMTWEGVYYSE-FXILSDISSA-N					doublet; removed another duplicate entry; compound annotation
0391_003944	FENRETINIDE	C26H33NO2	6.2708	5288209	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1	InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+	AKJHMTWEGVYYSE-FXILSDISSA-N					doublet; removed another duplicate entry; compound annotation
0391_003947	1-(2-ethoxy-2-oxoethyl)-6-methoxyquinolinium	C14H16NO3+	1.5469	130205		CCOC(=O)C[n+]1cccc2c1ccc(OC)c2	InChI=1S/C14H16NO3/c1-3-18-14(16)10-15-8-4-5-11-9-12(17-2)6-7-13(11)15/h4-9H,3,10H2,1-2H3/q+1	HEYSKURSHFYAMR-UHFFFAOYSA-N					compound annotation
0391_003948	Carbimazole	C7H10N2O2S	1.5923	31072		CCOC(=O)n1ccn(C)c1=S	InChI=1S/C7H10N2O2S/c1-3-11-7(10)9-5-4-8(2)6(9)12/h4-5H,3H2,1-2H3	CFOYWRHIYXMDOT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003950	tolperisone	C16H23NO	2.2198	5511		Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1	InChI=1S/C16H23NO/c1-13-6-8-15(9-7-13)16(18)14(2)12-17-10-4-3-5-11-17/h6-9,14H,3-5,10-12H2,1-2H3	FSKFPVLPFLJRQB-UHFFFAOYSA-N					compound annotation
0391_003951	bufexamac	C12H17NO3	2.9866	2466		CCCCOc1ccc(CC(=O)NO)cc1	InChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)	MXJWRABVEGLYDG-UHFFFAOYSA-N					compound annotation
0391_003952	IMAZALIL	C14H14Cl2N2O	3.0428	37175		C=CCOC(Cn1ccnc1)c1c(Cl)cc(Cl)cc1	InChI=1S/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2	PZBPKYOVPCNPJY-UHFFFAOYSA-N					compound annotation
0391_003953	norethindrone	C20H26O2	3.6158	6230	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C	InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1	VIKNJXKGJWUCNN-XGXHKTLJSA-N					compound annotation
0391_003954	fluocinonide	C26H32F2O7	4.1048	9642	CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C	CC(=O)OCC(=O)C12OC(C)(C)OC1CC1C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC12C	InChI=1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1	WJOHZNCJWYWUJD-IUGZLZTKSA-N					removed another duplicate entry; compound annotation
0391_003956	acemetacin	C21H18ClNO6	4.4216	1981		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)OCC(=O)O	InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)	FSQKKOOTNAMONP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003958	acemetacin	C21H18ClNO6	4.4246	1981		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)OCC(=O)O	InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)	FSQKKOOTNAMONP-UHFFFAOYSA-N					doublet; compound annotation
0391_003959	Cloquintocet-mexyl	C18H22ClNO3	5.1218	93528		CCCCCC(C)OC(=O)COc1c2ncccc2c(Cl)cc1	InChI=1S/C18H22ClNO3/c1-3-4-5-7-13(2)23-17(21)12-22-16-10-9-15(19)14-8-6-11-20-18(14)16/h6,8-11,13H,3-5,7,12H2,1-2H3	COYBRKAVBMYYSF-UHFFFAOYSA-N					doublet; compound annotation
0391_003960	Cloquintocet-mexyl	C18H22ClNO3	5.2011	93528		CCCCCC(C)OC(=O)COc1c2ncccc2c(Cl)cc1	InChI=1S/C18H22ClNO3/c1-3-4-5-7-13(2)23-17(21)12-22-16-10-9-15(19)14-8-6-11-20-18(14)16/h6,8-11,13H,3-5,7,12H2,1-2H3	COYBRKAVBMYYSF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003962	Pyronaridine	C29H32ClN5O2	1.3066	107771		COc1nc2c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c3c(cc(Cl)cc3)nc2cc1	InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)	DJUFPMUQJKWIJB-UHFFFAOYSA-N					compound annotation
0391_003963	120615-25-0	C11H12ClN3O2S	1.5364	129236		NCCNS(=O)(=O)c1c2cnccc2c(Cl)cc1	InChI=1S/C11H12ClN3O2S/c12-10-1-2-11(18(16,17)15-6-4-13)9-7-14-5-3-8(9)10/h1-3,5,7,15H,4,6,13H2	OGKYMFFYOWUTKV-UHFFFAOYSA-N					compound annotation
0391_003964	143797-63-1	C15H14N4O	1.8446	126769		Cn1ccc2c1ccc(NC(=O)Nc1cnccc1)c2	InChI=1S/C15H14N4O/c1-19-8-6-11-9-12(4-5-14(11)19)17-15(20)18-13-3-2-7-16-10-13/h2-10H,1H3,(H2,17,18,20)	OJZZJTLBYXHUSJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_003966	143797-63-1	C15H14N4O	2.7657	126769		Cn1ccc2c1ccc(NC(=O)Nc1cnccc1)c2	InChI=1S/C15H14N4O/c1-19-8-6-11-9-12(4-5-14(11)19)17-15(20)18-13-3-2-7-16-10-13/h2-10H,1H3,(H2,17,18,20)	OJZZJTLBYXHUSJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003967	BMS-599626	C27H27FN8O3	2.7657	10437018	CC1=C2C(=NC=NN2C=C1NC(=O)OC[C@@H]3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F	Cc1c2c(Nc3cc4c(cc3)n(Cc3cc(F)ccc3)nc4)ncnn2cc1NC(=O)OCC1COCCN1	InChI=1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1	LUJZZYWHBDHDQX-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_003969	GSK621	C26H20ClN3O5	4.1623	54577153		COc1cccc(-n2c(=O)[nH]c3c(c2=O)n(-c2ccc(-c4c(O)c(OC)ccc4)cc2)c(Cl)c3)c1	InChI=1S/C26H20ClN3O5/c1-34-18-6-3-5-17(13-18)30-25(32)23-20(28-26(30)33)14-22(27)29(23)16-11-9-15(10-12-16)19-7-4-8-21(35-2)24(19)31/h3-14,31H,1-2H3,(H,28,33)	KURYSXLJGKKDHT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003971	303126-97-8	C16H10ClF6NO2	4.2976	2323435		O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccccc1Cl	InChI=1S/C16H10ClF6NO2/c17-12-4-2-1-3-11(12)13(25)24-10-7-5-9(6-8-10)14(26,15(18,19)20)16(21,22)23/h1-8,26H,(H,24,25)	IZVBONMVWLTLNT-UHFFFAOYSA-N					compound annotation
0391_003972	RN-18	C20H16N2O4S	4.7524	1317590		COc1ccccc1NC(=O)c1ccccc1Sc1ccc([N+](=O)[O-])cc1	InChI=1S/C20H16N2O4S/c1-26-18-8-4-3-7-17(18)21-20(23)16-6-2-5-9-19(16)27-15-12-10-14(11-13-15)22(24)25/h2-13H,1H3,(H,21,23)	JKNUDHUHXMELIJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003975	SR9238	C31H33NO7S2	5.4293	71478195		CCOC(=O)c1ccc(CN(Cc2ccc(-c3cc(S(C)(=O)=O)ccc3)cc2)S(=O)(=O)c2c(C)cc(C)cc2C)o1	InChI=1S/C31H33NO7S2/c1-6-38-31(33)29-15-14-27(39-29)20-32(41(36,37)30-22(3)16-21(2)17-23(30)4)19-24-10-12-25(13-11-24)26-8-7-9-28(18-26)40(5,34)35/h7-18H,6,19-20H2,1-5H3	HDZWHJYZJWLTAG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003977	Rilmenidine	C10H16N2O	1.5632	68712		C1COC(NC(C2CC2)C2CC2)=N1	InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12)	CQXADFVORZEARL-UHFFFAOYSA-N					doublet; compound annotation
0391_003978	JAK3-IN-6	C19H18N4O3	2.6636	89629876		C=C(C)C(=O)Nc1cccc(-c2c3c(C(=O)OCC)c[nH]c3ncn2)c1	InChI=1S/C19H18N4O3/c1-4-26-19(25)14-9-20-17-15(14)16(21-10-22-17)12-6-5-7-13(8-12)23-18(24)11(2)3/h5-10H,2,4H2,1,3H3,(H,23,24)(H,20,21,22)	NJPHKVOXHRAPGJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003980	TPCA-1	C12H10FN3O2S	2.8468	9903786		NC(=O)Nc1c(C(N)=O)cc(-c2ccc(F)cc2)s1	InChI=1S/C12H10FN3O2S/c13-7-3-1-6(2-4-7)9-5-8(10(14)17)11(19-9)16-12(15)18/h1-5H,(H2,14,17)(H3,15,16,18)	SAYGKHKXGCPTLX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003982	1936421-41-8	C27H32F2N6O2	3.2887	121373418		CC(=O)N1CCc2c(C1)c(N1CCCc3cc(-c4cn(C)nc4)c(C(F)F)cc31)nn2C1CCOCC1	InChI=1S/C27H32F2N6O2/c1-17(36)33-9-5-24-23(16-33)27(31-35(24)20-6-10-37-11-7-20)34-8-3-4-18-12-21(19-14-30-32(2)15-19)22(26(28)29)13-25(18)34/h12-15,20,26H,3-11,16H2,1-2H3	LWXLECMNBTVASW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003985	Davercin	C38H65NO14	3.292	10033072	CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)C)OC(=O)O2)C	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C2OC(=O)OC12C	InChI=1S/C38H65NO14/c1-14-25-38(10)32(52-35(44)53-38)20(4)27(40)18(2)16-36(8,45)31(51-34-28(41)24(39(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-37(9,46-13)30(42)23(7)48-26/h18-26,28-32,34,41-42,45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30+,31-,32-,34+,36-,37-,38-/m1/s1	NKLGIWNNVDPGCA-ZDYKNUMJSA-N					doublet; compound annotation
0391_003986	Davercin	C38H65NO14	3.7063	10033072	CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)C)OC(=O)O2)C	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C2OC(=O)OC12C	InChI=1S/C38H65NO14/c1-14-25-38(10)32(52-35(44)53-38)20(4)27(40)18(2)16-36(8,45)31(51-34-28(41)24(39(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-37(9,46-13)30(42)23(7)48-26/h18-26,28-32,34,41-42,45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30+,31-,32-,34+,36-,37-,38-/m1/s1	NKLGIWNNVDPGCA-ZDYKNUMJSA-N					doublet; compound annotation
0391_003987	546141-08-6	C20H22N2O3	3.8948	1383884		NC(=O)c1cccc(-c2cc(OC(=O)NC3CCCCC3)ccc2)c1	InChI=1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)	ROFVXGGUISEHAM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003989	Ki16425	C23H23ClN2O5S	4.3295	10367662		Cc1noc(-c2ccc(CSCCC(=O)O)cc2)c1NC(=O)OC(C)c1ccccc1Cl	InChI=1S/C23H23ClN2O5S/c1-14-21(25-23(29)30-15(2)18-5-3-4-6-19(18)24)22(31-26-14)17-9-7-16(8-10-17)13-32-12-11-20(27)28/h3-10,15H,11-13H2,1-2H3,(H,25,29)(H,27,28)	LLIFMNUXGDHTRO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003991	1-(L-phenylalanyl)-3,5-bis(3,4-dichlorobenzylidene)piperidin-4-one	C28H22Cl4N2O2	4.4628	126843230	C\1N(C/C(=C/C2=CC(=C(C=C2)Cl)Cl)/C(=O)/C1=C\C3=CC(=C(C=C3)Cl)Cl)C(=O)[C@@H](N)CC4=CC=CC=C4	NC(Cc1ccccc1)C(=O)N1CC(=Cc2cc(Cl)c(Cl)cc2)C(=O)C(=Cc2cc(Cl)c(Cl)cc2)C1	InChI=1S/C28H22Cl4N2O2/c29-22-8-6-18(12-24(22)31)10-20-15-34(28(36)26(33)14-17-4-2-1-3-5-17)16-21(27(20)35)11-19-7-9-23(30)25(32)13-19/h1-13,26H,14-16,33H2/b20-10-,21-11-/t26-/m0/s1	IYJSFPQYTFFTKN-PIZYVJEOSA-N					doublet; compound annotation
0391_003992	1-(L-phenylalanyl)-3,5-bis(3,4-dichlorobenzylidene)piperidin-4-one	C28H22Cl4N2O2	4.6071	126843230	C\1N(C/C(=C/C2=CC(=C(C=C2)Cl)Cl)/C(=O)/C1=C\C3=CC(=C(C=C3)Cl)Cl)C(=O)[C@@H](N)CC4=CC=CC=C4	NC(Cc1ccccc1)C(=O)N1CC(=Cc2cc(Cl)c(Cl)cc2)C(=O)C(=Cc2cc(Cl)c(Cl)cc2)C1	InChI=1S/C28H22Cl4N2O2/c29-22-8-6-18(12-24(22)31)10-20-15-34(28(36)26(33)14-17-4-2-1-3-5-17)16-21(27(20)35)11-19-7-9-23(30)25(32)13-19/h1-13,26H,14-16,33H2/b20-10-,21-11-/t26-/m0/s1	IYJSFPQYTFFTKN-PIZYVJEOSA-N					doublet; compound annotation
0391_003993	280744-09-4	C19H12Cl2N2O2	4.6898	176158		Cn1cc(C2=C(c3c(Cl)cc(Cl)cc3)C(=O)NC2=O)c2ccccc21	InChI=1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25)	JCSGFHVFHSKIJH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_003995	UNC2541	C24H34FN7O2	1.9011	74538669	C1CCCNC2=NC=C(C(=N2)NCCCC[C@@H](C(=O)NCC1)N)C(=O)NCC3=CC=C(C=C3)F	NC1CCCCNc2nc(ncc2C(=O)NCc2ccc(F)cc2)NCCCCCCNC1=O	InChI=1S/C24H34FN7O2/c25-18-10-8-17(9-11-18)15-30-22(33)19-16-31-24-29-14-5-2-1-4-13-28-23(34)20(26)7-3-6-12-27-21(19)32-24/h8-11,16,20H,1-7,12-15,26H2,(H,28,34)(H,30,33)(H2,27,29,31,32)/t20-/m0/s1	ONIHBIZGUJZDHG-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_003997	167869-21-8	C16H13NO3	2.496	4713		COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	InChI=1S/C16H13NO3/c1-19-14-8-4-6-11(16(14)17)15-9-12(18)10-5-2-3-7-13(10)20-15/h2-9H,17H2,1H3	QFWCYNPOPKQOKV-UHFFFAOYSA-N					doublet; compound annotation
0391_003998	153436-54-5	C16H14BrN3O2	2.6796	4705		COc1c(OC)cc2c(Nc3cc(Br)ccc3)ncnc2c1	InChI=1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)	LSPANGZZENHZNJ-UHFFFAOYSA-N					doublet; compound annotation
0391_003999	SLV-2436	C19H15ClN4O	2.7309	129052025		Nc1n[nH]c2c1ccc(-c1cn(Cc3cc(Cl)ccc3)c(=O)cc1)c2	InChI=1S/C19H15ClN4O/c20-15-3-1-2-12(8-15)10-24-11-14(5-7-18(24)25)13-4-6-16-17(9-13)22-23-19(16)21/h1-9,11H,10H2,(H3,21,22,23)	YQVUADHJKWJHAF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004001	(rel)-AR234960	C27H30FN5O5S	3.1341	146025955	COC1=C(C=CC(=C1)[N+](=O)[O-])S(=O)(=O)N2C[C@H]([C@@H](C2)C3=CC(=CC=C3)F)CN4CCN(CC4)C5=CC=CC=N5	COc1c(S(=O)(=O)N2CC(CN3CCN(c4ccccn4)CC3)C(c3cc(F)ccc3)C2)ccc([N+](=O)[O-])c1	InChI=1S/C27H30FN5O5S/c1-38-25-16-23(33(34)35)8-9-26(25)39(36,37)32-18-21(24(19-32)20-5-4-6-22(28)15-20)17-30-11-13-31(14-12-30)27-7-2-3-10-29-27/h2-10,15-16,21,24H,11-14,17-19H2,1H3/t21-,24+/m1/s1	TUSCHIFEASZBBF-QPPBQGQZSA-N					doublet; compound annotation
0391_004002	(rel)-AR234960	C27H30FN5O5S	3.2274	146025955	COC1=C(C=CC(=C1)[N+](=O)[O-])S(=O)(=O)N2C[C@H]([C@@H](C2)C3=CC(=CC=C3)F)CN4CCN(CC4)C5=CC=CC=N5	COc1c(S(=O)(=O)N2CC(CN3CCN(c4ccccn4)CC3)C(c3cc(F)ccc3)C2)ccc([N+](=O)[O-])c1	InChI=1S/C27H30FN5O5S/c1-38-25-16-23(33(34)35)8-9-26(25)39(36,37)32-18-21(24(19-32)20-5-4-6-22(28)15-20)17-30-11-13-31(14-12-30)27-7-2-3-10-29-27/h2-10,15-16,21,24H,11-14,17-19H2,1H3/t21-,24+/m1/s1	TUSCHIFEASZBBF-QPPBQGQZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004004	167869-21-8	C16H13NO3	3.5055	4713		COc1cccc(-c2cc(=O)c3ccccc3o2)c1N	InChI=1S/C16H13NO3/c1-19-14-8-4-6-11(16(14)17)15-9-12(18)10-5-2-3-7-13(10)20-15/h2-9H,17H2,1H3	QFWCYNPOPKQOKV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004007	39122-38-8	C11H9N3S	4.0762	750538		SC(=Nc1ccccn1)c1ccccn1	InChI=1S/C11H9N3S/c15-11(9-5-1-3-7-12-9)14-10-6-2-4-8-13-10/h1-8H,(H,13,14,15)	UGWOJXZJIZUKDP-UHFFFAOYSA-N					compound annotation
0391_004008	Benzobicyclon	C22H19ClO4S2	4.4679	11236201		CS(=O)(=O)c1cc(Cl)c(C(=O)C2=C(Sc3ccccc3)C3CCC(C3)C2=O)cc1	InChI=1S/C22H19ClO4S2/c1-29(26,27)16-9-10-17(18(23)12-16)21(25)19-20(24)13-7-8-14(11-13)22(19)28-15-5-3-2-4-6-15/h2-6,9-10,12-14H,7-8,11H2,1H3	VIXCLRUCUMWJFF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004010	Sepantronium	C20H19N4O3+	2.0068	10126189		COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2nccnc2)c1C	InChI=1S/C20H19N4O3/c1-13-23(9-10-27-2)17-18(24(13)12-14-11-21-7-8-22-14)20(26)16-6-4-3-5-15(16)19(17)25/h3-8,11H,9-10,12H2,1-2H3/q+1	OTSOOHRUMBRSHZ-UHFFFAOYSA-N					compound annotation
0391_004011	GLPG0187	C29H37N7O5S	2.0236	53340771	CC1=C(N=C(N=C1N2CCC(CC2)C3=NC4=C(CCCN4)C=C3)C)NC[C@@H](C(=O)O)NS(=O)(=O)C5=CC=C(C=C5)OC	COc1ccc(S(=O)(=O)NC(CNc2c(C)c(N3CCC(c4nc5c(cc4)CCCN5)CC3)nc(C)n2)C(=O)O)cc1	InChI=1S/C29H37N7O5S/c1-18-26(31-17-25(29(37)38)35-42(39,40)23-9-7-22(41-3)8-10-23)32-19(2)33-28(18)36-15-12-20(13-16-36)24-11-6-21-5-4-14-30-27(21)34-24/h6-11,20,25,35H,4-5,12-17H2,1-3H3,(H,30,34)(H,37,38)(H,31,32,33)/t25-/m0/s1	CXHCNOMGODVIKB-VWLOTQADSA-N					compound annotation
0391_004012	GNE-477	C21H28N8O3S2	2.1804	25207689		Cc1c(CN2CCN(S(C)(=O)=O)CC2)sc2c1nc(-c1cnc(N)nc1)nc2N1CCOCC1	InChI=1S/C21H28N8O3S2/c1-14-16(13-27-3-5-29(6-4-27)34(2,30)31)33-18-17(14)25-19(15-11-23-21(22)24-12-15)26-20(18)28-7-9-32-10-8-28/h11-12H,3-10,13H2,1-2H3,(H2,22,23,24)	AKKCGLXULFRAET-UHFFFAOYSA-N					compound annotation
0391_004013	136831-48-6	C16H14N2O2	2.8206	5353927	COC1=C(C=C(C=C1)/C=C(/C#N)\C2=CN=CC=C2)OC	COc1c(OC)cc(C=C(C#N)c2cnccc2)cc1	InChI=1S/C16H14N2O2/c1-19-15-6-5-12(9-16(15)20-2)8-14(10-17)13-4-3-7-18-11-13/h3-9,11H,1-2H3/b14-8-	DBGZNJVTHYFQJI-ZSOIEALJSA-N					doublet; removed another duplicate entry; compound annotation
0391_004015	CeMMEC13	C19H16N2O4	3.0671	110694558		Cn1c(=O)cc(C(=O)Nc2cc3c(cc2)OCCO3)c2ccccc21	InChI=1S/C19H16N2O4/c1-21-15-5-3-2-4-13(15)14(11-18(21)22)19(23)20-12-6-7-16-17(10-12)25-9-8-24-16/h2-7,10-11H,8-9H2,1H3,(H,20,23)	NXKBPGZQDHACPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004017	I-BET762 carboxylic acid	C20H17ClN4O3	3.2963	67173666	CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=N[C@H]2CC(=O)O)C4=CC=C(C=C4)Cl	COc1cc2c(cc1)-n1c(C)nnc1C(CC(=O)O)N=C2c1ccc(Cl)cc1	InChI=1S/C20H17ClN4O3/c1-11-23-24-20-16(10-18(26)27)22-19(12-3-5-13(21)6-4-12)15-9-14(28-2)7-8-17(15)25(11)20/h3-9,16H,10H2,1-2H3,(H,26,27)/t16-/m0/s1	VEIZLTSJCDOIBH-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_004019	136831-48-6	C16H14N2O2	3.3144	5353927	COC1=C(C=C(C=C1)/C=C(/C#N)\C2=CN=CC=C2)OC	COc1c(OC)cc(C=C(C#N)c2cnccc2)cc1	InChI=1S/C16H14N2O2/c1-19-15-6-5-12(9-16(15)20-2)8-14(10-17)13-4-3-7-18-11-13/h3-9,11H,1-2H3/b14-8-	DBGZNJVTHYFQJI-ZSOIEALJSA-N					doublet; compound annotation
0391_004020	OF-1	C17H18BrN3O4S	3.6031	35397514		COc1cc2c(cc1NS(=O)(=O)c1c(C)cc(Br)cc1)n(C)c(=O)n2C	InChI=1S/C17H18BrN3O4S/c1-10-7-11(18)5-6-16(10)26(23,24)19-12-8-13-14(9-15(12)25-4)21(3)17(22)20(13)2/h5-9,19H,1-4H3	YUNQZQREIHWDQT-UHFFFAOYSA-N					doublet; compound annotation
0391_004021	Bimosiamose	C46H54O16	3.7262	9811353	C1=CC(=CC(=C1)C2=C(C=CC(=C2)CCCCCCC3=CC(=C(C=C3)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C5=CC=CC(=C5)CC(=O)O)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)CC(=O)O	O=C(O)Cc1cc(-c2cc(CCCCCCc3ccc(OC4OC(CO)C(O)C(O)C4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2OC2OC(CO)C(O)C(O)C2O)ccc1	InChI=1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1	RYWCQJDEHXJHRI-XJMXIVSISA-N					doublet; compound annotation
0391_004022	Bimosiamose	C46H54O16	3.7291	9811353	C1=CC(=CC(=C1)C2=C(C=CC(=C2)CCCCCCC3=CC(=C(C=C3)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C5=CC=CC(=C5)CC(=O)O)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)CC(=O)O	O=C(O)Cc1cc(-c2cc(CCCCCCc3ccc(OC4OC(CO)C(O)C(O)C4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2OC2OC(CO)C(O)C(O)C2O)ccc1	InChI=1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1	RYWCQJDEHXJHRI-XJMXIVSISA-N					doublet; compound annotation
0391_004023	OF-1	C17H18BrN3O4S	3.7322	35397514		COc1cc2c(cc1NS(=O)(=O)c1c(C)cc(Br)cc1)n(C)c(=O)n2C	InChI=1S/C17H18BrN3O4S/c1-10-7-11(18)5-6-16(10)26(23,24)19-12-8-13-14(9-15(12)25-4)21(3)17(22)20(13)2/h5-9,19H,1-4H3	YUNQZQREIHWDQT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004025	GSK8573	C20H21NO3	5.304	121230107		CCCOc1cc2c(-c3cc(OC)ccc3)cc(C(C)=O)n2cc1	InChI=1S/C20H21NO3/c1-4-10-24-17-8-9-21-19(14(2)22)13-18(20(21)12-17)15-6-5-7-16(11-15)23-3/h5-9,11-13H,4,10H2,1-3H3	QQBGNWWJANJWNY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004027	1599477-75-4	C19H23ClF3NO3	5.7916	73777063		O=C(O)CC1CCC2(CC1)CCN(c1c(Cl)ccc(OC(F)(F)F)c1)CC2	InChI=1S/C19H23ClF3NO3/c20-15-2-1-14(27-19(21,22)23)12-16(15)24-9-7-18(8-10-24)5-3-13(4-6-18)11-17(25)26/h1-2,12-13H,3-11H2,(H,25,26)	WUJVPELCYCESAP-UHFFFAOYSA-N					compound annotation
0391_004028	Pinoresinol diglucoside	C32H42O16	1.6037	174003	COC1=C(C=CC(=C1)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)ccc(C2OCC3C(c4cc(OC)c(OC5OC(CO)C(O)C(O)C5O)cc4)OCC23)c1	InChI=1S/C32H42O16/c1-41-19-7-13(3-5-17(19)45-31-27(39)25(37)23(35)21(9-33)47-31)29-15-11-44-30(16(15)12-43-29)14-4-6-18(20(8-14)42-2)46-32-28(40)26(38)24(36)22(10-34)48-32/h3-8,15-16,21-40H,9-12H2,1-2H3/t15-,16-,21+,22+,23+,24+,25-,26-,27+,28+,29+,30+,31+,32+/m0/s1	ZJSJQWDXAYNLNS-FUPWJLLWSA-N					compound annotation
0391_004029	OTX008	C52H72N8O8	1.9637	11953346		CN(C)CCNC(=O)COc1c2cccc1Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1cccc(c1OCC(=O)NCCN(C)C)Cc1c(OCC(=O)NCCN(C)C)c(ccc1)C2	InChI=1S/C52H72N8O8/c1-57(2)25-21-53-45(61)33-65-49-37-13-9-14-38(49)30-40-16-11-18-42(51(40)67-35-47(63)55-23-27-59(5)6)32-44-20-12-19-43(52(44)68-36-48(64)56-24-28-60(7)8)31-41-17-10-15-39(29-37)50(41)66-34-46(62)54-22-26-58(3)4/h9-20H,21-36H2,1-8H3,(H,53,61)(H,54,62)(H,55,63)(H,56,64)	CQVAQQNDZCZBSU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004031	Homoplantaginin	C22H22O11	2.1846	5318083	COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=C(C=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O	InChI=1S/C22H22O11/c1-30-21-14(32-22-20(29)19(28)17(26)15(8-23)33-22)7-13-16(18(21)27)11(25)6-12(31-13)9-2-4-10(24)5-3-9/h2-7,15,17,19-20,22-24,26-29H,8H2,1H3/t15-,17-,19+,20-,22-/m1/s1	GCLAFEGUXXHIFT-IWLDQSELSA-N					removed another duplicate entry; compound annotation
0391_004033	Beclamide	C10H12ClNO	2.4947	10391		O=C(CCCl)NCc1ccccc1	InChI=1S/C10H12ClNO/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H,12,13)	JPYQFYIEOUVJDU-UHFFFAOYSA-N					compound annotation
0391_004034	STO-609	C19H10N2O3	3.8133	3467590		O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21	InChI=1S/C19H10N2O3/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18/h1-9H,(H,23,24)	MYKOWOGZBMOVBJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004035	STO-609	C19H10N2O3	3.9127	3467590		O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21	InChI=1S/C19H10N2O3/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18/h1-9H,(H,23,24)	MYKOWOGZBMOVBJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004036	Haloxon	C14H14Cl3O6P	4.0311	9454		Cc1c(Cl)c(=O)oc2c1ccc(OP(=O)(OCCCl)OCCCl)c2	InChI=1S/C14H14Cl3O6P/c1-9-11-3-2-10(8-12(11)22-14(18)13(9)17)23-24(19,20-6-4-15)21-7-5-16/h2-3,8H,4-7H2,1H3	KULDXINYXFTXMO-UHFFFAOYSA-N					doublet; compound annotation
0391_004037	Haloxon	C14H14Cl3O6P	4.0346	9454		Cc1c(Cl)c(=O)oc2c1ccc(OP(=O)(OCCCl)OCCCl)c2	InChI=1S/C14H14Cl3O6P/c1-9-11-3-2-10(8-12(11)22-14(18)13(9)17)23-24(19,20-6-4-15)21-7-5-16/h2-3,8H,4-7H2,1H3	KULDXINYXFTXMO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004039	Coumarin 6	C20H18N2O2S	5.5001	100334		CCN(CC)c1cc2c(cc1)cc(-c1nc3ccccc3s1)c(=O)o2	InChI=1S/C20H18N2O2S/c1-3-22(4-2)14-10-9-13-11-15(20(23)24-17(13)12-14)19-21-16-7-5-6-8-18(16)25-19/h5-12H,3-4H2,1-2H3	VBVAVBCYMYWNOU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004042	Lucitanib	C26H25N3O4	1.6269	25031915		CNC(=O)c1cccc2c1ccc(Oc1ccnc3cc(OCC4(N)CC4)c(OC)cc13)c2	InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)	CUDVHEFYRIWYQD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004044	CP-409092	C17H19N3O2	1.7276	9839190		CNCc1ccc(NC(=O)c2c[nH]c3c2C(=O)CCC3)cc1	InChI=1S/C17H19N3O2/c1-18-9-11-5-7-12(8-6-11)20-17(22)13-10-19-14-3-2-4-15(21)16(13)14/h5-8,10,18-19H,2-4,9H2,1H3,(H,20,22)	XFJIYNUISLDNLP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004046	TRELAGLIPTIN	C18H20FN5O2	1.7635	15983988	CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCC[C@H](C3)N	Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2c(C#N)ccc(F)c2)c1=O	InChI=1S/C18H20FN5O2/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3/t15-/m1/s1	IWYJYHUNXVAVAA-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_004048	Lucitanib	C26H25N3O4	1.7635	25031915		CNC(=O)c1cccc2c1ccc(Oc1ccnc3cc(OCC4(N)CC4)c(OC)cc13)c2	InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)	CUDVHEFYRIWYQD-UHFFFAOYSA-N					doublet; compound annotation
0391_004049	Ro 25-6981	C22H29NO2	2.4689	6604887	C[C@@H](CN1CCC(CC1)CC2=CC=CC=C2)[C@H](C3=CC=C(C=C3)O)O	CC(CN1CCC(Cc2ccccc2)CC1)C(O)c1ccc(O)cc1	InChI=1S/C22H29NO2/c1-17(22(25)20-7-9-21(24)10-8-20)16-23-13-11-19(12-14-23)15-18-5-3-2-4-6-18/h2-10,17,19,22,24-25H,11-16H2,1H3/t17-,22+/m0/s1	WVZSEUPGUDIELE-HTAPYJJXSA-N					doublet; compound annotation
0391_004050	Ro 25-6981	C22H29NO2	2.5281	6604887	C[C@@H](CN1CCC(CC1)CC2=CC=CC=C2)[C@H](C3=CC=C(C=C3)O)O	CC(CN1CCC(Cc2ccccc2)CC1)C(O)c1ccc(O)cc1	InChI=1S/C22H29NO2/c1-17(22(25)20-7-9-21(24)10-8-20)16-23-13-11-19(12-14-23)15-18-5-3-2-4-6-18/h2-10,17,19,22,24-25H,11-16H2,1H3/t17-,22+/m0/s1	WVZSEUPGUDIELE-HTAPYJJXSA-N					doublet; compound annotation
0391_004051	Ro 25-6981	C22H29NO2	2.7247	6604887	C[C@@H](CN1CCC(CC1)CC2=CC=CC=C2)[C@H](C3=CC=C(C=C3)O)O	CC(CN1CCC(Cc2ccccc2)CC1)C(O)c1ccc(O)cc1	InChI=1S/C22H29NO2/c1-17(22(25)20-7-9-21(24)10-8-20)16-23-13-11-19(12-14-23)15-18-5-3-2-4-6-18/h2-10,17,19,22,24-25H,11-16H2,1H3/t17-,22+/m0/s1	WVZSEUPGUDIELE-HTAPYJJXSA-N					doublet; compound annotation
0391_004052	Aliskiren	C30H53N3O6	3.0449	5493444	CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N	COCCCOc1c(OC)ccc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)c1	InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1	UXOWGYHJODZGMF-QORCZRPOSA-N					doublet; removed another duplicate entry; compound annotation
0391_004054	PF-543	C27H31NO4S	3.0856	66577038	CC1=CC(=CC(=C1)OCC2=CC=C(C=C2)CN3CCC[C@@H]3CO)CS(=O)(=O)C4=CC=CC=C4	Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCCC3CO)cc2)c1	InChI=1S/C27H31NO4S/c1-21-14-24(20-33(30,31)27-7-3-2-4-8-27)16-26(15-21)32-19-23-11-9-22(10-12-23)17-28-13-5-6-25(28)18-29/h2-4,7-12,14-16,25,29H,5-6,13,17-20H2,1H3/t25-/m1/s1	NPUXORBZRBIOMQ-RUZDIDTESA-N					removed another duplicate entry; compound annotation
0391_004056	GDC-0834	C33H36N6O3S	3.3214	25234918	CC1=C(C=CC=C1NC(=O)C2=CC3=C(S2)CCCC3)C4=CN(C(=O)C(=N4)NC5=CC=C(C=C5)[C@@H]6C(=O)N(CCN6C)C)C	Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)cccc1NC(=O)c1cc2c(CCCC2)s1	InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7,9-10,12-15,18-19,29H,5-6,8,11,16-17H2,1-4H3,(H,34,35)(H,36,40)/t29-/m1/s1	CDOOFZZILLRUQH-GDLZYMKVSA-N					removed another duplicate entry; compound annotation
0391_004057	1133432-50-4	C33H36N6O3S	3.3214	25234917	CC1=C(C=CC=C1NC(=O)C2=CC3=C(S2)CCCC3)C4=CN(C(=O)C(=N4)NC5=CC=C(C=C5)[C@H]6C(=O)N(CCN6C)C)C	Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)cccc1NC(=O)c1cc2c(CCCC2)s1	InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7,9-10,12-15,18-19,29H,5-6,8,11,16-17H2,1-4H3,(H,34,35)(H,36,40)/t29-/m0/s1	CDOOFZZILLRUQH-LJAQVGFWSA-N					removed another duplicate entry; compound annotation
0391_004060	AZD2906	C26H25FN4O3	4.3827	25013811	C[C@@H]([C@@H](C1=CN=C(C=C1)OC)OC2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)NC(=O)C5CC5	COc1ncc(C(Oc2cc3c(cc2)n(-c2ccc(F)cc2)nc3)C(C)NC(=O)C2CC2)cc1	InChI=1S/C26H25FN4O3/c1-16(30-26(32)17-3-4-17)25(18-5-12-24(33-2)28-14-18)34-22-10-11-23-19(13-22)15-29-31(23)21-8-6-20(27)7-9-21/h5-17,25H,3-4H2,1-2H3,(H,30,32)/t16-,25-/m0/s1	YDRQCGICZKAGCQ-LMKMVOKYSA-N					removed another duplicate entry; compound annotation
0391_004064	BAY-293	C25H28N4O2S	2.1363	137322663	CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC	CNCc1ccccc1-c1csc(C(C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1	InChI=1S/C25H28N4O2S/c1-15(24-10-18(14-32-24)19-9-7-6-8-17(19)13-26-3)27-25-20-11-22(30-4)23(31-5)12-21(20)28-16(2)29-25/h6-12,14-15,26H,13H2,1-5H3,(H,27,28,29)/t15-/m1/s1	WEGLOYDTDILXDA-OAHLLOKOSA-N					compound annotation
0391_004065	GDC-0834 Racemate	C33H36N6O3S	3.3214	25235170		Cc1c(-c2cn(C)c(=O)c(Nc3ccc(C4C(=O)N(C)CCN4C)cc3)n2)cccc1NC(=O)c1cc2c(CCCC2)s1	InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7,9-10,12-15,18-19,29H,5-6,8,11,16-17H2,1-4H3,(H,34,35)(H,36,40)	CDOOFZZILLRUQH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004067	SRT3109	C18H23F2N5O4S2	3.4426	44602493	C[C@H]([C@H](CO)O)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)F)F)NS(=O)(=O)N3CCC3	CC(Nc1cc(NS(=O)(=O)N2CCC2)nc(SCc2c(F)c(F)ccc2)n1)C(O)CO	InChI=1S/C18H23F2N5O4S2/c1-11(14(27)9-26)21-15-8-16(24-31(28,29)25-6-3-7-25)23-18(22-15)30-10-12-4-2-5-13(19)17(12)20/h2,4-5,8,11,14,26-27H,3,6-7,9-10H2,1H3,(H2,21,22,23,24)/t11-,14+/m1/s1	QVKPEMXUBULFBM-RISCZKNCSA-N					removed another duplicate entry; compound annotation
0391_004069	448906-42-1	C14H10N2O3S	3.6336	4668801		COC(=O)c1csc(C(=O)c2c[nH]c3ccccc23)n1	InChI=1S/C14H10N2O3S/c1-19-14(18)11-7-20-13(16-11)12(17)9-6-15-10-5-3-2-4-8(9)10/h2-7,15H,1H3	KDDXOGDIPZSCTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004071	kn-93	C26H29ClN2O4S	3.7617	5312122	CN(C/C=C/C1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCO)S(=O)(=O)C3=CC=C(C=C3)OC	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)CC=Cc2ccc(Cl)cc2)cc1	InChI=1S/C26H29ClN2O4S/c1-28(17-5-6-21-9-11-23(27)12-10-21)20-22-7-3-4-8-26(22)29(18-19-30)34(31,32)25-15-13-24(33-2)14-16-25/h3-16,30H,17-20H2,1-2H3/b6-5+	LLLQTDSSHZREGW-AATRIKPKSA-N					doublet; compound annotation
0391_004072	Kaempferide	C16H12O6	3.8057	5281666		COc1ccc(-c2c(O)c(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C16H12O6/c1-21-10-4-2-8(3-5-10)16-15(20)14(19)13-11(18)6-9(17)7-12(13)22-16/h2-7,17-18,20H,1H3	SQFSKOYWJBQGKQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004074	1187187-10-5	C17H18BNO5	4.3395	46884349		CCCCOC(=O)c1cnc(Oc2cc3c(cc2)B(O)OC3)cc1	InChI=1S/C17H18BNO5/c1-2-3-8-22-17(20)12-4-7-16(19-10-12)24-14-5-6-15-13(9-14)11-23-18(15)21/h4-7,9-10,21H,2-3,8,11H2,1H3	BJXLLSAUQIAPDB-UHFFFAOYSA-N					compound annotation
0391_004075	LY2922470	C28H29NO4S	4.4547	71257551	CC#C[C@@H](CC(=O)O)C1=CC=C(C=C1)OCC2=CC=C(S2)CN3CCCC4=C3C(=CC=C4)OC	CC#CC(CC(=O)O)c1ccc(OCc2ccc(CN3CCCc4c3c(OC)ccc4)s2)cc1	InChI=1S/C28H29NO4S/c1-3-6-22(17-27(30)31)20-10-12-23(13-11-20)33-19-25-15-14-24(34-25)18-29-16-5-8-21-7-4-9-26(32-2)28(21)29/h4,7,9-15,22H,5,8,16-19H2,1-2H3,(H,30,31)/t22-/m0/s1	VJVDLRVFJTVWEO-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004077	LY2922470	C28H29NO4S	4.9726	71257551	CC#C[C@@H](CC(=O)O)C1=CC=C(C=C1)OCC2=CC=C(S2)CN3CCCC4=C3C(=CC=C4)OC	CC#CC(CC(=O)O)c1ccc(OCc2ccc(CN3CCCc4c3c(OC)ccc4)s2)cc1	InChI=1S/C28H29NO4S/c1-3-6-22(17-27(30)31)20-10-12-23(13-11-20)33-19-25-15-14-24(34-25)18-29-16-5-8-21-7-4-9-26(32-2)28(21)29/h4,7,9-15,22H,5,8,16-19H2,1-2H3,(H,30,31)/t22-/m0/s1	VJVDLRVFJTVWEO-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004080	LY2922470	C28H29NO4S	5.1681	71257551	CC#C[C@@H](CC(=O)O)C1=CC=C(C=C1)OCC2=CC=C(S2)CN3CCCC4=C3C(=CC=C4)OC	CC#CC(CC(=O)O)c1ccc(OCc2ccc(CN3CCCc4c3c(OC)ccc4)s2)cc1	InChI=1S/C28H29NO4S/c1-3-6-22(17-27(30)31)20-10-12-23(13-11-20)33-19-25-15-14-24(34-25)18-29-16-5-8-21-7-4-9-26(32-2)28(21)29/h4,7,9-15,22H,5,8,16-19H2,1-2H3,(H,30,31)/t22-/m0/s1	VJVDLRVFJTVWEO-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004082	RAD51 inhibitor B02	C22H17N3O	2.6927	5738263	C1=CC=C(C=C1)CN2C(=NC3=CC=CC=C3C2=O)/C=C/C4=CN=CC=C4	O=c1c2ccccc2nc(C=Cc2cnccc2)n1Cc1ccccc1	InChI=1S/C22H17N3O/c26-22-19-10-4-5-11-20(19)24-21(13-12-17-9-6-14-23-15-17)25(22)16-18-7-2-1-3-8-18/h1-15H,16H2/b13-12+	GEKDQXSPTHHANP-OUKQBFOZSA-N					doublet; compound annotation
0391_004083	1A-116	C16H16F3N3	2.8801	71543346		Cc1cc(C)cc(NC(N)=Nc2ccccc2C(F)(F)F)c1	InChI=1S/C16H16F3N3/c1-10-7-11(2)9-12(8-10)21-15(20)22-14-6-4-3-5-13(14)16(17,18)19/h3-9H,1-2H3,(H3,20,21,22)	DVIJFJSZZNOTLP-UHFFFAOYSA-N					compound annotation
0391_004084	Epertinib	C30H27ClFN5O3	3.2216	46701811	CC#C/C(=N\OC[C@H]1COCCN1)/C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	CC#CC(=NOCC1COCCN1)c1cc2c(cc1)ncnc2Nc1cc(Cl)c(OCc2cc(F)ccc2)cc1	InChI=1S/C30H27ClFN5O3/c1-2-4-27(37-40-18-24-17-38-12-11-33-24)21-7-9-28-25(14-21)30(35-19-34-28)36-23-8-10-29(26(31)15-23)39-16-20-5-3-6-22(32)13-20/h3,5-10,13-15,19,24,33H,11-12,16-18H2,1H3,(H,34,35,36)/b37-27+/t24-/m1/s1	IBCIAMOTBDGBJN-NRLRZRKLSA-N					doublet; compound annotation
0391_004085	Epertinib	C30H27ClFN5O3	3.293	46701811	CC#C/C(=N\OC[C@H]1COCCN1)/C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl	CC#CC(=NOCC1COCCN1)c1cc2c(cc1)ncnc2Nc1cc(Cl)c(OCc2cc(F)ccc2)cc1	InChI=1S/C30H27ClFN5O3/c1-2-4-27(37-40-18-24-17-38-12-11-33-24)21-7-9-28-25(14-21)30(35-19-34-28)36-23-8-10-29(26(31)15-23)39-16-20-5-3-6-22(32)13-20/h3,5-10,13-15,19,24,33H,11-12,16-18H2,1H3,(H,34,35,36)/b37-27+/t24-/m1/s1	IBCIAMOTBDGBJN-NRLRZRKLSA-N					doublet; compound annotation
0391_004086	RAD51 inhibitor B02	C22H17N3O	3.3479	5738263	C1=CC=C(C=C1)CN2C(=NC3=CC=CC=C3C2=O)/C=C/C4=CN=CC=C4	O=c1c2ccccc2nc(C=Cc2cnccc2)n1Cc1ccccc1	InChI=1S/C22H17N3O/c26-22-19-10-4-5-11-20(19)24-21(13-12-17-9-6-14-23-15-17)25(22)16-18-7-2-1-3-8-18/h1-15H,16H2/b13-12+	GEKDQXSPTHHANP-OUKQBFOZSA-N					doublet; compound annotation
0391_004087	proadifen	C23H31NO2	3.7318	4910		CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1	InChI=1S/C23H31NO2/c1-4-17-23(20-13-9-7-10-14-20,21-15-11-8-12-16-21)22(25)26-19-18-24(5-2)6-3/h7-16H,4-6,17-19H2,1-3H3	SNTQPLDRUZOSDP-UHFFFAOYSA-N					compound annotation
0391_004088	218457-67-1	C15H18N2O	3.9352	2735289		CC(C)(C)c1ccc(Oc2ncc(N)cc2)cc1	InChI=1S/C15H18N2O/c1-15(2,3)11-4-7-13(8-5-11)18-14-9-6-12(16)10-17-14/h4-10H,16H2,1-3H3	WHIWGRCYMQLLAO-UHFFFAOYSA-N					compound annotation
0391_004089	107257-28-3	C21H20FN3O3	4.475	122277		CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2c(F)ccc([N+](=O)[O-])c2)n1	InChI=1S/C21H20FN3O3/c1-4-13(2)24(3)21(26)19-11-14-7-5-6-8-16(14)20(23-19)17-12-15(25(27)28)9-10-18(17)22/h5-13H,4H2,1-3H3	GXXKDYZSBGOJQN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004091	HOE-S 785026	C25H24N6O	1.4746	10410101		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2cc(O)ccc2)[nH]4)[nH]3)CC1	InChI=1S/C25H24N6O/c1-30-9-11-31(12-10-30)18-6-8-21-23(15-18)29-25(27-21)17-5-7-20-22(14-17)28-24(26-20)16-3-2-4-19(32)13-16/h2-8,13-15,32H,9-12H2,1H3,(H,26,28)(H,27,29)	WOFDIDGQAOQHGY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004093	501364-82-5	C23H25N3O4S	2.23	9889396		O=c1[nH]c2c(Cc3c-2ccc(S(=O)(=O)NCCCN2CCOCC2)c3)c2ccccc12	InChI=1S/C23H25N3O4S/c27-23-20-5-2-1-4-19(20)21-15-16-14-17(6-7-18(16)22(21)25-23)31(28,29)24-8-3-9-26-10-12-30-13-11-26/h1-2,4-7,14,24H,3,8-13,15H2,(H,25,27)	LTZVLHHIAUKGBP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004095	SD-208	C17H10ClFN6	2.3433	10316032		Fc1c(-c2nc3nccnc3c(Nc3ccncc3)n2)cc(Cl)cc1	InChI=1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9H,(H,20,22,23,24,25)	BERLXWPRSBJFHO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004097	AZ505	C29H38Cl2N4O4	2.4272	24961094		O=C1COc2c(CCNCCN(C(=O)CCNCCc3cc(Cl)c(Cl)cc3)C3CCCCC3)ccc(O)c2N1	InChI=1S/C29H38Cl2N4O4/c30-23-8-6-20(18-24(23)31)10-13-32-15-12-27(38)35(22-4-2-1-3-5-22)17-16-33-14-11-21-7-9-25(36)28-29(21)39-19-26(37)34-28/h6-9,18,22,32-33,36H,1-5,10-17,19H2,(H,34,37)	LIBVHXXKHSODII-UHFFFAOYSA-N					doublet; compound annotation
0391_004098	AZ505	C29H38Cl2N4O4	2.43	24961094		O=C1COc2c(CCNCCN(C(=O)CCNCCc3cc(Cl)c(Cl)cc3)C3CCCCC3)ccc(O)c2N1	InChI=1S/C29H38Cl2N4O4/c30-23-8-6-20(18-24(23)31)10-13-32-15-12-27(38)35(22-4-2-1-3-5-22)17-16-33-14-11-21-7-9-25(36)28-29(21)39-19-26(37)34-28/h6-9,18,22,32-33,36H,1-5,10-17,19H2,(H,34,37)	LIBVHXXKHSODII-UHFFFAOYSA-N					doublet; compound annotation
0391_004099	SB1317	C23H24N4O	2.7284	16739650	CN1C/C=C/CCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1	CN1CC=CCCOc2cccc(c2)-c2nc(ncc2)Nc2cccc(c2)C1	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	VXBAJLGYBMTJCY-NSCUHMNNSA-N					doublet; compound annotation
0391_004100	SB1317	C23H24N4O	2.8612	16739650	CN1C/C=C/CCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1	CN1CC=CCCOc2cccc(c2)-c2nc(ncc2)Nc2cccc(c2)C1	InChI=1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+	VXBAJLGYBMTJCY-NSCUHMNNSA-N					doublet; compound annotation
0391_004101	Taselisib	C24H28N8O2	2.9583	51001932		Cc1nn(C(C)C)c(-c2cn3CCOc4c(ccc(-c5cn(C(C)(C)C(N)=O)nc5)c4)-c3n2)n1	InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)	BEUQXVWXFDOSAQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004103	221243-82-9	C19H19N5	3.7577	4877		CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21	InChI=1S/C19H19N5/c1-19(2,3)24-18-15(17(20)21-11-22-18)16(23-24)14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H2,20,21,22)	XSHQBIXMLULFEV-UHFFFAOYSA-N					doublet; compound annotation
0391_004104	221244-14-0	C20H21N5	3.9291	5154691		CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21	InChI=1S/C20H21N5/c1-20(2,3)25-19-17(18(21)22-12-23-19)16(24-25)11-14-9-6-8-13-7-4-5-10-15(13)14/h4-10,12H,11H2,1-3H3,(H2,21,22,23)	GDQXJQSQYMMKRA-UHFFFAOYSA-N					doublet; compound annotation
0391_004105	221244-14-0	C20H21N5	4.2343	5154691		CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21	InChI=1S/C20H21N5/c1-20(2,3)25-19-17(18(21)22-12-23-19)16(24-25)11-14-9-6-8-13-7-4-5-10-15(13)14/h4-10,12H,11H2,1-3H3,(H2,21,22,23)	GDQXJQSQYMMKRA-UHFFFAOYSA-N					doublet; compound annotation
0391_004106	Nsc 23766	C24H35N7	0.9657	409805		CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2cc3c(N)cc(C)nc3cc2)n1	InChI=1S/C24H35N7/c1-6-31(7-2)12-8-9-16(3)27-24-28-18(5)14-23(30-24)29-19-10-11-22-20(15-19)21(25)13-17(4)26-22/h10-11,13-16H,6-9,12H2,1-5H3,(H2,25,26)(H2,27,28,29,30)	DEFBCZWQLILOJF-UHFFFAOYSA-N					compound annotation
0391_004107	TBPB	C25H32N4O	1.3102	10092649		Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1	InChI=1S/C25H32N4O/c1-19-6-2-3-7-20(19)18-27-14-10-21(11-15-27)28-16-12-22(13-17-28)29-24-9-5-4-8-23(24)26-25(29)30/h2-9,21-22H,10-18H2,1H3,(H,26,30)	CWPKTBMRVATCBL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004109	Ralimetinib	C24H29FN6	2.3444	11539025		CC(C)(C)Cn1c(N)nc2c1nc(-c1c(-c3ccc(F)cc3)nc(C(C)(C)C)[nH]1)cc2	InChI=1S/C24H29FN6/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30)	XPPBBJCBDOEXDN-UHFFFAOYSA-N					compound annotation
0391_004110	Talampanel	C19H19N3O3	2.5889	164509	C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3	CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2CC1C)OCO3	InChI=1S/C19H19N3O3/c1-11-7-14-8-17-18(25-10-24-17)9-16(14)19(21-22(11)12(2)23)13-3-5-15(20)6-4-13/h3-6,8-9,11H,7,10,20H2,1-2H3/t11-/m1/s1	JACAAXNEHGBPOQ-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_004113	Inolitazone	C27H26N4O4S	3.0012	9832447		Cc1cc(Oc2cc3c(cc2)nc(COc2ccc(CC4SC(=O)NC4=O)cc2)n3C)cc(C)c1N	InChI=1S/C27H26N4O4S/c1-15-10-20(11-16(2)25(15)28)35-19-8-9-21-22(13-19)31(3)24(29-21)14-34-18-6-4-17(5-7-18)12-23-26(32)30-27(33)36-23/h4-11,13,23H,12,14,28H2,1-3H3,(H,30,32,33)	JCYNMRJCUYVDBC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004116	99420-15-2	C13H8N2OS	3.0709	9837640		O=c1nc(-c2ccccn2)sc2ccccc12	InChI=1S/C13H8N2OS/c16-12-9-5-1-2-7-11(9)17-13(15-12)10-6-3-4-8-14-10/h1-8H	GBAKVEWPYUIGHN-UHFFFAOYSA-N					doublet; compound annotation
0391_004117	99420-15-2	C13H8N2OS	3.2616	9837640		O=c1nc(-c2ccccn2)sc2ccccc12	InChI=1S/C13H8N2OS/c16-12-9-5-1-2-7-11(9)17-13(15-12)10-6-3-4-8-14-10/h1-8H	GBAKVEWPYUIGHN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004119	AVATROMBOPAG	C29H34Cl2N6O3S2	3.7805	9852519		O=C(Nc1nc(-c2cc(Cl)cs2)c(N2CCN(C3CCCCC3)CC2)s1)c1cc(Cl)c(N2CCC(C(=O)O)CC2)nc1	InChI=1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38)	OFZJKCQENFPZBH-UHFFFAOYSA-N					compound annotation
0391_004120	1226895-20-0	C21H19NO3S	4.65	25065981		COc1cc2c(cc1)cc(C(C)C(=O)Oc1ccc(C(N)=S)cc1)cc2	InChI=1S/C21H19NO3S/c1-13(21(23)25-18-8-5-14(6-9-18)20(22)26)15-3-4-17-12-19(24-2)10-7-16(17)11-15/h3-13H,1-2H3,(H2,22,26)	YCNMAPLPQYQJFC-UHFFFAOYSA-N					compound annotation
0391_004121	303997-35-5	C16H8ClF3N4S	5.3491	1486608		FC(F)(F)c1nnc2c(Sc3ccccc3)nc3c(cc(Cl)cc3)n12	InChI=1S/C16H8ClF3N4S/c17-9-6-7-11-12(8-9)24-13(22-23-15(24)16(18,19)20)14(21-11)25-10-4-2-1-3-5-10/h1-8H	SUUMKHOVGVYGOP-UHFFFAOYSA-N					doublet; compound annotation
0391_004122	303997-35-5	C16H8ClF3N4S	5.3521	1486608		FC(F)(F)c1nnc2c(Sc3ccccc3)nc3c(cc(Cl)cc3)n12	InChI=1S/C16H8ClF3N4S/c17-9-6-7-11-12(8-9)24-13(22-23-15(24)16(18,19)20)14(21-11)25-10-4-2-1-3-5-10/h1-8H	SUUMKHOVGVYGOP-UHFFFAOYSA-N					doublet; compound annotation
0391_004123	885434-70-8	C15H19NO2S	5.5463	22200891		Cc1cc(C)c(S(=O)(=O)n2cc(C)cc2C)c(C)c1	InChI=1S/C15H19NO2S/c1-10-6-12(3)15(13(4)7-10)19(17,18)16-9-11(2)8-14(16)5/h6-9H,1-5H3	AFZWZVLPIMHLSE-UHFFFAOYSA-N					compound annotation
0391_004124	linperlisib	C28H37FN6O5S	2.4844	91754520		COc1c(NS(C)(=O)=O)cc(-c2nc(N3CCOCC3)nc3c(CN4CCC(C(C)(C)O)CC4)cc(F)cc23)cn1	InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3	NVWKNQGHVMMAJW-UHFFFAOYSA-N					doublet; compound annotation
0391_004125	linperlisib	C28H37FN6O5S	2.6322	91754520		COc1c(NS(C)(=O)=O)cc(-c2nc(N3CCOCC3)nc3c(CN4CCC(C(C)(C)O)CC4)cc(F)cc23)cn1	InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3	NVWKNQGHVMMAJW-UHFFFAOYSA-N					doublet; compound annotation
0391_004126	Cediranib	C25H27FN4O3	2.8926	9933475		COc1c(OCCCN2CCCC2)cc2ncnc(Oc3c(F)c4c(cc3)[nH]c(C)c4)c2c1	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	XXJWYDDUDKYVKI-UHFFFAOYSA-N					doublet; compound annotation
0391_004127	Cediranib	C25H27FN4O3	2.9098	9933475		COc1c(OCCCN2CCCC2)cc2ncnc(Oc3c(F)c4c(cc3)[nH]c(C)c4)c2c1	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	XXJWYDDUDKYVKI-UHFFFAOYSA-N					doublet; compound annotation
0391_004128	Acrizanib	C20H18F3N7O2	2.9426	59394698		CNCc1cc(Oc2cc3c(cc2)n(C(=O)Nc2nn(C)c(C(F)(F)F)c2)cc3)ncn1	InChI=1S/C20H18F3N7O2/c1-24-10-13-8-18(26-11-25-13)32-14-3-4-15-12(7-14)5-6-30(15)19(31)27-17-9-16(20(21,22)23)29(2)28-17/h3-9,11,24H,10H2,1-2H3,(H,27,28,31)	XPIHPLVWOUDMPF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004130	GSK429286A	C21H16F4N4O2	3.0726	11373846		CC1=C(C(=O)Nc2c(F)cc3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1	InChI=1S/C21H16F4N4O2/c1-10-19(20(31)28-17-6-12-9-26-29-16(12)8-15(17)22)14(7-18(30)27-10)11-2-4-13(5-3-11)21(23,24)25/h2-6,8-9,14H,7H2,1H3,(H,26,29)(H,27,30)(H,28,31)	OLIIUAHHAZEXEX-UHFFFAOYSA-N					compound annotation
0391_004131	MTX-211	C20H14Cl2FN5O2S	3.0994	121416213		CS(=O)(=O)Nc1c(Cl)ncc(-c2cc3c(cc2)ncnc3Nc2cc(Cl)c(F)cc2)c1	InChI=1S/C20H14Cl2FN5O2S/c1-31(29,30)28-18-7-12(9-24-19(18)22)11-2-5-17-14(6-11)20(26-10-25-17)27-13-3-4-16(23)15(21)8-13/h2-10,28H,1H3,(H,25,26,27)	GUYKCXXNIKKSBC-UHFFFAOYSA-N					compound annotation
0391_004132	Rilzabrutinib	C36H40FN9O3	3.2694	73388818	CC(C)(/C=C(\C#N)/C(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7	CC(C)(C=C(C#N)C(=O)N1CCCC(n2nc(-c3c(F)cc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1	InChI=1S/C36H40FN9O3/c1-36(2,45-15-13-43(14-16-45)26-21-48-22-26)18-24(19-38)35(47)44-12-6-7-25(20-44)46-34-31(33(39)40-23-41-34)32(42-46)29-11-10-28(17-30(29)37)49-27-8-4-3-5-9-27/h3-5,8-11,17-18,23,25-26H,6-7,12-16,20-22H2,1-2H3,(H2,39,40,41)/b24-18+/t25-/m1/s1	LCFFREMLXLZNHE-GBOLQPHISA-N					doublet; compound annotation
0391_004133	Rilzabrutinib	C36H40FN9O3	3.2743	73388818	CC(C)(/C=C(\C#N)/C(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7	CC(C)(C=C(C#N)C(=O)N1CCCC(n2nc(-c3c(F)cc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1	InChI=1S/C36H40FN9O3/c1-36(2,45-15-13-43(14-16-45)26-21-48-22-26)18-24(19-38)35(47)44-12-6-7-25(20-44)46-34-31(33(39)40-23-41-34)32(42-46)29-11-10-28(17-30(29)37)49-27-8-4-3-5-9-27/h3-5,8-11,17-18,23,25-26H,6-7,12-16,20-22H2,1-2H3,(H2,39,40,41)/b24-18+/t25-/m1/s1	LCFFREMLXLZNHE-GBOLQPHISA-N					doublet; compound annotation
0391_004134	Mitochonic acid 5	C18H13F2NO3	3.7682	76070959		O=C(CC(C(=O)O)c1c[nH]c2ccccc12)c1c(F)cc(F)cc1	InChI=1S/C18H13F2NO3/c19-10-5-6-12(15(20)7-10)17(22)8-13(18(23)24)14-9-21-16-4-2-1-3-11(14)16/h1-7,9,13,21H,8H2,(H,23,24)	BOKQALWNGNLTOC-UHFFFAOYSA-N					compound annotation
0391_004135	Bragsin1	C11H6F3NO4	3.987	740511		Cc1c([N+](=O)[O-])c2c(cc1)oc(C(F)(F)F)cc2=O	InChI=1S/C11H6F3NO4/c1-5-2-3-7-9(10(5)15(17)18)6(16)4-8(19-7)11(12,13)14/h2-4H,1H3	WEUSXIBCGCFOQR-UHFFFAOYSA-N					compound annotation
0391_004136	33458-93-4	C17H14O5	4.0552	119461		CC(C)Oc1cc2c(cc1)c(=O)c1c(ccc(C(=O)O)c1)o2	InChI=1S/C17H14O5/c1-9(2)21-11-4-5-12-15(8-11)22-14-6-3-10(17(19)20)7-13(14)16(12)18/h3-9H,1-2H3,(H,19,20)	AQFFXPQJLZFABJ-UHFFFAOYSA-N					compound annotation
0391_004137	4-Azido-L-phenylalanine	C9H10N4O2	1.2344	86306412	C1=CC(=CC=C1C[C@@H](C(=O)[O-])[NH3+])N=[N+]=[N-]	[N-]=[N+]=Nc1ccc(CC(N)C(=O)O)cc1	InChI=1S/C9H10N4O2/c10-8(9(14)15)5-6-1-3-7(4-2-6)12-13-11/h1-4,8H,5,10H2,(H,14,15)/t8-/m0/s1	NEMHIKRLROONTL-QMMMGPOBSA-N					doublet; compound annotation
0391_004138	LDN-214117	C25H29N3O3	1.7982	91754554		COc1cc(-c2c(C)ncc(-c3ccc(N4CCNCC4)cc3)c2)cc(OC)c1OC	InChI=1S/C25H29N3O3/c1-17-22(19-14-23(29-2)25(31-4)24(15-19)30-3)13-20(16-27-17)18-5-7-21(8-6-18)28-11-9-26-10-12-28/h5-8,13-16,26H,9-12H2,1-4H3	BHUXVRVMMYAXKN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004140	SAR125844	C25H23FN8O2S2	2.9184	25182860		O=C(NCCN1CCOCC1)Nc1nc2c(cc(Sc3nnc4ccc(-c5ccc(F)cc5)nn34)cc2)s1	InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35)	ODIUNTQOXRXOIV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004142	Verinurad	C20H16N2O2S	3.0818	54767229		CC(C)(Sc1c(-c2ccc(C#N)c3ccccc23)cncc1)C(=O)O	InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)	YYBOLPLTQDKXPM-UHFFFAOYSA-N					doublet; compound annotation
0391_004143	SAR125844	C25H23FN8O2S2	3.0818	25182860		O=C(NCCN1CCOCC1)Nc1nc2c(cc(Sc3nnc4ccc(-c5ccc(F)cc5)nn34)cc2)s1	InChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35)	ODIUNTQOXRXOIV-UHFFFAOYSA-N					doublet; compound annotation
0391_004144	losartan	C22H23ClN6O	3.2657	3961		CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)	PSIFNNKUMBGKDQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004146	Verinurad	C20H16N2O2S	3.7292	54767229		CC(C)(Sc1c(-c2ccc(C#N)c3ccccc23)cncc1)C(=O)O	InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)	YYBOLPLTQDKXPM-UHFFFAOYSA-N					doublet; compound annotation
0391_004147	Z-Ile-Glu-Pro-Phe-Ome	C34H44N4O9	4.0522	10032234	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)OC)NC(=O)OCC3=CC=CC=C3	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CCC(=O)O)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)OC	InChI=1S/C34H44N4O9/c1-4-22(2)29(37-34(45)47-21-24-14-9-6-10-15-24)31(42)35-25(17-18-28(39)40)32(43)38-19-11-16-27(38)30(41)36-26(33(44)46-3)20-23-12-7-5-8-13-23/h5-10,12-15,22,25-27,29H,4,11,16-21H2,1-3H3,(H,35,42)(H,36,41)(H,37,45)(H,39,40)/t22-,25-,26-,27-,29-/m0/s1	NQFWNRFKRYMGAI-OXHJWIHTSA-N					removed another duplicate entry; compound annotation
0391_004149	182498-32-4	C13H10BrN3O4	4.0869	3854666		O=C(Nc1c(O)cc([N+](=O)[O-])cc1)Nc1ccccc1Br	InChI=1S/C13H10BrN3O4/c14-9-3-1-2-4-10(9)15-13(19)16-11-6-5-8(17(20)21)7-12(11)18/h1-7,18H,(H2,15,16,19)	MQBZVUNNWUIPMK-UHFFFAOYSA-N					compound annotation
0391_004150	A-385358	C32H41N5O5S2	4.314	11556440	CC1(CCN(CC1)C2=CC=C(C=C2)C(=O)NS(=O)(=O)C3=CC(=C(C=C3)N[C@H](CCN(C)C)CSC4=CC=CC=C4)[N+](=O)[O-])C	CN(C)CCC(CSc1ccccc1)Nc1c([N+](=O)[O-])cc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1	InChI=1S/C32H41N5O5S2/c1-32(2)17-20-36(21-18-32)26-12-10-24(11-13-26)31(38)34-44(41,42)28-14-15-29(30(22-28)37(39)40)33-25(16-19-35(3)4)23-43-27-8-6-5-7-9-27/h5-15,22,25,33H,16-21,23H2,1-4H3,(H,34,38)/t25-/m1/s1	DWEHITNKTMMZBR-RUZDIDTESA-N					doublet; compound annotation
0391_004151	A-385358	C32H41N5O5S2	4.3189	11556440	CC1(CCN(CC1)C2=CC=C(C=C2)C(=O)NS(=O)(=O)C3=CC(=C(C=C3)N[C@H](CCN(C)C)CSC4=CC=CC=C4)[N+](=O)[O-])C	CN(C)CCC(CSc1ccccc1)Nc1c([N+](=O)[O-])cc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C)(C)CC3)cc2)cc1	InChI=1S/C32H41N5O5S2/c1-32(2)17-20-36(21-18-32)26-12-10-24(11-13-26)31(38)34-44(41,42)28-14-15-29(30(22-28)37(39)40)33-25(16-19-35(3)4)23-43-27-8-6-5-7-9-27/h5-15,22,25,33H,16-21,23H2,1-4H3,(H,34,38)/t25-/m1/s1	DWEHITNKTMMZBR-RUZDIDTESA-N					doublet; compound annotation
0391_004152	ESI-09	C16H15ClN4O2	5.1884	5704083	CC(C)(C)C1=CC(=NO1)C(=O)/C(=N\NC2=CC(=CC=C2)Cl)/C#N	CC(C)(C)c1cc(C(=O)C(C#N)=NNc2cc(Cl)ccc2)no1	InChI=1S/C16H15ClN4O2/c1-16(2,3)14-8-12(21-23-14)15(22)13(9-18)20-19-11-6-4-5-10(17)7-11/h4-8,19H,1-3H3/b20-13-	DXEATJQGQHDURZ-MOSHPQCFSA-N					compound annotation
0391_004153	UNC2025	C28H40N6O	1.9197	73425588		CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn(C3CCC(O)CC3)c2n1	InChI=1S/C28H40N6O/c1-3-4-13-29-28-30-18-25-26(20-34(27(25)31-28)23-9-11-24(35)12-10-23)22-7-5-21(6-8-22)19-33-16-14-32(2)15-17-33/h5-8,18,20,23-24,35H,3-4,9-17,19H2,1-2H3,(H,29,30,31)	MJSHVHLADKXCML-UHFFFAOYSA-N					doublet; compound annotation
0391_004154	GSK8612	C17H17BrF3N7O2S	2.0992	137553174		Cc1nn(CC(F)(F)F)cc1Nc1ncc(Br)c(NCc2ccc(S(N)(=O)=O)cc2)n1	InChI=1S/C17H17BrF3N7O2S/c1-10-14(8-28(27-10)9-17(19,20)21)25-16-24-7-13(18)15(26-16)23-6-11-2-4-12(5-3-11)31(22,29)30/h2-5,7-8H,6,9H2,1H3,(H2,22,29,30)(H2,23,24,25,26)	FFPHMUIGESPOTK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004156	864863-72-9	C17H12FN5	2.1059	11301185		Cc1c(-c2cc3c(cc2)nccc3)nnn1-c1c(F)nccc1	InChI=1S/C17H12FN5/c1-11-16(13-6-7-14-12(10-13)4-2-8-19-14)21-22-23(11)15-5-3-9-20-17(15)18/h2-10H,1H3	RTUBNVSZHGWRCV-UHFFFAOYSA-N					compound annotation
0391_004157	WHI-P97	C16H13Br2N3O3	2.3972	3796		COc1c(OC)cc2c(Nc3cc(Br)c(O)c(Br)c3)ncnc2c1	InChI=1S/C16H13Br2N3O3/c1-23-13-5-9-12(6-14(13)24-2)19-7-20-16(9)21-8-3-10(17)15(22)11(18)4-8/h3-7,22H,1-2H3,(H,19,20,21)	YVCXQRVVNQMZEI-UHFFFAOYSA-N					compound annotation
0391_004158	218136-59-5	C27H29N5	2.4413	9845201	C1CN(CCN1CCCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)/N=C/C4=CN=CC=C4	N#CC(CCCN1CCN(N=Cc2cnccc2)CC1)(c1ccccc1)c1ccccc1	InChI=1S/C27H29N5/c28-23-27(25-10-3-1-4-11-25,26-12-5-2-6-13-26)14-8-16-31-17-19-32(20-18-31)30-22-24-9-7-15-29-21-24/h1-7,9-13,15,21-22H,8,14,16-20H2/b30-22+	QFYKXKMYVYOUNJ-JBASAIQMSA-N					doublet; compound annotation
0391_004159	218136-59-5	C27H29N5	2.6066	9845201	C1CN(CCN1CCCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)/N=C/C4=CN=CC=C4	N#CC(CCCN1CCN(N=Cc2cnccc2)CC1)(c1ccccc1)c1ccccc1	InChI=1S/C27H29N5/c28-23-27(25-10-3-1-4-11-25,26-12-5-2-6-13-26)14-8-16-31-17-19-32(20-18-31)30-22-24-9-7-15-29-21-24/h1-7,9-13,15,21-22H,8,14,16-20H2/b30-22+	QFYKXKMYVYOUNJ-JBASAIQMSA-N					doublet; compound annotation
0391_004160	Ubiquitin Isopeptidase Inhibitor II, F6	C21H21NO	3.1439	5351363	CC1=CC=C(C=C1)/C=C\2/C(=O)/C(=C/C3=CC=C(C=C3)C)/CNC2	Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1	InChI=1S/C21H21NO/c1-15-3-7-17(8-4-15)11-19-13-22-14-20(21(19)23)12-18-9-5-16(2)6-10-18/h3-12,22H,13-14H2,1-2H3/b19-11+,20-12+	PKCYYPHSCUSQDK-AYKLPDECSA-N					doublet; compound annotation
0391_004161	Ubiquitin Isopeptidase Inhibitor II, F6	C21H21NO	3.2961	5351363	CC1=CC=C(C=C1)/C=C\2/C(=O)/C(=C/C3=CC=C(C=C3)C)/CNC2	Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1	InChI=1S/C21H21NO/c1-15-3-7-17(8-4-15)11-19-13-22-14-20(21(19)23)12-18-9-5-16(2)6-10-18/h3-12,22H,13-14H2,1-2H3/b19-11+,20-12+	PKCYYPHSCUSQDK-AYKLPDECSA-N					doublet; removed another duplicate entry; compound annotation
0391_004163	SSE15206	C19H21N3O3S	3.7123	56944939		COc1cc(C2CC(c3ccccc3)=NN2C(N)=S)cc(OC)c1OC	InChI=1S/C19H21N3O3S/c1-23-16-9-13(10-17(24-2)18(16)25-3)15-11-14(21-22(15)19(20)26)12-7-5-4-6-8-12/h4-10,15H,11H2,1-3H3,(H2,20,26)	GONIBFCARADPAC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004165	FT011	C20H17NO5	3.8902	23648966	COC1=C(C=CC(=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OCC#C	C#CCOc1c(OC)cc(C=CC(=O)Nc2ccccc2C(=O)O)cc1	InChI=1S/C20H17NO5/c1-3-12-26-17-10-8-14(13-18(17)25-2)9-11-19(22)21-16-7-5-4-6-15(16)20(23)24/h1,4-11,13H,12H2,2H3,(H,21,22)(H,23,24)/b11-9+	UIWZIDIJCUEOMT-PKNBQFBNSA-N					compound annotation
0391_004166	328968-36-1	C24H19N3O6	4.8552	1285941	CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)/C=C\3/C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1ccc(-c2c([N+](=O)[O-])cc(C)c(C)c2)o1	InChI=1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12-	HEKJYZZSCQBJGB-UNOMPAQXSA-N					doublet; compound annotation
0391_004167	328968-36-1	C24H19N3O6	5.1477	1285941	CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)/C=C\3/C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1ccc(-c2c([N+](=O)[O-])cc(C)c(C)c2)o1	InChI=1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12-	HEKJYZZSCQBJGB-UNOMPAQXSA-N					doublet; removed another duplicate entry; compound annotation
0391_004169	Huperzine A	C15H18N2O	1.17	854026	C/C=C/1\[C@@H]2CC3=C([C@]1(CC(=C2)C)N)C=CC(=O)N3	CC=C1C2C=C(C)CC1(N)c1c(C2)[nH]c(=O)cc1	InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15+/m0/s1	ZRJBHWIHUMBLCN-YQEJDHNASA-N					removed another duplicate entry; compound annotation
0391_004171	Selonsertib	C24H24FN7O	2.1282	71245288		Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1	InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)	YIDDLAAKOYYGJG-UHFFFAOYSA-N					doublet; compound annotation
0391_004172	Selonsertib	C24H24FN7O	2.4269	71245288		Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1	InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)	YIDDLAAKOYYGJG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004174	PERINDOPRIL	C19H32N2O5	2.6087	40466996	CCC[C@@H](C(=O)OCC)[NH2+][C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)[O-]	CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC	InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1	IPVQLZZIHOAWMC-QXKUPLGCSA-N					removed another duplicate entry; compound annotation
0391_004176	RS102895	C21H21F3N2O2	2.7212	10000456		O=C1Nc2ccccc2C2(CCN(CCc3ccc(C(F)(F)F)cc3)CC2)O1	InChI=1S/C21H21F3N2O2/c22-21(23,24)16-7-5-15(6-8-16)9-12-26-13-10-20(11-14-26)17-3-1-2-4-18(17)25-19(27)28-20/h1-8H,9-14H2,(H,25,27)	HIDWEYPGMLIQSN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004178	ISA-2011B	C22H18ClN3O4	3.5137	49853637	CN1CC(=O)N2[C@H](C1=O)CC3=CC4=C(C=C3[C@H]2C5=CNC6=C5C=C(C=C6)Cl)OCO4	CN1CC(=O)N2C(Cc3cc4c(cc3C2c2c[nH]c3c2cc(Cl)cc3)OCO4)C1=O	InChI=1S/C22H18ClN3O4/c1-25-9-20(27)26-17(22(25)28)4-11-5-18-19(30-10-29-18)7-13(11)21(26)15-8-24-16-3-2-12(23)6-14(15)16/h2-3,5-8,17,21,24H,4,9-10H2,1H3/t17-,21-/m0/s1	FSEZESVJDPKRDS-UWJYYQICSA-N					removed another duplicate entry; compound annotation
0391_004181	purvalanol A	C19H25ClN6O	3.8614	456214	CC(C)[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC=C3)Cl	CC(C)C(CO)Nc1nc(Nc2cc(Cl)ccc2)c2ncn(C(C)C)c2n1	InChI=1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1	PMXCMJLOPOFPBT-HNNXBMFYSA-N					doublet; compound annotation
0391_004182	purvalanol A	C19H25ClN6O	3.9257	456214	CC(C)[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC=C3)Cl	CC(C)C(CO)Nc1nc(Nc2cc(Cl)ccc2)c2ncn(C(C)C)c2n1	InChI=1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1	PMXCMJLOPOFPBT-HNNXBMFYSA-N					doublet; compound annotation
0391_004183	ONO-AE3-208	C24H21FN2O3	4.059	10111831		CC(C(=O)Nc1c(CCCC(=O)O)ccc(C#N)c1)c1ccc(F)c2ccccc12	InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29)	MTDIMKNAJUQTIO-UHFFFAOYSA-N					doublet; compound annotation
0391_004184	ONO-AE3-208	C24H21FN2O3	4.0623	10111831		CC(C(=O)Nc1c(CCCC(=O)O)ccc(C#N)c1)c1ccc(F)c2ccccc12	InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29)	MTDIMKNAJUQTIO-UHFFFAOYSA-N					doublet; compound annotation
0391_004185	purvalanol A	C19H25ClN6O	4.1962	456214	CC(C)[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC=C3)Cl	CC(C)C(CO)Nc1nc(Nc2cc(Cl)ccc2)c2ncn(C(C)C)c2n1	InChI=1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1	PMXCMJLOPOFPBT-HNNXBMFYSA-N					doublet; compound annotation
0391_004186	2162962-69-6	C16H13NO2	1.9689	135567366		Cc1c(O)ccc(-c2ccnc3cc(O)ccc23)c1	InChI=1S/C16H13NO2/c1-10-8-11(2-5-16(10)19)13-6-7-17-15-9-12(18)3-4-14(13)15/h2-9,18-19H,1H3	QXFYDRYRLOHSBD-UHFFFAOYSA-N					compound annotation
0391_004187	Mozavaptan	C27H29N3O2	2.6024	119369		Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	InChI=1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31)	WRNXUQJJCIZICJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004188	Mozavaptan	C27H29N3O2	2.6051	119369		Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	InChI=1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31)	WRNXUQJJCIZICJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004189	RACLOPRIDE	C15H20Cl2N2O3	2.8001	3033769	CCN1CCC[C@H]1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O	CCN1CCCC1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC	InChI=1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1	WAOQONBSWFLFPE-VIFPVBQESA-N					compound annotation
0391_004190	AHR antagonist 2	C20H17F3N4O3	3.7384	138634553	C[C@@H](CO)NC(=O)C1=NC(=NC(=C1)C2=CC=C(C=C2)OC(F)(F)F)C3=CN=CC=C3	CC(CO)NC(=O)c1nc(-c2cnccc2)nc(-c2ccc(OC(F)(F)F)cc2)c1	InChI=1S/C20H17F3N4O3/c1-12(11-28)25-19(29)17-9-16(26-18(27-17)14-3-2-8-24-10-14)13-4-6-15(7-5-13)30-20(21,22)23/h2-10,12,28H,11H2,1H3,(H,25,29)/t12-/m0/s1	CSSGBPKFVJOAIZ-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_004192	GMB-475	C43H46F3N7O7S	4.0702	139600282	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCCOC4=CC=C(C=C4)C5=CC(=NC=N5)NC6=CC=C(C=C6)OC(F)(F)F)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)COCCOc3ccc(-c4cc(Nc5ccc(OC(F)(F)F)cc5)ncn4)cc3)C(C)(C)C)cc2)scn1	InChI=1S/C43H46F3N7O7S/c1-26-38(61-25-50-26)29-7-5-27(6-8-29)21-47-40(56)35-19-31(54)22-53(35)41(57)39(42(2,3)4)52-37(55)23-58-17-18-59-32-13-9-28(10-14-32)34-20-36(49-24-48-34)51-30-11-15-33(16-12-30)60-43(44,45)46/h5-16,20,24-25,31,35,39,54H,17-19,21-23H2,1-4H3,(H,47,56)(H,52,55)(H,48,49,51)/t31-,35+,39-/m1/s1	ONDVWISBMHHLGZ-SBJIGXGQSA-N					removed another duplicate entry; compound annotation
0391_004194	2162982-11-6	C20H17ClFN3O3	4.4848	132168144	C[C@@H](CO)NC(=O)C1=CC(=NN(C1=O)C2=CC(=CC=C2)F)C3=CC=C(C=C3)Cl	CC(CO)NC(=O)c1cc(-c2ccc(Cl)cc2)nn(-c2cc(F)ccc2)c1=O	InChI=1S/C20H17ClFN3O3/c1-12(11-26)23-19(27)17-10-18(13-5-7-14(21)8-6-13)24-25(20(17)28)16-4-2-3-15(22)9-16/h2-10,12,26H,11H2,1H3,(H,23,27)/t12-/m0/s1	RFGRNBWAUZSMBN-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_004196	587841-73-4	C21H19BrClN5O4S2	4.6466	1791111		Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3c(Cl)cc(Br)cc3)cc2)n1	InChI=1S/C21H19BrClN5O4S2/c1-12-9-13(2)25-20(24-12)28-34(30,31)16-6-4-15(5-7-16)26-21(33)27-19(29)11-32-18-8-3-14(22)10-17(18)23/h3-10H,11H2,1-2H3,(H,24,25,28)(H2,26,27,29,33)	XKZDWYDHEBCGCG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004198	CH7057288	C32H31N3O5S	4.7522	131839646		Cc1cc(C(=O)NC(C)(C)C)cc(C#Cc2cc3c(cc2)c2c(o3)C(C)(C)c3c(ccc(NS(C)(=O)=O)c3)C2=O)n1	InChI=1S/C32H31N3O5S/c1-18-14-20(30(37)34-31(2,3)4)16-21(33-18)10-8-19-9-12-24-26(15-19)40-29-27(24)28(36)23-13-11-22(35-41(7,38)39)17-25(23)32(29,5)6/h9,11-17,35H,1-7H3,(H,34,37)	DCGOHGQJHJXBGW-UHFFFAOYSA-N					compound annotation
0391_004199	Tropifexor	C29H25F4N3O5S	5.4263	121418176	C1C[C@H]2CC(C[C@@H]1N2C3=NC4=C(C=C(C=C4S3)C(=O)O)F)OCC5=C(ON=C5C6=CC=CC=C6OC(F)(F)F)C7CC7	O=C(O)c1cc(F)c2nc(N3C4CCC3CC(OCc3c(C5CC5)onc3-c3ccccc3OC(F)(F)F)C4)sc2c1	InChI=1S/C29H25F4N3O5S/c30-21-9-15(27(37)38)10-23-25(21)34-28(42-23)36-16-7-8-17(36)12-18(11-16)39-13-20-24(35-41-26(20)14-5-6-14)19-3-1-2-4-22(19)40-29(31,32)33/h1-4,9-10,14,16-18H,5-8,11-13H2,(H,37,38)/t16-,17+,18?	VYLOOGHLKSNNEK-JWTNVVGKSA-N					doublet; compound annotation
0391_004200	Tropifexor	C29H25F4N3O5S	5.7633	121418176	C1C[C@H]2CC(C[C@@H]1N2C3=NC4=C(C=C(C=C4S3)C(=O)O)F)OCC5=C(ON=C5C6=CC=CC=C6OC(F)(F)F)C7CC7	O=C(O)c1cc(F)c2nc(N3C4CCC3CC(OCc3c(C5CC5)onc3-c3ccccc3OC(F)(F)F)C4)sc2c1	InChI=1S/C29H25F4N3O5S/c30-21-9-15(27(37)38)10-23-25(21)34-28(42-23)36-16-7-8-17(36)12-18(11-16)39-13-20-24(35-41-26(20)14-5-6-14)19-3-1-2-4-22(19)40-29(31,32)33/h1-4,9-10,14,16-18H,5-8,11-13H2,(H,37,38)/t16-,17+,18?	VYLOOGHLKSNNEK-JWTNVVGKSA-N					doublet; compound annotation
0391_004201	BRD0705	C20H23N3O	3.1105	136980453	CC[C@@]1(C2=C(NC3=C1C(=O)CC(C3)(C)C)NN=C2)C4=CC=CC=C4	CCC1(c2ccccc2)C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2	InChI=1S/C20H23N3O/c1-4-20(13-8-6-5-7-9-13)14-12-21-23-18(14)22-15-10-19(2,3)11-16(24)17(15)20/h5-9,12H,4,10-11H2,1-3H3,(H2,21,22,23)/t20-/m0/s1	NCKLQXXBRWCYMA-FQEVSTJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004203	BRD0705	C20H23N3O	3.3882	136980453	CC[C@@]1(C2=C(NC3=C1C(=O)CC(C3)(C)C)NN=C2)C4=CC=CC=C4	CCC1(c2ccccc2)C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2	InChI=1S/C20H23N3O/c1-4-20(13-8-6-5-7-9-13)14-12-21-23-18(14)22-15-10-19(2,3)11-16(24)17(15)20/h5-9,12H,4,10-11H2,1-3H3,(H2,21,22,23)/t20-/m0/s1	NCKLQXXBRWCYMA-FQEVSTJZSA-N					doublet; compound annotation
0391_004204	desoximetasone	C22H29FO4	3.3912	5311067	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1C(=O)CO	InChI=1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1	VWVSBHGCDBMOOT-IIEHVVJPSA-N					removed another duplicate entry; compound annotation
0391_004206	MK-0557	C22H19FN4O3	3.523	11491176		O=C1OC2(CCC(C(=O)Nc3nn(-c4ccccc4F)cc3)CC2)c2cnccc12	InChI=1S/C22H19FN4O3/c23-17-3-1-2-4-18(17)27-12-8-19(26-27)25-20(28)14-5-9-22(10-6-14)16-13-24-11-7-15(16)21(29)30-22/h1-4,7-8,11-14H,5-6,9-10H2,(H,25,26,28)	RMYZIRFUCOMQRH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004208	199864-87-4	C17H16FN3	3.7567	196968		CC(C)c1nc(N)nc(-c2ccc(F)c3ccccc23)c1	InChI=1S/C17H16FN3/c1-10(2)15-9-16(21-17(19)20-15)13-7-8-14(18)12-6-4-3-5-11(12)13/h3-10H,1-2H3,(H2,19,20,21)	ZZZQXCUPAJFVBN-UHFFFAOYSA-N					compound annotation
0391_004209	D-3263	C21H31N3O3	3.9707	44137358	C[C@@H]1CC[C@H]([C@@H](C1)C(=O)N2C3=C(C=C(C=C3)OC)N(C2=O)CCN)C(C)C	COc1ccc2c(c1)n(CCN)c(=O)n2C(=O)C1CC(C)CCC1C(C)C	InChI=1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1	ZGTYTFYRCIRWBL-HYVNUMGLSA-N					doublet; compound annotation
0391_004210	D-3263	C21H31N3O3	3.9734	44137358	C[C@@H]1CC[C@H]([C@@H](C1)C(=O)N2C3=C(C=C(C=C3)OC)N(C2=O)CCN)C(C)C	COc1ccc2c(c1)n(CCN)c(=O)n2C(=O)C1CC(C)CCC1C(C)C	InChI=1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1	ZGTYTFYRCIRWBL-HYVNUMGLSA-N					doublet; compound annotation
0391_004211	NONIVAMIDE	C17H27NO3	4.121	2998		CCCCCCCCC(=O)NCc1cc(OC)c(O)cc1	InChI=1S/C17H27NO3/c1-3-4-5-6-7-8-9-17(20)18-13-14-10-11-15(19)16(12-14)21-2/h10-12,19H,3-9,13H2,1-2H3,(H,18,20)	RGOVYLWUIBMPGK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004213	D-3263	C21H31N3O3	4.1467	44137358	C[C@@H]1CC[C@H]([C@@H](C1)C(=O)N2C3=C(C=C(C=C3)OC)N(C2=O)CCN)C(C)C	COc1ccc2c(c1)n(CCN)c(=O)n2C(=O)C1CC(C)CCC1C(C)C	InChI=1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1	ZGTYTFYRCIRWBL-HYVNUMGLSA-N					doublet; compound annotation
0391_004214	NCGC00378997-05	C56H71N9O23S	4.1805	78357819	CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)C5[C@H]([C@H](CN5C(=O)C(NC(=O)C(NC(=O)C6C[C@H](CN6C(=O)C(NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O	CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(C(O)CC(N)=O)NC(=O)C(C(O)C(O)c5cc(OS(=O)(=O)O)c(O)cc5)NC(=O)C5CC(O)CN5C(=O)C(C(C)O)NC4=O)cc3)no2)cc1	InChI=1S/C56H71N9O23S/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85)/t25-,26+,31+,34-,35?,37+,38+,42?,43?,44?,45?,46-,47-,48-,52+/m0/s1	PIEUQSKUWLMALL-RPRGIWPCSA-N					compound annotation
0391_004215	Pradigastat	C25H24F3N3O2	4.2277	53387035		O=C(O)CC1CCC(c2ccc(-c3ncc(Nc4cnc(C(F)(F)F)cc4)cc3)cc2)CC1	InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)	GXALXAKNHIROPE-UHFFFAOYSA-N					compound annotation
0391_004216	difluprednate	C27H34F2O7	4.3172	443936	CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C(=O)COC(=O)C	CCCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1	WYQPLTPSGFELIB-JTQPXKBDSA-N					removed another duplicate entry; compound annotation
0391_004218	kb NB 142-70	C11H9NO2S2	2.0833	45258277		O=C1NCCSc2c1sc1c2cc(O)cc1	InChI=1S/C11H9NO2S2/c13-6-1-2-8-7(5-6)9-10(16-8)11(14)12-3-4-15-9/h1-2,5,13H,3-4H2,(H,12,14)	DHUAGGSHTKPOHU-UHFFFAOYSA-N					compound annotation
0391_004219	1338545-07-5	C23H24N2O2S	2.091	67448186	CC1=CC(=C(C2=C1NC(=O)C3=C2C=CS3)C4=CC=C(C=C4)[C@@H](C)CN(C)C)O	Cc1cc(O)c(-c2ccc(C(C)CN(C)C)cc2)c2c1[nH]c(=O)c1c2ccs1	InChI=1S/C23H24N2O2S/c1-13-11-18(26)19(16-7-5-15(6-8-16)14(2)12-25(3)4)20-17-9-10-28-22(17)23(27)24-21(13)20/h5-11,14,26H,12H2,1-4H3,(H,24,27)/t14-/m0/s1	XCFRUAOZMVFDPQ-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_004221	Eprosartan	C23H24N2O4S	2.3559	5281037	CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O	CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1	InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+	OROAFUQRIXKEMV-LDADJPATSA-N					doublet; compound annotation
0391_004222	Eprosartan	C23H24N2O4S	2.5294	5281037	CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O	CCCCc1ncc(C=C(Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1	InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+	OROAFUQRIXKEMV-LDADJPATSA-N					doublet; compound annotation
0391_004223	PLX647	C21H17F3N4	2.5521	11545419		FC(F)(F)c1ccc(CNc2ncc(Cc3c[nH]c4c3cccn4)cc2)cc1	InChI=1S/C21H17F3N4/c22-21(23,24)17-6-3-14(4-7-17)11-26-19-8-5-15(12-27-19)10-16-13-28-20-18(16)2-1-9-25-20/h1-9,12-13H,10-11H2,(H,25,28)(H,26,27)	NODCQQSEMCESEC-UHFFFAOYSA-N					compound annotation
0391_004224	41276-02-2	C24H26N4O	2.623	336423		Cc1ccccc1CN1C2=NCCN2C(=O)C2=C1CCN(Cc1ccccc1)C2	InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-22-11-13-26(15-19-8-3-2-4-9-19)17-21(22)23(29)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3	RSAQARAFWMUYLL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004226	1047634-63-8	C18H16Cl2F2N4OS	3.1615	57826797	CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)sc(C(=O)NC(CN)Cc2cc(F)c(F)cc2)c1	InChI=1S/C18H16Cl2F2N4OS/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1	AHDFWNJLFALBJP-JTQLQIEISA-N					doublet; compound annotation
0391_004227	1047634-63-8	C18H16Cl2F2N4OS	3.2404	57826797	CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=C(C=C3)F)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)sc(C(=O)NC(CN)Cc2cc(F)c(F)cc2)c1	InChI=1S/C18H16Cl2F2N4OS/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1	AHDFWNJLFALBJP-JTQLQIEISA-N					doublet; compound annotation
0391_004228	878739-06-1	C27H25N5O2	3.7365	11676786		Cc1c(Nc2cc3c(cc2)ncn(C)c3=O)cc(NC(=O)c2cc(C(C)(C)C#N)ccc2)cc1	InChI=1S/C27H25N5O2/c1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23/h5-14,16,30H,1-4H3,(H,31,33)	ZGBGPEDJXCYQPH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004230	1228690-36-5	C27H24N2O5	4.2931	46213949	CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)O	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)OC(C)c1ccccc1	InChI=1S/C27H24N2O5/c1-17-25(28-27(32)33-18(2)20-6-4-3-5-7-20)26(34-29-17)23-14-12-22(13-15-23)21-10-8-19(9-11-21)16-24(30)31/h3-15,18H,16H2,1-2H3,(H,28,32)(H,30,31)/t18-/m1/s1	LNDDRUPAICPXIN-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_004232	S0859	C29H24ClN3O3S	4.5261	70675849		Cc1ccc(CN(Cc2ccc(-c3ccccc3S(=O)(=O)NC#N)cc2)C(=O)c2ccccc2Cl)cc1	InChI=1S/C29H24ClN3O3S/c1-21-10-12-22(13-11-21)18-33(29(34)26-7-2-4-8-27(26)30)19-23-14-16-24(17-15-23)25-6-3-5-9-28(25)37(35,36)32-20-31/h2-17,32H,18-19H2,1H3	ITDBPOSLOROLMT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004234	5184-64-5	C16H18O2S	4.9428	272513		Cc1ccc(S(=O)(=O)c2c(C)cc(C)cc2C)cc1	InChI=1S/C16H18O2S/c1-11-5-7-15(8-6-11)19(17,18)16-13(3)9-12(2)10-14(16)4/h5-10H,1-4H3	CGPHOZWFSFNOEQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004236	N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3-toluidine	C12H19NO4S	1.1798	125979		CCN(CC(O)CS(=O)(=O)O)c1cccc(C)c1	InChI=1S/C12H19NO4S/c1-3-13(8-12(14)9-18(15,16)17)11-6-4-5-10(2)7-11/h4-7,12,14H,3,8-9H2,1-2H3,(H,15,16,17)	ZTQGWROHRVYSPW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004238	929007-72-7	C17H15N5O2	1.8164	16058637		NC(=O)c1ccccc1Nc1nc(Nc2cc(O)ccc2)ncc1	InChI=1S/C17H15N5O2/c18-16(24)13-6-1-2-7-14(13)21-15-8-9-19-17(22-15)20-11-4-3-5-12(23)10-11/h1-10,23H,(H2,18,24)(H2,19,20,21,22)	QHPKKGUGRGRSGA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004240	Istaroxime	C21H32N2O3	2.2954	9841834	C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C	CC12CCC3C(CC(=O)C4CC(=NOCCN)CCC43C)C1CCC2=O	InChI=1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1	MPYLDWFDPHRTEG-PAAYLBSLSA-N					doublet; removed another duplicate entry; compound annotation
0391_004242	Istaroxime	C21H32N2O3	2.3358	9841834	C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C	CC12CCC3C(CC(=O)C4CC(=NOCCN)CCC43C)C1CCC2=O	InChI=1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1	MPYLDWFDPHRTEG-PAAYLBSLSA-N					doublet; removed another duplicate entry; compound annotation
0391_004244	trichostatin A	C17H22N2O3	3.0595	444732	C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C	CC(C=CC(=O)NO)=CC(C)C(=O)c1ccc(N(C)C)cc1	InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	RTKIYFITIVXBLE-QEQCGCAPSA-N					doublet; compound annotation
0391_004245	trichostatin A	C17H22N2O3	3.1179	444732	C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C	CC(C=CC(=O)NO)=CC(C)C(=O)c1ccc(N(C)C)cc1	InChI=1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1	RTKIYFITIVXBLE-QEQCGCAPSA-N					doublet; removed another duplicate entry; compound annotation
0391_004248	Rociletinib	C27H28F3N7O3	3.1973	57335384		C=CC(=O)Nc1cccc(Nc2nc(Nc3c(OC)cc(N4CCN(C(C)=O)CC4)cc3)ncc2C(F)(F)F)c1	InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)	HUFOZJXAKZVRNJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004251	GNF-5	C20H17F3N4O3	3.3165	44129660		O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	InChI=1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27)	IIQUYGWWHIHOCF-UHFFFAOYSA-N					doublet; compound annotation
0391_004252	GNF-5	C20H17F3N4O3	3.3193	44129660		O=C(NCCO)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	InChI=1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27)	IIQUYGWWHIHOCF-UHFFFAOYSA-N					doublet; compound annotation
0391_004253	HC-030031	C18H21N5O3	3.4202	1150897		CC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1	InChI=1S/C18H21N5O3/c1-11(2)12-5-7-13(8-6-12)20-14(24)9-23-10-19-16-15(23)17(25)22(4)18(26)21(16)3/h5-8,10-11H,9H2,1-4H3,(H,20,24)	HEQDZPHDVAOBLN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004255	Rociletinib	C27H28F3N7O3	3.6801	57335384		C=CC(=O)Nc1cccc(Nc2nc(Nc3c(OC)cc(N4CCN(C(C)=O)CC4)cc3)ncc2C(F)(F)F)c1	InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)	HUFOZJXAKZVRNJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004256	332117-28-9	C19H23N5O3	3.7798	2873523		CCC(C)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1	InChI=1S/C19H23N5O3/c1-5-12(2)13-6-8-14(9-7-13)21-15(25)10-24-11-20-17-16(24)18(26)23(4)19(27)22(17)3/h6-9,11-12H,5,10H2,1-4H3,(H,21,25)	ZUTUWJYMCADJHD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004258	Desidustat	C16H16N2O6	3.8102	75593290		O=C(O)CNC(=O)c1c(O)c2ccccc2n(OCC2CC2)c1=O	InChI=1S/C16H16N2O6/c19-12(20)7-17-15(22)13-14(21)10-3-1-2-4-11(10)18(16(13)23)24-8-9-5-6-9/h1-4,9,21H,5-8H2,(H,17,22)(H,19,20)	IKRKQQLJYBAPQT-UHFFFAOYSA-N					doublet; compound annotation
0391_004259	Desidustat	C16H16N2O6	3.8138	75593290		O=C(O)CNC(=O)c1c(O)c2ccccc2n(OCC2CC2)c1=O	InChI=1S/C16H16N2O6/c19-12(20)7-17-15(22)13-14(21)10-3-1-2-4-11(10)18(16(13)23)24-8-9-5-6-9/h1-4,9,21H,5-8H2,(H,17,22)(H,19,20)	IKRKQQLJYBAPQT-UHFFFAOYSA-N					doublet; compound annotation
0391_004260	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	C12H15N	1.4921	1388		CN1CC=C(c2ccccc2)CC1	InChI=1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3	PLRACCBDVIHHLZ-UHFFFAOYSA-N					compound annotation
0391_004261	1356962-20-3	C24H25ClN6O	2.3849	56599293		COc1c(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)ccc(N2CCC(N)CC2)c1	InChI=1S/C24H25ClN6O/c1-32-22-12-16(31-10-8-15(26)9-11-31)6-7-21(22)29-24-28-14-19(25)23(30-24)18-13-27-20-5-3-2-4-17(18)20/h2-7,12-15,27H,8-11,26H2,1H3,(H,28,29,30)	GCYIGMXOIWJGBU-UHFFFAOYSA-N					doublet; compound annotation
0391_004262	VGX-1027	C11H11NO3	2.4252	10798271		O=C(O)CC1CC(c2ccccc2)=NO1	InChI=1S/C11H11NO3/c13-11(14)7-9-6-10(12-15-9)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,13,14)	MUFJHYRCIHHATF-UHFFFAOYSA-N					compound annotation
0391_004263	PFI-1	C16H17N3O4S	2.4808	71271629		COc1ccccc1S(=O)(=O)Nc1cc2c(cc1)NC(=O)N(C)C2	InChI=1S/C16H17N3O4S/c1-19-10-11-9-12(7-8-13(11)17-16(19)20)18-24(21,22)15-6-4-3-5-14(15)23-2/h3-9,18H,10H2,1-2H3,(H,17,20)	TXZPMHLMPKIUGK-UHFFFAOYSA-N					compound annotation
0391_004264	1356962-20-3	C24H25ClN6O	2.7922	56599293		COc1c(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)ccc(N2CCC(N)CC2)c1	InChI=1S/C24H25ClN6O/c1-32-22-12-16(31-10-8-15(26)9-11-31)6-7-21(22)29-24-28-14-19(25)23(30-24)18-13-27-20-5-3-2-4-17(18)20/h2-7,12-15,27H,8-11,26H2,1H3,(H,28,29,30)	GCYIGMXOIWJGBU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004266	Cabotegravir	C19H17F2N3O5	2.9567	54713659	C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	CC1COC2Cn3cc(C(=O)NCc4c(F)cc(F)cc4)c(=O)c(O)c3C(=O)N12	InChI=1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)/t9-,14+/m0/s1	WCWSTNLSLKSJPK-LKFCYVNXSA-N					removed another duplicate entry; compound annotation
0391_004268	NVS-ZP7-4	C28H28FN5OS	3.3103	134823928	C1CN(CCC12C3=CC=CC=C3NC(=O)N2)C[C@H](CC4=CC=CC=C4)NC5=NC6=C(S5)C=C(C=C6)F	O=C1Nc2ccccc2C2(CCN(CC(Cc3ccccc3)Nc3nc4c(cc(F)cc4)s3)CC2)N1	InChI=1S/C28H28FN5OS/c29-20-10-11-24-25(17-20)36-27(32-24)30-21(16-19-6-2-1-3-7-19)18-34-14-12-28(13-15-34)22-8-4-5-9-23(22)31-26(35)33-28/h1-11,17,21H,12-16,18H2,(H,30,32)(H2,31,33,35)/t21-/m0/s1	FZOFDZMKSAUTHT-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_004270	SR-3306	C28H26N8O	3.3648	57519510		Cc1ncc(-c2nn(-c3ccc(Nc4nccc(-c5cc(N6CCOCC6)ccc5)n4)cc3)cn2)cc1	InChI=1S/C28H26N8O/c1-20-5-6-22(18-30-20)27-31-19-36(34-27)24-9-7-23(8-10-24)32-28-29-12-11-26(33-28)21-3-2-4-25(17-21)35-13-15-37-16-14-35/h2-12,17-19H,13-16H2,1H3,(H,29,32,33)	QDMXVKKPYBGIAS-UHFFFAOYSA-N					doublet; compound annotation
0391_004271	SR-3306	C28H26N8O	3.3698	57519510		Cc1ncc(-c2nn(-c3ccc(Nc4nccc(-c5cc(N6CCOCC6)ccc5)n4)cc3)cn2)cc1	InChI=1S/C28H26N8O/c1-20-5-6-22(18-30-20)27-31-19-36(34-27)24-9-7-23(8-10-24)32-28-29-12-11-26(33-28)21-3-2-4-25(17-21)35-13-15-37-16-14-35/h2-12,17-19H,13-16H2,1H3,(H,29,32,33)	QDMXVKKPYBGIAS-UHFFFAOYSA-N					doublet; compound annotation
0391_004272	ML314	C24H28N4O3	3.4019	53245590		COc1c(OC)cc2c(N3CCN(c4ccccc4OC)CC3)nc(C3CC3)nc2c1	InChI=1S/C24H28N4O3/c1-29-20-7-5-4-6-19(20)27-10-12-28(13-11-27)24-17-14-21(30-2)22(31-3)15-18(17)25-23(26-24)16-8-9-16/h4-7,14-16H,8-13H2,1-3H3	SWEOAXMICIJCQC-UHFFFAOYSA-N					compound annotation
0391_004273	GW9662	C13H9ClN2O3	3.7574	644213		O=C(Nc1ccccc1)c1c(Cl)ccc([N+](=O)[O-])c1	InChI=1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17)	DNTSIBUQMRRYIU-UHFFFAOYSA-N					compound annotation
0391_004274	INH1	C18H16N2OS	4.828	959043		Cc1cc(C)c(-c2csc(NC(=O)c3ccccc3)n2)cc1	InChI=1S/C18H16N2OS/c1-12-8-9-15(13(2)10-12)16-11-22-18(19-16)20-17(21)14-6-4-3-5-7-14/h3-11H,1-2H3,(H,19,20,21)	JPMOKRWIYQGMJL-UHFFFAOYSA-N					doublet; compound annotation
0391_004275	INH1	C18H16N2OS	5.0085	959043		Cc1cc(C)c(-c2csc(NC(=O)c3ccccc3)n2)cc1	InChI=1S/C18H16N2OS/c1-12-8-9-15(13(2)10-12)16-11-22-18(19-16)20-17(21)14-6-4-3-5-7-14/h3-11H,1-2H3,(H,19,20,21)	JPMOKRWIYQGMJL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004277	Daporinad	C24H29N3O2	2.5502	6914657	C1CN(CCC1CCCCNC(=O)/C=C/C2=CN=CC=C2)C(=O)C3=CC=CC=C3	O=C(C=Cc1cnccc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1	InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+	KPBNHDGDUADAGP-VAWYXSNFSA-N					doublet; compound annotation
0391_004278	Daporinad	C24H29N3O2	2.7355	6914657	C1CN(CCC1CCCCNC(=O)/C=C/C2=CN=CC=C2)C(=O)C3=CC=CC=C3	O=C(C=Cc1cnccc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1	InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+	KPBNHDGDUADAGP-VAWYXSNFSA-N					doublet; removed another duplicate entry; compound annotation
0391_004280	Rivaroxaban	C19H18ClN3O5S	2.9384	9875401	C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl	O=C(NCC1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1	KGFYHTZWPPHNLQ-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_004283	RIPK1-IN-4	C23H23N5O2	3.1223	71816195		CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c3ccnc4N)cc2)no1	InChI=1S/C23H23N5O2/c1-23(2,3)19-13-20(28-30-19)27-22(29)26-15-9-7-14(8-10-15)16-5-4-6-18-17(16)11-12-25-21(18)24/h4-13H,1-3H3,(H2,24,25)(H2,26,27,28,29)	SLRYMOUSQMDJPH-UHFFFAOYSA-N					doublet; compound annotation
0391_004284	Acumapimod	C22H19N5O2	3.1383	11338127		Cc1c(-n2ncc(C(=O)c3cccc(C#N)c3)c2N)cc(C(=O)NC2CC2)cc1	InChI=1S/C22H19N5O2/c1-13-5-6-16(22(29)26-17-7-8-17)10-19(13)27-21(24)18(12-25-27)20(28)15-4-2-3-14(9-15)11-23/h2-6,9-10,12,17H,7-8,24H2,1H3,(H,26,29)	VGUSQKZDZHAAEE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004286	gamma-Secretase Modulators	C26H24F3N3O3	3.1717	24781184	CC1=CN(C=N1)C2=C(C=C(C=C2)/C=C/3\CC[C@H]4COC[C@H](N4C3=O)C5=CC(=C(C(=C5)F)F)F)OC	COc1c(-n2cnc(C)c2)ccc(C=C2CCC3COCC(c4cc(F)c(F)c(F)c4)N3C2=O)c1	InChI=1S/C26H24F3N3O3/c1-15-11-31(14-30-15)22-6-3-16(8-24(22)34-2)7-17-4-5-19-12-35-13-23(32(19)26(17)33)18-9-20(27)25(29)21(28)10-18/h3,6-11,14,19,23H,4-5,12-13H2,1-2H3/b17-7+/t19-,23-/m0/s1	VHNYOQKVZQVBLC-RTCGXNAVSA-N					compound annotation
0391_004287	RIPK1-IN-4	C23H23N5O2	3.3404	71816195		CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cccc4c3ccnc4N)cc2)no1	InChI=1S/C23H23N5O2/c1-23(2,3)19-13-20(28-30-19)27-22(29)26-15-9-7-14(8-10-15)16-5-4-6-18-17(16)11-12-25-21(18)24/h4-13H,1-3H3,(H2,24,25)(H2,26,27,28,29)	SLRYMOUSQMDJPH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004289	Nutlin-3	C30H30Cl2N4O4	3.6417	216345		COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)	BDUHCSBCVGXTJM-UHFFFAOYSA-N					compound annotation
0391_004290	GESTODENE	C21H26O2	3.7871	3033968	CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3CCC21CC	InChI=1S/C21H26O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,10,12-13,16-19,23H,3,5-9,11H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	SIGSPDASOTUPFS-XUDSTZEESA-N					compound annotation
0391_004291	Amiselimod	C19H30F3NO3	4.0917	16129483		CCCCCCCOc1c(C(F)(F)F)cc(CCC(N)(CO)CO)cc1	InChI=1S/C19H30F3NO3/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3	JVCPIJKPAKAIIP-UHFFFAOYSA-N					compound annotation
0391_004292	Tradipitant	C28H16ClF6N5O	4.7958	9916461		O=C(c1ccccc1Cl)c1cccnc1-c1c(-c2ccncc2)n(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1	InChI=1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2	CAVRKWRKTNINFF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004294	Tulathromycin A	C41H79N3O12	1.2836	9832301	CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@H]([C@]([C@H](OC(=O)[C@@H]2C)CC)(C)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O	CCCNCC1(O)C(C)OC(OC2C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)NCC(C)CC(C)(O)C(OC3OC(C)CC(N(C)C)C3O)C2C)CC1(C)OC	InChI=1S/C41H79N3O12/c1-15-17-42-22-41(50)28(8)53-31(20-39(41,10)51-14)55-33-25(5)35(56-37-32(45)29(44(12)13)18-24(4)52-37)38(9,48)19-23(3)21-43-27(7)34(46)40(11,49)30(16-2)54-36(47)26(33)6/h23-35,37,42-43,45-46,48-50H,15-22H2,1-14H3/t23-,24-,25+,26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,37+,38-,39-,40-,41+/m1/s1	GUARTUJKFNAVIK-QPTWMBCESA-N					doublet; removed another duplicate entry; compound annotation
0391_004296	1140964-99-3	C18H15N5O	1.3306	135565981		O=C1NNc2c3c1cccc3nc(CN1Cc3ccccc3C1)n2	InChI=1S/C18H15N5O/c24-18-13-6-3-7-14-16(13)17(21-22-18)20-15(19-14)10-23-8-11-4-1-2-5-12(11)9-23/h1-7H,8-10H2,(H,22,24)(H,19,20,21)	JLFSBHQQXIAQEC-UHFFFAOYSA-N					compound annotation
0391_004297	Tulathromycin A	C41H79N3O12	1.7253	9832301	CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@H]([C@]([C@H](OC(=O)[C@@H]2C)CC)(C)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O	CCCNCC1(O)C(C)OC(OC2C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)NCC(C)CC(C)(O)C(OC3OC(C)CC(N(C)C)C3O)C2C)CC1(C)OC	InChI=1S/C41H79N3O12/c1-15-17-42-22-41(50)28(8)53-31(20-39(41,10)51-14)55-33-25(5)35(56-37-32(45)29(44(12)13)18-24(4)52-37)38(9,48)19-23(3)21-43-27(7)34(46)40(11,49)30(16-2)54-36(47)26(33)6/h23-35,37,42-43,45-46,48-50H,15-22H2,1-14H3/t23-,24-,25+,26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,37+,38-,39-,40-,41+/m1/s1	GUARTUJKFNAVIK-QPTWMBCESA-N					doublet; removed another duplicate entry; compound annotation
0391_004299	H4 Receptor antagonist 1	C16H17ClN4O	1.8455	3934857		Cc1nc2c(oc3c2cc(Cl)cc3)c(N2CCN(C)CC2)n1	InChI=1S/C16H17ClN4O/c1-10-18-14-12-9-11(17)3-4-13(12)22-15(14)16(19-10)21-7-5-20(2)6-8-21/h3-4,9H,5-8H2,1-2H3	GUJLUPNSRRNJKP-UHFFFAOYSA-N					doublet; compound annotation
0391_004300	1124329-14-1	C24H32N6O3	2.1887	56973724		COc1c(Nc2ncc3c(n2)n(C2CCCC2)c(=O)n3C)ccc(OC2CCN(C)CC2)c1	InChI=1S/C24H32N6O3/c1-28-12-10-17(11-13-28)33-18-8-9-19(21(14-18)32-3)26-23-25-15-20-22(27-23)30(24(31)29(20)2)16-6-4-5-7-16/h8-9,14-17H,4-7,10-13H2,1-3H3,(H,25,26,27)	YUKWVHPTFRQHMF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004302	H4 Receptor antagonist 1	C16H17ClN4O	2.2073	3934857		Cc1nc2c(oc3c2cc(Cl)cc3)c(N2CCN(C)CC2)n1	InChI=1S/C16H17ClN4O/c1-10-18-14-12-9-11(17)3-4-13(12)22-15(14)16(19-10)21-7-5-20(2)6-8-21/h3-4,9H,5-8H2,1-2H3	GUJLUPNSRRNJKP-UHFFFAOYSA-N					doublet; compound annotation
0391_004303	PF-9366	C20H19ClN4	2.9386	12612431		CN(C)CCc1nnc2cc(-c3ccccc3)c3c(ccc(Cl)c3)n12	InChI=1S/C20H19ClN4/c1-24(2)11-10-19-22-23-20-13-16(14-6-4-3-5-7-14)17-12-15(21)8-9-18(17)25(19)20/h3-9,12-13H,10-11H2,1-2H3	LYLASWLQCMKZAT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004305	BLM-IN-1	C28H35FN4O	3.2906	137649032	CCN(CC)CCCNC1=C(C=C2C(=C1)N=C3/C(=C/C4=CC=C(C=C4)C(C)C)/CCN3C2=O)F	CCN(CC)CCCNc1c(F)cc2c(=O)n3CCC(=Cc4ccc(C(C)C)cc4)c3nc2c1	InChI=1S/C28H35FN4O/c1-5-32(6-2)14-7-13-30-26-18-25-23(17-24(26)29)28(34)33-15-12-22(27(33)31-25)16-20-8-10-21(11-9-20)19(3)4/h8-11,16-19,30H,5-7,12-15H2,1-4H3/b22-16+	GZSNGNPLURZQGM-CJLVFECKSA-N					doublet; compound annotation
0391_004306	BLM-IN-1	C28H35FN4O	3.662	137649032	CCN(CC)CCCNC1=C(C=C2C(=C1)N=C3/C(=C/C4=CC=C(C=C4)C(C)C)/CCN3C2=O)F	CCN(CC)CCCNc1c(F)cc2c(=O)n3CCC(=Cc4ccc(C(C)C)cc4)c3nc2c1	InChI=1S/C28H35FN4O/c1-5-32(6-2)14-7-13-30-26-18-25-23(17-24(26)29)28(34)33-15-12-22(27(33)31-25)16-20-8-10-21(11-9-20)19(3)4/h8-11,16-19,30H,5-7,12-15H2,1-4H3/b22-16+	GZSNGNPLURZQGM-CJLVFECKSA-N					doublet; removed another duplicate entry; compound annotation
0391_004308	Toxoflavin	C7H7N5O2	0.4907	66541		Cn1ncnc2-c1nc(=O)n(C)c2=O	InChI=1S/C7H7N5O2/c1-11-6(13)4-5(10-7(11)14)12(2)9-3-8-4/h3H,1-2H3	SLGRAIAQIAUZAQ-UHFFFAOYSA-N					compound annotation
0391_004309	Naltrindole	C26H26N2O3	2.4648	5497186	C1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6	Oc1c2OC3c4c(CC5(O)C6Cc(c2C35CCN6CC2CC2)cc1)c1ccccc1[nH]4	InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1	WIYUZYBFCWCCQJ-IFKAHUTRSA-N					compound annotation
0391_004310	1629138-41-5	C20H31N3O	2.845	77050694		O=C(NC1CCCCC1)N(Cc1ccccc1)CC1CCNCC1	InChI=1S/C20H31N3O/c24-20(22-19-9-5-2-6-10-19)23(15-17-7-3-1-4-8-17)16-18-11-13-21-14-12-18/h1,3-4,7-8,18-19,21H,2,5-6,9-16H2,(H,22,24)	LNOPAJNGRAPFKZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004312	PNU-74654	C19H16N2O3	4.0403	9836739	CC1=CC=C(O1)/C=N/NC(=O)C2=CC=CC=C2OC3=CC=CC=C3	Cc1ccc(C=NNC(=O)c2ccccc2Oc2ccccc2)o1	InChI=1S/C19H16N2O3/c1-14-11-12-16(23-14)13-20-21-19(22)17-9-5-6-10-18(17)24-15-7-3-2-4-8-15/h2-13H,1H3,(H,21,22)/b20-13+	JJEDWBQZCRESJL-DEDYPNTBSA-N					doublet; removed another duplicate entry; compound annotation
0391_004314	PNU-74654	C19H16N2O3	4.1159	9836739	CC1=CC=C(O1)/C=N/NC(=O)C2=CC=CC=C2OC3=CC=CC=C3	Cc1ccc(C=NNC(=O)c2ccccc2Oc2ccccc2)o1	InChI=1S/C19H16N2O3/c1-14-11-12-16(23-14)13-20-21-19(22)17-9-5-6-10-18(17)24-15-7-3-2-4-8-15/h2-13H,1H3,(H,21,22)/b20-13+	JJEDWBQZCRESJL-DEDYPNTBSA-N					doublet; removed another duplicate entry; compound annotation
0391_004316	HA15	C23H22N4O3S2	4.1525	73890923		CC(=O)Nc1nc(-c2cc(NS(=O)(=O)c3cccc4c3cccc4N(C)C)ccc2)cs1	InChI=1S/C23H22N4O3S2/c1-15(28)24-23-25-20(14-31-23)16-7-4-8-17(13-16)26-32(29,30)22-12-6-9-18-19(22)10-5-11-21(18)27(2)3/h4-14,26H,1-3H3,(H,24,25,28)	LBSMEKVVMYSTIH-UHFFFAOYSA-N					doublet; compound annotation
0391_004317	HA15	C23H22N4O3S2	4.1553	73890923		CC(=O)Nc1nc(-c2cc(NS(=O)(=O)c3cccc4c3cccc4N(C)C)ccc2)cs1	InChI=1S/C23H22N4O3S2/c1-15(28)24-23-25-20(14-31-23)16-7-4-8-17(13-16)26-32(29,30)22-12-6-9-18-19(22)10-5-11-21(18)27(2)3/h4-14,26H,1-3H3,(H,24,25,28)	LBSMEKVVMYSTIH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004319	Elvitegravir	C23H23ClFNO5	4.6753	5277135	CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O	COc1cc2c(cc1Cc1c(F)c(Cl)ccc1)c(=O)c(C(=O)O)cn2C(CO)C(C)C	InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1	JUZYLCPPVHEVSV-LJQANCHMSA-N					removed another duplicate entry; compound annotation
0391_004321	StemRegenin 1	C24H23N5OS	4.7393	46199207		CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	InChI=1S/C24H23N5OS/c1-15(2)29-14-26-21-23(25-12-11-16-7-9-17(30)10-8-16)27-22(28-24(21)29)19-13-31-20-6-4-3-5-18(19)20/h3-10,13-15,30H,11-12H2,1-2H3,(H,25,27,28)	BGFHMYJZJZLMHW-UHFFFAOYSA-N					doublet; compound annotation
0391_004322	StemRegenin 1	C24H23N5OS	4.8846	46199207		CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	InChI=1S/C24H23N5OS/c1-15(2)29-14-26-21-23(25-12-11-16-7-9-17(30)10-8-16)27-22(28-24(21)29)19-13-31-20-6-4-3-5-18(19)20/h3-10,13-15,30H,11-12H2,1-2H3,(H,25,27,28)	BGFHMYJZJZLMHW-UHFFFAOYSA-N					doublet; compound annotation
0391_004323	StemRegenin 1	C24H23N5OS	4.9579	46199207		CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	InChI=1S/C24H23N5OS/c1-15(2)29-14-26-21-23(25-12-11-16-7-9-17(30)10-8-16)27-22(28-24(21)29)19-13-31-20-6-4-3-5-18(19)20/h3-10,13-15,30H,11-12H2,1-2H3,(H,25,27,28)	BGFHMYJZJZLMHW-UHFFFAOYSA-N					doublet; compound annotation
0391_004324	TECARFARIN	C21H14F6O5	5.0275	54718618		CC(OC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F	InChI=1S/C21H14F6O5/c1-19(20(22,23)24,21(25,26)27)32-17(29)12-8-6-11(7-9-12)10-14-16(28)13-4-2-3-5-15(13)31-18(14)30/h2-9,28H,10H2,1H3	QFLNTQDOVCLQKW-UHFFFAOYSA-N					compound annotation
0391_004325	StemRegenin 1	C24H23N5OS	5.1275	46199207		CC(C)n1cnc2c(NCCc3ccc(O)cc3)nc(-c3csc4ccccc34)nc21	InChI=1S/C24H23N5OS/c1-15(2)29-14-26-21-23(25-12-11-16-7-9-17(30)10-8-16)27-22(28-24(21)29)19-13-31-20-6-4-3-5-18(19)20/h3-10,13-15,30H,11-12H2,1-2H3,(H,25,27,28)	BGFHMYJZJZLMHW-UHFFFAOYSA-N					doublet; compound annotation
0391_004326	E1R	C13H16N2O2	2.1854	52912210	C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2	CC1C(c2ccccc2)CC(=O)N1CC(N)=O	InChI=1S/C13H16N2O2/c1-9-11(10-5-3-2-4-6-10)7-13(17)15(9)8-12(14)16/h2-6,9,11H,7-8H2,1H3,(H2,14,16)/t9-,11-/m0/s1	ZTGRWYMPQCQTHD-ONGXEEELSA-N					removed another duplicate entry; compound annotation
0391_004328	Iguratimod	C17H14N2O6S	3.0298	124246		CS(=O)(=O)Nc1c(Oc2ccccc2)cc2c(=O)c(NC=O)coc2c1	InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)	ANMATWQYLIFGOK-UHFFFAOYSA-N					doublet; compound annotation
0391_004329	Iguratimod	C17H14N2O6S	3.0333	124246		CS(=O)(=O)Nc1c(Oc2ccccc2)cc2c(=O)c(NC=O)coc2c1	InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)	ANMATWQYLIFGOK-UHFFFAOYSA-N					doublet; compound annotation
0391_004330	Imidazole ketone erastin	C35H35ClN6O5	3.3084	91824786		CC(C)Oc1c(-n2c(CN3CCN(C(=O)COc4ccc(Cl)cc4)CC3)nc3ccccc3c2=O)cc(C(=O)Cn2ccnc2)cc1	InChI=1S/C35H35ClN6O5/c1-24(2)47-32-12-7-25(31(43)20-40-14-13-37-23-40)19-30(32)42-33(38-29-6-4-3-5-28(29)35(42)45)21-39-15-17-41(18-16-39)34(44)22-46-27-10-8-26(36)9-11-27/h3-14,19,23-24H,15-18,20-22H2,1-2H3	PSPXJPWGVFNGQI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004332	AMG-47a	C29H28F3N5O2	3.6747	16086114		Cc1c(-c2cc3cnc(NCCN4CCOCC4)nc3cc2)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C29H28F3N5O2/c1-19-5-6-21(27(38)35-24-4-2-3-23(17-24)29(30,31)32)16-25(19)20-7-8-26-22(15-20)18-34-28(36-26)33-9-10-37-11-13-39-14-12-37/h2-8,15-18H,9-14H2,1H3,(H,35,38)(H,33,34,36)	DVRSTRMZTAPMKO-UHFFFAOYSA-N					doublet; compound annotation
0391_004333	1029692-15-6	C22H22N4O2	3.8548	24963749	CC(C)OC(=O)N[C@H]1CC2=C(C1)N(C3=C2C=C(C=C3)C#N)CC4=CC=CC=N4	CC(C)OC(=O)NC1Cc2c(C1)n(Cc1ccccn1)c1c2cc(C#N)cc1	InChI=1S/C22H22N4O2/c1-14(2)28-22(27)25-17-10-19-18-9-15(12-23)6-7-20(18)26(21(19)11-17)13-16-5-3-4-8-24-16/h3-9,14,17H,10-11,13H2,1-2H3,(H,25,27)/t17-/m0/s1	IHIWYQYVBNODSV-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_004335	retro-2	C19H16N2OS	4.0034	71716811		Cc1ccc(C2Nc3ccccc3C(=O)N2c2ccccc2)s1	InChI=1S/C19H16N2OS/c1-13-11-12-17(23-13)18-20-16-10-6-5-9-15(16)19(22)21(18)14-7-3-2-4-8-14/h2-12,18,20H,1H3	BOAPXDSRULBILC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004337	AMG-47a	C29H28F3N5O2	4.0709	16086114		Cc1c(-c2cc3cnc(NCCN4CCOCC4)nc3cc2)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C29H28F3N5O2/c1-19-5-6-21(27(38)35-24-4-2-3-23(17-24)29(30,31)32)16-25(19)20-7-8-26-22(15-20)18-34-28(36-26)33-9-10-37-11-13-39-14-12-37/h2-8,15-18H,9-14H2,1H3,(H,35,38)(H,33,34,36)	DVRSTRMZTAPMKO-UHFFFAOYSA-N					doublet; compound annotation
0391_004338	GB1107	C20H16Cl2F3N3O4S	4.0793	122443390	C1=CC(=C(C=C1S[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)N3C=C(N=N3)C4=CC(=C(C(=C4)F)F)F)O)Cl)Cl	OCC1OC(Sc2cc(Cl)c(Cl)cc2)C(O)C(n2cc(-c3cc(F)c(F)c(F)c3)nn2)C1O	InChI=1S/C20H16Cl2F3N3O4S/c21-10-2-1-9(5-11(10)22)33-20-19(31)17(18(30)15(7-29)32-20)28-6-14(26-27-28)8-3-12(23)16(25)13(24)4-8/h1-6,15,17-20,29-31H,7H2/t15-,17+,18+,19-,20-/m1/s1	CSGJIUAIYDKFPC-DABHTEOTSA-N					compound annotation
0391_004339	758679-97-9	C28H39N3O3	4.2055	2858523		Cc1cc2c(cc1C)n(CC(=O)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)c(NCCCO)n2	InChI=1S/C28H39N3O3/c1-17-12-22-23(13-18(17)2)31(26(30-22)29-10-9-11-32)16-24(33)19-14-20(27(3,4)5)25(34)21(15-19)28(6,7)8/h12-15,32,34H,9-11,16H2,1-8H3,(H,29,30)	CYCGGKILBWERDJ-UHFFFAOYSA-N					compound annotation
0391_004340	ULK-101	C22H16F4N4OS	4.9739	137628686	C1CC1[C@@H](C(F)(F)F)NC(=O)C2=CC(=CS2)C3=C4N=CC(=CN4N=C3)C5=CC=C(C=C5)F	O=C(NC(C1CC1)C(F)(F)F)c1cc(-c2c3ncc(-c4ccc(F)cc4)cn3nc2)cs1	InChI=1S/C22H16F4N4OS/c23-16-5-3-12(4-6-16)15-8-27-20-17(9-28-30(20)10-15)14-7-18(32-11-14)21(31)29-19(13-1-2-13)22(24,25)26/h3-11,13,19H,1-2H2,(H,29,31)/t19-/m0/s1	PFZRXJIYAFANHP-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_004343	193746-75-7	C19H20FN5O	1.8592	9863367		COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1	InChI=1S/C19H20FN5O/c1-26-19-22-11-8-16(24-19)18-17(13-2-4-14(20)5-3-13)23-12-25(18)15-6-9-21-10-7-15/h2-5,8,11-12,15,21H,6-7,9-10H2,1H3	PDTYLGXVBIWRIM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004345	1206101-20-3	C21H23N5O3S	2.1666	49831257		O=C(Nc1nn2c(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)cccc2n1)C1CC1	InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)	RIJLVEAXPNLDTC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004347	Longdaysin	C16H16F3N5	2.8747	49830252		CC(C)n1cnc2c(NCc3cc(C(F)(F)F)ccc3)ncnc21	InChI=1S/C16H16F3N5/c1-10(2)24-9-23-13-14(21-8-22-15(13)24)20-7-11-4-3-5-12(6-11)16(17,18)19/h3-6,8-10H,7H2,1-2H3,(H,20,21,22)	REKSFCCYDQMSIN-UHFFFAOYSA-N					doublet; compound annotation
0391_004348	CAY10603	C22H30N4O6	3.4945	24951314		CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1	InChI=1S/C22H30N4O6/c1-22(2,3)31-21(29)24-16-11-9-15(10-12-16)18-14-17(26-32-18)20(28)23-13-7-5-4-6-8-19(27)25-30/h9-12,14,30H,4-8,13H2,1-3H3,(H,23,28)(H,24,29)(H,25,27)	WWGBHDIHIVGYLZ-UHFFFAOYSA-N					doublet; compound annotation
0391_004349	Mavatrep	C25H21F3N2O	3.5743	17751090	CC(C)(C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)/C=C/C4=CC=C(C=C4)C(F)(F)F)O	CC(C)(O)c1ccccc1-c1cc2c(cc1)nc(C=Cc1ccc(C(F)(F)F)cc1)[nH]2	InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+	ORDHXXHTBUZRCN-NTEUORMPSA-N					doublet; compound annotation
0391_004350	Longdaysin	C16H16F3N5	3.6269	49830252		CC(C)n1cnc2c(NCc3cc(C(F)(F)F)ccc3)ncnc21	InChI=1S/C16H16F3N5/c1-10(2)24-9-23-13-14(21-8-22-15(13)24)20-7-11-4-3-5-12(6-11)16(17,18)19/h3-6,8-10H,7H2,1-2H3,(H,20,21,22)	REKSFCCYDQMSIN-UHFFFAOYSA-N					doublet; compound annotation
0391_004351	Mavatrep	C25H21F3N2O	3.6368	17751090	CC(C)(C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)/C=C/C4=CC=C(C=C4)C(F)(F)F)O	CC(C)(O)c1ccccc1-c1cc2c(cc1)nc(C=Cc1ccc(C(F)(F)F)cc1)[nH]2	InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+	ORDHXXHTBUZRCN-NTEUORMPSA-N					doublet; compound annotation
0391_004352	1032229-33-6	C20H22ClN3O3	3.6454	24905400		CNC(=O)c1cc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)ccc1	InChI=1S/C20H22ClN3O3/c1-22-19(25)14-5-4-6-15(13-14)23-20(26)24-11-9-16(10-12-24)27-18-8-3-2-7-17(18)21/h2-8,13,16H,9-12H2,1H3,(H,22,25)(H,23,26)	DPYTYQFYDLYWHZ-UHFFFAOYSA-N					doublet; compound annotation
0391_004353	CAY10603	C22H30N4O6	3.6504	24951314		CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1	InChI=1S/C22H30N4O6/c1-22(2,3)31-21(29)24-16-11-9-15(10-12-16)18-14-17(26-32-18)20(28)23-13-7-5-4-6-8-19(27)25-30/h9-12,14,30H,4-8,13H2,1-3H3,(H,23,28)(H,24,29)(H,25,27)	WWGBHDIHIVGYLZ-UHFFFAOYSA-N					doublet; compound annotation
0391_004354	1032229-33-6	C20H22ClN3O3	3.655	24905400		CNC(=O)c1cc(NC(=O)N2CCC(Oc3ccccc3Cl)CC2)ccc1	InChI=1S/C20H22ClN3O3/c1-22-19(25)14-5-4-6-15(13-14)23-20(26)24-11-9-16(10-12-24)27-18-8-3-2-7-17(18)21/h2-8,13,16H,9-12H2,1H3,(H,22,25)(H,23,26)	DPYTYQFYDLYWHZ-UHFFFAOYSA-N					doublet; compound annotation
0391_004355	CAY10603	C22H30N4O6	3.655	24951314		CC(C)(C)OC(=O)Nc1ccc(-c2cc(C(=O)NCCCCCCC(=O)NO)no2)cc1	InChI=1S/C22H30N4O6/c1-22(2,3)31-21(29)24-16-11-9-15(10-12-16)18-14-17(26-32-18)20(28)23-13-7-5-4-6-8-19(27)25-30/h9-12,14,30H,4-8,13H2,1-3H3,(H,23,28)(H,24,29)(H,25,27)	WWGBHDIHIVGYLZ-UHFFFAOYSA-N					doublet; compound annotation
0391_004356	Mavatrep	C25H21F3N2O	4.4316	17751090	CC(C)(C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)/C=C/C4=CC=C(C=C4)C(F)(F)F)O	CC(C)(O)c1ccccc1-c1cc2c(cc1)nc(C=Cc1ccc(C(F)(F)F)cc1)[nH]2	InChI=1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+	ORDHXXHTBUZRCN-NTEUORMPSA-N					doublet; compound annotation
0391_004357	878489-28-2	C21H29ClN2O4S	4.438	11575823	CC(C)(C(=O)NC1[C@@H]2CC3C[C@H]1CC(C2)(C3)NS(=O)(=O)C)OC4=CC=C(C=C4)Cl	CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1C2CC3CC1CC(NS(C)(=O)=O)(C3)C2	InChI=1S/C21H29ClN2O4S/c1-20(2,28-17-6-4-16(22)5-7-17)19(25)23-18-14-8-13-9-15(18)12-21(10-13,11-14)24-29(3,26)27/h4-7,13-15,18,24H,8-12H2,1-3H3,(H,23,25)/t13?,14-,15+,18?,21?	OSGIRCJRKSAODN-DJASPMHUSA-N					doublet; compound annotation
0391_004358	BMS-5	C17H14Cl2F2N4OS	4.4428	56965901		CC(C)C(=O)Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1	InChI=1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)	IVUGBSGLHRJSSP-UHFFFAOYSA-N					compound annotation
0391_004359	878489-28-2	C21H29ClN2O4S	4.4428	11575823	CC(C)(C(=O)NC1[C@@H]2CC3C[C@H]1CC(C2)(C3)NS(=O)(=O)C)OC4=CC=C(C=C4)Cl	CC(C)(Oc1ccc(Cl)cc1)C(=O)NC1C2CC3CC1CC(NS(C)(=O)=O)(C3)C2	InChI=1S/C21H29ClN2O4S/c1-20(2,28-17-6-4-16(22)5-7-17)19(25)23-18-14-8-13-9-15(18)12-21(10-13,11-14)24-29(3,26)27/h4-7,13-15,18,24H,8-12H2,1-3H3,(H,23,25)/t13?,14-,15+,18?,21?	OSGIRCJRKSAODN-DJASPMHUSA-N					doublet; compound annotation
0391_004360	SR9243	C31H32BrNO4S2	6.1031	76073169		Cc1cc(C)c(S(=O)(=O)N(CCc2cc(Br)ccc2)Cc2ccc(-c3cc(S(C)(=O)=O)ccc3)cc2)c(C)c1	InChI=1S/C31H32BrNO4S2/c1-22-17-23(2)31(24(3)18-22)39(36,37)33(16-15-25-7-5-9-29(32)19-25)21-26-11-13-27(14-12-26)28-8-6-10-30(20-28)38(4,34)35/h5-14,17-20H,15-16,21H2,1-4H3	FYQFEJFTCLKXTQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004362	DDD107498	C27H31FN4O2	1.6011	71748268		O=C(NCCN1CCCC1)c1cc(-c2ccc(CN3CCOCC3)cc2)nc2c1cc(F)cc2	InChI=1S/C27H31FN4O2/c28-22-7-8-25-23(17-22)24(27(33)29-9-12-31-10-1-2-11-31)18-26(30-25)21-5-3-20(4-6-21)19-32-13-15-34-16-14-32/h3-8,17-18H,1-2,9-16,19H2,(H,29,33)	BENUHBSJOJMZEE-UHFFFAOYSA-N					compound annotation
0391_004363	GW-791343	C20H24F2N4O	2.0896	9848160		Cc1c(NC(=O)CNc2cc(F)c(F)cc2)cc(CN2CCNCC2)cc1	InChI=1S/C20H24F2N4O/c1-14-2-3-15(13-26-8-6-23-7-9-26)10-19(14)25-20(27)12-24-16-4-5-17(21)18(22)11-16/h2-5,10-11,23-24H,6-9,12-13H2,1H3,(H,25,27)	GRUWKTIRBBPZSD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004365	1-(1-Naphthylmethyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol	C20H19NO2	2.1533	9861306		Oc1c(O)cc2c(c1)CCNC2Cc1cccc2ccccc12	InChI=1S/C20H19NO2/c22-19-11-15-8-9-21-18(17(15)12-20(19)23)10-14-6-3-5-13-4-1-2-7-16(13)14/h1-7,11-12,18,21-23H,8-10H2	YGCQFKVNIBDJFW-UHFFFAOYSA-N					compound annotation
0391_004366	BIX 02565	C26H30N6O2	2.2503	53246941	C[C@@H]1CCNC(=O)C2=CC3=C(N12)C=C(C=C3)C(=O)NC4=NC5=CC=CC=C5N4CCCN(C)C	CC1CCNC(=O)c2cc3c(cc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3)n21	InChI=1S/C26H30N6O2/c1-17-11-12-27-25(34)23-15-18-9-10-19(16-22(18)32(17)23)24(33)29-26-28-20-7-4-5-8-21(20)31(26)14-6-13-30(2)3/h4-5,7-10,15-17H,6,11-14H2,1-3H3,(H,27,34)(H,28,29,33)/t17-/m1/s1	ZHMXXVNQAFCXKK-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_004368	APTO-253	C22H14FN5	2.4071	11960271		Cc1c(-c2nc3c4cccnc4c4ncccc4c3[nH]2)c2c(ccc(F)c2)[nH]1	InChI=1S/C22H14FN5/c1-11-17(15-10-12(23)6-7-16(15)26-11)22-27-20-13-4-2-8-24-18(13)19-14(21(20)28-22)5-3-9-25-19/h2-10,26H,1H3,(H,27,28)	NIRXBXIPHUTNNI-UHFFFAOYSA-N					doublet; compound annotation
0391_004369	APTO-253	C22H14FN5	2.4101	11960271		Cc1c(-c2nc3c4cccnc4c4ncccc4c3[nH]2)c2c(ccc(F)c2)[nH]1	InChI=1S/C22H14FN5/c1-11-17(15-10-12(23)6-7-16(15)26-11)22-27-20-13-4-2-8-24-18(13)19-14(21(20)28-22)5-3-9-25-19/h2-10,26H,1H3,(H,27,28)	NIRXBXIPHUTNNI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004371	A 438079	C13H9Cl2N5	2.669	11673921		Clc1cccc(-c2nnnn2Cc2cnccc2)c1Cl	InChI=1S/C13H9Cl2N5/c14-11-5-1-4-10(12(11)15)13-17-18-19-20(13)8-9-3-2-6-16-7-9/h1-7H,8H2	MMPAULQSJLVKHP-UHFFFAOYSA-N					doublet; compound annotation
0391_004372	56396-35-1	C18H12N2O2	4.2802	6438504	C1=CC=C(C=C1)N2C=C(C3=CC=CC=C32)/C=C(\C#N)/C(=O)O	N#CC(=Cc1cn(-c2ccccc2)c2ccccc12)C(=O)O	InChI=1S/C18H12N2O2/c19-11-13(18(21)22)10-14-12-20(15-6-2-1-3-7-15)17-9-5-4-8-16(14)17/h1-10,12H,(H,21,22)/b13-10+	BIZNHCWFGNKBBZ-JLHYYAGUSA-N					doublet; compound annotation
0391_004373	56396-35-1	C18H12N2O2	4.2857	6438504	C1=CC=C(C=C1)N2C=C(C3=CC=CC=C32)/C=C(\C#N)/C(=O)O	N#CC(=Cc1cn(-c2ccccc2)c2ccccc12)C(=O)O	InChI=1S/C18H12N2O2/c19-11-13(18(21)22)10-14-12-20(15-6-2-1-3-7-15)17-9-5-4-8-16(14)17/h1-10,12H,(H,21,22)/b13-10+	BIZNHCWFGNKBBZ-JLHYYAGUSA-N					doublet; compound annotation
0391_004374	56396-35-1	C18H12N2O2	4.3169	6438504	C1=CC=C(C=C1)N2C=C(C3=CC=CC=C32)/C=C(\C#N)/C(=O)O	N#CC(=Cc1cn(-c2ccccc2)c2ccccc12)C(=O)O	InChI=1S/C18H12N2O2/c19-11-13(18(21)22)10-14-12-20(15-6-2-1-3-7-15)17-9-5-4-8-16(14)17/h1-10,12H,(H,21,22)/b13-10+	BIZNHCWFGNKBBZ-JLHYYAGUSA-N					doublet; compound annotation
0391_004375	56396-35-1	C18H12N2O2	4.3199	6438504	C1=CC=C(C=C1)N2C=C(C3=CC=CC=C32)/C=C(\C#N)/C(=O)O	N#CC(=Cc1cn(-c2ccccc2)c2ccccc12)C(=O)O	InChI=1S/C18H12N2O2/c19-11-13(18(21)22)10-14-12-20(15-6-2-1-3-7-15)17-9-5-4-8-16(14)17/h1-10,12H,(H,21,22)/b13-10+	BIZNHCWFGNKBBZ-JLHYYAGUSA-N					doublet; compound annotation
0391_004376	1048973-47-2	C21H23N3O2	4.6864	135743701		CCCCCCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21	InChI=1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14,26H,2-4,10,15H2,1H3	ICNRTDOKKSWDRL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004378	BIO-Acetoxime	C18H12BrN3O3	4.795	135398521	CC(=O)O/N=C/1\C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC(=C4)Br)O	CC(=O)ON=C1C(c2c(O)[nH]c3c2ccc(Br)c3)=Nc2ccccc12	InChI=1S/C18H12BrN3O3/c1-9(23)25-22-16-12-4-2-3-5-13(12)20-17(16)15-11-7-6-10(19)8-14(11)21-18(15)24/h2-8,21,24H,1H3/b22-16+	HUDSYNWJCPDHLL-CJLVFECKSA-N					compound annotation
0391_004379	CCMI	C19H15Cl2N3O2	4.9951	17757386	CC1=NOC(=C1)/C(=C\NC2=CC=C(C=C2)Cl)/C(=O)NC3=CC=C(C=C3)Cl	Cc1noc(C(=CNc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C19H15Cl2N3O2/c1-12-10-18(26-24-12)17(11-22-15-6-2-13(20)3-7-15)19(25)23-16-8-4-14(21)5-9-16/h2-11,22H,1H3,(H,23,25)/b17-11+	VMAKIACTLSBBIY-GZTJUZNOSA-N					doublet; compound annotation
0391_004380	CCMI	C19H15Cl2N3O2	4.998	17757386	CC1=NOC(=C1)/C(=C\NC2=CC=C(C=C2)Cl)/C(=O)NC3=CC=C(C=C3)Cl	Cc1noc(C(=CNc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C19H15Cl2N3O2/c1-12-10-18(26-24-12)17(11-22-15-6-2-13(20)3-7-15)19(25)23-16-8-4-14(21)5-9-16/h2-11,22H,1H3,(H,23,25)/b17-11+	VMAKIACTLSBBIY-GZTJUZNOSA-N					doublet; removed another duplicate entry; compound annotation
0391_004382	1048973-47-2	C21H23N3O2	5.5865	135743701		CCCCCCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21	InChI=1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14,26H,2-4,10,15H2,1H3	ICNRTDOKKSWDRL-UHFFFAOYSA-N					doublet; compound annotation
0391_004383	1048973-47-2	C21H23N3O2	5.5905	135743701		CCCCCCn1c(O)c(N=NC(=O)c2ccccc2)c2ccccc21	InChI=1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14,26H,2-4,10,15H2,1H3	ICNRTDOKKSWDRL-UHFFFAOYSA-N					doublet; compound annotation
0391_004384	CCMI	C19H15Cl2N3O2	5.6445	17757386	CC1=NOC(=C1)/C(=C\NC2=CC=C(C=C2)Cl)/C(=O)NC3=CC=C(C=C3)Cl	Cc1noc(C(=CNc2ccc(Cl)cc2)C(=O)Nc2ccc(Cl)cc2)c1	InChI=1S/C19H15Cl2N3O2/c1-12-10-18(26-24-12)17(11-22-15-6-2-13(20)3-7-15)19(25)23-16-8-4-14(21)5-9-16/h2-11,22H,1H3,(H,23,25)/b17-11+	VMAKIACTLSBBIY-GZTJUZNOSA-N					doublet; compound annotation
0391_004385	cephapirin	C17H17N3O6S2	0.9897	30699	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O	CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CSc3ccncc3)C2SC1	InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1	UQLLWWBDSUHNEB-CZUORRHYSA-N					doublet; compound annotation
0391_004386	cephapirin	C17H17N3O6S2	1.0648	30699	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O	CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CSc3ccncc3)C2SC1	InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1	UQLLWWBDSUHNEB-CZUORRHYSA-N					doublet; compound annotation
0391_004387	ALK inhibitor 2	C23H28ClN7O3S	2.6299	66577032		CNS(=O)(=O)c1ccccc1Nc1nc(Nc2c(OC)cc(N3CCN(C)CC3)cc2)ncc1Cl	InChI=1S/C23H28ClN7O3S/c1-25-35(32,33)21-7-5-4-6-19(21)27-22-17(24)15-26-23(29-22)28-18-9-8-16(14-20(18)34-3)31-12-10-30(2)11-13-31/h4-9,14-15,25H,10-13H2,1-3H3,(H2,26,27,28,29)	NURCYJBMLKNYHB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004389	SAR131675	C18H22N4O4	2.7	71295845	CCN1C(=C(C(=O)C2=C1N=C(C=C2)C#C[C@](C)(COC)O)C(=O)NC)N	CCn1c(N)c(C(=O)NC)c(=O)c2c1nc(C#CC(C)(O)COC)cc2	InChI=1S/C18H22N4O4/c1-5-22-15(19)13(17(24)20-3)14(23)12-7-6-11(21-16(12)22)8-9-18(2,25)10-26-4/h6-7,25H,5,10,19H2,1-4H3,(H,20,24)/t18-/m1/s1	PFMPOBVAYMTUOX-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_004391	Basimglurant	C18H13ClFN3	3.0462	11438771		Cc1nc(C#Cc2cc(Cl)ncc2)c(C)n1-c1ccc(F)cc1	InChI=1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3	UPZWINBEAHDTLA-UHFFFAOYSA-N					doublet; compound annotation
0391_004392	Isopropyl Phenazone	C14H18N2O	3.0528	3778		Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C	InChI=1S/C14H18N2O/c1-10(2)13-11(3)15(4)16(14(13)17)12-8-6-5-7-9-12/h5-10H,1-4H3	PXWLVJLKJGVOKE-UHFFFAOYSA-N					compound annotation
0391_004393	83797-69-7	C12H21N3O2	3.3265	10354234		CCCCCCCCNc1cc(=O)[nH]c(=O)[nH]1	InChI=1S/C12H21N3O2/c1-2-3-4-5-6-7-8-13-10-9-11(16)15-12(17)14-10/h9H,2-8H2,1H3,(H3,13,14,15,16,17)	PFSWASUQURIOOR-UHFFFAOYSA-N					compound annotation
0391_004394	Kira8	C31H29ClN6O3S	3.3292	118721244	CC1=C(C2=C(C=C1)C(=CC=C2)NS(=O)(=O)C3=CC=CC=C3Cl)OC4=C(C=CC=N4)C5=NC(=NC=C5)N[C@H]6CCCNC6	Cc1c(Oc2ncccc2-c2nc(NC3CCCNC3)ncc2)c2c(cc1)c(NS(=O)(=O)c1ccccc1Cl)ccc2	InChI=1S/C31H29ClN6O3S/c1-20-13-14-22-23(8-4-11-27(22)38-42(39,40)28-12-3-2-10-25(28)32)29(20)41-30-24(9-6-17-34-30)26-15-18-35-31(37-26)36-21-7-5-16-33-19-21/h2-4,6,8-15,17-18,21,33,38H,5,7,16,19H2,1H3,(H,35,36,37)/t21-/m0/s1	XMWUCMFVDXDRDE-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_004396	Basimglurant	C18H13ClFN3	3.4236	11438771		Cc1nc(C#Cc2cc(Cl)ncc2)c(C)n1-c1ccc(F)cc1	InChI=1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3	UPZWINBEAHDTLA-UHFFFAOYSA-N					doublet; compound annotation
0391_004397	RNPA1000	C23H18BrN3O3	4.456	1268985	CC1=CC(=C(N1C2=CC=C(C=C2)C(=O)O)C)/C=C(\C#N)/C(=O)NC3=CC(=CC=C3)Br	Cc1cc(C=C(C#N)C(=O)Nc2cc(Br)ccc2)c(C)n1-c1ccc(C(=O)O)cc1	InChI=1S/C23H18BrN3O3/c1-14-10-17(15(2)27(14)21-8-6-16(7-9-21)23(29)30)11-18(13-25)22(28)26-20-5-3-4-19(24)12-20/h3-12H,1-2H3,(H,26,28)(H,29,30)/b18-11+	WQCMDUBFZYCGMI-WOJGMQOQSA-N					doublet; compound annotation
0391_004398	RNPA1000	C23H18BrN3O3	4.6838	1268985	CC1=CC(=C(N1C2=CC=C(C=C2)C(=O)O)C)/C=C(\C#N)/C(=O)NC3=CC(=CC=C3)Br	Cc1cc(C=C(C#N)C(=O)Nc2cc(Br)ccc2)c(C)n1-c1ccc(C(=O)O)cc1	InChI=1S/C23H18BrN3O3/c1-14-10-17(15(2)27(14)21-8-6-16(7-9-21)23(29)30)11-18(13-25)22(28)26-20-5-3-4-19(24)12-20/h3-12H,1-2H3,(H,26,28)(H,29,30)/b18-11+	WQCMDUBFZYCGMI-WOJGMQOQSA-N					doublet; removed another duplicate entry; compound annotation
0391_004400	Semagacestat	C19H27N3O4	2.4703	9843750	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O	CC(NC(=O)C(O)C(C)C)C(=O)NC1C(=O)N(C)CCc2ccccc21	InChI=1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1	PKXWXXPNHIWQHW-RCBQFDQVSA-N					removed another duplicate entry; compound annotation
0391_004402	132834-56-1	C10H11ClF3N3	2.5521	9796408		FC(F)(F)c1c(Cl)nc(N2CCNCC2)cc1	InChI=1S/C10H11ClF3N3/c11-9-7(10(12,13)14)1-2-8(16-9)17-5-3-15-4-6-17/h1-2,15H,3-6H2	QZYYPQAYSFBKPW-UHFFFAOYSA-N					compound annotation
0391_004403	UC-112	C22H24N2O2	2.8052	30918719		Oc1c2ncccc2c(COCc2ccccc2)cc1CN1CCCC1	InChI=1S/C22H24N2O2/c25-22-18(14-24-11-4-5-12-24)13-19(20-9-6-10-23-21(20)22)16-26-15-17-7-2-1-3-8-17/h1-3,6-10,13,25H,4-5,11-12,14-16H2	LTGLGIQQZXSLLF-UHFFFAOYSA-N					compound annotation
0391_004404	BMS-214662	C25H23N5O2S2	3.1503	448545	C1[C@H](N(CC2=C(N1CC3=CN=CN3)C=CC(=C2)C#N)S(=O)(=O)C4=CC=CS4)CC5=CC=CC=C5	N#Cc1cc2c(cc1)N(Cc1cnc[nH]1)CC(Cc1ccccc1)N(S(=O)(=O)c1cccs1)C2	InChI=1S/C25H23N5O2S2/c26-13-20-8-9-24-21(11-20)15-30(34(31,32)25-7-4-10-33-25)23(12-19-5-2-1-3-6-19)17-29(24)16-22-14-27-18-28-22/h1-11,14,18,23H,12,15-17H2,(H,27,28)/t23-/m1/s1	OLCWFLWEHWLBTO-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_004406	Cobimetinib (racemate)	C21H21F3IN3O2	3.3746	51038893		O=C(c1ccc(F)c(F)c1Nc1c(F)cc(I)cc1)N1CC(O)(C2CCCCN2)C1	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2	BSMCAPRUBJMWDF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004408	Danicopan	C26H23BrFN7O3	3.4352	118323590	CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4C[C@@H](C[C@H]4C(=O)NC5=NC(=CC=C5)Br)F	CC(=O)c1nn(CC(=O)N2CC(F)CC2C(=O)Nc2nc(Br)ccc2)c2c1cc(-c1cnc(C)nc1)cc2	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	PIBARDGJJAGJAJ-NQIIRXRSSA-N					doublet; compound annotation
0391_004409	Danicopan	C26H23BrFN7O3	3.4384	118323590	CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4C[C@@H](C[C@H]4C(=O)NC5=NC(=CC=C5)Br)F	CC(=O)c1nn(CC(=O)N2CC(F)CC2C(=O)Nc2nc(Br)ccc2)c2c1cc(-c1cnc(C)nc1)cc2	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	PIBARDGJJAGJAJ-NQIIRXRSSA-N					doublet; compound annotation
0391_004410	Cobimetinib (racemate)	C21H21F3IN3O2	3.5793	51038893		O=C(c1ccc(F)c(F)c1Nc1c(F)cc(I)cc1)N1CC(O)(C2CCCCN2)C1	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2	BSMCAPRUBJMWDF-UHFFFAOYSA-N					doublet; compound annotation
0391_004411	MD2-TLR4-IN-1	C22H14Cl2N4O	3.591	138454798		O=C(Nc1cc2c(cc1)[nH]nc2-c1cc2c(cc1)[nH]cc2)c1c(Cl)cccc1Cl	InChI=1S/C22H14Cl2N4O/c23-16-2-1-3-17(24)20(16)22(29)26-14-5-7-19-15(11-14)21(28-27-19)13-4-6-18-12(10-13)8-9-25-18/h1-11,25H,(H,26,29)(H,27,28)	AZPDJGLJPDRCDQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004413	MD2-TLR4-IN-1	C22H14Cl2N4O	3.594	138454798		O=C(Nc1cc2c(cc1)[nH]nc2-c1cc2c(cc1)[nH]cc2)c1c(Cl)cccc1Cl	InChI=1S/C22H14Cl2N4O/c23-16-2-1-3-17(24)20(16)22(29)26-14-5-7-19-15(11-14)21(28-27-19)13-4-6-18-12(10-13)8-9-25-18/h1-11,25H,(H,26,29)(H,27,28)	AZPDJGLJPDRCDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_004414	Mutant IDH1-IN-1	C30H31FN4O2	4.0757	89696514		Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1cnc2ccccc21)c1cc(F)ccc1	InChI=1S/C30H31FN4O2/c1-21-10-5-6-15-25(21)29(30(37)33-23-12-3-2-4-13-23)35(24-14-9-11-22(31)18-24)28(36)19-34-20-32-26-16-7-8-17-27(26)34/h5-11,14-18,20,23,29H,2-4,12-13,19H2,1H3,(H,33,37)	DXYIOARJXVTYJW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004416	SCHEMBL2105915	C26H37NO4S	5.6088	11963194		COC1CCC(N(C(=O)C2CCC(C)CC2)c2c(C(=O)O)sc(C3=CCCCC3)c2)CC1	InChI=1S/C26H37NO4S/c1-17-8-10-19(11-9-17)25(28)27(20-12-14-21(31-2)15-13-20)22-16-23(32-24(22)26(29)30)18-6-4-3-5-7-18/h6,16-17,19-21H,3-5,7-15H2,1-2H3,(H,29,30)	LNYKGELUODVSNS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004418	JANEX-1	C16H15N3O3	1.7097	3794		COc1c(OC)cc2c(Nc3ccc(O)cc3)ncnc2c1	InChI=1S/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-3-5-11(20)6-4-10/h3-9,20H,1-2H3,(H,17,18,19)	HOZUXBLMYUPGPZ-UHFFFAOYSA-N					compound annotation
0391_004419	WAY-262611	C20H22N4	1.7694	25199517		NCC1CCN(c2nccc(-c3cc4ccccc4cc3)n2)CC1	InChI=1S/C20H22N4/c21-14-15-8-11-24(12-9-15)20-22-10-7-19(23-20)18-6-5-16-3-1-2-4-17(16)13-18/h1-7,10,13,15H,8-9,11-12,14,21H2	QHLITPHIARVDJI-UHFFFAOYSA-N					doublet; compound annotation
0391_004420	WAY-262611	C20H22N4	2.9854	25199517		NCC1CCN(c2nccc(-c3cc4ccccc4cc3)n2)CC1	InChI=1S/C20H22N4/c21-14-15-8-11-24(12-9-15)20-22-10-7-19(23-20)18-6-5-16-3-1-2-4-17(16)13-18/h1-7,10,13,15H,8-9,11-12,14,21H2	QHLITPHIARVDJI-UHFFFAOYSA-N					doublet; compound annotation
0391_004421	CB-5083	C24H23N5O2	3.2907	73051434		Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(COCC2)c(NCc2ccccc2)n1	InChI=1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)	RDALZZCKQFLGJP-UHFFFAOYSA-N					doublet; compound annotation
0391_004422	CB-5083	C24H23N5O2	3.2982	73051434		Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(COCC2)c(NCc2ccccc2)n1	InChI=1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)	RDALZZCKQFLGJP-UHFFFAOYSA-N					doublet; compound annotation
0391_004423	CB-5083	C24H23N5O2	3.301	73051434		Cc1cc2c(C(N)=O)cccc2n1-c1nc2c(COCC2)c(NCc2ccccc2)n1	InChI=1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)	RDALZZCKQFLGJP-UHFFFAOYSA-N					doublet; compound annotation
0391_004424	130798-51-5	C12H9Cl2NO4	3.5012	446916		O=C(O)CCc1c(C(=O)O)[nH]c2c1c(Cl)cc(Cl)c2	InChI=1S/C12H9Cl2NO4/c13-5-3-7(14)10-6(1-2-9(16)17)11(12(18)19)15-8(10)4-5/h3-4,15H,1-2H2,(H,16,17)(H,18,19)	KNBSYZNKEAWABY-UHFFFAOYSA-N					compound annotation
0391_004425	Ertugliflozin	C22H25ClO7	3.5012	44814423	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C34OCC(CO)(O3)C(O)C(O)C4O)c2)cc1	InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	MCIACXAZCBVDEE-CUUWFGFTSA-N					doublet; removed another duplicate entry; compound annotation
0391_004427	Ertugliflozin	C22H25ClO7	3.5044	44814423	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C34OCC(CO)(O3)C(O)C(O)C4O)c2)cc1	InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1	MCIACXAZCBVDEE-CUUWFGFTSA-N					doublet; compound annotation
0391_004428	ETP-46464	C30H22N4O2	3.7983	72199292		CC(C)(C#N)c1ccc(N2C(=O)OCc3c2c2cc(-c4cc5ccccc5nc4)ccc2nc3)cc1	InChI=1S/C30H22N4O2/c1-30(2,18-31)23-8-10-24(11-9-23)34-28-22(17-36-29(34)35)16-33-27-12-7-19(14-25(27)28)21-13-20-5-3-4-6-26(20)32-15-21/h3-16H,17H2,1-2H3	DPLMXAYKJZOTKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004430	pramiracetam	C14H27N3O2	0.6432	51712		CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C	InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)	ZULJGOSFKWFVRX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004432	Azathramycin	C37H70N2O12	1.7309	9810601	CC[C@@H]1[C@@]([C@@H]([C@H](NC[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CNC(C)C(O)C1(C)O	InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)38-18-19(2)16-35(8,44)32(51-34-28(40)25(39(11)12)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1	HRKNNHYKWGYTEN-HOQMJRDDSA-N					doublet; compound annotation
0391_004433	Azathramycin	C37H70N2O12	2.1817	9810601	CC[C@@H]1[C@@]([C@@H]([C@H](NC[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CNC(C)C(O)C1(C)O	InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)38-18-19(2)16-35(8,44)32(51-34-28(40)25(39(11)12)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1	HRKNNHYKWGYTEN-HOQMJRDDSA-N					doublet; removed another duplicate entry; compound annotation
0391_004435	YHO-13177	C20H22N2O3S	2.2267	16757522	COC1=C(C=C(C=C1)/C(=C/C2=CC=C(S2)N3CCC(CC3)O)/C#N)OC	COc1c(OC)cc(C(C#N)=Cc2ccc(N3CCC(O)CC3)s2)cc1	InChI=1S/C20H22N2O3S/c1-24-18-5-3-14(12-19(18)25-2)15(13-21)11-17-4-6-20(26-17)22-9-7-16(23)8-10-22/h3-6,11-12,16,23H,7-10H2,1-2H3/b15-11+	NOGGBVNCVONHHC-RVDMUPIBSA-N					doublet; compound annotation
0391_004436	AF38469	C15H11F3N2O3	2.7062	72706115		Cc1nc(NC(=O)c2c(C(=O)O)cc(C(F)(F)F)cc2)ccc1	InChI=1S/C15H11F3N2O3/c1-8-3-2-4-12(19-8)20-13(21)10-6-5-9(15(16,17)18)7-11(10)14(22)23/h2-7H,1H3,(H,22,23)(H,19,20,21)	JWCUSQCZMQIBMR-UHFFFAOYSA-N					compound annotation
0391_004437	BLZ945	C20H22N4O3S	2.7107	46184986	CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)N[C@@H]4CCCC[C@H]4O	CNC(=O)c1nccc(Oc2cc3c(cc2)nc(NC2CCCCC2O)s3)c1	InChI=1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1	ADZBMFGQQWPHMJ-RHSMWYFYSA-N					removed another duplicate entry; compound annotation
0391_004439	YHO-13351 (free base)	C26H33N3O4S	3.1836	11964785	CCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)/C=C(\C#N)/C3=CC(=C(C=C3)OC)OC	CCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3cc(OC)c(OC)cc3)s2)CC1	InChI=1S/C26H33N3O4S/c1-5-28(6-2)18-26(30)33-21-11-13-29(14-12-21)25-10-8-22(34-25)15-20(17-27)19-7-9-23(31-3)24(16-19)32-4/h7-10,15-16,21H,5-6,11-14,18H2,1-4H3/b20-15+	STLNUMIUXISGQQ-HMMYKYKNSA-N					doublet; compound annotation
0391_004440	YHO-13351 (free base)	C26H33N3O4S	3.1864	11964785	CCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)/C=C(\C#N)/C3=CC(=C(C=C3)OC)OC	CCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3cc(OC)c(OC)cc3)s2)CC1	InChI=1S/C26H33N3O4S/c1-5-28(6-2)18-26(30)33-21-11-13-29(14-12-21)25-10-8-22(34-25)15-20(17-27)19-7-9-23(31-3)24(16-19)32-4/h7-10,15-16,21H,5-6,11-14,18H2,1-4H3/b20-15+	STLNUMIUXISGQQ-HMMYKYKNSA-N					doublet; removed another duplicate entry; compound annotation
0391_004442	Genz-123346	C24H38N2O4	3.2857	23652732	CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C24H38N2O4/c1-2-3-4-5-6-7-10-23(27)25-20(18-26-13-8-9-14-26)24(28)19-11-12-21-22(17-19)30-16-15-29-21/h11-12,17,20,24,28H,2-10,13-16,18H2,1H3,(H,25,27)/t20-,24-/m1/s1	JMNXWOFCUJJYEO-HYBUGGRVSA-N					doublet; compound annotation
0391_004443	Genz-123346	C24H38N2O4	3.364	23652732	CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C24H38N2O4/c1-2-3-4-5-6-7-10-23(27)25-20(18-26-13-8-9-14-26)24(28)19-11-12-21-22(17-19)30-16-15-29-21/h11-12,17,20,24,28H,2-10,13-16,18H2,1H3,(H,25,27)/t20-,24-/m1/s1	JMNXWOFCUJJYEO-HYBUGGRVSA-N					doublet; compound annotation
0391_004444	Genz-123346	C24H38N2O4	3.3672	23652732	CCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C24H38N2O4/c1-2-3-4-5-6-7-10-23(27)25-20(18-26-13-8-9-14-26)24(28)19-11-12-21-22(17-19)30-16-15-29-21/h11-12,17,20,24,28H,2-10,13-16,18H2,1H3,(H,25,27)/t20-,24-/m1/s1	JMNXWOFCUJJYEO-HYBUGGRVSA-N					doublet; compound annotation
0391_004445	YHO-13351 (free base)	C26H33N3O4S	3.4169	11964785	CCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)/C=C(\C#N)/C3=CC(=C(C=C3)OC)OC	CCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3cc(OC)c(OC)cc3)s2)CC1	InChI=1S/C26H33N3O4S/c1-5-28(6-2)18-26(30)33-21-11-13-29(14-12-21)25-10-8-22(34-25)15-20(17-27)19-7-9-23(31-3)24(16-19)32-4/h7-10,15-16,21H,5-6,11-14,18H2,1-4H3/b20-15+	STLNUMIUXISGQQ-HMMYKYKNSA-N					doublet; compound annotation
0391_004446	YHO-13351 (free base)	C26H33N3O4S	3.4198	11964785	CCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)/C=C(\C#N)/C3=CC(=C(C=C3)OC)OC	CCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3cc(OC)c(OC)cc3)s2)CC1	InChI=1S/C26H33N3O4S/c1-5-28(6-2)18-26(30)33-21-11-13-29(14-12-21)25-10-8-22(34-25)15-20(17-27)19-7-9-23(31-3)24(16-19)32-4/h7-10,15-16,21H,5-6,11-14,18H2,1-4H3/b20-15+	STLNUMIUXISGQQ-HMMYKYKNSA-N					doublet; removed another duplicate entry; compound annotation
0391_004448	A-836339	C16H26N2O2S	3.5156	17754357		COCCn1c(C)c(C)sc1=NC(=O)C1C(C)(C)C1(C)C	InChI=1S/C16H26N2O2S/c1-10-11(2)21-14(18(10)8-9-20-7)17-13(19)12-15(3,4)16(12,5)6/h12H,8-9H2,1-7H3	JKGIMVBQKSRTGX-UHFFFAOYSA-N					compound annotation
0391_004449	YHO-13177	C20H22N2O3S	3.556	16757522	COC1=C(C=C(C=C1)/C(=C/C2=CC=C(S2)N3CCC(CC3)O)/C#N)OC	COc1c(OC)cc(C(C#N)=Cc2ccc(N3CCC(O)CC3)s2)cc1	InChI=1S/C20H22N2O3S/c1-24-18-5-3-14(12-19(18)25-2)15(13-21)11-17-4-6-20(26-17)22-9-7-16(23)8-10-22/h3-6,11-12,16,23H,7-10H2,1-2H3/b15-11+	NOGGBVNCVONHHC-RVDMUPIBSA-N					doublet; compound annotation
0391_004450	Tanaproget	C16H15N3OS	3.8036	4369524		Cn1c(C#N)ccc1-c1cc2c(cc1)NC(=S)OC2(C)C	InChI=1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21)	PYVFWTPEBMRKSR-UHFFFAOYSA-N					compound annotation
0391_004451	YHO-13177	C20H22N2O3S	3.8166	16757522	COC1=C(C=C(C=C1)/C(=C/C2=CC=C(S2)N3CCC(CC3)O)/C#N)OC	COc1c(OC)cc(C(C#N)=Cc2ccc(N3CCC(O)CC3)s2)cc1	InChI=1S/C20H22N2O3S/c1-24-18-5-3-14(12-19(18)25-2)15(13-21)11-17-4-6-20(26-17)22-9-7-16(23)8-10-22/h3-6,11-12,16,23H,7-10H2,1-2H3/b15-11+	NOGGBVNCVONHHC-RVDMUPIBSA-N					doublet; compound annotation
0391_004452	.alpha.-Hypophamine	C43H66N12O12S2	1.9095	11979742	CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O	InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35?/m0/s1	XNOPRXBHLZRZKH-OMTOYRQASA-N					doublet; removed another duplicate entry; compound annotation
0391_004454	.alpha.-Hypophamine	C43H66N12O12S2	1.9941	11979742	CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O	InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35?/m0/s1	XNOPRXBHLZRZKH-OMTOYRQASA-N					doublet; compound annotation
0391_004455	TLR7 agonist T7	C16H17N5O5	2.0529	58019867		COCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(C(=O)O)cc3)c2n1	InChI=1S/C16H17N5O5/c1-25-6-7-26-15-19-12(17)11-13(20-15)21(16(24)18-11)8-9-2-4-10(5-3-9)14(22)23/h2-5H,6-8H2,1H3,(H,18,24)(H,22,23)(H2,17,19,20)	ATISKRYGYNSRNP-UHFFFAOYSA-N					doublet; compound annotation
0391_004456	TLR7 agonist T7	C16H17N5O5	2.0558	58019867		COCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(C(=O)O)cc3)c2n1	InChI=1S/C16H17N5O5/c1-25-6-7-26-15-19-12(17)11-13(20-15)21(16(24)18-11)8-9-2-4-10(5-3-9)14(22)23/h2-5H,6-8H2,1H3,(H,18,24)(H,22,23)(H2,17,19,20)	ATISKRYGYNSRNP-UHFFFAOYSA-N					doublet; compound annotation
0391_004457	.alpha.-Hypophamine	C43H66N12O12S2	2.0558	11979742	CC[C@H](C)C1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N	CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC1=O	InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35?/m0/s1	XNOPRXBHLZRZKH-OMTOYRQASA-N					doublet; compound annotation
0391_004458	504433-23-2	C17H13N3O	2.6793	9943465	CN1C=C(C2=CC=CC=C21)/C=C\3/C4=C(C=CC=N4)NC3=O	Cn1cc(C=C2C(=O)Nc3cccnc23)c2ccccc21	InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)/b13-9-	NXNQLECPAXXYTR-LCYFTJDESA-N					doublet; compound annotation
0391_004459	504433-23-2	C17H13N3O	2.6977	9943465	CN1C=C(C2=CC=CC=C21)/C=C\3/C4=C(C=CC=N4)NC3=O	Cn1cc(C=C2C(=O)Nc3cccnc23)c2ccccc21	InChI=1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)/b13-9-	NXNQLECPAXXYTR-LCYFTJDESA-N					doublet; compound annotation
0391_004460	Epothilone B	C27H41NO6S	3.3541	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	QXRSDHAAWVKZLJ-PVYNADRNSA-N					doublet; compound annotation
0391_004461	CYTOCHALASIN B	C29H37NO5	3.515	5311281	C[C@@H]1CCC[C@H](/C=C/C(=O)O[C@]23[C@@H](/C=C/C1)[C@@H](C(=C)[C@H]([C@H]2[C@@H](NC3=O)CC4=CC=CC=C4)C)O)O	C=C1C(C)C2C(Cc3ccccc3)NC(=O)C23OC(=O)C=CC(O)CCCC(C)CC=CC3C1O	InChI=1S/C29H37NO5/c1-18-9-7-13-22(31)15-16-25(32)35-29-23(14-8-10-18)27(33)20(3)19(2)26(29)24(30-28(29)34)17-21-11-5-4-6-12-21/h4-6,8,11-12,14-16,18-19,22-24,26-27,31,33H,3,7,9-10,13,17H2,1-2H3,(H,30,34)/b14-8+,16-15+/t18-,19-,22-,23+,24+,26+,27-,29-/m1/s1	GBOGMAARMMDZGR-TYHYBEHESA-N					removed another duplicate entry; compound annotation
0391_004463	510758-28-8	C30H30N10	3.5828	11203363		c1ccc(Cn2cc(CN(Cc3cn(Cc4ccccc4)nn3)Cc3cn(Cc4ccccc4)nn3)nn2)cc1	InChI=1S/C30H30N10/c1-4-10-25(11-5-1)16-38-22-28(31-34-38)19-37(20-29-23-39(35-32-29)17-26-12-6-2-7-13-26)21-30-24-40(36-33-30)18-27-14-8-3-9-15-27/h1-15,22-24H,16-21H2	WKGZJBVXZWCZQC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004465	Epothilone B	C27H41NO6S	3.7093	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	QXRSDHAAWVKZLJ-PVYNADRNSA-N					doublet; compound annotation
0391_004466	Epothilone B	C27H41NO6S	3.8906	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	QXRSDHAAWVKZLJ-PVYNADRNSA-N					doublet; removed another duplicate entry; compound annotation
0391_004468	36341-25-0	C14H11NO2S	3.8956	3155228		COc1c(O)ccc(-c2nc3ccccc3s2)c1	InChI=1S/C14H11NO2S/c1-17-12-8-9(6-7-11(12)16)14-15-10-4-2-3-5-13(10)18-14/h2-8,16H,1H3	KRVBOHJNAFQFPW-UHFFFAOYSA-N					doublet; compound annotation
0391_004469	Epothilone B	C27H41NO6S	4.0498	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	QXRSDHAAWVKZLJ-PVYNADRNSA-N					doublet; compound annotation
0391_004470	Epothilone B	C27H41NO6S	4.1238	448013	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	QXRSDHAAWVKZLJ-PVYNADRNSA-N					doublet; compound annotation
0391_004471	Pneumocandin B0	C50H80N8O17	4.3484	5742645	CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CC(=O)N)O)O)O)O	CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(O)NC(=O)C2C(O)CCN2C(=O)C(C(O)CC(N)=O)NC(=O)C(C(O)C(O)c2ccc(O)cc2)NC(=O)C2CC(O)CN2C(=O)C(C(C)O)NC1=O	InChI=1S/C50H80N8O17/c1-5-25(2)20-26(3)12-10-8-6-7-9-11-13-37(66)52-31-22-35(64)46(71)56-48(73)41-33(62)18-19-57(41)50(75)39(34(63)23-36(51)65)54-47(72)40(43(68)42(67)28-14-16-29(60)17-15-28)55-45(70)32-21-30(61)24-58(32)49(74)38(27(4)59)53-44(31)69/h14-17,25-27,30-35,38-43,46,59-64,67-68,71H,5-13,18-24H2,1-4H3,(H2,51,65)(H,52,66)(H,53,69)(H,54,72)(H,55,70)(H,56,73)/t25?,26?,27-,30-,31+,32+,33+,34-,35-,38+,39+,40+,41+,42+,43+,46-/m1/s1	DQXPFAADCTZLNL-ZESADUFFSA-N					doublet; compound annotation
0391_004472	Pneumocandin B0	C50H80N8O17	4.3534	5742645	CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CC(=O)N)O)O)O)O	CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(O)C(O)NC(=O)C2C(O)CCN2C(=O)C(C(O)CC(N)=O)NC(=O)C(C(O)C(O)c2ccc(O)cc2)NC(=O)C2CC(O)CN2C(=O)C(C(C)O)NC1=O	InChI=1S/C50H80N8O17/c1-5-25(2)20-26(3)12-10-8-6-7-9-11-13-37(66)52-31-22-35(64)46(71)56-48(73)41-33(62)18-19-57(41)50(75)39(34(63)23-36(51)65)54-47(72)40(43(68)42(67)28-14-16-29(60)17-15-28)55-45(70)32-21-30(61)24-58(32)49(74)38(27(4)59)53-44(31)69/h14-17,25-27,30-35,38-43,46,59-64,67-68,71H,5-13,18-24H2,1-4H3,(H2,51,65)(H,52,66)(H,53,69)(H,54,72)(H,55,70)(H,56,73)/t25?,26?,27-,30-,31+,32+,33+,34-,35-,38+,39+,40+,41+,42+,43+,46-/m1/s1	DQXPFAADCTZLNL-ZESADUFFSA-N					doublet; compound annotation
0391_004473	36341-25-0	C14H11NO2S	5.5105	3155228		COc1c(O)ccc(-c2nc3ccccc3s2)c1	InChI=1S/C14H11NO2S/c1-17-12-8-9(6-7-11(12)16)14-15-10-4-2-3-5-13(10)18-14/h2-8,16H,1H3	KRVBOHJNAFQFPW-UHFFFAOYSA-N					doublet; compound annotation
0391_004474	Tucatinib	C26H24N8O2	1.8832	51039094		Cc1c(Oc2cc3ncnn3cc2)ccc(Nc2ncnc3c2cc(NC2=NC(C)(C)CO2)cc3)c1	InChI=1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31)	SDEAXTCZPQIFQM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004476	Pitofenone	C22H25NO4	1.9616	121098		COC(=O)c1ccccc1C(=O)c1ccc(OCCN2CCCCC2)cc1	InChI=1S/C22H25NO4/c1-26-22(25)20-8-4-3-7-19(20)21(24)17-9-11-18(12-10-17)27-16-15-23-13-5-2-6-14-23/h3-4,7-12H,2,5-6,13-16H2,1H3	NZHMAQSCHUSSSJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004477	680622-70-2	C15H13F3N6O2	2.0354	29987694		Nc1nc2c([nH]cn2)c(OCc2ccc(CNC(=O)C(F)(F)F)cc2)n1	InChI=1S/C15H13F3N6O2/c16-15(17,18)13(25)20-5-8-1-3-9(4-2-8)6-26-12-10-11(22-7-21-10)23-14(19)24-12/h1-4,7H,5-6H2,(H,20,25)(H3,19,21,22,23,24)	AQFWAWXGBQPBIA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004479	Pitofenone	C22H25NO4	2.507	121098		COC(=O)c1ccccc1C(=O)c1ccc(OCCN2CCCCC2)cc1	InChI=1S/C22H25NO4/c1-26-22(25)20-8-4-3-7-19(20)21(24)17-9-11-18(12-10-17)27-16-15-23-13-5-2-6-14-23/h3-4,7-12H,2,5-6,13-16H2,1H3	NZHMAQSCHUSSSJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004481	Diphemanil	C20H24N+	2.9674	6127		C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1	InChI=1S/C20H24N/c1-21(2)15-13-19(14-16-21)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12H,13-16H2,1-2H3/q+1	LCTZPQRFOZKZNK-UHFFFAOYSA-N					compound annotation
0391_004482	BRD5648	C20H23N3O	3.1102	136980414	CC[C@]1(C2=C(NC3=C1C(=O)CC(C3)(C)C)NN=C2)C4=CC=CC=C4	CCC1(c2ccccc2)C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2	InChI=1S/C20H23N3O/c1-4-20(13-8-6-5-7-9-13)14-12-21-23-18(14)22-15-10-19(2,3)11-16(24)17(15)20/h5-9,12H,4,10-11H2,1-3H3,(H2,21,22,23)/t20-/m1/s1	NCKLQXXBRWCYMA-HXUWFJFHSA-N					removed another duplicate entry; compound annotation
0391_004484	Citarinostat	C24H26ClN5O3	3.5253	53340426		O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO	InChI=1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31)	VLIUIBXPEDFJRF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004487	SPP-86	C16H15N5	3.632	66549796		CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21	InChI=1S/C16H15N5/c1-11(2)21-16-14(15(17)18-10-19-16)13(20-21)9-8-12-6-4-3-5-7-12/h3-7,10-11H,1-2H3,(H2,17,18,19)	JQOIRTDBHMDWMT-UHFFFAOYSA-N					compound annotation
0391_004488	Citarinostat	C24H26ClN5O3	3.7478	53340426		O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO	InChI=1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31)	VLIUIBXPEDFJRF-UHFFFAOYSA-N					doublet; compound annotation
0391_004489	TEMOPORFIN	C44H32N4O4	5.2546	60751		Oc1cccc(-c2c3C=Cc(n3)c(-c3cc(O)ccc3)c3ccc(c(-c4cc(O)ccc4)c4nc(c(-c5cc(O)ccc5)c5ccc2[nH]5)CC4)[nH]3)c1	InChI=1S/C44H32N4O4/c49-29-9-1-5-25(21-29)41-33-13-15-35(45-33)42(26-6-2-10-30(50)22-26)37-17-19-39(47-37)44(28-8-4-12-32(52)24-28)40-20-18-38(48-40)43(36-16-14-34(41)46-36)27-7-3-11-31(51)23-27/h1-17,19,21-24,46-47,49-52H,18,20H2	LYPFDBRUNKHDGX-UHFFFAOYSA-N					doublet; compound annotation
0391_004490	TEMOPORFIN	C44H32N4O4	5.2588	60751		Oc1cccc(-c2c3C=Cc(n3)c(-c3cc(O)ccc3)c3ccc(c(-c4cc(O)ccc4)c4nc(c(-c5cc(O)ccc5)c5ccc2[nH]5)CC4)[nH]3)c1	InChI=1S/C44H32N4O4/c49-29-9-1-5-25(21-29)41-33-13-15-35(45-33)42(26-6-2-10-30(50)22-26)37-17-19-39(47-37)44(28-8-4-12-32(52)24-28)40-20-18-38(48-40)43(36-16-14-34(41)46-36)27-7-3-11-31(51)23-27/h1-17,19,21-24,46-47,49-52H,18,20H2	LYPFDBRUNKHDGX-UHFFFAOYSA-N					doublet; compound annotation
0391_004491	Ridinilazole	C24H16N6	1.7581	16659285		c1nccc(-c2nc3c(cc(-c4cc5c(cc4)nc(-c4ccncc4)[nH]5)cc3)[nH]2)c1	InChI=1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30)	UHQFBTAJFNVZIV-UHFFFAOYSA-N					compound annotation
0391_004492	KHK-IN-1	C21H26N8S	1.9779	53348216		CSc1ccccc1Nc1nc(N2CCNCC2)nc2c1ncnc2NCC1CC1	InChI=1S/C21H26N8S/c1-30-16-5-3-2-4-15(16)26-20-17-18(19(25-13-24-17)23-12-14-6-7-14)27-21(28-20)29-10-8-22-9-11-29/h2-5,13-14,22H,6-12H2,1H3,(H,23,24,25)(H,26,27,28)	HFLMLZKGLUEWBU-UHFFFAOYSA-N					doublet; compound annotation
0391_004493	KHK-IN-1	C21H26N8S	2.1159	53348216		CSc1ccccc1Nc1nc(N2CCNCC2)nc2c1ncnc2NCC1CC1	InChI=1S/C21H26N8S/c1-30-16-5-3-2-4-15(16)26-20-17-18(19(25-13-24-17)23-12-14-6-7-14)27-21(28-20)29-10-8-22-9-11-29/h2-5,13-14,22H,6-12H2,1H3,(H,23,24,25)(H,26,27,28)	HFLMLZKGLUEWBU-UHFFFAOYSA-N					doublet; compound annotation
0391_004494	Cilengitide	C27H40N8O7	2.1543	176873	CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N	CC(C)C1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(Cc2ccccc2)C(=O)N1C	InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	AMLYAMJWYAIXIA-VWNVYAMZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004496	327062-46-4	C10H9BrN2S	2.4452	727750		Nc1ncc(Cc2ccc(Br)cc2)s1	InChI=1S/C10H9BrN2S/c11-8-3-1-7(2-4-8)5-9-6-13-10(12)14-9/h1-4,6H,5H2,(H2,12,13)	HGWLTZOMQZIUBW-UHFFFAOYSA-N					compound annotation
0391_004497	199596-24-2	C17H13ClN4	2.9151	5825881	C1=CC=C(C=C1)/C(=N/NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17-	YHHFKWKMXWRVTJ-XLNRJJMWSA-N					doublet; compound annotation
0391_004498	199596-24-2	C17H13ClN4	2.9565	5825881	C1=CC=C(C=C1)/C(=N/NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17-	YHHFKWKMXWRVTJ-XLNRJJMWSA-N					doublet; compound annotation
0391_004499	199596-24-2	C17H13ClN4	2.9598	5825881	C1=CC=C(C=C1)/C(=N/NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17-	YHHFKWKMXWRVTJ-XLNRJJMWSA-N					doublet; compound annotation
0391_004500	Balaglitazone	C20H17N3O4S	3.3644	9889200		Cn1c(COc2ccc(CC3SC(=O)NC3=O)cc2)nc2ccccc2c1=O	InChI=1S/C20H17N3O4S/c1-23-17(21-15-5-3-2-4-14(15)19(23)25)11-27-13-8-6-12(7-9-13)10-16-18(24)22-20(26)28-16/h2-9,16H,10-11H2,1H3,(H,22,24,26)	IETKPTYAGKZLKY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004502	KHK-IN-1	C21H26N8S	3.4115	53348216		CSc1ccccc1Nc1nc(N2CCNCC2)nc2c1ncnc2NCC1CC1	InChI=1S/C21H26N8S/c1-30-16-5-3-2-4-15(16)26-20-17-18(19(25-13-24-17)23-12-14-6-7-14)27-21(28-20)29-10-8-22-9-11-29/h2-5,13-14,22H,6-12H2,1H3,(H,23,24,25)(H,26,27,28)	HFLMLZKGLUEWBU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004504	KHK-IN-1	C21H26N8S	3.6144	53348216		CSc1ccccc1Nc1nc(N2CCNCC2)nc2c1ncnc2NCC1CC1	InChI=1S/C21H26N8S/c1-30-16-5-3-2-4-15(16)26-20-17-18(19(25-13-24-17)23-12-14-6-7-14)27-21(28-20)29-10-8-22-9-11-29/h2-5,13-14,22H,6-12H2,1H3,(H,23,24,25)(H,26,27,28)	HFLMLZKGLUEWBU-UHFFFAOYSA-N					doublet; compound annotation
0391_004505	Kartogenin	C20H15NO3	3.7642	2826191		O=C(O)c1ccccc1C(=O)Nc1ccc(-c2ccccc2)cc1	InChI=1S/C20H15NO3/c22-19(17-8-4-5-9-18(17)20(23)24)21-16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13H,(H,21,22)(H,23,24)	SLUINPGXGFUMLL-UHFFFAOYSA-N					compound annotation
0391_004506	EML 425	C27H24N2O4	4.9553	91826273		Cc1cc(O)cc(C)c1C=C1C(=O)N(Cc2ccccc2)C(=O)N(Cc2ccccc2)C1=O	InChI=1S/C27H24N2O4/c1-18-13-22(30)14-19(2)23(18)15-24-25(31)28(16-20-9-5-3-6-10-20)27(33)29(26(24)32)17-21-11-7-4-8-12-21/h3-15,30H,16-17H2,1-2H3	LUGQBJDYUPNAQQ-UHFFFAOYSA-N					compound annotation
0391_004507	199596-24-2	C17H13ClN4	5.2609	5825881	C1=CC=C(C=C1)/C(=N/NC2=NC=C(C=C2)Cl)/C3=CC=CC=N3	Clc1cnc(NN=C(c2ccccc2)c2ccccn2)cc1	InChI=1S/C17H13ClN4/c18-14-9-10-16(20-12-14)21-22-17(13-6-2-1-3-7-13)15-8-4-5-11-19-15/h1-12H,(H,20,21)/b22-17-	YHHFKWKMXWRVTJ-XLNRJJMWSA-N					doublet; removed another duplicate entry; compound annotation
0391_004509	lycorine	C16H17NO4	0.5128	72378	C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4	OC1C=C2CCN3Cc4cc5c(cc4C(C1O)C23)OCO5	InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1	XGVJWXAYKUHDOO-DANNLKNASA-N					doublet; compound annotation
0391_004510	CLORPRENALINE	C11H16ClNO	1.6034	2810		CC(C)NCC(O)c1ccccc1Cl	InChI=1S/C11H16ClNO/c1-8(2)13-7-11(14)9-5-3-4-6-10(9)12/h3-6,8,11,13-14H,7H2,1-2H3	SSMSBSWKLKKXGG-UHFFFAOYSA-N					compound annotation
0391_004511	NS-018	C21H20FN7	2.7762	46866319	C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C	CC(Nc1cc(-c2cn(C)nc2)cc(Nc2nccnc2)n1)c1ccc(F)cc1	InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1	UQTPDWDAYHAZNT-AWEZNQCLSA-N					doublet; compound annotation
0391_004512	NS-018	C21H20FN7	2.7789	46866319	C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C	CC(Nc1cc(-c2cn(C)nc2)cc(Nc2nccnc2)n1)c1ccc(F)cc1	InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1	UQTPDWDAYHAZNT-AWEZNQCLSA-N					doublet; compound annotation
0391_004513	K-Ras(G12C) inhibitor 12	C15H17ClIN3O3	3.3188	73555129		C=CC(=O)N1CCN(C(=O)CNc2cc(I)c(Cl)cc2O)CC1	InChI=1S/C15H17ClIN3O3/c1-2-14(22)19-3-5-20(6-4-19)15(23)9-18-12-8-11(17)10(16)7-13(12)21/h2,7-8,18,21H,1,3-6,9H2	JFIFBWVNHLXJFY-UHFFFAOYSA-N					compound annotation
0391_004514	Brassinolide	C28H48O6	4.0063	115196	C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2COC(=O)[C@@H]4[C@@]3(C[C@H]([C@H](C4)O)O)C)C)[C@H]([C@@H]([C@@H](C)C(C)C)O)O	CC(C)C(C)C(O)C(O)C(C)C1CCC2C3COC(=O)C4CC(O)C(O)CC4(C)C3CCC12C	InChI=1S/C28H48O6/c1-14(2)15(3)24(31)25(32)16(4)18-7-8-19-17-13-34-26(33)21-11-22(29)23(30)12-28(21,6)20(17)9-10-27(18,19)5/h14-25,29-32H,7-13H2,1-6H3/t15-,16-,17-,18+,19-,20-,21+,22-,23+,24+,25+,27+,28+/m0/s1	IXVMHGVQKLDRKH-KNBKMWSGSA-N					compound annotation
0391_004515	ML-098	C19H19NO3	4.4711	7345532		Cc1cc(OCCn2cc(C(=O)O)c3ccccc32)c(C)cc1	InChI=1S/C19H19NO3/c1-13-7-8-14(2)18(11-13)23-10-9-20-12-16(19(21)22)15-5-3-4-6-17(15)20/h3-8,11-12H,9-10H2,1-2H3,(H,21,22)	LILIWWFBJKBUCO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004517	KJ Pyr 9	C22H15N3O4	4.5146	85855478		NC(=O)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(-c3ccco3)c2)cc1	InChI=1S/C22H15N3O4/c23-22(26)16-5-3-14(4-6-16)17-12-19(15-7-9-18(10-8-15)25(27)28)24-20(13-17)21-2-1-11-29-21/h1-13H,(H2,23,26)	GTTDVYCKFQYVNN-UHFFFAOYSA-N					compound annotation
0391_004518	BRD7116	C28H36N2O4S	5.6937	981129		CC1(C)C(C(=O)Nc2ccc(S(=O)(=O)c3ccc(NC(=O)C4C(C)(C)C4(C)C)cc3)cc2)C1(C)C	InChI=1S/C28H36N2O4S/c1-25(2)21(26(25,3)4)23(31)29-17-9-13-19(14-10-17)35(33,34)20-15-11-18(12-16-20)30-24(32)22-27(5,6)28(22,7)8/h9-16,21-22H,1-8H3,(H,29,31)(H,30,32)	UHXFWAHRAMUDLJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004519	BRD7116	C28H36N2O4S	5.697	981129		CC1(C)C(C(=O)Nc2ccc(S(=O)(=O)c3ccc(NC(=O)C4C(C)(C)C4(C)C)cc3)cc2)C1(C)C	InChI=1S/C28H36N2O4S/c1-25(2)21(26(25,3)4)23(31)29-17-9-13-19(14-10-17)35(33,34)20-15-11-18(12-16-20)30-24(32)22-27(5,6)28(22,7)8/h9-16,21-22H,1-8H3,(H,29,31)(H,30,32)	UHXFWAHRAMUDLJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004521	Atractyloside A	C21H36O10	1.1013	71307451	C[C@@]1([C@@H]2C[C@@H](CC[C@@]([C@H]2CC1=O)(CO)O)C(C)(C)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O	CC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC(O)(CO)C2CC(=O)C(C)(O)C2C1	InChI=1S/C21H36O10/c1-19(2,31-18-17(27)16(26)15(25)13(8-22)30-18)10-4-5-21(29,9-23)12-7-14(24)20(3,28)11(12)6-10/h10-13,15-18,22-23,25-29H,4-9H2,1-3H3/t10-,11-,12+,13-,15-,16+,17-,18+,20+,21+/m1/s1	QNBLVYVBWDIWDM-BSLJOXIBSA-N					compound annotation
0391_004522	7300-59-6	C11H13N3O5	1.3471	81732	C1=CC(=CC=C1NC(=O)CC[C@@H](C(=O)O)N)[N+](=O)[O-]	NC(CCC(=O)Nc1ccc([N+](=O)[O-])cc1)C(=O)O	InChI=1S/C11H13N3O5/c12-9(11(16)17)5-6-10(15)13-7-1-3-8(4-2-7)14(18)19/h1-4,9H,5-6,12H2,(H,13,15)(H,16,17)/t9-/m0/s1	WMZTYIRRBCGARG-VIFPVBQESA-N					compound annotation
0391_004523	Cridanimod	C15H11NO3	2.3088	38072		O=C(O)Cn1c2ccccc2c(=O)c2ccccc21	InChI=1S/C15H11NO3/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16/h1-8H,9H2,(H,17,18)	UOMKBIIXHQIERR-UHFFFAOYSA-N					compound annotation
0391_004524	Triphenyltetrazolium	C19H15N4+	2.9067	9284		c1ccc(-c2nn(-c3ccccc3)[n+](-c3ccccc3)n2)cc1	InChI=1S/C19H15N4/c1-4-10-16(11-5-1)19-20-22(17-12-6-2-7-13-17)23(21-19)18-14-8-3-9-15-18/h1-15H/q+1	LNOBZXNCABUBKK-UHFFFAOYSA-N					compound annotation
0391_004525	Brusatol	C26H32O11	2.9602	73432	CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C=C(C)C)(OC5)C(=O)OC)O)O)C)O	COC(=O)C12OCC34C(CC5C(C)=C(O)C(=O)CC5(C)C3C(O)C1O)OC(=O)C(OC(=O)C=C(C)C)C24	InChI=1S/C26H32O11/c1-10(2)6-15(28)37-18-20-25-9-35-26(20,23(33)34-5)21(31)17(30)19(25)24(4)8-13(27)16(29)11(3)12(24)7-14(25)36-22(18)32/h6,12,14,17-21,29-31H,7-9H2,1-5H3/t12-,14+,17+,18+,19+,20+,21-,24-,25+,26-/m0/s1	ZZZYHIMVKOHVIH-VILODJCFSA-N					removed another duplicate entry; compound annotation
0391_004527	XL-784 (free base)	C21H22ClF2N3O8S	4.1705	74439626		COCCOC(=O)N1CCN(S(=O)(=O)c2cc(F)c(Oc3ccc(Cl)cc3)c(F)c2)C(C(=O)NO)C1	InChI=1S/C21H22ClF2N3O8S/c1-33-8-9-34-21(29)26-6-7-27(18(12-26)20(28)25-30)36(31,32)15-10-16(23)19(17(24)11-15)35-14-4-2-13(22)3-5-14/h2-5,10-11,18,30H,6-9,12H2,1H3,(H,25,28)	PRIJGYZAOBNIPH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004529	cl-387785	C18H13BrN4O	2.7733	2776		CC#CC(=O)Nc1cc2c(cc1)ncnc2Nc1cc(Br)ccc1	InChI=1S/C18H13BrN4O/c1-2-4-17(24)22-14-7-8-16-15(10-14)18(21-11-20-16)23-13-6-3-5-12(19)9-13/h3,5-11H,1H3,(H,22,24)(H,20,21,23)	BTYYWOYVBXILOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004530	JNJ-7706621	C15H12F2N6O3S	2.8183	5330790		Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	InChI=1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19,25)26/h1-7H,(H2,19,25,26)(H3,18,20,21,22)	KDKUVYLMPJIGKA-UHFFFAOYSA-N					compound annotation
0391_004531	Naphthol AS-E phosphate	C17H13ClNO5P	2.9846	87517		O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1OP(=O)(O)O	InChI=1S/C17H13ClNO5P/c18-13-5-7-14(8-6-13)19-17(20)15-9-11-3-1-2-4-12(11)10-16(15)24-25(21,22)23/h1-10H,(H,19,20)(H2,21,22,23)	RQAQWBFHPMSXKR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004533	cl-387785	C18H13BrN4O	2.9924	2776		CC#CC(=O)Nc1cc2c(cc1)ncnc2Nc1cc(Br)ccc1	InChI=1S/C18H13BrN4O/c1-2-4-17(24)22-14-7-8-16-15(10-14)18(21-11-20-16)23-13-6-3-5-12(19)9-13/h3,5-11H,1H3,(H,22,24)(H,20,21,23)	BTYYWOYVBXILOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_004534	(2S,3R)-Voruciclib	C22H19ClF3NO5	3.0509	24888038	CN1CC[C@@H]([C@H]1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2c(Cl)cc(C(F)(F)F)cc2)cc3=O)C1CO	InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m0/s1	MRPGRAKIAJJGMM-GXTWGEPZSA-N					doublet; compound annotation
0391_004535	(2S,3R)-Voruciclib	C22H19ClF3NO5	3.1953	24888038	CN1CC[C@@H]([C@H]1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2c(Cl)cc(C(F)(F)F)cc2)cc3=O)C1CO	InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m0/s1	MRPGRAKIAJJGMM-GXTWGEPZSA-N					doublet; compound annotation
0391_004536	(2S,3R)-Voruciclib	C22H19ClF3NO5	3.4352	24888038	CN1CC[C@@H]([C@H]1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2c(Cl)cc(C(F)(F)F)cc2)cc3=O)C1CO	InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m0/s1	MRPGRAKIAJJGMM-GXTWGEPZSA-N					doublet; compound annotation
0391_004537	IPI-549	C30H24N8O2	3.6316	91933883	C[C@@H](C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5N	CC(NC(=O)c1c2ncccn2nc1N)c1cc2c(c(C#Cc3cn(C)nc3)ccc2)c(=O)n1-c1ccccc1	InChI=1S/C30H24N8O2/c1-19(34-29(39)26-27(31)35-37-15-7-14-32-28(26)37)24-16-22-9-6-8-21(13-12-20-17-33-36(2)18-20)25(22)30(40)38(24)23-10-4-3-5-11-23/h3-11,14-19H,1-2H3,(H2,31,35)(H,34,39)/t19-/m0/s1	XUMALORDVCFWKV-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_004539	209410-46-8	C19H9Cl2F2N3OS	3.9449	3038525		O=c1ncn2nc(Sc3c(F)cc(F)cc3)ccc2c1-c1c(Cl)cccc1Cl	InChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H	VEPKQEUBKLEPRA-UHFFFAOYSA-N					doublet; compound annotation
0391_004540	209410-46-8	C19H9Cl2F2N3OS	3.9498	3038525		O=c1ncn2nc(Sc3c(F)cc(F)cc3)ccc2c1-c1c(Cl)cccc1Cl	InChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H	VEPKQEUBKLEPRA-UHFFFAOYSA-N					doublet; compound annotation
0391_004541	Delamanid	C25H25F3N4O6	4.0469	6480466	C[C@@]1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)N4CCC(CC4)OC5=CC=C(C=C5)OC(F)(F)F	CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1	InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1	XDAOLTSRNUSPPH-XMMPIXPASA-N					doublet; removed another duplicate entry; compound annotation
0391_004543	Delamanid	C25H25F3N4O6	4.0513	6480466	C[C@@]1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)N4CCC(CC4)OC5=CC=C(C=C5)OC(F)(F)F	CC1(COc2ccc(N3CCC(Oc4ccc(OC(F)(F)F)cc4)CC3)cc2)Cn2cc([N+](=O)[O-])nc2O1	InChI=1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1	XDAOLTSRNUSPPH-XMMPIXPASA-N					doublet; compound annotation
0391_004544	AZD1283	C23H26N4O5S	4.6634	23649325		CCOC(=O)c1c(C)nc(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)c(C#N)c1	InChI=1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28)	NEMHKCNXXRQYRF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004546	Valbenazine	C24H38N2O4	1.6236	24795069	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21	InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1	GEJDGVNQKABXKG-CFKGEZKQSA-N					doublet; removed another duplicate entry; compound annotation
0391_004548	PKC-IN-1	C25H37FN8O2	1.709	25155745	C[C@H]1CN([C@@H](CN1C(=O)N2CC3=C(C2(C)C)NN=C3NC4=NC(=NC=C4F)C)C)CC5CCOCC5	Cc1ncc(F)c(Nc2n[nH]c3c2CN(C(=O)N2CC(C)N(CC4CCOCC4)CC2C)C3(C)C)n1	InChI=1S/C25H37FN8O2/c1-15-12-33(16(2)11-32(15)13-18-6-8-36-9-7-18)24(35)34-14-19-21(25(34,4)5)30-31-22(19)29-23-20(26)10-27-17(3)28-23/h10,15-16,18H,6-9,11-14H2,1-5H3,(H2,27,28,29,30,31)/t15-,16+/m1/s1	DKXZBPBWIGORKP-CVEARBPZSA-N					doublet; compound annotation
0391_004549	PKC-IN-1	C25H37FN8O2	1.7117	25155745	C[C@H]1CN([C@@H](CN1C(=O)N2CC3=C(C2(C)C)NN=C3NC4=NC(=NC=C4F)C)C)CC5CCOCC5	Cc1ncc(F)c(Nc2n[nH]c3c2CN(C(=O)N2CC(C)N(CC4CCOCC4)CC2C)C3(C)C)n1	InChI=1S/C25H37FN8O2/c1-15-12-33(16(2)11-32(15)13-18-6-8-36-9-7-18)24(35)34-14-19-21(25(34,4)5)30-31-22(19)29-23-20(26)10-27-17(3)28-23/h10,15-16,18H,6-9,11-14H2,1-5H3,(H2,27,28,29,30,31)/t15-,16+/m1/s1	DKXZBPBWIGORKP-CVEARBPZSA-N					doublet; compound annotation
0391_004550	Valbenazine	C24H38N2O4	2.9772	24795069	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21	InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1	GEJDGVNQKABXKG-CFKGEZKQSA-N					doublet; compound annotation
0391_004551	790702-57-7	C17H22N4O3S2	3.7674	2519269		Cc1cnc(NC(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)s1	InChI=1S/C17H22N4O3S2/c1-12-11-18-17(25-12)19-16(22)14-10-13(26(23,24)20(2)3)6-7-15(14)21-8-4-5-9-21/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,18,19,22)	QPKGRLIYJGBKJL-UHFFFAOYSA-N					doublet; compound annotation
0391_004552	790702-57-7	C17H22N4O3S2	3.7701	2519269		Cc1cnc(NC(=O)c2cc(S(=O)(=O)N(C)C)ccc2N2CCCC2)s1	InChI=1S/C17H22N4O3S2/c1-12-11-18-17(25-12)19-16(22)14-10-13(26(23,24)20(2)3)6-7-15(14)21-8-4-5-9-21/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,18,19,22)	QPKGRLIYJGBKJL-UHFFFAOYSA-N					doublet; compound annotation
0391_004553	442633-00-3	C18H17FN2O	3.7872	589075		Cc1c(CCNC(=O)c2ccccc2F)c2ccccc2[nH]1	InChI=1S/C18H17FN2O/c1-12-13(14-6-3-5-9-17(14)21-12)10-11-20-18(22)15-7-2-4-8-16(15)19/h2-9,21H,10-11H2,1H3,(H,20,22)	UXRKUKRXVWJFER-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004555	442633-00-3	C18H17FN2O	3.7918	589075		Cc1c(CCNC(=O)c2ccccc2F)c2ccccc2[nH]1	InChI=1S/C18H17FN2O/c1-12-13(14-6-3-5-9-17(14)21-12)10-11-20-18(22)15-7-2-4-8-16(15)19/h2-9,21H,10-11H2,1H3,(H,20,22)	UXRKUKRXVWJFER-UHFFFAOYSA-N					doublet; compound annotation
0391_004556	Decoglurant	C21H11F6N5	3.9947	71533696		Nc1ncc(C#Cc2c3nc(-c4ccc(C(F)(F)F)cc4)cc(C(F)(F)F)n3nc2)cc1	InChI=1S/C21H11F6N5/c22-20(23,24)15-6-4-13(5-7-15)16-9-17(21(25,26)27)32-19(31-16)14(11-30-32)3-1-12-2-8-18(28)29-10-12/h2,4-11H,(H2,28,29)	DMJHZVARRXJSEG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004558	Entasobulin	C26H18ClN3O2	4.3948	10203597		O=C(Nc1cc2c(cc1)nccc2)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12	InChI=1S/C26H18ClN3O2/c27-19-9-7-17(8-10-19)15-30-16-22(21-5-1-2-6-24(21)30)25(31)26(32)29-20-11-12-23-18(14-20)4-3-13-28-23/h1-14,16H,15H2,(H,29,32)	LJIUXAHLYIPHOK-UHFFFAOYSA-N					doublet; compound annotation
0391_004559	Entasobulin	C26H18ClN3O2	4.4394	10203597		O=C(Nc1cc2c(cc1)nccc2)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12	InChI=1S/C26H18ClN3O2/c27-19-9-7-17(8-10-19)15-30-16-22(21-5-1-2-6-24(21)30)25(31)26(32)29-20-11-12-23-18(14-20)4-3-13-28-23/h1-14,16H,15H2,(H,29,32)	LJIUXAHLYIPHOK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004561	Pexmetinib	C31H33FN6O3	4.4805	24765037		Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2cc3c(cc2)n(CCO)nc3)cc1	InChI=1S/C31H33FN6O3/c1-20-5-8-24(9-6-20)38-29(17-28(36-38)31(2,3)4)35-30(40)33-18-22-15-23(32)7-12-27(22)41-25-10-11-26-21(16-25)19-34-37(26)13-14-39/h5-12,15-17,19,39H,13-14,18H2,1-4H3,(H2,33,35,40)	LNMRSSIMGCDUTP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004563	Ralinepag	C23H26ClNO5	4.9119	44219292		O=C(O)COCC1CCC(COC(=O)N(c2ccccc2)c2ccc(Cl)cc2)CC1	InChI=1S/C23H26ClNO5/c24-19-10-12-21(13-11-19)25(20-4-2-1-3-5-20)23(28)30-15-18-8-6-17(7-9-18)14-29-16-22(26)27/h1-5,10-13,17-18H,6-9,14-16H2,(H,26,27)	NPDKXVKJRHPDQT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004565	ONX-0914	C31H40N4O7	2.9172	23642227	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C)NC(=O)CN4CCOCC4	COc1ccc(CC(NC(=O)C(C)NC(=O)CN2CCOCC2)C(=O)NC(Cc2ccccc2)C(=O)C2(C)CO2)cc1	InChI=1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1	WQAVPPWWLLVGFK-VTNASVEKSA-N					doublet; removed another duplicate entry; compound annotation
0391_004567	ONX-0914	C31H40N4O7	3.0278	23642227	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C)NC(=O)CN4CCOCC4	COc1ccc(CC(NC(=O)C(C)NC(=O)CN2CCOCC2)C(=O)NC(Cc2ccccc2)C(=O)C2(C)CO2)cc1	InChI=1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1	WQAVPPWWLLVGFK-VTNASVEKSA-N					doublet; compound annotation
0391_004568	1421227-53-3	C29H31F3N6O3	3.0682	71566751		CN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)Cc3ccc(Oc4ncnc(NC(=O)C5CC5)c4)cc3)cc2)CC1	InChI=1S/C29H31F3N6O3/c1-37-10-12-38(13-11-37)17-21-6-7-22(15-24(21)29(30,31)32)35-26(39)14-19-2-8-23(9-3-19)41-27-16-25(33-18-34-27)36-28(40)20-4-5-20/h2-3,6-9,15-16,18,20H,4-5,10-14,17H2,1H3,(H,35,39)(H,33,34,36,40)	FTODTDQFHDJWIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_004569	1421227-53-3	C29H31F3N6O3	3.071	71566751		CN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)Cc3ccc(Oc4ncnc(NC(=O)C5CC5)c4)cc3)cc2)CC1	InChI=1S/C29H31F3N6O3/c1-37-10-12-38(13-11-37)17-21-6-7-22(15-24(21)29(30,31)32)35-26(39)14-19-2-8-23(9-3-19)41-27-16-25(33-18-34-27)36-28(40)20-4-5-20/h2-3,6-9,15-16,18,20H,4-5,10-14,17H2,1H3,(H,35,39)(H,33,34,36,40)	FTODTDQFHDJWIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_004570	ONX-0914	C31H40N4O7	3.0759	23642227	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C)NC(=O)CN4CCOCC4	COc1ccc(CC(NC(=O)C(C)NC(=O)CN2CCOCC2)C(=O)NC(Cc2ccccc2)C(=O)C2(C)CO2)cc1	InChI=1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1	WQAVPPWWLLVGFK-VTNASVEKSA-N					doublet; compound annotation
0391_004571	ONX-0914	C31H40N4O7	3.0797	23642227	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C)NC(=O)CN4CCOCC4	COc1ccc(CC(NC(=O)C(C)NC(=O)CN2CCOCC2)C(=O)NC(Cc2ccccc2)C(=O)C2(C)CO2)cc1	InChI=1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1	WQAVPPWWLLVGFK-VTNASVEKSA-N					doublet; compound annotation
0391_004572	Bictegravir	C21H18F3N3O5	3.2391	90311989	C1C[C@@H]2C[C@H]1N3[C@H](O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F	O=C(NCc1c(F)cc(F)cc1F)c1cn2CC3OC4CCC(C4)N3C(=O)c2c(O)c1=O	InChI=1S/C21H18F3N3O5/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30)/t10-,11+,16+/m0/s1	SOLUWJRYJLAZCX-LYOVBCGYSA-N					removed another duplicate entry; compound annotation
0391_004574	CVT-12012	C21H21F3N4O3	3.3522	25195516		Cc1nc2c(cc(NCc3cc(C(F)(F)F)ccc3)cc2)n(CCNC(=O)CO)c1=O	InChI=1S/C21H21F3N4O3/c1-13-20(31)28(8-7-25-19(30)12-29)18-10-16(5-6-17(18)27-13)26-11-14-3-2-4-15(9-14)21(22,23)24/h2-6,9-10,26,29H,7-8,11-12H2,1H3,(H,25,30)	HRAQDVZJYIAWOV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004577	Bexagliflozin	C24H29ClO7	3.5428	25195624	C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl	OCC1OC(c2cc(Cc3ccc(OCCOC4CC4)cc3)c(Cl)cc2)C(O)C(O)C1O	InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1	BTCRKOKVYTVOLU-SJSRKZJXSA-N					removed another duplicate entry; compound annotation
0391_004579	ONX-0914	C31H40N4O7	3.7299	23642227	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)OC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C)NC(=O)CN4CCOCC4	COc1ccc(CC(NC(=O)C(C)NC(=O)CN2CCOCC2)C(=O)NC(Cc2ccccc2)C(=O)C2(C)CO2)cc1	InChI=1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1	WQAVPPWWLLVGFK-VTNASVEKSA-N					doublet; compound annotation
0391_004580	Tolvaptan	C26H25ClN2O3	4.0925	216237		Cc1ccccc1C(=O)Nc1cc(C)c(C(=O)N2CCCC(O)c3c2ccc(Cl)c3)cc1	InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)	GYHCTFXIZSNGJT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004582	Guacetisal	C16H14O5	4.1299	68749		COc1ccccc1OC(=O)c1ccccc1OC(C)=O	InChI=1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3	HSJFYRYGGKLQBT-UHFFFAOYSA-N					compound annotation
0391_004583	BIBR 1532	C21H17NO3	4.3753	9927531	C/C(=C\C(=O)NC1=CC=CC=C1C(=O)O)/C2=CC3=CC=CC=C3C=C2	CC(=CC(=O)Nc1ccccc1C(=O)O)c1cc2ccccc2cc1	InChI=1S/C21H17NO3/c1-14(16-11-10-15-6-2-3-7-17(15)13-16)12-20(23)22-19-9-5-4-8-18(19)21(24)25/h2-13H,1H3,(H,22,23)(H,24,25)/b14-12+	PGFQXGLPJUCTOI-WYMLVPIESA-N					compound annotation
0391_004584	210302-17-3	C16H10F2N6O	4.4987	565708		Fc1ccccc1Nc1nc2nonc2nc1Nc1ccccc1F	InChI=1S/C16H10F2N6O/c17-9-5-1-3-7-11(9)19-13-14(20-12-8-4-2-6-10(12)18)22-16-15(21-13)23-25-24-16/h1-8H,(H,19,21,23)(H,20,22,24)	OEGJBRZAJRPPHL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004586	Maribavir	C15H19Cl2N3O4	2.3029	471161	CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl	CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1C1OC(CO)C(O)C1O	InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1	KJFBVJALEQWJBS-XUXIUFHCSA-N					compound annotation
0391_004587	1235318-89-4	C12H12N6S	2.6031	46836872		Cc1nc(Nc2nc(-c3c[nH]nc3)c(C)s2)ncc1	InChI=1S/C12H12N6S/c1-7-3-4-13-11(16-7)18-12-17-10(8(2)19-12)9-5-14-15-6-9/h3-6H,1-2H3,(H,14,15)(H,13,16,17,18)	MIQNXKWDQRNHAU-UHFFFAOYSA-N					doublet; compound annotation
0391_004588	827327-28-6	C19H21N3O2	2.8081	1096509		COc1ccc(-c2cnc(NCc3cc(OC)ccc3)n2C)cc1	InChI=1S/C19H21N3O2/c1-22-18(15-7-9-16(23-2)10-8-15)13-21-19(22)20-12-14-5-4-6-17(11-14)24-3/h4-11,13H,12H2,1-3H3,(H,20,21)	LCVOJBGSGIOMKF-UHFFFAOYSA-N					compound annotation
0391_004589	MI-773	C29H34Cl2FN3O3	3.5069	52938482	CC(C)(C)C[C@@H]1[C@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23+,25-,29+/m1/s1	IDKAKZRYYDCJDU-YJRDPZTCSA-N					doublet; compound annotation
0391_004590	1235318-89-4	C12H12N6S	3.5605	46836872		Cc1nc(Nc2nc(-c3c[nH]nc3)c(C)s2)ncc1	InChI=1S/C12H12N6S/c1-7-3-4-13-11(16-7)18-12-17-10(8(2)19-12)9-5-14-15-6-9/h3-6H,1-2H3,(H,14,15)(H,13,16,17,18)	MIQNXKWDQRNHAU-UHFFFAOYSA-N					doublet; compound annotation
0391_004591	cilostazol	C20H27N5O2	3.5605	2754		O=C1CCc2c(ccc(OCCCCc3nnnn3C3CCCCC3)c2)N1	InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)	RRGUKTPIGVIEKM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004593	MI-773	C29H34Cl2FN3O3	3.6337	52938482	CC(C)(C)C[C@@H]1[C@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23+,25-,29+/m1/s1	IDKAKZRYYDCJDU-YJRDPZTCSA-N					doublet; compound annotation
0391_004594	MI-773	C29H34Cl2FN3O3	3.6385	52938482	CC(C)(C)C[C@@H]1[C@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23+,25-,29+/m1/s1	IDKAKZRYYDCJDU-YJRDPZTCSA-N					doublet; compound annotation
0391_004595	MI-773	C29H34Cl2FN3O3	3.8044	52938482	CC(C)(C)C[C@@H]1[C@]2([C@H]([C@@H](N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O	CC(C)(C)CC1NC(C(=O)NC2CCC(O)CC2)C(c2c(F)c(Cl)ccc2)C12C(=O)Nc1cc(Cl)ccc12	InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23+,25-,29+/m1/s1	IDKAKZRYYDCJDU-YJRDPZTCSA-N					doublet; removed another duplicate entry; compound annotation
0391_004597	Sivelestat	C20H22N2O7S	4.0547	107706		CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)	BTGNGJJLZOIYID-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004599	ADAMTS-5 inhibitor	C16H11ClF3N3OS3	5.088	16664963	CN1C(=C(C(=N1)C(F)(F)F)/C=C\2/C(=O)NC(=S)S2)SCC3=CC=C(C=C3)Cl	Cn1nc(C(F)(F)F)c(C=C2SC(=S)NC2=O)c1SCc1ccc(Cl)cc1	InChI=1S/C16H11ClF3N3OS3/c1-23-14(26-7-8-2-4-9(17)5-3-8)10(12(22-23)16(18,19)20)6-11-13(24)21-15(25)27-11/h2-6H,7H2,1H3,(H,21,24,25)/b11-6-	CVYPRDPBCXSVBN-WDZFZDKYSA-N					compound annotation
0391_004600	108237-91-8	C15H11BrN2S	5.4797	4456143		Brc1ccc(Nc2nc(-c3ccccc3)cs2)cc1	InChI=1S/C15H11BrN2S/c16-12-6-8-13(9-7-12)17-15-18-14(10-19-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)	OUFYYVAASPLOAA-UHFFFAOYSA-N					compound annotation
0391_004601	GW 6471	C35H36F3N3O4	5.4918	446738	CCC(=O)NC[C@H](CC1=CC=C(C=C1)OCCC2=C(OC(=N2)C3=CC=CC=C3)C)N/C(=C\C(=O)C4=CC=C(C=C4)C(F)(F)F)/C	CCC(=O)NCC(Cc1ccc(OCCc2c(C)oc(-c3ccccc3)n2)cc1)NC(C)=CC(=O)c1ccc(C(F)(F)F)cc1	InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43)/b23-20-/t29-/m0/s1	TYEFSRMOUXWTDN-DYQICHDWSA-N					doublet; removed another duplicate entry; compound annotation
0391_004603	Lotilaner	C20H14Cl3F6N3O3S	5.5387	76959255	CC1=C(SC(=C1)C2=NO[C@@](C2)(C3=CC(=C(C(=C3)Cl)Cl)Cl)C(F)(F)F)C(=O)NCC(=O)NCC(F)(F)F	Cc1c(C(=O)NCC(=O)NCC(F)(F)F)sc(C2=NOC(c3cc(Cl)c(Cl)c(Cl)c3)(C(F)(F)F)C2)c1	InChI=1S/C20H14Cl3F6N3O3S/c1-8-2-13(36-16(8)17(34)30-6-14(33)31-7-19(24,25)26)12-5-18(35-32-12,20(27,28)29)9-3-10(21)15(23)11(22)4-9/h2-4H,5-7H2,1H3,(H,30,34)(H,31,33)/t18-/m0/s1	HDKWFBCPLKNOCK-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_004605	GW 6471	C35H36F3N3O4	5.5794	446738	CCC(=O)NC[C@H](CC1=CC=C(C=C1)OCCC2=C(OC(=N2)C3=CC=CC=C3)C)N/C(=C\C(=O)C4=CC=C(C=C4)C(F)(F)F)/C	CCC(=O)NCC(Cc1ccc(OCCc2c(C)oc(-c3ccccc3)n2)cc1)NC(C)=CC(=O)c1ccc(C(F)(F)F)cc1	InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43)/b23-20-/t29-/m0/s1	TYEFSRMOUXWTDN-DYQICHDWSA-N					doublet; removed another duplicate entry; compound annotation
0391_004607	GW 6471	C35H36F3N3O4	6.3944	446738	CCC(=O)NC[C@H](CC1=CC=C(C=C1)OCCC2=C(OC(=N2)C3=CC=CC=C3)C)N/C(=C\C(=O)C4=CC=C(C=C4)C(F)(F)F)/C	CCC(=O)NCC(Cc1ccc(OCCc2c(C)oc(-c3ccccc3)n2)cc1)NC(C)=CC(=O)c1ccc(C(F)(F)F)cc1	InChI=1S/C35H36F3N3O4/c1-4-33(43)39-22-29(40-23(2)20-32(42)26-12-14-28(15-13-26)35(36,37)38)21-25-10-16-30(17-11-25)44-19-18-31-24(3)45-34(41-31)27-8-6-5-7-9-27/h5-17,20,29,40H,4,18-19,21-22H2,1-3H3,(H,39,43)/b23-20-/t29-/m0/s1	TYEFSRMOUXWTDN-DYQICHDWSA-N					doublet; compound annotation
0391_004608	Adenosine amine congener	C28H32N8O6	1.637	126054	C1=CC(=CC=C1CC(=O)NC2=CC=C(C=C2)CC(=O)NCCN)NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O	NCCNC(=O)Cc1ccc(NC(=O)Cc2ccc(Nc3c4ncn(C5OC(CO)C(O)C5O)c4ncn3)cc2)cc1	InChI=1S/C28H32N8O6/c29-9-10-30-21(38)11-16-1-5-18(6-2-16)34-22(39)12-17-3-7-19(8-4-17)35-26-23-27(32-14-31-26)36(15-33-23)28-25(41)24(40)20(13-37)42-28/h1-8,14-15,20,24-25,28,37,40-41H,9-13,29H2,(H,30,38)(H,34,39)(H,31,32,35)/t20-,24-,25-,28-/m1/s1	JFRJCQJVFMHZOO-QZHHGCDDSA-N					removed another duplicate entry; compound annotation
0391_004610	BoNT-IN-1	C23H20N4O3	2.9234	2944140		Cc1cc(NC(c2ccccc2[N+](=O)[O-])c2c(O)c3c(ccc(C)n3)cc2)ncc1	InChI=1S/C23H20N4O3/c1-14-11-12-24-20(13-14)26-22(17-5-3-4-6-19(17)27(29)30)18-10-9-16-8-7-15(2)25-21(16)23(18)28/h3-13,22,28H,1-2H3,(H,24,26)	VXPGAZJVEWWXED-UHFFFAOYSA-N					compound annotation
0391_004611	SNT-207858 (free base)	C32H43Cl2N5O3	3.0603	42630200	CC[C@H](COC1=C(N=CC=C1)C2CCN(CC2)C(=O)[C@@H](CC3=C(C=C(C=C3)Cl)Cl)NC(=O)N4CCCC4)N5CCCC5	CCC(COc1cccnc1C1CCN(C(=O)C(Cc2c(Cl)cc(Cl)cc2)NC(=O)N2CCCC2)CC1)N1CCCC1	InChI=1S/C32H43Cl2N5O3/c1-2-26(37-14-3-4-15-37)22-42-29-8-7-13-35-30(29)23-11-18-38(19-12-23)31(40)28(36-32(41)39-16-5-6-17-39)20-24-9-10-25(33)21-27(24)34/h7-10,13,21,23,26,28H,2-6,11-12,14-20,22H2,1H3,(H,36,41)/t26-,28-/m1/s1	GNSVFEJLUPMLCZ-IXCJQBJRSA-N					doublet; compound annotation
0391_004612	SNT-207858 (free base)	C32H43Cl2N5O3	3.0652	42630200	CC[C@H](COC1=C(N=CC=C1)C2CCN(CC2)C(=O)[C@@H](CC3=C(C=C(C=C3)Cl)Cl)NC(=O)N4CCCC4)N5CCCC5	CCC(COc1cccnc1C1CCN(C(=O)C(Cc2c(Cl)cc(Cl)cc2)NC(=O)N2CCCC2)CC1)N1CCCC1	InChI=1S/C32H43Cl2N5O3/c1-2-26(37-14-3-4-15-37)22-42-29-8-7-13-35-30(29)23-11-18-38(19-12-23)31(40)28(36-32(41)39-16-5-6-17-39)20-24-9-10-25(33)21-27(24)34/h7-10,13,21,23,26,28H,2-6,11-12,14-20,22H2,1H3,(H,36,41)/t26-,28-/m1/s1	GNSVFEJLUPMLCZ-IXCJQBJRSA-N					doublet; compound annotation
0391_004613	SNT-207858 (free base)	C32H43Cl2N5O3	3.1131	42630200	CC[C@H](COC1=C(N=CC=C1)C2CCN(CC2)C(=O)[C@@H](CC3=C(C=C(C=C3)Cl)Cl)NC(=O)N4CCCC4)N5CCCC5	CCC(COc1cccnc1C1CCN(C(=O)C(Cc2c(Cl)cc(Cl)cc2)NC(=O)N2CCCC2)CC1)N1CCCC1	InChI=1S/C32H43Cl2N5O3/c1-2-26(37-14-3-4-15-37)22-42-29-8-7-13-35-30(29)23-11-18-38(19-12-23)31(40)28(36-32(41)39-16-5-6-17-39)20-24-9-10-25(33)21-27(24)34/h7-10,13,21,23,26,28H,2-6,11-12,14-20,22H2,1H3,(H,36,41)/t26-,28-/m1/s1	GNSVFEJLUPMLCZ-IXCJQBJRSA-N					doublet; removed another duplicate entry; compound annotation
0391_004615	JI-101	C22H20BrN5O2	3.4011	11691242		COc1c(NC(=O)Nc2c3ccn(Cc4cc(N)ncc4)c3ccc2)cc(Br)cc1	InChI=1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29)	ZXBFYBLSJMEBEP-UHFFFAOYSA-N					doublet; compound annotation
0391_004616	JI-101	C22H20BrN5O2	3.4043	11691242		COc1c(NC(=O)Nc2c3ccn(Cc4cc(N)ncc4)c3ccc2)cc(Br)cc1	InChI=1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29)	ZXBFYBLSJMEBEP-UHFFFAOYSA-N					doublet; compound annotation
0391_004617	AUT1	C18H19N3O4	3.8093	53230344	CC[C@@H]1C(=O)N(C(=O)N1)C2=CN=C(C=C2)OC3=CC(=C(C=C3)C)OC	CCC1NC(=O)N(c2cnc(Oc3cc(OC)c(C)cc3)cc2)C1=O	InChI=1S/C18H19N3O4/c1-4-14-17(22)21(18(23)20-14)12-6-8-16(19-10-12)25-13-7-5-11(2)15(9-13)24-3/h5-10,14H,4H2,1-3H3,(H,20,23)/t14-/m1/s1	AMAOXEGBJHLCSF-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_004620	Firsocostat	C28H31N3O8S	4.4694	71528744	CC1=C(SC2=C1C(=O)N(C(=O)N2C[C@@H](C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5	COc1ccccc1C(Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c1sc(-c1ncco1)c2C)OC1CCOCC1	InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1	ZZWWXIBKLBMSCS-FQEVSTJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004622	448895-37-2	C15H10F6N2O3	4.5372	10177784		O=C(Nc1c(O)ccc(C(F)(F)F)c1)Nc1c(O)ccc(C(F)(F)F)c1	InChI=1S/C15H10F6N2O3/c16-14(17,18)7-1-3-11(24)9(5-7)22-13(26)23-10-6-8(15(19,20)21)2-4-12(10)25/h1-6,24-25H,(H2,22,23,26)	NJFVQMRYJZHGME-UHFFFAOYSA-N					compound annotation
0391_004623	943962-47-8	C19H15Cl2NO4S	5.1999	16747776		COc1c(NS(=O)(=O)c2c(O)c(Cl)cc(Cl)c2)cc(-c2ccccc2)cc1	InChI=1S/C19H15Cl2NO4S/c1-26-17-8-7-13(12-5-3-2-4-6-12)9-16(17)22-27(24,25)18-11-14(20)10-15(21)19(18)23/h2-11,22-23H,1H3	SIIPNDKXZOTLEA-UHFFFAOYSA-N					compound annotation
0391_004624	Firsocostat	C28H31N3O8S	5.9661	71528744	CC1=C(SC2=C1C(=O)N(C(=O)N2C[C@@H](C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5	COc1ccccc1C(Cn1c(=O)n(C(C)(C)C(=O)O)c(=O)c2c1sc(-c1ncco1)c2C)OC1CCOCC1	InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1	ZZWWXIBKLBMSCS-FQEVSTJZSA-N					doublet; compound annotation
0391_004625	05HQS4AI99	C45H74O11	6.029	52947716	CC[C@@H]\1CC[C@H]2[C@H]([C@H]([C@@H]([C@]3(O2)CC[C@@H]([C@@H](O3)C[C@@H](C)O)C)C)OC(=O)/C=C/[C@@H]([C@H]([C@@H](C(=O)[C@@H]([C@H]([C@@H](C(=O)[C@]([C@H]([C@@H](C/C=C/C=C1)C)O)(C)O)C)O)C)C)O)C)C	CCC1C=CC=CCC(C)C(O)C(C)(O)C(=O)C(C)C(O)C(C)C(=O)C(C)C(O)C(C)C=CC(=O)OC2C(C)C(CC1)OC1(CCC(C)C(CC(C)O)O1)C2C	InChI=1S/C45H74O11/c1-12-34-17-15-13-14-16-27(4)42(51)44(11,53)43(52)32(9)40(50)31(8)39(49)30(7)38(48)26(3)18-21-37(47)54-41-29(6)35(20-19-34)55-45(33(41)10)23-22-25(2)36(56-45)24-28(5)46/h13-15,17-18,21,25-36,38,40-42,46,48,50-51,53H,12,16,19-20,22-24H2,1-11H3/b14-13+,17-15+,21-18+/t25-,26-,27+,28+,29+,30-,31-,32-,33-,34-,35-,36-,38+,40+,41+,42-,44+,45-/m0/s1	MNULEGDCPYONBU-AWJDAWNUSA-N					removed another duplicate entry; compound annotation
0391_004627	Suplatast	C16H26NO4S+	1.285	71774		CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1	InChI=1S/C16H25NO4S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3/h5-8,14,18H,4,9-12H2,1-3H3/p+1	DYZJXZOQQRXDLE-UHFFFAOYSA-O					doublet; compound annotation
0391_004628	Suplatast	C16H26NO4S+	1.3624	71774		CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1	InChI=1S/C16H25NO4S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3/h5-8,14,18H,4,9-12H2,1-3H3/p+1	DYZJXZOQQRXDLE-UHFFFAOYSA-O					doublet; compound annotation
0391_004629	SU9516	C13H11N3O2	1.5019	5289419	COC1=CC\2=C(C=C1)NC(=O)/C2=C\C3=CN=CN3	COc1cc2c(cc1)NC(=O)C2=Cc1cnc[nH]1	InChI=1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-	QNUKRWAIZMBVCU-WCIBSUBMSA-N					doublet; compound annotation
0391_004630	BD-1047	C13H20Cl2N2	1.6306	188914		CN(C)CCN(C)CCc1cc(Cl)c(Cl)cc1	InChI=1S/C13H20Cl2N2/c1-16(2)8-9-17(3)7-6-11-4-5-12(14)13(15)10-11/h4-5,10H,6-9H2,1-3H3	MGVRNMUKTZOQOW-UHFFFAOYSA-N					compound annotation
0391_004631	SU9516	C13H11N3O2	1.6891	5289419	COC1=CC\2=C(C=C1)NC(=O)/C2=C\C3=CN=CN3	COc1cc2c(cc1)NC(=O)C2=Cc1cnc[nH]1	InChI=1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4-	QNUKRWAIZMBVCU-WCIBSUBMSA-N					doublet; removed another duplicate entry; compound annotation
0391_004633	1221186-53-3	C17H16N4O2S2	1.8434	44246499		Cn1c2c(sc([S+](C)[O-])c2)c2c1c(=O)n(Cc1cccc(N)c1)nc2	InChI=1S/C17H16N4O2S2/c1-20-13-7-14(25(2)23)24-16(13)12-8-19-21(17(22)15(12)20)9-10-4-3-5-11(18)6-10/h3-8H,9,18H2,1-2H3	ZWKJWVSEDISQIS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004636	Tiotropium	C19H22NO4S2+	2.0774	5487427	C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C	C[N+]1(C)C2CC(OC(=O)C(O)(c3cccs3)c3cccs3)CC1C1OC12	InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17+	LERNTVKEWCAPOY-FPISHFTHSA-N					compound annotation
0391_004637	Itacitinib	C26H23F4N9O	2.2416	53380437		N#CCC1(n2cc(-c3c4cc[nH]c4ncn3)cn2)CN(C2CCN(C(=O)c3c(F)c(C(F)(F)F)ncc3)CC2)C1	InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35)	KTBSXLIQKWEBRB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004639	RG2833	C20H25N3O2	2.6884	56654642		Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1	InChI=1S/C20H25N3O2/c1-15-10-12-16(13-11-15)20(25)22-14-6-2-3-9-19(24)23-18-8-5-4-7-17(18)21/h4-5,7-8,10-13H,2-3,6,9,14,21H2,1H3,(H,22,25)(H,23,24)	VOPDXHFYDJAYNS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004641	RG2833	C20H25N3O2	2.6933	56654642		Cc1ccc(C(=O)NCCCCCC(=O)Nc2ccccc2N)cc1	InChI=1S/C20H25N3O2/c1-15-10-12-16(13-11-15)20(25)22-14-6-2-3-9-19(24)23-18-8-5-4-7-17(18)21/h4-5,7-8,10-13H,2-3,6,9,14,21H2,1H3,(H,22,25)(H,23,24)	VOPDXHFYDJAYNS-UHFFFAOYSA-N					doublet; compound annotation
0391_004642	PFI-4	C21H24N4O3	3.0478	40642506		COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C	InChI=1S/C21H24N4O3/c1-23-17-12-15(22-20(26)14-8-4-5-9-19(14)28-3)16(25-10-6-7-11-25)13-18(17)24(2)21(23)27/h4-5,8-9,12-13H,6-7,10-11H2,1-3H3,(H,22,26)	QCIJLRJBZDBVDB-UHFFFAOYSA-N					doublet; compound annotation
0391_004643	PFI-4	C21H24N4O3	3.0507	40642506		COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCC1)n(C)c(=O)n2C	InChI=1S/C21H24N4O3/c1-23-17-12-15(22-20(26)14-8-4-5-9-19(14)28-3)16(25-10-6-7-11-25)13-18(17)24(2)21(23)27/h4-5,8-9,12-13H,6-7,10-11H2,1-3H3,(H,22,26)	QCIJLRJBZDBVDB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004645	TG6-10-1	C23H23F3N2O4	4.6234	71499384	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)NCCN2C3=CC=CC=C3C=C2C(F)(F)F	COc1cc(C=CC(=O)NCCn2c(C(F)(F)F)cc3ccccc32)cc(OC)c1OC	InChI=1S/C23H23F3N2O4/c1-30-18-12-15(13-19(31-2)22(18)32-3)8-9-21(29)27-10-11-28-17-7-5-4-6-16(17)14-20(28)23(24,25)26/h4-9,12-14H,10-11H2,1-3H3,(H,27,29)/b9-8+	WUYOECAJFJFUFC-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_004647	TG6-10-1	C23H23F3N2O4	4.6262	71499384	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)NCCN2C3=CC=CC=C3C=C2C(F)(F)F	COc1cc(C=CC(=O)NCCn2c(C(F)(F)F)cc3ccccc32)cc(OC)c1OC	InChI=1S/C23H23F3N2O4/c1-30-18-12-15(13-19(31-2)22(18)32-3)8-9-21(29)27-10-11-28-17-7-5-4-6-16(17)14-20(28)23(24,25)26/h4-9,12-14H,10-11H2,1-3H3,(H,27,29)/b9-8+	WUYOECAJFJFUFC-CMDGGOBGSA-N					doublet; compound annotation
0391_004648	RAFOXANIDE	C19H11Cl2I2NO3	6.7507	31475		O=C(Nc1cc(Cl)c(Oc2ccc(Cl)cc2)cc1)c1c(O)c(I)cc(I)c1	InChI=1S/C19H11Cl2I2NO3/c20-10-1-4-13(5-2-10)27-17-6-3-12(9-15(17)21)24-19(26)14-7-11(22)8-16(23)18(14)25/h1-9,25H,(H,24,26)	NEMNPWINWMHUMR-UHFFFAOYSA-N					compound annotation
0391_004649	lycorine	C16H17NO4	0.4974	72378	C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2C1=C[C@@H]([C@H]5O)O)OCO4	OC1C=C2CCN3Cc4cc5c(cc4C(C1O)C23)OCO5	InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1	XGVJWXAYKUHDOO-DANNLKNASA-N					doublet; compound annotation
0391_004650	iopromide	C18H24I3N3O8	0.8985	3736		COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I	InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29)	DGAIEPBNLOQYER-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004652	iopromide	C18H24I3N3O8	0.9499	3736		COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I	InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29)	DGAIEPBNLOQYER-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004654	eCF506	C26H38N8O3	2.0912	121231408		COc1c(NC(=O)OC(C)(C)C)ccc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)c1	InChI=1S/C26H38N8O3/c1-26(2,3)37-25(35)30-19-8-7-17(15-20(19)36-6)22-21-23(27)28-16-29-24(21)34(31-22)14-13-33-11-9-18(10-12-33)32(4)5/h7-8,15-16,18H,9-14H2,1-6H3,(H,30,35)(H2,27,28,29)	GMPQGWXPDRNCBL-UHFFFAOYSA-N					doublet; compound annotation
0391_004655	eCF506	C26H38N8O3	2.0961	121231408		COc1c(NC(=O)OC(C)(C)C)ccc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)c1	InChI=1S/C26H38N8O3/c1-26(2,3)37-25(35)30-19-8-7-17(15-20(19)36-6)22-21-23(27)28-16-29-24(21)34(31-22)14-13-33-11-9-18(10-12-33)32(4)5/h7-8,15-16,18H,9-14H2,1-6H3,(H,30,35)(H2,27,28,29)	GMPQGWXPDRNCBL-UHFFFAOYSA-N					doublet; compound annotation
0391_004656	1,3-Di-o-tolylguanidine	C15H17N3	2.1172	7333		Cc1ccccc1N=C(N)Nc1ccccc1C	InChI=1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)	OPNUROKCUBTKLF-UHFFFAOYSA-N					doublet; compound annotation
0391_004657	isoxsuprine	C18H23NO3	2.137	3783		CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1	InChI=1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3	BMUKKTUHUDJSNZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004659	1,3-Di-o-tolylguanidine	C15H17N3	2.3105	7333		Cc1ccccc1N=C(N)Nc1ccccc1C	InChI=1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)	OPNUROKCUBTKLF-UHFFFAOYSA-N					doublet; compound annotation
0391_004660	phenazopyridine	C11H11N5	2.3499	4756		Nc1nc(N)c(N=Nc2ccccc2)cc1	InChI=1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14)	QPFYXYFORQJZEC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004662	citalopram	C20H21FN2O	2.756	2771		CN(C)CCCC1(c2ccc(F)cc2)OCc2c1ccc(C#N)c2	InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3	WSEQXVZVJXJVFP-UHFFFAOYSA-N					compound annotation
0391_004663	CYPROHEPTADINE	C21H21N	3.0786	2913		CN1CCC(=C2c3ccccc3C=Cc3ccccc23)CC1	InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3	JJCFRYNCJDLXIK-UHFFFAOYSA-N					doublet; compound annotation
0391_004664	CINROMIDE	C11H12BrNO	3.3156	688145	CCNC(=O)/C=C/C1=CC(=CC=C1)Br	CCNC(=O)C=Cc1cc(Br)ccc1	InChI=1S/C11H12BrNO/c1-2-13-11(14)7-6-9-4-3-5-10(12)8-9/h3-8H,2H2,1H3,(H,13,14)/b7-6+	LDCXGZCEMNMWIL-VOTSOKGWSA-N					compound annotation
0391_004665	Hoku-81	C12H18ClNO2	1.3717	162846		CC(C)(C)NCC(O)c1c(Cl)cc(O)cc1	InChI=1S/C12H18ClNO2/c1-12(2,3)14-7-11(16)9-5-4-8(15)6-10(9)13/h4-6,11,14-16H,7H2,1-3H3	LIXBJWRFCNRAPA-UHFFFAOYSA-N					compound annotation
0391_004666	CARBADOX	C11H10N4O4	1.4775	135511839	COC(=O)N/N=C/C1=[N+](C2=CC=CC=C2[N+](=C1)[O-])[O-]	COC(=O)NN=Cc1[n+]([O-])c2ccccc2[n+]([O-])c1	InChI=1S/C11H10N4O4/c1-19-11(16)13-12-6-8-7-14(17)9-4-2-3-5-10(9)15(8)18/h2-7H,1H3,(H,13,16)/b12-6+	OVGGLBAWFMIPPY-WUXMJOGZSA-N					removed another duplicate entry; compound annotation
0391_004668	MK-0812	C24H34F3N3O3	2.664	11180808	CC(C)[C@@]1(CC[C@H](C1)N[C@H]2CCOC[C@H]2OC)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F	COC1COCCC1NC1CCC(C(=O)N2CCc3c(cc(C(F)(F)F)cn3)C2)(C(C)C)C1	InChI=1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/t18-,20+,21-,23+/m1/s1	MTMDXAIUENDNDL-RJSMDTJLSA-N					doublet; compound annotation
0391_004669	MK-0812	C24H34F3N3O3	2.668	11180808	CC(C)[C@@]1(CC[C@H](C1)N[C@H]2CCOC[C@H]2OC)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F	COC1COCCC1NC1CCC(C(=O)N2CCc3c(cc(C(F)(F)F)cn3)C2)(C(C)C)C1	InChI=1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/t18-,20+,21-,23+/m1/s1	MTMDXAIUENDNDL-RJSMDTJLSA-N					doublet; compound annotation
0391_004670	844499-71-4	C20H12N2O3S	3.0649	54708532		N#Cc1c(O)[nH]c2c(c(-c3ccc(-c4ccccc4O)cc3)cs2)c1=O	InChI=1S/C20H12N2O3S/c21-9-14-18(24)17-15(10-26-20(17)22-19(14)25)12-7-5-11(6-8-12)13-3-1-2-4-16(13)23/h1-8,10,23H,(H2,22,24,25)	CTESJDQKVOEUOY-UHFFFAOYSA-N					compound annotation
0391_004671	DGAT-1 inhibitor 2	C24H28N4O3	3.442	16202164		CC1(C)Oc2ncnc(N)c2N=C1c1ccc(C23CCC(CC(=O)O)(CC2)CC3)cc1	InChI=1S/C24H28N4O3/c1-22(2)19(28-18-20(25)26-14-27-21(18)31-22)15-3-5-16(6-4-15)24-10-7-23(8-11-24,9-12-24)13-17(29)30/h3-6,14H,7-13H2,1-2H3,(H,29,30)(H2,25,26,27)	VGPKUACRBMPJLF-UHFFFAOYSA-N					compound annotation
0391_004672	Endoxifen, (E)-	C25H27NO2	3.508	3035980	CC/C(=C(/C1=CC=C(C=C1)O)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24+	MHJBZVSGOZTKRH-OCOZRVBESA-N					doublet; compound annotation
0391_004673	Endoxifen, (E)-	C25H27NO2	3.5729	3035980	CC/C(=C(/C1=CC=C(C=C1)O)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24+	MHJBZVSGOZTKRH-OCOZRVBESA-N					doublet; compound annotation
0391_004674	Cinobufagin	C26H34O6	3.8376	11969542	CC(=O)O[C@@H]1[C@@H]([C@]2(CC[C@H]3[C@H]([C@@]24[C@@H]1O4)CC[C@H]5[C@@]3(CC[C@@H](C5)O)C)C)C6=COC(=O)C=C6	CC(=O)OC1C(c2coc(=O)cc2)C2(C)CCC3C(CCC4CC(O)CCC43C)C23OC13	InChI=1S/C26H34O6/c1-14(27)31-22-21(15-4-7-20(29)30-13-15)25(3)11-9-18-19(26(25)23(22)32-26)6-5-16-12-17(28)8-10-24(16,18)2/h4,7,13,16-19,21-23,28H,5-6,8-12H2,1-3H3/t16-,17+,18+,19-,21+,22-,23-,24+,25-,26-/m1/s1	SCULJPGYOQQXTK-OLRINKBESA-N					removed another duplicate entry; compound annotation
0391_004676	Endoxifen, (E)-	C25H27NO2	4.5601	3035980	CC/C(=C(/C1=CC=C(C=C1)O)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24+	MHJBZVSGOZTKRH-OCOZRVBESA-N					doublet; compound annotation
0391_004677	Endoxifen, (E)-	C25H27NO2	4.652	3035980	CC/C(=C(/C1=CC=C(C=C1)O)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24+	MHJBZVSGOZTKRH-OCOZRVBESA-N					doublet; compound annotation
0391_004678	212631-79-3	C17H14ClF2IN2O2	5.2954	6918454		O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1c(Cl)cc(I)cc1	InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)	GFMMXOIFOQCCGU-UHFFFAOYSA-N					compound annotation
0391_004679	MK 0893	C32H27Cl2N3O4	6.0128	11570626	C[C@@H](C1=CC=C(C=C1)C(=O)NCCC(=O)O)N2C(=CC(=N2)C3=CC(=CC(=C3)Cl)Cl)C4=CC5=C(C=C4)C=C(C=C5)OC	COc1cc2c(cc1)cc(-c1cc(-c3cc(Cl)cc(Cl)c3)nn1C(C)c1ccc(C(=O)NCCC(=O)O)cc1)cc2	InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1	DNTVJEMGHBIUMW-IBGZPJMESA-N					doublet; compound annotation
0391_004680	MK 0893	C32H27Cl2N3O4	6.0177	11570626	C[C@@H](C1=CC=C(C=C1)C(=O)NCCC(=O)O)N2C(=CC(=N2)C3=CC(=CC(=C3)Cl)Cl)C4=CC5=C(C=C4)C=C(C=C5)OC	COc1cc2c(cc1)cc(-c1cc(-c3cc(Cl)cc(Cl)c3)nn1C(C)c1ccc(C(=O)NCCC(=O)O)cc1)cc2	InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1	DNTVJEMGHBIUMW-IBGZPJMESA-N					doublet; compound annotation
0391_004681	Aconine	C25H41NO9	1.1064	20054813	CCN1C[C@@]2([C@@H](C[C@@H]([C@@]34[C@@H]2[C@H]([C@@H](C31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6O)([C@H]([C@@H]5O)OC)O)O)OC)OC)O)COC	CCN1CC2(COC)C(O)CC(OC)C34C5CC6(O)C(O)C5C(O)(C(O)C6OC)C(C(OC)C23)C14	InChI=1S/C25H41NO9/c1-6-26-9-22(10-32-2)12(27)7-13(33-3)24-11-8-23(30)19(28)14(11)25(31,20(29)21(23)35-5)15(18(24)26)16(34-4)17(22)24/h11-21,27-31H,6-10H2,1-5H3/t11-,12-,13+,14-,15+,16+,17-,18?,19-,20+,21+,22+,23-,24+,25-/m1/s1	SQMGCPHFHQGPIF-JIOYIOPFSA-N					doublet; compound annotation
0391_004682	Aconine	C25H41NO9	1.235	20054813	CCN1C[C@@]2([C@@H](C[C@@H]([C@@]34[C@@H]2[C@H]([C@@H](C31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6O)([C@H]([C@@H]5O)OC)O)O)OC)OC)O)COC	CCN1CC2(COC)C(O)CC(OC)C34C5CC6(O)C(O)C5C(O)(C(O)C6OC)C(C(OC)C23)C14	InChI=1S/C25H41NO9/c1-6-26-9-22(10-32-2)12(27)7-13(33-3)24-11-8-23(30)19(28)14(11)25(31,20(29)21(23)35-5)15(18(24)26)16(34-4)17(22)24/h11-21,27-31H,6-10H2,1-5H3/t11-,12-,13+,14-,15+,16+,17-,18?,19-,20+,21+,22+,23-,24+,25-/m1/s1	SQMGCPHFHQGPIF-JIOYIOPFSA-N					doublet; compound annotation
0391_004683	Eleutheroside E	C34H46O18	1.7237	71312557	COC1=CC(=CC(=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC)[C@H]3[C@@H]4CO[C@@H]([C@H]4CO3)C5=CC(=C(C(=C5)OC)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)OC	COc1c(OC2OC(CO)C(O)C(O)C2O)c(OC)cc(C2OCC3C(c4cc(OC)c(OC5OC(CO)C(O)C(O)C5O)c(OC)c4)OCC23)c1	InChI=1S/C34H46O18/c1-43-17-5-13(6-18(44-2)31(17)51-33-27(41)25(39)23(37)21(9-35)49-33)29-15-11-48-30(16(15)12-47-29)14-7-19(45-3)32(20(8-14)46-4)52-34-28(42)26(40)24(38)22(10-36)50-34/h5-8,15-16,21-30,33-42H,9-12H2,1-4H3/t15-,16+,21-,22-,23-,24-,25+,26+,27-,28-,29+,30-,33+,34+/m1/s1	FFDULTAFAQRACT-JSGUJALWSA-N					removed another duplicate entry; compound annotation
0391_004685	Calycosin	C16H12O5	2.6087	5280448		COc1c(O)cc(-c2coc3c(ccc(O)c3)c2=O)cc1	InChI=1S/C16H12O5/c1-20-14-5-2-9(6-13(14)18)12-8-21-15-7-10(17)3-4-11(15)16(12)19/h2-8,17-18H,1H3	ZZAJQOPSWWVMBI-UHFFFAOYSA-N					doublet; compound annotation
0391_004686	Calycosin	C16H12O5	2.6116	5280448		COc1c(O)cc(-c2coc3c(ccc(O)c3)c2=O)cc1	InChI=1S/C16H12O5/c1-20-14-5-2-9(6-13(14)18)12-8-21-15-7-10(17)3-4-11(15)16(12)19/h2-8,17-18H,1H3	ZZAJQOPSWWVMBI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004688	Erdafitinib	C25H30N6O2	2.7713	67462786		COc1cc(N(CCNC(C)C)c2cc3nc(-c4cn(C)nc4)cnc3cc2)cc(OC)c1	InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3	OLAHOMJCDNXHFI-UHFFFAOYSA-N					compound annotation
0391_004689	Erianin	C18H22O5	3.8055	356759		COc1c(O)cc(CCc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C18H22O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h7-11,19H,5-6H2,1-4H3	UXDFUVFNIAJEGM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004691	Erianin	C18H22O5	3.809	356759		COc1c(O)cc(CCc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C18H22O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h7-11,19H,5-6H2,1-4H3	UXDFUVFNIAJEGM-UHFFFAOYSA-N					doublet; compound annotation
0391_004692	Obacunone	C26H30O7	4.0348	119041	C[C@@]12CC[C@@H]3[C@]4(C=CC(=O)OC([C@@H]4CC(=O)[C@]3([C@@]15[C@H](O5)C(=O)O[C@H]2C6=COC=C6)C)(C)C)C	CC1(C)OC(=O)C=CC2(C)C1CC(=O)C1(C)C2CCC2(C)C(c3cocc3)OC(=O)C3OC321	InChI=1S/C26H30O7/c1-22(2)16-12-17(27)25(5)15(23(16,3)9-7-18(28)32-22)6-10-24(4)19(14-8-11-30-13-14)31-21(29)20-26(24,25)33-20/h7-9,11,13,15-16,19-20H,6,10,12H2,1-5H3/t15-,16+,19+,20-,23-,24+,25+,26-/m1/s1	MAYJEFRPIKEYBL-OASIGRBWSA-N					compound annotation
0391_004693	Astragaloside I	C45H72O16	4.1032	13996685	CC(=O)O[C@H]1[C@@H](CO[C@H]([C@@H]1OC(=O)C)O[C@H]2CC[C@]34C[C@]35CC[C@@]6([C@H]([C@H](C[C@]6([C@@H]5C[C@@H]([C@H]4C2(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C)O	CC(=O)OC1C(O)COC(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)C1OC(C)=O	InChI=1S/C45H72O16/c1-21(47)56-33-24(50)19-55-38(34(33)57-22(2)48)60-28-11-13-45-20-44(45)15-14-41(7)35(43(9)12-10-29(61-43)40(5,6)54)23(49)17-42(41,8)27(44)16-25(36(45)39(28,3)4)58-37-32(53)31(52)30(51)26(18-46)59-37/h23-38,46,49-54H,10-20H2,1-9H3/t23-,24+,25-,26+,27-,28-,29-,30+,31-,32+,33-,34+,35-,36-,37+,38-,41+,42-,43+,44-,45+/m0/s1	KXHCYYSIAXMSPA-OOCCOBHWSA-N					removed another duplicate entry; compound annotation
0391_004695	iodoquinol	C9H5I2NO	5.013	3728		Oc1c(I)cc(I)c2c1nccc2	InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	UXZFQZANDVDGMM-UHFFFAOYSA-N					compound annotation
0391_004696	Seladelpar	C21H23F3O5S	5.1418	11236126	CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C	CCOC(COc1ccc(C(F)(F)F)cc1)CSc1cc(C)c(OCC(=O)O)cc1	InChI=1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1	JWHYSEDOYMYMNM-QGZVFWFLSA-N					compound annotation
0391_004697	Rocuronium	C32H53N2O4+	1.822	441290	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C	C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1	InChI=1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35/h5,23-30,36H,1,6-21H2,2-4H3/q+1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1	YXRDKMPIGHSVRX-OOJCLDBCSA-N					compound annotation
0391_004698	NSC319726	C11H14N4S	2.1251	5351307	C/C(=N\NC(=S)N1CCC1)/C2=CC=CC=N2	CC(=NNC(=S)N1CCC1)c1ccccn1	InChI=1S/C11H14N4S/c1-9(10-5-2-3-6-12-10)13-14-11(16)15-7-4-8-15/h2-3,5-6H,4,7-8H2,1H3,(H,14,16)/b13-9+	XDHBUMNIQRLHGO-UKTHLTGXSA-N					removed another duplicate entry; compound annotation
0391_004700	Eslicarbazepine	C15H14N2O2	2.1985	9881504	C1[C@@H](C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O	NC(=O)N1c2ccccc2CC(O)c2ccccc21	InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1	BMPDWHIDQYTSHX-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_004702	A-381393	C20H24N4	2.5121	11301655		Cc1c(C)cc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1	InChI=1S/C20H24N4/c1-15-7-8-17(13-16(15)2)24-11-9-23(10-12-24)14-20-21-18-5-3-4-6-19(18)22-20/h3-8,13H,9-12,14H2,1-2H3,(H,21,22)	SAQMCVDGOIRQTC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004704	CNX-774	C26H22FN7O3	2.7874	59174579		C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4cc(C(=O)NC)ncc4)cc3)ncc2F)c1	InChI=1S/C26H22FN7O3/c1-3-23(35)31-17-5-4-6-18(13-17)32-24-21(27)15-30-26(34-24)33-16-7-9-19(10-8-16)37-20-11-12-29-22(14-20)25(36)28-2/h3-15H,1H2,2H3,(H,28,36)(H,31,35)(H2,30,32,33,34)	VVLHQJDAUIPZFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004706	Parbendazole	C13H17N3O2	2.8245	26596		CCCCc1cc2c(cc1)nc(NC(=O)OC)[nH]2	InChI=1S/C13H17N3O2/c1-3-4-5-9-6-7-10-11(8-9)15-12(14-10)16-13(17)18-2/h6-8H,3-5H2,1-2H3,(H2,14,15,16,17)	YRWLZFXJFBZBEY-UHFFFAOYSA-N					compound annotation
0391_004707	BML-277	C20H14ClN3O2	3.2308	9969021		NC(=O)c1cc2c(cc1)nc(-c1ccc(Oc3ccc(Cl)cc3)cc1)[nH]2	InChI=1S/C20H14ClN3O2/c21-14-4-8-16(9-5-14)26-15-6-1-12(2-7-15)20-23-17-10-3-13(19(22)25)11-18(17)24-20/h1-11H,(H2,22,25)(H,23,24)	UXGJAOIJSROTTN-UHFFFAOYSA-N					doublet; compound annotation
0391_004708	BML-277	C20H14ClN3O2	3.2335	9969021		NC(=O)c1cc2c(cc1)nc(-c1ccc(Oc3ccc(Cl)cc3)cc1)[nH]2	InChI=1S/C20H14ClN3O2/c21-14-4-8-16(9-5-14)26-15-6-1-12(2-7-15)20-23-17-10-3-13(19(22)25)11-18(17)24-20/h1-11H,(H2,22,25)(H,23,24)	UXGJAOIJSROTTN-UHFFFAOYSA-N					doublet; compound annotation
0391_004709	301305-73-7	C18H20N2O4S	3.9062	1048845		COc1c(OC)cc(C(=O)Nc2c(C(N)=O)c3c(CCCC3)s2)cc1	InChI=1S/C18H20N2O4S/c1-23-12-8-7-10(9-13(12)24-2)17(22)20-18-15(16(19)21)11-5-3-4-6-14(11)25-18/h7-9H,3-6H2,1-2H3,(H2,19,21)(H,20,22)	FSPQCTGGIANIJZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004712	Oxyclozanide	C13H6Cl5NO3	4.7115	16779		O=C(Nc1c(O)c(Cl)cc(Cl)c1)c1c(O)c(Cl)cc(Cl)c1Cl	InChI=1S/C13H6Cl5NO3/c14-4-1-6(16)11(20)8(2-4)19-13(22)9-10(18)5(15)3-7(17)12(9)21/h1-3,20-21H,(H,19,22)	JYWIYHUXVMAGLG-UHFFFAOYSA-N					compound annotation
0391_004713	SRPIN340	C18H18F3N3O	4.8074	2797577		O=C(Nc1cc(C(F)(F)F)ccc1N1CCCCC1)c1ccncc1	InChI=1S/C18H18F3N3O/c19-18(20,21)14-4-5-16(24-10-2-1-3-11-24)15(12-14)23-17(25)13-6-8-22-9-7-13/h4-9,12H,1-3,10-11H2,(H,23,25)	DWFGGOFPIISJIT-UHFFFAOYSA-N					compound annotation
0391_004714	608512-97-6	C13H8N4OS	0.9636	6490494	C1=CC2=C(C\3=C1NC(=O)/C3=C\C4=CN=CN4)SC=N2	O=C1Nc2c(C1=Cc1cnc[nH]1)c1c(cc2)ncs1	InChI=1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3-	VFBGXTUGODTSPK-BAQGIRSFSA-N					doublet; compound annotation
0391_004715	608512-97-6	C13H8N4OS	1.4789	6490494	C1=CC2=C(C\3=C1NC(=O)/C3=C\C4=CN=CN4)SC=N2	O=C1Nc2c(C1=Cc1cnc[nH]1)c1c(cc2)ncs1	InChI=1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3-	VFBGXTUGODTSPK-BAQGIRSFSA-N					doublet; compound annotation
0391_004716	EIDD 2801	C13H19N3O7	1.5903	145996610	CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O	CC(C)C(=O)OCC1OC(n2ccc(NO)nc2=O)C(O)C1O	InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1	HTNPEHXGEKVIHG-QCNRFFRDSA-N					removed another duplicate entry; compound annotation
0391_004718	1415379-56-4	C16H10FN3	2.0077	71059746		Fc1ncc(-c2cc3c(cc2)c2c(ccnc2)[nH]3)cc1	InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H	GETAAWDSFUCLBS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004720	2,4,5-TRIMETHOXYBENZALDEHYDE	C10H12O4	2.4169	20525		COc1cc(OC)c(OC)cc1C=O	InChI=1S/C10H12O4/c1-12-8-5-10(14-3)9(13-2)4-7(8)6-11/h4-6H,1-3H3	IAJBQAYHSQIQRE-UHFFFAOYSA-N					compound annotation
0391_004721	Deltarasin	C40H37N5O	2.6908	73292904	C1CNCCC1[C@@H](COC2=CC=C(C=C2)C3=NC4=CC=CC=C4N3CC5=CC=CC=C5)N6C7=CC=CC=C7N=C6C8=CC=CC=C8	c1ccc(Cn2c(-c3ccc(OCC(C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1	InChI=1S/C40H37N5O/c1-3-11-29(12-4-1)27-44-36-17-9-7-15-34(36)42-39(44)32-19-21-33(22-20-32)46-28-38(30-23-25-41-26-24-30)45-37-18-10-8-16-35(37)43-40(45)31-13-5-2-6-14-31/h1-22,30,38,41H,23-28H2/t38-/m1/s1	LTZKEDSUXKTTTC-KXQOOQHDSA-N					doublet; compound annotation
0391_004722	Deltarasin	C40H37N5O	2.6935	73292904	C1CNCCC1[C@@H](COC2=CC=C(C=C2)C3=NC4=CC=CC=C4N3CC5=CC=CC=C5)N6C7=CC=CC=C7N=C6C8=CC=CC=C8	c1ccc(Cn2c(-c3ccc(OCC(C4CCNCC4)n4c(-c5ccccc5)nc5ccccc54)cc3)nc3ccccc32)cc1	InChI=1S/C40H37N5O/c1-3-11-29(12-4-1)27-44-36-17-9-7-15-34(36)42-39(44)32-19-21-33(22-20-32)46-28-38(30-23-25-41-26-24-30)45-37-18-10-8-16-35(37)43-40(45)31-13-5-2-6-14-31/h1-22,30,38,41H,23-28H2/t38-/m1/s1	LTZKEDSUXKTTTC-KXQOOQHDSA-N					doublet; compound annotation
0391_004723	MK-8353	C37H41N9O3S	3.2001	58282870	CC(C)OC1=NC=C(C=C1)C2=NNC3=C2C=C(C=C3)NC(=O)[C@@]4(CCN(C4)CC(=O)N5CCC(=CC5)C6=CC=C(C=C6)C7=NN(C=N7)C)SC	CSC1(C(=O)Nc2cc3c(cc2)[nH]nc3-c2cnc(OC(C)C)cc2)CCN(CC(=O)N2CC=C(c3ccc(-c4nn(C)cn4)cc3)CC2)C1	InChI=1S/C37H41N9O3S/c1-24(2)49-32-12-9-28(20-38-32)34-30-19-29(10-11-31(30)41-42-34)40-36(48)37(50-4)15-18-45(22-37)21-33(47)46-16-13-26(14-17-46)25-5-7-27(8-6-25)35-39-23-44(3)43-35/h5-13,19-20,23-24H,14-18,21-22H2,1-4H3,(H,40,48)(H,41,42)/t37-/m0/s1	KPQQGHGDBBJGFA-QNGWXLTQSA-N					removed another duplicate entry; compound annotation
0391_004725	SCHEMBL2237596	C23H18N6O2	3.3751	44602526		N#Cc1ncc(COc2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)cc1	InChI=1S/C23H18N6O2/c24-12-18-9-4-15(13-25-18)14-31-19-10-7-16(8-11-19)20-2-1-3-21-26-23(28-29(20)21)27-22(30)17-5-6-17/h1-4,7-11,13,17H,5-6,14H2,(H,27,28,30)	QZXABVVSCDZCLR-UHFFFAOYSA-N					doublet; compound annotation
0391_004726	SCHEMBL2237596	C23H18N6O2	3.3784	44602526		N#Cc1ncc(COc2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)cc1	InChI=1S/C23H18N6O2/c24-12-18-9-4-15(13-25-18)14-31-19-10-7-16(8-11-19)20-2-1-3-21-26-23(28-29(20)21)27-22(30)17-5-6-17/h1-4,7-11,13,17H,5-6,14H2,(H,27,28,30)	QZXABVVSCDZCLR-UHFFFAOYSA-N					doublet; compound annotation
0391_004727	PACMA 31	C21H22N2O6S	3.632	66555902		C#CC(=O)N(c1c(OC)cc(OC)cc1)C(C(=O)NCC(=O)OCC)c1cccs1	InChI=1S/C21H22N2O6S/c1-5-18(24)23(15-10-9-14(27-3)12-16(15)28-4)20(17-8-7-11-30-17)21(26)22-13-19(25)29-6-2/h1,7-12,20H,6,13H2,2-4H3,(H,22,26)	AHOOZADJPNUFOQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004729	SKQ-1 ion	C36H42O2P+	4.2379	16679092		CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O	InChI=1S/C36H42O2P/c1-29-30(2)36(38)31(28-35(29)37)20-12-7-5-3-4-6-8-19-27-39(32-21-13-9-14-22-32,33-23-15-10-16-24-33)34-25-17-11-18-26-34/h9-11,13-18,21-26,28H,3-8,12,19-20,27H2,1-2H3/q+1	ZFUDULLGKXSPPH-UHFFFAOYSA-N					doublet; compound annotation
0391_004730	SKQ-1 ion	C36H42O2P+	4.5892	16679092		CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O	InChI=1S/C36H42O2P/c1-29-30(2)36(38)31(28-35(29)37)20-12-7-5-3-4-6-8-19-27-39(32-21-13-9-14-22-32,33-23-15-10-16-24-33)34-25-17-11-18-26-34/h9-11,13-18,21-26,28H,3-8,12,19-20,27H2,1-2H3/q+1	ZFUDULLGKXSPPH-UHFFFAOYSA-N					doublet; compound annotation
0391_004731	SKQ-1 ion	C36H42O2P+	5.0673	16679092		CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O	InChI=1S/C36H42O2P/c1-29-30(2)36(38)31(28-35(29)37)20-12-7-5-3-4-6-8-19-27-39(32-21-13-9-14-22-32,33-23-15-10-16-24-33)34-25-17-11-18-26-34/h9-11,13-18,21-26,28H,3-8,12,19-20,27H2,1-2H3/q+1	ZFUDULLGKXSPPH-UHFFFAOYSA-N					doublet; compound annotation
0391_004732	452342-67-5	C25H23N5O2	1.8583	10202642		O=C(NC1CCOCC1)c1ccc(-c2nccc(-c3c(-c4ccccn4)[nH]nc3)c2)cc1	InChI=1S/C25H23N5O2/c31-25(29-20-9-13-32-14-10-20)18-6-4-17(5-7-18)23-15-19(8-12-27-23)21-16-28-30-24(21)22-3-1-2-11-26-22/h1-8,11-12,15-16,20H,9-10,13-14H2,(H,28,30)(H,29,31)	SAGZIBJAQGBRQA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004734	GSK5182	C27H31NO3	2.636	6852176	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCO)\C2=CC=CC=C2)/C3=CC=C(C=C3)O	CN(C)CCOc1ccc(C(=C(CCCO)c2ccccc2)c2ccc(O)cc2)cc1	InChI=1S/C27H31NO3/c1-28(2)18-20-31-25-16-12-23(13-17-25)27(22-10-14-24(30)15-11-22)26(9-6-19-29)21-7-4-3-5-8-21/h3-5,7-8,10-17,29-30H,6,9,18-20H2,1-2H3/b27-26-	ZVSFNBNLNLXEFQ-RQZHXJHFSA-N					doublet; compound annotation
0391_004735	6H05	C20H30ClN3O2S3	2.6681	73443124		CN(C)CCSSCCNC(=O)C1CCN(C(=O)CSc2ccc(Cl)cc2)CC1	InChI=1S/C20H30ClN3O2S3/c1-23(2)12-14-29-28-13-9-22-20(26)16-7-10-24(11-8-16)19(25)15-27-18-5-3-17(21)4-6-18/h3-6,16H,7-15H2,1-2H3,(H,22,26)	WEEYMZOUPNIHLG-UHFFFAOYSA-N					doublet; compound annotation
0391_004736	6H05	C20H30ClN3O2S3	2.6713	73443124		CN(C)CCSSCCNC(=O)C1CCN(C(=O)CSc2ccc(Cl)cc2)CC1	InChI=1S/C20H30ClN3O2S3/c1-23(2)12-14-29-28-13-9-22-20(26)16-7-10-24(11-8-16)19(25)15-27-18-5-3-17(21)4-6-18/h3-6,16H,7-15H2,1-2H3,(H,22,26)	WEEYMZOUPNIHLG-UHFFFAOYSA-N					doublet; compound annotation
0391_004737	PDK4-IN-1	C22H19N3O2	2.6805	146026196		O=C1c2ccccc2C(=O)c2c(-c3cn(C4CCNCC4)nc3)cccc12	InChI=1S/C22H19N3O2/c26-21-17-4-1-2-5-18(17)22(27)20-16(6-3-7-19(20)21)14-12-24-25(13-14)15-8-10-23-11-9-15/h1-7,12-13,15,23H,8-11H2	RUCYSQLKCYBLDW-UHFFFAOYSA-N					doublet; compound annotation
0391_004738	PDK4-IN-1	C22H19N3O2	2.6838	146026196		O=C1c2ccccc2C(=O)c2c(-c3cn(C4CCNCC4)nc3)cccc12	InChI=1S/C22H19N3O2/c26-21-17-4-1-2-5-18(17)22(27)20-16(6-3-7-19(20)21)14-12-24-25(13-14)15-8-10-23-11-9-15/h1-7,12-13,15,23H,8-11H2	RUCYSQLKCYBLDW-UHFFFAOYSA-N					doublet; compound annotation
0391_004739	GSK5182	C27H31NO3	2.8063	6852176	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCO)\C2=CC=CC=C2)/C3=CC=C(C=C3)O	CN(C)CCOc1ccc(C(=C(CCCO)c2ccccc2)c2ccc(O)cc2)cc1	InChI=1S/C27H31NO3/c1-28(2)18-20-31-25-16-12-23(13-17-25)27(22-10-14-24(30)15-11-22)26(9-6-19-29)21-7-4-3-5-8-21/h3-5,7-8,10-17,29-30H,6,9,18-20H2,1-2H3/b27-26-	ZVSFNBNLNLXEFQ-RQZHXJHFSA-N					doublet; compound annotation
0391_004740	ML365	C22H20N2O3	3.1818	46785920		COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1	InChI=1S/C22H20N2O3/c1-15-7-5-8-16(13-15)21(25)23-17-9-6-10-18(14-17)24-22(26)19-11-3-4-12-20(19)27-2/h3-14H,1-2H3,(H,23,25)(H,24,26)	UTAJHKSGYJSZBR-UHFFFAOYSA-N					doublet; compound annotation
0391_004741	Merimepodib	C23H24N4O6	3.1847	153241	COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)O[C@H]3CCOC3)C4=CN=CO4	COc1c(-c2cnco2)ccc(NC(=O)Nc2cccc(CNC(=O)OC3CCOC3)c2)c1	InChI=1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1	JBPUGFODGPKTDW-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_004743	Velsecorat	C32H32F2N4O6	3.9472	67041274	C[C@@H]([C@@H](C1=CC2=C(C=C1)OCCO2)OC3=CC4=C(C=C3)N(N=C4)C5=CC=CC(=C5)C(=O)N[C@@H]6CCOC6)NC(=O)C(C)(F)F	CC(NC(=O)C(C)(F)F)C(Oc1cc2c(cc1)n(-c1cccc(C(=O)NC3CCOC3)c1)nc2)c1cc2c(cc1)OCCO2	InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23+,29-/m0/s1	ZZWJKLGCDHYVMB-BWGXUDETSA-N					doublet; compound annotation
0391_004744	Velsecorat	C32H32F2N4O6	4.0217	67041274	C[C@@H]([C@@H](C1=CC2=C(C=C1)OCCO2)OC3=CC4=C(C=C3)N(N=C4)C5=CC=CC(=C5)C(=O)N[C@@H]6CCOC6)NC(=O)C(C)(F)F	CC(NC(=O)C(C)(F)F)C(Oc1cc2c(cc1)n(-c1cccc(C(=O)NC3CCOC3)c1)nc2)c1cc2c(cc1)OCCO2	InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23+,29-/m0/s1	ZZWJKLGCDHYVMB-BWGXUDETSA-N					doublet; removed another duplicate entry; compound annotation
0391_004746	ML365	C22H20N2O3	4.2898	46785920		COc1ccccc1C(=O)Nc1cccc(NC(=O)c2cccc(C)c2)c1	InChI=1S/C22H20N2O3/c1-15-7-5-8-16(13-15)21(25)23-17-9-6-10-18(14-17)24-22(26)19-11-3-4-12-20(19)27-2/h3-14H,1-2H3,(H,23,25)(H,24,26)	UTAJHKSGYJSZBR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004748	2,2-Diphenyl-1-picrylhydrazyl	C18H12N5O6	5.0337	2735032		O=[N+]([O-])c1cc([N+](=O)[O-])c([N]N(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1	InChI=1S/C18H12N5O6/c24-21(25)15-11-16(22(26)27)18(17(12-15)23(28)29)19-20(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-12H	HHEAADYXPMHMCT-UHFFFAOYSA-N					compound annotation
0391_004749	hispidin	C13H10O5	1.9432	54685921	C1=CC(=C(C=C1/C=C/C2=CC(=CC(=O)O2)O)O)O	O=c1cc(O)cc(C=Cc2cc(O)c(O)cc2)o1	InChI=1S/C13H10O5/c14-9-6-10(18-13(17)7-9)3-1-8-2-4-11(15)12(16)5-8/h1-7,14-16H/b3-1+	SGJNQVTUYXCBKH-HNQUOIGGSA-N					doublet; compound annotation
0391_004750	hispidin	C13H10O5	2.1564	54685921	C1=CC(=C(C=C1/C=C/C2=CC(=CC(=O)O2)O)O)O	O=c1cc(O)cc(C=Cc2cc(O)c(O)cc2)o1	InChI=1S/C13H10O5/c14-9-6-10(18-13(17)7-9)3-1-8-2-4-11(15)12(16)5-8/h1-7,14-16H/b3-1+	SGJNQVTUYXCBKH-HNQUOIGGSA-N					doublet; compound annotation
0391_004751	TAS4464	C21H23FN6O6S	2.5913	124121703	CCOC1=C(C(=CC=C1)F)C#CC2=CN(C3=NC=NC(=C23)N)[C@H]4[C@@H]([C@@H]([C@H](O4)CNS(=O)(=O)N)O)O	CCOc1c(C#Cc2cn(C3OC(CNS(N)(=O)=O)C(O)C3O)c3ncnc(N)c23)c(F)ccc1	InChI=1S/C21H23FN6O6S/c1-2-33-14-5-3-4-13(22)12(14)7-6-11-9-28(20-16(11)19(23)25-10-26-20)21-18(30)17(29)15(34-21)8-27-35(24,31)32/h3-5,9-10,15,17-18,21,27,29-30H,2,8H2,1H3,(H2,23,25,26)(H2,24,31,32)/t15-,17-,18-,21-/m1/s1	TZTRUHFXPVXWRD-QTQZEZTPSA-N					doublet; removed another duplicate entry; compound annotation
0391_004754	Duvelisib R enantiomer	C22H17ClN6O	2.6423	68353646	C[C@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	CC(Nc1ncnc2c1[nH]cn2)c1cc2c(c(Cl)ccc2)c(=O)n1-c1ccccc1	InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m1/s1	SJVQHLPISAIATJ-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_004756	288250-47-5	C27H29ClN6O2	3.1971	22227931		Cc1c(C(=O)Nc2cc(C#N)c(N3CCC(N4CCOCC4)CC3)cc2)cnn1-c1ccc(Cl)cc1	InChI=1S/C27H29ClN6O2/c1-19-25(18-30-34(19)24-5-2-21(28)3-6-24)27(35)31-22-4-7-26(20(16-22)17-29)33-10-8-23(9-11-33)32-12-14-36-15-13-32/h2-7,16,18,23H,8-15H2,1H3,(H,31,35)	BWZNJVZTAWBIFG-UHFFFAOYSA-N					compound annotation
0391_004757	s55746	C43H42N4O6	3.396	71654876	C1CCN2C(=C(C=C2C3=CC4=C(C=C3C(=O)N5CC6=CC=CC=C6C[C@H]5CN7CCOCC7)OCO4)C(=O)N(C8=CC=CC=C8)C9=CC=C(C=C9)O)C1	O=C(c1c2CCCCn2c(-c2cc3c(cc2C(=O)N2Cc4ccccc4CC2CN2CCOCC2)OCO3)c1)N(c1ccccc1)c1ccc(O)cc1	InChI=1S/C43H42N4O6/c48-34-15-13-32(14-16-34)47(31-10-2-1-3-11-31)43(50)37-23-39(45-17-7-6-12-38(37)45)35-24-40-41(53-28-52-40)25-36(35)42(49)46-26-30-9-5-4-8-29(30)22-33(46)27-44-18-20-51-21-19-44/h1-5,8-11,13-16,23-25,33,48H,6-7,12,17-22,26-28H2/t33-/m0/s1	VYXJULKGMXJVGI-XIFFEERXSA-N					removed another duplicate entry; compound annotation
0391_004759	FGTI-2734	C26H31FN6O2S	3.6385	49783195		Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1c(F)cc(C#N)cc1	InChI=1S/C26H31FN6O2S/c1-31-20-29-17-23(31)19-32(25-11-10-22(16-28)15-24(25)27)13-14-33(18-21-7-3-2-4-8-21)36(34,35)26-9-5-6-12-30-26/h5-6,9-12,15,17,20-21H,2-4,7-8,13-14,18-19H2,1H3	BXNRVJLIEMQDOL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004761	2079895-42-2	C23H18N6O2S	3.8863	123132899		NS(=O)(=O)c1ccc(Nc2nc(-c3cccc(-c4ccccc4)c3)c3[nH]cnc3n2)cc1	InChI=1S/C23H18N6O2S/c24-32(30,31)19-11-9-18(10-12-19)27-23-28-20(21-22(29-23)26-14-25-21)17-8-4-7-16(13-17)15-5-2-1-3-6-15/h1-14H,(H2,24,30,31)(H2,25,26,27,28,29)	FUGRWXRQJGJIER-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004763	zafirlukast	C31H33N3O6S	5.1397	5717		COc1c(Cc2cn(C)c3c2cc(NC(=O)OC2CCCC2)cc3)ccc(C(=O)NS(=O)(=O)c2ccccc2C)c1	InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)	YEEZWCHGZNKEEK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004766	osilodrostat	C13H10FN3	1.3573	44139752	C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F	N#Cc1cc(F)c(C2CCc3cncn32)cc1	InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1	USUZGMWDZDXMDG-CYBMUJFWSA-N					doublet; compound annotation
0391_004767	osilodrostat	C13H10FN3	1.5193	44139752	C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F	N#Cc1cc(F)c(C2CCc3cncn32)cc1	InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1	USUZGMWDZDXMDG-CYBMUJFWSA-N					doublet; compound annotation
0391_004768	912545-86-9	C28H28ClN3OS	2.3208	5284330		CNC1CCC(N(Cc2cc(-c3ccncc3)ccc2)C(=O)c2c(Cl)c3ccccc3s2)CC1	InChI=1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3	VFSUUTYAEQOIMW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004770	cpsi-1306	C15H16F2N2O3	2.7487	59723793		O=C(CC1CC(c2c(F)cc(F)cc2)=NO1)N1CCOCC1	InChI=1S/C15H16F2N2O3/c16-10-1-2-12(13(17)7-10)14-8-11(22-18-14)9-15(20)19-3-5-21-6-4-19/h1-2,7,11H,3-6,8-9H2	GUWOSEVHCSNYFK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004772	Parecoxib	C19H18N2O4S	3.8952	119828		CCC(=O)NS(=O)(=O)c1ccc(-c2c(C)onc2-c2ccccc2)cc1	InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)	TZRHLKRLEZJVIJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004774	1554458-53-5	C27H24F5N5O3	4.6861	78320750		COc1c(F)c(F)c(Oc2nn3c(-c4cc(C)c(C(=O)NC5CC5)cc4)cnc3c(NCCC(F)(F)F)c2)cc1	InChI=1S/C27H24F5N5O3/c1-14-11-15(3-6-17(14)26(38)35-16-4-5-16)19-13-34-25-18(33-10-9-27(30,31)32)12-22(36-37(19)25)40-21-8-7-20(39-2)23(28)24(21)29/h3,6-8,11-13,16,33H,4-5,9-10H2,1-2H3,(H,35,38)	WNEILUNVMHVMPH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004776	1233948-35-0	C19H16N2O2S2	4.691	46847888		Cc1ccc(S(=O)(=O)Nc2c(C)ccc(-c3ccc(C#N)s3)c2)cc1	InChI=1S/C19H16N2O2S2/c1-13-3-8-17(9-4-13)25(22,23)21-18-11-15(6-5-14(18)2)19-10-7-16(12-20)24-19/h3-11,21H,1-2H3	GRYXROIHHXHFND-UHFFFAOYSA-N					compound annotation
0391_004777	celastrol	C29H38O4	5.8181	122724	CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)O)C)C)C)C)O	CC1=C(O)C(=O)C=C2C1=CC=C1C2(C)CCC2(C)C3CC(C)(C(=O)O)CCC3(C)CCC12C	InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1	KQJSQWZMSAGSHN-JJWQIEBTSA-N					removed another duplicate entry; compound annotation
0391_004780	azulene	C10H8	1.4896	9231		c1ccc2cccc-2cc1	InChI=1S/C10H8/c1-2-5-9-7-4-8-10(9)6-3-1/h1-8H	CUFNKYGDVFVPHO-UHFFFAOYSA-N					compound annotation
0391_004781	tetrahydrozoline	C13H16N2	1.4896	5419		c1ccc2c(c1)CCCC2C1=NCCN1	InChI=1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15)	BYJAVTDNIXVSPW-UHFFFAOYSA-N					compound annotation
0391_004782	trazodone	C19H22ClN5O	2.3735	5533		O=c1n(CCCN2CCN(c3cc(Cl)ccc3)CC2)nc2ccccn12	InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2	PHLBKPHSAVXXEF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004784	nabumetone	C15H16O2	4.1238	4409		COc1cc2c(cc1)cc(CCC(C)=O)cc2	InChI=1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3	BLXXJMDCKKHMKV-UHFFFAOYSA-N					compound annotation
0391_004785	Diniconazole	C15H17Cl2N3O	4.3457	6436605	CC(C)(C)C(/C(=C\C1=C(C=C(C=C1)Cl)Cl)/N2C=NC=N2)O	CC(C)(C)C(O)C(=Cc1c(Cl)cc(Cl)cc1)n1cncn1	InChI=1S/C15H17Cl2N3O/c1-15(2,3)14(21)13(20-9-18-8-19-20)6-10-4-5-11(16)7-12(10)17/h4-9,14,21H,1-3H3/b13-6+	FBOUIAKEJMZPQG-AWNIVKPZSA-N					doublet; compound annotation
0391_004786	Diniconazole	C15H17Cl2N3O	4.5529	6436605	CC(C)(C)C(/C(=C\C1=C(C=C(C=C1)Cl)Cl)/N2C=NC=N2)O	CC(C)(C)C(O)C(=Cc1c(Cl)cc(Cl)cc1)n1cncn1	InChI=1S/C15H17Cl2N3O/c1-15(2,3)14(21)13(20-9-18-8-19-20)6-10-4-5-11(16)7-12(10)17/h4-9,14,21H,1-3H3/b13-6+	FBOUIAKEJMZPQG-AWNIVKPZSA-N					doublet; compound annotation
0391_004787	Thifluzamide	C13H6Br2F6N2O2S	4.724	86389		Cc1nc(C(F)(F)F)c(C(=O)Nc2c(Br)cc(OC(F)(F)F)cc2Br)s1	InChI=1S/C13H6Br2F6N2O2S/c1-4-22-10(12(16,17)18)9(26-4)11(24)23-8-6(14)2-5(3-7(8)15)25-13(19,20)21/h2-3H,1H3,(H,23,24)	WOSNCVAPUOFXEH-UHFFFAOYSA-N					compound annotation
0391_004788	ALLYLTHIOUREA	C4H8N2S	0.5653	1549517		C=CCN=C(N)S	InChI=1S/C4H8N2S/c1-2-3-6-4(5)7/h2H,1,3H2,(H3,5,6,7)	HTKFORQRBXIQHD-UHFFFAOYSA-N					doublet; compound annotation
0391_004789	ALLYLTHIOUREA	C4H8N2S	0.6228	1549517		C=CCN=C(N)S	InChI=1S/C4H8N2S/c1-2-3-6-4(5)7/h2H,1,3H2,(H3,5,6,7)	HTKFORQRBXIQHD-UHFFFAOYSA-N					doublet; compound annotation
0391_004790	MOXONIDINE	C9H12ClN5O	0.7258	4810		COc1c(NC2=NCCN2)c(Cl)nc(C)n1	InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)	WPNJAUFVNXKLIM-UHFFFAOYSA-N					compound annotation
0391_004791	(+)-Tetrabenazine	C19H27NO3	1.6051	667453	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1	MKJIEFSOBYUXJB-GDBMZVCRSA-N					doublet; compound annotation
0391_004792	Buflomedil	C17H25NO4	2.001	2467		COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1	InChI=1S/C17H25NO4/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18/h11-12H,4-10H2,1-3H3	OWYLAEYXIQKAOL-UHFFFAOYSA-N					compound annotation
0391_004793	(+)-Tetrabenazine	C19H27NO3	2.1672	667453	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1	MKJIEFSOBYUXJB-GDBMZVCRSA-N					doublet; compound annotation
0391_004794	(+)-Tetrabenazine	C19H27NO3	2.2394	667453	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1	MKJIEFSOBYUXJB-GDBMZVCRSA-N					doublet; compound annotation
0391_004795	(+)-Tetrabenazine	C19H27NO3	2.3345	667453	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2CC1=O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1	MKJIEFSOBYUXJB-GDBMZVCRSA-N					doublet; compound annotation
0391_004796	FLUNIXIN	C14H11F3N2O2	3.5311	38081		Cc1c(C(F)(F)F)cccc1Nc1c(C(=O)O)cccn1	InChI=1S/C14H11F3N2O2/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12/h2-7H,1H3,(H,18,19)(H,20,21)	NOOCSNJCXJYGPE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004798	Tolclofos-methyl	C9H11Cl2O3PS	4.0743	91664		COP(=S)(OC)Oc1c(Cl)cc(C)cc1Cl	InChI=1S/C9H11Cl2O3PS/c1-6-4-7(10)9(8(11)5-6)14-15(16,12-2)13-3/h4-5H,1-3H3	OBZIQQJJIKNWNO-UHFFFAOYSA-N					compound annotation
0391_004799	FLUNIXIN	C14H11F3N2O2	4.3505	38081		Cc1c(C(F)(F)F)cccc1Nc1c(C(=O)O)cccn1	InChI=1S/C14H11F3N2O2/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12/h2-7H,1H3,(H,18,19)(H,20,21)	NOOCSNJCXJYGPE-UHFFFAOYSA-N					doublet; compound annotation
0391_004800	Fenoxaprop-P-ethyl	C18H16ClNO5	5.2693	91707	CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl	CCOC(=O)C(C)Oc1ccc(Oc2nc3c(cc(Cl)cc3)o2)cc1	InChI=1S/C18H16ClNO5/c1-3-22-17(21)11(2)23-13-5-7-14(8-6-13)24-18-20-15-9-4-12(19)10-16(15)25-18/h4-11H,3H2,1-2H3/t11-/m1/s1	PQKBPHSEKWERTG-LLVKDONJSA-N					doublet; compound annotation
0391_004801	Fenoxaprop-P-ethyl	C18H16ClNO5	5.272	91707	CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl	CCOC(=O)C(C)Oc1ccc(Oc2nc3c(cc(Cl)cc3)o2)cc1	InChI=1S/C18H16ClNO5/c1-3-22-17(21)11(2)23-13-5-7-14(8-6-13)24-18-20-15-9-4-12(19)10-16(15)25-18/h4-11H,3H2,1-2H3/t11-/m1/s1	PQKBPHSEKWERTG-LLVKDONJSA-N					doublet; compound annotation
0391_004802	37988-18-4	C15H21N3O6	0.6255	2054170		O=C(NCCO)c1cc(C(=O)NCCO)cc(C(=O)NCCO)c1	InChI=1S/C15H21N3O6/c19-4-1-16-13(22)10-7-11(14(23)17-2-5-20)9-12(8-10)15(24)18-3-6-21/h7-9,19-21H,1-6H2,(H,16,22)(H,17,23)(H,18,24)	RGWJKANXFYJKHN-UHFFFAOYSA-N					doublet; compound annotation
0391_004803	37988-18-4	C15H21N3O6	0.629	2054170		O=C(NCCO)c1cc(C(=O)NCCO)cc(C(=O)NCCO)c1	InChI=1S/C15H21N3O6/c19-4-1-16-13(22)10-7-11(14(23)17-2-5-20)9-12(8-10)15(24)18-3-6-21/h7-9,19-21H,1-6H2,(H,16,22)(H,17,23)(H,18,24)	RGWJKANXFYJKHN-UHFFFAOYSA-N					doublet; compound annotation
0391_004804	DBPR-108	C16H25FN4O2	1.3177	44201003	CC(C)(CC(=O)N1CCCC1)NCC(=O)N2C[C@H](C[C@H]2C#N)F	CC(C)(CC(=O)N1CCCC1)NCC(=O)N1CC(F)CC1C#N	InChI=1S/C16H25FN4O2/c1-16(2,8-14(22)20-5-3-4-6-20)19-10-15(23)21-11-12(17)7-13(21)9-18/h12-13,19H,3-8,10-11H2,1-2H3/t12-,13-/m0/s1	VQKSCYBKUIDZEI-STQMWFEESA-N					removed another duplicate entry; compound annotation
0391_004806	Biotinyl tyramide	C18H25N3O3S	1.9874	21826423	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCC3=CC=C(C=C3)O)NC(=O)N2	O=C(CCCCC1SCC2NC(=O)NC21)NCCc1ccc(O)cc1	InChI=1S/C18H25N3O3S/c22-13-7-5-12(6-8-13)9-10-19-16(23)4-2-1-3-15-17-14(11-25-15)20-18(24)21-17/h5-8,14-15,17,22H,1-4,9-11H2,(H,19,23)(H2,20,21,24)/t14-,15-,17-/m0/s1	VZWXNOBHWODXCW-ZOBUZTSGSA-N					removed another duplicate entry; compound annotation
0391_004808	Mps1-IN-2	C26H36N6O3	2.1346	44968267		CCOc1c(Nc2ncc3c(n2)N(C2CCCC2)CCC(=O)N3C)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H36N6O3/c1-3-35-23-16-19(31-13-10-20(33)11-14-31)8-9-21(23)28-26-27-17-22-25(29-26)32(18-6-4-5-7-18)15-12-24(34)30(22)2/h8-9,16-18,20,33H,3-7,10-15H2,1-2H3,(H,27,28,29)	WELBJLUKWAJOQV-UHFFFAOYSA-N					doublet; compound annotation
0391_004809	JNJ-37822681	C17H17F5N4	2.474	16058752		Fc1c(F)cc(CN2CCC(Nc3nnc(C(F)(F)F)cc3)CC2)cc1	InChI=1S/C17H17F5N4/c18-13-2-1-11(9-14(13)19)10-26-7-5-12(6-8-26)23-16-4-3-15(24-25-16)17(20,21)22/h1-4,9,12H,5-8,10H2,(H,23,25)	UVUYWJWYRLJHEN-UHFFFAOYSA-N					compound annotation
0391_004810	195055-03-9	C22H32N6	2.5609	9821250		CCCN(CCC)c1cc(C)nc2c(-c3cnc(N(C)C)cc3C)c(C)nn12	InChI=1S/C22H32N6/c1-8-10-27(11-9-2)20-13-16(4)24-22-21(17(5)25-28(20)22)18-14-23-19(26(6)7)12-15(18)3/h12-14H,8-11H2,1-7H3	ANNRUWYFVIGKHA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004812	Mps1-IN-2	C26H36N6O3	2.7841	44968267		CCOc1c(Nc2ncc3c(n2)N(C2CCCC2)CCC(=O)N3C)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H36N6O3/c1-3-35-23-16-19(31-13-10-20(33)11-14-31)8-9-21(23)28-26-27-17-22-25(29-26)32(18-6-4-5-7-18)15-12-24(34)30(22)2/h8-9,16-18,20,33H,3-7,10-15H2,1-2H3,(H,27,28,29)	WELBJLUKWAJOQV-UHFFFAOYSA-N					doublet; compound annotation
0391_004813	PF-4989216	C18H13FN6OS	3.097	51033720		N#Cc1cc(F)c(-c2c(-c3ncn[nH]3)sc(N3CCOCC3)c2C#N)cc1	InChI=1S/C18H13FN6OS/c19-14-7-11(8-20)1-2-12(14)15-13(9-21)18(25-3-5-26-6-4-25)27-16(15)17-22-10-23-24-17/h1-2,7,10H,3-6H2,(H,22,23,24)	MUENOTXSRZEFJV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004815	ML221	C17H11N3O6S	3.4541	7217941		O=C(Oc1coc(CSc2ncccn2)cc1=O)c1ccc([N+](=O)[O-])cc1	InChI=1S/C17H11N3O6S/c21-14-8-13(10-27-17-18-6-1-7-19-17)25-9-15(14)26-16(22)11-2-4-12(5-3-11)20(23)24/h1-9H,10H2	UASIRTUMPRQVFY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004817	HI-TOPK-032	C20H11N5OS	4.1597	1936439		N#Cc1c2cc(NC(=O)c3cccs3)ccn2c2nc3ccccc3nc12	InChI=1S/C20H11N5OS/c21-11-13-16-10-12(22-20(26)17-6-3-9-27-17)7-8-25(16)19-18(13)23-14-4-1-2-5-15(14)24-19/h1-10H,(H,22,26)	BCSBXWKRZUPFHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004819	MRS 1754	C26H26N6O4	4.3187	6603931		CCCn1c(=O)c2c(nc(-c3ccc(OCC(=O)Nc4ccc(C#N)cc4)cc3)[nH]2)n(CCC)c1=O	InChI=1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30)	AJBBEYXFRYFVNM-UHFFFAOYSA-N					compound annotation
0391_004820	SGX-523	C18H13N7S	2.1062	24779724		Cn1cc(-c2nn3c(Sc4cc5c(cc4)nccc5)nnc3cc2)cn1	InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3	BCZUAADEACICHN-UHFFFAOYSA-N					doublet; compound annotation
0391_004821	SGX-523	C18H13N7S	2.1092	24779724		Cn1cc(-c2nn3c(Sc4cc5c(cc4)nccc5)nnc3cc2)cn1	InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3	BCZUAADEACICHN-UHFFFAOYSA-N					doublet; compound annotation
0391_004822	PFK-158	C18H11F3N2O	3.2881	71730058	C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F	O=C(C=Cc1nc2c(ccc(C(F)(F)F)c2)cc1)c1ccncc1	InChI=1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+	IAJOMYABKVAZCN-AATRIKPKSA-N					doublet; compound annotation
0391_004823	BTRX-335140	C25H32FN5O2	3.4512	137434175		CCc1cc2c(C)c(-c3nc(C)no3)c(N3CCC(NC4CCOCC4)CC3)nc2c(F)c1	InChI=1S/C25H32FN5O2/c1-4-17-13-20-15(2)22(25-27-16(3)30-33-25)24(29-23(20)21(26)14-17)31-9-5-18(6-10-31)28-19-7-11-32-12-8-19/h13-14,18-19,28H,4-12H2,1-3H3	CQOJHAJWCDJEAT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004825	TM-N1324	C18H13ClFN7O	3.4905	135634901		Cc1nn(-c2ncnc3c2[nH]cn3)c2c1C(c1c(Cl)cc(F)cc1)CC(=O)N2	InChI=1S/C18H13ClFN7O/c1-8-14-11(10-3-2-9(20)4-12(10)19)5-13(28)25-17(14)27(26-8)18-15-16(22-6-21-15)23-7-24-18/h2-4,6-7,11H,5H2,1H3,(H,25,28)(H,21,22,23,24)	CYQNVXRIWKKWQG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004827	PFK-158	C18H11F3N2O	3.5975	71730058	C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F	O=C(C=Cc1nc2c(ccc(C(F)(F)F)c2)cc1)c1ccncc1	InChI=1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+	IAJOMYABKVAZCN-AATRIKPKSA-N					doublet; compound annotation
0391_004828	PIK-75	C16H14BrN5O4S	3.8088	10275789	CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)/N=C/C2=CN=C3N2C=C(C=C3)Br	Cc1c(S(=O)(=O)N(C)N=Cc2cnc3ccc(Br)cn23)cc([N+](=O)[O-])cc1	InChI=1S/C16H14BrN5O4S/c1-11-3-5-13(22(23)24)7-15(11)27(25,26)20(2)19-9-14-8-18-16-6-4-12(17)10-21(14)16/h3-10H,1-2H3/b19-9+	QTHCAAFKVUWAFI-DJKKODMXSA-N					compound annotation
0391_004829	PFK-158	C18H11F3N2O	3.9306	71730058	C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F	O=C(C=Cc1nc2c(ccc(C(F)(F)F)c2)cc1)c1ccncc1	InChI=1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+	IAJOMYABKVAZCN-AATRIKPKSA-N					doublet; compound annotation
0391_004830	PFK-158	C18H11F3N2O	4.2	71730058	C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F	O=C(C=Cc1nc2c(ccc(C(F)(F)F)c2)cc1)c1ccncc1	InChI=1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+	IAJOMYABKVAZCN-AATRIKPKSA-N					doublet; compound annotation
0391_004831	PFK-158	C18H11F3N2O	5.161	71730058	C1=CC(=CC2=C1C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3)C(F)(F)F	O=C(C=Cc1nc2c(ccc(C(F)(F)F)c2)cc1)c1ccncc1	InChI=1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+	IAJOMYABKVAZCN-AATRIKPKSA-N					doublet; compound annotation
0391_004832	Cav 2.2 blocker 1	C25H29ClN2O2	5.5975	73292924		COc1ccccc1-n1nc(C2CC(C)(C)OC(C)(C)C2)cc1-c1ccc(Cl)cc1	InChI=1S/C25H29ClN2O2/c1-24(2)15-18(16-25(3,4)30-24)20-14-22(17-10-12-19(26)13-11-17)28(27-20)21-8-6-7-9-23(21)29-5/h6-14,18H,15-16H2,1-5H3	LDURKOGJFOYENC-UHFFFAOYSA-N					doublet; compound annotation
0391_004833	Cav 2.2 blocker 1	C25H29ClN2O2	5.853	73292924		COc1ccccc1-n1nc(C2CC(C)(C)OC(C)(C)C2)cc1-c1ccc(Cl)cc1	InChI=1S/C25H29ClN2O2/c1-24(2)15-18(16-25(3,4)30-24)20-14-22(17-10-12-19(26)13-11-17)28(27-20)21-8-6-7-9-23(21)29-5/h6-14,18H,15-16H2,1-5H3	LDURKOGJFOYENC-UHFFFAOYSA-N					doublet; compound annotation
0391_004834	Tandutinib	C31H42N6O4	2.265	3038522		COc1c(OCCCN2CCCCC2)cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2c1	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	UXXQOJXBIDBUAC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004836	Ki20227	C24H24N4O5S	2.6664	9869779		COc1c(NC(=O)NC(C)c2nccs2)ccc(Oc2ccnc3cc(OC)c(OC)cc23)c1	InChI=1S/C24H24N4O5S/c1-14(23-26-9-10-34-23)27-24(29)28-17-6-5-15(11-20(17)30-2)33-19-7-8-25-18-13-22(32-4)21(31-3)12-16(18)19/h5-14H,1-4H3,(H2,27,28,29)	SHPFDGWALWEPGS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004838	Tandutinib	C31H42N6O4	2.8562	3038522		COc1c(OCCCN2CCCCC2)cc2ncnc(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)c2c1	InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)	UXXQOJXBIDBUAC-UHFFFAOYSA-N					doublet; compound annotation
0391_004839	Tyrosine kinase inhibitor	C31H31FN6O5	2.8621	24956525		O=C(NCCN1CCOCC1)c1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2[nH]1	InChI=1S/C31H31FN6O5/c32-20-1-3-21(4-2-20)35-29(40)31(10-11-31)30(41)36-22-5-7-23(8-6-22)43-26-9-12-33-27-24(26)19-25(37-27)28(39)34-13-14-38-15-17-42-18-16-38/h1-9,12,19H,10-11,13-18H2,(H,33,37)(H,34,39)(H,35,40)(H,36,41)	PKOVTRMHYNEBDU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004841	JNJ0966	C16H16N4O2S2	3.8372	1117189		COc1ccccc1Nc1nc(-c2c(C)nc(NC(C)=O)s2)cs1	InChI=1S/C16H16N4O2S2/c1-9-14(24-16(17-9)18-10(2)21)12-8-23-15(20-12)19-11-6-4-5-7-13(11)22-3/h4-8H,1-3H3,(H,19,20)(H,17,18,21)	ZADCDCMLLGDCRM-UHFFFAOYSA-N					doublet; compound annotation
0391_004842	JNJ0966	C16H16N4O2S2	3.8399	1117189		COc1ccccc1Nc1nc(-c2c(C)nc(NC(C)=O)s2)cs1	InChI=1S/C16H16N4O2S2/c1-9-14(24-16(17-9)18-10(2)21)12-8-23-15(20-12)19-11-6-4-5-7-13(11)22-3/h4-8H,1-3H3,(H,19,20)(H,17,18,21)	ZADCDCMLLGDCRM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004844	Alisertib	C27H20ClFN4O4	4.2205	24771867		COc1c(C(=O)O)ccc(Nc2ncc3CN=C(c4c(OC)cccc4F)c4c(ccc(Cl)c4)-c3n2)c1	InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)	ZLHFILGSQDJULK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004846	Mefentrifluconazole	C18H15ClF3N3O2	4.4923	71230671		CC(O)(Cn1cncn1)c1c(C(F)(F)F)cc(Oc2ccc(Cl)cc2)cc1	InChI=1S/C18H15ClF3N3O2/c1-17(26,9-25-11-23-10-24-25)15-7-6-14(8-16(15)18(20,21)22)27-13-4-2-12(19)3-5-13/h2-8,10-11,26H,9H2,1H3	JERZEQUMJNCPRJ-UHFFFAOYSA-N					compound annotation
0391_004847	CDDO-3P-Im	C39H46N4O3	4.5469	135397766	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)N6C=C(N=C6)C7=CN=CC=C7	CC1(C)CCC2(C(=O)n3cnc(-c4cnccc4)c3)CCC3(C)C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C39H46N4O3/c1-34(2)12-14-39(33(46)43-22-27(42-23-43)24-9-8-16-41-21-24)15-13-38(7)31(26(39)19-34)28(44)17-30-36(5)18-25(20-40)32(45)35(3,4)29(36)10-11-37(30,38)6/h8-9,16-18,21-23,26,29,31H,10-15,19H2,1-7H3/t26-,29-,31-,36-,37+,38+,39-/m0/s1	GXKRPLQWYWDFQN-CXUPGZSSSA-N					compound annotation
0391_004848	N6-(4-Hydroxybenzyl)-adenosine	C17H19N5O5	1.4536	10474479	C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)O	OCC1OC(n2cnc3c(NCc4ccc(O)cc4)ncnc32)C(O)C1O	InChI=1S/C17H19N5O5/c23-6-11-13(25)14(26)17(27-11)22-8-21-12-15(19-7-20-16(12)22)18-5-9-1-3-10(24)4-2-9/h1-4,7-8,11,13-14,17,23-26H,5-6H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1	UGVIXKXYLBAZND-LSCFUAHRSA-N					removed another duplicate entry; compound annotation
0391_004850	methocarbamol	C11H15NO5	2.0057	4107		COc1ccccc1OCC(O)COC(N)=O	InChI=1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14)	GNXFOGHNGIVQEH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004852	MAPK13-IN-1	C20H23N5O2	2.3965	17941505		Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1	InChI=1S/C20H23N5O2/c1-20(2,3)17-13-18(25(4)24-17)23-19(26)22-14-5-7-15(8-6-14)27-16-9-11-21-12-10-16/h5-13H,1-4H3,(H2,22,23,26)	MHSLDASSAFCCDO-UHFFFAOYSA-N					compound annotation
0391_004853	WEHI-345	C22H23N7O	2.5833	56602554		Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3ccncc3)c3ncnc(N)c23)cc1	InChI=1S/C22H23N7O/c1-14-4-6-15(7-5-14)18-17-19(23)26-13-27-20(17)29(28-18)22(2,3)12-25-21(30)16-8-10-24-11-9-16/h4-11,13H,12H2,1-3H3,(H,25,30)(H2,23,26,27)	LEBSTCDZKUSVOY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004855	GSK461364	C27H28F3N5O2S	2.7602	15983966	C[C@H](C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N	CC(Oc1c(C(N)=O)sc(-n2cnc3c2cc(CN2CCN(C)CC2)cc3)c1)c1ccccc1C(F)(F)F	InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1	ZHJGWYRLJUCMRT-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_004857	Farampator	C12H13N3O2	3.0842	4118151		O=C(c1cc2nonc2cc1)N1CCCCC1	InChI=1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2	XFVRBYKKGGDPAJ-UHFFFAOYSA-N					compound annotation
0391_004858	STAT5-IN-2	C26H27N3O	3.7809	137628635		CC1(C)CCN(CCOc2cc3c(cc2)[nH]cc3)c2c1cc(-c1cnccc1)cc2	InChI=1S/C26H27N3O/c1-26(2)10-13-29(14-15-30-22-6-7-24-20(16-22)9-12-28-24)25-8-5-19(17-23(25)26)21-4-3-11-27-18-21/h3-9,11-12,16-18,28H,10,13-15H2,1-2H3	BELIZDRKUICBJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004860	MIK665	C47H44ClFN6O6S	4.0321	118157243	CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)O[C@H](CC5=CC=CC=C5OCC6=NC(=NC=C6)C7=CC=CC=C7OC)C(=O)O)C8=CC=C(C=C8)F	COc1ccccc1-c1nccc(COc2ccccc2CC(Oc2c3c(-c4c(C)c(Cl)c(OCCN5CCN(C)CC5)cc4)c(-c4ccc(F)cc4)sc3ncn2)C(=O)O)n1	InChI=1S/C47H44ClFN6O6S/c1-29-34(16-17-38(42(29)48)59-25-24-55-22-20-54(2)21-23-55)40-41-45(51-28-52-46(41)62-43(40)30-12-14-32(49)15-13-30)61-39(47(56)57)26-31-8-4-6-10-36(31)60-27-33-18-19-50-44(53-33)35-9-5-7-11-37(35)58-3/h4-19,28,39H,20-27H2,1-3H3,(H,56,57)/t39-/m1/s1	PKYIMGFMRFVOMB-LDLOPFEMSA-N					doublet; compound annotation
0391_004861	ABBV-744	C28H30FN3O4	4.0861	132010322		CCNC(=O)c1cc2c([nH]1)c(=O)n(C)cc2-c1cc(C(C)(C)O)ccc1Oc1c(C)cc(F)cc1C	InChI=1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3,(H,30,33)	OEDSFMUSNZDJFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004864	MIK665	C47H44ClFN6O6S	4.3226	118157243	CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)O[C@H](CC5=CC=CC=C5OCC6=NC(=NC=C6)C7=CC=CC=C7OC)C(=O)O)C8=CC=C(C=C8)F	COc1ccccc1-c1nccc(COc2ccccc2CC(Oc2c3c(-c4c(C)c(Cl)c(OCCN5CCN(C)CC5)cc4)c(-c4ccc(F)cc4)sc3ncn2)C(=O)O)n1	InChI=1S/C47H44ClFN6O6S/c1-29-34(16-17-38(42(29)48)59-25-24-55-22-20-54(2)21-23-55)40-41-45(51-28-52-46(41)62-43(40)30-12-14-32(49)15-13-30)61-39(47(56)57)26-31-8-4-6-10-36(31)60-27-33-18-19-50-44(53-33)35-9-5-7-11-37(35)58-3/h4-19,28,39H,20-27H2,1-3H3,(H,56,57)/t39-/m1/s1	PKYIMGFMRFVOMB-LDLOPFEMSA-N					doublet; compound annotation
0391_004865	DREADD agonist 21	C17H18N4	1.1565	11818276		c1ccc2Nc3ccccc3C(N3CCNCC3)=Nc2c1	InChI=1S/C17H18N4/c1-2-6-14-13(5-1)17(21-11-9-18-10-12-21)20-16-8-4-3-7-15(16)19-14/h1-8,18-19H,9-12H2	JCBYXNSOLUVGTF-UHFFFAOYSA-N					compound annotation
0391_004866	Raphin1	C8H8Cl2N4	2.0832	5356739	C1=CC(=C(C(=C1)Cl)Cl)/C=N\N=C(N)N	NC(N)=NN=Cc1c(Cl)c(Cl)ccc1	InChI=1S/C8H8Cl2N4/c9-6-3-1-2-5(7(6)10)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4-	WLTSTDGGFCQWTK-PQMHYQBVSA-N					doublet; compound annotation
0391_004867	21561-09-1	C16H15N3O2	2.1002	3798		COc1c(OC)cc2c(Nc3ccccc3)ncnc2c1	InChI=1S/C16H15N3O2/c1-20-14-8-12-13(9-15(14)21-2)17-10-18-16(12)19-11-6-4-3-5-7-11/h3-10H,1-2H3,(H,17,18,19)	MJKCGAHOCZLYDG-UHFFFAOYSA-N					compound annotation
0391_004868	Raphin1	C8H8Cl2N4	2.3885	5356739	C1=CC(=C(C(=C1)Cl)Cl)/C=N\N=C(N)N	NC(N)=NN=Cc1c(Cl)c(Cl)ccc1	InChI=1S/C8H8Cl2N4/c9-6-3-1-2-5(7(6)10)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4-	WLTSTDGGFCQWTK-PQMHYQBVSA-N					doublet; compound annotation
0391_004869	Foretinib	C34H34F2N4O6	2.6898	42642645		COc1cc2c(Oc3c(F)cc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)ccnc2cc1OCCCN1CCOCC1	InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)	CXQHYVUVSFXTMY-UHFFFAOYSA-N					compound annotation
0391_004870	219580-11-7	C28H41N7O3	3.0992	1401		CCN(CC)CCCCNc1nc2nc(NC(=O)NC(C)(C)C)c(-c3cc(OC)cc(OC)c3)cc2cn1	InChI=1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36)	DXCUKNQANPLTEJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004872	545380-34-5	C22H20N4O	3.2866	509554		Nc1cc2c(cc1)ncnc2NCCc1ccc(Oc2ccccc2)cc1	InChI=1S/C22H20N4O/c23-17-8-11-21-20(14-17)22(26-15-25-21)24-13-12-16-6-9-19(10-7-16)27-18-4-2-1-3-5-18/h1-11,14-15H,12-13,23H2,(H,24,25,26)	IBAKVEUZKHOWNG-UHFFFAOYSA-N					compound annotation
0391_004873	172889-27-9	C15H16ClN5	3.8545	4878		CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21	InChI=1S/C15H16ClN5/c1-15(2,3)21-14-11(13(17)18-8-19-14)12(20-21)9-4-6-10(16)7-5-9/h4-8H,1-3H3,(H2,17,18,19)	PBBRWFOVCUAONR-UHFFFAOYSA-N					compound annotation
0391_004874	1628416-28-3	C27H23FN4O4	4.4483	86298861		CCOc1cc2c(cc1)c(-c1cc(F)ccc1)nn(CC(=O)N(C)c1cc3c(cc1)nc(C)o3)c2=O	InChI=1S/C27H23FN4O4/c1-4-35-20-9-10-21-22(14-20)27(34)32(30-26(21)17-6-5-7-18(28)12-17)15-25(33)31(3)19-8-11-23-24(13-19)36-16(2)29-23/h5-14H,4,15H2,1-3H3	XRPSUWYWZUQALB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004876	Dianemycin	C47H78O14	6.6116	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_004877	Dianemycin	C47H78O14	6.7436	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_004878	Dianemycin	C47H78O14	7.3032	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_004879	EDOXABAN	C24H30ClN7O4S	2.1091	10280735	CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C	CN1CCc2c(C1)sc(C(=O)NC1CC(C(=O)N(C)C)CCC1NC(=O)C(=O)Nc1ncc(Cl)cc1)n2	InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1	HGVDHZBSSITLCT-JLJPHGGASA-N					doublet; removed another duplicate entry; compound annotation
0391_004881	Linagliptin	C25H28N8O2	2.3417	10096344	CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)n1)c(=O)n2C	InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1	LTXREWYXXSTFRX-QGZVFWFLSA-N					doublet; compound annotation
0391_004882	Linagliptin	C25H28N8O2	2.3467	10096344	CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)n1)c(=O)n2C	InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1	LTXREWYXXSTFRX-QGZVFWFLSA-N					doublet; removed another duplicate entry; compound annotation
0391_004884	869288-64-2	C22H20F3N5O3S	2.5719	11612883		CS(=O)(=O)c1cccc(CNc2nc(Nc3cc4c(cc3)NC(=O)CC4)ncc2C(F)(F)F)c1	InChI=1S/C22H20F3N5O3S/c1-34(32,33)16-4-2-3-13(9-16)11-26-20-17(22(23,24)25)12-27-21(30-20)28-15-6-7-18-14(10-15)5-8-19(31)29-18/h2-4,6-7,9-10,12H,5,8,11H2,1H3,(H,29,31)(H2,26,27,28,30)	HESLKTSGTIBHJU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004887	Dapagliflozin	C21H25ClO6	3.4175	9887712	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C3OC(CO)C(O)C(O)C3O)c2)cc1	InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	JVHXJTBJCFBINQ-ADAARDCZSA-N					doublet; removed another duplicate entry; compound annotation
0391_004889	Linagliptin	C25H28N8O2	3.6433	10096344	CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C	CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc3ccccc3c(C)n1)c(=O)n2C	InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1	LTXREWYXXSTFRX-QGZVFWFLSA-N					doublet; compound annotation
0391_004890	balapiravir	C21H30N6O8	3.8643	53297462	CC(C)C(=O)OC[C@@]1([C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-]	CC(C)C(=O)OCC1(N=[N+]=[N-])OC(n2ccc(N)nc2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C	InChI=1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31)/t14-,15+,16-,21-/m1/s1	VKXWOLCNTHXCLF-DXEZIKHYSA-N					doublet; compound annotation
0391_004891	balapiravir	C21H30N6O8	3.9855	53297462	CC(C)C(=O)OC[C@@]1([C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-]	CC(C)C(=O)OCC1(N=[N+]=[N-])OC(n2ccc(N)nc2=O)C(OC(=O)C(C)C)C1OC(=O)C(C)C	InChI=1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31)/t14-,15+,16-,21-/m1/s1	VKXWOLCNTHXCLF-DXEZIKHYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004893	JNJ-17203212	C17H15F6N5O	4.5837	11339118		O=C(Nc1ncc(C(F)(F)F)cc1)N1CCN(c2c(C(F)(F)F)cccn2)CC1	InChI=1S/C17H15F6N5O/c18-16(19,20)11-3-4-13(25-10-11)26-15(29)28-8-6-27(7-9-28)14-12(17(21,22)23)2-1-5-24-14/h1-5,10H,6-9H2,(H,25,26,29)	JFRYYGVYCWYIDQ-UHFFFAOYSA-N					compound annotation
0391_004894	Taltirelin	C17H23N7O5	0.4701	114750	CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N	CN1C(=O)CC(C(=O)NC(Cc2cnc[nH]2)C(=O)N2CCCC2C(N)=O)NC1=O	InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1	LQZAIAZUDWIVPM-SRVKXCTJSA-N					removed another duplicate entry; compound annotation
0391_004896	70063-04-6	C10H12N4O5S	0.9273	40018		CN1c2cc(O)c(N=NC(N)=O)cc2CC1S(=O)(=O)O	InChI=1S/C10H12N4O5S/c1-14-7-4-8(15)6(12-13-10(11)16)2-5(7)3-9(14)20(17,18)19/h2,4,9,15H,3H2,1H3,(H2,11,16)(H,17,18,19)	OQVRCWUMFBNYKF-UHFFFAOYSA-N					compound annotation
0391_004897	TETRABENAZINE	C19H27NO3	1.6124	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_004898	alfuzosin	C19H27N5O4	1.9414	2092		COc1c(OC)cc2c(N)nc(N(C)CCCNC(=O)C3CCCO3)nc2c1	InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)	WNMJYKCGWZFFKR-UHFFFAOYSA-N					doublet; compound annotation
0391_004899	TETRABENAZINE	C19H27NO3	2.183	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_004900	TETRABENAZINE	C19H27NO3	2.2521	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_004901	TETRABENAZINE	C19H27NO3	2.2892	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_004902	TETRABENAZINE	C19H27NO3	2.3428	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_004903	trimebutine	C22H29NO5	2.8997	5573		CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C	InChI=1S/C22H29NO5/c1-7-22(23(2)3,17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5/h8-14H,7,15H2,1-6H3	LORDFXWUHHSAQU-UHFFFAOYSA-N					compound annotation
0391_004904	Terbutryn	C10H19N5S	3.1668	13450		CCNc1nc(NC(C)(C)C)nc(SC)n1	InChI=1S/C10H19N5S/c1-6-11-7-12-8(15-10(2,3)4)14-9(13-7)16-5/h6H2,1-5H3,(H2,11,12,13,14,15)	IROINLKCQGIITA-UHFFFAOYSA-N					compound annotation
0391_004905	Temocapril	C23H28N2O5S2	3.5767	443874	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CS[C@@H](CN(C2=O)CC(=O)O)C3=CC=CS3	CCOC(=O)C(CCc1ccccc1)NC1CSC(c2cccs2)CN(CC(=O)O)C1=O	InChI=1S/C23H28N2O5S2/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27)/t17-,18-,20-/m0/s1	FIQOFIRCTOWDOW-BJLQDIEVSA-N					removed another duplicate entry; compound annotation
0391_004907	Quizalofop-p-ethyl	C19H17ClN2O4	5.2651	1617113	CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl	CCOC(=O)C(C)Oc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1	InChI=1S/C19H17ClN2O4/c1-3-24-19(23)12(2)25-14-5-7-15(8-6-14)26-18-11-21-17-10-13(20)4-9-16(17)22-18/h4-12H,3H2,1-2H3/t12-/m1/s1	OSUHJPCHFDQAIT-GFCCVEGCSA-N					removed another duplicate entry; compound annotation
0391_004909	METHYL NICOTINATE	C7H7NO2	1.047	7151		COC(=O)c1cnccc1	InChI=1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3	YNBADRVTZLEFNH-UHFFFAOYSA-N					compound annotation
0391_004910	triamterene	C12H11N7	1.4815	5546		Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1	InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)	FNYLWPVRPXGIIP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004912	Propoxycaine	C16H26N2O3	1.7548	6843		CCCOc1c(C(=O)OCCN(CC)CC)ccc(N)c1	InChI=1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3	CAJIGINSTLKQMM-UHFFFAOYSA-N					compound annotation
0391_004913	Ropivacaine	C17H26N2O	2.035	175805	CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C	CCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1	ZKMNUMMKYBVTFN-HNNXBMFYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004915	(R)-Ketorolac	C15H13NO3	3.1432	181818	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)[C@@H]1C(=O)O	O=C(c1ccccc1)c1ccc2C(C(=O)O)CCn12	InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/t11-/m1/s1	OZWKMVRBQXNZKK-LLVKDONJSA-N					compound annotation
0391_004916	Ningetinib	C31H29FN4O5	3.1893	60165029		Cc1c(C(=O)Nc2cc(F)c(Oc3ccnc4cc(OCC(C)(C)O)ccc34)cc2)c(=O)n(-c2ccccc2)n1C	InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(35(19)4)21-8-6-5-7-9-21)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(11-12-23(25)26)40-18-31(2,3)39/h5-17,39H,18H2,1-4H3,(H,34,37)	VQYYQSZNRVQLIS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004918	CLK1-IN-1	C24H16FN5O	4.2801	129318964	C[C@@H](C1=CC=C(C=C1)F)N2C3=C4C=C(C=CC4=NC=C3N=N2)C5=CC6=C(C=C5)OC=N6	CC(c1ccc(F)cc1)n1nnc2c1c1cc(-c3cc4c(cc3)ocn4)ccc1nc2	InChI=1S/C24H16FN5O/c1-14(15-2-6-18(25)7-3-15)30-24-19-10-16(4-8-20(19)26-12-22(24)28-29-30)17-5-9-23-21(11-17)27-13-31-23/h2-14H,1H3/t14-/m0/s1	BHKVSOQUPYXVRZ-AWEZNQCLSA-N					compound annotation
0391_004919	benzethonium	C27H42NO2+	4.7776	2335		CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1	InChI=1S/C27H42NO2/c1-26(2,3)22-27(4,5)24-13-15-25(16-14-24)30-20-19-29-18-17-28(6,7)21-23-11-9-8-10-12-23/h8-16H,17-22H2,1-7H3/q+1	SIYLLGKDQZGJHK-UHFFFAOYSA-N					compound annotation
0391_004920	6,7-Dimethyl-2-phenylquinoxaline	C16H14N2	4.8419	2048		Cc1cc2ncc(-c3ccccc3)nc2cc1C	InChI=1S/C16H14N2/c1-11-8-14-15(9-12(11)2)18-16(10-17-14)13-6-4-3-5-7-13/h3-10H,1-2H3	FQNCLVJEQCJWSU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004922	Ospemifene	C24H23ClO2	5.2928	3036505	C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCCO)/CCCl	OCCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1	InChI=1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2/b24-23-	LUMKNAVTFCDUIE-VHXPQNKSSA-N					compound annotation
0391_004923	Saxagliptin	C18H25N3O2	1.2384	11243969	C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N	N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2	InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1	QGJUIPDUBHWZPV-SGTAVMJGSA-N					doublet; compound annotation
0391_004924	Saxagliptin	C18H25N3O2	1.5705	11243969	C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N	N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2	InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1	QGJUIPDUBHWZPV-SGTAVMJGSA-N					doublet; removed another duplicate entry; compound annotation
0391_004926	664969-54-4	C20H24N4O2S2	2.2212	1213452	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(=S)NC3=CC=C(C=C3)S(=O)(=O)N	NS(=O)(=O)c1ccc(NC(=S)N2CCN(CC=Cc3ccccc3)CC2)cc1	InChI=1S/C20H24N4O2S2/c21-28(25,26)19-10-8-18(9-11-19)22-20(27)24-15-13-23(14-16-24)12-4-7-17-5-2-1-3-6-17/h1-11H,12-16H2,(H,22,27)(H2,21,25,26)/b7-4+	ZUQIFHLBPBLRRM-QPJJXVBHSA-N					doublet; compound annotation
0391_004927	664969-54-4	C20H24N4O2S2	2.2686	1213452	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(=S)NC3=CC=C(C=C3)S(=O)(=O)N	NS(=O)(=O)c1ccc(NC(=S)N2CCN(CC=Cc3ccccc3)CC2)cc1	InChI=1S/C20H24N4O2S2/c21-28(25,26)19-10-8-18(9-11-19)22-20(27)24-15-13-23(14-16-24)12-4-7-17-5-2-1-3-6-17/h1-11H,12-16H2,(H,22,27)(H2,21,25,26)/b7-4+	ZUQIFHLBPBLRRM-QPJJXVBHSA-N					doublet; compound annotation
0391_004928	BGT-226 free base	C28H25F3N6O2	2.3611	11978790		COc1ncc(-c2cc3c4c(cnc3cc2)n(C)c(=O)n4-c2cc(C(F)(F)F)c(N3CCNCC3)cc2)cc1	InChI=1S/C28H25F3N6O2/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36/h3-8,13-16,32H,9-12H2,1-2H3	BMMXYEBLEBULND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004930	PD123319	C31H32N4O3	2.4248	5311345	CC1=C(C=CC(=C1)CN2C=NC3=C2C[C@H](N(C3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O)N(C)C	Cc1c(N(C)C)ccc(Cn2cnc3c2CC(C(=O)O)N(C(=O)C(c2ccccc2)c2ccccc2)C3)c1	InChI=1S/C31H32N4O3/c1-21-16-22(14-15-26(21)33(2)3)18-34-20-32-25-19-35(28(31(37)38)17-27(25)34)30(36)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-16,20,28-29H,17-19H2,1-3H3,(H,37,38)/t28-/m0/s1	YSTVFDAKLDMYCR-NDEPHWFRSA-N					removed another duplicate entry; compound annotation
0391_004932	donepezil	C24H29NO3	2.5211	3152		COc1c(OC)cc2C(=O)C(CC3CCN(Cc4ccccc4)CC3)Cc2c1	InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3	ADEBPBSSDYVVLD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004934	873225-46-8	C28H29N5OS	3.2443	9549298		O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1	InChI=1S/C28H29N5OS/c34-27(33-17-12-23(13-18-33)32-15-3-4-16-32)20-7-9-22(10-8-20)30-28-29-14-11-24(31-28)26-19-21-5-1-2-6-25(21)35-26/h1-2,5-11,14,19,23H,3-4,12-13,15-18H2,(H,29,30,31)	BWZJBXAPRCVCKQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004936	Varespladib	C21H20N2O5	3.3342	155815		CCc1c(C(=O)C(N)=O)c2c(cccc2OCC(=O)O)n1Cc1ccccc1	InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)	BHLXTPHDSZUFHR-UHFFFAOYSA-N					doublet; compound annotation
0391_004937	Varespladib	C21H20N2O5	3.3375	155815		CCc1c(C(=O)C(N)=O)c2c(cccc2OCC(=O)O)n1Cc1ccccc1	InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)	BHLXTPHDSZUFHR-UHFFFAOYSA-N					doublet; compound annotation
0391_004938	AZD5582	C58H78N8O8	3.4599	49847690	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)OCC#CC#CCO[C@@H]5CC6=CC=CC=C6[C@@H]5NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC1c2ccccc2CC1OCC#CC#CCOC1Cc2ccccc2C1NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)NC)C1CCCCC1)C1CCCCC1	InChI=1S/C58H78N8O8/c1-37(59-3)53(67)61-49(39-21-9-7-10-22-39)57(71)65-31-19-29-45(65)55(69)63-51-43-27-15-13-25-41(43)35-47(51)73-33-17-5-6-18-34-74-48-36-42-26-14-16-28-44(42)52(48)64-56(70)46-30-20-32-66(46)58(72)50(40-23-11-8-12-24-40)62-54(68)38(2)60-4/h13-16,25-28,37-40,45-52,59-60H,7-12,19-24,29-36H2,1-4H3,(H,61,67)(H,62,68)(H,63,69)(H,64,70)/t37-,38-,45-,46-,47+,48+,49-,50-,51-,52-/m0/s1	WLMCRYCCYXHPQF-ZVMUOSSASA-N					doublet; compound annotation
0391_004939	AZD5582	C58H78N8O8	3.4645	49847690	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)OCC#CC#CCO[C@@H]5CC6=CC=CC=C6[C@@H]5NC(=O)[C@@H]7CCCN7C(=O)[C@H](C8CCCCC8)NC(=O)[C@H](C)NC)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC1c2ccccc2CC1OCC#CC#CCOC1Cc2ccccc2C1NC(=O)C1CCCN1C(=O)C(NC(=O)C(C)NC)C1CCCCC1)C1CCCCC1	InChI=1S/C58H78N8O8/c1-37(59-3)53(67)61-49(39-21-9-7-10-22-39)57(71)65-31-19-29-45(65)55(69)63-51-43-27-15-13-25-41(43)35-47(51)73-33-17-5-6-18-34-74-48-36-42-26-14-16-28-44(42)52(48)64-56(70)46-30-20-32-66(46)58(72)50(40-23-11-8-12-24-40)62-54(68)38(2)60-4/h13-16,25-28,37-40,45-52,59-60H,7-12,19-24,29-36H2,1-4H3,(H,61,67)(H,62,68)(H,63,69)(H,64,70)/t37-,38-,45-,46-,47+,48+,49-,50-,51-,52-/m0/s1	WLMCRYCCYXHPQF-ZVMUOSSASA-N					doublet; compound annotation
0391_004940	664969-54-4	C20H24N4O2S2	3.7165	1213452	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(=S)NC3=CC=C(C=C3)S(=O)(=O)N	NS(=O)(=O)c1ccc(NC(=S)N2CCN(CC=Cc3ccccc3)CC2)cc1	InChI=1S/C20H24N4O2S2/c21-28(25,26)19-10-8-18(9-11-19)22-20(27)24-15-13-23(14-16-24)12-4-7-17-5-2-1-3-6-17/h1-11H,12-16H2,(H,22,27)(H2,21,25,26)/b7-4+	ZUQIFHLBPBLRRM-QPJJXVBHSA-N					doublet; compound annotation
0391_004941	2-NBDG	C12H14N4O8	0.6751	6711157	C1=C(C2=NON=C2C(=C1)[N+](=O)[O-])N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O	O=CC(Nc1ccc([N+](=O)[O-])c2nonc12)C(O)C(O)C(O)CO	InChI=1S/C12H14N4O8/c17-3-6(11(20)12(21)8(19)4-18)13-5-1-2-7(16(22)23)10-9(5)14-24-15-10/h1-3,6,8,11-13,18-21H,4H2/t6-,8+,11+,12+/m0/s1	QUTFFEUUGHUPQC-ILWYWAAHSA-N					doublet; removed another duplicate entry; compound annotation
0391_004943	2-NBDG	C12H14N4O8	0.9899	6711157	C1=C(C2=NON=C2C(=C1)[N+](=O)[O-])N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O	O=CC(Nc1ccc([N+](=O)[O-])c2nonc12)C(O)C(O)C(O)CO	InChI=1S/C12H14N4O8/c17-3-6(11(20)12(21)8(19)4-18)13-5-1-2-7(16(22)23)10-9(5)14-24-15-10/h1-3,6,8,11-13,18-21H,4H2/t6-,8+,11+,12+/m0/s1	QUTFFEUUGHUPQC-ILWYWAAHSA-N					doublet; removed another duplicate entry; compound annotation
0391_004945	946128-88-7	C21H18FN5O5S	2.9663	16719221		CNS(=O)(=O)Nc1nccc(Cc2c(C)c3c(cc(Oc4ncccn4)cc3)oc2=O)c1F	InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27)	LMMJFBMMJUMSJS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004947	GRL0617	C20H20N2O	3.0054	24941262	CC1=C(C=C(C=C1)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32	Cc1c(C(=O)NC(C)c2cccc3ccccc23)cc(N)cc1	InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1	UVERBUNNCOKGNZ-CQSZACIVSA-N					doublet; compound annotation
0391_004948	GRL0617	C20H20N2O	3.0087	24941262	CC1=C(C=C(C=C1)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32	Cc1c(C(=O)NC(C)c2cccc3ccccc23)cc(N)cc1	InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1	UVERBUNNCOKGNZ-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_004950	p38alpha inhibitor 1	C22H26F2N4O2	3.0573	46883775		CC(C)Cn1ncc2cc(Oc3c(F)cc(F)cc3)c(C(=O)NCCN(C)C)cc21	InChI=1S/C22H26F2N4O2/c1-14(2)13-28-19-11-17(22(29)25-7-8-27(3)4)21(9-15(19)12-26-28)30-20-6-5-16(23)10-18(20)24/h5-6,9-12,14H,7-8,13H2,1-4H3,(H,25,29)	IFGWYHGYNVGVRB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004952	382-44-5	C19H26O3	3.1242	94141	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O	CC12CC(O)C3C(CCC4=CC(=O)CCC43C)C1CCC2=O	InChI=1S/C19H26O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h9,13-15,17,21H,3-8,10H2,1-2H3/t13-,14-,15-,17+,18-,19-/m0/s1	WSCUHXPGYUMQEX-KCZNZURUSA-N					compound annotation
0391_004953	Kif15-IN-2	C20H20N6O4S	3.4516	60076305	CC1=C(SC(=N1)NC(=O)[C@H](C(C)C)N2C(=O)C3=CC=CC=C3NC2=O)C4=NN=C(O4)C	Cc1nnc(-c2c(C)nc(NC(=O)C(C(C)C)n3c(=O)[nH]c4ccccc4c3=O)s2)o1	InChI=1S/C20H20N6O4S/c1-9(2)14(26-18(28)12-7-5-6-8-13(12)22-20(26)29)16(27)23-19-21-10(3)15(31-19)17-25-24-11(4)30-17/h5-9,14H,1-4H3,(H,22,29)(H,21,23,27)/t14-/m0/s1	OHVKUJISCPKSER-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_004955	1595129-71-7	C31H40N8O3S	3.6995	73441802		CN1CCC(c2ccccc2CC(C)(C)Nc2nc(-n3c(S(C)(=O)=O)nc4ccccc43)nc(N3CCOCC3)n2)CC1	InChI=1S/C31H40N8O3S/c1-31(2,21-23-9-5-6-10-24(23)22-13-15-37(3)16-14-22)36-27-33-28(38-17-19-42-20-18-38)35-29(34-27)39-26-12-8-7-11-25(26)32-30(39)43(4,40)41/h5-12,22H,13-21H2,1-4H3,(H,33,34,35,36)	PGTXVGREXBMCCY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004957	GSK547	C20H18F2N6O	3.8097	134521814	C1CN(CCC1C(=O)N2[C@@H](CC=N2)C3=CC(=CC(=C3)F)F)C4=NC=NC(=C4)C#N	N#Cc1cc(N2CCC(C(=O)N3N=CCC3c3cc(F)cc(F)c3)CC2)ncn1	InChI=1S/C20H18F2N6O/c21-15-7-14(8-16(22)9-15)18-1-4-26-28(18)20(29)13-2-5-27(6-3-13)19-10-17(11-23)24-12-25-19/h4,7-10,12-13,18H,1-3,5-6H2/t18-/m0/s1	SJVGFKBLUYAEOK-SFHVURJKSA-N					compound annotation
0391_004958	ETOFENAMATE	C18H18F3NO4	4.6788	35375		O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1	InChI=1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2	XILVEPYQJIOVNB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004960	6-Hydroxy-4-methylcoumarin	C10H8O3	1.9024	75409		Cc1cc(=O)oc2c1cc(O)cc2	InChI=1S/C10H8O3/c1-6-4-10(12)13-9-3-2-7(11)5-8(6)9/h2-5,11H,1H3	IRUHWRSITUYICV-UHFFFAOYSA-N					compound annotation
0391_004961	Astilbin	C21H22O11	1.9292	119258	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O	CC1OC(OC2C(=O)c3c(O)cc(O)cc3OC2c2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C21H22O11/c1-7-15(26)17(28)18(29)21(30-7)32-20-16(27)14-12(25)5-9(22)6-13(14)31-19(20)8-2-3-10(23)11(24)4-8/h2-7,15,17-26,28-29H,1H3/t7-,15-,17+,18+,19+,20-,21-/m0/s1	ZROGCCBNZBKLEL-MPRHSVQHSA-N					doublet; removed another duplicate entry; compound annotation
0391_004963	Astilbin	C21H22O11	2.0811	119258	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O	CC1OC(OC2C(=O)c3c(O)cc(O)cc3OC2c2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C21H22O11/c1-7-15(26)17(28)18(29)21(30-7)32-20-16(27)14-12(25)5-9(22)6-13(14)31-19(20)8-2-3-10(23)11(24)4-8/h2-7,15,17-26,28-29H,1H3/t7-,15-,17+,18+,19+,20-,21-/m0/s1	ZROGCCBNZBKLEL-MPRHSVQHSA-N					doublet; compound annotation
0391_004964	1174161-69-3	C24H18ClF2N4O7P	2.652	44137813		Nc1nccc(Oc2c(F)cc(NC(=O)c3cn(COP(=O)(O)O)cc(-c4ccc(F)cc4)c3=O)cc2)c1Cl	InChI=1S/C24H18ClF2N4O7P/c25-21-20(7-8-29-23(21)28)38-19-6-5-15(9-18(19)27)30-24(33)17-11-31(12-37-39(34,35)36)10-16(22(17)32)13-1-3-14(26)4-2-13/h1-11H,12H2,(H2,28,29)(H,30,33)(H2,34,35,36)	KXDZWUPUSDCGDD-UHFFFAOYSA-N					compound annotation
0391_004965	Azoramide	C15H17ClN2OS	4.0264	7518316		CCCC(=O)NCCc1csc(-c2ccc(Cl)cc2)n1	InChI=1S/C15H17ClN2OS/c1-2-3-14(19)17-9-8-13-10-20-15(18-13)11-4-6-12(16)7-5-11/h4-7,10H,2-3,8-9H2,1H3,(H,17,19)	VYBFWKKCWTXCQX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004967	ML224	C31H31N3O5	4.0566	50897809		COc1c(COc2c(C)cc(NC(C)=O)cc2C)cc(C2Nc3ccccc3C(=O)N2Cc2ccco2)cc1	InChI=1S/C31H31N3O5/c1-19-14-24(32-21(3)35)15-20(2)29(19)39-18-23-16-22(11-12-28(23)37-4)30-33-27-10-6-5-9-26(27)31(36)34(30)17-25-8-7-13-38-25/h5-16,30,33H,17-18H2,1-4H3,(H,32,35)	BFTSWGYWHRJVNI-UHFFFAOYSA-N					doublet; compound annotation
0391_004968	ML224	C31H31N3O5	4.0599	50897809		COc1c(COc2c(C)cc(NC(C)=O)cc2C)cc(C2Nc3ccccc3C(=O)N2Cc2ccco2)cc1	InChI=1S/C31H31N3O5/c1-19-14-24(32-21(3)35)15-20(2)29(19)39-18-23-16-22(11-12-28(23)37-4)30-33-27-10-6-5-9-26(27)31(36)34(30)17-25-8-7-13-38-25/h5-16,30,33H,17-18H2,1-4H3,(H,32,35)	BFTSWGYWHRJVNI-UHFFFAOYSA-N					doublet; compound annotation
0391_004969	123066-64-8	C11H7F6N3	4.4016	2740668		Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1	InChI=1S/C11H7F6N3/c12-10(13,14)8-5-9(11(15,16)17)20(19-8)7-3-1-6(18)2-4-7/h1-5H,18H2	XOXBUERZFCPKDR-UHFFFAOYSA-N					compound annotation
0391_004970	448947-81-7	C13H8Cl2N4S2	4.8977	2746822		Clc1cccc(Cl)c1CSc1nnc(-c2nccnc2)s1	InChI=1S/C13H8Cl2N4S2/c14-9-2-1-3-10(15)8(9)7-20-13-19-18-12(21-13)11-6-16-4-5-17-11/h1-6H,7H2	BQNXBSYSQXSXPT-UHFFFAOYSA-N					compound annotation
0391_004971	PCI-27483	C26H24N6O9S	1.393	135425273	C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)N[C@@H](CC(=O)O)C(=O)O	N=C(N)c1cc2c(cc1)nc(-c1cc(CC(=O)NC(CC(=O)O)C(=O)O)cc(-c3c(O)ccc(S(N)(=O)=O)c3)c1O)[nH]2	InChI=1S/C26H24N6O9S/c27-24(28)12-1-3-17-18(8-12)32-25(31-17)16-6-11(7-21(34)30-19(26(38)39)10-22(35)36)5-15(23(16)37)14-9-13(42(29,40)41)2-4-20(14)33/h1-6,8-9,19,33,37H,7,10H2,(H3,27,28)(H,30,34)(H,31,32)(H,35,36)(H,38,39)(H2,29,40,41)/t19-/m0/s1	WDJHHCAKBRKCLW-IBGZPJMESA-N					compound annotation
0391_004972	Barasertib	C26H31FN7O6P	1.8539	11497983		CCN(CCCOc1cc2c(cc1)c(Nc1n[nH]c(CC(=O)Nc3cc(F)ccc3)c1)ncn2)CCOP(=O)(O)O	InChI=1S/C26H31FN7O6P/c1-2-34(10-12-40-41(36,37)38)9-4-11-39-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(35)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17H,2,4,9-12,15H2,1H3,(H,30,35)(H2,36,37,38)(H2,28,29,31,32,33)	GBJVVSCPOBPEIT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004974	hydroxybupropion	C13H18ClNO2	1.8699	446		CC(NC(C)(C)CO)C(=O)c1cc(Cl)ccc1	InChI=1S/C13H18ClNO2/c1-9(15-13(2,3)8-16)12(17)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3	AKOAEVOSDHIVFX-UHFFFAOYSA-N					compound annotation
0391_004975	Vesatolimod	C22H30N6O2	2.1508	46241268		CCCCOc1nc(N)c2NC(=O)CN(Cc3cccc(CN4CCCC4)c3)c2n1	InChI=1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26)	VFOKSTCIRGDTBR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004977	SANT-1	C23H27N5	2.7801	6878030	CC1=C(C(=NN1C2=CC=CC=C2)C)/C=N/N3CCN(CC3)CC4=CC=CC=C4	Cc1nn(-c2ccccc2)c(C)c1C=NN1CCN(Cc2ccccc2)CC1	InChI=1S/C23H27N5/c1-19-23(20(2)28(25-19)22-11-7-4-8-12-22)17-24-27-15-13-26(14-16-27)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18H2,1-2H3/b24-17+	FOORCIAZMIWALX-JJIBRWJFSA-N					removed another duplicate entry; compound annotation
0391_004979	BAY-299	C25H23N3O4	3.0253	122705990		Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C	InChI=1S/C25H23N3O4/c1-14-12-20-21(27(3)25(32)26(20)2)13-19(14)28-23(30)17-8-4-7-16-15(6-5-11-29)9-10-18(22(16)17)24(28)31/h4,7-10,12-13,29H,5-6,11H2,1-3H3	OFWWWKWUCDUISA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004982	importazole	C20H22N4	3.3908	2949965		CC(Nc1nc(N2CCCC2)nc2ccccc12)c1ccccc1	InChI=1S/C20H22N4/c1-15(16-9-3-2-4-10-16)21-19-17-11-5-6-12-18(17)22-20(23-19)24-13-7-8-14-24/h2-6,9-12,15H,7-8,13-14H2,1H3,(H,21,22,23)	HKGJEZIGDHFJFL-UHFFFAOYSA-N					compound annotation
0391_004983	Losartan carboxylic acid	C22H21ClN6O2	3.6683	108185		CCCCc1nc(Cl)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C22H21ClN6O2/c1-2-3-8-18-24-20(23)19(22(30)31)29(18)13-14-9-11-15(12-10-14)16-6-4-5-7-17(16)21-25-27-28-26-21/h4-7,9-12H,2-3,8,13H2,1H3,(H,30,31)(H,25,26,27,28)	ZEUXAIYYDDCIRX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_004985	TOLRESTAT	C16H14F3NO3S	3.8865	53359		COc1c(C(F)(F)F)c2c(cc1)c(C(=S)N(C)CC(=O)O)ccc2	InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)	LUBHDINQXIHVLS-UHFFFAOYSA-N					doublet; compound annotation
0391_004986	TOLRESTAT	C16H14F3NO3S	4.1048	53359		COc1c(C(F)(F)F)c2c(cc1)c(C(=S)N(C)CC(=O)O)ccc2	InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)	LUBHDINQXIHVLS-UHFFFAOYSA-N					doublet; compound annotation
0391_004987	Trifarotene	C29H33NO4	4.1775	11518241		CC(C)(C)c1c(N2CCCC2)ccc(-c2c(OCCO)ccc(-c3ccc(C(=O)O)cc3)c2)c1	InChI=1S/C29H33NO4/c1-29(2,3)25-19-23(10-12-26(25)30-14-4-5-15-30)24-18-22(11-13-27(24)34-17-16-31)20-6-8-21(9-7-20)28(32)33/h6-13,18-19,31H,4-5,14-17H2,1-3H3,(H,32,33)	MFBCDACCJCDGBA-UHFFFAOYSA-N					compound annotation
0391_004988	AS2863619 (free base)	C16H12N8O	0.4996	139600292		Cc1nc2c(cc(-n3c(-c4nonc4N)nc4cnccc43)cc2)[nH]1	InChI=1S/C16H12N8O/c1-8-19-10-3-2-9(6-11(10)20-8)24-13-4-5-18-7-12(13)21-16(24)14-15(17)23-25-22-14/h2-7H,1H3,(H2,17,23)(H,19,20)	OORKHRHPVSWORX-UHFFFAOYSA-N					doublet; compound annotation
0391_004989	TIRAPAZAMINE	C7H6N4O2	0.722	135413511		Nc1[n+]([O-])c2ccccc2[n+]([O-])n1	InChI=1S/C7H6N4O2/c8-7-9-11(13)6-4-2-1-3-5(6)10(7)12/h1-4H,(H2,8,9)	ORYDPOVDJJZGHQ-UHFFFAOYSA-N					compound annotation
0391_004990	Lomeguatrib	C10H8BrN5OS	1.7017	3025944		Nc1nc2c([nH]cn2)c(OCc2cc(Br)cs2)n1	InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)	JUJPKFNFCWJBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_004991	85081-18-1	C19H29NO3	1.7537	14580381	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(O)CC21	InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3/t14-,16-,17-/m1/s1	WEQLWGNDNRARGE-DJIMGWMZSA-N					doublet; compound annotation
0391_004992	Lomeguatrib	C10H8BrN5OS	1.8404	3025944		Nc1nc2c([nH]cn2)c(OCc2cc(Br)cs2)n1	InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)	JUJPKFNFCWJBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_004993	Lomeguatrib	C10H8BrN5OS	1.9842	3025944		Nc1nc2c([nH]cn2)c(OCc2cc(Br)cs2)n1	InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)	JUJPKFNFCWJBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_004994	85081-18-1	C19H29NO3	2.0086	14580381	CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1O)OC)OC	COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(O)CC21	InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3/t14-,16-,17-/m1/s1	WEQLWGNDNRARGE-DJIMGWMZSA-N					doublet; compound annotation
0391_004995	Lomeguatrib	C10H8BrN5OS	2.0298	3025944		Nc1nc2c([nH]cn2)c(OCc2cc(Br)cs2)n1	InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)	JUJPKFNFCWJBCX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_004997	PROTAC ERRalpha ligand 2	C20H13F6NO4	2.0978	139291005	COC1=C(C=CC(=C1)/C=C(\C#N)/C(=O)O)OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F	COc1c(OCc2c(C(F)(F)F)cc(C(F)(F)F)cc2)ccc(C=C(C#N)C(=O)O)c1	InChI=1S/C20H13F6NO4/c1-30-17-7-11(6-13(9-27)18(28)29)2-5-16(17)31-10-12-3-4-14(19(21,22)23)8-15(12)20(24,25)26/h2-8H,10H2,1H3,(H,28,29)/b13-6+	JRWKJGIKIBTXMV-AWNIVKPZSA-N					doublet; compound annotation
0391_004998	Viquidil	C20H24N2O2	2.1625	65753	COC1=CC2=C(C=CN=C2C=C1)C(=O)CC[C@@H]3CCNC[C@@H]3C=C	C=CC1CNCCC1CCC(=O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-14-13-21-10-8-15(14)4-7-20(23)17-9-11-22-19-6-5-16(24-2)12-18(17)19/h3,5-6,9,11-12,14-15,21H,1,4,7-8,10,13H2,2H3/t14-,15+/m0/s1	DKRSEIPLAZTSFD-LSDHHAIUSA-N					doublet; compound annotation
0391_004999	Viquidil	C20H24N2O2	2.2321	65753	COC1=CC2=C(C=CN=C2C=C1)C(=O)CC[C@@H]3CCNC[C@@H]3C=C	C=CC1CNCCC1CCC(=O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-14-13-21-10-8-15(14)4-7-20(23)17-9-11-22-19-6-5-16(24-2)12-18(17)19/h3,5-6,9,11-12,14-15,21H,1,4,7-8,10,13H2,2H3/t14-,15+/m0/s1	DKRSEIPLAZTSFD-LSDHHAIUSA-N					doublet; compound annotation
0391_005000	Lomeguatrib	C10H8BrN5OS	2.2977	3025944		Nc1nc2c([nH]cn2)c(OCc2cc(Br)cs2)n1	InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)	JUJPKFNFCWJBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_005001	SGC-CBP30	C28H33ClN4O3	2.8738	72201027	CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)C[C@H](C)N5CCOCC5	COc1c(Cl)cc(CCc2nc3c(ccc(-c4c(C)onc4C)c3)n2CC(C)N2CCOCC2)cc1	InChI=1S/C28H33ClN4O3/c1-18(32-11-13-35-14-12-32)17-33-25-8-7-22(28-19(2)31-36-20(28)3)16-24(25)30-27(33)10-6-21-5-9-26(34-4)23(29)15-21/h5,7-9,15-16,18H,6,10-14,17H2,1-4H3/t18-/m0/s1	GEPYBHCJBORHCE-SFHVURJKSA-N					compound annotation
0391_005002	Motolimod	C28H34N4O2	3.1476	16049404		CCCN(CCC)C(=O)C1=Cc2c(cc(-c3ccc(C(=O)N4CCCC4)cc3)cc2)N=C(N)C1	InChI=1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30)	QSPOQCXMGPDIHI-UHFFFAOYSA-N					doublet; compound annotation
0391_005003	Motolimod	C28H34N4O2	3.1508	16049404		CCCN(CCC)C(=O)C1=Cc2c(cc(-c3ccc(C(=O)N4CCCC4)cc3)cc2)N=C(N)C1	InChI=1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30)	QSPOQCXMGPDIHI-UHFFFAOYSA-N					doublet; compound annotation
0391_005004	gsk2830371	C23H29ClN4O2S	3.2732	70983932	CC1=C(C=C(C=N1)Cl)NCC2=CC=C(S2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4	Cc1c(NCc2ccc(C(=O)NC(CC3CCCC3)C(=O)NC3CC3)s2)cc(Cl)cn1	InChI=1S/C23H29ClN4O2S/c1-14-19(11-16(24)12-25-14)26-13-18-8-9-21(31-18)23(30)28-20(10-15-4-2-3-5-15)22(29)27-17-6-7-17/h8-9,11-12,15,17,20,26H,2-7,10,13H2,1H3,(H,27,29)(H,28,30)/t20-/m0/s1	IVDUVEGCMXCMSO-FQEVSTJZSA-N					doublet; compound annotation
0391_005005	gsk2830371	C23H29ClN4O2S	3.3624	70983932	CC1=C(C=C(C=N1)Cl)NCC2=CC=C(S2)C(=O)N[C@@H](CC3CCCC3)C(=O)NC4CC4	Cc1c(NCc2ccc(C(=O)NC(CC3CCCC3)C(=O)NC3CC3)s2)cc(Cl)cn1	InChI=1S/C23H29ClN4O2S/c1-14-19(11-16(24)12-25-14)26-13-18-8-9-21(31-18)23(30)28-20(10-15-4-2-3-5-15)22(29)27-17-6-7-17/h8-9,11-12,15,17,20,26H,2-7,10,13H2,1H3,(H,27,29)(H,28,30)/t20-/m0/s1	IVDUVEGCMXCMSO-FQEVSTJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_005007	PROTAC ERRalpha ligand 2	C20H13F6NO4	5.0106	139291005	COC1=C(C=CC(=C1)/C=C(\C#N)/C(=O)O)OCC2=C(C=C(C=C2)C(F)(F)F)C(F)(F)F	COc1c(OCc2c(C(F)(F)F)cc(C(F)(F)F)cc2)ccc(C=C(C#N)C(=O)O)c1	InChI=1S/C20H13F6NO4/c1-30-17-7-11(6-13(9-27)18(28)29)2-5-16(17)31-10-12-3-4-14(19(21,22)23)8-15(12)20(24,25)26/h2-8H,10H2,1H3,(H,28,29)/b13-6+	JRWKJGIKIBTXMV-AWNIVKPZSA-N					doublet; compound annotation
0391_005008	iopamidol	C17H22I3N3O8	0.4676	65492	C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O	CC(O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I	InChI=1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1	XQZXYNRDCRIARQ-LURJTMIESA-N					removed another duplicate entry; compound annotation
0391_005010	Nikethamide	C10H14N2O	1.2511	5497		CCN(CC)C(=O)c1cnccc1	InChI=1S/C10H14N2O/c1-3-12(4-2)10(13)9-6-5-7-11-8-9/h5-8H,3-4H2,1-2H3	NCYVXEGFNDZQCU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005012	pimobendan	C19H18N4O2	2.0286	4823		COc1ccc(-c2nc3c(cc(C4=NNC(=O)CC4C)cc3)[nH]2)cc1	InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)	GLBJJMFZWDBELO-UHFFFAOYSA-N					compound annotation
0391_005013	tranilast	C18H17NO5	3.3749	5282230	COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC	COc1c(OC)cc(C=CC(=O)Nc2ccccc2C(=O)O)cc1	InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+	NZHGWWWHIYHZNX-CSKARUKUSA-N					doublet; compound annotation
0391_005014	triflupromazine	C18H19F3N2S	3.5577	5568		CN(C)CCCN1c2ccccc2Sc2c1cc(C(F)(F)F)cc2	InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3	XSCGXQMFQXDFCW-UHFFFAOYSA-N					compound annotation
0391_005015	tranilast	C18H17NO5	3.6271	5282230	COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC	COc1c(OC)cc(C=CC(=O)Nc2ccccc2C(=O)O)cc1	InChI=1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+	NZHGWWWHIYHZNX-CSKARUKUSA-N					doublet; removed another duplicate entry; compound annotation
0391_005017	Norethindrone acetate	C22H28O3	4.5835	5832	CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C	C#CC1(OC(C)=O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C	InChI=1S/C22H28O3/c1-4-22(25-14(2)23)12-10-20-19-7-5-15-13-16(24)6-8-17(15)18(19)9-11-21(20,22)3/h1,13,17-20H,5-12H2,2-3H3/t17-,18+,19+,20-,21-,22-/m0/s1	IMONTRJLAWHYGT-ZCPXKWAGSA-N					compound annotation
0391_005018	IOPANOIC ACID	C11H12I3NO2	4.804	3735		CCC(Cc1c(I)c(N)c(I)cc1I)C(=O)O	InChI=1S/C11H12I3NO2/c1-2-5(11(16)17)3-6-7(12)4-8(13)10(15)9(6)14/h4-5H,2-3,15H2,1H3,(H,16,17)	OIRFJRBSRORBCM-UHFFFAOYSA-N					compound annotation
0391_005019	Tafluprost	C25H34F2O5	4.8172	9868491	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/C(COC2=CC=CC=C2)(F)F)O)O	CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COc1ccccc1	InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1	WSNODXPBBALQOF-VEJSHDCNSA-N					removed another duplicate entry; compound annotation
0391_005021	ABT-724	C17H19N5	0.8796	5025739		c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1	InChI=1S/C17H19N5/c1-2-6-15-14(5-1)19-16(20-15)13-21-9-11-22(12-10-21)17-7-3-4-8-18-17/h1-8H,9-13H2,(H,19,20)	FRPJGTNLZNXQEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005023	KX2-391	C26H29N3O3	1.8756	23635314		O=C(Cc1ncc(-c2ccc(OCCN3CCOCC3)cc2)cc1)NCc1ccccc1	InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30)	HUNGUWOZPQBXGX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005025	Falnidamol	C18H19ClFN7	2.6455	6918508		CN1CCC(Nc2ncc3ncnc(Nc4cc(Cl)c(F)cc4)c3n2)CC1	InChI=1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24)	FTFRZXFNZVCRSK-UHFFFAOYSA-N					compound annotation
0391_005026	METHYLPREDNISOLONE HEMISUCCINATE	C26H34O8	3.403	16923	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O	CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)COC(=O)CCC(=O)O)C2(C)C=CC(=O)C=C12	InChI=1S/C26H34O8/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31)/t14-,16-,17-,19-,23+,24-,25-,26-/m0/s1	IMBXEJJVJRTNOW-XYMSELFBSA-N					doublet; removed another duplicate entry; compound annotation
0391_005028	39711-79-0	C13H25NO	3.9575	62907		CCNC(=O)C1CC(C)CCC1C(C)C	InChI=1S/C13H25NO/c1-5-14-13(15)12-8-10(4)6-7-11(12)9(2)3/h9-12H,5-8H2,1-4H3,(H,14,15)	VUNOFAIHSALQQH-UHFFFAOYSA-N					compound annotation
0391_005029	Bromfenac	C15H12BrNO3	4.0661	60726		Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1	InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005030	lapachol	C15H14O3	4.4804	3884		CC(C)=CCC1=C(O)c2ccccc2C(=O)C1=O	InChI=1S/C15H14O3/c1-9(2)7-8-12-13(16)10-5-3-4-6-11(10)14(17)15(12)18/h3-7,16H,8H2,1-2H3	CWPGNVFCJOPXFB-UHFFFAOYSA-N					compound annotation
0391_005031	1314241-44-5	C15H20BrN3O	1.0885	46931242		O=C(c1cc(Br)cnc1)N1CCC(N2CCCC2)CC1	InChI=1S/C15H20BrN3O/c16-13-9-12(10-17-11-13)15(20)19-7-3-14(4-8-19)18-5-1-2-6-18/h9-11,14H,1-8H2	CQERVFFAOOUFEQ-UHFFFAOYSA-N					compound annotation
0391_005032	Philanthotoxin-74	C24H42N4O3	1.316	10122460	CCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCCCCCCCNCCCCN	CCCC(=O)NC(Cc1ccc(O)cc1)C(=O)NCCCCCCCNCCCCN	InChI=1S/C24H42N4O3/c1-2-10-23(30)28-22(19-20-11-13-21(29)14-12-20)24(31)27-18-8-5-3-4-7-16-26-17-9-6-15-25/h11-14,22,26,29H,2-10,15-19,25H2,1H3,(H,27,31)(H,28,30)/t22-/m0/s1	YKCMCIWNASWOOP-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_005034	Arry-380	C29H27N7O4S	1.837	42598643		Cc1c(Oc2cc3ncnn3cc2)ccc(Nc2ncnc3c2cc(-c2ccc(CNCCS(C)(=O)=O)o2)cc3)c1	InChI=1S/C29H27N7O4S/c1-19-13-21(4-7-26(19)39-22-9-11-36-28(15-22)32-18-34-36)35-29-24-14-20(3-6-25(24)31-17-33-29)27-8-5-23(40-27)16-30-10-12-41(2,37)38/h3-9,11,13-15,17-18,30H,10,12,16H2,1-2H3,(H,31,33,35)	QVMNYGOVNWWFKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005036	QX-314	C16H27N2O+	1.9289	3925		CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C	InChI=1S/C16H26N2O/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5/h9-11H,6-8,12H2,1-5H3/p+1	PYEBKOFMWAMBFV-UHFFFAOYSA-O					compound annotation
0391_005037	Balovaptan	C22H24ClN5O	2.6061	46200932		CN1Cc2c(ccc(Cl)c2)-n2c(nnc2C2CCC(Oc3ccccn3)CC2)C1	InChI=1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3	GMPZPHGHNDMRKL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005039	93718-83-3	C14H14O4S2	2.6527	262093		O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc12	InChI=1S/C14H14O4S2/c15-5-7-19-13-11(17)9-3-1-2-4-10(9)12(18)14(13)20-8-6-16/h1-4,15-16H,5-8H2	MAASHDQFQDDECQ-UHFFFAOYSA-N					compound annotation
0391_005040	MLI-2	C21H25N5O2	3.3033	78319901	C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C	CC1CN(c2ncnc(-c3n[nH]c4c3cc(OC3(C)CC3)cc4)c2)CC(C)O1	InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+	ATUUNJCZCOMUKD-OKILXGFUSA-N					removed another duplicate entry; compound annotation
0391_005042	KRN-633	C20H21ClN4O4	3.5159	9549295		CCCNC(=O)Nc1c(Cl)cc(Oc2ncnc3cc(OC)c(OC)cc23)cc1	InChI=1S/C20H21ClN4O4/c1-4-7-22-20(26)25-15-6-5-12(8-14(15)21)29-19-13-9-17(27-2)18(28-3)10-16(13)23-11-24-19/h5-6,8-11H,4,7H2,1-3H3,(H2,22,25,26)	VPBYZLCHOKSGRX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005044	BAY 87-2243	C26H26F3N7O2	3.8761	67377767		Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cc(N2CCN(C3CC3)CC2)ncc1	InChI=1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3	CDJNNOJINJAXPV-UHFFFAOYSA-N					doublet; compound annotation
0391_005045	BAY 87-2243	C26H26F3N7O2	3.8809	67377767		Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cc(N2CCN(C3CC3)CC2)ncc1	InChI=1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3	CDJNNOJINJAXPV-UHFFFAOYSA-N					doublet; compound annotation
0391_005046	TTA-Q6(isomer)	C20H15ClF3N3O	4.5612	124404458	C1CC1[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)N2CC(F)(F)F)C4=CC=C(C=C4)C#N	N#Cc1ccc(C2(C3CC3)c3cc(Cl)ccc3NC(=O)N2CC(F)(F)F)cc1	InChI=1S/C20H15ClF3N3O/c21-15-7-8-17-16(9-15)20(14-5-6-14,13-3-1-12(10-25)2-4-13)27(18(28)26-17)11-19(22,23)24/h1-4,7-9,14H,5-6,11H2,(H,26,28)/t20-/m0/s1	OVRNWJYZCIAMGV-FQEVSTJZSA-N					compound annotation
0391_005047	PF-3758309	C25H30N8OS	1.7342	25227462	CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)N[C@H](CN(C)C)C5=CC=CC=C5)SC=C2	Cc1nc2c(scc2)c(Nc2n[nH]c3c2CN(C(=O)NC(CN(C)C)c2ccccc2)C3(C)C)n1	InChI=1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1	AYCPARAPKDAOEN-LJQANCHMSA-N					compound annotation
0391_005048	s49076	C22H22N4O4S	2.0596	49870909	C1COCCN1CC2=CNC(=C2)/C=C\3/C4=C(C=CC(=C4)CN5C(=O)CSC5=O)NC3=O	O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2C1=Cc1cc(CN2CCOCC2)c[nH]1	InChI=1S/C22H22N4O4S/c27-20-13-31-22(29)26(20)12-14-1-2-19-17(8-14)18(21(28)24-19)9-16-7-15(10-23-16)11-25-3-5-30-6-4-25/h1-2,7-10,23H,3-6,11-13H2,(H,24,28)/b18-9-	AREYWCZYVPSHGS-NVMNQCDNSA-N					doublet; compound annotation
0391_005049	s49076	C22H22N4O4S	2.0628	49870909	C1COCCN1CC2=CNC(=C2)/C=C\3/C4=C(C=CC(=C4)CN5C(=O)CSC5=O)NC3=O	O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2C1=Cc1cc(CN2CCOCC2)c[nH]1	InChI=1S/C22H22N4O4S/c27-20-13-31-22(29)26(20)12-14-1-2-19-17(8-14)18(21(28)24-19)9-16-7-15(10-23-16)11-25-3-5-30-6-4-25/h1-2,7-10,23H,3-6,11-13H2,(H,24,28)/b18-9-	AREYWCZYVPSHGS-NVMNQCDNSA-N					doublet; compound annotation
0391_005050	s49076	C22H22N4O4S	2.4181	49870909	C1COCCN1CC2=CNC(=C2)/C=C\3/C4=C(C=CC(=C4)CN5C(=O)CSC5=O)NC3=O	O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2C1=Cc1cc(CN2CCOCC2)c[nH]1	InChI=1S/C22H22N4O4S/c27-20-13-31-22(29)26(20)12-14-1-2-19-17(8-14)18(21(28)24-19)9-16-7-15(10-23-16)11-25-3-5-30-6-4-25/h1-2,7-10,23H,3-6,11-13H2,(H,24,28)/b18-9-	AREYWCZYVPSHGS-NVMNQCDNSA-N					doublet; removed another duplicate entry; compound annotation
0391_005052	CZC24832	C15H17FN6O2S	2.595	42623951		CC(C)(C)NS(=O)(=O)c1cncc(-c2cn3nc(N)nc3c(F)c2)c1	InChI=1S/C15H17FN6O2S/c1-15(2,3)21-25(23,24)11-4-9(6-18-7-11)10-5-12(16)13-19-14(17)20-22(13)8-10/h4-8,21H,1-3H3,(H2,17,20)	RXRZPHQBTHQXSV-UHFFFAOYSA-N					compound annotation
0391_005053	Pizotifen	C19H21NS	3.0264	27400		CN1CCC(=C2c3ccccc3CCc3c2ccs3)CC1	InChI=1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3	FIADGNVRKBPQEU-UHFFFAOYSA-N					doublet; compound annotation
0391_005054	Pizotifen	C19H21NS	3.0972	27400		CN1CCC(=C2c3ccccc3CCc3c2ccs3)CC1	InChI=1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3	FIADGNVRKBPQEU-UHFFFAOYSA-N					doublet; compound annotation
0391_005055	RSV604 racemate	C22H17FN4O2	3.8265	5279171		O=C(Nc1ccccc1F)NC1N=C(c2ccccc2)c2ccccc2NC1=O	InChI=1S/C22H17FN4O2/c23-16-11-5-7-13-18(16)25-22(29)27-20-21(28)24-17-12-6-4-10-15(17)19(26-20)14-8-2-1-3-9-14/h1-13,20H,(H,24,28)(H2,25,27,29)	MTPVBMVUENFFLL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005057	Terbuthylazine	C9H16ClN5	3.8448	22206		CCNc1nc(NC(C)(C)C)nc(Cl)n1	InChI=1S/C9H16ClN5/c1-5-11-7-12-6(10)13-8(14-7)15-9(2,3)4/h5H2,1-4H3,(H2,11,12,13,14,15)	FZXISNSWEXTPMF-UHFFFAOYSA-N					compound annotation
0391_005058	Senicapoc	C20H15F2NO	4.4531	216327		NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1	InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24)	SCTZUZTYRMOMKT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005060	1228690-19-4	C27H23ClN2O5	4.5615	46240292	CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)C4=CC=C(C=C4)CC(=O)O	Cc1noc(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)c1NC(=O)OC(C)c1ccccc1Cl	InChI=1S/C27H23ClN2O5/c1-16-25(29-27(33)34-17(2)22-5-3-4-6-23(22)28)26(35-30-16)21-13-11-20(12-14-21)19-9-7-18(8-10-19)15-24(31)32/h3-14,17H,15H2,1-2H3,(H,29,33)(H,31,32)/t17-/m1/s1	WWQTWEWAPUCDDZ-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_005062	pindolol	C14H20N2O2	1.3718	4828		CC(C)NCC(O)COc1cccc2c1cc[nH]2	InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3	JZQKKSLKJUAGIC-UHFFFAOYSA-N					doublet; compound annotation
0391_005063	pindolol	C14H20N2O2	1.3745	4828		CC(C)NCC(O)COc1cccc2c1cc[nH]2	InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3	JZQKKSLKJUAGIC-UHFFFAOYSA-N					doublet; compound annotation
0391_005064	PJ34	C17H17N3O2	1.4068	4858		CN(C)CC(=O)Nc1cc2c(cc1)[nH]c(=O)c1ccccc12	InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22)	UYJZZVDLGDDTCL-UHFFFAOYSA-N					doublet; compound annotation
0391_005065	LXS196	C22H23F3N8O	1.9012	118873253		CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3c(C(F)(F)F)cccn3)cnc2N)CC1	InChI=1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34)	XXJXHXJWQSCNPX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005067	(R)-quinacrine	C23H30ClN3O	1.9269	446536	CCN(CC)CCC[C@@H](C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC	CCN(CC)CCCC(C)Nc1c2cc(OC)ccc2nc2c1ccc(Cl)c2	InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)/t16-/m1/s1	GPKJTRJOBQGKQK-MRXNPFEDSA-N					doublet; compound annotation
0391_005068	(R)-quinacrine	C23H30ClN3O	2.3381	446536	CCN(CC)CCC[C@@H](C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC	CCN(CC)CCCC(C)Nc1c2cc(OC)ccc2nc2c1ccc(Cl)c2	InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)/t16-/m1/s1	GPKJTRJOBQGKQK-MRXNPFEDSA-N					doublet; compound annotation
0391_005069	ASP3026	C29H40N8O3S	2.3381	25134326		COc1c(Nc2ncnc(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34)	MGGBYMDAPCCKCT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005072	JNJ-46281222	C23H25F3N4	2.527	49822115		FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C23H25F3N4/c24-23(25,26)21-19(10-13-30-20(14-16-6-7-16)27-28-22(21)30)15-29-11-8-18(9-12-29)17-4-2-1-3-5-17/h1-5,10,13,16,18H,6-9,11-12,14-15H2	LYDKDODJIBQNLK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005074	Brofaromine	C14H16BrNO2	2.7152	44571		COc1cc(Br)c2oc(C3CCNCC3)cc2c1	InChI=1S/C14H16BrNO2/c1-17-11-6-10-7-13(9-2-4-16-5-3-9)18-14(10)12(15)8-11/h6-9,16H,2-5H2,1H3	WZXHSWVDAYOFPE-UHFFFAOYSA-N					compound annotation
0391_005075	propoxur	C11H15NO3	2.9489	4944		CNC(=O)Oc1ccccc1OC(C)C	InChI=1S/C11H15NO3/c1-8(2)14-9-6-4-5-7-10(9)15-11(13)12-3/h4-8H,1-3H3,(H,12,13)	ISRUGXGCCGIOQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005077	XANOMELINE	C14H23N3OS	3.2671	60809		CCCCCCOc1nsnc1C1=CCCN(C)C1	InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3	JOLJIIDDOBNFHW-UHFFFAOYSA-N					doublet; compound annotation
0391_005078	XANOMELINE	C14H23N3OS	3.3968	60809		CCCCCCOc1nsnc1C1=CCCN(C)C1	InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3	JOLJIIDDOBNFHW-UHFFFAOYSA-N					doublet; compound annotation
0391_005079	862812-98-4	C22H19N3O5S2	3.6149	11626927		COc1c(OC)cc2c(c1)ncn2-c1cc(OCc2ccccc2S(C)(=O)=O)c(C#N)s1	InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3	LDTAHRLHGHFHKP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005082	JNJ-46281222	C23H25F3N4	4.1003	49822115		FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C23H25F3N4/c24-23(25,26)21-19(10-13-30-20(14-16-6-7-16)27-28-22(21)30)15-29-11-8-18(9-12-29)17-4-2-1-3-5-17/h1-5,10,13,16,18H,6-9,11-12,14-15H2	LYDKDODJIBQNLK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005084	JNJ-46281222	C23H25F3N4	4.3196	49822115		FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C23H25F3N4/c24-23(25,26)21-19(10-13-30-20(14-16-6-7-16)27-28-22(21)30)15-29-11-8-18(9-12-29)17-4-2-1-3-5-17/h1-5,10,13,16,18H,6-9,11-12,14-15H2	LYDKDODJIBQNLK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005086	JNJ-46281222	C23H25F3N4	4.3984	49822115		FC(F)(F)c1c(CN2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C23H25F3N4/c24-23(25,26)21-19(10-13-30-20(14-16-6-7-16)27-28-22(21)30)15-29-11-8-18(9-12-29)17-4-2-1-3-5-17/h1-5,10,13,16,18H,6-9,11-12,14-15H2	LYDKDODJIBQNLK-UHFFFAOYSA-N					doublet; compound annotation
0391_005087	PBD-150	C15H20N4O2S	1.3214	6539196		COc1c(OC)cc(NC(=S)NCCCn2ccnc2)cc1	InChI=1S/C15H20N4O2S/c1-20-13-5-4-12(10-14(13)21-2)18-15(22)17-6-3-8-19-9-7-16-11-19/h4-5,7,9-11H,3,6,8H2,1-2H3,(H2,17,18,22)	FZQXMGLQANXZRP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005089	Apilimod	C23H26N6O2	3.0234	10173277	CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4	Cc1cc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)ccc1	InChI=1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+	HSKAZIJJKRAJAV-KOEQRZSOSA-N					doublet; removed another duplicate entry; compound annotation
0391_005092	ROCK Inhibitor	C18H13ClF2N6O	3.1969	11524200		Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12	InChI=1S/C18H13ClF2N6O/c1-8-7-24-17-15(8)12(2-3-23-17)28-16-10(20)4-9(5-11(16)21)25-14-6-13(19)26-18(22)27-14/h2-7H,1H3,(H,23,24)(H3,22,25,26,27)	NRSGWEVTVGZDFC-UHFFFAOYSA-N					compound annotation
0391_005093	UPGL00004	C25H26N8O2S2	3.5333	121256411		O=C(Cc1ccccc1)Nc1nnc(NC2CCN(c3nnc(NC(=O)Cc4ccccc4)s3)CC2)s1	InChI=1S/C25H26N8O2S2/c34-20(15-17-7-3-1-4-8-17)27-23-30-29-22(36-23)26-19-11-13-33(14-12-19)25-32-31-24(37-25)28-21(35)16-18-9-5-2-6-10-18/h1-10,19H,11-16H2,(H,26,29)(H,27,30,34)(H,28,31,35)	MRYCNTHLPRENBA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005095	AZD1981	C19H17ClN2O3S	3.8959	11292191		CC(=O)Nc1c2c(Sc3ccc(Cl)cc3)c(C)n(CC(=O)O)c2ccc1	InChI=1S/C19H17ClN2O3S/c1-11-19(26-14-8-6-13(20)7-9-14)18-15(21-12(2)23)4-3-5-16(18)22(11)10-17(24)25/h3-9H,10H2,1-2H3,(H,21,23)(H,24,25)	JWYIGNODXSRKGP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005098	IMR-1	C15H15NO5S2	3.9337	1246059	CCOC(=O)COC1=C(C=C(C=C1)/C=C/2\C(=O)NC(=S)S2)OC	CCOC(=O)COc1c(OC)cc(C=C2SC(=S)NC2=O)cc1	InChI=1S/C15H15NO5S2/c1-3-20-13(17)8-21-10-5-4-9(6-11(10)19-2)7-12-14(18)16-15(22)23-12/h4-7H,3,8H2,1-2H3,(H,16,18,22)/b12-7+	QHPJWPQRZMBKTG-KPKJPENVSA-N					doublet; compound annotation
0391_005099	IMR-1	C15H15NO5S2	3.9629	1246059	CCOC(=O)COC1=C(C=C(C=C1)/C=C/2\C(=O)NC(=S)S2)OC	CCOC(=O)COc1c(OC)cc(C=C2SC(=S)NC2=O)cc1	InChI=1S/C15H15NO5S2/c1-3-20-13(17)8-21-10-5-4-9(6-11(10)19-2)7-12-14(18)16-15(22)23-12/h4-7H,3,8H2,1-2H3,(H,16,18,22)/b12-7+	QHPJWPQRZMBKTG-KPKJPENVSA-N					doublet; compound annotation
0391_005100	IMR-1	C15H15NO5S2	3.9684	1246059	CCOC(=O)COC1=C(C=C(C=C1)/C=C/2\C(=O)NC(=S)S2)OC	CCOC(=O)COc1c(OC)cc(C=C2SC(=S)NC2=O)cc1	InChI=1S/C15H15NO5S2/c1-3-20-13(17)8-21-10-5-4-9(6-11(10)19-2)7-12-14(18)16-15(22)23-12/h4-7H,3,8H2,1-2H3,(H,16,18,22)/b12-7+	QHPJWPQRZMBKTG-KPKJPENVSA-N					doublet; compound annotation
0391_005101	CCT020312	C31H30Br2N4O2	4.0552	3108148		CCN(CC)CCC(=O)N1N=C(c2c(-c3ccccc3)c3cc(Br)ccc3[nH]c2=O)CC1c1ccc(Br)cc1	InChI=1S/C31H30Br2N4O2/c1-3-36(4-2)17-16-28(38)37-27(20-10-12-22(32)13-11-20)19-26(35-37)30-29(21-8-6-5-7-9-21)24-18-23(33)14-15-25(24)34-31(30)39/h5-15,18,27H,3-4,16-17,19H2,1-2H3,(H,34,39)	OAXDKXMGESZLKV-UHFFFAOYSA-N					compound annotation
0391_005102	Enclomiphene	C26H28ClNO	4.1655	1548953	CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1	InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+	GKIRPKYJQBWNGO-OCEACIFDSA-N					doublet; compound annotation
0391_005103	SAFit1	C42H53NO11	5.3263	86277875	COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCC(=O)O)OC(=O)[C@@H]3CCCCN3C(=O)[C@@H](C4CCCCC4)C5=CC(=C(C(=C5)OC)OC)OC)OC	COc1c(OC)cc(CCC(OC(=O)C2CCCCN2C(=O)C(c2cc(OC)c(OC)c(OC)c2)C2CCCCC2)c2cc(OCC(=O)O)ccc2)cc1	InChI=1S/C42H53NO11/c1-48-34-20-18-27(22-35(34)49-2)17-19-33(29-14-11-15-31(23-29)53-26-38(44)45)54-42(47)32-16-9-10-21-43(32)41(46)39(28-12-7-6-8-13-28)30-24-36(50-3)40(52-5)37(25-30)51-4/h11,14-15,18,20,22-25,28,32-33,39H,6-10,12-13,16-17,19,21,26H2,1-5H3,(H,44,45)/t32-,33+,39-/m0/s1	OEQZPFWOEOOISR-AKTKKGGCSA-N					removed another duplicate entry; compound annotation
0391_005105	EPZ011989	C35H51N5O4	1.7987	73670548		CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCC(N(C)CCOC)CC1	InChI=1S/C35H51N5O4/c1-7-40(30-12-10-29(11-13-30)38(5)15-18-43-6)33-23-28(9-8-14-39-16-19-44-20-17-39)22-31(27(33)4)34(41)36-24-32-25(2)21-26(3)37-35(32)42/h21-23,29-30H,7,10-20,24H2,1-6H3,(H,36,41)(H,37,42)	XQFINGFCBFHOPE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005107	capmatinib	C23H17FN6O	1.9787	25145656		CNC(=O)c1c(F)cc(-c2nn3c(Cc4cc5c(cc4)nccc5)cnc3nc2)cc1	InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)	LIOLIMKSCNQPLV-UHFFFAOYSA-N					doublet; compound annotation
0391_005108	EPZ011989	C35H51N5O4	1.9787	73670548		CCN(c1cc(C#CCN2CCOCC2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCC(N(C)CCOC)CC1	InChI=1S/C35H51N5O4/c1-7-40(30-12-10-29(11-13-30)38(5)15-18-43-6)33-23-28(9-8-14-39-16-19-44-20-17-39)22-31(27(33)4)34(41)36-24-32-25(2)21-26(3)37-35(32)42/h21-23,29-30H,7,10-20,24H2,1-6H3,(H,36,41)(H,37,42)	XQFINGFCBFHOPE-UHFFFAOYSA-N					doublet; compound annotation
0391_005109	capmatinib	C23H17FN6O	1.9816	25145656		CNC(=O)c1c(F)cc(-c2nn3c(Cc4cc5c(cc4)nccc5)cnc3nc2)cc1	InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)	LIOLIMKSCNQPLV-UHFFFAOYSA-N					doublet; compound annotation
0391_005110	Bucetin	C12H17NO3	2.2738	14130		CCOc1ccc(NC(=O)CC(C)O)cc1	InChI=1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15)	LIAWQASKBFCRNR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005113	MEBROFENIN	C15H19BrN2O5	2.7621	54158		Cc1c(Br)c(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1	InChI=1S/C15H19BrN2O5/c1-8-4-9(2)15(10(3)14(8)16)17-11(19)5-18(6-12(20)21)7-13(22)23/h4H,5-7H2,1-3H3,(H,17,19)(H,20,21)(H,22,23)	MHPZZZZLAQGTHT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005115	ML347	C22H16N4O	2.9774	44577753		COc1ccc(-c2cn3ncc(-c4cccc5ncccc45)c3nc2)cc1	InChI=1S/C22H16N4O/c1-27-17-9-7-15(8-10-17)16-12-24-22-20(13-25-26(22)14-16)18-4-2-6-21-19(18)5-3-11-23-21/h2-14H,1H3	FVRYPYDPKSZGNS-UHFFFAOYSA-N					doublet; compound annotation
0391_005116	ML347	C22H16N4O	2.9801	44577753		COc1ccc(-c2cn3ncc(-c4cccc5ncccc45)c3nc2)cc1	InChI=1S/C22H16N4O/c1-27-17-9-7-15(8-10-17)16-12-24-22-20(13-25-26(22)14-16)18-4-2-6-21-19(18)5-3-11-23-21/h2-14H,1H3	FVRYPYDPKSZGNS-UHFFFAOYSA-N					doublet; compound annotation
0391_005117	PD0166285	C26H27Cl2N5O2	3.2604	5311382		CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1	InChI=1S/C26H27Cl2N5O2/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31)	IFPPYSWJNWHOLQ-UHFFFAOYSA-N					compound annotation
0391_005118	tolazamide	C14H21N3O3S	3.4732	5503		Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1	InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)	OUDSBRTVNLOZBN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005120	sulfinpyrazone	C23H20N2O3S	3.6799	5342		O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2	MBGGBVCUIVRRBF-UHFFFAOYSA-N					doublet; compound annotation
0391_005121	sulfinpyrazone	C23H20N2O3S	4.8841	5342		O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1	InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2	MBGGBVCUIVRRBF-UHFFFAOYSA-N					doublet; compound annotation
0391_005122	4-Methylbenzylidene camphor	C18H22O	5.5653	6440721	CC1=CC=C(C=C1)/C=C\2/C3CCC(C2=O)(C3(C)C)C	Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1	InChI=1S/C18H22O/c1-12-5-7-13(8-6-12)11-14-15-9-10-18(4,16(14)19)17(15,2)3/h5-8,11,15H,9-10H2,1-4H3/b14-11-	HEOCBCNFKCOKBX-KAMYIIQDSA-N					doublet; compound annotation
0391_005123	4-Methylbenzylidene camphor	C18H22O	5.874	6440721	CC1=CC=C(C=C1)/C=C\2/C3CCC(C2=O)(C3(C)C)C	Cc1ccc(C=C2C(=O)C3(C)CCC2C3(C)C)cc1	InChI=1S/C18H22O/c1-12-5-7-13(8-6-12)11-14-15-9-10-18(4,16(14)19)17(15,2)3/h5-8,11,15H,9-10H2,1-4H3/b14-11-	HEOCBCNFKCOKBX-KAMYIIQDSA-N					doublet; compound annotation
0391_005124	Golotimod	C16H19N3O5	1.4536	6992140	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CC[C@H](C(=O)O)N	NC(CCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O)C(=O)O	InChI=1S/C16H19N3O5/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24)/t11-,13+/m1/s1	CATMPQFFVNKDEY-YPMHNXCESA-N					compound annotation
0391_005125	AZD2858	C21H23N7O3S	1.7962	10138980		CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cnccc4)n3)cc2)CC1	InChI=1S/C21H23N7O3S/c1-27-9-11-28(12-10-27)32(30,31)17-6-4-15(5-7-17)18-14-24-20(22)19(26-18)21(29)25-16-3-2-8-23-13-16/h2-8,13-14H,9-12H2,1H3,(H2,22,24)(H,25,29)	FHCSBLWRGCOVPT-UHFFFAOYSA-N					compound annotation
0391_005126	skf-86002	C16H12FN3S	1.9477	5228		Fc1ccc(-c2c(-c3ccncc3)n3CCSc3n2)cc1	InChI=1S/C16H12FN3S/c17-13-3-1-11(2-4-13)14-15(12-5-7-18-8-6-12)20-9-10-21-16(20)19-14/h1-8H,9-10H2	YOELZIQOLWZLQC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005128	BDP5290	C17H18ClN7O	2.514	85325326		O=C(Nc1c(-c2ccccn2)[nH]nc1)c1nn(C2CCNCC2)cc1Cl	InChI=1S/C17H18ClN7O/c18-12-10-25(11-4-7-19-8-5-11)24-15(12)17(26)22-14-9-21-23-16(14)13-3-1-2-6-20-13/h1-3,6,9-11,19H,4-5,7-8H2,(H,21,23)(H,22,26)	BPVZKUXLOLRECL-UHFFFAOYSA-N					compound annotation
0391_005129	YKL-06-061	C30H37N7O2	2.9847	132992144		COc1c(Nc2ncc3CN(c4c(C)cccc4C)C(=O)N(C4CCC4)c3n2)ccc(N2CCN(C)CC2)c1	InChI=1S/C30H37N7O2/c1-20-7-5-8-21(2)27(20)36-19-22-18-31-29(33-28(22)37(30(36)38)23-9-6-10-23)32-25-12-11-24(17-26(25)39-4)35-15-13-34(3)14-16-35/h5,7-8,11-12,17-18,23H,6,9-10,13-16,19H2,1-4H3,(H,31,32,33)	GVBAXIVNAHMIGH-UHFFFAOYSA-N					doublet; compound annotation
0391_005130	YKL-06-061	C30H37N7O2	2.9888	132992144		COc1c(Nc2ncc3CN(c4c(C)cccc4C)C(=O)N(C4CCC4)c3n2)ccc(N2CCN(C)CC2)c1	InChI=1S/C30H37N7O2/c1-20-7-5-8-21(2)27(20)36-19-22-18-31-29(33-28(22)37(30(36)38)23-9-6-10-23)32-25-12-11-24(17-26(25)39-4)35-15-13-34(3)14-16-35/h5,7-8,11-12,17-18,23H,6,9-10,13-16,19H2,1-4H3,(H,31,32,33)	GVBAXIVNAHMIGH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005132	amlodipine	C20H25ClN2O5	3.1491	2162		CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl	InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3	HTIQEAQVCYTUBX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005134	Ningetinib	C31H29FN4O5	3.1938	60165029		Cc1c(C(=O)Nc2cc(F)c(Oc3ccnc4cc(OCC(C)(C)O)ccc34)cc2)c(=O)n(-c2ccccc2)n1C	InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(35(19)4)21-8-6-5-7-9-21)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(11-12-23(25)26)40-18-31(2,3)39/h5-17,39H,18H2,1-4H3,(H,34,37)	VQYYQSZNRVQLIS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005136	YKL-06-061	C30H37N7O2	3.565	132992144		COc1c(Nc2ncc3CN(c4c(C)cccc4C)C(=O)N(C4CCC4)c3n2)ccc(N2CCN(C)CC2)c1	InChI=1S/C30H37N7O2/c1-20-7-5-8-21(2)27(20)36-19-22-18-31-29(33-28(22)37(30(36)38)23-9-6-10-23)32-25-12-11-24(17-26(25)39-4)35-15-13-34(3)14-16-35/h5,7-8,11-12,17-18,23H,6,9-10,13-16,19H2,1-4H3,(H,31,32,33)	GVBAXIVNAHMIGH-UHFFFAOYSA-N					doublet; compound annotation
0391_005137	LDC1267	C30H26F2N4O5	3.8912	56847486		CCOc1cn(-c2c(C)cc(F)cc2)nc1C(=O)Nc1cc(F)c(Oc2ccnc3cc(OC)c(OC)cc23)cc1	InChI=1S/C30H26F2N4O5/c1-5-40-28-16-36(23-8-6-18(31)12-17(23)2)35-29(28)30(37)34-19-7-9-25(21(32)13-19)41-24-10-11-33-22-15-27(39-4)26(38-3)14-20(22)24/h6-16H,5H2,1-4H3,(H,34,37)	ISPBCAXOSOLFME-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005139	pyroxamide	C13H19N3O3	0.7922	4996		O=C(CCCCCCC(=O)Nc1cnccc1)NO	InChI=1S/C13H19N3O3/c17-12(15-11-6-5-9-14-10-11)7-3-1-2-4-8-13(18)16-19/h5-6,9-10,19H,1-4,7-8H2,(H,15,17)(H,16,18)	PTJGLFIIZFVFJV-UHFFFAOYSA-N					compound annotation
0391_005140	iodixanol	C35H44I6N6O15	1.0741	3724		CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)	NBQNWMBBSKPBAY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005142	iodixanol	C35H44I6N6O15	1.1818	3724		CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I	InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)	NBQNWMBBSKPBAY-UHFFFAOYSA-N					doublet; compound annotation
0391_005143	67287-49-4	C16H17NO2	1.4128	1242		Oc1c(O)cc2c(c1)CCNCC2c1ccccc1	InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2	JUDKOGFHZYMDMF-UHFFFAOYSA-N					compound annotation
0391_005144	Acetrizoic acid	C9H6I3NO3	1.576	6806		CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I	InChI=1S/C9H6I3NO3/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16/h2H,1H3,(H,13,14)(H,15,16)	GNOGSFBXBWBTIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005146	Eprobemide	C14H19ClN2O2	1.693	65659		O=C(NCCCN1CCOCC1)c1ccc(Cl)cc1	InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18)	YYFGRAGNYHYWEZ-UHFFFAOYSA-N					compound annotation
0391_005147	1301214-47-0	C23H27N5O2	1.8163	52934180		Cc1nc2c(cc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2)[nH]1	InChI=1S/C23H27N5O2/c1-14(2)28-21-17(13-24-28)11-23(12-20(21)29)6-8-27(9-7-23)22(30)16-4-5-18-19(10-16)26-15(3)25-18/h4-5,10,13-14H,6-9,11-12H2,1-3H3,(H,25,26)	BDXXSFOJPYSYOC-UHFFFAOYSA-N					doublet; compound annotation
0391_005148	1301214-47-0	C23H27N5O2	2.2881	52934180		Cc1nc2c(cc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2)[nH]1	InChI=1S/C23H27N5O2/c1-14(2)28-21-17(13-24-28)11-23(12-20(21)29)6-8-27(9-7-23)22(30)16-4-5-18-19(10-16)26-15(3)25-18/h4-5,10,13-14H,6-9,11-12H2,1-3H3,(H,25,26)	BDXXSFOJPYSYOC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005150	TOZADENANT	C19H26N4O4S	2.7967	11618368		COc1c2nc(NC(=O)N3CCC(C)(O)CC3)sc2c(N2CCOCC2)cc1	InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)	XNBRWUQWSKXMPW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005152	TOZADENANT	C19H26N4O4S	2.7999	11618368		COc1c2nc(NC(=O)N3CCC(C)(O)CC3)sc2c(N2CCOCC2)cc1	InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)	XNBRWUQWSKXMPW-UHFFFAOYSA-N					doublet; compound annotation
0391_005153	ONO-7300243	C28H31NO5	4.7384	66775043		COc1cc(C(=O)N(CCCc2ccccc2)Cc2ccc(CC(=O)O)cc2)cc(OC)c1C	InChI=1S/C28H31NO5/c1-20-25(33-2)17-24(18-26(20)34-3)28(32)29(15-7-10-21-8-5-4-6-9-21)19-23-13-11-22(12-14-23)16-27(30)31/h4-6,8-9,11-14,17-18H,7,10,15-16,19H2,1-3H3,(H,30,31)	WGABOZPQOOZAOI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005155	sulfamerazine	C11H12N4O2S	1.3109	5325		Cc1nc(NS(=O)(=O)c2ccc(N)cc2)ncc1	InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	QPPBRPIAZZHUNT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005157	Nampt-IN-1	C20H25N3O5S	1.6365	92044379		CC(C)(O)CS(=O)(=O)Nc1cc2c(cc1)CN(C(=O)COc1cnccc1)CC2	InChI=1S/C20H25N3O5S/c1-20(2,25)14-29(26,27)22-17-6-5-16-12-23(9-7-15(16)10-17)19(24)13-28-18-4-3-8-21-11-18/h3-6,8,10-11,22,25H,7,9,12-14H2,1-2H3	QHHSCLARESIWBH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005159	Prim-O-glucosylcimifugin	C22H28O11	1.7105	14034912	CC(C)([C@@H]1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1c2c(=O)cc(COC3OC(CO)C(O)C(O)C3O)oc2cc2c1CC(C(C)(C)O)O2	InChI=1S/C22H28O11/c1-22(2,28)15-5-10-12(32-15)6-13-16(20(10)29-3)11(24)4-9(31-13)8-30-21-19(27)18(26)17(25)14(7-23)33-21/h4,6,14-15,17-19,21,23,25-28H,5,7-8H2,1-3H3/t14-,15+,17-,18+,19-,21-/m1/s1	XIUVHOSBSDYXRG-UVTAEQIVSA-N					removed another duplicate entry; compound annotation
0391_005161	Articaine	C13H20N2O3S	1.7543	32170		CCCNC(C)C(=O)Nc1c(C(=O)OC)scc1C	InChI=1S/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4/h7,9,14H,5-6H2,1-4H3,(H,15,16)	QTGIAADRBBLJGA-UHFFFAOYSA-N					doublet; compound annotation
0391_005162	Articaine	C13H20N2O3S	1.7571	32170		CCCNC(C)C(=O)Nc1c(C(=O)OC)scc1C	InChI=1S/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4/h7,9,14H,5-6H2,1-4H3,(H,15,16)	QTGIAADRBBLJGA-UHFFFAOYSA-N					doublet; compound annotation
0391_005163	(S)-Ketorolac	C15H13NO3	3.1472	181817	C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)[C@H]1C(=O)O	O=C(c1ccccc1)c1ccc2C(C(=O)O)CCn12	InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/t11-/m0/s1	OZWKMVRBQXNZKK-NSHDSACASA-N					compound annotation
0391_005164	Altrenogest	C21H26O2	3.5116	10041070	C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC=C)O	C=CCC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C	InChI=1S/C21H26O2/c1-3-10-21(23)12-9-19-18-6-4-14-13-15(22)5-7-16(14)17(18)8-11-20(19,21)2/h3,8,11,13,18-19,23H,1,4-7,9-10,12H2,2H3/t18-,19+,20+,21+/m1/s1	VWAUPFMBXBWEQY-ANULTFPQSA-N					doublet; compound annotation
0391_005165	Epothilone D	C27H41NO5S	3.9021	447865	C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C	CC1=CCC(C(C)=Cc2csc(C)n2)OC(=O)CC(O)C(C)(C)C(=O)C(C)C(O)C(C)CCC1	InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1	XOZIUKBZLSUILX-GIQCAXHBSA-N					doublet; compound annotation
0391_005166	Altrenogest	C21H26O2	3.9923	10041070	C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC=C)O	C=CCC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21C	InChI=1S/C21H26O2/c1-3-10-21(23)12-9-19-18-6-4-14-13-15(22)5-7-16(14)17(18)8-11-20(19,21)2/h3,8,11,13,18-19,23H,1,4-7,9-10,12H2,2H3/t18-,19+,20+,21+/m1/s1	VWAUPFMBXBWEQY-ANULTFPQSA-N					doublet; removed another duplicate entry; compound annotation
0391_005168	Epothilone D	C27H41NO5S	4.664	447865	C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C	CC1=CCC(C(C)=Cc2csc(C)n2)OC(=O)CC(O)C(C)(C)C(=O)C(C)C(O)C(C)CCC1	InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1	XOZIUKBZLSUILX-GIQCAXHBSA-N					doublet; compound annotation
0391_005169	Epothilone D	C27H41NO5S	4.7278	447865	C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C	CC1=CCC(C(C)=Cc2csc(C)n2)OC(=O)CC(O)C(C)(C)C(=O)C(C)C(O)C(C)CCC1	InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1	XOZIUKBZLSUILX-GIQCAXHBSA-N					doublet; compound annotation
0391_005170	Epothilone D	C27H41NO5S	4.8645	447865	C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C	CC1=CCC(C(C)=Cc2csc(C)n2)OC(=O)CC(O)C(C)(C)C(=O)C(C)C(O)C(C)CCC1	InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1	XOZIUKBZLSUILX-GIQCAXHBSA-N					doublet; compound annotation
0391_005171	Epothilone D	C27H41NO5S	4.9328	447865	C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C	CC1=CCC(C(C)=Cc2csc(C)n2)OC(=O)CC(O)C(C)(C)C(=O)C(C)C(O)C(C)CCC1	InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1	XOZIUKBZLSUILX-GIQCAXHBSA-N					doublet; removed another duplicate entry; compound annotation
0391_005173	Tyrphostin A46	C10H8N2O3	1.2932	5328768	C1=CC(=C(C=C1/C=C(\C#N)/C(=O)N)O)O	N#CC(=Cc1cc(O)c(O)cc1)C(N)=O	InChI=1S/C10H8N2O3/c11-5-7(10(12)15)3-6-1-2-8(13)9(14)4-6/h1-4,13-14H,(H2,12,15)/b7-3+	USOXQZNJFMKTKJ-XVNBXDOJSA-N					compound annotation
0391_005174	7-Chlorokynurenic acid	C10H6ClNO3	1.7357	1884		O=C(O)c1cc(=O)c2c(cc(Cl)cc2)[nH]1	InChI=1S/C10H6ClNO3/c11-5-1-2-6-7(3-5)12-8(10(14)15)4-9(6)13/h1-4H,(H,12,13)(H,14,15)	UAWVRVFHMOSAPU-UHFFFAOYSA-N					doublet; compound annotation
0391_005175	Glutaminyl Cyclase Inhibitor 1	C21H24FN3O2	2.9574	134691747		COc1c(OC)cc(-c2cccc(F)c2NCCCn2cnc(C)c2)cc1	InChI=1S/C21H24FN3O2/c1-15-13-25(14-24-15)11-5-10-23-21-17(6-4-7-18(21)22)16-8-9-19(26-2)20(12-16)27-3/h4,6-9,12-14,23H,5,10-11H2,1-3H3	QBJVKQMFLLMSJR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005177	VH-298	C27H33N5O4S	3.1654	122199236	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)C#N)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)C3(C#N)CC3)C(C)(C)C)cc2)scn1	InChI=1S/C27H33N5O4S/c1-16-21(37-15-30-16)18-7-5-17(6-8-18)12-29-23(34)20-11-19(33)13-32(20)24(35)22(26(2,3)4)31-25(36)27(14-28)9-10-27/h5-8,15,19-20,22,33H,9-13H2,1-4H3,(H,29,34)(H,31,36)/t19-,20+,22-/m1/s1	NDVQUNZCNAMROD-RZUBCFFCSA-N					doublet; compound annotation
0391_005178	VH-298	C27H33N5O4S	3.1687	122199236	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)C#N)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)C3(C#N)CC3)C(C)(C)C)cc2)scn1	InChI=1S/C27H33N5O4S/c1-16-21(37-15-30-16)18-7-5-17(6-8-18)12-29-23(34)20-11-19(33)13-32(20)24(35)22(26(2,3)4)31-25(36)27(14-28)9-10-27/h5-8,15,19-20,22,33H,9-13H2,1-4H3,(H,29,34)(H,31,36)/t19-,20+,22-/m1/s1	NDVQUNZCNAMROD-RZUBCFFCSA-N					doublet; compound annotation
0391_005179	Tyrphostin AG 528	C18H14N2O3	3.2001	1838043	C1CN(C2=CC=CC=C21)C(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)N1CCc2ccccc21	InChI=1S/C18H14N2O3/c19-11-14(9-12-5-6-16(21)17(22)10-12)18(23)20-8-7-13-3-1-2-4-15(13)20/h1-6,9-10,21-22H,7-8H2/b14-9+	MYKCTDWWIWGLHW-NTEUORMPSA-N					doublet; compound annotation
0391_005180	MY-5445	C20H14ClN3	3.2421	1348		Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1	InChI=1S/C20H14ClN3/c21-15-9-6-10-16(13-15)22-20-18-12-5-4-11-17(18)19(23-24-20)14-7-2-1-3-8-14/h1-13H,(H,22,24)	CEHQLKSLMFIHBF-UHFFFAOYSA-N					compound annotation
0391_005181	Tyrphostin AG 528	C18H14N2O3	3.4746	1838043	C1CN(C2=CC=CC=C21)C(=O)/C(=C/C3=CC(=C(C=C3)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)N1CCc2ccccc21	InChI=1S/C18H14N2O3/c19-11-14(9-12-5-6-16(21)17(22)10-12)18(23)20-8-7-13-3-1-2-4-15(13)20/h1-6,9-10,21-22H,7-8H2/b14-9+	MYKCTDWWIWGLHW-NTEUORMPSA-N					doublet; removed another duplicate entry; compound annotation
0391_005183	GSK2193874	C37H38BrF3N4O	4.1119	53464483		O=C(NC1(c2ccccc2)CC1)c1c(CN2CCC(N3CCCCC3)CC2)c(-c2cc(C(F)(F)F)ccc2)nc2cc(Br)ccc12	InChI=1S/C37H38BrF3N4O/c38-28-12-13-30-32(23-28)42-34(25-8-7-11-27(22-25)37(39,40)41)31(24-44-20-14-29(15-21-44)45-18-5-2-6-19-45)33(30)35(46)43-36(16-17-36)26-9-3-1-4-10-26/h1,3-4,7-13,22-23,29H,2,5-6,14-21,24H2,(H,43,46)	UIVOZBSCHXCGPS-UHFFFAOYSA-N					compound annotation
0391_005184	ML402	C14H14ClNO2S	4.2973	592973		Cc1c(OCCNC(=O)c2cccs2)ccc(Cl)c1	InChI=1S/C14H14ClNO2S/c1-10-9-11(15)4-5-12(10)18-7-6-16-14(17)13-3-2-8-19-13/h2-5,8-9H,6-7H2,1H3,(H,16,17)	RULQUKFOBAPKKR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005186	WT-161	C27H30N4O3	4.351	44601455	C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=C(C=C3)/C=N/NC(=O)CCCCCCC(=O)NO	O=C(CCCCCCC(=O)NN=Cc1ccc(N(c2ccccc2)c2ccccc2)cc1)NO	InChI=1S/C27H30N4O3/c32-26(15-9-1-2-10-16-27(33)30-34)29-28-21-22-17-19-25(20-18-22)31(23-11-5-3-6-12-23)24-13-7-4-8-14-24/h3-8,11-14,17-21,34H,1-2,9-10,15-16H2,(H,29,32)(H,30,33)/b28-21+	KXWWYFKVBFUVIZ-SGWCAAJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_005188	WT-161	C27H30N4O3	4.354	44601455	C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=C(C=C3)/C=N/NC(=O)CCCCCCC(=O)NO	O=C(CCCCCCC(=O)NN=Cc1ccc(N(c2ccccc2)c2ccccc2)cc1)NO	InChI=1S/C27H30N4O3/c32-26(15-9-1-2-10-16-27(33)30-34)29-28-21-22-17-19-25(20-18-22)31(23-11-5-3-6-12-23)24-13-7-4-8-14-24/h3-8,11-14,17-21,34H,1-2,9-10,15-16H2,(H,29,32)(H,30,33)/b28-21+	KXWWYFKVBFUVIZ-SGWCAAJKSA-N					doublet; compound annotation
0391_005189	WT-161	C27H30N4O3	6.1039	44601455	C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=C(C=C3)/C=N/NC(=O)CCCCCCC(=O)NO	O=C(CCCCCCC(=O)NN=Cc1ccc(N(c2ccccc2)c2ccccc2)cc1)NO	InChI=1S/C27H30N4O3/c32-26(15-9-1-2-10-16-27(33)30-34)29-28-21-22-17-19-25(20-18-22)31(23-11-5-3-6-12-23)24-13-7-4-8-14-24/h3-8,11-14,17-21,34H,1-2,9-10,15-16H2,(H,29,32)(H,30,33)/b28-21+	KXWWYFKVBFUVIZ-SGWCAAJKSA-N					doublet; compound annotation
0391_005190	OG-L002	C15H15NO	1.9494	56639570	C1[C@@H]([C@H]1N)C2=CC=C(C=C2)C3=CC(=CC=C3)O	NC1CC1c1ccc(-c2cc(O)ccc2)cc1	InChI=1S/C15H15NO/c16-15-9-14(15)11-6-4-10(5-7-11)12-2-1-3-13(17)8-12/h1-8,14-15,17H,9,16H2/t14-,15+/m1/s1	DSOJSZXQRJGBCW-CABCVRRESA-N					compound annotation
0391_005191	Furprofen	C14H12O4	2.8609	162201		CC(C(=O)O)c1ccc(C(=O)c2ccco2)cc1	InChI=1S/C14H12O4/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)	ITJUVDBADHDNPU-UHFFFAOYSA-N					compound annotation
0391_005192	GIBH-130	C20H20N6O	3.1141	50938773		Cc1cc(-c2ccccc2)nnc1C(=O)N1CCN(c2ncccn2)CC1	InChI=1S/C20H20N6O/c1-15-14-17(16-6-3-2-4-7-16)23-24-18(15)19(27)25-10-12-26(13-11-25)20-21-8-5-9-22-20/h2-9,14H,10-13H2,1H3	ZTJHTEHADIHZJS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005194	DASA-58	C19H23N3O6S2	3.4838	44543605		Nc1cc(S(=O)(=O)N2CCCN(S(=O)(=O)c3cc4c(cc3)OCCO4)CC2)ccc1	InChI=1S/C19H23N3O6S2/c20-15-3-1-4-16(13-15)29(23,24)21-7-2-8-22(10-9-21)30(25,26)17-5-6-18-19(14-17)28-12-11-27-18/h1,3-6,13-14H,2,7-12,20H2	GMHIOMMKSMSRLY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005196	445295-04-5	C23H19FN2O7	3.5543	9955578	C[C@H](C(=O)O)OC1=CC(=C(C=C1)CNC(=O)C2=C(N=CC=C2)OC3=CC4=C(C=C3)OCO4)F	CC(Oc1cc(F)c(CNC(=O)c2cccnc2Oc2cc3c(cc2)OCO3)cc1)C(=O)O	InChI=1S/C23H19FN2O7/c1-13(23(28)29)32-15-5-4-14(18(24)9-15)11-26-21(27)17-3-2-8-25-22(17)33-16-6-7-19-20(10-16)31-12-30-19/h2-10,13H,11-12H2,1H3,(H,26,27)(H,28,29)/t13-/m1/s1	CNIGFESSDPOCKS-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_005198	306974-70-9	C27H25FN4O4S	3.7742	11692123		CCOC(=O)c1ccc(-n2cc(Cc3cnc(OCC)nc3)c(=O)nc2SCc2ccc(F)cc2)cc1	InChI=1S/C27H25FN4O4S/c1-3-35-25(34)20-7-11-23(12-8-20)32-16-21(13-19-14-29-26(30-15-19)36-4-2)24(33)31-27(32)37-17-18-5-9-22(28)10-6-18/h5-12,14-16H,3-4,13,17H2,1-2H3	PTPNCCWOTBBVJR-UHFFFAOYSA-N					doublet; compound annotation
0391_005199	306974-70-9	C27H25FN4O4S	4.429	11692123		CCOC(=O)c1ccc(-n2cc(Cc3cnc(OCC)nc3)c(=O)nc2SCc2ccc(F)cc2)cc1	InChI=1S/C27H25FN4O4S/c1-3-35-25(34)20-7-11-23(12-8-20)32-16-21(13-19-14-29-26(30-15-19)36-4-2)24(33)31-27(32)37-17-18-5-9-22(28)10-6-18/h5-12,14-16H,3-4,13,17H2,1-2H3	PTPNCCWOTBBVJR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005201	1048668-70-7	C25H31N3O3	4.5325	25006684		CC(C)(C)c1c(C(=O)NC2C3CC4CC(C3)CC2C4)cnn1-c1ccc(C(=O)O)cc1	InChI=1S/C25H31N3O3/c1-25(2,3)22-20(13-26-28(22)19-6-4-16(5-7-19)24(30)31)23(29)27-21-17-9-14-8-15(11-17)12-18(21)10-14/h4-7,13-15,17-18,21H,8-12H2,1-3H3,(H,27,29)(H,30,31)	XWBXJBSVYVJAMZ-UHFFFAOYSA-N					compound annotation
0391_005202	celecoxib	C17H14F3N3O2S	4.551	2662		Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)	RZEKVGVHFLEQIL-UHFFFAOYSA-N					compound annotation
0391_005203	(R)-VU 6008667	C24H17ClF2N2O2	4.9792	137661122	CC1=C(C=CC(=C1)[C@]23C4=CC=CC=C4C(=O)N2CCN3C(=O)C5=CC(=C(C=C5)F)F)Cl	Cc1c(Cl)ccc(C23c4ccccc4C(=O)N2CCN3C(=O)c2cc(F)c(F)cc2)c1	InChI=1S/C24H17ClF2N2O2/c1-14-12-16(7-8-19(14)25)24-18-5-3-2-4-17(18)23(31)29(24)11-10-28(24)22(30)15-6-9-20(26)21(27)13-15/h2-9,12-13H,10-11H2,1H3/t24-/m1/s1	XMSLRELXMCKGCB-XMMPIXPASA-N					compound annotation
0391_005204	Motesanib	C22H23N5O	1.6621	11667893		CC1(C)CNc2c1ccc(NC(=O)c1cccnc1NCc1ccncc1)c2	InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)	RAHBGWKEPAQNFF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005207	Dansylamide	C12H14N2O2S	2.2219	65077		CN(C)c1cccc2c1cccc2S(N)(=O)=O	InChI=1S/C12H14N2O2S/c1-14(2)11-7-3-6-10-9(11)5-4-8-12(10)17(13,15)16/h3-8H,1-2H3,(H2,13,15,16)	TYNBFJJKZPTRKS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005209	957054-30-7	C23H27N7O3S2	2.3997	17755052		CS(=O)(=O)N1CCN(Cc2cc3c(s2)c(N2CCOCC2)nc(-c2c4cn[nH]c4ccc2)n3)CC1	InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)	LHNIIDJUOCFXAP-UHFFFAOYSA-N					doublet; compound annotation
0391_005210	957054-30-7	C23H27N7O3S2	2.403	17755052		CS(=O)(=O)N1CCN(Cc2cc3c(s2)c(N2CCOCC2)nc(-c2c4cn[nH]c4ccc2)n3)CC1	InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)	LHNIIDJUOCFXAP-UHFFFAOYSA-N					doublet; compound annotation
0391_005211	Mericitabine	C18H26FN3O6	3.0623	16122663	CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C	CC(C)C(=O)OCC1OC(n2ccc(N)nc2=O)C(C)(F)C1OC(=O)C(C)C	InChI=1S/C18H26FN3O6/c1-9(2)14(23)26-8-11-13(28-15(24)10(3)4)18(5,19)16(27-11)22-7-6-12(20)21-17(22)25/h6-7,9-11,13,16H,8H2,1-5H3,(H2,20,21,25)/t11-,13-,16-,18-/m1/s1	MLESJYFEMSJZLZ-MAAOGQSESA-N					doublet; compound annotation
0391_005212	Mericitabine	C18H26FN3O6	3.1766	16122663	CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C	CC(C)C(=O)OCC1OC(n2ccc(N)nc2=O)C(C)(F)C1OC(=O)C(C)C	InChI=1S/C18H26FN3O6/c1-9(2)14(23)26-8-11-13(28-15(24)10(3)4)18(5,19)16(27-11)22-7-6-12(20)21-17(22)25/h6-7,9-11,13,16H,8H2,1-5H3,(H2,20,21,25)/t11-,13-,16-,18-/m1/s1	MLESJYFEMSJZLZ-MAAOGQSESA-N					doublet; removed another duplicate entry; compound annotation
0391_005214	TD-198946	C27H22N4O3S	3.4861	9826550		Cn1ncc2c1-c1c(Oc3ccc(OCc4nc5ccccc5cc4)cc3)sc(C(N)=O)c1CC2	InChI=1S/C27H22N4O3S/c1-31-24-17(14-29-31)7-13-21-23(24)27(35-25(21)26(28)32)34-20-11-9-19(10-12-20)33-15-18-8-6-16-4-2-3-5-22(16)30-18/h2-6,8-12,14H,7,13,15H2,1H3,(H2,28,32)	QGAMAWMLTUNPAB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005216	TD-198946	C27H22N4O3S	3.4895	9826550		Cn1ncc2c1-c1c(Oc3ccc(OCc4nc5ccccc5cc4)cc3)sc(C(N)=O)c1CC2	InChI=1S/C27H22N4O3S/c1-31-24-17(14-29-31)7-13-21-23(24)27(35-25(21)26(28)32)34-20-11-9-19(10-12-20)33-15-18-8-6-16-4-2-3-5-22(16)30-18/h2-6,8-12,14H,7,13,15H2,1H3,(H2,28,32)	QGAMAWMLTUNPAB-UHFFFAOYSA-N					doublet; compound annotation
0391_005217	GW1929	C30H29N3O4	3.5195	6518171	CN(CCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C4=CC=CC=N4	CN(CCOc1ccc(CC(Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1	InChI=1S/C30H29N3O4/c1-33(28-13-7-8-18-31-28)19-20-37-24-16-14-22(15-17-24)21-27(30(35)36)32-26-12-6-5-11-25(26)29(34)23-9-3-2-4-10-23/h2-18,27,32H,19-21H2,1H3,(H,35,36)/t27-/m0/s1	QTQMRBZOBKYXCG-MHZLTWQESA-N					removed another duplicate entry; compound annotation
0391_005219	1063331-94-1	C17H16ClN7	3.6561	44472568		Cc1nn(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)c(C)c1	InChI=1S/C17H16ClN7/c1-10-8-11(2)25(23-10)17-21-15(14-16(22-17)24(3)9-19-14)20-13-6-4-12(18)5-7-13/h4-9H,1-3H3,(H,20,21,22)	DVQOPNIPUIOXHU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005221	TD-198946	C27H22N4O3S	3.7539	9826550		Cn1ncc2c1-c1c(Oc3ccc(OCc4nc5ccccc5cc4)cc3)sc(C(N)=O)c1CC2	InChI=1S/C27H22N4O3S/c1-31-24-17(14-29-31)7-13-21-23(24)27(35-25(21)26(28)32)34-20-11-9-19(10-12-20)33-15-18-8-6-16-4-2-3-5-22(16)30-18/h2-6,8-12,14H,7,13,15H2,1H3,(H2,28,32)	QGAMAWMLTUNPAB-UHFFFAOYSA-N					doublet; compound annotation
0391_005222	econazole	C18H15Cl3N2O	3.8218	3198		Clc1ccc(COC(Cn2ccnc2)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2	LEZWWPYKPKIXLL-UHFFFAOYSA-N					compound annotation
0391_005223	1063331-94-1	C17H16ClN7	4.0491	44472568		Cc1nn(-c2nc(Nc3ccc(Cl)cc3)c3ncn(C)c3n2)c(C)c1	InChI=1S/C17H16ClN7/c1-10-8-11(2)25(23-10)17-21-15(14-16(22-17)24(3)9-19-14)20-13-6-4-12(18)5-7-13/h4-9H,1-3H3,(H,20,21,22)	DVQOPNIPUIOXHU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005225	629664-81-9	C25H24F2N2O3	6.0445	10026128		CC(C)OC(=O)C1=CN(C(=O)c2cc(F)c(F)cc2)CC(C)(C)c2c1[nH]c1ccccc21	InChI=1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3	INASOKQDNHHMRE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005227	Diatrizoic acid	C11H9I3N2O4	0.5433	2140		CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I	InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)	YVPYQUNUQOZFHG-UHFFFAOYSA-N					doublet; compound annotation
0391_005228	Diatrizoic acid	C11H9I3N2O4	0.5488	2140		CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I	InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)	YVPYQUNUQOZFHG-UHFFFAOYSA-N					doublet; compound annotation
0391_005229	ARGIPRESSIN	C46H65N15O12S2	1.4038	644077	C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N	NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O	InChI=1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1	KBZOIRJILGZLEJ-LGYYRGKSSA-N					compound annotation
0391_005230	Fertirelin	C55H76N16O12	1.9709	188304	CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6	CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(Cc1cnc[nH]1)NC(=O)C1CCC(=O)N1	InChI=1S/C55H76N16O12/c1-4-59-53(82)44-12-8-20-71(44)54(83)38(11-7-19-60-55(56)57)66-49(78)39(21-30(2)3)65-46(75)27-62-47(76)40(22-31-13-15-34(73)16-14-31)67-52(81)43(28-72)70-50(79)41(23-32-25-61-36-10-6-5-9-35(32)36)68-51(80)42(24-33-26-58-29-63-33)69-48(77)37-17-18-45(74)64-37/h5-6,9-10,13-16,25-26,29-30,37-44,61,72-73H,4,7-8,11-12,17-24,27-28H2,1-3H3,(H,58,63)(H,59,82)(H,62,76)(H,64,74)(H,65,75)(H,66,78)(H,67,81)(H,68,80)(H,69,77)(H,70,79)(H4,56,57,60)/t37-,38-,39-,40-,41-,42-,43-,44-/m0/s1	DGCPIBPDYFLAAX-YTAGXALCSA-N					compound annotation
0391_005231	Nithiamide	C5H5N3O3S	2.0212	8798		CC(=O)Nc1ncc([N+](=O)[O-])s1	InChI=1S/C5H5N3O3S/c1-3(9)7-5-6-2-4(12-5)8(10)11/h2H,1H3,(H,6,7,9)	UJRRDDHEMZLWFI-UHFFFAOYSA-N					compound annotation
0391_005232	Nonapeptide-1	C61H87N15O9S	2.2447	10418849	CC(C)[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCSC)N	CSCCC(N)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(C(N)=O)C(C)C	InChI=1S/C61H87N15O9S/c1-37(2)51(52(64)77)74-58(83)50-26-16-31-76(50)60(85)45(23-12-13-28-62)70-55(80)46(33-38-17-6-4-7-18-38)71-56(81)48(35-40-36-68-43-22-11-10-21-41(40)43)72-53(78)44(24-14-29-67-61(65)66)69-54(79)47(34-39-19-8-5-9-20-39)73-57(82)49-25-15-30-75(49)59(84)42(63)27-32-86-3/h4-11,17-22,36-37,42,44-51,68H,12-16,23-35,62-63H2,1-3H3,(H2,64,77)(H,69,79)(H,70,80)(H,71,81)(H,72,78)(H,73,82)(H,74,83)(H4,65,66,67)/t42-,44-,45-,46-,47+,48+,49-,50-,51-/m0/s1	KNFLNGRLKALWRF-LDXSYGEZSA-N					compound annotation
0391_005233	Wogonoside	C22H20O11	2.7964	3084961	COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O	COc1c(OC2OC(C(=O)O)C(O)C(O)C2O)cc(O)c2c1oc(-c1ccccc1)cc2=O	InChI=1S/C22H20O11/c1-30-18-13(32-22-17(27)15(25)16(26)20(33-22)21(28)29)8-11(24)14-10(23)7-12(31-19(14)18)9-5-3-2-4-6-9/h2-8,15-17,20,22,24-27H,1H3,(H,28,29)/t15-,16-,17+,20-,22+/m0/s1	LNOHXHDWGCMVCO-NTKSAMNMSA-N					removed another duplicate entry; compound annotation
0391_005235	hexetidine	C21H45N3	5.1147	3607		CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1	InChI=1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3	DTOUUUZOYKYHEP-UHFFFAOYSA-N					compound annotation
0391_005236	Cycloguanil	C11H14ClN5	1.7511	9049		CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1	InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)	QMNFFXRFOJIOKZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005237	Cycloguanil	C11H14ClN5	1.9073	9049		CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1	InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)	QMNFFXRFOJIOKZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005238	GDC-0623	C16H14FIN4O3	2.0284	42642654		O=C(NOCCO)c1c(Nc2c(F)cc(I)cc2)n2cncc2cc1	InChI=1S/C16H14FIN4O3/c17-13-7-10(18)1-4-14(13)20-15-12(16(24)21-25-6-5-23)3-2-11-8-19-9-22(11)15/h1-4,7-9,20,23H,5-6H2,(H,21,24)	RFWVETIZUQEJEF-UHFFFAOYSA-N					doublet; compound annotation
0391_005239	GDC-0623	C16H14FIN4O3	2.7285	42642654		O=C(NOCCO)c1c(Nc2c(F)cc(I)cc2)n2cncc2cc1	InChI=1S/C16H14FIN4O3/c17-13-7-10(18)1-4-14(13)20-15-12(16(24)21-25-6-5-23)3-2-11-8-19-9-22(11)15/h1-4,7-9,20,23H,5-6H2,(H,21,24)	RFWVETIZUQEJEF-UHFFFAOYSA-N					doublet; compound annotation
0391_005240	flecainide	C17H20F6N2O3	2.7978	3356		O=C(NCC1CCCCN1)c1c(OCC(F)(F)F)ccc(OCC(F)(F)F)c1	InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)	DJBNUMBKLMJRSA-UHFFFAOYSA-N					doublet; compound annotation
0391_005241	flecainide	C17H20F6N2O3	2.8034	3356		O=C(NCC1CCCCN1)c1c(OCC(F)(F)F)ccc(OCC(F)(F)F)c1	InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)	DJBNUMBKLMJRSA-UHFFFAOYSA-N					doublet; compound annotation
0391_005242	NVP-QAV-572	C17H19F2N7O3S2	2.9147	23581840		Cc1c(-c2cc(F)c(S(C)(=O)=O)cc2)sc(NC(=O)NCCc2nn(CCF)nn2)n1	InChI=1S/C17H19F2N7O3S2/c1-10-15(11-3-4-13(12(19)9-11)31(2,28)29)30-17(21-10)22-16(27)20-7-5-14-23-25-26(24-14)8-6-18/h3-4,9H,5-8H2,1-2H3,(H2,20,21,22,27)	UGEZRRNNFHAJTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005244	Basmisanil	C21H20FN3O5S	3.6838	57336276		Cc1c(COc2ncc(C(=O)N3CCS(=O)(=O)CC3)cc2)c(-c2ccc(F)cc2)no1	InChI=1S/C21H20FN3O5S/c1-14-18(20(24-30-14)15-2-5-17(22)6-3-15)13-29-19-7-4-16(12-23-19)21(26)25-8-10-31(27,28)11-9-25/h2-7,12H,8-11,13H2,1H3	VCGRFBXVSFAGGA-UHFFFAOYSA-N					compound annotation
0391_005245	MCC950	C20H24N2O5S	4.0333	9910393		CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3CCCc3cc3c2CCC3)c1	InChI=1S/C20H24N2O5S/c1-20(2,24)14-10-17(27-11-14)28(25,26)22-19(23)21-18-15-7-3-5-12(15)9-13-6-4-8-16(13)18/h9-11,24H,3-8H2,1-2H3,(H2,21,22,23)	HUUSXLKCTQDPGL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005247	Treprostinil	C23H34O5	4.1856	6918140	CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O	CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21	InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1	PAJMKGZZBBTTOY-ZFORQUDYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005249	BRD4770	C25H23N3O3	5.3693	72193870		COC(=O)c1cc2c(cc1)n(CCCc1ccccc1)c(NC(=O)c1ccccc1)n2	InChI=1S/C25H23N3O3/c1-31-24(30)20-14-15-22-21(17-20)26-25(27-23(29)19-12-6-3-7-13-19)28(22)16-8-11-18-9-4-2-5-10-18/h2-7,9-10,12-15,17H,8,11,16H2,1H3,(H,26,27,29)	UCGWYCMPZXDHNR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005251	flecainide	C17H20F6N2O3	5.5107	3356		O=C(NCC1CCCCN1)c1c(OCC(F)(F)F)ccc(OCC(F)(F)F)c1	InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)	DJBNUMBKLMJRSA-UHFFFAOYSA-N					doublet; compound annotation
0391_005252	Sapacitabine	C26H42N4O5	6.1467	153970	CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N	CCCCCCCCCCCCCCCC(=O)Nc1nc(=O)n(C2OC(CO)C(O)C2C#N)cc1	InChI=1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1	LBGFKUUHOPIEMA-PEARBKPGSA-N					doublet; compound annotation
0391_005253	Sapacitabine	C26H42N4O5	6.1517	153970	CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N	CCCCCCCCCCCCCCCC(=O)Nc1nc(=O)n(C2OC(CO)C(O)C2C#N)cc1	InChI=1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1	LBGFKUUHOPIEMA-PEARBKPGSA-N					doublet; compound annotation
0391_005254	CB1-IN-1	C33H31Cl2F3N6O3S2	6.4855	71515460		O=C(NN1CCCCC1)c1nn(-c2c(Cl)cc(Cl)cc2)c(-c2ccc(C#Cc3ccc(C(F)(F)F)cc3)s2)c1CNS(=O)(=O)N1CCCC1	InChI=1S/C33H31Cl2F3N6O3S2/c34-24-11-14-28(27(35)20-24)44-31(29-15-13-25(48-29)12-8-22-6-9-23(10-7-22)33(36,37)38)26(21-39-49(46,47)43-18-4-5-19-43)30(40-44)32(45)41-42-16-2-1-3-17-42/h6-7,9-11,13-15,20,39H,1-5,16-19,21H2,(H,41,45)	KAIYFJUWIBTYPK-UHFFFAOYSA-N					doublet; compound annotation
0391_005255	CB1-IN-1	C33H31Cl2F3N6O3S2	6.4904	71515460		O=C(NN1CCCCC1)c1nn(-c2c(Cl)cc(Cl)cc2)c(-c2ccc(C#Cc3ccc(C(F)(F)F)cc3)s2)c1CNS(=O)(=O)N1CCCC1	InChI=1S/C33H31Cl2F3N6O3S2/c34-24-11-14-28(27(35)20-24)44-31(29-15-13-25(48-29)12-8-22-6-9-23(10-7-22)33(36,37)38)26(21-39-49(46,47)43-18-4-5-19-43)30(40-44)32(45)41-42-16-2-1-3-17-42/h6-7,9-11,13-15,20,39H,1-5,16-19,21H2,(H,41,45)	KAIYFJUWIBTYPK-UHFFFAOYSA-N					doublet; compound annotation
0391_005256	nocodazole	C14H11N3O3S	2.4977	4122		COC(=O)Nc1nc2c(cc(C(=O)c3cccs3)cc2)[nH]1	InChI=1S/C14H11N3O3S/c1-20-14(19)17-13-15-9-5-4-8(7-10(9)16-13)12(18)11-3-2-6-21-11/h2-7H,1H3,(H2,15,16,17,19)	KYRVNWMVYQXFEU-UHFFFAOYSA-N					compound annotation
0391_005257	NVP-ADW742	C28H31N5O	2.5129	9825149		Nc1c2c(-c3cc(OCc4ccccc4)ccc3)cn(C3CC(CN4CCCC4)C3)c2ncn1	InChI=1S/C28H31N5O/c29-27-26-25(22-9-6-10-24(15-22)34-18-20-7-2-1-3-8-20)17-33(28(26)31-19-30-27)23-13-21(14-23)16-32-11-4-5-12-32/h1-3,6-10,15,17,19,21,23H,4-5,11-14,16,18H2,(H2,29,30,31)	LSFLAQVDISHMNB-UHFFFAOYSA-N					compound annotation
0391_005258	2797-51-5	C10H6ClNO2	2.6731	17748		NC1=C(Cl)C(=O)c2ccccc2C1=O	InChI=1S/C10H6ClNO2/c11-7-8(12)10(14)6-4-2-1-3-5(6)9(7)13/h1-4H,12H2	OBLNWSCLAYSJJR-UHFFFAOYSA-N					compound annotation
0391_005259	TRPM8 antagonist 2	C26H26N2O2	3.4237	57055437	COC(=O)[C@H](CC1=CNC2=CC=CC=C21)N(CC3=CC=CC=C3)CC4=CC=CC=C4	COC(=O)C(Cc1c[nH]c2ccccc12)N(Cc1ccccc1)Cc1ccccc1	InChI=1S/C26H26N2O2/c1-30-26(29)25(16-22-17-27-24-15-9-8-14-23(22)24)28(18-20-10-4-2-5-11-20)19-21-12-6-3-7-13-21/h2-15,17,25,27H,16,18-19H2,1H3/t25-/m0/s1	HHVOOJDLCVOLKI-VWLOTQADSA-N					doublet; compound annotation
0391_005260	2-((3,4-Bis((4-fluorobenzyl)oxy)benzyl)amino)ethan-1-ol	C23H23F2NO3	3.4651	118697467		OCCNCc1ccc(OCc2ccc(F)cc2)c(OCc2ccc(F)cc2)c1	InChI=1S/C23H23F2NO3/c24-20-6-1-17(2-7-20)15-28-22-10-5-19(14-26-11-12-27)13-23(22)29-16-18-3-8-21(25)9-4-18/h1-10,13,26-27H,11-12,14-16H2	VZUKTQVJGAPOKJ-UHFFFAOYSA-N					doublet; compound annotation
0391_005261	2-((3,4-Bis((4-fluorobenzyl)oxy)benzyl)amino)ethan-1-ol	C23H23F2NO3	3.4678	118697467		OCCNCc1ccc(OCc2ccc(F)cc2)c(OCc2ccc(F)cc2)c1	InChI=1S/C23H23F2NO3/c24-20-6-1-17(2-7-20)15-28-22-10-5-19(14-26-11-12-27)13-23(22)29-16-18-3-8-21(25)9-4-18/h1-10,13,26-27H,11-12,14-16H2	VZUKTQVJGAPOKJ-UHFFFAOYSA-N					doublet; compound annotation
0391_005262	727664-91-7	C15H12FNOS	4.3011	1510389		Cc1cc(-n2sc3c(ccc(F)c3)c2=O)c(C)cc1	InChI=1S/C15H12FNOS/c1-9-3-4-10(2)13(7-9)17-15(18)12-6-5-11(16)8-14(12)19-17/h3-8H,1-2H3	GRGDWLDSVPJEJU-UHFFFAOYSA-N					doublet; compound annotation
0391_005263	727664-91-7	C15H12FNOS	4.3038	1510389		Cc1cc(-n2sc3c(ccc(F)c3)c2=O)c(C)cc1	InChI=1S/C15H12FNOS/c1-9-3-4-10(2)13(7-9)17-15(18)12-6-5-11(16)8-14(12)19-17/h3-8H,1-2H3	GRGDWLDSVPJEJU-UHFFFAOYSA-N					doublet; compound annotation
0391_005264	472981-92-3	C16H14ClNO2	4.3631	667594	COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(C=C2)Cl	COc1cccc(NC(=O)C=Cc2ccc(Cl)cc2)c1	InChI=1S/C16H14ClNO2/c1-20-15-4-2-3-14(11-15)18-16(19)10-7-12-5-8-13(17)9-6-12/h2-11H,1H3,(H,18,19)/b10-7+	RYAMDQKWNKKFHD-JXMROGBWSA-N					removed another duplicate entry; compound annotation
0391_005267	MBQ-167	C22H18N4	4.9034	129896932		CCn1c2ccccc2c2c1ccc(-n1nncc1-c1ccccc1)c2	InChI=1S/C22H18N4/c1-2-25-20-11-7-6-10-18(20)19-14-17(12-13-21(19)25)26-22(15-23-24-26)16-8-4-3-5-9-16/h3-15H,2H2,1H3	LJCANTASZGYJLG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005270	TRPM8 antagonist 2	C26H26N2O2	5.7349	57055437	COC(=O)[C@H](CC1=CNC2=CC=CC=C21)N(CC3=CC=CC=C3)CC4=CC=CC=C4	COC(=O)C(Cc1c[nH]c2ccccc12)N(Cc1ccccc1)Cc1ccccc1	InChI=1S/C26H26N2O2/c1-30-26(29)25(16-22-17-27-24-15-9-8-14-23(22)24)28(18-20-10-4-2-5-11-20)19-21-12-6-3-7-13-21/h2-15,17,25,27H,16,18-19H2,1H3/t25-/m0/s1	HHVOOJDLCVOLKI-VWLOTQADSA-N					doublet; compound annotation
0391_005271	trimeprazine	C18H22N2S	3.1247	5574		CC(CN(C)C)CN1c2ccccc2Sc2ccccc21	InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3	ZZHLYYDVIOPZBE-UHFFFAOYSA-N					compound annotation
0391_005272	Olmesartan medoxomil	C29H30N6O6	3.1275	130881		CCCc1nc(C(C)(C)O)c(C(=O)OCc2c(C)oc(=O)o2)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)	UQGKUQLKSCSZGY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005274	SL327	C16H12F3N3S	3.5813	9549284	C1=CC=C(C(=C1)/C(=C(\N)/SC2=CC=C(C=C2)N)/C#N)C(F)(F)F	N#CC(=C(N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F	InChI=1S/C16H12F3N3S/c17-16(18,19)14-4-2-1-3-12(14)13(9-20)15(22)23-11-7-5-10(21)6-8-11/h1-8H,21-22H2/b15-13+	JLOXTZFYJNCPIS-FYWRMAATSA-N					doublet; removed another duplicate entry; compound annotation
0391_005277	Atrasentan	C29H38N2O6	3.8635	159594	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4	CCCCN(CCCC)C(=O)CN1CC(c2cc3c(cc2)OCO3)C(C(=O)O)C1c1ccc(OC)cc1	InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1	MOTJMGVDPWRKOC-QPVYNBJUSA-N					doublet; removed another duplicate entry; compound annotation
0391_005279	SL327	C16H12F3N3S	4.1041	9549284	C1=CC=C(C(=C1)/C(=C(\N)/SC2=CC=C(C=C2)N)/C#N)C(F)(F)F	N#CC(=C(N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F	InChI=1S/C16H12F3N3S/c17-16(18,19)14-4-2-1-3-12(14)13(9-20)15(22)23-11-7-5-10(21)6-8-11/h1-8H,21-22H2/b15-13+	JLOXTZFYJNCPIS-FYWRMAATSA-N					doublet; removed another duplicate entry; compound annotation
0391_005282	Atrasentan	C29H38N2O6	4.258	159594	CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4	CCCCN(CCCC)C(=O)CN1CC(c2cc3c(cc2)OCO3)C(C(=O)O)C1c1ccc(OC)cc1	InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1	MOTJMGVDPWRKOC-QPVYNBJUSA-N					doublet; compound annotation
0391_005283	A-867744	C20H19ClN2O3S	4.3811	23642319		CCC(=O)c1c(C)n(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(Cl)cc2)c1	InChI=1S/C20H19ClN2O3S/c1-3-20(24)18-12-19(14-4-6-15(21)7-5-14)23(13(18)2)16-8-10-17(11-9-16)27(22,25)26/h4-12H,3H2,1-2H3,(H2,22,25,26)	ABACVOXFUHDKNZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005285	1160247-92-6	C17H12F3NO4	4.5396	42633508		COc1ccc(CN2C(=O)C(=O)c3cc(OC(F)(F)F)ccc32)cc1	InChI=1S/C17H12F3NO4/c1-24-11-4-2-10(3-5-11)9-21-14-7-6-12(25-17(18,19)20)8-13(14)15(22)16(21)23/h2-8H,9H2,1H3	CKLGZXFOLMHCMC-UHFFFAOYSA-N					compound annotation
0391_005286	DO-264	C23H20Cl2F3N5O2S	4.5828	134813646		FC(F)(F)Oc1cc(Cl)c(Oc2c(Cl)c(N3CCC(NC(=S)Nc4cnccc4)CC3)ncc2)cc1	InChI=1S/C23H20Cl2F3N5O2S/c24-17-12-16(35-23(26,27)28)3-4-18(17)34-19-5-9-30-21(20(19)25)33-10-6-14(7-11-33)31-22(36)32-15-2-1-8-29-13-15/h1-5,8-9,12-14H,6-7,10-11H2,(H2,31,32,36)	PIEQDBPBBQPLPL-UHFFFAOYSA-N					compound annotation
0391_005287	salinomycin	C42H70O11	5.8508	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005288	salinomycin	C42H70O11	6.3795	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005289	salinomycin	C42H70O11	6.7088	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005290	salinomycin	C42H70O11	6.7863	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005291	salinomycin	C42H70O11	6.925	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005292	salinomycin	C42H70O11	7.015	3085092	CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O	CCC(C(=O)O)C1CCC(C)C(C(C)C(O)C(C)C(=O)C(CC)C2OC3(C=CC(O)C4(CCC(C)(C5CCC(O)(CC)C(C)O5)O4)O3)C(C)CC2C)O1	InChI=1S/C42H70O11/c1-11-29(38(46)47)31-15-14-23(4)36(50-31)27(8)34(44)26(7)35(45)30(12-2)37-24(5)22-25(6)41(51-37)19-16-32(43)42(53-41)21-20-39(10,52-42)33-17-18-40(48,13-3)28(9)49-33/h16,19,23-34,36-37,43-44,48H,11-15,17-18,20-22H2,1-10H3,(H,46,47)/t23-,24-,25+,26-,27-,28-,29+,30-,31+,32+,33+,34+,36+,37-,39-,40+,41-,42-/m0/s1	KQXDHUJYNAXLNZ-XQSDOZFQSA-N					doublet; compound annotation
0391_005293	sulfamethizole	C9H10N4O2S2	1.6081	5328		Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1	InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)	VACCAVUAMIDAGB-UHFFFAOYSA-N					compound annotation
0391_005294	Eperezolid	C18H23FN4O5	1.6637	73214	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F	CC(=O)NCC1CN(c2cc(F)c(N3CCN(C(=O)CO)CC3)cc2)C(=O)O1	InChI=1S/C18H23FN4O5/c1-12(25)20-9-14-10-23(18(27)28-14)13-2-3-16(15(19)8-13)21-4-6-22(7-5-21)17(26)11-24/h2-3,8,14,24H,4-7,9-11H2,1H3,(H,20,25)/t14-/m0/s1	SIMWTRCFFSTNMG-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_005296	Finafloxacin	C20H19FN4O4	1.6788	11567473	C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O	N#Cc1c2c(cc(F)c1N1CC3NCCOC3C1)c(=O)c(C(=O)O)cn2C1CC1	InChI=1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1	FYMHQCNFKNMJAV-HOTGVXAUSA-N					removed another duplicate entry; compound annotation
0391_005298	cefoperazone	C25H27N9O8S2	2.0793	44187	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O	CCN1CCN(C(=O)NC(C(=O)NC2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CSC23)c2ccc(O)cc2)C(=O)C1=O	InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1	GCFBRXLSHGKWDP-XCGNWRKASA-N					doublet; compound annotation
0391_005299	Daclatasvir	C40H50N8O6	2.3302	25154714	CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C	InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1	FKRSSPOQAMALKA-CUPIEXAXSA-N					doublet; removed another duplicate entry; compound annotation
0391_005301	Naftifine	C21H21N	3.175	47641	CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32	CN(CC=Cc1ccccc1)Cc1cccc2ccccc12	InChI=1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+	OZGNYLLQHRPOBR-DHZHZOJOSA-N					compound annotation
0391_005302	toremifene	C26H28ClNO	4.1698	3005573	CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3	CN(C)CCOc1ccc(C(=C(CCCl)c2ccccc2)c2ccccc2)cc1	InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-	XFCLJVABOIYOMF-QPLCGJKRSA-N					compound annotation
0391_005303	Erdosteine	C8H11NO4S2	0.9474	65632		O=C(O)CSCC(=O)NC1CCSC1=O	InChI=1S/C8H11NO4S2/c10-6(3-14-4-7(11)12)9-5-1-2-15-8(5)13/h5H,1-4H2,(H,9,10)(H,11,12)	QGFORSXNKQLDNO-UHFFFAOYSA-N					compound annotation
0391_005304	Khasianine	C39H63NO11	2.7714	21573759	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C39H63NO11/c1-18-8-13-39(40-16-18)19(2)28-26(51-39)15-25-23-7-6-21-14-22(9-11-37(21,4)24(23)10-12-38(25,28)5)48-36-33(46)31(44)34(27(17-41)49-36)50-35-32(45)30(43)29(42)20(3)47-35/h6,18-20,22-36,40-46H,7-17H2,1-5H3/t18-,19+,20+,22+,23-,24+,25+,26+,27-,28+,29+,30-,31-,32-,33-,34-,35+,36-,37+,38+,39-/m1/s1	KRQDMAXNTWLTDZ-HCTICQNOSA-N					compound annotation
0391_005305	CARBOXIN	C12H13NO2S	3.2286	21307		CC1=C(C(=O)Nc2ccccc2)SCCO1	InChI=1S/C12H13NO2S/c1-9-11(16-8-7-15-9)12(14)13-10-5-3-2-4-6-10/h2-6H,7-8H2,1H3,(H,13,14)	GYSSRZJIHXQEHQ-UHFFFAOYSA-N					compound annotation
0391_005306	Agomelatine	C15H17NO2	3.2635	82148		COc1cc2c(cccc2CCNC(C)=O)cc1	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	YJYPHIXNFHFHND-UHFFFAOYSA-N					doublet; compound annotation
0391_005307	Agomelatine	C15H17NO2	3.267	82148		COc1cc2c(cccc2CCNC(C)=O)cc1	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	YJYPHIXNFHFHND-UHFFFAOYSA-N					doublet; compound annotation
0391_005308	164178-33-0	C23H25IN2O3	3.4056	4302963		COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3c2ccc(I)c3)cc1	InChI=1S/C23H25IN2O3/c1-16-22(23(27)17-3-6-19(28-2)7-4-17)20-8-5-18(24)15-21(20)26(16)10-9-25-11-13-29-14-12-25/h3-8,15H,9-14H2,1-2H3	JHOTYHDSLIUKCJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005310	Fraxinellone	C14H16O3	4.1799	124039	CC1=C2C(=O)O[C@H]([C@@]2(CCC1)C)C3=COC=C3	CC1=C2C(=O)OC(c3cocc3)C2(C)CCC1	InChI=1S/C14H16O3/c1-9-4-3-6-14(2)11(9)13(15)17-12(14)10-5-7-16-8-10/h5,7-8,12H,3-4,6H2,1-2H3/t12-,14+/m0/s1	XYYAFLHHHZVPRN-GXTWGEPZSA-N					compound annotation
0391_005311	Moxidectin	C37H53NO8	6.5376	9832912	C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N\OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C	CON=C1CC2(CC3CC(CC=C(C)CC(C)C=CC=C4COC5C(O)C(C)=CC(C(=O)O3)C45O)O2)OC(C(C)=CC(C)C)C1C	InChI=1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1	YZBLFMPOMVTDJY-LSGXYNIPSA-N					compound annotation
0391_005312	ERAVACYCLINE	C27H31FN4O8	1.3141	54726192	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=C(C(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4CC3CC12	InChI=1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34-35,38,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1	AKLMFDDQCHURPW-ISIOAQNYSA-N					compound annotation
0391_005313	EFINACONAZOLE	C18H22F2N4O	2.1056	489181	C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3	C=C1CCN(C(C)C(O)(Cn2cncn2)c2c(F)cc(F)cc2)CC1	InChI=1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1	NFEZZTICAUWDHU-RDTXWAMCSA-N					compound annotation
0391_005314	Lu AF21934	C14H16Cl2N2O2	3.6258	66553157	C1CC[C@@H]([C@@H](C1)C(=O)N)C(=O)NC2=CC(=C(C=C2)Cl)Cl	NC(=O)C1CCCCC1C(=O)Nc1cc(Cl)c(Cl)cc1	InChI=1S/C14H16Cl2N2O2/c15-11-6-5-8(7-12(11)16)18-14(20)10-4-2-1-3-9(10)13(17)19/h5-7,9-10H,1-4H2,(H2,17,19)(H,18,20)/t9-,10+/m1/s1	AVKZWCJNDWOBAM-ZJUUUORDSA-N					removed another duplicate entry; compound annotation
0391_005316	2095719-92-7	C29H31ClFN5O5	3.7501	129053037	C[C@H](C(=O)N[C@H](CO)C1=CC(=CC(=C1)F)OC)N2CC3=C(C2=O)C=C(C=C3)C4=NC(=NC=C4Cl)NC5CCOCC5	COc1cc(F)cc(C(CO)NC(=O)C(C)N2Cc3c(cc(-c4nc(NC5CCOCC5)ncc4Cl)cc3)C2=O)c1	InChI=1S/C29H31ClFN5O5/c1-16(27(38)34-25(15-37)19-9-20(31)12-22(10-19)40-2)36-14-18-4-3-17(11-23(18)28(36)39)26-24(30)13-32-29(35-26)33-21-5-7-41-8-6-21/h3-4,9-13,16,21,25,37H,5-8,14-15H2,1-2H3,(H,34,38)(H,32,33,35)/t16-,25-/m1/s1	BVRGQPJKSKKGIH-PUAOIOHZSA-N					removed another duplicate entry; compound annotation
0391_005318	kenpaullone	C16H11BrN2O	3.7884	3820		O=C1Cc2c([nH]c3c2cc(Br)cc3)-c2ccccc2N1	InChI=1S/C16H11BrN2O/c17-9-5-6-14-11(7-9)12-8-15(20)18-13-4-2-1-3-10(13)16(12)19-14/h1-7,19H,8H2,(H,18,20)	QQUXFYAWXPMDOE-UHFFFAOYSA-N					compound annotation
0391_005319	Deferasirox	C21H15N3O4	4.2622	214348		O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1	InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)	BOFQWVMAQOTZIW-UHFFFAOYSA-N					doublet; compound annotation
0391_005320	Bedaquiline	C32H31BrN2O2	4.428	5388906	CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O	COc1c(C(c2ccccc2)C(O)(CCN(C)C)c2cccc3ccccc23)cc2cc(Br)ccc2n1	InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1	QUIJNHUBAXPXFS-XLJNKUFUSA-N					doublet; compound annotation
0391_005321	Bedaquiline	C32H31BrN2O2	4.5212	5388906	CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O	COc1c(C(c2ccccc2)C(O)(CCN(C)C)c2cccc3ccccc23)cc2cc(Br)ccc2n1	InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1	QUIJNHUBAXPXFS-XLJNKUFUSA-N					doublet; compound annotation
0391_005322	Anidulafungin	C58H73N7O17	4.5987	166548	CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O	CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)NC4CC(O)C(O)NC(=O)C5C(O)C(C)CN5C(=O)C(C(C)O)NC(=O)C(C(O)C(O)c5ccc(O)cc5)NC(=O)C5CC(O)CN5C(=O)C(C(C)O)NC4=O)cc3)cc2)cc1	InChI=1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1	JHVAMHSQVVQIOT-MFAJLEFUSA-N					removed another duplicate entry; compound annotation
0391_005324	FADROZOLE	C14H13N3	1.5831	59693		N#Cc1ccc(C2CCCc3cncn32)cc1	InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2	CLPFFLWZZBQMAO-UHFFFAOYSA-N					doublet; compound annotation
0391_005325	956123-34-5	C18H22N6O	1.7876	136189563	CC[C@H](CNC1=NC(=NC=C1)C2=C(C=CC(=C2)C3=CN(N=C3)C)O)N	CCC(N)CNc1nc(-c2c(O)ccc(-c3cn(C)nc3)c2)ncc1	InChI=1S/C18H22N6O/c1-3-14(19)10-21-17-6-7-20-18(23-17)15-8-12(4-5-16(15)25)13-9-22-24(2)11-13/h4-9,11,14,25H,3,10,19H2,1-2H3,(H,20,21,23)/t14-/m1/s1	SCJXQZZYGYLKJG-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_005327	MKC8866	C18H19NO7	2.3324	89542346		COc1c(O)c(C=O)c2oc(=O)c(CC(=O)N3CCOCC3)c(C)c2c1	InChI=1S/C18H19NO7/c1-10-11-7-14(24-2)16(22)13(9-20)17(11)26-18(23)12(10)8-15(21)19-3-5-25-6-4-19/h7,9,22H,3-6,8H2,1-2H3	IFDGMRMUJYGWQQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005329	Bilastine	C28H37N3O3	2.4344	185460		CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21	InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)	ACCMWZWAEFYUGZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005330	Bilastine	C28H37N3O3	2.4371	185460		CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21	InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)	ACCMWZWAEFYUGZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005331	nedisertib	C24H21ClFN5O3	3.0106	86292849	COC1=NN=C(C=C1)[C@H](C2=C(C=C(C(=C2)C3=NC=NC4=C3C=CC(=C4)N5CCOCC5)F)Cl)O	COc1nnc(C(O)c2c(Cl)cc(F)c(-c3ncnc4c3ccc(N3CCOCC3)c4)c2)cc1	InChI=1S/C24H21ClFN5O3/c1-33-22-5-4-20(29-30-22)24(32)16-11-17(19(26)12-18(16)25)23-15-3-2-14(10-21(15)27-13-28-23)31-6-8-34-9-7-31/h2-5,10-13,24,32H,6-9H2,1H3/t24-/m0/s1	MOWXJLUYGFNTAL-DEOSSOPVSA-N					removed another duplicate entry; compound annotation
0391_005333	Tecalcet	C18H22ClNO	3.126	158797	C[C@H](C1=CC(=CC=C1)OC)NCCCC2=CC=CC=C2Cl	COc1cccc(C(C)NCCCc2ccccc2Cl)c1	InChI=1S/C18H22ClNO/c1-14(16-8-5-10-17(13-16)21-2)20-12-6-9-15-7-3-4-11-18(15)19/h3-5,7-8,10-11,13-14,20H,6,9,12H2,1-2H3/t14-/m1/s1	ZVQUCWXZCKWZBP-CQSZACIVSA-N					compound annotation
0391_005334	NPS-2143	C24H25ClN2O2	3.4174	6918446	CC(C)(CC1=CC2=CC=CC=C2C=C1)NC[C@H](COC3=C(C(=CC=C3)Cl)C#N)O	CC(C)(Cc1cc2ccccc2cc1)NCC(O)COc1c(C#N)c(Cl)ccc1	InChI=1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1	PZUJQWHTIRWCID-HXUWFJFHSA-N					doublet; compound annotation
0391_005335	1072145-33-5	C21H19N3S2	3.522	25015530		C1=Cc2ccccc2C(N=C2SCCN2C2=NCCS2)c2ccccc12	InChI=1S/C21H19N3S2/c1-3-7-17-15(5-1)9-10-16-6-2-4-8-18(16)19(17)23-21-24(12-14-26-21)20-22-11-13-25-20/h1-10,19H,11-14H2	OWLQZFQCFCNPKV-UHFFFAOYSA-N					compound annotation
0391_005336	NPS-2143	C24H25ClN2O2	3.6313	6918446	CC(C)(CC1=CC2=CC=CC=C2C=C1)NC[C@H](COC3=C(C(=CC=C3)Cl)C#N)O	CC(C)(Cc1cc2ccccc2cc1)NCC(O)COc1c(C#N)c(Cl)ccc1	InChI=1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1	PZUJQWHTIRWCID-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_005338	Nucleozin	C21H19ClN4O4	3.808	2863945		Cc1c(C(=O)N2CCN(c3c(Cl)cc([N+](=O)[O-])cc3)CC2)c(-c2ccccc2)no1	InChI=1S/C21H19ClN4O4/c1-14-19(20(23-30-14)15-5-3-2-4-6-15)21(27)25-11-9-24(10-12-25)18-8-7-16(26(28)29)13-17(18)22/h2-8,13H,9-12H2,1H3	OWXBJAPOSQSWAO-UHFFFAOYSA-N					doublet; compound annotation
0391_005339	Nucleozin	C21H19ClN4O4	4.6876	2863945		Cc1c(C(=O)N2CCN(c3c(Cl)cc([N+](=O)[O-])cc3)CC2)c(-c2ccccc2)no1	InChI=1S/C21H19ClN4O4/c1-14-19(20(23-30-14)15-5-3-2-4-6-15)21(27)25-11-9-24(10-12-25)18-8-7-16(26(28)29)13-17(18)22/h2-8,13H,9-12H2,1H3	OWXBJAPOSQSWAO-UHFFFAOYSA-N					doublet; compound annotation
0391_005340	ST034307	C10H4Cl4O2	4.9066	867466		O=c1cc(C(Cl)(Cl)Cl)oc2c1cc(Cl)cc2	InChI=1S/C10H4Cl4O2/c11-5-1-2-8-6(3-5)7(15)4-9(16-8)10(12,13)14/h1-4H	NTDHYMSVCBGQJF-UHFFFAOYSA-N					compound annotation
0391_005341	Mebeverine alcohol	C16H27NO2	1.8333	26649		CCN(CCCCO)C(C)Cc1ccc(OC)cc1	InChI=1S/C16H27NO2/c1-4-17(11-5-6-12-18)14(2)13-15-7-9-16(19-3)10-8-15/h7-10,14,18H,4-6,11-13H2,1-3H3	ZGZAPRVKIAFOPL-UHFFFAOYSA-N					compound annotation
0391_005342	Briciclib	C19H23O10PS	2.7745	11248490	COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O	COc1cc(OC)c(C=CS(=O)(=O)Cc2cc(OP(=O)(O)O)c(OC)cc2)c(OC)c1	InChI=1S/C19H23O10PS/c1-25-14-10-17(27-3)15(18(11-14)28-4)7-8-31(23,24)12-13-5-6-16(26-2)19(9-13)29-30(20,21)22/h5-11H,12H2,1-4H3,(H2,20,21,22)/b8-7+	LXENKEWVEVKKGV-BQYQJAHWSA-N					removed another duplicate entry; compound annotation
0391_005344	Gallopamil	C28H40N2O5	3.2494	1234		COc1c(OC)cc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1	InChI=1S/C28H40N2O5/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5/h10-11,16-18,20H,9,12-15H2,1-8H3	XQLWNAFCTODIRK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005346	Upamostat	C32H47N5O6S	4.2608	90937527	CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)C(=NO)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C	CCOC(=O)N1CCN(C(=O)C(Cc2cc(C(N)=NO)ccc2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1	InChI=1S/C32H47N5O6S/c1-8-43-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34-40)35-44(41,42)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35,40H,8,12-15,17H2,1-7H3,(H2,33,34)/t28-/m0/s1	HUASEDVYRABWCV-NDEPHWFRSA-N					doublet; removed another duplicate entry; compound annotation
0391_005348	Upamostat	C32H47N5O6S	4.4586	90937527	CCOC(=O)N1CCN(CC1)C(=O)[C@H](CC2=CC(=CC=C2)C(=NO)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C	CCOC(=O)N1CCN(C(=O)C(Cc2cc(C(N)=NO)ccc2)NS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)CC1	InChI=1S/C32H47N5O6S/c1-8-43-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34-40)35-44(41,42)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35,40H,8,12-15,17H2,1-7H3,(H2,33,34)/t28-/m0/s1	HUASEDVYRABWCV-NDEPHWFRSA-N					doublet; compound annotation
0391_005349	VAS2870	C18H12N6OS	4.7332	4058452		c1ccc(Cn2nnc3c2ncnc3Sc2nc3ccccc3o2)cc1	InChI=1S/C18H12N6OS/c1-2-6-12(7-3-1)10-24-16-15(22-23-24)17(20-11-19-16)26-18-21-13-8-4-5-9-14(13)25-18/h1-9,11H,10H2	HZSOKHVVANONPV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005351	154566-12-8	C18H22Cl2O5	5.0443	10340264	C1[C@H](OC(=O)[C@]1(CC(=O)O)O)CCCCCCC2=C(C=C(C=C2)Cl)Cl	O=C(O)CC1(O)CC(CCCCCCc2c(Cl)cc(Cl)cc2)OC1=O	InChI=1S/C18H22Cl2O5/c19-13-8-7-12(15(20)9-13)5-3-1-2-4-6-14-10-18(24,11-16(21)22)17(23)25-14/h7-9,14,24H,1-6,10-11H2,(H,21,22)/t14-,18+/m1/s1	YTRNLFYTHYWDAU-KDOFPFPSSA-N					compound annotation
0391_005352	meta-topolin	C12H11N5O	1.2175	11557770		Oc1cccc(CNc2ncnc3c2[nH]cn3)c1	InChI=1S/C12H11N5O/c18-9-3-1-2-8(4-9)5-13-11-10-12(15-6-14-10)17-7-16-11/h1-4,6-7,18H,5H2,(H2,13,14,15,16,17)	BUDWTFCZGZYQHZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005354	8-OH-Dpat	C16H25NO	2.1155	1220		CCCN(CCC)C1CCc2c(C1)c(O)ccc2	InChI=1S/C16H25NO/c1-3-10-17(11-4-2)14-9-8-13-6-5-7-16(18)15(13)12-14/h5-7,14,18H,3-4,8-12H2,1-2H3	ASXGJMSKWNBENU-UHFFFAOYSA-N					compound annotation
0391_005355	Elenbecestat	C19H18F3N5O2S	2.3576	57827330	C[C@@H]1[C@H]2CSC(=N[C@]2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(N=C4)C(F)F)F)N	CC1OCC2(c3c(F)ccc(NC(=O)c4ncc(C(F)F)nc4)c3)N=C(N)SCC12	InChI=1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1	AACUJFVOHGRMTR-DPXNYUHVSA-N					removed another duplicate entry; compound annotation
0391_005357	PF-06751979	C18H19F2N5O3S2	2.6647	118435360	C[C@H]1C[C@H]2CSC(=N[C@]2(CO1)C3=NC(=CS3)NC(=O)C4=NC=C(C=C4)OC(F)F)N	CC1CC2CSC(N)=NC2(c2nc(NC(=O)c3ncc(OC(F)F)cc3)cs2)CO1	InChI=1S/C18H19F2N5O3S2/c1-9-4-10-6-30-17(21)25-18(10,8-27-9)15-24-13(7-29-15)23-14(26)12-3-2-11(5-22-12)28-16(19)20/h2-3,5,7,9-10,16H,4,6,8H2,1H3,(H2,21,25)(H,23,26)/t9-,10-,18-/m0/s1	ZLZUHACSRMOLLV-RAALSFIWSA-N					removed another duplicate entry; compound annotation
0391_005359	Cinaciguat	C36H39NO5	3.9518	9808022		O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41)	WPYWMXNXEZFMAK-UHFFFAOYSA-N					doublet; compound annotation
0391_005360	Cinaciguat	C36H39NO5	4.0376	9808022		O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41)	WPYWMXNXEZFMAK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005362	MS4078	C45H52ClN9O8S	4.0675	137628668		Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1	InChI=1S/C45H52ClN9O8S/c1-25(2)63-36-22-30(27(5)21-34(36)51-45-49-23-31(46)41(53-45)50-32-10-6-7-12-37(32)64(61,62)26(3)4)28-15-19-54(20-16-28)24-39(57)48-18-17-47-33-11-8-9-29-40(33)44(60)55(43(29)59)35-13-14-38(56)52-42(35)58/h6-12,21-23,25-26,28,35,47H,13-20,24H2,1-5H3,(H,48,57)(H,52,56,58)(H2,49,50,51,53)	AYMGZLUKTNXEMY-UHFFFAOYSA-N					doublet; compound annotation
0391_005363	MS4078	C45H52ClN9O8S	4.073	137628668		Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1	InChI=1S/C45H52ClN9O8S/c1-25(2)63-36-22-30(27(5)21-34(36)51-45-49-23-31(46)41(53-45)50-32-10-6-7-12-37(32)64(61,62)26(3)4)28-15-19-54(20-16-28)24-39(57)48-18-17-47-33-11-8-9-29-40(33)44(60)55(43(29)59)35-13-14-38(56)52-42(35)58/h6-12,21-23,25-26,28,35,47H,13-20,24H2,1-5H3,(H,48,57)(H,52,56,58)(H2,49,50,51,53)	AYMGZLUKTNXEMY-UHFFFAOYSA-N					doublet; compound annotation
0391_005364	AB-423	C17H17F3N2O3S	4.3545	90259477	CC[C@@H](C)NS(=O)(=O)C1=CC(=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)F)F	CCC(C)NS(=O)(=O)c1cc(C(=O)Nc2cc(F)c(F)cc2)c(F)cc1	InChI=1S/C17H17F3N2O3S/c1-3-10(2)22-26(24,25)12-5-7-14(18)13(9-12)17(23)21-11-4-6-15(19)16(20)8-11/h4-10,22H,3H2,1-2H3,(H,21,23)/t10-/m1/s1	BBLXLHYPDOMJMO-SNVBAGLBSA-N					removed another duplicate entry; compound annotation
0391_005366	Ombitasvir	C50H67N7O8	5.1668	54767916	CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(C2CCC(c3ccc(NC(=O)C4CCCN4C(=O)C(NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C	InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1	PIDFDZJZLOTZTM-KHVQSSSXSA-N					removed another duplicate entry; compound annotation
0391_005368	118414-82-7	C27H34ClNO2S	6.594	3651377		CC(C)c1cc2c(cc1)n(Cc1ccc(Cl)cc1)c(CC(C)(C)C(=O)O)c2SC(C)(C)C	InChI=1S/C27H34ClNO2S/c1-17(2)19-10-13-22-21(14-19)24(32-26(3,4)5)23(15-27(6,7)25(30)31)29(22)16-18-8-11-20(28)12-9-18/h8-14,17H,15-16H2,1-7H3,(H,30,31)	QAOAOVKBIIKRNL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005370	kynurenic acid	C10H7NO3	1.1113	3845		O=C(O)c1cc(=O)c2ccccc2[nH]1	InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	HCZHHEIFKROPDY-UHFFFAOYSA-N					doublet; compound annotation
0391_005371	Simurosertib	C17H19N5OS	1.4786	135564531	CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)[C@@H]4CC5CCN4CC5	Cc1c(-c2cc3c(s2)c(=O)nc(C2CC4CCN2CC4)[nH]3)cn[nH]1	InChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m0/s1	XGVXKJKTISMIOW-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_005373	kynurenic acid	C10H7NO3	2.4164	3845		O=C(O)c1cc(=O)c2ccccc2[nH]1	InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	HCZHHEIFKROPDY-UHFFFAOYSA-N					doublet; compound annotation
0391_005374	Batefenterol	C40H42ClN5O7	2.4164	10372836	COC1=CC(=C(C=C1CNC[C@@H](C2=C3C=CC(=O)NC3=C(C=C2)O)O)Cl)NC(=O)CCN4CCC(CC4)OC(=O)NC5=CC=CC=C5C6=CC=CC=C6	COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNCC(O)c1c2ccc(=O)[nH]c2c(O)cc1	InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1	URWYQGVSPQJGGB-DHUJRADRSA-N					removed another duplicate entry; compound annotation
0391_005376	76684-89-4	C15H26N2O5	2.9124	123664	CC(C)CCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1[C@H](O1)C(=O)O	CC(C)CCNC(=O)C(CC(C)C)NC(=O)C1OC1C(=O)O	InChI=1S/C15H26N2O5/c1-8(2)5-6-16-13(18)10(7-9(3)4)17-14(19)11-12(22-11)15(20)21/h8-12H,5-7H2,1-4H3,(H,16,18)(H,17,19)(H,20,21)/t10-,11-,12-/m0/s1	SCMSYZJDIQPSDI-SRVKXCTJSA-N					removed another duplicate entry; compound annotation
0391_005378	Danuglipron	C31H30FN5O4	2.9537	134611040	C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)n2)cc1	InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1	HYBAKUMPISVZQP-DEOSSOPVSA-N					doublet; compound annotation
0391_005379	Danuglipron	C31H30FN5O4	3.0749	134611040	C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)n2)cc1	InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1	HYBAKUMPISVZQP-DEOSSOPVSA-N					doublet; compound annotation
0391_005380	IWP-O1	C26H20N6O	3.2418	134154594		O=C(Cn1nnc(-c2ccncc2)c1-c1ccccc1)Nc1ncc(-c2ccccc2)cc1	InChI=1S/C26H20N6O/c33-24(29-23-12-11-22(17-28-23)19-7-3-1-4-8-19)18-32-26(21-9-5-2-6-10-21)25(30-31-32)20-13-15-27-16-14-20/h1-17H,18H2,(H,28,29,33)	GYYDQHBKIHQHEB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005382	FM-381	C24H24N6O2	3.2714	122197584	CN(C)C(=O)/C(=C/C1=CC=C(O1)C2=NC3=CN=C4C(=C3N2C5CCCCC5)C=CN4)/C#N	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1	InChI=1S/C24H24N6O2/c1-29(2)24(31)15(13-25)12-17-8-9-20(32-17)23-28-19-14-27-22-18(10-11-26-22)21(19)30(23)16-6-4-3-5-7-16/h8-12,14,16H,3-7H2,1-2H3,(H,26,27)/b15-12+	GJMZWYLOARVASY-NTCAYCPXSA-N					doublet; compound annotation
0391_005383	FM-381	C24H24N6O2	3.2746	122197584	CN(C)C(=O)/C(=C/C1=CC=C(O1)C2=NC3=CN=C4C(=C3N2C5CCCCC5)C=CN4)/C#N	CN(C)C(=O)C(C#N)=Cc1ccc(-c2nc3cnc4[nH]ccc4c3n2C2CCCCC2)o1	InChI=1S/C24H24N6O2/c1-29(2)24(31)15(13-25)12-17-8-9-20(32-17)23-28-19-14-27-22-18(10-11-26-22)21(19)30(23)16-6-4-3-5-7-16/h8-12,14,16H,3-7H2,1-2H3,(H,26,27)/b15-12+	GJMZWYLOARVASY-NTCAYCPXSA-N					doublet; compound annotation
0391_005384	Danuglipron	C31H30FN5O4	3.2773	134611040	C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)n2)cc1	InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1	HYBAKUMPISVZQP-DEOSSOPVSA-N					doublet; removed another duplicate entry; compound annotation
0391_005386	Complement factor D-IN-1	C21H19BrN6O3	3.285	86673884	C1[C@H]2[C@@H]1N([C@@H](C2)C(=O)NC3=NC(=CC=C3)Br)C(=O)CN4C5=CC=CC=C5C(=N4)C(=O)N	NC(=O)c1nn(CC(=O)N2C(C(=O)Nc3nc(Br)ccc3)CC3CC32)c2ccccc12	InChI=1S/C21H19BrN6O3/c22-16-6-3-7-17(24-16)25-21(31)15-9-11-8-14(11)28(15)18(29)10-27-13-5-2-1-4-12(13)19(26-27)20(23)30/h1-7,11,14-15H,8-10H2,(H2,23,30)(H,24,25,31)/t11-,14-,15+/m1/s1	CWZUTHDJLNZLCM-DFBGVHRSSA-N					doublet; compound annotation
0391_005387	Complement factor D-IN-1	C21H19BrN6O3	3.2897	86673884	C1[C@H]2[C@@H]1N([C@@H](C2)C(=O)NC3=NC(=CC=C3)Br)C(=O)CN4C5=CC=CC=C5C(=N4)C(=O)N	NC(=O)c1nn(CC(=O)N2C(C(=O)Nc3nc(Br)ccc3)CC3CC32)c2ccccc12	InChI=1S/C21H19BrN6O3/c22-16-6-3-7-17(24-16)25-21(31)15-9-11-8-14(11)28(15)18(29)10-27-13-5-2-1-4-12(13)19(26-27)20(23)30/h1-7,11,14-15H,8-10H2,(H2,23,30)(H,24,25,31)/t11-,14-,15+/m1/s1	CWZUTHDJLNZLCM-DFBGVHRSSA-N					doublet; compound annotation
0391_005388	Complement factor D-IN-1	C21H19BrN6O3	3.4152	86673884	C1[C@H]2[C@@H]1N([C@@H](C2)C(=O)NC3=NC(=CC=C3)Br)C(=O)CN4C5=CC=CC=C5C(=N4)C(=O)N	NC(=O)c1nn(CC(=O)N2C(C(=O)Nc3nc(Br)ccc3)CC3CC32)c2ccccc12	InChI=1S/C21H19BrN6O3/c22-16-6-3-7-17(24-16)25-21(31)15-9-11-8-14(11)28(15)18(29)10-27-13-5-2-1-4-12(13)19(26-27)20(23)30/h1-7,11,14-15H,8-10H2,(H2,23,30)(H,24,25,31)/t11-,14-,15+/m1/s1	CWZUTHDJLNZLCM-DFBGVHRSSA-N					doublet; removed another duplicate entry; compound annotation
0391_005390	Danuglipron	C31H30FN5O4	3.7148	134611040	C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)n2)cc1	InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1	HYBAKUMPISVZQP-DEOSSOPVSA-N					doublet; compound annotation
0391_005391	Danuglipron	C31H30FN5O4	3.8289	134611040	C1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4CC4CCO4)CC3)n2)cc1	InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1	HYBAKUMPISVZQP-DEOSSOPVSA-N					doublet; compound annotation
0391_005392	Brivanib	C19H19FN4O3	3.9569	11234052	CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C	Cc1cc2c(ccc(Oc3ncnn4cc(OCC(C)O)c(C)c34)c2F)[nH]1	InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1	WCWUXEGQKLTGDX-LLVKDONJSA-N					doublet; compound annotation
0391_005393	Brivanib	C19H19FN4O3	3.9596	11234052	CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C	Cc1cc2c(ccc(Oc3ncnn4cc(OCC(C)O)c(C)c34)c2F)[nH]1	InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1	WCWUXEGQKLTGDX-LLVKDONJSA-N					doublet; compound annotation
0391_005394	CAY10602	C22H15FN4O2S	4.1597	1915791		Nc1c(S(=O)(=O)c2ccccc2)c2nc3ccccc3nc2n1-c1ccc(F)cc1	InChI=1S/C22H15FN4O2S/c23-14-10-12-15(13-11-14)27-21(24)20(30(28,29)16-6-2-1-3-7-16)19-22(27)26-18-9-5-4-8-17(18)25-19/h1-13H,24H2	CSFVFDHRYKBBPD-UHFFFAOYSA-N					doublet; compound annotation
0391_005395	CAY10602	C22H15FN4O2S	4.1661	1915791		Nc1c(S(=O)(=O)c2ccccc2)c2nc3ccccc3nc2n1-c1ccc(F)cc1	InChI=1S/C22H15FN4O2S/c23-14-10-12-15(13-11-14)27-21(24)20(30(28,29)16-6-2-1-3-7-16)19-22(27)26-18-9-5-4-8-17(18)25-19/h1-13H,24H2	CSFVFDHRYKBBPD-UHFFFAOYSA-N					doublet; compound annotation
0391_005396	APY29	C17H16N8	1.1053	42627755		c1cc(Nc2n[nH]c(C3CC3)c2)nc(Nc2cc3c(cc2)nc[nH]3)n1	InChI=1S/C17H16N8/c1-2-10(1)13-8-16(25-24-13)22-15-5-6-18-17(23-15)21-11-3-4-12-14(7-11)20-9-19-12/h3-10H,1-2H2,(H,19,20)(H3,18,21,22,23,24,25)	WJNBSTLIALIIEW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005398	midodrine	C12H18N2O4	1.2128	4195		COc1cc(C(O)CNC(=O)CN)c(OC)cc1	InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)	PTKSEFOSCHHMPD-UHFFFAOYSA-N					compound annotation
0391_005399	APY29	C17H16N8	1.316	42627755		c1cc(Nc2n[nH]c(C3CC3)c2)nc(Nc2cc3c(cc2)nc[nH]3)n1	InChI=1S/C17H16N8/c1-2-10(1)13-8-16(25-24-13)22-15-5-6-18-17(23-15)21-11-3-4-12-14(7-11)20-9-19-12/h3-10H,1-2H2,(H,19,20)(H3,18,21,22,23,24,25)	WJNBSTLIALIIEW-UHFFFAOYSA-N					doublet; compound annotation
0391_005400	SUNIFIRAM	C14H18N2O2	2.0937	4223812		CCC(=O)N1CCN(C(=O)c2ccccc2)CC1	InChI=1S/C14H18N2O2/c1-2-13(17)15-8-10-16(11-9-15)14(18)12-6-4-3-5-7-12/h3-7H,2,8-11H2,1H3	DGOWDUFJCINDGI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005402	Guancydine	C7H14N4	2.4081	14211		CCC(C)(C)N=C(N)NC#N	InChI=1S/C7H14N4/c1-4-7(2,3)11-6(9)10-5-8/h4H2,1-3H3,(H3,9,10,11)	VZVGEDRCVUKSEL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005404	K-7174	C33H48N2O6	2.4853	9874191	COC1=CC(=CC(=C1OC)OC)/C=C/CCCN2CCN(CCC2)CCC/C=C/C3=CC(=C(C(=C3)OC)OC)OC	COc1c(OC)c(OC)cc(C=CCCCN2CCCN(CCCC=Cc3cc(OC)c(OC)c(OC)c3)CC2)c1	InChI=1S/C33H48N2O6/c1-36-28-22-26(23-29(37-2)32(28)40-5)14-9-7-11-16-34-18-13-19-35(21-20-34)17-12-8-10-15-27-24-30(38-3)33(41-6)31(25-27)39-4/h9-10,14-15,22-25H,7-8,11-13,16-21H2,1-6H3/b14-9+,15-10+	JXXCDAKRSXICGM-AOEKMSOUSA-N					removed another duplicate entry; compound annotation
0391_005406	STK16-IN-1	C17H12FN3O	2.7136	58525066		Cc1c(F)ccc(-n2c(=O)ccc3cnc4[nH]ccc4c32)c1	InChI=1S/C17H12FN3O/c1-10-8-12(3-4-14(10)18)21-15(22)5-2-11-9-20-17-13(16(11)21)6-7-19-17/h2-9H,1H3,(H,19,20)	WQNRDXHKVSKUPI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005408	ic261	C18H17NO4	3.7324	5288600	COC1=CC(=C(C(=C1)OC)/C=C/2\C3=CC=CC=C3NC2=O)OC	COc1cc(OC)c(C=C2C(=O)Nc3ccccc23)c(OC)c1	InChI=1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+	JBJYTZXCZDNOJW-JLHYYAGUSA-N					doublet; removed another duplicate entry; compound annotation
0391_005411	ic261	C18H17NO4	3.9202	5288600	COC1=CC(=C(C(=C1)OC)/C=C/2\C3=CC=CC=C3NC2=O)OC	COc1cc(OC)c(C=C2C(=O)Nc3ccccc23)c(OC)c1	InChI=1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+	JBJYTZXCZDNOJW-JLHYYAGUSA-N					doublet; removed another duplicate entry; compound annotation
0391_005413	ic261	C18H17NO4	3.9231	5288600	COC1=CC(=C(C(=C1)OC)/C=C/2\C3=CC=CC=C3NC2=O)OC	COc1cc(OC)c(C=C2C(=O)Nc3ccccc23)c(OC)c1	InChI=1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+	JBJYTZXCZDNOJW-JLHYYAGUSA-N					doublet; compound annotation
0391_005414	BLU9931	C26H22Cl2N4O3	4.5259	72710839		C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1	InChI=1S/C26H22Cl2N4O3/c1-5-21(33)30-18-8-6-7-14(2)25(18)32-26-29-13-16-11-15(9-10-17(16)31-26)22-23(27)19(34-3)12-20(35-4)24(22)28/h5-13H,1H2,2-4H3,(H,30,33)(H,29,31,32)	TXEBNKKOLVBTFK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005416	Salermide	C26H22N2O2	5.0313	135659046		CC(C(=O)Nc1cc(N=Cc2c(O)ccc3ccccc23)ccc1)c1ccccc1	InChI=1S/C26H22N2O2/c1-18(19-8-3-2-4-9-19)26(30)28-22-12-7-11-21(16-22)27-17-24-23-13-6-5-10-20(23)14-15-25(24)29/h2-18,29H,1H3,(H,28,30)	HQSSEGBEYORUBY-UHFFFAOYSA-N					compound annotation
0391_005417	1426802-50-7	C23H18Cl2F3NO4S	5.0807	71285927		CCS(=O)(=O)c1ccc(CC(=O)Nc2cc(Cl)c(-c3ccccc3OC(F)(F)F)c(Cl)c2)cc1	InChI=1S/C23H18Cl2F3NO4S/c1-2-34(31,32)16-9-7-14(8-10-16)11-21(30)29-15-12-18(24)22(19(25)13-15)17-5-3-4-6-20(17)33-23(26,27)28/h3-10,12-13H,2,11H2,1H3,(H,29,30)	CEICQMBWAQAIQX-UHFFFAOYSA-N					compound annotation
0391_005418	59887-89-7	C9H6O3	1.4519	5409279		O=c1ccoc2c1ccc(O)c2	InChI=1S/C9H6O3/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5,10H	WVJCRTSTRGRJJT-UHFFFAOYSA-N					compound annotation
0391_005419	(+)-Ajmaline	C20H26N2O2	1.8802	6100671	CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2C5O)N3C1O	InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1	CJDRUOGAGYHKKD-RQBLFBSQSA-N					doublet; compound annotation
0391_005420	(+)-Ajmaline	C20H26N2O2	1.935	6100671	CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2C5O)N3C1O	InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1	CJDRUOGAGYHKKD-RQBLFBSQSA-N					doublet; compound annotation
0391_005421	(+)-Ajmaline	C20H26N2O2	1.9378	6100671	CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@H]2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2C5O)N3C1O	InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1	CJDRUOGAGYHKKD-RQBLFBSQSA-N					doublet; compound annotation
0391_005422	A-443654	C24H23N5O	2.0784	10172943	CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N	Cc1c2cc(-c3cc(OCC(N)Cc4c[nH]c5ccccc45)cnc3)ccc2n[nH]1	InChI=1S/C24H23N5O/c1-15-22-10-16(6-7-24(22)29-28-15)17-9-20(13-26-11-17)30-14-19(25)8-18-12-27-23-5-3-2-4-21(18)23/h2-7,9-13,19,27H,8,14,25H2,1H3,(H,28,29)/t19-/m0/s1	YWTBGJGMTBHQTM-IBGZPJMESA-N					compound annotation
0391_005423	ketoconazole	C26H28Cl2N4O4	3.0665	456201	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1	XMAYWYJOQHXEEK-OZXSUGGESA-N					doublet; removed another duplicate entry; compound annotation
0391_005425	Cobimetinib	C21H21F3IN3O2	3.3764	16222096	C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O	O=C(c1ccc(F)c(F)c1Nc1c(F)cc(I)cc1)N1CC(O)(C2CCCCN2)C1	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1	BSMCAPRUBJMWDF-KRWDZBQOSA-N					doublet; compound annotation
0391_005426	Casticin	C19H18O8	3.6521	5315263		COc1c(O)cc(-c2c(OC)c(=O)c3c(O)c(OC)c(OC)cc3o2)cc1	InChI=1S/C19H18O8/c1-23-11-6-5-9(7-10(11)20)17-19(26-4)16(22)14-12(27-17)8-13(24-2)18(25-3)15(14)21/h5-8,20-21H,1-4H3	PJQLSMYMOKWUJG-UHFFFAOYSA-N					doublet; compound annotation
0391_005427	Casticin	C19H18O8	3.6554	5315263		COc1c(O)cc(-c2c(OC)c(=O)c3c(O)c(OC)c(OC)cc3o2)cc1	InChI=1S/C19H18O8/c1-23-11-6-5-9(7-10(11)20)17-19(26-4)16(22)14-12(27-17)8-13(24-2)18(25-3)15(14)21/h5-8,20-21H,1-4H3	PJQLSMYMOKWUJG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005429	Capsaicin	C18H27NO3	4.1294	1548943	CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC	COc1c(O)ccc(CNC(=O)CCCCC=CC(C)C)c1	InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+	YKPUWZUDDOIDPM-SOFGYWHQSA-N					compound annotation
0391_005430	3-[(2-Oxo-7-hydroxy-2H-1-benzopyran-3-yl)carbonylamino]-D-alanine	C13H12N2O6	0.9946	145709949	C1=CC2=C(C=C1O)OC(=O)C(=C2)C(=O)NC[C@H](C(=O)[O-])[NH3+]	NC(CNC(=O)c1cc2c(cc(O)cc2)oc1=O)C(=O)O	InChI=1S/C13H12N2O6/c14-9(12(18)19)5-15-11(17)8-3-6-1-2-7(16)4-10(6)21-13(8)20/h1-4,9,16H,5,14H2,(H,15,17)(H,18,19)/t9-/m1/s1	CXHGZENYYVZNDO-SECBINFHSA-N					compound annotation
0391_005431	tilorone	C25H34N2O3	1.6584	5475		CCN(CC)CCOc1cc2c(cc1)-c1c(cc(OCCN(CC)CC)cc1)C2=O	InChI=1S/C25H34N2O3/c1-5-26(6-2)13-15-29-19-9-11-21-22-12-10-20(30-16-14-27(7-3)8-4)18-24(22)25(28)23(21)17-19/h9-12,17-18H,5-8,13-16H2,1-4H3	MPMFCABZENCRHV-UHFFFAOYSA-N					compound annotation
0391_005432	Epirubicin	C27H29NO11	2.5306	41867	C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(=O)CO)CC3OC3CC(N)C(O)C(C)O3)c(O)c1C2=O	InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1	AOJJSUZBOXZQNB-VTZDEGQISA-N					compound annotation
0391_005433	Hederacoside C	C59H96O26	2.8259	11491905	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(CC[C@@H]8[C@@]7(CC[C@@H]([C@@]8(C)CO)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)C)C)[C@@H]4CC(CC5)(C)C)C)O)O)O)CO)O)O)O	CC1OC(OC2C(CO)OC(OCC3OC(OC(=O)C45CCC(C)(C)CC4C4=CCC6C7(C)CCC(OC8OCC(O)C(O)C8OC8OC(C)C(O)C(O)C8O)C(C)(CO)C7CCC6(C)C4(C)CC5)C(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C59H96O26/c1-24-34(63)38(67)42(71)49(78-24)83-46-29(20-60)80-48(45(74)41(46)70)77-22-30-37(66)40(69)44(73)51(81-30)85-53(75)59-17-15-54(3,4)19-27(59)26-9-10-32-55(5)13-12-33(56(6,23-61)31(55)11-14-58(32,8)57(26,7)16-18-59)82-52-47(36(65)28(62)21-76-52)84-50-43(72)39(68)35(64)25(2)79-50/h9,24-25,27-52,60-74H,10-23H2,1-8H3/t24-,25-,27-,28-,29+,30+,31+,32+,33-,34-,35-,36-,37+,38+,39+,40-,41+,42+,43+,44+,45+,46+,47+,48+,49-,50-,51-,52-,55-,56-,57+,58+,59-/m0/s1	RYHDIBJJJRNDSX-MCGLQMIESA-N					removed another duplicate entry; compound annotation
0391_005435	SB-633825	C28H25N3O3S	3.1185	44433173		COc1cc2c(cc1)cc(-c1c(-c3ccncc3)nc(-c3c(C)cc(S(C)(=O)=O)cc3)n1C)cc2	InChI=1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3	ZDSNJSQTPLXCSG-UHFFFAOYSA-N					compound annotation
0391_005436	GSK717	C28H28N4O2	3.5411	102369397		CN(CCc1nc2ccccc2n1CC(=O)Nc1cc2c(cc1)CCC2)C(=O)c1ccccc1	InChI=1S/C28H28N4O2/c1-31(28(34)21-8-3-2-4-9-21)17-16-26-30-24-12-5-6-13-25(24)32(26)19-27(33)29-23-15-14-20-10-7-11-22(20)18-23/h2-6,8-9,12-15,18H,7,10-11,16-17,19H2,1H3,(H,29,33)	YDOATJUIIFWTKQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005438	indomethacin	C19H16ClNO4	4.3286	3715		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)O	InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)	CGIGDMFJXJATDK-UHFFFAOYSA-N					doublet; compound annotation
0391_005439	Fosfluconazole	C13H13F2N6O4P	1.3635	214356		O=P(O)(O)OC(Cn1cncn1)(Cn1cncn1)c1c(F)cc(F)cc1	InChI=1S/C13H13F2N6O4P/c14-10-1-2-11(12(15)3-10)13(25-26(22,23)24,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9H,4-5H2,(H2,22,23,24)	GHJWNRRCRIGGIO-UHFFFAOYSA-N					compound annotation
0391_005440	Thiocolchicoside	C27H33NO10S	1.8881	9915886	CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)cc2CCC(NC(C)=O)c3cc(=O)c(SC)ccc3-c2c1OC	InChI=1S/C27H33NO10S/c1-12(30)28-16-7-5-13-9-18(37-27-24(34)23(33)22(32)19(11-29)38-27)25(35-2)26(36-3)21(13)14-6-8-20(39-4)17(31)10-15(14)16/h6,8-10,16,19,22-24,27,29,32-34H,5,7,11H2,1-4H3,(H,28,30)/t16-,19+,22+,23-,24+,27+/m0/s1	LEQAKWQJCITZNK-AXHKHJLKSA-N					removed another duplicate entry; compound annotation
0391_005442	ITX-5061 free base	C30H37N3O7S	3.3891	11786594		COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O	InChI=1S/C30H37N3O7S/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35)	UUROSJLZNDSXRF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005444	teniposide	C32H32O13S	3.4277	452548	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O	COc1cc(C2c3cc4c(cc3C(OC3OC5COC(c6cccs6)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O	InChI=1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1	NRUKOCRGYNPUPR-QBPJDGROSA-N					removed another duplicate entry; compound annotation
0391_005447	DM-01	C23H24F3N3O2	3.8953	141741918		Cc1cc(C)c(CNC(=O)c2c(C)n(Cc3ccc(C(F)(F)F)cc3)cc2C)c(=O)[nH]1	InChI=1S/C23H24F3N3O2/c1-13-9-15(3)28-21(30)19(13)10-27-22(31)20-14(2)11-29(16(20)4)12-17-5-7-18(8-6-17)23(24,25)26/h5-9,11H,10,12H2,1-4H3,(H,27,31)(H,28,30)	XHYKDXOCUIJBHL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005449	CANRENONE	C22H28O3	3.9508	13789	C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C	CC12CCC(=O)C=C1C=CC1C2CCC2(C)C1CCC21CCC(=O)O1	InChI=1S/C22H28O3/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21)12-8-19(24)25-22/h3-4,13,16-18H,5-12H2,1-2H3/t16-,17+,18+,20+,21+,22-/m1/s1	UJVLDDZCTMKXJK-WNHSNXHDSA-N					compound annotation
0391_005450	Cenicriviroc	C41H52N4O4S	5.2252	11285792	CCCCOCCOC1=CC=C(C=C1)C2=CC/3=C(C=C2)N(CCC/C(=C3)/C(=O)NC4=CC=C(C=C4)[S@@](=O)CC5=CN=CN5CCC)CC(C)C	CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1	InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1	PNDKCRDVVKJPKG-WHERJAGFSA-N					compound annotation
0391_005451	PHA-793887	C19H31N5O2	1.5639	46191454		CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)	HUXYBQXJVXOMKX-UHFFFAOYSA-N					doublet; compound annotation
0391_005452	PHA-793887	C19H31N5O2	1.617	46191454		CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C	InChI=1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25)	HUXYBQXJVXOMKX-UHFFFAOYSA-N					doublet; compound annotation
0391_005453	947303-87-9	C25H35N3O2	1.617	23661637	CCN(CC)CC1=CC=C(C=C1)C(=O)N(CCC2=CC=CC=C2OC)[C@@H]3CCNC3	CCN(CC)Cc1ccc(C(=O)N(CCc2ccccc2OC)C2CCNC2)cc1	InChI=1S/C25H35N3O2/c1-4-27(5-2)19-20-10-12-22(13-11-20)25(29)28(23-14-16-26-18-23)17-15-21-8-6-7-9-24(21)30-3/h6-13,23,26H,4-5,14-19H2,1-3H3/t23-/m1/s1	XKPJTOHUPQWSOJ-HSZRJFAPSA-N					compound annotation
0391_005454	Debio 0932	C22H30N6O2S	1.6986	44156921		CN(C)c1cc2c(cc1Sc1nc3c(ccnc3N)n1CCNCC(C)(C)C)OCO2	InChI=1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25)	RVJIQAYFTOPTKK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005457	KW-2478	C30H42N2O9	2.2638	23116322		CCc1c(CC(=O)N(CCOC)CCOC)c(C(=O)c2cc(OC)c(OCCN3CCOCC3)cc2)c(O)cc1O	InChI=1S/C30H42N2O9/c1-5-22-23(19-28(35)32(11-13-37-2)12-14-38-3)29(25(34)20-24(22)33)30(36)21-6-7-26(27(18-21)39-4)41-17-10-31-8-15-40-16-9-31/h6-7,18,20,33-34H,5,8-17,19H2,1-4H3	VFUXSYAXEKYYMB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005460	Debio 0932	C22H30N6O2S	2.3109	44156921		CN(C)c1cc2c(cc1Sc1nc3c(ccnc3N)n1CCNCC(C)(C)C)OCO2	InChI=1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25)	RVJIQAYFTOPTKK-UHFFFAOYSA-N					doublet; compound annotation
0391_005461	NSC348884	C38H40N10	2.7583	335974		Cc1cc2c(cc1)nc(CN(CCN(Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)[nH]2	InChI=1S/C38H40N10/c1-23-5-9-27-31(15-23)43-35(39-27)19-47(20-36-40-28-10-6-24(2)16-32(28)44-36)13-14-48(21-37-41-29-11-7-25(3)17-33(29)45-37)22-38-42-30-12-8-26(4)18-34(30)46-38/h5-12,15-18H,13-14,19-22H2,1-4H3,(H,39,43)(H,40,44)(H,41,45)(H,42,46)	KZOLQEUQAFTQFM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005463	NSC348884	C38H40N10	2.9498	335974		Cc1cc2c(cc1)nc(CN(CCN(Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)[nH]2	InChI=1S/C38H40N10/c1-23-5-9-27-31(15-23)43-35(39-27)19-47(20-36-40-28-10-6-24(2)16-32(28)44-36)13-14-48(21-37-41-29-11-7-25(3)17-33(29)45-37)22-38-42-30-12-8-26(4)18-34(30)46-38/h5-12,15-18H,13-14,19-22H2,1-4H3,(H,39,43)(H,40,44)(H,41,45)(H,42,46)	KZOLQEUQAFTQFM-UHFFFAOYSA-N					doublet; compound annotation
0391_005464	G-749	C25H25BrN6O2	2.9547	78357765		CN1CCC(Nc2nc3c(c(Nc4ccc(Oc5ccccc5)cc4)n2)c(=O)[nH]cc3Br)CC1	InChI=1S/C25H25BrN6O2/c1-32-13-11-17(12-14-32)29-25-30-22-20(26)15-27-24(33)21(22)23(31-25)28-16-7-9-19(10-8-16)34-18-5-3-2-4-6-18/h2-10,15,17H,11-14H2,1H3,(H,27,33)(H2,28,29,30,31)	SXWMIXPJPNCXQQ-UHFFFAOYSA-N					compound annotation
0391_005465	NSC348884	C38H40N10	2.9547	335974		Cc1cc2c(cc1)nc(CN(CCN(Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)Cc1nc3c(cc(C)cc3)[nH]1)[nH]2	InChI=1S/C38H40N10/c1-23-5-9-27-31(15-23)43-35(39-27)19-47(20-36-40-28-10-6-24(2)16-32(28)44-36)13-14-48(21-37-41-29-11-7-25(3)17-33(29)45-37)22-38-42-30-12-8-26(4)18-34(30)46-38/h5-12,15-18H,13-14,19-22H2,1-4H3,(H,39,43)(H,40,44)(H,41,45)(H,42,46)	KZOLQEUQAFTQFM-UHFFFAOYSA-N					doublet; compound annotation
0391_005466	Mubritinib	C25H23F3N4O2	5.071	6444692	C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F	FC(F)(F)c1ccc(C=Cc2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+	ZTFBIUXIQYRUNT-MDWZMJQESA-N					doublet; compound annotation
0391_005467	Mubritinib	C25H23F3N4O2	5.1527	6444692	C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F	FC(F)(F)c1ccc(C=Cc2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1	InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+	ZTFBIUXIQYRUNT-MDWZMJQESA-N					doublet; removed another duplicate entry; compound annotation
0391_005469	433249-94-6	C17H17NO	5.2699	2291556	CC1=CC(=C(C=C1)C)N/C=C/C(=O)C2=CC=CC=C2	Cc1cc(NC=CC(=O)c2ccccc2)c(C)cc1	InChI=1S/C17H17NO/c1-13-8-9-14(2)16(12-13)18-11-10-17(19)15-6-4-3-5-7-15/h3-12,18H,1-2H3/b11-10+	SARYOFMRLSHZFE-ZHACJKMWSA-N					compound annotation
0391_005470	Mirogabalin	C12H19NO2	2.0808	59509752	CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN	CCC1=CC2C(C1)CC2(CN)CC(=O)O	InChI=1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1	FTBQORVNHOIASH-CKYFFXLPSA-N					doublet; compound annotation
0391_005471	LY 344864	C21H22FN3O	2.2543	5311097	CN(C)[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)NC(=O)C4=CC=C(C=C4)F	CN(C)C1CCc2c(C1)c1c(ccc(NC(=O)c3ccc(F)cc3)c1)[nH]2	InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26)/t16-/m1/s1	GKWHICIUSVVNGX-MRXNPFEDSA-N					doublet; compound annotation
0391_005472	LY 344864	C21H22FN3O	2.257	5311097	CN(C)[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)NC(=O)C4=CC=C(C=C4)F	CN(C)C1CCc2c(C1)c1c(ccc(NC(=O)c3ccc(F)cc3)c1)[nH]2	InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26)/t16-/m1/s1	GKWHICIUSVVNGX-MRXNPFEDSA-N					doublet; compound annotation
0391_005473	WZ4003	C25H29ClN6O3	2.6595	72200024		CCC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30)	SDGJBAUIGHSMRI-UHFFFAOYSA-N					doublet; compound annotation
0391_005474	anastrozole	C17H19N5	3.062	2187		CC(C)(C#N)c1cc(C(C)(C)C#N)cc(Cn2cncn2)c1	InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3	YBBLVLTVTVSKRW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005476	WZ4003	C25H29ClN6O3	3.1698	72200024		CCC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30)	SDGJBAUIGHSMRI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005479	179248-59-0	C22H19N3O3	3.2555	1474853		COc1c(OC)cc2c(Nc3ccc(Oc4ccccc4)cc3)ncnc2c1	InChI=1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25)	DMWVGXGXHPOEPT-UHFFFAOYSA-N					compound annotation
0391_005480	WZ4003	C25H29ClN6O3	3.3023	72200024		CCC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30)	SDGJBAUIGHSMRI-UHFFFAOYSA-N					doublet; compound annotation
0391_005481	(Rac)-IDO1-IN-5	C23H25FN2O3	3.3316	132209615		CC(NC(=O)c1ccc(F)cc1)c1cc2c(cc1)N(C(=O)C1CCOCC1)CC2	InChI=1S/C23H25FN2O3/c1-15(25-22(27)16-2-5-20(24)6-3-16)18-4-7-21-19(14-18)8-11-26(21)23(28)17-9-12-29-13-10-17/h2-7,14-15,17H,8-13H2,1H3,(H,25,27)	NUBWFWVVKLRSHS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005483	180083-23-2	C32H32N4O3	3.6015	3378093		Cc1nc(-c2cc(C)c(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)cc2)no1	InChI=1S/C32H32N4O3/c1-20-16-25(30-33-21(2)39-34-30)8-9-26(20)22-4-6-23(7-5-22)31(37)36-13-10-24-17-29-27(18-28(24)36)32(19-38-29)11-14-35(3)15-12-32/h4-9,16-18H,10-15,19H2,1-3H3	ATQMRMGXINTJHV-UHFFFAOYSA-N					doublet; compound annotation
0391_005484	180083-23-2	C32H32N4O3	3.6456	3378093		Cc1nc(-c2cc(C)c(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)cc2)no1	InChI=1S/C32H32N4O3/c1-20-16-25(30-33-21(2)39-34-30)8-9-26(20)22-4-6-23(7-5-22)31(37)36-13-10-24-17-29-27(18-28(24)36)32(19-38-29)11-14-35(3)15-12-32/h4-9,16-18H,10-15,19H2,1-3H3	ATQMRMGXINTJHV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005487	Tulrampator	C20H17FN4O3	4.1456	24857397		O=C1c2c(cc3c(=O)n(CCc4cc(F)ccc4)nnc3c2)OCN1C1CC1	InChI=1S/C20H17FN4O3/c21-13-3-1-2-12(8-13)6-7-25-20(27)15-10-18-16(9-17(15)22-23-25)19(26)24(11-28-18)14-4-5-14/h1-3,8-10,14H,4-7,11H2	JHCFQXNWYDLBOG-UHFFFAOYSA-N					compound annotation
0391_005488	Taranabant ((1R,2R)stereoisomer)	C27H25ClF3N3O2	5.396	92979965	C[C@H]([C@H](CC1=CC=C(C=C1)Cl)C2=CC=CC(=C2)C#N)NC(=O)C(C)(C)OC3=NC=C(C=C3)C(F)(F)F	CC(NC(=O)C(C)(C)Oc1ncc(C(F)(F)F)cc1)C(Cc1ccc(Cl)cc1)c1cccc(C#N)c1	InChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m1/s1	QLYKJCMUNUWAGO-HXOBKFHXSA-N					removed another duplicate entry; compound annotation
0391_005490	TIOTIDINE	C10H16N8S2	1.3318	50287		CN=C(NC#N)NCCSCc1csc(N=C(N)N)n1	InChI=1S/C10H16N8S2/c1-14-9(16-6-11)15-2-3-19-4-7-5-20-10(17-7)18-8(12)13/h5H,2-4H2,1H3,(H2,14,15,16)(H4,12,13,17,18)	YDDXVAXDYKBWDX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005492	885325-71-3	C20H19ClFN5OS	2.0783	11676373		O=C(c1c(F)c(Cl)ccc1)N1CCN(Cc2nc(Nc3nccs3)ccc2)CC1	InChI=1S/C20H19ClFN5OS/c21-16-5-2-4-15(18(16)22)19(28)27-10-8-26(9-11-27)13-14-3-1-6-17(24-14)25-20-23-7-12-29-20/h1-7,12H,8-11,13H2,(H,23,24,25)	YCRFPWKUUNKNDN-UHFFFAOYSA-N					doublet; compound annotation
0391_005493	885325-71-3	C20H19ClFN5OS	2.1998	11676373		O=C(c1c(F)c(Cl)ccc1)N1CCN(Cc2nc(Nc3nccs3)ccc2)CC1	InChI=1S/C20H19ClFN5OS/c21-16-5-2-4-15(18(16)22)19(28)27-10-8-26(9-11-27)13-14-3-1-6-17(24-14)25-20-23-7-12-29-20/h1-7,12H,8-11,13H2,(H,23,24,25)	YCRFPWKUUNKNDN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005495	TC-S 7005	C21H17N3O3	2.4292	24971422	C[C@@H](C1=CC=CC=C1)NC2=NC=C3C(=C2)C(=NO3)C4=CC5=C(C=C4)OCO5	CC(Nc1ncc2onc(-c3cc4c(cc3)OCO4)c2c1)c1ccccc1	InChI=1S/C21H17N3O3/c1-13(14-5-3-2-4-6-14)23-20-10-16-19(11-22-20)27-24-21(16)15-7-8-17-18(9-15)26-12-25-17/h2-11,13H,12H2,1H3,(H,22,23)/t13-/m0/s1	DAAGOCSHXCDWDY-ZDUSSCGKSA-N					doublet; compound annotation
0391_005496	VTX-27	C20H24ClFN6O	2.4944	53354074	CC(C)[C@](C)([C@@H]1CN(CCN1)C2=C(C=C(C(=N2)C3=C4C=CC=NC4=NN3)F)Cl)O	CC(C)C(C)(O)C1CN(c2c(Cl)cc(F)c(-c3c4cccnc4n[nH]3)n2)CCN1	InChI=1S/C20H24ClFN6O/c1-11(2)20(3,29)15-10-28(8-7-23-15)19-13(21)9-14(22)17(25-19)16-12-5-4-6-24-18(12)27-26-16/h4-6,9,11,15,23,29H,7-8,10H2,1-3H3,(H,24,26,27)/t15-,20+/m0/s1	HXWARSZQGAFXJM-MGPUTAFESA-N					removed another duplicate entry; compound annotation
0391_005498	PHA-665752	C32H34Cl2N4O4S	2.9006	10461815	CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O	Cc1c(C(=O)N2CCCC2CN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc23)[nH]1	InChI=1S/C32H34Cl2N4O4S/c1-19-29(35-20(2)30(19)32(40)38-14-6-7-21(38)17-37-12-3-4-13-37)16-24-23-15-22(10-11-28(23)36-31(24)39)43(41,42)18-25-26(33)8-5-9-27(25)34/h5,8-11,15-16,21,35H,3-4,6-7,12-14,17-18H2,1-2H3,(H,36,39)/b24-16-/t21-/m1/s1	OYONTEXKYJZFHA-SSHUPFPWSA-N					doublet; removed another duplicate entry; compound annotation
0391_005500	Aftin-4	C20H28N6O	3.2039	5289296	CC[C@H](CO)NC1=NC2=C(C(=N1)N(C)CC3=CC=CC=C3)N=CN2C(C)C	CCC(CO)Nc1nc2c(ncn2C(C)C)c(N(C)Cc2ccccc2)n1	InChI=1S/C20H28N6O/c1-5-16(12-27)22-20-23-18(25(4)11-15-9-7-6-8-10-15)17-19(24-20)26(13-21-17)14(2)3/h6-10,13-14,16,27H,5,11-12H2,1-4H3,(H,22,23,24)/t16-/m1/s1	YPYWONAECUVKHY-MRXNPFEDSA-N					compound annotation
0391_005501	AR-9281	C18H29N3O2	3.2294	12000797		CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1	InChI=1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23)	HUDQLWBKJOMXSZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005503	1416258-16-6	C25H27NO4	3.3814	71592850		Cc1nc2ccccc2c(-c2cc3c(cc2)OCCC3)c1C(OC(C)(C)C)C(=O)O	InChI=1S/C25H27NO4/c1-15-21(23(24(27)28)30-25(2,3)4)22(18-9-5-6-10-19(18)26-15)17-11-12-20-16(14-17)8-7-13-29-20/h5-6,9-12,14,23H,7-8,13H2,1-4H3,(H,27,28)	ZFERZAMPQIXCPM-UHFFFAOYSA-N					compound annotation
0391_005504	PHA-665752	C32H34Cl2N4O4S	3.4279	10461815	CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)/C=C\4/C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O	Cc1c(C(=O)N2CCCC2CN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc23)[nH]1	InChI=1S/C32H34Cl2N4O4S/c1-19-29(35-20(2)30(19)32(40)38-14-6-7-21(38)17-37-12-3-4-13-37)16-24-23-15-22(10-11-28(23)36-31(24)39)43(41,42)18-25-26(33)8-5-9-27(25)34/h5,8-11,15-16,21,35H,3-4,6-7,12-14,17-18H2,1-2H3,(H,36,39)/b24-16-/t21-/m1/s1	OYONTEXKYJZFHA-SSHUPFPWSA-N					doublet; compound annotation
0391_005505	TC-S 7005	C21H17N3O3	3.57	24971422	C[C@@H](C1=CC=CC=C1)NC2=NC=C3C(=C2)C(=NO3)C4=CC5=C(C=C4)OCO5	CC(Nc1ncc2onc(-c3cc4c(cc3)OCO4)c2c1)c1ccccc1	InChI=1S/C21H17N3O3/c1-13(14-5-3-2-4-6-14)23-20-10-16-19(11-22-20)27-24-21(16)15-7-8-17-18(9-15)26-12-25-17/h2-11,13H,12H2,1H3,(H,22,23)/t13-/m0/s1	DAAGOCSHXCDWDY-ZDUSSCGKSA-N					doublet; compound annotation
0391_005506	Fluopyram	C16H11ClF6N2O	4.3422	11158353		O=C(NCCc1c(Cl)cc(C(F)(F)F)cn1)c1ccccc1C(F)(F)F	InChI=1S/C16H11ClF6N2O/c17-12-7-9(15(18,19)20)8-25-13(12)5-6-24-14(26)10-3-1-2-4-11(10)16(21,22)23/h1-4,7-8H,5-6H2,(H,24,26)	KVDJTXBXMWJJEF-UHFFFAOYSA-N					doublet; compound annotation
0391_005507	Fluopyram	C16H11ClF6N2O	4.3467	11158353		O=C(NCCc1c(Cl)cc(C(F)(F)F)cn1)c1ccccc1C(F)(F)F	InChI=1S/C16H11ClF6N2O/c17-12-7-9(15(18,19)20)8-25-13(12)5-6-24-14(26)10-3-1-2-4-11(10)16(21,22)23/h1-4,7-8H,5-6H2,(H,24,26)	KVDJTXBXMWJJEF-UHFFFAOYSA-N					doublet; compound annotation
0391_005508	TC-S 7005	C21H17N3O3	4.5436	24971422	C[C@@H](C1=CC=CC=C1)NC2=NC=C3C(=C2)C(=NO3)C4=CC5=C(C=C4)OCO5	CC(Nc1ncc2onc(-c3cc4c(cc3)OCO4)c2c1)c1ccccc1	InChI=1S/C21H17N3O3/c1-13(14-5-3-2-4-6-14)23-20-10-16-19(11-22-20)27-24-21(16)15-7-8-17-18(9-15)26-12-25-17/h2-11,13H,12H2,1H3,(H,22,23)/t13-/m0/s1	DAAGOCSHXCDWDY-ZDUSSCGKSA-N					doublet; compound annotation
0391_005509	TC-S 7005	C21H17N3O3	4.9198	24971422	C[C@@H](C1=CC=CC=C1)NC2=NC=C3C(=C2)C(=NO3)C4=CC5=C(C=C4)OCO5	CC(Nc1ncc2onc(-c3cc4c(cc3)OCO4)c2c1)c1ccccc1	InChI=1S/C21H17N3O3/c1-13(14-5-3-2-4-6-14)23-20-10-16-19(11-22-20)27-24-21(16)15-7-8-17-18(9-15)26-12-25-17/h2-11,13H,12H2,1H3,(H,22,23)/t13-/m0/s1	DAAGOCSHXCDWDY-ZDUSSCGKSA-N					doublet; compound annotation
0391_005510	TC-S 7005	C21H17N3O3	4.9226	24971422	C[C@@H](C1=CC=CC=C1)NC2=NC=C3C(=C2)C(=NO3)C4=CC5=C(C=C4)OCO5	CC(Nc1ncc2onc(-c3cc4c(cc3)OCO4)c2c1)c1ccccc1	InChI=1S/C21H17N3O3/c1-13(14-5-3-2-4-6-14)23-20-10-16-19(11-22-20)27-24-21(16)15-7-8-17-18(9-15)26-12-25-17/h2-11,13H,12H2,1H3,(H,22,23)/t13-/m0/s1	DAAGOCSHXCDWDY-ZDUSSCGKSA-N					doublet; compound annotation
0391_005511	PAT-1251	C18H17F4N3O3	2.0084	122536283	C1[C@H]([C@@H](CN1C(=O)C2=CC(=CC=C2)OC3=CC(=CC(=N3)C(F)(F)F)CN)F)O	NCc1cc(C(F)(F)F)nc(Oc2cccc(C(=O)N3CC(O)C(F)C3)c2)c1	InChI=1S/C18H17F4N3O3/c19-13-8-25(9-14(13)26)17(27)11-2-1-3-12(6-11)28-16-5-10(7-23)4-15(24-16)18(20,21)22/h1-6,13-14,26H,7-9,23H2/t13-,14-/m1/s1	ODGXXYXJORZPHE-ZIAGYGMSSA-N					removed another duplicate entry; compound annotation
0391_005513	Piboserod	C22H31N3O2	2.343	177336		CCCCN1CCC(CNC(=O)c2c3OCCCn3c3ccccc23)CC1	InChI=1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26)	KVCSJPATKXABRQ-UHFFFAOYSA-N					compound annotation
0391_005514	(+)-SHIN1	C24H24N4O2	3.0689	134335071	CC1=C2C(=NN1)OC(=C([C@@]2(C3=CC(=CC(=C3)C4=CC=CC=C4)CO)C(C)C)C#N)N	Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)/t24-/m0/s1	VVVOFJZXKJKHTD-DEOSSOPVSA-N					doublet; compound annotation
0391_005515	Tnp-470	C19H28ClNO6	3.265	369976	CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)NC(=O)CCl)OC)C	COC1C(OC(=O)NC(=O)CCl)CCC2(CO2)C1C1(C)OC1CC=C(C)C	InChI=1S/C19H28ClNO6/c1-11(2)5-6-13-18(3,27-13)16-15(24-4)12(7-8-19(16)10-25-19)26-17(23)21-14(22)9-20/h5,12-13,15-16H,6-10H2,1-4H3,(H,21,22,23)/t12-,13-,15-,16-,18+,19+/m1/s1	MSHZHSPISPJWHW-PVDLLORBSA-N					doublet; compound annotation
0391_005516	AZ PFKFB3 26	C24H26N4O2	3.4411	118735769	CC(C)CN1C=C(C2=C1C=CC(=C2)OC3=CC=C(C=C3)NC(=O)[C@@H]4CCCN4)C#N	CC(C)Cn1cc(C#N)c2c1ccc(Oc1ccc(NC(=O)C3CCCN3)cc1)c2	InChI=1S/C24H26N4O2/c1-16(2)14-28-15-17(13-25)21-12-20(9-10-23(21)28)30-19-7-5-18(6-8-19)27-24(29)22-4-3-11-26-22/h5-10,12,15-16,22,26H,3-4,11,14H2,1-2H3,(H,27,29)/t22-/m0/s1	OOGHGWKBJXQNEJ-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_005518	Tirabrutinib	C25H22N6O3	3.5098	54755438	CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	CC#CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	SEJLPXCPMNSRAM-GOSISDBHSA-N					doublet; compound annotation
0391_005519	Tirabrutinib	C25H22N6O3	3.5147	54755438	CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	CC#CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	SEJLPXCPMNSRAM-GOSISDBHSA-N					doublet; compound annotation
0391_005520	(+)-SHIN1	C24H24N4O2	3.5381	134335071	CC1=C2C(=NN1)OC(=C([C@@]2(C3=CC(=CC(=C3)C4=CC=CC=C4)CO)C(C)C)C#N)N	Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)/t24-/m0/s1	VVVOFJZXKJKHTD-DEOSSOPVSA-N					doublet; removed another duplicate entry; compound annotation
0391_005522	(+)-SHIN1	C24H24N4O2	3.6066	134335071	CC1=C2C(=NN1)OC(=C([C@@]2(C3=CC(=CC(=C3)C4=CC=CC=C4)CO)C(C)C)C#N)N	Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)/t24-/m0/s1	VVVOFJZXKJKHTD-DEOSSOPVSA-N					doublet; compound annotation
0391_005523	Tnp-470	C19H28ClNO6	3.9484	369976	CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)NC(=O)CCl)OC)C	COC1C(OC(=O)NC(=O)CCl)CCC2(CO2)C1C1(C)OC1CC=C(C)C	InChI=1S/C19H28ClNO6/c1-11(2)5-6-13-18(3,27-13)16-15(24-4)12(7-8-19(16)10-25-19)26-17(23)21-14(22)9-20/h5,12-13,15-16H,6-10H2,1-4H3,(H,21,22,23)/t12-,13-,15-,16-,18+,19+/m1/s1	MSHZHSPISPJWHW-PVDLLORBSA-N					doublet; removed another duplicate entry; compound annotation
0391_005525	Tirabrutinib	C25H22N6O3	4.0318	54755438	CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	CC#CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	SEJLPXCPMNSRAM-GOSISDBHSA-N					doublet; compound annotation
0391_005526	(+)-SHIN1	C24H24N4O2	4.3587	134335071	CC1=C2C(=NN1)OC(=C([C@@]2(C3=CC(=CC(=C3)C4=CC=CC=C4)CO)C(C)C)C#N)N	Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)/t24-/m0/s1	VVVOFJZXKJKHTD-DEOSSOPVSA-N					doublet; compound annotation
0391_005527	LY3214996	C22H27N7O2S	1.8972	121408882		Cn1nccc1Nc1nccc(-c2cc3c(s2)C(C)(C)N(CCN2CCOCC2)C3=O)n1	InChI=1S/C22H27N7O2S/c1-22(2)19-15(20(30)29(22)9-8-28-10-12-31-13-11-28)14-17(32-19)16-4-6-23-21(25-16)26-18-5-7-24-27(18)3/h4-7,14H,8-13H2,1-3H3,(H,23,25,26)	JNPRPMBJODOFEC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005529	NCT-503	C20H23F3N4S	2.7217	118796328		Cc1cc(C)nc(NC(=S)N2CCN(Cc3ccc(C(F)(F)F)cc3)CC2)c1	InChI=1S/C20H23F3N4S/c1-14-11-15(2)24-18(12-14)25-19(28)27-9-7-26(8-10-27)13-16-3-5-17(6-4-16)20(21,22)23/h3-6,11-12H,7-10,13H2,1-2H3,(H,24,25,28)	PJNSZIQUFLWRLH-UHFFFAOYSA-N					compound annotation
0391_005530	Temsavir	C24H23N7O4	2.7217	11317439		COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)c[nH]2	InChI=1S/C24H23N7O4/c1-15-27-14-31(28-15)22-20-19(18(35-2)13-26-22)17(12-25-20)21(32)24(34)30-10-8-29(9-11-30)23(33)16-6-4-3-5-7-16/h3-7,12-14,25H,8-11H2,1-2H3	QRPZBKAMSFHVRW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005532	Cyamemazine	C19H21N3S	3.064	62865		CC(CN(C)C)CN1c2ccccc2Sc2c1cc(C#N)cc2	InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3	SLFGIOIONGJGRT-UHFFFAOYSA-N					doublet; compound annotation
0391_005533	Cyamemazine	C19H21N3S	3.0688	62865		CC(CN(C)C)CN1c2ccccc2Sc2c1cc(C#N)cc2	InChI=1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3	SLFGIOIONGJGRT-UHFFFAOYSA-N					doublet; compound annotation
0391_005534	568544-03-6	C10H12Cl2N2O3S	3.0993	3860347		CN(C)S(=O)(=O)c1c(Cl)ccc(NC(=O)CCl)c1	InChI=1S/C10H12Cl2N2O3S/c1-14(2)18(16,17)9-5-7(3-4-8(9)12)13-10(15)6-11/h3-5H,6H2,1-2H3,(H,13,15)	YEHYODCKTNLFQU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005536	Luliconazole	C14H9Cl2N3S2	3.5279	3003141	C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl	N#CC(=C1SCC(c2c(Cl)cc(Cl)cc2)S1)n1ccnc1	InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1	YTAOBBFIOAEMLL-REQDGWNSSA-N					doublet; compound annotation
0391_005537	Luliconazole	C14H9Cl2N3S2	3.6331	3003141	C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl	N#CC(=C1SCC(c2c(Cl)cc(Cl)cc2)S1)n1ccnc1	InChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1	YTAOBBFIOAEMLL-REQDGWNSSA-N					doublet; compound annotation
0391_005538	Petesicatib	C25H23F6N5O4S	3.6581	59543597	CN1C=C(C=N1)C2=CC(=C(C=C2)S(=O)(=O)[C@@H]3C[C@H](N(C3)C(=O)C4(CC4)C(F)(F)F)C(=O)NC5(CC5)C#N)C(F)(F)F	Cn1cc(-c2cc(C(F)(F)F)c(S(=O)(=O)C3CC(C(=O)NC4(C#N)CC4)N(C(=O)C4(C(F)(F)F)CC4)C3)cc2)cn1	InChI=1S/C25H23F6N5O4S/c1-35-11-15(10-33-35)14-2-3-19(17(8-14)24(26,27)28)41(39,40)16-9-18(20(37)34-22(13-32)4-5-22)36(12-16)21(38)23(6-7-23)25(29,30)31/h2-3,8,10-11,16,18H,4-7,9,12H2,1H3,(H,34,37)/t16-,18+/m1/s1	KXAAIORSMACJSI-AEFFLSMTSA-N					removed another duplicate entry; compound annotation
0391_005540	MBX-4132	C18H15FN4O2	3.8895	134691207		O=C(Nc1nnc(-c2ccc(F)cc2)o1)N1CCc2ccccc2C1	InChI=1S/C18H15FN4O2/c19-15-7-5-13(6-8-15)16-21-22-17(25-16)20-18(24)23-10-9-12-3-1-2-4-14(12)11-23/h1-8H,9-11H2,(H,20,22,24)	OZHWSOOZCIJFQN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005542	Benvitimod	C17H18O2	4.1873	6439522	CC(C)C1=C(C=C(C=C1O)/C=C/C2=CC=CC=C2)O	CC(C)c1c(O)cc(C=Cc2ccccc2)cc1O	InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+	ZISJNXNHJRQYJO-CMDGGOBGSA-N					doublet; compound annotation
0391_005543	Benvitimod	C17H18O2	4.1912	6439522	CC(C)C1=C(C=C(C=C1O)/C=C/C2=CC=CC=C2)O	CC(C)c1c(O)cc(C=Cc2ccccc2)cc1O	InChI=1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+	ZISJNXNHJRQYJO-CMDGGOBGSA-N					doublet; compound annotation
0391_005544	Tideglusib	C19H14N2O2S	4.8196	11313622		O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1	InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2	PMJIHLSCWIDGMD-UHFFFAOYSA-N					compound annotation
0391_005545	abacavir	C14H18N6O	1.2407	441300	C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO	Nc1nc(NC2CC2)c2ncn(C3C=CC(CO)C3)c2n1	InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1	MCGSCOLBFJQGHM-SCZZXKLOSA-N					doublet; compound annotation
0391_005546	Mirabegron	C21H24N4O2S	1.3466	9865528	C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O	Nc1nc(CC(=O)Nc2ccc(CCNCC(O)c3ccccc3)cc2)cs1	InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1	PBAPPPCECJKMCM-IBGZPJMESA-N					compound annotation
0391_005547	Topiroxostat	C13H8N6	1.6046	5288320		N#Cc1nccc(-c2n[nH]c(-c3ccncc3)n2)c1	InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)	UBVZQGOVTLIHLH-UHFFFAOYSA-N					compound annotation
0391_005548	Itacitinib	C26H23F4N9O	2.2434	53380437		N#CCC1(n2cc(-c3c4cc[nH]c4ncn3)cn2)CN(C2CCN(C(=O)c3c(F)c(C(F)(F)F)ncc3)CC2)C1	InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35)	KTBSXLIQKWEBRB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005550	Fosamprenavir	C25H36N3O9PS	2.9468	131536	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N	CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1	InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1	MLBVMOWEQCZNCC-OEMFJLHTSA-N					doublet; compound annotation
0391_005551	Tivozanib	C22H19ClN4O5	3.0351	9911830		COc1c(OC)cc2c(Oc3cc(Cl)c(NC(=O)Nc4noc(C)c4)cc3)ccnc2c1	InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)	SPMVMDHWKHCIDT-UHFFFAOYSA-N					compound annotation
0391_005552	ampiroxicam	C20H21N3O7S	3.9107	2176		CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc12	InChI=1S/C20H21N3O7S/c1-4-28-20(25)30-13(2)29-18-14-9-5-6-10-15(14)31(26,27)23(3)17(18)19(24)22-16-11-7-8-12-21-16/h5-13H,4H2,1-3H3,(H,21,22,24)	LSNWBKACGXCGAJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005554	Tipranavir	C31H33F3N2O5S	5.0977	54682461	CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4	CCCC1(CCc2ccccc2)CC(O)=C(C(CC)c2cc(NS(=O)(=O)c3ncc(C(F)(F)F)cc3)ccc2)C(=O)O1	InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1	SUJUHGSWHZTSEU-FYBSXPHGSA-N					removed another duplicate entry; compound annotation
0391_005556	STIRIPENTOL	C14H18O3	6.4847	5311454	CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O	CC(C)(C)C(O)C=Cc1cc2c(cc1)OCO2	InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+	IBLNKMRFIPWSOY-FNORWQNLSA-N					compound annotation
0391_005557	ATROPINE	C17H23NO3	1.6155	174174	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16?	RKUNBYITZUJHSG-PJPHBNEVSA-N					doublet; compound annotation
0391_005558	Cilastatin	C16H26N2O5S	1.6631	6435415	CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C	CC1(C)CC1C(=O)NC(=CCCCCSCC(N)C(=O)O)C(=O)O	InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1	DHSUYTOATWAVLW-WFVMDLQDSA-N					removed another duplicate entry; compound annotation
0391_005560	BRD5529	C25H31N5O4	2.134	83288403		Cc1ccc(C(=O)Nc2cc(C(=O)O)c(N3CCC(C(N)=O)(N4CCCCC4)CC3)nc2)cc1	InChI=1S/C25H31N5O4/c1-17-5-7-18(8-6-17)22(31)28-19-15-20(23(32)33)21(27-16-19)29-13-9-25(10-14-29,24(26)34)30-11-3-2-4-12-30/h5-8,15-16H,2-4,9-14H2,1H3,(H2,26,34)(H,28,31)(H,32,33)	ZXWHESBABUHJBE-UHFFFAOYSA-N					compound annotation
0391_005561	GNE-1858	C21H26F2N8	2.4674	146026186		CC(C)n1ncc2cnc(Nc3nc(N4CCC(F)(F)C4)nc(C4CCNC4)c3)cc21	InChI=1S/C21H26F2N8/c1-13(2)31-17-8-18(25-10-15(17)11-26-31)28-19-7-16(14-3-5-24-9-14)27-20(29-19)30-6-4-21(22,23)12-30/h7-8,10-11,13-14,24H,3-6,9,12H2,1-2H3,(H,25,27,28,29)	JKPAJCPZQIJPPS-UHFFFAOYSA-N					compound annotation
0391_005562	glycodeoxycholic acid	C26H43NO5	3.9898	3035026	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-/m1/s1	WVULKSPCQVQLCU-BUXLTGKBSA-N					doublet; removed another duplicate entry; compound annotation
0391_005564	UNC3230	C17H20N4O2S	4.1573	46355372		NC(=O)c1c(NC(=O)C2CCCCC2)sc(Nc2ccccc2)n1	InChI=1S/C17H20N4O2S/c18-14(22)13-16(21-15(23)11-7-3-1-4-8-11)24-17(20-13)19-12-9-5-2-6-10-12/h2,5-6,9-11H,1,3-4,7-8H2,(H2,18,22)(H,19,20)(H,21,23)	RZCNASHHHSKTGP-UHFFFAOYSA-N					compound annotation
0391_005565	SSTC3	C23H17F3N4O3S2	4.1606	46912682		CN(c1ccc(C(F)(F)F)cc1)S(=O)(=O)c1ccc(C(=O)Nc2nc(-c3ccccn3)cs2)cc1	InChI=1S/C23H17F3N4O3S2/c1-30(17-9-7-16(8-10-17)23(24,25)26)35(32,33)18-11-5-15(6-12-18)21(31)29-22-28-20(14-34-22)19-4-2-3-13-27-19/h2-14H,1H3,(H,28,29,31)	HSFAATUFWDDUGW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005567	Triclabendazole	C14H9Cl3N2OS	4.6071	50248		CSc1nc2cc(Oc3c(Cl)c(Cl)ccc3)c(Cl)cc2[nH]1	InChI=1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)	NQPDXQQQCQDHHW-UHFFFAOYSA-N					compound annotation
0391_005568	Aripiprazole lauroxil	C36H51Cl2N3O4	5.4777	49831411		CCCCCCCCCCCC(=O)OCN1C(=O)CCc2c1cc(OCCCCN1CCN(c3c(Cl)c(Cl)ccc3)CC1)cc2	InChI=1S/C36H51Cl2N3O4/c1-2-3-4-5-6-7-8-9-10-16-35(43)45-28-41-33-27-30(19-17-29(33)18-20-34(41)42)44-26-12-11-21-39-22-24-40(25-23-39)32-15-13-14-31(37)36(32)38/h13-15,17,19,27H,2-12,16,18,20-26,28H2,1H3	DDINXHAORAAYAD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005570	Scutellarein	C15H10O6	2.3205	5281697		O=c1cc(-c2ccc(O)cc2)oc2c1c(O)c(O)c(O)c2	InChI=1S/C15H10O6/c16-8-3-1-7(2-4-8)11-5-9(17)13-12(21-11)6-10(18)14(19)15(13)20/h1-6,16,18-20H	JVXZRQGOGOXCEC-UHFFFAOYSA-N					compound annotation
0391_005571	Iloperidone	C24H27FN2O4	2.8645	71360		COc1c(OCCCN2CCC(c3noc4c3ccc(F)c4)CC2)ccc(C(C)=O)c1	InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3	XMXHEBAFVSFQEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005573	(2S,3S)-ethyl 3-((S)-1-(4-hydroxyphenethylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate	C20H28N2O6	3.0	11257859	CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC2=CC=C(C=C2)O	CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCc1ccc(O)cc1	InChI=1S/C20H28N2O6/c1-4-27-20(26)17-16(28-17)19(25)22-15(11-12(2)3)18(24)21-10-9-13-5-7-14(23)8-6-13/h5-8,12,15-17,23H,4,9-11H2,1-3H3,(H,21,24)(H,22,25)/t15-,16-,17-/m0/s1	VRFYYTLIPKHELT-ULQDDVLXSA-N					removed another duplicate entry; compound annotation
0391_005575	WS-383 (free base)	C18H20ClN9S2	3.0286	138319704		Cc1nc2nc(SCc3ccc(Cl)cc3)nn2c(Sc2nnnn2CCN(C)C)c1	InChI=1S/C18H20ClN9S2/c1-12-10-15(30-18-22-24-25-27(18)9-8-26(2)3)28-16(20-12)21-17(23-28)29-11-13-4-6-14(19)7-5-13/h4-7,10H,8-9,11H2,1-3H3	MGESDQAAIJOGJA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005577	2-Methoxyestradiol	C19H26O3	3.6776	66414	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)OC)O	COc1c(O)cc2CCC3C(CCC4(C)C(O)CCC34)c2c1	InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1	CQOQDQWUFQDJMK-SSTWWWIQSA-N					compound annotation
0391_005578	Ingenol mebutate	C25H34O6	4.8641	6918670	C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(=C[C@H](C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C	CC=C(C)C(=O)OC1C(C)=CC23C(=O)C(C=C(CO)C(O)C12O)C1C(CC3C)C1(C)C	InChI=1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/b12-7-/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1	VDJHFHXMUKFKET-WDUFCVPESA-N					removed another duplicate entry; compound annotation
0391_005580	41276-02-2	C24H26N4O	1.8388	336423		Cc1ccccc1CN1C2=NCCN2C(=O)C2=C1CCN(Cc1ccccc1)C2	InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-22-11-13-26(15-19-8-3-2-4-9-19)17-21(22)23(29)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3	RSAQARAFWMUYLL-UHFFFAOYSA-N					doublet; compound annotation
0391_005581	41276-02-2	C24H26N4O	1.9458	336423		Cc1ccccc1CN1C2=NCCN2C(=O)C2=C1CCN(Cc1ccccc1)C2	InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-22-11-13-26(15-19-8-3-2-4-9-19)17-21(22)23(29)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3	RSAQARAFWMUYLL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005583	FIPI	C23H24FN5O2	2.5593	16739265		O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1cc2c(ccc(F)c2)[nH]1	InChI=1S/C23H24FN5O2/c24-16-5-6-18-15(13-16)14-20(26-18)22(30)25-9-12-28-10-7-17(8-11-28)29-21-4-2-1-3-19(21)27-23(29)31/h1-6,13-14,17,26H,7-12H2,(H,25,30)(H,27,31)	LHABRXRGDLASIH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005585	SCR7 pyrazine	C18H12N4OS	3.5518	10688007		O=c1[nH]c(=S)[nH]c2c1nc(-c1ccccc1)c(-c1ccccc1)n2	InChI=1S/C18H12N4OS/c23-17-15-16(21-18(24)22-17)20-14(12-9-5-2-6-10-12)13(19-15)11-7-3-1-4-8-11/h1-10H,(H2,20,21,22,23,24)	GSRTWXVBHGOUBU-UHFFFAOYSA-N					compound annotation
0391_005586	T16AInh-A01	C19H20N4O3S2	3.9151	135460621		CCc1c(C)[nH]c(SCC(=O)Nc2nc(-c3ccc(OC)cc3)cs2)nc1=O	InChI=1S/C19H20N4O3S2/c1-4-14-11(2)20-18(23-17(14)25)28-10-16(24)22-19-21-15(9-27-19)12-5-7-13(26-3)8-6-12/h5-9H,4,10H2,1-3H3,(H,20,23,25)(H,21,22,24)	QSIYTNYMBWYHAA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005588	Autotaxin modulator 1	C28H31F6NO3	4.0215	90032900	C[C@H](C1=CC2=C(C=C1)C=CC(=C2C(F)(F)F)OC3CCC(CC3)C(F)(F)F)N4C5CCC4CC(C5)C(=O)O	CC(c1cc2c(cc1)ccc(OC1CCC(C(F)(F)F)CC1)c2C(F)(F)F)N1C2CCC1CC(C(=O)O)C2	InChI=1S/C28H31F6NO3/c1-15(35-20-7-8-21(35)13-18(12-20)26(36)37)17-3-2-16-4-11-24(25(23(16)14-17)28(32,33)34)38-22-9-5-19(6-10-22)27(29,30)31/h2-4,11,14-15,18-22H,5-10,12-13H2,1H3,(H,36,37)/t15-,18?,19?,20?,21?,22?/m1/s1	PZASAAIJIFDWSB-WMHNCSEASA-N					removed another duplicate entry; compound annotation
0391_005590	ufenamate	C18H18F3NO2	6.5294	5632		CCCCOC(=O)c1ccccc1Nc1cccc(C(F)(F)F)c1	InChI=1S/C18H18F3NO2/c1-2-3-11-24-17(23)15-9-4-5-10-16(15)22-14-8-6-7-13(12-14)18(19,20)21/h4-10,12,22H,2-3,11H2,1H3	JDLSRXWHEBFHNC-UHFFFAOYSA-N					compound annotation
0391_005591	Naspm	C22H34N4O	0.6917	129695		NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12	InChI=1S/C22H34N4O/c23-12-6-15-24-13-3-4-14-25-16-7-17-26-22(27)18-20-10-5-9-19-8-1-2-11-21(19)20/h1-2,5,8-11,24-25H,3-4,6-7,12-18,23H2,(H,26,27)	ZUINPPQIQARTKX-UHFFFAOYSA-N					doublet; compound annotation
0391_005592	Naspm	C22H34N4O	1.0501	129695		NCCCNCCCCNCCCNC(=O)Cc1cccc2ccccc12	InChI=1S/C22H34N4O/c23-12-6-15-24-13-3-4-14-25-16-7-17-26-22(27)18-20-10-5-9-19-8-1-2-11-21(19)20/h1-2,5,8-11,24-25H,3-4,6-7,12-18,23H2,(H,26,27)	ZUINPPQIQARTKX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005594	Imazamox	C15H19N3O4	1.9875	86137		COCc1cc(C(=O)O)c(C2=NC(C)(C(C)C)C(=O)N2)nc1	InChI=1S/C15H19N3O4/c1-8(2)15(3)14(21)17-12(18-15)11-10(13(19)20)5-9(6-16-11)7-22-4/h5-6,8H,7H2,1-4H3,(H,19,20)(H,17,18,21)	NUPJIGQFXCQJBK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005596	Imazamox	C15H19N3O4	3.0217	86137		COCc1cc(C(=O)O)c(C2=NC(C)(C(C)C)C(=O)N2)nc1	InChI=1S/C15H19N3O4/c1-8(2)15(3)14(21)17-12(18-15)11-10(13(19)20)5-9(6-16-11)7-22-4/h5-6,8H,7H2,1-4H3,(H,19,20)(H,17,18,21)	NUPJIGQFXCQJBK-UHFFFAOYSA-N					doublet; compound annotation
0391_005597	CPI-455	C16H14N4O	3.204	78426698		CC(C)c1c(-c2ccccc2)nc2c(C#N)c[nH]n2c1=O	InChI=1S/C16H14N4O/c1-10(2)13-14(11-6-4-3-5-7-11)19-15-12(8-17)9-18-20(15)16(13)21/h3-7,9-10,18H,1-2H3	VGXRQCOVGLGFIM-UHFFFAOYSA-N					doublet; compound annotation
0391_005598	CHEMBL3426805	C17H15FN2O3	3.268	71311876	CN1C(=CC=C1/C=C/C(=O)NO)/C=C/C(=O)C2=CC(=CC=C2)F	Cn1c(C=CC(=O)NO)ccc1C=CC(=O)c1cc(F)ccc1	InChI=1S/C17H15FN2O3/c1-20-14(5-6-15(20)8-10-17(22)19-23)7-9-16(21)12-3-2-4-13(18)11-12/h2-11,23H,1H3,(H,19,22)/b9-7+,10-8+	QQDIFLSJMFDTCQ-FIFLTTCUSA-N					removed another duplicate entry; compound annotation
0391_005600	CPI-455	C16H14N4O	3.3495	78426698		CC(C)c1c(-c2ccccc2)nc2c(C#N)c[nH]n2c1=O	InChI=1S/C16H14N4O/c1-10(2)13-14(11-6-4-3-5-7-11)19-15-12(8-17)9-18-20(15)16(13)21/h3-7,9-10,18H,1-2H3	VGXRQCOVGLGFIM-UHFFFAOYSA-N					doublet; compound annotation
0391_005601	CPI-455	C16H14N4O	3.3525	78426698		CC(C)c1c(-c2ccccc2)nc2c(C#N)c[nH]n2c1=O	InChI=1S/C16H14N4O/c1-10(2)13-14(11-6-4-3-5-7-11)19-15-12(8-17)9-18-20(15)16(13)21/h3-7,9-10,18H,1-2H3	VGXRQCOVGLGFIM-UHFFFAOYSA-N					doublet; compound annotation
0391_005602	Necrosulfonamide	C18H15N5O6S2	3.77	101561822	COC1=[NH+]C=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N=C(/C=C/C3=CC=C(S3)[N+](=O)[O-])[O-]	COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)C=Cc2ccc([N+](=O)[O-])s2)cc1	InChI=1S/C18H15N5O6S2/c1-29-18-17(19-10-11-20-18)22-31(27,28)14-6-2-12(3-7-14)21-15(24)8-4-13-5-9-16(30-13)23(25)26/h2-11H,1H3,(H,19,22)(H,21,24)/b8-4+	FNPPHVLYVGMZMZ-XBXARRHUSA-N					doublet; compound annotation
0391_005603	Necrosulfonamide	C18H15N5O6S2	3.7733	101561822	COC1=[NH+]C=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N=C(/C=C/C3=CC=C(S3)[N+](=O)[O-])[O-]	COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)C=Cc2ccc([N+](=O)[O-])s2)cc1	InChI=1S/C18H15N5O6S2/c1-29-18-17(19-10-11-20-18)22-31(27,28)14-6-2-12(3-7-14)21-15(24)8-4-13-5-9-16(30-13)23(25)26/h2-11H,1H3,(H,19,22)(H,21,24)/b8-4+	FNPPHVLYVGMZMZ-XBXARRHUSA-N					doublet; compound annotation
0391_005604	Necrosulfonamide	C18H15N5O6S2	3.8685	101561822	COC1=[NH+]C=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N=C(/C=C/C3=CC=C(S3)[N+](=O)[O-])[O-]	COc1nccnc1NS(=O)(=O)c1ccc(NC(=O)C=Cc2ccc([N+](=O)[O-])s2)cc1	InChI=1S/C18H15N5O6S2/c1-29-18-17(19-10-11-20-18)22-31(27,28)14-6-2-12(3-7-14)21-15(24)8-4-13-5-9-16(30-13)23(25)26/h2-11H,1H3,(H,19,22)(H,21,24)/b8-4+	FNPPHVLYVGMZMZ-XBXARRHUSA-N					doublet; compound annotation
0391_005605	901245-65-6	C22H26N4O3	3.8783	15990224		COc1ccccc1C(=O)Nc1cc2c(cc1N1CCCCC1)n(C)c(=O)n2C	InChI=1S/C22H26N4O3/c1-24-18-13-16(23-21(27)15-9-5-6-10-20(15)29-3)17(26-11-7-4-8-12-26)14-19(18)25(2)22(24)28/h5-6,9-10,13-14H,4,7-8,11-12H2,1-3H3,(H,23,27)	LTUGYAOMCKNTGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005608	CPI-455	C16H14N4O	4.6012	78426698		CC(C)c1c(-c2ccccc2)nc2c(C#N)c[nH]n2c1=O	InChI=1S/C16H14N4O/c1-10(2)13-14(11-6-4-3-5-7-11)19-15-12(8-17)9-18-20(15)16(13)21/h3-7,9-10,18H,1-2H3	VGXRQCOVGLGFIM-UHFFFAOYSA-N					doublet; compound annotation
0391_005609	ML385	C29H25N3O4S	4.8199	1383822		Cc1ccccc1C(=O)N1CCc2c1ccc(-c1c(C)sc(NC(=O)Cc3cc4c(cc3)OCO4)n1)c2	InChI=1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33)	LINHYWKZVCNAMQ-UHFFFAOYSA-N					doublet; compound annotation
0391_005610	ML385	C29H25N3O4S	4.8249	1383822		Cc1ccccc1C(=O)N1CCc2c1ccc(-c1c(C)sc(NC(=O)Cc3cc4c(cc3)OCO4)n1)c2	InChI=1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33)	LINHYWKZVCNAMQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005612	PRIDOPIDINE	C15H23NO2S	1.3516	9795739		CCCN1CCC(c2cc(S(C)(=O)=O)ccc2)CC1	InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3	YGKUEOZJFIXDGI-UHFFFAOYSA-N					compound annotation
0391_005613	Sulfachloropyridazine	C10H9ClN4O2S	1.8829	6634		Nc1ccc(S(=O)(=O)Nc2nnc(Cl)cc2)cc1	InChI=1S/C10H9ClN4O2S/c11-9-5-6-10(14-13-9)15-18(16,17)8-3-1-7(12)2-4-8/h1-6H,12H2,(H,14,15)	XOXHILFPRYWFOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005615	CINANSERIN	C20H24N2OS	2.6342	5475158	CN(C)CCCSC1=CC=CC=C1NC(=O)/C=C/C2=CC=CC=C2	CN(C)CCCSc1ccccc1NC(=O)C=Cc1ccccc1	InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+	RSUVYMGADVXGOU-BUHFOSPRSA-N					doublet; compound annotation
0391_005616	252917-06-9	C22H18Cl2N8	2.6901	9956119		Cc1cnc(-c2cnc(NCCNc3ncc(C#N)cc3)nc2-c2c(Cl)cc(Cl)cc2)[nH]1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)	AQGNHMOJWBZFQQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005618	CINANSERIN	C20H24N2OS	2.7902	5475158	CN(C)CCCSC1=CC=CC=C1NC(=O)/C=C/C2=CC=CC=C2	CN(C)CCCSc1ccccc1NC(=O)C=Cc1ccccc1	InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+	RSUVYMGADVXGOU-BUHFOSPRSA-N					doublet; compound annotation
0391_005619	FITM	C18H18FN5OS	3.0095	16660135		CC(C)Nc1ncnc(-c2csc(N(C)C(=O)c3ccc(F)cc3)n2)c1	InChI=1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22)	WIVGIKIKQHUFOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005621	Walrycin B	C14H10F3N5O2	3.3868	3164070		Cn1nc(-c2ccc(C(F)(F)F)cc2)nc2-c1nc(=O)n(C)c2=O	InChI=1S/C14H10F3N5O2/c1-21-12(23)9-11(19-13(21)24)22(2)20-10(18-9)7-3-5-8(6-4-7)14(15,16)17/h3-6H,1-2H3	XRVMPTWWKLKLPB-UHFFFAOYSA-N					doublet; compound annotation
0391_005622	tiaprofenic acid	C14H12O3S	3.501	5468		CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1	InChI=1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)	GUHPRPJDBZHYCJ-UHFFFAOYSA-N					compound annotation
0391_005623	splitomicin	C13H10O2	3.759	5269		O=C1CCc2c(ccc3ccccc23)O1	InChI=1S/C13H10O2/c14-13-8-6-11-10-4-2-1-3-9(10)5-7-12(11)15-13/h1-5,7H,6,8H2	ISFPDBUKMJDAJH-UHFFFAOYSA-N					compound annotation
0391_005624	LYN-1604	C33H43Cl2N3O2	4.1197	131801113		CC(C)CN(CC(=O)N1CCN(CC(OCc2cc3ccccc3cc2)c2c(Cl)cc(Cl)cc2)CC1)CC(C)C	InChI=1S/C33H43Cl2N3O2/c1-24(2)19-37(20-25(3)4)22-33(39)38-15-13-36(14-16-38)21-32(30-12-11-29(34)18-31(30)35)40-23-26-9-10-27-7-5-6-8-28(27)17-26/h5-12,17-18,24-25,32H,13-16,19-23H2,1-4H3	DVNVYWLKGWAELS-UHFFFAOYSA-N					doublet; compound annotation
0391_005625	LYN-1604	C33H43Cl2N3O2	4.2116	131801113		CC(C)CN(CC(=O)N1CCN(CC(OCc2cc3ccccc3cc2)c2c(Cl)cc(Cl)cc2)CC1)CC(C)C	InChI=1S/C33H43Cl2N3O2/c1-24(2)19-37(20-25(3)4)22-33(39)38-15-13-36(14-16-38)21-32(30-12-11-29(34)18-31(30)35)40-23-26-9-10-27-7-5-6-8-28(27)17-26/h5-12,17-18,24-25,32H,13-16,19-23H2,1-4H3	DVNVYWLKGWAELS-UHFFFAOYSA-N					doublet; compound annotation
0391_005626	Walrycin B	C14H10F3N5O2	4.6769	3164070		Cn1nc(-c2ccc(C(F)(F)F)cc2)nc2-c1nc(=O)n(C)c2=O	InChI=1S/C14H10F3N5O2/c1-21-12(23)9-11(19-13(21)24)22(2)20-10(18-9)7-3-5-8(6-4-7)14(15,16)17/h3-6H,1-2H3	XRVMPTWWKLKLPB-UHFFFAOYSA-N					doublet; compound annotation
0391_005627	IBR2	C24H20N2O2S	4.9506	4664423		O=S(=O)(Cc1ccccc1)N1C=Cc2ccccc2C1c1c[nH]c2ccccc12	InChI=1S/C24H20N2O2S/c27-29(28,17-18-8-2-1-3-9-18)26-15-14-19-10-4-5-11-20(19)24(26)22-16-25-23-13-7-6-12-21(22)23/h1-16,24-25H,17H2	YCOHEPDJLXZVBZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005630	3-Hydroxyacetaminophen	C8H9NO3	0.5629	161950		CC(=O)Nc1cc(O)c(O)cc1	InChI=1S/C8H9NO3/c1-5(10)9-6-2-3-7(11)8(12)4-6/h2-4,11-12H,1H3,(H,9,10)	IPFBMHOMTSBTSU-UHFFFAOYSA-N					compound annotation
0391_005631	dorzolamide	C10H16N2O4S3	0.8241	5284549	CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C	CCNC1CC(C)S(=O)(=O)c2c1cc(S(N)(=O)=O)s2	InChI=1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1	IAVUPMFITXYVAF-XPUUQOCRSA-N					compound annotation
0391_005632	Tigecycline	C29H39N5O8	0.9341	54686904	CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C	CN(C)c1c2CC3CC4C(N(C)C)C(=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)c2c(O)c(NC(=O)CNC(C)(C)C)c1	InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1	SOVUOXKZCCAWOJ-HJYUBDRYSA-N					doublet; compound annotation
0391_005633	Tigecycline	C29H39N5O8	0.9494	54686904	CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C	CN(C)c1c2CC3CC4C(N(C)C)C(=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)c2c(O)c(NC(=O)CNC(C)(C)C)c1	InChI=1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1	SOVUOXKZCCAWOJ-HJYUBDRYSA-N					doublet; compound annotation
0391_005634	N-Acetyl-DL-leucine	C8H15NO3	1.6682	5231552		CC(=O)NC(CC(C)C)C(=O)O	InChI=1S/C8H15NO3/c1-5(2)4-7(8(11)12)9-6(3)10/h5,7H,4H2,1-3H3,(H,9,10)(H,11,12)	WXNXCEHXYPACJF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005636	Imazapic	C14H17N3O3	1.979	91770		Cc1cc(C(=O)O)c(C2=NC(C)(C(C)C)C(=O)N2)nc1	InChI=1S/C14H17N3O3/c1-7(2)14(4)13(20)16-11(17-14)10-9(12(18)19)5-8(3)6-15-10/h5-7H,1-4H3,(H,18,19)(H,16,17,20)	PVSGXWMWNRGTKE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005638	N-Desmethylclozapine	C17H17ClN4	2.0995	135409468		Clc1cc2c(cc1)Nc1ccccc1C(N1CCNCC1)=N2	InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2	JNNOSTQEZICQQP-UHFFFAOYSA-N					compound annotation
0391_005639	5-Hydroxy-1-tetralone	C10H10O2	2.1382	119921		O=C1CCCc2c1cccc2O	InChI=1S/C10H10O2/c11-9-5-1-3-7-8(9)4-2-6-10(7)12/h1,3,5,11H,2,4,6H2	YPPZCRZRQHFRBH-UHFFFAOYSA-N					compound annotation
0391_005640	Nortadalafil	C21H17N3O4	3.1028	9820973	C1[C@@H]2C(=O)NCC(=O)N2[C@@H](C3=C1C4=CC=CC=C4N3)C5=CC6=C(C=C5)OCO6	O=C1NCC(=O)N2C1Cc1c([nH]c3ccccc13)C2c1cc2c(cc1)OCO2	InChI=1S/C21H17N3O4/c25-18-9-22-21(26)15-8-13-12-3-1-2-4-14(12)23-19(13)20(24(15)18)11-5-6-16-17(7-11)28-10-27-16/h1-7,15,20,23H,8-10H2,(H,22,26)/t15-,20-/m1/s1	XHDLVMPUSXRZOS-FOIQADDNSA-N					removed another duplicate entry; compound annotation
0391_005643	Prednisone acetate	C23H28O6	3.4335	91438	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC21C	InChI=1S/C23H28O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-17,20,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1	MOVRKLZUVNCBIP-RFZYENFJSA-N					removed another duplicate entry; compound annotation
0391_005645	LOXORIBINE	C13H17N5O6	0.9694	135410906	C=CCN1C2=C(N=C(NC2=O)N)N(C1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	C=CCn1c(=O)n(C2OC(CO)C(O)C2O)c2c1c(=O)nc(N)[nH]2	InChI=1S/C13H17N5O6/c1-2-3-17-6-9(15-12(14)16-10(6)22)18(13(17)23)11-8(21)7(20)5(4-19)24-11/h2,5,7-8,11,19-21H,1,3-4H2,(H3,14,15,16,22)/t5-,7-,8-,11-/m1/s1	VDCRFBBZFHHYGT-IOSLPCCCSA-N					removed another duplicate entry; compound annotation
0391_005647	FADROZOLE	C14H13N3	1.5778	59693		N#Cc1ccc(C2CCCc3cncn32)cc1	InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2	CLPFFLWZZBQMAO-UHFFFAOYSA-N					doublet; compound annotation
0391_005648	MRX-2843	C29H40N6O	1.9498	89495685		CN1CCN(Cc2ccc(-c3cn(C4CCC(O)CC4)c4nc(NCCC5CC5)ncc34)cc2)CC1	InChI=1S/C29H40N6O/c1-33-14-16-34(17-15-33)19-22-4-6-23(7-5-22)27-20-35(24-8-10-25(36)11-9-24)28-26(27)18-31-29(32-28)30-13-12-21-2-3-21/h4-7,18,20-21,24-25,36H,2-3,8-17,19H2,1H3,(H,30,31,32)	LBEJYFVJIPQSNX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005650	Pirodavir	C21H27N3O3	3.2492	71345		CCOC(=O)c1ccc(OCCC2CCN(c3nnc(C)cc3)CC2)cc1	InChI=1S/C21H27N3O3/c1-3-26-21(25)18-5-7-19(8-6-18)27-15-12-17-10-13-24(14-11-17)20-9-4-16(2)22-23-20/h4-9,17H,3,10-15H2,1-2H3	KCHIOGFOPPOUJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005652	175140-00-8	C21H30N2O	4.1179	9862166		CCC(CC)Nc1c(C)c(Oc2c(C)cc(C)cc2C)nc(C)c1	InChI=1S/C21H30N2O/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3,(H,22,23)	VIZBSVDBNLAVAW-UHFFFAOYSA-N					compound annotation
0391_005653	Lanifibranor	C19H15ClN2O4S2	4.4427	68677842		O=C(O)CCCc1cc2cc(Cl)ccc2n1S(=O)(=O)c1cc2c(cc1)ncs2	InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)	OQDQIFQRNZIEEJ-UHFFFAOYSA-N					compound annotation
0391_005654	TGR5 Receptor Agonist	C18H14Cl2N2O2	4.446	44605616		Cc1c(C(=O)N(C)c2ccc(Cl)cc2)c(-c2ccccc2Cl)no1	InChI=1S/C18H14Cl2N2O2/c1-11-16(17(21-24-11)14-5-3-4-6-15(14)20)18(23)22(2)13-9-7-12(19)8-10-13/h3-10H,1-2H3	IGRCWJPBLWGNPX-UHFFFAOYSA-N					compound annotation
0391_005655	TRIMETAZIDINE	C14H22N2O3	0.8139	21109		COc1c(OC)c(OC)c(CN2CCNCC2)cc1	InChI=1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3	UHWVSEOVJBQKBE-UHFFFAOYSA-N					compound annotation
0391_005656	pheniramine	C16H20N2	1.3515	4761		CN(C)CCC(c1ccccc1)c1ccccn1	InChI=1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3	IJHNSHDBIRRJRN-UHFFFAOYSA-N					compound annotation
0391_005657	mepivacaine	C15H22N2O	1.5954	4062		Cc1c(NC(=O)C2CCCCN2C)c(C)ccc1	InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)	INWLQCZOYSRPNW-UHFFFAOYSA-N					doublet; compound annotation
0391_005658	mepivacaine	C15H22N2O	1.5981	4062		Cc1c(NC(=O)C2CCCCN2C)c(C)ccc1	InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)	INWLQCZOYSRPNW-UHFFFAOYSA-N					doublet; compound annotation
0391_005659	faropenem	C12H15NO5S	1.9546	65894	C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)O)O	CC(O)C1C(=O)N2C(C(=O)O)=C(C3CCCO3)SC12	InChI=1S/C12H15NO5S/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6/h5-7,11,14H,2-4H2,1H3,(H,16,17)/t5-,6-,7+,11-/m1/s1	HGGAKXAHAYOLDJ-FHZUQPTBSA-N					compound annotation
0391_005660	4-Methoxysalicylic acid	C8H8O4	2.5216	75231		COc1cc(O)c(C(=O)O)cc1	InChI=1S/C8H8O4/c1-12-5-2-3-6(8(10)11)7(9)4-5/h2-4,9H,1H3,(H,10,11)	MRIXVKKOHPQOFK-UHFFFAOYSA-N					compound annotation
0391_005661	piperidolate	C21H25NO2	3.0052	4839		CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1	InChI=1S/C21H25NO2/c1-2-22-15-9-14-19(16-22)24-21(23)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-20H,2,9,14-16H2,1H3	KTHVBAZBLKXIHZ-UHFFFAOYSA-N					doublet; compound annotation
0391_005662	2-Isopropyl-5-methyl-4-nitrosophenol	C10H13NO2	3.2235	75393		Cc1cc(O)c(C(C)C)cc1N=O	InChI=1S/C10H13NO2/c1-6(2)8-5-9(11-13)7(3)4-10(8)12/h4-6,12H,1-3H3	YQVCMSSJMLGWAM-UHFFFAOYSA-N					compound annotation
0391_005663	Morusin	C25H24O6	5.2276	5281671		CC(C)=CCc1c(-c2c(O)cc(O)cc2)oc2c(c(O)cc3c2C=CC(C)(C)O3)c1=O	InChI=1S/C25H24O6/c1-13(2)5-7-17-22(29)21-19(28)12-20-16(9-10-25(3,4)31-20)24(21)30-23(17)15-8-6-14(26)11-18(15)27/h5-6,8-12,26-28H,7H2,1-4H3	XFFOMNJIDRDDLQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005665	I2906	C25H37N3O4	6.6007	54679506		CCCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O	InChI=1S/C25H37N3O4/c1-3-5-6-7-8-9-10-11-12-13-18-21(29)26-27-24(31)22-23(30)19-16-14-15-17-20(19)28(4-2)25(22)32/h14-17,30H,3-13,18H2,1-2H3,(H,26,29)(H,27,31)	WIEYSVJHCLJOJT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005667	396129-53-6	C17H12N4	1.3158	447966		c1ccc(-c2c(-c3ccnc4ccccc34)cn[nH]2)nc1	InChI=1S/C17H12N4/c1-2-6-15-13(5-1)12(8-10-19-15)14-11-20-21-17(14)16-7-3-4-9-18-16/h1-11H,(H,20,21)	IBCXZJCWDGCXQT-UHFFFAOYSA-N					doublet; compound annotation
0391_005668	396129-53-6	C17H12N4	1.3185	447966		c1ccc(-c2c(-c3ccnc4ccccc34)cn[nH]2)nc1	InChI=1S/C17H12N4/c1-2-6-15-13(5-1)12(8-10-19-15)14-11-20-21-17(14)16-7-3-4-9-18-16/h1-11H,(H,20,21)	IBCXZJCWDGCXQT-UHFFFAOYSA-N					doublet; compound annotation
0391_005669	251456-60-7	C16H25N3O3	2.1096	3994		CN(C)c1ccc(C(=O)NCCCCCCC(=O)NO)cc1	InChI=1S/C16H25N3O3/c1-19(2)14-10-8-13(9-11-14)16(21)17-12-6-4-3-5-7-15(20)18-22/h8-11,22H,3-7,12H2,1-2H3,(H,17,21)(H,18,20)	MXWDSZWTBOCWBK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005672	PF-4708671	C19H21F3N6	2.1502	51371303		CCc1cncnc1N1CCN(Cc2nc3c(cc(C(F)(F)F)cc3)[nH]2)CC1	InChI=1S/C19H21F3N6/c1-2-13-10-23-12-24-18(13)28-7-5-27(6-8-28)11-17-25-15-4-3-14(19(20,21)22)9-16(15)26-17/h3-4,9-10,12H,2,5-8,11H2,1H3,(H,25,26)	FBLPQCAQRNSVHB-UHFFFAOYSA-N					doublet; compound annotation
0391_005673	PF-4708671	C19H21F3N6	2.1535	51371303		CCc1cncnc1N1CCN(Cc2nc3c(cc(C(F)(F)F)cc3)[nH]2)CC1	InChI=1S/C19H21F3N6/c1-2-13-10-23-12-24-18(13)28-7-5-27(6-8-28)11-17-25-15-4-3-14(19(20,21)22)9-16(15)26-17/h3-4,9-10,12H,2,5-8,11H2,1H3,(H,25,26)	FBLPQCAQRNSVHB-UHFFFAOYSA-N					doublet; compound annotation
0391_005674	MK-0773	C27H34FN5O2	2.6633	11950726	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NCC4=NC5=C(N4)C=CC=N5)CC[C@@H]6[C@@]3(C=C(C(=O)N6C)F)C	CN1C(=O)C(F)=CC2(C)C3CCC4(C)C(C(=O)NCc5nc6c(cccn6)[nH]5)CCC4C3CCC12	InChI=1S/C27H34FN5O2/c1-26-11-10-17-15(6-9-21-27(17,2)13-19(28)25(35)33(21)3)16(26)7-8-18(26)24(34)30-14-22-31-20-5-4-12-29-23(20)32-22/h4-5,12-13,15-18,21H,6-11,14H2,1-3H3,(H,30,34)(H,29,31,32)/t15-,16-,17-,18+,21+,26-,27+/m0/s1	GBEUKTWTUSPHEE-JWJWXJQQSA-N					removed another duplicate entry; compound annotation
0391_005676	AZ-23	C17H19ClFN7O	3.0372	16097523	C[C@@H](C1=NC=C(C=C1)F)NC2=NC=C(C(=N2)NC3=CC(=NN3)OC(C)C)Cl	CC(C)Oc1n[nH]c(Nc2nc(NC(C)c3ncc(F)cc3)ncc2Cl)c1	InChI=1S/C17H19ClFN7O/c1-9(2)27-15-6-14(25-26-15)23-16-12(18)8-21-17(24-16)22-10(3)13-5-4-11(19)7-20-13/h4-10H,1-3H3,(H3,21,22,23,24,25,26)/t10-/m0/s1	LBVKEEFIPBQIMD-JTQLQIEISA-N					removed another duplicate entry; compound annotation
0391_005678	TAK-733	C17H15F2IN4O4	3.2743	24963252	CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)C[C@H](CO)O	Cn1c(=O)c(F)c(Nc2c(F)cc(I)cc2)c2c1ncn(CC(O)CO)c2=O	InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1	RCLQNICOARASSR-SECBINFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_005680	TAK-733	C17H15F2IN4O4	3.2776	24963252	CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)C[C@H](CO)O	Cn1c(=O)c(F)c(Nc2c(F)cc(I)cc2)c2c1ncn(CC(O)CO)c2=O	InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1	RCLQNICOARASSR-SECBINFHSA-N					doublet; compound annotation
0391_005681	SCHEMBL4669868	C32H43N5O	3.6479	25199514		CC(C)CCN(CCC(C)C)C(=O)c1cn2c(CCCN3CCCC3)c(-c3ccc(C#N)cc3)nc2cc1	InChI=1S/C32H43N5O/c1-24(2)15-20-36(21-16-25(3)4)32(38)28-13-14-30-34-31(27-11-9-26(22-33)10-12-27)29(37(30)23-28)8-7-19-35-17-5-6-18-35/h9-14,23-25H,5-8,15-21H2,1-4H3	UVWFHYIIBHXZCQ-UHFFFAOYSA-N					compound annotation
0391_005682	897732-93-3	C21H29N5O6S	4.0119	11691484		COc1c(Nc2c(C)nc(S(C)(=O)=O)cc2)ncnc1OC1CCN(C(=O)OC(C)C)CC1	InChI=1S/C21H29N5O6S/c1-13(2)31-21(27)26-10-8-15(9-11-26)32-20-18(30-4)19(22-12-23-20)25-16-6-7-17(24-14(16)3)33(5,28)29/h6-7,12-13,15H,8-11H2,1-5H3,(H,22,23,25)	WPDCHTSXOPUOII-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005684	232271-19-1	C24H21Cl2NO5	4.1425	9912743	COC1=C(C(=CC=C1)OC)C2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)C3=C(C=CC=C3Cl)Cl	COc1c(-c2ccc(CC(NC(=O)c3c(Cl)cccc3Cl)C(=O)O)cc2)c(OC)ccc1	InChI=1S/C24H21Cl2NO5/c1-31-19-7-4-8-20(32-2)21(19)15-11-9-14(10-12-15)13-18(24(29)30)27-23(28)22-16(25)5-3-6-17(22)26/h3-12,18H,13H2,1-2H3,(H,27,28)(H,29,30)/t18-/m0/s1	DRSJLVGDSNWQBI-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_005686	Biotin hydrazide	C10H18N4O2S	0.613	83872	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NN)NC(=O)N2	NNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C10H18N4O2S/c11-14-8(15)4-2-1-3-7-9-6(5-17-7)12-10(16)13-9/h6-7,9H,1-5,11H2,(H,14,15)(H2,12,13,16)/t6-,7-,9-/m0/s1	KOZWHQPRAOJMBN-ZKWXMUAHSA-N					doublet; compound annotation
0391_005687	Biotin hydrazide	C10H18N4O2S	0.6169	83872	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NN)NC(=O)N2	NNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C10H18N4O2S/c11-14-8(15)4-2-1-3-7-9-6(5-17-7)12-10(16)13-9/h6-7,9H,1-5,11H2,(H,14,15)(H2,12,13,16)/t6-,7-,9-/m0/s1	KOZWHQPRAOJMBN-ZKWXMUAHSA-N					doublet; compound annotation
0391_005688	tempol	C9H18NO2	1.4029	137994		CC1(C)CC(O)CC(C)(C)N1[O]	InChI=1S/C9H18NO2/c1-8(2)5-7(11)6-9(3,4)10(8)12/h7,11H,5-6H2,1-4H3	UZFMOKQJFYMBGY-UHFFFAOYSA-N					doublet; compound annotation
0391_005689	tempol	C9H18NO2	1.4066	137994		CC1(C)CC(O)CC(C)(C)N1[O]	InChI=1S/C9H18NO2/c1-8(2)5-7(11)6-9(3,4)10(8)12/h7,11H,5-6H2,1-4H3	UZFMOKQJFYMBGY-UHFFFAOYSA-N					doublet; compound annotation
0391_005690	AX15836	C32H40N8O5S	2.2787	122705989		CCOc1c(Nc2ncc3c(n2)N(S(C)(=O)=O)c2ccccc2C(=O)N3C)ccc(C(=O)N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C32H40N8O5S/c1-5-45-28-20-22(30(41)39-14-12-23(13-15-39)38-18-16-36(2)17-19-38)10-11-25(28)34-32-33-21-27-29(35-32)40(46(4,43)44)26-9-7-6-8-24(26)31(42)37(27)3/h6-11,20-21,23H,5,12-19H2,1-4H3,(H,33,34,35)	HTFNVAVTYILUCF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005692	2-[4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide	C23H30N6OS3	2.5571	9892288		CSc1c(NC(=O)CN2CCN(CCSc3nc4ccccc4[nH]3)CC2)c(SC)nc(C)c1	InChI=1S/C23H30N6OS3/c1-16-14-19(31-2)21(22(24-16)32-3)27-20(30)15-29-10-8-28(9-11-29)12-13-33-23-25-17-6-4-5-7-18(17)26-23/h4-7,14H,8-13,15H2,1-3H3,(H,25,26)(H,27,30)	VGGMTOYKEDKFLN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005694	LY2365109	C22H27NO5	3.4829	11552757		CN(CCOc1c(C(C)(C)C)cc(-c2cc3c(cc2)OCO3)cc1)CC(=O)O	InChI=1S/C22H27NO5/c1-22(2,3)17-11-15(16-6-8-19-20(12-16)28-14-27-19)5-7-18(17)26-10-9-23(4)13-21(24)25/h5-8,11-12H,9-10,13-14H2,1-4H3,(H,24,25)	FKPLJWGRBCQLTL-UHFFFAOYSA-N					doublet; compound annotation
0391_005695	LY2365109	C22H27NO5	3.4857	11552757		CN(CCOc1c(C(C)(C)C)cc(-c2cc3c(cc2)OCO3)cc1)CC(=O)O	InChI=1S/C22H27NO5/c1-22(2,3)17-11-15(16-6-8-19-20(12-16)28-14-27-19)5-7-18(17)26-10-9-23(4)13-21(24)25/h5-8,11-12H,9-10,13-14H2,1-4H3,(H,24,25)	FKPLJWGRBCQLTL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005697	HLCL-61	C23H24N2O	3.6003	2250650		CCn1c2ccccc2c2c1ccc(CNCc1ccccc1OC)c2	InChI=1S/C23H24N2O/c1-3-25-21-10-6-5-9-19(21)20-14-17(12-13-22(20)25)15-24-16-18-8-4-7-11-23(18)26-2/h4-14,24H,3,15-16H2,1-2H3	FIOIJUCPVZEPFX-UHFFFAOYSA-N					compound annotation
0391_005698	BFH772	C23H16F3N3O3	4.0952	24756034		O=C(Nc1cccc(C(F)(F)F)c1)c1cccc2c1ccc(Oc1ncnc(CO)c1)c2	InChI=1S/C23H16F3N3O3/c24-23(25,26)15-4-2-5-16(10-15)29-22(31)20-6-1-3-14-9-18(7-8-19(14)20)32-21-11-17(12-30)27-13-28-21/h1-11,13,30H,12H2,(H,29,31)	JNLSTLQFDDAULK-UHFFFAOYSA-N					compound annotation
0391_005699	3-Hydroxyflavone	C15H10O3	4.1711	11349		O=c1c(O)c(-c2ccccc2)oc2ccccc12	InChI=1S/C15H10O3/c16-13-11-8-4-5-9-12(11)18-15(14(13)17)10-6-2-1-3-7-10/h1-9,17H	HVQAJTFOCKOKIN-UHFFFAOYSA-N					compound annotation
0391_005700	Bifenazate	C17H20N2O3	4.3628	176879		COc1c(NNC(=O)OC(C)C)cc(-c2ccccc2)cc1	InChI=1S/C17H20N2O3/c1-12(2)22-17(20)19-18-15-11-14(9-10-16(15)21-3)13-7-5-4-6-8-13/h4-12,18H,1-3H3,(H,19,20)	VHLKTXFWDRXILV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005702	SAR-100842	C27H27NO5	4.6023	44481866		COc1c(OCCc2cccc(C)c2)cc(C(=O)NC2(C(=O)O)Cc3ccccc3C2)cc1	InChI=1S/C27H27NO5/c1-18-6-5-7-19(14-18)12-13-33-24-15-20(10-11-23(24)32-2)25(29)28-27(26(30)31)16-21-8-3-4-9-22(21)17-27/h3-11,14-15H,12-13,16-17H2,1-2H3,(H,28,29)(H,30,31)	SOJDTNUCCXWTMG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005704	XL228	C22H31N9O	1.8874	59757974		CC(C)c1noc(CNc2nc(Nc3n[nH]c(C4CC4)c3)cc(N3CCN(C)CC3)n2)c1	InChI=1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28)	ALKJNCZNEOTEMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005706	Teneligliptin	C22H30N6OS	1.9729	11949652	CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5	Cc1nn(-c2ccccc2)c(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)c1	InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1	WGRQANOPCQRCME-PMACEKPBSA-N					doublet; removed another duplicate entry; compound annotation
0391_005708	XL228	C22H31N9O	2.0534	59757974		CC(C)c1noc(CNc2nc(Nc3n[nH]c(C4CC4)c3)cc(N3CCN(C)CC3)n2)c1	InChI=1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28)	ALKJNCZNEOTEMP-UHFFFAOYSA-N					doublet; compound annotation
0391_005709	301836-41-9	C22H16N4O3	2.0593	4521392		NC(=O)c1ccc(-c2nc(-c3cc4c(cc3)OCO4)c(-c3ccccn3)[nH]2)cc1	InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)	FHYUGAJXYORMHI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005710	epsilon-momfluorothrin	C19H19F4NO3	2.0593	25015075	C/C(=C/[C@@H]1[C@H](C1(C)C)C(=O)OCC2=C(C(=C(C(=C2F)F)COC)F)F)/C#N	COCc1c(F)c(F)c(COC(=O)C2C(C=C(C)C#N)C2(C)C)c(F)c1F	InChI=1S/C19H19F4NO3/c1-9(6-24)5-12-13(19(12,2)3)18(25)27-8-11-16(22)14(20)10(7-26-4)15(21)17(11)23/h5,12-13H,7-8H2,1-4H3/b9-5-/t12-,13+/m1/s1	DPJITPZADZSLBP-DQXQJKBJSA-N					doublet; compound annotation
0391_005712	AZ82	C28H31F3N4O3S	3.9692	91885438	CCCC1=C(SC(=C1)C(=O)N[C@H](CC2=CN=C(C=C2)C3=CC(=CC=C3)OC(F)(F)F)C(=O)N[C@@H]4CCNC4)C	CCCc1c(C)sc(C(=O)NC(Cc2cnc(-c3cc(OC(F)(F)F)ccc3)cc2)C(=O)NC2CCNC2)c1	InChI=1S/C28H31F3N4O3S/c1-3-5-19-14-25(39-17(19)2)27(37)35-24(26(36)34-21-10-11-32-16-21)12-18-8-9-23(33-15-18)20-6-4-7-22(13-20)38-28(29,30)31/h4,6-9,13-15,21,24,32H,3,5,10-12,16H2,1-2H3,(H,34,36)(H,35,37)/t21-,24-/m1/s1	PMTLKNOARSHUJB-ZJSXRUAMSA-N					doublet; compound annotation
0391_005713	AZ82	C28H31F3N4O3S	4.0056	91885438	CCCC1=C(SC(=C1)C(=O)N[C@H](CC2=CN=C(C=C2)C3=CC(=CC=C3)OC(F)(F)F)C(=O)N[C@@H]4CCNC4)C	CCCc1c(C)sc(C(=O)NC(Cc2cnc(-c3cc(OC(F)(F)F)ccc3)cc2)C(=O)NC2CCNC2)c1	InChI=1S/C28H31F3N4O3S/c1-3-5-19-14-25(39-17(19)2)27(37)35-24(26(36)34-21-10-11-32-16-21)12-18-8-9-23(33-15-18)20-6-4-7-22(13-20)38-28(29,30)31/h4,6-9,13-15,21,24,32H,3,5,10-12,16H2,1-2H3,(H,34,36)(H,35,37)/t21-,24-/m1/s1	PMTLKNOARSHUJB-ZJSXRUAMSA-N					doublet; removed another duplicate entry; compound annotation
0391_005715	Lixivaptan	C27H21ClFN3O2	4.7515	172997		Cc1c(C(=O)Nc2cc(Cl)c(C(=O)N3Cc4cccn4Cc4ccccc43)cc2)cc(F)cc1	InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)	PPHTXRNHTVLQED-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005717	epsilon-momfluorothrin	C19H19F4NO3	5.0199	25015075	C/C(=C/[C@@H]1[C@H](C1(C)C)C(=O)OCC2=C(C(=C(C(=C2F)F)COC)F)F)/C#N	COCc1c(F)c(F)c(COC(=O)C2C(C=C(C)C#N)C2(C)C)c(F)c1F	InChI=1S/C19H19F4NO3/c1-9(6-24)5-12-13(19(12,2)3)18(25)27-8-11-16(22)14(20)10(7-26-4)15(21)17(11)23/h5,12-13H,7-8H2,1-4H3/b9-5-/t12-,13+/m1/s1	DPJITPZADZSLBP-DQXQJKBJSA-N					doublet; removed another duplicate entry; compound annotation
0391_005719	IDO-IN-6	C18H21FN2O2	1.6665	70914234	C1CC(CCC1[C@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O	OC1CCC(C(O)CC2c3c(F)cccc3-c3cncn32)CC1	InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17-/m0/s1	YGACXVRLDHEXKY-VDPJLGHJSA-N					compound annotation
0391_005720	BI 2536	C28H39N7O3	2.0048	11364421	CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C	CCC1C(=O)N(C)c2cnc(Nc3c(OC)cc(C(=O)NC4CCN(C)CC4)cc3)nc2N1C1CCCC1	InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1	XQVVPGYIWAGRNI-JOCHJYFZSA-N					removed another duplicate entry; compound annotation
0391_005722	5-R-Rivaroxaban	C19H18ClN3O5S	2.9404	11524901	C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl	O=C(NCC1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1	InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m1/s1	KGFYHTZWPPHNLQ-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_005724	Lck Inhibitor	C31H30N8O	3.0975	11785878		Cc1c(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c(C)ccc1	InChI=1S/C31H30N8O/c1-20-7-6-8-21(2)27(20)39-29(40)24-19-32-30(35-28(24)38-26-10-5-4-9-25(26)34-31(38)39)33-22-11-13-23(14-12-22)37-17-15-36(3)16-18-37/h4-14,19H,15-18H2,1-3H3,(H,32,33,35)	BHJJWVDKNXABFS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005727	AZD2932	C24H25N5O4	3.1305	11517980		COc1c(OC)cc2c(Oc3ccc(CC(=O)Nc4cn(C(C)C)nc4)cc3)ncnc2c1	InChI=1S/C24H25N5O4/c1-15(2)29-13-17(12-27-29)28-23(30)9-16-5-7-18(8-6-16)33-24-19-10-21(31-3)22(32-4)11-20(19)25-14-26-24/h5-8,10-15H,9H2,1-4H3,(H,28,30)	TWYCZJMOEMMCGC-UHFFFAOYSA-N					doublet; compound annotation
0391_005728	AZD2932	C24H25N5O4	3.1332	11517980		COc1c(OC)cc2c(Oc3ccc(CC(=O)Nc4cn(C(C)C)nc4)cc3)ncnc2c1	InChI=1S/C24H25N5O4/c1-15(2)29-13-17(12-27-29)28-23(30)9-16-5-7-18(8-6-16)33-24-19-10-21(31-3)22(32-4)11-20(19)25-14-26-24/h5-8,10-15H,9H2,1-4H3,(H,28,30)	TWYCZJMOEMMCGC-UHFFFAOYSA-N					doublet; compound annotation
0391_005729	Lck Inhibitor	C31H30N8O	3.1811	11785878		Cc1c(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c(C)ccc1	InChI=1S/C31H30N8O/c1-20-7-6-8-21(2)27(20)39-29(40)24-19-32-30(35-28(24)38-26-10-5-4-9-25(26)34-31(38)39)33-22-11-13-23(14-12-22)37-17-15-36(3)16-18-37/h4-14,19H,15-18H2,1-3H3,(H,32,33,35)	BHJJWVDKNXABFS-UHFFFAOYSA-N					doublet; compound annotation
0391_005730	Lck Inhibitor	C31H30N8O	3.2936	11785878		Cc1c(-n2c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n3c4ccccc4nc23)c(C)ccc1	InChI=1S/C31H30N8O/c1-20-7-6-8-21(2)27(20)39-29(40)24-19-32-30(35-28(24)38-26-10-5-4-9-25(26)34-31(38)39)33-22-11-13-23(14-12-22)37-17-15-36(3)16-18-37/h4-14,19H,15-18H2,1-3H3,(H,32,33,35)	BHJJWVDKNXABFS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005732	chloroxine	C9H5Cl2NO	4.1365	2722		Oc1c(Cl)cc(Cl)c2c1nccc2	InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	WDFKMLRRRCGAKS-UHFFFAOYSA-N					compound annotation
0391_005733	Calcium-Sensing Receptor Antagonists I	C23H24N2O2	4.325	10109178		C#CCOc1cc2c(cc1)n(C(C)C)c(=O)nc2-c1ccc(C(C)C)cc1	InChI=1S/C23H24N2O2/c1-6-13-27-19-11-12-21-20(14-19)22(24-23(26)25(21)16(4)5)18-9-7-17(8-10-18)15(2)3/h1,7-12,14-16H,13H2,2-5H3	RXVZJHDMMKTKDR-UHFFFAOYSA-N					doublet; compound annotation
0391_005734	Calcium-Sensing Receptor Antagonists I	C23H24N2O2	4.5856	10109178		C#CCOc1cc2c(cc1)n(C(C)C)c(=O)nc2-c1ccc(C(C)C)cc1	InChI=1S/C23H24N2O2/c1-6-13-27-19-11-12-21-20(14-19)22(24-23(26)25(21)16(4)5)18-9-7-17(8-10-18)15(2)3/h1,7-12,14-16H,13H2,2-5H3	RXVZJHDMMKTKDR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005736	TMP195	C23H19F3N4O3	5.5235	67324851		CC(C)(CNC(=O)c1cccc(-c2noc(C(F)(F)F)n2)c1)c1coc(-c2ccccc2)n1	InChI=1S/C23H19F3N4O3/c1-22(2,17-12-32-20(28-17)14-7-4-3-5-8-14)13-27-19(31)16-10-6-9-15(11-16)18-29-21(33-30-18)23(24,25)26/h3-12H,13H2,1-2H3,(H,27,31)	QTCSXAUJBQZZSN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005738	Pipamperone	C21H30FN3O2	1.4531	4830		NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	InChI=1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27)	AXKPFOAXAHJUAG-UHFFFAOYSA-N					doublet; compound annotation
0391_005739	Pipamperone	C21H30FN3O2	1.4563	4830		NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1	InChI=1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27)	AXKPFOAXAHJUAG-UHFFFAOYSA-N					doublet; compound annotation
0391_005740	Skf-82958	C19H20ClNO2	2.0143	1225		C=CCN1CCc2c(Cl)c(O)c(O)cc2C(c2ccccc2)C1	InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2	HJWHHQIVUHOBQN-UHFFFAOYSA-N					compound annotation
0391_005741	Eniporide	C14H16N4O3S	2.1995	6433092		Cc1cc(-n2cccc2)c(S(C)(=O)=O)cc1C(=O)N=C(N)N	InChI=1S/C14H16N4O3S/c1-9-7-11(18-5-3-4-6-18)12(22(2,20)21)8-10(9)13(19)17-14(15)16/h3-8H,1-2H3,(H4,15,16,17,19)	UADMBZFZZOBWBB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005743	Betrixaban	C23H22ClN5O3	2.8057	10275777		COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ncc(Cl)cc2)c1	InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)	XHOLNRLADUSQLD-UHFFFAOYSA-N					doublet; compound annotation
0391_005744	841290-80-0	C22H23FN6O5	3.0283	11213558		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4)n2)cc(OC)c1OC	InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)	NHHQJBCNYHBUSI-UHFFFAOYSA-N					doublet; compound annotation
0391_005745	Betrixaban	C23H22ClN5O3	3.0675	10275777		COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ncc(Cl)cc2)c1	InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)	XHOLNRLADUSQLD-UHFFFAOYSA-N					doublet; compound annotation
0391_005746	BI8622	C25H26N6O	3.073	138377590		Cc1c(C(=O)Nc2ccc(CN)cc2)ncnc1N1CCC(C#N)(c2ccccc2)CC1	InChI=1S/C25H26N6O/c1-18-22(24(32)30-21-9-7-19(15-26)8-10-21)28-17-29-23(18)31-13-11-25(16-27,12-14-31)20-5-3-2-4-6-20/h2-10,17H,11-15,26H2,1H3,(H,30,32)	IJHAXMJRQQTBPL-UHFFFAOYSA-N					doublet; compound annotation
0391_005747	BI8622	C25H26N6O	3.0762	138377590		Cc1c(C(=O)Nc2ccc(CN)cc2)ncnc1N1CCC(C#N)(c2ccccc2)CC1	InChI=1S/C25H26N6O/c1-18-22(24(32)30-21-9-7-19(15-26)8-10-21)28-17-29-23(18)31-13-11-25(16-27,12-14-31)20-5-3-2-4-6-20/h2-10,17H,11-15,26H2,1H3,(H,30,32)	IJHAXMJRQQTBPL-UHFFFAOYSA-N					doublet; compound annotation
0391_005748	841290-80-0	C22H23FN6O5	3.1482	11213558		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4)n2)cc(OC)c1OC	InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)	NHHQJBCNYHBUSI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005750	841290-80-0	C22H23FN6O5	3.1514	11213558		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4)n2)cc(OC)c1OC	InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)	NHHQJBCNYHBUSI-UHFFFAOYSA-N					doublet; compound annotation
0391_005751	ZL006	C14H11Cl2NO4	3.805	44207238		O=C(O)c1c(O)cc(NCc2c(O)c(Cl)cc(Cl)c2)cc1	InChI=1S/C14H11Cl2NO4/c15-8-3-7(13(19)11(16)4-8)6-17-9-1-2-10(14(20)21)12(18)5-9/h1-5,17-19H,6H2,(H,20,21)	RTEYSQSXRFVKTJ-UHFFFAOYSA-N					compound annotation
0391_005752	SecinH3	C24H20N4O4S	4.1231	1029232		COc1nn(-c2ccc(NC(=O)CSc3ccccc3)cc2)c(-c2cc3c(cc2)OCO3)n1	InChI=1S/C24H20N4O4S/c1-30-24-26-23(16-7-12-20-21(13-16)32-15-31-20)28(27-24)18-10-8-17(9-11-18)25-22(29)14-33-19-5-3-2-4-6-19/h2-13H,14-15H2,1H3,(H,25,29)	QPGYAMIHXLCFTJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005754	Tebanicline	C9H11ClN2O	0.9642	3075702	C1CN[C@H]1COC2=CN=C(C=C2)Cl	Clc1ncc(OCC2CCN2)cc1	InChI=1S/C9H11ClN2O/c10-9-2-1-8(5-12-9)13-6-7-3-4-11-7/h1-2,5,7,11H,3-4,6H2/t7-/m1/s1	MKTAGSRKQIGEBH-SSDOTTSWSA-N					compound annotation
0391_005755	ERK5-IN-1	C25H29N7O2	2.0169	46844147		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCN(C)CC2)c1	InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)	DDTPGANIPBKTNU-UHFFFAOYSA-N					doublet; compound annotation
0391_005756	607742-69-8	C19H19N3O2S	2.3739	11256720		O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1	InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2	JJZFWROHYSMCMU-UHFFFAOYSA-N					doublet; compound annotation
0391_005757	607742-69-8	C19H19N3O2S	2.3766	11256720		O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1	InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2	JJZFWROHYSMCMU-UHFFFAOYSA-N					doublet; compound annotation
0391_005758	ERK5-IN-1	C25H29N7O2	2.4421	46844147		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCN(C)CC2)c1	InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)	DDTPGANIPBKTNU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005761	ERK5-IN-1	C25H29N7O2	2.6215	46844147		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCN(C)CC2)c1	InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)	DDTPGANIPBKTNU-UHFFFAOYSA-N					doublet; compound annotation
0391_005762	ERK5-IN-1	C25H29N7O2	2.9981	46844147		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCN(C)CC2)c1	InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28)	DDTPGANIPBKTNU-UHFFFAOYSA-N					doublet; compound annotation
0391_005763	Apilimod	C23H26N6O2	3.0159	10173277	CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4	Cc1cc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)ccc1	InChI=1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+	HSKAZIJJKRAJAV-KOEQRZSOSA-N					doublet; compound annotation
0391_005764	Apilimod	C23H26N6O2	3.0219	10173277	CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4	Cc1cc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)ccc1	InChI=1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+	HSKAZIJJKRAJAV-KOEQRZSOSA-N					doublet; removed another duplicate entry; compound annotation
0391_005766	UPF 1069	C17H13NO3	3.0934	25015515		O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1	InChI=1S/C17H13NO3/c19-15(12-5-2-1-3-6-12)11-21-16-8-4-7-14-13(16)9-10-18-17(14)20/h1-10H,11H2,(H,18,20)	JJWMRRNGWSITSQ-UHFFFAOYSA-N					doublet; compound annotation
0391_005767	Apilimod	C23H26N6O2	3.0934	10173277	CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4	Cc1cc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)ccc1	InChI=1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+	HSKAZIJJKRAJAV-KOEQRZSOSA-N					doublet; compound annotation
0391_005768	UPF 1069	C17H13NO3	3.0963	25015515		O=C(COc1cccc2c1cc[nH]c2=O)c1ccccc1	InChI=1S/C17H13NO3/c19-15(12-5-2-1-3-6-12)11-21-16-8-4-7-14-13(16)9-10-18-17(14)20/h1-10H,11H2,(H,18,20)	JJWMRRNGWSITSQ-UHFFFAOYSA-N					doublet; compound annotation
0391_005769	116686-15-8	C15H13F2NO4S	3.5526	164009		CC(=O)c1cc(Oc2c(F)cc(F)cc2)c(NS(C)(=O)=O)cc1	InChI=1S/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3	DIIYLGZNZGPXRR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005771	Elagolix	C32H30F5N3O5	3.6633	11250647	CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F	COc1cccc(-c2c(C)n(Cc3c(C(F)(F)F)cccc3F)c(=O)n(CC(NCCCC(=O)O)c3ccccc3)c2=O)c1F	InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1	HEAUOKZIVMZVQL-VWLOTQADSA-N					doublet; removed another duplicate entry; compound annotation
0391_005773	GPR40 Activator 2	C28H29NO6S2	4.2755	67121842		Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc(-c3cc(=O)[nH][s+]3[O-])cc2)c1	InChI=1S/C28H29NO6S2/c1-19-14-25(34-12-5-13-37(3,32)33)15-20(2)28(19)23-7-4-6-21(16-23)18-35-24-10-8-22(9-11-24)26-17-27(30)29-36(26)31/h4,6-11,14-17H,5,12-13,18H2,1-3H3,(H,29,30)	AUYCNSCKGNAXFS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005776	gw5074	C15H8Br2INO2	4.3122	5924208	C1=CC2=C(C=C1I)/C(=C/C3=CC(=C(C(=C3)Br)O)Br)/C(=O)N2	O=C1Nc2c(cc(I)cc2)C1=Cc1cc(Br)c(O)c(Br)c1	InChI=1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3-	LMXYVLFTZRPNRV-KMKOMSMNSA-N					doublet; compound annotation
0391_005777	gw5074	C15H8Br2INO2	4.935	5924208	C1=CC2=C(C=C1I)/C(=C/C3=CC(=C(C(=C3)Br)O)Br)/C(=O)N2	O=C1Nc2c(cc(I)cc2)C1=Cc1cc(Br)c(O)c(Br)c1	InChI=1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3-	LMXYVLFTZRPNRV-KMKOMSMNSA-N					doublet; compound annotation
0391_005778	CM-4620	C19H11ClF3N3O3	5.1937	122507647		Cc1c(C(=O)Nc2ncc(-c3cc4c(cc3Cl)OC(F)(F)O4)nc2)c(F)ccc1	InChI=1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27)	QQMKTHUGOQDEIL-UHFFFAOYSA-N					compound annotation
0391_005779	TRC051384	C25H31N5O4	1.8072	11634093	C1COCCN1CCNC(=O)NC2=CC=C(C=C2)C(=O)/C=C/C3=NC(=CC=C3)N4CCOCC4	O=C(NCCN1CCOCC1)Nc1ccc(C(=O)C=Cc2nc(N3CCOCC3)ccc2)cc1	InChI=1S/C25H31N5O4/c31-23(9-8-21-2-1-3-24(27-21)30-14-18-34-19-15-30)20-4-6-22(7-5-20)28-25(32)26-10-11-29-12-16-33-17-13-29/h1-9H,10-19H2,(H2,26,28,32)/b9-8+	SQTSPANZQDCPLB-CMDGGOBGSA-N					doublet; compound annotation
0391_005780	Purpurogalline	C11H8O5	2.4053	5281571		O=c1cccc2cc(O)c(O)c(O)c2c1O	InChI=1S/C11H8O5/c12-6-3-1-2-5-4-7(13)10(15)11(16)8(5)9(6)14/h1-4,13,15-16H,(H,12,14)	WDGFFVCWBZVLCE-UHFFFAOYSA-N					compound annotation
0391_005781	E6130	C28H37ClF3N3O3	2.4652	71293692	C[C@H]1CN(C[C@@]1(CC(=O)O)C(=O)NC2CCN(CC2)CC3=CCCCC3)CC4=C(C=CC=C4Cl)C(F)(F)F	CC1CN(Cc2c(C(F)(F)F)cccc2Cl)CC1(CC(=O)O)C(=O)NC1CCN(CC2=CCCCC2)CC1	InChI=1S/C28H37ClF3N3O3/c1-19-15-35(17-22-23(28(30,31)32)8-5-9-24(22)29)18-27(19,14-25(36)37)26(38)33-21-10-12-34(13-11-21)16-20-6-3-2-4-7-20/h5-6,8-9,19,21H,2-4,7,10-18H2,1H3,(H,33,38)(H,36,37)/t19-,27+/m0/s1	JTJKDYLEMNXXER-UZTOHYMASA-N					compound annotation
0391_005782	TRC051384	C25H31N5O4	2.5221	11634093	C1COCCN1CCNC(=O)NC2=CC=C(C=C2)C(=O)/C=C/C3=NC(=CC=C3)N4CCOCC4	O=C(NCCN1CCOCC1)Nc1ccc(C(=O)C=Cc2nc(N3CCOCC3)ccc2)cc1	InChI=1S/C25H31N5O4/c31-23(9-8-21-2-1-3-24(27-21)30-14-18-34-19-15-30)20-4-6-22(7-5-20)28-25(32)26-10-11-29-12-16-33-17-13-29/h1-9H,10-19H2,(H2,26,28,32)/b9-8+	SQTSPANZQDCPLB-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_005784	Vorolanib	C23H26FN5O3	2.6317	59215954	CC1=C(NC(=C1C(=O)N[C@H]2CCN(C2)C(=O)N(C)C)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NC2CCN(C(=O)N(C)C)C2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H26FN5O3/c1-12-19(10-17-16-9-14(24)5-6-18(16)27-21(17)30)25-13(2)20(12)22(31)26-15-7-8-29(11-15)23(32)28(3)4/h5-6,9-10,15,25H,7-8,11H2,1-4H3,(H,26,31)(H,27,30)/b17-10-/t15-/m0/s1	KMIOJWCYOHBUJS-HAKPAVFJSA-N					doublet; removed another duplicate entry; compound annotation
0391_005787	WAY-213613	C16H13BrF2N2O4	3.1182	11531745	C1=CC(=CC=C1NC(=O)C[C@@H](C(=O)O)N)OC2=CC(=C(C=C2Br)F)F	NC(CC(=O)Nc1ccc(Oc2cc(F)c(F)cc2Br)cc1)C(=O)O	InChI=1S/C16H13BrF2N2O4/c17-10-5-11(18)12(19)6-14(10)25-9-3-1-8(2-4-9)21-15(22)7-13(20)16(23)24/h1-6,13H,7,20H2,(H,21,22)(H,23,24)/t13-/m0/s1	BNYDDAAZMBUFRG-ZDUSSCGKSA-N					compound annotation
0391_005788	TRC051384	C25H31N5O4	3.1182	11634093	C1COCCN1CCNC(=O)NC2=CC=C(C=C2)C(=O)/C=C/C3=NC(=CC=C3)N4CCOCC4	O=C(NCCN1CCOCC1)Nc1ccc(C(=O)C=Cc2nc(N3CCOCC3)ccc2)cc1	InChI=1S/C25H31N5O4/c31-23(9-8-21-2-1-3-24(27-21)30-14-18-34-19-15-30)20-4-6-22(7-5-20)28-25(32)26-10-11-29-12-16-33-17-13-29/h1-9H,10-19H2,(H2,26,28,32)/b9-8+	SQTSPANZQDCPLB-CMDGGOBGSA-N					doublet; compound annotation
0391_005789	PF-00446687	C28H36F2N2O2	3.2204	11328898	C[C@@H]1CN(C[C@@H](C1(C2=CC=CC=C2)O)C)C(=O)[C@@H]3CN(C[C@H]3C4=C(C=C(C=C4)F)F)C(C)(C)C	CC1CN(C(=O)C2CN(C(C)(C)C)CC2c2c(F)cc(F)cc2)CC(C)C1(O)c1ccccc1	InChI=1S/C28H36F2N2O2/c1-18-14-31(15-19(2)28(18,34)20-9-7-6-8-10-20)26(33)24-17-32(27(3,4)5)16-23(24)22-12-11-21(29)13-25(22)30/h6-13,18-19,23-24,34H,14-17H2,1-5H3/t18-,19+,23-,24+,28?/m0/s1	WHPJOAUPIZDJNX-YTEQHECZSA-N					compound annotation
0391_005790	2166616-75-5	C23H25FN2O3	3.3303	132209614	C[C@H](C1=CC2=C(C=C1)N(CC2)C(=O)C3CCOCC3)NC(=O)C4=CC=C(C=C4)F	CC(NC(=O)c1ccc(F)cc1)c1cc2c(cc1)N(C(=O)C1CCOCC1)CC2	InChI=1S/C23H25FN2O3/c1-15(25-22(27)16-2-5-20(24)6-3-16)18-4-7-21-19(14-18)8-11-26(21)23(28)17-9-12-29-13-10-17/h2-7,14-15,17H,8-13H2,1H3,(H,25,27)/t15-/m1/s1	NUBWFWVVKLRSHS-OAHLLOKOSA-N					doublet; compound annotation
0391_005791	2166616-75-5	C23H25FN2O3	3.3332	132209614	C[C@H](C1=CC2=C(C=C1)N(CC2)C(=O)C3CCOCC3)NC(=O)C4=CC=C(C=C4)F	CC(NC(=O)c1ccc(F)cc1)c1cc2c(cc1)N(C(=O)C1CCOCC1)CC2	InChI=1S/C23H25FN2O3/c1-15(25-22(27)16-2-5-20(24)6-3-16)18-4-7-21-19(14-18)8-11-26(21)23(28)17-9-12-29-13-10-17/h2-7,14-15,17H,8-13H2,1H3,(H,25,27)/t15-/m1/s1	NUBWFWVVKLRSHS-OAHLLOKOSA-N					doublet; compound annotation
0391_005792	Vorolanib	C23H26FN5O3	3.3332	59215954	CC1=C(NC(=C1C(=O)N[C@H]2CCN(C2)C(=O)N(C)C)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NC2CCN(C(=O)N(C)C)C2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H26FN5O3/c1-12-19(10-17-16-9-14(24)5-6-18(16)27-21(17)30)25-13(2)20(12)22(31)26-15-7-8-29(11-15)23(32)28(3)4/h5-6,9-10,15,25H,7-8,11H2,1-4H3,(H,26,31)(H,27,30)/b17-10-/t15-/m0/s1	KMIOJWCYOHBUJS-HAKPAVFJSA-N					doublet; removed another duplicate entry; compound annotation
0391_005795	UMECLIDINIUM	C29H34NO2+	3.5992	11519070		OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2	InChI=1S/C29H34NO2/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25/h1-15,31H,16-24H2/q+1	FVTWTVQXNAJTQP-UHFFFAOYSA-N					compound annotation
0391_005796	C25-140	C26H31N7O	3.8119	53093165		Cc1nn(-c2nn3c(C)nnc3cc2)c(C)c1CCC(=O)N1CCC(Cc2ccccc2)CC1	InChI=1S/C26H31N7O/c1-18-23(19(2)32(29-18)25-11-10-24-28-27-20(3)33(24)30-25)9-12-26(34)31-15-13-22(14-16-31)17-21-7-5-4-6-8-21/h4-8,10-11,22H,9,12-17H2,1-3H3	HFKVRXVHZGBRKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005798	Allosecurinine	C13H15NO2	0.4974	12305986	C1CCN2[C@@H](C1)[C@]34C[C@H]2C=CC3=CC(=O)O4	O=C1C=C2C=CC3CC2(O1)C1CCCCN31	InChI=1S/C13H15NO2/c15-12-7-9-4-5-10-8-13(9,16-12)11-3-1-2-6-14(10)11/h4-5,7,10-11H,1-3,6,8H2/t10-,11+,13+/m1/s1	SWZMSZQQJRKFBP-MDZLAQPJSA-N					removed another duplicate entry; compound annotation
0391_005800	dropropizine	C13H20N2O2	1.1136	3169		OCC(O)CN1CCN(c2ccccc2)CC1	InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2	PTVWPYVOOKLBCG-UHFFFAOYSA-N					compound annotation
0391_005801	Eurycomanone	C20H24O9	1.2526	13936691	CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@]([C@@H](C(=C)[C@@]4([C@H](C(=O)O3)O)O)O)(OC5)O)C)O	C=C1C(O)C2(O)OCC34C(CC5C(C)=CC(=O)C(O)C5(C)C23)OC(=O)C(O)C14O	InChI=1S/C20H24O9/c1-7-4-10(21)13(23)17(3)9(7)5-11-18-6-28-20(27,16(17)18)12(22)8(2)19(18,26)14(24)15(25)29-11/h4,9,11-14,16,22-24,26-27H,2,5-6H2,1,3H3/t9-,11+,12+,13+,14-,16+,17+,18+,19-,20-/m0/s1	UCUWZJWAQQRCOR-OKNZMGBLSA-N					removed another duplicate entry; compound annotation
0391_005803	(-)-Catechin gallate	C22H18O10	1.8642	6419835	C1[C@H]([C@@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O	O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)cc1)c1cc(O)c(O)c(O)c1	InChI=1S/C22H18O10/c23-11-6-14(25)12-8-19(32-22(30)10-4-16(27)20(29)17(28)5-10)21(31-18(12)7-11)9-1-2-13(24)15(26)3-9/h1-7,19,21,23-29H,8H2/t19-,21+/m1/s1	LSHVYAFMTMFKBA-CTNGQTDRSA-N					compound annotation
0391_005804	Ceftiofur	C19H17N5O7S3	2.2507	6328657	CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CSC12)c1csc(N)n1	InChI=1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1	ZBHXIWJRIFEVQY-IHMPYVIRSA-N					doublet; compound annotation
0391_005805	Ceftiofur	C19H17N5O7S3	2.3246	6328657	CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CSC12)c1csc(N)n1	InChI=1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1	ZBHXIWJRIFEVQY-IHMPYVIRSA-N					doublet; removed another duplicate entry; compound annotation
0391_005807	Ceftiofur	C19H17N5O7S3	2.46	6328657	CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSC(=O)c3ccco3)CSC12)c1csc(N)n1	InChI=1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1	ZBHXIWJRIFEVQY-IHMPYVIRSA-N					doublet; removed another duplicate entry; compound annotation
0391_005809	xylometazoline	C16H24N2	2.9355	5709		Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1	InChI=1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18)	HUCJFAOMUPXHDK-UHFFFAOYSA-N					compound annotation
0391_005810	prednisolone acetate	C23H30O6	3.3091	5834	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C	InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	LRJOMUJRLNCICJ-JZYPGELDSA-N					removed another duplicate entry; compound annotation
0391_005812	Oxeladin	C20H33NO3	3.3139	4619		CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1	InChI=1S/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1-4H3	IQADUMSPOQKAAO-UHFFFAOYSA-N					compound annotation
0391_005813	exalamide	C13H19NO2	4.1098	3316		CCCCCCOc1ccccc1C(N)=O	InChI=1S/C13H19NO2/c1-2-3-4-7-10-16-12-9-6-5-8-11(12)13(14)15/h5-6,8-9H,2-4,7,10H2,1H3,(H2,14,15)	CKSJXOVLXUMMFF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005815	Mexenone	C15H14O3	4.8748	71645		COc1cc(O)c(C(=O)c2ccc(C)cc2)cc1	InChI=1S/C15H14O3/c1-10-3-5-11(6-4-10)15(17)13-8-7-12(18-2)9-14(13)16/h3-9,16H,1-2H3	MJVGBKJNTFCUJM-UHFFFAOYSA-N					compound annotation
0391_005816	162857-78-5	C25H28O15	1.7522	11169063	COC1=C(C=C2C(=C1)C(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@](CO5)(CO)O)O)O)O)O)O)O	COc1c(O)cc2oc3c(c(O)c(C4OC(COC5OCC(O)(CO)C5O)C(O)C(O)C4O)c(O)c3)c(=O)c2c1	InChI=1S/C25H28O15/c1-36-12-2-8-11(3-9(12)27)39-13-4-10(28)15(19(31)16(13)17(8)29)22-21(33)20(32)18(30)14(40-22)5-37-24-23(34)25(35,6-26)7-38-24/h2-4,14,18,20-24,26-28,30-35H,5-7H2,1H3/t14-,18-,20+,21-,22+,23+,24-,25-/m1/s1	LLJUCXMVRPAONX-AYATVRNWSA-N					removed another duplicate entry; compound annotation
0391_005818	INDOLE-3-CARBOXALDEHYDE	C9H7NO	2.032	10256		O=Cc1c[nH]c2ccccc12	InChI=1S/C9H7NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-6,10H	OLNJUISKUQQNIM-UHFFFAOYSA-N					compound annotation
0391_005819	7-Methoxycoumarin	C10H8O3	2.6405	10748		COc1cc2c(cc1)ccc(=O)o2	InChI=1S/C10H8O3/c1-12-8-4-2-7-3-5-10(11)13-9(7)6-8/h2-6H,1H3	LIIALPBMIOVAHH-UHFFFAOYSA-N					compound annotation
0391_005820	2,6-Dihydroxyanthraquinone	C14H8O4	2.648	6776		O=C1c2c(cc(O)cc2)C(=O)c2c1cc(O)cc2	InChI=1S/C14H8O4/c15-7-1-3-9-11(5-7)14(18)10-4-2-8(16)6-12(10)13(9)17/h1-6,15-16H	APAJFZPFBHMFQR-UHFFFAOYSA-N					compound annotation
0391_005821	6-Methylcoumarin	C10H8O2	2.9443	7092		Cc1cc2c(cc1)oc(=O)cc2	InChI=1S/C10H8O2/c1-7-2-4-9-8(6-7)3-5-10(11)12-9/h2-6H,1H3	FXFYOPQLGGEACP-UHFFFAOYSA-N					doublet; compound annotation
0391_005822	6-Methylcoumarin	C10H8O2	3.1626	7092		Cc1cc2c(cc1)oc(=O)cc2	InChI=1S/C10H8O2/c1-7-2-4-9-8(6-7)3-5-10(11)12-9/h2-6H,1H3	FXFYOPQLGGEACP-UHFFFAOYSA-N					doublet; compound annotation
0391_005823	maprotiline	C20H23N	3.1626	4011		CNCCCC12CCC(c3ccccc31)c1ccccc12	InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3	QSLMDECMDJKHMQ-UHFFFAOYSA-N					compound annotation
0391_005824	20(R)-ginsenoside Rg3	C42H72O13	4.3826	46887680	CC(=CCC[C@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C	CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C	InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42+/m0/s1	RWXIFXNRCLMQCD-CZIWJLDFSA-N					compound annotation
0391_005825	22255-22-7	C17H18O3	5.0186	5388063	COC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)OC)OC	COc1ccc(C=Cc2cc(OC)cc(OC)c2)cc1	InChI=1S/C17H18O3/c1-18-15-8-6-13(7-9-15)4-5-14-10-16(19-2)12-17(11-14)20-3/h4-12H,1-3H3/b5-4+	GDHNBPHYVRHYCC-SNAWJCMRSA-N					removed another duplicate entry; compound annotation
0391_005827	daphnetin	C9H6O4	1.4642	5280569		O=c1ccc2c(o1)c(O)c(O)cc2	InChI=1S/C9H6O4/c10-6-3-1-5-2-4-7(11)13-9(5)8(6)12/h1-4,10,12H	ATEFPOUAMCWAQS-UHFFFAOYSA-N					compound annotation
0391_005828	928853-86-5	C16H19N5S	1.6522	44423602		Cc1c2Nc3ccccc3Sc2nc(N2CCN(C)CC2)n1	InChI=1S/C16H19N5S/c1-11-14-15(22-13-6-4-3-5-12(13)18-14)19-16(17-11)21-9-7-20(2)8-10-21/h3-6,18H,7-10H2,1-2H3	HYPHGMNLWIKEMB-UHFFFAOYSA-N					compound annotation
0391_005829	Samotolisib	C23H26N4O3	1.6779	57519748	C[C@@H](CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC	COC(C)Cn1c(=O)n(C)c2cnc3ccc(-c4cc(C(C)(C)O)cnc4)cc3c21	InChI=1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1	ACCFLVVUVBJNGT-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_005831	Metipranolol	C17H27NO4	2.4822	31477		CC(=O)Oc1c(C)c(C)c(OCC(O)CNC(C)C)cc1C	InChI=1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3	BQIPXWYNLPYNHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005833	VHL Ligand 8	C23H29N3O6	2.6886	145925677	CC1=NOC(=C1)[C@@H](C(C)C)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@H](CC(=O)O)C3=CC=CC=C3)O	Cc1noc(C(C(=O)N2CC(O)CC2C(=O)NC(CC(=O)O)c2ccccc2)C(C)C)c1	InChI=1S/C23H29N3O6/c1-13(2)21(19-9-14(3)25-32-19)23(31)26-12-16(27)10-18(26)22(30)24-17(11-20(28)29)15-7-5-4-6-8-15/h4-9,13,16-18,21,27H,10-12H2,1-3H3,(H,24,30)(H,28,29)/t16-,17+,18+,21-/m1/s1	BYUIKERVKHGIMC-OEMYIYORSA-N					removed another duplicate entry; compound annotation
0391_005835	NS-018	C21H20FN7	2.7795	46866319	C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C	CC(Nc1cc(-c2cn(C)nc2)cc(Nc2nccnc2)n1)c1ccc(F)cc1	InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1	UQTPDWDAYHAZNT-AWEZNQCLSA-N					doublet; compound annotation
0391_005836	Camalexin	C11H8N2S	2.8821	636970		c1ccc2c(-c3nccs3)c[nH]c2c1	InChI=1S/C11H8N2S/c1-2-4-10-8(3-1)9(7-13-10)11-12-5-6-14-11/h1-7,13H	IYODIJVWGPRBGQ-UHFFFAOYSA-N					compound annotation
0391_005837	TEDATIOXETINE	C18H21NS	3.3693	9878913		Cc1ccc(Sc2ccccc2C2CCNCC2)cc1	InChI=1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3	CVASBKDYSQKLSO-UHFFFAOYSA-N					compound annotation
0391_005838	EGCG Octaacetate	C38H34O19	4.5886	11787645	CC(=O)OC1=CC2=C(C[C@H]([C@H](O2)C3=CC(=C(C(=C3)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C4=CC(=C(C(=C4)OC(=O)C)OC(=O)C)OC(=O)C)C(=C1)OC(=O)C	CC(=O)Oc1cc2c(CC(OC(=O)c3cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c3)C(c3cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c3)O2)c(OC(C)=O)c1	InChI=1S/C38H34O19/c1-16(39)48-26-13-28(49-17(2)40)27-15-34(57-38(47)25-11-32(52-20(5)43)37(55-23(8)46)33(12-25)53-21(6)44)35(56-29(27)14-26)24-9-30(50-18(3)41)36(54-22(7)45)31(10-24)51-19(4)42/h9-14,34-35H,15H2,1-8H3/t34-,35-/m1/s1	SVHJCTSSYQPWEV-VSJLXWSYSA-N					compound annotation
0391_005839	Ursonic acid	C30H46O3	6.4781	9890209	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCC(=O)C5(C)C)C)C)[C@@H]2[C@H]1C)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(=O)C(C)(C)C5CCC43C)C2C1C	InChI=1S/C30H46O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18-19,21-22,24H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21+,22-,24+,27+,28-,29-,30+/m1/s1	MUCRYNWJQNHDJH-OADIDDRXSA-N					compound annotation
0391_005840	DIMINAZENE	C14H15N7	0.628	2354		N=C(N)c1ccc(N=NNc2ccc(C(=N)N)cc2)cc1	InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)	XNYZHCFCZNMTFY-UHFFFAOYSA-N					doublet; compound annotation
0391_005841	E-4031	C21H27N3O3S	1.3032	3185		Cc1nc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)ccc1	InChI=1S/C21H27N3O3S/c1-16-4-3-5-19(22-16)12-15-24-13-10-18(11-14-24)21(25)17-6-8-20(9-7-17)23-28(2,26)27/h3-9,18,23H,10-15H2,1-2H3	SRUISGSHWFJION-UHFFFAOYSA-N					compound annotation
0391_005842	LY2857785	C26H36N6O	1.6215	78357764		CC(C)c1c2cc(-c3nc(NC4CCC(NC5CCOCC5)CC4)ncc3)ccc2nn1C	InChI=1S/C26H36N6O/c1-17(2)25-22-16-18(4-9-24(22)31-32(25)3)23-10-13-27-26(30-23)29-20-7-5-19(6-8-20)28-21-11-14-33-15-12-21/h4,9-10,13,16-17,19-21,28H,5-8,11-12,14-15H2,1-3H3,(H,27,29,30)	LHIUZPIDLZYPRL-UHFFFAOYSA-N					doublet; compound annotation
0391_005843	ENMD-2076	C21H25N7	1.7447	16041424	CC1=CC(=NN1)NC2=CC(=NC(=N2)/C=C/C3=CC=CC=C3)N4CCN(CC4)C	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	BLQYVHBZHAISJM-CMDGGOBGSA-N					doublet; compound annotation
0391_005844	LY2857785	C26H36N6O	2.0085	78357764		CC(C)c1c2cc(-c3nc(NC4CCC(NC5CCOCC5)CC4)ncc3)ccc2nn1C	InChI=1S/C26H36N6O/c1-17(2)25-22-16-18(4-9-24(22)31-32(25)3)23-10-13-27-26(30-23)29-20-7-5-19(6-8-20)28-21-11-14-33-15-12-21/h4,9-10,13,16-17,19-21,28H,5-8,11-12,14-15H2,1-3H3,(H,27,29,30)	LHIUZPIDLZYPRL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005846	ENMD-2076	C21H25N7	2.0557	16041424	CC1=CC(=NN1)NC2=CC(=NC(=N2)/C=C/C3=CC=CC=C3)N4CCN(CC4)C	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1	InChI=1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+	BLQYVHBZHAISJM-CMDGGOBGSA-N					doublet; compound annotation
0391_005847	142557-61-7	C13H15N5O3	2.1243	14998470		CCn1c(=O)c2cc(C(N)=O)c(N)nc2n(C2CC2)c1=O	InChI=1S/C13H15N5O3/c1-2-17-12(20)8-5-7(10(15)19)9(14)16-11(8)18(13(17)21)6-3-4-6/h5-6H,2-4H2,1H3,(H2,14,16)(H2,15,19)	HWODCHXORCTEGU-UHFFFAOYSA-N					compound annotation
0391_005848	LY2857785	C26H36N6O	2.1243	78357764		CC(C)c1c2cc(-c3nc(NC4CCC(NC5CCOCC5)CC4)ncc3)ccc2nn1C	InChI=1S/C26H36N6O/c1-17(2)25-22-16-18(4-9-24(22)31-32(25)3)23-10-13-27-26(30-23)29-20-7-5-19(6-8-20)28-21-11-14-33-15-12-21/h4,9-10,13,16-17,19-21,28H,5-8,11-12,14-15H2,1-3H3,(H,27,29,30)	LHIUZPIDLZYPRL-UHFFFAOYSA-N					doublet; compound annotation
0391_005849	LY2857785	C26H36N6O	2.189	78357764		CC(C)c1c2cc(-c3nc(NC4CCC(NC5CCOCC5)CC4)ncc3)ccc2nn1C	InChI=1S/C26H36N6O/c1-17(2)25-22-16-18(4-9-24(22)31-32(25)3)23-10-13-27-26(30-23)29-20-7-5-19(6-8-20)28-21-11-14-33-15-12-21/h4,9-10,13,16-17,19-21,28H,5-8,11-12,14-15H2,1-3H3,(H,27,29,30)	LHIUZPIDLZYPRL-UHFFFAOYSA-N					doublet; compound annotation
0391_005850	ACHP	C21H24N4O2	2.6468	135465539		N#Cc1c(N)nc(-c2c(O)cccc2OCC2CC2)cc1C1CCNCC1	InChI=1S/C21H24N4O2/c22-11-16-15(14-6-8-24-9-7-14)10-17(25-21(16)23)20-18(26)2-1-3-19(20)27-12-13-4-5-13/h1-3,10,13-14,24,26H,4-9,12H2,(H2,23,25)	DYVFBWXIOCLHPP-UHFFFAOYSA-N					compound annotation
0391_005851	Taltobulin	C27H43N3O4	2.9344	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; removed another duplicate entry; compound annotation
0391_005853	A-770041	C34H39N9O3	2.985	9549184		COc1c(NC(=O)c2cc3ccccc3n2C)ccc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)c1	InChI=1S/C34H39N9O3/c1-21(44)41-14-16-42(17-15-41)24-9-11-25(12-10-24)43-33-30(32(35)36-20-37-33)31(39-43)23-8-13-26(29(19-23)46-3)38-34(45)28-18-22-6-4-5-7-27(22)40(28)2/h4-8,13,18-20,24-25H,9-12,14-17H2,1-3H3,(H,38,45)(H2,35,36,37)	ZMNWFTYYYCSSTF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005855	Taltobulin	C27H43N3O4	3.1773	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_005856	DIMINAZENE	C14H15N7	4.3196	2354		N=C(N)c1ccc(N=NNc2ccc(C(=N)N)cc2)cc1	InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)	XNYZHCFCZNMTFY-UHFFFAOYSA-N					doublet; compound annotation
0391_005857	325970-71-6	C16H14Br2N4O4	5.0002	135419707	CC1=C(C=C(C=C1Br)NCC(=O)N/N=C/C2=C(C=CC(=C2)[N+](=O)[O-])O)Br	Cc1c(Br)cc(NCC(=O)NN=Cc2c(O)ccc([N+](=O)[O-])c2)cc1Br	InChI=1S/C16H14Br2N4O4/c1-9-13(17)5-11(6-14(9)18)19-8-16(24)21-20-7-10-4-12(22(25)26)2-3-15(10)23/h2-7,19,23H,8H2,1H3,(H,21,24)/b20-7+	KFEPVFJQVOMODD-IFRROFPPSA-N					compound annotation
0391_005858	AMG319	C21H16FN7	2.3607	68947304	C[C@@H](C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5	CC(Nc1ncnc2c1[nH]cn2)c1cc2ccc(F)cc2nc1-c1ccccn1	InChI=1S/C21H16FN7/c1-12(28-21-19-20(25-10-24-19)26-11-27-21)15-8-13-5-6-14(22)9-17(13)29-18(15)16-4-2-3-7-23-16/h2-12H,1H3,(H2,24,25,26,27,28)/t12-/m0/s1	KWRYMZHCQIOOEB-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_005860	Cyt387	C23H22N6O2	2.6996	25062766		N#CCNC(=O)c1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)cc1	InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)	ZVHNDZWQTBEVRY-UHFFFAOYSA-N					doublet; compound annotation
0391_005861	215543-92-3	C17H16N2O3	2.9934	5289418	CC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O	Cc1c[nH]c(C=C2C(=O)Nc3ccccc23)c1CCC(=O)O	InChI=1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8-	JNDVEAXZWJIOKB-JYRVWZFOSA-N					doublet; removed another duplicate entry; compound annotation
0391_005864	AX-024	C21H22FNO2	3.041	56949412		COc1cc2c(cc1)OCC(CN1CCCC1)=C2c1ccc(F)cc1	InChI=1S/C21H22FNO2/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23/h4-9,12H,2-3,10-11,13-14H2,1H3	VMMKGVRPILDZML-UHFFFAOYSA-N					doublet; compound annotation
0391_005865	Bobcat339	C16H12ClN3O	3.2268	138319673		Nc1nc(=O)n(-c2cccc(-c3ccccc3)c2)cc1Cl	InChI=1S/C16H12ClN3O/c17-14-10-20(16(21)19-15(14)18)13-8-4-7-12(9-13)11-5-2-1-3-6-11/h1-10H,(H2,18,19,21)	QMGYGOOYCNTEQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005867	215543-92-3	C17H16N2O3	3.3917	5289418	CC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O	Cc1c[nH]c(C=C2C(=O)Nc3ccccc23)c1CCC(=O)O	InChI=1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8-	JNDVEAXZWJIOKB-JYRVWZFOSA-N					doublet; removed another duplicate entry; compound annotation
0391_005869	CDK12-IN-3	C23H28F2N8O	3.5041	134691746	CC(C)N1C=NC2=C(N=C(N=C21)N3CCCC[C@H]3CCO)NCC4=NC5=C(N4)C=CC(=C5F)F	CC(C)n1cnc2c(NCc3nc4c(ccc(F)c4F)[nH]3)nc(N3CCCCC3CCO)nc21	InChI=1S/C23H28F2N8O/c1-13(2)33-12-27-20-21(26-11-17-28-16-7-6-15(24)18(25)19(16)29-17)30-23(31-22(20)33)32-9-4-3-5-14(32)8-10-34/h6-7,12-14,34H,3-5,8-11H2,1-2H3,(H,28,29)(H,26,30,31)/t14-/m0/s1	KULPPFCRBINTBS-AWEZNQCLSA-N					doublet; compound annotation
0391_005870	CDK12-IN-3	C23H28F2N8O	3.5089	134691746	CC(C)N1C=NC2=C(N=C(N=C21)N3CCCC[C@H]3CCO)NCC4=NC5=C(N4)C=CC(=C5F)F	CC(C)n1cnc2c(NCc3nc4c(ccc(F)c4F)[nH]3)nc(N3CCCCC3CCO)nc21	InChI=1S/C23H28F2N8O/c1-13(2)33-12-27-20-21(26-11-17-28-16-7-6-15(24)18(25)19(16)29-17)30-23(31-22(20)33)32-9-4-3-5-14(32)8-10-34/h6-7,12-14,34H,3-5,8-11H2,1-2H3,(H,28,29)(H,26,30,31)/t14-/m0/s1	KULPPFCRBINTBS-AWEZNQCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_005872	Indibulin	C22H16ClN3O2	3.6226	2929		O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12	InChI=1S/C22H16ClN3O2/c23-16-7-5-15(6-8-16)13-26-14-19(18-3-1-2-4-20(18)26)21(27)22(28)25-17-9-11-24-12-10-17/h1-12,14H,13H2,(H,24,25,28)	SOLIIYNRSAWTSQ-UHFFFAOYSA-N					compound annotation
0391_005873	NELOTANSERIN	C18H15BrF2N4O2	4.0643	11683556		COc1c(-c2c(Br)cnn2C)cc(NC(=O)Nc2c(F)cc(F)cc2)cc1	InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)	COSPVUFTLGQDQL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005875	CHEMBL1624037	C18H27N3O3	2.0177	25010776		CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1	InChI=1S/C18H27N3O3/c1-3-24-18(23)21-12-8-15(9-13-21)19-10-11-20-17(22)16-7-5-4-6-14(16)2/h4-7,15,19H,3,8-13H2,1-2H3,(H,20,22)	ZBSSIYGXZQZYDM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005877	Naquotinib	C30H42N8O3	2.2522	71667668	CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C	C=CC(=O)N1CCC(Oc2c(CC)nc(C(N)=O)c(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)n2)C1	InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1	QKDCLUARMDUUKN-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_005880	RIP2 kinase inhibitor 2	C21H28N4O4S	2.3552	73426595		COCCOc1c(S(=O)(=O)C(C)(C)C)cc2c(Nc3n[nH]c(C)c3C)ccnc2c1	InChI=1S/C21H28N4O4S/c1-13-14(2)24-25-20(13)23-16-7-8-22-17-12-18(29-10-9-28-6)19(11-15(16)17)30(26,27)21(3,4)5/h7-8,11-12H,9-10H2,1-6H3,(H2,22,23,24,25)	QODPGRHWJBWTJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005882	Nelociguat	C19H17FN8O2	2.4859	11690019		COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3c2cccn3)nc1N	InChI=1S/C19H17FN8O2/c1-30-19(29)24-14-15(21)25-17(26-16(14)22)13-11-6-4-8-23-18(11)28(27-13)9-10-5-2-3-7-12(10)20/h2-8H,9H2,1H3,(H,24,29)(H4,21,22,25,26)	FTQHGWIXJSSWOY-UHFFFAOYSA-N					doublet; compound annotation
0391_005883	Nelociguat	C19H17FN8O2	2.4891	11690019		COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3c2cccn3)nc1N	InChI=1S/C19H17FN8O2/c1-30-19(29)24-14-15(21)25-17(26-16(14)22)13-11-6-4-8-23-18(11)28(27-13)9-10-5-2-3-7-12(10)20/h2-8H,9H2,1H3,(H,24,29)(H4,21,22,25,26)	FTQHGWIXJSSWOY-UHFFFAOYSA-N					doublet; compound annotation
0391_005884	SID 3712249	C17H21N7	2.5888	2997948		N#Cc1c(N2CCCC2)nc(N)c2c(N)nc(N3CCCC3)cc12	InChI=1S/C17H21N7/c18-10-12-11-9-13(23-5-1-2-6-23)21-15(19)14(11)16(20)22-17(12)24-7-3-4-8-24/h9H,1-8H2,(H2,19,21)(H2,20,22)	SSWVPYMSHHEYAB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005886	Lp-PLA2-IN-1	C21H17F5N4O3	3.3795	71236597		CN1CCCn2c1cc(OCc1cc(F)c(Oc3cnc(C(F)(F)F)cc3)c(F)c1)nc2=O	InChI=1S/C21H17F5N4O3/c1-29-5-2-6-30-18(29)9-17(28-20(30)31)32-11-12-7-14(22)19(15(23)8-12)33-13-3-4-16(27-10-13)21(24,25)26/h3-4,7-10H,2,5-6,11H2,1H3	QJIGPJZJKXZSNF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005888	Cinacalcet	C22H22F3N	3.738	156419	C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F	CC(NCCCc1cc(C(F)(F)F)ccc1)c1cccc2ccccc12	InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1	VDHAWDNDOKGFTD-MRXNPFEDSA-N					doublet; compound annotation
0391_005889	STING agonist-1	C21H16ClFN2O3S	3.9615	5077622		O=C(NCc1ccco1)c1cc2c(cc1)SCC(=O)N2Cc1c(F)cccc1Cl	InChI=1S/C21H16ClFN2O3S/c22-16-4-1-5-17(23)15(16)11-25-18-9-13(6-7-19(18)29-12-20(25)26)21(27)24-10-14-3-2-8-28-14/h1-9H,10-12H2,(H,24,27)	NAGKYJATVFXZKN-UHFFFAOYSA-N					doublet; compound annotation
0391_005890	STING agonist-1	C21H16ClFN2O3S	3.9643	5077622		O=C(NCc1ccco1)c1cc2c(cc1)SCC(=O)N2Cc1c(F)cccc1Cl	InChI=1S/C21H16ClFN2O3S/c22-16-4-1-5-17(23)15(16)11-25-18-9-13(6-7-19(18)29-12-20(25)26)21(27)24-10-14-3-2-8-28-14/h1-9H,10-12H2,(H,24,27)	NAGKYJATVFXZKN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005892	Ivosidenib	C28H22ClF3N6O3	4.1612	71657455	C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N	N#Cc1cc(N2C(=O)CCC2C(=O)N(c2cc(F)cnc2)C(C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)ncc1	InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1	WIJZXSAJMHAVGX-DHLKQENFSA-N					removed another duplicate entry; compound annotation
0391_005894	CUDC-427	C29H36N6O4S	3.1022	71600094	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)NC3=C(N=C(S3)C4=NC=CO4)C5=CC=CC=C5)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)Nc1c(-c2ccccc2)nc(-c2ncco2)s1)C1CCCCC1	InChI=1S/C29H36N6O4S/c1-18(30-2)24(36)32-23(20-12-7-4-8-13-20)29(38)35-16-9-14-21(35)25(37)34-27-22(19-10-5-3-6-11-19)33-28(40-27)26-31-15-17-39-26/h3,5-6,10-11,15,17-18,20-21,23,30H,4,7-9,12-14,16H2,1-2H3,(H,32,36)(H,34,37)/t18-,21-,23-/m0/s1	HSHPBORBOJIXSQ-HARLFGEKSA-N					removed another duplicate entry; compound annotation
0391_005896	Nosiheptide	C51H43N13O12S6	3.8508	16129696	C/C=C\1/C2=NC(=CS2)C(=O)NC3CC(C(=O)OCC4=C5C(=C(C(=O)SCC(C6=NC(=CS6)C7=NC(=C(C=C7C8=NC(=CS8)C(=O)NC(C(=O)N1)C(C)O)O)C9=NC(=CS9)C(=O)NC(=C)C(=O)N)NC(=O)C1=CSC3=N1)NC5=CC=C4)C)O	C=C(NC(=O)c1csc(-c2c(O)cc3-c4nc(cs4)C(=O)NC(C(C)O)C(=O)NC(=CC)c4nc(cs4)C(=O)NC4CC(O)C(=O)OCc5c6c(C)c([nH]c6ccc5)C(=O)SCC(NC(=O)c5csc4n5)c4nc(cs4)-c3n2)n1)C(N)=O	InChI=1S/C51H43N13O12S6/c1-5-23-46-60-28(14-79-46)41(70)56-25-10-33(67)50(74)76-11-21-7-6-8-24-34(21)18(2)35(54-24)51(75)82-17-31(57-42(71)29-15-80-47(25)61-29)48-58-26(12-78-48)37-22(45-59-30(13-77-45)43(72)64-36(20(4)65)44(73)55-23)9-32(66)38(63-37)49-62-27(16-81-49)40(69)53-19(3)39(52)68/h5-9,12-16,20,25,31,33,36,54,65-67H,3,10-11,17H2,1-2,4H3,(H2,52,68)(H,53,69)(H,55,73)(H,56,70)(H,57,71)(H,64,72)/b23-5-	OQAOHXRUMXWDLQ-FPQMYIDKSA-N					removed another duplicate entry; compound annotation
0391_005898	300353-13-3	C18H22N2O3S2	4.0983	9886086	CS(=O)(=O)C1=CC=C(C=C1)[C@@H](CC2CCCC2)C(=O)NC3=NC=CS3	CS(=O)(=O)c1ccc(C(CC2CCCC2)C(=O)Nc2nccs2)cc1	InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21)/t16-/m1/s1	NEQSWPCDHDQINX-MRXNPFEDSA-N					compound annotation
0391_005899	GSK-626616	C18H10Cl2N4OS	4.1317	135416229	C1=CC(=C(C(=C1)Cl)N=C2NC(=O)/C(=C/C3=CC4=NC=CN=C4C=C3)/S2)Cl	O=C1N=C(Nc2c(Cl)cccc2Cl)SC1=Cc1cc2nccnc2cc1	InChI=1S/C18H10Cl2N4OS/c19-11-2-1-3-12(20)16(11)23-18-24-17(25)15(26-18)9-10-4-5-13-14(8-10)22-7-6-21-13/h1-9H,(H,23,24,25)/b15-9-	RJPNRXFBYZVRIB-DHDCSXOGSA-N					removed another duplicate entry; compound annotation
0391_005901	T-5224	C29H27NO8	5.0066	23626877		O=C(O)CCc1c(OCc2cc3c(cc2)c(=O)[nH]o3)ccc(C(=O)c2c(O)cc(OC3CCCC3)cc2)c1	InChI=1S/C29H27NO8/c31-24-15-21(37-20-3-1-2-4-20)8-10-22(24)28(34)19-6-11-25(18(14-19)7-12-27(32)33)36-16-17-5-9-23-26(13-17)38-30-29(23)35/h5-6,8-11,13-15,20,31H,1-4,7,12,16H2,(H,30,35)(H,32,33)	DALCQQSLNPLQFZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005903	IMD-0560	C15H8BrF6NO2	5.3025	11464503		O=C(Nc1c(C(F)(F)F)ccc(C(F)(F)F)c1)c1c(O)ccc(Br)c1	InChI=1S/C15H8BrF6NO2/c16-8-2-4-12(24)9(6-8)13(25)23-11-5-7(14(17,18)19)1-3-10(11)15(20,21)22/h1-6,24H,(H,23,25)	SVGRIJCSKWXOPA-UHFFFAOYSA-N					compound annotation
0391_005904	SEC inhibitor KL-1	C18H16ClNO4	5.4753	46248683	CC1=C(C=C(C=C1)Cl)NC(=O)C(=O)/C=C(/C2=CC(=CC=C2)OC)\O	COc1cccc(C(O)=CC(=O)C(=O)Nc2c(C)ccc(Cl)c2)c1	InChI=1S/C18H16ClNO4/c1-11-6-7-13(19)9-15(11)20-18(23)17(22)10-16(21)12-4-3-5-14(8-12)24-2/h3-10,21H,1-2H3,(H,20,23)/b16-10-	ARTVILCEXNCVIN-YBEGLDIGSA-N					compound annotation
0391_005905	934593-90-5	C26H29NO5	5.7591	16124726		COC(=O)c1cc(NC(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c(O)cc1	InChI=1S/C26H29NO5/c1-31-25(30)19-2-7-23(28)22(11-19)27-24(29)15-32-21-5-3-20(4-6-21)26-12-16-8-17(13-26)10-18(9-16)14-26/h2-7,11,16-18,28H,8-10,12-15H2,1H3,(H,27,29)	BJRPPNOJYFZSLY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005907	934593-90-5	C26H29NO5	5.7642	16124726		COC(=O)c1cc(NC(=O)COc2ccc(C34CC5CC(CC(C5)C3)C4)cc2)c(O)cc1	InChI=1S/C26H29NO5/c1-31-25(30)19-2-7-23(28)22(11-19)27-24(29)15-32-21-5-3-20(4-6-21)26-12-16-8-17(13-26)10-18(9-16)14-26/h2-7,11,16-18,28H,8-10,12-15H2,1H3,(H,27,29)	BJRPPNOJYFZSLY-UHFFFAOYSA-N					doublet; compound annotation
0391_005908	UVI 3003	C28H36O4	5.8703	44566108	CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C	CCCCCOc1cc2c(cc1-c1c(O)ccc(C=CC(=O)O)c1)C(C)(C)CCC2(C)C	InChI=1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+	APJSHECCIRQQDV-ZRDIBKRKSA-N					doublet; compound annotation
0391_005909	UVI 3003	C28H36O4	5.8737	44566108	CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C	CCCCCOc1cc2c(cc1-c1c(O)ccc(C=CC(=O)O)c1)C(C)(C)CCC2(C)C	InChI=1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+	APJSHECCIRQQDV-ZRDIBKRKSA-N					doublet; compound annotation
0391_005910	UVI 3003	C28H36O4	6.0682	44566108	CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C	CCCCCOc1cc2c(cc1-c1c(O)ccc(C=CC(=O)O)c1)C(C)(C)CCC2(C)C	InChI=1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+	APJSHECCIRQQDV-ZRDIBKRKSA-N					doublet; removed another duplicate entry; compound annotation
0391_005912	Radezolid	C22H23FN6O3	1.6994	11224409	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F	CC(=O)NCC1CN(c2cc(F)c(-c3ccc(CNCc4n[nH]nc4)cc3)cc2)C(=O)O1	InChI=1S/C22H23FN6O3/c1-14(30)25-12-19-13-29(22(31)32-19)18-6-7-20(21(23)8-18)16-4-2-15(3-5-16)9-24-10-17-11-26-28-27-17/h2-8,11,19,24H,9-10,12-13H2,1H3,(H,25,30)(H,26,27,28)/t19-/m0/s1	BTTNOGHPGJANSW-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_005914	Sitagliptin	C16H15F6N5O	2.1133	4369359	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N	NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1	MFFMDFFZMYYVKS-SECBINFHSA-N					doublet; compound annotation
0391_005915	Sitagliptin	C16H15F6N5O	2.1161	4369359	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N	NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1	MFFMDFFZMYYVKS-SECBINFHSA-N					doublet; compound annotation
0391_005916	GDC-0077	C18H19F2N5O4	2.291	124173720	C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F	CC(Nc1cc2c(cc1)-c1nc(N3C(=O)OCC3C(F)F)cn1CCO2)C(N)=O	InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1	SGEUNORSOZVTOL-CABZTGNLSA-N					doublet; removed another duplicate entry; compound annotation
0391_005919	GDC-0077	C18H19F2N5O4	2.3425	124173720	C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F	CC(Nc1cc2c(cc1)-c1nc(N3C(=O)OCC3C(F)F)cn1CCO2)C(N)=O	InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1	SGEUNORSOZVTOL-CABZTGNLSA-N					doublet; removed another duplicate entry; compound annotation
0391_005922	AdipoRon	C27H28N2O3	2.8744	16307093		O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1	InChI=1S/C27H28N2O3/c30-26(28-24-15-17-29(18-16-24)19-21-7-3-1-4-8-21)20-32-25-13-11-23(12-14-25)27(31)22-9-5-2-6-10-22/h1-14,24H,15-20H2,(H,28,30)	SHHUPGSHGSNPDB-UHFFFAOYSA-N					doublet; compound annotation
0391_005923	AdipoRon	C27H28N2O3	2.8783	16307093		O=C(COc1ccc(C(=O)c2ccccc2)cc1)NC1CCN(Cc2ccccc2)CC1	InChI=1S/C27H28N2O3/c30-26(28-24-15-17-29(18-16-24)19-21-7-3-1-4-8-21)20-32-25-13-11-23(12-14-25)27(31)22-9-5-2-6-10-22/h1-14,24H,15-20H2,(H,28,30)	SHHUPGSHGSNPDB-UHFFFAOYSA-N					doublet; compound annotation
0391_005924	867334-05-2	C26H26ClN5O2	3.3478	11712625		Cc1cc(-c2c(Cl)ccc(O)c2)cc2c1nc(Nc1ccc(OCCN3CCCC3)cc1)nn2	InChI=1S/C26H26ClN5O2/c1-17-14-18(22-16-20(33)6-9-23(22)27)15-24-25(17)29-26(31-30-24)28-19-4-7-21(8-5-19)34-13-12-32-10-2-3-11-32/h4-9,14-16,33H,2-3,10-13H2,1H3,(H,28,29,31)	AQSSMEORRLJZLU-UHFFFAOYSA-N					compound annotation
0391_005925	Litronesib Racemate	C23H37N5O4S2	3.4545	11272219		CCNCCS(=O)(=O)NCC1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C	InChI=1S/C23H37N5O4S2/c1-8-24-14-15-34(31,32)25-16-23(17-12-10-9-11-13-17)28(19(30)22(5,6)7)27-20(33-23)26-18(29)21(2,3)4/h9-13,24-25H,8,14-16H2,1-7H3,(H,26,27,29)	YVAFBXLHPINSIK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005927	dBET1	C38H37ClN8O7S	3.6756	91799313	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCCNC(=O)COC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)NCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2c1ccc(Cl)cc1	InChI=1S/C38H37ClN8O7S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)42-25(34-45-44-21(3)46(34)38)17-29(49)40-15-4-5-16-41-30(50)18-54-27-8-6-7-24-32(27)37(53)47(36(24)52)26-13-14-28(48)43-35(26)51/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,49)(H,41,50)(H,43,48,51)/t25-,26?/m0/s1	LKEGXJXRNBALBV-PMCHYTPCSA-N					removed another duplicate entry; compound annotation
0391_005929	345630-40-2	C19H17NO3	3.7868	9926586		CC(C)(C)C(=O)Nc1cc2c(cc1)-c1ccccc1C(=O)C2=O	InChI=1S/C19H17NO3/c1-19(2,3)18(23)20-11-8-9-13-12-6-4-5-7-14(12)16(21)17(22)15(13)10-11/h4-10H,1-3H3,(H,20,23)	VZQDDSYKVYARDW-UHFFFAOYSA-N					doublet; compound annotation
0391_005930	345630-40-2	C19H17NO3	3.7923	9926586		CC(C)(C)C(=O)Nc1cc2c(cc1)-c1ccccc1C(=O)C2=O	InChI=1S/C19H17NO3/c1-19(2,3)18(23)20-11-8-9-13-12-6-4-5-7-14(12)16(21)17(22)15(13)10-11/h4-10H,1-3H3,(H,20,23)	VZQDDSYKVYARDW-UHFFFAOYSA-N					doublet; compound annotation
0391_005931	945976-43-2	C27H22F4N4O3	3.825	44560455	C1=CC(=CC(=C1)F)C2=CC=C(C=C2)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	Nc1nc(-c2ccc(CC(N)C(=O)O)cc2)cc(OC(c2ccc(-c3cc(F)ccc3)cc2)C(F)(F)F)n1	InChI=1S/C27H22F4N4O3/c28-20-3-1-2-19(13-20)16-8-10-18(11-9-16)24(27(29,30)31)38-23-14-22(34-26(33)35-23)17-6-4-15(5-7-17)12-21(32)25(36)37/h1-11,13-14,21,24H,12,32H2,(H,36,37)(H2,33,34,35)/t21-,24?/m0/s1	JZWUKILTKYJLCN-XEGCMXMBSA-N					doublet; compound annotation
0391_005932	345630-40-2	C19H17NO3	3.9015	9926586		CC(C)(C)C(=O)Nc1cc2c(cc1)-c1ccccc1C(=O)C2=O	InChI=1S/C19H17NO3/c1-19(2,3)18(23)20-11-8-9-13-12-6-4-5-7-14(12)16(21)17(22)15(13)10-11/h4-10H,1-3H3,(H,20,23)	VZQDDSYKVYARDW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005935	945976-43-2	C27H22F4N4O3	4.3984	44560455	C1=CC(=CC(=C1)F)C2=CC=C(C=C2)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N	Nc1nc(-c2ccc(CC(N)C(=O)O)cc2)cc(OC(c2ccc(-c3cc(F)ccc3)cc2)C(F)(F)F)n1	InChI=1S/C27H22F4N4O3/c28-20-3-1-2-19(13-20)16-8-10-18(11-9-16)24(27(29,30)31)38-23-14-22(34-26(33)35-23)17-6-4-15(5-7-17)12-21(32)25(36)37/h1-11,13-14,21,24H,12,32H2,(H,36,37)(H2,33,34,35)/t21-,24?/m0/s1	JZWUKILTKYJLCN-XEGCMXMBSA-N					doublet; compound annotation
0391_005936	MK-8998	C20H23F3N2O2	4.4831	24765479	C[C@H](C1=NC=C(C=C1)OCC(F)(F)F)NC(=O)CC2=CC=C(C=C2)C(C)C	CC(C)c1ccc(CC(=O)NC(C)c2ncc(OCC(F)(F)F)cc2)cc1	InChI=1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1	IQIKXZMPPBEWAD-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_005938	felbamate	C11H14N2O4	1.9583	3331		NC(=O)OCC(COC(N)=O)c1ccccc1	InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)	WKGXYQFOCVYPAC-UHFFFAOYSA-N					compound annotation
0391_005939	Ropivacaine	C17H26N2O	2.0281	175805	CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C	CCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1	ZKMNUMMKYBVTFN-HNNXBMFYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005941	Mosapride	C21H25ClFN3O3	2.4775	119584		CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1	InChI=1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27)	YPELFRMCRYSPKZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005943	BML-284	C19H18N4O3	2.7232	11210285		COc1cccc(-c2cc(NCc3cc4c(cc3)OCO4)nc(N)n2)c1	InChI=1S/C19H18N4O3/c1-24-14-4-2-3-13(8-14)15-9-18(23-19(20)22-15)21-10-12-5-6-16-17(7-12)26-11-25-16/h2-9H,10-11H2,1H3,(H3,20,21,22,23)	FABQUVYDAXWUQP-UHFFFAOYSA-N					compound annotation
0391_005944	Evenamide	C16H26N2O2	2.7566	25105689		CCCCOc1cccc(CCNCC(=O)N(C)C)c1	InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3	GRHBODILPPXVKN-UHFFFAOYSA-N					doublet; compound annotation
0391_005945	Evenamide	C16H26N2O2	2.7595	25105689		CCCCOc1cccc(CCNCC(=O)N(C)C)c1	InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3	GRHBODILPPXVKN-UHFFFAOYSA-N					doublet; compound annotation
0391_005946	PF-CBP1	C29H36N4O3	3.0347	119081417		CCCOc1ccc(CCc2nc3c(ccc(-c4c(C)onc4C)c3)n2CCN2CCOCC2)cc1	InChI=1S/C29H36N4O3/c1-4-17-35-25-9-5-23(6-10-25)7-12-28-30-26-20-24(29-21(2)31-36-22(29)3)8-11-27(26)33(28)14-13-32-15-18-34-19-16-32/h5-6,8-11,20H,4,7,12-19H2,1-3H3	CGWBJJZOKGZCSJ-UHFFFAOYSA-N					doublet; compound annotation
0391_005947	PF-CBP1	C29H36N4O3	3.0374	119081417		CCCOc1ccc(CCc2nc3c(ccc(-c4c(C)onc4C)c3)n2CCN2CCOCC2)cc1	InChI=1S/C29H36N4O3/c1-4-17-35-25-9-5-23(6-10-25)7-12-28-30-26-20-24(29-21(2)31-36-22(29)3)8-11-27(26)33(28)14-13-32-15-18-34-19-16-32/h5-6,8-11,20H,4,7,12-19H2,1-3H3	CGWBJJZOKGZCSJ-UHFFFAOYSA-N					doublet; compound annotation
0391_005948	(S)-(+)-rolipram	C16H21NO3	3.1443	158758	COC1=C(C=C(C=C1)[C@@H]2CC(=O)NC2)OC3CCCC3	COc1c(OC2CCCC2)cc(C2CNC(=O)C2)cc1	InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m1/s1	HJORMJIFDVBMOB-GFCCVEGCSA-N					removed another duplicate entry; compound annotation
0391_005951	Evenamide	C16H26N2O2	4.9998	25105689		CCCCOc1cccc(CCNCC(=O)N(C)C)c1	InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3	GRHBODILPPXVKN-UHFFFAOYSA-N					doublet; compound annotation
0391_005952	IRAK4-IN-1	C19H23N5O	0.6488	118475349		N#Cc1cc2c(cc1)ncnc2NC1CCC(N2CCOCC2)CC1	InChI=1S/C19H23N5O/c20-12-14-1-6-18-17(11-14)19(22-13-21-18)23-15-2-4-16(5-3-15)24-7-9-25-10-8-24/h1,6,11,13,15-16H,2-5,7-10H2,(H,21,22,23)	HVQXFGHHSFTACS-UHFFFAOYSA-N					compound annotation
0391_005953	1811510-56-1	C16H13ClN4	1.4719	118701008		Nc1ncc(-c2cc(-c3ccc(Cl)cc3)c(N)nc2)cc1	InChI=1S/C16H13ClN4/c17-13-4-1-10(2-5-13)14-7-12(9-21-16(14)19)11-3-6-15(18)20-8-11/h1-9H,(H2,18,20)(H2,19,21)	KHPCIHZXOGHCLY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005955	Senexin A	C17H14N4	2.4365	56927063		N#Cc1cc2c(cc1)ncnc2NCCc1ccccc1	InChI=1S/C17H14N4/c18-11-14-6-7-16-15(10-14)17(21-12-20-16)19-9-8-13-4-2-1-3-5-13/h1-7,10,12H,8-9H2,(H,19,20,21)	XBJCNHGQFJFCOY-UHFFFAOYSA-N					compound annotation
0391_005956	Torasemide	C16H20N4O3S	2.575	51371498		Cc1cc(Nc2c(S(=O)(=O)NC(=O)NC(C)C)cncc2)ccc1	InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)	NGBFQHCMQULJNZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005958	DESONIDE	C24H32O6	3.2074	5311066	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@]35C)O	CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1	WBGKWQHBNHJJPZ-LECWWXJVSA-N					compound annotation
0391_005959	TAUROCHENODEOXYCHOLIC ACID	C26H45NO6S	3.4803	387316	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1	BHTRKEVKTKCXOH-BJLOMENOSA-N					compound annotation
0391_005960	SBI-0640756	C23H14ClFN2O2	4.1691	121241171	C1=CC=C(C=C1)C2=C(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)/C=C/C4=CC(=CN=C4)F	O=C(C=Cc1cc(F)cnc1)c1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O	InChI=1S/C23H14ClFN2O2/c24-16-7-8-19-18(11-16)21(15-4-2-1-3-5-15)22(23(29)27-19)20(28)9-6-14-10-17(25)13-26-12-14/h1-13H,(H,27,29)/b9-6+	VVWGPQZBDQVQRC-RMKNXTFCSA-N					doublet; compound annotation
0391_005961	SBI-0640756	C23H14ClFN2O2	4.1724	121241171	C1=CC=C(C=C1)C2=C(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)/C=C/C4=CC(=CN=C4)F	O=C(C=Cc1cc(F)cnc1)c1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O	InChI=1S/C23H14ClFN2O2/c24-16-7-8-19-18(11-16)21(15-4-2-1-3-5-15)22(23(29)27-19)20(28)9-6-14-10-17(25)13-26-12-14/h1-13H,(H,27,29)/b9-6+	VVWGPQZBDQVQRC-RMKNXTFCSA-N					doublet; compound annotation
0391_005962	cyclofenil	C23H24O4	5.6904	2898		CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1	InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3	GVOUFPWUYJWQSK-UHFFFAOYSA-N					doublet; compound annotation
0391_005963	cyclofenil	C23H24O4	5.6934	2898		CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1	InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3	GVOUFPWUYJWQSK-UHFFFAOYSA-N					doublet; compound annotation
0391_005964	3'-Azido-3'-deoxy-5-fluorocytidine	C9H11FN6O4	0.6672	137628662	C1=C(C(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)N=[N+]=[N-])O)N)F	[N-]=[N+]=NC1C(CO)OC(n2cc(F)c(N)nc2=O)C1O	InChI=1S/C9H11FN6O4/c10-3-1-16(9(19)13-7(3)11)8-6(18)5(14-15-12)4(2-17)20-8/h1,4-6,8,17-18H,2H2,(H2,11,13,19)/t4-,5-,6-,8-/m1/s1	MOEHIWUXKDQZBL-UAKXSSHOSA-N					removed another duplicate entry; compound annotation
0391_005966	Dacisteine	C7H11NO4S	0.8948	65690	CC(=O)N[C@@H](CSC(=O)C)C(=O)O	CC(=O)NC(CSC(C)=O)C(=O)O	InChI=1S/C7H11NO4S/c1-4(9)8-6(7(11)12)3-13-5(2)10/h6H,3H2,1-2H3,(H,8,9)(H,11,12)/t6-/m0/s1	HSPYGHDTVQJUDE-LURJTMIESA-N					removed another duplicate entry; compound annotation
0391_005968	Osoresnontrine	C16H17N5O2	1.4448	135908617		O=c1[nH]c(Cc2ccccn2)nc2c1cnn2C1CCOCC1	InChI=1S/C16H17N5O2/c22-16-13-10-18-21(12-4-7-23-8-5-12)15(13)19-14(20-16)9-11-3-1-2-6-17-11/h1-3,6,10,12H,4-5,7-9H2,(H,19,20,22)	BZTIJCSHNVZMES-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005970	LRRK2-IN-1	C31H38N8O3	2.3446	46843906		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(C(=O)N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C31H38N8O3/c1-35-15-17-38(18-16-35)22-11-13-39(14-12-22)29(40)21-9-10-24(27(19-21)42-4)33-31-32-20-26-28(34-31)36(2)25-8-6-5-7-23(25)30(41)37(26)3/h5-10,19-20,22H,11-18H2,1-4H3,(H,32,33,34)	IWMCPJZTADUIFX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005972	AZD3229	C24H26FN7O3	2.4824	134814269		COCCOc1cc2c(c(F)c1)c(Nc1ccc(NC(=O)Cn3cc(C(C)C)nn3)cc1)ncn2	InChI=1S/C24H26FN7O3/c1-15(2)21-12-32(31-30-21)13-22(33)28-16-4-6-17(7-5-16)29-24-23-19(25)10-18(35-9-8-34-3)11-20(23)26-14-27-24/h4-7,10-12,14-15H,8-9,13H2,1-3H3,(H,28,33)(H,26,27,29)	FLJOFQUXYAWOPE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005974	Seclazone	C10H8ClNO3	2.6957	34443		O=C1c2c(ccc(Cl)c2)OC2CCON12	InChI=1S/C10H8ClNO3/c11-6-1-2-8-7(5-6)10(13)12-9(15-8)3-4-14-12/h1-2,5,9H,3-4H2	XWXVKXXKKLBDDJ-UHFFFAOYSA-N					compound annotation
0391_005975	LRRK2-IN-1	C31H38N8O3	3.0917	46843906		COc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(C(=O)N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C31H38N8O3/c1-35-15-17-38(18-16-35)22-11-13-39(14-12-22)29(40)21-9-10-24(27(19-21)42-4)33-31-32-20-26-28(34-31)36(2)25-8-6-5-7-23(25)30(41)37(26)3/h5-10,19-20,22H,11-18H2,1-4H3,(H,32,33,34)	IWMCPJZTADUIFX-UHFFFAOYSA-N					doublet; compound annotation
0391_005976	CHEMBL154668	C26H42N4O5S2	3.624	9893887	CC1=CC=CC=C1N2CCN(CC2)S(=O)(=O)CC34CCC(C3(C)C)C[C@@H]4NC(=O)[C@H](CCS(=O)(=O)C)N	Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(CC2NC(=O)C(N)CCS(C)(=O)=O)C3(C)C)CC1	InChI=1S/C26H42N4O5S2/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31)/t20?,21-,23-,26?/m0/s1	MWIASLNTAGRGGA-WVJGRJQASA-N					removed another duplicate entry; compound annotation
0391_005978	Elacytarabine	C27H45N3O6	5.5832	6438895	CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O	CCCCCCCCC=CCCCCCCCC(=O)OCC1OC(n2ccc(N)nc2=O)C(O)C1O	InChI=1S/C27H45N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(31)35-20-21-24(32)25(33)26(36-21)30-19-18-22(28)29-27(30)34/h9-10,18-19,21,24-26,32-33H,2-8,11-17,20H2,1H3,(H2,28,29,34)/b10-9+/t21-,24-,25+,26-/m1/s1	FLFGNMFWNBOBGE-FNNZEKJRSA-N					removed another duplicate entry; compound annotation
0391_005980	MYCi361	C26H16ClF9N2O2	6.3829	139600319		Cn1nc(C(F)(F)F)cc1-c1c(O)c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(OCc2ccc(Cl)cc2)cc1	InChI=1S/C26H16ClF9N2O2/c1-38-19(11-21(37-38)26(34,35)36)18-6-7-20(40-12-13-2-4-17(27)5-3-13)22(23(18)39)14-8-15(24(28,29)30)10-16(9-14)25(31,32)33/h2-11,39H,12H2,1H3	CKLCWLSEYDDTCN-UHFFFAOYSA-N					compound annotation
0391_005981	475150-69-7	C27H35N3O2	1.7499	10296561	C1C[C@@H](N(C1)CC2=CC=CC=C2)C(=O)NCCCN3CCC4(CC3)C5=CC=CC=C5CO4	O=C(NCCCN1CCC2(CC1)OCc1ccccc12)C1CCCN1Cc1ccccc1	InChI=1S/C27H35N3O2/c31-26(25-12-6-17-30(25)20-22-8-2-1-3-9-22)28-15-7-16-29-18-13-27(14-19-29)24-11-5-4-10-23(24)21-32-27/h1-5,8-11,25H,6-7,12-21H2,(H,28,31)/t25-/m1/s1	MAKMQGKJURAJEN-RUZDIDTESA-N					compound annotation
0391_005982	Ilomastat	C20H28N4O4	2.3807	132519	CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC	CNC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(=O)NO)CC(C)C	InChI=1S/C20H28N4O4/c1-12(2)8-13(10-18(25)24-28)19(26)23-17(20(27)21-3)9-14-11-22-16-7-5-4-6-15(14)16/h4-7,11-13,17,22,28H,8-10H2,1-3H3,(H,21,27)(H,23,26)(H,24,25)/t13-,17+/m1/s1	NITYDPDXAAFEIT-DYVFJYSZSA-N					removed another duplicate entry; compound annotation
0391_005984	194423-15-9	C17H13BrN4O	2.6792	4708		C=CC(=O)Nc1cc2c(cc1)ncnc2Nc1cc(Br)ccc1	InChI=1S/C17H13BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h2-10H,1H2,(H,21,23)(H,19,20,22)	HTUBKQUPEREOGA-UHFFFAOYSA-N					compound annotation
0391_005985	AMG-900	C28H21N7OS	3.038	24856041		Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4nc(N)ncc4)cc3)c3ccccc23)c1	InChI=1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33)	IVUGFMLRJOCGAS-UHFFFAOYSA-N					doublet; compound annotation
0391_005986	AMG-900	C28H21N7OS	3.0428	24856041		Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4nc(N)ncc4)cc3)c3ccccc23)c1	InChI=1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33)	IVUGFMLRJOCGAS-UHFFFAOYSA-N					doublet; compound annotation
0391_005987	IP3K Inhibitor	C20H16F3N7O2	3.3191	16760513		O=[N+]([O-])c1ccc(CNc2nc(NCc3cc(C(F)(F)F)ccc3)nc3c2[nH]cn3)cc1	InChI=1S/C20H16F3N7O2/c21-20(22,23)14-3-1-2-13(8-14)10-25-19-28-17(16-18(29-19)27-11-26-16)24-9-12-4-6-15(7-5-12)30(31)32/h1-8,11H,9-10H2,(H3,24,25,26,27,28,29)	DDSBPUYZPWNNGH-UHFFFAOYSA-N					doublet; compound annotation
0391_005988	IP3K Inhibitor	C20H16F3N7O2	3.3219	16760513		O=[N+]([O-])c1ccc(CNc2nc(NCc3cc(C(F)(F)F)ccc3)nc3c2[nH]cn3)cc1	InChI=1S/C20H16F3N7O2/c21-20(22,23)14-3-1-2-13(8-14)10-25-19-28-17(16-18(29-19)27-11-26-16)24-9-12-4-6-15(7-5-12)30(31)32/h1-8,11H,9-10H2,(H3,24,25,26,27,28,29)	DDSBPUYZPWNNGH-UHFFFAOYSA-N					doublet; compound annotation
0391_005989	VX-765	C24H33ClN4O6	3.3485	11398092	CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl	CCOC1OC(=O)CC1NC(=O)C1CCCN1C(=O)C(NC(=O)c1cc(Cl)c(N)cc1)C(C)(C)C	InChI=1S/C24H33ClN4O6/c1-5-34-23-16(12-18(30)35-23)27-21(32)17-7-6-10-29(17)22(33)19(24(2,3)4)28-20(31)13-8-9-15(26)14(25)11-13/h8-9,11,16-17,19,23H,5-7,10,12,26H2,1-4H3,(H,27,32)(H,28,31)/t16-,17-,19+,23+/m0/s1	SJDDOCKBXFJEJB-MOKWFATOSA-N					doublet; compound annotation
0391_005990	VX-765	C24H33ClN4O6	3.3515	11398092	CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl	CCOC1OC(=O)CC1NC(=O)C1CCCN1C(=O)C(NC(=O)c1cc(Cl)c(N)cc1)C(C)(C)C	InChI=1S/C24H33ClN4O6/c1-5-34-23-16(12-18(30)35-23)27-21(32)17-7-6-10-29(17)22(33)19(24(2,3)4)28-20(31)13-8-9-15(26)14(25)11-13/h8-9,11,16-17,19,23H,5-7,10,12,26H2,1-4H3,(H,27,32)(H,28,31)/t16-,17-,19+,23+/m0/s1	SJDDOCKBXFJEJB-MOKWFATOSA-N					doublet; compound annotation
0391_005991	GSK2578215A	C24H18FN3O2	3.5855	68107965		O=C(Nc1cnccc1)c1cc(-c2cc(F)ncc2)ccc1OCc1ccccc1	InChI=1S/C24H18FN3O2/c25-23-14-19(10-12-27-23)18-8-9-22(30-16-17-5-2-1-3-6-17)21(13-18)24(29)28-20-7-4-11-26-15-20/h1-15H,16H2,(H,28,29)	WCIGMFCFPXZRMQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_005993	ADX-47273	C20H17F2N3O2	4.498	11383075	C1C[C@@H](CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F	O=C(c1ccc(F)cc1)N1CCCC(c2nc(-c3ccc(F)cc3)no2)C1	InChI=1S/C20H17F2N3O2/c21-16-7-3-13(4-8-16)18-23-19(27-24-18)15-2-1-11-25(12-15)20(26)14-5-9-17(22)10-6-14/h3-10,15H,1-2,11-12H2/t15-/m0/s1	VXQCCZHCFBHTTD-HNNXBMFYSA-N					doublet; compound annotation
0391_005994	ADX-47273	C20H17F2N3O2	4.5007	11383075	C1C[C@@H](CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F	O=C(c1ccc(F)cc1)N1CCCC(c2nc(-c3ccc(F)cc3)no2)C1	InChI=1S/C20H17F2N3O2/c21-16-7-3-13(4-8-16)18-23-19(27-24-18)15-2-1-11-25(12-15)20(26)14-5-9-17(22)10-6-14/h3-10,15H,1-2,11-12H2/t15-/m0/s1	VXQCCZHCFBHTTD-HNNXBMFYSA-N					doublet; compound annotation
0391_005995	883050-24-6	C16H13FN2O2S	4.8688	2733079		Cc1ccc(-n2sc(=O)n(Cc3ccc(F)cc3)c2=O)cc1	InChI=1S/C16H13FN2O2S/c1-11-2-8-14(9-3-11)19-15(20)18(16(21)22-19)10-12-4-6-13(17)7-5-12/h2-9H,10H2,1H3	QUIIIYITNGOFEI-UHFFFAOYSA-N					compound annotation
0391_005996	NVP-231	C25H25N3O2S	5.0591	4096211		O=C(Nc1nc2c(cc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2)s1)c1ccccc1	InChI=1S/C25H25N3O2S/c29-22(18-4-2-1-3-5-18)28-24-27-20-7-6-19(11-21(20)31-24)26-23(30)25-12-15-8-16(13-25)10-17(9-15)14-25/h1-7,11,15-17H,8-10,12-14H2,(H,26,30)(H,27,28,29)	MVSSJPGNLQPWSW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_005999	NVP-231	C25H25N3O2S	5.2367	4096211		O=C(Nc1nc2c(cc(NC(=O)C34CC5CC(CC(C5)C3)C4)cc2)s1)c1ccccc1	InChI=1S/C25H25N3O2S/c29-22(18-4-2-1-3-5-18)28-24-27-20-7-6-19(11-21(20)31-24)26-23(30)25-12-15-8-16(13-25)10-17(9-15)14-25/h1-7,11,15-17H,8-10,12-14H2,(H,26,30)(H,27,28,29)	MVSSJPGNLQPWSW-UHFFFAOYSA-N					doublet; compound annotation
0391_006000	1227163-84-9	C24H16F3N5	2.1791	46202416	C1=CC(=CC(=C1)[C@@]2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC(=NC=C4)C(F)F)C5=CN=CN=C5	NC1=NC(c2cccc(-c3cncnc3)c2)(c2cc(C(F)F)ncc2)c2cccc(F)c12	InChI=1S/C24H16F3N5/c25-19-6-2-5-18-21(19)23(28)32-24(18,17-7-8-31-20(10-17)22(26)27)16-4-1-3-14(9-16)15-11-29-13-30-12-15/h1-13,22H,(H2,28,32)/t24-/m0/s1	MRXBCEQZNKUUIP-DEOSSOPVSA-N					compound annotation
0391_006001	117977-21-6	C18H21N3O2S	2.2871	9949996		COCCCOc1c(C)c(CSc2nc3ccccc3[nH]2)ncc1	InChI=1S/C18H21N3O2S/c1-13-16(19-9-8-17(13)23-11-5-10-22-2)12-24-18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)	BSXAHDOWMOSVAP-UHFFFAOYSA-N					compound annotation
0391_006002	PF-5274857	C20H25ClN4O3S	2.5672	56956240		Cc1cc(C)c(-c2cc(N3CCN(C(=O)CCS(C)(=O)=O)CC3)ncc2Cl)nc1	InChI=1S/C20H25ClN4O3S/c1-14-10-15(2)20(23-12-14)16-11-18(22-13-17(16)21)24-5-7-25(8-6-24)19(26)4-9-29(3,27)28/h10-13H,4-9H2,1-3H3	BBVNTTZIOTWDSV-UHFFFAOYSA-N					doublet; compound annotation
0391_006003	GNE-617	C21H15F2N3O3S	2.6257	68277611		O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1cn2ccnc2cc1	InChI=1S/C21H15F2N3O3S/c22-16-9-17(23)11-19(10-16)30(28,29)18-4-1-14(2-5-18)12-25-21(27)15-3-6-20-24-7-8-26(20)13-15/h1-11,13H,12H2,(H,25,27)	XRDVXQQZLHVEQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006004	PF-5274857	C20H25ClN4O3S	2.7714	56956240		Cc1cc(C)c(-c2cc(N3CCN(C(=O)CCS(C)(=O)=O)CC3)ncc2Cl)nc1	InChI=1S/C20H25ClN4O3S/c1-14-10-15(2)20(23-12-14)16-11-18(22-13-17(16)21)24-5-7-25(8-6-24)19(26)4-9-29(3,27)28/h10-13H,4-9H2,1-3H3	BBVNTTZIOTWDSV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006006	COUMESTROL	C15H8O5	2.8827	5281707		O=c1oc2c(ccc(O)c2)c2c1c1c(cc(O)cc1)o2	InChI=1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H	ZZIALNLLNHEQPJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006008	GNF-2	C18H13F3N4O2	3.4274	5311510		NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1	InChI=1S/C18H13F3N4O2/c19-18(20,21)27-14-6-4-13(5-7-14)25-16-9-15(23-10-24-16)11-2-1-3-12(8-11)17(22)26/h1-10H,(H2,22,26)(H,23,24,25)	WEVYNIUIFUYDGI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006010	TELOTRISTAT ETHYL	C27H26ClF3N6O3	4.0567	25181577	CCOC(=O)[C@H](CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N	CCOC(=O)C(N)Cc1ccc(-c2cc(OC(c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1	InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1	MDSQOJYHHZBZKA-GBXCKJPGSA-N					doublet; removed another duplicate entry; compound annotation
0391_006012	(R)-ADX-47273	C20H17F2N3O2	4.5014	11303165	C1C[C@H](CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F	O=C(c1ccc(F)cc1)N1CCCC(c2nc(-c3ccc(F)cc3)no2)C1	InChI=1S/C20H17F2N3O2/c21-16-7-3-13(4-8-16)18-23-19(27-24-18)15-2-1-11-25(12-15)20(26)14-5-9-17(22)10-6-14/h3-10,15H,1-2,11-12H2/t15-/m1/s1	VXQCCZHCFBHTTD-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_006014	TAK-632	C27H18F4N4O3S	4.9108	46209401		N#Cc1c(Oc2cc(NC(=O)Cc3cc(C(F)(F)F)ccc3)c(F)cc2)ccc2c1sc(NC(=O)C1CC1)n2	InChI=1S/C27H18F4N4O3S/c28-19-7-6-17(12-21(19)33-23(36)11-14-2-1-3-16(10-14)27(29,30)31)38-22-9-8-20-24(18(22)13-32)39-26(34-20)35-25(37)15-4-5-15/h1-3,6-10,12,15H,4-5,11H2,(H,33,36)(H,34,35,37)	OJFKUJDRGJSAQB-UHFFFAOYSA-N					doublet; compound annotation
0391_006015	TAK-632	C27H18F4N4O3S	4.9158	46209401		N#Cc1c(Oc2cc(NC(=O)Cc3cc(C(F)(F)F)ccc3)c(F)cc2)ccc2c1sc(NC(=O)C1CC1)n2	InChI=1S/C27H18F4N4O3S/c28-19-7-6-17(12-21(19)33-23(36)11-14-2-1-3-16(10-14)27(29,30)31)38-22-9-8-20-24(18(22)13-32)39-26(34-20)35-25(37)15-4-5-15/h1-3,6-10,12,15H,4-5,11H2,(H,33,36)(H,34,35,37)	OJFKUJDRGJSAQB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006017	1043854-13-2	C28H25ClN4O2S	5.72	45987688		O=C(O)c1ccc(CSc2nc(-c3ccccc3)cc(N3CCN(c4ccccc4Cl)CC3)n2)cc1	InChI=1S/C28H25ClN4O2S/c29-23-8-4-5-9-25(23)32-14-16-33(17-15-32)26-18-24(21-6-2-1-3-7-21)30-28(31-26)36-19-20-10-12-22(13-11-20)27(34)35/h1-13,18H,14-17,19H2,(H,34,35)	RSHUJZXWKLIBRE-UHFFFAOYSA-N					compound annotation
0391_006018	4-Aminohippuric acid	C9H10N2O3	0.4837	2148		Nc1ccc(C(=O)NCC(=O)O)cc1	InChI=1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)	HSMNQINEKMPTIC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006020	tolazoline	C10H12N2	0.789	5504		c1ccc(CC2=NCCN2)cc1	InChI=1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12)	JIVZKJJQOZQXQB-UHFFFAOYSA-N					compound annotation
0391_006021	Thiamethoxam	C8H10ClN5O3S	1.5974	5821911	CN\1COCN(/C1=N/[N+](=O)[O-])CC2=CN=C(S2)Cl	CN1COCN(Cc2cnc(Cl)s2)C1=N[N+](=O)[O-]	InChI=1S/C8H10ClN5O3S/c1-12-4-17-5-13(8(12)11-14(15)16)3-6-2-10-7(9)18-6/h2H,3-5H2,1H3/b11-8+	NWWZPOKUUAIXIW-DHZHZOJOSA-N					removed another duplicate entry; compound annotation
0391_006023	IT1t	C21H34N4S2	1.8826	25147749		CC1(C)CN2C(CSC(=NC3CCCCC3)NC3CCCCC3)=CSC2=N1	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N					doublet; compound annotation
0391_006024	spiramycin	C43H74N2O14	2.162	6419898	C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C	COC1C(O)CC(=O)OC(C)CC=CC=CC(OC2CCC(N(C)C)C(C)O2)C(C)CC(CC=O)C1OC1OC(C)C(OC2CC(C)(O)C(O)C(C)O2)C(N(C)C)C1O	InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26?,27?,28?,29+,30?,31-,32+,34?,35?,36?,37?,38?,39+,40+,41?,42?,43?/m1/s1	ACTOXUHEUCPTEW-JMRHEKERSA-N					compound annotation
0391_006025	IT1t	C21H34N4S2	2.4275	25147749		CC1(C)CN2C(CSC(=NC3CCCCC3)NC3CCCCC3)=CSC2=N1	InChI=1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23)	OOSUDWRRWZVFEB-UHFFFAOYSA-N					doublet; compound annotation
0391_006026	N-(4-Methoxybenzyl)-1-(naphthalen-1-yl)methanamine	C19H19NO	2.7365	781301		COc1ccc(CNCc2cccc3ccccc23)cc1	InChI=1S/C19H19NO/c1-21-18-11-9-15(10-12-18)13-20-14-17-7-4-6-16-5-2-3-8-19(16)17/h2-12,20H,13-14H2,1H3	GIFYKGIODMXYNT-UHFFFAOYSA-N					compound annotation
0391_006027	ciforadenant	C20H21N7O3	2.9724	44537963	CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)CO[C@H]5CCOC5	Cc1ccc(-c2c3nnn(Cc4nc(COC5CCOC5)ccc4)c3nc(N)n2)o1	InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1	KURQKNMKCGYWRJ-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_006029	53101-49-8	C14H18O4	3.1123	6541354	CC1=C(C2=C(CC[C@](O2)(C)C(=O)O)C(=C1O)C)C	Cc1c(C)c2c(CCC(C)(C(=O)O)O2)c(C)c1O	InChI=1S/C14H18O4/c1-7-8(2)12-10(9(3)11(7)15)5-6-14(4,18-12)13(16)17/h15H,5-6H2,1-4H3,(H,16,17)/t14-/m1/s1	GLEVLJDDWXEYCO-CQSZACIVSA-N					compound annotation
0391_006030	Substance P(1-7)	C41H65N13O10	0.8632	10440769	C1C[C@H](N(C1)C(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O	NCCCCC(NC(=O)C1CCCN1C(=O)C(N)CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C41H65N13O10/c42-19-5-4-12-28(51-37(60)30-13-7-21-53(30)38(61)25(43)11-6-20-48-41(46)47)39(62)54-22-8-14-31(54)36(59)50-27(16-18-33(45)56)34(57)49-26(15-17-32(44)55)35(58)52-29(40(63)64)23-24-9-2-1-3-10-24/h1-3,9-10,25-31H,4-8,11-23,42-43H2,(H2,44,55)(H2,45,56)(H,49,57)(H,50,59)(H,51,60)(H,52,58)(H,63,64)(H4,46,47,48)/t25-,26-,27-,28-,29-,30-,31-/m0/s1	KPHDBQWTCKBKIL-XIJWKTHWSA-N					removed another duplicate entry; compound annotation
0391_006032	Piperoxan	C14H19NO2	1.7385	6040		c1ccc2OC(CN3CCCCC3)COc2c1	InChI=1S/C14H19NO2/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12/h2-3,6-7,12H,1,4-5,8-11H2	LYKMMUBOEFYJQG-UHFFFAOYSA-N					compound annotation
0391_006033	Sotrastaurin	C25H22N6O2	2.4555	10296883		CN1CCN(c2nc3ccccc3c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1	InChI=1S/C25H22N6O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18/h2-9,14,26H,10-13H2,1H3,(H,29,32,33)	OAVGBZOFDPFGPJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006035	Zibotentan	C19H16N6O4S	2.4725	9910224		COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1	InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)	FJHHZXWJVIEFGJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006036	Zibotentan	C19H16N6O4S	2.4757	9910224		COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1	InChI=1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25)	FJHHZXWJVIEFGJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006037	ATM-3507	C37H46FN5O2	2.6474	118666864		Cc1c(C)n(CCCN2CCN(C)CC2)c2c1cc(Oc1cccc(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)c1)cc2	InChI=1S/C37H46FN5O2/c1-28-29(2)43(16-5-15-40-20-18-39(3)19-21-40)36-13-12-34(27-35(28)36)45-33-7-4-6-31(26-33)37(44)42-24-22-41(23-25-42)17-14-30-8-10-32(38)11-9-30/h4,6-13,26-27H,5,14-25H2,1-3H3	FNEHSJQRIWHZKS-UHFFFAOYSA-N					doublet; compound annotation
0391_006038	SAR-20347	C21H18ClFN4O4	3.1868	71727668		NC(=O)c1c(Nc2ccc(C(=O)N3CCOCC3)cc2)oc(-c2c(F)cccc2Cl)n1	InChI=1S/C21H18ClFN4O4/c22-14-2-1-3-15(23)16(14)19-26-17(18(24)28)20(31-19)25-13-6-4-12(5-7-13)21(29)27-8-10-30-11-9-27/h1-7,25H,8-11H2,(H2,24,28)	HEDPDFHTQKEORT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006041	ATM-3507	C37H46FN5O2	3.1868	118666864		Cc1c(C)n(CCCN2CCN(C)CC2)c2c1cc(Oc1cccc(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)c1)cc2	InChI=1S/C37H46FN5O2/c1-28-29(2)43(16-5-15-40-20-18-39(3)19-21-40)36-13-12-34(27-35(28)36)45-33-7-4-6-31(26-33)37(44)42-24-22-41(23-25-42)17-14-30-8-10-32(38)11-9-30/h4,6-13,26-27H,5,14-25H2,1-3H3	FNEHSJQRIWHZKS-UHFFFAOYSA-N					doublet; compound annotation
0391_006042	692269-09-3	C20H23N3O	3.2206	889692		C=CCc1c(O)c(CNc2nc3ccccc3n2CCC)ccc1	InChI=1S/C20H23N3O/c1-3-8-15-9-7-10-16(19(15)24)14-21-20-22-17-11-5-6-12-18(17)23(20)13-4-2/h3,5-7,9-12,24H,1,4,8,13-14H2,2H3,(H,21,22)	ZFHWEWJDCFGRBO-UHFFFAOYSA-N					doublet; compound annotation
0391_006043	692269-09-3	C20H23N3O	3.2792	889692		C=CCc1c(O)c(CNc2nc3ccccc3n2CCC)ccc1	InChI=1S/C20H23N3O/c1-3-8-15-9-7-10-16(19(15)24)14-21-20-22-17-11-5-6-12-18(17)23(20)13-4-2/h3,5-7,9-12,24H,1,4,8,13-14H2,2H3,(H,21,22)	ZFHWEWJDCFGRBO-UHFFFAOYSA-N					doublet; compound annotation
0391_006044	MD2-IN-1	C20H22O6	3.6629	5724738	COC1=C(C=C(C=C1)C(=O)/C=C/C2=CC(=C(C(=C2)OC)OC)OC)OC	COc1c(OC)cc(C(=O)C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C20H22O6/c1-22-16-9-7-14(12-17(16)23-2)15(21)8-6-13-10-18(24-3)20(26-5)19(11-13)25-4/h6-12H,1-5H3/b8-6+	ZKYRYELHPFTZTI-SOFGYWHQSA-N					doublet; removed another duplicate entry; compound annotation
0391_006047	MD2-IN-1	C20H22O6	3.9544	5724738	COC1=C(C=C(C=C1)C(=O)/C=C/C2=CC(=C(C(=C2)OC)OC)OC)OC	COc1c(OC)cc(C(=O)C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C20H22O6/c1-22-16-9-7-14(12-17(16)23-2)15(21)8-6-13-10-18(24-3)20(26-5)19(11-13)25-4/h6-12H,1-5H3/b8-6+	ZKYRYELHPFTZTI-SOFGYWHQSA-N					doublet; removed another duplicate entry; compound annotation
0391_006050	IDO-IN-2	C29H35N7O	5.435	90718185		Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(-c3ccccc3-c3n[nH]nn3)c2)cc1	InChI=1S/C29H35N7O/c1-19(2)17-36(18-20(3)4)27-15-12-22(24-8-6-7-9-25(24)28-32-34-35-33-28)16-26(27)31-29(37)30-23-13-10-21(5)11-14-23/h6-16,19-20H,17-18H2,1-5H3,(H2,30,31,37)(H,32,33,34,35)	CJNMMPAEIYFQIJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006051	IDO-IN-2	C29H35N7O	5.529	90718185		Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(-c3ccccc3-c3n[nH]nn3)c2)cc1	InChI=1S/C29H35N7O/c1-19(2)17-36(18-20(3)4)27-15-12-22(24-8-6-7-9-25(24)28-32-34-35-33-28)16-26(27)31-29(37)30-23-13-10-21(5)11-14-23/h6-16,19-20H,17-18H2,1-5H3,(H2,30,31,37)(H,32,33,34,35)	CJNMMPAEIYFQIJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006052	IDO-IN-2	C29H35N7O	5.5323	90718185		Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(-c3ccccc3-c3n[nH]nn3)c2)cc1	InChI=1S/C29H35N7O/c1-19(2)17-36(18-20(3)4)27-15-12-22(24-8-6-7-9-25(24)28-32-34-35-33-28)16-26(27)31-29(37)30-23-13-10-21(5)11-14-23/h6-16,19-20H,17-18H2,1-5H3,(H2,30,31,37)(H,32,33,34,35)	CJNMMPAEIYFQIJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006053	Xanthinol	C13H21N5O4	0.5507	9913		CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C	InChI=1S/C13H21N5O4/c1-15(4-5-19)6-9(20)7-18-8-14-11-10(18)12(21)17(3)13(22)16(11)2/h8-9,19-20H,4-7H2,1-3H3	DSFGXPJYDCSWTA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006055	GW 766994	C21H24Cl2N4O3	2.0331	10218765	C1CO[C@H](CN1CC2=CC(=C(C=C2)Cl)Cl)CNC(=O)NCC3=CC=C(C=C3)C(=O)N	NC(=O)c1ccc(CNC(=O)NCC2CN(Cc3cc(Cl)c(Cl)cc3)CCO2)cc1	InChI=1S/C21H24Cl2N4O3/c22-18-6-3-15(9-19(18)23)12-27-7-8-30-17(13-27)11-26-21(29)25-10-14-1-4-16(5-2-14)20(24)28/h1-6,9,17H,7-8,10-13H2,(H2,24,28)(H2,25,26,29)/t17-/m0/s1	GPLUUMAKBFSDIE-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_006057	Linsitinib	C26H23N5O	2.4508	11640390		CC1(O)CC(c2nc(-c3cc4c(cc3)ccc(-c3ccccc3)n4)c3c(N)nccn23)C1	InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)	PKCDDUHJAFVJJB-UHFFFAOYSA-N					doublet; compound annotation
0391_006058	Linsitinib	C26H23N5O	2.4536	11640390		CC1(O)CC(c2nc(-c3cc4c(cc3)ccc(-c3ccccc3)n4)c3c(N)nccn23)C1	InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)	PKCDDUHJAFVJJB-UHFFFAOYSA-N					doublet; compound annotation
0391_006059	Linsitinib	C26H23N5O	2.4585	11640390		CC1(O)CC(c2nc(-c3cc4c(cc3)ccc(-c3ccccc3)n4)c3c(N)nccn23)C1	InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)	PKCDDUHJAFVJJB-UHFFFAOYSA-N					doublet; compound annotation
0391_006060	ELEDOISIN	C54H85N13O15S	2.5556	10328936	CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCC(=O)N3	CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C1CCC(=O)N1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(N)=O	InChI=1S/C54H85N13O15S/c1-7-30(4)44(53(81)57-27-42(70)60-36(24-29(2)3)49(77)61-33(45(56)73)20-23-83-6)66-50(78)37(25-32-14-9-8-10-15-32)63-46(74)31(5)58-48(76)38(26-43(71)72)64-47(75)34(16-11-12-21-55)62-51(79)39(28-68)65-52(80)40-17-13-22-67(40)54(82)35-18-19-41(69)59-35/h8-10,14-15,29-31,33-40,44,68H,7,11-13,16-28,55H2,1-6H3,(H2,56,73)(H,57,81)(H,58,76)(H,59,69)(H,60,70)(H,61,77)(H,62,79)(H,63,74)(H,64,75)(H,65,80)(H,66,78)(H,71,72)/t30-,31-,33-,34-,35-,36-,37-,38-,39-,40-,44-/m0/s1	AYLPVIWBPZMVSH-FCKMLYJASA-N					compound annotation
0391_006061	Tryptanthrin	C15H8N2O2	3.3783	73549		O=C1c2ccccc2-n2c1nc1ccccc1c2=O	InChI=1S/C15H8N2O2/c18-13-10-6-2-4-8-12(10)17-14(13)16-11-7-3-1-5-9(11)15(17)19/h1-8H	VQQVWGVXDIPORV-UHFFFAOYSA-N					compound annotation
0391_006062	203640-27-1	C24H20N2O4S2	4.8293	10718956	CC1=CC=C(C=C1)C#CC2=CC=C(S2)S(=O)(=O)N[C@H](CC3=CNC4=CC=CC=C43)C(=O)O	Cc1ccc(C#Cc2ccc(S(=O)(=O)NC(Cc3c[nH]c4ccccc34)C(=O)O)s2)cc1	InChI=1S/C24H20N2O4S2/c1-16-6-8-17(9-7-16)10-11-19-12-13-23(31-19)32(29,30)26-22(24(27)28)14-18-15-25-21-5-3-2-4-20(18)21/h2-9,12-13,15,22,25-26H,14H2,1H3,(H,27,28)/t22-/m1/s1	YWCLDDLVLSQGSZ-JOCHJYFZSA-N					removed another duplicate entry; compound annotation
0391_006065	bis(1,3-dibutylbarbiturate)trimethine oxonol	C27H40N4O6	5.7903	6438341	CCCCN1C(=O)C(C(=O)N(C1=O)CCCC)/C=C/C=C2C(=O)N(C(=O)N(C2=O)CCCC)CCCC	CCCCN1C(=O)C(=CC=CC2C(=O)N(CCCC)C(=O)N(CCCC)C2=O)C(=O)N(CCCC)C1=O	InChI=1S/C27H40N4O6/c1-5-9-16-28-22(32)20(23(33)29(26(28)36)17-10-6-2)14-13-15-21-24(34)30(18-11-7-3)27(37)31(25(21)35)19-12-8-4/h13-15,20H,5-12,16-19H2,1-4H3/b14-13+	ATJCYSYHWGQAET-BUHFOSPRSA-N					removed another duplicate entry; compound annotation
0391_006067	edrophonium	C10H16NO+	0.4993	3202		CC[N+](C)(C)c1cc(O)ccc1	InChI=1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1	VWLHWLSRQJQWRG-UHFFFAOYSA-O					compound annotation
0391_006068	iproniazid	C9H13N3O	0.681	3748		CC(C)NNC(=O)c1ccncc1	InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)	NYMGNSNKLVNMIA-UHFFFAOYSA-N					doublet; compound annotation
0391_006069	CDKI-73	C15H15FN6O2S2	2.2409	71561915		CNc1nc(C)c(-c2nc(Nc3cc(S(N)(=O)=O)ccc3)ncc2F)s1	InChI=1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22)	GAIOPWBQKZMUNO-UHFFFAOYSA-N					doublet; compound annotation
0391_006070	CDKI-73	C15H15FN6O2S2	2.2437	71561915		CNc1nc(C)c(-c2nc(Nc3cc(S(N)(=O)=O)ccc3)ncc2F)s1	InChI=1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22)	GAIOPWBQKZMUNO-UHFFFAOYSA-N					doublet; compound annotation
0391_006071	CDKI-73	C15H15FN6O2S2	2.2469	71561915		CNc1nc(C)c(-c2nc(Nc3cc(S(N)(=O)=O)ccc3)ncc2F)s1	InChI=1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22)	GAIOPWBQKZMUNO-UHFFFAOYSA-N					doublet; compound annotation
0391_006072	1679333-73-3	C18H14Cl2N2O2	2.6892	7066918	C1[C@H]([NH2+][C@@H](C2=C1C3=CC=CC=C3N2)C4=C(C=C(C=C4)Cl)Cl)C(=O)[O-]	O=C(O)C1Cc2c([nH]c3ccccc23)C(c2c(Cl)cc(Cl)cc2)N1	InChI=1S/C18H14Cl2N2O2/c19-9-5-6-11(13(20)7-9)16-17-12(8-15(22-16)18(23)24)10-3-1-2-4-14(10)21-17/h1-7,15-16,21-22H,8H2,(H,23,24)/t15-,16+/m0/s1	ZJDRIKAAFJMYGX-JKSUJKDBSA-N					removed another duplicate entry; compound annotation
0391_006074	RK-287107	C22H26F2N4O2	2.9621	137701512		O=c1[nH]c(N2CCC3(CC2)CN(CCO)c2c3c(F)cc(F)c2)nc2c1CCCC2	InChI=1S/C22H26F2N4O2/c23-14-11-16(24)19-18(12-14)28(9-10-29)13-22(19)5-7-27(8-6-22)21-25-17-4-2-1-3-15(17)20(30)26-21/h11-12,29H,1-10,13H2,(H,25,26,30)	FZQYCOUBRJEYBC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006076	Voruciclib	C22H19ClF3NO5	3.1921	67409219	CN1CC[C@H]([C@@H]1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2c(Cl)cc(C(F)(F)F)cc2)cc3=O)C1CO	InChI=1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1	MRPGRAKIAJJGMM-OCCSQVGLSA-N					compound annotation
0391_006077	acetohexamide	C15H20N2O4S	3.3901	1989		CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1	InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)	VGZSUPCWNCWDAN-UHFFFAOYSA-N					compound annotation
0391_006078	iproniazid	C9H13N3O	3.8384	3748		CC(C)NNC(=O)c1ccncc1	InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)	NYMGNSNKLVNMIA-UHFFFAOYSA-N					doublet; compound annotation
0391_006079	ANETHOLE	C10H12O	4.1507	637563	C/C=C/C1=CC=C(C=C1)OC	CC=Cc1ccc(OC)cc1	InChI=1S/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3-8H,1-2H3/b4-3+	RUVINXPYWBROJD-ONEGZZNKSA-N					doublet; compound annotation
0391_006080	RTC-5	C24H22ClF3N2O3S	5.9906	71263344		O=S(=O)(NCCCN1c2ccccc2CCc2c1cc(Cl)cc2)c1ccc(OC(F)(F)F)cc1	InChI=1S/C24H22ClF3N2O3S/c25-19-9-8-18-7-6-17-4-1-2-5-22(17)30(23(18)16-19)15-3-14-29-34(31,32)21-12-10-20(11-13-21)33-24(26,27)28/h1-2,4-5,8-13,16,29H,3,6-7,14-15H2	QYOJMNDDVVEPFN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006082	Sodium formononetin-3'-sulfonate	C16H12O7S	1.7087	51037710		COc1c(S(=O)(=O)O)cc(-c2coc3c(ccc(O)c3)c2=O)cc1	InChI=1S/C16H12O7S/c1-22-13-5-2-9(6-15(13)24(19,20)21)12-8-23-14-7-10(17)3-4-11(14)16(12)18/h2-8,17H,1H3,(H,19,20,21)	BANYZHVPBUALPV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006084	1197958-12-5	C26H34ClN6O2P	1.8338	57390074		COc1c(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc(N2CCC(N(C)C)CC2)c1	InChI=1S/C26H34ClN6O2P/c1-32(2)18-12-14-33(15-13-18)19-10-11-21(23(16-19)35-3)30-26-28-17-20(27)25(31-26)29-22-8-6-7-9-24(22)36(4,5)34/h6-11,16-18H,12-15H2,1-5H3,(H2,28,29,30,31)	OVDSPTSBIQCAIN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006086	1197958-12-5	C26H34ClN6O2P	1.8371	57390074		COc1c(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc(N2CCC(N(C)C)CC2)c1	InChI=1S/C26H34ClN6O2P/c1-32(2)18-12-14-33(15-13-18)19-10-11-21(23(16-19)35-3)30-26-28-17-20(27)25(31-26)29-22-8-6-7-9-24(22)36(4,5)34/h6-11,16-18H,12-15H2,1-5H3,(H2,28,29,30,31)	OVDSPTSBIQCAIN-UHFFFAOYSA-N					doublet; compound annotation
0391_006087	459168-41-3	C14H16ClN3O	2.1652	4908365		CN1CCN(C(=O)c2cc3c(ccc(Cl)c3)[nH]2)CC1	InChI=1S/C14H16ClN3O/c1-17-4-6-18(7-5-17)14(19)13-9-10-8-11(15)2-3-12(10)16-13/h2-3,8-9,16H,4-7H2,1H3	HUQJRYMLJBBEDO-UHFFFAOYSA-N					compound annotation
0391_006088	Solasonine	C45H73NO16	2.4753	119247	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H73NO16/c1-19-8-13-45(46-16-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-42-39(61-40-36(54)34(52)31(49)21(3)56-40)38(33(51)29(18-48)59-42)60-41-37(55)35(53)32(50)28(17-47)58-41/h6,19-21,23-42,46-55H,7-18H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28-,29-,30+,31+,32-,33+,34-,35+,36-,37-,38+,39-,40+,41+,42-,43+,44+,45-/m1/s1	QCTMYNGDIBTNSK-XEAAVONHSA-N					doublet; compound annotation
0391_006089	Solasonine	C45H73NO16	2.5442	119247	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H73NO16/c1-19-8-13-45(46-16-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-42-39(61-40-36(54)34(52)31(49)21(3)56-40)38(33(51)29(18-48)59-42)60-41-37(55)35(53)32(50)28(17-47)58-41/h6,19-21,23-42,46-55H,7-18H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28-,29-,30+,31+,32-,33+,34-,35+,36-,37-,38+,39-,40+,41+,42-,43+,44+,45-/m1/s1	QCTMYNGDIBTNSK-XEAAVONHSA-N					doublet; compound annotation
0391_006090	MODALINE	C10H15N3	2.9815	17860		Cc1nccnc1N1CCCCC1	InChI=1S/C10H15N3/c1-9-10(12-6-5-11-9)13-7-3-2-4-8-13/h5-6H,2-4,7-8H2,1H3	BJHCGMHPEKLROM-UHFFFAOYSA-N					compound annotation
0391_006091	1247825-37-1	C18H11Cl2N3O3S3	4.3125	51031028		CS(=O)(=O)c1ccc(NC(=O)c2cc(C#N)c(Sc3c(Cl)cncc3Cl)s2)cc1	InChI=1S/C18H11Cl2N3O3S3/c1-29(25,26)12-4-2-11(3-5-12)23-17(24)15-6-10(7-21)18(27-15)28-16-13(19)8-22-9-14(16)20/h2-6,8-9H,1H3,(H,23,24)	GUDJFFQZIISQJB-UHFFFAOYSA-N					compound annotation
0391_006092	SR144528	C29H34ClN3O	6.6899	3081355	CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)N[C@H]3[C@]4(CC[C@H](C4)C3(C)C)C)C5=CC(=C(C=C5)Cl)C	Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2cc(C)c(Cl)cc2)cc1	InChI=1S/C29H34ClN3O/c1-18-6-8-20(9-7-18)17-33-25(21-10-11-23(30)19(2)14-21)15-24(32-33)26(34)31-27-28(3,4)22-12-13-29(27,5)16-22/h6-11,14-15,22,27H,12-13,16-17H2,1-5H3,(H,31,34)/t22-,27-,29+/m1/s1	SUGVYNSRNKFXQM-XRHWURSXSA-N					doublet; compound annotation
0391_006093	SR144528	C29H34ClN3O	6.8132	3081355	CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)N[C@H]3[C@]4(CC[C@H](C4)C3(C)C)C)C5=CC(=C(C=C5)Cl)C	Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2cc(C)c(Cl)cc2)cc1	InChI=1S/C29H34ClN3O/c1-18-6-8-20(9-7-18)17-33-25(21-10-11-23(30)19(2)14-21)15-24(32-33)26(34)31-27-28(3,4)22-12-13-29(27,5)16-22/h6-11,14-15,22,27H,12-13,16-17H2,1-5H3,(H,31,34)/t22-,27-,29+/m1/s1	SUGVYNSRNKFXQM-XRHWURSXSA-N					doublet; removed another duplicate entry; compound annotation
0391_006095	dethiobiotin	C10H18N2O3	1.7522	445027	C[C@H]1[C@H](NC(=O)N1)CCCCCC(=O)O	CC1NC(=O)NC1CCCCCC(=O)O	InChI=1S/C10H18N2O3/c1-7-8(12-10(15)11-7)5-3-2-4-6-9(13)14/h7-8H,2-6H2,1H3,(H,13,14)(H2,11,12,15)/t7-,8+/m0/s1	AUTOLBMXDDTRRT-JGVFFNPUSA-N					removed another duplicate entry; compound annotation
0391_006097	1346546-69-7	C19H17N3O2S2	2.0934	54674134		CC(C)S(=O)(=O)c1cc2c(Nc3cc4c(cc3)scn4)ccnc2cc1	InChI=1S/C19H17N3O2S2/c1-12(2)26(23,24)14-4-5-16-15(10-14)17(7-8-20-16)22-13-3-6-19-18(9-13)21-11-25-19/h3-12H,1-2H3,(H,20,22)	ZCDBTQNFAPKACC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006099	865305-30-2	C14H17IN4O2	2.8272	15953802		COc1c(I)cc(Oc2cnc(N)nc2N)c(C(C)C)c1	InChI=1S/C14H17IN4O2/c1-7(2)8-4-11(20-3)9(15)5-10(8)21-12-6-18-14(17)19-13(12)16/h4-7H,1-3H3,(H4,16,17,18,19)	AATPYXMXFBBKFO-UHFFFAOYSA-N					compound annotation
0391_006100	AZ32	C20H16N4O	2.9267	134814488		CNC(=O)c1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1	InChI=1S/C20H16N4O/c1-21-20(25)16-9-7-15(8-10-16)18-11-23-19-12-22-17(13-24(18)19)14-5-3-2-4-6-14/h2-13H,1H3,(H,21,25)	LCRTUEXVVKVKBD-UHFFFAOYSA-N					doublet; compound annotation
0391_006101	AZ32	C20H16N4O	2.9295	134814488		CNC(=O)c1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1	InChI=1S/C20H16N4O/c1-21-20(25)16-9-7-15(8-10-16)18-11-23-19-12-22-17(13-24(18)19)14-5-3-2-4-6-14/h2-13H,1H3,(H,21,25)	LCRTUEXVVKVKBD-UHFFFAOYSA-N					doublet; compound annotation
0391_006102	CASIN	C20H22N2O	3.1544	2882155		OCCNC1CCCc2c1[nH]c1c2cc(-c2ccccc2)cc1	InChI=1S/C20H22N2O/c23-12-11-21-19-8-4-7-16-17-13-15(14-5-2-1-3-6-14)9-10-18(17)22-20(16)19/h1-3,5-6,9-10,13,19,21-23H,4,7-8,11-12H2	RXIUMAOXORBRCY-UHFFFAOYSA-N					compound annotation
0391_006103	154447-36-6	C19H17NO3	3.4094	3973		O=c1cc(N2CCOCC2)oc2c1cccc2-c1ccccc1	InChI=1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2	CZQHHVNHHHRRDU-UHFFFAOYSA-N					doublet; compound annotation
0391_006104	154447-36-6	C19H17NO3	3.4133	3973		O=c1cc(N2CCOCC2)oc2c1cccc2-c1ccccc1	InChI=1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2	CZQHHVNHHHRRDU-UHFFFAOYSA-N					doublet; compound annotation
0391_006105	PF-3845	C24H23F3N4O2	3.7301	25154867		O=C(Nc1cnccc1)N1CCC(Cc2cc(Oc3ncc(C(F)(F)F)cc3)ccc2)CC1	InChI=1S/C24H23F3N4O2/c25-24(26,27)19-6-7-22(29-15-19)33-21-5-1-3-18(14-21)13-17-8-11-31(12-9-17)23(32)30-20-4-2-10-28-16-20/h1-7,10,14-17H,8-9,11-13H2,(H,30,32)	NBOJHRYUGLRASX-UHFFFAOYSA-N					doublet; compound annotation
0391_006106	PF-3845	C24H23F3N4O2	3.7335	25154867		O=C(Nc1cnccc1)N1CCC(Cc2cc(Oc3ncc(C(F)(F)F)cc3)ccc2)CC1	InChI=1S/C24H23F3N4O2/c25-24(26,27)19-6-7-22(29-15-19)33-21-5-1-3-18(14-21)13-17-8-11-31(12-9-17)23(32)30-20-4-2-10-28-16-20/h1-7,10,14-17H,8-9,11-13H2,(H,30,32)	NBOJHRYUGLRASX-UHFFFAOYSA-N					doublet; compound annotation
0391_006107	Mavoglurant	C19H23NO3	3.9892	9926832	CC1=CC(=CC=C1)C#C[C@@]2(CCC[C@@H]3[C@H]2CCN3C(=O)OC)O	COC(=O)N1CCC2C1CCCC2(O)C#Cc1cccc(C)c1	InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1	ZFPZEYHRWGMJCV-ZHALLVOQSA-N					compound annotation
0391_006108	Tectochrysin	C16H12O4	4.6024	5281954		COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1	InChI=1S/C16H12O4/c1-19-11-7-12(17)16-13(18)9-14(20-15(16)8-11)10-5-3-2-4-6-10/h2-9,17H,1H3	IRZVHDLBAYNPCT-UHFFFAOYSA-N					compound annotation
0391_006109	ML-18	C32H35N5O5	5.0047	91827363	COC1=CC=C(C=C1)C2(CCCCC2)CNC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)NC5=CC=C(C=C5)[N+](=O)[O-]	COc1ccc(C2(CNC(=O)C(Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)cc1	InChI=1S/C32H35N5O5/c1-42-26-15-9-23(10-16-26)32(17-5-2-6-18-32)21-34-30(38)29(19-22-20-33-28-8-4-3-7-27(22)28)36-31(39)35-24-11-13-25(14-12-24)37(40)41/h3-4,7-16,20,29,33H,2,5-6,17-19,21H2,1H3,(H,34,38)(H2,35,36,39)/t29-/m0/s1	JOKVJNCYOSFDGC-LJAQVGFWSA-N					removed another duplicate entry; compound annotation
0391_006111	Swertiamarin	C16H22O10	1.3426	442435	C=C[C@H]1[C@@H](OC=C2[C@]1(CCOC2=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	C=CC1C(OC2OC(CO)C(O)C(O)C2O)OC=C2C(=O)OCCC21O	InChI=1S/C16H22O10/c1-2-7-14(24-6-8-13(21)23-4-3-16(7,8)22)26-15-12(20)11(19)10(18)9(5-17)25-15/h2,6-7,9-12,14-15,17-20,22H,1,3-5H2/t7-,9+,10+,11-,12+,14-,15-,16+/m0/s1	HEYZWPRKKUGDCR-QBXMEVCASA-N					removed another duplicate entry; compound annotation
0391_006113	3,4-DIMETHOXYPHENOL	C8H10O3	1.5259	16251		COc1c(OC)cc(O)cc1	InChI=1S/C8H10O3/c1-10-7-4-3-6(9)5-8(7)11-2/h3-5,9H,1-2H3	SMFFZOQLHYIRDA-UHFFFAOYSA-N					compound annotation
0391_006114	Agarotetrol	C17H18O6	1.5709	13606036	C1=CC=C(C=C1)CCC2=CC(=O)C3=C(O2)[C@H]([C@@H]([C@@H]([C@H]3O)O)O)O	O=c1cc(CCc2ccccc2)oc2c1C(O)C(O)C(O)C2O	InChI=1S/C17H18O6/c18-11-8-10(7-6-9-4-2-1-3-5-9)23-17-12(11)13(19)14(20)15(21)16(17)22/h1-5,8,13-16,19-22H,6-7H2/t13-,14+,15+,16-/m0/s1	CWMIROLCTHMEEO-JJXSEGSLSA-N					doublet; compound annotation
0391_006115	Albiflorin	C23H28O11	1.5709	24868421	C[C@]12C[C@H]([C@@H]3C[C@]1([C@@]3(C(=O)O2)COC(=O)C4=CC=CC=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O	CC12CC(O)C3CC1(OC1OC(CO)C(O)C(O)C1O)C3(COC(=O)c1ccccc1)C(=O)O2	InChI=1S/C23H28O11/c1-21-8-13(25)12-7-23(21,33-19-17(28)16(27)15(26)14(9-24)32-19)22(12,20(30)34-21)10-31-18(29)11-5-3-2-4-6-11/h2-6,12-17,19,24-28H,7-10H2,1H3/t12-,13+,14+,15+,16-,17+,19-,21-,22-,23-/m0/s1	QQUHMASGPODSIW-ICECTASOSA-N					doublet; removed another duplicate entry; compound annotation
0391_006117	Agarotetrol	C17H18O6	1.8394	13606036	C1=CC=C(C=C1)CCC2=CC(=O)C3=C(O2)[C@H]([C@@H]([C@@H]([C@H]3O)O)O)O	O=c1cc(CCc2ccccc2)oc2c1C(O)C(O)C(O)C2O	InChI=1S/C17H18O6/c18-11-8-10(7-6-9-4-2-1-3-5-9)23-17-12(11)13(19)14(20)15(21)16(17)22/h1-5,8,13-16,19-22H,6-7H2/t13-,14+,15+,16-/m0/s1	CWMIROLCTHMEEO-JJXSEGSLSA-N					doublet; removed another duplicate entry; compound annotation
0391_006119	Albiflorin	C23H28O11	2.2778	24868421	C[C@]12C[C@H]([C@@H]3C[C@]1([C@@]3(C(=O)O2)COC(=O)C4=CC=CC=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O	CC12CC(O)C3CC1(OC1OC(CO)C(O)C(O)C1O)C3(COC(=O)c1ccccc1)C(=O)O2	InChI=1S/C23H28O11/c1-21-8-13(25)12-7-23(21,33-19-17(28)16(27)15(26)14(9-24)32-19)22(12,20(30)34-21)10-31-18(29)11-5-3-2-4-6-11/h2-6,12-17,19,24-28H,7-10H2,1H3/t12-,13+,14+,15+,16-,17+,19-,21-,22-,23-/m0/s1	QQUHMASGPODSIW-ICECTASOSA-N					doublet; removed another duplicate entry; compound annotation
0391_006121	Delafloxacin	C18H12ClF3N4O4	3.0368	487101		Nc1nc(-n2cc(C(=O)O)c(=O)c3cc(F)c(N4CC(O)C4)c(Cl)c32)c(F)cc1F	InChI=1S/C18H12ClF3N4O4/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30)	DYDCPNMLZGFQTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006123	Conivaptan	C32H26N4O2	3.1239	151171		Cc1nc2c(CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-2)[nH]1	InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37)	IKENVDNFQMCRTR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006125	Ibrutinib	C25H24N6O2	3.4513	24821094	C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1	XYFPWWZEPKGCCK-GOSISDBHSA-N					doublet; compound annotation
0391_006126	Branebrutinib	C20H23FN4O2	3.5458	121293929	CC#CC(=O)N[C@H]1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F	CC#CC(=O)NC1CCCN(c2c(F)cc(C(N)=O)c3c2c(C)c(C)[nH]3)C1	InChI=1S/C20H23FN4O2/c1-4-6-16(26)24-13-7-5-8-25(10-13)19-15(21)9-14(20(22)27)18-17(19)11(2)12(3)23-18/h9,13,23H,5,7-8,10H2,1-3H3,(H2,22,27)(H,24,26)/t13-/m0/s1	VJPPLCNBDLZIFG-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_006129	Ibrutinib	C25H24N6O2	3.7067	24821094	C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1	XYFPWWZEPKGCCK-GOSISDBHSA-N					doublet; removed another duplicate entry; compound annotation
0391_006131	Resibufogenin	C24H32O4	3.83	6917974	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@]35[C@H](O5)C[C@@H]4C6=COC(=O)C=C6)C)O	CC12CCC(O)CC1CCC1C2CCC2(C)C(c3coc(=O)cc3)CC3OC312	InChI=1S/C24H32O4/c1-22-9-7-16(25)11-15(22)4-5-18-17(22)8-10-23(2)19(12-20-24(18,23)28-20)14-3-6-21(26)27-13-14/h3,6,13,15-20,25H,4-5,7-12H2,1-2H3/t15-,16+,17+,18-,19-,20-,22+,23-,24-/m1/s1	ATLJNLYIJOCWJE-CWMZOUAVSA-N					removed another duplicate entry; compound annotation
0391_006133	850467-66-2	C25H24N2O2	4.3901	46673962		O=C(CNC(=O)c1ccc(-c2ccccc2)cc1)NC1CCCc2ccccc21	InChI=1S/C25H24N2O2/c28-24(27-23-12-6-10-20-9-4-5-11-22(20)23)17-26-25(29)21-15-13-19(14-16-21)18-7-2-1-3-8-18/h1-5,7-9,11,13-16,23H,6,10,12,17H2,(H,26,29)(H,27,28)	WQKXOAJVNFOHNZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006135	Proanthocyanidin A2	C30H24O12	1.7199	124025	C1[C@H]([C@H](OC2=C1C(=CC3=C2[C@@H]4[C@H]([C@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC(=C(C=C6)O)O)O)O)C7=CC(=C(C=C7)O)O)O	Oc1cc(O)c2c(c1)OC1(c3cc(O)c(O)cc3)Oc3c(c4c(CC(O)C(c5cc(O)c(O)cc5)O4)c(O)c3)C2C1O	InChI=1S/C30H24O12/c31-13-7-20(37)24-22(8-13)41-30(12-2-4-16(33)19(36)6-12)29(39)26(24)25-23(42-30)10-17(34)14-9-21(38)27(40-28(14)25)11-1-3-15(32)18(35)5-11/h1-8,10,21,26-27,29,31-39H,9H2/t21-,26-,27-,29-,30+/m1/s1	NSEWTSAADLNHNH-LSBOWGMISA-N					doublet; compound annotation
0391_006136	Proanthocyanidin A2	C30H24O12	1.8812	124025	C1[C@H]([C@H](OC2=C1C(=CC3=C2[C@@H]4[C@H]([C@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC(=C(C=C6)O)O)O)O)C7=CC(=C(C=C7)O)O)O	Oc1cc(O)c2c(c1)OC1(c3cc(O)c(O)cc3)Oc3c(c4c(CC(O)C(c5cc(O)c(O)cc5)O4)c(O)c3)C2C1O	InChI=1S/C30H24O12/c31-13-7-20(37)24-22(8-13)41-30(12-2-4-16(33)19(36)6-12)29(39)26(24)25-23(42-30)10-17(34)14-9-21(38)27(40-28(14)25)11-1-3-15(32)18(35)5-11/h1-8,10,21,26-27,29,31-39H,9H2/t21-,26-,27-,29-,30+/m1/s1	NSEWTSAADLNHNH-LSBOWGMISA-N					doublet; removed another duplicate entry; compound annotation
0391_006138	9-Hydroxycamptothecin	C20H16N2O5	2.1938	135403790	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5O)N=C4C3=C2)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4c(cc3Cn1c2=O)c(O)ccc4	InChI=1S/C20H16N2O5/c1-2-20(26)13-7-15-17-10(6-11-14(21-17)4-3-5-16(11)23)8-22(15)18(24)12(13)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1	LCZZWLIDINBPRC-FQEVSTJZSA-N					compound annotation
0391_006139	Gambogenic Acid	C38H46O8	2.4789	10794070	CC(=CCC/C(=C/CC1=C(C(=C2C(=C1O)C(=O)C3=C[C@@H]4C[C@@H]5[C@@]3(O2)[C@](C4=O)(OC5(C)C)C/C=C(/C)\C(=O)O)CC=C(C)C)O)/C)C	CC(C)=CCCC(C)=CCc1c(O)c(CC=C(C)C)c2OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c2c1O	InChI=1S/C38H46O8/c1-20(2)10-9-11-22(5)13-15-25-30(39)26(14-12-21(3)4)33-29(31(25)40)32(41)27-18-24-19-28-36(7,8)46-37(34(24)42,38(27,28)45-33)17-16-23(6)35(43)44/h10,12-13,16,18,24,28,39-40H,9,11,14-15,17,19H2,1-8H3,(H,43,44)/b22-13+,23-16-/t24-,28+,37+,38-/m1/s1	RCWNBHCZYXWDOV-VSFMGBBVSA-N					doublet; compound annotation
0391_006140	Methyllycaconitine	C37H50N2O10	2.6618	5311278	CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2[C@@H]([C@@](C31)([C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)C[C@@H](C8=O)C	CCN1CC2(COC(=O)c3ccccc3N3C(=O)CC(C)C3=O)CCC(OC)C34C5CC6C(OC)CC(O)(C5C6OC)C(O)(C(OC)C23)C14	InChI=1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19-,21+,22+,24-,25-,27+,28-,29+,30-,33?,34-,35+,36-,37+/m0/s1	XLTANAWLDBYGFU-UNYSBPQLSA-N					removed another duplicate entry; compound annotation
0391_006142	clomipramine	C19H23ClN2	3.4374	2801		CN(C)CCCN1c2ccccc2CCc2c1cc(Cl)cc2	InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3	GDLIGKIOYRNHDA-UHFFFAOYSA-N					compound annotation
0391_006143	GLYCOCHENODEOXYCHOLIC ACID	C26H43NO5	3.886	12544	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1	GHCZAUBVMUEKKP-GYPHWSFCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006145	Gambogenic Acid	C38H46O8	6.2375	10794070	CC(=CCC/C(=C/CC1=C(C(=C2C(=C1O)C(=O)C3=C[C@@H]4C[C@@H]5[C@@]3(O2)[C@](C4=O)(OC5(C)C)C/C=C(/C)\C(=O)O)CC=C(C)C)O)/C)C	CC(C)=CCCC(C)=CCc1c(O)c(CC=C(C)C)c2OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c2c1O	InChI=1S/C38H46O8/c1-20(2)10-9-11-22(5)13-15-25-30(39)26(14-12-21(3)4)33-29(31(25)40)32(41)27-18-24-19-28-36(7,8)46-37(34(24)42,38(27,28)45-33)17-16-23(6)35(43)44/h10,12-13,16,18,24,28,39-40H,9,11,14-15,17,19H2,1-8H3,(H,43,44)/b22-13+,23-16-/t24-,28+,37+,38-/m1/s1	RCWNBHCZYXWDOV-VSFMGBBVSA-N					doublet; compound annotation
0391_006146	Gambogenic Acid	C38H46O8	6.3995	10794070	CC(=CCC/C(=C/CC1=C(C(=C2C(=C1O)C(=O)C3=C[C@@H]4C[C@@H]5[C@@]3(O2)[C@](C4=O)(OC5(C)C)C/C=C(/C)\C(=O)O)CC=C(C)C)O)/C)C	CC(C)=CCCC(C)=CCc1c(O)c(CC=C(C)C)c2OC34C(=CC5CC3C(C)(C)OC4(CC=C(C)C(=O)O)C5=O)C(=O)c2c1O	InChI=1S/C38H46O8/c1-20(2)10-9-11-22(5)13-15-25-30(39)26(14-12-21(3)4)33-29(31(25)40)32(41)27-18-24-19-28-36(7,8)46-37(34(24)42,38(27,28)45-33)17-16-23(6)35(43)44/h10,12-13,16,18,24,28,39-40H,9,11,14-15,17,19H2,1-8H3,(H,43,44)/b22-13+,23-16-/t24-,28+,37+,38-/m1/s1	RCWNBHCZYXWDOV-VSFMGBBVSA-N					doublet; removed another duplicate entry; compound annotation
0391_006148	GSK583	C20H19FN4O2S	2.5031	67469084		CC(C)(C)S(=O)(=O)c1cc2c(Nc3n[nH]c4c3cc(F)cc4)ccnc2cc1	InChI=1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)	XLOGLWKOHPIJLV-UHFFFAOYSA-N					doublet; compound annotation
0391_006149	GSK583	C20H19FN4O2S	2.5058	67469084		CC(C)(C)S(=O)(=O)c1cc2c(Nc3n[nH]c4c3cc(F)cc4)ccnc2cc1	InChI=1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)	XLOGLWKOHPIJLV-UHFFFAOYSA-N					doublet; compound annotation
0391_006150	BI-847325	C29H28N4O2	2.7412	135567102		CCNC(=O)C#Cc1cc2c(cc1)c(C(=Nc1ccc(CN(C)C)cc1)c1ccccc1)c(O)[nH]2	InChI=1S/C29H28N4O2/c1-4-30-26(34)17-13-20-12-16-24-25(18-20)32-29(35)27(24)28(22-8-6-5-7-9-22)31-23-14-10-21(11-15-23)19-33(2)3/h5-12,14-16,18,32,35H,4,19H2,1-3H3,(H,30,34)	OCUQMWSIGPQEMX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006152	GSK583	C20H19FN4O2S	3.1563	67469084		CC(C)(C)S(=O)(=O)c1cc2c(Nc3n[nH]c4c3cc(F)cc4)ccnc2cc1	InChI=1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)	XLOGLWKOHPIJLV-UHFFFAOYSA-N					doublet; compound annotation
0391_006153	Calpain inhibitor I	C20H37N3O4	3.2255	443118	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(C)=O	InChI=1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1	FMYKJLXRRQTBOR-BZSNNMDCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006155	CHEMBL4539512	C27H31N5O3	3.2331	86340175	CN1C2=C(C=C(C=C2OC)C(=O)N3CC[C@H]([C@H](C3)N)O)N=C1C4=CC5=CC=CC=C5N4CC6CC6	COc1cc(C(=O)N2CCC(O)C(N)C2)cc2c1n(C)c(-c1cc3ccccc3n1CC1CC1)n2	InChI=1S/C27H31N5O3/c1-30-25-20(11-18(13-24(25)35-2)27(34)31-10-9-23(33)19(28)15-31)29-26(30)22-12-17-5-3-4-6-21(17)32(22)14-16-7-8-16/h3-6,11-13,16,19,23,33H,7-10,14-15,28H2,1-2H3/t19-,23+/m0/s1	BDYDINKSILYBOL-WMZHIEFXSA-N					removed another duplicate entry; compound annotation
0391_006157	Calpain inhibitor I	C20H37N3O4	3.2813	443118	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(C)=O	InChI=1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1	FMYKJLXRRQTBOR-BZSNNMDCSA-N					doublet; compound annotation
0391_006158	Calpain inhibitor I	C20H37N3O4	3.2863	443118	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(C)=O	InChI=1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1	FMYKJLXRRQTBOR-BZSNNMDCSA-N					doublet; compound annotation
0391_006159	Ramelteon	C16H21NO2	3.2913	208902	CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3	CCC(=O)NCCC1CCc2c1c1c(cc2)OCC1	InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1	YLXDSYKOBKBWJQ-LBPRGKRZSA-N					doublet; compound annotation
0391_006160	Ramelteon	C16H21NO2	3.2963	208902	CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3	CCC(=O)NCCC1CCc2c1c1c(cc2)OCC1	InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1	YLXDSYKOBKBWJQ-LBPRGKRZSA-N					doublet; compound annotation
0391_006161	Calpain inhibitor I	C20H37N3O4	3.4125	443118	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(C)=O	InChI=1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1	FMYKJLXRRQTBOR-BZSNNMDCSA-N					doublet; compound annotation
0391_006162	5-Methoxyflavone	C16H12O3	3.5244	94525		COc1cccc2c1c(=O)cc(-c1ccccc1)o2	InChI=1S/C16H12O3/c1-18-13-8-5-9-14-16(13)12(17)10-15(19-14)11-6-3-2-4-7-11/h2-10H,1H3	XRQSPUXANRGDAV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006164	ML239	C13H10Cl3N3O2	3.912	135999136	C1=CNC(=C1)/C=N/NC(=O)COC2=C(C=C(C=C2Cl)Cl)Cl	O=C(COc1c(Cl)cc(Cl)cc1Cl)NN=Cc1ccc[nH]1	InChI=1S/C13H10Cl3N3O2/c14-8-4-10(15)13(11(16)5-8)21-7-12(20)19-18-6-9-2-1-3-17-9/h1-6,17H,7H2,(H,19,20)/b18-6+	NVEDPFICKAIHKD-NGYBGAFCSA-N					doublet; compound annotation
0391_006165	FRENTIZOLE	C15H13N3O2S	3.9484	33334		COc1cc2c(cc1)nc(NC(=O)Nc1ccccc1)s2	InChI=1S/C15H13N3O2S/c1-20-11-7-8-12-13(9-11)21-15(17-12)18-14(19)16-10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)	JHBWYQRKOUBPCA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006167	Calpain inhibitor I	C20H37N3O4	3.9809	443118	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(C)=O	InChI=1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1	FMYKJLXRRQTBOR-BZSNNMDCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006169	ML239	C13H10Cl3N3O2	4.11	135999136	C1=CNC(=C1)/C=N/NC(=O)COC2=C(C=C(C=C2Cl)Cl)Cl	O=C(COc1c(Cl)cc(Cl)cc1Cl)NN=Cc1ccc[nH]1	InChI=1S/C13H10Cl3N3O2/c14-8-4-10(15)13(11(16)5-8)21-7-12(20)19-18-6-9-2-1-3-17-9/h1-6,17H,7H2,(H,19,20)/b18-6+	NVEDPFICKAIHKD-NGYBGAFCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006171	INH6	C19H18N2OS	5.1524	7918451		Cc1cc(C)c(-c2csc(NC(=O)c3ccccc3)n2)c(C)c1	InChI=1S/C19H18N2OS/c1-12-9-13(2)17(14(3)10-12)16-11-23-19(20-16)21-18(22)15-7-5-4-6-8-15/h4-11H,1-3H3,(H,20,21,22)	WCZLNJTXHZPHLM-UHFFFAOYSA-N					doublet; compound annotation
0391_006172	INH6	C19H18N2OS	5.1569	7918451		Cc1cc(C)c(-c2csc(NC(=O)c3ccccc3)n2)c(C)c1	InChI=1S/C19H18N2OS/c1-12-9-13(2)17(14(3)10-12)16-11-23-19(20-16)21-18(22)15-7-5-4-6-8-15/h4-11H,1-3H3,(H,20,21,22)	WCZLNJTXHZPHLM-UHFFFAOYSA-N					doublet; compound annotation
0391_006173	220246-81-1	C13H15N3O2	1.7272	9816296	C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NC(=O)C	CC(=O)Nc1ccc(C2=NNC(=O)CC2C)cc1	InChI=1S/C13H15N3O2/c1-8-7-12(18)15-16-13(8)10-3-5-11(6-4-10)14-9(2)17/h3-6,8H,7H2,1-2H3,(H,14,17)(H,15,18)/t8-/m1/s1	GDZXNMWZXLDEKG-MRVPVSSYSA-N					removed another duplicate entry; compound annotation
0391_006175	AVL-292	C22H22FN5O3	2.4556	59174488		C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1	InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)	KXBDTLQSDKGAEB-UHFFFAOYSA-N					doublet; compound annotation
0391_006176	AVL-292	C22H22FN5O3	2.4605	59174488		C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1	InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)	KXBDTLQSDKGAEB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006178	AVL-292	C22H22FN5O3	3.1505	59174488		C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1	InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)	KXBDTLQSDKGAEB-UHFFFAOYSA-N					doublet; compound annotation
0391_006179	Chikusetsusaponin iva	C42H66O14	3.4658	13909684	C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O	CC1(C)CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H66O14/c1-37(2)14-16-42(36(52)56-34-30(48)27(45)26(44)22(19-43)53-34)17-15-40(6)20(21(42)18-37)8-9-24-39(5)12-11-25(38(3,4)23(39)10-13-41(24,40)7)54-35-31(49)28(46)29(47)32(55-35)33(50)51/h8,21-32,34-35,43-49H,9-19H2,1-7H3,(H,50,51)/t21-,22+,23-,24+,25-,26+,27-,28-,29-,30+,31+,32-,34-,35+,39-,40+,41+,42-/m0/s1	YOSRLTNUOCHBEA-SGVKAIFKSA-N					compound annotation
0391_006180	beta-Lapachone	C15H14O3	3.8186	3885		CC1(C)CCC2=C(O1)c1ccccc1C(=O)C2=O	InChI=1S/C15H14O3/c1-15(2)8-7-11-13(17)12(16)9-5-3-4-6-10(9)14(11)18-15/h3-6H,7-8H2,1-2H3	QZPQTZZNNJUOLS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006182	Ispinesib	C30H33ClN4O2	4.0218	6851740	CC1=CC=C(C=C1)C(=O)N(CCCN)[C@@H](C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C	Cc1ccc(C(=O)N(CCCN)C(c2nc3c(ccc(Cl)c3)c(=O)n2Cc2ccccc2)C(C)C)cc1	InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1	QJZRFPJCWMNVAV-HHHXNRCGSA-N					doublet; compound annotation
0391_006183	Ispinesib	C30H33ClN4O2	4.0251	6851740	CC1=CC=C(C=C1)C(=O)N(CCCN)[C@@H](C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C	Cc1ccc(C(=O)N(CCCN)C(c2nc3c(ccc(Cl)c3)c(=O)n2Cc2ccccc2)C(C)C)cc1	InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1	QJZRFPJCWMNVAV-HHHXNRCGSA-N					doublet; compound annotation
0391_006184	38226-86-7	C21H20O6	5.5616	14583584		COc1ccc(-c2c(O)c(=O)c3c(o2)c2c(cc3O)OC(C)(C)CC2)cc1	InChI=1S/C21H20O6/c1-21(2)9-8-13-15(27-21)10-14(22)16-17(23)18(24)19(26-20(13)16)11-4-6-12(25-3)7-5-11/h4-7,10,22,24H,8-9H2,1-3H3	PPCHTBBOSVKORE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006186	Secoisolariciresinol diglucoside	C32H46O16	1.7406	9917980	COC1=C(C=CC(=C1)C[C@@H](CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@@H](CC3=CC(=C(C=C3)O)OC)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1c(O)ccc(CC(COC2OC(CO)C(O)C(O)C2O)C(COC2OC(CO)C(O)C(O)C2O)Cc2cc(OC)c(O)cc2)c1	InChI=1S/C32H46O16/c1-43-21-9-15(3-5-19(21)35)7-17(13-45-31-29(41)27(39)25(37)23(11-33)47-31)18(8-16-4-6-20(36)22(10-16)44-2)14-46-32-30(42)28(40)26(38)24(12-34)48-32/h3-6,9-10,17-18,23-42H,7-8,11-14H2,1-2H3/t17-,18-,23+,24+,25+,26+,27-,28-,29+,30+,31+,32+/m0/s1	SBVBJPHMDABKJV-PGCJWIIOSA-N					doublet; removed another duplicate entry; compound annotation
0391_006189	1436383-95-7	C21H19FN4O3S	2.4604	135742054		Cc1c(-c2cc(F)c(O)cc2)n2ccnc(NCc3cc(S(C)(=O)=O)ccc3)c2n1	InChI=1S/C21H19FN4O3S/c1-13-19(15-6-7-18(27)17(22)11-15)26-9-8-23-20(21(26)25-13)24-12-14-4-3-5-16(10-14)30(2,28)29/h3-11,27H,12H2,1-2H3,(H,23,24)	IMHZCCZYPHJVMS-UHFFFAOYSA-N					doublet; compound annotation
0391_006190	1436383-95-7	C21H19FN4O3S	2.4631	135742054		Cc1c(-c2cc(F)c(O)cc2)n2ccnc(NCc3cc(S(C)(=O)=O)ccc3)c2n1	InChI=1S/C21H19FN4O3S/c1-13-19(15-6-7-18(27)17(22)11-15)26-9-8-23-20(21(26)25-13)24-12-14-4-3-5-16(10-14)30(2,28)29/h3-11,27H,12H2,1-2H3,(H,23,24)	IMHZCCZYPHJVMS-UHFFFAOYSA-N					doublet; compound annotation
0391_006191	GNE-617	C21H15F2N3O3S	2.6264	68277611		O=C(NCc1ccc(S(=O)(=O)c2cc(F)cc(F)c2)cc1)c1cn2ccnc2cc1	InChI=1S/C21H15F2N3O3S/c22-16-9-17(23)11-19(10-16)30(28,29)18-4-1-14(2-5-18)12-25-21(27)15-3-6-20-24-7-8-26(20)13-15/h1-11,13H,12H2,(H,25,27)	XRDVXQQZLHVEQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006192	PREDNISOLONE HEMISUCCINATE	C25H32O8	3.1094	656804	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCC(=O)O)O)CCC4=CC(=O)C=C[C@]34C)O	CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O	InChI=1S/C25H32O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h7,9,11,16-18,22,27,32H,3-6,8,10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1	APGDTXUMTIZLCJ-CGVGKPPMSA-N					removed another duplicate entry; compound annotation
0391_006194	Asiatic acid	C30H48O5	4.053	119034	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5CCC43C)C2C1C	InChI=1S/C30H48O5/c1-17-9-12-30(25(34)35)14-13-28(5)19(23(30)18(17)2)7-8-22-26(3)15-20(32)24(33)27(4,16-31)21(26)10-11-29(22,28)6/h7,17-18,20-24,31-33H,8-16H2,1-6H3,(H,34,35)/t17-,18+,20-,21-,22-,23+,24+,26+,27+,28-,29-,30+/m1/s1	JXSVIVRDWWRQRT-UYDOISQJSA-N					removed another duplicate entry; compound annotation
0391_006196	suxibuzone	C24H26N2O6	4.2581	5362		CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O	InChI=1S/C24H26N2O6/c1-2-3-16-24(17-32-21(29)15-14-20(27)28)22(30)25(18-10-6-4-7-11-18)26(23(24)31)19-12-8-5-9-13-19/h4-13H,2-3,14-17H2,1H3,(H,27,28)	ONWXNHPOAGOMTG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006199	Gliquidone	C27H33N3O6S	4.8253	91610		COc1cc2c(cc1)C(C)(C)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C2=O	InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)	LLJFMFZYVVLQKT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006201	7803-88-5	C11H15N5O5	0.8865	96312	COC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N	COc1nc(N)nc2c1ncn2C1OC(CO)C(O)C1O	InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7-,10-/m1/s1	IXOXBSCIXZEQEQ-KQYNXXCUSA-N					removed another duplicate entry; compound annotation
0391_006203	BCI-121	C14H18BrN3O2	1.8674	795875		NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1	InChI=1S/C14H18BrN3O2/c15-11-1-3-12(4-2-11)17-13(19)9-18-7-5-10(6-8-18)14(16)20/h1-4,10H,5-9H2,(H2,16,20)(H,17,19)	KSUYPIXCRPCPGF-UHFFFAOYSA-N					doublet; compound annotation
0391_006204	BCI-121	C14H18BrN3O2	1.8707	795875		NC(=O)C1CCN(CC(=O)Nc2ccc(Br)cc2)CC1	InChI=1S/C14H18BrN3O2/c15-11-1-3-12(4-2-11)17-13(19)9-18-7-5-10(6-8-18)14(16)20/h1-4,10H,5-9H2,(H2,16,20)(H,17,19)	KSUYPIXCRPCPGF-UHFFFAOYSA-N					doublet; compound annotation
0391_006205	Onalespib	C24H31N3O3	2.2058	11955716		CC(C)c1cc(C(=O)N2Cc3c(cc(CN4CCN(C)CC4)cc3)C2)c(O)cc1O	InChI=1S/C24H31N3O3/c1-16(2)20-11-21(23(29)12-22(20)28)24(30)27-14-18-5-4-17(10-19(18)15-27)13-26-8-6-25(3)7-9-26/h4-5,10-12,16,28-29H,6-9,13-15H2,1-3H3	IFRGXKKQHBVPCQ-UHFFFAOYSA-N					compound annotation
0391_006206	L-745,870 hydrochloride	C18H19ClN4	2.3977	5311200		Clc1ccc(N2CCN(Cc3cnc4[nH]cccc-43)CC2)cc1	InChI=1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)	OGJGQVFWEPNYSB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006208	Pyridone 6	C18H16FN3O	2.4818	5494425		CC(C)(C)c1nc2c([nH]1)c1c(cc(F)cc1)c1c2cc[nH]c1=O	InChI=1S/C18H16FN3O/c1-18(2,3)17-21-14-10-5-4-9(19)8-12(10)13-11(15(14)22-17)6-7-20-16(13)23/h4-8H,1-3H3,(H,20,23)(H,21,22)	VNDWQCSOSCCWIP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006210	Autotaxin-IN-3	C22H21N9O2	3.0219	141724181		O=C(Cc1nnc(-c2cnc(NC3Cc4ccccc4C3)nc2)o1)N1CCc2n[nH]nc2C1	InChI=1S/C22H21N9O2/c32-20(31-6-5-17-18(12-31)27-30-26-17)9-19-28-29-21(33-19)15-10-23-22(24-11-15)25-16-7-13-3-1-2-4-14(13)8-16/h1-4,10-11,16H,5-9,12H2,(H,23,24,25)(H,26,27,30)	YJLUBHOZZTYQIP-UHFFFAOYSA-N					doublet; compound annotation
0391_006211	Darifenacin	C28H30N2O2	3.0251	444031	C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5	NC(=O)C(c1ccccc1)(c1ccccc1)C1CCN(CCc2cc3c(cc2)OCC3)C1	InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1	HXGBXQDTNZMWGS-RUZDIDTESA-N					doublet; compound annotation
0391_006212	Autotaxin-IN-3	C22H21N9O2	3.0251	141724181		O=C(Cc1nnc(-c2cnc(NC3Cc4ccccc4C3)nc2)o1)N1CCc2n[nH]nc2C1	InChI=1S/C22H21N9O2/c32-20(31-6-5-17-18(12-31)27-30-26-17)9-19-28-29-21(33-19)15-10-23-22(24-11-15)25-16-7-13-3-1-2-4-14(13)8-16/h1-4,10-11,16H,5-9,12H2,(H,23,24,25)(H,26,27,30)	YJLUBHOZZTYQIP-UHFFFAOYSA-N					doublet; compound annotation
0391_006213	NAcM-OPT	C23H29Cl2N3O	3.6977	126711307		CCCCN1CCC(N(Cc2ccccc2)C(=O)Nc2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C23H29Cl2N3O/c1-2-3-13-27-14-11-20(12-15-27)28(17-18-7-5-4-6-8-18)23(29)26-19-9-10-21(24)22(25)16-19/h4-10,16,20H,2-3,11-15,17H2,1H3,(H,26,29)	VPHJABWIKCBGMC-UHFFFAOYSA-N					compound annotation
0391_006214	TCS 1102	C27H26N4O2S	3.7699	11960895	CN1C2=CC=CC=C2N=C1SCC(=O)N3CCC[C@H]3C(=O)NC4=CC=CC=C4C5=CC=CC=C5	Cn1c(SCC(=O)N2CCCC2C(=O)Nc2ccccc2-c2ccccc2)nc2ccccc21	InChI=1S/C27H26N4O2S/c1-30-23-15-8-7-14-22(23)29-27(30)34-18-25(32)31-17-9-16-24(31)26(33)28-21-13-6-5-12-20(21)19-10-3-2-4-11-19/h2-8,10-15,24H,9,16-18H2,1H3,(H,28,33)/t24-/m0/s1	YSBGRVXJEMSEQY-DEOSSOPVSA-N					doublet; removed another duplicate entry; compound annotation
0391_006216	TCS 1102	C27H26N4O2S	3.9836	11960895	CN1C2=CC=CC=C2N=C1SCC(=O)N3CCC[C@H]3C(=O)NC4=CC=CC=C4C5=CC=CC=C5	Cn1c(SCC(=O)N2CCCC2C(=O)Nc2ccccc2-c2ccccc2)nc2ccccc21	InChI=1S/C27H26N4O2S/c1-30-23-15-8-7-14-22(23)29-27(30)34-18-25(32)31-17-9-16-24(31)26(33)28-21-13-6-5-12-20(21)19-10-3-2-4-11-19/h2-8,10-15,24H,9,16-18H2,1H3,(H,28,33)/t24-/m0/s1	YSBGRVXJEMSEQY-DEOSSOPVSA-N					doublet; compound annotation
0391_006217	GSK137647A	C16H19NO3S	4.3769	743974		COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1	InChI=1S/C16H19NO3S/c1-11-9-12(2)16(13(3)10-11)17-21(18,19)15-7-5-14(20-4)6-8-15/h5-10,17H,1-4H3	FQUAFMNPXPXOJE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006220	SLIGKV-NH2	C28H54N8O7	1.5176	10483914	CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N	CCC(C)C(NC(=O)C(CC(C)C)NC(=O)C(N)CO)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(N)=O)C(C)C	InChI=1S/C28H54N8O7/c1-7-17(6)23(36-27(42)20(12-15(2)3)34-25(40)18(30)14-37)28(43)32-13-21(38)33-19(10-8-9-11-29)26(41)35-22(16(4)5)24(31)39/h15-20,22-23,37H,7-14,29-30H2,1-6H3,(H2,31,39)(H,32,43)(H,33,38)(H,34,40)(H,35,41)(H,36,42)/t17-,18-,19-,20-,22-,23-/m0/s1	HOWDUIVVWDUEED-WAUHAFJUSA-N					removed another duplicate entry; compound annotation
0391_006222	Orientin	C21H20O11	1.6744	5281675	C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1cc(-c2cc(O)c(O)cc2)oc2c1c(O)cc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C21H20O11/c22-6-14-17(28)18(29)19(30)21(32-14)16-11(26)4-10(25)15-12(27)5-13(31-20(15)16)7-1-2-8(23)9(24)3-7/h1-5,14,17-19,21-26,28-30H,6H2/t14-,17-,18+,19-,21+/m1/s1	PLAPMLGJVGLZOV-VPRICQMDSA-N					compound annotation
0391_006223	Isoquercitrin	C21H20O12	1.6744	5280804	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1	OVSQVDMCBVZWGM-QSOFNFLRSA-N					doublet; compound annotation
0391_006224	Isoquercitrin	C21H20O12	1.8581	5280804	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1	OVSQVDMCBVZWGM-QSOFNFLRSA-N					doublet; removed another duplicate entry; compound annotation
0391_006226	Isorhynchophylline	C22H28N2O4	2.2913	3037048	CC[C@H]1CN2CC[C@@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1	DAXYUDFNWXHGBE-VKCGGMIFSA-N					doublet; compound annotation
0391_006227	Isorhynchophylline	C22H28N2O4	2.4438	3037048	CC[C@H]1CN2CC[C@@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1	DAXYUDFNWXHGBE-VKCGGMIFSA-N					doublet; compound annotation
0391_006228	Tricin	C17H14O7	2.4927	5281702		COc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc(OC)c1O	InChI=1S/C17H14O7/c1-22-14-3-8(4-15(23-2)17(14)21)12-7-11(20)16-10(19)5-9(18)6-13(16)24-12/h3-7,18-19,21H,1-2H3	HRGUSFBJBOKSML-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006230	bromhexine	C14H20Br2N2	2.9082	2442		CN(Cc1c(N)c(Br)cc(Br)c1)C1CCCCC1	InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3	OJGDCBLYJGHCIH-UHFFFAOYSA-N					compound annotation
0391_006231	Hispidulin	C16H12O6	2.9297	5281628		COc1c(O)c2c(cc1O)oc(-c1ccc(O)cc1)cc2=O	InChI=1S/C16H12O6/c1-21-16-11(19)7-13-14(15(16)20)10(18)6-12(22-13)8-2-4-9(17)5-3-8/h2-7,17,19-20H,1H3	IHFBPDAQLQOCBX-UHFFFAOYSA-N					compound annotation
0391_006232	Tricin	C17H14O7	3.0324	5281702		COc1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc(OC)c1O	InChI=1S/C17H14O7/c1-22-14-3-8(4-15(23-2)17(14)21)12-7-11(20)16-10(19)5-9(18)6-13(16)24-12/h3-7,18-19,21H,1-2H3	HRGUSFBJBOKSML-UHFFFAOYSA-N					doublet; compound annotation
0391_006233	Schisandrol B	C23H28O7	4.1375	634470		COc1c(OC)c(OC)c2c(c1)CC(C)(O)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C23H28O7/c1-12-7-13-8-16-20(30-11-29-16)22(28-6)17(13)18-14(10-23(12,2)24)9-15(25-3)19(26-4)21(18)27-5/h8-9,12,24H,7,10-11H2,1-6H3	ZWRRJEICIPUPHZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006235	Vilazodone	C26H27N5O2	2.4409	6918314		N#Cc1cc2c(cc1)[nH]cc2CCCCN1CCN(c2cc3c(cc2)oc(C(N)=O)c3)CC1	InChI=1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32)	SGEGOXDYSFKCPT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006237	Abarelix	C72H95ClN14O14	2.9722	16131215	C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C	CC(=O)NC(Cc1cc2ccccc2cc1)C(=O)NC(Cc1ccc(Cl)cc1)C(=O)NC(Cc1cnccc1)C(=O)NC(CO)C(=O)N(C)C(Cc1ccc(O)cc1)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(N)=O	InChI=1S/C72H95ClN14O14/c1-41(2)32-54(64(93)80-53(17-10-11-30-77-42(3)4)72(101)87-31-13-18-60(87)69(98)78-43(5)63(75)92)81-68(97)58(38-62(74)91)84-70(99)61(37-46-22-27-52(90)28-23-46)86(7)71(100)59(40-88)85-67(96)57(36-48-14-12-29-76-39-48)83-66(95)56(34-45-20-25-51(73)26-21-45)82-65(94)55(79-44(6)89)35-47-19-24-49-15-8-9-16-50(49)33-47/h8-9,12,14-16,19-29,33,39,41-43,53-61,77,88,90H,10-11,13,17-18,30-32,34-38,40H2,1-7H3,(H2,74,91)(H2,75,92)(H,78,98)(H,79,89)(H,80,93)(H,81,97)(H,82,94)(H,83,95)(H,84,99)(H,85,96)/t43-,53+,54+,55-,56-,57-,58-,59+,60+,61+/m1/s1	AIWRTTMUVOZGPW-HSPKUQOVSA-N					removed another duplicate entry; compound annotation
0391_006239	PF-03814735	C23H25F3N6O2	3.0361	51346455	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F	CC(=O)NCC(=O)N1C2CCC1c1c2ccc(Nc2ncc(C(F)(F)F)c(NC3CCC3)n2)c1	InChI=1S/C23H25F3N6O2/c1-12(33)27-11-20(34)32-18-7-8-19(32)16-9-14(5-6-15(16)18)30-22-28-10-17(23(24,25)26)21(31-22)29-13-3-2-4-13/h5-6,9-10,13,18-19H,2-4,7-8,11H2,1H3,(H,27,33)(H2,28,29,30,31)/t18-,19+/m0/s1	RYYNGWLOYLRZLK-RBUKOAKNSA-N					doublet; compound annotation
0391_006240	PF-03814735	C23H25F3N6O2	3.0388	51346455	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F	CC(=O)NCC(=O)N1C2CCC1c1c2ccc(Nc2ncc(C(F)(F)F)c(NC3CCC3)n2)c1	InChI=1S/C23H25F3N6O2/c1-12(33)27-11-20(34)32-18-7-8-19(32)16-9-14(5-6-15(16)18)30-22-28-10-17(23(24,25)26)21(31-22)29-13-3-2-4-13/h5-6,9-10,13,18-19H,2-4,7-8,11H2,1H3,(H,27,33)(H2,28,29,30,31)/t18-,19+/m0/s1	RYYNGWLOYLRZLK-RBUKOAKNSA-N					doublet; compound annotation
0391_006241	VU6015929	C24H19F4N5O2	3.5417	145925694		Cn1ccc(-c2cncc(CNc3c(F)ccc(C(=O)Nc4cc(OC(F)(F)F)ccc4)c3)c2)n1	InChI=1S/C24H19F4N5O2/c1-33-8-7-21(32-33)17-9-15(12-29-14-17)13-30-22-10-16(5-6-20(22)25)23(34)31-18-3-2-4-19(11-18)35-24(26,27)28/h2-12,14,30H,13H2,1H3,(H,31,34)	IZKVIUJIUTXIRH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006243	Efaproxiral	C20H23NO4	3.8821	122335		Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1	InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)	BNFRJXLZYUTIII-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006245	Dalosirvat	C18H16O4	4.1239	56837361		O=C(CCC(=O)c1cc2c(cc1)OCCO2)c1ccccc1	InChI=1S/C18H16O4/c19-15(13-4-2-1-3-5-13)7-8-16(20)14-6-9-17-18(12-14)22-11-10-21-17/h1-6,9,12H,7-8,10-11H2	AOCDRSSVFUCURK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006248	Efaproxiral	C20H23NO4	4.1239	122335		Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1	InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)	BNFRJXLZYUTIII-UHFFFAOYSA-N					doublet; compound annotation
0391_006249	FILOREXANT	C24H25FN4O2	4.4192	25128145	C[C@@H]1CC[C@H](CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F	Cc1ccc(-c2ncccn2)c(C(=O)N2CC(COc3ncc(F)cc3)CCC2C)c1	InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1	NPFDWHQSDBWQLH-QZTJIDSGSA-N					doublet; compound annotation
0391_006250	FILOREXANT	C24H25FN4O2	4.4231	25128145	C[C@@H]1CC[C@H](CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F	Cc1ccc(-c2ncccn2)c(C(=O)N2CC(COc3ncc(F)cc3)CCC2C)c1	InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1	NPFDWHQSDBWQLH-QZTJIDSGSA-N					doublet; compound annotation
0391_006251	Lenalidomide	C13H13N3O3	1.0801	216326		Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)	GOTYRUGSSMKFNF-UHFFFAOYSA-N					doublet; compound annotation
0391_006252	Lenalidomide	C13H13N3O3	1.0839	216326		Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)	GOTYRUGSSMKFNF-UHFFFAOYSA-N					doublet; compound annotation
0391_006253	minoxidil	C9H15N5O	1.5382	4201		N=c1nc(N2CCCCC2)cc(N)n1O	InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2	ZIMGGGWCDYVHOY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006255	minoxidil	C9H15N5O	1.5411	4201		N=c1nc(N2CCCCC2)cc(N)n1O	InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2	ZIMGGGWCDYVHOY-UHFFFAOYSA-N					doublet; compound annotation
0391_006256	methacycline	C22H22N2O8	2.1957	122706529	C[NH+](C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)[O-])O)O)O	C=C1c2c(C(O)=C3C(=O)C4(O)C(O)=C(C(N)=O)C(=O)C(N(C)C)C4C(O)C13)c(O)ccc2	InChI=1S/C22H22N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-6,10,14-15,17,25-27,30,32H,1H2,2-3H3,(H2,23,31)/t10-,14-,15+,17+,22+/m1/s1	XIYOPDCBBDCGOE-IWVLMIASSA-N					removed another duplicate entry; compound annotation
0391_006258	Mavacamten	C15H19N3O2	2.8389	117761397	C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C	CC(Nc1cc(=O)n(C(C)C)c(=O)[nH]1)c1ccccc1	InChI=1S/C15H19N3O2/c1-10(2)18-14(19)9-13(17-15(18)20)16-11(3)12-7-5-4-6-8-12/h4-11,16H,1-3H3,(H,17,20)/t11-/m0/s1	RLCLASQCAPXVLM-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_006260	Enarodustat	C17H16N4O4	3.827	50899324		O=C(O)CNC(=O)c1c2nc[nH]n2c(CCc2ccccc2)cc1=O	InChI=1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10H,6-7,9H2,(H,18,25)(H,19,20)(H,23,24)	FJYRBJKWDXVHHO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006262	Vidofludimus	C20H18FNO4	3.8895	9820008		COc1cccc(-c2cc(F)c(NC(=O)C3=C(C(=O)O)CCC3)cc2)c1	InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)	XPRDUGXOWVXZLL-UHFFFAOYSA-N					doublet; compound annotation
0391_006263	Gemcabene	C16H30O5	3.8927	157692		CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O	InChI=1S/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20)	SDMBRCRVFFHJKR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006265	Vidofludimus	C20H18FNO4	4.2445	9820008		COc1cccc(-c2cc(F)c(NC(=O)C3=C(C(=O)O)CCC3)cc2)c1	InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)	XPRDUGXOWVXZLL-UHFFFAOYSA-N					doublet; compound annotation
0391_006266	Vidofludimus	C20H18FNO4	4.2474	9820008		COc1cccc(-c2cc(F)c(NC(=O)C3=C(C(=O)O)CCC3)cc2)c1	InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)	XPRDUGXOWVXZLL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006268	Febuxostat	C16H16N2O3S	4.4333	134018		Cc1c(C(=O)O)sc(-c2cc(C#N)c(OCC(C)C)cc2)n1	InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)	BQSJTQLCZDPROO-UHFFFAOYSA-N					compound annotation
0391_006269	Z-5-(4-Hydroxybenzylidene)-2-imino-1,3-thiazolidin-4-one	C10H8N2O2S	1.5563	1206243	C1=CC(=CC=C1/C=C\2/C(=O)N=C(S2)N)O	NC1=NC(=O)C(=Cc2ccc(O)cc2)S1	InChI=1S/C10H8N2O2S/c11-10-12-9(14)8(15-10)5-6-1-3-7(13)4-2-6/h1-5,13H,(H2,11,12,14)/b8-5-	YBHQCJILTOVLHD-YVMONPNESA-N					removed another duplicate entry; compound annotation
0391_006271	Isoferulic acid	C10H10O4	1.9201	736186	COC1=C(C=C(C=C1)/C=C/C(=O)O)O	COc1c(O)cc(C=CC(=O)O)cc1	InChI=1S/C10H10O4/c1-14-9-4-2-7(6-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+	QURCVMIEKCOAJU-HWKANZROSA-N					compound annotation
0391_006272	czc-25146	C22H25FN6O4S	2.5111	44252884		COc1c(Nc2ncc(F)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25FN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	XXHHOTZUJIXPJX-UHFFFAOYSA-N					doublet; compound annotation
0391_006273	czc-25146	C22H25FN6O4S	2.5139	44252884		COc1c(Nc2ncc(F)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25FN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	XXHHOTZUJIXPJX-UHFFFAOYSA-N					doublet; compound annotation
0391_006274	Solabegron	C23H23ClN2O3	3.051	9887812	C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNC[C@@H](C3=CC(=CC=C3)Cl)O	O=C(O)c1cccc(-c2cc(NCCNCC(O)c3cc(Cl)ccc3)ccc2)c1	InChI=1S/C23H23ClN2O3/c24-20-8-2-6-18(13-20)22(27)15-25-10-11-26-21-9-3-5-17(14-21)16-4-1-7-19(12-16)23(28)29/h1-9,12-14,22,25-27H,10-11,15H2,(H,28,29)/t22-/m0/s1	LLDXOPKUNJTIRF-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_006276	Lorediplon	C20H15FN4O2S	3.188	12004146		CC(=O)N(C)c1c(F)ccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1	InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3	NQPOCLFSADOXBR-UHFFFAOYSA-N					doublet; compound annotation
0391_006277	Lorediplon	C20H15FN4O2S	3.2343	12004146		CC(=O)N(C)c1c(F)ccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1	InChI=1S/C20H15FN4O2S/c1-12(26)24(2)17-10-13(5-6-15(17)21)16-7-8-22-20-14(11-23-25(16)20)19(27)18-4-3-9-28-18/h3-11H,1-2H3	NQPOCLFSADOXBR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006279	czc-25146	C22H25FN6O4S	3.3075	44252884		COc1c(Nc2ncc(F)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25FN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	XXHHOTZUJIXPJX-UHFFFAOYSA-N					doublet; compound annotation
0391_006280	GSK840	C21H23N3O3	3.4198	138377545		CNC(=O)c1cc2c(cc1)n(-c1ccc(CC(=O)OC(C)(C)C)cc1)cn2	InChI=1S/C21H23N3O3/c1-21(2,3)27-19(25)11-14-5-8-16(9-6-14)24-13-23-17-12-15(20(26)22-4)7-10-18(17)24/h5-10,12-13H,11H2,1-4H3,(H,22,26)	UGTLDBJIOSYXRR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006282	Pluripotin	C27H25F3N8O2	3.656	12003241		Cc1nn(C)c(Nc2ncc3CN(c4c(C)ccc(NC(=O)c5cc(C(F)(F)F)ccc5)c4)C(=O)N(C)c3n2)c1	InChI=1S/C27H25F3N8O2/c1-15-8-9-20(32-24(39)17-6-5-7-19(11-17)27(28,29)30)12-21(15)38-14-18-13-31-25(34-23(18)36(3)26(38)40)33-22-10-16(2)35-37(22)4/h5-13H,14H2,1-4H3,(H,32,39)(H,31,33,34)	NBZFRTJWEIHFPF-UHFFFAOYSA-N					doublet; compound annotation
0391_006283	Pluripotin	C27H25F3N8O2	3.8525	12003241		Cc1nn(C)c(Nc2ncc3CN(c4c(C)ccc(NC(=O)c5cc(C(F)(F)F)ccc5)c4)C(=O)N(C)c3n2)c1	InChI=1S/C27H25F3N8O2/c1-15-8-9-20(32-24(39)17-6-5-7-19(11-17)27(28,29)30)12-21(15)38-14-18-13-31-25(34-23(18)36(3)26(38)40)33-22-10-16(2)35-37(22)4/h5-13H,14H2,1-4H3,(H,32,39)(H,31,33,34)	NBZFRTJWEIHFPF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006285	Ambrisentan	C22H22N2O4	4.1134	6918493	CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C	COC(c1ccccc1)(c1ccccc1)C(Oc1nc(C)cc(C)n1)C(=O)O	InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1	OUJTZYPIHDYQMC-LJQANCHMSA-N					removed another duplicate entry; compound annotation
0391_006287	1261289-04-6	C16H11Cl2N3O2S	4.6614	50923806		O=C(Nc1nc(=O)n(Cc2ccc(Cl)cc2)s1)c1ccc(Cl)cc1	InChI=1S/C16H11Cl2N3O2S/c17-12-5-1-10(2-6-12)9-21-16(23)20-15(24-21)19-14(22)11-3-7-13(18)8-4-11/h1-8H,9H2,(H,19,20,22,23)	WEDWLYRQKUTOAX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006289	AIM-100	C23H21N3O2	4.8993	11501591	C1C[C@H](OC1)CNC2=C3C(=C(OC3=NC=N2)C4=CC=CC=C4)C5=CC=CC=C5	c1ccc(-c2c(-c3ccccc3)c3c(ncnc3NCC3CCCO3)o2)cc1	InChI=1S/C23H21N3O2/c1-3-8-16(9-4-1)19-20-22(24-14-18-12-7-13-27-18)25-15-26-23(20)28-21(19)17-10-5-2-6-11-17/h1-6,8-11,15,18H,7,12-14H2,(H,24,25,26)/t18-/m0/s1	XNFHHOXCDUAYSR-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_006291	SB-590885	C27H27N5O2	1.4618	135398506	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC5=C(C=C4)/C(=N\O)/CC5	CN(C)CCOc1ccc(-c2nc(-c3cc4c(cc3)C(=NO)CC4)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24-	MLSAQOINCGAULQ-QLTSDVKISA-N					doublet; compound annotation
0391_006292	Norbinaltorphimine	C40H43N3O6	1.4911	5480230	C1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)[C@H]9[C@@]12CCN([C@@H]([C@@]1(C8)O)CC1=C2C(=C(C=C1)O)O9)CC1CC1	Oc1c2OC3c4c(CC5(O)C6Cc(c2C35CCN6CC2CC2)cc1)c1c([nH]4)C2Oc3c(O)ccc4c3C23CCN(CC2CC2)C(C4)C3(O)C1	InChI=1S/C40H43N3O6/c44-25-7-5-21-13-27-39(46)15-23-24-16-40(47)28-14-22-6-8-26(45)34-30(22)38(40,10-12-43(28)18-20-3-4-20)36(49-34)32(24)41-31(23)35-37(39,29(21)33(25)48-35)9-11-42(27)17-19-1-2-19/h5-8,19-20,27-28,35-36,41,44-47H,1-4,9-18H2/t27-,28-,35+,36+,37+,38+,39-,40-/m1/s1	APSUXPSYBJVPPS-YAUKWVCOSA-N					compound annotation
0391_006293	SB-590885	C27H27N5O2	1.5571	135398506	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC5=C(C=C4)/C(=N\O)/CC5	CN(C)CCOc1ccc(-c2nc(-c3cc4c(cc3)C(=NO)CC4)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24-	MLSAQOINCGAULQ-QLTSDVKISA-N					doublet; compound annotation
0391_006294	SB-590885	C27H27N5O2	1.5599	135398506	CN(C)CCOC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC5=C(C=C4)/C(=N\O)/CC5	CN(C)CCOc1ccc(-c2nc(-c3cc4c(cc3)C(=NO)CC4)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C27H27N5O2/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30)/b31-24-	MLSAQOINCGAULQ-QLTSDVKISA-N					doublet; compound annotation
0391_006295	4105-38-8	C15H18N2O9	2.0291	20058	CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C	CC(=O)OCC1OC(n2ccc(=O)[nH]c2=O)C(OC(C)=O)C1OC(C)=O	InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1	AUFUWRKPQLGTGF-FMKGYKFTSA-N					removed another duplicate entry; compound annotation
0391_006297	MK-1775	C27H32N8O2	2.2383	24856436		C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1	InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)	BKWJAKQVGHWELA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006300	ZL0420	C16H16N4O2	2.6709	137285011		Cc1cc(N=Nc2cc3c(cc2)NC(=O)CC3)c(N)cc1O	InChI=1S/C16H16N4O2/c1-9-6-14(12(17)8-15(9)21)20-19-11-3-4-13-10(7-11)2-5-16(22)18-13/h3-4,6-8,21H,2,5,17H2,1H3,(H,18,22)	ANMQADUROYWADA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006302	ZL0420	C16H16N4O2	2.9215	137285011		Cc1cc(N=Nc2cc3c(cc2)NC(=O)CC3)c(N)cc1O	InChI=1S/C16H16N4O2/c1-9-6-14(12(17)8-15(9)21)20-19-11-3-4-13-10(7-11)2-5-16(22)18-13/h3-4,6-8,21H,2,5,17H2,1H3,(H,18,22)	ANMQADUROYWADA-UHFFFAOYSA-N					doublet; compound annotation
0391_006303	BI-3406	C23H25F3N4O3	3.0529	138911318	CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CC(=C3)N)C(F)(F)F)O[C@H]4CCOC4)OC	COc1c(OC2CCOC2)cc2c(NC(C)c3cc(C(F)(F)F)cc(N)c3)nc(C)nc2c1	InChI=1S/C23H25F3N4O3/c1-12(14-6-15(23(24,25)26)8-16(27)7-14)28-22-18-9-21(33-17-4-5-32-11-17)20(31-3)10-19(18)29-13(2)30-22/h6-10,12,17H,4-5,11,27H2,1-3H3,(H,28,29,30)/t12-,17+/m1/s1	XVFDNRYZXDHTHT-PXAZEXFGSA-N					compound annotation
0391_006304	1134156-31-2	C25H23Cl2N7O4	3.115	25195348	C1=CC(=CC=C1COC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3NCC5=CC(=C(C=C5)Cl)Cl)N)O)O)C#N	N#Cc1ccc(COCC2OC(n3c(NCc4cc(Cl)c(Cl)cc4)nc4c(N)ncnc43)C(O)C2O)cc1	InChI=1S/C25H23Cl2N7O4/c26-16-6-5-15(7-17(16)27)9-30-25-33-19-22(29)31-12-32-23(19)34(25)24-21(36)20(35)18(38-24)11-37-10-14-3-1-13(8-28)2-4-14/h1-7,12,18,20-21,24,35-36H,9-11H2,(H,30,33)(H2,29,31,32)/t18-,20-,21-,24-/m1/s1	ZXGGCBQORXDVTE-UMCMBGNQSA-N					removed another duplicate entry; compound annotation
0391_006306	RG7112	C38H48Cl2N4O4S	4.2536	57406853	CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CCCS(=O)(=O)C)(C)C4=CC=C(C=C4)Cl)(C)C5=CC=C(C=C5)Cl	CCOc1c(C2=NC(C)(c3ccc(Cl)cc3)C(C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CCCS(C)(=O)=O)CC2)ccc(C(C)(C)C)c1	InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1	QBGKPEROWUKSBK-QPPIDDCLSA-N					compound annotation
0391_006307	MK-0752	C21H21ClF2O4S	4.4375	9803433		O=C(O)CCC1CCC(c2c(F)ccc(F)c2)(S(=O)(=O)c2ccc(Cl)cc2)CC1	InChI=1S/C21H21ClF2O4S/c22-15-2-5-17(6-3-15)29(27,28)21(18-13-16(23)4-7-19(18)24)11-9-14(10-12-21)1-8-20(25)26/h2-7,13-14H,1,8-12H2,(H,25,26)	XCGJIFAKUZNNOR-UHFFFAOYSA-N					compound annotation
0391_006308	948841-07-4	C15H14BrNOS	5.2394	101571768	CN(C)C1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(S2)Br	CN(C)c1ccc(C=CC(=O)c2ccc(Br)s2)cc1	InChI=1S/C15H14BrNOS/c1-17(2)12-6-3-11(4-7-12)5-8-13(18)14-9-10-15(16)19-14/h3-10H,1-2H3/b8-5+	PTLDLBSWTKNYCY-VMPITWQZSA-N					removed another duplicate entry; compound annotation
0391_006310	BGP-15 free base	C14H22N4O2	0.465	11637690	C1CCN(CC1)CC(CO/N=C(\C2=CN=CC=C2)/N)O	NC(=NOCC(O)CN1CCCCC1)c1cnccc1	InChI=1S/C14H22N4O2/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18/h4-6,9,13,19H,1-3,7-8,10-11H2,(H2,15,17)	MVLOQULXIYSERZ-UHFFFAOYSA-N					compound annotation
0391_006311	1194961-19-7	C18H24N6O	2.13	11493841	CC1=CC(=CC=C1)NC2=NC(=NC=C2C(=O)N)N[C@@H]3CCCC[C@@H]3N	Cc1cc(Nc2nc(NC3CCCCC3N)ncc2C(N)=O)ccc1	InChI=1S/C18H24N6O/c1-11-5-4-6-12(9-11)22-17-13(16(20)25)10-21-18(24-17)23-15-8-3-2-7-14(15)19/h4-6,9-10,14-15H,2-3,7-8,19H2,1H3,(H2,20,25)(H2,21,22,23,24)/t14-,15+/m0/s1	NZNTWOVDIXCHHS-LSDHHAIUSA-N					removed another duplicate entry; compound annotation
0391_006313	5465-86-1	C15H18N2	2.2304	230710		Cc1cc(N2CCCCC2)nc2ccccc12	InChI=1S/C15H18N2/c1-12-11-15(17-9-5-2-6-10-17)16-14-8-4-3-7-13(12)14/h3-4,7-8,11H,2,5-6,9-10H2,1H3	USYRQXDHKXGTCK-UHFFFAOYSA-N					doublet; compound annotation
0391_006314	vesnarinone	C22H25N3O4	2.3695	5663		COc1c(OC)cc(C(=O)N2CCN(c3cc4c(cc3)NC(=O)CC4)CC2)cc1	InChI=1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)	ZVNYJIZDIRKMBF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006317	371942-69-7	C25H21N7O3	2.7417	9956222		Nc1ncc(C(=O)Nc2cccc(-c3nc4c(oc5c4cccn5)c(N4CCOCC4)n3)c2)cc1	InChI=1S/C25H21N7O3/c26-19-7-6-16(14-28-19)24(33)29-17-4-1-3-15(13-17)22-30-20-18-5-2-8-27-25(18)35-21(20)23(31-22)32-9-11-34-12-10-32/h1-8,13-14H,9-12H2,(H2,26,28)(H,29,33)	YBPIBGNBHHGLEB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006319	vesnarinone	C22H25N3O4	2.7777	5663		COc1c(OC)cc(C(=O)N2CCN(c3cc4c(cc3)NC(=O)CC4)CC2)cc1	InChI=1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)	ZVNYJIZDIRKMBF-UHFFFAOYSA-N					doublet; compound annotation
0391_006320	761439-42-3	C30H40ClN7O3S	2.8361	16038120		COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35)	QQWUGDVOUVUTOY-UHFFFAOYSA-N					doublet; compound annotation
0391_006321	761439-42-3	C30H40ClN7O3S	2.8394	16038120		COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35)	QQWUGDVOUVUTOY-UHFFFAOYSA-N					doublet; compound annotation
0391_006322	761439-42-3	C30H40ClN7O3S	3.1628	16038120		COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35)	QQWUGDVOUVUTOY-UHFFFAOYSA-N					doublet; compound annotation
0391_006323	Autophinib	C14H11ClN6O3	3.6643	129626605		Cc1cc(Nc2cc(Cl)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1	InChI=1S/C14H11ClN6O3/c1-8-6-13(20-19-8)17-12-7-11(15)16-14(18-12)24-10-4-2-9(3-5-10)21(22)23/h2-7H,1H3,(H2,16,17,18,19,20)	CEUMAXLRGBKFQP-UHFFFAOYSA-N					compound annotation
0391_006324	371942-69-7	C25H21N7O3	4.041	9956222		Nc1ncc(C(=O)Nc2cccc(-c3nc4c(oc5c4cccn5)c(N4CCOCC4)n3)c2)cc1	InChI=1S/C25H21N7O3/c26-19-7-6-16(14-28-19)24(33)29-17-4-1-3-15(13-17)22-30-20-18-5-2-8-27-25(18)35-21(20)23(31-22)32-9-11-34-12-10-32/h1-8,13-14H,9-12H2,(H2,26,28)(H,29,33)	YBPIBGNBHHGLEB-UHFFFAOYSA-N					doublet; compound annotation
0391_006325	ML213	C17H23NO	4.415	3111211		Cc1cc(C)c(NC(=O)C2CC3CCC2C3)c(C)c1	InChI=1S/C17H23NO/c1-10-6-11(2)16(12(3)7-10)18-17(19)15-9-13-4-5-14(15)8-13/h6-7,13-15H,4-5,8-9H2,1-3H3,(H,18,19)	SIQGKPGBLYKQBB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006327	MCL-1/BCL-2-IN-3	C27H25BrN2O5S	5.0784	145712377		COC(=O)CCCCC(=O)NCCN1C(=O)c2c3c(ccc(Sc4ccc(Br)cc4)c3ccc2)C1=O	InChI=1S/C27H25BrN2O5S/c1-35-24(32)8-3-2-7-23(31)29-15-16-30-26(33)20-6-4-5-19-22(14-13-21(25(19)20)27(30)34)36-18-11-9-17(28)10-12-18/h4-6,9-14H,2-3,7-8,15-16H2,1H3,(H,29,31)	HZZXWFWVQWMGAR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006329	Safusidenib	C25H18Cl3FN2O4	5.4853	130306983	CC1=CN(C2=CC=CC(=C12)/C=C/C(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F	Cc1cn(C(=O)c2c(C(C)(C)F)onc2-c2c(Cl)cc(Cl)cc2Cl)c2cccc(C=CC(=O)O)c12	InChI=1S/C25H18Cl3FN2O4/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28/h4-11H,1-3H3,(H,32,33)/b8-7+	BOOMBLZEOHXPPX-BQYQJAHWSA-N					compound annotation
0391_006330	115453-99-1	C14H12N2O2	1.2447	5740547	C1=CC(=NC(=C1)C(=O)O)/C=C/C2=CC=C(C=C2)N	Nc1ccc(C=Cc2nc(C(=O)O)ccc2)cc1	InChI=1S/C14H12N2O2/c15-11-7-4-10(5-8-11)6-9-12-2-1-3-13(16-12)14(17)18/h1-9H,15H2,(H,17,18)/b9-6+	QASPDWZDKLUOPO-RMKNXTFCSA-N					doublet; compound annotation
0391_006331	115453-99-1	C14H12N2O2	1.248	5740547	C1=CC(=NC(=C1)C(=O)O)/C=C/C2=CC=C(C=C2)N	Nc1ccc(C=Cc2nc(C(=O)O)ccc2)cc1	InChI=1S/C14H12N2O2/c15-11-7-4-10(5-8-11)6-9-12-2-1-3-13(16-12)14(17)18/h1-9H,15H2,(H,17,18)/b9-6+	QASPDWZDKLUOPO-RMKNXTFCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006333	4-(2-Aminoethyl)benzenesulfonyl fluoride	C8H10FNO2S	1.5236	1701		NCCc1ccc(S(=O)(=O)F)cc1	InChI=1S/C8H10FNO2S/c9-13(11,12)8-3-1-7(2-4-8)5-6-10/h1-4H,5-6,10H2	MGSKVZWGBWPBTF-UHFFFAOYSA-N					compound annotation
0391_006334	KDU691	C22H18ClN5O2	2.5605	90157166		CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1	InChI=1S/C22H18ClN5O2/c1-24-21(29)15-5-3-14(4-6-15)19-11-26-20-12-25-18(13-28(19)20)22(30)27(2)17-9-7-16(23)8-10-17/h3-13H,1-2H3,(H,24,29)	TYMFFISSODJRDV-UHFFFAOYSA-N					doublet; compound annotation
0391_006335	Volinanserin	C22H28FNO3	2.5759	5311271	COC1=CC=CC(=C1OC)[C@@H](C2CCN(CC2)CCC3=CC=C(C=C3)F)O	COc1cccc(C(O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1	HXTGXYRHXAGCFP-OAQYLSRUSA-N					doublet; compound annotation
0391_006336	Volinanserin	C22H28FNO3	2.6258	5311271	COC1=CC=CC(=C1OC)[C@@H](C2CCN(CC2)CCC3=CC=C(C=C3)F)O	COc1cccc(C(O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC	InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1	HXTGXYRHXAGCFP-OAQYLSRUSA-N					doublet; compound annotation
0391_006337	KDU691	C22H18ClN5O2	2.8985	90157166		CNC(=O)c1ccc(-c2cnc3cnc(C(=O)N(C)c4ccc(Cl)cc4)cn23)cc1	InChI=1S/C22H18ClN5O2/c1-24-21(29)15-5-3-14(4-6-15)19-11-26-20-12-25-18(13-28(19)20)22(30)27(2)17-9-7-16(23)8-10-17/h3-13H,1-2H3,(H,24,29)	TYMFFISSODJRDV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006339	GSK2334470	C25H34N8O	2.9208	46215815	C[C@@H]1CC[C@@H](CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5	CNc1nc(-c2cc3c(cc2)c(N)n[nH]3)cc(N2CC(C(=O)NC3CCCCC3)CCC2C)n1	InChI=1S/C25H34N8O/c1-15-8-9-17(24(34)28-18-6-4-3-5-7-18)14-33(15)22-13-20(29-25(27-2)30-22)16-10-11-19-21(12-16)31-32-23(19)26/h10-13,15,17-18H,3-9,14H2,1-2H3,(H,28,34)(H3,26,31,32)(H,27,29,30)/t15-,17+/m1/s1	QLPHOXTXAKOFMU-WBVHZDCISA-N					doublet; compound annotation
0391_006340	GSK2334470	C25H34N8O	2.9257	46215815	C[C@@H]1CC[C@@H](CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5	CNc1nc(-c2cc3c(cc2)c(N)n[nH]3)cc(N2CC(C(=O)NC3CCCCC3)CCC2C)n1	InChI=1S/C25H34N8O/c1-15-8-9-17(24(34)28-18-6-4-3-5-7-18)14-33(15)22-13-20(29-25(27-2)30-22)16-10-11-19-21(12-16)31-32-23(19)26/h10-13,15,17-18H,3-9,14H2,1-2H3,(H,28,34)(H3,26,31,32)(H,27,29,30)/t15-,17+/m1/s1	QLPHOXTXAKOFMU-WBVHZDCISA-N					doublet; compound annotation
0391_006341	7beta-Hydroxylathyrol	C20H30O5	3.1319	24868376	C[C@H]1C[C@]2([C@H]([C@H]1O)[C@H](C(=C)[C@@H](C[C@H]3[C@H](C3(C)C)/C=C(\C2=O)/C)O)O)O	C=C1C(O)CC2C(C=C(C)C(=O)C3(O)CC(C)C(O)C3C1O)C2(C)C	InChI=1S/C20H30O5/c1-9-6-12-13(19(12,4)5)7-14(21)11(3)17(23)15-16(22)10(2)8-20(15,25)18(9)24/h6,10,12-17,21-23,25H,3,7-8H2,1-2,4-5H3/b9-6-/t10-,12+,13-,14+,15+,16-,17-,20+/m0/s1	NVDZRSWQWPPKAI-GNQYTXSHSA-N					doublet; compound annotation
0391_006342	midecamycin	C41H67NO15	3.1793	5282169	CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C	CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC	InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1	DMUAPQTXSSNEDD-QALJCMCCSA-N					doublet; compound annotation
0391_006343	Rociletinib	C27H28F3N7O3	3.1946	57335384		C=CC(=O)Nc1cccc(Nc2nc(Nc3c(OC)cc(N4CCN(C(C)=O)CC4)cc3)ncc2C(F)(F)F)c1	InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)	HUFOZJXAKZVRNJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006346	midecamycin	C41H67NO15	3.3269	5282169	CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C	CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC	InChI=1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1	DMUAPQTXSSNEDD-QALJCMCCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006348	7beta-Hydroxylathyrol	C20H30O5	3.4063	24868376	C[C@H]1C[C@]2([C@H]([C@H]1O)[C@H](C(=C)[C@@H](C[C@H]3[C@H](C3(C)C)/C=C(\C2=O)/C)O)O)O	C=C1C(O)CC2C(C=C(C)C(=O)C3(O)CC(C)C(O)C3C1O)C2(C)C	InChI=1S/C20H30O5/c1-9-6-12-13(19(12,4)5)7-14(21)11(3)17(23)15-16(22)10(2)8-20(15,25)18(9)24/h6,10,12-17,21-23,25H,3,7-8H2,1-2,4-5H3/b9-6-/t10-,12+,13-,14+,15+,16-,17-,20+/m0/s1	NVDZRSWQWPPKAI-GNQYTXSHSA-N					doublet; compound annotation
0391_006349	kobe2602	C14H9F4N5O4S	4.3889	3827738		O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1NNC(=S)Nc1ccc(F)cc1	InChI=1S/C14H9F4N5O4S/c15-8-1-3-9(4-2-8)19-13(28)21-20-12-10(22(24)25)5-7(14(16,17)18)6-11(12)23(26)27/h1-6,20H,(H2,19,21,28)	NNPBSITXCGPXJC-UHFFFAOYSA-N					compound annotation
0391_006350	amoxicillin	C16H19N3O5S	0.6394	33613	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	LSQZJLSUYDQPKJ-NJBDSQKTSA-N					doublet; compound annotation
0391_006351	amoxicillin	C16H19N3O5S	1.5087	33613	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	LSQZJLSUYDQPKJ-NJBDSQKTSA-N					doublet; compound annotation
0391_006352	CEFIXIME	C16H15N5O7S2	1.5593	5362065	C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O	C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCC(=O)O)c3csc(N)n3)C2SC1	InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1	OKBVVJOGVLARMR-QSWIMTSFSA-N					removed another duplicate entry; compound annotation
0391_006354	4-Methylesculetin	C10H8O4	1.6462	5319502		Cc1cc(=O)oc2cc(O)c(O)cc12	InChI=1S/C10H8O4/c1-5-2-10(13)14-9-4-8(12)7(11)3-6(5)9/h2-4,11-12H,1H3	KVOJTUXGYQVLAJ-UHFFFAOYSA-N					compound annotation
0391_006355	amoxicillin	C16H19N3O5S	1.9171	33613	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	LSQZJLSUYDQPKJ-NJBDSQKTSA-N					doublet; compound annotation
0391_006356	Cardamonin	C16H14O4	3.0727	641785	COC1=CC(=CC(=C1C(=O)/C=C/C2=CC=CC=C2)O)O	COc1cc(O)cc(O)c1C(=O)C=Cc1ccccc1	InChI=1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+	NYSZJNUIVUBQMM-BQYQJAHWSA-N					doublet; compound annotation
0391_006357	Gigantol	C16H18O4	3.2834	3085362		COc1cc(CCc2cc(O)c(OC)cc2)cc(O)c1	InChI=1S/C16H18O4/c1-19-14-8-12(7-13(17)10-14)4-3-11-5-6-16(20-2)15(18)9-11/h5-10,17-18H,3-4H2,1-2H3	SDXKZPQOVUDXIY-UHFFFAOYSA-N					doublet; compound annotation
0391_006358	Gigantol	C16H18O4	3.2868	3085362		COc1cc(CCc2cc(O)c(OC)cc2)cc(O)c1	InChI=1S/C16H18O4/c1-19-14-8-12(7-13(17)10-14)4-3-11-5-6-16(20-2)15(18)9-11/h5-10,17-18H,3-4H2,1-2H3	SDXKZPQOVUDXIY-UHFFFAOYSA-N					doublet; compound annotation
0391_006359	Cardamonin	C16H14O4	4.2874	641785	COC1=CC(=CC(=C1C(=O)/C=C/C2=CC=CC=C2)O)O	COc1cc(O)cc(O)c1C(=O)C=Cc1ccccc1	InChI=1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+	NYSZJNUIVUBQMM-BQYQJAHWSA-N					doublet; compound annotation
0391_006360	Quinine	C20H24N2O2	1.5136	3034034	COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1	LOUPRKONTZGTKE-WZBLMQSHSA-N					doublet; compound annotation
0391_006361	DEHYDROACETIC ACID	C8H8O4	2.2626	122903		CC(=O)C1C(=O)C=C(C)OC1=O	InChI=1S/C8H8O4/c1-4-3-6(10)7(5(2)9)8(11)12-4/h3,7H,1-2H3	PGRHXDWITVMQBC-UHFFFAOYSA-N					compound annotation
0391_006362	donepezil	C24H29NO3	2.5219	3152		COc1c(OC)cc2C(=O)C(CC3CCN(Cc4ccccc4)CC3)Cc2c1	InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3	ADEBPBSSDYVVLD-UHFFFAOYSA-N					doublet; compound annotation
0391_006363	1254977-87-1	C22H23F3N4	3.8446	49765871		FC(F)(F)c1c(N2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C22H23F3N4/c23-22(24,25)20-18(10-13-29-19(14-15-6-7-15)26-27-21(20)29)28-11-8-17(9-12-28)16-4-2-1-3-5-16/h1-5,10,13,15,17H,6-9,11-12,14H2	BQAVZGJJQFJSMW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006365	1254977-87-1	C22H23F3N4	3.9622	49765871		FC(F)(F)c1c(N2CCC(c3ccccc3)CC2)ccn2c(CC3CC3)nnc12	InChI=1S/C22H23F3N4/c23-22(24,25)20-18(10-13-29-19(14-15-6-7-15)26-27-21(20)29)28-11-8-17(9-12-28)16-4-2-1-3-5-16/h1-5,10,13,15,17H,6-9,11-12,14H2	BQAVZGJJQFJSMW-UHFFFAOYSA-N					doublet; compound annotation
0391_006366	oxiconazole	C18H13Cl4N3O	4.0765	5353853	C1=CC(=C(C=C1Cl)Cl)CO/N=C(\CN2C=CN=C2)/C3=C(C=C(C=C3)Cl)Cl	Clc1cc(Cl)c(CON=C(Cn2ccnc2)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C18H13Cl4N3O/c19-13-2-1-12(16(21)7-13)10-26-24-18(9-25-6-5-23-11-25)15-4-3-14(20)8-17(15)22/h1-8,11H,9-10H2/b24-18+	QRJJEGAJXVEBNE-HKOYGPOVSA-N					compound annotation
0391_006367	MEGESTROL ACETATE	C24H32O4	4.5341	11683	CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C	CC(=O)OC1(C(C)=O)CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C24H32O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h12-13,18-20H,6-11H2,1-5H3/t18-,19+,20+,22-,23+,24+/m1/s1	RQZAXGRLVPAYTJ-GQFGMJRRSA-N					compound annotation
0391_006368	57477-39-1	C14H18N2O	0.7203	2438		CN1CCC(c2c[nH]c3c2cc(O)cc3)CC1	InChI=1S/C14H18N2O/c1-16-6-4-10(5-7-16)13-9-15-14-3-2-11(17)8-12(13)14/h2-3,8-10,15,17H,4-7H2,1H3	WKNFADCGOAHBPG-UHFFFAOYSA-N					compound annotation
0391_006369	MK-0354	C7H8N6	1.5193	11159621		C1Cc2c(C1)c(-c1n[nH]nn1)n[nH]2	InChI=1S/C7H8N6/c1-2-4-5(3-1)8-9-6(4)7-10-12-13-11-7/h1-3H2,(H,8,9)(H,10,11,12,13)	LTQYSJKGRPGMPO-UHFFFAOYSA-N					compound annotation
0391_006370	Enpp-1-IN-1	C17H17N3O3S	1.7703	137524159		COc1cc2nccc(-c3ccc(CNS(N)(=O)=O)cc3)c2cc1	InChI=1S/C17H17N3O3S/c1-23-14-6-7-16-15(8-9-19-17(16)10-14)13-4-2-12(3-5-13)11-20-24(18,21)22/h2-10,20H,11H2,1H3,(H2,18,21,22)	UEJMNZDIQDULLP-UHFFFAOYSA-N					compound annotation
0391_006371	Prexasertib	C18H19N7O2	2.316	46700756		COc1c(-c2cc(Nc3ncc(C#N)nc3)n[nH]2)c(OCCCN)ccc1	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	DOTGPNHGTYJDEP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006373	CHEMBL68134	C20H22FN3O	2.3323	9840849		Oc1cc2c(cc1)nc(CN1CCC(Cc3ccccc3F)CC1)[nH]2	InChI=1S/C20H22FN3O/c21-17-4-2-1-3-15(17)11-14-7-9-24(10-8-14)13-20-22-18-6-5-16(25)12-19(18)23-20/h1-6,12,14,25H,7-11,13H2,(H,22,23)	RJZREMJRJAYQCL-UHFFFAOYSA-N					doublet; compound annotation
0391_006374	CHEMBL68134	C20H22FN3O	2.3356	9840849		Oc1cc2c(cc1)nc(CN1CCC(Cc3ccccc3F)CC1)[nH]2	InChI=1S/C20H22FN3O/c21-17-4-2-1-3-15(17)11-14-7-9-24(10-8-14)13-20-22-18-6-5-16(25)12-19(18)23-20/h1-6,12,14,25H,7-11,13H2,(H,22,23)	RJZREMJRJAYQCL-UHFFFAOYSA-N					doublet; compound annotation
0391_006375	184475-71-6	C15H11ClFN3O2	2.4208	10471217		COc1c(O)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1	InChI=1S/C15H11ClFN3O2/c1-22-14-6-12-9(5-13(14)21)15(19-7-18-12)20-8-2-3-11(17)10(16)4-8/h2-7,21H,1H3,(H,18,19,20)	JLVTVCRXFMLUIF-UHFFFAOYSA-N					compound annotation
0391_006376	Prexasertib	C18H19N7O2	2.52	46700756		COc1c(-c2cc(Nc3ncc(C#N)nc3)n[nH]2)c(OCCCN)ccc1	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	DOTGPNHGTYJDEP-UHFFFAOYSA-N					doublet; compound annotation
0391_006377	NBD-557	C17H24BrN3O2	2.6929	5279270		CC1(C)CC(NC(=O)C(=O)Nc2ccc(Br)cc2)CC(C)(C)N1	InChI=1S/C17H24BrN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23)	QQRFLGRIDNNARB-UHFFFAOYSA-N					compound annotation
0391_006378	THZ1	C31H28ClN7O2	3.2663	73602827	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl	CN(C)CC=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1	InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+	OBJNFLYHUXWUPF-IZZDOVSWSA-N					doublet; compound annotation
0391_006379	THZ1	C31H28ClN7O2	3.2711	73602827	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl	CN(C)CC=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1	InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+	OBJNFLYHUXWUPF-IZZDOVSWSA-N					doublet; compound annotation
0391_006380	THZ1	C31H28ClN7O2	3.3095	73602827	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl	CN(C)CC=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1	InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+	OBJNFLYHUXWUPF-IZZDOVSWSA-N					doublet; compound annotation
0391_006381	ent-Tadalafil	C22H19N3O4	3.3282	9908373	CN1CC(=O)N2[C@H](C1=O)CC3=C([C@@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36	CN1CC(=O)N2C(Cc3c([nH]c4ccccc34)C2c2cc3c(cc2)OCO3)C1=O	InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m0/s1	WOXKDUGGOYFFRN-KKSFZXQISA-N					removed another duplicate entry; compound annotation
0391_006384	667463-62-9	C16H10BrN3O2	4.079	448949		O=Nc1c(-c2c(O)[nH]c3c2ccc(Br)c3)[nH]c2ccccc12	InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,18-19,21H	SAQUSDSPQYQNBG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006386	GW311616	C19H31N3O4S	1.9255	9800961	CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)/C=C/CN3CCCCC3)N(C1=O)S(=O)(=O)C	CC(C)C1C(=O)N(S(C)(=O)=O)C2CCN(C(=O)C=CCN3CCCCC3)C12	InChI=1S/C19H31N3O4S/c1-14(2)17-18-15(22(19(17)24)27(3,25)26)9-13-21(18)16(23)8-7-12-20-10-5-4-6-11-20/h7-8,14-15,17-18H,4-6,9-13H2,1-3H3/b8-7+/t15-,17+,18-/m1/s1	NDNKNUMSTIMSHQ-URZKGLGPSA-N					doublet; compound annotation
0391_006387	GW311616	C19H31N3O4S	1.9283	9800961	CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)/C=C/CN3CCCCC3)N(C1=O)S(=O)(=O)C	CC(C)C1C(=O)N(S(C)(=O)=O)C2CCN(C(=O)C=CCN3CCCCC3)C12	InChI=1S/C19H31N3O4S/c1-14(2)17-18-15(22(19(17)24)27(3,25)26)9-13-21(18)16(23)8-7-12-20-10-5-4-6-11-20/h7-8,14-15,17-18H,4-6,9-13H2,1-3H3/b8-7+/t15-,17+,18-/m1/s1	NDNKNUMSTIMSHQ-URZKGLGPSA-N					doublet; compound annotation
0391_006388	Mexiletine	C11H17NO	1.9824	4178		Cc1c(OCC(C)N)c(C)ccc1	InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3	VLPIATFUUWWMKC-UHFFFAOYSA-N					compound annotation
0391_006389	Acetamiprid	C10H11ClN4	2.1153	213021		CC(=NC#N)N(C)Cc1cnc(Cl)cc1	InChI=1S/C10H11ClN4/c1-8(14-7-12)15(2)6-9-3-4-10(11)13-5-9/h3-5H,6H2,1-2H3	WCXDHFDTOYPNIE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006391	SCHEMBL14859389	C14H19N5O4	2.2672	89499050	C1=CC=C(C(=C1)COC(=O)NCCCC[C@@H](C(=O)O)N)N=[N+]=[N-]	[N-]=[N+]=Nc1ccccc1COC(=O)NCCCCC(N)C(=O)O	InChI=1S/C14H19N5O4/c15-11(13(20)21)6-3-4-8-17-14(22)23-9-10-5-1-2-7-12(10)18-19-16/h1-2,5,7,11H,3-4,6,8-9,15H2,(H,17,22)(H,20,21)/t11-/m0/s1	PGNICAOCNIVZRV-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_006393	1341224-83-6	C29H31F3N6O3	2.4095	11192346	C1CN(C[C@H]1NC2CCC(CC2)(C3=NC=C(C=C3)C4=NC=CC=N4)O)C(=O)CNC(=O)C5=CC(=CC=C5)C(F)(F)F	O=C(NCC(=O)N1CCC(NC2CCC(O)(c3ncc(-c4ncccn4)cc3)CC2)C1)c1cc(C(F)(F)F)ccc1	InChI=1S/C29H31F3N6O3/c30-29(31,32)21-4-1-3-19(15-21)27(40)36-17-25(39)38-14-9-23(18-38)37-22-7-10-28(41,11-8-22)24-6-5-20(16-35-24)26-33-12-2-13-34-26/h1-6,12-13,15-16,22-23,37,41H,7-11,14,17-18H2,(H,36,40)/t22?,23-,28?/m0/s1	ZNSVOHSYDRPBGI-CBQRAPNFSA-N					removed another duplicate entry; compound annotation
0391_006395	Arbidol	C22H25BrN2O3S	3.6022	28446253		CCOC(=O)c1c(CSc2ccccc2)n(C)c2cc(Br)c(O)c(CN(C)C)c12	InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3	KCFYEAOKVJSACF-UHFFFAOYSA-N					compound annotation
0391_006396	Andarine	C19H18F3N3O6	3.68	9824562	CC(=O)NC1=CC=C(C=C1)OC[C@@](C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O	CC(=O)Nc1ccc(OCC(C)(O)C(=O)Nc2cc(C(F)(F)F)c([N+](=O)[O-])cc2)cc1	InChI=1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m0/s1	YVXVTLGIDOACBJ-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_006399	Avasimibe	C29H43NO4S	6.541	166558		CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1	InChI=1S/C29H43NO4S/c1-17(2)22-14-25(20(7)8)27(26(15-22)21(9)10)16-28(31)30-35(32,33)34-29-23(18(3)4)12-11-13-24(29)19(5)6/h11-15,17-21H,16H2,1-10H3,(H,30,31)	PTQXTEKSNBVPQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006400	Avasimibe	C29H43NO4S	6.5445	166558		CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(C(C)C)cccc2C(C)C)c(C(C)C)c1	InChI=1S/C29H43NO4S/c1-17(2)22-14-25(20(7)8)27(26(15-22)21(9)10)16-28(31)30-35(32,33)34-29-23(18(3)4)12-11-13-24(29)19(5)6/h11-15,17-21H,16H2,1-10H3,(H,30,31)	PTQXTEKSNBVPQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006401	Tyrosine kinase-IN-1	C26H28FN5O	1.4404	10433653	CCN1CCC(CC1)NC2=CC\3=C(C=C2)NC(=O)/C3=C(/C4=CC(=CC=C4)F)\C5=NC=C(N5)C	CCN1CCC(Nc2cc3c(cc2)NC(=O)C3=C(c2cc(F)ccc2)c2ncc(C)[nH]2)CC1	InChI=1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23-	DMQYDVBIPXAAJA-VHXPQNKSSA-N					compound annotation
0391_006402	ME0328	C19H19N3O2	2.83	135566764	C[C@@H](C1=CC=CC=C1)NC(=O)CCC2=NC3=CC=CC=C3C(=O)N2	CC(NC(=O)CCc1nc(=O)c2ccccc2[nH]1)c1ccccc1	InChI=1S/C19H19N3O2/c1-13(14-7-3-2-4-8-14)20-18(23)12-11-17-21-16-10-6-5-9-15(16)19(24)22-17/h2-10,13H,11-12H2,1H3,(H,20,23)(H,21,22,24)/t13-/m0/s1	QIHBWVVVRYYYRO-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_006404	MRK-016	C17H20N8O2	2.9978	6918583		Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1	InChI=1S/C17H20N8O2/c1-10-6-11(23-27-10)15-21-19-7-12-14(17(2,3)4)16(22-25(12)15)26-8-13-18-9-20-24(13)5/h6-7,9H,8H2,1-5H3	QYSYOGCIDRANAR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006406	MRK-016	C17H20N8O2	3.2117	6918583		Cc1cc(-c2nncc3c(C(C)(C)C)c(OCc4ncnn4C)nn23)no1	InChI=1S/C17H20N8O2/c1-10-6-11(23-27-10)15-21-19-7-12-14(17(2,3)4)16(22-25(12)15)26-8-13-18-9-20-24(13)5/h6-7,9H,8H2,1-5H3	QYSYOGCIDRANAR-UHFFFAOYSA-N					doublet; compound annotation
0391_006407	251992-66-2	C15H12N2OS2	3.2761	9839311		Cc1ccc(Sc2c3cc(C(N)=O)sc3cnc2)cc1	InChI=1S/C15H12N2OS2/c1-9-2-4-10(5-3-9)19-13-7-17-8-14-11(13)6-12(20-14)15(16)18/h2-8H,1H3,(H2,16,18)	QQGWEXFLMJGCAL-UHFFFAOYSA-N					compound annotation
0391_006408	Naminidil	C15H19N5	3.5395	158438	C[C@H](C(C)(C)C)N=C(NC#N)NC1=CC=C(C=C1)C#N	CC(N=C(NC#N)Nc1ccc(C#N)cc1)C(C)(C)C	InChI=1S/C15H19N5/c1-11(15(2,3)4)19-14(18-10-17)20-13-7-5-12(9-16)6-8-13/h5-8,11H,1-4H3,(H2,18,19,20)/t11-/m1/s1	PGYDRGZVXVVZQC-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_006410	508186-14-9	C20H18N4O2S2	4.0924	2300455		COCCNC(=O)Nc1cc2c(cc1)nc(-c1cccs1)c(-c1cccs1)n2	InChI=1S/C20H18N4O2S2/c1-26-9-8-21-20(25)22-13-6-7-14-15(12-13)24-19(17-5-3-11-28-17)18(23-14)16-4-2-10-27-16/h2-7,10-12H,8-9H2,1H3,(H2,21,22,25)	CTPVNWVUAGMHEJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006412	Kinome_3764	C27H45N2+	5.8631	10436840		CCCCCCCCCCCCCCCCn1cc[n+](Cc2ccccc2)c1C	InChI=1S/C27H45N2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-28-23-24-29(26(28)2)25-27-20-17-16-18-21-27/h16-18,20-21,23-24H,3-15,19,22,25H2,1-2H3/q+1	ZZXUNAFAKNKXFW-UHFFFAOYSA-N					compound annotation
0391_006413	NSC59984	C12H15N3O4	0.5168	5356520	CN1CCN(CC1)C(=O)/C=C/C2=CC=C(O2)[N+](=O)[O-]	CN1CCN(C(=O)C=Cc2ccc([N+](=O)[O-])o2)CC1	InChI=1S/C12H15N3O4/c1-13-6-8-14(9-7-13)11(16)4-2-10-3-5-12(19-10)15(17)18/h2-5H,6-9H2,1H3/b4-2+	QKTRIGNWBRHBFV-DUXPYHPUSA-N					doublet; compound annotation
0391_006414	Adriforant	C13H22N6	0.5431	24745335	CN[C@@H]1CCN(C1)C2=NC(=NC(=C2)NCC3CC3)N	CNC1CCN(c2nc(N)nc(NCC3CC3)c2)C1	InChI=1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1	ISBHYKVAFKTATD-SNVBAGLBSA-N					compound annotation
0391_006415	NSC59984	C12H15N3O4	1.0098	5356520	CN1CCN(CC1)C(=O)/C=C/C2=CC=C(O2)[N+](=O)[O-]	CN1CCN(C(=O)C=Cc2ccc([N+](=O)[O-])o2)CC1	InChI=1S/C12H15N3O4/c1-13-6-8-14(9-7-13)11(16)4-2-10-3-5-12(19-10)15(17)18/h2-5H,6-9H2,1H3/b4-2+	QKTRIGNWBRHBFV-DUXPYHPUSA-N					doublet; compound annotation
0391_006416	Dp44mT	C14H15N5S	2.0302	10334137		CN(C)C(=S)NN=C(c1ccccn1)c1ccccn1	InChI=1S/C14H15N5S/c1-19(2)14(20)18-17-13(11-7-3-5-9-15-11)12-8-4-6-10-16-12/h3-10H,1-2H3,(H,18,20)	XOBIGRNRXCAMJQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006418	phthalylsulfathiazole	C17H13N3O5S2	2.1647	4806		O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	InChI=1S/C17H13N3O5S2/c21-15(13-3-1-2-4-14(13)16(22)23)19-11-5-7-12(8-6-11)27(24,25)20-17-18-9-10-26-17/h1-10H,(H,18,20)(H,19,21)(H,22,23)	PBMSWVPMRUJMPE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006420	RIP2 kinase inhibitor 1	C21H22N4O4S2	2.3033	71258526		CC(C)(C)S(=O)(=O)c1c(OCCO)cc2ncnc(Nc3cc4c(cc3)scn4)c2c1	InChI=1S/C21H22N4O4S2/c1-21(2,3)31(27,28)19-9-14-15(10-17(19)29-7-6-26)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-30-18/h4-5,8-12,26H,6-7H2,1-3H3,(H,22,23,25)	UHDOJINBFLDQJM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006422	Phensuximide	C11H11NO2	2.3908	6839		CN1C(=O)CC(c2ccccc2)C1=O	InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3	WLWFNJKHKGIJNW-UHFFFAOYSA-N					compound annotation
0391_006423	TAURODEOXYCHOLIC ACID	C26H45NO6S	3.0122	2733768	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1	AWDRATDZQPNJFN-VAYUFCLWSA-N					doublet; removed another duplicate entry; compound annotation
0391_006425	Butyl 4-aminobenzoate	C11H15NO2	3.7127	2482		CCCCOC(=O)c1ccc(N)cc1	InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3	IUWVALYLNVXWKX-UHFFFAOYSA-N					compound annotation
0391_006426	GSK2981278	C25H35NO5S	5.1108	89875987		CCc1ccc(N(CC(C)C)S(=O)(=O)c2cc(CO)c(OCC3CCOCC3)cc2)cc1	InChI=1S/C25H35NO5S/c1-4-20-5-7-23(8-6-20)26(16-19(2)3)32(28,29)24-9-10-25(22(15-24)17-27)31-18-21-11-13-30-14-12-21/h5-10,15,19,21,27H,4,11-14,16-18H2,1-3H3	LZLBRISQTJVZNP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006429	todralazine	C11H12N4O2	0.8954	5501		CCOC(=O)NNc1nncc2ccccc12	InChI=1S/C11H12N4O2/c1-2-17-11(16)15-14-10-9-6-4-3-5-8(9)7-12-13-10/h3-7H,2H2,1H3,(H,13,14)(H,15,16)	WGZDBVOTUVNQFP-UHFFFAOYSA-N					doublet; compound annotation
0391_006430	todralazine	C11H12N4O2	0.9017	5501		CCOC(=O)NNc1nncc2ccccc12	InChI=1S/C11H12N4O2/c1-2-17-11(16)15-14-10-9-6-4-3-5-8(9)7-12-13-10/h3-7H,2H2,1H3,(H,13,14)(H,15,16)	WGZDBVOTUVNQFP-UHFFFAOYSA-N					doublet; compound annotation
0391_006431	Pumosetrag	C15H17N3O2S	1.2155	154104	C1CN2CCC1[C@H](C2)NC(=O)C3=CNC4=C(C3=O)SC=C4	O=C(NC1CN2CCC1CC2)c1c[nH]c2c(scc2)c1=O	InChI=1S/C15H17N3O2S/c19-13-10(7-16-11-3-6-21-14(11)13)15(20)17-12-8-18-4-1-9(12)2-5-18/h3,6-7,9,12H,1-2,4-5,8H2,(H,16,19)(H,17,20)/t12-/m0/s1	AFUWQWYPPZFWCO-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_006433	Pelitinib	C24H23ClFN5O2	2.2359	6445562	CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C	CCOc1c(NC(=O)C=CCN(C)C)cc2c(Nc3cc(Cl)c(F)cc3)c(C#N)cnc2c1	InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+	WVUNYSQLFKLYNI-AATRIKPKSA-N					compound annotation
0391_006434	Chrysin-7-O-glucuronide	C21H18O10	2.6863	14135335	C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O	O=C(O)C1OC(Oc2cc(O)c3c(=O)cc(-c4ccccc4)oc3c2)C(O)C(O)C1O	InChI=1S/C21H18O10/c22-11-6-10(29-21-18(26)16(24)17(25)19(31-21)20(27)28)7-14-15(11)12(23)8-13(30-14)9-4-2-1-3-5-9/h1-8,16-19,21-22,24-26H,(H,27,28)/t16-,17-,18+,19-,21+/m0/s1	IDRSJGHHZXBATQ-ZFORQUDYSA-N					compound annotation
0391_006435	GSK 598809	C22H23F4N5OS	2.9257	11784937	CC1=C(OC=N1)C2=NN=C(N2C)SCCCN3C[C@@H]4C[C@@]4(C3)C5=C(C=C(C=C5)C(F)(F)F)F	Cc1c(-c2nnc(SCCCN3CC4CC4(c4c(F)cc(C(F)(F)F)cc4)C3)n2C)ocn1	InChI=1S/C22H23F4N5OS/c1-13-18(32-12-27-13)19-28-29-20(30(19)2)33-7-3-6-31-10-15-9-21(15,11-31)16-5-4-14(8-17(16)23)22(24,25)26/h4-5,8,12,15H,3,6-7,9-11H2,1-2H3/t15-,21-/m0/s1	ZKRWPAYTJMRKLJ-BTYIYWSLSA-N					compound annotation
0391_006436	nateglinide	C19H27NO3	4.4333	5311309	CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O	CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1	InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1	OELFLUMRDSZNSF-OFLPRAFFSA-N					removed another duplicate entry; compound annotation
0391_006438	Aristolone	C15H22O	4.443	165536	C[C@@H]1CCCC2=CC(=O)[C@@H]3[C@H]([C@@]12C)C3(C)C	CC1CCCC2=CC(=O)C3C(C3(C)C)C21C	InChI=1S/C15H22O/c1-9-6-5-7-10-8-11(16)12-13(14(12,2)3)15(9,10)4/h8-9,12-13H,5-7H2,1-4H3/t9-,12-,13+,15+/m1/s1	UGVIZCBJCSXBCJ-JWFUOXDNSA-N					compound annotation
0391_006439	AZD4320	C45H48ClF3N4O7S3	4.6695	86661883	CN(CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCC(CC4)[C@H](C5=CC=CC=C5C6=CC=C(C=C6)Cl)O)S(=O)(=O)C(F)(F)F)CCO	CN(CCO)CCC(CSc1ccccc1)Nc1c(S(=O)(=O)C(F)(F)F)cc(S(=O)(=O)NC(=O)c2ccc(N3CCC(C(O)c4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1	InChI=1S/C45H48ClF3N4O7S3/c1-52(27-28-54)24-23-35(30-61-37-7-3-2-4-8-37)50-41-20-19-38(29-42(41)62(57,58)45(47,48)49)63(59,60)51-44(56)33-13-17-36(18-14-33)53-25-21-32(22-26-53)43(55)40-10-6-5-9-39(40)31-11-15-34(46)16-12-31/h2-20,29,32,35,43,50,54-55H,21-28,30H2,1H3,(H,51,56)/t35-,43-/m1/s1	UNEJSHNDABUZNY-UJNHCCGESA-N					compound annotation
0391_006440	S119-8	C23H24N2O	5.191	1787280		CC(C)(C)c1ccc(C(=O)Nc2ccc(Nc3ccccc3)cc2)cc1	InChI=1S/C23H24N2O/c1-23(2,3)18-11-9-17(10-12-18)22(26)25-21-15-13-20(14-16-21)24-19-7-5-4-6-8-19/h4-16,24H,1-3H3,(H,25,26)	NEPKMQDGCTXOPG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006443	Adavivint	C29H24FN7O	2.7648	135565709		CC(C)CC(=O)Nc1cncc(-c2cc3c(cc2)[nH]nc3-c2nc3c(cncc3-c3cc(F)ccc3)[nH]2)c1	InChI=1S/C29H24FN7O/c1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18/h3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37)	AQDWDWAYVBQMAM-UHFFFAOYSA-N					compound annotation
0391_006444	2070015-24-4	C21H27N3O2	3.1762	118704757		Cc1ccc(NC(=O)CCCCCCC(=O)Nc2ccccc2N)cc1	InChI=1S/C21H27N3O2/c1-16-12-14-17(15-13-16)23-20(25)10-4-2-3-5-11-21(26)24-19-9-7-6-8-18(19)22/h6-9,12-15H,2-5,10-11,22H2,1H3,(H,23,25)(H,24,26)	NTVVDUQLJHPXJY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006446	Baccatin III	C31H38O11	3.222	65366	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)OC(=O)C	CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(O)C(C)=C1C2(C)C	InChI=1S/C31H38O11/c1-15-19(34)13-31(38)26(41-27(37)18-10-8-7-9-11-18)24-29(6,20(35)12-21-30(24,14-39-21)42-17(3)33)25(36)23(40-16(2)32)22(15)28(31,4)5/h7-11,19-21,23-24,26,34-35,38H,12-14H2,1-6H3/t19-,20-,21+,23+,24-,26-,29+,30-,31+/m0/s1	OVMSOCFBDVBLFW-VHLOTGQHSA-N					removed another duplicate entry; compound annotation
0391_006448	345304-65-6	C24H35ClN2O2	3.5289	10161381		O=C(NCC12CC3CC(CC(C3)C1)C2)c1c(Cl)ccc(CCCNCCCO)c1	InChI=1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29)	HSQAARMBHJCUOK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006450	GNE-7915	C19H21F4N5O3	3.5365	58539171		CCNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)c(F)c2)ncc1C(F)(F)F	InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)	XCFLWTZSJYBCPF-UHFFFAOYSA-N					doublet; compound annotation
0391_006451	GNE-7915	C19H21F4N5O3	3.6684	58539171		CCNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)c(F)c2)ncc1C(F)(F)F	InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27)	XCFLWTZSJYBCPF-UHFFFAOYSA-N					doublet; compound annotation
0391_006452	FPS-ZM1	C20H22ClNO	5.3776	24752728		O=C(c1ccc(Cl)cc1)N(Cc1ccccc1)C1CCCCC1	InChI=1S/C20H22ClNO/c21-18-13-11-17(12-14-18)20(23)22(19-9-5-2-6-10-19)15-16-7-3-1-4-8-16/h1,3-4,7-8,11-14,19H,2,5-6,9-10,15H2	XDFKWGIBQMHSOH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006454	Succinobucol	C35H52O5S2	7.0751	216325		CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(OC(=O)CCC(=O)O)c(C(C)(C)C)c1	InChI=1S/C35H52O5S2/c1-31(2,3)23-17-21(18-24(29(23)39)32(4,5)6)41-35(13,14)42-22-19-25(33(7,8)9)30(26(20-22)34(10,11)12)40-28(38)16-15-27(36)37/h17-20,39H,15-16H2,1-14H3,(H,36,37)	RKSMVPNZHBRNNS-UHFFFAOYSA-N					compound annotation
0391_006455	amygdalin	C20H27NO11	1.3446	656516	C1=CC=C(C=C1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O	N#CC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)c1ccccc1	InChI=1S/C20H27NO11/c21-6-10(9-4-2-1-3-5-9)30-20-18(28)16(26)14(24)12(32-20)8-29-19-17(27)15(25)13(23)11(7-22)31-19/h1-5,10-20,22-28H,7-8H2/t10-,11+,12+,13+,14+,15-,16-,17+,18+,19+,20+/m0/s1	XUCIJNAGGSZNQT-JHSLDZJXSA-N					removed another duplicate entry; compound annotation
0391_006457	BENZNIDAZOLE	C12H12N4O3	2.2216	31593		O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1	InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)	CULUWZNBISUWAS-UHFFFAOYSA-N					doublet; compound annotation
0391_006458	BENZNIDAZOLE	C12H12N4O3	2.2247	31593		O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1	InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)	CULUWZNBISUWAS-UHFFFAOYSA-N					doublet; compound annotation
0391_006459	Atipamezole	C14H16N2	2.3258	71310		CCC1(c2cnc[nH]2)Cc2ccccc2C1	InChI=1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16)	HSWPZIDYAHLZDD-UHFFFAOYSA-N					doublet; compound annotation
0391_006460	Chrysophanein	C21H20O9	2.7	6324923	CC1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2=O)C=CC=C4O	Cc1cc2c(C(=O)c3c(cccc3O)C2=O)c(OC2OC(CO)C(O)C(O)C2O)c1	InChI=1S/C21H20O9/c1-8-5-10-15(18(26)14-9(16(10)24)3-2-4-11(14)23)12(6-8)29-21-20(28)19(27)17(25)13(7-22)30-21/h2-6,13,17,19-23,25,27-28H,7H2,1H3/t13-,17-,19+,20-,21-/m1/s1	QKPDYSSHOSPOKH-JNHRPPPUSA-N					compound annotation
0391_006461	Demethylsuberosin	C14H14O3	3.8931	5316525		CC(C)=CCc1c(O)cc2oc(=O)ccc2c1	InChI=1S/C14H14O3/c1-9(2)3-4-10-7-11-5-6-14(16)17-13(11)8-12(10)15/h3,5-8,15H,4H2,1-2H3	FIDUIAPDSKSUGO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006463	clobetasone butyrate	C26H32ClFO5	4.9683	71386	CCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(CC(=O)[C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)C)C)C(=O)CCl	CCCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(=O)CC21C	InChI=1S/C26H32ClFO5/c1-5-6-22(32)33-26(21(31)14-27)15(2)11-19-18-8-7-16-12-17(29)9-10-23(16,3)25(18,28)20(30)13-24(19,26)4/h9-10,12,15,18-19H,5-8,11,13-14H2,1-4H3/t15-,18-,19-,23-,24-,25-,26-/m0/s1	FBRAWBYQGRLCEK-AVVSTMBFSA-N					removed another duplicate entry; compound annotation
0391_006465	amezinium	C11H12N3O+	1.4813	71927		COc1[n+](-c2ccccc2)ncc(N)c1	InChI=1S/C11H11N3O/c1-15-11-7-9(12)8-13-14(11)10-5-3-2-4-6-10/h2-8,12H,1H3/p+1	VXROHTDSRBRJLN-UHFFFAOYSA-O					compound annotation
0391_006466	TAS0728	C26H32N8O3	2.6596	130275856	CC1=C(C=CC(=C1C)NC(=O)C2=NN(C3=NC=NC(=C23)N)[C@@H]4CCCN(C4)C(=O)C=C)CC(=O)N(C)C	C=CC(=O)N1CCCC(n2nc(C(=O)Nc3c(C)c(C)c(CC(=O)N(C)C)cc3)c3c(N)ncnc32)C1	InChI=1S/C26H32N8O3/c1-6-20(35)33-11-7-8-18(13-33)34-25-22(24(27)28-14-29-25)23(31-34)26(37)30-19-10-9-17(15(2)16(19)3)12-21(36)32(4)5/h6,9-10,14,18H,1,7-8,11-13H2,2-5H3,(H,30,37)(H2,27,28,29)/t18-/m1/s1	JCCIICHPRAAMGK-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_006468	Dapivirine	C20H19N5	3.1545	214347		Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2)c(C)c1	InChI=1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25)	ILAYIAGXTHKHNT-UHFFFAOYSA-N					doublet; compound annotation
0391_006469	Dapivirine	C20H19N5	3.2619	214347		Cc1cc(C)c(Nc2nc(Nc3ccc(C#N)cc3)ncc2)c(C)c1	InChI=1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25)	ILAYIAGXTHKHNT-UHFFFAOYSA-N					doublet; compound annotation
0391_006470	FATOSTATIN	C18H18N2S	4.061	1889993		CCCc1nccc(-c2nc(-c3ccc(C)cc3)cs2)c1	InChI=1S/C18H18N2S/c1-3-4-16-11-15(9-10-19-16)18-20-17(12-21-18)14-7-5-13(2)6-8-14/h5-12H,3-4H2,1-2H3	ZROSUBKIGBSZCG-UHFFFAOYSA-N					doublet; compound annotation
0391_006471	Pranlukast	C27H23N5O4	4.4973	4887		O=C(Nc1cccc2c1oc(-c1n[nH]nn1)cc2=O)c1ccc(OCCCCc2ccccc2)cc1	InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)	NBQKINXMPLXUET-UHFFFAOYSA-N					doublet; compound annotation
0391_006472	IMD-0354	C15H8ClF6NO2	5.598	5081913		O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1c(O)ccc(Cl)c1	InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25)	CHILCFMQWMQVAL-UHFFFAOYSA-N					compound annotation
0391_006473	Salirasib	C22H30O2S	6.3319	5469318	CC(=CCC/C(=C/CC/C(=C/CSC1=CC=CC=C1C(=O)O)/C)/C)C	CC(C)=CCCC(C)=CCCC(C)=CCSc1ccccc1C(=O)O	InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+	WUILNKCFCLNXOK-CFBAGHHKSA-N					compound annotation
0391_006474	L-Praziquanamine	C12H14N2O	1.133	24797049	C1CN2[C@H](CNCC2=O)C3=CC=CC=C31	O=C1CNCC2c3ccccc3CCN12	InChI=1S/C12H14N2O/c15-12-8-13-7-11-10-4-2-1-3-9(10)5-6-14(11)12/h1-4,11,13H,5-8H2/t11-/m1/s1	GTRDOUXISKJZGL-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_006476	Nicotiflorin	C27H30O15	1.9633	5318767	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)C(O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H30O15/c1-9-17(31)20(34)22(36)26(39-9)38-8-15-18(32)21(35)23(37)27(41-15)42-25-19(33)16-13(30)6-12(29)7-14(16)40-24(25)10-2-4-11(28)5-3-10/h2-7,9,15,17-18,20-23,26-32,34-37H,8H2,1H3/t9-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1	RTATXGUCZHCSNG-QHWHWDPRSA-N					removed another duplicate entry; compound annotation
0391_006478	CX-6258	C26H24ClN3O3	2.547	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006479	CX-6258	C26H24ClN3O3	2.5693	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006480	chelerythrine	C21H18NO4+	2.7059	2703		COc1c(OC)c2c[n+](C)c3c4cc5c(cc4ccc3c2cc1)OCO5	InChI=1S/C21H18NO4/c1-22-10-16-13(6-7-17(23-2)21(16)24-3)14-5-4-12-8-18-19(26-11-25-18)9-15(12)20(14)22/h4-10H,11H2,1-3H3/q+1	LLEJIEBFSOEYIV-UHFFFAOYSA-N					compound annotation
0391_006481	CX-6258	C26H24ClN3O3	2.8124	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006482	CX-6258	C26H24ClN3O3	3.1883	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; removed another duplicate entry; compound annotation
0391_006484	4',5-Dihydroxyflavone	C15H10O4	3.6595	165521		O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12	InChI=1S/C15H10O4/c16-10-6-4-9(5-7-10)14-8-12(18)15-11(17)2-1-3-13(15)19-14/h1-8,16-17H	OKRNDQLCMXUCGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006486	6-Methylflavone	C16H12O2	4.2404	689013		Cc1cc2c(cc1)oc(-c1ccccc1)cc2=O	InChI=1S/C16H12O2/c1-11-7-8-15-13(9-11)14(17)10-16(18-15)12-5-3-2-4-6-12/h2-10H,1H3	NOQJBXPAMJLUSS-UHFFFAOYSA-N					doublet; compound annotation
0391_006487	6-Methylflavone	C16H12O2	4.2433	689013		Cc1cc2c(cc1)oc(-c1ccccc1)cc2=O	InChI=1S/C16H12O2/c1-11-7-8-15-13(9-11)14(17)10-16(18-15)12-5-3-2-4-6-12/h2-10H,1H3	NOQJBXPAMJLUSS-UHFFFAOYSA-N					doublet; compound annotation
0391_006488	4-Methoxyphenylacetic acid	C9H10O3	4.2873	7690		COc1ccc(CC(=O)O)cc1	InChI=1S/C9H10O3/c1-12-8-4-2-7(3-5-8)6-9(10)11/h2-5H,6H2,1H3,(H,10,11)	NRPFNQUDKRYCNX-UHFFFAOYSA-N					compound annotation
0391_006489	BUTYL ISOBUTYL PHTHALATE	C16H22O4	5.3578	28813		CCCCOC(=O)c1ccccc1C(=O)OCC(C)C	InChI=1S/C16H22O4/c1-4-5-10-19-15(17)13-8-6-7-9-14(13)16(18)20-11-12(2)3/h6-9,12H,4-5,10-11H2,1-3H3	UVIVWIFUPKGWGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006491	levistolide A	C24H28O4	5.4504	70698035	CCC/C=C\1/C2=C([C@H]3[C@@H](CC2)[C@@H]4CC[C@@]3\5C(=C4)C(=O)O/C5=C\CCC)C(=O)O1	CCCC=C1OC(=O)C2=C1CCC1C3C=C4C(=O)OC(=CCCC)C4(CC3)C21	InChI=1S/C24H28O4/c1-3-5-7-18-16-10-9-15-14-11-12-24(21(15)20(16)23(26)27-18)17(13-14)22(25)28-19(24)8-6-4-2/h7-8,13-15,21H,3-6,9-12H2,1-2H3/b18-7-,19-8-/t14-,15+,21-,24+/m1/s1	UBBRXVRQZJSDAK-ZJHGLIIDSA-N					removed another duplicate entry; compound annotation
0391_006493	L-Tryptophanamide	C11H13N3O	0.7988	439356	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N)N	NC(=O)C(N)Cc1c[nH]c2ccccc12	InChI=1S/C11H13N3O/c12-9(11(13)15)5-7-6-14-10-4-2-1-3-8(7)10/h1-4,6,9,14H,5,12H2,(H2,13,15)/t9-/m0/s1	JLSKPBDKNIXMBS-VIFPVBQESA-N					removed another duplicate entry; compound annotation
0391_006495	chlorothiazide	C7H6ClN3O4S2	0.9819	2720		NS(=O)(=O)c1c(Cl)cc2NC=NS(=O)(=O)c2c1	InChI=1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13)	JBMKAUGHUNFTOL-UHFFFAOYSA-N					compound annotation
0391_006496	Angoroside C	C36H48O19	2.2138	23757181	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)OC)CO[C@H]4[C@@H]([C@H]([C@H](CO4)O)O)O)OCCC5=CC(=C(C=C5)OC)O)O)O)O)O	COc1c(O)cc(CCOC2OC(COC3OCC(O)C(O)C3O)C(OC(=O)C=Cc3cc(OC)c(O)cc3)C(OC3OC(C)C(O)C(O)C3O)C2O)cc1	InChI=1S/C36H48O19/c1-16-26(41)28(43)30(45)36(52-16)55-33-31(46)35(49-11-10-18-5-8-22(47-2)20(38)12-18)53-24(15-51-34-29(44)27(42)21(39)14-50-34)32(33)54-25(40)9-6-17-4-7-19(37)23(13-17)48-3/h4-9,12-13,16,21,24,26-39,41-46H,10-11,14-15H2,1-3H3/b9-6+/t16-,21-,24+,26-,27-,28+,29+,30+,31+,32+,33+,34-,35+,36-/m0/s1	KLQXMRBGMLHBBQ-DQTDZZOCSA-N					doublet; compound annotation
0391_006497	Angoroside C	C36H48O19	2.2545	23757181	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)OC)CO[C@H]4[C@@H]([C@H]([C@H](CO4)O)O)O)OCCC5=CC(=C(C=C5)OC)O)O)O)O)O	COc1c(O)cc(CCOC2OC(COC3OCC(O)C(O)C3O)C(OC(=O)C=Cc3cc(OC)c(O)cc3)C(OC3OC(C)C(O)C(O)C3O)C2O)cc1	InChI=1S/C36H48O19/c1-16-26(41)28(43)30(45)36(52-16)55-33-31(46)35(49-11-10-18-5-8-22(47-2)20(38)12-18)53-24(15-51-34-29(44)27(42)21(39)14-50-34)32(33)54-25(40)9-6-17-4-7-19(37)23(13-17)48-3/h4-9,12-13,16,21,24,26-39,41-46H,10-11,14-15H2,1-3H3/b9-6+/t16-,21-,24+,26-,27-,28+,29+,30+,31+,32+,33+,34-,35+,36-/m0/s1	KLQXMRBGMLHBBQ-DQTDZZOCSA-N					doublet; compound annotation
0391_006498	PF-04995274	C23H32N2O6	2.303	53354764	C1COC[C@@H]1OC2=CC=CC3=C2C(=NO3)OCC4CCN(CC4)CC5(CCOCC5)O	OC1(CN2CCC(COc3noc4c3c(OC3CCOC3)ccc4)CC2)CCOCC1	InChI=1S/C23H32N2O6/c26-23(7-12-27-13-8-23)16-25-9-4-17(5-10-25)14-29-22-21-19(30-18-6-11-28-15-18)2-1-3-20(21)31-24-22/h1-3,17-18,26H,4-16H2/t18-/m1/s1	WLLOFQROROXOMO-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_006500	Prasugrel	C20H20FNO3S	2.8749	6918456		CC(=O)Oc1cc2c(CCN(C(C(=O)C3CC3)c3ccccc3F)C2)s1	InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3	DTGLZDAWLRGWQN-UHFFFAOYSA-N					doublet; compound annotation
0391_006501	Prasugrel	C20H20FNO3S	2.8777	6918456		CC(=O)Oc1cc2c(CCN(C(C(=O)C3CC3)c3ccccc3F)C2)s1	InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3	DTGLZDAWLRGWQN-UHFFFAOYSA-N					doublet; compound annotation
0391_006502	PF-4840154	C26H38N6O2	3.1279	53380803		CC(C)CNc1nc(N2CCN(CC3CCCOC3)CC2)ncc1C(=O)NCc1ccccc1	InChI=1S/C26H38N6O2/c1-20(2)15-27-24-23(25(33)28-16-21-7-4-3-5-8-21)17-29-26(30-24)32-12-10-31(11-13-32)18-22-9-6-14-34-19-22/h3-5,7-8,17,20,22H,6,9-16,18-19H2,1-2H3,(H,28,33)(H,27,29,30)	PPANZCQXFYBGHN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006504	ADAPALENE	C28H28O3	6.7583	60164		COc1c(C23CC4CC(CC(C4)C2)C3)cc(-c2cc3c(cc2)cc(C(=O)O)cc3)cc1	InChI=1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30)	LZCDAPDGXCYOEH-UHFFFAOYSA-N					compound annotation
0391_006505	Pymetrozine	C10H11N5O	0.511	9576037	CC1=NNC(=O)N(C1)/N=C/C2=CN=CC=C2	CC1=NNC(=O)N(N=Cc2cnccc2)C1	InChI=1S/C10H11N5O/c1-8-7-15(10(16)14-13-8)12-6-9-3-2-4-11-5-9/h2-6H,7H2,1H3,(H,14,16)/b12-6+	QHMTXANCGGJZRX-WUXMJOGZSA-N					removed another duplicate entry; compound annotation
0391_006507	376640-41-4	C17H21ClN4O3S2	2.324	6918651		Cc1c(S(=O)(=O)Nc2nc(CC(=O)N3CCN(C)CC3)cs2)cccc1Cl	InChI=1S/C17H21ClN4O3S2/c1-12-14(18)4-3-5-15(12)27(24,25)20-17-19-13(11-26-17)10-16(23)22-8-6-21(2)7-9-22/h3-5,11H,6-10H2,1-2H3,(H,19,20)	YDPRNGAPPNPYQQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006509	Tarloxotinib	C24H24BrClN9O3+	3.1564	51038316	CN1C=NC(=C1C[N+](C)(C)C/C=C/C(=O)NC2=NC=C3C(=C2)C(=NC=N3)NC4=CC(=C(C=C4)Cl)Br)[N+](=O)[O-]	Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)CC=CC(=O)Nc1ncc2ncnc(Nc3cc(Br)c(Cl)cc3)c2c1	InChI=1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+	MUJMYVFVAWFUJL-SNAWJCMRSA-O					compound annotation
0391_006510	GLPG0492	C19H14F3N3O3	3.9828	59317190	CN1C(=O)N(C(=O)[C@@]1(CO)C2=CC=CC=C2)C3=CC(=C(C=C3)C#N)C(F)(F)F	CN1C(=O)N(c2cc(C(F)(F)F)c(C#N)cc2)C(=O)C1(CO)c1ccccc1	InChI=1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20,21)22)16(27)18(24,11-26)13-5-3-2-4-6-13/h2-9,26H,11H2,1H3/t18-/m1/s1	VAJGULUVTFDTAS-GOSISDBHSA-N					compound annotation
0391_006511	TCS PIM-1 1	C18H11BrN2O2	4.0084	1235170		N#Cc1c(-c2ccccc2)cc(-c2c(O)ccc(Br)c2)[nH]c1=O	InChI=1S/C18H11BrN2O2/c19-12-6-7-17(22)14(8-12)16-9-13(11-4-2-1-3-5-11)15(10-20)18(23)21-16/h1-9,22H,(H,21,23)	SVSYJTYGPLVUOZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006514	flutamide	C11H11F3N2O3	4.1314	3397		CC(C)C(=O)Nc1cc(C(F)(F)F)c([N+](=O)[O-])cc1	InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)	MKXKFYHWDHIYRV-UHFFFAOYSA-N					compound annotation
0391_006515	Glecaprevir	C38H46F4N6O9S	5.4634	66828839	CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C	CC(C)(C)C1NC(=O)OC2CCCC2OCC=CC(F)(F)c2nc3ccccc3nc2OC2CC(C(=O)NC3(C(=O)NS(=O)(=O)C4(C)CC4)CC3C(F)F)N(C2)C1=O	InChI=1S/C38H46F4N6O9S/c1-35(2,3)28-32(50)48-19-20(17-24(48)30(49)46-37(18-21(37)29(39)40)33(51)47-58(53,54)36(4)14-15-36)56-31-27(43-22-9-5-6-10-23(22)44-31)38(41,42)13-8-16-55-25-11-7-12-26(25)57-34(52)45-28/h5-6,8-10,13,20-21,24-26,28-29H,7,11-12,14-19H2,1-4H3,(H,45,52)(H,46,49)(H,47,51)/b13-8+/t20-,21+,24+,25-,26-,28-,37-/m1/s1	MLSQGNCUYAMAHD-ITNVBOSISA-N					removed another duplicate entry; compound annotation
0391_006517	Olumacostat glasaretil	C26H43NO7	7.0092	89497391		CCCCCCCCCCCCCCOc1ccc(C(=O)OCC(=O)N(C)CC(=O)OCC)o1	InChI=1S/C26H43NO7/c1-4-6-7-8-9-10-11-12-13-14-15-16-19-32-25-18-17-22(34-25)26(30)33-21-23(28)27(3)20-24(29)31-5-2/h17-18H,4-16,19-21H2,1-3H3	FYJLDICZGDFWKP-UHFFFAOYSA-N					compound annotation
0391_006518	sulfameter	C11H12N4O3S	1.5973	5326		COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1	InChI=1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)	GPTONYMQFTZPKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006520	SCH772984	C33H33N9O2	1.8399	24866313	C1CN(C[C@@H]1C(=O)NC2=CC3=C(C=C2)NN=C3C4=CC=NC=C4)CC(=O)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	O=C(Nc1cc2c(cc1)[nH]nc2-c1ccncc1)C1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1	InChI=1S/C33H33N9O2/c43-30(42-18-16-41(17-19-42)27-5-2-24(3-6-27)32-35-11-1-12-36-32)22-40-15-10-25(21-40)33(44)37-26-4-7-29-28(20-26)31(39-38-29)23-8-13-34-14-9-23/h1-9,11-14,20,25H,10,15-19,21-22H2,(H,37,44)(H,38,39)/t25-/m1/s1	HDAJDNHIBCDLQF-RUZDIDTESA-N					doublet; removed another duplicate entry; compound annotation
0391_006522	NVP-AEW541	C27H29N5O	2.4137	11476171		Nc1c2c(-c3cc(OCc4ccccc4)ccc3)cn(C3CC(CN4CCC4)C3)c2ncn1	InChI=1S/C27H29N5O/c28-26-25-24(21-8-4-9-23(14-21)33-17-19-6-2-1-3-7-19)16-32(27(25)30-18-29-26)22-12-20(13-22)15-31-10-5-11-31/h1-4,6-9,14,16,18,20,22H,5,10-13,15,17H2,(H2,28,29,30)	AECDBHGVIIRMOI-UHFFFAOYSA-N					compound annotation
0391_006523	S-Ruxolitinib	C17H18N6	2.4594	50878566	C1CCC(C1)[C@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3	N#CCC(C1CCCC1)n1cc(-c2c3cc[nH]c3ncn2)cn1	InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m0/s1	HFNKQEVNSGCOJV-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_006525	riluzole	C8H5F3N2OS	3.0105	5070		Nc1nc2c(cc(OC(F)(F)F)cc2)s1	InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)	FTALBRSUTCGOEG-UHFFFAOYSA-N					doublet; compound annotation
0391_006526	566203-88-1	C11H9Cl2N3O3S	3.5231	10308720		COc1nccnc1NS(=O)(=O)c1c(Cl)c(Cl)ccc1	InChI=1S/C11H9Cl2N3O3S/c1-19-11-10(14-5-6-15-11)16-20(17,18)8-4-2-3-7(12)9(8)13/h2-6H,1H3,(H,14,16)	FLSMVCMSUNISFK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006528	Silmitasertib	C19H12ClN3O2	3.5961	24748573		O=C(O)c1cc2c(cc1)c1c(ccnc1)c(Nc1cc(Cl)ccc1)n2	InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)	MUOKSQABCJCOPU-UHFFFAOYSA-N					doublet; compound annotation
0391_006529	Linifanib	C21H18FN5O	3.7596	11485656		Cc1cc(NC(=O)Nc2ccc(-c3c4c(N)n[nH]c4ccc3)cc2)c(F)cc1	InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)	MPVGZUGXCQEXTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006531	SCH772984	C33H33N9O2	3.7757	24866313	C1CN(C[C@@H]1C(=O)NC2=CC3=C(C=C2)NN=C3C4=CC=NC=C4)CC(=O)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7	O=C(Nc1cc2c(cc1)[nH]nc2-c1ccncc1)C1CCN(CC(=O)N2CCN(c3ccc(-c4ncccn4)cc3)CC2)C1	InChI=1S/C33H33N9O2/c43-30(42-18-16-41(17-19-42)27-5-2-24(3-6-27)32-35-11-1-12-36-32)22-40-15-10-25(21-40)33(44)37-26-4-7-29-28(20-26)31(39-38-29)23-8-13-34-14-9-23/h1-9,11-14,20,25H,10,15-19,21-22H2,(H,37,44)(H,38,39)/t25-/m1/s1	HDAJDNHIBCDLQF-RUZDIDTESA-N					doublet; compound annotation
0391_006532	Saroglitazar	C25H29NO4S	5.1614	60151560	CCO[C@@H](CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O	CCOC(Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O	InChI=1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1	MRWFZSLZNUJVQW-DEOSSOPVSA-N					compound annotation
0391_006533	cFMS Receptor Inhibitor II	C23H20N4O	2.1272	25163930		Cc1c(C)cc(Nc2c(C(N)=O)cnc3cc(-c4ccncc4)ccc23)cc1	InChI=1S/C23H20N4O/c1-14-3-5-18(11-15(14)2)27-22-19-6-4-17(16-7-9-25-10-8-16)12-21(19)26-13-20(22)23(24)28/h3-13H,1-2H3,(H2,24,28)(H,26,27)	BIICXZWYHQOUEQ-UHFFFAOYSA-N					compound annotation
0391_006534	1414943-88-6	C18H18FN5O2S	2.3313	71618220		COc1c(-c2nc(Nc3cccc(CS(C)(=N)=O)c3)ncn2)ccc(F)c1	InChI=1S/C18H18FN5O2S/c1-26-16-9-13(19)6-7-15(16)17-21-11-22-18(24-17)23-14-5-3-4-12(8-14)10-27(2,20)25/h3-9,11,20H,10H2,1-2H3,(H,21,22,23,24)	ACWKGTGIJRCOOM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006536	iFSP1	C20H13N5	2.3341	699043		Cc1ccc(-c2c(C#N)c3nc4ccccc4n3c(N)c2C#N)cc1	InChI=1S/C20H13N5/c1-12-6-8-13(9-7-12)18-14(10-21)19(23)25-17-5-3-2-4-16(17)24-20(25)15(18)11-22/h2-9H,23H2,1H3	FNESYDFRCQEEKA-UHFFFAOYSA-N					doublet; compound annotation
0391_006537	3,7,4'-Trihydroxyflavone	C15H10O5	2.5269	5281611		O=c1c(O)c(-c2ccc(O)cc2)oc2c1ccc(O)c2	InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)15-14(19)13(18)11-6-5-10(17)7-12(11)20-15/h1-7,16-17,19H	OBWHQJYOOCRPST-UHFFFAOYSA-N					compound annotation
0391_006538	CeMMEC1	C19H16N2O4	3.0449	24152379		Cn1cc(C(=O)Nc2cc3c(cc2)OCCO3)c2ccccc2c1=O	InChI=1S/C19H16N2O4/c1-21-11-15(13-4-2-3-5-14(13)19(21)23)18(22)20-12-6-7-16-17(10-12)25-9-8-24-16/h2-7,10-11H,8-9H2,1H3,(H,20,22)	PEOQAZBGLOADFJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006541	Bimiralisib	C17H20F3N7O2	3.0521	58507717		Nc1ncc(-c2nc(N3CCOCC3)nc(N3CCOCC3)n2)c(C(F)(F)F)c1	InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)	ADGGYDAFIHSYFI-UHFFFAOYSA-N					compound annotation
0391_006542	1699750-95-2	C25H28Cl2N4O3	3.0876	91669215	CCCC(C1=CC=C(C=C1)OCCN2CCOCC2)NC(=O)/C(=C/C3=C(C=CC(=N3)Cl)Cl)/C#N	CCCC(NC(=O)C(C#N)=Cc1c(Cl)ccc(Cl)n1)c1ccc(OCCN2CCOCC2)cc1	InChI=1S/C25H28Cl2N4O3/c1-2-3-22(30-25(32)19(17-28)16-23-21(26)8-9-24(27)29-23)18-4-6-20(7-5-18)34-15-12-31-10-13-33-14-11-31/h4-9,16,22H,2-3,10-15H2,1H3,(H,30,32)/b19-16+	IIKVQQNZHGBYGQ-KNTRCKAVSA-N					doublet; compound annotation
0391_006543	elzovantinib	C20H20FN7O2	3.3335	137455315	CCN1CC2=C(C=CC(=C2C#N)F)O[C@H](CNC(=O)C3=C4N=C1C=CN4N=C3N)C	CCN1Cc2c(ccc(F)c2C#N)OC(C)CNC(=O)c2c3nc1ccn3nc2N	InChI=1S/C20H20FN7O2/c1-3-27-10-13-12(8-22)14(21)4-5-15(13)30-11(2)9-24-20(29)17-18(23)26-28-7-6-16(27)25-19(17)28/h4-7,11H,3,9-10H2,1-2H3,(H2,23,26)(H,24,29)/t11-/m0/s1	UUDPUQDMSHQSKH-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_006546	1699750-95-2	C25H28Cl2N4O3	3.5079	91669215	CCCC(C1=CC=C(C=C1)OCCN2CCOCC2)NC(=O)/C(=C/C3=C(C=CC(=N3)Cl)Cl)/C#N	CCCC(NC(=O)C(C#N)=Cc1c(Cl)ccc(Cl)n1)c1ccc(OCCN2CCOCC2)cc1	InChI=1S/C25H28Cl2N4O3/c1-2-3-22(30-25(32)19(17-28)16-23-21(26)8-9-24(27)29-23)18-4-6-20(7-5-18)34-15-12-31-10-13-33-14-11-31/h4-9,16,22H,2-3,10-15H2,1H3,(H,30,32)/b19-16+	IIKVQQNZHGBYGQ-KNTRCKAVSA-N					doublet; removed another duplicate entry; compound annotation
0391_006548	CHEMBL4797481	C28H45NO6	3.5378	11698848	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)[C@H](CC(=O)O)N)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(OC(=O)C(N)CC(=O)O)CCC4(C)C3CCC12C	InChI=1S/C28H45NO6/c1-16(4-9-24(30)31)20-7-8-21-19-6-5-17-14-18(35-26(34)23(29)15-25(32)33)10-12-27(17,2)22(19)11-13-28(20,21)3/h16-23H,4-15,29H2,1-3H3,(H,30,31)(H,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,27+,28-/m1/s1	NUUCRVJEHQBAKP-CNZWOIIDSA-N					doublet; compound annotation
0391_006549	iFSP1	C20H13N5	3.5662	699043		Cc1ccc(-c2c(C#N)c3nc4ccccc4n3c(N)c2C#N)cc1	InChI=1S/C20H13N5/c1-12-6-8-13(9-7-12)18-14(10-21)19(23)25-17-5-3-2-4-16(17)24-20(25)15(18)11-22/h2-9H,23H2,1H3	FNESYDFRCQEEKA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006552	c-Kit-IN-3	C26H20ClF3N2O4	3.802	139030518		COc1cc2nccc(Oc3ccc(NC(=O)Cc4cc(C(F)(F)F)c(Cl)cc4)cc3)c2cc1OC	InChI=1S/C26H20ClF3N2O4/c1-34-23-13-18-21(14-24(23)35-2)31-10-9-22(18)36-17-6-4-16(5-7-17)32-25(33)12-15-3-8-20(27)19(11-15)26(28,29)30/h3-11,13-14H,12H2,1-2H3,(H,32,33)	YOHLRCOPRAVUCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_006553	CHEMBL4797481	C28H45NO6	4.0155	11698848	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)[C@H](CC(=O)O)N)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(OC(=O)C(N)CC(=O)O)CCC4(C)C3CCC12C	InChI=1S/C28H45NO6/c1-16(4-9-24(30)31)20-7-8-21-19-6-5-17-14-18(35-26(34)23(29)15-25(32)33)10-12-27(17,2)22(19)11-13-28(20,21)3/h16-23H,4-15,29H2,1-3H3,(H,30,31)(H,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,27+,28-/m1/s1	NUUCRVJEHQBAKP-CNZWOIIDSA-N					doublet; removed another duplicate entry; compound annotation
0391_006555	Corydaline	C22H27NO4	2.425	101301	C[C@@H]1[C@@H]2C3=CC(=C(C=C3CCN2CC4=C1C=CC(=C4OC)OC)OC)OC	COc1c(OC)cc2c(c1)CCN1Cc3c(ccc(OC)c3OC)C(C)C21	InChI=1S/C22H27NO4/c1-13-15-6-7-18(24-2)22(27-5)17(15)12-23-9-8-14-10-19(25-3)20(26-4)11-16(14)21(13)23/h6-7,10-11,13,21H,8-9,12H2,1-5H3/t13-,21+/m0/s1	VRSRXLJTYQVOHC-YEJXKQKISA-N					compound annotation
0391_006556	Leniolisib	C21H25F3N6O2	2.6916	57495353	CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F	CCC(=O)N1CCC(Nc2ncnc3c2CN(c2cc(C(F)(F)F)c(OC)nc2)CC3)C1	InChI=1S/C21H25F3N6O2/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28)/t13-/m0/s1	MWKYMZXCGYXLPL-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_006558	LPA2 antagonist 1	C20H23Cl2N5O2S2	2.7058	24882686	CC1=CSC2=C1N=CN=C2N[C@@H](C)CN3CCN(CC3)S(=O)(=O)C4=CC(=C(C=C4)Cl)Cl	Cc1csc2c1ncnc2NC(C)CN1CCN(S(=O)(=O)c2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C20H23Cl2N5O2S2/c1-13-11-30-19-18(13)23-12-24-20(19)25-14(2)10-26-5-7-27(8-6-26)31(28,29)15-3-4-16(21)17(22)9-15/h3-4,9,11-12,14H,5-8,10H2,1-2H3,(H,23,24,25)/t14-/m0/s1	BPRNMVDTWIHULJ-AWEZNQCLSA-N					compound annotation
0391_006559	S1RA	C20H23N3O2	2.8415	44247568		Cc1cc(OCCN2CCOCC2)nn1-c1cc2ccccc2cc1	InChI=1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3	DGPGXHRHNRYVDH-UHFFFAOYSA-N					doublet; compound annotation
0391_006560	S1RA	C20H23N3O2	2.8464	44247568		Cc1cc(OCCN2CCOCC2)nn1-c1cc2ccccc2cc1	InChI=1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3	DGPGXHRHNRYVDH-UHFFFAOYSA-N					doublet; compound annotation
0391_006561	942142-51-0	C26H41ClN4O5	3.1211	16126898	CN[C@@H](C[C@H]1CCCOC1)CNC(=O)N2CCC[C@H](C2)[C@H](C3=CC(=CC=C3)Cl)OCCNC(=O)OC	CNC(CNC(=O)N1CCCC(C(OCCNC(=O)OC)c2cc(Cl)ccc2)C1)CC1CCCOC1	InChI=1S/C26H41ClN4O5/c1-28-23(14-19-6-5-12-35-18-19)16-30-25(32)31-11-4-8-21(17-31)24(20-7-3-9-22(27)15-20)36-13-10-29-26(33)34-2/h3,7,9,15,19,21,23-24,28H,4-6,8,10-14,16-18H2,1-2H3,(H,29,33)(H,30,32)/t19-,21-,23+,24+/m1/s1	NXWASIVXQMMPLM-ZXMXYHOLSA-N					doublet; removed another duplicate entry; compound annotation
0391_006563	FLAVANONE	C15H12O2	4.2814	10251		O=C1CC(c2ccccc2)Oc2ccccc12	InChI=1S/C15H12O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-9,15H,10H2	ZONYXWQDUYMKFB-UHFFFAOYSA-N					doublet; compound annotation
0391_006564	FLAVANONE	C15H12O2	4.9213	10251		O=C1CC(c2ccccc2)Oc2ccccc12	InChI=1S/C15H12O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-9,15H,10H2	ZONYXWQDUYMKFB-UHFFFAOYSA-N					doublet; compound annotation
0391_006565	Nastorazepide	C29H36N4O5	5.0174	9872609	CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4	CC(C)(C)C(=O)CN1C(=O)C(NC(=O)Nc2cccc(C(=O)O)c2)CN(C2CCCCC2)c2ccccc21	InChI=1S/C29H36N4O5/c1-29(2,3)25(34)18-33-24-15-8-7-14-23(24)32(21-12-5-4-6-13-21)17-22(26(33)35)31-28(38)30-20-11-9-10-19(16-20)27(36)37/h7-11,14-16,21-22H,4-6,12-13,17-18H2,1-3H3,(H,36,37)(H2,30,31,38)/t22-/m1/s1	VIJCCFFEBCOOIE-JOCHJYFZSA-N					doublet; compound annotation
0391_006566	Nastorazepide	C29H36N4O5	5.0206	9872609	CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4	CC(C)(C)C(=O)CN1C(=O)C(NC(=O)Nc2cccc(C(=O)O)c2)CN(C2CCCCC2)c2ccccc21	InChI=1S/C29H36N4O5/c1-29(2,3)25(34)18-33-24-15-8-7-14-23(24)32(21-12-5-4-6-13-21)17-22(26(33)35)31-28(38)30-20-11-9-10-19(16-20)27(36)37/h7-11,14-16,21-22H,4-6,12-13,17-18H2,1-3H3,(H,36,37)(H2,30,31,38)/t22-/m1/s1	VIJCCFFEBCOOIE-JOCHJYFZSA-N					doublet; compound annotation
0391_006567	Edasalonexent	C31H42N2O3	6.3872	44626120	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)C1=CC=CC=C1O	CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCNC(=O)c1ccccc1O	InChI=1S/C31H42N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25-30(35)32-26-27-33-31(36)28-23-21-22-24-29(28)34/h3-4,6-7,9-10,12-13,15-16,18-19,21-24,34H,2,5,8,11,14,17,20,25-27H2,1H3,(H,32,35)(H,33,36)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-	JQLBBYLGWHUHRW-KUBAVDMBSA-N					removed another duplicate entry; compound annotation
0391_006569	Prinomastat	C18H21N3O5S2	1.8563	466151	CC1([C@@H](N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=NC=C3)C(=O)NO)C	CC1(C)SCCN(S(=O)(=O)c2ccc(Oc3ccncc3)cc2)C1C(=O)NO	InChI=1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1	YKPYIPVDTNNYCN-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_006571	A-674563	C22H22N4O	2.0521	11314340	CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CC=CC=C4)N	Cc1c2cc(-c3cc(OCC(N)Cc4ccccc4)cnc3)ccc2n[nH]1	InChI=1S/C22H22N4O/c1-15-21-11-17(7-8-22(21)26-25-15)18-10-20(13-24-12-18)27-14-19(23)9-16-5-3-2-4-6-16/h2-8,10-13,19H,9,14,23H2,1H3,(H,25,26)/t19-/m0/s1	BPNUQXPIQBZCMR-IBGZPJMESA-N					compound annotation
0391_006572	Tame	C14H22N4O4S	2.057	1550286	CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)OC	COC(=O)C(CCCN=C(N)N)NS(=O)(=O)c1ccc(C)cc1	InChI=1S/C14H22N4O4S/c1-10-5-7-11(8-6-10)23(20,21)18-12(13(19)22-2)4-3-9-17-14(15)16/h5-8,12,18H,3-4,9H2,1-2H3,(H4,15,16,17)/t12-/m0/s1	FKMJXALNHKIDOD-LBPRGKRZSA-N					doublet; compound annotation
0391_006573	183321-86-0	C21H21N3O4	2.2966	10317566		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)ccc1	InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)	KOQIAZNBAWFSQM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006575	183321-86-0	C21H21N3O4	2.4606	10317566		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)ccc1	InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)	KOQIAZNBAWFSQM-UHFFFAOYSA-N					doublet; compound annotation
0391_006576	1300031-49-5	C23H21N5O3	2.4606	52912189	CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)[C@H](C)C5=CC=CC=N5)OC	COc1c(-c2c(C)onc2C)cc2ncc3c(c2c1)n(C(C)c1ccccn1)c(=O)[nH]3	InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1	VUVUVNZRUGEAHB-CYBMUJFWSA-N					doublet; compound annotation
0391_006577	1300031-49-5	C23H21N5O3	2.4638	52912189	CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)[C@H](C)C5=CC=CC=N5)OC	COc1c(-c2c(C)onc2C)cc2ncc3c(c2c1)n(C(C)c1ccccn1)c(=O)[nH]3	InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1	VUVUVNZRUGEAHB-CYBMUJFWSA-N					doublet; compound annotation
0391_006578	HLY78	C17H17NO2	3.7075	44422459		CCc1c2c(ccc1)-c1cc3c(cc1CN2C)OCO3	InChI=1S/C17H17NO2/c1-3-11-5-4-6-13-14-8-16-15(19-10-20-16)7-12(14)9-18(2)17(11)13/h4-8H,3,9-10H2,1-2H3	FAZZYPIBZBGQSH-UHFFFAOYSA-N					compound annotation
0391_006579	BAY-1797	C20H17ClN2O4S	4.0782	124125214		NS(=O)(=O)c1c(Oc2cc(Cl)ccc2)ccc(NC(=O)Cc2ccccc2)c1	InChI=1S/C20H17ClN2O4S/c21-15-7-4-8-17(12-15)27-18-10-9-16(13-19(18)28(22,25)26)23-20(24)11-14-5-2-1-3-6-14/h1-10,12-13H,11H2,(H,23,24)(H2,22,25,26)	CSJYMAFXYMYNCK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006582	Aslan003	C19H14F2N2O3	4.2722	24986824		COc1cccc(-c2cc(F)c(Nc3c(C(=O)O)cccn3)c(F)c2)c1	InChI=1S/C19H14F2N2O3/c1-26-13-5-2-4-11(8-13)12-9-15(20)17(16(21)10-12)23-18-14(19(24)25)6-3-7-22-18/h2-10H,1H3,(H,22,23)(H,24,25)	OMPATGZMNFWVOH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006584	AGX51	C27H29NO4	5.0922	2920302		CCC(=O)N(CCC(c1cc2c(cc1)OCO2)c1ccccc1OC)Cc1ccccc1	InChI=1S/C27H29NO4/c1-3-27(29)28(18-20-9-5-4-6-10-20)16-15-22(23-11-7-8-12-24(23)30-2)21-13-14-25-26(17-21)32-19-31-25/h4-14,17,22H,3,15-16,18-19H2,1-2H3	SRADCMOCDMFMPS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006586	CXCR7 modulator 2	C29H42N6O3	1.275	134694953	CCC1=C(C2=NC=CN2C=C1)N3CCCN(CC3)[C@@H](CC(=O)N)C4CCN(CC4)C(=O)[C@H]5C[C@@H]6CC[C@H]5O6	CCc1c(N2CCCN(C(CC(N)=O)C3CCN(C(=O)C4CC5CCC4O5)CC3)CC2)c2nccn2cc1	InChI=1S/C29H42N6O3/c1-2-20-6-12-34-15-9-31-28(34)27(20)33-11-3-10-32(16-17-33)24(19-26(30)36)21-7-13-35(14-8-21)29(37)23-18-22-4-5-25(23)38-22/h6,9,12,15,21-25H,2-5,7-8,10-11,13-14,16-19H2,1H3,(H2,30,36)/t22-,23-,24-,25+/m0/s1	CERHKHQEGFSIHF-OJJQZRKESA-N					removed another duplicate entry; compound annotation
0391_006588	GDC-0575	C16H20BrN5O	1.6437	46917793	C1C[C@H](CN(C1)C2=C3C(=CNC3=NC=C2Br)NC(=O)C4CC4)N	NC1CCCN(c2c3c(NC(=O)C4CC4)c[nH]c3ncc2Br)C1	InChI=1S/C16H20BrN5O/c17-11-6-19-15-13(14(11)22-5-1-2-10(18)8-22)12(7-20-15)21-16(23)9-3-4-9/h6-7,9-10H,1-5,8,18H2,(H,19,20)(H,21,23)/t10-/m1/s1	BAZRWWGASYWYGB-SNVBAGLBSA-N					compound annotation
0391_006589	260264-93-5	C21H33N3O4	2.9235	9952396	C[C@@H]([C@@H](CCCC1=CC=CC=C1)C(=O)N[C@H](C(=O)NC)C(C)(C)C)N(C=O)O	CNC(=O)C(NC(=O)C(CCCc1ccccc1)C(C)N(O)C=O)C(C)(C)C	InChI=1S/C21H33N3O4/c1-15(24(28)14-25)17(13-9-12-16-10-7-6-8-11-16)19(26)23-18(20(27)22-5)21(2,3)4/h6-8,10-11,14-15,17-18,28H,9,12-13H2,1-5H3,(H,22,27)(H,23,26)/t15-,17+,18+/m0/s1	GHVMTHKJUAOZJP-CGTJXYLNSA-N					removed another duplicate entry; compound annotation
0391_006591	Tarafenacin	C21H20F4N2O2	3.3608	25147683	C1CN2CCC1[C@H](C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F	O=C(OC1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cc(F)ccc1	InChI=1S/C21H20F4N2O2/c22-15-2-1-3-16(10-15)27(11-13-8-17(23)20(25)18(24)9-13)21(28)29-19-12-26-6-4-14(19)5-7-26/h1-3,8-10,14,19H,4-7,11-12H2/t19-/m0/s1	UXZDMXYRRQJIBJ-IBGZPJMESA-N					compound annotation
0391_006592	223499-30-7	C15H9F6N5OS	4.866	2455		Cc1c(C(=O)Nc2ccc(-n3nc(C(F)(F)F)cc3C(F)(F)F)cc2)snn1	InChI=1S/C15H9F6N5OS/c1-7-12(28-25-23-7)13(27)22-8-2-4-9(5-3-8)26-11(15(19,20)21)6-10(24-26)14(16,17)18/h2-6H,1H3,(H,22,27)	XPRZIORDEVHURQ-UHFFFAOYSA-N					compound annotation
0391_006593	FUBP1-IN-1	C19H14F3N3O2S	5.3354	2823337		COc1c(OC)cc(-c2nc3cc(-c4cccs4)nn3c(C(F)(F)F)c2)cc1	InChI=1S/C19H14F3N3O2S/c1-26-14-6-5-11(8-15(14)27-2)12-9-17(19(20,21)22)25-18(23-12)10-13(24-25)16-4-3-7-28-16/h3-10H,1-2H3	CLFOYJSEPPNFQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006594	FUBP1-IN-1	C19H14F3N3O2S	5.3386	2823337		COc1c(OC)cc(-c2nc3cc(-c4cccs4)nn3c(C(F)(F)F)c2)cc1	InChI=1S/C19H14F3N3O2S/c1-26-14-6-5-11(8-15(14)27-2)12-9-17(19(20,21)22)25-18(23-12)10-13(24-25)16-4-3-7-28-16/h3-10H,1-2H3	CLFOYJSEPPNFQZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006595	ML364	C24H18F3N3O3S2	5.5509	70789348		Cc1ccc(S(=O)(=O)Nc2cc(C(F)(F)F)ccc2C(=O)Nc2nc(-c3ccccc3)cs2)cc1	InChI=1S/C24H18F3N3O3S2/c1-15-7-10-18(11-8-15)35(32,33)30-20-13-17(24(25,26)27)9-12-19(20)22(31)29-23-28-21(14-34-23)16-5-3-2-4-6-16/h2-14,30H,1H3,(H,28,29,31)	QZUGMNXETPARLI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006597	125316-60-1	C27H26O3	5.6097	135411		O=C(O)c1cc2c(cc1)cc(-c1cc(C34CC5CC(CC(C5)C3)C4)c(O)cc1)cc2	InChI=1S/C27H26O3/c28-25-6-5-22(20-1-2-21-11-23(26(29)30)4-3-19(21)10-20)12-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30)	LDGIHZJOIQSHPB-UHFFFAOYSA-N					compound annotation
0391_006598	MYCi975	C25H16Cl2F6N2O2	6.2672	139600320		Cn1nc(C(F)(F)F)cc1-c1c(O)c(-c2cc(C(F)(F)F)c(Cl)cc2)c(OCc2ccc(Cl)cc2)cc1	InChI=1S/C25H16Cl2F6N2O2/c1-35-19(11-21(34-35)25(31,32)33)16-7-9-20(37-12-13-2-5-15(26)6-3-13)22(23(16)36)14-4-8-18(27)17(10-14)24(28,29)30/h2-11,36H,12H2,1H3	VSDFDVBYONIJLD-UHFFFAOYSA-N					compound annotation
0391_006599	1-aminobenzotriazole	C6H6N4	1.2138	1367		Nn1nnc2ccccc21	InChI=1S/C6H6N4/c7-10-6-4-2-1-3-5(6)8-9-10/h1-4H,7H2	JCXKHYLLVKZPKE-UHFFFAOYSA-N					compound annotation
0391_006600	1792180-81-4	C15H19N5O	1.4947	118115473	C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3	C=CC(=O)N1CC(Nc2ncnc3c2cc[nH]3)CCC1C	InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1	CBRJPFGIXUFMTM-WDEREUQCSA-N					doublet; removed another duplicate entry; compound annotation
0391_006602	452105-23-6	C23H27FN4O4	1.805	10138259	CC1=C(NC(=C1C(=O)NC[C@@H](CN2CCOCC2)O)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCC(O)CN2CCOCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	CTNPALGJUAXMMC-PMFHANACSA-N					doublet; removed another duplicate entry; compound annotation
0391_006604	1792180-81-4	C15H19N5O	1.8962	118115473	C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3	C=CC(=O)N1CC(Nc2ncnc3c2cc[nH]3)CCC1C	InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1	CBRJPFGIXUFMTM-WDEREUQCSA-N					doublet; compound annotation
0391_006605	445430-58-0	C14H17N5	1.9442	9813758		Cc1cc2c(cc1)nc(NCCN)c1ncc(C)n12	InChI=1S/C14H17N5/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18)	PSPFQEBFYXJZEV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006607	452105-23-6	C23H27FN4O4	2.4936	10138259	CC1=C(NC(=C1C(=O)NC[C@@H](CN2CCOCC2)O)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCC(O)CN2CCOCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	CTNPALGJUAXMMC-PMFHANACSA-N					doublet; removed another duplicate entry; compound annotation
0391_006609	Cevipabulin	C18H18ClF5N6O	2.6166	11488110	C[C@@H](C(F)(F)F)NC1=C(C(=NC2=NC=NN12)Cl)C3=C(C=C(C=C3F)OCCCNC)F	CNCCCOc1cc(F)c(-c2c(NC(C)C(F)(F)F)n3ncnc3nc2Cl)c(F)c1	InChI=1S/C18H18ClF5N6O/c1-9(18(22,23)24)28-16-14(15(19)29-17-26-8-27-30(16)17)13-11(20)6-10(7-12(13)21)31-5-3-4-25-2/h6-9,25,28H,3-5H2,1-2H3/t9-/m0/s1	ZUZPCOQWSYNWLU-VIFPVBQESA-N					doublet; removed another duplicate entry; compound annotation
0391_006611	72926-24-0	C13H15N3O2S	2.7372	2930014		CC(=O)NC1=NN(C(C)=O)C(C)(c2ccccc2)S1	InChI=1S/C13H15N3O2S/c1-9(17)14-12-15-16(10(2)18)13(3,19-12)11-7-5-4-6-8-11/h4-8H,1-3H3,(H,14,15,17)	JEFVYQYZCAVNTP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006613	Balicatib	C23H33N5O2	1.9769	10201696		CCCN1CCN(c2ccc(C(=O)NC3(C(=O)NCC#N)CCCCC3)cc2)CC1	InChI=1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29)	LLCRBOWRJOUJAE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006615	Sutezolid	C16H20FN3O3S	2.9355	465951	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCSCC3)F	CC(=O)NCC1CN(c2cc(F)c(N3CCSCC3)cc2)C(=O)O1	InChI=1S/C16H20FN3O3S/c1-11(21)18-9-13-10-20(16(22)23-13)12-2-3-15(14(17)8-12)19-4-6-24-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1	FNDDDNOJWPQCBZ-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_006618	465539-70-2	C42H52N4O7S	3.5125	9853583	C[C@@H]1CCC[C@@H](N1CC2=CC=C(C=C2)C[C@H](C(=O)N(C)C(C)C)NC(=O)C[C@H](C3=CC4=C(C=C3)OCO4)NS(=O)(=O)C5=CC6=C(C=C5)C=C(C=C6)OC)C	COc1cc2c(cc1)cc(S(=O)(=O)NC(CC(=O)NC(Cc1ccc(CN3C(C)CCCC3C)cc1)C(=O)N(C)C(C)C)c1cc3c(cc1)OCO3)cc2	InChI=1S/C42H52N4O7S/c1-27(2)45(5)42(48)38(20-30-10-12-31(13-11-30)25-46-28(3)8-7-9-29(46)4)43-41(47)24-37(34-16-19-39-40(23-34)53-26-52-39)44-54(49,50)36-18-15-32-21-35(51-6)17-14-33(32)22-36/h10-19,21-23,27-29,37-38,44H,7-9,20,24-26H2,1-6H3,(H,43,47)/t28-,29+,37-,38-/m1/s1	QGWIQIAWOCJRPI-WSCVWKGISA-N					compound annotation
0391_006619	PF-3274167	C19H19ClFN5O3	3.6627	11683187		COCc1nnc(N2CC(Oc3c(Cl)cc(F)cc3)C2)n1-c1cnc(OC)cc1	InChI=1S/C19H19ClFN5O3/c1-27-11-17-23-24-19(26(17)13-4-6-18(28-2)22-8-13)25-9-14(10-25)29-16-5-3-12(21)7-15(16)20/h3-8,14H,9-11H2,1-2H3	HNIFCPBQMKPRCX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006621	Avagacestat	C20H17ClF4N4O4S	4.4821	46883536	C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl	NC(=O)C(CCC(F)(F)F)N(Cc1c(F)cc(-c2nocn2)cc1)S(=O)(=O)c1ccc(Cl)cc1	InChI=1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1	XEAOPVUAMONVLA-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_006623	BT-13	C23H27F4N3O4S	4.5413	46088379		CCN(CC)S(=O)(=O)c1cc(N2CCN(C(=O)c3c(C(F)(F)F)cc(F)cc3)CC2)c(OC)cc1	InChI=1S/C23H27F4N3O4S/c1-4-30(5-2)35(32,33)17-7-9-21(34-3)20(15-17)28-10-12-29(13-11-28)22(31)18-8-6-16(24)14-19(18)23(25,26)27/h6-9,14-15H,4-5,10-13H2,1-3H3	GTDJOGZANHPKMR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006625	BT-13	C23H27F4N3O4S	4.5461	46088379		CCN(CC)S(=O)(=O)c1cc(N2CCN(C(=O)c3c(C(F)(F)F)cc(F)cc3)CC2)c(OC)cc1	InChI=1S/C23H27F4N3O4S/c1-4-30(5-2)35(32,33)17-7-9-21(34-3)20(15-17)28-10-12-29(13-11-28)22(31)18-8-6-16(24)14-19(18)23(25,26)27/h6-9,14-15H,4-5,10-13H2,1-3H3	GTDJOGZANHPKMR-UHFFFAOYSA-N					doublet; compound annotation
0391_006626	DM4	C38H54ClN3O10S	4.6364	11686439	C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)\C)OC)(NC(=O)O2)O	COc1cc2cc(c1Cl)N(C)C(=O)CC(OC(=O)C(C)N(C)C(=O)CCC(C)(C)S)C1(C)OC1C(C)C1CC(O)(NC(=O)O1)C(OC)C=CC=C(C)C2	InChI=1S/C38H54ClN3O10S/c1-21-12-11-13-28(49-10)38(47)20-27(50-35(46)40-38)22(2)33-37(6,52-33)29(51-34(45)23(3)41(7)30(43)14-15-36(4,5)53)19-31(44)42(8)25-17-24(16-21)18-26(48-9)32(25)39/h11-13,17-18,22-23,27-29,33,47,53H,14-16,19-20H2,1-10H3,(H,40,46)/b13-11+,21-12+/t22-,23+,27+,28-,29+,33+,37+,38+/m1/s1	JFCFGYGEYRIEBE-YVLHJLIDSA-N					removed another duplicate entry; compound annotation
0391_006628	Veliparib	C13H16N4O	0.9542	11960529	C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N	CC1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1	InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1	JNAHVYVRKWKWKQ-CYBMUJFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_006630	AZ191	C24H27N7O	1.2001	72716071		COc1c(Nc2nccc(-c3cn(C)c4c3ccnc4)n2)ccc(N2CCN(C)CC2)c1	InChI=1S/C24H27N7O/c1-29-10-12-31(13-11-29)17-4-5-21(23(14-17)32-3)28-24-26-9-7-20(27-24)19-16-30(2)22-15-25-8-6-18(19)22/h4-9,14-16H,10-13H2,1-3H3,(H,26,27,28)	ZYVXTMKTGDARKR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006632	865362-74-9	C18H13N7	1.5515	53338808		Nc1c2cc(-c3c4ccccn4nc3-c3ccccc3)nnc2n[nH]1	InChI=1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)	XVECMUKVOMUNLE-UHFFFAOYSA-N					doublet; compound annotation
0391_006633	Iberdomide	C25H27N3O5	1.8272	67335295	C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5	O=C1CCC(N2Cc3c(cccc3OCc3ccc(CN4CCOCC4)cc3)C2=O)C(=O)N1	InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1	IXZOHGPZAQLIBH-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_006635	CVT-313	C20H28N6O3	2.4536	6918386		COc1ccc(CNc2c3ncn(C(C)C)c3nc(N(CCO)CCO)n2)cc1	InChI=1S/C20H28N6O3/c1-14(2)26-13-22-17-18(21-12-15-4-6-16(29-3)7-5-15)23-20(24-19(17)26)25(8-10-27)9-11-28/h4-7,13-14,27-28H,8-12H2,1-3H3,(H,21,23,24)	NQVIIUBWMBHLOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006636	CVT-313	C20H28N6O3	2.4563	6918386		COc1ccc(CNc2c3ncn(C(C)C)c3nc(N(CCO)CCO)n2)cc1	InChI=1S/C20H28N6O3/c1-14(2)26-13-22-17-18(21-12-15-4-6-16(29-3)7-5-15)23-20(24-19(17)26)25(8-10-27)9-11-28/h4-7,13-14,27-28H,8-12H2,1-3H3,(H,21,23,24)	NQVIIUBWMBHLOZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006638	865362-74-9	C18H13N7	2.5275	53338808		Nc1c2cc(-c3c4ccccn4nc3-c3ccccc3)nnc2n[nH]1	InChI=1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)	XVECMUKVOMUNLE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006640	IITZ-01	C26H23FN8O	3.3311	134817273		Fc1ccc(Nc2nc(N3CCOCC3)nc(Nc3ccc(-c4nc5ccccc5[nH]4)cc3)n2)cc1	InChI=1S/C26H23FN8O/c27-18-7-11-20(12-8-18)29-25-32-24(33-26(34-25)35-13-15-36-16-14-35)28-19-9-5-17(6-10-19)23-30-21-3-1-2-4-22(21)31-23/h1-12H,13-16H2,(H,30,31)(H2,28,29,32,33,34)	XGEDDGLPNSLBFE-UHFFFAOYSA-N					compound annotation
0391_006641	FPH2	C14H16ClN5O2S	3.5089	2208391		CCn1cc(NC(=S)Nc2c(OC)ccc(Cl)c2)c(C(N)=O)n1	InChI=1S/C14H16ClN5O2S/c1-3-20-7-10(12(19-20)13(16)21)18-14(23)17-9-6-8(15)4-5-11(9)22-2/h4-7H,3H2,1-2H3,(H2,16,21)(H2,17,18,23)	PCHRYHSDDPPZBV-UHFFFAOYSA-N					compound annotation
0391_006642	Umbralisib	C31H24F3N5O3	4.7371	72950888	C[C@@H](C1=C(C(=O)C2=C(O1)C=CC(=C2)F)C3=CC(=CC=C3)F)N4C5=NC=NC(=C5C(=N4)C6=CC(=C(C=C6)OC(C)C)F)N	CC(C)Oc1c(F)cc(-c2nn(C(C)c3c(-c4cc(F)ccc4)c(=O)c4c(ccc(F)c4)o3)c3ncnc(N)c23)cc1	InChI=1S/C31H24F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H2,35,36,37)/t16-/m0/s1	IUVCFHHAEHNCFT-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_006644	2244678-29-1	C24H26N2O3S	4.8002	137796294		CCCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1	InChI=1S/C24H26N2O3S/c1-2-3-18-26(19-20-10-6-4-7-11-20)24(27)21-14-16-23(17-15-21)30(28,29)25-22-12-8-5-9-13-22/h4-17,25H,2-3,18-19H2,1H3	VNCIWNGCMAKKEO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006646	2244678-29-1	C24H26N2O3S	4.8029	137796294		CCCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1	InChI=1S/C24H26N2O3S/c1-2-3-18-26(19-20-10-6-4-7-11-20)24(27)21-14-16-23(17-15-21)30(28,29)25-22-12-8-5-9-13-22/h4-17,25H,2-3,18-19H2,1H3	VNCIWNGCMAKKEO-UHFFFAOYSA-N					doublet; compound annotation
0391_006647	Omaveloxolone	C33H44F2N2O3	5.5544	71811910	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F	CC1(C)CCC2(NC(=O)C(C)(F)F)CCC3(C)C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C33H44F2N2O3/c1-27(2)11-13-33(37-26(40)32(8,34)35)14-12-31(7)24(20(33)17-27)21(38)15-23-29(5)16-19(18-36)25(39)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3,(H,37,40)/t20-,22-,24-,29-,30+,31+,33-/m0/s1	RJCWBNBKOKFWNY-IDPLTSGASA-N					removed another duplicate entry; compound annotation
0391_006649	GSK3368715	C20H38N4O2	1.7654	90462880		CCOCC1(COCC)CCC(c2c(CN(C)CCNC)cn[nH]2)CC1	InChI=1S/C20H38N4O2/c1-5-25-15-20(16-26-6-2)9-7-17(8-10-20)19-18(13-22-23-19)14-24(4)12-11-21-3/h13,17,21H,5-12,14-16H2,1-4H3,(H,22,23)	SPEGERVLTUWZPA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006651	35973-25-2	C10H6N2O5	2.0297	225906		O=C(O)c1c[nH]c2c(cccc2[N+](=O)[O-])c1=O	InChI=1S/C10H6N2O5/c13-9-5-2-1-3-7(12(16)17)8(5)11-4-6(9)10(14)15/h1-4H,(H,11,13)(H,14,15)	BMIZBCVEHSUUNO-UHFFFAOYSA-N					compound annotation
0391_006652	CEP-37440	C30H38ClN7O3	2.3594	71721648	CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C4=C(C[C@H](CCC4)N5CCN(CC5)CCO)C=C3)OC	CNC(=O)c1ccccc1Nc1nc(Nc2c(OC)c3c(cc2)CC(N2CCN(CCO)CC2)CCC3)ncc1Cl	InChI=1S/C30H38ClN7O3/c1-32-29(40)23-7-3-4-9-25(23)34-28-24(31)19-33-30(36-28)35-26-11-10-20-18-21(6-5-8-22(20)27(26)41-2)38-14-12-37(13-15-38)16-17-39/h3-4,7,9-11,19,21,39H,5-6,8,12-18H2,1-2H3,(H,32,40)(H2,33,34,35,36)/t21-/m0/s1	BCSHRERPHLTPEE-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_006654	Ulixertinib	C21H22Cl2N4O2	2.8305	11719003	CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl	CC(C)Nc1ncc(Cl)c(-c2c[nH]c(C(=O)NC(CO)c3cc(Cl)ccc3)c2)c1	InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1	KSERXGMCDHOLSS-LJQANCHMSA-N					doublet; compound annotation
0391_006655	LY2334737	C17H25F2N3O5	3.24	11646777	CCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F	CCCC(CCC)C(=O)Nc1nc(=O)n(C2OC(CO)C(O)C2(F)F)cc1	InChI=1S/C17H25F2N3O5/c1-3-5-10(6-4-2)14(25)20-12-7-8-22(16(26)21-12)15-17(18,19)13(24)11(9-23)27-15/h7-8,10-11,13,15,23-24H,3-6,9H2,1-2H3,(H,20,21,25,26)/t11-,13-,15-/m1/s1	MEOYFIHNRBNEPI-UXIGCNINSA-N					removed another duplicate entry; compound annotation
0391_006657	1096708-71-2	C17H12Cl2F3N7O2S	3.7799	25161177	C[C@H](C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl	CC(NC(=O)c1c(Cl)c(N)ncn1)c1ncc(C(=O)Nc2ncc(Cl)c(C(F)(F)F)c2)s1	InChI=1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1	VWMJHAFYPMOMGF-ZCFIWIBFSA-N					removed another duplicate entry; compound annotation
0391_006659	HC-070	C22H20Cl2N4O4	4.8176	85473309		Cn1c(=O)n(CCCO)c(=O)c2c1nc(Oc1cc(Cl)ccc1)n2Cc1ccc(Cl)cc1	InChI=1S/C22H20Cl2N4O4/c1-26-19-18(20(30)27(22(26)31)10-3-11-29)28(13-14-6-8-15(23)9-7-14)21(25-19)32-17-5-2-4-16(24)12-17/h2,4-9,12,29H,3,10-11,13H2,1H3	VYJPVPHNGWEIBT-UHFFFAOYSA-N					doublet; compound annotation
0391_006660	HC-070	C22H20Cl2N4O4	4.8208	85473309		Cn1c(=O)n(CCCO)c(=O)c2c1nc(Oc1cc(Cl)ccc1)n2Cc1ccc(Cl)cc1	InChI=1S/C22H20Cl2N4O4/c1-26-19-18(20(30)27(22(26)31)10-3-11-29)28(13-14-6-8-15(23)9-7-14)21(25-19)32-17-5-2-4-16(24)12-17/h2,4-9,12,29H,3,10-11,13H2,1H3	VYJPVPHNGWEIBT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006662	Palovarotene	C27H30N2O2	5.2268	10295295	CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C	CC1(C)CCC(C)(C)c2c1cc(C=Cc1ccc(C(=O)O)cc1)c(Cn1cccn1)c2	InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+	YTFHCXIPDIHOIA-DHZHZOJOSA-N					doublet; compound annotation
0391_006663	Palovarotene	C27H30N2O2	5.5925	10295295	CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C	CC1(C)CCC(C)(C)c2c1cc(C=Cc1ccc(C(=O)O)cc1)c(Cn1cccn1)c2	InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+	YTFHCXIPDIHOIA-DHZHZOJOSA-N					doublet; compound annotation
0391_006664	Palovarotene	C27H30N2O2	5.7998	10295295	CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C	CC1(C)CCC(C)(C)c2c1cc(C=Cc1ccc(C(=O)O)cc1)c(Cn1cccn1)c2	InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+	YTFHCXIPDIHOIA-DHZHZOJOSA-N					doublet; compound annotation
0391_006665	KX-01-191	C28H39N3OSn	6.3497	138911352		CCCC[Sn](CCCC)(CCCC)c1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1	InChI=1S/C16H12N3O.3C4H9.Sn/c20-16-12-7-4-8-13-14(12)19(10-9-17-16)15(18-13)11-5-2-1-3-6-11;3*1-3-4-2;/h2-8H,9-10H2,(H,17,20);3*1,3-4H2,2H3;	AOQSHPQTNVDAAF-UHFFFAOYSA-N					compound annotation
0391_006666	AST 487	C26H30F3N7O2	2.4941	11409972		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)Nc3ccc(Oc4ncnc(NC)c4)cc3)cc2)CC1	InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)	ODPGGGTTYSGTGO-UHFFFAOYSA-N					compound annotation
0391_006667	5-carboxy methylrhodamine	C25H23N2O5+	2.6955	2762603		CN(C)c1cc2c(cc1)c(-c1c(C(=O)O)cc(C(=O)O)cc1)c1ccc(=[N+](C)C)cc-1o2	InChI=1S/C25H22N2O5/c1-26(2)15-6-9-18-21(12-15)32-22-13-16(27(3)4)7-10-19(22)23(18)17-8-5-14(24(28)29)11-20(17)25(30)31/h5-13H,1-4H3,(H-,28,29,30,31)/p+1	YMZMTOFQCVHHFB-UHFFFAOYSA-O					compound annotation
0391_006668	SBE13	C24H27ClN2O4	2.7896	4719406		COc1c(OC)cc(CCNCc2cc(OC)c(OCc3cnc(Cl)cc3)cc2)cc1	InChI=1S/C24H27ClN2O4/c1-28-20-7-4-17(12-22(20)29-2)10-11-26-14-18-5-8-21(23(13-18)30-3)31-16-19-6-9-24(25)27-15-19/h4-9,12-13,15,26H,10-11,14,16H2,1-3H3	XNPRQBVQOJZMMA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006670	SBE13	C24H27ClN2O4	2.8978	4719406		COc1c(OC)cc(CCNCc2cc(OC)c(OCc3cnc(Cl)cc3)cc2)cc1	InChI=1S/C24H27ClN2O4/c1-28-20-7-4-17(12-22(20)29-2)10-11-26-14-18-5-8-21(23(13-18)30-3)31-16-19-6-9-24(25)27-15-19/h4-9,12-13,15,26H,10-11,14,16H2,1-3H3	XNPRQBVQOJZMMA-UHFFFAOYSA-N					doublet; compound annotation
0391_006671	mAChR-IN-1	C23H25IN2O2	2.901	14479846		O=C1CCC(c2ccccc2)(C2CCN(Cc3ccc(I)cc3)CC2)C(=O)N1	InChI=1S/C23H25IN2O2/c24-20-8-6-17(7-9-20)16-26-14-11-19(12-15-26)23(18-4-2-1-3-5-18)13-10-21(27)25-22(23)28/h1-9,19H,10-16H2,(H,25,27,28)	WJLRTFJPHDSXAF-UHFFFAOYSA-N					compound annotation
0391_006672	BQ-123	C31H42N6O7	3.3875	443289	CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43	CC(C)CC1NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(CC(=O)O)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O	InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1	VYCMAAOURFJIHD-PJNXIOHISA-N					removed another duplicate entry; compound annotation
0391_006675	Letermovir	C29H28F4N4O4	3.6592	45138674	COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O	COc1cccc(N2CCN(C3=Nc4c(cccc4F)C(CC(=O)O)N3c3c(OC)ccc(C(F)(F)F)c3)CC2)c1	InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1	FWYSMLBETOMXAG-QHCPKHFHSA-N					doublet; compound annotation
0391_006676	Letermovir	C29H28F4N4O4	3.6625	45138674	COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O	COc1cccc(N2CCN(C3=Nc4c(cccc4F)C(CC(=O)O)N3c3c(OC)ccc(C(F)(F)F)c3)CC2)c1	InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1	FWYSMLBETOMXAG-QHCPKHFHSA-N					doublet; compound annotation
0391_006677	2-Cl-IB-Meca	C18H18ClIN6O4	3.7329	3035850	CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O	CNC(=O)C1OC(n2cnc3c(NCc4cc(I)ccc4)nc(Cl)nc32)C(O)C1O	InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1	IPSYPUKKXMNCNQ-PFHKOEEOSA-N					removed another duplicate entry; compound annotation
0391_006679	ZLDI-8	C24H23N3O3S	4.3718	989566		Cc1cc(C)c(OCCn2c(C)c(C=C3C(=O)NC(=S)NC3=O)c3ccccc32)cc1	InChI=1S/C24H23N3O3S/c1-14-8-9-21(15(2)12-14)30-11-10-27-16(3)18(17-6-4-5-7-20(17)27)13-19-22(28)25-24(31)26-23(19)29/h4-9,12-13H,10-11H2,1-3H3,(H2,25,26,28,29,31)	GNBZGGYWSRGVBG-UHFFFAOYSA-N					compound annotation
0391_006680	GSK1379725A	C23H23FN6O3	2.9696	44525934		COC(=O)c1cc(NC(=O)NC2CCN(c3nc(Nc4ccc(F)cc4)ncc3)C2)ccc1	InChI=1S/C23H23FN6O3/c1-33-21(31)15-3-2-4-18(13-15)27-23(32)28-19-10-12-30(14-19)20-9-11-25-22(29-20)26-17-7-5-16(24)6-8-17/h2-9,11,13,19H,10,12,14H2,1H3,(H,25,26,29)(H2,27,28,32)	LLVPDBRSUHNJQQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006682	BMS-911543	C23H28N8O	3.1436	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006685	Eliprodil	C20H23ClFNO	3.2016	60703		OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1	InChI=1S/C20H23ClFNO/c21-18-5-3-17(4-6-18)20(24)14-23-11-9-16(10-12-23)13-15-1-7-19(22)8-2-15/h1-8,16,20,24H,9-14H2	GGUSQTSTQSHJAH-UHFFFAOYSA-N					compound annotation
0391_006686	BMS-911543	C23H28N8O	3.564	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; compound annotation
0391_006687	BMS-911543	C23H28N8O	3.8006	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; compound annotation
0391_006688	Scabertopin	C20H22O6	3.8213	21575211	C/C=C(/C)\C(=O)O[C@H]1CC2=C[C@H](C/C(=C/[C@@H]3[C@@H]1C(=C)C(=O)O3)/C)OC2=O	C=C1C(=O)OC2C=C(C)CC3C=C(CC(OC(=O)C(C)=CC)C12)C(=O)O3	InChI=1S/C20H22O6/c1-5-11(3)18(21)25-16-9-13-8-14(24-20(13)23)6-10(2)7-15-17(16)12(4)19(22)26-15/h5,7-8,14-17H,4,6,9H2,1-3H3/b10-7+,11-5-/t14-,15+,16-,17-/m0/s1	FTPHYXGWMIZVMP-RZYABJHASA-N					removed another duplicate entry; compound annotation
0391_006690	BMS-911543	C23H28N8O	3.893	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; compound annotation
0391_006691	BMS-911543	C23H28N8O	4.0432	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; compound annotation
0391_006692	reparixin	C14H21NO3S	4.2633	9838712	C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)NS(=O)(=O)C	CC(C)Cc1ccc(C(C)C(=O)NS(C)(=O)=O)cc1	InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1	KQDRVXQXKZXMHP-LLVKDONJSA-N					doublet; compound annotation
0391_006693	BMS-911543	C23H28N8O	4.3154	50922691		CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(c(Nc4nn(C)c(C)c4)nc21)ncn3C	InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)	JCINBYQJBYJGDM-UHFFFAOYSA-N					doublet; compound annotation
0391_006694	AZD9496	C25H25F3N2O2	4.7129	86287635	C[C@@H]1CC2=C([C@H](N1CC(C)(C)F)C3=C(C=C(C=C3F)/C=C/C(=O)O)F)NC4=CC=CC=C24	CC1Cc2c([nH]c3ccccc23)C(c2c(F)cc(C=CC(=O)O)cc2F)N1CC(C)(C)F	InChI=1S/C25H25F3N2O2/c1-14-10-17-16-6-4-5-7-20(16)29-23(17)24(30(14)13-25(2,3)28)22-18(26)11-15(12-19(22)27)8-9-21(31)32/h4-9,11-12,14,24,29H,10,13H2,1-3H3,(H,31,32)/b9-8+/t14-,24-/m1/s1	DFBDRVGWBHBJNR-BBNFHIFMSA-N					removed another duplicate entry; compound annotation
0391_006696	Schisantherin A	C30H32O9	4.8139	151529	C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4[C@@H]([C@@]1(C)O)OC(=O)C5=CC=CC=C5)OC)OC)OC)OC)OCO3	COc1c(OC)c(OC)c2c(c1)C(OC(=O)c1ccccc1)C(C)(O)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C30H32O9/c1-16-12-18-13-21-25(38-15-37-21)26(35-5)22(18)23-19(14-20(33-3)24(34-4)27(23)36-6)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1	UFCGDBKFOKKVAC-DSASHONVSA-N					doublet; compound annotation
0391_006697	Schisantherin A	C30H32O9	4.8167	151529	C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4[C@@H]([C@@]1(C)O)OC(=O)C5=CC=CC=C5)OC)OC)OC)OC)OCO3	COc1c(OC)c(OC)c2c(c1)C(OC(=O)c1ccccc1)C(C)(O)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C30H32O9/c1-16-12-18-13-21-25(38-15-37-21)26(35-5)22(18)23-19(14-20(33-3)24(34-4)27(23)36-6)28(30(16,2)32)39-29(31)17-10-8-7-9-11-17/h7-11,13-14,16,28,32H,12,15H2,1-6H3/t16-,28-,30-/m0/s1	UFCGDBKFOKKVAC-DSASHONVSA-N					doublet; compound annotation
0391_006698	Tiplaxtinin	C24H16F3NO4	5.2063	6450819		O=C(O)C(=O)c1cn(Cc2ccccc2)c2c1cc(-c1ccc(OC(F)(F)F)cc1)cc2	InChI=1S/C24H16F3NO4/c25-24(26,27)32-18-9-6-16(7-10-18)17-8-11-21-19(12-17)20(22(29)23(30)31)14-28(21)13-15-4-2-1-3-5-15/h1-12,14H,13H2,(H,30,31)	ODXQFEWQSHNQNI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006700	1,3,5-TRIMETHYLPYRAZOLE	C6H10N2	0.8294	14081		Cc1nn(C)c(C)c1	InChI=1S/C6H10N2/c1-5-4-6(2)8(3)7-5/h4H,1-3H3	HNOQAFMOBRWDKQ-UHFFFAOYSA-N					compound annotation
0391_006701	Phenethylamine	C8H11N	0.8407	1001		NCCc1ccccc1	InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2	BHHGXPLMPWCGHP-UHFFFAOYSA-N					doublet; compound annotation
0391_006702	PKC-iota inhibitor 1	C21H22N6O	1.0957	138377600		Nc1c(C(=O)Nc2ccncc2)cc(-c2cc(N3CCNCC3)ccc2)cn1	InChI=1S/C21H22N6O/c22-20-19(21(28)26-17-4-6-23-7-5-17)13-16(14-25-20)15-2-1-3-18(12-15)27-10-8-24-9-11-27/h1-7,12-14,24H,8-11H2,(H2,22,25)(H,23,26,28)	YDMJAALVMGFGRY-UHFFFAOYSA-N					compound annotation
0391_006703	2-Acetamidophenol	C8H9NO2	1.2978	11972		CC(=O)Nc1ccccc1O	InChI=1S/C8H9NO2/c1-6(10)9-7-4-2-3-5-8(7)11/h2-5,11H,1H3,(H,9,10)	ADVGKWPZRIDURE-UHFFFAOYSA-N					compound annotation
0391_006704	223463-14-7	C5H5BBrNO2	1.6441	2762706		OB(O)c1cnc(Br)cc1	InChI=1S/C5H5BBrNO2/c7-5-2-1-4(3-8-5)6(9)10/h1-3,9-10H	BCYWDUVHAPHGIP-UHFFFAOYSA-N					compound annotation
0391_006705	LESINURAD	C17H14BrN3O2S	3.8587	53465279		O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)	FGQFOYHRJSUHMR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006707	SIAIS178	C50H62ClN11O6S2	3.9599	139474625	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)C(=O)CCCCCCC(=O)N[C@H](C(=O)N5C[C@@H](C[C@H]5C(=O)NCC6=CC=C(C=C6)C7=C(N=CS7)C)O)C(C)(C)C	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(C(=O)CCCCCCC(=O)NC(C(=O)N3CC(O)CC3C(=O)NCc3ccc(-c4c(C)ncs4)cc3)C(C)(C)C)CC2)n1	InChI=1S/C50H62ClN11O6S2/c1-30-12-11-13-36(51)43(30)59-47(67)38-27-53-49(70-38)57-39-25-40(56-32(3)55-39)60-20-22-61(23-21-60)42(65)15-10-8-7-9-14-41(64)58-45(50(4,5)6)48(68)62-28-35(63)24-37(62)46(66)52-26-33-16-18-34(19-17-33)44-31(2)54-29-69-44/h11-13,16-19,25,27,29,35,37,45,63H,7-10,14-15,20-24,26,28H2,1-6H3,(H,52,66)(H,58,64)(H,59,67)(H,53,55,56,57)/t35-,37+,45-/m1/s1	YGQREOJIRFCRKQ-ZIBKGDFVSA-N					removed another duplicate entry; compound annotation
0391_006709	CE-245677	C24H22Cl2N6O3	4.0657	16048643		COc1c(NC(=O)Nc2c(Cl)cc(Cl)cc2)cc(C(=O)c2cn(C(C)C)c3ncnc(N)c23)cc1	InChI=1S/C24H22Cl2N6O3/c1-12(2)32-10-15(20-22(27)28-11-29-23(20)32)21(33)13-4-7-19(35-3)18(8-13)31-24(34)30-17-6-5-14(25)9-16(17)26/h4-12H,1-3H3,(H2,27,28,29)(H2,30,31,34)	VFCRSIORGUNNGT-UHFFFAOYSA-N					compound annotation
0391_006710	schisandrin C	C22H24O6	5.7799	119112		COc1c2c(cc3c1OCO3)CC(C)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C22H24O6/c1-11-5-13-7-15-19(27-9-25-15)21(23-3)17(13)18-14(6-12(11)2)8-16-20(22(18)24-4)28-10-26-16/h7-8,11-12H,5-6,9-10H2,1-4H3	HTBWBWWADZJXID-UHFFFAOYSA-N					doublet; compound annotation
0391_006711	schisandrin C	C22H24O6	5.7852	119112		COc1c2c(cc3c1OCO3)CC(C)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C22H24O6/c1-11-5-13-7-15-19(27-9-25-15)21(23-3)17(13)18-14(6-12(11)2)8-16-20(22(18)24-4)28-10-26-16/h7-8,11-12H,5-6,9-10H2,1-4H3	HTBWBWWADZJXID-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006713	217099-14-4	C27H41N9O8	0.4797	11157853	C1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN=C(N)N)CCCCN)CC2=CC=C(C=C2)O)CC(=O)O	NCCCCC1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC1=O	InChI=1S/C27H41N9O8/c28-10-2-1-4-18-24(42)34-17(5-3-11-31-27(29)30)23(41)32-14-21(38)33-20(13-22(39)40)26(44)36-19(25(43)35-18)12-15-6-8-16(37)9-7-15/h6-9,17-20,37H,1-5,10-14,28H2,(H,32,41)(H,33,38)(H,34,42)(H,35,43)(H,36,44)(H,39,40)(H4,29,30,31)/t17-,18-,19+,20-/m0/s1	LAROZEWEPNAWMD-HAGHYFMRSA-N					compound annotation
0391_006714	AZ1495	C21H31N5O2	0.9161	131839619		c1nc2c(c(C3CCOCC3)c[nH]2)c(NC2CCC(N3CCOCC3)CC2)n1	InChI=1S/C21H31N5O2/c1-3-17(26-7-11-28-12-8-26)4-2-16(1)25-21-19-18(15-5-9-27-10-6-15)13-22-20(19)23-14-24-21/h13-17H,1-12H2,(H2,22,23,24,25)	DJVYXMINSBMUHH-UHFFFAOYSA-N					compound annotation
0391_006715	GR79236	C15H21N5O5	1.1675	9884817	C1C[C@@H]([C@H](C1)O)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NC4CCCC4O)ncnc32)C(O)C1O	InChI=1S/C15H21N5O5/c21-4-9-11(23)12(24)15(25-9)20-6-18-10-13(16-5-17-14(10)20)19-7-2-1-3-8(7)22/h5-9,11-12,15,21-24H,1-4H2,(H,16,17,19)/t7-,8-,9+,11+,12+,15+/m0/s1	GYWXTRVEUURNEW-TVDBPQCTSA-N					removed another duplicate entry; compound annotation
0391_006717	UNC0631	C37H61N7O2	1.2811	53315868		COc1c(OCCCN2CCCCC2)cc2nc(N3CCCN(C(C)C)CC3)nc(NC3CCN(CC4CCCCC4)CC3)c2c1	InChI=1S/C37H61N7O2/c1-29(2)43-19-10-20-44(24-23-43)37-39-33-27-35(46-25-11-18-41-16-8-5-9-17-41)34(45-3)26-32(33)36(40-37)38-31-14-21-42(22-15-31)28-30-12-6-4-7-13-30/h26-27,29-31H,4-25,28H2,1-3H3,(H,38,39,40)	XFAXSWXKPQWHDW-UHFFFAOYSA-N					compound annotation
0391_006718	Diphenyleneiodonium	C12H8I+	1.6707	3101		c1ccc2c(c1)[I+]c1ccccc1-2	InChI=1S/C12H8I/c1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11/h1-8H/q+1	QFXKXRXFBRLLPQ-UHFFFAOYSA-N					compound annotation
0391_006719	Maraviroc	C29H41F2N5O	2.3977	3002977	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)c1ccccc1	InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1	GSNHKUDZZFZSJB-HLMSNRGBSA-N					doublet; compound annotation
0391_006720	Maraviroc	C29H41F2N5O	2.4009	3002977	CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C	Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)c1ccccc1	InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1	GSNHKUDZZFZSJB-HLMSNRGBSA-N					doublet; compound annotation
0391_006721	I-BRD9	C22H22F3N3O3S2	2.9193	91668541		CCn1cc(-c2cc(C(F)(F)F)ccc2)c2c(cc(C(N)=NC3CCS(=O)(=O)CC3)s2)c1=O	InChI=1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27)	WRUWGLUCNBMGPS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006723	Ginsenoside Ro	C48H76O19	3.2523	11815492	C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O	CC1(C)CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(CO)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C48H76O19/c1-43(2)14-16-48(42(61)67-40-35(58)31(54)29(52)24(20-50)63-40)17-15-46(6)21(22(48)18-43)8-9-26-45(5)12-11-27(44(3,4)25(45)10-13-47(26,46)7)64-41-37(33(56)32(55)36(65-41)38(59)60)66-39-34(57)30(53)28(51)23(19-49)62-39/h8,22-37,39-41,49-58H,9-20H2,1-7H3,(H,59,60)/t22-,23+,24+,25-,26+,27-,28+,29+,30-,31-,32-,33-,34+,35+,36-,37+,39-,40-,41+,45-,46+,47+,48-/m0/s1	NFZYDZXHKFHPGA-QQHDHSITSA-N					compound annotation
0391_006724	2095393-15-8	C25H23ClN4O4	3.392	129045720	C1C[C@H](OC[C@@H]1NC2=NC=NC3=C2C(=CN3)C(=O)C4=C(C=C(C=C4)OC5=CC=CC=C5)Cl)CO	O=C(c1c(Cl)cc(Oc2ccccc2)cc1)c1c[nH]c2c1c(NC1CCC(CO)OC1)ncn2	InChI=1S/C25H23ClN4O4/c26-21-10-17(34-16-4-2-1-3-5-16)8-9-19(21)23(32)20-11-27-24-22(20)25(29-14-28-24)30-15-6-7-18(12-31)33-13-15/h1-5,8-11,14-15,18,31H,6-7,12-13H2,(H2,27,28,29,30)/t15-,18+/m1/s1	JSFCZQSJQXFJDS-QAPCUYQASA-N					doublet; compound annotation
0391_006725	2095393-15-8	C25H23ClN4O4	3.7227	129045720	C1C[C@H](OC[C@@H]1NC2=NC=NC3=C2C(=CN3)C(=O)C4=C(C=C(C=C4)OC5=CC=CC=C5)Cl)CO	O=C(c1c(Cl)cc(Oc2ccccc2)cc1)c1c[nH]c2c1c(NC1CCC(CO)OC1)ncn2	InChI=1S/C25H23ClN4O4/c26-21-10-17(34-16-4-2-1-3-5-16)8-9-19(21)23(32)20-11-27-24-22(20)25(29-14-28-24)30-15-6-7-18(12-31)33-13-15/h1-5,8-11,14-15,18,31H,6-7,12-13H2,(H2,27,28,29,30)/t15-,18+/m1/s1	JSFCZQSJQXFJDS-QAPCUYQASA-N					doublet; removed another duplicate entry; compound annotation
0391_006727	GB-88	C32H42N4O4	4.2562	57330164	CC[C@H](C)[C@@H](C(=O)N1CCC2(CC1)C=CC3=CC=CC=C23)NC(=O)[C@H](CC4CCCCC4)NC(=O)C5=CC=NO5	CCC(C)C(NC(=O)C(CC1CCCCC1)NC(=O)c1ccno1)C(=O)N1CCC2(C=Cc3ccccc32)CC1	InChI=1S/C32H42N4O4/c1-3-22(2)28(31(39)36-19-16-32(17-20-36)15-13-24-11-7-8-12-25(24)32)35-29(37)26(21-23-9-5-4-6-10-23)34-30(38)27-14-18-33-40-27/h7-8,11-15,18,22-23,26,28H,3-6,9-10,16-17,19-21H2,1-2H3,(H,34,38)(H,35,37)/t22-,26-,28-/m0/s1	DCUDDCGUKZLQLN-MCOVPRHSSA-N					doublet; compound annotation
0391_006728	GB-88	C32H42N4O4	5.274	57330164	CC[C@H](C)[C@@H](C(=O)N1CCC2(CC1)C=CC3=CC=CC=C23)NC(=O)[C@H](CC4CCCCC4)NC(=O)C5=CC=NO5	CCC(C)C(NC(=O)C(CC1CCCCC1)NC(=O)c1ccno1)C(=O)N1CCC2(C=Cc3ccccc32)CC1	InChI=1S/C32H42N4O4/c1-3-22(2)28(31(39)36-19-16-32(17-20-36)15-13-24-11-7-8-12-25(24)32)35-29(37)26(21-23-9-5-4-6-10-23)34-30(38)27-14-18-33-40-27/h7-8,11-15,18,22-23,26,28H,3-6,9-10,16-17,19-21H2,1-2H3,(H,34,38)(H,35,37)/t22-,26-,28-/m0/s1	DCUDDCGUKZLQLN-MCOVPRHSSA-N					doublet; removed another duplicate entry; compound annotation
0391_006730	Cefodizime	C20H20N6O7S4	2.0376	6321412	CC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CSC12)c1csc(N)n1	InChI=1S/C20H20N6O7S4/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32)/b25-12+/t13-,17-/m1/s1	XDZKBRJLTGRPSS-ZSKFQXOHSA-N					compound annotation
0391_006731	EED226-COOH	C17H13N5O3	2.7627	146047129		O=C(O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1	InChI=1S/C17H13N5O3/c23-16(24)12-5-3-11(4-6-12)14-9-19-17(22-10-20-21-15(14)22)18-8-13-2-1-7-25-13/h1-7,9-10H,8H2,(H,18,19)(H,23,24)	MTAJESLOWNUVMU-UHFFFAOYSA-N					compound annotation
0391_006732	TAURODEOXYCHOLIC ACID	C26H45NO6S	3.5871	2733768	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1	AWDRATDZQPNJFN-VAYUFCLWSA-N					doublet; removed another duplicate entry; compound annotation
0391_006734	PSN632408	C18H24N4O4	3.6687	11462546		CC(C)(C)OC(=O)N1CCC(OCc2nc(-c3ccncc3)no2)CC1	InChI=1S/C18H24N4O4/c1-18(2,3)25-17(23)22-10-6-14(7-11-22)24-12-15-20-16(21-26-15)13-4-8-19-9-5-13/h4-5,8-9,14H,6-7,10-12H2,1-3H3	LHZWKWCEAXQUMX-UHFFFAOYSA-N					doublet; compound annotation
0391_006735	PSN632408	C18H24N4O4	3.6715	11462546		CC(C)(C)OC(=O)N1CCC(OCc2nc(-c3ccncc3)no2)CC1	InChI=1S/C18H24N4O4/c1-18(2,3)25-17(23)22-10-6-14(7-11-22)24-12-15-20-16(21-26-15)13-4-8-19-9-5-13/h4-5,8-9,14H,6-7,10-12H2,1-3H3	LHZWKWCEAXQUMX-UHFFFAOYSA-N					doublet; compound annotation
0391_006736	LY2183240	C17H17N5O	4.2539	11507802		CN(C)C(=O)n1nnnc1Cc1ccc(-c2ccccc2)cc1	InChI=1S/C17H17N5O/c1-21(2)17(23)22-16(18-19-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3	GZNIYOXWFCDBBJ-UHFFFAOYSA-N					compound annotation
0391_006737	4-(6-Bromo-2-benzothiazolyl)benzenamine	C13H9BrN2S	4.6385	10335228		Nc1ccc(-c2nc3c(cc(Br)cc3)s2)cc1	InChI=1S/C13H9BrN2S/c14-9-3-6-11-12(7-9)17-13(16-11)8-1-4-10(15)5-2-8/h1-7H,15H2	WZRRXNJALRCBNH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006739	Carbendazim	C9H9N3O2	1.0586	25429		COC(=O)Nc1nc2ccccc2[nH]1	InChI=1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)	TWFZGCMQGLPBSX-UHFFFAOYSA-N					compound annotation
0391_006740	LML134	C19H29N5O3	1.5054	72948400		Cn1nc(N2CCC(OC(=O)N3CCN(C4CCC4)CC3)CC2)ccc1=O	InChI=1S/C19H29N5O3/c1-21-18(25)6-5-17(20-21)23-9-7-16(8-10-23)27-19(26)24-13-11-22(12-14-24)15-3-2-4-15/h5-6,15-16H,2-4,7-14H2,1H3	BVUJMFFRMZRNAT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006742	GAL-021	C11H22N6O	2.6804	57340959		CCCNc1nc(NCCC)nc(N(C)OC)n1	InChI=1S/C11H22N6O/c1-5-7-12-9-14-10(13-8-6-2)16-11(15-9)17(3)18-4/h5-8H2,1-4H3,(H2,12,13,14,15,16)	FJNLCHNQVJVCPY-UHFFFAOYSA-N					compound annotation
0391_006743	LUT014	C27H19F3N8O	2.9144	138319775		Cc1c(Nc2ncccc2-c2c3[nH]cnc3ncn2)c2c(cc1)c(Nc1cc(OC(F)(F)F)ccc1)ncc2	InChI=1S/C27H19F3N8O/c1-15-7-8-19-18(9-11-32-24(19)37-16-4-2-5-17(12-16)39-27(28,29)30)21(15)38-25-20(6-3-10-31-25)22-23-26(35-13-33-22)36-14-34-23/h2-14H,1H3,(H,31,38)(H,32,37)(H,33,34,35,36)	FZPYULHBUBXPIG-UHFFFAOYSA-N					doublet; compound annotation
0391_006744	LUT014	C27H19F3N8O	3.0293	138319775		Cc1c(Nc2ncccc2-c2c3[nH]cnc3ncn2)c2c(cc1)c(Nc1cc(OC(F)(F)F)ccc1)ncc2	InChI=1S/C27H19F3N8O/c1-15-7-8-19-18(9-11-32-24(19)37-16-4-2-5-17(12-16)39-27(28,29)30)21(15)38-25-20(6-3-10-31-25)22-23-26(35-13-33-22)36-14-34-23/h2-14H,1H3,(H,31,38)(H,32,37)(H,33,34,35,36)	FZPYULHBUBXPIG-UHFFFAOYSA-N					doublet; compound annotation
0391_006745	AZD-8835	C22H31N9O3	3.0952	76685059		CCn1nc(C2CCN(C(=O)CCO)CC2)nc1-c1cnc(N)c(-c2nnc(C(C)(C)C)o2)n1	InChI=1S/C22H31N9O3/c1-5-31-19(26-18(29-31)13-6-9-30(10-7-13)15(33)8-11-32)14-12-24-17(23)16(25-14)20-27-28-21(34-20)22(2,3)4/h12-13,32H,5-11H2,1-4H3,(H2,23,24)	ZGRDYKFVDCFJCZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006747	MCB-3681	C31H32F2N4O8	3.222	11273606	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)OCC3(CCN(CC3)C4=C(C=C5C(=C4)N(C=C(C5=O)C(=O)O)C6CC6)F)O)F	CC(=O)NCC1CN(c2cc(F)c(OCC3(O)CCN(c4c(F)cc5c(=O)c(C(=O)O)cn(C6CC6)c5c4)CC3)cc2)C(=O)O1	InChI=1S/C31H32F2N4O8/c1-17(38)34-13-20-14-37(30(42)45-20)19-4-5-27(24(33)10-19)44-16-31(43)6-8-35(9-7-31)26-12-25-21(11-23(26)32)28(39)22(29(40)41)15-36(25)18-2-3-18/h4-5,10-12,15,18,20,43H,2-3,6-9,13-14,16H2,1H3,(H,34,38)(H,40,41)/t20-/m0/s1	YEDRNPDLVCNIAV-FQEVSTJZSA-N					doublet; compound annotation
0391_006748	BMS-754807	C23H24FN9O	3.2253	24785538	C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F	CC1(C(=O)Nc2cnc(F)cc2)CCCN1c1nn2cccc2c(Nc2n[nH]c(C3CC3)c2)n1	InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	LQVXSNNAFNGRAH-QHCPKHFHSA-N					doublet; compound annotation
0391_006749	MCB-3681	C31H32F2N4O8	3.2253	11273606	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)OCC3(CCN(CC3)C4=C(C=C5C(=C4)N(C=C(C5=O)C(=O)O)C6CC6)F)O)F	CC(=O)NCC1CN(c2cc(F)c(OCC3(O)CCN(c4c(F)cc5c(=O)c(C(=O)O)cn(C6CC6)c5c4)CC3)cc2)C(=O)O1	InChI=1S/C31H32F2N4O8/c1-17(38)34-13-20-14-37(30(42)45-20)19-4-5-27(24(33)10-19)44-16-31(43)6-8-35(9-7-31)26-12-25-21(11-23(26)32)28(39)22(29(40)41)15-36(25)18-2-3-18/h4-5,10-12,15,18,20,43H,2-3,6-9,13-14,16H2,1H3,(H,34,38)(H,40,41)/t20-/m0/s1	YEDRNPDLVCNIAV-FQEVSTJZSA-N					doublet; compound annotation
0391_006750	BMS-754807	C23H24FN9O	3.3219	24785538	C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F	CC1(C(=O)Nc2cnc(F)cc2)CCCN1c1nn2cccc2c(Nc2n[nH]c(C3CC3)c2)n1	InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	LQVXSNNAFNGRAH-QHCPKHFHSA-N					doublet; compound annotation
0391_006751	BMS-754807	C23H24FN9O	3.777	24785538	C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F	CC1(C(=O)Nc2cnc(F)cc2)CCCN1c1nn2cccc2c(Nc2n[nH]c(C3CC3)c2)n1	InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1	LQVXSNNAFNGRAH-QHCPKHFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_006753	329198-87-0	C17H10N2O5	4.5264	2866412		O=C(Nc1cc2c(cc1)c1ccccc1o2)c1ccc([N+](=O)[O-])o1	InChI=1S/C17H10N2O5/c20-17(14-7-8-16(24-14)19(21)22)18-10-5-6-12-11-3-1-2-4-13(11)23-15(12)9-10/h1-9H,(H,18,20)	URUVDCCYSJEGQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_006754	329198-87-0	C17H10N2O5	4.53	2866412		O=C(Nc1cc2c(cc1)c1ccccc1o2)c1ccc([N+](=O)[O-])o1	InChI=1S/C17H10N2O5/c20-17(14-7-8-16(24-14)19(21)22)18-10-5-6-12-11-3-1-2-4-13(11)23-15(12)9-10/h1-9H,(H,18,20)	URUVDCCYSJEGQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_006755	TM38837	C30H25Cl2F3N4OS	6.7505	49779607		CCc1c(-c2ccc(C#Cc3ccc(C(F)(F)F)cc3)s2)n(-c2c(Cl)cc(Cl)cc2)nc1C(=O)NN1CCCCC1	InChI=1S/C30H25Cl2F3N4OS/c1-2-23-27(29(40)37-38-16-4-3-5-17-38)36-39(25-14-11-21(31)18-24(25)32)28(23)26-15-13-22(41-26)12-8-19-6-9-20(10-7-19)30(33,34)35/h6-7,9-11,13-15,18H,2-5,16-17H2,1H3,(H,37,40)	VQOCBFYUDSBDCZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006757	IPTG	C9H18O5S	0.6225	656894	CC(C)S[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	CC(C)SC1OC(CO)C(O)C(O)C1O	InChI=1S/C9H18O5S/c1-4(2)15-9-8(13)7(12)6(11)5(3-10)14-9/h4-13H,3H2,1-2H3/t5-,6+,7+,8-,9+/m1/s1	BPHPUYQFMNQIOC-NXRLNHOXSA-N					compound annotation
0391_006758	4-Azido-L-phenylalanine	C9H10N4O2	1.2406	86306412	C1=CC(=CC=C1C[C@@H](C(=O)[O-])[NH3+])N=[N+]=[N-]	[N-]=[N+]=Nc1ccc(CC(N)C(=O)O)cc1	InChI=1S/C9H10N4O2/c10-8(9(14)15)5-6-1-3-7(4-2-6)12-13-11/h1-4,8H,5,10H2,(H,14,15)/t8-/m0/s1	NEMHIKRLROONTL-QMMMGPOBSA-N					doublet; compound annotation
0391_006759	(rac)-BAY1238097	C25H33N5O3	1.9875	73294353		CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)	CJIPEACKIJJYED-UHFFFAOYSA-N					doublet; compound annotation
0391_006760	(rac)-BAY1238097	C25H33N5O3	1.9908	73294353		CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)	CJIPEACKIJJYED-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006762	Fanapanel	C14H15F3N3O6P	2.0572	208953		O=c1[nH]c2c(cc(N3CCOCC3)c(C(F)(F)F)c2)n(CP(=O)(O)O)c1=O	InChI=1S/C14H15F3N3O6P/c15-14(16,17)8-5-9-11(6-10(8)19-1-3-26-4-2-19)20(7-27(23,24)25)13(22)12(21)18-9/h5-6H,1-4,7H2,(H,18,21)(H2,23,24,25)	WZMQMKNCWDCCMT-UHFFFAOYSA-N					compound annotation
0391_006763	GGTI-2418	C23H31N5O4	2.4991	11539477	CC1=C(N=CN1)CN2CCN([C@H](C2=O)CC3=CC=CC=C3)C(=O)N[C@@H](CC(C)C)C(=O)O	Cc1c(CN2CCN(C(=O)NC(CC(C)C)C(=O)O)C(Cc3ccccc3)C2=O)nc[nH]1	InChI=1S/C23H31N5O4/c1-15(2)11-18(22(30)31)26-23(32)28-10-9-27(13-19-16(3)24-14-25-19)21(29)20(28)12-17-7-5-4-6-8-17/h4-8,14-15,18,20H,9-13H2,1-3H3,(H,24,25)(H,26,32)(H,30,31)/t18-,20-/m0/s1	COLCNDRDBCLVOC-ICSRJNTNSA-N					removed another duplicate entry; compound annotation
0391_006765	CB30865	C26H22BrN5O2	2.5587	135528987		C#CCN(Cc1cc2c(cc1Br)[nH]c(C)nc2=O)c1ccc(C(=O)NCc2cnccc2)cc1	InChI=1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34)	SHNBLWMBWXIKMR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006767	(E/Z)-Endoxifen	C25H27NO2	3.5032	130621		CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3	MHJBZVSGOZTKRH-UHFFFAOYSA-N					doublet; compound annotation
0391_006768	(E/Z)-Endoxifen	C25H27NO2	3.5658	130621		CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3	MHJBZVSGOZTKRH-UHFFFAOYSA-N					doublet; compound annotation
0391_006769	Penthiopyrad	C16H20F3N3OS	4.8281	11388558		CC(C)CC(C)c1c(NC(=O)c2cn(C)nc2C(F)(F)F)ccs1	InChI=1S/C16H20F3N3OS/c1-9(2)7-10(3)13-12(5-6-24-13)20-15(23)11-8-22(4)21-14(11)16(17,18)19/h5-6,8-10H,7H2,1-4H3,(H,20,23)	PFFIDZXUXFLSSR-UHFFFAOYSA-N					doublet; compound annotation
0391_006770	Penthiopyrad	C16H20F3N3OS	4.8316	11388558		CC(C)CC(C)c1c(NC(=O)c2cn(C)nc2C(F)(F)F)ccs1	InChI=1S/C16H20F3N3OS/c1-9(2)7-10(3)13-12(5-6-24-13)20-15(23)11-8-22(4)21-14(11)16(17,18)19/h5-6,8-10H,7H2,1-4H3,(H,20,23)	PFFIDZXUXFLSSR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006772	NSC305787	C25H30Cl2N2O	4.8751	470998		OC(c1cc(C23CC4CC(CC(C4)C2)C3)nc2c1cc(Cl)cc2Cl)C1CCCCN1	InChI=1S/C25H30Cl2N2O/c26-17-8-18-19(24(30)21-3-1-2-4-28-21)10-22(29-23(18)20(27)9-17)25-11-14-5-15(12-25)7-16(6-14)13-25/h8-10,14-16,21,24,28,30H,1-7,11-13H2	YNGQUUFYBFKLNH-UHFFFAOYSA-N					doublet; compound annotation
0391_006773	HYDROQUININE	C20H26N2O2	1.6693	121515	CC[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=C4C=C(C=CC4=NC=C3)OC)O	CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19-,20+/m0/s1	LJOQGZACKSYWCH-WZBLMQSHSA-N					compound annotation
0391_006774	3,4-Dimethoxybenzaldehyde	C9H10O3	2.1808	8419		COc1c(OC)cc(C=O)cc1	InChI=1S/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H3	WJUFSDZVCOTFON-UHFFFAOYSA-N					doublet; compound annotation
0391_006775	Neotame	C20H30N2O5	2.9622	9810996	CC(C)(C)CCN[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NCCC(C)(C)C	InChI=1S/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1	HLIAVLHNDJUHFG-HOTGVXAUSA-N					doublet; compound annotation
0391_006776	Neotame	C20H30N2O5	2.9649	9810996	CC(C)(C)CCN[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC	COC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NCCC(C)(C)C	InChI=1S/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1	HLIAVLHNDJUHFG-HOTGVXAUSA-N					doublet; compound annotation
0391_006777	Monobenzyl phthalate	C15H12O4	3.5005	31736		O=C(O)c1ccccc1C(=O)OCc1ccccc1	InChI=1S/C15H12O4/c16-14(17)12-8-4-5-9-13(12)15(18)19-10-11-6-2-1-3-7-11/h1-9H,10H2,(H,16,17)	XIKIUQUXDNHBFR-UHFFFAOYSA-N					compound annotation
0391_006778	3,4-Dimethoxybenzaldehyde	C9H10O3	4.2873	8419		COc1c(OC)cc(C=O)cc1	InChI=1S/C9H10O3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6H,1-2H3	WJUFSDZVCOTFON-UHFFFAOYSA-N					doublet; compound annotation
0391_006779	CX-6258	C26H24ClN3O3	2.4691	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006780	CX-6258	C26H24ClN3O3	2.5457	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006781	CX-6258	C26H24ClN3O3	2.5672	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006782	Verdiperstat	C11H15N3O2S	2.6097	11528958		CC(C)OCCn1c(=S)[nH]c(=O)c2c1cc[nH]2	InChI=1S/C11H15N3O2S/c1-7(2)16-6-5-14-8-3-4-12-9(8)10(15)13-11(14)17/h3-4,7,12H,5-6H2,1-2H3,(H,13,15,17)	FVJCUZCRPIMVLB-UHFFFAOYSA-N					compound annotation
0391_006783	Acebilustat	C29H27N3O4	2.6641	68488178	C1[C@H]2CN([C@@H]1CN2CC3=CC=C(C=C3)OC4=CC=C(C=C4)C5=NC=CO5)CC6=CC=C(C=C6)C(=O)O	O=C(O)c1ccc(CN2CC3CC2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1	InChI=1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1	GERJIEKMNDGSCS-DQEYMECFSA-N					doublet; compound annotation
0391_006784	Acebilustat	C29H27N3O4	2.7445	68488178	C1[C@H]2CN([C@@H]1CN2CC3=CC=C(C=C3)OC4=CC=C(C=C4)C5=NC=CO5)CC6=CC=C(C=C6)C(=O)O	O=C(O)c1ccc(CN2CC3CC2CN3Cc2ccc(Oc3ccc(-c4ncco4)cc3)cc2)cc1	InChI=1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1	GERJIEKMNDGSCS-DQEYMECFSA-N					doublet; compound annotation
0391_006785	Pulchinenoside C	C59H96O26	2.7445	11636713	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@]45CC[C@H]([C@@H]4[C@H]6CC[C@@H]7[C@]8(CC[C@@H]([C@@]([C@@H]8CC[C@]7([C@@]6(CC5)C)C)(C)CO)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)C)C(=C)C)O)O)O)CO)O)O)O	C=C(C)C1CCC2(C(=O)OC3OC(COC4OC(CO)C(OC5OC(C)C(O)C(O)C5O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(CCC4C5(C)CCC(OC6OCC(O)C(O)C6OC6OC(C)C(O)C(O)C6O)C(C)(CO)C5CCC43C)C12	InChI=1S/C59H96O26/c1-23(2)26-11-16-59(54(75)85-52-45(73)41(69)38(66)30(81-52)21-77-49-46(74)42(70)47(29(19-60)80-49)83-50-43(71)39(67)35(63)24(3)78-50)18-17-57(7)27(34(26)59)9-10-32-55(5)14-13-33(56(6,22-61)31(55)12-15-58(32,57)8)82-53-48(37(65)28(62)20-76-53)84-51-44(72)40(68)36(64)25(4)79-51/h24-53,60-74H,1,9-22H2,2-8H3/t24-,25-,26-,27+,28-,29+,30+,31+,32+,33-,34+,35-,36-,37-,38+,39+,40+,41-,42+,43+,44+,45+,46+,47+,48+,49+,50-,51-,52-,53-,55-,56-,57+,58+,59-/m0/s1	OUHBKBTZUPLIIA-OTEDBJMHSA-N					doublet; removed another duplicate entry; compound annotation
0391_006787	CX-6258	C26H24ClN3O3	2.8134	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; compound annotation
0391_006788	Pulchinenoside C	C59H96O26	2.8287	11636713	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@]45CC[C@H]([C@@H]4[C@H]6CC[C@@H]7[C@]8(CC[C@@H]([C@@]([C@@H]8CC[C@]7([C@@]6(CC5)C)C)(C)CO)O[C@H]9[C@@H]([C@H]([C@H](CO9)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)C)C(=C)C)O)O)O)CO)O)O)O	C=C(C)C1CCC2(C(=O)OC3OC(COC4OC(CO)C(OC5OC(C)C(O)C(O)C5O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(CCC4C5(C)CCC(OC6OCC(O)C(O)C6OC6OC(C)C(O)C(O)C6O)C(C)(CO)C5CCC43C)C12	InChI=1S/C59H96O26/c1-23(2)26-11-16-59(54(75)85-52-45(73)41(69)38(66)30(81-52)21-77-49-46(74)42(70)47(29(19-60)80-49)83-50-43(71)39(67)35(63)24(3)78-50)18-17-57(7)27(34(26)59)9-10-32-55(5)14-13-33(56(6,22-61)31(55)12-15-58(32,57)8)82-53-48(37(65)28(62)20-76-53)84-51-44(72)40(68)36(64)25(4)79-51/h24-53,60-74H,1,9-22H2,2-8H3/t24-,25-,26-,27+,28-,29+,30+,31+,32+,33-,34+,35-,36-,37-,38+,39+,40+,41-,42+,43+,44+,45+,46+,47+,48+,49+,50-,51-,52-,53-,55-,56-,57+,58+,59-/m0/s1	OUHBKBTZUPLIIA-OTEDBJMHSA-N					doublet; removed another duplicate entry; compound annotation
0391_006790	CX-6258	C26H24ClN3O3	3.191	44545852	CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O	CN1CCCN(C(=O)c2cccc(-c3ccc(C=C4C(=O)Nc5ccc(Cl)cc45)o3)c2)CC1	InChI=1S/C26H24ClN3O3/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31)/b22-16+	KGBPLKOPSFDBOX-CJLVFECKSA-N					doublet; removed another duplicate entry; compound annotation
0391_006792	ALW-II-41-27	C32H32F3N5O2S	3.3524	42628503		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(NC(=O)c4cncc(-c5cccs5)c4)c(C)cc3)cc2)CC1	InChI=1S/C32H32F3N5O2S/c1-3-39-10-12-40(13-11-39)20-23-8-9-26(17-27(23)32(33,34)35)37-30(41)22-7-6-21(2)28(16-22)38-31(42)25-15-24(18-36-19-25)29-5-4-14-43-29/h4-9,14-19H,3,10-13,20H2,1-2H3,(H,37,41)(H,38,42)	HYWXBDQAYLPMIX-UHFFFAOYSA-N					doublet; compound annotation
0391_006793	TL02-59	C32H34F3N5O4	3.3983	71254350		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(Oc4ncnc5cc(OC)c(OC)cc45)c(C)cc3)cc2)CC1	InChI=1S/C32H34F3N5O4/c1-5-39-10-12-40(13-11-39)18-22-8-9-23(15-25(22)32(33,34)35)38-30(41)21-7-6-20(2)27(14-21)44-31-24-16-28(42-3)29(43-4)17-26(24)36-19-37-31/h6-9,14-17,19H,5,10-13,18H2,1-4H3,(H,38,41)	AMHWQBGAKJESFB-UHFFFAOYSA-N					compound annotation
0391_006794	ALW-II-41-27	C32H32F3N5O2S	3.4183	42628503		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(NC(=O)c4cncc(-c5cccs5)c4)c(C)cc3)cc2)CC1	InChI=1S/C32H32F3N5O2S/c1-3-39-10-12-40(13-11-39)20-23-8-9-26(17-27(23)32(33,34)35)37-30(41)22-7-6-21(2)28(16-22)38-31(42)25-15-24(18-36-19-25)29-5-4-14-43-29/h4-9,14-19H,3,10-13,20H2,1-2H3,(H,37,41)(H,38,42)	HYWXBDQAYLPMIX-UHFFFAOYSA-N					doublet; compound annotation
0391_006795	NKP608	C31H24ClF6N3O2	4.9718	9917079	C1CN([C@@H](C[C@H]1NC(=O)C2=CC=NC3=CC=CC=C23)CC4=CC=C(C=C4)Cl)C(=O)C5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F	O=C(NC1CCN(C(=O)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(Cc2ccc(Cl)cc2)C1)c1ccnc2ccccc12	InChI=1S/C31H24ClF6N3O2/c32-22-7-5-18(6-8-22)13-24-17-23(40-28(42)26-9-11-39-27-4-2-1-3-25(26)27)10-12-41(24)29(43)19-14-20(30(33,34)35)16-21(15-19)31(36,37)38/h1-9,11,14-16,23-24H,10,12-13,17H2,(H,40,42)/t23-,24+/m0/s1	NXLUTEDAEFXMQR-BJKOFHAPSA-N					compound annotation
0391_006796	Hexythiazox	C17H21ClN2O2S	5.6574	13218777	C[C@H]1[C@@H](SC(=O)N1C(=O)NC2CCCCC2)C3=CC=C(C=C3)Cl	CC1C(c2ccc(Cl)cc2)SC(=O)N1C(=O)NC1CCCCC1	InChI=1S/C17H21ClN2O2S/c1-11-15(12-7-9-13(18)10-8-12)23-17(22)20(11)16(21)19-14-5-3-2-4-6-14/h7-11,14-15H,2-6H2,1H3,(H,19,21)/t11-,15+/m0/s1	XGWIJUOSCAQSSV-XHDPSFHLSA-N					compound annotation
0391_006797	KB0742 2HCl	C16H25N5	0.9545	146502834	CCC(CC)C1=NC2=CC=NN2C(=C1)N[C@H]3CC[C@@H](C3)N	CCC(CC)c1nc2ccnn2c(NC2CCC(N)C2)c1	InChI=1S/C16H25N5/c1-3-11(4-2)14-10-16(19-13-6-5-12(17)9-13)21-15(20-14)7-8-18-21/h7-8,10-13,19H,3-6,9,17H2,1-2H3/t12-,13-/m0/s1	VYKCLMALANGCDF-STQMWFEESA-N					compound annotation
0391_006798	GSK2656157	C23H21FN6O	1.5764	53469059		Cc1nc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)ccc1	InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27)	PRWSIEBRGXYXAJ-UHFFFAOYSA-N					compound annotation
0391_006799	Epiberberine	C20H18NO4+	2.2188	160876		COc1c(OC)cc2c(c1)CC[n+]1c-2cc2ccc3c(OCO3)c2c1	InChI=1S/C20H18NO4/c1-22-18-8-13-5-6-21-10-15-12(3-4-17-20(15)25-11-24-17)7-16(21)14(13)9-19(18)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1	FPJQGFLUORYYPE-UHFFFAOYSA-N					doublet; compound annotation
0391_006800	Selgantolimod	C14H20FN5O	2.463	122585078	CCCC[C@](C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N	CCCCC(C)(CO)Nc1nc(N)nc2c1ncc(F)c2	InChI=1S/C14H20FN5O/c1-3-4-5-14(2,8-21)20-12-11-10(18-13(16)19-12)6-9(15)7-17-11/h6-7,21H,3-5,8H2,1-2H3,(H3,16,18,19,20)/t14-/m1/s1	HTCJUBZBSJQWBW-CQSZACIVSA-N					compound annotation
0391_006801	Chlorsulfaquinoxaline	C14H11ClN4O2S	3.0458	72462		Nc1ccc(S(=O)(=O)Nc2cnc3c(Cl)cccc3n2)cc1	InChI=1S/C14H11ClN4O2S/c15-11-2-1-3-12-14(11)17-8-13(18-12)19-22(20,21)10-6-4-9(16)5-7-10/h1-8H,16H2,(H,18,19)	CTSNHMQGVWXIEG-UHFFFAOYSA-N					compound annotation
0391_006802	nafronyl	C24H33NO3	3.3023	4417		CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1	InChI=1S/C24H33NO3/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3	KBAFPSLPKGSANY-UHFFFAOYSA-N					compound annotation
0391_006803	ON-013100	C19H22O7S	3.567	11269418	COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)O	COc1cc(OC)c(C=CS(=O)(=O)Cc2cc(O)c(OC)cc2)c(OC)c1	InChI=1S/C19H22O7S/c1-23-14-10-18(25-3)15(19(11-14)26-4)7-8-27(21,22)12-13-5-6-17(24-2)16(20)9-13/h5-11,20H,12H2,1-4H3/b8-7+	GHPUSRLWNSTQIK-BQYQJAHWSA-N					removed another duplicate entry; compound annotation
0391_006805	PKG drug G1	C13H11N3OS	2.6164	135402990	CC\1=NC2=CC=CC=C2/C1=C/C3=C(NC(=S)N3)O	CC1=Nc2ccccc2C1=Cc1c(O)[nH]c(=S)[nH]1	InChI=1S/C13H11N3OS/c1-7-9(6-11-12(17)16-13(18)15-11)8-4-2-3-5-10(8)14-7/h2-6,17H,1H3,(H2,15,16,18)/b9-6+	BPJCCABLAZZIEJ-RMKNXTFCSA-N					compound annotation
0391_006806	1-(2-Thiazolylazo)-2-naphthol	C13H9N3OS	2.6202	93572		Oc1c(N=Nc2nccs2)c2ccccc2cc1	InChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8,17H	IOMXCGDXEUDZAK-UHFFFAOYSA-N					doublet; compound annotation
0391_006807	685543-66-2	C22H29N5O8	2.8468	11294791	CCOC(=O)/C=C/C(=O)N(CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1	CCOC(=O)C=CC(=O)N(CC(N)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)OCc1ccccc1	InChI=1S/C22H29N5O8/c1-4-34-19(30)11-10-18(29)27(12-17(23)28)26-21(32)15(3)24-20(31)14(2)25-22(33)35-13-16-8-6-5-7-9-16/h5-11,14-15H,4,12-13H2,1-3H3,(H2,23,28)(H,24,31)(H,25,33)(H,26,32)/b11-10+/t14-,15-/m0/s1	YGVKPQSVBJEMMQ-BWLFODOESA-N					removed another duplicate entry; compound annotation
0391_006809	1-(2-Thiazolylazo)-2-naphthol	C13H9N3OS	3.3979	93572		Oc1c(N=Nc2nccs2)c2ccccc2cc1	InChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8,17H	IOMXCGDXEUDZAK-UHFFFAOYSA-N					doublet; compound annotation
0391_006810	tolmetin	C15H15NO3	3.4817	5509		Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1	InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)	UPSPUYADGBWSHF-UHFFFAOYSA-N					doublet; compound annotation
0391_006811	314054-00-7	C11H7IN2O4	4.1777	1103958		O=C(Nc1ccc(I)cc1)c1ccc([N+](=O)[O-])o1	InChI=1S/C11H7IN2O4/c12-7-1-3-8(4-2-7)13-11(15)9-5-6-10(18-9)14(16)17/h1-6H,(H,13,15)	JBIKQXOZLBLMKI-UHFFFAOYSA-N					compound annotation
0391_006812	1-(2-Thiazolylazo)-2-naphthol	C13H9N3OS	4.6078	93572		Oc1c(N=Nc2nccs2)c2ccccc2cc1	InChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8,17H	IOMXCGDXEUDZAK-UHFFFAOYSA-N					doublet; compound annotation
0391_006813	DAMGO	C26H35N5O6	1.6948	5462471	C[C@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N	CC(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)C(Cc1ccccc1)C(=O)NCCO	InChI=1S/C26H35N5O6/c1-17(30-25(36)21(27)14-19-8-10-20(33)11-9-19)24(35)29-16-23(34)31(2)22(26(37)28-12-13-32)15-18-6-4-3-5-7-18/h3-11,17,21-22,32-33H,12-16,27H2,1-2H3,(H,28,37)(H,29,35)(H,30,36)/t17-,21+,22+/m1/s1	HPZJMUBDEAMBFI-WTNAPCKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_006815	Eriocitrin	C27H32O15	1.8223	83489	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(c5cc(O)c(O)cc5)Oc4c3)C(O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H32O15/c1-9-20(32)22(34)24(36)26(39-9)38-8-18-21(33)23(35)25(37)27(42-18)40-11-5-14(30)19-15(31)7-16(41-17(19)6-11)10-2-3-12(28)13(29)4-10/h2-6,9,16,18,20-30,32-37H,7-8H2,1H3/t9-,16-,18+,20-,21+,22+,23-,24+,25+,26+,27+/m0/s1	OMQADRGFMLGFJF-MNPJBKLOSA-N					doublet; compound annotation
0391_006816	Eriocitrin	C27H32O15	1.8256	83489	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3cc(O)c4C(=O)CC(c5cc(O)c(O)cc5)Oc4c3)C(O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H32O15/c1-9-20(32)22(34)24(36)26(39-9)38-8-18-21(33)23(35)25(37)27(42-18)40-11-5-14(30)19-15(31)7-16(41-17(19)6-11)10-2-3-12(28)13(29)4-10/h2-6,9,16,18,20-30,32-37H,7-8H2,1H3/t9-,16-,18+,20-,21+,22+,23-,24+,25+,26+,27+/m0/s1	OMQADRGFMLGFJF-MNPJBKLOSA-N					doublet; compound annotation
0391_006817	64963-01-5	C29H39N5O7	2.2553	10099522	C[C@H](C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C(C)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)O	InChI=1S/C29H39N5O7/c1-17(2)13-24(29(40)41)34-28(39)23(15-19-7-5-4-6-8-19)33-25(36)16-31-26(37)18(3)32-27(38)22(30)14-20-9-11-21(35)12-10-20/h4-12,17-18,22-24,35H,13-16,30H2,1-3H3,(H,31,37)(H,32,38)(H,33,36)(H,34,39)(H,40,41)/t18-,22+,23+,24+/m1/s1	ZHUJMSMQIPIPTF-JMBSJVKXSA-N					removed another duplicate entry; compound annotation
0391_006819	Endomorphin 1	C34H38N6O5	2.4234	5311080	C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N	NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C1CCCN1C(=O)C(N)Cc1ccc(O)cc1	InChI=1S/C34H38N6O5/c35-26(17-22-12-14-24(41)15-13-22)34(45)40-16-6-11-30(40)33(44)39-29(19-23-20-37-27-10-5-4-9-25(23)27)32(43)38-28(31(36)42)18-21-7-2-1-3-8-21/h1-5,7-10,12-15,20,26,28-30,37,41H,6,11,16-19,35H2,(H2,36,42)(H,38,43)(H,39,44)/t26-,28-,29-,30-/m0/s1	ZEXLJFNSKAHNFH-SYKYGTKKSA-N					removed another duplicate entry; compound annotation
0391_006821	4'-Hydroxychalcone	C15H12O2	3.4964	5282362	C1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(C=C2)O	O=C(C=Cc1ccccc1)c1ccc(O)cc1	InChI=1S/C15H12O2/c16-14-9-7-13(8-10-14)15(17)11-6-12-4-2-1-3-5-12/h1-11,16H/b11-6+	UAHGNXFYLAJDIN-IZZDOVSWSA-N					doublet; compound annotation
0391_006822	Xanthoxylin	C10H12O4	3.6564	66654		COc1cc(O)c(C(C)=O)c(OC)c1	InChI=1S/C10H12O4/c1-6(11)10-8(12)4-7(13-2)5-9(10)14-3/h4-5,12H,1-3H3	FBUBVLUPUDBFME-UHFFFAOYSA-N					compound annotation
0391_006823	4'-Hydroxychalcone	C15H12O2	3.6961	5282362	C1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(C=C2)O	O=C(C=Cc1ccccc1)c1ccc(O)cc1	InChI=1S/C15H12O2/c16-14-9-7-13(8-10-14)15(17)11-6-12-4-2-1-3-5-12/h1-11,16H/b11-6+	UAHGNXFYLAJDIN-IZZDOVSWSA-N					doublet; compound annotation
0391_006824	Neobavaisoflavone	C20H18O4	3.8668	5320053		CC(C)=CCc1c(O)ccc(-c2coc3c(ccc(O)c3)c2=O)c1	InChI=1S/C20H18O4/c1-12(2)3-4-14-9-13(5-8-18(14)22)17-11-24-19-10-15(21)6-7-16(19)20(17)23/h3,5-11,21-22H,4H2,1-2H3	OBGPEBYHGIUFBN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006826	GLYCOCHENODEOXYCHOLIC ACID	C26H43NO5	3.8795	12544	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1	GHCZAUBVMUEKKP-GYPHWSFCSA-N					doublet; compound annotation
0391_006827	GLYCOCHENODEOXYCHOLIC ACID	C26H43NO5	3.8844	12544	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1	GHCZAUBVMUEKKP-GYPHWSFCSA-N					doublet; compound annotation
0391_006828	Schizandrin A	C24H32O6	5.3929	155256	C[C@@H]1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3C[C@@H]1C)OC)OC)OC)OC)OC)OC	COc1c(OC)c(OC)c2c(c1)CC(C)C(C)Cc1cc(OC)c(OC)c(OC)c1-2	InChI=1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3/t13-,14+	JEJFTTRHGBKKEI-OKILXGFUSA-N					removed another duplicate entry; compound annotation
0391_006831	Aloesin	C19H22O9	1.1941	160190	CC1=CC(=C(C2=C1C(=O)C=C(O2)CC(=O)C)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O	CC(=O)Cc1cc(=O)c2c(o1)c(C1OC(CO)C(O)C(O)C1O)c(O)cc2C	InChI=1S/C19H22O9/c1-7-3-10(22)14(19-17(26)16(25)15(24)12(6-20)28-19)18-13(7)11(23)5-9(27-18)4-8(2)21/h3,5,12,15-17,19-20,22,24-26H,4,6H2,1-2H3/t12-,15-,16+,17-,19+/m1/s1	HKIKAXXIWJHWLY-ZIIYPAMZSA-N					removed another duplicate entry; compound annotation
0391_006833	1270014-40-8	C19H21ClN6O	2.6762	50924632		O=C(CNc1cc(Cl)ccc1)NC1CCCN(c2ncnc3c2cc[nH]3)C1	InChI=1S/C19H21ClN6O/c20-13-3-1-4-14(9-13)22-10-17(27)25-15-5-2-8-26(11-15)19-16-6-7-21-18(16)23-12-24-19/h1,3-4,6-7,9,12,15,22H,2,5,8,10-11H2,(H,25,27)(H,21,23,24)	SPSNKQVUYDXOGY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006835	ML264	C17H21ClN2O4S	2.898	51003603	CN(C1CCS(=O)(=O)CC1)C(=O)CNC(=O)/C=C/C2=CC(=CC=C2)Cl	CN(C(=O)CNC(=O)C=Cc1cc(Cl)ccc1)C1CCS(=O)(=O)CC1	InChI=1S/C17H21ClN2O4S/c1-20(15-7-9-25(23,24)10-8-15)17(22)12-19-16(21)6-5-13-3-2-4-14(18)11-13/h2-6,11,15H,7-10,12H2,1H3,(H,19,21)/b6-5+	AJCDZIDKYKCOMZ-AATRIKPKSA-N					removed another duplicate entry; compound annotation
0391_006837	AX-024	C21H22FNO2	3.0411	56949412		COc1cc2c(cc1)OCC(CN1CCCC1)=C2c1ccc(F)cc1	InChI=1S/C21H22FNO2/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23/h4-9,12H,2-3,10-11,13-14H2,1H3	VMMKGVRPILDZML-UHFFFAOYSA-N					doublet; compound annotation
0391_006838	Aldose reductase-IN-1	C17H10F3N5O3S	3.2837	56639723		O=C(O)Cc1nn(Cc2nc3c(ccc(C(F)(F)F)c3)s2)c(=O)c2nccnc12	InChI=1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27)	YRGPAXAVTDMKDK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006840	Fedovapagon	C27H34N4O3	3.3689	10298385	CC1=C(C=CC(=C1)C(=O)N2CCCCC3=CC=CC=C32)CNC(=O)N4CCC[C@H]4C(=O)N(C)C	Cc1c(CNC(=O)N2CCCC2C(=O)N(C)C)ccc(C(=O)N2CCCCc3ccccc32)c1	InChI=1S/C27H34N4O3/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(34)31-16-8-12-24(31)26(33)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,34)/t24-/m0/s1	RUOLFWZIFNQQGH-DEOSSOPVSA-N					removed another duplicate entry; compound annotation
0391_006842	Rbin-1	C13H12N4S	3.6695	5731061		C=C(C)CSc1nc2c(nn1)c1ccccc1[nH]2	InChI=1S/C13H12N4S/c1-8(2)7-18-13-15-12-11(16-17-13)9-5-3-4-6-10(9)14-12/h3-6H,1,7H2,2H3,(H,14,15,17)	LPCWHNSRTRBKBO-UHFFFAOYSA-N					compound annotation
0391_006843	Vercirnon	C22H21ClN2O4S	4.259	10343454		CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3	JRWROCIMSDXGOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006844	TM5441	C21H17ClN2O6	4.2618	44250349		O=C(COCC(=O)Nc1c(C(=O)O)cc(Cl)cc1)Nc1cccc(-c2cocc2)c1	InChI=1S/C21H17ClN2O6/c22-15-4-5-18(17(9-15)21(27)28)24-20(26)12-30-11-19(25)23-16-3-1-2-13(8-16)14-6-7-29-10-14/h1-10H,11-12H2,(H,23,25)(H,24,26)(H,27,28)	BGGMLMAPVODXAU-UHFFFAOYSA-N					compound annotation
0391_006845	Vercirnon	C22H21ClN2O4S	4.2618	10343454		CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3	JRWROCIMSDXGOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006846	Semaxanib	C15H14N2O	4.4998	5329098	CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C	Cc1cc(C)c(C=C2C(=O)Nc3ccccc23)[nH]1	InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-	WUWDLXZGHZSWQZ-WQLSENKSSA-N					removed another duplicate entry; compound annotation
0391_006848	Golvatinib	C33H37F2N7O4	2.5571	16118392		CN1CCN(C2CCN(C(=O)Nc3nccc(Oc4cc(F)c(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4)c3)CC2)CC1	InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)	UQRCJCNVNUFYDX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006850	WNK-IN-11	C21H21Cl2N5OS	2.6179	133080583		CNc1nc(-c2ncc(Cl)c(C(=O)N3CCN(Cc4ccc(Cl)cc4)CC3)c2)cs1	InChI=1S/C21H21Cl2N5OS/c1-24-21-26-19(13-30-21)18-10-16(17(23)11-25-18)20(29)28-8-6-27(7-9-28)12-14-2-4-15(22)5-3-14/h2-5,10-11,13H,6-9,12H2,1H3,(H,24,26)	MVXAYIXYYOVALX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006852	CTS-1027	C19H20ClNO6S	3.4864	3342298		O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1	InChI=1S/C19H20ClNO6S/c20-14-1-3-15(4-2-14)27-16-5-7-17(8-6-16)28(24,25)13-19(18(22)21-23)9-11-26-12-10-19/h1-8,23H,9-13H2,(H,21,22)	ROSNVSQTEGHUKU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006854	Metarrestin	C31H30N4O	3.7644	50985821		N=c1c2c(ncn1C1CCC(O)CC1)n(Cc1ccccc1)c(-c1ccccc1)c2-c1ccccc1	InChI=1S/C31H30N4O/c32-30-28-27(23-12-6-2-7-13-23)29(24-14-8-3-9-15-24)34(20-22-10-4-1-5-11-22)31(28)33-21-35(30)25-16-18-26(36)19-17-25/h1-15,21,25-26,32,36H,16-20H2	WSMXAUJFLWRPNT-UHFFFAOYSA-N					doublet; compound annotation
0391_006855	BPTES	C24H24N6O2S3	3.9067	3372016		O=C(Cc1ccccc1)Nc1nnc(CCSCCc2nnc(NC(=O)Cc3ccccc3)s2)s1	InChI=1S/C24H24N6O2S3/c31-19(15-17-7-3-1-4-8-17)25-23-29-27-21(34-23)11-13-33-14-12-22-28-30-24(35-22)26-20(32)16-18-9-5-2-6-10-18/h1-10H,11-16H2,(H,25,29,31)(H,26,30,32)	MDJIPXYRSZHCFS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006857	Metarrestin	C31H30N4O	4.092	50985821		N=c1c2c(ncn1C1CCC(O)CC1)n(Cc1ccccc1)c(-c1ccccc1)c2-c1ccccc1	InChI=1S/C31H30N4O/c32-30-28-27(23-12-6-2-7-13-23)29(24-14-8-3-9-15-24)34(20-22-10-4-1-5-11-22)31(28)33-21-35(30)25-16-18-26(36)19-17-25/h1-15,21,25-26,32,36H,16-20H2	WSMXAUJFLWRPNT-UHFFFAOYSA-N					doublet; compound annotation
0391_006858	Metarrestin	C31H30N4O	4.7495	50985821		N=c1c2c(ncn1C1CCC(O)CC1)n(Cc1ccccc1)c(-c1ccccc1)c2-c1ccccc1	InChI=1S/C31H30N4O/c32-30-28-27(23-12-6-2-7-13-23)29(24-14-8-3-9-15-24)34(20-22-10-4-1-5-11-22)31(28)33-21-35(30)25-16-18-26(36)19-17-25/h1-15,21,25-26,32,36H,16-20H2	WSMXAUJFLWRPNT-UHFFFAOYSA-N					doublet; compound annotation
0391_006859	4-Nitro-1-trityl-1H-imidazole	C22H17N3O2	4.9666	618227		O=[N+]([O-])c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1	InChI=1S/C22H17N3O2/c26-25(27)21-16-24(17-23-21)22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-17H	MUQGVERJAKANJN-UHFFFAOYSA-N					compound annotation
0391_006860	4E1RCat	C28H18N2O6	5.0589	78357788	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(O3)C4=CC=C(C=C4)[N+](=O)[O-])/C(=O)N2C5=CC=C(C=C5)C(=O)O	O=C(O)c1ccc(N2C(=O)C(=Cc3ccc(-c4ccc([N+](=O)[O-])cc4)o3)C=C2c2ccccc2)cc1	InChI=1S/C28H18N2O6/c31-27-21(16-24-14-15-26(36-24)19-6-12-23(13-7-19)30(34)35)17-25(18-4-2-1-3-5-18)29(27)22-10-8-20(9-11-22)28(32)33/h1-17H,(H,32,33)/b21-16-	BBQRBOIMSKMFFO-PGMHBOJBSA-N					doublet; compound annotation
0391_006861	4E1RCat	C28H18N2O6	5.0623	78357788	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(O3)C4=CC=C(C=C4)[N+](=O)[O-])/C(=O)N2C5=CC=C(C=C5)C(=O)O	O=C(O)c1ccc(N2C(=O)C(=Cc3ccc(-c4ccc([N+](=O)[O-])cc4)o3)C=C2c2ccccc2)cc1	InChI=1S/C28H18N2O6/c31-27-21(16-24-14-15-26(36-24)19-6-12-23(13-7-19)30(34)35)17-25(18-4-2-1-3-5-18)29(27)22-10-8-20(9-11-22)28(32)33/h1-17H,(H,32,33)/b21-16-	BBQRBOIMSKMFFO-PGMHBOJBSA-N					doublet; compound annotation
0391_006862	4E1RCat	C28H18N2O6	5.4993	78357788	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(O3)C4=CC=C(C=C4)[N+](=O)[O-])/C(=O)N2C5=CC=C(C=C5)C(=O)O	O=C(O)c1ccc(N2C(=O)C(=Cc3ccc(-c4ccc([N+](=O)[O-])cc4)o3)C=C2c2ccccc2)cc1	InChI=1S/C28H18N2O6/c31-27-21(16-24-14-15-26(36-24)19-6-12-23(13-7-19)30(34)35)17-25(18-4-2-1-3-5-18)29(27)22-10-8-20(9-11-22)28(32)33/h1-17H,(H,32,33)/b21-16-	BBQRBOIMSKMFFO-PGMHBOJBSA-N					doublet; compound annotation
0391_006863	Dianemycin	C47H78O14	6.4862	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_006864	Dianemycin	C47H78O14	6.614	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_006865	Dianemycin	C47H78O14	6.7566	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_006866	Dianemycin	C47H78O14	7.3013	86278938	C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@]3(O2)[C@@H]([C@H](C[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)C)O)C)O[C@@H]6CC[C@@H]([C@H](O6)C)OC)C)C)(CO)O)C	COC1CCC(OC2CC(C3(C)CCC4(CC(O)C(C)C(C(C)C=C(C)C(=O)C(C)CC(C)C(=O)O)O4)O3)OC3(OC(C4OC(O)(CO)C(C)CC4C)CC3C)C2C)OC1C	InChI=1S/C47H78O14/c1-24(40(50)25(2)18-28(5)43(51)52)17-26(3)41-31(8)34(49)22-45(59-41)16-15-44(11,61-45)38-21-36(56-39-14-13-35(54-12)33(10)55-39)32(9)47(58-38)30(7)20-37(57-47)42-27(4)19-29(6)46(53,23-48)60-42/h17,25-39,41-42,48-49,53H,13-16,18-23H2,1-12H3,(H,51,52)/b24-17+/t25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35+,36+,37-,38-,39-,41-,42+,44+,45-,46+,47+/m1/s1	FELYAZAWTURXNF-KWJIWYEDSA-N					doublet; compound annotation
0391_006867	445430-58-0	C14H17N5	1.943	9813758		Cc1cc2c(cc1)nc(NCCN)c1ncc(C)n12	InChI=1S/C14H17N5/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18)	PSPFQEBFYXJZEV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006869	Olcegepant	C38H47Br2N9O5	2.2563	6918509	C1CN(CCC1N2CC3=CC=CC=C3NC2=O)C(=O)N[C@H](CC4=CC(=C(C(=C4)Br)O)Br)C(=O)N[C@@H](CCCCN)C(=O)N5CCN(CC5)C6=CC=NC=C6	NCCCCC(NC(=O)C(Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1	InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1	ITIXDWVDFFXNEG-JHOUSYSJSA-N					doublet; compound annotation
0391_006870	Olcegepant	C38H47Br2N9O5	2.2596	6918509	C1CN(CCC1N2CC3=CC=CC=C3NC2=O)C(=O)N[C@H](CC4=CC(=C(C(=C4)Br)O)Br)C(=O)N[C@@H](CCCCN)C(=O)N5CCN(CC5)C6=CC=NC=C6	NCCCCC(NC(=O)C(Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(N2Cc3ccccc3NC2=O)CC1)C(=O)N1CCN(c2ccncc2)CC1	InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1	ITIXDWVDFFXNEG-JHOUSYSJSA-N					doublet; compound annotation
0391_006871	Cyt387	C23H22N6O2	2.7028	25062766		N#CCNC(=O)c1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)cc1	InChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)	ZVHNDZWQTBEVRY-UHFFFAOYSA-N					doublet; compound annotation
0391_006872	Golgicide A	C17H14F2N2	2.9626	25113626	C1C=C[C@H]2[C@@H]1C(NC3=C2C=C(C=C3F)F)C4=CN=CC=C4	Fc1cc2c(NC(c3cnccc3)C3CC=CC23)c(F)c1	InChI=1S/C17H14F2N2/c18-11-7-14-12-4-1-5-13(12)16(10-3-2-6-20-9-10)21-17(14)15(19)8-11/h1-4,6-9,12-13,16,21H,5H2/t12-,13+,16?/m0/s1	NJZHEQOUHLZCOX-FTLRAWMYSA-N					doublet; compound annotation
0391_006873	Golgicide A	C17H14F2N2	3.0715	25113626	C1C=C[C@H]2[C@@H]1C(NC3=C2C=C(C=C3F)F)C4=CN=CC=C4	Fc1cc2c(NC(c3cnccc3)C3CC=CC23)c(F)c1	InChI=1S/C17H14F2N2/c18-11-7-14-12-4-1-5-13(12)16(10-3-2-6-20-9-10)21-17(14)15(19)8-11/h1-4,6-9,12-13,16,21H,5H2/t12-,13+,16?/m0/s1	NJZHEQOUHLZCOX-FTLRAWMYSA-N					doublet; compound annotation
0391_006874	Prinaberel	C15H10FNO3	3.3352	656954		C=Cc1c2oc(-c3cc(F)c(O)cc3)nc2cc(O)c1	InChI=1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2	MQIMZDXIAHJKQP-UHFFFAOYSA-N					doublet; compound annotation
0391_006875	Prinaberel	C15H10FNO3	3.6951	656954		C=Cc1c2oc(-c3cc(F)c(O)cc3)nc2cc(O)c1	InChI=1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2	MQIMZDXIAHJKQP-UHFFFAOYSA-N					doublet; compound annotation
0391_006876	Vanoxerine	C28H32F2N2O	3.7782	3455		Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1	InChI=1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2	NAUWTFJOPJWYOT-UHFFFAOYSA-N					compound annotation
0391_006877	Navitoclax	C47H55ClF3N5O6S3	4.0588	24978538	CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cc(S(=O)(=O)C(F)(F)F)c(NC(CCN5CCOCC5)CSc5ccccc5)cc4)cc3)CC2)C1	InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1	JLYAXFNOILIKPP-KXQOOQHDSA-N					compound annotation
0391_006878	Velneperit	C17H24F3N3O3S	4.0773	20629114		CC(C)(C)S(=O)(=O)NC1CCC(C(=O)Nc2ncc(C(F)(F)F)cc2)CC1	InChI=1S/C17H24F3N3O3S/c1-16(2,3)27(25,26)23-13-7-4-11(5-8-13)15(24)22-14-9-6-12(10-21-14)17(18,19)20/h6,9-11,13,23H,4-5,7-8H2,1-3H3,(H,21,22,24)	WGEWUYACXPEFPO-UHFFFAOYSA-N					compound annotation
0391_006879	10074-G5	C18H12N4O3	4.6633	2836600		O=[N+]([O-])c1ccc(Nc2ccccc2-c2ccccc2)c2nonc12	InChI=1S/C18H12N4O3/c23-22(24)16-11-10-15(17-18(16)21-25-20-17)19-14-9-5-4-8-13(14)12-6-2-1-3-7-12/h1-11,19H	KMJPYSQOCBYMCF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006882	1607837-31-9	C21H23ClN6O	1.8273	74222277		Cn1ncc2c1ccc(-c1cnc(N)c(Cl)c1N1CCC3(CCNC3=O)CC1)c2	InChI=1S/C21H23ClN6O/c1-27-16-3-2-13(10-14(16)11-26-27)15-12-25-19(23)17(22)18(15)28-8-5-21(6-9-28)4-7-24-20(21)29/h2-3,10-12H,4-9H2,1H3,(H2,23,25)(H,24,29)	VPJXPDLMACOGIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006883	1607837-31-9	C21H23ClN6O	1.8823	74222277		Cn1ncc2c1ccc(-c1cnc(N)c(Cl)c1N1CCC3(CCNC3=O)CC1)c2	InChI=1S/C21H23ClN6O/c1-27-16-3-2-13(10-14(16)11-26-27)15-12-25-19(23)17(22)18(15)28-8-5-21(6-9-28)4-7-24-20(21)29/h2-3,10-12H,4-9H2,1H3,(H2,23,25)(H,24,29)	VPJXPDLMACOGIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006884	1607837-31-9	C21H23ClN6O	1.8872	74222277		Cn1ncc2c1ccc(-c1cnc(N)c(Cl)c1N1CCC3(CCNC3=O)CC1)c2	InChI=1S/C21H23ClN6O/c1-27-16-3-2-13(10-14(16)11-26-27)15-12-25-19(23)17(22)18(15)28-8-5-21(6-9-28)4-7-24-20(21)29/h2-3,10-12H,4-9H2,1H3,(H2,23,25)(H,24,29)	VPJXPDLMACOGIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006885	Givinostat	C24H27N3O4	2.0336	9804992		CCN(CC)Cc1cc2c(cc1)cc(COC(=O)Nc1ccc(C(=O)NO)cc1)cc2	InChI=1S/C24H27N3O4/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28)	YALNUENQHAQXEA-UHFFFAOYSA-N					doublet; compound annotation
0391_006886	1607837-31-9	C21H23ClN6O	2.0369	74222277		Cn1ncc2c1ccc(-c1cnc(N)c(Cl)c1N1CCC3(CCNC3=O)CC1)c2	InChI=1S/C21H23ClN6O/c1-27-16-3-2-13(10-14(16)11-26-27)15-12-25-19(23)17(22)18(15)28-8-5-21(6-9-28)4-7-24-20(21)29/h2-3,10-12H,4-9H2,1H3,(H2,23,25)(H,24,29)	VPJXPDLMACOGIZ-UHFFFAOYSA-N					doublet; compound annotation
0391_006887	Givinostat	C24H27N3O4	2.0369	9804992		CCN(CC)Cc1cc2c(cc1)cc(COC(=O)Nc1ccc(C(=O)NO)cc1)cc2	InChI=1S/C24H27N3O4/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28)	YALNUENQHAQXEA-UHFFFAOYSA-N					doublet; compound annotation
0391_006888	3-(benzo[d][1,3]dioxol-5-yl)-5-((1-cyclobutylpiperidin-4-yl)methyl)-1,2,4-oxadiazole	C19H23N3O3	2.4475	71664257		c1cc2c(cc1-c1noc(CC3CCN(C4CCC4)CC3)n1)OCO2	InChI=1S/C19H23N3O3/c1-2-15(3-1)22-8-6-13(7-9-22)10-18-20-19(21-25-18)14-4-5-16-17(11-14)24-12-23-16/h4-5,11,13,15H,1-3,6-10,12H2	ATGQONNRRWKPGJ-UHFFFAOYSA-N					compound annotation
0391_006889	WZ4002	C25H27ClN6O3	2.6564	44607530		C=CC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30)	ITTRLTNMFYIYPA-UHFFFAOYSA-N					doublet; compound annotation
0391_006890	702675-74-9	C23H26IN7O2S	2.6564	10077147		O=C(NCCCNc1nc(Nc2cc(NC(=O)N3CCCC3)ccc2)ncc1I)c1cccs1	InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)	VAVXGGRQQJZYBL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006892	702675-74-9	C23H26IN7O2S	3.0523	10077147		O=C(NCCCNc1nc(Nc2cc(NC(=O)N3CCCC3)ccc2)ncc1I)c1cccs1	InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)	VAVXGGRQQJZYBL-UHFFFAOYSA-N					doublet; compound annotation
0391_006893	WZ4002	C25H27ClN6O3	3.1673	44607530		C=CC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30)	ITTRLTNMFYIYPA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006896	WZ4002	C25H27ClN6O3	3.2668	44607530		C=CC(=O)Nc1cc(Oc2nc(Nc3c(OC)cc(N4CCN(C)CC4)cc3)ncc2Cl)ccc1	InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30)	ITTRLTNMFYIYPA-UHFFFAOYSA-N					doublet; compound annotation
0391_006897	YU238259	C22H22ClN3O4S	3.4876	121473004		COc1ccc(S(=O)(=O)NCc2ccc(C(=O)NCCc3ncc(Cl)cc3)cc2)cc1	InChI=1S/C22H22ClN3O4S/c1-30-20-8-10-21(11-9-20)31(28,29)26-14-16-2-4-17(5-3-16)22(27)24-13-12-19-7-6-18(23)15-25-19/h2-11,15,26H,12-14H2,1H3,(H,24,27)	BIHURSOREGLQBB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006899	Ciliobrevin A	C17H9Cl2N3O2	4.0394	135535957	C1=CC=C2C(=C1)C(=O)NC(=N2)/C(=C(/C3=C(C=C(C=C3)Cl)Cl)\O)/C#N	N#CC(=C(O)c1c(Cl)cc(Cl)cc1)c1nc2ccccc2c(=O)[nH]1	InChI=1S/C17H9Cl2N3O2/c18-9-5-6-10(13(19)7-9)15(23)12(8-20)16-21-14-4-2-1-3-11(14)17(24)22-16/h1-7,23H,(H,21,22,24)/b15-12-	UEZZGQDPOFILFH-QINSGFPZSA-N					compound annotation
0391_006900	PF-04418948	C23H20FNO5	4.0474	25114442		COc1cc2c(cc1)cc(OCC1(C(=O)O)CN(C(=O)c3ccc(F)cc3)C1)cc2	InChI=1S/C23H20FNO5/c1-29-19-8-4-17-11-20(9-5-16(17)10-19)30-14-23(22(27)28)12-25(13-23)21(26)15-2-6-18(24)7-3-15/h2-11H,12-14H2,1H3,(H,27,28)	LWJGMYMNSNVCEM-UHFFFAOYSA-N					doublet; compound annotation
0391_006901	PF-04418948	C23H20FNO5	4.0524	25114442		COc1cc2c(cc1)cc(OCC1(C(=O)O)CN(C(=O)c3ccc(F)cc3)C1)cc2	InChI=1S/C23H20FNO5/c1-29-19-8-4-17-11-20(9-5-16(17)10-19)30-14-23(22(27)28)12-25(13-23)21(26)15-2-6-18(24)7-3-15/h2-11H,12-14H2,1H3,(H,27,28)	LWJGMYMNSNVCEM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006903	2126040-21-7	C18H21ClFN3O	4.142	146014436		Cc1nn(C2CCCCC2)c(NC(=O)Cc2cc(Cl)c(F)cc2)c1	InChI=1S/C18H21ClFN3O/c1-12-9-17(23(22-12)14-5-3-2-4-6-14)21-18(24)11-13-7-8-16(20)15(19)10-13/h7-10,14H,2-6,11H2,1H3,(H,21,24)	HNJJARDABGKWSO-UHFFFAOYSA-N					compound annotation
0391_006904	927871-76-9	C11H15NOS	1.6017	24763624		COc1cc2c(cc1)SCCN(C)C2	InChI=1S/C11H15NOS/c1-12-5-6-14-11-4-3-10(13-2)7-9(11)8-12/h3-4,7H,5-6,8H2,1-2H3	BGVCEGVSQDOGSB-UHFFFAOYSA-N					doublet; compound annotation
0391_006905	PNU-159682	C32H35NO13	3.3089	9874188	C[C@H]1[C@@H]2[C@H](C[C@@H](O1)O[C@H]3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)OC)O)(C(=O)CO)O)N7CCO[C@@H]([C@H]7O2)OC	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(=O)CO)CC3OC3CC4C(OC5C(OC)OCCN45)C(C)O3)c(O)c1C2=O	InChI=1S/C32H35NO13/c1-13-29-16(33-7-8-43-31(42-3)30(33)46-29)9-20(44-13)45-18-11-32(40,19(35)12-34)10-15-22(18)28(39)24-23(26(15)37)25(36)14-5-4-6-17(41-2)21(14)27(24)38/h4-6,13,16,18,20,29-31,34,37,39-40H,7-12H2,1-3H3/t13-,16-,18-,20-,29+,30+,31-,32-/m0/s1	SLURUCSFDHKXFR-WWMWMSKMSA-N					compound annotation
0391_006906	4-Hydroxytamoxifen	C26H29NO2	3.5574	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_006907	4-Hydroxytamoxifen	C26H29NO2	3.6149	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_006908	327092-81-9	C16H15NO4S	3.6803	712934		O=C(O)c1cc(S(=O)(=O)N2CCc3ccccc3C2)ccc1	InChI=1S/C16H15NO4S/c18-16(19)13-6-3-7-15(10-13)22(20,21)17-9-8-12-4-1-2-5-14(12)11-17/h1-7,10H,8-9,11H2,(H,18,19)	ZGVIUMKHTXKKOX-UHFFFAOYSA-N					compound annotation
0391_006909	4-Hydroxytamoxifen	C26H29NO2	3.7582	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_006910	4-Hydroxytamoxifen	C26H29NO2	3.8299	449459	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-	TXUZVZSFRXZGTL-QPLCGJKRSA-N					doublet; compound annotation
0391_006911	sulconazole	C18H15Cl3N2S	3.8722	5318		Clc1ccc(CSC(Cn2ccnc2)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C18H15Cl3N2S/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2	AFNXATANNDIXLG-UHFFFAOYSA-N					compound annotation
0391_006912	AD80	C22H19F4N7O	3.961	71578106		CC(C)n1nc(-c2ccc(NC(=O)Nc3c(F)ccc(C(F)(F)F)c3)cc2)c2c(N)ncnc21	InChI=1S/C22H19F4N7O/c1-11(2)33-20-17(19(27)28-10-29-20)18(32-33)12-3-6-14(7-4-12)30-21(34)31-16-9-13(22(24,25)26)5-8-15(16)23/h3-11H,1-2H3,(H2,27,28,29)(H2,30,31,34)	CYORWDWRQMVGHN-UHFFFAOYSA-N					compound annotation
0391_006913	AF64394	C21H20ClN5O	4.7916	125286314		CC(C)Oc1c(CNc2cc(-c3ccccc3)nc3ncnn23)ccc(Cl)c1	InChI=1S/C21H20ClN5O/c1-14(2)28-19-10-17(22)9-8-16(19)12-23-20-11-18(15-6-4-3-5-7-15)26-21-24-13-25-27(20)21/h3-11,13-14,23H,12H2,1-2H3	WBYNZQXAAWPAGR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006915	DWK-1339	C20H22O4	5.0547	24764491		COCCCc1cc2c(cc1)oc(-c1cc(OC)c(OC)cc1)c2	InChI=1S/C20H22O4/c1-21-10-4-5-14-6-8-17-16(11-14)13-19(24-17)15-7-9-18(22-2)20(12-15)23-3/h6-9,11-13H,4-5,10H2,1-3H3	CUEPJIGXQLIOIK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006917	cefazolin	C14H14N8O4S3	1.7403	33255	CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)C(NC(=O)Cn4cnnn4)C3SC2)s1	InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1	MLYYVTUWGNIJIB-BXKDBHETSA-N					doublet; compound annotation
0391_006918	RSV-IN-1	C20H21N5O4S	2.6937	3943763		COc1c(-c2nnc3c4ccccc4c(C)nn23)cc(S(=O)(=O)N(C)CCO)cc1	InChI=1S/C20H21N5O4S/c1-13-15-6-4-5-7-16(15)19-21-22-20(25(19)23-13)17-12-14(8-9-18(17)29-3)30(27,28)24(2)10-11-26/h4-9,12,26H,10-11H2,1-3H3	RKHSOIYWKCMPHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006920	TAS-119	C23H22Cl2FN5O3	3.072	71696703		Cc1cc(Nc2c(F)ccc(CC3(C(=O)O)CCN(C(=O)c4c(Cl)c(Cl)ccc4)CC3)n2)n[nH]1	InChI=1S/C23H22Cl2FN5O3/c1-13-11-18(30-29-13)28-20-17(26)6-5-14(27-20)12-23(22(33)34)7-9-31(10-8-23)21(32)15-3-2-4-16(24)19(15)25/h2-6,11H,7-10,12H2,1H3,(H,33,34)(H2,27,28,29,30)	PLAVWQHGBMTMFR-UHFFFAOYSA-N					compound annotation
0391_006921	CMS121	C20H19NO3	3.087	135741221		Oc1c(O)cc(-c2nc3ccccc3c(OC3CCCC3)c2)cc1	InChI=1S/C20H19NO3/c22-18-10-9-13(11-19(18)23)17-12-20(24-14-5-1-2-6-14)15-7-3-4-8-16(15)21-17/h3-4,7-12,14,22-23H,1-2,5-6H2	OMHNVUCFPJJLKD-UHFFFAOYSA-N					compound annotation
0391_006922	Apcin	C13H14Cl3N7O4	3.1102	2830389		Cc1ncc([N+](=O)[O-])n1CCOC(=O)NC(Nc1ncccn1)C(Cl)(Cl)Cl	InChI=1S/C13H14Cl3N7O4/c1-8-19-7-9(23(25)26)22(8)5-6-27-12(24)21-10(13(14,15)16)20-11-17-3-2-4-18-11/h2-4,7,10H,5-6H2,1H3,(H,21,24)(H,17,18,20)	ZEXHXVOGJFGTRX-UHFFFAOYSA-N					compound annotation
0391_006923	N2,N3-bis(4-fluorophenyl)quinoxaline-2,3-diamine	C20H14F2N4	5.3968	468690		Fc1ccc(Nc2nc3ccccc3nc2Nc2ccc(F)cc2)cc1	InChI=1S/C20H14F2N4/c21-13-5-9-15(10-6-13)23-19-20(24-16-11-7-14(22)8-12-16)26-18-4-2-1-3-17(18)25-19/h1-12H,(H,23,25)(H,24,26)	DKPCKOKYSVPFEB-UHFFFAOYSA-N					compound annotation
0391_006924	AKBA	C32H48O5	6.6458	11168203	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)O)OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C	CC(=O)OC1CCC2(C)C(CCC3(C)C2C(=O)C=C2C4C(C)C(C)CCC4(C)CCC23C)C1(C)C(=O)O	InChI=1S/C32H48O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23-,24-,25+,26-,28-,29+,30-,31-,32-/m1/s1	HMMGKOVEOFBCAU-BCDBGHSCSA-N					compound annotation
0391_006925	Sipatrigine	C15H16Cl3N5	2.2145	60803		CN1CCN(c2ncc(-c3c(Cl)c(Cl)cc(Cl)c3)c(N)n2)CC1	InChI=1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21)	PDOCBJADCWMDGL-UHFFFAOYSA-N					compound annotation
0391_006926	hesperetin	C16H14O6	3.0106	72281	COC1=C(C=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O	COc1c(O)cc(C2CC(=O)c3c(O)cc(O)cc3O2)cc1	InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1	AIONOLUJZLIMTK-AWEZNQCLSA-N					compound annotation
0391_006927	GFB-8438	C16H14ClF3N4O2	3.0728	138471783		O=C1CN(c2c(Cl)c(=O)[nH]nc2)CCN1Cc1ccccc1C(F)(F)F	InChI=1S/C16H14ClF3N4O2/c17-14-12(7-21-22-15(14)26)23-5-6-24(13(25)9-23)8-10-3-1-2-4-11(10)16(18,19)20/h1-4,7H,5-6,8-9H2,(H,22,26)	MITRKIWBJVJRAM-UHFFFAOYSA-N					compound annotation
0391_006928	ML218	C19H26Cl2N2O	3.2042	45115620	CC(C)(C)CCN1C[C@@H]2[C@H](C1)C2CNC(=O)C3=CC(=CC(=C3)Cl)Cl	CC(C)(C)CCN1CC2C(CNC(=O)c3cc(Cl)cc(Cl)c3)C2C1	InChI=1S/C19H26Cl2N2O/c1-19(2,3)4-5-23-10-16-15(17(16)11-23)9-22-18(24)12-6-13(20)8-14(21)7-12/h6-8,15-17H,4-5,9-11H2,1-3H3,(H,22,24)/t15?,16-,17+	GSJIGYLGKSBYBC-ALOPSCKCSA-N					compound annotation
0391_006929	valsartan	C24H29N5O3	3.9023	60846	CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1)C(C(=O)O)C(C)C	InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1	ACWBQPMHZXGDFX-QFIPXVFZSA-N					doublet; compound annotation
0391_006930	ORBIFLOXACIN	C19H20F3N3O3	1.7454	7061800	C[C@@H]1CN(C[C@@H]([NH2+]1)C)C2=C(C3=C(C(=C2F)F)C(=O)C(=CN3C4CC4)C(=O)[O-])F	CC1CN(c2c(F)c3c(c(F)c2F)c(=O)c(C(=O)O)cn3C2CC2)CC(C)N1	InChI=1S/C19H20F3N3O3/c1-8-5-24(6-9(2)23-8)17-14(21)13(20)12-16(15(17)22)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6H2,1-2H3,(H,27,28)/t8-,9+	QIPQASLPWJVQMH-DTORHVGOSA-N					removed another duplicate entry; compound annotation
0391_006932	Jatrorrhizine	C20H20NO4+	2.2371	72323		COc1c(O)cc2CC[n+]3c(cc4ccc(OC)c(OC)c4c3)-c2c1	InChI=1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1	MXTLAHSTUOXGQF-UHFFFAOYSA-O					doublet; compound annotation
0391_006933	Jatrorrhizine	C20H20NO4+	2.3552	72323		COc1c(O)cc2CC[n+]3c(cc4ccc(OC)c(OC)c4c3)-c2c1	InChI=1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1	MXTLAHSTUOXGQF-UHFFFAOYSA-O					doublet; compound annotation
0391_006934	Canadine	C20H21NO4	2.3552	34458		COc1c(OC)c2c(cc1)CC1c3cc4c(cc3CCN1C2)OCO4	InChI=1S/C20H21NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,8-9,16H,5-7,10-11H2,1-2H3	VZTUIEROBZXUFA-UHFFFAOYSA-N					compound annotation
0391_006935	Jatrorrhizine	C20H20NO4+	2.5008	72323		COc1c(O)cc2CC[n+]3c(cc4ccc(OC)c(OC)c4c3)-c2c1	InChI=1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1	MXTLAHSTUOXGQF-UHFFFAOYSA-O					doublet; compound annotation
0391_006936	amoxapine	C17H16ClN3O	2.7807	2170		Clc1cc2c(cc1)Oc1ccccc1N=C2N1CCNCC1	InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	QWGDMFLQWFTERH-UHFFFAOYSA-N					doublet; compound annotation
0391_006937	YK-4-279	C17H13Cl2NO4	3.5084	44632017		COc1ccc(C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c32)cc1	InChI=1S/C17H13Cl2NO4/c1-24-10-4-2-9(3-5-10)13(21)8-17(23)14-11(18)6-7-12(19)15(14)20-16(17)22/h2-7,23H,8H2,1H3,(H,20,22)	HLXSCTYHLQHQDJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006939	Daprodustat	C19H27N3O6	5.5244	91617630		O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O	InChI=1S/C19H27N3O6/c23-14(24)11-20-16(25)15-17(26)21(12-7-3-1-4-8-12)19(28)22(18(15)27)13-9-5-2-6-10-13/h12-13,15H,1-11H2,(H,20,25)(H,23,24)	RUEYEZADQJCKGV-UHFFFAOYSA-N					compound annotation
0391_006940	amoxapine	C17H16ClN3O	5.8648	2170		Clc1cc2c(cc1)Oc1ccccc1N=C2N1CCNCC1	InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2	QWGDMFLQWFTERH-UHFFFAOYSA-N					doublet; compound annotation
0391_006941	Methyl syringate	C10H12O5	2.327	70164		COC(=O)c1cc(OC)c(O)c(OC)c1	InChI=1S/C10H12O5/c1-13-7-4-6(10(12)15-3)5-8(14-2)9(7)11/h4-5,11H,1-3H3	ZMXJAEGJWHJMGX-UHFFFAOYSA-N					doublet; compound annotation
0391_006942	Methyl syringate	C10H12O5	2.3311	70164		COC(=O)c1cc(OC)c(O)c(OC)c1	InChI=1S/C10H12O5/c1-13-7-4-6(10(12)15-3)5-8(14-2)9(7)11/h4-5,11H,1-3H3	ZMXJAEGJWHJMGX-UHFFFAOYSA-N					doublet; compound annotation
0391_006943	JNJ-31020028	C34H36FN5O2	2.6168	25134625		CCN(CC)C(=O)C(c1ccccc1)N1CCN(c2c(F)cc(NC(=O)c3ccccc3-c3cnccc3)cc2)CC1	InChI=1S/C34H36FN5O2/c1-3-38(4-2)34(42)32(25-11-6-5-7-12-25)40-21-19-39(20-22-40)31-17-16-27(23-30(31)35)37-33(41)29-15-9-8-14-28(29)26-13-10-18-36-24-26/h5-18,23-24,32H,3-4,19-22H2,1-2H3,(H,37,41)	OVUNRYUVDVWTTE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006945	209481-20-9	C20H22ClN3O3S2	2.7391	5312149		COc1c(N2CCNCC2)cc(NS(=O)(=O)c2c(C)c3c(ccc(Cl)c3)s2)cc1	InChI=1S/C20H22ClN3O3S2/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25,26)23-15-4-5-18(27-2)17(12-15)24-9-7-22-8-10-24/h3-6,11-12,22-23H,7-10H2,1-2H3	LOCQRDBFWSXQQI-UHFFFAOYSA-N					doublet; compound annotation
0391_006946	Ethyl caffeate	C11H12O4	2.7427	5317238	CCOC(=O)/C=C/C1=CC(=C(C=C1)O)O	CCOC(=O)C=Cc1cc(O)c(O)cc1	InChI=1S/C11H12O4/c1-2-15-11(14)6-4-8-3-5-9(12)10(13)7-8/h3-7,12-13H,2H2,1H3/b6-4+	WDKYDMULARNCIS-GQCTYLIASA-N					compound annotation
0391_006947	209481-20-9	C20H22ClN3O3S2	3.1954	5312149		COc1c(N2CCNCC2)cc(NS(=O)(=O)c2c(C)c3c(ccc(Cl)c3)s2)cc1	InChI=1S/C20H22ClN3O3S2/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25,26)23-15-4-5-18(27-2)17(12-15)24-9-7-22-8-10-24/h3-6,11-12,22-23H,7-10H2,1-2H3	LOCQRDBFWSXQQI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006949	Azilsartan	C25H20N4O5	3.544	135415867		CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nc(=O)o[nH]2)cc1	InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)	KGSXMPPBFPAXLY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006951	41332-24-5	C32H32N2O	4.5513	4988454		O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1	InChI=1S/C32H32N2O/c35-31(25-30(26-13-5-1-6-14-26)27-15-7-2-8-16-27)33-21-23-34(24-22-33)32(28-17-9-3-10-18-28)29-19-11-4-12-20-29/h1-20,30,32H,21-25H2	VCPMZDWBEWTGNW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006953	Dalcetrapib	C23H35NO2S	6.6937	6918540		CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1	InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)	YZQLWPMZQVHJED-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006955	Typhaneoside	C34H42O20	1.7655	44566503	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)O)O)O)O)O	COc1c(O)ccc(-c2c(OC3OC(COC4OC(C)C(O)C(O)C4O)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)c(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C34H42O20/c1-10-20(38)24(42)27(45)32(49-10)48-9-18-22(40)26(44)31(54-33-28(46)25(43)21(39)11(2)50-33)34(52-18)53-30-23(41)19-15(37)7-13(35)8-17(19)51-29(30)12-4-5-14(36)16(6-12)47-3/h4-8,10-11,18,20-22,24-28,31-40,42-46H,9H2,1-3H3/t10-,11-,18+,20-,21-,22+,24+,25+,26-,27+,28+,31+,32+,33-,34-/m0/s1	POMAQDQEVHXLGT-QDYYQVSOSA-N					compound annotation
0391_006956	alfuzosin	C19H27N5O4	1.9302	2092		COc1c(OC)cc2c(N)nc(N(C)CCCNC(=O)C3CCCO3)nc2c1	InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)	WNMJYKCGWZFFKR-UHFFFAOYSA-N					doublet; compound annotation
0391_006957	PIRFENIDONE	C12H11NO	2.3704	40632		Cc1cn(-c2ccccc2)c(=O)cc1	InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3	ISWRGOKTTBVCFA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006959	naringin dihydrochalcone	C27H34O14	2.3704	9894584	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC=C(C=C4)O)O)CO)O)O)O)O)O	CC1OC(OC2C(Oc3cc(O)c(C(=O)CCc4ccc(O)cc4)c(O)c3)OC(CO)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H34O14/c1-11-20(33)22(35)24(37)26(38-11)41-25-23(36)21(34)18(10-28)40-27(25)39-14-8-16(31)19(17(32)9-14)15(30)7-4-12-2-5-13(29)6-3-12/h2-3,5-6,8-9,11,18,20-29,31-37H,4,7,10H2,1H3/t11-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1	CWBZAESOUBENAP-QVNVHUMTSA-N					compound annotation
0391_006960	Sivelestat	C20H22N2O7S	4.0555	107706		CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)	BTGNGJJLZOIYID-UHFFFAOYSA-N					doublet; compound annotation
0391_006961	N-[4-[(1S,2R)-2-(cyclopropylmethylamino)cyclopropyl]phenyl]-1-methylpyrazole-4-carboxamide	C18H22N4O	1.6122	86729933	CN1C=C(C=N1)C(=O)NC2=CC=C(C=C2)[C@@H]3C[C@H]3NCC4CC4	Cn1cc(C(=O)Nc2ccc(C3CC3NCC3CC3)cc2)cn1	InChI=1S/C18H22N4O/c1-22-11-14(10-20-22)18(23)21-15-6-4-13(5-7-15)16-8-17(16)19-9-12-2-3-12/h4-7,10-12,16-17,19H,2-3,8-9H2,1H3,(H,21,23)/t16-,17+/m0/s1	NTRMVYTYDOLCRU-DLBZAZTESA-N					removed another duplicate entry; compound annotation
0391_006963	1038915-58-0	C19H20N4O	2.0408	24958199	C1C[C@@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m0/s1	PCHKPVIQAHNQLW-AWEZNQCLSA-N					doublet; compound annotation
0391_006964	1038915-58-0	C19H20N4O	2.0457	24958199	C1C[C@@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m0/s1	PCHKPVIQAHNQLW-AWEZNQCLSA-N					doublet; compound annotation
0391_006965	9-Aminocamptothecin	C20H17N3O4	2.1803	72402	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4cccc(N)c4cc3Cn1c2=O	InChI=1S/C20H17N3O4/c1-2-20(26)13-7-16-17-10(6-11-14(21)4-3-5-15(11)22-17)8-23(16)18(24)12(13)9-27-19(20)25/h3-7,26H,2,8-9,21H2,1H3/t20-/m0/s1	FUXVKZWTXQUGMW-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_006967	BB-Cl-Amidine	C26H26ClN5O	2.6429	129021946	C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)N[C@@H](CCCN=C(CCl)N)C3=NC4=CC=CC=C4N3	NC(CCl)=NCCCC(NC(=O)c1ccc(-c2ccccc2)cc1)c1nc2ccccc2[nH]1	InChI=1S/C26H26ClN5O/c27-17-24(28)29-16-6-11-23(25-30-21-9-4-5-10-22(21)31-25)32-26(33)20-14-12-19(13-15-20)18-7-2-1-3-8-18/h1-5,7-10,12-15,23H,6,11,16-17H2,(H2,28,29)(H,30,31)(H,32,33)/t23-/m0/s1	YDOAWJHYHGBQFI-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_006969	Hispidol	C15H10O4	2.7574	5281254	C1=CC(=CC=C1/C=C\2/C(=O)C3=C(O2)C=C(C=C3)O)O	O=C1C(=Cc2ccc(O)cc2)Oc2c1ccc(O)c2	InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)7-14-15(18)12-6-5-11(17)8-13(12)19-14/h1-8,16-17H/b14-7-	KEZLDSPIRVZOKZ-AUWJEWJLSA-N					doublet; removed another duplicate entry; compound annotation
0391_006971	Mcl1-IN-1	C23H18ClN3O4	2.9088	2966040		O=C(O)COc1ccccc1C(Nc1ccccn1)c1cc(Cl)c2cccnc2c1O	InChI=1S/C23H18ClN3O4/c24-17-12-16(23(30)22-14(17)7-5-11-26-22)21(27-19-9-3-4-10-25-19)15-6-1-2-8-18(15)31-13-20(28)29/h1-12,21,30H,13H2,(H,25,27)(H,28,29)	VMEDTSNKTYMQLG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006973	Hispidol	C15H10O4	2.9792	5281254	C1=CC(=CC=C1/C=C\2/C(=O)C3=C(O2)C=C(C=C3)O)O	O=C1C(=Cc2ccc(O)cc2)Oc2c1ccc(O)c2	InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)7-14-15(18)12-6-5-11(17)8-13(12)19-14/h1-8,16-17H/b14-7-	KEZLDSPIRVZOKZ-AUWJEWJLSA-N					doublet; compound annotation
0391_006974	CPI-169	C27H36N4O5S	3.2585	78357814		CCS(=O)(=O)N1CCC(C(C)n2c(C)c(C(=O)NCc3c(OC)cc(C)[nH]c3=O)c3ccccc32)CC1	InChI=1S/C27H36N4O5S/c1-6-37(34,35)30-13-11-20(12-14-30)18(3)31-19(4)25(21-9-7-8-10-23(21)31)27(33)28-16-22-24(36-5)15-17(2)29-26(22)32/h7-10,15,18,20H,6,11-14,16H2,1-5H3,(H,28,33)(H,29,32)	LHGUZCKPFXXVPV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006976	HJB97	C26H28N8O3	3.3758	135397673		CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C26H28N8O3/c1-6-34-20(11-17(32-34)14-7-8-14)29-24-22-15-10-19(36-5)16(21-12(2)33-37-13(21)3)9-18(15)28-23(22)30-25(31-24)26(35)27-4/h9-11,14H,6-8H2,1-5H3,(H,27,35)(H2,28,29,30,31)	JNYHQYRTYFSMSQ-UHFFFAOYSA-N					doublet; compound annotation
0391_006977	HJB97	C26H28N8O3	3.379	135397673		CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C26H28N8O3/c1-6-34-20(11-17(32-34)14-7-8-14)29-24-22-15-10-19(36-5)16(21-12(2)33-37-13(21)3)9-18(15)28-23(22)30-25(31-24)26(35)27-4/h9-11,14H,6-8H2,1-5H3,(H,27,35)(H2,28,29,30,31)	JNYHQYRTYFSMSQ-UHFFFAOYSA-N					doublet; compound annotation
0391_006978	ACY-775	C17H19FN4O2	3.4851	57382288		O=C(NO)c1cnc(NC2(c3cc(F)ccc3)CCCCC2)nc1	InChI=1S/C17H19FN4O2/c18-14-6-4-5-13(9-14)17(7-2-1-3-8-17)21-16-19-10-12(11-20-16)15(23)22-24/h4-6,9-11,24H,1-3,7-8H2,(H,22,23)(H,19,20,21)	IYBURCQQEUNLDL-UHFFFAOYSA-N					doublet; compound annotation
0391_006979	ACY-775	C17H19FN4O2	3.4885	57382288		O=C(NO)c1cnc(NC2(c3cc(F)ccc3)CCCCC2)nc1	InChI=1S/C17H19FN4O2/c18-14-6-4-5-13(9-14)17(7-2-1-3-8-17)21-16-19-10-12(11-20-16)15(23)22-24/h4-6,9-11,24H,1-3,7-8H2,(H,22,23)(H,19,20,21)	IYBURCQQEUNLDL-UHFFFAOYSA-N					doublet; compound annotation
0391_006980	HJB97	C26H28N8O3	3.4918	135397673		CCn1nc(C2CC2)cc1Nc1nc(C(=O)NC)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C26H28N8O3/c1-6-34-20(11-17(32-34)14-7-8-14)29-24-22-15-10-19(36-5)16(21-12(2)33-37-13(21)3)9-18(15)28-23(22)30-25(31-24)26(35)27-4/h9-11,14H,6-8H2,1-5H3,(H,27,35)(H2,28,29,30,31)	JNYHQYRTYFSMSQ-UHFFFAOYSA-N					doublet; compound annotation
0391_006981	AVE 0991	C29H32N4O5S2	5.1745	9851724		CCNC(=O)NS(=O)(=O)c1c(-c2ccc(Cn3c(-c4ccccc4)nc(OC)c3C=O)cc2)cc(CC(C)C)s1	InChI=1S/C29H32N4O5S2/c1-5-30-29(35)32-40(36,37)28-24(16-23(39-28)15-19(2)3)21-13-11-20(12-14-21)17-33-25(18-34)27(38-4)31-26(33)22-9-7-6-8-10-22/h6-14,16,18-19H,5,15,17H2,1-4H3,(H2,30,32,35)	QTOZBSNPDCWHPV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_006983	8-HYDROXYQUINOLINE	C9H7NO	0.6165	1923		Oc1cccc2c1nccc2	InChI=1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H	MCJGNVYPOGVAJF-UHFFFAOYSA-N					compound annotation
0391_006984	Marbofloxacin	C17H19FN4O4	1.4245	60651		CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1	InChI=1S/C17H19FN4O4/c1-19-3-5-21(6-4-19)14-12(18)7-10-13-16(14)26-9-20(2)22(13)8-11(15(10)23)17(24)25/h7-8H,3-6,9H2,1-2H3,(H,24,25)	BPFYOAJNDMUVBL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006986	Arotinolol	C15H21N3O2S3	1.9156	2239		CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1	InChI=1S/C15H21N3O2S3/c1-15(2,3)17-6-9(19)7-21-14-18-10(8-22-14)11-4-5-12(23-11)13(16)20/h4-5,8-9,17,19H,6-7H2,1-3H3,(H2,16,20)	BHIAIPWSVYSKJS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_006988	Imperialine	C27H43NO3	2.0169	442977	C[C@H]1CC[C@H]2[C@@]([C@@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4CC(=O)[C@@H]6[C@@]5(CC[C@@H](C6)O)C)(C)O	CC1CCC2N(C1)CC1C3CC4C(CC(=O)C5CC(O)CCC54C)C3CCC1C2(C)O	InChI=1S/C27H43NO3/c1-15-4-7-25-27(3,31)21-6-5-17-18(20(21)14-28(25)13-15)11-22-19(17)12-24(30)23-10-16(29)8-9-26(22,23)2/h15-23,25,29,31H,4-14H2,1-3H3/t15-,16-,17+,18+,19-,20-,21+,22-,23+,25-,26+,27-/m0/s1	IQDIERHFZVCNRZ-LRCDAWNTSA-N					doublet; compound annotation
0391_006989	Imperialine	C27H43NO3	2.1738	442977	C[C@H]1CC[C@H]2[C@@]([C@@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4CC(=O)[C@@H]6[C@@]5(CC[C@@H](C6)O)C)(C)O	CC1CCC2N(C1)CC1C3CC4C(CC(=O)C5CC(O)CCC54C)C3CCC1C2(C)O	InChI=1S/C27H43NO3/c1-15-4-7-25-27(3,31)21-6-5-17-18(20(21)14-28(25)13-15)11-22-19(17)12-24(30)23-10-16(29)8-9-26(22,23)2/h15-23,25,29,31H,4-14H2,1-3H3/t15-,16-,17+,18+,19-,20-,21+,22-,23+,25-,26+,27-/m0/s1	IQDIERHFZVCNRZ-LRCDAWNTSA-N					doublet; compound annotation
0391_006990	217645-70-0	C21H24ClFN4O3	2.4547	512282	C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F	CC1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1c(NC(N)=O)cc(Cl)cc1	InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1	XQYASZNUFDVMFH-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_006992	Apremilast	C22H24N2O7S	3.4402	11561674	CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC	CCOc1c(OC)ccc(C(CS(C)(=O)=O)N2C(=O)c3c(C2=O)c(NC(C)=O)ccc3)c1	InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1	IMOZEMNVLZVGJZ-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_006995	Gestrinone	C21H24O2	3.7364	27812	CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21CC	InChI=1S/C21H24O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,9,11,13,18-19,23H,3,5-8,10,12H2,1H3/t18-,19+,20+,21+/m1/s1	BJJXHLWLUDYTGC-ANULTFPQSA-N					doublet; compound annotation
0391_006996	Gestrinone	C21H24O2	3.7392	27812	CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C#C)O	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C=CC21CC	InChI=1S/C21H24O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,9,11,13,18-19,23H,3,5-8,10,12H2,1H3/t18-,19+,20+,21+/m1/s1	BJJXHLWLUDYTGC-ANULTFPQSA-N					doublet; removed another duplicate entry; compound annotation
0391_006998	PEXACERFONT	C18H24N6O	3.9528	9884366	CC[C@@H](C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(N=C(C=C3)OC)C)C	CCC(C)Nc1nc(C)nc2c(-c3c(C)nc(OC)cc3)c(C)nn12	InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1	LBWQSAZEYIZZCE-SNVBAGLBSA-N					compound annotation
0391_006999	clofazimine	C27H22Cl2N4	4.3722	2794		CC(C)N=c1cc2-c(nc3ccccc3n2-c2ccc(Cl)cc2)cc1Nc1ccc(Cl)cc1	InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3	WDQPAMHFFCXSNU-UHFFFAOYSA-N					compound annotation
0391_007000	Torcetrapib	C26H25F9N2O4	6.1584	159325	CC[C@@H]1C[C@@H](C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC	CCOC(=O)N1c2c(cc(C(F)(F)F)cc2)C(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)CC1CC	InChI=1S/C26H25F9N2O4/c1-4-18-12-21(19-11-15(24(27,28)29)6-7-20(19)37(18)23(39)41-5-2)36(22(38)40-3)13-14-8-16(25(30,31)32)10-17(9-14)26(33,34)35/h6-11,18,21H,4-5,12-13H2,1-3H3/t18-,21+/m1/s1	CMSGWTNRGKRWGS-NQIIRXRSSA-N					compound annotation
0391_007001	DDP38003 trihydrochloride	C21H26N4O	0.851	86287623	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)[C@@H]4C[C@H]4N	CN1CCN(c2ccc(C(=O)Nc3ccc(C4CC4N)cc3)cc2)CC1	InChI=1S/C21H26N4O/c1-24-10-12-25(13-11-24)18-8-4-16(5-9-18)21(26)23-17-6-2-15(3-7-17)19-14-20(19)22/h2-9,19-20H,10-14,22H2,1H3,(H,23,26)/t19-,20+/m0/s1	SSWIQIUOBLUKHT-VQTJNVASSA-N					doublet; removed another duplicate entry; compound annotation
0391_007003	DDP38003 trihydrochloride	C21H26N4O	2.5687	86287623	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)[C@@H]4C[C@H]4N	CN1CCN(c2ccc(C(=O)Nc3ccc(C4CC4N)cc3)cc2)CC1	InChI=1S/C21H26N4O/c1-24-10-12-25(13-11-24)18-8-4-16(5-9-18)21(26)23-17-6-2-15(3-7-17)19-14-20(19)22/h2-9,19-20H,10-14,22H2,1H3,(H,23,26)/t19-,20+/m0/s1	SSWIQIUOBLUKHT-VQTJNVASSA-N					doublet; compound annotation
0391_007004	DDP38003 trihydrochloride	C21H26N4O	2.6273	86287623	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)[C@@H]4C[C@H]4N	CN1CCN(c2ccc(C(=O)Nc3ccc(C4CC4N)cc3)cc2)CC1	InChI=1S/C21H26N4O/c1-24-10-12-25(13-11-24)18-8-4-16(5-9-18)21(26)23-17-6-2-15(3-7-17)19-14-20(19)22/h2-9,19-20H,10-14,22H2,1H3,(H,23,26)/t19-,20+/m0/s1	SSWIQIUOBLUKHT-VQTJNVASSA-N					doublet; compound annotation
0391_007005	IDO-IN-3	C11H12BrFN6O2	2.6273	136898218		NCCNc1nonc1C(=Nc1cc(Br)c(F)cc1)NO	InChI=1S/C11H12BrFN6O2/c12-7-5-6(1-2-8(7)13)16-11(17-20)9-10(15-4-3-14)19-21-18-9/h1-2,5,20H,3-4,14H2,(H,15,19)(H,16,17)	DAPNMIADTFAXEG-UHFFFAOYSA-N					compound annotation
0391_007006	TPOP146	C27H35N3O5	2.677	122172830	CCC(=O)N1CCOC2=C(C1)C=C(C=C2C(=O)N[C@H]3CCCN(C3)C)C4=CC(=CC(=C4)OC)OC	CCC(=O)N1CCOc2c(cc(-c3cc(OC)cc(OC)c3)cc2C(=O)NC2CCCN(C)C2)C1	InChI=1S/C27H35N3O5/c1-5-25(31)30-9-10-35-26-20(16-30)11-18(19-12-22(33-3)15-23(13-19)34-4)14-24(26)27(32)28-21-7-6-8-29(2)17-21/h11-15,21H,5-10,16-17H2,1-4H3,(H,28,32)/t21-/m0/s1	CUJLWYCUPPPASA-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_007008	BMX-IN-1	C29H24N4O4S	2.7627	71576693		C=CC(=O)Nc1c(C)ccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)c1	InChI=1S/C29H24N4O4S/c1-4-27(34)31-26-16-23(12-5-18(26)2)33-28(35)14-9-21-17-30-25-13-8-20(15-24(25)29(21)33)19-6-10-22(11-7-19)32-38(3,36)37/h4-17,32H,1H2,2-3H3,(H,31,34)	SFMJNHNUOVADRW-UHFFFAOYSA-N					doublet; compound annotation
0391_007009	BMX-IN-1	C29H24N4O4S	2.7654	71576693		C=CC(=O)Nc1c(C)ccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(NS(C)(=O)=O)cc5)cc4c32)c1	InChI=1S/C29H24N4O4S/c1-4-27(34)31-26-16-23(12-5-18(26)2)33-28(35)14-9-21-17-30-25-13-8-20(15-24(25)29(21)33)19-6-10-22(11-7-19)32-38(3,36)37/h4-17,32H,1H2,2-3H3,(H,31,34)	SFMJNHNUOVADRW-UHFFFAOYSA-N					doublet; compound annotation
0391_007010	DDP38003 trihydrochloride	C21H26N4O	2.9263	86287623	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)[C@@H]4C[C@H]4N	CN1CCN(c2ccc(C(=O)Nc3ccc(C4CC4N)cc3)cc2)CC1	InChI=1S/C21H26N4O/c1-24-10-12-25(13-11-24)18-8-4-16(5-9-18)21(26)23-17-6-2-15(3-7-17)19-14-20(19)22/h2-9,19-20H,10-14,22H2,1H3,(H,23,26)/t19-,20+/m0/s1	SSWIQIUOBLUKHT-VQTJNVASSA-N					doublet; compound annotation
0391_007011	DDP38003 trihydrochloride	C21H26N4O	3.1111	86287623	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)[C@@H]4C[C@H]4N	CN1CCN(c2ccc(C(=O)Nc3ccc(C4CC4N)cc3)cc2)CC1	InChI=1S/C21H26N4O/c1-24-10-12-25(13-11-24)18-8-4-16(5-9-18)21(26)23-17-6-2-15(3-7-17)19-14-20(19)22/h2-9,19-20H,10-14,22H2,1H3,(H,23,26)/t19-,20+/m0/s1	SSWIQIUOBLUKHT-VQTJNVASSA-N					doublet; compound annotation
0391_007012	GNE-781	C27H33F2N7O2	3.1834	132275066		CNC(=O)N1CCc2c(C1)c(N1CCCc3cc(-c4cn(C)nc4)c(C(F)F)cc31)nn2C1CCOCC1	InChI=1S/C27H33F2N7O2/c1-30-27(37)34-9-5-23-22(16-34)26(32-36(23)19-6-10-38-11-7-19)35-8-3-4-17-12-20(18-14-31-33(2)15-18)21(25(28)29)13-24(17)35/h12-15,19,25H,3-11,16H2,1-2H3,(H,30,37)	CQCWHSDMJBAGDC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007015	GSK 525768A	C22H22ClN5O2	3.3709	52934127	CCNC(=O)C[C@@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C	CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(ccc(OC)c2)-n2c(C)nnc12	InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m1/s1	AAAQFGUYHFJNHI-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_007017	dBET6	C42H45ClN8O7S	4.1171	121427831	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCCCCCCNC(=O)COC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)NCCCCCCCCNC(=O)COc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)N=C2c1ccc(Cl)cc1	InChI=1S/C42H45ClN8O7S/c1-23-24(2)59-42-35(23)37(26-13-15-27(43)16-14-26)46-29(38-49-48-25(3)50(38)42)21-33(53)44-19-8-6-4-5-7-9-20-45-34(54)22-58-31-12-10-11-28-36(31)41(57)51(40(28)56)30-17-18-32(52)47-39(30)55/h10-16,29-30H,4-9,17-22H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1	JGQPZPLJOBHHBK-UFXYQILXSA-N					removed another duplicate entry; compound annotation
0391_007019	MZP-55	C57H70ClN7O10S	4.2204	122539896	C[C@H]1C[C@H](C2=C(N1C(=O)C)C=CC(=C2)C3=CC=C(C=C3)C(=O)NCCOCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)NCC5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)NC7=CC=C(C=C7)Cl	CC(=O)N1c2c(cc(-c3ccc(C(=O)NCCOCCOCCOCCOCC(=O)NC(C(=O)N4CC(O)CC4C(=O)NCc4ccc(-c5c(C)ncs5)cc4)C(C)(C)C)cc3)cc2)C(Nc2ccc(Cl)cc2)CC1C	InChI=1S/C57H70ClN7O10S/c1-36-29-48(62-45-18-16-44(58)17-19-45)47-30-43(15-20-49(47)65(36)38(3)66)40-11-13-42(14-12-40)54(69)59-21-22-72-23-24-73-25-26-74-27-28-75-34-51(68)63-53(57(4,5)6)56(71)64-33-46(67)31-50(64)55(70)60-32-39-7-9-41(10-8-39)52-37(2)61-35-76-52/h7-20,30,35-36,46,48,50,53,62,67H,21-29,31-34H2,1-6H3,(H,59,69)(H,60,70)(H,63,68)/t36-,46+,48+,50-,53+/m0/s1	UHWNJFZTYJNBAN-HYXXSBGTSA-N					removed another duplicate entry; compound annotation
0391_007021	MZP-54	C55H66ClN7O9S	4.2285	122551841	C[C@H]1C[C@H](C2=C(N1C(=O)C)C=CC(=C2)C3=CC=C(C=C3)C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)NCC5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)NC7=CC=C(C=C7)Cl	CC(=O)N1c2c(cc(-c3ccc(C(=O)NCCOCCOCCOCC(=O)NC(C(=O)N4CC(O)CC4C(=O)NCc4ccc(-c5c(C)ncs5)cc4)C(C)(C)C)cc3)cc2)C(Nc2ccc(Cl)cc2)CC1C	InChI=1S/C55H66ClN7O9S/c1-34-27-46(60-43-18-16-42(56)17-19-43)45-28-41(15-20-47(45)63(34)36(3)64)38-11-13-40(14-12-38)52(67)57-21-22-70-23-24-71-25-26-72-32-49(66)61-51(55(4,5)6)54(69)62-31-44(65)29-48(62)53(68)58-30-37-7-9-39(10-8-37)50-35(2)59-33-73-50/h7-20,28,33-34,44,46,48,51,60,65H,21-27,29-32H2,1-6H3,(H,57,67)(H,58,68)(H,61,66)/t34-,44+,46+,48-,51+/m0/s1	FYSWLIFIYIVHPI-DDWISSAJSA-N					doublet; compound annotation
0391_007022	MZP-54	C55H66ClN7O9S	4.2371	122551841	C[C@H]1C[C@H](C2=C(N1C(=O)C)C=CC(=C2)C3=CC=C(C=C3)C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N4C[C@@H](C[C@H]4C(=O)NCC5=CC=C(C=C5)C6=C(N=CS6)C)O)C(C)(C)C)NC7=CC=C(C=C7)Cl	CC(=O)N1c2c(cc(-c3ccc(C(=O)NCCOCCOCCOCC(=O)NC(C(=O)N4CC(O)CC4C(=O)NCc4ccc(-c5c(C)ncs5)cc4)C(C)(C)C)cc3)cc2)C(Nc2ccc(Cl)cc2)CC1C	InChI=1S/C55H66ClN7O9S/c1-34-27-46(60-43-18-16-42(56)17-19-43)45-28-41(15-20-47(45)63(34)36(3)64)38-11-13-40(14-12-38)52(67)57-21-22-70-23-24-71-25-26-72-32-49(66)61-51(55(4,5)6)54(69)62-31-44(65)29-48(62)53(68)58-30-37-7-9-39(10-8-37)50-35(2)59-33-73-50/h7-20,28,33-34,44,46,48,51,60,65H,21-27,29-32H2,1-6H3,(H,57,67)(H,58,68)(H,61,66)/t34-,44+,46+,48-,51+/m0/s1	FYSWLIFIYIVHPI-DDWISSAJSA-N					doublet; compound annotation
0391_007023	N6-Cyclopentyladenosine	C15H21N5O4	1.602	657378	C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NC4CCCC4)ncnc32)C(O)C1O	InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1	SQMWSBKSHWARHU-SDBHATRESA-N					compound annotation
0391_007024	101155-02-6	C13H12FN5	1.9202	127779		CNc1c2ncn(Cc3ccccc3F)c2ncn1	InChI=1S/C13H12FN5/c1-15-12-11-13(17-7-16-12)19(8-18-11)6-9-4-2-3-5-10(9)14/h2-5,7-8H,6H2,1H3,(H,15,16,17)	MZABAGHILOTTOD-UHFFFAOYSA-N					compound annotation
0391_007025	Fananserin	C23H24FN3O2S	3.0971	60785		O=S1(=O)c2cccc3c2c(ccc3)N1CCCN1CCN(c2ccc(F)cc2)CC1	InChI=1S/C23H24FN3O2S/c24-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-3-13-27-21-6-1-4-18-5-2-7-22(23(18)21)30(27,28)29/h1-2,4-11H,3,12-17H2	VGIGHGMPMUCLIQ-UHFFFAOYSA-N					compound annotation
0391_007026	870843-42-8	C25H26FN3O2	3.2925	11560787	CC1=CN(C=N1)C2=C(C=C(C=C2)/C=C/3\CCCN(C3=O)[C@@H](C)C4=CC=C(C=C4)F)OC	COc1c(-n2cnc(C)c2)ccc(C=C2CCCN(C(C)c3ccc(F)cc3)C2=O)c1	InChI=1S/C25H26FN3O2/c1-17-15-28(16-27-17)23-11-6-19(14-24(23)31-3)13-21-5-4-12-29(25(21)30)18(2)20-7-9-22(26)10-8-20/h6-11,13-16,18H,4-5,12H2,1-3H3/b21-13+/t18-/m0/s1	PUOAETJYKQITMO-LANLRWRYSA-N					doublet; compound annotation
0391_007027	Vismodegib	C19H14Cl2N2O3S	3.3538	24776445		CS(=O)(=O)c1cc(Cl)c(C(=O)Nc2cc(-c3ccccn3)c(Cl)cc2)cc1	InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)	BPQMGSKTAYIVFO-UHFFFAOYSA-N					compound annotation
0391_007028	870843-42-8	C25H26FN3O2	3.3573	11560787	CC1=CN(C=N1)C2=C(C=C(C=C2)/C=C/3\CCCN(C3=O)[C@@H](C)C4=CC=C(C=C4)F)OC	COc1c(-n2cnc(C)c2)ccc(C=C2CCCN(C(C)c3ccc(F)cc3)C2=O)c1	InChI=1S/C25H26FN3O2/c1-17-15-28(16-27-17)23-11-6-19(14-24(23)31-3)13-21-5-4-12-29(25(21)30)18(2)20-7-9-22(26)10-8-20/h6-11,13-16,18H,4-5,12H2,1-3H3/b21-13+/t18-/m0/s1	PUOAETJYKQITMO-LANLRWRYSA-N					doublet; compound annotation
0391_007029	WNK463	C21H24F3N7O2	3.4575	121487936		CC(C)(C)NC(=O)c1cncn1C1CCN(c2ncc(-c3nnc(C(F)(F)F)o3)cc2)CC1	InChI=1S/C21H24F3N7O2/c1-20(2,3)27-17(32)15-11-25-12-31(15)14-6-8-30(9-7-14)16-5-4-13(10-26-16)18-28-29-19(33-18)21(22,23)24/h4-5,10-12,14H,6-9H2,1-3H3,(H,27,32)	HWSHOMMVLGBIDN-UHFFFAOYSA-N					compound annotation
0391_007030	BAY 60-6583	C19H17N5O2S	3.6854	11717831		N#Cc1c(-c2ccc(OCC3CC3)cc2)c(C#N)c(SCC(N)=O)nc1N	InChI=1S/C19H17N5O2S/c20-7-14-17(12-3-5-13(6-4-12)26-9-11-1-2-11)15(8-21)19(24-18(14)23)27-10-16(22)25/h3-6,11H,1-2,9-10H2,(H2,22,25)(H2,23,24)	ZTYHZMAZUWOXNC-UHFFFAOYSA-N					compound annotation
0391_007031	mitoquinone	C37H44O4P+	4.79	11388332		COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O	InChI=1S/C37H44O4P/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3/q+1	OIIMUKXVVLRCAF-UHFFFAOYSA-N					doublet; compound annotation
0391_007032	mitoquinone	C37H44O4P+	5.0214	11388332		COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O	InChI=1S/C37H44O4P/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3/q+1	OIIMUKXVVLRCAF-UHFFFAOYSA-N					doublet; compound annotation
0391_007033	mitoquinone	C37H44O4P+	5.1217	11388332		COC1=C(OC)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=C(C)C1=O	InChI=1S/C37H44O4P/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3/q+1	OIIMUKXVVLRCAF-UHFFFAOYSA-N					doublet; compound annotation
0391_007034	TH1834	C33H40N6O3	2.3108	91826512		O=C(O)Cn1nnc(-c2ccc(CN(CCCCOc3ccc(CN4CCCC4)cc3)CCc3ccccc3)cc2)n1	InChI=1S/C33H40N6O3/c40-32(41)26-39-35-33(34-36-39)30-14-10-28(11-15-30)25-38(22-18-27-8-2-1-3-9-27)21-6-7-23-42-31-16-12-29(13-17-31)24-37-19-4-5-20-37/h1-3,8-17H,4-7,18-26H2,(H,40,41)	XERATECPNBWJFP-UHFFFAOYSA-N					doublet; compound annotation
0391_007035	Eprazinone	C24H32N2O2	3.1053	3245		CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1	InChI=1S/C24H32N2O2/c1-3-28-23(21-10-6-4-7-11-21)19-26-16-14-25(15-17-26)18-20(2)24(27)22-12-8-5-9-13-22/h4-13,20,23H,3,14-19H2,1-2H3	BSHWLCACYCVCJE-UHFFFAOYSA-N					compound annotation
0391_007036	Melitracen	C21H25N	3.4084	25382		CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc12	InChI=1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3	GWWLWDURRGNSRS-UHFFFAOYSA-N					compound annotation
0391_007037	griseofulvin	C17H17ClO6	3.4707	441140	C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC	COC1=CC(=O)CC(C)C12Oc1c(C2=O)c(OC)cc(OC)c1Cl	InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1	DDUHZTYCFQRHIY-RBHXEPJQSA-N					compound annotation
0391_007038	K-Ras-PDEdelta-IN-1	C25H26FN5O2	3.9799	118583099		Cc1ccc(-n2cc3c(C)nn(CCCC(=O)NCCc4ccc(F)cc4)c(=O)c3n2)cc1	InChI=1S/C25H26FN5O2/c1-17-5-11-21(12-6-17)31-16-22-18(2)28-30(25(33)24(22)29-31)15-3-4-23(32)27-14-13-19-7-9-20(26)10-8-19/h5-12,16H,3-4,13-15H2,1-2H3,(H,27,32)	RRELLHHWESTKAK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007040	Panaxatriol	C30H52O4	4.7852	73599	C[C@@]1(CCCC(O1)(C)C)[C@H]2CC[C@@]3([C@@H]2[C@@H](C[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)O)C)O)C	CC1(C)CCCC(C)(C2CCC3(C)C2C(O)CC2C4(C)CCC(O)C(C)(C)C4C(O)CC23C)O1	InChI=1S/C30H52O4/c1-25(2)12-9-13-30(8,34-25)18-10-15-28(6)23(18)19(31)16-21-27(5)14-11-22(33)26(3,4)24(27)20(32)17-29(21,28)7/h18-24,31-33H,9-17H2,1-8H3/t18-,19+,20+,21+,22-,23-,24-,27+,28+,29+,30+/m0/s1	QFJUYMMIBFBOJY-UXZRXANASA-N					compound annotation
0391_007041	Tolycaine	C15H22N2O3	1.6081	72137		CCN(CC)CC(=O)Nc1c(C)cccc1C(=O)OC	InChI=1S/C15H22N2O3/c1-5-17(6-2)10-13(18)16-14-11(3)8-7-9-12(14)15(19)20-4/h7-9H,5-6,10H2,1-4H3,(H,16,18)	UDKICLZCJWQTLS-UHFFFAOYSA-N					compound annotation
0391_007042	DEXETIMIDE	C23H26N2O2	2.3309	30843	C1CN(CCC1[C@@]2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4	O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1	InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m1/s1	LQQIVYSCPWCSSD-HSZRJFAPSA-N					compound annotation
0391_007043	Atuveciclib S-Enantiomer	C18H18FN5O2S	2.3309	124647268	COC1=C(C=CC(=C1)F)C2=NC(=NC=N2)NC3=CC=CC(=C3)C[S@@](=N)(=O)C	COc1c(-c2nc(Nc3cccc(CS(C)(=N)=O)c3)ncn2)ccc(F)c1	InChI=1S/C18H18FN5O2S/c1-26-16-9-13(19)6-7-15(16)17-21-11-22-18(24-17)23-14-5-3-4-12(8-14)10-27(2,20)25/h3-9,11,20H,10H2,1-2H3,(H,21,22,23,24)/t27-/m0/s1	ACWKGTGIJRCOOM-MHZLTWQESA-N					removed another duplicate entry; compound annotation
0391_007045	TAS-116	C25H26N8O	2.648	67501411		CCc1c(-n2nc(C(C)C)c3c(-n4cnc(-c5cn(C)nc5)c4)ccnc32)ccc(C(N)=O)c1	InChI=1S/C25H26N8O/c1-5-16-10-17(24(26)34)6-7-20(16)33-25-22(23(30-33)15(2)3)21(8-9-27-25)32-13-19(28-14-32)18-11-29-31(4)12-18/h6-15H,5H2,1-4H3,(H2,26,34)	NVVPMZUGELHVMH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007047	1262770-73-9	C18H21N5S	3.4074	71304818		CC(C)CNc1nc(NCc2csc(-c3ccccc3)n2)ncc1	InChI=1S/C18H21N5S/c1-13(2)10-20-16-8-9-19-18(23-16)21-11-15-12-24-17(22-15)14-6-4-3-5-7-14/h3-9,12-13H,10-11H2,1-2H3,(H2,19,20,21,23)	DGRJOOOHPBSAHD-UHFFFAOYSA-N					compound annotation
0391_007048	944808-88-2	C18H17ClFN5O2	4.0049	16732433		Cc1nnc(-c2nnc(N3CCC(Oc4c(Cl)ccc(F)c4)CC3)cc2)o1	InChI=1S/C18H17ClFN5O2/c1-11-21-24-18(26-11)15-4-5-17(23-22-15)25-8-6-13(7-9-25)27-16-10-12(20)2-3-14(16)19/h2-5,10,13H,6-9H2,1H3	WFOFPVXMPTVOTJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007050	Brilanestrant	C26H20ClFN2O2	4.7708	56941241	CC/C(=C(/C1=CC=C(C=C1)/C=C/C(=O)O)\C2=CC3=C(C=C2)NN=C3)/C4=C(C=C(C=C4)F)Cl	CCC(=C(c1ccc(C=CC(=O)O)cc1)c1cc2c(cc1)[nH]nc2)c1c(Cl)cc(F)cc1	InChI=1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+	BURHGPHDEVGCEZ-KJGLQBJMSA-N					compound annotation
0391_007051	galanthamine	C17H21NO3	0.7719	9651	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	COc1c2OC3CC(O)C=CC34CCN(C)Cc(c24)cc1	InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1	ASUTZQLVASHGKV-JDFRZJQESA-N					doublet; removed another duplicate entry; compound annotation
0391_007053	Dapiprazole	C19H27N5	1.766	3033538		Cc1ccccc1N1CCN(CCc2nnc3CCCCn32)CC1	InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3	RFWZESUMWJKKRN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007055	cc-115	C16H16N8O	1.8824	58298318		CCN1C(=O)CNc2ncc(-c3c(C)nc(-c4ncn[nH]4)cc3)nc21	InChI=1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23)	GMYLVKUGJMYTFB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007057	Dehydrocorydaline	C22H24NO4+	2.6481	34781		COc1c(OC)cc2c(c1)CC[n+]1c-2c(C)c2ccc(OC)c(OC)c2c1	InChI=1S/C22H24NO4/c1-13-15-6-7-18(24-2)22(27-5)17(15)12-23-9-8-14-10-19(25-3)20(26-4)11-16(14)21(13)23/h6-7,10-12H,8-9H2,1-5H3/q+1	RFKQJTRWODZPHF-UHFFFAOYSA-N					doublet; compound annotation
0391_007058	Senaparib	C24H20F2N6O3	2.9788	68389008		O=C(c1c(F)ccc(Cn2c(=O)[nH]c(=O)c3c(F)cccc32)c1)N1CCN(c2ncccn2)CC1	InChI=1S/C24H20F2N6O3/c25-17-6-5-15(14-32-19-4-1-3-18(26)20(19)21(33)29-24(32)35)13-16(17)22(34)30-9-11-31(12-10-30)23-27-7-2-8-28-23/h1-8,13H,9-12,14H2,(H,29,33,35)	VBTUJTGLLREMNW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007060	Alectinib	C30H34N4O2	3.1232	49806720		CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3	KDGFLJKFZUIJMX-UHFFFAOYSA-N					doublet; compound annotation
0391_007061	calpeptin	C20H30N2O4	4.159	73364	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1	InChI=1S/C20H30N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,13,15,17-18H,4-5,11-12,14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1	PGGUOGKHUUUWAF-ROUUACIJSA-N					doublet; compound annotation
0391_007062	calpeptin	C20H30N2O4	4.1624	73364	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1	InChI=1S/C20H30N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,13,15,17-18H,4-5,11-12,14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1	PGGUOGKHUUUWAF-ROUUACIJSA-N					doublet; compound annotation
0391_007063	calpeptin	C20H30N2O4	4.4472	73364	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1	InChI=1S/C20H30N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,13,15,17-18H,4-5,11-12,14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1	PGGUOGKHUUUWAF-ROUUACIJSA-N					doublet; compound annotation
0391_007064	calpeptin	C20H30N2O4	4.4506	73364	CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1	CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1	InChI=1S/C20H30N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,13,15,17-18H,4-5,11-12,14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1	PGGUOGKHUUUWAF-ROUUACIJSA-N					doublet; compound annotation
0391_007065	BA-53038B	C14H16ClNO	4.613	138454763		O=C(Nc1cc(Cl)ccc1)C1C2CCCCC21	InChI=1S/C14H16ClNO/c15-9-4-3-5-10(8-9)16-14(17)13-11-6-1-2-7-12(11)13/h3-5,8,11-13H,1-2,6-7H2,(H,16,17)	ZLCICHYECNOTGG-UHFFFAOYSA-N					compound annotation
0391_007066	Liensinine	C37H42N2O6	1.6316	160644	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)O)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC	COc1c(OC)cc2c(c1)CCN(C)C2Cc1cc(Oc2c(OC)cc3CCN(C)C(Cc4ccc(O)cc4)c3c2)c(O)cc1	InChI=1S/C37H42N2O6/c1-38-14-13-26-20-35(43-4)37(22-29(26)30(38)16-23-6-9-27(40)10-7-23)45-33-18-24(8-11-32(33)41)17-31-28-21-36(44-5)34(42-3)19-25(28)12-15-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	XCUCMLUTCAKSOZ-FIRIVFDPSA-N					doublet; compound annotation
0391_007067	Liensinine	C37H42N2O6	1.6343	160644	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)O)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC	COc1c(OC)cc2c(c1)CCN(C)C2Cc1cc(Oc2c(OC)cc3CCN(C)C(Cc4ccc(O)cc4)c3c2)c(O)cc1	InChI=1S/C37H42N2O6/c1-38-14-13-26-20-35(43-4)37(22-29(26)30(38)16-23-6-9-27(40)10-7-23)45-33-18-24(8-11-32(33)41)17-31-28-21-36(44-5)34(42-3)19-25(28)12-15-39(31)2/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3/t30-,31-/m1/s1	XCUCMLUTCAKSOZ-FIRIVFDPSA-N					doublet; compound annotation
0391_007068	Liquiritigenin	C15H12O4	2.4907	114829	C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O	O=C1CC(c2ccc(O)cc2)Oc2c1ccc(O)c2	InChI=1S/C15H12O4/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14,16-17H,8H2/t14-/m0/s1	FURUXTVZLHCCNA-AWEZNQCLSA-N					doublet; compound annotation
0391_007069	NIK SMI1	C20H19N3O4	2.7702	117902000	CN1CC[C@](C1=O)(C#CC2=CC(=CC=C2)C3=NC(=CC(=C3)OC)C(=O)N)O	COc1cc(-c2cccc(C#CC3(O)CCN(C)C3=O)c2)nc(C(N)=O)c1	InChI=1S/C20H19N3O4/c1-23-9-8-20(26,19(23)25)7-6-13-4-3-5-14(10-13)16-11-15(27-2)12-17(22-16)18(21)24/h3-5,10-12,26H,8-9H2,1-2H3,(H2,21,24)/t20-/m0/s1	LQSHXYHWYGKAMX-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_007071	Z-WEHD-FMK	C37H42FN7O10	3.1852	25108687	COC(=O)CC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4	COC(=O)CCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OCc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(=O)OC)C(=O)CF	InChI=1S/C37H42FN7O10/c1-53-32(47)13-12-27(34(49)44-30(15-24-19-39-21-41-24)36(51)43-28(31(46)17-38)16-33(48)54-2)42-35(50)29(14-23-18-40-26-11-7-6-10-25(23)26)45-37(52)55-20-22-8-4-3-5-9-22/h3-11,18-19,21,27-30,40H,12-17,20H2,1-2H3,(H,39,41)(H,42,50)(H,43,51)(H,44,49)(H,45,52)/t27-,28-,29-,30-/m0/s1	NLZNSSWGRVBWIX-KRCBVYEFSA-N					doublet; compound annotation
0391_007072	Liquiritigenin	C15H12O4	3.1883	114829	C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O	O=C1CC(c2ccc(O)cc2)Oc2c1ccc(O)c2	InChI=1S/C15H12O4/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14,16-17H,8H2/t14-/m0/s1	FURUXTVZLHCCNA-AWEZNQCLSA-N					doublet; compound annotation
0391_007073	Z-WEHD-FMK	C37H42FN7O10	3.1883	25108687	COC(=O)CC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4	COC(=O)CCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OCc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(CC(=O)OC)C(=O)CF	InChI=1S/C37H42FN7O10/c1-53-32(47)13-12-27(34(49)44-30(15-24-19-39-21-41-24)36(51)43-28(31(46)17-38)16-33(48)54-2)42-35(50)29(14-23-18-40-26-11-7-6-10-25(23)26)45-37(52)55-20-22-8-4-3-5-9-22/h3-11,18-19,21,27-30,40H,12-17,20H2,1-2H3,(H,39,41)(H,42,50)(H,43,51)(H,44,49)(H,45,52)/t27-,28-,29-,30-/m0/s1	NLZNSSWGRVBWIX-KRCBVYEFSA-N					doublet; compound annotation
0391_007074	Remibrutinib	C27H27F2N5O3	3.2019	118107483		C=CC(=O)N(C)CCOc1c(-c2c(C)c(NC(=O)c3c(F)cc(C4CC4)cc3)cc(F)c2)ncnc1N	InChI=1S/C27H27F2N5O3/c1-4-23(35)34(3)9-10-37-25-24(31-14-32-26(25)30)20-12-18(28)13-22(15(20)2)33-27(36)19-8-7-17(11-21(19)29)16-5-6-16/h4,7-8,11-14,16H,1,5-6,9-10H2,2-3H3,(H,33,36)(H2,30,31,32)	CUABMPOJOBCXJI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007076	GW843682X	C22H18F3N3O4S	3.5599	9826308		COc1c(OC)cc2c(c1)ncn2-c1cc(OCc2ccccc2C(F)(F)F)c(C(N)=O)s1	InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)	JSKUWFIZUALZLX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007078	GW843682X	C22H18F3N3O4S	3.5648	9826308		COc1c(OC)cc2c(c1)ncn2-c1cc(OCc2ccccc2C(F)(F)F)c(C(N)=O)s1	InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)	JSKUWFIZUALZLX-UHFFFAOYSA-N					doublet; compound annotation
0391_007079	Chrysosplenetin	C19H18O8	3.6511	5281608		COc1c(O)ccc(-c2c(OC)c(=O)c3c(O)c(OC)c(OC)cc3o2)c1	InChI=1S/C19H18O8/c1-23-11-7-9(5-6-10(11)20)17-19(26-4)16(22)14-12(27-17)8-13(24-2)18(25-3)15(14)21/h5-8,20-21H,1-4H3	NBVTYGIYKCPHQN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007082	ORM-10103	C20H16N2O4	5.3369	17978512		O=[N+]([O-])c1cnc(Oc2cc3c(cc2)OC(c2ccccc2)CC3)cc1	InChI=1S/C20H16N2O4/c23-22(24)16-7-11-20(21-13-16)25-17-8-10-19-15(12-17)6-9-18(26-19)14-4-2-1-3-5-14/h1-5,7-8,10-13,18H,6,9H2	GZONLGPIHCCJOI-UHFFFAOYSA-N					doublet; compound annotation
0391_007083	ORM-10103	C20H16N2O4	5.3398	17978512		O=[N+]([O-])c1cnc(Oc2cc3c(cc2)OC(c2ccccc2)CC3)cc1	InChI=1S/C20H16N2O4/c23-22(24)16-7-11-20(21-13-16)25-17-8-10-19-15(12-17)6-9-18(26-19)14-4-2-1-3-5-14/h1-5,7-8,10-13,18H,6,9H2	GZONLGPIHCCJOI-UHFFFAOYSA-N					doublet; compound annotation
0391_007084	p32 Inhibitor M36	C23H28N8O2	1.1619	416381		O=C(NCCCNC(=O)Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1	InChI=1S/C23H28N8O2/c32-22(30-18-6-1-4-16(14-18)20-24-10-11-25-20)28-8-3-9-29-23(33)31-19-7-2-5-17(15-19)21-26-12-13-27-21/h1-2,4-7,14-15H,3,8-13H2,(H,24,25)(H,26,27)(H2,28,30,32)(H2,29,31,33)	HHFOXYBNULCICF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007086	ML324	C21H23N3O2	1.3518	44143209		CN(C)CCCNC(=O)c1ccc(-c2cc(O)c3ncccc3c2)cc1	InChI=1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26)	QDBVSOZTVKXUES-UHFFFAOYSA-N					compound annotation
0391_007087	p32 Inhibitor M36	C23H28N8O2	1.4749	416381		O=C(NCCCNC(=O)Nc1cccc(C2=NCCN2)c1)Nc1cccc(C2=NCCN2)c1	InChI=1S/C23H28N8O2/c32-22(30-18-6-1-4-16(14-18)20-24-10-11-25-20)28-8-3-9-29-23(33)31-19-7-2-5-17(15-19)21-26-12-13-27-21/h1-2,4-7,14-15H,3,8-13H2,(H,24,25)(H,26,27)(H2,28,30,32)(H2,29,31,33)	HHFOXYBNULCICF-UHFFFAOYSA-N					doublet; compound annotation
0391_007088	(R)-Simurosertib	C17H19N5OS	1.4809	136443810	CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)[C@H]4CC5CCN4CC5	Cc1c(-c2cc3c(s2)c(=O)nc(C2CC4CCN2CC4)[nH]3)cn[nH]1	InChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m1/s1	XGVXKJKTISMIOW-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_007090	Imepitoin	C13H14ClN3O2	2.5025	3083511		O=C1N=C(N2CCOCC2)CN1c1ccc(Cl)cc1	InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2	IQHYCZKIFIHTAI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007092	PF-06459988	C19H22ClN7O3	2.8473	71535003	CN1C=C(C=N1)NC2=NC3=C(C(=CN3)Cl)C(=N2)OC[C@H]4CN(C[C@@H]4OC)C(=O)C=C	C=CC(=O)N1CC(COc2nc(Nc3cn(C)nc3)nc3c2c(Cl)c[nH]3)C(OC)C1	InChI=1S/C19H22ClN7O3/c1-4-15(28)27-7-11(14(9-27)29-3)10-30-18-16-13(20)6-21-17(16)24-19(25-18)23-12-5-22-26(2)8-12/h4-6,8,11,14H,1,7,9-10H2,2-3H3,(H2,21,23,24,25)/t11-,14+/m1/s1	ODMXWZROLKITMS-RISCZKNCSA-N					removed another duplicate entry; compound annotation
0391_007094	indapamide	C16H16ClN3O3S	3.0486	3702		CC1Cc2ccccc2N1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1	InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)	NDDAHWYSQHTHNT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007096	indapamide	C16H16ClN3O3S	3.0517	3702		CC1Cc2ccccc2N1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1	InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)	NDDAHWYSQHTHNT-UHFFFAOYSA-N					doublet; compound annotation
0391_007097	1370256-78-2	C25H27N7O3S2	3.062	57412684		Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4c3ccc(OCCCN3CCOCC3)c4)s2)cc1	InChI=1S/C25H27N7O3S2/c1-17-3-5-18(6-4-17)28-23(33)29-24-30-31-25(37-24)36-22-20-8-7-19(15-21(20)26-16-27-22)35-12-2-9-32-10-13-34-14-11-32/h3-8,15-16H,2,9-14H2,1H3,(H2,28,29,30,33)	LKXFSTAQMOENSC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007099	Brequinar	C23H15F2NO2	3.8934	57030		Cc1c(C(=O)O)c2c(ccc(F)c2)nc1-c1ccc(-c2ccccc2F)cc1	InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28)	PHEZJEYUWHETKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007101	126411-39-0	C24H42O7P2	4.8682	446313		CCOP(=O)(OCC)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OCC)OCC	InChI=1S/C24H42O7P2/c1-11-28-32(26,29-12-2)21(33(27,30-13-3)31-14-4)17-18-15-19(23(5,6)7)22(25)20(16-18)24(8,9)10/h15-17,25H,11-14H2,1-10H3	YQLJDECYQDRSBI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007103	126411-39-0	C24H42O7P2	5.268	446313		CCOP(=O)(OCC)C(=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OCC)OCC	InChI=1S/C24H42O7P2/c1-11-28-32(26,29-12-2)21(33(27,30-13-3)31-14-4)17-18-15-19(23(5,6)7)22(25)20(16-18)24(8,9)10/h15-17,25H,11-14H2,1-10H3	YQLJDECYQDRSBI-UHFFFAOYSA-N					doublet; compound annotation
0391_007104	Oxolamine	C14H19N3O	1.9994	13738		CCN(CC)CCc1nc(-c2ccccc2)no1	InChI=1S/C14H19N3O/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3	IDCHQQSVJAAUQQ-UHFFFAOYSA-N					compound annotation
0391_007105	tenoxicam	C13H11N3O4S2	2.231	54677971		CN1C(C(=O)Nc2ccccn2)=C(O)c2c(ccs2)S1(=O)=O	InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)	LZNWYQJJBLGYLT-UHFFFAOYSA-N					doublet; compound annotation
0391_007106	tenoxicam	C13H11N3O4S2	2.234	54677971		CN1C(C(=O)Nc2ccccn2)=C(O)c2c(ccs2)S1(=O)=O	InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)	LZNWYQJJBLGYLT-UHFFFAOYSA-N					doublet; compound annotation
0391_007107	phenacetin	C10H13NO2	2.2821	4754		CCOc1ccc(NC(C)=O)cc1	InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)	CPJSUEIXXCENMM-UHFFFAOYSA-N					compound annotation
0391_007108	Ftaxilide	C16H15NO3	2.9349	71895		Cc1c(NC(=O)c2ccccc2C(=O)O)c(C)ccc1	InChI=1S/C16H15NO3/c1-10-6-5-7-11(2)14(10)17-15(18)12-8-3-4-9-13(12)16(19)20/h3-9H,1-2H3,(H,17,18)(H,19,20)	LLECMGGNFBKPRH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007110	Icariside I	C27H30O11	3.6841	5745470	CC(=CCC1=C(C=C(C2=C1OC(=C(C2=O)O)C3=CC=C(C=C3)OC)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C	COc1ccc(-c2c(O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C27H30O11/c1-12(2)4-9-15-17(36-27-24(34)22(32)20(30)18(11-28)37-27)10-16(29)19-21(31)23(33)25(38-26(15)19)13-5-7-14(35-3)8-6-13/h4-8,10,18,20,22,24,27-30,32-34H,9,11H2,1-3H3/t18-,20-,22+,24-,27-/m1/s1	IYCPMVXIUPYNHI-WPKKLUCLSA-N					compound annotation
0391_007111	Enclomiphene	C26H28ClNO	4.1601	1548953	CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3	CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1	InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+	GKIRPKYJQBWNGO-OCEACIFDSA-N					doublet; compound annotation
0391_007112	danazol	C22H27NO2	4.4648	28417	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5	C#CC1(O)CCC2C3CCC4=Cc5c(cno5)CC4(C)C3CCC21C	InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1	POZRVZJJTULAOH-LHZXLZLDSA-N					doublet; compound annotation
0391_007113	danazol	C22H27NO2	4.6227	28417	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5	C#CC1(O)CCC2C3CCC4=Cc5c(cno5)CC4(C)C3CCC21C	InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1	POZRVZJJTULAOH-LHZXLZLDSA-N					doublet; compound annotation
0391_007114	AZ3451	C30H27BrN4O3	5.3153	126961335	C[C@@H](C1CCCCC1)N2C3=C(C=C(C=C3)C(=O)NC4=CC=C(C=C4)C#N)N=C2C5=CC6=C(C=C5Br)OCO6	CC(C1CCCCC1)n1c(-c2cc3c(cc2Br)OCO3)nc2cc(C(=O)Nc3ccc(C#N)cc3)ccc21	InChI=1S/C30H27BrN4O3/c1-18(20-5-3-2-4-6-20)35-26-12-9-21(30(36)33-22-10-7-19(16-32)8-11-22)13-25(26)34-29(35)23-14-27-28(15-24(23)31)38-17-37-27/h7-15,18,20H,2-6,17H2,1H3,(H,33,36)/t18-/m0/s1	FJAOGFGHTPYADT-SFHVURJKSA-N					compound annotation
0391_007115	sotalol	C12H20N2O3S	0.7266	5253		CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1	InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3	ZBMZVLHSJCTVON-UHFFFAOYSA-N					compound annotation
0391_007116	Phellodendrine	C20H24NO4+	1.4077	3081405	C[N@@+]12CCC3=CC(=C(C=C3[C@@H]1CC4=CC(=C(C=C4C2)OC)O)O)OC	COc1c(O)cc2CC3c4cc(O)c(OC)cc4CC[N+]3(C)Cc2c1	InChI=1S/C20H23NO4/c1-21-5-4-12-8-19(24-2)18(23)10-15(12)16(21)6-13-7-17(22)20(25-3)9-14(13)11-21/h7-10,16H,4-6,11H2,1-3H3,(H-,22,23)/p+1/t16-,21-/m0/s1	RBBVPNQTBKHOEQ-KKSFZXQISA-O					doublet; compound annotation
0391_007117	Neuromedin N	C38H63N7O8	2.2498	9940301	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)N	CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C(NC(=O)C(N)CCCCN)C(C)CC)C(=O)NC(CC(C)C)C(=O)O	InChI=1S/C38H63N7O8/c1-7-23(5)31(36(50)42-29(38(52)53)20-22(3)4)43-34(48)28(21-25-14-16-26(46)17-15-25)41-35(49)30-13-11-19-45(30)37(51)32(24(6)8-2)44-33(47)27(40)12-9-10-18-39/h14-17,22-24,27-32,46H,7-13,18-21,39-40H2,1-6H3,(H,41,49)(H,42,50)(H,43,48)(H,44,47)(H,52,53)/t23-,24-,27-,28-,29-,30-,31-,32-/m0/s1	RZMLVIHXZGQADB-YLUGYNJDSA-N					removed another duplicate entry; compound annotation
0391_007119	Columbin	C20H22O6	2.8756	442015	C[C@@]12CC[C@H]3C(=O)O[C@@H](C[C@]3([C@@H]1[C@H]4C=C[C@@]2(C(=O)O4)O)C)C5=COC=C5	CC12CC(c3cocc3)OC(=O)C1CCC1(C)C2C2C=CC1(O)C(=O)O2	InChI=1S/C20H22O6/c1-18-9-14(11-5-8-24-10-11)25-16(21)12(18)3-6-19(2)15(18)13-4-7-20(19,23)17(22)26-13/h4-5,7-8,10,12-15,23H,3,6,9H2,1-2H3/t12-,13+,14-,15-,18+,19+,20-/m0/s1	AALLCALQGXXWNA-QJNFORGASA-N					compound annotation
0391_007120	1225278-16-9	C26H21F2N5O3	3.4606	46208890		Cn1cc(-c2nccc(Oc3c(F)cc(NC(=O)C4(C(=O)Nc5ccccc5)CC4)c(F)c3)c2)cn1	InChI=1S/C26H21F2N5O3/c1-33-15-16(14-30-33)21-11-18(7-10-29-21)36-23-13-19(27)22(12-20(23)28)32-25(35)26(8-9-26)24(34)31-17-5-3-2-4-6-17/h2-7,10-15H,8-9H2,1H3,(H,31,34)(H,32,35)	WWOXKWLDMLMYQY-UHFFFAOYSA-N					doublet; compound annotation
0391_007121	1225278-16-9	C26H21F2N5O3	3.4633	46208890		Cn1cc(-c2nccc(Oc3c(F)cc(NC(=O)C4(C(=O)Nc5ccccc5)CC4)c(F)c3)c2)cn1	InChI=1S/C26H21F2N5O3/c1-33-15-16(14-30-33)21-11-18(7-10-29-21)36-23-13-19(27)22(12-20(23)28)32-25(35)26(8-9-26)24(34)31-17-5-3-2-4-6-17/h2-7,10-15H,8-9H2,1H3,(H,31,34)(H,32,35)	WWOXKWLDMLMYQY-UHFFFAOYSA-N					doublet; compound annotation
0391_007122	Tebuconazole	C16H22ClN3O	3.6338	86102		CC(C)(C)C(O)(CCc1ccc(Cl)cc1)Cn1cncn1	InChI=1S/C16H22ClN3O/c1-15(2,3)16(21,10-20-12-18-11-19-20)9-8-13-4-6-14(17)7-5-13/h4-7,11-12,21H,8-10H2,1-3H3	PXMNMQRDXWABCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007123	ceritinib	C28H36ClN5O3S	3.788	57379345		Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)	VERWOWGGCGHDQE-UHFFFAOYSA-N					doublet; compound annotation
0391_007124	ceritinib	C28H36ClN5O3S	3.7912	57379345		Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)	VERWOWGGCGHDQE-UHFFFAOYSA-N					doublet; compound annotation
0391_007125	Tebuconazole	C16H22ClN3O	4.3107	86102		CC(C)(C)C(O)(CCc1ccc(Cl)cc1)Cn1cncn1	InChI=1S/C16H22ClN3O/c1-15(2,3)16(21,10-20-12-18-11-19-20)9-8-13-4-6-14(17)7-5-13/h4-7,11-12,21H,8-10H2,1-3H3	PXMNMQRDXWABCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007126	BIIB021	C14H15ClN6O	1.7134	16736529		COc1c(C)c(Cn2cnc3c2nc(N)nc3Cl)ncc1C	InChI=1S/C14H15ClN6O/c1-7-4-17-9(8(2)11(7)22-3)5-21-6-18-10-12(15)19-14(16)20-13(10)21/h4,6H,5H2,1-3H3,(H2,16,19,20)	QULDDKSCVCJTPV-UHFFFAOYSA-N					compound annotation
0391_007127	AC-73	C21H21NO2	2.8	2989791		Oc1cccc(C(O)CNCc2ccc(-c3ccccc3)cc2)c1	InChI=1S/C21H21NO2/c23-20-8-4-7-19(13-20)21(24)15-22-14-16-9-11-18(12-10-16)17-5-2-1-3-6-17/h1-13,21-24H,14-15H2	UECKKYNEEBRMIL-UHFFFAOYSA-N					compound annotation
0391_007128	501925-31-1	C13H14ClN3O4	3.6898	311434		COc1c(Cl)cc(NC(=O)Nc2noc(C)c2)c(OC)c1	InChI=1S/C13H14ClN3O4/c1-7-4-12(17-21-7)16-13(18)15-9-5-8(14)10(19-2)6-11(9)20-3/h4-6H,1-3H3,(H2,15,16,17,18)	CEIIEALEIHQDBX-UHFFFAOYSA-N					doublet; compound annotation
0391_007129	501925-31-1	C13H14ClN3O4	3.6935	311434		COc1c(Cl)cc(NC(=O)Nc2noc(C)c2)c(OC)c1	InChI=1S/C13H14ClN3O4/c1-7-4-12(17-21-7)16-13(18)15-9-5-8(14)10(19-2)6-11(9)20-3/h4-6H,1-3H3,(H2,15,16,17,18)	CEIIEALEIHQDBX-UHFFFAOYSA-N					doublet; compound annotation
0391_007130	IWR-1-endo	C25H19N3O3	4.221	44483163	C1[C@@H]2C=C[C@H]1[C@@H]3[C@H]2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6	O=C(Nc1cccc2c1nccc2)c1ccc(N2C(=O)C3C4C=CC(C4)C3C2=O)cc1	InChI=1S/C25H19N3O3/c29-23(27-19-5-1-3-14-4-2-12-26-22(14)19)15-8-10-18(11-9-15)28-24(30)20-16-6-7-17(13-16)21(20)25(28)31/h1-12,16-17,20-21H,13H2,(H,27,29)/t16-,17+,20-,21+	ZGSXEXBYLJIOGF-ALFLXDJESA-N					compound annotation
0391_007131	Stearyldiethanolamine	C22H47NO2	5.4896	61494		CCCCCCCCCCCCCCCCCCN(CCO)CCO	InChI=1S/C22H47NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(19-21-24)20-22-25/h24-25H,2-22H2,1H3	NDLNTMNRNCENRZ-UHFFFAOYSA-N					compound annotation
0391_007132	Sarafloxacin	C20H17F2N3O3	1.8672	25273230		O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O	InChI=1S/C20H17F2N3O3/c21-12-1-3-13(4-2-12)25-11-15(20(27)28)19(26)14-9-16(22)18(10-17(14)25)24-7-5-23-6-8-24/h1-4,9-11,23H,5-8H2,(H,27,28)	XBHBWNFJWIASRO-UHFFFAOYSA-N					compound annotation
0391_007133	93076-89-2	C27H26FN3OS	3.4335	3012		Cc1c(CCN2CCC(=C(c3ccccc3)c3ccc(F)cc3)CC2)c(=O)n2ccsc2n1	InChI=1S/C27H26FN3OS/c1-19-24(26(32)31-17-18-33-27(31)29-19)13-16-30-14-11-22(12-15-30)25(20-5-3-2-4-6-20)21-7-9-23(28)10-8-21/h2-10,17-18H,11-16H2,1H3	MFVJXLPANKSLLD-UHFFFAOYSA-N					compound annotation
0391_007134	936339-60-5	C21H18N4O2	3.0566	16719049		Nc1c(-c2cc(Cc3ccc(COc4ccccn4)cc3)no2)cccn1	InChI=1S/C21H18N4O2/c22-21-18(4-3-11-24-21)19-13-17(25-27-19)12-15-6-8-16(9-7-15)14-26-20-5-1-2-10-23-20/h1-11,13H,12,14H2,(H2,22,24)	WSEKTEUGRLFBSE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007136	naftopidil	C24H28N2O3	3.1927	4418		COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1	InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3	HRRBJVNMSRJFHQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007138	AC710	C31H42N6O4	3.4912	54760053		CCN1C(C)(C)CC(Oc2cnc(C(=O)Nc3ccc(NC(=O)Nc4noc(C(C)(C)C)c4)cc3)cc2)CC1(C)C	InChI=1S/C31H42N6O4/c1-9-37-30(5,6)17-23(18-31(37,7)8)40-22-14-15-24(32-19-22)27(38)33-20-10-12-21(13-11-20)34-28(39)35-26-16-25(41-36-26)29(2,3)4/h10-16,19,23H,9,17-18H2,1-8H3,(H,33,38)(H2,34,35,36,39)	JVCWPUFNLFSKFS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007140	ACT-709478	C22H18F3N5O	4.1061	118560618		N#Cc1cnc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)cc1	InChI=1S/C22H18F3N5O/c23-22(24,25)21(8-9-21)17-4-1-15(2-5-17)11-20(31)28-19-7-10-30(29-19)14-18-6-3-16(12-26)13-27-18/h1-7,10,13H,8-9,11,14H2,(H,28,29,31)	LSYANGLAZUZYFX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007142	LHF-535	C27H28N2O2	4.3265	71711529	CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C\C4=CC=C(C=C4)C(C)(C)O	CC(C)Oc1ccc(-n2cnc3c2ccc(C=Cc2ccc(C(C)(C)O)cc2)c3)cc1	InChI=1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5-	DBNZTRPIBJSUIX-WAYWQWQTSA-N					doublet; compound annotation
0391_007143	LHF-535	C27H28N2O2	4.4079	71711529	CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)/C=C\C4=CC=C(C=C4)C(C)(C)O	CC(C)Oc1ccc(-n2cnc3c2ccc(C=Cc2ccc(C(C)(C)O)cc2)c3)cc1	InChI=1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5-	DBNZTRPIBJSUIX-WAYWQWQTSA-N					doublet; removed another duplicate entry; compound annotation
0391_007146	Quiflapon	C34H35ClN2O3S	5.9985	60923		CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2c1cc(OCc1nc3ccccc3cc1)cc2	InChI=1S/C34H35ClN2O3S/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39/h6-18H,19-21H2,1-5H3,(H,38,39)	NZOONKHCNQFYCI-UHFFFAOYSA-N					doublet; compound annotation
0391_007147	Quiflapon	C34H35ClN2O3S	6.0013	60923		CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2c1cc(OCc1nc3ccccc3cc1)cc2	InChI=1S/C34H35ClN2O3S/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39/h6-18H,19-21H2,1-5H3,(H,38,39)	NZOONKHCNQFYCI-UHFFFAOYSA-N					doublet; compound annotation
0391_007148	ARS-1620	C21H17ClF2N4O2	3.01	137003167		C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1	InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2	ZRPZPNYZFSJUPA-UHFFFAOYSA-N					doublet; compound annotation
0391_007149	Tenacissoside H	C42H66O14	4.5579	75412560	CCC(C)C(=O)O[C@H]1[C@@H]2[C@]3(CC[C@@H](C[C@@H]3CC[C@@]24[C@@]5(O4)CC[C@H]([C@]5([C@@H]1OC(=O)C)C)C(=O)C)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O[C@H]7[C@@H]([C@@H]([C@@H]([C@H](O7)C)O)OC)O)OC)C	CCC(C)C(=O)OC1C2C3(C)CCC(OC4CC(OC)C(OC5OC(C)C(O)C(OC)C5O)C(C)O4)CC3CCC23OC32CCC(C(C)=O)C2(C)C1OC(C)=O	InChI=1S/C42H66O14/c1-11-20(2)37(47)54-34-35-39(7)15-13-26(53-29-19-28(48-9)32(23(5)50-29)55-38-31(46)33(49-10)30(45)22(4)51-38)18-25(39)12-16-41(35)42(56-41)17-14-27(21(3)43)40(42,8)36(34)52-24(6)44/h20,22-23,25-36,38,45-46H,11-19H2,1-10H3/t20?,22-,23-,25+,26+,27+,28-,29+,30-,31-,32-,33-,34+,35-,36-,38+,39+,40+,41+,42-/m1/s1	HRSFCYYMBMDMOU-ZIAOJATMSA-N					compound annotation
0391_007150	ETC-206	C25H20N4O2	2.2071	71766360		N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1	InChI=1S/C25H20N4O2/c26-15-18-1-3-20(4-2-18)23-16-27-24-10-9-22(17-29(23)24)19-5-7-21(8-6-19)25(30)28-11-13-31-14-12-28/h1-10,16-17H,11-14H2	FWRFPHJSGLYXTD-UHFFFAOYSA-N					compound annotation
0391_007151	INCB054329	C19H16N4O3	2.6828	90410660	CC1=C(C(=NO1)C)C2=C3C4=C(C=C2)NC(=O)N4[C@H](CO3)C5=CC=CC=N5	Cc1noc(C)c1-c1ccc2[nH]c(=O)n3c2c1OCC3c1ccccn1	InChI=1S/C19H16N4O3/c1-10-16(11(2)26-22-10)12-6-7-14-17-18(12)25-9-15(23(17)19(24)21-14)13-5-3-4-8-20-13/h3-8,15H,9H2,1-2H3,(H,21,24)/t15-/m1/s1	XYLPKCDRAAYATL-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_007153	Aurora Kinase Inhibitor III	C21H18F3N5O	3.106	9549303		O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1	InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(11-14)26-18-9-10-25-20(29-18)28-17-6-2-5-16(12-17)27-19(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,27,30)(H2,25,26,28,29)	RDTDWGQDFJPTPD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007155	1442472-39-0	C24H21BrFN5O2	3.1706	71584930		CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21	InChI=1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33)	CEFJVGZHQAGLHS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007157	JZL195	C24H23N3O5	3.4955	46232606		O=C(Oc1ccc([N+](=O)[O-])cc1)N1CCN(Cc2cc(Oc3ccccc3)ccc2)CC1	InChI=1S/C24H23N3O5/c28-24(32-22-11-9-20(10-12-22)27(29)30)26-15-13-25(14-16-26)18-19-5-4-8-23(17-19)31-21-6-2-1-3-7-21/h1-12,17H,13-16,18H2	QNYRAEKLMNDRFY-UHFFFAOYSA-N					compound annotation
0391_007158	GW806742X	C25H22F3N7O4S	3.5629	5329829		CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1nc(Nc2cc(S(N)(=O)=O)ccc2)ncc1	InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)	SNRUTMWCDZHKKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007160	BQU57	C16H13F3N4O	3.6782	77845606		Cc1nn(C)c2c1C(c1ccc(C(F)(F)F)cc1)C(C#N)=C(N)O2	InChI=1S/C16H13F3N4O/c1-8-12-13(9-3-5-10(6-4-9)16(17,18)19)11(7-20)14(21)24-15(12)23(2)22-8/h3-6,13H,21H2,1-2H3	IJCMHHSFXFMZAI-UHFFFAOYSA-N					compound annotation
0391_007161	amiodarone	C25H29I2NO3	4.6543	2157		CCCCc1c(C(=O)c2cc(I)c(OCCN(CC)CC)c(I)c2)c2ccccc2o1	InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3	IYIKLHRQXLHMJQ-UHFFFAOYSA-N					compound annotation
0391_007162	Monepantel	C20H13F6N3O2S	5.0648	44449087	C[C@@](COC1=C(C=CC(=C1)C#N)C(F)(F)F)(C#N)NC(=O)C2=CC=C(C=C2)SC(F)(F)F	CC(C#N)(COc1c(C(F)(F)F)ccc(C#N)c1)NC(=O)c1ccc(SC(F)(F)F)cc1	InChI=1S/C20H13F6N3O2S/c1-18(10-28,11-31-16-8-12(9-27)2-7-15(16)19(21,22)23)29-17(30)13-3-5-14(6-4-13)32-20(24,25)26/h2-8H,11H2,1H3,(H,29,30)/t18-/m0/s1	WTERNLDOAPYGJD-SFHVURJKSA-N					compound annotation
0391_007163	SGC3027	C41H47ClN6O6S	5.1623	137333447	CC1=C(C(=O)C(=C(C1=O)C)C(C)(C)CC(=O)N(CCCCSC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)CC5=CC(=CC=C5)C6=CC=C(C=C6)Cl)C	CC1=C(C)C(=O)C(C(C)(C)CC(=O)N(CCCCSCC2OC(n3cnc4c(N)ncnc43)C(O)C2O)Cc2cc(-c3ccc(Cl)cc3)ccc2)=C(C)C1=O	InChI=1S/C41H47ClN6O6S/c1-23-24(2)35(51)32(25(3)34(23)50)41(4,5)18-31(49)47(19-26-9-8-10-28(17-26)27-11-13-29(42)14-12-27)15-6-7-16-55-20-30-36(52)37(53)40(54-30)48-22-46-33-38(43)44-21-45-39(33)48/h8-14,17,21-22,30,36-37,40,52-53H,6-7,15-16,18-20H2,1-5H3,(H2,43,44,45)/t30-,36-,37-,40-/m1/s1	MLJVGAYSVYMPSB-MSUKGTQXSA-N					compound annotation
0391_007164	Mizolastine	C24H25FN6O	2.4374	65906		CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1	InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)	PVLJETXTTWAYEW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007166	N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide	C14H10N4O3	2.7297	3572750		O=C(Nc1nc2ccccc2[nH]1)c1cc([N+](=O)[O-])ccc1	InChI=1S/C14H10N4O3/c19-13(9-4-3-5-10(8-9)18(20)21)17-14-15-11-6-1-2-7-12(11)16-14/h1-8H,(H2,15,16,17,19)	QPKROMNIEAEFQA-UHFFFAOYSA-N					compound annotation
0391_007167	Nav1.1 activator 1	C24H23F3N4O	3.0973	146014435	CC(C)C1=NC=C(C=C1)NC(=O)C2=C(C=CN=C2N3CC[C@@H](C3)F)C4=C(C=CC(=C4)F)F	CC(C)c1ncc(NC(=O)c2c(-c3c(F)ccc(F)c3)ccnc2N2CCC(F)C2)cc1	InChI=1S/C24H23F3N4O/c1-14(2)21-6-4-17(12-29-21)30-24(32)22-18(19-11-15(25)3-5-20(19)27)7-9-28-23(22)31-10-8-16(26)13-31/h3-7,9,11-12,14,16H,8,10,13H2,1-2H3,(H,30,32)/t16-/m0/s1	HRGJTEFGFUJXIF-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_007169	quinapril	C25H30N2O5	3.2128	54892	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2ccccc2CC1C(=O)O	InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1	JSDRRTOADPPCHY-HSQYWUDLSA-N					compound annotation
0391_007170	GSK481	C21H19N3O4	4.0624	90351311	CN1C2=CC=CC=C2OC[C@@H](C1=O)NC(=O)C3=NOC(=C3)CC4=CC=CC=C4	CN1C(=O)C(NC(=O)c2noc(Cc3ccccc3)c2)COc2ccccc21	InChI=1S/C21H19N3O4/c1-24-18-9-5-6-10-19(18)27-13-17(21(24)26)22-20(25)16-12-15(28-23-16)11-14-7-3-2-4-8-14/h2-10,12,17H,11,13H2,1H3,(H,22,25)/t17-/m0/s1	KNOUWGGQMADIBV-KRWDZBQOSA-N					doublet; compound annotation
0391_007171	GSK481	C21H19N3O4	4.3035	90351311	CN1C2=CC=CC=C2OC[C@@H](C1=O)NC(=O)C3=NOC(=C3)CC4=CC=CC=C4	CN1C(=O)C(NC(=O)c2noc(Cc3ccccc3)c2)COc2ccccc21	InChI=1S/C21H19N3O4/c1-24-18-9-5-6-10-19(18)27-13-17(21(24)26)22-20(25)16-12-15(28-23-16)11-14-7-3-2-4-8-14/h2-10,12,17H,11,13H2,1H3,(H,22,25)/t17-/m0/s1	KNOUWGGQMADIBV-KRWDZBQOSA-N					doublet; compound annotation
0391_007172	GSK481	C21H19N3O4	4.3064	90351311	CN1C2=CC=CC=C2OC[C@@H](C1=O)NC(=O)C3=NOC(=C3)CC4=CC=CC=C4	CN1C(=O)C(NC(=O)c2noc(Cc3ccccc3)c2)COc2ccccc21	InChI=1S/C21H19N3O4/c1-24-18-9-5-6-10-19(18)27-13-17(21(24)26)22-20(25)16-12-15(28-23-16)11-14-7-3-2-4-8-14/h2-10,12,17H,11,13H2,1H3,(H,22,25)/t17-/m0/s1	KNOUWGGQMADIBV-KRWDZBQOSA-N					doublet; compound annotation
0391_007173	PTP1B-IN-2	C34H36N2O9S2	5.0893	127050086		COC(=O)CN(c1ccc(CN(c2cc(C(=O)OC)c(OCc3ccc(C)cc3)cc2)S(=O)(=O)Cc2ccccc2)cc1)S(C)(=O)=O	InChI=1S/C34H36N2O9S2/c1-25-10-12-27(13-11-25)23-45-32-19-18-30(20-31(32)34(38)44-3)36(47(41,42)24-28-8-6-5-7-9-28)21-26-14-16-29(17-15-26)35(46(4,39)40)22-33(37)43-2/h5-20H,21-24H2,1-4H3	IPNJQCVHNPGYOX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007176	Decursinol	C14H14O4	2.5723	442127	CC1([C@H](CC2=C(O1)C=C3C(=C2)C=CC(=O)O3)O)C	CC1(C)Oc2c(cc3ccc(=O)oc3c2)CC1O	InChI=1S/C14H14O4/c1-14(2)12(15)6-9-5-8-3-4-13(16)17-10(8)7-11(9)18-14/h3-5,7,12,15H,6H2,1-2H3/t12-/m0/s1	BGXFQDFSVDZUIW-LBPRGKRZSA-N					compound annotation
0391_007177	24916-90-3	C22H28O5	3.2015	11143226	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@]1(C(=O)CO)O)C)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C34OC4CC2(C)C1(O)C(=O)CO	InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)22(15)18(27-22)10-20(16,3)21(12,26)17(25)11-23/h6-7,9,12,15-16,18,23,26H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19+,20+,21+,22-/m1/s1	GBDXNHBVYAMODG-QDBZYVRYSA-N					compound annotation
0391_007178	ozagrel	C13H12N2O2	0.9107	5282440	C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O	O=C(O)C=Cc1ccc(Cn2ccnc2)cc1	InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+	SHZKQBHERIJWAO-AATRIKPKSA-N					doublet; compound annotation
0391_007179	salicin	C13H18O7	0.9563	439503	C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O	OCc1ccccc1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1	NGFMICBWJRZIBI-UJPOAAIJSA-N					compound annotation
0391_007180	ozagrel	C13H12N2O2	1.1603	5282440	C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O	O=C(O)C=Cc1ccc(Cn2ccnc2)cc1	InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+	SHZKQBHERIJWAO-AATRIKPKSA-N					doublet; compound annotation
0391_007181	Akt1 and Akt2-IN-1	C33H29N7O	2.2471	11656753		O=c1[nH]ccc2c1cc(-c1ccccc1)c(-c1ccc(CN3CCC(c4nc(-c5ccccn5)n[nH]4)CC3)cc1)n2	InChI=1S/C33H29N7O/c41-33-27-20-26(23-6-2-1-3-7-23)30(36-28(27)13-17-35-33)24-11-9-22(10-12-24)21-40-18-14-25(15-19-40)31-37-32(39-38-31)29-8-4-5-16-34-29/h1-13,16-17,20,25H,14-15,18-19,21H2,(H,35,41)(H,37,38,39)	BTUWHHFNOHVCMQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007183	AZ7550	C27H31N7O2	2.312	71496459		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCNC	InChI=1S/C27H31N7O2/c1-6-26(35)30-21-15-22(25(36-5)16-24(21)33(3)14-13-28-2)32-27-29-12-11-20(31-27)19-17-34(4)23-10-8-7-9-18(19)23/h6-12,15-17,28H,1,13-14H2,2-5H3,(H,30,35)(H,29,31,32)	ZROCWKZRGJYPTG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007185	AZ7550	C27H31N7O2	2.3152	71496459		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCNC	InChI=1S/C27H31N7O2/c1-6-26(35)30-21-15-22(25(36-5)16-24(21)33(3)14-13-28-2)32-27-29-12-11-20(31-27)19-17-34(4)23-10-8-7-9-18(19)23/h6-12,15-17,28H,1,13-14H2,2-5H3,(H,30,35)(H,29,31,32)	ZROCWKZRGJYPTG-UHFFFAOYSA-N					doublet; compound annotation
0391_007186	Dovitinib	C21H21FN6O	2.3201	135398510		CN1CCN(c2cc3c(cc2)nc(-c2c(N)c4c(cccc4F)[nH]c2=O)[nH]3)CC1	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	PIQCTGMSNWUMAF-UHFFFAOYSA-N					doublet; compound annotation
0391_007187	Dovitinib	C21H21FN6O	2.3287	135398510		CN1CCN(c2cc3c(cc2)nc(-c2c(N)c4c(cccc4F)[nH]c2=O)[nH]3)CC1	InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)	PIQCTGMSNWUMAF-UHFFFAOYSA-N					doublet; compound annotation
0391_007188	Evodiamine	C19H17N3O	3.8988	442088	CN1[C@@H]2C3=C(CCN2C(=O)C4=CC=CC=C41)C5=CC=CC=C5N3	CN1c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)C21	InChI=1S/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3/t18-/m0/s1	TXDUTHBFYKGSAH-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_007190	cefmenoxime	C16H17N9O5S3	1.6253	9570757	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CSC12)c1csc(N)n1	InChI=1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1	HJJDBAOLQAWBMH-YCRCPZNHSA-N					removed another duplicate entry; compound annotation
0391_007192	Quercetagitrin	C21H20O13	1.6337	5320826	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O)O)O	O=c1c(O)c(-c2cc(O)c(O)cc2)oc2cc(OC3OC(CO)C(O)C(O)C3O)c(O)c(O)c12	InChI=1S/C21H20O13/c22-5-11-14(26)17(29)19(31)21(34-11)33-10-4-9-12(15(27)13(10)25)16(28)18(30)20(32-9)6-1-2-7(23)8(24)3-6/h1-4,11,14,17,19,21-27,29-31H,5H2/t11-,14-,17+,19-,21-/m1/s1	IDTDRZPBDLMCLB-HSOQPIRZSA-N					removed another duplicate entry; compound annotation
0391_007194	1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine	C13H18Cl2N2	2.1977	574780		CN1CCN(CCc2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C13H18Cl2N2/c1-16-6-8-17(9-7-16)5-4-11-2-3-12(14)13(15)10-11/h2-3,10H,4-9H2,1H3	SUIZRDJCBVPASY-UHFFFAOYSA-N					compound annotation
0391_007195	zomepirac	C15H14ClNO3	3.8308	5733		Cc1c(C(=O)c2ccc(Cl)cc2)n(C)c(CC(=O)O)c1	InChI=1S/C15H14ClNO3/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10/h3-7H,8H2,1-2H3,(H,18,19)	ZXVNMYWKKDOREA-UHFFFAOYSA-N					compound annotation
0391_007196	AGI-24512	C24H24N4O2	4.0271	134307780		Cc1c(-c2ccc(O)cc2)c(=O)n2[nH]c(-c3ccccc3)c(N3CCCCC3)c2n1	InChI=1S/C24H24N4O2/c1-16-20(17-10-12-19(29)13-11-17)24(30)28-23(25-16)22(27-14-6-3-7-15-27)21(26-28)18-8-4-2-5-9-18/h2,4-5,8-13,26,29H,3,6-7,14-15H2,1H3	VFEXODVWKUOZBF-UHFFFAOYSA-N					compound annotation
0391_007197	vicagrel	C18H18ClNO4S	4.1723	53378151	CC(=O)OC1=CC2=C(S1)CCN(C2)[C@@H](C3=CC=CC=C3Cl)C(=O)OC	COC(=O)C(c1ccccc1Cl)N1CCc2c(cc(OC(C)=O)s2)C1	InChI=1S/C18H18ClNO4S/c1-11(21)24-16-9-12-10-20(8-7-15(12)25-16)17(18(22)23-2)13-5-3-4-6-14(13)19/h3-6,9,17H,7-8,10H2,1-2H3/t17-/m0/s1	GNHHCBSBCDGWND-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_007199	Curdione	C15H24O2	4.3177	6441391	C[C@H]1CC/C=C(/CC(=O)[C@@H](CC1=O)C(C)C)\C	CC1=CCCC(C)C(=O)CC(C(C)C)C(=O)C1	InChI=1S/C15H24O2/c1-10(2)13-9-14(16)12(4)7-5-6-11(3)8-15(13)17/h6,10,12-13H,5,7-9H2,1-4H3/b11-6+/t12-,13-/m0/s1	KDPFMRXIVDLQKX-NHFJXKHHSA-N					removed another duplicate entry; compound annotation
0391_007201	HALOBETASOL PROPIONATE	C25H31ClF2O5	4.5314	6918178	CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl	CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1	BDSYKGHYMJNPAB-LICBFIPMSA-N					compound annotation
0391_007202	1494675-86-3	C18H21N5O3	1.8631	72792692		COc1ncnc(Cn2cc(C(=O)NCCO)c3c2cc(C)cn3)c1C	InChI=1S/C18H21N5O3/c1-11-6-15-16(20-7-11)13(17(25)19-4-5-24)8-23(15)9-14-12(2)18(26-3)22-10-21-14/h6-8,10,24H,4-5,9H2,1-3H3,(H,19,25)	VDRYGTNDKXIPSK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007204	14003-96-4	C11H8O4	2.6762	12934390		Cc1cc(=O)oc2c1ccc(O)c2C=O	InChI=1S/C11H8O4/c1-6-4-10(14)15-11-7(6)2-3-9(13)8(11)5-12/h2-5,13H,1H3	RTHHSXOVIJWFQP-UHFFFAOYSA-N					compound annotation
0391_007205	Alpinetin	C16H14O4	3.0694	154279	COC1=CC(=CC2=C1C(=O)C[C@H](O2)C3=CC=CC=C3)O	COc1cc(O)cc2c1C(=O)CC(c1ccccc1)O2	InChI=1S/C16H14O4/c1-19-14-7-11(17)8-15-16(14)12(18)9-13(20-15)10-5-3-2-4-6-10/h2-8,13,17H,9H2,1H3/t13-/m0/s1	QQQCWVDPMPFUGF-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_007207	Valnemulin (Hydrochloride)	C31H52N2O5S	3.4021	127791	C[C@@H]1CCC23CCC(=O)[C@H]2C1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)[C@@H](C(C)C)N)C	C=CC1(C)CC(OC(=O)CSC(C)(C)CNC(=O)C(N)C(C)C)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C31H52N2O5S/c1-10-29(8)15-22(38-23(35)16-39-28(6,7)17-33-27(37)24(32)18(2)3)30(9)19(4)11-13-31(20(5)26(29)36)14-12-21(34)25(30)31/h10,18-20,22,24-26,36H,1,11-17,32H2,2-9H3,(H,33,37)/t19-,20+,22-,24-,25+,26+,29-,30?,31?/m1/s1	LLYYNOVSVPBRGV-FMWPFBIJSA-N					doublet; removed another duplicate entry; compound annotation
0391_007209	MUT056399	C15H13F2NO3	3.4922	44208849		CCc1cc(O)c(Oc2c(F)cc(C(N)=O)cc2)cc1F	InChI=1S/C15H13F2NO3/c1-2-8-6-12(19)14(7-10(8)16)21-13-4-3-9(15(18)20)5-11(13)17/h3-7,19H,2H2,1H3,(H2,18,20)	QUHARGDBJJUOEB-UHFFFAOYSA-N					compound annotation
0391_007210	ML240	C23H20N6O	3.5051	49830258		COc1cccc2c1nc(-n1c(N)nc3ccccc31)nc2NCc1ccccc1	InChI=1S/C23H20N6O/c1-30-19-13-7-10-16-20(19)27-23(28-21(16)25-14-15-8-3-2-4-9-15)29-18-12-6-5-11-17(18)26-22(29)24/h2-13H,14H2,1H3,(H2,24,26)(H,25,27,28)	NHAMBLRUUJAFOY-UHFFFAOYSA-N					compound annotation
0391_007211	Valnemulin (Hydrochloride)	C31H52N2O5S	3.7109	127791	C[C@@H]1CCC23CCC(=O)[C@H]2C1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC(C)(C)CNC(=O)[C@@H](C(C)C)N)C	C=CC1(C)CC(OC(=O)CSC(C)(C)CNC(=O)C(N)C(C)C)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C31H52N2O5S/c1-10-29(8)15-22(38-23(35)16-39-28(6,7)17-33-27(37)24(32)18(2)3)30(9)19(4)11-13-31(20(5)26(29)36)14-12-21(34)25(30)31/h10,18-20,22,24-26,36H,1,11-17,32H2,2-9H3,(H,33,37)/t19-,20+,22-,24-,25+,26+,29-,30?,31?/m1/s1	LLYYNOVSVPBRGV-FMWPFBIJSA-N					doublet; compound annotation
0391_007212	TMP269	C25H21F3N4O3S	4.3196	53344908		O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1	InChI=1S/C25H21F3N4O3S/c26-25(27,28)22-31-20(32-35-22)17-7-4-8-18(13-17)21(33)29-15-24(9-11-34-12-10-24)23-30-19(14-36-23)16-5-2-1-3-6-16/h1-8,13-14H,9-12,15H2,(H,29,33)	HORXBWNTEDOVKN-UHFFFAOYSA-N					doublet; compound annotation
0391_007213	TMP780	C31H30N2O4	4.617	145925629	CC1=CC(=C(C=C1)[C@H](C2=CC=CC=C2)NC(=O)CC3=CC4=C(C=C3)OC(=C4)[C@@H](C5=C(ON=C5C)C)O)C	Cc1cc(C)c(C(NC(=O)Cc2cc3c(cc2)oc(C(O)c2c(C)onc2C)c3)c2ccccc2)cc1	InChI=1S/C31H30N2O4/c1-18-10-12-25(19(2)14-18)30(23-8-6-5-7-9-23)32-28(34)16-22-11-13-26-24(15-22)17-27(36-26)31(35)29-20(3)33-37-21(29)4/h5-15,17,30-31,35H,16H2,1-4H3,(H,32,34)/t30-,31-/m0/s1	DIURRJOJDQOMFC-CONSDPRKSA-N					removed another duplicate entry; compound annotation
0391_007215	TMP269	C25H21F3N4O3S	5.2234	53344908		O=C(NCC1(c2nc(-c3ccccc3)cs2)CCOCC1)c1cccc(-c2noc(C(F)(F)F)n2)c1	InChI=1S/C25H21F3N4O3S/c26-25(27,28)22-31-20(32-35-22)17-7-4-8-18(13-17)21(33)29-15-24(9-11-34-12-10-24)23-30-19(14-36-23)16-5-2-1-3-6-16/h1-8,13-14H,9-12,15H2,(H,29,33)	HORXBWNTEDOVKN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007217	PHA-767491	C12H11N3O	0.5079	11715767		O=C1NCCc2c1cc(-c1ccncc1)[nH]2	InChI=1S/C12H11N3O/c16-12-9-7-11(8-1-4-13-5-2-8)15-10(9)3-6-14-12/h1-2,4-5,7,15H,3,6H2,(H,14,16)	DKXHSOUZPMHNIZ-UHFFFAOYSA-N					compound annotation
0391_007218	Flurofamide	C7H9FN3O2P	1.0067	51173		NP(N)(=O)NC(=O)c1ccc(F)cc1	InChI=1S/C7H9FN3O2P/c8-6-3-1-5(2-4-6)7(12)11-14(9,10)13/h1-4H,(H5,9,10,11,12,13)	QWZFVMCWPLMLTL-UHFFFAOYSA-N					compound annotation
0391_007219	NVP-BEP800	C21H23Cl2N5O2S	2.6116	25210273		CCNC(=O)c1cc2c(-c3cc(OCCN4CCCC4)c(Cl)cc3Cl)nc(N)nc2s1	InChI=1S/C21H23Cl2N5O2S/c1-2-25-19(29)17-10-13-18(26-21(24)27-20(13)31-17)12-9-16(15(23)11-14(12)22)30-8-7-28-5-3-4-6-28/h9-11H,2-8H2,1H3,(H,25,29)(H2,24,26,27)	WJUNQSYQHHIVFX-UHFFFAOYSA-N					compound annotation
0391_007220	BML-210	C20H25N3O2	2.8457	9543540		Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccccc1	InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)	RFLHBLWLFUFFDZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007221	937039-45-7	C20H25N3O2	2.8457	16070100		Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1	InChI=1S/C20H25N3O2/c1-15-11-13-16(14-12-15)22-19(24)9-3-2-4-10-20(25)23-18-8-6-5-7-17(18)21/h5-8,11-14H,2-4,9-10,21H2,1H3,(H,22,24)(H,23,25)	WTKBRPXPNAKVEQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007224	BML-210	C20H25N3O2	2.919	9543540		Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccccc1	InChI=1S/C20H25N3O2/c21-17-12-8-9-13-18(17)23-20(25)15-7-2-1-6-14-19(24)22-16-10-4-3-5-11-16/h3-5,8-13H,1-2,6-7,14-15,21H2,(H,22,24)(H,23,25)	RFLHBLWLFUFFDZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007225	937039-45-7	C20H25N3O2	2.919	16070100		Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1	InChI=1S/C20H25N3O2/c1-15-11-13-16(14-12-15)22-19(24)9-3-2-4-10-20(25)23-18-8-6-5-7-17(18)21/h5-8,11-14H,2-4,9-10,21H2,1H3,(H,22,24)(H,23,25)	WTKBRPXPNAKVEQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007228	924473-59-6	C19H14F3N3O3	4.1876	9438169		Cc1noc(C(=O)Nc2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)c1	InChI=1S/C19H14F3N3O3/c1-11-8-16(28-25-11)18(27)24-14-6-2-4-12(9-14)17(26)23-15-7-3-5-13(10-15)19(20,21)22/h2-10H,1H3,(H,23,26)(H,24,27)	XVOKFRPKSAWELK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007230	mn-64	C18H16O2	4.9777	2802462		CC(C)c1ccc(-c2cc(=O)c3ccccc3o2)cc1	InChI=1S/C18H16O2/c1-12(2)13-7-9-14(10-8-13)18-11-16(19)15-5-3-4-6-17(15)20-18/h3-12H,1-2H3	PYTOHIUBXSJKQH-UHFFFAOYSA-N					compound annotation
0391_007231	1-cyclohexyl-3-dodecylurea	C19H38N2O	6.1745	4437430		CCCCCCCCCCCCNC(=O)NC1CCCCC1	InChI=1S/C19H38N2O/c1-2-3-4-5-6-7-8-9-10-14-17-20-19(22)21-18-15-12-11-13-16-18/h18H,2-17H2,1H3,(H2,20,21,22)	POEWFBSYPFIYSK-UHFFFAOYSA-N					compound annotation
0391_007232	MCL-1/BCL-2-IN-1	C31H27BrN2O3S	6.2002	145712375		CC(C)(C)c1ccc(C(=O)NCCN2C(=O)c3cccc4c(Sc5ccc(Br)cc5)ccc(c34)C2=O)cc1	InChI=1S/C31H27BrN2O3S/c1-31(2,3)20-9-7-19(8-10-20)28(35)33-17-18-34-29(36)24-6-4-5-23-26(16-15-25(27(23)24)30(34)37)38-22-13-11-21(32)12-14-22/h4-16H,17-18H2,1-3H3,(H,33,35)	FDTLPRMIVMUNSD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007234	IAXO-102	C35H71NO5	7.0412	25222900	CCCCCCCCCCCCCCO[C@H]1[C@@H]([C@H](O[C@@H]([C@@H]1OCCCCCCCCCCCCCC)OC)CN)O	CCCCCCCCCCCCCCOC1C(OC)OC(CN)C(O)C1OCCCCCCCCCCCCCC	InChI=1S/C35H71NO5/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-39-33-32(37)31(30-36)41-35(38-3)34(33)40-29-27-25-23-21-19-17-15-13-11-9-7-5-2/h31-35,37H,4-30,36H2,1-3H3/t31-,32-,33+,34-,35+/m1/s1	DJVFNDPRLMVKKO-KJQSSVQNSA-N					compound annotation
0391_007235	1,5-isoquinolinediol	C9H7NO2	1.0735	1340		O=c1[nH]ccc2c1cccc2O	InChI=1S/C9H7NO2/c11-8-3-1-2-7-6(8)4-5-10-9(7)12/h1-5,11H,(H,10,12)	LFUJIPVWTMGYDG-UHFFFAOYSA-N					compound annotation
0391_007236	TAS6417	C23H20N6O	2.095	117918742	CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C	C=CC(=O)NC1C=C(C)c2c(-c3cc4ccccc4nc3)c3c(N)ncnc3n2C1	InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1	MKCYPWYURWOKST-INIZCTEOSA-N					doublet; compound annotation
0391_007237	TAS6417	C23H20N6O	2.2	117918742	CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C	C=CC(=O)NC1C=C(C)c2c(-c3cc4ccccc4nc3)c3c(N)ncnc3n2C1	InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1	MKCYPWYURWOKST-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_007239	TAS6417	C23H20N6O	2.2029	117918742	CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C	C=CC(=O)NC1C=C(C)c2c(-c3cc4ccccc4nc3)c3c(N)ncnc3n2C1	InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1	MKCYPWYURWOKST-INIZCTEOSA-N					doublet; compound annotation
0391_007240	M443	C31H30F3N7O2	3.2531	92042851		C=CC(=O)N1CCCC(c2nc(Nc3c(C)ccc(C(=O)Nc4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)c3)ncc2)C1	InChI=1S/C31H30F3N7O2/c1-4-28(42)40-11-5-6-22(17-40)26-9-10-35-30(38-26)39-27-12-21(8-7-19(27)2)29(43)37-24-13-23(31(32,33)34)14-25(15-24)41-16-20(3)36-18-41/h4,7-10,12-16,18,22H,1,5-6,11,17H2,2-3H3,(H,37,43)(H,35,38,39)	QAQFNUYJUCJMKF-UHFFFAOYSA-N					doublet; compound annotation
0391_007241	M443	C31H30F3N7O2	3.3291	92042851		C=CC(=O)N1CCCC(c2nc(Nc3c(C)ccc(C(=O)Nc4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)c3)ncc2)C1	InChI=1S/C31H30F3N7O2/c1-4-28(42)40-11-5-6-22(17-40)26-9-10-35-30(38-26)39-27-12-21(8-7-19(27)2)29(43)37-24-13-23(31(32,33)34)14-25(15-24)41-16-20(3)36-18-41/h4,7-10,12-16,18,22H,1,5-6,11,17H2,2-3H3,(H,37,43)(H,35,38,39)	QAQFNUYJUCJMKF-UHFFFAOYSA-N					doublet; compound annotation
0391_007242	423735-93-7	C17H17BrN2O2	3.4585	1048267		CCCC(=O)Nc1cc(NC(=O)c2ccccc2Br)ccc1	InChI=1S/C17H17BrN2O2/c1-2-6-16(21)19-12-7-5-8-13(11-12)20-17(22)14-9-3-4-10-15(14)18/h3-5,7-11H,2,6H2,1H3,(H,19,21)(H,20,22)	DFOVLSMXPWPCFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007244	C188-9	C27H21NO5S	4.2175	1324494		COc1ccc(S(=O)(=O)Nc2cc(-c3c(O)ccc4ccccc34)c(O)c3ccccc23)cc1	InChI=1S/C27H21NO5S/c1-33-18-11-13-19(14-12-18)34(31,32)28-24-16-23(27(30)22-9-5-4-8-21(22)24)26-20-7-3-2-6-17(20)10-15-25(26)29/h2-16,28-30H,1H3	QDCJDYWGYVPBDO-UHFFFAOYSA-N					doublet; compound annotation
0391_007245	2'-Methoxykurarinone	C27H32O6	4.3058	11982641	CC(=CC[C@H](CC1=C2C(=C(C=C1O)OC)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C	C=C(C)C(CC=C(C)C)Cc1c2OC(c3c(OC)cc(O)cc3)CC(=O)c2c(OC)cc1O	InChI=1S/C27H32O6/c1-15(2)7-8-17(16(3)4)11-20-21(29)13-25(32-6)26-22(30)14-24(33-27(20)26)19-10-9-18(28)12-23(19)31-5/h7,9-10,12-13,17,24,28-29H,3,8,11,14H2,1-2,4-6H3/t17-,24+/m1/s1	KTAQQSUPNZAWEY-OSPHWJPCSA-N					doublet; compound annotation
0391_007246	2'-Methoxykurarinone	C27H32O6	4.3092	11982641	CC(=CC[C@H](CC1=C2C(=C(C=C1O)OC)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C	C=C(C)C(CC=C(C)C)Cc1c2OC(c3c(OC)cc(O)cc3)CC(=O)c2c(OC)cc1O	InChI=1S/C27H32O6/c1-15(2)7-8-17(16(3)4)11-20-21(29)13-25(32-6)26-22(30)14-24(33-27(20)26)19-10-9-18(28)12-23(19)31-5/h7,9-10,12-13,17,24,28-29H,3,8,11,14H2,1-2,4-6H3/t17-,24+/m1/s1	KTAQQSUPNZAWEY-OSPHWJPCSA-N					doublet; compound annotation
0391_007247	C188-9	C27H21NO5S	4.7985	1324494		COc1ccc(S(=O)(=O)Nc2cc(-c3c(O)ccc4ccccc34)c(O)c3ccccc23)cc1	InChI=1S/C27H21NO5S/c1-33-18-11-13-19(14-12-18)34(31,32)28-24-16-23(27(30)22-9-5-4-8-21(22)24)26-20-7-3-2-6-17(20)10-15-25(26)29/h2-16,28-30H,1H3	QDCJDYWGYVPBDO-UHFFFAOYSA-N					doublet; compound annotation
0391_007248	SBI-797812	C19H22N4O4S	1.8116	135222620		O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)N2CC3CCC(C2)O3)cc1	InChI=1S/C19H22N4O4S/c24-19(21-11-14-7-9-20-10-8-14)22-15-1-5-18(6-2-15)28(25,26)23-12-16-3-4-17(13-23)27-16/h1-2,5-10,16-17H,3-4,11-13H2,(H2,21,22,24)	KTSOHNHLOLGQCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007249	XL019	C25H28N6O2	2.114	57990869	C1C[C@H](NC1)C(=O)NC2=CC=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5	O=C(Nc1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)cc1)C1CCCN1	InChI=1S/C25H28N6O2/c32-24(23-2-1-12-26-23)28-19-5-3-18(4-6-19)22-11-13-27-25(30-22)29-20-7-9-21(10-8-20)31-14-16-33-17-15-31/h3-11,13,23,26H,1-2,12,14-17H2,(H,28,32)(H,27,29,30)/t23-/m0/s1	ISOCDPQFIXDIMS-QHCPKHFHSA-N					doublet; compound annotation
0391_007250	Onvansertib	C24H27F3N8O3	2.3173	49792852		CN1CCN(c2cc(Nc3ncc4CCc5c(-c4n3)n(CCO)nc5C(N)=O)c(OC(F)(F)F)cc2)CC1	InChI=1S/C24H27F3N8O3/c1-33-6-8-34(9-7-33)15-3-5-18(38-24(25,26)27)17(12-15)30-23-29-13-14-2-4-16-20(22(28)37)32-35(10-11-36)21(16)19(14)31-23/h3,5,12-13,36H,2,4,6-11H2,1H3,(H2,28,37)(H,29,30,31)	QHLVBNKYJGBCQJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007252	Onvansertib	C24H27F3N8O3	2.3206	49792852		CN1CCN(c2cc(Nc3ncc4CCc5c(-c4n3)n(CCO)nc5C(N)=O)c(OC(F)(F)F)cc2)CC1	InChI=1S/C24H27F3N8O3/c1-33-6-8-34(9-7-33)15-3-5-18(38-24(25,26)27)17(12-15)30-23-29-13-14-2-4-16-20(22(28)37)32-35(10-11-36)21(16)19(14)31-23/h3,5,12-13,36H,2,4,6-11H2,1H3,(H2,28,37)(H,29,30,31)	QHLVBNKYJGBCQJ-UHFFFAOYSA-N					doublet; compound annotation
0391_007253	Nomegestrol acetate	C23H30O4	2.3556	91668	CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4	CC(=O)OC1(C(C)=O)CCC2C3C=C(C)C4=CC(=O)CCC4C3CCC21C	InChI=1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1	IIVBFTNIGYRNQY-YQLZSBIMSA-N					doublet; compound annotation
0391_007254	BMS-582949	C22H26N6O2	2.8222	10409068		CCCNC(=O)c1cn2ncnc(Nc3c(C)ccc(C(=O)NC4CC4)c3)c2c1C	InChI=1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27)	GDTQLZHHDRRBEB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007256	XL019	C25H28N6O2	2.8556	57990869	C1C[C@H](NC1)C(=O)NC2=CC=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5	O=C(Nc1ccc(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)cc1)C1CCCN1	InChI=1S/C25H28N6O2/c32-24(23-2-1-12-26-23)28-19-5-3-18(4-6-19)22-11-13-27-25(30-22)29-20-7-9-21(10-8-20)31-14-16-33-17-15-31/h3-11,13,23,26H,1-2,12,14-17H2,(H,28,32)(H,27,29,30)/t23-/m0/s1	ISOCDPQFIXDIMS-QHCPKHFHSA-N					doublet; compound annotation
0391_007257	Plinabulin	C19H20N4O2	3.0859	9949641	CC(C)(C)C1=C(N=CN1)/C=C\2/C(=O)N/C(=C\C3=CC=CC=C3)/C(=O)N2	CC(C)(C)c1c(C=c2[nH]c(=O)c(=Cc3ccccc3)[nH]c2=O)nc[nH]1	InChI=1S/C19H20N4O2/c1-19(2,3)16-13(20-11-21-16)10-15-18(25)22-14(17(24)23-15)9-12-7-5-4-6-8-12/h4-11H,1-3H3,(H,20,21)(H,22,25)(H,23,24)/b14-9-,15-10-	UNRCMCRRFYFGFX-TYPNBTCFSA-N					doublet; compound annotation
0391_007258	855-97-0	C19H18O6	3.3356	631170		COc1cc2c(c(OC)c1)c(=O)cc(-c1cc(OC)c(OC)cc1)o2	InChI=1S/C19H18O6/c1-21-12-8-17(24-4)19-13(20)10-15(25-18(19)9-12)11-5-6-14(22-2)16(7-11)23-3/h5-10H,1-4H3	CLXVBVLQKLQNRQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007260	Plinabulin	C19H20N4O2	3.4891	9949641	CC(C)(C)C1=C(N=CN1)/C=C\2/C(=O)N/C(=C\C3=CC=CC=C3)/C(=O)N2	CC(C)(C)c1c(C=c2[nH]c(=O)c(=Cc3ccccc3)[nH]c2=O)nc[nH]1	InChI=1S/C19H20N4O2/c1-19(2,3)16-13(20-11-21-16)10-15-18(25)22-14(17(24)23-15)9-12-7-5-4-6-8-12/h4-11H,1-3H3,(H,20,21)(H,22,25)(H,23,24)/b14-9-,15-10-	UNRCMCRRFYFGFX-TYPNBTCFSA-N					doublet; compound annotation
0391_007261	yc-1	C19H16N2O2	4.0074	5712		OCc1ccc(-c2nn(Cc3ccccc3)c3ccccc23)o1	InChI=1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2	OQQVFCKUDYMWGV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007263	Nomegestrol acetate	C23H30O4	4.3457	91668	CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4	CC(=O)OC1(C(C)=O)CCC2C3C=C(C)C4=CC(=O)CCC4C3CCC21C	InChI=1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1	IIVBFTNIGYRNQY-YQLZSBIMSA-N					doublet; compound annotation
0391_007264	Talnetant	C25H22N2O2	4.6779	5311424	CC[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)O	CCC(NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1	BIAVGWDGIJKWRM-FQEVSTJZSA-N					doublet; compound annotation
0391_007265	SBI-797812	C19H22N4O4S	4.8395	135222620		O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)N2CC3CCC(C2)O3)cc1	InChI=1S/C19H22N4O4S/c24-19(21-11-14-7-9-20-10-8-14)22-15-1-5-18(6-2-15)28(25,26)23-12-16-3-4-17(13-23)27-16/h1-2,5-10,16-17H,3-4,11-13H2,(H2,21,22,24)	KTSOHNHLOLGQCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007266	Talnetant	C25H22N2O2	5.4022	5311424	CC[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)O	CCC(NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1	BIAVGWDGIJKWRM-FQEVSTJZSA-N					doublet; compound annotation
0391_007267	720690-73-3	C21H25N3O2	1.7891	9798547		CNC(=O)c1cnc(Oc2cc3c(cc2)CCN(C2CCC2)CC3)cc1	InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)	WROHEWWOCPRMIA-UHFFFAOYSA-N					compound annotation
0391_007268	60559-98-0	C12H17N5	2.1079	43345		CCC(C)(C)N=C(NC#N)Nc1cnccc1	InChI=1S/C12H17N5/c1-4-12(2,3)17-11(15-9-13)16-10-6-5-7-14-8-10/h5-8H,4H2,1-3H3,(H2,15,16,17)	HKZNADVVGXKQDL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007270	NCT-501	C21H32N6O3	2.8651	92044412		CC(C)CCn1c(CN2CCN(C(=O)C3CC3)CC2)nc2c1c(=O)n(C)c(=O)n2C	InChI=1S/C21H32N6O3/c1-14(2)7-8-27-16(22-18-17(27)20(29)24(4)21(30)23(18)3)13-25-9-11-26(12-10-25)19(28)15-5-6-15/h14-15H,5-13H2,1-4H3	FSXIBBYWVGWQJL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007272	Fruquintinib	C21H19N3O5	3.036	44480399		CNC(=O)c1c(C)oc2c1ccc(Oc1ncnc3cc(OC)c(OC)cc13)c2	InChI=1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25)	BALLNEJQLSTPIO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007274	(S)-IDO1-IN-5	C23H25FN2O3	3.3302	132209650	C[C@@H](C1=CC2=C(C=C1)N(CC2)C(=O)C3CCOCC3)NC(=O)C4=CC=C(C=C4)F	CC(NC(=O)c1ccc(F)cc1)c1cc2c(cc1)N(C(=O)C1CCOCC1)CC2	InChI=1S/C23H25FN2O3/c1-15(25-22(27)16-2-5-20(24)6-3-16)18-4-7-21-19(14-18)8-11-26(21)23(28)17-9-12-29-13-10-17/h2-7,14-15,17H,8-13H2,1H3,(H,25,27)/t15-/m0/s1	NUBWFWVVKLRSHS-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_007276	(-)-SHIN1	C24H24N4O2	3.5345	134337375	CC1=C2C(=NN1)OC(=C([C@]2(C3=CC(=CC(=C3)C4=CC=CC=C4)CO)C(C)C)C#N)N	Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)/t24-/m1/s1	VVVOFJZXKJKHTD-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_007278	Cinaciguat	C36H39NO5	3.9445	9808022		O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41)	WPYWMXNXEZFMAK-UHFFFAOYSA-N					doublet; compound annotation
0391_007279	Cinaciguat	C36H39NO5	4.0311	9808022		O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1	InChI=1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41)	WPYWMXNXEZFMAK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007281	GNE-6468	C23H16ClN3O4	4.6333	117964975		O=C(O)c1c(O)cc(-c2c3ncccn3c(C(=O)c3c(Cl)cccc3C3CC3)n2)cc1	InChI=1S/C23H16ClN3O4/c24-16-4-1-3-14(12-5-6-12)18(16)20(29)22-26-19(21-25-9-2-10-27(21)22)13-7-8-15(23(30)31)17(28)11-13/h1-4,7-12,28H,5-6H2,(H,30,31)	GIYKJPISDNWSJD-UHFFFAOYSA-N					compound annotation
0391_007282	2-(pyridin-2-yldisulfanyl)ethanamine	C7H10N2S2	1.1637	128546		NCCSSc1ccccn1	InChI=1S/C7H10N2S2/c8-4-6-10-11-7-3-1-2-5-9-7/h1-3,5H,4,6,8H2	WGGFHAVVTPGHRD-UHFFFAOYSA-N					compound annotation
0391_007283	301836-43-1	C23H18N4O3	2.1168	6419753		NC(=O)c1ccc(-c2nc(-c3cc4c(cc3)OCCO4)c(-c3ccccn3)[nH]2)cc1	InChI=1S/C23H18N4O3/c24-22(28)14-4-6-15(7-5-14)23-26-20(21(27-23)17-3-1-2-10-25-17)16-8-9-18-19(13-16)30-12-11-29-18/h1-10,13H,11-12H2,(H2,24,28)(H,26,27)	DPDZHVCKYBCJHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007285	Paprotrain	C16H11N3	2.5768	12248889	C1=CC=C2C(=C1)C(=CN2)/C(=C/C3=CN=CC=C3)/C#N	N#CC(=Cc1cnccc1)c1c[nH]c2ccccc12	InChI=1S/C16H11N3/c17-9-13(8-12-4-3-7-18-10-12)15-11-19-16-6-2-1-5-14(15)16/h1-8,10-11,19H/b13-8+	YMYYQRZCCKBFBE-MDWZMJQESA-N					doublet; compound annotation
0391_007286	Paprotrain	C16H11N3	2.8111	12248889	C1=CC=C2C(=C1)C(=CN2)/C(=C/C3=CN=CC=C3)/C#N	N#CC(=Cc1cnccc1)c1c[nH]c2ccccc12	InChI=1S/C16H11N3/c17-9-13(8-12-4-3-7-18-10-12)15-11-19-16-6-2-1-5-14(15)16/h1-8,10-11,19H/b13-8+	YMYYQRZCCKBFBE-MDWZMJQESA-N					doublet; compound annotation
0391_007287	BMS-935177	C31H26N4O3	3.6054	70647728		Cc1c(-c2c3c(c(C(N)=O)cc2)[nH]c2cc(C(C)(C)O)ccc23)cccc1-n1cnc2ccccc2c1=O	InChI=1S/C31H26N4O3/c1-17-19(8-6-10-26(17)35-16-33-24-9-5-4-7-22(24)30(35)37)20-13-14-23(29(32)36)28-27(20)21-12-11-18(31(2,3)38)15-25(21)34-28/h4-16,34,38H,1-3H3,(H2,32,36)	TVJRDCQUZMGBAB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007289	BMS-935177	C31H26N4O3	3.6081	70647728		Cc1c(-c2c3c(c(C(N)=O)cc2)[nH]c2cc(C(C)(C)O)ccc23)cccc1-n1cnc2ccccc2c1=O	InChI=1S/C31H26N4O3/c1-17-19(8-6-10-26(17)35-16-33-24-9-5-4-7-22(24)30(35)37)20-13-14-23(29(32)36)28-27(20)21-12-11-18(31(2,3)38)15-25(21)34-28/h4-16,34,38H,1-3H3,(H2,32,36)	TVJRDCQUZMGBAB-UHFFFAOYSA-N					doublet; compound annotation
0391_007290	PDK1 inhibitor	C28H22F2N4O4	3.7545	49766501	C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F	O=C(NC(COc1cc2c(cc1)[nH]c(=O)[nH]2)c1ccccc1)c1cccn(Cc2cc(F)c(F)cc2)c1=O	InChI=1S/C28H22F2N4O4/c29-21-10-8-17(13-22(21)30)15-34-12-4-7-20(27(34)36)26(35)31-25(18-5-2-1-3-6-18)16-38-19-9-11-23-24(14-19)33-28(37)32-23/h1-14,25H,15-16H2,(H,31,35)(H2,32,33,37)/t25-/m0/s1	GCWCGSPBENFEPE-VWLOTQADSA-N					removed another duplicate entry; compound annotation
0391_007292	BMS-986142	C32H30F2N4O4	4.0571	86582336	CC1=C(C=CC=C1N2C(=O)C3=C(C(=CC=C3)F)N(C2=O)C)C4=C(C=C(C5=C4C6=C(N5)C[C@H](CC6)C(C)(C)O)C(=O)N)F	Cc1c(-c2c(F)cc(C(N)=O)c3c2c2c(CC(C(C)(C)O)CC2)[nH]3)cccc1-n1c(=O)c2c(c(F)ccc2)n(C)c1=O	InChI=1S/C32H30F2N4O4/c1-15-17(7-6-10-24(15)38-30(40)19-8-5-9-21(33)28(19)37(4)31(38)41)25-22(34)14-20(29(35)39)27-26(25)18-12-11-16(32(2,3)42)13-23(18)36-27/h5-10,14,16,36,42H,11-13H2,1-4H3,(H2,35,39)/t16-/m0/s1	ZRYMMWAJAFUANM-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_007295	BMS-986020	C29H26N2O5	4.609	49792850	CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O	Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1NC(=O)OC(C)c1ccccc1	InChI=1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m1/s1	GQBRZBHEPUQRPL-LJQANCHMSA-N					doublet; removed another duplicate entry; compound annotation
0391_007297	whi-p180	C16H15N3O3	1.7953	5687		COc1c(OC)cc2c(Nc3cc(O)ccc3)ncnc2c1	InChI=1S/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-4-3-5-11(20)6-10/h3-9,20H,1-2H3,(H,17,18,19)	BNDYIYYKEIXHNK-UHFFFAOYSA-N					compound annotation
0391_007298	1431985-92-0	C20H20N2O4	2.4865	46173038		COc1cc(-c2c(N)ncc(-c3cc(O)ccc3)c2)cc(OC)c1OC	InChI=1S/C20H20N2O4/c1-24-17-9-13(10-18(25-2)19(17)26-3)16-8-14(11-22-20(16)21)12-5-4-6-15(23)7-12/h4-11,23H,1-3H3,(H2,21,22)	CJLMANFTWLNAKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007300	FLUOROFENIDONE	C12H10FNO	2.5285	11851183		Cc1cn(-c2cc(F)ccc2)c(=O)cc1	InChI=1S/C12H10FNO/c1-9-5-6-12(15)14(8-9)11-4-2-3-10(13)7-11/h2-8H,1H3	JDZYVVUJIQYGRX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007302	919486-40-1	C20H20ClN5O2	2.9112	10340781		NC(=O)c1cnc(NCCc2cc(Cl)c(O)cc2)nc1NCc1ccccc1	InChI=1S/C20H20ClN5O2/c21-16-10-13(6-7-17(16)27)8-9-23-20-25-12-15(18(22)28)19(26-20)24-11-14-4-2-1-3-5-14/h1-7,10,12,27H,8-9,11H2,(H2,22,28)(H2,23,24,25,26)	OZRMEKAUZBKTTC-UHFFFAOYSA-N					compound annotation
0391_007303	1418308-27-6	C23H26N4O2	3.7105	72199293		CCC(CC)n1ccc2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(C#N)cc21	InChI=1S/C23H26N4O2/c1-5-17(6-2)27-8-7-18-19(10-16(12-24)11-21(18)27)22(28)25-13-20-14(3)9-15(4)26-23(20)29/h7-11,17H,5-6,13H2,1-4H3,(H,25,28)(H,26,29)	PFHDWRIVDDIFRP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007305	1418308-27-6	C23H26N4O2	3.78	72199293		CCC(CC)n1ccc2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(C#N)cc21	InChI=1S/C23H26N4O2/c1-5-17(6-2)27-8-7-18-19(10-16(12-24)11-21(18)27)22(28)25-13-20-14(3)9-15(4)26-23(20)29/h7-11,17H,5-6,13H2,1-4H3,(H,25,28)(H,26,29)	PFHDWRIVDDIFRP-UHFFFAOYSA-N					doublet; compound annotation
0391_007306	4-iodo-6-phenylpyrimidine	C10H7IN2	4.05	817368		Ic1ncnc(-c2ccccc2)c1	InChI=1S/C10H7IN2/c11-10-6-9(12-7-13-10)8-4-2-1-3-5-8/h1-7H	ZTCJXHNJVLUUMR-UHFFFAOYSA-N					compound annotation
0391_007307	314042-01-8	C18H18N2O4S2	4.2074	1067700		CC1(C)Cc2c(CO1)sc(NC(=S)NC(=O)c1ccccc1)c2C(=O)O	InChI=1S/C18H18N2O4S2/c1-18(2)8-11-12(9-24-18)26-15(13(11)16(22)23)20-17(25)19-14(21)10-6-4-3-5-7-10/h3-7H,8-9H2,1-2H3,(H,22,23)(H2,19,20,21,25)	ATSWBWHRHAQVFM-UHFFFAOYSA-N					compound annotation
0391_007308	TCH-165	C39H37N3O3	4.6341	71762768	CCOC(=O)[C@]1([C@H](N(C(=N1)C2=CC=C(C=C2)OC)CC3=CC=CC=C3)C4=CC=C(C=C4)NCC5=CC=CC=C5)C6=CC=CC=C6	CCOC(=O)C1(c2ccccc2)N=C(c2ccc(OC)cc2)N(Cc2ccccc2)C1c1ccc(NCc2ccccc2)cc1	InChI=1S/C39H37N3O3/c1-3-45-38(43)39(33-17-11-6-12-18-33)36(31-19-23-34(24-20-31)40-27-29-13-7-4-8-14-29)42(28-30-15-9-5-10-16-30)37(41-39)32-21-25-35(44-2)26-22-32/h4-26,36,40H,3,27-28H2,1-2H3/t36-,39-/m1/s1	XXDLWRCUPASJGY-AEGYFVCZSA-N					doublet; compound annotation
0391_007309	TCH-165	C39H37N3O3	5.2529	71762768	CCOC(=O)[C@]1([C@H](N(C(=N1)C2=CC=C(C=C2)OC)CC3=CC=CC=C3)C4=CC=C(C=C4)NCC5=CC=CC=C5)C6=CC=CC=C6	CCOC(=O)C1(c2ccccc2)N=C(c2ccc(OC)cc2)N(Cc2ccccc2)C1c1ccc(NCc2ccccc2)cc1	InChI=1S/C39H37N3O3/c1-3-45-38(43)39(33-17-11-6-12-18-33)36(31-19-23-34(24-20-31)40-27-29-13-7-4-8-14-29)42(28-30-15-9-5-10-16-30)37(41-39)32-21-25-35(44-2)26-22-32/h4-26,36,40H,3,27-28H2,1-2H3/t36-,39-/m1/s1	XXDLWRCUPASJGY-AEGYFVCZSA-N					doublet; compound annotation
0391_007310	1190379-70-4	C25H34N6O	1.5885	59225335		CN1CCc2c(ccc(Nc3ncc(C4CC4)c(NCCCNC(=O)C4CCC4)n3)c2)C1	InChI=1S/C25H34N6O/c1-31-13-10-19-14-21(9-8-20(19)16-31)29-25-28-15-22(17-6-7-17)23(30-25)26-11-3-12-27-24(32)18-4-2-5-18/h8-9,14-15,17-18H,2-7,10-13,16H2,1H3,(H,27,32)(H2,26,28,29,30)	KKISLZKMBSCLSS-UHFFFAOYSA-N					compound annotation
0391_007311	78538-74-6	C13H11N3O	1.9613	4375		CNC(=O)c1ncc2[nH]c3ccccc3c2c1	InChI=1S/C13H11N3O/c1-14-13(17)11-6-9-8-4-2-3-5-10(8)16-12(9)7-15-11/h2-7,16H,1H3,(H,14,17)	QMCOPDWHWYSJSA-UHFFFAOYSA-N					compound annotation
0391_007312	CA-074 methyl ester	C19H31N3O6	2.8009	6610318	CCCNC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)OC	CCCNC(=O)C1OC1C(=O)NC(C(=O)N1CCCC1C(=O)OC)C(C)CC	InChI=1S/C19H31N3O6/c1-5-9-20-16(23)14-15(28-14)17(24)21-13(11(3)6-2)18(25)22-10-7-8-12(22)19(26)27-4/h11-15H,5-10H2,1-4H3,(H,20,23)(H,21,24)/t11-,12-,13-,14-,15-/m0/s1	XGWSRLSPWIEMLQ-YTFOTSKYSA-N					compound annotation
0391_007313	BAY-524	C24H24F2N6O3	3.3057	71611179		CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c(C)c2OC)c(F)c1	InChI=1S/C24H24F2N6O3/c1-5-35-16-10-18(25)17(19(26)11-16)13-32-24(34-4)14(2)21(31-32)23-28-12-20(33-3)22(30-23)29-15-6-8-27-9-7-15/h6-12H,5,13H2,1-4H3,(H,27,28,29,30)	LMRCQVHTZUUHFN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007315	CZ415	C22H29N5O4S	3.4995	71547699	CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CS(=O)(=O)C3(C)C)C(=N2)N4CCOC[C@@H]4C	CCNC(=O)Nc1ccc(-c2nc3c(CS(=O)(=O)C3(C)C)c(N3CCOCC3C)n2)cc1	InChI=1S/C22H29N5O4S/c1-5-23-21(28)24-16-8-6-15(7-9-16)19-25-18-17(13-32(29,30)22(18,3)4)20(26-19)27-10-11-31-12-14(27)2/h6-9,14H,5,10-13H2,1-4H3,(H2,23,24,28)/t14-/m0/s1	IZLPVLBNRGPOHA-AWEZNQCLSA-N					compound annotation
0391_007316	AGK2	C23H13Cl2N3O2	3.7926	2130404	C1=CC2=C(C=CC=N2)C(=C1)NC(=O)/C(=C/C3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)/C#N	N#CC(=Cc1ccc(-c2c(Cl)ccc(Cl)c2)o1)C(=O)Nc1cccc2c1cccn2	InChI=1S/C23H13Cl2N3O2/c24-15-6-8-19(25)18(12-15)22-9-7-16(30-22)11-14(13-26)23(29)28-21-5-1-4-20-17(21)3-2-10-27-20/h1-12H,(H,28,29)/b14-11+	SVENPFFEMUOOGK-SDNWHVSQSA-N					compound annotation
0391_007317	199433-58-4	C16H16N4O	4.3176	9810884	C[C@H](C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N	CC(N)c1ccc(C(=O)Nc2c3cc[nH]c3ncc2)cc1	InChI=1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1	JTVBXQAYBIJXRP-SNVBAGLBSA-N					doublet; compound annotation
0391_007318	LY2109761	C26H27N5O2	1.2468	11655119		c1ccc(-c2nn3CCCc3c2-c2ccnc3cc(OCCN4CCOCC4)ccc23)nc1	InChI=1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2	IHLVSLOZUHKNMQ-UHFFFAOYSA-N					compound annotation
0391_007319	711085-63-1	C14H17ClN2O	1.806	9795278	C1CN2CCC1[C@H](C2)NC(=O)C3=CC=C(C=C3)Cl	O=C(NC1CN2CCC1CC2)c1ccc(Cl)cc1	InChI=1S/C14H17ClN2O/c15-12-3-1-11(2-4-12)14(18)16-13-9-17-7-5-10(13)6-8-17/h1-4,10,13H,5-9H2,(H,16,18)/t13-/m0/s1	WECKJONDRAUFDD-ZDUSSCGKSA-N					compound annotation
0391_007320	R-268712	C20H18FN5O	2.0472	11703284		Cc1nc(-c2c(-c3cc(-c4cn(CCO)nc4)c(F)cc3)cn[nH]2)ccc1	InChI=1S/C20H18FN5O/c1-13-3-2-4-19(24-13)20-17(11-22-25-20)14-5-6-18(21)16(9-14)15-10-23-26(12-15)7-8-27/h2-6,9-12,27H,7-8H2,1H3,(H,22,25)	JQGOCCALXFSRHZ-UHFFFAOYSA-N					compound annotation
0391_007321	RSV604	C22H17FN4O2	3.8251	5279172	C1=CC=C(C=C1)C2=N[C@@H](C(=O)NC3=CC=CC=C32)NC(=O)NC4=CC=CC=C4F	O=C(Nc1ccccc1F)NC1N=C(c2ccccc2)c2ccccc2NC1=O	InChI=1S/C22H17FN4O2/c23-16-11-5-7-13-18(16)25-22(29)27-20-21(28)24-17-12-6-4-10-15(17)19(26-20)14-8-2-1-3-9-14/h1-13,20H,(H,24,28)(H2,25,27,29)/t20-/m1/s1	MTPVBMVUENFFLL-HXUWFJFHSA-N					compound annotation
0391_007322	1349796-36-6	C31H29N5O6S	5.3972	49867926		COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3cc(OC)c(C)cc3)cc2)cc(OC)c1	InChI=1S/C31H29N5O6S/c1-19-9-10-20(15-28(19)42-4)31(37)33-21-11-13-25(14-12-21)43(38,39)36-30-29(34-26-7-5-6-8-27(26)35-30)32-22-16-23(40-2)18-24(17-22)41-3/h5-18H,1-4H3,(H,32,34)(H,33,37)(H,35,36)	HJSSPYJVWLTYHG-UHFFFAOYSA-N					compound annotation
0391_007323	AZD0156	C26H31N5O3	1.6164	118502708		CN(C)CCCOc1ncc(-c2cc3c4c(cnc3cc2)n(C)c(=O)n4C2CCOCC2)cc1	InChI=1S/C26H31N5O3/c1-29(2)11-4-12-34-24-8-6-19(16-28-24)18-5-7-22-21(15-18)25-23(17-27-22)30(3)26(32)31(25)20-9-13-33-14-10-20/h5-8,15-17,20H,4,9-14H2,1-3H3	AOTRIQLYUAFVSC-UHFFFAOYSA-N					compound annotation
0391_007324	TLR7/8 agonist 1	C22H25N5	1.6244	52945312		CCCCc1nc2c(c3ccccc3nc2N)n1Cc1ccc(CN)cc1	InChI=1S/C22H25N5/c1-2-3-8-19-26-20-21(17-6-4-5-7-18(17)25-22(20)24)27(19)14-16-11-9-15(13-23)10-12-16/h4-7,9-12H,2-3,8,13-14,23H2,1H3,(H2,24,25)	SDSKFWHQCNBICO-UHFFFAOYSA-N					compound annotation
0391_007325	ROXATIDINE ACETATE	C19H28N2O4	1.7011	5105		CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	InChI=1S/C19H28N2O4/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23)	SMTZFNFIKUPEJC-UHFFFAOYSA-N					doublet; compound annotation
0391_007326	ROXATIDINE ACETATE	C19H28N2O4	1.7043	5105		CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1	InChI=1S/C19H28N2O4/c1-16(22)25-15-19(23)20-9-6-12-24-18-8-5-7-17(13-18)14-21-10-3-2-4-11-21/h5,7-8,13H,2-4,6,9-12,14-15H2,1H3,(H,20,23)	SMTZFNFIKUPEJC-UHFFFAOYSA-N					doublet; compound annotation
0391_007327	512784-93-9	C42H49N5O5	3.7335	44428550	C[C@H](C1=CC=CC=C1)NC(=O)[C@@H](CC(=O)N2CCC(CC2)N3CCCCC3)N4[C@@H]([C@@H](C4=O)N5[C@H](COC5=O)C6=CC=CC=C6)/C=C/C7=CC=CC=C7	CC(NC(=O)C(CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)C(N2C(=O)OCC2c2ccccc2)C1C=Cc1ccccc1)c1ccccc1	InChI=1S/C42H49N5O5/c1-30(32-16-8-3-9-17-32)43-40(49)36(28-38(48)45-26-22-34(23-27-45)44-24-12-5-13-25-44)46-35(21-20-31-14-6-2-7-15-31)39(41(46)50)47-37(29-52-42(47)51)33-18-10-4-11-19-33/h2-4,6-11,14-21,30,34-37,39H,5,12-13,22-29H2,1H3,(H,43,49)/b21-20+/t30-,35-,36-,37-,39+/m1/s1	FJUKOXWSIGULLE-JVOQCOEYSA-N					doublet; compound annotation
0391_007328	GSK3179106	C22H21F4N3O4	3.7869	78427026		CCOc1cc(=O)[nH]cc1-c1cc(F)c(CC(=O)Nc2noc(C(C)(C)C(F)(F)F)c2)cc1	InChI=1S/C22H21F4N3O4/c1-4-32-16-9-19(30)27-11-14(16)12-5-6-13(15(23)7-12)8-20(31)28-18-10-17(33-29-18)21(2,3)22(24,25)26/h5-7,9-11H,4,8H2,1-3H3,(H,27,30)(H,28,29,31)	IDXKJSSOUXWLDB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007330	512784-93-9	C42H49N5O5	3.8207	44428550	C[C@H](C1=CC=CC=C1)NC(=O)[C@@H](CC(=O)N2CCC(CC2)N3CCCCC3)N4[C@@H]([C@@H](C4=O)N5[C@H](COC5=O)C6=CC=CC=C6)/C=C/C7=CC=CC=C7	CC(NC(=O)C(CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)C(N2C(=O)OCC2c2ccccc2)C1C=Cc1ccccc1)c1ccccc1	InChI=1S/C42H49N5O5/c1-30(32-16-8-3-9-17-32)43-40(49)36(28-38(48)45-26-22-34(23-27-45)44-24-12-5-13-25-44)46-35(21-20-31-14-6-2-7-15-31)39(41(46)50)47-37(29-52-42(47)51)33-18-10-4-11-19-33/h2-4,6-11,14-21,30,34-37,39H,5,12-13,22-29H2,1H3,(H,43,49)/b21-20+/t30-,35-,36-,37-,39+/m1/s1	FJUKOXWSIGULLE-JVOQCOEYSA-N					doublet; compound annotation
0391_007331	512784-93-9	C42H49N5O5	3.8236	44428550	C[C@H](C1=CC=CC=C1)NC(=O)[C@@H](CC(=O)N2CCC(CC2)N3CCCCC3)N4[C@@H]([C@@H](C4=O)N5[C@H](COC5=O)C6=CC=CC=C6)/C=C/C7=CC=CC=C7	CC(NC(=O)C(CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)C(N2C(=O)OCC2c2ccccc2)C1C=Cc1ccccc1)c1ccccc1	InChI=1S/C42H49N5O5/c1-30(32-16-8-3-9-17-32)43-40(49)36(28-38(48)45-26-22-34(23-27-45)44-24-12-5-13-25-44)46-35(21-20-31-14-6-2-7-15-31)39(41(46)50)47-37(29-52-42(47)51)33-18-10-4-11-19-33/h2-4,6-11,14-21,30,34-37,39H,5,12-13,22-29H2,1H3,(H,43,49)/b21-20+/t30-,35-,36-,37-,39+/m1/s1	FJUKOXWSIGULLE-JVOQCOEYSA-N					doublet; compound annotation
0391_007332	JTE-013	C17H19Cl2N7O	3.8818	10223146		Cc1nn(C)c2c1c(C(C)C)cc(NNC(=O)Nc1cc(Cl)nc(Cl)c1)n2	InChI=1S/C17H19Cl2N7O/c1-8(2)11-7-14(22-16-15(11)9(3)25-26(16)4)23-24-17(27)20-10-5-12(18)21-13(19)6-10/h5-8H,1-4H3,(H,22,23)(H2,20,21,24,27)	RNSLRQNDXRSASX-UHFFFAOYSA-N					compound annotation
0391_007333	Vorasidenib	C14H13ClF6N6	4.4995	117817422	C[C@H](C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)N[C@H](C)C(F)(F)F	CC(Nc1nc(NC(C)C(F)(F)F)nc(-c2nc(Cl)ccc2)n1)C(F)(F)F	InChI=1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1	QCZAWDGAVJMPTA-RNFRBKRXSA-N					removed another duplicate entry; compound annotation
0391_007335	Difenoconazole	C19H17Cl2N3O3	4.7962	86173		CC1COC(Cn2cncn2)(c2c(Cl)cc(Oc3ccc(Cl)cc3)cc2)O1	InChI=1S/C19H17Cl2N3O3/c1-13-9-25-19(27-13,10-24-12-22-11-23-24)17-7-6-16(8-18(17)21)26-15-4-2-14(20)3-5-15/h2-8,11-13H,9-10H2,1H3	BQYJATMQXGBDHF-UHFFFAOYSA-N					compound annotation
0391_007336	Endovion	C16H9BrF6N6O	5.4017	10005966		O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1ccc(Br)cc1-c1n[nH]nn1	InChI=1S/C16H9BrF6N6O/c17-9-1-2-12(11(6-9)13-26-28-29-27-13)25-14(30)24-10-4-7(15(18,19)20)3-8(5-10)16(21,22)23/h1-6H,(H2,24,25,30)(H,26,27,28,29)	AEFYFGMSRKDXHZ-UHFFFAOYSA-N					compound annotation
0391_007337	189744-46-5	C17H20N4	1.1827	16759175		Cc1ncc(CN2CC=C(c3ccccc3)CC2)c(N)n1	InChI=1S/C17H20N4/c1-13-19-11-16(17(18)20-13)12-21-9-7-15(8-10-21)14-5-3-2-4-6-14/h2-7,11H,8-10,12H2,1H3,(H2,18,19,20)	KABDATZAOUSYES-UHFFFAOYSA-N					compound annotation
0391_007338	7-Chlorokynurenic acid	C10H6ClNO3	1.7471	1884		O=C(O)c1cc(=O)c2c(cc(Cl)cc2)[nH]1	InChI=1S/C10H6ClNO3/c11-5-1-2-6-7(3-5)12-8(10(14)15)4-9(6)13/h1-4H,(H,12,13)(H,14,15)	UAWVRVFHMOSAPU-UHFFFAOYSA-N					doublet; compound annotation
0391_007339	GPR84 antagonist 8	C23H23N3O5	2.5289	71598639		O=c1nc(OCC2COCCO2)cc2-c3c(cc(OCc4ccccn4)cc3)CCn21	InChI=1S/C23H23N3O5/c27-23-25-22(31-15-19-14-28-9-10-29-19)12-21-20-5-4-18(11-16(20)6-8-26(21)23)30-13-17-3-1-2-7-24-17/h1-5,7,11-12,19H,6,8-10,13-15H2	KSGKMLVYIUJQMZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007341	192185-71-0	C27H22Cl2N4O	3.1266	9935249	CN1C=NC=C1[C@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N	Cn1cncc1C(N)(c1ccc(Cl)cc1)c1cc2c(cc1)n(C)c(=O)cc2-c1cc(Cl)ccc1	InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m0/s1	PLHJCIYEEKOWNM-MHZLTWQESA-N					compound annotation
0391_007342	BCI-215	C22H22BrNO	3.4579	46912328	C1CCC(CC1)NC\2C3=C(C=CC(=C3)Br)C(=O)/C2=C/C4=CC=CC=C4	O=C1C(=Cc2ccccc2)C(NC2CCCCC2)c2cc(Br)ccc12	InChI=1S/C22H22BrNO/c23-16-11-12-18-19(14-16)21(24-17-9-5-2-6-10-17)20(22(18)25)13-15-7-3-1-4-8-15/h1,3-4,7-8,11-14,17,21,24H,2,5-6,9-10H2/b20-13+	JGWQWVVSCQBAFC-DEDYPNTBSA-N					compound annotation
0391_007343	Gbr 12935	C28H34N2O	3.6043	3456		c1ccc(CCCN2CCN(CCOC(c3ccccc3)c3ccccc3)CC2)cc1	InChI=1S/C28H34N2O/c1-4-11-25(12-5-1)13-10-18-29-19-21-30(22-20-29)23-24-31-28(26-14-6-2-7-15-26)27-16-8-3-9-17-27/h1-9,11-12,14-17,28H,10,13,18-24H2	RAQPOZGWANIDQT-UHFFFAOYSA-N					compound annotation
0391_007344	Ciliobrevin D	C17H8Cl3N3O2	4.4643	136257953		N#CC(=C(O)c1c(Cl)cc(Cl)cc1)c1nc2c(ccc(Cl)c2)c(=O)[nH]1	InChI=1S/C17H8Cl3N3O2/c18-8-1-3-10(13(20)5-8)15(24)12(7-21)16-22-14-6-9(19)2-4-11(14)17(25)23-16/h1-6,24H,(H,22,23,25)	HVJSIEVASHGLBF-UHFFFAOYSA-N					compound annotation
0391_007345	1360705-96-9	C22H20Cl2N4O4	5.5779	49766530		Cc1c([N+](=O)[O-])c(C(=O)N2CCN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)CC2)no1	InChI=1S/C22H20Cl2N4O4/c1-14-20(28(30)31)19(25-32-14)22(29)27-12-10-26(11-13-27)21(15-2-6-17(23)7-3-15)16-4-8-18(24)9-5-16/h2-9,21H,10-13H2,1H3	VIBHJPDPEVVDTB-UHFFFAOYSA-N					compound annotation
0391_007346	Puromycin aminonucleoside	C12H18N6O3	0.6102	6020	CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)N)O	CN(C)c1ncnc2c1ncn2C1OC(CO)C(N)C1O	InChI=1S/C12H18N6O3/c1-17(2)10-8-11(15-4-14-10)18(5-16-8)12-9(20)7(13)6(3-19)21-12/h4-7,9,12,19-20H,3,13H2,1-2H3/t6-,7-,9-,12-/m1/s1	RYSMHWILUNYBFW-GRIPGOBMSA-N					compound annotation
0391_007347	283609-79-0	C21H42N6O5	0.7877	71312184	CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N)N	CC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O	InChI=1S/C21H42N6O5/c1-12(2)9-14(23)19(30)27-17(11-28)21(32)25-15(7-5-6-8-22)20(31)26-16(18(24)29)10-13(3)4/h12-17,28H,5-11,22-23H2,1-4H3,(H2,24,29)(H,25,32)(H,26,31)(H,27,30)/t14-,15-,16-,17-/m0/s1	YOKXDNNIFSAXBY-QAETUUGQSA-N					removed another duplicate entry; compound annotation
0391_007349	159432-28-7	C39H60N12O11	1.1907	10169886	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N	CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(=O)O)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(C)C(=O)O	InChI=1S/C39H60N12O11/c1-6-20(4)31(37(60)49-28(15-23-17-43-18-45-23)34(57)46-21(5)38(61)62)51-35(58)27(14-22-9-11-24(52)12-10-22)48-36(59)30(19(2)3)50-33(56)26(8-7-13-44-39(41)42)47-32(55)25(40)16-29(53)54/h9-12,17-21,25-28,30-31,52H,6-8,13-16,40H2,1-5H3,(H,43,45)(H,46,57)(H,47,55)(H,48,59)(H,49,60)(H,50,56)(H,51,58)(H,53,54)(H,61,62)(H4,41,42,44)/t20-,21+,25-,26-,27-,28-,30-,31-/m0/s1	GZSZZUXDAPDPOR-NGIFJXEWSA-N					compound annotation
0391_007350	476159-98-5	C23H27ClN4O3	1.8788	5330175		COc1cc(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c(Cl)cc1	InChI=1S/C23H27ClN4O3/c1-28-8-6-15(7-9-28)13-31-22-12-19-17(11-21(22)30-3)23(26-14-25-19)27-20-10-16(29-2)4-5-18(20)24/h4-5,10-12,14-15H,6-9,13H2,1-3H3,(H,25,26,27)	WPOXAFXHRJYEIC-UHFFFAOYSA-N					compound annotation
0391_007351	GNE-3511	C23H26F2N6O	2.0351	72547959		N#Cc1cc(Nc2nc(N3CCC(F)(F)C3)cc(C3CCN(C4COC4)CC3)c2)ncc1	InChI=1S/C23H26F2N6O/c24-23(25)4-8-31(15-23)22-11-18(17-2-6-30(7-3-17)19-13-32-14-19)10-21(29-22)28-20-9-16(12-26)1-5-27-20/h1,5,9-11,17,19H,2-4,6-8,13-15H2,(H,27,28,29)	RHFIAUKMKYHHFA-UHFFFAOYSA-N					compound annotation
0391_007352	Tipepidine	C15H17NS2	2.5827	5484		CN1CCCC(=C(c2cccs2)c2cccs2)C1	InChI=1S/C15H17NS2/c1-16-8-2-5-12(11-16)15(13-6-3-9-17-13)14-7-4-10-18-14/h3-4,6-7,9-10H,2,5,8,11H2,1H3	JWIXXNLOKOAAQT-UHFFFAOYSA-N					compound annotation
0391_007353	UNC1999	C33H43N7O2	2.8252	72551585		CCCc1c(CNC(=O)c2c3cnn(C(C)C)c3cc(-c3cnc(N4CCN(C(C)C)CC4)cc3)c2)c(=O)[nH]c(C)c1	InChI=1S/C33H43N7O2/c1-7-8-24-15-23(6)37-33(42)28(24)19-35-32(41)27-16-26(17-30-29(27)20-36-40(30)22(4)5)25-9-10-31(34-18-25)39-13-11-38(12-14-39)21(2)3/h9-10,15-18,20-22H,7-8,11-14,19H2,1-6H3,(H,35,41)(H,37,42)	DPJNKUOXBZSZAI-UHFFFAOYSA-N					doublet; compound annotation
0391_007354	UNC1999	C33H43N7O2	2.9432	72551585		CCCc1c(CNC(=O)c2c3cnn(C(C)C)c3cc(-c3cnc(N4CCN(C(C)C)CC4)cc3)c2)c(=O)[nH]c(C)c1	InChI=1S/C33H43N7O2/c1-7-8-24-15-23(6)37-33(42)28(24)19-35-32(41)27-16-26(17-30-29(27)20-36-40(30)22(4)5)25-9-10-31(34-18-25)39-13-11-38(12-14-39)21(2)3/h9-10,15-18,20-22H,7-8,11-14,19H2,1-6H3,(H,35,41)(H,37,42)	DPJNKUOXBZSZAI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007356	914471-09-3	C9H7ClFN5O2	3.38	135424953		Nc1nonc1C(=Nc1cc(Cl)c(F)cc1)NO	InChI=1S/C9H7ClFN5O2/c10-5-3-4(1-2-6(5)11)13-9(14-17)7-8(12)16-18-15-7/h1-3,17H,(H2,12,16)(H,13,14)	HGXSLPIXNPASGZ-UHFFFAOYSA-N					compound annotation
0391_007357	Sirtinol	C26H22N2O2	4.5242	2827646		CC(NC(=O)c1ccccc1N=Cc1c(O)ccc2ccccc12)c1ccccc1	InChI=1S/C26H22N2O2/c1-18(19-9-3-2-4-10-19)28-26(30)22-13-7-8-14-24(22)27-17-23-21-12-6-5-11-20(21)15-16-25(23)29/h2-18,29H,1H3,(H,28,30)	UXJFDYIHRJGPFS-UHFFFAOYSA-N					compound annotation
0391_007358	300842-64-2	C21H17BrN4	1.99	6918616		Cc1c(Br)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	InChI=1S/C21H17BrN4/c1-14-6-7-16(13-19(14)22)24-21-18-5-3-2-4-17(18)20(25-26-21)12-15-8-10-23-11-9-15/h2-11,13H,12H2,1H3,(H,24,26)	GXWKSXUPEFVUOO-UHFFFAOYSA-N					doublet; compound annotation
0391_007359	300842-64-2	C21H17BrN4	1.9949	6918616		Cc1c(Br)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1	InChI=1S/C21H17BrN4/c1-14-6-7-16(13-19(14)22)24-21-18-5-3-2-4-17(18)20(25-26-21)12-15-8-10-23-11-9-15/h2-11,13H,12H2,1H3,(H,24,26)	GXWKSXUPEFVUOO-UHFFFAOYSA-N					doublet; compound annotation
0391_007360	MCB-613	C20H20N2O	2.0476	2175947	CCC1C/C(=C\C2=CN=CC=C2)/C(=O)/C(=C/C3=CN=CC=C3)/C1	CCC1CC(=Cc2cnccc2)C(=O)C(=Cc2cnccc2)C1	InChI=1S/C20H20N2O/c1-2-15-9-18(11-16-5-3-7-21-13-16)20(23)19(10-15)12-17-6-4-8-22-14-17/h3-8,11-15H,2,9-10H2,1H3/b18-11+,19-12+	MMBSCBVEHMETSA-GDAWTGGTSA-N					doublet; compound annotation
0391_007361	MCB-613	C20H20N2O	2.1277	2175947	CCC1C/C(=C\C2=CN=CC=C2)/C(=O)/C(=C/C3=CN=CC=C3)/C1	CCC1CC(=Cc2cnccc2)C(=O)C(=Cc2cnccc2)C1	InChI=1S/C20H20N2O/c1-2-15-9-18(11-16-5-3-7-21-13-16)20(23)19(10-15)12-17-6-4-8-22-14-17/h3-8,11-15H,2,9-10H2,1H3/b18-11+,19-12+	MMBSCBVEHMETSA-GDAWTGGTSA-N					doublet; removed another duplicate entry; compound annotation
0391_007363	MCB-613	C20H20N2O	2.2129	2175947	CCC1C/C(=C\C2=CN=CC=C2)/C(=O)/C(=C/C3=CN=CC=C3)/C1	CCC1CC(=Cc2cnccc2)C(=O)C(=Cc2cnccc2)C1	InChI=1S/C20H20N2O/c1-2-15-9-18(11-16-5-3-7-21-13-16)20(23)19(10-15)12-17-6-4-8-22-14-17/h3-8,11-15H,2,9-10H2,1H3/b18-11+,19-12+	MMBSCBVEHMETSA-GDAWTGGTSA-N					doublet; compound annotation
0391_007364	GSK2636771	C22H22F3N3O3	2.2788	56949517		Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)	XTKLTGBKIDQGQL-UHFFFAOYSA-N					doublet; compound annotation
0391_007365	Eplerenone	C24H30O6	2.9911	443872	C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC	COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13	InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1	JUKPWJGBANNWMW-VWBFHTRKSA-N					doublet; removed another duplicate entry; compound annotation
0391_007367	YKL-06-062	C31H39N7O	3.0361	139600310		Cc1c(N2Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3N(C3CCCCC3)C2=O)c(C)ccc1	InChI=1S/C31H39N7O/c1-22-8-7-9-23(2)28(22)37-21-24-20-32-30(34-29(24)38(31(37)39)27-10-5-4-6-11-27)33-25-12-14-26(15-13-25)36-18-16-35(3)17-19-36/h7-9,12-15,20,27H,4-6,10-11,16-19,21H2,1-3H3,(H,32,33,34)	GFXPGVPPWWPDPV-UHFFFAOYSA-N					doublet; compound annotation
0391_007368	GSK2636771	C22H22F3N3O3	3.1044	56949517		Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F	InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)	XTKLTGBKIDQGQL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007371	YKL-06-062	C31H39N7O	3.2439	139600310		Cc1c(N2Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3N(C3CCCCC3)C2=O)c(C)ccc1	InChI=1S/C31H39N7O/c1-22-8-7-9-23(2)28(22)37-21-24-20-32-30(34-29(24)38(31(37)39)27-10-5-4-6-11-27)33-25-12-14-26(15-13-25)36-18-16-35(3)17-19-36/h7-9,12-15,20,27H,4-6,10-11,16-19,21H2,1-3H3,(H,32,33,34)	GFXPGVPPWWPDPV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007373	flunarizine	C26H26F2N2	3.9387	941361	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F	Fc1ccc(C(c2ccc(F)cc2)N2CCN(CC=Cc3ccccc3)CC2)cc1	InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+	SMANXXCATUTDDT-QPJJXVBHSA-N					compound annotation
0391_007374	Eplerenone	C24H30O6	4.0961	443872	C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC	COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13	InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1	JUKPWJGBANNWMW-VWBFHTRKSA-N					doublet; removed another duplicate entry; compound annotation
0391_007376	Eplerenone	C24H30O6	4.3179	443872	C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC	COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13	InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1	JUKPWJGBANNWMW-VWBFHTRKSA-N					doublet; removed another duplicate entry; compound annotation
0391_007378	KRN5	C27H22FNO5	4.7519	91820677		COc1c(OC)c2c(cc1)c(Cc1ccccc1F)c1-c3cc4c(cc3CCn1c2=O)OCO4	InChI=1S/C27H22FNO5/c1-31-21-8-7-17-19(11-16-5-3-4-6-20(16)28)25-18-13-23-22(33-14-34-23)12-15(18)9-10-29(25)27(30)24(17)26(21)32-2/h3-8,12-13H,9-11,14H2,1-2H3	WSIOACCDMOKVNM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007380	KRN5	C27H22FNO5	4.7548	91820677		COc1c(OC)c2c(cc1)c(Cc1ccccc1F)c1-c3cc4c(cc3CCn1c2=O)OCO4	InChI=1S/C27H22FNO5/c1-31-21-8-7-17-19(11-16-5-3-4-6-20(16)28)25-18-13-23-22(33-14-34-23)12-15(18)9-10-29(25)27(30)24(17)26(21)32-2/h3-8,12-13H,9-11,14H2,1-2H3	WSIOACCDMOKVNM-UHFFFAOYSA-N					doublet; compound annotation
0391_007381	phenylbiguanide	C8H11N5	0.5767	4780		NC(N)=NC(N)=Nc1ccccc1	InChI=1S/C8H11N5/c9-7(10)13-8(11)12-6-4-2-1-3-5-6/h1-5H,(H6,9,10,11,12,13)	CUQCMXFWIMOWRP-UHFFFAOYSA-N					compound annotation
0391_007382	Cutamesine	C23H32N2O2	2.2189	9907323		COc1c(OC)cc(CCN2CCN(CCCc3ccccc3)CC2)cc1	InChI=1S/C23H32N2O2/c1-26-22-11-10-21(19-23(22)27-2)12-14-25-17-15-24(16-18-25)13-6-9-20-7-4-3-5-8-20/h3-5,7-8,10-11,19H,6,9,12-18H2,1-2H3	UVSWWUWQVAQPJR-UHFFFAOYSA-N					compound annotation
0391_007383	Rabusertib	C18H22BrN5O3	2.7692	11955855	CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OC[C@@H]3CNCCO3	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OCC2CNCCO2)cn1	InChI=1S/C18H22BrN5O3/c1-11-5-16(27-10-13-8-20-3-4-26-13)15(6-14(11)19)23-18(25)24-17-9-21-12(2)7-22-17/h5-7,9,13,20H,3-4,8,10H2,1-2H3,(H2,22,23,24,25)/t13-/m0/s1	SYYBDNPGDKKJDU-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_007385	Taltobulin	C27H43N3O4	2.9316	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_007386	Taltobulin	C27H43N3O4	2.9343	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_007387	Taltobulin	C27H43N3O4	3.174	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_007388	Taltobulin	C27H43N3O4	3.2267	6918637	CC(C)[C@@H](/C=C(\C)/C(=O)O)N(C)C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C(C)(C)C1=CC=CC=C1)NC	CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1	InChI=1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1	CNTMOLDWXSVYKD-PSRNMDMQSA-N					doublet; compound annotation
0391_007389	1257628-77-5	C29H27F3N6O	3.3501	51038269		Cc1c(C#Cc2cc3c(nc2)[nH]nc3)cc(C(=O)Nc2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36)	TZKBVRDEOITLRB-UHFFFAOYSA-N					doublet; compound annotation
0391_007390	1613710-01-2	C19H16N2O2S	3.3997	74766530		COc1cc(OC)c(-c2c[nH]c3nccc(-c4cscc4)c23)cc1	InChI=1S/C19H16N2O2S/c1-22-13-3-4-15(17(9-13)23-2)16-10-21-19-18(16)14(5-7-20-19)12-6-8-24-11-12/h3-11H,1-2H3,(H,20,21)	WEHOIIGXTMKVRG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007392	A-317491	C33H27NO8	4.2782	9829395	C1C[C@@H](C2=CC=CC=C2C1)N(CC3=CC(=CC=C3)OC4=CC=CC=C4)C(=O)C5=CC(=C(C=C5C(=O)O)C(=O)O)C(=O)O	O=C(O)c1c(C(=O)O)cc(C(=O)N(Cc2cc(Oc3ccccc3)ccc2)C2CCCc3ccccc32)c(C(=O)O)c1	InChI=1S/C33H27NO8/c35-30(25-17-27(32(38)39)28(33(40)41)18-26(25)31(36)37)34(29-15-7-10-21-9-4-5-14-24(21)29)19-20-8-6-13-23(16-20)42-22-11-2-1-3-12-22/h1-6,8-9,11-14,16-18,29H,7,10,15,19H2,(H,36,37)(H,38,39)(H,40,41)/t29-/m0/s1	VQGBOYBIENNKMI-LJAQVGFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_007394	GNF-5837	C28H21F4N5O2	4.7896	59397065	CC1=C(C=C(C=C1)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)F)NC3=CC4=C(C=C3)/C(=C/C5=CC=CN5)/C(=O)N4	Cc1c(Nc2cc3c(cc2)C(=Cc2ccc[nH]2)C(=O)N3)cc(NC(=O)Nc2c(F)ccc(C(F)(F)F)c2)cc1	InChI=1S/C28H21F4N5O2/c1-15-4-6-19(35-27(39)37-25-11-16(28(30,31)32)5-9-22(25)29)13-23(15)34-18-7-8-20-21(12-17-3-2-10-33-17)26(38)36-24(20)14-18/h2-14,33-34H,1H3,(H,36,38)(H2,35,37,39)/b21-12-	YYDUWLSETXNJJT-MTJSOVHGSA-N					doublet; removed another duplicate entry; compound annotation
0391_007396	GNF-5837	C28H21F4N5O2	5.3304	59397065	CC1=C(C=C(C=C1)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)F)NC3=CC4=C(C=C3)/C(=C/C5=CC=CN5)/C(=O)N4	Cc1c(Nc2cc3c(cc2)C(=Cc2ccc[nH]2)C(=O)N3)cc(NC(=O)Nc2c(F)ccc(C(F)(F)F)c2)cc1	InChI=1S/C28H21F4N5O2/c1-15-4-6-19(35-27(39)37-25-11-16(28(30,31)32)5-9-22(25)29)13-23(15)34-18-7-8-20-21(12-17-3-2-10-33-17)26(38)36-24(20)14-18/h2-14,33-34H,1H3,(H,36,38)(H2,35,37,39)/b21-12-	YYDUWLSETXNJJT-MTJSOVHGSA-N					doublet; compound annotation
0391_007397	Ensulizole	C13H10N2O3S	1.0871	33919		O=S(=O)(O)c1cc2c(cc1)nc(-c1ccccc1)[nH]2	InChI=1S/C13H10N2O3S/c16-19(17,18)10-6-7-11-12(8-10)15-13(14-11)9-4-2-1-3-5-9/h1-8H,(H,14,15)(H,16,17,18)	UVCJGUGAGLDPAA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007399	2055990-90-2	C24H25FN4O4	2.3125	126476626	C1CNC[C@H]([C@@H]1C2=CC(=C(C=C2)F)C(=O)NCC3=CC=NN3)COC4=CC5=C(C=C4)OCO5	O=C(NCc1ccn[nH]1)c1c(F)ccc(C2CCNCC2COc2cc3c(cc2)OCO3)c1	InChI=1S/C24H25FN4O4/c25-21-3-1-15(9-20(21)24(30)27-12-17-5-8-28-29-17)19-6-7-26-11-16(19)13-31-18-2-4-22-23(10-18)33-14-32-22/h1-5,8-10,16,19,26H,6-7,11-14H2,(H,27,30)(H,28,29)/t16-,19-/m0/s1	XQUKEAYUAYTIBV-LPHOPBHVSA-N					doublet; compound annotation
0391_007400	2055990-90-2	C24H25FN4O4	2.3157	126476626	C1CNC[C@H]([C@@H]1C2=CC(=C(C=C2)F)C(=O)NCC3=CC=NN3)COC4=CC5=C(C=C4)OCO5	O=C(NCc1ccn[nH]1)c1c(F)ccc(C2CCNCC2COc2cc3c(cc2)OCO3)c1	InChI=1S/C24H25FN4O4/c25-21-3-1-15(9-20(21)24(30)27-12-17-5-8-28-29-17)19-6-7-26-11-16(19)13-31-18-2-4-22-23(10-18)33-14-32-22/h1-5,8-10,16,19,26H,6-7,11-14H2,(H,27,30)(H,28,29)/t16-,19-/m0/s1	XQUKEAYUAYTIBV-LPHOPBHVSA-N					doublet; compound annotation
0391_007401	Atuveciclib	C18H18FN5O2S	2.3339	121488167	COC1=C(C=CC(=C1)F)C2=NC(=NC=N2)NC3=CC=CC(=C3)C[S@](=N)(=O)C	COc1c(-c2nc(Nc3cccc(CS(C)(=N)=O)c3)ncn2)ccc(F)c1	InChI=1S/C18H18FN5O2S/c1-26-16-9-13(19)6-7-15(16)17-21-11-22-18(24-17)23-14-5-3-4-12(8-14)10-27(2,20)25/h3-9,11,20H,10H2,1-2H3,(H,21,22,23,24)/t27-/m1/s1	ACWKGTGIJRCOOM-HHHXNRCGSA-N					removed another duplicate entry; compound annotation
0391_007403	Levcromakalim	C16H18N2O3	2.727	93504	CC1([C@H]([C@@H](C2=C(O1)C=CC(=C2)C#N)N3CCCC3=O)O)C	CC1(C)Oc2c(cc(C#N)cc2)C(N2CCCC2=O)C1O	InChI=1S/C16H18N2O3/c1-16(2)15(20)14(18-7-3-4-13(18)19)11-8-10(9-17)5-6-12(11)21-16/h5-6,8,14-15,20H,3-4,7H2,1-2H3/t14-,15+/m1/s1	TVZCRIROJQEVOT-CABCVRRESA-N					removed another duplicate entry; compound annotation
0391_007405	NCC007	C22H28F3N7	2.7676	138403252		CC(C1CC1)n1cnc2c(NCc3cc(C(F)(F)F)ccc3)nc(NCCN(C)C)nc21	InChI=1S/C22H28F3N7/c1-14(16-7-8-16)32-13-28-18-19(29-21(30-20(18)32)26-9-10-31(2)3)27-12-15-5-4-6-17(11-15)22(23,24)25/h4-6,11,13-14,16H,7-10,12H2,1-3H3,(H2,26,27,29,30)	GHRNSZVMIARHIS-UHFFFAOYSA-N					doublet; compound annotation
0391_007406	NCC007	C22H28F3N7	2.8401	138403252		CC(C1CC1)n1cnc2c(NCc3cc(C(F)(F)F)ccc3)nc(NCCN(C)C)nc21	InChI=1S/C22H28F3N7/c1-14(16-7-8-16)32-13-28-18-19(29-21(30-20(18)32)26-9-10-31(2)3)27-12-15-5-4-6-17(11-15)22(23,24)25/h4-6,11,13-14,16H,7-10,12H2,1-3H3,(H2,26,27,29,30)	GHRNSZVMIARHIS-UHFFFAOYSA-N					doublet; compound annotation
0391_007407	Pralsetinib	C27H32FN9O2	2.8484	129073603	CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC	COC1(C(=O)NC(C)c2cnc(-n3cc(F)cn3)cc2)CCC(c2nc(C)cc(Nc3n[nH]c(C)c3)n2)CC1	InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1	GBLBJPZSROAGMF-SIYOEGHHSA-N					doublet; compound annotation
0391_007408	2055990-90-2	C24H25FN4O4	2.8754	126476626	C1CNC[C@H]([C@@H]1C2=CC(=C(C=C2)F)C(=O)NCC3=CC=NN3)COC4=CC5=C(C=C4)OCO5	O=C(NCc1ccn[nH]1)c1c(F)ccc(C2CCNCC2COc2cc3c(cc2)OCO3)c1	InChI=1S/C24H25FN4O4/c25-21-3-1-15(9-20(21)24(30)27-12-17-5-8-28-29-17)19-6-7-26-11-16(19)13-31-18-2-4-22-23(10-18)33-14-32-22/h1-5,8-10,16,19,26H,6-7,11-14H2,(H,27,30)(H,28,29)/t16-,19-/m0/s1	XQUKEAYUAYTIBV-LPHOPBHVSA-N					doublet; compound annotation
0391_007409	Pralsetinib	C27H32FN9O2	3.4247	129073603	CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC	COC1(C(=O)NC(C)c2cnc(-n3cc(F)cn3)cc2)CCC(c2nc(C)cc(Nc3n[nH]c(C)c3)n2)CC1	InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1	GBLBJPZSROAGMF-SIYOEGHHSA-N					doublet; compound annotation
0391_007410	Lersivirine	C17H18N4O2	3.4409	16739244		CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1	InChI=1S/C17H18N4O2/c1-3-15-17(16(4-2)21(20-15)5-6-22)23-14-8-12(10-18)7-13(9-14)11-19/h7-9,22H,3-6H2,1-2H3	MCPUZZJBAHRIPO-UHFFFAOYSA-N					compound annotation
0391_007411	1235403-62-9	C18H12Cl2FN5O3S2	3.6351	46840946		Nc1c(-c2cc(Cl)ccc2Oc2cc(F)c(S(=O)(=O)Nc3cscn3)cc2Cl)cn[nH]1	InChI=1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25)	ZYSCOUXLBXGGIM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007413	LESINURAD	C17H14BrN3O2S	3.8586	53465279		O=C(O)CSc1nnc(Br)n1-c1ccc(C2CC2)c2ccccc12	InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)	FGQFOYHRJSUHMR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007415	hDHODH-IN-4	C21H24N4O2	4.2969	118430507		Cc1c(C(O)c2ccccc2)c(OC(C)C)nn1-c1ncc(C2CC2)cn1	InChI=1S/C21H24N4O2/c1-13(2)27-20-18(19(26)16-7-5-4-6-8-16)14(3)25(24-20)21-22-11-17(12-23-21)15-9-10-15/h4-8,11-13,15,19,26H,9-10H2,1-3H3	BSNKBAPMWCMENP-UHFFFAOYSA-N					doublet; compound annotation
0391_007416	hDHODH-IN-4	C21H24N4O2	4.3065	118430507		Cc1c(C(O)c2ccccc2)c(OC(C)C)nn1-c1ncc(C2CC2)cn1	InChI=1S/C21H24N4O2/c1-13(2)27-20-18(19(26)16-7-5-4-6-8-16)14(3)25(24-20)21-22-11-17(12-23-21)15-9-10-15/h4-8,11-13,15,19,26H,9-10H2,1-3H3	BSNKBAPMWCMENP-UHFFFAOYSA-N					doublet; compound annotation
0391_007417	Pralsetinib	C27H32FN9O2	4.4927	129073603	CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC	COC1(C(=O)NC(C)c2cnc(-n3cc(F)cn3)cc2)CCC(c2nc(C)cc(Nc3n[nH]c(C)c3)n2)CC1	InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1	GBLBJPZSROAGMF-SIYOEGHHSA-N					doublet; compound annotation
0391_007418	1235403-62-9	C18H12Cl2FN5O3S2	5.4995	46840946		Nc1c(-c2cc(Cl)ccc2Oc2cc(F)c(S(=O)(=O)Nc3cscn3)cc2Cl)cn[nH]1	InChI=1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25)	ZYSCOUXLBXGGIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007419	1235403-62-9	C18H12Cl2FN5O3S2	5.6524	46840946		Nc1c(-c2cc(Cl)ccc2Oc2cc(F)c(S(=O)(=O)Nc3cscn3)cc2Cl)cn[nH]1	InChI=1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25)	ZYSCOUXLBXGGIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007420	N,N'-Diacetyl-L-cystine	C10H16N2O6S2	0.7163	6995101	CC(=O)N[C@@H](CSSC[C@@H](C(=O)O)NC(=O)C)C(=O)O	CC(=O)NC(CSSCC(NC(C)=O)C(=O)O)C(=O)O	InChI=1S/C10H16N2O6S2/c1-5(13)11-7(9(15)16)3-19-20-4-8(10(17)18)12-6(2)14/h7-8H,3-4H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)(H,17,18)/t7-,8-/m0/s1	YTPQSLLEROSACP-YUMQZZPRSA-N					compound annotation
0391_007421	UNC0638	C30H47N5O2	1.567	46224516		COc1c(OCCCN2CCCC2)cc2nc(C3CCCCC3)nc(NC3CCN(C(C)C)CC3)c2c1	InChI=1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33)	QOECJCJVIMVJGX-UHFFFAOYSA-N					compound annotation
0391_007422	Mirogabalin	C12H19NO2	1.9749	59509752	CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN	CCC1=CC2C(C1)CC2(CN)CC(=O)O	InChI=1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1	FTBQORVNHOIASH-CKYFFXLPSA-N					doublet; compound annotation
0391_007423	Mirogabalin	C12H19NO2	2.0804	59509752	CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN	CCC1=CC2C(C1)CC2(CN)CC(=O)O	InChI=1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1	FTBQORVNHOIASH-CKYFFXLPSA-N					doublet; compound annotation
0391_007424	MOLI001013	C27H33N2O6S2+	2.4712	4695		CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2c(S(=O)(=O)O)ccc(S(=O)(=O)O)c2)cc1	InChI=1S/C27H32N2O6S2/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35)/p+1	YFKDCGWIINMRQY-UHFFFAOYSA-O					compound annotation
0391_007425	1265229-25-1	C20H16N6O	2.5931	66555680		Cc1nc2c(cc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2)[nH]1	InChI=1S/C20H16N6O/c1-11-23-16-7-6-13(9-17(16)24-11)26-20(21)14(10-22-26)19(27)18-8-12-4-2-3-5-15(12)25-18/h2-10,25H,21H2,1H3,(H,23,24)	BEMNJULZEQTDJY-UHFFFAOYSA-N					compound annotation
0391_007426	1959551-26-8	C24H23F4N7O3	3.6463	121457027	C1CN(CCC1(CN2C=NC3=C(C2=O)C=NN3C4=CC=C(C=C4)F)O)C(=O)C[C@@H](C(F)F)N5C=CC(=N5)F	O=C(CC(C(F)F)n1ccc(F)n1)N1CCC(O)(Cn2cnc3c(cnn3-c3ccc(F)cc3)c2=O)CC1	InChI=1S/C24H23F4N7O3/c25-15-1-3-16(4-2-15)35-22-17(12-30-35)23(37)33(14-29-22)13-24(38)6-9-32(10-7-24)20(36)11-18(21(27)28)34-8-5-19(26)31-34/h1-5,8,12,14,18,21,38H,6-7,9-11,13H2/t18-/m0/s1	BLSNYSFLZAWBIV-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_007428	1133819-87-0	C19H17NO5S	3.8015	25230266		COc1cccc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)c1	InChI=1S/C19H17NO5S/c1-24-15-4-2-3-13(10-15)16(21)11-25-14-7-5-12(6-8-14)9-17-18(22)20-19(23)26-17/h2-8,10,17H,9,11H2,1H3,(H,20,22,23)	YAUMOGALQJYOJQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007430	Cilomilast	C20H25NO4	4.0872	151170		COc1c(OC2CCCC2)cc(C2(C#N)CCC(C(=O)O)CC2)cc1	InChI=1S/C20H25NO4/c1-24-17-7-6-15(12-18(17)25-16-4-2-3-5-16)20(13-21)10-8-14(9-11-20)19(22)23/h6-7,12,14,16H,2-5,8-11H2,1H3,(H,22,23)	CFBUZOUXXHZCFB-UHFFFAOYSA-N					compound annotation
0391_007431	VU6005649	C16H12F5N3O	4.8606	131954513		COc1c(F)c(F)c(-c2c3nc(C)cc(C(F)(F)F)n3nc2C)cc1	InChI=1S/C16H12F5N3O/c1-7-6-11(16(19,20)21)24-15(22-7)12(8(2)23-24)9-4-5-10(25-3)14(18)13(9)17/h4-6H,1-3H3	NYBZCKAQIIPSDS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007433	DL-TBOA	C11H13NO5	0.798	5311218	C1=CC=C(C=C1)CO[C@@H]([C@@H](C(=O)O)N)C(=O)O	NC(C(=O)O)C(OCc1ccccc1)C(=O)O	InChI=1S/C11H13NO5/c12-8(10(13)14)9(11(15)16)17-6-7-4-2-1-3-5-7/h1-5,8-9H,6,12H2,(H,13,14)(H,15,16)/t8-,9-/m0/s1	BYOBCYXURWDEDS-IUCAKERBSA-N					compound annotation
0391_007434	521937-07-5	C12H11NO3	1.5998	755673		O=C1NCCCc2c1oc1c2cc(O)cc1	InChI=1S/C12H11NO3/c14-7-3-4-10-9(6-7)8-2-1-5-13-12(15)11(8)16-10/h3-4,6,14H,1-2,5H2,(H,13,15)	AACFPJSJOWQNBN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007436	Clomethiazole	C6H8ClNS	2.1575	10783		Cc1c(CCCl)scn1	InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3	PCLITLDOTJTVDJ-UHFFFAOYSA-N					doublet; compound annotation
0391_007437	(Rac)-NMDAR antagonist 1	C20H20BrN3O2	2.2193	137333444		O=C(NCCc1ccc(O)cc1)C1CCC2=Nc3c(cc(Br)cc3)CN21	InChI=1S/C20H20BrN3O2/c21-15-3-6-17-14(11-15)12-24-18(7-8-19(24)23-17)20(26)22-10-9-13-1-4-16(25)5-2-13/h1-6,11,18,25H,7-10,12H2,(H,22,26)	NCHFPVRYYJGAJY-UHFFFAOYSA-N					compound annotation
0391_007438	IPI-3063	C25H25N7O2	2.8167	71276090	C[C@@H](C1=CC2=C(C(=CC=C2)C3=CN(C(=O)C=C3)C)C(=O)N1C(C)C)NC4=NC=NC(=C4C#N)N	CC(Nc1ncnc(N)c1C#N)c1cc2c(c(-c3cn(C)c(=O)cc3)ccc2)c(=O)n1C(C)C	InChI=1S/C25H25N7O2/c1-14(2)32-20(15(3)30-24-19(11-26)23(27)28-13-29-24)10-16-6-5-7-18(22(16)25(32)34)17-8-9-21(33)31(4)12-17/h5-10,12-15H,1-4H3,(H3,27,28,29,30)/t15-/m0/s1	OBHAYOJCPNWKBL-HNNXBMFYSA-N					doublet; compound annotation
0391_007439	IPI-3063	C25H25N7O2	2.8195	71276090	C[C@@H](C1=CC2=C(C(=CC=C2)C3=CN(C(=O)C=C3)C)C(=O)N1C(C)C)NC4=NC=NC(=C4C#N)N	CC(Nc1ncnc(N)c1C#N)c1cc2c(c(-c3cn(C)c(=O)cc3)ccc2)c(=O)n1C(C)C	InChI=1S/C25H25N7O2/c1-14(2)32-20(15(3)30-24-19(11-26)23(27)28-13-29-24)10-16-6-5-7-18(22(16)25(32)34)17-8-9-21(33)31(4)12-17/h5-10,12-15H,1-4H3,(H3,27,28,29,30)/t15-/m0/s1	OBHAYOJCPNWKBL-HNNXBMFYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007441	AG 555	C19H18N2O3	3.3013	5328770	C1=CC=C(C=C1)CCCNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)NCCCc1ccccc1	InChI=1S/C19H18N2O3/c20-13-16(11-15-8-9-17(22)18(23)12-15)19(24)21-10-4-7-14-5-2-1-3-6-14/h1-3,5-6,8-9,11-12,22-23H,4,7,10H2,(H,21,24)/b16-11+	GSQOBTOAOGXIFL-LFIBNONCSA-N					doublet; compound annotation
0391_007442	LP-211	C30H34N4O	3.4588	25107716		N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1	InChI=1S/C30H34N4O/c31-23-25-14-16-26(17-15-25)24-32-30(35)13-5-2-8-18-33-19-21-34(22-20-33)29-12-7-6-11-28(29)27-9-3-1-4-10-27/h1,3-4,6-7,9-12,14-17H,2,5,8,13,18-22,24H2,(H,32,35)	BQEDZLDNNBDKDS-UHFFFAOYSA-N					compound annotation
0391_007443	AMG 579	C25H23N5O3	3.5082	59351313		CC(=O)N1CCC(c2nccnc2Oc2ccc(C(=O)c3nc4ccccc4[nH]3)cc2)CC1	InChI=1S/C25H23N5O3/c1-16(31)30-14-10-17(11-15-30)22-25(27-13-12-26-22)33-19-8-6-18(7-9-19)23(32)24-28-20-4-2-3-5-21(20)29-24/h2-9,12-13,17H,10-11,14-15H2,1H3,(H,28,29)	ZNPDAYJZIRPRFQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007445	AG 555	C19H18N2O3	3.6517	5328770	C1=CC=C(C=C1)CCCNC(=O)/C(=C/C2=CC(=C(C=C2)O)O)/C#N	N#CC(=Cc1cc(O)c(O)cc1)C(=O)NCCCc1ccccc1	InChI=1S/C19H18N2O3/c20-13-16(11-15-8-9-17(22)18(23)12-15)19(24)21-10-4-7-14-5-2-1-3-6-14/h1-3,5-6,8-9,11-12,22-23H,4,7,10H2,(H,21,24)/b16-11+	GSQOBTOAOGXIFL-LFIBNONCSA-N					doublet; compound annotation
0391_007446	1047953-91-2	C19H17Cl3N4O3	4.2617	45942672		COCCOc1nn(-c2ccc(NC(=O)CCl)cc2)c(-c2cc(Cl)c(Cl)cc2)n1	InChI=1S/C19H17Cl3N4O3/c1-28-8-9-29-19-24-18(12-2-7-15(21)16(22)10-12)26(25-19)14-5-3-13(4-6-14)23-17(27)11-20/h2-7,10H,8-9,11H2,1H3,(H,23,27)	TWJGQZBSEMDPQP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007448	Milciclib	C25H32N8O	1.9316	16718576		CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	RXZMYLDMFYNEIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007449	1169562-71-3	C14H12ClN3O2	2.0368	135564632	C1C[C@H](NC1)C2=NC3=C(C(=O)N2)OC4=C3C=C(C=C4)Cl	O=c1nc(C2CCCN2)[nH]c2c1oc1c2cc(Cl)cc1	InChI=1S/C14H12ClN3O2/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9/h3-4,6,9,16H,1-2,5H2,(H,17,18,19)/t9-/m0/s1	JJWLXRKVUJDJKG-VIFPVBQESA-N					removed another duplicate entry; compound annotation
0391_007451	AZD1390	C27H32FN5O2	2.1262	126689157		CC(C)n1c(=O)n(C)c2c1c1cc(-c3cnc(OCCCN4CCCCC4)cc3)c(F)cc1nc2	InChI=1S/C27H32FN5O2/c1-18(2)33-26-21-14-20(22(28)15-23(21)29-17-24(26)31(3)27(33)34)19-8-9-25(30-16-19)35-13-7-12-32-10-5-4-6-11-32/h8-9,14-18H,4-7,10-13H2,1-3H3	VQSZIPCGAGVRRP-UHFFFAOYSA-N					compound annotation
0391_007452	Milciclib	C25H32N8O	2.3244	16718576		CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	RXZMYLDMFYNEIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007453	Milciclib	C25H32N8O	2.329	16718576		CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	RXZMYLDMFYNEIM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007455	890190-22-4	C21H25N3O4	2.3911	6457069		COC(=O)c1ccc(N2CCN(C)CC2)c(NC(=O)c2cc(OC)ccc2)c1	InChI=1S/C21H25N3O4/c1-23-9-11-24(12-10-23)19-8-7-16(21(26)28-3)14-18(19)22-20(25)15-5-4-6-17(13-15)27-2/h4-8,13-14H,9-12H2,1-3H3,(H,22,25)	ZPLBXOVTSNRBFB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007457	SEL120-34A	C15H18Br2N4	2.6675	73776233		Cc1c2nc(N3CCNCC3)n3CCCc(c23)c(Br)c1Br	InChI=1S/C15H18Br2N4/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20/h18H,2-8H2,1H3	FSBMCTDYWXIBLM-UHFFFAOYSA-N					doublet; compound annotation
0391_007458	SEL120-34A	C15H18Br2N4	2.6722	73776233		Cc1c2nc(N3CCNCC3)n3CCCc(c23)c(Br)c1Br	InChI=1S/C15H18Br2N4/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20/h18H,2-8H2,1H3	FSBMCTDYWXIBLM-UHFFFAOYSA-N					doublet; compound annotation
0391_007459	GNF-7	C28H24F3N7O2	3.2734	11478363		Cc1ncc(Nc2ncc3CN(c4c(C)ccc(NC(=O)c5cc(C(F)(F)F)ccc5)c4)C(=O)N(C)c3n2)cc1	InChI=1S/C28H24F3N7O2/c1-16-7-9-21(34-25(39)18-5-4-6-20(11-18)28(29,30)31)12-23(16)38-15-19-13-33-26(36-24(19)37(3)27(38)40)35-22-10-8-17(2)32-14-22/h4-14H,15H2,1-3H3,(H,34,39)(H,33,35,36)	SZNYUUZOQHNEKB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007461	Etofylline clofibrate	C19H21ClN4O5	3.6482	41109		Cn1c(=O)c2c(ncn2CCOC(=O)C(C)(C)Oc2ccc(Cl)cc2)n(C)c1=O	InChI=1S/C19H21ClN4O5/c1-19(2,29-13-7-5-12(20)6-8-13)17(26)28-10-9-24-11-21-15-14(24)16(25)23(4)18(27)22(15)3/h5-8,11H,9-10H2,1-4H3	KYAKGJDISSNVPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007463	Milciclib	C25H32N8O	4.0977	16718576		CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	RXZMYLDMFYNEIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007464	Milciclib	C25H32N8O	4.3162	16718576		CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2	InChI=1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29)	RXZMYLDMFYNEIM-UHFFFAOYSA-N					doublet; compound annotation
0391_007465	24144-92-1	C18H20O4	4.9778	5354004	COC1=CC(=C(C=C1)/C=C/C2=CC(=CC(=C2)OC)OC)OC	COc1cc(C=Cc2c(OC)cc(OC)cc2)cc(OC)c1	InChI=1S/C18H20O4/c1-19-15-8-7-14(18(12-15)22-4)6-5-13-9-16(20-2)11-17(10-13)21-3/h5-12H,1-4H3/b6-5+	JDBCWSHYEQUBLW-AATRIKPKSA-N					doublet; compound annotation
0391_007466	24144-92-1	C18H20O4	5.0499	5354004	COC1=CC(=C(C=C1)/C=C/C2=CC(=CC(=C2)OC)OC)OC	COc1cc(C=Cc2c(OC)cc(OC)cc2)cc(OC)c1	InChI=1S/C18H20O4/c1-19-15-8-7-14(18(12-15)22-4)6-5-13-9-16(20-2)11-17(10-13)21-3/h5-12H,1-4H3/b6-5+	JDBCWSHYEQUBLW-AATRIKPKSA-N					doublet; compound annotation
0391_007467	24144-92-1	C18H20O4	5.0539	5354004	COC1=CC(=C(C=C1)/C=C/C2=CC(=CC(=C2)OC)OC)OC	COc1cc(C=Cc2c(OC)cc(OC)cc2)cc(OC)c1	InChI=1S/C18H20O4/c1-19-15-8-7-14(18(12-15)22-4)6-5-13-9-16(20-2)11-17(10-13)21-3/h5-12H,1-4H3/b6-5+	JDBCWSHYEQUBLW-AATRIKPKSA-N					doublet; compound annotation
0391_007468	Veliparib	C13H16N4O	0.9557	11960529	C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N	CC1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1	InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1	JNAHVYVRKWKWKQ-CYBMUJFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_007470	Kaempferitrin	C27H30O14	1.8957	5486199	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC(=C3C(=C2)OC(=C(C3=O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)C)O)O)O)C5=CC=C(C=C5)O)O)O)O)O	CC1OC(Oc2cc(O)c3c(=O)c(OC4OC(C)C(O)C(O)C4O)c(-c4ccc(O)cc4)oc3c2)C(O)C(O)C1O	InChI=1S/C27H30O14/c1-9-17(30)20(33)22(35)26(37-9)39-13-7-14(29)16-15(8-13)40-24(11-3-5-12(28)6-4-11)25(19(16)32)41-27-23(36)21(34)18(31)10(2)38-27/h3-10,17-18,20-23,26-31,33-36H,1-2H3/t9-,10-,17-,18-,20+,21+,22+,23+,26-,27-/m0/s1	PUPKKEQDLNREIM-QNSQPKOQSA-N					removed another duplicate entry; compound annotation
0391_007472	2-chloro-N-(3,4-dimethoxybenzyl)acetamide	C11H14ClNO3	2.1255	2392259		COc1c(OC)cc(CNC(=O)CCl)cc1	InChI=1S/C11H14ClNO3/c1-15-9-4-3-8(5-10(9)16-2)7-13-11(14)6-12/h3-5H,6-7H2,1-2H3,(H,13,14)	CETPWRGZGWGPSV-UHFFFAOYSA-N					compound annotation
0391_007473	252917-06-9	C22H18Cl2N8	2.6889	9956119		Cc1cnc(-c2cnc(NCCNc3ncc(C#N)cc3)nc2-c2c(Cl)cc(Cl)cc2)[nH]1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)	AQGNHMOJWBZFQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_007474	252917-06-9	C22H18Cl2N8	2.6917	9956119		Cc1cnc(-c2cnc(NCCNc3ncc(C#N)cc3)nc2-c2c(Cl)cc(Cl)cc2)[nH]1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)	AQGNHMOJWBZFQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_007475	1846-76-0	C12H10O4	2.9735	15800		CCOC(=O)c1cc2ccccc2oc1=O	InChI=1S/C12H10O4/c1-2-15-11(13)9-7-8-5-3-4-6-10(8)16-12(9)14/h3-7H,2H2,1H3	XKHPEMKBJGUYCM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007477	MK-6892	C19H22N4O5	3.2902	135416394		CC(C)(Cc1nc(-c2ncc(O)cc2)no1)C(=O)NC1=C(C(=O)O)CCCC1	InChI=1S/C19H22N4O5/c1-19(2,18(27)21-13-6-4-3-5-12(13)17(25)26)9-15-22-16(23-28-15)14-8-7-11(24)10-20-14/h7-8,10,24H,3-6,9H2,1-2H3,(H,21,27)(H,25,26)	CJHXBFSJXDUJHP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007479	SK1-IN-1	C22H30N4O3	3.5021	46911228	C[C@@H](C1=CC=C(C=C1)C2=NOC(=N2)CCC3CCCC3)NC(=O)[C@@H]4[C@H](CCN4)O	CC(NC(=O)C1NCCC1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	InChI=1S/C22H30N4O3/c1-14(24-22(28)20-18(27)12-13-23-20)16-7-9-17(10-8-16)21-25-19(29-26-21)11-6-15-4-2-3-5-15/h7-10,14-15,18,20,23,27H,2-6,11-13H2,1H3,(H,24,28)/t14-,18-,20-/m0/s1	GDJANRNMFHNVOW-DCPHZVHLSA-N					doublet; compound annotation
0391_007480	SK1-IN-1	C22H30N4O3	3.6022	46911228	C[C@@H](C1=CC=C(C=C1)C2=NOC(=N2)CCC3CCCC3)NC(=O)[C@@H]4[C@H](CCN4)O	CC(NC(=O)C1NCCC1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	InChI=1S/C22H30N4O3/c1-14(24-22(28)20-18(27)12-13-23-20)16-7-9-17(10-8-16)21-25-19(29-26-21)11-6-15-4-2-3-5-15/h7-10,14-15,18,20,23,27H,2-6,11-13H2,1H3,(H,24,28)/t14-,18-,20-/m0/s1	GDJANRNMFHNVOW-DCPHZVHLSA-N					doublet; compound annotation
0391_007481	SK1-IN-1	C22H30N4O3	3.605	46911228	C[C@@H](C1=CC=C(C=C1)C2=NOC(=N2)CCC3CCCC3)NC(=O)[C@@H]4[C@H](CCN4)O	CC(NC(=O)C1NCCC1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	InChI=1S/C22H30N4O3/c1-14(24-22(28)20-18(27)12-13-23-20)16-7-9-17(10-8-16)21-25-19(29-26-21)11-6-15-4-2-3-5-15/h7-10,14-15,18,20,23,27H,2-6,11-13H2,1H3,(H,24,28)/t14-,18-,20-/m0/s1	GDJANRNMFHNVOW-DCPHZVHLSA-N					doublet; compound annotation
0391_007482	MLN8054	C25H15ClF2N4O2	4.2073	11712649		O=C(O)c1ccc(Nc2ncc3CN=C(c4c(F)cccc4F)c4c(ccc(Cl)c4)-c3n2)cc1	InChI=1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10,12H,11H2,(H,33,34)(H,30,31,32)	HHFBDROWDBDFBR-UHFFFAOYSA-N					doublet; compound annotation
0391_007483	MLN8054	C25H15ClF2N4O2	4.3667	11712649		O=C(O)c1ccc(Nc2ncc3CN=C(c4c(F)cccc4F)c4c(ccc(Cl)c4)-c3n2)cc1	InChI=1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10,12H,11H2,(H,33,34)(H,30,31,32)	HHFBDROWDBDFBR-UHFFFAOYSA-N					doublet; compound annotation
0391_007484	VU 6008667	C24H17ClF2N2O2	4.9765	134824563	CC1=C(C=CC(=C1)[C@@]23C4=CC=CC=C4C(=O)N2CCN3C(=O)C5=CC(=C(C=C5)F)F)Cl	Cc1c(Cl)ccc(C23c4ccccc4C(=O)N2CCN3C(=O)c2cc(F)c(F)cc2)c1	InChI=1S/C24H17ClF2N2O2/c1-14-12-16(7-8-19(14)25)24-18-5-3-2-4-17(18)23(31)29(24)11-10-28(24)22(30)15-6-9-20(26)21(27)13-15/h2-9,12-13H,10-11H2,1H3/t24-/m0/s1	XMSLRELXMCKGCB-DEOSSOPVSA-N					compound annotation
0391_007485	SK1-IN-1	C22H30N4O3	6.1234	46911228	C[C@@H](C1=CC=C(C=C1)C2=NOC(=N2)CCC3CCCC3)NC(=O)[C@@H]4[C@H](CCN4)O	CC(NC(=O)C1NCCC1O)c1ccc(-c2noc(CCC3CCCC3)n2)cc1	InChI=1S/C22H30N4O3/c1-14(24-22(28)20-18(27)12-13-23-20)16-7-9-17(10-8-16)21-25-19(29-26-21)11-6-15-4-2-3-5-15/h7-10,14-15,18,20,23,27H,2-6,11-13H2,1H3,(H,24,28)/t14-,18-,20-/m0/s1	GDJANRNMFHNVOW-DCPHZVHLSA-N					doublet; compound annotation
0391_007486	Larazotide	C32H55N9O10	1.6065	9810532	CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CN	CC(C)CC(NC(=O)C(NC(=O)CNC(=O)CN)C(C)C)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NCC(=O)O)C(C)C	InChI=1S/C32H55N9O10/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46)/t19-,20-,21-,26-,27-/m0/s1	ORFLZNAGUTZRLQ-ZMBVWFSWSA-N					compound annotation
0391_007487	Notoginsenoside R1	C47H80O18	2.3286	441934	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C	CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3OC3OCC(O)C(O)C3O)CC12C	InChI=1S/C47H80O18/c1-21(2)10-9-13-47(8,65-41-37(59)34(56)32(54)26(18-48)62-41)22-11-15-45(6)30(22)23(50)16-28-44(5)14-12-29(52)43(3,4)39(44)25(17-46(28,45)7)61-42-38(35(57)33(55)27(19-49)63-42)64-40-36(58)31(53)24(51)20-60-40/h10,22-42,48-59H,9,11-20H2,1-8H3/t22-,23+,24+,25-,26+,27+,28+,29-,30-,31-,32+,33+,34-,35-,36+,37+,38+,39-,40-,41-,42+,44+,45+,46+,47-/m0/s1	LLPWNQMSUYAGQI-OOSPGMBYSA-N					compound annotation
0391_007488	Ziritaxestat	C30H33FN8O2S	2.5543	90420193		CCc1c(N(C)c2nc(-c3ccc(F)cc3)c(C#N)s2)n2cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cc(C)c2n1	InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3	REQQVBGILUTQNN-UHFFFAOYSA-N					compound annotation
0391_007489	ACP-105	C16H19ClN2O	4.3583	11638442	CC1=C(C=CC(=C1Cl)C#N)N2[C@@H]3CC[C@H]2CC(C3)(C)O	Cc1c(N2C3CCC2CC(C)(O)C3)ccc(C#N)c1Cl	InChI=1S/C16H19ClN2O/c1-10-14(6-3-11(9-18)15(10)17)19-12-4-5-13(19)8-16(2,20)7-12/h3,6,12-13,20H,4-5,7-8H2,1-2H3/t12-,13+,16?	OUEODVPKPRQETQ-OCZCAGDBSA-N					removed another duplicate entry; compound annotation
0391_007491	Icaritin	C21H20O6	4.9987	5318980		COc1ccc(-c2c(O)c(=O)c3c(O)cc(O)c(CC=C(C)C)c3o2)cc1	InChI=1S/C21H20O6/c1-11(2)4-9-14-15(22)10-16(23)17-18(24)19(25)20(27-21(14)17)12-5-7-13(26-3)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3	TUUXBSASAQJECY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007493	e-64	C15H27N5O5	1.2423	123985	CC(C)C[C@@H](C(=O)NCCCCN=C(N)N)NC(=O)[C@@H]1[C@H](O1)C(=O)O	CC(C)CC(NC(=O)C1OC1C(=O)O)C(=O)NCCCCN=C(N)N	InChI=1S/C15H27N5O5/c1-8(2)7-9(20-13(22)10-11(25-10)14(23)24)12(21)18-5-3-4-6-19-15(16)17/h8-11H,3-7H2,1-2H3,(H,18,21)(H,20,22)(H,23,24)(H4,16,17,19)/t9-,10-,11-/m0/s1	LTLYEAJONXGNFG-DCAQKATOSA-N					removed another duplicate entry; compound annotation
0391_007495	SGC707	C16H18N4O2	1.3884	90642938		O=C(NCC(=O)N1CCCC1)Nc1cc2c(cc1)cncc2	InChI=1S/C16H18N4O2/c21-15(20-7-1-2-8-20)11-18-16(22)19-14-4-3-13-10-17-6-5-12(13)9-14/h3-6,9-10H,1-2,7-8,11H2,(H2,18,19,22)	DMIDPTCQPIJYFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007497	Galunisertib	C22H19N5O	1.4368	10090485		Cc1nc(-c2nn3CCCc3c2-c2ccnc3ccc(C(N)=O)cc23)ccc1	InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)	IVRXNBXKWIJUQB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007499	olafertinib	C29H28F2N6O2	3.0686	117909640		C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4c(F)c(F)c(N5CCN(CCO)CC5)cc4)nc23)c1	InChI=1S/C29H28F2N6O2/c1-2-25(39)33-21-7-3-5-19(17-21)22-8-4-6-20-18-32-29(35-28(20)22)34-23-9-10-24(27(31)26(23)30)37-13-11-36(12-14-37)15-16-38/h2-10,17-18,38H,1,11-16H2,(H,33,39)(H,32,34,35)	IDRGFNPZDVBSSE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007502	ML241	C23H24N4O	3.5041	49830260		c1ccc(CNc2nc(N3CCOc4ccccc43)nc3c2CCCC3)cc1	InChI=1S/C23H24N4O/c1-2-8-17(9-3-1)16-24-22-18-10-4-5-11-19(18)25-23(26-22)27-14-15-28-21-13-7-6-12-20(21)27/h1-3,6-9,12-13H,4-5,10-11,14-16H2,(H,24,25,26)	RMZPVQQGYVSLAP-UHFFFAOYSA-N					compound annotation
0391_007503	GGTI298	C27H33N3O3S	3.9062	9811606	CC(C)C[C@@H](C(=O)OC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC3=CC=CC=C32	COC(=O)C(CC(C)C)NC(=O)c1c(-c2cccc3ccccc23)cc(NCC(N)CS)cc1	InChI=1S/C27H33N3O3S/c1-17(2)13-25(27(32)33-3)30-26(31)23-12-11-20(29-15-19(28)16-34)14-24(23)22-10-6-8-18-7-4-5-9-21(18)22/h4-12,14,17,19,25,29,34H,13,15-16,28H2,1-3H3,(H,30,31)/t19-,25+/m1/s1	XVWPFYDMUFBHBF-CLOONOSVSA-N					doublet; compound annotation
0391_007504	120173-57-1	C32H36N2O13	3.9062	10908465	CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1OC[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)COC(=O)C)OC(=O)C)OC(=O)C	CC(=O)NC1C(OCC(NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)OC(COC(C)=O)C(OC(C)=O)C1OC(C)=O	InChI=1S/C32H36N2O13/c1-16(35)33-27-29(46-19(4)38)28(45-18(3)37)26(15-42-17(2)36)47-31(27)43-14-25(30(39)40)34-32(41)44-13-24-22-11-7-5-9-20(22)21-10-6-8-12-23(21)24/h5-12,24-29,31H,13-15H2,1-4H3,(H,33,35)(H,34,41)(H,39,40)/t25-,26+,27+,28-,29+,31-/m0/s1	ORICVOOXZDVFIP-VOZJJELXSA-N					removed another duplicate entry; compound annotation
0391_007506	JW74	C24H20N6O2S	4.0023	16013152		COc1ccc(-n2c(SCc3nc(-c4ccc(C)cc4)no3)nnc2-c2ccncc2)cc1	InChI=1S/C24H20N6O2S/c1-16-3-5-17(6-4-16)22-26-21(32-29-22)15-33-24-28-27-23(18-11-13-25-14-12-18)30(24)19-7-9-20(31-2)10-8-19/h3-14H,15H2,1-2H3	KRIKILRRJCIWNB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007508	Epoxyoleic acid	C18H34O3	4.7434	119250	CCCCCCCC[C@@H]1[C@@H](O1)CCCCCCCC(=O)O	CCCCCCCCC1OC1CCCCCCCC(=O)O	InChI=1S/C18H34O3/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)/t16-,17+/m1/s1	IMYZYCNQZDBZBQ-SJORKVTESA-N					doublet; compound annotation
0391_007509	L-798,106	C27H22BrNO4S	5.4294	15551229	COC1=C(C=C(C=C1)Br)S(=O)(=O)NC(=O)/C=C/C2=CC=CC=C2CC3=CC4=CC=CC=C4C=C3	COc1c(S(=O)(=O)NC(=O)C=Cc2ccccc2Cc2cc3ccccc3cc2)cc(Br)cc1	InChI=1S/C27H22BrNO4S/c1-33-25-14-13-24(28)18-26(25)34(31,32)29-27(30)15-12-21-7-3-5-9-23(21)17-19-10-11-20-6-2-4-8-22(20)16-19/h2-16,18H,17H2,1H3,(H,29,30)/b15-12+	ODTKFNUPVBULRJ-NTCAYCPXSA-N					removed another duplicate entry; compound annotation
0391_007511	Epoxyoleic acid	C18H34O3	5.8783	119250	CCCCCCCC[C@@H]1[C@@H](O1)CCCCCCCC(=O)O	CCCCCCCCC1OC1CCCCCCCC(=O)O	InChI=1S/C18H34O3/c1-2-3-4-5-7-10-13-16-17(21-16)14-11-8-6-9-12-15-18(19)20/h16-17H,2-15H2,1H3,(H,19,20)/t16-,17+/m1/s1	IMYZYCNQZDBZBQ-SJORKVTESA-N					doublet; compound annotation
0391_007512	2,4-Diamino-6-hydroxypyrimidine	C4H6N4O	0.4725	135408763		Nc1cc(=O)nc(N)[nH]1	InChI=1S/C4H6N4O/c5-2-1-3(9)8-4(6)7-2/h1H,(H5,5,6,7,8,9)	SWELIMKTDYHAOY-UHFFFAOYSA-N					compound annotation
0391_007513	Leupeptin	C20H38N6O4	1.8512	72429	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N	InChI=1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1	GDBQQVLCIARPGH-ULQDDVLXSA-N					doublet; compound annotation
0391_007514	edaravone	C10H10N2O	1.9274	4021		CC1=NN(c2ccccc2)C(=O)C1	InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3	QELUYTUMUWHWMC-UHFFFAOYSA-N					compound annotation
0391_007515	497839-62-0	C27H32N6	1.9355	10297043	CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4N[C@H](C)C5=CC=CC=C5	CCN1CCN(Cc2ccc(-c3cc4c(ncnc4NC(C)c4ccccc4)[nH]3)cc2)CC1	InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1	OONFNUWBHFSNBT-HXUWFJFHSA-N					compound annotation
0391_007516	Leupeptin	C20H38N6O4	1.967	72429	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N	InChI=1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1	GDBQQVLCIARPGH-ULQDDVLXSA-N					doublet; compound annotation
0391_007517	Leupeptin	C20H38N6O4	2.0416	72429	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N	InChI=1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1	GDBQQVLCIARPGH-ULQDDVLXSA-N					doublet; compound annotation
0391_007518	Leupeptin	C20H38N6O4	2.1281	72429	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N	InChI=1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1	GDBQQVLCIARPGH-ULQDDVLXSA-N					doublet; compound annotation
0391_007519	Leupeptin	C20H38N6O4	2.1997	72429	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C=O)NC(=O)C	CC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N	InChI=1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1	GDBQQVLCIARPGH-ULQDDVLXSA-N					doublet; compound annotation
0391_007520	NCB-0846	C21H21N5O2	2.542	91801204		OC1CCC(Oc2cccc3cnc(Nc4cc5c(cc4)nc[nH]5)nc23)CC1	InChI=1S/C21H21N5O2/c27-15-5-7-16(8-6-15)28-19-3-1-2-13-11-22-21(26-20(13)19)25-14-4-9-17-18(10-14)24-12-23-17/h1-4,9-12,15-16,27H,5-8H2,(H,23,24)(H,22,25,26)	FYWRWBSYRGSWIQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007523	143692-18-6	C19H20N4O3	2.602	126758		CNC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2CC1C)OCO3	InChI=1S/C19H20N4O3/c1-11-7-13-8-16-17(26-10-25-16)9-15(13)18(22-23(11)19(24)21-2)12-3-5-14(20)6-4-12/h3-6,8-9,11H,7,10,20H2,1-2H3,(H,21,24)	SMGACXZFVXKEAX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007526	NCB-0846	C21H21N5O2	2.776	91801204		OC1CCC(Oc2cccc3cnc(Nc4cc5c(cc4)nc[nH]5)nc23)CC1	InChI=1S/C21H21N5O2/c27-15-5-7-16(8-6-15)28-19-3-1-2-13-11-22-21(26-20(13)19)25-14-4-9-17-18(10-14)24-12-23-17/h1-4,9-12,15-16,27H,5-8H2,(H,23,24)(H,22,25,26)	FYWRWBSYRGSWIQ-UHFFFAOYSA-N					doublet; compound annotation
0391_007527	200484-11-3	C19H22ClN5O	3.3551	148198		N#CNC(=NCCCCCCOc1ccc(Cl)cc1)Nc1ccncc1	InChI=1S/C19H22ClN5O/c20-16-5-7-18(8-6-16)26-14-4-2-1-3-11-23-19(24-15-21)25-17-9-12-22-13-10-17/h5-10,12-13H,1-4,11,14H2,(H2,22,23,24,25)	BOIPLTNGIAPDBY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007529	UNC3866	C43H66N6O8	3.8077	101043861	CCN(CC)CCCC[C@@H](C(=O)N[C@@H](CO)C(=O)OC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)C(C)(C)C	CCN(CC)CCCCC(NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(Cc1ccccc1)NC(=O)c1ccc(C(C)(C)C)cc1)C(=O)NC(CO)C(=O)OC	InChI=1S/C43H66N6O8/c1-10-49(11-2)24-16-15-19-33(39(53)48-36(27-50)42(56)57-9)45-41(55)34(25-28(3)4)46-37(51)29(5)44-40(54)35(26-30-17-13-12-14-18-30)47-38(52)31-20-22-32(23-21-31)43(6,7)8/h12-14,17-18,20-23,28-29,33-36,50H,10-11,15-16,19,24-27H2,1-9H3,(H,44,54)(H,45,55)(H,46,51)(H,47,52)(H,48,53)/t29-,33-,34-,35-,36-/m0/s1	UMRRDXVUROEIKJ-JCXBGQGISA-N					removed another duplicate entry; compound annotation
0391_007531	(R)-GNE-140	C25H23ClN2O3S2	3.8168	121225870	C1COCCN1C2=CC=C(C=C2)[C@]3(CC(=C(C(=O)N3)SC4=CC=CC=C4Cl)O)C5=CSC=C5	O=C1NC(c2ccc(N3CCOCC3)cc2)(c2cscc2)CC(O)=C1Sc1ccccc1Cl	InChI=1S/C25H23ClN2O3S2/c26-20-3-1-2-4-22(20)33-23-21(29)15-25(27-24(23)30,18-9-14-32-16-18)17-5-7-19(8-6-17)28-10-12-31-13-11-28/h1-9,14,16,29H,10-13,15H2,(H,27,30)/t25-/m1/s1	SUFXXEIVBZJOAP-RUZDIDTESA-N					removed another duplicate entry; compound annotation
0391_007533	2-Nitroimidazole	C3H3N3O2	0.46	10701		O=[N+]([O-])c1ncc[nH]1	InChI=1S/C3H3N3O2/c7-6(8)3-4-1-2-5-3/h1-2H,(H,4,5)	YZEUHQHUFTYLPH-UHFFFAOYSA-N					compound annotation
0391_007534	JNK-IN-7	C28H27N7O2	2.0351	57340685	CN(C)C/C=C/C(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CN=CC=C4	CN(C)CC=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3nccc(-c4cnccc4)n3)cc2)c1	InChI=1S/C28H27N7O2/c1-35(2)17-5-9-26(36)31-24-8-3-6-20(18-24)27(37)32-22-10-12-23(13-11-22)33-28-30-16-14-25(34-28)21-7-4-15-29-19-21/h3-16,18-19H,17H2,1-2H3,(H,31,36)(H,32,37)(H,30,33,34)/b9-5+	RADRIIWGHYFWPP-WEVVVXLNSA-N					removed another duplicate entry; compound annotation
0391_007536	Peimine	C27H45NO3	2.1524	131900	C[C@H]1CC[C@H]2[C@@]([C@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)(C)O	CC1CCC2N(C1)CC1C3CC4C(CC(O)C5CC(O)CCC54C)C3CCC1C2(C)O	InChI=1S/C27H45NO3/c1-15-4-7-25-27(3,31)21-6-5-17-18(20(21)14-28(25)13-15)11-22-19(17)12-24(30)23-10-16(29)8-9-26(22,23)2/h15-25,29-31H,4-14H2,1-3H3/t15-,16-,17+,18+,19-,20-,21-,22-,23+,24-,25-,26+,27-/m0/s1	IUKLSMSEHKDIIP-BZMYINFQSA-N					doublet; compound annotation
0391_007537	JNJ-38877605	C19H13F2N7	2.4708	46911863		Cn1cc(-c2nn3c(C(F)(F)c4cc5c(cc4)nccc5)nnc3cc2)cn1	InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3	JRWCBEOAFGHNNU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007539	1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane	C11H11Cl2N	2.4806	9795276		Clc1c(Cl)cc(C23CNCC2C3)cc1	InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2	BSMNRYCSBFHEMQ-UHFFFAOYSA-N					compound annotation
0391_007540	Peimine	C27H45NO3	2.526	131900	C[C@H]1CC[C@H]2[C@@]([C@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)(C)O	CC1CCC2N(C1)CC1C3CC4C(CC(O)C5CC(O)CCC54C)C3CCC1C2(C)O	InChI=1S/C27H45NO3/c1-15-4-7-25-27(3,31)21-6-5-17-18(20(21)14-28(25)13-15)11-22-19(17)12-24(30)23-10-16(29)8-9-26(22,23)2/h15-25,29-31H,4-14H2,1-3H3/t15-,16-,17+,18+,19-,20-,21-,22-,23+,24-,25-,26+,27-/m0/s1	IUKLSMSEHKDIIP-BZMYINFQSA-N					doublet; compound annotation
0391_007541	JNJ-38877605	C19H13F2N7	2.6016	46911863		Cn1cc(-c2nn3c(C(F)(F)c4cc5c(cc4)nccc5)nnc3cc2)cn1	InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3	JRWCBEOAFGHNNU-UHFFFAOYSA-N					doublet; compound annotation
0391_007542	Glyoxalase I inhibitor free base	C21H29BrN4O8S	2.8661	66577014	CCOC(=O)CNC(=O)[C@H](CSC(=O)N(C1=CC=C(C=C1)Br)O)NC(=O)CC[C@@H](C(=O)OCC)N	CCOC(=O)CNC(=O)C(CSC(=O)N(O)c1ccc(Br)cc1)NC(=O)CCC(N)C(=O)OCC	InChI=1S/C21H29BrN4O8S/c1-3-33-18(28)11-24-19(29)16(25-17(27)10-9-15(23)20(30)34-4-2)12-35-21(31)26(32)14-7-5-13(22)6-8-14/h5-8,15-16,32H,3-4,9-12,23H2,1-2H3,(H,24,29)(H,25,27)/t15-,16-/m0/s1	PYPKSBBTQSNXLR-HOTGVXAUSA-N					doublet; removed another duplicate entry; compound annotation
0391_007544	JNJ-38877605	C19H13F2N7	2.9354	46911863		Cn1cc(-c2nn3c(C(F)(F)c4cc5c(cc4)nccc5)nnc3cc2)cn1	InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3	JRWCBEOAFGHNNU-UHFFFAOYSA-N					doublet; compound annotation
0391_007545	Epacadostat	C11H13BrFN7O4S	3.3846	135564890		NS(=O)(=O)NCCNc1nonc1C(=Nc1cc(Br)c(F)cc1)NO	InChI=1S/C11H13BrFN7O4S/c12-7-5-6(1-2-8(7)13)17-11(18-21)9-10(20-24-19-9)15-3-4-16-25(14,22)23/h1-2,5,16,21H,3-4H2,(H,15,20)(H,17,18)(H2,14,22,23)	FBKMWOJEPMPVTQ-UHFFFAOYSA-N					compound annotation
0391_007546	Atractylenolide III	C15H20O3	4.0007	155948	CC1=C2C[C@H]3C(=C)CCC[C@@]3(C[C@@]2(OC1=O)O)C	C=C1CCCC2(C)CC3(O)OC(=O)C(C)=C3CC12	InChI=1S/C15H20O3/c1-9-5-4-6-14(3)8-15(17)12(7-11(9)14)10(2)13(16)18-15/h11,17H,1,4-8H2,2-3H3/t11-,14+,15-/m0/s1	FBMORZZOJSDNRQ-GLQYFDAESA-N					doublet; compound annotation
0391_007547	Pulchinenoside A	C41H66O12	4.0334	11721847	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@@]4([C@H]5CC[C@@H]6[C@H]7[C@@H](CC[C@@]7(CC[C@]6([C@@]5(CC[C@H]4[C@]3(C)CO)C)C)C(=O)O)C(=C)C)C)O)O)O)O)O	C=C(C)C1CCC2(C(=O)O)CCC3(C)C(CCC4C5(C)CCC(OC6OCC(O)C(O)C6OC6OC(C)C(O)C(O)C6O)C(C)(CO)C5CCC43C)C12	InChI=1S/C41H66O12/c1-20(2)22-10-15-41(36(48)49)17-16-39(6)23(28(22)41)8-9-26-37(4)13-12-27(38(5,19-42)25(37)11-14-40(26,39)7)52-35-33(30(45)24(43)18-50-35)53-34-32(47)31(46)29(44)21(3)51-34/h21-35,42-47H,1,8-19H2,2-7H3,(H,48,49)/t21-,22-,23+,24-,25+,26+,27-,28+,29-,30-,31+,32+,33+,34-,35-,37-,38-,39+,40+,41-/m0/s1	ISNDTNDJSXYNKT-DVIRKNLQSA-N					removed another duplicate entry; compound annotation
0391_007549	76666-32-5	C16H12O4	4.194	676296		COc1cccc(-c2c(O)c(=O)c3ccccc3o2)c1	InChI=1S/C16H12O4/c1-19-11-6-4-5-10(9-11)16-15(18)14(17)12-7-2-3-8-13(12)20-16/h2-9,18H,1H3	GYLGASXCHFNKHD-UHFFFAOYSA-N					compound annotation
0391_007550	Atractylenolide III	C15H20O3	6.9577	155948	CC1=C2C[C@H]3C(=C)CCC[C@@]3(C[C@@]2(OC1=O)O)C	C=C1CCCC2(C)CC3(O)OC(=O)C(C)=C3CC12	InChI=1S/C15H20O3/c1-9-5-4-6-14(3)8-15(17)12(7-11(9)14)10(2)13(16)18-15/h11,17H,1,4-8H2,2-3H3/t11-,14+,15-/m0/s1	FBMORZZOJSDNRQ-GLQYFDAESA-N					doublet; compound annotation
0391_007551	Atractylenolide III	C15H20O3	7.0486	155948	CC1=C2C[C@H]3C(=C)CCC[C@@]3(C[C@@]2(OC1=O)O)C	C=C1CCCC2(C)CC3(O)OC(=O)C(C)=C3CC12	InChI=1S/C15H20O3/c1-9-5-4-6-14(3)8-15(17)12(7-11(9)14)10(2)13(16)18-15/h11,17H,1,4-8H2,2-3H3/t11-,14+,15-/m0/s1	FBMORZZOJSDNRQ-GLQYFDAESA-N					doublet; compound annotation
0391_007552	SMARCA-BD ligand 1 for Protac	C14H17N5O	0.5525	137045944		Nc1nnc(-c2ccccc2O)cc1N1CCNCC1	InChI=1S/C14H17N5O/c15-14-12(19-7-5-16-6-8-19)9-11(17-18-14)10-3-1-2-4-13(10)20/h1-4,9,16,20H,5-8H2,(H2,15,18)	SZKHGLTYXIDOFH-UHFFFAOYSA-N					compound annotation
0391_007553	201038-74-6	C18H28N2O3S	2.1171	6604889	CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O	CC1CCN(CCC2CCCN2S(=O)(=O)c2cccc(O)c2)CC1	InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1	HWKROQUZSKPIKQ-MRXNPFEDSA-N					compound annotation
0391_007554	PD-168077	C20H22N4O	2.5996	3645619		Cc1cc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)ccc1	InChI=1S/C20H22N4O/c1-16-5-4-7-17(13-16)20(25)22-15-23-9-11-24(12-10-23)19-8-3-2-6-18(19)14-21/h2-8,13H,9-12,15H2,1H3,(H,22,25)	DNULYRGWTFLJQL-UHFFFAOYSA-N					compound annotation
0391_007555	diABZI STING agonist-1	C42H51N13O7	2.6809	131986624	CCN1C(=CC(=N1)C)C(=O)NC2=NC3=C(N2C/C=C/CN4C5=C(C=C(C=C5OCCCN6CCOCC6)C(=O)N)N=C4NC(=O)C7=CC(=NN7CC)C)C(=CC(=C3)C(=O)N)OC	CCn1nc(C)cc1C(=O)Nc1nc2c(c(OC)cc(C(N)=O)c2)n1CC=CCn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCN3CCOCC3)c21	InChI=1S/C42H51N13O7/c1-6-54-31(19-25(3)49-54)39(58)47-41-45-29-21-27(37(43)56)23-33(60-5)35(29)52(41)12-8-9-13-53-36-30(46-42(53)48-40(59)32-20-26(4)50-55(32)7-2)22-28(38(44)57)24-34(36)62-16-10-11-51-14-17-61-18-15-51/h8-9,19-24H,6-7,10-18H2,1-5H3,(H2,43,56)(H2,44,57)(H,45,47,58)(H,46,48,59)/b9-8+	JGLMVXWAHNTPRF-CMDGGOBGSA-N					removed another duplicate entry; compound annotation
0391_007557	Vofopitant	C21H23F3N6O	2.8807	6918331	COC1=C(C=C(C=C1)N2C(=NN=N2)C(F)(F)F)CN[C@H]3CCCN[C@H]3C4=CC=CC=C4	COc1c(CNC2CCCNC2c2ccccc2)cc(-n2nnnc2C(F)(F)F)cc1	InChI=1S/C21H23F3N6O/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3/t17-,19-/m0/s1	XILNRORTJVDYRH-HKUYNNGSSA-N					doublet; compound annotation
0391_007558	Pulrodemstat	C24H23F2N5O2	2.8953	118483201		COc1c(F)cc(-c2c(-c3cc(F)c(C#N)cc3)nc(N3CCC(N)CC3)n(C)c2=O)cc1	InChI=1S/C24H23F2N5O2/c1-30-23(32)21(14-5-6-20(33-2)19(26)11-14)22(15-3-4-16(13-27)18(25)12-15)29-24(30)31-9-7-17(28)8-10-31/h3-6,11-12,17H,7-10,28H2,1-2H3	NBAIXBAUHIQQGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007561	1675201-83-8	C29H33NO5	4.1806	91663303	CC1=C(C=CC=C1C2=CC=CC=C2)COC3=CC(=C(C(=C3)OC)CN4CCCC[C@H]4C(=O)O)OC	COc1cc(OCc2c(C)c(-c3ccccc3)ccc2)cc(OC)c1CN1CCCCC1C(=O)O	InChI=1S/C29H33NO5/c1-20-22(12-9-13-24(20)21-10-5-4-6-11-21)19-35-23-16-27(33-2)25(28(17-23)34-3)18-30-15-8-7-14-26(30)29(31)32/h4-6,9-13,16-17,26H,7-8,14-15,18-19H2,1-3H3,(H,31,32)/t26-/m0/s1	ZBOYJODMIAUJHH-SANMLTNESA-N					removed another duplicate entry; compound annotation
0391_007563	Higenamine	C16H17NO3	1.0184	114840		Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1	InChI=1S/C16H17NO3/c18-12-3-1-10(2-4-12)7-14-13-9-16(20)15(19)8-11(13)5-6-17-14/h1-4,8-9,14,17-20H,5-7H2	WZRCQWQRFZITDX-UHFFFAOYSA-N					compound annotation
0391_007564	salicylamide	C7H7NO2	1.565	5147		NC(=O)c1ccccc1O	InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)	SKZKKFZAGNVIMN-UHFFFAOYSA-N					compound annotation
0391_007565	alrestatin	C14H9NO4	2.6827	2120		O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O	InChI=1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)	GCUCIFQCGJIRNT-UHFFFAOYSA-N					compound annotation
0391_007566	Echinatin	C16H14O4	2.8733	6442675	COC1=C(C=CC(=C1)O)/C=C/C(=O)C2=CC=C(C=C2)O	COc1c(C=CC(=O)c2ccc(O)cc2)ccc(O)c1	InChI=1S/C16H14O4/c1-20-16-10-14(18)8-4-12(16)5-9-15(19)11-2-6-13(17)7-3-11/h2-10,17-18H,1H3/b9-5+	QJKMIJNRNRLQSS-WEVVVXLNSA-N					doublet; compound annotation
0391_007567	Echinatin	C16H14O4	2.8767	6442675	COC1=C(C=CC(=C1)O)/C=C/C(=O)C2=CC=C(C=C2)O	COc1c(C=CC(=O)c2ccc(O)cc2)ccc(O)c1	InChI=1S/C16H14O4/c1-20-16-10-14(18)8-4-12(16)5-9-15(19)11-2-6-13(17)7-3-11/h2-10,17-18H,1H3/b9-5+	QJKMIJNRNRLQSS-WEVVVXLNSA-N					doublet; compound annotation
0391_007568	192705-79-6	C20H24N6O3	3.2765	5328127		COc1cc(-c2c(NC(=O)NC(C)(C)C)nc3nc(N)ncc3c2)cc(OC)c1	InChI=1S/C20H24N6O3/c1-20(2,3)26-19(27)25-17-15(8-12-10-22-18(21)24-16(12)23-17)11-6-13(28-4)9-14(7-11)29-5/h6-10H,1-5H3,(H4,21,22,23,24,25,26,27)	NHJSWORVNIOXIT-UHFFFAOYSA-N					doublet; compound annotation
0391_007569	192705-79-6	C20H24N6O3	3.2797	5328127		COc1cc(-c2c(NC(=O)NC(C)(C)C)nc3nc(N)ncc3c2)cc(OC)c1	InChI=1S/C20H24N6O3/c1-20(2,3)26-19(27)25-17-15(8-12-10-22-18(21)24-16(12)23-17)11-6-13(28-4)9-14(7-11)29-5/h6-10H,1-5H3,(H4,21,22,23,24,25,26,27)	NHJSWORVNIOXIT-UHFFFAOYSA-N					doublet; compound annotation
0391_007570	Bavachinin	C21H22O4	3.6165	10337211	CC(=CCC1=CC2=C(C=C1OC)O[C@@H](CC2=O)C3=CC=C(C=C3)O)C	COc1cc2c(cc1CC=C(C)C)C(=O)CC(c1ccc(O)cc1)O2	InChI=1S/C21H22O4/c1-13(2)4-5-15-10-17-18(23)11-20(14-6-8-16(22)9-7-14)25-21(17)12-19(15)24-3/h4,6-10,12,20,22H,5,11H2,1-3H3/t20-/m0/s1	VOCGSQHKPZSIKB-FQEVSTJZSA-N					doublet; compound annotation
0391_007571	(+)-Eudesmin	C22H26O6	3.6196	73117	COC1=C(C=C(C=C1)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C=C4)OC)OC)OC	COc1c(OC)cc(C2OCC3C(c4cc(OC)c(OC)cc4)OCC23)cc1	InChI=1S/C22H26O6/c1-23-17-7-5-13(9-19(17)25-3)21-15-11-28-22(16(15)12-27-21)14-6-8-18(24-2)20(10-14)26-4/h5-10,15-16,21-22H,11-12H2,1-4H3/t15-,16-,21+,22+/m0/s1	PEUUVVGQIVMSAW-RZTYQLBFSA-N					compound annotation
0391_007572	1021497-97-1	C20H18BrN3O3S	4.305	25009726		O=C(CSc1ccc(Br)cc1)Nc1cn(CCc2ccccc2)nc1C(=O)O	InChI=1S/C20H18BrN3O3S/c21-15-6-8-16(9-7-15)28-13-18(25)22-17-12-24(23-19(17)20(26)27)11-10-14-4-2-1-3-5-14/h1-9,12H,10-11,13H2,(H,22,25)(H,26,27)	ZRLJEHIUGYTTSZ-UHFFFAOYSA-N					compound annotation
0391_007573	Echinatin	C16H14O4	4.8099	6442675	COC1=C(C=CC(=C1)O)/C=C/C(=O)C2=CC=C(C=C2)O	COc1c(C=CC(=O)c2ccc(O)cc2)ccc(O)c1	InChI=1S/C16H14O4/c1-20-16-10-14(18)8-4-12(16)5-9-15(19)11-2-6-13(17)7-3-11/h2-10,17-18H,1H3/b9-5+	QJKMIJNRNRLQSS-WEVVVXLNSA-N					doublet; compound annotation
0391_007574	Bavachinin	C21H22O4	4.8099	10337211	CC(=CCC1=CC2=C(C=C1OC)O[C@@H](CC2=O)C3=CC=C(C=C3)O)C	COc1cc2c(cc1CC=C(C)C)C(=O)CC(c1ccc(O)cc1)O2	InChI=1S/C21H22O4/c1-13(2)4-5-15-10-17-18(23)11-20(14-6-8-16(22)9-7-14)25-21(17)12-19(15)24-3/h4,6-10,12,20,22H,5,11H2,1-3H3/t20-/m0/s1	VOCGSQHKPZSIKB-FQEVSTJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_007576	Bavachinin	C21H22O4	5.2608	10337211	CC(=CCC1=CC2=C(C=C1OC)O[C@@H](CC2=O)C3=CC=C(C=C3)O)C	COc1cc2c(cc1CC=C(C)C)C(=O)CC(c1ccc(O)cc1)O2	InChI=1S/C21H22O4/c1-13(2)4-5-15-10-17-18(23)11-20(14-6-8-16(22)9-7-14)25-21(17)12-19(15)24-3/h4,6-10,12,20,22H,5,11H2,1-3H3/t20-/m0/s1	VOCGSQHKPZSIKB-FQEVSTJZSA-N					doublet; compound annotation
0391_007577	64048-12-0	C24H16N4S	1.096	253078		c1nccc(-c2c(-c3ccncc3)c(-c3ccncc3)c(-c3ccncc3)s2)c1	InChI=1S/C24H16N4S/c1-9-25-10-2-17(1)21-22(18-3-11-26-12-4-18)24(20-7-15-28-16-8-20)29-23(21)19-5-13-27-14-6-19/h1-16H	USWLOKMMUTWFMD-UHFFFAOYSA-N					compound annotation
0391_007578	Serabelisib	C19H17N5O3	1.5883	70798655		Nc1nc2c(ccc(-c3cn4c(C(=O)N5CCOCC5)cnc4cc3)c2)o1	InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)	BLGWHBSBBJNKJO-UHFFFAOYSA-N					compound annotation
0391_007579	PF-04217903	C19H16N8O	1.7007	17754438		OCCn1cc(-c2cnc3nnn(Cc4cc5c(cc4)nccc5)c3n2)cn1	InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2	PDMUGYOXRHVNMO-UHFFFAOYSA-N					doublet; compound annotation
0391_007580	MSX-122	C16H16N6	1.9835	11687907		c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1	InChI=1S/C16H16N6/c1-7-17-15(18-8-1)21-11-13-3-5-14(6-4-13)12-22-16-19-9-2-10-20-16/h1-10H,11-12H2,(H,17,18,21)(H,19,20,22)	PXZXYRKDDXKDTK-UHFFFAOYSA-N					compound annotation
0391_007581	Gts-21	C19H20N2O2	2.0773	5310985	COC1=CC(=C(C=C1)/C=C/2\CCCN=C2C3=CN=CC=C3)OC	COc1cc(OC)c(C=C2CCCN=C2c2cnccc2)cc1	InChI=1S/C19H20N2O2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16/h3,6-9,11-13H,4-5,10H2,1-2H3/b15-11+	RPYWXZCFYPVCNQ-RVDMUPIBSA-N					doublet; compound annotation
0391_007582	Gts-21	C19H20N2O2	2.2963	5310985	COC1=CC(=C(C=C1)/C=C/2\CCCN=C2C3=CN=CC=C3)OC	COc1cc(OC)c(C=C2CCCN=C2c2cnccc2)cc1	InChI=1S/C19H20N2O2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16/h3,6-9,11-13H,4-5,10H2,1-2H3/b15-11+	RPYWXZCFYPVCNQ-RVDMUPIBSA-N					doublet; compound annotation
0391_007583	130477-52-0	C18H19N3O4	2.7077	5311203	CCOC(=O)C1=C2[C@@H]3CCCN3C(=O)C4=C(N2C=N1)C=CC(=C4)OC	CCOC(=O)c1c2C3CCCN3C(=O)c3c(ccc(OC)c3)-n2cn1	InChI=1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1	YKYOQIXTECBVBB-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_007585	PI3K/mTOR Inhibitor-2	C20H13ClF2N4O4S	3.7962	118616775		COc1c(NS(=O)(=O)c2c(F)cc(F)cc2)cc(-c2cn3c(=O)c(Cl)cnc3cc2)cn1	InChI=1S/C20H13ClF2N4O4S/c1-31-19-16(26-32(29,30)17-4-3-13(22)7-15(17)23)6-12(8-25-19)11-2-5-18-24-9-14(21)20(28)27(18)10-11/h2-10,26H,1H3	LQTYGHZRBUVRMR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007588	GSK2033	C29H28F3NO5S2	5.7653	46203250		Cc1cc(C)c(S(=O)(=O)N(Cc2ccc(-c3cc(S(C)(=O)=O)ccc3)cc2)Cc2ccc(C(F)(F)F)o2)c(C)c1	InChI=1S/C29H28F3NO5S2/c1-19-14-20(2)28(21(3)15-19)40(36,37)33(18-25-12-13-27(38-25)29(30,31)32)17-22-8-10-23(11-9-22)24-6-5-7-26(16-24)39(4,34)35/h5-16H,17-18H2,1-4H3	PSOXOVKYGWBTPB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007590	Bardoxolone methyl	C32H43NO4	6.0334	400769	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)OC	COC(=O)C12CCC(C)(C)CC1C1C(=O)C=C3C4(C)C=C(C#N)C(=O)C(C)(C)C4CCC3(C)C1(C)CC2	InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1	WPTTVJLTNAWYAO-KPOXMGGZSA-N					removed another duplicate entry; compound annotation
0391_007593	1191237-69-0	C12H13N5O4	0.5337	44468216	C1=C2C(=NC=NN2C(=C1)[C@]3([C@@H]([C@@H]([C@H](O3)CO)O)O)C#N)N	N#CC1(c2ccc3c(N)ncnn23)OC(CO)C(O)C1O	InChI=1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1	BRDWIEOJOWJCLU-LTGWCKQJSA-N					removed another duplicate entry; compound annotation
0391_007595	Carcainium	C18H22N3O2+	2.5504	13967		C[N+](C)(CC(=O)Nc1ccccc1)CC(=O)Nc1ccccc1	InChI=1S/C18H21N3O2/c1-21(2,13-17(22)19-15-9-5-3-6-10-15)14-18(23)20-16-11-7-4-8-12-16/h3-12H,13-14H2,1-2H3,(H-,19,20,22,23)/p+1	MPOXTHSNJVUPKR-UHFFFAOYSA-O					compound annotation
0391_007596	BI-78D3	C13H9N5O5S2	3.1153	2747117		O=c1[nH]nc(Sc2ncc([N+](=O)[O-])s2)n1-c1cc2c(cc1)OCCO2	InChI=1S/C13H9N5O5S2/c19-11-15-16-12(25-13-14-6-10(24-13)18(20)21)17(11)7-1-2-8-9(5-7)23-4-3-22-8/h1-2,5-6H,3-4H2,(H,15,19)	QFRLDZGQEZCCJZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007598	Saredutant	C31H35Cl2N3O2	3.2835	104974	CC(=O)NC1(CCN(CC1)CC[C@H](CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4	CC(=O)NC1(c2ccccc2)CCN(CCC(CN(C)C(=O)c2ccccc2)c2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1	PGKXDIMONUAMFR-AREMUKBSSA-N					doublet; compound annotation
0391_007599	Saredutant	C31H35Cl2N3O2	3.2884	104974	CC(=O)NC1(CCN(CC1)CC[C@H](CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4	CC(=O)NC1(c2ccccc2)CCN(CCC(CN(C)C(=O)c2ccccc2)c2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1	PGKXDIMONUAMFR-AREMUKBSSA-N					doublet; compound annotation
0391_007600	TAS-115	C27H23FN4O4S	3.3027	44247727		CNC(=O)c1cc2c(Oc3c(F)cc(NC(=S)NC(=O)Cc4ccccc4)cc3)ccnc2cc1OC	InChI=1S/C27H23FN4O4S/c1-29-26(34)19-14-18-21(15-24(19)35-2)30-11-10-22(18)36-23-9-8-17(13-20(23)28)31-27(37)32-25(33)12-16-6-4-3-5-7-16/h3-11,13-15H,12H2,1-2H3,(H,29,34)(H2,31,32,33,37)	ORRNXRYWGDUDOG-UHFFFAOYSA-N					compound annotation
0391_007601	1633350-06-7	C27H29N5O3	3.5447	135905454		C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1	InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)	RNOAOAWBMHREKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007603	SB-705498	C17H16BrF3N4O	3.906	9910486	C1CN(C[C@@H]1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F	O=C(Nc1ccccc1Br)NC1CCN(c2ncc(C(F)(F)F)cc2)C1	InChI=1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1	JYILLRHXRVTRSH-GFCCVEGCSA-N					doublet; compound annotation
0391_007604	SB-705498	C17H16BrF3N4O	3.9109	9910486	C1CN(C[C@@H]1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F	O=C(Nc1ccccc1Br)NC1CCN(c2ncc(C(F)(F)F)cc2)C1	InChI=1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1	JYILLRHXRVTRSH-GFCCVEGCSA-N					doublet; compound annotation
0391_007605	4-P-PDOT	C19H21NO	4.1295	3976006		CCC(=O)NC1Cc2ccccc2C(c2ccccc2)C1	InChI=1S/C19H21NO/c1-2-19(21)20-16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,2,12-13H2,1H3,(H,20,21)	RCYLUNPFECYGDW-UHFFFAOYSA-N					doublet; compound annotation
0391_007606	4-P-PDOT	C19H21NO	4.1323	3976006		CCC(=O)NC1Cc2ccccc2C(c2ccccc2)C1	InChI=1S/C19H21NO/c1-2-19(21)20-16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,2,12-13H2,1H3,(H,20,21)	RCYLUNPFECYGDW-UHFFFAOYSA-N					doublet; compound annotation
0391_007607	JNJ-10229570	C22H19N3O2S	4.3863	10110895		COc1ccccc1-c1nc(=Nc2ccccc2)sn1-c1ccccc1OC	InChI=1S/C22H19N3O2S/c1-26-19-14-8-6-12-17(19)21-24-22(23-16-10-4-3-5-11-16)28-25(21)18-13-7-9-15-20(18)27-2/h3-15H,1-2H3	XTHRTBCPBWJYRO-UHFFFAOYSA-N					compound annotation
0391_007608	ibuprofen piconol	C19H23NO2	4.9539	3673		CC(C)Cc1ccc(C(C)C(=O)OCc2ccccn2)cc1	InChI=1S/C19H23NO2/c1-14(2)12-16-7-9-17(10-8-16)15(3)19(21)22-13-18-6-4-5-11-20-18/h4-11,14-15H,12-13H2,1-3H3	ACEWLPOYLGNNHV-UHFFFAOYSA-N					doublet; compound annotation
0391_007609	ibuprofen piconol	C19H23NO2	5.0273	3673		CC(C)Cc1ccc(C(C)C(=O)OCc2ccccn2)cc1	InChI=1S/C19H23NO2/c1-14(2)12-16-7-9-17(10-8-16)15(3)19(21)22-13-18-6-4-5-11-20-18/h4-11,14-15H,12-13H2,1-3H3	ACEWLPOYLGNNHV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007611	NK-252	C13H11N5O3	1.1929	71618700		O=C(NCc1ccccn1)Nc1nnc(-c2ccco2)o1	InChI=1S/C13H11N5O3/c19-12(15-8-9-4-1-2-6-14-9)16-13-18-17-11(21-13)10-5-3-7-20-10/h1-7H,8H2,(H2,15,16,18,19)	FNSCFQXZZNCDAI-UHFFFAOYSA-N					doublet; compound annotation
0391_007612	NK-252	C13H11N5O3	1.1958	71618700		O=C(NCc1ccccn1)Nc1nnc(-c2ccco2)o1	InChI=1S/C13H11N5O3/c19-12(15-8-9-4-1-2-6-14-9)16-13-18-17-11(21-13)10-5-3-7-20-10/h1-7H,8H2,(H2,15,16,18,19)	FNSCFQXZZNCDAI-UHFFFAOYSA-N					doublet; compound annotation
0391_007613	732983-37-8	C20H18N6O3	1.4408	10200390		COc1c(OC)cc(-c2cc3nccn3c(Nc3c(C(N)=O)cccn3)n2)cc1	InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)	JWQOJVOKBAAAAR-UHFFFAOYSA-N					doublet; compound annotation
0391_007614	732983-37-8	C20H18N6O3	1.5812	10200390		COc1c(OC)cc(-c2cc3nccn3c(Nc3c(C(N)=O)cccn3)n2)cc1	InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)	JWQOJVOKBAAAAR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007616	N-[(7-Hydroxy-4-Methyl-2-Oxo-2h-Chromen-8-Yl)methyl]-L-Leucine	C17H21NO5	1.8266	6920573	CC1=CC(=O)OC2=C1C=CC(=C2C[NH2+][C@@H](CC(C)C)C(=O)[O-])O	Cc1cc(=O)oc2c1ccc(O)c2CNC(CC(C)C)C(=O)O	InChI=1S/C17H21NO5/c1-9(2)6-13(17(21)22)18-8-12-14(19)5-4-11-10(3)7-15(20)23-16(11)12/h4-5,7,9,13,18-19H,6,8H2,1-3H3,(H,21,22)/t13-/m0/s1	YPJLUCAXHFPZJD-ZDUSSCGKSA-N					compound annotation
0391_007617	732983-37-8	C20H18N6O3	2.0993	10200390		COc1c(OC)cc(-c2cc3nccn3c(Nc3c(C(N)=O)cccn3)n2)cc1	InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)	JWQOJVOKBAAAAR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007619	732983-37-8	C20H18N6O3	2.1023	10200390		COc1c(OC)cc(-c2cc3nccn3c(Nc3c(C(N)=O)cccn3)n2)cc1	InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)	JWQOJVOKBAAAAR-UHFFFAOYSA-N					doublet; compound annotation
0391_007620	Avitinib	C26H26FN7O2	2.3749	72734520		C=CC(=O)Nc1cc(Oc2nc(Nc3cc(F)c(N4CCN(C)CC4)cc3)nc3c2cc[nH]3)ccc1	InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)	UOFYSRZSLXWIQB-UHFFFAOYSA-N					doublet; compound annotation
0391_007621	Avitinib	C26H26FN7O2	2.7724	72734520		C=CC(=O)Nc1cc(Oc2nc(Nc3cc(F)c(N4CCN(C)CC4)cc3)nc3c2cc[nH]3)ccc1	InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)	UOFYSRZSLXWIQB-UHFFFAOYSA-N					doublet; compound annotation
0391_007622	Avitinib	C26H26FN7O2	2.7756	72734520		C=CC(=O)Nc1cc(Oc2nc(Nc3cc(F)c(N4CCN(C)CC4)cc3)nc3c2cc[nH]3)ccc1	InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)	UOFYSRZSLXWIQB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007624	EPZ005687	C32H37N5O3	2.8897	60160561		Cc1cc(C)c(CNC(=O)c2c3cnn(C4CCCC4)c3cc(-c3ccc(CN4CCOCC4)cc3)c2)c(=O)[nH]1	InChI=1S/C32H37N5O3/c1-21-15-22(2)35-32(39)28(21)18-33-31(38)27-16-25(17-30-29(27)19-34-37(30)26-5-3-4-6-26)24-9-7-23(8-10-24)20-36-11-13-40-14-12-36/h7-10,15-17,19,26H,3-6,11-14,18,20H2,1-2H3,(H,33,38)(H,35,39)	ZOIBZSZLMJDVDQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007626	Danirixin	C19H21ClFN3O4S	3.0366	24780598	CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)[C@H]3CCCNC3)O	Cc1c(NC(=O)Nc2c(O)c(S(=O)(=O)C3CCCNC3)c(Cl)cc2)cccc1F	InChI=1S/C19H21ClFN3O4S/c1-11-14(21)5-2-6-15(11)23-19(26)24-16-8-7-13(20)18(17(16)25)29(27,28)12-4-3-9-22-10-12/h2,5-8,12,22,25H,3-4,9-10H2,1H3,(H2,23,24,26)/t12-/m0/s1	NGYNBSHYFOFVLS-LBPRGKRZSA-N					compound annotation
0391_007627	1675203-84-5	C25H29N3O3	3.66	117951478		COc1c(CNCCNC(C)=O)ccc(OCc2c(C)c(-c3ccccc3)ccc2)n1	InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29)	JEDPSOYOYVELLZ-UHFFFAOYSA-N					doublet; compound annotation
0391_007628	1675203-84-5	C25H29N3O3	3.7737	117951478		COc1c(CNCCNC(C)=O)ccc(OCc2c(C)c(-c3ccccc3)ccc2)n1	InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29)	JEDPSOYOYVELLZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007630	1675203-84-5	C25H29N3O3	3.9209	117951478		COc1c(CNCCNC(C)=O)ccc(OCc2c(C)c(-c3ccccc3)ccc2)n1	InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29)	JEDPSOYOYVELLZ-UHFFFAOYSA-N					doublet; compound annotation
0391_007631	T6167923	C17H20BrN3O3S2	4.0902	25648555	C[C@@H](C1=CC=CS1)NC(=O)N2CCN(CC2)S(=O)(=O)C3=CC(=CC=C3)Br	CC(NC(=O)N1CCN(S(=O)(=O)c2cc(Br)ccc2)CC1)c1cccs1	InChI=1S/C17H20BrN3O3S2/c1-13(16-6-3-11-25-16)19-17(22)20-7-9-21(10-8-20)26(23,24)15-5-2-4-14(18)12-15/h2-6,11-13H,7-10H2,1H3,(H,19,22)/t13-/m0/s1	PNTQVMBKHCOLQD-ZDUSSCGKSA-N					doublet; compound annotation
0391_007632	T6167923	C17H20BrN3O3S2	4.0931	25648555	C[C@@H](C1=CC=CS1)NC(=O)N2CCN(CC2)S(=O)(=O)C3=CC(=CC=C3)Br	CC(NC(=O)N1CCN(S(=O)(=O)c2cc(Br)ccc2)CC1)c1cccs1	InChI=1S/C17H20BrN3O3S2/c1-13(16-6-3-11-25-16)19-17(22)20-7-9-21(10-8-20)26(23,24)15-5-2-4-14(18)12-15/h2-6,11-13H,7-10H2,1H3,(H,19,22)/t13-/m0/s1	PNTQVMBKHCOLQD-ZDUSSCGKSA-N					doublet; compound annotation
0391_007633	1231952-55-8	C31H31N5O2S2	4.2175	46245047		COCCCc1c(C(=O)Nc2ccccc2-c2nc3c(ncc(CN4CCCC4)c3)s2)nc(-c2ccccc2)s1	InChI=1S/C31H31N5O2S2/c1-38-17-9-14-26-27(35-29(39-26)22-10-3-2-4-11-22)28(37)33-24-13-6-5-12-23(24)30-34-25-18-21(19-32-31(25)40-30)20-36-15-7-8-16-36/h2-6,10-13,18-19H,7-9,14-17,20H2,1H3,(H,33,37)	MRRXPMZNBRXCPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007635	Apimostinel	C25H37N5O6	1.6504	71249967	C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@@]2(CC3=CC=CC=C3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O	CC(O)C(N)C(=O)N1CCCC1C(=O)N1CCCC1(Cc1ccccc1)C(=O)NC(C(N)=O)C(C)O	InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1	DVBUEXCIEIAXPM-PJUQSVSOSA-N					doublet; compound annotation
0391_007636	Apimostinel	C25H37N5O6	1.8126	71249967	C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@@]2(CC3=CC=CC=C3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O	CC(O)C(N)C(=O)N1CCCC1C(=O)N1CCCC1(Cc1ccccc1)C(=O)NC(C(N)=O)C(C)O	InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1	DVBUEXCIEIAXPM-PJUQSVSOSA-N					doublet; removed another duplicate entry; compound annotation
0391_007638	Apimostinel	C25H37N5O6	1.9062	71249967	C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@@]2(CC3=CC=CC=C3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O	CC(O)C(N)C(=O)N1CCCC1C(=O)N1CCCC1(Cc1ccccc1)C(=O)NC(C(N)=O)C(C)O	InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1	DVBUEXCIEIAXPM-PJUQSVSOSA-N					doublet; compound annotation
0391_007639	Talmapimod	C27H30ClFN4O3	2.4962	9871074	C[C@@H]1CN([C@H](CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F	CC1CN(C(=O)c2c(Cl)cc3c(c2)c(C(=O)C(=O)N(C)C)cn3C)C(C)CN1Cc1ccc(F)cc1	InChI=1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1	ZMELOYOKMZBMRB-DLBZAZTESA-N					doublet; removed another duplicate entry; compound annotation
0391_007641	Talmapimod	C27H30ClFN4O3	2.6669	9871074	C[C@@H]1CN([C@H](CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F	CC1CN(C(=O)c2c(Cl)cc3c(c2)c(C(=O)C(=O)N(C)C)cn3C)C(C)CN1Cc1ccc(F)cc1	InChI=1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1	ZMELOYOKMZBMRB-DLBZAZTESA-N					doublet; compound annotation
0391_007642	Valecobulin	C26H28N6O5S	2.7267	44243402	CC(C)[C@@H](C(=O)NC1=NC(=CS1)C2=CC(=C(C=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC)N4C=NC=N4)N	COc1cc(C(=O)c2ccc(-c3csc(NC(=O)C(N)C(C)C)n3)cc2-n2cncn2)cc(OC)c1OC	InChI=1S/C26H28N6O5S/c1-14(2)22(27)25(34)31-26-30-18(11-38-26)15-6-7-17(19(8-15)32-13-28-12-29-32)23(33)16-9-20(35-3)24(37-5)21(10-16)36-4/h6-14,22H,27H2,1-5H3,(H,30,31,34)/t22-/m0/s1	UKKRUIXIDCWALA-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_007644	RN-1734	C14H22Cl2N2O2S	2.8966	3601086		CC(C)NCCN(C(C)C)S(=O)(=O)c1c(Cl)cc(Cl)cc1	InChI=1S/C14H22Cl2N2O2S/c1-10(2)17-7-8-18(11(3)4)21(19,20)14-6-5-12(15)9-13(14)16/h5-6,9-11,17H,7-8H2,1-4H3	IHYZMEAZAIFMTN-UHFFFAOYSA-N					compound annotation
0391_007645	KM11060	C19H17Cl2N3O2S	3.1269	1241327		O=S(=O)(c1ccc(Cl)cc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1	InChI=1S/C19H17Cl2N3O2S/c20-14-1-4-16(5-2-14)27(25,26)24-11-9-23(10-12-24)19-7-8-22-18-13-15(21)3-6-17(18)19/h1-8,13H,9-12H2	GIEHIZKCIZLXLF-UHFFFAOYSA-N					doublet; compound annotation
0391_007646	KM11060	C19H17Cl2N3O2S	3.1881	1241327		O=S(=O)(c1ccc(Cl)cc1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1	InChI=1S/C19H17Cl2N3O2S/c20-14-1-4-16(5-2-14)27(25,26)24-11-9-23(10-12-24)19-7-8-22-18-13-15(21)3-6-17(18)19/h1-8,13H,9-12H2	GIEHIZKCIZLXLF-UHFFFAOYSA-N					doublet; compound annotation
0391_007647	IL-15-IN-1	C30H36N6O4S	4.0162	129320517		CCOC(=O)c1cc(NC(=O)CCCCCCCSc2nnc(Cc3nn(C)c(=O)c4ccccc34)n2C)ccc1	InChI=1S/C30H36N6O4S/c1-4-40-29(39)21-13-12-14-22(19-21)31-27(37)17-8-6-5-7-11-18-41-30-33-32-26(35(30)2)20-25-23-15-9-10-16-24(23)28(38)36(3)34-25/h9-10,12-16,19H,4-8,11,17-18,20H2,1-3H3,(H,31,37)	GWNFQAKCJYEJEW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007649	IL-15-IN-1	C30H36N6O4S	4.1445	129320517		CCOC(=O)c1cc(NC(=O)CCCCCCCSc2nnc(Cc3nn(C)c(=O)c4ccccc34)n2C)ccc1	InChI=1S/C30H36N6O4S/c1-4-40-29(39)21-13-12-14-22(19-21)31-27(37)17-8-6-5-7-11-18-41-30-33-32-26(35(30)2)20-25-23-15-9-10-16-24(23)28(38)36(3)34-25/h9-10,12-16,19H,4-8,11,17-18,20H2,1-3H3,(H,31,37)	GWNFQAKCJYEJEW-UHFFFAOYSA-N					doublet; compound annotation
0391_007650	selamectin	C43H63NO11	6.7625	9578507	C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N/O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)\C)O[C@@H]1C7CCCCC7	COC1CC(OC2C(C)=CCC3CC(CC4(CCC(C)C(C5CCCCC5)O4)O3)OC(=O)C3C=C(C)C(=NO)C4OCC(=CC=CC2C)C34O)OC(C)C1O	InChI=1S/C43H63NO11/c1-24-11-10-14-30-23-50-40-36(44-48)27(4)19-33(43(30,40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-12-8-7-9-13-29/h10-11,14-15,19,24,26,28-29,31-35,37-40,45,47-48H,7-9,12-13,16-18,20-23H2,1-6H3/b11-10+,25-15+,30-14+,44-36-/t24-,26-,28-,31+,32-,33-,34-,35-,37-,38-,39-,40+,42+,43+/m0/s1	AFJYYKSVHJGXSN-XHKIUTQPSA-N					doublet; compound annotation
0391_007651	selamectin	C43H63NO11	6.7676	9578507	C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N/O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)\C)O[C@@H]1C7CCCCC7	COC1CC(OC2C(C)=CCC3CC(CC4(CCC(C)C(C5CCCCC5)O4)O3)OC(=O)C3C=C(C)C(=NO)C4OCC(=CC=CC2C)C34O)OC(C)C1O	InChI=1S/C43H63NO11/c1-24-11-10-14-30-23-50-40-36(44-48)27(4)19-33(43(30,40)47)41(46)52-32-20-31(16-15-25(2)38(24)53-35-21-34(49-6)37(45)28(5)51-35)54-42(22-32)18-17-26(3)39(55-42)29-12-8-7-9-13-29/h10-11,14-15,19,24,26,28-29,31-35,37-40,45,47-48H,7-9,12-13,16-18,20-23H2,1-6H3/b11-10+,25-15+,30-14+,44-36-/t24-,26-,28-,31+,32-,33-,34-,35-,37-,38-,39-,40+,42+,43+/m0/s1	AFJYYKSVHJGXSN-XHKIUTQPSA-N					doublet; compound annotation
0391_007652	CCT245737	C16H16F3N7O	1.4653	72165232	C1CO[C@H](CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N	N#Cc1cnc(Nc2ncc(C(F)(F)F)c(NCC3CNCCO3)c2)cn1	InChI=1S/C16H16F3N7O/c17-16(18,19)12-8-25-14(26-15-9-22-10(4-20)5-24-15)3-13(12)23-7-11-6-21-1-2-27-11/h3,5,8-9,11,21H,1-2,6-7H2,(H2,23,24,25,26)/t11-/m1/s1	YBYYWUUUGCNAHQ-LLVKDONJSA-N					compound annotation
0391_007653	Luteolin 7-glucuronide	C21H18O12	1.8939	5280601	C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O)O	O=C(O)C1OC(Oc2cc(O)c3c(=O)cc(-c4cc(O)c(O)cc4)oc3c2)C(O)C(O)C1O	InChI=1S/C21H18O12/c22-9-2-1-7(3-10(9)23)13-6-12(25)15-11(24)4-8(5-14(15)32-13)31-21-18(28)16(26)17(27)19(33-21)20(29)30/h1-6,16-19,21-24,26-28H,(H,29,30)/t16-,17-,18+,19-,21+/m0/s1	VSUOKLTVXQRUSG-ZFORQUDYSA-N					compound annotation
0391_007654	SQ109	C22H38N2	2.4973	5274428	CC(=CCC/C(=C/CNCCNC1C2CC3CC(C2)CC1C3)/C)C	CC(C)=CCCC(C)=CCNCCNC1C2CC3CC(C2)CC1C3	InChI=1S/C22H38N2/c1-16(2)5-4-6-17(3)7-8-23-9-10-24-22-20-12-18-11-19(14-20)15-21(22)13-18/h5,7,18-24H,4,6,8-15H2,1-3H3/b17-7+	JFIBVDBTCDTBRH-REZTVBANSA-N					compound annotation
0391_007655	861393-28-4	C26H30N6O3	2.7848	11351968	CC(C)(C)C(NC(=O)CC1=CC(=C(C=C1)OC)OC)/N=C(\NC#N)/NC2=CC=CC3=C2C=CC=N3	COc1c(OC)cc(CC(=O)NC(N=C(NC#N)Nc2cccc3c2cccn3)C(C)(C)C)cc1	InChI=1S/C26H30N6O3/c1-26(2,3)24(31-23(33)15-17-11-12-21(34-4)22(14-17)35-5)32-25(29-16-27)30-20-10-6-9-19-18(20)8-7-13-28-19/h6-14,24H,15H2,1-5H3,(H,31,33)(H2,29,30,32)	PUHSRMSFDASMAE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007657	211096-49-0	C14H9BrN6O	3.7749	9841667		N#Cc1ccc(NC(=O)Nc2ccccc2Br)c2n[nH]nc12	InChI=1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21)	SEDUMQWZEOMXSO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007659	Tangeretin	C20H20O7	3.9825	68077		COc1ccc(-c2cc(=O)c3c(o2)c(OC)c(OC)c(OC)c3OC)cc1	InChI=1S/C20H20O7/c1-22-12-8-6-11(7-9-12)14-10-13(21)15-16(23-2)18(24-3)20(26-5)19(25-4)17(15)27-14/h6-10H,1-5H3	ULSUXBXHSYSGDT-UHFFFAOYSA-N					doublet; compound annotation
0391_007660	Tangeretin	C20H20O7	3.9864	68077		COc1ccc(-c2cc(=O)c3c(o2)c(OC)c(OC)c(OC)c3OC)cc1	InChI=1S/C20H20O7/c1-22-12-8-6-11(7-9-12)14-10-13(21)15-16(23-2)18(24-3)20(26-5)19(25-4)17(15)27-14/h6-10H,1-5H3	ULSUXBXHSYSGDT-UHFFFAOYSA-N					doublet; compound annotation
0391_007661	Pleconaril	C18H18F3N3O3	4.1122	1684		Cc1noc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)c1	InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3	KQOXLKOJHVFTRN-UHFFFAOYSA-N					doublet; compound annotation
0391_007662	Pleconaril	C18H18F3N3O3	4.6776	1684		Cc1noc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)c1	InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3	KQOXLKOJHVFTRN-UHFFFAOYSA-N					doublet; compound annotation
0391_007663	MRE-269	C25H29N3O3	5.0614	9931891		CC(C)N(CCCCOCC(=O)O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1	InChI=1S/C25H29N3O3/c1-19(2)28(15-9-10-16-31-18-23(29)30)22-17-26-24(20-11-5-3-6-12-20)25(27-22)21-13-7-4-8-14-21/h3-8,11-14,17,19H,9-10,15-16,18H2,1-2H3,(H,29,30)	OJQMKCBWYCWFPU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007665	GRA EX-25	C29H36F3N3O5	5.1748	16100296		CC(C)(C)C1CCC(N(Cc2ccc(C(=O)NCCC(=O)O)cc2)C(=O)Nc2ccc(OC(F)(F)F)cc2)CC1	InChI=1S/C29H36F3N3O5/c1-28(2,3)21-8-12-23(13-9-21)35(27(39)34-22-10-14-24(15-11-22)40-29(30,31)32)18-19-4-6-20(7-5-19)26(38)33-17-16-25(36)37/h4-7,10-11,14-15,21,23H,8-9,12-13,16-18H2,1-3H3,(H,33,38)(H,34,39)(H,36,37)	BZXMLCVDKDXRQY-UHFFFAOYSA-N					doublet; compound annotation
0391_007666	GRA EX-25	C29H36F3N3O5	5.2764	16100296		CC(C)(C)C1CCC(N(Cc2ccc(C(=O)NCCC(=O)O)cc2)C(=O)Nc2ccc(OC(F)(F)F)cc2)CC1	InChI=1S/C29H36F3N3O5/c1-28(2,3)21-8-12-23(13-9-21)35(27(39)34-22-10-14-24(15-11-22)40-29(30,31)32)18-19-4-6-20(7-5-19)26(38)33-17-16-25(36)37/h4-7,10-11,14-15,21,23H,8-9,12-13,16-18H2,1-3H3,(H,33,38)(H,34,39)(H,36,37)	BZXMLCVDKDXRQY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007668	Pleconaril	C18H18F3N3O3	5.6907	1684		Cc1noc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)c1	InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3	KQOXLKOJHVFTRN-UHFFFAOYSA-N					doublet; compound annotation
0391_007669	400611-95-2	C10H11N5O2S	0.5355	2608		Nc1cc(Nc2ccc(S(N)(=O)=O)cc2)ncn1	InChI=1S/C10H11N5O2S/c11-9-5-10(14-6-13-9)15-7-1-3-8(4-2-7)18(12,16)17/h1-6H,(H2,12,16,17)(H3,11,13,14,15)	FVFVVRPJERUECT-UHFFFAOYSA-N					compound annotation
0391_007670	IMISOPASEM	C21H35N5	0.5821	6918488	C1CC[C@@H]2[C@@H](C1)NCCN[C@@H]3CCCC[C@H]3NCC4=CC=CC(=N4)CN2	c1cc2nc(c1)CNC1CCCCC1NCCNC1CCCCC1NC2	InChI=1S/C21H35N5/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20/h5-7,18-25H,1-4,8-15H2/t18-,19-,20-,21-/m1/s1	MTQZSJFDXWEENV-XRXFAXGQSA-N					compound annotation
0391_007671	258843-62-8	C29H30N6O3	1.8549	12116202		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2cc(OCCCC(=O)O)ccc2)[nH]4)[nH]3)CC1	InChI=1S/C29H30N6O3/c1-34-11-13-35(14-12-34)21-8-10-24-26(18-21)33-29(31-24)20-7-9-23-25(17-20)32-28(30-23)19-4-2-5-22(16-19)38-15-3-6-27(36)37/h2,4-5,7-10,16-18H,3,6,11-15H2,1H3,(H,30,32)(H,31,33)(H,36,37)	QXQZJBBLMSBZHP-UHFFFAOYSA-N					compound annotation
0391_007672	7-Ethyl-10-hydroxycamptothecin	C22H20N2O5	2.551	104842	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O	CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2c1cc(O)cc2	InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1	FJHBVJOVLFPMQE-QFIPXVFZSA-N					compound annotation
0391_007673	UCT943	C22H20F3N5O	2.7435	71711915		Nc1ncc(-c2ccc(C(=O)N3CCNCC3)cc2)nc1-c1ccc(C(F)(F)F)cc1	InChI=1S/C22H20F3N5O/c23-22(24,25)17-7-5-15(6-8-17)19-20(26)28-13-18(29-19)14-1-3-16(4-2-14)21(31)30-11-9-27-10-12-30/h1-8,13,27H,9-12H2,(H2,26,28)	GGOFGCMPKAWHEZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007675	GSK3145095	C20H17F2N5O2	3.0793	118557502	C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4	O=C(NC1CCc2c(NC1=O)c(F)cc(F)c2)c1n[nH]c(Cc2ccccc2)n1	InChI=1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1	ATQAGKAMBISZQM-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_007677	GSTO-IN-2	C33H52N2O9	3.6175	45102203	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)[C@H](CC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(OC(=O)C(CC(=O)O)NC(=O)CCC(N)C(=O)O)CCC4(C)C3CCC12C	InChI=1S/C33H52N2O9/c1-18(4-11-28(37)38)22-7-8-23-21-6-5-19-16-20(12-14-32(19,2)24(21)13-15-33(22,23)3)44-31(43)26(17-29(39)40)35-27(36)10-9-25(34)30(41)42/h18-26H,4-17,34H2,1-3H3,(H,35,36)(H,37,38)(H,39,40)(H,41,42)/t18-,19-,20-,21+,22-,23+,24+,25+,26+,32+,33-/m1/s1	GEYBDXYFLCDBPT-RHGDXGROSA-N					doublet; compound annotation
0391_007678	GSK-J4	C24H27N5O2	3.7547	71729975		CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28)	WBKCKEHGXNWYMO-UHFFFAOYSA-N					doublet; compound annotation
0391_007679	GSTO-IN-2	C33H52N2O9	4.0689	45102203	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)[C@H](CC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(OC(=O)C(CC(=O)O)NC(=O)CCC(N)C(=O)O)CCC4(C)C3CCC12C	InChI=1S/C33H52N2O9/c1-18(4-11-28(37)38)22-7-8-23-21-6-5-19-16-20(12-14-32(19,2)24(21)13-15-33(22,23)3)44-31(43)26(17-29(39)40)35-27(36)10-9-25(34)30(41)42/h18-26H,4-17,34H2,1-3H3,(H,35,36)(H,37,38)(H,39,40)(H,41,42)/t18-,19-,20-,21+,22-,23+,24+,25+,26+,32+,33-/m1/s1	GEYBDXYFLCDBPT-RHGDXGROSA-N					doublet; removed another duplicate entry; compound annotation
0391_007681	TAK-779 cation	C33H39N2O2+	4.2162	183790		Cc1ccc(-c2cc3c(cc2)CCCC(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)=C3)cc1	InChI=1S/C33H38N2O2/c1-24-7-11-27(12-8-24)28-14-13-26-5-4-6-29(22-30(26)21-28)33(36)34-31-15-9-25(10-16-31)23-35(2,3)32-17-19-37-20-18-32/h7-16,21-22,32H,4-6,17-20,23H2,1-3H3/p+1	XNHZXMPLVSJQFK-UHFFFAOYSA-O					compound annotation
0391_007682	GSK-J4	C24H27N5O2	4.3159	71729975		CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28)	WBKCKEHGXNWYMO-UHFFFAOYSA-N					doublet; compound annotation
0391_007683	MF-094	C30H37N3O4S	4.7055	138319686	CC(C)(C)NS(=O)(=O)C1=CC=CC2=C1C=CC=C2NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)C4CCCCC4	CC(C)(C)NS(=O)(=O)c1cccc2c1cccc2NC(=O)C(Cc1ccccc1)NC(=O)C1CCCCC1	InChI=1S/C30H37N3O4S/c1-30(2,3)33-38(36,37)27-19-11-16-23-24(27)17-10-18-25(23)31-29(35)26(20-21-12-6-4-7-13-21)32-28(34)22-14-8-5-9-15-22/h4,6-7,10-13,16-19,22,26,33H,5,8-9,14-15,20H2,1-3H3,(H,31,35)(H,32,34)/t26-/m0/s1	DQXORJHBZHLLTE-SANMLTNESA-N					removed another duplicate entry; compound annotation
0391_007685	Compound 48/80 trihydrochloride	C32H45N3O3	1.684	2855		CNCCc1cc(Cc2cc(CCNC)cc(Cc3c(OC)ccc(CCNC)c3)c2OC)c(OC)cc1	InChI=1S/C32H45N3O3/c1-33-14-11-23-7-9-30(36-4)26(17-23)21-28-19-25(13-16-35-3)20-29(32(28)38-6)22-27-18-24(12-15-34-2)8-10-31(27)37-5/h7-10,17-20,33-35H,11-16,21-22H2,1-6H3	DXEVTBAWIGXNAW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007687	cyclopentolate	C17H25NO3	2.2558	2905		CN(C)CCOC(=O)C(c1ccccc1)C1(O)CCCC1	InChI=1S/C17H25NO3/c1-18(2)12-13-21-16(19)15(14-8-4-3-5-9-14)17(20)10-6-7-11-17/h3-5,8-9,15,20H,6-7,10-13H2,1-2H3	SKYSRIRYMSLOIN-UHFFFAOYSA-N					compound annotation
0391_007688	venlafaxine	C17H27NO2	2.2959	5656		COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1	InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3	PNVNVHUZROJLTJ-UHFFFAOYSA-N					compound annotation
0391_007689	MI-3454	C32H35F3N8OS	2.5867	130443890		CNc1nc(NC2CCN(Cc3c(C)c4c(cc3)n(CC35CC(NC=O)(C3)C5)c(C#N)c4)CC2)c2cc(CC(F)(F)F)sc2n1	InChI=1S/C32H35F3N8OS/c1-19-20(3-4-26-24(19)9-22(12-36)43(26)17-30-14-31(15-30,16-30)38-18-44)13-42-7-5-21(6-8-42)39-27-25-10-23(11-32(33,34)35)45-28(25)41-29(37-2)40-27/h3-4,9-10,18,21H,5-8,11,13-17H2,1-2H3,(H,38,44)(H2,37,39,40,41)	MBFYNGBMAACLAT-UHFFFAOYSA-N					compound annotation
0391_007690	bacampicillin	C21H27N3O7S	2.9276	441397	CCOC(=O)OC(C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](C3=CC=CC=C3)N)(C)C	CCOC(=O)OC(C)OC(=O)C1N2C(=O)C(NC(=O)C(N)c3ccccc3)C2SC1(C)C	InChI=1S/C21H27N3O7S/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25)/t11?,13-,14-,15+,18-/m1/s1	PFOLLRNADZZWEX-FFGRCDKISA-N					compound annotation
0391_007691	Norverapamil	C26H36N2O4	3.0994	104972		COc1c(OC)cc(CCNCCCC(C#N)(c2cc(OC)c(OC)cc2)C(C)C)cc1	InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3	UPKQNCPKPOLASS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007693	PS372424	C33H44N6O4	3.4449	12000484	C1CCC(CC1)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CC3=CC=CC=C3CN2C(=O)CCC(=O)C4=CC=CC=C4	NC(N)=NCCCC(NC(=O)C1Cc2ccccc2CN1C(=O)CCC(=O)c1ccccc1)C(=O)NCC1CCCCC1	InChI=1S/C33H44N6O4/c34-33(35)36-19-9-16-27(31(42)37-21-23-10-3-1-4-11-23)38-32(43)28-20-25-14-7-8-15-26(25)22-39(28)30(41)18-17-29(40)24-12-5-2-6-13-24/h2,5-8,12-15,23,27-28H,1,3-4,9-11,16-22H2,(H,37,42)(H,38,43)(H4,34,35,36)/t27-,28-/m0/s1	KEDBAZLDJVHMAV-NSOVKSMOSA-N					removed another duplicate entry; compound annotation
0391_007695	eFT508	C17H20N6O2	1.7172	118598754		Cc1c2C(=O)NC3(CCCCC3)n2c(=O)c(Nc2ncnc(N)c2)c1	InChI=1S/C17H20N6O2/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21)	HKTBYUWLRDZAJK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007698	GSK 4027	C17H21BrN4O	1.9251	126961735	CN1C[C@H](C[C@H](C1)NC2=C(C(=O)N(N=C2)C)Br)C3=CC=CC=C3	CN1CC(Nc2c(Br)c(=O)n(C)nc2)CC(c2ccccc2)C1	InChI=1S/C17H21BrN4O/c1-21-10-13(12-6-4-3-5-7-12)8-14(11-21)20-15-9-19-22(2)17(23)16(15)18/h3-7,9,13-14,20H,8,10-11H2,1-2H3/t13-,14+/m0/s1	VZAFGXCWAWRULT-UONOGXRCSA-N					doublet; compound annotation
0391_007699	GSK 4027	C17H21BrN4O	1.9278	126961735	CN1C[C@H](C[C@H](C1)NC2=C(C(=O)N(N=C2)C)Br)C3=CC=CC=C3	CN1CC(Nc2c(Br)c(=O)n(C)nc2)CC(c2ccccc2)C1	InChI=1S/C17H21BrN4O/c1-21-10-13(12-6-4-3-5-7-12)8-14(11-21)20-15-9-19-22(2)17(23)16(15)18/h3-7,9,13-14,20H,8,10-11H2,1-2H3/t13-,14+/m0/s1	VZAFGXCWAWRULT-UONOGXRCSA-N					doublet; compound annotation
0391_007700	PDE-9 inhibitor	C22H27N5O2	1.9539	135886459	C[C@@H]1CN(C[C@H]1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=CC=CC=C5	CC1CN(Cc2ccccc2)CC1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	InChI=1S/C22H27N5O2/c1-15-12-26(13-16-5-3-2-4-6-16)14-19(15)20-24-21-18(22(28)25-20)11-23-27(21)17-7-9-29-10-8-17/h2-6,11,15,17,19H,7-10,12-14H2,1H3,(H,24,25,28)/t15-,19-/m1/s1	RVEJWGYZBXCGGM-DNVCBOLYSA-N					doublet; compound annotation
0391_007701	PDE-9 inhibitor	C22H27N5O2	1.9567	135886459	C[C@@H]1CN(C[C@H]1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=CC=CC=C5	CC1CN(Cc2ccccc2)CC1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1	InChI=1S/C22H27N5O2/c1-15-12-26(13-16-5-3-2-4-6-16)14-19(15)20-24-21-18(22(28)25-20)11-23-27(21)17-7-9-29-10-8-17/h2-6,11,15,17,19H,7-10,12-14H2,1H3,(H,24,25,28)/t15-,19-/m1/s1	RVEJWGYZBXCGGM-DNVCBOLYSA-N					doublet; compound annotation
0391_007702	(R)-BAY1238097	C25H33N5O3	1.996	90041345	C[C@@H]1CC2=CC(=C(C=C2C(=NN1C(=O)NC)C3=CC=C(C=C3)N4CCN(CC4)C)OC)OC	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)/t17-/m1/s1	CJIPEACKIJJYED-QGZVFWFLSA-N					doublet; removed another duplicate entry; compound annotation
0391_007705	(R)-BAY1238097	C25H33N5O3	2.1256	90041345	C[C@@H]1CC2=CC(=C(C=C2C(=NN1C(=O)NC)C3=CC=C(C=C3)N4CCN(CC4)C)OC)OC	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)/t17-/m1/s1	CJIPEACKIJJYED-QGZVFWFLSA-N					doublet; compound annotation
0391_007706	Cy5-YNE	C36H44N3O7S2+	2.3947	100912273		C#CCNC(=O)CCCCC[N+]1=C(C=CC=CC=C2N(CC)c3c(cc(S(=O)(=O)O)cc3)C2(C)C)C(C)(C)c2c1ccc(S(=O)(=O)O)c2	InChI=1S/C36H43N3O7S2/c1-7-22-37-34(40)17-13-10-14-23-39-31-21-19-27(48(44,45)46)25-29(31)36(5,6)33(39)16-12-9-11-15-32-35(3,4)28-24-26(47(41,42)43)18-20-30(28)38(32)8-2/h1,9,11-12,15-16,18-21,24-25H,8,10,13-14,17,22-23H2,2-6H3,(H2-,37,40,41,42,43,44,45,46)/p+1	SDCASIAEYVOHMO-UHFFFAOYSA-O					compound annotation
0391_007707	BET-IN-1	C25H30N4O4	2.6477	71258968	CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=N4)C5CCOCC5)[C@H](C)COC)OC	COCC(C)n1c(C2CCOCC2)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1nc2	InChI=1S/C25H30N4O4/c1-14(13-30-4)29-24-18-11-22(31-5)19(23-15(2)28-33-16(23)3)10-20(18)26-12-21(24)27-25(29)17-6-8-32-9-7-17/h10-12,14,17H,6-9,13H2,1-5H3/t14-/m1/s1	HYPXHDJBILNWLI-CQSZACIVSA-N					compound annotation
0391_007708	GSK467	C17H13N5O2	2.679	135567128		O=c1nc(Oc2cn(Cc3ccccc3)nc2)[nH]c2c1ccnc2	InChI=1S/C17H13N5O2/c23-16-14-6-7-18-9-15(14)20-17(21-16)24-13-8-19-22(11-13)10-12-4-2-1-3-5-12/h1-9,11H,10H2,(H,20,21,23)	ZTYRLXUTLYBVHH-UHFFFAOYSA-N					doublet; compound annotation
0391_007709	GSK467	C17H13N5O2	2.6819	135567128		O=c1nc(Oc2cn(Cc3ccccc3)nc2)[nH]c2c1ccnc2	InChI=1S/C17H13N5O2/c23-16-14-6-7-18-9-15(14)20-17(21-16)24-13-8-19-22(11-13)10-12-4-2-1-3-5-12/h1-9,11H,10H2,(H,20,21,23)	ZTYRLXUTLYBVHH-UHFFFAOYSA-N					doublet; compound annotation
0391_007710	878451-87-7	C16H13N5O2S	2.9388	6485821		Cn1c(Sc2nc3ccccc3cc2)nc2c1c(=O)[nH]c(=O)n2C	InChI=1S/C16H13N5O2S/c1-20-12-13(21(2)15(23)19-14(12)22)18-16(20)24-11-8-7-9-5-3-4-6-10(9)17-11/h3-8H,1-2H3,(H,19,22,23)	UHUHSGFUUWVRBO-UHFFFAOYSA-N					compound annotation
0391_007711	BAY-598	C22H20Cl2F2N6O3	4.3369	117072551	CCN([C@H]1CN(N=C1C2=CC(=C(C=C2)Cl)Cl)C(=NC3=CC(=CC=C3)OC(F)F)NC#N)C(=O)CO	CCN(C(=O)CO)C1CN(C(=Nc2cc(OC(F)F)ccc2)NC#N)N=C1c1cc(Cl)c(Cl)cc1	InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29)/t18-/m0/s1	OTTJIRVZJJGFTK-SFHVURJKSA-N					doublet; compound annotation
0391_007712	BAY-598	C22H20Cl2F2N6O3	4.3402	117072551	CCN([C@H]1CN(N=C1C2=CC(=C(C=C2)Cl)Cl)C(=NC3=CC(=CC=C3)OC(F)F)NC#N)C(=O)CO	CCN(C(=O)CO)C1CN(C(=Nc2cc(OC(F)F)ccc2)NC#N)N=C1c1cc(Cl)c(Cl)cc1	InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29)/t18-/m0/s1	OTTJIRVZJJGFTK-SFHVURJKSA-N					doublet; compound annotation
0391_007713	BI-9564	C20H23N3O3	1.0941	117072549		COc1cc(-c2cn(C)c(=O)c3c2ccnc3)c(OC)cc1CN(C)C	InChI=1S/C20H23N3O3/c1-22(2)11-13-8-19(26-5)15(9-18(13)25-4)17-12-23(3)20(24)16-10-21-7-6-14(16)17/h6-10,12H,11H2,1-5H3	BJFSUDWKXGMUKA-UHFFFAOYSA-N					compound annotation
0391_007714	PFK-015	C17H12N2O	1.4713	25142799	C1=CC=C2C(=C1)C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3	O=C(C=Cc1nc2ccccc2cc1)c1ccncc1	InChI=1S/C17H12N2O/c20-17(14-9-11-18-12-10-14)8-7-15-6-5-13-3-1-2-4-16(13)19-15/h1-12H/b8-7+	UJJUKZPBUMCSJZ-BQYQJAHWSA-N					doublet; compound annotation
0391_007715	MK-0429	C23H29N5O4	2.1252	9853559	COC1=NC=C(C=C1)[C@H](CC(=O)O)N2CCN(C2=O)CCCC3=NC4=C(CCCN4)C=C3	COc1ncc(C(CC(=O)O)N2CCN(CCCc3nc4c(cc3)CCCN4)C2=O)cc1	InChI=1S/C23H29N5O4/c1-32-20-9-7-17(15-25-20)19(14-21(29)30)28-13-12-27(23(28)31)11-3-5-18-8-6-16-4-2-10-24-22(16)26-18/h6-9,15,19H,2-5,10-14H2,1H3,(H,24,26)(H,29,30)/t19-/m0/s1	HGFOOLONGOBCMP-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_007717	PFK-015	C17H12N2O	2.5042	25142799	C1=CC=C2C(=C1)C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3	O=C(C=Cc1nc2ccccc2cc1)c1ccncc1	InChI=1S/C17H12N2O/c20-17(14-9-11-18-12-10-14)8-7-15-6-5-13-3-1-2-4-16(13)19-15/h1-12H/b8-7+	UJJUKZPBUMCSJZ-BQYQJAHWSA-N					doublet; compound annotation
0391_007718	SBC-115076	C31H33N3O5	2.6983	6172109	CC1=C(C=CC(=C1)/C(=C\2/C(N(C(=O)C2=O)CCC[NH+]3CCOCC3)C4=CC=NC=C4)/[O-])OCC5=CC=CC=C5	Cc1c(OCc2ccccc2)ccc(C(O)=C2C(=O)C(=O)N(CCCN3CCOCC3)C2c2ccncc2)c1	InChI=1S/C31H33N3O5/c1-22-20-25(8-9-26(22)39-21-23-6-3-2-4-7-23)29(35)27-28(24-10-12-32-13-11-24)34(31(37)30(27)36)15-5-14-33-16-18-38-19-17-33/h2-4,6-13,20,28,35H,5,14-19,21H2,1H3/b29-27+	VVYIXKBHQQSREP-ORIPQNMZSA-N					compound annotation
0391_007719	Grp94 Inhibitor-1	C22H28N2O2	2.9315	137321151		CC(C)c1ccc(-c2cc(C(N)=O)c(NC3CCC(O)CC3)cc2)cc1	InChI=1S/C22H28N2O2/c1-14(2)15-3-5-16(6-4-15)17-7-12-21(20(13-17)22(23)26)24-18-8-10-19(25)11-9-18/h3-7,12-14,18-19,24-25H,8-11H2,1-2H3,(H2,23,26)	JMGDXIHGWTVBMX-UHFFFAOYSA-N					doublet; compound annotation
0391_007720	PFK-015	C17H12N2O	3.0039	25142799	C1=CC=C2C(=C1)C=CC(=N2)/C=C/C(=O)C3=CC=NC=C3	O=C(C=Cc1nc2ccccc2cc1)c1ccncc1	InChI=1S/C17H12N2O/c20-17(14-9-11-18-12-10-14)8-7-15-6-5-13-3-1-2-4-16(13)19-15/h1-12H/b8-7+	UJJUKZPBUMCSJZ-BQYQJAHWSA-N					doublet; compound annotation
0391_007721	212779-48-1	C16H19ClN6O	3.036	2856		CC(C)n1cnc2c(Nc3cc(Cl)ccc3)nc(NCCO)nc21	InChI=1S/C16H19ClN6O/c1-10(2)23-9-19-13-14(20-12-5-3-4-11(17)8-12)21-16(18-6-7-24)22-15(13)23/h3-5,8-10,24H,6-7H2,1-2H3,(H2,18,20,21,22)	XZEFMZCNXDQXOZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007723	212779-48-1	C16H19ClN6O	3.0436	2856		CC(C)n1cnc2c(Nc3cc(Cl)ccc3)nc(NCCO)nc21	InChI=1S/C16H19ClN6O/c1-10(2)23-9-19-13-14(20-12-5-3-4-11(17)8-12)21-16(18-6-7-24)22-15(13)23/h3-5,8-10,24H,6-7H2,1-2H3,(H2,18,20,21,22)	XZEFMZCNXDQXOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_007724	LCL521	C31H52N4O7	3.9295	46200045	CCCCCCCCCCCCCC(=O)N[C@H](COC(=O)CN(C)C)[C@@H](C1=CC=C(C=C1)[N+](=O)[O-])OC(=O)CN(C)C	CCCCCCCCCCCCCC(=O)NC(COC(=O)CN(C)C)C(OC(=O)CN(C)C)c1ccc([N+](=O)[O-])cc1	InChI=1S/C31H52N4O7/c1-6-7-8-9-10-11-12-13-14-15-16-17-28(36)32-27(24-41-29(37)22-33(2)3)31(42-30(38)23-34(4)5)25-18-20-26(21-19-25)35(39)40/h18-21,27,31H,6-17,22-24H2,1-5H3,(H,32,36)/t27-,31-/m1/s1	ANWWJORIPQKJFW-DLFZDVPBSA-N					doublet; removed another duplicate entry; compound annotation
0391_007726	Grp94 Inhibitor-1	C22H28N2O2	4.2611	137321151		CC(C)c1ccc(-c2cc(C(N)=O)c(NC3CCC(O)CC3)cc2)cc1	InChI=1S/C22H28N2O2/c1-14(2)15-3-5-16(6-4-15)17-7-12-21(20(13-17)22(23)26)24-18-8-10-19(25)11-9-18/h3-7,12-14,18-19,24-25H,8-11H2,1-2H3,(H2,23,26)	JMGDXIHGWTVBMX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007728	diclofenac	C14H11Cl2NO2	4.3059	3033		O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	DCOPUUMXTXDBNB-UHFFFAOYSA-N					doublet; compound annotation
0391_007729	NITROBLUE TETRAZOLIUM	C40H30N10O6+2	5.6535	9282		COc1c(-[n+]2nc(-c3ccccc3)nn2-c2ccc([N+](=O)[O-])cc2)ccc(-c2cc(OC)c(-[n+]3nc(-c4ccccc4)nn3-c3ccc([N+](=O)[O-])cc3)cc2)c1	InChI=1S/C40H30N10O6/c1-55-37-25-29(13-23-35(37)47-43-39(27-9-5-3-6-10-27)41-45(47)31-15-19-33(20-16-31)49(51)52)30-14-24-36(38(26-30)56-2)48-44-40(28-11-7-4-8-12-28)42-46(48)32-17-21-34(22-18-32)50(53)54/h3-26H,1-2H3/q+2	JPXMTWWFLBLUCD-UHFFFAOYSA-N					compound annotation
0391_007730	10,10'-dimethyl-9,9'-biacridinium	C28H22N2+2	0.6849	65100		C[n+]1c2ccccc2c(-c2c3ccccc3[n+](C)c3ccccc23)c2ccccc21	InChI=1S/C28H22N2/c1-29-23-15-7-3-11-19(23)27(20-12-4-8-16-24(20)29)28-21-13-5-9-17-25(21)30(2)26-18-10-6-14-22(26)28/h3-18H,1-2H3/q+2	FULGIHLPACFUCU-UHFFFAOYSA-N					compound annotation
0391_007731	PluriSln 1	C12H11N3O	1.4429	225362		O=C(NNc1ccccc1)c1ccncc1	InChI=1S/C12H11N3O/c16-12(10-6-8-13-9-7-10)15-14-11-4-2-1-3-5-11/h1-9,14H,(H,15,16)	HUDWXDLBWRHCKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007733	Nomifensine	C16H18N2	2.0912	4528		CN1Cc2c(cccc2N)C(c2ccccc2)C1	InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3	XXPANQJNYNUNES-UHFFFAOYSA-N					doublet; compound annotation
0391_007734	nefopam	C17H19NO	2.3198	4450		CN1CCOC(c2ccccc2)c2ccccc2C1	InChI=1S/C17H19NO/c1-18-11-12-19-17(14-7-3-2-4-8-14)16-10-6-5-9-15(16)13-18/h2-10,17H,11-13H2,1H3	RGPDEAGGEXEMMM-UHFFFAOYSA-N					compound annotation
0391_007735	178606-66-1	C13H12FN3O3S	2.7292	310360		NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1	InChI=1S/C13H12FN3O3S/c14-9-1-3-10(4-2-9)16-13(18)17-11-5-7-12(8-6-11)21(15,19)20/h1-8H,(H2,15,19,20)(H2,16,17,18)	YJQZNWPYLCNRLP-UHFFFAOYSA-N					compound annotation
0391_007736	Vecabrutinib	C22H24ClF4N7O2	3.3521	72547837	C1C[C@H](C(=O)N(C1)[C@H]2CN(CC[C@@H]2C(=O)N)C3=NC=NC(=C3F)N)NC4=CC(=CC(=C4)C(F)(F)F)Cl	NC(=O)C1CCN(c2ncnc(N)c2F)CC1N1CCCC(Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O	InChI=1S/C22H24ClF4N7O2/c23-12-6-11(22(25,26)27)7-13(8-12)32-15-2-1-4-34(21(15)36)16-9-33(5-3-14(16)19(29)35)20-17(24)18(28)30-10-31-20/h6-8,10,14-16,32H,1-5,9H2,(H2,29,35)(H2,28,30,31)/t14-,15+,16-/m0/s1	QLRRJMOBVVGXEJ-XHSDSOJGSA-N					removed another duplicate entry; compound annotation
0391_007738	2728373-94-0	C23H21F2N3O2	4.0572	145925691		Cc1c(F)ccc(CNC(=O)c2cc(C(=O)NCc3cc(C)c(F)cc3)cnc2)c1	InChI=1S/C23H21F2N3O2/c1-14-7-16(3-5-20(14)24)10-27-22(29)18-9-19(13-26-12-18)23(30)28-11-17-4-6-21(25)15(2)8-17/h3-9,12-13H,10-11H2,1-2H3,(H,27,29)(H,28,30)	OJLMGGCCARSXJV-UHFFFAOYSA-N					compound annotation
0391_007739	chlormadinone acetate	C23H29ClO4	4.6288	9324	CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C23H29ClO4/c1-13(25)23(28-14(2)26)10-7-18-16-12-20(24)19-11-15(27)5-8-21(19,3)17(16)6-9-22(18,23)4/h11-12,16-18H,5-10H2,1-4H3/t16-,17+,18+,21-,22+,23+/m1/s1	QMBJSIBWORFWQT-DFXBJWIESA-N					compound annotation
0391_007740	Molidustat	C13H14N8O2	1.6635	59603622		O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1	InChI=1S/C13H14N8O2/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19/h1-2,7-9,17H,3-6H2	IJMBOKOTALXLKS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007742	1435467-38-1	C14H15N3O4S	1.8804	71568997		COc1cc(-c2cc(=O)[nH]c(=S)n2CC(N)=O)c(OC)cc1	InChI=1S/C14H15N3O4S/c1-20-8-3-4-11(21-2)9(5-8)10-6-13(19)16-14(22)17(10)7-12(15)18/h3-6H,7H2,1-2H3,(H2,15,18)(H,16,19,22)	LJBUZOGABRDGBR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007744	Palbociclib-propargyl	C27H31N7O2	2.4642	139600348		C#CCN1CCN(c2cnc(Nc3ncc4c(C)c(C(C)=O)c(=O)n(C5CCCC5)c4n3)cc2)CC1	InChI=1S/C27H31N7O2/c1-4-11-32-12-14-33(15-13-32)21-9-10-23(28-16-21)30-27-29-17-22-18(2)24(19(3)35)26(36)34(25(22)31-27)20-7-5-6-8-20/h1,9-10,16-17,20H,5-8,11-15H2,2-3H3,(H,28,29,30,31)	SLFZXPQZLOODKL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007747	Tyk2-IN-5	C21H19FN8O2	2.7682	91809175	CNC1=CC(=NN2C1=NC=C2C(=O)N[C@@H]3C[C@@H]3F)NC4=CC=CN(C4=O)C5=CC=CC=N5	CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CC3F)cnc12	InChI=1S/C21H19FN8O2/c1-23-15-10-17(26-13-5-4-8-29(21(13)32)18-6-2-3-7-24-18)28-30-16(11-25-19(15)30)20(31)27-14-9-12(14)22/h2-8,10-12,14,23H,9H2,1H3,(H,26,28)(H,27,31)/t12-,14+/m0/s1	YITUGUNLCGLOII-GXTWGEPZSA-N					doublet; removed another duplicate entry; compound annotation
0391_007749	KRIBB11	C13H12N6O2	2.872	69894253		CNc1nc(Nc2cc3c(cc2)[nH]nc3)c([N+](=O)[O-])cc1	InChI=1S/C13H12N6O2/c1-14-12-5-4-11(19(20)21)13(17-12)16-9-2-3-10-8(6-9)7-15-18-10/h2-7H,1H3,(H,15,18)(H2,14,16,17)	NDJJEQIMIJJCLL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007752	Tyk2-IN-5	C21H19FN8O2	2.9119	91809175	CNC1=CC(=NN2C1=NC=C2C(=O)N[C@@H]3C[C@@H]3F)NC4=CC=CN(C4=O)C5=CC=CC=N5	CNc1cc(Nc2cccn(-c3ccccn3)c2=O)nn2c(C(=O)NC3CC3F)cnc12	InChI=1S/C21H19FN8O2/c1-23-15-10-17(26-13-5-4-8-29(21(13)32)18-6-2-3-7-24-18)28-30-16(11-25-19(15)30)20(31)27-14-9-12(14)22/h2-8,10-12,14,23H,9H2,1H3,(H,26,28)(H,27,31)/t12-,14+/m0/s1	YITUGUNLCGLOII-GXTWGEPZSA-N					doublet; compound annotation
0391_007753	FAS-IN-1	C26H27N3O4S	2.9119	69085357		O=C1COC2(CCN(S(=O)(=O)c3ccc(-c4cc5c(cccn5)cc4)cc3)CC2)CN1C1CC1	InChI=1S/C26H27N3O4S/c30-25-17-33-26(18-29(25)22-7-8-22)11-14-28(15-12-26)34(31,32)23-9-5-19(6-10-23)21-4-3-20-2-1-13-27-24(20)16-21/h1-6,9-10,13,16,22H,7-8,11-12,14-15,17-18H2	OGGOWHOQMIINAZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007755	58816-69-6	C18H18N2O5	3.9032	9840971	CCOC(=O)[C@H](CC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)C2=CC=CC=C2	CCOC(=O)C(Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1	InChI=1S/C18H18N2O5/c1-2-25-18(22)16(19-17(21)14-6-4-3-5-7-14)12-13-8-10-15(11-9-13)20(23)24/h3-11,16H,2,12H2,1H3,(H,19,21)/t16-/m0/s1	BEZXGSZPWXRHIN-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_007757	Mitoglitazone	C19H18N2O4S	3.9744	10429242		CCc1cnc(C(=O)COc2ccc(CC3SC(=O)NC3=O)cc2)cc1	InChI=1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24)	IRNJSRAGRIZIHD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007759	KSI-3716	C17H11BrCl2N2O2	4.9269	44565901		CC(=O)c1c(Nc2ccc(Cl)cc2)[nH]c2c(Br)ccc(Cl)c2c1=O	InChI=1S/C17H11BrCl2N2O2/c1-8(23)13-16(24)14-12(20)7-6-11(18)15(14)22-17(13)21-10-4-2-9(19)3-5-10/h2-7H,1H3,(H2,21,22,24)	URUPDOIKTMCJNA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007761	diethyl hydrogen phosphate	C4H11O4P	0.462	654		CCOP(=O)(O)OCC	InChI=1S/C4H11O4P/c1-3-7-9(5,6)8-4-2/h3-4H2,1-2H3,(H,5,6)	UCQFCFPECQILOL-UHFFFAOYSA-N					compound annotation
0391_007762	211555-30-5	C5H5N3O3	0.8229	11182729		Nc1c([N+](=O)[O-])ccc(=O)[nH]1	InChI=1S/C5H5N3O3/c6-5-3(8(10)11)1-2-4(9)7-5/h1-2H,(H3,6,7,9)	JFGLOZOVAGYLKU-UHFFFAOYSA-N					compound annotation
0391_007763	ISCK03	C19H21N3O2S	3.0124	3792751		CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-n3ccnc3)cc2)cc1	InChI=1S/C19H21N3O2S/c1-19(2,3)15-4-10-18(11-5-15)25(23,24)21-16-6-8-17(9-7-16)22-13-12-20-14-22/h4-14,21H,1-3H3	XQABBHBFHWHMKF-UHFFFAOYSA-N					compound annotation
0391_007764	BVT-14225	C16H20ClN3O3S2	3.5863	6918663		CCN(CC)C(=O)Cc1csc(NS(=O)(=O)c2c(C)c(Cl)ccc2)n1	InChI=1S/C16H20ClN3O3S2/c1-4-20(5-2)15(21)9-12-10-24-16(18-12)19-25(22,23)14-8-6-7-13(17)11(14)3/h6-8,10H,4-5,9H2,1-3H3,(H,18,19)	PNFMZAHWOASGJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007766	BET-BAY 002	C22H18ClN5O	3.674	73425805	CC1=NN=C2N1C3=CC=CC=C3C(=C[C@H]2CC4=NN=C(O4)C)C5=CC=C(C=C5)Cl	Cc1nnc(CC2C=C(c3ccc(Cl)cc3)c3ccccc3-n3c(C)nnc23)o1	InChI=1S/C22H18ClN5O/c1-13-24-27-22-16(12-21-26-25-14(2)29-21)11-19(15-7-9-17(23)10-8-15)18-5-3-4-6-20(18)28(13)22/h3-11,16H,12H2,1-2H3/t16-/m0/s1	AGYIAWHWIUZNSD-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_007768	NVP-CGM097	C38H47ClN4O4	3.8337	53240420	CC(C)OC1=C(C=C2CC(=O)N([C@H](C2=C1)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)N(C)CC5CCC(CC5)N6CCN(C(=O)C6)C)OC	COc1c(OC(C)C)cc2c(c1)CC(=O)N(c1ccc(N(C)CC3CCC(N4CCN(C)C(=O)C4)CC3)cc1)C2c1ccc(Cl)cc1	InChI=1S/C38H47ClN4O4/c1-25(2)47-35-22-33-28(20-34(35)46-5)21-36(44)43(38(33)27-8-10-29(39)11-9-27)32-16-14-30(15-17-32)41(4)23-26-6-12-31(13-7-26)42-19-18-40(3)37(45)24-42/h8-11,14-17,20,22,25-26,31,38H,6-7,12-13,18-19,21,23-24H2,1-5H3/t26?,31?,38-/m0/s1	CLRSLRWKONPSRQ-CPOWQTMSSA-N					doublet; removed another duplicate entry; compound annotation
0391_007771	881487-77-0	C22H21NO5S2	4.354	1652783		CC(C)(C)c1ccc(S(=O)(=O)N=C2C=C(SCC(=O)O)C(=O)c3ccccc23)cc1	InChI=1S/C22H21NO5S2/c1-22(2,3)14-8-10-15(11-9-14)30(27,28)23-18-12-19(29-13-20(24)25)21(26)17-7-5-4-6-16(17)18/h4-12H,13H2,1-3H3,(H,24,25)	BXWWOKYIKNEEHJ-UHFFFAOYSA-N					compound annotation
0391_007772	330786-25-9	C22H21N5O	4.4933	22347110		Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCC3)c2ncn1	InChI=1S/C22H21N5O/c23-21-19-20(26-27(16-6-4-5-7-16)22(19)25-14-24-21)15-10-12-18(13-11-15)28-17-8-2-1-3-9-17/h1-3,8-14,16H,4-7H2,(H2,23,24,25)	GMJUPMONHWAZCP-UHFFFAOYSA-N					doublet; compound annotation
0391_007773	330786-25-9	C22H21N5O	4.4982	22347110		Nc1c2c(-c3ccc(Oc4ccccc4)cc3)nn(C3CCCC3)c2ncn1	InChI=1S/C22H21N5O/c23-21-19-20(26-27(16-6-4-5-7-16)22(19)25-14-24-21)15-10-12-18(13-11-15)28-17-8-2-1-3-9-17/h1-3,8-14,16H,4-7H2,(H2,23,24,25)	GMJUPMONHWAZCP-UHFFFAOYSA-N					doublet; compound annotation
0391_007774	GW3965	C33H31ClF3NO3	5.2543	447905		O=C(O)Cc1cc(OCCCN(Cc2c(Cl)c(C(F)(F)F)ccc2)CC(c2ccccc2)c2ccccc2)ccc1	InChI=1S/C33H31ClF3NO3/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40)	NAXSRXHZFIBFMI-UHFFFAOYSA-N					doublet; compound annotation
0391_007775	GW3965	C33H31ClF3NO3	5.371	447905		O=C(O)Cc1cc(OCCCN(Cc2c(Cl)c(C(F)(F)F)ccc2)CC(c2ccccc2)c2ccccc2)ccc1	InChI=1S/C33H31ClF3NO3/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40)	NAXSRXHZFIBFMI-UHFFFAOYSA-N					doublet; compound annotation
0391_007776	CHEMBL4596378	C20H23FN4O2S	1.3054	130302687	CC1=C(C2=C(N1C/C(=C/CN)/F)C=CC=N2)C3=CC(=CC=C3)S(=O)(=O)N(C)C	Cc1c(-c2cc(S(=O)(=O)N(C)C)ccc2)c2c(cccn2)n1CC(F)=CCN	InChI=1S/C20H23FN4O2S/c1-14-19(15-6-4-7-17(12-15)28(26,27)24(2)3)20-18(8-5-11-23-20)25(14)13-16(21)9-10-22/h4-9,11-12H,10,13,22H2,1-3H3/b16-9-	YNYGVGYGPMQAEL-SXGWCWSVSA-N					removed another duplicate entry; compound annotation
0391_007778	Cefcapene pivoxil	C23H29N5O8S2	2.7949	5282438	CC/C=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C	CCC=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CSC12)c1csc(N)n1	InChI=1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1	WVPAABNYMHNFJG-QDVBXLKVSA-N					doublet; compound annotation
0391_007779	Evocalcet	C24H26N2O2	2.8741	71242808	C[C@H](C1=CC=CC2=CC=CC=C21)N[C@H]3CCN(C3)C4=CC=C(C=C4)CC(=O)O	CC(NC1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12	InChI=1S/C24H26N2O2/c1-17(22-8-4-6-19-5-2-3-7-23(19)22)25-20-13-14-26(16-20)21-11-9-18(10-12-21)15-24(27)28/h2-12,17,20,25H,13-16H2,1H3,(H,27,28)/t17-,20+/m1/s1	RZNUIYPHQFXBAN-XLIONFOSSA-N					compound annotation
0391_007780	Cefcapene pivoxil	C23H29N5O8S2	2.952	5282438	CC/C=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C	CCC=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CSC12)c1csc(N)n1	InChI=1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1	WVPAABNYMHNFJG-QDVBXLKVSA-N					doublet; compound annotation
0391_007781	Cefcapene pivoxil	C23H29N5O8S2	2.9569	5282438	CC/C=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C	CCC=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CSC12)c1csc(N)n1	InChI=1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1	WVPAABNYMHNFJG-QDVBXLKVSA-N					doublet; compound annotation
0391_007782	FT827	C27H28N6O5S	2.9664	121435663		C=CS(=O)(=O)Nc1ccccc1-c1ccc(C(=O)N2CCC(O)(Cn3cnc4c(cnn4C)c3=O)CC2)cc1	InChI=1S/C27H28N6O5S/c1-3-39(37,38)30-23-7-5-4-6-21(23)19-8-10-20(11-9-19)25(34)32-14-12-27(36,13-15-32)17-33-18-28-24-22(26(33)35)16-29-31(24)2/h3-11,16,18,30,36H,1,12-15,17H2,2H3	GFNJQQBUZURQMA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007784	Cefcapene pivoxil	C23H29N5O8S2	3.048	5282438	CC/C=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C	CCC=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(COC(N)=O)CSC12)c1csc(N)n1	InChI=1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1	WVPAABNYMHNFJG-QDVBXLKVSA-N					doublet; removed another duplicate entry; compound annotation
0391_007786	Keratinocyte Differentiation Inducer	C24H23N5O3	3.4845	11453158		COc1cc(Nc2ncc3ccn(-c4cccc(CCC#N)c4)c3n2)cc(OC)c1OC	InChI=1S/C24H23N5O3/c1-30-20-13-18(14-21(31-2)22(20)32-3)27-24-26-15-17-9-11-29(23(17)28-24)19-8-4-6-16(12-19)7-5-10-25/h4,6,8-9,11-15H,5,7H2,1-3H3,(H,26,27,28)	KKVZKYOBQGDKIB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007789	GCN2iB	C18H12ClF2N5O3S	3.9341	134814489		COc1c(S(=O)(=O)Nc2c(F)c(C#Cc3cnc(N)nc3)c(F)cc2)cc(Cl)cn1	InChI=1S/C18H12ClF2N5O3S/c1-29-17-15(6-11(19)9-23-17)30(27,28)26-14-5-4-13(20)12(16(14)21)3-2-10-7-24-18(22)25-8-10/h4-9,26H,1H3,(H2,22,24,25)	JGHVXJKGYJYWOP-UHFFFAOYSA-N					compound annotation
0391_007790	Rilapladib	C40H38F5N3O3S	3.9724	9918381		COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3c(F)c(F)ccc3)cc(=O)c3ccccc32)CC1	InChI=1S/C40H38F5N3O3S/c1-51-22-21-46-19-17-32(18-20-46)47(24-27-9-11-28(12-10-27)29-13-15-31(16-14-29)40(43,44)45)37(50)25-48-35-8-3-2-6-33(35)36(49)23-38(48)52-26-30-5-4-7-34(41)39(30)42/h2-16,23,32H,17-22,24-26H2,1H3	NNBGCSGCRSCFEA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007792	IM-12	C22H20FN3O2	4.377	25209788		Cc1c(C2=C(NCCc3ccc(F)cc3)C(=O)N(C)C2=O)c2ccccc2[nH]1	InChI=1S/C22H20FN3O2/c1-13-18(16-5-3-4-6-17(16)25-13)19-20(22(28)26(2)21(19)27)24-12-11-14-7-9-15(23)10-8-14/h3-10,24-25H,11-12H2,1-2H3	ZKJAZFUFPPSFCO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007795	BRD9539	C24H21N3O3	4.7322	73755260		O=C(O)c1ccc2c(c1)nc(NC(=O)c1ccccc1)n2CCCc1ccccc1	InChI=1S/C24H21N3O3/c28-22(18-11-5-2-6-12-18)26-24-25-20-16-19(23(29)30)13-14-21(20)27(24)15-7-10-17-8-3-1-4-9-17/h1-6,8-9,11-14,16H,7,10,15H2,(H,29,30)(H,25,26,28)	WPXMEOBILYVKBC-UHFFFAOYSA-N					doublet; compound annotation
0391_007796	BRD9539	C24H21N3O3	4.7349	73755260		O=C(O)c1ccc2c(c1)nc(NC(=O)c1ccccc1)n2CCCc1ccccc1	InChI=1S/C24H21N3O3/c28-22(18-11-5-2-6-12-18)26-24-25-20-16-19(23(29)30)13-14-21(20)27(24)15-7-10-17-8-3-1-4-9-17/h1-6,8-9,11-14,16H,7,10,15H2,(H,29,30)(H,25,26,28)	WPXMEOBILYVKBC-UHFFFAOYSA-N					doublet; compound annotation
0391_007797	ciproxifan	C16H18N2O2	1.5708	6422124		O=C(c1ccc(OCCCc2cnc[nH]2)cc1)C1CC1	InChI=1S/C16H18N2O2/c19-16(12-3-4-12)13-5-7-15(8-6-13)20-9-1-2-14-10-17-11-18-14/h5-8,10-12H,1-4,9H2,(H,17,18)	ACQBHJXEAYTHCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007798	127500-84-9	C12H12FN3OS	1.8085	5086		NCCNC(=O)c1c(-c2cc(F)ccc2)scn1	InChI=1S/C12H12FN3OS/c13-9-3-1-2-8(6-9)11-10(16-7-18-11)12(17)15-5-4-14/h1-3,6-7H,4-5,14H2,(H,15,17)	SCKBPXUWGMKLDM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007800	DMCM	C17H18N2O4	2.0836	104999		CCc1c2c(cnc1C(=O)OC)[nH]c1cc(OC)c(OC)cc12	InChI=1S/C17H18N2O4/c1-5-9-15-10-6-13(21-2)14(22-3)7-11(10)19-12(15)8-18-16(9)17(20)23-4/h6-8,19H,5H2,1-4H3	GADIKQPUNWAMEB-UHFFFAOYSA-N					doublet; compound annotation
0391_007801	ciproxifan	C16H18N2O2	2.2294	6422124		O=C(c1ccc(OCCCc2cnc[nH]2)cc1)C1CC1	InChI=1S/C16H18N2O2/c19-16(12-3-4-12)13-5-7-15(8-6-13)20-9-1-2-14-10-17-11-18-14/h5-8,10-12H,1-4,9H2,(H,17,18)	ACQBHJXEAYTHCY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007803	GSK6853	C22H27N5O3	2.2672	121232405	C[C@@H]1CNCCN1C2=CC3=C(C=C2NC(=O)C4=CC=CC=C4OC)N(C(=O)N3C)C	COc1ccccc1C(=O)Nc1cc2c(cc1N1CCNCC1C)n(C)c(=O)n2C	InChI=1S/C22H27N5O3/c1-14-13-23-9-10-27(14)17-12-19-18(25(2)22(29)26(19)3)11-16(17)24-21(28)15-7-5-6-8-20(15)30-4/h5-8,11-12,14,23H,9-10,13H2,1-4H3,(H,24,28)/t14-/m1/s1	FQWDVNSBYDXPIO-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_007806	Ebrotidine	C14H17BrN6O2S3	2.4729	65869		NC(N)=Nc1nc(CSCCN=CNS(=O)(=O)c2ccc(Br)cc2)cs1	InChI=1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)	ZQHFZHPUZXNPMF-UHFFFAOYSA-N					doublet; compound annotation
0391_007807	DMCM	C17H18N2O4	2.4805	104999		CCc1c2c(cnc1C(=O)OC)[nH]c1cc(OC)c(OC)cc12	InChI=1S/C17H18N2O4/c1-5-9-15-10-6-13(21-2)14(22-3)7-11(10)19-12(15)8-18-16(9)17(20)23-4/h6-8,19H,5H2,1-4H3	GADIKQPUNWAMEB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007809	Ebrotidine	C14H17BrN6O2S3	2.5554	65869		NC(N)=Nc1nc(CSCCN=CNS(=O)(=O)c2ccc(Br)cc2)cs1	InChI=1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)	ZQHFZHPUZXNPMF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007811	AZ20	C21H24N4O3S	2.7791	46244454	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=O)(=O)C)C4=C5C=CNC5=CC=C4	CC1COCCN1c1nc(-c2c3cc[nH]c3ccc2)nc(C2(S(C)(=O)=O)CC2)c1	InChI=1S/C21H24N4O3S/c1-14-13-28-11-10-25(14)19-12-18(21(7-8-21)29(2,26)27)23-20(24-19)16-4-3-5-17-15(16)6-9-22-17/h3-6,9,12,14,22H,7-8,10-11,13H2,1-2H3/t14-/m1/s1	SCGCBAAYLFTIJU-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_007813	nelfinavir	C32H45N3O4S	3.3699	64143	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	Cc1c(C(=O)NC(CSc2ccccc2)C(O)CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)cccc1O	InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1	QAGYKUNXZHXKMR-HKWSIXNMSA-N					doublet; compound annotation
0391_007814	nelfinavir	C32H45N3O4S	3.4671	64143	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	Cc1c(C(=O)NC(CSc2ccccc2)C(O)CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)cccc1O	InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1	QAGYKUNXZHXKMR-HKWSIXNMSA-N					doublet; compound annotation
0391_007815	nelfinavir	C32H45N3O4S	3.4703	64143	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	Cc1c(C(=O)NC(CSc2ccccc2)C(O)CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)cccc1O	InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1	QAGYKUNXZHXKMR-HKWSIXNMSA-N					doublet; compound annotation
0391_007816	nelfinavir	C32H45N3O4S	3.6033	64143	CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O	Cc1c(C(=O)NC(CSc2ccccc2)C(O)CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)cccc1O	InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1	QAGYKUNXZHXKMR-HKWSIXNMSA-N					doublet; compound annotation
0391_007817	Skepinone-L	C24H21F2NO4	3.9481	45279963	C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O	O=C1c2c(cc(Nc3c(F)cc(F)cc3)cc2)CCc2c1cc(OCC(O)CO)cc2	InChI=1S/C24H21F2NO4/c25-16-4-8-23(22(26)10-16)27-17-5-7-20-15(9-17)2-1-14-3-6-19(11-21(14)24(20)30)31-13-18(29)12-28/h3-11,18,27-29H,1-2,12-13H2/t18-/m1/s1	HXMGCTFLLWPVFM-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_007820	ciproxifan	C16H18N2O2	4.1604	6422124		O=C(c1ccc(OCCCc2cnc[nH]2)cc1)C1CC1	InChI=1S/C16H18N2O2/c19-16(12-3-4-12)13-5-7-15(8-6-13)20-9-1-2-14-10-17-11-18-14/h5-8,10-12H,1-4,9H2,(H,17,18)	ACQBHJXEAYTHCY-UHFFFAOYSA-N					doublet; compound annotation
0391_007821	321695-57-2	C15H15NO5S	4.5102	2221149		COc1ccc(S(=O)(=O)ON=C2C=C(C)C(=O)C(C)=C2)cc1	InChI=1S/C15H15NO5S/c1-10-8-12(9-11(2)15(10)17)16-21-22(18,19)14-6-4-13(20-3)5-7-14/h4-9H,1-3H3	VEWFTYOFWIXCIO-UHFFFAOYSA-N					compound annotation
0391_007822	BMS-986020	C29H26N2O5	4.6075	49792850	CC1=NOC(=C1NC(=O)O[C@H](C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O	Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1NC(=O)OC(C)c1ccccc1	InChI=1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m1/s1	GQBRZBHEPUQRPL-LJQANCHMSA-N					doublet; removed another duplicate entry; compound annotation
0391_007824	Enalaprilat	C18H24N2O5	1.6046	5462501	C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O	CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O	InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1	LZFZMUMEGBBDTC-QEJZJMRPSA-N					compound annotation
0391_007825	urolithin B	C13H8O3	3.1381	5380406		O=c1oc2c(ccc(O)c2)c2ccccc12	InChI=1S/C13H8O3/c14-8-5-6-10-9-3-1-2-4-11(9)13(15)16-12(10)7-8/h1-7,14H	WXUQMTRHPNOXBV-UHFFFAOYSA-N					compound annotation
0391_007826	tiagabine	C20H25NO2S2	3.2183	60648	CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C	Cc1c(C(=CCCN2CCCC(C(=O)O)C2)c2c(C)ccs2)scc1	InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1	PBJUNZJWGZTSKL-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_007828	936563-87-0	C25H24N6O2	3.7005	16126651		C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)	XYFPWWZEPKGCCK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007830	hydrocortisone butyrate	C25H36O6	3.7682	26133	CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO	CCCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C	InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1	BMCQMVFGOVHVNG-TUFAYURCSA-N					compound annotation
0391_007831	936563-87-0	C25H24N6O2	4.0078	16126651		C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)	XYFPWWZEPKGCCK-UHFFFAOYSA-N					doublet; compound annotation
0391_007832	Deguelin	C23H22O6	4.6021	107935	CC1(C=CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC)C	COc1c(OC)cc2c(c1)OCC1Oc3c(ccc4c3C=CC(C)(C)O4)C(=O)C21	InChI=1S/C23H22O6/c1-23(2)8-7-12-15(29-23)6-5-13-21(24)20-14-9-17(25-3)18(26-4)10-16(14)27-11-19(20)28-22(12)13/h5-10,19-20H,11H2,1-4H3/t19-,20+/m1/s1	ORDAZKGHSNRHTD-UXHICEINSA-N					removed another duplicate entry; compound annotation
0391_007834	B I09	C16H17NO5	1.3166	86290458		O=c1oc2c(ccc(O)c2C2OCCCO2)c2c1CNCC2	InChI=1S/C16H17NO5/c18-12-3-2-10-9-4-5-17-8-11(9)15(19)22-14(10)13(12)16-20-6-1-7-21-16/h2-3,16-18H,1,4-8H2	UYYMWNUDIOPESF-UHFFFAOYSA-N					compound annotation
0391_007835	Triglycidyl isocyanurate	C12H15N3O6	1.5044	17142		O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1	InChI=1S/C12H15N3O6/c16-10-13(1-7-4-19-7)11(17)15(3-9-6-21-9)12(18)14(10)2-8-5-20-8/h7-9H,1-6H2	OUPZKGBUJRBPGC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007837	CD80-IN-3	C17H10FN3O3	2.6227	644103		O=C(O)c1ccc(-n2[nH]c3c4cccc(F)c4ncc3c2=O)cc1	InChI=1S/C17H10FN3O3/c18-13-3-1-2-11-14-12(8-19-15(11)13)16(22)21(20-14)10-6-4-9(5-7-10)17(23)24/h1-8,20H,(H,23,24)	NLGJRBLPUVEYKC-UHFFFAOYSA-N					compound annotation
0391_007838	PGAM1-IN-2	C25H16N2O7S	5.3176	138454805		O=c1c2c(ccc([N+](=O)[O-])c2)oc2cc(NS(=O)(=O)c3ccc(-c4ccccc4)cc3)cc(O)c12	InChI=1S/C25H16N2O7S/c28-21-12-17(13-23-24(21)25(29)20-14-18(27(30)31)8-11-22(20)34-23)26-35(32,33)19-9-6-16(7-10-19)15-4-2-1-3-5-15/h1-14,26,28H	BRBFEAYMCMDULD-UHFFFAOYSA-N					compound annotation
0391_007839	Vimseltinib	C23H25N7O2	2.1133	86267612		Cc1c(Oc2cc(-c3cn(C)nc3)ncc2)ccc(-c2cnc(NC(C)C)n(C)c2=O)n1	InChI=1S/C23H25N7O2/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16/h6-14H,1-5H3,(H,25,27)	TVGAHWWPABTBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_007840	Vimseltinib	C23H25N7O2	2.116	86267612		Cc1c(Oc2cc(-c3cn(C)nc3)ncc2)ccc(-c2cnc(NC(C)C)n(C)c2=O)n1	InChI=1S/C23H25N7O2/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16/h6-14H,1-5H3,(H,25,27)	TVGAHWWPABTBCX-UHFFFAOYSA-N					doublet; compound annotation
0391_007841	bupivacaine	C18H28N2O	2.3675	2474		CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)	LEBVLXFERQHONN-UHFFFAOYSA-N					compound annotation
0391_007842	A2ti-1	C20H22N4O2S	3.8515	1431565		CCc1ccccc1-n1c(COc2ccccc2C)nnc1SCC(N)=O	InChI=1S/C20H22N4O2S/c1-3-15-9-5-6-10-16(15)24-19(22-23-20(24)27-13-18(21)25)12-26-17-11-7-4-8-14(17)2/h4-11H,3,12-13H2,1-2H3,(H2,21,25)	KNQGIFUBCFRGDB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007844	146998-31-4	C19H18N4O4	4.5813	4206604		CN(C)c1ccc(N=Nc2ccc(C(=O)ON3C(=O)CCC3=O)cc2)cc1	InChI=1S/C19H18N4O4/c1-22(2)16-9-7-15(8-10-16)21-20-14-5-3-13(4-6-14)19(26)27-23-17(24)11-12-18(23)25/h3-10H,11-12H2,1-2H3	IBOVDNBDQHYNJI-UHFFFAOYSA-N					doublet; compound annotation
0391_007845	146998-31-4	C19H18N4O4	4.5866	4206604		CN(C)c1ccc(N=Nc2ccc(C(=O)ON3C(=O)CCC3=O)cc2)cc1	InChI=1S/C19H18N4O4/c1-22(2)16-9-7-15(8-10-16)21-20-14-5-3-13(4-6-14)19(26)27-23-17(24)11-12-18(23)25/h3-10H,11-12H2,1-2H3	IBOVDNBDQHYNJI-UHFFFAOYSA-N					doublet; compound annotation
0391_007846	Siponimod	C29H35F3N2O3	4.6975	44599207	CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O	CCc1c(CN2CC(C(=O)O)C2)ccc(C(C)=NOCc2cc(C(F)(F)F)c(C3CCCCC3)cc2)c1	InChI=1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+	KIHYPELVXPAIDH-HNSNBQBZSA-N					doublet; compound annotation
0391_007847	Siponimod	C29H35F3N2O3	4.9843	44599207	CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O	CCc1c(CN2CC(C(=O)O)C2)ccc(C(C)=NOCc2cc(C(F)(F)F)c(C3CCCCC3)cc2)c1	InChI=1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+	KIHYPELVXPAIDH-HNSNBQBZSA-N					doublet; compound annotation
0391_007848	Siponimod	C29H35F3N2O3	4.9875	44599207	CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O	CCc1c(CN2CC(C(=O)O)C2)ccc(C(C)=NOCc2cc(C(F)(F)F)c(C3CCCCC3)cc2)c1	InChI=1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+	KIHYPELVXPAIDH-HNSNBQBZSA-N					doublet; compound annotation
0391_007849	APS6-45	C23H16F8N4O3	5.0341	131953288		CNC(=O)c1nccc(Oc2ccc(NC(=O)Nc3c(F)ccc(C(F)(C(F)(F)F)C(F)(F)F)c3)cc2)c1	InChI=1S/C23H16F8N4O3/c1-32-19(36)18-11-15(8-9-33-18)38-14-5-3-13(4-6-14)34-20(37)35-17-10-12(2-7-16(17)24)21(25,22(26,27)28)23(29,30)31/h2-11H,1H3,(H,32,36)(H2,34,35,37)	MVUPJRHPAMCBQJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007851	UNC1215	C32H43N5O2	1.2855	57339144		O=C(c1cc(Nc2ccccc2)c(C(=O)N2CCC(N3CCCC3)CC2)cc1)N1CCC(N2CCCC2)CC1	InChI=1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2	PQOOIERVZAXHBP-UHFFFAOYSA-N					doublet; compound annotation
0391_007852	UNC1215	C32H43N5O2	1.2883	57339144		O=C(c1cc(Nc2ccccc2)c(C(=O)N2CCC(N3CCCC3)CC2)cc1)N1CCC(N2CCCC2)CC1	InChI=1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2	PQOOIERVZAXHBP-UHFFFAOYSA-N					doublet; compound annotation
0391_007853	Akt inhibitor VIII	C34H29N7O	2.3538	135398501		O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3c(-c4ccccc4)nc4cc5ncnc5cc4[nH]3)cc2)CC1	InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25,38H,14-17,20H2,(H,39,42)	IWCQHVUQEFDRIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007855	Sotorasib	C30H30F2N6O3	2.7685	137278711	C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C	C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)C(C)C1	InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1	NXQKSXLFSAEQCZ-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_007857	SAR7334	C21H22ClN3O	2.7712	53378752	C1C[C@H](CN(C1)[C@@H]2CC3=CC=CC=C3[C@H]2OC4=C(C=C(C=C4)C#N)Cl)N	N#Cc1cc(Cl)c(OC2c3ccccc3CC2N2CCCC(N)C2)cc1	InChI=1S/C21H22ClN3O/c22-18-10-14(12-23)7-8-20(18)26-21-17-6-2-1-4-15(17)11-19(21)25-9-3-5-16(24)13-25/h1-2,4,6-8,10,16,19,21H,3,5,9,11,13,24H2/t16-,19-,21-/m1/s1	RLKRLNQEXBPQGQ-OZOXKJRCSA-N					doublet; compound annotation
0391_007858	WH-4-023	C32H36N6O4	3.273	11844351		COc1cc(OC)c(N(C(=O)Oc2c(C)cccc2C)c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2)cc1	InChI=1S/C32H36N6O4/c1-22-7-6-8-23(2)30(22)42-32(39)38(27-14-13-26(40-4)21-28(27)41-5)29-15-16-33-31(35-29)34-24-9-11-25(12-10-24)37-19-17-36(3)18-20-37/h6-16,21H,17-20H2,1-5H3,(H,33,34,35)	NBTNHSGBRGTFJS-UHFFFAOYSA-N					doublet; compound annotation
0391_007859	6,7-dimethoxy-N-(3-phenoxyphenyl)quinolin-4-amine	C23H20N2O3	3.3936	44531022		COc1cc2nccc(Nc3cc(Oc4ccccc4)ccc3)c2cc1OC	InChI=1S/C23H20N2O3/c1-26-22-14-19-20(11-12-24-21(19)15-23(22)27-2)25-16-7-6-10-18(13-16)28-17-8-4-3-5-9-17/h3-15H,1-2H3,(H,24,25)	LEEMRFWMAIVHQY-UHFFFAOYSA-N					compound annotation
0391_007860	WH-4-023	C32H36N6O4	3.5899	11844351		COc1cc(OC)c(N(C(=O)Oc2c(C)cccc2C)c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2)cc1	InChI=1S/C32H36N6O4/c1-22-7-6-8-23(2)30(22)42-32(39)38(27-14-13-26(40-4)21-28(27)41-5)29-15-16-33-31(35-29)34-24-9-11-25(12-10-24)37-19-17-36(3)18-20-37/h6-16,21H,17-20H2,1-5H3,(H,33,34,35)	NBTNHSGBRGTFJS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007862	FG-2216	C12H9ClN2O4	3.6379	6914666		O=C(O)CNC(=O)c1c(O)c2ccccc2c(Cl)n1	InChI=1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17)	OUQVKRKGTAUJQA-UHFFFAOYSA-N					compound annotation
0391_007863	BMS-1166	C36H33ClN2O7	4.1913	118434635	CC1=C(C=CC=C1C2=CC3=C(C=C2)OCCO3)COC4=C(C=C(C(=C4)OCC5=CC(=CC=C5)C#N)CN6C[C@@H](C[C@@H]6C(=O)O)O)Cl	Cc1c(COc2c(Cl)cc(CN3CC(O)CC3C(=O)O)c(OCc3cc(C#N)ccc3)c2)cccc1-c1cc2c(cc1)OCCO2	InChI=1S/C36H33ClN2O7/c1-22-26(6-3-7-29(22)25-8-9-32-35(14-25)44-11-10-43-32)21-46-34-16-33(45-20-24-5-2-4-23(12-24)17-38)27(13-30(34)37)18-39-19-28(40)15-31(39)36(41)42/h2-9,12-14,16,28,31,40H,10-11,15,18-21H2,1H3,(H,41,42)/t28-,31-/m1/s1	QBXVXKRWOVBUDB-GRKNLSHJSA-N					removed another duplicate entry; compound annotation
0391_007865	Trifloxystrobin	C20H19F3N2O4	5.0368	11664966	C/C(=N\OCC1=CC=CC=C1/C(=N\OC)/C(=O)OC)/C2=CC(=CC=C2)C(F)(F)F	CON=C(C(=O)OC)c1ccccc1CON=C(C)c1cc(C(F)(F)F)ccc1	InChI=1S/C20H19F3N2O4/c1-13(14-8-6-9-16(11-14)20(21,22)23)24-29-12-15-7-4-5-10-17(15)18(25-28-3)19(26)27-2/h4-11H,12H2,1-3H3/b24-13+,25-18+	ONCZDRURRATYFI-TVJDWZFNSA-N					doublet; compound annotation
0391_007866	Trifloxystrobin	C20H19F3N2O4	5.2857	11664966	C/C(=N\OCC1=CC=CC=C1/C(=N\OC)/C(=O)OC)/C2=CC(=CC=C2)C(F)(F)F	CON=C(C(=O)OC)c1ccccc1CON=C(C)c1cc(C(F)(F)F)ccc1	InChI=1S/C20H19F3N2O4/c1-13(14-8-6-9-16(11-14)20(21,22)23)24-29-12-15-7-4-5-10-17(15)18(25-28-3)19(26)27-2/h4-11H,12H2,1-3H3/b24-13+,25-18+	ONCZDRURRATYFI-TVJDWZFNSA-N					doublet; removed another duplicate entry; compound annotation
0391_007868	desethylamodiaquine	C18H18ClN3O	1.1808	122068		CCNCc1c(O)ccc(Nc2ccnc3cc(Cl)ccc23)c1	InChI=1S/C18H18ClN3O/c1-2-20-11-12-9-14(4-6-18(12)23)22-16-7-8-21-17-10-13(19)3-5-15(16)17/h3-10,20,23H,2,11H2,1H3,(H,21,22)	VRXFDHAGFYWGHT-UHFFFAOYSA-N					compound annotation
0391_007869	887603-94-3	C15H12N2O	1.4765	10220323		O=C1N=C2C=CC=CN2C12Cc1ccccc1C2	InChI=1S/C15H12N2O/c18-14-15(17-8-4-3-7-13(17)16-14)9-11-5-1-2-6-12(11)10-15/h1-8H,9-10H2	QZWYXEBIQWJXAR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007871	Rebaudioside C	C44H70O22	3.0038	60208888	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@]34CC[C@H]5[C@@]6(CCC[C@@]([C@H]6CC[C@]5(C3)CC4=C)(C)C(=O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O	C=C1CC23CCC4C(C)(C(=O)OC5OC(CO)C(O)C(O)C5O)CCCC4(C)C2CCC1(OC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2O)C1OC1OC(C)C(O)C(O)C1O)C3	InChI=1S/C44H70O22/c1-17-12-43-10-6-22-41(3,8-5-9-42(22,4)40(58)65-38-33(57)30(54)26(50)20(14-46)61-38)23(43)7-11-44(17,16-43)66-39-35(64-36-31(55)28(52)24(48)18(2)59-36)34(27(51)21(15-47)62-39)63-37-32(56)29(53)25(49)19(13-45)60-37/h18-39,45-57H,1,5-16H2,2-4H3/t18-,19+,20+,21+,22-,23-,24-,25+,26+,27+,28+,29-,30-,31+,32+,33+,34-,35+,36-,37-,38-,39-,41+,42+,43+,44-/m0/s1	QSRAJVGDWKFOGU-WBXIDTKBSA-N					compound annotation
0391_007872	Triptonide	C20H22O6	3.516	65411	CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4(C2=O)O7)COC6=O)C	CC(C)C12OC1C1OC13C1(C)CCC4=C(COC4=O)C1CC1OC13C2=O	InChI=1S/C20H22O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14H,4-7H2,1-3H3/t11-,12-,13-,14-,17-,18-,19+,20+/m0/s1	SWOVVKGLGOOUKI-ZHGGVEMFSA-N					compound annotation
0391_007873	Seco Rapamycin ethyl ester	C53H83NO13	6.0976	154573775	CCOC(=O)[C@@H]1CCCCN1C(=O)C(=O)[C@]2([C@@H](CC[C@H](O2)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)O)/C)O)OC)/C)OC)C)O	CCOC(=O)C1CCCCN1C(=O)C(=O)C1(O)OC(CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C=CC(C)CC2CCC(O)C(OC)C2)CCC1C	InChI=1S/C53H83NO13/c1-12-66-52(61)42-20-16-17-27-54(42)51(60)50(59)53(62)39(8)22-24-41(67-53)32-45(63-9)35(4)19-15-13-14-18-33(2)28-37(6)47(57)49(65-11)48(58)38(7)30-36(5)43(55)25-21-34(3)29-40-23-26-44(56)46(31-40)64-10/h13-15,18-19,21,25,30,33-34,36-37,39-42,44-46,48-49,56,58,62H,12,16-17,20,22-24,26-29,31-32H2,1-11H3/b15-13+,18-14+,25-21+,35-19+,38-30+/t33-,34+,36-,37-,39-,40+,41+,42+,44-,45+,46-,48-,49+,53-/m1/s1	AFZMAZIUJNBBML-CCDOOBSISA-N					compound annotation
0391_007874	EPZ020411	C25H38N4O3	1.8838	91668547		CNCCN(C)Cc1c(-c2ccc(OC3CC(OCCC4CCOCC4)C3)cc2)[nH]nc1	InChI=1S/C25H38N4O3/c1-26-10-11-29(2)18-21-17-27-28-25(21)20-3-5-22(6-4-20)32-24-15-23(16-24)31-14-9-19-7-12-30-13-8-19/h3-6,17,19,23-24,26H,7-16,18H2,1-2H3,(H,27,28)	QMDKVNSQXPVCRD-UHFFFAOYSA-N					doublet; compound annotation
0391_007875	EPZ020411	C25H38N4O3	1.9504	91668547		CNCCN(C)Cc1c(-c2ccc(OC3CC(OCCC4CCOCC4)C3)cc2)[nH]nc1	InChI=1S/C25H38N4O3/c1-26-10-11-29(2)18-21-17-27-28-25(21)20-3-5-22(6-4-20)32-24-15-23(16-24)31-14-9-19-7-12-30-13-8-19/h3-6,17,19,23-24,26H,7-16,18H2,1-2H3,(H,27,28)	QMDKVNSQXPVCRD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007877	223568-55-6	C18H23FN2O6	2.1496	9907987	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)CF)NC(=O)OCC1=CC=CC=C1	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF	InChI=1S/C18H23FN2O6/c1-11(2)16(17(25)20-13(8-15(23)24)14(22)9-19)21-18(26)27-10-12-6-4-3-5-7-12/h3-7,11,13,16H,8-10H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t13-,16-/m0/s1	LYBWGROBJJXCJJ-BBRMVZONSA-N					doublet; compound annotation
0391_007878	223568-55-6	C18H23FN2O6	2.2178	9907987	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)CF)NC(=O)OCC1=CC=CC=C1	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF	InChI=1S/C18H23FN2O6/c1-11(2)16(17(25)20-13(8-15(23)24)14(22)9-19)21-18(26)27-10-12-6-4-3-5-7-12/h3-7,11,13,16H,8-10H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t13-,16-/m0/s1	LYBWGROBJJXCJJ-BBRMVZONSA-N					doublet; compound annotation
0391_007879	Chitinase-IN-2	C20H21N5O2S	2.3166	86223064		Cc1nnc(CNCCN2C(=O)c3cccc4c(N(C)C)ccc(c34)C2=O)s1	InChI=1S/C20H21N5O2S/c1-12-22-23-17(28-12)11-21-9-10-25-19(26)14-6-4-5-13-16(24(2)3)8-7-15(18(13)14)20(25)27/h4-8,21H,9-11H2,1-3H3	MZVBLDCRQKXSHR-UHFFFAOYSA-N					doublet; compound annotation
0391_007880	Chitinase-IN-2	C20H21N5O2S	2.3198	86223064		Cc1nnc(CNCCN2C(=O)c3cccc4c(N(C)C)ccc(c34)C2=O)s1	InChI=1S/C20H21N5O2S/c1-12-22-23-17(28-12)11-21-9-10-25-19(26)14-6-4-5-13-16(24(2)3)8-7-15(18(13)14)20(25)27/h4-8,21H,9-11H2,1-3H3	MZVBLDCRQKXSHR-UHFFFAOYSA-N					doublet; compound annotation
0391_007881	91757-46-9	C15H14N4	2.5951	353494		Cc1nc2ccccc2nc1NNc1ccccc1	InChI=1S/C15H14N4/c1-11-15(19-18-12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11/h2-10,18H,1H3,(H,17,19)	LGFSRIOYSFTORO-UHFFFAOYSA-N					compound annotation
0391_007882	Chitinase-IN-2	C20H21N5O2S	2.5979	86223064		Cc1nnc(CNCCN2C(=O)c3cccc4c(N(C)C)ccc(c34)C2=O)s1	InChI=1S/C20H21N5O2S/c1-12-22-23-17(28-12)11-21-9-10-25-19(26)14-6-4-5-13-16(24(2)3)8-7-15(18(13)14)20(25)27/h4-8,21H,9-11H2,1-3H3	MZVBLDCRQKXSHR-UHFFFAOYSA-N					doublet; compound annotation
0391_007883	Avoralstat	C28H27N5O5	2.5979	86566678		C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2c(C(=O)O)nc(C(=O)NCC3CC3)cc2)cc1OC	InChI=1S/C28H27N5O5/c1-3-16-12-21(26(34)32-18-8-6-17(7-9-18)25(29)30)20(13-23(16)38-2)19-10-11-22(33-24(19)28(36)37)27(35)31-14-15-4-5-15/h3,6-13,15H,1,4-5,14H2,2H3,(H3,29,30)(H,31,35)(H,32,34)(H,36,37)	TUWMKPVJGGWGNL-UHFFFAOYSA-N					doublet; compound annotation
0391_007884	Avoralstat	C28H27N5O5	2.6026	86566678		C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2c(C(=O)O)nc(C(=O)NCC3CC3)cc2)cc1OC	InChI=1S/C28H27N5O5/c1-3-16-12-21(26(34)32-18-8-6-17(7-9-18)25(29)30)20(13-23(16)38-2)19-10-11-22(33-24(19)28(36)37)27(35)31-14-15-4-5-15/h3,6-13,15H,1,4-5,14H2,2H3,(H3,29,30)(H,31,35)(H,32,34)(H,36,37)	TUWMKPVJGGWGNL-UHFFFAOYSA-N					doublet; compound annotation
0391_007885	223568-55-6	C18H23FN2O6	3.087	9907987	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)CF)NC(=O)OCC1=CC=CC=C1	CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(CC(=O)O)C(=O)CF	InChI=1S/C18H23FN2O6/c1-11(2)16(17(25)20-13(8-15(23)24)14(22)9-19)21-18(26)27-10-12-6-4-3-5-7-12/h3-7,11,13,16H,8-10H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t13-,16-/m0/s1	LYBWGROBJJXCJJ-BBRMVZONSA-N					doublet; removed another duplicate entry; compound annotation
0391_007887	Y06137	C27H32N4O2	3.21	137333445	C[C@H]1COCCN1C2=CC3=C(C=C2)N=C(N3CC4CCCCC4)C5=CC6=C(C=C5)ON=C6C	Cc1noc2c1cc(-c1nc3c(cc(N4CCOCC4C)cc3)n1CC1CCCCC1)cc2	InChI=1S/C27H32N4O2/c1-18-17-32-13-12-30(18)22-9-10-24-25(15-22)31(16-20-6-4-3-5-7-20)27(28-24)21-8-11-26-23(14-21)19(2)29-33-26/h8-11,14-15,18,20H,3-7,12-13,16-17H2,1-2H3/t18-/m0/s1	JYCNBHVRGVCHIQ-SFHVURJKSA-N					doublet; compound annotation
0391_007888	Y06137	C27H32N4O2	3.5207	137333445	C[C@H]1COCCN1C2=CC3=C(C=C2)N=C(N3CC4CCCCC4)C5=CC6=C(C=C5)ON=C6C	Cc1noc2c1cc(-c1nc3c(cc(N4CCOCC4C)cc3)n1CC1CCCCC1)cc2	InChI=1S/C27H32N4O2/c1-18-17-32-13-12-30(18)22-9-10-24-25(15-22)31(16-20-6-4-3-5-7-20)27(28-24)21-8-11-26-23(14-21)19(2)29-33-26/h8-11,14-15,18,20H,3-7,12-13,16-17H2,1-2H3/t18-/m0/s1	JYCNBHVRGVCHIQ-SFHVURJKSA-N					doublet; compound annotation
0391_007889	Y06137	C27H32N4O2	3.7138	137333445	C[C@H]1COCCN1C2=CC3=C(C=C2)N=C(N3CC4CCCCC4)C5=CC6=C(C=C5)ON=C6C	Cc1noc2c1cc(-c1nc3c(cc(N4CCOCC4C)cc3)n1CC1CCCCC1)cc2	InChI=1S/C27H32N4O2/c1-18-17-32-13-12-30(18)22-9-10-24-25(15-22)31(16-20-6-4-3-5-7-20)27(28-24)21-8-11-26-23(14-21)19(2)29-33-26/h8-11,14-15,18,20H,3-7,12-13,16-17H2,1-2H3/t18-/m0/s1	JYCNBHVRGVCHIQ-SFHVURJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_007891	(S)-GNE-140	C25H23ClN2O3S2	3.821	131801110	C1COCCN1C2=CC=C(C=C2)[C@@]3(CC(=C(C(=O)N3)SC4=CC=CC=C4Cl)O)C5=CSC=C5	O=C1NC(c2ccc(N3CCOCC3)cc2)(c2cscc2)CC(O)=C1Sc1ccccc1Cl	InChI=1S/C25H23ClN2O3S2/c26-20-3-1-2-4-22(20)33-23-21(29)15-25(27-24(23)30,18-9-14-32-16-18)17-5-7-19(8-6-17)28-10-12-31-13-11-28/h1-9,14,16,29H,10-13,15H2,(H,27,30)/t25-/m0/s1	SUFXXEIVBZJOAP-VWLOTQADSA-N					removed another duplicate entry; compound annotation
0391_007893	SCD inhibitor 1	C18H16Cl2N4O2	4.0057	42603008		Cc1c(C(=O)Nc2ccc(CO)cc2)nnn1Cc1cc(Cl)c(Cl)cc1	InChI=1S/C18H16Cl2N4O2/c1-11-17(18(26)21-14-5-2-12(10-25)3-6-14)22-23-24(11)9-13-4-7-15(19)16(20)8-13/h2-8,25H,9-10H2,1H3,(H,21,26)	QQRGSFYTPBYCFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007895	CHIR-090	C24H27N3O5	1.5806	11546620	C[C@H]([C@@H](C(=O)NO)NC(=O)C1=CC=C(C=C1)C#CC2=CC=C(C=C2)CN3CCOCC3)O	CC(O)C(NC(=O)c1ccc(C#Cc2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO	InChI=1S/C24H27N3O5/c1-17(28)22(24(30)26-31)25-23(29)21-10-8-19(9-11-21)3-2-18-4-6-20(7-5-18)16-27-12-14-32-15-13-27/h4-11,17,22,28,31H,12-16H2,1H3,(H,25,29)(H,26,30)/t17-,22+/m1/s1	FQYBTYFKOHPWQT-VGSWGCGISA-N					doublet; removed another duplicate entry; compound annotation
0391_007897	Glucose-conjugated MGMT inhibitor	C24H34BrN5O7S	2.0696	10438805	C1=C(SC=C1Br)COC2=NC(=NC3=C2N=CN3CCCCCCCCO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)N	Nc1nc2c(ncn2CCCCCCCCOC2OC(CO)C(O)C(O)C2O)c(OCc2cc(Br)cs2)n1	InChI=1S/C24H34BrN5O7S/c25-14-9-15(38-12-14)11-36-22-17-21(28-24(26)29-22)30(13-27-17)7-5-3-1-2-4-6-8-35-23-20(34)19(33)18(32)16(10-31)37-23/h9,12-13,16,18-20,23,31-34H,1-8,10-11H2,(H2,26,28,29)/t16-,18-,19+,20-,23-/m1/s1	WAAZBVOGWRQLMB-PUIBNRJISA-N					doublet; compound annotation
0391_007898	Glucose-conjugated MGMT inhibitor	C24H34BrN5O7S	2.2236	10438805	C1=C(SC=C1Br)COC2=NC(=NC3=C2N=CN3CCCCCCCCO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)N	Nc1nc2c(ncn2CCCCCCCCOC2OC(CO)C(O)C(O)C2O)c(OCc2cc(Br)cs2)n1	InChI=1S/C24H34BrN5O7S/c25-14-9-15(38-12-14)11-36-22-17-21(28-24(26)29-22)30(13-27-17)7-5-3-1-2-4-6-8-35-23-20(34)19(33)18(32)16(10-31)37-23/h9,12-13,16,18-20,23,31-34H,1-8,10-11H2,(H2,26,28,29)/t16-,18-,19+,20-,23-/m1/s1	WAAZBVOGWRQLMB-PUIBNRJISA-N					doublet; compound annotation
0391_007899	Cysteine Protease inhibitor	C18H14N4O	2.5517	12000657		N#Cc1nccc(Oc2cccc(-c3ccc(CN)cc3)c2)n1	InChI=1S/C18H14N4O/c19-11-13-4-6-14(7-5-13)15-2-1-3-16(10-15)23-18-8-9-21-17(12-20)22-18/h1-10H,11,19H2	RMVQVAZRAZGSTH-UHFFFAOYSA-N					doublet; compound annotation
0391_007900	GSK343	C31H39N7O2	2.6242	71268957		CCCc1c(CNC(=O)c2c3cnn(C(C)C)c3cc(-c3cc(N4CCN(C)CC4)ncc3)c2)c(=O)[nH]c(C)c1	InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)	ULNXAWLQFZMIHX-UHFFFAOYSA-N					doublet; compound annotation
0391_007901	Glucose-conjugated MGMT inhibitor	C24H34BrN5O7S	2.6564	10438805	C1=C(SC=C1Br)COC2=NC(=NC3=C2N=CN3CCCCCCCCO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)N	Nc1nc2c(ncn2CCCCCCCCOC2OC(CO)C(O)C(O)C2O)c(OCc2cc(Br)cs2)n1	InChI=1S/C24H34BrN5O7S/c25-14-9-15(38-12-14)11-36-22-17-21(28-24(26)29-22)30(13-27-17)7-5-3-1-2-4-6-8-35-23-20(34)19(33)18(32)16(10-31)37-23/h9,12-13,16,18-20,23,31-34H,1-8,10-11H2,(H2,26,28,29)/t16-,18-,19+,20-,23-/m1/s1	WAAZBVOGWRQLMB-PUIBNRJISA-N					doublet; compound annotation
0391_007902	GNE-272	C22H25FN6O2	2.7377	121372887	CC(=O)N1CCC2=C(C1)C(=NN2[C@H]3CCOC3)NC4=C(C=C(C=C4)C5=CN(N=C5)C)F	CC(=O)N1CCc2c(C1)c(Nc1c(F)cc(-c3cn(C)nc3)cc1)nn2C1CCOC1	InChI=1S/C22H25FN6O2/c1-14(30)28-7-5-21-18(12-28)22(26-29(21)17-6-8-31-13-17)25-20-4-3-15(9-19(20)23)16-10-24-27(2)11-16/h3-4,9-11,17H,5-8,12-13H2,1-2H3,(H,25,26)/t17-/m0/s1	NKOJNOBJGYTLLZ-KRWDZBQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_007905	GSK343	C31H39N7O2	2.7837	71268957		CCCc1c(CNC(=O)c2c3cnn(C(C)C)c3cc(-c3cc(N4CCN(C)CC4)ncc3)c2)c(=O)[nH]c(C)c1	InChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)	ULNXAWLQFZMIHX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007907	GNE-272	C22H25FN6O2	2.8084	121372887	CC(=O)N1CCC2=C(C1)C(=NN2[C@H]3CCOC3)NC4=C(C=C(C=C4)C5=CN(N=C5)C)F	CC(=O)N1CCc2c(C1)c(Nc1c(F)cc(-c3cn(C)nc3)cc1)nn2C1CCOC1	InChI=1S/C22H25FN6O2/c1-14(30)28-7-5-21-18(12-28)22(26-29(21)17-6-8-31-13-17)25-20-4-3-15(9-19(20)23)16-10-24-27(2)11-16/h3-4,9-11,17H,5-8,12-13H2,1-2H3,(H,25,26)/t17-/m0/s1	NKOJNOBJGYTLLZ-KRWDZBQOSA-N					doublet; compound annotation
0391_007908	Glucose-conjugated MGMT inhibitor	C24H34BrN5O7S	2.925	10438805	C1=C(SC=C1Br)COC2=NC(=NC3=C2N=CN3CCCCCCCCO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)N	Nc1nc2c(ncn2CCCCCCCCOC2OC(CO)C(O)C(O)C2O)c(OCc2cc(Br)cs2)n1	InChI=1S/C24H34BrN5O7S/c25-14-9-15(38-12-14)11-36-22-17-21(28-24(26)29-22)30(13-27-17)7-5-3-1-2-4-6-8-35-23-20(34)19(33)18(32)16(10-31)37-23/h9,12-13,16,18-20,23,31-34H,1-8,10-11H2,(H2,26,28,29)/t16-,18-,19+,20-,23-/m1/s1	WAAZBVOGWRQLMB-PUIBNRJISA-N					doublet; compound annotation
0391_007909	CHIR-090	C24H27N3O5	3.3412	11546620	C[C@H]([C@@H](C(=O)NO)NC(=O)C1=CC=C(C=C1)C#CC2=CC=C(C=C2)CN3CCOCC3)O	CC(O)C(NC(=O)c1ccc(C#Cc2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO	InChI=1S/C24H27N3O5/c1-17(28)22(24(30)26-31)25-23(29)21-10-8-19(9-11-21)3-2-18-4-6-20(7-5-18)16-27-12-14-32-15-13-27/h4-11,17,22,28,31H,12-16H2,1H3,(H,25,29)(H,26,30)/t17-,22+/m1/s1	FQYBTYFKOHPWQT-VGSWGCGISA-N					doublet; compound annotation
0391_007910	Daun02	C41H44N2O20	3.4782	74891316	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)OCC6=CC(=C(C=C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O)[N+](=O)[O-])O	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(C)=O)CC3OC3CC(NC(=O)OCc4cc([N+](=O)[O-])c(OC5OC(CO)C(O)C(O)C5O)cc4)C(O)C(C)O3)c(O)c1C2=O	InChI=1S/C41H44N2O20/c1-15-31(46)20(42-40(54)59-14-17-7-8-22(21(9-17)43(56)57)62-39-38(53)37(52)34(49)25(13-44)63-39)10-26(60-15)61-24-12-41(55,16(2)45)11-19-28(24)36(51)30-29(33(19)48)32(47)18-5-4-6-23(58-3)27(18)35(30)50/h4-9,15,20,24-26,31,34,37-39,44,46,48-49,51-53,55H,10-14H2,1-3H3,(H,42,54)/t15-,20-,24-,25+,26-,31+,34-,37-,38+,39+,41-/m0/s1	BOIXMGNMIWJAEW-LCTCPDETSA-N					compound annotation
0391_007911	ITI214 free base	C29H26FN7O	3.5578	42639643	CN1C(=O)C2=C(N(N=C2N3C1=N[C@H]4[C@@H]3CCC4)CC5=CC=C(C=C5)C6=NC(=CC=C6)F)NC7=CC=CC=C7	CN1C(=O)c2c(Nc3ccccc3)n(Cc3ccc(-c4nc(F)ccc4)cc3)nc2N2C1=NC1CCCC12	InChI=1S/C29H26FN7O/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3/t22-,23+/m1/s1	BBIPVJCGIASXJB-PKTZIBPZSA-N					compound annotation
0391_007912	Z-Ile-Leu-aldehyde	C20H30N2O4	3.7171	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007913	Pyraclonil	C15H15ClN6	3.7205	11563984		C#CCN(C)c1c(C#N)cnn1-c1nn2CCCCc2c1Cl	InChI=1S/C15H15ClN6/c1-3-7-20(2)15-11(9-17)10-18-22(15)14-13(16)12-6-4-5-8-21(12)19-14/h1,10H,4-8H2,2H3	IHHMUBRVTJMLQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007915	Z-Ile-Leu-aldehyde	C20H30N2O4	3.7205	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007916	Z-Ile-Leu-aldehyde	C20H30N2O4	4.063	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007917	Z-Ile-Leu-aldehyde	C20H30N2O4	4.0684	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007918	Z-Ile-Leu-aldehyde	C20H30N2O4	4.204	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007919	Z-Ile-Leu-aldehyde	C20H30N2O4	4.3709	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007920	Z-Ile-Leu-aldehyde	C20H30N2O4	4.3742	44366908	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C=O)NC(=O)OCC1=CC=CC=C1	CCC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C=O)CC(C)C	InChI=1S/C20H30N2O4/c1-5-15(4)18(19(24)21-17(12-23)11-14(2)3)22-20(25)26-13-16-9-7-6-8-10-16/h6-10,12,14-15,17-18H,5,11,13H2,1-4H3,(H,21,24)(H,22,25)/t15-,17-,18-/m0/s1	WJQLUFQGNVGLKR-SZMVWBNQSA-N					doublet; compound annotation
0391_007921	BAY 59-3074	C18H13F6NO4S	5.0809	10479060		N#Cc1c(C(F)(F)F)cccc1Oc1cc(OS(=O)(=O)CCCC(F)(F)F)ccc1	InChI=1S/C18H13F6NO4S/c19-17(20,21)8-3-9-30(26,27)29-13-5-1-4-12(10-13)28-16-7-2-6-15(14(16)11-25)18(22,23)24/h1-2,4-7,10H,3,8-9H2	LWUSZIVDPJPVBW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007923	EPZ015666	C20H25N5O3	1.4054	90241673	C1CN(CC2=CC=CC=C21)C[C@H](CNC(=O)C3=CC(=NC=N3)NC4COC4)O	O=C(NCC(O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1	InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16-17,26H,5-6,8-12H2,(H,21,27)(H,22,23,24)/t17-/m0/s1	ZKXZLIFRWWKZRY-KRWDZBQOSA-N					doublet; compound annotation
0391_007924	EPZ015666	C20H25N5O3	1.4406	90241673	C1CN(CC2=CC=CC=C21)C[C@H](CNC(=O)C3=CC(=NC=N3)NC4COC4)O	O=C(NCC(O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1	InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16-17,26H,5-6,8-12H2,(H,21,27)(H,22,23,24)/t17-/m0/s1	ZKXZLIFRWWKZRY-KRWDZBQOSA-N					doublet; compound annotation
0391_007925	EPZ015666	C20H25N5O3	1.4434	90241673	C1CN(CC2=CC=CC=C21)C[C@H](CNC(=O)C3=CC(=NC=N3)NC4COC4)O	O=C(NCC(O)CN1CCc2ccccc2C1)c1cc(NC2COC2)ncn1	InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16-17,26H,5-6,8-12H2,(H,21,27)(H,22,23,24)/t17-/m0/s1	ZKXZLIFRWWKZRY-KRWDZBQOSA-N					doublet; compound annotation
0391_007926	JNJ-64619178	C22H23BrN6O2	1.6999	126637809	C1[C@@H]([C@H]([C@H]([C@@H]1N2C=CC3=C(N=CN=C32)N)O)O)CCC4=CC5=NC(=C(C=C5C=C4)Br)N	Nc1c(Br)cc2ccc(CCC3CC(n4ccc5c(N)ncnc54)C(O)C3O)cc2n1	InChI=1S/C22H23BrN6O2/c23-15-8-12-3-1-11(7-16(12)28-21(15)25)2-4-13-9-17(19(31)18(13)30)29-6-5-14-20(24)26-10-27-22(14)29/h1,3,5-8,10,13,17-19,30-31H,2,4,9H2,(H2,25,28)(H2,24,26,27)/t13-,17+,18+,19-/m0/s1	DBSMLQTUDJVICQ-CJODITQLSA-N					compound annotation
0391_007927	BAY1238097	C25H33N5O3	1.999	118237331	C[C@H]1CC2=CC(=C(C=C2C(=NN1C(=O)NC)C3=CC=C(C=C3)N4CCN(CC4)C)OC)OC	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)/t17-/m0/s1	CJIPEACKIJJYED-KRWDZBQOSA-N					doublet; compound annotation
0391_007928	BAY1238097	C25H33N5O3	2.0023	118237331	C[C@H]1CC2=CC(=C(C=C2C(=NN1C(=O)NC)C3=CC=C(C=C3)N4CCN(CC4)C)OC)OC	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)/t17-/m0/s1	CJIPEACKIJJYED-KRWDZBQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_007930	BAY1238097	C25H33N5O3	2.1305	118237331	C[C@H]1CC2=CC(=C(C=C2C(=NN1C(=O)NC)C3=CC=C(C=C3)N4CCN(CC4)C)OC)OC	CNC(=O)N1N=C(c2ccc(N3CCN(C)CC3)cc2)c2cc(OC)c(OC)cc2CC1C	InChI=1S/C25H33N5O3/c1-17-14-19-15-22(32-4)23(33-5)16-21(19)24(27-30(17)25(31)26-2)18-6-8-20(9-7-18)29-12-10-28(3)11-13-29/h6-9,15-17H,10-14H2,1-5H3,(H,26,31)/t17-/m0/s1	CJIPEACKIJJYED-KRWDZBQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_007932	MI-503	C28H27F3N8S	2.9467	91667931		Cc1c(CN2CCC(Nc3c4cc(CC(F)(F)F)sc4ncn3)CC2)ccc2c1cc(C#N)n2Cc1c[nH]nc1	InChI=1S/C28H27F3N8S/c1-17-19(2-3-25-23(17)8-21(11-32)39(25)14-18-12-35-36-13-18)15-38-6-4-20(5-7-38)37-26-24-9-22(10-28(29,30)31)40-27(24)34-16-33-26/h2-3,8-9,12-13,16,20H,4-7,10,14-15H2,1H3,(H,35,36)(H,33,34,37)	DETOMBLLEOZTMZ-UHFFFAOYSA-N					compound annotation
0391_007933	PF-915275	C18H14N4O2S	2.9722	23725123		N#Cc1ccc(-c2ccc(S(=O)(=O)Nc3cccc(N)n3)cc2)cc1	InChI=1S/C18H14N4O2S/c19-12-13-4-6-14(7-5-13)15-8-10-16(11-9-15)25(23,24)22-18-3-1-2-17(20)21-18/h1-11H,(H3,20,21,22)	ZESFDAKNYJQYKO-UHFFFAOYSA-N					compound annotation
0391_007934	PROTAC BET Degrader-1	C44H45N11O9	3.5532	134691733		CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C44H45N11O9/c1-5-54-32(19-27(52-54)23-11-12-23)48-39-37-25-18-31(62-4)26(35-21(2)53-64-22(35)3)17-28(25)47-38(37)50-40(51-39)42(59)46-16-7-6-15-45-34(57)20-63-30-10-8-9-24-36(30)44(61)55(43(24)60)29-13-14-33(56)49-41(29)58/h8-10,17-19,23,29H,5-7,11-16,20H2,1-4H3,(H,45,57)(H,46,59)(H,49,56,58)(H2,47,48,50,51)	TXLUZGFDBDQACL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007936	1889279-16-6	C25H24F4N4O5	4.1968	118958122	C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O	CNC(=O)Nc1cc2c(cc1)C1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)C(C)C(F)(F)F)C1=O	InChI=1S/C25H24F4N4O5/c1-14(25(27,28)29)32(12-15-3-5-17(26)6-4-15)20(34)13-33-21(35)24(38-23(33)37)10-9-16-11-18(7-8-19(16)24)31-22(36)30-2/h3-8,11,14H,9-10,12-13H2,1-2H3,(H2,30,31,36)/t14-,24+/m0/s1	VRVJKILQRBSEAG-LFPIHBKWSA-N					removed another duplicate entry; compound annotation
0391_007938	142326-59-8	C21H14ClNO3	4.2055	54682505		O=c1c(-c2cc(Oc3ccccc3)ccc2)c(O)[nH]c2c1ccc(Cl)c2	InChI=1S/C21H14ClNO3/c22-14-9-10-17-18(12-14)23-21(25)19(20(17)24)13-5-4-8-16(11-13)26-15-6-2-1-3-7-15/h1-12H,(H2,23,24,25)	FLVRDMUHUXVRET-UHFFFAOYSA-N					compound annotation
0391_007939	DC_517	C33H35N3O2	4.4029	3713657		CC(C)NCC(O)COC(Cn1c2ccccc2c2ccccc21)Cn1c2ccccc2c2ccccc21	InChI=1S/C33H35N3O2/c1-23(2)34-19-24(37)22-38-25(20-35-30-15-7-3-11-26(30)27-12-4-8-16-31(27)35)21-36-32-17-9-5-13-28(32)29-14-6-10-18-33(29)36/h3-18,23-25,34,37H,19-22H2,1-2H3	BLTONWSCODZCNA-UHFFFAOYSA-N					compound annotation
0391_007940	naringenin	C15H12O5	2.8744	439246	C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O	O=C1CC(c2ccc(O)cc2)Oc2cc(O)cc(O)c12	InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1	FTVWIRXFELQLPI-ZDUSSCGKSA-N					compound annotation
0391_007941	tetramethylrhodamine ethyl ester(1+)	C26H27N2O3+	3.6436	2762683		CCOC(=O)c1ccccc1-c1c2ccc(=[N+](C)C)cc-2oc2c1ccc(N(C)C)c2	InChI=1S/C26H27N2O3/c1-6-30-26(29)20-10-8-7-9-19(20)25-21-13-11-17(27(2)3)15-23(21)31-24-16-18(28(4)5)12-14-22(24)25/h7-16H,6H2,1-5H3/q+1	PQMJQYONVLIFOV-UHFFFAOYSA-N					compound annotation
0391_007942	diflapolin	C22H17Cl2N3O2S	5.2511	4560409		Cc1c(NC(=O)Nc2cc(Cl)c(Cl)cc2)ccc(OCc2nc3ccccc3s2)c1	InChI=1S/C22H17Cl2N3O2S/c1-13-10-15(29-12-21-26-19-4-2-3-5-20(19)30-21)7-9-18(13)27-22(28)25-14-6-8-16(23)17(24)11-14/h2-11H,12H2,1H3,(H2,25,27,28)	FGXLEECGXSDIMM-UHFFFAOYSA-N					compound annotation
0391_007943	1438071-12-5	C20H18Cl2N2O2S	6.6027	71682479		Cc1c(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)ccc(Cl)c1	InChI=1S/C20H18Cl2N2O2S/c1-14-10-18(22)7-4-16(14)12-23(11-15-2-5-17(21)6-3-15)13-19-8-9-20(27-19)24(25)26/h2-10H,11-13H2,1H3	NXCSEAQOKPSNJV-UHFFFAOYSA-N					compound annotation
0391_007944	N-METHYLBENZYLAMINE	C8H11N	0.5832	7669		CNCc1ccccc1	InChI=1S/C8H11N/c1-9-7-8-5-3-2-4-6-8/h2-6,9H,7H2,1H3	RIWRFSMVIUAEBX-UHFFFAOYSA-N					compound annotation
0391_007945	Benzylideneacetone	C10H10O	3.1146	637759	CC(=O)/C=C/C1=CC=CC=C1	CC(=O)C=Cc1ccccc1	InChI=1S/C10H10O/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8H,1H3/b8-7+	BWHOZHOGCMHOBV-BQYQJAHWSA-N					doublet; compound annotation
0391_007946	53518-15-3	C10H6F3NO2	3.2605	100641		Nc1cc2c(cc1)c(C(F)(F)F)cc(=O)o2	InChI=1S/C10H6F3NO2/c11-10(12,13)7-4-9(15)16-8-3-5(14)1-2-6(7)8/h1-4H,14H2	JBNOVHJXQSHGRL-UHFFFAOYSA-N					compound annotation
0391_007947	amprenavir	C25H35N3O6S	3.6929	65016	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N	CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1	InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1	YMARZQAQMVYCKC-OEMFJLHTSA-N					removed another duplicate entry; compound annotation
0391_007949	24393-56-4	C12H14O3	4.1624	5281783	CCOC(=O)/C=C/C1=CC=C(C=C1)OC	CCOC(=O)C=Cc1ccc(OC)cc1	InChI=1S/C12H14O3/c1-3-15-12(13)9-6-10-4-7-11(14-2)8-5-10/h4-9H,3H2,1-2H3/b9-6+	DHNGCHLFKUPGPX-RMKNXTFCSA-N					compound annotation
0391_007950	Levosulpiride	C15H23N3O4S	0.8912	688272	CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC	CCN1CCCC1CNC(=O)c1c(OC)ccc(S(N)(=O)=O)c1	InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1	BGRJTUBHPOOWDU-NSHDSACASA-N					compound annotation
0391_007951	Syk-IN-4	C21H25N9O	2.159	154573768		CNC(=O)c1nn(C)c2c1cc(Nc1nccc(-n3cc(CN(C)C)c(C)n3)n1)cc2	InChI=1S/C21H25N9O/c1-13-14(11-28(3)4)12-30(26-13)18-8-9-23-21(25-18)24-15-6-7-17-16(10-15)19(20(31)22-2)27-29(17)5/h6-10,12H,11H2,1-5H3,(H,22,31)(H,23,24,25)	IXNQUCOVJRJRGJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007953	Phenserine	C20H23N3O2	2.658	192706	C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C	CN1CCC2(C)c3c(ccc(OC(=O)Nc4ccccc4)c3)N(C)C12	InChI=1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1	PBHFNBQPZCRWQP-QUCCMNQESA-N					removed another duplicate entry; compound annotation
0391_007955	CYPROHEPTADINE	C21H21N	3.0746	2913		CN1CCC(=C2c3ccccc3C=Cc3ccccc23)CC1	InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3	JJCFRYNCJDLXIK-UHFFFAOYSA-N					doublet; compound annotation
0391_007956	(S,R,S)-AHPC-Boc	C27H38N4O5S	3.6094	117727555	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)OC(C)(C)C)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)cc2)scn1	InChI=1S/C27H38N4O5S/c1-16-21(37-15-29-16)18-10-8-17(9-11-18)13-28-23(33)20-12-19(32)14-31(20)24(34)22(26(2,3)4)30-25(35)36-27(5,6)7/h8-11,15,19-20,22,32H,12-14H2,1-7H3,(H,28,33)(H,30,35)/t19-,20+,22-/m1/s1	PKNFPFFOAWITLF-RZUBCFFCSA-N					removed another duplicate entry; compound annotation
0391_007958	SR-05000001456	C21H47NO4P+	5.0771	3600		CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C	InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3/p+1	PQLXHQMOHUQAKB-UHFFFAOYSA-O					compound annotation
0391_007959	epinastine	C16H15N3	2.4059	3241		NC1=NCC2c3ccccc3Cc3ccccc3N12	InChI=1S/C16H15N3/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16/h1-8,15H,9-10H2,(H2,17,18)	WHWZLSFABNNENI-UHFFFAOYSA-N					doublet; compound annotation
0391_007960	Dasatinib	C22H26ClN7O2S	2.5621	3062316		Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	ZBNZXTGUTAYRHI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007962	Tylosin	C46H77NO17	2.9854	5280440	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1	WBPYTXDJUQJLPQ-VMXQISHHSA-N					doublet; compound annotation
0391_007963	Tylosin	C46H77NO17	3.072	5280440	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(O)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1	WBPYTXDJUQJLPQ-VMXQISHHSA-N					doublet; compound annotation
0391_007964	Encorafenib	C22H27ClFN7O4S	3.1177	50922675	C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC	COC(=O)NC(C)CNc1nccc(-c2cn(C(C)C)nc2-c2c(F)c(NS(C)(=O)=O)cc(Cl)c2)n1	InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1	CMJCXYNUCSMDBY-ZDUSSCGKSA-N					doublet; compound annotation
0391_007965	Encorafenib	C22H27ClFN7O4S	3.206	50922675	C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC	COC(=O)NC(C)CNc1nccc(-c2cn(C(C)C)nc2-c2c(F)c(NS(C)(=O)=O)cc(Cl)c2)n1	InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1	CMJCXYNUCSMDBY-ZDUSSCGKSA-N					doublet; compound annotation
0391_007966	Encorafenib	C22H27ClFN7O4S	3.209	50922675	C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC	COC(=O)NC(C)CNc1nccc(-c2cn(C(C)C)nc2-c2c(F)c(NS(C)(=O)=O)cc(Cl)c2)n1	InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1	CMJCXYNUCSMDBY-ZDUSSCGKSA-N					doublet; compound annotation
0391_007967	PROTAC BET Degrader-10	C39H39ClN8O6S	3.7408	124190914	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NCCCCCC(=O)NCC4=C5C(=CC=C4)C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)NCCCCCC(=O)NCc1c3C(=O)N(C4CCC(=O)NC4=O)C(=O)c3ccc1)N=C2c1ccc(Cl)cc1	InChI=1S/C39H39ClN8O6S/c1-20-21(2)55-39-32(20)34(23-11-13-25(40)14-12-23)43-27(35-46-45-22(3)47(35)39)18-31(51)41-17-6-4-5-10-29(49)42-19-24-8-7-9-26-33(24)38(54)48(37(26)53)28-15-16-30(50)44-36(28)52/h7-9,11-14,27-28H,4-6,10,15-19H2,1-3H3,(H,41,51)(H,42,49)(H,44,50,52)/t27-,28?/m0/s1	KVKRYCAWRGWYNN-MBMZGMDYSA-N					removed another duplicate entry; compound annotation
0391_007969	Nebentan	C24H21N5O5S	3.9998	9957262	COC1=CC=CC=C1OC2=C(N=C(N=C2OC)C3=NC=CC=N3)NS(=O)(=O)/C=C/C4=CC=CC=C4	COc1ccccc1Oc1c(OC)nc(-c2ncccn2)nc1NS(=O)(=O)C=Cc1ccccc1	InChI=1S/C24H21N5O5S/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22/h3-16H,1-2H3,(H,27,28,29)/b16-13+	LONWRQOYFPYMQD-DTQAZKPQSA-N					doublet; removed another duplicate entry; compound annotation
0391_007971	Praliciguat	C21H14F8N6O2	4.8156	86269973		OC(CNc1nc(-c2nn(Cc3ccccc3F)c(-c3nocc3)c2)ncc1F)(C(F)(F)F)C(F)(F)F	InChI=1S/C21H14F8N6O2/c22-12-4-2-1-3-11(12)9-35-16(14-5-6-37-34-14)7-15(33-35)18-30-8-13(23)17(32-18)31-10-19(36,20(24,25)26)21(27,28)29/h1-8,36H,9-10H2,(H,30,31,32)	CYSJNTQNMDWAJV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007973	hexestrol	C18H22O2	4.9769	192197	CC[C@H](C1=CC=C(C=C1)O)[C@@H](CC)C2=CC=C(C=C2)O	CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1	InChI=1S/C18H22O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,17-20H,3-4H2,1-2H3/t17-,18+	PBBGSZCBWVPOOL-HDICACEKSA-N					compound annotation
0391_007974	DZ2002	C10H13N5O3	0.4776	11658872		COC(=O)C(O)CCn1cnc2c(N)ncnc21	InChI=1S/C10H13N5O3/c1-18-10(17)6(16)2-3-15-5-14-7-8(11)12-4-13-9(7)15/h4-6,16H,2-3H2,1H3,(H2,11,12,13)	HNKGMGPCSSJYOT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007976	N-Desmethyl Imatinib	C28H29N7O	1.911	9869737		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1	InChI=1S/C28H29N7O/c1-20-4-9-24(17-26(20)34-28-31-12-10-25(33-28)23-3-2-11-30-18-23)32-27(36)22-7-5-21(6-8-22)19-35-15-13-29-14-16-35/h2-12,17-18,29H,13-16,19H2,1H3,(H,32,36)(H,31,33,34)	BQQYXPHRXIZMDM-UHFFFAOYSA-N					doublet; compound annotation
0391_007977	N-Desmethyl Imatinib	C28H29N7O	1.9138	9869737		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1	InChI=1S/C28H29N7O/c1-20-4-9-24(17-26(20)34-28-31-12-10-25(33-28)23-3-2-11-30-18-23)32-27(36)22-7-5-21(6-8-22)19-35-15-13-29-14-16-35/h2-12,17-18,29H,13-16,19H2,1H3,(H,32,36)(H,31,33,34)	BQQYXPHRXIZMDM-UHFFFAOYSA-N					doublet; compound annotation
0391_007978	GSK4028	C17H21BrN4O	1.9312	132941768	CN1C[C@@H](C[C@@H](C1)NC2=C(C(=O)N(N=C2)C)Br)C3=CC=CC=C3	CN1CC(Nc2c(Br)c(=O)n(C)nc2)CC(c2ccccc2)C1	InChI=1S/C17H21BrN4O/c1-21-10-13(12-6-4-3-5-7-12)8-14(11-21)20-15-9-19-22(2)17(23)16(15)18/h3-7,9,13-14,20H,8,10-11H2,1-2H3/t13-,14+/m1/s1	VZAFGXCWAWRULT-KGLIPLIRSA-N					doublet; removed another duplicate entry; compound annotation
0391_007980	GSK4028	C17H21BrN4O	2.4299	132941768	CN1C[C@@H](C[C@@H](C1)NC2=C(C(=O)N(N=C2)C)Br)C3=CC=CC=C3	CN1CC(Nc2c(Br)c(=O)n(C)nc2)CC(c2ccccc2)C1	InChI=1S/C17H21BrN4O/c1-21-10-13(12-6-4-3-5-7-12)8-14(11-21)20-15-9-19-22(2)17(23)16(15)18/h3-7,9,13-14,20H,8,10-11H2,1-2H3/t13-,14+/m1/s1	VZAFGXCWAWRULT-KGLIPLIRSA-N					doublet; compound annotation
0391_007981	MAC-13243 (free base)	C20H24ClN3O2S	2.8049	2806782		COc1c(OC)cc(CCN2CN=C(SCc3ccc(Cl)cc3)NC2)cc1	InChI=1S/C20H24ClN3O2S/c1-25-18-8-5-15(11-19(18)26-2)9-10-24-13-22-20(23-14-24)27-12-16-3-6-17(21)7-4-16/h3-8,11H,9-10,12-14H2,1-2H3,(H,22,23)	JRZNGLZDQHVIOO-UHFFFAOYSA-N					compound annotation
0391_007982	MI-538	C27H25F3N8OS	2.8187	117636625		N#Cc1cc2cc(CN3CCC(Nc4c5cc(CC(F)(F)F)sc5ncn4)CC3)c(O)cc2n1Cc1c[nH]nc1	InChI=1S/C27H25F3N8OS/c28-27(29,30)9-21-7-22-25(32-15-33-26(22)40-21)36-19-1-3-37(4-2-19)14-18-5-17-6-20(10-31)38(23(17)8-24(18)39)13-16-11-34-35-12-16/h5-8,11-12,15,19,39H,1-4,9,13-14H2,(H,34,35)(H,32,33,36)	QXLJOBRSTCFLMC-UHFFFAOYSA-N					compound annotation
0391_007983	MI-463	C24H23F3N6S	2.9332	90455046		Cc1c(CN2CCC(Nc3c4cc(CC(F)(F)F)sc4ncn3)CC2)ccc2c1cc(C#N)[nH]2	InChI=1S/C24H23F3N6S/c1-14-15(2-3-21-19(14)8-17(11-28)31-21)12-33-6-4-16(5-7-33)32-22-20-9-18(10-24(25,26)27)34-23(20)30-13-29-22/h2-3,8-9,13,16,31H,4-7,10,12H2,1H3,(H,29,30,32)	DZACSLYTXLZAAF-UHFFFAOYSA-N					compound annotation
0391_007984	JQEZ5	C30H38N8O2	2.9988	121322599		CCCc1c(CNC(=O)c2cc(-c3cnc(N4CCN(C)CC4)cc3)nc3c2cnn3C(C)C)c(=O)[nH]c(C)c1	InChI=1S/C30H38N8O2/c1-6-7-21-14-20(4)34-30(40)24(21)17-32-29(39)23-15-26(35-28-25(23)18-33-38(28)19(2)3)22-8-9-27(31-16-22)37-12-10-36(5)11-13-37/h8-9,14-16,18-19H,6-7,10-13,17H2,1-5H3,(H,32,39)(H,34,40)	LQTWDAYNGMMHLV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007986	ARV-825	C46H47ClN8O9S	4.5628	92044400	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)OCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C8=CC=C(C=C8)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)Nc1ccc(OCCOCCOCCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)N=C2c1ccc(Cl)cc1	InChI=1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1	RWLOGRLTDKDANT-TYIYNAFKSA-N					removed another duplicate entry; compound annotation
0391_007988	RI-2	C21H18Cl2N2O4	5.2555	71547138		COc1ccc(C2=C(N3CCOCC3)C(=O)N(c3cc(Cl)c(Cl)cc3)C2=O)cc1	InChI=1S/C21H18Cl2N2O4/c1-28-15-5-2-13(3-6-15)18-19(24-8-10-29-11-9-24)21(27)25(20(18)26)14-4-7-16(22)17(23)12-14/h2-7,12H,8-11H2,1H3	JMPJNNOSVCHYOU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_007990	KDM4D-IN-1	C11H7N5O	1.5653	137174251		Cc1nn2c(c1C#N)[nH]c(=O)c1c2nccc1	InChI=1S/C11H7N5O/c1-6-8(5-12)10-14-11(17)7-3-2-4-13-9(7)16(10)15-6/h2-4H,1H3,(H,14,17)	FIRSAIIBSBCBTF-UHFFFAOYSA-N					compound annotation
0391_007991	GSK9311	C24H31N5O3	2.2429	121232406	CCN(C1=C(C=C2C(=C1)N(C(=O)N2C)C)N3CCNC[C@H]3C)C(=O)C4=CC=CC=C4OC	CCN(C(=O)c1ccccc1OC)c1cc2c(cc1N1CCNCC1C)n(C)c(=O)n2C	InChI=1S/C24H31N5O3/c1-6-28(23(30)17-9-7-8-10-22(17)32-5)20-13-18-19(27(4)24(31)26(18)3)14-21(20)29-12-11-25-15-16(29)2/h7-10,13-14,16,25H,6,11-12,15H2,1-5H3/t16-/m1/s1	WFXIHQFRQPGCCR-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_007994	I-CBP112	C27H36N2O5	2.5872	90488984	CCC(=O)N1CCOC2=C(C1)C=C(C=C2OC[C@H]3CCCN(C3)C)C4=CC(=C(C=C4)OC)OC	CCC(=O)N1CCOc2c(cc(-c3cc(OC)c(OC)cc3)cc2OCC2CCCN(C)C2)C1	InChI=1S/C27H36N2O5/c1-5-26(30)29-11-12-33-27-22(17-29)13-21(20-8-9-23(31-3)24(14-20)32-4)15-25(27)34-18-19-7-6-10-28(2)16-19/h8-9,13-15,19H,5-7,10-12,16-18H2,1-4H3/t19-/m0/s1	YKNAKDFZAWQEEO-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_007996	CHMFL-BMX-078	C33H35N7O6	3.2359	122633900		C=CC(=O)Nc1c(C)ccc(Nc2ncc(C(=O)Nc3c(C)ccc(NC(=O)c4cc(OC)c(OC)c(OC)c4)c3)c(NC)n2)c1	InChI=1S/C33H35N7O6/c1-8-28(41)38-24-16-22(12-10-18(24)2)37-33-35-17-23(30(34-4)40-33)32(43)39-25-15-21(11-9-19(25)3)36-31(42)20-13-26(44-5)29(46-7)27(14-20)45-6/h8-17H,1H2,2-7H3,(H,36,42)(H,38,41)(H,39,43)(H2,34,35,37,40)	XURALSVDCFXBAX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_007998	BMS-983970	C26H26F4N4O3	3.663	73388374	C1CC1C[C@@H]([C@@H](CCC(F)(F)F)C(=O)N[C@@H]2C(=O)NC3=C(C=CC=C3F)C(=N2)C4=CC=CC=C4)C(=O)N	NC(=O)C(CC1CC1)C(CCC(F)(F)F)C(=O)NC1N=C(c2ccccc2)c2c(NC1=O)c(F)ccc2	InChI=1S/C26H26F4N4O3/c27-19-8-4-7-17-20(15-5-2-1-3-6-15)32-23(25(37)33-21(17)19)34-24(36)16(11-12-26(28,29)30)18(22(31)35)13-14-9-10-14/h1-8,14,16,18,23H,9-13H2,(H2,31,35)(H,33,37)(H,34,36)/t16-,18+,23-/m1/s1	RANYIWAZSQWERN-WLENULPWSA-N					doublet; compound annotation
0391_007999	BMS-983970	C26H26F4N4O3	3.6657	73388374	C1CC1C[C@@H]([C@@H](CCC(F)(F)F)C(=O)N[C@@H]2C(=O)NC3=C(C=CC=C3F)C(=N2)C4=CC=CC=C4)C(=O)N	NC(=O)C(CC1CC1)C(CCC(F)(F)F)C(=O)NC1N=C(c2ccccc2)c2c(NC1=O)c(F)ccc2	InChI=1S/C26H26F4N4O3/c27-19-8-4-7-17-20(15-5-2-1-3-6-15)32-23(25(37)33-21(17)19)34-24(36)16(11-12-26(28,29)30)18(22(31)35)13-14-9-10-14/h1-8,14,16,18,23H,9-13H2,(H2,31,35)(H,33,37)(H,34,36)/t16-,18+,23-/m1/s1	RANYIWAZSQWERN-WLENULPWSA-N					doublet; compound annotation
0391_008000	CHMFL-BMX-078	C33H35N7O6	3.8907	122633900		C=CC(=O)Nc1c(C)ccc(Nc2ncc(C(=O)Nc3c(C)ccc(NC(=O)c4cc(OC)c(OC)c(OC)c4)c3)c(NC)n2)c1	InChI=1S/C33H35N7O6/c1-8-28(41)38-24-16-22(12-10-18(24)2)37-33-35-17-23(30(34-4)40-33)32(43)39-25-15-21(11-9-19(25)3)36-31(42)20-13-26(44-5)29(46-7)27(14-20)45-6/h8-17H,1H2,2-7H3,(H,36,42)(H,38,41)(H,39,43)(H2,34,35,37,40)	XURALSVDCFXBAX-UHFFFAOYSA-N					doublet; compound annotation
0391_008001	AI-10-49	C30H22F6N6O5	4.1624	49806644		FC(F)(F)Oc1cc2c(cc1)nc(-c1ncc(OCCOCCOc3cnc(-c4nc5c(cc(OC(F)(F)F)cc5)[nH]4)cc3)cc1)[nH]2	InChI=1S/C30H22F6N6O5/c31-29(32,33)46-17-1-5-21-25(13-17)41-27(39-21)23-7-3-19(15-37-23)44-11-9-43-10-12-45-20-4-8-24(38-16-20)28-40-22-6-2-18(14-26(22)42-28)47-30(34,35)36/h1-8,13-16H,9-12H2,(H,39,41)(H,40,42)	WJBSSBFGPKTMQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008002	AI-10-49	C30H22F6N6O5	4.1926	49806644		FC(F)(F)Oc1cc2c(cc1)nc(-c1ncc(OCCOCCOc3cnc(-c4nc5c(cc(OC(F)(F)F)cc5)[nH]4)cc3)cc1)[nH]2	InChI=1S/C30H22F6N6O5/c31-29(32,33)46-17-1-5-21-25(13-17)41-27(39-21)23-7-3-19(15-37-23)44-11-9-43-10-12-45-20-4-8-24(38-16-20)28-40-22-6-2-18(14-26(22)42-28)47-30(34,35)36/h1-8,13-16H,9-12H2,(H,39,41)(H,40,42)	WJBSSBFGPKTMQQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008004	JI051	C22H24N2O3	4.2385	138319697	CCOC1=CC=CC=C1CCNC(=O)/C=C/C2=CNC3=C2C=CC=C3OC	CCOc1ccccc1CCNC(=O)C=Cc1c[nH]c2c1cccc2OC	InChI=1S/C22H24N2O3/c1-3-27-19-9-5-4-7-16(19)13-14-23-21(25)12-11-17-15-24-22-18(17)8-6-10-20(22)26-2/h4-12,15,24H,3,13-14H2,1-2H3,(H,23,25)/b12-11+	CQZPBIZGVIRKOC-VAWYXSNFSA-N					doublet; removed another duplicate entry; compound annotation
0391_008006	GSK2801	C20H21NO4S	4.376	73010930		CCCOc1cc2c(-c3ccccc3S(C)(=O)=O)cc(C(C)=O)n2cc1	InChI=1S/C20H21NO4S/c1-4-11-25-15-9-10-21-18(14(2)22)13-17(19(21)12-15)16-7-5-6-8-20(16)26(3,23)24/h5-10,12-13H,4,11H2,1-3H3	KHWCPNJRJCNVRI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008009	JI051	C22H24N2O3	4.5104	138319697	CCOC1=CC=CC=C1CCNC(=O)/C=C/C2=CNC3=C2C=CC=C3OC	CCOc1ccccc1CCNC(=O)C=Cc1c[nH]c2c1cccc2OC	InChI=1S/C22H24N2O3/c1-3-27-19-9-5-4-7-16(19)13-14-23-21(25)12-11-17-15-24-22-18(17)8-6-10-20(22)26-2/h4-12,15,24H,3,13-14H2,1-2H3,(H,23,25)/b12-11+	CQZPBIZGVIRKOC-VAWYXSNFSA-N					doublet; removed another duplicate entry; compound annotation
0391_008011	inS3-54A18	C23H16ClNO2	5.1428	1920398	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(C=C3)Cl)/C(=O)N2C4=CC=C(C=C4)O	O=C1C(=Cc2ccc(Cl)cc2)C=C(c2ccccc2)N1c1ccc(O)cc1	InChI=1S/C23H16ClNO2/c24-19-8-6-16(7-9-19)14-18-15-22(17-4-2-1-3-5-17)25(23(18)27)20-10-12-21(26)13-11-20/h1-15,26H/b18-14-	IMHWQIPPIXOVRK-JXAWBTAJSA-N					doublet; removed another duplicate entry; compound annotation
0391_008014	inS3-54A18	C23H16ClNO2	5.2785	1920398	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(C=C3)Cl)/C(=O)N2C4=CC=C(C=C4)O	O=C1C(=Cc2ccc(Cl)cc2)C=C(c2ccccc2)N1c1ccc(O)cc1	InChI=1S/C23H16ClNO2/c24-19-8-6-16(7-9-19)14-18-15-22(17-4-2-1-3-5-17)25(23(18)27)20-10-12-21(26)13-11-20/h1-15,26H/b18-14-	IMHWQIPPIXOVRK-JXAWBTAJSA-N					doublet; compound annotation
0391_008015	AI-10-49	C30H22F6N6O5	5.3815	49806644		FC(F)(F)Oc1cc2c(cc1)nc(-c1ncc(OCCOCCOc3cnc(-c4nc5c(cc(OC(F)(F)F)cc5)[nH]4)cc3)cc1)[nH]2	InChI=1S/C30H22F6N6O5/c31-29(32,33)46-17-1-5-21-25(13-17)41-27(39-21)23-7-3-19(15-37-23)44-11-9-43-10-12-45-20-4-8-24(38-16-20)28-40-22-6-2-18(14-26(22)42-28)47-30(34,35)36/h1-8,13-16H,9-12H2,(H,39,41)(H,40,42)	WJBSSBFGPKTMQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008016	Neuropathiazol	C19H18N2O2S	5.6214	11667240		CCOC(=O)c1ccc(N(C)c2csc(-c3ccccc3)n2)cc1	InChI=1S/C19H18N2O2S/c1-3-23-19(22)15-9-11-16(12-10-15)21(2)17-13-24-18(20-17)14-7-5-4-6-8-14/h4-13H,3H2,1-2H3	MGKYEWWFHSESJN-UHFFFAOYSA-N					doublet; compound annotation
0391_008017	Neuropathiazol	C19H18N2O2S	5.6247	11667240		CCOC(=O)c1ccc(N(C)c2csc(-c3ccccc3)n2)cc1	InChI=1S/C19H18N2O2S/c1-3-23-19(22)15-9-11-16(12-10-15)21(2)17-13-24-18(20-17)14-7-5-4-6-8-14/h4-13H,3H2,1-2H3	MGKYEWWFHSESJN-UHFFFAOYSA-N					doublet; compound annotation
0391_008018	inS3-54A18	C23H16ClNO2	5.683	1920398	C1=CC=C(C=C1)C2=C/C(=C/C3=CC=C(C=C3)Cl)/C(=O)N2C4=CC=C(C=C4)O	O=C1C(=Cc2ccc(Cl)cc2)C=C(c2ccccc2)N1c1ccc(O)cc1	InChI=1S/C23H16ClNO2/c24-19-8-6-16(7-9-19)14-18-15-22(17-4-2-1-3-5-17)25(23(18)27)20-10-12-21(26)13-11-20/h1-15,26H/b18-14-	IMHWQIPPIXOVRK-JXAWBTAJSA-N					doublet; compound annotation
0391_008019	FL-411	C18H19N3O2S	1.7796	135567026		Cc1cc(-c2nc3c(c4c(CN(C)CC4)s3)c(=O)[nH]2)cc(C)c1O	InChI=1S/C18H19N3O2S/c1-9-6-11(7-10(2)15(9)22)16-19-17(23)14-12-4-5-21(3)8-13(12)24-18(14)20-16/h6-7,22H,4-5,8H2,1-3H3,(H,19,20,23)	PXJZRFLBUBYEPV-UHFFFAOYSA-N					compound annotation
0391_008020	Seclidemstat	C20H23ClN4O4S	2.4252	135565033	C/C(=N\NC(=O)C1=CC(=CC=C1)S(=O)(=O)N2CCN(CC2)C)/C3=C(C=CC(=C3)Cl)O	CC(=NNC(=O)c1cc(S(=O)(=O)N2CCN(C)CC2)ccc1)c1c(O)ccc(Cl)c1	InChI=1S/C20H23ClN4O4S/c1-14(18-13-16(21)6-7-19(18)26)22-23-20(27)15-4-3-5-17(12-15)30(28,29)25-10-8-24(2)9-11-25/h3-7,12-13,26H,8-11H2,1-2H3,(H,23,27)/b22-14+	MVSQDUZRRVBYLA-HYARGMPZSA-N					doublet; compound annotation
0391_008021	1311423-89-8	C20H22ClF3N2O3	2.4252	53230697		CCOc1c(C(=O)Nc2cc(C(F)(F)F)c(Cl)cc2)c(OCCN(C)C)ccc1	InChI=1S/C20H22ClF3N2O3/c1-4-28-16-6-5-7-17(29-11-10-26(2)3)18(16)19(27)25-13-8-9-15(21)14(12-13)20(22,23)24/h5-9,12H,4,10-11H2,1-3H3,(H,25,27)	TZHLDFAKTWDTOW-UHFFFAOYSA-N					doublet; compound annotation
0391_008022	CHEMBL3134377	C24H23N3O	3.0252	72793898	CC1=CC=C(C=C1)C2=C(C=C(C=N2)OC[C@@H]3CCNC3)C4=CC=C(C=C4)C#N	Cc1ccc(-c2ncc(OCC3CCNC3)cc2-c2ccc(C#N)cc2)cc1	InChI=1S/C24H23N3O/c1-17-2-6-21(7-3-17)24-23(20-8-4-18(13-25)5-9-20)12-22(15-27-24)28-16-19-10-11-26-14-19/h2-9,12,15,19,26H,10-11,14,16H2,1H3/t19-/m1/s1	IQVDLEXWAPYWDT-LJQANCHMSA-N					compound annotation
0391_008023	Seclidemstat	C20H23ClN4O4S	3.0474	135565033	C/C(=N\NC(=O)C1=CC(=CC=C1)S(=O)(=O)N2CCN(CC2)C)/C3=C(C=CC(=C3)Cl)O	CC(=NNC(=O)c1cc(S(=O)(=O)N2CCN(C)CC2)ccc1)c1c(O)ccc(Cl)c1	InChI=1S/C20H23ClN4O4S/c1-14(18-13-16(21)6-7-19(18)26)22-23-20(27)15-4-3-5-17(12-15)30(28,29)25-10-8-24(2)9-11-25/h3-7,12-13,26H,8-11H2,1-2H3,(H,23,27)/b22-14+	MVSQDUZRRVBYLA-HYARGMPZSA-N					doublet; removed another duplicate entry; compound annotation
0391_008024	1311423-89-8	C20H22ClF3N2O3	3.0474	53230697		CCOc1c(C(=O)Nc2cc(C(F)(F)F)c(Cl)cc2)c(OCCN(C)C)ccc1	InChI=1S/C20H22ClF3N2O3/c1-4-28-16-6-5-7-17(29-11-10-26(2)3)18(16)19(27)25-13-8-9-15(21)14(12-13)20(22,23)24/h5-9,12H,4,10-11H2,1-3H3,(H,25,27)	TZHLDFAKTWDTOW-UHFFFAOYSA-N					doublet; compound annotation
0391_008026	Glucocorticoid receptor agonist	C20H20F4N2O2	3.0798	46937290	CC(C)(C[C@@](CC1=CC2=C(N1)C=NC=C2)(C(F)(F)F)O)C3=C(C=CC(=C3)F)O	CC(C)(CC(O)(Cc1cc2c(cncc2)[nH]1)C(F)(F)F)c1c(O)ccc(F)c1	InChI=1S/C20H20F4N2O2/c1-18(2,15-8-13(21)3-4-17(15)27)11-19(28,20(22,23)24)9-14-7-12-5-6-25-10-16(12)26-14/h3-8,10,26-28H,9,11H2,1-2H3/t19-/m0/s1	JFUAWXPBHXKZGA-IBGZPJMESA-N					compound annotation
0391_008027	TM-25659	C30H28N8	3.0939	49821008		CCCCc1nc2c(nc(C)c(-c3cnccc3)c2)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C30H28N8/c1-3-4-11-28-33-27-17-26(23-8-7-16-31-18-23)20(2)32-30(27)38(28)19-21-12-14-22(15-13-21)24-9-5-6-10-25(24)29-34-36-37-35-29/h5-10,12-18H,3-4,11,19H2,1-2H3,(H,34,35,36,37)	KCOQNLYGMQJUJD-UHFFFAOYSA-N					doublet; compound annotation
0391_008028	TM-25659	C30H28N8	3.0973	49821008		CCCCc1nc2c(nc(C)c(-c3cnccc3)c2)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C30H28N8/c1-3-4-11-28-33-27-17-26(23-8-7-16-31-18-23)20(2)32-30(27)38(28)19-21-12-14-22(15-13-21)24-9-5-6-10-25(24)29-34-36-37-35-29/h5-10,12-18H,3-4,11,19H2,1-2H3,(H,34,35,36,37)	KCOQNLYGMQJUJD-UHFFFAOYSA-N					doublet; compound annotation
0391_008029	IACS-9571	C32H42N4O8S	3.1057	91808039		CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2cc(OC)c(OC)cc2)n(C)c(=O)n3C)c1	InChI=1S/C32H42N4O8S/c1-8-14-42-22-16-23(43-15-10-9-13-34(2)3)18-24(17-22)44-30-21-28-27(35(4)32(37)36(28)5)20-26(30)33-45(38,39)25-11-12-29(40-6)31(19-25)41-7/h11-12,16-21,33H,8-10,13-15H2,1-7H3	HYQBRUSSCIAOOD-UHFFFAOYSA-N					doublet; compound annotation
0391_008030	IACS-9571	C32H42N4O8S	3.1106	91808039		CCCOc1cc(OCCCCN(C)C)cc(Oc2cc3c(cc2NS(=O)(=O)c2cc(OC)c(OC)cc2)n(C)c(=O)n3C)c1	InChI=1S/C32H42N4O8S/c1-8-14-42-22-16-23(43-15-10-9-13-34(2)3)18-24(17-22)44-30-21-28-27(35(4)32(37)36(28)5)20-26(30)33-45(38,39)25-11-12-29(40-6)31(19-25)41-7/h11-12,16-21,33H,8-10,13-15H2,1-7H3	HYQBRUSSCIAOOD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008032	THZ1	C31H28ClN7O2	3.263	73602827	CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl	CN(C)CC=CC(=O)Nc1ccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)cc1	InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+	OBJNFLYHUXWUPF-IZZDOVSWSA-N					doublet; removed another duplicate entry; compound annotation
0391_008034	1311423-89-8	C20H22ClF3N2O3	3.466	53230697		CCOc1c(C(=O)Nc2cc(C(F)(F)F)c(Cl)cc2)c(OCCN(C)C)ccc1	InChI=1S/C20H22ClF3N2O3/c1-4-28-16-6-5-7-17(29-11-10-26(2)3)18(16)19(27)25-13-8-9-15(21)14(12-13)20(22,23)24/h5-9,12H,4,10-11H2,1-3H3,(H,25,27)	TZHLDFAKTWDTOW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008036	QC6352	C24H25N3O2	3.766	118598059	CN(C1=CC=CC=C1)C2=CC3=C(C=C2)[C@@H](CCC3)CNC4=C(C=CN=C4)C(=O)O	CN(c1ccccc1)c1cc2c(cc1)C(CNc1c(C(=O)O)ccnc1)CCC2	InChI=1S/C24H25N3O2/c1-27(19-8-3-2-4-9-19)20-10-11-21-17(14-20)6-5-7-18(21)15-26-23-16-25-13-12-22(23)24(28)29/h2-4,8-14,16,18,26H,5-7,15H2,1H3,(H,28,29)/t18-/m0/s1	XSMABFRQESMONQ-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_008039	(S)-Mapracorat	C25H26F4N2O2	3.7937	24993922	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m0/s1	VJGFOYBQOIPQFY-DEOSSOPVSA-N					doublet; compound annotation
0391_008040	TM-25659	C30H28N8	3.8151	49821008		CCCCc1nc2c(nc(C)c(-c3cnccc3)c2)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C30H28N8/c1-3-4-11-28-33-27-17-26(23-8-7-16-31-18-23)20(2)32-30(27)38(28)19-21-12-14-22(15-13-21)24-9-5-6-10-25(24)29-34-36-37-35-29/h5-10,12-18H,3-4,11,19H2,1-2H3,(H,34,35,36,37)	KCOQNLYGMQJUJD-UHFFFAOYSA-N					doublet; compound annotation
0391_008041	(S)-Mapracorat	C25H26F4N2O2	5.202	24993922	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m0/s1	VJGFOYBQOIPQFY-DEOSSOPVSA-N					doublet; compound annotation
0391_008042	(S)-Mapracorat	C25H26F4N2O2	5.5536	24993922	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m0/s1	VJGFOYBQOIPQFY-DEOSSOPVSA-N					doublet; compound annotation
0391_008043	(S)-Mapracorat	C25H26F4N2O2	5.6416	24993922	CC1=NC2=C(C=C1)C(=CC=C2)NC[C@@](CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O	Cc1nc2c(cc1)c(NCC(O)(CC(C)(C)c1cc(F)cc3c1OCC3)C(F)(F)F)ccc2	InChI=1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m0/s1	VJGFOYBQOIPQFY-DEOSSOPVSA-N					doublet; compound annotation
0391_008044	NCGC00247743	C24H29N3O2	1.7958	89564218		CN(C)CCCCCCNC(=O)c1cccc(-c2cc(O)c3ncccc3c2)c1	InChI=1S/C24H29N3O2/c1-27(2)14-6-4-3-5-12-26-24(29)20-10-7-9-18(15-20)21-16-19-11-8-13-25-23(19)22(28)17-21/h7-11,13,15-17,28H,3-6,12,14H2,1-2H3,(H,26,29)	RAUALYDCIUPMKI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008046	SGC-iMLLT	C22H24N6O	1.8228	134820948	C[C@H]1CCCN1CC2=NC3=C(N2)C=C(C=C3)NC(=O)C4=CC5=C(C=C4)N(N=C5)C	CC1CCCN1Cc1nc2c(cc(NC(=O)c3cc4c(cc3)n(C)nc4)cc2)[nH]1	InChI=1S/C22H24N6O/c1-14-4-3-9-28(14)13-21-25-18-7-6-17(11-19(18)26-21)24-22(29)15-5-8-20-16(10-15)12-23-27(20)2/h5-8,10-12,14H,3-4,9,13H2,1-2H3,(H,24,29)(H,25,26)/t14-/m0/s1	QGNDVASWIHEXCL-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_008048	Chitinase-IN-1	C18H16N4O2S	1.9224	86223063		Cc1nnc(CNCCN2C(=O)c3cccc4c3c(ccc4)C2=O)s1	InChI=1S/C18H16N4O2S/c1-11-20-21-15(25-11)10-19-8-9-22-17(23)13-6-2-4-12-5-3-7-14(16(12)13)18(22)24/h2-7,19H,8-10H2,1H3	YHPDOCZSFWEMOD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008050	5465-86-1	C15H18N2	2.2284	230710		Cc1cc(N2CCCCC2)nc2ccccc12	InChI=1S/C15H18N2/c1-12-11-15(17-9-5-2-6-10-17)16-14-8-4-3-7-13(12)14/h3-4,7-8,11H,2,5-6,9-10H2,1H3	USYRQXDHKXGTCK-UHFFFAOYSA-N					doublet; compound annotation
0391_008051	NCGC00247743	C24H29N3O2	2.3287	89564218		CN(C)CCCCCCNC(=O)c1cccc(-c2cc(O)c3ncccc3c2)c1	InChI=1S/C24H29N3O2/c1-27(2)14-6-4-3-5-12-26-24(29)20-10-7-9-18(15-20)21-16-19-11-8-13-25-23(19)22(28)17-21/h7-11,13,15-17,28H,3-6,12,14H2,1-2H3,(H,26,29)	RAUALYDCIUPMKI-UHFFFAOYSA-N					doublet; compound annotation
0391_008052	AR-C155858	C21H27N5O5S	2.3336	10226546	CC1=C(C(=NN1)C)CC2=C(C3=C(S2)N(C(=O)N(C3=O)C)CC(C)C)C(=O)N4C[C@@H](CO4)O	Cc1n[nH]c(C)c1Cc1c(C(=O)N2CC(O)CO2)c2c(s1)n(CC(C)C)c(=O)n(C)c2=O	InChI=1S/C21H27N5O5S/c1-10(2)7-25-20-17(18(28)24(5)21(25)30)16(19(29)26-8-13(27)9-31-26)15(32-20)6-14-11(3)22-23-12(14)4/h10,13,27H,6-9H2,1-5H3,(H,22,23)/t13-/m0/s1	ISIVOJWVBJIOFM-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_008054	CPI-169	C27H36N4O5S	3.255	78357814		CCS(=O)(=O)N1CCC(C(C)n2c(C)c(C(=O)NCc3c(OC)cc(C)[nH]c3=O)c3ccccc32)CC1	InChI=1S/C27H36N4O5S/c1-6-37(34,35)30-13-11-20(12-14-30)18(3)31-19(4)25(21-9-7-8-10-23(21)31)27(33)28-16-22-24(36-5)15-17(2)29-26(22)32/h7-10,15,18,20H,6,11-14,16H2,1-5H3,(H,28,33)(H,29,32)	LHGUZCKPFXXVPV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008056	CARM1-IN-1	C26H21Br2NO3	3.4398	24827559	C\1N(C/C(=C\C2=CC(=C(C=C2)O)Br)/C(=O)/C1=C/C3=CC(=C(C=C3)O)Br)CC4=CC=CC=C4	O=C1C(=Cc2cc(Br)c(O)cc2)CN(Cc2ccccc2)CC1=Cc1cc(Br)c(O)cc1	InChI=1S/C26H21Br2NO3/c27-22-12-18(6-8-24(22)30)10-20-15-29(14-17-4-2-1-3-5-17)16-21(26(20)32)11-19-7-9-25(31)23(28)13-19/h1-13,30-31H,14-16H2/b20-10+,21-11+	KNMFTTWVELIVCC-CLVAPQHMSA-N					compound annotation
0391_008057	GSK3787	C15H12ClF3N2O3S	3.6757	2800647		O=C(NCCS(=O)(=O)c1ncc(C(F)(F)F)cc1)c1ccc(Cl)cc1	InChI=1S/C15H12ClF3N2O3S/c16-12-4-1-10(2-5-12)14(22)20-7-8-25(23,24)13-6-3-11(9-21-13)15(17,18)19/h1-6,9H,7-8H2,(H,20,22)	JFUIMTGOQCQTPF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008059	Y06036	C16H15BrN2O5S	4.1318	134159768		COc1c(NS(=O)(=O)c2c(OC)ccc(Br)c2)cc2c(C)noc2c1	InChI=1S/C16H15BrN2O5S/c1-9-11-7-12(15(23-3)8-14(11)24-18-9)19-25(20,21)16-6-10(17)4-5-13(16)22-2/h4-8,19H,1-3H3	KVGNGFGTOSOVPB-UHFFFAOYSA-N					compound annotation
0391_008060	4-Aminosalicylic acid	C7H7NO3	0.9358	4649		Nc1cc(O)c(C(=O)O)cc1	InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)	WUBBRNOQWQTFEX-UHFFFAOYSA-N					doublet; compound annotation
0391_008061	clonidine	C9H9Cl2N3	1.046	2803		Clc1cccc(Cl)c1NC1=NCCN1	InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	GJSURZIOUXUGAL-UHFFFAOYSA-N					doublet; compound annotation
0391_008062	1628830-21-6	C29H37ClN6O5	2.5743	90425581	CC1=C(N=C(N=C1N2CC3(C2)CCN(CC3)C(=O)OC)C4=C(C=CC(=C4)OC[C@@H](CNC)O)Cl)C5=C(ON=C5C)C	CNCC(O)COc1cc(-c2nc(-c3c(C)onc3C)c(C)c(N3CC4(CCN(C(=O)OC)CC4)C3)n2)c(Cl)cc1	InChI=1S/C29H37ClN6O5/c1-17-25(24-18(2)34-41-19(24)3)32-26(22-12-21(6-7-23(22)30)40-14-20(37)13-31-4)33-27(17)36-15-29(16-36)8-10-35(11-9-29)28(38)39-5/h6-7,12,20,31,37H,8-11,13-16H2,1-5H3/t20-/m1/s1	OWCOTUVKROVONT-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_008064	osalmid	C13H11NO3	2.8023	4602		O=C(Nc1ccc(O)cc1)c1ccccc1O	InChI=1S/C13H11NO3/c15-10-7-5-9(6-8-10)14-13(17)11-3-1-2-4-12(11)16/h1-8,15-16H,(H,14,17)	LGCMKPRGGJRYGM-UHFFFAOYSA-N					compound annotation
0391_008065	1628830-21-6	C29H37ClN6O5	3.1928	90425581	CC1=C(N=C(N=C1N2CC3(C2)CCN(CC3)C(=O)OC)C4=C(C=CC(=C4)OC[C@@H](CNC)O)Cl)C5=C(ON=C5C)C	CNCC(O)COc1cc(-c2nc(-c3c(C)onc3C)c(C)c(N3CC4(CCN(C(=O)OC)CC4)C3)n2)c(Cl)cc1	InChI=1S/C29H37ClN6O5/c1-17-25(24-18(2)34-41-19(24)3)32-26(22-12-21(6-7-23(22)30)40-14-20(37)13-31-4)33-27(17)36-15-29(16-36)8-10-35(11-9-29)28(38)39-5/h6-7,12,20,31,37H,8-11,13-16H2,1-5H3/t20-/m1/s1	OWCOTUVKROVONT-HXUWFJFHSA-N					doublet; compound annotation
0391_008066	NCGC00244536	C25H22N2O2	3.4762	127030711		O=C(NCCCc1ccccc1)c1cccc(-c2cc(O)c3ncccc3c2)c1	InChI=1S/C25H22N2O2/c28-23-17-22(16-20-12-6-13-26-24(20)23)19-10-4-11-21(15-19)25(29)27-14-5-9-18-7-2-1-3-8-18/h1-4,6-8,10-13,15-17,28H,5,9,14H2,(H,27,29)	NYKBXXGHEMXSBB-UHFFFAOYSA-N					doublet; compound annotation
0391_008067	NCGC00244536	C25H22N2O2	3.4789	127030711		O=C(NCCCc1ccccc1)c1cccc(-c2cc(O)c3ncccc3c2)c1	InChI=1S/C25H22N2O2/c28-23-17-22(16-20-12-6-13-26-24(20)23)19-10-4-11-21(15-19)25(29)27-14-5-9-18-7-2-1-3-8-18/h1-4,6-8,10-13,15-17,28H,5,9,14H2,(H,27,29)	NYKBXXGHEMXSBB-UHFFFAOYSA-N					doublet; compound annotation
0391_008068	5-O-Methylvisammioside	C22H28O10	2.1067	21670038	CC1=CC(=O)C2=C(C3=C(C=C2O1)O[C@@H](C3)C(C)(C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC	COc1c2c(=O)cc(C)oc2cc2c1CC(C(C)(C)OC1OC(CO)C(O)C(O)C1O)O2	InChI=1S/C22H28O10/c1-9-5-11(24)16-13(29-9)7-12-10(20(16)28-4)6-15(30-12)22(2,3)32-21-19(27)18(26)17(25)14(8-23)31-21/h5,7,14-15,17-19,21,23,25-27H,6,8H2,1-4H3/t14-,15+,17-,18+,19-,21+/m1/s1	QVGFPTYGKPLXPK-OOBAEQHESA-N					removed another duplicate entry; compound annotation
0391_008070	BGG463	C30H29F3N6O3	3.0607	67406169		CC(=O)Nc1cc(Oc2cc3c(cc2)c(C(=O)Nc2cc(C(F)(F)F)c(CN4CCN(C)CC4)cc2)ccc3)ncn1	InChI=1S/C30H29F3N6O3/c1-19(40)36-27-16-28(35-18-34-27)42-23-8-9-24-20(14-23)4-3-5-25(24)29(41)37-22-7-6-21(26(15-22)30(31,32)33)17-39-12-10-38(2)11-13-39/h3-9,14-16,18H,10-13,17H2,1-2H3,(H,37,41)(H,34,35,36,40)	MZZJNOOADWVFPD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008072	Abiraterone	C24H31NO	3.2865	132971	C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O	CC12CCC(O)CC1=CCC1C2CCC2(C)C(c3cnccc3)=CCC12	InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1	GZOSMCIZMLWJML-VJLLXTKPSA-N					compound annotation
0391_008073	benzo[a]pyrene	C20H12	6.2244	2336		c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34	InChI=1S/C20H12/c1-2-7-17-15(4-1)12-16-9-8-13-5-3-6-14-10-11-18(17)20(16)19(13)14/h1-12H	FMMWHPNWAFZXNH-UHFFFAOYSA-N					compound annotation
0391_008074	5852-78-8	C10H7NO3	0.827	459617		O=C(O)c1c2cccnc2c(O)cc1	InChI=1S/C10H7NO3/c12-8-4-3-7(10(13)14)6-2-1-5-11-9(6)8/h1-5,12H,(H,13,14)	JGRPKOGHYBAVMW-UHFFFAOYSA-N					compound annotation
0391_008075	ceftibuten	C15H14N4O6S2	0.9956	5282242	C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)/C3=CSC(=N3)N)C(=O)O	Nc1nc(C(=CCC(=O)O)C(=O)NC2C(=O)N3C(C(=O)O)=CCSC23)cs1	InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1	UNJFKXSSGBWRBZ-BJCIPQKHSA-N					doublet; compound annotation
0391_008076	ceftibuten	C15H14N4O6S2	1.0556	5282242	C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)/C3=CSC(=N3)N)C(=O)O	Nc1nc(C(=CCC(=O)O)C(=O)NC2C(=O)N3C(C(=O)O)=CCSC23)cs1	InChI=1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1	UNJFKXSSGBWRBZ-BJCIPQKHSA-N					doublet; compound annotation
0391_008077	Wnt-C59	C25H21N3O	1.5579	57519544		Cc1nccc(-c2ccc(CC(=O)Nc3ccc(-c4cnccc4)cc3)cc2)c1	InChI=1S/C25H21N3O/c1-18-15-22(12-14-27-18)20-6-4-19(5-7-20)16-25(29)28-24-10-8-21(9-11-24)23-3-2-13-26-17-23/h2-15,17H,16H2,1H3,(H,28,29)	KHZOJCQBHJUJFY-UHFFFAOYSA-N					compound annotation
0391_008078	DGAT1-IN-3	C20H19F3N4O3	3.5173	16757107		COCCN(C)c1ncc(NC(=O)c2c(C(F)(F)F)oc(-c3ccccc3)n2)cc1	InChI=1S/C20H19F3N4O3/c1-27(10-11-29-2)15-9-8-14(12-24-15)25-18(28)16-17(20(21,22)23)30-19(26-16)13-6-4-3-5-7-13/h3-9,12H,10-11H2,1-2H3,(H,25,28)	QEZWDFXCTTZZRI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008080	Licoflavone A	C20H18O4	3.6878	5319000		CC(C)=CCc1cc2c(cc1O)oc(-c1ccc(O)cc1)cc2=O	InChI=1S/C20H18O4/c1-12(2)3-4-14-9-16-18(23)11-19(24-20(16)10-17(14)22)13-5-7-15(21)8-6-13/h3,5-11,21-22H,4H2,1-2H3	HJGURBGBPIKRER-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008082	(1R,2S)-VU0155041	C14H15Cl2NO3	4.1714	888023	C1CC[C@H]([C@H](C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)C(=O)O	O=C(O)C1CCCCC1C(=O)Nc1cc(Cl)cc(Cl)c1	InChI=1S/C14H15Cl2NO3/c15-8-5-9(16)7-10(6-8)17-13(18)11-3-1-2-4-12(11)14(19)20/h5-7,11-12H,1-4H2,(H,17,18)(H,19,20)/t11-,12+/m0/s1	VSMUYYFJVFSVCA-NWDGAFQWSA-N					compound annotation
0391_008083	GSK2837808A	C31H25F2N5O7S	4.299	71533725		COc1ncc(-c2cc3ncc(S(=O)(=O)NC4CC4)c(Nc4cc(Oc5cc(F)cc(F)c5)cc(C(=O)O)c4)c3cc2)c(OC)n1	InChI=1S/C31H25F2N5O7S/c1-43-29-25(14-35-31(37-29)44-2)16-3-6-24-26(9-16)34-15-27(46(41,42)38-20-4-5-20)28(24)36-21-7-17(30(39)40)8-22(13-21)45-23-11-18(32)10-19(33)12-23/h3,6-15,20,38H,4-5H2,1-2H3,(H,34,36)(H,39,40)	RZBCPMYJIARMGV-UHFFFAOYSA-N					compound annotation
0391_008084	A-1331852	C38H38N6O3S	5.7926	71565985		Cc1c(-c2c(C(=O)O)nc(N3CCc4c(C3)c(C(=O)Nc3nc5ccccc5s3)ccc4)cc2)cnn1CC12CC3CC(CC(C3)C1)C2	InChI=1S/C38H38N6O3S/c1-22-29(19-39-44(22)21-38-16-23-13-24(17-38)15-25(14-23)18-38)27-9-10-33(41-34(27)36(46)47)43-12-11-26-5-4-6-28(30(26)20-43)35(45)42-37-40-31-7-2-3-8-32(31)48-37/h2-10,19,23-25H,11-18,20-21H2,1H3,(H,46,47)(H,40,42,45)	QCQQONWEDCOTBV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008086	PROCAINAMIDE	C13H21N3O	0.5132	4913		CCN(CC)CCNC(=O)c1ccc(N)cc1	InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)	REQCZEXYDRLIBE-UHFFFAOYSA-N					doublet; compound annotation
0391_008087	N-Acetyl-DL-phenylalanine	C11H13NO3	1.8442	2000		CC(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)	CBQJSKKFNMDLON-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008089	Gemifloxacin	C18H20FN5O4	1.9662	9571107	CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F	CON=C1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3n2)CC1CN	InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+	ZRCVYEYHRGVLOC-HYARGMPZSA-N					doublet; compound annotation
0391_008090	Gemifloxacin	C18H20FN5O4	2.0614	9571107	CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F	CON=C1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3n2)CC1CN	InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+	ZRCVYEYHRGVLOC-HYARGMPZSA-N					doublet; removed another duplicate entry; compound annotation
0391_008092	Dansylcadaverine	C17H25N3O2S	2.3005	4247		CN(C)c1cccc2c1cccc2S(=O)(=O)NCCCCCN	InChI=1S/C17H25N3O2S/c1-20(2)16-10-6-9-15-14(16)8-7-11-17(15)23(21,22)19-13-5-3-4-12-18/h6-11,19H,3-5,12-13,18H2,1-2H3	MLEBFEHOJICQQS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008094	liothyronine	C15H12I3NO4	2.9467	7048703	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O	NC(Cc1cc(I)c(Oc2cc(I)c(O)cc2)c(I)c1)C(=O)O	InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1	AUYYCJSJGJYCDS-LBPRGKRZSA-N					doublet; removed another duplicate entry; compound annotation
0391_008096	Pristinamycin IA	C45H54N8O10	3.4798	11136668	CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3CCC(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=C(C=C6)N(C)C)C	CCC1NC(=O)C(NC(=O)c2c(O)cccn2)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccc(N(C)C)cc2)N(C)C(=O)C2CCCN2C1=O	InChI=1S/C45H54N8O10/c1-6-31-42(59)52-22-11-14-32(52)43(60)51(5)34(24-27-16-18-29(19-17-27)50(3)4)44(61)53-23-20-30(54)25-33(53)39(56)49-37(28-12-8-7-9-13-28)45(62)63-26(2)36(40(57)47-31)48-41(58)38-35(55)15-10-21-46-38/h7-10,12-13,15-19,21,26,31-34,36-37,55H,6,11,14,20,22-25H2,1-5H3,(H,47,57)(H,48,58)(H,49,56)/t26-,31-,32+,33+,34+,36+,37+/m1/s1	YGXCETJZBDTKRY-DZCVGBHJSA-N					removed another duplicate entry; compound annotation
0391_008099	PROCAINAMIDE	C13H21N3O	4.9493	4913		CCN(CC)CCNC(=O)c1ccc(N)cc1	InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)	REQCZEXYDRLIBE-UHFFFAOYSA-N					doublet; compound annotation
0391_008100	Glycitein	C16H12O5	1.669	5317750		COc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1	InChI=1S/C16H12O5/c1-20-15-6-11-14(7-13(15)18)21-8-12(16(11)19)9-2-4-10(17)5-3-9/h2-8,17-18H,1H3	DXYUAIFZCFRPTH-UHFFFAOYSA-N					doublet; compound annotation
0391_008101	Glycitin	C22H22O10	1.669	187808	COC1=C(C=C2C(=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1	InChI=1S/C22H22O10/c1-29-15-6-12-14(30-9-13(18(12)25)10-2-4-11(24)5-3-10)7-16(15)31-22-21(28)20(27)19(26)17(8-23)32-22/h2-7,9,17,19-24,26-28H,8H2,1H3/t17-,19-,20+,21-,22-/m1/s1	OZBAVEKZGSOMOJ-MIUGBVLSSA-N					doublet; compound annotation
0391_008102	Glycitin	C22H22O10	1.672	187808	COC1=C(C=C2C(=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1	InChI=1S/C22H22O10/c1-29-15-6-12-14(30-9-13(18(12)25)10-2-4-11(24)5-3-10)7-16(15)31-22-21(28)20(27)19(26)17(8-23)32-22/h2-7,9,17,19-24,26-28H,8H2,1H3/t17-,19-,20+,21-,22-/m1/s1	OZBAVEKZGSOMOJ-MIUGBVLSSA-N					doublet; compound annotation
0391_008103	Benzamil	C13H14ClN7O	2.1187	108107		NC(=NCc1ccccc1)NC(=O)c1c(N)nc(N)c(Cl)n1	InChI=1S/C13H14ClN7O/c14-9-11(16)20-10(15)8(19-9)12(22)21-13(17)18-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,15,16,20)(H3,17,18,21,22)	KXDROGADUISDGY-UHFFFAOYSA-N					compound annotation
0391_008104	CHZ868	C22H19F2N5O2	2.1187	91885989		CC(=O)Nc1nccc(Oc2c(C)c3c(cc2)n(C)c(Nc2c(F)cc(F)cc2)n3)c1	InChI=1S/C22H19F2N5O2/c1-12-19(31-15-8-9-25-20(11-15)26-13(2)30)7-6-18-21(12)28-22(29(18)3)27-17-5-4-14(23)10-16(17)24/h4-11H,1-3H3,(H,27,28)(H,25,26,30)	KQQLBXFPTDVFAJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008106	3248-93-9	C20H19N3	2.4649	12448		CC1=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=CC1=N	InChI=1S/C20H19N3/c1-13-12-16(6-11-19(13)23)20(14-2-7-17(21)8-3-14)15-4-9-18(22)10-5-15/h2-12,23H,21-22H2,1H3	YDCMWLQSPFTWCS-UHFFFAOYSA-N					compound annotation
0391_008107	Glycitein	C16H12O5	2.5361	5317750		COc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1	InChI=1S/C16H12O5/c1-20-15-6-11-14(7-13(15)18)21-8-12(16(11)19)9-2-4-10(17)5-3-9/h2-8,17-18H,1H3	DXYUAIFZCFRPTH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008109	LRE1	C12H13ClN4S	3.9362	47279808		Nc1nc(N(Cc2cccs2)C2CC2)cc(Cl)n1	InChI=1S/C12H13ClN4S/c13-10-6-11(16-12(14)15-10)17(8-3-4-8)7-9-2-1-5-18-9/h1-2,5-6,8H,3-4,7H2,(H2,14,15,16)	PDWZXKSZLRVSEH-UHFFFAOYSA-N					compound annotation
0391_008110	NPS-1034	C31H23F2N5O3	3.9813	136693733		Cc1c(C(=O)Nc2cc(F)c(Oc3c4c(-c5ccccc5)c[nH]c4ncc3)cc2)c(=O)n(-c2ccc(F)cc2)n1C	InChI=1S/C31H23F2N5O3/c1-18-27(31(40)38(37(18)2)22-11-8-20(32)9-12-22)30(39)36-21-10-13-25(24(33)16-21)41-26-14-15-34-29-28(26)23(17-35-29)19-6-4-3-5-7-19/h3-17H,1-2H3,(H,34,35)(H,36,39)	RGAZVGZUBCFHRJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008112	NPS-1034	C31H23F2N5O3	3.9862	136693733		Cc1c(C(=O)Nc2cc(F)c(Oc3c4c(-c5ccccc5)c[nH]c4ncc3)cc2)c(=O)n(-c2ccc(F)cc2)n1C	InChI=1S/C31H23F2N5O3/c1-18-27(31(40)38(37(18)2)22-11-8-20(32)9-12-22)30(39)36-21-10-13-25(24(33)16-21)41-26-14-15-34-29-28(26)23(17-35-29)19-6-4-3-5-7-19/h3-17H,1-2H3,(H,34,35)(H,36,39)	RGAZVGZUBCFHRJ-UHFFFAOYSA-N					doublet; compound annotation
0391_008113	su6656	C19H21N3O3S	4.5858	5312137	CN(C)S(=O)(=O)C1=CC\2=C(C=C1)NC(=O)/C2=C\C3=CC4=C(N3)CCCC4	CN(C)S(=O)(=O)c1cc2c(cc1)NC(=O)C2=Cc1cc2c(CCCC2)[nH]1	InChI=1S/C19H21N3O3S/c1-22(2)26(24,25)14-7-8-18-15(11-14)16(19(23)21-18)10-13-9-12-5-3-4-6-17(12)20-13/h7-11,20H,3-6H2,1-2H3,(H,21,23)/b16-10-	LOGJQOUIVKBFGH-YBEGLDIGSA-N					removed another duplicate entry; compound annotation
0391_008115	4E2RCat	C22H14ClNO4S2	5.4159	2287236	C1=CC=C(C=C1)CN2C(=O)/C(=C/C3=CC=C(O3)C4=CC(=C(C=C4)Cl)C(=O)O)/SC2=S	O=C(O)c1c(Cl)ccc(-c2ccc(C=C3SC(=S)N(Cc4ccccc4)C3=O)o2)c1	InChI=1S/C22H14ClNO4S2/c23-17-8-6-14(10-16(17)21(26)27)18-9-7-15(28-18)11-19-20(25)24(22(29)30-19)12-13-4-2-1-3-5-13/h1-11H,12H2,(H,26,27)/b19-11-	WOBPZFKXPCYOLU-ODLFYWEKSA-N					compound annotation
0391_008116	1,3-Dimethyluric acid	C7H8N4O3	0.5896	70346		Cn1c(=O)c2c([nH]c(=O)[nH]2)n(C)c1=O	InChI=1S/C7H8N4O3/c1-10-4-3(8-6(13)9-4)5(12)11(2)7(10)14/h1-2H3,(H2,8,9,13)	OTSBKHHWSQYEHK-UHFFFAOYSA-N					compound annotation
0391_008117	Simetryn	C8H15N5S	2.239	13905		CCNc1nc(NCC)nc(SC)n1	InChI=1S/C8H15N5S/c1-4-9-6-11-7(10-5-2)13-8(12-6)14-3/h4-5H2,1-3H3,(H2,9,10,11,12,13)	MGLWZSOBALDPEK-UHFFFAOYSA-N					compound annotation
0391_008118	3-[3-(3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholan-24-ylamino)propyldimethylaminio]-1-propanesulfonic acid	C32H59N2O7S+	2.9839	107671	C[C@H](CCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C	CC(CCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C32H58N2O7S/c1-21(8-11-29(38)33-14-6-15-34(4,5)16-7-17-42(39,40)41)24-9-10-25-30-26(20-28(37)32(24,25)3)31(2)13-12-23(35)18-22(31)19-27(30)36/h21-28,30,35-37H,6-20H2,1-5H3,(H-,33,38,39,40,41)/p+1/t21-,22+,23-,24-,25+,26+,27-,28+,30+,31+,32-/m1/s1	UMCMPZBLKLEWAF-BCTGSCMUSA-O					compound annotation
0391_008119	GSK-J1	C22H23N5O2	3.2395	56963315		O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	InChI=1S/C22H23N5O2/c28-21(29)8-12-24-19-15-20(26-22(25-19)18-7-3-4-11-23-18)27-13-9-16-5-1-2-6-17(16)10-14-27/h1-7,11,15H,8-10,12-14H2,(H,28,29)(H,24,25,26)	AVZCPICCWKMZDT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008121	Sacubitrilat	C22H25NO5	3.5034	10430040	C[C@H](C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O)C(=O)O	CC(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O)C(=O)O	InChI=1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1	DOBNVUFHFMVMDB-BEFAXECRSA-N					removed another duplicate entry; compound annotation
0391_008123	BRD7552	C33H33N3O15	4.1794	23891512	CCOC(=O)C1=CC=C(C=C1)NC(=O)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2OC(=O)NC3=CC4=C(C=C3)OCO4)OC(=O)NC5=CC6=C(C=C5)OCO6)OC)CO	CCOC(=O)c1ccc(NC(=O)OC2C(CO)OC(OC)C(OC(=O)Nc3cc4c(cc3)OCO4)C2OC(=O)Nc2cc3c(cc2)OCO3)cc1	InChI=1S/C33H33N3O15/c1-3-43-29(38)17-4-6-18(7-5-17)34-31(39)49-26-25(14-37)48-30(42-2)28(51-33(41)36-20-9-11-22-24(13-20)47-16-45-22)27(26)50-32(40)35-19-8-10-21-23(12-19)46-15-44-21/h4-13,25-28,30,37H,3,14-16H2,1-2H3,(H,34,39)(H,35,40)(H,36,41)/t25-,26-,27+,28-,30+/m1/s1	AAOLIMLEFKWKOY-IXMSMLDRSA-N					removed another duplicate entry; compound annotation
0391_008126	835621-11-9	C21H15ClF4N4O4	4.2136	53491674		CNC(=O)c1[n+]([O-])ccc(Oc2cc(F)c(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3)cc2)c1	InChI=1S/C21H15ClF4N4O4/c1-27-19(31)18-10-13(6-7-30(18)33)34-12-3-5-17(16(23)9-12)29-20(32)28-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,28,29,32)	NUCXNEKIESREQY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008128	DIBUTYL SEBACATE	C18H34O4	6.3907	7986		CCCCOC(=O)CCCCCCCCC(=O)OCCCC	InChI=1S/C18H34O4/c1-3-5-15-21-17(19)13-11-9-7-8-10-12-14-18(20)22-16-6-4-2/h3-16H2,1-2H3	PYGXAGIECVVIOZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008130	GSK-LSD1	C14H20N2	0.5541	71522234	C1CNCCC1N[C@@H]2C[C@H]2C3=CC=CC=C3	c1ccc(C2CC2NC2CCNCC2)cc1	InChI=1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1	BASFYRLYJAZPPL-UONOGXRCSA-N					compound annotation
0391_008131	Canertinib	C24H25ClFN5O3	2.229	156414		C=CC(=O)Nc1c(OCCCN2CCOCC2)cc2ncnc(Nc3cc(Cl)c(F)cc3)c2c1	InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)	OMZCMEYTWSXEPZ-UHFFFAOYSA-N					doublet; compound annotation
0391_008132	Sdz mks 492	C20H27N5O6	2.4326	163931	CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)N[C@@H](CO)C3=CC(=C(C=C3)OC)OC)CCOC	COCCn1c(NC(CO)c2cc(OC)c(OC)cc2)nc2c1c(=O)n(C)c(=O)n2C	InChI=1S/C20H27N5O6/c1-23-17-16(18(27)24(2)20(23)28)25(8-9-29-3)19(22-17)21-13(11-26)12-6-7-14(30-4)15(10-12)31-5/h6-7,10,13,26H,8-9,11H2,1-5H3,(H,21,22)/t13-/m0/s1	VZLFAVFWNOZVFM-ZDUSSCGKSA-N					compound annotation
0391_008133	1093222-27-5	C20H13N5O	2.5225	44588117		N#Cc1ccc(-c2cc3c(nc2)[nH]cc3NC(=O)c2cnccc2)cc1	InChI=1S/C20H13N5O/c21-9-13-3-5-14(6-4-13)16-8-17-18(12-24-19(17)23-11-16)25-20(26)15-2-1-7-22-10-15/h1-8,10-12H,(H,23,24)(H,25,26)	JTSLALYXYSRPGW-UHFFFAOYSA-N					compound annotation
0391_008134	flopropione	C9H10O4	2.5704	3362		CCC(=O)c1c(O)cc(O)cc1O	InChI=1S/C9H10O4/c1-2-6(11)9-7(12)3-5(10)4-8(9)13/h3-4,10,12-13H,2H2,1H3	PTHLEKANMPKYDB-UHFFFAOYSA-N					compound annotation
0391_008135	Vapendavir	C21H26N4O3	3.3374	504457		CCOc1noc2c1ccc(OCCC1CCN(c3nnc(C)cc3)CC1)c2	InChI=1S/C21H26N4O3/c1-3-26-21-18-6-5-17(14-19(18)28-24-21)27-13-10-16-8-11-25(12-9-16)20-7-4-15(2)22-23-20/h4-7,14,16H,3,8-13H2,1-2H3	DKSVBVKHUICELN-UHFFFAOYSA-N					doublet; compound annotation
0391_008136	Vapendavir	C21H26N4O3	3.3401	504457		CCOc1noc2c1ccc(OCCC1CCN(c3nnc(C)cc3)CC1)c2	InChI=1S/C21H26N4O3/c1-3-26-21-18-6-5-17(14-19(18)28-24-21)27-13-10-16-8-11-25(12-9-16)20-7-4-15(2)22-23-20/h4-7,14,16H,3,8-13H2,1-2H3	DKSVBVKHUICELN-UHFFFAOYSA-N					doublet; compound annotation
0391_008137	NPS-2143	C24H25ClN2O2	3.4115	6918446	CC(C)(CC1=CC2=CC=CC=C2C=C1)NC[C@H](COC3=C(C(=CC=C3)Cl)C#N)O	CC(C)(Cc1cc2ccccc2cc1)NCC(O)COc1c(C#N)c(Cl)ccc1	InChI=1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1	PZUJQWHTIRWCID-HXUWFJFHSA-N					doublet; compound annotation
0391_008138	NPS-2143	C24H25ClN2O2	3.6258	6918446	CC(C)(CC1=CC2=CC=CC=C2C=C1)NC[C@H](COC3=C(C(=CC=C3)Cl)C#N)O	CC(C)(Cc1cc2ccccc2cc1)NCC(O)COc1c(C#N)c(Cl)ccc1	InChI=1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1	PZUJQWHTIRWCID-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_008140	BTZ043	C17H16F3N3O5S	4.2127	42609849	C[C@H]1COC2(O1)CCN(CC2)C3=NC(=O)C4=C(S3)C(=CC(=C4)C(F)(F)F)[N+](=O)[O-]	CC1COC2(CCN(c3nc(=O)c4c(s3)c([N+](=O)[O-])cc(C(F)(F)F)c4)CC2)O1	InChI=1S/C17H16F3N3O5S/c1-9-8-27-16(28-9)2-4-22(5-3-16)15-21-14(24)11-6-10(17(18,19)20)7-12(23(25)26)13(11)29-15/h6-7,9H,2-5,8H2,1H3/t9-/m0/s1	GTUIRORNXIOHQR-VIFPVBQESA-N					removed another duplicate entry; compound annotation
0391_008142	NRX-252262	C23H17Cl2F3N2O4S	4.3182	138319682		COc1c(OC)cc2CN(C(=O)c3c(Sc4c(Cl)cccc4Cl)cc(C(F)(F)F)[nH]c3=O)Cc2c1	InChI=1S/C23H17Cl2F3N2O4S/c1-33-15-6-11-9-30(10-12(11)7-16(15)34-2)22(32)19-17(8-18(23(26,27)28)29-21(19)31)35-20-13(24)4-3-5-14(20)25/h3-8H,9-10H2,1-2H3,(H,29,31)	SPAYLOCXFWJEBL-UHFFFAOYSA-N					doublet; compound annotation
0391_008143	NRX-252262	C23H17Cl2F3N2O4S	4.323	138319682		COc1c(OC)cc2CN(C(=O)c3c(Sc4c(Cl)cccc4Cl)cc(C(F)(F)F)[nH]c3=O)Cc2c1	InChI=1S/C23H17Cl2F3N2O4S/c1-33-15-6-11-9-30(10-12(11)7-16(15)34-2)22(32)19-17(8-18(23(26,27)28)29-21(19)31)35-20-13(24)4-3-5-14(20)25/h3-8H,9-10H2,1-2H3,(H,29,31)	SPAYLOCXFWJEBL-UHFFFAOYSA-N					doublet; compound annotation
0391_008144	Arimoclomol	C14H20ClN3O3	0.8665	9818287	C1CCN(CC1)CC(CO/N=C(/C2=C[N+](=CC=C2)[O-])\Cl)O	[O-][n+]1cccc(C(Cl)=NOCC(O)CN2CCCCC2)c1	InChI=1S/C14H20ClN3O3/c15-14(12-5-4-8-18(20)9-12)16-21-11-13(19)10-17-6-2-1-3-7-17/h4-5,8-9,13,19H,1-3,6-7,10-11H2/b16-14-	SGEIEGAXKLMUIZ-PEZBUJJGSA-N					removed another duplicate entry; compound annotation
0391_008146	VERALIPRIDE	C17H25N3O5S	1.3804	47979		C=CCN1CCCC1CNC(=O)c1c(OC)c(OC)cc(S(N)(=O)=O)c1	InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)	RYJXBGGBZJGVQF-UHFFFAOYSA-N					compound annotation
0391_008147	PHA-680632	C28H35N7O2	2.5062	11249084		CCc1c(NC(=O)N2Cc3c(C2)c(NC(=O)c2ccc(N4CCN(C)CC4)cc2)n[nH]3)c(CC)ccc1	InChI=1S/C28H35N7O2/c1-4-19-7-6-8-20(5-2)25(19)29-28(37)35-17-23-24(18-35)31-32-26(23)30-27(36)21-9-11-22(12-10-21)34-15-13-33(3)14-16-34/h6-12H,4-5,13-18H2,1-3H3,(H,29,37)(H2,30,31,32,36)	OBWNXGOQPLDDPS-UHFFFAOYSA-N					doublet; compound annotation
0391_008148	PHA-680632	C28H35N7O2	2.5094	11249084		CCc1c(NC(=O)N2Cc3c(C2)c(NC(=O)c2ccc(N4CCN(C)CC4)cc2)n[nH]3)c(CC)ccc1	InChI=1S/C28H35N7O2/c1-4-19-7-6-8-20(5-2)25(19)29-28(37)35-17-23-24(18-35)31-32-26(23)30-27(36)21-9-11-22(12-10-21)34-15-13-33(3)14-16-34/h6-12H,4-5,13-18H2,1-3H3,(H,29,37)(H2,30,31,32,36)	OBWNXGOQPLDDPS-UHFFFAOYSA-N					doublet; compound annotation
0391_008149	252917-06-9	C22H18Cl2N8	2.6872	9956119		Cc1cnc(-c2cnc(NCCNc3ncc(C#N)cc3)nc2-c2c(Cl)cc(Cl)cc2)[nH]1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)	AQGNHMOJWBZFQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008150	252917-06-9	C22H18Cl2N8	2.69	9956119		Cc1cnc(-c2cnc(NCCNc3ncc(C#N)cc3)nc2-c2c(Cl)cc(Cl)cc2)[nH]1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)	AQGNHMOJWBZFQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008151	129-56-6	C14H8N2O	3.1798	8515		O=C1c2ccccc2-c2n[nH]c3c2c1ccc3	InChI=1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16)	ACPOUJIDANTYHO-UHFFFAOYSA-N					compound annotation
0391_008152	TVB-3166	C24H24N4O	3.5426	72947731		Cc1c(C(=O)N2CC(c3ccc(C#N)cc3)C2)cc(-c2n[nH]c(C)c2C)c(C)c1	InChI=1S/C24H24N4O/c1-14-9-15(2)22(10-21(14)23-16(3)17(4)26-27-23)24(29)28-12-20(13-28)19-7-5-18(11-25)6-8-19/h5-10,20H,12-13H2,1-4H3,(H,26,27)	ICDQFUFDAFKCAX-UHFFFAOYSA-N					doublet; compound annotation
0391_008153	TVB-3166	C24H24N4O	3.5453	72947731		Cc1c(C(=O)N2CC(c3ccc(C#N)cc3)C2)cc(-c2n[nH]c(C)c2C)c(C)c1	InChI=1S/C24H24N4O/c1-14-9-15(2)22(10-21(14)23-16(3)17(4)26-27-23)24(29)28-12-20(13-28)19-7-5-18(11-25)6-8-19/h5-10,20H,12-13H2,1-4H3,(H,26,27)	ICDQFUFDAFKCAX-UHFFFAOYSA-N					doublet; compound annotation
0391_008154	2-HBA	C17H14O3	3.553	5472867	C1=CC=C(C(=C1)/C=C/C(=O)/C=C/C2=CC=CC=C2O)O	O=C(C=Cc1ccccc1O)C=Cc1ccccc1O	InChI=1S/C17H14O3/c18-15(11-9-13-5-1-3-7-16(13)19)12-10-14-6-2-4-8-17(14)20/h1-12,19-20H/b11-9+,12-10+	YNVAHBUBGBLIEY-WGDLNXRISA-N					compound annotation
0391_008155	PHA-680632	C28H35N7O2	3.7683	11249084		CCc1c(NC(=O)N2Cc3c(C2)c(NC(=O)c2ccc(N4CCN(C)CC4)cc2)n[nH]3)c(CC)ccc1	InChI=1S/C28H35N7O2/c1-4-19-7-6-8-20(5-2)25(19)29-28(37)35-17-23-24(18-35)31-32-26(23)30-27(36)21-9-11-22(12-10-21)34-15-13-33(3)14-16-34/h6-12H,4-5,13-18H2,1-3H3,(H,29,37)(H2,30,31,32,36)	OBWNXGOQPLDDPS-UHFFFAOYSA-N					doublet; compound annotation
0391_008156	PHA-680632	C28H35N7O2	3.9769	11249084		CCc1c(NC(=O)N2Cc3c(C2)c(NC(=O)c2ccc(N4CCN(C)CC4)cc2)n[nH]3)c(CC)ccc1	InChI=1S/C28H35N7O2/c1-4-19-7-6-8-20(5-2)25(19)29-28(37)35-17-23-24(18-35)31-32-26(23)30-27(36)21-9-11-22(12-10-21)34-15-13-33(3)14-16-34/h6-12H,4-5,13-18H2,1-3H3,(H,29,37)(H2,30,31,32,36)	OBWNXGOQPLDDPS-UHFFFAOYSA-N					doublet; compound annotation
0391_008157	PHA-680632	C28H35N7O2	4.4331	11249084		CCc1c(NC(=O)N2Cc3c(C2)c(NC(=O)c2ccc(N4CCN(C)CC4)cc2)n[nH]3)c(CC)ccc1	InChI=1S/C28H35N7O2/c1-4-19-7-6-8-20(5-2)25(19)29-28(37)35-17-23-24(18-35)31-32-26(23)30-27(36)21-9-11-22(12-10-21)34-15-13-33(3)14-16-34/h6-12H,4-5,13-18H2,1-3H3,(H,29,37)(H2,30,31,32,36)	OBWNXGOQPLDDPS-UHFFFAOYSA-N					doublet; compound annotation
0391_008158	EB-47	C24H27N9O6	0.6217	9871899	C1CN(CCN1CC(=O)NC2=CC=CC3=C2CNC3=O)C(=O)[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O	Nc1c2ncn(C3OC(C(=O)N4CCN(CC(=O)Nc5cccc6c5CNC6=O)CC4)C(O)C3O)c2ncn1	InChI=1S/C24H27N9O6/c25-20-16-21(28-10-27-20)33(11-29-16)24-18(36)17(35)19(39-24)23(38)32-6-4-31(5-7-32)9-15(34)30-14-3-1-2-12-13(14)8-26-22(12)37/h1-3,10-11,17-19,24,35-36H,4-9H2,(H,26,37)(H,30,34)(H2,25,27,28)/t17-,18+,19-,24+/m0/s1	DDFLFKTXUWPNMV-UAKAABGRSA-N					removed another duplicate entry; compound annotation
0391_008160	Inarigivir soproxil	C25H34N7O13PS	1.9402	24737742	CC(C)OC(=O)OCSP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O[C@@H]4[C@H](O[C@H]([C@@H]4OC)N5C=CC(=O)NC5=O)CO	COC1C(OP(=O)(OCC2OC(n3cnc4c(N)ncnc43)CC2O)SCOC(=O)OC(C)C)C(CO)OC1n1ccc(=O)[nH]c1=O	InChI=1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1	CJCYTUJOSMYXLE-JDLSZIHUSA-N					doublet; compound annotation
0391_008161	Inarigivir soproxil	C25H34N7O13PS	1.9469	24737742	CC(C)OC(=O)OCSP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O[C@@H]4[C@H](O[C@H]([C@@H]4OC)N5C=CC(=O)NC5=O)CO	COC1C(OP(=O)(OCC2OC(n3cnc4c(N)ncnc43)CC2O)SCOC(=O)OC(C)C)C(CO)OC1n1ccc(=O)[nH]c1=O	InChI=1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1	CJCYTUJOSMYXLE-JDLSZIHUSA-N					doublet; compound annotation
0391_008162	302776-68-7	C24H31NO4	2.1653	10111431		CCCCCCOC(=O)c1ccccc1C(=O)c1c(O)cc(N(CC)CC)cc1	InChI=1S/C24H31NO4/c1-4-7-8-11-16-29-24(28)20-13-10-9-12-19(20)23(27)21-15-14-18(17-22(21)26)25(5-2)6-3/h9-10,12-15,17,26H,4-8,11,16H2,1-3H3	FDATWRLUYRHCJE-UHFFFAOYSA-N					doublet; compound annotation
0391_008163	AZD7762	C17H19FN4O2S	2.2994	11152667	C1C[C@@H](CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N	NC(=O)Nc1c(C(=O)NC2CCCNC2)sc(-c2cc(F)ccc2)c1	InChI=1S/C17H19FN4O2S/c18-11-4-1-3-10(7-11)14-8-13(22-17(19)24)15(25-14)16(23)21-12-5-2-6-20-9-12/h1,3-4,7-8,12,20H,2,5-6,9H2,(H,21,23)(H3,19,22,24)/t12-/m0/s1	IAYGCINLNONXHY-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_008165	302776-68-7	C24H31NO4	2.7276	10111431		CCCCCCOC(=O)c1ccccc1C(=O)c1c(O)cc(N(CC)CC)cc1	InChI=1S/C24H31NO4/c1-4-7-8-11-16-29-24(28)20-13-10-9-12-19(20)23(27)21-15-14-18(17-22(21)26)25(5-2)6-3/h9-10,12-15,17,26H,4-8,11,16H2,1-3H3	FDATWRLUYRHCJE-UHFFFAOYSA-N					doublet; compound annotation
0391_008166	154229-21-7	C24H29NO	3.3159	196941	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C	CC12CCC(=O)C=C1CCC1C2CCC2(C)C(c3cnccc3)=CCC12	InChI=1S/C24H29NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-4,7,13-15,19,21-22H,5-6,8-12H2,1-2H3/t19-,21-,22-,23-,24+/m0/s1	GYJZZAJJENTSTP-NHFPKVKZSA-N					compound annotation
0391_008167	302776-68-7	C24H31NO4	3.6405	10111431		CCCCCCOC(=O)c1ccccc1C(=O)c1c(O)cc(N(CC)CC)cc1	InChI=1S/C24H31NO4/c1-4-7-8-11-16-29-24(28)20-13-10-9-12-19(20)23(27)21-15-14-18(17-22(21)26)25(5-2)6-3/h9-10,12-15,17,26H,4-8,11,16H2,1-3H3	FDATWRLUYRHCJE-UHFFFAOYSA-N					doublet; compound annotation
0391_008168	MS7972	C14H13NO2	3.6841	853608		CC(=O)n1c2c(CCCC2=O)c2ccccc21	InChI=1S/C14H13NO2/c1-9(16)15-12-7-3-2-5-10(12)11-6-4-8-13(17)14(11)15/h2-3,5,7H,4,6,8H2,1H3	MIGJEXKBUJPKJF-UHFFFAOYSA-N					compound annotation
0391_008169	302776-68-7	C24H31NO4	6.1191	10111431		CCCCCCOC(=O)c1ccccc1C(=O)c1c(O)cc(N(CC)CC)cc1	InChI=1S/C24H31NO4/c1-4-7-8-11-16-29-24(28)20-13-10-9-12-19(20)23(27)21-15-14-18(17-22(21)26)25(5-2)6-3/h9-10,12-15,17,26H,4-8,11,16H2,1-3H3	FDATWRLUYRHCJE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008172	TAXIFOLIN	C15H12O7	1.8769	439533	C1=CC(=C(C=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	O=C1c2c(O)cc(O)cc2OC(c2cc(O)c(O)cc2)C1O	InChI=1S/C15H12O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,14-19,21H/t14-,15+/m0/s1	CXQWRCVTCMQVQX-LSDHHAIUSA-N					compound annotation
0391_008173	551-08-6	C12H12O2	2.0783	642376	CCC/C=C\1/C2=CC=CC=C2C(=O)O1	CCCC=C1OC(=O)c2ccccc12	InChI=1S/C12H12O2/c1-2-3-8-11-9-6-4-5-7-10(9)12(13)14-11/h4-8H,2-3H2,1H3/b11-8-	WMBOCUXXNSOQHM-FLIBITNWSA-N					compound annotation
0391_008174	13074-31-2	C20H25NO4	2.0783	5418		COc1c(OC)cc(CC2NCCc3cc(OC)c(OC)cc32)cc1	InChI=1S/C20H25NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-6,10-12,16,21H,7-9H2,1-4H3	YXWQTVWJNHKSCC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008176	132201-33-3	C16H15NO4	2.4518	2762289	C1=CC=C(C=C1)[C@@H]([C@H](C(=O)O)O)NC(=O)C2=CC=CC=C2	O=C(NC(c1ccccc1)C(O)C(=O)O)c1ccccc1	InChI=1S/C16H15NO4/c18-14(16(20)21)13(11-7-3-1-4-8-11)17-15(19)12-9-5-2-6-10-12/h1-10,13-14,18H,(H,17,19)(H,20,21)/t13-,14+/m0/s1	HYJVYOWKYPNSTK-UONOGXRCSA-N					removed another duplicate entry; compound annotation
0391_008178	ARS-1620	C21H17ClF2N4O2	3.0108	137003167		C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1	InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2	ZRPZPNYZFSJUPA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008180	Dioscin	C45H72O16	4.7308	119245	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H72O16/c1-19-9-14-45(54-18-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(52)34(50)32(48)22(4)56-41)37(53)38(29(17-46)58-42)59-40-35(51)33(49)31(47)21(3)55-40/h7,19-22,24-42,46-53H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1	VNONINPVFQTJOC-ZGXDEBHDSA-N					removed another duplicate entry; compound annotation
0391_008182	Sclareolide	C16H26O2	5.2163	929262	C[C@]12CCCC([C@@H]1CC[C@@]3([C@@H]2CC(=O)O3)C)(C)C	CC1(C)CCCC2(C)C1CCC1(C)OC(=O)CC12	InChI=1S/C16H26O2/c1-14(2)7-5-8-15(3)11(14)6-9-16(4)12(15)10-13(17)18-16/h11-12H,5-10H2,1-4H3/t11-,12+,15-,16+/m0/s1	IMKJGXCIJJXALX-SHUKQUCYSA-N					compound annotation
0391_008183	AB-MECA	C18H21N7O4	1.1595	5310992	CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NCC4=CC=C(C=C4)N)O)O	CNC(=O)C1OC(n2cnc3c(NCc4ccc(N)cc4)ncnc32)C(O)C1O	InChI=1S/C18H21N7O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-2-4-10(19)5-3-9/h2-5,7-8,12-14,18,26-27H,6,19H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1	LDYMCRRFCMRFKB-MOROJQBDSA-N					removed another duplicate entry; compound annotation
0391_008185	Ethyl maltol	C7H8O3	1.5235	21059		CCc1c(O)c(=O)cco1	InChI=1S/C7H8O3/c1-2-6-7(9)5(8)3-4-10-6/h3-4,9H,2H2,1H3	YIKYNHJUKRTCJL-UHFFFAOYSA-N					compound annotation
0391_008186	2365-40-4	C10H13N5	1.5698	92180		CC(C)=CCNc1ncnc2c1[nH]cn2	InChI=1S/C10H13N5/c1-7(2)3-4-11-9-8-10(13-5-12-8)15-6-14-9/h3,5-6H,4H2,1-2H3,(H2,11,12,13,14,15)	HYVABZIGRDEKCD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008188	Corynoline	C21H21NO5	2.1937	177014	C[C@]12[C@H](CC3=CC4=C(C=C3[C@H]1N(CC5=C2C=CC6=C5OCO6)C)OCO4)O	CN1Cc2c(ccc3c2OCO3)C2(C)C(O)Cc3cc4c(cc3C12)OCO4	InChI=1S/C21H21NO5/c1-21-14-3-4-15-19(27-10-24-15)13(14)8-22(2)20(21)12-7-17-16(25-9-26-17)5-11(12)6-18(21)23/h3-5,7,18,20,23H,6,8-10H2,1-2H3/t18-,20+,21-/m0/s1	IQUGPRHKZNCHGC-TYPHKJRUSA-N					doublet; compound annotation
0391_008189	AZD3264	C21H23N5O4S	2.2368	91666658	CC1=C(C(=NO1)C)C2=CC(=C(C=C2)C3=CC(=C(S3)NC(=O)N)C(=O)N)O[C@H]4CCNC4	Cc1noc(C)c1-c1cc(OC2CCNC2)c(-c2cc(C(N)=O)c(NC(N)=O)s2)cc1	InChI=1S/C21H23N5O4S/c1-10-18(11(2)30-26-10)12-3-4-14(16(7-12)29-13-5-6-24-9-13)17-8-15(19(22)27)20(31-17)25-21(23)28/h3-4,7-8,13,24H,5-6,9H2,1-2H3,(H2,22,27)(H3,23,25,28)/t13-/m0/s1	NMFIXEFNQPDISY-ZDUSSCGKSA-N					doublet; removed another duplicate entry; compound annotation
0391_008191	AZD3264	C21H23N5O4S	2.2398	91666658	CC1=C(C(=NO1)C)C2=CC(=C(C=C2)C3=CC(=C(S3)NC(=O)N)C(=O)N)O[C@H]4CCNC4	Cc1noc(C)c1-c1cc(OC2CCNC2)c(-c2cc(C(N)=O)c(NC(N)=O)s2)cc1	InChI=1S/C21H23N5O4S/c1-10-18(11(2)30-26-10)12-3-4-14(16(7-12)29-13-5-6-24-9-13)17-8-15(19(22)27)20(31-17)25-21(23)28/h3-4,7-8,13,24H,5-6,9H2,1-2H3,(H2,22,27)(H3,23,25,28)/t13-/m0/s1	NMFIXEFNQPDISY-ZDUSSCGKSA-N					doublet; compound annotation
0391_008192	TA-01	C20H12F3N3	2.3306	91691129		Fc1ccc(-c2c(-c3ccncc3)[nH]c(-c3c(F)cccc3F)n2)cc1	InChI=1S/C20H12F3N3/c21-14-6-4-12(5-7-14)18-19(13-8-10-24-11-9-13)26-20(25-18)17-15(22)2-1-3-16(17)23/h1-11H,(H,25,26)	TWPJJJZCYVFUOA-UHFFFAOYSA-N					doublet; compound annotation
0391_008193	AZD3264	C21H23N5O4S	2.3479	91666658	CC1=C(C(=NO1)C)C2=CC(=C(C=C2)C3=CC(=C(S3)NC(=O)N)C(=O)N)O[C@H]4CCNC4	Cc1noc(C)c1-c1cc(OC2CCNC2)c(-c2cc(C(N)=O)c(NC(N)=O)s2)cc1	InChI=1S/C21H23N5O4S/c1-10-18(11(2)30-26-10)12-3-4-14(16(7-12)29-13-5-6-24-9-13)17-8-15(19(22)27)20(31-17)25-21(23)28/h3-4,7-8,13,24H,5-6,9H2,1-2H3,(H2,22,27)(H3,23,25,28)/t13-/m0/s1	NMFIXEFNQPDISY-ZDUSSCGKSA-N					doublet; compound annotation
0391_008194	Corynoline	C21H21NO5	2.4222	177014	C[C@]12[C@H](CC3=CC4=C(C=C3[C@H]1N(CC5=C2C=CC6=C5OCO6)C)OCO4)O	CN1Cc2c(ccc3c2OCO3)C2(C)C(O)Cc3cc4c(cc3C12)OCO4	InChI=1S/C21H21NO5/c1-21-14-3-4-15-19(27-10-24-15)13(14)8-22(2)20(21)12-7-17-16(25-9-26-17)5-11(12)6-18(21)23/h3-5,7,18,20,23H,6,8-10H2,1-2H3/t18-,20+,21-/m0/s1	IQUGPRHKZNCHGC-TYPHKJRUSA-N					doublet; compound annotation
0391_008195	GDC-0326	C19H22N6O3	2.6234	58204997	C[C@@H](C(=O)N)OC1=CC2=C(C=C1)C3=NC(=CN3CCO2)C4=NC=NN4C(C)C	CC(Oc1cc2c(cc1)-c1nc(-c3ncnn3C(C)C)cn1CCO2)C(N)=O	InChI=1S/C19H22N6O3/c1-11(2)25-19(21-10-22-25)15-9-24-6-7-27-16-8-13(28-12(3)17(20)26)4-5-14(16)18(24)23-15/h4-5,8-12H,6-7H2,1-3H3,(H2,20,26)/t12-/m0/s1	SIKYDKLGPWRPMZ-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_008197	TA-01	C20H12F3N3	2.6527	91691129		Fc1ccc(-c2c(-c3ccncc3)[nH]c(-c3c(F)cccc3F)n2)cc1	InChI=1S/C20H12F3N3/c21-14-6-4-12(5-7-14)18-19(13-8-10-24-11-9-13)26-20(25-18)17-15(22)2-1-3-16(17)23/h1-11H,(H,25,26)	TWPJJJZCYVFUOA-UHFFFAOYSA-N					doublet; compound annotation
0391_008198	KNK437	C13H11NO4	3.0442	46195007	C\1CN(C(=O)/C1=C/C2=CC3=C(C=C2)OCO3)C=O	O=CN1CCC(=Cc2cc3c(cc2)OCO3)C1=O	InChI=1S/C13H11NO4/c15-7-14-4-3-10(13(14)16)5-9-1-2-11-12(6-9)18-8-17-11/h1-2,5-7H,3-4,8H2/b10-5+	LZGGUFLRKIMBDQ-BJMVGYQFSA-N					doublet; compound annotation
0391_008199	KNK437	C13H11NO4	3.0478	46195007	C\1CN(C(=O)/C1=C/C2=CC3=C(C=C2)OCO3)C=O	O=CN1CCC(=Cc2cc3c(cc2)OCO3)C1=O	InChI=1S/C13H11NO4/c15-7-14-4-3-10(13(14)16)5-9-1-2-11-12(6-9)18-8-17-11/h1-2,5-7H,3-4,8H2/b10-5+	LZGGUFLRKIMBDQ-BJMVGYQFSA-N					doublet; removed another duplicate entry; compound annotation
0391_008201	KNK437	C13H11NO4	3.2225	46195007	C\1CN(C(=O)/C1=C/C2=CC3=C(C=C2)OCO3)C=O	O=CN1CCC(=Cc2cc3c(cc2)OCO3)C1=O	InChI=1S/C13H11NO4/c15-7-14-4-3-10(13(14)16)5-9-1-2-11-12(6-9)18-8-17-11/h1-2,5-7H,3-4,8H2/b10-5+	LZGGUFLRKIMBDQ-BJMVGYQFSA-N					doublet; compound annotation
0391_008202	RSL3	C23H21ClN2O5	4.2255	1750826	COC(=O)[C@H]1CC2=C([C@@H](N1C(=O)CCl)C3=CC=C(C=C3)C(=O)OC)NC4=CC=CC=C24	COC(=O)c1ccc(C2c3c(CC(C(=O)OC)N2C(=O)CCl)c2ccccc2[nH]3)cc1	InChI=1S/C23H21ClN2O5/c1-30-22(28)14-9-7-13(8-10-14)21-20-16(15-5-3-4-6-17(15)25-20)11-18(23(29)31-2)26(21)19(27)12-24/h3-10,18,21,25H,11-12H2,1-2H3/t18-,21+/m1/s1	TXJZRSRTYPUYRW-NQIIRXRSSA-N					removed another duplicate entry; compound annotation
0391_008205	292632-98-5	C39H52N4O6	4.8113	5479543	CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)OC(C)(C)C)O	CC(C)CC(NC(=O)C(Cc1ccccc1)CC(O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C39H52N4O6/c1-26(2)21-33(37(47)41-32(35(40)45)24-29-19-13-8-14-20-29)42-36(46)30(22-27-15-9-6-10-16-27)25-34(44)31(23-28-17-11-7-12-18-28)43-38(48)49-39(3,4)5/h6-20,26,30-34,44H,21-25H2,1-5H3,(H2,40,45)(H,41,47)(H,42,46)(H,43,48)/t30-,31+,32+,33+,34-/m1/s1	MURCDOXDAHPNRQ-ZJKZPDEISA-N					removed another duplicate entry; compound annotation
0391_008207	AMILORIDE	C6H8ClN7O	0.6921	16231		NC(N)=NC(=O)c1c(N)nc(N)c(Cl)n1	InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)	XSDQTOBWRPYKKA-UHFFFAOYSA-N					doublet; compound annotation
0391_008208	1977-07-7	C18H20N4	1.2702	16103		CN1CCN(C2=Nc3ccccc3Nc3ccccc23)CC1	InChI=1S/C18H20N4/c1-21-10-12-22(13-11-21)18-14-6-2-3-7-15(14)19-16-8-4-5-9-17(16)20-18/h2-9,19H,10-13H2,1H3	VQHITFFJBFOMBG-UHFFFAOYSA-N					compound annotation
0391_008209	Prucalopride	C18H26ClN3O3	1.7372	3052762		COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)	ZPMNHBXQOOVQJL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008211	CRAC intermediate 1	C10H7F2N3O	1.8234	59547942		O=C(Nc1ccn[nH]1)c1c(F)cccc1F	InChI=1S/C10H7F2N3O/c11-6-2-1-3-7(12)9(6)10(16)14-8-4-5-13-15-8/h1-5H,(H2,13,14,15,16)	UMBVHXNGQIFPCN-UHFFFAOYSA-N					doublet; compound annotation
0391_008212	CRAC intermediate 1	C10H7F2N3O	1.8267	59547942		O=C(Nc1ccn[nH]1)c1c(F)cccc1F	InChI=1S/C10H7F2N3O/c11-6-2-1-3-7(12)9(6)10(16)14-8-4-5-13-15-8/h1-5H,(H2,13,14,15,16)	UMBVHXNGQIFPCN-UHFFFAOYSA-N					doublet; compound annotation
0391_008213	CRAC intermediate 1	C10H7F2N3O	2.2711	59547942		O=C(Nc1ccn[nH]1)c1c(F)cccc1F	InChI=1S/C10H7F2N3O/c11-6-2-1-3-7(12)9(6)10(16)14-8-4-5-13-15-8/h1-5H,(H2,13,14,15,16)	UMBVHXNGQIFPCN-UHFFFAOYSA-N					doublet; compound annotation
0391_008214	3-(4-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione	C13H11BrN2O3	2.4713	131986901		O=C1CCC(N2Cc3c(cccc3Br)C2=O)C(=O)N1	InChI=1S/C13H11BrN2O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6H2,(H,15,17,18)	SCZFMUWTABGOGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008216	PF-2545920	C25H20N4O	2.6174	11581936		Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	AZEXWHKOMMASPA-UHFFFAOYSA-N					doublet; compound annotation
0391_008217	PF-2545920	C25H20N4O	2.6265	11581936		Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	AZEXWHKOMMASPA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008219	suprofen	C14H12O3S	3.3435	5359		CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1	InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)	MDKGKXOCJGEUJW-UHFFFAOYSA-N					compound annotation
0391_008220	MK 571	C26H27ClN2O3S2	4.0218	5281888	CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+	AXUZQJFHDNNPFG-UXBLZVDNSA-N					doublet; compound annotation
0391_008221	MK 571	C26H27ClN2O3S2	4.0248	5281888	CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+	AXUZQJFHDNNPFG-UXBLZVDNSA-N					doublet; compound annotation
0391_008222	MK 571	C26H27ClN2O3S2	4.2957	5281888	CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+	AXUZQJFHDNNPFG-UXBLZVDNSA-N					doublet; compound annotation
0391_008223	MK 571	C26H27ClN2O3S2	4.2984	5281888	CN(C)C(=O)CCSC(C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O	CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(C=Cc2nc3c(ccc(Cl)c3)cc2)c1	InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+	AXUZQJFHDNNPFG-UXBLZVDNSA-N					doublet; compound annotation
0391_008224	486427-17-2	C26H26ClNO5	4.7213	4231127		COc1ccc(OCC2c3cc(OC)c(OC)cc3CCN2C(=O)c2cc(Cl)ccc2)cc1	InChI=1S/C26H26ClNO5/c1-30-20-7-9-21(10-8-20)33-16-23-22-15-25(32-3)24(31-2)14-17(22)11-12-28(23)26(29)18-5-4-6-19(27)13-18/h4-10,13-15,23H,11-12,16H2,1-3H3	VYMILMYEENZHAR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008226	Dehydroemetine	C29H38N2O4	1.5432	21022	CCC1=C(C[C@H]2C3=CC(=C(C=C3CCN2C1)OC)OC)C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC	CCC1=C(CC2NCCc3cc(OC)c(OC)cc32)CC2c3cc(OC)c(OC)cc3CCN2C1	InChI=1S/C29H38N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,24-25,30H,6-12,17H2,1-5H3/t24-,25+/m1/s1	XXLZPUYGHQWHRN-RPBOFIJWSA-N					compound annotation
0391_008227	cwhm-12	C26H32BrN5O6	2.9011	124584648	CC(C)(C)C1=CC(=CC(=C1)[C@H](CC(=O)O)NC(=O)CNC(=O)C2=CC(=CC(=C2)O)NC3=NC[C@H](CN3)O)Br	CC(C)(C)c1cc(Br)cc(C(CC(=O)O)NC(=O)CNC(=O)c2cc(NC3=NCC(O)CN3)cc(O)c2)c1	InChI=1S/C26H32BrN5O6/c1-26(2,3)16-4-14(5-17(27)8-16)21(10-23(36)37)32-22(35)13-28-24(38)15-6-18(9-19(33)7-15)31-25-29-11-20(34)12-30-25/h4-9,20-21,33-34H,10-13H2,1-3H3,(H,28,38)(H,32,35)(H,36,37)(H2,29,30,31)/t21-/m0/s1	YDHAGPCZRFQPOI-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_008229	HG6-64-1	C32H34F3N5O2	2.9687	53302361	CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)/C=C/C4=CN=C5C(=C4OC)C=CN5)C(F)(F)F	CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(C=Cc4cnc5[nH]ccc5c4OC)c(C)cc3)cc2)CC1	InChI=1S/C32H34F3N5O2/c1-4-39-13-15-40(16-14-39)20-25-9-10-26(18-28(25)32(33,34)35)38-31(41)23-6-5-21(2)22(17-23)7-8-24-19-37-30-27(11-12-36-30)29(24)42-3/h5-12,17-19H,4,13-16,20H2,1-3H3,(H,36,37)(H,38,41)/b8-7+	UMBFDGUGXMOMHX-BQYQJAHWSA-N					doublet; compound annotation
0391_008230	HG6-64-1	C32H34F3N5O2	3.0272	53302361	CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)/C=C/C4=CN=C5C(=C4OC)C=CN5)C(F)(F)F	CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(C=Cc4cnc5[nH]ccc5c4OC)c(C)cc3)cc2)CC1	InChI=1S/C32H34F3N5O2/c1-4-39-13-15-40(16-14-39)20-25-9-10-26(18-28(25)32(33,34)35)38-31(41)23-6-5-21(2)22(17-23)7-8-24-19-37-30-27(11-12-36-30)29(24)42-3/h5-12,17-19H,4,13-16,20H2,1-3H3,(H,36,37)(H,38,41)/b8-7+	UMBFDGUGXMOMHX-BQYQJAHWSA-N					doublet; compound annotation
0391_008231	796-42-9	C17H13N3O2	3.2384	4491		O=C(NN=Cc1c(O)ccc2ccccc12)c1ccncc1	InChI=1S/C17H13N3O2/c21-16-6-5-12-3-1-2-4-14(12)15(16)11-19-20-17(22)13-7-9-18-10-8-13/h1-11,21H,(H,20,22)	WQSHHAVECQJKLX-UHFFFAOYSA-N					compound annotation
0391_008232	CAM-IN-1	C15H11BrN2O2S	3.4937	10361323		CNC(=O)c1cc2c(cncc2Oc2ccc(Br)cc2)s1	InChI=1S/C15H11BrN2O2S/c1-17-15(19)13-6-11-12(7-18-8-14(11)21-13)20-10-4-2-9(16)3-5-10/h2-8H,1H3,(H,17,19)	OFXAEWYLVPBGGU-UHFFFAOYSA-N					compound annotation
0391_008233	GLPG0492 R enantiomer	C19H14F3N3O3	3.9826	59317173	CN1C(=O)N(C(=O)[C@]1(CO)C2=CC=CC=C2)C3=CC(=C(C=C3)C#N)C(F)(F)F	CN1C(=O)N(c2cc(C(F)(F)F)c(C#N)cc2)C(=O)C1(CO)c1ccccc1	InChI=1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20,21)22)16(27)18(24,11-26)13-5-3-2-4-6-13/h2-9,26H,11H2,1H3/t18-/m0/s1	VAJGULUVTFDTAS-SFHVURJKSA-N					doublet; compound annotation
0391_008234	GLPG0492 R enantiomer	C19H14F3N3O3	4.1196	59317173	CN1C(=O)N(C(=O)[C@]1(CO)C2=CC=CC=C2)C3=CC(=C(C=C3)C#N)C(F)(F)F	CN1C(=O)N(c2cc(C(F)(F)F)c(C#N)cc2)C(=O)C1(CO)c1ccccc1	InChI=1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20,21)22)16(27)18(24,11-26)13-5-3-2-4-6-13/h2-9,26H,11H2,1H3/t18-/m0/s1	VAJGULUVTFDTAS-SFHVURJKSA-N					doublet; compound annotation
0391_008235	Clindamycin palmitate	C34H63ClN2O6S	6.0776	16052039	CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)Cl)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O	CCCCCCCCCCCCCCCC(=O)OC1C(SC)OC(C(NC(=O)C2CC(CCC)CN2C)C(C)Cl)C(O)C1O	InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/t24-,25+,26-,28+,29+,30-,31+,32+,34+/m0/s1	OYSKUZDIHNKWLV-PRUAPSLNSA-N					doublet; compound annotation
0391_008236	Clindamycin palmitate	C34H63ClN2O6S	6.0806	16052039	CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)Cl)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O	CCCCCCCCCCCCCCCC(=O)OC1C(SC)OC(C(NC(=O)C2CC(CCC)CN2C)C(C)Cl)C(O)C1O	InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/t24-,25+,26-,28+,29+,30-,31+,32+,34+/m0/s1	OYSKUZDIHNKWLV-PRUAPSLNSA-N					doublet; compound annotation
0391_008237	CHEMBL1095672	C40H61N11O9	1.6995	9854089	C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C)N)O	CC(C)CC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(NC(=O)C(C)N)C(C)O)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)O	InChI=1S/C40H61N11O9/c1-21(2)18-29(48-34(54)28(19-24-20-45-26-11-6-5-10-25(24)26)47-36(56)32(23(4)52)49-33(53)22(3)41)37(57)51-17-9-14-31(51)38(58)50-16-8-13-30(50)35(55)46-27(39(59)60)12-7-15-44-40(42)43/h5-6,10-11,20-23,27-32,45,52H,7-9,12-19,41H2,1-4H3,(H,46,55)(H,47,56)(H,48,54)(H,49,53)(H,59,60)(H4,42,43,44)/t22-,23+,27-,28-,29-,30-,31-,32-/m0/s1	MKSPBYRGLCNGRC-OEMOKZHXSA-N					compound annotation
0391_008238	WM-1119	C18H13F2N3O3S	3.3076	133080719		O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1	InChI=1S/C18H13F2N3O3S/c19-14-10-12(16-6-3-4-8-21-16)9-13(11-14)18(24)22-23-27(25,26)17-7-2-1-5-15(17)20/h1-11,23H,(H,22,24)	QLXULUNLCRKWRD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008240	LDN-27219	C20H16N4O2S2	3.4427	1150683		NNC(=O)CSc1nc2c(c(-c3ccccc3)cs2)c(=O)n1-c1ccccc1	InChI=1S/C20H16N4O2S2/c21-23-16(25)12-28-20-22-18-17(15(11-27-18)13-7-3-1-4-8-13)19(26)24(20)14-9-5-2-6-10-14/h1-11H,12,21H2,(H,23,25)	WLBUICQBNZXIDJ-UHFFFAOYSA-N					doublet; compound annotation
0391_008241	LDN-27219	C20H16N4O2S2	3.4456	1150683		NNC(=O)CSc1nc2c(c(-c3ccccc3)cs2)c(=O)n1-c1ccccc1	InChI=1S/C20H16N4O2S2/c21-23-16(25)12-28-20-22-18-17(15(11-27-18)13-7-3-1-4-8-13)19(26)24(20)14-9-5-2-6-10-14/h1-11H,12,21H2,(H,23,25)	WLBUICQBNZXIDJ-UHFFFAOYSA-N					doublet; compound annotation
0391_008242	Silvestrol aglycone	C27H26O8	3.6581	24178739	COC1=CC=C(C=C1)[C@]23[C@@H]([C@H]([C@H]([C@]2(C4=C(O3)C=C(C=C4OC)O)O)O)C(=O)OC)C5=CC=CC=C5	COC(=O)C1C(O)C2(O)c3c(cc(O)cc3OC)OC2(c2ccc(OC)cc2)C1c1ccccc1	InChI=1S/C27H26O8/c1-32-18-11-9-16(10-12-18)27-22(15-7-5-4-6-8-15)21(25(30)34-3)24(29)26(27,31)23-19(33-2)13-17(28)14-20(23)35-27/h4-14,21-22,24,28-29,31H,1-3H3/t21-,22-,24-,26+,27+/m1/s1	HYLOONIBWUNKDH-PXIJUOARSA-N					removed another duplicate entry; compound annotation
0391_008244	iCRT3	C23H26N2O2S	4.7287	6622273		CCc1ccc(-c2nc(CSCC(=O)NCCc3ccccc3)c(C)o2)cc1	InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12H,3,13-16H2,1-2H3,(H,24,26)	QTDYVSIBWGVBKU-UHFFFAOYSA-N					doublet; compound annotation
0391_008245	216691-95-1	C27H21ClN2O2	4.8198	644335		CN1C(=O)C(Cc2cc3ccccc3cc2)N=C(c2ccc(O)cc2)c2c1ccc(Cl)c2	InChI=1S/C27H21ClN2O2/c1-30-25-13-10-21(28)16-23(25)26(19-8-11-22(31)12-9-19)29-24(27(30)32)15-17-6-7-18-4-2-3-5-20(18)14-17/h2-14,16,24,31H,15H2,1H3	HIJCSNHREFFOML-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008247	iCRT3	C23H26N2O2S	4.9929	6622273		CCc1ccc(-c2nc(CSCC(=O)NCCc3ccccc3)c(C)o2)cc1	InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12H,3,13-16H2,1-2H3,(H,24,26)	QTDYVSIBWGVBKU-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008249	XEN907	C21H21NO4	5.0725	11998198		CCCCCN1C(=O)C2(COc3cc4c(cc32)OCO4)c2ccccc21	InChI=1S/C21H21NO4/c1-2-3-6-9-22-16-8-5-4-7-14(16)21(20(22)23)12-24-17-11-19-18(10-15(17)21)25-13-26-19/h4-5,7-8,10-11H,2-3,6,9,12-13H2,1H3	PHMRUZIIERITEP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008252	LDN-27219	C20H16N4O2S2	5.2807	1150683		NNC(=O)CSc1nc2c(c(-c3ccccc3)cs2)c(=O)n1-c1ccccc1	InChI=1S/C20H16N4O2S2/c21-23-16(25)12-28-20-22-18-17(15(11-27-18)13-7-3-1-4-8-13)19(26)24(20)14-9-5-2-6-10-14/h1-11H,12,21H2,(H,23,25)	WLBUICQBNZXIDJ-UHFFFAOYSA-N					doublet; compound annotation
0391_008253	ABX-464	C16H10ClF3N2O	5.7006	49846599		FC(F)(F)Oc1ccc(Nc2nc3c(cccc3Cl)cc2)cc1	InChI=1S/C16H10ClF3N2O/c17-13-3-1-2-10-4-9-14(22-15(10)13)21-11-5-7-12(8-6-11)23-16(18,19)20/h1-9H,(H,21,22)	OZOGDCZJYVSUBR-UHFFFAOYSA-N					compound annotation
0391_008254	Abemaciclib metabolite M18	C25H28F2N8O	1.7492	145925652		CC(C)n1c(CO)nc2c1cc(-c1nc(Nc3ncc(CN4CCNCC4)cc3)ncc1F)cc2F	InChI=1S/C25H28F2N8O/c1-15(2)35-20-10-17(9-18(26)24(20)32-22(35)14-36)23-19(27)12-30-25(33-23)31-21-4-3-16(11-29-21)13-34-7-5-28-6-8-34/h3-4,9-12,15,28,36H,5-8,13-14H2,1-2H3,(H,29,30,31,33)	YQMRQLBCUBZXEP-UHFFFAOYSA-N					compound annotation
0391_008255	N6022	C24H22N4O3	2.0737	44623946		Cc1c(-n2c(CCC(=O)O)ccc2-c2ccc(-n3ccnc3)cc2)ccc(C(N)=O)c1	InChI=1S/C24H22N4O3/c1-16-14-18(24(25)31)4-9-21(16)28-20(8-11-23(29)30)7-10-22(28)17-2-5-19(6-3-17)27-13-12-26-15-27/h2-7,9-10,12-15H,8,11H2,1H3,(H2,25,31)(H,29,30)	YVPGZQLRPAGKLA-UHFFFAOYSA-N					compound annotation
0391_008256	Acalisib	C21H16FN7O	2.6786	11618268	C[C@@H](C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	CC(Nc1ncnc2c1[nH]cn2)c1nc2c(cc(F)cc2)c(=O)n1-c1ccccc1	InChI=1S/C21H16FN7O/c1-12(27-19-17-18(24-10-23-17)25-11-26-19)20-28-16-8-7-13(22)9-15(16)21(30)29(20)14-5-3-2-4-6-14/h2-12H,1H3,(H2,23,24,25,26,27)/t12-/m0/s1	DOCINCLJNAXZQF-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_008258	Gemigliptin	C18H19F8N5O2	2.9729	11953153	C1CC(CN(C1=O)C[C@H](CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F	NC(CC(=O)N1CCc2c(C1)nc(C(F)(F)F)nc2C(F)(F)F)CN1CC(F)(F)CCC1=O	InChI=1S/C18H19F8N5O2/c19-16(20)3-1-12(32)31(8-16)6-9(27)5-13(33)30-4-2-10-11(7-30)28-15(18(24,25)26)29-14(10)17(21,22)23/h9H,1-8,27H2/t9-/m0/s1	ZWPRRQZNBDYKLH-VIFPVBQESA-N					compound annotation
0391_008259	(S,R,S)-AHPC-propargyl	C27H34N4O5S	3.0782	138991775	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COCC#C)O	C#CCOCC(=O)NC(C(=O)N1CC(O)CC1C(=O)NCc1ccc(-c2c(C)ncs2)cc1)C(C)(C)C	InChI=1S/C27H34N4O5S/c1-6-11-36-15-22(33)30-24(27(3,4)5)26(35)31-14-20(32)12-21(31)25(34)28-13-18-7-9-19(10-8-18)23-17(2)29-16-37-23/h1,7-10,16,20-21,24,32H,11-15H2,2-5H3,(H,28,34)(H,30,33)/t20-,21+,24-/m1/s1	UGJHKPQUMUDIQJ-ZFGGDYGUSA-N					removed another duplicate entry; compound annotation
0391_008261	Iodonitrotetrazolium	C19H13IN5O2+	3.4109	64958		O=[N+]([O-])c1ccc(-[n+]2nc(-c3ccccc3)nn2-c2ccc(I)cc2)cc1	InChI=1S/C19H13IN5O2/c20-15-6-8-16(9-7-15)23-21-19(14-4-2-1-3-5-14)22-24(23)17-10-12-18(13-11-17)25(26)27/h1-13H/q+1	YCMNFTXISHKEBZ-UHFFFAOYSA-N					compound annotation
0391_008262	Taprenepag	C24H22N4O5S	3.511	18376177		O=C(O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cnccc2)c1	InChI=1S/C24H22N4O5S/c29-24(30)18-33-22-5-1-4-20(14-22)17-27(34(31,32)23-6-2-11-25-15-23)16-19-7-9-21(10-8-19)28-13-3-12-26-28/h1-15H,16-18H2,(H,29,30)	MFFBXYNKZHTCEY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008264	Firategrast	C27H27F2NO6	4.1315	9935681	CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC	CCOCc1cc(OC)c(-c2ccc(CC(NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1	InChI=1S/C27H27F2NO6/c1-4-36-15-17-13-22(34-2)24(23(14-17)35-3)18-10-8-16(9-11-18)12-21(27(32)33)30-26(31)25-19(28)6-5-7-20(25)29/h5-11,13-14,21H,4,12,15H2,1-3H3,(H,30,31)(H,32,33)/t21-/m0/s1	YLFZHHDVRSYTKT-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_008267	R(+)-IAA-94	C17H18Cl2O4	4.4502	656717	C[C@]1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3CCCC3	CC1(C2CCCC2)Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O	InChI=1S/C17H18Cl2O4/c1-17(10-4-2-3-5-10)7-9-6-11(23-8-12(20)21)14(18)15(19)13(9)16(17)22/h6,10H,2-5,7-8H2,1H3,(H,20,21)/t17-/m0/s1	RNOJGTHBMJBOSP-KRWDZBQOSA-N					compound annotation
0391_008268	Camicinal	C25H33FN4O	2.3375	15984937	C[C@H]1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F	CC1CN(Cc2ccc(CC(=O)N3CCC(Nc4cc(F)ccc4)CC3)cc2)CCN1	InChI=1S/C25H33FN4O/c1-19-17-29(14-11-27-19)18-21-7-5-20(6-8-21)15-25(31)30-12-9-23(10-13-30)28-24-4-2-3-22(26)16-24/h2-8,16,19,23,27-28H,9-15,17-18H2,1H3/t19-/m0/s1	RZKDEGZIFSJVNA-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_008270	BAY885	C25H28F3N7O2	2.6062	134128280		CN1CCN(c2cc3c(nc2)c(C2CCN(C(=O)c4c(N)cc(OC(F)(F)F)cc4)CC2)ncn3)CC1	InChI=1S/C25H28F3N7O2/c1-33-8-10-34(11-9-33)17-12-21-23(30-14-17)22(32-15-31-21)16-4-6-35(7-5-16)24(36)19-3-2-18(13-20(19)29)37-25(26,27)28/h2-3,12-16H,4-11,29H2,1H3	QXURFIGBRGWPQD-UHFFFAOYSA-N					doublet; compound annotation
0391_008271	BAY885	C25H28F3N7O2	2.6371	134128280		CN1CCN(c2cc3c(nc2)c(C2CCN(C(=O)c4c(N)cc(OC(F)(F)F)cc4)CC2)ncn3)CC1	InChI=1S/C25H28F3N7O2/c1-33-8-10-34(11-9-33)17-12-21-23(30-14-17)22(32-15-31-21)16-4-6-35(7-5-16)24(36)19-3-2-18(13-20(19)29)37-25(26,27)28/h2-3,12-16H,4-11,29H2,1H3	QXURFIGBRGWPQD-UHFFFAOYSA-N					doublet; compound annotation
0391_008272	BAY885	C25H28F3N7O2	2.6398	134128280		CN1CCN(c2cc3c(nc2)c(C2CCN(C(=O)c4c(N)cc(OC(F)(F)F)cc4)CC2)ncn3)CC1	InChI=1S/C25H28F3N7O2/c1-33-8-10-34(11-9-33)17-12-21-23(30-14-17)22(32-15-31-21)16-4-6-35(7-5-16)24(36)19-3-2-18(13-20(19)29)37-25(26,27)28/h2-3,12-16H,4-11,29H2,1H3	QXURFIGBRGWPQD-UHFFFAOYSA-N					doublet; compound annotation
0391_008273	175340-20-2	C10H12N2O2S	2.6796	637863	C1C[C@@H]2NS(=O)(=O)C3=CC=CC=C3N2C1	O=S1(=O)NC2CCCN2c2ccccc21	InChI=1S/C10H12N2O2S/c13-15(14)9-5-2-1-4-8(9)12-7-3-6-10(12)11-15/h1-2,4-5,10-11H,3,6-7H2/t10-/m1/s1	MNTIJYGEITVWHU-SNVBAGLBSA-N					removed another duplicate entry; compound annotation
0391_008275	Tyk2-IN-8	C20H17N9	2.8225	130339268		Cn1cc(-c2cn3nccc3c(-c3cn(C4(CC#N)CC(C#N)C4)nc3)n2)cn1	InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3	XPLZTJWZDBFWDE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008277	Tyk2-IN-8	C20H17N9	2.8254	130339268		Cn1cc(-c2cn3nccc3c(-c3cn(C4(CC#N)CC(C#N)C4)nc3)n2)cn1	InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3	XPLZTJWZDBFWDE-UHFFFAOYSA-N					doublet; compound annotation
0391_008278	ELIGLUSTAT	C23H36N2O4	2.9591	23652731	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1	FJZZPCZKBUKGGU-AUSIDOKSSA-N					doublet; compound annotation
0391_008279	ELIGLUSTAT	C23H36N2O4	3.0406	23652731	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1	FJZZPCZKBUKGGU-AUSIDOKSSA-N					doublet; compound annotation
0391_008280	FT113	C22H20FN3O4	3.287	118621601		O=C(c1ccc(-c2nc3c(cc(F)cc3)o2)cc1)N1CCN(C(=O)C2(O)CC2)CC1	InChI=1S/C22H20FN3O4/c23-16-5-6-17-18(13-16)30-19(24-17)14-1-3-15(4-2-14)20(27)25-9-11-26(12-10-25)21(28)22(29)7-8-22/h1-6,13,29H,7-12H2	DSTWHRGOCUOKDE-UHFFFAOYSA-N					doublet; compound annotation
0391_008281	FT113	C22H20FN3O4	3.2897	118621601		O=C(c1ccc(-c2nc3c(cc(F)cc3)o2)cc1)N1CCN(C(=O)C2(O)CC2)CC1	InChI=1S/C22H20FN3O4/c23-16-5-6-17-18(13-16)30-19(24-17)14-1-3-15(4-2-14)20(27)25-9-11-26(12-10-25)21(28)22(29)7-8-22/h1-6,13,29H,7-12H2	DSTWHRGOCUOKDE-UHFFFAOYSA-N					doublet; compound annotation
0391_008282	MIBAMPATOR	C21H30N2O4S2	3.8799	9889366	C[C@@H](CNS(=O)(=O)C(C)C)C1=CC=C(C=C1)C2=CC=C(C=C2)CCNS(=O)(=O)C	CC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(CCNS(C)(=O)=O)cc2)cc1	InChI=1S/C21H30N2O4S2/c1-16(2)29(26,27)23-15-17(3)19-9-11-21(12-10-19)20-7-5-18(6-8-20)13-14-22-28(4,24)25/h5-12,16-17,22-23H,13-15H2,1-4H3/t17-/m0/s1	ULRDYYKSPCRXAJ-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_008285	376594-67-1	C19H22F2N2O3S	4.071	9843690	C[C@@H](CNS(=O)(=O)C(C)C)C1=CC=C(C=C1)NC(=O)C2=CC(=CC(=C2)F)F	CC(CNS(=O)(=O)C(C)C)c1ccc(NC(=O)c2cc(F)cc(F)c2)cc1	InChI=1S/C19H22F2N2O3S/c1-12(2)27(25,26)22-11-13(3)14-4-6-18(7-5-14)23-19(24)15-8-16(20)10-17(21)9-15/h4-10,12-13,22H,11H2,1-3H3,(H,23,24)/t13-/m0/s1	ACOXQYLJOQAHST-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_008287	CINCHONIDINE	C19H22N2O	1.286	101744	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=CC=NC4=CC=CC=C34)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccccc12	InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18-,19+/m0/s1	KMPWYEUPVWOPIM-KODHJQJWSA-N					doublet; compound annotation
0391_008288	CINCHONIDINE	C19H22N2O	1.3434	101744	C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=CC=NC4=CC=CC=C34)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccccc12	InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18-,19+/m0/s1	KMPWYEUPVWOPIM-KODHJQJWSA-N					doublet; compound annotation
0391_008289	Ziresovir	C22H25N5O3S	1.5764	71262247		Cc1cc2c(cc1)nc(N1CCS(=O)(=O)c3ccccc3C1)nc2NCC1(N)COC1	InChI=1S/C22H25N5O3S/c1-15-6-7-18-17(10-15)20(24-12-22(23)13-30-14-22)26-21(25-18)27-8-9-31(28,29)19-5-3-2-4-16(19)11-27/h2-7,10H,8-9,11-14,23H2,1H3,(H,24,25,26)	GAAICKUTDBZCMT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008292	H-Arg-4MbetaNA	C17H23N5O2	1.7726	16218937	COC1=CC(=CC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N	COc1cc(NC(=O)C(N)CCCN=C(N)N)cc2ccccc12	InChI=1S/C17H23N5O2/c1-24-15-10-12(9-11-5-2-3-6-13(11)15)22-16(23)14(18)7-4-8-21-17(19)20/h2-3,5-6,9-10,14H,4,7-8,18H2,1H3,(H,22,23)(H4,19,20,21)/t14-/m0/s1	XVHWVDFGKDNOBO-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_008294	SGI-1776	C20H22F3N5O	2.1201	24795070		CN1CCC(CNc2nn3c(-c4cc(OC(F)(F)F)ccc4)cnc3cc2)CC1	InChI=1S/C20H22F3N5O/c1-27-9-7-14(8-10-27)12-24-18-5-6-19-25-13-17(28(19)26-18)15-3-2-4-16(11-15)29-20(21,22)23/h2-6,11,13-14H,7-10,12H2,1H3,(H,24,26)	MHXGEROHKGDZGO-UHFFFAOYSA-N					compound annotation
0391_008295	AG-1478	C16H14ClN3O2	2.5813	2051		COc1c(OC)cc2c(Nc3cc(Cl)ccc3)ncnc2c1	InChI=1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)	GFNNBHLJANVSQV-UHFFFAOYSA-N					compound annotation
0391_008296	Hexahydrocurcumin	C21H26O6	2.8545	5318039		COc1c(O)ccc(CCC(=O)CC(O)CCc2cc(OC)c(O)cc2)c1	InChI=1S/C21H26O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16,22,24-25H,3-4,7-8,13H2,1-2H3	RSAHICAPUYTWHW-UHFFFAOYSA-N					compound annotation
0391_008297	GSK-J2	C22H23N5O2	2.9997	73010924		O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cnccc2)n1	InChI=1S/C22H23N5O2/c28-21(29)7-11-24-19-14-20(26-22(25-19)18-6-3-10-23-15-18)27-12-8-16-4-1-2-5-17(16)9-13-27/h1-6,10,14-15H,7-9,11-13H2,(H,28,29)(H,24,25,26)	LJIFOCRGDDQFJF-UHFFFAOYSA-N					doublet; compound annotation
0391_008298	GSK-J2	C22H23N5O2	3.003	73010924		O=C(O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2cnccc2)n1	InChI=1S/C22H23N5O2/c28-21(29)7-11-24-19-14-20(26-22(25-19)18-6-3-10-23-15-18)27-12-8-16-4-1-2-5-17(16)9-13-27/h1-6,10,14-15H,7-9,11-13H2,(H,28,29)(H,24,25,26)	LJIFOCRGDDQFJF-UHFFFAOYSA-N					doublet; compound annotation
0391_008299	65373-29-7	C10H11N3S2	3.0432	805117		CNc1nnc(SCc2ccccc2)s1	InChI=1S/C10H11N3S2/c1-11-9-12-13-10(15-9)14-7-8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,11,12)	KFLNRVSOQJTXDG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008301	SNAP-94847	C29H32F2N2O2	3.832	16756754		Cc1c(C2CCN(Cc3ccc(Oc4cc(F)c(F)cc4)cc3)CC2)cc(NC(=O)C(C)C)cc1	InChI=1S/C29H32F2N2O2/c1-19(2)29(34)32-23-7-4-20(3)26(16-23)22-12-14-33(15-13-22)18-21-5-8-24(9-6-21)35-25-10-11-27(30)28(31)17-25/h4-11,16-17,19,22H,12-15,18H2,1-3H3,(H,32,34)	VMLZFUVIKCGATC-UHFFFAOYSA-N					compound annotation
0391_008302	Exo1	C15H12FNO3	4.6605	310557		COC(=O)c1ccccc1NC(=O)c1ccc(F)cc1	InChI=1S/C15H12FNO3/c1-20-15(19)12-4-2-3-5-13(12)17-14(18)10-6-8-11(16)9-7-10/h2-9H,1H3,(H,17,18)	KIAPWMKFHIKQOZ-UHFFFAOYSA-N					compound annotation
0391_008303	levornidazole	C7H10ClN3O3	1.6396	6541429	CC1=NC=C(N1C[C@@H](CCl)O)[N+](=O)[O-]	Cc1ncc([N+](=O)[O-])n1CC(O)CCl	InChI=1S/C7H10ClN3O3/c1-5-9-3-7(11(13)14)10(5)4-6(12)2-8/h3,6,12H,2,4H2,1H3/t6-/m1/s1	IPWKIXLWTCNBKN-ZCFIWIBFSA-N					compound annotation
0391_008304	tulobuterol	C12H18ClNO	1.8561	5606		CC(C)(C)NCC(O)c1ccccc1Cl	InChI=1S/C12H18ClNO/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13/h4-7,11,14-15H,8H2,1-3H3	YREYLAVBNPACJM-UHFFFAOYSA-N					compound annotation
0391_008305	pGlu-Pro-Arg-MNA	C23H32N8O7	1.8928	92044478	COC1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCC(=O)N3	COc1c(NC(=O)C(CCCN=C(N)N)NC(=O)C2CCCN2C(=O)C2CCC(=O)N2)ccc([N+](=O)[O-])c1	InChI=1S/C23H32N8O7/c1-38-18-12-13(31(36)37)6-7-14(18)28-20(33)15(4-2-10-26-23(24)25)29-21(34)17-5-3-11-30(17)22(35)16-8-9-19(32)27-16/h6-7,12,15-17H,2-5,8-11H2,1H3,(H,27,32)(H,28,33)(H,29,34)(H4,24,25,26)/t15-,16-,17-/m0/s1	PWEMRMLJCWKESY-ULQDDVLXSA-N					doublet; compound annotation
0391_008306	pGlu-Pro-Arg-MNA	C23H32N8O7	2.1203	92044478	COC1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCC(=O)N3	COc1c(NC(=O)C(CCCN=C(N)N)NC(=O)C2CCCN2C(=O)C2CCC(=O)N2)ccc([N+](=O)[O-])c1	InChI=1S/C23H32N8O7/c1-38-18-12-13(31(36)37)6-7-14(18)28-20(33)15(4-2-10-26-23(24)25)29-21(34)17-5-3-11-30(17)22(35)16-8-9-19(32)27-16/h6-7,12,15-17H,2-5,8-11H2,1H3,(H,27,32)(H,28,33)(H,29,34)(H4,24,25,26)/t15-,16-,17-/m0/s1	PWEMRMLJCWKESY-ULQDDVLXSA-N					doublet; compound annotation
0391_008307	pGlu-Pro-Arg-MNA	C23H32N8O7	2.1236	92044478	COC1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCC(=O)N3	COc1c(NC(=O)C(CCCN=C(N)N)NC(=O)C2CCCN2C(=O)C2CCC(=O)N2)ccc([N+](=O)[O-])c1	InChI=1S/C23H32N8O7/c1-38-18-12-13(31(36)37)6-7-14(18)28-20(33)15(4-2-10-26-23(24)25)29-21(34)17-5-3-11-30(17)22(35)16-8-9-19(32)27-16/h6-7,12,15-17H,2-5,8-11H2,1H3,(H,27,32)(H,28,33)(H,29,34)(H4,24,25,26)/t15-,16-,17-/m0/s1	PWEMRMLJCWKESY-ULQDDVLXSA-N					doublet; compound annotation
0391_008308	BRD73954	C16H16N2O3	2.3888	71680913		O=C(NO)c1cccc(C(=O)NCCc2ccccc2)c1	InChI=1S/C16H16N2O3/c19-15(17-10-9-12-5-2-1-3-6-12)13-7-4-8-14(11-13)16(20)18-21/h1-8,11,21H,9-10H2,(H,17,19)(H,18,20)	FIHKWEQJEDRIFS-UHFFFAOYSA-N					compound annotation
0391_008309	Fezolinetant	C16H15FN6OS	2.9504	117604931	C[C@@H]1C2=NN=C(N2CCN1C(=O)C3=CC=C(C=C3)F)C4=NC(=NS4)C	Cc1nsc(-c2nnc3C(C)N(C(=O)c4ccc(F)cc4)CCn23)n1	InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1	PPSNFPASKFYPMN-SECBINFHSA-N					removed another duplicate entry; compound annotation
0391_008311	Tauroursodeoxycholic acid	C26H45NO6S	3.0195	9848818	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1	BHTRKEVKTKCXOH-LBSADWJPSA-N					doublet; removed another duplicate entry; compound annotation
0391_008313	STF-31	C23H25N3O3S	3.4169	984333		CC(C)(C)c1ccc(S(=O)(=O)NCc2ccc(C(=O)Nc3cnccc3)cc2)cc1	InChI=1S/C23H25N3O3S/c1-23(2,3)19-10-12-21(13-11-19)30(28,29)25-15-17-6-8-18(9-7-17)22(27)26-20-5-4-14-24-16-20/h4-14,16,25H,15H2,1-3H3,(H,26,27)	NGQPRVWTFNBUHA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008315	Endoxifen	C25H27NO2	3.5012	10090750	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24-	MHJBZVSGOZTKRH-IZHYLOQSSA-N					doublet; compound annotation
0391_008316	Endoxifen	C25H27NO2	3.5662	10090750	CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24-	MHJBZVSGOZTKRH-IZHYLOQSSA-N					doublet; compound annotation
0391_008317	475231-21-1	C16H16O4	3.6898	10038868	COC1=CC(=CC(=C1)/C=C/C2=CC(=C(C=C2)O)O)OC	COc1cc(OC)cc(C=Cc2cc(O)c(O)cc2)c1	InChI=1S/C16H16O4/c1-19-13-7-12(8-14(10-13)20-2)4-3-11-5-6-15(17)16(18)9-11/h3-10,17-18H,1-2H3/b4-3+	UQRBFXIUUDJHSN-ONEGZZNKSA-N					compound annotation
0391_008318	PPQ-102	C26H22N4O3	4.5395	16016583		Cc1ccc(C2Nc3ccccc3-n3c(-c4ccccc4)c4c(=O)n(C)c(=O)n(C)c4c23)o1	InChI=1S/C26H22N4O3/c1-15-13-14-19(33-15)21-24-23-20(25(31)29(3)26(32)28(23)2)22(16-9-5-4-6-10-16)30(24)18-12-8-7-11-17(18)27-21/h4-14,21,27H,1-3H3	MNOOVRNGPIWJDI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008320	BYK204165	C15H12N2O2	3.1804	25113764	CN1C=CC=C1/C=C\2/C3=CC=CC=C3C(=O)NC2=O	Cn1cccc1C=C1C(=O)NC(=O)c2ccccc12	InChI=1S/C15H12N2O2/c1-17-8-4-5-10(17)9-13-11-6-2-3-7-12(11)14(18)16-15(13)19/h2-9H,1H3,(H,16,18,19)/b13-9-	BTYSIDSTHDDAJW-LCYFTJDESA-N					compound annotation
0391_008321	asciminib	C20H18ClF2N5O3	3.304	72165228	C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CCC(O)C2)c(-c2ccn[nH]2)c1	InChI=1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H,25,27)(H,26,30)/t14-/m1/s1	VOVZXURTCKPRDQ-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_008323	Bemcentinib	C30H34N8	3.3257	46215462	C1CCN(C1)[C@H]2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76	Nc1nc(Nc2cc3c(cc2)CCC(N2CCCC2)CC3)nn1-c1nnc2c(c1)CCCc1ccccc1-2	InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1	KXMZDGSRSGHMMK-VWLOTQADSA-N					compound annotation
0391_008324	cloprostenol	C22H29ClO6	3.3761	5311053	C1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](COC2=CC(=CC=C2)Cl)O)C/C=C\CCCC(=O)O)O	O=C(O)CCCC=CCC1C(O)CC(O)C1C=CC(O)COc1cc(Cl)ccc1	InChI=1S/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1	VJGGHXVGBSZVMZ-QIZQQNKQSA-N					doublet; compound annotation
0391_008325	bezafibrate	C19H20ClNO4	3.692	39042		CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O	InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)	IIBYAHWJQTYFKB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008327	BREVILIN A	C20H26O5	3.9687	12302076	C/C=C(/C)\C(=O)O[C@H]1[C@@H]2[C@@H](C(=O)O[C@@H]2C[C@H]([C@H]3[C@]1(C(=O)C=C3)C)C)C	CC=C(C)C(=O)OC1C2C(CC(C)C3C=CC(=O)C31C)OC(=O)C2C	InChI=1S/C20H26O5/c1-6-10(2)18(22)25-17-16-12(4)19(23)24-14(16)9-11(3)13-7-8-15(21)20(13,17)5/h6-8,11-14,16-17H,9H2,1-5H3/b10-6-/t11-,12+,13+,14-,16-,17+,20+/m1/s1	KUPPZVXLWANEJJ-UXPPPGSFSA-N					removed another duplicate entry; compound annotation
0391_008329	NSC-379443	C37H37N2O10S3+	2.3894	16888		CCN(Cc1cc(S(=O)(=O)O)ccc1)c1ccc(C(=C2C=CC(=[N+](CC)Cc3cc(S(=O)(=O)O)ccc3)C=C2)c2c(S(=O)(=O)O)cc(O)cc2)cc1	InChI=1S/C37H36N2O10S3/c1-3-38(24-26-7-5-9-33(21-26)50(41,42)43)30-15-11-28(12-16-30)37(35-20-19-32(40)23-36(35)52(47,48)49)29-13-17-31(18-14-29)39(4-2)25-27-8-6-10-34(22-27)51(44,45)46/h5-23H,3-4,24-25H2,1-2H3,(H3,41,42,43,44,45,46,47,48,49)/p+1	VVJKKKDJADMKNM-UHFFFAOYSA-O					compound annotation
0391_008330	meprednisone	C22H28O5	3.043	5284587	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3C(=O)C[C@@]2([C@]1(C(=O)CO)O)C)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(=O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1	PIDANAQULIKBQS-RNUIGHNZSA-N					removed another duplicate entry; compound annotation
0391_008332	PF-2771	C29H36ClN5O4	3.2337	118704759	CC(C)OC1=C(C=C(C=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)C3=CN(C(=N3)C(=O)C)C)CNC(=O)CN(C)C)Cl	CC(=O)c1nc(-c2ccc(CC(CNC(=O)CN(C)C)NC(=O)c3cc(Cl)c(OC(C)C)cc3)cc2)cn1C	InChI=1S/C29H36ClN5O4/c1-18(2)39-26-12-11-22(14-24(26)30)29(38)32-23(15-31-27(37)17-34(4)5)13-20-7-9-21(10-8-20)25-16-35(6)28(33-25)19(3)36/h7-12,14,16,18,23H,13,15,17H2,1-6H3,(H,31,37)(H,32,38)/t23-/m0/s1	VHBJNUOZEQTSNN-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_008334	CALMAGITE	C17H14N2O5S	3.4098	2530		Cc1cc(N=Nc2c(O)cc(S(=O)(=O)O)c3ccccc23)c(O)cc1	InChI=1S/C17H14N2O5S/c1-10-6-7-14(20)13(8-10)18-19-17-12-5-3-2-4-11(12)16(9-15(17)21)25(22,23)24/h2-9,20-21H,1H3,(H,22,23,24)	VBRNLOQCBCPPHL-UHFFFAOYSA-N					compound annotation
0391_008335	903895-98-7	C20H21ClN4O2	3.4517	24776341		CC(C)c1c(NC(=O)Nc2ccc(Cl)cc2)c(=O)n(-c2ccccc2)n1C	InChI=1S/C20H21ClN4O2/c1-13(2)18-17(23-20(27)22-15-11-9-14(21)10-12-15)19(26)25(24(18)3)16-7-5-4-6-8-16/h4-13H,1-3H3,(H2,22,23,27)	PAEBEUZTAPIOIO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008337	Latanoprostene BUNOD	C27H41NO8	4.5533	11156438	C1[C@H]([C@@H]([C@H]([C@H]1O)C/C=C\CCCC(=O)OCCCCO[N+](=O)[O-])CC[C@H](CCC2=CC=CC=C2)O)O	O=C(CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1)OCCCCO[N+](=O)[O-]	InChI=1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1	LOVMMUBRQUFEAH-UIEAZXIASA-N					doublet; compound annotation
0391_008338	Latanoprostene BUNOD	C27H41NO8	4.5562	11156438	C1[C@H]([C@@H]([C@H]([C@H]1O)C/C=C\CCCC(=O)OCCCCO[N+](=O)[O-])CC[C@H](CCC2=CC=CC=C2)O)O	O=C(CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1)OCCCCO[N+](=O)[O-]	InChI=1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1	LOVMMUBRQUFEAH-UIEAZXIASA-N					doublet; compound annotation
0391_008339	PK 11195	C21H21ClN2O	4.7285	1345		CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1	InChI=1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3	RAVIZVQZGXBOQO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008341	DTP3	C26H35N7O5	1.7113	86295191	CC(=O)N[C@H](CC1=CC=C(C=C1)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N	CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C26H35N7O5/c1-16(34)31-22(15-18-9-11-19(35)12-10-18)25(38)32-20(8-5-13-30-26(28)29)24(37)33-21(23(27)36)14-17-6-3-2-4-7-17/h2-4,6-7,9-12,20-22,35H,5,8,13-15H2,1H3,(H2,27,36)(H,31,34)(H,32,38)(H,33,37)(H4,28,29,30)/t20-,21-,22-/m1/s1	AOUZPXZGMZUQQS-YPAWHYETSA-N					doublet; compound annotation
0391_008342	DTP3	C26H35N7O5	1.7146	86295191	CC(=O)N[C@H](CC1=CC=C(C=C1)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N	CC(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C26H35N7O5/c1-16(34)31-22(15-18-9-11-19(35)12-10-18)25(38)32-20(8-5-13-30-26(28)29)24(37)33-21(23(27)36)14-17-6-3-2-4-7-17/h2-4,6-7,9-12,20-22,35H,5,8,13-15H2,1H3,(H2,27,36)(H,31,34)(H,32,38)(H,33,37)(H4,28,29,30)/t20-,21-,22-/m1/s1	AOUZPXZGMZUQQS-YPAWHYETSA-N					doublet; compound annotation
0391_008343	PIK-93	C14H16ClN3O4S2	2.5086	6852167		CC(=O)Nc1nc(C)c(-c2cc(S(=O)(=O)NCCO)c(Cl)cc2)s1	InChI=1S/C14H16ClN3O4S2/c1-8-13(23-14(17-8)18-9(2)20)10-3-4-11(15)12(7-10)24(21,22)16-5-6-19/h3-4,7,16,19H,5-6H2,1-2H3,(H,17,18,20)	JFVNFXCESCXMBC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008345	KU-60019	C30H33N3O5S	2.5585	15953870	C[C@@H]1CN(C[C@@H](O1)C)CC(=O)NC2=CC3=C(C=C2)SC4=C(C3)C=CC=C4C5=CC(=O)C=C(O5)N6CCOCC6	CC1CN(CC(=O)Nc2cc3c(cc2)Sc2c(cccc2-c2cc(=O)cc(N4CCOCC4)o2)C3)CC(C)O1	InChI=1S/C30H33N3O5S/c1-19-16-32(17-20(2)37-19)18-28(35)31-23-6-7-27-22(13-23)12-21-4-3-5-25(30(21)39-27)26-14-24(34)15-29(38-26)33-8-10-36-11-9-33/h3-7,13-15,19-20H,8-12,16-18H2,1-2H3,(H,31,35)/t19-,20+	SCELLOWTHJGVIC-BGYRXZFFSA-N					removed another duplicate entry; compound annotation
0391_008347	JAK/HDAC-IN-1	C19H21Cl2N7O2	2.5878	138377596		O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	InChI=1S/C19H21Cl2N7O2/c20-13-5-7-14(8-6-13)24-18-16(21)11-22-19(26-18)25-15-10-23-28(12-15)9-3-1-2-4-17(29)27-30/h5-8,10-12,30H,1-4,9H2,(H,27,29)(H2,22,24,25,26)	MTOQNLGMTJOJOF-UHFFFAOYSA-N					doublet; compound annotation
0391_008348	JAK/HDAC-IN-1	C19H21Cl2N7O2	2.5905	138377596		O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	InChI=1S/C19H21Cl2N7O2/c20-13-5-7-14(8-6-13)24-18-16(21)11-22-19(26-18)25-15-10-23-28(12-15)9-3-1-2-4-17(29)27-30/h5-8,10-12,30H,1-4,9H2,(H,27,29)(H2,22,24,25,26)	MTOQNLGMTJOJOF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008350	152121-53-4	C20H13FN4O2	2.7524	4712		O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	InChI=1S/C20H13FN4O2/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(8-4-15)25(26)27/h1-12H,(H,23,24)	BGIYKDUASORTBB-UHFFFAOYSA-N					compound annotation
0391_008351	B022	C19H16ClN5OS	2.8384	58221879		CC(O)(C#Cc1cc2c(cc1)CCN2c1nc(N)ncc1Cl)c1nccs1	InChI=1S/C19H16ClN5OS/c1-19(26,17-22-7-9-27-17)6-4-12-2-3-13-5-8-25(15(13)10-12)16-14(20)11-23-18(21)24-16/h2-3,7,9-11,26H,5,8H2,1H3,(H2,21,23,24)	OKFYOOFXVBCIIP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008353	AZD8330	C16H17FIN3O4	2.8608	16666708		Cc1cc(C(=O)NOCCO)c(Nc2c(F)cc(I)cc2)n(C)c1=O	InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)	RWEVIPRMPFNTLO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008355	AZD8330	C16H17FIN3O4	2.866	16666708		Cc1cc(C(=O)NOCCO)c(Nc2c(F)cc(I)cc2)n(C)c1=O	InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)	RWEVIPRMPFNTLO-UHFFFAOYSA-N					doublet; compound annotation
0391_008356	273727-89-2	C23H25NO	3.2492	3797		CC(C)N(CCC(=O)c1cc2ccccc2cc1)Cc1ccccc1	InChI=1S/C23H25NO/c1-18(2)24(17-19-8-4-3-5-9-19)15-14-23(25)22-13-12-20-10-6-7-11-21(20)16-22/h3-13,16,18H,14-15,17H2,1-2H3	JSASWRWALCMOQP-UHFFFAOYSA-N					compound annotation
0391_008357	BAY-678	C20H15F3N4O2	3.5942	23728722	CC1=C([C@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)NC1c1cnc(C#N)cc1	InChI=1S/C20H15F3N4O2/c1-11-17(12(2)28)18(13-6-7-15(9-24)25-10-13)26-19(29)27(11)16-5-3-4-14(8-16)20(21,22)23/h3-8,10,18H,1-2H3,(H,26,29)/t18-/m1/s1	PGIVGIFOWOVINL-GOSISDBHSA-N					doublet; compound annotation
0391_008358	BAY-678	C20H15F3N4O2	3.5969	23728722	CC1=C([C@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)NC1c1cnc(C#N)cc1	InChI=1S/C20H15F3N4O2/c1-11-17(12(2)28)18(13-6-7-15(9-24)25-10-13)26-19(29)27(11)16-5-3-4-14(8-16)20(21,22)23/h3-8,10,18H,1-2H3,(H,26,29)/t18-/m1/s1	PGIVGIFOWOVINL-GOSISDBHSA-N					doublet; compound annotation
0391_008359	JAK/HDAC-IN-1	C19H21Cl2N7O2	3.7328	138377596		O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	InChI=1S/C19H21Cl2N7O2/c20-13-5-7-14(8-6-13)24-18-16(21)11-22-19(26-18)25-15-10-23-28(12-15)9-3-1-2-4-17(29)27-30/h5-8,10-12,30H,1-4,9H2,(H,27,29)(H2,22,24,25,26)	MTOQNLGMTJOJOF-UHFFFAOYSA-N					doublet; compound annotation
0391_008360	AZD8330	C16H17FIN3O4	3.7328	16666708		Cc1cc(C(=O)NOCCO)c(Nc2c(F)cc(I)cc2)n(C)c1=O	InChI=1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23)	RWEVIPRMPFNTLO-UHFFFAOYSA-N					doublet; compound annotation
0391_008361	QUINPIROLE	C13H21N3	0.5921	54562	CCCN1CCC[C@H]2[C@H]1CC3=C(C2)NN=C3	CCCN1CCCC2Cc3c(cn[nH]3)CC21	InChI=1S/C13H21N3/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12/h9-10,13H,2-8H2,1H3,(H,14,15)/t10-,13-/m1/s1	FTSUPYGMFAPCFZ-ZWNOBZJWSA-N					compound annotation
0391_008362	Lavendustin A	C21H19NO6	1.9446	3894		O=C(O)c1c(O)ccc(N(Cc2ccccc2O)Cc2c(O)ccc(O)c2)c1	InChI=1S/C21H19NO6/c23-16-6-8-19(25)14(9-16)12-22(11-13-3-1-2-4-18(13)24)15-5-7-20(26)17(10-15)21(27)28/h1-10,23-26H,11-12H2,(H,27,28)	ULTTYPMRMMDONC-UHFFFAOYSA-N					compound annotation
0391_008363	946518-61-2	C24H29ClN6OS	2.3296	16720762		CN1CCN(CCCNc2ncc(Cl)c(-c3cc4c(C(=O)NC5CC5)cccc4s3)n2)CC1	InChI=1S/C24H29ClN6OS/c1-30-10-12-31(13-11-30)9-3-8-26-24-27-15-19(25)22(29-24)21-14-18-17(4-2-5-20(18)33-21)23(32)28-16-6-7-16/h2,4-5,14-16H,3,6-13H2,1H3,(H,28,32)(H,26,27,29)	BNFAYJPQCPZQND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008365	Obatoclax	C20H19N3O	3.3644	11404337	CC1=CC(=C(N1)/C=C\2/C(=C/C(=C/3\C=C4C=CC=CC4=N3)/N2)OC)C	COc1cc(=C2C=c3ccccc3=N2)[nH]c1=Cc1c(C)cc(C)[nH]1	InChI=1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21,23H,1-3H3/b18-17-,19-10-	CVCLJVVBHYOXDC-IAZSKANUSA-N					removed another duplicate entry; compound annotation
0391_008367	lifirafenib	C25H17F3N4O3	3.6418	89670174	C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)O[C@H]5[C@@H]4[C@@H]5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F	O=C1CCc2c(Oc3cc4c(cc3)OC3C(c5nc6c(cc(C(F)(F)F)cc6)[nH]5)C43)ccnc2N1	InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1	NGFFVZQXSRKHBM-FKBYEOEOSA-N					compound annotation
0391_008368	Isoconazole	C18H14Cl4N2O	3.8796	3760		Clc1cc(Cl)c(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)cc1	InChI=1S/C18H14Cl4N2O/c19-12-4-5-13(17(22)8-12)18(9-24-7-6-23-11-24)25-10-14-15(20)2-1-3-16(14)21/h1-8,11,18H,9-10H2	MPIPASJGOJYODL-UHFFFAOYSA-N					doublet; compound annotation
0391_008369	Derazantinib	C29H29FN4O	3.9405	46834118	COCCNCCC1=CC(=CC=C1)NC2=NC=C3C[C@H](C4=CC=CC=C4C3=N2)C5=CC=CC=C5F	COCCNCCc1cc(Nc2ncc3CC(c4ccccc4F)c4ccccc4-c3n2)ccc1	InChI=1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1	KPJDVVCDVBFRMU-AREMUKBSSA-N					removed another duplicate entry; compound annotation
0391_008371	Deoxyarbutin	C11H14O3	4.2854	11745519		Oc1ccc(OC2CCCCO2)cc1	InChI=1S/C11H14O3/c12-9-4-6-10(7-5-9)14-11-3-1-2-8-13-11/h4-7,11-12H,1-3,8H2	GFBCWCDNXDKFRH-UHFFFAOYSA-N					compound annotation
0391_008372	TAS-301	C23H19NO3	4.5433	9885087		COc1ccc(C(=C2C(=O)Nc3ccccc23)c2ccc(OC)cc2)cc1	InChI=1S/C23H19NO3/c1-26-17-11-7-15(8-12-17)21(16-9-13-18(27-2)14-10-16)22-19-5-3-4-6-20(19)24-23(22)25/h3-14H,1-2H3,(H,24,25)	KUEYYIJXBRWZIB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008374	TAS-301	C23H19NO3	4.5465	9885087		COc1ccc(C(=C2C(=O)Nc3ccccc23)c2ccc(OC)cc2)cc1	InChI=1S/C23H19NO3/c1-26-17-11-7-15(8-12-17)21(16-9-13-18(27-2)14-10-16)22-19-5-3-4-6-20(19)24-23(22)25/h3-14H,1-2H3,(H,24,25)	KUEYYIJXBRWZIB-UHFFFAOYSA-N					doublet; compound annotation
0391_008375	Isoconazole	C18H14Cl4N2O	5.0705	3760		Clc1cc(Cl)c(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)cc1	InChI=1S/C18H14Cl4N2O/c19-12-4-5-13(17(22)8-12)18(9-24-7-6-23-11-24)25-10-14-15(20)2-1-3-16(14)21/h1-8,11,18H,9-10H2	MPIPASJGOJYODL-UHFFFAOYSA-N					doublet; compound annotation
0391_008376	CM-272	C28H38N4O3	1.2934	118607432		COc1c(OCCCN2CCCC2)cc2nc(-c3ccc(C)o3)cc(NC3CCN(C)CC3)c2c1	InChI=1S/C28H38N4O3/c1-20-7-8-26(35-20)25-18-23(29-21-9-14-31(2)15-10-21)22-17-27(33-3)28(19-24(22)30-25)34-16-6-13-32-11-4-5-12-32/h7-8,17-19,21H,4-6,9-16H2,1-3H3,(H,29,30)	RLQLKZTYUYIWDB-UHFFFAOYSA-N					compound annotation
0391_008377	BMS-816336	C21H27NO3	2.4137	59336911		O=C(CC1(c2ccccc2)C2CC3CC1CC(C2)C3O)N1CC(O)C1	InChI=1S/C21H27NO3/c23-18-11-22(12-18)19(24)10-21(15-4-2-1-3-5-15)16-6-13-7-17(21)9-14(8-16)20(13)25/h1-5,13-14,16-18,20,23,25H,6-12H2	OAAZMUGLOXGVNH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008379	GSK-25	C24H16Cl2F2N6O	2.5029	11548023		CC1=C(C(=O)Nc2c(F)cc3[nH]ncc3c2)C(c2c(F)cc(Cl)cc2)N=C(c2cc(Cl)ncc2)N1	InChI=1S/C24H16Cl2F2N6O/c1-11-21(24(35)32-19-6-13-10-30-34-18(13)9-17(19)28)22(15-3-2-14(25)8-16(15)27)33-23(31-11)12-4-5-29-20(26)7-12/h2-10,22H,1H3,(H,30,34)(H,31,33)(H,32,35)	KZYAHEIPPAPADQ-UHFFFAOYSA-N					compound annotation
0391_008380	AC-55541	C25H20BrN5O3	2.5029	9589606	C/C(=N\NC(=O)C(C1=NNC(=O)C2=CC=CC=C21)NC(=O)C3=CC=CC=C3)/C4=CC(=CC=C4)Br	CC(=NNC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cc(Br)ccc1	InChI=1S/C25H20BrN5O3/c1-15(17-10-7-11-18(26)14-17)28-31-25(34)22(27-23(32)16-8-3-2-4-9-16)21-19-12-5-6-13-20(19)24(33)30-29-21/h2-14,22H,1H3,(H,27,32)(H,30,33)(H,31,34)/b28-15+	UCUHFWIFSHROPY-RWPZCVJISA-N					doublet; compound annotation
0391_008381	Necrostatin 2	C13H12ClN3O2	2.799	11288934	CN1C(=O)[C@H](NC1=O)CC2=CNC3=C2C=CC=C3Cl	CN1C(=O)NC(Cc2c[nH]c3c2cccc3Cl)C1=O	InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)/t10-/m1/s1	WIKGAEMMNQTUGL-SNVBAGLBSA-N					compound annotation
0391_008382	EBE-A22	C17H16BrN3O2	2.8516	5328227		COc1c(OC)cc2c(N(C)c3cc(Br)ccc3)ncnc2c1	InChI=1S/C17H16BrN3O2/c1-21(12-6-4-5-11(18)7-12)17-13-8-15(22-2)16(23-3)9-14(13)19-10-20-17/h4-10H,1-3H3	IPWGDOZPSOZFOD-UHFFFAOYSA-N					compound annotation
0391_008383	Vilanterol	C24H33Cl2NO5	3.1726	10184665	C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl	OCc1c(O)ccc(C(O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)c1	InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1	DAFYYTQWSAWIGS-DEOSSOPVSA-N					doublet; removed another duplicate entry; compound annotation
0391_008385	AC-55541	C25H20BrN5O3	3.9069	9589606	C/C(=N\NC(=O)C(C1=NNC(=O)C2=CC=CC=C21)NC(=O)C3=CC=CC=C3)/C4=CC(=CC=C4)Br	CC(=NNC(=O)C(NC(=O)c1ccccc1)c1n[nH]c(=O)c2ccccc12)c1cc(Br)ccc1	InChI=1S/C25H20BrN5O3/c1-15(17-10-7-11-18(26)14-17)28-31-25(34)22(27-23(32)16-8-3-2-4-9-16)21-19-12-5-6-13-20(19)24(33)30-29-21/h2-14,22H,1H3,(H,27,32)(H,30,33)(H,31,34)/b28-15+	UCUHFWIFSHROPY-RWPZCVJISA-N					doublet; removed another duplicate entry; compound annotation
0391_008387	ANA-12	C22H21N3O3S	4.298	2799722		O=C(Nc1ccccc1C(=O)NC1CCCCNC1=O)c1cc2ccccc2s1	InChI=1S/C22H21N3O3S/c26-20(25-17-10-5-6-12-23-21(17)27)15-8-2-3-9-16(15)24-22(28)19-13-14-7-1-4-11-18(14)29-19/h1-4,7-9,11,13,17H,5-6,10,12H2,(H,23,27)(H,24,28)(H,25,26)	TUSCYCAIGRVBMD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008389	ACETYLLOVASTATIN	C26H38O6	5.6869	90477402	CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)OC(=O)C)C	CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(OC(C)=O)CC(=O)O3)C21	InChI=1S/C26H38O6/c1-6-16(3)26(29)32-23-12-15(2)11-19-8-7-17(4)22(25(19)23)10-9-20-13-21(30-18(5)27)14-24(28)31-20/h7-8,11,15-17,20-23,25H,6,9-10,12-14H2,1-5H3/t15-,16-,17-,20+,21+,22-,23-,25-/m0/s1	OYNSFDWALRRTFU-QQVNEASTSA-N					removed another duplicate entry; compound annotation
0391_008391	925676-48-8	C18H14FN5O	2.2153	16071896		O=C(Nc1cnc(-c2c(F)cncc2)c(-c2cnccc2)n1)C1CC1	InChI=1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)	XUYURJQIMYCWBB-UHFFFAOYSA-N					doublet; compound annotation
0391_008392	925676-48-8	C18H14FN5O	2.2723	16071896		O=C(Nc1cnc(-c2c(F)cncc2)c(-c2cnccc2)n1)C1CC1	InChI=1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)	XUYURJQIMYCWBB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008394	Prexasertib	C18H19N7O2	2.3138	46700756		COc1c(-c2cc(Nc3ncc(C#N)nc3)n[nH]2)c(OCCCN)ccc1	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	DOTGPNHGTYJDEP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008396	Bicyclomycin benzoate	C19H22N2O8	2.4791	91618023	C[C@](COC(=O)C1=CC=CC=C1)([C@@H]([C@@]23C(=O)N[C@@](C(=C)CCO2)(C(=O)N3)O)O)O	C=C1CCOC2(C(O)C(C)(O)COC(=O)c3ccccc3)NC(=O)C1(O)NC2=O	InChI=1S/C19H22N2O8/c1-11-8-9-29-19(16(25)20-18(11,27)15(24)21-19)14(23)17(2,26)10-28-13(22)12-6-4-3-5-7-12/h3-7,14,23,26-27H,1,8-10H2,2H3,(H,20,25)(H,21,24)/t14-,17-,18+,19-/m0/s1	YYGLCPHONATYBU-FZDIXFNVSA-N					compound annotation
0391_008397	Neticonazole	C17H22N2OS	3.3971	5282433	CCCCCOC1=CC=CC=C1/C(=C\SC)/N2C=CN=C2	CCCCCOc1ccccc1C(=CSC)n1ccnc1	InChI=1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+	VWOIKFDZQQLJBJ-DTQAZKPQSA-N					doublet; compound annotation
0391_008398	Neticonazole	C17H22N2OS	3.4594	5282433	CCCCCOC1=CC=CC=C1/C(=C\SC)/N2C=CN=C2	CCCCCOc1ccccc1C(=CSC)n1ccnc1	InChI=1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+	VWOIKFDZQQLJBJ-DTQAZKPQSA-N					doublet; compound annotation
0391_008399	BLU-554	C24H24Cl2N4O4	3.5107	91885617	COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)N[C@@H]4COCC[C@@H]4NC(=O)C=C)Cl)OC	C=CC(=O)NC1CCOCC1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1	InChI=1S/C24H24Cl2N4O4/c1-4-20(31)28-16-7-8-34-12-17(16)30-24-27-11-14-9-13(5-6-15(14)29-24)21-22(25)18(32-2)10-19(33-3)23(21)26/h4-6,9-11,16-17H,1,7-8,12H2,2-3H3,(H,28,31)(H,27,29,30)/t16-,17+/m0/s1	MGZKYOAQVGSSGC-DLBZAZTESA-N					doublet; compound annotation
0391_008400	BLU-554	C24H24Cl2N4O4	3.5167	91885617	COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)N[C@@H]4COCC[C@@H]4NC(=O)C=C)Cl)OC	C=CC(=O)NC1CCOCC1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1	InChI=1S/C24H24Cl2N4O4/c1-4-20(31)28-16-7-8-34-12-17(16)30-24-27-11-14-9-13(5-6-15(14)29-24)21-22(25)18(32-2)10-19(33-3)23(21)26/h4-6,9-11,16-17H,1,7-8,12H2,2-3H3,(H,28,31)(H,27,29,30)/t16-,17+/m0/s1	MGZKYOAQVGSSGC-DLBZAZTESA-N					doublet; compound annotation
0391_008401	SCHEMBL16884427	C27H23FNO4+	3.5212	71611939		COc1c(OC)c2c[n+]3c(-c4cc5c(cc4CC3)OCO5)c(Cc3ccccc3F)c2cc1	InChI=1S/C27H23FNO4/c1-30-23-8-7-18-20(11-17-5-3-4-6-22(17)28)26-19-13-25-24(32-15-33-25)12-16(19)9-10-29(26)14-21(18)27(23)31-2/h3-8,12-14H,9-11,15H2,1-2H3/q+1	AKHXIJSYNWSILX-UHFFFAOYSA-N					compound annotation
0391_008402	Anle138b	C16H11BrN2O2	4.5867	44608289		Brc1cccc(-c2n[nH]c(-c3cc4c(cc3)OCO4)c2)c1	InChI=1S/C16H11BrN2O2/c17-12-3-1-2-10(6-12)13-8-14(19-18-13)11-4-5-15-16(7-11)21-9-20-15/h1-8H,9H2,(H,18,19)	RCQIIBJSUWYYFU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008404	Gentiopicroside	C16H20O9	1.4774	88708	C=C[C@H]1[C@@H](OC=C2C1=CCOC2=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	C=CC1C2=CCOC(=O)C2=COC1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C16H20O9/c1-2-7-8-3-4-22-14(21)9(8)6-23-15(7)25-16-13(20)12(19)11(18)10(5-17)24-16/h2-3,6-7,10-13,15-20H,1,4-5H2/t7-,10-,11-,12+,13-,15+,16+/m1/s1	DUAGQYUORDTXOR-GPQRQXLASA-N					compound annotation
0391_008405	terazosin	C19H25N5O4	1.7707	5401		COc1c(OC)cc2c(N)nc(N3CCN(C(=O)C4CCCO4)CC3)nc2c1	InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)	VCKUSRYTPJJLNI-UHFFFAOYSA-N					doublet; compound annotation
0391_008406	terazosin	C19H25N5O4	1.774	5401		COc1c(OC)cc2c(N)nc(N3CCN(C(=O)C4CCCO4)CC3)nc2c1	InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)	VCKUSRYTPJJLNI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008408	AT7519	C16H17Cl2N5O2	1.9853	11338033		O=C(NC1CCNCC1)c1c(NC(=O)c2c(Cl)cccc2Cl)cn[nH]1	InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)	OVPNQJVDAFNBDN-UHFFFAOYSA-N					doublet; compound annotation
0391_008409	AT7519	C16H17Cl2N5O2	1.988	11338033		O=C(NC1CCNCC1)c1c(NC(=O)c2c(Cl)cccc2Cl)cn[nH]1	InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)	OVPNQJVDAFNBDN-UHFFFAOYSA-N					doublet; compound annotation
0391_008410	Florfenicol	C12H14Cl2FNO4S	2.0756	114811	CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CF)NC(=O)C(Cl)Cl)O	CS(=O)(=O)c1ccc(C(O)C(CF)NC(=O)C(Cl)Cl)cc1	InChI=1S/C12H14Cl2FNO4S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-15)16-12(18)11(13)14/h2-5,9-11,17H,6H2,1H3,(H,16,18)/t9-,10-/m1/s1	AYIRNRDRBQJXIF-NXEZZACHSA-N					removed another duplicate entry; compound annotation
0391_008412	5-Carboxyfluorescein	C21H12O7	2.5919	123755		O=C(O)c1cc2c(cc1)C1(OC2=O)c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C21H12O7/c22-11-2-5-15-17(8-11)27-18-9-12(23)3-6-16(18)21(15)14-4-1-10(19(24)25)7-13(14)20(26)28-21/h1-9,22-23H,(H,24,25)	NJYVEMPWNAYQQN-UHFFFAOYSA-N					compound annotation
0391_008413	PF-2545920	C25H20N4O	2.6253	11581936		Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	AZEXWHKOMMASPA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008415	PF-2545920	C25H20N4O	2.6282	11581936		Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	AZEXWHKOMMASPA-UHFFFAOYSA-N					doublet; compound annotation
0391_008416	PF-2545920	C25H20N4O	2.739	11581936		Cn1cc(-c2ccncc2)c(-c2ccc(OCc3nc4ccccc4cc3)cc2)n1	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3	AZEXWHKOMMASPA-UHFFFAOYSA-N					doublet; compound annotation
0391_008417	Apixaban	C25H25N5O4	2.8985	10182969		COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1	InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)	QNZCBYKSOIHPEH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008419	278779-30-9	C28H22Cl3NO4	5.8958	9893571	CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)/C=C/C4=CC(=CC=C4)C(=O)O)Cl	CC(C)c1c(COc2cc(Cl)c(C=Cc3cc(C(=O)O)ccc3)cc2)c(-c2c(Cl)cccc2Cl)no1	InChI=1S/C28H22Cl3NO4/c1-16(2)27-21(26(32-36-27)25-22(29)7-4-8-23(25)30)15-35-20-12-11-18(24(31)14-20)10-9-17-5-3-6-19(13-17)28(33)34/h3-14,16H,15H2,1-2H3,(H,33,34)/b10-9+	BYTNEISLBIENSA-MDZDMXLPSA-N					removed another duplicate entry; compound annotation
0391_008421	Diatrizoic acid	C11H9I3N2O4	0.5457	2140		CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I	InChI=1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20)	YVPYQUNUQOZFHG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008423	Vinburnine	C19H22N2O	2.2887	71203	CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2	CCC12CCCN3CCc4c(C31)n(C(=O)C2)c1ccccc41	InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1	WYJAPUKIYAZSEM-MOPGFXCFSA-N					compound annotation
0391_008424	Ampalex	C14H15N3O	2.3766	148184		O=C(c1cc2nccnc2cc1)N1CCCCC1	InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2	ANDGGVOPIJEHOF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008426	Chlormidazole	C15H13ClN2	2.6012	71821		Cc1nc2ccccc2n1Cc1ccc(Cl)cc1	InChI=1S/C15H13ClN2/c1-11-17-14-4-2-3-5-15(14)18(11)10-12-6-8-13(16)9-7-12/h2-9H,10H2,1H3	WNAQOLSMVPFGTE-UHFFFAOYSA-N					compound annotation
0391_008427	Steviolbioside	C32H50O13	3.3245	16401639	C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@](C3)(C(=C)C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)(C)C(=O)O	C=C1CC23CCC4C(C)(C(=O)O)CCCC4(C)C2CCC1(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O)C3	InChI=1S/C32H50O13/c1-15-11-31-9-5-18-29(2,7-4-8-30(18,3)28(40)41)19(31)6-10-32(15,14-31)45-27-25(23(38)21(36)17(13-34)43-27)44-26-24(39)22(37)20(35)16(12-33)42-26/h16-27,33-39H,1,4-14H2,2-3H3,(H,40,41)/t16-,17-,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,29-,30-,31-,32+/m1/s1	OMHUCGDTACNQEX-OSHKXICASA-N					compound annotation
0391_008428	Dehydrocostus lactone	C15H18O2	4.6077	73174	C=C1CC[C@@H]2[C@@H]([C@@H]3[C@H]1CCC3=C)OC(=O)C2=C	C=C1C(=O)OC2C1CCC(=C)C1CCC(=C)C12	InChI=1S/C15H18O2/c1-8-4-7-12-10(3)15(16)17-14(12)13-9(2)5-6-11(8)13/h11-14H,1-7H2/t11-,12-,13-,14-/m0/s1	NETSQGRTUNRXEO-XUXIUFHCSA-N					compound annotation
0391_008429	levocarnitine-propionate	C10H20NO4+	0.4747	157837	CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3/p+1/t8-/m1/s1	UFAHZIUFPNSHSL-MRVPVSSYSA-O					compound annotation
0391_008430	Pyrithioxin	C16H20N2O4S2	0.9514	14190		Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O	InChI=1S/C16H20N2O4S2/c1-9-15(21)13(5-19)11(3-17-9)7-23-24-8-12-4-18-10(2)16(22)14(12)6-20/h3-4,19-22H,5-8H2,1-2H3	SIXLXDIJGIWWFU-UHFFFAOYSA-N					compound annotation
0391_008431	Ornidazole	C7H10ClN3O3	1.6403	28061		Cc1ncc([N+](=O)[O-])n1CC(O)CCl	InChI=1S/C7H10ClN3O3/c1-5-9-3-7(11(13)14)10(5)4-6(12)2-8/h3,6,12H,2,4H2,1H3	IPWKIXLWTCNBKN-UHFFFAOYSA-N					compound annotation
0391_008432	urapidil	C20H29N5O3	1.7264	5639		COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3	ICMGLRUYEQNHPF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008434	cefmetazole	C15H17N7O5S3	1.8454	42008	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O	COC1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CSC21	InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1	SNBUBQHDYVFSQF-HIFRSBDPSA-N					removed another duplicate entry; compound annotation
0391_008436	ACETOPHENAZINE	C23H29N3O2S	2.6904	17676		CC(=O)c1cc2c(cc1)Sc1ccccc1N2CCCN1CCN(CCO)CC1	InChI=1S/C23H29N3O2S/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27/h2-3,5-8,17,27H,4,9-16H2,1H3	WNTYBHLDCKXEOT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008438	ACETOPHENAZINE	C23H29N3O2S	2.6937	17676		CC(=O)c1cc2c(cc1)Sc1ccccc1N2CCCN1CCN(CCO)CC1	InChI=1S/C23H29N3O2S/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27/h2-3,5-8,17,27H,4,9-16H2,1H3	WNTYBHLDCKXEOT-UHFFFAOYSA-N					doublet; compound annotation
0391_008439	thiostrepton	C72H85N19O18S5	4.144	101290202	CCC(C)C1C(=NC(C(=NC(=C)C(=NC(C(=NC23CCC(=NC2C4=CSC(=N4)C(C(OC(=O)C5=NC6=C(C=CC(C6O)N1)C(=C5)C(C)O)C)N=C(C7=CSC(=N7)C(N=C(C8CSC(=N8)/C(=C\C)/N=C(C(N=C(C9=CSC3=N9)O)C(C)O)O)O)C(C)(C(C)O)O)O)C1=NC(=CS1)C(=NC(=C)C(=NC(=C)C(=N)O)O)O)O)C)O)O)C)O	C=C(NC(=O)C(=C)NC(=O)c1csc(C2=NC3c4csc(n4)C4NC(=O)c5csc(n5)C(C(C)(O)C(C)O)NC(=O)C5CSC(=N5)C(=CC)NC(=O)C(C(C)O)NC(=O)c5csc(n5)C3(CC2)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC2C=Cc3c(nc(cc3C(C)O)C(=O)OC4C)C2O)n1)C(N)=O	InChI=1S/C72H85N19O18S5/c1-14-26(3)47-63(105)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)109-69(107)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-60(102)44-24-113-68(86-44)53(71(13,108)35(12)94)90-62(104)45-23-110-65(84-45)38(15-2)82-64(106)48(33(10)93)88-61(103)46-25-114-70(72)87-46/h15-17,20-22,24-26,30-35,39,45,47-49,51-53,79,92-95,108H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,105)(H,82,106)(H,88,103)(H,89,102)(H,90,104)(H,91,100)/b38-15+	NSFFHOGKXHRQEW-DVRIZHICSA-N					compound annotation
0391_008440	Hydroxysafflor Yellow A	C27H32O16	1.2283	6443665	C1=CC(=CC=C1/C=C/C(=C\2/C(=C(C(=O)C(C2=O)([C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)/O)O	O=C1C(=C(O)C=Cc2ccc(O)cc2)C(O)=C(C2OC(CO)C(O)C(O)C2O)C(=O)C1(O)C1OC(CO)C(O)C(O)C1O	InChI=1S/C27H32O16/c28-7-12-16(32)19(35)21(37)23(42-12)15-18(34)14(11(31)6-3-9-1-4-10(30)5-2-9)24(39)27(41,25(15)40)26-22(38)20(36)17(33)13(8-29)43-26/h1-6,12-13,16-17,19-23,26,28-38,41H,7-8H2/b6-3+,14-11+/t12-,13-,16-,17-,19+,20+,21-,22-,23+,26-,27?/m1/s1	IAVUBSCVWHLRGE-UXEKTNMQSA-N					removed another duplicate entry; compound annotation
0391_008442	Isosakuranin	C22H24O10	2.8345	102004611	COC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1ccc(C2CC(=O)c3c(O)cc(OC4OC(CO)C(O)C(O)C4O)cc3O2)cc1	InChI=1S/C22H24O10/c1-29-11-4-2-10(3-5-11)15-8-14(25)18-13(24)6-12(7-16(18)31-15)30-22-21(28)20(27)19(26)17(9-23)32-22/h2-7,15,17,19-24,26-28H,8-9H2,1H3/t15-,17+,19+,20-,21+,22+/m0/s1	KEEWIHDTSNESJZ-ZJHVPRRPSA-N					doublet; compound annotation
0391_008443	Isosakuranin	C22H24O10	2.8378	102004611	COC1=CC=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1ccc(C2CC(=O)c3c(O)cc(OC4OC(CO)C(O)C(O)C4O)cc3O2)cc1	InChI=1S/C22H24O10/c1-29-11-4-2-10(3-5-11)15-8-14(25)18-13(24)6-12(7-16(18)31-15)30-22-21(28)20(27)19(26)17(9-23)32-22/h2-7,15,17,19-24,26-28H,8-9H2,1H3/t15-,17+,19+,20-,21+,22+/m0/s1	KEEWIHDTSNESJZ-ZJHVPRRPSA-N					doublet; compound annotation
0391_008444	nefazodone	C25H32ClN5O2	3.361	4449		CCc1nn(CCCN2CCN(c3cc(Cl)ccc3)CC2)c(=O)n1CCOc1ccccc1	InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3	VRBKIVRKKCLPHA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008446	Cdc7-IN-1	C21H16ClN3O4	3.5308	136230445	CCOC(=O)C1=C(OC(=C1O)/C=C/2\C=NC3=C2C=CC=N3)NC4=CC=CC=C4Cl	CCOC(=O)c1c(Nc2ccccc2Cl)oc(C=C2C=Nc3c2cccn3)c1O	InChI=1S/C21H16ClN3O4/c1-2-28-21(27)17-18(26)16(10-12-11-24-19-13(12)6-5-9-23-19)29-20(17)25-15-8-4-3-7-14(15)22/h3-11,25-26H,2H2,1H3/b12-10+	MNEODYFHQBZJNQ-ZRDIBKRKSA-N					doublet; compound annotation
0391_008447	Cdc7-IN-1	C21H16ClN3O4	3.5355	136230445	CCOC(=O)C1=C(OC(=C1O)/C=C/2\C=NC3=C2C=CC=N3)NC4=CC=CC=C4Cl	CCOC(=O)c1c(Nc2ccccc2Cl)oc(C=C2C=Nc3c2cccn3)c1O	InChI=1S/C21H16ClN3O4/c1-2-28-21(27)17-18(26)16(10-12-11-24-19-13(12)6-5-9-23-19)29-20(17)25-15-8-4-3-7-14(15)22/h3-11,25-26H,2H2,1H3/b12-10+	MNEODYFHQBZJNQ-ZRDIBKRKSA-N					doublet; compound annotation
0391_008448	BPK-29	C26H32ClN3O3	3.6427	135397651		O=C(c1ccc(N2CCOCC2)cc1)N1CCCC(N(Cc2ccccc2)C(=O)CCl)CC1	InChI=1S/C26H32ClN3O3/c27-19-25(31)30(20-21-5-2-1-3-6-21)24-7-4-13-29(14-12-24)26(32)22-8-10-23(11-9-22)28-15-17-33-18-16-28/h1-3,5-6,8-11,24H,4,7,12-20H2	ZKWKNYRAPOSUDO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008450	Canagliflozin	C24H25FO5S	3.8899	24812758	CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F	Cc1c(Cc2ccc(-c3ccc(F)cc3)s2)cc(C2OC(CO)C(O)C(O)C2O)cc1	InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1	XTNGUQKDFGDXSJ-ZXGKGEBGSA-N					removed another duplicate entry; compound annotation
0391_008452	Indeglitazar	C19H19NO6S	4.0304	11395145		COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3c2ccc(OC)c3)cc1	InChI=1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22)	YMPALHOKRBVHOJ-UHFFFAOYSA-N					compound annotation
0391_008453	FATOSTATIN	C18H18N2S	4.0583	1889993		CCCc1nccc(-c2nc(-c3ccc(C)cc3)cs2)c1	InChI=1S/C18H18N2S/c1-3-4-16-11-15(9-10-19-16)18-20-17(12-21-18)14-7-5-13(2)6-8-14/h5-12H,3-4H2,1-2H3	ZROSUBKIGBSZCG-UHFFFAOYSA-N					doublet; compound annotation
0391_008454	Cdc7-IN-1	C21H16ClN3O4	4.3044	136230445	CCOC(=O)C1=C(OC(=C1O)/C=C/2\C=NC3=C2C=CC=N3)NC4=CC=CC=C4Cl	CCOC(=O)c1c(Nc2ccccc2Cl)oc(C=C2C=Nc3c2cccn3)c1O	InChI=1S/C21H16ClN3O4/c1-2-28-21(27)17-18(26)16(10-12-11-24-19-13(12)6-5-9-23-19)29-20(17)25-15-8-4-3-7-14(15)22/h3-11,25-26H,2H2,1H3/b12-10+	MNEODYFHQBZJNQ-ZRDIBKRKSA-N					doublet; compound annotation
0391_008455	Cdc7-IN-1	C21H16ClN3O4	4.3073	136230445	CCOC(=O)C1=C(OC(=C1O)/C=C/2\C=NC3=C2C=CC=N3)NC4=CC=CC=C4Cl	CCOC(=O)c1c(Nc2ccccc2Cl)oc(C=C2C=Nc3c2cccn3)c1O	InChI=1S/C21H16ClN3O4/c1-2-28-21(27)17-18(26)16(10-12-11-24-19-13(12)6-5-9-23-19)29-20(17)25-15-8-4-3-7-14(15)22/h3-11,25-26H,2H2,1H3/b12-10+	MNEODYFHQBZJNQ-ZRDIBKRKSA-N					doublet; compound annotation
0391_008456	ITD-1	C27H29NO3	4.7322	44135961		CCOC(=O)C1=C(C)NC2=C(C(=O)CC(C)(C)C2)C1c1ccc(-c2ccccc2)cc1	InChI=1S/C27H29NO3/c1-5-31-26(30)23-17(2)28-21-15-27(3,4)16-22(29)25(21)24(23)20-13-11-19(12-14-20)18-9-7-6-8-10-18/h6-14,24,28H,5,15-16H2,1-4H3	ULFUJLFTRWWLPO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008458	Nitenpyram	C11H15ClN4O2	1.3592	3034287	CCN(CC1=CN=C(C=C1)Cl)/C(=C/[N+](=O)[O-])/NC	CCN(Cc1cnc(Cl)cc1)C(=C[N+](=O)[O-])NC	InChI=1S/C11H15ClN4O2/c1-3-15(11(13-2)8-16(17)18)7-9-4-5-10(12)14-6-9/h4-6,8,13H,3,7H2,1-2H3/b11-8+	CFRPSFYHXJZSBI-DHZHZOJOSA-N					removed another duplicate entry; compound annotation
0391_008460	Methylproamine	C28H31N7	1.7226	448201		Cc1c(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)ccc(N(C)C)c1	InChI=1S/C28H31N7/c1-18-15-20(33(2)3)6-8-22(18)28-30-23-9-5-19(16-25(23)32-28)27-29-24-10-7-21(17-26(24)31-27)35-13-11-34(4)12-14-35/h5-10,15-17H,11-14H2,1-4H3,(H,29,31)(H,30,32)	ADKLMOJIJGHCCD-UHFFFAOYSA-N					doublet; compound annotation
0391_008461	Methylproamine	C28H31N7	1.726	448201		Cc1c(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)ccc(N(C)C)c1	InChI=1S/C28H31N7/c1-18-15-20(33(2)3)6-8-22(18)28-30-23-9-5-19(16-25(23)32-28)27-29-24-10-7-21(17-26(24)31-27)35-13-11-34(4)12-14-35/h5-10,15-17H,11-14H2,1-4H3,(H,29,31)(H,30,32)	ADKLMOJIJGHCCD-UHFFFAOYSA-N					doublet; compound annotation
0391_008462	HOE 32020	C25H23ClN6	2.0529	71576674		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2ccc(Cl)cc2)[nH]4)[nH]3)CC1	InChI=1S/C25H23ClN6/c1-31-10-12-32(13-11-31)19-7-9-21-23(15-19)30-25(28-21)17-4-8-20-22(14-17)29-24(27-20)16-2-5-18(26)6-3-16/h2-9,14-15H,10-13H2,1H3,(H,27,29)(H,28,30)	QXGLWDFFMBHOFL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008464	TRICYCLAZOLE	C9H7N3S	2.1827	39040		Cc1c2c(ccc1)sc1nncn12	InChI=1S/C9H7N3S/c1-6-3-2-4-7-8(6)12-5-10-11-9(12)13-7/h2-5H,1H3	DQJCHOQLCLEDLL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008466	150322-05-7	C25H22N2O5	2.4094	4612276		CN(C)c1cc2c(cc1)C1(OC(=O)c3cc(C(=O)O)ccc31)c1c(cc(N(C)C)cc1)O2	InChI=1S/C25H22N2O5/c1-26(2)15-6-9-19-21(12-15)31-22-13-16(27(3)4)7-10-20(22)25(19)18-8-5-14(23(28)29)11-17(18)24(30)32-25/h5-13H,1-4H3,(H,28,29)	DCVXPZDNLDPUES-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008468	HOE 32020	C25H23ClN6	2.4275	71576674		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2ccc(Cl)cc2)[nH]4)[nH]3)CC1	InChI=1S/C25H23ClN6/c1-31-10-12-32(13-11-31)19-7-9-21-23(15-19)30-25(28-21)17-4-8-20-22(14-17)29-24(27-20)16-2-5-18(26)6-3-16/h2-9,14-15H,10-13H2,1H3,(H,27,29)(H,28,30)	QXGLWDFFMBHOFL-UHFFFAOYSA-N					doublet; compound annotation
0391_008469	150322-05-7	C25H22N2O5	2.6937	4612276		CN(C)c1cc2c(cc1)C1(OC(=O)c3cc(C(=O)O)ccc31)c1c(cc(N(C)C)cc1)O2	InChI=1S/C25H22N2O5/c1-26(2)15-6-9-19-21(12-15)31-22-13-16(27(3)4)7-10-20(22)25(19)18-8-5-14(23(28)29)11-17(18)24(30)32-25/h5-13H,1-4H3,(H,28,29)	DCVXPZDNLDPUES-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008471	Tenalisib	C23H18FN5O2	3.1389	86291103	CC[C@@H](C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5	CCC(Nc1ncnc2c1[nH]cn2)c1c(-c2cc(F)ccc2)c(=O)c2ccccc2o1	InChI=1S/C23H18FN5O2/c1-2-16(29-23-19-22(26-11-25-19)27-12-28-23)21-18(13-6-5-7-14(24)10-13)20(30)15-8-3-4-9-17(15)31-21/h3-12,16H,2H2,1H3,(H2,25,26,27,28,29)/t16-/m0/s1	HDXDQPRPFRKGKZ-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_008473	Pivmecillinam	C21H33N3O5S	3.1614	115163	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C	CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C	InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1	NPGNOVNWUSPMDP-HLLBOEOZSA-N					doublet; compound annotation
0391_008474	Pivmecillinam	C21H33N3O5S	3.3325	115163	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C	CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C	InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1	NPGNOVNWUSPMDP-HLLBOEOZSA-N					doublet; compound annotation
0391_008475	Pivmecillinam	C21H33N3O5S	3.3773	115163	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C	CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)C(N=CN3CCCCCC3)C2SC1(C)C	InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1	NPGNOVNWUSPMDP-HLLBOEOZSA-N					doublet; removed another duplicate entry; compound annotation
0391_008477	GSK-J4	C24H27N5O2	3.7538	71729975		CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28)	WBKCKEHGXNWYMO-UHFFFAOYSA-N					doublet; compound annotation
0391_008478	143360-00-3	C13H19NO	3.8786	2747581		CCCCc1cc(C)c(NC(C)=O)cc1	InChI=1S/C13H19NO/c1-4-5-6-12-7-8-13(10(2)9-12)14-11(3)15/h7-9H,4-6H2,1-3H3,(H,14,15)	ZFVMECVBUGMWIX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008480	GSK-J4	C24H27N5O2	4.318	71729975		CCOC(=O)CCNc1cc(N2CCc3ccccc3CC2)nc(-c2ccccn2)n1	InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28)	WBKCKEHGXNWYMO-UHFFFAOYSA-N					doublet; compound annotation
0391_008481	319460-94-1	C26H22FN7O	2.8324	9934283	CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)/C=C/C5=CC=CC=N5)F)C	Cc1nn(C)c(C(=O)Nc2c(F)ccc(Nc3cc4c(cc3)c(C=Cc3ccccn3)n[nH]4)c2)c1	InChI=1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+	JXSVVZKPEDIRTN-DHZHZOJOSA-N					doublet; removed another duplicate entry; compound annotation
0391_008483	319460-94-1	C26H22FN7O	2.9702	9934283	CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)/C=C/C5=CC=CC=N5)F)C	Cc1nn(C)c(C(=O)Nc2c(F)ccc(Nc3cc4c(cc3)c(C=Cc3ccccn3)n[nH]4)c2)c1	InChI=1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+	JXSVVZKPEDIRTN-DHZHZOJOSA-N					doublet; compound annotation
0391_008484	Aliskiren	C30H53N3O6	3.0358	5493444	CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N	COCCCOc1c(OC)ccc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)c1	InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1	UXOWGYHJODZGMF-QORCZRPOSA-N					doublet; compound annotation
0391_008485	Aliskiren	C30H53N3O6	3.0386	5493444	CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N	COCCCOc1c(OC)ccc(CC(CC(N)C(O)CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)c1	InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1	UXOWGYHJODZGMF-QORCZRPOSA-N					doublet; compound annotation
0391_008486	319460-94-1	C26H22FN7O	3.4027	9934283	CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)/C=C/C5=CC=CC=N5)F)C	Cc1nn(C)c(C(=O)Nc2c(F)ccc(Nc3cc4c(cc3)c(C=Cc3ccccn3)n[nH]4)c2)c1	InChI=1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+	JXSVVZKPEDIRTN-DHZHZOJOSA-N					doublet; compound annotation
0391_008487	AT-007	C17H10F3N3O3S2	3.7077	132260161		O=C(O)Cc1nn(Cc2nc3c(ccc(C(F)(F)F)c3)s2)c(=O)c2cscc12	InChI=1S/C17H10F3N3O3S2/c18-17(19,20)8-1-2-13-12(3-8)21-14(28-13)5-23-16(26)10-7-27-6-9(10)11(22-23)4-15(24)25/h1-3,6-7H,4-5H2,(H,24,25)	ORQGHAJIWGGFJK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008489	Tenovin-6	C25H34N4O2S	3.7632	24772043		CN(C)CCCCC(=O)Nc1ccc(NC(=S)NC(=O)c2ccc(C(C)(C)C)cc2)cc1	InChI=1S/C25H34N4O2S/c1-25(2,3)19-11-9-18(10-12-19)23(31)28-24(32)27-21-15-13-20(14-16-21)26-22(30)8-6-7-17-29(4)5/h9-16H,6-8,17H2,1-5H3,(H,26,30)(H2,27,28,31,32)	BVJSXSQRIUSRCO-UHFFFAOYSA-N					compound annotation
0391_008490	Umbralisib	C31H24F3N5O3	4.7338	72950888	C[C@@H](C1=C(C(=O)C2=C(O1)C=CC(=C2)F)C3=CC(=CC=C3)F)N4C5=NC=NC(=C5C(=N4)C6=CC(=C(C=C6)OC(C)C)F)N	CC(C)Oc1c(F)cc(-c2nn(C(C)c3c(-c4cc(F)ccc4)c(=O)c4c(ccc(F)c4)o3)c3ncnc(N)c23)cc1	InChI=1S/C31H24F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H2,35,36,37)/t16-/m0/s1	IUVCFHHAEHNCFT-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_008492	NS 1738	C14H9Cl2F3N2O2	4.9426	310378		O=C(Nc1c(O)ccc(Cl)c1)Nc1c(Cl)ccc(C(F)(F)F)c1	InChI=1S/C14H9Cl2F3N2O2/c15-8-2-4-12(22)11(6-8)21-13(23)20-10-5-7(14(17,18)19)1-3-9(10)16/h1-6,22H,(H2,20,21,23)	OUDXRNQPVSMGDW-UHFFFAOYSA-N					compound annotation
0391_008493	Malonoben	C18H22N2O	5.4858	5614		CC(C)(C)c1cc(C=C(C#N)C#N)cc(C(C)(C)C)c1O	InChI=1S/C18H22N2O/c1-17(2,3)14-8-12(7-13(10-19)11-20)9-15(16(14)21)18(4,5)6/h7-9,21H,1-6H3	MZOPWQKISXCCTP-UHFFFAOYSA-N					compound annotation
0391_008494	2411853-34-2	C17H14Cl2FN3OS	6.1704	138319699		CC1CN(C(=O)Nc2cc(Cl)c(Cl)cc2)C(=Nc2ccc(F)cc2)S1	InChI=1S/C17H14Cl2FN3OS/c1-10-9-23(16(24)21-13-6-7-14(18)15(19)8-13)17(25-10)22-12-4-2-11(20)3-5-12/h2-8,10H,9H2,1H3,(H,21,24)	SHKNIJKASRGSEG-UHFFFAOYSA-N					compound annotation
0391_008495	Pardoprunox	C12H15N3O2	0.6171	6918525		CN1CCN(c2cccc3c2oc(=O)[nH]3)CC1	InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)	YVPUUUDAZYFFQT-UHFFFAOYSA-N					doublet; compound annotation
0391_008496	piribedil	C16H18N4O2	1.6995	4850		c1cnc(N2CCN(Cc3cc4c(cc3)OCO4)CC2)nc1	InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2	OQDPVLVUJFGPGQ-UHFFFAOYSA-N					compound annotation
0391_008497	Pardoprunox	C12H15N3O2	2.9648	6918525		CN1CCN(c2cccc3c2oc(=O)[nH]3)CC1	InChI=1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)	YVPUUUDAZYFFQT-UHFFFAOYSA-N					doublet; compound annotation
0391_008498	622864-54-4	C20H12N2O3	3.2918	4369491		O=C1NC(=O)c2c1c(-c1ccccc1)cc1c2c2c(ccc(O)c2)[nH]1	InChI=1S/C20H12N2O3/c23-11-6-7-14-13(8-11)16-15(21-14)9-12(10-4-2-1-3-5-10)17-18(16)20(25)22-19(17)24/h1-9,21,23H,(H,22,24,25)	IAUZTOZLTFSMIE-UHFFFAOYSA-N					compound annotation
0391_008499	ns6180	C16H12F3NOS	4.7319	11837221		O=C1CSc2ccccc2N1Cc1cc(C(F)(F)F)ccc1	InChI=1S/C16H12F3NOS/c17-16(18,19)12-5-3-4-11(8-12)9-20-13-6-1-2-7-14(13)22-10-15(20)21/h1-8H,9-10H2	ZUIJXKLTUFCDGO-UHFFFAOYSA-N					compound annotation
0391_008500	TAFAMIDIS	C14H7Cl2NO3	4.9297	11001318		O=C(O)c1cc2c(cc1)nc(-c1cc(Cl)cc(Cl)c1)o2	InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)	TXEIIPDJKFWEEC-UHFFFAOYSA-N					doublet; compound annotation
0391_008501	Delpazolid	C14H17FN4O3	0.9399	44205191	CN1CCN(C=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CO)F	CN1CCN(c2c(F)cc(N3CC(CO)OC3=O)cc2)C=N1	InChI=1S/C14H17FN4O3/c1-17-4-5-18(9-16-17)13-3-2-10(6-12(13)15)19-7-11(8-20)22-14(19)21/h2-3,6,9,11,20H,4-5,7-8H2,1H3/t11-/m1/s1	QLUWQAFDTNAYPN-LLVKDONJSA-N					doublet; compound annotation
0391_008502	Delpazolid	C14H17FN4O3	0.9453	44205191	CN1CCN(C=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CO)F	CN1CCN(c2c(F)cc(N3CC(CO)OC3=O)cc2)C=N1	InChI=1S/C14H17FN4O3/c1-17-4-5-18(9-16-17)13-3-2-10(6-12(13)15)19-7-11(8-20)22-14(19)21/h2-3,6,9,11,20H,4-5,7-8H2,1H3/t11-/m1/s1	QLUWQAFDTNAYPN-LLVKDONJSA-N					doublet; compound annotation
0391_008503	Islatravir	C12H12FN5O3	1.1573	6483431	C#C[C@]1([C@H](C[C@@H](O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO	C#CC1(CO)OC(n2cnc3c(N)nc(F)nc32)CC1O	InChI=1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1	IKKXOSBHLYMWAE-QRPMWFLTSA-N					removed another duplicate entry; compound annotation
0391_008505	BIX-01294	C28H38N6O2	1.1849	25150857		COc1c(OC)cc2c(NC3CCN(Cc4ccccc4)CC3)nc(N3CCCN(C)CC3)nc2c1	InChI=1S/C28H38N6O2/c1-32-12-7-13-34(17-16-32)28-30-24-19-26(36-3)25(35-2)18-23(24)27(31-28)29-22-10-14-33(15-11-22)20-21-8-5-4-6-9-21/h4-6,8-9,18-19,22H,7,10-17,20H2,1-3H3,(H,29,30,31)	OSXFATOLZGZLSK-UHFFFAOYSA-N					compound annotation
0391_008506	Canertinib	C24H25ClFN5O3	2.2268	156414		C=CC(=O)Nc1c(OCCCN2CCOCC2)cc2ncnc(Nc3cc(Cl)c(F)cc3)c2c1	InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)	OMZCMEYTWSXEPZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008508	BAY1125976	C23H21N5O	2.2599	70817911		NC(=O)c1nn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2cc1	InChI=1S/C23H21N5O/c24-22(29)18-11-12-19-26-20(21(28(19)27-18)16-5-2-1-3-6-16)15-7-9-17(10-8-15)23(25)13-4-14-23/h1-3,5-12H,4,13-14,25H2,(H2,24,29)	JBGYKRAZYDNCNV-UHFFFAOYSA-N					doublet; compound annotation
0391_008509	BAY1125976	C23H21N5O	2.2626	70817911		NC(=O)c1nn2c(-c3ccccc3)c(-c3ccc(C4(N)CCC4)cc3)nc2cc1	InChI=1S/C23H21N5O/c24-22(29)18-11-12-19-26-20(21(28(19)27-18)16-5-2-1-3-6-16)15-7-9-17(10-8-15)23(25)13-4-14-23/h1-3,5-12H,4,13-14,25H2,(H2,24,29)	JBGYKRAZYDNCNV-UHFFFAOYSA-N					doublet; compound annotation
0391_008510	AM-2394	C22H25N5O4	2.4904	71603585		CNC(=O)Nc1ncc(-c2cnc(OCC(C)(C)O)cc2)c(Oc2cncc(C)c2)c1	InChI=1S/C22H25N5O4/c1-14-7-16(11-24-9-14)31-18-8-19(27-21(28)23-4)25-12-17(18)15-5-6-20(26-10-15)30-13-22(2,3)29/h5-12,29H,13H2,1-4H3,(H2,23,25,27,28)	QUISANLDBDCMPD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008512	CP21R7	C19H15N3O2	2.7541	5327711		Cn1cc(C2=C(c3cc(N)ccc3)C(=O)NC2=O)c2ccccc21	InChI=1S/C19H15N3O2/c1-22-10-14(13-7-2-3-8-15(13)22)17-16(18(23)21-19(17)24)11-5-4-6-12(20)9-11/h2-10H,20H2,1H3,(H,21,23,24)	RGTAEYDIDMGJLX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008514	Pan-RAS-IN-1	C36H41Cl2F3N6O2	3.2065	102004330		NC1(C(=O)NCCCn2cc(-c3ccc(OC(F)(F)F)cc3)c3c2ccc(CN2CCN(Cc4c(Cl)cccc4Cl)CC2)c3)CCNCC1	InChI=1S/C36H41Cl2F3N6O2/c37-31-3-1-4-32(38)30(31)23-46-19-17-45(18-20-46)22-25-5-10-33-28(21-25)29(26-6-8-27(9-7-26)49-36(39,40)41)24-47(33)16-2-13-44-34(48)35(42)11-14-43-15-12-35/h1,3-10,21,24,43H,2,11-20,22-23,42H2,(H,44,48)	GMDFJPPJWWJNKF-UHFFFAOYSA-N					compound annotation
0391_008515	EAI045	C19H14FN3O3S	3.4618	121231412		O=C(Nc1nccs1)C(c1c(O)ccc(F)c1)N1Cc2ccccc2C1=O	InChI=1S/C19H14FN3O3S/c20-12-5-6-15(24)14(9-12)16(17(25)22-19-21-7-8-27-19)23-10-11-3-1-2-4-13(11)18(23)26/h1-9,16,24H,10H2,(H,21,22,25)	YTUFHOKUFOQRDF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008517	461054-93-3	C26H35N3O5	4.453	10322450	CC(C)C[C@H]1C2=C(C[C@@H]3N1C(=O)[C@@H](NC3=O)CCC(=O)OC(C)(C)C)C4=C(N2)C=C(C=C4)OC	COc1cc2c(cc1)c1c([nH]2)C(CC(C)C)N2C(=O)C(CCC(=O)OC(C)(C)C)NC(=O)C2C1	InChI=1S/C26H35N3O5/c1-14(2)11-20-23-17(16-8-7-15(33-6)12-19(16)27-23)13-21-24(31)28-18(25(32)29(20)21)9-10-22(30)34-26(3,4)5/h7-8,12,14,18,20-21,27H,9-11,13H2,1-6H3,(H,28,31)/t18-,20-,21-/m0/s1	NXNRAECHCJZNRF-JBACZVJFSA-N					compound annotation
0391_008518	84468-24-6	C13H15N3O2S	1.0926	3545		O=S(=O)(c1cccc2c1ccnc2)N1CCNCC1	InChI=1S/C13H15N3O2S/c17-19(18,16-8-6-14-7-9-16)13-3-1-2-11-10-15-5-4-12(11)13/h1-5,10,14H,6-9H2	UPTYCYWTFGTCCG-UHFFFAOYSA-N					compound annotation
0391_008519	NMS-P118	C20H24F3N3O2	1.613	49843531		NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2	InChI=1S/C20H24F3N3O2/c21-13-9-12-11-26(19(28)17(12)16(10-13)18(24)27)15-3-7-25(8-4-15)14-1-5-20(22,23)6-2-14/h9-10,14-15H,1-8,11H2,(H2,24,27)	ARYVAQSYRLZVQD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008521	TEMANOGREL	C24H28N4O4	2.3735	11604525		COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1	InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)	ZEOQUKRCASTCFR-UHFFFAOYSA-N					doublet; compound annotation
0391_008522	TEMANOGREL	C24H28N4O4	2.3762	11604525		COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1	InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)	ZEOQUKRCASTCFR-UHFFFAOYSA-N					doublet; compound annotation
0391_008523	GCN2-IN-1	C19H18N10O	2.8543	89720372		c1nn(C2CCOCC2)cc1Nc1ncc2nnn(-c3cc4c(cc3)cn[nH]4)c2n1	InChI=1S/C19H18N10O/c1-2-15(7-16-12(1)8-21-25-16)29-18-17(26-27-29)10-20-19(24-18)23-13-9-22-28(11-13)14-3-5-30-6-4-14/h1-2,7-11,14H,3-6H2,(H,21,25)(H,20,23,24)	CFNFLNGJQOHNPR-UHFFFAOYSA-N					compound annotation
0391_008524	GNF362	C22H21F3N6	3.0868	57999583	C[C@@H]1CN(CCN1C2=NC=C(C=C2)C(F)(F)F)CC3=C(NN=C3)C4=CC=C(C=C4)C#N	CC1CN(Cc2c(-c3ccc(C#N)cc3)[nH]nc2)CCN1c1ncc(C(F)(F)F)cc1	InChI=1S/C22H21F3N6/c1-15-13-30(8-9-31(15)20-7-6-19(12-27-20)22(23,24)25)14-18-11-28-29-21(18)17-4-2-16(10-26)3-5-17/h2-7,11-12,15H,8-9,13-14H2,1H3,(H,28,29)/t15-/m1/s1	VNTCGXMLDSKOKN-OAHLLOKOSA-N					compound annotation
0391_008525	RAD140	C20H16ClN5O2	3.8503	44200882	CC1=C(C=CC(=C1Cl)C#N)N[C@@H](C2=NN=C(O2)C3=CC=C(C=C3)C#N)[C@H](C)O	Cc1c(NC(c2nnc(-c3ccc(C#N)cc3)o2)C(C)O)ccc(C#N)c1Cl	InChI=1S/C20H16ClN5O2/c1-11-16(8-7-15(10-23)17(11)21)24-18(12(2)27)20-26-25-19(28-20)14-5-3-13(9-22)4-6-14/h3-8,12,18,24,27H,1-2H3/t12-,18+/m0/s1	XMBUPPIEVAFYHO-KPZWWZAWSA-N					compound annotation
0391_008526	Pyr10	C18H13F6N3O2S	5.1719	53475435		Cc1ccc(S(=O)(=O)Nc2ccc(-n3nc(C(F)(F)F)cc3C(F)(F)F)cc2)cc1	InChI=1S/C18H13F6N3O2S/c1-11-2-8-14(9-3-11)30(28,29)26-12-4-6-13(7-5-12)27-16(18(22,23)24)10-15(25-27)17(19,20)21/h2-10,26H,1H3	CVALMMCIOLXHDM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008528	H-ILE-TRP-OH	C17H23N3O3	1.744	7019084	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)[O-])[NH3+]	CCC(C)C(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C17H23N3O3/c1-3-10(2)15(18)16(21)20-14(17(22)23)8-11-9-19-13-7-5-4-6-12(11)13/h4-7,9-10,14-15,19H,3,8,18H2,1-2H3,(H,20,21)(H,22,23)/t10-,14-,15-/m0/s1	BVRPESWOSNFUCJ-LKTVYLICSA-N					compound annotation
0391_008529	Ozenoxacin	C21H21N3O3	2.002	9863827		CNc1ncc(-c2c(C)c3c(cc2)c(=O)c(C(=O)O)cn3C2CC2)cc1C	InChI=1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27)	XPIJWUTXQAGSLK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008531	AZD7986	C23H24N4O4	2.5108	118253852	CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)OC1=O	Cn1c(=O)oc2c1cc(-c1ccc(CC(C#N)NC(=O)C3CNCCCO3)cc1)cc2	InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1	AEXFXNFMSAAELR-RXVVDRJESA-N					removed another duplicate entry; compound annotation
0391_008533	3,3'-Diiodo-L-thyronine	C15H13I2NO4	2.7167	44237213	C1=CC(=C(C=C1C[C@@H](C(=O)[O-])[NH3+])I)OC2=CC(=C(C=C2)O)I	NC(Cc1cc(I)c(Oc2cc(I)c(O)cc2)cc1)C(=O)O	InChI=1S/C15H13I2NO4/c16-10-7-9(2-3-13(10)19)22-14-4-1-8(5-11(14)17)6-12(18)15(20)21/h1-5,7,12,19H,6,18H2,(H,20,21)/t12-/m0/s1	CPCJBZABTUOGNM-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_008535	EIPA	C11H18ClN7O	2.8481	1795		CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C	InChI=1S/C11H18ClN7O/c1-4-19(5(2)3)9-7(12)16-6(8(13)17-9)10(20)18-11(14)15/h5H,4H2,1-3H3,(H2,13,17)(H4,14,15,18,20)	QDERNBXNXJCIQK-UHFFFAOYSA-N					doublet; compound annotation
0391_008536	EIPA	C11H18ClN7O	2.9326	1795		CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C	InChI=1S/C11H18ClN7O/c1-4-19(5(2)3)9-7(12)16-6(8(13)17-9)10(20)18-11(14)15/h5H,4H2,1-3H3,(H2,13,17)(H4,14,15,18,20)	QDERNBXNXJCIQK-UHFFFAOYSA-N					doublet; compound annotation
0391_008537	ebselen	C13H9NOSe	3.276	3194		O=c1c2ccccc2[se]n1-c1ccccc1	InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H	DYEFUKCXAQOFHX-UHFFFAOYSA-N					compound annotation
0391_008538	FMF-04-159-2	C28H30Cl3N7O5S	3.3206	138454780	CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)S(=O)(=O)N2CCC(CC2)NC(=O)C3=C(C=NN3)NC(=O)C4=C(C=C(C=C4Cl)Cl)Cl	CN(C)CC=CC(=O)Nc1cc(S(=O)(=O)N2CCC(NC(=O)c3c(NC(=O)c4c(Cl)cc(Cl)cc4Cl)cn[nH]3)CC2)ccc1	InChI=1S/C28H30Cl3N7O5S/c1-37(2)10-4-7-24(39)33-19-5-3-6-20(15-19)44(42,43)38-11-8-18(9-12-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)13-17(29)14-22(25)31/h3-7,13-16,18H,8-12H2,1-2H3,(H,32,36)(H,33,39)(H,34,41)(H,35,40)/b7-4+	HZPYSAHDRSBARR-QPJJXVBHSA-N					removed another duplicate entry; compound annotation
0391_008540	MBX-2982	C22H24N8OS	4.2309	25025505		CCc1cnc(N2CCC(c3nc(COc4ccc(-n5cnnn5)cc4)cs3)CC2)nc1	InChI=1S/C22H24N8OS/c1-2-16-11-23-22(24-12-16)29-9-7-17(8-10-29)21-26-18(14-32-21)13-31-20-5-3-19(4-6-20)30-15-25-27-28-30/h3-6,11-12,14-15,17H,2,7-10,13H2,1H3	NFTMKHWBOINJGM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008542	Sobetirome	C20H24O4	4.2782	9862248		Cc1cc(OCC(=O)O)cc(C)c1Cc1cc(C(C)C)c(O)cc1	InChI=1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23)	QNAZTOHXCZPOSA-UHFFFAOYSA-N					compound annotation
0391_008543	CCT251545	C23H24ClN5O	2.1783	77050682		Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1	InChI=1S/C23H24ClN5O/c1-28-15-18(12-27-28)16-2-4-17(5-3-16)19-13-25-14-20(24)21(19)29-10-7-23(8-11-29)6-9-26-22(23)30/h2-5,12-15H,6-11H2,1H3,(H,26,30)	LBFYQISQYCGDDW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008545	YYA-021	C18H27N3O2	2.4167	3107635		Cc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cc1	InChI=1S/C18H27N3O2/c1-12-6-8-13(9-7-12)19-15(22)16(23)20-14-10-17(2,3)21-18(4,5)11-14/h6-9,14,21H,10-11H2,1-5H3,(H,19,22)(H,20,23)	AYAGJQPDCPRMNG-UHFFFAOYSA-N					compound annotation
0391_008546	PF-04620110	C21H24N4O4	2.6634	46926360		Nc1c2C(=O)N(c3ccc(C4CCC(CC(=O)O)CC4)cc3)CCOc2ncn1	InChI=1S/C21H24N4O4/c22-19-18-20(24-12-23-19)29-10-9-25(21(18)28)16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-17(26)27/h5-8,12-14H,1-4,9-11H2,(H,26,27)(H2,22,23,24)	GEVVQZHMFVFGLN-UHFFFAOYSA-N					compound annotation
0391_008547	ASP5878	C18H19F2N5O4	2.9747	71736582		COc1cc(OC)c(F)c(COc2cnc(Nc3cn(CCO)nc3)nc2)c1F	InChI=1S/C18H19F2N5O4/c1-27-14-5-15(28-2)17(20)13(16(14)19)10-29-12-7-21-18(22-8-12)24-11-6-23-25(9-11)3-4-26/h5-9,26H,3-4,10H2,1-2H3,(H,21,22,24)	VDZZYOJYLLNBTD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008549	ASP5878	C18H19F2N5O4	2.9774	71736582		COc1cc(OC)c(F)c(COc2cnc(Nc3cn(CCO)nc3)nc2)c1F	InChI=1S/C18H19F2N5O4/c1-27-14-5-15(28-2)17(20)13(16(14)19)10-29-12-7-21-18(22-8-12)24-11-6-23-25(9-11)3-4-26/h5-9,26H,3-4,10H2,1-2H3,(H,21,22,24)	VDZZYOJYLLNBTD-UHFFFAOYSA-N					doublet; compound annotation
0391_008550	DMU2139	C19H15NO2	3.0822	13615899	COC1=CC2=C(C=C1)C=C(C=C2)C(=O)/C=C/C3=CN=CC=C3	COc1cc2c(cc1)cc(C(=O)C=Cc1cnccc1)cc2	InChI=1S/C19H15NO2/c1-22-18-8-7-15-11-17(6-5-16(15)12-18)19(21)9-4-14-3-2-10-20-13-14/h2-13H,1H3/b9-4+	MPDPEUALCUWORP-RUDMXATFSA-N					doublet; compound annotation
0391_008551	537672-41-6	C11H15BrN2O	3.0943	4596836		CCCCNNC(=O)c1ccc(Br)cc1	InChI=1S/C11H15BrN2O/c1-2-3-8-13-14-11(15)9-4-6-10(12)7-5-9/h4-7,13H,2-3,8H2,1H3,(H,14,15)	BVQCFCYPFJOOAV-UHFFFAOYSA-N					compound annotation
0391_008552	acelarin	C25H27F2N4O8P	3.0975	11169170	C[C@@H](C(=O)OCC1=CC=CC=C1)NP(=O)(OC[C@@H]2[C@H](C([C@@H](O2)N3C=CC(=NC3=O)N)(F)F)O)OC4=CC=CC=C4	CC(NP(=O)(OCC1OC(n2ccc(N)nc2=O)C(F)(F)C1O)Oc1ccccc1)C(=O)OCc1ccccc1	InChI=1S/C25H27F2N4O8P/c1-16(22(33)36-14-17-8-4-2-5-9-17)30-40(35,39-18-10-6-3-7-11-18)37-15-19-21(32)25(26,27)23(38-19)31-13-12-20(28)29-24(31)34/h2-13,16,19,21,23,32H,14-15H2,1H3,(H,30,35)(H2,28,29,34)/t16-,19+,21+,23+,40?/m0/s1	NHTKGYOMICWFQZ-KKQYNPQSSA-N					removed another duplicate entry; compound annotation
0391_008554	DELAPRIL	C26H32N2O5	3.3564	40466929	CCOC(=O)[C@H](CCC1=CC=CC=C1)[NH2+][C@@H](C)C(=O)N(CC(=O)[O-])C2CC3=CC=CC=C3C2	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1	InChI=1S/C26H32N2O5/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30)/t18-,23-/m0/s1	WOUOLAUOZXOLJQ-MBSDFSHPSA-N					removed another duplicate entry; compound annotation
0391_008556	449811-92-1	C19H18F2N4O3	3.4735	11406590		Cn1c(=O)c(Oc2c(F)cc(F)cc2)cc2cnc(NC3CCOCC3)nc21	InChI=1S/C19H18F2N4O3/c1-25-17-11(10-22-19(24-17)23-13-4-6-27-7-5-13)8-16(18(25)26)28-15-3-2-12(20)9-14(15)21/h2-3,8-10,13H,4-7H2,1H3,(H,22,23,24)	KKKRKRMVJRHDMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008558	DMU2139	C19H15NO2	3.5275	13615899	COC1=CC2=C(C=C1)C=C(C=C2)C(=O)/C=C/C3=CN=CC=C3	COc1cc2c(cc1)cc(C(=O)C=Cc1cnccc1)cc2	InChI=1S/C19H15NO2/c1-22-18-8-7-15-11-17(6-5-16(15)12-18)19(21)9-4-14-3-2-10-20-13-14/h2-13H,1H3/b9-4+	MPDPEUALCUWORP-RUDMXATFSA-N					doublet; compound annotation
0391_008559	DMU2139	C19H15NO2	3.7786	13615899	COC1=CC2=C(C=C1)C=C(C=C2)C(=O)/C=C/C3=CN=CC=C3	COc1cc2c(cc1)cc(C(=O)C=Cc1cnccc1)cc2	InChI=1S/C19H15NO2/c1-22-18-8-7-15-11-17(6-5-16(15)12-18)19(21)9-4-14-3-2-10-20-13-14/h2-13H,1H3/b9-4+	MPDPEUALCUWORP-RUDMXATFSA-N					doublet; compound annotation
0391_008560	449811-92-1	C19H18F2N4O3	3.9758	11406590		Cn1c(=O)c(Oc2c(F)cc(F)cc2)cc2cnc(NC3CCOCC3)nc21	InChI=1S/C19H18F2N4O3/c1-25-17-11(10-22-19(24-17)23-13-4-6-27-7-5-13)8-16(18(25)26)28-15-3-2-12(20)9-14(15)21/h2-3,8-10,13H,4-7H2,1H3,(H,22,23,24)	KKKRKRMVJRHDMG-UHFFFAOYSA-N					doublet; compound annotation
0391_008561	223749-46-0	C17H24F3NO5S	4.3448	9887834	CC1([C@@H]([C@H](C2=C(O1)C=CC(=C2)OCCCC(F)(F)F)N(C)S(=O)(=O)C)O)C	CN(C1c2c(ccc(OCCCC(F)(F)F)c2)OC(C)(C)C1O)S(C)(=O)=O	InChI=1S/C17H24F3NO5S/c1-16(2)15(22)14(21(3)27(4,23)24)12-10-11(6-7-13(12)26-16)25-9-5-8-17(18,19)20/h6-7,10,14-15,22H,5,8-9H2,1-4H3/t14-,15+/m0/s1	SRZRLJWUQFIZRH-LSDHHAIUSA-N					removed another duplicate entry; compound annotation
0391_008563	Tazemetostat	C34H44N4O4	1.9527	66558664		CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1	InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40)	NSQSAUGJQHDYNO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008565	Tazemetostat	C34H44N4O4	1.9556	66558664		CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1	InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40)	NSQSAUGJQHDYNO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008567	DRF-1042	C22H20N2O6	2.4924	23631031	CC[C@@]1(C2=C(COC1=O)C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3C(OCCO)n1c2=O	InChI=1S/C22H20N2O6/c1-2-22(28)15-10-17-18-13(9-12-5-3-4-6-16(12)23-18)20(29-8-7-25)24(17)19(26)14(15)11-30-21(22)27/h3-6,9-10,20,25,28H,2,7-8,11H2,1H3/t20?,22-/m0/s1	XAKLYHGHEFMDAP-IAXKEJLGSA-N					removed another duplicate entry; compound annotation
0391_008569	AZD-7325	C19H19FN4O2	2.6644	23581869		CCCNC(=O)c1nnc2c(-c3c(OC)cccc3F)cccc2c1N	InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)	KYDURMHFWXCKMW-UHFFFAOYSA-N					compound annotation
0391_008570	Gallein	C20H12O7	2.7848	73685		O=C1OC2(c3ccccc13)c1ccc(O)c(O)c1Oc1c2ccc(O)c1O	InChI=1S/C20H12O7/c21-13-7-5-11-17(15(13)23)26-18-12(6-8-14(22)16(18)24)20(11)10-4-2-1-3-9(10)19(25)27-20/h1-8,21-24H	PHLYOKFVXIVOJC-UHFFFAOYSA-N					compound annotation
0391_008571	Losmapimod	C22H26FN3O2	3.6852	11552706		Cc1c(-c2ncc(C(=O)NCC(C)(C)C)cc2)cc(C(=O)NC2CC2)cc1F	InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)	KKYABQBFGDZVNQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008573	Sulbentine	C17H18N2S2	4.8416	67686		S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1	InChI=1S/C17H18N2S2/c20-17-19(12-16-9-5-2-6-10-16)13-18(14-21-17)11-15-7-3-1-4-8-15/h1-10H,11-14H2	QFVAWNPSRQWSDU-UHFFFAOYSA-N					compound annotation
0391_008574	8-Bromo-cGMP (sodium)	C10H11BrN5O7P	0.6264	135419186	C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=C(C(=O)NC(=N4)N)N=C3Br)O)OP(=O)(O1)O	Nc1nc(=O)c2c([nH]1)n(C1OC3COP(=O)(O)OC3C1O)c(Br)n2	InChI=1S/C10H11BrN5O7P/c11-9-13-3-6(14-10(12)15-7(3)18)16(9)8-4(17)5-2(22-8)1-21-24(19,20)23-5/h2,4-5,8,17H,1H2,(H,19,20)(H3,12,14,15,18)/t2-,4-,5-,8-/m1/s1	YUFCOOWNNHGGOD-UMMCILCDSA-N					compound annotation
0391_008575	Malic Enzyme inhibitor ME1	C20H21N3O3	1.8316	2936632		O=C1CC(N2CCN(c3ccc(O)cc3)CC2)C(=O)N1c1ccccc1	InChI=1S/C20H21N3O3/c24-17-8-6-15(7-9-17)21-10-12-22(13-11-21)18-14-19(25)23(20(18)26)16-4-2-1-3-5-16/h1-9,18,24H,10-14H2	JJFJQFJFFVLMCX-UHFFFAOYSA-N					compound annotation
0391_008576	MELK-T1	C21H22N4O2	1.9304	73442760		COc1c(C(=O)Nc2cc3c(cc2)CCNCC3)ccc(-c2c[nH]nc2)c1	InChI=1S/C21H22N4O2/c1-27-20-11-15(17-12-23-24-13-17)3-5-19(20)21(26)25-18-4-2-14-6-8-22-9-7-16(14)10-18/h2-5,10-13,22H,6-9H2,1H3,(H,23,24)(H,25,26)	GMZCYCKIXQZORP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008578	JNK-IN-8	C29H29N7O2	2.095	57340686	CC1=C(C=CC(=C1)NC(=O)C2=CC(=CC=C2)NC(=O)/C=C/CN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4	Cc1c(Nc2nccc(-c3cnccc3)n2)ccc(NC(=O)c2cc(NC(=O)C=CCN(C)C)ccc2)c1	InChI=1S/C29H29N7O2/c1-20-17-24(11-12-25(20)34-29-31-15-13-26(35-29)22-8-5-14-30-19-22)33-28(38)21-7-4-9-23(18-21)32-27(37)10-6-16-36(2)3/h4-15,17-19H,16H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)/b10-6+	GJFCSAPFHAXMSF-UXBLZVDNSA-N					doublet; compound annotation
0391_008579	JNK-IN-8	C29H29N7O2	2.0999	57340686	CC1=C(C=CC(=C1)NC(=O)C2=CC(=CC=C2)NC(=O)/C=C/CN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4	Cc1c(Nc2nccc(-c3cnccc3)n2)ccc(NC(=O)c2cc(NC(=O)C=CCN(C)C)ccc2)c1	InChI=1S/C29H29N7O2/c1-20-17-24(11-12-25(20)34-29-31-15-13-26(35-29)22-8-5-14-30-19-22)33-28(38)21-7-4-9-23(18-21)32-27(37)10-6-16-36(2)3/h4-15,17-19H,16H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)/b10-6+	GJFCSAPFHAXMSF-UXBLZVDNSA-N					doublet; compound annotation
0391_008580	c-Met inhibitor 1	C17H14N8S	2.4426	56650915		Cn1cc(-c2nn3c(Sc4cc5cn(C)nc5cc4)nnc3cc2)cn1	InChI=1S/C17H14N8S/c1-23-10-12(8-18-23)15-5-6-16-19-20-17(25(16)22-15)26-13-3-4-14-11(7-13)9-24(2)21-14/h3-10H,1-2H3	JYXHZDNTBJUJNH-UHFFFAOYSA-N					doublet; compound annotation
0391_008581	c-Met inhibitor 1	C17H14N8S	2.4459	56650915		Cn1cc(-c2nn3c(Sc4cc5cn(C)nc5cc4)nnc3cc2)cn1	InChI=1S/C17H14N8S/c1-23-10-12(8-18-23)15-5-6-16-19-20-17(25(16)22-15)26-13-3-4-14-11(7-13)9-24(2)21-14/h3-10H,1-2H3	JYXHZDNTBJUJNH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008583	c-Met inhibitor 1	C17H14N8S	2.6829	56650915		Cn1cc(-c2nn3c(Sc4cc5cn(C)nc5cc4)nnc3cc2)cn1	InChI=1S/C17H14N8S/c1-23-10-12(8-18-23)15-5-6-16-19-20-17(25(16)22-15)26-13-3-4-14-11(7-13)9-24(2)21-14/h3-10H,1-2H3	JYXHZDNTBJUJNH-UHFFFAOYSA-N					doublet; compound annotation
0391_008584	MKC9989	C17H20O7	3.0509	89542001		COCCOCCc1c(C)c2cc(OC)c(O)c(C=O)c2oc1=O	InChI=1S/C17H20O7/c1-10-11(4-5-23-7-6-21-2)17(20)24-16-12(10)8-14(22-3)15(19)13(16)9-18/h8-9,19H,4-7H2,1-3H3	QSVDQIXSUDHAOF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008586	MELK-T1	C21H22N4O2	3.3963	73442760		COc1c(C(=O)Nc2cc3c(cc2)CCNCC3)ccc(-c2c[nH]nc2)c1	InChI=1S/C21H22N4O2/c1-27-20-11-15(17-12-23-24-13-17)3-5-19(20)21(26)25-18-4-2-14-6-8-22-9-7-16(14)10-18/h2-5,10-13,22H,6-9H2,1H3,(H,23,24)(H,25,26)	GMZCYCKIXQZORP-UHFFFAOYSA-N					doublet; compound annotation
0391_008587	HSP27 inhibitor J2	C13H12O4S	4.0193	135384973		Cc1cc(=O)c2c(O)cc(OCC3CS3)cc2o1	InChI=1S/C13H12O4S/c1-7-2-10(14)13-11(15)3-8(4-12(13)17-7)16-5-9-6-18-9/h2-4,9,15H,5-6H2,1H3	VDCWAGBPDCXRDU-UHFFFAOYSA-N					compound annotation
0391_008588	1228280-29-2	C18H16N4O2S	4.2264	46234348		Cc1ccc(C(=O)Nc2c(C(N)=O)nc(Nc3ccccc3)s2)cc1	InChI=1S/C18H16N4O2S/c1-11-7-9-12(10-8-11)16(24)22-17-14(15(19)23)21-18(25-17)20-13-5-3-2-4-6-13/h2-10H,1H3,(H2,19,23)(H,20,21)(H,22,24)	WCEDGRTWDSHZHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008590	TAFAMIDIS	C14H7Cl2NO3	4.9302	11001318		O=C(O)c1cc2c(cc1)nc(-c1cc(Cl)cc(Cl)c1)o2	InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)	TXEIIPDJKFWEEC-UHFFFAOYSA-N					doublet; compound annotation
0391_008591	AKT Kinase Inhibitor	C16H19N7O3	1.6219	25023726		CCn1c(-c2nonc2N)nc2c1c(OCCCN)cnc2C#CCO	InChI=1S/C16H19N7O3/c1-2-23-14-11(25-8-4-6-17)9-19-10(5-3-7-24)12(14)20-16(23)13-15(18)22-26-21-13/h9,24H,2,4,6-8,17H2,1H3,(H2,18,22)	LWLOLQIXHMFYND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008593	benzyl 5-amino-4-oxopentanoate	C12H15NO3	1.7732	9964521		NCC(=O)CCC(=O)OCc1ccccc1	InChI=1S/C12H15NO3/c13-8-11(14)6-7-12(15)16-9-10-4-2-1-3-5-10/h1-5H,6-9,13H2	AFFZCQDLQIEQGB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008595	1072959-67-1	C22H24N4O4	2.3739	25093235		CN(C)CCOc1c(NC(=O)C2COc3ccccc3O2)ccc(-c2c[nH]nc2)c1	InChI=1S/C22H24N4O4/c1-26(2)9-10-28-20-11-15(16-12-23-24-13-16)7-8-17(20)25-22(27)21-14-29-18-5-3-4-6-19(18)30-21/h3-8,11-13,21H,9-10,14H2,1-2H3,(H,23,24)(H,25,27)	OQWZIAVXCYIZNN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008597	HMN-154	C20H18N2O3S	2.4436	6366736	COC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2/C=C/C3=CC=NC=C3	COc1ccc(S(=O)(=O)Nc2ccccc2C=Cc2ccncc2)cc1	InChI=1S/C20H18N2O3S/c1-25-18-8-10-19(11-9-18)26(23,24)22-20-5-3-2-4-17(20)7-6-16-12-14-21-15-13-16/h2-15,22H,1H3/b7-6+	CIJCDFMGZYKSSC-VOTSOKGWSA-N					doublet; compound annotation
0391_008598	HMN-154	C20H18N2O3S	2.4468	6366736	COC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2/C=C/C3=CC=NC=C3	COc1ccc(S(=O)(=O)Nc2ccccc2C=Cc2ccncc2)cc1	InChI=1S/C20H18N2O3S/c1-25-18-8-10-19(11-9-18)26(23,24)22-20-5-3-2-4-17(20)7-6-16-12-14-21-15-13-16/h2-15,22H,1H3/b7-6+	CIJCDFMGZYKSSC-VOTSOKGWSA-N					doublet; compound annotation
0391_008599	HMN-154	C20H18N2O3S	2.5792	6366736	COC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2/C=C/C3=CC=NC=C3	COc1ccc(S(=O)(=O)Nc2ccccc2C=Cc2ccncc2)cc1	InChI=1S/C20H18N2O3S/c1-25-18-8-10-19(11-9-18)26(23,24)22-20-5-3-2-4-17(20)7-6-16-12-14-21-15-13-16/h2-15,22H,1H3/b7-6+	CIJCDFMGZYKSSC-VOTSOKGWSA-N					doublet; compound annotation
0391_008600	AZD4547	C26H33N5O3	2.7176	51039095	C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1	InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+	VRQMAABPASPXMW-HDICACEKSA-N					removed another duplicate entry; compound annotation
0391_008602	Org 27569	C24H28ClN3O	3.4021	44828492		CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2c1cc(Cl)cc2	InChI=1S/C24H28ClN3O/c1-2-20-21-16-18(25)8-11-22(21)27-23(20)24(29)26-13-12-17-6-9-19(10-7-17)28-14-4-3-5-15-28/h6-11,16,27H,2-5,12-15H2,1H3,(H,26,29)	AHFZDNYNXFMRFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008603	Org 27569	C24H28ClN3O	3.5253	44828492		CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2c1cc(Cl)cc2	InChI=1S/C24H28ClN3O/c1-2-20-21-16-18(25)8-11-22(21)27-23(20)24(29)26-13-12-17-6-9-19(10-7-17)28-14-4-3-5-15-28/h6-11,16,27H,2-5,12-15H2,1H3,(H,26,29)	AHFZDNYNXFMRFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008604	beraprost	C24H30O5	3.6715	5282428	CC#CCC(C)C(/C=C/C1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O	CC#CCC(C)C(O)C=CC1C(O)CC2Oc3c(CCCC(=O)O)cccc3C21	InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+	CTPOHARTNNSRSR-OUKQBFOZSA-N					doublet; compound annotation
0391_008605	chrysin	C15H10O4	3.6744	5281607		O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H	RTIXKCRFFJGDFG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008607	beraprost	C24H30O5	3.7102	5282428	CC#CCC(C)C(/C=C/C1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O	CC#CCC(C)C(O)C=CC1C(O)CC2Oc3c(CCCC(=O)O)cccc3C21	InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+	CTPOHARTNNSRSR-OUKQBFOZSA-N					doublet; compound annotation
0391_008608	Dabrafenib	C23H20F3N5O2S2	4.1724	44462760		CC(C)(C)c1nc(-c2c(F)c(NS(=O)(=O)c3c(F)cccc3F)ccc2)c(-c2nc(N)ncc2)s1	InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)	BFSMGDJOXZAERB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008610	PK150	C15H8ClF5N2O3	5.3206	132190620		O=C(Nc1cc2c(cc1)OC(F)(F)O2)Nc1cc(C(F)(F)F)c(Cl)cc1	InChI=1S/C15H8ClF5N2O3/c16-10-3-1-7(5-9(10)14(17,18)19)22-13(24)23-8-2-4-11-12(6-8)26-15(20,21)25-11/h1-6H,(H2,22,23,24)	SHPYXCLUNMOJOB-UHFFFAOYSA-N					compound annotation
0391_008611	MRT67307	C26H36N6O2	1.6546	44464263		O=C(NCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)ncc1C1CC1)C1CCC1	InChI=1S/C26H36N6O2/c33-25(21-5-2-6-21)28-11-3-10-27-24-23(20-8-9-20)17-29-26(31-24)30-22-7-1-4-19(16-22)18-32-12-14-34-15-13-32/h1,4,7,16-17,20-21H,2-3,5-6,8-15,18H2,(H,28,33)(H2,27,29,30,31)	UKBGBACORPRCGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008613	Cediranib	C25H27FN4O3	2.8869	9933475		COc1c(OCCCN2CCCC2)cc2ncnc(Oc3c(F)c4c(cc3)[nH]c(C)c4)c2c1	InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3	XXJWYDDUDKYVKI-UHFFFAOYSA-N					doublet; compound annotation
0391_008614	CDK inhibitor II	C18H19ClFN3O2	2.8924	50991505	COC1=C(C=C(C=C1)F)C2=CC(=NC=C2Cl)NC(=O)[C@@H]3CCCNC3	COc1c(-c2cc(NC(=O)C3CCCNC3)ncc2Cl)cc(F)cc1	InChI=1S/C18H19ClFN3O2/c1-25-16-5-4-12(20)7-14(16)13-8-17(22-10-15(13)19)23-18(24)11-3-2-6-21-9-11/h4-5,7-8,10-11,21H,2-3,6,9H2,1H3,(H,22,23,24)/t11-/m1/s1	AHMKHNVZGOQLRQ-LLVKDONJSA-N					doublet; compound annotation
0391_008615	CDK inhibitor II	C18H19ClFN3O2	2.8963	50991505	COC1=C(C=C(C=C1)F)C2=CC(=NC=C2Cl)NC(=O)[C@@H]3CCCNC3	COc1c(-c2cc(NC(=O)C3CCCNC3)ncc2Cl)cc(F)cc1	InChI=1S/C18H19ClFN3O2/c1-25-16-5-4-12(20)7-14(16)13-8-17(22-10-15(13)19)23-18(24)11-3-2-6-21-9-11/h4-5,7-8,10-11,21H,2-3,6,9H2,1H3,(H,22,23,24)/t11-/m1/s1	AHMKHNVZGOQLRQ-LLVKDONJSA-N					doublet; compound annotation
0391_008616	Lp-PLA2-IN-3	C20H13ClF3N3O3S	4.6645	132427687		N#Cc1c(Oc2cc(C(F)(F)F)c(Cl)cc2)ccc(NS(=O)(=O)c2ccc(N)cc2)c1	InChI=1S/C20H13ClF3N3O3S/c21-18-7-4-15(10-17(18)20(22,23)24)30-19-8-3-14(9-12(19)11-25)27-31(28,29)16-5-1-13(26)2-6-16/h1-10,27H,26H2	GADGQEKPNKSGMT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008618	1268524-70-4	C23H25ClN4O2S	4.9618	46907787	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)OC(C)(C)C)N=C2c1ccc(Cl)cc1	InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1	DNVXATUJJDPFDM-KRWDZBQOSA-N					doublet; compound annotation
0391_008619	1268524-70-4	C23H25ClN4O2S	4.9645	46907787	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)OC(C)(C)C)N=C2c1ccc(Cl)cc1	InChI=1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1	DNVXATUJJDPFDM-KRWDZBQOSA-N					doublet; compound annotation
0391_008620	j147	C18H17F3N2O2	5.502	25229652	CC1=CC(=C(C=C1)N(C(=O)C(F)(F)F)/N=C/C2=CC(=CC=C2)OC)C	COc1cccc(C=NN(C(=O)C(F)(F)F)c2c(C)cc(C)cc2)c1	InChI=1S/C18H17F3N2O2/c1-12-7-8-16(13(2)9-12)23(17(24)18(19,20)21)22-11-14-5-4-6-15(10-14)25-3/h4-11H,1-3H3/b22-11+	HYMZAYGFKNNHDN-SSDVNMTOSA-N					compound annotation
0391_008621	TW-37	C33H35NO6S	5.7482	11455910		CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O	InChI=1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38)	PQAPVTKIEGUPRN-UHFFFAOYSA-N					compound annotation
0391_008622	SULFISOMIDINE	C12H14N4O2S	0.9477	5343		Cc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1	InChI=1S/C12H14N4O2S/c1-8-7-12(15-9(2)14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)	YZMCKZRAOLZXAZ-UHFFFAOYSA-N					compound annotation
0391_008623	Zeatin riboside	C15H21N5O5	1.0899	6440982	C/C(=C\CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)/CO	CC(=CCNc1c2ncn(C3OC(CO)C(O)C3O)c2ncn1)CO	InChI=1S/C15H21N5O5/c1-8(4-21)2-3-16-13-10-14(18-6-17-13)20(7-19-10)15-12(24)11(23)9(5-22)25-15/h2,6-7,9,11-12,15,21-24H,3-5H2,1H3,(H,16,17,18)/b8-2+/t9-,11-,12-,15-/m1/s1	GOSWTRUMMSCNCW-HNNGNKQASA-N					doublet; compound annotation
0391_008624	Zeatin riboside	C15H21N5O5	1.1554	6440982	C/C(=C\CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)/CO	CC(=CCNc1c2ncn(C3OC(CO)C(O)C3O)c2ncn1)CO	InChI=1S/C15H21N5O5/c1-8(4-21)2-3-16-13-10-14(18-6-17-13)20(7-19-10)15-12(24)11(23)9(5-22)25-15/h2,6-7,9,11-12,15,21-24H,3-5H2,1H3,(H,16,17,18)/b8-2+/t9-,11-,12-,15-/m1/s1	GOSWTRUMMSCNCW-HNNGNKQASA-N					doublet; removed another duplicate entry; compound annotation
0391_008626	Zeatin riboside	C15H21N5O5	1.242	6440982	C/C(=C\CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)/CO	CC(=CCNc1c2ncn(C3OC(CO)C(O)C3O)c2ncn1)CO	InChI=1S/C15H21N5O5/c1-8(4-21)2-3-16-13-10-14(18-6-17-13)20(7-19-10)15-12(24)11(23)9(5-22)25-15/h2,6-7,9,11-12,15,21-24H,3-5H2,1H3,(H,16,17,18)/b8-2+/t9-,11-,12-,15-/m1/s1	GOSWTRUMMSCNCW-HNNGNKQASA-N					doublet; compound annotation
0391_008627	Leu-Enkephalin amide	C28H38N6O6	2.0159	9985128	CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(N)=O	InChI=1S/C28H38N6O6/c1-17(2)12-22(26(30)38)34-28(40)23(14-18-6-4-3-5-7-18)33-25(37)16-31-24(36)15-32-27(39)21(29)13-19-8-10-20(35)11-9-19/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,38)(H,31,36)(H,32,39)(H,33,37)(H,34,40)/t21-,22-,23-/m0/s1	YZXGODHVAJPXSG-VABKMULXSA-N					compound annotation
0391_008628	aromadendrin	C15H12O6	2.1834	122850	C1=CC(=CC=C1[C@@H]2[C@H](C(=O)C3=C(C=C(C=C3O2)O)O)O)O	O=C1c2c(O)cc(O)cc2OC(c2ccc(O)cc2)C1O	InChI=1S/C15H12O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,14-18,20H/t14-,15+/m0/s1	PADQINQHPQKXNL-LSDHHAIUSA-N					compound annotation
0391_008629	efavirenz	C14H9ClF3NO2	4.5552	64139	C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F	O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1	InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1	XPOQHMRABVBWPR-ZDUSSCGKSA-N					compound annotation
0391_008630	Lonafarnib	C27H31Br2ClN4O2	4.6567	148195	C1CN(CCC1CC(=O)N2CCC(CC2)[C@@H]3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N	NC(=O)N1CCC(CC(=O)N2CCC(C3c4ncc(Br)cc4CCc4c3c(Br)cc(Cl)c4)CC2)CC1	InChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1	DHMTURDWPRKSOA-RUZDIDTESA-N					removed another duplicate entry; compound annotation
0391_008632	lidocaine	C14H22N2O	1.5745	3676		CCN(CC)CC(=O)Nc1c(C)cccc1C	InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)	NNJVILVZKWQKPM-UHFFFAOYSA-N					doublet; compound annotation
0391_008633	Nicosulfuron	C15H18N6O6S	2.6649	51380907		COc1nc(NC(=O)NS(=O)(=O)c2c(C(=O)N(C)C)cccn2)nc(OC)c1	InChI=1S/C15H18N6O6S/c1-21(2)13(22)9-6-5-7-16-12(9)28(24,25)20-15(23)19-14-17-10(26-3)8-11(18-14)27-4/h5-8H,1-4H3,(H2,17,18,19,20,23)	RTCOGUMHFFWOJV-UHFFFAOYSA-N					compound annotation
0391_008634	CUDC-907	C23H24N8O4S	2.7298	54575456		COc1ncc(-c2nc3c(sc(CN(C)c4ncc(C(=O)NO)cn4)c3)c(N3CCOCC3)n2)cc1	InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)	JOWXJLIFIIOYMS-UHFFFAOYSA-N					compound annotation
0391_008635	Pexidartinib	C20H15ClF3N5	2.8677	25151352		FC(F)(F)c1ncc(CNc2ncc(Cc3c[nH]c4c3cc(Cl)cn4)cc2)cc1	InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)	JGWRKYUXBBNENE-UHFFFAOYSA-N					doublet; compound annotation
0391_008636	CARBOPROST	C21H36O5	3.4273	5281075	CCCCC[C@@](C)(/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O	CCCCCC(C)(O)C=CC1C(O)CC(O)C1CC=CCCCC(=O)O	InChI=1S/C21H36O5/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25/h5,7,12,14,16-19,22-23,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25)/b7-5-,14-12+/t16-,17-,18+,19-,21+/m1/s1	DLJKPYFALUEJCK-IIELGFQLSA-N					compound annotation
0391_008637	Licochalcone D	C21H22O5	3.7569	10473311	CC(=CCC1=C(C=CC(=C1)C(=O)/C=C/C2=C(C(=C(C=C2)O)O)OC)O)C	COc1c(C=CC(=O)c2cc(CC=C(C)C)c(O)cc2)ccc(O)c1O	InChI=1S/C21H22O5/c1-13(2)4-5-15-12-16(8-10-18(15)23)17(22)9-6-14-7-11-19(24)20(25)21(14)26-3/h4,6-12,23-25H,5H2,1-3H3/b9-6+	RETRVWFVEFCGOK-RMKNXTFCSA-N					compound annotation
0391_008638	Clofarabine	C10H11ClFN5O3	1.2461	119182	C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N	Nc1c2ncn(C3OC(CO)C(O)C3F)c2nc(Cl)n1	InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1	WDDPHFBMKLOVOX-AYQXTPAHSA-N					removed another duplicate entry; compound annotation
0391_008640	NEDOCROMIL	C19H17NO7	1.5585	50294		CCCc1c2c(cc3c1oc(C(=O)O)cc3=O)c(=O)cc(C(=O)O)n2CC	InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)	RQTOOFIXOKYGAN-UHFFFAOYSA-N					compound annotation
0391_008641	GSK2245035	C20H34N6O2	2.4683	44623937	CCC[C@H](C)OC1=NC(=C2C(=N1)N(C(=O)N2)CCCCCN3CCCCC3)N	CCCC(C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1	InChI=1S/C20H34N6O2/c1-3-10-15(2)28-19-23-17(21)16-18(24-19)26(20(27)22-16)14-9-5-8-13-25-11-6-4-7-12-25/h15H,3-14H2,1-2H3,(H,22,27)(H2,21,23,24)/t15-/m0/s1	LFMPVTVPXHNXOT-HNNXBMFYSA-N					compound annotation
0391_008642	1415637-72-7	C20H18F3N7	2.9726	71488864		Cn1ncc(-c2nn(C)c3c2c(N2CCC2)ncn3)c1-c1ccc(C(F)(F)F)cc1	InChI=1S/C20H18F3N7/c1-28-17(12-4-6-13(7-5-12)20(21,22)23)14(10-26-28)16-15-18(29(2)27-16)24-11-25-19(15)30-8-3-9-30/h4-7,10-11H,3,8-9H2,1-2H3	SHAVEYUXRBIMLA-UHFFFAOYSA-N					doublet; compound annotation
0391_008643	1415637-72-7	C20H18F3N7	3.0082	71488864		Cn1ncc(-c2nn(C)c3c2c(N2CCC2)ncn3)c1-c1ccc(C(F)(F)F)cc1	InChI=1S/C20H18F3N7/c1-28-17(12-4-6-13(7-5-12)20(21,22)23)14(10-26-28)16-15-18(29(2)27-16)24-11-25-19(15)30-8-3-9-30/h4-7,10-11H,3,8-9H2,1-2H3	SHAVEYUXRBIMLA-UHFFFAOYSA-N					doublet; compound annotation
0391_008644	1415637-72-7	C20H18F3N7	3.0112	71488864		Cn1ncc(-c2nn(C)c3c2c(N2CCC2)ncn3)c1-c1ccc(C(F)(F)F)cc1	InChI=1S/C20H18F3N7/c1-28-17(12-4-6-13(7-5-12)20(21,22)23)14(10-26-28)16-15-18(29(2)27-16)24-11-25-19(15)30-8-3-9-30/h4-7,10-11H,3,8-9H2,1-2H3	SHAVEYUXRBIMLA-UHFFFAOYSA-N					doublet; compound annotation
0391_008645	2306193-99-5	C26H33FN4O5S	3.1151	137628614	CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)F)O)O	Cc1c(-c2cc(O)c(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)C3(F)CC3)C(C)(C)C)cc2)scn1	InChI=1S/C26H33FN4O5S/c1-14-20(37-13-29-14)15-5-6-16(19(33)9-15)11-28-22(34)18-10-17(32)12-31(18)23(35)21(25(2,3)4)30-24(36)26(27)7-8-26/h5-6,9,13,17-18,21,32-33H,7-8,10-12H2,1-4H3,(H,28,34)(H,30,36)/t17-,18+,21-/m1/s1	OKBLHQUBMCCFKE-LVCYWYKZSA-N					doublet; compound annotation
0391_008646	2306193-99-5	C26H33FN4O5S	3.118	137628614	CC1=C(SC=N1)C2=CC(=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)C4(CC4)F)O)O	Cc1c(-c2cc(O)c(CNC(=O)C3CC(O)CN3C(=O)C(NC(=O)C3(F)CC3)C(C)(C)C)cc2)scn1	InChI=1S/C26H33FN4O5S/c1-14-20(37-13-29-14)15-5-6-16(19(33)9-15)11-28-22(34)18-10-17(32)12-31(18)23(35)21(25(2,3)4)30-24(36)26(27)7-8-26/h5-6,9,13,17-18,21,32-33H,7-8,10-12H2,1-4H3,(H,28,34)(H,30,36)/t17-,18+,21-/m1/s1	OKBLHQUBMCCFKE-LVCYWYKZSA-N					doublet; compound annotation
0391_008647	HQNO	C16H21NO2	3.6484	1561		CCCCCCCc1cc(=O)c2ccccc2n1O	InChI=1S/C16H21NO2/c1-2-3-4-5-6-9-13-12-16(18)14-10-7-8-11-15(14)17(13)19/h7-8,10-12,19H,2-6,9H2,1H3	ICTVCUOZYWNYHM-UHFFFAOYSA-N					compound annotation
0391_008648	Rezafungin	C63H85N8O17+	4.0974	78318119	CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)OCC[N+](C)(C)C)O	CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)NC4CC(O)C(OCC[N+](C)(C)C)NC(=O)C5C(O)C(C)CN5C(=O)C(C(C)O)NC(=O)C(C(O)C(O)c5ccc(O)cc5)NC(=O)C5CC(O)CN5C(=O)C(C(C)O)NC4=O)cc3)cc2)cc1	InChI=1S/C63H84N8O17/c1-8-9-10-28-87-45-25-21-40(22-26-45)38-13-11-37(12-14-38)39-15-17-42(18-16-39)56(80)64-46-31-48(76)61(88-29-27-71(5,6)7)68-60(84)52-53(77)34(2)32-70(52)63(86)50(36(4)73)66-59(83)51(55(79)54(78)41-19-23-43(74)24-20-41)67-58(82)47-30-44(75)33-69(47)62(85)49(35(3)72)65-57(46)81/h11-26,34-36,44,46-55,61,72-73,75-79H,8-10,27-33H2,1-7H3,(H5-,64,65,66,67,68,74,80,81,82,83,84)/p+1/t34-,35+,36+,44+,46-,47-,48+,49-,50-,51-,52-,53-,54-,55-,61+/m0/s1	LNFCWEXGZIEGJW-TXSVMFMRSA-O					compound annotation
0391_008649	892489-52-0	C23H22F2N4O4	4.201	23648867		O=C(O)CC1CCC(c2ccc(NC(=O)c3nnc(Nc4cc(F)c(F)cc4)o3)cc2)CC1	InChI=1S/C23H22F2N4O4/c24-18-10-9-17(12-19(18)25)27-23-29-28-22(33-23)21(32)26-16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-20(30)31/h5-10,12-14H,1-4,11H2,(H,26,32)(H,27,29)(H,30,31)	NGEBYTLALFOQKI-UHFFFAOYSA-N					compound annotation
0391_008650	Talniflumate	C21H13F3N2O4	5.4782	48229		O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc12	InChI=1S/C21H13F3N2O4/c22-21(23,24)12-5-3-6-13(11-12)26-17-16(9-4-10-25-17)19(28)30-20-15-8-2-1-7-14(15)18(27)29-20/h1-11,20H,(H,25,26)	ANMLJLFWUCQGKZ-UHFFFAOYSA-N					compound annotation
0391_008651	Methylhomatropine	C17H24NO3+	1.1448	5282592	C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C	C[N+]1(C)C2CCC1CC(OC(=O)C(O)c1ccccc1)C2	InChI=1S/C17H24NO3/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12/h3-7,13-16,19H,8-11H2,1-2H3/q+1/t13-,14+,15?,16?	WKWOJBUWWZTUQV-PJPHBNEVSA-N					compound annotation
0391_008652	3367-88-2	C14H10N2O	1.455	5796182	C1=CC=C2C(=C1)/C(=C/C3=CC=CC=N3)/C(=O)N2	O=C1Nc2ccccc2C1=Cc1ccccn1	InChI=1S/C14H10N2O/c17-14-12(9-10-5-3-4-8-15-10)11-6-1-2-7-13(11)16-14/h1-9H,(H,16,17)/b12-9-	YKQONSWBHGBDSB-XFXZXTDPSA-N					doublet; compound annotation
0391_008653	Cynaroside	C21H20O11	1.9007	5280637	C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O	O=c1cc(-c2cc(O)c(O)cc2)oc2cc(OC3OC(CO)C(O)C(O)C3O)cc(O)c12	InChI=1S/C21H20O11/c22-7-16-18(27)19(28)20(29)21(32-16)30-9-4-12(25)17-13(26)6-14(31-15(17)5-9)8-1-2-10(23)11(24)3-8/h1-6,16,18-25,27-29H,7H2/t16-,18-,19+,20-,21-/m1/s1	PEFNSGRTCBGNAN-QNDFHXLGSA-N					compound annotation
0391_008654	Clozapine N-oxide	C18H19ClN4O	2.5054	135445691		C[N+]1([O-])CCN(C2=Nc3c(ccc(Cl)c3)Nc3ccccc23)CC1	InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3	OGUCZBIQSYYWEF-UHFFFAOYSA-N					doublet; compound annotation
0391_008655	Ginkgolide B	C20H24O10	2.5393	6324617	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3([C@H]2O)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O	CC1C(=O)OC2C(O)C34C5CC(C(C)(C)C)C36C(OC(=O)C6O)OC4(C(=O)O5)C12O	InChI=1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11+,15+,17+,18+,19-,20-/m1/s1	SQOJOAFXDQDRGF-MMQTXUMRSA-N					compound annotation
0391_008656	3367-88-2	C14H10N2O	2.88	5796182	C1=CC=C2C(=C1)/C(=C/C3=CC=CC=N3)/C(=O)N2	O=C1Nc2ccccc2C1=Cc1ccccn1	InChI=1S/C14H10N2O/c17-14-12(9-10-5-3-4-8-15-10)11-6-1-2-7-13(11)16-14/h1-9H,(H,16,17)/b12-9-	YKQONSWBHGBDSB-XFXZXTDPSA-N					doublet; compound annotation
0391_008657	Norethisterone enanthate	C27H38O3	6.3071	229295	CCCCCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C	C#CC1(OC(=O)CCCCCC)CCC2C3CCC4=CC(=O)CCC4C3CCC21C	InChI=1S/C27H38O3/c1-4-6-7-8-9-25(29)30-27(5-2)17-15-24-23-12-10-19-18-20(28)11-13-21(19)22(23)14-16-26(24,27)3/h2,18,21-24H,4,6-17H2,1,3H3/t21-,22+,23+,24-,26-,27-/m0/s1	APTGJECXMIKIET-WOSSHHRXSA-N					compound annotation
0391_008658	Spautin-1	C15H11F2N3	2.1968	51037431		Fc1ccc(CNc2ncnc3c2cc(F)cc3)cc1	InChI=1S/C15H11F2N3/c16-11-3-1-10(2-4-11)8-18-15-13-7-12(17)5-6-14(13)19-9-20-15/h1-7,9H,8H2,(H,18,19,20)	AWIVHRPYFSSVOG-UHFFFAOYSA-N					doublet; compound annotation
0391_008659	Spautin-1	C15H11F2N3	2.2422	51037431		Fc1ccc(CNc2ncnc3c2cc(F)cc3)cc1	InChI=1S/C15H11F2N3/c16-11-3-1-10(2-4-11)8-18-15-13-7-12(17)5-6-14(13)19-9-20-15/h1-7,9H,8H2,(H,18,19,20)	AWIVHRPYFSSVOG-UHFFFAOYSA-N					doublet; compound annotation
0391_008660	54827-17-7	C16H20N2	2.3891	41206		Cc1c(N)c(C)cc(-c2cc(C)c(N)c(C)c2)c1	InChI=1S/C16H20N2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8H,17-18H2,1-4H3	UAIUNKRWKOVEES-UHFFFAOYSA-N					doublet; compound annotation
0391_008661	Cevipabulin	C18H18ClF5N6O	2.6141	11488110	C[C@@H](C(F)(F)F)NC1=C(C(=NC2=NC=NN12)Cl)C3=C(C=C(C=C3F)OCCCNC)F	CNCCCOc1cc(F)c(-c2c(NC(C)C(F)(F)F)n3ncnc3nc2Cl)c(F)c1	InChI=1S/C18H18ClF5N6O/c1-9(18(22,23)24)28-16-14(15(19)29-17-26-8-27-30(16)17)13-11(20)6-10(7-12(13)21)31-5-3-4-25-2/h6-9,25,28H,3-5H2,1-2H3/t9-/m0/s1	ZUZPCOQWSYNWLU-VIFPVBQESA-N					doublet; removed another duplicate entry; compound annotation
0391_008663	Tosedostat	C21H30N2O6	3.6137	15547703	CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](C1=CC=CC=C1)C(=O)OC2CCCC2	CC(C)CC(C(=O)NC(C(=O)OC1CCCC1)c1ccccc1)C(O)C(=O)NO	InChI=1S/C21H30N2O6/c1-13(2)12-16(18(24)20(26)23-28)19(25)22-17(14-8-4-3-5-9-14)21(27)29-15-10-6-7-11-15/h3-5,8-9,13,15-18,24,28H,6-7,10-12H2,1-2H3,(H,22,25)(H,23,26)/t16-,17+,18+/m1/s1	FWFGIHPGRQZWIW-SQNIBIBYSA-N					doublet; compound annotation
0391_008664	Tosedostat	C21H30N2O6	3.6165	15547703	CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@@H](C1=CC=CC=C1)C(=O)OC2CCCC2	CC(C)CC(C(=O)NC(C(=O)OC1CCCC1)c1ccccc1)C(O)C(=O)NO	InChI=1S/C21H30N2O6/c1-13(2)12-16(18(24)20(26)23-28)19(25)22-17(14-8-4-3-5-9-14)21(27)29-15-10-6-7-11-15/h3-5,8-9,13,15-18,24,28H,6-7,10-12H2,1-2H3,(H,22,25)(H,23,26)/t16-,17+,18+/m1/s1	FWFGIHPGRQZWIW-SQNIBIBYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008666	Tizoxanide	C10H7N3O4S	3.6852	394397		O=C(Nc1ncc([N+](=O)[O-])s1)c1ccccc1O	InChI=1S/C10H7N3O4S/c14-7-4-2-1-3-6(7)9(15)12-10-11-5-8(18-10)13(16)17/h1-5,14H,(H,11,12,15)	FDTZUTSGGSRHQF-UHFFFAOYSA-N					compound annotation
0391_008667	EACC	C13H11N3O6S2	3.9523	3704668		CCOC(=O)NC(=O)c1c(NC(=O)c2ccc([N+](=O)[O-])s2)scc1	InChI=1S/C13H11N3O6S2/c1-2-22-13(19)15-10(17)7-5-6-23-12(7)14-11(18)8-3-4-9(24-8)16(20)21/h3-6H,2H2,1H3,(H,14,18)(H,15,17,19)	ISLJZDYAPAUORR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008669	N-Desmethyltamoxifen	C25H27NO	4.0588	6378383	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO/c1-3-24(20-10-6-4-7-11-20)25(21-12-8-5-9-13-21)22-14-16-23(17-15-22)27-19-18-26-2/h4-17,26H,3,18-19H2,1-2H3/b25-24-	NYDCDZSEEAUOHN-IZHYLOQSSA-N					doublet; compound annotation
0391_008670	N-Desmethyltamoxifen	C25H27NO	4.2112	6378383	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCNC)cc1)c1ccccc1	InChI=1S/C25H27NO/c1-3-24(20-10-6-4-7-11-20)25(21-12-8-5-9-13-21)22-14-16-23(17-15-22)27-19-18-26-2/h4-17,26H,3,18-19H2,1-2H3/b25-24-	NYDCDZSEEAUOHN-IZHYLOQSSA-N					doublet; compound annotation
0391_008671	4,4'-Dimethoxychalcone	C17H16O3	4.3615	5377817	COC1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(C=C2)OC	COc1ccc(C=CC(=O)c2ccc(OC)cc2)cc1	InChI=1S/C17H16O3/c1-19-15-8-3-13(4-9-15)5-12-17(18)14-6-10-16(20-2)11-7-14/h3-12H,1-2H3/b12-5+	HDXVSZWKIHQDES-LFYBBSHMSA-N					doublet; compound annotation
0391_008672	4,4'-Dimethoxychalcone	C17H16O3	4.365	5377817	COC1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(C=C2)OC	COc1ccc(C=CC(=O)c2ccc(OC)cc2)cc1	InChI=1S/C17H16O3/c1-19-15-8-3-13(4-9-15)5-12-17(18)14-6-10-16(20-2)11-7-14/h3-12H,1-2H3/b12-5+	HDXVSZWKIHQDES-LFYBBSHMSA-N					doublet; removed another duplicate entry; compound annotation
0391_008674	4,4'-Dimethoxychalcone	C17H16O3	4.4382	5377817	COC1=CC=C(C=C1)/C=C/C(=O)C2=CC=C(C=C2)OC	COc1ccc(C=CC(=O)c2ccc(OC)cc2)cc1	InChI=1S/C17H16O3/c1-19-15-8-3-13(4-9-15)5-12-17(18)14-6-10-16(20-2)11-7-14/h3-12H,1-2H3/b12-5+	HDXVSZWKIHQDES-LFYBBSHMSA-N					doublet; removed another duplicate entry; compound annotation
0391_008677	GSK2879552	C23H28N2O2	1.2325	66571643	C1CN(CCC1CN[C@@H]2C[C@H]2C3=CC=CC=C3)CC4=CC=C(C=C4)C(=O)O	O=C(O)c1ccc(CN2CCC(CNC3CC3c3ccccc3)CC2)cc1	InChI=1S/C23H28N2O2/c26-23(27)20-8-6-18(7-9-20)16-25-12-10-17(11-13-25)15-24-22-14-21(22)19-4-2-1-3-5-19/h1-9,17,21-22,24H,10-16H2,(H,26,27)/t21-,22+/m0/s1	LRULVYSBRWUVGR-FCHUYYIVSA-N					compound annotation
0391_008678	OICR-9429	C29H32F3N5O3	1.568	91623360		CN1CCN(c2ccc(-c3cccc(CN4CCOCC4)c3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1	InChI=1S/C29H32F3N5O3/c1-35-7-9-37(10-8-35)26-6-5-22(21-4-2-3-20(15-21)19-36-11-13-40-14-12-36)16-25(26)34-28(39)23-18-33-27(38)17-24(23)29(30,31)32/h2-6,15-18H,7-14,19H2,1H3,(H,33,38)(H,34,39)	DJOVLOYCGXNVPI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008680	DHMEQ	C13H11NO5	1.9059	9881652	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@@H]3[C@H]([C@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m0/s1	IUOMATKBBPCLFR-TUAOUCFPSA-N					doublet; compound annotation
0391_008681	AZ084	C26H34N4O2	2.0358	16065569		CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ncc(N)cc3)CC4)cccc2O1	InChI=1S/C26H34N4O2/c1-25(2)16-21-19(4-3-5-23(21)32-25)18-29-12-8-26(9-13-29)10-14-30(15-11-26)24(31)22-7-6-20(27)17-28-22/h3-7,17H,8-16,18,27H2,1-2H3	WIGFMKMFRGRSDE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008683	DHMEQ	C13H11NO5	2.1227	9881652	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@@H]3[C@H]([C@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m0/s1	IUOMATKBBPCLFR-TUAOUCFPSA-N					doublet; compound annotation
0391_008684	Pazopanib	C21H23N7O2S	2.4026	10113978		Cc1c(S(N)(=O)=O)cc(Nc2nccc(N(C)c3cc4nn(C)c(C)c4cc3)n2)cc1	InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)	CUIHSIWYWATEQL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008687	DHMEQ	C13H11NO5	2.4212	9881652	C1=CC=C(C(=C1)C(=O)NC2=CC(=O)[C@@H]3[C@H]([C@H]2O)O3)O	O=C(NC1=CC(=O)C2OC2C1O)c1ccccc1O	InChI=1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m0/s1	IUOMATKBBPCLFR-TUAOUCFPSA-N					doublet; compound annotation
0391_008688	DBeQ	C22H20N4	3.4086	676352		c1ccc(CNc2nc3ccccc3c(NCc3ccccc3)n2)cc1	InChI=1S/C22H20N4/c1-3-9-17(10-4-1)15-23-21-19-13-7-8-14-20(19)25-22(26-21)24-16-18-11-5-2-6-12-18/h1-14H,15-16H2,(H2,23,24,25,26)	QAIMUUJJAJBPCL-UHFFFAOYSA-N					compound annotation
0391_008689	biochanin A	C16H12O5	3.8321	5280373		COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1	InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)12-8-21-14-7-10(17)6-13(18)15(14)16(12)19/h2-8,17-18H,1H3	WUADCCWRTIWANL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008691	mometasone furoate	C27H30Cl2O6	4.6327	441336	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)c1ccco1)C(=O)CCl	InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1	WOFMFGQZHJDGCX-ZULDAHANSA-N					removed another duplicate entry; compound annotation
0391_008693	Tacedinaline	C15H15N3O2	1.586	2746		CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1	InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)	VAZAPHZUAVEOMC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008695	Cinepazide	C22H31N3O5	1.8226	5282459	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3	COc1cc(C=CC(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC	InChI=1S/C22H31N3O5/c1-28-18-14-17(15-19(29-2)22(18)30-3)6-7-20(26)25-12-10-23(11-13-25)16-21(27)24-8-4-5-9-24/h6-7,14-15H,4-5,8-13,16H2,1-3H3/b7-6+	RCUDFXMNPQNBDU-VOTSOKGWSA-N					doublet; compound annotation
0391_008696	Cinepazide	C22H31N3O5	1.9885	5282459	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCN(CC2)CC(=O)N3CCCC3	COc1cc(C=CC(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC	InChI=1S/C22H31N3O5/c1-28-18-14-17(15-19(29-2)22(18)30-3)6-7-20(26)25-12-10-23(11-13-25)16-21(27)24-8-4-5-9-24/h6-7,14-15H,4-5,8-13,16H2,1-3H3/b7-6+	RCUDFXMNPQNBDU-VOTSOKGWSA-N					doublet; removed another duplicate entry; compound annotation
0391_008698	proparacaine	C16H26N2O3	2.0873	4935		CCCOc1c(N)cc(C(=O)OCCN(CC)CC)cc1	InChI=1S/C16H26N2O3/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3	KCLANYCVBBTKTO-UHFFFAOYSA-N					compound annotation
0391_008699	Mogroside V	C60H102O29	2.3352	24721270	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)[C@H]4CC[C@@]5([C@@]4(C[C@H]([C@@]6([C@H]5CC=C7[C@H]6CC[C@@H](C7(C)C)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O)O)C)O)C)C	CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(COC6OC(CO)C(O)C(O)C6O)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C60H102O29/c1-23(9-13-35(57(4,5)79)88-55-50(89-54-49(78)43(72)38(67)29(20-63)84-54)45(74)40(69)31(86-55)22-81-52-47(76)42(71)37(66)28(19-62)83-52)24-15-16-58(6)32-12-10-25-26(60(32,8)33(64)17-59(24,58)7)11-14-34(56(25,2)3)87-53-48(77)44(73)39(68)30(85-53)21-80-51-46(75)41(70)36(65)27(18-61)82-51/h10,23-24,26-55,61-79H,9,11-22H2,1-8H3/t23-,24-,26-,27-,28-,29-,30-,31-,32+,33-,34+,35-,36-,37-,38-,39-,40-,41+,42+,43+,44+,45+,46-,47-,48-,49-,50-,51-,52-,53+,54+,55+,58+,59-,60+/m1/s1	GHBNZZJYBXQAHG-KUVSNLSMSA-N					removed another duplicate entry; compound annotation
0391_008701	Benzoylpaeoniflorin	C30H32O12	2.907	21631106	C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)C5=CC=CC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)COC(=O)C7=CC=CC=C7)O)O)O)O	CC12CC3(O)OC(O1)C1(COC(=O)c4ccccc4)C3CC21OC1OC(COC(=O)c2ccccc2)C(O)C(O)C1O	InChI=1S/C30H32O12/c1-27-14-29(36)19-12-30(27,28(19,26(41-27)42-29)15-38-24(35)17-10-6-3-7-11-17)40-25-22(33)21(32)20(31)18(39-25)13-37-23(34)16-8-4-2-5-9-16/h2-11,18-22,25-26,31-33,36H,12-15H2,1H3/t18-,19-,20-,21+,22-,25+,26-,27+,28+,29-,30+/m1/s1	LATYEZNGPQKAIK-HRCYFWENSA-N					compound annotation
0391_008702	918505-84-7	C17H14ClF2N3O3S	3.8812	24180719		CCCS(=O)(=O)Nc1c(F)c(C(=O)c2c[nH]c3c2cc(Cl)cn3)c(F)cc1	InChI=1S/C17H14ClF2N3O3S/c1-2-5-27(25,26)23-13-4-3-12(19)14(15(13)20)16(24)11-8-22-17-10(11)6-9(18)7-21-17/h3-4,6-8,23H,2,5H2,1H3,(H,21,22)	YZDJQTHVDDOVHR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008704	Cucurbitacin E	C32H44O8	4.1055	5281319	CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C=C(C(=O)C4(C)C)O)C)C)C)O)O	CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(C=C(O)C(=O)C4(C)C)C3(C)C(=O)CC12C	InChI=1S/C32H44O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,12-14,19,21-22,25,34-35,39H,11,15-16H2,1-9H3/b13-12+/t19-,21-,22+,25+,29+,30-,31+,32+/m1/s1	NDYMQXYDSVBNLL-MUYMLXPFSA-N					removed another duplicate entry; compound annotation
0391_008706	IMPERATORIN	C16H14O4	4.2484	10212		CC(C)=CCOc1c2oc(=O)ccc2cc2c1occ2	InChI=1S/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H3	OLOOJGVNMBJLLR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008708	naratriptan	C17H25N3O2S	1.5318	4440		CNS(=O)(=O)CCc1cc2c(cc1)[nH]cc2C1CCN(C)CC1	InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3	AMKVXSZCKVJAGH-UHFFFAOYSA-N					compound annotation
0391_008709	vincamine	C21H26N2O3	2.178	15376	CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O	CCC12CCCN3CCc4c(C31)n(c1ccccc41)C(O)(C(=O)OC)C2	InChI=1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1	RXPRRQLKFXBCSJ-GIVPXCGWSA-N					compound annotation
0391_008710	Ruxolitinib	C17H18N6	2.4561	25126798	C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3	N#CCC(C1CCCC1)n1cc(-c2c3cc[nH]c3ncn2)cn1	InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1	HFNKQEVNSGCOJV-OAHLLOKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_008712	Lemborexant	C22H20F2N4O2	3.6435	56944144	CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C	Cc1ncc(OCC2(c3cc(F)ccc3)CC2C(=O)Nc2ncc(F)cc2)c(C)n1	InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1	MUGXRYIUWFITCP-PGRDOPGGSA-N					compound annotation
0391_008713	trioxsalen	C14H12O3	4.0947	5585		Cc1cc2cc3c(oc(=O)cc3C)c(C)c2o1	InChI=1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3	FMHHVULEAZTJMA-UHFFFAOYSA-N					compound annotation
0391_008714	Isavuconazole	C22H17F2N5OS	4.4824	6918485	C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O	CC(c1nc(-c2ccc(C#N)cc2)cs1)C(O)(Cn1cncn1)c1c(F)ccc(F)c1	InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-8-17(23)6-7-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1	DDFOUSQFMYRUQK-RCDICMHDSA-N					compound annotation
0391_008715	Aldoxycarb	C7H14N2O4S	1.2079	9570093	CC(C)(/C=N/OC(=O)NC)S(=O)(=O)C	CNC(=O)ON=CC(C)(C)S(C)(=O)=O	InChI=1S/C7H14N2O4S/c1-7(2,14(4,11)12)5-9-13-6(10)8-3/h5H,1-4H3,(H,8,10)/b9-5+	YRRKLBAKDXSTNC-WEVVVXLNSA-N					removed another duplicate entry; compound annotation
0391_008717	MAZ51	C21H18N2O	2.095	53230017	CN(C)C1=CC=C(C2=CC=CC=C21)/C=C/3\C4=CC=CC=C4NC3=O	CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)c2ccccc12	InChI=1S/C21H18N2O/c1-23(2)20-12-11-14(15-7-3-4-9-17(15)20)13-18-16-8-5-6-10-19(16)22-21(18)24/h3-13H,1-2H3,(H,22,24)/b18-13+	VFCXONOPGCDDBQ-QGOAFFKASA-N					doublet; compound annotation
0391_008718	Cysteine Protease inhibitor	C18H14N4O	2.5484	12000657		N#Cc1nccc(Oc2cccc(-c3ccc(CN)cc3)c2)n1	InChI=1S/C18H14N4O/c19-11-13-4-6-14(7-5-13)15-2-1-3-16(10-15)23-18-8-9-21-17(12-20)22-18/h1-10H,11,19H2	RMVQVAZRAZGSTH-UHFFFAOYSA-N					doublet; compound annotation
0391_008719	MAZ51	C21H18N2O	2.6008	53230017	CN(C)C1=CC=C(C2=CC=CC=C21)/C=C/3\C4=CC=CC=C4NC3=O	CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)c2ccccc12	InChI=1S/C21H18N2O/c1-23(2)20-12-11-14(15-7-3-4-9-17(15)20)13-18-16-8-5-6-10-19(16)22-21(18)24/h3-13H,1-2H3,(H,22,24)/b18-13+	VFCXONOPGCDDBQ-QGOAFFKASA-N					doublet; compound annotation
0391_008720	Solithromycin	C43H65FN6O10	2.8997	25242512	CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@](C(=O)O1)(C)F)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=N4)C5=CC(=CC=C5)N)C	CCC1OC(=O)C(C)(F)C(=O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C2N(CCCCn3cc(-c4cc(N)ccc4)nn3)C(=O)OC12C	InChI=1S/C43H65FN6O10/c1-12-32-43(8)35(50(40(55)60-43)19-14-13-18-49-23-30(46-47-49)28-16-15-17-29(45)21-28)26(4)33(51)24(2)22-41(6,56-11)37(27(5)36(53)42(7,44)39(54)58-32)59-38-34(52)31(48(9)10)20-25(3)57-38/h15-17,21,23-27,31-32,34-35,37-38,52H,12-14,18-20,22,45H2,1-11H3/t24-,25-,26+,27+,31+,32-,34-,35-,37-,38+,41-,42+,43-/m1/s1	IXXFZUPTQVDPPK-ZAWHAJPISA-N					removed another duplicate entry; compound annotation
0391_008722	Presatovir	C24H30ClN7O3S	3.1045	58029842	CC1=CN2C(=CC(=N2)[C@@H]3CCCCN3C(=O)C4=C(C=CC(=C4)Cl)NS(=O)(=O)C)N=C1N5CC[C@@H](C5)N	Cc1cn2nc(C3CCCCN3C(=O)c3c(NS(C)(=O)=O)ccc(Cl)c3)cc2nc1N1CCC(N)C1	InChI=1S/C24H30ClN7O3S/c1-15-13-32-22(27-23(15)30-10-8-17(26)14-30)12-20(28-32)21-5-3-4-9-31(21)24(33)18-11-16(25)6-7-19(18)29-36(2,34)35/h6-7,11-13,17,21,29H,3-5,8-10,14,26H2,1-2H3/t17-,21-/m0/s1	GOFXWTVKPWJNGD-UWJYYQICSA-N					doublet; removed another duplicate entry; compound annotation
0391_008724	Presatovir	C24H30ClN7O3S	3.1485	58029842	CC1=CN2C(=CC(=N2)[C@@H]3CCCCN3C(=O)C4=C(C=CC(=C4)Cl)NS(=O)(=O)C)N=C1N5CC[C@@H](C5)N	Cc1cn2nc(C3CCCCN3C(=O)c3c(NS(C)(=O)=O)ccc(Cl)c3)cc2nc1N1CCC(N)C1	InChI=1S/C24H30ClN7O3S/c1-15-13-32-22(27-23(15)30-10-8-17(26)14-30)12-20(28-32)21-5-3-4-9-31(21)24(33)18-11-16(25)6-7-19(18)29-36(2,34)35/h6-7,11-13,17,21,29H,3-5,8-10,14,26H2,1-2H3/t17-,21-/m0/s1	GOFXWTVKPWJNGD-UWJYYQICSA-N					doublet; removed another duplicate entry; compound annotation
0391_008726	VER-246608	C28H23ClF2N4O4	3.6576	86280454		Cc1cnc(Cl)nc1-c1ccc(N(Cc2ccc(CNC(=O)C(F)F)cc2)C(=O)c2c(O)cc(O)cc2)cc1	InChI=1S/C28H23ClF2N4O4/c1-16-13-33-28(29)34-24(16)19-6-8-20(9-7-19)35(27(39)22-11-10-21(36)12-23(22)37)15-18-4-2-17(3-5-18)14-32-26(38)25(30)31/h2-13,25,36-37H,14-15H2,1H3,(H,32,38)	LCGNLQSOSJFLKR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008728	Racecadotril	C21H23NO4S	4.2932	107751		CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1	InChI=1S/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,22,25)	ODUOJXZPIYUATO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008730	MAZ51	C21H18N2O	4.3469	53230017	CN(C)C1=CC=C(C2=CC=CC=C21)/C=C/3\C4=CC=CC=C4NC3=O	CN(C)c1ccc(C=C2C(=O)Nc3ccccc23)c2ccccc12	InChI=1S/C21H18N2O/c1-23(2)20-12-11-14(15-7-3-4-9-17(15)20)13-18-16-8-5-6-10-19(16)22-21(18)24/h3-13H,1-2H3,(H,22,24)/b18-13+	VFCXONOPGCDDBQ-QGOAFFKASA-N					doublet; removed another duplicate entry; compound annotation
0391_008733	TBOPP	C24H21F3N2O4S	4.7359	122508151		O=C(Cn1cc(S(=O)(=O)N2CCCC2)ccc1=O)c1ccc(-c2cc(C(F)(F)F)ccc2)cc1	InChI=1S/C24H21F3N2O4S/c25-24(26,27)20-5-3-4-19(14-20)17-6-8-18(9-7-17)22(30)16-28-15-21(10-11-23(28)31)34(32,33)29-12-1-2-13-29/h3-11,14-15H,1-2,12-13,16H2	ZMPDEBWNVHAKBB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008735	aztreonam	C13H17N5O8S2	1.2274	5742832	C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N	CC1C(NC(=O)C(=NOC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O	InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1	WZPBZJONDBGPKJ-VEHQQRBSSA-N					compound annotation
0391_008736	Ribociclib	C23H30N8O	1.7175	44631912		CN(C)C(=O)c1cc2cnc(Nc3ncc(N4CCNCC4)cc3)nc2n1C1CCCC1	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	RHXHGRAEPCAFML-UHFFFAOYSA-N					doublet; compound annotation
0391_008737	578-74-5	C21H20O10	2.1089	5280704	C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2cc(OC3OC(CO)C(O)C(O)C3O)cc(O)c12	InChI=1S/C21H20O10/c22-8-16-18(26)19(27)20(28)21(31-16)29-11-5-12(24)17-13(25)7-14(30-15(17)6-11)9-1-3-10(23)4-2-9/h1-7,16,18-24,26-28H,8H2/t16-,18-,19+,20-,21-/m1/s1	KMOUJOKENFFTPU-QNDFHXLGSA-N					compound annotation
0391_008738	quercetin	C15H10O7	2.5672	5280343		O=c1c(O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H	REFJWTPEDVJJIY-UHFFFAOYSA-N					doublet; compound annotation
0391_008739	SNS-032	C17H24N4O2S2	2.6565	3025986		CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1	InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)	OUSFTKFNBAZUKL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008741	1033836-12-2	C19H19F4N3O	3.3232	24991044		O=C(NC1CCN(CC(F)(F)F)CC1)c1cnc(-c2cc(F)ccc2)cc1	InChI=1S/C19H19F4N3O/c20-15-3-1-2-13(10-15)17-5-4-14(11-24-17)18(27)25-16-6-8-26(9-7-16)12-19(21,22)23/h1-5,10-11,16H,6-9,12H2,(H,25,27)	LPUCBGGXXIUBAZ-UHFFFAOYSA-N					compound annotation
0391_008742	piperine	C17H19NO3	3.9624	638024	C1CCN(CC1)C(=O)/C=C/C=C/C2=CC3=C(C=C2)OCO3	O=C(C=CC=Cc1cc2c(cc1)OCO2)N1CCCCC1	InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+	MXXWOMGUGJBKIW-YPCIICBESA-N					doublet; removed another duplicate entry; compound annotation
0391_008744	piperine	C17H19NO3	4.0146	638024	C1CCN(CC1)C(=O)/C=C/C=C/C2=CC3=C(C=C2)OCO3	O=C(C=CC=Cc1cc2c(cc1)OCO2)N1CCCCC1	InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+	MXXWOMGUGJBKIW-YPCIICBESA-N					doublet; removed another duplicate entry; compound annotation
0391_008746	piperine	C17H19NO3	4.0695	638024	C1CCN(CC1)C(=O)/C=C/C=C/C2=CC3=C(C=C2)OCO3	O=C(C=CC=Cc1cc2c(cc1)OCO2)N1CCCCC1	InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+	MXXWOMGUGJBKIW-YPCIICBESA-N					doublet; removed another duplicate entry; compound annotation
0391_008748	Pamicogrel	C25H24N2O4S	5.795	65870		CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1	InChI=1S/C25H24N2O4S/c1-4-31-22(28)16-27-15-5-6-21(27)25-26-23(17-7-11-19(29-2)12-8-17)24(32-25)18-9-13-20(30-3)14-10-18/h5-15H,4,16H2,1-3H3	ISCHOARKJADAKJ-UHFFFAOYSA-N					doublet; compound annotation
0391_008749	Pamicogrel	C25H24N2O4S	5.7982	65870		CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1	InChI=1S/C25H24N2O4S/c1-4-31-22(28)16-27-15-5-6-21(27)25-26-23(17-7-11-19(29-2)12-8-17)24(32-25)18-9-13-20(30-3)14-10-18/h5-15H,4,16H2,1-3H3	ISCHOARKJADAKJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008751	Ursolic acid	C30H48O3	6.1065	64945	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1C	InChI=1S/C30H48O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1	WCGUUGGRBIKTOS-GPOJBZKASA-N					compound annotation
0391_008752	1,5,5-Trimethylhydantoin	C6H10N2O2	0.9118	81295		CN1C(=O)NC(=O)C1(C)C	InChI=1S/C6H10N2O2/c1-6(2)4(9)7-5(10)8(6)3/h1-3H3,(H,7,9,10)	ZNYIPTYJBRGSSL-UHFFFAOYSA-N					compound annotation
0391_008753	(6S)-6-[[(5R)-5,6,7,8-Tetrahydro-6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolin-6-ium]-5alpha-yl]furo[3,4-e]-1,3-benzodioxol-8(6H)-one	C21H20NO6+	1.7383	185827	C[N+]1(CCC2=CC3=C(C=C2[C@@H]1[C@@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3)C	C[N+]1(C)CCc2cc3c(cc2C1C1OC(=O)c2c4OCOc4ccc21)OCO3	InChI=1S/C21H20NO6/c1-22(2)6-5-11-7-15-16(26-9-25-15)8-13(11)18(22)19-12-3-4-14-20(27-10-24-14)17(12)21(23)28-19/h3-4,7-8,18-19H,5-6,9-10H2,1-2H3/q+1/t18-,19+/m1/s1	WDIQXKYUSINZME-MOPGFXCFSA-N					compound annotation
0391_008754	Teneligliptin	C22H30N6OS	1.9825	11949652	CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5	Cc1nn(-c2ccccc2)c(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)c1	InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1	WGRQANOPCQRCME-PMACEKPBSA-N					doublet; removed another duplicate entry; compound annotation
0391_008756	CCR2 antagonist 3	C17H25FN2O2	2.3057	57345449	CC1=C(C=CC(=C1)C(=O)N(C)[C@H](CN2CC(C2)O)C(C)C)F	Cc1c(F)ccc(C(=O)N(C)C(CN2CC(O)C2)C(C)C)c1	InChI=1S/C17H25FN2O2/c1-11(2)16(10-20-8-14(21)9-20)19(4)17(22)13-5-6-15(18)12(3)7-13/h5-7,11,14,16,21H,8-10H2,1-4H3/t16-/m1/s1	GAHPWXLXWUVMIV-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_008758	Safinamide	C17H19FN2O2	2.4935	131682	C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F	CC(NCc1ccc(OCc2cc(F)ccc2)cc1)C(N)=O	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	NEMGRZFTLSKBAP-LBPRGKRZSA-N					doublet; removed another duplicate entry; compound annotation
0391_008760	MSA-2	C14H14O5S	2.8229	23035251		COc1c(OC)cc2sc(C(=O)CCC(=O)O)cc2c1	InChI=1S/C14H14O5S/c1-18-10-5-8-6-13(9(15)3-4-14(16)17)20-12(8)7-11(10)19-2/h5-7H,3-4H2,1-2H3,(H,16,17)	APCLRHPWFCQIMG-UHFFFAOYSA-N					compound annotation
0391_008761	FzM1.8	C18H14N2O4	3.3003	137553171		O=C(Nc1cc(O)cc(C(=O)O)c1)Nc1cc2ccccc2cc1	InChI=1S/C18H14N2O4/c21-16-9-13(17(22)23)8-15(10-16)20-18(24)19-14-6-5-11-3-1-2-4-12(11)7-14/h1-10,21H,(H,22,23)(H2,19,20,24)	XGNNCRZDDAJBFU-UHFFFAOYSA-N					compound annotation
0391_008762	Quinine	C20H24N2O2	1.5114	3034034	COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1	LOUPRKONTZGTKE-WZBLMQSHSA-N					doublet; compound annotation
0391_008763	FLT3-IN-3	C27H38N8O	1.7066	133081975		NC1CCC(Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1	InChI=1S/C27H38N8O/c28-20-7-11-22(12-8-20)31-27-32-25(24-26(33-27)35(18-29-24)23-3-1-2-4-23)30-21-9-5-19(6-10-21)17-34-13-15-36-16-14-34/h5-6,9-10,18,20,22-23H,1-4,7-8,11-17,28H2,(H2,30,31,32,33)	SAEGVASGMTZGFI-UHFFFAOYSA-N					compound annotation
0391_008764	912545-86-9	C28H28ClN3OS	2.3162	5284330		CNC1CCC(N(Cc2cc(-c3ccncc3)ccc2)C(=O)c2c(Cl)c3ccccc3s2)CC1	InChI=1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3	VFSUUTYAEQOIMW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008766	neohesperidin dihydrochalcone	C28H36O15	2.5133	30231	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC(=C(C=C4)OC)O)O)CO)O)O)O)O)O	COc1c(O)cc(CCC(=O)c2c(O)cc(OC3OC(CO)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)cc2O)cc1	InChI=1S/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3/t11-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1	ITVGXXMINPYUHD-CUVHLRMHSA-N					doublet; compound annotation
0391_008767	neohesperidin dihydrochalcone	C28H36O15	2.5171	30231	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C(C(=C3)O)C(=O)CCC4=CC(=C(C=C4)OC)O)O)CO)O)O)O)O)O	COc1c(O)cc(CCC(=O)c2c(O)cc(OC3OC(CO)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)cc2O)cc1	InChI=1S/C28H36O15/c1-11-21(34)23(36)25(38)27(40-11)43-26-24(37)22(35)19(10-29)42-28(26)41-13-8-16(32)20(17(33)9-13)14(30)5-3-12-4-6-18(39-2)15(31)7-12/h4,6-9,11,19,21-29,31-38H,3,5,10H2,1-2H3/t11-,19+,21-,22+,23+,24-,25+,26+,27-,28+/m0/s1	ITVGXXMINPYUHD-CUVHLRMHSA-N					doublet; compound annotation
0391_008768	1125758-85-1	C19H17N5	2.6164	53325874	C[C@@H](C1=CC=CC=C1)N=C(NC#N)NC2=CC=CC3=C2C=CC=N3	CC(N=C(NC#N)Nc1cccc2c1cccn2)c1ccccc1	InChI=1S/C19H17N5/c1-14(15-7-3-2-4-8-15)23-19(22-13-20)24-18-11-5-10-17-16(18)9-6-12-21-17/h2-12,14H,1H3,(H2,22,23,24)/t14-/m0/s1	PQYCRDPLPKGSME-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_008770	EZ-482	C23H19ClN4O5S	3.5515	24673104		Cn1nc(CC(=O)Nc2c(O)ccc(S(=O)(=O)Nc3cc(Cl)ccc3)c2)c2ccccc2c1=O	InChI=1S/C23H19ClN4O5S/c1-28-23(31)18-8-3-2-7-17(18)19(26-28)13-22(30)25-20-12-16(9-10-21(20)29)34(32,33)27-15-6-4-5-14(24)11-15/h2-12,27,29H,13H2,1H3,(H,25,30)	CLWDCBBEVQRZLY-UHFFFAOYSA-N					compound annotation
0391_008771	PI4KIIIbeta-IN-9	C23H25N3O5S2	3.68	71533728		COc1c(S(=O)(=O)Nc2ccc(O)cc2)cc(-c2c(C)nc(NC(=O)C3CCCC3)s2)cc1	InChI=1S/C23H25N3O5S2/c1-14-21(32-23(24-14)25-22(28)15-5-3-4-6-15)16-7-12-19(31-2)20(13-16)33(29,30)26-17-8-10-18(27)11-9-17/h7-13,15,26-27H,3-6H2,1-2H3,(H,24,25,28)	KAXNDTMKFONXJM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008773	T-26c	C24H21N3O6S	3.8265	11525848		COc1cccc(CNC(=O)c2nc3c(c(COCc4ccc(C(=O)O)cc4)cs3)c(=O)[nH]2)c1	InChI=1S/C24H21N3O6S/c1-32-18-4-2-3-15(9-18)10-25-22(29)20-26-21(28)19-17(13-34-23(19)27-20)12-33-11-14-5-7-16(8-6-14)24(30)31/h2-9,13H,10-12H2,1H3,(H,25,29)(H,30,31)(H,26,27,28)	CDQRIIUMNLMHRH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008775	ritonavir	C37H48N6O5S2	4.4701	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1	InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1	NCDNCNXCDXHOMX-XGKFQTDJSA-N					doublet; compound annotation
0391_008776	ritonavir	C37H48N6O5S2	4.473	392622	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O	CC(C)c1nc(CN(C)C(=O)NC(C(=O)NC(Cc2ccccc2)CC(O)C(Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1	InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1	NCDNCNXCDXHOMX-XGKFQTDJSA-N					doublet; compound annotation
0391_008777	UNC2025	C28H40N6O	1.9106	73425588		CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn(C3CCC(O)CC3)c2n1	InChI=1S/C28H40N6O/c1-3-4-13-29-28-30-18-25-26(20-34(27(25)31-28)23-9-11-24(35)12-10-23)22-7-5-21(6-8-22)19-33-16-14-32(2)15-17-33/h5-8,18,20,23-24,35H,3-4,9-17,19H2,1-2H3,(H,29,30,31)	MJSHVHLADKXCML-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008779	2-((5-Chloroquinolin-8-yl)oxy)-N,N-diethylethan-1-amine	C15H19ClN2O	2.3331	146013303		CCN(CC)CCOc1c2ncccc2c(Cl)cc1	InChI=1S/C15H19ClN2O/c1-3-18(4-2)10-11-19-14-8-7-13(16)12-6-5-9-17-15(12)14/h5-9H,3-4,10-11H2,1-2H3	LLWBUUWHYXOKCL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008781	CU-CPT-8m	C14H12N4O	2.9318	15042086		Cc1cc(-c2ccnc3c(C(N)=O)cnn23)ccc1	InChI=1S/C14H12N4O/c1-9-3-2-4-10(7-9)12-5-6-16-14-11(13(15)19)8-17-18(12)14/h2-8H,1H3,(H2,15,19)	HNKGGVGQAVODNJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008783	Nav1.7-IN-2	C22H22FN5O2	3.0954	53348208		CNC(=O)c1cc(Nc2nccc(N3CC(Oc4c(C)cc(F)cc4)C3)n2)ccc1	InChI=1S/C22H22FN5O2/c1-14-10-16(23)6-7-19(14)30-18-12-28(13-18)20-8-9-25-22(27-20)26-17-5-3-4-15(11-17)21(29)24-2/h3-11,18H,12-13H2,1-2H3,(H,24,29)(H,25,26,27)	MFAKJGXMORSMIX-UHFFFAOYSA-N					doublet; compound annotation
0391_008784	Nav1.7-IN-2	C22H22FN5O2	3.0982	53348208		CNC(=O)c1cc(Nc2nccc(N3CC(Oc4c(C)cc(F)cc4)C3)n2)ccc1	InChI=1S/C22H22FN5O2/c1-14-10-16(23)6-7-19(14)30-18-12-28(13-18)20-8-9-25-22(27-20)26-17-5-3-4-15(11-17)21(29)24-2/h3-11,18H,12-13H2,1-2H3,(H,24,29)(H,25,26,27)	MFAKJGXMORSMIX-UHFFFAOYSA-N					doublet; compound annotation
0391_008785	SR17018	C19H18Cl3N3O	3.1233	130431397		O=c1[nH]c2cc(Cl)c(Cl)cc2n1C1CCN(Cc2ccc(Cl)cc2)CC1	InChI=1S/C19H18Cl3N3O/c20-13-3-1-12(2-4-13)11-24-7-5-14(6-8-24)25-18-10-16(22)15(21)9-17(18)23-19(25)26/h1-4,9-10,14H,5-8,11H2,(H,23,26)	LAGUDYUGRSQDKS-UHFFFAOYSA-N					compound annotation
0391_008786	TBAJ-587	C30H33BrFN3O5	4.1365	138319677	CN(C)CC[C@@](C1=CC(=NC(=C1)OC)OC)([C@H](C2=C(C(=CC=C2)OC)F)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O	COc1cc(C(O)(CCN(C)C)C(c2c(OC)nc3ccc(Br)cc3c2)c2c(F)c(OC)ccc2)cc(OC)n1	InChI=1S/C30H33BrFN3O5/c1-35(2)13-12-30(36,19-16-25(38-4)34-26(17-19)39-5)27(21-8-7-9-24(37-3)28(21)32)22-15-18-14-20(31)10-11-23(18)33-29(22)40-6/h7-11,14-17,27,36H,12-13H2,1-6H3/t27-,30-/m1/s1	JJEGOJPMKLRSPJ-POURPWNDSA-N					doublet; compound annotation
0391_008787	TBAJ-587	C30H33BrFN3O5	4.3041	138319677	CN(C)CC[C@@](C1=CC(=NC(=C1)OC)OC)([C@H](C2=C(C(=CC=C2)OC)F)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O	COc1cc(C(O)(CCN(C)C)C(c2c(OC)nc3ccc(Br)cc3c2)c2c(F)c(OC)ccc2)cc(OC)n1	InChI=1S/C30H33BrFN3O5/c1-35(2)13-12-30(36,19-16-25(38-4)34-26(17-19)39-5)27(21-8-7-9-24(37-3)28(21)32)22-15-18-14-20(31)10-11-23(18)33-29(22)40-6/h7-11,14-17,27,36H,12-13H2,1-6H3/t27-,30-/m1/s1	JJEGOJPMKLRSPJ-POURPWNDSA-N					doublet; compound annotation
0391_008788	BCTC	C20H25ClN4O	4.8019	9929425		CC(C)(C)c1ccc(NC(=O)N2CCN(c3c(Cl)cccn3)CC2)cc1	InChI=1S/C20H25ClN4O/c1-20(2,3)15-6-8-16(9-7-15)23-19(26)25-13-11-24(12-14-25)18-17(21)5-4-10-22-18/h4-10H,11-14H2,1-3H3,(H,23,26)	ROGUAPYLUCHQGK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008790	galanthamine	C17H21NO3	0.7606	9651	CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O	COc1c2OC3CC(O)C=CC34CCN(C)Cc(c24)cc1	InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1	ASUTZQLVASHGKV-JDFRZJQESA-N					doublet; removed another duplicate entry; compound annotation
0391_008792	pipemidic acid	C14H17N5O3	1.2239	4831		CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21	InChI=1S/C14H17N5O3/c1-2-18-8-10(13(21)22)11(20)9-7-16-14(17-12(9)18)19-5-3-15-4-6-19/h7-8,15H,2-6H2,1H3,(H,21,22)	JOHZPMXAZQZXHR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008794	Moxisylyte	C16H25NO3	2.6086	4260		CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C	InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3	VRYMTAVOXVTQEF-UHFFFAOYSA-N					compound annotation
0391_008795	Levobetaxolol	C18H29NO3	2.6308	60657	CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O	CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1	InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3/t17-/m0/s1	NWIUTZDMDHAVTP-KRWDZBQOSA-N					compound annotation
0391_008796	afloqualone	C16H14FN3O	2.6959	2040		Cc1ccccc1-n1c(CF)nc2c(cc(N)cc2)c1=O	InChI=1S/C16H14FN3O/c1-10-4-2-3-5-14(10)20-15(9-17)19-13-7-6-11(18)8-12(13)16(20)21/h2-8H,9,18H2,1H3	VDOSWXIDETXFET-UHFFFAOYSA-N					compound annotation
0391_008797	Dolutegravir	C20H19F2N3O5	3.149	54726191	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	CC1CCOC2Cn3cc(C(=O)NCc4c(F)cc(F)cc4)c(=O)c(O)c3C(=O)N12	InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1	RHWKPHLQXYSBKR-BMIGLBTASA-N					doublet; removed another duplicate entry; compound annotation
0391_008799	SR18662	C16H19Cl2N3O4S	3.4277	146674222	CS(=O)(=O)N1CCN(CC1)C(=O)CNC(=O)/C=C/C2=CC(=C(C=C2)Cl)Cl	CS(=O)(=O)N1CCN(C(=O)CNC(=O)C=Cc2cc(Cl)c(Cl)cc2)CC1	InChI=1S/C16H19Cl2N3O4S/c1-26(24,25)21-8-6-20(7-9-21)16(23)11-19-15(22)5-3-12-2-4-13(17)14(18)10-12/h2-5,10H,6-9,11H2,1H3,(H,19,22)/b5-3+	WUJBXFXHDUVSFM-HWKANZROSA-N					removed another duplicate entry; compound annotation
0391_008801	DIAZOLIDINYL UREA	C8H14N4O7	3.5527	62277		O=C1C(N(CO)C(=O)NCO)N(CO)C(=O)N1CO	InChI=1S/C8H14N4O7/c13-1-9-7(18)10(2-14)5-6(17)12(4-16)8(19)11(5)3-15/h5,13-16H,1-4H2,(H,9,18)	SOROIESOUPGGFO-UHFFFAOYSA-N					compound annotation
0391_008802	Fumarate hydratase-IN-1	C27H30N2O4	3.9703	121230973	CCOC(=O)[C@@]12CCCC=C1N(C(=O)[C@H]2CC(=O)NC)CC3=CC=C(C=C3)C4=CC=CC=C4	CCOC(=O)C12CCCC=C1N(Cc1ccc(-c3ccccc3)cc1)C(=O)C2CC(=O)NC	InChI=1S/C27H30N2O4/c1-3-33-26(32)27-16-8-7-11-23(27)29(25(31)22(27)17-24(30)28-2)18-19-12-14-21(15-13-19)20-9-5-4-6-10-20/h4-6,9-15,22H,3,7-8,16-18H2,1-2H3,(H,28,30)/t22-,27-/m1/s1	VFGLXHHVYNTCPD-AJTFRIOCSA-N					doublet; compound annotation
0391_008803	Fumarate hydratase-IN-1	C27H30N2O4	4.5974	121230973	CCOC(=O)[C@@]12CCCC=C1N(C(=O)[C@H]2CC(=O)NC)CC3=CC=C(C=C3)C4=CC=CC=C4	CCOC(=O)C12CCCC=C1N(Cc1ccc(-c3ccccc3)cc1)C(=O)C2CC(=O)NC	InChI=1S/C27H30N2O4/c1-3-33-26(32)27-16-8-7-11-23(27)29(25(31)22(27)17-24(30)28-2)18-19-12-14-21(15-13-19)20-9-5-4-6-10-20/h4-6,9-15,22H,3,7-8,16-18H2,1-2H3,(H,28,30)/t22-,27-/m1/s1	VFGLXHHVYNTCPD-AJTFRIOCSA-N					doublet; removed another duplicate entry; compound annotation
0391_008805	AZ6102	C25H28N6O	2.135	135905416	C[C@@H]1CN(C[C@@H](N1)C)C2=NC=C(C(=C2)C)C3=CC=C(C=C3)C4=NC5=C(C=CN5C)C(=O)N4	Cc1cc(N2CC(C)NC(C)C2)ncc1-c1ccc(-c2nc(=O)c3c([nH]2)n(C)cc3)cc1	InChI=1S/C25H28N6O/c1-15-11-22(31-13-16(2)27-17(3)14-31)26-12-21(15)18-5-7-19(8-6-18)23-28-24-20(25(32)29-23)9-10-30(24)4/h5-12,16-17,27H,13-14H2,1-4H3,(H,28,29,32)/t16-,17+	WCPTUQOMNJBIET-CALCHBBNSA-N					doublet; compound annotation
0391_008806	AZ6102	C25H28N6O	2.1378	135905416	C[C@@H]1CN(C[C@@H](N1)C)C2=NC=C(C(=C2)C)C3=CC=C(C=C3)C4=NC5=C(C=CN5C)C(=O)N4	Cc1cc(N2CC(C)NC(C)C2)ncc1-c1ccc(-c2nc(=O)c3c([nH]2)n(C)cc3)cc1	InChI=1S/C25H28N6O/c1-15-11-22(31-13-16(2)27-17(3)14-31)26-12-21(15)18-5-7-19(8-6-18)23-28-24-20(25(32)29-23)9-10-30(24)4/h5-12,16-17,27H,13-14H2,1-4H3,(H,28,29,32)/t16-,17+	WCPTUQOMNJBIET-CALCHBBNSA-N					doublet; compound annotation
0391_008807	Adarotene	C25H26O3	2.4851	9864378	C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC=C(C=C5)/C=C/C(=O)O)O	O=C(O)C=Cc1ccc(-c2cc(C34CC5CC(CC(C5)C3)C4)c(O)cc2)cc1	InChI=1S/C25H26O3/c26-23-7-6-21(20-4-1-16(2-5-20)3-8-24(27)28)12-22(23)25-13-17-9-18(14-25)11-19(10-17)15-25/h1-8,12,17-19,26H,9-11,13-15H2,(H,27,28)/b8-3+	QAWBIEIZDDIEMW-FPYGCLRLSA-N					doublet; compound annotation
0391_008808	EDO-S101	C19H28Cl2N4O2	2.6425	46836227		Cn1c(CCCCCCC(=O)NO)nc2c1ccc(N(CCCl)CCCl)c2	InChI=1S/C19H28Cl2N4O2/c1-24-17-9-8-15(25(12-10-20)13-11-21)14-16(17)22-18(24)6-4-2-3-5-7-19(26)23-27/h8-9,14,27H,2-7,10-13H2,1H3,(H,23,26)	GISXTRIGVCKQBX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008811	Rilematovir	C21H20ClF3N4O3S	2.9045	118892432		CS(=O)(=O)CCCn1c(Cn2c(=O)n(CC(F)(F)F)c3ccncc32)cc2c1ccc(Cl)c2	InChI=1S/C21H20ClF3N4O3S/c1-33(31,32)8-2-7-27-16(10-14-9-15(22)3-4-17(14)27)12-28-19-11-26-6-5-18(19)29(20(28)30)13-21(23,24)25/h3-6,9-11H,2,7-8,12-13H2,1H3	GTQTUABHRCWVLL-UHFFFAOYSA-N					doublet; compound annotation
0391_008812	Rilematovir	C21H20ClF3N4O3S	3.054	118892432		CS(=O)(=O)CCCn1c(Cn2c(=O)n(CC(F)(F)F)c3ccncc32)cc2c1ccc(Cl)c2	InChI=1S/C21H20ClF3N4O3S/c1-33(31,32)8-2-7-27-16(10-14-9-15(22)3-4-17(14)27)12-28-19-11-26-6-5-18(19)29(20(28)30)13-21(23,24)25/h3-6,9-11H,2,7-8,12-13H2,1H3	GTQTUABHRCWVLL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008814	Mirodenafil dihydrochloride	C26H37N5O5S	3.3546	135497803		CCCOc1c(-c2nc(=O)c3c([nH]2)c(CCC)cn3CC)cc(S(=O)(=O)N2CCN(CCO)CC2)cc1	InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)	MIJFNYMSCFYZNY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008816	Prolylleucine	C19H26N2O5	3.4373	173815	CC(C)C[C@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)OCC2=CC=CC=C2	CC(C)CC(NC(=O)C1CCCN1C(=O)OCc1ccccc1)C(=O)O	InChI=1S/C19H26N2O5/c1-13(2)11-15(18(23)24)20-17(22)16-9-6-10-21(16)19(25)26-12-14-7-4-3-5-8-14/h3-5,7-8,13,15-16H,6,9-12H2,1-2H3,(H,20,22)(H,23,24)/t15-,16+/m1/s1	YCYXUKRYYSXSLJ-CVEARBPZSA-N					removed another duplicate entry; compound annotation
0391_008818	Tasquinimod	C20H17F3N2O4	3.5122	54682876		COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C	InChI=1S/C20H17F3N2O4/c1-24(12-9-7-11(8-10-12)20(21,22)23)18(27)16-17(26)15-13(25(2)19(16)28)5-4-6-14(15)29-3/h4-10,26H,1-3H3	ONDYALNGTUAJDX-UHFFFAOYSA-N					doublet; compound annotation
0391_008819	Tasquinimod	C20H17F3N2O4	3.515	54682876		COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C	InChI=1S/C20H17F3N2O4/c1-24(12-9-7-11(8-10-12)20(21,22)23)18(27)16-17(26)15-13(25(2)19(16)28)5-4-6-14(15)29-3/h4-10,26H,1-3H3	ONDYALNGTUAJDX-UHFFFAOYSA-N					doublet; compound annotation
0391_008820	FTBMT	C19H16F4N4O	3.5458	56649300		Cc1c(C(N)=O)ccc(-n2nc(Cc3cc(C(F)(F)F)cc(F)c3)nc2C)c1	InChI=1S/C19H16F4N4O/c1-10-5-15(3-4-16(10)18(24)28)27-11(2)25-17(26-27)8-12-6-13(19(21,22)23)9-14(20)7-12/h3-7,9H,8H2,1-2H3,(H2,24,28)	TYXSIXOYTBHZFA-UHFFFAOYSA-N					compound annotation
0391_008821	CDK9-IN-7	C29H37N7O2S	4.3332	138911336		CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1	InChI=1S/C29H37N7O2S/c1-35(2)28(38)25-18-21-19-31-29(34-27(21)36(25)24-10-7-8-11-24)33-23-15-13-22(14-16-23)32-26(37)12-6-4-3-5-9-17-30-20-39/h13-16,18-19,24H,3-12,17H2,1-2H3,(H,32,37)(H,31,33,34)	LLMKBTGLZJIAMY-UHFFFAOYSA-N					doublet; compound annotation
0391_008822	CDK9-IN-7	C29H37N7O2S	4.338	138911336		CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1	InChI=1S/C29H37N7O2S/c1-35(2)28(38)25-18-21-19-31-29(34-27(21)36(25)24-10-7-8-11-24)33-23-15-13-22(14-16-23)32-26(37)12-6-4-3-5-9-17-30-20-39/h13-16,18-19,24H,3-12,17H2,1-2H3,(H,32,37)(H,31,33,34)	LLMKBTGLZJIAMY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008824	NTP42	C25H23F2N3O5S	4.9242	124147085		CC(C)(C)NC(=O)NS(=O)(=O)c1c(Oc2cccc(-c3ccc(OC(F)F)cc3)c2)ccc(C#N)c1	InChI=1S/C25H23F2N3O5S/c1-25(2,3)29-24(31)30-36(32,33)22-13-16(15-28)7-12-21(22)34-20-6-4-5-18(14-20)17-8-10-19(11-9-17)35-23(26)27/h4-14,23H,1-3H3,(H2,29,30,31)	RIIKDGPBTPECSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008826	Adarotene	C25H26O3	5.3325	9864378	C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC=C(C=C5)/C=C/C(=O)O)O	O=C(O)C=Cc1ccc(-c2cc(C34CC5CC(CC(C5)C3)C4)c(O)cc2)cc1	InChI=1S/C25H26O3/c26-23-7-6-21(20-4-1-16(2-5-20)3-8-24(27)28)12-22(23)25-13-17-9-18(14-25)11-19(10-17)15-25/h1-8,12,17-19,26H,9-11,13-15H2,(H,27,28)/b8-3+	QAWBIEIZDDIEMW-FPYGCLRLSA-N					doublet; removed another duplicate entry; compound annotation
0391_008828	Sulfacarbamide	C7H9N3O3S	0.5939	11033		NC(=O)NS(=O)(=O)c1ccc(N)cc1	InChI=1S/C7H9N3O3S/c8-5-1-3-6(4-2-5)14(12,13)10-7(9)11/h1-4H,8H2,(H3,9,10,11)	WVAKABMNNSMCDK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008830	Benzetimide	C23H26N2O2	2.3282	21847		O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1	InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)	LQQIVYSCPWCSSD-UHFFFAOYSA-N					compound annotation
0391_008831	BENACTYZINE	C20H25NO3	2.5086	9330		CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1	InChI=1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3	IVQOFBKHQCTVQV-UHFFFAOYSA-N					compound annotation
0391_008832	cyclobenzaprine	C20H21N	3.0802	2895		CN(C)CCC=C1c2ccccc2C=Cc2ccccc12	InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3	JURKNVYFZMSNLP-UHFFFAOYSA-N					compound annotation
0391_008833	gliclazide	C15H21N3O3S	3.7863	3475		Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1	InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)	BOVGTQGAOIONJV-UHFFFAOYSA-N					doublet; compound annotation
0391_008834	gliclazide	C15H21N3O3S	3.7892	3475		Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1	InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)	BOVGTQGAOIONJV-UHFFFAOYSA-N					doublet; compound annotation
0391_008835	FIMASARTAN	C27H31N7OS	3.8073	9870652		CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C27H31N7OS/c1-5-6-11-24-28-18(2)23(16-25(36)33(3)4)27(35)34(24)17-19-12-14-20(15-13-19)21-9-7-8-10-22(21)26-29-31-32-30-26/h7-10,12-15H,5-6,11,16-17H2,1-4H3,(H,29,30,31,32)	AMEROGPZOLAFBN-UHFFFAOYSA-N					compound annotation
0391_008836	ibudilast	C14H18N2O	4.1273	3671		CC(C)C(=O)c1c2ccccn2nc1C(C)C	InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3	ZJVFLBOZORBYFE-UHFFFAOYSA-N					compound annotation
0391_008837	1675238-75-1	C42H44ClN2+	6.1712	126455665	CCN1C2=C(C3=CC=CC=C3C=C2)C(C1=C/C=C/4\CCCC(=C4Cl)/C=C/C5=[N+](C6=C(C5(C)C)C7=CC=CC=C7C=C6)CC)(C)C	CCN1C(=CC=C2CCCC(C=CC3=[N+](CC)c4c(c5ccccc5cc4)C3(C)C)=C2Cl)C(C)(C)c2c1ccc1ccccc21	InChI=1S/C42H44ClN2/c1-7-44-34-24-20-28-14-9-11-18-32(28)38(34)41(3,4)36(44)26-22-30-16-13-17-31(40(30)43)23-27-37-42(5,6)39-33-19-12-10-15-29(33)21-25-35(39)45(37)8-2/h9-12,14-15,18-27H,7-8,13,16-17H2,1-6H3/q+1	OYVKEIIHSIVUMC-UHFFFAOYSA-N					compound annotation
0391_008838	Benzyl-alpha-galnac	C15H21NO6	1.6495	122253	CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1OCC2=CC=CC=C2)CO)O)O	CC(=O)NC1C(OCc2ccccc2)OC(CO)C(O)C1O	InChI=1S/C15H21NO6/c1-9(18)16-12-14(20)13(19)11(7-17)22-15(12)21-8-10-5-3-2-4-6-10/h2-6,11-15,17,19-20H,7-8H2,1H3,(H,16,18)/t11-,12-,13+,14-,15+/m1/s1	SKOZFDIGKDPQBO-QMIVOQANSA-N					removed another duplicate entry; compound annotation
0391_008840	1633009-87-6	C16H18N4O2	1.7812	86305663		COCc1cc(-c2cc3c(nc2)N(C(N)=O)CCC3)cnc1	InChI=1S/C16H18N4O2/c1-22-10-11-5-13(8-18-7-11)14-6-12-3-2-4-20(16(17)21)15(12)19-9-14/h5-9H,2-4,10H2,1H3,(H2,17,21)	DJFDCVNQDFICKV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008842	TG101209	C26H35N7O2S	1.8743	16722832		Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cc(S(=O)(=O)NC(C)(C)C)ccc1	InChI=1S/C26H35N7O2S/c1-19-18-27-25(29-20-9-11-22(12-10-20)33-15-13-32(5)14-16-33)30-24(19)28-21-7-6-8-23(17-21)36(34,35)31-26(2,3)4/h6-12,17-18,31H,13-16H2,1-5H3,(H2,27,28,29,30)	JVDOKQYTTYUYDV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008845	Futibatinib	C22H22N6O3	3.2545	71621331	COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC	C=CC(=O)N1CCC(n2nc(C#Cc3cc(OC)cc(OC)c3)c3c(N)ncnc32)C1	InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1	KEIPNCCJPRMIAX-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_008847	BAY 60-7550	C27H32N4O4	3.3824	135564787	CC1=C2C(=O)NC(=NN2C(=N1)[C@@H](CCCC3=CC=CC=C3)[C@@H](C)O)CC4=CC(=C(C=C4)OC)OC	COc1c(OC)cc(Cc2nc(=O)c3c(C)nc(C(CCCc4ccccc4)C(C)O)n3[nH]2)cc1	InChI=1S/C27H32N4O4/c1-17-25-27(33)29-24(16-20-13-14-22(34-3)23(15-20)35-4)30-31(25)26(28-17)21(18(2)32)12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,18,21,32H,8,11-12,16H2,1-4H3,(H,29,30,33)/t18-,21+/m1/s1	MYTWFJKBZGMYCS-NQIIRXRSSA-N					removed another duplicate entry; compound annotation
0391_008849	BQCA	C18H15NO4	3.4184	1476756		COc1ccc(Cn2cc(C(=O)O)c(=O)c3ccccc32)cc1	InChI=1S/C18H15NO4/c1-23-13-8-6-12(7-9-13)10-19-11-15(18(21)22)17(20)14-4-2-3-5-16(14)19/h2-9,11H,10H2,1H3,(H,21,22)	BZBBTGCKPRSPGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008851	JH-VIII-157-02	C28H27N5O2	3.636	127037084		CCc1cc2c(cc1-c1cn(CC(=O)N(C)C)nc1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C28H27N5O2/c1-6-17-10-21-22(11-20(17)18-13-30-33(14-18)15-24(34)32(4)5)28(2,3)27-25(26(21)35)19-8-7-16(12-29)9-23(19)31-27/h7-11,13-14,31H,6,15H2,1-5H3	IDGNCVHQDDOPND-UHFFFAOYSA-N					doublet; compound annotation
0391_008852	JH-VIII-157-02	C28H27N5O2	3.8227	127037084		CCc1cc2c(cc1-c1cn(CC(=O)N(C)C)nc1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C28H27N5O2/c1-6-17-10-21-22(11-20(17)18-13-30-33(14-18)15-24(34)32(4)5)28(2,3)27-25(26(21)35)19-8-7-16(12-29)9-23(19)31-27/h7-11,13-14,31H,6,15H2,1-5H3	IDGNCVHQDDOPND-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008855	Dihydrofluorescein diacetate	C24H18O7	4.2852	629056		CC(=O)Oc1cc2c(cc1)C(c1ccccc1C(=O)O)c1c(cc(OC(C)=O)cc1)O2	InChI=1S/C24H18O7/c1-13(25)29-15-7-9-19-21(11-15)31-22-12-16(30-14(2)26)8-10-20(22)23(19)17-5-3-4-6-18(17)24(27)28/h3-12,23H,1-2H3,(H,27,28)	YKSJJXGQHSESKB-UHFFFAOYSA-N					compound annotation
0391_008856	1253643-88-7	C11H20N4O4	1.4205	66825403	CC1(N=N1)CCOC(=O)NCCCC[C@@H](C(=O)O)N	CC1(CCOC(=O)NCCCCC(N)C(=O)O)N=N1	InChI=1S/C11H20N4O4/c1-11(14-15-11)5-7-19-10(18)13-6-3-2-4-8(12)9(16)17/h8H,2-7,12H2,1H3,(H,13,18)(H,16,17)/t8-/m0/s1	LUCMNTLJAFTFDU-QMMMGPOBSA-N					compound annotation
0391_008857	Albendazole oxide	C12H15N3O3S	1.7191	83969		CCC[S+]([O-])c1ccc2nc(NC(=O)OC)[nH]c2c1	InChI=1S/C12H15N3O3S/c1-3-6-19(17)8-4-5-9-10(7-8)14-11(13-9)15-12(16)18-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)	VXTGHWHFYNYFFV-UHFFFAOYSA-N					compound annotation
0391_008858	Chloropyramine	C16H20ClN3	2.6356	25295		CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1	InChI=1S/C16H20ClN3/c1-19(2)11-12-20(16-5-3-4-10-18-16)13-14-6-8-15(17)9-7-14/h3-10H,11-13H2,1-2H3	ICKFFNBDFNZJSX-UHFFFAOYSA-N					compound annotation
0391_008859	IACS-13909	C17H18Cl2N6	3.2166	132166923		CC1(N)CCN(c2nc3n[nH]c(-c4c(Cl)c(Cl)ccc4)c3nc2)CC1	InChI=1S/C17H18Cl2N6/c1-17(20)5-7-25(8-6-17)12-9-21-15-14(23-24-16(15)22-12)10-3-2-4-11(18)13(10)19/h2-4,9H,5-8,20H2,1H3,(H,22,23,24)	AMADCPJVPLUGQO-UHFFFAOYSA-N					compound annotation
0391_008860	terbinafine	C21H25N	3.5609	1549008	CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21	CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12	InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+	DOMXUEMWDBAQBQ-WEVVVXLNSA-N					doublet; compound annotation
0391_008861	146535-11-7	C16H14N2O2	3.8754	2049		COc1c(OC)cc2nc(-c3ccccc3)cnc2c1	InChI=1S/C16H14N2O2/c1-19-15-8-12-13(9-16(15)20-2)18-14(10-17-12)11-6-4-3-5-7-11/h3-10H,1-2H3	QNOXYUNHIGOWNY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008863	eIF4A3-IN-1	C29H23BrClN5O2	4.6039	137640621	CC1=C(C=NN1C2=CC=CC(=C2)C#N)C(=O)N3CCN([C@H](C3)C4=CC=C(C=C4)Cl)C(=O)C5=CC=C(C=C5)Br	Cc1c(C(=O)N2CCN(C(=O)c3ccc(Br)cc3)C(c3ccc(Cl)cc3)C2)cnn1-c1cccc(C#N)c1	InChI=1S/C29H23BrClN5O2/c1-19-26(17-33-36(19)25-4-2-3-20(15-25)16-32)29(38)34-13-14-35(28(37)22-5-9-23(30)10-6-22)27(18-34)21-7-11-24(31)12-8-21/h2-12,15,17,27H,13-14,18H2,1H3/t27-/m1/s1	BDGKKHWJYBQRIE-HHHXNRCGSA-N					compound annotation
0391_008864	Src Inhibitor 3	C34H32ClFN8O4	4.654	139600340		COc1cn2ncc(C(=O)Nc3c(Cl)cc(NC(=O)c4nn(C5CCN(C(=O)CC(C)(C)C#N)CC5)c5ccc(F)cc45)cc3)c2cc1	InChI=1S/C34H32ClFN8O4/c1-34(2,19-37)16-30(45)42-12-10-22(11-13-42)44-29-8-4-20(36)14-24(29)31(41-44)33(47)39-21-5-7-27(26(35)15-21)40-32(46)25-17-38-43-18-23(48-3)6-9-28(25)43/h4-9,14-15,17-18,22H,10-13,16H2,1-3H3,(H,39,47)(H,40,46)	LQQYARMJQBHKQQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008866	80259-18-3	C24H24N4	1.5393	540335		CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1	InChI=1S/C24H24N4/c1-27-14-16-28(17-15-27)19-12-10-18(11-13-19)25-24-20-6-2-4-8-22(20)26-23-9-5-3-7-21(23)24/h2-13H,14-17H2,1H3,(H,25,26)	QZKGUNQLVFEEBA-UHFFFAOYSA-N					doublet; compound annotation
0391_008867	80259-18-3	C24H24N4	1.5427	540335		CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1	InChI=1S/C24H24N4/c1-27-14-16-28(17-15-27)19-12-10-18(11-13-19)25-24-20-6-2-4-8-22(20)26-23-9-5-3-7-21(23)24/h2-13H,14-17H2,1H3,(H,25,26)	QZKGUNQLVFEEBA-UHFFFAOYSA-N					doublet; compound annotation
0391_008868	Abemaciclib	C27H32F2N8	1.895	46220502		CCN1CCN(Cc2cnc(Nc3ncc(F)c(-c4cc5c(nc(C)n5C(C)C)c(F)c4)n3)cc2)CC1	InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)	UZWDCWONPYILKI-UHFFFAOYSA-N					doublet; compound annotation
0391_008869	Masitinib	C28H30N6OS	1.9893	10074640		Cc1c(Nc2nc(-c3cnccc3)cs2)cc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)	WJEOLQLKVOPQFV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008871	oxprenolol	C15H23NO3	2.2045	4631		C=CCOc1ccccc1OCC(O)CNC(C)C	InChI=1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3	CEMAWMOMDPGJMB-UHFFFAOYSA-N					compound annotation
0391_008872	Agomelatine	C15H17NO2	3.2624	82148		COc1cc2c(cccc2CCNC(C)=O)cc1	InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)	YJYPHIXNFHFHND-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008874	Opicapone	C15H10Cl2N4O6	3.408	135565903		Cc1c(-c2noc(-c3cc([N+](=O)[O-])c(O)c(O)c3)n2)c(Cl)[n+]([O-])c(C)c1Cl	InChI=1S/C15H10Cl2N4O6/c1-5-10(13(17)20(24)6(2)11(5)16)14-18-15(27-19-14)7-3-8(21(25)26)12(23)9(22)4-7/h3-4,22-23H,1-2H3	ASOADIZOVZTJSR-UHFFFAOYSA-N					compound annotation
0391_008875	VORTIOXETINE	C18H22N2S	3.4958	9966051		Cc1cc(C)c(Sc2ccccc2N2CCNCC2)cc1	InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3	YQNWZWMKLDQSAC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008877	001, RAD	C53H83NO14	5.5717	6442177	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OCCO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1	HKVAMNSJSFKALM-GKUWKFKPSA-N					compound annotation
0391_008878	AZATADINE	C20H22N2	1.475	19861		CN1CCC(=C2c3ccccc3CCc3c2nccc3)CC1	InChI=1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3	SEBMTIQKRHYNIT-UHFFFAOYSA-N					compound annotation
0391_008879	CFMTI	C19H16FN5O	2.019	11175501		Cc1c(-c2cc3c(cc2)C(=O)N(C2CC2)C3)nnn1-c1c(F)nccc1	InChI=1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3	XZBFQWRAIYRPPZ-UHFFFAOYSA-N					doublet; compound annotation
0391_008880	CFMTI	C19H16FN5O	2.1048	11175501		Cc1c(-c2cc3c(cc2)C(=O)N(C2CC2)C3)nnn1-c1c(F)nccc1	InChI=1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3	XZBFQWRAIYRPPZ-UHFFFAOYSA-N					doublet; compound annotation
0391_008881	CFMTI	C19H16FN5O	2.4434	11175501		Cc1c(-c2cc3c(cc2)C(=O)N(C2CC2)C3)nnn1-c1c(F)nccc1	InChI=1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3	XZBFQWRAIYRPPZ-UHFFFAOYSA-N					doublet; compound annotation
0391_008882	PONATINIB	C29H27F3N6O	3.3238	24826799		Cc1c(C#Cc2cnc3cccnn23)cc(C(=O)Nc2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)	PHXJVRSECIGDHY-UHFFFAOYSA-N					compound annotation
0391_008883	Quizartinib	C29H32N6O4S	3.3301	24889392		CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3c4ccc(OCCN4CCOCC4)c3)cc2)no1	InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)	CVWXJKQAOSCOAB-UHFFFAOYSA-N					compound annotation
0391_008884	Pseudoginsenoside Rt1	C47H74O18	3.35	21633069	C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O	CC1(C)CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OCC(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C47H74O18/c1-42(2)14-16-47(41(59)65-39-34(56)30(52)29(51)24(19-48)61-39)17-15-45(6)21(22(47)18-42)8-9-26-44(5)12-11-27(43(3,4)25(44)10-13-46(26,45)7)62-40-36(32(54)31(53)35(63-40)37(57)58)64-38-33(55)28(50)23(49)20-60-38/h8,22-36,38-40,48-56H,9-20H2,1-7H3,(H,57,58)/t22-,23+,24+,25-,26+,27-,28-,29+,30-,31-,32-,33+,34+,35-,36+,38-,39-,40+,44-,45+,46+,47-/m0/s1	YTPBUIWNJRGZFW-HONMPOSFSA-N					compound annotation
0391_008885	166038-00-2	C27H38BrN3O6S	3.8533	127939	C1CCC(C1)OC(=O)CNC(=O)[C@H](CSCC2=CC=C(C=C2)Br)NC(=O)CC[C@@H](C(=O)OC3CCCC3)N	NC(CCC(=O)NC(CSCc1ccc(Br)cc1)C(=O)NCC(=O)OC1CCCC1)C(=O)OC1CCCC1	InChI=1S/C27H38BrN3O6S/c28-19-11-9-18(10-12-19)16-38-17-23(26(34)30-15-25(33)36-20-5-1-2-6-20)31-24(32)14-13-22(29)27(35)37-21-7-3-4-8-21/h9-12,20-23H,1-8,13-17,29H2,(H,30,34)(H,31,32)/t22-,23-/m0/s1	QIFSPGPRHFNZNN-GOTSBHOMSA-N					removed another duplicate entry; compound annotation
0391_008887	sulfadimethoxine	C12H14N4O4S	2.4995	5323		COc1nc(OC)nc(NS(=O)(=O)c2ccc(N)cc2)c1	InChI=1S/C12H14N4O4S/c1-19-11-7-10(14-12(15-11)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	ZZORFUFYDOWNEF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008889	BO-264	C18H19N5O3	2.7353	146018837		COc1ccc(-c2noc(Nc3nc(N4CCOCC4)ncc3)c2)cc1	InChI=1S/C18H19N5O3/c1-24-14-4-2-13(3-5-14)15-12-17(26-22-15)20-16-6-7-19-18(21-16)23-8-10-25-11-9-23/h2-7,12H,8-11H2,1H3,(H,19,20,21)	WRCGBYNVBFVRTN-UHFFFAOYSA-N					compound annotation
0391_008890	Erythromycin propionate	C40H71NO14	3.3291	71277	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O	CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C	InChI=1S/C40H71NO14/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-/m1/s1	TYQXKHPOXXXCTP-CSLYCKPJSA-N					compound annotation
0391_008891	bendazac	C16H14N2O3	3.7714	2313		O=C(O)COc1nn(Cc2ccccc2)c2ccccc12	InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)	BYFMCKSPFYVMOU-UHFFFAOYSA-N					doublet; compound annotation
0391_008892	Mevidalen	C24H29Cl2NO3	4.3341	86290953	C[C@H]1C2=CC=CC(=C2C[C@@H](N1C(=O)CC3=C(C=CC=C3Cl)Cl)CO)CCC(C)(C)O	CC1c2cccc(CCC(C)(C)O)c2CC(CO)N1C(=O)Cc1c(Cl)cccc1Cl	InChI=1S/C24H29Cl2NO3/c1-15-18-7-4-6-16(10-11-24(2,3)30)19(18)12-17(14-28)27(15)23(29)13-20-21(25)8-5-9-22(20)26/h4-9,15,17,28,30H,10-14H2,1-3H3/t15-,17+/m0/s1	XHCSBQBBGNQINS-DOTOQJQBSA-N					doublet; compound annotation
0391_008893	Mevidalen	C24H29Cl2NO3	4.3391	86290953	C[C@H]1C2=CC=CC(=C2C[C@@H](N1C(=O)CC3=C(C=CC=C3Cl)Cl)CO)CCC(C)(C)O	CC1c2cccc(CCC(C)(C)O)c2CC(CO)N1C(=O)Cc1c(Cl)cccc1Cl	InChI=1S/C24H29Cl2NO3/c1-15-18-7-4-6-16(10-11-24(2,3)30)19(18)12-17(14-28)27(15)23(29)13-20-21(25)8-5-9-22(20)26/h4-9,15,17,28,30H,10-14H2,1-3H3/t15-,17+/m0/s1	XHCSBQBBGNQINS-DOTOQJQBSA-N					doublet; compound annotation
0391_008894	MK6-83	C16H20N2O2S2	4.9008	18191179		Cc1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2)s1	InChI=1S/C16H20N2O2S2/c1-13-9-10-16(21-13)22(19,20)17-14-7-3-4-8-15(14)18-11-5-2-6-12-18/h3-4,7-10,17H,2,5-6,11-12H2,1H3	IRGYSXZCDAWOOC-UHFFFAOYSA-N					doublet; compound annotation
0391_008895	MK6-83	C16H20N2O2S2	5.0193	18191179		Cc1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2)s1	InChI=1S/C16H20N2O2S2/c1-13-9-10-16(21-13)22(19,20)17-14-7-3-4-8-15(14)18-11-5-2-6-12-18/h3-4,7-10,17H,2,5-6,11-12H2,1H3	IRGYSXZCDAWOOC-UHFFFAOYSA-N					doublet; compound annotation
0391_008896	M4284	C23H28N2O8	1.548	57413592	CC1=C(C=CC(=C1)C2=CC(=CC(=C2)C(=O)NC)C(=O)NC)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	CNC(=O)c1cc(-c2cc(C)c(OC3OC(CO)C(O)C(O)C3O)cc2)cc(C(=O)NC)c1	InChI=1S/C23H28N2O8/c1-11-6-12(13-7-14(21(30)24-2)9-15(8-13)22(31)25-3)4-5-16(11)32-23-20(29)19(28)18(27)17(10-26)33-23/h4-9,17-20,23,26-29H,10H2,1-3H3,(H,24,30)(H,25,31)/t17-,18-,19+,20+,23+/m1/s1	CPNXCPWXQQMNFG-WCZGSDDISA-N					doublet; compound annotation
0391_008897	M4284	C23H28N2O8	1.7407	57413592	CC1=C(C=CC(=C1)C2=CC(=CC(=C2)C(=O)NC)C(=O)NC)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	CNC(=O)c1cc(-c2cc(C)c(OC3OC(CO)C(O)C(O)C3O)cc2)cc(C(=O)NC)c1	InChI=1S/C23H28N2O8/c1-11-6-12(13-7-14(21(30)24-2)9-15(8-13)22(31)25-3)4-5-16(11)32-23-20(29)19(28)18(27)17(10-26)33-23/h4-9,17-20,23,26-29H,10H2,1-3H3,(H,24,30)(H,25,31)/t17-,18-,19+,20+,23+/m1/s1	CPNXCPWXQQMNFG-WCZGSDDISA-N					doublet; removed another duplicate entry; compound annotation
0391_008899	M4284	C23H28N2O8	1.8011	57413592	CC1=C(C=CC(=C1)C2=CC(=CC(=C2)C(=O)NC)C(=O)NC)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	CNC(=O)c1cc(-c2cc(C)c(OC3OC(CO)C(O)C(O)C3O)cc2)cc(C(=O)NC)c1	InChI=1S/C23H28N2O8/c1-11-6-12(13-7-14(21(30)24-2)9-15(8-13)22(31)25-3)4-5-16(11)32-23-20(29)19(28)18(27)17(10-26)33-23/h4-9,17-20,23,26-29H,10H2,1-3H3,(H,24,30)(H,25,31)/t17-,18-,19+,20+,23+/m1/s1	CPNXCPWXQQMNFG-WCZGSDDISA-N					doublet; compound annotation
0391_008900	M4284	C23H28N2O8	2.1171	57413592	CC1=C(C=CC(=C1)C2=CC(=CC(=C2)C(=O)NC)C(=O)NC)O[C@@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	CNC(=O)c1cc(-c2cc(C)c(OC3OC(CO)C(O)C(O)C3O)cc2)cc(C(=O)NC)c1	InChI=1S/C23H28N2O8/c1-11-6-12(13-7-14(21(30)24-2)9-15(8-13)22(31)25-3)4-5-16(11)32-23-20(29)19(28)18(27)17(10-26)33-23/h4-9,17-20,23,26-29H,10H2,1-3H3,(H,24,30)(H,25,31)/t17-,18-,19+,20+,23+/m1/s1	CPNXCPWXQQMNFG-WCZGSDDISA-N					doublet; compound annotation
0391_008901	Elesclomol	C19H20N4O2S2	3.4407	300471		CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1	InChI=1S/C19H20N4O2S2/c1-22(18(26)14-9-5-3-6-10-14)20-16(24)13-17(25)21-23(2)19(27)15-11-7-4-8-12-15/h3-12H,13H2,1-2H3,(H,20,24)(H,21,25)	BKJIXTWSNXCKJH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008903	Domiphen	C22H40NO+	4.8893	3149		CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1	InChI=1S/C22H40NO/c1-4-5-6-7-8-9-10-11-12-16-19-23(2,3)20-21-24-22-17-14-13-15-18-22/h13-15,17-18H,4-12,16,19-21H2,1-3H3/q+1	YXUPZGKORWTXID-UHFFFAOYSA-N					compound annotation
0391_008904	288150-92-5	C19H18F2N4O	1.4671	4331799		Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26)	JTARFZSNUAGHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_008905	288150-92-5	C19H18F2N4O	1.6117	4331799		Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26)	JTARFZSNUAGHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_008906	288150-92-5	C19H18F2N4O	1.6154	4331799		Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26)	JTARFZSNUAGHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_008907	Dabigatran ethyl ester	C27H29N7O3	1.8941	446804		CCOC(=O)CCN(C(=O)c1cc2c(cc1)n(C)c(CNc1ccc(C(=N)N)cc1)n2)c1ccccn1	InChI=1S/C27H29N7O3/c1-3-37-25(35)13-15-34(23-6-4-5-14-30-23)27(36)19-9-12-22-21(16-19)32-24(33(22)2)17-31-20-10-7-18(8-11-20)26(28)29/h4-12,14,16,31H,3,13,15,17H2,1-2H3,(H3,28,29)	BGLLICFSSKPUMR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008909	Alvimopan	C25H32N2O4	2.3407	51397022	C[C@H]1C[NH+](CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)[O-]	CC1CN(CC(Cc2ccccc2)C(=O)NCC(=O)O)CCC1(C)c1cc(O)ccc1	InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1	UPNUIXSCZBYVBB-JVFUWBCBSA-N					removed another duplicate entry; compound annotation
0391_008911	Denatonium	C21H29N2O+	2.8207	15488		CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc1ccccc1	InChI=1S/C21H28N2O/c1-5-23(6-2,15-19-13-8-7-9-14-19)16-20(24)22-21-17(3)11-10-12-18(21)4/h7-14H,5-6,15-16H2,1-4H3/p+1	ZFQMTVNLDNXRNQ-UHFFFAOYSA-O					compound annotation
0391_008912	tolmetin	C15H15NO3	3.4779	5509		Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1	InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)	UPSPUYADGBWSHF-UHFFFAOYSA-N					doublet; compound annotation
0391_008913	Fendizoic acid	C20H14O4	3.568	163447		O=C(O)c1ccccc1C(=O)c1cc(-c2ccccc2)c(O)cc1	InChI=1S/C20H14O4/c21-18-11-10-14(12-17(18)13-6-2-1-3-7-13)19(22)15-8-4-5-9-16(15)20(23)24/h1-12,21H,(H,23,24)	PKHPZNKXOBWFCX-UHFFFAOYSA-N					doublet; compound annotation
0391_008914	Fendizoic acid	C20H14O4	3.5713	163447		O=C(O)c1ccccc1C(=O)c1cc(-c2ccccc2)c(O)cc1	InChI=1S/C20H14O4/c21-18-11-10-14(12-17(18)13-6-2-1-3-7-13)19(22)15-8-4-5-9-16(15)20(23)24/h1-12,21H,(H,23,24)	PKHPZNKXOBWFCX-UHFFFAOYSA-N					doublet; compound annotation
0391_008915	Robenidine	C15H13Cl2N5	3.5913	9570438	C1=CC(=CC=C1/C=N/N/C(=N/N=C/C2=CC=C(C=C2)Cl)/N)Cl	NC(=NN=Cc1ccc(Cl)cc1)NN=Cc1ccc(Cl)cc1	InChI=1S/C15H13Cl2N5/c16-13-5-1-11(2-6-13)9-19-21-15(18)22-20-10-12-3-7-14(17)8-4-12/h1-10H,(H3,18,21,22)/b19-9+,20-10+	MOOFYEJFXBSZGE-LQGKIZFRSA-N					compound annotation
0391_008916	bendazac	C16H14N2O3	3.7674	2313		O=C(O)COc1nn(Cc2ccccc2)c2ccccc12	InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)	BYFMCKSPFYVMOU-UHFFFAOYSA-N					doublet; compound annotation
0391_008917	Dronedarone	C31H44N2O5S	4.1991	208898		CCCCc1c(C(=O)c2ccc(OCCCN(CCCC)CCCC)cc2)c2c(ccc(NS(C)(=O)=O)c2)o1	InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008918	288150-92-5	C19H18F2N4O	5.1284	4331799		Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1	InChI=1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26)	JTARFZSNUAGHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_008919	levamisole	C11H12N2S	1.1504	26879	C1CSC2=N[C@H](CN21)C3=CC=CC=C3	c1ccc(C2CN3CCSC3=N2)cc1	InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1	HLFSDGLLUJUHTE-SNVBAGLBSA-N					compound annotation
0391_008920	NF-56-EJ40	C27H29N3O3	2.1868	138811017		CN1CCN(Cc2ccc(-c3cc(C(=O)Nc4ccccc4CC(=O)O)ccc3)cc2)CC1	InChI=1S/C27H29N3O3/c1-29-13-15-30(16-14-29)19-20-9-11-21(12-10-20)22-6-4-7-24(17-22)27(33)28-25-8-3-2-5-23(25)18-26(31)32/h2-12,17H,13-16,18-19H2,1H3,(H,28,33)(H,31,32)	UTWXDNZWMQAUKL-UHFFFAOYSA-N					compound annotation
0391_008921	ZD-4190	C19H16BrFN6O2	2.5895	5329032		COc1c(OCCn2ccnn2)cc2ncnc(Nc3c(F)cc(Br)cc3)c2c1	InChI=1S/C19H16BrFN6O2/c1-28-17-9-13-16(10-18(17)29-7-6-27-5-4-24-26-27)22-11-23-19(13)25-15-3-2-12(20)8-14(15)21/h2-5,8-11H,6-7H2,1H3,(H,22,23,25)	YBTGTVGEKMZEQX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008923	PIPERACETAZINE	C24H30N2O2S	2.961	19675		CC(=O)c1cc2c(cc1)Sc1ccccc1N2CCCN1CCC(CCO)CC1	InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3	BTFMCMVEUCGQDX-UHFFFAOYSA-N					compound annotation
0391_008924	7-Ethylcamptothecin	C22H20N2O4	3.1961	127584	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=CC=CC=C51	CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2ccccc12	InChI=1S/C22H20N2O4/c1-3-12-13-7-5-6-8-17(13)23-19-14(12)10-24-18(19)9-16-15(20(24)25)11-28-21(26)22(16,27)4-2/h5-9,27H,3-4,10-11H2,1-2H3/t22-/m0/s1	MYQKIWCVEPUPIL-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_008926	3,6-Bis(dimethylamino)-10-nonylacridinium	C26H38N3+	5.0678	115086		CCCCCCCCC[n+]1c2cc(N(C)C)ccc2cc2c1cc(N(C)C)cc2	InChI=1S/C26H38N3/c1-6-7-8-9-10-11-12-17-29-25-19-23(27(2)3)15-13-21(25)18-22-14-16-24(28(4)5)20-26(22)29/h13-16,18-20H,6-12,17H2,1-5H3/q+1	CHKMESCAQLVOQU-UHFFFAOYSA-N					compound annotation
0391_008927	202592-23-2	C19H17ClN4O2S	3.6022	66828107	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)O)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC(=O)O)N=C2c1ccc(Cl)cc1	InChI=1S/C19H17ClN4O2S/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)21-14(8-15(25)26)18-23-22-11(3)24(18)19/h4-7,14H,8H2,1-3H3,(H,25,26)/t14-/m0/s1	LJOSBOOJFIRCSO-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_008929	157341-41-8	C31H40N4O6	3.9682	177992	CCC[C@H](C1=CC2=C(C=C1)OCO2)NC(=O)N3[C@H](C(C3=O)(CC)CC)OC4=CC=C(C=C4)C(=O)N5CCN(CC5)C	CCCC(NC(=O)N1C(=O)C(CC)(CC)C1Oc1ccc(C(=O)N2CCN(C)CC2)cc1)c1cc2c(cc1)OCO2	InChI=1S/C31H40N4O6/c1-5-8-24(22-11-14-25-26(19-22)40-20-39-25)32-30(38)35-28(37)31(6-2,7-3)29(35)41-23-12-9-21(10-13-23)27(36)34-17-15-33(4)16-18-34/h9-14,19,24,29H,5-8,15-18,20H2,1-4H3,(H,32,38)/t24-,29+/m1/s1	ZSDCIRYNTCVTMF-GIGWZHCTSA-N					removed another duplicate entry; compound annotation
0391_008931	878006-06-5	C17H24O3	4.9832	6438480	CCCCCCCC(=O)/C=C/C1=CC(=C(C=C1)O)OC	CCCCCCCC(=O)C=Cc1cc(OC)c(O)cc1	InChI=1S/C17H24O3/c1-3-4-5-6-7-8-15(18)11-9-14-10-12-16(19)17(13-14)20-2/h9-13,19H,3-8H2,1-2H3/b11-9+	AXMBOMODZLJDKX-PKNBQFBNSA-N					compound annotation
0391_008932	cefepime	C19H25N6O5S2+	0.5555	5491295	C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CSC12)c1csc(N)n1	InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/p+1/b23-12-/t13-,17-/m1/s1	HVFLCNVBZFFHBT-ZKDACBOMSA-O					compound annotation
0391_008933	sulfadiazine	C10H10N4O2S	0.9887	5215		Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1	InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)	SEEPANYCNGTZFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008934	Fasudil	C14H17N3O2S	1.0225	3547		O=S(=O)(c1cccc2c1ccnc2)N1CCCNCC1	InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2	NGOGFTYYXHNFQH-UHFFFAOYSA-N					compound annotation
0391_008935	timolol	C13H24N4O3S	1.7879	33624	CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O	CC(C)(C)NCC(O)COc1nsnc1N1CCOCC1	InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1	BLJRIMJGRPQVNF-JTQLQIEISA-N					compound annotation
0391_008936	Isofraxidin	C11H10O5	1.8952	5318565		COc1c(O)c(OC)c2oc(=O)ccc2c1	InChI=1S/C11H10O5/c1-14-7-5-6-3-4-8(12)16-10(6)11(15-2)9(7)13/h3-5,13H,1-2H3	HOEVRHHMDJKUMZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008938	Pazopanib	C21H23N7O2S	2.4099	10113978		Cc1c(S(N)(=O)=O)cc(Nc2nccc(N(C)c3cc4nn(C)c(C)c4cc3)n2)cc1	InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)	CUIHSIWYWATEQL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_008940	Pseudoprotodioscin	C51H82O21	2.6386	51346147	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)C)O)O)O)OC4CC[C@@]5([C@H]6CC[C@]7([C@H]([C@@H]6CC=C5C4)C[C@H]8[C@@H]7C(=C(O8)CC[C@@H](C)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)C)C)C)CO)O)O)O	CC1=C(CCC(C)COC2OC(CO)C(O)C(O)C2O)OC2CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C12	InChI=1S/C51H82O21/c1-20(19-64-46-40(60)39(59)36(56)31(17-52)69-46)7-10-29-21(2)33-30(68-29)16-28-26-9-8-24-15-25(11-13-50(24,5)27(26)12-14-51(28,33)6)67-49-45(72-48-42(62)38(58)35(55)23(4)66-48)43(63)44(32(18-53)70-49)71-47-41(61)37(57)34(54)22(3)65-47/h8,20,22-23,25-28,30-49,52-63H,7,9-19H2,1-6H3/t20-,22+,23+,25?,26-,27+,28+,30+,31-,32-,33+,34+,35+,36-,37-,38-,39+,40-,41-,42-,43+,44-,45-,46-,47+,48+,49-,50+,51+/m1/s1	MDCUMTGKKLOMCW-MQDUZHDNSA-N					compound annotation
0391_008941	Anamorelin	C31H42N6O3	3.351	9828911	CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@](C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N	CN(C)N(C)C(=O)C1(Cc2ccccc2)CCCN(C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1	InChI=1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1	VQPFSIRUEPQQPP-MXBOTTGLSA-N					doublet; removed another duplicate entry; compound annotation
0391_008943	SERTINDOLE	C24H26ClFN4O	3.5355	60149		O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3c2cc(Cl)cc3)CC1	InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)	GZKLJWGUPQBVJQ-UHFFFAOYSA-N					compound annotation
0391_008944	GSK-3beta inhibitor 2	C14H14N4O3S	2.4917	73333976		COc1c(C(N)=O)sc(-c2cc(NC(=O)C3CC3)ncc2)n1	InChI=1S/C14H14N4O3S/c1-21-13-10(11(15)19)22-14(18-13)8-4-5-16-9(6-8)17-12(20)7-2-3-7/h4-7H,2-3H2,1H3,(H2,15,19)(H,16,17,20)	CYADPSMQNARVII-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008946	Bevantolol	C20H27NO4	2.679	2372		COc1c(OC)cc(CCNCC(O)COc2cccc(C)c2)cc1	InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3	HXLAFSUPPDYFEO-UHFFFAOYSA-N					doublet; compound annotation
0391_008947	Bevantolol	C20H27NO4	2.6817	2372		COc1c(OC)cc(CCNCC(O)COc2cccc(C)c2)cc1	InChI=1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3	HXLAFSUPPDYFEO-UHFFFAOYSA-N					doublet; compound annotation
0391_008948	Ethyl ferulate	C12H14O4	3.2839	736681	CCOC(=O)/C=C/C1=CC(=C(C=C1)O)OC	CCOC(=O)C=Cc1cc(OC)c(O)cc1	InChI=1S/C12H14O4/c1-3-16-12(14)7-5-9-4-6-10(13)11(8-9)15-2/h4-8,13H,3H2,1-2H3/b7-5+	ATJVZXXHKSYELS-FNORWQNLSA-N					compound annotation
0391_008949	Tesaglitazar	C20H24O7S	3.9454	208901	CCO[C@@H](CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O	CCOC(Cc1ccc(OCCc2ccc(OS(C)(=O)=O)cc2)cc1)C(=O)O	InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1	CXGTZJYQWSUFET-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_008951	carbenoxolone	C34H50O7	5.3865	636403	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CCC(=O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC(=O)CCC(=O)O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1	OBZHEBDUNPOCJG-WBXJDKIVSA-N					compound annotation
0391_008952	BRD3308	C15H14FN3O2	2.0822	72734382		CC(=O)Nc1ccc(C(=O)Nc2c(N)cc(F)cc2)cc1	InChI=1S/C15H14FN3O2/c1-9(20)18-12-5-2-10(3-6-12)15(21)19-14-7-4-11(16)8-13(14)17/h2-8H,17H2,1H3,(H,18,20)(H,19,21)	RRJDFENBXIEAPD-UHFFFAOYSA-N					compound annotation
0391_008953	candesartan	C24H20N6O3	3.2993	2541		CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)	HTQMVQVXFRQIKW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008955	2',4'-Dimethylacetophenone	C10H12O	4.1472	6985		CC(=O)c1c(C)cc(C)cc1	InChI=1S/C10H12O/c1-7-4-5-10(9(3)11)8(2)6-7/h4-6H,1-3H3	HSDSKVWQTONQBJ-UHFFFAOYSA-N					compound annotation
0391_008956	4-ETHYLBENZALDEHYDE	C9H10O	4.3145	20861		CCc1ccc(C=O)cc1	InChI=1S/C9H10O/c1-2-8-3-5-9(7-10)6-4-8/h3-7H,2H2,1H3	QNGNSVIICDLXHT-UHFFFAOYSA-N					compound annotation
0391_008957	COR659	C16H16ClNO3S	5.9806	897320		CCc1c(C)sc(NC(=O)c2ccc(Cl)cc2)c1C(=O)OC	InChI=1S/C16H16ClNO3S/c1-4-12-9(2)22-15(13(12)16(20)21-3)18-14(19)10-5-7-11(17)8-6-10/h5-8H,4H2,1-3H3,(H,18,19)	AAFLALGGEYRGTR-UHFFFAOYSA-N					compound annotation
0391_008958	2,3,5-Trimethylpyrazine	C7H10N2	1.2454	26808		Cc1cnc(C)c(C)n1	InChI=1S/C7H10N2/c1-5-4-8-6(2)7(3)9-5/h4H,1-3H3	IAEGWXHKWJGQAZ-UHFFFAOYSA-N					compound annotation
0391_008959	Lancerin	C19H18O10	1.6632	5281645	C1=CC2=C(C=C1O)C(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	O=c1c2c(ccc(O)c2)oc2c1c(O)cc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C19H18O10/c20-5-11-15(25)16(26)17(27)19(29-11)13-9(23)4-8(22)12-14(24)7-3-6(21)1-2-10(7)28-18(12)13/h1-4,11,15-17,19-23,25-27H,5H2/t11-,15-,16+,17-,19+/m1/s1	JUZGXATTXYZBGK-HBVDJMOISA-N					compound annotation
0391_008960	Levomepromazine	C19H24N2OS	3.1885	72287	C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C	COc1cc2c(cc1)Sc1ccccc1N2CC(C)CN(C)C	InChI=1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1	VRQVVMDWGGWHTJ-CQSZACIVSA-N					compound annotation
0391_008961	pentagastrin	C37H49N7O9S	3.567	9853654	CC(C)(C)OC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N	CSCCC(NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)/t26-,27-,28-,29-/m0/s1	NEYNJQRKHLUJRU-DZUOILHNSA-N					compound annotation
0391_008962	meloxicam	C14H13N3O4S2	3.617	54677470		Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1	InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)	ZRVUJXDFFKFLMG-UHFFFAOYSA-N					compound annotation
0391_008963	Octadecanedioic acid	C18H34O4	5.258	70095		O=C(O)CCCCCCCCCCCCCCCCC(=O)O	InChI=1S/C18H34O4/c19-17(20)15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18(21)22/h1-16H2,(H,19,20)(H,21,22)	BNJOQKFENDDGSC-UHFFFAOYSA-N					compound annotation
0391_008964	Val-Tyr	C14H20N2O4	0.6362	7009555	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N	CC(C)C(N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O	InChI=1S/C14H20N2O4/c1-8(2)12(15)13(18)16-11(14(19)20)7-9-3-5-10(17)6-4-9/h3-6,8,11-12,17H,7,15H2,1-2H3,(H,16,18)(H,19,20)/t11-,12-/m0/s1	VEYJKJORLPYVLO-RYUDHWBXSA-N					compound annotation
0391_008965	MALTOL	C6H6O3	0.8762	8369		Cc1c(O)c(=O)cco1	InChI=1S/C6H6O3/c1-4-6(8)5(7)2-3-9-4/h2-3,8H,1H3	XPCTZQVDEJYUGT-UHFFFAOYSA-N					compound annotation
0391_008966	zonisamide	C8H8N2O3S	1.7905	5734		NS(=O)(=O)Cc1noc2ccccc12	InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)	UBQNRHZMVUUOMG-UHFFFAOYSA-N					compound annotation
0391_008967	PI3Kalpha-IN-4	C25H23ClFN5O5S	3.5716	154573770	C[C@H](CN1C=NC2=C(C1=O)C=C(C=C2)C3=CC(=C(N=C3)OC)NS(=O)(=O)C4=C(C=C(C=C4)F)Cl)C(=O)NC	CNC(=O)C(C)Cn1cnc2c(cc(-c3cc(NS(=O)(=O)c4c(Cl)cc(F)cc4)c(OC)nc3)cc2)c1=O	InChI=1S/C25H23ClFN5O5S/c1-14(23(33)28-2)12-32-13-30-20-6-4-15(8-18(20)25(32)34)16-9-21(24(37-3)29-11-16)31-38(35,36)22-7-5-17(27)10-19(22)26/h4-11,13-14,31H,12H2,1-3H3,(H,28,33)/t14-/m1/s1	LPATWVFSBNDSHR-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_008969	1-HYDROXYPYRENE	C16H10O	4.4746	21387		Oc1c2ccc3c4c(ccc3)ccc(c24)cc1	InChI=1S/C16H10O/c17-14-9-7-12-5-4-10-2-1-3-11-6-8-13(14)16(12)15(10)11/h1-9,17H	BIJNHUAPTJVVNQ-UHFFFAOYSA-N					compound annotation
0391_008970	Bergaptol	C11H6O4	2.5279	5280371		O=c1ccc2c(O)c3c(cc2o1)occ3	InChI=1S/C11H6O4/c12-10-2-1-6-9(15-10)5-8-7(11(6)13)3-4-14-8/h1-5,13H	GIJHDGJRTUSBJR-UHFFFAOYSA-N					compound annotation
0391_008971	Aurora A Inhibitor I	C31H31ClFN7O2	2.6181	44139710		CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1	InChI=1S/C31H31ClFN7O2/c1-2-39-15-17-40(18-16-39)28(41)19-21-7-11-24(12-8-21)36-31-34-20-26(33)29(38-31)35-23-13-9-22(10-14-23)30(42)37-27-6-4-3-5-25(27)32/h3-14,20H,2,15-19H2,1H3,(H,37,42)(H2,34,35,36,38)	AKSIZPIFQAYJGF-UHFFFAOYSA-N					doublet; compound annotation
0391_008972	Aurora A Inhibitor I	C31H31ClFN7O2	2.6231	44139710		CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1	InChI=1S/C31H31ClFN7O2/c1-2-39-15-17-40(18-16-39)28(41)19-21-7-11-24(12-8-21)36-31-34-20-26(33)29(38-31)35-23-13-9-22(10-14-23)30(42)37-27-6-4-3-5-25(27)32/h3-14,20H,2,15-19H2,1H3,(H,37,42)(H2,34,35,36,38)	AKSIZPIFQAYJGF-UHFFFAOYSA-N					doublet; compound annotation
0391_008973	Aurora A Inhibitor I	C31H31ClFN7O2	2.7614	44139710		CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1	InChI=1S/C31H31ClFN7O2/c1-2-39-15-17-40(18-16-39)28(41)19-21-7-11-24(12-8-21)36-31-34-20-26(33)29(38-31)35-23-13-9-22(10-14-23)30(42)37-27-6-4-3-5-25(27)32/h3-14,20H,2,15-19H2,1H3,(H,37,42)(H2,34,35,36,38)	AKSIZPIFQAYJGF-UHFFFAOYSA-N					doublet; compound annotation
0391_008974	BQR-695	C19H20N4O3	2.7646	112499905		CNC(=O)CNc1cnc2ccc(-c3cc(OC)c(OC)cc3)cc2n1	InChI=1S/C19H20N4O3/c1-20-19(24)11-22-18-10-21-14-6-4-12(8-15(14)23-18)13-5-7-16(25-2)17(9-13)26-3/h4-10H,11H2,1-3H3,(H,20,24)(H,22,23)	LYPCULYCGFOIDA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008976	VR23	C19H16ClN5O6S	3.1527	73442847		O=[N+]([O-])c1cc([N+](=O)[O-])c(S(=O)(=O)N2CCN(c3ccnc4cc(Cl)ccc34)CC2)cc1	InChI=1S/C19H16ClN5O6S/c20-13-1-3-15-16(11-13)21-6-5-17(15)22-7-9-23(10-8-22)32(30,31)19-4-2-14(24(26)27)12-18(19)25(28)29/h1-6,11-12H,7-10H2	PDQVZPPIHADUOO-UHFFFAOYSA-N					compound annotation
0391_008977	B-Raf inhibitor	C29H31F3N6O2	3.3331	71254032		CCN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)c3cc(Oc4ncnc5c4cc(C)[nH]5)c(C)cc3)cc2)CC1	InChI=1S/C29H31F3N6O2/c1-4-37-9-11-38(12-10-37)16-21-7-8-22(15-24(21)29(30,31)32)36-27(39)20-6-5-18(2)25(14-20)40-28-23-13-19(3)35-26(23)33-17-34-28/h5-8,13-15,17H,4,9-12,16H2,1-3H3,(H,36,39)(H,33,34,35)	RWNAOXLCVXJMGM-UHFFFAOYSA-N					compound annotation
0391_008978	MRS 1706	C27H29N5O5	4.1819	5139184		CCCn1c(=O)c2c(nc(-c3ccc(OCC(=O)Nc4ccc(C(C)=O)cc4)cc3)[nH]2)n(CCC)c1=O	InChI=1S/C27H29N5O5/c1-4-14-31-25-23(26(35)32(15-5-2)27(31)36)29-24(30-25)19-8-12-21(13-9-19)37-16-22(34)28-20-10-6-18(7-11-20)17(3)33/h6-13H,4-5,14-16H2,1-3H3,(H,28,34)(H,29,30)	ZKUCFFYOQOJLGT-UHFFFAOYSA-N					compound annotation
0391_008979	Cephalomannine	C45H53NO14	4.2007	6436208	C/C=C(\C)/C(=O)N[C@@H](C1=CC=CC=C1)[C@H](C(=O)O[C@H]2C[C@]3([C@H]([C@H]4[C@@]([C@H](C[C@@H]5[C@]4(CO5)OC(=O)C)O)(C(=O)[C@@H](C(=C2C)C3(C)C)OC(=O)C)C)OC(=O)C6=CC=CC=C6)O)O	CC=C(C)C(=O)NC(c1ccccc1)C(O)C(=O)OC1CC2(O)C(OC(=O)c3ccccc3)C3C4(OC(C)=O)COC4CC(O)C3(C)C(=O)C(OC(C)=O)C(=C1C)C2(C)C	InChI=1S/C45H53NO14/c1-9-23(2)39(52)46-33(27-16-12-10-13-17-27)34(50)41(54)58-29-21-45(55)38(59-40(53)28-18-14-11-15-19-28)36-43(8,30(49)20-31-44(36,22-56-31)60-26(5)48)37(51)35(57-25(4)47)32(24(29)3)42(45,6)7/h9-19,29-31,33-36,38,49-50,55H,20-22H2,1-8H3,(H,46,52)/b23-9+/t29-,30-,31+,33-,34+,35+,36-,38-,43+,44-,45+/m0/s1	DBXFAPJCZABTDR-WBYYIXQISA-N					removed another duplicate entry; compound annotation
0391_008981	Lomibuvir	C25H35NO4S	5.0246	24798764		CC1CCC(C(=O)N(c2c(C(=O)O)sc(C#CC(C)(C)C)c2)C2CCC(O)CC2)CC1	InChI=1S/C25H35NO4S/c1-16-5-7-17(8-6-16)23(28)26(18-9-11-19(27)12-10-18)21-15-20(13-14-25(2,3)4)31-22(21)24(29)30/h15-19,27H,5-12H2,1-4H3,(H,29,30)	WPMJNLCLKAKMLA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008983	1616391-87-7	C22H28N4O2	1.2728	117072552	C1CC(C1)NC2=NC=CC(=C2)C(=O)NC[C@@H](CN3CCC4=CC=CC=C4C3)O	O=C(NCC(O)CN1CCc2ccccc2C1)c1cc(NC2CCC2)ncc1	InChI=1S/C22H28N4O2/c27-20(15-26-11-9-16-4-1-2-5-18(16)14-26)13-24-22(28)17-8-10-23-21(12-17)25-19-6-3-7-19/h1-2,4-5,8,10,12,19-20,27H,3,6-7,9,11,13-15H2,(H,23,25)(H,24,28)/t20-/m0/s1	TWKYXZSXXXKKJU-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_008985	1875036-75-1	C25H28N8	1.7116	138377589		NCc1cc(CNc2ncnc3c2ncnc3N2CCN(Cc3ccccc3)CC2)ccc1	InChI=1S/C25H28N8/c26-14-20-7-4-8-21(13-20)15-27-24-22-23(29-17-30-24)25(31-18-28-22)33-11-9-32(10-12-33)16-19-5-2-1-3-6-19/h1-8,13,17-18H,9-12,14-16,26H2,(H,27,29,30)	DZDNGSNKWIORRZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008987	Flumexadol	C11H12F3NO	2.1475	65774		FC(F)(F)c1cccc(C2CNCCO2)c1	InChI=1S/C11H12F3NO/c12-11(13,14)9-3-1-2-8(6-9)10-7-15-4-5-16-10/h1-3,6,10,15H,4-5,7H2	GXPYCYWPUGKQIJ-UHFFFAOYSA-N					compound annotation
0391_008988	184582-62-5	C18H20N2O2S	2.2736	53390843		COc1cc2c(cc1)nc1ccc(OC)cc1c2SCCCN	InChI=1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3	ZFOMCSNUEHMROO-UHFFFAOYSA-N					doublet; compound annotation
0391_008989	LS-3360	C25H41NO2	2.5312	9954083	CCN(CC)CCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C	CCN(CC)CCOC1CCC2(C)C(=CCC3C4CCC(=O)C4(C)CCC32)C1	InChI=1S/C25H41NO2/c1-5-26(6-2)15-16-28-19-11-13-24(3)18(17-19)7-8-20-21-9-10-23(27)25(21,4)14-12-22(20)24/h7,19-22H,5-6,8-17H2,1-4H3/t19-,20-,21-,22-,24-,25-/m0/s1	DMZCCFMMPHJWQY-BKWLFHPQSA-N					doublet; compound annotation
0391_008990	184582-62-5	C18H20N2O2S	2.8715	53390843		COc1cc2c(cc1)nc1ccc(OC)cc1c2SCCCN	InChI=1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3	ZFOMCSNUEHMROO-UHFFFAOYSA-N					doublet; compound annotation
0391_008991	184582-62-5	C18H20N2O2S	2.972	53390843		COc1cc2c(cc1)nc1ccc(OC)cc1c2SCCCN	InChI=1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3	ZFOMCSNUEHMROO-UHFFFAOYSA-N					doublet; compound annotation
0391_008992	LS-3360	C25H41NO2	3.3999	9954083	CCN(CC)CCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C	CCN(CC)CCOC1CCC2(C)C(=CCC3C4CCC(=O)C4(C)CCC32)C1	InChI=1S/C25H41NO2/c1-5-26(6-2)15-16-28-19-11-13-24(3)18(17-19)7-8-20-21-9-10-23(27)25(21,4)14-12-22(20)24/h7,19-22H,5-6,8-17H2,1-4H3/t19-,20-,21-,22-,24-,25-/m0/s1	DMZCCFMMPHJWQY-BKWLFHPQSA-N					doublet; compound annotation
0391_008993	794568-90-4	C15H12ClF3N4O	3.8035	135495130		CC(Cc1nc2c(cnn2-c2ccccc2Cl)c(=O)[nH]1)C(F)(F)F	InChI=1S/C15H12ClF3N4O/c1-8(15(17,18)19)6-12-21-13-9(14(24)22-12)7-20-23(13)11-5-3-2-4-10(11)16/h2-5,7-8H,6H2,1H3,(H,21,22,24)	FFPXPXOAFQCNBS-UHFFFAOYSA-N					compound annotation
0391_008994	Methyl mycophenolate	C18H22O6	4.2143	6478685	CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OC)O	COC(=O)CCC(C)=CCc1c(OC)c(C)c2COC(=O)c2c1O	InChI=1S/C18H22O6/c1-10(6-8-14(19)22-3)5-7-12-16(20)15-13(9-24-18(15)21)11(2)17(12)23-4/h5,20H,6-9H2,1-4H3/b10-5+	ZPXRQFLATDNYSS-BJMVGYQFSA-N					removed another duplicate entry; compound annotation
0391_008996	Anguizole	C17H11ClF2N4O2S	4.4265	1046082		O=C(NCc1cccs1)c1nn2c(C(F)(F)Cl)cc(-c3ccco3)nc2c1	InChI=1S/C17H11ClF2N4O2S/c18-17(19,20)14-7-11(13-4-1-5-26-13)22-15-8-12(23-24(14)15)16(25)21-9-10-3-2-6-27-10/h1-8H,9H2,(H,21,25)	GBNREAYNZPJROB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_008998	Eltrombopag	C25H22N4O4	5.6551	135449332		Cc1c(C)cc(-n2[nH]c(C)c(N=Nc3cccc(-c4cc(C(=O)O)ccc4)c3O)c2=O)cc1	InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33)	SVOQIEJWJCQGDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_008999	Fabomotizole	C15H21N3O2S	1.8387	9862937		CCOc1cc2c(cc1)nc(SCCN1CCOCC1)[nH]2	InChI=1S/C15H21N3O2S/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17)	WWNUCVSRRUDYPP-UHFFFAOYSA-N					compound annotation
0391_009000	chlorthalidone	C14H11ClN2O4S	2.1433	2732		NS(=O)(=O)c1c(Cl)ccc(C2(O)NC(=O)c3ccccc32)c1	InChI=1S/C14H11ClN2O4S/c15-11-6-5-8(7-12(11)22(16,20)21)14(19)10-4-2-1-3-9(10)13(18)17-14/h1-7,19H,(H,17,18)(H2,16,20,21)	JIVPVXMEBJLZRO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009002	URMC-099	C27H27N5	2.2907	54764565		CN1CCN(Cc2ccc(-c3cc4c(nc3)[nH]cc4-c3cc4c(cc3)[nH]cc4)cc2)CC1	InChI=1S/C27H27N5/c1-31-10-12-32(13-11-31)18-19-2-4-20(5-3-19)23-15-24-25(17-30-27(24)29-16-23)21-6-7-26-22(14-21)8-9-28-26/h2-9,14-17,28H,10-13,18H2,1H3,(H,29,30)	QKKIWEILHCXECO-UHFFFAOYSA-N					compound annotation
0391_009003	CP-673451	C24H27N5O2	2.3224	10158940		COCCOc1cc2c(cc1)n(-c1nc3c(cccc3N3CCC(N)CC3)cc1)cn2	InChI=1S/C24H27N5O2/c1-30-13-14-31-19-6-7-21-20(15-19)26-16-29(21)23-8-5-17-3-2-4-22(24(17)27-23)28-11-9-18(25)10-12-28/h2-8,15-16,18H,9-14,25H2,1H3	DEEOXSOLTLIWMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009005	CP-673451	C24H27N5O2	2.3274	10158940		COCCOc1cc2c(cc1)n(-c1nc3c(cccc3N3CCC(N)CC3)cc1)cn2	InChI=1S/C24H27N5O2/c1-30-13-14-31-19-6-7-21-20(15-19)26-16-29(21)23-8-5-17-3-2-4-22(24(17)27-23)28-11-9-18(25)10-12-28/h2-8,15-16,18H,9-14,25H2,1H3	DEEOXSOLTLIWMG-UHFFFAOYSA-N					doublet; compound annotation
0391_009006	TCMDC-135051	C29H33N3O3	2.8965	139035060		CCN(CC)Cc1cc(-c2cc3c(-c4cc(C(C)C)c(C(=O)O)cc4)ccnc3[nH]2)c(OC)cc1	InChI=1S/C29H33N3O3/c1-6-32(7-2)17-19-8-11-27(35-5)25(14-19)26-16-24-21(12-13-30-28(24)31-26)20-9-10-22(29(33)34)23(15-20)18(3)4/h8-16,18H,6-7,17H2,1-5H3,(H,30,31)(H,33,34)	XKLPRHHLSQBUIC-UHFFFAOYSA-N					compound annotation
0391_009007	CHEMBL1269133	C33H48N6O5	2.9681	49788311	CC[C@H](C)[C@@H](C(=O)NCC1=CC(=CC=C1)C(=O)N2CCC(CC2)CN)NC(=O)[C@H](CC3CCCCC3)NC(=O)C4=CC=NO4	CCC(C)C(NC(=O)C(CC1CCCCC1)NC(=O)c1ccno1)C(=O)NCc1cc(C(=O)N2CCC(CN)CC2)ccc1	InChI=1S/C33H48N6O5/c1-3-22(2)29(38-30(40)27(19-23-8-5-4-6-9-23)37-31(41)28-12-15-36-44-28)32(42)35-21-25-10-7-11-26(18-25)33(43)39-16-13-24(20-34)14-17-39/h7,10-12,15,18,22-24,27,29H,3-6,8-9,13-14,16-17,19-21,34H2,1-2H3,(H,35,42)(H,37,41)(H,38,40)/t22-,27-,29-/m0/s1	HXLQLJFWNKMGET-NVLPUFGLSA-N					doublet; compound annotation
0391_009008	CHEMBL1269133	C33H48N6O5	2.9708	49788311	CC[C@H](C)[C@@H](C(=O)NCC1=CC(=CC=C1)C(=O)N2CCC(CC2)CN)NC(=O)[C@H](CC3CCCCC3)NC(=O)C4=CC=NO4	CCC(C)C(NC(=O)C(CC1CCCCC1)NC(=O)c1ccno1)C(=O)NCc1cc(C(=O)N2CCC(CN)CC2)ccc1	InChI=1S/C33H48N6O5/c1-3-22(2)29(38-30(40)27(19-23-8-5-4-6-9-23)37-31(41)28-12-15-36-44-28)32(42)35-21-25-10-7-11-26(18-25)33(43)39-16-13-24(20-34)14-17-39/h7,10-12,15,18,22-24,27,29H,3-6,8-9,13-14,16-17,19-21,34H2,1-2H3,(H,35,42)(H,37,41)(H,38,40)/t22-,27-,29-/m0/s1	HXLQLJFWNKMGET-NVLPUFGLSA-N					doublet; compound annotation
0391_009009	Tariquidar	C38H38N4O6	3.3076	148201		COc1c(OC)cc2CN(CCc3ccc(NC(=O)c4cc(OC)c(OC)cc4NC(=O)c4cc5ccccc5nc4)cc3)CCc2c1	InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)	LGGHDPFKSSRQNS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009011	PD318088	C16H13BrF3IN2O4	4.2627	10231331		O=C(NOCC(O)CO)c1cc(Br)c(F)c(F)c1Nc1c(F)cc(I)cc1	InChI=1S/C16H13BrF3IN2O4/c17-10-4-9(16(26)23-27-6-8(25)5-24)15(14(20)13(10)19)22-12-2-1-7(21)3-11(12)18/h1-4,8,22,24-25H,5-6H2,(H,23,26)	XXSSGBYXSKOLAM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009013	NSC 405020	C12H15Cl2NO	4.4999	346721		CCCC(C)NC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C12H15Cl2NO/c1-3-4-8(2)15-12(16)9-5-6-10(13)11(14)7-9/h5-8H,3-4H2,1-2H3,(H,15,16)	ARDYECYBETXQFD-UHFFFAOYSA-N					compound annotation
0391_009014	KY-226	C27H31NO3S2	5.9511	76955652		CCCCCCS(=O)(=O)NC(=O)c1ccc(CSCc2ccc(-c3ccccc3)cc2)cc1	InChI=1S/C27H31NO3S2/c1-2-3-4-8-19-33(30,31)28-27(29)26-17-13-23(14-18-26)21-32-20-22-11-15-25(16-12-22)24-9-6-5-7-10-24/h5-7,9-18H,2-4,8,19-21H2,1H3,(H,28,29)	MKXMABKUVSOEJF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009016	Gatifloxacin	C19H22FN3O4	1.8198	5379		COc1c2c(cc(F)c1N1CCNC(C)C1)c(=O)c(C(=O)O)cn2C1CC1	InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)	XUBOMFCQGDBHNK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009018	PHTHALYLSULFACETAMIDE	C16H14N2O6S	2.0846	8574		CC(=O)NS(=O)(=O)c1ccc(NC(=O)c2ccccc2C(=O)O)cc1	InChI=1S/C16H14N2O6S/c1-10(19)18-25(23,24)12-8-6-11(7-9-12)17-15(20)13-4-2-3-5-14(13)16(21)22/h2-9H,1H3,(H,17,20)(H,18,19)(H,21,22)	SNWQKAWITMVCQW-UHFFFAOYSA-N					compound annotation
0391_009019	LY 303511	C19H18N2O2	2.2058	3971		O=c1cc(N2CCNCC2)oc2c1cccc2-c1ccccc1	InChI=1S/C19H18N2O2/c22-17-13-18(21-11-9-20-10-12-21)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13,20H,9-12H2	NGAGMBNBKCDCDJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009021	OT-82	C26H21FN4O	2.856	118203189		O=C(NCCCc1c[nH]nc1)c1ccc(-c2ccncc2)c(C#Cc2ccc(F)cc2)c1	InChI=1S/C26H21FN4O/c27-24-8-4-19(5-9-24)3-6-22-16-23(7-10-25(22)21-11-14-28-15-12-21)26(32)29-13-1-2-20-17-30-31-18-20/h4-5,7-12,14-18H,1-2,13H2,(H,29,32)(H,30,31)	CEPAXRIKSUXHHB-UHFFFAOYSA-N					compound annotation
0391_009022	ELIGLUSTAT	C23H36N2O4	3.0414	23652731	CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O	CCCCCCCC(=O)NC(CN1CCCC1)C(O)c1cc2c(cc1)OCCO2	InChI=1S/C23H36N2O4/c1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20/h10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26)/t19-,23-/m1/s1	FJZZPCZKBUKGGU-AUSIDOKSSA-N					doublet; removed another duplicate entry; compound annotation
0391_009024	GSK-356278	C21H25N7O2S	3.1134	10252640		CCn1ncc2c(NC3CCOCC3)c(-c3nnc(Cc4c(C)nc(C)s4)o3)cnc21	InChI=1S/C21H25N7O2S/c1-4-28-20-15(11-23-28)19(25-14-5-7-29-8-6-14)16(10-22-20)21-27-26-18(30-21)9-17-12(2)24-13(3)31-17/h10-11,14H,4-9H2,1-3H3,(H,22,25)	AWDJJMXJUOHGLC-UHFFFAOYSA-N					compound annotation
0391_009025	Cabozantinib	C28H24FN3O5	3.3031	25102847		COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC	InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)	ONIQOQHATWINJY-UHFFFAOYSA-N					doublet; compound annotation
0391_009026	abacavir	C14H18N6O	1.2355	441300	C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO	Nc1nc(NC2CC2)c2ncn(C3C=CC(CO)C3)c2n1	InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1	MCGSCOLBFJQGHM-SCZZXKLOSA-N					doublet; compound annotation
0391_009027	SCHEMBL14774979	C18H22N2O2	1.3003	54673543		O=c1ccccn1CC1(O)CCN(Cc2ccccc2)CC1	InChI=1S/C18H22N2O2/c21-17-8-4-5-11-20(17)15-18(22)9-12-19(13-10-18)14-16-6-2-1-3-7-16/h1-8,11,22H,9-10,12-15H2	BGMVOROUOUVVRV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009029	Urolithin C	C13H8O5	2.0001	60198001		O=c1oc2c(ccc(O)c2)c2cc(O)c(O)cc12	InChI=1S/C13H8O5/c14-6-1-2-7-8-4-10(15)11(16)5-9(8)13(17)18-12(7)3-6/h1-5,14-16H	HHXMEXZVPJFAIJ-UHFFFAOYSA-N					compound annotation
0391_009030	LY3295668	C24H26ClF2N5O2	2.2952	121333423	C[C@@H]1C[C@](CCN1CC2=C(C(=CC=C2)Cl)F)(CC3=C(C=CC(=N3)NC4=NNC(=C4)C)F)C(=O)O	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(Cc4c(F)c(Cl)ccc4)C(C)C3)c(F)cc2)n[nH]1	InChI=1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1	YQQZZYYQTCPEAS-OYLFLEFRSA-N					compound annotation
0391_009031	Relugolix	C29H27F2N7O5S	2.8448	10348973		CONC(=O)Nc1ccc(-c2c(CN(C)C)c3c(s2)n(Cc2c(F)cccc2F)c(=O)n(-c2nnc(OC)cc2)c3=O)cc1	InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)	AOMXMOCNKJTRQP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009033	AZD7545	C19H18ClF3N2O5S	3.5971	16741245	C[C@@](C(=O)NC1=C(C=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C)Cl)(C(F)(F)F)O	CN(C)C(=O)c1ccc(S(=O)(=O)c2cc(Cl)c(NC(=O)C(C)(O)C(F)(F)F)cc2)cc1	InChI=1S/C19H18ClF3N2O5S/c1-18(28,19(21,22)23)17(27)24-15-9-8-13(10-14(15)20)31(29,30)12-6-4-11(5-7-12)16(26)25(2)3/h4-10,28H,1-3H3,(H,24,27)/t18-/m1/s1	DTDZLJHKVNTQGZ-GOSISDBHSA-N					compound annotation
0391_009034	TAS-114	C21H29N3O6S	3.6537	53630253	C[C@H](C1=CC(=CC=C1)OC2CCCC2)NS(=O)(=O)CCCOCN3C=CC(=O)NC3=O	CC(NS(=O)(=O)CCCOCn1ccc(=O)[nH]c1=O)c1cc(OC2CCCC2)ccc1	InChI=1S/C21H29N3O6S/c1-16(17-6-4-9-19(14-17)30-18-7-2-3-8-18)23-31(27,28)13-5-12-29-15-24-11-10-20(25)22-21(24)26/h4,6,9-11,14,16,18,23H,2-3,5,7-8,12-13,15H2,1H3,(H,22,25,26)/t16-/m1/s1	AMCGLRWKUQPNKD-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_009036	Fenofibric acid	C17H15ClO4	4.316	64929		CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O	InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)	MQOBSOSZFYZQOK-UHFFFAOYSA-N					doublet; compound annotation
0391_009037	Sophoridine	C15H24N2O	0.559	165549	C1C[C@@H]2[C@H]3CCCN4[C@H]3[C@H](CCC4)CN2C(=O)C1	O=C1CCCC2C3CCCN4CCCC(CN12)C34	InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12-,13-,15+/m1/s1	ZSBXGIUJOOQZMP-BHPKHCPMSA-N					doublet; compound annotation
0391_009038	Sophoridine	C15H24N2O	0.5682	165549	C1C[C@@H]2[C@H]3CCCN4[C@H]3[C@H](CCC4)CN2C(=O)C1	O=C1CCCC2C3CCCN4CCCC(CN12)C34	InChI=1S/C15H24N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h11-13,15H,1-10H2/t11-,12-,13-,15+/m1/s1	ZSBXGIUJOOQZMP-BHPKHCPMSA-N					doublet; compound annotation
0391_009039	Phellodendrine	C20H24NO4+	1.4137	3081405	C[N@@+]12CCC3=CC(=C(C=C3[C@@H]1CC4=CC(=C(C=C4C2)OC)O)O)OC	COc1c(O)cc2CC3c4cc(O)c(OC)cc4CC[N+]3(C)Cc2c1	InChI=1S/C20H23NO4/c1-21-5-4-12-8-19(24-2)18(23)10-15(12)16(21)6-13-7-17(22)20(25-3)9-14(13)11-21/h7-10,16H,4-6,11H2,1-3H3,(H-,22,23)/p+1/t16-,21-/m0/s1	RBBVPNQTBKHOEQ-KKSFZXQISA-O					doublet; compound annotation
0391_009040	EMETINE	C29H40N2O4	1.6039	10219	CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC	CCC1CN2CCc3cc(OC)c(OC)cc3C2CC1CC1NCCc2cc(OC)c(OC)cc21	InChI=1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1	AUVVAXYIELKVAI-CKBKHPSWSA-N					removed another duplicate entry; compound annotation
0391_009042	925434-55-5	C25H23N7OS	3.1801	24180125		O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1nc2ccccc2nc1	InChI=1S/C25H23N7OS/c33-24(22-13-27-20-7-3-4-8-21(20)28-22)29-19-6-2-1-5-18(19)23-15-32-17(16-34-25(32)30-23)14-31-11-9-26-10-12-31/h1-8,13,15-16,26H,9-12,14H2,(H,29,33)	IASPBORHOMBZMY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009044	JC-171	C16H17ClN2O5S	3.2601	134600183		COc1c(C(=O)NCCc2ccc(S(=O)(=O)NO)cc2)cc(Cl)cc1	InChI=1S/C16H17ClN2O5S/c1-24-15-7-4-12(17)10-14(15)16(20)18-9-8-11-2-5-13(6-3-11)25(22,23)19-21/h2-7,10,19,21H,8-9H2,1H3,(H,18,20)	KQRQPMUPYDOTCA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009046	Levonorgestrel	C21H28O2	4.0208	13109	CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC	InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	WWYNJERNGUHSAO-XUDSTZEESA-N					doublet; compound annotation
0391_009047	TK216	C19H15Cl2NO3	4.1369	121268274		O=C(CC1(O)C(=O)Nc2c(Cl)ccc(Cl)c21)c1ccc(C2CC2)cc1	InChI=1S/C19H15Cl2NO3/c20-13-7-8-14(21)17-16(13)19(25,18(24)22-17)9-15(23)12-5-3-11(4-6-12)10-1-2-10/h3-8,10,25H,1-2,9H2,(H,22,24)	ZWHNLSHDLKIXOG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009049	3-Methylxanthine	C6H6N4O2	0.4869	70639		Cn1c(=O)[nH]c(=O)c2c1nc[nH]2	InChI=1S/C6H6N4O2/c1-10-4-3(7-2-8-4)5(11)9-6(10)12/h2H,1H3,(H,7,8)(H,9,11,12)	GMSNIKWWOQHZGF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009051	Difloxacin	C21H19F2N3O3	1.8916	40473223		CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(-c4ccc(F)cc4)c3c2)CC1	InChI=1S/C21H19F2N3O3/c1-24-6-8-25(9-7-24)19-11-18-15(10-17(19)23)20(27)16(21(28)29)12-26(18)14-4-2-13(22)3-5-14/h2-5,10-12H,6-9H2,1H3,(H,28,29)	NOCJXYPHIIZEHN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009053	Roluperidone	C22H23FN2O2	2.1888	9799284		O=C(CN1CCC(CN2Cc3ccccc3C2=O)CC1)c1ccc(F)cc1	InChI=1S/C22H23FN2O2/c23-19-7-5-17(6-8-19)21(26)15-24-11-9-16(10-12-24)13-25-14-18-3-1-2-4-20(18)22(25)27/h1-8,16H,9-15H2	RNRYULFRLCBRQS-UHFFFAOYSA-N					compound annotation
0391_009054	Bromisoval	C6H11BrN2O2	2.2612	2447		CC(C)C(Br)C(=O)NC(N)=O	InChI=1S/C6H11BrN2O2/c1-3(2)4(7)5(10)9-6(8)11/h3-4H,1-2H3,(H3,8,9,10,11)	CMCCHHWTTBEZNM-UHFFFAOYSA-N					compound annotation
0391_009055	ETHOPABATE	C12H15NO4	2.4526	6034		CCOc1c(C(=O)OC)ccc(NC(C)=O)c1	InChI=1S/C12H15NO4/c1-4-17-11-7-9(13-8(2)14)5-6-10(11)12(15)16-3/h5-7H,4H2,1-3H3,(H,13,14)	GOVWOKSKFSBNGD-UHFFFAOYSA-N					doublet; compound annotation
0391_009056	ETHOPABATE	C12H15NO4	2.4555	6034		CCOc1c(C(=O)OC)ccc(NC(C)=O)c1	InChI=1S/C12H15NO4/c1-4-17-11-7-9(13-8(2)14)5-6-10(11)12(15)16-3/h5-7H,4H2,1-3H3,(H,13,14)	GOVWOKSKFSBNGD-UHFFFAOYSA-N					doublet; compound annotation
0391_009057	azobenzene	C12H10N2	3.7747	2272		c1ccc(N=Nc2ccccc2)cc1	InChI=1S/C12H10N2/c1-3-7-11(8-4-1)13-14-12-9-5-2-6-10-12/h1-10H	DMLAVOWQYNRWNQ-UHFFFAOYSA-N					compound annotation
0391_009058	meclofenamic acid	C14H11Cl2NO2	4.7258	4037		Cc1c(Cl)c(Nc2ccccc2C(=O)O)c(Cl)cc1	InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)	SBDNJUWAMKYJOX-UHFFFAOYSA-N					compound annotation
0391_009059	Buformin	C6H15N5	0.4897	2468		CCCCN=C(N)N=C(N)N	InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11)	XSEUMFJMFFMCIU-UHFFFAOYSA-N					compound annotation
0391_009060	Reynoutrin	C20H18O11	1.9338	5320861	C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O	O=c1c(OC2OCC(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C20H18O11/c21-8-4-11(24)14-13(5-8)30-18(7-1-2-9(22)10(23)3-7)19(16(14)27)31-20-17(28)15(26)12(25)6-29-20/h1-5,12,15,17,20-26,28H,6H2/t12-,15+,17-,20+/m1/s1	PZZRDJXEMZMZFD-BWYUNELBSA-N					removed another duplicate entry; compound annotation
0391_009062	(S)-crizotinib	C21H22Cl2FN5O	2.1013	56671814	C[C@@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N	CC(Oc1c(N)ncc(-c2cn(C3CCNCC3)nc2)c1)c1c(Cl)ccc(F)c1Cl	InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m0/s1	KTEIFNKAUNYNJU-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_009064	Duvelisib	C22H17ClN6O	2.642	50905713	C[C@@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	CC(Nc1ncnc2c1[nH]cn2)c1cc2c(c(Cl)ccc2)c(=O)n1-c1ccccc1	InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1	SJVQHLPISAIATJ-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_009066	409345-29-5	C20H23NO3	3.2104	11313361		COC1CCC(C(=O)c2cc3cc4c(nc3cc2)OCCC4)CC1	InChI=1S/C20H23NO3/c1-23-17-7-4-13(5-8-17)19(22)14-6-9-18-16(11-14)12-15-3-2-10-24-20(15)21-18/h6,9,11-13,17H,2-5,7-8,10H2,1H3	QOTAQTRFJWLFCR-UHFFFAOYSA-N					doublet; compound annotation
0391_009067	Raltegravir	C20H21FN6O5	3.2447	54671008		Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1	InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)	CZFFBEXEKNGXKS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009069	409345-29-5	C20H23NO3	3.3076	11313361		COC1CCC(C(=O)c2cc3cc4c(nc3cc2)OCCC4)CC1	InChI=1S/C20H23NO3/c1-23-17-7-4-13(5-8-17)19(22)14-6-9-18-16(11-14)12-15-3-2-10-24-20(15)21-18/h6,9,11-13,17H,2-5,7-8,10H2,1H3	QOTAQTRFJWLFCR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009071	Dronedarone	C31H44N2O5S	4.1995	208898		CCCCc1c(C(=O)c2ccc(OCCCN(CCCC)CCCC)cc2)c2c(ccc(NS(C)(=O)=O)c2)o1	InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009072	terbutaline	C12H19NO3	0.6388	5403		CC(C)(C)NCC(O)c1cc(O)cc(O)c1	InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3	XWTYSIMOBUGWOL-UHFFFAOYSA-N					compound annotation
0391_009073	(-)-Epicatechin	C15H14O6	1.4397	72276	C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O	Oc1cc(O)c2CC(O)C(c3cc(O)c(O)cc3)Oc2c1	InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m1/s1	PFTAWBLQPZVEMU-UKRRQHHQSA-N					compound annotation
0391_009074	Rufinamide	C10H8F2N4O	2.0037	129228		NC(=O)c1cn(Cc2c(F)cccc2F)nn1	InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)	POGQSBRIGCQNEG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009076	Tame	C14H22N4O4S	2.0557	1550286	CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CCCN=C(N)N)C(=O)OC	COC(=O)C(CCCN=C(N)N)NS(=O)(=O)c1ccc(C)cc1	InChI=1S/C14H22N4O4S/c1-10-5-7-11(8-6-10)23(20,21)18-12(13(19)22-2)4-3-9-17-14(15)16/h5-8,12,18H,3-4,9H2,1-2H3,(H4,15,16,17)/t12-/m0/s1	FKMJXALNHKIDOD-LBPRGKRZSA-N					doublet; compound annotation
0391_009077	1439399-45-7	C19H19F3N6O2S	3.3109	74982828		Nc1nnc(CCCCc2nnc(NC(=O)Cc3cc(OC(F)(F)F)ccc3)cc2)s1	InChI=1S/C19H19F3N6O2S/c20-19(21,22)30-14-6-3-4-12(10-14)11-16(29)24-15-9-8-13(25-26-15)5-1-2-7-17-27-28-18(23)31-17/h3-4,6,8-10H,1-2,5,7,11H2,(H2,23,28)(H,24,26,29)	SXFQBUKKIKMRPM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009079	Deracoxib	C17H14F3N3O3S	3.8968	3058754		COc1c(F)cc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1	InChI=1S/C17H14F3N3O3S/c1-26-16-7-2-10(8-13(16)18)15-9-14(17(19)20)22-23(15)11-3-5-12(6-4-11)27(21,24)25/h2-9,17H,1H3,(H2,21,24,25)	WAZQAZKAZLXFMK-UHFFFAOYSA-N					compound annotation
0391_009080	Paquinimod	C21H22N2O3	4.091	54684617		CCc1c2c(O)c(C(=O)N(CC)c3ccccc3)c(=O)n(C)c2ccc1	InChI=1S/C21H22N2O3/c1-4-14-10-9-13-16-17(14)19(24)18(20(25)22(16)3)21(26)23(5-2)15-11-7-6-8-12-15/h6-13,24H,4-5H2,1-3H3	DIKSYHCCYVYKRO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009082	fumagillin	C26H34O7	4.5653	6917655	CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)OC)C	COC1C(OC(=O)C=CC=CC=CC=CC(=O)O)CCC2(CO2)C1C1(C)OC1CC=C(C)C	InChI=1S/C26H34O7/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28)/b7-5+,8-6+,11-9+,12-10+/t19-,20-,23-,24-,25+,26+/m1/s1	NGGMYCMLYOUNGM-CSDLUJIJSA-N					doublet; removed another duplicate entry; compound annotation
0391_009084	fumagillin	C26H34O7	4.659	6917655	CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)OC)C	COC1C(OC(=O)C=CC=CC=CC=CC(=O)O)CCC2(CO2)C1C1(C)OC1CC=C(C)C	InChI=1S/C26H34O7/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28)/b7-5+,8-6+,11-9+,12-10+/t19-,20-,23-,24-,25+,26+/m1/s1	NGGMYCMLYOUNGM-CSDLUJIJSA-N					doublet; removed another duplicate entry; compound annotation
0391_009086	Asunaprevir	C35H46ClN5O9S	5.6404	16076883	CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C	C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3c2cc(Cl)cc3)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1	InChI=1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1	XRWSZZJLZRKHHD-WVWIJVSJSA-N					doublet; compound annotation
0391_009087	ZT-1a	C22H15Cl3N2O2	5.6442	10789506		Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1c(O)ccc(Cl)c1	InChI=1S/C22H15Cl3N2O2/c1-12-8-16(18(11-26)13-2-4-14(23)5-3-13)19(25)10-20(12)27-22(29)17-9-15(24)6-7-21(17)28/h2-10,18,28H,1H3,(H,27,29)	RPTKRVXJNWPJLU-UHFFFAOYSA-N					compound annotation
0391_009088	Asunaprevir	C35H46ClN5O9S	5.6442	16076883	CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C	C=CC1CC1(NC(=O)C1CC(Oc2ncc(OC)c3c2cc(Cl)cc3)CN1C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1	InChI=1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1	XRWSZZJLZRKHHD-WVWIJVSJSA-N					doublet; compound annotation
0391_009089	DL-Tryptophan	C11H12N2O2	0.9689	4099458		NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)	QIVBCDIJIAJPQS-UHFFFAOYSA-N					doublet; compound annotation
0391_009090	DL-Tryptophan	C11H12N2O2	1.9699	4099458		NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)	QIVBCDIJIAJPQS-UHFFFAOYSA-N					doublet; compound annotation
0391_009091	N-Acetyl-L-tryptophan	C13H14N2O3	1.9699	700653	CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O	CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C13H14N2O3/c1-8(16)15-12(13(17)18)6-9-7-14-11-5-3-2-4-10(9)11/h2-5,7,12,14H,6H2,1H3,(H,15,16)(H,17,18)/t12-/m0/s1	DZTHIGRZJZPRDV-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_009093	prazosin	C19H21N5O4	1.9909	4893		COc1c(OC)cc2c(N)nc(N3CCN(C(=O)c4ccco4)CC3)nc2c1	InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)	IENZQIKPVFGBNW-UHFFFAOYSA-N					doublet; compound annotation
0391_009094	prazosin	C19H21N5O4	1.9939	4893		COc1c(OC)cc2c(N)nc(N3CCN(C(=O)c4ccco4)CC3)nc2c1	InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)	IENZQIKPVFGBNW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009096	nadifloxacin	C19H21FN2O4	2.8466	4410		CC1CCc2c3c(cc(F)c2N2CCC(O)CC2)c(=O)c(C(=O)O)cn31	InChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)	JYJTVFIEFKZWCJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009098	METHYL 4-METHOXYBENZOATE	C9H10O3	4.2812	8499		COC(=O)c1ccc(OC)cc1	InChI=1S/C9H10O3/c1-11-8-5-3-7(4-6-8)9(10)12-2/h3-6H,1-2H3	DDIZAANNODHTRB-UHFFFAOYSA-N					compound annotation
0391_009099	A 1120	C20H19F3N2O3	4.605	25138295		O=C(O)c1ccccc1NC(=O)N1CCC(c2ccccc2C(F)(F)F)CC1	InChI=1S/C20H19F3N2O3/c21-20(22,23)16-7-3-1-5-14(16)13-9-11-25(12-10-13)19(28)24-17-8-4-2-6-15(17)18(26)27/h1-8,13H,9-12H2,(H,24,28)(H,26,27)	MEAQCLPMSVEOQF-UHFFFAOYSA-N					compound annotation
0391_009100	SMN-C3	C24H28N6O	1.8313	89741632		CCN1CCC(c2cn3c(=O)cc(-c4nn5cc(C)nc(C)c5c4)nc3c(C)c2)CC1	InChI=1S/C24H28N6O/c1-5-28-8-6-18(7-9-28)19-10-15(2)24-26-20(12-23(31)29(24)14-19)21-11-22-17(4)25-16(3)13-30(22)27-21/h10-14,18H,5-9H2,1-4H3	ZACWYYKZMLGOTG-UHFFFAOYSA-N					doublet; compound annotation
0391_009101	TG100-115	C18H14N6O2	1.9163	10427712		Nc1nc(N)c2nc(-c3cc(O)ccc3)c(-c3cc(O)ccc3)nc2n1	InChI=1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24)	UJIAQDJKSXQLIT-UHFFFAOYSA-N					doublet; compound annotation
0391_009102	TG100-115	C18H14N6O2	1.9191	10427712		Nc1nc(N)c2nc(-c3cc(O)ccc3)c(-c3cc(O)ccc3)nc2n1	InChI=1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24)	UJIAQDJKSXQLIT-UHFFFAOYSA-N					doublet; compound annotation
0391_009103	SMN-C3	C24H28N6O	2.03	89741632		CCN1CCC(c2cn3c(=O)cc(-c4nn5cc(C)nc(C)c5c4)nc3c(C)c2)CC1	InChI=1S/C24H28N6O/c1-5-28-8-6-18(7-9-28)19-10-15(2)24-26-20(12-23(31)29(24)14-19)21-11-22-17(4)25-16(3)13-30(22)27-21/h10-14,18H,5-9H2,1-4H3	ZACWYYKZMLGOTG-UHFFFAOYSA-N					doublet; compound annotation
0391_009104	SMN-C3	C24H28N6O	2.2775	89741632		CCN1CCC(c2cn3c(=O)cc(-c4nn5cc(C)nc(C)c5c4)nc3c(C)c2)CC1	InChI=1S/C24H28N6O/c1-5-28-8-6-18(7-9-28)19-10-15(2)24-26-20(12-23(31)29(24)14-19)21-11-22-17(4)25-16(3)13-30(22)27-21/h10-14,18H,5-9H2,1-4H3	ZACWYYKZMLGOTG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009106	294646-77-8	C24H29N7O	2.343	10224714	CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=C(C=C3)C4=CC=CC=N4	CCC(CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1	InChI=1S/C24H29N7O/c1-4-19(14-32)28-24-29-22(21-23(30-24)31(15-27-21)16(2)3)26-13-17-8-10-18(11-9-17)20-7-5-6-12-25-20/h5-12,15-16,19,32H,4,13-14H2,1-3H3,(H2,26,28,29,30)/t19-/m1/s1	HOCBJBNQIQQQGT-LJQANCHMSA-N					removed another duplicate entry; compound annotation
0391_009109	IC-87114	C22H19N7O	2.6765	9908783		Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O	InChI=1S/C22H19N7O/c1-13-6-3-4-9-16(13)29-17(27-15-8-5-7-14(2)18(15)22(29)30)10-28-12-26-19-20(23)24-11-25-21(19)28/h3-9,11-12H,10H2,1-2H3,(H2,23,24,25)	GNWHRHGTIBRNSM-UHFFFAOYSA-N					doublet; compound annotation
0391_009110	IC-87114	C22H19N7O	2.8018	9908783		Cc1ccccc1-n1c(Cn2cnc3c(N)ncnc32)nc2cccc(C)c2c1=O	InChI=1S/C22H19N7O/c1-13-6-3-4-9-16(13)29-17(27-15-8-5-7-14(2)18(15)22(29)30)10-28-12-26-19-20(23)24-11-25-21(19)28/h3-9,11-12H,10H2,1-2H3,(H2,23,24,25)	GNWHRHGTIBRNSM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009112	Solifenacin	C23H26N2O2	3.1718	154059	C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5	O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1	InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1	FBOUYBDGKBSUES-VXKWHMMOSA-N					doublet; compound annotation
0391_009113	MK-8617	C24H21N5O4	3.4813	44230662		COc1ccc(C(NC(=O)c2cnc(-c3nnccc3)[nH]c2=O)c2ccc(OC)cc2)cc1	InChI=1S/C24H21N5O4/c1-32-17-9-5-15(6-10-17)21(16-7-11-18(33-2)12-8-16)27-23(30)19-14-25-22(28-24(19)31)20-4-3-13-26-29-20/h3-14,21H,1-2H3,(H,27,30)(H,25,28,31)	WXLPERVDMILVIF-UHFFFAOYSA-N					compound annotation
0391_009114	152273-12-6	C17H21N3O2	3.6215	197626		CC(C)(C)OC(=O)c1c2n(cn1)-c1ccccc1NC2(C)C	InChI=1S/C17H21N3O2/c1-16(2,3)22-15(21)13-14-17(4,5)19-11-8-6-7-9-12(11)20(14)10-18-13/h6-10,19H,1-5H3	NXBSEJKZKXIYMD-UHFFFAOYSA-N					doublet; compound annotation
0391_009115	152273-12-6	C17H21N3O2	3.6248	197626		CC(C)(C)OC(=O)c1c2n(cn1)-c1ccccc1NC2(C)C	InChI=1S/C17H21N3O2/c1-16(2,3)22-15(21)13-14-17(4,5)19-11-8-6-7-9-12(11)20(14)10-18-13/h6-10,19H,1-5H3	NXBSEJKZKXIYMD-UHFFFAOYSA-N					doublet; compound annotation
0391_009116	Tivantinib	C23H19N3O2	3.92	11494412	C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65	O=C1NC(=O)C(c2cn3CCCc4cccc2c43)C1c1c[nH]c2ccccc12	InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1	UCEQXRCJXIVODC-PMACEKPBSA-N					removed another duplicate entry; compound annotation
0391_009119	Telacebec	C29H28ClF3N4O2	4.5364	68234908		CCc1c(C(=O)NCc2ccc(N3CCC(c4ccc(OC(F)(F)F)cc4)CC3)cc2)n2cc(Cl)ccc2n1	InChI=1S/C29H28ClF3N4O2/c1-2-25-27(37-18-22(30)7-12-26(37)35-25)28(38)34-17-19-3-8-23(9-4-19)36-15-13-21(14-16-36)20-5-10-24(11-6-20)39-29(31,32)33/h3-12,18,21H,2,13-17H2,1H3,(H,34,38)	OJICYBSWSZGRFB-UHFFFAOYSA-N					compound annotation
0391_009120	3',4'-Dihydroxyacetophenone	C8H8O3	1.2992	14530		CC(=O)c1cc(O)c(O)cc1	InChI=1S/C8H8O3/c1-5(9)6-2-3-7(10)8(11)4-6/h2-4,10-11H,1H3	UCQUAMAQHHEXGD-UHFFFAOYSA-N					compound annotation
0391_009121	3,5-Dimethoxyphenol	C8H10O3	2.2072	10383		COc1cc(OC)cc(O)c1	InChI=1S/C8H10O3/c1-10-7-3-6(9)4-8(5-7)11-2/h3-5,9H,1-2H3	XQDNFAMOIPNVES-UHFFFAOYSA-N					compound annotation
0391_009122	1-Methylxanthine	C6H6N4O2	0.5029	80220		Cn1c(=O)[nH]c2c([nH]cn2)c1=O	InChI=1S/C6H6N4O2/c1-10-5(11)3-4(8-2-7-3)9-6(10)12/h2H,1H3,(H,7,8)(H,9,12)	MVOYJPOZRLFTCP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009124	5-Methoxyindole-3-acetic acid	C11H11NO3	2.1356	18986		COc1cc2c(cc1)[nH]cc2CC(=O)O	InChI=1S/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)	COCNDHOPIHDTHK-UHFFFAOYSA-N					doublet; compound annotation
0391_009125	5-Methoxyindole-3-acetic acid	C11H11NO3	2.1394	18986		COc1cc2c(cc1)[nH]cc2CC(=O)O	InChI=1S/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)	COCNDHOPIHDTHK-UHFFFAOYSA-N					doublet; compound annotation
0391_009126	AMG-511	C22H28FN9O3S	2.6144	56947516	CC1=NC(=NC(=N1)N)C2=C(N=CC(=C2)[C@@H](C)N3CCN(CC3)S(=O)(=O)C)NC4=CC(=C(N=C4)OC)F	COc1c(F)cc(Nc2ncc(C(C)N3CCN(S(C)(=O)=O)CC3)cc2-c2nc(N)nc(C)n2)cn1	InChI=1S/C22H28FN9O3S/c1-13(31-5-7-32(8-6-31)36(4,33)34)15-9-17(20-27-14(2)28-22(24)30-20)19(25-11-15)29-16-10-18(23)21(35-3)26-12-16/h9-13H,5-8H2,1-4H3,(H,25,29)(H2,24,27,28,30)/t13-/m1/s1	KUGIFHQBIIHRIZ-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_009129	Telmisartan	C33H30N4O2	3.1815	65999		CCCc1nc2c(cc(-c3nc4ccccc4n3C)cc2C)n1Cc1ccc(-c2ccccc2C(=O)O)cc1	InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)	RMMXLENWKUUMAY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009131	oxybutynin	C22H31NO3	3.3722	4634		CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3	XIQVNETUBQGFHX-UHFFFAOYSA-N					doublet; compound annotation
0391_009132	methazolamide	C5H8N4O3S2	1.3889	4100		CC(=O)N=c1sc(S(N)(=O)=O)nn1C	InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)	FLOSMHQXBMRNHR-UHFFFAOYSA-N					compound annotation
0391_009133	NITROXOLINE	C9H6N2O3	2.4829	19910		O=[N+]([O-])c1c2cccnc2c(O)cc1	InChI=1S/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12H	RJIWZDNTCBHXAL-UHFFFAOYSA-N					compound annotation
0391_009134	BMS-794833	C23H15ClF2N4O3	3.1831	44155856		Nc1nccc(Oc2c(F)cc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2)c1Cl	InChI=1S/C23H15ClF2N4O3/c24-20-19(7-8-29-22(20)27)33-18-6-5-14(9-17(18)26)30-23(32)16-11-28-10-15(21(16)31)12-1-3-13(25)4-2-12/h1-11H,(H2,27,29)(H,28,31)(H,30,32)	PDYXPCKITKHFOZ-UHFFFAOYSA-N					compound annotation
0391_009135	AR-A014418	C12H12N4O4S	3.5114	448014		COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1	InChI=1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17)	YAEMHJKFIIIULI-UHFFFAOYSA-N					compound annotation
0391_009136	317318-70-0	C21H18F3NO3S2	5.3363	9803963		Cc1c(OCC(=O)O)ccc(SCc2c(C)nc(-c3ccc(C(F)(F)F)cc3)s2)c1	InChI=1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27)	YDBLKRPLXZNVNB-UHFFFAOYSA-N					compound annotation
0391_009137	Broxaldine	C17H11Br2NO2	5.7988	77262		Cc1nc2c(cc1)c(Br)cc(Br)c2OC(=O)c1ccccc1	InChI=1S/C17H11Br2NO2/c1-10-7-8-12-13(18)9-14(19)16(15(12)20-10)22-17(21)11-5-3-2-4-6-11/h2-9H,1H3	IJTPLVAAROHGGB-UHFFFAOYSA-N					compound annotation
0391_009138	4931-66-2	C6H9NO3	0.5773	78646	COC(=O)[C@@H]1CCC(=O)N1	COC(=O)C1CCC(=O)N1	InChI=1S/C6H9NO3/c1-10-6(9)4-2-3-5(8)7-4/h4H,2-3H2,1H3,(H,7,8)/t4-/m0/s1	HQGPKMSGXAUKHT-BYPYZUCNSA-N					compound annotation
0391_009139	enalapril	C20H28N2O5	2.544	40466924	CCOC(=O)[C@H](CCC1=CC=CC=C1)[NH2+][C@@H](C)C(=O)N2CCC[C@H]2C(=O)[O-]	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1CCCC1C(=O)O	InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1	GBXSMTUPTTWBMN-XIRDDKMYSA-N					compound annotation
0391_009140	1418741-86-2	C28H42N4O2	0.5807	70679311		O=C(c1ccc(C(=O)N2CCC(N3CCCCC3)CC2)cc1)N1CCC(N2CCCCC2)CC1	InChI=1S/C28H42N4O2/c33-27(31-19-11-25(12-20-31)29-15-3-1-4-16-29)23-7-9-24(10-8-23)28(34)32-21-13-26(14-22-32)30-17-5-2-6-18-30/h7-10,25-26H,1-6,11-22H2	HOUMUCTZMMLNTR-UHFFFAOYSA-N					compound annotation
0391_009141	(-)-Syringaresnol-4-O-|A-D-apiofuranosyl-(1 inverted exclamation marku2)-|A-D-glucopyranoside	C33H44O17	2.0574	101604422	COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3CO[C@H]([C@@H]3CO2)C4=CC(=C(C(=C4)OC)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@](CO6)(CO)O)O)OC	COc1cc(C2OCC3C(c4cc(OC)c(OC5OC(CO)C(O)C(O)C5OC5OCC(O)(CO)C5O)c(OC)c4)OCC23)cc(OC)c1O	InChI=1S/C33H44O17/c1-41-18-5-14(6-19(42-2)23(18)36)26-16-10-46-27(17(16)11-45-26)15-7-20(43-3)28(21(8-15)44-4)49-31-29(25(38)24(37)22(9-34)48-31)50-32-30(39)33(40,12-35)13-47-32/h5-8,16-17,22,24-27,29-32,34-40H,9-13H2,1-4H3/t16-,17-,22-,24-,25+,26+,27+,29-,30+,31+,32+,33-/m1/s1	BUBVKRMIMSPLND-XSTKEGOHSA-N					compound annotation
0391_009142	Bisdemethoxycurcumin	C19H16O4	2.942	5315472	C1=CC(=CC=C1/C=C/C(=O)CC(=O)/C=C/C2=CC=C(C=C2)O)O	O=C(C=Cc1ccc(O)cc1)CC(=O)C=Cc1ccc(O)cc1	InChI=1S/C19H16O4/c20-16-7-1-14(2-8-16)5-11-18(22)13-19(23)12-6-15-3-9-17(21)10-4-15/h1-12,20-21H,13H2/b11-5+,12-6+	PREBVFJICNPEKM-YDWXAUTNSA-N					doublet; removed another duplicate entry; compound annotation
0391_009144	Bisdemethoxycurcumin	C19H16O4	3.8544	5315472	C1=CC(=CC=C1/C=C/C(=O)CC(=O)/C=C/C2=CC=C(C=C2)O)O	O=C(C=Cc1ccc(O)cc1)CC(=O)C=Cc1ccc(O)cc1	InChI=1S/C19H16O4/c20-16-7-1-14(2-8-16)5-11-18(22)13-19(23)12-6-15-3-9-17(21)10-4-15/h1-12,20-21H,13H2/b11-5+,12-6+	PREBVFJICNPEKM-YDWXAUTNSA-N					doublet; compound annotation
0391_009145	CUDA	C19H36N2O3	4.2626	22978774		O=C(O)CCCCCCCCCCCNC(=O)NC1CCCCC1	InChI=1S/C19H36N2O3/c22-18(23)15-11-6-4-2-1-3-5-7-12-16-20-19(24)21-17-13-9-8-10-14-17/h17H,1-16H2,(H,22,23)(H2,20,21,24)	HPTJABJPZMULFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009147	Auraptene	C19H22O3	5.6138	1550607	CC(=CCC/C(=C/COC1=CC2=C(C=C1)C=CC(=O)O2)/C)C	CC(C)=CCCC(C)=CCOc1cc2c(cc1)ccc(=O)o2	InChI=1S/C19H22O3/c1-14(2)5-4-6-15(3)11-12-21-17-9-7-16-8-10-19(20)22-18(16)13-17/h5,7-11,13H,4,6,12H2,1-3H3/b15-11+	RSDDHGSKLOSQFK-RVDMUPIBSA-N					compound annotation
0391_009148	Pristimerin	C30H40O4	6.5887	159516	CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)OC)C)C)C)C)O	COC(=O)C1(C)CCC2(C)CCC3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)C4(C)CCC3(C)C2C1	InChI=1S/C30H40O4/c1-18-19-8-9-22-28(4,20(19)16-21(31)24(18)32)13-15-30(6)23-17-27(3,25(33)34-7)11-10-26(23,2)12-14-29(22,30)5/h8-9,16,23,32H,10-15,17H2,1-7H3/t23-,26-,27-,28+,29-,30+/m1/s1	JFACETXYABVHFD-WXPPGMDDSA-N					compound annotation
0391_009149	HYDROXYFASUDIL	C14H17N3O3S	1.1561	3064778		O=c1[nH]ccc2c1cccc2S(=O)(=O)N1CCCNCC1	InChI=1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18)	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009150	Fostamatinib	C23H26FN6O9P	2.4576	11671467		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4COP(=O)(O)O)n2)cc(OC)c1OC	InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)	GKDRMWXFWHEQQT-UHFFFAOYSA-N					doublet; compound annotation
0391_009151	Kaempferol 7-O-rhamnoside	C21H20O10	2.5997	25079965	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=CC(=C3C(=C2)OC(=C(C3=O)O)C4=CC=C(C=C4)O)O)O)O)O	CC1OC(Oc2cc(O)c3c(=O)c(O)c(-c4ccc(O)cc4)oc3c2)C(O)C(O)C1O	InChI=1S/C21H20O10/c1-8-15(24)17(26)19(28)21(29-8)30-11-6-12(23)14-13(7-11)31-20(18(27)16(14)25)9-2-4-10(22)5-3-9/h2-8,15,17,19,21-24,26-28H,1H3/t8-,15-,17+,19+,21-/m0/s1	HQNOUCSPWAGQND-GKLNBGJFSA-N					compound annotation
0391_009152	Dihydroergocristine	C35H41N5O5	3.0057	107715	CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C	CC(C)C1(NC(=O)C2CC3c4c5c(c[nH]c5ccc4)CC3N(C)C2)OC2(O)C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O	InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)/t23-,25-,27-,28+,29+,34-,35+/m1/s1	DEQITUUQPICUMR-HJPBWRTMSA-N					removed another duplicate entry; compound annotation
0391_009154	Ro64-6198	C26H31N3O	3.2368	9844019	C1C[C@H]2CC[C@@H](C3=CC=CC(=C23)C1)N4CCC5(CC4)C(=O)NCN5C6=CC=CC=C6	O=C1NCN(c2ccccc2)C12CCN(C1CCC3CCCc4cccc1c43)CC2	InChI=1S/C26H31N3O/c30-25-26(29(18-27-25)21-9-2-1-3-10-21)14-16-28(17-15-26)23-13-12-20-7-4-6-19-8-5-11-22(23)24(19)20/h1-3,5,8-11,20,23H,4,6-7,12-18H2,(H,27,30)/t20-,23-/m0/s1	JLFMYEAXZNPWBK-REWPJTCUSA-N					compound annotation
0391_009155	Elubrixin	C17H17Cl2FN4O4S	3.2647	10479502		O=C(Nc1c(O)c(S(=O)(=O)N2CCNCC2)c(Cl)cc1)Nc1c(Cl)c(F)ccc1	InChI=1S/C17H17Cl2FN4O4S/c18-10-4-5-13(23-17(26)22-12-3-1-2-11(20)14(12)19)15(25)16(10)29(27,28)24-8-6-21-7-9-24/h1-5,21,25H,6-9H2,(H2,22,23,26)	YQYFEGTYCUQBEI-UHFFFAOYSA-N					compound annotation
0391_009156	cloxacillin	C19H18ClN3O5S	3.5057	6098	CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Cc1c(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c(-c2ccccc2Cl)no1	InChI=1S/C19H18ClN3O5S/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27)/t13-,14+,17-/m1/s1	LQOLIRLGBULYKD-JKIFEVAISA-N					compound annotation
0391_009157	PROPICONAZOLE	C15H17Cl2N3O2	4.0968	43234		CCCC1COC(Cn2cncn2)(c2c(Cl)cc(Cl)cc2)O1	InChI=1S/C15H17Cl2N3O2/c1-2-3-12-7-21-15(22-12,8-20-10-18-9-19-20)13-5-4-11(16)6-14(13)17/h4-6,9-10,12H,2-3,7-8H2,1H3	STJLVHWMYQXCPB-UHFFFAOYSA-N					doublet; compound annotation
0391_009158	PROPICONAZOLE	C15H17Cl2N3O2	4.1706	43234		CCCC1COC(Cn2cncn2)(c2c(Cl)cc(Cl)cc2)O1	InChI=1S/C15H17Cl2N3O2/c1-2-3-12-7-21-15(22-12,8-20-10-18-9-19-20)13-5-4-11(16)6-14(13)17/h4-6,9-10,12H,2-3,7-8H2,1H3	STJLVHWMYQXCPB-UHFFFAOYSA-N					doublet; compound annotation
0391_009159	PROPICONAZOLE	C15H17Cl2N3O2	4.5378	43234		CCCC1COC(Cn2cncn2)(c2c(Cl)cc(Cl)cc2)O1	InChI=1S/C15H17Cl2N3O2/c1-2-3-12-7-21-15(22-12,8-20-10-18-9-19-20)13-5-4-11(16)6-14(13)17/h4-6,9-10,12H,2-3,7-8H2,1H3	STJLVHWMYQXCPB-UHFFFAOYSA-N					doublet; compound annotation
0391_009160	22246-18-0	C9H9NO2	1.4854	2785758		O=C1CCc2c(cc(O)cc2)N1	InChI=1S/C9H9NO2/c11-7-3-1-6-2-4-9(12)10-8(6)5-7/h1,3,5,11H,2,4H2,(H,10,12)	LKLSFDWYIBUGNT-UHFFFAOYSA-N					compound annotation
0391_009161	Corynoxine B	C22H28N2O4	2.3515	10091424	CC[C@@H]1CN2CC[C@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22-/m1/s1	DAXYUDFNWXHGBE-XYEDMTIPSA-N					doublet; compound annotation
0391_009162	Corynoxine B	C22H28N2O4	2.3542	10091424	CC[C@@H]1CN2CC[C@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22-/m1/s1	DAXYUDFNWXHGBE-XYEDMTIPSA-N					doublet; compound annotation
0391_009163	Corynoxine B	C22H28N2O4	2.527	10091424	CC[C@@H]1CN2CC[C@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15+,19+,22-/m1/s1	DAXYUDFNWXHGBE-XYEDMTIPSA-N					doublet; compound annotation
0391_009164	Arteannuin B	C15H20O3	3.7798	6543478	C[C@@H]1CC[C@H]2C(=C)C(=O)O[C@]23[C@H]1CC[C@@]4([C@H]3O4)C	C=C1C(=O)OC23C1CCC(C)C2CCC1(C)OC13	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)12(16)17-15(11)10(8)6-7-14(3)13(15)18-14/h8,10-11,13H,2,4-7H2,1,3H3/t8-,10+,11+,13-,14-,15-/m1/s1	QWQSMEDUZQDVLA-KPHNHPKPSA-N					doublet; removed another duplicate entry; compound annotation
0391_009166	Mulberrin	C25H26O6	4.3965	5481958		CC(C)=CCc1c(-c2c(O)cc(O)cc2)oc2c(CC=C(C)C)c(O)cc(O)c2c1=O	InChI=1S/C25H26O6/c1-13(2)5-8-17-20(28)12-21(29)22-23(30)18(9-6-14(3)4)24(31-25(17)22)16-10-7-15(26)11-19(16)27/h5-7,10-12,26-29H,8-9H2,1-4H3	UWQYBLOHTQWSQD-UHFFFAOYSA-N					compound annotation
0391_009167	CPTH2	C14H14ClN3S	4.9872	25193530		Clc1ccc(-c2csc(NN=C3CCCC3)n2)cc1	InChI=1S/C14H14ClN3S/c15-11-7-5-10(6-8-11)13-9-19-14(16-13)18-17-12-3-1-2-4-12/h5-9H,1-4H2,(H,16,18)	YYTHPXHGWSAKIZ-UHFFFAOYSA-N					compound annotation
0391_009168	Arteannuin B	C15H20O3	6.9557	6543478	C[C@@H]1CC[C@H]2C(=C)C(=O)O[C@]23[C@H]1CC[C@@]4([C@H]3O4)C	C=C1C(=O)OC23C1CCC(C)C2CCC1(C)OC13	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)12(16)17-15(11)10(8)6-7-14(3)13(15)18-14/h8,10-11,13H,2,4-7H2,1,3H3/t8-,10+,11+,13-,14-,15-/m1/s1	QWQSMEDUZQDVLA-KPHNHPKPSA-N					doublet; compound annotation
0391_009169	Arteannuin B	C15H20O3	7.0471	6543478	C[C@@H]1CC[C@H]2C(=C)C(=O)O[C@]23[C@H]1CC[C@@]4([C@H]3O4)C	C=C1C(=O)OC23C1CCC(C)C2CCC1(C)OC13	InChI=1S/C15H20O3/c1-8-4-5-11-9(2)12(16)17-15(11)10(8)6-7-14(3)13(15)18-14/h8,10-11,13H,2,4-7H2,1,3H3/t8-,10+,11+,13-,14-,15-/m1/s1	QWQSMEDUZQDVLA-KPHNHPKPSA-N					doublet; compound annotation
0391_009170	Phe-ala	C12H16N2O3	0.7074	5488196	C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N	CC(NC(=O)C(N)Cc1ccccc1)C(=O)O	InChI=1S/C12H16N2O3/c1-8(12(16)17)14-11(15)10(13)7-9-5-3-2-4-6-9/h2-6,8,10H,7,13H2,1H3,(H,14,15)(H,16,17)/t8-,10-/m0/s1	MIDZLCFIAINOQN-WPRPVWTQSA-N					compound annotation
0391_009171	N-Isovaleroylglycine	C7H13NO3	1.0902	546304		CC(C)CC(=O)NCC(=O)O	InChI=1S/C7H13NO3/c1-5(2)3-6(9)8-4-7(10)11/h5H,3-4H2,1-2H3,(H,8,9)(H,10,11)	ZRQXMKMBBMNNQC-UHFFFAOYSA-N					compound annotation
0391_009172	irinotecan	C33H38N4O6	2.3174	60838	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7	CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2c1cc(OC(=O)N1CCC(N3CCCCC3)CC1)cc2	InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1	UWKQSNNFCGGAFS-XIFFEERXSA-N					doublet; compound annotation
0391_009173	TETRADECANEDIOIC ACID	C14H26O4	4.0014	13185		O=C(O)CCCCCCCCCCCCC(=O)O	InChI=1S/C14H26O4/c15-13(16)11-9-7-5-3-1-2-4-6-8-10-12-14(17)18/h1-12H2,(H,15,16)(H,17,18)	HQHCYKULIHKCEB-UHFFFAOYSA-N					compound annotation
0391_009174	PF-03463275	C19H22ClFN4O	1.8571	44156901	CN1C[C@@H]2[C@H](C1)C2CN(CC3=CC(=C(C=C3)F)Cl)C(=O)C4=CN(C=N4)C	CN1CC2C(C1)C2CN(Cc1cc(Cl)c(F)cc1)C(=O)c1cn(C)cn1	InChI=1S/C19H22ClFN4O/c1-23-7-13-14(8-23)15(13)9-25(19(26)18-10-24(2)11-22-18)6-12-3-4-17(21)16(20)5-12/h3-5,10-11,13-15H,6-9H2,1-2H3/t13-,14+,15?	KYLOBHXXQOZRKK-YIONKMFJSA-N					removed another duplicate entry; compound annotation
0391_009176	1912-33-0	C11H11NO2	3.095	74706		COC(=O)Cc1c[nH]c2ccccc12	InChI=1S/C11H11NO2/c1-14-11(13)6-8-7-12-10-5-3-2-4-9(8)10/h2-5,7,12H,6H2,1H3	KTHADMDGDNYQRX-UHFFFAOYSA-N					compound annotation
0391_009177	Benzylideneacetone	C10H10O	3.11	637759	CC(=O)/C=C/C1=CC=CC=C1	CC(=O)C=Cc1ccccc1	InChI=1S/C10H10O/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8H,1H3/b8-7+	BWHOZHOGCMHOBV-BQYQJAHWSA-N					doublet; compound annotation
0391_009178	BCH001	C20H15F3N2O5	3.5266	1043578		CCOC(=O)c1cnc2ccc(OC(F)(F)F)cc2c1Nc1ccccc1C(=O)O	InChI=1S/C20H15F3N2O5/c1-2-29-19(28)14-10-24-15-8-7-11(30-20(21,22)23)9-13(15)17(14)25-16-6-4-3-5-12(16)18(26)27/h3-10H,2H2,1H3,(H,24,25)(H,26,27)	FWJMVZAVAUGMDX-UHFFFAOYSA-N					compound annotation
0391_009179	1477-57-2	C12H20Cl4N2O2	3.7348	15134		O=C(NCCCCCCCCNC(=O)C(Cl)Cl)C(Cl)Cl	InChI=1S/C12H20Cl4N2O2/c13-9(14)11(19)17-7-5-3-1-2-4-6-8-18-12(20)10(15)16/h9-10H,1-8H2,(H,17,19)(H,18,20)	FAOMZVDZARKPFJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009181	protriptyline	C19H21N	3.0438	4976		CNCCCC1c2ccccc2C=Cc2ccccc21	InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3	BWPIARFWQZKAIA-UHFFFAOYSA-N					compound annotation
0391_009182	Orelabrutinib	C26H25N3O3	3.3973	91667513		C=CC(=O)N1CCC(c2nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)cc2)CC1	InChI=1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31)	MZPVEMOYADUARK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009184	pimozide	C28H29F2N3O	3.5486	16362		O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)	YVUQSNJEYSNKRX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009186	Gimatecan	C25H25N3O5	4.0739	9577124	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)/C=N/OC(C)(C)C)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4c(C=NOC(C)(C)C)c3Cn1c2=O	InChI=1S/C25H25N3O5/c1-5-25(31)18-10-20-21-16(12-28(20)22(29)17(18)13-32-23(25)30)15(11-26-33-24(2,3)4)14-8-6-7-9-19(14)27-21/h6-11,31H,5,12-13H2,1-4H3/b26-11+/t25-/m0/s1	UIVFUQKYVFCEKJ-OPTOVBNMSA-N					doublet; compound annotation
0391_009187	SPL-410	C24H31F3N2O4S	4.1772	138911346	CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)N(C[C@@H]([C@H](C2=CC=C(C=C2)OC(F)(F)F)N)O)C3CCC3	CC(C)(C)c1ccc(S(=O)(=O)N(CC(O)C(N)c2ccc(OC(F)(F)F)cc2)C2CCC2)cc1	InChI=1S/C24H31F3N2O4S/c1-23(2,3)17-9-13-20(14-10-17)34(31,32)29(18-5-4-6-18)15-21(30)22(28)16-7-11-19(12-8-16)33-24(25,26)27/h7-14,18,21-22,30H,4-6,15,28H2,1-3H3/t21-,22-/m0/s1	KEEHEUGOPCFXAV-VXKWHMMOSA-N					compound annotation
0391_009188	Gimatecan	C25H25N3O5	4.3394	9577124	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)/C=N/OC(C)(C)C)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4c(C=NOC(C)(C)C)c3Cn1c2=O	InChI=1S/C25H25N3O5/c1-5-25(31)18-10-20-21-16(12-28(20)22(29)17(18)13-32-23(25)30)15(11-26-33-24(2,3)4)14-8-6-7-9-19(14)27-21/h6-11,31H,5,12-13H2,1-4H3/b26-11+/t25-/m0/s1	UIVFUQKYVFCEKJ-OPTOVBNMSA-N					doublet; compound annotation
0391_009189	MD-224	C48H43Cl2FN6O6	4.5863	131986956	C1CCC2(CC1)[C@@]3([C@H]([C@@H](N2)C(=O)NC4=CC=C(C=C4)C(=O)NCCCC#CC5=C6CN(C(=O)C6=CC=C5)C7CCC(=O)NC7=O)C8=C(C(=CC=C8)Cl)F)C9=C(C=C(C=C9)Cl)NC3=O	O=C1CCC(N2Cc3c(C#CCCCNC(=O)c4ccc(NC(=O)C5NC6(CCCCC6)C6(C(=O)Nc7cc(Cl)ccc76)C5c5c(F)c(Cl)ccc5)cc4)cccc3C2=O)C(=O)N1	InChI=1S/C48H43Cl2FN6O6/c49-29-16-19-34-36(25-29)54-46(63)48(34)39(32-12-8-13-35(50)40(32)51)41(56-47(48)22-4-2-5-23-47)44(61)53-30-17-14-28(15-18-30)42(59)52-24-6-1-3-9-27-10-7-11-31-33(27)26-57(45(31)62)37-20-21-38(58)55-43(37)60/h7-8,10-19,25,37,39,41,56H,1-2,4-6,20-24,26H2,(H,52,59)(H,53,61)(H,54,63)(H,55,58,60)/t37?,39-,41+,48+/m0/s1	ZLGNYFOIDAVMHY-MPKOGUQCSA-N					compound annotation
0391_009190	PIMONIDAZOLE	C11H18N4O3	0.4704	50981		O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1	InChI=1S/C11H18N4O3/c16-10(8-13-5-2-1-3-6-13)9-14-7-4-12-11(14)15(17)18/h4,7,10,16H,1-3,5-6,8-9H2	WVWOOAYQYLJEFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009192	452105-23-6	C23H27FN4O4	1.8034	10138259	CC1=C(NC(=C1C(=O)NC[C@@H](CN2CCOCC2)O)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCC(O)CN2CCOCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	CTNPALGJUAXMMC-PMFHANACSA-N					doublet; removed another duplicate entry; compound annotation
0391_009194	452105-23-6	C23H27FN4O4	2.4931	10138259	CC1=C(NC(=C1C(=O)NC[C@@H](CN2CCOCC2)O)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCC(O)CN2CCOCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-/m0/s1	CTNPALGJUAXMMC-PMFHANACSA-N					doublet; removed another duplicate entry; compound annotation
0391_009196	Cobicistat	C40H53N7O5S2	3.6791	25151504	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	CC(C)c1nc(CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1	ZCIGNRJZKPOIKD-CQXVEOKZSA-N					doublet; compound annotation
0391_009197	Cobicistat	C40H53N7O5S2	3.7347	25151504	CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5	CC(C)c1nc(CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1	InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1	ZCIGNRJZKPOIKD-CQXVEOKZSA-N					doublet; removed another duplicate entry; compound annotation
0391_009199	Almorexant	C29H31F3N2O3	3.7476	23727689	CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC	CNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1CCc1ccc(C(F)(F)F)cc1	InChI=1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1	DKMACHNQISHMDN-RPLLCQBOSA-N					doublet; compound annotation
0391_009200	Almorexant	C29H31F3N2O3	3.7521	23727689	CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC	CNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1CCc1ccc(C(F)(F)F)cc1	InChI=1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1	DKMACHNQISHMDN-RPLLCQBOSA-N					doublet; compound annotation
0391_009201	Wilforine	C43H49NO18	4.492	601100		CC(=O)OCC12C(OC(C)=O)C(OC(C)=O)C3C(OC(C)=O)C14OC3(C)COC(=O)c1c(CCC(C)C(=O)OC(C(OC(=O)c3ccccc3)C2OC(C)=O)C4(C)O)nccc1	InChI=1S/C43H49NO18/c1-21-16-17-29-28(15-12-18-44-29)39(52)55-19-40(7)30-31(56-23(3)46)35(58-25(5)48)42(20-54-22(2)45)36(59-26(6)49)32(60-38(51)27-13-10-9-11-14-27)34(61-37(21)50)41(8,53)43(42,62-40)33(30)57-24(4)47/h9-15,18,21,30-36,53H,16-17,19-20H2,1-8H3	ZOCKGJZEUVPPPI-UHFFFAOYSA-N					doublet; compound annotation
0391_009202	Wilforine	C43H49NO18	4.4947	601100		CC(=O)OCC12C(OC(C)=O)C(OC(C)=O)C3C(OC(C)=O)C14OC3(C)COC(=O)c1c(CCC(C)C(=O)OC(C(OC(=O)c3ccccc3)C2OC(C)=O)C4(C)O)nccc1	InChI=1S/C43H49NO18/c1-21-16-17-29-28(15-12-18-44-29)39(52)55-19-40(7)30-31(56-23(3)46)35(58-25(5)48)42(20-54-22(2)45)36(59-26(6)49)32(60-38(51)27-13-10-9-11-14-27)34(61-37(21)50)41(8,53)43(42,62-40)33(30)57-24(4)47/h9-15,18,21,30-36,53H,16-17,19-20H2,1-8H3	ZOCKGJZEUVPPPI-UHFFFAOYSA-N					doublet; compound annotation
0391_009203	JT010	C16H19ClN2O3S	4.7158	18524489		COCCCN(C(=O)CCl)c1nc(-c2ccc(OC)cc2)cs1	InChI=1S/C16H19ClN2O3S/c1-21-9-3-8-19(15(20)10-17)16-18-14(11-23-16)12-4-6-13(22-2)7-5-12/h4-7,11H,3,8-10H2,1-2H3	KZMAWJRXKGLWGS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009205	JT010	C16H19ClN2O3S	4.7186	18524489		COCCCN(C(=O)CCl)c1nc(-c2ccc(OC)cc2)cs1	InChI=1S/C16H19ClN2O3S/c1-21-9-3-8-19(15(20)10-17)16-18-14(11-23-16)12-4-6-13(22-2)7-5-12/h4-7,11H,3,8-10H2,1-2H3	KZMAWJRXKGLWGS-UHFFFAOYSA-N					doublet; compound annotation
0391_009206	ginsenoside C-K	C36H62O8	4.9688	9852086	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C	CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC12C	InChI=1S/C36H62O8/c1-20(2)10-9-14-36(8,44-31-30(42)29(41)28(40)23(19-37)43-31)21-11-16-35(7)27(21)22(38)18-25-33(5)15-13-26(39)32(3,4)24(33)12-17-34(25,35)6/h10,21-31,37-42H,9,11-19H2,1-8H3/t21-,22+,23+,24-,25+,26-,27-,28+,29-,30+,31-,33-,34+,35+,36-/m0/s1	FVIZARNDLVOMSU-IRFFNABBSA-N					compound annotation
0391_009207	SR-01000003151	C9H15N4O4+	1.1925	4239		CCOC(=O)Nc1c[n+](N2CCOCC2)no1	InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3/p+1	XLFWDASMENKTKL-UHFFFAOYSA-O					compound annotation
0391_009208	sulfamethoxypyridazine	C11H12N4O3S	1.6374	5330		COc1nnc(NS(=O)(=O)c2ccc(N)cc2)cc1	InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	VLYWMPOKSSWJAL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009210	Branaplam	C22H27N5O2	2.1758	135565042		CC1(C)CC(Oc2nnc(-c3c(O)cc(-c4c[nH]nc4)cc3)cc2)CC(C)(C)N1	InChI=1S/C22H27N5O2/c1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15/h5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24)	STWTUEAWRAIWJG-UHFFFAOYSA-N					compound annotation
0391_009211	NSC-23925	C22H24N2O2	2.2464	409823		COc1ccc(-c2nc3ccccc3c(C(O)C3CCCCN3)c2)cc1	InChI=1S/C22H24N2O2/c1-26-16-11-9-15(10-12-16)21-14-18(17-6-2-3-7-19(17)24-21)22(25)20-8-4-5-13-23-20/h2-3,6-7,9-12,14,20,22-23,25H,4-5,8,13H2,1H3	PKDJQOGOVQLPPG-UHFFFAOYSA-N					compound annotation
0391_009212	BMS-509744	C32H41N5O4S2	3.153	11467730		COc1c(C(=O)N2CCN(C(C)=O)CC2)cc(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)c(C)c1	InChI=1S/C32H41N5O4S2/c1-20-16-26(41-7)25(30(40)37-14-12-36(13-15-37)22(3)38)17-27(20)42-28-19-34-31(43-28)35-29(39)24-10-8-23(9-11-24)18-33-21(2)32(4,5)6/h8-11,16-17,19,21,33H,12-15,18H2,1-7H3,(H,34,35,39)	ZHXNIYGJAOPMSO-UHFFFAOYSA-N					doublet; compound annotation
0391_009213	BMS-509744	C32H41N5O4S2	3.1558	11467730		COc1c(C(=O)N2CCN(C(C)=O)CC2)cc(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)c(C)c1	InChI=1S/C32H41N5O4S2/c1-20-16-26(41-7)25(30(40)37-14-12-36(13-15-37)22(3)38)17-27(20)42-28-19-34-31(43-28)35-29(39)24-10-8-23(9-11-24)18-33-21(2)32(4,5)6/h8-11,16-17,19,21,33H,12-15,18H2,1-7H3,(H,34,35,39)	ZHXNIYGJAOPMSO-UHFFFAOYSA-N					doublet; compound annotation
0391_009214	acacetin	C16H12O5	3.6941	5280442		COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3	DANYIYRPLHHOCZ-UHFFFAOYSA-N					compound annotation
0391_009215	10-Gingerol	C21H34O4	5.2823	168115	CCCCCCCCC[C@@H](CC(=O)CCC1=CC(=C(C=C1)O)OC)O	CCCCCCCCCC(O)CC(=O)CCc1cc(OC)c(O)cc1	InChI=1S/C21H34O4/c1-3-4-5-6-7-8-9-10-18(22)16-19(23)13-11-17-12-14-20(24)21(15-17)25-2/h12,14-15,18,22,24H,3-11,13,16H2,1-2H3/t18-/m0/s1	AIULWNKTYPZYAN-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_009217	Melittoside	C21H32O15	0.4887	11968737	C1=CO[C@H]([C@H]2[C@@]1([C@@H](C=C2CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	OCC1=CC(O)C2(OC3OC(CO)C(O)C(O)C3O)C=COC(OC3OC(CO)C(O)C(O)C3O)C12	InChI=1S/C21H32O15/c22-4-7-3-10(25)21(36-20-17(31)15(29)13(27)9(6-24)34-20)1-2-32-18(11(7)21)35-19-16(30)14(28)12(26)8(5-23)33-19/h1-3,8-20,22-31H,4-6H2/t8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18+,19+,20+,21-/m1/s1	LZKBAGSBRBMVBE-GVKBFFPQSA-N					compound annotation
0391_009218	53209-27-1	C28H24O16	1.857	6453359	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O	O=C(OC1C(Oc2c(-c3cc(O)c(O)cc3)oc3cc(O)cc(O)c3c2=O)OC(CO)C(O)C1O)c1cc(O)c(O)c(O)c1	InChI=1S/C28H24O16/c29-8-18-21(37)23(39)26(43-27(40)10-4-15(34)20(36)16(35)5-10)28(42-18)44-25-22(38)19-14(33)6-11(30)7-17(19)41-24(25)9-1-2-12(31)13(32)3-9/h1-7,18,21,23,26,28-37,39H,8H2/t18-,21+,23+,26-,28+/m1/s1	PXGWEUQZDRUMRE-UNZYZCBSSA-N					removed another duplicate entry; compound annotation
0391_009220	32233-40-2	C8H12O4	1.8756	2724453	C1[C@H]([C@@H]([C@@H]2[C@H]1OC(=O)C2)CO)O	O=C1CC2C(CC(O)C2CO)O1	InChI=1S/C8H12O4/c9-3-5-4-1-8(11)12-7(4)2-6(5)10/h4-7,9-10H,1-3H2/t4-,5-,6-,7+/m1/s1	VYTZWRCSPHQSFX-GBNDHIKLSA-N					compound annotation
0391_009221	Noreugenin	C10H8O4	2.3374	5375252		Cc1cc(=O)c2c(O)cc(O)cc2o1	InChI=1S/C10H8O4/c1-5-2-7(12)10-8(13)3-6(11)4-9(10)14-5/h2-4,11,13H,1H3	NCUJRUDLFCGVOE-UHFFFAOYSA-N					compound annotation
0391_009222	Solamargine	C45H73NO15	2.4522	73611	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H73NO15/c1-19-9-14-45(46-17-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(53)34(51)32(49)22(4)56-41)37(54)38(29(18-47)58-42)59-40-35(52)33(50)31(48)21(3)55-40/h7,19-22,24-42,46-54H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1	MBWUSSKCCUMJHO-ZGXDEBHDSA-N					doublet; compound annotation
0391_009223	Solamargine	C45H73NO15	2.5408	73611	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H73NO15/c1-19-9-14-45(46-17-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(53)34(51)32(49)22(4)56-41)37(54)38(29(18-47)58-42)59-40-35(52)33(50)31(48)21(3)55-40/h7,19-22,24-42,46-54H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1	MBWUSSKCCUMJHO-ZGXDEBHDSA-N					doublet; compound annotation
0391_009224	7,8-dihydroxyflavone	C15H10O4	2.5708	1880		O=c1cc(-c2ccccc2)oc2c1ccc(O)c2O	InChI=1S/C15H10O4/c16-11-7-6-10-12(17)8-13(19-15(10)14(11)18)9-4-2-1-3-5-9/h1-8,16,18H	COCYGNDCWFKTMF-UHFFFAOYSA-N					compound annotation
0391_009225	Isoastragaloside II	C43H70O15	3.8026	60148655	CC(=O)O[C@H]1[C@@H](CO[C@H]([C@@H]1O)O[C@H]2CC[C@]34C[C@]35CC[C@@]6([C@H]([C@H](C[C@]6([C@@H]5C[C@@H]([C@H]4C2(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)[C@]8(CC[C@H](O8)C(C)(C)O)C)C)O	CC(=O)OC1C(O)COC(OC2CCC34CC35CCC3(C)C(C6(C)CCC(C(C)(C)O)O6)C(O)CC3(C)C5CC(OC3OC(CO)C(O)C(O)C3O)C4C2(C)C)C1O	InChI=1S/C43H70O15/c1-20(45)54-32-22(47)18-53-35(31(32)51)57-26-10-12-43-19-42(43)14-13-39(6)33(41(8)11-9-27(58-41)38(4,5)52)21(46)16-40(39,7)25(42)15-23(34(43)37(26,2)3)55-36-30(50)29(49)28(48)24(17-44)56-36/h21-36,44,46-52H,9-19H2,1-8H3/t21-,22+,23-,24+,25-,26-,27-,28+,29-,30+,31+,32-,33-,34-,35-,36+,39+,40-,41+,42-,43+/m0/s1	SMZYCXAYGPGYRS-NGTUZWGPSA-N					removed another duplicate entry; compound annotation
0391_009227	gamma-Mangostin	C23H24O6	5.4558	5464078		CC(C)=CCc1c(O)c2c(cc1O)oc1c(c(CC=C(C)C)c(O)c(O)c1)c2=O	InChI=1S/C23H24O6/c1-11(2)5-7-13-15(24)9-18-20(22(13)27)23(28)19-14(8-6-12(3)4)21(26)16(25)10-17(19)29-18/h5-6,9-10,24-27H,7-8H2,1-4H3	VEZXFTKZUMARDU-UHFFFAOYSA-N					compound annotation
0391_009228	130199-65-4	C11H12N2S	1.5535	10198148	C1=CC=C(C=C1)C[C@@H](C2=NC=CS2)N	NC(Cc1ccccc1)c1nccs1	InChI=1S/C11H12N2S/c12-10(11-13-6-7-14-11)8-9-4-2-1-3-5-9/h1-7,10H,8,12H2/t10-/m0/s1	ADXGZQRJIYRSGK-JTQLQIEISA-N					compound annotation
0391_009229	piperidolate	C21H25NO2	3.0002	4839		CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1	InChI=1S/C21H25NO2/c1-2-22-15-9-14-19(16-22)24-21(23)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-20H,2,9,14-16H2,1H3	KTHVBAZBLKXIHZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009230	Moguisteine	C16H21NO5S	3.6605	65935		CCOC(=O)CC(=O)N1CCSC1COc1ccccc1OC	InChI=1S/C16H21NO5S/c1-3-21-16(19)10-14(18)17-8-9-23-15(17)11-22-13-7-5-4-6-12(13)20-2/h4-7,15H,3,8-11H2,1-2H3	WSYVIAQNTFPTBI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009232	dioxybenzone	C14H12O4	3.8846	8569		COc1cc(O)c(C(=O)c2ccccc2O)cc1	InChI=1S/C14H12O4/c1-18-9-6-7-11(13(16)8-9)14(17)10-4-2-3-5-12(10)15/h2-8,15-16H,1H3	MEZZCSHVIGVWFI-UHFFFAOYSA-N					compound annotation
0391_009233	Oxethazaine	C28H41N3O3	3.9783	4621		CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1	InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3	FTLDJPRFCGDUFH-UHFFFAOYSA-N					doublet; compound annotation
0391_009234	Oxethazaine	C28H41N3O3	3.9815	4621		CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1	InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3	FTLDJPRFCGDUFH-UHFFFAOYSA-N					doublet; compound annotation
0391_009235	Efloxate	C19H16O5	4.0109	8395		CCOC(=O)COc1cc2c(cc1)c(=O)cc(-c1ccccc1)o2	InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3	ZVXBAHLOGZCFTP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009237	mefenamic acid	C15H15NO2	4.6995	4044		Cc1c(C)c(Nc2ccccc2C(=O)O)ccc1	InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)	HYYBABOKPJLUIN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009239	USL311	C24H34N6O	0.4848	56961879		CC(C)N1CCC(N2CCCN(c3cccc(C(=O)Nc4ccncc4)n3)CC2)CC1	InChI=1S/C24H34N6O/c1-19(2)28-15-9-21(10-16-28)29-13-4-14-30(18-17-29)23-6-3-5-22(27-23)24(31)26-20-7-11-25-12-8-20/h3,5-8,11-12,19,21H,4,9-10,13-18H2,1-2H3,(H,25,26,31)	XNUNVQKARNSSEO-UHFFFAOYSA-N					compound annotation
0391_009240	Verbenalin	C17H24O10	1.5072	73467	C[C@H]1CC(=O)[C@H]2[C@@H]1[C@@H](OC=C2C(=O)OC)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C(C)CC(=O)C12	InChI=1S/C17H24O10/c1-6-3-8(19)11-7(15(23)24-2)5-25-16(10(6)11)27-17-14(22)13(21)12(20)9(4-18)26-17/h5-6,9-14,16-18,20-22H,3-4H2,1-2H3/t6-,9+,10+,11-,12+,13-,14+,16-,17-/m0/s1	HLXRWTJXGMHOFN-XJSNKYLASA-N					removed another duplicate entry; compound annotation
0391_009242	6-Benzylaminopurine	C12H11N5	1.6874	62389		c1ccc(CNc2ncnc3c2[nH]cn3)cc1	InChI=1S/C12H11N5/c1-2-4-9(5-3-1)6-13-11-10-12(15-7-14-10)17-8-16-11/h1-5,7-8H,6H2,(H2,13,14,15,16,17)	NWBJYWHLCVSVIJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009244	SD-06	C20H20ClN5O2	2.7997	9865587		O=C(CO)N1CCC(c2c(-c3ncncc3)c(-c3ccc(Cl)cc3)n[nH]2)CC1	InChI=1S/C20H20ClN5O2/c21-15-3-1-13(2-4-15)19-18(16-5-8-22-12-23-16)20(25-24-19)14-6-9-26(10-7-14)17(28)11-27/h1-5,8,12,14,27H,6-7,9-11H2,(H,24,25)	CATQHDWESBRRQA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009246	santacruzamate A	C15H22N2O3	2.825	72946782		CCOC(=O)NCCCC(=O)NCCc1ccccc1	InChI=1S/C15H22N2O3/c1-2-20-15(19)17-11-6-9-14(18)16-12-10-13-7-4-3-5-8-13/h3-5,7-8H,2,6,9-12H2,1H3,(H,16,18)(H,17,19)	HTOYBIILVCHURC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009248	MI-3	C18H25N5S2	2.8292	51001299		CC(C)c1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1	InChI=1S/C18H25N5S2/c1-12(2)14-9-13-15(20-11-21-16(13)24-14)22-5-7-23(8-6-22)17-19-10-18(3,4)25-17/h9,11-12H,5-8,10H2,1-4H3	FUGQNAUKABUDQI-UHFFFAOYSA-N					compound annotation
0391_009249	Budipine	C21H27N	2.909	68778		CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1	InChI=1S/C21H27N/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13H,14-17H2,1-3H3	QIHLUZAFSSMXHQ-UHFFFAOYSA-N					compound annotation
0391_009250	CHEMBL474635	C32H68N6O2	3.3182	10144565	CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](C(=O)NCCCNCCCCNCCCN)N	CCCCCCCCCCCCCCCC(=O)NCCCCC(N)C(=O)NCCCNCCCCNCCCN	InChI=1S/C32H68N6O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-22-31(39)37-28-16-15-21-30(34)32(40)38-29-20-27-36-25-18-17-24-35-26-19-23-33/h30,35-36H,2-29,33-34H2,1H3,(H,37,39)(H,38,40)/t30-/m1/s1	USNCWPSRPOWEBG-SSEXGKCCSA-N					removed another duplicate entry; compound annotation
0391_009252	ATP-Red 1	C34H36BN3O4	4.372	132274056		CCN(CC)c1ccc2c(c1)Oc1c(ccc(N(CC)CC)c1)C21c2ccccc2C(=O)N1c1ccccc1B(O)O	InChI=1S/C34H36BN3O4/c1-5-36(6-2)23-17-19-27-31(21-23)42-32-22-24(37(7-3)8-4)18-20-28(32)34(27)26-14-10-9-13-25(26)33(39)38(34)30-16-12-11-15-29(30)35(40)41/h9-22,40-41H,5-8H2,1-4H3	SSNKNUIFMZUJTL-UHFFFAOYSA-N					compound annotation
0391_009253	Dinaciclib	C21H28N6O2	1.5858	46926350	CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO	CCc1c2nc(N3CCCCC3CCO)cc(NCc3c[n+]([O-])ccc3)n2nc1	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	PIMQWRZWLQKKBJ-SFHVURJKSA-N					doublet; compound annotation
0391_009254	Dinaciclib	C21H28N6O2	2.0507	46926350	CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO	CCc1c2nc(N3CCCCC3CCO)cc(NCc3c[n+]([O-])ccc3)n2nc1	InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1	PIMQWRZWLQKKBJ-SFHVURJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_009256	Piromelatine	C17H16N2O4	2.3774	24815904		COc1cc2c(cc1)[nH]cc2CCNC(=O)c1cc(=O)cco1	InChI=1S/C17H16N2O4/c1-22-13-2-3-15-14(9-13)11(10-19-15)4-6-18-17(21)16-8-12(20)5-7-23-16/h2-3,5,7-10,19H,4,6H2,1H3,(H,18,21)	PNTNBIHOAPJYDB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009258	Pevonedistat	C21H25N5O4S	2.4433	16720766	C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N	NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O	InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	MPUQHZXIXSTTDU-QXGSTGNESA-N					doublet; compound annotation
0391_009259	Tipifarnib	C27H22Cl2N4O	3.1204	159324	CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N	Cn1cncc1C(N)(c1ccc(Cl)cc1)c1cc2c(cc1)n(C)c(=O)cc2-c1cc(Cl)ccc1	InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1	PLHJCIYEEKOWNM-HHHXNRCGSA-N					compound annotation
0391_009260	GSK1904529A	C44H47F2N9O5S	3.3052	137216822		CCc1cc(Nc2nccc(-c3c(-c4cc(C(=O)Nc5c(F)cccc5F)c(OC)cc4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1	InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49)	MOSKATHMXWSZTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009261	GSK1904529A	C44H47F2N9O5S	3.3091	137216822		CCc1cc(Nc2nccc(-c3c(-c4cc(C(=O)Nc5c(F)cccc5F)c(OC)cc4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1	InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49)	MOSKATHMXWSZTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009262	GSK1904529A	C44H47F2N9O5S	3.6502	137216822		CCc1cc(Nc2nccc(-c3c(-c4cc(C(=O)Nc5c(F)cccc5F)c(OC)cc4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1	InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49)	MOSKATHMXWSZTQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009263	Darapladib	C36H38F4N4O2S	3.8015	9939609		CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3	WDPFJWLDPVQCAJ-UHFFFAOYSA-N					doublet; compound annotation
0391_009264	Darapladib	C36H38F4N4O2S	3.8048	9939609		CCN(CC)CCN(Cc1ccc(-c2ccc(C(F)(F)F)cc2)cc1)C(=O)Cn1c(SCc2ccc(F)cc2)nc(=O)c2c1CCC2	InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3	WDPFJWLDPVQCAJ-UHFFFAOYSA-N					doublet; compound annotation
0391_009265	Loreclezole	C10H6Cl3N3	4.1608	3034012	C1=CC(=C(C=C1Cl)Cl)/C(=C/N2C=NC=N2)/Cl	ClC(=Cn1cncn1)c1c(Cl)cc(Cl)cc1	InChI=1S/C10H6Cl3N3/c11-7-1-2-8(9(12)3-7)10(13)4-16-6-14-5-15-16/h1-6H/b10-4-	XGLHZTBDUXXHOM-WMZJFQQLSA-N					compound annotation
0391_009266	Bitopertin	C21H20F7N3O4S	4.6852	24946690	C[C@@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F	CC(Oc1c(C(=O)N2CCN(c3c(F)cc(C(F)(F)F)cn3)CC2)cc(S(C)(=O)=O)cc1)C(F)(F)F	InChI=1S/C21H20F7N3O4S/c1-12(20(23,24)25)35-17-4-3-14(36(2,33)34)10-15(17)19(32)31-7-5-30(6-8-31)18-16(22)9-13(11-29-18)21(26,27)28/h3-4,9-12H,5-8H2,1-2H3/t12-/m0/s1	YUUGYIUSCYNSQR-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_009268	LDH-IN-1	C30H26N4O4S2	4.8964	131955127		NS(=O)(=O)c1ccc(Cc2c(CC3CC3)n(-c3nc(C(=O)O)cs3)nc2-c2cccc(-c3ccccc3)c2)cc1	InChI=1S/C30H26N4O4S2/c31-40(37,38)24-13-11-19(12-14-24)15-25-27(16-20-9-10-20)34(30-32-26(18-39-30)29(35)36)33-28(25)23-8-4-7-22(17-23)21-5-2-1-3-6-21/h1-8,11-14,17-18,20H,9-10,15-16H2,(H,35,36)(H2,31,37,38)	ALJORCZKMBZYCR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009270	AM580	C22H25NO3	4.9879	2126		CC1(C)CCC(C)(C)c2c1ccc(C(=O)Nc1ccc(C(=O)O)cc1)c2	InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-15(7-10-17(18)21)19(24)23-16-8-5-14(6-9-16)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)	SZWKGOZKRMMLAJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009272	Calcein Blue	C15H15NO7	1.2196	5393133		Cc1cc(=O)oc2c1ccc(O)c2CN(CC(=O)O)CC(=O)O	InChI=1S/C15H15NO7/c1-8-4-14(22)23-15-9(8)2-3-11(17)10(15)5-16(6-12(18)19)7-13(20)21/h2-4,17H,5-7H2,1H3,(H,18,19)(H,20,21)	RJPSHDMGSVVHFA-UHFFFAOYSA-N					compound annotation
0391_009273	ofloxacin	C18H20FN3O4	1.5124	4583		CC1COc2c3c(cc(F)c2N2CCN(C)CC2)c(=O)c(C(=O)O)cn31	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)	GSDSWSVVBLHKDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009274	ofloxacin	C18H20FN3O4	1.5159	4583		CC1COc2c3c(cc(F)c2N2CCN(C)CC2)c(=O)c(C(=O)O)cn31	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)	GSDSWSVVBLHKDQ-UHFFFAOYSA-N					doublet; compound annotation
0391_009275	XMD8-92	C26H30N6O3	2.7126	46843772		CCOc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29)	QAPAJIZPZGWAND-UHFFFAOYSA-N					doublet; compound annotation
0391_009276	Demethoxycurcumin	C20H18O5	3.0211	5469424	COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC=C(C=C2)O)O	COc1c(O)ccc(C=CC(=O)CC(=O)C=Cc2ccc(O)cc2)c1	InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+	HJTVQHVGMGKONQ-LUZURFALSA-N					doublet; removed another duplicate entry; compound annotation
0391_009278	Litronesib	C23H37N5O4S2	3.4503	25167017	CCNCCS(=O)(=O)NC[C@@]1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2	CCNCCS(=O)(=O)NCC1(c2ccccc2)SC(NC(=O)C(C)(C)C)=NN1C(=O)C(C)(C)C	InChI=1S/C23H37N5O4S2/c1-8-24-14-15-34(31,32)25-16-23(17-12-10-9-11-13-17)28(19(30)22(5,6)7)27-20(33-23)26-18(29)21(2,3)4/h9-13,24-25H,8,14-16H2,1-7H3,(H,26,27,29)/t23-/m0/s1	YVAFBXLHPINSIK-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_009280	XMD8-92	C26H30N6O3	3.5374	46843772		CCOc1c(Nc2ncc3c(n2)N(C)c2ccccc2C(=O)N3C)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29)	QAPAJIZPZGWAND-UHFFFAOYSA-N					doublet; compound annotation
0391_009281	Demethoxycurcumin	C20H18O5	3.9416	5469424	COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC=C(C=C2)O)O	COc1c(O)ccc(C=CC(=O)CC(=O)C=Cc2ccc(O)cc2)c1	InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+	HJTVQHVGMGKONQ-LUZURFALSA-N					doublet; compound annotation
0391_009282	33069-62-4	C47H51NO14	4.2995	36314	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C	CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C	InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1	RCINICONZNJXQF-MZXODVADSA-N					removed another duplicate entry; compound annotation
0391_009284	260415-63-2	C21H16Cl2N4OS	5.0468	447077		CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1	InChI=1S/C21H16Cl2N4OS/c1-27-19-12(9-15(20(27)28)18-16(22)7-4-8-17(18)23)11-24-21(26-19)25-13-5-3-6-14(10-13)29-2/h3-11H,1-2H3,(H,24,25,26)	VAARYSWULJUGST-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009286	ZINC13466751	C20H21N5O2	5.1206	3120439		Cc1c(N=Nc2ccc(N3CCOCC3)cc2)c(=O)n(-c2ccccc2)[nH]1	InChI=1S/C20H21N5O2/c1-15-19(20(26)25(23-15)18-5-3-2-4-6-18)22-21-16-7-9-17(10-8-16)24-11-13-27-14-12-24/h2-10,23H,11-14H2,1H3	BPLMVWHZMFTKIE-UHFFFAOYSA-N					compound annotation
0391_009287	C 87	C24H15ClN6O3S	6.1632	4016403		O=c1c(N=Nc2cc([N+](=O)[O-])c(Cl)cc2)c(-c2ccccc2)[nH]n1-c1nc(-c2ccccc2)cs1	InChI=1S/C24H15ClN6O3S/c25-18-12-11-17(13-20(18)31(33)34)27-28-22-21(16-9-5-2-6-10-16)29-30(23(22)32)24-26-19(14-35-24)15-7-3-1-4-8-15/h1-14,29H	HTEQQWJUYYUNQG-UHFFFAOYSA-N					compound annotation
0391_009288	DAZOXIBEN	C12H12N2O3	0.8463	53001		O=C(O)c1ccc(OCCn2ccnc2)cc1	InChI=1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)	XQGZSYKGWHUSDH-UHFFFAOYSA-N					compound annotation
0391_009289	Pamapimod	C19H20F2N4O4	2.5733	16220188		Cn1c(=O)c(Oc2c(F)cc(F)cc2)cc2cnc(NC(CCO)CCO)nc21	InChI=1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24)	JYYLVUFNAHSSFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009292	AZD8055	C25H31N5O4	2.6712	25262965	C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C	COc1c(CO)cc(-c2nc3c(cc2)c(N2CCOCC2C)nc(N2CCOCC2C)n3)cc1	InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1	KVLFRAWTRWDEDF-IRXDYDNUSA-N					doublet; removed another duplicate entry; compound annotation
0391_009294	AZD8055	C25H31N5O4	3.0115	25262965	C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C	COc1c(CO)cc(-c2nc3c(cc2)c(N2CCOCC2C)nc(N2CCOCC2C)n3)cc1	InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1	KVLFRAWTRWDEDF-IRXDYDNUSA-N					doublet; compound annotation
0391_009295	Mcl1-IN-8	C22H23N3O2S	3.0142	988971	C1CN(CCN1CCO)C2=NC(=O)/C(=C/C3=CC=C(C=C3)C4=CC=CC=C4)/S2	O=C1N=C(N2CCN(CCO)CC2)SC1=Cc1ccc(-c2ccccc2)cc1	InChI=1S/C22H23N3O2S/c26-15-14-24-10-12-25(13-11-24)22-23-21(27)20(28-22)16-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,16,26H,10-15H2/b20-16-	IBEWMFVUBLAYJT-SILNSSARSA-N					doublet; removed another duplicate entry; compound annotation
0391_009297	Mcl1-IN-8	C22H23N3O2S	3.0732	988971	C1CN(CCN1CCO)C2=NC(=O)/C(=C/C3=CC=C(C=C3)C4=CC=CC=C4)/S2	O=C1N=C(N2CCN(CCO)CC2)SC1=Cc1ccc(-c2ccccc2)cc1	InChI=1S/C22H23N3O2S/c26-15-14-24-10-12-25(13-11-24)22-23-21(27)20(28-22)16-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,16,26H,10-15H2/b20-16-	IBEWMFVUBLAYJT-SILNSSARSA-N					doublet; removed another duplicate entry; compound annotation
0391_009299	Rubusoside	C32H50O13	3.1494	24721373	C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@](C3)(C(=C)C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)(C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O	C=C1CC23CCC4C(C)(C(=O)OC5OC(CO)C(O)C(O)C5O)CCCC4(C)C2CCC1(OC1OC(CO)C(O)C(O)C1O)C3	InChI=1S/C32H50O13/c1-15-11-31-9-5-18-29(2,7-4-8-30(18,3)28(41)44-26-24(39)22(37)20(35)16(12-33)42-26)19(31)6-10-32(15,14-31)45-27-25(40)23(38)21(36)17(13-34)43-27/h16-27,33-40H,1,4-14H2,2-3H3/t16-,17-,18+,19+,20-,21-,22+,23+,24-,25-,26+,27+,29-,30-,31-,32+/m1/s1	YWPVROCHNBYFTP-OSHKXICASA-N					compound annotation
0391_009300	755002-90-5	C20H31BrN2O2	3.285	1319582		CC(C)c1cc(Br)c(OCC(=O)NC2CC(C)(C)NC(C)(C)C2)cc1	InChI=1S/C20H31BrN2O2/c1-13(2)14-7-8-17(16(21)9-14)25-12-18(24)22-15-10-19(3,4)23-20(5,6)11-15/h7-9,13,15,23H,10-12H2,1-6H3,(H,22,24)	OTTDLWFVHQYRDA-UHFFFAOYSA-N					compound annotation
0391_009301	GSK1292263	C23H28N4O4S	4.1918	24996872		CC(C)c1noc(N2CCC(COc3cnc(-c4ccc(S(C)(=O)=O)cc4)cc3)CC2)n1	InChI=1S/C23H28N4O4S/c1-16(2)22-25-23(31-26-22)27-12-10-17(11-13-27)15-30-19-6-9-21(24-14-19)18-4-7-20(8-5-18)32(3,28)29/h4-9,14,16-17H,10-13,15H2,1-3H3	AYJRTVVIBJSSKN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009303	125404-04-8	C12H11N3	2.0559	46911068	C1=CC=C(C=C1)/C=C/C2=NC(=NC=C2)N	Nc1nccc(C=Cc2ccccc2)n1	InChI=1S/C12H11N3/c13-12-14-9-8-11(15-12)7-6-10-4-2-1-3-5-10/h1-9H,(H2,13,14,15)/b7-6+	LNUXNUNUGIHCPA-VOTSOKGWSA-N					doublet; compound annotation
0391_009304	3-Ethoxy-4-hydroxybenzaldehyde	C9H10O3	2.1598	8467		CCOc1c(O)ccc(C=O)c1	InChI=1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3	CBOQJANXLMLOSS-UHFFFAOYSA-N					doublet; compound annotation
0391_009305	125404-04-8	C12H11N3	2.169	46911068	C1=CC=C(C=C1)/C=C/C2=NC(=NC=C2)N	Nc1nccc(C=Cc2ccccc2)n1	InChI=1S/C12H11N3/c13-12-14-9-8-11(15-12)7-6-10-4-2-1-3-5-10/h1-9H,(H2,13,14,15)/b7-6+	LNUXNUNUGIHCPA-VOTSOKGWSA-N					doublet; compound annotation
0391_009306	125404-04-8	C12H11N3	2.1723	46911068	C1=CC=C(C=C1)/C=C/C2=NC(=NC=C2)N	Nc1nccc(C=Cc2ccccc2)n1	InChI=1S/C12H11N3/c13-12-14-9-8-11(15-12)7-6-10-4-2-1-3-5-10/h1-9H,(H2,13,14,15)/b7-6+	LNUXNUNUGIHCPA-VOTSOKGWSA-N					doublet; compound annotation
0391_009307	Monochlorobimane	C10H11ClN2O2	2.2957	114886		Cc1c(C)n2c(CCl)c(C)c(=O)n2c1=O	InChI=1S/C10H11ClN2O2/c1-5-7(3)12-8(4-11)6(2)10(15)13(12)9(5)14/h4H2,1-3H3	SUIPVTCEECPFIB-UHFFFAOYSA-N					doublet; compound annotation
0391_009308	Monochlorobimane	C10H11ClN2O2	2.2986	114886		Cc1c(C)n2c(CCl)c(C)c(=O)n2c1=O	InChI=1S/C10H11ClN2O2/c1-5-7(3)12-8(4-11)6(2)10(15)13(12)9(5)14/h4H2,1-3H3	SUIPVTCEECPFIB-UHFFFAOYSA-N					doublet; compound annotation
0391_009309	5-CHLORO-8-HYDROXYQUINOLINE	C9H6ClNO	2.5233	2817		Oc1c2ncccc2c(Cl)cc1	InChI=1S/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H	CTQMJYWDVABFRZ-UHFFFAOYSA-N					compound annotation
0391_009310	flumequine	C14H12FNO3	2.9613	3374		CC1CCc2c3c(cc(F)c2)c(=O)c(C(=O)O)cn31	InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)	DPSPPJIUMHPXMA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009312	flumequine	C14H12FNO3	3.2674	3374		CC1CCc2c3c(cc(F)c2)c(=O)c(C(=O)O)cn31	InChI=1S/C14H12FNO3/c1-7-2-3-8-4-9(15)5-10-12(8)16(7)6-11(13(10)17)14(18)19/h4-7H,2-3H2,1H3,(H,18,19)	DPSPPJIUMHPXMA-UHFFFAOYSA-N					doublet; compound annotation
0391_009313	Cipargamin	C19H14Cl2FN3O	3.391	44469321	C[C@H]1CC2=C([C@]3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl	CC1Cc2c([nH]c3cc(Cl)c(F)cc23)C2(N1)C(=O)Nc1ccc(Cl)cc12	InChI=1S/C19H14Cl2FN3O/c1-8-4-11-10-6-14(22)13(21)7-16(10)23-17(11)19(25-8)12-5-9(20)2-3-15(12)24-18(19)26/h2-3,5-8,23,25H,4H2,1H3,(H,24,26)/t8-,19+/m0/s1	CKLPLPZSUQEDRT-WPCRTTGESA-N					compound annotation
0391_009314	125404-04-8	C12H11N3	3.5275	46911068	C1=CC=C(C=C1)/C=C/C2=NC(=NC=C2)N	Nc1nccc(C=Cc2ccccc2)n1	InChI=1S/C12H11N3/c13-12-14-9-8-11(15-12)7-6-10-4-2-1-3-5-10/h1-9H,(H2,13,14,15)/b7-6+	LNUXNUNUGIHCPA-VOTSOKGWSA-N					doublet; compound annotation
0391_009315	3-Ethoxy-4-hydroxybenzaldehyde	C9H10O3	4.2813	8467		CCOc1c(O)ccc(C=O)c1	InChI=1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3	CBOQJANXLMLOSS-UHFFFAOYSA-N					doublet; compound annotation
0391_009316	latanoprost	C26H40O5	4.4487	5311221	CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O	CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1CCC(O)CCc1ccccc1	InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1	GGXICVAJURFBLW-CEYXHVGTSA-N					removed another duplicate entry; compound annotation
0391_009318	GSK4112	C18H21ClN2O4S	6.0213	50905018		CC(C)(C)OC(=O)CN(Cc1ccc(Cl)cc1)Cc1ccc([N+](=O)[O-])s1	InChI=1S/C18H21ClN2O4S/c1-18(2,3)25-17(22)12-20(10-13-4-6-14(19)7-5-13)11-15-8-9-16(26-15)21(23)24/h4-9H,10-12H2,1-3H3	WYSLOKHVFKLWOU-UHFFFAOYSA-N					compound annotation
0391_009319	3-(6-methoxyquinolin-1-ium-1-yl)propane-1-sulfonic acid	C13H16NO4S+	0.7505	101599381		COc1cc2c(cc1)[n+](CCCS(=O)(=O)O)ccc2	InChI=1S/C13H15NO4S/c1-18-12-5-6-13-11(10-12)4-2-7-14(13)8-3-9-19(15,16)17/h2,4-7,10H,3,8-9H2,1H3/p+1	ZVDGOJFPFMINBM-UHFFFAOYSA-O					compound annotation
0391_009320	127657-29-8	C7H11NO4S	1.8281	11615393		CCOC(=O)N1CSCC1C(=O)O	InChI=1S/C7H11NO4S/c1-2-12-7(11)8-4-13-3-5(8)6(9)10/h5H,2-4H2,1H3,(H,9,10)	XBJWOGLKABXFJE-UHFFFAOYSA-N					compound annotation
0391_009321	exo-Granisetron (Granisetron Impurity F)	C18H24N4O	1.9807	3510		CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2	InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)	MFWNKCLOYSRHCJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009323	SANGUINARINE	C20H14NO4+	2.4159	5154		C[n+]1c2c3cc4c(cc3ccc2c2ccc3c(OCO3)c2c1)OCO4	InChI=1S/C20H14NO4/c1-21-8-15-12(4-5-16-20(15)25-10-22-16)13-3-2-11-6-17-18(24-9-23-17)7-14(11)19(13)21/h2-8H,9-10H2,1H3/q+1	INVGWHRKADIJHF-UHFFFAOYSA-N					compound annotation
0391_009324	delta-Valerolactone	C5H8O2	2.5503	10953		O=C1CCCCO1	InChI=1S/C5H8O2/c6-5-3-1-2-4-7-5/h1-4H2	OZJPLYNZGCXSJM-UHFFFAOYSA-N					compound annotation
0391_009325	PF-06424439	C22H26ClN7O	2.6614	71766156	C1CCN(C1)C(=O)[C@@H]2CCCN(C2)C3=NC4=C(C=C3)NC(=N4)C5(CC5)N6C=C(C=N6)Cl	O=C(C1CCCN(c2nc3c(cc2)[nH]c(C2(n4cc(Cl)cn4)CC2)n3)C1)N1CCCC1	InChI=1S/C22H26ClN7O/c23-16-12-24-30(14-16)22(7-8-22)21-25-17-5-6-18(26-19(17)27-21)29-11-3-4-15(13-29)20(31)28-9-1-2-10-28/h5-6,12,14-15H,1-4,7-11,13H2,(H,25,26,27)/t15-/m1/s1	PZHNKPBYOPQTRG-OAHLLOKOSA-N					doublet; compound annotation
0391_009326	PF-06424439	C22H26ClN7O	2.6663	71766156	C1CCN(C1)C(=O)[C@@H]2CCCN(C2)C3=NC4=C(C=C3)NC(=N4)C5(CC5)N6C=C(C=N6)Cl	O=C(C1CCCN(c2nc3c(cc2)[nH]c(C2(n4cc(Cl)cn4)CC2)n3)C1)N1CCCC1	InChI=1S/C22H26ClN7O/c23-16-12-24-30(14-16)22(7-8-22)21-25-17-5-6-18(26-19(17)27-21)29-11-3-4-15(13-29)20(31)28-9-1-2-10-28/h5-6,12,14-15H,1-4,7-11,13H2,(H,25,26,27)/t15-/m1/s1	PZHNKPBYOPQTRG-OAHLLOKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_009328	PDD 00017273	C23H26N6O4S2	3.2545	121398766		Cc1nn(C)c(Cn2c(=O)n(Cc3cnc(C)s3)c(=O)c3cc(S(=O)(=O)NC4(C)CC4)ccc32)c1	InChI=1S/C23H26N6O4S2/c1-14-9-16(27(4)25-14)12-28-20-6-5-18(35(32,33)26-23(3)7-8-23)10-19(20)21(30)29(22(28)31)13-17-11-24-15(2)34-17/h5-6,9-11,26H,7-8,12-13H2,1-4H3	IFWUBRBMMNTBRZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009330	Octadecyl rhodamine 101 ester	C32H31N2O3+	4.2432	153491		O=C(O)c1ccccc1C1=c2cc3CCC[N+]4=c3c(c2Oc2c1cc1CCCN3CCCc2c13)CCC4	InChI=1S/C32H30N2O3/c35-32(36)22-10-2-1-9-21(22)27-25-17-19-7-3-13-33-15-5-11-23(28(19)33)30(25)37-31-24-12-6-16-34-14-4-8-20(29(24)34)18-26(27)31/h1-2,9-10,17-18H,3-8,11-16H2/p+1	MUSLHCJRTRQOSP-UHFFFAOYSA-O					doublet; compound annotation
0391_009331	Octadecyl rhodamine 101 ester	C32H31N2O3+	4.3797	153491		O=C(O)c1ccccc1C1=c2cc3CCC[N+]4=c3c(c2Oc2c1cc1CCCN3CCCc2c13)CCC4	InChI=1S/C32H30N2O3/c35-32(36)22-10-2-1-9-21(22)27-25-17-19-7-3-13-33-15-5-11-23(28(19)33)30(25)37-31-24-12-6-16-34-14-4-8-20(29(24)34)18-26(27)31/h1-2,9-10,17-18H,3-8,11-16H2/p+1	MUSLHCJRTRQOSP-UHFFFAOYSA-O					doublet; compound annotation
0391_009332	607737-87-1	C18H14N4	1.373	10469233		Cc1nc(-c2c(-c3ccnc4ccccc34)cn[nH]2)ccc1	InChI=1S/C18H14N4/c1-12-5-4-8-17(21-12)18-15(11-20-22-18)13-9-10-19-16-7-3-2-6-14(13)16/h2-11H,1H3,(H,20,22)	KJTYZDORHCDZPS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009334	Navoximod	C18H21FN2O2	1.6579	70914230	C1CC(CCC1[C@@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O	OC1CCC(C(O)CC2c3c(F)cccc3-c3cncn32)CC1	InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m0/s1	YGACXVRLDHEXKY-LHPNLFKDSA-N					doublet; compound annotation
0391_009335	IDO-IN-8	C18H21FN2O2	1.6579	70914212	C1CC(CCC1[C@H](C[C@@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O	OC1CCC(C(O)CC2c3c(F)cccc3-c3cncn32)CC1	InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m1/s1	YGACXVRLDHEXKY-LHLWNEDTSA-N					doublet; compound annotation
0391_009336	Navoximod	C18H21FN2O2	1.8925	70914230	C1CC(CCC1[C@@H](C[C@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O	OC1CCC(C(O)CC2c3c(F)cccc3-c3cncn32)CC1	InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m0/s1	YGACXVRLDHEXKY-LHPNLFKDSA-N					doublet; compound annotation
0391_009337	IDO-IN-8	C18H21FN2O2	1.8925	70914212	C1CC(CCC1[C@H](C[C@@H]2C3=C(C=CC=C3F)C4=CN=CN24)O)O	OC1CCC(C(O)CC2c3c(F)cccc3-c3cncn32)CC1	InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m1/s1	YGACXVRLDHEXKY-LHLWNEDTSA-N					doublet; compound annotation
0391_009338	AZD-7648	C18H20N8O2	1.9548	135151360		Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C	InChI=1S/C18H20N8O2/c1-11-7-15-20-10-21-25(15)9-13(11)22-17-19-8-14-16(23-17)26(18(27)24(14)2)12-3-5-28-6-4-12/h7-10,12H,3-6H2,1-2H3,(H,19,22,23)	XISVSTPEXYIKJL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009340	1080622-86-1	C17H15N7O2	2.4966	44551660		COc1c(OC)cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2c1	InChI=1S/C17H15N7O2/c1-25-13-7-10-12(8-14(13)26-2)20-9-21-16(10)24-17(18)22-15(23-24)11-5-3-4-6-19-11/h3-9H,1-2H3,(H2,18,22,23)	ILBRKJBKDGCSCB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009342	cilostamide	C20H26N2O3	3.2419	2753		CN(C(=O)CCCOc1cc2c(cc1)[nH]c(=O)cc2)C1CCCCC1	InChI=1S/C20H26N2O3/c1-22(16-6-3-2-4-7-16)20(24)8-5-13-25-17-10-11-18-15(14-17)9-12-19(23)21-18/h9-12,14,16H,2-8,13H2,1H3,(H,21,23)	UIAYVIIHMORPSJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009344	BI-749327	C23H21F3N4O2	3.386	138377580		Nc1nnc(C2CCN(C(=O)c3ccc(Oc4ccc(C(F)(F)F)cc4)cc3)CC2)cc1	InChI=1S/C23H21F3N4O2/c24-23(25,26)17-3-7-19(8-4-17)32-18-5-1-16(2-6-18)22(31)30-13-11-15(12-14-30)20-9-10-21(27)29-28-20/h1-10,15H,11-14H2,(H2,27,29)	RGYMFGHHIDRCBN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009346	Glycyrrhizic acid	C42H62O16	3.4731	14982	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1	LPLVUJXQOOQHMX-QWBHMCJMSA-N					doublet; compound annotation
0391_009347	Glycyrrhizic acid	C42H62O16	3.4766	14982	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1	LPLVUJXQOOQHMX-QWBHMCJMSA-N					doublet; compound annotation
0391_009348	Glycyrrhizic acid	C42H62O16	3.6863	14982	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1	LPLVUJXQOOQHMX-QWBHMCJMSA-N					doublet; compound annotation
0391_009349	ID-8	C16H14N2O4	3.8922	791637		COc1ccc(-n2c(C)c([N+](=O)[O-])c3c2cc(O)cc3)cc1	InChI=1S/C16H14N2O4/c1-10-16(18(20)21)14-8-5-12(19)9-15(14)17(10)11-3-6-13(22-2)7-4-11/h3-9,19H,1-2H3	VVZNWYXIOADGSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009352	Seltorexant	C21H22FN7O	2.3239	67116280		Cc1cc(C)nc(N2CC3CN(C(=O)c4c(F)cccc4-n4nccn4)CC3C2)n1	InChI=1S/C21H22FN7O/c1-13-8-14(2)26-21(25-13)28-11-15-9-27(10-16(15)12-28)20(30)19-17(22)4-3-5-18(19)29-23-6-7-24-29/h3-8,15-16H,9-12H2,1-2H3	SQOCEMCKYDVLMM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009354	Dolutegravir	C20H19F2N3O5	3.1498	54726191	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	CC1CCOC2Cn3cc(C(=O)NCc4c(F)cc(F)cc4)c(=O)c(O)c3C(=O)N12	InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1	RHWKPHLQXYSBKR-BMIGLBTASA-N					doublet; compound annotation
0391_009355	Dolutegravir	C20H19F2N3O5	3.1546	54726191	C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O	CC1CCOC2Cn3cc(C(=O)NCc4c(F)cc(F)cc4)c(=O)c(O)c3C(=O)N12	InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1	RHWKPHLQXYSBKR-BMIGLBTASA-N					doublet; compound annotation
0391_009356	SB-423562	C26H32N2O4	3.2332	9910902	CC(C)(CC1CC2=CC=CC=C2C1)NC[C@H](COC3=C(C=CC(=C3)CCC(=O)O)C#N)O	CC(C)(CC1Cc2ccccc2C1)NCC(O)COc1c(C#N)ccc(CCC(=O)O)c1	InChI=1S/C26H32N2O4/c1-26(2,14-19-11-20-5-3-4-6-21(20)12-19)28-16-23(29)17-32-24-13-18(8-10-25(30)31)7-9-22(24)15-27/h3-7,9,13,19,23,28-29H,8,10-12,14,16-17H2,1-2H3,(H,30,31)/t23-/m1/s1	NJBFJCJKWWIKRD-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_009358	Dabrafenib	C23H20F3N5O2S2	4.1704	44462760		CC(C)(C)c1nc(-c2c(F)c(NS(=O)(=O)c3c(F)cccc3F)ccc2)c(-c2nc(N)ncc2)s1	InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)	BFSMGDJOXZAERB-UHFFFAOYSA-N					doublet; compound annotation
0391_009359	SH5-07	C29H28F5N3O5S	5.3768	72550504		CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)NO)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F	InChI=1S/C29H28F5N3O5S/c1-36(43(41,42)28-26(33)24(31)23(30)25(32)27(28)34)16-22(38)37(21-13-11-20(12-14-21)29(39)35-40)15-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h7-14,18,40H,2-6,15-16H2,1H3,(H,35,39)	QPSUYVALAOXFGL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009361	94164-88-2	C18H19NO2S2	5.3798	131698387		CC1=C(CSC(=S)N2CCCCC2)C(=O)c2ccccc2C1=O	InChI=1S/C18H19NO2S2/c1-12-15(11-23-18(22)19-9-5-2-6-10-19)17(21)14-8-4-3-7-13(14)16(12)20/h3-4,7-8H,2,5-6,9-11H2,1H3	STAFOGVMELKGRI-UHFFFAOYSA-N					compound annotation
0391_009362	Pipofezine	C16H19N5O	1.0761	159977		CN1CCN(c2nnc3Oc4ccccc4N(C)c3c2)CC1	InChI=1S/C16H19N5O/c1-19-7-9-21(10-8-19)15-11-13-16(18-17-15)22-14-6-4-3-5-12(14)20(13)2/h3-6,11H,7-10H2,1-2H3	SDYYIRPAZHJOLM-UHFFFAOYSA-N					compound annotation
0391_009363	CEP-28122	C28H35ClN6O3	1.9919	57325421	COC1=C(C=CC2=C1CC[C@H](CC2)N3CCOCC3)NC4=NC=C(C(=N4)N[C@@H]5[C@@H]6C[C@H]([C@@H]5C(=O)N)C=C6)Cl	COc1c(Nc2ncc(Cl)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc2c1CCC(N1CCOCC1)CC2	InChI=1S/C28H35ClN6O3/c1-37-25-20-8-7-19(35-10-12-38-13-11-35)6-4-16(20)5-9-22(25)32-28-31-15-21(29)27(34-28)33-24-18-3-2-17(14-18)23(24)26(30)36/h2-3,5,9,15,17-19,23-24H,4,6-8,10-14H2,1H3,(H2,30,36)(H2,31,32,33,34)/t17-,18+,19+,23+,24-/m1/s1	LAJAFFLJAJMYLK-CVOKMOJFSA-N					removed another duplicate entry; compound annotation
0391_009365	ANAGRELIDE HYDROCHLORIDE	C10H7Cl2N3O	2.4774	135409400		O=C1CN2Cc3c(ccc(Cl)c3Cl)NC2=N1	InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)	OTBXOEAOVRKTNQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009367	Mozavaptan	C27H29N3O2	2.6002	119369		Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1	InChI=1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31)	WRNXUQJJCIZICJ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009369	Ku-0063794	C25H31N5O4	2.6256	16736978	C[C@@H]1CN(C[C@@H](O1)C)C2=NC3=C(C=CC(=N3)C4=CC(=C(C=C4)OC)CO)C(=N2)N5CCOCC5	COc1c(CO)cc(-c2nc3c(cc2)c(N2CCOCC2)nc(N2CC(C)OC(C)C2)n3)cc1	InChI=1S/C25H31N5O4/c1-16-13-30(14-17(2)34-16)25-27-23-20(24(28-25)29-8-10-33-11-9-29)5-6-21(26-23)18-4-7-22(32-3)19(12-18)15-31/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17+	RFSMUFRPPYDYRD-CALCHBBNSA-N					doublet; compound annotation
0391_009370	Ku-0063794	C25H31N5O4	2.7188	16736978	C[C@@H]1CN(C[C@@H](O1)C)C2=NC3=C(C=CC(=N3)C4=CC(=C(C=C4)OC)CO)C(=N2)N5CCOCC5	COc1c(CO)cc(-c2nc3c(cc2)c(N2CCOCC2)nc(N2CC(C)OC(C)C2)n3)cc1	InChI=1S/C25H31N5O4/c1-16-13-30(14-17(2)34-16)25-27-23-20(24(28-25)29-8-10-33-11-9-29)5-6-21(26-23)18-4-7-22(32-3)19(12-18)15-31/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17+	RFSMUFRPPYDYRD-CALCHBBNSA-N					doublet; removed another duplicate entry; compound annotation
0391_009372	RN486	C35H35FN6O3	2.7584	46908026		CN1CCN(c2cnc(Nc3cc(-c4c(CO)c(-n5ccc6cc(C7CC7)cc(F)c6c5=O)ccc4)cn(C)c3=O)cc2)CC1	InChI=1S/C35H35FN6O3/c1-39-12-14-41(15-13-39)26-8-9-32(37-19-26)38-30-18-25(20-40(2)34(30)44)27-4-3-5-31(28(27)21-43)42-11-10-23-16-24(22-6-7-22)17-29(36)33(23)35(42)45/h3-5,8-11,16-20,22,43H,6-7,12-15,21H2,1-2H3,(H,37,38)	ZTUJNJAKTLHBEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009374	tolterodine	C22H31NO	3.058	443879	CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2	Cc1cc(C(CCN(C(C)C)C(C)C)c2ccccc2)c(O)cc1	InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1	OOGJQPCLVADCPB-HXUWFJFHSA-N					doublet; compound annotation
0391_009375	Compound 401	C16H15N3O2	3.1977	10039361		O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12	InChI=1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2	BVRDQVRQVGRNHG-UHFFFAOYSA-N					doublet; compound annotation
0391_009376	Compound 401	C16H15N3O2	3.2006	10039361		O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12	InChI=1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2	BVRDQVRQVGRNHG-UHFFFAOYSA-N					doublet; compound annotation
0391_009377	AGI-5198	C27H31FN4O2	3.6253	56645356		Cc1ccccc1C(C(=O)NC1CCCCC1)N(C(=O)Cn1ccnc1C)c1cc(F)ccc1	InChI=1S/C27H31FN4O2/c1-19-9-6-7-14-24(19)26(27(34)30-22-11-4-3-5-12-22)32(23-13-8-10-21(28)17-23)25(33)18-31-16-15-29-20(31)2/h6-10,13-17,22,26H,3-5,11-12,18H2,1-2H3,(H,30,34)	FNYGWXSATBUBER-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009379	NBTGR	C17H18N6O6S	2.5809	96048	C1=CC(=CC=C1CSC2=NC(=NC3=C2N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N)[N+](=O)[O-]	Nc1nc2c(ncn2C2OC(CO)C(O)C2O)c(SCc2ccc([N+](=O)[O-])cc2)n1	InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12-,13-,16-/m1/s1	BRSNNJIJEZWSBU-XNIJJKJLSA-N					compound annotation
0391_009380	Vabicaserin	C15H20N2	2.5963	11521822	C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1	c1cc2c3c(c1)C1CCCC1CN3CCNC2	InChI=1S/C15H20N2/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17/h1,3,6,12-13,16H,2,4-5,7-10H2/t12-,13-/m0/s1	NPTIPEQJIDTVKR-STQMWFEESA-N					removed another duplicate entry; compound annotation
0391_009382	Telatinib	C20H16ClN5O3	2.9685	9808844		CNC(=O)c1nccc(COc2nnc(Nc3ccc(Cl)cc3)c3c2occ3)c1	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	QFCXANHHBCGMAS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009384	SJB3-019A	C16H8N2O3	3.129	78358325		O=C1c2ccccc2C(=O)c2c1nc(-c1cnccc1)o2	InChI=1S/C16H8N2O3/c19-13-10-5-1-2-6-11(10)14(20)15-12(13)18-16(21-15)9-4-3-7-17-8-9/h1-8H	DOYPPVCQHGJUBC-UHFFFAOYSA-N					compound annotation
0391_009385	951650-22-9	C23H19N3O	3.2183	16747643		CC(C)(O)c1cc2c(cc1)n(-c1cccc(-c3ccccc3C#N)c1)cn2	InChI=1S/C23H19N3O/c1-23(2,27)18-10-11-22-21(13-18)25-15-26(22)19-8-5-7-16(12-19)20-9-4-3-6-17(20)14-24/h3-13,15,27H,1-2H3	HLKYSQGBIIIQJN-UHFFFAOYSA-N					doublet; compound annotation
0391_009386	951650-22-9	C23H19N3O	3.221	16747643		CC(C)(O)c1cc2c(cc1)n(-c1cccc(-c3ccccc3C#N)c1)cn2	InChI=1S/C23H19N3O/c1-23(2,27)18-10-11-22-21(13-18)25-15-26(22)19-8-5-7-16(12-19)20-9-4-3-6-17(20)14-24/h3-13,15,27H,1-2H3	HLKYSQGBIIIQJN-UHFFFAOYSA-N					doublet; compound annotation
0391_009387	Telatinib	C20H16ClN5O3	3.4095	9808844		CNC(=O)c1nccc(COc2nnc(Nc3ccc(Cl)cc3)c3c2occ3)c1	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	QFCXANHHBCGMAS-UHFFFAOYSA-N					doublet; compound annotation
0391_009388	Bioymifi	C22H12BrN3O4S	3.8973	70678419	C1=CC(=CC=C1N2C(=O)/C(=C/C3=CC=C(O3)C4=CC5=C(C=C4)C(=O)NC5=O)/SC2=N)Br	N=C1SC(=Cc2ccc(-c3cc4c(cc3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Br)cc1	InChI=1S/C22H12BrN3O4S/c23-12-2-4-13(5-3-12)26-21(29)18(31-22(26)24)10-14-6-8-17(30-14)11-1-7-15-16(9-11)20(28)25-19(15)27/h1-10,24H,(H,25,27,28)/b18-10-,24-22?	ULBOWKXOFOTCMU-NLDKGBHCSA-N					doublet; compound annotation
0391_009389	Telatinib	C20H16ClN5O3	3.9206	9808844		CNC(=O)c1nccc(COc2nnc(Nc3ccc(Cl)cc3)c3c2occ3)c1	InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)	QFCXANHHBCGMAS-UHFFFAOYSA-N					doublet; compound annotation
0391_009390	Bioymifi	C22H12BrN3O4S	4.1179	70678419	C1=CC(=CC=C1N2C(=O)/C(=C/C3=CC=C(O3)C4=CC5=C(C=C4)C(=O)NC5=O)/SC2=N)Br	N=C1SC(=Cc2ccc(-c3cc4c(cc3)C(=O)NC4=O)o2)C(=O)N1c1ccc(Br)cc1	InChI=1S/C22H12BrN3O4S/c23-12-2-4-13(5-3-12)26-21(29)18(31-22(26)24)10-14-6-8-17(30-14)11-1-7-15-16(9-11)20(28)25-19(15)27/h1-10,24H,(H,25,27,28)/b18-10-,24-22?	ULBOWKXOFOTCMU-NLDKGBHCSA-N					doublet; compound annotation
0391_009391	Resatorvid	C15H17ClFNO4S	4.311	11703255	CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl	CCOC(=O)C1=CCCCC1S(=O)(=O)Nc1c(Cl)cc(F)cc1	InChI=1S/C15H17ClFNO4S/c1-2-22-15(19)11-5-3-4-6-14(11)23(20,21)18-13-8-7-10(17)9-12(13)16/h5,7-9,14,18H,2-4,6H2,1H3/t14-/m1/s1	LEEIJTHMHDMWLJ-CQSZACIVSA-N					compound annotation
0391_009392	Peiminine	C27H43NO3	2.253	167691	C[C@H]1CC[C@H]2[C@@]([C@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4CC(=O)[C@@H]6[C@@]5(CC[C@@H](C6)O)C)(C)O	CC1CCC2N(C1)CC1C3CC4C(CC(=O)C5CC(O)CCC54C)C3CCC1C2(C)O	InChI=1S/C27H43NO3/c1-15-4-7-25-27(3,31)21-6-5-17-18(20(21)14-28(25)13-15)11-22-19(17)12-24(30)23-10-16(29)8-9-26(22,23)2/h15-23,25,29,31H,4-14H2,1-3H3/t15-,16-,17+,18+,19-,20-,21-,22-,23+,25-,26+,27-/m0/s1	IQDIERHFZVCNRZ-YUYPDVIUSA-N					compound annotation
0391_009393	perphenazine	C21H26ClN3OS	3.1422	4748		OCCN1CCN(CCCN2c3ccccc3Sc3c2cc(Cl)cc3)CC1	InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2	RGCVKNLCSQQDEP-UHFFFAOYSA-N					compound annotation
0391_009394	BI-1935	C24H21F3N6O3	3.1901	57861407		CCOCCn1cc(C(=O)Nc2ncc(-n3nc(-c4cnccc4)cc3C(F)(F)F)cc2)ccc1=O	InChI=1S/C24H21F3N6O3/c1-2-36-11-10-32-15-17(5-8-22(32)34)23(35)30-21-7-6-18(14-29-21)33-20(24(25,26)27)12-19(31-33)16-4-3-9-28-13-16/h3-9,12-15H,2,10-11H2,1H3,(H,29,30,35)	KMESAVNRPDKZCQ-UHFFFAOYSA-N					compound annotation
0391_009395	Robustine	C12H9NO3	3.3449	164950		COc1c2ccoc2nc2c1cccc2O	InChI=1S/C12H9NO3/c1-15-11-7-3-2-4-9(14)10(7)13-12-8(11)5-6-16-12/h2-6,14H,1H3	VGVNNMLKTSWBAR-UHFFFAOYSA-N					compound annotation
0391_009396	316173-57-6	C20H19N7O2	3.7702	10668061		COc1ccc(CCCn2ncc3c2nc(N)n2nc(-c4ccco4)nc32)cc1	InChI=1S/C20H19N7O2/c1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18/h3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24)	AEULVFLPCJOBCE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009398	Difamilast	C23H24F2N2O5	4.9872	57855696		CCOc1ccccc1C(=O)NCc1coc(-c2cc(OC(C)C)c(OC(F)F)cc2)n1	InChI=1S/C23H24F2N2O5/c1-4-29-18-8-6-5-7-17(18)21(28)26-12-16-13-30-22(27-16)15-9-10-19(32-23(24)25)20(11-15)31-14(2)3/h5-11,13-14,23H,4,12H2,1-3H3,(H,26,28)	VFBILHPIHUPBPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009400	Galanthaminone	C17H19NO3	0.8849	10356588	CN1CC[C@@]23C=CC(=O)C[C@@H]2OC4=C(C=CC(=C34)C1)OC	COc1c2OC3CC(=O)C=CC34CCN(C)Cc(c24)cc1	InChI=1S/C17H19NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,14H,7-10H2,1-2H3/t14-,17-/m0/s1	QENVUHCAYXAROT-YOEHRIQHSA-N					doublet; compound annotation
0391_009401	Acetylpyrazine	C6H6N2O	1.0165	30914		CC(=O)c1nccnc1	InChI=1S/C6H6N2O/c1-5(9)6-4-7-2-3-8-6/h2-4H,1H3	DBZAKQWXICEWNW-UHFFFAOYSA-N					compound annotation
0391_009402	Galanthaminone	C17H19NO3	1.0885	10356588	CN1CC[C@@]23C=CC(=O)C[C@@H]2OC4=C(C=CC(=C34)C1)OC	COc1c2OC3CC(=O)C=CC34CCN(C)Cc(c24)cc1	InChI=1S/C17H19NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,14H,7-10H2,1-2H3/t14-,17-/m0/s1	QENVUHCAYXAROT-YOEHRIQHSA-N					doublet; compound annotation
0391_009403	Galanthaminone	C17H19NO3	1.2757	10356588	CN1CC[C@@]23C=CC(=O)C[C@@H]2OC4=C(C=CC(=C34)C1)OC	COc1c2OC3CC(=O)C=CC34CCN(C)Cc(c24)cc1	InChI=1S/C17H19NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,14H,7-10H2,1-2H3/t14-,17-/m0/s1	QENVUHCAYXAROT-YOEHRIQHSA-N					doublet; removed another duplicate entry; compound annotation
0391_009405	Leonurine	C14H21N3O5	1.6824	161464		COc1cc(C(=O)OCCCCN=C(N)N)cc(OC)c1O	InChI=1S/C14H21N3O5/c1-20-10-7-9(8-11(21-2)12(10)18)13(19)22-6-4-3-5-17-14(15)16/h7-8,18H,3-6H2,1-2H3,(H4,15,16,17)	WNGSUWLDMZFYNZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009407	Columbamine	C20H20NO4+	2.2002	72310		COc1c(O)cc2c(c1)CC[n+]1c-2cc2ccc(OC)c(OC)c2c1	InChI=1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-17(22)19(24-2)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1	YYFOFDHQVIODOQ-UHFFFAOYSA-O					compound annotation
0391_009408	Tubeimoside II	C63H98O30	2.9301	14037387		CC1OC2OC3C(OCC(O)C3O)OC(=O)C34CCC(C)(C)CC3C3=CCC5C6(C)CC(O)C(OC7OC(CO)C(O)C(O)C7OC7OCC(OC(=O)CC(C)(O)CC(=O)OC1C(OC1OCC(O)C(O)C1O)C2O)C(O)C7O)C(C)(CO)C6CCC5(C)C3(C)CC4O	InChI=1S/C63H98O30/c1-25-46-47(89-51-43(77)38(72)29(67)21-82-51)45(79)53(85-25)91-48-39(73)30(68)22-83-54(48)93-56(80)63-14-13-57(2,3)15-27(63)26-9-10-34-59(5)16-28(66)50(60(6,24-65)33(59)11-12-61(34,7)62(26,8)17-35(63)69)92-55-49(42(76)40(74)31(20-64)87-55)90-52-44(78)41(75)32(23-84-52)86-36(70)18-58(4,81)19-37(71)88-46/h9,25,27-35,38-55,64-69,72-79,81H,10-24H2,1-8H3	GBWAAJJGXQJTTA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009410	GSK2850163	C24H29Cl2N3O	3.4137	73291790	CC1=CC=C(C=C1)CNC(=O)N2CCC[C@@]3(C2)CCN(C3)CC4=CC(=C(C=C4)Cl)Cl	Cc1ccc(CNC(=O)N2CCCC3(CCN(Cc4cc(Cl)c(Cl)cc4)C3)C2)cc1	InChI=1S/C24H29Cl2N3O/c1-18-3-5-19(6-4-18)14-27-23(30)29-11-2-9-24(17-29)10-12-28(16-24)15-20-7-8-21(25)22(26)13-20/h3-8,13H,2,9-12,14-17H2,1H3,(H,27,30)/t24-/m1/s1	YFDASBFQKMHSSJ-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_009412	Digitonin	C56H92O29	3.6751	6474107	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)[C@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(C[C@H]([C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1	CC1CCC2(OC1)OC1C(O)C3C4CCC5CC(OC6OC(CO)C(OC7OC(CO)C(O)C(OC8OCC(O)C(O)C8O)C7OC7OC(CO)C(O)C(OC8OC(CO)C(O)C(O)C8O)C7O)C(O)C6O)C(O)CC5(C)C4CCC3(C)C1C2C	InChI=1S/C56H92O29/c1-19-7-10-56(75-17-19)20(2)31-45(85-56)37(67)32-22-6-5-21-11-26(24(61)12-55(21,4)23(22)8-9-54(31,32)3)76-50-42(72)39(69)44(30(16-60)80-50)81-53-48(47(36(66)29(15-59)79-53)83-49-40(70)33(63)25(62)18-74-49)84-52-43(73)46(35(65)28(14-58)78-52)82-51-41(71)38(68)34(64)27(13-57)77-51/h19-53,57-73H,5-18H2,1-4H3/t19-,20+,21+,22-,23+,24-,25-,26-,27-,28-,29-,30-,31+,32-,33+,34-,35+,36-,37+,38+,39-,40-,41-,42-,43-,44+,45-,46+,47+,48-,49+,50-,51+,52+,53+,54-,55+,56-/m1/s1	UVYVLBIGDKGWPX-KUAJCENISA-N					removed another duplicate entry; compound annotation
0391_009414	CFM-2	C17H17N3O3	1.9133	4377504		COc1c(OC)cc2C(c3ccc(N)cc3)=NNC(=O)Cc2c1	InChI=1S/C17H17N3O3/c1-22-14-7-11-8-16(21)19-20-17(13(11)9-15(14)23-2)10-3-5-12(18)6-4-10/h3-7,9H,8,18H2,1-2H3,(H,19,21)	MJKADKZSYQWGLL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009417	AT7867	C20H20ClN3	2.5313	11175137		Clc1ccc(C2(c3ccc(-c4c[nH]nc4)cc3)CCNCC2)cc1	InChI=1S/C20H20ClN3/c21-19-7-5-18(6-8-19)20(9-11-22-12-10-20)17-3-1-15(2-4-17)16-13-23-24-14-16/h1-8,13-14,22H,9-12H2,(H,23,24)	LZMOSYUFVYJEPY-UHFFFAOYSA-N					doublet; compound annotation
0391_009418	Bozitinib	C20H15F3N8	3.0205	72202701		Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cn(C6CC6)nc5)nn34)c(F)cc2n1	InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3	QHXLXUIZUCJRKV-UHFFFAOYSA-N					doublet; compound annotation
0391_009419	Bozitinib	C20H15F3N8	3.0254	72202701		Cn1cc2cc(C(F)(F)c3nnc4ccc(-c5cn(C6CC6)nc5)nn34)c(F)cc2n1	InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3	QHXLXUIZUCJRKV-UHFFFAOYSA-N					doublet; compound annotation
0391_009420	barnidipine	C27H29N3O6	3.1422	443869	CC1=C([C@@H](C(=C(N1)C)C(=O)O[C@H]2CCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC	COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(Cc3ccccc3)C2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C27H29N3O6/c1-17-23(26(31)35-3)25(20-10-7-11-21(14-20)30(33)34)24(18(2)28-17)27(32)36-22-12-13-29(16-22)15-19-8-5-4-6-9-19/h4-11,14,22,25,28H,12-13,15-16H2,1-3H3/t22-,25-/m0/s1	VXMOONUMYLCFJD-DHLKQENFSA-N					removed another duplicate entry; compound annotation
0391_009422	AZD-0284	C21H18F6N2O5S	3.3389	129205086	CC(=O)N1CC2=C([C@@H]1C(=O)NC3=CC=C(C=C3)C(C(F)(F)F)(C(F)(F)F)O)C=CC(=C2)S(=O)(=O)C	CC(=O)N1Cc2c(ccc(S(C)(=O)=O)c2)C1C(=O)Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1	InChI=1S/C21H18F6N2O5S/c1-11(30)29-10-12-9-15(35(2,33)34)7-8-16(12)17(29)18(31)28-14-5-3-13(4-6-14)19(32,20(22,23)24)21(25,26)27/h3-9,17,32H,10H2,1-2H3,(H,28,31)/t17-/m1/s1	QYYZXEPEVBXNNA-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_009424	Idalopirdine	C20H19F5N2O	3.3438	21071390		Fc1cc2c(cc1)c(CCNCc1cc(OCC(F)(F)C(F)F)ccc1)c[nH]2	InChI=1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2	YBAWYTYNMZWMMJ-UHFFFAOYSA-N					compound annotation
0391_009425	Salmeterol	C25H37NO4	3.3528	5152		OCc1c(O)ccc(C(O)CNCCCCCCOCCCCc2ccccc2)c1	InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2	GIIZNNXWQWCKIB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009427	Pavinetant	C26H25N3O3S	4.1508	23649245	CC[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)NS(=O)(=O)C	CCC(NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1	InChI=1S/C26H25N3O3S/c1-3-21(18-12-6-4-7-13-18)28-26(30)23-20-16-10-11-17-22(20)27-24(19-14-8-5-9-15-19)25(23)29-33(2,31)32/h4-17,21,29H,3H2,1-2H3,(H,28,30)/t21-/m0/s1	QYTBBBAHNIWFOD-NRFANRHFSA-N					removed another duplicate entry; compound annotation
0391_009429	17374-26-4	C6HBr4N3	4.1601	1694		Brc1c(Br)c2n[nH]nc2c(Br)c1Br	InChI=1S/C6HBr4N3/c7-1-2(8)4(10)6-5(3(1)9)11-13-12-6/h(H,11,12,13)	OMZYUVOATZSGJY-UHFFFAOYSA-N					compound annotation
0391_009430	diprotin A	C17H31N3O4	1.7127	11902899	CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)[O-])[NH3+]	CCC(C)C(N)C(=O)N1CCCC1C(=O)NC(C(=O)O)C(C)CC	InChI=1S/C17H31N3O4/c1-5-10(3)13(18)16(22)20-9-7-8-12(20)15(21)19-14(17(23)24)11(4)6-2/h10-14H,5-9,18H2,1-4H3,(H,19,21)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1	JNTMAZFVYNDPLB-PEDHHIEDSA-N					compound annotation
0391_009431	2-ETHOXYBENZAMIDE	C9H11NO2	2.1897	3282		CCOc1ccccc1C(N)=O	InChI=1S/C9H11NO2/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H2,10,11)	SBNKFTQSBPKMBZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009433	AS-605240	C12H7N3O2S	2.338	5289247	C1=CC2=NC=CN=C2C=C1/C=C\3/C(=O)NC(=O)S3	O=C1NC(=O)C(=Cc2cc3nccnc3cc2)S1	InChI=1S/C12H7N3O2S/c16-11-10(18-12(17)15-11)6-7-1-2-8-9(5-7)14-4-3-13-8/h1-6H,(H,15,16,17)/b10-6-	SQWZFLMPDUSYGV-POHAHGRESA-N					doublet; compound annotation
0391_009434	AS-605240	C12H7N3O2S	2.4565	5289247	C1=CC2=NC=CN=C2C=C1/C=C\3/C(=O)NC(=O)S3	O=C1NC(=O)C(=Cc2cc3nccnc3cc2)S1	InChI=1S/C12H7N3O2S/c16-11-10(18-12(17)15-11)6-7-1-2-8-9(5-7)14-4-3-13-8/h1-6H,(H,15,16,17)/b10-6-	SQWZFLMPDUSYGV-POHAHGRESA-N					doublet; compound annotation
0391_009435	Ocaperidone	C24H25FN4O2	2.7585	71351		Cc1c(CCN2CCC(c3noc4c3ccc(F)c4)CC2)c(=O)n2cccc(C)c2n1	InChI=1S/C24H25FN4O2/c1-15-4-3-10-29-23(15)26-16(2)19(24(29)30)9-13-28-11-7-17(8-12-28)22-20-6-5-18(25)14-21(20)31-27-22/h3-6,10,14,17H,7-9,11-13H2,1-2H3	ZZQNEJILGNNOEP-UHFFFAOYSA-N					compound annotation
0391_009436	josamycin	C42H69NO15	3.3784	5282165	C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O	COC1C(OC(C)=O)CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C1OC1OC(C)C(OC2CC(C)(O)C(OC(=O)CC(C)C)C(C)O2)C(N(C)C)C1O	InChI=1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1	XJSFLOJWULLJQS-NGVXBBESSA-N					doublet; compound annotation
0391_009437	josamycin	C42H69NO15	3.4927	5282165	C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O	COC1C(OC(C)=O)CC(=O)OC(C)CC=CC=CC(O)C(C)CC(CC=O)C1OC1OC(C)C(OC2CC(C)(O)C(OC(=O)CC(C)C)C(C)O2)C(N(C)C)C1O	InChI=1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1	XJSFLOJWULLJQS-NGVXBBESSA-N					doublet; removed another duplicate entry; compound annotation
0391_009439	142878-12-4	C29H42N2O3	3.6238	114825	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NCCCCCCN4C(=O)CCC4=O)CCC5=C3C=CC(=C5)OC	COc1cc2c(cc1)C1CCC3(C)C(NCCCCCCN4C(=O)CCC4=O)CCC3C1CC2	InChI=1S/C29H42N2O3/c1-29-16-15-23-22-10-8-21(34-2)19-20(22)7-9-24(23)25(29)11-12-26(29)30-17-5-3-4-6-18-31-27(32)13-14-28(31)33/h8,10,19,23-26,30H,3-7,9,11-18H2,1-2H3/t23-,24-,25+,26+,29+/m1/s1	CJHWFIUASFBCKN-ZRJUGLEFSA-N					compound annotation
0391_009440	Orteronel	C18H17N3O2	1.2502	9796590	CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)[C@]3(CCN4C3=CN=C4)O	CNC(=O)c1cc2c(cc1)cc(C1(O)CCn3cncc31)cc2	InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1	OZPFIJIOIVJZMN-SFHVURJKSA-N					compound annotation
0391_009441	JDTic	C28H39N3O3	1.4484	9956146	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](C(C)C)NC(=O)[C@H]3CC4=C(CN3)C=C(C=C4)O	CC(C)C(CN1CCC(C)(c2cc(O)ccc2)C(C)C1)NC(=O)C1Cc2c(cc(O)cc2)CN1	InChI=1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1	ZLVXBBHTMQJRSX-VMGNSXQWSA-N					doublet; compound annotation
0391_009442	Pivagabine	C9H17NO3	1.5164	68888		CC(C)(C)C(=O)NCCCC(=O)O	InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12)	SRPNQDXRVRCTNK-UHFFFAOYSA-N					doublet; compound annotation
0391_009443	Pivagabine	C9H17NO3	1.5197	68888		CC(C)(C)C(=O)NCCCC(=O)O	InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12)	SRPNQDXRVRCTNK-UHFFFAOYSA-N					doublet; compound annotation
0391_009444	1005504-62-0	C21H23Cl2N5O	1.5655	53258905		Nc1nc2c(c(OCC3CCN(Cc4c(Cl)cccc4Cl)CC3)ccc2)c(N)n1	InChI=1S/C21H23Cl2N5O/c22-15-3-1-4-16(23)14(15)11-28-9-7-13(8-10-28)12-29-18-6-2-5-17-19(18)20(24)27-21(25)26-17/h1-6,13H,7-12H2,(H4,24,25,26,27)	MNLHFGXIUJNDAF-UHFFFAOYSA-N					compound annotation
0391_009445	JDTic	C28H39N3O3	1.6376	9956146	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](C(C)C)NC(=O)[C@H]3CC4=C(CN3)C=C(C=C4)O	CC(C)C(CN1CCC(C)(c2cc(O)ccc2)C(C)C1)NC(=O)C1Cc2c(cc(O)cc2)CN1	InChI=1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1	ZLVXBBHTMQJRSX-VMGNSXQWSA-N					doublet; compound annotation
0391_009446	SPOP-IN-6b	C28H32N6O3	2.0862	127244279		Cc1cccn2c(=O)c3c(nc12)n(CCc1ccccc1)c(=N)c(C(=O)NCCCN1CCOCC1)c3	InChI=1S/C28H32N6O3/c1-20-7-5-13-34-25(20)31-26-23(28(34)36)19-22(24(29)33(26)14-10-21-8-3-2-4-9-21)27(35)30-11-6-12-32-15-17-37-18-16-32/h2-5,7-9,13,19,29H,6,10-12,14-18H2,1H3,(H,30,35)	RYTGHNMOSCSWJT-UHFFFAOYSA-N					compound annotation
0391_009447	LEXIBULIN	C24H30N6O2	2.2885	11351021	CCC[C@@H](C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC	CCCC(Nc1nc(-c2cc(OC)c(NC(=O)NCC)cc2)ncc1C)c1cnccc1	InChI=1S/C24H30N6O2/c1-5-8-19(18-9-7-12-25-15-18)28-22-16(3)14-27-23(30-22)17-10-11-20(21(13-17)32-4)29-24(31)26-6-2/h7,9-15,19H,5-6,8H2,1-4H3,(H2,26,29,31)(H,27,28,30)/t19-/m0/s1	MTJHLONVHHPNSI-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_009449	JDTic	C28H39N3O3	2.7851	9956146	C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](C(C)C)NC(=O)[C@H]3CC4=C(CN3)C=C(C=C4)O	CC(C)C(CN1CCC(C)(c2cc(O)ccc2)C(C)C1)NC(=O)C1Cc2c(cc(O)cc2)CN1	InChI=1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1	ZLVXBBHTMQJRSX-VMGNSXQWSA-N					doublet; compound annotation
0391_009450	BI-D1870	C19H23F2N5O2	2.7939	25023738		CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C	InChI=1S/C19H23F2N5O2/c1-10(2)5-6-26-11(3)18(28)25(4)15-9-22-19(24-17(15)26)23-12-7-13(20)16(27)14(21)8-12/h7-11,27H,5-6H2,1-4H3,(H,22,23,24)	DTEKTGDVSARYDS-UHFFFAOYSA-N					compound annotation
0391_009451	SC75741	C29H23N7O2S2	3.2518	23661638		O=C(c1ccccc1)c1cc2c(cc1)nc(NC(=O)c1csc(C3CCN(c4ncnc5c4scc5)CC3)n1)[nH]2	InChI=1S/C29H23N7O2S2/c37-24(17-4-2-1-3-5-17)19-6-7-20-22(14-19)34-29(33-20)35-27(38)23-15-40-28(32-23)18-8-11-36(12-9-18)26-25-21(10-13-39-25)30-16-31-26/h1-7,10,13-16,18H,8-9,11-12H2,(H2,33,34,35,38)	QNZVBFMXWNWVKG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009453	213743-31-8	C23H22N4O	4.0132	6603792		Nc1c2c(-c3ccc(Oc4ccccc4)cc3)cn(C3CCCC3)c2ncn1	InChI=1S/C23H22N4O/c24-22-21-20(14-27(17-6-4-5-7-17)23(21)26-15-25-22)16-10-12-19(13-11-16)28-18-8-2-1-3-9-18/h1-3,8-15,17H,4-7H2,(H2,24,25,26)	FMETVQKSDIOGPX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009455	AZD-5423	C25H21F4N3O3	5.2107	24825740	C[C@@H]([C@@H](C1=CC(=CC=C1)OC)OC2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)NC(=O)C(F)(F)F	COc1cccc(C(Oc2cc3c(cc2)n(-c2ccc(F)cc2)nc3)C(C)NC(=O)C(F)(F)F)c1	InChI=1S/C25H21F4N3O3/c1-15(31-24(33)25(27,28)29)23(16-4-3-5-20(12-16)34-2)35-21-10-11-22-17(13-21)14-30-32(22)19-8-6-18(26)7-9-19/h3-15,23H,1-2H3,(H,31,33)/t15-,23-/m0/s1	FCNQMDSJHADDFT-WNSKOXEYSA-N					compound annotation
0391_009456	1004990-28-6	C20H22F2N6O	1.6013	25061501	CCC1=CNC2=C1C(=NC=N2)N3CC[C@@](C3)(CNC(=O)C4=C(C=C(C=C4)F)F)N	CCc1c[nH]c2c1c(N1CCC(N)(CNC(=O)c3c(F)cc(F)cc3)C1)ncn2	InChI=1S/C20H22F2N6O/c1-2-12-8-24-17-16(12)18(27-11-26-17)28-6-5-20(23,10-28)9-25-19(29)14-4-3-13(21)7-15(14)22/h3-4,7-8,11H,2,5-6,9-10,23H2,1H3,(H,25,29)(H,24,26,27)/t20-/m0/s1	MOZRQQTUYAYCQT-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_009458	BIX02189	C27H28N4O2	2.4664	135659062		CN(C)Cc1cc(N=C(c2ccccc2)c2c(O)[nH]c3c2ccc(C(=O)N(C)C)c3)ccc1	InChI=1S/C27H28N4O2/c1-30(2)17-18-9-8-12-21(15-18)28-25(19-10-6-5-7-11-19)24-22-14-13-20(27(33)31(3)4)16-23(22)29-26(24)32/h5-16,29,32H,17H2,1-4H3	ZGXOBLVQIVXKEB-UHFFFAOYSA-N					doublet; compound annotation
0391_009459	BIX02189	C27H28N4O2	2.4713	135659062		CN(C)Cc1cc(N=C(c2ccccc2)c2c(O)[nH]c3c2ccc(C(=O)N(C)C)c3)ccc1	InChI=1S/C27H28N4O2/c1-30(2)17-18-9-8-12-21(15-18)28-25(19-10-6-5-7-11-19)24-22-14-13-20(27(33)31(3)4)16-23(22)29-26(24)32/h5-16,29,32H,17H2,1-4H3	ZGXOBLVQIVXKEB-UHFFFAOYSA-N					doublet; compound annotation
0391_009460	CLONIXIN	C13H11ClN2O2	2.8087	28718		Cc1c(Nc2c(C(=O)O)cccn2)cccc1Cl	InChI=1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18)	CLOMYZFHNHFSIQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009462	SCHEMBL20127881	C14H23N3	2.9994	4122936		CCCCCCNC(N)=NCc1ccccc1	InChI=1S/C14H23N3/c1-2-3-4-8-11-16-14(15)17-12-13-9-6-5-7-10-13/h5-7,9-10H,2-4,8,11-12H2,1H3,(H3,15,16,17)	SOKBOENXKNZLSO-UHFFFAOYSA-N					compound annotation
0391_009463	Ki8751	C24H18F3N3O4	3.3018	11317348		COc1cc2nccc(Oc3cc(F)c(NC(=O)Nc4c(F)cc(F)cc4)cc3)c2cc1OC	InChI=1S/C24H18F3N3O4/c1-32-22-11-15-20(12-23(22)33-2)28-8-7-21(15)34-14-4-6-19(17(27)10-14)30-24(31)29-18-5-3-13(25)9-16(18)26/h3-12H,1-2H3,(H2,29,30,31)	LFKQSJNCVRGFCC-UHFFFAOYSA-N					compound annotation
0391_009464	484049-04-9	C18H13FN4O2	3.4486	660311		O=C1NC(=O)C(c2cn(-c3ccccc3)nc2-c2ccc(F)cc2)N1	InChI=1S/C18H13FN4O2/c19-12-8-6-11(7-9-12)15-14(16-17(24)21-18(25)20-16)10-23(22-15)13-4-2-1-3-5-13/h1-10,16H,(H2,20,21,24,25)	MPQWYPLPWGUMJE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009466	Hck-IN-1	C16H11ClN6O3S	4.7387	4553981		NC(=S)n1[nH]c(-c2ccc([N+](=O)[O-])cc2)c(N=Nc2cc(Cl)ccc2)c1=O	InChI=1S/C16H11ClN6O3S/c17-10-2-1-3-11(8-10)19-20-14-13(21-22(15(14)24)16(18)27)9-4-6-12(7-5-9)23(25)26/h1-8,21H,(H2,18,27)	LEQSBTDRMOZWRP-UHFFFAOYSA-N					compound annotation
0391_009467	AZ12601011	C19H15N5	1.5887	137796280		c1ccc(-c2nc3c(CCC3)c(-n3ccc4c3ccnc4)n2)nc1	InChI=1S/C19H15N5/c1-2-9-21-16(5-1)18-22-15-6-3-4-14(15)19(23-18)24-11-8-13-12-20-10-7-17(13)24/h1-2,5,7-12H,3-4,6H2	KQCNNLRNSIXEJU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009469	1062368-24-4	C25H22N6	1.6754	25195294		c1ccc2c(-c3c4ncc(-c5ccc(N6CCNCC6)cc5)cn4nc3)ccnc2c1	InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2	CDOVNWNANFFLFJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009471	nmdpef	C21H18N4O3	2.9965	46861897		COc1nc2c(cc1)n1Cc3c(nccc3)-c1c2CCNC(=O)c1ccco1	InChI=1S/C21H18N4O3/c1-27-17-7-6-15-19(24-17)14(8-10-23-21(26)16-5-3-11-28-16)20-18-13(12-25(15)20)4-2-9-22-18/h2-7,9,11H,8,10,12H2,1H3,(H,23,26)	XJIUMLVQBQKCJA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009473	920022-47-5	C25H28ClN3O2	3.2381	59657596		CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2c1cc(Cl)cc2	InChI=1S/C25H28ClN3O2/c1-27(2)13-14-29-16-21(20-8-7-19(26)15-23(20)29)24(30)28-11-9-25(10-12-28)22-6-4-3-5-18(22)17-31-25/h3-8,15-16H,9-14,17H2,1-2H3	QZXVLRCMAHJVIP-UHFFFAOYSA-N					doublet; compound annotation
0391_009474	920022-47-5	C25H28ClN3O2	3.2409	59657596		CN(C)CCn1cc(C(=O)N2CCC3(CC2)OCc2ccccc23)c2c1cc(Cl)cc2	InChI=1S/C25H28ClN3O2/c1-27(2)13-14-29-16-21(20-8-7-19(26)15-23(20)29)24(30)28-11-9-25(10-12-28)22-6-4-3-5-18(22)17-31-25/h3-8,15-16H,9-14,17H2,1-2H3	QZXVLRCMAHJVIP-UHFFFAOYSA-N					doublet; compound annotation
0391_009475	MCL-1/BCL-2-IN-2	C20H15BrN2O2S	3.6439	145712376		NCCN1C(=O)c2c3c(ccc(Sc4ccc(Br)cc4)c3ccc2)C1=O	InChI=1S/C20H15BrN2O2S/c21-12-4-6-13(7-5-12)26-17-9-8-16-18-14(17)2-1-3-15(18)19(24)23(11-10-22)20(16)25/h1-9H,10-11,22H2	LPOALFWTLPKKNW-UHFFFAOYSA-N					compound annotation
0391_009476	DPA-714	C22H27FN4O2	3.8871	24895172		CCN(CC)C(=O)Cc1c2nc(C)cc(C)n2nc1-c1ccc(OCCF)cc1	InChI=1S/C22H27FN4O2/c1-5-26(6-2)20(28)14-19-21(17-7-9-18(10-8-17)29-12-11-23)25-27-16(4)13-15(3)24-22(19)27/h7-10,13H,5-6,11-12,14H2,1-4H3	FLZZFWBNYJNHMY-UHFFFAOYSA-N					doublet; compound annotation
0391_009477	DPA-714	C22H27FN4O2	3.8898	24895172		CCN(CC)C(=O)Cc1c2nc(C)cc(C)n2nc1-c1ccc(OCCF)cc1	InChI=1S/C22H27FN4O2/c1-5-26(6-2)20(28)14-19-21(17-7-9-18(10-8-17)29-12-11-23)25-27-16(4)13-15(3)24-22(19)27/h7-10,13H,5-6,11-12,14H2,1-4H3	FLZZFWBNYJNHMY-UHFFFAOYSA-N					doublet; compound annotation
0391_009478	BTZ043 Racemate	C17H16F3N3O5S	4.2138	49769085		CC1COC2(CCN(c3nc(=O)c4c(s3)c([N+](=O)[O-])cc(C(F)(F)F)c4)CC2)O1	InChI=1S/C17H16F3N3O5S/c1-9-8-27-16(28-9)2-4-22(5-3-16)15-21-14(24)11-6-10(17(18,19)20)7-12(23(25)26)13(11)29-15/h6-7,9H,2-5,8H2,1H3	GTUIRORNXIOHQR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009480	CDDO-2P-Im	C39H46N4O3	5.0826	135397767	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)N6C=C(N=C6)C7=CC=CC=N7	CC1(C)CCC2(C(=O)n3cnc(-c4ccccn4)c3)CCC3(C)C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C39H46N4O3/c1-34(2)13-15-39(33(46)43-22-27(42-23-43)26-10-8-9-17-41-26)16-14-38(7)31(25(39)20-34)28(44)18-30-36(5)19-24(21-40)32(45)35(3,4)29(36)11-12-37(30,38)6/h8-10,17-19,22-23,25,29,31H,11-16,20H2,1-7H3/t25-,29-,31-,36-,37+,38+,39-/m0/s1	NXUDOCUNEVFUGK-DIJMLVISSA-N					removed another duplicate entry; compound annotation
0391_009482	Vildagliptin	C17H25N3O2	1.0045	6918537	C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N	N#CC1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2	InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1	SYOKIDBDQMKNDQ-XWTIBIIYSA-N					removed another duplicate entry; compound annotation
0391_009484	Miridesap	C16H24N2O6	1.6781	125516	C1C[C@@H](N(C1)C(=O)CCCCC(=O)N2CCC[C@@H]2C(=O)O)C(=O)O	O=C(O)C1CCCN1C(=O)CCCCC(=O)N1CCCC1C(=O)O	InChI=1S/C16H24N2O6/c19-13(17-9-3-5-11(17)15(21)22)7-1-2-8-14(20)18-10-4-6-12(18)16(23)24/h11-12H,1-10H2,(H,21,22)(H,23,24)/t11-,12-/m1/s1	HZLAWYIBLZNRFZ-VXGBXAGGSA-N					removed another duplicate entry; compound annotation
0391_009486	Samuraciclib	C22H30N6O	2.1227	91844733	CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O	CC(C)c1c2nc(NCC3CCNCC3O)cc(NCc3ccccc3)n2nc1	InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1	YCVGLKWJKIKVBI-MJGOQNOKSA-N					doublet; compound annotation
0391_009487	Samuraciclib	C22H30N6O	2.1303	91844733	CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O	CC(C)c1c2nc(NCC3CCNCC3O)cc(NCc3ccccc3)n2nc1	InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1	YCVGLKWJKIKVBI-MJGOQNOKSA-N					doublet; compound annotation
0391_009488	Samuraciclib	C22H30N6O	2.6908	91844733	CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC[C@H]4CCNC[C@@H]4O	CC(C)c1c2nc(NCC3CCNCC3O)cc(NCc3ccccc3)n2nc1	InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1	YCVGLKWJKIKVBI-MJGOQNOKSA-N					doublet; compound annotation
0391_009489	TPPU	C16H20F3N3O3	3.4748	44142782		CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1	InChI=1S/C16H20F3N3O3/c1-2-14(23)22-9-7-12(8-10-22)21-15(24)20-11-3-5-13(6-4-11)25-16(17,18)19/h3-6,12H,2,7-10H2,1H3,(H2,20,21,24)	AAJMQTLFRTZCJK-UHFFFAOYSA-N					doublet; compound annotation
0391_009490	TPPU	C16H20F3N3O3	3.4781	44142782		CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1	InChI=1S/C16H20F3N3O3/c1-2-14(23)22-9-7-12(8-10-22)21-15(24)20-11-3-5-13(6-4-11)25-16(17,18)19/h3-6,12H,2,7-10H2,1H3,(H2,20,21,24)	AAJMQTLFRTZCJK-UHFFFAOYSA-N					doublet; compound annotation
0391_009491	DMU2105	C18H13NO	3.8143	8854335	C1=CC=C2C=C(C=CC2=C1)/C=C/C(=O)C3=CN=CC=C3	O=C(C=Cc1cc2ccccc2cc1)c1cnccc1	InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H/b10-8+	VWBDGXJRQZDLRV-CSKARUKUSA-N					doublet; compound annotation
0391_009492	ZM223	C23H17F3N4O2S2	3.9653	137628630		Nc1ccc(SCC(=O)Nc2cc3c(cc2)nc(NC(=O)c2ccc(C(F)(F)F)cc2)s3)cc1	InChI=1S/C23H17F3N4O2S2/c24-23(25,26)14-3-1-13(2-4-14)21(32)30-22-29-18-10-7-16(11-19(18)34-22)28-20(31)12-33-17-8-5-15(27)6-9-17/h1-11H,12,27H2,(H,28,31)(H,29,30,32)	XPPKZMFJCSEUSX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009495	DMU2105	C18H13NO	4.0535	8854335	C1=CC=C2C=C(C=CC2=C1)/C=C/C(=O)C3=CN=CC=C3	O=C(C=Cc1cc2ccccc2cc1)c1cnccc1	InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H/b10-8+	VWBDGXJRQZDLRV-CSKARUKUSA-N					doublet; removed another duplicate entry; compound annotation
0391_009497	HCH6-1	C28H27N3O4	4.1294	71697968	COC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)C4=CC=CC=C4	COC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1	InChI=1S/C28H27N3O4/c1-35-28(34)25(16-19-10-4-2-5-11-19)31-27(33)24(30-26(32)20-12-6-3-7-13-20)17-21-18-29-23-15-9-8-14-22(21)23/h2-15,18,24-25,29H,16-17H2,1H3,(H,30,32)(H,31,33)/t24-,25+/m0/s1	MPFZAIDTRUPTSU-LOSJGSFVSA-N					removed another duplicate entry; compound annotation
0391_009499	DMU2105	C18H13NO	4.6095	8854335	C1=CC=C2C=C(C=CC2=C1)/C=C/C(=O)C3=CN=CC=C3	O=C(C=Cc1cc2ccccc2cc1)c1cnccc1	InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H/b10-8+	VWBDGXJRQZDLRV-CSKARUKUSA-N					doublet; compound annotation
0391_009500	DMU2105	C18H13NO	4.8116	8854335	C1=CC=C2C=C(C=CC2=C1)/C=C/C(=O)C3=CN=CC=C3	O=C(C=Cc1cc2ccccc2cc1)c1cnccc1	InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H/b10-8+	VWBDGXJRQZDLRV-CSKARUKUSA-N					doublet; compound annotation
0391_009501	DC260126	C16H18FNO2S	5.0551	2843133		CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1	InChI=1S/C16H18FNO2S/c1-2-3-4-13-5-9-15(10-6-13)18-21(19,20)16-11-7-14(17)8-12-16/h5-12,18H,2-4H2,1H3	CNGHPXKWPGIDSK-UHFFFAOYSA-N					compound annotation
0391_009502	DMU2105	C18H13NO	5.3702	8854335	C1=CC=C2C=C(C=CC2=C1)/C=C/C(=O)C3=CN=CC=C3	O=C(C=Cc1cc2ccccc2cc1)c1cnccc1	InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H/b10-8+	VWBDGXJRQZDLRV-CSKARUKUSA-N					doublet; compound annotation
0391_009503	Anacetrapib	C30H25F10NO3	6.5778	11556427	C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)OC(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1C	InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1	MZZLGJHLQGUVPN-HAWMADMCSA-N					doublet; compound annotation
0391_009504	Anacetrapib	C30H25F10NO3	6.5812	11556427	C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F	COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)OC(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)C1C	InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1	MZZLGJHLQGUVPN-HAWMADMCSA-N					doublet; removed another duplicate entry; compound annotation
0391_009506	Cortexolone	C21H30O4	3.1977	440707	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C	CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)CO	InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1	WHBHBVVOGNECLV-OBQKJFGGSA-N					compound annotation
0391_009507	2314467-59-7	C25H22F2N4O2	3.2465	137628676		CN1CCN(c2nc3c(cccc3F)c(=O)n2-c2ccc(Oc3ccc(F)cc3)cc2)CC1	InChI=1S/C25H22F2N4O2/c1-29-13-15-30(16-14-29)25-28-23-21(3-2-4-22(23)27)24(32)31(25)18-7-11-20(12-8-18)33-19-9-5-17(26)6-10-19/h2-12H,13-16H2,1H3	NUGPMKZYSBKNPU-UHFFFAOYSA-N					compound annotation
0391_009508	Afizagabar	C19H12FN3O2S	3.8625	136209703		CC1=NN=C(c2cc3c(F)cccc3s2)c2cc3c(cc2C1)[nH]c(=O)o3	InChI=1S/C19H12FN3O2S/c1-9-5-10-6-14-15(25-19(24)21-14)7-11(10)18(23-22-9)17-8-12-13(20)3-2-4-16(12)26-17/h2-4,6-8H,5H2,1H3,(H,21,24)	WNUWGRVHGICCLS-UHFFFAOYSA-N					compound annotation
0391_009509	Clesacostat	C28H30N4O5	4.0269	57496611		COc1cc(C(=O)N2CCC3(CC2)CC(=O)c2c(cnn2C(C)C)C3)cc(-c2ccc(C(=O)O)cc2)n1	InChI=1S/C28H30N4O5/c1-17(2)32-25-21(16-29-32)14-28(15-23(25)33)8-10-31(11-9-28)26(34)20-12-22(30-24(13-20)37-3)18-4-6-19(7-5-18)27(35)36/h4-7,12-13,16-17H,8-11,14-15H2,1-3H3,(H,35,36)	LXZMHBHEXAELHH-UHFFFAOYSA-N					compound annotation
0391_009510	5-amino-1-methylquinolinium	C10H11N2+	0.4886	950107		C[n+]1cccc2c(N)cccc21	InChI=1S/C10H10N2/c1-12-7-3-4-8-9(11)5-2-6-10(8)12/h2-7,11H,1H3/p+1	ZMJBCEIHNOWCMC-UHFFFAOYSA-O					compound annotation
0391_009511	Diosmetin 7-glucuronide	C22H20O12	2.2272	54462250	COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O	COc1c(O)cc(-c2cc(=O)c3c(O)cc(OC4OC(C(=O)O)C(O)C(O)C4O)cc3o2)cc1	InChI=1S/C22H20O12/c1-31-13-3-2-8(4-10(13)23)14-7-12(25)16-11(24)5-9(6-15(16)33-14)32-22-19(28)17(26)18(27)20(34-22)21(29)30/h2-7,17-20,22-24,26-28H,1H3,(H,29,30)/t17-,18-,19+,20-,22+/m0/s1	XCKMDTYMOHXUHG-SXFAUFNYSA-N					compound annotation
0391_009512	P2X3 antagonist 34	C24H26F2N4O3	2.3243	132129813	CC1=CC2=NC(=C(N2C=C1)C[C@@H]3CCCN(C3)C(=O)OC)C4=C(C=C(C=C4F)C(=O)NC)F	CNC(=O)c1cc(F)c(-c2c(CC3CCCN(C(=O)OC)C3)n3ccc(C)cc3n2)c(F)c1	InChI=1S/C24H26F2N4O3/c1-14-6-8-30-19(10-15-5-4-7-29(13-15)24(32)33-3)22(28-20(30)9-14)21-17(25)11-16(12-18(21)26)23(31)27-2/h6,8-9,11-12,15H,4-5,7,10,13H2,1-3H3,(H,27,31)/t15-/m0/s1	HHJIZLMOCIYWJF-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_009514	zaprinast	C13H13N5O2	2.8365	135399235		CCCOc1ccccc1-c1nc(=O)c2n[nH][nH]c-2n1	InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)	REZGGXNDEMKIQB-UHFFFAOYSA-N					compound annotation
0391_009515	chlorotrianisene	C23H21ClO3	5.7213	11289		COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1	InChI=1S/C23H21ClO3/c1-25-19-10-4-16(5-11-19)22(17-6-12-20(26-2)13-7-17)23(24)18-8-14-21(27-3)15-9-18/h4-15H,1-3H3	BFPSDSIWYFKGBC-UHFFFAOYSA-N					compound annotation
0391_009516	1,3-bis(3,5-dichlorophenyl)urea	C13H8Cl4N2O	5.7996	595311		O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cc(Cl)cc(Cl)c1	InChI=1S/C13H8Cl4N2O/c14-7-1-8(15)4-11(3-7)18-13(20)19-12-5-9(16)2-10(17)6-12/h1-6H,(H2,18,19,20)	VKVJIWVUYNTBEZ-UHFFFAOYSA-N					compound annotation
0391_009517	dorsomorphin	C24H25N5O	1.5354	11524144		c1nccc(-c2c3ncc(-c4ccc(OCCN5CCCCC5)cc4)cn3nc2)c1	InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2	XHBVYDAKJHETMP-UHFFFAOYSA-N					doublet; compound annotation
0391_009518	Piperlongumine	C17H19NO5	3.3647	637858	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCC=CC2=O	COc1cc(C=CC(=O)N2CCC=CC2=O)cc(OC)c1OC	InChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+	VABYUUZNAVQNPG-BQYQJAHWSA-N					doublet; compound annotation
0391_009519	Piperlongumine	C17H19NO5	3.3685	637858	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCC=CC2=O	COc1cc(C=CC(=O)N2CCC=CC2=O)cc(OC)c1OC	InChI=1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+	VABYUUZNAVQNPG-BQYQJAHWSA-N					doublet; removed another duplicate entry; compound annotation
0391_009521	3,4-Dehydrocilostazol	C20H25N5O2	3.3817	10021885		O=c1ccc2c(ccc(OCCCCc3nnnn3C3CCCCC3)c2)[nH]1	InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)	GHALECSGOJQOHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009523	EGFR Inhibitor	C21H18F3N5O	3.473	9549299		O=C(Nc1cccc(Nc2ncnc(Nc3cccc(C(F)(F)F)c3)c2)c1)C1CC1	InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(9-14)27-18-11-19(26-12-25-18)28-16-5-2-6-17(10-16)29-20(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,29,30)(H2,25,26,27,28)	YOHYSYJDKVYCJI-UHFFFAOYSA-N					doublet; compound annotation
0391_009524	EGFR Inhibitor	C21H18F3N5O	3.4766	9549299		O=C(Nc1cccc(Nc2ncnc(Nc3cccc(C(F)(F)F)c3)c2)c1)C1CC1	InChI=1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(9-14)27-18-11-19(26-12-25-18)28-16-5-2-6-17(10-16)29-20(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,29,30)(H2,25,26,27,28)	YOHYSYJDKVYCJI-UHFFFAOYSA-N					doublet; compound annotation
0391_009525	Forsythoside B	C34H44O19	1.8173	23928102	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)O)CO[C@H]4[C@@H]([C@](CO4)(CO)O)O)OCCC5=CC(=C(C=C5)O)O)O)O)O)O	CC1OC(OC2C(O)C(OCCc3cc(O)c(O)cc3)OC(COC3OCC(O)(CO)C3O)C2OC(=O)C=Cc2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C34H44O19/c1-15-24(41)25(42)26(43)32(50-15)53-29-27(44)31(47-9-8-17-3-6-19(37)21(39)11-17)51-22(12-48-33-30(45)34(46,13-35)14-49-33)28(29)52-23(40)7-4-16-2-5-18(36)20(38)10-16/h2-7,10-11,15,22,24-33,35-39,41-46H,8-9,12-14H2,1H3/b7-4+/t15-,22+,24-,25+,26+,27+,28+,29+,30-,31+,32-,33+,34+/m0/s1	JMBINOWGIHWPJI-UNSOMVRXSA-N					compound annotation
0391_009526	Forsythoside A	C29H36O15	1.8812	5281773	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC(=C(C=C3)O)O)O)O)OC(=O)/C=C/C4=CC(=C(C=C4)O)O)O)O)O	CC1OC(OCC2OC(OCCc3cc(O)c(O)cc3)C(O)C(O)C2OC(=O)C=Cc2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C29H36O15/c1-13-22(35)23(36)25(38)29(42-13)41-12-20-27(44-21(34)7-4-14-2-5-16(30)18(32)10-14)24(37)26(39)28(43-20)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29+/m0/s1	DTOUWTJYUCZJQD-UJERWXFOSA-N					compound annotation
0391_009527	nylidrin	C19H25NO2	2.3683	4567		CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1	InChI=1S/C19H25NO2/c1-14(8-9-16-6-4-3-5-7-16)20-15(2)19(22)17-10-12-18(21)13-11-17/h3-7,10-15,19-22H,8-9H2,1-2H3	PTGXAUBQBSGPKF-UHFFFAOYSA-N					compound annotation
0391_009528	217645-70-0	C21H24ClFN4O3	2.4499	512282	C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F	CC1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1c(NC(N)=O)cc(Cl)cc1	InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1	XQYASZNUFDVMFH-CQSZACIVSA-N					doublet; compound annotation
0391_009529	217645-70-0	C21H24ClFN4O3	2.4532	512282	C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F	CC1CN(Cc2ccc(F)cc2)CCN1C(=O)COc1c(NC(N)=O)cc(Cl)cc1	InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1	XQYASZNUFDVMFH-CQSZACIVSA-N					doublet; compound annotation
0391_009530	PROTAC BET-binding moiety 1	C25H25N7O4	3.2377	131988582		CCn1nc(C2CC2)cc1Nc1nc(C(=O)O)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C25H25N7O4/c1-5-32-19(10-16(30-32)13-6-7-13)27-23-21-14-9-18(35-4)15(20-11(2)31-36-12(20)3)8-17(14)26-22(21)28-24(29-23)25(33)34/h8-10,13H,5-7H2,1-4H3,(H,33,34)(H2,26,27,28,29)	DSICVZUZCUHARI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009532	PROTAC BET-binding moiety 1	C25H25N7O4	3.2412	131988582		CCn1nc(C2CC2)cc1Nc1nc(C(=O)O)nc2c1c1cc(OC)c(-c3c(C)onc3C)cc1[nH]2	InChI=1S/C25H25N7O4/c1-5-32-19(10-16(30-32)13-6-7-13)27-23-21-14-9-18(35-4)15(20-11(2)31-36-12(20)3)8-17(14)26-22(21)28-24(29-23)25(33)34/h8-10,13H,5-7H2,1-4H3,(H,33,34)(H2,26,27,28,29)	DSICVZUZCUHARI-UHFFFAOYSA-N					doublet; compound annotation
0391_009533	THIQ	C33H41ClN6O2	3.5041	9938402	C1CCC(CC1)C2(CCN(CC2)C(=O)[C@@H](CC3=CC=C(C=C3)Cl)NC(=O)[C@H]4CC5=CC=CC=C5CN4)CN6C=NC=N6	O=C(NC(Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)C1Cc2ccccc2CN1	InChI=1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1	HLCHESOMJVGDSJ-LOYHVIPDSA-N					doublet; compound annotation
0391_009534	THIQ	C33H41ClN6O2	3.509	9938402	C1CCC(CC1)C2(CCN(CC2)C(=O)[C@@H](CC3=CC=C(C=C3)Cl)NC(=O)[C@H]4CC5=CC=CC=C5CN4)CN6C=NC=N6	O=C(NC(Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)C1Cc2ccccc2CN1	InChI=1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1	HLCHESOMJVGDSJ-LOYHVIPDSA-N					doublet; compound annotation
0391_009535	THIQ	C33H41ClN6O2	3.7035	9938402	C1CCC(CC1)C2(CCN(CC2)C(=O)[C@@H](CC3=CC=C(C=C3)Cl)NC(=O)[C@H]4CC5=CC=CC=C5CN4)CN6C=NC=N6	O=C(NC(Cc1ccc(Cl)cc1)C(=O)N1CCC(Cn2cncn2)(C2CCCCC2)CC1)C1Cc2ccccc2CN1	InChI=1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1	HLCHESOMJVGDSJ-LOYHVIPDSA-N					doublet; compound annotation
0391_009536	XANTHONE	C13H8O2	3.8933	7020		O=c1c2ccccc2oc2ccccc12	InChI=1S/C13H8O2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H	JNELGWHKGNBSMD-UHFFFAOYSA-N					compound annotation
0391_009537	SB-743921	C31H33ClN2O3	3.9725	9936388	CC1=CC=C(C=C1)C(=O)N(CCCN)[C@@H](C2=C(C(=O)C3=C(O2)C=C(C=C3)Cl)CC4=CC=CC=C4)C(C)C	Cc1ccc(C(=O)N(CCCN)C(c2c(Cc3ccccc3)c(=O)c3c(cc(Cl)cc3)o2)C(C)C)cc1	InChI=1S/C31H33ClN2O3/c1-20(2)28(34(17-7-16-33)31(36)23-12-10-21(3)11-13-23)30-26(18-22-8-5-4-6-9-22)29(35)25-15-14-24(32)19-27(25)37-30/h4-6,8-15,19-20,28H,7,16-18,33H2,1-3H3/t28-/m1/s1	PGXYIBJJCLWJST-MUUNZHRXSA-N					removed another duplicate entry; compound annotation
0391_009539	PHT-427	C20H31N3O2S2	6.4837	44240850		CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1	InChI=1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23)	BYWWNRBKPCPJMG-UHFFFAOYSA-N					doublet; compound annotation
0391_009540	PHT-427	C20H31N3O2S2	6.5545	44240850		CCCCCCCCCCCCc1ccc(S(=O)(=O)Nc2nncs2)cc1	InChI=1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23)	BYWWNRBKPCPJMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009542	KHK-IN-2	C16H19F3N4O3	2.684	129900198	C[C@@]1(CCN(C1)C2=C(C(=CC(=N2)N3C[C@@H]([C@H](C3)O)O)C(F)(F)F)C#N)O	CC1(O)CCN(c2c(C#N)c(C(F)(F)F)cc(N3CC(O)C(O)C3)n2)C1	InChI=1S/C16H19F3N4O3/c1-15(26)2-3-22(8-15)14-9(5-20)10(16(17,18)19)4-13(21-14)23-6-11(24)12(25)7-23/h4,11-12,24-26H,2-3,6-8H2,1H3/t11-,12-,15-/m0/s1	FAXXYODRCHXHTQ-HUBLWGQQSA-N					doublet; removed another duplicate entry; compound annotation
0391_009545	KHK-IN-2	C16H19F3N4O3	2.8066	129900198	C[C@@]1(CCN(C1)C2=C(C(=CC(=N2)N3C[C@@H]([C@H](C3)O)O)C(F)(F)F)C#N)O	CC1(O)CCN(c2c(C#N)c(C(F)(F)F)cc(N3CC(O)C(O)C3)n2)C1	InChI=1S/C16H19F3N4O3/c1-15(26)2-3-22(8-15)14-9(5-20)10(16(17,18)19)4-13(21-14)23-6-11(24)12(25)7-23/h4,11-12,24-26H,2-3,6-8H2,1H3/t11-,12-,15-/m0/s1	FAXXYODRCHXHTQ-HUBLWGQQSA-N					doublet; compound annotation
0391_009546	CHEMBL4550214	C24H21N3O4	3.5892	138377601		O=C(NO)c1ccc(Cn2c(=O)n(CCc3ccccc3)c(=O)c3ccccc32)cc1	InChI=1S/C24H21N3O4/c28-22(25-31)19-12-10-18(11-13-19)16-27-21-9-5-4-8-20(21)23(29)26(24(27)30)15-14-17-6-2-1-3-7-17/h1-13,31H,14-16H2,(H,25,28)	JBJIKUXUKSADFV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009548	WYE-354	C24H29N7O5	3.8197	44219749		COC(=O)Nc1ccc(-c2nc3c(cnn3C3CCN(C(=O)OC)CC3)c(N3CCOCC3)n2)cc1	InChI=1S/C24H29N7O5/c1-34-23(32)26-17-5-3-16(4-6-17)20-27-21(29-11-13-36-14-12-29)19-15-25-31(22(19)28-20)18-7-9-30(10-8-18)24(33)35-2/h3-6,15,18H,7-14H2,1-2H3,(H,26,32)	IMXHGCRIEAKIBU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009550	ZEARALENONE	C18H22O5	3.9544	5281576	C[C@H]1CCCC(=O)CCC/C=C/C2=C(C(=CC(=C2)O)O)C(=O)O1	CC1CCCC(=O)CCCC=Cc2c(C(=O)O1)c(O)cc(O)c2	InChI=1S/C18H22O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h3,7,10-12,20-21H,2,4-6,8-9H2,1H3/b7-3+/t12-/m0/s1	MBMQEIFVQACCCH-QBODLPLBSA-N					compound annotation
0391_009551	153587-01-0	C15H8F6N2O2	4.1872	4552		O=c1[nH]c2c(ccc(C(F)(F)F)c2)n1-c1c(O)ccc(C(F)(F)F)c1	InChI=1S/C15H8F6N2O2/c16-14(17,18)7-1-3-10-9(5-7)22-13(25)23(10)11-6-8(15(19,20)21)2-4-12(11)24/h1-6,24H,(H,22,25)	YLFMCMWKHSDUCT-UHFFFAOYSA-N					compound annotation
0391_009552	Demethylzeylasteral	C29H36O6	5.1751	10322911	C[C@]12CC[C@@](C[C@H]1[C@@]3(CC[C@]4(C5=CC(=C(C(=C5C(=O)C=C4[C@]3(CC2)C)C=O)O)O)C)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C4=CC(=O)c5c(C=O)c(O)c(O)cc5C4(C)CCC3(C)C2C1	InChI=1S/C29H36O6/c1-25-6-7-26(2,24(34)35)14-21(25)29(5)11-9-27(3)17-12-19(32)23(33)16(15-30)22(17)18(31)13-20(27)28(29,4)10-8-25/h12-13,15,21,32-33H,6-11,14H2,1-5H3,(H,34,35)/t21-,25-,26-,27+,28-,29+/m1/s1	ZDZSFWLPCFRASW-CPISFEQASA-N					compound annotation
0391_009553	MAK683	C20H17FN6O	2.1506	121412508		Cc1c(-c2cnc(NCc3c(F)ccc4c3CCO4)n3cnnc23)cccn1	InChI=1S/C20H17FN6O/c1-12-13(3-2-7-22-12)16-10-24-20(27-11-25-26-19(16)27)23-9-15-14-6-8-28-18(14)5-4-17(15)21/h2-5,7,10-11H,6,8-9H2,1H3,(H,23,24)	XLIBABIFOBYHSV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009555	MAK683	C20H17FN6O	2.4017	121412508		Cc1c(-c2cnc(NCc3c(F)ccc4c3CCO4)n3cnnc23)cccn1	InChI=1S/C20H17FN6O/c1-12-13(3-2-7-22-12)16-10-24-20(27-11-25-26-19(16)27)23-9-15-14-6-8-28-18(14)5-4-17(15)21/h2-5,7,10-11H,6,8-9H2,1H3,(H,23,24)	XLIBABIFOBYHSV-UHFFFAOYSA-N					doublet; compound annotation
0391_009556	LCH-7749944	C20H22N4O2	2.7538	2951910		COc1cccc(Nc2nc3ccccc3c(NCC3CCCO3)n2)c1	InChI=1S/C20H22N4O2/c1-25-15-7-4-6-14(12-15)22-20-23-18-10-3-2-9-17(18)19(24-20)21-13-16-8-5-11-26-16/h2-4,6-7,9-10,12,16H,5,8,11,13H2,1H3,(H2,21,22,23,24)	FBWZAFQEOKNGQL-UHFFFAOYSA-N					compound annotation
0391_009557	EIPA	C11H18ClN7O	2.8482	1795		CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C	InChI=1S/C11H18ClN7O/c1-4-19(5(2)3)9-7(12)16-6(8(13)17-9)10(20)18-11(14)15/h5H,4H2,1-3H3,(H2,13,17)(H4,14,15,18,20)	QDERNBXNXJCIQK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009559	vinorelbine	C45H54N4O8	2.8778	5311497	CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC	CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)C(C(=O)OC)(c1c(OC)cc3c(c1)C14CCN5CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C1N3C)C54)C2	InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1	GBABOYUKABKIAF-IELIFDKJSA-N					doublet; removed another duplicate entry; compound annotation
0391_009561	EIPA	C11H18ClN7O	2.9345	1795		CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C	InChI=1S/C11H18ClN7O/c1-4-19(5(2)3)9-7(12)16-6(8(13)17-9)10(20)18-11(14)15/h5H,4H2,1-3H3,(H2,13,17)(H4,14,15,18,20)	QDERNBXNXJCIQK-UHFFFAOYSA-N					doublet; compound annotation
0391_009562	vinorelbine	C45H54N4O8	2.9446	5311497	CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC	CCC1=CC2CN(C1)Cc1c([nH]c3ccccc13)C(C(=O)OC)(c1c(OC)cc3c(c1)C14CCN5CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C1N3C)C54)C2	InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1	GBABOYUKABKIAF-IELIFDKJSA-N					doublet; compound annotation
0391_009563	1467057-23-3	C19H16ClNO3	3.4121	71748255		O=C(O)c1c[nH]c2cc(Cl)c(-c3ccc(C4(O)CCC4)cc3)cc12	InChI=1S/C19H16ClNO3/c20-16-9-17-14(15(10-21-17)18(22)23)8-13(16)11-2-4-12(5-3-11)19(24)6-1-7-19/h2-5,8-10,21,24H,1,6-7H2,(H,22,23)	FHQXLWCFSUSXBF-UHFFFAOYSA-N					compound annotation
0391_009564	ALMITRINE	C26H29F2N7	4.254	33887		C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1	InChI=1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33)	OBDOVFRMEYHSQB-UHFFFAOYSA-N					compound annotation
0391_009565	Voclosporin	C63H111N11O12	6.0321	6918486	CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C	C=CC=CCC(C)C(O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C	InChI=1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/b28-27+/t41-,42+,43-,44+,45+,46+,47+,48+,50+,51+,52+,53-/m1/s1	BICRTLVBTLFLRD-PTWUADNWSA-N					compound annotation
0391_009566	N-Cyclohexyl-4-methoxy-6-(4-(trifluoromethyl)phenyl)pyrimidin-2-amine	C18H20F3N3O	6.0401	131839613		COc1nc(NC2CCCCC2)nc(-c2ccc(C(F)(F)F)cc2)c1	InChI=1S/C18H20F3N3O/c1-25-16-11-15(12-7-9-13(10-8-12)18(19,20)21)23-17(24-16)22-14-5-3-2-4-6-14/h7-11,14H,2-6H2,1H3,(H,22,23,24)	XZQPKRXLQDGSLD-UHFFFAOYSA-N					compound annotation
0391_009567	Zylofuramine	C14H21NO	1.9151	71129	CCN[C@H](CC1=CC=CC=C1)[C@H]2CCCO2	CCNC(Cc1ccccc1)C1CCCO1	InChI=1S/C14H21NO/c1-2-15-13(14-9-6-10-16-14)11-12-7-4-3-5-8-12/h3-5,7-8,13-15H,2,6,9-11H2,1H3/t13-,14-/m1/s1	DOFCLOLKFGSRTG-ZIAGYGMSSA-N					compound annotation
0391_009568	XEN445	C18H17F3N2O3	2.6239	72736173	C1CN(C[C@H]1OCC2=CC=CC=N2)C3=C(C=C(C=C3)C(F)(F)F)C(=O)O	O=C(O)c1c(N2CCC(OCc3ccccn3)C2)ccc(C(F)(F)F)c1	InChI=1S/C18H17F3N2O3/c19-18(20,21)12-4-5-16(15(9-12)17(24)25)23-8-6-14(10-23)26-11-13-3-1-2-7-22-13/h1-5,7,9,14H,6,8,10-11H2,(H,24,25)/t14-/m0/s1	NBGRERFNOKZQLO-AWEZNQCLSA-N					compound annotation
0391_009569	Hesperin	C8H15NOS2	2.7396	9815648		C[S+]([O-])CCCCCCN=C=S	InChI=1S/C8H15NOS2/c1-12(10)7-5-3-2-4-6-9-8-11/h2-7H2,1H3	XQZVZULJKVALRI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009571	IQ 1	C21H22N4O2	2.8402	5823908	CC(=O)C1=CC=C(C=C1)N/N=C(\C2=NC(CC3=CC=CC=C32)(C)C)/C(=O)N	CC(=O)c1ccc(NN=C(C(N)=O)C2=NC(C)(C)Cc3ccccc23)cc1	InChI=1S/C21H22N4O2/c1-13(26)14-8-10-16(11-9-14)24-25-19(20(22)27)18-17-7-5-4-6-15(17)12-21(2,3)23-18/h4-11,24H,12H2,1-3H3,(H2,22,27)/b25-19+	ALJIEVIJBAJISI-NCELDCMTSA-N					removed another duplicate entry; compound annotation
0391_009573	BMS-777607	C25H19ClF2N4O4	2.8876	24794418		CCOc1c(C(=O)Nc2cc(F)c(Oc3c(Cl)c(N)ncc3)cc2)c(=O)n(-c2ccc(F)cc2)cc1	InChI=1S/C25H19ClF2N4O4/c1-2-35-19-10-12-32(16-6-3-14(27)4-7-16)25(34)21(19)24(33)31-15-5-8-18(17(28)13-15)36-20-9-11-30-23(29)22(20)26/h3-13H,2H2,1H3,(H2,29,30)(H,31,33)	VNBRGSXVFBYQNN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009575	K145	C18H24N2O3S	3.6199	71714682	CCCCOC1=CC=C(C=C1)CC/C=C\2/C(=O)N(C(=O)S2)CCN	CCCCOc1ccc(CCC=C2SC(=O)N(CCN)C2=O)cc1	InChI=1S/C18H24N2O3S/c1-2-3-13-23-15-9-7-14(8-10-15)5-4-6-16-17(21)20(12-11-19)18(22)24-16/h6-10H,2-5,11-13,19H2,1H3/b16-6-	MPZXLTZVPUSTFY-SOFYXZRVSA-N					doublet; compound annotation
0391_009576	K145	C18H24N2O3S	3.6227	71714682	CCCCOC1=CC=C(C=C1)CC/C=C\2/C(=O)N(C(=O)S2)CCN	CCCCOc1ccc(CCC=C2SC(=O)N(CCN)C2=O)cc1	InChI=1S/C18H24N2O3S/c1-2-3-13-23-15-9-7-14(8-10-15)5-4-6-16-17(21)20(12-11-19)18(22)24-16/h6-10H,2-5,11-13,19H2,1H3/b16-6-	MPZXLTZVPUSTFY-SOFYXZRVSA-N					doublet; compound annotation
0391_009577	RS-17053	C24H29ClN2O2	3.7568	3894573		CC(C)(Cc1c[nH]c2c1cc(Cl)cc2)NCCOc1ccccc1OCC1CC1	InChI=1S/C24H29ClN2O2/c1-24(2,14-18-15-26-21-10-9-19(25)13-20(18)21)27-11-12-28-22-5-3-4-6-23(22)29-16-17-7-8-17/h3-6,9-10,13,15,17,26-27H,7-8,11-12,14,16H2,1-2H3	XLZHXAXXJVKTFM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009579	APX-115 free base	C17H17N3O	4.6235	51036475		CCCc1c(-c2ccccc2)[nH]n(-c2ccccn2)c1=O	InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3	GIWZEELPLKPYBA-UHFFFAOYSA-N					doublet; compound annotation
0391_009580	APX-115 free base	C17H17N3O	4.9914	51036475		CCCc1c(-c2ccccc2)[nH]n(-c2ccccn2)c1=O	InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3	GIWZEELPLKPYBA-UHFFFAOYSA-N					doublet; compound annotation
0391_009581	APX-115 free base	C17H17N3O	5.0772	51036475		CCCc1c(-c2ccccc2)[nH]n(-c2ccccn2)c1=O	InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3	GIWZEELPLKPYBA-UHFFFAOYSA-N					doublet; compound annotation
0391_009582	APX-115 free base	C17H17N3O	5.1662	51036475		CCCc1c(-c2ccccc2)[nH]n(-c2ccccn2)c1=O	InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3	GIWZEELPLKPYBA-UHFFFAOYSA-N					doublet; compound annotation
0391_009583	Poloxin	C18H19NO3	5.1983	9613592	CC1=CC=CC=C1C(=O)O/N=C\2/C=C(C(=O)C=C2C)C(C)C	CC1=CC(=O)C(C(C)C)=CC1=NOC(=O)c1ccccc1C	InChI=1S/C18H19NO3/c1-11(2)15-10-16(13(4)9-17(15)20)19-22-18(21)14-8-6-5-7-12(14)3/h5-11H,1-4H3/b19-16-	CMOJHDQJJPIVEC-MNDPQUGUSA-N					doublet; compound annotation
0391_009584	APX-115 free base	C17H17N3O	5.251	51036475		CCCc1c(-c2ccccc2)[nH]n(-c2ccccn2)c1=O	InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3	GIWZEELPLKPYBA-UHFFFAOYSA-N					doublet; compound annotation
0391_009585	Poloxin	C18H19NO3	5.3885	9613592	CC1=CC=CC=C1C(=O)O/N=C\2/C=C(C(=O)C=C2C)C(C)C	CC1=CC(=O)C(C(C)C)=CC1=NOC(=O)c1ccccc1C	InChI=1S/C18H19NO3/c1-11(2)15-10-16(13(4)9-17(15)20)19-22-18(21)14-8-6-5-7-12(14)3/h5-11H,1-4H3/b19-16-	CMOJHDQJJPIVEC-MNDPQUGUSA-N					doublet; compound annotation
0391_009586	YLF-466D	C29H20ClNO3	5.4319	51033997	C1=CC=C(C=C1)/C(=C\2/C3=CC=CC=C3N(C2=O)CC4=CC(=CC=C4)C(=O)O)/C5=CC=C(C=C5)Cl	O=C(O)c1cccc(CN2C(=O)C(=C(c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1	InChI=1S/C29H20ClNO3/c30-23-15-13-21(14-16-23)26(20-8-2-1-3-9-20)27-24-11-4-5-12-25(24)31(28(27)32)18-19-7-6-10-22(17-19)29(33)34/h1-17H,18H2,(H,33,34)/b27-26+	BPBOVHROVFJFAH-CYYJNZCTSA-N					doublet; compound annotation
0391_009587	YLF-466D	C29H20ClNO3	5.4367	51033997	C1=CC=C(C=C1)/C(=C\2/C3=CC=CC=C3N(C2=O)CC4=CC(=CC=C4)C(=O)O)/C5=CC=C(C=C5)Cl	O=C(O)c1cccc(CN2C(=O)C(=C(c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1	InChI=1S/C29H20ClNO3/c30-23-15-13-21(14-16-23)26(20-8-2-1-3-9-20)27-24-11-4-5-12-25(24)31(28(27)32)18-19-7-6-10-22(17-19)29(33)34/h1-17H,18H2,(H,33,34)/b27-26+	BPBOVHROVFJFAH-CYYJNZCTSA-N					doublet; compound annotation
0391_009588	YLF-466D	C29H20ClNO3	5.4412	51033997	C1=CC=C(C=C1)/C(=C\2/C3=CC=CC=C3N(C2=O)CC4=CC(=CC=C4)C(=O)O)/C5=CC=C(C=C5)Cl	O=C(O)c1cccc(CN2C(=O)C(=C(c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1	InChI=1S/C29H20ClNO3/c30-23-15-13-21(14-16-23)26(20-8-2-1-3-9-20)27-24-11-4-5-12-25(24)31(28(27)32)18-19-7-6-10-22(17-19)29(33)34/h1-17H,18H2,(H,33,34)/b27-26+	BPBOVHROVFJFAH-CYYJNZCTSA-N					doublet; compound annotation
0391_009589	1-Naphthohydroxamic acid	C11H9NO2	1.8573	23382		O=C(NO)c1cccc2ccccc12	InChI=1S/C11H9NO2/c13-11(12-14)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,14H,(H,12,13)	JRZGPWOEHDOVMC-UHFFFAOYSA-N					compound annotation
0391_009590	PFE-360	C16H16N6O	2.027	89915073		Cn1cc(-c2c[nH]c3c2c(N2CCOCC2)ncn3)cc1C#N	InChI=1S/C16H16N6O/c1-21-9-11(6-12(21)7-17)13-8-18-15-14(13)16(20-10-19-15)22-2-4-23-5-3-22/h6,8-10H,2-5H2,1H3,(H,18,19,20)	IYQTYHISVSPMSU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009592	1263130-79-5	C24H24N4S	2.065	72201050		CN(CCc1ccc(Nc2ncc(-c3cnccc3)s2)cc1)Cc1ccccc1	InChI=1S/C24H24N4S/c1-28(18-20-6-3-2-4-7-20)15-13-19-9-11-22(12-10-19)27-24-26-17-23(29-24)21-8-5-14-25-16-21/h2-12,14,16-17H,13,15,18H2,1H3,(H,26,27)	HCWMMJROAJNTCM-UHFFFAOYSA-N					compound annotation
0391_009593	Oprozomib	C25H32N4O7S	2.6577	25067547	CC1=NC=C(S1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C	COCC(NC(=O)c1cnc(C)s1)C(=O)NC(COC)C(=O)NC(Cc1ccccc1)C(=O)C1(C)CO1	InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1	SWZXEVABPLUDIO-WSZYKNRRSA-N					doublet; compound annotation
0391_009594	HG-9-91-01	C32H37N7O3	2.8327	78357808		COc1cc(OC)c(N(C(=O)Nc2c(C)cccc2C)c2ncnc(Nc3ccc(N4CCN(C)CC4)cc3)c2)cc1	InChI=1S/C32H37N7O3/c1-22-7-6-8-23(2)31(22)36-32(40)39(27-14-13-26(41-4)19-28(27)42-5)30-20-29(33-21-34-30)35-24-9-11-25(12-10-24)38-17-15-37(3)16-18-38/h6-14,19-21H,15-18H2,1-5H3,(H,36,40)(H,33,34,35)	UYUHRKLITDJEHB-UHFFFAOYSA-N					doublet; compound annotation
0391_009595	Oprozomib	C25H32N4O7S	3.0211	25067547	CC1=NC=C(S1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C	COCC(NC(=O)c1cnc(C)s1)C(=O)NC(COC)C(=O)NC(Cc1ccccc1)C(=O)C1(C)CO1	InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1	SWZXEVABPLUDIO-WSZYKNRRSA-N					doublet; compound annotation
0391_009596	131848-97-0	C26H24N4O2	3.0238	2404		Cn1cc(C2=C(c3c4CC(CN)CCn4c4ccccc34)C(=O)NC2=O)c2ccccc21	InChI=1S/C26H24N4O2/c1-29-14-18(16-6-2-4-8-19(16)29)23-24(26(32)28-25(23)31)22-17-7-3-5-9-20(17)30-11-10-15(13-27)12-21(22)30/h2-9,14-15H,10-13,27H2,1H3,(H,28,31,32)	QQKKPWJFHBFCTH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009599	Oprozomib	C25H32N4O7S	3.0711	25067547	CC1=NC=C(S1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C	COCC(NC(=O)c1cnc(C)s1)C(=O)NC(COC)C(=O)NC(Cc1ccccc1)C(=O)C1(C)CO1	InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1	SWZXEVABPLUDIO-WSZYKNRRSA-N					doublet; compound annotation
0391_009600	HG-9-91-01	C32H37N7O3	3.1348	78357808		COc1cc(OC)c(N(C(=O)Nc2c(C)cccc2C)c2ncnc(Nc3ccc(N4CCN(C)CC4)cc3)c2)cc1	InChI=1S/C32H37N7O3/c1-22-7-6-8-23(2)31(22)36-32(40)39(27-14-13-26(41-4)19-28(27)42-5)30-20-29(33-21-34-30)35-24-9-11-25(12-10-24)38-17-15-37(3)16-18-38/h6-14,19-21H,15-18H2,1-5H3,(H,36,40)(H,33,34,35)	UYUHRKLITDJEHB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009602	Oprozomib	C25H32N4O7S	3.2782	25067547	CC1=NC=C(S1)C(=O)N[C@@H](COC)C(=O)N[C@@H](COC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[C@]3(CO3)C	COCC(NC(=O)c1cnc(C)s1)C(=O)NC(COC)C(=O)NC(Cc1ccccc1)C(=O)C1(C)CO1	InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1	SWZXEVABPLUDIO-WSZYKNRRSA-N					doublet; removed another duplicate entry; compound annotation
0391_009604	Epothilone A	C26H39NO6S	3.7266	448799	C[C@H]1CCC[C@@H]2[C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C	CC(=Cc1csc(C)n1)C1CC2OC2CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)O1	InChI=1S/C26H39NO6S/c1-14-8-7-9-19-21(32-19)11-20(15(2)10-18-13-34-17(4)27-18)33-23(29)12-22(28)26(5,6)25(31)16(3)24(14)30/h10,13-14,16,19-22,24,28,30H,7-9,11-12H2,1-6H3/b15-10+/t14-,16+,19+,20-,21-,22-,24-/m0/s1	HESCAJZNRMSMJG-KKQRBIROSA-N					removed another duplicate entry; compound annotation
0391_009606	A-317491	C33H27NO8	4.2794	9829395	C1C[C@@H](C2=CC=CC=C2C1)N(CC3=CC(=CC=C3)OC4=CC=CC=C4)C(=O)C5=CC(=C(C=C5C(=O)O)C(=O)O)C(=O)O	O=C(O)c1c(C(=O)O)cc(C(=O)N(Cc2cc(Oc3ccccc3)ccc2)C2CCCc3ccccc32)c(C(=O)O)c1	InChI=1S/C33H27NO8/c35-30(25-17-27(32(38)39)28(33(40)41)18-26(25)31(36)37)34(29-15-7-10-21-9-4-5-14-24(21)29)19-20-8-6-13-23(16-20)42-22-11-2-1-3-12-22/h1-6,8-9,11-14,16-18,29H,7,10,15,19H2,(H,36,37)(H,38,39)(H,40,41)/t29-/m0/s1	VQGBOYBIENNKMI-LJAQVGFWSA-N					doublet; removed another duplicate entry; compound annotation
0391_009608	GW9508	C22H21NO3	4.3344	11595431		O=C(O)CCc1ccc(NCc2cc(Oc3ccccc3)ccc2)cc1	InChI=1S/C22H21NO3/c24-22(25)14-11-17-9-12-19(13-10-17)23-16-18-5-4-8-21(15-18)26-20-6-2-1-3-7-20/h1-10,12-13,15,23H,11,14,16H2,(H,24,25)	DGENZVKCTGIDRZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009610	Esculetin	C9H6O4	1.284	5281416		O=c1ccc2cc(O)c(O)cc2o1	InChI=1S/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11H	ILEDWLMCKZNDJK-UHFFFAOYSA-N					compound annotation
0391_009611	Neoline	C24H39NO6	1.5004	120682		CCN1CC2(COC)CCC(O)C34C5CC6C(OC)CC(O)(C5C6O)C(C(OC)C23)C14	InChI=1S/C24H39NO6/c1-5-25-10-22(11-29-2)7-6-15(26)24-13-8-12-14(30-3)9-23(28,16(13)18(12)27)17(21(24)25)19(31-4)20(22)24/h12-21,26-28H,5-11H2,1-4H3	XRARAKHBJHWUHW-UHFFFAOYSA-N					compound annotation
0391_009612	ZERANOL	C18H26O5	3.4854	2999413	C[C@H]1CCC[C@@H](CCCCCC2=C(C(=CC(=C2)O)O)C(=O)O1)O	CC1CCCC(O)CCCCCc2c(C(=O)O1)c(O)cc(O)c2	InChI=1S/C18H26O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h10-12,14,19-21H,2-9H2,1H3/t12-,14+/m0/s1	DWTTZBARDOXEAM-GXTWGEPZSA-N					compound annotation
0391_009613	KH7	C17H15BrN4O2S	3.8237	135496218	CC(C(=O)N/N=C/C1=C(C=CC(=C1)Br)O)SC2=NC3=CC=CC=C3N2	CC(Sc1nc2ccccc2[nH]1)C(=O)NN=Cc1c(O)ccc(Br)c1	InChI=1S/C17H15BrN4O2S/c1-10(25-17-20-13-4-2-3-5-14(13)21-17)16(24)22-19-9-11-8-12(18)6-7-15(11)23/h2-10,23H,1H3,(H,20,21)(H,22,24)/b19-9+	WILMXUAKQKGGCC-DJKKODMXSA-N					compound annotation
0391_009614	221671-61-0	C32H36ClN3O5S	6.2463	9852833		COc1c(Cl)cc(OC)c(-c2c(CCC3CCCCC3)sc(NC(=O)c3cc4cc(C)cc(C)c4n3CC(=O)O)n2)c1	InChI=1S/C32H36ClN3O5S/c1-18-12-19(2)30-21(13-18)14-24(36(30)17-28(37)38)31(39)35-32-34-29(22-15-26(41-4)23(33)16-25(22)40-3)27(42-32)11-10-20-8-6-5-7-9-20/h12-16,20H,5-11,17H2,1-4H3,(H,37,38)(H,34,35,39)	NFDFTMICKVDYLQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009616	Niaprazine	C20H25FN4O	1.7597	71919		CC(CCN1CCN(c2ccc(F)cc2)CC1)NC(=O)c1cnccc1	InChI=1S/C20H25FN4O/c1-16(23-20(26)17-3-2-9-22-15-17)8-10-24-11-13-25(14-12-24)19-6-4-18(21)5-7-19/h2-7,9,15-16H,8,10-14H2,1H3,(H,23,26)	RSKQGBFMNPDPLR-UHFFFAOYSA-N					compound annotation
0391_009617	Sitagliptin	C16H15F6N5O	2.1134	4369359	C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N	NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F	InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1	MFFMDFFZMYYVKS-SECBINFHSA-N					doublet; compound annotation
0391_009618	Ac-DEVD-pNA	C26H34N6O13	2.3238	11527474	CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)C	CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(=O)NC(CC(=O)O)C(=O)Nc1ccc([N+](=O)[O-])cc1)C(C)C	InChI=1S/C26H34N6O13/c1-12(2)22(26(43)30-18(11-21(38)39)24(41)28-14-4-6-15(7-5-14)32(44)45)31-23(40)16(8-9-19(34)35)29-25(42)17(10-20(36)37)27-13(3)33/h4-7,12,16-18,22H,8-11H2,1-3H3,(H,27,33)(H,28,41)(H,29,42)(H,30,43)(H,31,40)(H,34,35)(H,36,37)(H,38,39)/t16-,17-,18-,22-/m0/s1	GGXRLUDNGFFUKI-ORGXJRBJSA-N					compound annotation
0391_009619	AC260584	C20H29FN2O2	3.204	9928284		CCCCC1CCN(CCCN2C(=O)COc3c2ccc(F)c3)CC1	InChI=1S/C20H29FN2O2/c1-2-3-5-16-8-12-22(13-9-16)10-4-11-23-18-7-6-17(21)14-19(18)25-15-20(23)24/h6-7,14,16H,2-5,8-13,15H2,1H3	BWAKMLKESHKOHK-UHFFFAOYSA-N					compound annotation
0391_009620	CHEMBL4575419	C38H50N6O5	3.553	66577040	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1CC([C@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1nc2ccccc2cc1	InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31+,32-,33?/m0/s1	QWAXKHKRTORLEM-ZIMYYZQPSA-N					removed another duplicate entry; compound annotation
0391_009622	SALICYLANILIDE	C13H11NO2	3.7296	6872		O=C(Nc1ccccc1)c1ccccc1O	InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16)	WKEDVNSFRWHDNR-UHFFFAOYSA-N					doublet; compound annotation
0391_009623	BI-99179	C23H25N3O3	3.7751	51346964	CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3	CCC(=O)NC1CCC(C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1	InChI=1S/C23H25N3O3/c1-3-21(27)24-17-11-8-16(14-17)23(28)26(2)18-12-9-15(10-13-18)22-25-19-6-4-5-7-20(19)29-22/h4-7,9-10,12-13,16-17H,3,8,11,14H2,1-2H3,(H,24,27)/t16-,17+/m1/s1	YNFDIGJKJPNFFD-SJORKVTESA-N					removed another duplicate entry; compound annotation
0391_009625	61350-00-3	C12H9ClN2O	4.122	836002		O=C(Nc1cc(Cl)ccc1)c1ccccn1	InChI=1S/C12H9ClN2O/c13-9-4-3-5-10(8-9)15-12(16)11-6-1-2-7-14-11/h1-8H,(H,15,16)	SUYUTNCKIOLMAJ-UHFFFAOYSA-N					compound annotation
0391_009626	SALICYLANILIDE	C13H11NO2	4.3202	6872		O=C(Nc1ccccc1)c1ccccc1O	InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16)	WKEDVNSFRWHDNR-UHFFFAOYSA-N					doublet; compound annotation
0391_009627	Derenofylline	C18H20N4O	1.9726	9953065		OC1CCC(Nc2nc(-c3ccccc3)nc3c2cc[nH]3)CC1	InChI=1S/C18H20N4O/c23-14-8-6-13(7-9-14)20-18-15-10-11-19-17(15)21-16(22-18)12-4-2-1-3-5-12/h1-5,10-11,13-14,23H,6-9H2,(H2,19,20,21,22)	RBZNJGHIKXAKQE-UHFFFAOYSA-N					compound annotation
0391_009628	207679-81-0	C22H31NO2	2.2373	9819382	CC(C)N(CC[C@H](C1=CC=CC=C1)C2=C(C=CC(=C2)CO)O)C(C)C	CC(C)N(CCC(c1ccccc1)c1c(O)ccc(CO)c1)C(C)C	InChI=1S/C22H31NO2/c1-16(2)23(17(3)4)13-12-20(19-8-6-5-7-9-19)21-14-18(15-24)10-11-22(21)25/h5-11,14,16-17,20,24-25H,12-13,15H2,1-4H3/t20-/m1/s1	DUXZAXCGJSBGDW-HXUWFJFHSA-N					removed another duplicate entry; compound annotation
0391_009630	Acoramidis	C15H17FN2O3	2.4992	71464713		Cc1n[nH]c(C)c1CCCOc1c(F)ccc(C(=O)O)c1	InChI=1S/C15H17FN2O3/c1-9-12(10(2)18-17-9)4-3-7-21-14-8-11(15(19)20)5-6-13(14)16/h5-6,8H,3-4,7H2,1-2H3,(H,17,18)(H,19,20)	WBFUHHBPNXWNCC-UHFFFAOYSA-N					compound annotation
0391_009631	Eslicarbazepine acetate	C17H16N2O3	2.8781	179344	CC(=O)O[C@H]1CC2=CC=CC=C2N(C3=CC=CC=C13)C(=O)N	CC(=O)OC1Cc2ccccc2N(C(N)=O)c2ccccc21	InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1	QIALRBLEEWJACW-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_009633	SKI V	C15H10O4	3.0941	5793932	C1=CC=C2C(=C1)C(=O)/C(=C/C3=CC(=C(C=C3)O)O)/O2	O=C1C(=Cc2cc(O)c(O)cc2)Oc2ccccc12	InChI=1S/C15H10O4/c16-11-6-5-9(7-12(11)17)8-14-15(18)10-3-1-2-4-13(10)19-14/h1-8,16-17H/b14-8-	HCBULGQMULJTCM-ZSOIEALJSA-N					compound annotation
0391_009634	Fenofibric acid	C17H15ClO4	4.3191	64929		CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)O	InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)	MQOBSOSZFYZQOK-UHFFFAOYSA-N					doublet; compound annotation
0391_009635	Deoxycorticosterone acetate	C23H32O4	4.4185	5952	CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC(=O)OCC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C23H32O4/c1-14(24)27-13-21(26)20-7-6-18-17-5-4-15-12-16(25)8-10-22(15,2)19(17)9-11-23(18,20)3/h12,17-20H,4-11,13H2,1-3H3/t17-,18-,19-,20+,22-,23-/m0/s1	VPGRYOFKCNULNK-ACXQXYJUSA-N					compound annotation
0391_009636	ipriflavone	C18H16O3	4.7901	3747		CC(C)Oc1cc2c(cc1)c(=O)c(-c1ccccc1)co2	InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3	SFBODOKJTYAUCM-UHFFFAOYSA-N					doublet; compound annotation
0391_009637	ipriflavone	C18H16O3	4.7932	3747		CC(C)Oc1cc2c(cc1)c(=O)c(-c1ccccc1)co2	InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3	SFBODOKJTYAUCM-UHFFFAOYSA-N					doublet; compound annotation
0391_009638	Finerenone	C21H22N4O3	2.1492	60150535	CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C	CCOc1ncc(C)c2c1C(c1c(OC)cc(C#N)cc1)C(C(N)=O)=C(C)N2	InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1	BTBHLEZXCOBLCY-QGZVFWFLSA-N					compound annotation
0391_009639	Neratinib	C30H29ClN6O3	2.1766	9915743	CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C	CCOc1c(NC(=O)C=CCN(C)C)cc2c(Nc3cc(Cl)c(OCc4ccccn4)cc3)c(C#N)cnc2c1	InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+	JWNPDZNEKVCWMY-VQHVLOKHSA-N					removed another duplicate entry; compound annotation
0391_009641	675104-49-1	C12H12N4O2S2	3.3313	2807230		C=CCn1c(CSc2ccccc2[N+](=O)[O-])n[nH]c1=S	InChI=1S/C12H12N4O2S2/c1-2-7-15-11(13-14-12(15)19)8-20-10-6-4-3-5-9(10)16(17)18/h2-6H,1,7-8H2,(H,14,19)	VWFIHGWHMXSTAO-UHFFFAOYSA-N					compound annotation
0391_009642	Prochloraz	C15H16Cl3N3O2	3.9431	73665		CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1	InChI=1S/C15H16Cl3N3O2/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18/h3,5,8-10H,2,4,6-7H2,1H3	TVLSRXXIMLFWEO-UHFFFAOYSA-N					compound annotation
0391_009643	Curcumenol	C15H22O2	3.9847	167812	C[C@H]1CC[C@@H]2[C@]13CC(=C(C)C)[C@](O3)(C=C2C)O	CC1=CC2(O)OC3(CC2=C(C)C)C(C)CCC13	InChI=1S/C15H22O2/c1-9(2)13-8-14-11(4)5-6-12(14)10(3)7-15(13,16)17-14/h7,11-12,16H,5-6,8H2,1-4H3/t11-,12-,14-,15+/m0/s1	ISFMXVMWEWLJGJ-NZBPQXDJSA-N					doublet; compound annotation
0391_009644	9-ING-41	C22H13FN2O5	4.1599	44582816		Cn1cc(C2=C(c3coc4c3cc(F)cc4)C(=O)NC2=O)c2cc3c(cc21)OCO3	InChI=1S/C22H13FN2O5/c1-25-7-13(11-5-17-18(6-15(11)25)30-9-29-17)19-20(22(27)24-21(19)26)14-8-28-16-3-2-10(23)4-12(14)16/h2-8H,9H2,1H3,(H,24,26,27)	FARXPFGGGGLENU-UHFFFAOYSA-N					compound annotation
0391_009645	7-BIA	C15H18O6	4.3185	137321149		CCCCOc1c(OC)c(C=O)c2CC(O)OC(=O)c2c1	InChI=1S/C15H18O6/c1-3-4-5-20-12-6-10-9(7-13(17)21-15(10)18)11(8-16)14(12)19-2/h6,8,13,17H,3-5,7H2,1-2H3	DAVCIYWSVYDJKW-UHFFFAOYSA-N					compound annotation
0391_009646	Curcumenol	C15H22O2	4.9526	167812	C[C@H]1CC[C@@H]2[C@]13CC(=C(C)C)[C@](O3)(C=C2C)O	CC1=CC2(O)OC3(CC2=C(C)C)C(C)CCC13	InChI=1S/C15H22O2/c1-9(2)13-8-14-11(4)5-6-12(14)10(3)7-15(13,16)17-14/h7,11-12,16H,5-6,8H2,1-4H3/t11-,12-,14-,15+/m0/s1	ISFMXVMWEWLJGJ-NZBPQXDJSA-N					doublet; compound annotation
0391_009647	Candesartan cilexetil	C33H34N6O6	5.3306	2540		CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1	InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)	GHOSNRCGJFBJIB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009649	Nampt-IN-5	C25H25N5O2	2.2849	146014464		CCOc1nc2ccccc2n1Cc1ccc(NC(=O)N2CC(c3cnccc3)C2)cc1	InChI=1S/C25H25N5O2/c1-2-32-25-28-22-7-3-4-8-23(22)30(25)15-18-9-11-21(12-10-18)27-24(31)29-16-20(17-29)19-6-5-13-26-14-19/h3-14,20H,2,15-17H2,1H3,(H,27,31)	JWEBCHOGBDMGBY-UHFFFAOYSA-N					compound annotation
0391_009650	Erlotinib	C22H23N3O4	2.6733	176870		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)ccc1	InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)	AAKJLRGGTJKAMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009652	gabexate	C16H23N3O4	2.8314	3447		CCOC(=O)c1ccc(OC(=O)CCCCCN=C(N)N)cc1	InChI=1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19)	YKGYIDJEEQRWQH-UHFFFAOYSA-N					compound annotation
0391_009653	bromocriptine	C32H40BrN5O5	3.0873	31101	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O	CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5c6c(c(Br)[nH]c6ccc5)CC4N(C)C3)(C(C)C)C(=O)N12	InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1	OZVBMTJYIDMWIL-AYFBDAFISA-N					doublet; removed another duplicate entry; compound annotation
0391_009655	Isopimpinellin	C13H10O5	3.2543	68079		COc1c2ccoc2c(OC)c2c1ccc(=O)o2	InChI=1S/C13H10O5/c1-15-10-7-3-4-9(14)18-12(7)13(16-2)11-8(10)5-6-17-11/h3-6H,1-2H3	DFMAXQKDIGCMTL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009657	bromocriptine	C32H40BrN5O5	3.2907	31101	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O	CC(C)CC1C(=O)N2CCCC2C2(O)OC(NC(=O)C3C=C4c5c6c(c(Br)[nH]c6ccc5)CC4N(C)C3)(C(C)C)C(=O)N12	InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1	OZVBMTJYIDMWIL-AYFBDAFISA-N					doublet; compound annotation
0391_009658	I3MT-3	C17H14N2O2S	3.4409	135412420		Cc1cc(=O)nc(SCC(=O)c2cccc3ccccc23)[nH]1	InChI=1S/C17H14N2O2S/c1-11-9-16(21)19-17(18-11)22-10-15(20)14-8-4-6-12-5-2-3-7-13(12)14/h2-9H,10H2,1H3,(H,18,19,21)	KKPLVAUVHOSUPR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009660	KSC-34	C21H28ClN7O	3.565	154573750		C#CCNc1nc(N(C)CCCCc2ccccc2)nc(NCCNC(=O)CCl)n1	InChI=1S/C21H28ClN7O/c1-3-12-24-19-26-20(25-14-13-23-18(30)16-22)28-21(27-19)29(2)15-8-7-11-17-9-5-4-6-10-17/h1,4-6,9-10H,7-8,11-16H2,2H3,(H,23,30)(H2,24,25,26,27,28)	QBGDVCZDAPRIMJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009662	Pranlukast	C27H23N5O4	4.5067	4887		O=C(Nc1cccc2c1oc(-c1n[nH]nn1)cc2=O)c1ccc(OCCCCc2ccccc2)cc1	InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)	NBQKINXMPLXUET-UHFFFAOYSA-N					doublet; compound annotation
0391_009663	(Z)-Guggulsterone	C21H28O2	4.6365	6450278	C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4+/t15-,17+,18+,20+,21-/m1/s1	WDXRGPWQVHZTQJ-OSJVMJFVSA-N					doublet; compound annotation
0391_009664	LEVOBUNOLOL	C17H25NO3	1.9249	39468	CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O	CC(C)(C)NCC(O)COc1cccc2c1CCCC2=O	InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1	IXHBTMCLRNMKHZ-LBPRGKRZSA-N					compound annotation
0391_009665	CZC-54252	C22H25ClN6O4S	2.8762	44252734		COc1c(Nc2ncc(Cl)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25ClN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	CLGWUCNXOBLWFM-UHFFFAOYSA-N					doublet; compound annotation
0391_009666	CZC-54252	C22H25ClN6O4S	2.8789	44252734		COc1c(Nc2ncc(Cl)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25ClN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	CLGWUCNXOBLWFM-UHFFFAOYSA-N					doublet; compound annotation
0391_009667	fluorometholone	C22H29FO4	3.386	9878	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O	CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1	FAOZLTXFLGPHNG-KNAQIMQKSA-N					removed another duplicate entry; compound annotation
0391_009669	CZC-54252	C22H25ClN6O4S	3.668	44252734		COc1c(Nc2ncc(Cl)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc(N2CCOCC2)c1	InChI=1S/C22H25ClN6O4S/c1-32-20-13-15(29-9-11-33-12-10-29)7-8-19(20)26-22-24-14-16(23)21(27-22)25-17-5-3-4-6-18(17)28-34(2,30)31/h3-8,13-14,28H,9-12H2,1-2H3,(H2,24,25,26,27)	CLGWUCNXOBLWFM-UHFFFAOYSA-N					doublet; compound annotation
0391_009670	lomerizine	C27H30F2N2O3	3.8526	3949		COc1c(OC)c(OC)c(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1	InChI=1S/C27H30F2N2O3/c1-32-24-13-8-21(26(33-2)27(24)34-3)18-30-14-16-31(17-15-30)25(19-4-9-22(28)10-5-19)20-6-11-23(29)12-7-20/h4-13,25H,14-18H2,1-3H3	JQSAYKKFZOSZGJ-UHFFFAOYSA-N					compound annotation
0391_009671	rotenone	C23H22O6	4.4646	6758	CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC	C=C(C)C1Cc2c(ccc3c2OC2COc4cc(OC)c(OC)cc4C2C3=O)O1	InChI=1S/C23H22O6/c1-11(2)16-8-14-15(28-16)6-5-12-22(24)21-13-7-18(25-3)19(26-4)9-17(13)27-10-20(21)29-23(12)14/h5-7,9,16,20-21H,1,8,10H2,2-4H3/t16-,20-,21+/m1/s1	JUVIOZPCNVVQFO-HBGVWJBISA-N					doublet; compound annotation
0391_009672	rotenone	C23H22O6	4.5147	6758	CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC	C=C(C)C1Cc2c(ccc3c2OC2COc4cc(OC)c(OC)cc4C2C3=O)O1	InChI=1S/C23H22O6/c1-11(2)16-8-14-15(28-16)6-5-12-22(24)21-13-7-18(25-3)19(26-4)9-17(13)27-10-20(21)29-23(12)14/h5-7,9,16,20-21H,1,8,10H2,2-4H3/t16-,20-,21+/m1/s1	JUVIOZPCNVVQFO-HBGVWJBISA-N					doublet; removed another duplicate entry; compound annotation
0391_009674	rotenone	C23H22O6	4.5197	6758	CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC	C=C(C)C1Cc2c(ccc3c2OC2COc4cc(OC)c(OC)cc4C2C3=O)O1	InChI=1S/C23H22O6/c1-11(2)16-8-14-15(28-16)6-5-12-22(24)21-13-7-18(25-3)19(26-4)9-17(13)27-10-20(21)29-23(12)14/h5-7,9,16,20-21H,1,8,10H2,2-4H3/t16-,20-,21+/m1/s1	JUVIOZPCNVVQFO-HBGVWJBISA-N					doublet; compound annotation
0391_009675	rotenone	C23H22O6	4.6024	6758	CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC	C=C(C)C1Cc2c(ccc3c2OC2COc4cc(OC)c(OC)cc4C2C3=O)O1	InChI=1S/C23H22O6/c1-11(2)16-8-14-15(28-16)6-5-12-22(24)21-13-7-18(25-3)19(26-4)9-17(13)27-10-20(21)29-23(12)14/h5-7,9,16,20-21H,1,8,10H2,2-4H3/t16-,20-,21+/m1/s1	JUVIOZPCNVVQFO-HBGVWJBISA-N					doublet; compound annotation
0391_009676	OXADIAZON	C15H18Cl2N2O3	5.6355	29732		CC(C)Oc1c(Cl)cc(Cl)c(-n2nc(C(C)(C)C)oc2=O)c1	InChI=1S/C15H18Cl2N2O3/c1-8(2)21-12-7-11(9(16)6-10(12)17)19-14(20)22-13(18-19)15(3,4)5/h6-8H,1-5H3	CHNUNORXWHYHNE-UHFFFAOYSA-N					compound annotation
0391_009677	Bis(2-ethylhexyl) phthalate	C24H38O4	7.2985	8343		CCCCC(CC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC	InChI=1S/C24H38O4/c1-5-9-13-19(7-3)17-27-23(25)21-15-11-12-16-22(21)24(26)28-18-20(8-4)14-10-6-2/h11-12,15-16,19-20H,5-10,13-14,17-18H2,1-4H3	BJQHLKABXJIVAM-UHFFFAOYSA-N					doublet; compound annotation
0391_009678	Bis(2-ethylhexyl) phthalate	C24H38O4	7.3022	8343		CCCCC(CC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC	InChI=1S/C24H38O4/c1-5-9-13-19(7-3)17-27-23(25)21-15-11-12-16-22(21)24(26)28-18-20(8-4)14-10-6-2/h11-12,15-16,19-20H,5-10,13-14,17-18H2,1-4H3	BJQHLKABXJIVAM-UHFFFAOYSA-N					doublet; compound annotation
0391_009679	Rotigaptide	C28H39N7O9	1.3714	9938933	C[C@H](C(=O)NCC(=O)N)NC(=O)CNC(=O)[C@H]1C[C@@H](CN1C(=O)[C@H]2CCCN2C(=O)[C@@H](CC3=CC=C(C=C3)O)NC(=O)C)O	CC(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)N1CC(O)CC1C(=O)NCC(=O)NC(C)C(=O)NCC(N)=O	InChI=1S/C28H39N7O9/c1-15(25(41)30-12-23(29)39)32-24(40)13-31-26(42)22-11-19(38)14-35(22)28(44)21-4-3-9-34(21)27(43)20(33-16(2)36)10-17-5-7-18(37)8-6-17/h5-8,15,19-22,37-38H,3-4,9-14H2,1-2H3,(H2,29,39)(H,30,41)(H,31,42)(H,32,40)(H,33,36)/t15-,19+,20-,21-,22-/m1/s1	GFJRASPBQLDRRY-TWTQBQJDSA-N					removed another duplicate entry; compound annotation
0391_009681	N-tert-butyl isoquine	C20H22ClN3O	1.4292	10316203		CC(C)(C)NCc1c(O)cc(Nc2ccnc3cc(Cl)ccc23)cc1	InChI=1S/C20H22ClN3O/c1-20(2,3)23-12-13-4-6-15(11-19(13)25)24-17-8-9-22-18-10-14(21)5-7-16(17)18/h4-11,23,25H,12H2,1-3H3,(H,22,24)	ZVMMVSSEAMUNGI-UHFFFAOYSA-N					compound annotation
0391_009682	hg-10-102-01	C17H20ClN5O3	1.9142	58539301		CNc1nc(Nc2c(OC)cc(C(=O)N3CCOCC3)cc2)ncc1Cl	InChI=1S/C17H20ClN5O3/c1-19-15-12(18)10-20-17(22-15)21-13-4-3-11(9-14(13)25-2)16(24)23-5-7-26-8-6-23/h3-4,9-10H,5-8H2,1-2H3,(H2,19,20,21,22)	YEVOZZZLKJKCCD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009684	BI-167107	C21H26N2O4	2.3407	45483813		Cc1ccccc1CC(C)(C)NCC(O)c1c2OCC(=O)Nc2c(O)cc1	InChI=1S/C21H26N2O4/c1-13-6-4-5-7-14(13)10-21(2,3)22-11-17(25)15-8-9-16(24)19-20(15)27-12-18(26)23-19/h4-9,17,22,24-25H,10-12H2,1-3H3,(H,23,26)	NWQXBEWHTDRJIP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009686	GSK126	C31H38N6O2	2.8263	68210102	CC[C@H](C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C	CCC(C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3cnc(N4CCNCC4)cc3)cc21	InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1	FKSFKBQGSFSOSM-QFIPXVFZSA-N					doublet; compound annotation
0391_009687	GSK126	C31H38N6O2	2.829	68210102	CC[C@H](C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C	CCC(C)n1cc(C)c2c(C(=O)NCc3c(C)cc(C)[nH]c3=O)cc(-c3cnc(N4CCNCC4)cc3)cc21	InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1	FKSFKBQGSFSOSM-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_009689	1260612-13-2	C19H22N4O3	2.8882	135565159	C[C@H]1CC2=CC=CC=C2N1C(=O)CC3=NC(=CC(=O)N3)N4CCOCC4	CC1Cc2ccccc2N1C(=O)Cc1nc(=O)cc(N2CCOCC2)[nH]1	InChI=1S/C19H22N4O3/c1-13-10-14-4-2-3-5-15(14)23(13)19(25)11-16-20-17(12-18(24)21-16)22-6-8-26-9-7-22/h2-5,12-13H,6-11H2,1H3,(H,20,21,24)/t13-/m0/s1	UAXHPOBBKRWJGA-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_009691	638156-11-3	C22H21ClN2O3	3.1934	2011756		O=C(Nc1ccc(CN2CCOCC2)cc1)c1ccc(-c2cc(Cl)ccc2)o1	InChI=1S/C22H21ClN2O3/c23-18-3-1-2-17(14-18)20-8-9-21(28-20)22(26)24-19-6-4-16(5-7-19)15-25-10-12-27-13-11-25/h1-9,14H,10-13,15H2,(H,24,26)	XQJWTJLJEYIUDZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009693	154992-24-2	C17H18F3N3O3	3.5224	132981		CC1(C)C(=O)N(c2cc(C(F)(F)F)c(C#N)cc2)C(=O)N1CCCCO	InChI=1S/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3	ARBYGDBJECGMGA-UHFFFAOYSA-N					compound annotation
0391_009694	APD668	C21H24FN5O5S	4.1405	11705608		CC(C)OC(=O)N1CCC(Oc2ncnc3c2cnn3-c2c(F)cc(S(C)(=O)=O)cc2)CC1	InChI=1S/C21H24FN5O5S/c1-13(2)31-21(28)26-8-6-14(7-9-26)32-20-16-11-25-27(19(16)23-12-24-20)18-5-4-15(10-17(18)22)33(3,29)30/h4-5,10-14H,6-9H2,1-3H3	XTRUQJBVQBUKSQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009696	20448-79-7	C8H13NO2	0.5179	115288		NC1(C(=O)O)CC2CCC1C2	InChI=1S/C8H13NO2/c9-8(7(10)11)4-5-1-2-6(8)3-5/h5-6H,1-4,9H2,(H,10,11)	MPUVBVXDFRDIPT-UHFFFAOYSA-N					compound annotation
0391_009697	MS049	C15H24N2O	0.9556	53868701		CNCCN1CCC(OCc2ccccc2)CC1	InChI=1S/C15H24N2O/c1-16-9-12-17-10-7-15(8-11-17)18-13-14-5-3-2-4-6-14/h2-6,15-16H,7-13H2,1H3	HBOJWAYLSJLULG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009699	GSK1059615	C18H11N3O2S	1.995	23582824	C1=CC2=NC=CC(=C2C=C1/C=C\3/C(=O)NC(=O)S3)C4=CC=NC=C4	O=C1NC(=O)C(=Cc2cc3c(-c4ccncc4)ccnc3cc2)S1	InChI=1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10-	QDITZBLZQQZVEE-YBEGLDIGSA-N					doublet; compound annotation
0391_009700	GSK1059615	C18H11N3O2S	2.1437	23582824	C1=CC2=NC=CC(=C2C=C1/C=C\3/C(=O)NC(=O)S3)C4=CC=NC=C4	O=C1NC(=O)C(=Cc2cc3c(-c4ccncc4)ccnc3cc2)S1	InChI=1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10-	QDITZBLZQQZVEE-YBEGLDIGSA-N					doublet; compound annotation
0391_009701	TAS-103	C20H19N3O2	2.2736	135413533		CN(C)CCNc1nc2c(ccc(O)c2)c2c1C(=O)c1ccccc1-2	InChI=1S/C20H19N3O2/c1-23(2)10-9-21-20-18-17(13-5-3-4-6-14(13)19(18)25)15-8-7-12(24)11-16(15)22-20/h3-8,11,24H,9-10H2,1-2H3,(H,21,22)	ROWSTIYZUWEOMM-UHFFFAOYSA-N					doublet; compound annotation
0391_009702	TAS-103	C20H19N3O2	2.7252	135413533		CN(C)CCNc1nc2c(ccc(O)c2)c2c1C(=O)c1ccccc1-2	InChI=1S/C20H19N3O2/c1-23(2)10-9-21-20-18-17(13-5-3-4-6-14(13)19(18)25)15-8-7-12(24)11-16(15)22-20/h3-8,11,24H,9-10H2,1-2H3,(H,21,22)	ROWSTIYZUWEOMM-UHFFFAOYSA-N					doublet; compound annotation
0391_009703	S1p receptor agonist 1	C23H24FN3O3	4.0512	117972004		CC(C)Cc1ccc(-c2nc(-c3cc(F)c(CN4CC(C(=O)O)C4)cc3)no2)cc1	InChI=1S/C23H24FN3O3/c1-14(2)9-15-3-5-16(6-4-15)22-25-21(26-30-22)17-7-8-18(20(24)10-17)11-27-12-19(13-27)23(28)29/h3-8,10,14,19H,9,11-13H2,1-2H3,(H,28,29)	YBIFMTGYWXNIRZ-UHFFFAOYSA-N					compound annotation
0391_009704	Karenitecin	C25H28N2O4Si	4.7471	148202	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4c(CC[Si](C)(C)C)c3Cn1c2=O	InChI=1S/C25H28N2O4Si/c1-5-25(30)19-12-21-22-17(13-27(21)23(28)18(19)14-31-24(25)29)15(10-11-32(2,3)4)16-8-6-7-9-20(16)26-22/h6-9,12,30H,5,10-11,13-14H2,1-4H3/t25-/m0/s1	POADTFBBIXOWFJ-VWLOTQADSA-N					compound annotation
0391_009705	(S)-Carvedilol	C24H26N2O4	2.9526	185395	COC1=CC=CC=C1OCCNC[C@@H](COC2=CC=CC3=C2C4=CC=CC=C4N3)O	COc1ccccc1OCCNCC(O)COc1cccc2c1c1ccccc1[nH]2	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3/t17-/m0/s1	OGHNVEJMJSYVRP-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_009707	Ledipasvir	C49H54F2N8O6	3.4371	67505836	CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CC2(CC2)CC1c1ncc(-c2cc3c(cc2)-c2c(cc(-c4cc5c(cc4)nc(C4C6CCC(C6)N4C(=O)C(NC(=O)OC)C(C)C)[nH]5)cc2)C3(F)F)[nH]1)C(C)C	InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1	VRTWBAAJJOHBQU-KMWAZVGDSA-N					doublet; compound annotation
0391_009708	2242464-44-2	C18H18ClN5O3	3.604	135303769	C[C@@H](CO)NC(=O)C1=CC(=NN(C1=O)C2=CN(N=C2)C)C3=CC=C(C=C3)Cl	CC(CO)NC(=O)c1cc(-c2ccc(Cl)cc2)nn(-c2cn(C)nc2)c1=O	InChI=1S/C18H18ClN5O3/c1-11(10-25)21-17(26)15-7-16(12-3-5-13(19)6-4-12)22-24(18(15)27)14-8-20-23(2)9-14/h3-9,11,25H,10H2,1-2H3,(H,21,26)/t11-/m0/s1	YAGSZKAJPHGVOV-NSHDSACASA-N					compound annotation
0391_009709	958843-91-9	C31H31NO6	4.6454	16746438		COc1ccc(C(CC(=O)N2CCCC2)c2c(OC)cc(OC)c3c2oc(=O)cc3-c2ccccc2)cc1	InChI=1S/C31H31NO6/c1-35-22-13-11-21(12-14-22)23(17-27(33)32-15-7-8-16-32)29-25(36-2)19-26(37-3)30-24(18-28(34)38-31(29)30)20-9-5-4-6-10-20/h4-6,9-14,18-19,23H,7-8,15-17H2,1-3H3	PROGRNRRJJYCNX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009711	AMPKINONE	C31H23NO6	5.0365	49843507		COc1c(O)c2c(cc1)-c1c(c3c(cc1)C(=O)N(c1ccc(C(=O)c4ccccc4)cc1)C3=O)C(C)(C)O2	InChI=1S/C31H23NO6/c1-31(2)25-20(21-15-16-23(37-3)27(34)28(21)38-31)13-14-22-24(25)30(36)32(29(22)35)19-11-9-18(10-12-19)26(33)17-7-5-4-6-8-17/h4-16,34H,1-3H3	BRRCHDIWBKOMEC-UHFFFAOYSA-N					compound annotation
0391_009712	Meclinertant	C32H31ClN4O5	5.3002	119192		COc1c(-c2cc(C(=O)NC3(C(=O)O)C4CC5CC(C4)CC3C5)nn2-c2ccnc3cc(Cl)ccc23)c(OC)ccc1	InChI=1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40)	DYLJVOXRWLXDIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009714	N-Acetyldopamine	C10H13NO3	0.9852	100526		CC(=O)NCCc1cc(O)c(O)cc1	InChI=1S/C10H13NO3/c1-7(12)11-5-4-8-2-3-9(13)10(14)6-8/h2-3,6,13-14H,4-5H2,1H3,(H,11,12)	OFSAJYZMIPNPHE-UHFFFAOYSA-N					compound annotation
0391_009715	AT-56	C25H27N5	3.1373	11741525		C1=Cc2ccccc2C(=C2CCN(CCCCc3n[nH]nn3)CC2)c2ccccc12	InChI=1S/C25H27N5/c1-3-9-22-19(7-1)12-13-20-8-2-4-10-23(20)25(22)21-14-17-30(18-15-21)16-6-5-11-24-26-28-29-27-24/h1-4,7-10,12-13H,5-6,11,14-18H2,(H,26,27,28,29)	LQNGMDUIRLSESZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009716	313984-77-9	C16H12N4S	3.6632	720937		c1ccc2c(CSc3ncnc4c3[nH]cn4)cccc2c1	InChI=1S/C16H12N4S/c1-2-7-13-11(4-1)5-3-6-12(13)8-21-16-14-15(18-9-17-14)19-10-20-16/h1-7,9-10H,8H2,(H,17,18,19,20)	BGMSTNYJYPSLHN-UHFFFAOYSA-N					compound annotation
0391_009717	ionomycin	C41H72O9	5.5977	6912226	C[C@H](CCC(=O)O)C[C@H](C)C[C@H](C)C(=O)/C=C(/[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@H]([C@@H](C)[C@H](C[C@@H]1CC[C@@](O1)(C)[C@H]2CC[C@@](O2)(C)[C@@H](C)O)O)O)\O	CC(CCC(=O)O)CC(C)CC(C)C(=O)C=C(O)C(C)CC(C)CC=CC(C)C(O)C(C)C(O)CC1CCC(C)(C2CCC(C)(C(C)O)O2)O1	InChI=1S/C41H72O9/c1-25(21-29(5)34(43)24-35(44)30(6)22-27(3)20-26(2)14-15-38(46)47)12-11-13-28(4)39(48)31(7)36(45)23-33-16-18-41(10,49-33)37-17-19-40(9,50-37)32(8)42/h11,13,24-33,36-37,39,42-43,45,48H,12,14-23H2,1-10H3,(H,46,47)/b13-11+,34-24-/t25-,26-,27+,28-,29-,30+,31+,32-,33+,36+,37-,39-,40+,41+/m1/s1	PGHMRUGBZOYCAA-ADZNBVRBSA-N					doublet; removed another duplicate entry; compound annotation
0391_009719	AT-56	C25H27N5	6.1246	11741525		C1=Cc2ccccc2C(=C2CCN(CCCCc3n[nH]nn3)CC2)c2ccccc12	InChI=1S/C25H27N5/c1-3-9-22-19(7-1)12-13-20-8-2-4-10-23(20)25(22)21-14-17-30(18-15-21)16-6-5-11-24-26-28-29-27-24/h1-4,7-10,12-13H,5-6,11,14-18H2,(H,26,27,28,29)	LQNGMDUIRLSESZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009720	ionomycin	C41H72O9	6.3207	6912226	C[C@H](CCC(=O)O)C[C@H](C)C[C@H](C)C(=O)/C=C(/[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@H]([C@@H](C)[C@H](C[C@@H]1CC[C@@](O1)(C)[C@H]2CC[C@@](O2)(C)[C@@H](C)O)O)O)\O	CC(CCC(=O)O)CC(C)CC(C)C(=O)C=C(O)C(C)CC(C)CC=CC(C)C(O)C(C)C(O)CC1CCC(C)(C2CCC(C)(C(C)O)O2)O1	InChI=1S/C41H72O9/c1-25(21-29(5)34(43)24-35(44)30(6)22-27(3)20-26(2)14-15-38(46)47)12-11-13-28(4)39(48)31(7)36(45)23-33-16-18-41(10,49-33)37-17-19-40(9,50-37)32(8)42/h11,13,24-33,36-37,39,42-43,45,48H,12,14-23H2,1-10H3,(H,46,47)/b13-11+,34-24-/t25-,26-,27+,28-,29-,30+,31+,32-,33+,36+,37-,39-,40+,41+/m1/s1	PGHMRUGBZOYCAA-ADZNBVRBSA-N					doublet; removed another duplicate entry; compound annotation
0391_009722	DOXOFYLLINE	C11H14N4O4	1.5595	50942		Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O	InChI=1S/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3	HWXIGFIVGWUZAO-UHFFFAOYSA-N					compound annotation
0391_009723	ARRY-382	C32H36N8O2	1.6819	67259771		Cc1nc(Cn2nc(C3CC3)c3c(NC(=O)c4cnc5cc(OCCN6CCN(C)CC6)ccn45)cccc32)ccc1	InChI=1S/C32H36N8O2/c1-22-5-3-6-24(34-22)21-40-27-8-4-7-26(30(27)31(36-40)23-9-10-23)35-32(41)28-20-33-29-19-25(11-12-39(28)29)42-18-17-38-15-13-37(2)14-16-38/h3-8,11-12,19-20,23H,9-10,13-18,21H2,1-2H3,(H,35,41)	JUPOTOIJLKDAPF-UHFFFAOYSA-N					compound annotation
0391_009724	Raltitrexed	C21H22N4O6S	1.9315	135400182	CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N1	Cc1nc(=O)c2c(ccc(CN(C)c3ccc(C(=O)NC(CCC(=O)O)C(=O)O)s3)c2)[nH]1	InChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1	IVTVGDXNLFLDRM-HNNXBMFYSA-N					compound annotation
0391_009725	DIPHENIDOL	C21H27NO	2.6907	3055		OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1	InChI=1S/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2	OGAKLTJNUQRZJU-UHFFFAOYSA-N					compound annotation
0391_009726	LS-102	C24H36N8O	3.3173	118518043	CCNCCN(CC)C1=NC(=NC(=N1)N[C@@H](C)C2CCCCC2)NC3=CC4=C(C=C3)N=CO4	CCNCCN(CC)c1nc(Nc2cc3c(cc2)nco3)nc(NC(C)C2CCCCC2)n1	InChI=1S/C24H36N8O/c1-4-25-13-14-32(5-2)24-30-22(27-17(3)18-9-7-6-8-10-18)29-23(31-24)28-19-11-12-20-21(15-19)33-16-26-20/h11-12,15-18,25H,4-10,13-14H2,1-3H3,(H2,27,28,29,30,31)/t17-/m0/s1	DEDHMXBDEJSZFE-KRWDZBQOSA-N					compound annotation
0391_009727	Z-Lvg-chn2	C22H31N5O5	3.6767	135801679	CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)C=[N+]=[N-])NC(=O)OCC1=CC=CC=C1	CC(C)CC(NC(=O)OCc1ccccc1)C(=O)NC(C(=O)NCC(=O)C=[N+]=[N-])C(C)C	InChI=1S/C22H31N5O5/c1-14(2)10-18(26-22(31)32-13-16-8-6-5-7-9-16)20(29)27-19(15(3)4)21(30)24-11-17(28)12-25-23/h5-9,12,14-15,18-19H,10-11,13H2,1-4H3,(H,24,30)(H,26,31)(H,27,29)/t18-,19-/m0/s1	KRMMQWXJLDORCJ-OALUTQOASA-N					compound annotation
0391_009728	Trametinib	C26H23FIN5O4	4.3378	11707110		CC(=O)Nc1cc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4c(F)cc(I)cc4)n(C)c(=O)c(C)c32)ccc1	InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)	LIRYPHYGHXZJBZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009730	1186372-20-2	C21H14ClFN2O2	4.8661	44249042		O=C(NC(=O)c1c(F)cccc1Cl)NC1c2ccccc2-c2ccccc21	InChI=1S/C21H14ClFN2O2/c22-16-10-5-11-17(23)18(16)20(26)25-21(27)24-19-14-8-3-1-6-12(14)13-7-2-4-9-15(13)19/h1-11,19H,(H2,24,25,26,27)	SFNLLCUAISZNRV-UHFFFAOYSA-N					compound annotation
0391_009731	pentanoylcarnitine	C12H24NO4+	1.3967	10157322	CCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C12H23NO4/c1-5-6-7-12(16)17-10(8-11(14)15)9-13(2,3)4/h10H,5-9H2,1-4H3/p+1/t10-/m1/s1	VSNFQQXVMPSASB-SNVBAGLBSA-O					compound annotation
0391_009732	tetrahydropalmatine	C21H25NO4	2.2498	5417		COc1c(OC)cc2c(c1)CCN1Cc3c(ccc(OC)c3OC)CC21	InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3	AEQDJSLRWYMAQI-UHFFFAOYSA-N					compound annotation
0391_009733	(R)-Carvedilol	C24H26N2O4	2.955	185394	COC1=CC=CC=C1OCCNC[C@H](COC2=CC=CC3=C2C4=CC=CC=C4N3)O	COc1ccccc1OCCNCC(O)COc1cccc2c1c1ccccc1[nH]2	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3/t17-/m1/s1	OGHNVEJMJSYVRP-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_009735	Azumolene	C13H9BrN4O3	3.2432	9568620	C1C(=O)NC(=O)N1/N=C/C2=NC=C(O2)C3=CC=C(C=C3)Br	O=C1CN(N=Cc2ncc(-c3ccc(Br)cc3)o2)C(=O)N1	InChI=1S/C13H9BrN4O3/c14-9-3-1-8(2-4-9)10-5-15-12(21-10)6-16-18-7-11(19)17-13(18)20/h1-6H,7H2,(H,17,19,20)/b16-6+	SEGCNGONCZQFDW-OMCISZLKSA-N					compound annotation
0391_009736	FLUDROCORTISONE ACETATE	C23H31FO6	3.3712	225609	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3(F)C(O)CC21C	InChI=1S/C23H31FO6/c1-13(25)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(26)6-8-20(14,2)23(17,24)18(27)11-21(16,22)3/h10,16-18,27,29H,4-9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1	SYWHXTATXSMDSB-GSLJADNHSA-N					compound annotation
0391_009737	Tormentic acid	C30H48O5	4.1707	73193	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H](C5(C)C)O)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O	CC1CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C)C5CCC43C)C2C1(C)O	InChI=1S/C30H48O5/c1-17-10-13-30(24(33)34)15-14-27(5)18(22(30)29(17,7)35)8-9-21-26(4)16-19(31)23(32)25(2,3)20(26)11-12-28(21,27)6/h8,17,19-23,31-32,35H,9-16H2,1-7H3,(H,33,34)/t17-,19-,20+,21-,22-,23+,26+,27-,28-,29-,30+/m1/s1	OXVUXGFZHDKYLS-BLIWDXROSA-N					compound annotation
0391_009738	SU5204	C17H15NO2	4.1818	6509031	CCOC1=CC=CC=C1/C=C\2/C3=CC=CC=C3NC2=O	CCOc1ccccc1C=C1C(=O)Nc2ccccc12	InChI=1S/C17H15NO2/c1-2-20-16-10-6-3-7-12(16)11-14-13-8-4-5-9-15(13)18-17(14)19/h3-11H,2H2,1H3,(H,18,19)/b14-11-	MEZFKCPUSMBMAY-KAMYIIQDSA-N					doublet; compound annotation
0391_009739	SU5204	C17H15NO2	4.3917	6509031	CCOC1=CC=CC=C1/C=C\2/C3=CC=CC=C3NC2=O	CCOc1ccccc1C=C1C(=O)Nc2ccccc12	InChI=1S/C17H15NO2/c1-2-20-16-10-6-3-7-12(16)11-14-13-8-4-5-9-15(13)18-17(14)19/h3-11H,2H2,1H3,(H,18,19)/b14-11-	MEZFKCPUSMBMAY-KAMYIIQDSA-N					doublet; compound annotation
0391_009740	dimetridazole	C5H7N3O2	0.7708	3090		Cc1ncc([N+](=O)[O-])n1C	InChI=1S/C5H7N3O2/c1-4-6-3-5(7(4)2)8(9)10/h3H,1-2H3	IBXPYPUJPLLOIN-UHFFFAOYSA-N					doublet; compound annotation
0391_009741	dimetridazole	C5H7N3O2	0.9066	3090		Cc1ncc([N+](=O)[O-])n1C	InChI=1S/C5H7N3O2/c1-4-6-3-5(7(4)2)8(9)10/h3H,1-2H3	IBXPYPUJPLLOIN-UHFFFAOYSA-N					doublet; compound annotation
0391_009742	topotecan	C23H23N3O5	1.5902	60700	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4c(cc3Cn1c2=O)c(CN(C)C)c(O)cc4	InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1	UCFGDBYHRUNTLO-QHCPKHFHSA-N					compound annotation
0391_009743	puromycin	C22H29N7O5	1.6844	439530	CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O	COc1ccc(CC(N)C(=O)NC2C(CO)OC(n3cnc4c3ncnc4N(C)C)C2O)cc1	InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1	RXWNCPJZOCPEPQ-NVWDDTSBSA-N					removed another duplicate entry; compound annotation
0391_009745	Idelalisib	C22H18FN7O	2.7705	11625818	CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5	CCC(Nc1ncnc2c1[nH]cn2)c1nc2c(c(F)ccc2)c(=O)n1-c1ccccc1	InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1	IFSDAJWBUCMOAH-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_009747	clarithromycin	C38H69NO13	3.2931	84029	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O	InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1	AGOYDEPGAOXOCK-KCBOHYOISA-N					removed another duplicate entry; compound annotation
0391_009749	Benzyl butyl phthalate	C19H20O4	5.2861	2347		CCCCOC(=O)c1ccccc1C(=O)OCc1ccccc1	InChI=1S/C19H20O4/c1-2-3-13-22-18(20)16-11-7-8-12-17(16)19(21)23-14-15-9-5-4-6-10-15/h4-12H,2-3,13-14H2,1H3	IRIAEXORFWYRCZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009751	thonzonium	C32H55N4O+	5.988	5456		CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1	InChI=1S/C32H55N4O/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-27-36(2,3)28-26-35(32-33-24-19-25-34-32)29-30-20-22-31(37-4)23-21-30/h19-25H,5-18,26-29H2,1-4H3/q+1	IOYZYMQFUSNATM-UHFFFAOYSA-N					compound annotation
0391_009752	beta-Mangostin	C25H28O6	6.5956	5495925		COc1c(CC=C(C)C)c(O)c2c(=O)c3c(cc(O)c(OC)c3CC=C(C)C)oc2c1	InChI=1S/C25H28O6/c1-13(2)7-9-15-18(29-5)12-20-22(23(15)27)24(28)21-16(10-8-14(3)4)25(30-6)17(26)11-19(21)31-20/h7-8,11-12,26-27H,9-10H2,1-6H3	YRKKJHJIWCRNCW-UHFFFAOYSA-N					compound annotation
0391_009753	23666-13-9	C27H30O15	1.4653	442664	C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2c(C3OC(CO)C(O)C(O)C3O)c(O)c(C3OC(CO)C(O)C(O)C3O)c(O)c12	InChI=1S/C27H30O15/c28-6-12-17(32)21(36)23(38)26(41-12)15-19(34)14-10(31)5-11(8-1-3-9(30)4-2-8)40-25(14)16(20(15)35)27-24(39)22(37)18(33)13(7-29)42-27/h1-5,12-13,17-18,21-24,26-30,32-39H,6-7H2/t12-,13-,17-,18-,21+,22+,23-,24-,26+,27+/m1/s1	FIAAVMJLAGNUKW-VQVVXJKKSA-N					removed another duplicate entry; compound annotation
0391_009755	oxytetracycline	C22H24N2O9	1.5265	54675779	C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)C(C)(O)C3C(O)C12	InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1	OWFJMIVZYSDULZ-PXOLEDIWSA-N					doublet; compound annotation
0391_009756	1,4-DPCA ethyl ester	C15H12N2O3	2.3077	327508		CCOC(=O)c1c[nH]c2c(ccc3c2nccc3)c1=O	InChI=1S/C15H12N2O3/c1-2-20-15(19)11-8-17-13-10(14(11)18)6-5-9-4-3-7-16-12(9)13/h3-8H,2H2,1H3,(H,17,18)	YUPWGIFULUYTQG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009758	Isorhamnetin	C16H12O7	3.01	5281654		COc1c(O)ccc(-c2c(O)c(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3	IZQSVPBOUDKVDZ-UHFFFAOYSA-N					compound annotation
0391_009759	ketoconazole	C26H28Cl2N4O4	3.0642	456201	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1	XMAYWYJOQHXEEK-OZXSUGGESA-N					doublet; removed another duplicate entry; compound annotation
0391_009761	2OH-BNPP1	C16H19N5O	3.1143	59796535		CC(C)(C)n1nc(Cc2ccccc2O)c2c(N)ncnc21	InChI=1S/C16H19N5O/c1-16(2,3)21-15-13(14(17)18-9-19-15)11(20-21)8-10-6-4-5-7-12(10)22/h4-7,9,22H,8H2,1-3H3,(H2,17,18,19)	LWLCFWPPMNPMOI-UHFFFAOYSA-N					compound annotation
0391_009762	Isobavachin	C20H20O4	3.6811	193679	CC(=CCC1=C(C=CC2=C1O[C@@H](CC2=O)C3=CC=C(C=C3)O)O)C	CC(C)=CCc1c(O)ccc2c1OC(c1ccc(O)cc1)CC2=O	InChI=1S/C20H20O4/c1-12(2)3-8-15-17(22)10-9-16-18(23)11-19(24-20(15)16)13-4-6-14(21)7-5-13/h3-7,9-10,19,21-22H,8,11H2,1-2H3/t19-/m0/s1	KYFBXCHUXFKMGQ-IBGZPJMESA-N					compound annotation
0391_009763	digitoxin	C41H64O13	3.9165	441207	C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O	CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O	InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1	WDJUZGPOPHTGOT-XUDUSOBPSA-N					compound annotation
0391_009764	DMT1 blocker 2	C16H13N3O	4.3129	25016113		O=c1c2c(CCc3ccccc3-2)[nH]n1-c1ccccn1	InChI=1S/C16H13N3O/c20-16-15-12-6-2-1-5-11(12)8-9-13(15)18-19(16)14-7-3-4-10-17-14/h1-7,10,18H,8-9H2	BKZBNMNLRQXSHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009766	Pseudoginsenoside F11	C42H72O14	3.0748	21633072	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5[C@@]6(CC[C@@H](O6)C(C)(C)O)C)C)O)[C@@]7([C@@H]3C([C@H](CC7)O)(C)C)C)C)CO)O)O)O)O)O	CC1OC(OC2C(OC3CC4(C)C(CC(O)C5C(C6(C)CCC(C(C)(C)O)O6)CCC54C)C4(C)CCC(O)C(C)(C)C34)OC(CO)C(O)C2O)C(O)C(O)C1O	InChI=1S/C42H72O14/c1-19-28(46)30(48)32(50)35(52-19)55-33-31(49)29(47)23(18-43)54-36(33)53-22-17-41(8)24(39(6)13-11-25(45)37(2,3)34(22)39)16-21(44)27-20(10-14-40(27,41)7)42(9)15-12-26(56-42)38(4,5)51/h19-36,43-51H,10-18H2,1-9H3/t19-,20-,21+,22-,23+,24+,25-,26+,27-,28-,29+,30+,31-,32+,33+,34-,35-,36+,39+,40+,41+,42-/m0/s1	JBGYSAVRIDZNKA-NKECSCAMSA-N					removed another duplicate entry; compound annotation
0391_009768	YIQTLNB50N	C19H18N4O3S	3.2921	74223604	C[C@@H](C1=CC2=C(C=C1)NC(=O)S2)C3=NN(C=C3)C4=NC=C(C=C4)OCCO	CC(c1cc2c(cc1)[nH]c(=O)s2)c1nn(-c2ncc(OCCO)cc2)cc1	InChI=1S/C19H18N4O3S/c1-12(13-2-4-16-17(10-13)27-19(25)21-16)15-6-7-23(22-15)18-5-3-14(11-20-18)26-9-8-24/h2-7,10-12,24H,8-9H2,1H3,(H,21,25)/t12-/m0/s1	HLTKOFPQDKJCAN-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_009770	DESERPIDINE	C32H38N2O8	3.3474	8550	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	COC(=O)C1C2CC3c4c(CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC)c1ccccc1[nH]4	InChI=1S/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34)15-21(18)27(30(26)40-4)32(36)41-5/h6-9,12-13,18,21,23,26-27,30,33H,10-11,14-16H2,1-5H3/t18-,21+,23-,26-,27+,30+/m1/s1	CVBMAZKKCSYWQR-WCGOZPBSSA-N					compound annotation
0391_009771	Hydnocarpin	C25H20O9	3.4532	5489114		COc1c(O)ccc(C2Oc3c(cc(-c4cc(=O)c5c(O)cc(O)cc5o4)cc3)OC2CO)c1	InChI=1S/C25H20O9/c1-31-20-7-13(2-4-15(20)28)25-23(11-26)33-21-6-12(3-5-18(21)34-25)19-10-17(30)24-16(29)8-14(27)9-22(24)32-19/h2-10,23,25-29H,11H2,1H3	NMICSFNNFDNGEL-UHFFFAOYSA-N					compound annotation
0391_009772	10-Deacetyltaxol	C45H49NO13	3.9651	155831	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)O	CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)c4ccccc4)c4ccccc4)CC(O)(C(OC(=O)c4ccccc4)C21)C3(C)C	InChI=1S/C45H49NO13/c1-24-29(57-41(54)35(50)33(26-15-9-6-10-16-26)46-39(52)27-17-11-7-12-18-27)22-45(55)38(58-40(53)28-19-13-8-14-20-28)36-43(5,37(51)34(49)32(24)42(45,3)4)30(48)21-31-44(36,23-56-31)59-25(2)47/h6-20,29-31,33-36,38,48-50,55H,21-23H2,1-5H3,(H,46,52)/t29-,30-,31+,33-,34+,35+,36-,38-,43+,44-,45+/m0/s1	TYLVGQKNNUHXIP-MHHARFCSSA-N					removed another duplicate entry; compound annotation
0391_009774	1417700-13-0	C26H31N3O3	4.0859	46897844	CC(C)(C)C1=CC=C(C=C1)N([C@H](C2=CN=CC=C2)C(=O)NC(C)(C)C)C(=O)C3=CC=CO3	CC(C)(C)NC(=O)C(c1cnccc1)N(C(=O)c1ccco1)c1ccc(C(C)(C)C)cc1	InChI=1S/C26H31N3O3/c1-25(2,3)19-11-13-20(14-12-19)29(24(31)21-10-8-16-32-21)22(18-9-7-15-27-17-18)23(30)28-26(4,5)6/h7-17,22H,1-6H3,(H,28,30)/t22-/m1/s1	JXGIYKRRPGCLFV-JOCHJYFZSA-N					removed another duplicate entry; compound annotation
0391_009776	SR-318	C27H33N5O2	4.5573	139030333		Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1	InChI=1S/C27H33N5O2/c28-25-24(19-31-32(25)23-11-5-2-6-12-23)27(34)30-18-21-13-15-22(16-14-21)26(33)29-17-7-10-20-8-3-1-4-9-20/h2,5-6,11-16,19-20H,1,3-4,7-10,17-18,28H2,(H,29,33)(H,30,34)	HXNUFFCHRIWTRZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009778	Gardiquimod	C17H23N5O	0.7316	44592366		CCNCc1nc2c(c3ccccc3nc2N)n1CC(C)(C)O	InChI=1S/C17H23N5O/c1-4-19-9-13-21-14-15(22(13)10-17(2,3)23)11-7-5-6-8-12(11)20-16(14)18/h5-8,19,23H,4,9-10H2,1-3H3,(H2,18,20)	FHJATBIERQTCTN-UHFFFAOYSA-N					compound annotation
0391_009779	Danusertib	C26H30N6O3	1.9137	11442891	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)[C@@H](C5=CC=CC=C5)OC	COC(C(=O)N1Cc2c(C1)c(NC(=O)c1ccc(N3CCN(C)CC3)cc1)n[nH]2)c1ccccc1	InChI=1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1	XKFTZKGMDDZMJI-HSZRJFAPSA-N					doublet; compound annotation
0391_009780	Danusertib	C26H30N6O3	1.9301	11442891	CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)[C@@H](C5=CC=CC=C5)OC	COC(C(=O)N1Cc2c(C1)c(NC(=O)c1ccc(N3CCN(C)CC3)cc1)n[nH]2)c1ccccc1	InChI=1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1	XKFTZKGMDDZMJI-HSZRJFAPSA-N					doublet; compound annotation
0391_009781	ACY-738	C14H14N4O2	2.1128	57381425		O=C(NO)c1cnc(NC2(c3ccccc3)CC2)nc1	InChI=1S/C14H14N4O2/c19-12(18-20)10-8-15-13(16-9-10)17-14(6-7-14)11-4-2-1-3-5-11/h1-5,8-9,20H,6-7H2,(H,18,19)(H,15,16,17)	LIIWIMDSZVNYHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009783	(S)-Ceralasertib	C20H24N6O2S	2.1476	54761305	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@@](=N)(=O)C)C4=C5C=CNC5=NC=C4	CC1COCCN1c1nc(-c2c3cc[nH]c3ncc2)nc(C2(S(C)(=N)=O)CC2)c1	InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)17-11-16(20(5-6-20)29(2,21)27)24-19(25-17)15-4-8-23-18-14(15)3-7-22-18/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29+/m1/s1	OHUHVTCQTUDPIJ-MUWSIPGASA-N					removed another duplicate entry; compound annotation
0391_009785	Blarcamesine	C19H23NO	2.726	9882189		CN(C)CC1CCOC1(c1ccccc1)c1ccccc1	InChI=1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3	BOTHKNZTGGXFEQ-UHFFFAOYSA-N					compound annotation
0391_009786	Vadadustat	C14H11ClN2O4	3.9757	23634441		O=C(O)CNC(=O)c1c(O)cc(-c2cc(Cl)ccc2)cn1	InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)	JGRXMPYUTJLTKT-UHFFFAOYSA-N					compound annotation
0391_009787	Aglafoline	C28H28O8	4.2446	393601	COC1=CC=C(C=C1)[C@]23[C@@H]([C@H]([C@H]([C@]2(C4=C(O3)C=C(C=C4OC)OC)O)O)C(=O)OC)C5=CC=CC=C5	COC(=O)C1C(O)C2(O)c3c(cc(OC)cc3OC)OC2(c2ccc(OC)cc2)C1c1ccccc1	InChI=1S/C28H28O8/c1-32-18-12-10-17(11-13-18)28-23(16-8-6-5-7-9-16)22(26(30)35-4)25(29)27(28,31)24-20(34-3)14-19(33-2)15-21(24)36-28/h5-15,22-23,25,29,31H,1-4H3/t22-,23-,25-,27+,28+/m1/s1	VFTGDXPPYSWBSO-GWNOIRNCSA-N					removed another duplicate entry; compound annotation
0391_009789	su1498	C25H30N2O2	4.8608	5941539	CC(C)C1=CC(=CC(=C1O)C(C)C)/C=C(\C#N)/C(=O)NCCCC2=CC=CC=C2	CC(C)c1cc(C=C(C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O	InChI=1S/C25H30N2O2/c1-17(2)22-14-20(15-23(18(3)4)24(22)28)13-21(16-26)25(29)27-12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,17-18,28H,8,11-12H2,1-4H3,(H,27,29)/b21-13+	JANPYFTYAGTSIN-FYJGNVAPSA-N					doublet; removed another duplicate entry; compound annotation
0391_009791	E3330	C21H30O6	5.2058	6439397	CCCCCCCCC/C(=C\C1=C(C(=O)C(=C(C1=O)OC)OC)C)/C(=O)O	CCCCCCCCCC(=CC1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O	InChI=1S/C21H30O6/c1-5-6-7-8-9-10-11-12-15(21(24)25)13-16-14(2)17(22)19(26-3)20(27-4)18(16)23/h13H,5-12H2,1-4H3,(H,24,25)/b15-13+	AALSSIXXBDPENJ-FYWRMAATSA-N					compound annotation
0391_009792	su1498	C25H30N2O2	5.2954	5941539	CC(C)C1=CC(=CC(=C1O)C(C)C)/C=C(\C#N)/C(=O)NCCCC2=CC=CC=C2	CC(C)c1cc(C=C(C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O	InChI=1S/C25H30N2O2/c1-17(2)22-14-20(15-23(18(3)4)24(22)28)13-21(16-26)25(29)27-12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,17-18,28H,8,11-12H2,1-4H3,(H,27,29)/b21-13+	JANPYFTYAGTSIN-FYJGNVAPSA-N					doublet; removed another duplicate entry; compound annotation
0391_009795	Thiomyristoyl	C34H51N3O3S	6.881	126843233	CCCCCCCCCCCCCC(=S)NCCCC[C@@H](C(=O)NC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2	CCCCCCCCCCCCCC(=S)NCCCCC(NC(=O)OCc1ccccc1)C(=O)Nc1ccccc1	InChI=1S/C34H51N3O3S/c1-2-3-4-5-6-7-8-9-10-11-18-26-32(41)35-27-20-19-25-31(33(38)36-30-23-16-13-17-24-30)37-34(39)40-28-29-21-14-12-15-22-29/h12-17,21-24,31H,2-11,18-20,25-28H2,1H3,(H,35,41)(H,36,38)(H,37,39)/t31-/m0/s1	CJQGLLUJIVNREL-HKBQPEDESA-N					removed another duplicate entry; compound annotation
0391_009797	Sinoacutine	C19H21NO4	1.5803	821366	CN1CC[C@@]23C=C(C(=O)C=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC	COC1=CC23CCN(C)C(Cc4c2c(O)c(OC)cc4)C3=CC1=O	InChI=1S/C19H21NO4/c1-20-7-6-19-10-16(24-3)14(21)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9-10,13,22H,6-8H2,1-3H3/t13-,19+/m0/s1	GVTRUVGBZQJVTF-ORAYPTAESA-N					removed another duplicate entry; compound annotation
0391_009799	PF-5190457	C29H32N6OS	1.6093	58438464	CC1=CC(=NC=N1)C2=CC3=C(C=C2)[C@@H](CC3)N4CC5(C4)CCN(CC5)C(=O)CC6=CN7C=C(SC7=N6)C	Cc1cc(-c2cc3c(cc2)C(N2CC4(CCN(C(=O)Cc5cn6cc(C)sc6n5)CC4)C2)CC3)ncn1	InChI=1S/C29H32N6OS/c1-19-11-25(31-18-30-19)22-3-5-24-21(12-22)4-6-26(24)35-16-29(17-35)7-9-33(10-8-29)27(36)13-23-15-34-14-20(2)37-28(34)32-23/h3,5,11-12,14-15,18,26H,4,6-10,13,16-17H2,1-2H3/t26-/m1/s1	ZIUDADZJCKGWKR-AREMUKBSSA-N					compound annotation
0391_009800	NVP-BSK805	C27H28F2N6O	1.8717	46398810		Fc1cc(-c2cccc3ncc(-c4cn(C5CCNCC5)nc4)nc23)cc(F)c1CN1CCOCC1	InChI=1S/C27H28F2N6O/c28-23-12-18(13-24(29)22(23)17-34-8-10-36-11-9-34)21-2-1-3-25-27(21)33-26(15-31-25)19-14-32-35(16-19)20-4-6-30-7-5-20/h1-3,12-16,20,30H,4-11,17H2	IBPVXAOOVUAOKJ-UHFFFAOYSA-N					compound annotation
0391_009801	SBP-7455	C16H17F3N4O2	2.5129	132178569		COc1c(OC)cc(Nc2ncc(C(F)(F)F)c(NC3CC3)n2)cc1	InChI=1S/C16H17F3N4O2/c1-24-12-6-5-10(7-13(12)25-2)22-15-20-8-11(16(17,18)19)14(23-15)21-9-3-4-9/h5-9H,3-4H2,1-2H3,(H2,20,21,22,23)	BQROJYIEHOOQBY-UHFFFAOYSA-N					doublet; compound annotation
0391_009802	N-Deshydroxyethyl Dasatinib	C20H22ClN7OS	2.5548	11669430		Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCNCC2)n1	InChI=1S/C20H22ClN7OS/c1-12-4-3-5-14(21)18(12)27-19(29)15-11-23-20(30-15)26-16-10-17(25-13(2)24-16)28-8-6-22-7-9-28/h3-5,10-11,22H,6-9H2,1-2H3,(H,27,29)(H,23,24,25,26)	DOBZFFWLHXORTB-UHFFFAOYSA-N					compound annotation
0391_009803	SBP-7455	C16H17F3N4O2	3.0961	132178569		COc1c(OC)cc(Nc2ncc(C(F)(F)F)c(NC3CC3)n2)cc1	InChI=1S/C16H17F3N4O2/c1-24-12-6-5-10(7-13(12)25-2)22-15-20-8-11(16(17,18)19)14(23-15)21-9-3-4-9/h5-9H,3-4H2,1-2H3,(H2,20,21,22,23)	BQROJYIEHOOQBY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009805	Cyprodinil	C14H15N3	3.4909	86367		Cc1cc(C2CC2)nc(Nc2ccccc2)n1	InChI=1S/C14H15N3/c1-10-9-13(11-7-8-11)17-14(15-10)16-12-5-3-2-4-6-12/h2-6,9,11H,7-8H2,1H3,(H,15,16,17)	HAORKNGNJCEJBX-UHFFFAOYSA-N					compound annotation
0391_009806	GSK-3484862	C19H19N5OS	3.915	132233666	CCC1=C(C(=NC(=C1C#N)S[C@H](C2=CC=CC=C2)C(=O)N)N(C)C)C#N	CCc1c(C#N)c(N(C)C)nc(SC(C(N)=O)c2ccccc2)c1C#N	InChI=1S/C19H19N5OS/c1-4-13-14(10-20)18(24(2)3)23-19(15(13)11-21)26-16(17(22)25)12-8-6-5-7-9-12/h5-9,16H,4H2,1-3H3,(H2,22,25)/t16-/m1/s1	KIEQQZZDWUNUQK-MRXNPFEDSA-N					doublet; compound annotation
0391_009807	GSK-3484862	C19H19N5OS	3.918	132233666	CCC1=C(C(=NC(=C1C#N)S[C@H](C2=CC=CC=C2)C(=O)N)N(C)C)C#N	CCc1c(C#N)c(N(C)C)nc(SC(C(N)=O)c2ccccc2)c1C#N	InChI=1S/C19H19N5OS/c1-4-13-14(10-20)18(24(2)3)23-19(15(13)11-21)26-16(17(22)25)12-8-6-5-7-9-12/h5-9,16H,4H2,1-3H3,(H2,22,25)/t16-/m1/s1	KIEQQZZDWUNUQK-MRXNPFEDSA-N					doublet; compound annotation
0391_009808	EGFR-IN-8	C32H23ClF3N7O4	4.2626	139035057		O=C(Nc1cccc(-c2nc(-c3c(Cl)cc(NC(=O)c4cnccc4)cc3)no2)c1)Nc1cc(C(F)(F)F)c(NC(=O)C2CC2)cc1	InChI=1S/C32H23ClF3N7O4/c33-25-15-22(38-29(45)19-4-2-12-37-16-19)8-10-23(25)27-42-30(47-43-27)18-3-1-5-20(13-18)39-31(46)40-21-9-11-26(24(14-21)32(34,35)36)41-28(44)17-6-7-17/h1-5,8-17H,6-7H2,(H,38,45)(H,41,44)(H2,39,40,46)	IIUNSVLRVWGJRM-UHFFFAOYSA-N					compound annotation
0391_009809	183321-86-0	C21H21N3O4	2.3972	10317566		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)ccc1	InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)	KOQIAZNBAWFSQM-UHFFFAOYSA-N					doublet; compound annotation
0391_009810	183321-86-0	C21H21N3O4	2.4001	10317566		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCO)cc23)ccc1	InChI=1S/C21H21N3O4/c1-3-15-5-4-6-16(11-15)24-21-17-12-19(27-8-7-25)20(28-10-9-26-2)13-18(17)22-14-23-21/h1,4-6,11-14,25H,7-10H2,2H3,(H,22,23,24)	KOQIAZNBAWFSQM-UHFFFAOYSA-N					doublet; compound annotation
0391_009811	trandolapril	C24H34N2O5	3.2581	37888437	CCOC(=O)[C@H](CCC1=CC=CC=C1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)[O-]	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21	InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1	VXFJYXUZANRPDJ-WTNASJBWSA-N					doublet; compound annotation
0391_009812	trandolapril	C24H34N2O5	3.2614	37888437	CCOC(=O)[C@H](CCC1=CC=CC=C1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)[O-]	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21	InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1	VXFJYXUZANRPDJ-WTNASJBWSA-N					doublet; compound annotation
0391_009813	THZ2	C31H28ClN7O2	3.2773	78357763	CN(C)C/C=C/C(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl	CN(C)CC=CC(=O)Nc1cccc(C(=O)Nc2cccc(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)c2)c1	InChI=1S/C31H28ClN7O2/c1-39(2)15-7-14-28(40)35-21-9-5-8-20(16-21)30(41)36-22-10-6-11-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-13-4-3-12-24(25)27/h3-14,16-19,33H,15H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b14-7+	FONRCZUZCHXWBD-VGOFMYFVSA-N					compound annotation
0391_009814	URB937	C20H22N2O4	3.4453	53394762		NC(=O)c1cccc(-c2c(O)ccc(OC(=O)NC3CCCCC3)c2)c1	InChI=1S/C20H22N2O4/c21-19(24)14-6-4-5-13(11-14)17-12-16(9-10-18(17)23)26-20(25)22-15-7-2-1-3-8-15/h4-6,9-12,15,23H,1-3,7-8H2,(H2,21,24)(H,22,25)	CMEQHOXCIGFZNJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009816	Kawain	C14H14O3	3.5731	5281565	COC1=CC(=O)O[C@H](C1)/C=C/C2=CC=CC=C2	COC1=CC(=O)OC(C=Cc2ccccc2)C1	InChI=1S/C14H14O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-8,10,12H,9H2,1H3/b8-7+/t12-/m0/s1	XEAQIWGXBXCYFX-GUOLPTJISA-N					doublet; removed another duplicate entry; compound annotation
0391_009818	Oxyberberine	C20H17NO5	3.7572	11066		COc1c(OC)c2c(cc1)cc1-c3cc4c(cc3CCn1c2=O)OCO4	InChI=1S/C20H17NO5/c1-23-15-4-3-12-7-14-13-9-17-16(25-10-26-17)8-11(13)5-6-21(14)20(22)18(12)19(15)24-2/h3-4,7-9H,5-6,10H2,1-2H3	ZHYQCBCBTQWPLC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009821	Fedratinib	C27H36N6O3S	2.0099	16722836		Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cc(S(=O)(=O)NC(C)(C)C)ccc1	InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)	JOOXLOJCABQBSG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009823	Camizestrant	C24H28F4N6	2.0343	134453496	C[C@@H]1CC2=C(C=CC3=C2C=NN3)[C@H](N1CC(F)(F)F)C4=NC=C(C=C4)NC5CN(C5)CCCF	CC1Cc2c(ccc3c2cn[nH]3)C(c2ncc(NC3CN(CCCF)C3)cc2)N1CC(F)(F)F	InChI=1S/C24H28F4N6/c1-15-9-19-18(4-6-21-20(19)11-30-32-21)23(34(15)14-24(26,27)28)22-5-3-16(10-29-22)31-17-12-33(13-17)8-2-7-25/h3-6,10-11,15,17,23,31H,2,7-9,12-14H2,1H3,(H,30,32)/t15-,23+/m1/s1	WDHOIABIERMLGY-CMJOXMDJSA-N					removed another duplicate entry; compound annotation
0391_009825	356559-20-1	C21H21N5	2.1386	9967941		Cc1nc(-c2c(-c3cc4nccnc4cc3)nc(C(C)(C)C)[nH]2)ccc1	InChI=1S/C21H21N5/c1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15/h5-12H,1-4H3,(H,25,26)	DKPQHFZUICCZHF-UHFFFAOYSA-N					compound annotation
0391_009826	Pioglitazone	C19H20N2O3S	2.3023	4829		CCc1cnc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)cc1	InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)	HYAFETHFCAUJAY-UHFFFAOYSA-N					doublet; compound annotation
0391_009827	1,4-DPCA	C13H8N2O3	2.3858	459803		O=C(O)c1c[nH]c2c(ccc3c2nccc3)c1=O	InChI=1S/C13H8N2O3/c16-12-8-4-3-7-2-1-5-14-10(7)11(8)15-6-9(12)13(17)18/h1-6H,(H,15,16)(H,17,18)	XZZHOJONZJQARN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009829	Mps1-IN-3	C26H31N7O4S	2.4958	91885443		COc1c(Nc2nc3c([nH]cn3)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H31N7O4S/c1-16(2)38(35,36)22-7-5-4-6-20(22)29-25-23-24(28-15-27-23)31-26(32-25)30-19-9-8-17(14-21(19)37-3)33-12-10-18(34)11-13-33/h4-9,14-16,18,34H,10-13H2,1-3H3,(H3,27,28,29,30,31,32)	OFRMASLPWOMYHN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009831	Chrysoeriol	C16H12O6	2.956	5280666		COc1c(O)ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C16H12O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-7,17-19H,1H3	SCZVLDHREVKTSH-UHFFFAOYSA-N					compound annotation
0391_009832	Mps1-IN-3	C26H31N7O4S	2.9913	91885443		COc1c(Nc2nc3c([nH]cn3)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc(N2CCC(O)CC2)c1	InChI=1S/C26H31N7O4S/c1-16(2)38(35,36)22-7-5-4-6-20(22)29-25-23-24(28-15-27-23)31-26(32-25)30-19-9-8-17(14-21(19)37-3)33-12-10-18(34)11-13-33/h4-9,14-16,18,34H,10-13H2,1-3H3,(H3,27,28,29,30,31,32)	OFRMASLPWOMYHN-UHFFFAOYSA-N					doublet; compound annotation
0391_009833	Dihydrolycorine	C16H19NO4	0.6543	11876135	C1CN2CC3=CC4=C(C=C3[C@H]5[C@H]2[C@H]1C[C@@H]([C@H]5O)O)OCO4	OC1CC2CCN3Cc4cc5c(cc4C(C1O)C23)OCO5	InChI=1S/C16H19NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h4-5,8,11,14-16,18-19H,1-3,6-7H2/t8-,11+,14+,15-,16-/m1/s1	VJILFEGOWCJNIK-MGRBZGILSA-N					compound annotation
0391_009834	guanabenz	C8H8Cl2N4	1.8417	5702063	C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl	NC(N)=NN=Cc1c(Cl)cccc1Cl	InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+	WDZVGELJXXEGPV-YIXHJXPBSA-N					doublet; compound annotation
0391_009835	guanabenz	C8H8Cl2N4	2.0386	5702063	C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl	NC(N)=NN=Cc1c(Cl)cccc1Cl	InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+	WDZVGELJXXEGPV-YIXHJXPBSA-N					doublet; compound annotation
0391_009836	dibucaine	C20H29N3O2	3.1746	3025		CCCCOc1nc2ccccc2c(C(=O)NCCN(CC)CC)c1	InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)	PUFQVTATUTYEAL-UHFFFAOYSA-N					doublet; compound annotation
0391_009837	loperamide	C29H33ClN2O2	3.5909	3955		CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1	InChI=1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3	RDOIQAHITMMDAJ-UHFFFAOYSA-N					compound annotation
0391_009838	Zandelisib	C31H38F2N8O	3.7851	66571003		CN1CCC(c2ccccc2CC(C)(C)Nc2nc(-n3c(C(F)F)nc4ccccc43)nc(N3CCOCC3)n2)CC1	InChI=1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38)	WPFUFWIHMYZXSF-UHFFFAOYSA-N					compound annotation
0391_009839	ML380	C23H25F3N4O3S	4.0966	71737672		CCN(Cc1ccccc1C(F)(F)F)C(=O)C1CCN(S(=O)(=O)c2cc3c(cc2)[nH]nc3)CC1	InChI=1S/C23H25F3N4O3S/c1-2-29(15-17-5-3-4-6-20(17)23(24,25)26)22(31)16-9-11-30(12-10-16)34(32,33)19-7-8-21-18(13-19)14-27-28-21/h3-8,13-14,16H,2,9-12,15H2,1H3,(H,27,28)	FJPQEOQGIZSLES-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009841	ketotifen	C19H19NOS	2.3662	3827		CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1	InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3	ZCVMWBYGMWKGHF-UHFFFAOYSA-N					compound annotation
0391_009842	WYC-210	C18H16N2O3S	2.5005	130417724		CC1(C)CC[S+]([O-])c2ccc(C#Cc3ncc(C(=O)O)cn3)cc21	InChI=1S/C18H16N2O3S/c1-18(2)7-8-24(23)15-5-3-12(9-14(15)18)4-6-16-19-10-13(11-20-16)17(21)22/h3,5,9-11H,7-8H2,1-2H3,(H,21,22)	NENFGFHRYIOMTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009844	Ergolide	C17H22O5	3.3616	185786	C[C@@H]1C[C@H]2[C@H]([C@@H]([C@]3([C@H]1CCC3=O)C)OC(=O)C)C(=C)C(=O)O2	C=C1C(=O)OC2CC(C)C3CCC(=O)C3(C)C(OC(C)=O)C12	InChI=1S/C17H22O5/c1-8-7-12-14(9(2)16(20)22-12)15(21-10(3)18)17(4)11(8)5-6-13(17)19/h8,11-12,14-15H,2,5-7H2,1,3-4H3/t8-,11+,12+,14-,15+,17+/m1/s1	JCDZXDWMCKMXFF-MMLVVLEOSA-N					compound annotation
0391_009845	Ochromycinone	C19H14O4	4.4244	11808929	C[C@H]1CC2=C(C(=O)C1)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O	CC1CC(=O)c2c(ccc3c2C(=O)c2c(C3=O)c(O)ccc2)C1	InChI=1S/C19H14O4/c1-9-7-10-5-6-12-17(15(10)14(21)8-9)19(23)11-3-2-4-13(20)16(11)18(12)22/h2-6,9,20H,7-8H2,1H3/t9-/m0/s1	ZAWXOCUFQSQDJS-VIFPVBQESA-N					removed another duplicate entry; compound annotation
0391_009847	ebastine	C32H39NO2	4.5498	3191		CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1	InChI=1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3	MJJALKDDGIKVBE-UHFFFAOYSA-N					compound annotation
0391_009848	Emamectin (Benzoate)	C49H75NO13	4.7002	118704766	CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@H]([C@@H]([C@H](O7)C)NC)OC)OC)\C)C	CCC(C)C1OC2(C=CC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(NC)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	InChI=1S/C49H75NO13/c1-12-26(2)44-29(5)18-19-48(63-44)24-35-21-34(62-48)17-16-28(4)43(27(3)14-13-15-33-25-56-46-42(51)30(6)20-36(47(52)59-35)49(33,46)53)60-40-23-38(55-11)45(32(8)58-40)61-39-22-37(54-10)41(50-9)31(7)57-39/h13-16,18-20,26-27,29,31-32,34-46,50-51,53H,12,17,21-25H2,1-11H3/b14-13+,28-16+,33-15+/t26?,27-,29-,31+,32-,34+,35-,36-,37+,38-,39-,40-,41+,42+,43-,44+,45-,46+,48+,49+/m0/s1	CXEGAUYXQAKHKJ-PPHFJQMLSA-N					doublet; removed another duplicate entry; compound annotation
0391_009850	Emamectin (Benzoate)	C49H75NO13	4.885	118704766	CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@H]([C@@H]([C@H](O7)C)NC)OC)OC)\C)C	CCC(C)C1OC2(C=CC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(NC)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	InChI=1S/C49H75NO13/c1-12-26(2)44-29(5)18-19-48(63-44)24-35-21-34(62-48)17-16-28(4)43(27(3)14-13-15-33-25-56-46-42(51)30(6)20-36(47(52)59-35)49(33,46)53)60-40-23-38(55-11)45(32(8)58-40)61-39-22-37(54-10)41(50-9)31(7)57-39/h13-16,18-20,26-27,29,31-32,34-46,50-51,53H,12,17,21-25H2,1-11H3/b14-13+,28-16+,33-15+/t26?,27-,29-,31+,32-,34+,35-,36-,37+,38-,39-,40-,41+,42+,43-,44+,45-,46+,48+,49+/m0/s1	CXEGAUYXQAKHKJ-PPHFJQMLSA-N					doublet; compound annotation
0391_009851	Dimethyloctadecylbenzylammonium	C27H50N+	6.0746	31205		CCCCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	InChI=1S/C27H50N/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-25-28(2,3)26-27-23-20-19-21-24-27/h19-21,23-24H,4-18,22,25-26H2,1-3H3/q+1	FWLORMQUOWCQPO-UHFFFAOYSA-N					compound annotation
0391_009852	NICORANDIL	C8H9N3O4	0.998	47528		O=C(NCCO[N+](=O)[O-])c1cnccc1	InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)	LBHIOVVIQHSOQN-UHFFFAOYSA-N					compound annotation
0391_009853	Dauricine	C38H44N2O6	1.8961	73400	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC	COc1c(OC)cc2c(c1)CCN(C)C2Cc1ccc(Oc2c(O)ccc(CC3c4cc(OC)c(OC)cc4CCN3C)c2)cc1	InChI=1S/C38H44N2O6/c1-39-15-13-26-20-35(42-3)37(44-5)22-29(26)31(39)17-24-7-10-28(11-8-24)46-34-19-25(9-12-33(34)41)18-32-30-23-38(45-6)36(43-4)21-27(30)14-16-40(32)2/h7-12,19-23,31-32,41H,13-18H2,1-6H3/t31-,32-/m1/s1	AQASRZOCERRGBL-ROJLCIKYSA-N					compound annotation
0391_009854	Lenalidomide-I	C13H11IN2O3	2.6317	134348132		O=C1CCC(N2Cc3c(cccc3I)C2=O)C(=O)N1	InChI=1S/C13H11IN2O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6H2,(H,15,17,18)	BKIUJJLYXXEGFT-UHFFFAOYSA-N					compound annotation
0391_009855	1391737-01-1	C19H18N4OS2	4.0931	70690453		Cc1csc(N(C(=O)CSc2nnc(-c3ccccc3)cc2)C2CC2)n1	InChI=1S/C19H18N4OS2/c1-13-11-26-19(20-13)23(15-7-8-15)18(24)12-25-17-10-9-16(21-22-17)14-5-3-2-4-6-14/h2-6,9-11,15H,7-8,12H2,1H3	DPONSKCACOZTGN-UHFFFAOYSA-N					doublet; compound annotation
0391_009856	1391737-01-1	C19H18N4OS2	4.0968	70690453		Cc1csc(N(C(=O)CSc2nnc(-c3ccccc3)cc2)C2CC2)n1	InChI=1S/C19H18N4OS2/c1-13-11-26-19(20-13)23(15-7-8-15)18(24)12-25-17-10-9-16(21-22-17)14-5-3-2-4-6-14/h2-6,9-11,15H,7-8,12H2,1H3	DPONSKCACOZTGN-UHFFFAOYSA-N					doublet; compound annotation
0391_009857	busulfan	C6H14O6S2	1.6595	2478		CS(=O)(=O)OCCCCOS(C)(=O)=O	InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3	COVZYZSDYWQREU-UHFFFAOYSA-N					compound annotation
0391_009858	102029-74-3	C44H61N7O11	2.4323	4424653		CCC(C)C(NC(=O)C1CCCN1C(=O)C(CCC(=O)O)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C1CCCN1C(=O)C(N)Cc1ccc(O)cc1)C(C)C)C(=O)O	InChI=1S/C44H61N7O11/c1-5-26(4)37(44(61)62)49-40(57)34-14-10-22-51(34)43(60)31(19-20-35(53)54)46-41(58)36(25(2)3)48-38(55)32(24-27-11-7-6-8-12-27)47-39(56)33-13-9-21-50(33)42(59)30(45)23-28-15-17-29(52)18-16-28/h6-8,11-12,15-18,25-26,30-34,36-37,52H,5,9-10,13-14,19-24,45H2,1-4H3,(H,46,58)(H,47,56)(H,48,55)(H,49,57)(H,53,54)(H,61,62)	ADBHAJDGVKLXHK-UHFFFAOYSA-N					compound annotation
0391_009859	mianserin	C18H20N2	2.7017	4184		CN1CCN2c3ccccc3Cc3ccccc3C2C1	InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3	UEQUQVLFIPOEMF-UHFFFAOYSA-N					compound annotation
0391_009860	Gly-beta-MCA	C26H43NO6	2.9845	137333454	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H]([C@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C	InChI=1S/C26H43NO6/c1-14(4-7-20(29)27-13-21(30)31)16-5-6-17-22-18(9-11-25(16,17)2)26(3)10-8-15(28)12-19(26)23(32)24(22)33/h14-19,22-24,28,32-33H,4-13H2,1-3H3,(H,27,29)(H,30,31)/t14-,15-,16-,17+,18+,19+,22+,23+,24-,25-,26-/m1/s1	ZQYUKJFJPJDMMR-IIWZPVADSA-N					compound annotation
0391_009861	Cobimetinib	C21H21F3IN3O2	3.3696	16222096	C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O	O=C(c1ccc(F)c(F)c1Nc1c(F)cc(I)cc1)N1CC(O)(C2CCCCN2)C1	InChI=1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1	BSMCAPRUBJMWDF-KRWDZBQOSA-N					doublet; compound annotation
0391_009862	Glycyrrhizic acid	C42H62O16	3.4784	14982	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1	LPLVUJXQOOQHMX-QWBHMCJMSA-N					doublet; compound annotation
0391_009863	SAR502250	C19H18FN5O2	3.5029	56589672	CN1C(=O)C=C(N=C1N2CCO[C@H](C2)C3=CC=C(C=C3)F)C4=NC=NC=C4	Cn1c(N2CCOC(c3ccc(F)cc3)C2)nc(-c2ncncc2)cc1=O	InChI=1S/C19H18FN5O2/c1-24-18(26)10-16(15-6-7-21-12-22-15)23-19(24)25-8-9-27-17(11-25)13-2-4-14(20)5-3-13/h2-7,10,12,17H,8-9,11H2,1H3/t17-/m1/s1	NKUNFNVAHJNALA-QGZVFWFLSA-N					compound annotation
0391_009864	sulfapyridine	C11H11N3O2S	1.2241	5336		Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1	InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)	GECHUMIMRBOMGK-UHFFFAOYSA-N					compound annotation
0391_009865	Vaccarin	C32H38O19	1.5261	71307582	C1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2C3=C(C4=C(C=C3O)OC(=CC4=O)C5=CC=C(C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)CO)O)O)O)O)O	O=c1cc(-c2ccc(OC3OC(CO)C(O)C(O)C3O)cc2)oc2c1c(O)c(C1OC(CO)C(O)C(O)C1OC1OCC(O)C(O)C1O)c(O)c2	InChI=1S/C32H38O19/c33-7-17-23(40)26(43)30(51-31-27(44)21(38)14(37)9-46-31)29(49-17)20-13(36)6-16-19(24(20)41)12(35)5-15(48-16)10-1-3-11(4-2-10)47-32-28(45)25(42)22(39)18(8-34)50-32/h1-6,14,17-18,21-23,25-34,36-45H,7-9H2/t14-,17+,18+,21-,22+,23+,25-,26-,27+,28+,29-,30+,31-,32+/m0/s1	GYIKGLVKALOGDP-HLEFUGOVSA-N					compound annotation
0391_009866	thiotepa	C6H12N3PS	1.8296	5453		S=P(N1CC1)(N1CC1)N1CC1	InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2	FOCVUCIESVLUNU-UHFFFAOYSA-N					compound annotation
0391_009867	osimertinib	C28H33N7O2	2.3524	71496458		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)	DUYJMQONPNNFPI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009869	Oleuropein	C25H32O13	2.3524	5281544	C/C=C/1\[C@@H](C(=CO[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OCCC3=CC(=C(C=C3)O)O	CC=C1C(OC2OC(CO)C(O)C(O)C2O)OC=C(C(=O)OC)C1CC(=O)OCCc1cc(O)c(O)cc1	InChI=1S/C25H32O13/c1-3-13-14(9-19(29)35-7-6-12-4-5-16(27)17(28)8-12)15(23(33)34-2)11-36-24(13)38-25-22(32)21(31)20(30)18(10-26)37-25/h3-5,8,11,14,18,20-22,24-28,30-32H,6-7,9-10H2,1-2H3/b13-3+/t14-,18+,20+,21-,22+,24-,25-/m0/s1	RFWGABANNQMHMZ-ZCHJGGQASA-N					compound annotation
0391_009870	Fesoterodine	C26H37NO3	3.2027	6918558	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2	CC(C)C(=O)Oc1c(C(CCN(C(C)C)C(C)C)c2ccccc2)cc(CO)cc1	InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1	DCCSDBARQIPTGU-HSZRJFAPSA-N					doublet; compound annotation
0391_009871	AMG-1	C31H29FN4O5	3.2705	16757524		COc1ccc2c(Oc3c(F)cc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)cc3)ccnc2c1	InChI=1S/C31H29FN4O5/c1-19-28(30(38)36(21-8-6-5-7-9-21)35(19)18-31(2,3)39)29(37)34-20-10-13-27(24(32)16-20)41-26-14-15-33-25-17-22(40-4)11-12-23(25)26/h5-17,39H,18H2,1-4H3,(H,34,37)	UYMSIPINLJNNOU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009873	PMX-53	C47H65N11O7	3.3741	6918468	CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H]2CCCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H]3CCCN3C2=O)CC4CCCCC4)CC5=CNC6=CC=CC=C65)CCCN=C(N)N	CC(=O)NC(Cc1ccccc1)C(=O)NC1CCCNC(=O)C(CCCN=C(N)N)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC2CCCCC2)NC(=O)C2CCCN2C1=O	InChI=1S/C47H65N11O7/c1-29(59)53-37(25-30-13-4-2-5-14-30)42(61)55-36-20-11-22-50-41(60)35(19-10-23-51-47(48)49)54-44(63)39(27-32-28-52-34-18-9-8-17-33(32)34)56-43(62)38(26-31-15-6-3-7-16-31)57-45(64)40-21-12-24-58(40)46(36)65/h2,4-5,8-9,13-14,17-18,28,31,35-40,52H,3,6-7,10-12,15-16,19-27H2,1H3,(H,50,60)(H,53,59)(H,54,63)(H,55,61)(H,56,62)(H,57,64)(H4,48,49,51)/t35-,36-,37-,38+,39-,40-/m0/s1	YOKBGCTZYPOSQM-HPSWDUTRSA-N					compound annotation
0391_009874	2002-44-0	C13H24N4O3	0.5453	92910	CC(C)C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1	CC(C)CC(NC(=O)C1CCCN1)C(=O)NCC(N)=O	InChI=1S/C13H24N4O3/c1-8(2)6-10(12(19)16-7-11(14)18)17-13(20)9-4-3-5-15-9/h8-10,15H,3-7H2,1-2H3,(H2,14,18)(H,16,19)(H,17,20)/t9-,10-/m0/s1	NOOJLZTTWSNHOX-UWVGGRQHSA-N					removed another duplicate entry; compound annotation
0391_009876	CHEMBL5028245	C14H19N2O2+	1.1788	442107	C[N+](C)(C)[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O	C[N+](C)(C)C(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C14H18N2O2/c1-16(2,3)13(14(17)18)8-10-9-15-12-7-5-4-6-11(10)12/h4-7,9,13,15H,8H2,1-3H3/p+1/t13-/m0/s1	AOHCBEAZXHZMOR-ZDUSSCGKSA-O					compound annotation
0391_009877	Toloxatone	C11H13NO3	2.3772	34521		Cc1cc(N2CC(CO)OC2=O)ccc1	InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3	MXUNKHLAEDCYJL-UHFFFAOYSA-N					compound annotation
0391_009878	ensartinib	C26H27Cl2FN6O3	2.8633	56960363	C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N	CC1CN(C(=O)c2ccc(NC(=O)c3nnc(N)c(OC(C)c4c(Cl)ccc(F)c4Cl)c3)cc2)CC(C)N1	InChI=1S/C26H27Cl2FN6O3/c1-13-11-35(12-14(2)31-13)26(37)16-4-6-17(7-5-16)32-25(36)20-10-21(24(30)34-33-20)38-15(3)22-18(27)8-9-19(29)23(22)28/h4-10,13-15,31H,11-12H2,1-3H3,(H2,30,34)(H,32,36)/t13-,14+,15-/m1/s1	GLYMPHUVMRFTFV-QLFBSQMISA-N					compound annotation
0391_009879	ketorolac	C15H13NO3	3.1425	3826		O=C(c1ccccc1)c1ccc2C(C(=O)O)CCn12	InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)	OZWKMVRBQXNZKK-UHFFFAOYSA-N					compound annotation
0391_009880	Loxoprofen	C15H18O3	3.2497	3965		CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1	InChI=1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)	YMBXTVYHTMGZDW-UHFFFAOYSA-N					doublet; compound annotation
0391_009881	cloperastine	C20H24ClNO	3.4363	2805		Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1	InChI=1S/C20H24ClNO/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22/h1,3-4,7-12,20H,2,5-6,13-16H2	FLNXBVJLPJNOSI-UHFFFAOYSA-N					compound annotation
0391_009882	863588-32-3	C20H25ClN4O2	4.2194	3238389		O=c1cc(N2CCN(c3cc(Cl)ccc3)CC2)[nH]c(=O)n1C1CCCCC1	InChI=1S/C20H25ClN4O2/c21-15-5-4-8-17(13-15)23-9-11-24(12-10-23)18-14-19(26)25(20(27)22-18)16-6-2-1-3-7-16/h4-5,8,13-14,16H,1-3,6-7,9-12H2,(H,22,27)	CHMQQIFPOIZPIJ-UHFFFAOYSA-N					compound annotation
0391_009883	FTI-2153	C25H30N4O3S	2.1552	6918458	CC1=CC=CC=C1C2=C(C=CC(=C2)CNCC3=CN=CN3)C(=O)N[C@@H](CCSC)C(=O)OC	COC(=O)C(CCSC)NC(=O)c1c(-c2ccccc2C)cc(CNCc2cnc[nH]2)cc1	InChI=1S/C25H30N4O3S/c1-17-6-4-5-7-20(17)22-12-18(13-26-14-19-15-27-16-28-19)8-9-21(22)24(30)29-23(10-11-33-3)25(31)32-2/h4-9,12,15-16,23,26H,10-11,13-14H2,1-3H3,(H,27,28)(H,29,30)/t23-/m0/s1	KZCMMZOLCBZLNG-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_009885	fipexide	C20H21ClN2O4	2.6531	3351		O=C(COc1ccc(Cl)cc1)N1CCN(Cc2cc3c(cc2)OCO3)CC1	InChI=1S/C20H21ClN2O4/c21-16-2-4-17(5-3-16)25-13-20(24)23-9-7-22(8-10-23)12-15-1-6-18-19(11-15)27-14-26-18/h1-6,11H,7-10,12-14H2	BFUJHVVEMMWLHC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009887	Olmutinib	C26H26N6O2S	2.8446	54758501		C=CC(=O)Nc1cc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3c2scc3)ccc1	InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)	FDMQDKQUTRLUBU-UHFFFAOYSA-N					compound annotation
0391_009888	Deoxylimonin	C26H30O7	3.2371	100026		CC1(C)OC2CC(=O)OCC23C1CC(=O)C1(C)C2=CC(=O)OC(c4cocc4)C2(C)CCC13	InChI=1S/C26H30O7/c1-23(2)16-9-18(27)25(4)15(26(16)13-31-20(28)11-19(26)33-23)5-7-24(3)17(25)10-21(29)32-22(24)14-6-8-30-12-14/h6,8,10,12,15-16,19,22H,5,7,9,11,13H2,1-4H3	QUTATOGBENCRSS-UHFFFAOYSA-N					compound annotation
0391_009889	sertraline	C17H17Cl2N	3.3455	68617	CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl	CNC1CCC(c2cc(Cl)c(Cl)cc2)c2ccccc21	InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1	VGKDLMBJGBXTGI-SJCJKPOMSA-N					compound annotation
0391_009890	Dot1L-IN-4	C28H27ClF2N8O5S	3.5557	145704695	COC1=NC(=NC(=N1)N2CCNCC2)NC3=C(C=CC(=C3)S(=O)(=O)C)N[C@@H](C4=C5C(=CC=C4)OC(O5)(F)F)C6=C(C=CC=N6)Cl	COc1nc(Nc2cc(S(C)(=O)=O)ccc2NC(c2c3OC(F)(F)Oc3ccc2)c2c(Cl)cccn2)nc(N2CCNCC2)n1	InChI=1S/C28H27ClF2N8O5S/c1-42-27-37-25(36-26(38-27)39-13-11-32-12-14-39)35-20-15-16(45(2,40)41)8-9-19(20)34-22(23-18(29)6-4-10-33-23)17-5-3-7-21-24(17)44-28(30,31)43-21/h3-10,15,22,32,34H,11-14H2,1-2H3,(H,35,36,37,38)/t22-/m0/s1	QJIMSJUUARCROQ-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_009892	Fosifloxuridine nafalbenamide	C29H29FN3O9P	3.7755	53373585	C[C@@H](C(=O)OCC1=CC=CC=C1)NP(=O)(OC[C@@H]2[C@H](C[C@@H](O2)N3C=C(C(=O)NC3=O)F)O)OC4=CC=CC5=CC=CC=C54	CC(NP(=O)(OCC1OC(n2cc(F)c(=O)[nH]c2=O)CC1O)Oc1cccc2ccccc12)C(=O)OCc1ccccc1	InChI=1S/C29H29FN3O9P/c1-18(28(36)39-16-19-8-3-2-4-9-19)32-43(38,42-24-13-7-11-20-10-5-6-12-21(20)24)40-17-25-23(34)14-26(41-25)33-15-22(30)27(35)31-29(33)37/h2-13,15,18,23,25-26,34H,14,16-17H2,1H3,(H,32,38)(H,31,35,37)/t18-,23-,25+,26+,43?/m0/s1	BIOWRMNRHMERIO-ZVAHOJSLSA-N					removed another duplicate entry; compound annotation
0391_009894	6268-49-1	C15H15N3O2	4.132	22650		CN(C)c1ccc(N=Nc2ccc(C(=O)O)cc2)cc1	InChI=1S/C15H15N3O2/c1-18(2)14-9-7-13(8-10-14)17-16-12-5-3-11(4-6-12)15(19)20/h3-10H,1-2H3,(H,19,20)	WCKQPPQRFNHPRJ-UHFFFAOYSA-N					compound annotation
0391_009895	2446154-84-1	C30H25Cl2N3O4	4.4985	137700533		Cc1c(CNc2cccc(C(=O)c3cn(CCCC(=O)O)c4ccccc34)c2)c(-c2c(Cl)cccc2Cl)no1	InChI=1S/C30H25Cl2N3O4/c1-18-22(29(34-39-18)28-24(31)10-5-11-25(28)32)16-33-20-8-4-7-19(15-20)30(38)23-17-35(14-6-13-27(36)37)26-12-3-2-9-21(23)26/h2-5,7-12,15,17,33H,6,13-14,16H2,1H3,(H,36,37)	VIWYGRDFHWYDRW-UHFFFAOYSA-N					compound annotation
0391_009896	ethyl icosapentate	C22H34O2	6.966	9831415	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC	InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-	SSQPWTVBQMWLSZ-AAQCHOMXSA-N					compound annotation
0391_009897	lamivudine	C8H11N3O3S	0.46	60825	C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N	Nc1nc(=O)n(C2CSC(CO)O2)cc1	InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1	JTEGQNOMFQHVDC-NKWVEPMBSA-N					compound annotation
0391_009898	500565-15-1	C26H27ClN4O2	1.874	421105		COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCN(C)CC4)c(O)cc3)c2c1	InChI=1S/C26H27ClN4O2/c1-30-9-11-31(12-10-30)16-17-13-19(4-8-25(17)32)28-26-21-6-3-18(27)14-24(21)29-23-7-5-20(33-2)15-22(23)26/h3-8,13-15,32H,9-12,16H2,1-2H3,(H,28,29)	SUSDGTMJKOGWSZ-UHFFFAOYSA-N					compound annotation
0391_009899	bucladesine	C18H24N5O8P	2.054	9687	CCCC(=O)NC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@H]4[C@H](O3)COP(=O)(O4)O)OC(=O)CCC	CCCC(=O)Nc1c2ncn(C3OC4COP(=O)(O)OC4C3OC(=O)CCC)c2ncn1	InChI=1S/C18H24N5O8P/c1-3-5-11(24)22-16-13-17(20-8-19-16)23(9-21-13)18-15(30-12(25)6-4-2)14-10(29-18)7-28-32(26,27)31-14/h8-10,14-15,18H,3-7H2,1-2H3,(H,26,27)(H,19,20,22,24)/t10-,14-,15-,18-/m1/s1	CJGYSWNGNKCJSB-YVLZZHOMSA-N					removed another duplicate entry; compound annotation
0391_009901	ESMOLOL	C16H25NO4	2.057	59768		COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3	AQNDDEOPVVGCPG-UHFFFAOYSA-N					doublet; compound annotation
0391_009902	ESMOLOL	C16H25NO4	2.0599	59768		COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1	InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3	AQNDDEOPVVGCPG-UHFFFAOYSA-N					doublet; compound annotation
0391_009903	RIPK-IN-4	C18H21FN4O3S	2.5132	131801159		CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C	InChI=1S/C18H21FN4O3S/c1-5-26-13-8-17-21-9-12(11-6-15(19)22-16(20)7-11)23(17)10-14(13)27(24,25)18(2,3)4/h6-10H,5H2,1-4H3,(H2,20,22)	QWDMZDSZMVJFFJ-UHFFFAOYSA-N					compound annotation
0391_009904	PF-8380	C22H21Cl2N3O5	3.1493	25265312		O=C(CCN1CCN(C(=O)OCc2cc(Cl)cc(Cl)c2)CC1)c1cc2c(cc1)[nH]c(=O)o2	InChI=1S/C22H21Cl2N3O5/c23-16-9-14(10-17(24)12-16)13-31-22(30)27-7-5-26(6-8-27)4-3-19(28)15-1-2-18-20(11-15)32-21(29)25-18/h1-2,9-12H,3-8,13H2,(H,25,29)	JMSUDQYHPSNBSN-UHFFFAOYSA-N					compound annotation
0391_009905	Scutellarein tetramethyl ether	C19H18O6	3.7241	96118		COc1ccc(-c2cc(=O)c3c(OC)c(OC)c(OC)cc3o2)cc1	InChI=1S/C19H18O6/c1-21-12-7-5-11(6-8-12)14-9-13(20)17-15(25-14)10-16(22-2)18(23-3)19(17)24-4/h5-10H,1-4H3	URSUMOWUGDXZHU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009907	fusaric acid	C10H13NO2	1.6669	3442		CCCCc1cnc(C(=O)O)cc1	InChI=1S/C10H13NO2/c1-2-3-4-8-5-6-9(10(12)13)11-7-8/h5-7H,2-4H2,1H3,(H,12,13)	DGMPVYSXXIOGJY-UHFFFAOYSA-N					compound annotation
0391_009908	1-(6-chloropyridin-2-yl)piperidin-4-amine	C10H14ClN3	1.8286	131747		NC1CCN(c2nc(Cl)ccc2)CC1	InChI=1S/C10H14ClN3/c11-9-2-1-3-10(13-9)14-6-4-8(12)5-7-14/h1-3,8H,4-7,12H2	WPVVMKYQOMJPIN-UHFFFAOYSA-N					compound annotation
0391_009909	Rho-Kinase-IN-1	C20H24N4S	2.0998	25008330		CSc1ccc(CN2CCCC(Nc3cc4c(cc3)[nH]nc4)C2)cc1	InChI=1S/C20H24N4S/c1-25-19-7-4-15(5-8-19)13-24-10-2-3-18(14-24)22-17-6-9-20-16(11-17)12-21-23-20/h4-9,11-12,18,22H,2-3,10,13-14H2,1H3,(H,21,23)	DPZSYTMLVCLGRU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009911	Geissoschizine methyl ether	C22H26N2O3	2.8766	6443046	C/C=C\1/CN2CCC3=C([C@@H]2C[C@@H]1/C(=C/OC)/C(=O)OC)NC4=CC=CC=C34	CC=C1CN2CCc3c([nH]c4ccccc34)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O3/c1-4-14-12-24-10-9-16-15-7-5-6-8-19(15)23-21(16)20(24)11-17(14)18(13-26-2)22(25)27-3/h4-8,13,17,20,23H,9-12H2,1-3H3/b14-4-,18-13-/t17-,20-/m0/s1	VAMJZLUOKJRHOW-XEASWFAXSA-N					compound annotation
0391_009912	925432-73-1	C26H29N5O4S	3.1265	24180124		COc1cc(C(=O)Nc2ccccc2-c2cn3c(CN4CCNCC4)csc3n2)cc(OC)c1OC	InChI=1S/C26H29N5O4S/c1-33-22-12-17(13-23(34-2)24(22)35-3)25(32)28-20-7-5-4-6-19(20)21-15-31-18(16-36-26(31)29-21)14-30-10-8-27-9-11-30/h4-7,12-13,15-16,27H,8-11,14H2,1-3H3,(H,28,32)	SBEWVVLMFLTQFE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009914	ML406	C20H20N2O4	3.2613	1245700		CC(=O)c1ccc(N2CCN(C(=O)c3cc4c(cc3)OCO4)CC2)cc1	InChI=1S/C20H20N2O4/c1-14(23)15-2-5-17(6-3-15)21-8-10-22(11-9-21)20(24)16-4-7-18-19(12-16)26-13-25-18/h2-7,12H,8-11,13H2,1H3	DMJGPASMZSNEAZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009915	ML406	C20H20N2O4	3.2649	1245700		CC(=O)c1ccc(N2CCN(C(=O)c3cc4c(cc3)OCO4)CC2)cc1	InChI=1S/C20H20N2O4/c1-14(23)15-2-5-17(6-3-15)21-8-10-22(11-9-21)20(24)16-4-7-18-19(12-16)26-13-25-18/h2-7,12H,8-11,13H2,1H3	DMJGPASMZSNEAZ-UHFFFAOYSA-N					doublet; compound annotation
0391_009916	Thalidomide-O-C8-COOH	C22H26N2O7	3.5452	139433330		O=C(O)CCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C22H26N2O7/c25-17-12-11-15(20(28)23-17)24-21(29)14-8-7-9-16(19(14)22(24)30)31-13-6-4-2-1-3-5-10-18(26)27/h7-9,15H,1-6,10-13H2,(H,26,27)(H,23,25,28)	JDVPWEYIVOQCDX-UHFFFAOYSA-N					doublet; compound annotation
0391_009917	Thalidomide-O-C8-COOH	C22H26N2O7	5.1179	139433330		O=C(O)CCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C22H26N2O7/c25-17-12-11-15(20(28)23-17)24-21(29)14-8-7-9-16(19(14)22(24)30)31-13-6-4-2-1-3-5-10-18(26)27/h7-9,15H,1-6,10-13H2,(H,26,27)(H,23,25,28)	JDVPWEYIVOQCDX-UHFFFAOYSA-N					doublet; compound annotation
0391_009918	Thalidomide-O-C8-Boc	C26H34N2O7	5.1179	146454256		CC(C)(C)OC(=O)CCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C26H34N2O7/c1-26(2,3)35-21(30)13-8-6-4-5-7-9-16-34-19-12-10-11-17-22(19)25(33)28(24(17)32)18-14-15-20(29)27-23(18)31/h10-12,18H,4-9,13-16H2,1-3H3,(H,27,29,31)	XHFRZVFJJQOBAQ-UHFFFAOYSA-N					compound annotation
0391_009919	Z-ALA-ALA-ASN-AMC	C28H31N5O8	2.0472	90470169	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)OCC3=CC=CC=C3	Cc1cc(=O)oc2c1ccc(NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)OCc1ccccc1)c2	InChI=1S/C28H31N5O8/c1-15-11-24(35)41-22-12-19(9-10-20(15)22)32-27(38)21(13-23(29)34)33-26(37)16(2)30-25(36)17(3)31-28(39)40-14-18-7-5-4-6-8-18/h4-12,16-17,21H,13-14H2,1-3H3,(H2,29,34)(H,30,36)(H,31,39)(H,32,38)(H,33,37)/t16-,17-,21-/m0/s1	WVJTXYIHBUISHX-FIKGOQFSSA-N					doublet; compound annotation
0391_009920	Nucleoprotein (396-404)	C50H71N13O14	2.0472	446529	CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=CC=C3)N	CCC(C)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCC(N)=O)NC(=O)C(N)Cc1ccccc1)C(=O)O	InChI=1S/C50H71N13O14/c1-3-27(2)42(50(76)77)62-47(73)34(24-29-13-8-5-9-14-29)60-45(71)31(16-19-37(52)64)57-41(68)26-56-44(70)35(25-40(55)67)61-46(72)32(17-20-38(53)65)58-48(74)36-15-10-22-63(36)49(75)33(18-21-39(54)66)59-43(69)30(51)23-28-11-6-4-7-12-28/h4-9,11-14,27,30-36,42H,3,10,15-26,51H2,1-2H3,(H2,52,64)(H2,53,65)(H2,54,66)(H2,55,67)(H,56,70)(H,57,68)(H,58,74)(H,59,69)(H,60,71)(H,61,72)(H,62,73)(H,76,77)/t27-,30-,31-,32-,33-,34-,35-,36-,42-/m0/s1	LXMKAPMSYYEFSM-FQQQFTRISA-N					compound annotation
0391_009921	Z-ALA-ALA-ASN-AMC	C28H31N5O8	2.9732	90470169	CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)OCC3=CC=CC=C3	Cc1cc(=O)oc2c1ccc(NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(C)NC(=O)OCc1ccccc1)c2	InChI=1S/C28H31N5O8/c1-15-11-24(35)41-22-12-19(9-10-20(15)22)32-27(38)21(13-23(29)34)33-26(37)16(2)30-25(36)17(3)31-28(39)40-14-18-7-5-4-6-8-18/h4-12,16-17,21H,13-14H2,1-3H3,(H2,29,34)(H,30,36)(H,31,39)(H,32,38)(H,33,37)/t16-,17-,21-/m0/s1	WVJTXYIHBUISHX-FIKGOQFSSA-N					doublet; removed another duplicate entry; compound annotation
0391_009923	Mogroside II-A2	C42H72O14	3.0062	102594495	C[C@H](CC[C@H](C(C)(C)O)O)C1CC[C@@]2([C@@]1(C[C@H]([C@@]3(C2CC=C4C3CC[C@@H](C4(C)C)OC5[C@@H]([C@H]([C@@H]([C@H](O5)CO[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O)O)C)O)C)C	CC(CCC(O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(COC6OC(CO)C(O)C(O)C6O)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C42H72O14/c1-20(9-13-27(44)39(4,5)52)21-15-16-40(6)26-12-10-22-23(42(26,8)28(45)17-41(21,40)7)11-14-29(38(22,2)3)56-37-35(51)33(49)31(47)25(55-37)19-53-36-34(50)32(48)30(46)24(18-43)54-36/h10,20-21,23-37,43-52H,9,11-19H2,1-8H3/t20-,21?,23?,24-,25-,26?,27-,28-,29+,30-,31-,32+,33+,34-,35-,36-,37?,40+,41-,42+/m1/s1	SLAWMGMTBGDBFT-UMIXZHIDSA-N					removed another duplicate entry; compound annotation
0391_009925	rizatriptan	C15H19N5	1.054	5078		CN(C)CCc1c[nH]c2c1cc(Cn1cncn1)cc2	InChI=1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3	ULFRLSNUDGIQQP-UHFFFAOYSA-N					compound annotation
0391_009926	Icotinib	C22H21N3O4	2.4056	22024915		C#Cc1cc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)ccc1	InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)	QQLKULDARVNMAL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009928	SP-96	C25H20FN7O	2.8536	154573766		Cn1cc(-c2cc3c(cc2)c(Nc2cc(NC(=O)Nc4cc(F)ccc4)ccc2)ncn3)cn1	InChI=1S/C25H20FN7O/c1-33-14-17(13-29-33)16-8-9-22-23(10-16)27-15-28-24(22)30-20-6-3-7-21(12-20)32-25(34)31-19-5-2-4-18(26)11-19/h2-15H,1H3,(H,27,28,30)(H2,31,32,34)	CGDYRZUPKPBLND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009930	Perillartine	C10H15NO	3.8492	5365782	CC(=C)C1CCC(=CC1)/C=N/O	C=C(C)C1CC=C(C=NO)CC1	InChI=1S/C10H15NO/c1-8(2)10-5-3-9(4-6-10)7-11-12/h3,7,10,12H,1,4-6H2,2H3/b11-7+	XCOJIVIDDFTHGB-YRNVUSSQSA-N					compound annotation
0391_009931	Enasidenib	C19H17F6N7O	3.9779	89683805		CC(C)(O)CNc1nc(Nc2cc(C(F)(F)F)ncc2)nc(-c2nc(C(F)(F)F)ccc2)n1	InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)	DYLUUSLLRIQKOE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009933	9-Ethyladenine	C7H9N5	0.4806	7		CCn1cnc2c(N)ncnc21	InChI=1S/C7H9N5/c1-2-12-4-11-5-6(8)9-3-10-7(5)12/h3-4H,2H2,1H3,(H2,8,9,10)	MUIPLRMGAXZWSQ-UHFFFAOYSA-N					compound annotation
0391_009934	Cerdulatinib	C20H27N7O3S	2.4819	44595079		CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1	InChI=1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25)	BGLPECHZZQDNCD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009937	berberine	C20H18NO4+	2.516	2353		COc1c(OC)c2c[n+]3c(cc2cc1)-c1cc2c(cc1CC3)OCO2	InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1	YBHILYKTIRIUTE-UHFFFAOYSA-N					doublet; compound annotation
0391_009938	DTXSID6046428	C14H10ClN3S2	2.9875	9927058	C1C(S/C(=C(/C#N)\N2C=CN=C2)/S1)C3=CC=CC=C3Cl	N#CC(=C1SCC(c2ccccc2Cl)S1)n1ccnc1	InChI=1S/C14H10ClN3S2/c15-11-4-2-1-3-10(11)13-8-19-14(20-13)12(7-16)18-6-5-17-9-18/h1-6,9,13H,8H2/b14-12-	ZRTQSJFIDWNVJW-OWBHPGMISA-N					compound annotation
0391_009939	4-CMTB	C14H15ClN2OS	4.5122	4307629		CC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1	InChI=1S/C14H15ClN2OS/c1-9(2)12(10-3-5-11(15)6-4-10)13(18)17-14-16-7-8-19-14/h3-9,12H,1-2H3,(H,16,17,18)	AZYDQCGCBQYFSE-UHFFFAOYSA-N					compound annotation
0391_009940	GUANFACINE	C9H9Cl2N3O	1.9535	3519		NC(N)=NC(=O)Cc1c(Cl)cccc1Cl	InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15)	INJOMKTZOLKMBF-UHFFFAOYSA-N					compound annotation
0391_009941	39674-97-0	C14H11NO3	2.2211	6604934		CC1(C)C(=O)NC2=C1C(=O)C(=O)c1ccccc21	InChI=1S/C14H11NO3/c1-14(2)9-10(15-13(14)18)7-5-3-4-6-8(7)11(16)12(9)17/h3-6H,1-2H3,(H,15,18)	LLPBUXODFQZPFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009943	RETF	C32H43N9O10	2.6328	90488886	C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)O	CC(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)O)C(=O)NC(C(=O)NC(Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1)C(C)O	InChI=1S/C32H43N9O10/c1-18(42)27(40-29(47)24(14-15-26(44)45)38-28(46)23(36-19(2)43)9-6-16-35-32(33)34)31(49)39-25(17-20-7-4-3-5-8-20)30(48)37-21-10-12-22(13-11-21)41(50)51/h3-5,7-8,10-13,18,23-25,27,42H,6,9,14-17H2,1-2H3,(H,36,43)(H,37,48)(H,38,46)(H,39,49)(H,40,47)(H,44,45)(H4,33,34,35)/t18-,23+,24+,25+,27+/m1/s1	MGCWUIJMQAZRNY-SJYYQWPBSA-N					removed another duplicate entry; compound annotation
0391_009945	genistein	C15H10O5	2.8658	5280961		O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12	InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H	TZBJGXHYKVUXJN-UHFFFAOYSA-N					compound annotation
0391_009946	CCT369260	C24H31ClF2N6O2	4.1968	135386938	C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl	CC1CN(c2ncc(Cl)c(Nc3cc4c(cc3)n(C)c(=O)n4CCC(C)(C)O)n2)CC(C)C1(F)F	InChI=1S/C24H31ClF2N6O2/c1-14-12-32(13-15(2)24(14,26)27)21-28-11-17(25)20(30-21)29-16-6-7-18-19(10-16)33(22(34)31(18)5)9-8-23(3,4)35/h6-7,10-11,14-15,35H,8-9,12-13H2,1-5H3,(H,28,29,30)/t14-,15+	VFNPUAOAEFMXQI-GASCZTMLSA-N					removed another duplicate entry; compound annotation
0391_009949	Glabridin	C20H20O4	4.4546	124052	CC1(C=CC2=C(O1)C=CC3=C2OC[C@H](C3)C4=C(C=C(C=C4)O)O)C	CC1(C)C=Cc2c(ccc3c2OCC(c2c(O)cc(O)cc2)C3)O1	InChI=1S/C20H20O4/c1-20(2)8-7-16-18(24-20)6-3-12-9-13(11-23-19(12)16)15-5-4-14(21)10-17(15)22/h3-8,10,13,21-22H,9,11H2,1-2H3/t13-/m0/s1	LBQIJVLKGVZRIW-ZDUSSCGKSA-N					compound annotation
0391_009950	homoharringtonine	C29H39NO9	1.9832	285033	CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O	COC(=O)CC(O)(CCCC(C)(C)O)C(=O)OC1C(OC)=CC23CCCN2CCc2cc4c(cc2C13)OCO4	InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1	HYFHYPWGAURHIV-JFIAXGOJSA-N					doublet; compound annotation
0391_009951	homoharringtonine	C29H39NO9	1.986	285033	CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O	COC(=O)CC(O)(CCCC(C)(C)O)C(=O)OC1C(OC)=CC23CCCN2CCc2cc4c(cc2C13)OCO4	InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1	HYFHYPWGAURHIV-JFIAXGOJSA-N					doublet; compound annotation
0391_009952	Desloratadine	C19H19ClN2	2.0041	124087		Clc1cc2c(cc1)C(=C1CCNCC1)c1c(cccn1)CC2	InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2	JAUOIFJMECXRGI-UHFFFAOYSA-N					compound annotation
0391_009953	homoharringtonine	C29H39NO9	2.0529	285033	CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O	COC(=O)CC(O)(CCCC(C)(C)O)C(=O)OC1C(OC)=CC23CCCN2CCc2cc4c(cc2C13)OCO4	InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1	HYFHYPWGAURHIV-JFIAXGOJSA-N					doublet; compound annotation
0391_009954	Fisetin	C15H10O6	2.1949	5281614		O=c1c(O)c(-c2cc(O)c(O)cc2)oc2c1ccc(O)c2	InChI=1S/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20H	XHEFDIBZLJXQHF-UHFFFAOYSA-N					compound annotation
0391_009955	Hupehenine	C27H45NO2	2.4431	14240934	C[C@H]1CC[C@H]2[C@@H]([C@@H]3CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4C[C@H]([C@@H]6[C@@]5(CC[C@@H](C6)O)C)O)C	CC1CCC2C(C)C3CCC4C(CC5C4CC(O)C4CC(O)CCC45C)C3CN2C1	InChI=1S/C27H45NO2/c1-15-4-7-25-16(2)18-5-6-19-20(22(18)14-28(25)13-15)11-23-21(19)12-26(30)24-10-17(29)8-9-27(23,24)3/h15-26,29-30H,4-14H2,1-3H3/t15-,16+,17-,18-,19+,20+,21-,22+,23-,24+,25-,26+,27+/m0/s1	NEMWYOKGHGSVSC-MSSYMPDSSA-N					compound annotation
0391_009956	MK-28	C24H20N4O2	4.5457	135715675	CN(C1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3)/N=C/C4=CC(=C(C=C4)O)O	CN(N=Cc1cc(O)c(O)cc1)c1nc(-c2ccccc2)cc(-c2ccccc2)n1	InChI=1S/C24H20N4O2/c1-28(25-16-17-12-13-22(29)23(30)14-17)24-26-20(18-8-4-2-5-9-18)15-21(27-24)19-10-6-3-7-11-19/h2-16,29-30H,1H3/b25-16+	GKOVHCFOVLXKFL-PCLIKHOPSA-N					compound annotation
0391_009957	SIMEPREVIR	C38H47N5O7S2	6.1023	24873435	CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC	COc1c(C)c2c(cc1)c(OC1CC3C(=O)NC4(C(=O)NS(=O)(=O)C5CC5)CC4C=CCCCCN(C)C(=O)C3C1)cc(-c1nc(C(C)C)cs1)n2	InChI=1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1	JTZZSQYMACOLNN-VDWJNHBNSA-N					removed another duplicate entry; compound annotation
0391_009959	dapsone	C12H12N2O2S	1.7828	2955		Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1	InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2	MQJKPEGWNLWLTK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009961	Diroximel fumarate	C11H13NO6	1.9248	73330464	COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O	COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O	InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+	YIMYDTCOUQIDMT-SNAWJCMRSA-N					compound annotation
0391_009962	Nifuroxazide	C12H9N3O5	2.2387	5337997	C1=CC(=CC=C1C(=O)N/N=C/C2=CC=C(O2)[N+](=O)[O-])O	O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1ccc(O)cc1	InChI=1S/C12H9N3O5/c16-9-3-1-8(2-4-9)12(17)14-13-7-10-5-6-11(20-10)15(18)19/h1-7,16H,(H,14,17)/b13-7+	YCWSUKQGVSGXJO-NTUHNPAUSA-N					doublet; removed another duplicate entry; compound annotation
0391_009964	Nifuroxazide	C12H9N3O5	2.2867	5337997	C1=CC(=CC=C1C(=O)N/N=C/C2=CC=C(O2)[N+](=O)[O-])O	O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1ccc(O)cc1	InChI=1S/C12H9N3O5/c16-9-3-1-8(2-4-9)12(17)14-13-7-10-5-6-11(20-10)15(18)19/h1-7,16H,(H,14,17)/b13-7+	YCWSUKQGVSGXJO-NTUHNPAUSA-N					doublet; removed another duplicate entry; compound annotation
0391_009966	camptothecin	C20H16N2O4	2.6666	24360	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1	VSJKWCGYPAHWDS-FQEVSTJZSA-N					compound annotation
0391_009967	Lazertinib	C30H34N8O3	3.4356	121269225		C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1	InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)	RRMJMHOQSALEJJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009969	Supinoxin	C22H24FN5O4	4.1908	11619093		COc1cc(OC)cc(N2CCN(C(=O)Nc3nc4c(ccc(F)c4)nc3OC)CC2)c1	InChI=1S/C22H24FN5O4/c1-30-16-11-15(12-17(13-16)31-2)27-6-8-28(9-7-27)22(29)26-20-21(32-3)25-18-5-4-14(23)10-19(18)24-20/h4-5,10-13H,6-9H2,1-3H3,(H,24,26,29)	KAKPGJJRYRYSTP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009971	Tebufenozide	C22H28N2O2	4.6607	91773		CCc1ccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)cc1	InChI=1S/C22H28N2O2/c1-7-17-8-10-18(11-9-17)20(25)23-24(22(4,5)6)21(26)19-13-15(2)12-16(3)14-19/h8-14H,7H2,1-6H3,(H,23,25)	QYPNKSZPJQQLRK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009973	5-hydroxy-L-tryptophan	C11H12N2O3	0.466	6971044	C1=CC2=C(C=C1O)C(=CN2)C[C@@H](C(=O)[O-])[NH3+]	NC(Cc1c[nH]c2c1cc(O)cc2)C(=O)O	InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1	LDCYZAJDBXYCGN-VIFPVBQESA-N					compound annotation
0391_009974	Boldine	C19H21NO4	1.4809	10154	CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)OC)O	COc1c(O)cc2CC3c4c(-c2c1)c(OC)c(O)cc4CCN3C	InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1	LZJRNLRASBVRRX-ZDUSSCGKSA-N					compound annotation
0391_009975	Trabodenoson	C15H20N6O6	2.3892	11610599	C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO[N+](=O)[O-])O)O	O=[N+]([O-])OCC1OC(n2cnc3c(NC4CCCC4)ncnc32)C(O)C1O	InChI=1S/C15H20N6O6/c22-11-9(5-26-21(24)25)27-15(12(11)23)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,22-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1	AQLVRTWKJDTWQQ-SDBHATRESA-N					compound annotation
0391_009976	Iptacopan	C25H30N2O4	2.7355	90467622	CCO[C@H]1CCN([C@@H](C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC	CCOC1CCN(Cc2c(OC)cc(C)c3c2cc[nH]3)C(c2ccc(C(=O)O)cc2)C1	InChI=1S/C25H30N2O4/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29)/t19-,22-/m0/s1	RENRQMCACQEWFC-UGKGYDQZSA-N					compound annotation
0391_009977	Icariin	C33H40O15	2.772	5318997	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O)O)O	COc1ccc(-c2c(OC3OC(C)C(O)C(O)C3O)c(=O)c3c(o2)c(CC=C(C)C)c(OC2OC(CO)C(O)C(O)C2O)cc3O)cc1	InChI=1S/C33H40O15/c1-13(2)5-10-17-19(45-33-28(42)26(40)23(37)20(12-34)46-33)11-18(35)21-24(38)31(48-32-27(41)25(39)22(36)14(3)44-32)29(47-30(17)21)15-6-8-16(43-4)9-7-15/h5-9,11,14,20,22-23,25-28,32-37,39-42H,10,12H2,1-4H3/t14-,20+,22-,23+,25+,26-,27+,28+,32-,33+/m0/s1	TZJALUIVHRYQQB-XLRXWWTNSA-N					removed another duplicate entry; compound annotation
0391_009979	daunorubicin	C27H29NO10	2.8118	30323	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(C)=O)CC3OC3CC(N)C(O)C(C)O3)c(O)c1C2=O	InChI=1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1	STQGQHZAVUOBTE-VGBVRHCVSA-N					compound annotation
0391_009980	PI-103	C19H16N4O3	3.2984	9884685		Oc1cccc(-c2nc3c(oc4c3cccn4)c(N3CCOCC3)n2)c1	InChI=1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2	TUVCWJQQGGETHL-UHFFFAOYSA-N					doublet; compound annotation
0391_009981	HBV-IN-4	C24H19ClFN5O3	3.5619	146653485		N#Cc1ccc(Cn2nc(-c3cc(Cl)c(NCC(O)CO)nc3F)c3ccccc3c2=O)cc1	InChI=1S/C24H19ClFN5O3/c25-20-9-19(22(26)29-23(20)28-11-16(33)13-32)21-17-3-1-2-4-18(17)24(34)31(30-21)12-15-7-5-14(10-27)6-8-15/h1-9,16,32-33H,11-13H2,(H,28,29)	WTCNPITUIDRZKR-UHFFFAOYSA-N					compound annotation
0391_009982	Gamabufotalin	C24H34O5	2.2955	259803	C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2[C@@H](C[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O)O	CC12CCC(O)CC1CCC1C2C(O)CC2(C)C(c3coc(=O)cc3)CCC12O	InChI=1S/C24H34O5/c1-22-9-7-16(25)11-15(22)4-5-18-21(22)19(26)12-23(2)17(8-10-24(18,23)28)14-3-6-20(27)29-13-14/h3,6,13,15-19,21,25-26,28H,4-5,7-12H2,1-2H3/t15-,16+,17-,18-,19-,21-,22+,23-,24+/m1/s1	FMTLOAVOGWSPEF-KJRPADTMSA-N					removed another duplicate entry; compound annotation
0391_009984	OSI-027	C21H22N6O3	3.0459	135398516		COc1cccc2c1[nH]c(-c1c3c(N)ncnn3c(C3CCC(C(=O)O)CC3)n1)c2	InChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24)	JROFGZPOBKIAEW-UHFFFAOYSA-N					doublet; compound annotation
0391_009985	OSI-027	C21H22N6O3	3.2034	135398516		COc1cccc2c1[nH]c(-c1c3c(N)ncnn3c(C3CCC(C(=O)O)CC3)n1)c2	InChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24)	JROFGZPOBKIAEW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_009987	Sarpogrelate	C24H31NO6	3.2983	5160		COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1	InChI=1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27)	FFYNAVGJSYHHFO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009989	A2ti-2	C18H18N4O2S	3.4181	1076904		Cc1ccccc1OCc1nnc(SCC(N)=O)n1-c1ccccc1	InChI=1S/C18H18N4O2S/c1-13-7-5-6-10-15(13)24-11-17-20-21-18(25-12-16(19)23)22(17)14-8-3-2-4-9-14/h2-10H,11-12H2,1H3,(H2,19,23)	DRZJLOOZLBTLAL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_009991	Furamidine	C18H16N4O	1.2802	126437		N=C(N)c1ccc(-c2ccc(-c3ccc(C(=N)N)cc3)o2)cc1	InChI=1S/C18H16N4O/c19-17(20)13-5-1-11(2-6-13)15-9-10-16(23-15)12-3-7-14(8-4-12)18(21)22/h1-10H,(H3,19,20)(H3,21,22)	ZJHZBDRZEZEDGB-UHFFFAOYSA-N					compound annotation
0391_009992	Tofacitinib	C16H20N6O	1.4025	9926791	C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2c1cc[nH]2	InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1	UJLAWZDWDVHWOW-YPMHNXCESA-N					doublet; removed another duplicate entry; compound annotation
0391_009994	Wedelolactone	C16H10O7	2.6539	5281813		COc1cc(O)c2c(c1)oc(=O)c1c2oc2cc(O)c(O)cc21	InChI=1S/C16H10O7/c1-21-6-2-10(19)14-12(3-6)23-16(20)13-7-4-8(17)9(18)5-11(7)22-15(13)14/h2-5,17-19H,1H3	XQDCKJKKMFWXGB-UHFFFAOYSA-N					compound annotation
0391_009995	hydrocortisone hemisuccinate	C25H34O8	3.1468	16623	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)O)O)C)O	CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O	InChI=1S/C25H34O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1	VWQWXZAWFPZJDA-CGVGKPPMSA-N					compound annotation
0391_009996	rofecoxib	C17H14O4S	3.1677	5090		CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1	InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3	RZJQGNCSTQAWON-UHFFFAOYSA-N					compound annotation
0391_009997	TETRABENAZINE	C19H27NO3	1.6014	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_009998	pinacidil	C13H19N5	1.9372	4826		CC(N=C(NC#N)Nc1ccncc1)C(C)(C)C	InChI=1S/C13H19N5/c1-10(13(2,3)4)17-12(16-9-14)18-11-5-7-15-8-6-11/h5-8,10H,1-4H3,(H2,15,16,17,18)	IVVNZDGDKPTYHK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010000	TETRABENAZINE	C19H27NO3	2.1674	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_010001	TETRABENAZINE	C19H27NO3	2.2389	6018		COc1c(OC)cc2c(c1)CCN1CC(CC(C)C)C(=O)CC21	InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3	MKJIEFSOBYUXJB-UHFFFAOYSA-N					doublet; compound annotation
0391_010002	Mogroside IV	C54H92O24	2.5176	102004786	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C)O)C)C	CC(CCC(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(COC6OC(CO)C(O)C(O)C6O)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C54H92O24/c1-22(9-13-33(51(4,5)70)77-49-45(41(66)36(61)28(20-57)74-49)78-48-44(69)39(64)35(60)27(19-56)73-48)23-15-16-52(6)30-12-10-24-25(54(30,8)31(58)17-53(23,52)7)11-14-32(50(24,2)3)76-47-43(68)40(65)37(62)29(75-47)21-71-46-42(67)38(63)34(59)26(18-55)72-46/h10,22-23,25-49,55-70H,9,11-21H2,1-8H3/t22-,23-,25-,26-,27-,28-,29-,30-,31-,32+,33-,34-,35-,36-,37-,38+,39+,40+,41+,42-,43-,44-,45-,46-,47+,48+,49+,52+,53-,54+/m1/s1	WRPAFPPCKSYACJ-KGFBLRRZSA-N					removed another duplicate entry; compound annotation
0391_010004	kamebakaurin	C20H30O5	2.5939	13945489	CC1(CC[C@@H]([C@@]2([C@@H]1C[C@H]([C@]34[C@H]2CC[C@H]([C@H]3O)C(=C)C4=O)O)CO)O)C	C=C1C(=O)C23C(O)CC4C(C)(C)CCC(O)C4(CO)C2CCC1C3O	InChI=1S/C20H30O5/c1-10-11-4-5-12-19(9-21)13(18(2,3)7-6-14(19)22)8-15(23)20(12,16(10)24)17(11)25/h11-15,17,21-23,25H,1,4-9H2,2-3H3/t11-,12-,13+,14-,15+,17+,19-,20-/m0/s1	WHSUEVLJUHPROF-BIGDWJEQSA-N					compound annotation
0391_010005	Ziyuglycoside I	C41H66O13	3.2169	71609288	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O[C@H]6[C@@H]([C@H]([C@H](CO6)O)O)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O	CC1CCC2(C(=O)OC3OC(CO)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1(C)O	InChI=1S/C41H66O13/c1-20-10-15-41(35(49)54-34-31(48)29(46)28(45)23(18-42)52-34)17-16-38(5)21(32(41)40(20,7)50)8-9-25-37(4)13-12-26(36(2,3)24(37)11-14-39(25,38)6)53-33-30(47)27(44)22(43)19-51-33/h8,20,22-34,42-48,50H,9-19H2,1-7H3/t20-,22+,23-,24+,25-,26+,27+,28-,29+,30-,31-,32-,33+,34+,37+,38-,39-,40-,41+/m1/s1	WCHBFWOEFOZHMK-MLHVESHNSA-N					compound annotation
0391_010006	Tonapofylline	C22H32N4O4	3.9237	216466		CCCn1c(=O)c2c(nc(C34CCC(CCC(=O)O)(CC3)CC4)[nH]2)n(CCC)c1=O	InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)	ZWTVVWUOTJRXKM-UHFFFAOYSA-N					compound annotation
0391_010007	Barbadin	C19H15N3OS	4.3978	727640		Nn1cnc2c(c(-c3ccc(Cc4ccccc4)cc3)cs2)c1=O	InChI=1S/C19H15N3OS/c20-22-12-21-18-17(19(22)23)16(11-24-18)15-8-6-14(7-9-15)10-13-4-2-1-3-5-13/h1-9,11-12H,10,20H2	OCBXPCSXEQQADU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010009	n-oleoylethanolamine	C20H39NO2	6.1647	5283454	CCCCCCCC/C=C\CCCCCCCC(=O)NCCO	CCCCCCCCC=CCCCCCCCC(=O)NCCO	InChI=1S/C20H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9-	BOWVQLFMWHZBEF-KTKRTIGZSA-N					compound annotation
0391_010010	4-(2-Aminoethyl)-2-methoxyphenol	C9H13NO2	0.4824	1669		COc1c(O)ccc(CCN)c1	InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3	DIVQKHQLANKJQO-UHFFFAOYSA-N					compound annotation
0391_010011	TRAP-6	C34H56N10O9	1.7906	9831933	CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)N	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(N)CO)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(N)=O)C(=O)O	InChI=1S/C34H56N10O9/c1-18(2)13-23(30(49)40-22(11-8-12-39-34(37)38)29(48)44-26(33(52)53)16-27(36)46)42-31(50)24(14-19(3)4)43-32(51)25(41-28(47)21(35)17-45)15-20-9-6-5-7-10-20/h5-7,9-10,18-19,21-26,45H,8,11-17,35H2,1-4H3,(H2,36,46)(H,40,49)(H,41,47)(H,42,50)(H,43,51)(H,44,48)(H,52,53)(H4,37,38,39)/t21-,22-,23-,24-,25-,26-/m0/s1	HAGOWCONESKMDW-FRSCJGFNSA-N					compound annotation
0391_010012	Nalpha-Azidoacetyl-L-Arg-Gly-6-oxy-6-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-yl]valerylamino]propoxy]ethoxy]ethoxy]propylamino]hexyl NH2	C36H65N13O9S	1.9302	122202057	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCCCNC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN=[N+]=[N-])NC(=O)N2	[N-]=[N+]=NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NCCCCCC(=O)NCCCOCCOCCOCCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C36H65N13O9S/c37-35(38)43-14-6-9-26(46-32(53)24-45-49-39)34(54)44-23-31(52)42-13-5-1-2-11-29(50)40-15-7-17-56-19-21-58-22-20-57-18-8-16-41-30(51)12-4-3-10-28-33-27(25-59-28)47-36(55)48-33/h26-28,33H,1-25H2,(H,40,50)(H,41,51)(H,42,52)(H,44,54)(H,46,53)(H4,37,38,43)(H2,47,48,55)/t26-,27-,28-,33-/m0/s1	CCAVSNHPARTJIZ-JIOPRJIZSA-N					compound annotation
0391_010013	RSVA405	C17H20N4O2	2.6903	135400298	CCN(CC)C1=CC(=C(C=C1)/C=N/NC(=O)C2=CC=NC=C2)O	CCN(CC)c1cc(O)c(C=NNC(=O)c2ccncc2)cc1	InChI=1S/C17H20N4O2/c1-3-21(4-2)15-6-5-14(16(22)11-15)12-19-20-17(23)13-7-9-18-10-8-13/h5-12,22H,3-4H2,1-2H3,(H,20,23)/b19-12+	GWQPCBPAOAFXSJ-XDHOZWIPSA-N					removed another duplicate entry; compound annotation
0391_010015	TAK-243	C19H20F3N5O5S2	2.9907	71715374	C1[C@@H]([C@H]([C@H]([C@@H]1NC2=CC=NC3=CC(=NN23)C4=CC(=CC=C4)SC(F)(F)F)O)O)COS(=O)(=O)N	NS(=O)(=O)OCC1CC(Nc2ccnc3cc(-c4cc(SC(F)(F)F)ccc4)nn23)C(O)C1O	InChI=1S/C19H20F3N5O5S2/c20-19(21,22)33-12-3-1-2-10(6-12)13-8-16-24-5-4-15(27(16)26-13)25-14-7-11(17(28)18(14)29)9-32-34(23,30)31/h1-6,8,11,14,17-18,25,28-29H,7,9H2,(H2,23,30,31)/t11-,14-,17-,18+/m1/s1	KJDAGXLMHXUAGV-DGWLBADLSA-N					removed another duplicate entry; compound annotation
0391_010017	clopidogrel	C16H16ClNO2S	3.8879	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	COC(=O)C(c1ccccc1Cl)N1CCc2c(ccs2)C1	InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1	GKTWGGQPFAXNFI-HNNXBMFYSA-N					doublet; compound annotation
0391_010018	IQ-3	C20H11N3O3	4.5277	5405540	C1=CC=C\2C(=C1)C3=NC4=CC=CC=C4N=C3/C2=N/OC(=O)C5=CC=CO5	O=C(ON=C1c2ccccc2-c2nc3ccccc3nc12)c1ccco1	InChI=1S/C20H11N3O3/c24-20(16-10-5-11-25-16)26-23-18-13-7-2-1-6-12(13)17-19(18)22-15-9-4-3-8-14(15)21-17/h1-11H/b23-18+	WBSWWONMTZEOGS-PTGBLXJZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010020	IQ-3	C20H11N3O3	4.7627	5405540	C1=CC=C\2C(=C1)C3=NC4=CC=CC=C4N=C3/C2=N/OC(=O)C5=CC=CO5	O=C(ON=C1c2ccccc2-c2nc3ccccc3nc12)c1ccco1	InChI=1S/C20H11N3O3/c24-20(16-10-5-11-25-16)26-23-18-13-7-2-1-6-12(13)17-19(18)22-15-9-4-3-8-14(15)21-17/h1-11H/b23-18+	WBSWWONMTZEOGS-PTGBLXJZSA-N					doublet; compound annotation
0391_010021	Oxymatrine	C15H24N2O2	0.7203	114850	C1C[C@@H]2[C@H]3CCC[N+]4([C@H]3[C@@H](CCC4)CN2C(=O)C1)[O-]	O=C1CCCC2C3CCC[N+]4([O-])CCCC(CN12)C34	InChI=1S/C15H24N2O2/c18-14-7-1-6-13-12-5-3-9-17(19)8-2-4-11(15(12)17)10-16(13)14/h11-13,15H,1-10H2/t11-,12+,13+,15-,17?/m0/s1	XVPBINOPNYFXID-LHDUFFHYSA-N					compound annotation
0391_010022	Troxerutin	C33H42O19	1.8985	5486699	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)OCCO)C5=CC(=C(C=C5)OCCO)OCCO)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3c(-c4cc(OCCO)c(OCCO)cc4)oc4cc(OCCO)cc(O)c4c3=O)C(O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C33H42O19/c1-14-23(38)26(41)28(43)32(49-14)48-13-21-24(39)27(42)29(44)33(51-21)52-31-25(40)22-17(37)11-16(45-7-4-34)12-20(22)50-30(31)15-2-3-18(46-8-5-35)19(10-15)47-9-6-36/h2-3,10-12,14,21,23-24,26-29,32-39,41-44H,4-9,13H2,1H3/t14-,21+,23-,24+,26+,27-,28+,29+,32+,33-/m0/s1	IYVFNTXFRYQLRP-VVSTWUKXSA-N					removed another duplicate entry; compound annotation
0391_010024	Crizotinib	C21H22Cl2FN5O	2.0937	11626560	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N	CC(Oc1c(N)ncc(-c2cn(C3CCNCC3)nc2)c1)c1c(Cl)ccc(F)c1Cl	InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1	KTEIFNKAUNYNJU-GFCCVEGCSA-N					doublet; removed another duplicate entry; compound annotation
0391_010026	CHEMBL196666	C32H35N5O3	3.6125	11591924	C[C@@H]1CN(C[C@@H](N1)C)C2=C(C=C3CCN(C3=C2)C(=O)C4=CC=C(C=C4)C5=C(C=C(C=C5)C6=NOC(=N6)C)C)OC	COc1c(N2CC(C)NC(C)C2)cc2c(c1)CCN2C(=O)c1ccc(-c2c(C)cc(-c3noc(C)n3)cc2)cc1	InChI=1S/C32H35N5O3/c1-19-14-26(31-34-22(4)40-35-31)10-11-27(19)23-6-8-24(9-7-23)32(38)37-13-12-25-15-30(39-5)29(16-28(25)37)36-17-20(2)33-21(3)18-36/h6-11,14-16,20-21,33H,12-13,17-18H2,1-5H3/t20-,21+	QNLSCNDZNSALTM-OYRHEFFESA-N					removed another duplicate entry; compound annotation
0391_010028	VAF347	C17H11ClF3N3	5.7544	10172275		FC(F)(F)c1ccc(Nc2nccc(-c3cc(Cl)ccc3)n2)cc1	InChI=1S/C17H11ClF3N3/c18-13-3-1-2-11(10-13)15-8-9-22-16(24-15)23-14-6-4-12(5-7-14)17(19,20)21/h1-10H,(H,22,23,24)	XTKUZTBZRIJTFR-UHFFFAOYSA-N					compound annotation
0391_010029	2',5'-Dideoxyadenosine	C10H13N5O2	0.5279	65166	C[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O	CC1OC(n2cnc3c(N)ncnc32)CC1O	InChI=1S/C10H13N5O2/c1-5-6(16)2-7(17-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7,16H,2H2,1H3,(H2,11,12,13)/t5-,6+,7-/m1/s1	FFHPXOJTVQDVMO-DSYKOEDSSA-N					compound annotation
0391_010030	DAMGO	C26H35N5O6	1.6937	5462471	C[C@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N	CC(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NCC(=O)N(C)C(Cc1ccccc1)C(=O)NCCO	InChI=1S/C26H35N5O6/c1-17(30-25(36)21(27)14-19-8-10-20(33)11-9-19)24(35)29-16-23(34)31(2)22(26(37)28-12-13-32)15-18-6-4-3-5-7-18/h3-11,17,21-22,32-33H,12-16,27H2,1-2H3,(H,28,37)(H,29,35)(H,30,36)/t17-,21+,22+/m1/s1	HPZJMUBDEAMBFI-WTNAPCKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_010032	BAZ2-ICR	C20H19N7	1.8172	91654625		Cn1cc(CCn2cnc(-c3cn(C)nc3)c2-c2ccc(C#N)cc2)cn1	InChI=1S/C20H19N7/c1-25-12-16(10-23-25)7-8-27-14-22-19(18-11-24-26(2)13-18)20(27)17-5-3-15(9-21)4-6-17/h3-6,10-14H,7-8H2,1-2H3	RRZVGDGTWNQAPW-UHFFFAOYSA-N					compound annotation
0391_010033	GNE-371	C24H25N5O3	1.9489	121335283		C=CCCn1cc(-c2c3ncn(C)c3cc(C(=O)N3CCOCC3)c2)c2c([nH]cc2)c1=O	InChI=1S/C24H25N5O3/c1-3-4-7-29-14-19(17-5-6-25-22(17)24(29)31)18-12-16(13-20-21(18)26-15-27(20)2)23(30)28-8-10-32-11-9-28/h3,5-6,12-15,25H,1,4,7-11H2,2H3	XJRUWGFZGQNPPD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010035	GNE-371	C24H25N5O3	1.9519	121335283		C=CCCn1cc(-c2c3ncn(C)c3cc(C(=O)N3CCOCC3)c2)c2c([nH]cc2)c1=O	InChI=1S/C24H25N5O3/c1-3-4-7-29-14-19(17-5-6-25-22(17)24(29)31)18-12-16(13-20-21(18)26-15-27(20)2)23(30)28-8-10-32-11-9-28/h3,5-6,12-15,25H,1,4,7-11H2,2H3	XJRUWGFZGQNPPD-UHFFFAOYSA-N					doublet; compound annotation
0391_010036	Frakefamide	C30H34FN5O5	2.6221	9829352	C[C@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)O)N	CC(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(Cc1ccc(F)cc1)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C30H34FN5O5/c1-18(34-29(40)24(32)15-20-9-13-23(37)14-10-20)28(39)36-26(17-21-7-11-22(31)12-8-21)30(41)35-25(27(33)38)16-19-5-3-2-4-6-19/h2-14,18,24-26,37H,15-17,32H2,1H3,(H2,33,38)(H,34,40)(H,35,41)(H,36,39)/t18-,24+,25+,26+/m1/s1	GTPHQORJKFJIRB-JTQLPTLWSA-N					removed another duplicate entry; compound annotation
0391_010038	NCGC00092410	C21H27N3O2	2.706	5067281		Cc1cc(N2CCOCC2)nc2c1cc(NC(=O)C1CCCCC1)cc2	InChI=1S/C21H27N3O2/c1-15-13-20(24-9-11-26-12-10-24)23-19-8-7-17(14-18(15)19)22-21(25)16-5-3-2-4-6-16/h7-8,13-14,16H,2-6,9-12H2,1H3,(H,22,25)	BXVNPOBNVRBOOV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010041	lonidamine	C15H10Cl2N2O2	4.3274	39562		O=C(O)c1nn(Cc2c(Cl)cc(Cl)cc2)c2ccccc12	InChI=1S/C15H10Cl2N2O2/c16-10-6-5-9(12(17)7-10)8-19-13-4-2-1-3-11(13)14(18-19)15(20)21/h1-7H,8H2,(H,20,21)	WDRYRZXSPDWGEB-UHFFFAOYSA-N					compound annotation
0391_010042	pentamidine	C19H24N4O2	1.7202	4735		N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1	InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)	XDRYMKDFEDOLFX-UHFFFAOYSA-N					compound annotation
0391_010043	cirazoline	C13H16N2O	2.0569	2765		c1ccc(C2CC2)c(OCC2=NCCN2)c1	InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)	YAORIDZYZDUZCM-UHFFFAOYSA-N					compound annotation
0391_010044	RBPJ INHIBITOR-1	C17H14FN3O2	2.9361	146019721		Cn1nccc1-c1cc(Oc2ccccc2F)c(C(N)=O)cc1	InChI=1S/C17H14FN3O2/c1-21-14(8-9-20-21)11-6-7-12(17(19)22)16(10-11)23-15-5-3-2-4-13(15)18/h2-10H,1H3,(H2,19,22)	MFSSHRCJKRDIOL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010046	bd750	C14H13N3OS	3.2919	16459674		O=c1c2c(CCCC2)[nH]n1-c1nc2ccccc2s1	InChI=1S/C14H13N3OS/c18-13-9-5-1-2-6-10(9)16-17(13)14-15-11-7-3-4-8-12(11)19-14/h3-4,7-8,16H,1-2,5-6H2	QWUHPPCZZXKXOQ-UHFFFAOYSA-N					compound annotation
0391_010047	GOT1 inhibitor-1	C19H19ClN4O	3.6329	2802665		O=C(Nc1ccc(Cl)cc1)N1CCN(c2cccc3c2cc[nH]3)CC1	InChI=1S/C19H19ClN4O/c20-14-4-6-15(7-5-14)22-19(25)24-12-10-23(11-13-24)18-3-1-2-17-16(18)8-9-21-17/h1-9,21H,10-13H2,(H,22,25)	VVVZKBOSNCHQEJ-UHFFFAOYSA-N					compound annotation
0391_010048	artemisinin	C15H22O5	4.175	68827	C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C	CC1CCC2C(C)C(=O)OC3OC4(C)CCC1C32OO4	InChI=1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1	BLUAFEHZUWYNDE-NNWCWBAJSA-N					compound annotation
0391_010049	Peficitinib	C18H22N4O2	1.5316	57928403	C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O	NC(=O)c1cnc2[nH]ccc2c1NC1C2CC3CC1CC(O)(C3)C2	InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14?,18?	DREIJXJRTLTGJC-JQCLMNFQSA-N					compound annotation
0391_010050	Desvenlafaxine	C16H25NO2	1.6817	125017		CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1	InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3	KYYIDSXMWOZKMP-UHFFFAOYSA-N					doublet; compound annotation
0391_010051	245329-02-6	C39H60N10O8	2.0964	73352412	CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)N	CC(C)CC(NC(=O)C(CO)NC(=O)C(N)Cc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1ccc(O)cc1)C(N)=O	InChI=1S/C39H60N10O8/c1-22(2)17-30(36(55)45-28(11-8-16-44-39(42)43)35(54)46-29(33(41)52)20-25-12-14-26(51)15-13-25)47-37(56)31(18-23(3)4)48-38(57)32(21-50)49-34(53)27(40)19-24-9-6-5-7-10-24/h5-7,9-10,12-15,22-23,27-32,50-51H,8,11,16-21,40H2,1-4H3,(H2,41,52)(H,45,55)(H,46,54)(H,47,56)(H,48,57)(H,49,53)(H4,42,43,44)/t27-,28-,29-,30-,31-,32-/m0/s1	KMSCNWHRNILNRJ-JNRWAQIZSA-N					compound annotation
0391_010052	PAEONOL	C9H10O3	3.1187	11092		COc1cc(O)c(C(C)=O)cc1	InChI=1S/C9H10O3/c1-6(10)8-4-3-7(12-2)5-9(8)11/h3-5,11H,1-2H3	UILPJVPSNHJFIK-UHFFFAOYSA-N					doublet; compound annotation
0391_010053	Repaglinide	C27H36N2O4	3.5332	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	CCOc1c(C(=O)O)ccc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)c1	InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1	FAEKWTJYAYMJKF-QHCPKHFHSA-N					doublet; compound annotation
0391_010054	Repaglinide	C27H36N2O4	3.5359	65981	CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O	CCOc1c(C(=O)O)ccc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)c1	InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1	FAEKWTJYAYMJKF-QHCPKHFHSA-N					doublet; compound annotation
0391_010055	136194-77-9	C24H18N4O	3.828	3501		Cn1c2ccccc2c2c3C(=O)NCc3c3c4ccccc4n(CCC#N)c3c21	InChI=1S/C24H18N4O/c1-27-17-9-4-2-7-14(17)20-21-16(13-26-24(21)29)19-15-8-3-5-10-18(15)28(12-6-11-25)23(19)22(20)27/h2-5,7-10H,6,12-13H2,1H3,(H,26,29)	VWVYILCFSYNJHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010058	PAEONOL	C9H10O3	4.2842	11092		COc1cc(O)c(C(C)=O)cc1	InChI=1S/C9H10O3/c1-6(10)8-4-3-7(12-2)5-9(8)11/h3-5,11H,1-2H3	UILPJVPSNHJFIK-UHFFFAOYSA-N					doublet; compound annotation
0391_010059	tetrahydro-pyridin-3-yl]-pyrazin-2-yl}-benzamide	C21H19F2N5OS	2.9667	45274293		CC1=C(c2cnc(NC(=O)c3c(F)cccc3F)cn2)CN(c2ncc(C)s2)CC1	InChI=1S/C21H19F2N5OS/c1-12-6-7-28(21-26-8-13(2)30-21)11-14(12)17-9-25-18(10-24-17)27-20(29)19-15(22)4-3-5-16(19)23/h3-5,8-10H,6-7,11H2,1-2H3,(H,25,27,29)	XGJCUFHRNSRFBO-UHFFFAOYSA-N					doublet; compound annotation
0391_010060	tetrahydro-pyridin-3-yl]-pyrazin-2-yl}-benzamide	C21H19F2N5OS	2.9697	45274293		CC1=C(c2cnc(NC(=O)c3c(F)cccc3F)cn2)CN(c2ncc(C)s2)CC1	InChI=1S/C21H19F2N5OS/c1-12-6-7-28(21-26-8-13(2)30-21)11-14(12)17-9-25-18(10-24-17)27-20(29)19-15(22)4-3-5-16(19)23/h3-5,8-10H,6-7,11H2,1-2H3,(H,25,27,29)	XGJCUFHRNSRFBO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010062	(Rac)-JBJ-04-125-02	C29H26FN5O3S	3.0072	132020316		O=C(Nc1nccs1)C(c1c(O)ccc(F)c1)N1Cc2c(cc(-c3ccc(N4CCNCC4)cc3)cc2)C1=O	InChI=1S/C29H26FN5O3S/c30-21-5-8-25(36)24(16-21)26(27(37)33-29-32-11-14-39-29)35-17-20-2-1-19(15-23(20)28(35)38)18-3-6-22(7-4-18)34-12-9-31-10-13-34/h1-8,11,14-16,26,31,36H,9-10,12-13,17H2,(H,32,33,37)	VHQVOTINPRYDAO-UHFFFAOYSA-N					compound annotation
0391_010063	Rhamnetin	C16H12O7	3.3868	5281691		COc1cc(O)c2c(=O)c(O)c(-c3cc(O)c(O)cc3)oc2c1	InChI=1S/C16H12O7/c1-22-8-5-11(19)13-12(6-8)23-16(15(21)14(13)20)7-2-3-9(17)10(18)4-7/h2-6,17-19,21H,1H3	JGUZGNYPMHHYRK-UHFFFAOYSA-N					compound annotation
0391_010064	Trotabresib	C21H21NO4S	3.5486	118021883		Cn1cc(-c2cc(S(C)(=O)=O)ccc2OCC2CC2)c2ccccc2c1=O	InChI=1S/C21H21NO4S/c1-22-12-19(16-5-3-4-6-17(16)21(22)23)18-11-15(27(2,24)25)9-10-20(18)26-13-14-7-8-14/h3-6,9-12,14H,7-8,13H2,1-2H3	UWZAJPITKGWMFJ-UHFFFAOYSA-N					compound annotation
0391_010065	1571-87-5	C13H8ClN3O2	3.8397	376353		O=[N+]([O-])c1cc2c(cc1)nc(-c1ccc(Cl)cc1)[nH]2	InChI=1S/C13H8ClN3O2/c14-9-3-1-8(2-4-9)13-15-11-6-5-10(17(18)19)7-12(11)16-13/h1-7H,(H,15,16)	KJXNOHLXULKUIZ-UHFFFAOYSA-N					compound annotation
0391_010066	tropisetron	C17H20N2O2	1.9868	656665	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43	CN1C2CCC1CC(OC(=O)c1c[nH]c3ccccc13)C2	InChI=1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13?	ZNRGQMMCGHDTEI-FUNVUKJBSA-N					compound annotation
0391_010067	Pioglitazone	C19H20N2O3S	2.3026	4829		CCc1cnc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)cc1	InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)	HYAFETHFCAUJAY-UHFFFAOYSA-N					doublet; compound annotation
0391_010068	Linaprazan	C21H26N4O2	2.3367	9951066		Cc1c(CNc2cc(C(=O)NCCO)cn3c(C)c(C)nc23)c(C)ccc1	InChI=1S/C21H26N4O2/c1-13-6-5-7-14(2)18(13)11-23-19-10-17(21(27)22-8-9-26)12-25-16(4)15(3)24-20(19)25/h5-7,10,12,23,26H,8-9,11H2,1-4H3,(H,22,27)	GHVIMBCFLRTFHI-UHFFFAOYSA-N					doublet; compound annotation
0391_010069	Linaprazan	C21H26N4O2	2.3394	9951066		Cc1c(CNc2cc(C(=O)NCCO)cn3c(C)c(C)nc23)c(C)ccc1	InChI=1S/C21H26N4O2/c1-13-6-5-7-14(2)18(13)11-23-19-10-17(21(27)22-8-9-26)12-25-16(4)15(3)24-20(19)25/h5-7,10,12,23,26H,8-9,11H2,1-4H3,(H,22,27)	GHVIMBCFLRTFHI-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010071	Erlotinib	C22H23N3O4	2.6701	176870		C#Cc1cc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)ccc1	InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)	AAKJLRGGTJKAMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010073	nicardipine	C26H29N3O6	3.1008	4474		COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3	ZBBHBTPTTSWHBA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010075	formononetin	C16H12O4	3.2951	5280378		COc1ccc(-c2coc3c(ccc(O)c3)c2=O)cc1	InChI=1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3	HKQYGTCOTHHOMP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010077	beta-Asarone	C12H16O3	3.9111	5281758	C/C=C\C1=CC(=C(C=C1OC)OC)OC	CC=Cc1cc(OC)c(OC)cc1OC	InChI=1S/C12H16O3/c1-5-6-9-7-11(14-3)12(15-4)8-10(9)13-2/h5-8H,1-4H3/b6-5-	RKFAZBXYICVSKP-WAYWQWQTSA-N					compound annotation
0391_010078	PBIT	C14H11NOS	4.0298	935415		Cc1ccc(-n2sc3ccccc3c2=O)cc1	InChI=1S/C14H11NOS/c1-10-6-8-11(9-7-10)15-14(16)12-4-2-3-5-13(12)17-15/h2-9H,1H3	KRXMYBAZKJBJAB-UHFFFAOYSA-N					doublet; compound annotation
0391_010079	PBIT	C14H11NOS	4.0328	935415		Cc1ccc(-n2sc3ccccc3c2=O)cc1	InChI=1S/C14H11NOS/c1-10-6-8-11(9-7-10)15-14(16)12-4-2-3-5-13(12)17-15/h2-9H,1H3	KRXMYBAZKJBJAB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010081	488097-06-9	C16H11ClF6N4O2	4.4809	1941609		Cn1c2c(c(=O)n(C)c1=O)C(C(F)(F)F)(C(F)(F)F)N=C(c1ccc(Cl)cc1)N2	InChI=1S/C16H11ClF6N4O2/c1-26-11-9(12(28)27(2)13(26)29)14(15(18,19)20,16(21,22)23)25-10(24-11)7-3-5-8(17)6-4-7/h3-6H,1-2H3,(H,24,25)	MFEIZMHODFOWAT-UHFFFAOYSA-N					compound annotation
0391_010082	Fostamatinib	C23H26FN6O9P	2.4575	11671467		COc1cc(Nc2ncc(F)c(Nc3nc4c(cc3)OC(C)(C)C(=O)N4COP(=O)(O)O)n2)cc(OC)c1OC	InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)	GKDRMWXFWHEQQT-UHFFFAOYSA-N					doublet; compound annotation
0391_010083	Tegaserod	C16H23N5O	3.0532	135409453	CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC	CCCCCN=C(N)NN=Cc1c[nH]c2c1cc(OC)cc2	InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+	IKBKZGMPCYNSLU-RGVLZGJSSA-N					doublet; compound annotation
0391_010084	Orexin receptor antagonist 2	C25H31N5O2	3.0532	72704097		COc1cc2c(cc1)[nH]cc2CN1CCCC2(CCN(c3nc(C)cc(C)n3)CC2)C1=O	InChI=1S/C25H31N5O2/c1-17-13-18(2)28-24(27-17)29-11-8-25(9-12-29)7-4-10-30(23(25)31)16-19-15-26-22-6-5-20(32-3)14-21(19)22/h5-6,13-15,26H,4,7-12,16H2,1-3H3	GKTSTVGKOKZFKP-UHFFFAOYSA-N					compound annotation
0391_010085	Tegaserod	C16H23N5O	3.0562	135409453	CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC	CCCCCN=C(N)NN=Cc1c[nH]c2c1cc(OC)cc2	InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+	IKBKZGMPCYNSLU-RGVLZGJSSA-N					doublet; compound annotation
0391_010086	baicalein	C15H10O5	3.1467	5281605		O=c1cc(-c2ccccc2)oc2c1c(O)c(O)c(O)c2	InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H	FXNFHKRTJBSTCS-UHFFFAOYSA-N					compound annotation
0391_010087	TYLVALOSIN	C53H87NO19	3.6611	6441094	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(OC(C)=O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC(C)C)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C53H87NO19/c1-16-38-36(26-65-52-49(64-15)48(63-14)44(60)31(7)67-52)22-28(4)17-18-37(57)29(5)23-35(19-20-55)46(30(6)39(69-34(10)56)24-41(59)70-38)73-51-45(61)43(54(12)13)47(32(8)68-51)72-42-25-53(11,62)50(33(9)66-42)71-40(58)21-27(2)3/h17-18,20,22,27,29-33,35-36,38-39,42-52,60-62H,16,19,21,23-26H2,1-15H3/b18-17+,28-22+/t29-,30+,31-,32-,33+,35+,36-,38-,39-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-/m1/s1	KCJJINQANFZSAM-HZDSEHBESA-N					doublet; compound annotation
0391_010088	TYLVALOSIN	C53H87NO19	3.8783	6441094	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC	CCC1OC(=O)CC(OC(C)=O)C(C)C(OC2OC(C)C(OC3CC(C)(O)C(OC(=O)CC(C)C)C(C)O3)C(N(C)C)C2O)C(CC=O)CC(C)C(=O)C=CC(C)=CC1COC1OC(C)C(O)C(OC)C1OC	InChI=1S/C53H87NO19/c1-16-38-36(26-65-52-49(64-15)48(63-14)44(60)31(7)67-52)22-28(4)17-18-37(57)29(5)23-35(19-20-55)46(30(6)39(69-34(10)56)24-41(59)70-38)73-51-45(61)43(54(12)13)47(32(8)68-51)72-42-25-53(11,62)50(33(9)66-42)71-40(58)21-27(2)3/h17-18,20,22,27,29-33,35-36,38-39,42-52,60-62H,16,19,21,23-26H2,1-15H3/b18-17+,28-22+/t29-,30+,31-,32-,33+,35+,36-,38-,39-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-/m1/s1	KCJJINQANFZSAM-HZDSEHBESA-N					doublet; compound annotation
0391_010089	TML-6	C30H37NO7	3.9797	72705569	CCN(C(=O)CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C)CC	CCN(CC)C(=O)CC(C)(C(=O)C=Cc1cc(OC)c(OC)cc1)C(=O)C=Cc1cc(OC)c(OC)cc1	InChI=1S/C30H37NO7/c1-8-31(9-2)29(34)20-30(3,27(32)16-12-21-10-14-23(35-4)25(18-21)37-6)28(33)17-13-22-11-15-24(36-5)26(19-22)38-7/h10-19H,8-9,20H2,1-7H3/b16-12+,17-13+	UWVCYNXVZRDWSD-UNZYHPAISA-N					doublet; compound annotation
0391_010090	TML-6	C30H37NO7	3.999	72705569	CCN(C(=O)CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C)CC	CCN(CC)C(=O)CC(C)(C(=O)C=Cc1cc(OC)c(OC)cc1)C(=O)C=Cc1cc(OC)c(OC)cc1	InChI=1S/C30H37NO7/c1-8-31(9-2)29(34)20-30(3,27(32)16-12-21-10-14-23(35-4)25(18-21)37-6)28(33)17-13-22-11-15-24(36-5)26(19-22)38-7/h10-19H,8-9,20H2,1-7H3/b16-12+,17-13+	UWVCYNXVZRDWSD-UNZYHPAISA-N					doublet; compound annotation
0391_010091	TML-6	C30H37NO7	4.3154	72705569	CCN(C(=O)CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C)CC	CCN(CC)C(=O)CC(C)(C(=O)C=Cc1cc(OC)c(OC)cc1)C(=O)C=Cc1cc(OC)c(OC)cc1	InChI=1S/C30H37NO7/c1-8-31(9-2)29(34)20-30(3,27(32)16-12-21-10-14-23(35-4)25(18-21)37-6)28(33)17-13-22-11-15-24(36-5)26(19-22)38-7/h10-19H,8-9,20H2,1-7H3/b16-12+,17-13+	UWVCYNXVZRDWSD-UNZYHPAISA-N					doublet; compound annotation
0391_010092	TML-6	C30H37NO7	4.3183	72705569	CCN(C(=O)CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C)CC	CCN(CC)C(=O)CC(C)(C(=O)C=Cc1cc(OC)c(OC)cc1)C(=O)C=Cc1cc(OC)c(OC)cc1	InChI=1S/C30H37NO7/c1-8-31(9-2)29(34)20-30(3,27(32)16-12-21-10-14-23(35-4)25(18-21)37-6)28(33)17-13-22-11-15-24(36-5)26(19-22)38-7/h10-19H,8-9,20H2,1-7H3/b16-12+,17-13+	UWVCYNXVZRDWSD-UNZYHPAISA-N					doublet; compound annotation
0391_010093	TML-6	C30H37NO7	4.4285	72705569	CCN(C(=O)CC(C(=O)/C=C/C1=CC(=C(C=C1)OC)OC)(C(=O)/C=C/C2=CC(=C(C=C2)OC)OC)C)CC	CCN(CC)C(=O)CC(C)(C(=O)C=Cc1cc(OC)c(OC)cc1)C(=O)C=Cc1cc(OC)c(OC)cc1	InChI=1S/C30H37NO7/c1-8-31(9-2)29(34)20-30(3,27(32)16-12-21-10-14-23(35-4)25(18-21)37-6)28(33)17-13-22-11-15-24(36-5)26(19-22)38-7/h10-19H,8-9,20H2,1-7H3/b16-12+,17-13+	UWVCYNXVZRDWSD-UNZYHPAISA-N					doublet; compound annotation
0391_010094	145084-28-2	C32H28N4O3	5.0574	122130	CC1=CC(=CC=C1)NC(=O)N[C@H]2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)C5=CC=CC=C5C	Cc1cc(NC(=O)NC2N=C(c3ccccc3)c3ccccc3N(CC(=O)c3ccccc3C)C2=O)ccc1	InChI=1S/C32H28N4O3/c1-21-11-10-15-24(19-21)33-32(39)35-30-31(38)36(20-28(37)25-16-7-6-12-22(25)2)27-18-9-8-17-26(27)29(34-30)23-13-4-3-5-14-23/h3-19,30H,20H2,1-2H3,(H2,33,35,39)/t30-/m0/s1	YCXFHPUBGMMWJQ-PMERELPUSA-N					removed another duplicate entry; compound annotation
0391_010096	TPC2-A1-P	C20H21BrF3NO3	5.7751	154730265		Cc1c(C(=O)O)cc(-c2c(OC(F)(F)F)ccc(Br)c2)n1CC1CCCCC1	InChI=1S/C20H21BrF3NO3/c1-12-15(19(26)27)10-17(25(12)11-13-5-3-2-4-6-13)16-9-14(21)7-8-18(16)28-20(22,23)24/h7-10,13H,2-6,11H2,1H3,(H,26,27)	INDFMVADKKBSSU-UHFFFAOYSA-N					compound annotation
0391_010097	lappaconitine	C32H44N2O8	2.3007	441743	CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2C[C@@H](C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C	CCN1CC2(OC(=O)c3ccccc3NC(C)=O)CCC(OC)C34C1C(CC23)C1(O)CC(OC)C2CC4C1(O)C2OC	InChI=1S/C32H44N2O8/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35)/t19-,20+,22+,23-,24+,25+,26?,27+,29-,30+,31+,32+/m1/s1	NWBWCXBPKTTZNQ-BAERZWJTSA-N					doublet; compound annotation
0391_010098	lappaconitine	C32H44N2O8	2.3034	441743	CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2C[C@@H](C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C	CCN1CC2(OC(=O)c3ccccc3NC(C)=O)CCC(OC)C34C1C(CC23)C1(O)CC(OC)C2CC4C1(O)C2OC	InChI=1S/C32H44N2O8/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35)/t19-,20+,22+,23-,24+,25+,26?,27+,29-,30+,31+,32+/m1/s1	NWBWCXBPKTTZNQ-BAERZWJTSA-N					doublet; compound annotation
0391_010099	lappaconitine	C32H44N2O8	2.368	441743	CCN1C[C@@]2(CC[C@@H]([C@@]34[C@@H]2C[C@@H](C31)[C@]5(C[C@@H]([C@H]6C[C@@H]4[C@@]5([C@H]6OC)O)OC)O)OC)OC(=O)C7=CC=CC=C7NC(=O)C	CCN1CC2(OC(=O)c3ccccc3NC(C)=O)CCC(OC)C34C1C(CC23)C1(O)CC(OC)C2CC4C1(O)C2OC	InChI=1S/C32H44N2O8/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35)/t19-,20+,22+,23-,24+,25+,26?,27+,29-,30+,31+,32+/m1/s1	NWBWCXBPKTTZNQ-BAERZWJTSA-N					doublet; compound annotation
0391_010100	Tebipenem pivoxil	C22H31N3O6S2	2.7559	9892071	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)[C@@H](C)O	CC(O)C1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)C(C)C12	InChI=1S/C22H31N3O6S2/c1-11-15-14(12(2)26)18(27)25(15)16(19(28)30-10-31-20(29)22(3,4)5)17(11)33-13-8-24(9-13)21-23-6-7-32-21/h11-15,26H,6-10H2,1-5H3/t11-,12-,14-,15-/m1/s1	SNUDIPVBUUXCDG-QHSBEEBCSA-N					doublet; compound annotation
0391_010101	Tebipenem pivoxil	C22H31N3O6S2	2.7589	9892071	C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)[C@@H](C)O	CC(O)C1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(SC3CN(C4=NCCS4)C3)C(C)C12	InChI=1S/C22H31N3O6S2/c1-11-15-14(12(2)26)18(27)25(15)16(19(28)30-10-31-20(29)22(3,4)5)17(11)33-13-8-24(9-13)21-23-6-7-32-21/h11-15,26H,6-10H2,1-5H3/t11-,12-,14-,15-/m1/s1	SNUDIPVBUUXCDG-QHSBEEBCSA-N					doublet; compound annotation
0391_010102	Blonanserin	C23H30FN3	2.7746	125564		CCN1CCN(c2nc3c(CCCCCC3)c(-c3ccc(F)cc3)c2)CC1	InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3	XVGOZDAJGBALKS-UHFFFAOYSA-N					doublet; compound annotation
0391_010103	Ibutilide	C20H36N2O3S	2.7775	60753		CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3	ALOBUEHUHMBRLE-UHFFFAOYSA-N					doublet; compound annotation
0391_010104	Blonanserin	C23H30FN3	3.1275	125564		CCN1CCN(c2nc3c(CCCCCC3)c(-c3ccc(F)cc3)c2)CC1	InChI=1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3	XVGOZDAJGBALKS-UHFFFAOYSA-N					doublet; compound annotation
0391_010105	1G244	C29H30F2N4O2	3.3676	56658139	C1CN(CCN1C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)C[C@@H](C(=O)N4CC5=CC=CC=C5C4)N	NC(CC(=O)N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)C(=O)N1Cc2ccccc2C1	InChI=1S/C29H30F2N4O2/c30-24-9-5-20(6-10-24)28(21-7-11-25(31)12-8-21)34-15-13-33(14-16-34)27(36)17-26(32)29(37)35-18-22-3-1-2-4-23(22)19-35/h1-12,26,28H,13-19,32H2/t26-/m0/s1	ZKIQFLSGMMYCGS-SANMLTNESA-N					removed another duplicate entry; compound annotation
0391_010107	Ibutilide	C20H36N2O3S	3.382	60753		CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1	InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3	ALOBUEHUHMBRLE-UHFFFAOYSA-N					doublet; compound annotation
0391_010108	Heteroclitin D	C27H30O8	4.8241	10367978	C/C=C(/C)\C(=O)O[C@@H]1[C@@H]([C@@H](CC2=CC(=C(C(=O)[C@@]23COC4=C3C1=CC5=C4OCO5)OC)OC)C)C	CC=C(C)C(=O)OC1c2c3c(c4OCOc4c2)OCC32C(=O)C(OC)=C(OC)C=C2CC(C)C1C	InChI=1S/C27H30O8/c1-7-13(2)26(29)35-21-15(4)14(3)8-16-9-18(30-5)23(31-6)25(28)27(16)11-32-24-20(27)17(21)10-19-22(24)34-12-33-19/h7,9-10,14-15,21H,8,11-12H2,1-6H3/b13-7-/t14-,15-,21-,27+/m1/s1	CGWKMZYZZCWGCK-YSKMNHBWSA-N					removed another duplicate entry; compound annotation
0391_010110	pargyline	C11H13N	1.0457	4688		C#CCN(C)Cc1ccccc1	InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3	DPWPWRLQFGFJFI-UHFFFAOYSA-N					compound annotation
0391_010111	ORG-26576	C11H12N2O2	1.3509	13584912	C1C[C@H]2COC3=C(C=CC=N3)C(=O)N2C1	O=C1c2c(nccc2)OCC2CCCN12	InChI=1S/C11H12N2O2/c14-11-9-4-1-5-12-10(9)15-7-8-3-2-6-13(8)11/h1,4-5,8H,2-3,6-7H2/t8-/m0/s1	FIKUEZUFASUKAH-QMMMGPOBSA-N					compound annotation
0391_010112	N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline	C13H21NO6S	1.5134	134346		CCN(CC(O)CS(=O)(=O)O)c1cc(OC)cc(OC)c1	InChI=1S/C13H21NO6S/c1-4-14(8-11(15)9-21(16,17)18)10-5-12(19-2)7-13(6-10)20-3/h5-7,11,15H,4,8-9H2,1-3H3,(H,16,17,18)	BTIDJAQNJLWPTI-UHFFFAOYSA-N					compound annotation
0391_010113	prilocaine	C13H20N2O	1.6479	4906		CCCNC(C)C(=O)Nc1ccccc1C	InChI=1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)	MVFGUOIZUNYYSO-UHFFFAOYSA-N					compound annotation
0391_010114	santonin	C15H18O3	2.9942	221071	C[C@H]1[C@@H]2CC[C@]3(C=CC(=O)C(=C3[C@H]2OC1=O)C)C	CC1=C2C3OC(=O)C(C)C3CCC2(C)C=CC1=O	InChI=1S/C15H18O3/c1-8-10-4-6-15(3)7-5-11(16)9(2)12(15)13(10)18-14(8)17/h5,7-8,10,13H,4,6H2,1-3H3/t8-,10-,13-,15-/m0/s1	XJHDMGJURBVLLE-BOCCBSBMSA-N					compound annotation
0391_010115	L-thyroxine	C15H11I4NO4	3.2677	5819	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N	NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1	XUIIKFGFIJCVMT-LBPRGKRZSA-N					doublet; compound annotation
0391_010116	Hydrocortisone buteprate	C28H40O7	4.7694	636398	CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)COC(=O)CC	CCCC(=O)OC1(C(=O)COC(=O)CC)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C	InChI=1S/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1	FOGXJPFPZOHSQS-AYVLZSQQSA-N					removed another duplicate entry; compound annotation
0391_010118	Edicotinib	C27H35N5O2	5.4472	25230468		CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2ncc(C#N)[nH]2)CC1	InChI=1S/C27H35N5O2/c1-25(2)11-9-17(10-12-25)22-21(32-24(33)23-29-16-19(15-28)30-23)8-7-20(31-22)18-13-26(3,4)34-27(5,6)14-18/h7-9,16,18H,10-14H2,1-6H3,(H,29,30)(H,32,33)	BNVPFDRNGHMRJS-UHFFFAOYSA-N					compound annotation
0391_010119	Umbelliferone	C9H6O3	1.762	5281426		O=c1ccc2c(cc(O)cc2)o1	InChI=1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H	ORHBXUUXSCNDEV-UHFFFAOYSA-N					compound annotation
0391_010120	GNE-0877	C14H16F3N7	2.2555	69093374		CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F	InChI=1S/C14H16F3N7/c1-8-10(6-24(23-8)13(2,3)7-18)21-12-20-5-9(14(15,16)17)11(19-4)22-12/h5-6H,1-4H3,(H2,19,20,21,22)	ZPPUMAMZIMPJGP-UHFFFAOYSA-N					compound annotation
0391_010121	Acetylcorynoline	C23H23NO6	2.5812	177015	CC(=O)O[C@H]1CC2=CC3=C(C=C2[C@@H]4[C@]1(C5=C(CN4C)C6=C(C=C5)OCO6)C)OCO3	CC(=O)OC1Cc2cc3c(cc2C2N(C)Cc4c(ccc5c4OCO5)C12C)OCO3	InChI=1S/C23H23NO6/c1-12(25)30-20-7-13-6-18-19(28-10-27-18)8-14(13)22-23(20,2)16-4-5-17-21(29-11-26-17)15(16)9-24(22)3/h4-6,8,20,22H,7,9-11H2,1-3H3/t20-,22+,23-/m0/s1	PUHCFWFODBLSAP-WWNPGLIZSA-N					compound annotation
0391_010122	Setiptiline	C19H19N	2.6829	5205		CN1CCC2=C(C1)c1ccccc1Cc1ccccc21	InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3	GVPIXRLYKVFFMK-UHFFFAOYSA-N					doublet; compound annotation
0391_010123	propantheline	C23H30NO3+	3.1409	4934		CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C	InChI=1S/C23H30NO3/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22/h6-13,16-17,22H,14-15H2,1-5H3/q+1	VVWYOYDLCMFIEM-UHFFFAOYSA-N					compound annotation
0391_010124	9-(2,4-dihydroxyphenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione	C23H26O5	3.2629	991372		CC1(C)CC(=O)C2=C(C1)OC1=C(C(=O)CC(C)(C)C1)C2c1c(O)cc(O)cc1	InChI=1S/C23H26O5/c1-22(2)8-15(26)20-17(10-22)28-18-11-23(3,4)9-16(27)21(18)19(20)13-6-5-12(24)7-14(13)25/h5-7,19,24-25H,8-11H2,1-4H3	OKXVTYXMGOFJFT-UHFFFAOYSA-N					doublet; compound annotation
0391_010125	9-(2,4-dihydroxyphenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione	C23H26O5	3.2665	991372		CC1(C)CC(=O)C2=C(C1)OC1=C(C(=O)CC(C)(C)C1)C2c1c(O)cc(O)cc1	InChI=1S/C23H26O5/c1-22(2)8-15(26)20-17(10-22)28-18-11-23(3,4)9-16(27)21(18)19(20)13-6-5-12(24)7-14(13)25/h5-7,19,24-25H,8-11H2,1-4H3	OKXVTYXMGOFJFT-UHFFFAOYSA-N					doublet; compound annotation
0391_010126	Zamifenacin	C27H29NO3	3.7313	3086618	C1C[C@H](CN(C1)CCC2=CC3=C(C=C2)OCO3)OC(C4=CC=CC=C4)C5=CC=CC=C5	c1ccc(C(OC2CCCN(CCc3cc4c(cc3)OCO4)C2)c2ccccc2)cc1	InChI=1S/C27H29NO3/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2/t24-/m1/s1	BDNFQGRSKSQXRI-XMMPIXPASA-N					doublet; compound annotation
0391_010127	Cucurbitacin B	C32H46O8	3.8382	5281316	CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)C)C)C)O)O	CC(=O)OC(C)(C)C=CC(=O)C(C)(O)C1C(O)CC2(C)C3CC=C4C(CC(O)C(=O)C4(C)C)C3(C)C(=O)CC12C	InChI=1S/C32H46O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,12-13,19-22,25,34-35,39H,11,14-16H2,1-9H3/b13-12+/t19-,20+,21-,22+,25+,29+,30-,31+,32+/m1/s1	IXQKXEUSCPEQRD-DKRGWESNSA-N					compound annotation
0391_010128	Lenvatinib	C21H19ClN4O4	1.9915	9823820		COc1cc2nccc(Oc3cc(Cl)c(NC(=O)NC4CC4)cc3)c2cc1C(N)=O	InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)	WOSKHXYHFSIKNG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010130	Safinamide	C17H19FN2O2	2.489	131682	C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F	CC(NCc1ccc(OCc2cc(F)ccc2)cc1)C(N)=O	InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1	NEMGRZFTLSKBAP-LBPRGKRZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010132	(E/Z)-BCI	C22H23NO	2.8912	5475586	C1CCC(CC1)NC\2C3=CC=CC=C3C(=O)/C2=C\C4=CC=CC=C4	O=C1C(=Cc2ccccc2)C(NC2CCCCC2)c2ccccc12	InChI=1S/C22H23NO/c24-22-19-14-8-7-13-18(19)21(23-17-11-5-2-6-12-17)20(22)15-16-9-3-1-4-10-16/h1,3-4,7-10,13-15,17,21,23H,2,5-6,11-12H2/b20-15-	XJDKPLZUXCIMIS-HKWRFOASSA-N					doublet; compound annotation
0391_010133	(E/Z)-BCI	C22H23NO	3.0526	5475586	C1CCC(CC1)NC\2C3=CC=CC=C3C(=O)/C2=C\C4=CC=CC=C4	O=C1C(=Cc2ccccc2)C(NC2CCCCC2)c2ccccc12	InChI=1S/C22H23NO/c24-22-19-14-8-7-13-18(19)21(23-17-11-5-2-6-12-17)20(22)15-16-9-3-1-4-10-16/h1,3-4,7-10,13-15,17,21,23H,2,5-6,11-12H2/b20-15-	XJDKPLZUXCIMIS-HKWRFOASSA-N					doublet; compound annotation
0391_010134	Ozanimod	C23H24N4O3	3.2933	52938427	CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N	CC(C)Oc1c(C#N)cc(-c2nc(-c3c4CCC(NCCO)c4ccc3)no2)cc1	InChI=1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/t20-/m0/s1	XRVDGNKRPOAQTN-FQEVSTJZSA-N					compound annotation
0391_010135	Trametinib	C26H23FIN5O4	4.3336	11707110		CC(=O)Nc1cc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4c(F)cc(I)cc4)n(C)c(=O)c(C)c32)ccc1	InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)	LIRYPHYGHXZJBZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010137	BETAMETHASONE DIPROPIONATE	C28H37FO7	4.6977	21800	CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)OC(=O)CC	CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1	CIWBQSYVNNPZIQ-XYWKZLDCSA-N					removed another duplicate entry; compound annotation
0391_010139	CLK-IN-T3	C28H30N6O2	1.6337	132585205		CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1	InChI=1S/C28H30N6O2/c1-28(2,27(36)33-16-14-32(3)15-17-33)23-7-4-21(5-8-23)26(35)31-24-19-34-18-22(6-9-25(34)30-24)20-10-12-29-13-11-20/h4-13,18-19H,14-17H2,1-3H3,(H,31,35)	IEFFSHLHNYVSEF-UHFFFAOYSA-N					compound annotation
0391_010140	Fosdagrocorat	C29H30F3N2O5P	2.2358	24872952	CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)[C@@]4(CC[C@@](C[C@H]4CC3)(C(F)(F)F)OP(=O)(O)O)CC5=CC=CC=C5	Cc1c(NC(=O)c2cc3c(cc2)C2(Cc4ccccc4)CCC(OP(=O)(O)O)(C(F)(F)F)CC2CC3)cccn1	InChI=1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1	BVXLAHSJXXSWFF-KEKPKEOLSA-N					compound annotation
0391_010141	METOPRINE	C11H10Cl2N4	2.3318	24466		Cc1c(-c2cc(Cl)c(Cl)cc2)c(N)nc(N)n1	InChI=1S/C11H10Cl2N4/c1-5-9(10(14)17-11(15)16-5)6-2-3-7(12)8(13)4-6/h2-4H,1H3,(H4,14,15,16,17)	VQJHOPSWBGJHQS-UHFFFAOYSA-N					compound annotation
0391_010142	epinastine	C16H15N3	2.4057	3241		NC1=NCC2c3ccccc3Cc3ccccc3N12	InChI=1S/C16H15N3/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16/h1-8,15H,9-10H2,(H2,17,18)	WHWZLSFABNNENI-UHFFFAOYSA-N					doublet; compound annotation
0391_010143	GNF179	C22H23ClFN5O	2.8532	58178960		CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(Cl)cc3)n2CCN1C(=O)CN	InChI=1S/C22H23ClFN5O/c1-22(2)21-27-19(14-3-7-16(24)8-4-14)20(26-17-9-5-15(23)6-10-17)28(21)11-12-29(22)18(30)13-25/h3-10,26H,11-13,25H2,1-2H3	KFSKTWYDIHJITF-UHFFFAOYSA-N					compound annotation
0391_010144	Vonafexor	C19H15Cl3N2O5S	4.574	67202717		O=C(O)c1cc2c(ccc(N3CCN(S(=O)(=O)c4c(Cl)cccc4Cl)CC3)c2Cl)o1	InChI=1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26)	XLGQSYUNOIJBNR-UHFFFAOYSA-N					compound annotation
0391_010145	Suberosin	C15H16O3	4.6897	68486		COc1c(CC=C(C)C)cc2ccc(=O)oc2c1	InChI=1S/C15H16O3/c1-10(2)4-5-11-8-12-6-7-15(16)18-14(12)9-13(11)17-3/h4,6-9H,5H2,1-3H3	RSZDAYHEZSRVHS-UHFFFAOYSA-N					compound annotation
0391_010146	autogramin-2	C21H27N3O4S	4.896	36765911		CC(C)Oc1ccc(C(=O)Nc2nc3c(CN(C(=O)OC(C)(C)C)CC3)s2)cc1	InChI=1S/C21H27N3O4S/c1-13(2)27-15-8-6-14(7-9-15)18(25)23-19-22-16-10-11-24(12-17(16)29-19)20(26)28-21(3,4)5/h6-9,13H,10-12H2,1-5H3,(H,22,23,25)	PNSFNXURLSDVRV-UHFFFAOYSA-N					compound annotation
0391_010147	D-Tryptophan	C11H12N2O2	0.9819	9060	C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)O)N	NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m1/s1	QIVBCDIJIAJPQS-SECBINFHSA-N					compound annotation
0391_010148	Revefenacin	C35H43N5O4	2.191	11753673		CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1	InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)	FYDWDCIFZSGNBU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010150	Ziprasidone	C21H21ClN4OS	2.6006	60854		O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)	MVWVFYHBGMAFLY-UHFFFAOYSA-N					doublet; compound annotation
0391_010151	mefloquine	C17H16F6N2O	3.3477	40692	C1CCN[C@H](C1)[C@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O	OC(c1cc(C(F)(F)F)nc2c1cccc2C(F)(F)F)C1CCCCN1	InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1	XEEQGYMUWCZPDN-DOMZBBRYSA-N					compound annotation
0391_010152	Deltasonamide 2	C30H39ClN6O4S2	3.83	135222708		CNc1nccc(CN(C2CCC(N)CC2)S(=O)(=O)c2ccc(S(=O)(=O)N(Cc3ccc(Cl)cc3)C3CCCC3)cc2)n1	InChI=1S/C30H39ClN6O4S2/c1-33-30-34-19-18-25(35-30)21-37(27-12-10-24(32)11-13-27)43(40,41)29-16-14-28(15-17-29)42(38,39)36(26-4-2-3-5-26)20-22-6-8-23(31)9-7-22/h6-9,14-19,24,26-27H,2-5,10-13,20-21,32H2,1H3,(H,33,34,35)	ZLDUVUWIYLENNC-UHFFFAOYSA-N					doublet; compound annotation
0391_010153	Meisoindigo	C17H12N2O2	3.9169	126274		Cn1c(O)c(C2=c3ccccc3=NC2=O)c2ccccc21	InChI=1S/C17H12N2O2/c1-19-13-9-5-3-7-11(13)15(17(19)21)14-10-6-2-4-8-12(10)18-16(14)20/h2-9,21H,1H3	XZYXCQXTKOYHGK-UHFFFAOYSA-N					compound annotation
0391_010154	Ex229	C24H18ClN3O3	4.3344	45256693		Cc1c(C(=O)O)cc(Oc2nc3c(cc(Cl)c(-c4cc5c(cc4)n(C)cc5)c3)[nH]2)cc1	InChI=1S/C24H18ClN3O3/c1-13-3-5-16(10-17(13)23(29)30)31-24-26-20-11-18(19(25)12-21(20)27-24)14-4-6-22-15(9-14)7-8-28(22)2/h3-12H,1-2H3,(H,26,27)(H,29,30)	FHWSAZXFPUMKFL-UHFFFAOYSA-N					compound annotation
0391_010155	olanzapine	C17H20N4S	1.1992	135398745		Cc1cc2c(Nc3ccccc3N=C2N2CCN(C)CC2)s1	InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3	KVWDHTXUZHCGIO-UHFFFAOYSA-N					compound annotation
0391_010156	DUP-734 free base	C17H22FNO	2.2376	121968		O=C(CC1CCN(CC2CC2)CC1)c1ccc(F)cc1	InChI=1S/C17H22FNO/c18-16-5-3-15(4-6-16)17(20)11-13-7-9-19(10-8-13)12-14-1-2-14/h3-6,13-14H,1-2,7-12H2	KWRMWQDKOGFMKP-UHFFFAOYSA-N					compound annotation
0391_010157	Sitafloxacin	C19H18ClF2N3O3	2.2376	40466933	C1CC12CN(C[C@H]2[NH3+])C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)[O-])[C@@H]5C[C@@H]5F)F	NC1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4F)c3c2Cl)CC12CC2	InChI=1S/C19H18ClF2N3O3/c20-14-15-8(17(26)9(18(27)28)5-25(15)12-4-10(12)21)3-11(22)16(14)24-6-13(23)19(7-24)1-2-19/h3,5,10,12-13H,1-2,4,6-7,23H2,(H,27,28)/t10-,12+,13+/m0/s1	PNUZDKCDAWUEGK-CYZMBNFOSA-N					removed another duplicate entry; compound annotation
0391_010159	Mogroside III	C48H82O19	2.5835	24720988	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)C)C	CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(CO)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C48H82O19/c1-21(9-13-31(45(4,5)61)67-43-40(60)37(57)34(54)27(65-43)20-62-41-38(58)35(55)32(52)25(18-49)63-41)22-15-16-46(6)28-12-10-23-24(48(28,8)29(51)17-47(22,46)7)11-14-30(44(23,2)3)66-42-39(59)36(56)33(53)26(19-50)64-42/h10,21-22,24-43,49-61H,9,11-20H2,1-8H3/t21-,22-,24-,25-,26-,27-,28+,29-,30+,31-,32-,33-,34-,35+,36+,37+,38-,39-,40-,41-,42+,43+,46+,47-,48+/m1/s1	KYVIPFHNYCKOMQ-YMRJDYICSA-N					doublet; compound annotation
0391_010160	Mogroside III	C48H82O19	2.5873	24720988	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)C)C	CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(CO)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C48H82O19/c1-21(9-13-31(45(4,5)61)67-43-40(60)37(57)34(54)27(65-43)20-62-41-38(58)35(55)32(52)25(18-49)63-41)22-15-16-46(6)28-12-10-23-24(48(28,8)29(51)17-47(22,46)7)11-14-30(44(23,2)3)66-42-39(59)36(56)33(53)26(19-50)64-42/h10,21-22,24-43,49-61H,9,11-20H2,1-8H3/t21-,22-,24-,25-,26-,27-,28+,29-,30+,31-,32-,33-,34-,35+,36+,37+,38-,39-,40-,41-,42+,43+,46+,47-,48+/m1/s1	KYVIPFHNYCKOMQ-YMRJDYICSA-N					doublet; compound annotation
0391_010161	32981-85-4	C17H17NO4	2.8981	182104	COC(=O)[C@@H]([C@H](C1=CC=CC=C1)NC(=O)C2=CC=CC=C2)O	COC(=O)C(O)C(NC(=O)c1ccccc1)c1ccccc1	InChI=1S/C17H17NO4/c1-22-17(21)15(19)14(12-8-4-2-5-9-12)18-16(20)13-10-6-3-7-11-13/h2-11,14-15,19H,1H3,(H,18,20)/t14-,15+/m0/s1	UYJLJICUXJPKTB-LSDHHAIUSA-N					removed another duplicate entry; compound annotation
0391_010163	Desoxycortone	C21H30O3	3.6861	6166	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C	CC12CCC(=O)C=C1CCC1C2CCC2(C)C(C(=O)CO)CCC12	InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1	ZESRJSPZRDMNHY-YFWFAHHUSA-N					compound annotation
0391_010164	Licochalcone C	C21H22O4	4.1527	9840805	CC(=CCC1=C(C=CC(=C1OC)/C=C/C(=O)C2=CC=C(C=C2)O)O)C	COc1c(C=CC(=O)c2ccc(O)cc2)ccc(O)c1CC=C(C)C	InChI=1S/C21H22O4/c1-14(2)4-11-18-20(24)13-8-16(21(18)25-3)7-12-19(23)15-5-9-17(22)10-6-15/h4-10,12-13,22,24H,11H2,1-3H3/b12-7+	WBDNTJSRHDSPSR-KPKJPENVSA-N					compound annotation
0391_010165	Cyperquat	C12H12N+	1.1192	39484		C[n+]1ccc(-c2ccccc2)cc1	InChI=1S/C12H12N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-10H,1H3/q+1	FMGYKKMPNATWHP-UHFFFAOYSA-N					compound annotation
0391_010166	Genipin 1-gentiobioside	C23H34O15	1.3055	3082301	COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O	COC(=O)C1=COC(OC2OC(COC3OC(CO)C(O)C(O)C3O)C(O)C(O)C2O)C2C(CO)=CCC12	InChI=1S/C23H34O15/c1-33-20(32)10-6-34-21(13-8(4-24)2-3-9(10)13)38-23-19(31)17(29)15(27)12(37-23)7-35-22-18(30)16(28)14(26)11(5-25)36-22/h2,6,9,11-19,21-31H,3-5,7H2,1H3/t9-,11-,12-,13-,14-,15-,16+,17+,18-,19-,21+,22-,23+/m1/s1	FYZYXYLPBWLLGI-AUOPOVQUSA-N					compound annotation
0391_010167	hydroquinidine	C20H26N2O2	1.6036	91503	CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O	CCC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H26N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h4-6,8,11,13-14,19-20,23H,3,7,9-10,12H2,1-2H3/t13-,14-,19+,20-/m0/s1	LJOQGZACKSYWCH-LHHVKLHASA-N					compound annotation
0391_010168	Oroxin A	C21H20O10	2.4263	5320313	C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1cc(-c2ccccc2)oc2cc(OC3OC(CO)C(O)C(O)C3O)c(O)c(O)c12	InChI=1S/C21H20O10/c22-8-14-17(25)19(27)20(28)21(31-14)30-13-7-12-15(18(26)16(13)24)10(23)6-11(29-12)9-4-2-1-3-5-9/h1-7,14,17,19-22,24-28H,8H2/t14-,17-,19+,20-,21-/m1/s1	IPQKDIRUZHOIOM-IAAKTDFRSA-N					compound annotation
0391_010169	KB-5492 (free base)	C23H30N2O6	2.5214	131083		COc1ccc(OC(=O)CN2CCN(Cc3cc(OC)c(OC)c(OC)c3)CC2)cc1	InChI=1S/C23H30N2O6/c1-27-18-5-7-19(8-6-18)31-22(26)16-25-11-9-24(10-12-25)15-17-13-20(28-2)23(30-4)21(14-17)29-3/h5-8,13-14H,9-12,15-16H2,1-4H3	RVYZAZTXLLAVGZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010171	AZD-8529	C24H24F3N5O3	3.3898	25125217		Cc1cc(-c2nc(CN3CCNCC3)no2)cc2c1C(=O)N(Cc1ccc(OC(F)(F)F)cc1)C2	InChI=1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3	IPCYZQQFECEHLI-UHFFFAOYSA-N					doublet; compound annotation
0391_010172	Tirabrutinib	C25H22N6O3	3.5112	54755438	CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	CC#CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	SEJLPXCPMNSRAM-GOSISDBHSA-N					doublet; compound annotation
0391_010173	Tirabrutinib	C25H22N6O3	3.5143	54755438	CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N	CC#CC(=O)N1CCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1	InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1	SEJLPXCPMNSRAM-GOSISDBHSA-N					doublet; compound annotation
0391_010174	4-methylumbelliferone	C10H8O3	2.1528	5280567		Cc1cc(=O)oc2c1ccc(O)c2	InChI=1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3	HSHNITRMYYLLCV-UHFFFAOYSA-N					compound annotation
0391_010175	CAPECITABINE	C15H22FN3O6	2.6853	60953	CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O	CCCCCOC(=O)Nc1nc(=O)n(C2OC(C)C(O)C2O)cc1F	InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1	GAGWJHPBXLXJQN-UORFTKCHSA-N					removed another duplicate entry; compound annotation
0391_010177	Centhaquine	C22H25N3	2.961	162163		Cc1cc(N2CCN(CCc3nc4ccccc4cc3)CC2)ccc1	InChI=1S/C22H25N3/c1-18-5-4-7-21(17-18)25-15-13-24(14-16-25)12-11-20-10-9-19-6-2-3-8-22(19)23-20/h2-10,17H,11-16H2,1H3	UJNWGFBJUHIJKK-UHFFFAOYSA-N					compound annotation
0391_010178	Cdk1/2 Inhibitor III	C15H13F2N7O2S2	3.292	5330812		Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F	InChI=1S/C15H13F2N7O2S2/c16-10-2-1-3-11(17)12(10)21-15(27)24-13(18)22-14(23-24)20-8-4-6-9(7-5-8)28(19,25)26/h1-7H,(H,21,27)(H2,19,25,26)(H3,18,20,22,23)	ARIOBGGRZJITQX-UHFFFAOYSA-N					compound annotation
0391_010179	Gypenoside XVII	C48H82O18	3.6056	44584555	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C	CC(C)=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C	InChI=1S/C48H82O18/c1-22(2)10-9-14-48(8,66-43-40(60)37(57)34(54)27(64-43)21-61-41-38(58)35(55)32(52)25(19-49)62-41)23-11-16-47(7)31(23)24(51)18-29-45(5)15-13-30(44(3,4)28(45)12-17-46(29,47)6)65-42-39(59)36(56)33(53)26(20-50)63-42/h10,23-43,49-60H,9,11-21H2,1-8H3/t23-,24+,25+,26+,27+,28-,29+,30-,31-,32+,33+,34+,35-,36-,37-,38+,39+,40+,41+,42-,43-,45-,46+,47+,48-/m0/s1	ZRBFCAALKKNCJG-SJYBZOGZSA-N					compound annotation
0391_010180	loviride	C17H16Cl2N2O2	3.9067	3963		CC(=O)c1c(NC(C(N)=O)c2c(Cl)cccc2Cl)cc(C)cc1	InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)	CJPLEFFCVDQQFZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010182	broxyquinoline	C9H5Br2NO	4.5315	2453		Oc1c(Br)cc(Br)c2c1nccc2	InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	ZDASUJMDVPTNTF-UHFFFAOYSA-N					compound annotation
0391_010183	FURSULTIAMINE	C17H26N4O3S2	1.666	3002119	CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(\CCO)/SSCC2CCCO2)/C	CC(=C(CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C17H26N4O3S2/c1-12(16(5-6-22)26-25-10-15-4-3-7-24-15)21(11-23)9-14-8-19-13(2)20-17(14)18/h8,11,15,22H,3-7,9-10H2,1-2H3,(H2,18,19,20)/b16-12+	JTLXCMOFVBXEKD-FOWTUZBSSA-N					compound annotation
0391_010184	Niraparib	C19H20N4O	2.0516	24958200	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	PCHKPVIQAHNQLW-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_010186	Halofuginone	C16H17BrClN3O3	2.3084	400772	C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O	O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m0/s1	LVASCWIMLIKXLA-LSDHHAIUSA-N					doublet; compound annotation
0391_010187	SIRT7 inhibitor 97491	C15H12ClN3O	3.2574	146018038		Nc1cc(Nc2ncc(-c3ccc(Cl)cc3)o2)ccc1	InChI=1S/C15H12ClN3O/c16-11-6-4-10(5-7-11)14-9-18-15(20-14)19-13-3-1-2-12(17)8-13/h1-9H,17H2,(H,18,19)	RMRVZWMKRCLSFX-UHFFFAOYSA-N					compound annotation
0391_010188	VORTIOXETINE	C18H22N2S	3.4968	9966051		Cc1cc(C)c(Sc2ccccc2N2CCNCC2)cc1	InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3	YQNWZWMKLDQSAC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010190	Wogonin	C16H12O5	3.6384	5281703		COc1c(O)cc(O)c2c1oc(-c1ccccc1)cc2=O	InChI=1S/C16H12O5/c1-20-15-12(19)7-10(17)14-11(18)8-13(21-16(14)15)9-5-3-2-4-6-9/h2-8,17,19H,1H3	XLTFNNCXVBYBSX-UHFFFAOYSA-N					compound annotation
0391_010191	glycodeoxycholic acid	C26H43NO5	3.9869	3035026	C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C	CC(CCC(=O)NCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-/m1/s1	WVULKSPCQVQLCU-BUXLTGKBSA-N					doublet; removed another duplicate entry; compound annotation
0391_010193	Fargesin	C21H22O6	4.1027	10926754	COC1=C(C=C(C=C1)[C@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC5=C(C=C4)OCO5)OC	COc1c(OC)cc(C2OCC3C(c4cc5c(cc4)OCO5)OCC23)cc1	InChI=1S/C21H22O6/c1-22-16-5-3-12(7-18(16)23-2)20-14-9-25-21(15(14)10-24-20)13-4-6-17-19(8-13)27-11-26-17/h3-8,14-15,20-21H,9-11H2,1-2H3/t14-,15-,20-,21+/m0/s1	AWOGQCSIVCQXBT-LATRNWQMSA-N					compound annotation
0391_010194	1430089-64-7	C19H24N8	1.2392	90369695		NCCCNc1ccc(Nc2nccc(Nc3n[nH]c(C4CC4)c3)n2)cc1	InChI=1S/C19H24N8/c20-9-1-10-21-14-4-6-15(7-5-14)23-19-22-11-8-17(25-19)24-18-12-16(26-27-18)13-2-3-13/h4-8,11-13,21H,1-3,9-10,20H2,(H3,22,23,24,25,26,27)	UYYZTTPXKIYERF-UHFFFAOYSA-N					compound annotation
0391_010195	SCHEMBL16519381	C28H27NO3P+	2.7061	49801834		COc1c(O)ccc(C(=O)NCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1	InChI=1S/C28H26NO3P/c1-32-27-21-22(17-18-26(27)30)28(31)29-19-20-33(23-11-5-2-6-12-23,24-13-7-3-8-14-24)25-15-9-4-10-16-25/h2-18,21H,19-20H2,1H3,(H-,29,30,31)/p+1	BPTRKVHQQGFTPI-UHFFFAOYSA-O					compound annotation
0391_010196	JND3229	C33H41ClN8O2	2.9157	137628688		CCC(=O)NC1CCC(N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4cc(C)c(N5CCN(C)CC5)cc4)nc32)CC1	InChI=1S/C33H41ClN8O2/c1-4-30(43)36-24-9-12-26(13-10-24)42-31-23(21-41(33(42)44)29-8-6-5-7-27(29)34)20-35-32(38-31)37-25-11-14-28(22(2)19-25)40-17-15-39(3)16-18-40/h5-8,11,14,19-20,24,26H,4,9-10,12-13,15-18,21H2,1-3H3,(H,36,43)(H,35,37,38)	WVLWGBZNXIVAKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010198	p-MPPI	C25H27IN4O2	3.3805	4658		COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1	InChI=1S/C25H27IN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3	DHMLNZRDVQLQBB-UHFFFAOYSA-N					doublet; compound annotation
0391_010199	p-MPPI	C25H27IN4O2	3.3834	4658		COc1ccccc1N1CCN(CCN(C(=O)c2ccc(I)cc2)c2ccccn2)CC1	InChI=1S/C25H27IN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3	DHMLNZRDVQLQBB-UHFFFAOYSA-N					doublet; compound annotation
0391_010200	Didesmethylrocaglamide	C27H27NO7	3.4528	397614	COC1=CC=C(C=C1)[C@]23[C@@H]([C@H]([C@H]([C@]2(C4=C(O3)C=C(C=C4OC)OC)O)O)C(=O)N)C5=CC=CC=C5	COc1ccc(C23Oc4c(c(OC)cc(OC)c4)C2(O)C(O)C(C(N)=O)C3c2ccccc2)cc1	InChI=1S/C27H27NO7/c1-32-17-11-9-16(10-12-17)27-22(15-7-5-4-6-8-15)21(25(28)30)24(29)26(27,31)23-19(34-3)13-18(33-2)14-20(23)35-27/h4-14,21-22,24,29,31H,1-3H3,(H2,28,30)/t21-,22-,24-,26+,27+/m1/s1	RMNPQEWLGQURNX-PXIJUOARSA-N					removed another duplicate entry; compound annotation
0391_010202	Indirubin	C16H10N2O2	4.0503	10177		O=C1C(c2c(O)[nH]c3ccccc23)=Nc2ccccc12	InChI=1S/C16H10N2O2/c19-15-10-6-2-4-8-12(10)17-14(15)13-9-5-1-3-7-11(9)18-16(13)20/h1-8,18,20H	JNLNPCNGMHKCKO-UHFFFAOYSA-N					compound annotation
0391_010203	CDPPB	C23H16N4O	4.409	11245456		N#Cc1cc(C(=O)Nc2cc(-c3ccccc3)nn2-c2ccccc2)ccc1	InChI=1S/C23H16N4O/c24-16-17-8-7-11-19(14-17)23(28)25-22-15-21(18-9-3-1-4-10-18)26-27(22)20-12-5-2-6-13-20/h1-15H,(H,25,28)	BKUIZWILNWHFHD-UHFFFAOYSA-N					compound annotation
0391_010204	STAT3-IN-1	C28H29NO6	4.9365	134130166	COC1=CC(=CC(=C1)/C=C/C2=CC=C(C=C2)NC(=O)/C=C/C3=CC(=C(C(=C3)OC)OC)OC)OC	COc1cc(OC)cc(C=Cc2ccc(NC(=O)C=Cc3cc(OC)c(OC)c(OC)c3)cc2)c1	InChI=1S/C28H29NO6/c1-31-23-14-20(15-24(18-23)32-2)7-6-19-8-11-22(12-9-19)29-27(30)13-10-21-16-25(33-3)28(35-5)26(17-21)34-4/h6-18H,1-5H3,(H,29,30)/b7-6+,13-10+	KOZAEBHIXYBHKA-FCXQYMQBSA-N					removed another duplicate entry; compound annotation
0391_010206	MEPHENYTOIN	C12H14N2O2	2.6334	4060		CCC1(c2ccccc2)NC(=O)N(C)C1=O	InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)	GMHKMTDVRCWUDX-UHFFFAOYSA-N					compound annotation
0391_010207	OPC-14523	C23H28ClN3O2	3.1655	9892540		COc1cccc2c1CCC(=O)N2CCCN1CCN(c2cc(Cl)ccc2)CC1	InChI=1S/C23H28ClN3O2/c1-29-22-8-3-7-21-20(22)9-10-23(28)27(21)12-4-11-25-13-15-26(16-14-25)19-6-2-5-18(24)17-19/h2-3,5-8,17H,4,9-16H2,1H3	TZZGTNZBLPCBIS-UHFFFAOYSA-N					compound annotation
0391_010208	Yangonin	C15H14O4	3.6655	5281575	COC1=CC=C(C=C1)/C=C/C2=CC(=CC(=O)O2)OC	COc1ccc(C=Cc2cc(OC)cc(=O)o2)cc1	InChI=1S/C15H14O4/c1-17-12-6-3-11(4-7-12)5-8-13-9-14(18-2)10-15(16)19-13/h3-10H,1-2H3/b8-5+	XLHIYUYCSMZCCC-VMPITWQZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010210	Yangonin	C15H14O4	3.7796	5281575	COC1=CC=C(C=C1)/C=C/C2=CC(=CC(=O)O2)OC	COc1ccc(C=Cc2cc(OC)cc(=O)o2)cc1	InChI=1S/C15H14O4/c1-17-12-6-3-11(4-7-12)5-8-13-9-14(18-2)10-15(16)19-13/h3-10H,1-2H3/b8-5+	XLHIYUYCSMZCCC-VMPITWQZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010212	timosaponin AIII	C39H64O13	4.5777	15953793	C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CCC5CC(OC6OC(CO)C(O)C(O)C6OC6OC(CO)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C39H64O13/c1-18-7-12-39(47-17-18)19(2)28-25(52-39)14-24-22-6-5-20-13-21(8-10-37(20,3)23(22)9-11-38(24,28)4)48-36-34(32(45)30(43)27(16-41)50-36)51-35-33(46)31(44)29(42)26(15-40)49-35/h18-36,40-46H,5-17H2,1-4H3/t18-,19-,20+,21-,22+,23-,24-,25-,26+,27+,28-,29+,30-,31-,32-,33+,34+,35-,36+,37-,38-,39+/m0/s1	MMTWXUQMLQGAPC-YXOKLLKRSA-N					compound annotation
0391_010213	Pteryxin	C21H22O7	4.6527	5281425	C/C=C(/C)\C(=O)O[C@H]1[C@H](C(OC2=C1C3=C(C=C2)C=CC(=O)O3)(C)C)OC(=O)C	CC=C(C)C(=O)OC1c2c(ccc3c2oc(=O)cc3)OC(C)(C)C1OC(C)=O	InChI=1S/C21H22O7/c1-6-11(2)20(24)27-18-16-14(28-21(4,5)19(18)25-12(3)22)9-7-13-8-10-15(23)26-17(13)16/h6-10,18-19H,1-5H3/b11-6-/t18-,19-/m1/s1	LYUZYPKZQDYMEE-YRCPKEQFSA-N					compound annotation
0391_010214	Gardenoside	C17H24O11	0.9506	24721095	COC(=O)C1=CO[C@@H]([C@@H]2[C@H]1C=C[C@]2(CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C1C=CC2(O)CO	InChI=1S/C17H24O11/c1-25-14(23)8-5-26-15(10-7(8)2-3-17(10,24)6-19)28-16-13(22)12(21)11(20)9(4-18)27-16/h2-3,5,7,9-13,15-16,18-22,24H,4,6H2,1H3/t7-,9+,10-,11+,12-,13+,15+,16-,17+/m0/s1	XJMPAUZQVRGFRE-ZYEJEXACSA-N					compound annotation
0391_010215	Narciclasine	C14H13NO7	1.5117	72376	C1OC2=C(O1)C(=C3C(=C2)C4=C[C@@H]([C@H]([C@H]([C@@H]4NC3=O)O)O)O)O	O=C1NC2C(=CC(O)C(O)C2O)c2cc3c(OCO3)c(O)c12	InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1	LZAZURSABQIKGB-AEKGRLRDSA-N					compound annotation
0391_010216	FRAX1036	C28H32ClN7O	2.9801	71557891		CCn1c(=O)c(-c2c(Cl)cc(-c3nc(C)cnc3)cc2)cc2cnc(NCCC3CCN(C)CC3)nc21	InChI=1S/C28H32ClN7O/c1-4-36-26-21(16-32-28(34-26)31-10-7-19-8-11-35(3)12-9-19)13-23(27(36)37)22-6-5-20(14-24(22)29)25-17-30-15-18(2)33-25/h5-6,13-17,19H,4,7-12H2,1-3H3,(H,31,32,34)	RYCBSFIKWACFBY-UHFFFAOYSA-N					compound annotation
0391_010217	diflorasone	C22H28F2O5	3.0306	71415	C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C)F	CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13-,14-,16-,17-,19-,20-,21-,22-/m0/s1	WXURHACBFYSXBI-XHIJKXOTSA-N					compound annotation
0391_010218	Androgen receptor antagonist 1	C21H25ClN4O3	3.8794	56643472		CC1(C)C(NC(=O)c2cn(CCO)nc2)C(C)(C)C1Oc1cc(Cl)c(C#N)cc1	InChI=1S/C21H25ClN4O3/c1-20(2)18(25-17(28)14-11-24-26(12-14)7-8-27)21(3,4)19(20)29-15-6-5-13(10-23)16(22)9-15/h5-6,9,11-12,18-19,27H,7-8H2,1-4H3,(H,25,28)	HJJNHDLYWZTKGQ-UHFFFAOYSA-N					compound annotation
0391_010219	Schisantherin B	C28H34O9	4.8567	6438572	C/C=C(/C)\C(=O)O[C@H]1C2=CC(=C(C(=C2C3=C(C4=C(C=C3C[C@@H]([C@]1(C)O)C)OCO4)OC)OC)OC)OC	CC=C(C)C(=O)OC1c2cc(OC)c(OC)c(OC)c2-c2c(OC)c3c(cc2CC(C)C1(C)O)OCO3	InChI=1S/C28H34O9/c1-9-14(2)27(29)37-26-17-12-18(31-5)22(32-6)25(34-8)21(17)20-16(10-15(3)28(26,4)30)11-19-23(24(20)33-7)36-13-35-19/h9,11-12,15,26,30H,10,13H2,1-8H3/b14-9-/t15-,26-,28-/m0/s1	BKGUPIVDQHHVMV-RZGKOBFOSA-N					removed another duplicate entry; compound annotation
0391_010221	8-Shogaol	C19H28O3	5.433	6442560	CCCCCCC/C=C/C(=O)CCC1=CC(=C(C=C1)O)OC	CCCCCCCC=CC(=O)CCc1cc(OC)c(O)cc1	InChI=1S/C19H28O3/c1-3-4-5-6-7-8-9-10-17(20)13-11-16-12-14-18(21)19(15-16)22-2/h9-10,12,14-15,21H,3-8,11,13H2,1-2H3/b10-9+	LGZSMXJRMTYABD-MDZDMXLPSA-N					compound annotation
0391_010222	Isocorydine	C20H23NO4	1.8345	10143	CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC)OC	COc1c(O)c2c(cc1)CC1c3c-2c(OC)c(OC)cc3CCN1C	InChI=1S/C20H23NO4/c1-21-8-7-12-10-15(24-3)20(25-4)18-16(12)13(21)9-11-5-6-14(23-2)19(22)17(11)18/h5-6,10,13,22H,7-9H2,1-4H3/t13-/m0/s1	QELDJEKNFOQJOY-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_010224	kaempferol 3-neohesperidoside	C27H30O15	1.8565	5318761	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)CO)O)O)O)O)O	CC1OC(OC2C(Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)OC(CO)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H30O15/c1-9-17(32)20(35)22(37)26(38-9)42-25-21(36)18(33)15(8-28)40-27(25)41-24-19(34)16-13(31)6-12(30)7-14(16)39-23(24)10-2-4-11(29)5-3-10/h2-7,9,15,17-18,20-22,25-33,35-37H,8H2,1H3/t9-,15+,17-,18+,20+,21-,22+,25+,26-,27-/m0/s1	OHOBPOYHROOXEI-JWMUNMLDSA-N					removed another duplicate entry; compound annotation
0391_010226	UNC10217938A	C26H28N6O2	2.8111	57402790		CCOC(=O)Nc1nc2c(nc(-c3ccccc3)c(-c3ccccc3)n2)c(NCCN(C)C)c1	InChI=1S/C26H28N6O2/c1-4-34-26(33)29-21-17-20(27-15-16-32(2)3)24-25(28-21)31-23(19-13-9-6-10-14-19)22(30-24)18-11-7-5-8-12-18/h5-14,17H,4,15-16H2,1-3H3,(H2,27,28,29,31,33)	HHICWLZMNOCMIQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010228	atrazine	C8H14ClN5	3.1925	2256		CCNc1nc(NC(C)C)nc(Cl)n1	InChI=1S/C8H14ClN5/c1-4-10-7-12-6(9)13-8(14-7)11-5(2)3/h5H,4H2,1-3H3,(H2,10,11,12,13,14)	MXWJVTOOROXGIU-UHFFFAOYSA-N					compound annotation
0391_010229	Flavokawain A	C18H18O5	3.8027	5355469	COC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2OC)OC)O	COc1ccc(C=CC(=O)c2c(O)cc(OC)cc2OC)cc1	InChI=1S/C18H18O5/c1-21-13-7-4-12(5-8-13)6-9-15(19)18-16(20)10-14(22-2)11-17(18)23-3/h4-11,20H,1-3H3/b9-6+	CGIBCVBDFUTMPT-RMKNXTFCSA-N					doublet; compound annotation
0391_010230	Glycycoumarin	C21H20O6	3.9239	5317756		COc1c(CC=C(C)C)c(O)cc2c1cc(-c1c(O)cc(O)cc1)c(=O)o2	InChI=1S/C21H20O6/c1-11(2)4-6-14-18(24)10-19-16(20(14)26-3)9-15(21(25)27-19)13-7-5-12(22)8-17(13)23/h4-5,7-10,22-24H,6H2,1-3H3	NZYSZZDSYIBYLC-UHFFFAOYSA-N					compound annotation
0391_010231	TrkA-IN-1	C25H20N4O	4.01	117967296		Cc1ncc(NC(=O)NC2c3ccccc3-c3ccccc32)c(-c2ccccc2)n1	InChI=1S/C25H20N4O/c1-16-26-15-22(23(27-16)17-9-3-2-4-10-17)28-25(30)29-24-20-13-7-5-11-18(20)19-12-6-8-14-21(19)24/h2-15,24H,1H3,(H2,28,29,30)	PKOROKYRNIDSPX-UHFFFAOYSA-N					compound annotation
0391_010232	sauchinone	C20H20O6	4.5616	11725801	C[C@@H]1C[C@@H]2[C@H]3[C@@H]([C@H]1C)C4=CC5=C(C=C4O[C@@]36C(=CC2=O)OCO6)OCO5	CC1CC2C(=O)C=C3OCOC34Oc3cc5c(cc3C(C1C)C24)OCO5	InChI=1S/C20H20O6/c1-9-3-11-13(21)5-17-20(25-8-24-17)19(11)18(10(9)2)12-4-15-16(23-7-22-15)6-14(12)26-20/h4-6,9-11,18-19H,3,7-8H2,1-2H3/t9-,10+,11+,18+,19+,20+/m1/s1	GMTJIWUFFXGFHH-WPAOEJHSSA-N					removed another duplicate entry; compound annotation
0391_010234	Flavokawain A	C18H18O5	5.0052	5355469	COC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2OC)OC)O	COc1ccc(C=CC(=O)c2c(O)cc(OC)cc2OC)cc1	InChI=1S/C18H18O5/c1-21-13-7-4-12(5-8-13)6-9-15(19)18-16(20)10-14(22-2)11-17(18)23-3/h4-11,20H,1-3H3/b9-6+	CGIBCVBDFUTMPT-RMKNXTFCSA-N					doublet; compound annotation
0391_010235	TNF-alpha-IN-1	C16H14ClN3O5	2.0297	10270102		O=C(CCl)NCc1c2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2ccc1	InChI=1S/C16H14ClN3O5/c17-6-12(22)18-7-8-2-1-3-9-13(8)16(25)20(15(9)24)10-4-5-11(21)19-14(10)23/h1-3,10H,4-7H2,(H,18,22)(H,19,21,23)	XRAYWKDMFVKUTJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010237	Toddalolactone	C16H20O6	2.5569	160485	CC(C)([C@@H](CC1=C(C=C2C(=C1OC)C=CC(=O)O2)OC)O)O	COc1c(CC(O)C(C)(C)O)c(OC)c2ccc(=O)oc2c1	InChI=1S/C16H20O6/c1-16(2,19)13(17)7-10-11(20-3)8-12-9(15(10)21-4)5-6-14(18)22-12/h5-6,8,13,17,19H,7H2,1-4H3/t13-/m1/s1	GLWPLQBQHWYKRK-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_010239	Daphnoretin	C19H12O7	3.0685	5281406		COc1c(O)cc2oc(=O)c(Oc3cc4c(cc3)ccc(=O)o4)cc2c1	InChI=1S/C19H12O7/c1-23-16-6-11-7-17(19(22)26-15(11)9-13(16)20)24-12-4-2-10-3-5-18(21)25-14(10)8-12/h2-9,20H,1H3	JRHMMVBOTXEHGJ-UHFFFAOYSA-N					compound annotation
0391_010240	Amcenestrant	C31H30Cl2FNO3	4.2461	130232326	C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O[C@H]5CCN(C5)CCCF	O=C(O)c1cc2c(cc1)C(c1ccc(OC3CCN(CCCF)C3)cc1)=C(c1c(Cl)cc(Cl)cc1)CCC2	InChI=1S/C31H30Cl2FNO3/c32-23-8-12-27(29(33)18-23)28-4-1-3-21-17-22(31(36)37)7-11-26(21)30(28)20-5-9-24(10-6-20)38-25-13-16-35(19-25)15-2-14-34/h5-12,17-18,25H,1-4,13-16,19H2,(H,36,37)/t25-/m0/s1	KISZAGQTIXIVAR-VWLOTQADSA-N					compound annotation
0391_010241	CH6953755	C26H22F2N6O4S	4.3161	124149825		Cc1cc2c(cc1NS(C)(=O)=O)[nH]c(C(=O)c1c(N)n(-c3cnc(Oc4c(F)cccc4F)cc3C)nc1)c2	InChI=1S/C26H22F2N6O4S/c1-13-7-15-9-21(32-20(15)10-19(13)33-39(3,36)37)24(35)16-11-31-34(26(16)29)22-12-30-23(8-14(22)2)38-25-17(27)5-4-6-18(25)28/h4-12,32-33H,29H2,1-3H3	YVXUHNOWRKWXSJ-UHFFFAOYSA-N					compound annotation
0391_010242	ZL0580	C25H23F3N4O4S	4.7109	139524511	C1C[C@H](N(C1)S(=O)(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(=O)NC4=CC=CC=C4	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1ccc(S(=O)(=O)N2CCCC2C(=O)Nc2ccccc2)cc1	InChI=1S/C25H23F3N4O4S/c26-25(27,28)17-8-10-19(11-9-17)30-24(34)31-20-12-14-21(15-13-20)37(35,36)32-16-4-7-22(32)23(33)29-18-5-2-1-3-6-18/h1-3,5-6,8-15,22H,4,7,16H2,(H,29,33)(H2,30,31,34)/t22-/m0/s1	DKFYGSWCJGXEJY-QFIPXVFZSA-N					doublet; compound annotation
0391_010243	Epristeride	C25H37NO3	4.7143	68741	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC=C4[C@@]3(CCC(=C4)C(=O)O)C	CC(C)(C)NC(=O)C1CCC2C3CC=C4C=C(C(=O)O)CCC4(C)C3CCC12C	InChI=1S/C25H37NO3/c1-23(2,3)26-21(27)20-9-8-18-17-7-6-16-14-15(22(28)29)10-12-24(16,4)19(17)11-13-25(18,20)5/h6,14,17-20H,7-13H2,1-5H3,(H,26,27)(H,28,29)/t17-,18-,19-,20+,24-,25-/m0/s1	VAPSMQAHNAZRKC-PQWRYPMOSA-N					compound annotation
0391_010244	ZL0580	C25H23F3N4O4S	4.7143	139524511	C1C[C@H](N(C1)S(=O)(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C(F)(F)F)C(=O)NC4=CC=CC=C4	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1ccc(S(=O)(=O)N2CCCC2C(=O)Nc2ccccc2)cc1	InChI=1S/C25H23F3N4O4S/c26-25(27,28)17-8-10-19(11-9-17)30-24(34)31-20-12-14-21(15-13-20)37(35,36)32-16-4-7-22(32)23(33)29-18-5-2-1-3-6-18/h1-3,5-6,8-15,22H,4,7,16H2,(H,29,33)(H2,30,31,34)/t22-/m0/s1	DKFYGSWCJGXEJY-QFIPXVFZSA-N					doublet; compound annotation
0391_010245	amodiaquine	C20H22ClN3O	1.3035	2165		CCN(CC)Cc1c(O)ccc(Nc2ccnc3cc(Cl)ccc23)c1	InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)	OVCDSSHSILBFBN-UHFFFAOYSA-N					doublet; compound annotation
0391_010246	186268-78-0	C12H19NO4	2.8572	9837656	CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)O	CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)O	InChI=1S/C12H19NO4/c1-4-12(2,3)9(14)10(15)13-7-5-6-8(13)11(16)17/h8H,4-7H2,1-3H3,(H,16,17)/t8-/m0/s1	FOPALECPEUVCTL-QMMMGPOBSA-N					compound annotation
0391_010247	Larotrectinib	C21H22F2N6O2	2.8691	46188928	C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F	O=C(Nc1c2nc(N3CCCC3c3c(F)ccc(F)c3)ccn2nc1)N1CCC(O)C1	InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	NYNZQNWKBKUAII-KBXCAEBGSA-N					doublet; compound annotation
0391_010248	hydrocortisone acetate	C23H32O6	3.3539	5744	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC21C	InChI=1S/C23H32O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-18,20,26,28H,4-9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1	ALEXXDVDDISNDU-JZYPGELDSA-N					compound annotation
0391_010249	3-(4-Hydroxyphenyl)propionic acid	C9H10O3	4.2788	10394		O=C(O)CCc1ccc(O)cc1	InChI=1S/C9H10O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-2,4-5,10H,3,6H2,(H,11,12)	NMHMNPHRMNGLLB-UHFFFAOYSA-N					compound annotation
0391_010250	Vemurafenib	C23H18ClF2N3O3S	4.6477	42611257		CCCS(=O)(=O)Nc1c(F)c(C(=O)c2c[nH]c3c2cc(-c2ccc(Cl)cc2)cn3)c(F)cc1	InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)	GPXBXXGIAQBQNI-UHFFFAOYSA-N					compound annotation
0391_010251	Dexpanthenol	C9H19NO4	0.6778	131204	CC(C)(CO)[C@H](C(=O)NCCCO)O	CC(C)(CO)C(O)C(=O)NCCCO	InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1	SNPLKNRPJHDVJA-ZETCQYMHSA-N					removed another duplicate entry; compound annotation
0391_010253	IMAZETHAPYR	C15H19N3O3	2.4013	54740		CCc1cc(C(=O)O)c(C2=NC(C)(C(C)C)C(=O)N2)nc1	InChI=1S/C15H19N3O3/c1-5-9-6-10(13(19)20)11(16-7-9)12-17-14(21)15(4,18-12)8(2)3/h6-8H,5H2,1-4H3,(H,19,20)(H,17,18,21)	XVOKUMIPKHGGTN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010255	FB23	C18H14Cl2N2O3	4.5698	138393314		Cc1noc(C)c1-c1cc(Cl)c(Nc2ccccc2C(=O)O)c(Cl)c1	InChI=1S/C18H14Cl2N2O3/c1-9-16(10(2)25-22-9)11-7-13(19)17(14(20)8-11)21-15-6-4-3-5-12(15)18(23)24/h3-8,21H,1-2H3,(H,23,24)	VUXZATVQMFSUCM-UHFFFAOYSA-N					compound annotation
0391_010256	Veraguensin	C22H28O5	4.6551	443026	C[C@H]1[C@@H]([C@H](O[C@H]1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C	COc1c(OC)cc(C2OC(c3cc(OC)c(OC)cc3)C(C)C2C)cc1	InChI=1S/C22H28O5/c1-13-14(2)22(16-8-10-18(24-4)20(12-16)26-6)27-21(13)15-7-9-17(23-3)19(11-15)25-5/h7-14,21-22H,1-6H3/t13-,14-,21-,22+/m0/s1	JLJAVUZBHSLLJL-GKHNXXNSSA-N					removed another duplicate entry; compound annotation
0391_010259	S-23	C18H13ClF4N2O3	4.7959	24892822	C[C@](COC1=CC(=C(C=C1)Cl)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O	CC(O)(COc1cc(F)c(Cl)cc1)C(=O)Nc1cc(C(F)(F)F)c(C#N)cc1	InChI=1S/C18H13ClF4N2O3/c1-17(27,9-28-12-4-5-14(19)15(20)7-12)16(26)25-11-3-2-10(8-24)13(6-11)18(21,22)23/h2-7,27H,9H2,1H3,(H,25,26)/t17-/m0/s1	SSFVOEAXHZGTRJ-KRWDZBQOSA-N					compound annotation
0391_010260	voxtalisib	C13H14N6O	1.8503	16123056		CCn1c(=O)c(-c2ccn[nH]2)cc2c(C)nc(N)nc21	InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17)	RGHYDLZMTYDBDT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010262	Rilpivirine	C22H18N6	2.9264	6451164	CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N	Cc1cc(C=CC#N)cc(C)c1Nc1nc(Nc2ccc(C#N)cc2)ncc1	InChI=1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+	YIBOMRUWOWDFLG-ONEGZZNKSA-N					removed another duplicate entry; compound annotation
0391_010264	lanoconazole	C14H10ClN3S2	2.9854	3002820	C1C(S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=CC=CC=C3Cl	N#CC(=C1SCC(c2ccccc2Cl)S1)n1ccnc1	InChI=1S/C14H10ClN3S2/c15-11-4-2-1-3-10(11)13-8-19-14(20-13)12(7-16)18-6-5-17-9-18/h1-6,9,13H,8H2/b14-12+	ZRTQSJFIDWNVJW-WYMLVPIESA-N					doublet; compound annotation
0391_010265	lanoconazole	C14H10ClN3S2	3.0896	3002820	C1C(S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=CC=CC=C3Cl	N#CC(=C1SCC(c2ccccc2Cl)S1)n1ccnc1	InChI=1S/C14H10ClN3S2/c15-11-4-2-1-3-10(11)13-8-19-14(20-13)12(7-16)18-6-5-17-9-18/h1-6,9,13H,8H2/b14-12+	ZRTQSJFIDWNVJW-WYMLVPIESA-N					doublet; compound annotation
0391_010266	reserpine	C33H40N2O9	3.326	5770	CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC	COC(=O)C1C2CC3c4c(CCN3CC2CC(OC(=O)c2cc(OC)c(OC)c(OC)c2)C1OC)c1c(cc(OC)cc1)[nH]4	InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1	QEVHRUUCFGRFIF-MDEJGZGSSA-N					doublet; compound annotation
0391_010267	GW406108X	C20H11Cl2NO4	3.4828	44312236	C1=COC(=C1)C(=O)C2=CC\3=C(C=C2)NC(=O)/C3=C\C4=CC(=C(C(=C4)Cl)O)Cl	O=C1Nc2c(cc(C(=O)c3ccco3)cc2)C1=Cc1cc(Cl)c(O)c(Cl)c1	InChI=1S/C20H11Cl2NO4/c21-14-7-10(8-15(22)19(14)25)6-13-12-9-11(3-4-16(12)23-20(13)26)18(24)17-2-1-5-27-17/h1-9,25H,(H,23,26)/b13-6-	XKTUKRBLWOHYIL-MLPAPPSSSA-N					compound annotation
0391_010268	1394371-71-1	C24H20ClN3O4	4.088	89558344	C1[C@H]([C@@H]2[C@H](O1)[C@@H](CO2)OC3=NC4=NC(=C(C=C4N3)Cl)C5=CC=C(C=C5)C6=CC=CC=C6)O	OC1COC2C(Oc3nc4nc(-c5ccc(-c6ccccc6)cc5)c(Cl)cc4[nH]3)COC12	InChI=1S/C24H20ClN3O4/c25-16-10-17-23(28-24(26-17)32-19-12-31-21-18(29)11-30-22(19)21)27-20(16)15-8-6-14(7-9-15)13-4-2-1-3-5-13/h1-10,18-19,21-22,29H,11-12H2,(H,26,27,28)/t18-,19-,21-,22-/m1/s1	XQMNBTZLYOOAGA-UGESXGAOSA-N					compound annotation
0391_010269	Cetalkonium	C25H46N+	5.69	31203		CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	InChI=1S/C25H46N/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25/h17-19,21-22H,4-16,20,23-24H2,1-3H3/q+1	QDYLMAYUEZBUFO-UHFFFAOYSA-N					compound annotation
0391_010270	2'-O-Methyladenosine	C11H15N5O4	0.4929	102213	CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O	COC1C(O)C(CO)OC1n1cnc2c(N)ncnc21	InChI=1S/C11H15N5O4/c1-19-8-7(18)5(2-17)20-11(8)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1	FPUGCISOLXNPPC-IOSLPCCCSA-N					compound annotation
0391_010271	(R)-(+)-Atenolol	C14H22N2O3	0.7724	180559	CC(C)NC[C@H](COC1=CC=C(C=C1)CC(=O)N)O	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/t12-/m1/s1	METKIMKYRPQLGS-GFCCVEGCSA-N					compound annotation
0391_010272	Procyanidin B2	C30H26O12	1.326	122738	C1[C@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O	Oc1cc(O)c2c(c1)OC(c1cc(O)c(O)cc1)C(O)C2c1c(O)cc(O)c2c1OC(c1cc(O)c(O)cc1)C(O)C2	InChI=1S/C30H26O12/c31-13-7-20(37)24-23(8-13)41-29(12-2-4-16(33)19(36)6-12)27(40)26(24)25-21(38)10-17(34)14-9-22(39)28(42-30(14)25)11-1-3-15(32)18(35)5-11/h1-8,10,22,26-29,31-40H,9H2/t22-,26-,27-,28-,29-/m1/s1	XFZJEEAOWLFHDH-NFJBMHMQSA-N					compound annotation
0391_010273	Osthole	C15H16O3	4.4596	10228		COc1c(CC=C(C)C)c2c(cc1)ccc(=O)o2	InChI=1S/C15H16O3/c1-10(2)4-7-12-13(17-3)8-5-11-6-9-14(16)18-15(11)12/h4-6,8-9H,7H2,1-3H3	MBRLOUHOWLUMFF-UHFFFAOYSA-N					compound annotation
0391_010274	ERAP1-IN-1	C20H21F3N2O5S	4.7794	4798291		COc1c(S(=O)(=O)Nc2cc(C(F)(F)F)ccc2N2CCCCC2)cc(C(=O)O)cc1	InChI=1S/C20H21F3N2O5S/c1-30-17-8-5-13(19(26)27)11-18(17)31(28,29)24-15-12-14(20(21,22)23)6-7-16(15)25-9-3-2-4-10-25/h5-8,11-12,24H,2-4,9-10H2,1H3,(H,26,27)	NDYXAJZYGMHQDN-UHFFFAOYSA-N					compound annotation
0391_010275	sulfacetamide	C8H10N2O3S	0.8199	5320		CC(=O)NS(=O)(=O)c1ccc(N)cc1	InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)	SKIVFJLNDNKQPD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010277	fluconazole	C13H12F2N6O	1.8526	3365		OC(Cn1cncn1)(Cn1cncn1)c1c(F)cc(F)cc1	InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2	RFHAOTPXVQNOHP-UHFFFAOYSA-N					compound annotation
0391_010278	benazepril	C24H28N2O5	2.9777	5362124	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O	CCOC(=O)C(CCc1ccccc1)NC1CCc2ccccc2N(CC(=O)O)C1=O	InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1	XPCFTKFZXHTYIP-PMACEKPBSA-N					removed another duplicate entry; compound annotation
0391_010280	Bosentan	C27H29N5O6S	4.2323	104865		COc1ccccc1Oc1c(OCCO)nc(-c2ncccn2)nc1NS(=O)(=O)c1ccc(C(C)(C)C)cc1	InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)	GJPICJJJRGTNOD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010282	(S)-5-Amino-2-((1-(trans-4-methylcyClohexyl)-1H-imidazol-4-yl)methyl)pentanoic acid	C16H27N3O2	1.2487	53464327	CC1CCC(CC1)N2C=C(N=C2)C[C@H](CCCN)C(=O)O	CC1CCC(n2cnc(CC(CCCN)C(=O)O)c2)CC1	InChI=1S/C16H27N3O2/c1-12-4-6-15(7-5-12)19-10-14(18-11-19)9-13(16(20)21)3-2-8-17/h10-13,15H,2-9,17H2,1H3,(H,20,21)/t12?,13-,15?/m0/s1	AEHFUSPLVGWEEP-OWYJLGKBSA-N					compound annotation
0391_010283	3'-Methoxypuerarin	C22H22O10	1.4855	5319485	COC1=C(C=CC(=C1)C2=COC3=C(C2=O)C=CC(=C3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	COc1c(O)ccc(-c2coc3c(ccc(O)c3C3OC(CO)C(O)C(O)C3O)c2=O)c1	InChI=1S/C22H22O10/c1-30-14-6-9(2-4-12(14)24)11-8-31-21-10(17(11)26)3-5-13(25)16(21)22-20(29)19(28)18(27)15(7-23)32-22/h2-6,8,15,18-20,22-25,27-29H,7H2,1H3/t15-,18-,19+,20-,22+/m1/s1	HQQUZVFMUSCUJS-PGPONNFDSA-N					removed another duplicate entry; compound annotation
0391_010285	1-(anilinocarbonyl)proline	C12H14N2O3	1.9446	2946785		O=C(O)C1CCCN1C(=O)Nc1ccccc1	InChI=1S/C12H14N2O3/c15-11(16)10-7-4-8-14(10)12(17)13-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H2,(H,13,17)(H,15,16)	ZEEAHHXBZHTCOI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010287	Indole-3-carboxylic acid	C9H7NO2	2.0191	69867		O=C(O)c1c[nH]c2ccccc12	InChI=1S/C9H7NO2/c11-9(12)7-5-10-8-4-2-1-3-6(7)8/h1-5,10H,(H,11,12)	KMAKOBLIOCQGJP-UHFFFAOYSA-N					compound annotation
0391_010288	Ginsenoside RG1	C42H72O14	2.4348	441923	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C	CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3O)CC12C	InChI=1S/C42H72O14/c1-20(2)10-9-13-42(8,56-37-34(52)32(50)30(48)25(19-44)55-37)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36+,37-,39+,40+,41+,42-/m0/s1	YURJSTAIMNSZAE-HHNZYBFYSA-N					compound annotation
0391_010289	AZ12672857	C26H30N8O2	2.4709	49831162		CN(c1nc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)ncc1)c1cccc2c1cn[nH]2	InChI=1S/C26H30N8O2/c1-32(24-4-2-3-23-22(24)18-28-31-23)25-5-6-27-26(30-25)29-19-15-20(33-7-11-35-12-8-33)17-21(16-19)34-9-13-36-14-10-34/h2-6,15-18H,7-14H2,1H3,(H,28,31)(H,27,29,30)	QLFGDTPACJHLRY-UHFFFAOYSA-N					compound annotation
0391_010290	Bufotalin	C26H36O6	3.1712	12302120	CC(=O)O[C@H]1C[C@@]2([C@@H]3CC[C@@H]4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@H]1C5=COC(=O)C=C5)C)C)O)O	CC(=O)OC1CC2(O)C3CCC4CC(O)CCC4(C)C3CCC2(C)C1c1coc(=O)cc1	InChI=1S/C26H36O6/c1-15(27)32-21-13-26(30)20-6-5-17-12-18(28)8-10-24(17,2)19(20)9-11-25(26,3)23(21)16-4-7-22(29)31-14-16/h4,7,14,17-21,23,28,30H,5-6,8-13H2,1-3H3/t17-,18+,19+,20-,21+,23+,24+,25-,26+/m1/s1	VOZHMAYHYHEWBW-NVOOAVKYSA-N					doublet; compound annotation
0391_010291	Bufotalin	C26H36O6	3.1747	12302120	CC(=O)O[C@H]1C[C@@]2([C@@H]3CC[C@@H]4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@H]1C5=COC(=O)C=C5)C)C)O)O	CC(=O)OC1CC2(O)C3CCC4CC(O)CCC4(C)C3CCC2(C)C1c1coc(=O)cc1	InChI=1S/C26H36O6/c1-15(27)32-21-13-26(30)20-6-5-17-12-18(28)8-10-24(17,2)19(20)9-11-25(26,3)23(21)16-4-7-22(29)31-14-16/h4,7,14,17-21,23,28,30H,5-6,8-13H2,1-3H3/t17-,18+,19+,20-,21+,23+,24+,25-,26+/m1/s1	VOZHMAYHYHEWBW-NVOOAVKYSA-N					doublet; compound annotation
0391_010292	Melphalan flufenamide	C24H30Cl2FN3O3	3.7545	9935639	CCOC(=O)[C@H](CC1=CC=C(C=C1)F)NC(=O)[C@H](CC2=CC=C(C=C2)N(CCCl)CCCl)N	CCOC(=O)C(Cc1ccc(F)cc1)NC(=O)C(N)Cc1ccc(N(CCCl)CCCl)cc1	InChI=1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1	YQZNKYXGZSVEHI-VXKWHMMOSA-N					removed another duplicate entry; compound annotation
0391_010294	Aloxistatin	C17H30N2O5	3.7702	65663	CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C	CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCC(C)C	InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1	SRVFFFJZQVENJC-IHRRRGAJSA-N					removed another duplicate entry; compound annotation
0391_010296	693228-63-6	C18H20N6OS	1.908	6420138		Cc1c(-c2nc(Nc3ccc(N4CCOCC4)cc3)ncc2)sc(N)n1	InChI=1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-7H,8-11H2,1H3,(H2,19,21)(H,20,22,23)	GPSZYOIFQZPWEJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010298	n-tert-butyl-alpha-phenylnitrone	C11H15NO	2.3917	638877	CC(C)(C)/[N+](=C/C1=CC=CC=C1)/[O-]	CC(C)(C)[N+]([O-])=Cc1ccccc1	InChI=1S/C11H15NO/c1-11(2,3)12(13)9-10-7-5-4-6-8-10/h4-9H,1-3H3/b12-9-	IYSYLWYGCWTJSG-XFXZXTDPSA-N					compound annotation
0391_010299	flumazenil	C15H14FN3O3	2.4114	3373		CCOC(=O)c1c2CN(C)C(=O)c3c(ccc(F)c3)-n2cn1	InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3	OFBIFZUFASYYRE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010301	Antidepressant agent 1	C16H19BrN2	2.8944	2882138		CCN1CCn2c3c(CCCC31)c1c2ccc(Br)c1	InChI=1S/C16H19BrN2/c1-2-18-8-9-19-14-7-6-11(17)10-13(14)12-4-3-5-15(18)16(12)19/h6-7,10,15H,2-5,8-9H2,1H3	VRTKXFMWBVSAET-UHFFFAOYSA-N					compound annotation
0391_010302	Zamifenacin	C27H29NO3	3.7293	3086618	C1C[C@H](CN(C1)CCC2=CC3=C(C=C2)OCO3)OC(C4=CC=CC=C4)C5=CC=CC=C5	c1ccc(C(OC2CCCN(CCc3cc4c(cc3)OCO4)C2)c2ccccc2)cc1	InChI=1S/C27H29NO3/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2/t24-/m1/s1	BDNFQGRSKSQXRI-XMMPIXPASA-N					doublet; compound annotation
0391_010303	Loureirin B	C18H20O5	3.835	189670		COc1cc(OC)c(CCC(=O)c2ccc(O)cc2)c(OC)c1	InChI=1S/C18H20O5/c1-21-14-10-17(22-2)15(18(11-14)23-3)8-9-16(20)12-4-6-13(19)7-5-12/h4-7,10-11,19H,8-9H2,1-3H3	ZPFRAPVRYLGYEC-UHFFFAOYSA-N					doublet; compound annotation
0391_010304	Loureirin B	C18H20O5	3.8386	189670		COc1cc(OC)c(CCC(=O)c2ccc(O)cc2)c(OC)c1	InChI=1S/C18H20O5/c1-21-14-10-17(22-2)15(18(11-14)23-3)8-9-16(20)12-4-6-13(19)7-5-12/h4-7,10-11,19H,8-9H2,1-3H3	ZPFRAPVRYLGYEC-UHFFFAOYSA-N					doublet; compound annotation
0391_010305	NCGC00024645-01	C19H38NO4+	4.1387	168382	CCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C19H37NO4/c1-5-6-7-8-9-10-11-12-13-14-19(23)24-17(15-18(21)22)16-20(2,3)4/h17H,5-16H2,1-4H3/p+1/t17-/m1/s1	FUJLYHJROOYKRA-QGZVFWFLSA-O					compound annotation
0391_010306	SR8278	C18H19NO3S2	4.6466	53393127		CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1	InChI=1S/C18H19NO3S2/c1-3-22-18(21)14-10-12-6-4-5-7-13(12)11-19(14)17(20)15-8-9-16(23-2)24-15/h4-9,14H,3,10-11H2,1-2H3	UIEBLUZPSFAFOC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010308	M2 ion channel blocker	C18H27N3O2	1.8538	78357934	COC(=O)[C@H](CC1C=NC=N1)NCC23CC4CC(C2)CC(C4)C3	COC(=O)C(CC1C=NC=N1)NCC12CC3CC(CC(C3)C1)C2	InChI=1S/C18H27N3O2/c1-23-17(22)16(5-15-9-19-11-21-15)20-10-18-6-12-2-13(7-18)4-14(3-12)8-18/h9,11-16,20H,2-8,10H2,1H3/t12?,13?,14?,15?,16-,18?/m0/s1	KKMJGUDIUVOQTI-STWSTGMMSA-N					compound annotation
0391_010309	Isoquercitrin	C21H20O12	1.8567	5280804	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1	OVSQVDMCBVZWGM-QSOFNFLRSA-N					doublet; compound annotation
0391_010310	Isoquercitrin	C21H20O12	1.8597	5280804	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1	OVSQVDMCBVZWGM-QSOFNFLRSA-N					doublet; compound annotation
0391_010311	6975-75-3	C10H12N6O	2.1562	228619		COc1ccc(N=Nc2c(N)[nH]nc2N)cc1	InChI=1S/C10H12N6O/c1-17-7-4-2-6(3-5-7)13-14-8-9(11)15-16-10(8)12/h2-5H,1H3,(H5,11,12,15,16)	QNRNTYHAOBVOKW-UHFFFAOYSA-N					doublet; compound annotation
0391_010312	Kgp-IN-1	C19H24F4N4O3	2.5713	129115728	C1CCC(C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)COC2=C(C(=CC(=C2F)F)F)F	NC(N)=NCCCC(NC(=O)C1CCCC1)C(=O)COc1c(F)c(F)cc(F)c1F	InChI=1S/C19H24F4N4O3/c20-11-8-12(21)16(23)17(15(11)22)30-9-14(28)13(6-3-7-26-19(24)25)27-18(29)10-4-1-2-5-10/h8,10,13H,1-7,9H2,(H,27,29)(H4,24,25,26)/t13-/m0/s1	KGRLRBFIDBTADP-ZDUSSCGKSA-N					doublet; compound annotation
0391_010313	6975-75-3	C10H12N6O	2.967	228619		COc1ccc(N=Nc2c(N)[nH]nc2N)cc1	InChI=1S/C10H12N6O/c1-17-7-4-2-6(3-5-7)13-14-8-9(11)15-16-10(8)12/h2-5H,1H3,(H5,11,12,15,16)	QNRNTYHAOBVOKW-UHFFFAOYSA-N					doublet; compound annotation
0391_010314	Kgp-IN-1	C19H24F4N4O3	3.0187	129115728	C1CCC(C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)COC2=C(C(=CC(=C2F)F)F)F	NC(N)=NCCCC(NC(=O)C1CCCC1)C(=O)COc1c(F)c(F)cc(F)c1F	InChI=1S/C19H24F4N4O3/c20-11-8-12(21)16(23)17(15(11)22)30-9-14(28)13(6-3-7-26-19(24)25)27-18(29)10-4-1-2-5-10/h8,10,13H,1-7,9H2,(H,27,29)(H4,24,25,26)/t13-/m0/s1	KGRLRBFIDBTADP-ZDUSSCGKSA-N					doublet; compound annotation
0391_010315	Kgp-IN-1	C19H24F4N4O3	4.3175	129115728	C1CCC(C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)COC2=C(C(=CC(=C2F)F)F)F	NC(N)=NCCCC(NC(=O)C1CCCC1)C(=O)COc1c(F)c(F)cc(F)c1F	InChI=1S/C19H24F4N4O3/c20-11-8-12(21)16(23)17(15(11)22)30-9-14(28)13(6-3-7-26-19(24)25)27-18(29)10-4-1-2-5-10/h8,10,13H,1-7,9H2,(H,27,29)(H4,24,25,26)/t13-/m0/s1	KGRLRBFIDBTADP-ZDUSSCGKSA-N					doublet; compound annotation
0391_010316	SLF-amido-C2-COOH	C34H44N2O9	4.6632	121427834	CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC2=CC(=C(C=C2)OC)OC)C3=CC(=CC=C3)NC(=O)CCC(=O)O	CCC(C)(C)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1cc(OC)c(OC)cc1)c1cc(NC(=O)CCC(=O)O)ccc1	InChI=1S/C34H44N2O9/c1-6-34(2,3)31(40)32(41)36-19-8-7-12-25(36)33(42)45-26(15-13-22-14-16-27(43-4)28(20-22)44-5)23-10-9-11-24(21-23)35-29(37)17-18-30(38)39/h9-11,14,16,20-21,25-26H,6-8,12-13,15,17-19H2,1-5H3,(H,35,37)(H,38,39)/t25-,26+/m0/s1	FTAKPNRZIJEFIG-IZZNHLLZSA-N					removed another duplicate entry; compound annotation
0391_010318	PBOX-6	C25H20N2O3	5.3948	9865511		CN(C)C(=O)OC1=C(c2cccc3ccccc23)Oc2ccccc2-n2cccc12	InChI=1S/C25H20N2O3/c1-26(2)25(28)30-24-21-14-8-16-27(21)20-13-5-6-15-22(20)29-23(24)19-12-7-10-17-9-3-4-11-18(17)19/h3-16H,1-2H3	SOIZAFVNIXAZFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_010319	PBOX-6	C25H20N2O3	5.3983	9865511		CN(C)C(=O)OC1=C(c2cccc3ccccc23)Oc2ccccc2-n2cccc12	InChI=1S/C25H20N2O3/c1-26(2)25(28)30-24-21-14-8-16-27(21)20-13-5-6-15-22(20)29-23(24)19-12-7-10-17-9-3-4-11-18(17)19/h3-16H,1-2H3	SOIZAFVNIXAZFQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010321	153559-46-7	C23H26O3	5.6197	9810431		Cc1cc2c(cc1C(=O)c1ccc(C(=O)O)cc1)C(C)(C)CCC2(C)C	InChI=1S/C23H26O3/c1-14-12-18-19(23(4,5)11-10-22(18,2)3)13-17(14)20(24)15-6-8-16(9-7-15)21(25)26/h6-9,12-13H,10-11H2,1-5H3,(H,25,26)	QADGBOQVBUXZKO-UHFFFAOYSA-N					compound annotation
0391_010322	ONC206	C23H22F2N4O	1.8641	135297777		O=C1C2=C(CCN(Cc3ccccc3)C2)N2CCN=C2N1Cc1c(F)cc(F)cc1	InChI=1S/C23H22F2N4O/c24-18-7-6-17(20(25)12-18)14-29-22(30)19-15-27(13-16-4-2-1-3-5-16)10-8-21(19)28-11-9-26-23(28)29/h1-7,12H,8-11,13-15H2	ITMGVSSHWMTJRR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010324	Cariporide	C12H17N3O3S	1.8994	151172		CC(C)c1c(S(C)(=O)=O)cc(C(=O)N=C(N)N)cc1	InChI=1S/C12H17N3O3S/c1-7(2)9-5-4-8(11(16)15-12(13)14)6-10(9)19(3,17)18/h4-7H,1-3H3,(H4,13,14,15,16)	IWXNYAIICFKCTM-UHFFFAOYSA-N					compound annotation
0391_010325	PIRMENOL	C22H30N2O	1.9053	65502	C[C@@H]1CCC[C@@H](N1CCCC(C2=CC=CC=C2)(C3=CC=CC=N3)O)C	CC1CCCC(C)N1CCCC(O)(c1ccccc1)c1ccccn1	InChI=1S/C22H30N2O/c1-18-10-8-11-19(2)24(18)17-9-15-22(25,20-12-4-3-5-13-20)21-14-6-7-16-23-21/h3-7,12-14,16,18-19,25H,8-11,15,17H2,1-2H3/t18-,19+,22?	APUDBKTWDCXQJA-QIDMFYOTSA-N					compound annotation
0391_010326	Nuezhenide	C31H42O17	2.0508	91895359	C/C=C/1\[C@@H](C(=CO[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OCCC4=CC=C(C=C4)O)O)O)O	CC=C1C(OC2OC(CO)C(O)C(O)C2O)OC=C(C(=O)OC)C1CC(=O)OCC1OC(OCCc2ccc(O)cc2)C(O)C(O)C1O	InChI=1S/C31H42O17/c1-3-16-17(18(28(41)42-2)12-45-29(16)48-31-27(40)24(37)22(35)19(11-32)46-31)10-21(34)44-13-20-23(36)25(38)26(39)30(47-20)43-9-8-14-4-6-15(33)7-5-14/h3-7,12,17,19-20,22-27,29-33,35-40H,8-11,13H2,1-2H3/b16-3+/t17-,19+,20+,22+,23+,24-,25-,26+,27+,29-,30+,31-/m0/s1	STKUCSFEBXPTAY-DTYPFZMBSA-N					compound annotation
0391_010327	AZD-8529	C24H24F3N5O3	3.3893	25125217		Cc1cc(-c2nc(CN3CCNCC3)no2)cc2c1C(=O)N(Cc1ccc(OC(F)(F)F)cc1)C2	InChI=1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3	IPCYZQQFECEHLI-UHFFFAOYSA-N					doublet; compound annotation
0391_010328	Furobufen	C16H12O4	3.7562	38117		O=C(O)CCC(=O)c1cc2c(cc1)oc1ccccc12	InChI=1S/C16H12O4/c17-13(6-8-16(18)19)10-5-7-15-12(9-10)11-3-1-2-4-14(11)20-15/h1-5,7,9H,6,8H2,(H,18,19)	LQVMQEYROPXMQH-UHFFFAOYSA-N					compound annotation
0391_010329	medroxyprogesterone	C22H32O3	4.2006	10631	C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C	CC(=O)C1(O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1	FRQMUZJSZHZSGN-HBNHAYAOSA-N					compound annotation
0391_010330	AZD-8529	C24H24F3N5O3	6.3213	25125217		Cc1cc(-c2nc(CN3CCNCC3)no2)cc2c1C(=O)N(Cc1ccc(OC(F)(F)F)cc1)C2	InChI=1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3	IPCYZQQFECEHLI-UHFFFAOYSA-N					doublet; compound annotation
0391_010331	GDC-0276	C24H31FN2O4S	6.3243	91809347		O=C(NS(=O)(=O)N1CCC1)c1c(F)cc(OCC23CC4CC(CC(C4)C2)C3)c(C2CC2)c1	InChI=1S/C24H31FN2O4S/c25-21-10-22(31-14-24-11-15-6-16(12-24)8-17(7-15)13-24)19(18-2-3-18)9-20(21)23(28)26-32(29,30)27-4-1-5-27/h9-10,15-18H,1-8,11-14H2,(H,26,28)	PTCBNPULJWGSML-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010333	Spinosin	C28H32O15	1.801	155692	COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O	COc1c(C2OC(CO)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)c(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1	InChI=1S/C28H32O15/c1-39-14-7-15-18(12(32)6-13(40-15)10-2-4-11(31)5-3-10)22(35)19(14)26-27(24(37)21(34)16(8-29)41-26)43-28-25(38)23(36)20(33)17(9-30)42-28/h2-7,16-17,20-21,23-31,33-38H,8-9H2,1H3/t16-,17-,20-,21-,23+,24+,25-,26+,27-,28+/m1/s1	VGGSULWDCMWZPO-ODEMIOGVSA-N					removed another duplicate entry; compound annotation
0391_010335	risperidone	C23H27FN4O2	2.1634	5073		Cc1c(CCN2CCC(c3noc4c3ccc(F)c4)CC2)c(=O)n2CCCCc2n1	InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3	RAPZEAPATHNIPO-UHFFFAOYSA-N					compound annotation
0391_010336	domperidone	C22H24ClN5O2	2.3874	3151		O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1	InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30)	FGXWKSZFVQUSTL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010338	prednisolone	C21H28O5	2.6753	5755	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O	CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO	InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	OIGNJSKKLXVSLS-VWUMJDOOSA-N					compound annotation
0391_010339	Lornoxicam	C13H10ClN3O4S2	3.0144	54690031		CN1C(C(=O)Nc2ccccn2)=C(O)c2c(cc(Cl)s2)S1(=O)=O	InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)	WLHQHAUOOXYABV-UHFFFAOYSA-N					compound annotation
0391_010340	Skf 89976A	C22H25NO2	3.1028	92409		O=C(O)C1CCCN(CCC=C(c2ccccc2)c2ccccc2)C1	InChI=1S/C22H25NO2/c24-22(25)20-13-7-15-23(17-20)16-8-14-21(18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-6,9-12,14,20H,7-8,13,15-17H2,(H,24,25)	TXQKSMSLZVKQBI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010342	SR-3029	C23H19F3N8O	3.8109	60196195		Fc1cccc(-n2cnc3c(NCc4nc5c(ccc(F)c5F)[nH]4)nc(N4CCOCC4)nc32)c1	InChI=1S/C23H19F3N8O/c24-13-2-1-3-14(10-13)34-12-28-20-21(31-23(32-22(20)34)33-6-8-35-9-7-33)27-11-17-29-16-5-4-15(25)18(26)19(16)30-17/h1-5,10,12H,6-9,11H2,(H,29,30)(H,27,31,32)	CEBMEQPREMCWOL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010345	11-Keto-beta-boswellic acid	C30H46O4	5.8788	9847548	C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC(=O)[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@H]([C@]5(C)C(=O)O)O)C)C)[C@@H]2[C@H]1C)C)C	CC1CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(O)C(C)(C(=O)O)C5CCC43C)C2C1C	InChI=1S/C30H46O4/c1-17-8-11-26(3)14-15-28(5)19(23(26)18(17)2)16-20(31)24-27(4)12-10-22(32)30(7,25(33)34)21(27)9-13-29(24,28)6/h16-18,21-24,32H,8-15H2,1-7H3,(H,33,34)/t17-,18+,21-,22-,23+,24-,26-,27+,28-,29-,30-/m1/s1	YIMHGPSYDOGBPI-YZCVQEKWSA-N					compound annotation
0391_010346	Brinzolamide	C12H21N3O5S3	1.633	68844	CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC	CCNC1CN(CCCOC)S(=O)(=O)c2c1cc(S(N)(=O)=O)s2	InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1	HCRKCZRJWPKOAR-JTQLQIEISA-N					compound annotation
0391_010347	pantethine	C22H42N4O8S2	1.7349	452306	CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@@H](C(C)(C)CO)O)O	CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO	InChI=1S/C22H42N4O8S2/c1-21(2,13-27)17(31)19(33)25-7-5-15(29)23-9-11-35-36-12-10-24-16(30)6-8-26-20(34)18(32)22(3,4)14-28/h17-18,27-28,31-32H,5-14H2,1-4H3,(H,23,29)(H,24,30)(H,25,33)(H,26,34)/t17-,18-/m0/s1	DJWYOLJPSHDSAL-ROUUACIJSA-N					removed another duplicate entry; compound annotation
0391_010349	Prucalopride	C18H26ClN3O3	1.7378	3052762		COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1	InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23)	ZPMNHBXQOOVQJL-UHFFFAOYSA-N					doublet; compound annotation
0391_010350	trimethobenzamide	C21H28N2O5	2.0159	5577		COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC	InChI=1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24)	FEZBIKUBAYAZIU-UHFFFAOYSA-N					compound annotation
0391_010351	pirarubicin	C32H37NO12	2.9495	11296583	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O[C@@H]6CCCCO6	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(=O)CO)CC3OC3CC(N)C(OC4CCCCO4)C(C)O3)c(O)c1C2=O	InChI=1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21+,22-,31+,32-/m0/s1	KMSKQZKKOZQFFG-YXRRJAAWSA-N					compound annotation
0391_010352	688309-70-8	C15H15Br2N3O	3.0012	2810999		CC(C)c1cc(Br)c(NC(=O)Nc2cnccc2)c(Br)c1	InChI=1S/C15H15Br2N3O/c1-9(2)10-6-12(16)14(13(17)7-10)20-15(21)19-11-4-3-5-18-8-11/h3-9H,1-2H3,(H2,19,20,21)	JFNKIJKRXKPQCC-UHFFFAOYSA-N					compound annotation
0391_010353	argatroban	C23H36N6O5S	3.2139	92722	C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C	CC1CNc2c(cccc2S(=O)(=O)NC(CCCN=C(N)N)C(=O)N2CCC(C)CC2C(=O)O)C1	InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1	KXNPVXPOPUZYGB-IOVMHBDKSA-N					compound annotation
0391_010354	Atazanavir	C38H52N6O7	3.6088	148192	CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC	COC(=O)NC(C(=O)NC(Cc1ccccc1)C(O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)C(NC(=O)OC)C(C)(C)C)C(C)(C)C	InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1	AXRYRYVKAWYZBR-GASGPIRDSA-N					removed another duplicate entry; compound annotation
0391_010356	ouabain	C29H44O12	1.5152	439501	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O	CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O	InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1	LPMXVESGRSUGHW-HBYQJFLCSA-N					removed another duplicate entry; compound annotation
0391_010358	vanillin	C8H8O3	1.6417	1183		COc1c(O)ccc(C=O)c1	InChI=1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3	MWOOGOJBHIARFG-UHFFFAOYSA-N					compound annotation
0391_010359	Lofexidine	C11H12Cl2N2O	1.8335	30668		CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)	KSMAGQUYOIHWFS-UHFFFAOYSA-N					doublet; compound annotation
0391_010360	Tasimelteon	C15H19NO2	3.0518	10220503	CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2	CCC(=O)NCC1CC1c1c2CCOc2ccc1	InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1	PTOIAAWZLUQTIO-GXFFZTMASA-N					compound annotation
0391_010361	ADRENOSTERONE	C19H24O3	3.145	223997	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C	CC12CC(=O)C3C(CCC4=CC(=O)CCC43C)C1CCC2=O	InChI=1S/C19H24O3/c1-18-8-7-12(20)9-11(18)3-4-13-14-5-6-16(22)19(14,2)10-15(21)17(13)18/h9,13-14,17H,3-8,10H2,1-2H3/t13-,14-,17+,18-,19-/m0/s1	RZRPTBIGEANTGU-IRIMSJTPSA-N					compound annotation
0391_010362	503468-95-9	C25H19NO3S	4.4751	11327430		O=c1cc(N2CCOCC2)oc2c1cccc2-c1cccc2c1sc1ccccc12	InChI=1S/C25H19NO3S/c27-21-15-23(26-11-13-28-14-12-26)29-24-17(6-3-9-20(21)24)19-8-4-7-18-16-5-1-2-10-22(16)30-25(18)19/h1-10,15H,11-14H2	JAMULYFATHSZJM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010364	isoproterenol	C11H17NO3	0.4717	3779		CC(C)NCC(O)c1cc(O)c(O)cc1	InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3	JWZZKOKVBUJMES-UHFFFAOYSA-N					compound annotation
0391_010365	Lorlatinib	C21H19FN6O2	2.1217	71731823	C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C	CC1Oc2c(N)ncc(c2)-c2c(C#N)n(C)nc2CN(C)C(=O)c2c1cc(F)cc2	InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1	IIXWYSCJSQVBQM-LLVKDONJSA-N					compound annotation
0391_010366	podophyllotoxin	C22H22O8	3.1206	10607	COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O	COc1cc(C2c3cc4c(cc3C(O)C3COC(=O)C23)OCO4)cc(OC)c1OC	InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1	YJGVMLPVUAXIQN-XVVDYKMHSA-N					removed another duplicate entry; compound annotation
0391_010369	Cabozantinib	C28H24FN3O5	3.3068	25102847		COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC	InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)	ONIQOQHATWINJY-UHFFFAOYSA-N					doublet; compound annotation
0391_010370	Kushenol I	C26H30O7	3.7665	20832634	CC(=CC[C@H](CC1=C2C(=C(C=C1O)OC)C(=O)[C@@H]([C@H](O2)C3=C(C=C(C=C3)O)O)O)C(=C)C)C	C=C(C)C(CC=C(C)C)Cc1c2OC(c3c(O)cc(O)cc3)C(O)C(=O)c2c(OC)cc1O	InChI=1S/C26H30O7/c1-13(2)6-7-15(14(3)4)10-18-20(29)12-21(32-5)22-23(30)24(31)26(33-25(18)22)17-9-8-16(27)11-19(17)28/h6,8-9,11-12,15,24,26-29,31H,3,7,10H2,1-2,4-5H3/t15-,24+,26-/m1/s1	QKEDJCCCNZWOBS-SGOPFIAHSA-N					compound annotation
0391_010371	FLUOROMETHOLONE ACETATE	C24H31FO5	3.8488	240767	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C24H31FO5/c1-13-10-19-17-7-9-23(14(2)26,30-15(3)27)22(17,5)12-20(29)24(19,25)21(4)8-6-16(28)11-18(13)21/h6,8,11,13,17,19-20,29H,7,9-10,12H2,1-5H3/t13-,17-,19-,20-,21-,22-,23-,24-/m0/s1	YRFXGQHBPBMFHW-SBTZIJSASA-N					compound annotation
0391_010372	ZINGERONE	C11H14O3	4.2815	31211		COc1c(O)ccc(CCC(C)=O)c1	InChI=1S/C11H14O3/c1-8(12)3-4-9-5-6-10(13)11(7-9)14-2/h5-7,13H,3-4H2,1-2H3	OJYLAHXKWMRDGS-UHFFFAOYSA-N					compound annotation
0391_010373	urapidil	C20H29N5O3	1.7346	5639		COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1	InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3	ICMGLRUYEQNHPF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010375	1797406-78-0	C22H30N4O3S	2.0916	135157223	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@@H](CN3C(=O)[C@H](C(C)(C)C)N)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(N)C(C)(C)C)cc2)scn1	InChI=1S/C22H30N4O3S/c1-13-18(30-12-25-13)15-7-5-14(6-8-15)10-24-20(28)17-9-16(27)11-26(17)21(29)19(23)22(2,3)4/h5-8,12,16-17,19,27H,9-11,23H2,1-4H3,(H,24,28)/t16-,17-,19+/m0/s1	ZLOXMSNKPDWMEF-JENIJYKNSA-N					doublet; compound annotation
0391_010376	1797406-78-0	C22H30N4O3S	2.0954	135157223	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@@H](CN3C(=O)[C@H](C(C)(C)C)N)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(N)C(C)(C)C)cc2)scn1	InChI=1S/C22H30N4O3S/c1-13-18(30-12-25-13)15-7-5-14(6-8-15)10-24-20(28)17-9-16(27)11-26(17)21(29)19(23)22(2,3)4/h5-8,12,16-17,19,27H,9-11,23H2,1-4H3,(H,24,28)/t16-,17-,19+/m0/s1	ZLOXMSNKPDWMEF-JENIJYKNSA-N					doublet; compound annotation
0391_010377	Gamithromycin	C40H76N2O12	2.3671	59364992	CCCN1C[C@@H]([C@H]([C@]([C@H](OC(=O)[C@@H]([C@H]([C@@H]([C@H]([C@](C[C@H]1C)(C)O)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)CC)(C)O)O)C	CCCN1CC(C)C(O)C(C)(O)C(CC)OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC1C	InChI=1S/C40H76N2O12/c1-15-17-42-21-22(3)33(44)40(11,48)29(16-2)52-36(46)26(7)32(53-30-20-39(10,49-14)34(45)27(8)51-30)25(6)35(38(9,47)19-23(42)4)54-37-31(43)28(41(12)13)18-24(5)50-37/h22-35,37,43-45,47-48H,15-21H2,1-14H3/t22-,23+,24+,25-,26+,27-,28-,29+,30-,31+,32-,33+,34-,35+,37-,38+,39+,40+/m0/s1	VWAMTBXLZPEDQO-UZSBJOJWSA-N					compound annotation
0391_010378	CHEMBL3407862	C34H28N4O2	3.3569	86583045		Cc1nc2c(cc1)cc(-c1c(C)ccc(C(=O)c3c(-c4ccccc4)n(C)n(-c4ccccc4)c3=O)c1N)cc2	InChI=1S/C34H28N4O2/c1-21-14-18-27(31(35)29(21)25-17-19-28-24(20-25)16-15-22(2)36-28)33(39)30-32(23-10-6-4-7-11-23)37(3)38(34(30)40)26-12-8-5-9-13-26/h4-20H,35H2,1-3H3	YPPSMYLMSKHYAY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010380	diacylglycerol kinase inhibitor ii	C28H25F2N3OS	3.864	657356		O=c1c2ccccc2nc(S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1	InChI=1S/C28H25F2N3OS/c29-22-9-5-19(6-10-22)26(20-7-11-23(30)12-8-20)21-13-15-32(16-14-21)17-18-33-27(34)24-3-1-2-4-25(24)31-28(33)35/h1-12H,13-18H2,(H,31,35)	ZCNBZFRECRPCKU-UHFFFAOYSA-N					compound annotation
0391_010381	Aprepitant	C23H21F7N4O3	4.534	135413536	C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F	CC(OC1OCCN(Cc2nc(=O)[nH][nH]2)C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1	ATALOFNDEOCMKK-OITMNORJSA-N					compound annotation
0391_010382	96969-83-4	C30H26N2O4	4.7438	2817242		O=C1c2ccccc2C(=O)c2c(NCCc3ccc(O)cc3)ccc(NCCc3ccc(O)cc3)c12	InChI=1S/C30H26N2O4/c33-21-9-5-19(6-10-21)15-17-31-25-13-14-26(32-18-16-20-7-11-22(34)12-8-20)28-27(25)29(35)23-3-1-2-4-24(23)30(28)36/h1-14,31-34H,15-18H2	UUJHFIBEJJLZBF-UHFFFAOYSA-N					compound annotation
0391_010383	H-1152	C16H21N3O2S	1.42	448043	C[C@H]1CNCCCN1S(=O)(=O)C2=CC=CC3=C2C(=CN=C3)C	Cc1cncc2c1c(S(=O)(=O)N1CCCNCC1C)ccc2	InChI=1S/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3/t13-/m0/s1	AWDORCFLUJZUQS-ZDUSSCGKSA-N					compound annotation
0391_010384	Silodosin	C25H32F3N3O4	2.1299	5312125	C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F	CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F	InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1	PNCPYILNMDWPEY-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_010386	AZ9482	C26H22N6O2	3.2377	92045137		N#Cc1c(N2CCN(C(=O)c3cccc(Cc4n[nH]c(=O)c5ccccc45)c3)CC2)nccc1	InChI=1S/C26H22N6O2/c27-17-20-7-4-10-28-24(20)31-11-13-32(14-12-31)26(34)19-6-3-5-18(15-19)16-23-21-8-1-2-9-22(21)25(33)30-29-23/h1-10,15H,11-14,16H2,(H,30,33)	ZDDPBFWHZOJFHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010388	chlorprothixene	C18H18ClNS	3.3878	667467	CN(C)CC/C=C\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	CN(C)CCC=C1c2ccccc2Sc2c1cc(Cl)cc2	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	WSPOMRSOLSGNFJ-AUWJEWJLSA-N					doublet; compound annotation
0391_010389	chlorprothixene	C18H18ClNS	3.4558	667467	CN(C)CC/C=C\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	CN(C)CCC=C1c2ccccc2Sc2c1cc(Cl)cc2	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	WSPOMRSOLSGNFJ-AUWJEWJLSA-N					doublet; compound annotation
0391_010390	Dutasteride	C27H30F6N2O2	4.9962	6918296	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C	CC12C=CC(=O)NC1CCC1C2CCC2(C)C(C(=O)Nc3c(C(F)(F)F)ccc(C(F)(F)F)c3)CCC12	InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1	JWJOTENAMICLJG-QWBYCMEYSA-N					compound annotation
0391_010391	Isovitexin	C21H20O10	1.8231	162350	C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2c1c(O)c(C1OC(CO)C(O)C(O)C1O)c(O)c2	InChI=1S/C21H20O10/c22-7-14-17(26)19(28)20(29)21(31-14)16-11(25)6-13-15(18(16)27)10(24)5-12(30-13)8-1-3-9(23)4-2-8/h1-6,14,17,19-23,25-29H,7H2/t14-,17-,19+,20-,21+/m1/s1	MYXNWGACZJSMBT-VJXVFPJBSA-N					compound annotation
0391_010392	7-Hydroxy-5-methoxy-6-methyl-2-phenylchromenylium	C17H15O3+	2.8033	26339657		COc1c(C)c(O)cc2c1ccc(-c1ccccc1)[o+]2	InChI=1S/C17H14O3/c1-11-14(18)10-16-13(17(11)19-2)8-9-15(20-16)12-6-4-3-5-7-12/h3-10H,1-2H3/p+1	UCZJPQIEFFTIEV-UHFFFAOYSA-O					compound annotation
0391_010393	RG108	C19H14N2O4	3.2681	702558	C1=CC=C2C(=C1)C(=O)N(C2=O)[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O	O=C(O)C(Cc1c[nH]c2ccccc12)N1C(=O)c2ccccc2C1=O	InChI=1S/C19H14N2O4/c22-17-13-6-1-2-7-14(13)18(23)21(17)16(19(24)25)9-11-10-20-15-8-4-3-5-12(11)15/h1-8,10,16,20H,9H2,(H,24,25)/t16-/m0/s1	HPTXLHAHLXOAKV-INIZCTEOSA-N					compound annotation
0391_010394	H3B-6545	C30H29F4N5O2	3.5306	124091040	CN(C)C(=O)/C=C/CNCCOC1=NC=C(C=C1)/C(=C(/CC(F)(F)F)\C2=CC=CC=C2)/C3=CC4=C(NN=C4C=C3)F	CN(C)C(=O)C=CCNCCOc1ncc(C(=C(CC(F)(F)F)c2ccccc2)c2cc3c(F)[nH]nc3cc2)cc1	InChI=1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24-	JPFTZIJTXCHJNE-HMOQVRKWSA-N					doublet; removed another duplicate entry; compound annotation
0391_010396	Galangin 3-methyl ether	C16H12O5	3.9527	5281946		COc1c(-c2ccccc2)oc2cc(O)cc(O)c2c1=O	InChI=1S/C16H12O5/c1-20-16-14(19)13-11(18)7-10(17)8-12(13)21-15(16)9-5-3-2-4-6-9/h2-8,17-18H,1H3	LYISDADPVOHJBJ-UHFFFAOYSA-N					compound annotation
0391_010397	LEI-401	C24H31N5O2	4.17	145998143	C1C[C@H](CN(C1)C2=NC(=CC(=N2)N3CC[C@@H](C3)O)C(=O)NCC4CC4)C5=CC=CC=C5	O=C(NCC1CC1)c1cc(N2CCC(O)C2)nc(N2CCCC(c3ccccc3)C2)n1	InChI=1S/C24H31N5O2/c30-20-10-12-28(16-20)22-13-21(23(31)25-14-17-8-9-17)26-24(27-22)29-11-4-7-19(15-29)18-5-2-1-3-6-18/h1-3,5-6,13,17,19-20,30H,4,7-12,14-16H2,(H,25,31)/t19-,20+/m1/s1	GFHJYPQZBBHOCC-UXHICEINSA-N					removed another duplicate entry; compound annotation
0391_010399	pentoxifylline	C13H18N4O3	1.9498	4740		CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O	InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3	BYPFEZZEUUWMEJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010401	H-D-Phe-pip-arg-pna	C27H36N8O5	2.3517	123853	C1CCN([C@@H](C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])C(=O)[C@@H](CC3=CC=CC=C3)N	NC(N)=NCCCC(NC(=O)C1CCCCN1C(=O)C(N)Cc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1	InChI=1S/C27H36N8O5/c28-21(17-18-7-2-1-3-8-18)26(38)34-16-5-4-10-23(34)25(37)33-22(9-6-15-31-27(29)30)24(36)32-19-11-13-20(14-12-19)35(39)40/h1-3,7-8,11-14,21-23H,4-6,9-10,15-17,28H2,(H,32,36)(H,33,37)(H4,29,30,31)/t21-,22+,23+/m1/s1	YDMBNDUHUNWWRP-VJBWXMMDSA-N					compound annotation
0391_010402	berberine	C20H18NO4+	2.5088	2353		COc1c(OC)c2c[n+]3c(cc2cc1)-c1cc2c(cc1CC3)OCO2	InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1	YBHILYKTIRIUTE-UHFFFAOYSA-N					doublet; compound annotation
0391_010403	S.pombe lumazine synthase-IN-1	C14H13N3O6	2.5953	5334447	COC1=C(C=C(C=C1)/C=C/C2=C(C(=O)NC(=O)N2)[N+](=O)[O-])OC	COc1c(OC)cc(C=Cc2c([N+](=O)[O-])c(=O)[nH]c(=O)[nH]2)cc1	InChI=1S/C14H13N3O6/c1-22-10-6-4-8(7-11(10)23-2)3-5-9-12(17(20)21)13(18)16-14(19)15-9/h3-7H,1-2H3,(H2,15,16,18,19)/b5-3+	PKSLOHMKDSSQHQ-HWKANZROSA-N					compound annotation
0391_010404	Chlorphenoxamine	C18H22ClNO	3.3022	6475		CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1	InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3	KKHPNPMTPORSQE-UHFFFAOYSA-N					compound annotation
0391_010405	515141-51-2	C25H24ClN3O3S	3.454	9826520		COc1c(OCCN2CCCC2)ccc(-n2cnc3c(sc(-c4ccc(Cl)cc4)c3)c2=O)c1	InChI=1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3	MWULMTACIBZPGN-UHFFFAOYSA-N					doublet; compound annotation
0391_010406	515141-51-2	C25H24ClN3O3S	3.4567	9826520		COc1c(OCCN2CCCC2)ccc(-n2cnc3c(sc(-c4ccc(Cl)cc4)c3)c2=O)c1	InChI=1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3	MWULMTACIBZPGN-UHFFFAOYSA-N					doublet; compound annotation
0391_010407	DSM265	C14H12F7N5S	4.2889	51347395		Cc1nc2nc(C(C)(F)F)nn2c(Nc2ccc(S(F)(F)(F)(F)F)cc2)c1	InChI=1S/C14H12F7N5S/c1-8-7-11(26-13(22-8)24-12(25-26)14(2,15)16)23-9-3-5-10(6-4-9)27(17,18,19,20)21/h3-7,23H,1-2H3	OIZSVTOIBNSVOS-UHFFFAOYSA-N					doublet; compound annotation
0391_010408	DSM265	C14H12F7N5S	4.2937	51347395		Cc1nc2nc(C(C)(F)F)nn2c(Nc2ccc(S(F)(F)(F)(F)F)cc2)c1	InChI=1S/C14H12F7N5S/c1-8-7-11(26-13(22-8)24-12(25-26)14(2,15)16)23-9-3-5-10(6-4-9)27(17,18,19,20)21/h3-7,23H,1-2H3	OIZSVTOIBNSVOS-UHFFFAOYSA-N					doublet; compound annotation
0391_010409	Penconazole	C13H15Cl2N3	4.4128	91693		CCCC(Cn1cncn1)c1c(Cl)cc(Cl)cc1	InChI=1S/C13H15Cl2N3/c1-2-3-10(7-18-9-16-8-17-18)12-5-4-11(14)6-13(12)15/h4-6,8-10H,2-3,7H2,1H3	WKBPZYKAUNRMKP-UHFFFAOYSA-N					compound annotation
0391_010410	Biphenylindanone A	C30H30O4	6.0371	9868580		Cc1c(OCc2cc(-c3ccc(C(=O)O)cc3)ccc2)cc2CC(C3CCCC3)C(=O)c2c1C	InChI=1S/C30H30O4/c1-18-19(2)28-25(15-26(29(28)31)22-7-3-4-8-22)16-27(18)34-17-20-6-5-9-24(14-20)21-10-12-23(13-11-21)30(32)33/h5-6,9-14,16,22,26H,3-4,7-8,15,17H2,1-2H3,(H,32,33)	KMKBEESNZAPKMP-UHFFFAOYSA-N					compound annotation
0391_010411	701-44-0	C7H8N2O2	0.4601	69698		Cn1cc(C(N)=O)ccc1=O	InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11)	JLQSXXWTCJPCBC-UHFFFAOYSA-N					compound annotation
0391_010412	Esculin	C15H16O9	1.0143	5281417	C1=CC(=O)OC2=CC(=C(C=C21)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O	O=c1ccc2cc(OC3OC(CO)C(O)C(O)C3O)c(O)cc2o1	InChI=1S/C15H16O9/c16-5-10-12(19)13(20)14(21)15(24-10)23-9-3-6-1-2-11(18)22-8(6)4-7(9)17/h1-4,10,12-17,19-21H,5H2/t10-,12-,13+,14-,15-/m1/s1	XHCADAYNFIFUHF-TVKJYDDYSA-N					compound annotation
0391_010413	4-Methoxycinnamic acid	C10H10O3	2.7726	699414	COC1=CC=C(C=C1)/C=C/C(=O)O	COc1ccc(C=CC(=O)O)cc1	InChI=1S/C10H10O3/c1-13-9-5-2-8(3-6-9)4-7-10(11)12/h2-7H,1H3,(H,11,12)/b7-4+	AFDXODALSZRGIH-QPJJXVBHSA-N					doublet; compound annotation
0391_010414	Etomidate	C14H16N2O2	2.7841	667484	CCOC(=O)C1=CN=CN1[C@H](C)C2=CC=CC=C2	CCOC(=O)c1cncn1C(C)c1ccccc1	InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1	NPUKDXXFDDZOKR-LLVKDONJSA-N					doublet; compound annotation
0391_010415	Mupirocin	C26H44O9	3.3818	446596	C[C@H]([C@H]1[C@@H](O1)C[C@H]2CO[C@H]([C@@H]([C@@H]2O)O)C/C(=C/C(=O)OCCCCCCCCC(=O)O)/C)[C@H](C)O	CC(=CC(=O)OCCCCCCCCC(=O)O)CC1OCC(CC2OC2C(C)C(C)O)C(O)C1O	InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1	MINDHVHHQZYEEK-HBBNESRFSA-N					removed another duplicate entry; compound annotation
0391_010417	Ethylparaben	C9H10O3	4.2813	8434		CCOC(=O)c1ccc(O)cc1	InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3	NUVBSKCKDOMJSU-UHFFFAOYSA-N					compound annotation
0391_010418	Aucubin	C15H22O9	0.4957	91458	C1=CO[C@H]([C@H]2[C@@H]1[C@@H](C=C2CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	OCC1=CC(O)C2C=COC(OC3OC(CO)C(O)C(O)C3O)C12	InChI=1S/C15H22O9/c16-4-6-3-8(18)7-1-2-22-14(10(6)7)24-15-13(21)12(20)11(19)9(5-17)23-15/h1-3,7-21H,4-5H2/t7-,8+,9+,10+,11+,12-,13+,14-,15-/m0/s1	RJWJHRPNHPHBRN-FKVJWERZSA-N					compound annotation
0391_010419	Puerarin	C21H20O9	1.4073	5281807	C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(-c2ccc(O)cc2)coc2c1ccc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2/t14-,17-,18+,19-,21+/m1/s1	HKEAFJYKMMKDOR-VPRICQMDSA-N					removed another duplicate entry; compound annotation
0391_010421	furazolidone	C8H7N3O5	1.6542	5323714	C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]	O=C1OCCN1N=Cc1ccc([N+](=O)[O-])o1	InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+	PLHJDBGFXBMTGZ-WEVVVXLNSA-N					removed another duplicate entry; compound annotation
0391_010423	Baicalin	C21H18O11	2.4131	64982	C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)O)O	O=C(O)C1OC(Oc2c(O)c(O)c3c(=O)cc(-c4ccccc4)oc3c2)C(O)C(O)C1O	InChI=1S/C21H18O11/c22-9-6-10(8-4-2-1-3-5-8)30-11-7-12(14(23)15(24)13(9)11)31-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21,23-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1	IKIIZLYTISPENI-ZFORQUDYSA-N					compound annotation
0391_010424	SR-59230A free base	C21H27NO2	3.3559	5311452	CCC1=CC=CC=C1OC[C@H](CN[C@H]2CCCC3=CC=CC=C23)O	CCc1ccccc1OCC(O)CNC1CCCc2ccccc21	InChI=1S/C21H27NO2/c1-2-16-8-4-6-13-21(16)24-15-18(23)14-22-20-12-7-10-17-9-3-5-11-19(17)20/h3-6,8-9,11,13,18,20,22-23H,2,7,10,12,14-15H2,1H3/t18-,20-/m0/s1	VFDHMSXXELYMRW-ICSRJNTNSA-N					doublet; compound annotation
0391_010425	valsartan	C24H29N5O3	3.9037	60846	CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2n[nH]nn2)cc1)C(C(=O)O)C(C)C	InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1	ACWBQPMHZXGDFX-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010427	MDR-652	C22H23ClFN3O2S	4.7748	121364823		CC(C)(C)c1nc(-c2cc(Cl)ccc2)c(CNC(=O)Nc2cc(F)c(CO)cc2)s1	InChI=1S/C22H23ClFN3O2S/c1-22(2,3)20-27-19(13-5-4-6-15(23)9-13)18(30-20)11-25-21(29)26-16-8-7-14(12-28)17(24)10-16/h4-10,28H,11-12H2,1-3H3,(H2,25,26,29)	HKMPJRGWSUCANB-UHFFFAOYSA-N					compound annotation
0391_010428	N6-Methyladenosine	C11H15N5O4	0.4998	102175	CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	CNc1c2ncn(C3OC(CO)C(O)C3O)c2ncn1	InChI=1S/C11H15N5O4/c1-12-9-6-10(14-3-13-9)16(4-15-6)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11,17-19H,2H2,1H3,(H,12,13,14)/t5-,7-,8-,11-/m1/s1	VQAYFKKCNSOZKM-IOSLPCCCSA-N					compound annotation
0391_010429	N-Acetyl-5-hydroxytryptamine	C12H14N2O2	1.2562	903		CC(=O)NCCc1c[nH]c2c1cc(O)cc2	InChI=1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)	MVAWJSIDNICKHF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010431	alminoprofen	C13H17NO2	2.8673	2097		C=C(C)CNc1ccc(C(C)C(=O)O)cc1	InChI=1S/C13H17NO2/c1-9(2)8-14-12-6-4-11(5-7-12)10(3)13(15)16/h4-7,10,14H,1,8H2,2-3H3,(H,15,16)	FPHLBGOJWPEVME-UHFFFAOYSA-N					compound annotation
0391_010432	roflumilast N-oxide	C17H14Cl2F2N2O4	3.5998	9940999		O=C(N=c1c(Cl)cn(O)cc1Cl)c1cc(OCC2CC2)c(OC(F)F)cc1	InChI=1S/C17H14Cl2F2N2O4/c18-11-6-23(25)7-12(19)15(11)22-16(24)10-3-4-13(27-17(20)21)14(5-10)26-8-9-1-2-9/h3-7,9,17,25H,1-2,8H2	KHXXMSARUQULRI-UHFFFAOYSA-N					compound annotation
0391_010433	TMP778	C31H30N2O4	4.6194	71247311	CC1=CC(=C(C=C1)[C@H](C2=CC=CC=C2)NC(=O)CC3=CC4=C(C=C3)OC(=C4)[C@H](C5=C(ON=C5C)C)O)C	Cc1cc(C)c(C(NC(=O)Cc2cc3c(cc2)oc(C(O)c2c(C)onc2C)c3)c2ccccc2)cc1	InChI=1S/C31H30N2O4/c1-18-10-12-25(19(2)14-18)30(23-8-6-5-7-9-23)32-28(34)16-22-11-13-26-24(15-22)17-27(36-26)31(35)29-20(3)33-37-21(29)4/h5-15,17,30-31,35H,16H2,1-4H3,(H,32,34)/t30-,31+/m0/s1	DIURRJOJDQOMFC-IOWSJCHKSA-N					removed another duplicate entry; compound annotation
0391_010435	famotidine	C8H15N7O2S3	0.689	5353622	C1=C(N=C(S1)N=C(N)N)CSCC/C(=N\S(=O)(=O)N)/N	NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1	InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)	XUFQPHANEAPEMJ-UHFFFAOYSA-N					compound annotation
0391_010436	trimethoprim	C14H18N4O3	1.432	5578		COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC	InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)	IEDVJHCEMCRBQM-UHFFFAOYSA-N					compound annotation
0391_010437	Indacaterol	C24H28N2O3	2.8652	6918554	CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC	CCc1c(CC)cc2CC(NCC(O)c3c4ccc(=O)[nH]c4c(O)cc3)Cc2c1	InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1	QZZUEBNBZAPZLX-QFIPXVFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010439	carbamazepine	C15H12N2O	2.9332	2554		NC(=O)N1c2ccccc2C=Cc2ccccc21	InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)	FFGPTBGBLSHEPO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010441	trihexyphenidyl	C20H31NO	3.0803	5572		OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1	InChI=1S/C20H31NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2	HWHLPVGTWGOCJO-UHFFFAOYSA-N					compound annotation
0391_010442	Rocagloic Acid	C27H26O8	3.7235	10322821	COC1=CC=C(C=C1)[C@]23[C@@H]([C@H]([C@H]([C@]2(C4=C(O3)C=C(C=C4OC)OC)O)O)C(=O)O)C5=CC=CC=C5	COc1ccc(C23Oc4c(c(OC)cc(OC)c4)C2(O)C(O)C(C(=O)O)C3c2ccccc2)cc1	InChI=1S/C27H26O8/c1-32-17-11-9-16(10-12-17)27-22(15-7-5-4-6-8-15)21(25(29)30)24(28)26(27,31)23-19(34-3)13-18(33-2)14-20(23)35-27/h4-14,21-22,24,28,31H,1-3H3,(H,29,30)/t21-,22-,24-,26+,27+/m1/s1	HLORMQRMDNZHJH-PXIJUOARSA-N					removed another duplicate entry; compound annotation
0391_010444	MSC2360844	C26H27FN4O5S	1.9277	66580799		O=C(c1nn(-c2ccc(CN3CCOCC3)cc2)c2c1CS(=O)(=O)c1c-2cccc1F)N1CCOCC1	InChI=1S/C26H27FN4O5S/c27-22-3-1-2-20-24-21(17-37(33,34)25(20)22)23(26(32)30-10-14-36-15-11-30)28-31(24)19-6-4-18(5-7-19)16-29-8-12-35-13-9-29/h1-7H,8-17H2	NFHSJYKXENYICE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010446	Rhynchophylline	C22H28N2O4	2.3012	5281408	CC[C@H]1CN2CC[C@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	DAXYUDFNWXHGBE-KAXDATADSA-N					doublet; compound annotation
0391_010447	Rhynchophylline	C22H28N2O4	2.4478	5281408	CC[C@H]1CN2CC[C@]3([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)C4=CC=CC=C4NC3=O	CCC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H28N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h5-8,13-15,19H,4,9-12H2,1-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	DAXYUDFNWXHGBE-KAXDATADSA-N					doublet; removed another duplicate entry; compound annotation
0391_010449	948557-43-5	C26H21N3O2S	2.5068	23625762		COc1ccc2cc(-c3c(-c4ccncc4)[nH]c(-c4ccc([S+](C)[O-])cc4)n3)ccc2c1	InChI=1S/C26H21N3O2S/c1-31-22-8-5-19-15-21(4-3-20(19)16-22)25-24(17-11-13-27-14-12-17)28-26(29-25)18-6-9-23(10-7-18)32(2)30/h3-16H,1-2H3,(H,28,29)	SINQIEAULQKUPD-UHFFFAOYSA-N					compound annotation
0391_010450	PQR530	C18H23F2N7O2	2.9051	121334433	C[C@H]1COCCN1C2=NC(=NC(=N2)N3CCOCC3)C4=CN=C(C=C4C(F)F)N	CC1COCCN1c1nc(-c2cnc(N)cc2C(F)F)nc(N2CCOCC2)n1	InChI=1S/C18H23F2N7O2/c1-11-10-29-7-4-27(11)18-24-16(13-9-22-14(21)8-12(13)15(19)20)23-17(25-18)26-2-5-28-6-3-26/h8-9,11,15H,2-7,10H2,1H3,(H2,21,22)/t11-/m0/s1	SYKBZXMKAPICSO-NSHDSACASA-N					compound annotation
0391_010451	as1949490	C20H18ClNO2S	5.0438	44473434	C[C@@H](C1=CC=CC=C1)NC(=O)C2=C(C=CS2)OCC3=CC=C(C=C3)Cl	CC(NC(=O)c1c(OCc2ccc(Cl)cc2)ccs1)c1ccccc1	InChI=1S/C20H18ClNO2S/c1-14(16-5-3-2-4-6-16)22-20(23)19-18(11-12-25-19)24-13-15-7-9-17(21)10-8-15/h2-12,14H,13H2,1H3,(H,22,23)/t14-/m0/s1	RFZPGNRLOKVZJY-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_010453	sumatriptan	C14H21N3O2S	1.1238	5358		CNS(=O)(=O)Cc1cc2c(cc1)[nH]cc2CCN(C)C	InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3	KQKPFRSPSRPDEB-UHFFFAOYSA-N					compound annotation
0391_010454	MMG-11	C15H14O7	3.0321	854609		CCOC(=O)c1ccc(CC(=O)c2c(O)c(O)c(O)cc2)o1	InChI=1S/C15H14O7/c1-2-21-15(20)12-6-3-8(22-12)7-11(17)9-4-5-10(16)14(19)13(9)18/h3-6,16,18-19H,2,7H2,1H3	IIDUJWIVMGALOG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010456	LETESTUIANIN B	C21H22O6	3.1186	10429233	COC1=C(C=CC(=C1)CCC(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O	COc1c(O)ccc(C=CC(=O)CC(=O)CCc2cc(OC)c(O)cc2)c1	InChI=1S/C21H22O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3,5-7,9-12,24-25H,4,8,13H2,1-2H3/b7-3+	MUYJSOCNDLUHPJ-XVNBXDOJSA-N					doublet; removed another duplicate entry; compound annotation
0391_010458	925434-55-5	C25H23N7OS	3.1778	24180125		O=C(Nc1ccccc1-c1cn2c(CN3CCNCC3)csc2n1)c1nc2ccccc2nc1	InChI=1S/C25H23N7OS/c33-24(22-13-27-20-7-3-4-8-21(20)28-22)29-19-6-2-1-5-18(19)23-15-32-17(16-34-25(32)30-23)14-31-11-9-26-10-12-31/h1-8,13,15-16,26H,9-12,14H2,(H,29,33)	IASPBORHOMBZMY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010460	GW806742X	C25H22F3N7O4S	3.5618	5329829		CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1nc(Nc2cc(S(N)(=O)=O)ccc2)ncc1	InChI=1S/C25H22F3N7O4S/c1-35(22-13-14-30-23(34-22)31-18-3-2-4-21(15-18)40(29,37)38)19-9-5-16(6-10-19)32-24(36)33-17-7-11-20(12-8-17)39-25(26,27)28/h2-15H,1H3,(H2,29,37,38)(H,30,31,34)(H2,32,33,36)	SNRUTMWCDZHKKM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010462	LETESTUIANIN B	C21H22O6	3.989	10429233	COC1=C(C=CC(=C1)CCC(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O	COc1c(O)ccc(C=CC(=O)CC(=O)CCc2cc(OC)c(O)cc2)c1	InChI=1S/C21H22O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3,5-7,9-12,24-25H,4,8,13H2,1-2H3/b7-3+	MUYJSOCNDLUHPJ-XVNBXDOJSA-N					doublet; compound annotation
0391_010463	Regadenoson	C15H18N8O5	1.1959	219024	CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	CNC(=O)c1cn(-c2nc(N)c3ncn(C4OC(CO)C(O)C4O)c3n2)nc1	InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1	LZPZPHGJDAGEJZ-AKAIJSEGSA-N					removed another duplicate entry; compound annotation
0391_010465	10-Hydroxycamptothecin	C20H16N2O5	2.1872	97226	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O	CCC1(O)C(=O)OCc2c1cc1-c3c(cc4cc(O)ccc4n3)Cn1c2=O	InChI=1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1	HAWSQZCWOQZXHI-FQEVSTJZSA-N					compound annotation
0391_010466	Decloxizine	C21H28N2O2	2.6885	71135		OCCOCCN1CCN(C(c2ccccc2)c2ccccc2)CC1	InChI=1S/C21H28N2O2/c24-16-18-25-17-15-22-11-13-23(14-12-22)21(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-10,21,24H,11-18H2	OXBBIHZWNDPBMQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010468	ML417	C22H25N3O3	2.7395	27842480		COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1	InChI=1S/C22H25N3O3/c1-27-18-6-8-19(9-7-18)28-15-14-24-10-12-25(13-11-24)22(26)21-16-17-4-2-3-5-20(17)23-21/h2-9,16,23H,10-15H2,1H3	HAZPAMUWUHDPDA-UHFFFAOYSA-N					compound annotation
0391_010469	Lifitegrast	C29H24Cl2N2O7S	3.3981	11965427	CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl	CS(=O)(=O)c1cccc(CC(NC(=O)c2c(Cl)cc3CN(C(=O)c4cc5c(cco5)cc4)CCc3c2Cl)C(=O)O)c1	InChI=1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1	JFOZKMSJYSPYLN-QHCPKHFHSA-N					removed another duplicate entry; compound annotation
0391_010471	manidipine	C35H38N4O6	4.0014	4008		COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3	ANEBWFXPVPTEET-UHFFFAOYSA-N					compound annotation
0391_010472	Ulotaront	C9H13NOS	1.0357	89532783	CNC[C@H]1C2=C(CCO1)C=CS2	CNCC1OCCc2c1scc2	InChI=1S/C9H13NOS/c1-10-6-8-9-7(2-4-11-8)3-5-12-9/h3,5,8,10H,2,4,6H2,1H3/t8-/m0/s1	ABDDQTDRAHXHOC-QMMMGPOBSA-N					compound annotation
0391_010473	Bradykinin (1-6)	C30H45N9O8	1.1552	11763739	C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)O	NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)O	InChI=1S/C30H45N9O8/c31-19(9-4-12-34-30(32)33)27(44)39-14-6-11-23(39)28(45)38-13-5-10-22(38)26(43)35-16-24(41)36-20(15-18-7-2-1-3-8-18)25(42)37-21(17-40)29(46)47/h1-3,7-8,19-23,40H,4-6,9-17,31H2,(H,35,43)(H,36,41)(H,37,42)(H,46,47)(H4,32,33,34)/t19-,20-,21-,22-,23-/m0/s1	DXJRNQYAYGIHLF-VUBDRERZSA-N					compound annotation
0391_010474	Koumine	C20H22N2O	1.6073	91895267	CN1C[C@]2([C@@H]3C[C@@H]4C5=NC6=CC=CC=C6[C@]52C[C@H]1[C@H]3CO4)C=C	C=CC12CN(C)C3CC14C(=Nc1ccccc14)C1CC2C3CO1	InChI=1S/C20H22N2O/c1-3-19-11-22(2)16-9-20(19)13-6-4-5-7-15(13)21-18(20)17-8-14(19)12(16)10-23-17/h3-7,12,14,16-17H,1,8-11H2,2H3/t12-,14+,16-,17+,19-,20+/m0/s1	VTLYEMHGPMGUOT-FXWNUWCSSA-N					compound annotation
0391_010475	1928763-08-9	C19H24ClN3O3	2.503	91667465		CC(C)OC(=O)NC1CCN(Cc2cc(Cl)c3cccnc3c2O)CC1	InChI=1S/C19H24ClN3O3/c1-12(2)26-19(25)22-14-5-8-23(9-6-14)11-13-10-16(20)15-4-3-7-21-17(15)18(13)24/h3-4,7,10,12,14,24H,5-6,8-9,11H2,1-2H3,(H,22,25)	CWIXCQOSULUGBT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010477	ingenol	C20H28O5	3.0278	442042	C[C@@H]1C[C@@H]2[C@@H](C2(C)C)[C@@H]3C=C([C@H]([C@]4([C@@]1(C3=O)C=C([C@@H]4O)C)O)O)CO	CC1=CC23C(=O)C(C=C(CO)C(O)C2(O)C1O)C1C(CC3C)C1(C)C	InChI=1S/C20H28O5/c1-9-7-19-10(2)5-13-14(18(13,3)4)12(17(19)24)6-11(8-21)16(23)20(19,25)15(9)22/h6-7,10,12-16,21-23,25H,5,8H2,1-4H3/t10-,12+,13-,14+,15+,16-,19+,20-/m1/s1	VEBVPUXQAPLADL-POYOOMFHSA-N					compound annotation
0391_010478	Malachite green cation	C23H25N2+	3.6358	11295		CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccccc2)cc1	InChI=1S/C23H25N2/c1-24(2)21-14-10-19(11-15-21)23(18-8-6-5-7-9-18)20-12-16-22(17-13-20)25(3)4/h5-17H,1-4H3/q+1	VFCNQNZNPKRXIT-UHFFFAOYSA-N					compound annotation
0391_010479	PTUPB	C26H24F3N5O3S	4.3577	52951990		NS(=O)(=O)c1ccc(-n2nc(CCCNC(=O)Nc3ccc(C(F)(F)F)cc3)cc2-c2ccccc2)cc1	InChI=1S/C26H24F3N5O3S/c27-26(28,29)19-8-10-20(11-9-19)32-25(35)31-16-4-7-21-17-24(18-5-2-1-3-6-18)34(33-21)22-12-14-23(15-13-22)38(30,36)37/h1-3,5-6,8-15,17H,4,7,16H2,(H2,30,36,37)(H2,31,32,35)	CSEPEVFNTFMBAE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010481	Oxysophocarpine	C15H22N2O2	0.6857	24721085	C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2[N@@+](C1)(CCC4)[O-]	O=C1C=CCC2C3CCC[N+]4([O-])CCCC(CN12)C34	InChI=1S/C15H22N2O2/c18-14-7-1-6-13-12-5-3-9-17(19)8-2-4-11(15(12)17)10-16(13)14/h1,7,11-13,15H,2-6,8-10H2/t11-,12+,13+,15-,17+/m0/s1	QMGGMESMCJCABO-JARXUMMXSA-N					compound annotation
0391_010482	Proanthocyanidin A1	C30H24O12	1.6843	9872976	C1[C@@H]([C@H](OC2=C1C(=CC3=C2[C@@H]4[C@H]([C@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC(=C(C=C6)O)O)O)O)C7=CC(=C(C=C7)O)O)O	Oc1cc(O)c2c(c1)OC1(c3cc(O)c(O)cc3)Oc3c(c4c(CC(O)C(c5cc(O)c(O)cc5)O4)c(O)c3)C2C1O	InChI=1S/C30H24O12/c31-13-7-20(37)24-22(8-13)41-30(12-2-4-16(33)19(36)6-12)29(39)26(24)25-23(42-30)10-17(34)14-9-21(38)27(40-28(14)25)11-1-3-15(32)18(35)5-11/h1-8,10,21,26-27,29,31-39H,9H2/t21-,26+,27+,29+,30-/m0/s1	NSEWTSAADLNHNH-TXZJYACMSA-N					compound annotation
0391_010483	SR-717 (free acid)	C15H9F2N5O3	2.7585	139434659		O=C(Nc1cc(F)c(F)cc1C(=O)O)c1nnc(-n2ccnc2)cc1	InChI=1S/C15H9F2N5O3/c16-9-5-8(15(24)25)12(6-10(9)17)19-14(23)11-1-2-13(21-20-11)22-4-3-18-7-22/h1-7H,(H,19,23)(H,24,25)	WEBVQIJGIZVRGA-UHFFFAOYSA-N					compound annotation
0391_010484	3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane	C21H25NO	3.2419	2344		CN1C2CCC1CC(OC(c1ccccc1)c1ccccc1)C2	InChI=1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3	GIJXKZJWITVLHI-UHFFFAOYSA-N					compound annotation
0391_010485	4-(benzo[d]thiazol-2-ylthio)-3-chloroaniline	C13H9ClN2S2	4.3851	667738		Nc1cc(Cl)c(Sc2nc3ccccc3s2)cc1	InChI=1S/C13H9ClN2S2/c14-9-7-8(15)5-6-11(9)17-13-16-10-3-1-2-4-12(10)18-13/h1-7H,15H2	DTSNLMOLTVGCGZ-UHFFFAOYSA-N					compound annotation
0391_010486	300657-03-8	C31H26N2O3	5.287	16122583		CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cc(OCC(=O)O)ccc1	InChI=1S/C31H26N2O3/c1-2-27-30(22-12-5-3-6-13-22)31(23-14-7-4-8-15-23)32-33(27)28-19-10-9-18-26(28)24-16-11-17-25(20-24)36-21-29(34)35/h3-20H,2,21H2,1H3,(H,34,35)	SJRVJRYZAQYCEE-UHFFFAOYSA-N					doublet; compound annotation
0391_010487	Vamifeport	C21H21FN6O2	1.3929	129052159		O=C(NCc1c(F)cccn1)c1coc(CCNCCc2nc3ccccc3[nH]2)n1	InChI=1S/C21H21FN6O2/c22-14-4-3-9-24-17(14)12-25-21(29)18-13-30-20(28-18)8-11-23-10-7-19-26-15-5-1-2-6-16(15)27-19/h1-6,9,13,23H,7-8,10-12H2,(H,25,29)(H,26,27)	KNYVRFXIVWUGBZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010489	RUCAPARIB	C19H18FN3O	1.8098	9931954		CNCc1ccc(-c2c3CCNC(=O)c4c3c(cc(F)c4)[nH]2)cc1	InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)	HMABYWSNWIZPAG-UHFFFAOYSA-N					doublet; compound annotation
0391_010490	BDTX-189	C29H29ClN6O4	2.0912	154824631		C=CC(=O)Nc1c(OCCN2CCOCC2)cc2ncnc(Nc3cc(Cl)c(OCc4ccccn4)cc3)c2c1	InChI=1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34)	HIBPKFXWOPYJPZ-UHFFFAOYSA-N					compound annotation
0391_010491	DIPQUO	C20H17N3O	2.7913	50950764		Cc1cc(C)c2[nH]c(=O)c(-c3c(-c4ccccc4)nc[nH]3)cc2c1	InChI=1S/C20H17N3O/c1-12-8-13(2)17-15(9-12)10-16(20(24)23-17)19-18(21-11-22-19)14-6-4-3-5-7-14/h3-11H,1-2H3,(H,21,22)(H,23,24)	KTMBLNYSLKFCIR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010493	DIPQUO	C20H17N3O	2.921	50950764		Cc1cc(C)c2[nH]c(=O)c(-c3c(-c4ccccc4)nc[nH]3)cc2c1	InChI=1S/C20H17N3O/c1-12-8-13(2)17-15(9-12)10-16(20(24)23-17)19-18(21-11-22-19)14-6-4-3-5-7-14/h3-11H,1-2H3,(H,21,22)(H,23,24)	KTMBLNYSLKFCIR-UHFFFAOYSA-N					doublet; compound annotation
0391_010494	isoliquiritigenin	C15H12O4	3.1854	638278	C1=CC(=CC=C1/C=C/C(=O)C2=C(C=C(C=C2)O)O)O	O=C(C=Cc1ccc(O)cc1)c1c(O)cc(O)cc1	InChI=1S/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3+	DXDRHHKMWQZJHT-FPYGCLRLSA-N					compound annotation
0391_010495	37413-91-5	C23H26O4	3.953	10926647	CC(=O)OCC(=O)C1=CC[C@@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)C=C[C@@]43C)C	CC(=O)OCC(=O)C1=CCC2C3CCC4=CC(=O)C=CC4(C)C3=CCC12C	InChI=1S/C23H26O4/c1-14(24)27-13-21(26)20-7-6-18-17-5-4-15-12-16(25)8-10-22(15,2)19(17)9-11-23(18,20)3/h7-10,12,17-18H,4-6,11,13H2,1-3H3/t17-,18-,22-,23-/m0/s1	UFEOMHFPJREVTP-PTRHGPIFSA-N					compound annotation
0391_010496	Pogostone	C12H16O4	4.6144	54695756		Cc1cc(O)c(C(=O)CCC(C)C)c(=O)o1	InChI=1S/C12H16O4/c1-7(2)4-5-9(13)11-10(14)6-8(3)16-12(11)15/h6-7,14H,4-5H2,1-3H3	AJFJTORMMHWKFW-UHFFFAOYSA-N					compound annotation
0391_010497	N-[(4-Aminophenyl)methyl]adenosine	C17H20N6O4	0.8758	125347	C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	Nc1ccc(CNc2c3ncn(C4OC(CO)C(O)C4O)c3ncn2)cc1	InChI=1S/C17H20N6O4/c18-10-3-1-9(2-4-10)5-19-15-12-16(21-7-20-15)23(8-22-12)17-14(26)13(25)11(6-24)27-17/h1-4,7-8,11,13-14,17,24-26H,5-6,18H2,(H,19,20,21)/t11-,13-,14-,17-/m1/s1	PMUVNAUPWLXPSA-LSCFUAHRSA-N					compound annotation
0391_010498	Protodioscin	C51H84O22	2.6384	441891	C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@@H]([C@H]([C@@H](O7)C)O)O)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O[C@@]1(CC[C@@H](C)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O	CC(CCC1(O)OC2CC3C4CC=C5CC(OC6OC(CO)C(OC7OC(C)C(O)C(O)C7O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C2C1C)COC1OC(CO)C(O)C(O)C1O	InChI=1S/C51H84O22/c1-20(19-65-45-39(60)38(59)35(56)30(17-52)69-45)9-14-51(64)21(2)32-29(73-51)16-28-26-8-7-24-15-25(10-12-49(24,5)27(26)11-13-50(28,32)6)68-48-44(72-47-41(62)37(58)34(55)23(4)67-47)42(63)43(31(18-53)70-48)71-46-40(61)36(57)33(54)22(3)66-46/h7,20-23,25-48,52-64H,8-19H2,1-6H3/t20-,21+,22+,23+,25+,26-,27+,28+,29+,30-,31-,32+,33+,34+,35-,36-,37-,38+,39-,40-,41-,42+,43-,44-,45-,46+,47+,48-,49+,50+,51-/m1/s1	LVTJOONKWUXEFR-UEZXSUPNSA-N					compound annotation
0391_010499	A 438079	C13H9Cl2N5	2.6663	11673921		Clc1cccc(-c2nnnn2Cc2cnccc2)c1Cl	InChI=1S/C13H9Cl2N5/c14-11-5-1-4-10(12(11)15)13-17-18-19-20(13)8-9-3-2-6-16-7-9/h1-7H,8H2	MMPAULQSJLVKHP-UHFFFAOYSA-N					doublet; compound annotation
0391_010500	1235397-05-3	C20H15N5O3S2	3.2283	71718072		Cn1nccc1-c1ccccc1Oc1c(C#N)cc(S(=O)(=O)Nc2nccs2)cc1	InChI=1S/C20H15N5O3S2/c1-25-17(8-9-23-25)16-4-2-3-5-19(16)28-18-7-6-15(12-14(18)13-21)30(26,27)24-20-22-10-11-29-20/h2-12H,1H3,(H,22,24)	MKSKJVIBSRUWSZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010502	dactolisib	C30H23N5O	3.2317	11977753		Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c1cnc1ccc(-c3cc4ccccc4nc3)cc12	InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3	JOGKUKXHTYWRGZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010504	trimipramine	C20H26N2	3.2602	5584		CC(CN(C)C)CN1c2ccccc2CCc2ccccc21	InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3	ZSCDBOWYZJWBIY-UHFFFAOYSA-N					compound annotation
0391_010505	SAQUINAVIR	C38H50N6O5	3.5503	441243	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1nc2ccccc2cc1	InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1	QWAXKHKRTORLEM-UGJKXSETSA-N					removed another duplicate entry; compound annotation
0391_010507	121345-64-0	C32H40N2O5S	3.6319	129426		COc1c(OC)cc(CCN(C)CCCOc2ccc(S(=O)(=O)c3c(C(C)C)n(C)c4ccccc34)cc2)cc1	InChI=1S/C32H40N2O5S/c1-23(2)31-32(27-10-7-8-11-28(27)34(31)4)40(35,36)26-15-13-25(14-16-26)39-21-9-19-33(3)20-18-24-12-17-29(37-5)30(22-24)38-6/h7-8,10-17,22-23H,9,18-21H2,1-6H3	OGLMUIRZIMTHMN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010509	Valacyclovir hydrochloride	C13H20N6O4	0.5113	135398742	CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N	CC(C)C(N)C(=O)OCCOCn1cnc2c1[nH]c(N)nc2=O	InChI=1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1	HDOVUKNUBWVHOX-QMMMGPOBSA-N					compound annotation
0391_010510	gartisertib	C25H29F2N9O3	1.863	86720912		Nc1nn2cc(F)cnc2c1C(=O)Nc1cncc(F)c1N1CCC(C(=O)N2CCN(C3COC3)CC2)CC1	InChI=1S/C25H29F2N9O3/c26-16-9-30-23-20(22(28)32-36(23)12-16)24(37)31-19-11-29-10-18(27)21(19)34-3-1-15(2-4-34)25(38)35-7-5-33(6-8-35)17-13-39-14-17/h9-12,15,17H,1-8,13-14H2,(H2,28,32)(H,31,37)	QAYHKBLKSXWOEO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010512	cinoxacin	C12H10N2O5	2.0932	2762		CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17)	VDUWPHTZYNWKRN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010514	Atabecestat	C18H14FN5OS	2.2819	68254185	C[C@]1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F	CC1(c2c(F)ccc(NC(=O)c3ncc(C#N)cc3)c2)C=CSC(N)=N1	InChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1	VLLFGVHGKLDDLW-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_010516	Dexverapamil	C27H38N2O4	3.1549	65808	CC(C)[C@@](CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	COc1c(OC)cc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)cc2)C(C)C)cc1	InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/t27-/m1/s1	SGTNSNPWRIOYBX-HHHXNRCGSA-N					removed another duplicate entry; compound annotation
0391_010518	Fesoterodine	C26H37NO3	3.2048	6918558	CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2	CC(C)C(=O)Oc1c(C(CCN(C(C)C)C(C)C)c2ccccc2)cc(CO)cc1	InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1	DCCSDBARQIPTGU-HSZRJFAPSA-N					doublet; compound annotation
0391_010519	Sacubitril	C24H29NO5	4.1865	9811834	CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O	CCOC(=O)C(C)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O	InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21+/m1/s1	PYNXFZCZUAOOQC-UTKZUKDTSA-N					doublet; removed another duplicate entry; compound annotation
0391_010521	Ribociclib	C23H30N8O	1.7153	44631912		CN(C)C(=O)c1cc2cnc(Nc3ncc(N4CCNCC4)cc3)nc2n1C1CCCC1	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	RHXHGRAEPCAFML-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010523	Alcaftadine	C19H21N3O	1.7752	19371515		CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc23)CC1	InChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3	MWTBKTRZPHJQLH-UHFFFAOYSA-N					compound annotation
0391_010524	clidinium	C22H26NO3+	2.4638	2784		C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2	InChI=1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1	HOOSGZJRQIVJSZ-UHFFFAOYSA-N					compound annotation
0391_010525	Bavachin	C20H20O4	4.002	14236566	CC(=CCC1=CC2=C(C=C1O)O[C@@H](CC2=O)C3=CC=C(C=C3)O)C	CC(C)=CCc1cc2c(cc1O)OC(c1ccc(O)cc1)CC2=O	InChI=1S/C20H20O4/c1-12(2)3-4-14-9-16-18(23)11-19(24-20(16)10-17(14)22)13-5-7-15(21)8-6-13/h3,5-10,19,21-22H,4,11H2,1-2H3/t19-/m0/s1	OAUREGNZECGNQS-IBGZPJMESA-N					compound annotation
0391_010526	AVE-3085	C17H13F2NO3	4.4802	3510704		O=C(NC1Cc2ccccc2C1)c1cc2c(cc1)OC(F)(F)O2	InChI=1S/C17H13F2NO3/c18-17(19)22-14-6-5-12(9-15(14)23-17)16(21)20-13-7-10-3-1-2-4-11(10)8-13/h1-6,9,13H,7-8H2,(H,20,21)	OKCJNSDIVCXYAL-UHFFFAOYSA-N					compound annotation
0391_010527	sulfamethazine	C12H14N4O2S	1.5616	5327		Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1	InChI=1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)	ASWVTGNCAZCNNR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010529	Picroside II	C23H28O13	1.907	3081484		COc1c(O)ccc(C(=O)OC2C3C=COC(OC4OC(CO)C(O)C(O)C4O)C3C3(CO)OC23)c1	InChI=1S/C23H28O13/c1-31-12-6-9(2-3-11(12)26)20(30)34-18-10-4-5-32-21(14(10)23(8-25)19(18)36-23)35-22-17(29)16(28)15(27)13(7-24)33-22/h2-6,10,13-19,21-22,24-29H,7-8H2,1H3	AKNILCMFRRDTEY-UHFFFAOYSA-N					compound annotation
0391_010530	triacetin	C9H14O6	2.0741	5541		CC(=O)OCC(COC(C)=O)OC(C)=O	InChI=1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3	URAYPUMNDPQOKB-UHFFFAOYSA-N					compound annotation
0391_010531	19-Hydroxybufalin	C24H34O5	2.735	101375811	C[C@]12CC[C@H]3[C@H]([C@]1(CC[C@@H]2C4=COC(=O)C=C4)O)CC[C@H]5[C@@]3(CC[C@@H](C5)O)CO	CC12CCC3C(CCC4CC(O)CCC43CO)C1(O)CCC2c1coc(=O)cc1	InChI=1S/C24H34O5/c1-22-9-7-19-20(4-3-16-12-17(26)6-10-23(16,19)14-25)24(22,28)11-8-18(22)15-2-5-21(27)29-13-15/h2,5,13,16-20,25-26,28H,3-4,6-12,14H2,1H3/t16-,17+,18-,19+,20-,22-,23-,24+/m1/s1	AXTYMYOHGWVSQN-KLAFWMLLSA-N					compound annotation
0391_010532	Sivelestat	C20H22N2O7S	4.0551	107706		CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1	InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)	BTGNGJJLZOIYID-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010534	sulfacetamide	C8H10N2O3S	0.8265	5320		CC(=O)NS(=O)(=O)c1ccc(N)cc1	InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)	SKIVFJLNDNKQPD-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010536	Oridonin	C20H28O6	2.4973	5321010	CC1(CC[C@@H]([C@]23[C@@H]1[C@@H]([C@]([C@]45[C@H]2CC[C@H]([C@H]4O)C(=C)C5=O)(OC3)O)O)O)C	C=C1C(=O)C23C(O)C1CCC2C12COC3(O)C(O)C1C(C)(C)CCC2O	InChI=1S/C20H28O6/c1-9-10-4-5-11-18-8-26-20(25,19(11,14(9)22)15(10)23)16(24)13(18)17(2,3)7-6-12(18)21/h10-13,15-16,21,23-25H,1,4-8H2,2-3H3/t10-,11-,12-,13+,15+,16-,18+,19-,20+/m0/s1	SDHTXBWLVGWJFT-XKCURVIJSA-N					compound annotation
0391_010537	mequitazine	C20H22N2S	3.2702	4066		c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2	InChI=1S/C20H22N2S/c1-3-7-19-17(5-1)22(18-6-2-4-8-20(18)23-19)14-16-13-21-11-9-15(16)10-12-21/h1-8,15-16H,9-14H2	HOKDBMAJZXIPGC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010539	Darunavir	C27H37N3O7S	3.6965	213039	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1	InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1	CJBJHOAVZSMMDJ-HEXNFIEUSA-N					doublet; removed another duplicate entry; compound annotation
0391_010541	Levonorgestrel	C21H28O2	4.0211	13109	CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34	C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21CC	InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1	WWYNJERNGUHSAO-XUDSTZEESA-N					doublet; compound annotation
0391_010542	DSR-141562	C19H25F3N4O3	4.1881	122540493		Cn1c(OCC2CCC(C(F)(F)F)CC2)nn2c(C3CCOCC3)ncc2c1=O	InChI=1S/C19H25F3N4O3/c1-25-17(27)15-10-23-16(13-6-8-28-9-7-13)26(15)24-18(25)29-11-12-2-4-14(5-3-12)19(20,21)22/h10,12-14H,2-9,11H2,1H3	LNELWUPBSLZUIQ-UHFFFAOYSA-N					compound annotation
0391_010543	Pachymic acid	C33H52O5	6.086	5484385	CC(C)C(=C)CC[C@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)OC(=O)C)C)C)C)O)C(=O)O	C=C(CCC(C(=O)O)C1C(O)CC2(C)C3=C(CCC12C)C1(C)CCC(OC(C)=O)C(C)(C)C1CC3)C(C)C	InChI=1S/C33H52O5/c1-19(2)20(3)10-11-22(29(36)37)28-25(35)18-33(9)24-12-13-26-30(5,6)27(38-21(4)34)15-16-31(26,7)23(24)14-17-32(28,33)8/h19,22,25-28,35H,3,10-18H2,1-2,4-9H3,(H,36,37)/t22-,25-,26+,27+,28+,31-,32-,33+/m1/s1	VDYCLYGKCGVBHN-DRCQUEPLSA-N					compound annotation
0391_010544	DEXCHLORPHENIRAMINE	C16H19ClN2	2.0964	33036	CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2	CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1	SOYKEARSMXGVTM-HNNXBMFYSA-N					compound annotation
0391_010545	EGFR-IN-1	C28H30N6O4	2.353	86303858		C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4c(OC)cc(OCCN(C)C)cc4)nc32)ccc1	InChI=1S/C28H30N6O4/c1-6-25(35)30-19-8-7-9-20(15-19)34-26(36)14-18(2)22-17-29-28(32-27(22)34)31-23-11-10-21(16-24(23)37-5)38-13-12-33(3)4/h6-11,14-17H,1,12-13H2,2-5H3,(H,30,35)(H,29,31,32)	RGZXAQQHXALOBL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010548	A|A42-IN-2	C24H26N6O2	2.4638	134391556	CC1=CC(=NN=C1N[C@@H](C)C2=CC=C(C=C2)OC)C3=NC(=C(C=C3)N4C=C(N=C4)C)OC	COc1ccc(C(C)Nc2nnc(-c3nc(OC)c(-n4cnc(C)c4)cc3)cc2C)cc1	InChI=1S/C24H26N6O2/c1-15-12-21(20-10-11-22(24(27-20)32-5)30-13-16(2)25-14-30)28-29-23(15)26-17(3)18-6-8-19(31-4)9-7-18/h6-14,17H,1-5H3,(H,26,29)/t17-/m0/s1	LUJVPGJMVNXPHO-KRWDZBQOSA-N					compound annotation
0391_010549	2-propylthiazolo[4,5-c]quinolin-4-amine	C13H13N3S	2.505	10198719		CCCc1nc2c(s1)c1ccccc1nc2N	InChI=1S/C13H13N3S/c1-2-5-10-16-11-12(17-10)8-6-3-4-7-9(8)15-13(11)14/h3-4,6-7H,2,5H2,1H3,(H2,14,15)	NFYMGJSUKCDVJR-UHFFFAOYSA-N					compound annotation
0391_010550	TCY-NH2	C40H49N7O7	2.6823	11479675	C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)/C=C/C3=CC=CC=C3)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N	NCCCCC(NC(=O)CNC(=O)C1CCCN1C(=O)C(Cc1ccc(O)cc1)NC(=O)C=Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C40H49N7O7/c41-22-8-7-14-31(38(52)46-32(37(42)51)24-28-12-5-2-6-13-28)44-36(50)26-43-39(53)34-15-9-23-47(34)40(54)33(25-29-16-19-30(48)20-17-29)45-35(49)21-18-27-10-3-1-4-11-27/h1-6,10-13,16-21,31-34,48H,7-9,14-15,22-26,41H2,(H2,42,51)(H,43,53)(H,44,50)(H,45,49)(H,46,52)/b21-18+/t31-,32-,33-,34-/m0/s1	XKRAKQXQVIGYQC-PHOSSJRVSA-N					compound annotation
0391_010551	BT18	C30H31F4N3O6S	4.5675	46088742		COc1c(OC)cc2CN(S(=O)(=O)c3cc(N4CCN(C(=O)c5c(C(F)(F)F)cc(F)cc5)CC4)c(OC)cc3)CCc2c1	InChI=1S/C30H31F4N3O6S/c1-41-26-7-5-22(44(39,40)37-9-8-19-14-27(42-2)28(43-3)15-20(19)18-37)17-25(26)35-10-12-36(13-11-35)29(38)23-6-4-21(31)16-24(23)30(32,33)34/h4-7,14-17H,8-13,18H2,1-3H3	QVIIZVVDZZHGCB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010553	105827-78-9	C9H10ClN5O2	1.9394	86287518	C1CN(/C(=N/[N+](=O)[O-])/N1)CC2=CN=C(C=C2)Cl	O=[N+]([O-])NC1=NCCN1Cc1cnc(Cl)cc1	InChI=1S/C9H10ClN5O2/c10-8-2-1-7(5-12-8)6-14-4-3-11-9(14)13-15(16)17/h1-2,5H,3-4,6H2,(H,11,13)	YWTYJOPNNQFBPC-UHFFFAOYSA-N					compound annotation
0391_010554	Xanthotoxol	C11H6O4	2.2617	65090		O=c1ccc2cc3c(occ3)c(O)c2o1	InChI=1S/C11H6O4/c12-8-2-1-6-5-7-3-4-14-10(7)9(13)11(6)15-8/h1-5,13H	JWVYQQGERKEAHW-UHFFFAOYSA-N					compound annotation
0391_010555	proglumide	C18H26N2O4	3.1449	4922		CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22)	DGMKFQYCZXERLX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010557	lamotrigine	C9H7Cl2N5	1.7584	3878		Nc1nc(N)c(-c2c(Cl)c(Cl)ccc2)nn1	InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)	PYZRQGJRPPTADH-UHFFFAOYSA-N					compound annotation
0391_010558	Masitinib	C28H30N6OS	1.9914	10074640		Cc1c(Nc2nc(-c3cnccc3)cs2)cc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)	WJEOLQLKVOPQFV-UHFFFAOYSA-N					doublet; compound annotation
0391_010559	GRP-60367	C21H27N3O2	2.0563	56713854		Cc1cc(OCCNC2CCN(C(=O)c3ccncc3)CC2)c(C)cc1	InChI=1S/C21H27N3O2/c1-16-3-4-17(2)20(15-16)26-14-11-23-19-7-12-24(13-8-19)21(25)18-5-9-22-10-6-18/h3-6,9-10,15,19,23H,7-8,11-14H2,1-2H3	WNJMKSOJWRDLLM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010561	DMT1 blocker 1	C16H14N4O2	3.1564	25098135		Cc1c(C(=O)Nc2ccccc2)c(=O)n(-c2ccccn2)[nH]1	InChI=1S/C16H14N4O2/c1-11-14(15(21)18-12-7-3-2-4-8-12)16(22)20(19-11)13-9-5-6-10-17-13/h2-10,19H,1H3,(H,18,21)	QJEBTCLOCMTSJU-UHFFFAOYSA-N					doublet; compound annotation
0391_010562	DMT1 blocker 1	C16H14N4O2	4.3157	25098135		Cc1c(C(=O)Nc2ccccc2)c(=O)n(-c2ccccn2)[nH]1	InChI=1S/C16H14N4O2/c1-11-14(15(21)18-12-7-3-2-4-8-12)16(22)20(19-11)13-9-5-6-10-17-13/h2-10,19H,1H3,(H,18,21)	QJEBTCLOCMTSJU-UHFFFAOYSA-N					doublet; compound annotation
0391_010563	DANOPREVIR	C35H46FN5O9S	4.9349	11285588	CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6	CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(C(=O)NS(=O)(=O)C2CC2)NC(=O)C2CC(OC(=O)N3Cc4c(C3)c(F)ccc4)CN2C1=O	InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27+,28+,35-/m1/s1	ZVTDLPBHTSMEJZ-JSZLBQEHSA-N					removed another duplicate entry; compound annotation
0391_010565	1205550-99-7	C32H40N2O8S	5.6678	46842948	CC1=CC=C(C=C1)S(=O)(=O)OCCOCCOCCOC2=NC=C(C=C2)/C=C/C3=CC=C(C=C3)N(C)C(=O)OC(C)(C)C	Cc1ccc(S(=O)(=O)OCCOCCOCCOc2ncc(C=Cc3ccc(N(C)C(=O)OC(C)(C)C)cc3)cc2)cc1	InChI=1S/C32H40N2O8S/c1-25-6-15-29(16-7-25)43(36,37)41-23-21-39-19-18-38-20-22-40-30-17-12-27(24-33-30)9-8-26-10-13-28(14-11-26)34(5)31(35)42-32(2,3)4/h6-17,24H,18-23H2,1-5H3/b9-8+	MDBUGPWBKWJULZ-CMDGGOBGSA-N					doublet; removed another duplicate entry; compound annotation
0391_010567	1205550-99-7	C32H40N2O8S	5.7672	46842948	CC1=CC=C(C=C1)S(=O)(=O)OCCOCCOCCOC2=NC=C(C=C2)/C=C/C3=CC=C(C=C3)N(C)C(=O)OC(C)(C)C	Cc1ccc(S(=O)(=O)OCCOCCOCCOc2ncc(C=Cc3ccc(N(C)C(=O)OC(C)(C)C)cc3)cc2)cc1	InChI=1S/C32H40N2O8S/c1-25-6-15-29(16-7-25)43(36,37)41-23-21-39-19-18-38-20-22-40-30-17-12-27(24-33-30)9-8-26-10-13-28(14-11-26)34(5)31(35)42-32(2,3)4/h6-17,24H,18-23H2,1-5H3/b9-8+	MDBUGPWBKWJULZ-CMDGGOBGSA-N					doublet; compound annotation
0391_010568	tetracycline	C22H24N2O8	1.4598	54675776	C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)C(C)(O)C3CC12	InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1	NWXMGUDVXFXRIG-WESIUVDSSA-N					doublet; compound annotation
0391_010569	tetracycline	C22H24N2O8	1.6466	54675776	C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)C(C)(O)C3CC12	InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1	NWXMGUDVXFXRIG-WESIUVDSSA-N					doublet; compound annotation
0391_010570	N-Nornuciferine	C18H19NO2	2.4184	12313579	COC1=C(C2=C3[C@@H](CC4=CC=CC=C42)NCCC3=C1)OC	COc1c(OC)c2c3c(c1)CCNC3Cc1ccccc1-2	InChI=1S/C18H19NO2/c1-20-15-10-12-7-8-19-14-9-11-5-3-4-6-13(11)17(16(12)14)18(15)21-2/h3-6,10,14,19H,7-9H2,1-2H3/t14-/m1/s1	QQKAHDMMPBQDAC-CQSZACIVSA-N					compound annotation
0391_010571	Selpercatinib	C29H31N7O3	2.4334	134436906		COc1ncc(CN2C3CC2CN(c2ncc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cc2)C3)cc1	InChI=1S/C29H31N7O3/c1-29(2,37)18-39-24-9-25(28-21(10-30)13-33-36(28)17-24)20-5-6-26(31-12-20)34-15-22-8-23(16-34)35(22)14-19-4-7-27(38-3)32-11-19/h4-7,9,11-13,17,22-23,37H,8,14-16,18H2,1-3H3	XIIOFHFUYBLOLW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010573	Nuciferine	C19H21NO2	2.4592	10146	CN1CCC2=CC(=C(C3=C2[C@H]1CC4=CC=CC=C43)OC)OC	COc1c(OC)c2c3c(c1)CCN(C)C3Cc1ccccc1-2	InChI=1S/C19H21NO2/c1-20-9-8-13-11-16(21-2)19(22-3)18-14-7-5-4-6-12(14)10-15(20)17(13)18/h4-7,11,15H,8-10H2,1-3H3/t15-/m1/s1	ORJVQPIHKOARKV-OAHLLOKOSA-N					compound annotation
0391_010574	3,6-bis(dimethylamino)xanthylium	C17H19N2O+	2.5992	7086		CN(C)c1cc2c(cc1)cc1ccc(=[N+](C)C)cc-1o2	InChI=1S/C17H19N2O/c1-18(2)14-7-5-12-9-13-6-8-15(19(3)4)11-17(13)20-16(12)10-14/h5-11H,1-4H3/q+1	MTENKDNBVMPHAS-UHFFFAOYSA-N					compound annotation
0391_010575	3-(3-hydroxyphenyl)propanoic acid	C9H10O3	4.281	91		O=C(O)CCc1cc(O)ccc1	InChI=1S/C9H10O3/c10-8-3-1-2-7(6-8)4-5-9(11)12/h1-3,6,10H,4-5H2,(H,11,12)	QVWAEZJXDYOKEH-UHFFFAOYSA-N					compound annotation
0391_010576	Armepavine	C19H23NO3	1.7048	442169	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)O)OC)OC	COc1c(OC)cc2c(c1)CCN(C)C2Cc1ccc(O)cc1	InChI=1S/C19H23NO3/c1-20-9-8-14-11-18(22-2)19(23-3)12-16(14)17(20)10-13-4-6-15(21)7-5-13/h4-7,11-12,17,21H,8-10H2,1-3H3/t17-/m1/s1	ZBKFZIUKXTWQTP-QGZVFWFLSA-N					compound annotation
0391_010577	20-HYDROXYECDYSONE	C27H44O7	1.9434	5459840	C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)[C@@]1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O	CC(C)(O)CCC(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C	InChI=1S/C27H44O7/c1-23(2,32)9-8-22(31)26(5,33)21-7-11-27(34)16-12-18(28)17-13-19(29)20(30)14-24(17,3)15(16)6-10-25(21,27)4/h12,15,17,19-22,29-34H,6-11,13-14H2,1-5H3/t15-,17-,19+,20-,21-,22+,24+,25+,26+,27+/m0/s1	NKDFYOWSKOHCCO-YPVLXUMRSA-N					compound annotation
0391_010578	Heraclenin	C16H14O5	2.4414	458010	CC1([C@H](O1)COC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3)C	CC1(C)OC1COc1c2oc(=O)ccc2cc2c1occ2	InChI=1S/C16H14O5/c1-16(2)11(21-16)8-19-15-13-10(5-6-18-13)7-9-3-4-12(17)20-14(9)15/h3-7,11H,8H2,1-2H3/t11-/m1/s1	CTJZWFCPUDPLME-LLVKDONJSA-N					doublet; compound annotation
0391_010579	Cariprazine	C21H32Cl2N4O	2.943	11154555		CN(C)C(=O)NC1CCC(CCN2CCN(c3c(Cl)c(Cl)ccc3)CC2)CC1	InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)	KPWSJANDNDDRMB-UHFFFAOYSA-N					compound annotation
0391_010580	Heraclenin	C16H14O5	3.4077	458010	CC1([C@H](O1)COC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3)C	CC1(C)OC1COc1c2oc(=O)ccc2cc2c1occ2	InChI=1S/C16H14O5/c1-16(2)11(21-16)8-19-15-13-10(5-6-18-13)7-9-3-4-12(17)20-14(9)15/h3-7,11H,8H2,1-2H3/t11-/m1/s1	CTJZWFCPUDPLME-LLVKDONJSA-N					doublet; removed another duplicate entry; compound annotation
0391_010582	alpha-Mangostin	C24H26O6	5.8546	5281650		COc1c(CC=C(C)C)c2c(cc1O)oc1c(c(O)c(CC=C(C)C)c(O)c1)c2=O	InChI=1S/C24H26O6/c1-12(2)6-8-14-16(25)10-19-21(22(14)27)23(28)20-15(9-7-13(3)4)24(29-5)17(26)11-18(20)30-19/h6-7,10-11,25-27H,8-9H2,1-5H3	GNRIZKKCNOBBMO-UHFFFAOYSA-N					compound annotation
0391_010583	OCLACITINIB	C15H23N5O2S	1.5605	44631938		CNS(=O)(=O)CC1CCC(N(C)c2ncnc3c2cc[nH]3)CC1	InChI=1S/C15H23N5O2S/c1-16-23(21,22)9-11-3-5-12(6-4-11)20(2)15-13-7-8-17-14(13)18-10-19-15/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,17,18,19)	HJWLJNBZVZDLAQ-UHFFFAOYSA-N					compound annotation
0391_010584	Belotecan	C25H27N3O4	2.0346	6456014	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4ccccc4c(CCNC(C)C)c3Cn1c2=O	InChI=1S/C25H27N3O4/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22/h5-8,11,14,26,31H,4,9-10,12-13H2,1-3H3/t25-/m0/s1	LNHWXBUNXOXMRL-VWLOTQADSA-N					compound annotation
0391_010585	Halofuginone	C16H17BrClN3O3	2.3109	400772	C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O	O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m0/s1	LVASCWIMLIKXLA-LSDHHAIUSA-N					doublet; compound annotation
0391_010586	amsacrine	C21H19N3O3S	2.3142	2179		COc1c(Nc2c3ccccc3nc3ccccc23)ccc(NS(C)(=O)=O)c1	InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)	XCPGHVQEEXUHNC-UHFFFAOYSA-N					doublet; compound annotation
0391_010587	Halofuginone	C16H17BrClN3O3	2.419	400772	C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O	O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O	InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m0/s1	LVASCWIMLIKXLA-LSDHHAIUSA-N					doublet; compound annotation
0391_010588	Bendamustine	C16H21Cl2N3O2	2.6026	65628		Cn1c(CCCC(=O)O)nc2c1ccc(N(CCCl)CCCl)c2	InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)	YTKUWDBFDASYHO-UHFFFAOYSA-N					compound annotation
0391_010589	Irisflorentin	C20H18O8	3.5765	170569		COc1cc(-c2coc3cc4c(OCO4)c(OC)c3c2=O)cc(OC)c1OC	InChI=1S/C20H18O8/c1-22-13-5-10(6-14(23-2)18(13)24-3)11-8-26-12-7-15-19(28-9-27-15)20(25-4)16(12)17(11)21/h5-8H,9H2,1-4H3	RISXUTCDCPHJFQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010592	Rolapitant	C25H26F6N2O2	3.7241	10311306	C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4	CC(OCC1(c2ccccc2)CCC2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	InChI=1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/t16-,22-,23-/m1/s1	FIVSJYGQAIEMOC-ZGNKEGEESA-N					removed another duplicate entry; compound annotation
0391_010594	oxaprozin	C18H15NO3	4.0546	4614		O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1	InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)	OFPXSFXSNFPTHF-UHFFFAOYSA-N					compound annotation
0391_010595	Apafant	C22H22ClN5O2S	2.4729	65889		Cc1nnc2CN=C(c3ccccc3Cl)c3c(sc(CCC(=O)N4CCOCC4)c3)-n12	InChI=1S/C22H22ClN5O2S/c1-14-25-26-19-13-24-21(16-4-2-3-5-18(16)23)17-12-15(31-22(17)28(14)19)6-7-20(29)27-8-10-30-11-9-27/h2-5,12H,6-11,13H2,1H3	JGPJQFOROWSRRS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010597	Boceprevir	C27H45N5O5	3.6884	10324367	CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C	CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1	LHHCSNFAOIFYRV-DOVBMPENSA-N					doublet; compound annotation
0391_010598	Boceprevir	C27H45N5O5	4.1734	10324367	CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C	CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1	LHHCSNFAOIFYRV-DOVBMPENSA-N					doublet; removed another duplicate entry; compound annotation
0391_010600	PF-02413873	C18H21N3O3S	4.2076	16662425		Cc1cc(Oc2c(C)n(CS(C)(=O)=O)nc2C2CC2)cc(C)c1C#N	InChI=1S/C18H21N3O3S/c1-11-7-15(8-12(2)16(11)9-19)24-18-13(3)21(10-25(4,22)23)20-17(18)14-5-6-14/h7-8,14H,5-6,10H2,1-4H3	QSFGZNVRVZHUGV-UHFFFAOYSA-N					compound annotation
0391_010601	Boceprevir	C27H45N5O5	4.2668	10324367	CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C	CC(C)(C)NC(=O)NC(C(=O)N1CC2C(C1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C	InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1	LHHCSNFAOIFYRV-DOVBMPENSA-N					doublet; removed another duplicate entry; compound annotation
0391_010603	Ceapin-A7	C20H12F6N4O3	4.9931	154730128		O=C(Nc1cn(Cc2c(C(F)(F)F)cc(C(F)(F)F)cc2)nc1)c1noc(-c2ccco2)c1	InChI=1S/C20H12F6N4O3/c21-19(22,23)12-4-3-11(14(6-12)20(24,25)26)9-30-10-13(8-27-30)28-18(31)15-7-17(33-29-15)16-2-1-5-32-16/h1-8,10H,9H2,(H,28,31)	UJTDYOXTXGBHEG-UHFFFAOYSA-N					compound annotation
0391_010604	2',3'-Dideoxyadenosine	C10H13N5O2	0.5354	20039	C1C[C@@H](O[C@@H]1CO)N2C=NC3=C(N=CN=C32)N	Nc1c2ncn(C3CCC(CO)O3)c2ncn1	InChI=1S/C10H13N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h4-7,16H,1-3H2,(H2,11,12,13)/t6-,7+/m0/s1	WVXRAFOPTSTNLL-NKWVEPMBSA-N					removed another duplicate entry; compound annotation
0391_010606	ethionamide	C8H10N2S	0.7023	2761171		CCc1nccc(C(=N)S)c1	InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)	AEOCXXJPGCBFJA-UHFFFAOYSA-N					compound annotation
0391_010607	N-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide	C12H13ClN2O2S	2.4191	1960		NCCNS(=O)(=O)c1cccc2c1cccc2Cl	InChI=1S/C12H13ClN2O2S/c13-11-5-1-4-10-9(11)3-2-6-12(10)18(16,17)15-8-7-14/h1-6,15H,7-8,14H2	ACIMRXKJKQGBGL-UHFFFAOYSA-N					compound annotation
0391_010608	ganaplacide	C22H23F2N5O	2.5081	49856296		CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)cc3)n2CCN1C(=O)CN	InChI=1S/C22H23F2N5O/c1-22(2)21-27-19(14-3-5-15(23)6-4-14)20(26-17-9-7-16(24)8-10-17)28(21)11-12-29(22)18(30)13-25/h3-10,26H,11-13,25H2,1-2H3	BUPRVECGWBHCQV-UHFFFAOYSA-N					compound annotation
0391_010609	Evogliptin	C19H26F3N3O3	2.4458	25022354	CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](CC2=CC(=C(C=C2F)F)F)N	CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(N)Cc1cc(F)c(F)cc1F	InChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1	LCDDAGSJHKEABN-MLGOLLRUSA-N					removed another duplicate entry; compound annotation
0391_010611	Risocaine	C10H13NO2	3.1672	7174		CCCOC(=O)c1ccc(N)cc1	InChI=1S/C10H13NO2/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6H,2,7,11H2,1H3	NBFQYHKHPBMJJV-UHFFFAOYSA-N					compound annotation
0391_010612	DS-1971a	C20H21ClFN5O3S	3.1985	71711862	CN1C(=CC=N1)[C@H]2CCCC[C@@H]2OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=NC=NC=C4)F	Cn1nccc1C1CCCCC1Oc1cc(F)c(S(=O)(=O)Nc2ncncc2)cc1Cl	InChI=1S/C20H21ClFN5O3S/c1-27-16(6-9-25-27)13-4-2-3-5-17(13)30-18-11-15(22)19(10-14(18)21)31(28,29)26-20-7-8-23-12-24-20/h6-13,17H,2-5H2,1H3,(H,23,24,26)/t13-,17+/m1/s1	OJKONCJPCULNOW-DYVFJYSZSA-N					removed another duplicate entry; compound annotation
0391_010614	Raltegravir	C20H21FN6O5	3.2445	54671008		Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1	InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)	CZFFBEXEKNGXKS-UHFFFAOYSA-N					doublet; compound annotation
0391_010615	droperidol	C22H22FN3O2	2.4651	3168		O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1	InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)	RMEDXOLNCUSCGS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010617	Ginsenoside Rf	C42H72O14	3.0498	441922	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O)C	CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3OC3OC(CO)C(O)C(O)C3O)CC12C	InChI=1S/C42H72O14/c1-20(2)10-9-13-42(8,52)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-37-34(32(50)30(48)25(19-44)55-37)56-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36-,37+,39+,40+,41+,42-/m0/s1	UZIOUZHBUYLDHW-XUBRWZAZSA-N					compound annotation
0391_010618	Parcetasal	C17H15NO5	3.4684	65656		CC(=O)Nc1ccc(OC2(C)OC(=O)c3ccccc3O2)cc1	InChI=1S/C17H15NO5/c1-11(19)18-12-7-9-13(10-8-12)21-17(2)22-15-6-4-3-5-14(15)16(20)23-17/h3-10H,1-2H3,(H,18,19)	ZAPRLADYRFPQSH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010620	amlexanox	C16H14N2O4	3.6559	2161		CC(C)c1cc2c(cc1)oc1nc(N)c(C(=O)O)cc1c2=O	InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)	SGRYPYWGNKJSDL-UHFFFAOYSA-N					compound annotation
0391_010621	BI-4916	C23H24Cl2N2O6S	4.5652	138911337	CCOC(=O)CS(=O)(=O)C1=CC=C(C=C1)[C@@H](CO)NC(=O)C2=CC3=C(N2C)C=C(C(=C3Cl)Cl)C	CCOC(=O)CS(=O)(=O)c1ccc(C(CO)NC(=O)c2cc3c(cc(C)c(Cl)c3Cl)n2C)cc1	InChI=1S/C23H24Cl2N2O6S/c1-4-33-20(29)12-34(31,32)15-7-5-14(6-8-15)17(11-28)26-23(30)19-10-16-18(27(19)3)9-13(2)21(24)22(16)25/h5-10,17,28H,4,11-12H2,1-3H3,(H,26,30)/t17-/m1/s1	HCDAVCLCBXIYPW-QGZVFWFLSA-N					removed another duplicate entry; compound annotation
0391_010623	Boldenone undecylenate	C30H44O3	7.102	11954310	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCCCCCCCC=C)CCC4=CC(=O)C=C[C@]34C	C=CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)C=CC4(C)C3CCC12C	InChI=1S/C30H44O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h4,17,19,21,24-27H,1,5-16,18,20H2,2-3H3/t24-,25-,26-,27-,29-,30-/m0/s1	AHMMSNQYOPMLSX-CNQKSJKFSA-N					compound annotation
0391_010624	62289-81-0	C10H8N2OS	1.2462	790407		O=C(Nc1cnccc1)c1cccs1	InChI=1S/C10H8N2OS/c13-10(9-4-2-6-14-9)12-8-3-1-5-11-7-8/h1-7H,(H,12,13)	UPLHUDRMLWWFRE-UHFFFAOYSA-N					compound annotation
0391_010625	HARMINE	C13H12N2O	1.9146	5280953		COc1cc2c(cc1)c1c([nH]2)c(C)ncc1	InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3	BXNJHAXVSOCGBA-UHFFFAOYSA-N					compound annotation
0391_010626	imidapril	C20H27N3O6	2.4588	5464343	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@@H](CN(C2=O)C)C(=O)O	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(=O)N(C)CC1C(=O)O	InChI=1S/C20H27N3O6/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26)/t13-,15-,16-/m0/s1	KLZWOWYOHUKJIG-BPUTZDHNSA-N					removed another duplicate entry; compound annotation
0391_010628	WAY-181187	C15H13ClN4O2S2	2.7338	10150497		NCCc1cn(S(=O)(=O)c2c(Cl)nc3sccn23)c2ccccc12	InChI=1S/C15H13ClN4O2S2/c16-13-14(19-7-8-23-15(19)18-13)24(21,22)20-9-10(5-6-17)11-3-1-2-4-12(11)20/h1-4,7-9H,5-6,17H2	RYBOXBBYCVOYNO-UHFFFAOYSA-N					compound annotation
0391_010629	(+)-JQ-1-aldehyde	C19H17ClN4OS	3.6115	121448545	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC=O)C4=CC=C(C=C4)Cl)C	Cc1c(C)c2c(s1)-n1c(C)nnc1C(CC=O)N=C2c1ccc(Cl)cc1	InChI=1S/C19H17ClN4OS/c1-10-11(2)26-19-16(10)17(13-4-6-14(20)7-5-13)21-15(8-9-25)18-23-22-12(3)24(18)19/h4-7,9,15H,8H2,1-3H3/t15-/m0/s1	YVZIYJGNGNZVCF-HNNXBMFYSA-N					compound annotation
0391_010630	Dorzagliatin	C22H27ClN4O5	3.6413	57920094	CC(C)C[C@@H](C(=O)NC1=NN(C=C1)C[C@H](CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl	CC(C)CC(C(=O)Nc1nn(CC(O)CO)cc1)N1CC(Oc2ccccc2Cl)=CC1=O	InChI=1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18+/m1/s1	HMUMWSORCUWQJO-QAPCUYQASA-N					removed another duplicate entry; compound annotation
0391_010632	GLPG0974	C25H25ClN2O4S	4.1443	57520598	C[C@@]1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl	CC1(C(=O)N(CCCC(=O)O)Cc2cc(Cl)ccc2)CCN1C(=O)c1csc2ccccc12	InChI=1S/C25H25ClN2O4S/c1-25(11-13-28(25)23(31)20-16-33-21-9-3-2-8-19(20)21)24(32)27(12-5-10-22(29)30)15-17-6-4-7-18(26)14-17/h2-4,6-9,14,16H,5,10-13,15H2,1H3,(H,29,30)/t25-/m1/s1	MPMKMQHJHDHPBE-RUZDIDTESA-N					removed another duplicate entry; compound annotation
0391_010634	Etalocib	C33H33FO6	6.0958	177941		CCCc1c(OCCCOc2cc(O)c(-c3ccc(F)cc3)cc2CC)cccc1Oc1ccccc1C(=O)O	InChI=1S/C33H33FO6/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37)	YFIZRWPXUYFCSN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010637	ISOQUINOLINE	C9H7N	0.5778	8405		c1ccc2cnccc2c1	InChI=1S/C9H7N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-7H	AWJUIBRHMBBTKR-UHFFFAOYSA-N					compound annotation
0391_010638	Cladribine	C10H12ClN5O3	1.1074	20279	C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O	Nc1c2ncn(C3CC(O)C(CO)O3)c2nc(Cl)n1	InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1	PTOAARAWEBMLNO-KVQBGUIXSA-N					removed another duplicate entry; compound annotation
0391_010640	ENMD-1068	C15H29N3O2	1.4656	9950925		CC(C)CC(=O)N1CCN(C(=O)CCCCCN)CC1	InChI=1S/C15H29N3O2/c1-13(2)12-15(20)18-10-8-17(9-11-18)14(19)6-4-3-5-7-16/h13H,3-12,16H2,1-2H3	VRZYMMVEALDDBH-UHFFFAOYSA-N					compound annotation
0391_010641	Secoxyloganin	C17H24O11	1.665	162868	COC(=O)C1=CO[C@H]([C@@H]([C@@H]1CC(=O)O)C=C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O	C=CC1C(OC2OC(CO)C(O)C(O)C2O)OC=C(C(=O)OC)C1CC(=O)O	InChI=1S/C17H24O11/c1-3-7-8(4-11(19)20)9(15(24)25-2)6-26-16(7)28-17-14(23)13(22)12(21)10(5-18)27-17/h3,6-8,10,12-14,16-18,21-23H,1,4-5H2,2H3,(H,19,20)/t7-,8+,10-,12-,13+,14-,16+,17+/m1/s1	MQLSOVRLZHTATK-PEYNGXJCSA-N					compound annotation
0391_010642	PF-06447475	C17H15N5O	2.4472	72706840		N#Cc1cc(-c2c[nH]c3c2c(N2CCOCC2)ncn3)ccc1	InChI=1S/C17H15N5O/c18-9-12-2-1-3-13(8-12)14-10-19-16-15(14)17(21-11-20-16)22-4-6-23-7-5-22/h1-3,8,10-11H,4-7H2,(H,19,20,21)	BHTWDJBVZQBRKP-UHFFFAOYSA-N					compound annotation
0391_010643	silibinin	C25H22O10	2.8442	31553	COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O	COc1c(O)ccc(C2Oc3c(ccc(C4Oc5cc(O)cc(O)c5C(=O)C4O)c3)OC2CO)c1	InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23+,24-,25-/m1/s1	SEBFKMXJBCUCAI-HKTJVKLFSA-N					compound annotation
0391_010644	2-Amino-5-phenylpyridine	C11H10N2	1.6476	105097		Nc1ncc(-c2ccccc2)cc1	InChI=1S/C11H10N2/c12-11-7-6-10(8-13-11)9-4-2-1-3-5-9/h1-8H,(H2,12,13)	OAPVIBHQRYFYSE-UHFFFAOYSA-N					compound annotation
0391_010645	Methyl 3,4,5-trimethoxybenzoate	C11H14O5	3.0747	15956		COC(=O)c1cc(OC)c(OC)c(OC)c1	InChI=1S/C11H14O5/c1-13-8-5-7(11(12)16-4)6-9(14-2)10(8)15-3/h5-6H,1-4H3	KACHFMOHOPLTNX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010647	12-Ketolithocholic acid	C24H38O4	4.1833	3080612	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(=O)C12C	InChI=1S/C24H38O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-20,25H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,23+,24-/m1/s1	CVNYHSDFZXHMMJ-VPUMZWJWSA-N					removed another duplicate entry; compound annotation
0391_010649	3-Methoxyphenylacetic acid	C9H10O3	4.2789	15719		COc1cccc(CC(=O)O)c1	InChI=1S/C9H10O3/c1-12-8-4-2-3-7(5-8)6-9(10)11/h2-5H,6H2,1H3,(H,10,11)	LEGPZHPSIPPYIO-UHFFFAOYSA-N					compound annotation
0391_010650	L-tryptophan	C11H12N2O2	0.9721	6923516	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)[O-])[NH3+]	NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1	QIVBCDIJIAJPQS-VIFPVBQESA-N					compound annotation
0391_010651	Danofloxacin	C19H20FN3O3	1.6473	71335	CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F	CN1CC2CC1CN2c1c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c2c1	InChI=1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1	QMLVECGLEOSESV-RYUDHWBXSA-N					removed another duplicate entry; compound annotation
0391_010653	5,7-DIHYDROXY-4-METHYLCOUMARIN	C10H8O4	1.9744	5354284		Cc1cc(=O)oc2cc(O)cc(O)c12	InChI=1S/C10H8O4/c1-5-2-9(13)14-8-4-6(11)3-7(12)10(5)8/h2-4,11-12H,1H3	QNVWGEJMXOQQPM-UHFFFAOYSA-N					compound annotation
0391_010654	Rauwolscine	C21H26N2O3	2.0494	643606	COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O	COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15+,17+,18+,19+/m1/s1	BLGXFZZNTVWLAY-DIRVCLHFSA-N					compound annotation
0391_010655	Halofantrine	C26H30Cl2F3NO	4.7315	37393		CCCCN(CCCC)CCC(O)c1c2ccc(C(F)(F)F)cc2c2cc(Cl)cc(Cl)c2c1	InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3	FOHHNHSLJDZUGQ-UHFFFAOYSA-N					compound annotation
0391_010656	Sec	C22H23ClN2O5	4.7871	146681186	CCOC(=O)C1=CC(=NN1C[C@@H](COC2=CC=C(C=C2)Cl)O)C3=CC=C(C=C3)OC	CCOC(=O)c1cc(-c2ccc(OC)cc2)nn1CC(O)COc1ccc(Cl)cc1	InChI=1S/C22H23ClN2O5/c1-3-29-22(27)21-12-20(15-4-8-18(28-2)9-5-15)24-25(21)13-17(26)14-30-19-10-6-16(23)7-11-19/h4-12,17,26H,3,13-14H2,1-2H3/t17-/m0/s1	OFKGGSVHXHMDDN-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_010658	gomisin N	C23H28O6	5.6425	158103	C[C@H]1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4C[C@H]1C)OC)OC)OC)OC)OCO3	COc1c(OC)c(OC)c2c(c1)CC(C)C(C)Cc1cc3c(OCO3)c(OC)c1-2	InChI=1S/C23H28O6/c1-12-7-14-9-16(24-3)20(25-4)22(26-5)18(14)19-15(8-13(12)2)10-17-21(23(19)27-6)29-11-28-17/h9-10,12-13H,7-8,11H2,1-6H3/t12-,13+/m1/s1	RTZKSTLPRTWFEV-OLZOCXBDSA-N					removed another duplicate entry; compound annotation
0391_010661	sulfadiazine	C10H10N4O2S	0.9943	5215		Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1	InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)	SEEPANYCNGTZFQ-UHFFFAOYSA-N					doublet; compound annotation
0391_010662	amodiaquine	C20H22ClN3O	1.3033	2165		CCN(CC)Cc1c(O)ccc(Nc2ccnc3cc(Cl)ccc23)c1	InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)	OVCDSSHSILBFBN-UHFFFAOYSA-N					doublet; compound annotation
0391_010663	NAE-IN-M22	C20H24Cl2N2	1.9483	6456370		Clc1cc(Cl)c(CCNC2CCN(Cc3ccccc3)CC2)cc1	InChI=1S/C20H24Cl2N2/c21-18-7-6-17(20(22)14-18)8-11-23-19-9-12-24(13-10-19)15-16-4-2-1-3-5-16/h1-7,14,19,23H,8-13,15H2	WMEXQHGRMWPOEF-UHFFFAOYSA-N					compound annotation
0391_010664	ENOXIMONE	C12H12N2O2S	2.4424	53708		CSc1ccc(C(=O)c2c(C)[nH]c(=O)[nH]2)cc1	InChI=1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16)	ZJKNESGOIKRXQY-UHFFFAOYSA-N					compound annotation
0391_010665	Filibuvir	C29H37N5O3	2.5617	54708673	CCC1=CC(=CC(=N1)CC)CC[C@@]2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5	CCc1cc(CCC2(C3CCCC3)CC(O)=C(Cc3nn4c(C)cc(C)nc4n3)C(=O)O2)cc(CC)n1	InChI=1S/C29H37N5O3/c1-5-22-14-20(15-23(6-2)31-22)11-12-29(21-9-7-8-10-21)17-25(35)24(27(36)37-29)16-26-32-28-30-18(3)13-19(4)34(28)33-26/h13-15,21,35H,5-12,16-17H2,1-4H3/t29-/m1/s1	SLVAPEZTBDBAPI-GDLZYMKVSA-N					removed another duplicate entry; compound annotation
0391_010667	PQR626	C20H27F2N7O2	3.554	121334440	C[C@@H]1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)F)N)N4[C@@H](COC[C@@H]4C)C	CC1COCCN1c1nc(N2C(C)COCC2C)nc(-c2cnc(N)cc2C(F)F)n1	InChI=1S/C20H27F2N7O2/c1-11-8-30-5-4-28(11)19-25-18(15-7-24-16(23)6-14(15)17(21)22)26-20(27-19)29-12(2)9-31-10-13(29)3/h6-7,11-13,17H,4-5,8-10H2,1-3H3,(H2,23,24)/t11-,12-,13+/m1/s1	YXQKBQLVKBUCLZ-UPJWGTAASA-N					compound annotation
0391_010668	Syringin	C17H24O9	1.2378	5316860	COC1=CC(=CC(=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)OC)/C=C/CO	COc1cc(C=CCO)cc(OC)c1OC1OC(CO)C(O)C(O)C1O	InChI=1S/C17H24O9/c1-23-10-6-9(4-3-5-18)7-11(24-2)16(10)26-17-15(22)14(21)13(20)12(8-19)25-17/h3-4,6-7,12-15,17-22H,5,8H2,1-2H3/b4-3+/t12-,13-,14+,15-,17+/m1/s1	QJVXKWHHAMZTBY-GCPOEHJPSA-N					compound annotation
0391_010669	N-trans-Feruloyloctopamine	C18H19NO5	1.8152	24096391	COC1=C(C=CC(=C1)/C=C/C(=O)NCC(C2=CC=C(C=C2)O)O)O	COc1c(O)ccc(C=CC(=O)NCC(O)c2ccc(O)cc2)c1	InChI=1S/C18H19NO5/c1-24-17-10-12(2-8-15(17)21)3-9-18(23)19-11-16(22)13-4-6-14(20)7-5-13/h2-10,16,20-22H,11H2,1H3,(H,19,23)/b9-3+	VJSCHQMOTSXAKB-YCRREMRBSA-N					doublet; compound annotation
0391_010670	N-trans-Feruloyloctopamine	C18H19NO5	1.9456	24096391	COC1=C(C=CC(=C1)/C=C/C(=O)NCC(C2=CC=C(C=C2)O)O)O	COc1c(O)ccc(C=CC(=O)NCC(O)c2ccc(O)cc2)c1	InChI=1S/C18H19NO5/c1-24-17-10-12(2-8-15(17)21)3-9-18(23)19-11-16(22)13-4-6-14(20)7-5-13/h2-10,16,20-22H,11H2,1H3,(H,19,23)/b9-3+	VJSCHQMOTSXAKB-YCRREMRBSA-N					doublet; compound annotation
0391_010671	IPN60090	C24H27F3N8O3	2.2003	118627280	CC1=CC(=CC(=N1)CC(=O)NC2=NN=C(C=C2)CC[C@H](CN3C=C(N=N3)C(=O)NC)F)OC4CC(C4)(F)F	CNC(=O)c1cn(CC(F)CCc2nnc(NC(=O)Cc3nc(C)cc(OC4CC(F)(F)C4)c3)cc2)nn1	InChI=1S/C24H27F3N8O3/c1-14-7-18(38-19-10-24(26,27)11-19)8-17(29-14)9-22(36)30-21-6-5-16(31-33-21)4-3-15(25)12-35-13-20(32-34-35)23(37)28-2/h5-8,13,15,19H,3-4,9-12H2,1-2H3,(H,28,37)(H,30,33,36)/t15-/m1/s1	GEHZIZWHNLQFAS-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_010673	oxybutynin	C22H31NO3	3.3726	4634		CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1	InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3	XIQVNETUBQGFHX-UHFFFAOYSA-N					doublet; compound annotation
0391_010674	Afoxolaner	C26H17ClF9N3O3	5.5245	25154249		O=C(CNC(=O)c1ccc(C2=NOC(c3cc(C(F)(F)F)cc(Cl)c3)(C(F)(F)F)C2)c2ccccc12)NCC(F)(F)F	InChI=1S/C26H17ClF9N3O3/c27-15-8-13(7-14(9-15)25(31,32)33)23(26(34,35)36)10-20(39-42-23)18-5-6-19(17-4-2-1-3-16(17)18)22(41)37-11-21(40)38-12-24(28,29)30/h1-9H,10-12H2,(H,37,41)(H,38,40)	OXDDDHGGRFRLEE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010676	dobutamine	C18H23NO3	1.6003	36811		CC(CCc1ccc(O)cc1)NCCc1cc(O)c(O)cc1	InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3	JRWZLRBJNMZMFE-UHFFFAOYSA-N					compound annotation
0391_010677	SYRINGALDEHYDE	C9H10O4	1.7567	8655		COc1cc(C=O)cc(OC)c1O	InChI=1S/C9H10O4/c1-12-7-3-6(5-10)4-8(13-2)9(7)11/h3-5,11H,1-2H3	KCDXJAYRVLXPFO-UHFFFAOYSA-N					compound annotation
0391_010678	Bepotastine	C21H25ClN2O3	2.2872	164522	C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O	O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1	InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1	YWGDOWXRIALTES-NRFANRHFSA-N					doublet; removed another duplicate entry; compound annotation
0391_010680	Ketanserin	C22H22FN3O3	2.4211	3822		O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)	FPCCSQOGAWCVBH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010682	pergolide	C19H26N2S	2.7126	47811	CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC	CCCN1CC(CSC)CC2c3c4c(c[nH]c4ccc3)CC21	InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1	YEHCICAEULNIGD-MZMPZRCHSA-N					compound annotation
0391_010683	Sciadopitysin	C33H24O10	4.9043	5281696		COc1ccc(-c2cc(=O)c3c(o2)c(-c2c(OC)ccc(-c4cc(=O)c5c(O)cc(OC)cc5o4)c2)c(O)cc3O)cc1	InChI=1S/C33H24O10/c1-39-18-7-4-16(5-8-18)27-15-25(38)32-23(36)13-22(35)30(33(32)43-27)20-10-17(6-9-26(20)41-3)28-14-24(37)31-21(34)11-19(40-2)12-29(31)42-28/h4-15,34-36H,1-3H3	YCXRBCHEOFVYEN-UHFFFAOYSA-N					compound annotation
0391_010684	Inz-5	C18H14F4N6	5.0552	73504559		Cc1c2c(ccc1)c(-c1c(F)ccc(C(F)(F)F)c1)nn2Cc1nn(C)nn1	InChI=1S/C18H14F4N6/c1-10-4-3-5-12-16(13-8-11(18(20,21)22)6-7-14(13)19)25-28(17(10)12)9-15-23-26-27(2)24-15/h3-8H,9H2,1-2H3	MMEFXWUINPSTPN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010686	doxylamine	C17H22N2O	1.3409	3162		CN(C)CCOC(C)(c1ccccc1)c1ccccn1	InChI=1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3	HCFDWZZGGLSKEP-UHFFFAOYSA-N					compound annotation
0391_010687	nevirapine	C15H14N4O	2.103	4463		Cc1c2NC(=O)c3c(nccc3)N(C3CC3)c2ncc1	InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)	NQDJXKOVJZTUJA-UHFFFAOYSA-N					compound annotation
0391_010688	Ziprasidone	C21H21ClN4OS	2.6151	60854		O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1	InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)	MVWVFYHBGMAFLY-UHFFFAOYSA-N					doublet; compound annotation
0391_010689	Solifenacin	C23H26N2O2	3.1863	154059	C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5	O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1	InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1	FBOUYBDGKBSUES-VXKWHMMOSA-N					doublet; compound annotation
0391_010690	Methoxyfenozide	C22H28N2O3	4.3572	105010		COc1cccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)c1C	InChI=1S/C22H28N2O3/c1-14-11-15(2)13-17(12-14)21(26)24(22(4,5)6)23-20(25)18-9-8-10-19(27-7)16(18)3/h8-13H,1-7H3,(H,23,25)	QCAWEPFNJXQPAN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010692	fenoldopam	C16H16ClNO3	1.1715	3341		Oc1ccc(C2CNCCc3c(Cl)c(O)c(O)cc32)cc1	InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2	TVURRHSHRRELCG-UHFFFAOYSA-N					compound annotation
0391_010693	anisomycin	C14H19NO4	1.5142	253602	CC(=O)O[C@@H]1[C@H](CN[C@@H]1CC2=CC=C(C=C2)OC)O	COc1ccc(CC2NCC(O)C2OC(C)=O)cc1	InChI=1S/C14H19NO4/c1-9(16)19-14-12(15-8-13(14)17)7-10-3-5-11(18-2)6-4-10/h3-6,12-15,17H,7-8H2,1-2H3/t12-,13+,14+/m1/s1	YKJYKKNCCRKFSL-RDBSUJKOSA-N					compound annotation
0391_010694	Rhoifolin	C27H30O14	2.0825	5282150	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O	CC1OC(OC2C(Oc3cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc4c3)OC(CO)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H30O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-8,10,18,20-30,32-36H,9H2,1H3/t10-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1	RPMNUQRUHXIGHK-PYXJVEIZSA-N					removed another duplicate entry; compound annotation
0391_010696	Tryptophol	C10H11NO	2.2204	10685		OCCc1c[nH]c2ccccc12	InChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2	MBBOMCVGYCRMEA-UHFFFAOYSA-N					compound annotation
0391_010697	L-692429	C29H31N7O2	2.8014	121879	CC(C)(CC(=O)N[C@@H]1CCC2=CC=CC=C2N(C1=O)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)N	CC(C)(N)CC(=O)NC1CCc2ccccc2N(Cc2ccc(-c3ccccc3-c3n[nH]nn3)cc2)C1=O	InChI=1S/C29H31N7O2/c1-29(2,30)17-26(37)31-24-16-15-21-7-3-6-10-25(21)36(28(24)38)18-19-11-13-20(14-12-19)22-8-4-5-9-23(22)27-32-34-35-33-27/h3-14,24H,15-18,30H2,1-2H3,(H,31,37)(H,32,33,34,35)/t24-/m1/s1	SBJLJOFPWOYATP-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_010699	PRI-724	C33H35N6O7P	2.9113	71509318	C[C@H]1[C@H]2N([C@H](C(=O)N1CC3=CC=CC4=C3N=CC=C4)CC5=CC=C(C=C5)OP(=O)(O)O)C(=O)CN(N2C(=O)NCC6=CC=CC=C6)C	CC1C2N(C(=O)CN(C)N2C(=O)NCc2ccccc2)C(Cc2ccc(OP(=O)(O)O)cc2)C(=O)N1Cc1cccc2c1nccc2	InChI=1S/C33H35N6O7P/c1-22-31-38(29(40)21-36(2)39(31)33(42)35-19-24-8-4-3-5-9-24)28(18-23-13-15-27(16-14-23)46-47(43,44)45)32(41)37(22)20-26-11-6-10-25-12-7-17-34-30(25)26/h3-17,22,28,31H,18-21H2,1-2H3,(H,35,42)(H2,43,44,45)/t22-,28-,31-/m0/s1	VHOZWHQPEJGPCC-AZXNYEMZSA-N					compound annotation
0391_010700	CCR1 antagonist 8	C22H18FN5O3S	3.0768	52916803		CS(=O)(=O)c1nccc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)c1	InChI=1S/C22H18FN5O3S/c1-32(30,31)20-10-14(6-9-25-20)22(7-8-22)27-21(29)18-11-24-13-19-17(18)12-26-28(19)16-4-2-15(23)3-5-16/h2-6,9-13H,7-8H2,1H3,(H,27,29)	PXQATVYJKMMHAU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010702	PK11007	C15H11ClFN5O3S2	3.3585	16446482		Cc1nnc(NC(=O)c2nc(S(=O)(=O)Cc3ccc(F)cc3)ncc2Cl)s1	InChI=1S/C15H11ClFN5O3S2/c1-8-21-22-14(26-8)20-13(23)12-11(16)6-18-15(19-12)27(24,25)7-9-2-4-10(17)5-3-9/h2-6H,7H2,1H3,(H,20,22,23)	IVZQUWCWXYFPOQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010704	CaCCinh-A01	C18H21NO4S	5.3591	2898877		CC(C)(C)C1CCc2c(C1)sc(NC(=O)c1ccco1)c2C(=O)O	InChI=1S/C18H21NO4S/c1-18(2,3)10-6-7-11-13(9-10)24-16(14(11)17(21)22)19-15(20)12-5-4-8-23-12/h4-5,8,10H,6-7,9H2,1-3H3,(H,19,20)(H,21,22)	ACLUEOBQFRYTQS-UHFFFAOYSA-N					doublet; compound annotation
0391_010705	CaCCinh-A01	C18H21NO4S	5.3621	2898877		CC(C)(C)C1CCc2c(C1)sc(NC(=O)c1ccco1)c2C(=O)O	InChI=1S/C18H21NO4S/c1-18(2,3)10-6-7-11-13(9-10)24-16(14(11)17(21)22)19-15(20)12-5-4-8-23-12/h4-5,8,10H,6-7,9H2,1-3H3,(H,19,20)(H,21,22)	ACLUEOBQFRYTQS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010707	Sophocarpine	C15H22N2O	0.5812	115269	C1C[C@H]2CN3[C@H](CC=CC3=O)[C@@H]4[C@H]2N(C1)CCC4	O=C1C=CCC2C3CCCN4CCCC(CN12)C34	InChI=1S/C15H22N2O/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14/h1,7,11-13,15H,2-6,8-10H2/t11-,12+,13+,15-/m0/s1	AAGFPTSOPGCENQ-JLNYLFASSA-N					compound annotation
0391_010708	Orexin receptor antagonist 3	C21H22N8O3	2.1876	67116386		Cc1cc(C)nc(N2CC3CN(C(=O)c4c([N+](=O)[O-])cccc4-n4nccn4)CC3C2)n1	InChI=1S/C21H22N8O3/c1-13-8-14(2)25-21(24-13)27-11-15-9-26(10-16(15)12-27)20(30)19-17(28-22-6-7-23-28)4-3-5-18(19)29(31)32/h3-8,15-16H,9-12H2,1-2H3	MPDQVXKSEUGRGO-UHFFFAOYSA-N					doublet; compound annotation
0391_010709	Orexin receptor antagonist 3	C21H22N8O3	2.2628	67116386		Cc1cc(C)nc(N2CC3CN(C(=O)c4c([N+](=O)[O-])cccc4-n4nccn4)CC3C2)n1	InChI=1S/C21H22N8O3/c1-13-8-14(2)25-21(24-13)27-11-15-9-26(10-16(15)12-27)20(30)19-17(28-22-6-7-23-28)4-3-5-18(19)29(31)32/h3-8,15-16H,9-12H2,1-2H3	MPDQVXKSEUGRGO-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010711	Ceefourin 1	C11H10N4S3	3.1801	704306		Cn1c(CSc2nc3ccccc3s2)n[nH]c1=S	InChI=1S/C11H10N4S3/c1-15-9(13-14-10(15)16)6-17-11-12-7-4-2-3-5-8(7)18-11/h2-5H,6H2,1H3,(H,14,16)	KVNBVHCJAUXKPJ-UHFFFAOYSA-N					compound annotation
0391_010712	Lu AE98134	C21H23N5O3S	3.6225	2044236		CCCCNS(=O)(=O)c1cc(-c2nnc3c4ccccc4c(C)nn23)c(OC)cc1	InChI=1S/C21H23N5O3S/c1-4-5-12-22-30(27,28)15-10-11-19(29-3)18(13-15)21-24-23-20-17-9-7-6-8-16(17)14(2)25-26(20)21/h6-11,13,22H,4-5,12H2,1-3H3	KLTJHVNRXQKMLY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010714	VU0467154	C17H15F3N4O3S2	3.7385	73774630		Cc1c(C)c2c(nn1)sc(C(=O)NCc1ccc(S(=O)(=O)C(F)(F)F)cc1)c2N	InChI=1S/C17H15F3N4O3S2/c1-8-9(2)23-24-16-12(8)13(21)14(28-16)15(25)22-7-10-3-5-11(6-4-10)29(26,27)17(18,19)20/h3-6H,7,21H2,1-2H3,(H,22,25)	UDSFKIFLJPECRN-UHFFFAOYSA-N					compound annotation
0391_010715	AP-1/NF-kappaB activation inhibitor 1	C13H11F3N4O4	3.8527	44289488		CCOC(=O)c1cnc(C(F)(F)F)nc1NN1C(=O)C=C(C)C1=O	InChI=1S/C13H11F3N4O4/c1-3-24-11(23)7-5-17-12(13(14,15)16)18-9(7)19-20-8(21)4-6(2)10(20)22/h4-5H,3H2,1-2H3,(H,17,18,19)	JWIIKHRJOUQCQG-UHFFFAOYSA-N					compound annotation
0391_010716	(+)-Usnic acid	C18H16O7	4.2499	442614	CC1=C(C(=C2C(=C1O)[C@]3(C(=CC(=C(C3=O)C(=O)C)O)O2)C)C(=O)C)O	CC(=O)C1=C(O)C=C2Oc3c(C(C)=O)c(O)c(C)c(O)c3C2(C)C1=O	InChI=1S/C18H16O7/c1-6-14(22)12(8(3)20)16-13(15(6)23)18(4)10(25-16)5-9(21)11(7(2)19)17(18)24/h5,21-23H,1-4H3/t18-/m1/s1	WEYVVCKOOFYHRW-GOSISDBHSA-N					doublet; compound annotation
0391_010717	halcinonide	C24H32ClFO5	4.4223	443943	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F	CC1(C)OC2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(C(=O)CCl)O1	InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	MUQNGPZZQDCDFT-JNQJZLCISA-N					compound annotation
0391_010718	(+)-Usnic acid	C18H16O7	5.4384	442614	CC1=C(C(=C2C(=C1O)[C@]3(C(=CC(=C(C3=O)C(=O)C)O)O2)C)C(=O)C)O	CC(=O)C1=C(O)C=C2Oc3c(C(C)=O)c(O)c(C)c(O)c3C2(C)C1=O	InChI=1S/C18H16O7/c1-6-14(22)12(8(3)20)16-13(15(6)23)18(4)10(25-16)5-9(21)11(7(2)19)17(18)24/h5,21-23H,1-4H3/t18-/m1/s1	WEYVVCKOOFYHRW-GOSISDBHSA-N					doublet; compound annotation
0391_010719	Phenamil methanesulfonate	C12H12ClN7O	1.8082	135403792		NC(=NC(=O)c1c(N)nc(N)c(Cl)n1)Nc1ccccc1	InChI=1S/C12H12ClN7O/c13-8-10(15)19-9(14)7(18-8)11(21)20-12(16)17-6-4-2-1-3-5-6/h1-5H,(H4,14,15,19)(H3,16,17,20,21)	NIOHELZQFBGCEO-UHFFFAOYSA-N					compound annotation
0391_010720	2,6-DIMETHOXYBENZOIC ACID	C9H10O4	1.8111	15109		COc1c(C(=O)O)c(OC)ccc1	InChI=1S/C9H10O4/c1-12-6-4-3-5-7(13-2)8(6)9(10)11/h3-5H,1-2H3,(H,10,11)	MBIZFBDREVRUHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010722	DPDPE	C30H39N5O7S2	2.2114	104787	CC1([C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(SS1)(C)C)C(=O)O)CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C	CC1(C)SSC(C)(C)C(NC(=O)C(N)Cc2ccc(O)cc2)C(=O)NCC(=O)NC(Cc2ccccc2)C(=O)NC1C(=O)O	InChI=1S/C30H39N5O7S2/c1-29(2)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44-43-29/h5-13,20-21,23-24,36H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20-,21-,23-,24-/m0/s1	MCMMCRYPQBNCPH-WMIMKTLMSA-N					compound annotation
0391_010723	Methylnissolin-3-O-glucoside	C23H26O10	2.5824	101679160	COC1=C(C2=C(C=C1)[C@@H]3COC4=C([C@@H]3O2)C=CC(=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC	COc1c(OC)c2c(cc1)C1COc3c(ccc(OC4OC(CO)C(O)C(O)C4O)c3)C1O2	InChI=1S/C23H26O10/c1-28-14-6-5-11-13-9-30-15-7-10(3-4-12(15)20(13)33-21(11)22(14)29-2)31-23-19(27)18(26)17(25)16(8-24)32-23/h3-7,13,16-20,23-27H,8-9H2,1-2H3/t13-,16+,17+,18-,19+,20-,23+/m0/s1	PCIXSTFFMHVOMF-PBGSHFJYSA-N					compound annotation
0391_010724	L-741,626	C20H21ClN2O	2.7309	133633		OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1	InChI=1S/C20H21ClN2O/c21-17-7-5-16(6-8-17)20(24)9-11-23(12-10-20)14-15-13-22-19-4-2-1-3-18(15)19/h1-8,13,22,24H,9-12,14H2	LLBLNMUONVVVPG-UHFFFAOYSA-N					compound annotation
0391_010725	carvedilol	C24H26N2O4	2.9514	2585		COc1ccccc1OCCNCC(O)COc1cccc2c1c1ccccc1[nH]2	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3	OGHNVEJMJSYVRP-UHFFFAOYSA-N					doublet; compound annotation
0391_010726	carvedilol	C24H26N2O4	2.9543	2585		COc1ccccc1OCCNCC(O)COc1cccc2c1c1ccccc1[nH]2	InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3	OGHNVEJMJSYVRP-UHFFFAOYSA-N					doublet; compound annotation
0391_010727	MARK4 inhibitor 1	C20H18N6O3	3.7219	138454765		COc1ccc(Cn2cc(C(=O)N=Nc3c(O)[nH]c4c(C)cccc34)nn2)cc1	InChI=1S/C20H18N6O3/c1-12-4-3-5-15-17(12)21-20(28)18(15)23-24-19(27)16-11-26(25-22-16)10-13-6-8-14(29-2)9-7-13/h3-9,11,21,28H,10H2,1-2H3	KACGMLSYPGROFF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010729	Tiafenacil	C19H18ClF4N3O5S	3.812	67295585		COC(=O)CCNC(=O)C(C)Sc1c(Cl)cc(F)c(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)c1	InChI=1S/C19H18ClF4N3O5S/c1-9(17(30)25-5-4-16(29)32-3)33-13-7-12(11(21)6-10(13)20)27-15(28)8-14(19(22,23)24)26(2)18(27)31/h6-9H,4-5H2,1-3H3,(H,25,30)	QPTPZPIXUPELRM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010731	TMCB	C11H9Br4N3O2	4.1216	46943415		CN(C)c1nc2c(c(Br)c(Br)c(Br)c2Br)n1CC(=O)O	InChI=1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)	PHAOTASRLQMKBE-UHFFFAOYSA-N					compound annotation
0391_010732	apraclonidine	C9H10Cl2N4	0.713	2216		Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1	InChI=1S/C9H10Cl2N4/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9/h3-4H,1-2,12H2,(H2,13,14,15)	IEJXVRYNEISIKR-UHFFFAOYSA-N					compound annotation
0391_010733	CYANAZINE	C9H13ClN6	2.7642	30773		CCNc1nc(NC(C)(C)C#N)nc(Cl)n1	InChI=1S/C9H13ClN6/c1-4-12-7-13-6(10)14-8(15-7)16-9(2,3)5-11/h4H2,1-3H3,(H2,12,13,14,15,16)	MZZBPDKVEFVLFF-UHFFFAOYSA-N					compound annotation
0391_010734	RBN012759	C19H23FN2O3S	3.1317	138696916		O=c1[nH]c(CSC2CCC(O)CC2)nc2c1c(F)cc(OCC1CC1)c2	InChI=1S/C19H23FN2O3S/c20-15-7-13(25-9-11-1-2-11)8-16-18(15)19(24)22-17(21-16)10-26-14-5-3-12(23)4-6-14/h7-8,11-12,14,23H,1-6,9-10H2,(H,21,22,24)	NKZDEFKPZSLQRF-UHFFFAOYSA-N					doublet; compound annotation
0391_010735	RBN012759	C19H23FN2O3S	3.1351	138696916		O=c1[nH]c(CSC2CCC(O)CC2)nc2c1c(F)cc(OCC1CC1)c2	InChI=1S/C19H23FN2O3S/c20-15-7-13(25-9-11-1-2-11)8-16-18(15)19(24)22-17(21-16)10-26-14-5-3-12(23)4-6-14/h7-8,11-12,14,23H,1-6,9-10H2,(H,21,22,24)	NKZDEFKPZSLQRF-UHFFFAOYSA-N					doublet; compound annotation
0391_010736	TVB-3166	C24H24N4O	3.5433	72947731		Cc1c(C(=O)N2CC(c3ccc(C#N)cc3)C2)cc(-c2n[nH]c(C)c2C)c(C)c1	InChI=1S/C24H24N4O/c1-14-9-15(2)22(10-21(14)23-16(3)17(4)26-27-23)24(29)28-12-20(13-28)19-7-5-18(11-25)6-8-19/h5-10,20H,12-13H2,1-4H3,(H,26,27)	ICDQFUFDAFKCAX-UHFFFAOYSA-N					doublet; compound annotation
0391_010737	TVB-3166	C24H24N4O	3.546	72947731		Cc1c(C(=O)N2CC(c3ccc(C#N)cc3)C2)cc(-c2n[nH]c(C)c2C)c(C)c1	InChI=1S/C24H24N4O/c1-14-9-15(2)22(10-21(14)23-16(3)17(4)26-27-23)24(29)28-12-20(13-28)19-7-5-18(11-25)6-8-19/h5-10,20H,12-13H2,1-4H3,(H,26,27)	ICDQFUFDAFKCAX-UHFFFAOYSA-N					doublet; compound annotation
0391_010738	CICLOPIROX	C12H17NO2	3.6315	2749		Cc1cc(=O)n(O)c(C2CCCCC2)c1	InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3	SCKYRAXSEDYPSA-UHFFFAOYSA-N					compound annotation
0391_010739	PENDIMETHALIN	C13H19N3O4	4.3158	38479		CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]	InChI=1S/C13H19N3O4/c1-5-10(6-2)14-12-11(15(17)18)7-8(3)9(4)13(12)16(19)20/h7,10,14H,5-6H2,1-4H3	CHIFOSRWCNZCFN-UHFFFAOYSA-N					doublet; compound annotation
0391_010740	PENDIMETHALIN	C13H19N3O4	5.6465	38479		CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-]	InChI=1S/C13H19N3O4/c1-5-10(6-2)14-12-11(15(17)18)7-8(3)9(4)13(12)16(19)20/h7,10,14H,5-6H2,1-4H3	CHIFOSRWCNZCFN-UHFFFAOYSA-N					doublet; compound annotation
0391_010741	Sparteine	C15H26N2	0.6263	644020	C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@H]3CCCC4	C1CCN2CC3CC(CN4CCCCC34)C2C1	InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m0/s1	SLRCCWJSBJZJBV-ZQDZILKHSA-N					doublet; compound annotation
0391_010742	Neferine	C38H44N2O6	1.9441	159654	CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)C[C@@H]5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC	COc1ccc(CC2c3cc(Oc4c(O)ccc(CC5c6cc(OC)c(OC)cc6CCN5C)c4)c(OC)cc3CCN2C)cc1	InChI=1S/C38H44N2O6/c1-39-15-14-27-21-36(44-5)38(23-30(27)31(39)17-24-7-10-28(42-3)11-8-24)46-34-19-25(9-12-33(34)41)18-32-29-22-37(45-6)35(43-4)20-26(29)13-16-40(32)2/h7-12,19-23,31-32,41H,13-18H2,1-6H3/t31-,32-/m1/s1	MIBATSHDJRIUJK-ROJLCIKYSA-N					compound annotation
0391_010743	buspirone	C21H31N5O2	2.372	2477		O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1	InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2	QWCRAEMEVRGPNT-UHFFFAOYSA-N					compound annotation
0391_010744	CBR-470-2	C12H13Cl2NO6S2	2.9104	155819525	C1[C@@H]([C@H](CS1(=O)=O)S(=O)(=O)C2=CC(=C(C=C2)Cl)Cl)NCC(=O)O	O=C(O)CNC1CS(=O)(=O)CC1S(=O)(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C12H13Cl2NO6S2/c13-8-2-1-7(3-9(8)14)23(20,21)11-6-22(18,19)5-10(11)15-4-12(16)17/h1-3,10-11,15H,4-6H2,(H,16,17)/t10-,11-/m0/s1	FNQDSYKGBCVHHI-QWRGUYRKSA-N					compound annotation
0391_010745	cilnidipine	C27H28N2O7	5.0548	5282138	CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC=Cc2ccccc2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+	KJEBULYHNRNJTE-DHZHZOJOSA-N					compound annotation
0391_010746	Methylatropine	C18H26NO3+	1.5173	656598	C[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C	C[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	InChI=1S/C18H26NO3/c1-19(2)14-8-9-15(19)11-16(10-14)22-18(21)17(12-20)13-6-4-3-5-7-13/h3-7,14-17,20H,8-12H2,1-2H3/q+1/t14-,15+,16?,17?	PIPAJLPNWZMYQA-RYTJFDOTSA-N					compound annotation
0391_010747	480-66-0	C8H8O4	1.9543	68073		CC(=O)c1c(O)cc(O)cc1O	InChI=1S/C8H8O4/c1-4(9)8-6(11)2-5(10)3-7(8)12/h2-3,10-12H,1H3	XLEYFDVVXLMULC-UHFFFAOYSA-N					compound annotation
0391_010748	Ivabradine	C27H36N2O5	2.2991	132999	CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)C[C@H]3CC4=CC(=C(C=C34)OC)OC	COc1c(OC)cc2CC(=O)N(CCCN(C)CC3Cc4cc(OC)c(OC)cc43)CCc2c1	InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/t21-/m1/s1	ACRHBAYQBXXRTO-OAQYLSRUSA-N					compound annotation
0391_010749	Rimegepant	C28H28F2N6O3	2.4948	51049968	C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6	NC1c2c(nccc2)C(OC(=O)N2CCC(n3c(=O)[nH]c4c3cccn4)CC2)CCC1c1c(F)c(F)ccc1	InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/t18-,22+,24-/m0/s1	KRNAOFGYEFKHPB-ANJVHQHFSA-N					removed another duplicate entry; compound annotation
0391_010751	pimethixene	C19H19NS	3.0506	4822		CN1CCC(=C2c3ccccc3Sc3ccccc23)CC1	InChI=1S/C19H19NS/c1-20-12-10-14(11-13-20)19-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)19/h2-9H,10-13H2,1H3	NZLVRVYNQYGMAB-UHFFFAOYSA-N					compound annotation
0391_010752	testosterone propionate	C22H32O3	5.4013	5995	CCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1	PDMMFKSKQVNJMI-BLQWBTBKSA-N					compound annotation
0391_010753	Solriamfetol	C10H14N2O2	1.0048	10130337	C1=CC=C(C=C1)C[C@H](COC(=O)N)N	NC(=O)OCC(N)Cc1ccccc1	InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1	UCTRAOBQFUDCSR-SECBINFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_010755	lafutidine	C22H29N3O4S	1.7297	5282136	C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3	O=C(C[S+]([O-])Cc1ccco1)NCC=CCOc1cc(CN2CCCCC2)ccn1	InChI=1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2-	KMZQAVXSMUKBPD-DJWKRKHSSA-N					removed another duplicate entry; compound annotation
0391_010757	2'-Aminoacetophenone	C8H9NO	2.3052	11086		CC(=O)c1ccccc1N	InChI=1S/C8H9NO/c1-6(10)7-4-2-3-5-8(7)9/h2-5H,9H2,1H3	GTDQGKWDWVUKTI-UHFFFAOYSA-N					compound annotation
0391_010758	Madecassoside	C48H78O20	2.4854	45356919	C[C@@H]1CC[C@@]2(CC[C@]3(C(=CC[C@H]4[C@]3(C[C@H]([C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)O)C)[C@@H]2[C@H]1C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O)O)O)O	CC1CCC2(C(=O)OC3OC(COC4OC(CO)C(OC5OC(C)C(O)C(O)C5O)C(O)C4O)C(O)C(O)C3O)CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(CO)C5C(O)CC43C)C2C1C	InChI=1S/C48H78O20/c1-19-10-11-48(13-12-46(6)22(28(48)20(19)2)8-9-27-44(4)14-24(52)39(61)45(5,18-50)38(44)23(51)15-47(27,46)7)43(62)68-42-35(59)32(56)30(54)26(66-42)17-63-40-36(60)33(57)37(25(16-49)65-40)67-41-34(58)31(55)29(53)21(3)64-41/h8,19-21,23-42,49-61H,9-18H2,1-7H3/t19-,20+,21+,23-,24-,25-,26-,27-,28+,29+,30-,31-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42+,44-,45+,46+,47-,48+/m1/s1	BNMGUJRJUUDLHW-CIZDPPTDSA-N					compound annotation
0391_010759	OXCARBAZEPINE	C15H12N2O2	2.5696	34312		NC(=O)N1c2ccccc2CC(=O)c2ccccc21	InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)	CTRLABGOLIVAIY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010761	Enzastaurin	C32H29N5O2	3.1493	176167		Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21	InChI=1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39)	AXRCEOKUDYDWLF-UHFFFAOYSA-N					compound annotation
0391_010762	JNK Inhibitor VIII	C18H20N4O4	3.9484	11624601		CCOc1c(C#N)c(N)cc(NC(=O)Cc2c(OC)ccc(OC)c2)n1	InChI=1S/C18H20N4O4/c1-4-26-18-13(10-19)14(20)9-16(22-18)21-17(23)8-11-7-12(24-2)5-6-15(11)25-3/h5-7,9H,4,8H2,1-3H3,(H3,20,21,22,23)	KQMPRSZTUSSXND-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010764	Psoralidin	C20H16O5	4.3011	5281806		CC(C)=CCc1cc2c(cc1O)oc(=O)c1c2oc2c1ccc(O)c2	InChI=1S/C20H16O5/c1-10(2)3-4-11-7-14-17(9-15(11)22)25-20(23)18-13-6-5-12(21)8-16(13)24-19(14)18/h3,5-9,21-22H,4H2,1-2H3	YABIJLLNNFURIJ-UHFFFAOYSA-N					compound annotation
0391_010765	Ribociclib	C23H30N8O	1.7176	44631912		CN(C)C(=O)c1cc2cnc(Nc3ncc(N4CCNCC4)cc3)nc2n1C1CCCC1	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	RHXHGRAEPCAFML-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010767	Hyperoside	C21H20O12	1.8264	5281643	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15+,17+,18-,21+/m1/s1	OVSQVDMCBVZWGM-DTGCRPNFSA-N					removed another duplicate entry; compound annotation
0391_010769	AZD-1940	C20H29F2N3O2S	2.8803	11675994		CCS(=O)(=O)Nc1cc2c(cc1)n(CC1CCC(F)(F)CC1)c(C(C)(C)C)n2	InChI=1S/C20H29F2N3O2S/c1-5-28(26,27)24-15-6-7-17-16(12-15)23-18(19(2,3)4)25(17)13-14-8-10-20(21,22)11-9-14/h6-7,12,14,24H,5,8-11,13H2,1-4H3	ZAGGGZCIFUQHOH-UHFFFAOYSA-N					compound annotation
0391_010770	926927-42-6	C15H13F5N2O2	3.0028	15953875		CCOC(=O)C1=Cc2c(cc(C(F)(F)C(F)(F)F)cc2)N=C(N)C1	InChI=1S/C15H13F5N2O2/c1-2-24-13(23)9-5-8-3-4-10(14(16,17)15(18,19)20)7-11(8)22-12(21)6-9/h3-5,7H,2,6H2,1H3,(H2,21,22)	ICZPANLPYRTVSF-UHFFFAOYSA-N					compound annotation
0391_010771	Asimadoline	C27H30N2O2	3.2476	179340	CN([C@H](CN1CC[C@@H](C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4	CN(C(=O)C(c1ccccc1)c1ccccc1)C(CN1CCC(O)C1)c1ccccc1	InChI=1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1	JHLHNYVMZCADTC-LOSJGSFVSA-N					removed another duplicate entry; compound annotation
0391_010773	aclarubicin	C42H53NO15	3.6591	86289437	CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)[O-])O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)[NH+](C)C)O	CCC1(O)CC(OC2CC(N(C)C)C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)c2c(O)c3c(cc2C1C(=O)OC)C(=O)c1c(C3=O)c(O)ccc1	InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1	USZYSDMBJDPRIF-SVEJIMAYSA-N					compound annotation
0391_010774	VII-31	C23H25NO5S	4.3461	146673076		COc1ccc(CN(C(=O)Cc2cccs2)c2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C23H25NO5S/c1-26-18-9-7-16(8-10-18)15-24(22(25)14-19-6-5-11-30-19)17-12-20(27-2)23(29-4)21(13-17)28-3/h5-13H,14-15H2,1-4H3	CGVFRZMQURRQIE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010776	544678-85-5	C22H20F2N4O2	4.6296	5289110		Cc1c(F)ccc(CNC(=O)c2cc(C(=O)NCc3cc(C)c(F)cc3)ncn2)c1	InChI=1S/C22H20F2N4O2/c1-13-7-15(3-5-17(13)23)10-25-21(29)19-9-20(28-12-27-19)22(30)26-11-16-4-6-18(24)14(2)8-16/h3-9,12H,10-11H2,1-2H3,(H,25,29)(H,26,30)	PYFRREJCFXFNRR-UHFFFAOYSA-N					compound annotation
0391_010777	LTX-401	C23H33N3O	2.4584	51050457		NCCNC(=O)C(CN)(CCCc1ccccc1)CCCc1ccccc1	InChI=1S/C23H33N3O/c24-17-18-26-22(27)23(19-25,15-7-13-20-9-3-1-4-10-20)16-8-14-21-11-5-2-6-12-21/h1-6,9-12H,7-8,13-19,24-25H2,(H,26,27)	JVOZATDVXUSPKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010779	Binimetinib	C17H15BrF2N4O3	2.7505	10288191		Cn1cnc2c1cc(C(=O)NOCCO)c(Nc1c(F)cc(Br)cc1)c2F	InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	ACWZRVQXLIRSDF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010781	Nintedanib	C31H33N5O4	2.9881	135423438		COC(=O)c1cc2c(cc1)c(C(=Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)c(O)[nH]2	InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3	CPMDPSXJELVGJG-UHFFFAOYSA-N					doublet; compound annotation
0391_010782	Nintedanib	C31H33N5O4	2.9908	135423438		COC(=O)c1cc2c(cc1)c(C(=Nc1ccc(N(C)C(=O)CN3CCN(C)CC3)cc1)c1ccccc1)c(O)[nH]2	InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3	CPMDPSXJELVGJG-UHFFFAOYSA-N					doublet; compound annotation
0391_010783	BNTA	C17H11BrClNO3S2	3.9055	2819453		O=C(Nc1c(Br)scc1S(=O)(=O)c1ccccc1)c1ccccc1Cl	InChI=1S/C17H11BrClNO3S2/c18-16-15(20-17(21)12-8-4-5-9-13(12)19)14(10-24-16)25(22,23)11-6-2-1-3-7-11/h1-10H,(H,20,21)	OCNJYMSNHNAZON-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010785	TC-G 1005	C25H25N3O2	4.2906	71450251		Cc1cc(Oc2ccncc2C(=O)N2CCN(C3CC3)c3ccccc32)c(C)cc1	InChI=1S/C25H25N3O2/c1-17-7-8-18(2)24(15-17)30-23-11-12-26-16-20(23)25(29)28-14-13-27(19-9-10-19)21-5-3-4-6-22(21)28/h3-8,11-12,15-16,19H,9-10,13-14H2,1-2H3	JQULIQJSYPZQMA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010787	Flavokawain C	C17H16O5	2.9729	6293081	COC1=CC(=C(C(=C1)OC)C(=O)/C=C/C2=CC=C(C=C2)O)O	COc1cc(O)c(C(=O)C=Cc2ccc(O)cc2)c(OC)c1	InChI=1S/C17H16O5/c1-21-13-9-15(20)17(16(10-13)22-2)14(19)8-5-11-3-6-12(18)7-4-11/h3-10,18,20H,1-2H3/b8-5+	UXUFMIJZNYXWDX-VMPITWQZSA-N					doublet; compound annotation
0391_010788	Stafia-1	C24H27O10P	3.0347	146681206		COc1c(OC)c(OC)cc(-c2cc(OP(=O)(O)O)cc(-c3cc(OC)c(OC)c(OC)c3)c2)c1	InChI=1S/C24H27O10P/c1-28-19-10-16(11-20(29-2)23(19)32-5)14-7-15(9-18(8-14)34-35(25,26)27)17-12-21(30-3)24(33-6)22(13-17)31-4/h7-13H,1-6H3,(H2,25,26,27)	UGUOUFLCZFMHNI-UHFFFAOYSA-N					compound annotation
0391_010789	imipramine	C19H24N2	3.0896	3696		CN(C)CCCN1c2ccccc2CCc2ccccc21	InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3	BCGWQEUPMDMJNV-UHFFFAOYSA-N					compound annotation
0391_010790	TOFOGLIFLOZIN	C22H26O6	3.2906	46908929	CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2	CCc1ccc(Cc2cc3c(cc2)COC32OC(CO)C(O)C(O)C2O)cc1	InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1	VWVKUNOPTJGDOB-BDHVOXNPSA-N					compound annotation
0391_010791	Resorcinolnaphthalein	C24H14O5	3.7096	337218		O=C1OC2(c3ccc(O)cc3Oc3c2ccc(O)c3)c2cccc3cccc1c23	InChI=1S/C24H14O5/c25-14-7-9-17-20(11-14)28-21-12-15(26)8-10-18(21)24(17)19-6-2-4-13-3-1-5-16(22(13)19)23(27)29-24/h1-12,25-26H	FTUOFHGOGJGQAB-UHFFFAOYSA-N					doublet; compound annotation
0391_010792	Resorcinolnaphthalein	C24H14O5	3.713	337218		O=C1OC2(c3ccc(O)cc3Oc3c2ccc(O)c3)c2cccc3cccc1c23	InChI=1S/C24H14O5/c25-14-7-9-17-20(11-14)28-21-12-15(26)8-10-18(21)24(17)19-6-2-4-13-3-1-5-16(22(13)19)23(27)29-24/h1-12,25-26H	FTUOFHGOGJGQAB-UHFFFAOYSA-N					doublet; compound annotation
0391_010793	LCL521	C31H52N4O7	3.9297	46200045	CCCCCCCCCCCCCC(=O)N[C@H](COC(=O)CN(C)C)[C@@H](C1=CC=C(C=C1)[N+](=O)[O-])OC(=O)CN(C)C	CCCCCCCCCCCCCC(=O)NC(COC(=O)CN(C)C)C(OC(=O)CN(C)C)c1ccc([N+](=O)[O-])cc1	InChI=1S/C31H52N4O7/c1-6-7-8-9-10-11-12-13-14-15-16-17-28(36)32-27(24-41-29(37)22-33(2)3)31(42-30(38)23-34(4)5)25-18-20-26(21-19-25)35(39)40/h18-21,27,31H,6-17,22-24H2,1-5H3,(H,32,36)/t27-,31-/m1/s1	ANWWJORIPQKJFW-DLFZDVPBSA-N					doublet; compound annotation
0391_010794	Flavokawain C	C17H16O5	4.1379	6293081	COC1=CC(=C(C(=C1)OC)C(=O)/C=C/C2=CC=C(C=C2)O)O	COc1cc(O)c(C(=O)C=Cc2ccc(O)cc2)c(OC)c1	InChI=1S/C17H16O5/c1-21-13-9-15(20)17(16(10-13)22-2)14(19)8-5-11-3-6-12(18)7-4-11/h3-10,18,20H,1-2H3/b8-5+	UXUFMIJZNYXWDX-VMPITWQZSA-N					doublet; compound annotation
0391_010795	dacarbazine	C6H10N6O	0.4855	135398738	CN(C)/N=N/C1=C(NC=N1)C(=O)N	CN(C)N=Nc1c(C(N)=O)[nH]cn1	InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+	FDKXTQMXEQVLRF-ZHACJKMWSA-N					removed another duplicate entry; compound annotation
0391_010797	theophylline	C7H8N4O2	0.9229	2153		Cn1c(=O)c2c(nc[nH]2)n(C)c1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	ZFXYFBGIUFBOJW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010799	biotin	C10H16N2O3S	1.4923	171548	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)O)NC(=O)N2	O=C(O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1	YBJHBAHKTGYVGT-ZKWXMUAHSA-N					compound annotation
0391_010800	Rapacuronium	C37H61N2O4+	2.6002	5311399	CCC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C	C=CC[N+]1(C2CC3C4CCC5CC(OC(C)=O)C(N6CCCCC6)CC5(C)C4CCC3(C)C2OC(=O)CC)CCCCC1	InChI=1S/C37H61N2O4/c1-6-20-39(21-12-9-13-22-39)32-24-30-28-15-14-27-23-33(42-26(3)40)31(38-18-10-8-11-19-38)25-37(27,5)29(28)16-17-36(30,4)35(32)43-34(41)7-2/h6,27-33,35H,1,7-25H2,2-5H3/q+1/t27-,28+,29-,30-,31-,32-,33-,35-,36-,37-/m0/s1	HTIKWNNIPGXLGM-YLINKJIISA-N					compound annotation
0391_010801	2-(phenylamino)benzamide	C13H12N2O	3.4953	96455		NC(=O)c1ccccc1Nc1ccccc1	InChI=1S/C13H12N2O/c14-13(16)11-8-4-5-9-12(11)15-10-6-2-1-3-7-10/h1-9,15H,(H2,14,16)	JKWQUMKCVDUICQ-UHFFFAOYSA-N					compound annotation
0391_010802	ceritinib	C28H36ClN5O3S	3.7866	57379345		Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)	VERWOWGGCGHDQE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010804	AMPK activator 4	C24H21ClN2O3	5.2354	154573764		CC(C)(Oc1ccc(Cl)cc1)C(=O)Nc1ccc(OCc2ccc(C#N)cc2)cc1	InChI=1S/C24H21ClN2O3/c1-24(2,30-22-11-7-19(25)8-12-22)23(28)27-20-9-13-21(14-10-20)29-16-18-5-3-17(15-26)4-6-18/h3-14H,16H2,1-2H3,(H,27,28)	OSSMPMZJYDZMFX-UHFFFAOYSA-N					compound annotation
0391_010805	Prunin	C21H22O10	2.1255	92794	C1[C@H](OC2=CC(=CC(=C2C1=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O	O=C1CC(c2ccc(O)cc2)Oc2cc(OC3OC(CO)C(O)C(O)C3O)cc(O)c12	InChI=1S/C21H22O10/c22-8-16-18(26)19(27)20(28)21(31-16)29-11-5-12(24)17-13(25)7-14(30-15(17)6-11)9-1-3-10(23)4-2-9/h1-6,14,16,18-24,26-28H,7-8H2/t14-,16+,18+,19-,20+,21+/m0/s1	DLIKSSGEMUFQOK-SFTVRKLSSA-N					compound annotation
0391_010806	7,4'-Dihydroxyflavone	C15H10O4	2.3292	5282073		O=c1cc(-c2ccc(O)cc2)oc2c1ccc(O)c2	InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-8,16-17H	LCAWNFIFMLXZPQ-UHFFFAOYSA-N					compound annotation
0391_010807	Almonertinib	C30H35N7O2	2.7449	121280087		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)	DOEOECWDNSEFDN-UHFFFAOYSA-N					doublet; compound annotation
0391_010808	doxepin	C19H21NO	2.8016	667477	CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31	CN(C)CCC=C1c2ccccc2COc2ccccc12	InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+	ODQWQRRAPPTVAG-GZTJUZNOSA-N					compound annotation
0391_010809	thiothixene	C23H29N3O2S2	2.9309	941651	CN1CCN(CC1)CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	CN1CCN(CCC=C2c3ccccc3Sc3c2cc(S(=O)(=O)N(C)C)cc3)CC1	InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-	GFBKORZTTCHDGY-UWVJOHFNSA-N					doublet; compound annotation
0391_010810	thiothixene	C23H29N3O2S2	3.1008	941651	CN1CCN(CC1)CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C	CN1CCN(CCC=C2c3ccccc3Sc3c2cc(S(=O)(=O)N(C)C)cc3)CC1	InChI=1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8-	GFBKORZTTCHDGY-UWVJOHFNSA-N					doublet; removed another duplicate entry; compound annotation
0391_010812	MR-L2	C19H16Cl3FN4O	5.0048	138911347		CCc1nc(-c2cc(F)c(Cl)cc2)nn1CC(=O)NCc1cc(Cl)cc(Cl)c1	InChI=1S/C19H16Cl3FN4O/c1-2-17-25-19(12-3-4-15(22)16(23)7-12)26-27(17)10-18(28)24-9-11-5-13(20)8-14(21)6-11/h3-8H,2,9-10H2,1H3,(H,24,28)	JXACCOKEEPXHCF-UHFFFAOYSA-N					compound annotation
0391_010813	TED-347	C15H11ClF3NO	5.3259	137796964		O=C(CCl)c1ccccc1Nc1cccc(C(F)(F)F)c1	InChI=1S/C15H11ClF3NO/c16-9-14(21)12-6-1-2-7-13(12)20-11-5-3-4-10(8-11)15(17,18)19/h1-8,20H,9H2	JPVDFGYNLUBCSD-UHFFFAOYSA-N					compound annotation
0391_010814	Sulforaphene	C6H9NOS2	1.8278	6433206	CS(=O)/C=C/CCN=C=S	C[S+]([O-])C=CCCN=C=S	InChI=1S/C6H9NOS2/c1-10(8)5-3-2-4-7-6-9/h3,5H,2,4H2,1H3/b5-3+	QKGJFQMGPDVOQE-HWKANZROSA-N					compound annotation
0391_010815	Dilazep	C31H44N2O10	2.3929	3074		COc1c(OC)c(OC)cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)c1	InChI=1S/C31H44N2O10/c1-36-24-18-22(19-25(37-2)28(24)40-5)30(34)42-16-8-12-32-10-7-11-33(15-14-32)13-9-17-43-31(35)23-20-26(38-3)29(41-6)27(21-23)39-4/h18-21H,7-17H2,1-6H3	QVZCXCJXTMIDME-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010817	ZZW-115	C24H31F3N4S	2.8284	25010688		CN(C)CCN1CCN(CCCN2c3ccccc3Sc3c2cc(C(F)(F)F)cc3)CC1	InChI=1S/C24H31F3N4S/c1-28(2)12-13-30-16-14-29(15-17-30)10-5-11-31-20-6-3-4-7-22(20)32-23-9-8-19(18-21(23)31)24(25,26)27/h3-4,6-9,18H,5,10-17H2,1-2H3	HUDONDPCYIGAMQ-UHFFFAOYSA-N					compound annotation
0391_010818	Neriifolin	C30H46O8	3.4169	441867	C[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C)O)OC)O	COC1C(O)C(C)OC(OC2CCC3(C)C(CCC4C3CCC3(C)C(C5=CC(=O)OC5)CCC43O)C2)C1O	InChI=1S/C30H46O8/c1-16-24(32)26(35-4)25(33)27(37-16)38-19-7-10-28(2)18(14-19)5-6-22-21(28)8-11-29(3)20(9-12-30(22,29)34)17-13-23(31)36-15-17/h13,16,18-22,24-27,32-34H,5-12,14-15H2,1-4H3/t16-,18+,19-,20+,21-,22+,24-,25-,26+,27-,28-,29+,30-/m0/s1	VPUNMTHWNSJUOG-BAOINKAISA-N					removed another duplicate entry; compound annotation
0391_010820	Cimicifugoside M	C35H56O9	4.0523	15541911	C[C@@H]1C[C@@H]2[C@H](O[C@]3([C@H]1[C@]4(CC[C@@]56C[C@@]57CC[C@@H](C([C@@H]7CC[C@H]6[C@@]4([C@H]3O)C)(C)C)O[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O)C)O2)C(C)(C)O	CC1CC2OC3(OC2C(C)(C)O)C1C1(C)CCC24CC25CCC(OC2OCC(O)C(O)C2O)C(C)(C)C5CCC4C1(C)C3O	InChI=1S/C35H56O9/c1-17-14-19-26(30(4,5)40)44-35(43-19)25(17)31(6)12-13-34-16-33(34)11-10-22(42-27-24(38)23(37)18(36)15-41-27)29(2,3)20(33)8-9-21(34)32(31,7)28(35)39/h17-28,36-40H,8-16H2,1-7H3/t17-,18+,19-,20+,21+,22+,23+,24-,25-,26+,27+,28-,31-,32-,33-,34+,35+/m1/s1	BTPYUWOBZFGKAI-BKJHYQRZSA-N					compound annotation
0391_010821	dehydropachymic acid	C33H50O5	5.9718	15226717	CC(C)C(=C)CC[C@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)OC(=O)C)C)C)C)O)C(=O)O	C=C(CCC(C(=O)O)C1C(O)CC2(C)C3=CCC4C(C)(CCC(OC(C)=O)C4(C)C)C3=CCC12C)C(C)C	InChI=1S/C33H50O5/c1-19(2)20(3)10-11-22(29(36)37)28-25(35)18-33(9)24-12-13-26-30(5,6)27(38-21(4)34)15-16-31(26,7)23(24)14-17-32(28,33)8/h12,14,19,22,25-28,35H,3,10-11,13,15-18H2,1-2,4-9H3,(H,36,37)/t22-,25-,26+,27+,28+,31-,32-,33+/m1/s1	RWIALJIVPUCERT-DRCQUEPLSA-N					compound annotation
0391_010822	racanisodamine	C17H23NO4	1.2036	2198		CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C(O)C2	InChI=1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3	WTQYWNWRJNXDEG-UHFFFAOYSA-N					doublet; compound annotation
0391_010823	racanisodamine	C17H23NO4	1.3415	2198		CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C(O)C2	InChI=1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3	WTQYWNWRJNXDEG-UHFFFAOYSA-N					doublet; compound annotation
0391_010824	Dibutyryl-cGMP (sodium)	C18H24N5O9P	2.0955	135488018	CCCC(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@H]4[C@H](O3)COP(=O)(O4)O)OC(=O)CCC	CCCC(=O)Nc1nc(=O)c2c([nH]1)n(C1OC3COP(=O)(O)OC3C1OC(=O)CCC)cn2	InChI=1S/C18H24N5O9P/c1-3-5-10(24)20-18-21-15-12(16(26)22-18)19-8-23(15)17-14(31-11(25)6-4-2)13-9(30-17)7-29-33(27,28)32-13/h8-9,13-14,17H,3-7H2,1-2H3,(H,27,28)(H2,20,21,22,24,26)/t9-,13-,14-,17-/m1/s1	SWTMOFFYOXKQNN-KRQFVHPKSA-N					compound annotation
0391_010825	2-Methyl-5-((4-(methyl(3-methyl-1H-indazol-6-yl)amino)pyrimidin-2-yl)amino)benzenesulfonamide	C20H21N7O2S	2.3909	10202534		Cc1c(S(N)(=O)=O)cc(Nc2nccc(N(C)c3cc4n[nH]c(C)c4cc3)n2)cc1	InChI=1S/C20H21N7O2S/c1-12-4-5-14(10-18(12)30(21,28)29)23-20-22-9-8-19(24-20)27(3)15-6-7-16-13(2)25-26-17(16)11-15/h4-11H,1-3H3,(H,25,26)(H2,21,28,29)(H,22,23,24)	BRBRXNGJZMGEHY-UHFFFAOYSA-N					compound annotation
0391_010826	BPN-15606	C23H23FN6O	2.6599	121305852	CC1=CC(=NN=C1N[C@@H](C)C2=CC=C(C=C2)F)C3=NC(=C(C=C3)N4C=C(N=C4)C)OC	COc1c(-n2cnc(C)c2)ccc(-c2nnc(NC(C)c3ccc(F)cc3)c(C)c2)n1	InChI=1S/C23H23FN6O/c1-14-11-20(28-29-22(14)26-16(3)17-5-7-18(24)8-6-17)19-9-10-21(23(27-19)31-4)30-12-15(2)25-13-30/h5-13,16H,1-4H3,(H,26,29)/t16-/m0/s1	JZCREVMHGYOLRL-INIZCTEOSA-N					compound annotation
0391_010827	diclofenac	C14H11Cl2NO2	4.3087	3033		O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	DCOPUUMXTXDBNB-UHFFFAOYSA-N					doublet; compound annotation
0391_010828	acebutolol	C18H28N2O4	1.8106	1978		CCCC(=O)Nc1cc(C(C)=O)c(OCC(O)CNC(C)C)cc1	InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)	GOEMGAFJFRBGGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010830	25679-24-7	C49H62N10O13S2	2.7558	444998	CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CC(=O)O)N	CSCCC(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(N)CC(=O)O)C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(N)=O	InChI=1S/C49H62N10O13S2/c1-73-18-16-34(55-47(70)37(21-28-12-14-30(60)15-13-28)58-44(67)32(50)23-41(62)63)45(68)53-26-40(61)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(71)56-35(17-19-74-2)46(69)59-39(24-42(64)65)49(72)57-36(43(51)66)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52,60H,16-24,26,50H2,1-2H3,(H2,51,66)(H,53,68)(H,54,61)(H,55,70)(H,56,71)(H,57,72)(H,58,67)(H,59,69)(H,62,63)(H,64,65)/t32-,34-,35-,36-,37-,38-,39-/m0/s1	OIXQINQYMGNCII-YRVFCXMDSA-N					compound annotation
0391_010831	Methyl indole-3-carboxylate	C10H9NO2	2.9161	589098		COC(=O)c1c[nH]c2ccccc12	InChI=1S/C10H9NO2/c1-13-10(12)8-6-11-9-5-3-2-4-7(8)9/h2-6,11H,1H3	QXAUTQFAWKKNLM-UHFFFAOYSA-N					compound annotation
0391_010832	Tolcapone	C14H11NO5	3.748	4659569		Cc1ccc(C(=O)c2cc([N+](=O)[O-])c(O)c(O)c2)cc1	InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3	MIQPIUSUKVNLNT-UHFFFAOYSA-N					compound annotation
0391_010833	isobutyrylcarnitine	C11H22NO4+	0.7755	168380	CC(C)C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CC(C)C(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C11H21NO4/c1-8(2)11(15)16-9(6-10(13)14)7-12(3,4)5/h8-9H,6-7H2,1-5H3/p+1/t9-/m1/s1	LRCNOZRCYBNMEP-SECBINFHSA-O					compound annotation
0391_010834	1-Phenyl-2-(pyridin-2-yl)ethanamine	C13H14N2	0.9855	3038485		NC(Cc1ccccn1)c1ccccc1	InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2	FWUQWDCOOWEXRY-UHFFFAOYSA-N					compound annotation
0391_010835	minaprine	C17H22N4O	1.4477	4199		Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1	InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)	LDMWSLGGVTVJPG-UHFFFAOYSA-N					compound annotation
0391_010836	168705-70-2	C11H13NO3	2.3179	9837165		CC(=O)N(C)Cc1cc2c(cc1)OCO2	InChI=1S/C11H13NO3/c1-8(13)12(2)6-9-3-4-10-11(5-9)15-7-14-10/h3-5H,6-7H2,1-2H3	JIWDGIYBLGMPRV-UHFFFAOYSA-N					compound annotation
0391_010837	dansyl glutathione	C22H28N4O8S2	2.3866	129723635	CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O	CN(C)c1cccc2c1cccc2S(=O)(=O)NC(CCC(=O)NC(CS)C(=O)NCC(=O)O)C(=O)O	InChI=1S/C22H28N4O8S2/c1-26(2)17-7-3-6-14-13(17)5-4-8-18(14)36(33,34)25-15(22(31)32)9-10-19(27)24-16(12-35)21(30)23-11-20(28)29/h3-8,15-16,25,35H,9-12H2,1-2H3,(H,23,30)(H,24,27)(H,28,29)(H,31,32)/t15-,16-/m0/s1	FFXGOBFBYCOXAJ-HOTGVXAUSA-N					compound annotation
0391_010838	Byakangelicol	C17H16O6	2.6887	3055167	CC1([C@H](O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C	COc1c2ccoc2c(OCC2OC2(C)C)c2c1ccc(=O)o2	InChI=1S/C17H16O6/c1-17(2)11(23-17)8-21-16-14-10(6-7-20-14)13(19-3)9-4-5-12(18)22-15(9)16/h4-7,11H,8H2,1-3H3/t11-/m1/s1	ORBITTMJKIGFNH-LLVKDONJSA-N					doublet; compound annotation
0391_010839	Byakangelicol	C17H16O6	3.3224	3055167	CC1([C@H](O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C	COc1c2ccoc2c(OCC2OC2(C)C)c2c1ccc(=O)o2	InChI=1S/C17H16O6/c1-17(2)11(23-17)8-21-16-14-10(6-7-20-14)13(19-3)9-4-5-12(18)22-15(9)16/h4-7,11H,8H2,1-3H3/t11-/m1/s1	ORBITTMJKIGFNH-LLVKDONJSA-N					doublet; compound annotation
0391_010840	WDR5-IN-4	C25H22Cl2FN5O	3.418	138319680		Cc1c(-c2cc(C(=O)NCc3cc(Cl)c(Cl)cc3)cc(Cn3ccn(C)c3=N)c2)ccc(F)n1	InChI=1S/C25H22Cl2FN5O/c1-15-20(4-6-23(28)31-15)18-9-17(14-33-8-7-32(2)25(33)29)10-19(12-18)24(34)30-13-16-3-5-21(26)22(27)11-16/h3-12,29H,13-14H2,1-2H3,(H,30,34)	ZPVQIJIWGMKMQN-UHFFFAOYSA-N					compound annotation
0391_010841	Byakangelicol	C17H16O6	3.6255	3055167	CC1([C@H](O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C	COc1c2ccoc2c(OCC2OC2(C)C)c2c1ccc(=O)o2	InChI=1S/C17H16O6/c1-17(2)11(23-17)8-21-16-14-10(6-7-20-14)13(19-3)9-4-5-12(18)22-15(9)16/h4-7,11H,8H2,1-3H3/t11-/m1/s1	ORBITTMJKIGFNH-LLVKDONJSA-N					doublet; removed another duplicate entry; compound annotation
0391_010843	Carboxyamidotriazole	C17H12Cl3N5O2	4.0914	108144		NC(=O)c1c(N)n(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)nn1	InChI=1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27)	WNRZHQBJSXRYJK-UHFFFAOYSA-N					doublet; compound annotation
0391_010844	LMT-28	C17H29NO4	4.931	49846977	CCCCCC(=C)[C@H]([C@H](C)C(=O)N1[C@H](COC1=O)C(C)C)O	C=C(CCCCC)C(O)C(C)C(=O)N1C(=O)OCC1C(C)C	InChI=1S/C17H29NO4/c1-6-7-8-9-12(4)15(19)13(5)16(20)18-14(11(2)3)10-22-17(18)21/h11,13-15,19H,4,6-10H2,1-3,5H3/t13-,14+,15+/m0/s1	UDXWSYOXIRPYFK-RRFJBIMHSA-N					compound annotation
0391_010845	clonidine	C9H9Cl2N3	1.0526	2803		Clc1cccc(Cl)c1NC1=NCCN1	InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)	GJSURZIOUXUGAL-UHFFFAOYSA-N					doublet; compound annotation
0391_010846	benfotiamine	C19H23N4O6PS	1.5261	3032771	CC1=NC=C(C(=N1)N)CN(C=O)/C(=C(/CCOP(=O)(O)O)\SC(=O)C2=CC=CC=C2)/C	CC(=C(CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N	InChI=1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13-	BTNNPSLJPBRMLZ-LGMDPLHJSA-N					compound annotation
0391_010847	sulfasalazine	C18H14N4O5S	3.0442	5339		O=C(O)c1c(O)ccc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)c1	InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)	NCEXYHBECQHGNR-UHFFFAOYSA-N					compound annotation
0391_010848	Valrubicin	C34H36F3NO13	5.1381	454216	CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O	CCCCC(=O)OCC(=O)C1(O)Cc2c(c(O)c3C(=O)c4c(cccc4OC)C(=O)c3c2O)C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1	InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1	ZOCKGBMQLCSHFP-KQRAQHLDSA-N					compound annotation
0391_010849	Dibenzoylmethane	C15H12O2	5.1583	8433		O=C(CC(=O)c1ccccc1)c1ccccc1	InChI=1S/C15H12O2/c16-14(12-7-3-1-4-8-12)11-15(17)13-9-5-2-6-10-13/h1-10H,11H2	NZZIMKJIVMHWJC-UHFFFAOYSA-N					compound annotation
0391_010850	PHTHALIDE	C8H6O2	1.7341	6885		O=C1OCc2ccccc12	InChI=1S/C8H6O2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2	WNZQDUSMALZDQF-UHFFFAOYSA-N					compound annotation
0391_010851	38048-32-7	C17H17N5O6S	2.8217	65407	C1=CC(=CC=C1CSC2=NC=NC3=C2N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)[N+](=O)[O-]	O=[N+]([O-])c1ccc(CSc2ncnc3c2ncn3C2OC(CO)C(O)C2O)cc1	InChI=1S/C17H17N5O6S/c23-5-11-13(24)14(25)17(28-11)21-8-20-12-15(21)18-7-19-16(12)29-6-9-1-3-10(4-2-9)22(26)27/h1-4,7-8,11,13-14,17,23-25H,5-6H2/t11-,13-,14-,17-/m1/s1	DYCJFJRCWPVDHY-LSCFUAHRSA-N					compound annotation
0391_010852	Levamlodipine	C20H25ClN2O5	3.1426	9822750	CCOC(=O)C1=C(NC(=C([C@@H]1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl	InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3/t17-/m0/s1	HTIQEAQVCYTUBX-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_010854	TRIDECANEDIOIC ACID	C13H24O4	3.6781	10458		O=C(O)CCCCCCCCCCCC(=O)O	InChI=1S/C13H24O4/c14-12(15)10-8-6-4-2-1-3-5-7-9-11-13(16)17/h1-11H2,(H,14,15)(H,16,17)	DXNCZXXFRKPEPY-UHFFFAOYSA-N					compound annotation
0391_010855	Fmoc-D-Trp(Boc)-OH	C31H30N2O6	5.5249	16213150	CC(C)(C)OC(=O)N1C=C(C2=CC=CC=C21)C[C@H](C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35	CC(C)(C)OC(=O)n1cc(CC(NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)c2ccccc21	InChI=1S/C31H30N2O6/c1-31(2,3)39-30(37)33-17-19(20-10-8-9-15-27(20)33)16-26(28(34)35)32-29(36)38-18-25-23-13-6-4-11-21(23)22-12-5-7-14-24(22)25/h4-15,17,25-26H,16,18H2,1-3H3,(H,32,36)(H,34,35)/t26-/m1/s1	ADOHASQZJSJZBT-AREMUKBSSA-N					removed another duplicate entry; compound annotation
0391_010857	Paliperidone Palmitate	C39H57FN4O4	6.0141	9852746		CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4c3ccc(F)c4)CC1)c2=O	InChI=1S/C39H57FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-36(45)47-34-17-16-24-44-38(34)41-29(2)32(39(44)46)23-27-43-25-21-30(22-26-43)37-33-20-19-31(40)28-35(33)48-42-37/h19-20,28,30,34H,3-18,21-27H2,1-2H3	VOMKSBFLAZZBOW-UHFFFAOYSA-N					compound annotation
0391_010858	Scopolin	C16H18O9	1.251	439514	COC1=C(C=C2C(=C1)C=CC(=O)O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	COc1c(OC2OC(CO)C(O)C(O)C2O)cc2oc(=O)ccc2c1	InChI=1S/C16H18O9/c1-22-9-4-7-2-3-12(18)23-8(7)5-10(9)24-16-15(21)14(20)13(19)11(6-17)25-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13-,14+,15-,16-/m1/s1	SGTCGCCQZOUMJJ-YMILTQATSA-N					compound annotation
0391_010859	Synucleozid	C22H20N6	1.9073	435840		N=C(N)c1ccc(Nc2ccc(-c3cc4c(cc(C(=N)N)cc4)[nH]3)cc2)cc1	InChI=1S/C22H20N6/c23-21(24)14-5-9-18(10-6-14)27-17-7-3-13(4-8-17)19-11-15-1-2-16(22(25)26)12-20(15)28-19/h1-12,27-28H,(H3,23,24)(H3,25,26)	TZRXNWCLKYWDNH-UHFFFAOYSA-N					compound annotation
0391_010860	dolasetron	C19H20N2O3	2.0263	3033818	C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54	O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12	InChI=1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14?	UKTAZPQNNNJVKR-AKJUYKBHSA-N					doublet; compound annotation
0391_010861	831234-13-0	C19H17N3O	2.8374	667146		c1ccc(Cn2c(NCc3ccco3)nc3ccccc32)cc1	InChI=1S/C19H17N3O/c1-2-7-15(8-3-1)14-22-18-11-5-4-10-17(18)21-19(22)20-13-16-9-6-12-23-16/h1-12H,13-14H2,(H,20,21)	OECUWHDVQIITIS-UHFFFAOYSA-N					compound annotation
0391_010862	Laquinimod	C19H17ClN2O3	3.5256	54677946		CCN(C(=O)c1c(O)c2c(cccc2Cl)n(C)c1=O)c1ccccc1	InChI=1S/C19H17ClN2O3/c1-3-22(12-8-5-4-6-9-12)19(25)16-17(23)15-13(20)10-7-11-14(15)21(2)18(16)24/h4-11,23H,3H2,1-2H3	GKWPCEFFIHSJOE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010864	bepridil	C24H34N2O	4.0344	2351		CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1	InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3	UIEATEWHFDRYRU-UHFFFAOYSA-N					doublet; compound annotation
0391_010865	Tubulin inhibitor 6	C20H14ClNO2S	5.4387	2359994		COc1ccc(C(=O)N2c3ccccc3Sc3c2cc(Cl)cc3)cc1	InChI=1S/C20H14ClNO2S/c1-24-15-9-6-13(7-10-15)20(23)22-16-4-2-3-5-18(16)25-19-11-8-14(21)12-17(19)22/h2-12H,1H3	CSWHYHPUEDNIQY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010867	278605-15-5	C11H11NO2	1.1109	25216972	C#CC1=CC=C(C=C1)C[C@@H](C(=O)O)N	C#Cc1ccc(CC(N)C(=O)O)cc1	InChI=1S/C11H11NO2/c1-2-8-3-5-9(6-4-8)7-10(12)11(13)14/h1,3-6,10H,7,12H2,(H,13,14)/t10-/m0/s1	PPDNGMUGVMESGE-JTQLQIEISA-N					doublet; compound annotation
0391_010868	BDP-13176	C24H22Cl2N6O2	2.2239	137333984		O=C(Nc1ccncc1)c1cn(Cc2cc(Cl)c(Cl)cc2)c(=O)c2c1n(C1CCNCC1)nc2	InChI=1S/C24H22Cl2N6O2/c25-20-2-1-15(11-21(20)26)13-31-14-19(23(33)30-16-3-7-27-8-4-16)22-18(24(31)34)12-29-32(22)17-5-9-28-10-6-17/h1-4,7-8,11-12,14,17,28H,5-6,9-10,13H2,(H,27,30,33)	BMOUOZDRMBLNSI-UHFFFAOYSA-N					compound annotation
0391_010869	Palonosetron	C19H24N2O	2.371	6337614	C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5	O=C1c2c3c(ccc2)CCCC3CN1C1CN2CCC1CC2	InChI=1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1	CPZBLNMUGSZIPR-NVXWUHKLSA-N					compound annotation
0391_010870	Pevonedistat	C21H25N5O4S	2.4457	16720766	C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N	NS(=O)(=O)OCC1CC(n2ccc3c(NC4CCc5ccccc54)ncnc32)CC1O	InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1	MPUQHZXIXSTTDU-QXGSTGNESA-N					doublet; compound annotation
0391_010871	Trimethyltetradecylammonium	C17H38N+	4.7156	14251		CCCCCCCCCCCCCC[N+](C)(C)C	InChI=1S/C17H38N/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18(2,3)4/h5-17H2,1-4H3/q+1	GLFDLEXFOHUASB-UHFFFAOYSA-N					compound annotation
0391_010872	TD-106	C12H11N5O3	2.0289	137628679		Nc1c2c(=O)n(C3CCC(=O)NC3=O)nnc2ccc1	InChI=1S/C12H11N5O3/c13-6-2-1-3-7-10(6)12(20)17(16-15-7)8-4-5-9(18)14-11(8)19/h1-3,8H,4-5,13H2,(H,14,18,19)	DXZBHVQOULDEPN-UHFFFAOYSA-N					compound annotation
0391_010873	Gusacitinib	C24H28N8O2	2.3473	71269142		N#CCC1CCN(c2nc3c(c(Nc4ccc(N5CCC(O)CC5)cc4)n2)c(=O)[nH]nc3)CC1	InChI=1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29)	NLFLXLJXEIUQDL-UHFFFAOYSA-N					compound annotation
0391_010874	ACY-957	C24H23N5OS	2.4676	72374405		Nc1c(NC(=O)c2cc3c(cc2)nc(N2CCNCC2)cc3)cc(-c2cccs2)cc1	InChI=1S/C24H23N5OS/c25-19-6-3-17(22-2-1-13-31-22)15-21(19)28-24(30)18-4-7-20-16(14-18)5-8-23(27-20)29-11-9-26-10-12-29/h1-8,13-15,26H,9-12,25H2,(H,28,30)	VURDNNVAYZDGDK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010876	VU0650786	C18H15ClFN5O2	3.867	122190433	C[C@@H]1CN(C(=O)C2=CC(=NN12)COC3=NC=C(C=C3)Cl)C4=C(N=CC=C4)F	CC1CN(c2c(F)nccc2)C(=O)c2cc(COc3ncc(Cl)cc3)nn21	InChI=1S/C18H15ClFN5O2/c1-11-9-24(14-3-2-6-21-17(14)20)18(26)15-7-13(23-25(11)15)10-27-16-5-4-12(19)8-22-16/h2-8,11H,9-10H2,1H3/t11-/m1/s1	RXRVCJFGSOVYLG-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_010878	Cruzain-IN-1	C14H10F2N6	4.2593	44143088		CCn1cnc2c(Nc3cc(F)cc(F)c3)nc(C#N)nc21	InChI=1S/C14H10F2N6/c1-2-22-7-18-12-13(20-11(6-17)21-14(12)22)19-10-4-8(15)3-9(16)5-10/h3-5,7H,2H2,1H3,(H,19,20,21)	SZYYBVWPURUFRR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010880	Antifungal agent 1	C19H13ClN2O3	4.3567	131704488		Cn1c2c(C(=O)C(Nc3ccc(Cl)cc3)=CC2=O)c2c1ccc(O)c2	InChI=1S/C19H13ClN2O3/c1-22-15-7-6-12(23)8-13(15)17-18(22)16(24)9-14(19(17)25)21-11-4-2-10(20)3-5-11/h2-9,21,23H,1H3	QUAFTMJUVQDZHE-UHFFFAOYSA-N					compound annotation
0391_010881	SBC-110736	C26H27N3O2	4.4339	78425817		CC(=O)Nc1ccc(C(=O)N2CCN(c3ccc(C)cc3)CC2c2ccccc2)cc1	InChI=1S/C26H27N3O2/c1-19-8-14-24(15-9-19)28-16-17-29(25(18-28)21-6-4-3-5-7-21)26(31)22-10-12-23(13-11-22)27-20(2)30/h3-15,25H,16-18H2,1-2H3,(H,27,30)	PILMFSWQYWYOJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010883	WS-12	C18H27NO2	4.8654	11266244	C[C@@H]1CC[C@H]([C@@H](C1)C(=O)NC2=CC=C(C=C2)OC)C(C)C	COc1ccc(NC(=O)C2CC(C)CCC2C(C)C)cc1	InChI=1S/C18H27NO2/c1-12(2)16-10-5-13(3)11-17(16)18(20)19-14-6-8-15(21-4)9-7-14/h6-9,12-13,16-17H,5,10-11H2,1-4H3,(H,19,20)/t13-,16+,17-/m1/s1	HNSGVPAAXJJOPQ-XOKHGSTOSA-N					doublet; removed another duplicate entry; compound annotation
0391_010885	WS-12	C18H27NO2	4.8702	11266244	C[C@@H]1CC[C@H]([C@@H](C1)C(=O)NC2=CC=C(C=C2)OC)C(C)C	COc1ccc(NC(=O)C2CC(C)CCC2C(C)C)cc1	InChI=1S/C18H27NO2/c1-12(2)16-10-5-13(3)11-17(16)18(20)19-14-6-8-15(21-4)9-7-14/h6-9,12-13,16-17H,5,10-11H2,1-4H3,(H,19,20)/t13-,16+,17-/m1/s1	HNSGVPAAXJJOPQ-XOKHGSTOSA-N					doublet; compound annotation
0391_010886	Pyr3	C16H11Cl3F3N3O3	5.032	56964346		CCOC(=O)c1c(C(F)(F)F)n(-c2ccc(NC(=O)C(Cl)=C(Cl)Cl)cc2)nc1	InChI=1S/C16H11Cl3F3N3O3/c1-2-28-15(27)10-7-23-25(12(10)16(20,21)22)9-5-3-8(4-6-9)24-14(26)11(17)13(18)19/h3-7H,2H2,1H3,(H,24,26)	RZHGONNSASQOAY-UHFFFAOYSA-N					compound annotation
0391_010887	ronidazole	C6H8N4O4	0.9684	5094		Cn1c([N+](=O)[O-])cnc1COC(N)=O	InChI=1S/C6H8N4O4/c1-9-4(3-14-6(7)11)8-2-5(9)10(12)13/h2H,3H2,1H3,(H2,7,11)	PQFRTXSWDXZRRS-UHFFFAOYSA-N					compound annotation
0391_010888	BIO-11006	C46H75N13O15	1.1414	11622197	C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)CNC(=O)C)O	CC(=O)NCC(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)O)C(C)O	InChI=1S/C46H75N13O15/c1-24(51-36(64)22-50-28(5)62)39(66)54-31(17-18-35(49)63)41(68)57-33(21-29-13-7-6-8-14-29)43(70)58-34(23-60)44(71)55-30(15-9-11-19-47)42(69)59-37(27(4)61)45(72)53-25(2)38(65)52-26(3)40(67)56-32(46(73)74)16-10-12-20-48/h6-8,13-14,24-27,30-34,37,60-61H,9-12,15-23,47-48H2,1-5H3,(H2,49,63)(H,50,62)(H,51,64)(H,52,65)(H,53,72)(H,54,66)(H,55,71)(H,56,67)(H,57,68)(H,58,70)(H,59,69)(H,73,74)/t24-,25-,26-,27+,30-,31-,32-,33-,34-,37-/m0/s1	KCSNGWMKFYVMKF-HGYIIGRXSA-N					compound annotation
0391_010889	115871-02-8	C25H30N6O2	1.8002	443301	C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC2=CC3=CC=CC=C3C=C2)N	NC(N)=NCCCC(NC(=O)C(N)Cc1ccccc1)C(=O)Nc1cc2ccccc2cc1	InChI=1S/C25H30N6O2/c26-21(15-17-7-2-1-3-8-17)23(32)31-22(11-6-14-29-25(27)28)24(33)30-20-13-12-18-9-4-5-10-19(18)16-20/h1-5,7-10,12-13,16,21-22H,6,11,14-15,26H2,(H,30,33)(H,31,32)(H4,27,28,29)/t21-,22-/m0/s1	ZNHUFUZDUQRKBB-VXKWHMMOSA-N					doublet; compound annotation
0391_010890	115871-02-8	C25H30N6O2	1.8035	443301	C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC2=CC3=CC=CC=C3C=C2)N	NC(N)=NCCCC(NC(=O)C(N)Cc1ccccc1)C(=O)Nc1cc2ccccc2cc1	InChI=1S/C25H30N6O2/c26-21(15-17-7-2-1-3-8-17)23(32)31-22(11-6-14-29-25(27)28)24(33)30-20-13-12-18-9-4-5-10-19(18)16-20/h1-5,7-10,12-13,16,21-22H,6,11,14-15,26H2,(H,30,33)(H,31,32)(H4,27,28,29)/t21-,22-/m0/s1	ZNHUFUZDUQRKBB-VXKWHMMOSA-N					doublet; compound annotation
0391_010891	Tedizolid	C17H15FN6O3	2.5641	11234049	CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F	Cn1nnc(-c2ncc(-c3c(F)cc(N4CC(CO)OC4=O)cc3)cc2)n1	InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1	XFALPSLJIHVRKE-GFCCVEGCSA-N					removed another duplicate entry; compound annotation
0391_010893	roxithromycin	C41H76N2O15	3.1661	6915744	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O	InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1	RXZBMPWDPOLZGW-XMRMVWPWSA-N					doublet; compound annotation
0391_010894	roxithromycin	C41H76N2O15	3.1696	6915744	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O	InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1	RXZBMPWDPOLZGW-XMRMVWPWSA-N					doublet; compound annotation
0391_010895	bicyclol	C19H18O9	3.1783	9821754		COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1CO	InChI=1S/C19H18O9/c1-22-11-4-9(6-20)13(17-15(11)25-7-27-17)14-10(19(21)24-3)5-12(23-2)16-18(14)28-8-26-16/h4-5,20H,6-8H2,1-3H3	KXMTXZACPVCDMH-UHFFFAOYSA-N					compound annotation
0391_010896	roxithromycin	C41H76N2O15	3.345	6915744	CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O	InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1	RXZBMPWDPOLZGW-XMRMVWPWSA-N					doublet; removed another duplicate entry; compound annotation
0391_010898	Incyclinide	C19H17NO7	3.5262	54678924	C1[C@@H]2CC3=C(C(=CC=C3)O)C(=C2C(=O)[C@]4([C@@H]1CC(=O)C(=C4O)C(=O)N)O)O	NC(=O)C1=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)CC3CC2CC1=O	InChI=1S/C19H17NO7/c20-18(26)14-11(22)6-9-5-8-4-7-2-1-3-10(21)12(7)15(23)13(8)16(24)19(9,27)17(14)25/h1-3,8-9,21,23,25,27H,4-6H2,(H2,20,26)/t8-,9-,19-/m0/s1	NBRQRXRBIHVLGI-OWXODZSWSA-N					compound annotation
0391_010899	MOZ-IN-3	C20H17FN2O3S	4.3006	133053564		Cc1cc(-c2ccccc2)cc(C(=O)NNS(=O)(=O)c2ccccc2)c1F	InChI=1S/C20H17FN2O3S/c1-14-12-16(15-8-4-2-5-9-15)13-18(19(14)21)20(24)22-23-27(25,26)17-10-6-3-7-11-17/h2-13,23H,1H3,(H,22,24)	PHHZKBMVRPULAW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010901	Fulacimstat	C23H16F3N3O6	4.4146	91758792	CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)[C@@H]4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O	Cn1c(=O)oc2c1ccc(-n1cc(C(=O)O)c(=O)n(C3CCc4c3cccc4C(F)(F)F)c1=O)c2	InChI=1S/C23H16F3N3O6/c1-27-17-7-5-11(9-18(17)35-22(27)34)28-10-14(20(31)32)19(30)29(21(28)33)16-8-6-12-13(16)3-2-4-15(12)23(24,25)26/h2-5,7,9-10,16H,6,8H2,1H3,(H,31,32)/t16-/m1/s1	JDARDSVOVYVQST-MRXNPFEDSA-N					compound annotation
0391_010902	2,6-DIMETHYLQUINOLINE	C11H11N	1.2428	13414		Cc1cc2c(cc1)nc(C)cc2	InChI=1S/C11H11N/c1-8-3-6-11-10(7-8)5-4-9(2)12-11/h3-7H,1-2H3	JJPSZKIOGBRMHK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010904	GNE-6640	C20H18N4O	2.1096	122531786		CCc1c(-c2ccc(O)cc2)c(N)ncc1-c1cc2c(cc1)[nH]nc2	InChI=1S/C20H18N4O/c1-2-16-17(13-5-8-18-14(9-13)10-23-24-18)11-22-20(21)19(16)12-3-6-15(25)7-4-12/h3-11,25H,2H2,1H3,(H2,21,22)(H,23,24)	ZHYXJQQBKROZDX-UHFFFAOYSA-N					doublet; compound annotation
0391_010905	GNE-6640	C20H18N4O	2.1123	122531786		CCc1c(-c2ccc(O)cc2)c(N)ncc1-c1cc2c(cc1)[nH]nc2	InChI=1S/C20H18N4O/c1-2-16-17(13-5-8-18-14(9-13)10-23-24-18)11-22-20(21)19(16)12-3-6-15(25)7-4-12/h3-11,25H,2H2,1H3,(H2,21,22)(H,23,24)	ZHYXJQQBKROZDX-UHFFFAOYSA-N					doublet; compound annotation
0391_010906	Nezukone	C10H12O	2.5404	570867		CC(C)c1cccc(=O)cc1	InChI=1S/C10H12O/c1-8(2)9-4-3-5-10(11)7-6-9/h3-8H,1-2H3	IWPWMAJDSLSRIP-UHFFFAOYSA-N					doublet; compound annotation
0391_010907	Raxatrigine	C18H19FN2O2	2.5928	16046068	C1C[C@H](N[C@H]1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N	NC(=O)C1CCC(c2ccc(OCc3ccccc3F)cc2)N1	InChI=1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1	JESCETIFNOFKEU-SJORKVTESA-N					doublet; compound annotation
0391_010908	Raxatrigine	C18H19FN2O2	2.6517	16046068	C1C[C@H](N[C@H]1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N	NC(=O)C1CCC(c2ccc(OCc3ccccc3F)cc2)N1	InChI=1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1	JESCETIFNOFKEU-SJORKVTESA-N					doublet; removed another duplicate entry; compound annotation
0391_010910	150493-34-8	C15H11ClF3N3	3.244	127722		Nc1nc2cc(C(F)(F)F)ccc2n1Cc1ccc(Cl)cc1	InChI=1S/C15H11ClF3N3/c16-11-4-1-9(2-5-11)8-22-13-6-3-10(15(17,18)19)7-12(13)21-14(22)20/h1-7H,8H2,(H2,20,21)	GXQCVUZORDAARJ-UHFFFAOYSA-N					doublet; compound annotation
0391_010911	150493-34-8	C15H11ClF3N3	3.2978	127722		Nc1nc2cc(C(F)(F)F)ccc2n1Cc1ccc(Cl)cc1	InChI=1S/C15H11ClF3N3/c16-11-4-1-9(2-5-11)8-22-13-6-3-10(15(17,18)19)7-12(13)21-14(22)20/h1-7H,8H2,(H2,20,21)	GXQCVUZORDAARJ-UHFFFAOYSA-N					doublet; compound annotation
0391_010912	SHIN1	C24H24N4O2	3.5338	134335083		Cc1c2c(n[nH]1)OC(N)=C(C#N)C2(c1cc(CO)cc(-c2ccccc2)c1)C(C)C	InChI=1S/C24H24N4O2/c1-14(2)24(20(12-25)22(26)30-23-21(24)15(3)27-28-23)19-10-16(13-29)9-18(11-19)17-7-5-4-6-8-17/h4-11,14,29H,13,26H2,1-3H3,(H,27,28)	VVVOFJZXKJKHTD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010914	ST-193	C24H25N3O	3.949	3697969		COc1ccc(-n2cnc3c2ccc(NCc2ccc(C(C)C)cc2)c3)cc1	InChI=1S/C24H25N3O/c1-17(2)19-6-4-18(5-7-19)15-25-20-8-13-24-23(14-20)26-16-27(24)21-9-11-22(28-3)12-10-21/h4-14,16-17,25H,15H2,1-3H3	JPSZEXYTKSIPDW-UHFFFAOYSA-N					doublet; compound annotation
0391_010915	ST-193	C24H25N3O	3.9524	3697969		COc1ccc(-n2cnc3c2ccc(NCc2ccc(C(C)C)cc2)c3)cc1	InChI=1S/C24H25N3O/c1-17(2)19-6-4-18(5-7-19)15-25-20-8-13-24-23(14-20)26-16-27(24)21-9-11-22(28-3)12-10-21/h4-14,16-17,25H,15H2,1-3H3	JPSZEXYTKSIPDW-UHFFFAOYSA-N					doublet; compound annotation
0391_010916	Nezukone	C10H12O	4.1463	570867		CC(C)c1cccc(=O)cc1	InChI=1S/C10H12O/c1-8(2)9-4-3-5-10(11)7-6-9/h3-8H,1-2H3	IWPWMAJDSLSRIP-UHFFFAOYSA-N					doublet; compound annotation
0391_010917	NITD-349	C17H20F2N2O	4.9179	72711190		CC1(C)CCC(NC(=O)c2cc3c(cc(F)cc3F)[nH]2)CC1	InChI=1S/C17H20F2N2O/c1-17(2)5-3-11(4-6-17)20-16(22)15-9-12-13(19)7-10(18)8-14(12)21-15/h7-9,11,21H,3-6H2,1-2H3,(H,20,22)	UATYSFRIVIHVKL-UHFFFAOYSA-N					compound annotation
0391_010918	10538-99-5	C20H21N7O7	1.0016	135484014	C1C2CN(C(=O)N2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Nc1nc(=O)c2c(NCC3CN(c4ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc4)C(=O)N23)[nH]1	InChI=1S/C20H21N7O7/c21-19-24-15-14(17(31)25-19)27-11(7-22-15)8-26(20(27)34)10-3-1-9(2-4-10)16(30)23-12(18(32)33)5-6-13(28)29/h1-4,11-12H,5-8H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t11?,12-/m0/s1	JSNFRYBHBVDHSG-KIYNQFGBSA-N					compound annotation
0391_010919	GSK163090	C25H29N5O	1.3624	11292933		Cc1nc2c(cc1)c(N1CCN(CCc3cc(N4CCNC4=O)ccc3)CC1)ccc2	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	ANGUXJDGJCHGOG-UHFFFAOYSA-N					doublet; compound annotation
0391_010920	GSK163090	C25H29N5O	1.3673	11292933		Cc1nc2c(cc1)c(N1CCN(CCc3cc(N4CCNC4=O)ccc3)CC1)ccc2	InChI=1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31)	ANGUXJDGJCHGOG-UHFFFAOYSA-N					doublet; compound annotation
0391_010921	DLK-IN-1	C20H24F3N5O2	2.0535	90292823	CC(C)N1C(=CC(=N1)C2=CC(=C(N=C2)N)OC(F)(F)F)C3[C@H]4[C@@H]3CN(C4)C5COC5	CC(C)n1nc(-c2cc(OC(F)(F)F)c(N)nc2)cc1C1C2CN(C3COC3)CC21	InChI=1S/C20H24F3N5O2/c1-10(2)28-16(18-13-6-27(7-14(13)18)12-8-29-9-12)4-15(26-28)11-3-17(19(24)25-5-11)30-20(21,22)23/h3-5,10,12-14,18H,6-9H2,1-2H3,(H2,24,25)/t13-,14+,18?	UHEFRVBGJORHNV-UUVAVEHKSA-N					compound annotation
0391_010922	Boc-D-FMK	C11H18FNO5	2.9168	16760348		COC(=O)CC(NC(=O)OC(C)(C)C)C(=O)CF	InChI=1S/C11H18FNO5/c1-11(2,3)18-10(16)13-7(8(14)6-12)5-9(15)17-4/h7H,5-6H2,1-4H3,(H,13,16)	MXOOUCRHWJYCAL-UHFFFAOYSA-N					compound annotation
0391_010923	MS417	C20H19ClN4O2S	4.1367	59190723	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(sc(C)c2C)-n2c(C)nnc12	InChI=1S/C20H19ClN4O2S/c1-10-11(2)28-20-17(10)18(13-5-7-14(21)8-6-13)22-15(9-16(26)27-4)19-24-23-12(3)25(19)20/h5-8,15H,9H2,1-4H3/t15-/m0/s1	GGRCIHACOIMRKY-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_010925	1570496-34-2	C25H25F3N6O4S	4.6423	86711931		Cc1nc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1cc(N2CCC(S(C)(=O)=O)CC2)ccc1	InChI=1S/C25H25F3N6O4S/c1-16-29-23(24-30-22(32-38-24)18-6-8-20(9-7-18)37-25(26,27)28)31-34(16)15-17-4-3-5-19(14-17)33-12-10-21(11-13-33)39(2,35)36/h3-9,14,21H,10-13,15H2,1-2H3	HWJWNWZJUYCGKV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010927	GPR30 Agonist, G-1	C21H18BrNO3	5.0849	5322399	CC(=O)C1=CC2=C(C=C1)N[C@H]([C@@H]3[C@H]2C=CC3)C4=CC5=C(C=C4Br)OCO5	CC(=O)c1cc2c(cc1)NC(c1cc3c(cc1Br)OCO3)C1CC=CC21	InChI=1S/C21H18BrNO3/c1-11(24)12-5-6-18-15(7-12)13-3-2-4-14(13)21(23-18)16-8-19-20(9-17(16)22)26-10-25-19/h2-3,5-9,13-14,21,23H,4,10H2,1H3/t13-,14+,21-/m1/s1	VHSVKVWHYFBIFJ-HKZYLEAXSA-N					removed another duplicate entry; compound annotation
0391_010930	VU0661013	C39H39Cl2N5O4	5.879	134828256	C[C@@H]1CN(C(=O)C2=C(C3=C(N12)C(=C(C=C3)Cl)C4=C(N(N=C4C)C)C)CCCOC5=CC(=C(C(=C5)C)Cl)C)C6=CN(C7=C6C=C(C=C7)C(=O)O)C	Cc1cc(OCCCc2c3C(=O)N(c4cn(C)c5c4cc(C(=O)O)cc5)CC(C)n3c3c2ccc(Cl)c3-c2c(C)n(C)nc2C)cc(C)c1Cl	InChI=1S/C39H39Cl2N5O4/c1-20-15-26(16-21(2)35(20)41)50-14-8-9-27-28-11-12-30(40)34(33-23(4)42-44(7)24(33)5)36(28)46-22(3)18-45(38(47)37(27)46)32-19-43(6)31-13-10-25(39(48)49)17-29(31)32/h10-13,15-17,19,22H,8-9,14,18H2,1-7H3,(H,48,49)/t22-/m1/s1	BSAYHBZFNXDOIJ-JOCHJYFZSA-N					removed another duplicate entry; compound annotation
0391_010933	CHEMBL439319	C52H79N5O12	5.927	44405767	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@@H]([C@@H](C4)OC)N5N=CN=N5)C)/C)O)OC)C)C)/C)OC	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(n3ncnn3)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-54-30-53-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1	IURNHYDSJVLLPN-JUKNQOCSSA-N					compound annotation
0391_010934	2-Acetylphenothiazine	C14H11NOS	2.4528	81131		CC(=O)c1cc2c(cc1)Sc1ccccc1N2	InChI=1S/C14H11NOS/c1-9(16)10-6-7-14-12(8-10)15-11-4-2-3-5-13(11)17-14/h2-8,15H,1H3	JWGBOHJGWOPYCL-UHFFFAOYSA-N					doublet; compound annotation
0391_010935	1234708-04-3	C22H20N6O3	2.531	46700750		CC(C)(O)c1nc(-c2cccc(CNC(=O)c3cnc(-c4ccccn4)nc3)c2)no1	InChI=1S/C22H20N6O3/c1-22(2,30)21-27-18(28-31-21)15-7-5-6-14(10-15)11-26-20(29)16-12-24-19(25-13-16)17-8-3-4-9-23-17/h3-10,12-13,30H,11H2,1-2H3,(H,26,29)	VJCLAPUACUQZOV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010937	MV1	C33H44N4O5	3.468	23657865	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)OC)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)OC)C(c1ccccc1)c1ccccc1)C1CCCCC1	InChI=1S/C33H44N4O5/c1-22(34-2)30(38)35-28(25-18-11-6-12-19-25)32(40)37-21-13-20-26(37)31(39)36-29(33(41)42-3)27(23-14-7-4-8-15-23)24-16-9-5-10-17-24/h4-5,7-10,14-17,22,25-29,34H,6,11-13,18-21H2,1-3H3,(H,35,38)(H,36,39)/t22-,26-,28-,29-/m0/s1	UUPZYAHONNHULX-CJBSCAABSA-N					doublet; removed another duplicate entry; compound annotation
0391_010939	MV1	C33H44N4O5	3.5444	23657865	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)OC)NC	CNC(C)C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)OC)C(c1ccccc1)c1ccccc1)C1CCCCC1	InChI=1S/C33H44N4O5/c1-22(34-2)30(38)35-28(25-18-11-6-12-19-25)32(40)37-21-13-20-26(37)31(39)36-29(33(41)42-3)27(23-14-7-4-8-15-23)24-16-9-5-10-17-24/h4-5,7-10,14-17,22,25-29,34H,6,11-13,18-21H2,1-3H3,(H,35,38)(H,36,39)/t22-,26-,28-,29-/m0/s1	UUPZYAHONNHULX-CJBSCAABSA-N					doublet; removed another duplicate entry; compound annotation
0391_010941	BAY-677	C20H15F3N4O2	3.5971	68944900	CC1=C([C@@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)NC1c1cnc(C#N)cc1	InChI=1S/C20H15F3N4O2/c1-11-17(12(2)28)18(13-6-7-15(9-24)25-10-13)26-19(29)27(11)16-5-3-4-14(8-16)20(21,22)23/h3-8,10,18H,1-2H3,(H,26,29)/t18-/m0/s1	PGIVGIFOWOVINL-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_010943	Encequidar	C38H36N6O7	3.6078	11399764		COc1c(OC)cc2CN(CCc3ccc(-n4nnc(-c5cc(OC)c(OC)cc5NC(=O)c5cc(=O)c6ccccc6o5)n4)cc3)CCc2c1	InChI=1S/C38H36N6O7/c1-47-32-17-24-14-16-43(22-25(24)18-33(32)48-2)15-13-23-9-11-26(12-10-23)44-41-37(40-42-44)28-19-34(49-3)35(50-4)20-29(28)39-38(46)36-21-30(45)27-7-5-6-8-31(27)51-36/h5-12,17-21H,13-16,22H2,1-4H3,(H,39,46)	AHJUHHDDCJQACA-UHFFFAOYSA-N					doublet; compound annotation
0391_010944	Encequidar	C38H36N6O7	3.6666	11399764		COc1c(OC)cc2CN(CCc3ccc(-n4nnc(-c5cc(OC)c(OC)cc5NC(=O)c5cc(=O)c6ccccc6o5)n4)cc3)CCc2c1	InChI=1S/C38H36N6O7/c1-47-32-17-24-14-16-43(22-25(24)18-33(32)48-2)15-13-23-9-11-26(12-10-23)44-41-37(40-42-44)28-19-34(49-3)35(50-4)20-29(28)39-38(46)36-21-30(45)27-7-5-6-8-31(27)51-36/h5-12,17-21H,13-16,22H2,1-4H3,(H,39,46)	AHJUHHDDCJQACA-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010946	Synta66	C20H17FN2O3	3.9357	11337104		COc1cc(-c2ccc(NC(=O)c3c(F)cncc3)cc2)c(OC)cc1	InChI=1S/C20H17FN2O3/c1-25-15-7-8-19(26-2)17(11-15)13-3-5-14(6-4-13)23-20(24)16-9-10-22-12-18(16)21/h3-12H,1-2H3,(H,23,24)	GFEIWXNLDKUWIK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010948	PZ-2891	C20H23N5O	3.9384	132260806		CC(C)c1ccc(CC(=O)N2CCN(c3nnc(C#N)cc3)CC2)cc1	InChI=1S/C20H23N5O/c1-15(2)17-5-3-16(4-6-17)13-20(26)25-11-9-24(10-12-25)19-8-7-18(14-21)22-23-19/h3-8,15H,9-13H2,1-2H3	LGWDVWIZDPGCFG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010950	2-Acetylphenothiazine	C14H11NOS	4.3032	81131		CC(=O)c1cc2c(cc1)Sc1ccccc1N2	InChI=1S/C14H11NOS/c1-9(16)10-6-7-14-12(8-10)15-11-4-2-3-5-13(11)17-14/h2-8,15H,1H3	JWGBOHJGWOPYCL-UHFFFAOYSA-N					doublet; compound annotation
0391_010951	tocainide	C11H16N2O	1.2545	38945		Cc1c(NC(=O)C(C)N)c(C)ccc1	InChI=1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14)	BUJAGSGYPOAWEI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010953	GSK256073	C10H13ClN4O2	2.8358	46215799		CCCCCn1c(=O)[nH]c(=O)c2c1nc(Cl)[nH]2	InChI=1S/C10H13ClN4O2/c1-2-3-4-5-15-7-6(12-9(11)13-7)8(16)14-10(15)17/h2-5H2,1H3,(H,12,13)(H,14,16,17)	CGAMDQCXAAOFSR-UHFFFAOYSA-N					compound annotation
0391_010954	ENTACAPONE	C14H15N3O5	3.089	5281081	CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N	CCN(CC)C(=O)C(C#N)=Cc1cc([N+](=O)[O-])c(O)c(O)c1	InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+	JRURYQJSLYLRLN-BJMVGYQFSA-N					compound annotation
0391_010955	BUTYLPARABEN	C11H14O3	4.2843	7184		CCCCOC(=O)c1ccc(O)cc1	InChI=1S/C11H14O3/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7,12H,2-3,8H2,1H3	QFOHBWFCKVYLES-UHFFFAOYSA-N					compound annotation
0391_010956	KH-CB19	C15H13Cl2N3O2	4.424	44237094	CCOC(=O)C1=C(C2=C(N1C)C(=C(C=C2)Cl)Cl)/C(=C\N)/C#N	CCOC(=O)c1c(C(C#N)=CN)c2c(c(Cl)c(Cl)cc2)n1C	InChI=1S/C15H13Cl2N3O2/c1-3-22-15(21)14-11(8(6-18)7-19)9-4-5-10(16)12(17)13(9)20(14)2/h4-6H,3,18H2,1-2H3/b8-6-	CXJCGSPAPOTTSF-VURMDHGXSA-N					doublet; compound annotation
0391_010957	phytosphingosine	C18H39NO3	4.4726	122121	CCCCCCCCCCCCCC[C@H]([C@H]([C@H](CO)N)O)O	CCCCCCCCCCCCCCC(O)C(O)C(N)CO	InChI=1S/C18H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(21)18(22)16(19)15-20/h16-18,20-22H,2-15,19H2,1H3/t16-,17+,18-/m0/s1	AERBNCYCJBRYDG-KSZLIROESA-N					compound annotation
0391_010958	PI-1840	C22H26N4O3	4.4985	56945245		CCCc1ccc(OCC(=O)N(Cc2nc(-c3cnccc3)no2)C(C)C)cc1	InChI=1S/C22H26N4O3/c1-4-6-17-8-10-19(11-9-17)28-15-21(27)26(16(2)3)14-20-24-22(25-29-20)18-7-5-12-23-13-18/h5,7-13,16H,4,6,14-15H2,1-3H3	ZVVXAODXPVWGMF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010960	KH-CB19	C15H13Cl2N3O2	4.7579	44237094	CCOC(=O)C1=C(C2=C(N1C)C(=C(C=C2)Cl)Cl)/C(=C\N)/C#N	CCOC(=O)c1c(C(C#N)=CN)c2c(c(Cl)c(Cl)cc2)n1C	InChI=1S/C15H13Cl2N3O2/c1-3-22-15(21)14-11(8(6-18)7-19)9-4-5-10(16)12(17)13(9)20(14)2/h4-6H,3,18H2,1-2H3/b8-6-	CXJCGSPAPOTTSF-VURMDHGXSA-N					doublet; compound annotation
0391_010961	Clitocine	C9H13N5O6	0.4783	129111	C1=NC(=C(C(=N1)N[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)[N+](=O)[O-])N	Nc1c([N+](=O)[O-])c(NC2OC(CO)C(O)C2O)ncn1	InChI=1S/C9H13N5O6/c10-7-4(14(18)19)8(12-2-11-7)13-9-6(17)5(16)3(1-15)20-9/h2-3,5-6,9,15-17H,1H2,(H3,10,11,12,13)/t3-,5-,6-,9-/m1/s1	OHEMBWZZEKCBAS-UUOKFMHZSA-N					compound annotation
0391_010962	DB1976	C20H16N8Se	1.2884	141655595		N=C(N)c1cc2c(cc1)nc(-c1ccc(-c3nc4c(cc(C(=N)N)cc4)[nH]3)[se]1)[nH]2	InChI=1S/C20H16N8Se/c21-17(22)9-1-3-11-13(7-9)27-19(25-11)15-5-6-16(29-15)20-26-12-4-2-10(18(23)24)8-14(12)28-20/h1-8H,(H3,21,22)(H3,23,24)(H,25,27)(H,26,28)	NXECULIQZLOKFU-UHFFFAOYSA-N					compound annotation
0391_010963	SCHEMBL424527	C16H24NO5+	1.4088	89287		COc1cc(C=CC(=O)OCC[N+](C)(C)C)cc(OC)c1O	InChI=1S/C16H23NO5/c1-17(2,3)8-9-22-15(18)7-6-12-10-13(20-4)16(19)14(11-12)21-5/h6-7,10-11H,8-9H2,1-5H3/p+1	HUJXHFRXWWGYQH-UHFFFAOYSA-O					doublet; compound annotation
0391_010964	SCHEMBL424527	C16H24NO5+	1.4901	89287		COc1cc(C=CC(=O)OCC[N+](C)(C)C)cc(OC)c1O	InChI=1S/C16H23NO5/c1-17(2,3)8-9-22-15(18)7-6-12-10-13(20-4)16(19)14(11-12)21-5/h6-7,10-11H,8-9H2,1-5H3/p+1	HUJXHFRXWWGYQH-UHFFFAOYSA-O					doublet; compound annotation
0391_010965	ondansetron	C18H19N3O	2.0959	4595		Cc1nccn1CC1CCc2c(C1=O)c1ccccc1n2C	InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3	FELGMEQIXOGIFQ-UHFFFAOYSA-N					compound annotation
0391_010966	RIPGBM	C26H21FN2O3	4.6111	3793001		CC(=O)N(Cc1ccc(F)cc1)C1=C(NCc2ccccc2)C(=O)c2ccccc2C1=O	InChI=1S/C26H21FN2O3/c1-17(30)29(16-19-11-13-20(27)14-12-19)24-23(28-15-18-7-3-2-4-8-18)25(31)21-9-5-6-10-22(21)26(24)32/h2-14,28H,15-16H2,1H3	COATXBHZYVUJQP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010968	Prosapogenin A	C39H62O12	4.9176	11061578	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(O)C(O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C39H62O12/c1-18-8-13-39(46-17-18)19(2)28-26(51-39)15-25-23-7-6-21-14-22(9-11-37(21,4)24(23)10-12-38(25,28)5)48-36-34(32(44)30(42)27(16-40)49-36)50-35-33(45)31(43)29(41)20(3)47-35/h6,18-20,22-36,40-45H,7-17H2,1-5H3/t18-,19+,20+,22+,23-,24+,25+,26+,27-,28+,29+,30-,31-,32+,33-,34-,35+,36-,37+,38+,39-/m1/s1	HDXIQHTUNGFJIC-FOAHKCLGSA-N					compound annotation
0391_010969	Irsogladine	C9H7Cl2N5	2.0435	3752		Nc1nc(-c2c(Cl)ccc(Cl)c2)nc(N)n1	InChI=1S/C9H7Cl2N5/c10-4-1-2-6(11)5(3-4)7-14-8(12)16-9(13)15-7/h1-3H,(H4,12,13,14,15,16)	ATCGGEJZONJOCL-UHFFFAOYSA-N					compound annotation
0391_010970	NEO2734	C22H24F3N3O3	2.4382	126582741		Cc1cc(-c2cc3c(cc2)nc(C2CCOCC2)n3CCOC(F)(F)F)cn(C)c1=O	InChI=1S/C22H24F3N3O3/c1-14-11-17(13-27(2)21(14)29)16-3-4-18-19(12-16)28(7-10-31-22(23,24)25)20(26-18)15-5-8-30-9-6-15/h3-4,11-13,15H,5-10H2,1-2H3	KPWWFNXRLAAREN-UHFFFAOYSA-N					doublet; compound annotation
0391_010971	NEO2734	C22H24F3N3O3	2.4411	126582741		Cc1cc(-c2cc3c(cc2)nc(C2CCOCC2)n3CCOC(F)(F)F)cn(C)c1=O	InChI=1S/C22H24F3N3O3/c1-14-11-17(13-27(2)21(14)29)16-3-4-18-19(12-16)28(7-10-31-22(23,24)25)20(26-18)15-5-8-30-9-6-15/h3-4,11-13,15H,5-10H2,1-2H3	KPWWFNXRLAAREN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010973	NEO2734	C22H24F3N3O3	2.89	126582741		Cc1cc(-c2cc3c(cc2)nc(C2CCOCC2)n3CCOC(F)(F)F)cn(C)c1=O	InChI=1S/C22H24F3N3O3/c1-14-11-17(13-27(2)21(14)29)16-3-4-18-19(12-16)28(7-10-31-22(23,24)25)20(26-18)15-5-8-30-9-6-15/h3-4,11-13,15H,5-10H2,1-2H3	KPWWFNXRLAAREN-UHFFFAOYSA-N					doublet; compound annotation
0391_010974	oxatomide	C27H30N4O	3.2522	4615		O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1	InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)	BAINIUMDFURPJM-UHFFFAOYSA-N					compound annotation
0391_010975	ALVERINE	C20H27N	3.2905	3678		CCN(CCCc1ccccc1)CCCc1ccccc1	InChI=1S/C20H27N/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20/h3-8,11-14H,2,9-10,15-18H2,1H3	ZPFXAOWNKLFJDN-UHFFFAOYSA-N					compound annotation
0391_010976	AR-13324 M1 metabolite	C19H19N3O2	0.4866	134128281	C1=CC(=CC=C1CO)[C@@H](CN)C(=O)NC2=CC3=C(C=C2)C=NC=C3	NCC(C(=O)Nc1cc2c(cc1)cncc2)c1ccc(CO)cc1	InChI=1S/C19H19N3O2/c20-10-18(14-3-1-13(12-23)2-4-14)19(24)22-17-6-5-16-11-21-8-7-15(16)9-17/h1-9,11,18,23H,10,12,20H2,(H,22,24)/t18-/m1/s1	LTXBFJFJUIJOQE-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_010978	2-Methylhippuric acid	C10H11NO3	1.5522	91637		Cc1ccccc1C(=O)NCC(=O)O	InChI=1S/C10H11NO3/c1-7-4-2-3-5-8(7)10(14)11-6-9(12)13/h2-5H,6H2,1H3,(H,11,14)(H,12,13)	YOEBAVRJHRCKRE-UHFFFAOYSA-N					compound annotation
0391_010979	AZD5904	C10H12N4O2S	1.7616	10264211	C1C[C@@H](OC1)CN2C3=C(C(=O)NC2=S)NC=N3	O=c1[nH]c(=S)n(CC2CCCO2)c2c1[nH]cn2	InChI=1S/C10H12N4O2S/c15-9-7-8(12-5-11-7)14(10(17)13-9)4-6-2-1-3-16-6/h5-6H,1-4H2,(H,11,12)(H,13,15,17)/t6-/m1/s1	RSPDBEVKURKEII-ZCFIWIBFSA-N					removed another duplicate entry; compound annotation
0391_010981	batimastat	C23H31N3O4S2	3.0429	5362422	CC(C)C[C@H]([C@H](CSC1=CC=CS1)C(=O)NO)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NC	CNC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)C(CSc1cccs1)C(=O)NO	InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1	XFILPEOLDIKJHX-QYZOEREBSA-N					removed another duplicate entry; compound annotation
0391_010983	Ingliforib	C23H24ClN3O5	3.3823	6451325	C1[C@H]([C@H](CN1C(=O)[C@@H]([C@H](CC2=CC=CC=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl)O)O)O	O=C(NC(Cc1ccccc1)C(O)C(=O)N1CC(O)C(O)C1)c1cc2c(ccc(Cl)c2)[nH]1	InChI=1S/C23H24ClN3O5/c24-15-6-7-16-14(9-15)10-18(25-16)22(31)26-17(8-13-4-2-1-3-5-13)21(30)23(32)27-11-19(28)20(29)12-27/h1-7,9-10,17,19-21,25,28-30H,8,11-12H2,(H,26,31)/t17-,19-,20+,21+/m0/s1	GVDRRZOORHCTAN-MJUUVYJYSA-N					removed another duplicate entry; compound annotation
0391_010985	praziquantel	C19H24N2O2	3.6478	4891		O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1	InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2	FSVJFNAIGNNGKK-UHFFFAOYSA-N					compound annotation
0391_010986	AVN-944	C25H27N5O5	3.7849	9918559	CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC	CCC(CC#N)OC(=O)NC(C)c1cc(NC(=O)Nc2cc(OC)c(-c3cnco3)cc2)ccc1	InChI=1S/C25H27N5O5/c1-4-20(10-11-26)35-25(32)28-16(2)17-6-5-7-18(12-17)29-24(31)30-19-8-9-21(22(13-19)33-3)23-14-27-15-34-23/h5-9,12-16,20H,4,10H2,1-3H3,(H,28,32)(H2,29,30,31)/t16-,20+/m0/s1	GYCPCOJTCINIFZ-OXJNMPFZSA-N					doublet; removed another duplicate entry; compound annotation
0391_010988	AVN-944	C25H27N5O5	3.7877	9918559	CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC	CCC(CC#N)OC(=O)NC(C)c1cc(NC(=O)Nc2cc(OC)c(-c3cnco3)cc2)ccc1	InChI=1S/C25H27N5O5/c1-4-20(10-11-26)35-25(32)28-16(2)17-6-5-7-18(12-17)29-24(31)30-19-8-9-21(22(13-19)33-3)23-14-27-15-34-23/h5-9,12-16,20H,4,10H2,1-3H3,(H,28,32)(H2,29,30,31)/t16-,20+/m0/s1	GYCPCOJTCINIFZ-OXJNMPFZSA-N					doublet; compound annotation
0391_010989	CID 1375606	C20H14Cl2N2O2	4.2934	1375606		O=C(Nc1ccccc1)c1ccc(NC(=O)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C20H14Cl2N2O2/c21-14-8-11-17(18(22)12-14)20(26)24-16-9-6-13(7-10-16)19(25)23-15-4-2-1-3-5-15/h1-12H,(H,23,25)(H,24,26)	PFHDXBXPRBQVAV-UHFFFAOYSA-N					doublet; compound annotation
0391_010990	CID 1375606	C20H14Cl2N2O2	4.2966	1375606		O=C(Nc1ccccc1)c1ccc(NC(=O)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C20H14Cl2N2O2/c21-14-8-11-17(18(22)12-14)20(26)24-16-9-6-13(7-10-16)19(25)23-15-4-2-1-3-5-15/h1-12H,(H,23,25)(H,24,26)	PFHDXBXPRBQVAV-UHFFFAOYSA-N					doublet; compound annotation
0391_010991	Smurf1-IN-A01	C22H20ClF3N4O3S	4.6825	17555704		Cc1ccnn1-c1ccc(C(=O)N2CCN(S(=O)(=O)c3cc(C(F)(F)F)c(Cl)cc3)CC2)cc1	InChI=1S/C22H20ClF3N4O3S/c1-15-8-9-27-30(15)17-4-2-16(3-5-17)21(31)28-10-12-29(13-11-28)34(32,33)18-6-7-20(23)19(14-18)22(24,25)26/h2-9,14H,10-13H2,1H3	QFYLTUDRXBNZFQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_010993	RUTIN	C27H30O16	1.7887	5280805	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O	CC1OC(OCC2OC(Oc3c(-c4cc(O)c(O)cc4)oc4cc(O)cc(O)c4c3=O)C(O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1	IKGXIBQEEMLURG-NVPNHPEKSA-N					removed another duplicate entry; compound annotation
0391_010995	821794-92-7	C18H19FN4O2	2.3319	644243		Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1	InChI=1S/C18H19FN4O2/c1-11-3-5-12(6-4-11)14-15-17(20)21-10-22-18(15)23(7-2-8-24)16(14)13(25)9-19/h3-6,10,24H,2,7-9H2,1H3,(H2,20,21,22)	IKLGYJACVCXYIL-UHFFFAOYSA-N					doublet; compound annotation
0391_010996	821794-92-7	C18H19FN4O2	2.3665	644243		Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1	InChI=1S/C18H19FN4O2/c1-11-3-5-12(6-4-11)14-15-17(20)21-10-22-18(15)23(7-2-8-24)16(14)13(25)9-19/h3-6,10,24H,2,7-9H2,1H3,(H2,20,21,22)	IKLGYJACVCXYIL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_010998	Prulifloxacin	C21H20FN3O6S	2.3965	65947		Cc1c(CN2CCN(c3c(F)cc4c(=O)c(C(=O)O)c5SC(C)n5c4c3)CC2)oc(=O)o1	InChI=1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)	PWNMXPDKBYZCOO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011000	BCX 1470	C14H10N2O2S2	2.5562	9822205		N=C(N)c1cc2c(cc(OC(=O)c3cccs3)cc2)s1	InChI=1S/C14H10N2O2S2/c15-13(16)12-6-8-3-4-9(7-11(8)20-12)18-14(17)10-2-1-5-19-10/h1-7H,(H3,15,16)	OTGQTQBPQCRNRG-UHFFFAOYSA-N					compound annotation
0391_011001	915759-45-4	C18H19F3N2O4S2	2.6928	16727102		O=S(=O)(NC1CCNCC1)c1c(C(F)(F)F)ccc(S(=O)(=O)c2ccccc2)c1	InChI=1S/C18H19F3N2O4S2/c19-18(20,21)16-7-6-15(28(24,25)14-4-2-1-3-5-14)12-17(16)29(26,27)23-13-8-10-22-11-9-13/h1-7,12-13,22-23H,8-11H2	ITBGJNVZJBVPLJ-UHFFFAOYSA-N					compound annotation
0391_011002	Kinase inhibitor-1	C19H18BrClN6O	2.9633	51037658	CN(C)C/C=C/C(=O)NC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)Br	CN(C)CC=CC(=O)Nc1ncc2ncnc(Nc3cc(Br)c(Cl)cc3)c2c1	InChI=1S/C19H18BrClN6O/c1-27(2)7-3-4-18(28)26-17-9-13-16(10-22-17)23-11-24-19(13)25-12-5-6-15(21)14(20)8-12/h3-6,8-11H,7H2,1-2H3,(H,22,26,28)(H,23,24,25)/b4-3+	QBACGOWRJDBXSG-ONEGZZNKSA-N					removed another duplicate entry; compound annotation
0391_011004	MK-2461	C24H25N5O5S	3.0943	44137946	CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)C[C@@H]5COCCO5)N=C2	CN(CC1COCCO1)S(=O)(=O)Nc1cc2c(cc1)ccc1c(cc(-c3cn(C)nc3)cn1)c2=O	InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1	JGEBLDKNWBUGRZ-HXUWFJFHSA-N					doublet; compound annotation
0391_011005	MK-2461	C24H25N5O5S	3.1494	44137946	CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)C[C@@H]5COCCO5)N=C2	CN(CC1COCCO1)S(=O)(=O)Nc1cc2c(cc1)ccc1c(cc(-c3cn(C)nc3)cn1)c2=O	InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1	JGEBLDKNWBUGRZ-HXUWFJFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_011007	RG7834	C22H27NO6	3.3773	134305955	CC(C)[C@@H]1CC2=CC(=C(C=C2C3=CC(=O)C(=C[NH+]13)C(=O)[O-])OC)OCCCOC	COCCCOc1c(OC)cc2c(c1)CC(C(C)C)n1cc(C(=O)O)c(=O)cc-21	InChI=1S/C22H27NO6/c1-13(2)17-8-14-9-21(29-7-5-6-27-3)20(28-4)10-15(14)18-11-19(24)16(22(25)26)12-23(17)18/h9-13,17H,5-8H2,1-4H3,(H,25,26)/t17-/m0/s1	KBXLMOYQNDMHQT-KRWDZBQOSA-N					removed another duplicate entry; compound annotation
0391_011009	BAY-1436032	C26H30F3N3O3	4.179	118310260	C[C@H]1C[C@H](CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F	CC1CC(n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1	InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1	RNMAUIMMNAHKQR-QFBILLFUSA-N					doublet; compound annotation
0391_011010	CIL56	C23H27N3O5S2	4.7857	654092		O=S(=O)(c1cc2c(cc1)-c1c(cc(S(=O)(=O)N3CCCCC3)cc1)C2=NO)N1CCCCC1	InChI=1S/C23H27N3O5S2/c27-24-23-21-15-17(32(28,29)25-11-3-1-4-12-25)7-9-19(21)20-10-8-18(16-22(20)23)33(30,31)26-13-5-2-6-14-26/h7-10,15-16,27H,1-6,11-14H2	XYZXEEIUKQGUHB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011013	BAY-1436032	C26H30F3N3O3	5.5594	118310260	C[C@H]1C[C@H](CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F	CC1CC(n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1	InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1	RNMAUIMMNAHKQR-QFBILLFUSA-N					doublet; compound annotation
0391_011014	BAY-1436032	C26H30F3N3O3	5.7168	118310260	C[C@H]1C[C@H](CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F	CC1CC(n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1	InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1	RNMAUIMMNAHKQR-QFBILLFUSA-N					doublet; compound annotation
0391_011015	6310-41-4	C9H11NOS	2.1523	237769		CSc1ccccc1NC(C)=O	InChI=1S/C9H11NOS/c1-7(11)10-8-5-3-4-6-9(8)12-2/h3-6H,1-2H3,(H,10,11)	AMWFIKFWXRBICX-UHFFFAOYSA-N					compound annotation
0391_011016	Chlorazanil	C9H8ClN5	2.1973	10374		Nc1nc(Nc2ccc(Cl)cc2)ncn1	InChI=1S/C9H8ClN5/c10-6-1-3-7(4-2-6)14-9-13-5-12-8(11)15-9/h1-5H,(H3,11,12,13,14,15)	YRZQHIVOIFJEEE-UHFFFAOYSA-N					compound annotation
0391_011017	5-Aminofluorescein	C20H13NO5	2.4037	76845		Nc1cc2c(cc1)C1(OC2=O)c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C20H13NO5/c21-10-1-4-14-13(7-10)19(24)26-20(14)15-5-2-11(22)8-17(15)25-18-9-12(23)3-6-16(18)20/h1-9,22-23H,21H2	GZAJOEGTZDUSKS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011019	HDAC-IN-3	C22H33N3O4	2.6186	53630042	C1CCC(CC1)[C@@H](C(=O)OC2CCCC2)NCC3=CN=C(C=C3)CCC(=O)NO	O=C(CCc1ncc(CNC(C(=O)OC2CCCC2)C2CCCCC2)cc1)NO	InChI=1S/C22H33N3O4/c26-20(25-28)13-12-18-11-10-16(14-23-18)15-24-21(17-6-2-1-3-7-17)22(27)29-19-8-4-5-9-19/h10-11,14,17,19,21,24,28H,1-9,12-13,15H2,(H,25,26)/t21-/m0/s1	AFDPFLDWOXXHQM-NRFANRHFSA-N					doublet; compound annotation
0391_011020	HDAC-IN-3	C22H33N3O4	2.6214	53630042	C1CCC(CC1)[C@@H](C(=O)OC2CCCC2)NCC3=CN=C(C=C3)CCC(=O)NO	O=C(CCc1ncc(CNC(C(=O)OC2CCCC2)C2CCCCC2)cc1)NO	InChI=1S/C22H33N3O4/c26-20(25-28)13-12-18-11-10-16(14-23-18)15-24-21(17-6-2-1-3-7-17)22(27)29-19-8-4-5-9-19/h10-11,14,17,19,21,24,28H,1-9,12-13,15H2,(H,25,26)/t21-/m0/s1	AFDPFLDWOXXHQM-NRFANRHFSA-N					doublet; removed another duplicate entry; compound annotation
0391_011022	Cinoctramide	C19H27NO4	3.7905	6443803	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCCCCCC2	COc1cc(C=CC(=O)N2CCCCCCC2)cc(OC)c1OC	InChI=1S/C19H27NO4/c1-22-16-13-15(14-17(23-2)19(16)24-3)9-10-18(21)20-11-7-5-4-6-8-12-20/h9-10,13-14H,4-8,11-12H2,1-3H3/b10-9+	MDGVCMGGLSOVIQ-MDZDMXLPSA-N					doublet; removed another duplicate entry; compound annotation
0391_011025	Cinoctramide	C19H27NO4	3.9501	6443803	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCCCCCC2	COc1cc(C=CC(=O)N2CCCCCCC2)cc(OC)c1OC	InChI=1S/C19H27NO4/c1-22-16-13-15(14-17(23-2)19(16)24-3)9-10-18(21)20-11-7-5-4-6-8-12-20/h9-10,13-14H,4-8,11-12H2,1-3H3/b10-9+	MDGVCMGGLSOVIQ-MDZDMXLPSA-N					doublet; compound annotation
0391_011026	Cinoctramide	C19H27NO4	3.9533	6443803	COC1=CC(=CC(=C1OC)OC)/C=C/C(=O)N2CCCCCCC2	COc1cc(C=CC(=O)N2CCCCCCC2)cc(OC)c1OC	InChI=1S/C19H27NO4/c1-22-16-13-15(14-17(23-2)19(16)24-3)9-10-18(21)20-11-7-5-4-6-8-12-20/h9-10,13-14H,4-8,11-12H2,1-3H3/b10-9+	MDGVCMGGLSOVIQ-MDZDMXLPSA-N					doublet; removed another duplicate entry; compound annotation
0391_011028	Fluazinam	C13H4Cl2F6N4O4	5.5545	91731		O=[N+]([O-])c1c(Nc2c(Cl)cc(C(F)(F)F)cn2)c([N+](=O)[O-])c(Cl)c(C(F)(F)F)c1	InChI=1S/C13H4Cl2F6N4O4/c14-6-1-4(12(16,17)18)3-22-11(6)23-9-7(24(26)27)2-5(13(19,20)21)8(15)10(9)25(28)29/h1-3H,(H,22,23)	UZCGKGPEKUCDTF-UHFFFAOYSA-N					compound annotation
0391_011029	AVERMECTIN B1A	C48H72O14	6.0235	6434889	CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C	CCC(C)C1OC2(C=CC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	InChI=1S/C48H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,17-19,25-26,28,30-31,33-45,49-50,52H,11,16,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1	RRZXIRBKKLTSOM-XPNPUAGNSA-N					removed another duplicate entry; compound annotation
0391_011031	N6,N6-Dimethyladenosine	C12H17N5O4	0.9297	440004	CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	CN(C)c1ncnc2c1ncn2C1OC(CO)C(O)C1O	InChI=1S/C12H17N5O4/c1-16(2)10-7-11(14-4-13-10)17(5-15-7)12-9(20)8(19)6(3-18)21-12/h4-6,8-9,12,18-20H,3H2,1-2H3/t6-,8-,9-,12-/m1/s1	WVGPGNPCZPYCLK-WOUKDFQISA-N					compound annotation
0391_011032	Acridine orange	C17H19N3	2.7883	62344		CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2	InChI=1S/C17H19N3/c1-19(2)14-7-5-12-9-13-6-8-15(20(3)4)11-17(13)18-16(12)10-14/h5-11H,1-4H3	DPKHZNPWBDQZCN-UHFFFAOYSA-N					doublet; compound annotation
0391_011033	Acridine orange	C17H19N3	2.7911	62344		CN(C)c1cc2c(cc1)cc1ccc(N(C)C)cc1n2	InChI=1S/C17H19N3/c1-19(2)14-7-5-12-9-13-6-8-15(20(3)4)11-17(13)18-16(12)10-14/h5-11H,1-4H3	DPKHZNPWBDQZCN-UHFFFAOYSA-N					doublet; compound annotation
0391_011034	VERUCERFONT	C22H26N6O2	3.2111	11596613	CC[C@@H](C1=NC(=NO1)C)NC2=CC(=NC3=C(C(=NN23)C)C4=C(C=C(C=C4)OC)C)C	CCC(Nc1cc(C)nc2c(-c3c(C)cc(OC)cc3)c(C)nn12)c1nc(C)no1	InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1	VKHVAUKFLBBZFJ-SFHVURJKSA-N					doublet; compound annotation
0391_011035	VERUCERFONT	C22H26N6O2	3.3082	11596613	CC[C@@H](C1=NC(=NO1)C)NC2=CC(=NC3=C(C(=NN23)C)C4=C(C=C(C=C4)OC)C)C	CCC(Nc1cc(C)nc2c(-c3c(C)cc(OC)cc3)c(C)nn12)c1nc(C)no1	InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1	VKHVAUKFLBBZFJ-SFHVURJKSA-N					doublet; compound annotation
0391_011036	amyloid P-IN-1	C30H44N2O14	3.3598	92136018	C1C[C@@H](N(C1)C(=O)CCCCC(=O)N2CCC[C@@H]2C(=O)OCOC(=O)OC3CCOCC3)C(=O)OCOC(=O)OC4CCOCC4	O=C(OCOC(=O)C1CCCN1C(=O)CCCCC(=O)N1CCCC1C(=O)OCOC(=O)OC1CCOCC1)OC1CCOCC1	InChI=1S/C30H44N2O14/c33-25(31-13-3-5-23(31)27(35)41-19-43-29(37)45-21-9-15-39-16-10-21)7-1-2-8-26(34)32-14-4-6-24(32)28(36)42-20-44-30(38)46-22-11-17-40-18-12-22/h21-24H,1-20H2/t23-,24-/m1/s1	KSKLDMGKWDUQCT-DNQXCXABSA-N					removed another duplicate entry; compound annotation
0391_011038	gamma-secretase modulator 2	C25H22F4N6O2	3.41	59472574		COc1c(-n2cnc(C)c2)ccc(-c2cn(C3CCc4c(cccc4F)N(CC(F)(F)F)C3=O)nn2)c1	InChI=1S/C25H22F4N6O2/c1-15-11-33(14-30-15)21-8-6-16(10-23(21)37-2)19-12-35(32-31-19)22-9-7-17-18(26)4-3-5-20(17)34(24(22)36)13-25(27,28)29/h3-6,8,10-12,14,22H,7,9,13H2,1-2H3	AAHNBILIYONQLX-UHFFFAOYSA-N					compound annotation
0391_011039	PGD2-IN-1	C23H23Cl2N3O3	3.9292	11669780		COc1nc(-c2cc(C(C)(C)C(=O)O)ccc2)cc(NCCc2c(Cl)cc(Cl)cc2)n1	InChI=1S/C23H23Cl2N3O3/c1-23(2,21(29)30)16-6-4-5-15(11-16)19-13-20(28-22(27-19)31-3)26-10-9-14-7-8-17(24)12-18(14)25/h4-8,11-13H,9-10H2,1-3H3,(H,29,30)(H,26,27,28)	FJKKCRCBBAXLQZ-UHFFFAOYSA-N					compound annotation
0391_011040	SGN-2FF	C6H11FO4	4.2824	44544736	C[C@H]1[C@H]([C@H]([C@@H](C(O1)O)F)O)O	CC1OC(O)C(F)C(O)C1O	InChI=1S/C6H11FO4/c1-2-4(8)5(9)3(7)6(10)11-2/h2-6,8-10H,1H3/t2-,3-,4+,5-,6?/m0/s1	IRKXGKIPOMIQOD-ZZWDRFIYSA-N					compound annotation
0391_011041	KIN1148	C19H11N3OS2	4.5998	71549151		O=C(Nc1nc2c(s1)c1c(cc2)scn1)c1cc2ccccc2cc1	InChI=1S/C19H11N3OS2/c23-18(13-6-5-11-3-1-2-4-12(11)9-13)22-19-21-14-7-8-15-16(17(14)25-19)20-10-24-15/h1-10H,(H,21,22,23)	YAISOECYKYATLL-UHFFFAOYSA-N					compound annotation
0391_011042	300657-03-8	C31H26N2O3	5.2868	16122583		CCc1c(-c2ccccc2)c(-c2ccccc2)nn1-c1ccccc1-c1cc(OCC(=O)O)ccc1	InChI=1S/C31H26N2O3/c1-2-27-30(22-12-5-3-6-13-22)31(23-14-7-4-8-15-23)32-33(27)28-19-10-9-18-26(28)24-16-11-17-25(20-24)36-21-29(34)35/h3-20H,2,21H2,1H3,(H,34,35)	SJRVJRYZAQYCEE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011044	Sinomenine	C19H23NO4	1.2334	5459308	CN1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC	COC1=CC2C3Cc4c(c(O)c(OC)cc4)C2(CCN3C)CC1=O	InChI=1S/C19H23NO4/c1-20-7-6-19-10-14(21)16(24-3)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9,12-13,22H,6-8,10H2,1-3H3/t12-,13+,19-/m1/s1	INYYVPJSBIVGPH-QHRIQVFBSA-N					doublet; removed another duplicate entry; compound annotation
0391_011046	Sinomenine	C19H23NO4	1.3956	5459308	CN1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC	COC1=CC2C3Cc4c(c(O)c(OC)cc4)C2(CCN3C)CC1=O	InChI=1S/C19H23NO4/c1-20-7-6-19-10-14(21)16(24-3)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9,12-13,22H,6-8,10H2,1-3H3/t12-,13+,19-/m1/s1	INYYVPJSBIVGPH-QHRIQVFBSA-N					doublet; compound annotation
0391_011047	SCHEMBL9978379	C18H22F2N4O2	2.1509	54673648		CC(=O)N1CCN(CCOCc2nn(-c3cc(F)c(F)cc3)cc2)CC1	InChI=1S/C18H22F2N4O2/c1-14(25)23-8-6-22(7-9-23)10-11-26-13-15-4-5-24(21-15)16-2-3-17(19)18(20)12-16/h2-5,12H,6-11,13H2,1H3	COKUNRYWXTVUAH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011049	Nilotinib	C28H22F3N7O	2.9359	644241		Cc1cn(-c2cc(C(F)(F)F)cc(NC(=O)c3cc(Nc4nccc(-c5cnccc5)n4)c(C)cc3)c2)cn1	InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)	HHZIURLSWUIHRB-UHFFFAOYSA-N					doublet; compound annotation
0391_011050	PERHEXILINE	C19H35N	4.2233	4746		C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1	InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2	CYXKNKQEMFBLER-UHFFFAOYSA-N					compound annotation
0391_011051	Ethylene dimethanesulfonate	C4H10O6S2	0.916	20796		CS(=O)(=O)OCCOS(C)(=O)=O	InChI=1S/C4H10O6S2/c1-11(5,6)9-3-4-10-12(2,7)8/h3-4H2,1-2H3	QSQFARNGNIZGAW-UHFFFAOYSA-N					compound annotation
0391_011052	TETRAMISOLE	C11H12N2S	1.1444	3913		c1ccc(C2CN3CCSC3=N2)cc1	InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2	HLFSDGLLUJUHTE-UHFFFAOYSA-N					compound annotation
0391_011053	Ropivacaine	C17H26N2O	2.0308	175805	CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C	CCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1	ZKMNUMMKYBVTFN-HNNXBMFYSA-N					doublet; compound annotation
0391_011054	propranolol	C16H21NO2	2.5163	4946		CC(C)NCC(O)COc1cccc2ccccc12	InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3	AQHHHDLHHXJYJD-UHFFFAOYSA-N					compound annotation
0391_011055	Platycodin D	C57H92O28	2.7509	162859	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2OC(=O)[C@]34CCC(C[C@H]3C5=CC[C@H]6[C@]([C@@]5(C[C@H]4O)C)(CC[C@@H]7[C@@]6(C[C@@H]([C@@H](C7(CO)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)C)(C)C)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O[C@H]1[C@@H]([C@](CO1)(CO)O)O)O	CC1OC(OC2C(OC(=O)C34CCC(C)(C)CC3C3=CCC5C6(C)CC(O)C(OC7OC(CO)C(O)C(O)C7O)C(CO)(CO)C6CCC5(C)C3(C)CC4O)OCC(O)C2O)C(O)C(O)C1OC1OCC(O)C(OC2OCC(O)(CO)C2O)C1O	InChI=1S/C57H92O28/c1-23-40(81-45-39(72)41(28(64)18-76-45)82-49-43(73)56(75,21-61)22-78-49)36(69)38(71)46(79-23)83-42-33(66)27(63)17-77-48(42)85-50(74)57-12-11-51(2,3)13-25(57)24-7-8-30-52(4)14-26(62)44(84-47-37(70)35(68)34(67)29(16-58)80-47)55(19-59,20-60)31(52)9-10-53(30,5)54(24,6)15-32(57)65/h7,23,25-49,58-73,75H,8-22H2,1-6H3/t23-,25-,26-,27-,28+,29+,30+,31+,32+,33-,34+,35-,36-,37+,38+,39+,40-,41-,42+,43-,44-,45-,46-,47-,48-,49-,52+,53+,54+,56+,57+/m0/s1	CYBWUNOAQPMRBA-NDTOZIJESA-N					removed another duplicate entry; compound annotation
0391_011057	hypocrellin a	C30H26O10	4.8346	3664		COc1c(O)c2c3c(c4c(OC)cc(=O)c5c(O)c(OC)c6c(c54)c3c1CC(C)(O)C6C(C)=O)c(OC)cc2=O	InChI=1S/C30H26O10/c1-10(31)25-24-22-16-11(9-30(25,2)36)28(39-5)26(34)17-12(32)7-14(37-3)19(21(16)17)20-15(38-4)8-13(33)18(23(20)22)27(35)29(24)40-6/h7-8,25,34-36H,9H2,1-6H3	VANSZAOQCMTTPB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011059	hyoscyamine	C17H23NO3	1.6104	154417	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16-/m1/s1	RKUNBYITZUJHSG-VFSICIBPSA-N					compound annotation
0391_011060	AZD6738	C20H24N6O2S	2.1449	54761306	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4	CC1COCCN1c1nc(-c2c3cc[nH]c3ncc2)nc(C2(S(C)(=N)=O)CC2)c1	InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)17-11-16(20(5-6-20)29(2,21)27)24-19(25-17)15-4-8-23-18-14(15)3-7-22-18/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1	OHUHVTCQTUDPIJ-JYCIKRDWSA-N					doublet; compound annotation
0391_011061	AZD6738	C20H24N6O2S	2.1479	54761306	C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4	CC1COCCN1c1nc(-c2c3cc[nH]c3ncc2)nc(C2(S(C)(=N)=O)CC2)c1	InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)17-11-16(20(5-6-20)29(2,21)27)24-19(25-17)15-4-8-23-18-14(15)3-7-22-18/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1	OHUHVTCQTUDPIJ-JYCIKRDWSA-N					doublet; compound annotation
0391_011062	Vilanterol	C24H33Cl2NO5	3.1748	10184665	C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl	OCc1c(O)ccc(C(O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)c1	InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1	DAFYYTQWSAWIGS-DEOSSOPVSA-N					doublet; compound annotation
0391_011063	L-thyroxine	C15H11I4NO4	3.271	5819	C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N	NC(Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O	InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1	XUIIKFGFIJCVMT-LBPRGKRZSA-N					doublet; compound annotation
0391_011064	2244035-16-1	C26H24ClNO3	4.4881	139035046	CC(C1=C(C=CC=C1Cl)C2CC2)OC3=CC4=C(C(=CN=C4C=C3)/C=C/C(=O)O)C5CC5	CC(Oc1cc2c(C3CC3)c(C=CC(=O)O)cnc2cc1)c1c(Cl)cccc1C1CC1	InChI=1S/C26H24ClNO3/c1-15(25-20(16-5-6-16)3-2-4-22(25)27)31-19-10-11-23-21(13-19)26(17-7-8-17)18(14-28-23)9-12-24(29)30/h2-4,9-17H,5-8H2,1H3,(H,29,30)/b12-9+	HOMQCLNBKVHZGD-FMIVXFBMSA-N					doublet; compound annotation
0391_011065	2244035-16-1	C26H24ClNO3	4.9061	139035046	CC(C1=C(C=CC=C1Cl)C2CC2)OC3=CC4=C(C(=CN=C4C=C3)/C=C/C(=O)O)C5CC5	CC(Oc1cc2c(C3CC3)c(C=CC(=O)O)cnc2cc1)c1c(Cl)cccc1C1CC1	InChI=1S/C26H24ClNO3/c1-15(25-20(16-5-6-16)3-2-4-22(25)27)31-19-10-11-23-21(13-19)26(17-7-8-17)18(14-28-23)9-12-24(29)30/h2-4,9-17H,5-8H2,1H3,(H,29,30)/b12-9+	HOMQCLNBKVHZGD-FMIVXFBMSA-N					doublet; compound annotation
0391_011066	UBCS039	C16H13N3	2.4709	2803797		c1cc(C2Nc3ccccc3-n3cccc23)cnc1	InChI=1S/C16H13N3/c1-2-7-14-13(6-1)18-16(12-5-3-9-17-11-12)15-8-4-10-19(14)15/h1-11,16,18H	BSOBGTYXYGHUTD-UHFFFAOYSA-N					compound annotation
0391_011067	N-Ethyl-1,2-dimethyl-6-(methylimino)-N-phenyl-1,6-dihydropyrimidin-4-amine	C15H20N4	2.7101	123984		CCN(c1ccccc1)c1cc(=NC)n(C)c(C)n1	InChI=1S/C15H20N4/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15/h6-11H,5H2,1-4H3	JABSKGQQWUDVRU-UHFFFAOYSA-N					compound annotation
0391_011068	nile blue(1+)	C20H20N3O+	3.3611	16939		CC[N+](CC)=c1ccc2nc3c(cc(N)c4ccccc43)oc-2c1	InChI=1S/C20H19N3O/c1-3-23(4-2)13-9-10-17-18(11-13)24-19-12-16(21)14-7-5-6-8-15(14)20(19)22-17/h5-12,21H,3-4H2,1-2H3/p+1	YQSIDWSTCJNDPD-UHFFFAOYSA-O					compound annotation
0391_011069	DC_05	C25H25N3O	3.4396	16451230		OC(CNCCc1c[nH]c2ccccc12)Cn1c2ccccc2c2ccccc21	InChI=1S/C25H25N3O/c29-19(16-26-14-13-18-15-27-23-10-4-1-7-20(18)23)17-28-24-11-5-2-8-21(24)22-9-3-6-12-25(22)28/h1-12,15,19,26-27,29H,13-14,16-17H2	LJWMTSMUQJNHOC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011071	AZD7687	C21H25N3O3	3.502	42636350		Cc1nc(C)c(-c2ccc(C3CCC(CC(=O)O)CC3)cc2)nc1C(N)=O	InChI=1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26)	YXFNPRHZMOGREC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011073	SW-100	C17H17ClN2O2	4.027	130345472		O=C(NO)c1ccc(CN2CCCc3c2ccc(Cl)c3)cc1	InChI=1S/C17H17ClN2O2/c18-15-7-8-16-14(10-15)2-1-9-20(16)11-12-3-5-13(6-4-12)17(21)19-22/h3-8,10,22H,1-2,9,11H2,(H,19,21)	MNAYBFFSFQRSIT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011075	388592-44-7	C17H16BrNO3S	4.3418	3574452		COc1cc(OC)c(N2C(=O)CSC2c2cc(Br)ccc2)cc1	InChI=1S/C17H16BrNO3S/c1-21-13-6-7-14(15(9-13)22-2)19-16(20)10-23-17(19)11-4-3-5-12(18)8-11/h3-9,17H,10H2,1-2H3	MVWNPZYLNLATCH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011077	388592-44-7	C17H16BrNO3S	4.3464	3574452		COc1cc(OC)c(N2C(=O)CSC2c2cc(Br)ccc2)cc1	InChI=1S/C17H16BrNO3S/c1-21-13-6-7-14(15(9-13)22-2)19-16(20)10-23-17(19)11-4-3-5-12(18)8-11/h3-9,17H,10H2,1-2H3	MVWNPZYLNLATCH-UHFFFAOYSA-N					doublet; compound annotation
0391_011078	CHEMBL4803554	C27H32F3N2O2+	4.6688	129230522	C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)CN2C3=CC=CC=C3[N+](=C2C4=CC(=CC=C4)C(F)(F)F)C)C(C)C	CC1CCC(C(C)C)C(OC(=O)Cn2c(-c3cc(C(F)(F)F)ccc3)[n+](C)c3ccccc32)C1	InChI=1S/C27H32F3N2O2/c1-17(2)21-13-12-18(3)14-24(21)34-25(33)16-32-23-11-6-5-10-22(23)31(4)26(32)19-8-7-9-20(15-19)27(28,29)30/h5-11,15,17-18,21,24H,12-14,16H2,1-4H3/q+1/t18-,21+,24-/m1/s1	SEQMOATXHAQCSW-UTSGNWPNSA-N					compound annotation
0391_011079	Veledimex	C27H38N2O3	5.6601	57751161	CCC[C@H](C(C)(C)C)N(C(=O)C1=CC(=CC(=C1)C)C)NC(=O)C2=C(C(=CC=C2)OC)CC	CCCC(N(NC(=O)c1c(CC)c(OC)ccc1)C(=O)c1cc(C)cc(C)c1)C(C)(C)C	InChI=1S/C27H38N2O3/c1-9-12-24(27(5,6)7)29(26(31)20-16-18(3)15-19(4)17-20)28-25(30)22-13-11-14-23(32-8)21(22)10-2/h11,13-17,24H,9-10,12H2,1-8H3,(H,28,30)/t24-/m1/s1	LZWZPGLVHLSWQX-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_011081	1,3-Dimethyluracil	C6H8N2O2	0.6306	70122		Cn1ccc(=O)n(C)c1=O	InChI=1S/C6H8N2O2/c1-7-4-3-5(9)8(2)6(7)10/h3-4H,1-2H3	JSDBKAHWADVXFU-UHFFFAOYSA-N					compound annotation
0391_011082	2-Amino-3-hydroxybenzoic acid	C7H7NO3	0.7632	86		Nc1c(C(=O)O)cccc1O	InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)	WJXSWCUQABXPFS-UHFFFAOYSA-N					compound annotation
0391_011083	835872-35-0	C32H53N9O7S	2.402	11600115	CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N	CCC(C)C(NC(=O)C(CS)NC(=O)C(N)Cc1ccccc1)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)O	InChI=1S/C32H53N9O7S/c1-5-19(4)26(41-29(45)24(17-49)40-27(43)21(33)15-20-10-7-6-8-11-20)30(46)37-16-25(42)38-22(12-9-13-36-32(34)35)28(44)39-23(31(47)48)14-18(2)3/h6-8,10-11,18-19,21-24,26,49H,5,9,12-17,33H2,1-4H3,(H,37,46)(H,38,42)(H,39,44)(H,40,43)(H,41,45)(H,47,48)(H4,34,35,36)/t19-,21-,22-,23-,24-,26-/m0/s1	LADIUXCZKYKVRR-PSEZLDIXSA-N					compound annotation
0391_011084	1103500-20-4	C28H27Cl2N3O4	3.3899	25204767		Cn1cc(C(=O)O)c2c1cc(N1CCC(OCc3c(C4CC4)onc3-c3c(Cl)cccc3Cl)CC1)cc2	InChI=1S/C28H27Cl2N3O4/c1-32-14-20(28(34)35)19-8-7-17(13-24(19)32)33-11-9-18(10-12-33)36-15-21-26(31-37-27(21)16-5-6-16)25-22(29)3-2-4-23(25)30/h2-4,7-8,13-14,16,18H,5-6,9-12,15H2,1H3,(H,34,35)	RPVDFHPBGBMWID-UHFFFAOYSA-N					doublet; compound annotation
0391_011085	1103500-20-4	C28H27Cl2N3O4	3.4318	25204767		Cn1cc(C(=O)O)c2c1cc(N1CCC(OCc3c(C4CC4)onc3-c3c(Cl)cccc3Cl)CC1)cc2	InChI=1S/C28H27Cl2N3O4/c1-32-14-20(28(34)35)19-8-7-17(13-24(19)32)33-11-9-18(10-12-33)36-15-21-26(31-37-27(21)16-5-6-16)25-22(29)3-2-4-23(25)30/h2-4,7-8,13-14,16,18H,5-6,9-12,15H2,1H3,(H,34,35)	RPVDFHPBGBMWID-UHFFFAOYSA-N					doublet; compound annotation
0391_011086	CD73-IN-1	C18H17N3O4S	3.4398	130406413		NC(=O)c1c(O)ccc(S(=O)(=O)Nc2cc3c(cc2)cc(C2CC2)[nH]3)c1	InChI=1S/C18H17N3O4S/c19-18(23)14-9-13(5-6-17(14)22)26(24,25)21-12-4-3-11-7-15(10-1-2-10)20-16(11)8-12/h3-10,20-22H,1-2H2,(H2,19,23)	YUGALILHRFUCAY-UHFFFAOYSA-N					doublet; compound annotation
0391_011087	BET bromodomain inhibitor	C24H20ClN5O2	3.4906	72203613	CC1=NOC2=C1C3=C(C=C(C=C3)C4=CN(N=C4)C)C(=N[C@H]2CC(=O)N)C5=CC=C(C=C5)Cl	Cc1noc2c1-c1c(cc(-c3cn(C)nc3)cc1)C(c1ccc(Cl)cc1)=NC2CC(N)=O	InChI=1S/C24H20ClN5O2/c1-13-22-18-8-5-15(16-11-27-30(2)12-16)9-19(18)23(14-3-6-17(25)7-4-14)28-20(10-21(26)31)24(22)32-29-13/h3-9,11-12,20H,10H2,1-2H3,(H2,26,31)/t20-/m0/s1	QFLGNZXBWIQDLQ-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_011089	CD73-IN-1	C18H17N3O4S	3.4955	130406413		NC(=O)c1c(O)ccc(S(=O)(=O)Nc2cc3c(cc2)cc(C2CC2)[nH]3)c1	InChI=1S/C18H17N3O4S/c19-18(23)14-9-13(5-6-17(14)22)26(24,25)21-12-4-3-11-7-15(10-1-2-10)20-16(11)8-12/h3-10,20-22H,1-2H2,(H2,19,23)	YUGALILHRFUCAY-UHFFFAOYSA-N					doublet; compound annotation
0391_011090	1103500-20-4	C28H27Cl2N3O4	3.5673	25204767		Cn1cc(C(=O)O)c2c1cc(N1CCC(OCc3c(C4CC4)onc3-c3c(Cl)cccc3Cl)CC1)cc2	InChI=1S/C28H27Cl2N3O4/c1-32-14-20(28(34)35)19-8-7-17(13-24(19)32)33-11-9-18(10-12-33)36-15-21-26(31-37-27(21)16-5-6-16)25-22(29)3-2-4-23(25)30/h2-4,7-8,13-14,16,18H,5-6,9-12,15H2,1H3,(H,34,35)	RPVDFHPBGBMWID-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011092	PF-06869206	C15H14ClF3N4O2	3.6528	134159047	CC1=C(C2=C(N1)C(=C(C(=N2)C(F)(F)F)C#N)N3CCO[C@@H](C3)CO)Cl	Cc1c(Cl)c2c([nH]1)c(N1CCOC(CO)C1)c(C#N)c(C(F)(F)F)n2	InChI=1S/C15H14ClF3N4O2/c1-7-10(16)11-12(21-7)13(23-2-3-25-8(5-23)6-24)9(4-20)14(22-11)15(17,18)19/h8,21,24H,2-3,5-6H2,1H3/t8-/m0/s1	ATFQBBCQZKVZJN-QMMMGPOBSA-N					compound annotation
0391_011093	ST-193	C24H25N3O	3.953	3697969		COc1ccc(-n2cnc3c2ccc(NCc2ccc(C(C)C)cc2)c3)cc1	InChI=1S/C24H25N3O/c1-17(2)19-6-4-18(5-7-19)15-25-20-8-13-24-23(14-20)26-16-27(24)21-9-11-22(28-3)12-10-21/h4-14,16-17,25H,15H2,1-3H3	JPSZEXYTKSIPDW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011095	Phenethylamine	C8H11N	0.796	1001		NCCc1ccccc1	InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2	BHHGXPLMPWCGHP-UHFFFAOYSA-N					doublet; compound annotation
0391_011096	138529-46-1	C16H30N4O4S	1.0309	11199678	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCN)NC(=O)N2	NCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C16H30N4O4S/c17-5-7-23-9-10-24-8-6-18-14(21)4-2-1-3-13-15-12(11-25-13)19-16(22)20-15/h12-13,15H,1-11,17H2,(H,18,21)(H2,19,20,22)/t12-,13-,15-/m0/s1	LWISPDYGRSGXME-YDHLFZDLSA-N					doublet; removed another duplicate entry; compound annotation
0391_011098	138529-46-1	C16H30N4O4S	1.4519	11199678	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCN)NC(=O)N2	NCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C16H30N4O4S/c17-5-7-23-9-10-24-8-6-18-14(21)4-2-1-3-13-15-12(11-25-13)19-16(22)20-15/h12-13,15H,1-11,17H2,(H,18,21)(H2,19,20,22)/t12-,13-,15-/m0/s1	LWISPDYGRSGXME-YDHLFZDLSA-N					doublet; compound annotation
0391_011099	GNE 220	C25H26N8	2.0435	58279916		Cc1c2[nH]c3c(cc(-c4ccc(N5CCN(C)CC5)cc4)cn3)c2nc(-c2cn(C)nc2)n1	InChI=1S/C25H26N8/c1-16-22-23(30-24(28-16)19-14-27-32(3)15-19)21-12-18(13-26-25(21)29-22)17-4-6-20(7-5-17)33-10-8-31(2)9-11-33/h4-7,12-15H,8-11H2,1-3H3,(H,26,29)	HXIPOURWZRATPT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011101	582323-16-8	C11H6ClF2N3O	3.3216	10149311		O=C(Nc1cnc(Cl)nc1)c1cc(F)c(F)cc1	InChI=1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18)	IIBSHMFXVWTQSJ-UHFFFAOYSA-N					compound annotation
0391_011102	923562-23-6	C21H16ClF3N4	3.3463	59593294		FC(F)(F)c1ccc(CNc2ncc(Cc3c[nH]c4c3cc(Cl)cn4)cc2)cc1	InChI=1S/C21H16ClF3N4/c22-17-8-18-15(11-28-20(18)29-12-17)7-14-3-6-19(27-10-14)26-9-13-1-4-16(5-2-13)21(23,24)25/h1-6,8,10-12H,7,9H2,(H,26,27)(H,28,29)	MFXPJGJSKHZZGC-UHFFFAOYSA-N					doublet; compound annotation
0391_011103	848193-68-0	C13H13ClN2O	3.5546	707029	C1C[C@@H](C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N	NC(=O)C1CCCc2c1[nH]c1c2cc(Cl)cc1	InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)/t9-/m0/s1	FUZYTVDVLBBXDL-VIFPVBQESA-N					compound annotation
0391_011104	CBR-5884	C14H12N2O4S2	4.3151	4674993		CCOC(=O)c1c(C)c(SC#N)c(NC(=O)c2ccco2)s1	InChI=1S/C14H12N2O4S2/c1-3-19-14(18)11-8(2)10(21-7-15)13(22-11)16-12(17)9-5-4-6-20-9/h4-6H,3H2,1-2H3,(H,16,17)	QBVIRPJBDIZKBC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011106	923562-23-6	C21H16ClF3N4	4.4214	59593294		FC(F)(F)c1ccc(CNc2ncc(Cc3c[nH]c4c3cc(Cl)cn4)cc2)cc1	InChI=1S/C21H16ClF3N4/c22-17-8-18-15(11-28-20(18)29-12-17)7-14-3-6-19(27-10-14)26-9-13-1-4-16(5-2-13)21(23,24)25/h1-6,8,10-12H,7,9H2,(H,26,27)(H,28,29)	MFXPJGJSKHZZGC-UHFFFAOYSA-N					doublet; compound annotation
0391_011107	NSC305787	C25H30Cl2N2O	4.752	470998		OC(c1cc(C23CC4CC(CC(C4)C2)C3)nc2c1cc(Cl)cc2Cl)C1CCCCN1	InChI=1S/C25H30Cl2N2O/c26-17-8-18-19(24(30)21-3-1-2-4-28-21)10-22(29-23(18)20(27)9-17)25-11-14-5-15(12-25)7-16(6-14)13-25/h8-10,14-16,21,24,28,30H,1-7,11-13H2	YNGQUUFYBFKLNH-UHFFFAOYSA-N					doublet; compound annotation
0391_011108	NSC305787	C25H30Cl2N2O	4.862	470998		OC(c1cc(C23CC4CC(CC(C4)C2)C3)nc2c1cc(Cl)cc2Cl)C1CCCCN1	InChI=1S/C25H30Cl2N2O/c26-17-8-18-19(24(30)21-3-1-2-4-28-21)10-22(29-23(18)20(27)9-17)25-11-14-5-15(12-25)7-16(6-14)13-25/h8-10,14-16,21,24,28,30H,1-7,11-13H2	YNGQUUFYBFKLNH-UHFFFAOYSA-N					doublet; compound annotation
0391_011109	Sarolaner	C23H18Cl2F4N2O5S	5.1497	73169092	CS(=O)(=O)CC(=O)N1CC2(C1)C3=C(CO2)C=C(C=C3)C4=NO[C@@](C4)(C5=CC(=C(C(=C5)Cl)F)Cl)C(F)(F)F	CS(=O)(=O)CC(=O)N1CC2(C1)OCc1c2ccc(C2=NOC(c3cc(Cl)c(F)c(Cl)c3)(C(F)(F)F)C2)c1	InChI=1S/C23H18Cl2F4N2O5S/c1-37(33,34)9-19(32)31-10-21(11-31)15-3-2-12(4-13(15)8-35-21)18-7-22(36-30-18,23(27,28)29)14-5-16(24)20(26)17(25)6-14/h2-6H,7-11H2,1H3/t22-/m0/s1	FLEFKKUZMDEUIP-QFIPXVFZSA-N					doublet; compound annotation
0391_011110	Sarolaner	C23H18Cl2F4N2O5S	5.1527	73169092	CS(=O)(=O)CC(=O)N1CC2(C1)C3=C(CO2)C=C(C=C3)C4=NO[C@@](C4)(C5=CC(=C(C(=C5)Cl)F)Cl)C(F)(F)F	CS(=O)(=O)CC(=O)N1CC2(C1)OCc1c2ccc(C2=NOC(c3cc(Cl)c(F)c(Cl)c3)(C(F)(F)F)C2)c1	InChI=1S/C23H18Cl2F4N2O5S/c1-37(33,34)9-19(32)31-10-21(11-31)15-3-2-12(4-13(15)8-35-21)18-7-22(36-30-18,23(27,28)29)14-5-16(24)20(26)17(25)6-14/h2-6H,7-11H2,1H3/t22-/m0/s1	FLEFKKUZMDEUIP-QFIPXVFZSA-N					doublet; compound annotation
0391_011111	SC-560	C17H12ClF3N2O	5.6155	4306515		COc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	InChI=1S/C17H12ClF3N2O/c1-24-14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3	PQUGCKBLVKJMNT-UHFFFAOYSA-N					compound annotation
0391_011112	(Z)-9-Propenyladenine	C8H9N5	0.7092	97304985	C/C=C\N1C=NC2=C(N=CN=C21)N	CC=Cn1cnc2c(N)ncnc21	InChI=1S/C8H9N5/c1-2-3-13-5-12-6-7(9)10-4-11-8(6)13/h2-5H,1H3,(H2,9,10,11)/b3-2-	ACWCANXGLNLMJB-IHWYPQMZSA-N					doublet; compound annotation
0391_011113	(Z)-9-Propenyladenine	C8H9N5	1.0361	97304985	C/C=C\N1C=NC2=C(N=CN=C21)N	CC=Cn1cnc2c(N)ncnc21	InChI=1S/C8H9N5/c1-2-3-13-5-12-6-7(9)10-4-11-8(6)13/h2-5H,1H3,(H2,9,10,11)/b3-2-	ACWCANXGLNLMJB-IHWYPQMZSA-N					doublet; compound annotation
0391_011114	Mutated EGFR-IN-1	C25H31N7O	2.0602	78358313		COc1c(Nc2nccc(-c3cn(C)c4ccccc34)n2)cc(N)c(N(C)CCN(C)C)c1	InChI=1S/C25H31N7O/c1-30(2)12-13-31(3)23-15-24(33-5)21(14-19(23)26)29-25-27-11-10-20(28-25)18-16-32(4)22-9-7-6-8-17(18)22/h6-11,14-16H,12-13,26H2,1-5H3,(H,27,28,29)	HTNTZPBKKCORTP-UHFFFAOYSA-N					compound annotation
0391_011115	DC661	C31H39Cl2N5	2.6495	130467298		CN(CCCCCCNc1ccnc2cc(Cl)ccc12)CCCCCCNc1ccnc2cc(Cl)ccc12	InChI=1S/C31H39Cl2N5/c1-38(20-8-4-2-6-16-34-28-14-18-36-30-22-24(32)10-12-26(28)30)21-9-5-3-7-17-35-29-15-19-37-31-23-25(33)11-13-27(29)31/h10-15,18-19,22-23H,2-9,16-17,20-21H2,1H3,(H,34,36)(H,35,37)	VJKCWFZTSDXOBS-UHFFFAOYSA-N					compound annotation
0391_011116	Flavopiridol	C21H20ClNO5	2.6528	5287969	CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2ccccc2Cl)cc3=O)C(O)C1	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	BIIVYFLTOXDAOV-YVEFUNNKSA-N					doublet; compound annotation
0391_011117	Flavopiridol	C21H20ClNO5	2.9522	5287969	CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O	CN1CCC(c2c(O)cc(O)c3c2oc(-c2ccccc2Cl)cc3=O)C(O)C1	InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	BIIVYFLTOXDAOV-YVEFUNNKSA-N					doublet; compound annotation
0391_011118	NIH-12848	C20H14F3N3S	3.4255	3235425		FC(F)(F)c1ccccc1-c1nc2ccccc2c(NCc2cccs2)n1	InChI=1S/C20H14F3N3S/c21-20(22,23)16-9-3-1-7-14(16)19-25-17-10-4-2-8-15(17)18(26-19)24-12-13-6-5-11-27-13/h1-11H,12H2,(H,24,25,26)	QBDAEJRHUCSSPR-UHFFFAOYSA-N					compound annotation
0391_011119	IDO-IN-1	C9H7BrFN5O2	3.4414	135741412		Nc1nonc1C(=Nc1cc(Br)c(F)cc1)NO	InChI=1S/C9H7BrFN5O2/c10-5-3-4(1-2-6(5)11)13-9(14-17)7-8(12)16-18-15-7/h1-3,17H,(H2,12,16)(H,13,14)	ORHZJUSHZUCMKR-UHFFFAOYSA-N					compound annotation
0391_011120	VT-464 (R enantiomer)	C18H17F4N3O3	4.1125	78357817	CC(C)[C@@](C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O	CC(C)C(O)(c1cc2cc(OC(F)F)c(OC(F)F)cc2cc1)c1n[nH]nc1	InChI=1S/C18H17F4N3O3/c1-9(2)18(26,15-8-23-25-24-15)12-4-3-10-6-13(27-16(19)20)14(28-17(21)22)7-11(10)5-12/h3-9,16-17,26H,1-2H3,(H,23,24,25)/t18-/m1/s1	ZBRAJOQFSNYJMF-GOSISDBHSA-N					compound annotation
0391_011121	939981-37-0	C40H49Cl2N5O4	4.2909	17754765	CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CC(=O)N4CCOCC4)(C)C5=CC=C(C=C5)Cl)(C)C6=CC=C(C=C6)Cl	CCOc1c(C2=NC(C)(c3ccc(Cl)cc3)C(C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CC(=O)N3CCOCC3)CC2)ccc(C(C)(C)C)c1	InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1	DJZBZZRLUQDRII-IOLBBIBUSA-N					doublet; compound annotation
0391_011122	939981-37-0	C40H49Cl2N5O4	4.7423	17754765	CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CC(=O)N4CCOCC4)(C)C5=CC=C(C=C5)Cl)(C)C6=CC=C(C=C6)Cl	CCOc1c(C2=NC(C)(c3ccc(Cl)cc3)C(C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CC(=O)N3CCOCC3)CC2)ccc(C(C)(C)C)c1	InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1	DJZBZZRLUQDRII-IOLBBIBUSA-N					doublet; compound annotation
0391_011123	945128-26-7	C19H28N2O2	5.4571	17253208		O=C(c1noc(C2CC2)c1)N(C1CCCCC1)C1CCCCC1	InChI=1S/C19H28N2O2/c22-19(17-13-18(23-20-17)14-11-12-14)21(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h13-16H,1-12H2	NDKGACIWVAOUQH-UHFFFAOYSA-N					doublet; compound annotation
0391_011124	945128-26-7	C19H28N2O2	5.5249	17253208		O=C(c1noc(C2CC2)c1)N(C1CCCCC1)C1CCCCC1	InChI=1S/C19H28N2O2/c22-19(17-13-18(23-20-17)14-11-12-14)21(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h13-16H,1-12H2	NDKGACIWVAOUQH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011126	Milnacipran	C15H22N2O	2.2226	65833	CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1	GJJFMKBJSRMPLA-HIFRSBDPSA-N					removed another duplicate entry; compound annotation
0391_011128	Tilianin	C22H22O10	2.7377	5321954	COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	COc1ccc(-c2cc(=O)c3c(O)cc(OC4OC(CO)C(O)C(O)C4O)cc3o2)cc1	InChI=1S/C22H22O10/c1-29-11-4-2-10(3-5-11)15-8-14(25)18-13(24)6-12(7-16(18)31-15)30-22-21(28)20(27)19(26)17(9-23)32-22/h2-8,17,19-24,26-28H,9H2,1H3/t17-,19-,20+,21-,22-/m1/s1	NLZCOTZRUWYPTP-MIUGBVLSSA-N					compound annotation
0391_011129	dinoprost	C20H34O5	3.2901	5280363	CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O	CCCCCC(O)C=CC1C(O)CC(O)C1CC=CCCCC(=O)O	InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1	PXGPLTODNUVGFL-YNNPMVKQSA-N					compound annotation
0391_011130	Salmeterol	C25H37NO4	3.3611	5152		OCc1c(O)ccc(C(O)CNCCCCCCOCCCCc2ccccc2)c1	InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2	GIIZNNXWQWCKIB-UHFFFAOYSA-N					doublet; compound annotation
0391_011131	Dopamine D2 receptor antagonist-1	C14H17N3S	3.7631	145712390		c1nc(NC2CCC2)c2c3c(CCCC3)sc2n1	InChI=1S/C14H17N3S/c1-2-7-11-10(6-1)12-13(17-9-4-3-5-9)15-8-16-14(12)18-11/h8-9H,1-7H2,(H,15,16,17)	ANUJDLRACOBTTB-UHFFFAOYSA-N					compound annotation
0391_011132	clopidogrel	C16H16ClNO2S	3.8917	60606	COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3	COC(=O)C(c1ccccc1Cl)N1CCc2c(ccs2)C1	InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1	GKTWGGQPFAXNFI-HNNXBMFYSA-N					doublet; compound annotation
0391_011133	Loteprednol etabonate	C24H31ClO7	4.4745	444025	CCOC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C(=O)OCCl	CCOC(=O)OC1(C(=O)OCCl)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C	InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1	DMKSVUSAATWOCU-HROMYWEYSA-N					compound annotation
0391_011134	TMC647055	C32H38N4O6S	5.1656	44556044		COc1cc2c(cc1)-c1c(C3CCCCC3)c3c4cc(cc3)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C(=O)C(=C2)Cn14	InChI=1S/C32H38N4O6S/c1-34-13-15-42-16-14-35(2)43(39,40)33-31(37)22-9-11-27-28(19-22)36-20-24(32(34)38)17-23-18-25(41-3)10-12-26(23)30(36)29(27)21-7-5-4-6-8-21/h9-12,17-19,21H,4-8,13-16,20H2,1-3H3,(H,33,37)	UOBYJVFBFSLCTQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011136	O-Desmethylangolensin	C15H14O4	3.224	89472		CC(C(=O)c1c(O)cc(O)cc1)c1ccc(O)cc1	InChI=1S/C15H14O4/c1-9(10-2-4-11(16)5-3-10)15(19)13-7-6-12(17)8-14(13)18/h2-9,16-18H,1H3	JDJPNKPFDDUBFV-UHFFFAOYSA-N					compound annotation
0391_011137	BI-2545	C23H19F6N5O3	4.2315	131953432	C1[C@@H]2[C@@H](C2CNC(=O)C3=CC4=NNN=C4C=C3)CN1C(=O)OCC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F	O=C(NCC1C2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC12)c1cc2n[nH]nc2cc1	InChI=1S/C23H19F6N5O3/c24-22(25,26)13-3-11(4-14(6-13)23(27,28)29)10-37-21(36)34-8-16-15(17(16)9-34)7-30-20(35)12-1-2-18-19(5-12)32-33-31-18/h1-6,15-17H,7-10H2,(H,30,35)(H,31,32,33)/t15?,16-,17+	ZDOBSAPHUUUOHX-ALOPSCKCSA-N					compound annotation
0391_011138	Palmitoyl-L-(-)-carnitin [German]	C23H46NO4+	5.2357	167760	CCCCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/p+1/t21-/m1/s1	XOMRRQXKHMYMOC-OAQYLSRUSA-O					compound annotation
0391_011139	broflanilide	C25H14BrF11N2O2	5.3057	53341374		CN(C(=O)c1ccccc1)c1cccc(C(=O)Nc2c(C(F)(F)F)cc(C(F)(C(F)(F)F)C(F)(F)F)cc2Br)c1F	InChI=1S/C25H14BrF11N2O2/c1-39(21(41)12-6-3-2-4-7-12)17-9-5-8-14(18(17)27)20(40)38-19-15(23(29,30)31)10-13(11-16(19)26)22(28,24(32,33)34)25(35,36)37/h2-11H,1H3,(H,38,40)	QSLZKWPYTWEWHC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011141	Avermectin	C48H72O14	6.0247	6858006	CCC(C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C	CCC(C)C1OC2(C=CC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	InChI=1S/C48H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,17-19,25-26,28,30-31,33-45,49-50,52H,11,16,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25?,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1	RRZXIRBKKLTSOM-VDYLCOMISA-N					compound annotation
0391_011142	ranitidine	C13H22N4O3S	0.7835	3001055	CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1	InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+	VMXUWOKSQNHOCA-UKTHLTGXSA-N					compound annotation
0391_011143	71079-08-8	C16H15N3O4	1.7554	130395		NC(N)=Nc1ccc(C(=O)Oc2ccc(CC(=O)O)cc2)cc1	InChI=1S/C16H15N3O4/c17-16(18)19-12-5-3-11(4-6-12)15(22)23-13-7-1-10(2-8-13)9-14(20)21/h1-8H,9H2,(H,20,21)(H4,17,18,19)	XTKGXPFBKPYFDW-UHFFFAOYSA-N					compound annotation
0391_011144	sulfaphenazole	C15H14N4O2S	2.5352	5335		Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1	InChI=1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2	QWCJHSGMANYXCW-UHFFFAOYSA-N					compound annotation
0391_011145	7326-19-4	C9H10O3	4.2885	643327	C1=CC=C(C=C1)C[C@H](C(=O)O)O	O=C(O)C(O)Cc1ccccc1	InChI=1S/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)/t8-/m1/s1	VOXXWSYKYCBWHO-MRVPVSSYSA-N					compound annotation
0391_011146	OGT 2115	C24H16BrFN2O4	4.7384	44402523	C1=CC(=CC=C1/C=C/C(=O)NC2=C(C=C(C=C2)C3=NC4=C(O3)C=CC(=C4)CC(=O)O)F)Br	O=C(O)Cc1cc2c(cc1)oc(-c1cc(F)c(NC(=O)C=Cc3ccc(Br)cc3)cc1)n2	InChI=1S/C24H16BrFN2O4/c25-17-6-1-14(2-7-17)4-10-22(29)27-19-8-5-16(13-18(19)26)24-28-20-11-15(12-23(30)31)3-9-21(20)32-24/h1-11,13H,12H2,(H,27,29)(H,30,31)/b10-4+	LKBXWNYXDMSFQU-ONNFQVAWSA-N					compound annotation
0391_011147	Clodinafop-Propargyl	C17H13ClFNO4	4.8812	92431	C[C@H](C(=O)OCC#C)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)Cl)F	C#CCOC(=O)C(C)Oc1ccc(Oc2c(F)cc(Cl)cn2)cc1	InChI=1S/C17H13ClFNO4/c1-3-8-22-17(21)11(2)23-13-4-6-14(7-5-13)24-16-15(19)9-12(18)10-20-16/h1,4-7,9-11H,8H2,2H3/t11-/m1/s1	JBDHZKLJNAIJNC-LLVKDONJSA-N					compound annotation
0391_011148	cimetidine	C10H16N6S	0.7114	2756		CN=C(NC#N)NCCSCc1c(C)[nH]cn1	InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)	AQIXAKUUQRKLND-UHFFFAOYSA-N					doublet; compound annotation
0391_011149	cimetidine	C10H16N6S	0.7152	2756		CN=C(NC#N)NCCSCc1c(C)[nH]cn1	InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)	AQIXAKUUQRKLND-UHFFFAOYSA-N					doublet; compound annotation
0391_011150	BI-9321	C22H21FN4	1.3332	138115329		Cc1cc(CN)cc(C)c1-c1c(-c2ccnc3cc(F)ccc23)n(C)cn1	InChI=1S/C22H21FN4/c1-13-8-15(11-24)9-14(2)20(13)21-22(27(3)12-26-21)18-6-7-25-19-10-16(23)4-5-17(18)19/h4-10,12H,11,24H2,1-3H3	WOAOENGFAAUUGT-UHFFFAOYSA-N					compound annotation
0391_011151	sulfamethoxazole	C10H11N3O3S	2.036	5329		Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1	InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)	JLKIGFTWXXRPMT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011153	Bacoside A3	C47H76O18	3.4698	91827005	CC(=C[C@H]1C[C@]([C@@H]2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@]36C[C@@]2(O1)OC6)C)(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](O9)CO)O)O)C)(C)O)C	CC(C)=CC1CC(C)(O)C2C3CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(CO)C(O)C6O)C(C)(C)C5CCC4(C)C34COC2(C4)O1	InChI=1S/C47H76O18/c1-21(2)14-22-15-45(7,57)38-23-8-9-28-43(5)12-11-29(42(3,4)27(43)10-13-44(28,6)46(23)19-47(38,65-22)58-20-46)62-41-37(64-39-34(55)31(52)25(17-49)60-39)36(32(53)26(18-50)61-41)63-40-35(56)33(54)30(51)24(16-48)59-40/h14,22-41,48-57H,8-13,15-20H2,1-7H3/t22-,23+,24+,25-,26+,27-,28+,29-,30+,31-,32+,33-,34+,35+,36-,37+,38-,39-,40-,41-,43-,44+,45-,46-,47-/m0/s1	CDEVGTJBRPBOPH-INTDMYAHSA-N					compound annotation
0391_011154	budesonide	C25H34O6	3.7368	5281004	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1	VOVIALXJUBGFJZ-KWVAZRHASA-N					doublet; compound annotation
0391_011155	budesonide	C25H34O6	3.7772	5281004	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C	CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1	VOVIALXJUBGFJZ-KWVAZRHASA-N					doublet; compound annotation
0391_011156	Paritaprevir	C40H43N7O7S	5.2964	45110509	CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8	Cc1cnc(C(=O)NC2CCCCCC=CC3CC3(C(=O)NS(=O)(=O)C3CC3)NC(=O)C3CC(Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1	InChI=1S/C40H43N7O7S/c1-24-21-42-33(22-41-24)35(48)43-32-16-6-4-2-3-5-11-25-20-40(25,39(51)46-55(52,53)27-17-18-27)45-36(49)34-19-26(23-47(34)38(32)50)54-37-30-14-8-7-12-28(30)29-13-9-10-15-31(29)44-37/h5,7-15,21-22,25-27,32,34H,2-4,6,16-20,23H2,1H3,(H,43,48)(H,45,49)(H,46,51)/b11-5-/t25-,26-,32+,34+,40-/m1/s1	UAUIUKWPKRJZJV-QPLHLKROSA-N					removed another duplicate entry; compound annotation
0391_011158	Omidenepag	C23H22N6O4S	2.6312	44230575		O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cnccc2)n1	InChI=1S/C23H22N6O4S/c30-23(31)15-25-22-6-1-4-19(27-22)17-28(34(32,33)21-5-2-11-24-14-21)16-18-7-9-20(10-8-18)29-13-3-12-26-29/h1-14H,15-17H2,(H,25,27)(H,30,31)	YHGSTSNEOJUIRN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011160	azelastine	C22H24ClN3O	3.073	2267		CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1	InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3	MBUVEWMHONZEQD-UHFFFAOYSA-N					compound annotation
0391_011161	Ezatiostat	C27H35N3O6S	3.3524	5310939	CCOC(=O)[C@H](CCC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)N[C@H](C2=CC=CC=C2)C(=O)OCC)N	CCOC(=O)C(N)CCC(=O)NC(CSCc1ccccc1)C(=O)NC(C(=O)OCC)c1ccccc1	InChI=1S/C27H35N3O6S/c1-3-35-26(33)21(28)15-16-23(31)29-22(18-37-17-19-11-7-5-8-12-19)25(32)30-24(27(34)36-4-2)20-13-9-6-10-14-20/h5-14,21-22,24H,3-4,15-18,28H2,1-2H3,(H,29,31)(H,30,32)/t21-,22-,24+/m0/s1	GWEJFLVSOGNLSS-WPFOTENUSA-N					removed another duplicate entry; compound annotation
0391_011163	Ginsenoside F1	C36H62O9	3.4614	9809542	CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C	CC(C)=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(O)CC12C	InChI=1S/C36H62O9/c1-19(2)10-9-13-36(8,45-31-29(43)28(42)27(41)23(18-37)44-31)20-11-15-34(6)26(20)21(38)16-24-33(5)14-12-25(40)32(3,4)30(33)22(39)17-35(24,34)7/h10,20-31,37-43H,9,11-18H2,1-8H3/t20-,21+,22-,23+,24+,25-,26-,27+,28-,29+,30-,31-,33+,34+,35+,36-/m0/s1	XNGXWSFSJIQMNC-FIYORUNESA-N					compound annotation
0391_011164	Pinocembrin	C15H12O4	3.7626	68071	C1[C@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=CC=C3	O=C1CC(c2ccccc2)Oc2cc(O)cc(O)c12	InChI=1S/C15H12O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-7,13,16-17H,8H2/t13-/m0/s1	URFCJEUYXNAHFI-ZDUSSCGKSA-N					compound annotation
0391_011165	Parecoxib	C19H18N2O4S	3.8931	119828		CCC(=O)NS(=O)(=O)c1ccc(-c2c(C)onc2-c2ccccc2)cc1	InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)	TZRHLKRLEZJVIJ-UHFFFAOYSA-N					doublet; compound annotation
0391_011166	Regorafenib	C21H15ClF4N4O3	4.7185	11167602		CNC(=O)c1nccc(Oc2cc(F)c(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3)cc2)c1	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	FNHKPVJBJVTLMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011168	atenolol	C14H22N2O3	0.7267	2249		CC(C)NCC(O)COc1ccc(CC(N)=O)cc1	InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)	METKIMKYRPQLGS-UHFFFAOYSA-N					compound annotation
0391_011169	Schaftoside	C26H28O14	1.6096	442658	C1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C3C(=C(C(=C2O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)C(=O)C=C(O3)C5=CC=C(C=C5)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2c(C3OCC(O)C(O)C3O)c(O)c(C3OC(CO)C(O)C(O)C3O)c(O)c12	InChI=1S/C26H28O14/c27-6-13-18(32)21(35)23(37)26(40-13)15-19(33)14-10(29)5-12(8-1-3-9(28)4-2-8)39-24(14)16(20(15)34)25-22(36)17(31)11(30)7-38-25/h1-5,11,13,17-18,21-23,25-28,30-37H,6-7H2/t11-,13+,17-,18+,21-,22+,23+,25-,26-/m0/s1	MMDUKUSNQNWVET-VYUBKLCTSA-N					removed another duplicate entry; compound annotation
0391_011171	Pyrimethanil	C12H13N3	2.7585	91650		Cc1cc(C)nc(Nc2ccccc2)n1	InChI=1S/C12H13N3/c1-9-8-10(2)14-12(13-9)15-11-6-4-3-5-7-11/h3-8H,1-2H3,(H,13,14,15)	ZLIBICFPKPWGIZ-UHFFFAOYSA-N					compound annotation
0391_011172	Flubendazole	C16H12FN3O3	2.9072	35802		COC(=O)Nc1nc2c(cc(C(=O)c3ccc(F)cc3)cc2)[nH]1	InChI=1S/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)	CPEUVMUXAHMANV-UHFFFAOYSA-N					compound annotation
0391_011173	paroxetine	C19H20FNO3	2.9959	43815	C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4	Fc1ccc(C2CCNCC2COc2cc3c(cc2)OCO3)cc1	InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1	AHOUBRCZNHFOSL-YOEHRIQHSA-N					compound annotation
0391_011174	vamorolone	C22H28O4	3.3173	3035000	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1(O)C(=O)CO	InChI=1S/C22H28O4/c1-13-10-18-16-5-4-14-11-15(24)6-8-20(14,2)17(16)7-9-21(18,3)22(13,26)19(25)12-23/h6-8,11,13,16,18,23,26H,4-5,9-10,12H2,1-3H3/t13-,16-,18+,20+,21+,22+/m1/s1	ZYTXTXAMMDTYDQ-DGEXFFLYSA-N					compound annotation
0391_011175	SB 243213	C22H19F3N4O2	3.7579	443391		Cc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1cnc(Oc3c(C)nccc3)cc1)CC2	InChI=1S/C22H19F3N4O2/c1-13-10-15-7-9-29(18(15)11-17(13)22(23,24)25)21(30)28-16-5-6-20(27-12-16)31-19-4-3-8-26-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,28,30)	ZETBBVYSBABLHL-UHFFFAOYSA-N					compound annotation
0391_011176	Phyllanthin	C24H34O6	4.5653	358901	COC[C@@H](CC1=CC(=C(C=C1)OC)OC)[C@H](CC2=CC(=C(C=C2)OC)OC)COC	COCC(Cc1cc(OC)c(OC)cc1)C(COC)Cc1cc(OC)c(OC)cc1	InChI=1S/C24H34O6/c1-25-15-19(11-17-7-9-21(27-3)23(13-17)29-5)20(16-26-2)12-18-8-10-22(28-4)24(14-18)30-6/h7-10,13-14,19-20H,11-12,15-16H2,1-6H3/t19-,20-/m1/s1	KFLQGJQSLUYUBF-WOJBJXKFSA-N					removed another duplicate entry; compound annotation
0391_011179	Ribociclib	C23H30N8O	1.7187	44631912		CN(C)C(=O)c1cc2cnc(Nc3ncc(N4CCNCC4)cc3)nc2n1C1CCCC1	InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)	RHXHGRAEPCAFML-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011181	Fangchinoline	C37H40N2O6	1.9798	73481	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC	COc1c2cc(cc1)CC1c3c(Oc4c(OC)cc5CCN(C)C(Cc6ccc(cc6)O2)c5c4)c(O)c(OC)cc3CCN1C	InChI=1S/C37H40N2O6/c1-38-14-12-24-19-31(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-32-18-23(8-11-30(32)41-3)17-29-35-25(13-15-39(29)2)20-34(43-5)36(40)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29-/m0/s1	IIQSJHUEZBTSAT-VMPREFPWSA-N					compound annotation
0391_011182	mycophenolate mofetil	C23H31NO7	2.7879	5281078	CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O	COc1c(CC=C(C)CCC(=O)OCCN2CCOCC2)c(O)c2C(=O)OCc2c1C	InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+	RTGDFNSFWBGLEC-SYZQJQIISA-N					removed another duplicate entry; compound annotation
0391_011184	Tectorigenin	C16H12O6	2.9131	5281811		COc1c(O)c2c(cc1O)occ(-c1ccc(O)cc1)c2=O	InChI=1S/C16H12O6/c1-21-16-11(18)6-12-13(15(16)20)14(19)10(7-22-12)8-2-4-9(17)5-3-8/h2-7,17-18,20H,1H3	OBBCRPUNCUPUOS-UHFFFAOYSA-N					compound annotation
0391_011185	forskolin	C22H34O7	4.1326	47936	CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O	C=CC1(C)CC(=O)C2(O)C(C)(O1)C(OC(C)=O)C(O)C1C(C)(C)CCC(O)C12C	InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1	OHCQJHSOBUTRHG-KGGHGJDLSA-N					compound annotation
0391_011186	diflucortolone valerate	C27H36F2O5	4.973	91670	CCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C	CCCCC(=O)OCC(=O)C1C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C27H36F2O5/c1-5-6-7-23(33)34-14-21(31)24-15(2)10-17-18-12-20(28)19-11-16(30)8-9-26(19,4)27(18,29)22(32)13-25(17,24)3/h8-9,11,15,17-18,20,22,24,32H,5-7,10,12-14H2,1-4H3/t15-,17+,18+,20+,22+,24-,25+,26+,27+/m1/s1	HHJIUUAMYGBVSD-YTFFSALGSA-N					compound annotation
0391_011187	Ruscogenin	C27H42O4	5.4312	441893	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CC=C5CC(O)CC(O)C5(C)C4CCC3(C)C1C2C	InChI=1S/C27H42O4/c1-15-7-10-27(30-14-15)16(2)24-22(31-27)13-21-19-6-5-17-11-18(28)12-23(29)26(17,4)20(19)8-9-25(21,24)3/h5,15-16,18-24,28-29H,6-14H2,1-4H3/t15-,16+,18-,19-,20+,21+,22+,23-,24+,25+,26+,27-/m1/s1	QMQIQBOGXYYATH-IDABPMKMSA-N					compound annotation
0391_011188	Niraparib metabolite M1	C19H19N3O2	2.1546	118737587	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)O	O=C(O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H19N3O2/c23-19(24)17-5-1-3-15-12-22(21-18(15)17)16-8-6-13(7-9-16)14-4-2-10-20-11-14/h1,3,5-9,12,14,20H,2,4,10-11H2,(H,23,24)/t14-/m1/s1	HDQHGRLURKGIFL-CQSZACIVSA-N					doublet; compound annotation
0391_011189	Niraparib metabolite M1	C19H19N3O2	2.1574	118737587	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)O	O=C(O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H19N3O2/c23-19(24)17-5-1-3-15-12-22(21-18(15)17)16-8-6-13(7-9-16)14-4-2-10-20-11-14/h1,3,5-9,12,14,20H,2,4,10-11H2,(H,23,24)/t14-/m1/s1	HDQHGRLURKGIFL-CQSZACIVSA-N					doublet; compound annotation
0391_011190	96392-15-3	C19H21N5O4	2.4701	13424663	C1CC2=CC=CC=C2[C@@H]1NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CO)O)O	OCC1OC(n2cnc3c(NC4CCc5ccccc54)ncnc32)C(O)C1O	InChI=1S/C19H21N5O4/c25-7-13-15(26)16(27)19(28-13)24-9-22-14-17(20-8-21-18(14)24)23-12-6-5-10-3-1-2-4-11(10)12/h1-4,8-9,12-13,15-16,19,25-27H,5-7H2,(H,20,21,23)/t12-,13-,15-,16-,19-/m1/s1	FSKMJUWPFLDDRS-BYMDKACISA-N					removed another duplicate entry; compound annotation
0391_011192	913064-47-8	C29H29ClN4O2	2.8455	11848206		O=C(c1cc(N2Cc3c(C2=O)c(Cl)ccc3)ccc1)N1CCC2(CC1)CCN(c1ccncc1)CC2	InChI=1S/C29H29ClN4O2/c30-25-6-2-4-22-20-34(28(36)26(22)25)24-5-1-3-21(19-24)27(35)33-17-11-29(12-18-33)9-15-32(16-10-29)23-7-13-31-14-8-23/h1-8,13-14,19H,9-12,15-18,20H2	ARYQHSWJGHCGJS-UHFFFAOYSA-N					doublet; compound annotation
0391_011193	913064-47-8	C29H29ClN4O2	2.8482	11848206		O=C(c1cc(N2Cc3c(C2=O)c(Cl)ccc3)ccc1)N1CCC2(CC1)CCN(c1ccncc1)CC2	InChI=1S/C29H29ClN4O2/c30-25-6-2-4-22-20-34(28(36)26(22)25)24-5-1-3-21(19-24)27(35)33-17-11-29(12-18-33)9-15-32(16-10-29)23-7-13-31-14-8-23/h1-8,13-14,19H,9-12,15-18,20H2	ARYQHSWJGHCGJS-UHFFFAOYSA-N					doublet; compound annotation
0391_011194	NI-57	C19H17N3O4S	3.0285	91827373		COc1c(S(=O)(=O)Nc2cc3c(cc2)n(C)c(=O)c(C)c3)ccc(C#N)c1	InChI=1S/C19H17N3O4S/c1-12-8-14-10-15(5-6-16(14)22(2)19(12)23)21-27(24,25)18-7-4-13(11-20)9-17(18)26-3/h4-10,21H,1-3H3	UEMQPCYDWCSVCU-UHFFFAOYSA-N					doublet; compound annotation
0391_011195	942142-51-0	C26H41ClN4O5	3.1255	16126898	CN[C@@H](C[C@H]1CCCOC1)CNC(=O)N2CCC[C@H](C2)[C@H](C3=CC(=CC=C3)Cl)OCCNC(=O)OC	CNC(CNC(=O)N1CCCC(C(OCCNC(=O)OC)c2cc(Cl)ccc2)C1)CC1CCCOC1	InChI=1S/C26H41ClN4O5/c1-28-23(14-19-6-5-12-35-18-19)16-30-25(32)31-11-4-8-21(17-31)24(20-7-3-9-22(27)15-20)36-13-10-29-26(33)34-2/h3,7,9,15,19,21,23-24,28H,4-6,8,10-14,16-18H2,1-2H3,(H,29,33)(H,30,32)/t19-,21-,23+,24+/m1/s1	NXWASIVXQMMPLM-ZXMXYHOLSA-N					doublet; removed another duplicate entry; compound annotation
0391_011197	NI-57	C19H17N3O4S	3.1487	91827373		COc1c(S(=O)(=O)Nc2cc3c(cc2)n(C)c(=O)c(C)c3)ccc(C#N)c1	InChI=1S/C19H17N3O4S/c1-12-8-14-10-15(5-6-16(14)22(2)19(12)23)21-27(24,25)18-7-4-13(11-20)9-17(18)26-3/h4-10,21H,1-3H3	UEMQPCYDWCSVCU-UHFFFAOYSA-N					doublet; compound annotation
0391_011198	GSK-2881078	C14H13F3N2O2S	3.6546	86709174	C[C@H](CS(=O)(=O)C)N1C=CC2=C1C=CC(=C2C(F)(F)F)C#N	CC(CS(C)(=O)=O)n1ccc2c1ccc(C#N)c2C(F)(F)F	InChI=1S/C14H13F3N2O2S/c1-9(8-22(2,20)21)19-6-5-11-12(19)4-3-10(7-18)13(11)14(15,16)17/h3-6,9H,8H2,1-2H3/t9-/m1/s1	SKDVMPZQJMZEAC-SECBINFHSA-N					removed another duplicate entry; compound annotation
0391_011200	875051-72-2	C13H10Cl3N3O	3.8285	11659955		CNC(=O)c1nc(N)c(-c2c(Cl)c(Cl)cc(Cl)c2)cc1	InChI=1S/C13H10Cl3N3O/c1-18-13(20)10-3-2-7(12(17)19-10)8-4-6(14)5-9(15)11(8)16/h2-5H,1H3,(H2,17,19)(H,18,20)	HPIUHDCRVYDAEJ-UHFFFAOYSA-N					compound annotation
0391_011201	1668553-26-1	C46H55N7O7S	4.6124	66575373		Cc1nn(C)c(COc2ccc(N3CCN(S(=O)(=O)N(C)C)CC3)cc2)c1-c1cccc2c1n(CCN1CCOCC1)c(C(=O)O)c2CCCOc1cccc2ccccc12	InChI=1S/C46H55N7O7S/c1-33-43(41(49(4)47-33)32-60-36-19-17-35(18-20-36)51-22-24-52(25-23-51)61(56,57)48(2)3)40-14-8-13-38-39(15-9-29-59-42-16-7-11-34-10-5-6-12-37(34)42)45(46(54)55)53(44(38)40)26-21-50-27-30-58-31-28-50/h5-8,10-14,16-20H,9,15,21-32H2,1-4H3,(H,54,55)	XMVAWGSQPHFXKU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011203	IDO-IN-4	C26H35N3O3	4.6693	118676157	CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[C@H]3C[C@H]3C(=O)O)N(CC(C)C)CC(C)C	Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(C3CC3C(=O)O)c2)cc1	InChI=1S/C26H35N3O3/c1-16(2)14-29(15-17(3)4)24-11-8-19(21-13-22(21)25(30)31)12-23(24)28-26(32)27-20-9-6-18(5)7-10-20/h6-12,16-17,21-22H,13-15H2,1-5H3,(H,30,31)(H2,27,28,32)/t21-,22-/m1/s1	VZYCPKLOYXSKAB-FGZHOGPDSA-N					doublet; compound annotation
0391_011204	IDO-IN-4	C26H35N3O3	5.0112	118676157	CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[C@H]3C[C@H]3C(=O)O)N(CC(C)C)CC(C)C	Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(C3CC3C(=O)O)c2)cc1	InChI=1S/C26H35N3O3/c1-16(2)14-29(15-17(3)4)24-11-8-19(21-13-22(21)25(30)31)12-23(24)28-26(32)27-20-9-6-18(5)7-10-20/h6-12,16-17,21-22H,13-15H2,1-5H3,(H,30,31)(H2,27,28,32)/t21-,22-/m1/s1	VZYCPKLOYXSKAB-FGZHOGPDSA-N					doublet; removed another duplicate entry; compound annotation
0391_011206	IDO-IN-4	C26H35N3O3	5.2641	118676157	CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[C@H]3C[C@H]3C(=O)O)N(CC(C)C)CC(C)C	Cc1ccc(NC(=O)Nc2c(N(CC(C)C)CC(C)C)ccc(C3CC3C(=O)O)c2)cc1	InChI=1S/C26H35N3O3/c1-16(2)14-29(15-17(3)4)24-11-8-19(21-13-22(21)25(30)31)12-23(24)28-26(32)27-20-9-6-18(5)7-10-20/h6-12,16-17,21-22H,13-15H2,1-5H3,(H,30,31)(H2,27,28,32)/t21-,22-/m1/s1	VZYCPKLOYXSKAB-FGZHOGPDSA-N					doublet; compound annotation
0391_011207	cc-115	C16H16N8O	1.8832	58298318		CCN1C(=O)CNc2ncc(-c3c(C)nc(-c4ncn[nH]4)cc3)nc21	InChI=1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23)	GMYLVKUGJMYTFB-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011209	labetalol	C19H24N2O3	2.3008	3869		CC(CCc1ccccc1)NCC(O)c1cc(C(N)=O)c(O)cc1	InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)	SGUAFYQXFOLMHL-UHFFFAOYSA-N					compound annotation
0391_011210	Valpromide	C8H17NO	2.5411	71113		CCCC(CCC)C(N)=O	InChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10)	OMOMUFTZPTXCHP-UHFFFAOYSA-N					compound annotation
0391_011211	Phillyrin	C27H34O11	2.5411	101712	COC1=C(C=C(C=C1)[C@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC)OC	COc1c(OC)cc(C2OCC3C(c4cc(OC)c(OC5OC(CO)C(O)C(O)C5O)cc4)OCC23)cc1	InChI=1S/C27H34O11/c1-32-17-6-4-13(8-19(17)33-2)25-15-11-36-26(16(15)12-35-25)14-5-7-18(20(9-14)34-3)37-27-24(31)23(30)22(29)21(10-28)38-27/h4-9,15-16,21-31H,10-12H2,1-3H3/t15-,16-,21+,22+,23-,24+,25-,26+,27+/m0/s1	KFFCKOBAHMGTMW-LGQRSHAYSA-N					compound annotation
0391_011212	Pectolinarin	C29H34O15	2.6164	168849	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)O)OC)O)O)O)O)O)O	COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3o2)cc1	InChI=1S/C29H34O15/c1-11-20(31)23(34)25(36)28(41-11)40-10-18-21(32)24(35)26(37)29(44-18)43-17-9-16-19(22(33)27(17)39-3)14(30)8-15(42-16)12-4-6-13(38-2)7-5-12/h4-9,11,18,20-21,23-26,28-29,31-37H,10H2,1-3H3/t11-,18+,20-,21+,23+,24-,25+,26+,28+,29+/m0/s1	DUXQKCCELUKXOE-CBBZIXHGSA-N					removed another duplicate entry; compound annotation
0391_011214	Rebaudioside A	C44H70O23	2.8667	6918840	C[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@](C3)(C(=C)C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)(C)C(=O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O	C=C1CC23CCC4C(C)(C(=O)OC5OC(CO)C(O)C(O)C5O)CCCC4(C)C2CCC1(OC1OC(CO)C(O)C(OC2OC(CO)C(O)C(O)C2O)C1OC1OC(CO)C(O)C(O)C1O)C3	InChI=1S/C44H70O23/c1-17-11-43-9-5-22-41(2,7-4-8-42(22,3)40(59)66-38-33(58)30(55)26(51)20(14-47)62-38)23(43)6-10-44(17,16-43)67-39-35(65-37-32(57)29(54)25(50)19(13-46)61-37)34(27(52)21(15-48)63-39)64-36-31(56)28(53)24(49)18(12-45)60-36/h18-39,45-58H,1,4-16H2,2-3H3/t18-,19-,20-,21-,22+,23+,24-,25-,26-,27-,28+,29+,30+,31-,32-,33-,34+,35-,36+,37+,38+,39+,41-,42-,43-,44+/m1/s1	HELXLJCILKEWJH-NCGAPWICSA-N					compound annotation
0391_011215	Levonebivolol	C22H25F2NO4	3.1904	9844194	C1CC2=C(C=CC(=C2)F)O[C@H]1[C@H](CNC[C@@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O	OC(CNCC(O)C1CCc2c(ccc(F)c2)O1)C1CCc2c(ccc(F)c2)O1	InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2/t17-,18-,21-,22+/m0/s1	KOHIRBRYDXPAMZ-YHDSQAASSA-N					removed another duplicate entry; compound annotation
0391_011217	CCR2 antagonist 1	C28H32BrF3N2O	4.255	73334813	CC(C)[C@@]1(CC[C@H](C1)N[C@@H]2CCC3=C2C=CC(=C3)Br)C(=O)N4CCC5=C(C4)C=C(C=C5)C(F)(F)F	CC(C)C1(C(=O)N2CCc3c(cc(C(F)(F)F)cc3)C2)CCC(NC2CCc3c2ccc(Br)c3)C1	InChI=1S/C28H32BrF3N2O/c1-17(2)27(11-9-23(15-27)33-25-8-4-19-14-22(29)6-7-24(19)25)26(35)34-12-10-18-3-5-21(28(30,31)32)13-20(18)16-34/h3,5-7,13-14,17,23,25,33H,4,8-12,15-16H2,1-2H3/t23-,25-,27+/m1/s1	QYDUEIJZRKTNKN-HYZYYIOASA-N					compound annotation
0391_011218	Ponicidin	C20H26O6	1.9963	92043456	CC1(CC[C@@H]([C@]23[C@@H]1[C@@H]([C@@]4([C@]56[C@H]2CCC([C@@H]5O[C@H]3O4)C(=C)C6=O)O)O)O)C	C=C1C(=O)C23C4OC5OC2(O)C(O)C2C(C)(C)CCC(O)C52C3CCC14	InChI=1S/C20H26O6/c1-8-9-4-5-10-18-11(21)6-7-17(2,3)12(18)14(23)20(24)19(10,13(8)22)15(9)25-16(18)26-20/h9-12,14-16,21,23-24H,1,4-7H2,2-3H3/t9?,10-,11-,12+,14-,15-,16-,18-,19-,20+/m0/s1	WHRDRHNMTIXZNY-CJZVHFPTSA-N					compound annotation
0391_011219	Pralsetinib	C27H32FN9O2	2.8498	129073603	CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC	COC1(C(=O)NC(C)c2cnc(-n3cc(F)cn3)cc2)CCC(c2nc(C)cc(Nc3n[nH]c(C)c3)n2)CC1	InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1	GBLBJPZSROAGMF-SIYOEGHHSA-N					doublet; compound annotation
0391_011220	Integrin modulator 1	C13H14N2O4	2.8619	154734317		Cc1ccccc1NC(=O)N1C(=O)CC1CC(=O)O	InChI=1S/C13H14N2O4/c1-8-4-2-3-5-10(8)14-13(19)15-9(6-11(15)16)7-12(17)18/h2-5,9H,6-7H2,1H3,(H,14,19)(H,17,18)	NMHXECODTXNHIV-UHFFFAOYSA-N					compound annotation
0391_011221	1253491-42-7	C22H16N2O	2.9084	59620153		COc1cc2c(cc1)[nH]c1c2ccnc1-c1cccc2ccccc12	InChI=1S/C22H16N2O/c1-25-15-9-10-20-19(13-15)18-11-12-23-21(22(18)24-20)17-8-4-6-14-5-2-3-7-16(14)17/h2-13,24H,1H3	AABFWJDLCCDJJN-UHFFFAOYSA-N					compound annotation
0391_011222	SR9011	C23H31ClN4O3S	5.4007	57394021		CCCCCNC(=O)N1CCC(CN(Cc2ccc(Cl)cc2)Cc2ccc([N+](=O)[O-])s2)C1	InChI=1S/C23H31ClN4O3S/c1-2-3-4-12-25-23(29)27-13-11-19(16-27)15-26(14-18-5-7-20(24)8-6-18)17-21-9-10-22(32-21)28(30)31/h5-10,19H,2-4,11-17H2,1H3,(H,25,29)	PPUYOYQTTWJTIU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011224	BRD6989	C16H16N4	2.425	3835861		CC1CCc2c(C1)c(-c1cnccc1)c(C#N)c(N)n2	InChI=1S/C16H16N4/c1-10-4-5-14-12(7-10)15(11-3-2-6-19-9-11)13(8-17)16(18)20-14/h2-3,6,9-10H,4-5,7H2,1H3,(H2,18,20)	QSYBDNXNOJIKML-UHFFFAOYSA-N					compound annotation
0391_011225	Prasugrel	C20H20FNO3S	2.874	6918456		CC(=O)Oc1cc2c(CCN(C(C(=O)C3CC3)c3ccccc3F)C2)s1	InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3	DTGLZDAWLRGWQN-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011227	rac-Acolbifene	C29H31NO4	2.9335	9804157		CC1=C(c2ccc(O)cc2)C(c2ccc(OCCN3CCCCC3)cc2)Oc2c1ccc(O)c2	InChI=1S/C29H31NO4/c1-20-26-14-11-24(32)19-27(26)34-29(28(20)21-5-9-23(31)10-6-21)22-7-12-25(13-8-22)33-18-17-30-15-3-2-4-16-30/h5-14,19,29,31-32H,2-4,15-18H2,1H3	DUYNJNWVGIWJRI-UHFFFAOYSA-N					compound annotation
0391_011228	CDK12-IN-E9	C24H30N6O2	3.1938	122596923	CCC1=C2N=C(C=C(N2N=C1)NC3=CC(=CC=C3)NC(=O)C=C)N4CCCC[C@H]4CCO	C=CC(=O)Nc1cccc(Nc2cc(N3CCCCC3CCO)nc3c(CC)cnn23)c1	InChI=1S/C24H30N6O2/c1-3-17-16-25-30-22(26-18-8-7-9-19(14-18)27-23(32)4-2)15-21(28-24(17)30)29-12-6-5-10-20(29)11-13-31/h4,7-9,14-16,20,26,31H,2-3,5-6,10-13H2,1H3,(H,27,32)/t20-/m0/s1	CDCHESFKYUNJPV-FQEVSTJZSA-N					compound annotation
0391_011229	5,7-Dimethoxyflavone	C17H14O4	3.6095	88881		COc1cc2c(c(OC)c1)c(=O)cc(-c1ccccc1)o2	InChI=1S/C17H14O4/c1-19-12-8-15(20-2)17-13(18)10-14(21-16(17)9-12)11-6-4-3-5-7-11/h3-10H,1-2H3	JRFZSUMZAUHNSL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011231	312608-54-1	C12H11N3O4S	4.1288	2858708		CCOc1ccc(C(=O)Nc2ncc([N+](=O)[O-])s2)cc1	InChI=1S/C12H11N3O4S/c1-2-19-9-5-3-8(4-6-9)11(16)14-12-13-7-10(20-12)15(17)18/h3-7H,2H2,1H3,(H,13,14,16)	LMDLIMGAGZHZSR-UHFFFAOYSA-N					compound annotation
0391_011232	CETYLPYRIDINIUM	C21H38N+	4.7079	2683		CCCCCCCCCCCCCCCC[n+]1ccccc1	InChI=1S/C21H38N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22/h15,17-18,20-21H,2-14,16,19H2,1H3/q+1	NEUSVAOJNUQRTM-UHFFFAOYSA-N					doublet; compound annotation
0391_011233	CETYLPYRIDINIUM	C21H38N+	5.3378	2683		CCCCCCCCCCCCCCCC[n+]1ccccc1	InChI=1S/C21H38N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22/h15,17-18,20-21H,2-14,16,19H2,1H3/q+1	NEUSVAOJNUQRTM-UHFFFAOYSA-N					doublet; compound annotation
0391_011234	harringtonine	C28H37NO9	1.769	276389	CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O	COC(=O)CC(O)(CCC(C)(C)O)C(=O)OC1C(OC)=CC23CCCN2CCc2cc4c(cc2C13)OCO4	InChI=1S/C28H37NO9/c1-26(2,32)8-9-28(33,15-22(30)35-4)25(31)38-24-21(34-3)14-27-7-5-10-29(27)11-6-17-12-19-20(37-16-36-19)13-18(17)23(24)27/h12-14,23-24,32-33H,5-11,15-16H2,1-4H3/t23-,24-,27+,28-/m1/s1	HAVJATCHLFRDHY-KSZYUSJVSA-N					removed another duplicate entry; compound annotation
0391_011236	(R)-3-CARBOXY-2-(HEXANOYLOXY)-N,N,N-TRIMETHYLPROPAN-1-AMINIUM	C13H26NO4+	1.917	3246939	CCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C13H25NO4/c1-5-6-7-8-13(17)18-11(9-12(15)16)10-14(2,3)4/h11H,5-10H2,1-4H3/p+1/t11-/m1/s1	VVPRQWTYSNDTEA-LLVKDONJSA-O					compound annotation
0391_011237	GSK620	C18H19N3O3	2.8167	126648559		CNC(=O)c1cc(C(=O)NC2CC2)cn(Cc2ccccc2)c1=O	InChI=1S/C18H19N3O3/c1-19-17(23)15-9-13(16(22)20-14-7-8-14)11-21(18(15)24)10-12-5-3-2-4-6-12/h2-6,9,11,14H,7-8,10H2,1H3,(H,19,23)(H,20,22)	QZZCUOVXHPAQRQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011239	40592-88-9	C17H27NO9	2.8389	91691128	CC(C)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C	CC(=O)NC1C(OC(C)C)OC(COC(C)=O)C(OC(C)=O)C1OC(C)=O	InChI=1S/C17H27NO9/c1-8(2)24-17-14(18-9(3)19)16(26-12(6)22)15(25-11(5)21)13(27-17)7-23-10(4)20/h8,13-17H,7H2,1-6H3,(H,18,19)/t13-,14-,15-,16-,17+/m1/s1	KMIQMFHPUJUDMC-HHARLNAUSA-N					removed another duplicate entry; compound annotation
0391_011241	CCR2 antagonist 4	C21H21ClF3N3O2	2.9073	44453327	C1CN(C[C@@H]1NC(=O)CNC(=O)C2=CC(=CC=C2)C(F)(F)F)CC3=CC=C(C=C3)Cl	O=C(CNC(=O)c1cc(C(F)(F)F)ccc1)NC1CCN(Cc2ccc(Cl)cc2)C1	InChI=1S/C21H21ClF3N3O2/c22-17-6-4-14(5-7-17)12-28-9-8-18(13-28)27-19(29)11-26-20(30)15-2-1-3-16(10-15)21(23,24)25/h1-7,10,18H,8-9,11-13H2,(H,26,30)(H,27,29)/t18-/m1/s1	BAOQJSULMWXFRK-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_011243	(-)-verapamil	C27H38N2O4	3.1559	92305	CC(C)[C@](CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC	COc1c(OC)cc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)cc2)C(C)C)cc1	InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/t27-/m0/s1	SGTNSNPWRIOYBX-MHZLTWQESA-N					removed another duplicate entry; compound annotation
0391_011245	9-Dihydro-13-acetylbaccatin III	C33H42O12	3.4916	3083352	CC1=C2[C@H]([C@@H]([C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)C)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)C)O)C)O)OC(=O)C	CC(=O)OC1CC2(O)C(OC(=O)c3ccccc3)C3C4(OC(C)=O)COC4CC(O)C3(C)C(O)C(OC(C)=O)C(=C1C)C2(C)C	InChI=1S/C33H42O12/c1-16-21(42-17(2)34)14-33(40)28(44-29(39)20-11-9-8-10-12-20)26-31(7,22(37)13-23-32(26,15-41-23)45-19(4)36)27(38)25(43-18(3)35)24(16)30(33,5)6/h8-12,21-23,25-28,37-38,40H,13-15H2,1-7H3/t21-,22-,23+,25+,26-,27-,28-,31+,32-,33+/m0/s1	WPPPFZJNKLMYBW-FAEUQDRCSA-N					compound annotation
0391_011246	KCC2 blocker 1	C22H25NO5S	3.5896	46866400		CC(=O)N1CCCC1(Cc1ccc(S(C)(=O)=O)cc1)C(=O)OCc1ccccc1	InChI=1S/C22H25NO5S/c1-17(24)23-14-6-13-22(23,21(25)28-16-19-7-4-3-5-8-19)15-18-9-11-20(12-10-18)29(2,26)27/h3-5,7-12H,6,13-16H2,1-2H3	XFXZWVGQXNFWDE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011248	miconazole	C18H14Cl4N2O	4.076	4189		Clc1cc(Cl)c(COC(Cn2ccnc2)c2c(Cl)cc(Cl)cc2)cc1	InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2	BYBLEWFAAKGYCD-UHFFFAOYSA-N					compound annotation
0391_011249	estrone	C18H22O2	4.9811	5870	C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O	CC12CCC3c4c(cc(O)cc4)CCC3C1CCC2=O	InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1	DNXHEGUUPJUMQT-CBZIJGRNSA-N					compound annotation
0391_011250	SMER28	C11H10BrN3	1.6731	1560402		C=CCNc1ncnc2c1cc(Br)cc2	InChI=1S/C11H10BrN3/c1-2-5-13-11-9-6-8(12)3-4-10(9)14-7-15-11/h2-4,6-7H,1,5H2,(H,13,14,15)	BCPOLXUSCUFDGE-UHFFFAOYSA-N					compound annotation
0391_011251	Carbutamide	C11H17N3O3S	2.4044	9564		CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1	InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)	VDTNNGKXZGSZIP-UHFFFAOYSA-N					compound annotation
0391_011252	Mebhydrolin	C19H20N2	2.8389	22530		CN1CCc2c(C1)c1ccccc1n2Cc1ccccc1	InChI=1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3	FQQIIPAOSKSOJM-UHFFFAOYSA-N					compound annotation
0391_011253	syrosingopine	C35H42N2O11	3.6729	6769	CCOC(=O)OC1=C(C=C(C=C1OC)C(=O)O[C@@H]2C[C@@H]3CN4CCC5=C([C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC)NC6=C5C=CC(=C6)OC)OC	CCOC(=O)Oc1c(OC)cc(C(=O)OC2CC3CN4CCc5c([nH]c6c5ccc(OC)c6)C4CC3C(C(=O)OC)C2OC)cc1OC	InChI=1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3/t19-,23+,25-,28-,29+,32+/m1/s1	ZCDNRPPFBQDQHR-SSYATKPKSA-N					compound annotation
0391_011254	Moslosooflavone	C17H14O5	4.3372	188316		COc1c(OC)c2c(c(O)c1)c(=O)cc(-c1ccccc1)o2	InChI=1S/C17H14O5/c1-20-14-9-12(19)15-11(18)8-13(10-6-4-3-5-7-10)22-17(15)16(14)21-2/h3-9,19H,1-2H3	IHLSBQVBFDTNTC-UHFFFAOYSA-N					compound annotation
0391_011255	92-78-4	C17H12ClNO2	4.9132	66720		O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2cc1O	InChI=1S/C17H12ClNO2/c18-13-5-7-14(8-6-13)19-17(21)15-9-11-3-1-2-4-12(11)10-16(15)20/h1-10,20H,(H,19,21)	OHAXNCGNVGGWSO-UHFFFAOYSA-N					compound annotation
0391_011256	1-Methylinosine	C11H14N4O5	0.4938	65095	CN1C=NC2=C(C1=O)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	Cn1cnc2c(ncn2C2OC(CO)C(O)C2O)c1=O	InChI=1S/C11H14N4O5/c1-14-3-13-9-6(10(14)19)12-4-15(9)11-8(18)7(17)5(2-16)20-11/h3-5,7-8,11,16-18H,2H2,1H3/t5-,7-,8-,11-/m1/s1	WJNGQIYEQLPJMN-IOSLPCCCSA-N					removed another duplicate entry; compound annotation
0391_011258	5'-deoxyadenosine	C10H13N5O3	0.4996	439182	C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	CC1OC(n2cnc3c(N)ncnc32)C(O)C1O	InChI=1S/C10H13N5O3/c1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15/h2-4,6-7,10,16-17H,1H3,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1	XGYIMTFOTBMPFP-KQYNXXCUSA-N					compound annotation
0391_011259	mepivacaine	C15H22N2O	1.5946	4062		Cc1c(NC(=O)C2CCCCN2C)c(C)ccc1	InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)	INWLQCZOYSRPNW-UHFFFAOYSA-N					doublet; compound annotation
0391_011260	Ketanserin	C22H22FN3O3	2.4188	3822		O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1	InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)	FPCCSQOGAWCVBH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011262	Harpagoside	C24H30O11	2.7147	5281542	C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4	CC1(OC(=O)C=Cc2ccccc2)CC(O)C2(O)C=COC(OC3OC(CO)C(O)C(O)C3O)C12	InChI=1S/C24H30O11/c1-23(35-16(27)8-7-13-5-3-2-4-6-13)11-15(26)24(31)9-10-32-22(20(23)24)34-21-19(30)18(29)17(28)14(12-25)33-21/h2-10,14-15,17-22,25-26,28-31H,11-12H2,1H3/b8-7+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1	KVRQGMOSZKPBNS-FMHLWDFHSA-N					compound annotation
0391_011263	FEN1 Inhibitor C3	C15H12N2O4	2.7978	132585224		COc1ccc(-n2c(=O)n(O)c(=O)c3ccccc32)cc1	InChI=1S/C15H12N2O4/c1-21-11-8-6-10(7-9-11)16-13-5-3-2-4-12(13)14(18)17(20)15(16)19/h2-9,20H,1H3	BBJIIPZSHQTBLW-UHFFFAOYSA-N					compound annotation
0391_011264	Alobresib	C26H23N5O2	2.3542	86281210		Cc1noc(C)c1-c1cc(C(O)(c2ccccn2)c2ccccn2)c2nc(C3CC3)[nH]c2c1	InChI=1S/C26H23N5O2/c1-15-23(16(2)33-31-15)18-13-19(24-20(14-18)29-25(30-24)17-9-10-17)26(32,21-7-3-5-11-27-21)22-8-4-6-12-28-22/h3-8,11-14,17,32H,9-10H2,1-2H3,(H,29,30)	CMSUJGUHYXQSOK-UHFFFAOYSA-N					compound annotation
0391_011265	SB 258719	C18H30N2O2S	2.7209	5312148	CC1CCN(CC1)CC[C@@H](C)N(C)S(=O)(=O)C2=CC=CC(=C2)C	Cc1cc(S(=O)(=O)N(C)C(C)CCN2CCC(C)CC2)ccc1	InChI=1S/C18H30N2O2S/c1-15-8-11-20(12-9-15)13-10-17(3)19(4)23(21,22)18-7-5-6-16(2)14-18/h5-7,14-15,17H,8-13H2,1-4H3/t17-/m1/s1	AGVNHDNTFYHZNL-QGZVFWFLSA-N					compound annotation
0391_011266	Vindoline	C25H32N2O6	2.7877	260535	CC[C@@]12C=CCN3[C@@H]1[C@]4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)O)N(C5=C4C=CC(=C5)OC)C	CCC12C=CCN3CCC4(c5c(cc(OC)cc5)N(C)C4C(O)(C(=O)OC)C1OC(C)=O)C32	InChI=1S/C25H32N2O6/c1-6-23-10-7-12-27-13-11-24(19(23)27)17-9-8-16(31-4)14-18(17)26(3)20(24)25(30,22(29)32-5)21(23)33-15(2)28/h7-10,14,19-21,30H,6,11-13H2,1-5H3/t19-,20+,21+,23+,24+,25-/m0/s1	CXBGOBGJHGGWIE-ACSXSLCXSA-N					compound annotation
0391_011267	Psoralen	C11H6O3	2.8504	6199		O=c1ccc2cc3c(cc2o1)occ3	InChI=1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H	ZCCUUQDIBDJBTK-UHFFFAOYSA-N					compound annotation
0391_011268	394237-61-7	C17H16N2O3	3.1008	764764		COc1ccc(-c2c(C)[nH]nc2-c2c(O)cc(O)cc2)cc1	InChI=1S/C17H16N2O3/c1-10-16(11-3-6-13(22-2)7-4-11)17(19-18-10)14-8-5-12(20)9-15(14)21/h3-9,20-21H,1-2H3,(H,18,19)	GSBFARPNIZUMHA-UHFFFAOYSA-N					compound annotation
0391_011269	8-M-PDOT	C14H19NO2	3.1659	5170952		CCC(=O)NC1CCc2c(C1)c(OC)ccc2	InChI=1S/C14H19NO2/c1-3-14(16)15-11-8-7-10-5-4-6-13(17-2)12(10)9-11/h4-6,11H,3,7-9H2,1-2H3,(H,15,16)	RVIGBTUDFAGRTQ-UHFFFAOYSA-N					compound annotation
0391_011270	Dihydrocapsaicin	C18H29NO3	4.4371	107982		COc1c(O)ccc(CNC(=O)CCCCCCC(C)C)c1	InChI=1S/C18H29NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h10-12,14,20H,4-9,13H2,1-3H3,(H,19,21)	XJQPQKLURWNAAH-UHFFFAOYSA-N					compound annotation
0391_011271	Pyraclostrobin	C19H18ClN3O4	4.9724	6422843		COC(=O)N(OC)c1ccccc1COc1nn(-c2ccc(Cl)cc2)cc1	InChI=1S/C19H18ClN3O4/c1-25-19(24)23(26-2)17-6-4-3-5-14(17)13-27-18-11-12-22(21-18)16-9-7-15(20)8-10-16/h3-12H,13H2,1-2H3	HZRSNVGNWUDEFX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011273	Vardenafil hydrochloride	C23H32N6O4S	2.4041	135400189		CCCc1nc(C)c2c(=O)nc(-c3c(OCC)ccc(S(=O)(=O)N4CCN(CC)CC4)c3)[nH]n12	InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)	SECKRCOLJRRGGV-UHFFFAOYSA-N					compound annotation
0391_011274	Astragaloside III	C41H68O14	3.4551	441905	C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O)(C)C)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O	CC(C)(O)C1CCC(C)(C2C(O)CC3(C)C4CC(O)C5C(C)(C)C(OC6OCC(O)C(O)C6OC6OC(CO)C(O)C(O)C6O)CCC56CC46CCC23C)O1	InChI=1S/C41H68O14/c1-35(2)24(53-34-30(26(46)21(45)17-51-34)54-33-29(49)28(48)27(47)22(16-42)52-33)9-11-41-18-40(41)13-12-37(5)32(39(7)10-8-25(55-39)36(3,4)50)20(44)15-38(37,6)23(40)14-19(43)31(35)41/h19-34,42-50H,8-18H2,1-7H3/t19-,20-,21+,22+,23-,24-,25-,26-,27+,28-,29+,30+,31-,32-,33-,34-,37+,38-,39+,40-,41+/m0/s1	FVFSMBDVZVUETN-BQAOMNQWSA-N					removed another duplicate entry; compound annotation
0391_011276	TTP-8307	C27H21FN4O	3.4616	16739062	C[C@H](C1=CC=C(C=C1)F)NC(=O)C2=CC=CC(=C2)C3=CN=C(N3)C4=CC5=CC=CC=C5C=N4	CC(NC(=O)c1cccc(-c2cnc(-c3cc4ccccc4cn3)[nH]2)c1)c1ccc(F)cc1	InChI=1S/C27H21FN4O/c1-17(18-9-11-23(28)12-10-18)31-27(33)21-8-4-7-20(13-21)25-16-30-26(32-25)24-14-19-5-2-3-6-22(19)15-29-24/h2-17H,1H3,(H,30,32)(H,31,33)/t17-/m1/s1	SIBDJDZVNXVLEX-QGZVFWFLSA-N					doublet; compound annotation
0391_011277	TTP-8307	C27H21FN4O	3.4668	16739062	C[C@H](C1=CC=C(C=C1)F)NC(=O)C2=CC=CC(=C2)C3=CN=C(N3)C4=CC5=CC=CC=C5C=N4	CC(NC(=O)c1cccc(-c2cnc(-c3cc4ccccc4cn3)[nH]2)c1)c1ccc(F)cc1	InChI=1S/C27H21FN4O/c1-17(18-9-11-23(28)12-10-18)31-27(33)21-8-4-7-20(13-21)25-16-30-26(32-25)24-14-19-5-2-3-6-22(19)15-29-24/h2-17H,1H3,(H,30,32)(H,31,33)/t17-/m1/s1	SIBDJDZVNXVLEX-QGZVFWFLSA-N					doublet; compound annotation
0391_011278	197855-65-5	C21H23FN2O4	3.8408	6915837	CC(C(=O)CF)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2	CC(NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF	InChI=1S/C21H23FN2O4/c1-15(19(25)13-22)23-20(26)18(12-16-8-4-2-5-9-16)24-21(27)28-14-17-10-6-3-7-11-17/h2-11,15,18H,12-14H2,1H3,(H,23,26)(H,24,27)/t15?,18-/m0/s1	ASXVEBPEZMSPHB-PKHIMPSTSA-N					doublet; compound annotation
0391_011279	197855-65-5	C21H23FN2O4	3.864	6915837	CC(C(=O)CF)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2	CC(NC(=O)C(Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)CF	InChI=1S/C21H23FN2O4/c1-15(19(25)13-22)23-20(26)18(12-16-8-4-2-5-9-16)24-21(27)28-14-17-10-6-3-7-11-17/h2-11,15,18H,12-14H2,1H3,(H,23,26)(H,24,27)/t15?,18-/m0/s1	ASXVEBPEZMSPHB-PKHIMPSTSA-N					doublet; compound annotation
0391_011280	HNASH	C18H14N2O3	4.422	135458654	C1=CC=C2C(=C1)C=CC(=C2/C=N/NC(=O)C3=CC=CC=C3O)O	O=C(NN=Cc1c(O)ccc2ccccc12)c1ccccc1O	InChI=1S/C18H14N2O3/c21-16-8-4-3-7-14(16)18(23)20-19-11-15-13-6-2-1-5-12(13)9-10-17(15)22/h1-11,21-22H,(H,20,23)/b19-11+	ZZSJOLDICPVVAV-YBFXNURJSA-N					compound annotation
0391_011281	Mitochondrial Fusion Promoter M1	C14H10Cl4N2O	6.1086	136672588	C/C(=N/NC1=C(C=C(C=C1Cl)Cl)Cl)/C2=C(C=CC(=C2)Cl)O	CC(=NNc1c(Cl)cc(Cl)cc1Cl)c1c(O)ccc(Cl)c1	InChI=1S/C14H10Cl4N2O/c1-7(10-4-8(15)2-3-13(10)21)19-20-14-11(17)5-9(16)6-12(14)18/h2-6,20-21H,1H3/b19-7-	CYVDGZYJHHYIIU-GXHLCREISA-N					compound annotation
0391_011282	Rotundine	C21H25NO4	2.2498	72301	COC1=C(C2=C(C[C@H]3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC	COc1c(OC)cc2c(c1)CCN1Cc3c(ccc(OC)c3OC)CC21	InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1	AEQDJSLRWYMAQI-KRWDZBQOSA-N					compound annotation
0391_011283	BRAF inhibitor	C22H18F2N4O3S	2.4321	53438230		CC(C)S(=O)(=O)Nc1c(F)c(C(=O)c2c[nH]c3c2cc(-c2cnccc2)cn3)c(F)cc1	InChI=1S/C22H18F2N4O3S/c1-12(2)32(30,31)28-18-6-5-17(23)19(20(18)24)21(29)16-11-27-22-15(16)8-14(10-26-22)13-4-3-7-25-9-13/h3-12,28H,1-2H3,(H,26,27)	SUNCACOTKLUNHD-UHFFFAOYSA-N					compound annotation
0391_011284	ASIATICOSIDE B	C48H78O20	2.4708	91618002	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CC[C@H]7[C@]6(C[C@H]([C@@H]8[C@@]7(C[C@H]([C@@H]([C@@]8(C)CO)O)O)C)O)C)[C@@H]4CC(CC5)(C)C)C)O)O)O)CO)O)O)O	CC1OC(OC2C(CO)OC(OCC3OC(OC(=O)C45CCC(C)(C)CC4C4=CCC6C7(C)CC(O)C(O)C(C)(CO)C7C(O)CC6(C)C4(C)CC5)C(O)C(O)C3O)C(O)C2O)C(O)C(O)C1O	InChI=1S/C48H78O20/c1-20-28(53)30(55)33(58)40(64-20)67-36-25(17-49)65-39(35(60)32(36)57)63-18-26-29(54)31(56)34(59)41(66-26)68-42(62)48-12-10-43(2,3)14-22(48)21-8-9-27-44(4)15-24(52)38(61)45(5,19-50)37(44)23(51)16-47(27,7)46(21,6)11-13-48/h8,20,22-41,49-61H,9-19H2,1-7H3/t20-,22-,23+,24+,25+,26+,27+,28-,29+,30+,31-,32+,33+,34+,35+,36+,37+,38-,39+,40-,41-,44+,45-,46+,47+,48-/m0/s1	NNWMHSNRRWMMBI-PJISEHJASA-N					compound annotation
0391_011285	cisapride	C23H29ClFN3O4	2.8447	6917698	CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC	InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1	DCSUBABJRXZOMT-IRLDBZIGSA-N					removed another duplicate entry; compound annotation
0391_011287	tacrolimus	C44H69NO12	5.4583	445643	C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC	C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(O)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC	InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1	QJJXYPPXXYFBGM-LFZNUXCKSA-N					compound annotation
0391_011288	Oroxin B	C27H30O15	2.1316	10077207	C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O)O	O=c1cc(-c2ccccc2)oc2cc(OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)c(O)c(O)c12	InChI=1S/C27H30O15/c28-8-15-19(31)22(34)24(36)26(41-15)38-9-16-20(32)23(35)25(37)27(42-16)40-14-7-13-17(21(33)18(14)30)11(29)6-12(39-13)10-4-2-1-3-5-10/h1-7,15-16,19-20,22-28,30-37H,8-9H2/t15-,16-,19-,20-,22+,23+,24-,25-,26-,27-/m1/s1	HAYLVXFWJCKKDW-IJTBWITGSA-N					compound annotation
0391_011289	Imidafenacin	C20H21N3O	2.2438	6433090		Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1	InChI=1S/C20H21N3O/c1-16-22-13-15-23(16)14-12-20(19(21)24,17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,13,15H,12,14H2,1H3,(H2,21,24)	SQKXYSGRELMAAU-UHFFFAOYSA-N					compound annotation
0391_011290	Tromantadine	C16H28N2O2	2.3661	64377		CN(C)CCOCC(=O)NC12CC3CC(CC(C3)C1)C2	InChI=1S/C16H28N2O2/c1-18(2)3-4-20-11-15(19)17-16-8-12-5-13(9-16)7-14(6-12)10-16/h12-14H,3-11H2,1-2H3,(H,17,19)	UXQDWARBDDDTKG-UHFFFAOYSA-N					compound annotation
0391_011291	Eletriptan	C22H26N2O2S	2.5195	77993	CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4	CN1CCCC1Cc1c[nH]c2c1cc(CCS(=O)(=O)c1ccccc1)cc2	InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1	PWVXXGRKLHYWKM-LJQANCHMSA-N					compound annotation
0391_011292	TP-004	C17H16F3N5O	2.8969	89794927	CC1=NC(=NC=C1C2=C3C=NNC3=CC(=C2)C(F)(F)F)N4CC[C@H](C4)O	Cc1nc(N2CCC(O)C2)ncc1-c1c2cn[nH]c2cc(C(F)(F)F)c1	InChI=1S/C17H16F3N5O/c1-9-13(6-21-16(23-9)25-3-2-11(26)8-25)12-4-10(17(18,19)20)5-15-14(12)7-22-24-15/h4-7,11,26H,2-3,8H2,1H3,(H,22,24)/t11-/m1/s1	BNTAEJNPQLMGDJ-LLVKDONJSA-N					compound annotation
0391_011293	Cixiophiopogon A	C44H70O18	3.6075	102004869	C[C@@H]1CC[C@@]2([C@H]([C@]3([C@@H](O2)C[C@@]4([C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)O)O)C)OC1	CC1CCC2(OC1)OC1CC3(O)C4CC=C5CC(OC6OC(CO)C(O)C(OC7OCC(O)C(O)C7O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1(O)C2C	InChI=1S/C44H70O18/c1-19-8-13-43(56-17-19)21(3)44(54)28(62-43)15-42(53)25-7-6-22-14-23(9-11-40(22,4)24(25)10-12-41(42,44)5)58-39-36(61-38-34(52)32(50)29(47)20(2)57-38)35(31(49)27(16-45)59-39)60-37-33(51)30(48)26(46)18-55-37/h6,19-21,23-39,45-54H,7-18H2,1-5H3/t19-,20+,21-,23+,24+,25-,26-,27-,28+,29+,30+,31-,32-,33-,34-,35+,36-,37+,38+,39-,40+,41+,42-,43-,44-/m1/s1	XEMVQWDHRXAQNR-YVEJFGEMSA-N					compound annotation
0391_011294	PENFLURIDOL	C28H27ClF5NO	4.1777	33630		OC1(c2cc(C(F)(F)F)c(Cl)cc2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1	InChI=1S/C28H27ClF5NO/c29-26-12-7-21(18-25(26)28(32,33)34)27(36)13-16-35(17-14-27)15-1-2-24(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24,36H,1-2,13-17H2	MDLAAYDRRZXJIF-UHFFFAOYSA-N					compound annotation
0391_011295	cabergoline	C26H37N5O2	1.6331	54746	CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C	C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3c4c(c[nH]c4ccc3)CC21	InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1	KORNTPPJEAJQIU-KJXAQDMKSA-N					compound annotation
0391_011296	Lenvatinib	C21H19ClN4O4	1.9941	9823820		COc1cc2nccc(Oc3cc(Cl)c(NC(=O)NC4CC4)cc3)c2cc1C(N)=O	InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)	WOSKHXYHFSIKNG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011298	294623-49-7	C24H30N6O2S	2.3297	9912381		CN1CCN(c2nc(-c3ccc(C(=O)NC4(C(=O)NCC#N)CCCCC4)cc3)cs2)CC1	InChI=1S/C24H30N6O2S/c1-29-13-15-30(16-14-29)23-27-20(17-33-23)18-5-7-19(8-6-18)21(31)28-24(9-3-2-4-10-24)22(32)26-12-11-25/h5-8,17H,2-4,9-10,12-16H2,1H3,(H,26,32)(H,28,31)	FIVYCSWOCXEWSE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011300	MKI-1	C18H14N4O	3.1896	27649598		O=C(Nc1nc2ccccc2[nH]1)c1cc(-n2cccc2)ccc1	InChI=1S/C18H14N4O/c23-17(21-18-19-15-8-1-2-9-16(15)20-18)13-6-5-7-14(12-13)22-10-3-4-11-22/h1-12H,(H2,19,20,21,23)	XKDZPQAMBMLCDQ-UHFFFAOYSA-N					compound annotation
0391_011301	1407966-77-1	C30H33N7O2	4.0587	71450146	CC1=C(C=CC(=C1)NC(=O)C2=CC=CC(=C2)C3=NN(C4=NC=NC(=C34)N)[C@@H]5CCCN(C5)C(=O)C=C)C(C)C	C=CC(=O)N1CCCC(n2nc(-c3cc(C(=O)Nc4cc(C)c(C(C)C)cc4)ccc3)c3c(N)ncnc32)C1	InChI=1S/C30H33N7O2/c1-5-25(38)36-13-7-10-23(16-36)37-29-26(28(31)32-17-33-29)27(35-37)20-8-6-9-21(15-20)30(39)34-22-11-12-24(18(2)3)19(4)14-22/h5-6,8-9,11-12,14-15,17-18,23H,1,7,10,13,16H2,2-4H3,(H,34,39)(H2,31,32,33)/t23-/m1/s1	CGJVMKJGKFEHTL-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_011303	J-113863 cation, cis-	C30H37Cl2N2O2+	4.207	6918497	CC[N+]1(CCC(CC1)NC(=O)C2C3=C(C=CC(=C3)Cl)OC4=C2C=C(C=C4)Cl)C/C/5=C/CCCCCC5	CC[N+]1(CC2=CCCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3c2cc(Cl)cc3)CC1	InChI=1S/C30H36Cl2N2O2/c1-2-34(20-21-8-6-4-3-5-7-9-21)16-14-24(15-17-34)33-30(35)29-25-18-22(31)10-12-27(25)36-28-13-11-23(32)19-26(28)29/h8,10-13,18-19,24,29H,2-7,9,14-17,20H2,1H3/p+1/b21-8+	VQHKDCUXFKNNMT-ODCIPOBUSA-O					doublet; compound annotation
0391_011304	J-113863 cation, cis-	C30H37Cl2N2O2+	4.276	6918497	CC[N+]1(CCC(CC1)NC(=O)C2C3=C(C=CC(=C3)Cl)OC4=C2C=C(C=C4)Cl)C/C/5=C/CCCCCC5	CC[N+]1(CC2=CCCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3c2cc(Cl)cc3)CC1	InChI=1S/C30H36Cl2N2O2/c1-2-34(20-21-8-6-4-3-5-7-9-21)16-14-24(15-17-34)33-30(35)29-25-18-22(31)10-12-27(25)36-28-13-11-23(32)19-26(28)29/h8,10-13,18-19,24,29H,2-7,9,14-17,20H2,1H3/p+1/b21-8+	VQHKDCUXFKNNMT-ODCIPOBUSA-O					doublet; compound annotation
0391_011305	FGFR1/DDR2 inhibitor 1	C28H22F3N5O	4.8302	138454761		Cc1c(-c2cc3c(cc2)c(-c2cn(C4CC4)nc2)n[nH]3)cc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1	InChI=1S/C28H22F3N5O/c1-16-5-6-18(27(37)33-21-4-2-3-20(13-21)28(29,30)31)11-24(16)17-7-10-23-25(12-17)34-35-26(23)19-14-32-36(15-19)22-8-9-22/h2-7,10-15,22H,8-9H2,1H3,(H,33,37)(H,34,35)	ZEOWTGPWHLSLOG-UHFFFAOYSA-N					compound annotation
0391_011306	ALK2-IN-4	C26H30FN7O	1.4652	142464264		COc1c(F)cc2nccc(-c3c4ncc(N5CCC(N6CCN(C)CC6)CC5)cn4nc3)c2c1	InChI=1S/C26H30FN7O/c1-31-9-11-33(12-10-31)18-4-7-32(8-5-18)19-15-29-26-22(16-30-34(26)17-19)20-3-6-28-24-14-23(27)25(35-2)13-21(20)24/h3,6,13-18H,4-5,7-12H2,1-2H3	UYQADNMBNQEQQG-UHFFFAOYSA-N					compound annotation
0391_011307	M-110	C22H28ClN5O3	2.6212	136246423	CC/C(=N\NC(=O)C1=CC(=NC=C1)NCCCN2CCOCC2)/C3=C(C=C(C=C3)Cl)O	CCC(=NNC(=O)c1cc(NCCCN2CCOCC2)ncc1)c1c(O)cc(Cl)cc1	InChI=1S/C22H28ClN5O3/c1-2-19(18-5-4-17(23)15-20(18)29)26-27-22(30)16-6-8-25-21(14-16)24-7-3-9-28-10-12-31-13-11-28/h4-6,8,14-15,29H,2-3,7,9-13H2,1H3,(H,24,25)(H,27,30)/b26-19+	FXXCNYVQIONABS-LGUFXXKBSA-N					compound annotation
0391_011308	CCR1 antagonist 9	C20H16FN5O3S	2.9535	59278314		CS(=O)(=O)c1nccc(CNC(=O)c2cncc3c2cnn3-c2ccc(F)cc2)c1	InChI=1S/C20H16FN5O3S/c1-30(28,29)19-8-13(6-7-23-19)9-24-20(27)17-10-22-12-18-16(17)11-25-26(18)15-4-2-14(21)3-5-15/h2-8,10-12H,9H2,1H3,(H,24,27)	DCHROQCNJDJPGN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011310	(Rac)-X77	C27H33N5O2	3.128	132058207		CC(C)(C)c1ccc(N(C(=O)c2cnc[nH]2)C(C(=O)NC2CCCCC2)c2cnccc2)cc1	InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33)	MUNFBYOTGGMQOS-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011312	Eupatorin	C18H16O7	3.4706	97214		COc1c(O)cc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1	InChI=1S/C18H16O7/c1-22-12-5-4-9(6-10(12)19)13-7-11(20)16-14(25-13)8-15(23-2)18(24-3)17(16)21/h4-8,19,21H,1-3H3	KLAOKWJLUQKWIF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011314	MMPI-1154	C26H24FN3O3	3.6029	68027884		O=C(O)c1cnc(CN(Cc2ccc(F)cc2)Cc2ccc(OCc3ccccc3)cc2)[nH]1	InChI=1S/C26H24FN3O3/c27-22-10-6-19(7-11-22)15-30(17-25-28-14-24(29-25)26(31)32)16-20-8-12-23(13-9-20)33-18-21-4-2-1-3-5-21/h1-14H,15-18H2,(H,28,29)(H,31,32)	QLTNFRCPUOPISS-UHFFFAOYSA-N					compound annotation
0391_011315	883031-03-6	C26H28F3N3O2	3.6146	2742550		Cc1c(C(=O)Nc2cccc(C(F)(F)F)c2)cc(-c2ccccc2)n1CCCN1CCOCC1	InChI=1S/C26H28F3N3O2/c1-19-23(25(33)30-22-10-5-9-21(17-22)26(27,28)29)18-24(20-7-3-2-4-8-20)32(19)12-6-11-31-13-15-34-16-14-31/h2-5,7-10,17-18H,6,11-16H2,1H3,(H,30,33)	NCZYSQOTAYFTNM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011317	(Rac)-X77	C27H33N5O2	4.0981	132058207		CC(C)(C)c1ccc(N(C(=O)c2cnc[nH]2)C(C(=O)NC2CCCCC2)c2cnccc2)cc1	InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33)	MUNFBYOTGGMQOS-UHFFFAOYSA-N					doublet; compound annotation
0391_011318	(Rac)-X77	C27H33N5O2	4.3173	132058207		CC(C)(C)c1ccc(N(C(=O)c2cnc[nH]2)C(C(=O)NC2CCCCC2)c2cnccc2)cc1	InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33)	MUNFBYOTGGMQOS-UHFFFAOYSA-N					doublet; compound annotation
0391_011319	PC945	C38H37F3N6O3	4.8483	121383526	CC1=C(C=CC(=C1)N2CCN(CC2)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)F)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F	Cc1c(OCC2COC(Cn3cncn3)(c3c(F)cc(F)cc3)C2)ccc(N2CCN(c3ccc(C(=O)Nc4ccc(F)cc4)cc3)CC2)c1	InChI=1S/C38H37F3N6O3/c1-26-18-33(46-16-14-45(15-17-46)32-9-2-28(3-10-32)37(48)44-31-7-4-29(39)5-8-31)11-13-36(26)49-21-27-20-38(50-22-27,23-47-25-42-24-43-47)34-12-6-30(40)19-35(34)41/h2-13,18-19,24-25,27H,14-17,20-23H2,1H3,(H,44,48)/t27-,38+/m1/s1	OSAMZQJKSCAOHA-CWRQMEKBSA-N					removed another duplicate entry; compound annotation
0391_011322	ML-7	C15H17IN2O2S	2.9634	4216		O=S(=O)(c1cccc2c1cccc2I)N1CCCNCC1	InChI=1S/C15H17IN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2	GEHJIACZUFWBTK-UHFFFAOYSA-N					compound annotation
0391_011323	methoxsalen	C12H8O4	2.9842	4114		COc1c2oc(=O)ccc2cc2c1occ2	InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3	QXKHYNVANLEOEG-UHFFFAOYSA-N					compound annotation
0391_011324	Isoalantolactone	C15H20O2	4.7042	73285	C[C@]12CCCC(=C)[C@@H]1C[C@H]3[C@@H](C2)OC(=O)C3=C	C=C1C(=O)OC2CC3(C)CCCC(=C)C3CC12	InChI=1S/C15H20O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h11-13H,1-2,4-8H2,3H3/t11-,12+,13-,15-/m1/s1	CVUANYCQTOGILD-QVHKTLOISA-N					compound annotation
0391_011325	Temsirolimus	C56H87NO16	5.5421	6918289	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OC(=O)C(C)(CO)CO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1	CBPNZQVSJQDFBE-FUXHJELOSA-N					compound annotation
0391_011326	N-(3-Azidopropyl)biotinamide	C13H22N6O2S	1.963	59828156	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCN=[N+]=[N-])NC(=O)N2	[N-]=[N+]=NCCCNC(=O)CCCCC1SCC2NC(=O)NC21	InChI=1S/C13H22N6O2S/c14-19-16-7-3-6-15-11(20)5-2-1-4-10-12-9(8-22-10)17-13(21)18-12/h9-10,12H,1-8H2,(H,15,20)(H2,17,18,21)/t9-,10-,12-/m0/s1	SWODDJWJUGOAQB-NHCYSSNCSA-N					removed another duplicate entry; compound annotation
0391_011328	Mitraphylline	C21H24N2O4	2.0613	94160	C[C@H]1[C@H]2CN3CC[C@]4([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)C5=CC=CC=C5NC4=O	COC(=O)C1=COC(C)C2CN3CCC4(C(=O)Nc5ccccc54)C3CC12	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14+,18-,21+/m0/s1	JMIAZDVHNCCPDM-DAFCLMLCSA-N					doublet; compound annotation
0391_011329	Mitraphylline	C21H24N2O4	2.115	94160	C[C@H]1[C@H]2CN3CC[C@]4([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)C5=CC=CC=C5NC4=O	COC(=O)C1=COC(C)C2CN3CCC4(C(=O)Nc5ccccc54)C3CC12	InChI=1S/C21H24N2O4/c1-12-14-10-23-8-7-21(16-5-3-4-6-17(16)22-20(21)25)18(23)9-13(14)15(11-27-12)19(24)26-2/h3-6,11-14,18H,7-10H2,1-2H3,(H,22,25)/t12-,13-,14+,18-,21+/m0/s1	JMIAZDVHNCCPDM-DAFCLMLCSA-N					doublet; compound annotation
0391_011330	FEN1 Inhibitor C2	C12H12N2O3	2.4004	121231495		O=c1c2ccccc2n(CC2CC2)c(=O)n1O	InChI=1S/C12H12N2O3/c15-11-9-3-1-2-4-10(9)13(7-8-5-6-8)12(16)14(11)17/h1-4,8,17H,5-7H2	JAFLWTUYSKADJS-UHFFFAOYSA-N					compound annotation
0391_011331	Asenapine	C17H16ClNO	2.8538	3036780	CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24	CN1CC2c3ccccc3Oc3c(cc(Cl)cc3)C2C1	InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m0/s1	VSWBSWWIRNCQIJ-GJZGRUSLSA-N					compound annotation
0391_011332	Medroxyprogesterone acetate	C24H34O4	4.6491	6279	C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C	CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1	PSGAAPLEWMOORI-PEINSRQWSA-N					compound annotation
0391_011333	Euphorbia Factor L2	C38H42O9	6.084	10627939	C[C@H]1C[C@]2([C@H]([C@H]1OC(=O)C3=CC=CC=C3)[C@H](C(=C)[C@@H](C[C@H]4[C@H](C4(C)C)/C=C(/C2=O)\C)OC(=O)C5=CC=CC=C5)OC(=O)C)OC(=O)C	C=C1C(OC(=O)c2ccccc2)CC2C(C=C(C)C(=O)C3(OC(C)=O)CC(C)C(OC(=O)c4ccccc4)C3C1OC(C)=O)C2(C)C	InChI=1S/C38H42O9/c1-21-18-28-29(37(28,6)7)19-30(45-35(42)26-14-10-8-11-15-26)23(3)33(44-24(4)39)31-32(46-36(43)27-16-12-9-13-17-27)22(2)20-38(31,34(21)41)47-25(5)40/h8-18,22,28-33H,3,19-20H2,1-2,4-7H3/b21-18+/t22-,28+,29-,30+,31+,32-,33-,38+/m0/s1	AFRGWGGHJYMSDU-LVFBPYTJSA-N					removed another duplicate entry; compound annotation
0391_011335	Huperzine A	C15H18N2O	1.1681	449069	CC=C1[C@@H]2CC3=C([C@]1(CC(=C2)C)N)C=CC(=O)N3	CC=C1C2C=C(C)CC1(N)c1c(C2)[nH]c(=O)cc1	InChI=1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/t10-,15+/m0/s1	ZRJBHWIHUMBLCN-ZUZCIYMTSA-N					compound annotation
0391_011336	OAC1	C14H11N3O	1.7384	789882		O=C(Nc1ncc2[nH]ccc2c1)c1ccccc1	InChI=1S/C14H11N3O/c18-14(10-4-2-1-3-5-10)17-13-8-11-6-7-15-12(11)9-16-13/h1-9,15H,(H,16,17,18)	HWJRIFZDXJKJJN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011338	sulfamonomethoxine	C11H12N4O3S	1.8359	5332		COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1	InChI=1S/C11H12N4O3S/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,14,15)	WMPXPUYPYQKQCX-UHFFFAOYSA-N					compound annotation
0391_011339	WWL70	C27H23N3O3	2.6954	17759121		CN(Cc1cc(-c2ccncc2)ccc1)C(=O)Oc1ccc(-c2ccc(C(N)=O)cc2)cc1	InChI=1S/C27H23N3O3/c1-30(18-19-3-2-4-24(17-19)22-13-15-29-16-14-22)27(32)33-25-11-9-21(10-12-25)20-5-7-23(8-6-20)26(28)31/h2-17H,18H2,1H3,(H2,28,31)	QTWNORFUQILKJL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011341	AZA1	C22H20N6	2.8938	25104141		Cc1cc2c(ccc(Nc3nc(Nc4cc5c(cc4)[nH]c(C)c5)ncc3)c2)[nH]1	InChI=1S/C22H20N6/c1-13-9-15-11-17(3-5-19(15)24-13)26-21-7-8-23-22(28-21)27-18-4-6-20-16(12-18)10-14(2)25-20/h3-12,24-25H,1-2H3,(H2,23,26,27,28)	SYWHWWKOIJCMKF-UHFFFAOYSA-N					compound annotation
0391_011342	Roflumilast	C17H14Cl2F2N2O3	4.3477	449193		O=C(Nc1c(Cl)cncc1Cl)c1cc(OCC2CC2)c(OC(F)F)cc1	InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)	MNDBXUUTURYVHR-UHFFFAOYSA-N					compound annotation
0391_011343	IK1 inhibitor PA-6	C31H32N4O2	2.4399	11752239		NC(=Nc1ccc(OCCCCCOc2ccc(N=C(N)c3ccccc3)cc2)cc1)c1ccccc1	InChI=1S/C31H32N4O2/c32-30(24-10-4-1-5-11-24)34-26-14-18-28(19-15-26)36-22-8-3-9-23-37-29-20-16-27(17-21-29)35-31(33)25-12-6-2-7-13-25/h1-2,4-7,10-21H,3,8-9,22-23H2,(H2,32,34)(H2,33,35)	PETGITKEGWIZEL-UHFFFAOYSA-N					compound annotation
0391_011344	trans-Ned 19	C30H31FN4O3	2.4399	1427628	COC1=C(C=C(C=C1)[C@@H]2C3=C(C[C@H](N2)C(=O)O)C4=CC=CC=C4N3)CN5CCN(CC5)C6=CC=CC=C6F	COc1c(CN2CCN(c3ccccc3F)CC2)cc(C2NC(C(=O)O)Cc3c2[nH]c2ccccc32)cc1	InChI=1S/C30H31FN4O3/c1-38-27-11-10-19(16-20(27)18-34-12-14-35(15-13-34)26-9-5-3-7-23(26)31)28-29-22(17-25(33-28)30(36)37)21-6-2-4-8-24(21)32-29/h2-11,16,25,28,32-33H,12-15,17-18H2,1H3,(H,36,37)/t25-,28+/m0/s1	FUHCEERDBRGPQZ-LBNVMWSVSA-N					compound annotation
0391_011345	Trospium	C25H30NO3+	2.6469	5284632	C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O	O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1	InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?	OYYDSUSKLWTMMQ-AIZNXBIQSA-N					doublet; compound annotation
0391_011346	Zanubrutinib	C27H29N5O3	3.5502	135565884	C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N	C=CC(=O)N1CCC(C2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1	InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1	RNOAOAWBMHREKO-QFIPXVFZSA-N					removed another duplicate entry; compound annotation
0391_011348	Trospium	C25H30NO3+	4.1008	5284632	C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O	O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1	InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?	OYYDSUSKLWTMMQ-AIZNXBIQSA-N					doublet; compound annotation
0391_011349	Trospium	C25H30NO3+	4.3202	5284632	C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O	O=C(OC1CC2CCC(C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1	InChI=1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23?	OYYDSUSKLWTMMQ-AIZNXBIQSA-N					doublet; compound annotation
0391_011350	Gracillin	C45H72O17	4.7534	159861	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CC=C5CC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6OC6OC(C)C(O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C45H72O17/c1-19-8-13-45(55-18-19)20(2)30-27(62-45)15-26-24-7-6-22-14-23(9-11-43(22,4)25(24)10-12-44(26,30)5)57-42-39(61-40-36(53)34(51)31(48)21(3)56-40)38(33(50)29(17-47)59-42)60-41-37(54)35(52)32(49)28(16-46)58-41/h6,19-21,23-42,46-54H,7-18H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28-,29-,30+,31+,32-,33-,34-,35+,36-,37-,38+,39-,40+,41+,42-,43+,44+,45-/m1/s1	YQEMAEKYNNOCBY-IEMDQPGHSA-N					compound annotation
0391_011351	XY 018	C23H15F7N2O4	4.8207	130248006		O=C(Cc1ccccc1[N+](=O)[O-])Nc1ccc(-c2c(F)cc(C(O)(C(F)(F)F)C(F)(F)F)cc2)cc1	InChI=1S/C23H15F7N2O4/c24-18-12-15(21(34,22(25,26)27)23(28,29)30)7-10-17(18)13-5-8-16(9-6-13)31-20(33)11-14-3-1-2-4-19(14)32(35)36/h1-10,12,34H,11H2,(H,31,33)	MNVXADPCMINSEC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011353	Azvudine	C9H11FN6O4	0.4671	24769759	C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@](O2)(CO)N=[N+]=[N-])O)F	[N-]=[N+]=NC1(CO)OC(n2ccc(N)nc2=O)C(F)C1O	InChI=1S/C9H11FN6O4/c10-5-6(18)9(3-17,14-15-12)20-7(5)16-2-1-4(11)13-8(16)19/h1-2,5-7,17-18H,3H2,(H2,11,13,19)/t5-,6-,7+,9+/m0/s1	KTOLOIKYVCHRJW-XZMZPDFPSA-N					removed another duplicate entry; compound annotation
0391_011355	Lenalidomide-OH	C13H12N2O4	1.1905	71517902		O=C1CCC(N2Cc3c(ccc(O)c3)C2=O)C(=O)N1	InChI=1S/C13H12N2O4/c16-8-1-2-9-7(5-8)6-15(13(9)19)10-3-4-11(17)14-12(10)18/h1-2,5,10,16H,3-4,6H2,(H,14,17,18)	JJUMFQGCQAUIFH-UHFFFAOYSA-N					compound annotation
0391_011356	Paeoniflorin	C23H28O11	1.6723	442534	C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4([C@H](O2)O3)COC(=O)C5=CC=CC=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O	CC12CC3(O)OC(O1)C1(COC(=O)c4ccccc4)C3CC21OC1OC(CO)C(O)C(O)C1O	InChI=1S/C23H28O11/c1-20-9-22(29)13-7-23(20,32-18-16(27)15(26)14(25)12(8-24)31-18)21(13,19(33-20)34-22)10-30-17(28)11-5-3-2-4-6-11/h2-6,12-16,18-19,24-27,29H,7-10H2,1H3/t12-,13-,14-,15+,16-,18+,19-,20+,21+,22-,23+/m1/s1	YKRGDOXKVOZESV-WRJNSLSBSA-N					compound annotation
0391_011357	desipramine	C18H22N2	3.0397	2995		CNCCCN1c2ccccc2CCc2ccccc21	InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3	HCYAFALTSJYZDH-UHFFFAOYSA-N					compound annotation
0391_011358	PCO371	C29H32F3N5O6S	4.0647	76283707		Cc1cc(N2C(=O)NC(=O)C2(C)C)cc(C)c1CCS(=O)(=O)N1CCC2(CC1)N=C(c1ccc(OC(F)(F)F)cc1)NC2=O	InChI=1S/C29H32F3N5O6S/c1-17-15-20(37-26(40)34-24(38)27(37,3)4)16-18(2)22(17)9-14-44(41,42)36-12-10-28(11-13-36)25(39)33-23(35-28)19-5-7-21(8-6-19)43-29(30,31)32/h5-8,15-16H,9-14H2,1-4H3,(H,33,35,39)(H,34,38,40)	LDZJFVOUPUFOHX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011360	5-Hydroxyflavone	C15H10O3	4.5134	68112		O=c1cc(-c2ccccc2)oc2cccc(O)c12	InChI=1S/C15H10O3/c16-11-7-4-8-13-15(11)12(17)9-14(18-13)10-5-2-1-3-6-10/h1-9,16H	IYBLVRRCNVHZQJ-UHFFFAOYSA-N					compound annotation
0391_011361	BioE-1115	C19H18FN3O2	4.754	50922674		CC(C)N(C)c1nc2c(ccc(C(=O)O)c2)nc1-c1ccc(F)cc1	InChI=1S/C19H18FN3O2/c1-11(2)23(3)18-17(12-4-7-14(20)8-5-12)21-15-9-6-13(19(24)25)10-16(15)22-18/h4-11H,1-3H3,(H,24,25)	JKKRYYTVQXUOKL-UHFFFAOYSA-N					compound annotation
0391_011362	Liranaftate	C18H20N2O2S	5.6016	3936		COc1cccc(N(C)C(=S)Oc2cc3c(cc2)CCCC3)n1	InChI=1S/C18H20N2O2S/c1-20(16-8-5-9-17(19-16)21-2)18(23)22-15-11-10-13-6-3-4-7-14(13)12-15/h5,8-12H,3-4,6-7H2,1-2H3	VPHPQNGOVQYUMG-UHFFFAOYSA-N					compound annotation
0391_011363	NIMUSTINE	C9H13ClN6O2	1.1518	39214		Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1	InChI=1S/C9H13ClN6O2/c1-6-12-4-7(8(11)14-6)5-13-9(17)16(15-18)3-2-10/h4H,2-3,5H2,1H3,(H,13,17)(H2,11,12,14)	VFEDRRNHLBGPNN-UHFFFAOYSA-N					compound annotation
0391_011364	Medetomidine	C13H16N2	2.2794	68602		Cc1c(C)c(C(C)c2cnc[nH]2)ccc1	InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)	CUHVIMMYOGQXCV-UHFFFAOYSA-N					doublet; compound annotation
0391_011365	Pyrintegrin	C23H25N5O3S	2.812	46223724		O=S(=O)(NCC1CC1)c1ccc(Nc2nccc(N3CCCc4c3ccc(O)c4)n2)cc1	InChI=1S/C23H25N5O3S/c29-19-7-10-21-17(14-19)2-1-13-28(21)22-11-12-24-23(27-22)26-18-5-8-20(9-6-18)32(30,31)25-15-16-3-4-16/h5-12,14,16,25,29H,1-4,13,15H2,(H,24,26,27)	QRJTZIJWDLJKQO-UHFFFAOYSA-N					compound annotation
0391_011366	PI-103	C19H16N4O3	3.2989	9884685		Oc1cccc(-c2nc3c(oc4c3cccn4)c(N3CCOCC3)n2)c1	InChI=1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2	TUVCWJQQGGETHL-UHFFFAOYSA-N					doublet; compound annotation
0391_011367	PGAM1-IN-1	C19H11ClFNO6S	5.1269	138454804		O=c1c2c(O)cccc2oc2cc(NS(=O)(=O)c3c(F)c(Cl)ccc3)cc(O)c12	InChI=1S/C19H11ClFNO6S/c20-10-3-1-6-15(18(10)21)29(26,27)22-9-7-12(24)17-14(8-9)28-13-5-2-4-11(23)16(13)19(17)25/h1-8,22-24H	HOMMZVQJPVUUEL-UHFFFAOYSA-N					compound annotation
0391_011368	Trovafloxacin	C20H15F3N4O3	2.1581	11464175	C1[C@@H]2[C@@H](C2[NH3+])CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)[O-])F	NC1C2CN(c3c(F)cc4c(=O)c(C(=O)O)cn(-c5c(F)cc(F)cc5)c4n3)CC12	InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16?	WVPSKSLAZQPAKQ-SOSAQKQKSA-N					removed another duplicate entry; compound annotation
0391_011370	Dehydrocorydaline	C22H24NO4+	2.6507	34781		COc1c(OC)cc2c(c1)CC[n+]1c-2c(C)c2ccc(OC)c(OC)c2c1	InChI=1S/C22H24NO4/c1-13-15-6-7-18(24-2)22(27-5)17(15)12-23-9-8-14-10-19(25-3)20(26-4)11-16(14)21(13)23/h6-7,10-12H,8-9H2,1-5H3/q+1	RFKQJTRWODZPHF-UHFFFAOYSA-N					doublet; compound annotation
0391_011371	Diosbulbin B	C19H20O6	2.7245	9974762	C[C@@]12C[C@@H](O[C@@]13C[C@@H]([C@H]4[C@H]2C[C@@H]5C[C@H]4C(=O)O5)OC3=O)C6=COC=C6	CC12CC(c3cocc3)OC13CC(OC3=O)C1C3CC(CC12)OC3=O	InChI=1S/C19H20O6/c1-18-6-13(9-2-3-22-8-9)25-19(18)7-14(24-17(19)21)15-11-4-10(5-12(15)18)23-16(11)20/h2-3,8,10-15H,4-7H2,1H3/t10-,11+,12+,13+,14-,15+,18-,19+/m0/s1	QEANLIISUSNNDX-YHPVUIEZSA-N					compound annotation
0391_011372	bisindolylmaleimide IX	C25H23N5O2S	3.0043	5083		Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21	InChI=1S/C25H23N5O2S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32)	DSXXEELGXBCYNQ-UHFFFAOYSA-N					compound annotation
0391_011373	Drospirenone	C24H30O3	3.929	68873	C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C	CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1	InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1	METQSPRSQINEEU-HXCATZOESA-N					compound annotation
0391_011374	remogliflozin etabonate	C26H38N2O9	4.1545	9871420	CCOC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=NN(C(=C2CC3=CC=C(C=C3)OC(C)C)C)C(C)C)O)O)O	CCOC(=O)OCC1OC(Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)C(O)C(O)C1O	InChI=1S/C26H38N2O9/c1-7-33-26(32)34-13-20-21(29)22(30)23(31)25(36-20)37-24-19(16(6)28(27-24)14(2)3)12-17-8-10-18(11-9-17)35-15(4)5/h8-11,14-15,20-23,25,29-31H,7,12-13H2,1-6H3/t20-,21-,22+,23-,25+/m1/s1	UAOCLDQAQNNEAX-ABMICEGHSA-N					removed another duplicate entry; compound annotation
0391_011376	Flavokawain A	C18H18O5	5.0092	5355469	COC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2OC)OC)O	COc1ccc(C=CC(=O)c2c(O)cc(OC)cc2OC)cc1	InChI=1S/C18H18O5/c1-21-13-7-4-12(5-8-13)6-9-15(19)18-16(20)10-14(22-2)11-17(18)23-3/h4-11,20H,1-3H3/b9-6+	CGIBCVBDFUTMPT-RMKNXTFCSA-N					doublet; compound annotation
0391_011377	Eact	C22H24N2O5S	5.0171	3173542		COCCN(C(=O)c1cc(OC)c(OC)c(OC)c1)c1nc(-c2ccccc2)cs1	InChI=1S/C22H24N2O5S/c1-26-11-10-24(22-23-17(14-30-22)15-8-6-5-7-9-15)21(25)16-12-18(27-2)20(29-4)19(13-16)28-3/h5-9,12-14H,10-11H2,1-4H3	ZUXNHFFVQWADJL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011379	9H-Pyrido[3,4-B]indole	C11H8N2	1.4882	64961		c1ccc2c(c1)[nH]c1c2ccnc1	InChI=1S/C11H8N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-7,13H	AIFRHYZBTHREPW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011381	Niraparib	C19H20N4O	2.0402	24958200	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	PCHKPVIQAHNQLW-CQSZACIVSA-N					doublet; compound annotation
0391_011382	Niraparib	C19H20N4O	2.0436	24958200	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	PCHKPVIQAHNQLW-CQSZACIVSA-N					doublet; compound annotation
0391_011383	Ruxolitinib	C17H18N6	2.4569	25126798	C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3	N#CCC(C1CCCC1)n1cc(-c2c3cc[nH]c3ncn2)cn1	InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1	HFNKQEVNSGCOJV-OAHLLOKOSA-N					doublet; removed another duplicate entry; compound annotation
0391_011385	876310-60-0	C26H38N6O3	2.9658	53320361	C1C2CC3CC1CC(C2)(C3)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N	NC(=O)C(Cc1ccccc1)NC(=O)C(CCCN=C(N)N)NC(=O)C12CC3CC(CC(C3)C1)C2	InChI=1S/C26H38N6O3/c27-22(33)21(12-16-5-2-1-3-6-16)31-23(34)20(7-4-8-30-25(28)29)32-24(35)26-13-17-9-18(14-26)11-19(10-17)15-26/h1-3,5-6,17-21H,4,7-15H2,(H2,27,33)(H,31,34)(H,32,35)(H4,28,29,30)/t17?,18?,19?,20-,21-,26?/m0/s1	UMKHUSRDQFQHAK-RNJMTYCLSA-N					doublet; compound annotation
0391_011386	delta-Tocotrienol	C27H40O2	7.2464	5282350	CC1=CC(=CC2=C1O[C@](CC2)(C)CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C)O	CC(C)=CCCC(C)=CCCC(C)=CCCC1(C)CCc2c(O1)c(C)cc(O)c2	InChI=1S/C27H40O2/c1-20(2)10-7-11-21(3)12-8-13-22(4)14-9-16-27(6)17-15-24-19-25(28)18-23(5)26(24)29-27/h10,12,14,18-19,28H,7-9,11,13,15-17H2,1-6H3/b21-12+,22-14+/t27-/m1/s1	ODADKLYLWWCHNB-LDYBVBFYSA-N					compound annotation
0391_011387	SHP836	C16H19Cl2N5	1.7205	76966642	C[C@@H]1CN(C[C@@H](N1)C)C2=NC=C(C(=N2)N)C3=C(C(=CC=C3)Cl)Cl	CC1CN(c2ncc(-c3c(Cl)c(Cl)ccc3)c(N)n2)CC(C)N1	InChI=1S/C16H19Cl2N5/c1-9-7-23(8-10(2)21-9)16-20-6-12(15(19)22-16)11-4-3-5-13(17)14(11)18/h3-6,9-10,21H,7-8H2,1-2H3,(H2,19,20,22)/t9-,10+	SKFRRNOLFFQBQU-AOOOYVTPSA-N					compound annotation
0391_011388	SNDX-5613	C32H47FN6O4S	2.1317	132212657		CCN(C(=O)c1c(Oc2cncnc2N2CC3(CCN(CC4CCC(NS(=O)(=O)CC)CC4)CC3)C2)ccc(F)c1)C(C)C	InChI=1S/C32H47FN6O4S/c1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2/h9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3	FRVSRBKUQZKTOW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011390	Medetomidine	C13H16N2	2.2793	68602		Cc1c(C)c(C(C)c2cnc[nH]2)ccc1	InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)	CUHVIMMYOGQXCV-UHFFFAOYSA-N					doublet; compound annotation
0391_011391	Glycopyrronium	C19H28NO3+	2.6107	3494		C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1	InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1	ANGKOCUUWGHLCE-UHFFFAOYSA-N					compound annotation
0391_011392	RA-9	C19H15N3O5	2.804	5469266	C\1NC/C(=C\C2=CC=C(C=C2)[N+](=O)[O-])/C(=O)/C1=C/C3=CC=C(C=C3)[N+](=O)[O-]	O=C1C(=Cc2ccc([N+](=O)[O-])cc2)CNCC1=Cc1ccc([N+](=O)[O-])cc1	InChI=1S/C19H15N3O5/c23-19-15(9-13-1-5-17(6-2-13)21(24)25)11-20-12-16(19)10-14-3-7-18(8-4-14)22(26)27/h1-10,20H,11-12H2/b15-9+,16-10+	YUYPWAMLWZVHAE-KAVGSWPWSA-N					doublet; compound annotation
0391_011393	RA-9	C19H15N3O5	2.854	5469266	C\1NC/C(=C\C2=CC=C(C=C2)[N+](=O)[O-])/C(=O)/C1=C/C3=CC=C(C=C3)[N+](=O)[O-]	O=C1C(=Cc2ccc([N+](=O)[O-])cc2)CNCC1=Cc1ccc([N+](=O)[O-])cc1	InChI=1S/C19H15N3O5/c23-19-15(9-13-1-5-17(6-2-13)21(24)25)11-20-12-16(19)10-14-3-7-18(8-4-14)22(26)27/h1-10,20H,11-12H2/b15-9+,16-10+	YUYPWAMLWZVHAE-KAVGSWPWSA-N					doublet; compound annotation
0391_011394	Brassinazole	C18H18ClN3O	4.1646	15477807		CC(O)(c1ccccc1)C(Cc1ccc(Cl)cc1)n1cncn1	InChI=1S/C18H18ClN3O/c1-18(23,15-5-3-2-4-6-15)17(22-13-20-12-21-22)11-14-7-9-16(19)10-8-14/h2-10,12-13,17,23H,11H2,1H3	YULDTPKHZNKFEY-UHFFFAOYSA-N					compound annotation
0391_011395	PHENPROCOUMON	C18H16O3	4.1708	54680692		CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O	InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3	DQDAYGNAKTZFIW-UHFFFAOYSA-N					compound annotation
0391_011396	Demethyleneberberine	C19H18NO4+	1.9716	363209		COc1c(OC)c2c[n+]3c(cc2cc1)-c1cc(O)c(O)cc1CC3	InChI=1S/C19H17NO4/c1-23-18-4-3-11-7-15-13-9-17(22)16(21)8-12(13)5-6-20(15)10-14(11)19(18)24-2/h3-4,7-10,22H,5-6H2,1-2H3/p+1	HVTCKKMWZDDWOY-UHFFFAOYSA-O					compound annotation
0391_011397	4-Hydroxycoumarin	C9H6O3	2.2532	54682930		O=c1cc(O)c2ccccc2o1	InChI=1S/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10H	VXIXUWQIVKSKSA-UHFFFAOYSA-N					compound annotation
0391_011398	Rotigotine	C19H25NOS	2.6449	59227	CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O	CCCN(CCc1cccs1)C1CCc2c(cccc2O)C1	InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1	KFQYTPMOWPVWEJ-INIZCTEOSA-N					doublet; compound annotation
0391_011399	Salvigenin	C18H16O6	4.2342	161271		COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1	InChI=1S/C18H16O6/c1-21-11-6-4-10(5-7-11)13-8-12(19)16-14(24-13)9-15(22-2)18(23-3)17(16)20/h4-9,20H,1-3H3	QCDYOIZVELGOLZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011401	4'-O-Methylochnaflavone	C31H20O10	4.3796	5384799		COc1c(Oc2ccc(-c3cc(=O)c4c(O)cc(O)cc4o3)cc2)cc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1	InChI=1S/C31H20O10/c1-38-24-7-4-16(26-14-23(37)31-21(35)10-18(33)12-29(31)41-26)8-27(24)39-19-5-2-15(3-6-19)25-13-22(36)30-20(34)9-17(32)11-28(30)40-25/h2-14,32-35H,1H3	PRQWQWSKFNQAOG-UHFFFAOYSA-N					compound annotation
0391_011402	ozagrel	C13H12N2O2	0.9095	5282440	C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O	O=C(O)C=Cc1ccc(Cn2ccnc2)cc1	InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+	SHZKQBHERIJWAO-AATRIKPKSA-N					doublet; compound annotation
0391_011403	metyrapone	C14H14N2O	1.2622	4174		CC(C)(C(=O)c1cnccc1)c1cnccc1	InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3	FJLBFSROUSIWMA-UHFFFAOYSA-N					compound annotation
0391_011404	Oglufanide	C16H19N3O5	1.3233	100094	C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)N	NC(CCC(=O)O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C16H19N3O5/c17-11(5-6-14(20)21)15(22)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1	LLEUXCDZPQOJMY-AAEUAGOBSA-N					compound annotation
0391_011405	6RK73	C13H17N5O2S	2.1429	121248200	C1CN(C[C@H]1C(=O)NC2=NC=C(S2)N3CCOCC3)C#N	N#CN1CCC(C(=O)Nc2ncc(N3CCOCC3)s2)C1	InChI=1S/C13H17N5O2S/c14-9-17-2-1-10(8-17)12(19)16-13-15-7-11(21-13)18-3-5-20-6-4-18/h7,10H,1-6,8H2,(H,15,16,19)/t10-/m0/s1	ONIHSXKWNFYNNS-JTQLQIEISA-N					compound annotation
0391_011406	erythromycin ethylsuccinate	C43H75NO16	3.5144	443953	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O	CCOC(=O)CCC(=O)OC1C(OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)OC(C)CC1N(C)C	InChI=1S/C43H75NO16/c1-15-29-43(11,52)36(48)24(5)33(47)22(3)20-41(9,51)38(25(6)34(26(7)39(50)57-29)59-32-21-42(10,53-14)37(49)27(8)56-32)60-40-35(28(44(12)13)19-23(4)55-40)58-31(46)18-17-30(45)54-16-2/h22-29,32,34-38,40,48-49,51-52H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,32+,34+,35-,36-,37+,38-,40+,41-,42-,43-/m1/s1	NSYZCCDSJNWWJL-YXOIYICCSA-N					compound annotation
0391_011407	ML382	C18H20N2O4S	4.3919	71598556		CCOc1ccccc1NC(=O)c1ccccc1NS(=O)(=O)C1CC1	InChI=1S/C18H20N2O4S/c1-2-24-17-10-6-5-9-16(17)19-18(21)14-7-3-4-8-15(14)20-25(22,23)13-11-12-13/h3-10,13,20H,2,11-12H2,1H3,(H,19,21)	RCSLEKLNDJJJLF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011409	metronidazole	C6H9N3O3	0.7655	4173		Cc1ncc([N+](=O)[O-])n1CCO	InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3	VAOCPAMSLUNLGC-UHFFFAOYSA-N					compound annotation
0391_011410	Liquiritin	C21H22O9	1.8556	503737	C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O	O=C1CC(c2ccc(OC3OC(CO)C(O)C(O)C3O)cc2)Oc2c1ccc(O)c2	InChI=1S/C21H22O9/c22-9-17-18(25)19(26)20(27)21(30-17)28-12-4-1-10(2-5-12)15-8-14(24)13-6-3-11(23)7-16(13)29-15/h1-7,15,17-23,25-27H,8-9H2/t15-,17+,18+,19-,20+,21+/m0/s1	DEMKZLAVQYISIA-ZRWXNEIDSA-N					compound annotation
0391_011411	diuron	C9H10Cl2N2O	3.3484	3120		CN(C)C(=O)Nc1cc(Cl)c(Cl)cc1	InChI=1S/C9H10Cl2N2O/c1-13(2)9(14)12-6-3-4-7(10)8(11)5-6/h3-5H,1-2H3,(H,12,14)	XMTQQYYKAHVGBJ-UHFFFAOYSA-N					compound annotation
0391_011412	PONALRESTAT	C17H12BrFN2O3	3.7464	5278		O=C(O)Cc1nn(Cc2c(F)cc(Br)cc2)c(=O)c2ccccc12	InChI=1S/C17H12BrFN2O3/c18-11-6-5-10(14(19)7-11)9-21-17(24)13-4-2-1-3-12(13)15(20-21)8-16(22)23/h1-7H,8-9H2,(H,22,23)	LKBFFDOJUKLQNY-UHFFFAOYSA-N					compound annotation
0391_011413	Deltasonamide 2	C30H39ClN6O4S2	3.8326	135222708		CNc1nccc(CN(C2CCC(N)CC2)S(=O)(=O)c2ccc(S(=O)(=O)N(Cc3ccc(Cl)cc3)C3CCCC3)cc2)n1	InChI=1S/C30H39ClN6O4S2/c1-33-30-34-19-18-25(35-30)21-37(27-12-10-24(32)11-13-27)43(40,41)29-16-14-28(15-17-29)42(38,39)36(26-4-2-3-5-26)20-22-6-8-23(31)9-7-22/h6-9,14-19,24,26-27H,2-5,10-13,20-21,32H2,1H3,(H,33,34,35)	ZLDUVUWIYLENNC-UHFFFAOYSA-N					doublet; compound annotation
0391_011414	LXH254	C25H25F3N4O4	4.1611	90456533		Cc1c(-c2cc(N3CCOCC3)nc(OCCO)c2)cc(NC(=O)c2cc(C(F)(F)F)ncc2)cc1	InChI=1S/C25H25F3N4O4/c1-16-2-3-19(30-24(34)17-4-5-29-21(12-17)25(26,27)28)15-20(16)18-13-22(32-6-9-35-10-7-32)31-23(14-18)36-11-8-33/h2-5,12-15,33H,6-11H2,1H3,(H,30,34)	UEPXBTCUIIGYCY-UHFFFAOYSA-N					compound annotation
0391_011415	Chlorquinaldol	C10H7Cl2NO	4.6044	6301		Cc1nc2c(cc1)c(Cl)cc(Cl)c2O	InChI=1S/C10H7Cl2NO/c1-5-2-3-6-7(11)4-8(12)10(14)9(6)13-5/h2-4,14H,1H3	GPTXWRGISTZRIO-UHFFFAOYSA-N					compound annotation
0391_011416	HJC0197	C19H21N3OS	5.2232	136228204		Cc1cc(CSc2nc(=O)c(C#N)c(C3CCCC3)[nH]2)c(C)cc1	InChI=1S/C19H21N3OS/c1-12-7-8-13(2)15(9-12)11-24-19-21-17(14-5-3-4-6-14)16(10-20)18(23)22-19/h7-9,14H,3-6,11H2,1-2H3,(H,21,22,23)	QLLWRTHDHRGHQZ-UHFFFAOYSA-N					compound annotation
0391_011417	2414909-94-5	C19H16N6O	1.527	145994823		NC(=O)c1ccc(-c2c3nc(NCc4cnccc4)ccn3nc2)cc1	InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24)	LMGXQBQAUALFTB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011419	Oseltamivir acid	C14H24N2O4	1.6253	44310478	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)[NH3+])C(=O)[O-]	CCC(CC)OC1C=C(C(=O)O)CC(N)C1NC(C)=O	InChI=1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)/t11-,12+,13+/m0/s1	NENPYTRHICXVCS-YNEHKIRRSA-N					compound annotation
0391_011420	Nepinalone	C18H25NO	2.1471	3047788		CC1(CCN2CCCCC2)C(=O)CCc2ccccc21	InChI=1S/C18H25NO/c1-18(11-14-19-12-5-2-6-13-19)16-8-4-3-7-15(16)9-10-17(18)20/h3-4,7-8H,2,5-6,9-14H2,1H3	RVXGRCNWGOHSDE-UHFFFAOYSA-N					compound annotation
0391_011421	BKI-1369	C23H27N7O	2.2795	122453014		CCOc1nc2c(cc1)cc(-c1nn(CC3CCN(C)CC3)c3ncnc(N)c13)cc2	InChI=1S/C23H27N7O/c1-3-31-19-7-5-16-12-17(4-6-18(16)27-19)21-20-22(24)25-14-26-23(20)30(28-21)13-15-8-10-29(2)11-9-15/h4-7,12,14-15H,3,8-11,13H2,1-2H3,(H2,24,25,26)	AWJAAKKEYXUCFY-UHFFFAOYSA-N					compound annotation
0391_011422	(6-(1-((6-Methoxypyridin-3-yl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2-yl)(4-(4-(trifluoromethyl)benzyl)piperazin-1-yl)methanone	C32H35F3N6O2	2.3606	86292820		COc1ncc(CN2CCC(c3cc4c(cc3)nc(C(=O)N3CCN(Cc5ccc(C(F)(F)F)cc5)CC3)[nH]4)CC2)cc1	InChI=1S/C32H35F3N6O2/c1-43-29-9-4-23(19-36-29)21-39-12-10-24(11-13-39)25-5-8-27-28(18-25)38-30(37-27)31(42)41-16-14-40(15-17-41)20-22-2-6-26(7-3-22)32(33,34)35/h2-9,18-19,24H,10-17,20-21H2,1H3,(H,37,38)	KKRRTZFDLYCBDK-UHFFFAOYSA-N					compound annotation
0391_011423	Noopept	C17H22N2O4	2.5853	180496	CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2	CCOC(=O)CNC(=O)C1CCCN1C(=O)Cc1ccccc1	InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1	PJNSMUBMSNAEEN-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_011425	1432500-66-7	C26H26N2O5	4.1258	56840728	C1CC[C@@H]([C@@H](C1)C(=O)N2CCC3=CC=CC=C3[C@H]2CN4C(=O)C5=CC=CC=C5C4=O)C(=O)O	O=C(O)C1CCCCC1C(=O)N1CCc2ccccc2C1CN1C(=O)c2ccccc2C1=O	InChI=1S/C26H26N2O5/c29-23(20-11-5-6-12-21(20)26(32)33)27-14-13-16-7-1-2-8-17(16)22(27)15-28-24(30)18-9-3-4-10-19(18)25(28)31/h1-4,7-10,20-22H,5-6,11-15H2,(H,32,33)/t20-,21+,22-/m1/s1	LNENLABLFGGAFF-BHIFYINESA-N					removed another duplicate entry; compound annotation
0391_011427	5-Methyl-7-methoxyisoflavone	C17H14O3	4.6805	2734290		COc1cc2c(c(C)c1)c(=O)c(-c1ccccc1)co2	InChI=1S/C17H14O3/c1-11-8-13(19-2)9-15-16(11)17(18)14(10-20-15)12-6-4-3-5-7-12/h3-10H,1-2H3	WGOUYULOZZRTFS-UHFFFAOYSA-N					compound annotation
0391_011428	GR 125743	C25H28N4O2	1.5299	5311130		COc1c(N2CCN(C)CC2)cc(NC(=O)c2cc(C)c(-c3ccncc3)cc2)cc1	InChI=1S/C25H28N4O2/c1-18-16-20(4-6-22(18)19-8-10-26-11-9-19)25(30)27-21-5-7-24(31-3)23(17-21)29-14-12-28(2)13-15-29/h4-11,16-17H,12-15H2,1-3H3,(H,27,30)	GNOXPYACARZYMW-UHFFFAOYSA-N					compound annotation
0391_011429	CEPHARANTHINE	C37H38N2O6	2.1051	10206	CN1CCC2=CC3=C(C4=C2[C@@H]1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)C[C@@H]7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3	COc1c2cc(cc1)CC1c3cc(c(OC)cc3CCN1C)Oc1c3c(cc4c1OCO4)CCN(C)C3Cc1ccc(cc1)O2	InChI=1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1	YVPXVXANRNDGTA-WDYNHAJCSA-N					compound annotation
0391_011430	RAS inhibitor Abd-7	C23H25N3O3	3.3594	134812710		COc1c(Nc2ccc(CN(C)C)cc2)ccc(-c2c3OCCOc3ccc2)n1	InChI=1S/C23H25N3O3/c1-26(2)15-16-7-9-17(10-8-16)24-20-12-11-19(25-23(20)27-3)18-5-4-6-21-22(18)29-14-13-28-21/h4-12,24H,13-15H2,1-3H3	MJHHFDJNRRCUOB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011432	Ganoderic Acid D	C30H42O7	3.6126	14109406	C[C@H](CC(=O)CC(C)C(=O)O)[C@H]1CC(=O)[C@@]2([C@@]1(CC(=O)C3=C2[C@H](C[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)O)C)C	CC(CC(=O)CC(C)C1CC(=O)C2(C)C3=C(C(=O)CC12C)C1(C)CCC(=O)C(C)(C)C1CC3O)C(=O)O	InChI=1S/C30H42O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18-19,21,32H,8-14H2,1-7H3,(H,36,37)/t15-,16?,18-,19+,21+,28+,29-,30+/m1/s1	YTVGSCZIHGRVAV-IYAQLQCNSA-N					compound annotation
0391_011433	picrotin	C15H18O7	1.9152	442291	C[C@@]12[C@H]3[C@H]4[C@H]([C@@H]([C@@]1(C[C@@H]5[C@]2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O	CC(C)(O)C1C2OC(=O)C1C1(O)CC3OC34C(=O)OC2C14C	InChI=1S/C15H18O7/c1-12(2,18)6-7-10(16)20-8(6)9-13(3)14(7,19)4-5-15(13,22-5)11(17)21-9/h5-9,18-19H,4H2,1-3H3/t5-,6+,7-,8-,9-,13-,14-,15+/m1/s1	RYEFFICCPKWYML-QCGISDTRSA-N					compound annotation
0391_011434	HYDRASTINE	C21H21NO6	1.9748	197835	CN1CCC2=CC3=C(C=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OCO3	COc1ccc2c(c1OC)C(=O)OC2C1c2cc3c(cc2CCN1C)OCO3	InChI=1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1	JZUTXVTYJDCMDU-MOPGFXCFSA-N					removed another duplicate entry; compound annotation
0391_011436	oseltamivir	C16H28N2O4	2.3882	65028	CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC	CCOC(=O)C1=CC(OC(CC)CC)C(NC(C)=O)C(N)C1	InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1	VSZGPKBBMSAYNT-RRFJBIMHSA-N					removed another duplicate entry; compound annotation
0391_011438	azlocillin	C20H23N5O6S	2.4958	6479523	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C	CC1(C)SC2C(NC(=O)C(NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1	JTWOMNBEOCYFNV-NFFDBFGFSA-N					removed another duplicate entry; compound annotation
0391_011440	isocarboxazid	C12H13N3O2	2.6057	3759		Cc1cc(C(=O)NNCc2ccccc2)no1	InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)	XKFPYPQQHFEXRZ-UHFFFAOYSA-N					compound annotation
0391_011441	Cadazolid	C29H29F2N3O8	3.1574	44242317	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCC(CC4)(COC5=C(C=C(C=C5)N6C[C@@H](OC6=O)CO)F)O)F)C(=O)O	O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4c(F)cc(N5CC(CO)OC5=O)cc4)CC3)c(F)cc2c1=O	InChI=1S/C29H29F2N3O8/c30-21-10-19-23(33(16-1-2-16)13-20(26(19)36)27(37)38)11-24(21)32-7-5-29(40,6-8-32)15-41-25-4-3-17(9-22(25)31)34-12-18(14-35)42-28(34)39/h3-4,9-11,13,16,18,35,40H,1-2,5-8,12,14-15H2,(H,37,38)/t18-/m1/s1	XWFCFMXQTBGXQW-GOSISDBHSA-N					doublet; compound annotation
0391_011442	Cadazolid	C29H29F2N3O8	3.2549	44242317	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCC(CC4)(COC5=C(C=C(C=C5)N6C[C@@H](OC6=O)CO)F)O)F)C(=O)O	O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4c(F)cc(N5CC(CO)OC5=O)cc4)CC3)c(F)cc2c1=O	InChI=1S/C29H29F2N3O8/c30-21-10-19-23(33(16-1-2-16)13-20(26(19)36)27(37)38)11-24(21)32-7-5-29(40,6-8-32)15-41-25-4-3-17(9-22(25)31)34-12-18(14-35)42-28(34)39/h3-4,9-11,13,16,18,35,40H,1-2,5-8,12,14-15H2,(H,37,38)/t18-/m1/s1	XWFCFMXQTBGXQW-GOSISDBHSA-N					doublet; compound annotation
0391_011443	Cadazolid	C29H29F2N3O8	3.2577	44242317	C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCC(CC4)(COC5=C(C=C(C=C5)N6C[C@@H](OC6=O)CO)F)O)F)C(=O)O	O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4c(F)cc(N5CC(CO)OC5=O)cc4)CC3)c(F)cc2c1=O	InChI=1S/C29H29F2N3O8/c30-21-10-19-23(33(16-1-2-16)13-20(26(19)36)27(37)38)11-24(21)32-7-5-29(40,6-8-32)15-41-25-4-3-17(9-22(25)31)34-12-18(14-35)42-28(34)39/h3-4,9-11,13,16,18,35,40H,1-2,5-8,12,14-15H2,(H,37,38)/t18-/m1/s1	XWFCFMXQTBGXQW-GOSISDBHSA-N					doublet; compound annotation
0391_011444	Bestatin	C16H24N2O4	2.0711	6992132	CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)[NH3+])O	CC(C)CC(NC(=O)C(O)C(N)Cc1ccccc1)C(=O)O	InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1	VGGGPCQERPFHOB-RDBSUJKOSA-N					doublet; compound annotation
0391_011445	PYBG	C16H15N5O2	2.212	58596748		C#CCOCc1ccc(COc2nc(N)nc3c2[nH]cn3)cc1	InChI=1S/C16H15N5O2/c1-2-7-22-8-11-3-5-12(6-4-11)9-23-15-13-14(19-10-18-13)20-16(17)21-15/h1,3-6,10H,7-9H2,(H3,17,18,19,20,21)	LZDBKQCASZCNSH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011447	Tomatidine	C27H45NO2	3.0142	65576	C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CCC5CC(O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C27H45NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28-29H,5-15H2,1-4H3/t16-,17-,18-,19-,20+,21-,22-,23-,24-,25-,26-,27-/m0/s1	XYNPYHXGMWJBLV-VXPJTDKGSA-N					doublet; compound annotation
0391_011448	sulindac	C20H17FO3S	3.275	1548887	CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc([S+](C)[O-])cc1	InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-	MLKXDPUZXIRXEP-MFOYZWKCSA-N					doublet; compound annotation
0391_011449	Tomatidine	C27H45NO2	3.3831	65576	C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CCC5CC(O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C27H45NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28-29H,5-15H2,1-4H3/t16-,17-,18-,19-,20+,21-,22-,23-,24-,25-,26-,27-/m0/s1	XYNPYHXGMWJBLV-VXPJTDKGSA-N					doublet; compound annotation
0391_011450	sulindac	C20H17FO3S	3.4423	1548887	CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O	CC1=C(CC(=O)O)c2cc(F)ccc2C1=Cc1ccc([S+](C)[O-])cc1	InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-	MLKXDPUZXIRXEP-MFOYZWKCSA-N					doublet; compound annotation
0391_011451	Midostaurin	C35H30N4O4	4.4696	9829523	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC	COC1C(N(C)C(=O)c2ccccc2)CC2OC1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c31	InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1	BMGQWWVMWDBQGC-IIFHNQTCSA-N					removed another duplicate entry; compound annotation
0391_011454	Acteoside	C29H36O15	1.9219	5281800	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O	CC1OC(OC2C(O)C(OCCc3cc(O)c(O)cc3)OC(CO)C2OC(=O)C=Cc2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1	FBSKJMQYURKNSU-ZLSOWSIRSA-N					compound annotation
0391_011455	Irigenin	C18H16O8	3.0901	5464170		COc1cc(-c2coc3c(c(O)c(OC)c(O)c3)c2=O)cc(O)c1OC	InChI=1S/C18H16O8/c1-23-13-5-8(4-10(19)17(13)24-2)9-7-26-12-6-11(20)18(25-3)16(22)14(12)15(9)21/h4-7,19-20,22H,1-3H3	TUGWPJJTQNLKCL-UHFFFAOYSA-N					compound annotation
0391_011456	SHIP2-IN-1	C17H13Cl2FN4O	3.5459	138319691	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CN=CC(=C2)C3=CN=C(N=C3)N	CC(Oc1cncc(-c2cnc(N)nc2)c1)c1c(Cl)ccc(F)c1Cl	InChI=1S/C17H13Cl2FN4O/c1-9(15-13(18)2-3-14(20)16(15)19)25-12-4-10(5-22-8-12)11-6-23-17(21)24-7-11/h2-9H,1H3,(H2,21,23,24)/t9-/m1/s1	ATPYDXUUBCDYKQ-SECBINFHSA-N					compound annotation
0391_011457	Pirimiphos-methyl	C11H20N3O3PS	4.7428	34526		CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1	InChI=1S/C11H20N3O3PS/c1-6-14(7-2)11-12-9(3)8-10(13-11)17-18(19,15-4)16-5/h8H,6-7H2,1-5H3	QHOQHJPRIBSPCY-UHFFFAOYSA-N					compound annotation
0391_011458	426834-69-7	C16H8Br2F6N6O	4.8134	11642685		O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)Nc1c(Br)cc(Br)cc1-c1n[nH]nn1	InChI=1S/C16H8Br2F6N6O/c17-8-4-10(13-27-29-30-28-13)12(11(18)5-8)26-14(31)25-9-2-6(15(19,20)21)1-7(3-9)16(22,23)24/h1-5H,(H2,25,26,31)(H,27,28,29,30)	UZWJWROOLOOCPQ-UHFFFAOYSA-N					compound annotation
0391_011459	Calmidazolium	C31H23Cl6N2O+	5.3842	2531		Clc1ccc(C(c2ccc(Cl)cc2)n2cc[n+](CC(OCc3c(Cl)cc(Cl)cc3)c3c(Cl)cc(Cl)cc3)c2)cc1	InChI=1S/C31H23Cl6N2O/c32-23-6-1-20(2-7-23)31(21-3-8-24(33)9-4-21)39-14-13-38(19-39)17-30(27-12-11-26(35)16-29(27)37)40-18-22-5-10-25(34)15-28(22)36/h1-16,19,30-31H,17-18H2/q+1	CTKNMSVWMRRCPW-UHFFFAOYSA-N					compound annotation
0391_011460	N6-(2-Phenylethyl)adenosine	C18H21N5O4	2.2119	9929340	C1=CC=C(C=C1)CCNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NCCc4ccccc4)ncnc32)C(O)C1O	InChI=1S/C18H21N5O4/c24-8-12-14(25)15(26)18(27-12)23-10-22-13-16(20-9-21-17(13)23)19-7-6-11-4-2-1-3-5-11/h1-5,9-10,12,14-15,18,24-26H,6-8H2,(H,19,20,21)/t12-,14-,15-,18-/m1/s1	LGZYEDZSPHLISU-SCFUHWHPSA-N					compound annotation
0391_011461	Diloxanide	C9H9Cl2NO2	2.4005	11367		CN(C(=O)C(Cl)Cl)c1ccc(O)cc1	InChI=1S/C9H9Cl2NO2/c1-12(9(14)8(10)11)6-2-4-7(13)5-3-6/h2-5,8,13H,1H3	GZZZSOOGQLOEOB-UHFFFAOYSA-N					compound annotation
0391_011462	1024033-43-9	C22H33N3O3S	4.7172	24946280	CCCSC1=C(C=CC(=N1)N2CCC[C@H](C2)CC(=O)O)C(=O)NC3CCCCC3	CCCSc1c(C(=O)NC2CCCCC2)ccc(N2CCCC(CC(=O)O)C2)n1	InChI=1S/C22H33N3O3S/c1-2-13-29-22-18(21(28)23-17-8-4-3-5-9-17)10-11-19(24-22)25-12-6-7-16(15-25)14-20(26)27/h10-11,16-17H,2-9,12-15H2,1H3,(H,23,28)(H,26,27)/t16-/m0/s1	NCDZABJPWMBMIQ-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_011464	Tegatrabetan	C28H36N4O6S2	5.4817	46212391	C[C@@H]1C[C@@H](CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5C[C@@H](C[C@@H](C5)C)C)NO)C	CC1CC(C)CN(S(=O)(=O)c2cc3c(cc2)c(NO)c2ccc(S(=O)(=O)N4CC(C)CC(C)C4)cc2c3N=O)C1	InChI=1S/C28H36N4O6S2/c1-17-9-18(2)14-31(13-17)39(35,36)21-5-7-23-25(11-21)28(30-34)26-12-22(6-8-24(26)27(23)29-33)40(37,38)32-15-19(3)10-20(4)16-32/h5-8,11-12,17-20,29,33H,9-10,13-16H2,1-4H3/t17-,18+,19-,20+	OMWCXCBGEFHCTN-FGYAAKKASA-N					compound annotation
0391_011465	99295-33-7	C17H18BrNO	2.1679	1243		CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1	InChI=1S/C17H18BrNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3	XFTVOHWWEQGXLS-UHFFFAOYSA-N					compound annotation
0391_011466	Nevadensin	C18H16O7	3.7378	160921		COc1ccc(-c2cc(=O)c3c(O)c(OC)c(O)c(OC)c3o2)cc1	InChI=1S/C18H16O7/c1-22-10-6-4-9(5-7-10)12-8-11(19)13-14(20)17(23-2)15(21)18(24-3)16(13)25-12/h4-8,20-21H,1-3H3	KRFBMPVGAYGGJE-UHFFFAOYSA-N					compound annotation
0391_011467	Kurarinone	C26H30O6	3.9362	11982640	CC(=CC[C@H](CC1=C2C(=C(C=C1O)OC)C(=O)C[C@H](O2)C3=C(C=C(C=C3)O)O)C(=C)C)C	C=C(C)C(CC=C(C)C)Cc1c2OC(c3c(O)cc(O)cc3)CC(=O)c2c(OC)cc1O	InChI=1S/C26H30O6/c1-14(2)6-7-16(15(3)4)10-19-21(29)12-24(31-5)25-22(30)13-23(32-26(19)25)18-9-8-17(27)11-20(18)28/h6,8-9,11-12,16,23,27-29H,3,7,10,13H2,1-2,4-5H3/t16-,23+/m1/s1	LTTQKYMNTNISSZ-MWTRTKDXSA-N					removed another duplicate entry; compound annotation
0391_011469	(Z)-Guggulsterone	C21H28O2	4.3637	6450278	C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4+/t15-,17+,18+,20+,21-/m1/s1	WDXRGPWQVHZTQJ-OSJVMJFVSA-N					doublet; compound annotation
0391_011470	CLOBETASOL PROPIONATE	C25H32ClFO5	4.5512	32798	CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl	CCC(=O)OC1(C(=O)CCl)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1	CBGUOGMQLZIXBE-XGQKBEPLSA-N					compound annotation
0391_011471	(Z)-Guggulsterone	C21H28O2	4.6369	6450278	C/C=C/1\C(=O)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC=C1C(=O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4+/t15-,17+,18+,20+,21-/m1/s1	WDXRGPWQVHZTQJ-OSJVMJFVSA-N					doublet; compound annotation
0391_011472	Acefylline	C9H10N4O4	0.9392	69550		Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O	InChI=1S/C9H10N4O4/c1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4H,3H2,1-2H3,(H,14,15)	HCYFGRCYSCXKNQ-UHFFFAOYSA-N					compound annotation
0391_011473	215803-78-4	C28H30N4O	2.0494	5311096		N#Cc1cc2c(cc1)CN(CCC1CCC(NC(=O)c3ccnc4ccccc34)CC1)CC2	InChI=1S/C28H30N4O/c29-18-21-5-8-23-19-32(16-13-22(23)17-21)15-12-20-6-9-24(10-7-20)31-28(33)26-11-14-30-27-4-2-1-3-25(26)27/h1-5,8,11,14,17,20,24H,6-7,9-10,12-13,15-16,19H2,(H,31,33)	OLWRVVHPJFLNPW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011475	Asenapine	C17H16ClNO	2.8529	163091	CN1C[C@H]2[C@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24	CN1CC2c3ccccc3Oc3c(cc(Cl)cc3)C2C1	InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m1/s1	VSWBSWWIRNCQIJ-HUUCEWRRSA-N					doublet; compound annotation
0391_011476	JTC-801 free base	C26H25N3O2	3.4563	5311340		CCc1ccc(OCc2ccccc2C(=O)Nc2cc3c(N)cc(C)nc3cc2)cc1	InChI=1S/C26H25N3O2/c1-3-18-8-11-21(12-9-18)31-16-19-6-4-5-7-22(19)26(30)29-20-10-13-25-23(15-20)24(27)14-17(2)28-25/h4-15H,3,16H2,1-2H3,(H2,27,28)(H,29,30)	VTGBZWHPJFMTKS-UHFFFAOYSA-N					compound annotation
0391_011477	Pentagamavunon-1	C23H24O3	4.3545	10760152	CC1=CC(=CC(=C1O)C)/C=C\2/C(=O)/C(=C/C3=CC(=C(C(=C3)C)O)C)/CC2	Cc1c(O)c(C)cc(C=C2CCC(=Cc3cc(C)c(O)c(C)c3)C2=O)c1	InChI=1S/C23H24O3/c1-13-7-17(8-14(2)21(13)24)11-19-5-6-20(23(19)26)12-18-9-15(3)22(25)16(4)10-18/h7-12,24-25H,5-6H2,1-4H3/b19-11+,20-12+	OHSKJRMWVIVJCP-AYKLPDECSA-N					compound annotation
0391_011478	Grazoprevir	C38H50N6O9S	5.5499	44603531	CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1	C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(C(C)(C)C)NC(=O)OC1CC1CCCCCc1nc3c(cc(OC)cc3)nc1O2)C(=O)NS(=O)(=O)C1CC1	InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1	OBMNJSNZOWALQB-NCQNOWPTSA-N					doublet; removed another duplicate entry; compound annotation
0391_011480	iproniazid	C9H13N3O	0.658	3748		CC(C)NNC(=O)c1ccncc1	InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)	NYMGNSNKLVNMIA-UHFFFAOYSA-N					doublet; compound annotation
0391_011481	BI-7273	C20H23N3O3	1.3857	118796358		COc1cc(-c2cn(C)c(=O)c3c2ccnc3)cc(OC)c1CN(C)C	InChI=1S/C20H23N3O3/c1-22(2)11-17-18(25-4)8-13(9-19(17)26-5)16-12-23(3)20(24)15-10-21-7-6-14(15)16/h6-10,12H,11H2,1-5H3	RBUYFHLQNPJMQM-UHFFFAOYSA-N					compound annotation
0391_011482	CHEMBL221319	C19H14O5S	1.9869	9950469		O=C1C=CC(=C(c2ccc(O)cc2)c2ccccc2S(=O)(=O)O)C=C1	InChI=1S/C19H14O5S/c20-15-9-5-13(6-10-15)19(14-7-11-16(21)12-8-14)17-3-1-2-4-18(17)25(22,23)24/h1-12,20H,(H,22,23,24)	NUKDWKHUQCAPFT-UHFFFAOYSA-N					doublet; compound annotation
0391_011483	CHEMBL221319	C19H14O5S	2.1186	9950469		O=C1C=CC(=C(c2ccc(O)cc2)c2ccccc2S(=O)(=O)O)C=C1	InChI=1S/C19H14O5S/c20-15-9-5-13(6-10-15)19(14-7-11-16(21)12-8-14)17-3-1-2-4-18(17)25(22,23)24/h1-12,20H,(H,22,23,24)	NUKDWKHUQCAPFT-UHFFFAOYSA-N					doublet; compound annotation
0391_011484	indinavir	C36H47N5O4	2.6298	5362440	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5	CC(C)(C)NC(=O)C1CN(Cc2cnccc2)CCN1CC(O)CC(Cc1ccccc1)C(=O)NC1c2ccccc2CC1O	InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1	CBVCZFGXHXORBI-PXQQMZJSSA-N					removed another duplicate entry; compound annotation
0391_011486	SRI-29329	C20H26ClN7	3.1093	134397451	CC(C)N1C=NC2=C(N=C(N=C21)N[C@H]3CCCC[C@@H]3N)NC4=CC(=CC=C4)Cl	CC(C)n1cnc2c(Nc3cc(Cl)ccc3)nc(NC3CCCCC3N)nc21	InChI=1S/C20H26ClN7/c1-12(2)28-11-23-17-18(24-14-7-5-6-13(21)10-14)26-20(27-19(17)28)25-16-9-4-3-8-15(16)22/h5-7,10-12,15-16H,3-4,8-9,22H2,1-2H3,(H2,24,25,26,27)/t15-,16-/m0/s1	JPJBCKSRGYPABG-HOTGVXAUSA-N					compound annotation
0391_011487	DEXAMETHASONE ACETATE	C24H31FO6	3.7257	236702	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C	CC(=O)OCC(=O)C1(O)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C24H31FO6/c1-13-9-18-17-6-5-15-10-16(27)7-8-21(15,3)23(17,25)19(28)11-22(18,4)24(13,30)20(29)12-31-14(2)26/h7-8,10,13,17-19,28,30H,5-6,9,11-12H2,1-4H3/t13-,17+,18+,19+,21+,22+,23+,24+/m1/s1	AKUJBENLRBOFTD-RPRRAYFGSA-N					compound annotation
0391_011488	CVT-6883	C21H21F3N6O2	4.173	11270783		CCCn1c(=O)c2c(nc(-c3cn(Cc4cc(C(F)(F)F)ccc4)nc3)[nH]2)n(CC)c1=O	InChI=1S/C21H21F3N6O2/c1-3-8-30-19(31)16-18(29(4-2)20(30)32)27-17(26-16)14-10-25-28(12-14)11-13-6-5-7-15(9-13)21(22,23)24/h5-7,9-10,12H,3-4,8,11H2,1-2H3,(H,26,27)	KOYXXLLNCXWUNF-UHFFFAOYSA-N					compound annotation
0391_011489	HAMI 3379	C34H45NO8	5.2124	91523600	C1CCC(CC1)OCCCCOC2=CC=C(C=C2)CCCOC3=C(C=C(C=C3)C(=O)O)C(=O)N[C@H]4CCC[C@@H](C4)C(=O)O	O=C(O)c1ccc(OCCCc2ccc(OCCCCOC3CCCCC3)cc2)c(C(=O)NC2CCCC(C(=O)O)C2)c1	InChI=1S/C34H45NO8/c36-32(35-27-10-6-9-25(22-27)33(37)38)30-23-26(34(39)40)15-18-31(30)43-21-7-8-24-13-16-29(17-14-24)42-20-5-4-19-41-28-11-2-1-3-12-28/h13-18,23,25,27-28H,1-12,19-22H2,(H,35,36)(H,37,38)(H,39,40)/t25-,27-/m0/s1	HRJWSEPIRZRGCL-BDYUSTAISA-N					doublet; compound annotation
0391_011490	HAMI 3379	C34H45NO8	5.3004	91523600	C1CCC(CC1)OCCCCOC2=CC=C(C=C2)CCCOC3=C(C=C(C=C3)C(=O)O)C(=O)N[C@H]4CCC[C@@H](C4)C(=O)O	O=C(O)c1ccc(OCCCc2ccc(OCCCCOC3CCCCC3)cc2)c(C(=O)NC2CCCC(C(=O)O)C2)c1	InChI=1S/C34H45NO8/c36-32(35-27-10-6-9-25(22-27)33(37)38)30-23-26(34(39)40)15-18-31(30)43-21-7-8-24-13-16-29(17-14-24)42-20-5-4-19-41-28-11-2-1-3-12-28/h13-18,23,25,27-28H,1-12,19-22H2,(H,35,36)(H,37,38)(H,39,40)/t25-,27-/m0/s1	HRJWSEPIRZRGCL-BDYUSTAISA-N					doublet; removed another duplicate entry; compound annotation
0391_011492	N-acetylsphingosine	C20H39NO3	5.6691	5497136	CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)C)O	CCCCCCCCCCCCCC=CC(O)C(CO)NC(C)=O	InChI=1S/C20H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(24)19(17-22)21-18(2)23/h15-16,19-20,22,24H,3-14,17H2,1-2H3,(H,21,23)/b16-15+/t19-,20+/m0/s1	BLTCBVOJNNKFKC-QUDYQQOWSA-N					compound annotation
0391_011493	ATROPINE	C17H23NO3	1.6105	174174	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3	CN1C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16?	RKUNBYITZUJHSG-PJPHBNEVSA-N					doublet; compound annotation
0391_011494	BISOPROLOL	C18H31NO4	2.3386	2405		CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1	InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3	VHYCDWMUTMEGQY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011496	ML-9 free base	C15H17ClN2O2S	2.7643	4217		O=S(=O)(c1cccc2c1cccc2Cl)N1CCCNCC1	InChI=1S/C15H17ClN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2	OZSMSRIUUDGTEP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011498	PND-1186	C25H26F3N5O3	2.7879	25073775		CNC(=O)c1ccccc1Nc1cc(Nc2c(OC)cc(N3CCOCC3)cc2)ncc1C(F)(F)F	InChI=1S/C25H26F3N5O3/c1-29-24(34)17-5-3-4-6-19(17)31-21-14-23(30-15-18(21)25(26,27)28)32-20-8-7-16(13-22(20)35-2)33-9-11-36-12-10-33/h3-8,13-15H,9-12H2,1-2H3,(H,29,34)(H2,30,31,32)	IGUBBWJDMLCRIK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011500	Salcaprozic acid	C15H21NO4	3.4422	158789		O=C(O)CCCCCCCNC(=O)c1ccccc1O	InChI=1S/C15H21NO4/c17-13-9-6-5-8-12(13)15(20)16-11-7-3-1-2-4-10-14(18)19/h5-6,8-9,17H,1-4,7,10-11H2,(H,16,20)(H,18,19)	NJEKDCUDSORUJA-UHFFFAOYSA-N					compound annotation
0391_011501	Gemcitabine elaidate	C27H43F2N3O5	6.0708	9828310	CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@@H]1[C@H](C([C@@H](O1)N2C=CC(=NC2=O)N)(F)F)O	CCCCCCCCC=CCCCCCCCC(=O)OCC1OC(n2ccc(N)nc2=O)C(F)(F)C1O	InChI=1S/C27H43F2N3O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(33)36-20-21-24(34)27(28,29)25(37-21)32-19-18-22(30)31-26(32)35/h9-10,18-19,21,24-25,34H,2-8,11-17,20H2,1H3,(H2,30,31,35)/b10-9+/t21-,24-,25-/m1/s1	HESSNRGIEVBPRB-QDDPNBLJSA-N					removed another duplicate entry; compound annotation
0391_011503	Rhodopsin Epitope Tag	C37H62N10O16	1.0619	134611628	C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)N)O	CC(NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(CCC(=O)O)NC(=O)C(N)C(C)O)C(C)O)C(C)C)C(=O)O	InChI=1S/C37H62N10O16/c1-15(2)27(34(59)40-16(3)36(61)47-13-7-8-23(47)32(57)41-17(4)37(62)63)45-29(54)20(9-11-24(38)51)42-31(56)22(14-48)44-35(60)28(19(6)50)46-30(55)21(10-12-25(52)53)43-33(58)26(39)18(5)49/h15-23,26-28,48-50H,7-14,39H2,1-6H3,(H2,38,51)(H,40,59)(H,41,57)(H,42,56)(H,43,58)(H,44,60)(H,45,54)(H,46,55)(H,52,53)(H,62,63)/t16-,17-,18+,19+,20-,21-,22-,23-,26-,27-,28-/m0/s1	YNNNDDQTLPJPIA-KCMKZVLYSA-N					compound annotation
0391_011504	sulforaphane	C6H11NOS2	1.8505	5350		C[S+]([O-])CCCCN=C=S	InChI=1S/C6H11NOS2/c1-10(8)5-3-2-4-7-6-9/h2-5H2,1H3	SUVMJBTUFCVSAD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011506	Thalidomide-NH-CH2-COOH	C15H13N3O6	2.0876	58827328		O=C(O)CNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C15H13N3O6/c19-10-5-4-9(13(22)17-10)18-14(23)7-2-1-3-8(12(7)15(18)24)16-6-11(20)21/h1-3,9,16H,4-6H2,(H,20,21)(H,17,19,22)	LRGLFYOYKPSPJQ-UHFFFAOYSA-N					compound annotation
0391_011507	ML297	C17H14F2N4O	3.7318	56642816		Cc1nn(-c2ccccc2)c(NC(=O)Nc2cc(F)c(F)cc2)c1	InChI=1S/C17H14F2N4O/c1-11-9-16(23(22-11)13-5-3-2-4-6-13)21-17(24)20-12-7-8-14(18)15(19)10-12/h2-10H,1H3,(H2,20,21,24)	IEKSMUSSYJUQMY-UHFFFAOYSA-N					compound annotation
0391_011508	170569-86-5	C16H11ClF3N3O2S	4.5775	9865808		NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cl)cc2)cc1	InChI=1S/C16H11ClF3N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)	NSQNZEUFHPTJME-UHFFFAOYSA-N					compound annotation
0391_011509	N-oleoylglycine	C20H37NO3	6.2124	6436908	CCCCCCCC/C=C\CCCCCCCC(=O)NCC(=O)O	CCCCCCCCC=CCCCCCCCC(=O)NCC(=O)O	InChI=1S/C20H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(22)21-18-20(23)24/h9-10H,2-8,11-18H2,1H3,(H,21,22)(H,23,24)/b10-9-	HPFXACZRFJDURI-KTKRTIGZSA-N					compound annotation
0391_011510	Garcinol	C38H50O6	7.1072	5281560	CC(=CC[C@@H]1C[C@@]2(C(=O)/C(=C(\C3=CC(=C(C=C3)O)O)/O)/C(=O)[C@@](C2=O)(C1(C)C)CC=C(C)C)C[C@H](CC=C(C)C)C(=C)C)C	C=C(C)C(CC=C(C)C)CC12CC(CC=C(C)C)C(C)(C)C(CC=C(C)C)(C(=O)C(=C(O)c3cc(O)c(O)cc3)C1=O)C2=O	InChI=1S/C38H50O6/c1-22(2)11-13-27(25(7)8)20-37-21-28(15-12-23(3)4)36(9,10)38(35(37)44,18-17-24(5)6)34(43)31(33(37)42)32(41)26-14-16-29(39)30(40)19-26/h11-12,14,16-17,19,27-28,39-41H,7,13,15,18,20-21H2,1-6,8-10H3/b32-31-/t27-,28+,37+,38-/m0/s1	DTTONLKLWRTCAB-BZSUNBQASA-N					compound annotation
0391_011511	BAY-474	C17H15N5	2.6596	24959105		CC1=C(C#N)C(c2cc3c(C)[nH]nc3cc2)C(C#N)=C(C)N1	InChI=1S/C17H15N5/c1-9-14(7-18)17(15(8-19)10(2)20-9)12-4-5-16-13(6-12)11(3)21-22-16/h4-6,17,20H,1-3H3,(H,21,22)	QKVFMAAIXZONRN-UHFFFAOYSA-N					compound annotation
0391_011512	Olean-12-ene-28,29-dioic acid,3-[(4-O-b-D-glucopyranosyl-b-D-xylopyranosyl)oxy]-2,23-dihydroxy-,29-methyl ester, (2b,3b,4a,20b)-	C42H66O16	3.1613	11657924	C[C@@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C)C)[C@@H]2C1)C)C(=O)O)C(=O)OC	COC(=O)C1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CC(O)C(OC6OCC(OC7OC(CO)C(O)C(O)C7O)C(O)C6O)C(C)(CO)C5CCC43C)C2C1	InChI=1S/C42H66O16/c1-37(36(53)54-6)11-13-42(35(51)52)14-12-40(4)20(21(42)15-37)7-8-26-38(2)16-22(45)32(39(3,19-44)25(38)9-10-41(26,40)5)58-33-30(49)28(47)24(18-55-33)57-34-31(50)29(48)27(46)23(17-43)56-34/h7,21-34,43-50H,8-19H2,1-6H3,(H,51,52)/t21-,22-,23+,24+,25+,26+,27+,28-,29-,30+,31+,32-,33-,34-,37-,38-,39-,40+,41+,42-/m0/s1	ZMXKPCHQLHYTHY-OWRBLJEPSA-N					removed another duplicate entry; compound annotation
0391_011514	Jarin-1	C28H29N3O4	3.7888	7142742	COCCC(=O)N1C[C@@H]2C[C@H](C1)C3=CC=C(C(=O)N3C2)NC(=O)C4=CC=C(C=C4)C5=CC=CC=C5	COCCC(=O)N1CC2CC(C1)c1ccc(NC(=O)c3ccc(-c4ccccc4)cc3)c(=O)n1C2	InChI=1S/C28H29N3O4/c1-35-14-13-26(32)30-16-19-15-23(18-30)25-12-11-24(28(34)31(25)17-19)29-27(33)22-9-7-21(8-10-22)20-5-3-2-4-6-20/h2-12,19,23H,13-18H2,1H3,(H,29,33)/t19-,23+/m0/s1	LMVUVKIGGHXSJX-WMZHIEFXSA-N					removed another duplicate entry; compound annotation
0391_011516	Lirimilast	C17H12Cl2N2O6S	4.1517	6433118		CS(=O)(=O)Oc1cc2c(cc1)c(NC(N)=O)c(C(=O)c1c(Cl)cc(Cl)cc1)o2	InChI=1S/C17H12Cl2N2O6S/c1-28(24,25)27-9-3-5-11-13(7-9)26-16(14(11)21-17(20)23)15(22)10-4-2-8(18)6-12(10)19/h2-7H,1H3,(H3,20,21,23)	YPFLFUJKZDAXRA-UHFFFAOYSA-N					compound annotation
0391_011517	925705-73-3	C12H10N6O	1.3829	17751063		Nc1nc2ncc(-c3cc(O)ccc3)nc2c(N)n1	InChI=1S/C12H10N6O/c13-10-9-11(18-12(14)17-10)15-5-8(16-9)6-2-1-3-7(19)4-6/h1-5,19H,(H4,13,14,15,17,18)	UOORQSPLBHUQDQ-UHFFFAOYSA-N					compound annotation
0391_011518	GPLGIAGQ	C31H53N9O10	1.7273	11721776	CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CN	CCC(C)C(NC(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)CN)C(=O)NC(C)C(=O)NCC(=O)NC(CCC(N)=O)C(=O)O	InChI=1S/C31H53N9O10/c1-6-17(4)26(30(48)36-18(5)27(45)34-14-23(42)37-19(31(49)50)9-10-22(33)41)39-24(43)15-35-28(46)20(12-16(2)3)38-29(47)21-8-7-11-40(21)25(44)13-32/h16-21,26H,6-15,32H2,1-5H3,(H2,33,41)(H,34,45)(H,35,46)(H,36,48)(H,37,42)(H,38,47)(H,39,43)(H,49,50)/t17-,18-,19-,20-,21-,26-/m0/s1	BLNMYSBCIVAVFK-PFZXUFBWSA-N					removed another duplicate entry; compound annotation
0391_011520	UCB-9260	C26H25N5O	2.4301	72700327		Cc1cc(Cn2c(C(O)c3ccncc3)nc3ccc(-c4cn(C)nc4)cc32)c(C)cc1	InChI=1S/C26H25N5O/c1-17-4-5-18(2)21(12-17)16-31-24-13-20(22-14-28-30(3)15-22)6-7-23(24)29-26(31)25(32)19-8-10-27-11-9-19/h4-15,25,32H,16H2,1-3H3	RZGFWGNCSYUEPR-UHFFFAOYSA-N					compound annotation
0391_011521	antazoline	C17H19N3	2.5367	2200		c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1	InChI=1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19)	REYFJDPCWQRWAA-UHFFFAOYSA-N					compound annotation
0391_011522	GSK046	C23H27FN2O4	2.7658	146018690	C[C@@H](C1=CC=CC=C1)OC2=C(C(=CC(=C2)C(=O)NC3CCC(CC3)O)F)NC(=O)C	CC(=O)Nc1c(OC(C)c2ccccc2)cc(C(=O)NC2CCC(O)CC2)cc1F	InChI=1S/C23H27FN2O4/c1-14(16-6-4-3-5-7-16)30-21-13-17(12-20(24)22(21)25-15(2)27)23(29)26-18-8-10-19(28)11-9-18/h3-7,12-14,18-19,28H,8-11H2,1-2H3,(H,25,27)(H,26,29)/t14-,18?,19?/m0/s1	FRBRZGLUFOZRGD-YCMKEVRSSA-N					compound annotation
0391_011523	876310-60-0	C26H38N6O3	3.0038	53320361	C1C2CC3CC1CC(C2)(C3)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N	NC(=O)C(Cc1ccccc1)NC(=O)C(CCCN=C(N)N)NC(=O)C12CC3CC(CC(C3)C1)C2	InChI=1S/C26H38N6O3/c27-22(33)21(12-16-5-2-1-3-6-16)31-23(34)20(7-4-8-30-25(28)29)32-24(35)26-13-17-9-18(14-26)11-19(10-17)15-26/h1-3,5-6,17-21H,4,7-15H2,(H2,27,33)(H,31,34)(H,32,35)(H4,28,29,30)/t17?,18?,19?,20-,21-,26?/m0/s1	UMKHUSRDQFQHAK-RNJMTYCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_011525	cIAP1 ligand 1	C31H42N4O6S	4.6092	138911355	C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC(=CC=C4)O)N(C)C(=O)OC(C)(C)C	CC(C(=O)NC(C(=O)N1CCCC1c1nc(C(=O)c2cc(O)ccc2)cs1)C1CCCCC1)N(C)C(=O)OC(C)(C)C	InChI=1S/C31H42N4O6S/c1-19(34(5)30(40)41-31(2,3)4)27(38)33-25(20-11-7-6-8-12-20)29(39)35-16-10-15-24(35)28-32-23(18-42-28)26(37)21-13-9-14-22(36)17-21/h9,13-14,17-20,24-25,36H,6-8,10-12,15-16H2,1-5H3,(H,33,38)/t19-,24-,25-/m0/s1	SPXBMEKMIPOEMC-LQGLAIQGSA-N					removed another duplicate entry; compound annotation
0391_011527	Paliperidone	C23H27FN4O3	2.1337	115237		Cc1c(CCN2CCC(c3noc4c3ccc(F)c4)CC2)c(=O)n2CCCC(O)c2n1	InChI=1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3	PMXMIIMHBWHSKN-UHFFFAOYSA-N					compound annotation
0391_011528	pyrimethamine	C12H13ClN4	2.2486	4993		CCc1c(-c2ccc(Cl)cc2)c(N)nc(N)n1	InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)	WKSAUQYGYAYLPV-UHFFFAOYSA-N					compound annotation
0391_011529	rebamipide	C19H15ClN2O4	2.7294	5042		O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1	InChI=1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26)	ALLWOAVDORUJLA-UHFFFAOYSA-N					compound annotation
0391_011530	Pecazine	C19H22N2S	3.1456	6075		CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1	InChI=1S/C19H22N2S/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21/h2-5,8-11,15H,6-7,12-14H2,1H3	CBHCDHNUZWWAPP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011532	Butylphthalide	C12H14O2	4.0407	61361		CCCCC1OC(=O)c2ccccc21	InChI=1S/C12H14O2/c1-2-3-8-11-9-6-4-5-7-10(9)12(13)14-11/h4-7,11H,2-3,8H2,1H3	HJXMNVQARNZTEE-UHFFFAOYSA-N					compound annotation
0391_011533	Neuraminidase-IN-1	C14H11N3O6	2.1913	154585120	C1=CC(=C(C=C1/C=N/NC(=O)C2=CC(=CC(=C2)O)O)[N+](=O)[O-])O	O=C(NN=Cc1cc([N+](=O)[O-])c(O)cc1)c1cc(O)cc(O)c1	InChI=1S/C14H11N3O6/c18-10-4-9(5-11(19)6-10)14(21)16-15-7-8-1-2-13(20)12(3-8)17(22)23/h1-7,18-20H,(H,16,21)/b15-7+	MCGROFKAAXXTBN-VIZOYTHASA-N					compound annotation
0391_011534	bromperidol	C21H23BrFNO2	2.9257	2448		O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1	InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2	RKLNONIVDFXQRX-UHFFFAOYSA-N					compound annotation
0391_011535	CD38 inhibitor 1	C22H27N3O3S	3.0283	118736856		COCCOC1CCC(Nc2cc(=O)n(C)c3c2cc(-c2cncs2)cc3)CC1	InChI=1S/C22H27N3O3S/c1-25-20-8-3-15(21-13-23-14-29-21)11-18(20)19(12-22(25)26)24-16-4-6-17(7-5-16)28-10-9-27-2/h3,8,11-14,16-17,24H,4-7,9-10H2,1-2H3	VJQALSOBHVEJQM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011537	Norelgestromin	C21H29NO2	3.9555	9568628	CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C/C(=N/O)/CC[C@H]34	C#CC1(O)CCC2C3CCC4=CC(=NO)CCC4C3CCC21CC	InChI=1S/C21H29NO2/c1-3-20-11-9-17-16-8-6-15(22-24)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23-24H,3,5-12H2,1H3/b22-15+/t16-,17+,18+,19-,20-,21-/m0/s1	ISHXLNHNDMZNMC-VTKCIJPMSA-N					compound annotation
0391_011538	GSK1702934A	C22H25N3O2S	4.2282	16376051		O=C(c1cc2c(CCCCC2)s1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1	InChI=1S/C22H25N3O2S/c26-21(20-14-15-6-2-1-3-9-19(15)28-20)24-12-10-16(11-13-24)25-18-8-5-4-7-17(18)23-22(25)27/h4-5,7-8,14,16H,1-3,6,9-13H2,(H,23,27)	AXWRAIIIBRLXBP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011540	GSK726701A	C24H22FNO5	4.8947	16678098		CCOc1c2CN(c3cc(F)c(CC(=O)O)cc3)C(=O)c2c(OCC)c2ccccc12	InChI=1S/C24H22FNO5/c1-3-30-22-16-7-5-6-8-17(16)23(31-4-2)21-18(22)13-26(24(21)29)15-10-9-14(11-20(27)28)19(25)12-15/h5-10,12H,3-4,11,13H2,1-2H3,(H,27,28)	YJEFCZJZEASKIO-UHFFFAOYSA-N					compound annotation
0391_011541	ANGSTROM6	C39H62N10O15	0.8843	156612996		CC(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(N)=O)C(=O)O	InChI=1S/C39H62N10O15/c1-21(52)42-23(7-2-3-15-40)36(60)47-16-4-8-27(47)35(59)45-25(19-50)33(57)46-26(20-51)37(61)49-18-6-10-29(49)38(62)48-17-5-9-28(48)34(58)43-22(12-14-31(54)55)32(56)44-24(39(63)64)11-13-30(41)53/h22-29,50-51H,2-20,40H2,1H3,(H2,41,53)(H,42,52)(H,43,58)(H,44,56)(H,45,59)(H,46,57)(H,54,55)(H,63,64)	YUDSEXRLRQZDOS-UHFFFAOYSA-N					compound annotation
0391_011542	rimantadine	C12H21N	2.2334	5071		CC(N)C12CC3CC(CC(C3)C1)C2	InChI=1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3	UBCHPRBFMUDMNC-UHFFFAOYSA-N					compound annotation
0391_011543	amitriptyline	C20H23N	3.1873	2160		CN(C)CCC=C1c2ccccc2CCc2ccccc12	InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3	KRMDCWKBEZIMAB-UHFFFAOYSA-N					compound annotation
0391_011544	CVT-10216	C24H19NO7S	3.5777	23661666		CS(=O)(=O)Nc1ccc(-c2coc3c(ccc(OCc4cc(C(=O)O)ccc4)c3)c2=O)cc1	InChI=1S/C24H19NO7S/c1-33(29,30)25-18-7-5-16(6-8-18)21-14-32-22-12-19(9-10-20(22)23(21)26)31-13-15-3-2-4-17(11-15)24(27)28/h2-12,14,25H,13H2,1H3,(H,27,28)	YYOOFJZTRCPVFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011546	cinnarizine	C26H28N2	3.8199	1547484	C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4	C(=Cc1ccccc1)CN1CCN(C(c2ccccc2)c2ccccc2)CC1	InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+	DERZBLKQOCDDDZ-JLHYYAGUSA-N					compound annotation
0391_011547	1443290-89-8	C18H17Cl2N5	5.0291	86272454		CC1(C)c2c(ccc(Cl)c2)N(CCc2n[nH]nn2)c2c1cc(Cl)cc2	InChI=1S/C18H17Cl2N5/c1-18(2)13-9-11(19)3-5-15(13)25(8-7-17-21-23-24-22-17)16-6-4-12(20)10-14(16)18/h3-6,9-10H,7-8H2,1-2H3,(H,21,22,23,24)	GQPMJOXQJUGJPG-UHFFFAOYSA-N					compound annotation
0391_011548	orlistat	C29H53NO5	7.1709	3034010	CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O	CCCCCCCCCCCC(CC1OC(=O)C1CCCCCC)OC(=O)C(CC(C)C)NC=O	InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1	AHLBNYSZXLDEJQ-FWEHEUNISA-N					removed another duplicate entry; compound annotation
0391_011550	278605-15-5	C11H11NO2	1.1148	25216972	C#CC1=CC=C(C=C1)C[C@@H](C(=O)O)N	C#Cc1ccc(CC(N)C(=O)O)cc1	InChI=1S/C11H11NO2/c1-2-8-3-5-9(6-4-8)7-10(12)11(13)14/h1,3-6,10H,7,12H2,(H,13,14)/t10-/m0/s1	PPDNGMUGVMESGE-JTQLQIEISA-N					doublet; compound annotation
0391_011551	Sonolisib	C29H35NO8	2.6731	9849735	CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@]4([C@H](OC(=O)/C(=C/N(CC=C)CC=C)/C4=C(C3=O)O)COC)C)C	C=CCN(C=C1C(=O)OC(COC)C2(C)C1=C(O)C(=O)C1=C2C(OC(C)=O)CC2(C)C(=O)CCC12)CC=C	InChI=1S/C29H35NO8/c1-7-11-30(12-8-2)14-17-23-26(34)25(33)22-18-9-10-20(32)28(18,4)13-19(37-16(3)31)24(22)29(23,5)21(15-36-6)38-27(17)35/h7-8,14,18-19,21,34H,1-2,9-13,15H2,3-6H3/b17-14+/t18-,19+,21+,28-,29-/m0/s1	QIUASFSNWYMDFS-NILGECQDSA-N					removed another duplicate entry; compound annotation
0391_011553	BF 227	C16H16FN3O2S	3.1285	10404577	CN(C)C1=NC=C(S1)/C=C/C2=NC3=C(O2)C=C(C=C3)OCCF	CN(C)c1ncc(C=Cc2nc3c(cc(OCCF)cc3)o2)s1	InChI=1S/C16H16FN3O2S/c1-20(2)16-18-10-12(23-16)4-6-15-19-13-5-3-11(21-8-7-17)9-14(13)22-15/h3-6,9-10H,7-8H2,1-2H3/b6-4+	GSZMUPHKOPBPPS-GQCTYLIASA-N					doublet; compound annotation
0391_011554	BF 227	C16H16FN3O2S	3.3594	10404577	CN(C)C1=NC=C(S1)/C=C/C2=NC3=C(O2)C=C(C=C3)OCCF	CN(C)c1ncc(C=Cc2nc3c(cc(OCCF)cc3)o2)s1	InChI=1S/C16H16FN3O2S/c1-20(2)16-18-10-12(23-16)4-6-15-19-13-5-3-11(21-8-7-17)9-14(13)22-15/h3-6,9-10H,7-8H2,1-2H3/b6-4+	GSZMUPHKOPBPPS-GQCTYLIASA-N					doublet; removed another duplicate entry; compound annotation
0391_011556	BF 227	C16H16FN3O2S	3.5442	10404577	CN(C)C1=NC=C(S1)/C=C/C2=NC3=C(O2)C=C(C=C3)OCCF	CN(C)c1ncc(C=Cc2nc3c(cc(OCCF)cc3)o2)s1	InChI=1S/C16H16FN3O2S/c1-20(2)16-18-10-12(23-16)4-6-15-19-13-5-3-11(21-8-7-17)9-14(13)22-15/h3-6,9-10H,7-8H2,1-2H3/b6-4+	GSZMUPHKOPBPPS-GQCTYLIASA-N					doublet; removed another duplicate entry; compound annotation
0391_011558	BF 227	C16H16FN3O2S	3.6776	10404577	CN(C)C1=NC=C(S1)/C=C/C2=NC3=C(O2)C=C(C=C3)OCCF	CN(C)c1ncc(C=Cc2nc3c(cc(OCCF)cc3)o2)s1	InChI=1S/C16H16FN3O2S/c1-20(2)16-18-10-12(23-16)4-6-15-19-13-5-3-11(21-8-7-17)9-14(13)22-15/h3-6,9-10H,7-8H2,1-2H3/b6-4+	GSZMUPHKOPBPPS-GQCTYLIASA-N					doublet; removed another duplicate entry; compound annotation
0391_011560	CE3F4	C11H10Br2FNO	4.6129	21781066		CC1CCc2c(Br)c(F)c(Br)cc2N1C=O	InChI=1S/C11H10Br2FNO/c1-6-2-3-7-9(15(6)5-16)4-8(12)11(14)10(7)13/h4-6H,2-3H2,1H3	ZZLQPWXVZCPUGC-UHFFFAOYSA-N					compound annotation
0391_011561	IGS-1.76	C22H18N2OS	4.8522	591698		O=C(CC(c1ccccc1)c1ccccc1)Nc1nc2ccccc2s1	InChI=1S/C22H18N2OS/c25-21(24-22-23-19-13-7-8-14-20(19)26-22)15-18(16-9-3-1-4-10-16)17-11-5-2-6-12-17/h1-14,18H,15H2,(H,23,24,25)	GYQWKTIZRYVFEM-UHFFFAOYSA-N					compound annotation
0391_011562	Laurocapram	C18H35NO	6.4004	42981		CCCCCCCCCCCCN1CCCCCC1=O	InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-13-16-19-17-14-11-12-15-18(19)20/h2-17H2,1H3	AXTGDCSMTYGJND-UHFFFAOYSA-N					compound annotation
0391_011563	CHEMBL4303798	C19H18N9O5S2+	0.6331	5491955	CO/N=C(/C1=NSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C[n+]3c4cccnn4cc3)CSC12)c1nsc(N)n1	InChI=1S/C19H17N9O5S2/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32)/p+1/b24-11-/t12-,17-/m1/s1	QDUIJCOKQCCXQY-WHJQOFBOSA-O					compound annotation
0391_011564	Isoschaftoside	C26H28O14	1.6919	3084995	C1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C(C(=C3C(=C2O)C(=O)C=C(O3)C4=CC=C(C=C4)O)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)O	O=c1cc(-c2ccc(O)cc2)oc2c(C3OC(CO)C(O)C(O)C3O)c(O)c(C3OCC(O)C(O)C3O)c(O)c12	InChI=1S/C26H28O14/c27-6-13-18(32)21(35)23(37)26(40-13)16-20(34)15(25-22(36)17(31)11(30)7-38-25)19(33)14-10(29)5-12(39-24(14)16)8-1-3-9(28)4-2-8/h1-5,11,13,17-18,21-23,25-28,30-37H,6-7H2/t11-,13+,17-,18+,21-,22+,23+,25-,26-/m0/s1	OVMFOVNOXASTPA-VYUBKLCTSA-N					compound annotation
0391_011565	naphazoline	C14H14N2	1.756	4436		c1ccc2c(CC3=NCCN3)cccc2c1	InChI=1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)	CNIIGCLFLJGOGP-UHFFFAOYSA-N					compound annotation
0391_011566	Afuresertib	C18H17Cl2FN4OS	3.1342	46843057	CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)N[C@@H](CC3=CC(=CC=C3)F)CN)Cl	Cn1ncc(Cl)c1-c1c(Cl)sc(C(=O)NC(CN)Cc2cc(F)ccc2)c1	InChI=1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1	AFJRDFWMXUECEW-LBPRGKRZSA-N					doublet; compound annotation
0391_011567	nicergoline	C24H26BrN3O3	3.2171	34040	CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br	COC12CC(COC(=O)c3cc(Br)cnc3)CN(C)C1Cc1cn(C)c3cccc2c13	InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1	YSEXMKHXIOCEJA-FVFQAYNVSA-N					compound annotation
0391_011568	CHEMBL363419	C17H19N5O	3.7684	11771279		c1ccc(Oc2nc3c([nH]cn3)c(NC3CCCCC3)n2)cc1	InChI=1S/C17H19N5O/c1-3-7-12(8-4-1)20-16-14-15(19-11-18-14)21-17(22-16)23-13-9-5-2-6-10-13/h2,5-6,9-12H,1,3-4,7-8H2,(H2,18,19,20,21,22)	OGCQBCHLFMBCCE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011570	CHEMBL363419	C17H19N5O	4.2054	11771279		c1ccc(Oc2nc3c([nH]cn3)c(NC3CCCCC3)n2)cc1	InChI=1S/C17H19N5O/c1-3-7-12(8-4-1)20-16-14-15(19-11-18-14)21-17(22-16)23-13-9-5-2-6-10-13/h2,5-6,9-12H,1,3-4,7-8H2,(H2,18,19,20,21,22)	OGCQBCHLFMBCCE-UHFFFAOYSA-N					doublet; compound annotation
0391_011571	Atractylenolide I	C15H18O2	5.0267	5321018	CC1=C2C[C@H]3C(=C)CCC[C@@]3(C=C2OC1=O)C	C=C1CCCC2(C)C=C3OC(=O)C(C)=C3CC12	InChI=1S/C15H18O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h8,12H,1,4-7H2,2-3H3/t12-,15+/m0/s1	ZTVSGQPHMUYCRS-SWLSCSKDSA-N					compound annotation
0391_011572	Mecillinam	C15H23N3O3S	1.7043	36273	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)O)C	CC1(C)SC2C(N=CN3CCCCCC3)C(=O)N2C1C(=O)O	InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/t10-,11+,13-/m1/s1	BWWVAEOLVKTZFQ-NTZNESFSSA-N					doublet; compound annotation
0391_011573	rivastigmine	C14H22N2O2	1.8779	77991	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	CCN(C)C(=O)Oc1cccc(C(C)N(C)C)c1	InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1	XSVMFMHYUFZWBK-NSHDSACASA-N					doublet; compound annotation
0391_011574	Mecillinam	C15H23N3O3S	2.5569	36273	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)O)C	CC1(C)SC2C(N=CN3CCCCCC3)C(=O)N2C1C(=O)O	InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/t10-,11+,13-/m1/s1	BWWVAEOLVKTZFQ-NTZNESFSSA-N					doublet; compound annotation
0391_011575	Poseltinib	C26H26N6O3	2.6148	56644522		C=CC(=O)Nc1cc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3c2occ3)ccc1	InChI=1S/C26H26N6O3/c1-3-23(33)27-19-5-4-6-21(17-19)35-25-24-22(11-16-34-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)	LZMJNVRJMFMYQS-UHFFFAOYSA-N					compound annotation
0391_011576	CORTICOSTERONE	C21H30O4	3.1326	5753	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O	CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C(C(=O)CO)CCC12	InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1	OMFXVFTZEKFJBZ-HJTSIMOOSA-N					compound annotation
0391_011577	Xanthatin	C15H18O3	3.1499	5281511	C[C@H]1C[C@H]2[C@H](CC=C1/C=C/C(=O)C)C(=C)C(=O)O2	C=C1C(=O)OC2CC(C)C(C=CC(C)=O)=CCC12	InChI=1S/C15H18O3/c1-9-8-14-13(11(3)15(17)18-14)7-6-12(9)5-4-10(2)16/h4-6,9,13-14H,3,7-8H2,1-2H3/b5-4+/t9-,13+,14-/m0/s1	RBRPTFMVULVGIC-ZTIIIDENSA-N					compound annotation
0391_011578	Nomilin	C28H34O9	3.7662	72320	CC(=O)O[C@H]1CC(=O)OC([C@H]2[C@]1([C@H]3CC[C@]4([C@@H](OC(=O)[C@@H]5[C@@]4([C@@]3(C(=O)C2)C)O5)C6=COC=C6)C)C)(C)C	CC(=O)OC1CC(=O)OC(C)(C)C2CC(=O)C3(C)C(CCC4(C)C(c5cocc5)OC(=O)C5OC543)C12C	InChI=1S/C28H34O9/c1-14(29)34-19-12-20(31)36-24(2,3)17-11-18(30)27(6)16(26(17,19)5)7-9-25(4)21(15-8-10-33-13-15)35-23(32)22-28(25,27)37-22/h8,10,13,16-17,19,21-22H,7,9,11-12H2,1-6H3/t16-,17+,19+,21+,22-,25+,26-,27+,28-/m1/s1	KPDOJFFZKAUIOE-WNGDLQANSA-N					compound annotation
0391_011579	IMT1	C21H21NO4	3.8978	138490559		Cc1ccccc1-c1cc(=O)oc2c1ccc(OC(C)C(=O)N(C)C)c2	InChI=1S/C21H21NO4/c1-13-7-5-6-8-16(13)18-12-20(23)26-19-11-15(9-10-17(18)19)25-14(2)21(24)22(3)4/h5-12,14H,1-4H3	DBIPGWVTQBAHGP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011581	Glyco-diosgenin	C56H92O25	4.4988	162642462	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)OCCC(CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)C)OC1	CC1CCC2(OC1)OC1CC3C4CC=C5CC(OCCC(COC6OC(CO)C(OC7OC(CO)C(O)C(O)C7O)C(O)C6O)COC6OC(CO)C(OC7OC(CO)C(O)C(O)C7O)C(O)C6O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C56H92O25/c1-24-7-13-56(74-21-24)25(2)37-32(81-56)16-31-29-6-5-27-15-28(8-11-54(27,3)30(29)9-12-55(31,37)4)71-14-10-26(22-72-50-46(69)42(65)48(35(19-59)77-50)79-52-44(67)40(63)38(61)33(17-57)75-52)23-73-51-47(70)43(66)49(36(20-60)78-51)80-53-45(68)41(64)39(62)34(18-58)76-53/h5,24-26,28-53,57-70H,6-23H2,1-4H3/t24-,25+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54+,55+,56-/m1/s1	LKBFXDNKNZXHHW-OWZYDGQDSA-N					removed another duplicate entry; compound annotation
0391_011583	dicumarol	C19H12O6	4.9106	54676038		O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O	InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2	DOBMPNYZJYQDGZ-UHFFFAOYSA-N					compound annotation
0391_011584	3'-Hydroxypuerarin	C21H20O10	1.1967	5748205	C1=CC(=C(C=C1C2=COC3=C(C2=O)C=CC(=C3[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O	O=c1c(-c2cc(O)c(O)cc2)coc2c1ccc(O)c2C1OC(CO)C(O)C(O)C1O	InChI=1S/C21H20O10/c22-6-14-17(27)18(28)19(29)21(31-14)15-12(24)4-2-9-16(26)10(7-30-20(9)15)8-1-3-11(23)13(25)5-8/h1-5,7,14,17-19,21-25,27-29H,6H2/t14-,17-,18+,19-,21+/m1/s1	GARZMRVWLORUSR-VPRICQMDSA-N					removed another duplicate entry; compound annotation
0391_011586	Forsythoside I	C29H36O15	1.7931	23958169	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OCCC3=CC(=C(C=C3)O)O)O)OC(=O)/C=C/C4=CC(=C(C=C4)O)O)O)O)O)O	CC1OC(OCC2OC(OCCc3cc(O)c(O)cc3)C(O)C(OC(=O)C=Cc3cc(O)c(O)cc3)C2O)C(O)C(O)C1O	InChI=1S/C29H36O15/c1-13-22(35)24(37)25(38)28(42-13)41-12-20-23(36)27(44-21(34)7-4-14-2-5-16(30)18(32)10-14)26(39)29(43-20)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27-,28+,29+/m0/s1	GKRBWXABVALDGQ-GCELSKRESA-N					compound annotation
0391_011587	EST73502	C19H26F2N2O2	2.0389	118561036	CCN1CC2(CCN(CC2)CCC3=C(C=CC(=C3)F)F)O[C@@H](C1=O)C	CCN1CC2(CCN(CCc3c(F)ccc(F)c3)CC2)OC(C)C1=O	InChI=1S/C19H26F2N2O2/c1-3-23-13-19(25-14(2)18(23)24)7-10-22(11-8-19)9-6-15-12-16(20)4-5-17(15)21/h4-5,12,14H,3,6-11,13H2,1-2H3/t14-/m1/s1	KALIKXMQWFLZKB-CQSZACIVSA-N					compound annotation
0391_011588	Tandospirone	C21H29N5O2	2.1172	91273	C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5	O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ncccn2)CC1	InChI=1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18-	CEIJFEGBUDEYSX-FZDBZEDMSA-N					doublet; compound annotation
0391_011589	Telithromycin	C43H65N5O10	2.2659	3002190	CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C	CCC1OC(=O)C(C)C(=O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C2N(CCCCn3cnc(-c4cnccc4)c3)C(=O)OC12C	InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1	LJVAJPDWBABPEJ-PNUFFHFMSA-N					compound annotation
0391_011590	amsacrine	C21H19N3O3S	2.3074	2179		COc1c(Nc2c3ccccc3nc3ccccc23)ccc(NS(C)(=O)=O)c1	InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)	XCPGHVQEEXUHNC-UHFFFAOYSA-N					doublet; compound annotation
0391_011591	enoxolone	C30H46O4	5.2865	10114	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1	MPDGHEJMBKOTSU-YKLVYJNSSA-N					compound annotation
0391_011592	Rimonabant	C22H21Cl3N4O	5.4378	104850		Cc1c(-c2ccc(Cl)cc2)n(-c2c(Cl)cc(Cl)cc2)nc1C(=O)NN1CCCCC1	InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	JZCPYUJPEARBJL-UHFFFAOYSA-N					doublet; compound annotation
0391_011593	Rimonabant	C22H21Cl3N4O	5.4406	104850		Cc1c(-c2ccc(Cl)cc2)n(-c2c(Cl)cc(Cl)cc2)nc1C(=O)NN1CCCCC1	InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)	JZCPYUJPEARBJL-UHFFFAOYSA-N					doublet; compound annotation
0391_011594	6-dimethylaminopurine	C7H9N5	0.4723	3134		CN(C)c1ncnc2c1[nH]cn2	InChI=1S/C7H9N5/c1-12(2)7-5-6(9-3-8-5)10-4-11-7/h3-4H,1-2H3,(H,8,9,10,11)	BVIAOQMSVZHOJM-UHFFFAOYSA-N					compound annotation
0391_011595	Vandetanib	C22H24BrFN4O2	2.1098	3081361		COc1c(OCC2CCN(C)CC2)cc2ncnc(Nc3c(F)cc(Br)cc3)c2c1	InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)	UHTHHESEBZOYNR-UHFFFAOYSA-N					compound annotation
0391_011596	Dasatinib	C22H26ClN7O2S	2.5618	3062316		Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1	InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)	ZBNZXTGUTAYRHI-UHFFFAOYSA-N					doublet; compound annotation
0391_011597	liothyronine	C15H12I3NO4	2.9484	7048703	C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)[O-])[NH3+])I)I)O	NC(Cc1cc(I)c(Oc2cc(I)c(O)cc2)c(I)c1)C(=O)O	InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1	AUYYCJSJGJYCDS-LBPRGKRZSA-N					doublet; compound annotation
0391_011598	16673-34-0	C16H17ClN2O4S	3.1719	85542		COc1c(C(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc(Cl)cc1	InChI=1S/C16H17ClN2O4S/c1-23-15-7-4-12(17)10-14(15)16(20)19-9-8-11-2-5-13(6-3-11)24(18,21)22/h2-7,10H,8-9H2,1H3,(H,19,20)(H2,18,21,22)	KVWWTCSJLGHLRM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011600	Calcimycin	C29H37N3O6	4.4983	11957499	C[C@@H]1CC[C@]2([C@@H](C[C@H]([C@H](O2)[C@H](C)C(=O)C3=CC=CN3)C)C)O[C@@H]1CC4=NC5=C(O4)C=CC(=C5C(=O)O)NC	CNc1c(C(=O)O)c2c(cc1)oc(CC1OC3(CCC1C)OC(C(C)C(=O)c1ccc[nH]1)C(C)CC3C)n2	InChI=1S/C29H37N3O6/c1-15-10-11-29(17(3)13-16(2)27(38-29)18(4)26(33)20-7-6-12-31-20)37-22(15)14-23-32-25-21(36-23)9-8-19(30-5)24(25)28(34)35/h6-9,12,15-18,22,27,30-31H,10-11,13-14H2,1-5H3,(H,34,35)/t15-,16-,17-,18-,22-,27+,29+/m1/s1	HIYAVKIYRIFSCZ-CYEMHPAKSA-N					doublet; compound annotation
0391_011601	Calcimycin	C29H37N3O6	6.3443	11957499	C[C@@H]1CC[C@]2([C@@H](C[C@H]([C@H](O2)[C@H](C)C(=O)C3=CC=CN3)C)C)O[C@@H]1CC4=NC5=C(O4)C=CC(=C5C(=O)O)NC	CNc1c(C(=O)O)c2c(cc1)oc(CC1OC3(CCC1C)OC(C(C)C(=O)c1ccc[nH]1)C(C)CC3C)n2	InChI=1S/C29H37N3O6/c1-15-10-11-29(17(3)13-16(2)27(38-29)18(4)26(33)20-7-6-12-31-20)37-22(15)14-23-32-25-21(36-23)9-8-19(30-5)24(25)28(34)35/h6-9,12,15-18,22,27,30-31H,10-11,13-14H2,1-5H3,(H,34,35)/t15-,16-,17-,18-,22-,27+,29+/m1/s1	HIYAVKIYRIFSCZ-CYEMHPAKSA-N					doublet; compound annotation
0391_011602	thiabendazole	C10H7N3S	1.2074	5430		c1ccc2[nH]c(-c3cscn3)nc2c1	InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)	WJCNZQLZVWNLKY-UHFFFAOYSA-N					compound annotation
0391_011603	daidzein	C15H10O4	2.4376	5281708		O=c1c(-c2ccc(O)cc2)coc2c1ccc(O)c2	InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H	ZQSIJRDFPHDXIC-UHFFFAOYSA-N					compound annotation
0391_011604	prednisone	C21H26O5	2.669	5865	C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C	CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO	InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1	XOFYZVNMUHMLCC-ZPOLXVRWSA-N					compound annotation
0391_011605	AZD3458	C20H23N3O4S2	3.2057	134611894	CC1=C(SC(=N1)NC(=O)C)C2=CC3=C(C(=C2)S(=O)(=O)C)C(=O)N(C3)[C@@H](C)C4CC4	CC(=O)Nc1nc(C)c(-c2cc3c(C(=O)N(C(C)C4CC4)C3)c(S(C)(=O)=O)c2)s1	InChI=1S/C20H23N3O4S2/c1-10-18(28-20(21-10)22-12(3)24)14-7-15-9-23(11(2)13-5-6-13)19(25)17(15)16(8-14)29(4,26)27/h7-8,11,13H,5-6,9H2,1-4H3,(H,21,22,24)/t11-/m0/s1	PAQUFWFUOVDUIO-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_011607	Sparteine	C15H26N2	0.6106	644020	C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@H]3CCCC4	C1CCN2CC3CC(CN4CCCCC34)C2C1	InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m0/s1	SLRCCWJSBJZJBV-ZQDZILKHSA-N					doublet; compound annotation
0391_011608	cefotaxime	C16H17N5O7S2	1.5638	5742673	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O	CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(C)=O)CSC12)c1csc(N)n1	InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1	GPRBEKHLDVQUJE-QSWIMTSFSA-N					compound annotation
0391_011609	Narcissoside	C28H32O16	2.0018	5481663	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)O)O)O)O)O)O	COc1c(O)ccc(-c2c(OC3OC(COC4OC(C)C(O)C(O)C4O)C(O)C(O)C3O)c(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C28H32O16/c1-9-18(32)21(35)23(37)27(41-9)40-8-16-19(33)22(36)24(38)28(43-16)44-26-20(34)17-13(31)6-11(29)7-15(17)42-25(26)10-3-4-12(30)14(5-10)39-2/h3-7,9,16,18-19,21-24,27-33,35-38H,8H2,1-2H3/t9-,16+,18-,19+,21+,22-,23+,24+,27+,28-/m0/s1	UIDGLYUNOUKLBM-GEBJFKNCSA-N					removed another duplicate entry; compound annotation
0391_011611	VUT-MK142	C17H22N4O	2.9452	53261094		COc1ccc(Nc2cc(NC3CCCCC3)ncn2)cc1	InChI=1S/C17H22N4O/c1-22-15-9-7-14(8-10-15)21-17-11-16(18-12-19-17)20-13-5-3-2-4-6-13/h7-13H,2-6H2,1H3,(H2,18,19,20,21)	YPIHLCLKUNREAT-UHFFFAOYSA-N					compound annotation
0391_011612	Bombykol	C16H30O	6.4819	445128	CCC/C=C\C=C\CCCCCCCCCO	CCCC=CC=CCCCCCCCCCO	InChI=1S/C16H30O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h4-7,17H,2-3,8-16H2,1H3/b5-4-,7-6+	CIVIWCVVOFNUST-SCFJQAPRSA-N					compound annotation
0391_011613	55033-90-4	C28H32O16	1.8917	11664505	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)OC)CO)O)O)O)O)O	COc1c(O)ccc(-c2c(OC3OC(CO)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)c(=O)c3c(O)cc(O)cc3o2)c1	InChI=1S/C28H32O16/c1-9-18(33)21(36)23(38)27(40-9)44-26-22(37)19(34)16(8-29)42-28(26)43-25-20(35)17-13(32)6-11(30)7-15(17)41-24(25)10-3-4-12(31)14(5-10)39-2/h3-7,9,16,18-19,21-23,26-34,36-38H,8H2,1-2H3/t9-,16+,18-,19+,21+,22-,23+,26+,27-,28-/m0/s1	QHLKSZBFIJJREC-SPSUIZEHSA-N					removed another duplicate entry; compound annotation
0391_011615	UCSF924	C20H22N2O2	2.272	72901200		Cc1cc2c(cc1)[nH]c(CNCCCOc1ccccc1)cc2=O	InChI=1S/C20H22N2O2/c1-15-8-9-19-18(12-15)20(23)13-16(22-19)14-21-10-5-11-24-17-6-3-2-4-7-17/h2-4,6-9,12-13,21H,5,10-11,14H2,1H3,(H,22,23)	RPHDOVLXDYWDGF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011617	UCSF924	C20H22N2O2	2.8475	72901200		Cc1cc2c(cc1)[nH]c(CNCCCOc1ccccc1)cc2=O	InChI=1S/C20H22N2O2/c1-15-8-9-19-18(12-15)20(23)13-16(22-19)14-21-10-5-11-24-17-6-3-2-4-7-17/h2-4,6-9,12-13,21H,5,10-11,14H2,1H3,(H,22,23)	RPHDOVLXDYWDGF-UHFFFAOYSA-N					doublet; compound annotation
0391_011618	PF-06952229	C23H24ClFN4O3	2.8584	118211239		CC(C)c1cnc(-c2c(F)ccc(Cl)c2)cc1Nc1c(C(=O)NC(CO)CO)cncc1	InChI=1S/C23H24ClFN4O3/c1-13(2)17-10-27-21(16-7-14(24)3-4-19(16)25)8-22(17)29-20-5-6-26-9-18(20)23(32)28-15(11-30)12-31/h3-10,13,15,30-31H,11-12H2,1-2H3,(H,28,32)(H,26,27,29)	IPBLCOKXDQHSQW-UHFFFAOYSA-N					compound annotation
0391_011619	PF-04937319	C22H20N6O4	3.1481	46916694		Cc1cnc(NC(=O)c2cc3c(cc(C)o3)c(Oc3cnc(C(=O)N(C)C)nc3)c2)cn1	InChI=1S/C22H20N6O4/c1-12-8-24-19(11-23-12)27-21(29)14-6-17-16(5-13(2)31-17)18(7-14)32-15-9-25-20(26-10-15)22(30)28(3)4/h5-11H,1-4H3,(H,24,27,29)	MASKQITXHVYVFL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011621	NP-G2-044	C21H16F3N3O2	4.8228	91844684		Cc1c(C(=O)Nc2nn(Cc3ccc(C(F)(F)F)cc3)c3ccccc23)cco1	InChI=1S/C21H16F3N3O2/c1-13-16(10-11-29-13)20(28)25-19-17-4-2-3-5-18(17)27(26-19)12-14-6-8-15(9-7-14)21(22,23)24/h2-11H,12H2,1H3,(H,25,26,28)	XLLRLAABUFOJPC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011623	(S)-2,5-dimethoxy-N-(quinuclidin-3-yl)benzamide	C16H22N2O3	1.6967	45381614	COC1=CC(=C(C=C1)OC)C(=O)N[C@@H]2CN3CCC2CC3	COc1cc(C(=O)NC2CN3CCC2CC3)c(OC)cc1	InChI=1S/C16H22N2O3/c1-20-12-3-4-15(21-2)13(9-12)16(19)17-14-10-18-7-5-11(14)6-8-18/h3-4,9,11,14H,5-8,10H2,1-2H3,(H,17,19)/t14-/m1/s1	PIRVMXMBHKHJCD-CQSZACIVSA-N					compound annotation
0391_011624	Apitolisib	C23H30N8O3S	1.8031	25254071	CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O	Cc1c(CN2CCN(C(=O)C(C)O)CC2)sc2c1nc(-c1cnc(N)nc1)nc2N1CCOCC1	InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1	YOVVNQKCSKSHKT-HNNXBMFYSA-N					compound annotation
0391_011625	Tpl2 Kinase Inhibitor	C21H14ClFN6	2.4957	9549300		N#Cc1c(Nc2cc(Cl)c(F)cc2)c2cc(NCc3cnccc3)ncc2nc1	InChI=1S/C21H14ClFN6/c22-17-6-15(3-4-18(17)23)29-21-14(8-24)11-26-19-12-28-20(7-16(19)21)27-10-13-2-1-5-25-9-13/h1-7,9,11-12H,10H2,(H,26,29)(H,27,28)	NMEUKWOOQOHUNA-UHFFFAOYSA-N					compound annotation
0391_011626	nalidixic acid	C12H12N2O3	2.8266	4421		CCn1cc(C(=O)O)c(=O)c2c1nc(C)cc2	InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)	MHWLWQUZZRMNGJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011628	PTGR2-IN-1	C19H22N2O2	3.5552	912698		COc1ccccc1N1CCN(C(=O)Cc2ccccc2)CC1	InChI=1S/C19H22N2O2/c1-23-18-10-6-5-9-17(18)20-11-13-21(14-12-20)19(22)15-16-7-3-2-4-8-16/h2-10H,11-15H2,1H3	TVIOYMPBWXQRRQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011631	861875-60-7	C22H15F3N4O2	3.6466	16004702		Nc1nccc(Oc2cc3c(cc2)c(C(=O)Nc2cccc(C(F)(F)F)c2)ccc3)n1	InChI=1S/C22H15F3N4O2/c23-22(24,25)14-4-2-5-15(12-14)28-20(30)18-6-1-3-13-11-16(7-8-17(13)18)31-19-9-10-27-21(26)29-19/h1-12H,(H,28,30)(H2,26,27,29)	MLLQJNIKDWEEFT-UHFFFAOYSA-N					compound annotation
0391_011632	Solriamfetol	C10H14N2O2	0.9871	10130337	C1=CC=C(C=C1)C[C@H](COC(=O)N)N	NC(=O)OCC(N)Cc1ccccc1	InChI=1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1	UCTRAOBQFUDCSR-SECBINFHSA-N					doublet; compound annotation
0391_011633	GNF-Pf-5485	C16H15N2+	1.6275	423846		C[n+]1ccc(C=Cc2c[nH]c3ccccc23)cc1	InChI=1S/C16H14N2/c1-18-10-8-13(9-11-18)6-7-14-12-17-16-5-3-2-4-15(14)16/h2-12H,1H3/p+1	REPRLCRXMJXHAW-UHFFFAOYSA-O					doublet; compound annotation
0391_011634	GNF-Pf-5485	C16H15N2+	2.0656	423846		C[n+]1ccc(C=Cc2c[nH]c3ccccc23)cc1	InChI=1S/C16H14N2/c1-18-10-8-13(9-11-18)6-7-14-12-17-16-5-3-2-4-15(14)16/h2-12H,1H3/p+1	REPRLCRXMJXHAW-UHFFFAOYSA-O					doublet; compound annotation
0391_011635	noscapine	C22H23NO7	2.2738	275196	CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3	COc1ccc2c(c1OC)C(=O)OC2C1c2c(OC)c3c(cc2CCN1C)OCO3	InChI=1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1	AKNNEGZIBPJZJG-MSOLQXFVSA-N					removed another duplicate entry; compound annotation
0391_011637	PROTAC RIPK degrader-6	C43H48N6O11S2	2.6634	126696039		CC(C)(C)S(=O)(=O)c1cc2c(Nc3cc4c(cc3)scn4)ccnc2cc1OCCOCCOCCOCCOCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	InChI=1S/C43H48N6O11S2/c1-43(2,3)62(54,55)38-22-29-32(46-27-7-9-37-34(21-27)45-26-61-37)11-12-44-33(29)23-36(38)60-20-19-58-16-15-56-13-14-57-17-18-59-25-40(51)47-31-6-4-5-28-30(31)24-49(42(28)53)35-8-10-39(50)48-41(35)52/h4-7,9,11-12,21-23,26,35H,8,10,13-20,24-25H2,1-3H3,(H,44,46)(H,47,51)(H,48,50,52)	BRZGXSNAXRPPFI-UHFFFAOYSA-N					doublet; compound annotation
0391_011638	PROTAC RIPK degrader-6	C43H48N6O11S2	2.6672	126696039		CC(C)(C)S(=O)(=O)c1cc2c(Nc3cc4c(cc3)scn4)ccnc2cc1OCCOCCOCCOCCOCC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	InChI=1S/C43H48N6O11S2/c1-43(2,3)62(54,55)38-22-29-32(46-27-7-9-37-34(21-27)45-26-61-37)11-12-44-33(29)23-36(38)60-20-19-58-16-15-56-13-14-57-17-18-59-25-40(51)47-31-6-4-5-28-30(31)24-49(42(28)53)35-8-10-39(50)48-41(35)52/h4-7,9,11-12,21-23,26,35H,8,10,13-20,24-25H2,1-3H3,(H,44,46)(H,47,51)(H,48,50,52)	BRZGXSNAXRPPFI-UHFFFAOYSA-N					doublet; compound annotation
0391_011639	methylprednisolone	C22H30O5	3.0047	6741	C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O	CC1CC2C(C(O)CC3(C)C2CCC3(O)C(=O)CO)C2(C)C=CC(=O)C=C12	InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1	VHRSUDSXCMQTMA-PJHHCJLFSA-N					compound annotation
0391_011640	Benzododecinium	C21H38N+	4.704	8754		CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1	InChI=1S/C21H38N/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21/h13-15,17-18H,4-12,16,19-20H2,1-3H3/q+1	CYDRXTMLKJDRQH-UHFFFAOYSA-N					compound annotation
0391_011641	GNF-Pf-5485	C16H15N2+	6.4813	423846		C[n+]1ccc(C=Cc2c[nH]c3ccccc23)cc1	InChI=1S/C16H14N2/c1-18-10-8-13(9-11-18)6-7-14-12-17-16-5-3-2-4-15(14)16/h2-12H,1H3/p+1	REPRLCRXMJXHAW-UHFFFAOYSA-O					doublet; compound annotation
0391_011642	Danicamtiv	C16H20F3N5O4S	3.0021	122424426	C[C@@](C1CCN(CC1)C(=O)NC2=NOC=C2)(F)S(=O)(=O)C3=CN(N=C3C(F)F)C	Cn1cc(S(=O)(=O)C(C)(F)C2CCN(C(=O)Nc3nocc3)CC2)c(C(F)F)n1	InChI=1S/C16H20F3N5O4S/c1-16(19,29(26,27)11-9-23(2)21-13(11)14(17)18)10-3-6-24(7-4-10)15(25)20-12-5-8-28-22-12/h5,8-10,14H,3-4,6-7H2,1-2H3,(H,20,22,25)/t16-/m1/s1	NREKKBAMVWQRES-MRXNPFEDSA-N					removed another duplicate entry; compound annotation
0391_011644	Tuberculosis inhibitor 3	C21H22F6N4O3S	3.0503	145985088		O=c1nc(N2CCC(CN3CCC(C(F)(F)F)CC3)CC2)sc2c1cc(C(F)(F)F)cc2[N+](=O)[O-]	InChI=1S/C21H22F6N4O3S/c22-20(23,24)13-3-5-29(6-4-13)11-12-1-7-30(8-2-12)19-28-18(32)15-9-14(21(25,26)27)10-16(31(33)34)17(15)35-19/h9-10,12-13H,1-8,11H2	UFMNTAVTSIJODG-UHFFFAOYSA-N					compound annotation
0391_011645	1257628-77-5	C29H27F3N6O	3.3551	51038269		Cc1c(C#Cc2cc3c(nc2)[nH]nc3)cc(C(=O)Nc2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36)	TZKBVRDEOITLRB-UHFFFAOYSA-N					doublet; compound annotation
0391_011646	GNE-618	C21H15F3N4O3S	3.5619	66613669		O=C(NCc1ccc(S(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)c1cnc2[nH]ncc2c1	InChI=1S/C21H15F3N4O3S/c22-21(23,24)16-2-1-3-18(9-16)32(30,31)17-6-4-13(5-7-17)10-26-20(29)15-8-14-12-27-28-19(14)25-11-15/h1-9,11-12H,10H2,(H,26,29)(H,25,27,28)	LKBHAGGICJWHQQ-UHFFFAOYSA-N					compound annotation
0391_011647	Ly93	C21H20N2O2	3.75	118911741		CCc1ccccc1COc1ccccc1C(=O)Nc1cnccc1	InChI=1S/C21H20N2O2/c1-2-16-8-3-4-9-17(16)15-25-20-12-6-5-11-19(20)21(24)23-18-10-7-13-22-14-18/h3-14H,2,15H2,1H3,(H,23,24)	YRUSTWBJNUPPQI-UHFFFAOYSA-N					compound annotation
0391_011648	BJE6-106	C26H23NO2	5.9628	85471521		CC1(C)C=Cc2c(O1)c(C=O)cc(CCn1c3ccccc3c3ccccc31)c2	InChI=1S/C26H23NO2/c1-26(2)13-11-19-15-18(16-20(17-28)25(19)29-26)12-14-27-23-9-5-3-7-21(23)22-8-4-6-10-24(22)27/h3-11,13,15-17H,12,14H2,1-2H3	QLDDENZBVHBRKN-UHFFFAOYSA-N					doublet; compound annotation
0391_011649	BJE6-106	C26H23NO2	5.9666	85471521		CC1(C)C=Cc2c(O1)c(C=O)cc(CCn1c3ccccc3c3ccccc31)c2	InChI=1S/C26H23NO2/c1-26(2)13-11-19-15-18(16-20(17-28)25(19)29-26)12-14-27-23-9-5-3-7-21(23)22-8-4-6-10-24(22)27/h3-11,13,15-17H,12,14H2,1-2H3	QLDDENZBVHBRKN-UHFFFAOYSA-N					doublet; compound annotation
0391_011650	CHEMBL4743301	C10H20NO4+	0.4612	107739		CCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3/p+1	UFAHZIUFPNSHSL-UHFFFAOYSA-O					compound annotation
0391_011651	TOYOCAMYCIN	C12H13N5O4	0.6112	11824	C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C#N	N#Cc1cn(C2OC(CO)C(O)C2O)c2ncnc(N)c12	InChI=1S/C12H13N5O4/c13-1-5-2-17(11-7(5)10(14)15-4-16-11)12-9(20)8(19)6(3-18)21-12/h2,4,6,8-9,12,18-20H,3H2,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1	XOKJUSAYZUAMGJ-WOUKDFQISA-N					compound annotation
0391_011652	CHEMBL3892042	C26H34N6O6S	2.1427	117978172	C1C[C@H](N(C1)S(=O)(=O)C2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=C(C=C3)NC(=O)CCCCN=C(N)N)C(=O)O	NC(N)=NCCCCC(=O)Nc1ccc(CC(NC(=O)C2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1	InChI=1S/C26H34N6O6S/c27-26(28)29-15-5-4-10-23(33)30-19-13-11-18(12-14-19)17-21(25(35)36)31-24(34)22-9-6-16-32(22)39(37,38)20-7-2-1-3-8-20/h1-3,7-8,11-14,21-22H,4-6,9-10,15-17H2,(H,30,33)(H,31,34)(H,35,36)(H4,27,28,29)/t21-,22-/m0/s1	BLLLAUHTNAVSQR-VXKWHMMOSA-N					doublet; removed another duplicate entry; compound annotation
0391_011654	CHEMBL3892042	C26H34N6O6S	2.2534	117978172	C1C[C@H](N(C1)S(=O)(=O)C2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=C(C=C3)NC(=O)CCCCN=C(N)N)C(=O)O	NC(N)=NCCCCC(=O)Nc1ccc(CC(NC(=O)C2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1	InChI=1S/C26H34N6O6S/c27-26(28)29-15-5-4-10-23(33)30-19-13-11-18(12-14-19)17-21(25(35)36)31-24(34)22-9-6-16-32(22)39(37,38)20-7-2-1-3-8-20/h1-3,7-8,11-14,21-22H,4-6,9-10,15-17H2,(H,30,33)(H,31,34)(H,35,36)(H4,27,28,29)/t21-,22-/m0/s1	BLLLAUHTNAVSQR-VXKWHMMOSA-N					doublet; compound annotation
0391_011655	cetirizine	C21H25ClN2O3	3.2031	2678		O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)	ZKLPARSLTMPFCP-UHFFFAOYSA-N					compound annotation
0391_011656	Lorglumide	C22H32Cl2N2O4	5.3302	3960		CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C22H32Cl2N2O4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28)	IEKOTSCYBBDIJC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011658	Resiquimod	C17H22N4O2	1.9432	159603		CCOCc1nc2c(c3ccccc3nc2N)n1CC(C)(C)O	InChI=1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19)	BXNMTOQRYBFHNZ-UHFFFAOYSA-N					compound annotation
0391_011659	Ixabepilone	C27H42N2O5S	2.3165	6445540	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1	InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	FABUFPQFXZVHFB-PVYNADRNSA-N					doublet; compound annotation
0391_011660	Ixabepilone	C27H42N2O5S	2.7327	6445540	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1	InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	FABUFPQFXZVHFB-PVYNADRNSA-N					doublet; compound annotation
0391_011661	Spiramide	C22H26FN3O2	2.7979	68186		O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2	InChI=1S/C22H26FN3O2/c23-18-7-9-20(10-8-18)28-16-4-13-25-14-11-22(12-15-25)21(27)24-17-26(22)19-5-2-1-3-6-19/h1-3,5-10H,4,11-17H2,(H,24,27)	FJUKDAZEABGEIH-UHFFFAOYSA-N					compound annotation
0391_011662	1384984-18-2	C21H25FN6O3	2.8841	57524959	CCNC(=O)NC1=NC2=C(N1)C=C(C(=C2[C@H]3CCCO3)F)C4=CN=C(N=C4)C(C)(C)O	CCNC(=O)Nc1nc2c(cc(-c3cnc(C(C)(C)O)nc3)c(F)c2C2CCCO2)[nH]1	InChI=1S/C21H25FN6O3/c1-4-23-20(29)28-19-26-13-8-12(11-9-24-18(25-10-11)21(2,3)30)16(22)15(17(13)27-19)14-6-5-7-31-14/h8-10,14,30H,4-7H2,1-3H3,(H3,23,26,27,28,29)/t14-/m1/s1	BKUISYCLLXCBJV-CQSZACIVSA-N					compound annotation
0391_011663	Ixabepilone	C27H42N2O5S	3.2352	6445540	C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C	CC(=Cc1csc(C)n1)C1CC2OC2(C)CCCC(C)C(O)C(C)C(=O)C(C)(C)C(O)CC(=O)N1	InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1	FABUFPQFXZVHFB-PVYNADRNSA-N					doublet; compound annotation
0391_011664	megestrol	C22H30O3	4.0492	19090	CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C	CC(=O)C1(O)CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1	VXIMPSPISRVBPZ-NWUMPJBXSA-N					compound annotation
0391_011665	34564-13-1	C21H20N2O3	4.9571	15538560		CCN(CC)c1cc2c(cc1)cc(-c1nc3c(ccc(C)c3)o1)c(=O)o2	InChI=1S/C21H20N2O3/c1-4-23(5-2)15-8-7-14-11-16(21(24)26-19(14)12-15)20-22-17-10-13(3)6-9-18(17)25-20/h6-12H,4-5H2,1-3H3	PTAGJQADNFQMGR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011668	Mogroside III-E	C48H82O19	2.6303	102350789	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C)O)C)C	CC(CCC(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(CO)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C48H82O19/c1-21(9-13-31(45(4,5)61)66-43-40(37(58)34(55)27(20-51)64-43)67-42-39(60)36(57)33(54)26(19-50)63-42)22-15-16-46(6)28-12-10-23-24(48(28,8)29(52)17-47(22,46)7)11-14-30(44(23,2)3)65-41-38(59)35(56)32(53)25(18-49)62-41/h10,21-22,24-43,49-61H,9,11-20H2,1-8H3/t21-,22-,24-,25-,26-,27-,28+,29-,30+,31-,32-,33-,34-,35+,36+,37+,38-,39-,40-,41+,42+,43+,46+,47-,48+/m1/s1	QATISCJMIITVAB-CNEPTXDISA-N					removed another duplicate entry; compound annotation
0391_011670	iGOT1-01	C19H20N4O	2.9368	2818038		O=C(Nc1ccccc1)N1CCN(c2cccc3c2cc[nH]3)CC1	InChI=1S/C19H20N4O/c24-19(21-15-5-2-1-3-6-15)23-13-11-22(12-14-23)18-8-4-7-17-16(18)9-10-20-17/h1-10,20H,11-14H2,(H,21,24)	MGSDOEMLWKEWSV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011672	iGOT1-01	C19H20N4O	2.9427	2818038		O=C(Nc1ccccc1)N1CCN(c2cccc3c2cc[nH]3)CC1	InChI=1S/C19H20N4O/c24-19(21-15-5-2-1-3-6-15)23-13-11-22(12-14-23)18-8-4-7-17-16(18)9-10-20-17/h1-10,20H,11-14H2,(H,21,24)	MGSDOEMLWKEWSV-UHFFFAOYSA-N					doublet; compound annotation
0391_011673	1422365-93-2	C13H16F3N5O	2.997	78092899		NC(=Nc1ccc(OC(F)(F)F)cc1)N=C(N)N1CCCC1	InChI=1S/C13H16F3N5O/c14-13(15,16)22-10-5-3-9(4-6-10)19-11(17)20-12(18)21-7-1-2-8-21/h3-6H,1-2,7-8H2,(H4,17,18,19,20)	NGFUHJWVBKTNOE-UHFFFAOYSA-N					compound annotation
0391_011674	benzthiazide	C15H14ClN3O4S3	3.1468	2343		NS(=O)(=O)c1c(Cl)cc2NC(CSCc3ccccc3)=NS(=O)(=O)c2c1	InChI=1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21)	NDTSRXAMMQDVSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011676	FLAVONE	C15H10O2	3.8444	10680		O=c1cc(-c2ccccc2)oc2ccccc12	InChI=1S/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H	VHBFFQKBGNRLFZ-UHFFFAOYSA-N					compound annotation
0391_011677	TRIADIMEFON	C14H16ClN3O2	4.1759	39385		CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1cncn1	InChI=1S/C14H16ClN3O2/c1-14(2,3)12(19)13(18-9-16-8-17-18)20-11-6-4-10(15)5-7-11/h4-9,13H,1-3H3	WURBVZBTWMNKQT-UHFFFAOYSA-N					compound annotation
0391_011678	BERBAMINE	C37H40N2O6	1.8671	275182	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC	COc1c2cc3c(c1)CCN(C)C3Cc1ccc(cc1)Oc1c(O)ccc(c1)CC1c3c(O2)c(OC)c(OC)cc3CCN1C	InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(41-3)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-31-18-23(8-11-30(31)40)17-29-35-25(13-15-39(29)2)20-34(42-4)36(43-5)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1	DFOCUWZXJBAUSQ-URLMMPGGSA-N					doublet; compound annotation
0391_011679	Reboxetine	C19H23NO3	2.8065	127151	CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3	CCOc1ccccc1OC(c1ccccc1)C1CNCCO1	InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1	CBQGYUDMJHNJBX-RTBURBONSA-N					removed another duplicate entry; compound annotation
0391_011681	AN7973	C19H17BClN3O3	3.5908	77846210		CC1(C)OB(O)c2c1ccc(NC(=O)c1c(Cl)cc(-n3cccn3)cc1)c2	InChI=1S/C19H17BClN3O3/c1-19(2)15-7-4-12(10-16(15)20(26)27-19)23-18(25)14-6-5-13(11-17(14)21)24-9-3-8-22-24/h3-11,26H,1-2H3,(H,23,25)	JUSVAUWJLCQPHI-UHFFFAOYSA-N					compound annotation
0391_011682	parthenolide	C15H20O3	3.6065	7251185	C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C	C=C1C(=O)OC2C1CCC(C)=CCCC1(C)OC21	InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1	KTEXNACQROZXEV-PVLRGYAZSA-N					doublet; removed another duplicate entry; compound annotation
0391_011684	parthenolide	C15H20O3	6.9561	7251185	C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C	C=C1C(=O)OC2C1CCC(C)=CCCC1(C)OC21	InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1	KTEXNACQROZXEV-PVLRGYAZSA-N					doublet; compound annotation
0391_011685	parthenolide	C15H20O3	7.0503	7251185	C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C	C=C1C(=O)OC2C1CCC(C)=CCCC1(C)OC21	InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1	KTEXNACQROZXEV-PVLRGYAZSA-N					doublet; compound annotation
0391_011686	CARTEOLOL	C16H24N2O3	1.3346	2583		CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2	InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)	LWAFSWPYPHEXKX-UHFFFAOYSA-N					compound annotation
0391_011687	LP-922761	C21H26N6O3	2.1149	86696405		CN(CCNc1nn2c(-c3ccc(C(N)=O)cc3)cnc2cc1)C(=O)OC(C)(C)C	InChI=1S/C21H26N6O3/c1-21(2,3)30-20(29)26(4)12-11-23-17-9-10-18-24-13-16(27(18)25-17)14-5-7-15(8-6-14)19(22)28/h5-10,13H,11-12H2,1-4H3,(H2,22,28)(H,23,25)	YNQNYIHMAZLJAV-UHFFFAOYSA-N					doublet; compound annotation
0391_011688	Bropirimine	C10H8BrN3O	2.1381	135413497		Nc1nc(=O)c(Br)c(-c2ccccc2)[nH]1	InChI=1S/C10H8BrN3O/c11-7-8(6-4-2-1-3-5-6)13-10(12)14-9(7)15/h1-5H,(H3,12,13,14,15)	CIUUIPMOFZIWIZ-UHFFFAOYSA-N					compound annotation
0391_011689	LP-922761	C21H26N6O3	2.1602	86696405		CN(CCNc1nn2c(-c3ccc(C(N)=O)cc3)cnc2cc1)C(=O)OC(C)(C)C	InChI=1S/C21H26N6O3/c1-21(2,3)30-20(29)26(4)12-11-23-17-9-10-18-24-13-16(27(18)25-17)14-5-7-15(8-6-14)19(22)28/h5-10,13H,11-12H2,1-4H3,(H2,22,28)(H,23,25)	YNQNYIHMAZLJAV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011691	Clebopride	C20H24ClN3O2	2.193	2780		COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1	InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25)	BVPWJMCABCPUQY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011693	albendazole	C12H15N3O2S	2.7733	2082		CCCSc1cc2c(cc1)nc(NC(=O)OC)[nH]2	InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)	HXHWSAZORRCQMX-UHFFFAOYSA-N					compound annotation
0391_011694	729-46-4	C10H16N2O2S4	3.216	12892		S=C(SSC(=S)N1CCOCC1)N1CCOCC1	InChI=1S/C10H16N2O2S4/c15-9(11-1-5-13-6-2-11)17-18-10(16)12-3-7-14-8-4-12/h1-8H2	KKVYOWPPMNSLCP-UHFFFAOYSA-N					compound annotation
0391_011695	Lercanidipine	C36H41N3O6	4.074	65866		COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3	ZDXUKAKRHYTAKV-UHFFFAOYSA-N					compound annotation
0391_011696	635324-72-0	C21H13F4N5O	4.4262	101136468		Cn1ncc2c3[nH]n(-c4ccc(F)cc4)c(=O)c3c(-c3cc(C(F)(F)F)ccc3)nc21	InChI=1S/C21H13F4N5O/c1-29-19-15(10-26-29)18-16(20(31)30(28-18)14-7-5-13(22)6-8-14)17(27-19)11-3-2-4-12(9-11)21(23,24)25/h2-10,28H,1H3	WQKVVTLTCHDAST-UHFFFAOYSA-N					doublet; compound annotation
0391_011697	635324-72-0	C21H13F4N5O	4.4303	101136468		Cn1ncc2c3[nH]n(-c4ccc(F)cc4)c(=O)c3c(-c3cc(C(F)(F)F)ccc3)nc21	InChI=1S/C21H13F4N5O/c1-29-19-15(10-26-29)18-16(20(31)30(28-18)14-7-5-13(22)6-8-14)17(27-19)11-3-2-4-12(9-11)21(23,24)25/h2-10,28H,1H3	WQKVVTLTCHDAST-UHFFFAOYSA-N					doublet; compound annotation
0391_011698	ZYZ-488	C20H29N3O11	1.2783	138454738	COC1=CC(=CC(=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)OC)C(=O)OCCCCN=C(N)N	COc1cc(C(=O)OCCCCN=C(N)N)cc(OC)c1OC1OC(C(=O)O)C(O)C(O)C1O	InChI=1S/C20H29N3O11/c1-30-10-7-9(18(29)32-6-4-3-5-23-20(21)22)8-11(31-2)15(10)33-19-14(26)12(24)13(25)16(34-19)17(27)28/h7-8,12-14,16,19,24-26H,3-6H2,1-2H3,(H,27,28)(H4,21,22,23)/t12-,13-,14+,16-,19+/m0/s1	PVTAIJDQJJZCJP-WXZWTWHISA-N					removed another duplicate entry; compound annotation
0391_011700	CBS1117	C15H20Cl2N2O	1.4421	25236799		CC(C)N1CCC(NC(=O)c2c(Cl)cccc2Cl)CC1	InChI=1S/C15H20Cl2N2O/c1-10(2)19-8-6-11(7-9-19)18-15(20)14-12(16)4-3-5-13(14)17/h3-5,10-11H,6-9H2,1-2H3,(H,18,20)	OUZZSIOQTSNTTI-UHFFFAOYSA-N					compound annotation
0391_011701	mirtazapine	C17H19N3	1.7266	4205		CN1CCN2c3c(cccn3)Cc3ccccc3C2C1	InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3	RONZAEMNMFQXRA-UHFFFAOYSA-N					compound annotation
0391_011702	ANETHOLE	C10H12O	4.1536	637563	C/C=C/C1=CC=C(C=C1)OC	CC=Cc1ccc(OC)cc1	InChI=1S/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3-8H,1-2H3/b4-3+	RUVINXPYWBROJD-ONEGZZNKSA-N					doublet; compound annotation
0391_011703	VU041	C19H20F3N3O	4.9497	1129704		O=C(Cn1nc(C(F)(F)F)c2c1CCCC2)N1CCCc2ccccc21	InChI=1S/C19H20F3N3O/c20-19(21,22)18-14-8-2-4-10-16(14)25(23-18)12-17(26)24-11-5-7-13-6-1-3-9-15(13)24/h1,3,6,9H,2,4-5,7-8,10-12H2	DLAGRCZUELSZFG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011705	demeclocycline	C21H21ClN2O8	1.6764	54680690	CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4C(O)C3CC12	InChI=1S/C21H21ClN2O8/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31/h3-4,6-7,14-15,25-27,30,32H,5H2,1-2H3,(H2,23,31)/t6-,7-,14-,15-,21-/m0/s1	GUXHBMASAHGULD-SEYHBJAFSA-N					doublet; compound annotation
0391_011706	demeclocycline	C21H21ClN2O8	1.8574	54680690	CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4C(O)C3CC12	InChI=1S/C21H21ClN2O8/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31/h3-4,6-7,14-15,25-27,30,32H,5H2,1-2H3,(H2,23,31)/t6-,7-,14-,15-,21-/m0/s1	GUXHBMASAHGULD-SEYHBJAFSA-N					doublet; compound annotation
0391_011707	IMIQUIMOD	C14H16N4	2.1262	57469		CC(C)Cn1cnc2c1c1ccccc1nc2N	InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)	DOUYETYNHWVLEO-UHFFFAOYSA-N					doublet; compound annotation
0391_011708	apigenin	C15H10O5	2.8713	5280443		O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H	KZNIFHPLKGYRTM-UHFFFAOYSA-N					compound annotation
0391_011709	diphenylpyraline	C19H23NO	2.9429	3103		CN1CCC(OC(c2ccccc2)c2ccccc2)CC1	InChI=1S/C19H23NO/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-19H,12-15H2,1H3	OWQUZNMMYNAXSL-UHFFFAOYSA-N					doublet; compound annotation
0391_011710	Blumeatin	C16H14O6	3.3227	70696494	COC1=CC(=C2C(=O)C[C@H](OC2=C1)C3=CC(=CC(=C3)O)O)O	COc1cc(O)c2C(=O)CC(c3cc(O)cc(O)c3)Oc2c1	InChI=1S/C16H14O6/c1-21-11-5-12(19)16-13(20)7-14(22-15(16)6-11)8-2-9(17)4-10(18)3-8/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1	YEYLMQKEGSQNGZ-AWEZNQCLSA-N					compound annotation
0391_011711	LMD-009	C29H33N3O3	3.3737	91032188		COc1ccccc1Oc1cccc(CN2CCC3(CC2)C(=O)NCN3CCc2ccccc2)c1	InChI=1S/C29H33N3O3/c1-34-26-12-5-6-13-27(26)35-25-11-7-10-24(20-25)21-31-18-15-29(16-19-31)28(33)30-22-32(29)17-14-23-8-3-2-4-9-23/h2-13,20H,14-19,21-22H2,1H3,(H,30,33)	MRXASGVUQJVWMP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011713	916232-21-8	C28H19FN2O4	5.3342	121513876	C1=CC=C(C=C1)CC\2=NN(C(=O)/C2=C/C3=CC=C(O3)C4=CC=CC=C4F)C5=CC=C(C=C5)C(=O)O	O=C(O)c1ccc(N2N=C(Cc3ccccc3)C(=Cc3ccc(-c4ccccc4F)o3)C2=O)cc1	InChI=1S/C28H19FN2O4/c29-24-9-5-4-8-22(24)26-15-14-21(35-26)17-23-25(16-18-6-2-1-3-7-18)30-31(27(23)32)20-12-10-19(11-13-20)28(33)34/h1-15,17H,16H2,(H,33,34)/b23-17+	IZPMWFSVTDOCDI-HAVVHWLPSA-N					doublet; compound annotation
0391_011714	916232-21-8	C28H19FN2O4	5.794	121513876	C1=CC=C(C=C1)CC\2=NN(C(=O)/C2=C/C3=CC=C(O3)C4=CC=CC=C4F)C5=CC=C(C=C5)C(=O)O	O=C(O)c1ccc(N2N=C(Cc3ccccc3)C(=Cc3ccc(-c4ccccc4F)o3)C2=O)cc1	InChI=1S/C28H19FN2O4/c29-24-9-5-4-8-22(24)26-15-14-21(35-26)17-23-25(16-18-6-2-1-3-7-18)30-31(27(23)32)20-12-10-19(11-13-20)28(33)34/h1-15,17H,16H2,(H,33,34)/b23-17+	IZPMWFSVTDOCDI-HAVVHWLPSA-N					doublet; compound annotation
0391_011715	Bepotastine	C21H25ClN2O3	2.2823	164522	C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O	O=C(O)CCCN1CCC(OC(c2ccc(Cl)cc2)c2ccccn2)CC1	InChI=1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1	YWGDOWXRIALTES-NRFANRHFSA-N					doublet; compound annotation
0391_011716	Ibrutinib-MPEA	C32H39N9O2	2.5592	59799011	C1C[C@H](CN(C1)C(=O)/C=C/CN2CCN(CC2)CCN)N3C4=NC=NC(=C4C(=N3)C5=CC=C(C=C5)OC6=CC=CC=C6)N	NCCN1CCN(CC=CC(=O)N2CCCC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)C2)CC1	InChI=1S/C32H39N9O2/c33-14-17-39-20-18-38(19-21-39)15-5-9-28(42)40-16-4-6-25(22-40)41-32-29(31(34)35-23-36-32)30(37-41)24-10-12-27(13-11-24)43-26-7-2-1-3-8-26/h1-3,5,7-13,23,25H,4,6,14-22,33H2,(H2,34,35,36)/b9-5+/t25-/m1/s1	RQQVGXHWCJBNPV-DSCGJTOLSA-N					compound annotation
0391_011717	HS38	C14H12ClN5O2S	2.948	135398509		CC(Sc1nc2c(cnn2-c2cc(Cl)ccc2)c(=O)[nH]1)C(N)=O	InChI=1S/C14H12ClN5O2S/c1-7(11(16)21)23-14-18-12-10(13(22)19-14)6-17-20(12)9-4-2-3-8(15)5-9/h2-7H,1H3,(H2,16,21)(H,18,19,22)	NASYEGAVCTZSDO-UHFFFAOYSA-N					compound annotation
0391_011718	MOEXIPRIL	C27H34N2O7	3.0256	91270	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1Cc2cc(OC)c(OC)cc2CC1C(=O)O	InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1	UWWDHYUMIORJTA-HSQYWUDLSA-N					compound annotation
0391_011719	BRD3731	C24H31N3O	4.1559	135567205	C[C@]1(C2=C(CC(CC2=O)(C)C)NC3=NNC(=C31)CC(C)(C)C)C4=CC=CC=C4	CC(C)(C)CC1=C2C(=NC3=C(C(=O)CC(C)(C)C3)C2(C)c2ccccc2)NN1	InChI=1S/C24H31N3O/c1-22(2,3)12-17-20-21(27-26-17)25-16-13-23(4,5)14-18(28)19(16)24(20,6)15-10-8-7-9-11-15/h7-11H,12-14H2,1-6H3,(H2,25,26,27)/t24-/m1/s1	YZRXTIGAQRIAEX-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_011721	Hypophyllanthin	C24H30O7	4.5832	182140	COC[C@@H]1CC2=CC(=C3C(=C2[C@@H]([C@H]1COC)C4=CC(=C(C=C4)OC)OC)OCO3)OC	COCC1Cc2cc(OC)c3OCOc3c2C(c2cc(OC)c(OC)cc2)C1COC	InChI=1S/C24H30O7/c1-25-11-16-8-15-10-20(29-5)23-24(31-13-30-23)22(15)21(17(16)12-26-2)14-6-7-18(27-3)19(9-14)28-4/h6-7,9-10,16-17,21H,8,11-13H2,1-5H3/t16-,17-,21+/m0/s1	LBJCUHLNHSKZBW-XGHQBKJUSA-N					compound annotation
0391_011722	1-Methylguanosine	C11H15N5O5	0.4638	96373	CN1C(=O)C2=C(N=C1N)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	Cn1c(N)nc2c(ncn2C2OC(CO)C(O)C2O)c1=O	InChI=1S/C11H15N5O5/c1-15-9(20)5-8(14-11(15)12)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14)/t4-,6-,7-,10-/m1/s1	UTAIYTHAJQNQDW-KQYNXXCUSA-N					removed another duplicate entry; compound annotation
0391_011724	YM 750	C31H36N2O	6.4562	9911716		Cc1cc(C)c(NC(=O)N(Cc2cc3c(cc2)-c2ccccc2C3)C2CCCCCC2)c(C)c1	InChI=1S/C31H36N2O/c1-21-16-22(2)30(23(3)17-21)32-31(34)33(27-11-6-4-5-7-12-27)20-24-14-15-29-26(18-24)19-25-10-8-9-13-28(25)29/h8-10,13-18,27H,4-7,11-12,19-20H2,1-3H3,(H,32,34)	FMLJREWZCZHGGW-UHFFFAOYSA-N					doublet; compound annotation
0391_011725	YM 750	C31H36N2O	6.4607	9911716		Cc1cc(C)c(NC(=O)N(Cc2cc3c(cc2)-c2ccccc2C3)C2CCCCCC2)c(C)c1	InChI=1S/C31H36N2O/c1-21-16-22(2)30(23(3)17-21)32-31(34)33(27-11-6-4-5-7-12-27)20-24-14-15-29-26(18-24)19-25-10-8-9-13-28(25)29/h8-10,13-18,27H,4-7,11-12,19-20H2,1-3H3,(H,32,34)	FMLJREWZCZHGGW-UHFFFAOYSA-N					doublet; compound annotation
0391_011726	lincomycin	C18H34N2O6S	1.2748	3000540	CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O	CCCC1CC(C(=O)NC(C(C)O)C2OC(SC)C(O)C(O)C2O)N(C)C1	InChI=1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1	OJMMVQQUTAEWLP-KIDUDLJLSA-N					compound annotation
0391_011727	Retagliptin	C19H18F6N4O3	2.4856	44193830	COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N	COC(=O)c1c2CN(C(=O)CC(N)Cc3cc(F)c(F)cc3F)CCn2c(C(F)(F)F)n1	InChI=1S/C19H18F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(30)6-10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10H,2-4,6,8,26H2,1H3/t10-/m1/s1	WIIAMRXFUJLYEF-SNVBAGLBSA-N					removed another duplicate entry; compound annotation
0391_011729	ramipril	C23H32N2O5	2.9469	6992028	CCOC(=O)[C@H](CCC1=CC=CC=C1)[NH2+][C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)[O-]	CCOC(=O)C(CCc1ccccc1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21	InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1	HDACQVRGBOVJII-JBDAPHQKSA-N					compound annotation
0391_011730	nortriptyline	C19H21N	3.1339	4543		CNCCC=C1c2ccccc2CCc2ccccc12	InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3	PHVGLTMQBUFIQQ-UHFFFAOYSA-N					compound annotation
0391_011731	Panamesine	C23H26N2O6	2.2095	3047810	COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O	COc1ccc(N2CC(CN3CCC(O)(c4cc5c(cc4)OCO5)CC3)OC2=O)cc1	InChI=1S/C23H26N2O6/c1-28-18-5-3-17(4-6-18)25-14-19(31-22(25)26)13-24-10-8-23(27,9-11-24)16-2-7-20-21(12-16)30-15-29-20/h2-7,12,19,27H,8-11,13-15H2,1H3/t19-/m0/s1	NINYZUDVKTUKIA-IBGZPJMESA-N					compound annotation
0391_011732	Heterophyllin B	C40H58N8O8	3.0912	102022989	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N3CCC[C@H]3C(=O)N4CCC[C@H]4C(=O)N1)CC(C)C)CC5=CC=CC=C5	CCC(C)C1NC(=O)C2CCCN2C(=O)C2CCCN2C(=O)C2CCCN2C(=O)C(CC(C)C)NC(=O)CNC(=O)CNC(=O)C(Cc2ccccc2)NC1=O	InChI=1S/C40H58N8O8/c1-5-25(4)34-37(53)44-27(21-26-12-7-6-8-13-26)35(51)42-22-32(49)41-23-33(50)43-28(20-24(2)3)38(54)47-18-10-15-30(47)40(56)48-19-11-16-31(48)39(55)46-17-9-14-29(46)36(52)45-34/h6-8,12-13,24-25,27-31,34H,5,9-11,14-23H2,1-4H3,(H,41,49)(H,42,51)(H,43,50)(H,44,53)(H,45,52)/t25-,27-,28-,29-,30-,31-,34-/m0/s1	KYAVLJJQNUHRMR-PPLFBOPFSA-N					removed another duplicate entry; compound annotation
0391_011734	GKI-1	C15H12ClN3	4.1389	137333439		Clc1ccc(Nc2cccc(-c3c[nH]nc3)c2)cc1	InChI=1S/C15H12ClN3/c16-13-4-6-14(7-5-13)19-15-3-1-2-11(8-15)12-9-17-18-10-12/h1-10,19H,(H,17,18)	GPXJDHFWTOJHQQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011736	Riboflavin tetrabutyrate	C33H44N4O10	5.1235	92140	CCCC(=O)OC[C@H]([C@H]([C@H](CN1C2=C(C=C(C(=C2)C)C)N=C3C1=NC(=O)NC3=O)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC	CCCC(=O)OCC(OC(=O)CCC)C(OC(=O)CCC)C(Cn1c2nc(=O)[nH]c(=O)c-2nc2c1cc(C)c(C)c2)OC(=O)CCC	InChI=1S/C33H44N4O10/c1-7-11-25(38)44-18-24(46-27(40)13-9-3)30(47-28(41)14-10-4)23(45-26(39)12-8-2)17-37-22-16-20(6)19(5)15-21(22)34-29-31(37)35-33(43)36-32(29)42/h15-16,23-24,30H,7-14,17-18H2,1-6H3,(H,36,42,43)/t23-,24+,30-/m0/s1	MJNIWUJSIGSWKK-BBANNHEPSA-N					removed another duplicate entry; compound annotation
0391_011738	Efonidipine	C34H38N3O7P	5.1747	119171		CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cc([N+](=O)[O-])ccc2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1	InChI=1S/C34H38N3O7P/c1-24-30(33(38)42-19-18-36(28-15-9-6-10-16-28)21-26-12-7-5-8-13-26)31(27-14-11-17-29(20-27)37(39)40)32(25(2)35-24)45(41)43-22-34(3,4)23-44-45/h5-17,20,31,35H,18-19,21-23H2,1-4H3	NSVFSAJIGAJDMR-UHFFFAOYSA-N					doublet; compound annotation
0391_011739	Efonidipine	C34H38N3O7P	5.1783	119171		CC1=C(C(=O)OCCN(Cc2ccccc2)c2ccccc2)C(c2cc([N+](=O)[O-])ccc2)C(P2(=O)OCC(C)(C)CO2)=C(C)N1	InChI=1S/C34H38N3O7P/c1-24-30(33(38)42-19-18-36(28-15-9-6-10-16-28)21-26-12-7-5-8-13-26)31(27-14-11-17-29(20-27)37(39)40)32(25(2)35-24)45(41)43-22-34(3,4)23-44-45/h5-17,20,31,35H,18-19,21-23H2,1-4H3	NSVFSAJIGAJDMR-UHFFFAOYSA-N					doublet; compound annotation
0391_011740	GKI-1	C15H12ClN3	5.2592	137333439		Clc1ccc(Nc2cccc(-c3c[nH]nc3)c2)cc1	InChI=1S/C15H12ClN3/c16-13-4-6-14(7-5-13)19-15-3-1-2-11(8-15)12-9-17-18-10-12/h1-10,19H,(H,17,18)	GPXJDHFWTOJHQQ-UHFFFAOYSA-N					doublet; compound annotation
0391_011741	90417-38-2	C9H8N2O2	0.8639	135398517		Cc1nc(=O)c2c([nH]1)c(O)ccc2	InChI=1S/C9H8N2O2/c1-5-10-8-6(9(13)11-5)3-2-4-7(8)12/h2-4,12H,1H3,(H,10,11,13)	YJDAOHJWLUNFLX-UHFFFAOYSA-N					compound annotation
0391_011742	HSD1590	C20H18BN3O3	2.0403	139030519		COc1c(B(O)O)cccc1-c1nc2c(c3c1CCC3)c1c(cc2)[nH]nc1	InChI=1S/C20H18BN3O3/c1-27-20-13(6-3-7-15(20)21(25)26)19-12-5-2-4-11(12)18-14-10-22-24-16(14)8-9-17(18)23-19/h3,6-10,25-26H,2,4-5H2,1H3,(H,22,24)	WTZMCUOBQPTERK-UHFFFAOYSA-N					compound annotation
0391_011743	Vilazodone	C26H27N5O2	2.4381	6918314		N#Cc1cc2c(cc1)[nH]cc2CCCCN1CCN(c2cc3c(cc2)oc(C(N)=O)c3)CC1	InChI=1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32)	SGEGOXDYSFKCPT-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011745	metolazone	C16H16ClN3O3S	2.8227	4170		Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C	InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23)	AQCHWTWZEMGIFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011747	Retosiban	C27H34N4O5	3.679	11340891	CC[C@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4	CCC(C)C1C(=O)NC(C2Cc3ccccc3C2)C(=O)N1C(C(=O)N1CCOCC1)c1coc(C)n1	InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1	PLVGDGRBPMVYPB-FDUHJNRSSA-N					removed another duplicate entry; compound annotation
0391_011749	Nobiletin	C21H22O8	3.6977	72344		COc1c(OC)cc(-c2cc(=O)c3c(o2)c(OC)c(OC)c(OC)c3OC)cc1	InChI=1S/C21H22O8/c1-23-13-8-7-11(9-15(13)24-2)14-10-12(22)16-17(25-3)19(26-4)21(28-6)20(27-5)18(16)29-14/h7-10H,1-6H3	MRIAQLRQZPPODS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011751	Esaxerenone	C22H21F3N2O4S	3.8255	25052023		Cc1c(-c2ccccc2C(F)(F)F)n(CCO)cc1C(=O)Nc1ccc(S(C)(=O)=O)cc1	InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)	NOSNHVJANRODGR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011753	2219320-08-6	C29H29F3N2	4.1358	139035043		Fc1ccc(C(CCCNCC2CCc3c(C2)c2c(ccc(F)c2)[nH]3)c2ccc(F)cc2)cc1	InChI=1S/C29H29F3N2/c30-22-8-4-20(5-9-22)25(21-6-10-23(31)11-7-21)2-1-15-33-18-19-3-13-28-26(16-19)27-17-24(32)12-14-29(27)34-28/h4-12,14,17,19,25,33-34H,1-3,13,15-16,18H2	OCZIMUMAPGQEBH-UHFFFAOYSA-N					compound annotation
0391_011754	CI-1044	C23H19N5O2	1.8655	9843744	C1CN2C(=O)[C@@H](N=C(C3=CC(=CC1=C32)N)C4=CC=CC=C4)NC(=O)C5=CN=CC=C5	Nc1cc2c3c(c1)C(c1ccccc1)=NC(NC(=O)c1cnccc1)C(=O)N3CC2	InChI=1S/C23H19N5O2/c24-17-11-15-8-10-28-20(15)18(12-17)19(14-5-2-1-3-6-14)26-21(23(28)30)27-22(29)16-7-4-9-25-13-16/h1-7,9,11-13,21H,8,10,24H2,(H,27,29)/t21-/m0/s1	XGXOSJSGDNPEEF-NRFANRHFSA-N					doublet; compound annotation
0391_011755	CI-1044	C23H19N5O2	1.8684	9843744	C1CN2C(=O)[C@@H](N=C(C3=CC(=CC1=C32)N)C4=CC=CC=C4)NC(=O)C5=CN=CC=C5	Nc1cc2c3c(c1)C(c1ccccc1)=NC(NC(=O)c1cnccc1)C(=O)N3CC2	InChI=1S/C23H19N5O2/c24-17-11-15-8-10-28-20(15)18(12-17)19(14-5-2-1-3-6-14)26-21(23(28)30)27-22(29)16-7-4-9-25-13-16/h1-7,9,11-13,21H,8,10,24H2,(H,27,29)/t21-/m0/s1	XGXOSJSGDNPEEF-NRFANRHFSA-N					doublet; compound annotation
0391_011756	quinacrine	C23H30ClN3O	1.9312	237		CCN(CC)CCCC(C)Nc1c2cc(OC)ccc2nc2c1ccc(Cl)c2	InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)	GPKJTRJOBQGKQK-UHFFFAOYSA-N					compound annotation
0391_011757	Afatinib	C24H25ClFN5O3	2.018	10184653	CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4	CN(C)CC=CC(=O)Nc1c(OC2CCOC2)cc2ncnc(Nc3cc(Cl)c(F)cc3)c2c1	InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1	ULXXDDBFHOBEHA-CWDCEQMOSA-N					doublet; compound annotation
0391_011758	Crizotinib	C21H22Cl2FN5O	2.0934	11626560	C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N	CC(Oc1c(N)ncc(-c2cn(C3CCNCC3)nc2)c1)c1c(Cl)ccc(F)c1Cl	InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1	KTEIFNKAUNYNJU-GFCCVEGCSA-N					doublet; removed another duplicate entry; compound annotation
0391_011760	Tolebrutinib	C26H25N5O3	2.9301	124111565	C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5	C=CC(=O)N1CCCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1	InChI=1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1	KOEUOFPEZFUWRF-LJQANCHMSA-N					doublet; compound annotation
0391_011761	Tolebrutinib	C26H25N5O3	2.9331	124111565	C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5	C=CC(=O)N1CCCC(n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1	InChI=1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1	KOEUOFPEZFUWRF-LJQANCHMSA-N					doublet; compound annotation
0391_011762	1550371-22-6	C27H32N6O2	2.9331	118158953	C[C@H]1CC[C@H](CN1C(=O)C2=CC3=C(C(=C2)OC)N(C(=N3)C4=CC5=C(N4CC6CC6)N=CC=C5)C)N	COc1cc(C(=O)N2CC(N)CCC2C)cc2c1n(C)c(-c1cc3c(nccc3)n1CC1CC1)n2	InChI=1S/C27H32N6O2/c1-16-6-9-20(28)15-32(16)27(34)19-11-21-24(23(13-19)35-3)31(2)26(30-21)22-12-18-5-4-10-29-25(18)33(22)14-17-7-8-17/h4-5,10-13,16-17,20H,6-9,14-15,28H2,1-3H3/t16-,20+/m0/s1	PXJXCBYHGJEEJH-OXJNMPFZSA-N					compound annotation
0391_011763	Gabapentin enacarbil	C16H27NO6	3.9405	9883933		CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C	InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)	TZDUHAJSIBHXDL-UHFFFAOYSA-N					compound annotation
0391_011764	brimonidine	C11H10BrN5	0.7354	2435		Brc1c(NC2=NCCN2)ccc2nccnc12	InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)	XYLJNLCSTIOKRM-UHFFFAOYSA-N					doublet; compound annotation
0391_011765	Lazabemide	C8H10ClN3O	0.9893	71307		NCCNC(=O)c1ncc(Cl)cc1	InChI=1S/C8H10ClN3O/c9-6-1-2-7(12-5-6)8(13)11-4-3-10/h1-2,5H,3-4,10H2,(H,11,13)	JZXRLKWWVNUZRB-UHFFFAOYSA-N					compound annotation
0391_011766	amisulpride	C17H27N3O4S	1.5458	2159		CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC	InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)	NTJOBXMMWNYJFB-UHFFFAOYSA-N					compound annotation
0391_011767	Groenlandicine	C19H16NO4+	1.9492	101650328		COc1c(O)cc2CC[n+]3c(cc4ccc5c(OCO5)c4c3)-c2c1	InChI=1S/C19H15NO4/c1-22-18-8-13-12(7-16(18)21)4-5-20-9-14-11(6-15(13)20)2-3-17-19(14)24-10-23-17/h2-3,6-9H,4-5,10H2,1H3/p+1	PGIOBGCIEGZHJH-UHFFFAOYSA-O					compound annotation
0391_011768	Metixene	C20H23NS	3.2951	4167		CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1	InChI=1S/C20H23NS/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20/h2-5,8-11,15,18H,6-7,12-14H2,1H3	MJFJKKXQDNNUJF-UHFFFAOYSA-N					compound annotation
0391_011769	c-Kit-IN-3	C26H20ClF3N2O4	3.8074	139030518		COc1cc2nccc(Oc3ccc(NC(=O)Cc4cc(C(F)(F)F)c(Cl)cc4)cc3)c2cc1OC	InChI=1S/C26H20ClF3N2O4/c1-34-23-13-18-21(14-24(23)35-2)31-10-9-22(18)36-17-6-4-16(5-7-17)32-25(33)12-15-3-8-20(27)19(11-15)26(28,29)30/h3-11,13-14H,12H2,1-2H3,(H,32,33)	YOHLRCOPRAVUCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_011770	Fingolimod	C19H33NO2	4.1257	107970		CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1	InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3	KKGQTZUTZRNORY-UHFFFAOYSA-N					doublet; compound annotation
0391_011771	NOOTKATONE	C15H22O	4.7435	1268142	C[C@@H]1CC(=O)C=C2[C@]1(C[C@@H](CC2)C(=C)C)C	C=C(C)C1CCC2=CC(=O)CC(C)C2(C)C1	InChI=1S/C15H22O/c1-10(2)12-5-6-13-8-14(16)7-11(3)15(13,4)9-12/h8,11-12H,1,5-7,9H2,2-4H3/t11-,12-,15+/m1/s1	WTOYNNBCKUYIKC-JMSVASOKSA-N					compound annotation
0391_011772	LCKLSL	C30H57N7O8S	2.1581	146681222	CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N	CC(C)CC(N)C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)O	InChI=1S/C30H57N7O8S/c1-16(2)11-19(32)25(39)37-24(15-46)29(43)33-20(9-7-8-10-31)26(40)34-21(12-17(3)4)27(41)36-23(14-38)28(42)35-22(30(44)45)13-18(5)6/h16-24,38,46H,7-15,31-32H2,1-6H3,(H,33,43)(H,34,40)(H,35,42)(H,36,41)(H,37,39)(H,44,45)/t19-,20-,21-,22-,23-,24-/m0/s1	HTBYABHLBWELKC-BTNSXGMBSA-N					compound annotation
0391_011773	sulfisoxazole	C11H13N3O3S	2.1934	5344		Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C	InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3	NHUHCSRWZMLRLA-UHFFFAOYSA-N					compound annotation
0391_011774	doxazosin	C23H25N5O5	2.6615	3157		COc1c(OC)cc2c(N)nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc2c1	InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)	RUZYUOTYCVRMRZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011777	BRD9500	C15H18FN3O2	2.7044	71576771	C[C@@H]1CC(=O)NN=C1C2=CC(=C(C=C2)N3CCOCC3)F	CC1CC(=O)NN=C1c1cc(F)c(N2CCOCC2)cc1	InChI=1S/C15H18FN3O2/c1-10-8-14(20)17-18-15(10)11-2-3-13(12(16)9-11)19-4-6-21-7-5-19/h2-3,9-10H,4-8H2,1H3,(H,17,20)/t10-/m1/s1	GJGGSLDXABLZLP-SNVBAGLBSA-N					removed another duplicate entry; compound annotation
0391_011779	veratridine	C36H51NO11	2.8413	6280	C[C@H]1CC[C@H]2[C@@]([C@]3([C@H](C[C@]4([C@@H]5CC[C@H]6[C@]7([C@]5(C[C@]4([C@@H]3CN2C1)O)O[C@@]6([C@H](CC7)OC(=O)C8=CC(=C(C=C8)OC)OC)O)C)O)O)O)(C)O	COc1c(OC)cc(C(=O)OC2CCC3(C)C4CCC5C6(O)CC(O)C7(O)C(CN8CC(C)CCC8C7(C)O)C6(O)CC53OC24O)cc1	InChI=1S/C36H51NO11/c1-19-6-11-26-31(3,40)35(43)25(17-37(26)16-19)33(42)18-34-24(32(33,41)15-27(35)38)10-9-23-30(34,2)13-12-28(36(23,44)48-34)47-29(39)20-7-8-21(45-4)22(14-20)46-5/h7-8,14,19,23-28,38,40-44H,6,9-13,15-18H2,1-5H3/t19-,23-,24-,25-,26-,27-,28-,30-,31+,32+,33+,34+,35-,36-/m0/s1	FVECELJHCSPHKY-YFUMOZOISA-N					compound annotation
0391_011780	Larotrectinib	C21H22F2N6O2	2.8728	46188928	C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F	O=C(Nc1c2nc(N3CCCC3c3c(F)ccc(F)c3)ccn2nc1)N1CCC(O)C1	InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	NYNZQNWKBKUAII-KBXCAEBGSA-N					doublet; compound annotation
0391_011781	Larotrectinib	C21H22F2N6O2	2.8758	46188928	C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F	O=C(Nc1c2nc(N3CCCC3c3c(F)ccc(F)c3)ccn2nc1)N1CCC(O)C1	InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1	NYNZQNWKBKUAII-KBXCAEBGSA-N					doublet; compound annotation
0391_011782	MF-438	C19H18F3N5OS	4.5526	16042458		Cc1nnc(-c2nnc(N3CCC(Oc4ccccc4C(F)(F)F)CC3)cc2)s1	InChI=1S/C19H18F3N5OS/c1-12-23-26-18(29-12)15-6-7-17(25-24-15)27-10-8-13(9-11-27)28-16-5-3-2-4-14(16)19(20,21)22/h2-7,13H,8-11H2,1H3	NVUJDKDVOZVALT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011784	9-AMINOACRIDINE	C13H10N2	1.5364	7019		Nc1c2ccccc2nc2ccccc12	InChI=1S/C13H10N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H,(H2,14,15)	XJGFWWJLMVZSIG-UHFFFAOYSA-N					compound annotation
0391_011785	Bestatin	C16H24N2O4	2.0704	6992132	CC(C)C[C@@H](C(=O)[O-])NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)[NH3+])O	CC(C)CC(NC(=O)C(O)C(N)Cc1ccccc1)C(=O)O	InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1	VGGGPCQERPFHOB-RDBSUJKOSA-N					doublet; compound annotation
0391_011786	JCN037	C16H11BrFN3O2	2.5526	138513760		Fc1c(Nc2ncnc3cc4c(cc23)OCCO4)cccc1Br	InChI=1S/C16H11BrFN3O2/c17-10-2-1-3-11(15(10)18)21-16-9-6-13-14(23-5-4-22-13)7-12(9)19-8-20-16/h1-3,6-8H,4-5H2,(H,19,20,21)	MTLUFWWVOINWEL-UHFFFAOYSA-N					compound annotation
0391_011787	88349-90-0	C13H12ClNO3	3.1949	21933492		CCOC(=O)COc1c2ncccc2c(Cl)cc1	InChI=1S/C13H12ClNO3/c1-2-17-12(16)8-18-11-6-5-10(14)9-4-3-7-15-13(9)11/h3-7H,2,8H2,1H3	JEMXUSHXYOXNFL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011789	ioxilan	C18H24I3N3O8	0.5505	3743		CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I	InChI=1S/C18H24I3N3O8/c1-8(28)24(5-10(30)7-27)16-14(20)11(17(31)22-2-3-25)13(19)12(15(16)21)18(32)23-4-9(29)6-26/h9-10,25-27,29-30H,2-7H2,1H3,(H,22,31)(H,23,32)	UUMLTINZBQPNGF-UHFFFAOYSA-N					compound annotation
0391_011790	HYDROXYFASUDIL	C14H17N3O3S	1.1536	3064778		O=c1[nH]ccc2c1cccc2S(=O)(=O)N1CCCNCC1	InChI=1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18)	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N					doublet; compound annotation
0391_011791	Myriocin	C21H39NO6	3.7466	6438394	CCCCCCC(=O)CCCCCC/C=C/C[C@H]([C@@H]([C@@](CO)(C(=O)O)N)O)O	CCCCCCC(=O)CCCCCCC=CCC(O)C(O)C(N)(CO)C(=O)O	InChI=1S/C21H39NO6/c1-2-3-4-10-13-17(24)14-11-8-6-5-7-9-12-15-18(25)19(26)21(22,16-23)20(27)28/h9,12,18-19,23,25-26H,2-8,10-11,13-16,22H2,1H3,(H,27,28)/b12-9+/t18-,19+,21+/m1/s1	ZZIKIHCNFWXKDY-GNTQXERDSA-N					compound annotation
0391_011792	N-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide	C16H17NO2	3.8325	882909		Cc1cc(NC(=O)CCc2ccccc2)c(O)cc1	InChI=1S/C16H17NO2/c1-12-7-9-15(18)14(11-12)17-16(19)10-8-13-5-3-2-4-6-13/h2-7,9,11,18H,8,10H2,1H3,(H,17,19)	AWHLTHOHBAGPMY-UHFFFAOYSA-N					doublet; compound annotation
0391_011793	N-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide	C16H17NO2	3.8811	882909		Cc1cc(NC(=O)CCc2ccccc2)c(O)cc1	InChI=1S/C16H17NO2/c1-12-7-9-15(18)14(11-12)17-16(19)10-8-13-5-3-2-4-6-13/h2-7,9,11,18H,8,10H2,1H3,(H,17,19)	AWHLTHOHBAGPMY-UHFFFAOYSA-N					doublet; compound annotation
0391_011794	Efaproxiral	C20H23NO4	3.8811	122335		Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1	InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)	BNFRJXLZYUTIII-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011796	Pinaverium	C26H41BrNO4+	4.4262	40704		COc1c(OC)cc(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)c(Br)c1	InChI=1S/C26H41BrNO4/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27/h15,17,19,21-22H,5-14,16,18H2,1-4H3/q+1	DDHUTBKXLWCZCO-UHFFFAOYSA-N					compound annotation
0391_011797	TFAP	C13H10F3N3O	2.5395	24752865		Nc1cnc(NC(=O)c2ccc(C(F)(F)F)cc2)cc1	InChI=1S/C13H10F3N3O/c14-13(15,16)9-3-1-8(2-4-9)12(20)19-11-6-5-10(17)7-18-11/h1-7H,17H2,(H,18,19,20)	BTCFFMPDIBWZLF-UHFFFAOYSA-N					compound annotation
0391_011798	Voriconazole	C16H14F3N5O	3.2797	71616	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	CC(c1ncncc1F)C(O)(Cn1cncn1)c1c(F)cc(F)cc1	InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1	BCEHBSKCWLPMDN-MGPLVRAMSA-N					compound annotation
0391_011799	nafcillin	C21H22N2O5S	3.6343	8982	CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	CCOc1c(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c2ccccc2cc1	InChI=1S/C21H22N2O5S/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27)/t15-,16+,19-/m1/s1	GPXLMGHLHQJAGZ-JTDSTZFVSA-N					compound annotation
0391_011800	Desmorpholinyl Navitoclax-NH-Me	C44H51ClF3N5O5S3	4.0057	139331525	CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCNC)CSC5=CC=CC=C5)S(=O)(=O)C(F)(F)F)C6=CC=C(C=C6)Cl)C	CNCCC(CSc1ccccc1)Nc1c(S(=O)(=O)C(F)(F)F)cc(S(=O)(=O)NC(=O)c2ccc(N3CCN(CC4=C(c5ccc(Cl)cc5)CCC(C)(C)C4)CC3)cc2)cc1	InChI=1S/C44H51ClF3N5O5S3/c1-43(2)21-19-39(31-9-13-34(45)14-10-31)33(28-43)29-52-23-25-53(26-24-52)36-15-11-32(12-16-36)42(54)51-61(57,58)38-17-18-40(41(27-38)60(55,56)44(46,47)48)50-35(20-22-49-3)30-59-37-7-5-4-6-8-37/h4-18,27,35,49-50H,19-26,28-30H2,1-3H3,(H,51,54)/t35-/m1/s1	CNTHZPROCQHGOX-PGUFJCEWSA-N					compound annotation
0391_011801	Lin28-let-7a antagonist 1	C31H29N5O7	4.9687	134694995		CC1(C)Oc2cc(N3CCN(C(=O)OCc4ccccc4)CC3)c([N+](=O)[O-])cc2-c2c1cnn2-c1ccc(C(=O)O)cc1	InChI=1S/C31H29N5O7/c1-31(2)24-18-32-35(22-10-8-21(9-11-22)29(37)38)28(24)23-16-26(36(40)41)25(17-27(23)43-31)33-12-14-34(15-13-33)30(39)42-19-20-6-4-3-5-7-20/h3-11,16-18H,12-15,19H2,1-2H3,(H,37,38)	GBHKWXUSQTVIBN-UHFFFAOYSA-N					compound annotation
0391_011802	36948-76-2	C22H20O11	2.6737	14655552	COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O	COc1c(OC2OC(C(=O)O)C(O)C(O)C2O)cc2oc(-c3ccccc3)cc(=O)c2c1O	InChI=1S/C22H20O11/c1-30-19-13(32-22-18(27)16(25)17(26)20(33-22)21(28)29)8-12-14(15(19)24)10(23)7-11(31-12)9-5-3-2-4-6-9/h2-8,16-18,20,22,24-27H,1H3,(H,28,29)/t16-,17-,18+,20-,22+/m0/s1	QXIPXNZUEQYPLZ-QSUZLTIMSA-N					compound annotation
0391_011803	Delavirdine	C22H28N6O3S	2.6849	5625		CC(C)Nc1c(N2CCN(C(=O)c3cc4c(ccc(NS(C)(=O)=O)c4)[nH]3)CC2)nccc1	InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3	WHBIGIKBNXZKFE-UHFFFAOYSA-N					compound annotation
0391_011804	Byakangelicin	C17H18O7	2.6887	10211	CC(C)([C@@H](COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O	COc1c2ccoc2c(OCC(O)C(C)(C)O)c2c1ccc(=O)o2	InChI=1S/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3/t11-/m1/s1	PKRPFNXROFUNDE-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_011806	cortisone	C21H28O5	2.723	222786	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C	CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO	InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1	MFYSYFVPBJMHGN-ZPOLXVRWSA-N					compound annotation
0391_011807	DBCO-PEG4-Biotin	C39H51N5O8S	3.351	91757917	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCOCCOCCOCCOCCC(=O)NCCC(=O)N3CC4=CC=CC=C4C#CC5=CC=CC=C53)NC(=O)N2	O=C(CCCCC1SCC2NC(=O)NC21)NCCOCCOCCOCCOCCC(=O)NCCC(=O)N1Cc2ccccc2C#Cc2ccccc21	InChI=1S/C39H51N5O8S/c45-35(12-6-5-11-34-38-32(28-53-34)42-39(48)43-38)41-18-20-50-22-24-52-26-25-51-23-21-49-19-16-36(46)40-17-15-37(47)44-27-31-9-2-1-7-29(31)13-14-30-8-3-4-10-33(30)44/h1-4,7-10,32,34,38H,5-6,11-12,15-28H2,(H,40,46)(H,41,45)(H2,42,43,48)/t32-,34-,38-/m0/s1	LNHSQAOQVNHUGL-QRBHCBQLSA-N					removed another duplicate entry; compound annotation
0391_011809	virginiamycin m1	C28H35N3O7	3.4314	5459319	C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)/C	CC1=CC(O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)OC(C(C)C)C(C)C=CC(=O)NCC=C1	InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1	DAIKHDNSXMZDCU-FQTGFAPKSA-N					removed another duplicate entry; compound annotation
0391_011811	Tavapadon	C19H16F3N3O3	3.8364	86764100		Cc1c(-c2c(C)c(=O)[nH]c(=O)n2C)ccc(Oc2c(C(F)(F)F)cccn2)c1	InChI=1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17)6-7-13(10)15-11(2)16(26)24-18(27)25(15)3/h4-9H,1-3H3,(H,24,26,27)	AKQXQLUNFKDZBN-UHFFFAOYSA-N					compound annotation
0391_011812	5-O-Demethylnobiletin	C20H20O8	4.1814	358832		COc1c(OC)cc(-c2cc(=O)c3c(O)c(OC)c(OC)c(OC)c3o2)cc1	InChI=1S/C20H20O8/c1-23-12-7-6-10(8-14(12)24-2)13-9-11(21)15-16(22)18(25-3)20(27-5)19(26-4)17(15)28-13/h6-9,22H,1-5H3	DOFJNFPSMUCECH-UHFFFAOYSA-N					compound annotation
0391_011813	WEHI-9625	C34H27NO5S2	5.0086	138805616		COc1ccc(C(=O)c2ccccc2-c2cc3c(cc2)-c2c(cc(C(=O)NCc4ccc(C)cc4)s2)CS3(=O)=O)cc1	InChI=1S/C34H27NO5S2/c1-21-7-9-22(10-8-21)19-35-34(37)30-17-25-20-42(38,39)31-18-24(13-16-29(31)33(25)41-30)27-5-3-4-6-28(27)32(36)23-11-14-26(40-2)15-12-23/h3-18H,19-20H2,1-2H3,(H,35,37)	DQVRUUKJUZNKSW-UHFFFAOYSA-N					doublet; compound annotation
0391_011814	WEHI-9625	C34H27NO5S2	5.0124	138805616		COc1ccc(C(=O)c2ccccc2-c2cc3c(cc2)-c2c(cc(C(=O)NCc4ccc(C)cc4)s2)CS3(=O)=O)cc1	InChI=1S/C34H27NO5S2/c1-21-7-9-22(10-8-21)19-35-34(37)30-17-25-20-42(38,39)31-18-24(13-16-29(31)33(25)41-30)27-5-3-4-6-28(27)32(36)23-11-14-26(40-2)15-12-23/h3-18H,19-20H2,1-2H3,(H,35,37)	DQVRUUKJUZNKSW-UHFFFAOYSA-N					doublet; compound annotation
0391_011815	Tamibarotene	C22H25NO3	5.0223	108143		CC1(C)CCC(C)(C)c2c1ccc(NC(=O)c1ccc(C(=O)O)cc1)c2	InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)	MUTNCGKQJGXKEM-UHFFFAOYSA-N					compound annotation
0391_011816	moclobemide	C13H17ClN2O2	1.5923	4235		O=C(NCCN1CCOCC1)c1ccc(Cl)cc1	InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)	YHXISWVBGDMDLQ-UHFFFAOYSA-N					compound annotation
0391_011817	carbinoxamine	C16H19ClN2O	2.1274	2564		CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1	InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3	OJFSXZCBGQGRNV-UHFFFAOYSA-N					compound annotation
0391_011818	CHEMBL2402018	C23H45N3O5	2.7797	71713800	CC(C)(C)NC(=O)N(CCCCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)C2CCCCC2	CC(C)(C)NC(=O)N(CCCCCCN1CC(O)C(O)C(O)C1CO)C1CCCCC1	InChI=1S/C23H45N3O5/c1-23(2,3)24-22(31)26(17-11-7-6-8-12-17)14-10-5-4-9-13-25-15-19(28)21(30)20(29)18(25)16-27/h17-21,27-30H,4-16H2,1-3H3,(H,24,31)/t18-,19+,20-,21-/m1/s1	GFBNIASMQRMEDU-PLACYPQZSA-N					doublet; removed another duplicate entry; compound annotation
0391_011820	ethoxzolamide	C9H10N2O3S2	2.93	3295		CCOc1cc2c(cc1)nc(S(N)(=O)=O)s2	InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)	OUZWUKMCLIBBOG-UHFFFAOYSA-N					compound annotation
0391_011821	VBY-825	C23H29F4N3O5S	3.8289	70945511	CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](C3=CC=C(C=C3)F)C(F)(F)F	CCC(NC(=O)C(CS(=O)(=O)CC1CC1)NC(c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1	InChI=1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1	PPUXXDKQNAHHON-BJLQDIEVSA-N					doublet; compound annotation
0391_011822	VBY-825	C23H29F4N3O5S	4.1915	70945511	CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](C3=CC=C(C=C3)F)C(F)(F)F	CCC(NC(=O)C(CS(=O)(=O)CC1CC1)NC(c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1	InChI=1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1	PPUXXDKQNAHHON-BJLQDIEVSA-N					doublet; compound annotation
0391_011823	O4I2	C12H11ClN2O2S	4.2622	53428670		CCOC(=O)c1csc(Nc2ccc(Cl)cc2)n1	InChI=1S/C12H11ClN2O2S/c1-2-17-11(16)10-7-18-12(15-10)14-9-5-3-8(13)4-6-9/h3-7H,2H2,1H3,(H,14,15)	ULUBAPWNHROTEU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011825	CD 3254	C24H28O3	4.2835	44566110	CC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C	Cc1cc2c(cc1-c1c(O)ccc(C=CC(=O)O)c1)C(C)(C)CCC2(C)C	InChI=1S/C24H28O3/c1-15-12-19-20(24(4,5)11-10-23(19,2)3)14-17(15)18-13-16(6-8-21(18)25)7-9-22(26)27/h6-9,12-14,25H,10-11H2,1-5H3,(H,26,27)/b9-7+	DYLLZSVPAUUSSB-VQHVLOKHSA-N					doublet; compound annotation
0391_011826	VBY-825	C23H29F4N3O5S	4.291	70945511	CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](C3=CC=C(C=C3)F)C(F)(F)F	CCC(NC(=O)C(CS(=O)(=O)CC1CC1)NC(c1ccc(F)cc1)C(F)(F)F)C(=O)C(=O)NC1CC1	InChI=1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1	PPUXXDKQNAHHON-BJLQDIEVSA-N					doublet; removed another duplicate entry; compound annotation
0391_011828	Mycro3	C24H17ClF2N6O4	4.779	1045147		CCOC(=O)c1c(NC(=O)c2nn3c(C(F)(F)Cl)cc(-c4ccco4)nc3c2)n(-c2ccccc2)nc1	InChI=1S/C24H17ClF2N6O4/c1-2-36-23(35)15-13-28-32(14-7-4-3-5-8-14)21(15)30-22(34)17-12-20-29-16(18-9-6-10-37-18)11-19(24(25,26)27)33(20)31-17/h3-13H,2H2,1H3,(H,30,34)	YPPNLSKYXDXQGD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011830	CD 3254	C24H28O3	5.0496	44566110	CC1=CC2=C(C=C1C3=C(C=CC(=C3)/C=C/C(=O)O)O)C(CCC2(C)C)(C)C	Cc1cc2c(cc1-c1c(O)ccc(C=CC(=O)O)c1)C(C)(C)CCC2(C)C	InChI=1S/C24H28O3/c1-15-12-19-20(24(4,5)11-10-23(19,2)3)14-17(15)18-13-16(6-8-21(18)25)7-9-22(26)27/h6-9,12-14,25H,10-11H2,1-5H3,(H,26,27)/b9-7+	DYLLZSVPAUUSSB-VQHVLOKHSA-N					doublet; compound annotation
0391_011831	CHEMBL2402018	C23H45N3O5	6.1536	71713800	CC(C)(C)NC(=O)N(CCCCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)C2CCCCC2	CC(C)(C)NC(=O)N(CCCCCCN1CC(O)C(O)C(O)C1CO)C1CCCCC1	InChI=1S/C23H45N3O5/c1-23(2,3)24-22(31)26(17-11-7-6-8-12-17)14-10-5-4-9-13-25-15-19(28)21(30)20(29)18(25)16-27/h17-21,27-30H,4-16H2,1-3H3,(H,24,31)/t18-,19+,20-,21-/m1/s1	GFBNIASMQRMEDU-PLACYPQZSA-N					doublet; compound annotation
0391_011832	betamethasone	C22H29FO5	2.1261	9782	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	UREBDLICKHMUKA-DVTGEIKXSA-N					doublet; compound annotation
0391_011833	Flesinoxan	C22H26FN3O4	2.1261	57347	C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=C4C(=CC=C3)O[C@H](CO4)CO	O=C(NCCN1CCN(c2c3OCC(CO)Oc3ccc2)CC1)c1ccc(F)cc1	InChI=1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)/t18-/m0/s1	NYSDRDDQELAVKP-SFHVURJKSA-N					removed another duplicate entry; compound annotation
0391_011836	Methylbenactyzium	C21H28NO3+	2.4461	4134		CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1	InChI=1S/C21H28NO3/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,24H,4-5,16-17H2,1-3H3/q+1	HDAMOICMOAXFLJ-UHFFFAOYSA-N					compound annotation
0391_011837	Mogroside IV-A	C54H92O24	2.4549	101207514	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C)O)C)C	CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(COC6OC(CO)C(O)C(O)C6O)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C54H92O24/c1-22(9-13-33(51(4,5)70)78-49-45(69)41(65)37(61)29(76-49)21-72-47-43(67)39(63)35(59)27(19-56)74-47)23-15-16-52(6)30-12-10-24-25(54(30,8)31(57)17-53(23,52)7)11-14-32(50(24,2)3)77-48-44(68)40(64)36(60)28(75-48)20-71-46-42(66)38(62)34(58)26(18-55)73-46/h10,22-23,25-49,55-70H,9,11-21H2,1-8H3/t22-,23-,25-,26-,27-,28-,29-,30+,31-,32+,33-,34-,35-,36-,37-,38+,39+,40+,41+,42-,43-,44-,45-,46-,47-,48+,49+,52+,53-,54+/m1/s1	OKGRRPCHOJYNKX-APMSXLJSSA-N					doublet; compound annotation
0391_011838	Mogroside IV-A	C54H92O24	2.4578	101207514	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C)O)C)C	CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(COC6OC(CO)C(O)C(O)C6O)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C54H92O24/c1-22(9-13-33(51(4,5)70)78-49-45(69)41(65)37(61)29(76-49)21-72-47-43(67)39(63)35(59)27(19-56)74-47)23-15-16-52(6)30-12-10-24-25(54(30,8)31(57)17-53(23,52)7)11-14-32(50(24,2)3)77-48-44(68)40(64)36(60)28(75-48)20-71-46-42(66)38(62)34(58)26(18-55)73-46/h10,22-23,25-49,55-70H,9,11-21H2,1-8H3/t22-,23-,25-,26-,27-,28-,29-,30+,31-,32+,33-,34-,35-,36-,37-,38+,39+,40+,41+,42-,43-,44-,45-,46-,47-,48+,49+,52+,53-,54+/m1/s1	OKGRRPCHOJYNKX-APMSXLJSSA-N					doublet; compound annotation
0391_011839	Sultamicillin (tosylate)	C25H30N4O9S2	2.615	56841011	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)OCOC(=O)[C@H]4C(S(=O)(=O)C5N4C(=O)C5)(C)C)C	CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)OCOC(=O)C1N2C(=O)CC2S(=O)(=O)C1(C)C	InChI=1S/C25H30N4O9S2/c1-24(2)17(29-20(32)16(21(29)39-24)27-19(31)15(26)12-8-6-5-7-9-12)22(33)37-11-38-23(34)18-25(3,4)40(35,36)14-10-13(30)28(14)18/h5-9,14-18,21H,10-11,26H2,1-4H3,(H,27,31)/t14?,15-,16-,17+,18+,21-/m1/s1	OPYGFNJSCUDTBT-WWLRNLOPSA-N					compound annotation
0391_011840	betamethasone	C22H29FO5	3.0323	9782	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1	UREBDLICKHMUKA-DVTGEIKXSA-N					doublet; compound annotation
0391_011841	Pimavanserin	C25H34FN3O2	3.5749	10071196		CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)	RKEWSXXUOLRFBX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011843	clemastine	C21H26ClNO	3.6858	26987	C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C	CN1CCCC1CCOC(C)(c1ccccc1)c1ccc(Cl)cc1	InChI=1S/C21H26ClNO/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3/t20-,21-/m1/s1	YNNUSGIPVFPVBX-NHCUHLMSSA-N					compound annotation
0391_011844	MK-3903	C27H19ClN2O3	5.095	45256689		Cc1c(C(=O)O)cc(Oc2nc3c(cc(Cl)c(-c4ccc(-c5ccccc5)cc4)c3)[nH]2)cc1	InChI=1S/C27H19ClN2O3/c1-16-7-12-20(13-21(16)26(31)32)33-27-29-24-14-22(23(28)15-25(24)30-27)19-10-8-18(9-11-19)17-5-3-2-4-6-17/h2-15H,1H3,(H,29,30)(H,31,32)	FIKQZQDYGXAUHC-UHFFFAOYSA-N					compound annotation
0391_011845	methylergonovine	C20H25N3O2	1.5577	8226	CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C	CCC(CO)NC(=O)C1C=C2c3c4c(c[nH]c4ccc3)CC2N(C)C1	InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1	UNBRKDKAWYKMIV-QWQRMKEZSA-N					compound annotation
0391_011846	(+/-)-Corypalmine	C20H23NO4	2.012	185605		COc1c(O)cc2CCN3Cc4c(ccc(OC)c4OC)CC3c2c1	InChI=1S/C20H23NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,9-10,16,22H,6-8,11H2,1-3H3	BMCZTYDZHNTKPR-UHFFFAOYSA-N					compound annotation
0391_011847	1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidino prop-1-ene	C19H22N2	2.2666	5588		Cc1ccc(C(=CCN2CCCC2)c2ccccn2)cc1	InChI=1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3	CBEQULMOCCWAQT-UHFFFAOYSA-N					compound annotation
0391_011848	Desacetylcinobufotalin	C24H32O6	2.7038	15513544	C[C@]12CC[C@@H](C[C@]1(CC[C@@H]3[C@@H]2CC[C@]4([C@]35[C@H](O5)[C@@H]([C@@H]4C6=COC(=O)C=C6)O)C)O)O	CC12CCC(O)CC1(O)CCC1C2CCC2(C)C(c3coc(=O)cc3)C(O)C3OC132	InChI=1S/C24H32O6/c1-21-8-5-14(25)11-23(21,28)10-7-16-15(21)6-9-22(2)18(13-3-4-17(26)29-12-13)19(27)20-24(16,22)30-20/h3-4,12,14-16,18-20,25,27-28H,5-11H2,1-2H3/t14-,15-,16+,18-,19+,20+,21+,22+,23-,24+/m0/s1	FRYICJTUIXEEGK-NNWVIVGYSA-N					compound annotation
0391_011849	141360-89-6	C28H44O6	2.9899	15168041	CC(C)C(=C)C[C@H]([C@@](C)([C@H]1CC[C@@]2([C@@]1(CC[C@H]3C2=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)C)O)O)O	C=C(CC(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C)C(C)C	InChI=1S/C28H44O6/c1-15(2)16(3)11-24(32)27(6,33)23-8-10-28(34)18-12-20(29)19-13-21(30)22(31)14-25(19,4)17(18)7-9-26(23,28)5/h12,15,17,19,21-24,30-34H,3,7-11,13-14H2,1-2,4-6H3/t17-,19-,21+,22-,23-,24+,25+,26+,27+,28+/m0/s1	OQDKHYZVFZGSRC-DWJOQFFMSA-N					compound annotation
0391_011850	348622-88-8	C15H24N4O4	3.44	9818682	C1CCC(CC1)CCC[C@H](CC(=O)NO)C2=NC(=NO2)C(=O)N	NC(=O)c1noc(C(CCCC2CCCCC2)CC(=O)NO)n1	InChI=1S/C15H24N4O4/c16-13(21)14-17-15(23-19-14)11(9-12(20)18-22)8-4-7-10-5-2-1-3-6-10/h10-11,22H,1-9H2,(H2,16,21)(H,18,20)/t11-/m1/s1	ARJCBSRIPGJMAD-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_011852	Teglarinad	C30H43ClN5O8+	3.6884	9961435		COCCOCCOCCOCCOC(=O)OC[n+]1ccc(NC(=NCCCCCCOc2ccc(Cl)cc2)NC#N)cc1	InChI=1S/C30H42ClN5O8/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34)/p+1	RXXJCNMVVRGOJB-UHFFFAOYSA-O					compound annotation
0391_011853	rosiglitazone	C18H19N3O3S	1.9974	77999		CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)	YASAKCUCGLMORW-UHFFFAOYSA-N					doublet; compound annotation
0391_011854	LYS-006	C16H14ClFN6O3	2.8809	118166560	C1=CC(=CC=C1C2=NN(N=N2)C[C@H](CC(=O)O)N)OC3=C(C=C(C=N3)Cl)F	NC(CC(=O)O)Cn1nnc(-c2ccc(Oc3c(F)cc(Cl)cn3)cc2)n1	InChI=1S/C16H14ClFN6O3/c17-10-5-13(18)16(20-7-10)27-12-3-1-9(2-4-12)15-21-23-24(22-15)8-11(19)6-14(25)26/h1-5,7,11H,6,8,19H2,(H,25,26)/t11-/m0/s1	ZEGMEJVULDALSH-NSHDSACASA-N					compound annotation
0391_011855	N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE	C16H21ClN2O2S	2.9754	5681		NCCCCCCNS(=O)(=O)c1cccc2c1cccc2Cl	InChI=1S/C16H21ClN2O2S/c17-15-9-5-8-14-13(15)7-6-10-16(14)22(20,21)19-12-4-2-1-3-11-18/h5-10,19H,1-4,11-12,18H2	IDEHCMNLNCJQST-UHFFFAOYSA-N					compound annotation
0391_011856	189349-50-6	C27H34N6O5	3.1183	6603904	CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)OCC2=CC=CC=C2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC	COc1c(OC)cc2c(N)nc(N3CCN(C(=O)OCc4ccccc4)C(C(=O)NC(C)(C)C)C3)nc2c1	InChI=1S/C27H34N6O5/c1-27(2,3)31-24(34)20-15-32(11-12-33(20)26(35)38-16-17-9-7-6-8-10-17)25-29-19-14-22(37-5)21(36-4)13-18(19)23(28)30-25/h6-10,13-14,20H,11-12,15-16H2,1-5H3,(H,31,34)(H2,28,29,30)/t20-/m0/s1	CGWOIDCAGBKOQL-FQEVSTJZSA-N					removed another duplicate entry; compound annotation
0391_011858	Leucomalachite green	C23H26N2	3.2466	67215		CN(C)c1ccc(C(c2ccccc2)c2ccc(N(C)C)cc2)cc1	InChI=1S/C23H26N2/c1-24(2)21-14-10-19(11-15-21)23(18-8-6-5-7-9-18)20-12-16-22(17-13-20)25(3)4/h5-17,23H,1-4H3	WZKXBGJNNCGHIC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011860	Syk Inhibitor II	C14H15F3N6O	1.9773	9549296		NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1	InChI=1S/C14H15F3N6O/c15-14(16,17)8-2-1-3-9(6-8)22-12-10(11(19)24)7-21-13(23-12)20-5-4-18/h1-3,6-7H,4-5,18H2,(H2,19,24)(H2,20,21,22,23)	FQNFLNSVHWCZML-UHFFFAOYSA-N					compound annotation
0391_011861	dihydrodaidzein	C15H12O4	2.4615	176907		O=C1c2c(cc(O)cc2)OCC1c1ccc(O)cc1	InChI=1S/C15H12O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-7,13,16-17H,8H2	JHYXBPPMXZIHKG-UHFFFAOYSA-N					compound annotation
0391_011862	Indacaterol	C24H28N2O3	2.8689	6918554	CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC	CCc1c(CC)cc2CC(NCC(O)c3c4ccc(=O)[nH]c4c(O)cc3)Cc2c1	InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1	QZZUEBNBZAPZLX-QFIPXVFZSA-N					doublet; compound annotation
0391_011863	riluzole	C8H5F3N2OS	3.0099	5070		Nc1nc2c(cc(OC(F)(F)F)cc2)s1	InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)	FTALBRSUTCGOEG-UHFFFAOYSA-N					doublet; compound annotation
0391_011864	Nebentan	C24H21N5O5S	3.8434	9957262	COC1=CC=CC=C1OC2=C(N=C(N=C2OC)C3=NC=CC=N3)NS(=O)(=O)/C=C/C4=CC=CC=C4	COc1ccccc1Oc1c(OC)nc(-c2ncccn2)nc1NS(=O)(=O)C=Cc1ccccc1	InChI=1S/C24H21N5O5S/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22/h3-16H,1-2H3,(H,27,28,29)/b16-13+	LONWRQOYFPYMQD-DTQAZKPQSA-N					doublet; compound annotation
0391_011865	Nebentan	C24H21N5O5S	4.0011	9957262	COC1=CC=CC=C1OC2=C(N=C(N=C2OC)C3=NC=CC=N3)NS(=O)(=O)/C=C/C4=CC=CC=C4	COc1ccccc1Oc1c(OC)nc(-c2ncccn2)nc1NS(=O)(=O)C=Cc1ccccc1	InChI=1S/C24H21N5O5S/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22/h3-16H,1-2H3,(H,27,28,29)/b16-13+	LONWRQOYFPYMQD-DTQAZKPQSA-N					doublet; removed another duplicate entry; compound annotation
0391_011867	GLYCEROL PHENYLBUTYRATE	C33H38O6	6.4489	10482134		O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1	InChI=1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2	ZSDBFLMJVAGKOU-UHFFFAOYSA-N					compound annotation
0391_011868	N-benzylpalmitamide	C23H39NO	6.9884	11198769		CCCCCCCCCCCCCCCC(=O)NCc1ccccc1	InChI=1S/C23H39NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-23(25)24-21-22-18-15-14-16-19-22/h14-16,18-19H,2-13,17,20-21H2,1H3,(H,24,25)	MLGPKWUKOQAAGI-UHFFFAOYSA-N					compound annotation
0391_011869	602306-29-6	C18H21N5O2S	1.8921	16747683		Cc1ncc(-c2nc(Nc3ccc(S(C)(=O)=O)cc3)ncc2)n1C(C)C	InChI=1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22)	WJRRGYBTGDJBFX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011871	Taletrectinib	C23H24FN5O	1.9532	72202474	C[C@H](COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)N[C@H](C)C4=CC(=CC=C4)F)N	CC(N)COc1ccc(-c2cnc3ccc(NC(C)c4cc(F)ccc4)nn23)cc1	InChI=1S/C23H24FN5O/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18/h3-13,15-16H,14,25H2,1-2H3,(H,27,28)/t15-,16-/m1/s1	HEVHTYMYEMEBPX-HZPDHXFCSA-N					compound annotation
0391_011872	1359164-11-6	C26H24F7N3O	2.663	51035449		OC(c1cc(F)c(-c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)cc1)(C(F)(F)F)C(F)(F)F	InChI=1S/C26H24F7N3O/c27-23-15-21(24(37,25(28,29)30)26(31,32)33)5-6-22(23)20-3-1-18(2-4-20)16-35-11-13-36(14-12-35)17-19-7-9-34-10-8-19/h1-10,15,37H,11-14,16-17H2	KVHKWAZUPPBMLL-UHFFFAOYSA-N					compound annotation
0391_011873	GT 949	C30H37N7O2	2.9787	3195790		COc1cc2c(cc1)[nH]c(=O)c(C(c1nnnn1CCc1ccccc1)N1CCN(C3CCCCC3)CC1)c2	InChI=1S/C30H37N7O2/c1-39-25-12-13-27-23(20-25)21-26(30(38)31-27)28(36-18-16-35(17-19-36)24-10-6-3-7-11-24)29-32-33-34-37(29)15-14-22-8-4-2-5-9-22/h2,4-5,8-9,12-13,20-21,24,28H,3,6-7,10-11,14-19H2,1H3,(H,31,38)	ZVWPOIUAPXDLMB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011875	MLS000544460	C17H12FN3O2S	3.4132	7285259	C1=CC=NC(=C1)SC2=CC=C(O2)/C=N/NC(=O)C3=CC(=CC=C3)F	O=C(NN=Cc1ccc(Sc2ccccn2)o1)c1cc(F)ccc1	InChI=1S/C17H12FN3O2S/c18-13-5-3-4-12(10-13)17(22)21-20-11-14-7-8-16(23-14)24-15-6-1-2-9-19-15/h1-11H,(H,21,22)/b20-11+	VDKNIVFIPSLUFD-RGVLZGJSSA-N					doublet; removed another duplicate entry; compound annotation
0391_011877	MLS000544460	C17H12FN3O2S	3.5339	7285259	C1=CC=NC(=C1)SC2=CC=C(O2)/C=N/NC(=O)C3=CC(=CC=C3)F	O=C(NN=Cc1ccc(Sc2ccccn2)o1)c1cc(F)ccc1	InChI=1S/C17H12FN3O2S/c18-13-5-3-4-12(10-13)17(22)21-20-11-14-7-8-16(23-14)24-15-6-1-2-9-19-15/h1-11H,(H,21,22)/b20-11+	VDKNIVFIPSLUFD-RGVLZGJSSA-N					doublet; removed another duplicate entry; compound annotation
0391_011879	Kawain	C14H14O3	3.5759	5281565	COC1=CC(=O)O[C@H](C1)/C=C/C2=CC=CC=C2	COC1=CC(=O)OC(C=Cc2ccccc2)C1	InChI=1S/C14H14O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-8,10,12H,9H2,1H3/b8-7+/t12-/m0/s1	XEAQIWGXBXCYFX-GUOLPTJISA-N					doublet; removed another duplicate entry; compound annotation
0391_011881	Beclomethasone 17-Propionate	C25H33ClO6	3.9422	62965	CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)C(=O)CO	CCC(=O)OC1(C(=O)CO)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C	InChI=1S/C25H33ClO6/c1-5-21(31)32-25(20(30)13-27)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,26)19(29)12-23(18,25)4/h8-9,11,14,17-19,27,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1	OHYGPBKGZGRQKT-XGQKBEPLSA-N					compound annotation
0391_011882	Pazufloxacin	C16H15FN2O4	1.544	40466872	C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)[NH3+])F)C(=O)[O-]	CC1COc2c3c(cc(F)c2C2(N)CC2)c(=O)c(C(=O)O)cn31	InChI=1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1	XAGMUUZPGZWTRP-ZETCQYMHSA-N					removed another duplicate entry; compound annotation
0391_011884	Mogroside IIe	C42H72O14	2.796	24721558	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)[C@H]2CC[C@@]3([C@@]2(C[C@H]([C@@]4([C@H]3CC=C5[C@H]4CC[C@@H](C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)C	CC(CCC(OC1OC(CO)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(OC5OC(CO)C(O)C(O)C5O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C42H72O14/c1-20(9-13-29(39(4,5)52)56-37-35(51)33(49)31(47)25(19-44)54-37)21-15-16-40(6)26-12-10-22-23(42(26,8)27(45)17-41(21,40)7)11-14-28(38(22,2)3)55-36-34(50)32(48)30(46)24(18-43)53-36/h10,20-21,23-37,43-52H,9,11-19H2,1-8H3/t20-,21-,23-,24-,25-,26+,27-,28+,29-,30-,31-,32+,33+,34-,35-,36+,37+,40+,41-,42+/m1/s1	WVXIMWMLKSCVTD-JLRHFDOOSA-N					removed another duplicate entry; compound annotation
0391_011886	Mogroside I A1	C36H62O9	3.4564	101135270	C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)[C@H]2CC[C@@]3([C@@]2(C[C@H]([C@@]4([C@H]3CC=C5[C@H]4CC[C@@H](C5(C)C)O)C)O)C)C	CC(CCC(OC1OC(CO)C(O)C(O)C1O)C(C)(C)O)C1CCC2(C)C3CC=C4C(CCC(O)C4(C)C)C3(C)C(O)CC12C	InChI=1S/C36H62O9/c1-19(9-14-27(33(4,5)43)45-31-30(42)29(41)28(40)23(18-37)44-31)20-15-16-34(6)24-12-10-21-22(11-13-25(38)32(21,2)3)36(24,8)26(39)17-35(20,34)7/h10,19-20,22-31,37-43H,9,11-18H2,1-8H3/t19-,20-,22-,23-,24+,25+,26-,27-,28-,29+,30-,31+,34+,35-,36+/m1/s1	UNCMRQFSKAVFQU-QZGPORMMSA-N					compound annotation
0391_011887	H3B-120	C19H24N4O2S	3.6323	132355378		Cc1csc(NC(=O)C2CCN(C(=O)N(C)Cc3ccccc3)CC2)n1	InChI=1S/C19H24N4O2S/c1-14-13-26-18(20-14)21-17(24)16-8-10-23(11-9-16)19(25)22(2)12-15-6-4-3-5-7-15/h3-7,13,16H,8-12H2,1-2H3,(H,20,21,24)	ZEVOZXRSCSSPAO-UHFFFAOYSA-N					compound annotation
0391_011888	Olinciguat	C21H16F5N7O3	3.784	90445883	C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NC[C@@](C(=O)N)(C(F)(F)F)O)F)C4=NOC=C4)F	NC(=O)C(O)(CNc1nc(-c2nn(Cc3ccccc3F)c(-c3nocc3)c2)ncc1F)C(F)(F)F	InChI=1S/C21H16F5N7O3/c22-12-4-2-1-3-11(12)9-33-16(14-5-6-36-32-14)7-15(31-33)18-28-8-13(23)17(30-18)29-10-20(35,19(27)34)21(24,25)26/h1-8,35H,9-10H2,(H2,27,34)(H,28,29,30)/t20-/m1/s1	YWQFJNWMWZMXRW-HXUWFJFHSA-N					removed another duplicate entry; compound annotation
0391_011890	Dynarrestin	C22H23F2N3O2S	4.4934	137919864		CCOC(=O)c1c(-c2ccc(N(CC)CC)cc2)nc(Nc2c(F)cc(F)cc2)s1	InChI=1S/C22H23F2N3O2S/c1-4-27(5-2)16-10-7-14(8-11-16)19-20(21(28)29-6-3)30-22(26-19)25-18-12-9-15(23)13-17(18)24/h7-13H,4-6H2,1-3H3,(H,25,26)	UZNNDDDSGCMQOQ-UHFFFAOYSA-N					compound annotation
0391_011891	succinylsulfathiazole	C13H13N3O5S2	1.5704	5315		O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1	InChI=1S/C13H13N3O5S2/c17-11(5-6-12(18)19)15-9-1-3-10(4-2-9)23(20,21)16-13-14-7-8-22-13/h1-4,7-8H,5-6H2,(H,14,16)(H,15,17)(H,18,19)	SKVLYVHULOWXTD-UHFFFAOYSA-N					compound annotation
0391_011892	ropinirole	C16H24N2O	1.5822	5095		CCCN(CCC)CCc1c2CC(=O)Nc2ccc1	InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)	UHSKFQJFRQCDBE-UHFFFAOYSA-N					compound annotation
0391_011893	RANOLAZINE	C24H33N3O4	2.5312	56959		COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)	XKLMZUWKNUAPSZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011895	Reldesemtiv	C19H18F2N6O	2.7822	67454400		NC(=O)c1cn(-c2cnc(NCC3(c4c(F)cccn4)CC(F)C3)nc2)cc1	InChI=1S/C19H18F2N6O/c20-13-6-19(7-13,16-15(21)2-1-4-23-16)11-26-18-24-8-14(9-25-18)27-5-3-12(10-27)17(22)28/h1-5,8-10,13H,6-7,11H2,(H2,22,28)(H,24,25,26)	MQXWPWOCXGARRK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011897	Cinobufotalin	C26H34O7	3.2821	259776	CC(=O)O[C@@H]1[C@@H]([C@]2(CC[C@H]3[C@H]([C@@]24[C@@H]1O4)CC[C@]5([C@@]3(CC[C@@H](C5)O)C)O)C)C6=COC(=O)C=C6	CC(=O)OC1C(c2coc(=O)cc2)C2(C)CCC3C(CCC4(O)CC(O)CCC34C)C23OC13	InChI=1S/C26H34O7/c1-14(27)32-21-20(15-4-5-19(29)31-13-15)24(3)10-7-17-18(26(24)22(21)33-26)8-11-25(30)12-16(28)6-9-23(17,25)2/h4-5,13,16-18,20-22,28,30H,6-12H2,1-3H3/t16-,17-,18+,20-,21+,22+,23+,24+,25-,26+/m0/s1	KBKUJJFDSHBPPA-ZNCGZLKOSA-N					compound annotation
0391_011898	triacetylresveratrol	C20H18O6	4.4159	5962587	CC(=O)OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)OC(=O)C)OC(=O)C	CC(=O)Oc1ccc(C=Cc2cc(OC(C)=O)cc(OC(C)=O)c2)cc1	InChI=1S/C20H18O6/c1-13(21)24-18-8-6-16(7-9-18)4-5-17-10-19(25-14(2)22)12-20(11-17)26-15(3)23/h4-12H,1-3H3/b5-4+	PDAYUJSOJIMKIS-SNAWJCMRSA-N					doublet; compound annotation
0391_011899	triacetylresveratrol	C20H18O6	4.4194	5962587	CC(=O)OC1=CC=C(C=C1)/C=C/C2=CC(=CC(=C2)OC(=O)C)OC(=O)C	CC(=O)Oc1ccc(C=Cc2cc(OC(C)=O)cc(OC(C)=O)c2)cc1	InChI=1S/C20H18O6/c1-13(21)24-18-8-6-16(7-9-18)4-5-17-10-19(25-14(2)22)12-20(11-17)26-15(3)23/h4-12H,1-3H3/b5-4+	PDAYUJSOJIMKIS-SNAWJCMRSA-N					doublet; compound annotation
0391_011900	Quininic acid	C11H9NO3	0.6382	345824		COc1cc2c(C(=O)O)ccnc2cc1	InChI=1S/C11H9NO3/c1-15-7-2-3-10-9(6-7)8(11(13)14)4-5-12-10/h2-6H,1H3,(H,13,14)	XXLFLUJXWKXUGS-UHFFFAOYSA-N					compound annotation
0391_011901	Lanicemine	C13H14N2	0.9832	9794203	C1=CC=C(C=C1)[C@H](CC2=CC=CC=N2)N	NC(Cc1ccccn1)c1ccccc1	InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1	FWUQWDCOOWEXRY-ZDUSSCGKSA-N					compound annotation
0391_011902	Niraparib	C19H20N4O	2.0422	24958200	C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N	NC(=O)c1cccc2cn(-c3ccc(C4CCCNC4)cc3)nc12	InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1	PCHKPVIQAHNQLW-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_011904	Torin 2	C24H15F3N4O	2.2275	51358113		Nc1ncc(-c2cc3c4c(cnc3cc2)ccc(=O)n4-c2cccc(C(F)(F)F)c2)cc1	InChI=1S/C24H15F3N4O/c25-24(26,27)17-2-1-3-18(11-17)31-22(32)9-6-16-13-29-20-7-4-14(10-19(20)23(16)31)15-5-8-21(28)30-12-15/h1-13H,(H2,28,30)	GUXXEUUYCAYESJ-UHFFFAOYSA-N					compound annotation
0391_011905	ACRIVASTINE	C22H24N2O2	2.3604	5284514	CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O	Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1	InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+	PWACSDKDOHSSQD-IUTFFREVSA-N					doublet; compound annotation
0391_011906	ACRIVASTINE	C22H24N2O2	2.7845	5284514	CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O	Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1	InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+	PWACSDKDOHSSQD-IUTFFREVSA-N					doublet; compound annotation
0391_011907	ACRIVASTINE	C22H24N2O2	2.8548	5284514	CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O	Cc1ccc(C(=CCN2CCCC2)c2cccc(C=CC(=O)O)n2)cc1	InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+	PWACSDKDOHSSQD-IUTFFREVSA-N					doublet; compound annotation
0391_011908	Entrectinib	C31H34F2N6O2	3.3057	25141092		CN1CCN(c2cc(NC3CCOCC3)c(C(=O)Nc3n[nH]c4c3cc(Cc3cc(F)cc(F)c3)cc4)cc2)CC1	InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)	HAYYBYPASCDWEQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011910	terconazole	C26H31Cl2N5O3	3.3085	441383	CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl	CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1	BLSQLHNBWJLIBQ-OZXSUGGESA-N					doublet; compound annotation
0391_011911	terconazole	C26H31Cl2N5O3	3.3134	441383	CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl	CC(C)N1CCN(c2ccc(OCC3COC(Cn4cncn4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1	BLSQLHNBWJLIBQ-OZXSUGGESA-N					doublet; compound annotation
0391_011912	Combretastatin A4	C18H20O5	3.9307	5351344	COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)O	COc1c(O)cc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-	HVXBOLULGPECHP-WAYWQWQTSA-N					compound annotation
0391_011913	(R)-Terazosin	C19H25N5O4	1.7782	1398859	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)[C@H]4CCCO4)N)OC	COc1c(OC)cc2c(N)nc(N3CCN(C(=O)C4CCCO4)CC3)nc2c1	InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)/t14-/m1/s1	VCKUSRYTPJJLNI-CQSZACIVSA-N					removed another duplicate entry; compound annotation
0391_011916	SULFADOXINE	C12H14N4O4S	2.0425	17134		COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC	InChI=1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16)	PJSFRIWCGOHTNF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011918	Licochalcone B	C16H14O5	2.4369	5318999	COC1=C(C=CC(=C1O)O)/C=C/C(=O)C2=CC=C(C=C2)O	COc1c(C=CC(=O)c2ccc(O)cc2)ccc(O)c1O	InChI=1S/C16H14O5/c1-21-16-11(5-9-14(19)15(16)20)4-8-13(18)10-2-6-12(17)7-3-10/h2-9,17,19-20H,1H3/b8-4+	DRDRYGIIYOPBBZ-XBXARRHUSA-N					compound annotation
0391_011919	Aurantio-obtusin	C17H14O7	3.3304	155011		COc1c(O)cc2C(=O)c3c(C(=O)c2c1O)c(OC)c(O)c(C)c3	InChI=1S/C17H14O7/c1-6-4-7-11(17(24-3)12(6)19)14(21)10-8(13(7)20)5-9(18)16(23-2)15(10)22/h4-5,18-19,22H,1-3H3	RNXZPKOEJUFJON-UHFFFAOYSA-N					compound annotation
0391_011920	Farrerol	C17H16O5	3.5372	91144		Cc1c(O)c(C)c2OC(c3ccc(O)cc3)CC(=O)c2c1O	InChI=1S/C17H16O5/c1-8-15(20)9(2)17-14(16(8)21)12(19)7-13(22-17)10-3-5-11(18)6-4-10/h3-6,13,18,20-21H,7H2,1-2H3	DYHOLQACRGJEHX-UHFFFAOYSA-N					compound annotation
0391_011921	CMPD1	C22H20FNO2	4.2979	11382492		O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1	InChI=1S/C22H20FNO2/c23-21-6-2-1-5-20(21)17-10-8-16(9-11-17)4-3-7-22(26)24-18-12-14-19(25)15-13-18/h1-2,5-6,8-15,25H,3-4,7H2,(H,24,26)	ODYAQBDIXCVKAE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011923	TAPRENEPAG ISOPROPYL	C27H28N4O5S	4.5437	23729077		CC(C)OC(=O)COc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cnccc2)c1	InChI=1S/C27H28N4O5S/c1-21(2)36-27(32)20-35-25-7-3-6-23(16-25)19-30(37(33,34)26-8-4-13-28-17-26)18-22-9-11-24(12-10-22)31-15-5-14-29-31/h3-17,21H,18-20H2,1-2H3	NVPXUFQLKWKBHK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011925	monocrotaline	C16H23NO6	0.6127	9415	C[C@H]1C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC(=O)[C@]([C@]1(C)O)(C)O	CC1C(=O)OC2CCN3CC=C(COC(=O)C(C)(O)C1(C)O)C23	InChI=1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1	QVCMHGGNRFRMAD-XFGHUUIASA-N					compound annotation
0391_011926	Daidzin	C21H20O9	1.6136	107971	C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1c(-c2ccc(O)cc2)coc2c1ccc(OC1OC(CO)C(O)C(O)C1O)c2	InChI=1S/C21H20O9/c22-8-16-18(25)19(26)20(27)21(30-16)29-12-5-6-13-15(7-12)28-9-14(17(13)24)10-1-3-11(23)4-2-10/h1-7,9,16,18-23,25-27H,8H2/t16-,18-,19+,20-,21-/m1/s1	KYQZWONCHDNPDP-QNDFHXLGSA-N					removed another duplicate entry; compound annotation
0391_011928	metoprolol	C15H25NO3	1.8723	4171		COCCc1ccc(OCC(O)CNC(C)C)cc1	InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3	IUBSYMUCCVWXPE-UHFFFAOYSA-N					compound annotation
0391_011929	luteolin	C15H10O6	2.5643	5280445		O=c1cc(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H	IQPNAANSBPBGFQ-UHFFFAOYSA-N					compound annotation
0391_011930	BI-4924	C21H20Cl2N2O6S	3.9189	138756831	CC1=CC2=C(C=C(N2C)C(=O)N[C@H](CO)C3=CC=C(C=C3)S(=O)(=O)CC(=O)O)C(=C1Cl)Cl	Cc1cc2c(cc(C(=O)NC(CO)c3ccc(S(=O)(=O)CC(=O)O)cc3)n2C)c(Cl)c1Cl	InChI=1S/C21H20Cl2N2O6S/c1-11-7-16-14(20(23)19(11)22)8-17(25(16)2)21(29)24-15(9-26)12-3-5-13(6-4-12)32(30,31)10-18(27)28/h3-8,15,26H,9-10H2,1-2H3,(H,24,29)(H,27,28)/t15-/m1/s1	CJEJFFCPVBZSIE-OAHLLOKOSA-N					compound annotation
0391_011931	Anethole trithione	C10H8OS3	4.5383	2194		COc1ccc(-c2cc(=S)ss2)cc1	InChI=1S/C10H8OS3/c1-11-8-4-2-7(3-5-8)9-6-10(12)14-13-9/h2-6H,1H3	KYLIZBIRMBGUOP-UHFFFAOYSA-N					compound annotation
0391_011932	felodipine	C18H19Cl2NO4	4.7379	3333		CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1c(Cl)c(Cl)ccc1	InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3	RZTAMFZIAATZDJ-UHFFFAOYSA-N					compound annotation
0391_011933	2,2'-BIPYRIDINE	C10H8N2	0.8058	1474		c1ccc(-c2ccccn2)nc1	InChI=1S/C10H8N2/c1-3-7-11-9(5-1)10-6-2-4-8-12-10/h1-8H	ROFVEXUMMXZLPA-UHFFFAOYSA-N					compound annotation
0391_011934	Methylthioadenosine	C11H15N5O3S	0.9458	439176	CSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	CSCC1OC(n2cnc3c(N)ncnc32)C(O)C1O	InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1	WUUGFSXJNOTRMR-IOSLPCCCSA-N					compound annotation
0391_011935	hydrocortisone	C21H30O5	2.7051	5754	C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O	CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO	InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1	JYGXADMDTFJGBT-VWUMJDOOSA-N					compound annotation
0391_011936	1024448-59-6	C17H18ClN3O4S	2.92	5068295		O=[N+]([O-])c1c(S(=O)(=O)N2CCN(Cc3ccccc3)CC2)ccc(Cl)c1	InChI=1S/C17H18ClN3O4S/c18-15-6-7-17(16(12-15)21(22)23)26(24,25)20-10-8-19(9-11-20)13-14-4-2-1-3-5-14/h1-7,12H,8-11,13H2	ZNLVYSJQUMALEO-UHFFFAOYSA-N					compound annotation
0391_011937	Isosinensetin	C20H20O7	3.2034	632135		COc1c(OC)cc(-c2cc(=O)c3c(o2)c(OC)c(OC)cc3OC)cc1	InChI=1S/C20H20O7/c1-22-13-7-6-11(8-15(13)23-2)14-9-12(21)18-16(24-3)10-17(25-4)19(26-5)20(18)27-14/h6-10H,1-5H3	UYCWETIUOAGWIL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011939	MS402	C20H19ClN2O3	3.2063	90718189		COc1ccc(NC(=O)c2cc(Cl)c(NC3=C(C)C(=O)CC3)cc2)cc1	InChI=1S/C20H19ClN2O3/c1-12-17(9-10-19(12)24)23-18-8-3-13(11-16(18)21)20(25)22-14-4-6-15(26-2)7-5-14/h3-8,11,23H,9-10H2,1-2H3,(H,22,25)	VZTVTSICPINUNG-UHFFFAOYSA-N					compound annotation
0391_011940	BMS 753	C21H21NO4	3.8767	9884820		CC1(C)C(=O)C(C)(C)c2c1ccc(C(=O)Nc1ccc(C(=O)O)cc1)c2	InChI=1S/C21H21NO4/c1-20(2)15-10-7-13(11-16(15)21(3,4)19(20)26)17(23)22-14-8-5-12(6-9-14)18(24)25/h5-11H,1-4H3,(H,22,23)(H,24,25)	KFBPBWUZXBYJDG-UHFFFAOYSA-N					compound annotation
0391_011941	EBOV/MARV-IN-1	C25H30F3N3O2	4.2136	154729054		CC1CCN(c2c(C(F)(F)F)cc(NC(=O)c3ccc(CN4CCOCC4)cc3)cc2)CC1	InChI=1S/C25H30F3N3O2/c1-18-8-10-31(11-9-18)23-7-6-21(16-22(23)25(26,27)28)29-24(32)20-4-2-19(3-5-20)17-30-12-14-33-15-13-30/h2-7,16,18H,8-15,17H2,1H3,(H,29,32)	VVJSZYWIEBDKTC-UHFFFAOYSA-N					compound annotation
0391_011942	Levetiracetam	C8H14N2O2	0.9928	5284583	CC[C@@H](C(=O)N)N1CCCC1=O	CCC(C(N)=O)N1CCCC1=O	InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1	HPHUVLMMVZITSG-LURJTMIESA-N					removed another duplicate entry; compound annotation
0391_011944	6-Acetamidohexanoic acid	C8H15NO3	1.0445	2005		CC(=O)NCCCCCC(=O)O	InChI=1S/C8H15NO3/c1-7(10)9-6-4-2-3-5-8(11)12/h2-6H2,1H3,(H,9,10)(H,11,12)	WDSCBUNMANHPFH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011946	Ginkgolide A	C20H24O9	2.5379	9909368	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)O[C@H]5[C@]3(C2)[C@@]6([C@@H](C5)C(C)(C)C)[C@H](C(=O)O[C@H]6O4)O)O	CC1C(=O)OC2CC34C5CC(C(C)(C)C)C36C(OC(=O)C6O)OC4(C(=O)O5)C21O	InChI=1S/C20H24O9/c1-7-12(22)26-10-6-17-9-5-8(16(2,3)4)18(17)11(21)13(23)28-15(18)29-20(17,14(24)27-9)19(7,10)25/h7-11,15,21,25H,5-6H2,1-4H3/t7-,8+,9-,10+,11+,15+,17-,18+,19-,20-/m1/s1	FPUXKXIZEIDQKW-VKMVSBOZSA-N					removed another duplicate entry; compound annotation
0391_011948	Flibanserin	C20H21F3N4O	2.8165	6918248		O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1	InChI=1S/C20H21F3N4O/c21-20(22,23)15-4-3-5-16(14-15)26-11-8-25(9-12-26)10-13-27-18-7-2-1-6-17(18)24-19(27)28/h1-7,14H,8-13H2,(H,24,28)	PPRRDFIXUUSXRA-UHFFFAOYSA-N					compound annotation
0391_011949	flunisolide	C24H31FO6	3.2428	82153	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O	CC1(C)OC2CC3C4CC(F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C24H31FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h5-7,13-14,16-17,19-20,26,28H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1	XSFJVAJPIHIPKU-XWCQMRHXSA-N					compound annotation
0391_011950	Vercirnon	C22H21ClN2O4S	4.2658	10343454		CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1	InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3	JRWROCIMSDXGOZ-UHFFFAOYSA-N					doublet; compound annotation
0391_011951	LtaS-IN-1	C24H17N3O5	4.3659	16286907		O=C(COC(=O)Cc1coc2c1c1ccccc1cc2)Nc1nnc(-c2ccccc2)o1	InChI=1S/C24H17N3O5/c28-20(25-24-27-26-23(32-24)16-7-2-1-3-8-16)14-31-21(29)12-17-13-30-19-11-10-15-6-4-5-9-18(15)22(17)19/h1-11,13H,12,14H2,(H,25,27,28)	KNJXREYSQNBQEX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011953	90779-69-4	C43H67N11O12S2	2.7586	68613	CC[C@H](C)[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O	CCOc1ccc(CC2NC(=O)CCSSCC(C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC2=O)cc1	InChI=1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36?/m0/s1	VWXRQYYUEIYXCZ-AVTFEHRISA-N					compound annotation
0391_011954	AG1341	C32H45N3O4S	3.4736	4451		Cc1c(C(=O)NC(CSc2ccccc2)C(O)CN2CC3CCCCC3CC2C(=O)NC(C)(C)C)cccc1O	InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)	QAGYKUNXZHXKMR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011956	JNJ-10198409	C18H16FN3O2	3.4889	9797370		COc1c(OC)cc2c(c1)Cc1c-2[nH]nc1Nc1cc(F)ccc1	InChI=1S/C18H16FN3O2/c1-23-15-7-10-6-14-17(13(10)9-16(15)24-2)21-22-18(14)20-12-5-3-4-11(19)8-12/h3-5,7-9H,6H2,1-2H3,(H2,20,21,22)	ZDNURMVOKAERHZ-UHFFFAOYSA-N					compound annotation
0391_011957	practolol	C14H22N2O3	0.9393	4883		CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1	InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)	DURULFYMVIFBIR-UHFFFAOYSA-N					compound annotation
0391_011958	SULFALENE	C11H12N4O3S	1.8341	9047		COc1nccnc1NS(=O)(=O)c1ccc(N)cc1	InChI=1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)	KXRZBTAEDBELFD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011960	KGA-2727	C26H40N4O8	1.9705	10052896	CC1=C(C=CC(=C1)OCCCNCCC(=O)N)CC2=C(NN=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(C)C	Cc1c(Cc2c(C(C)C)[nH]nc2OC2OC(CO)C(O)C(O)C2O)ccc(OCCCNCCC(N)=O)c1	InChI=1S/C26H40N4O8/c1-14(2)21-18(25(30-29-21)38-26-24(35)23(34)22(33)19(13-31)37-26)12-16-5-6-17(11-15(16)3)36-10-4-8-28-9-7-20(27)32/h5-6,11,14,19,22-24,26,28,31,33-35H,4,7-10,12-13H2,1-3H3,(H2,27,32)(H,29,30)/t19-,22-,23+,24-,26+/m1/s1	MDBARDSTXONTFS-MNDUUMEHSA-N					compound annotation
0391_011961	RBN-2397	C20H23F6N7O3	3.5439	146047148	C[C@@H](COCCC(=O)N1CCN(CC1)C2=NC=C(C=N2)C(F)(F)F)NC3=C(C(=O)NN=C3)C(F)(F)F	CC(COCCC(=O)N1CCN(c2ncc(C(F)(F)F)cn2)CC1)Nc1c(C(F)(F)F)c(=O)[nH]nc1	InChI=1S/C20H23F6N7O3/c1-12(30-14-10-29-31-17(35)16(14)20(24,25)26)11-36-7-2-15(34)32-3-5-33(6-4-32)18-27-8-13(9-28-18)19(21,22)23/h8-10,12H,2-7,11H2,1H3,(H2,30,31,35)/t12-/m0/s1	UQZCQKXJAXKZQH-LBPRGKRZSA-N					removed another duplicate entry; compound annotation
0391_011963	204067-01-6	C32H36N6O5	3.985	9829828	C[C@](CC1=CNC2=CC=CC=C21)(C(=O)NCC3(CCCCC3)C4=NC=C(C=C4)OC)NC(=O)NC5=CC=C(C=C5)[N+](=O)[O-]	COc1cnc(C2(CNC(=O)C(C)(Cc3c[nH]c4ccccc34)NC(=O)Nc3ccc([N+](=O)[O-])cc3)CCCCC2)cc1	InChI=1S/C32H36N6O5/c1-31(18-22-19-33-27-9-5-4-8-26(22)27,37-30(40)36-23-10-12-24(13-11-23)38(41)42)29(39)35-21-32(16-6-3-7-17-32)28-15-14-25(43-2)20-34-28/h4-5,8-15,19-20,33H,3,6-7,16-18,21H2,1-2H3,(H,35,39)(H2,36,37,40)/t31-/m0/s1	NNFUWNLENRUDHR-HKBQPEDESA-N					compound annotation
0391_011964	TELOTRISTAT ETHYL	C27H26ClF3N6O3	4.0577	25181577	CCOC(=O)[C@H](CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)O[C@H](C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N	CCOC(=O)C(N)Cc1ccc(-c2cc(OC(c3ccc(Cl)cc3-n3ccc(C)n3)C(F)(F)F)nc(N)n2)cc1	InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1	MDSQOJYHHZBZKA-GBXCKJPGSA-N					doublet; compound annotation
0391_011965	Pralatrexate	C23H23N7O5	1.679	148121	C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1	InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1	OGSBUKJUDHAQEA-WMCAAGNKSA-N					compound annotation
0391_011966	1428327-31-4	C28H32N4O2S	3.0187	66553218		O=C(NCC1(N2CCN(c3ccccc3)CC2)CCOCC1)c1cccnc1Sc1ccccc1	InChI=1S/C28H32N4O2S/c33-26(25-12-7-15-29-27(25)35-24-10-5-2-6-11-24)30-22-28(13-20-34-21-14-28)32-18-16-31(17-19-32)23-8-3-1-4-9-23/h1-12,15H,13-14,16-22H2,(H,30,33)	XREFXUCWSYMIOG-UHFFFAOYSA-N					compound annotation
0391_011967	terfenadine	C32H41NO2	3.9599	5405		CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3	GUGOEEXESWIERI-UHFFFAOYSA-N					compound annotation
0391_011968	Navitoclax-piperazine	C47H56ClF3N6O5S3	4.0248	132020434	CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCNCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C	CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cc(S(=O)(=O)C(F)(F)F)c(NC(CCN5CCNCC5)CSc5ccccc5)cc4)cc3)CC2)C1	InChI=1S/C47H56ClF3N6O5S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-56-26-28-57(29-27-56)39-14-10-35(11-15-39)45(58)54-65(61,62)41-16-17-43(44(30-41)64(59,60)47(49,50)51)53-38(19-23-55-24-21-52-22-25-55)33-63-40-6-4-3-5-7-40/h3-17,30,38,52-53H,18-29,31-33H2,1-2H3,(H,54,58)/t38-/m1/s1	CRPNZDFOWRFBLZ-KXQOOQHDSA-N					compound annotation
0391_011969	5-(4-Phenoxybutoxy)psoralen	C21H18O5	5.0731	11302540		O=c1ccc2c(OCCCCOc3ccccc3)c3c(cc2o1)occ3	InChI=1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2	KINMYBBFQRSVLL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011971	theophylline	C7H8N4O2	0.9193	2153		Cn1c(=O)c2c(nc[nH]2)n(C)c1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	ZFXYFBGIUFBOJW-UHFFFAOYSA-N					doublet; compound annotation
0391_011972	D-Glc	C6H12O6	0.9193	5793	C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O	OCC1OC(O)C(O)C(O)C1O	InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1	WQZGKKKJIJFFOK-GASJEMHNSA-N					compound annotation
0391_011973	Palbociclib	C24H29N7O2	2.1921	5330286		CC(=O)c1c(C)c2cnc(Nc3ncc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O	InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)	AHJRHEGDXFFMBM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011976	mebendazole	C16H13N3O3	2.7349	4030		COC(=O)Nc1nc2c(cc(C(=O)c3ccccc3)cc2)[nH]1	InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)	OPXLLQIJSORQAM-UHFFFAOYSA-N					compound annotation
0391_011977	piroxicam	C15H13N3O4S	2.9751	54676228		CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O	InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)	QYSPLQLAKJAUJT-UHFFFAOYSA-N					compound annotation
0391_011978	dexamethasone	C22H29FO5	3.0627	5743	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO	InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1	UREBDLICKHMUKA-CXSFZGCWSA-N					compound annotation
0391_011979	mycophenolic acid	C17H20O6	3.4596	446541	CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O	COc1c(CC=C(C)CCC(=O)O)c(O)c2C(=O)OCc2c1C	InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+	HPNSFSBZBAHARI-RUDMXATFSA-N					removed another duplicate entry; compound annotation
0391_011981	Ivermectin B1a	C48H74O14	6.7215	6321424	CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C	CCC(C)C1OC2(CCC1C)CC1CC(CC=C(C)C(OC3CC(OC)C(OC4CC(OC)C(O)C(C)O4)C(C)O3)C(C)C=CC=C3COC4C(O)C(C)=CC(C(=O)O1)C34O)O2	InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1	AZSNMRSAGSSBNP-XPNPUAGNSA-N					compound annotation
0391_011982	Peimisine	C27H41NO3	2.0662	161294	C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC(=O)[C@H]6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1	CC1=C2CC3C(CC(=O)C4CC(O)CCC43C)C2CCC12OC1CC(C)CNC1C2C	InChI=1S/C27H41NO3/c1-14-9-24-25(28-13-14)16(3)27(31-24)8-6-18-19(15(27)2)11-21-20(18)12-23(30)22-10-17(29)5-7-26(21,22)4/h14,16-18,20-22,24-25,28-29H,5-13H2,1-4H3/t14-,16+,17-,18+,20-,21-,22+,24+,25-,26+,27-/m0/s1	KYELXPJVGNZIGC-GKFGJCLESA-N					doublet; compound annotation
0391_011983	Peimisine	C27H41NO3	2.1462	161294	C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC(=O)[C@H]6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1	CC1=C2CC3C(CC(=O)C4CC(O)CCC43C)C2CCC12OC1CC(C)CNC1C2C	InChI=1S/C27H41NO3/c1-14-9-24-25(28-13-14)16(3)27(31-24)8-6-18-19(15(27)2)11-21-20(18)12-23(30)22-10-17(29)5-7-26(21,22)4/h14,16-18,20-22,24-25,28-29H,5-13H2,1-4H3/t14-,16+,17-,18+,20-,21-,22+,24+,25-,26+,27-/m0/s1	KYELXPJVGNZIGC-GKFGJCLESA-N					doublet; compound annotation
0391_011984	Pimavanserin	C25H34FN3O2	3.5761	10071196		CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1	InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)	RKEWSXXUOLRFBX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_011986	drofenine	C20H31NO2	3.5839	3166		CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1	InChI=1S/C20H31NO2/c1-3-21(4-2)15-16-23-20(22)19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5,7-8,11-12,18-19H,3-4,6,9-10,13-16H2,1-2H3	AGJBLWCLQCKRJP-UHFFFAOYSA-N					compound annotation
0391_011987	FT895	C16H15F3N4O2	3.9608	134492522		CC1(C)c2cccc(C(=O)NO)c2CN1c1ncc(C(F)(F)F)nc1	InChI=1S/C16H15F3N4O2/c1-15(2)11-5-3-4-9(14(24)22-25)10(11)8-23(15)13-7-20-12(6-21-13)16(17,18)19/h3-7,25H,8H2,1-2H3,(H,22,24)	XCLPBILTRRWOIL-UHFFFAOYSA-N					compound annotation
0391_011988	Artesunate	C19H28O8	4.1097	6917864	C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C	CC1CCC2C(C)C(OC(=O)CCC(=O)O)OC3OC4(C)CCC1C32OO4	InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1	FIHJKUPKCHIPAT-AHIGJZGOSA-N					compound annotation
0391_011989	TBAP-001	C27H23F2N7O3	4.146	91799359		CC(C)(C)c1nn(-c2cc(F)ccc2)c(NC(=O)Nc2c(F)cc(Oc3c4ncc(=O)[nH]c4ncc3)cc2)c1	InChI=1S/C27H23F2N7O3/c1-27(2,3)21-13-22(36(35-21)16-6-4-5-15(28)11-16)33-26(38)32-19-8-7-17(12-18(19)29)39-20-9-10-30-25-24(20)31-14-23(37)34-25/h4-14H,1-3H3,(H,30,34,37)(H2,32,33,38)	AJFKKXIBHCRFJO-UHFFFAOYSA-N					compound annotation
0391_011990	CABAZITAXEL	C45H57NO14	4.774	9854073	CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC	COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C	InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1	BMQGVNUXMIRLCK-OAGWZNDDSA-N					removed another duplicate entry; compound annotation
0391_011992	tazarotene	C21H21NO2S	5.7804	5381		CCOC(=O)c1cnc(C#Cc2cc3c(cc2)SCCC3(C)C)cc1	InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3	OGQICQVSFDPSEI-UHFFFAOYSA-N					compound annotation
0391_011993	Lenalidomide	C13H13N3O3	1.0853	216326		Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O	InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)	GOTYRUGSSMKFNF-UHFFFAOYSA-N					doublet; compound annotation
0391_011994	BMS-986235	C18H17F2N3O3	3.1161	122583088	COC1=CC(=C(C(=C1)F)[C@@H]2CNC(=O)[C@H]2NC(=O)NC3=CC=CC=C3)F	COc1cc(F)c(C2CNC(=O)C2NC(=O)Nc2ccccc2)c(F)c1	InChI=1S/C18H17F2N3O3/c1-26-11-7-13(19)15(14(20)8-11)12-9-21-17(24)16(12)23-18(25)22-10-5-3-2-4-6-10/h2-8,12,16H,9H2,1H3,(H,21,24)(H2,22,23,25)/t12-,16-/m0/s1	FJZNNKJZHQFMCK-LRDDRELGSA-N					removed another duplicate entry; compound annotation
0391_011996	EMI56	C21H20N2O3	4.9298	145864056		CCN(CC)c1cc2c(cc1C)cc(-c1nc3ccccc3o1)c(=O)o2	InChI=1S/C21H20N2O3/c1-4-23(5-2)17-12-19-14(10-13(17)3)11-15(21(24)26-19)20-22-16-8-6-7-9-18(16)25-20/h6-12H,4-5H2,1-3H3	OYQNORRYAWXDHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_011998	(-)-Rapamycin	C51H79NO13	5.5698	5284616	C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1	QFJCIRLUMZQUOT-HPLJOQBZSA-N					compound annotation
0391_011999	quercetin	C15H10O7	2.5709	5280343		O=c1c(O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H	REFJWTPEDVJJIY-UHFFFAOYSA-N					doublet; compound annotation
0391_012000	Olaparib	C24H23FN4O3	2.6665	23725625		O=C(c1c(F)ccc(Cc2n[nH]c(=O)c3ccccc23)c1)N1CCN(C(=O)C2CC2)CC1	InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)	FDLYAMZZIXQODN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012002	AFLATOXIN B1	C17H12O6	2.8441	186907	COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1	COc1c2c3c(C(=O)CC3)c(=O)oc2c2c(c1)OC1OC=CC21	InChI=1S/C17H12O6/c1-20-10-6-11-14(8-4-5-21-17(8)22-11)15-13(10)7-2-3-9(18)12(7)16(19)23-15/h4-6,8,17H,2-3H2,1H3/t8-,17+/m0/s1	OQIQSTLJSLGHID-WNWIJWBNSA-N					removed another duplicate entry; compound annotation
0391_012004	Bergapten	C12H8O4	3.2342	2355		COc1c2ccc(=O)oc2cc2c1cco2	InChI=1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3	BGEBZHIAGXMEMV-UHFFFAOYSA-N					compound annotation
0391_012005	Benidipine	C28H31N3O6	3.2596	656668	CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC	COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCCN(Cc3ccccc3)C2)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C28H31N3O6/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3/t23-,26-/m1/s1	QZVNQOLPLYWLHQ-ZEQKJWHPSA-N					compound annotation
0391_012006	tamoxifen	C26H29NO	4.1297	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-	NKANXQFJJICGDU-QPLCGJKRSA-N					doublet; compound annotation
0391_012007	tamoxifen	C26H29NO	4.2871	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-	NKANXQFJJICGDU-QPLCGJKRSA-N					doublet; compound annotation
0391_012008	quinidine	C20H24N2O2	1.4452	441074	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1	LOUPRKONTZGTKE-LHHVKLHASA-N					doublet; compound annotation
0391_012009	299442-43-6	C12H11N3O2	2.1067	2772368		Nc1ncc2C(=O)CC(c3ccco3)Cc2n1	InChI=1S/C12H11N3O2/c13-12-14-6-8-9(15-12)4-7(5-10(8)16)11-2-1-3-17-11/h1-3,6-7H,4-5H2,(H2,13,14,15)	SOJUSNIBPPMLCC-UHFFFAOYSA-N					compound annotation
0391_012010	alprenolol	C15H23NO2	2.5596	2119		C=CCc1ccccc1OCC(O)CNC(C)C	InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3	PAZJSJFMUHDSTF-UHFFFAOYSA-N					compound annotation
0391_012011	890764-36-0	C22H16N4O3	4.5989	11610682		O=C(Nc1cc(-c2ccccc2)nn1-c1ccccc1)c1ccc([N+](=O)[O-])cc1	InChI=1S/C22H16N4O3/c27-22(17-11-13-19(14-12-17)26(28)29)23-21-15-20(16-7-3-1-4-8-16)24-25(21)18-9-5-2-6-10-18/h1-15H,(H,23,27)	KIALCSMRIHRFPL-UHFFFAOYSA-N					compound annotation
0391_012012	FLUTICASONE PROPIONATE	C25H31F3O5S	4.622	444036	CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF	CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C	InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1	WMWTYOKRWGGJOA-CENSZEJFSA-N					compound annotation
0391_012013	Ramosetron	C17H17N3O	2.1785	108000	CN1C=C(C2=CC=CC=C21)C(=O)[C@@H]3CCC4=C(C3)NC=N4	Cn1cc(C(=O)C2CCc3c(C2)[nH]cn3)c2ccccc21	InChI=1S/C17H17N3O/c1-20-9-13(12-4-2-3-5-16(12)20)17(21)11-6-7-14-15(8-11)19-10-18-14/h2-5,9-11H,6-8H2,1H3,(H,18,19)/t11-/m1/s1	NTHPAPBPFQJABD-LLVKDONJSA-N					removed another duplicate entry; compound annotation
0391_012015	TANZISERTIB	C21H23F3N6O2	2.2127	11597537	C1COC[C@H]1N2C3=NC(=NC=C3N=C2NC4=C(C=C(C=C4F)F)F)NC5CCC(CC5)O	OC1CCC(Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n(C4CCOC4)c3n2)CC1	InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12?,13-,14?/m0/s1	IBGLGMOPHJQDJB-MOKVOYLWSA-N					doublet; compound annotation
0391_012016	TANZISERTIB	C21H23F3N6O2	2.2204	11597537	C1COC[C@H]1N2C3=NC(=NC=C3N=C2NC4=C(C=C(C=C4F)F)F)NC5CCC(CC5)O	OC1CCC(Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n(C4CCOC4)c3n2)CC1	InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12?,13-,14?/m0/s1	IBGLGMOPHJQDJB-MOKVOYLWSA-N					doublet; removed another duplicate entry; compound annotation
0391_012018	OAC2	C15H12N2O	3.0026	2814138		O=C(Nc1cc2c(cc1)[nH]cc2)c1ccccc1	InChI=1S/C15H12N2O/c18-15(11-4-2-1-3-5-11)17-13-6-7-14-12(10-13)8-9-16-14/h1-10,16H,(H,17,18)	JCAFGYWSIWYMOX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012020	OAC2	C15H12N2O	3.006	2814138		O=C(Nc1cc2c(cc1)[nH]cc2)c1ccccc1	InChI=1S/C15H12N2O/c18-15(11-4-2-1-3-5-11)17-13-6-7-14-12(10-13)8-9-16-14/h1-10,16H,(H,17,18)	JCAFGYWSIWYMOX-UHFFFAOYSA-N					doublet; compound annotation
0391_012021	triptolide	C20H24O6	2.6995	107985	CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C	CC(C)C12OC1C1OC13C1(C)CCC4=C(COC4=O)C1CC1OC13C2O	InChI=1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11-,12-,13-,14-,16+,17-,18-,19+,20+/m0/s1	DFBIRQPKNDILPW-CIVMWXNOSA-N					compound annotation
0391_012022	STING agonist-3	C37H42N12O6	2.8473	131986567	CCN1C(=CC(=N1)C)C(=O)NC2=NC3=C(N2C/C=C/CN4C5=C(C=C(C=C5OCCCO)C(=O)N)N=C4NC(=O)C6=CC(=NN6CC)C)C=CC(=C3)C(=O)N	CCn1nc(C)cc1C(=O)Nc1nc2c(ccc(C(N)=O)c2)n1CC=CCn1c(NC(=O)c2cc(C)nn2CC)nc2cc(C(N)=O)cc(OCCCO)c21	InChI=1S/C37H42N12O6/c1-5-48-28(16-21(3)44-48)34(53)42-36-40-25-18-23(32(38)51)10-11-27(25)46(36)12-7-8-13-47-31-26(19-24(33(39)52)20-30(31)55-15-9-14-50)41-37(47)43-35(54)29-17-22(4)45-49(29)6-2/h7-8,10-11,16-20,50H,5-6,9,12-15H2,1-4H3,(H2,38,51)(H2,39,52)(H,40,42,53)(H,41,43,54)/b8-7+	VHCDRDBBENBVEK-BQYQJAHWSA-N					compound annotation
0391_012023	Amorolfine	C21H35NO	3.8479	54260	CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2C[C@H](O[C@H](C2)C)C	CCC(C)(C)c1ccc(CC(C)CN2CC(C)OC(C)C2)cc1	InChI=1S/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+	MQHLMHIZUIDKOO-AYHJJNSGSA-N					doublet; compound annotation
0391_012024	Amorolfine	C21H35NO	3.9317	54260	CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2C[C@H](O[C@H](C2)C)C	CCC(C)(C)c1ccc(CC(C)CN2CC(C)OC(C)C2)cc1	InChI=1S/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+	MQHLMHIZUIDKOO-AYHJJNSGSA-N					doublet; compound annotation
0391_012025	niflumic acid	C13H9F3N2O2	4.1841	4488		O=C(O)c1c(Nc2cccc(C(F)(F)F)c2)nccc1	InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)	JZFPYUNJRRFVQU-UHFFFAOYSA-N					compound annotation
0391_012026	Nalfurafine	C28H32N2O5	2.1964	6445230	CN([C@@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)/C=C/C7=COC=C7	CN(C(=O)C=Cc1cocc1)C1CCC2(O)C3Cc4c5c(c(O)cc4)OC1C52CCN3CC1CC1	InChI=1S/C28H32N2O5/c1-29(23(32)7-4-18-9-13-34-16-18)20-8-10-28(33)22-14-19-5-6-21(31)25-24(19)27(28,26(20)35-25)11-12-30(22)15-17-2-3-17/h4-7,9,13,16-17,20,22,26,31,33H,2-3,8,10-12,14-15H2,1H3/b7-4+/t20-,22-,26+,27+,28-/m1/s1	XGZZHZMWIXFATA-UEZBDDGYSA-N					removed another duplicate entry; compound annotation
0391_012028	sulfabenzamide	C13H12N2O3S	2.3542	5319		Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1	InChI=1S/C13H12N2O3S/c14-11-6-8-12(9-7-11)19(17,18)15-13(16)10-4-2-1-3-5-10/h1-9H,14H2,(H,15,16)	PBCZLFBEBARBBI-UHFFFAOYSA-N					doublet; compound annotation
0391_012029	sulfabenzamide	C13H12N2O3S	2.358	5319		Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1	InChI=1S/C13H12N2O3S/c14-11-6-8-12(9-7-11)19(17,18)15-13(16)10-4-2-1-3-5-10/h1-9H,14H2,(H,15,16)	PBCZLFBEBARBBI-UHFFFAOYSA-N					doublet; compound annotation
0391_012030	A-196	C18H16Cl2N4	2.5236	117072548		Clc1c(Cl)cc2c(-c3ccncc3)nnc(NC3CCCC3)c2c1	InChI=1S/C18H16Cl2N4/c19-15-9-13-14(10-16(15)20)18(22-12-3-1-2-4-12)24-23-17(13)11-5-7-21-8-6-11/h5-10,12H,1-4H2,(H,22,24)	ABGOSOMRWSYAOB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012032	Purfalcamine	C29H33FN8O	3.0556	24762166		NC1CCC(Nc2nc(Nc3ccc(C(=O)N4CCCCC4)cc3)c3ncn(-c4cc(F)ccc4)c3n2)CC1	InChI=1S/C29H33FN8O/c30-20-5-4-6-24(17-20)38-18-32-25-26(35-29(36-27(25)38)34-23-13-9-21(31)10-14-23)33-22-11-7-19(8-12-22)28(39)37-15-2-1-3-16-37/h4-8,11-12,17-18,21,23H,1-3,9-10,13-16,31H2,(H2,33,34,35,36)	KRCOMOOXOZSNAJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012034	(+)-Penbutolol	C18H29NO2	3.2918	162302	CC(C)(C)NC[C@H](COC1=CC=CC=C1C2CCCC2)O	CC(C)(C)NCC(O)COc1ccccc1C1CCCC1	InChI=1S/C18H29NO2/c1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14/h6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3/t15-/m1/s1	KQXKVJAGOJTNJS-OAHLLOKOSA-N					compound annotation
0391_012035	JNJ-42226314	C26H24FN5O2S	3.3241	59625954		O=C(c1cc2c(cc1)n(-c1ccc(F)cc1)cc2)N1CC(N2CCN(C(=O)c3nccs3)CC2)C1	InChI=1S/C26H24FN5O2S/c27-20-2-4-21(5-3-20)32-9-7-18-15-19(1-6-23(18)32)25(33)31-16-22(17-31)29-10-12-30(13-11-29)26(34)24-28-8-14-35-24/h1-9,14-15,22H,10-13,16-17H2	IVOACCSOISMVBL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012037	SCHEMBL2120201	C28H36N4O2S	3.5148	53486330	C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O	O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1	InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18?,19?,20-,21-,24?,25?/m0/s1	PQXKDMSYBGKCJA-RBKORJQFSA-N					compound annotation
0391_012038	Palomid 529	C24H22O6	4.2014	11998575		COc1ccc(COc2c(OC)cc3c(c2)oc(=O)c2c3ccc(C(C)O)c2)cc1	InChI=1S/C24H22O6/c1-14(25)16-6-9-18-19-11-22(28-3)23(12-21(19)30-24(26)20(18)10-16)29-13-15-4-7-17(27-2)8-5-15/h4-12,14,25H,13H2,1-3H3	YEAHTLOYHVWAKW-UHFFFAOYSA-N					compound annotation
0391_012039	Millepachine	C22H22O4	5.3437	66573474	CC1(C=CC2=C(C=CC(=C2O1)C(=O)/C=C/C3=CC=C(C=C3)OC)OC)C	COc1ccc(C=CC(=O)c2c3OC(C)(C)C=Cc3c(OC)cc2)cc1	InChI=1S/C22H22O4/c1-22(2)14-13-18-20(25-4)12-10-17(21(18)26-22)19(23)11-7-15-5-8-16(24-3)9-6-15/h5-14H,1-4H3/b11-7+	GZUOKKIDYHPTAZ-YRNVUSSQSA-N					removed another duplicate entry; compound annotation
0391_012041	actinonin	C19H35N3O5	2.3547	443600	CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO	CCCCCC(CC(=O)NO)C(=O)NC(C(=O)N1CCCC1CO)C(C)C	InChI=1S/C19H35N3O5/c1-4-5-6-8-14(11-16(24)21-27)18(25)20-17(13(2)3)19(26)22-10-7-9-15(22)12-23/h13-15,17,23,27H,4-12H2,1-3H3,(H,20,25)(H,21,24)/t14-,15+,17+/m1/s1	XJLATMLVMSFZBN-VYDXJSESSA-N					removed another duplicate entry; compound annotation
0391_012043	Pyrazoloacridine	C19H21N5O3	2.4372	339455		COc1cc2c(cc1)Nc1c([N+](=O)[O-])ccc3c1c-2nn3CCCN(C)C	InChI=1S/C19H21N5O3/c1-22(2)9-4-10-23-15-7-8-16(24(25)26)19-17(15)18(21-23)13-11-12(27-3)5-6-14(13)20-19/h5-8,11,20H,4,9-10H2,1-3H3	HZCWPKGYTCJSEB-UHFFFAOYSA-N					compound annotation
0391_012044	Cirsimaritin	C17H14O6	3.3969	188323		COc1c(OC)c(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1	InChI=1S/C17H14O6/c1-21-14-8-13-15(16(20)17(14)22-2)11(19)7-12(23-13)9-3-5-10(18)6-4-9/h3-8,18,20H,1-2H3	ZIIAJIWLQUVGHB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012046	6-Demethoxytangeretin	C19H18O6	3.477	629964		COc1ccc(-c2cc(=O)c3c(o2)c(OC)c(OC)cc3OC)cc1	InChI=1S/C19H18O6/c1-21-12-7-5-11(6-8-12)14-9-13(20)17-15(22-2)10-16(23-3)18(24-4)19(17)25-14/h5-10H,1-4H3	DDGJUTBQQURRGE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012048	NCGC00024654-01	C21H42NO4+	4.7109	6604733	CCCCCCCCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C21H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h19H,5-18H2,1-4H3/p+1/t19-/m1/s1	PSHXNVGSVNEJBD-LJQANCHMSA-O					compound annotation
0391_012049	XE991	C26H20N2O	0.7553	656732		O=C1c2ccccc2C(Cc2ccncc2)(Cc2ccncc2)c2ccccc12	InChI=1S/C26H20N2O/c29-25-21-5-1-3-7-23(21)26(17-19-9-13-27-14-10-19,18-20-11-15-28-16-12-20)24-8-4-2-6-22(24)25/h1-16H,17-18H2	KHJFBUUFMUBONL-UHFFFAOYSA-N					compound annotation
0391_012050	(S)-Terazosin	C19H25N5O4	1.7795	969465	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4CCCO4)N)OC	COc1c(OC)cc2c(N)nc(N3CCN(C(=O)C4CCCO4)CC3)nc2c1	InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)/t14-/m0/s1	VCKUSRYTPJJLNI-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_012053	MSC2360844	C26H27FN4O5S	1.9197	66580799		O=C(c1nn(-c2ccc(CN3CCOCC3)cc2)c2c1CS(=O)(=O)c1c-2cccc1F)N1CCOCC1	InChI=1S/C26H27FN4O5S/c27-22-3-1-2-20-24-21(17-37(33,34)25(20)22)23(26(32)30-10-14-36-15-11-30)28-31(24)19-6-4-18(5-7-19)16-29-8-12-35-13-9-29/h1-7H,8-17H2	NFHSJYKXENYICE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012055	Perospirone	C23H30N4O2S	2.8993	115368	C1CC[C@H]2[C@@H](C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54	O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1	InChI=1S/C23H30N4O2S/c28-22-17-7-1-2-8-18(17)23(29)27(22)12-6-5-11-25-13-15-26(16-14-25)21-19-9-3-4-10-20(19)30-24-21/h3-4,9-10,17-18H,1-2,5-8,11-16H2/t17-,18+	FBVFZWUMDDXLLG-HDICACEKSA-N					compound annotation
0391_012056	Coproporphyrin III	C36H38N4O8	3.5102	114935		CC1=C(CCC(=O)O)c2cc3nc(cc4c(C)c(CCC(=O)O)c(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)[nH]4)C(CCC(=O)O)=C3C	InChI=1S/C36H38N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h13-16,38,40H,5-12H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)	XNBNKCLBGTWWSD-UHFFFAOYSA-N					compound annotation
0391_012057	Treprostinil	C23H34O5	4.1852	6918140	CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O	CCCCCC(O)CCC1C(O)CC2Cc3c(cccc3OCC(=O)O)CC21	InChI=1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1	PAJMKGZZBBTTOY-ZFORQUDYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012059	SCHEMBL15453030	C15H17NO3	1.8852	89953482	CC1=C(C(=O)C=CN1[C@H](CC2=CC=CC=C2)CO)O	Cc1c(O)c(=O)ccn1C(CO)Cc1ccccc1	InChI=1S/C15H17NO3/c1-11-15(19)14(18)7-8-16(11)13(10-17)9-12-5-3-2-4-6-12/h2-8,13,17,19H,9-10H2,1H3/t13-/m1/s1	FAYRGKKCBATAET-CYBMUJFWSA-N					compound annotation
0391_012060	Imatinib	C29H31N7O	2.0364	5291		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)	KTUFNOKKBVMGRW-UHFFFAOYSA-N					doublet; compound annotation
0391_012061	chlorpheniramine	C16H19ClN2	2.1004	2725		CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1	InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3	SOYKEARSMXGVTM-UHFFFAOYSA-N					compound annotation
0391_012062	Ifenprodil	C21H27NO2	2.5869	3689		CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1	InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3	UYNVMODNBIQBMV-UHFFFAOYSA-N					compound annotation
0391_012063	Antibiotic-5d	C13H18N2O4S	2.9867	10709196	CC(C)(C)OC(=O)N1CCC[C@H]1C2=NC(=CS2)C(=O)O	CC(C)(C)OC(=O)N1CCCC1c1nc(C(=O)O)cs1	InChI=1S/C13H18N2O4S/c1-13(2,3)19-12(18)15-6-4-5-9(15)10-14-8(7-20-10)11(16)17/h7,9H,4-6H2,1-3H3,(H,16,17)/t9-/m0/s1	DPLVJSMBNOUIIM-VIFPVBQESA-N					compound annotation
0391_012064	fexofenadine	C32H39NO4	3.1777	74685737		CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1	InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)	RWTNPBWLLIMQHL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012066	fenofibrate	C20H21ClO4	5.6483	3339		CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1	InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3	YMTINGFKWWXKFG-UHFFFAOYSA-N					compound annotation
0391_012067	Betamipron	C10H11NO3	1.5065	71651		O=C(O)CCNC(=O)c1ccccc1	InChI=1S/C10H11NO3/c12-9(13)6-7-11-10(14)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,14)(H,12,13)	CWXYHOHYCJXYFQ-UHFFFAOYSA-N					compound annotation
0391_012068	Yohimbine	C21H26N2O3	2.0443	8969	COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O	COC(=O)C1C(O)CCC2CN3CCc4c([nH]c5ccccc45)C3CC21	InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1	BLGXFZZNTVWLAY-SCYLSFHTSA-N					compound annotation
0391_012069	colchicine	C22H25NO6	2.536	6167	CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	COc1c(OC)c(OC)c2c(c1)CCC(NC(C)=O)c1cc(=O)c(OC)ccc1-2	InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1	IAKHMKGGTNLKSZ-INIZCTEOSA-N					doublet; removed another duplicate entry; compound annotation
0391_012071	Selumetinib	C17H15BrClFN4O3	3.0383	10127622		Cn1cnc2c1cc(C(=O)NOCCO)c(Nc1c(Cl)cc(Br)cc1)c2F	InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	CYOHGALHFOKKQC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012073	colchicine	C22H25NO6	3.048	6167	CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC	COc1c(OC)c(OC)c2c(c1)CCC(NC(C)=O)c1cc(=O)c(OC)ccc1-2	InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1	IAKHMKGGTNLKSZ-INIZCTEOSA-N					doublet; compound annotation
0391_012074	mGluR2 antagonist 1	C21H16FN3O3	3.3949	71566598		NC(=O)c1nc2c(ccc(CN3C(=O)CCC3=O)c2)c(-c2ccc(F)cc2)c1	InChI=1S/C21H16FN3O3/c22-14-4-2-13(3-5-14)16-10-18(21(23)28)24-17-9-12(1-6-15(16)17)11-25-19(26)7-8-20(25)27/h1-6,9-10H,7-8,11H2,(H2,23,28)	XSTBUOHORFUCIB-UHFFFAOYSA-N					compound annotation
0391_012075	indomethacin	C19H16ClNO4	4.3334	3715		COc1cc2c(cc1)n(C(=O)c1ccc(Cl)cc1)c(C)c2CC(=O)O	InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)	CGIGDMFJXJATDK-UHFFFAOYSA-N					doublet; compound annotation
0391_012076	SCHEMBL10319958	C26H32N4O6S2	4.8208	51353218		CCNS(=O)(=O)NC(=O)c1csc(CN(CCCc2ccccc2)C(=O)c2cc(OC)c(C)c(OC)c2)n1	InChI=1S/C26H32N4O6S2/c1-5-27-38(33,34)29-25(31)21-17-37-24(28-21)16-30(13-9-12-19-10-7-6-8-11-19)26(32)20-14-22(35-3)18(2)23(15-20)36-4/h6-8,10-11,14-15,17,27H,5,9,12-13,16H2,1-4H3,(H,29,31)	UXDXPNBXKOIRKE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012078	xanthurenic acid	C10H7NO4	0.9386	5699		O=C(O)c1cc(=O)c2c([nH]1)c(O)ccc2	InChI=1S/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4,12H,(H,11,13)(H,14,15)	FBZONXHGGPHHIY-UHFFFAOYSA-N					compound annotation
0391_012079	GELSENICINE	C19H22N2O3	1.855	21123652	CCC1=N[C@H]2C[C@@]3([C@H]4C[C@@H]1[C@@H]2CO4)C5=CC=CC=C5N(C3=O)OC	CCC1=NC2CC3(C(=O)N(OC)c4ccccc43)C3CC1C2CO3	InChI=1S/C19H22N2O3/c1-3-14-11-8-17-19(9-15(20-14)12(11)10-24-17)13-6-4-5-7-16(13)21(23-2)18(19)22/h4-7,11-12,15,17H,3,8-10H2,1-2H3/t11-,12+,15+,17-,19+/m1/s1	BIGABVPVCRHEES-NWPJSNQLSA-N					compound annotation
0391_012080	Bosutinib	C26H29Cl2N5O3	2.3741	5328940		COc1c(Cl)cc(Cl)c(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c1	InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)	UBPYILGKFZZVDX-UHFFFAOYSA-N					compound annotation
0391_012081	NS-8593	C17H17N3	2.4753	11587013	C1C[C@H](C2=CC=CC=C2C1)NC3=NC4=CC=CC=C4N3	c1ccc2c(c1)CCCC2Nc1nc2ccccc2[nH]1	InChI=1S/C17H17N3/c1-2-8-13-12(6-1)7-5-11-14(13)18-17-19-15-9-3-4-10-16(15)20-17/h1-4,6,8-10,14H,5,7,11H2,(H2,18,19,20)/t14-/m1/s1	XZIZUQSOFMLIIR-CQSZACIVSA-N					compound annotation
0391_012082	MK-0941 free base	C21H24N4O6S	2.7702	25235801	CCS(=O)(=O)C1=NC=C(C=C1)OC2=CC(=CC(=C2)C(=O)NC3=NN(C=C3)C)O[C@@H](C)CO	CCS(=O)(=O)c1ncc(Oc2cc(OC(C)CO)cc(C(=O)Nc3nn(C)cc3)c2)cc1	InChI=1S/C21H24N4O6S/c1-4-32(28,29)20-6-5-16(12-22-20)31-18-10-15(9-17(11-18)30-14(2)13-26)21(27)23-19-7-8-25(3)24-19/h5-12,14,26H,4,13H2,1-3H3,(H,23,24,27)/t14-/m0/s1	KJSGTWFWVTYPFZ-AWEZNQCLSA-N					removed another duplicate entry; compound annotation
0391_012084	Nelonemdaz	C15H8F7NO3	3.46	9951955		O=C(O)c1c(O)ccc(NCc2c(F)c(F)c(C(F)(F)F)c(F)c2F)c1	InChI=1S/C15H8F7NO3/c16-10-7(11(17)13(19)9(12(10)18)15(20,21)22)4-23-5-1-2-8(24)6(3-5)14(25)26/h1-3,23-24H,4H2,(H,25,26)	HABROHXUHNHQMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012085	Nelonemdaz	C15H8F7NO3	4.3073	9951955		O=C(O)c1c(O)ccc(NCc2c(F)c(F)c(C(F)(F)F)c(F)c2F)c1	InChI=1S/C15H8F7NO3/c16-10-7(11(17)13(19)9(12(10)18)15(20,21)22)4-23-5-1-2-8(24)6(3-5)14(25)26/h1-3,23-24H,4H2,(H,25,26)	HABROHXUHNHQMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012086	Isobavachalcone	C20H20O4	4.6605	5281255	CC(=CCC1=C(C=CC(=C1O)C(=O)/C=C/C2=CC=C(C=C2)O)O)C	CC(C)=CCc1c(O)ccc(C(=O)C=Cc2ccc(O)cc2)c1O	InChI=1S/C20H20O4/c1-13(2)3-9-16-19(23)12-10-17(20(16)24)18(22)11-6-14-4-7-15(21)8-5-14/h3-8,10-12,21,23-24H,9H2,1-2H3/b11-6+	DUWPGRAKHMEPCM-IZZDOVSWSA-N					compound annotation
0391_012087	MBCQ	C16H12ClN3O2	2.3944	6610310		Clc1cc2c(cc1)ncnc2NCc1cc2c(cc1)OCO2	InChI=1S/C16H12ClN3O2/c17-11-2-3-13-12(6-11)16(20-8-19-13)18-7-10-1-4-14-15(5-10)22-9-21-14/h1-6,8H,7,9H2,(H,18,19,20)	CNODHOSDWZLJGA-UHFFFAOYSA-N					compound annotation
0391_012088	2719-05-3	C17H18N2O2	2.5925	94990		CC(=O)Nc1ccc(Cc2ccc(NC(C)=O)cc2)cc1	InChI=1S/C17H18N2O2/c1-12(20)18-16-7-3-14(4-8-16)11-15-5-9-17(10-6-15)19-13(2)21/h3-10H,11H2,1-2H3,(H,18,20)(H,19,21)	OEXMNSOPAKOPEF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012090	1207358-59-5	C25H30N8O2	2.7157	59239114	CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4=NC=CC=N4)C(=N2)N5CCOC[C@@H]5C	CCNC(=O)Nc1ccc(-c2nc3c(CCN(c4ncccn4)C3)c(N3CCOCC3C)n2)cc1	InChI=1S/C25H30N8O2/c1-3-26-25(34)29-19-7-5-18(6-8-19)22-30-21-15-32(24-27-10-4-11-28-24)12-9-20(21)23(31-22)33-13-14-35-16-17(33)2/h4-8,10-11,17H,3,9,12-16H2,1-2H3,(H2,26,29,34)/t17-/m0/s1	WQBAZXIQANTUOY-KRWDZBQOSA-N					doublet; compound annotation
0391_012091	1207358-59-5	C25H30N8O2	2.78	59239114	CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4=NC=CC=N4)C(=N2)N5CCOC[C@@H]5C	CCNC(=O)Nc1ccc(-c2nc3c(CCN(c4ncccn4)C3)c(N3CCOCC3C)n2)cc1	InChI=1S/C25H30N8O2/c1-3-26-25(34)29-19-7-5-18(6-8-19)22-30-21-15-32(24-27-10-4-11-28-24)12-9-20(21)23(31-22)33-13-14-35-16-17(33)2/h4-8,10-11,17H,3,9,12-16H2,1-2H3,(H2,26,29,34)/t17-/m0/s1	WQBAZXIQANTUOY-KRWDZBQOSA-N					doublet; removed another duplicate entry; compound annotation
0391_012093	Rupintrivir	C31H39FN4O7	3.8626	6440352	CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC2=CC=C(C=C2)F)CC(=O)[C@H](C(C)C)NC(=O)C3=NOC(=C3)C	CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(CC(=O)C(NC(=O)c1noc(C)c1)C(C)C)Cc1ccc(F)cc1	InChI=1S/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1	CAYJBRBGZBCZKO-BHGBQCOSSA-N					removed another duplicate entry; compound annotation
0391_012095	DL-Panthenol	C9H19NO4	0.6581	4678		CC(C)(CO)C(O)C(=O)NCCCO	InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)	SNPLKNRPJHDVJA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012097	CHEMBL4576512	C20H30NO3+	1.7144	73440752	CC(C)[N+]1([C@H]2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C	CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2	InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17?,18?,19?,21?/m0/s1	OEXHQOGQTVQTAT-PDRSHUBSSA-N					compound annotation
0391_012098	Vafidemstat	C19H20N4O2	2.734	66714983	C1[C@H]([C@@H]1NCC2=NN=C(O2)N)C3=CC=C(C=C3)OCC4=CC=CC=C4	Nc1nnc(CNC2CC2c2ccc(OCc3ccccc3)cc2)o1	InChI=1S/C19H20N4O2/c20-19-23-22-18(25-19)11-21-17-10-16(17)14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16-17,21H,10-12H2,(H2,20,23)/t16-,17+/m0/s1	XBBRLCXCBCZIOI-DLBZAZTESA-N					doublet; compound annotation
0391_012099	Vafidemstat	C19H20N4O2	2.7374	66714983	C1[C@H]([C@@H]1NCC2=NN=C(O2)N)C3=CC=C(C=C3)OCC4=CC=CC=C4	Nc1nnc(CNC2CC2c2ccc(OCc3ccccc3)cc2)o1	InChI=1S/C19H20N4O2/c20-19-23-22-18(25-19)11-21-17-10-16(17)14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16-17,21H,10-12H2,(H2,20,23)/t16-,17+/m0/s1	XBBRLCXCBCZIOI-DLBZAZTESA-N					doublet; compound annotation
0391_012100	Azoxystrobin	C22H17N3O5	4.1347	3034285	CO/C=C(\C1=CC=CC=C1OC2=NC=NC(=C2)OC3=CC=CC=C3C#N)/C(=O)OC	COC=C(C(=O)OC)c1ccccc1Oc1ncnc(Oc2ccccc2C#N)c1	InChI=1S/C22H17N3O5/c1-27-13-17(22(26)28-2)16-8-4-6-10-19(16)30-21-11-20(24-14-25-21)29-18-9-5-3-7-15(18)12-23/h3-11,13-14H,1-2H3/b17-13+	WFDXOXNFNRHQEC-GHRIWEEISA-N					removed another duplicate entry; compound annotation
0391_012102	Cycloastragenol	C30H50O5	4.2082	13943286	C[C@]12CC[C@@]34C[C@@]35CC[C@@H](C([C@@H]5[C@H](C[C@H]4[C@@]1(C[C@@H]([C@@H]2[C@]6(CC[C@H](O6)C(C)(C)O)C)O)C)O)(C)C)O	CC(C)(O)C1CCC(C)(C2C(O)CC3(C)C4CC(O)C5C(C)(C)C(O)CCC56CC46CCC23C)O1	InChI=1S/C30H50O5/c1-24(2)20(33)8-11-30-16-29(30)13-12-26(5)23(28(7)10-9-21(35-28)25(3,4)34)18(32)15-27(26,6)19(29)14-17(31)22(24)30/h17-23,31-34H,8-16H2,1-7H3/t17-,18-,19-,20-,21-,22-,23-,26+,27-,28+,29-,30+/m0/s1	WENNXORDXYGDTP-UOUCMYEWSA-N					doublet; compound annotation
0391_012103	(11-((4-Hydroxy-3-methoxybenzoyl)oxy)undecyl)triphenylphosphonium	C37H44O4P+	4.7035	49802418		COc1c(O)ccc(C(=O)OCCCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1	InChI=1S/C37H43O4P/c1-40-36-30-31(26-27-35(36)38)37(39)41-28-18-7-5-3-2-4-6-8-19-29-42(32-20-12-9-13-21-32,33-22-14-10-15-23-33)34-24-16-11-17-25-34/h9-17,20-27,30H,2-8,18-19,28-29H2,1H3/p+1	IPYVPVIBAGRGSO-UHFFFAOYSA-O					compound annotation
0391_012104	Levodropropizine	C13H20N2O2	1.1127	65859	C1CN(CCN1C[C@@H](CO)O)C2=CC=CC=C2	OCC(O)CN1CCN(c2ccccc2)CC1	InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1	PTVWPYVOOKLBCG-ZDUSSCGKSA-N					compound annotation
0391_012105	Antineoplaston A10	C13H14N2O3	1.7242	56260	C1CC(=O)NC(=O)[C@H]1NC(=O)CC2=CC=CC=C2	O=C1CCC(NC(=O)Cc2ccccc2)C(=O)N1	InChI=1S/C13H14N2O3/c16-11-7-6-10(13(18)15-11)14-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,17)(H,15,16,18)/t10-/m0/s1	OQGRFQCUGLKSAV-JTQLQIEISA-N					compound annotation
0391_012106	Dacomitinib	C24H25ClFN5O2	2.1163	11511120	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4	COc1c(NC(=O)C=CCN2CCCCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1	InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+	LVXJQMNHJWSHET-AATRIKPKSA-N					compound annotation
0391_012107	Fingolimod	C19H33NO2	4.1233	107970		CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1	InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3	KKGQTZUTZRNORY-UHFFFAOYSA-N					doublet; compound annotation
0391_012108	Baimaside	C27H30O17	1.5862	5282166	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O	O=c1c(OC2OC(CO)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)c(-c2cc(O)c(O)cc2)oc2cc(O)cc(O)c12	InChI=1S/C27H30O17/c28-6-14-17(34)20(37)22(39)26(41-14)44-25-21(38)18(35)15(7-29)42-27(25)43-24-19(36)16-12(33)4-9(30)5-13(16)40-23(24)8-1-2-10(31)11(32)3-8/h1-5,14-15,17-18,20-22,25-35,37-39H,6-7H2/t14-,15-,17-,18-,20+,21+,22-,25-,26+,27+/m1/s1	RDUAJIJVNHKTQC-UJECXLDQSA-N					compound annotation
0391_012109	coumarin	C9H6O2	2.2805	323		O=c1ccc2ccccc2o1	InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H	ZYGHJZDHTFUPRJ-UHFFFAOYSA-N					compound annotation
0391_012110	staurosporine	C28H26N4O3	2.7076	44259	C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c31	InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1	HKSZLNNOFSGOKW-FYTWVXJKSA-N					removed another duplicate entry; compound annotation
0391_012113	lumateperone	C24H28FN3O	3.0973	21302490	CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F	CN1CCN2c3c1cccc3C1CN(CCCC(=O)c3ccc(F)cc3)CCC12	InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1	HOIIHACBCFLJET-SFTDATJTSA-N					removed another duplicate entry; compound annotation
0391_012115	CHEMBL4174914	C11H9Br3FNO	4.8871	145951693		CC1CCc2c(c(Br)c(Br)c(F)c2Br)N1C=O	InChI=1S/C11H9Br3FNO/c1-5-2-3-6-7(12)10(15)8(13)9(14)11(6)16(5)4-17/h4-5H,2-3H2,1H3	SVSYDDSARYTIKE-UHFFFAOYSA-N					compound annotation
0391_012116	L-kynurenine	C10H12N2O3	0.5497	6971029	C1=CC=C(C(=C1)C(=O)C[C@@H](C(=O)[O-])[NH3+])N	Nc1ccccc1C(=O)CC(N)C(=O)O	InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m0/s1	YGPSJZOEDVAXAB-QMMMGPOBSA-N					compound annotation
0391_012117	Apovincaminic acid	C20H22N2O2	1.8531	160154	CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)O	CCC12C=C(C(=O)O)n3c4c(CCN(CCC1)C42)c1ccccc13	InChI=1S/C20H22N2O2/c1-2-20-9-5-10-21-11-8-14-13-6-3-4-7-15(13)22(17(14)18(20)21)16(12-20)19(23)24/h3-4,6-7,12,18H,2,5,8-11H2,1H3,(H,23,24)/t18-,20+/m1/s1	ZFCQLDAGNBFMJQ-QUCCMNQESA-N					compound annotation
0391_012118	irinotecan	C33H38N4O6	2.319	60838	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7	CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2c1cc(OC(=O)N1CCC(N3CCCCC3)CC1)cc2	InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1	UWKQSNNFCGGAFS-XIFFEERXSA-N					doublet; compound annotation
0391_012119	TAMSULOSIN	C20H28N2O5S	2.3356	129211	CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N	CCOc1ccccc1OCCNC(C)Cc1cc(S(N)(=O)=O)c(OC)cc1	InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1	DRHKJLXJIQTDTD-OAHLLOKOSA-N					removed another duplicate entry; compound annotation
0391_012121	Setiptiline	C19H19N	2.6845	5205		CN1CCC2=C(C1)c1ccccc1Cc1ccccc21	InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3	GVPIXRLYKVFFMK-UHFFFAOYSA-N					doublet; compound annotation
0391_012122	loxapine	C18H18ClN3O	2.8739	3964		CN1CCN(C2=Nc3ccccc3Oc3c2cc(Cl)cc3)CC1	InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3	XJGVXQDUIWGIRW-UHFFFAOYSA-N					doublet; compound annotation
0391_012123	BCL6-IN-5	C17H19Cl2N5O2	3.1466	135386935		Cn1c(=O)n(CCC(C)(C)O)c2c1ccc(Nc1nc(Cl)ncc1Cl)c2	InChI=1S/C17H19Cl2N5O2/c1-17(2,26)6-7-24-13-8-10(4-5-12(13)23(3)16(24)25)21-14-11(18)9-20-15(19)22-14/h4-5,8-9,26H,6-7H2,1-3H3,(H,20,21,22)	NKMQWLPBEJJYCN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012125	Azaperone	C19H22FN3O	1.7008	15443		O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1	InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2	XTKDAFGWCDAMPY-UHFFFAOYSA-N					compound annotation
0391_012126	AZD2014	C25H30N6O3	2.4203	25262792	C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOC[C@@H]5C	CNC(=O)c1cccc(-c2nc3c(cc2)c(N2CCOCC2C)nc(N2CCOCC2C)n3)c1	InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1	JUSFANSTBFGBAF-IRXDYDNUSA-N					compound annotation
0391_012127	quetiapine	C21H25N3O2S	2.5319	5002		OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc23)CC1	InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2	URKOMYMAXPYINW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012129	Fluphenazine decanoate	C32H44F3N3O2S	5.402	3388		CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3c2cc(C(F)(F)F)cc3)CC1	InChI=1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3	VIQCGTZFEYDQMR-UHFFFAOYSA-N					compound annotation
0391_012130	PAF C-16-d4	C26H55NO7P+	5.7348	108157	CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C	CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC(C)=O	InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/p+1/t26-/m1/s1	HVAUUPRFYPCOCA-AREMUKBSSA-O					doublet; compound annotation
0391_012131	PAF C-16-d4	C26H55NO7P+	5.7853	108157	CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C	CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC(C)=O	InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/p+1/t26-/m1/s1	HVAUUPRFYPCOCA-AREMUKBSSA-O					doublet; compound annotation
0391_012132	MS117	C17H22N4O	0.9659	138753329		C=CC(=O)Nc1cccc(-c2c[nH]cc2CN(C)CCN)c1	InChI=1S/C17H22N4O/c1-3-17(22)20-15-6-4-5-13(9-15)16-11-19-10-14(16)12-21(2)8-7-18/h3-6,9-11,19H,1,7-8,12,18H2,2H3,(H,20,22)	HVDMIAFOVVMNJF-UHFFFAOYSA-N					compound annotation
0391_012133	methotrexate	C20H22N8O5	1.3476	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1	InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1	FBOZXECLQNJBKD-ZDUSSCGKSA-N					doublet; compound annotation
0391_012134	(S)-UFR2709	C13H17NO2	1.5566	73351944	CN1CCC[C@H]1COC(=O)C2=CC=CC=C2	CN1CCCC1COC(=O)c1ccccc1	InChI=1S/C13H17NO2/c1-14-9-5-8-12(14)10-16-13(15)11-6-3-2-4-7-11/h2-4,6-7,12H,5,8-10H2,1H3/t12-/m0/s1	PXVQMUATEFMGFD-LBPRGKRZSA-N					compound annotation
0391_012135	Iobenguane	C8H10IN3	1.8829	60860		NC(N)=NCc1cc(I)ccc1	InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)	PDWUPXJEEYOOTR-UHFFFAOYSA-N					compound annotation
0391_012136	Solifenacin	C23H26N2O2	3.1774	154059	C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5	O=C(OC1CN2CCC1CC2)N1CCc2ccccc2C1c1ccccc1	InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1	FBOUYBDGKBSUES-VXKWHMMOSA-N					doublet; compound annotation
0391_012137	Saikosaponin A	C42H68O13	3.754	167928	C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@H]([C@]2(C)CO)CC[C@@]4([C@@H]3C=C[C@@]56[C@]4(C[C@@H]([C@@]7([C@H]5CC(CC7)(C)C)CO6)O)C)C)C)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O	CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC35OCC6(CCC(C)(C)CC63)C(O)CC45C)C2(C)CO)C(O)C(OC2OC(CO)C(O)C(O)C2O)C1O	InChI=1S/C42H68O13/c1-21-28(46)33(55-34-31(49)30(48)29(47)22(18-43)53-34)32(50)35(52-21)54-27-10-11-37(4)23(38(27,5)19-44)8-12-39(6)24(37)9-13-42-25-16-36(2,3)14-15-41(25,20-51-42)26(45)17-40(39,42)7/h9,13,21-35,43-50H,8,10-12,14-20H2,1-7H3/t21-,22-,23-,24-,25-,26+,27+,28+,29-,30+,31-,32-,33+,34+,35+,37+,38+,39-,40+,41-,42+/m1/s1	KYWSCMDFVARMPN-MSSMMRRTSA-N					compound annotation
0391_012138	tamoxifen	C26H29NO	4.1276	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-	NKANXQFJJICGDU-QPLCGJKRSA-N					doublet; compound annotation
0391_012139	tamoxifen	C26H29NO	4.288	2733526	CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3	CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1	InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-	NKANXQFJJICGDU-QPLCGJKRSA-N					doublet; compound annotation
0391_012140	521310-51-0	C33H36N2O3	4.3166	10229237		COc1c(OCc2ccccc2)ccc(CN(CCc2ccccn2)C(=O)CCCCc2ccccc2)c1	InChI=1S/C33H36N2O3/c1-37-32-24-29(19-20-31(32)38-26-28-15-6-3-7-16-28)25-35(23-21-30-17-10-11-22-34-30)33(36)18-9-8-14-27-12-4-2-5-13-27/h2-7,10-13,15-17,19-20,22,24H,8-9,14,18,21,23,25-26H2,1H3	JWLZIHLAMJDONF-UHFFFAOYSA-N					doublet; compound annotation
0391_012141	521310-51-0	C33H36N2O3	4.3196	10229237		COc1c(OCc2ccccc2)ccc(CN(CCc2ccccn2)C(=O)CCCCc2ccccc2)c1	InChI=1S/C33H36N2O3/c1-37-32-24-29(19-20-31(32)38-26-28-15-6-3-7-16-28)25-35(23-21-30-17-10-11-22-34-30)33(36)18-9-8-14-27-12-4-2-5-13-27/h2-7,10-13,15-17,19-20,22,24H,8-9,14,18,21,23,25-26H2,1H3	JWLZIHLAMJDONF-UHFFFAOYSA-N					doublet; compound annotation
0391_012142	chloroquine	C18H26ClN3	1.2369	2719		CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2ncc1	InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)	WHTVZRBIWZFKQO-UHFFFAOYSA-N					doublet; compound annotation
0391_012143	quetiapine	C21H25N3O2S	2.5292	5002		OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc23)CC1	InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2	URKOMYMAXPYINW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012145	fluvoxamine	C15H21F3N2O2	3.1288	5324346	COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F	COCCCCC(=NOCCN)c1ccc(C(F)(F)F)cc1	InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+	CJOFXWAVKWHTFT-XSFVSMFZSA-N					compound annotation
0391_012146	ICCB280	C23H18N2O4	3.4735	135500267	COC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)/C=C/C4=CC(=C(C=C4)O)O	COc1ccccc1-n1c(C=Cc2cc(O)c(O)cc2)nc2ccccc2c1=O	InChI=1S/C23H18N2O4/c1-29-21-9-5-4-8-18(21)25-22(13-11-15-10-12-19(26)20(27)14-15)24-17-7-3-2-6-16(17)23(25)28/h2-14,26-27H,1H3/b13-11+	OTKDKQJFWIGZLU-ACCUITESSA-N					doublet; compound annotation
0391_012147	ICCB280	C23H18N2O4	3.477	135500267	COC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)/C=C/C4=CC(=C(C=C4)O)O	COc1ccccc1-n1c(C=Cc2cc(O)c(O)cc2)nc2ccccc2c1=O	InChI=1S/C23H18N2O4/c1-29-21-9-5-4-8-18(21)25-22(13-11-15-10-12-19(26)20(27)14-15)24-17-7-3-2-6-16(17)23(25)28/h2-14,26-27H,1H3/b13-11+	OTKDKQJFWIGZLU-ACCUITESSA-N					doublet; compound annotation
0391_012148	BAY 73-1449	C26H23N3O3	3.5539	9910289	C1=CC=C(C=C1)C[C@H](C(=O)O)NC2=NC=NC(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4	O=C(O)C(Cc1ccccc1)Nc1ncnc(-c2ccc(OCc3ccccc3)cc2)c1	InChI=1S/C26H23N3O3/c30-26(31)24(15-19-7-3-1-4-8-19)29-25-16-23(27-18-28-25)21-11-13-22(14-12-21)32-17-20-9-5-2-6-10-20/h1-14,16,18,24H,15,17H2,(H,30,31)(H,27,28,29)/t24-/m1/s1	RRYFPNITZGCUPZ-XMMPIXPASA-N					removed another duplicate entry; compound annotation
0391_012150	RAF709	C28H29F3N4O4	3.5787	90408826		Cc1c(-c2cc(N3CCOCC3)c(OC3CCOCC3)nc2)cc(NC(=O)c2cc(C(F)(F)F)ccc2)cn1	InChI=1S/C28H29F3N4O4/c1-18-24(15-22(17-32-18)34-26(36)19-3-2-4-21(13-19)28(29,30)31)20-14-25(35-7-11-38-12-8-35)27(33-16-20)39-23-5-9-37-10-6-23/h2-4,13-17,23H,5-12H2,1H3,(H,34,36)	FYNMINFUAIDIFL-UHFFFAOYSA-N					doublet; compound annotation
0391_012151	RAF709	C28H29F3N4O4	3.5814	90408826		Cc1c(-c2cc(N3CCOCC3)c(OC3CCOCC3)nc2)cc(NC(=O)c2cc(C(F)(F)F)ccc2)cn1	InChI=1S/C28H29F3N4O4/c1-18-24(15-22(17-32-18)34-26(36)19-3-2-4-21(13-19)28(29,30)31)20-14-25(35-7-11-38-12-8-35)27(33-16-20)39-23-5-9-37-10-6-23/h2-4,13-17,23H,5-12H2,1H3,(H,34,36)	FYNMINFUAIDIFL-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012153	DEVAZEPIDE	C25H20N4O2	4.3497	443375	CN1C2=CC=CC=C2C(=N[C@@H](C1=O)NC(=O)C3=CC4=CC=CC=C4N3)C5=CC=CC=C5	CN1C(=O)C(NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21	InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1	NFHRQQKPEBFUJK-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_012155	Regorafenib	C21H15ClF4N4O3	4.7208	11167602		CNC(=O)c1nccc(Oc2cc(F)c(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3)cc2)c1	InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)	FNHKPVJBJVTLMP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012157	nizatidine	C12H21N5O2S2	0.5638	3033637	CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1	InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+	SGXXNSQHWDMGGP-IZZDOVSWSA-N					removed another duplicate entry; compound annotation
0391_012159	dorsomorphin	C24H25N5O	1.54	11524144		c1nccc(-c2c3ncc(-c4ccc(OCCN5CCCCC5)cc4)cn3nc2)c1	InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2	XHBVYDAKJHETMP-UHFFFAOYSA-N					doublet; compound annotation
0391_012160	Camostat	C20H22N4O5	1.9703	2536		CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(N=C(N)N)cc2)cc1	InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)	XASIMHXSUQUHLV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012162	diosmin	C28H32O15	2.1235	5281613	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O	COc1c(O)cc(-c2cc(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3o2)cc1	InChI=1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1	GZSOSUNBTXMUFQ-YFAPSIMESA-N					compound annotation
0391_012163	Camptothecin-20-O-propionate	C23H20N2O5	3.6598	9887472	CCC(=O)O[C@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)CC	CCC(=O)OC1(CC)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O	InChI=1S/C23H20N2O5/c1-3-19(26)30-23(4-2)16-10-18-20-14(9-13-7-5-6-8-17(13)24-20)11-25(18)21(27)15(16)12-29-22(23)28/h5-10H,3-4,11-12H2,1-2H3/t23-/m0/s1	YCNIQYLWIPCLNY-QHCPKHFHSA-N					compound annotation
0391_012164	ML 145	C24H22N2O5S2	4.9862	2286812	C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CCCC(=O)NC3=CC(=C(C=C3)C(=O)O)O	CC(=Cc1ccccc1)C=C1SC(=S)N(CCCC(=O)Nc2cc(O)c(C(=O)O)cc2)C1=O	InChI=1S/C24H22N2O5S2/c1-15(12-16-6-3-2-4-7-16)13-20-22(29)26(24(32)33-20)11-5-8-21(28)25-17-9-10-18(23(30)31)19(27)14-17/h2-4,6-7,9-10,12-14,27H,5,8,11H2,1H3,(H,25,28)(H,30,31)/b15-12+,20-13-	COFMYJWNXSFLKQ-QIROLCGISA-N					doublet; compound annotation
0391_012165	ML 145	C24H22N2O5S2	5.0555	2286812	C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CCCC(=O)NC3=CC(=C(C=C3)C(=O)O)O	CC(=Cc1ccccc1)C=C1SC(=S)N(CCCC(=O)Nc2cc(O)c(C(=O)O)cc2)C1=O	InChI=1S/C24H22N2O5S2/c1-15(12-16-6-3-2-4-7-16)13-20-22(29)26(24(32)33-20)11-5-8-21(28)25-17-9-10-18(23(30)31)19(27)14-17/h2-4,6-7,9-10,12-14,27H,5,8,11H2,1H3,(H,25,28)(H,30,31)/b15-12+,20-13-	COFMYJWNXSFLKQ-QIROLCGISA-N					doublet; compound annotation
0391_012166	N-Acetyl-L-tyrosine	C11H13NO4	1.0188	68310	CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O	CC(=O)NC(Cc1ccc(O)cc1)C(=O)O	InChI=1S/C11H13NO4/c1-7(13)12-10(11(15)16)6-8-2-4-9(14)5-3-8/h2-5,10,14H,6H2,1H3,(H,12,13)(H,15,16)/t10-/m0/s1	CAHKINHBCWCHCF-JTQLQIEISA-N					compound annotation
0391_012167	Belinostat	C15H14N2O4S	2.6624	6918638	C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO	O=C(C=Cc1cc(S(=O)(=O)Nc2ccccc2)ccc1)NO	InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+	NCNRHFGMJRPRSK-MDZDMXLPSA-N					compound annotation
0391_012168	Rubitecan	C20H15N3O6	2.8732	472335	CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O	CCC1(O)C(=O)OCc2c1cc1-c3nc4c(cc3Cn1c2=O)c([N+](=O)[O-])ccc4	InChI=1S/C20H15N3O6/c1-2-20(26)13-7-16-17-10(8-22(16)18(24)12(13)9-29-19(20)25)6-11-14(21-17)4-3-5-15(11)23(27)28/h3-7,26H,2,8-9H2,1H3/t20-/m0/s1	VHXNKPBCCMUMSW-FQEVSTJZSA-N					compound annotation
0391_012169	Azeliragon	C32H38ClN3O2	3.6282	11180124		CCCCc1nc(-c2ccc(OCCCN(CC)CC)cc2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1	InChI=1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3	KJNNWYBAOPXVJY-UHFFFAOYSA-N					compound annotation
0391_012170	DTHIB	C13H9ClFN3O3	4.2936	108866909		O=C(Nc1ccc(F)cc1)Nc1cc([N+](=O)[O-])c(Cl)cc1	InChI=1S/C13H9ClFN3O3/c14-11-6-5-10(7-12(11)18(20)21)17-13(19)16-9-3-1-8(15)2-4-9/h1-7H,(H2,16,17,19)	DWVIOMKFHSRQQM-UHFFFAOYSA-N					compound annotation
0391_012171	Mefenpyr-diethyl	C16H18Cl2N2O4	5.0472	10937610		CCOC(=O)C1=NN(c2c(Cl)cc(Cl)cc2)C(C)(C(=O)OCC)C1	InChI=1S/C16H18Cl2N2O4/c1-4-23-14(21)12-9-16(3,15(22)24-5-2)20(19-12)13-7-6-10(17)8-11(13)18/h6-8H,4-5,9H2,1-3H3	OPGCOAPTHCZZIW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012173	amantadine	C10H17N	1.4711	2130		NC12CC3CC(CC(C3)C1)C2	InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2	DKNWSYNQZKUICI-UHFFFAOYSA-N					compound annotation
0391_012174	doxorubicin	C27H29NO11	2.4456	31703	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O	COc1cccc2c1C(=O)c1c(O)c3c(CC(O)(C(=O)CO)CC3OC3CC(N)C(O)C(C)O3)c(O)c1C2=O	InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1	AOJJSUZBOXZQNB-TZSSRYMLSA-N					compound annotation
0391_012175	Rotigotine	C19H25NOS	2.6442	59227	CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O	CCCN(CCc1cccs1)C1CCc2c(cccc2O)C1	InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1	KFQYTPMOWPVWEJ-INIZCTEOSA-N					doublet; compound annotation
0391_012176	cilazapril	C22H31N3O5	2.9155	56330	CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O	CCOC(=O)C(CCc1ccccc1)NC1CCCN2CCCC(C(=O)O)N2C1=O	InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1	HHHKFGXWKKUNCY-FHWLQOOXSA-N					compound annotation
0391_012177	Dihydroartemisinin	C15H24O5	3.595	3000518	C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C	CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4	InChI=1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12+,13-,14-,15-/m1/s1	BJDCWCLMFKKGEE-ISOSDAIHSA-N					compound annotation
0391_012178	NF-kappaBeta activator 1	C16H11FN2O2S	4.0675	151901137		O=C(O)c1cccc(-c2csc(Nc3ccccc3F)n2)c1	InChI=1S/C16H11FN2O2S/c17-12-6-1-2-7-13(12)18-16-19-14(9-22-16)10-4-3-5-11(8-10)15(20)21/h1-9H,(H,18,19)(H,20,21)	SSUFECODNVILSX-UHFFFAOYSA-N					compound annotation
0391_012179	UK 356618	C34H43N3O4	4.7923	10370504	CC1=C(C=CC(=C1)CCC[C@H](CC(=O)NO)C(=O)N[C@H](C(=O)N[C@H](C)C2=CC=CC=C2)C(C)(C)C)C3=CC=CC=C3	Cc1c(-c2ccccc2)ccc(CCCC(CC(=O)NO)C(=O)NC(C(=O)NC(C)c2ccccc2)C(C)(C)C)c1	InChI=1S/C34H43N3O4/c1-23-21-25(19-20-29(23)27-16-10-7-11-17-27)13-12-18-28(22-30(38)37-41)32(39)36-31(34(3,4)5)33(40)35-24(2)26-14-8-6-9-15-26/h6-11,14-17,19-21,24,28,31,41H,12-13,18,22H2,1-5H3,(H,35,40)(H,36,39)(H,37,38)/t24-,28-,31-/m1/s1	JJHRUUKMPWUYIB-HVOSOHGQSA-N					removed another duplicate entry; compound annotation
0391_012181	SWE101	C19H15Cl2NO3	5.0696	139035063		O=C(O)CCCc1nc(-c2cc(Cl)c(Cl)cc2)c(-c2ccccc2)o1	InChI=1S/C19H15Cl2NO3/c20-14-10-9-13(11-15(14)21)18-19(12-5-2-1-3-6-12)25-16(22-18)7-4-8-17(23)24/h1-3,5-6,9-11H,4,7-8H2,(H,23,24)	UIADWSXPNFQQCZ-UHFFFAOYSA-N					compound annotation
0391_012182	Melanin probe-1	C12H18FN3O	1.03	71562765		CCN(CC)CCNC(=O)c1ncc(F)cc1	InChI=1S/C12H18FN3O/c1-3-16(4-2)8-7-14-12(17)11-6-5-10(13)9-15-11/h5-6,9H,3-4,7-8H2,1-2H3,(H,14,17)	TWRNBUQZDSVURX-UHFFFAOYSA-N					compound annotation
0391_012183	Fidarestat	C12H10FN3O4	1.5114	160024	C1[C@H](OC2=C([C@]13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N	NC(=O)C1CC2(NC(=O)NC2=O)c2c(ccc(F)c2)O1	InChI=1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12-/m0/s1	WAAPEIZFCHNLKK-UFBFGSQYSA-N					compound annotation
0391_012184	SCHEMBL18818234	C26H25NO2PS+	2.8451	54761419		Cc1c(CCOC(=O)C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)scn1	InChI=1S/C26H25NO2PS/c1-21-25(31-20-27-21)17-18-29-26(28)19-30(22-11-5-2-6-12-22,23-13-7-3-8-14-23)24-15-9-4-10-16-24/h2-16,20H,17-19H2,1H3/q+1	SXHOZMKCSIRFRM-UHFFFAOYSA-N					compound annotation
0391_012185	CHEMBL4216092	C28H28ClN3O5	3.5523	25174437		O=C(COCC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1)Nc1c(C(=O)O)cc(Cl)cc1	InChI=1S/C28H28ClN3O5/c29-22-11-12-24(23(17-22)28(35)36)30-25(33)18-37-19-26(34)31-13-15-32(16-14-31)27(20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-12,17,27H,13-16,18-19H2,(H,30,33)(H,35,36)	NYFQDUPIZKZQAX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012187	mTOR inhibitor-8	C24H19ClN4OS	4.3624	154573769		COc1ccc(C2CC(c3ccc(Cl)cc3)=NN2c2nc(-c3ccncc3)cs2)cc1	InChI=1S/C24H19ClN4OS/c1-30-20-8-4-18(5-9-20)23-14-21(16-2-6-19(25)7-3-16)28-29(23)24-27-22(15-31-24)17-10-12-26-13-11-17/h2-13,15,23H,14H2,1H3	YYORGGAMBAZQIJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012189	progesterone	C21H30O2	4.5441	5994	CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1	RJKFOVLPORLFTN-LEKSSAKUSA-N					compound annotation
0391_012190	153559-76-3	C24H29NO2	6.0366	3922		Cc1cc2c(cc1C1(c3ncc(C(=O)O)cc3)CC1)C(C)(C)CCC2(C)C	InChI=1S/C24H29NO2/c1-15-12-18-19(23(4,5)9-8-22(18,2)3)13-17(15)24(10-11-24)20-7-6-16(14-25-20)21(26)27/h6-7,12-14H,8-11H2,1-5H3,(H,26,27)	SLXTWXQUEZSSTJ-UHFFFAOYSA-N					compound annotation
0391_012191	pirenzepine	C19H21N5O2	1.3905	4848		CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3c2nccc3)CC1	InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)	RMHMFHUVIITRHF-UHFFFAOYSA-N					compound annotation
0391_012192	RET-IN-3	C18H21N5O2	2.2174	146018674		CN(C)CCCNc1nc2c(-c3cc4c(cc3)OCO4)cnn2cc1	InChI=1S/C18H21N5O2/c1-22(2)8-3-7-19-17-6-9-23-18(21-17)14(11-20-23)13-4-5-15-16(10-13)25-12-24-15/h4-6,9-11H,3,7-8,12H2,1-2H3,(H,19,21)	DQYRQFLRDJTHQM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012194	WSF1-IN-1	C20H21F3N8O	2.3222	146194099	C[C@H]1C(=O)NC2=C(N=C(N=C2N1C)NCC3=CN(N=C3)CC4=CN=C(C=C4)C(F)(F)F)C	Cc1c2NC(=O)C(C)N(C)c2nc(NCc2cn(Cc3cnc(C(F)(F)F)cc3)nc2)n1	InChI=1S/C20H21F3N8O/c1-11-16-17(30(3)12(2)18(32)28-16)29-19(27-11)25-7-14-8-26-31(10-14)9-13-4-5-15(24-6-13)20(21,22)23/h4-6,8,10,12H,7,9H2,1-3H3,(H,28,32)(H,25,27,29)/t12-/m0/s1	KKHCZENFFDIZHM-LBPRGKRZSA-N					compound annotation
0391_012195	CYCLAPOLIN 9	C9H4F3N3O4S	2.9287	2779952		NC(=O)c1[n+]([O-])c2c(s1)c([N+](=O)[O-])cc(C(F)(F)F)c2	InChI=1S/C9H4F3N3O4S/c10-9(11,12)3-1-4-6(5(2-3)15(18)19)20-8(7(13)16)14(4)17/h1-2H,(H2,13,16)	FHFLXKUKCSDMLD-UHFFFAOYSA-N					compound annotation
0391_012196	vinpocetine	C22H26N2O2	3.0843	443955	CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC	CCOC(=O)C1=CC2(CC)CCCN3CCc4c(C32)n1c1ccccc41	InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1	DDNCQMVWWZOMLN-IRLDBZIGSA-N					compound annotation
0391_012197	Pitolisant	C17H26ClNO	3.1618	9948102		Clc1ccc(CCCOCCCN2CCCCC2)cc1	InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2	NNACHAUCXXVJSP-UHFFFAOYSA-N					compound annotation
0391_012198	alpelisib	C19H22F3N5O2S	3.2075	56649450	CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F	Cc1c(-c2cc(C(C)(C)C(F)(F)F)ncc2)sc(NC(=O)N2CCCC2C(N)=O)n1	InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1	STUWGJZDJHPWGZ-LBPRGKRZSA-N					compound annotation
0391_012199	Aclidinium	C26H30NO4S2+	3.3512	11434515	C1C[N+]2(CCC1[C@H](C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5	O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1	InChI=1S/C26H30NO4S2/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2/q+1/t20?,22-,27?/m0/s1	ASMXXROZKSBQIH-VITNCHFBSA-N					compound annotation
0391_012200	CORTISONE ACETATE	C23H30O6	3.4844	5745	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3C(=O)CC21C	InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1	ITRJWOMZKQRYTA-RFZYENFJSA-N					compound annotation
0391_012201	quinidine	C20H24N2O2	1.4426	441074	COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccc(OC)cc12	InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1	LOUPRKONTZGTKE-LHHVKLHASA-N					doublet; compound annotation
0391_012202	D-Ala-Lys-AMCA	C21H28N4O6	1.4639	101147902	CC1=C(C(=O)OC2=C1C=CC(=C2)N)CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@@H](C)N	Cc1c(CC(=O)NCCCCC(NC(=O)C(C)N)C(=O)O)c(=O)oc2c1ccc(N)c2	InChI=1S/C21H28N4O6/c1-11-14-7-6-13(23)9-17(14)31-21(30)15(11)10-18(26)24-8-4-3-5-16(20(28)29)25-19(27)12(2)22/h6-7,9,12,16H,3-5,8,10,22-23H2,1-2H3,(H,24,26)(H,25,27)(H,28,29)/t12-,16+/m1/s1	JBMWHNASOBPJQQ-WBMJQRKESA-N					removed another duplicate entry; compound annotation
0391_012204	WF-47-JS03	C30H38N6O2	1.9305	145996543		COc1c(OC)cc(-c2c3nc(NC4CC(C)(C)N(C)C(C)(C)C4)c(-c4ccccc4)c(N)n3nc2)cc1	InChI=1S/C30H38N6O2/c1-29(2)16-21(17-30(3,4)35(29)5)33-27-25(19-11-9-8-10-12-19)26(31)36-28(34-27)22(18-32-36)20-13-14-23(37-6)24(15-20)38-7/h8-15,18,21H,16-17,31H2,1-7H3,(H,33,34)	YRBWLEAMGAGYBK-UHFFFAOYSA-N					doublet; compound annotation
0391_012205	Heptamidine	C21H28N4O2	2.2144	9929221		N=C(N)c1ccc(OCCCCCCCOc2ccc(C(=N)N)cc2)cc1	InChI=1S/C21H28N4O2/c22-20(23)16-6-10-18(11-7-16)26-14-4-2-1-3-5-15-27-19-12-8-17(9-13-19)21(24)25/h6-13H,1-5,14-15H2,(H3,22,23)(H3,24,25)	IUJKKCRARYRWFG-UHFFFAOYSA-N					compound annotation
0391_012206	WF-47-JS03	C30H38N6O2	3.1117	145996543		COc1c(OC)cc(-c2c3nc(NC4CC(C)(C)N(C)C(C)(C)C4)c(-c4ccccc4)c(N)n3nc2)cc1	InChI=1S/C30H38N6O2/c1-29(2)16-21(17-30(3,4)35(29)5)33-27-25(19-11-9-8-10-12-19)26(31)36-28(34-27)22(18-32-36)20-13-14-23(37-6)24(15-20)38-7/h8-15,18,21H,16-17,31H2,1-7H3,(H,33,34)	YRBWLEAMGAGYBK-UHFFFAOYSA-N					doublet; compound annotation
0391_012207	WF-47-JS03	C30H38N6O2	3.1146	145996543		COc1c(OC)cc(-c2c3nc(NC4CC(C)(C)N(C)C(C)(C)C4)c(-c4ccccc4)c(N)n3nc2)cc1	InChI=1S/C30H38N6O2/c1-29(2)16-21(17-30(3,4)35(29)5)33-27-25(19-11-9-8-10-12-19)26(31)36-28(34-27)22(18-32-36)20-13-14-23(37-6)24(15-20)38-7/h8-15,18,21H,16-17,31H2,1-7H3,(H,33,34)	YRBWLEAMGAGYBK-UHFFFAOYSA-N					doublet; compound annotation
0391_012208	cloprostenol	C22H29ClO6	3.3784	5311053	C1[C@@H]([C@@H]([C@H]([C@@H]1O)/C=C/[C@H](COC2=CC(=CC=C2)Cl)O)C/C=C\CCCC(=O)O)O	O=C(O)CCCC=CCC1C(O)CC(O)C1C=CC(O)COc1cc(Cl)ccc1	InChI=1S/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1	VJGGHXVGBSZVMZ-QIZQQNKQSA-N					doublet; compound annotation
0391_012209	Palmatine	C21H22NO4+	2.4962	19009		COc1c(OC)cc2c(c1)CC[n+]1c-2cc2ccc(OC)c(OC)c2c1	InChI=1S/C21H22NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,9-12H,7-8H2,1-4H3/q+1	QUCQEUCGKKTEBI-UHFFFAOYSA-N					compound annotation
0391_012210	sildenafil	C22H30N6O4S	2.7427	135398744		CCCc1nn(C)c2c1[nH]c(-c1c(OCC)ccc(S(=O)(=O)N3CCN(C)CC3)c1)nc2=O	InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)	BNRNXUUZRGQAQC-UHFFFAOYSA-N					doublet; compound annotation
0391_012211	dicyclomine	C19H35NO2	3.7497	3042		CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1	InChI=1S/C19H35NO2/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17/h17H,3-16H2,1-2H3	CURUTKGFNZGFSE-UHFFFAOYSA-N					compound annotation
0391_012212	2'-METHYLACETOPHENONE	C9H10O	4.322	11340		CC(=O)c1ccccc1C	InChI=1S/C9H10O/c1-7-5-3-4-6-9(7)8(2)10/h3-6H,1-2H3	YXWWHNCQZBVZPV-UHFFFAOYSA-N					compound annotation
0391_012213	Afatinib	C24H25ClFN5O3	2.0273	10184653	CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4	CN(C)CC=CC(=O)Nc1c(OC2CCOC2)cc2ncnc(Nc3cc(Cl)c(F)cc3)c2c1	InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1	ULXXDDBFHOBEHA-CWDCEQMOSA-N					doublet; compound annotation
0391_012214	160588-45-4	C26H18F2N2O	3.9658	9887884		O=C1c2ccccc2C(Cc2cc(F)ncc2)(Cc2cc(F)ncc2)c2ccccc12	InChI=1S/C26H18F2N2O/c27-23-13-17(9-11-29-23)15-26(16-18-10-12-30-24(28)14-18)21-7-3-1-5-19(21)25(31)20-6-2-4-8-22(20)26/h1-14H,15-16H2	MUJBUUDUXGDXLW-UHFFFAOYSA-N					compound annotation
0391_012215	Venetoclax	C45H50ClN7O7S	4.4683	49846579		CC1(C)CCC(CN2CCN(c3cc(Oc4cnc5[nH]ccc5c4)c(C(=O)NS(=O)(=O)c4cc([N+](=O)[O-])c(NCC5CCOCC5)cc4)cc3)CC2)=C(c2ccc(Cl)cc2)C1	InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)	LQBVNQSMGBZMKD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012217	BC-DXI-843	C28H26N4O4S2	4.7923	146673132	CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)NC4=NC(=CS4)C5=CC=C(C=C5)OC	COc1ccc(-c2csc(NC(=O)C(Cc3c[nH]c4ccccc34)NS(=O)(=O)c3ccc(C)cc3)n2)cc1	InChI=1S/C28H26N4O4S2/c1-18-7-13-22(14-8-18)38(34,35)32-25(15-20-16-29-24-6-4-3-5-23(20)24)27(33)31-28-30-26(17-37-28)19-9-11-21(36-2)12-10-19/h3-14,16-17,25,29,32H,15H2,1-2H3,(H,30,31,33)/t25-/m0/s1	VLPGAOXBMXGNGM-VWLOTQADSA-N					removed another duplicate entry; compound annotation
0391_012219	Geniposide	C17H24O10	1.479	107848	COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	COC(=O)C1=COC(OC2OC(CO)C(O)C(O)C2O)C2C(CO)=CCC12	InChI=1S/C17H24O10/c1-24-15(23)9-6-25-16(11-7(4-18)2-3-8(9)11)27-17-14(22)13(21)12(20)10(5-19)26-17/h2,6,8,10-14,16-22H,3-5H2,1H3/t8-,10-,11-,12-,13+,14-,16+,17+/m1/s1	IBFYXTRXDNAPMM-BVTMAQQCSA-N					compound annotation
0391_012220	norfloxacin	C16H18FN3O3	1.5017	4539		CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21	InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)	OGJPXUAPXNRGGI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012222	Baricitinib	C16H17N7O2S	1.7829	44205240		CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3c4cc[nH]c4ncn3)cn2)C1	InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)	XUZMWHLSFXCVMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012224	Lofexidine	C11H12Cl2N2O	1.8322	30668		CC(Oc1c(Cl)cccc1Cl)C1=NCCN1	InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)	KSMAGQUYOIHWFS-UHFFFAOYSA-N					doublet; compound annotation
0391_012225	Ropivacaine	C17H26N2O	2.0305	175805	CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C	CCCN1CCCCC1C(=O)Nc1c(C)cccc1C	InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1	ZKMNUMMKYBVTFN-HNNXBMFYSA-N					doublet; compound annotation
0391_012226	etoposide	C29H32O13	2.6878	36462	C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O	COc1cc(C2c3cc4c(cc3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)cc(OC)c1O	InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1	VJJPUSNTGOMMGY-MRVIYFEKSA-N					compound annotation
0391_012227	c-Kit-IN-3	C26H20ClF3N2O4	3.8073	139030518		COc1cc2nccc(Oc3ccc(NC(=O)Cc4cc(C(F)(F)F)c(Cl)cc4)cc3)c2cc1OC	InChI=1S/C26H20ClF3N2O4/c1-34-23-13-18-21(14-24(23)35-2)31-10-9-22(18)36-17-6-4-16(5-7-17)32-25(33)12-15-3-8-20(27)19(11-15)26(28,29)30/h3-11,13-14H,12H2,1-2H3,(H,32,33)	YOHLRCOPRAVUCJ-UHFFFAOYSA-N					doublet; compound annotation
0391_012228	766454-72-2	C14H14N2O	0.4876	6918822		C#CCN(C)Cc1c2cccnc2c(O)cc1	InChI=1S/C14H14N2O/c1-3-9-16(2)10-11-6-7-13(17)14-12(11)5-4-8-15-14/h1,4-8,17H,9-10H2,2H3	FQFLPZZATVCNLA-UHFFFAOYSA-N					compound annotation
0391_012229	N,N-Dimethylguanosine	C12H17N5O5	0.623	135501639	CN(C)C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	CN(C)c1nc(=O)c2c([nH]1)n(C1OC(CO)C(O)C1O)cn2	InChI=1S/C12H17N5O5/c1-16(2)12-14-9-6(10(21)15-12)13-4-17(9)11-8(20)7(19)5(3-18)22-11/h4-5,7-8,11,18-20H,3H2,1-2H3,(H,14,15,21)/t5-,7-,8-,11-/m1/s1	RSPURTUNRHNVGF-IOSLPCCCSA-N					removed another duplicate entry; compound annotation
0391_012231	Nafamostat	C19H17N5O2	1.1885	4413		N=C(N)c1cc2c(cc1)cc(OC(=O)c1ccc(N=C(N)N)cc1)cc2	InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)	MQQNFDZXWVTQEH-UHFFFAOYSA-N					compound annotation
0391_012232	proxyphylline	C10H14N4O3	1.3311	4977		CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C	InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3	KYHQZNGJUGFTGR-UHFFFAOYSA-N					compound annotation
0391_012233	Amarogentin	C29H30O13	2.4027	115149	C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC(=O)C4=C(C=C(C=C4O)O)C5=CC(=CC=C5)O	C=CC1C(OC2OC(CO)C(O)C(O)C2OC(=O)c2c(O)cc(O)cc2-c2cc(O)ccc2)OC=C2C(=O)OCCC21	InChI=1S/C29H30O13/c1-2-16-17-6-7-38-26(36)19(17)12-39-28(16)42-29-25(24(35)23(34)21(11-30)40-29)41-27(37)22-18(9-15(32)10-20(22)33)13-4-3-5-14(31)8-13/h2-5,8-10,12,16-17,21,23-25,28-35H,1,6-7,11H2/t16-,17+,21-,23-,24+,25-,28+,29+/m1/s1	DBOVHQOUSDWAPQ-WTONXPSSSA-N					removed another duplicate entry; compound annotation
0391_012235	vincristine	C46H56N4O10	2.533	5388993	CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3c(OC)cc4c(c3)C35CCN6CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C3N4C=O)C65)C2)C1	InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1	OGWKCGZFUXNPDA-CFWMRBGOSA-N					removed another duplicate entry; compound annotation
0391_012237	500-92-5	C11H16ClN5	2.5455	4923		CC(C)N=C(N)N=C(N)Nc1ccc(Cl)cc1	InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)	SSOLNOMRVKKSON-UHFFFAOYSA-N					compound annotation
0391_012238	AZD7624	C27H30FN5O3	2.6376	25143624		CNCCOc1ccccc1C1(Nc2nccn(-c3c(C)c(F)cc(C(=O)NC4CC4)c3)c2=O)CC1	InChI=1S/C27H30FN5O3/c1-17-21(28)15-18(25(34)31-19-7-8-19)16-22(17)33-13-11-30-24(26(33)35)32-27(9-10-27)20-5-3-4-6-23(20)36-14-12-29-2/h3-6,11,13,15-16,19,29H,7-10,12,14H2,1-2H3,(H,30,32)(H,31,34)	NNKPHNTWNILINE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012240	20312-36-1	C9H10O3	4.2867	444718	C1=CC=C(C=C1)C[C@@H](C(=O)O)O	O=C(O)C(O)Cc1ccccc1	InChI=1S/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)/t8-/m0/s1	VOXXWSYKYCBWHO-QMMMGPOBSA-N					compound annotation
0391_012241	N-Acetyltyramine	C10H13NO2	1.26	121051		CC(=O)NCCc1ccc(O)cc1	InChI=1S/C10H13NO2/c1-8(12)11-7-6-9-2-4-10(13)5-3-9/h2-5,13H,6-7H2,1H3,(H,11,12)	ATDWJOOPFDQZNK-UHFFFAOYSA-N					compound annotation
0391_012242	chromocarb	C10H6O4	1.26	2741		O=C(O)c1cc(=O)c2ccccc2o1	InChI=1S/C10H6O4/c11-7-5-9(10(12)13)14-8-4-2-1-3-6(7)8/h1-5H,(H,12,13)	RVMGXWBCQGAWBR-UHFFFAOYSA-N					compound annotation
0391_012243	hesperidin	C28H34O15	2.1677	10621	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O	COc1c(O)cc(C2CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2)cc1	InChI=1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1	QUQPHWDTPGMPEX-QJBIFVCTSA-N					removed another duplicate entry; compound annotation
0391_012245	Methylene Blue cation	C16H18N3S+	2.3426	4139		CN(C)c1cc2c(cc1)nc1ccc(=[N+](C)C)cc-1s2	InChI=1S/C16H18N3S/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13/h5-10H,1-4H3/q+1	RBTBFTRPCNLSDE-UHFFFAOYSA-N					compound annotation
0391_012246	Abiraterone acetate	C26H33NO2	4.7041	9821849	CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C	CC(=O)OC1CCC2(C)C(=CCC3C2CCC2(C)C(c4cnccc4)=CCC32)C1	InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1	UVIQSJCZCSLXRZ-UBUQANBQSA-N					compound annotation
0391_012247	tCFA15	C24H44O2	6.7666	9799188		CC1=C(CCCCCCCCCCCCCCCO)C(C)(C)CCC1=O	InChI=1S/C24H44O2/c1-21-22(24(2,3)19-18-23(21)26)17-15-13-11-9-7-5-4-6-8-10-12-14-16-20-25/h25H,4-20H2,1-3H3	FGMAOXGOTRUOKJ-UHFFFAOYSA-N					doublet; compound annotation
0391_012248	tCFA15	C24H44O2	6.7696	9799188		CC1=C(CCCCCCCCCCCCCCCO)C(C)(C)CCC1=O	InChI=1S/C24H44O2/c1-21-22(24(2,3)19-18-23(21)26)17-15-13-11-9-7-5-4-6-8-10-12-14-16-20-25/h25H,4-20H2,1-3H3	FGMAOXGOTRUOKJ-UHFFFAOYSA-N					doublet; compound annotation
0391_012249	temozolomide	C6H6N6O2	0.5672	5394		Cn1nnc2c(C(N)=O)ncn2c1=O	InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)	BPEGJWRSRHCHSN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012251	emedastine	C17H26N4O	1.1502	3219		CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21	InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3	KBUZBQVCBVDWKX-UHFFFAOYSA-N					compound annotation
0391_012252	piperidinyl]amino]sulfonyl]-1-naphthalenyl]-2-methyl-	C27H32N4O4S	2.8046	57564362	C[C@@H]1CN(CC[C@H]1NS(=O)(=O)C2=CC=C(C3=CC=CC=C32)NC(=O)C4=CC=CC=C4C)C(=O)[C@H](C)N	Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C(C)N)CC2C)c2ccccc12	InChI=1S/C27H32N4O4S/c1-17-8-4-5-9-20(17)26(32)29-24-12-13-25(22-11-7-6-10-21(22)24)36(34,35)30-23-14-15-31(16-18(23)2)27(33)19(3)28/h4-13,18-19,23,30H,14-16,28H2,1-3H3,(H,29,32)/t18-,19+,23-/m1/s1	FABRBEGQMXBELT-SELNLUPBSA-N					compound annotation
0391_012253	cmp-5	C21H21N3	3.0901	4722595		CCn1c2ccccc2c2c1ccc(CNCc1ccccn1)c2	InChI=1S/C21H21N3/c1-2-24-20-9-4-3-8-18(20)19-13-16(10-11-21(19)24)14-22-15-17-7-5-6-12-23-17/h3-13,22H,2,14-15H2,1H3	YPJMOVVQKBFRNH-UHFFFAOYSA-N					compound annotation
0391_012254	curcumin	C21H20O6	3.0931	969516	COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O	COc1c(O)ccc(C=CC(=O)CC(=O)C=Cc2cc(OC)c(O)cc2)c1	InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+	VFLDPWHFBUODDF-FCXRPNKRSA-N					doublet; compound annotation
0391_012255	curcumin	C21H20O6	3.0978	969516	COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O	COc1c(O)ccc(C=CC(=O)CC(=O)C=Cc2cc(OC)c(O)cc2)c1	InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+	VFLDPWHFBUODDF-FCXRPNKRSA-N					doublet; compound annotation
0391_012256	N-Nitrosodibutylamine	C8H18N2O	4.0224	13542		CCCCN(CCCC)N=O	InChI=1S/C8H18N2O/c1-3-5-7-10(9-11)8-6-4-2/h3-8H2,1-2H3	YGJHZCLPZAZIHH-UHFFFAOYSA-N					compound annotation
0391_012257	curcumin	C21H20O6	4.0299	969516	COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O	COc1c(O)ccc(C=CC(=O)CC(=O)C=Cc2cc(OC)c(O)cc2)c1	InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+	VFLDPWHFBUODDF-FCXRPNKRSA-N					doublet; compound annotation
0391_012258	sphingosine	C18H37NO2	4.6463	5280335	CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)N)O	CCCCCCCCCCCCCC=CC(O)C(N)CO	InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/b15-14+/t17-,18+/m0/s1	WWUZIQQURGPMPG-KRWOKUGFSA-N					compound annotation
0391_012259	AMILORIDE	C6H8ClN7O	0.7013	16231		NC(N)=NC(=O)c1c(N)nc(N)c(Cl)n1	InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)	XSDQTOBWRPYKKA-UHFFFAOYSA-N					doublet; compound annotation
0391_012260	Tofacitinib	C16H20N6O	1.4001	9926791	C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2c1cc[nH]2	InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1	UJLAWZDWDVHWOW-YPMHNXCESA-N					doublet; compound annotation
0391_012261	Baricitinib	C16H17N7O2S	1.7814	44205240		CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3c4cc[nH]c4ncn3)cn2)C1	InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)	XUZMWHLSFXCVMG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012263	tripelennamine	C16H21N3	1.9275	5587		CN(C)CCN(Cc1ccccc1)c1ccccn1	InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3	UFLGIAIHIAPJJC-UHFFFAOYSA-N					compound annotation
0391_012264	Prexasertib	C18H19N7O2	2.3167	46700756		COc1c(-c2cc(Nc3ncc(C#N)nc3)n[nH]2)c(OCCCN)ccc1	InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)	DOTGPNHGTYJDEP-UHFFFAOYSA-N					doublet; compound annotation
0391_012265	Levocetirizine	C21H25ClN2O3	3.2004	28145931	C1CN(CC[NH+]1CCOCC(=O)[O-])[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl	O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)/t21-/m1/s1	ZKLPARSLTMPFCP-OAQYLSRUSA-N					compound annotation
0391_012266	hydroxyprogesterone	C21H30O3	3.8638	6238	CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O	CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C	InChI=1S/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3/t16-,17+,18+,19+,20+,21+/m1/s1	DBPWSSGDRRHUNT-CEGNMAFCSA-N					compound annotation
0391_012267	Mangiferin	C19H18O11	1.3853	5281647	C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O	O=c1c2cc(O)c(O)cc2oc2c1c(O)c(C1OC(CO)C(O)C(O)C1O)c(O)c2	InChI=1S/C19H18O11/c20-4-11-15(25)17(27)18(28)19(30-11)12-8(23)3-10-13(16(12)26)14(24)5-1-6(21)7(22)2-9(5)29-10/h1-3,11,15,17-23,25-28H,4H2/t11-,15-,17+,18-,19+/m1/s1	AEDDIBAIWPIIBD-ZJKJAXBQSA-N					compound annotation
0391_012268	Sweroside	C16H22O9	1.5259	161036	C=C[C@@H]1[C@@H]2CCOC(=O)C2=CO[C@H]1O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O	C=CC1C(OC2OC(CO)C(O)C(O)C2O)OC=C2C(=O)OCCC21	InChI=1S/C16H22O9/c1-2-7-8-3-4-22-14(21)9(8)6-23-15(7)25-16-13(20)12(19)11(18)10(5-17)24-16/h2,6-8,10-13,15-20H,1,3-5H2/t7-,8+,10-,11-,12+,13-,15+,16+/m1/s1	VSJGJMKGNMDJCI-ZASXJUAOSA-N					removed another duplicate entry; compound annotation
0391_012270	5-bromo-N-(2-(diethylamino)ethyl)picolinamide	C12H18BrN3O	1.5785	62952677		CCN(CC)CCNC(=O)c1ncc(Br)cc1	InChI=1S/C12H18BrN3O/c1-3-16(4-2)8-7-14-12(17)11-6-5-10(13)9-15-11/h5-6,9H,3-4,7-8H2,1-2H3,(H,14,17)	BSMXWXBEJYOUAH-UHFFFAOYSA-N					compound annotation
0391_012271	vinblastine	C46H58N4O9	2.6893	13342	CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O	CCC1(O)CC2CN(CCc3c([nH]c4ccccc34)C(C(=O)OC)(c3c(OC)cc4c(c3)C35CCN6CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C3N4C)C65)C2)C1	InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1	JXLYSJRDGCGARV-CFWMRBGOSA-N					compound annotation
0391_012272	GZD856	C29H27F3N6O	3.5569	51037822		Cc1c(C#Cc2cn3nccc3nc2)cc(C(=O)Nc2cc(C(F)(F)F)c(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H27F3N6O/c1-20-3-5-23(15-22(20)6-4-21-17-33-27-9-10-34-38(27)18-21)28(39)35-25-8-7-24(26(16-25)29(30,31)32)19-37-13-11-36(2)12-14-37/h3,5,7-10,15-18H,11-14,19H2,1-2H3,(H,35,39)	FSLXBWOKEGSUPS-UHFFFAOYSA-N					compound annotation
0391_012273	220904-99-4	C15H8Br2ClNO2	4.1131	25014542	C1=CC2=C(C=C1Cl)/C(=C/C3=CC(=C(C(=C3)Br)O)Br)/C(=O)N2	O=C1Nc2c(cc(Cl)cc2)C1=Cc1cc(Br)c(O)c(Br)c1	InChI=1S/C15H8Br2ClNO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3-	MPIHOJMBMIMKAJ-KMKOMSMNSA-N					compound annotation
0391_012274	promazine	C17H20N2S	1.8957	4926		CN(C)CCCN1c2ccccc2Sc2ccccc21	InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3	ZGUGWUXLJSTTMA-UHFFFAOYSA-N					doublet; compound annotation
0391_012275	Fedratinib	C27H36N6O3S	2.0119	16722836		Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cc(S(=O)(=O)NC(C)(C)C)ccc1	InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)	JOOXLOJCABQBSG-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012277	Vofopitant	C21H23F3N6O	2.8839	6918331	COC1=C(C=C(C=C1)N2C(=NN=N2)C(F)(F)F)CN[C@H]3CCCN[C@H]3C4=CC=CC=C4	COc1c(CNC2CCCNC2c2ccccc2)cc(-n2nnnc2C(F)(F)F)cc1	InChI=1S/C21H23F3N6O/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3/t17-,19-/m0/s1	XILNRORTJVDYRH-HKUYNNGSSA-N					doublet; compound annotation
0391_012278	p38alpha inhibitor 2	C27H33N5O3	2.9677	25145735		CNCCOc1ccccc1C(C)(C)Nc1nccn(-c2c(C)ccc(C(=O)NC3CC3)c2)c1=O	InChI=1S/C27H33N5O3/c1-18-9-10-19(25(33)30-20-11-12-20)17-22(18)32-15-13-29-24(26(32)34)31-27(2,3)21-7-5-6-8-23(21)35-16-14-28-4/h5-10,13,15,17,20,28H,11-12,14,16H2,1-4H3,(H,29,31)(H,30,33)	SAZVRXTVWZAHBI-UHFFFAOYSA-N					compound annotation
0391_012279	promazine	C17H20N2S	2.9707	4926		CN(C)CCCN1c2ccccc2Sc2ccccc21	InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3	ZGUGWUXLJSTTMA-UHFFFAOYSA-N					doublet; compound annotation
0391_012280	promazine	C17H20N2S	2.9736	4926		CN(C)CCCN1c2ccccc2Sc2ccccc21	InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3	ZGUGWUXLJSTTMA-UHFFFAOYSA-N					doublet; compound annotation
0391_012281	dantrolene	C14H10N4O5	3.0232	2952		O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1	InChI=1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)	OZOMQRBLCMDCEG-UHFFFAOYSA-N					compound annotation
0391_012282	CDK5 inhibitor 20-223	C19H19N3O	3.8544	69761759		O=C(Cc1cc2ccccc2cc1)Nc1n[nH]c(C2CCC2)c1	InChI=1S/C19H19N3O/c23-19(20-18-12-17(21-22-18)15-6-3-7-15)11-13-8-9-14-4-1-2-5-16(14)10-13/h1-2,4-5,8-10,12,15H,3,6-7,11H2,(H2,20,21,22,23)	AGVIDDQHAQSPIZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012284	Bardoxolone	C31H41NO4	5.1907	400010	C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)C(=O)O	CC1(C)CCC2(C(=O)O)CCC3(C)C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1	TXGZJQLMVSIZEI-UQMAOPSPSA-N					compound annotation
0391_012285	PROFENOFOS	C11H15BrClO3PS	5.214	38779		CCCSP(=O)(OCC)Oc1c(Cl)cc(Br)cc1	InChI=1S/C11H15BrClO3PS/c1-3-7-18-17(14,15-4-2)16-11-6-5-9(12)8-10(11)13/h5-6,8H,3-4,7H2,1-2H3	QYMMJNLHFKGANY-UHFFFAOYSA-N					compound annotation
0391_012286	nitrofurazone	C6H6N4O4	1.3267	5447130	C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)N	NC(=O)NN=Cc1ccc([N+](=O)[O-])o1	InChI=1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+	IAIWVQXQOWNYOU-FPYGCLRLSA-N					compound annotation
0391_012287	RANOLAZINE	C24H33N3O4	2.5274	56959		COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1	InChI=1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29)	XKLMZUWKNUAPSZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012289	Istradefylline	C20H24N4O4	3.5531	5311037	CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C	CCn1c(=O)c2c(nc(C=Cc3cc(OC)c(OC)cc3)n2C)n(CC)c1=O	InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+	IQVRBWUUXZMOPW-PKNBQFBNSA-N					doublet; compound annotation
0391_012290	Istradefylline	C20H24N4O4	3.5562	5311037	CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C	CCn1c(=O)c2c(nc(C=Cc3cc(OC)c(OC)cc3)n2C)n(CC)c1=O	InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+	IQVRBWUUXZMOPW-PKNBQFBNSA-N					doublet; compound annotation
0391_012291	Istradefylline	C20H24N4O4	3.9611	5311037	CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C	CCn1c(=O)c2c(nc(C=Cc3cc(OC)c(OC)cc3)n2C)n(CC)c1=O	InChI=1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+	IQVRBWUUXZMOPW-PKNBQFBNSA-N					doublet; removed another duplicate entry; compound annotation
0391_012293	KS15	C20H22BrNO4	5.1367	25114872	CCO[C@H](CC1=CC(=CC=C1)/C(=N/OCC2=CC=C(C=C2)Br)/C)C(=O)O	CCOC(Cc1cc(C(C)=NOCc2ccc(Br)cc2)ccc1)C(=O)O	InChI=1S/C20H22BrNO4/c1-3-25-19(20(23)24)12-16-5-4-6-17(11-16)14(2)22-26-13-15-7-9-18(21)10-8-15/h4-11,19H,3,12-13H2,1-2H3,(H,23,24)/b22-14+/t19-/m1/s1	GWSVRVKPZVYTCS-VZMFNRANSA-N					compound annotation
0391_012294	Emtricitabine	C8H10FN3O3S	0.6455	60877	C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F	Nc1nc(=O)n(C2CSC(CO)O2)cc1F	InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1	XQSPYNMVSIKCOC-NTSWFWBYSA-N					removed another duplicate entry; compound annotation
0391_012296	dyphylline	C10H14N4O4	0.998	3182		Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O	InChI=1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3	KSCFJBIXMNOVSH-UHFFFAOYSA-N					compound annotation
0391_012297	SNIPER(ABL)-020	C44H59ClN10O8S	3.3349	138377570	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)C(=O)COCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](CC5=CC=CC=C5)N)O	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(C(=O)COCCOCCOCCNC(=O)C(CC(C)C)NC(=O)C(O)C(N)Cc3ccccc3)CC2)n1	InChI=1S/C44H59ClN10O8S/c1-28(2)23-34(51-43(60)40(57)33(46)24-31-10-6-5-7-11-31)41(58)47-13-18-61-19-20-62-21-22-63-27-38(56)55-16-14-54(15-17-55)37-25-36(49-30(4)50-37)52-44-48-26-35(64-44)42(59)53-39-29(3)9-8-12-32(39)45/h5-12,25-26,28,33-34,40,57H,13-24,27,46H2,1-4H3,(H,47,58)(H,51,60)(H,53,59)(H,48,49,50,52)/t33-,34+,40+/m1/s1	YYNXYOVXFJJJHD-OCIHUODESA-N					doublet; compound annotation
0391_012298	SNIPER(ABL)-020	C44H59ClN10O8S	3.3377	138377570	CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)C(=O)COCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](CC5=CC=CC=C5)N)O	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(C(=O)COCCOCCOCCNC(=O)C(CC(C)C)NC(=O)C(O)C(N)Cc3ccccc3)CC2)n1	InChI=1S/C44H59ClN10O8S/c1-28(2)23-34(51-43(60)40(57)33(46)24-31-10-6-5-7-11-31)41(58)47-13-18-61-19-20-62-21-22-63-27-38(56)55-16-14-54(15-17-55)37-25-36(49-30(4)50-37)52-44-48-26-35(64-44)42(59)53-39-29(3)9-8-12-32(39)45/h5-12,25-26,28,33-34,40,57H,13-24,27,46H2,1-4H3,(H,47,58)(H,51,60)(H,53,59)(H,48,49,50,52)/t33-,34+,40+/m1/s1	YYNXYOVXFJJJHD-OCIHUODESA-N					doublet; compound annotation
0391_012299	ERK1/2 inhibitor 1	C29H32ClN5O4	3.7523	129053491	CC1=CC(=CC=C1)[C@@H](CO)NC(=O)[C@@H](C)N2CC3=C(C2=O)C=C(C=C3)C4=NC(=NC=C4Cl)NC5CCOCC5	Cc1cc(C(CO)NC(=O)C(C)N2Cc3c(cc(-c4nc(NC5CCOCC5)ncc4Cl)cc3)C2=O)ccc1	InChI=1S/C29H32ClN5O4/c1-17-4-3-5-19(12-17)25(16-36)33-27(37)18(2)35-15-21-7-6-20(13-23(21)28(35)38)26-24(30)14-31-29(34-26)32-22-8-10-39-11-9-22/h3-7,12-14,18,22,25,36H,8-11,15-16H2,1-2H3,(H,33,37)(H,31,32,34)/t18-,25-/m1/s1	XHOJEECXVUMYMF-IQGLISFBSA-N					removed another duplicate entry; compound annotation
0391_012301	cefdinir	C14H13N5O5S2	1.2985	6915944	C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O	C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NO)c3csc(N)n3)C2SC1	InChI=1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1	RTXOFQZKPXMALH-GHXIOONMSA-N					compound annotation
0391_012302	oxytetracycline	C22H24N2O9	1.4656	54675779	C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)C(C)(O)C3C(O)C12	InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1	OWFJMIVZYSDULZ-PXOLEDIWSA-N					doublet; compound annotation
0391_012303	oxytetracycline	C22H24N2O9	1.5299	54675779	C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O	CN(C)C1C(=O)C(C(N)=O)=C(O)C2(O)C(=O)C3=C(O)c4c(cccc4O)C(C)(O)C3C(O)C12	InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1	OWFJMIVZYSDULZ-PXOLEDIWSA-N					doublet; compound annotation
0391_012304	Imatinib	C29H31N7O	2.0359	5291		Cc1c(Nc2nccc(-c3cnccc3)n2)cc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1	InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)	KTUFNOKKBVMGRW-UHFFFAOYSA-N					doublet; compound annotation
0391_012305	Rupatadine	C26H26ClN3	2.2969	133017		Cc1cc(CN2CCC(=C3c4ccc(Cl)cc4CCc4c3nccc4)CC2)cnc1	InChI=1S/C26H26ClN3/c1-18-13-19(16-28-15-18)17-30-11-8-20(9-12-30)25-24-7-6-23(27)14-22(24)5-4-21-3-2-10-29-26(21)25/h2-3,6-7,10,13-16H,4-5,8-9,11-12,17H2,1H3	WUZYKBABMWJHDL-UHFFFAOYSA-N					compound annotation
0391_012306	330786-24-8	C17H13N5O	2.7366	22346757		Nc1ncnc2n[nH]c(-c3ccc(Oc4ccccc4)cc3)c12	InChI=1S/C17H13N5O/c18-16-14-15(21-22-17(14)20-10-19-16)11-6-8-13(9-7-11)23-12-4-2-1-3-5-12/h1-10H,(H3,18,19,20,21,22)	YYVUOZULIDAKRN-UHFFFAOYSA-N					compound annotation
0391_012307	Lapatinib	C29H26ClFN4O4S	3.0324	208908		CS(=O)(=O)CCNCc1ccc(-c2cc3c(cc2)ncnc3Nc2cc(Cl)c(OCc3cc(F)ccc3)cc2)o1	InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)	BCFGMOOMADDAQU-UHFFFAOYSA-N					compound annotation
0391_012308	CYM5442	C23H27N3O4	3.2808	25110406		CCOc1c(OCC)cc(-c2nc(-c3c4CCC(NCCO)c4ccc3)no2)cc1	InChI=1S/C23H27N3O4/c1-3-28-20-11-8-15(14-21(20)29-4-2)23-25-22(26-30-23)18-7-5-6-17-16(18)9-10-19(17)24-12-13-27/h5-8,11,14,19,24,27H,3-4,9-10,12-13H2,1-2H3	NUIKTBLZSPQGCP-UHFFFAOYSA-N					compound annotation
0391_012309	clioquinol	C9H5ClINO	4.7039	2788		Oc1c(I)cc(Cl)c2c1nccc2	InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H	QCDFBFJGMNKBDO-UHFFFAOYSA-N					compound annotation
0391_012310	lidocaine	C14H22N2O	1.5696	3676		CCN(CC)CC(=O)Nc1c(C)cccc1C	InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)	NNJVILVZKWQKPM-UHFFFAOYSA-N					doublet; compound annotation
0391_012311	irinotecan	C33H38N4O6	2.3171	60838	CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7	CCc1c2Cn3c(cc4c(COC(=O)C4(O)CC)c3=O)-c2nc2c1cc(OC(=O)N1CCC(N3CCCCC3)CC1)cc2	InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1	UWKQSNNFCGGAFS-XIFFEERXSA-N					doublet; compound annotation
0391_012312	aniracetam	C12H13NO3	2.4348	2196		COc1ccc(C(=O)N2CCCC2=O)cc1	InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3	ZXNRTKGTQJPIJK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012314	phloretin	C15H14O5	2.9092	4788		O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O	InChI=1S/C15H14O5/c16-10-4-1-9(2-5-10)3-6-12(18)15-13(19)7-11(17)8-14(15)20/h1-2,4-5,7-8,16-17,19-20H,3,6H2	VGEREEWJJVICBM-UHFFFAOYSA-N					compound annotation
0391_012315	aniracetam	C12H13NO3	2.9394	2196		COc1ccc(C(=O)N2CCCC2=O)cc1	InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3	ZXNRTKGTQJPIJK-UHFFFAOYSA-N					doublet; compound annotation
0391_012316	Clemizole	C19H20ClN3	2.9394	2782		Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1	InChI=1S/C19H20ClN3/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22/h1-2,5-10H,3-4,11-14H2	CJXAEXPPLWQRFR-UHFFFAOYSA-N					compound annotation
0391_012317	TRIAMCINOLONE ACETONIDE	C24H31FO6	3.2049	6436	C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O	CC1(C)OC2CC3C4CCC5=CC(=O)C=CC5(C)C4(F)C(O)CC3(C)C2(C(=O)CO)O1	InChI=1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1	YNDXUCZADRHECN-JNQJZLCISA-N					compound annotation
0391_012318	Darunavir	C27H37N3O7S	3.6976	213039	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N	CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)OC1COC2OCCC12)S(=O)(=O)c1ccc(N)cc1	InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1	CJBJHOAVZSMMDJ-HEXNFIEUSA-N					doublet; removed another duplicate entry; compound annotation
0391_012320	disulfiram	C10H20N2S4	4.837	3117		CCN(CC)C(=S)SSC(=S)N(CC)CC	InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3	AUZONCFQVSMFAP-UHFFFAOYSA-N					compound annotation
0391_012321	disopyramide	C21H29N3O	2.0585	3114		CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C	InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)	UVTNFZQICZKOEM-UHFFFAOYSA-N					compound annotation
0391_012322	398MJD2ACQ	C18H23N3O3	2.1017	202786		COc1cccc(-c2nn(CCN3CCOCC3)c(=O)c(C)c2)c1	InChI=1S/C18H23N3O3/c1-14-12-17(15-4-3-5-16(13-15)23-2)19-21(18(14)22)7-6-20-8-10-24-11-9-20/h3-5,12-13H,6-11H2,1-2H3	MFRBFANVIMHOEQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012324	Cynaropicrin	C19H22O6	2.4369	119093	C=C1C[C@@H]([C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O)OC(=O)C2=C)OC(=O)C(=C)CO	C=C(CO)C(=O)OC1CC(=C)C2CC(O)C(=C)C2C2OC(=O)C(=C)C12	InChI=1S/C19H22O6/c1-8-5-14(24-18(22)9(2)7-20)16-11(4)19(23)25-17(16)15-10(3)13(21)6-12(8)15/h12-17,20-21H,1-7H2/t12-,13-,14-,15-,16+,17+/m0/s1	KHSCYOFDKADJDJ-NQLMQOPMSA-N					doublet; compound annotation
0391_012325	Cynaropicrin	C19H22O6	2.5068	119093	C=C1C[C@@H]([C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O)OC(=O)C2=C)OC(=O)C(=C)CO	C=C(CO)C(=O)OC1CC(=C)C2CC(O)C(=C)C2C2OC(=O)C(=C)C12	InChI=1S/C19H22O6/c1-8-5-14(24-18(22)9(2)7-20)16-11(4)19(23)25-17(16)15-10(3)13(21)6-12(8)15/h12-17,20-21H,1-7H2/t12-,13-,14-,15-,16+,17+/m0/s1	KHSCYOFDKADJDJ-NQLMQOPMSA-N					doublet; compound annotation
0391_012326	Cynaropicrin	C19H22O6	2.5772	119093	C=C1C[C@@H]([C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O)OC(=O)C2=C)OC(=O)C(=C)CO	C=C(CO)C(=O)OC1CC(=C)C2CC(O)C(=C)C2C2OC(=O)C(=C)C12	InChI=1S/C19H22O6/c1-8-5-14(24-18(22)9(2)7-20)16-11(4)19(23)25-17(16)15-10(3)13(21)6-12(8)15/h12-17,20-21H,1-7H2/t12-,13-,14-,15-,16+,17+/m0/s1	KHSCYOFDKADJDJ-NQLMQOPMSA-N					doublet; compound annotation
0391_012327	KIRA6	C28H25F3N6O	3.7263	73425700		CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	InChI=1S/C28H25F3N6O/c1-27(2,3)25-36-22(23-24(32)33-13-14-37(23)25)20-11-12-21(19-10-5-4-9-18(19)20)35-26(38)34-17-8-6-7-16(15-17)28(29,30)31/h4-15H,1-3H3,(H2,32,33)(H2,34,35,38)	NOHQEAFAESMMDX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012329	KIRA6	C28H25F3N6O	3.729	73425700		CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	InChI=1S/C28H25F3N6O/c1-27(2,3)25-36-22(23-24(32)33-13-14-37(23)25)20-11-12-21(19-10-5-4-9-18(19)20)35-26(38)34-17-8-6-7-16(15-17)28(29,30)31/h4-15H,1-3H3,(H2,32,33)(H2,34,35,38)	NOHQEAFAESMMDX-UHFFFAOYSA-N					doublet; compound annotation
0391_012330	KIRA6	C28H25F3N6O	5.0319	73425700		CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	InChI=1S/C28H25F3N6O/c1-27(2,3)25-36-22(23-24(32)33-13-14-37(23)25)20-11-12-21(19-10-5-4-9-18(19)20)35-26(38)34-17-8-6-7-16(15-17)28(29,30)31/h4-15H,1-3H3,(H2,32,33)(H2,34,35,38)	NOHQEAFAESMMDX-UHFFFAOYSA-N					doublet; compound annotation
0391_012331	KIRA6	C28H25F3N6O	5.5152	73425700		CC(C)(C)c1nc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c3ccccc23)c2c(N)nccn12	InChI=1S/C28H25F3N6O/c1-27(2,3)25-36-22(23-24(32)33-13-14-37(23)25)20-11-12-21(19-10-5-4-9-18(19)20)35-26(38)34-17-8-6-7-16(15-17)28(29,30)31/h4-15H,1-3H3,(H2,32,33)(H2,34,35,38)	NOHQEAFAESMMDX-UHFFFAOYSA-N					doublet; compound annotation
0391_012332	XCT790	C23H13F9N4O3S	5.8037	6918788	COC1=C(C=CC(=C1)/C=C(\C#N)/C(=O)NC2=NN=C(S2)C(F)(F)F)OCC3=C(C=C(C=C3)C(F)(F)F)C(F)(F)F	COc1c(OCc2c(C(F)(F)F)cc(C(F)(F)F)cc2)ccc(C=C(C#N)C(=O)Nc2nnc(C(F)(F)F)s2)c1	InChI=1S/C23H13F9N4O3S/c1-38-17-7-11(6-13(9-33)18(37)34-20-36-35-19(40-20)23(30,31)32)2-5-16(17)39-10-12-3-4-14(21(24,25)26)8-15(12)22(27,28)29/h2-8H,10H2,1H3,(H,34,36,37)/b13-6+	HQFNFOOGGLSBBT-AWNIVKPZSA-N					doublet; compound annotation
0391_012333	XCT790	C23H13F9N4O3S	5.8606	6918788	COC1=C(C=CC(=C1)/C=C(\C#N)/C(=O)NC2=NN=C(S2)C(F)(F)F)OCC3=C(C=C(C=C3)C(F)(F)F)C(F)(F)F	COc1c(OCc2c(C(F)(F)F)cc(C(F)(F)F)cc2)ccc(C=C(C#N)C(=O)Nc2nnc(C(F)(F)F)s2)c1	InChI=1S/C23H13F9N4O3S/c1-38-17-7-11(6-13(9-33)18(37)34-20-36-35-19(40-20)23(30,31)32)2-5-16(17)39-10-12-3-4-14(21(24,25)26)8-15(12)22(27,28)29/h2-8H,10H2,1H3,(H,34,36,37)/b13-6+	HQFNFOOGGLSBBT-AWNIVKPZSA-N					doublet; compound annotation
0391_012334	guaifenesin	C10H14O4	1.8322	3516		COc1ccccc1OCC(O)CO	InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3	HSRJKNPTNIJEKV-UHFFFAOYSA-N					compound annotation
0391_012335	BERBAMINE	C37H40N2O6	1.8668	275182	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC	COc1c2cc3c(c1)CCN(C)C3Cc1ccc(cc1)Oc1c(O)ccc(c1)CC1c3c(O2)c(OC)c(OC)cc3CCN1C	InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(41-3)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-31-18-23(8-11-30(31)40)17-29-35-25(13-15-39(29)2)20-34(42-4)36(43-5)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1	DFOCUWZXJBAUSQ-URLMMPGGSA-N					doublet; compound annotation
0391_012336	Bambuterol	C18H29N3O5	2.1673	54766		CN(C)C(=O)Oc1cc(C(O)CNC(C)(C)C)cc(OC(=O)N(C)C)c1	InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3	ANZXOIAKUNOVQU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012338	osimertinib	C28H33N7O2	2.3519	71496458		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)	DUYJMQONPNNFPI-UHFFFAOYSA-N					doublet; compound annotation
0391_012339	Selumetinib	C17H15BrClFN4O3	3.0369	10127622		Cn1cnc2c1cc(C(=O)NOCCO)c(Nc1c(Cl)cc(Br)cc1)c2F	InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)	CYOHGALHFOKKQC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012341	ketoprofen	C16H14O3	3.5887	3825		CC(C(=O)O)c1cc(C(=O)c2ccccc2)ccc1	InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)	DKYWVDODHFEZIM-UHFFFAOYSA-N					compound annotation
0391_012342	apalutamide	C21H15F4N5O2S	4.2526	24872560		CNC(=O)c1c(F)cc(N2C(=S)N(c3cc(C(F)(F)F)c(C#N)nc3)C(=O)C23CCC3)cc1	InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)	HJBWBFZLDZWPHF-UHFFFAOYSA-N					compound annotation
0391_012343	Lacidipine	C26H33NO6	5.3819	5311217	CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1C=CC(=O)OC(C)(C)C	InChI=1S/C26H33NO6/c1-8-31-24(29)21-16(3)27-17(4)22(25(30)32-9-2)23(21)19-13-11-10-12-18(19)14-15-20(28)33-26(5,6)7/h10-15,23,27H,8-9H2,1-7H3/b15-14+	GKQPCPXONLDCMU-CCEZHUSRSA-N					compound annotation
0391_012344	37052-78-1	C8H8N2OS	1.6374	665603		COc1cc2c(cc1)[nH]c(=S)[nH]2	InChI=1S/C8H8N2OS/c1-11-5-2-3-6-7(4-5)10-8(12)9-6/h2-4H,1H3,(H2,9,10,12)	KOFBRZWVWJCLGM-UHFFFAOYSA-N					compound annotation
0391_012345	methicillin	C17H20N2O6S	1.7855	6087	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C	COc1cccc(OC)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O	InChI=1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1	RJQXTJLFIWVMTO-TYNCELHUSA-N					doublet; compound annotation
0391_012346	methicillin	C17H20N2O6S	2.655	6087	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C	COc1cccc(OC)c1C(=O)NC1C(=O)N2C1SC(C)(C)C2C(=O)O	InChI=1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1	RJQXTJLFIWVMTO-TYNCELHUSA-N					doublet; compound annotation
0391_012347	CNX-1351	C30H35N7O3S	2.7417	58441401		CC(C)=CC(=O)CCC(=O)N1CCN(Cc2cc3c(s2)c(N2CCOCC2)nc(-c2c4cn[nH]c4ccc2)n3)CC1	InChI=1S/C30H35N7O3S/c1-20(2)16-21(38)6-7-27(39)36-10-8-35(9-11-36)19-22-17-26-28(41-22)30(37-12-14-40-15-13-37)33-29(32-26)23-4-3-5-25-24(23)18-31-34-25/h3-5,16-18H,6-15,19H2,1-2H3,(H,31,34)	DLNUPKDFXMWRFP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012349	4'-Methylacetophenone	C9H10O	4.3179	8500		CC(=O)c1ccc(C)cc1	InChI=1S/C9H10O/c1-7-3-5-9(6-4-7)8(2)10/h3-6H,1-2H3	GNKZMNRKLCTJAY-UHFFFAOYSA-N					compound annotation
0391_012350	Apoptosis Activator 2	C15H9Cl2NO2	4.4589	1901244		O=C1C(=O)N(Cc2cc(Cl)c(Cl)cc2)c2ccccc12	InChI=1S/C15H9Cl2NO2/c16-11-6-5-9(7-12(11)17)8-18-13-4-2-1-3-10(13)14(19)15(18)20/h1-7H,8H2	KGRJPLRFGLMQMV-UHFFFAOYSA-N					compound annotation
0391_012351	Panidazole	C11H12N4O2	0.6527	72080		Cc1ncc([N+](=O)[O-])n1CCc1ccncc1	InChI=1S/C11H12N4O2/c1-9-13-8-11(15(16)17)14(9)7-4-10-2-5-12-6-3-10/h2-3,5-6,8H,4,7H2,1H3	ARYPMCPJIWUCIP-UHFFFAOYSA-N					compound annotation
0391_012352	para-iodoHoechst 33258	C25H23IN6	2.2625	10437137		CN1CCN(c2cc3c(cc2)nc(-c2cc4c(cc2)nc(-c2ccc(I)cc2)[nH]4)[nH]3)CC1	InChI=1S/C25H23IN6/c1-31-10-12-32(13-11-31)19-7-9-21-23(15-19)30-25(28-21)17-4-8-20-22(14-17)29-24(27-20)16-2-5-18(26)6-3-16/h2-9,14-15H,10-13H2,1H3,(H,27,29)(H,28,30)	WSBVZEKIZWIJQO-UHFFFAOYSA-N					compound annotation
0391_012353	Sigma-1 receptor antagonist 3	C19H23ClFN3O	3.514	118723363		Cc1c(Cl)c(OCCCN2CCCCC2)nc(-c2ccc(F)cc2)n1	InChI=1S/C19H23ClFN3O/c1-14-17(20)19(25-13-5-12-24-10-3-2-4-11-24)23-18(22-14)15-6-8-16(21)9-7-15/h6-9H,2-5,10-13H2,1H3	OAIHSWLLDNASTO-UHFFFAOYSA-N					compound annotation
0391_012354	4'-Methoxyflavonol	C16H12O4	4.1634	97141		COc1ccc(-c2c(O)c(=O)c3ccccc3o2)cc1	InChI=1S/C16H12O4/c1-19-11-8-6-10(7-9-11)16-15(18)14(17)12-4-2-3-5-13(12)20-16/h2-9,18H,1H3	IIBBFGMVMNZMGA-UHFFFAOYSA-N					compound annotation
0391_012355	2227549-00-8	C19H19Cl2FN2O3S	4.5628	134604213		O=C(NCc1ccc(F)cc1)C1CCN(S(=O)(=O)c2cc(Cl)cc(Cl)c2)CC1	InChI=1S/C19H19Cl2FN2O3S/c20-15-9-16(21)11-18(10-15)28(26,27)24-7-5-14(6-8-24)19(25)23-12-13-1-3-17(22)4-2-13/h1-4,9-11,14H,5-8,12H2,(H,23,25)	VUOYAALVGSMUHC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012357	Diethyl-pythiDC	C14H14N2O4S	4.7657	122554535		CCOC(=O)c1cnc(-c2ncc(C(=O)OCC)s2)cc1	InChI=1S/C14H14N2O4S/c1-3-19-13(17)9-5-6-10(15-7-9)12-16-8-11(21-12)14(18)20-4-2/h5-8H,3-4H2,1-2H3	NSMODRMOSSBWGQ-UHFFFAOYSA-N					compound annotation
0391_012358	NVX-207	C36H59NO6	4.7801	9960374	CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C)C)C(=O)OCC(CO)(CO)N	C=C(C)C1CCC2(C(=O)OCC(N)(CO)CO)CCC3(C)C(CCC4C5(C)CCC(OC(C)=O)C(C)(C)C5CCC43C)C12	InChI=1S/C36H59NO6/c1-22(2)24-11-16-36(30(41)42-21-35(37,19-38)20-39)18-17-33(7)25(29(24)36)9-10-27-32(6)14-13-28(43-23(3)40)31(4,5)26(32)12-15-34(27,33)8/h24-29,38-39H,1,9-21,37H2,2-8H3/t24-,25+,26-,27+,28-,29+,32-,33+,34+,36-/m0/s1	KQZVSTAVTJCKDG-DRSBITMPSA-N					removed another duplicate entry; compound annotation
0391_012360	sulfaquinoxaline	C14H12N4O2S	2.5257	5338		Nc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2)cc1	InChI=1S/C14H12N4O2S/c15-10-5-7-11(8-6-10)21(19,20)18-14-9-16-12-3-1-2-4-13(12)17-14/h1-9H,15H2,(H,17,18)	NHZLNPMOSADWGC-UHFFFAOYSA-N					compound annotation
0391_012361	Tenofovir disoproxil	C19H30N5O10P	2.7871	5481350	C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C	CC(C)OC(=O)OCOP(=O)(COC(C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C	InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1	JFVZFKDSXNQEJW-CQSZACIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_012363	chlorpropamide	C10H13ClN2O3S	3.1564	2727		CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1	InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)	RKWGIWYCVPQPMF-UHFFFAOYSA-N					compound annotation
0391_012364	crotamiton	C13H17NO	3.6786	688020	CCN(C1=CC=CC=C1C)C(=O)/C=C/C	CC=CC(=O)N(CC)c1ccccc1C	InChI=1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4+	DNTGGZPQPQTDQF-XBXARRHUSA-N					compound annotation
0391_012365	Posaconazole	C37H42F2N8O4	3.9684	468595	CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F	CCC(C(C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6c(F)cc(F)cc6)C5)cc4)CC3)cc2)c1=O	InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1	RAGOYPUPXAKGKH-XAKZXMRKSA-N					removed another duplicate entry; compound annotation
0391_012367	CETYLPYRIDINIUM	C21H38N+	4.7035	2683		CCCCCCCCCCCCCCCC[n+]1ccccc1	InChI=1S/C21H38N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22/h15,17-18,20-21H,2-14,16,19H2,1H3/q+1	NEUSVAOJNUQRTM-UHFFFAOYSA-N					doublet; compound annotation
0391_012368	CETYLPYRIDINIUM	C21H38N+	5.3405	2683		CCCCCCCCCCCCCCCC[n+]1ccccc1	InChI=1S/C21H38N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22/h15,17-18,20-21H,2-14,16,19H2,1H3/q+1	NEUSVAOJNUQRTM-UHFFFAOYSA-N					doublet; compound annotation
0391_012369	Mitapivat	C24H26N4O3S	2.1292	59634741		O=C(c1ccc(NS(=O)(=O)c2cccc3c2nccc3)cc1)N1CCN(CC2CC2)CC1	InChI=1S/C24H26N4O3S/c29-24(28-15-13-27(14-16-28)17-18-6-7-18)20-8-10-21(11-9-20)26-32(30,31)22-5-1-3-19-4-2-12-25-23(19)22/h1-5,8-12,18,26H,6-7,13-17H2	XAYGBKHKBBXDAK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012371	113104-25-9	C11H6N4O4S	2.2466	313619		O=[N+]([O-])c1ccc(Sc2cccc[n+]2[O-])c2nonc12	InChI=1S/C11H6N4O4S/c16-14-6-2-1-3-9(14)20-8-5-4-7(15(17)18)10-11(8)13-19-12-10/h1-6H	ICCFXXDUYSPKOL-UHFFFAOYSA-N					compound annotation
0391_012372	INCB-057643	C20H21N3O5S	2.6099	118467751		CN1C(=O)C(C)(C)Oc2c(-c3cn(C)c(=O)c4c3cc[nH]4)cc(S(C)(=O)=O)cc21	InChI=1S/C20H21N3O5S/c1-20(2)19(25)23(4)15-9-11(29(5,26)27)8-13(17(15)28-20)14-10-22(3)18(24)16-12(14)6-7-21-16/h6-10,21H,1-5H3	VZSAMEOETVNDQH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012374	orphenadrine	C18H23NO	2.9567	4601		Cc1ccccc1C(OCCN(C)C)c1ccccc1	InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3	QVYRGXJJSLMXQH-UHFFFAOYSA-N					compound annotation
0391_012375	1260907-17-2	C22H22ClN5O2	3.3749	46943432	CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C	CCNC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(ccc(OC)c2)-n2c(C)nnc12	InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1	AAAQFGUYHFJNHI-SFHVURJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_012377	GSK2643943A	C17H12FN3	4.2514	137319705	C1=CC(=CC(=C1)F)/C=C/C2=CC3=C(C=C2)C(=C(N3)N)C#N	N#Cc1c(N)[nH]c2c1ccc(C=Cc1cc(F)ccc1)c2	InChI=1S/C17H12FN3/c18-13-3-1-2-11(8-13)4-5-12-6-7-14-15(10-19)17(20)21-16(14)9-12/h1-9,21H,20H2/b5-4+	CGXBPMZRTMXEIA-SNAWJCMRSA-N					doublet; removed another duplicate entry; compound annotation
0391_012379	GSK2643943A	C17H12FN3	4.306	137319705	C1=CC(=CC(=C1)F)/C=C/C2=CC3=C(C=C2)C(=C(N3)N)C#N	N#Cc1c(N)[nH]c2c1ccc(C=Cc1cc(F)ccc1)c2	InChI=1S/C17H12FN3/c18-13-3-1-2-11(8-13)4-5-12-6-7-14-15(10-19)17(20)21-16(14)9-12/h1-9,21H,20H2/b5-4+	CGXBPMZRTMXEIA-SNAWJCMRSA-N					doublet; removed another duplicate entry; compound annotation
0391_012381	nimodipine	C21H26N2O7	4.4261	4497		COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cc([N+](=O)[O-])ccc1	InChI=1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3	UIAGMCDKSXEBJQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012383	LUF6000	C22H20Cl2N4	4.4577	11711282		Clc1c(Cl)cc(Nc2nc3ccccc3c3c2[nH]c(C2CCCCC2)n3)cc1	InChI=1S/C22H20Cl2N4/c23-16-11-10-14(12-17(16)24)25-22-20-19(15-8-4-5-9-18(15)26-22)27-21(28-20)13-6-2-1-3-7-13/h4-5,8-13H,1-3,6-7H2,(H,25,26)(H,27,28)	UWJVRSIGHHSDSJ-UHFFFAOYSA-N					compound annotation
0391_012384	16-Dehydroprogesterone	C21H28O2	4.5219	101964	CC(=O)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C	CC(=O)C1=CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C	InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h6,12,16,18-19H,4-5,7-11H2,1-3H3/t16-,18-,19-,20-,21+/m0/s1	VRRHHTISESGZFN-RKFFNLMFSA-N					compound annotation
0391_012385	2,6-Dichloro-N-phenylaniline	C12H9Cl2N	4.8669	84867		Clc1cccc(Cl)c1Nc1ccccc1	InChI=1S/C12H9Cl2N/c13-10-7-4-8-11(14)12(10)15-9-5-2-1-3-6-9/h1-8,15H	HDUUZPLYVVQTKN-UHFFFAOYSA-N					compound annotation
0391_012386	Secnidazole	C7H11N3O3	1.2207	71815		Cc1ncc([N+](=O)[O-])n1CC(C)O	InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3	KPQZUUQMTUIKBP-UHFFFAOYSA-N					compound annotation
0391_012387	2097938-51-5	C20H19ClN6O2	2.1841	129896912		COC(=O)c1cc2c(cc1)nc(C1CCN(c3ncnc4c3c(Cl)c[nH]4)CC1)[nH]2	InChI=1S/C20H19ClN6O2/c1-29-20(28)12-2-3-14-15(8-12)26-17(25-14)11-4-6-27(7-5-11)19-16-13(21)9-22-18(16)23-10-24-19/h2-3,8-11H,4-7H2,1H3,(H,25,26)(H,22,23,24)	MGRJCGXCUUCOQG-UHFFFAOYSA-N					compound annotation
0391_012388	ERK-IN-3	C22H25ClFN7O2	2.6344	124122366	CC1=CN=C(N=C1N2C=C(N=C2)C(=O)N[C@H](CN)C3=CC(=CC(=C3)Cl)F)NC4CCOCC4	Cc1cnc(NC2CCOCC2)nc1-n1cnc(C(=O)NC(CN)c2cc(F)cc(Cl)c2)c1	InChI=1S/C22H25ClFN7O2/c1-13-10-26-22(28-17-2-4-33-5-3-17)30-20(13)31-11-19(27-12-31)21(32)29-18(9-25)14-6-15(23)8-16(24)7-14/h6-8,10-12,17-18H,2-5,9,25H2,1H3,(H,29,32)(H,26,28,30)/t18-/m1/s1	PWHIUQBBGPGFFV-GOSISDBHSA-N					removed another duplicate entry; compound annotation
0391_012390	Lefamulin	C28H45NO5S	2.8459	25185057	C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CS[C@@H]4CC[C@H](C[C@H]4O)N)C	C=CC1(C)CC(OC(=O)CSC2CCC(N)CC2O)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O	InChI=1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16-,17+,18-,20-,21-,22-,24+,25+,26-,27+,28+/m1/s1	KPVIXBKIJXZQJX-FCEONZPQSA-N					removed another duplicate entry; compound annotation
0391_012392	ADEFOVIR DIPIVOXIL	C20H32N5O8P	3.0832	60871		CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C	InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)	WOZSCQDILHKSGG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012394	Arterolane	C22H36N2O4	3.658	10475633		CC(C)(N)CNC(=O)CC1CCC2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3	InChI=1S/C22H36N2O4/c1-20(2,23)13-24-19(25)12-14-3-5-21(6-4-14)26-22(28-27-21)17-8-15-7-16(10-17)11-18(22)9-15/h14-18H,3-13,23H2,1-2H3,(H,24,25)	VXYZBLXGCYNIHP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012396	CHEBI:45367	C46H62N4O11	3.731	135415564	C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)/C	COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c1=NC5(CCN(CC(C)C)CC5)N=c1c4c3C2=O	InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,52-55H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1	AZFBLLCNOQPJGJ-VXTBVIBXSA-N					removed another duplicate entry; compound annotation
0391_012398	RIFAPENTINE	C47H64N4O12	4.338	135403821	C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C	COC1C=COC2(C)Oc3c(C2=O)c2c(O)c(C=NN4CCN(C5CCCC5)CC4)c(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c(O)c2c(O)c3C	InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1	WDZCUPBHRAEYDL-GZAUEHORSA-N					compound annotation
0391_012399	ascomycin	C43H69NO12	5.3957	5282071	CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC)C)\C	CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)=CC3CCC(O)C(OC)C3)C(C)C(O)CC1=O)C(C)CC2OC	InChI=1S/C43H69NO12/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)44-16-12-11-13-31(44)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-32(45)35(22-29)52-7/h18,20,25,27-33,35-39,45-46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32+,33-,35+,36-,37-,38+,39+,43+/m0/s1	ZDQSOHOQTUFQEM-NURRSENYSA-N					compound annotation
0391_012400	Iadademstat	C15H22N2	0.6518	71543365	C1CC(CCC1N)N[C@@H]2C[C@H]2C3=CC=CC=C3	NC1CCC(NC2CC2c2ccccc2)CC1	InChI=1S/C15H22N2/c16-12-6-8-13(9-7-12)17-15-10-14(15)11-4-2-1-3-5-11/h1-5,12-15,17H,6-10,16H2/t12?,13?,14-,15+/m0/s1	ALHBJBCQLJZYON-PFSRBDOWSA-N					compound annotation
0391_012401	19970-45-7	C13H17N5O2	1.7605	3162678		CCn1c(C)c(C)n2c3c(nc12)n(C)c(=O)n(C)c3=O	InChI=1S/C13H17N5O2/c1-6-17-7(2)8(3)18-9-10(14-12(17)18)15(4)13(20)16(5)11(9)19/h6H2,1-5H3	JKJLETUKWLALKV-UHFFFAOYSA-N					doublet; compound annotation
0391_012402	OICR-0547	C28H29F3N4O4	2.5054	91801179		O=C(Nc1cc(-c2cccc(CN3CCOCC3)c2)ccc1N1CCOCC1)c1c[nH]c(=O)cc1C(F)(F)F	InChI=1S/C28H29F3N4O4/c29-28(30,31)23-16-26(36)32-17-22(23)27(37)33-24-15-21(4-5-25(24)35-8-12-39-13-9-35)20-3-1-2-19(14-20)18-34-6-10-38-11-7-34/h1-5,14-17H,6-13,18H2,(H,32,36)(H,33,37)	RFHOOFYUTGZPFH-UHFFFAOYSA-N					doublet; compound annotation
0391_012403	OICR-0547	C28H29F3N4O4	2.5081	91801179		O=C(Nc1cc(-c2cccc(CN3CCOCC3)c2)ccc1N1CCOCC1)c1c[nH]c(=O)cc1C(F)(F)F	InChI=1S/C28H29F3N4O4/c29-28(30,31)23-16-26(36)32-17-22(23)27(37)33-24-15-21(4-5-25(24)35-8-12-39-13-9-35)20-3-1-2-19(14-20)18-34-6-10-38-11-7-34/h1-5,14-17H,6-13,18H2,(H,32,36)(H,33,37)	RFHOOFYUTGZPFH-UHFFFAOYSA-N					doublet; compound annotation
0391_012404	19970-45-7	C13H17N5O2	2.5954	3162678		CCn1c(C)c(C)n2c3c(nc12)n(C)c(=O)n(C)c3=O	InChI=1S/C13H17N5O2/c1-6-17-7(2)8(3)18-9-10(14-12(17)18)15(4)13(20)16(5)11(9)19/h6H2,1-5H3	JKJLETUKWLALKV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012406	19970-45-7	C13H17N5O2	2.5984	3162678		CCn1c(C)c(C)n2c3c(nc12)n(C)c(=O)n(C)c3=O	InChI=1S/C13H17N5O2/c1-6-17-7(2)8(3)18-9-10(14-12(17)18)15(4)13(20)16(5)11(9)19/h6H2,1-5H3	JKJLETUKWLALKV-UHFFFAOYSA-N					doublet; compound annotation
0391_012407	TUG-1375	C22H19ClN2O4S	4.0747	138319694	CC1=C(C(=NO1)C)C2=CC=C(C=C2)C(=O)N3[C@@H](CS[C@@H]3C4=CC=CC=C4Cl)C(=O)O	Cc1noc(C)c1-c1ccc(C(=O)N2C(C(=O)O)CSC2c2ccccc2Cl)cc1	InChI=1S/C22H19ClN2O4S/c1-12-19(13(2)29-24-12)14-7-9-15(10-8-14)20(26)25-18(22(27)28)11-30-21(25)16-5-3-4-6-17(16)23/h3-10,18,21H,11H2,1-2H3,(H,27,28)/t18-,21+/m0/s1	RZAMDGBOOPJHJQ-GHTZIAJQSA-N					compound annotation
0391_012408	BAY-8002	C20H14ClNO5S	4.1942	992293		O=C(Nc1ccccc1C(=O)O)c1c(Cl)ccc(S(=O)(=O)c2ccccc2)c1	InChI=1S/C20H14ClNO5S/c21-17-11-10-14(28(26,27)13-6-2-1-3-7-13)12-16(17)19(23)22-18-9-5-4-8-15(18)20(24)25/h1-12H,(H,22,23)(H,24,25)	CLAUJSRBKSRTGQ-UHFFFAOYSA-N					compound annotation
0391_012409	TRi-1	C12H9ClN2O5S	4.283	2801235		COc1nc(S(=O)(=O)c2ccc(Cl)cc2)c([N+](=O)[O-])cc1	InChI=1S/C12H9ClN2O5S/c1-20-11-7-6-10(15(16)17)12(14-11)21(18,19)9-4-2-8(13)3-5-9/h2-7H,1H3	PRKWNRUVAZZHPH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012411	SN-6	C20H22N2O5S	4.5654	10222761		CCOC(=O)C1CSC(Cc2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2)N1	InChI=1S/C20H22N2O5S/c1-2-26-20(23)18-13-28-19(21-18)11-14-5-9-17(10-6-14)27-12-15-3-7-16(8-4-15)22(24)25/h3-10,18-19,21H,2,11-13H2,1H3	ZVYIJXLMBWCGHP-UHFFFAOYSA-N					doublet; compound annotation
0391_012412	SN-6	C20H22N2O5S	4.716	10222761		CCOC(=O)C1CSC(Cc2ccc(OCc3ccc([N+](=O)[O-])cc3)cc2)N1	InChI=1S/C20H22N2O5S/c1-2-26-20(23)18-13-28-19(21-18)11-14-5-9-17(10-6-14)27-12-15-3-7-16(8-4-15)22(24)25/h3-10,18-19,21H,2,11-13H2,1H3	ZVYIJXLMBWCGHP-UHFFFAOYSA-N					doublet; compound annotation
0391_012413	AU1235	C17H19F3N2O	4.9376	54752297		O=C(Nc1c(F)c(F)c(F)cc1)NC12CC3CC(CC(C3)C1)C2	InChI=1S/C17H19F3N2O/c18-12-1-2-13(15(20)14(12)19)21-16(23)22-17-6-9-3-10(7-17)5-11(4-9)8-17/h1-2,9-11H,3-8H2,(H2,21,22,23)	PYDHHHKUANVSJV-UHFFFAOYSA-N					compound annotation
0391_012414	thiamphenicol	C12H15Cl2NO5S	1.5202	27200	CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O	CS(=O)(=O)c1ccc(C(O)C(CO)NC(=O)C(Cl)Cl)cc1	InChI=1S/C12H15Cl2NO5S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-16)15-12(18)11(13)14/h2-5,9-11,16-17H,6H2,1H3,(H,15,18)/t9-,10-/m1/s1	OTVAEFIXJLOWRX-NXEZZACHSA-N					removed another duplicate entry; compound annotation
0391_012416	Daclatasvir	C40H50N8O6	2.3196	25154714	CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C	InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1	FKRSSPOQAMALKA-CUPIEXAXSA-N					doublet; compound annotation
0391_012417	Daclatasvir	C40H50N8O6	2.3225	25154714	CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc(C5CCCN5C(=O)C(NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C	InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1	FKRSSPOQAMALKA-CUPIEXAXSA-N					doublet; compound annotation
0391_012418	GDC-0339	C20H22F3N7OS	2.4546	73603034	CN1C(=C(C=N1)NC(=O)C2=C(SC(=N2)C3=C(C=CC=C3F)F)N)N4CC[C@H]([C@@H](CC4)F)N	Cn1ncc(NC(=O)c2c(N)sc(-c3c(F)cccc3F)n2)c1N1CCC(N)C(F)CC1	InChI=1S/C20H22F3N7OS/c1-29-20(30-7-5-10(21)13(24)6-8-30)14(9-26-29)27-18(31)16-17(25)32-19(28-16)15-11(22)3-2-4-12(15)23/h2-4,9-10,13H,5-8,24-25H2,1H3,(H,27,31)/t10-,13-/m1/s1	NHXVGMQFCYBLTL-ZWNOBZJWSA-N					removed another duplicate entry; compound annotation
0391_012420	Neticonazole	C17H22N2OS	3.3987	5282433	CCCCCOC1=CC=CC=C1/C(=C\SC)/N2C=CN=C2	CCCCCOc1ccccc1C(=CSC)n1ccnc1	InChI=1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+	VWOIKFDZQQLJBJ-DTQAZKPQSA-N					doublet; compound annotation
0391_012421	Neticonazole	C17H22N2OS	3.4638	5282433	CCCCCOC1=CC=CC=C1/C(=C\SC)/N2C=CN=C2	CCCCCOc1ccccc1C(=CSC)n1ccnc1	InChI=1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+	VWOIKFDZQQLJBJ-DTQAZKPQSA-N					doublet; compound annotation
0391_012422	Oroxylin A	C16H12O5	3.7739	5320315		COc1c(O)c2c(cc1O)oc(-c1ccccc1)cc2=O	InChI=1S/C16H12O5/c1-20-16-11(18)8-13-14(15(16)19)10(17)7-12(21-13)9-5-3-2-4-6-9/h2-8,18-19H,1H3	LKOJGSWUMISDOF-UHFFFAOYSA-N					compound annotation
0391_012423	Sertaconazole	C20H15Cl3N2OS	4.1167	65863		Clc1cc(Cl)c(C(Cn2ccnc2)OCc2csc3c2cccc3Cl)cc1	InChI=1S/C20H15Cl3N2OS/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22/h1-8,11-12,19H,9-10H2	JLGKQTAYUIMGRK-UHFFFAOYSA-N					compound annotation
0391_012424	Xanthohumol	C21H22O5	4.6943	639665	CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)/C=C/C2=CC=C(C=C2)O)O)C	COc1c(C(=O)C=Cc2ccc(O)cc2)c(O)c(CC=C(C)C)c(O)c1	InChI=1S/C21H22O5/c1-13(2)4-10-16-18(24)12-19(26-3)20(21(16)25)17(23)11-7-14-5-8-15(22)9-6-14/h4-9,11-12,22,24-25H,10H2,1-3H3/b11-7+	ORXQGKIUCDPEAJ-YRNVUSSQSA-N					compound annotation
0391_012425	Valganciclovir hydrochloride	C14H22N6O5	0.466	135413535	CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N	CC(C)C(N)C(=O)OCC(CO)OCn1cnc2c1[nH]c(N)nc2=O	InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1	WPVFJKSGQUFQAP-GKAPJAKFSA-N					compound annotation
0391_012426	Pidotimod	C9H12N2O4S	0.6307	65944	C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)O	O=C1CCC(C(=O)N2CSCC2C(=O)O)N1	InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1	UUTKICFRNVKFRG-WDSKDSINSA-N					compound annotation
0391_012427	amoxicillin	C16H19N3O5S	1.914	33613	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	LSQZJLSUYDQPKJ-NJBDSQKTSA-N					doublet; compound annotation
0391_012428	amoxicillin	C16H19N3O5S	2.0692	33613	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	CC1(C)SC2C(NC(=O)C(N)c3ccc(O)cc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1	LSQZJLSUYDQPKJ-NJBDSQKTSA-N					doublet; compound annotation
0391_012429	piperacillin	C23H27N5O7S	2.751	43672	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	CCN1CCN(C(=O)NC(C(=O)NC2C(=O)N3C2SC(C)(C)C3C(=O)O)c2ccccc2)C(=O)C1=O	InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1	IVBHGBMCVLDMKU-GXNBUGAJSA-N					compound annotation
0391_012430	SOFOSBUVIR	C22H29FN3O9P	3.0977	45375808	C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3	CC(C)OC(=O)C(C)NP(=O)(OCC1OC(n2ccc(=O)[nH]c2=O)C(C)(F)C1O)Oc1ccccc1	InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1	TTZHDVOVKQGIBA-IQWMDFIBSA-N					removed another duplicate entry; compound annotation
0391_012432	Dasabuvir	C26H27N3O5S	4.1562	56640146		COc1c(-c2cc3c(cc2)cc(NS(C)(=O)=O)cc3)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C	InChI=1S/C26H27N3O5S/c1-26(2,3)22-15-20(29-11-10-23(30)27-25(29)31)14-21(24(22)34-4)18-7-6-17-13-19(28-35(5,32)33)9-8-16(17)12-18/h6-15,28H,1-5H3,(H,27,30,31)	NBRBXGKOEOGLOI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012434	cefoperazone	C25H27N9O8S2	2.0717	44187	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O	CCN1CCN(C(=O)NC(C(=O)NC2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CSC23)c2ccc(O)cc2)C(=O)C1=O	InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1	GCFBRXLSHGKWDP-XCGNWRKASA-N					doublet; compound annotation
0391_012435	ETHACRIDINE	C15H15N3O	2.1828	2017		CCOc1cc2c(N)c3c(cc(N)cc3)nc2cc1	InChI=1S/C15H15N3O/c1-2-19-10-4-6-13-12(8-10)15(17)11-5-3-9(16)7-14(11)18-13/h3-8H,2,16H2,1H3,(H2,17,18)	CIKWKGFPFXJVGW-UHFFFAOYSA-N					doublet; compound annotation
0391_012436	Cefetamet pivoxil	C20H25N5O7S2	3.4921	5486182	CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C	CON=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CSC12)c1csc(N)n1	InChI=1S/C20H25N5O7S2/c1-9-6-33-16-12(23-14(26)11(24-30-5)10-7-34-19(21)22-10)15(27)25(16)13(9)17(28)31-8-32-18(29)20(2,3)4/h7,12,16H,6,8H2,1-5H3,(H2,21,22)(H,23,26)/b24-11-/t12-,16-/m1/s1	DASYMCLQENWCJG-XUKDPADISA-N					compound annotation
0391_012437	Pretomanid	C14H12F3N3O5	3.8658	456199	C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F	O=[N+]([O-])c1cn2CC(OCc3ccc(OC(F)(F)F)cc3)COc2n1	InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1	ZLHZLMOSPGACSZ-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_012439	73573-88-3	C23H34O5	4.8338	64715	CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O	CCC(C)C(=O)OC1CCC=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21	InChI=1S/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3/t14-,15-,17+,18+,19-,20-,22-/m0/s1	AJLFOPYRIVGYMJ-INTXDZFKSA-N					removed another duplicate entry; compound annotation
0391_012441	PIPERONYL BUTOXIDE	C19H30O5	5.4014	5794		CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2	InChI=1S/C19H30O5/c1-3-5-7-20-8-9-21-10-11-22-14-17-13-19-18(23-15-24-19)12-16(17)6-4-2/h12-13H,3-11,14-15H2,1-2H3	FIPWRIJSWJWJAI-UHFFFAOYSA-N					compound annotation
0391_012442	cefazolin	C14H14N8O4S3	1.7352	33255	CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)C(NC(=O)Cn4cnnn4)C3SC2)s1	InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1	MLYYVTUWGNIJIB-BXKDBHETSA-N					doublet; compound annotation
0391_012443	TENOFOVIR ALAFENAMIDE	C21H29N6O5P	2.512	9574768	C[C@H](CN1C=NC2=C(N=CN=C21)N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3=CC=CC=C3	CC(C)OC(=O)C(C)NP(=O)(COC(C)Cn1cnc2c(N)ncnc21)Oc1ccccc1	InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1	LDEKQSIMHVQZJK-CAQYMETFSA-N					doublet; removed another duplicate entry; compound annotation
0391_012445	MEZLOCILLIN	C21H25N5O8S2	2.9566	656511	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C	CC1(C)SC2C(NC(=O)C(NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1	YPBATNHYBCGSSN-VWPFQQQWSA-N					removed another duplicate entry; compound annotation
0391_012447	306959-01-3	C24H21N5O2S	3.7233	1142445		Cc1nn(-c2ccccc2)c2c1cc(C(=O)Nc1c(C)n(C)n(-c3ccccc3)c1=O)s2	InChI=1S/C24H21N5O2S/c1-15-19-14-20(32-24(19)28(26-15)17-10-6-4-7-11-17)22(30)25-21-16(2)27(3)29(23(21)31)18-12-8-5-9-13-18/h4-14H,1-3H3,(H,25,30)	WIEJADKUYLLKPX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012449	tolnaftate	C19H17NOS	5.446	5510		Cc1cc(N(C)C(=S)Oc2cc3ccccc3cc2)ccc1	InChI=1S/C19H17NOS/c1-14-6-5-9-17(12-14)20(2)19(22)21-18-11-10-15-7-3-4-8-16(15)13-18/h3-13H,1-2H3	FUSNMLFNXJSCDI-UHFFFAOYSA-N					compound annotation
0391_012450	4-Aminosalicylic acid	C7H7NO3	0.9334	4649		Nc1cc(O)c(C(=O)O)cc1	InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)	WUBBRNOQWQTFEX-UHFFFAOYSA-N					doublet; compound annotation
0391_012451	tinidazole	C8H13N3O4S	1.3788	5479		CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C	InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3	HJLSLZFTEKNLFI-UHFFFAOYSA-N					compound annotation
0391_012452	BIIB068	C23H29N7O2	2.1898	118139356		Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2nc(Nc3cn(C)nc3)ncc2)c1	InChI=1S/C23H29N7O2/c1-15(2)32-20-13-30(14-20)23(31)25-10-18-6-5-17(9-16(18)3)21-7-8-24-22(28-21)27-19-11-26-29(4)12-19/h5-9,11-12,15,20H,10,13-14H2,1-4H3,(H,25,31)(H,24,27,28)	BMWMKGNVAMXXCH-UHFFFAOYSA-N					doublet; compound annotation
0391_012453	BIIB068	C23H29N7O2	2.4568	118139356		Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2nc(Nc3cn(C)nc3)ncc2)c1	InChI=1S/C23H29N7O2/c1-15(2)32-20-13-30(14-20)23(31)25-10-18-6-5-17(9-16(18)3)21-7-8-24-22(28-21)27-19-11-26-29(4)12-19/h5-9,11-12,15,20H,10,13-14H2,1-4H3,(H,25,31)(H,24,27,28)	BMWMKGNVAMXXCH-UHFFFAOYSA-N					doublet; compound annotation
0391_012454	MRT199665	C28H31N5O2	2.5952	71725150	CC1(C2=CN=C(N=C2N(C1=O)[C@H]3CCC4=C3C=CC=C4O)NC5=CC=CC(=C5)CN6CCCC6)C	CC1(C)C(=O)N(C2CCc3c2cccc3O)c2nc(Nc3cccc(CN4CCCC4)c3)ncc21	InChI=1S/C28H31N5O2/c1-28(2)22-16-29-27(30-19-8-5-7-18(15-19)17-32-13-3-4-14-32)31-25(22)33(26(28)35)23-12-11-21-20(23)9-6-10-24(21)34/h5-10,15-16,23,34H,3-4,11-14,17H2,1-2H3,(H,29,30,31)/t23-/m0/s1	OFIFLUFVENTCNZ-QHCPKHFHSA-N					compound annotation
0391_012455	BIIB068	C23H29N7O2	2.8985	118139356		Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2nc(Nc3cn(C)nc3)ncc2)c1	InChI=1S/C23H29N7O2/c1-15(2)32-20-13-30(14-20)23(31)25-10-18-6-5-17(9-16(18)3)21-7-8-24-22(28-21)27-19-11-26-29(4)12-19/h5-9,11-12,15,20H,10,13-14H2,1-4H3,(H,25,31)(H,24,27,28)	BMWMKGNVAMXXCH-UHFFFAOYSA-N					doublet; compound annotation
0391_012456	BIIB068	C23H29N7O2	2.9033	118139356		Cc1c(CNC(=O)N2CC(OC(C)C)C2)ccc(-c2nc(Nc3cn(C)nc3)ncc2)c1	InChI=1S/C23H29N7O2/c1-15(2)32-20-13-30(14-20)23(31)25-10-18-6-5-17(9-16(18)3)21-7-8-24-22(28-21)27-19-11-26-29(4)12-19/h5-9,11-12,15,20H,10,13-14H2,1-4H3,(H,25,31)(H,24,27,28)	BMWMKGNVAMXXCH-UHFFFAOYSA-N					doublet; compound annotation
0391_012457	bifonazole	C22H18N2	3.4729	2378		c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1	InChI=1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H	OCAPBUJLXMYKEJ-UHFFFAOYSA-N					compound annotation
0391_012458	(R)-BRD3731	C24H31N3O	4.1528	154828619	C[C@@]1(C2=C(CC(CC2=O)(C)C)NC3=NNC(=C31)CC(C)(C)C)C4=CC=CC=C4	CC(C)(C)Cc1c2c(n[nH]1)NC1=C(C(=O)CC(C)(C)C1)C2(C)c1ccccc1	InChI=1S/C24H31N3O/c1-22(2,3)12-17-20-21(27-26-17)25-16-13-23(4,5)14-18(28)19(16)24(20,6)15-10-8-7-9-11-15/h7-11H,12-14H2,1-6H3,(H2,25,26,27)/t24-/m0/s1	YZRXTIGAQRIAEX-DEOSSOPVSA-N					removed another duplicate entry; compound annotation
0391_012460	GLX351322	C21H25N3O5S	4.6441	2697686		CCOC(=O)c1c(NC(=O)CN2CCN(C(=O)c3ccco3)CC2)sc2c1CCC2	InChI=1S/C21H25N3O5S/c1-2-28-21(27)18-14-5-3-7-16(14)30-19(18)22-17(25)13-23-8-10-24(11-9-23)20(26)15-6-4-12-29-15/h4,6,12H,2-3,5,7-11,13H2,1H3,(H,22,25)	KEVHLTCEMHIJTQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012462	famciclovir	C14H19N5O4	1.4695	3324		CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O	InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)	GGXKWVWZWMLJEH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012464	meclocycline	C22H21ClN2O8	2.5024	54676539	CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O	C=C1c2c(Cl)ccc(O)c2C(O)=C2C(=O)C3(O)C(O)=C(C(N)=O)C(=O)C(N(C)C)C3C(O)C12	InChI=1S/C22H21ClN2O8/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30/h4-5,10,14-15,17,26-28,31,33H,1H2,2-3H3,(H2,24,32)/t10-,14-,15+,17+,22+/m1/s1	RNIADBXQDMCFEN-IWVLMIASSA-N					doublet; compound annotation
0391_012465	meclocycline	C22H21ClN2O8	2.5598	54676539	CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O	C=C1c2c(Cl)ccc(O)c2C(O)=C2C(=O)C3(O)C(O)=C(C(N)=O)C(=O)C(N(C)C)C3C(O)C12	InChI=1S/C22H21ClN2O8/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30/h4-5,10,14-15,17,26-28,31,33H,1H2,2-3H3,(H2,24,32)/t10-,14-,15+,17+,22+/m1/s1	RNIADBXQDMCFEN-IWVLMIASSA-N					doublet; compound annotation
0391_012466	erythromycin	C37H67NO13	2.816	12560	CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O	InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1	ULGZDMOVFRHVEP-RWJQBGPGSA-N					removed another duplicate entry; compound annotation
0391_012468	Diethyltoluamide	C12H17NO	3.3287	4284		CCN(CC)C(=O)c1cccc(C)c1	InChI=1S/C12H17NO/c1-4-13(5-2)12(14)11-8-6-7-10(3)9-11/h6-9H,4-5H2,1-3H3	MMOXZBCLCQITDF-UHFFFAOYSA-N					doublet; compound annotation
0391_012469	Diethyltoluamide	C12H17NO	3.3322	4284		CCN(CC)C(=O)c1cccc(C)c1	InChI=1S/C12H17NO/c1-4-13(5-2)12(14)11-8-6-7-10(3)9-11/h6-9H,4-5H2,1-3H3	MMOXZBCLCQITDF-UHFFFAOYSA-N					doublet; compound annotation
0391_012470	Bedaquiline	C32H31BrN2O2	4.5097	5388906	CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O	COc1c(C(c2ccccc2)C(O)(CCN(C)C)c2cccc3ccccc23)cc2cc(Br)ccc2n1	InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1	QUIJNHUBAXPXFS-XLJNKUFUSA-N					doublet; compound annotation
0391_012471	flufenamic acid	C14H10F3NO2	4.6939	3371		O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1	InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)	LPEPZBJOKDYZAD-UHFFFAOYSA-N					compound annotation
0391_012472	bergenin	C14H16O9	1.0706	66065	COC1=C(C=C2C(=C1O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)OC2=O)O	COc1c(O)cc2C(=O)OC3C(OC(CO)C(O)C3O)c2c1O	InChI=1S/C14H16O9/c1-21-11-5(16)2-4-7(9(11)18)12-13(23-14(4)20)10(19)8(17)6(3-15)22-12/h2,6,8,10,12-13,15-19H,3H2,1H3/t6-,8-,10+,12+,13-/m1/s1	YWJXCIXBAKGUKZ-HJJNZUOJSA-N					compound annotation
0391_012473	Omadacycline	C29H40N4O7	1.3788	54697325	CC(C)(C)CNCC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C	CN(C)c1c2CC3CC4C(N(C)C)C(=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)c2c(O)c(CNCC(C)(C)C)c1	InChI=1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34-35,38,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1	VJYKVCURWJGLPG-IQZGDKDPSA-N					compound annotation
0391_012474	Hesperidin methylchalcone	C29H36O15	2.4233	6436550	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C(C(=C3)OC)C(=O)/C=C/C4=CC(=C(C=C4)OC)O)O)O)O)O)O)O)O	COc1c(O)cc(C=CC(=O)c2c(O)cc(OC3OC(COC4OC(C)C(O)C(O)C4O)C(O)C(O)C3O)cc2OC)cc1	InChI=1S/C29H36O15/c1-12-22(33)24(35)26(37)28(42-12)41-11-20-23(34)25(36)27(38)29(44-20)43-14-9-17(32)21(19(10-14)40-3)15(30)6-4-13-5-7-18(39-2)16(31)8-13/h4-10,12,20,22-29,31-38H,11H2,1-3H3/b6-4+/t12-,20+,22-,23+,24+,25-,26+,27+,28+,29+/m0/s1	FDHNLHLOJLLXDH-JIYHLSBYSA-N					removed another duplicate entry; compound annotation
0391_012476	TENOFOVIR ALAFENAMIDE	C21H29N6O5P	2.5109	9574768	C[C@H](CN1C=NC2=C(N=CN=C21)N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3=CC=CC=C3	CC(C)OC(=O)C(C)NP(=O)(COC(C)Cn1cnc2c(N)ncnc21)Oc1ccccc1	InChI=1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1	LDEKQSIMHVQZJK-CAQYMETFSA-N					doublet; removed another duplicate entry; compound annotation
0391_012478	terbinafine	C21H25N	3.5645	1549008	CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21	CN(CC=CC#CC(C)(C)C)Cc1cccc2ccccc12	InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+	DOMXUEMWDBAQBQ-WEVVVXLNSA-N					doublet; compound annotation
0391_012479	Magnolin	C23H28O7	3.7126	169234	COC1=C(C=C(C=C1)[C@@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C(=C4)OC)OC)OC)OC	COc1c(OC)cc(C2OCC3C(c4cc(OC)c(OC)c(OC)c4)OCC23)cc1	InChI=1S/C23H28O7/c1-24-17-7-6-13(8-18(17)25-2)21-15-11-30-22(16(15)12-29-21)14-9-19(26-3)23(28-5)20(10-14)27-4/h6-10,15-16,21-22H,11-12H2,1-5H3/t15-,16-,21+,22+/m0/s1	MFIHSKBTNZNJIK-RZTYQLBFSA-N					removed another duplicate entry; compound annotation
0391_012482	Rifaximin	C43H51N3O11	4.1181	6436173	C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C	COC1C=COC2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)c1c(nc5cc(C)ccn51)c4c3C2=O	InChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1	NZCRJKRKKOLAOJ-XRCRFVBUSA-N					removed another duplicate entry; compound annotation
0391_012484	glyburide	C23H28ClN3O5S	4.3149	3488		COc1c(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cc(Cl)cc1	InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)	ZNNLBTZKUZBEKO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012486	Fluralaner	C22H17Cl2F6N3O3	5.2127	25144319		Cc1c(C(=O)NCC(=O)NCC(F)(F)F)ccc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)c1	InChI=1S/C22H17Cl2F6N3O3/c1-11-4-12(2-3-16(11)19(35)31-9-18(34)32-10-21(25,26)27)17-8-20(36-33-17,22(28,29)30)13-5-14(23)7-15(24)6-13/h2-7H,8-10H2,1H3,(H,31,35)(H,32,34)	MLBZKOGAMRTSKP-UHFFFAOYSA-N					compound annotation
0391_012487	3'-Azido-3'-deoxy-5-methylcytidine	C10H14N6O4	0.5228	101644650	CC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)N=[N+]=[N-])O	Cc1cn(C2OC(CO)C(N=[N+]=[N-])C2O)c(=O)nc1N	InChI=1S/C10H14N6O4/c1-4-2-16(10(19)13-8(4)11)9-7(18)6(14-15-12)5(3-17)20-9/h2,5-7,9,17-18H,3H2,1H3,(H2,11,13,19)/t5-,6-,7-,9-/m1/s1	HQIDXEHGLJUNPT-JXOAFFINSA-N					doublet; compound annotation
0391_012488	3'-Azido-3'-deoxy-5-methylcytidine	C10H14N6O4	0.5287	101644650	CC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)N=[N+]=[N-])O	Cc1cn(C2OC(CO)C(N=[N+]=[N-])C2O)c(=O)nc1N	InChI=1S/C10H14N6O4/c1-4-2-16(10(19)13-8(4)11)9-7(18)6(14-15-12)5(3-17)20-9/h2,5-7,9,17-18H,3H2,1H3,(H2,11,13,19)/t5-,6-,7-,9-/m1/s1	HQIDXEHGLJUNPT-JXOAFFINSA-N					doublet; compound annotation
0391_012489	195371-52-9	C23H24N2O	1.6522	238484		CC(CCc1ccccn1)(CCc1ccccn1)C(=O)c1ccccc1	InChI=1S/C23H24N2O/c1-23(15-13-20-11-5-7-17-24-20,16-14-21-12-6-8-18-25-21)22(26)19-9-3-2-4-10-19/h2-12,17-18H,13-16H2,1H3	SETYDCSRABYHSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012491	1439934-41-4	C22H24ClN7O	1.994	71558939		CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCNCC3)cc2)ncc1Cl	InChI=1S/C22H24ClN7O/c1-24-21(31)17-4-2-3-5-19(17)28-20-18(23)14-26-22(29-20)27-15-6-8-16(9-7-15)30-12-10-25-11-13-30/h2-9,14,25H,10-13H2,1H3,(H,24,31)(H2,26,27,28,29)	FCLOIQHNUARDSR-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012494	VL285	C29H32N4O4S	3.155	71667162	CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)C)N4CC5=CC=CC=C5C4=O)O	Cc1c(-c2ccc(CNC(=O)C3CC(O)CN3C(=O)C(C(C)C)N3Cc4ccccc4C3=O)cc2)scn1	InChI=1S/C29H32N4O4S/c1-17(2)25(33-14-21-6-4-5-7-23(21)28(33)36)29(37)32-15-22(34)12-24(32)27(35)30-13-19-8-10-20(11-9-19)26-18(3)31-16-38-26/h4-11,16-17,22,24-25,34H,12-15H2,1-3H3,(H,30,35)/t22-,24+,25+/m1/s1	HEDFFPYRFJKXQP-VJTSUQJLSA-N					removed another duplicate entry; compound annotation
0391_012496	TES-1025	C18H13N3O3S2	3.4714	137142885		N#Cc1c(-c2cccs2)[nH]c(SCc2cccc(CC(=O)O)c2)nc1=O	InChI=1S/C18H13N3O3S2/c19-9-13-16(14-5-2-6-25-14)20-18(21-17(13)24)26-10-12-4-1-3-11(7-12)8-15(22)23/h1-7H,8,10H2,(H,22,23)(H,20,21,24)	RJQYGCGMQYVVIB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012498	1613617-05-2	C33H55ClN4O11	3.6177	86274259		O=C(CCCCCCC(=O)Nc1ccc(CNC(=O)OCCOCCOCCOC(=O)NCCOCCOCCCCCCCl)cc1)NO	InChI=1S/C33H55ClN4O11/c34-15-7-3-4-8-17-44-19-20-45-18-16-35-32(41)48-25-23-46-21-22-47-24-26-49-33(42)36-27-28-11-13-29(14-12-28)37-30(39)9-5-1-2-6-10-31(40)38-43/h11-14,43H,1-10,15-27H2,(H,35,41)(H,36,42)(H,37,39)(H,38,40)	QJTGTGYXESVKJU-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012501	LSZ-102	C25H17F3O4S	4.6244	118574930	CC(C1=C(C=CC(=C1)F)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)/C=C/C(=O)O)(F)F	CC(F)(F)c1c(-c2c(Oc3ccc(C=CC(=O)O)cc3)c3ccc(O)cc3s2)ccc(F)c1	InChI=1S/C25H17F3O4S/c1-25(27,28)20-12-15(26)5-9-18(20)24-23(19-10-6-16(29)13-21(19)33-24)32-17-7-2-14(3-8-17)4-11-22(30)31/h2-13,29H,1H3,(H,30,31)/b11-4+	SJXNPGGVGZXKKI-NYYWCZLTSA-N					compound annotation
0391_012502	439288-66-1	C30H28N2O6S	5.1461	5312130		CCOc1c2CN(c3ccc(CC(=O)NS(=O)(=O)c4ccccc4)cc3)C(=O)c2c(OCC)c2ccccc12	InChI=1S/C30H28N2O6S/c1-3-37-28-23-12-8-9-13-24(23)29(38-4-2)27-25(28)19-32(30(27)34)21-16-14-20(15-17-21)18-26(33)31-39(35,36)22-10-6-5-7-11-22/h5-17H,3-4,18-19H2,1-2H3,(H,31,33)	XREWXJVMYAXCJV-UHFFFAOYSA-N					doublet; compound annotation
0391_012503	439288-66-1	C30H28N2O6S	5.1489	5312130		CCOc1c2CN(c3ccc(CC(=O)NS(=O)(=O)c4ccccc4)cc3)C(=O)c2c(OCC)c2ccccc12	InChI=1S/C30H28N2O6S/c1-3-37-28-23-12-8-9-13-24(23)29(38-4-2)27-25(28)19-32(30(27)34)21-16-14-20(15-17-21)18-26(33)31-39(35,36)22-10-6-5-7-11-22/h5-17H,3-4,18-19H2,1-2H3,(H,31,33)	XREWXJVMYAXCJV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012505	SEA0400	C21H19F2NO3	5.2537	644100		CCOc1cc(N)c(Oc2ccc(OCc3c(F)ccc(F)c3)cc2)cc1	InChI=1S/C21H19F2NO3/c1-2-25-18-8-10-21(20(24)12-18)27-17-6-4-16(5-7-17)26-13-14-11-15(22)3-9-19(14)23/h3-12H,2,13,24H2,1H3	YSUBLPUJDOWYDP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012507	6-Fluoro-1H-indazol-3(2H)-one	C7H5FN2O	1.3424	24728218		O=c1[nH][nH]c2c1ccc(F)c2	InChI=1S/C7H5FN2O/c8-4-1-2-5-6(3-4)9-10-7(5)11/h1-3H,(H2,9,10,11)	KBPHAHZMJXVUPU-UHFFFAOYSA-N					compound annotation
0391_012508	UAMC00039	C16H24ClN3O	1.4123	11232124	C1CCN(CC1)C(=O)[C@H](CCNCC2=CC=C(C=C2)Cl)N	NC(CCNCc1ccc(Cl)cc1)C(=O)N1CCCCC1	InChI=1S/C16H24ClN3O/c17-14-6-4-13(5-7-14)12-19-9-8-15(18)16(21)20-10-2-1-3-11-20/h4-7,15,19H,1-3,8-12,18H2/t15-/m0/s1	DNVZYSMOLXCOLY-HNNXBMFYSA-N					removed another duplicate entry; compound annotation
0391_012510	nazartinib	C26H31ClN6O2	2.1839	72703790	CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)C(=CC=C3)Cl	Cc1nccc(C(=O)Nc2nc3c(c(Cl)ccc3)n2C2CCCCN(C(=O)C=CCN(C)C)C2)c1	InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1	IOMMMLWIABWRKL-WUTDNEBXSA-N					doublet; compound annotation
0391_012511	nazartinib	C26H31ClN6O2	2.1888	72703790	CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)C(=CC=C3)Cl	Cc1nccc(C(=O)Nc2nc3c(c(Cl)ccc3)n2C2CCCCN(C(=O)C=CCN(C)C)C2)c1	InChI=1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1	IOMMMLWIABWRKL-WUTDNEBXSA-N					doublet; compound annotation
0391_012512	E3 ligase Ligand 1A	C23H32N4O3S	2.2123	122422951	CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)N)O	Cc1c(-c2ccc(C(C)NC(=O)C3CC(O)CN3C(=O)C(N)C(C)(C)C)cc2)scn1	InChI=1S/C23H32N4O3S/c1-13(15-6-8-16(9-7-15)19-14(2)25-12-31-19)26-21(29)18-10-17(28)11-27(18)22(30)20(24)23(3,4)5/h6-9,12-13,17-18,20,28H,10-11,24H2,1-5H3,(H,26,29)/t13-,17+,18-,20+/m0/s1	JOSFQWNOUSNZBP-UUZHKXTQSA-N					removed another duplicate entry; compound annotation
0391_012514	335165-68-9	C19H21Br2N3O	3.3789	2729027		OC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2c1ccc(Br)c2	InChI=1S/C19H21Br2N3O/c20-13-1-3-18-16(9-13)17-10-14(21)2-4-19(17)24(18)12-15(25)11-23-7-5-22-6-8-23/h1-4,9-10,15,22,25H,5-8,11-12H2	KUUJEXLRLIPQQJ-UHFFFAOYSA-N					compound annotation
0391_012515	NSC781406	C29H27F2N5O5S2	3.4579	127025628		COc1c(NS(=O)(=O)c2c(F)cc(F)cc2)cc(-c2cc3c(C#CCN4CCN(S(C)(=O)=O)CC4)ccnc3cc2)cn1	InChI=1S/C29H27F2N5O5S2/c1-41-29-27(34-43(39,40)28-8-6-23(30)18-25(28)31)17-22(19-33-29)21-5-7-26-24(16-21)20(9-10-32-26)4-3-11-35-12-14-36(15-13-35)42(2,37)38/h5-10,16-19,34H,11-15H2,1-2H3	BBRINJUWZRLWKK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012517	alpha-2,3-sialyltransferase-IN-1	C28H45NO6	4.0171	11663206	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)[C@@H](CC(=O)O)N)C)C	CC(CCC(=O)O)C1CCC2C3CCC4CC(OC(=O)C(N)CC(=O)O)CCC4(C)C3CCC12C	InChI=1S/C28H45NO6/c1-16(4-9-24(30)31)20-7-8-21-19-6-5-17-14-18(35-26(34)23(29)15-25(32)33)10-12-27(17,2)22(19)11-13-28(20,21)3/h16-23H,4-15,29H2,1-3H3,(H,30,31)(H,32,33)/t16-,17-,18-,19+,20-,21+,22+,23-,27+,28-/m1/s1	NUUCRVJEHQBAKP-GCHQISOYSA-N					removed another duplicate entry; compound annotation
0391_012519	MF498	C32H33N3O7S	4.2598	15948325		CCOc1c2C(=O)N(c3c(C)cc(CS(=O)(=O)NC(=O)Cc4ccccc4OC)cc3)Cc2c(OCC)c2c1cccn2	InChI=1S/C32H33N3O7S/c1-5-41-30-23-11-9-15-33-29(23)31(42-6-2)24-18-35(32(37)28(24)30)25-14-13-21(16-20(25)3)19-43(38,39)34-27(36)17-22-10-7-8-12-26(22)40-4/h7-16H,5-6,17-19H2,1-4H3,(H,34,36)	WVLIUERFVJYBNY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012521	NSC781406	C29H27F2N5O5S2	4.3226	127025628		COc1c(NS(=O)(=O)c2c(F)cc(F)cc2)cc(-c2cc3c(C#CCN4CCN(S(C)(=O)=O)CC4)ccnc3cc2)cn1	InChI=1S/C29H27F2N5O5S2/c1-41-29-27(34-43(39,40)28-8-6-23(30)18-25(28)31)17-22(19-33-29)21-5-7-26-24(16-21)20(9-10-32-26)4-3-11-35-12-14-36(15-13-35)42(2,37)38/h5-10,16-19,34H,11-15H2,1-2H3	BBRINJUWZRLWKK-UHFFFAOYSA-N					doublet; compound annotation
0391_012522	Sirt2-IN-1	C28H27N7O2S2	4.3307	112499922		Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cc(OCc4cn(Cc5ccccc5)nn4)ccc3)s2)n1	InChI=1S/C28H27N7O2S2/c1-19-11-20(2)31-28(30-19)38-18-26(36)32-27-29-14-25(39-27)13-22-9-6-10-24(12-22)37-17-23-16-35(34-33-23)15-21-7-4-3-5-8-21/h3-12,14,16H,13,15,17-18H2,1-2H3,(H,29,32,36)	YWLNYZXFIAFWSF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012524	(1S,2S,3R)-DT-061	C25H23F3N2O5S	5.4534	118374168	C1C[C@@H]([C@H]([C@@H](C1)N2C3=CC=CC=C3OC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F	O=S(=O)(NC1CCCC(N2c3ccccc3Oc3ccccc32)C1O)c1ccc(OC(F)(F)F)cc1	InChI=1S/C25H23F3N2O5S/c26-25(27,28)35-16-12-14-17(15-13-16)36(32,33)29-18-6-5-9-21(24(18)31)30-19-7-1-3-10-22(19)34-23-11-4-2-8-20(23)30/h1-4,7-8,10-15,18,21,24,29,31H,5-6,9H2/t18-,21+,24+/m0/s1	WGKGADVPRVLHHZ-SNYIIPAISA-N					removed another duplicate entry; compound annotation
0391_012527	N-Desethyl Sunitinib	C20H23FN4O2	1.8609	10292573	CCNCCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	CCNCCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc23)c1C	InChI=1S/C20H23FN4O2/c1-4-22-7-8-23-20(27)18-11(2)17(24-12(18)3)10-15-14-9-13(21)5-6-16(14)25-19(15)26/h5-6,9-10,22,24H,4,7-8H2,1-3H3,(H,23,27)(H,25,26)/b15-10-	LIZNIAKSBJKPQC-GDNBJRDFSA-N					doublet; compound annotation
0391_012528	PH-002	C27H33N5O4	2.478	71451956		Cn1nc(CC(=O)Nc2ccc(CN3CCN(C(=O)OC(C)(C)C)CC3)cc2)c2ccccc2c1=O	InChI=1S/C27H33N5O4/c1-27(2,3)36-26(35)32-15-13-31(14-16-32)18-19-9-11-20(12-10-19)28-24(33)17-23-21-7-5-6-8-22(21)25(34)30(4)29-23/h5-12H,13-18H2,1-4H3,(H,28,33)	GSXXTLWPQMHHDJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012530	N-Desethyl Sunitinib	C20H23FN4O2	2.5685	10292573	CCNCCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C	CCNCCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc23)c1C	InChI=1S/C20H23FN4O2/c1-4-22-7-8-23-20(27)18-11(2)17(24-12(18)3)10-15-14-9-13(21)5-6-16(14)25-19(15)26/h5-6,9-10,22,24H,4,7-8H2,1-3H3,(H,23,27)(H,25,26)/b15-10-	LIZNIAKSBJKPQC-GDNBJRDFSA-N					doublet; compound annotation
0391_012531	ketoconazole	C26H28Cl2N4O4	3.0614	47576	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1	XMAYWYJOQHXEEK-ZEQKJWHPSA-N					doublet; compound annotation
0391_012532	ketoconazole	C26H28Cl2N4O4	3.0647	47576	CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4c(Cl)cc(Cl)cc4)O3)cc2)CC1	InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1	XMAYWYJOQHXEEK-ZEQKJWHPSA-N					doublet; compound annotation
0391_012533	BI-3802	C24H29ClN6O3	3.2312	131632978	C[C@@H]1C[C@@H](CN(C1)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)C(=C4)OCC(=O)NC)C)Cl)C	CNC(=O)COc1cc2c(ccc(Nc3nc(N4CC(C)CC(C)C4)ncc3Cl)c2)n(C)c1=O	InChI=1S/C24H29ClN6O3/c1-14-7-15(2)12-31(11-14)24-27-10-18(25)22(29-24)28-17-5-6-19-16(8-17)9-20(23(33)30(19)4)34-13-21(32)26-3/h5-6,8-10,14-15H,7,11-13H2,1-4H3,(H,26,32)(H,27,28,29)/t14-,15+	GXTJETQFYHZHNB-GASCZTMLSA-N					removed another duplicate entry; compound annotation
0391_012535	Chlorantraniliprole	C18H14BrCl2N5O2	3.7463	11271640		CNC(=O)c1c(NC(=O)c2cc(Br)nn2-c2c(Cl)cccn2)c(C)cc(Cl)c1	InChI=1S/C18H14BrCl2N5O2/c1-9-6-10(20)7-11(17(27)22-2)15(9)24-18(28)13-8-14(19)25-26(13)16-12(21)4-3-5-23-16/h3-8H,1-2H3,(H,22,27)(H,24,28)	PSOVNZZNOMJUBI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012537	Padsevonil	C14H14ClF5N4O2S	3.8479	52911611	COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3C[C@H](CC3=O)CC(F)(F)Cl	COCc1nn2c(CN3CC(CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1	InChI=1S/C14H14ClF5N4O2S/c1-26-6-9-22-24-8(11(14(18,19)20)21-12(24)27-9)5-23-4-7(2-10(23)25)3-13(15,16)17/h7H,2-6H2,1H3/t7-/m1/s1	DCXFIOLWWRXEQH-SSDOTTSWSA-N					doublet; compound annotation
0391_012538	Padsevonil	C14H14ClF5N4O2S	3.8513	52911611	COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3C[C@H](CC3=O)CC(F)(F)Cl	COCc1nn2c(CN3CC(CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1	InChI=1S/C14H14ClF5N4O2S/c1-26-6-9-22-24-8(11(14(18,19)20)21-12(24)27-9)5-23-4-7(2-10(23)25)3-13(15,16)17/h7H,2-6H2,1H3/t7-/m1/s1	DCXFIOLWWRXEQH-SSDOTTSWSA-N					doublet; compound annotation
0391_012539	FICZ	C19H12N2O	4.5078	1863		O=Cc1c2[nH]c3ccccc3c2cc2c1c1ccccc1[nH]2	InChI=1S/C19H12N2O/c22-10-14-18-12-6-2-4-8-16(12)20-17(18)9-13-11-5-1-3-7-15(11)21-19(13)14/h1-10,20-21H	ZUDXFBWDXVNRKF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012541	Quinoline-2-carboxylic acid	C10H7NO2	1.1084	7124		O=C(O)c1nc2ccccc2cc1	InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13)	LOAUVZALPPNFOQ-UHFFFAOYSA-N					compound annotation
0391_012542	Upadacitinib	C17H19F3N6O	1.9233	58557659	CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F	CCC1CN(C(=O)NCC(F)(F)F)CC1c1cnc2cnc3c(cc[nH]3)n12	InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1	WYQFJHHDOKWSHR-MNOVXSKESA-N					removed another duplicate entry; compound annotation
0391_012544	alpha-Asarone	C12H16O3	4.0492	636822	C/C=C/C1=CC(=C(C=C1OC)OC)OC	CC=Cc1cc(OC)c(OC)cc1OC	InChI=1S/C12H16O3/c1-5-6-9-7-11(14-3)12(15-4)8-10(9)13-2/h5-8H,1-4H3/b6-5+	RKFAZBXYICVSKP-AATRIKPKSA-N					removed another duplicate entry; compound annotation
0391_012546	Triptophenolide	C20H24O3	4.3272	173273	CC(C)C1=C(C2=C(C=C1)[C@]3(CCC4=C([C@@H]3CC2)COC4=O)C)O	CC(C)c1c(O)c2c(cc1)C1(C)CCC3=C(COC3=O)C1CC2	InChI=1S/C20H24O3/c1-11(2)12-4-6-16-14(18(12)21)5-7-17-15-10-23-19(22)13(15)8-9-20(16,17)3/h4,6,11,17,21H,5,7-10H2,1-3H3/t17-,20+/m0/s1	KPXIBWGPZSPABK-FXAWDEMLSA-N					removed another duplicate entry; compound annotation
0391_012548	GARCINONE D	C24H28O7	4.6465	5495926		COc1c(CCC(C)(C)O)c2c(cc1O)oc1c(c(O)c(CC=C(C)C)c(O)c1)c2=O	InChI=1S/C24H28O7/c1-12(2)6-7-13-15(25)10-18-20(21(13)27)22(28)19-14(8-9-24(3,4)29)23(30-5)16(26)11-17(19)31-18/h6,10-11,25-27,29H,7-9H2,1-5H3	TYALNCRUIKOKGP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012550	GARCINONE D	C24H28O7	4.707	5495926		COc1c(CCC(C)(C)O)c2c(cc1O)oc1c(c(O)c(CC=C(C)C)c(O)c1)c2=O	InChI=1S/C24H28O7/c1-12(2)6-7-13-15(25)10-18-20(21(13)27)22(28)19-14(8-9-24(3,4)29)23(30-5)16(26)11-17(19)31-18/h6,10-11,25-27,29H,7-9H2,1-5H3	TYALNCRUIKOKGP-UHFFFAOYSA-N					doublet; compound annotation
0391_012551	Coixol	C8H7NO3	2.023	10772		COc1cc2c(cc1)[nH]c(=O)o2	InChI=1S/C8H7NO3/c1-11-5-2-3-6-7(4-5)12-8(10)9-6/h2-4H,1H3,(H,9,10)	MKMCJLMBVKHUMS-UHFFFAOYSA-N					compound annotation
0391_012552	Dapagliflozin impurity	C21H25ClO7	3.1657	59648701	CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@]3([C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)Cl	CCOc1ccc(Cc2c(Cl)ccc(C3(O)OC(CO)C(O)C(O)C3O)c2)cc1	InChI=1S/C21H25ClO7/c1-2-28-15-6-3-12(4-7-15)9-13-10-14(5-8-16(13)22)21(27)20(26)19(25)18(24)17(11-23)29-21/h3-8,10,17-20,23-27H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1	KYDGWGYAUCJZDV-ADAARDCZSA-N					compound annotation
0391_012553	Gypenoside XLIX	C52H86O21	3.1657	16007240	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@@]4([C@H]5CC[C@@H]6[C@H](CC[C@]6([C@@]5(CC[C@H]4C3(C)C)C)C)[C@@](CCC=C(C)C)(CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)C=O)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O)O)O	CC(C)=CCCC(O)(COC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1CCC1C3(C=O)CCC(OC4OCC(O)C(OC5OCC(O)C(O)C5O)C4OC4OC(C)C(O)C(O)C4O)C(C)(C)C3CCC12C	InChI=1S/C52H86O21/c1-24(2)9-8-15-52(65,23-68-45-40(63)38(61)36(59)30(19-53)70-45)27-12-16-49(6)26(27)10-11-32-50(49,7)17-13-31-48(4,5)33(14-18-51(31,32)22-54)71-47-43(73-46-41(64)37(60)34(57)25(3)69-46)42(29(56)21-67-47)72-44-39(62)35(58)28(55)20-66-44/h9,22,25-47,53,55-65H,8,10-21,23H2,1-7H3/t25-,26+,27-,28+,29-,30+,31-,32-,33-,34-,35-,36+,37+,38-,39+,40+,41+,42-,43+,44-,45+,46-,47-,49+,50+,51+,52+/m0/s1	AFEVCSJFNQWWDF-AZFNEDKCSA-N					compound annotation
0391_012554	5-Carboxyfluorescein diacetate	C25H16O9	3.9108	133314		CC(=O)Oc1cc2c(cc1)C1(OC(=O)c3cc(C(=O)O)ccc31)c1c(cc(OC(C)=O)cc1)O2	InChI=1S/C25H16O9/c1-12(26)31-15-4-7-19-21(10-15)33-22-11-16(32-13(2)27)5-8-20(22)25(19)18-6-3-14(23(28)29)9-17(18)24(30)34-25/h3-11H,1-2H3,(H,28,29)	WPUZGNPQMIWOHE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012556	Fmoc-N-Me-Val-OH	C21H23NO4	4.6166	978328	CC(C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13	CC(C)C(C(=O)O)N(C)C(=O)OCC1c2ccccc2-c2ccccc21	InChI=1S/C21H23NO4/c1-13(2)19(20(23)24)22(3)21(25)26-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,13,18-19H,12H2,1-3H3,(H,23,24)/t19-/m0/s1	YCXXXPZNQXXRIG-IBGZPJMESA-N					removed another duplicate entry; compound annotation
0391_012558	Muscone	C16H30O	6.4821	10947		CC1CCCCCCCCCCCCC(=O)C1	InChI=1S/C16H30O/c1-15-12-10-8-6-4-2-3-5-7-9-11-13-16(17)14-15/h15H,2-14H2,1H3	ALHUZKCOMYUFRB-UHFFFAOYSA-N					compound annotation
0391_012559	Astringin	C20H22O9	1.7279	5281712	C1=CC(=C(C=C1/C=C/C2=CC(=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O	OCC1OC(Oc2cc(C=Cc3cc(O)c(O)cc3)cc(O)c2)C(O)C(O)C1O	InChI=1S/C20H22O9/c21-9-16-17(25)18(26)19(27)20(29-16)28-13-6-11(5-12(22)8-13)2-1-10-3-4-14(23)15(24)7-10/h1-8,16-27H,9H2/b2-1+/t16-,17-,18+,19-,20-/m1/s1	PERPNFLGJXUDDW-CUYWLFDKSA-N					compound annotation
0391_012560	87075-17-0	C17H18ClNO	2.0543	3036864	CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)Cl	CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1	InChI=1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3/t15-/m1/s1	GOTMKOSCLKVOGG-OAHLLOKOSA-N					compound annotation
0391_012561	1094069-99-4	C20H26N8OS	2.19	25144732		CCN(Cc1nsc(Nc2nc(C)cn3c(-c4c[nH]nc4)cnc23)c1)C(C)(C)CO	InChI=1S/C20H26N8OS/c1-5-27(20(3,4)12-29)11-15-6-17(30-26-15)25-18-19-21-9-16(14-7-22-23-8-14)28(19)10-13(2)24-18/h6-10,29H,5,11-12H2,1-4H3,(H,22,23)(H,24,25)	RHGZQGXELRMGES-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012563	136259-18-2	C18H26N4O5	2.3348	9209502	C1CCN(C1)C(=O)[C@H](CCCCNC(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])N	NC(CCCCNC(=O)OCc1ccc([N+](=O)[O-])cc1)C(=O)N1CCCC1	InChI=1S/C18H26N4O5/c19-16(17(23)21-11-3-4-12-21)5-1-2-10-20-18(24)27-13-14-6-8-15(9-7-14)22(25)26/h6-9,16H,1-5,10-13,19H2,(H,20,24)/t16-/m0/s1	YDYSCRZHYWLSPQ-INIZCTEOSA-N					removed another duplicate entry; compound annotation
0391_012565	1222810-74-3	C16H12N6O5	2.9174	44123657		O=[N+]([O-])c1cc2c(cc1)nc(COCc1nc3c(cc([N+](=O)[O-])cc3)[nH]1)[nH]2	InChI=1S/C16H12N6O5/c23-21(24)9-1-3-11-13(5-9)19-15(17-11)7-27-8-16-18-12-4-2-10(22(25)26)6-14(12)20-16/h1-6H,7-8H2,(H,17,19)(H,18,20)	ZQPXNYLXYNRFNP-UHFFFAOYSA-N					doublet; compound annotation
0391_012566	Tomeglovir	C23H27N3O4S	3.552	475330		CN(C)c1cccc2c1cccc2S(=O)(=O)Nc1ccc(NC(=O)C(C)(C)CO)cc1	InChI=1S/C23H27N3O4S/c1-23(2,15-27)22(28)24-16-11-13-17(14-12-16)25-31(29,30)21-10-6-7-18-19(21)8-5-9-20(18)26(3)4/h5-14,25,27H,15H2,1-4H3,(H,24,28)	OSQAKHSYTKBSPB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012569	Eprotirome	C18H17Br2NO5	3.9999	10299876		CC(C)c1c(O)ccc(Oc2c(Br)cc(NC(=O)CC(=O)O)cc2Br)c1	InChI=1S/C18H17Br2NO5/c1-9(2)12-7-11(3-4-15(12)22)26-18-13(19)5-10(6-14(18)20)21-16(23)8-17(24)25/h3-7,9,22H,8H2,1-2H3,(H,21,23)(H,24,25)	VPCSYAVXDAUHLT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012571	1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid	C7H7NO3	0.565	592704		Cn1cc(C(=O)O)ccc1=O	InChI=1S/C7H7NO3/c1-8-4-5(7(10)11)2-3-6(8)9/h2-4H,1H3,(H,10,11)	RGZCKPXTNJAWMR-UHFFFAOYSA-N					compound annotation
0391_012572	Kinetin riboside	C15H17N5O5	1.6635	20345	C1=COC(=C1)CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	OCC1OC(n2cnc3c(NCc4ccco4)ncnc32)C(O)C1O	InChI=1S/C15H17N5O5/c21-5-9-11(22)12(23)15(25-9)20-7-19-10-13(17-6-18-14(10)20)16-4-8-2-1-3-24-8/h1-3,6-7,9,11-12,15,21-23H,4-5H2,(H,16,17,18)/t9-,11-,12-,15-/m1/s1	CAGLGYNQQSIUGX-SDBHATRESA-N					compound annotation
0391_012573	Etosalamide	C11H15NO3	2.3282	208946		CCOCCOc1ccccc1C(N)=O	InChI=1S/C11H15NO3/c1-2-14-7-8-15-10-6-4-3-5-9(10)11(12)13/h3-6H,2,7-8H2,1H3,(H2,12,13)	XBNRCMFFZFCWMH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012575	1430218-51-1	C22H25N5O2	2.6502	89510076		NCCOc1ccc(Nc2ncc3ccc(=O)n(C4CC5CCC4C5)c3n2)cc1	InChI=1S/C22H25N5O2/c23-9-10-29-18-6-4-17(5-7-18)25-22-24-13-16-3-8-20(28)27(21(16)26-22)19-12-14-1-2-15(19)11-14/h3-8,13-15,19H,1-2,9-12,23H2,(H,24,25,26)	RCSLGYIVHUXZCI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012578	133454-55-4	C24H29FN2O4	2.683	9823904		COc1c(OCCCN2CCC(c3noc4c3ccc(F)c4)CC2)ccc(C(C)O)c1	InChI=1S/C24H29FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-17,28H,3,8-13H2,1-2H3	SBKZGLWZGZQVHA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012580	CHEMBL4803823	C22H33N2O2+	4.049	1381284	CCC1=[N+](C2=CC=CC=C2N1CC(=O)O[C@@H]3C[C@@H](CC[C@H]3C(C)C)C)C	CCc1[n+](C)c2ccccc2n1CC(=O)OC1CC(C)CCC1C(C)C	InChI=1S/C22H33N2O2/c1-6-21-23(5)18-9-7-8-10-19(18)24(21)14-22(25)26-20-13-16(4)11-12-17(20)15(2)3/h7-10,15-17,20H,6,11-14H2,1-5H3/q+1/t16-,17+,20-/m1/s1	FXJNAOPQWIPEMZ-FUHIMQAGSA-N					compound annotation
0391_012581	Etofibrate	C18H18ClNO5	4.283	65777		CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cnccc1	InChI=1S/C18H18ClNO5/c1-18(2,25-15-7-5-14(19)6-8-15)17(22)24-11-10-23-16(21)13-4-3-9-20-12-13/h3-9,12H,10-11H2,1-2H3	XXRVYAFBUDSLJX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012583	beta-lactamase-IN-1	C11H13N3O4	1.4017	66658480		COc1nc2c(cc1)ncc(=O)n2C(CO)CO	InChI=1S/C11H13N3O4/c1-18-9-3-2-8-11(13-9)14(7(5-15)6-16)10(17)4-12-8/h2-4,7,15-16H,5-6H2,1H3	VOAJCTMMHSBQGS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012585	Cy3-YNE	C34H42N3O7S2+	2.0859	118990158	CCN\1C2=C(C=C(C=C2)S(=O)(=O)O)C(/C1=C\C=C\C3=[N+](C4=C(C3(C)C)C=C(C=C4)S(=O)(=O)O)CCCCCC(=O)NCC#C)(C)C	C#CCNC(=O)CCCCC[N+]1=C(C=CC=C2N(CC)c3c(cc(S(=O)(=O)O)cc3)C2(C)C)C(C)(C)c2c1ccc(S(=O)(=O)O)c2	InChI=1S/C34H41N3O7S2/c1-7-20-35-32(38)15-10-9-11-21-37-29-19-17-25(46(42,43)44)23-27(29)34(5,6)31(37)14-12-13-30-33(3,4)26-22-24(45(39,40)41)16-18-28(26)36(30)8-2/h1,12-14,16-19,22-23H,8-11,15,20-21H2,2-6H3,(H2-,35,38,39,40,41,42,43,44)/p+1	DVBDEKRWCVSXGU-UHFFFAOYSA-O					compound annotation
0391_012586	Trovirdine	C13H13BrN4S	2.0888	3000870		SC(=NCCc1ccccn1)Nc1ncc(Br)cc1	InChI=1S/C13H13BrN4S/c14-10-4-5-12(17-9-10)18-13(19)16-8-6-11-3-1-2-7-15-11/h1-5,7,9H,6,8H2,(H2,16,17,18,19)	HOCFDYZWQYGULA-UHFFFAOYSA-N					compound annotation
0391_012587	SCHEMBL24370812	C33H41N2O8S2+	2.3931	12037276	CCN\1C2=C(C=C(C=C2)S(=O)(=O)O)C(/C1=C/C=C/C=C/C3=[N+](C4=C(C3(C)C)C=C(C=C4)S(=O)(=O)O)CCCCCC(=O)O)(C)C	CCN1C(=CC=CC=CC2=[N+](CCCCCC(=O)O)c3c(cc(S(=O)(=O)O)cc3)C2(C)C)C(C)(C)c2c1ccc(S(=O)(=O)O)c2	InChI=1S/C33H40N2O8S2/c1-6-34-27-18-16-23(44(38,39)40)21-25(27)32(2,3)29(34)13-9-7-10-14-30-33(4,5)26-22-24(45(41,42)43)17-19-28(26)35(30)20-12-8-11-15-31(36)37/h7,9-10,13-14,16-19,21-22H,6,8,11-12,15,20H2,1-5H3,(H2-,36,37,38,39,40,41,42,43)/p+1	HPICMEGAGMPYID-UHFFFAOYSA-O					compound annotation
0391_012588	Rhodanine 6GDN	C28H30N2O3	4.0722	13807		CCN=c1cc2oc3c(cc(C)c(NCC)c3)c(-c3ccccc3C(=O)OCC)c-2cc1C	InChI=1S/C28H30N2O3/c1-6-29-23-15-25-21(13-17(23)4)27(19-11-9-10-12-20(19)28(31)32-8-3)22-14-18(5)24(30-7-2)16-26(22)33-25/h9-16,29H,6-8H2,1-5H3	IWWWBRIIGAXLCJ-UHFFFAOYSA-N					compound annotation
0391_012589	1258275-73-8	C21H32O6	5.7705	60146245		CCCCCCCC(=O)c1cc(OC)c(OC)c(OC)c1CC(=O)OCC	InChI=1S/C21H32O6/c1-6-8-9-10-11-12-17(22)15-13-18(24-3)21(26-5)20(25-4)16(15)14-19(23)27-7-2/h13H,6-12,14H2,1-5H3	WCYMJQXRLIDSAQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012591	Nemifitide	C33H43FN10O6	1.5992	6918348	C1[C@H](CN([C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N)C(=O)[C@H](CC4=CC=C(C=C4)F)N)O	NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)C1CC(O)CN1C(=O)C(N)Cc1ccc(F)cc1	InChI=1S/C33H43FN10O6/c34-20-9-7-18(8-10-20)12-23(35)32(50)44-17-21(45)14-27(44)31(49)43-25(6-3-11-39-33(37)38)30(48)41-16-28(46)42-26(29(36)47)13-19-15-40-24-5-2-1-4-22(19)24/h1-2,4-5,7-10,15,21,23,25-27,40,45H,3,6,11-14,16-17,35H2,(H2,36,47)(H,41,48)(H,42,46)(H,43,49)(H4,37,38,39)/t21-,23+,25+,26+,27+/m1/s1	SGXPTOACEHQGHL-RCNLLYRESA-N					removed another duplicate entry; compound annotation
0391_012593	4-Iodo-3-nitrobenzamide	C7H5IN2O3	2.478	9796068		NC(=O)c1cc([N+](=O)[O-])c(I)cc1	InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11)	MDOJTZQKHMAPBK-UHFFFAOYSA-N					compound annotation
0391_012594	1222810-74-3	C16H12N6O5	2.9163	44123657		O=[N+]([O-])c1cc2c(cc1)nc(COCc1nc3c(cc([N+](=O)[O-])cc3)[nH]1)[nH]2	InChI=1S/C16H12N6O5/c23-21(24)9-1-3-11-13(5-9)19-15(17-11)7-27-8-16-18-12-4-2-10(22(25)26)6-14(12)20-16/h1-6H,7-8H2,(H,17,19)(H,18,20)	ZQPXNYLXYNRFNP-UHFFFAOYSA-N					doublet; compound annotation
0391_012595	1222810-74-3	C16H12N6O5	2.9195	44123657		O=[N+]([O-])c1cc2c(cc1)nc(COCc1nc3c(cc([N+](=O)[O-])cc3)[nH]1)[nH]2	InChI=1S/C16H12N6O5/c23-21(24)9-1-3-11-13(5-9)19-15(17-11)7-27-8-16-18-12-4-2-10(22(25)26)6-14(12)20-16/h1-6H,7-8H2,(H,17,19)(H,18,20)	ZQPXNYLXYNRFNP-UHFFFAOYSA-N					doublet; compound annotation
0391_012596	1079400-07-9	C17H16ClN5O2	3.4898	57582353		COc1cc(-c2c(N)nc(NC(=O)c3ccnn3C)cc2)c(Cl)cc1	InChI=1S/C17H16ClN5O2/c1-23-14(7-8-20-23)17(24)22-15-6-4-11(16(19)21-15)12-9-10(25-2)3-5-13(12)18/h3-9H,1-2H3,(H3,19,21,22,24)	ZRJGMDIPCQOGNI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012598	Fantofarone	C31H38N2O5S	3.5492	119349		COc1c(OC)cc(CCN(C)CCCOc2ccc(S(=O)(=O)c3c4ccccn4cc3C(C)C)cc2)cc1	InChI=1S/C31H38N2O5S/c1-23(2)27-22-33-18-7-6-9-28(33)31(27)39(34,35)26-13-11-25(12-14-26)38-20-8-17-32(3)19-16-24-10-15-29(36-4)30(21-24)37-5/h6-7,9-15,18,21-23H,8,16-17,19-20H2,1-5H3	ITAMRBIZWGDOHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012600	587871-26-9	C21H17NO3S2	3.9749	5278396		O=c1cc(-c2c3Sc4ccccc4Sc3ccc2)oc(N2CCOCC2)c1	InChI=1S/C21H17NO3S2/c23-14-12-16(25-20(13-14)22-8-10-24-11-9-22)15-4-3-7-19-21(15)27-18-6-2-1-5-17(18)26-19/h1-7,12-13H,8-11H2	XRKYMMUGXMWDAO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012602	HIV-1 integrase inhibitor 2	C21H20ClNO2	4.3578	24800940		CCCC(C(=O)O)c1c(C)nc2ccc(Cl)cc2c1-c1ccccc1	InChI=1S/C21H20ClNO2/c1-3-7-16(21(24)25)19-13(2)23-18-11-10-15(22)12-17(18)20(19)14-8-5-4-6-9-14/h4-6,8-12,16H,3,7H2,1-2H3,(H,24,25)	XRPUJSGGRFQZPJ-UHFFFAOYSA-N					compound annotation
0391_012603	CCG-203971	C23H21ClN2O3	4.5277	71681561		O=C(Nc1ccc(Cl)cc1)C1CCCN(C(=O)c2cccc(-c3ccco3)c2)C1	InChI=1S/C23H21ClN2O3/c24-19-8-10-20(11-9-19)25-22(27)18-6-2-12-26(15-18)23(28)17-5-1-4-16(14-17)21-7-3-13-29-21/h1,3-5,7-11,13-14,18H,2,6,12,15H2,(H,25,27)	HERLZBNILRVHQN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012605	6-Chrysenamine	C18H13N	4.561	17534		Nc1cc2c(ccc3ccccc32)c2ccccc12	InChI=1S/C18H13N/c19-18-11-17-13-6-2-1-5-12(13)9-10-15(17)14-7-3-4-8-16(14)18/h1-11H,19H2	KIVUHCNVDWYUNP-UHFFFAOYSA-N					doublet; compound annotation
0391_012606	6-Chrysenamine	C18H13N	4.5648	17534		Nc1cc2c(ccc3ccccc32)c2ccccc12	InChI=1S/C18H13N/c19-18-11-17-13-6-2-1-5-12(13)9-10-15(17)14-7-3-4-8-16(14)18/h1-11H,19H2	KIVUHCNVDWYUNP-UHFFFAOYSA-N					doublet; compound annotation
0391_012607	clindamycin	C18H33ClN2O5S	2.2853	446598	CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl	CCCC1CC(C(=O)NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)N(C)C1	InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1	KDLRVYVGXIQJDK-AWPVFWJPSA-N					compound annotation
0391_012608	TH34	C15H16N2O2	2.8066	134159676		Cc1c(NCc2ccccc2)cc(C(=O)NO)cc1	InChI=1S/C15H16N2O2/c1-11-7-8-13(15(18)17-19)9-14(11)16-10-12-5-3-2-4-6-12/h2-9,16,19H,10H2,1H3,(H,17,18)	PZBARTUEWCQNSN-UHFFFAOYSA-N					doublet; compound annotation
0391_012609	TH34	C15H16N2O2	2.8124	134159676		Cc1c(NCc2ccccc2)cc(C(=O)NO)cc1	InChI=1S/C15H16N2O2/c1-11-7-8-13(15(18)17-19)9-14(11)16-10-12-5-3-2-4-6-12/h2-9,16,19H,10H2,1H3,(H,17,18)	PZBARTUEWCQNSN-UHFFFAOYSA-N					doublet; compound annotation
0391_012610	TCV-309 cation	C30H34BrN4O4+	2.9862	6918167		CCC[n+]1cc(C(=O)N(CCC(=O)NCCOC(=O)N2CCc3ccccc3C2)c2ccccc2)cc(Br)c1	InChI=1S/C30H33BrN4O4/c1-2-15-33-20-25(19-26(31)22-33)29(37)35(27-10-4-3-5-11-27)17-13-28(36)32-14-18-39-30(38)34-16-12-23-8-6-7-9-24(23)21-34/h3-11,19-20,22H,2,12-18,21H2,1H3/p+1	NWWZMECSQFUIGC-UHFFFAOYSA-O					compound annotation
0391_012611	Amenamevir	C24H26N4O5S	3.3579	11397521		Cc1c(N(CC(=O)Nc2ccc(-c3nocn3)cc2)C(=O)C2CCS(=O)(=O)CC2)c(C)ccc1	InChI=1S/C24H26N4O5S/c1-16-4-3-5-17(2)22(16)28(24(30)19-10-12-34(31,32)13-11-19)14-21(29)26-20-8-6-18(7-9-20)23-25-15-33-27-23/h3-9,15,19H,10-14H2,1-2H3,(H,26,29)	MNHNIVNAFBSLLX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012613	Esonarimod	C14H16O4S	3.4851	127998		CC(=O)SCC(CC(=O)c1ccc(C)cc1)C(=O)O	InChI=1S/C14H16O4S/c1-9-3-5-11(6-4-9)13(16)7-12(14(17)18)8-19-10(2)15/h3-6,12H,7-8H2,1-2H3,(H,17,18)	YRSSFEUQNAXQMX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012615	Amenamevir	C24H26N4O5S	3.494	11397521		Cc1c(N(CC(=O)Nc2ccc(-c3nocn3)cc2)C(=O)C2CCS(=O)(=O)CC2)c(C)ccc1	InChI=1S/C24H26N4O5S/c1-16-4-3-5-17(2)22(16)28(24(30)19-10-12-34(31,32)13-11-19)14-21(29)26-20-8-6-18(7-9-20)23-25-15-33-27-23/h3-9,15,19H,10-14H2,1-2H3,(H,26,29)	MNHNIVNAFBSLLX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012617	NCT-502	C18H20F3N5S	3.5493	49853368		Cc1cc(C)nc(NC(=S)N2CCN(c3ncc(C(F)(F)F)cc3)CC2)c1	InChI=1S/C18H20F3N5S/c1-12-9-13(2)23-15(10-12)24-17(27)26-7-5-25(6-8-26)16-4-3-14(11-22-16)18(19,20)21/h3-4,9-11H,5-8H2,1-2H3,(H,23,24,27)	HHKPPMSUPATMKP-UHFFFAOYSA-N					compound annotation
0391_012618	DUPA(OtBu)-OH	C23H40N2O9	4.3304	87285592	CC(C)(C)OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C	CC(C)(C)OC(=O)CCC(NC(=O)NC(CCC(=O)O)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C23H40N2O9/c1-21(2,3)32-17(28)13-11-15(19(30)34-23(7,8)9)25-20(31)24-14(10-12-16(26)27)18(29)33-22(4,5)6/h14-15H,10-13H2,1-9H3,(H,26,27)(H2,24,25,31)/t14-,15-/m0/s1	KBDDHSXZOLZZGF-GJZGRUSLSA-N					doublet; compound annotation
0391_012619	DUPA(OtBu)-OH	C23H40N2O9	4.3354	87285592	CC(C)(C)OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C	CC(C)(C)OC(=O)CCC(NC(=O)NC(CCC(=O)O)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C23H40N2O9/c1-21(2,3)32-17(28)13-11-15(19(30)34-23(7,8)9)25-20(31)24-14(10-12-16(26)27)18(29)33-22(4,5)6/h14-15H,10-13H2,1-9H3,(H,26,27)(H2,24,25,31)/t14-,15-/m0/s1	KBDDHSXZOLZZGF-GJZGRUSLSA-N					doublet; compound annotation
0391_012620	Evatanepag	C25H28N2O5S	4.6096	9890801		CC(C)(C)c1ccc(CN(Cc2cc(OCC(=O)O)ccc2)S(=O)(=O)c2cnccc2)cc1	InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29)	WOHRHWDYFNWPNG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012622	DUPA(OtBu)-OH	C23H40N2O9	5.5379	87285592	CC(C)(C)OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@@H](CCC(=O)O)C(=O)OC(C)(C)C	CC(C)(C)OC(=O)CCC(NC(=O)NC(CCC(=O)O)C(=O)OC(C)(C)C)C(=O)OC(C)(C)C	InChI=1S/C23H40N2O9/c1-21(2,3)32-17(28)13-11-15(19(30)34-23(7,8)9)25-20(31)24-14(10-12-16(26)27)18(29)33-22(4,5)6/h14-15H,10-13H2,1-9H3,(H,26,27)(H2,24,25,31)/t14-,15-/m0/s1	KBDDHSXZOLZZGF-GJZGRUSLSA-N					doublet; compound annotation
0391_012623	912545-86-9	C28H28ClN3OS	2.3228	5284330		CNC1CCC(N(Cc2cc(-c3ccncc3)ccc2)C(=O)c2c(Cl)c3ccccc3s2)CC1	InChI=1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3	VFSUUTYAEQOIMW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012625	Crenigacestat	C22H23F3N4O4	2.5171	71236992	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=C(N=CC=C3)N(C1=O)CCO)NC(=O)CCC(F)(F)F	CC(NC(=O)CCC(F)(F)F)C(=O)NC1C(=O)N(CCO)c2c(cccn2)-c2ccccc21	InChI=1S/C22H23F3N4O4/c1-13(27-17(31)8-9-22(23,24)25)20(32)28-18-15-6-3-2-5-14(15)16-7-4-10-26-19(16)29(11-12-30)21(18)33/h2-7,10,13,18,30H,8-9,11-12H2,1H3,(H,27,31)(H,28,32)/t13-,18-/m0/s1	YCBAQKQAINQRFW-UGSOOPFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_012627	Crenigacestat	C22H23F3N4O4	2.7704	71236992	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=C(N=CC=C3)N(C1=O)CCO)NC(=O)CCC(F)(F)F	CC(NC(=O)CCC(F)(F)F)C(=O)NC1C(=O)N(CCO)c2c(cccn2)-c2ccccc21	InChI=1S/C22H23F3N4O4/c1-13(27-17(31)8-9-22(23,24)25)20(32)28-18-15-6-3-2-5-14(15)16-7-4-10-26-19(16)29(11-12-30)21(18)33/h2-7,10,13,18,30H,8-9,11-12H2,1H3,(H,27,31)(H,28,32)/t13-,18-/m0/s1	YCBAQKQAINQRFW-UGSOOPFHSA-N					doublet; compound annotation
0391_012628	NS-018	C21H20FN7	2.7731	46866319	C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C	CC(Nc1cc(-c2cn(C)nc2)cc(Nc2nccnc2)n1)c1ccc(F)cc1	InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1	UQTPDWDAYHAZNT-AWEZNQCLSA-N					doublet; compound annotation
0391_012629	NS-018	C21H20FN7	2.778	46866319	C[C@@H](C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C	CC(Nc1cc(-c2cn(C)nc2)cc(Nc2nccnc2)n1)c1ccc(F)cc1	InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1	UQTPDWDAYHAZNT-AWEZNQCLSA-N					doublet; compound annotation
0391_012630	Crenigacestat	C22H23F3N4O4	2.856	71236992	C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2C3=C(N=CC=C3)N(C1=O)CCO)NC(=O)CCC(F)(F)F	CC(NC(=O)CCC(F)(F)F)C(=O)NC1C(=O)N(CCO)c2c(cccn2)-c2ccccc21	InChI=1S/C22H23F3N4O4/c1-13(27-17(31)8-9-22(23,24)25)20(32)28-18-15-6-3-2-5-14(15)16-7-4-10-26-19(16)29(11-12-30)21(18)33/h2-7,10,13,18,30H,8-9,11-12H2,1H3,(H,27,31)(H,28,32)/t13-,18-/m0/s1	YCBAQKQAINQRFW-UGSOOPFHSA-N					doublet; removed another duplicate entry; compound annotation
0391_012632	4,4'-Dimethoxybenzil	C16H14O4	4.2566	71043		COc1ccc(C(=O)C(=O)c2ccc(OC)cc2)cc1	InChI=1S/C16H14O4/c1-19-13-7-3-11(4-8-13)15(17)16(18)12-5-9-14(20-2)10-6-12/h3-10H,1-2H3	YNANGXWUZWWFKX-UHFFFAOYSA-N					doublet; compound annotation
0391_012633	4,4'-Dimethoxybenzil	C16H14O4	4.2625	71043		COc1ccc(C(=O)C(=O)c2ccc(OC)cc2)cc1	InChI=1S/C16H14O4/c1-19-13-7-3-11(4-8-13)15(17)16(18)12-5-9-14(20-2)10-6-12/h3-10H,1-2H3	YNANGXWUZWWFKX-UHFFFAOYSA-N					doublet; compound annotation
0391_012634	Tenovin-3	C18H21N3OS	4.2775	24772097		CC(C)(C)c1ccc(C(=O)NC(=S)Nc2ccc(N)cc2)cc1	InChI=1S/C18H21N3OS/c1-18(2,3)13-6-4-12(5-7-13)16(22)21-17(23)20-15-10-8-14(19)9-11-15/h4-11H,19H2,1-3H3,(H2,20,21,22,23)	NLAXTZPUTNGRDU-UHFFFAOYSA-N					compound annotation
0391_012635	ELQ-300	C24H17ClF3NO4	4.7875	67016608		COc1c(Cl)cc2c(=O)c(-c3ccc(Oc4ccc(OC(F)(F)F)cc4)cc3)c(C)[nH]c2c1	InChI=1S/C24H17ClF3NO4/c1-13-22(23(30)18-11-19(25)21(31-2)12-20(18)29-13)14-3-5-15(6-4-14)32-16-7-9-17(10-8-16)33-24(26,27)28/h3-12H,1-2H3,(H,29,30)	WZDNKHCQIZRDKW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012637	GPR120 modulator 2	C20H18ClNO3S	4.8734	25017837		Cc1c(CCC(=O)O)ccc(OCc2nc(-c3ccccc3Cl)cs2)c1	InChI=1S/C20H18ClNO3S/c1-13-10-15(8-6-14(13)7-9-20(23)24)25-11-19-22-18(12-26-19)16-4-2-3-5-17(16)21/h2-6,8,10,12H,7,9,11H2,1H3,(H,23,24)	PNGZPTUFKSLWEZ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012639	GPR120 modulator 2	C20H18ClNO3S	5.0386	25017837		Cc1c(CCC(=O)O)ccc(OCc2nc(-c3ccccc3Cl)cs2)c1	InChI=1S/C20H18ClNO3S/c1-13-10-15(8-6-14(13)7-9-20(23)24)25-11-19-22-18(12-26-19)16-4-2-3-5-17(16)21/h2-6,8,10,12H,7,9,11H2,1H3,(H,23,24)	PNGZPTUFKSLWEZ-UHFFFAOYSA-N					doublet; compound annotation
0391_012640	PHTPP	C20H11F6N3O	5.2978	11201035		Oc1ccc(-c2c3nc(C(F)(F)F)cc(C(F)(F)F)n3nc2-c2ccccc2)cc1	InChI=1S/C20H11F6N3O/c21-19(22,23)14-10-15(20(24,25)26)29-18(27-14)16(11-6-8-13(30)9-7-11)17(28-29)12-4-2-1-3-5-12/h1-10,30H	AEZPAUSGTAHLOQ-UHFFFAOYSA-N					compound annotation
0391_012641	Taranabant	C27H25ClF3N3O2	5.3937	11226090	C[C@@H]([C@@H](CC1=CC=C(C=C1)Cl)C2=CC=CC(=C2)C#N)NC(=O)C(C)(C)OC3=NC=C(C=C3)C(F)(F)F	CC(NC(=O)C(C)(C)Oc1ncc(C(F)(F)F)cc1)C(Cc1ccc(Cl)cc1)c1cccc(C#N)c1	InChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1	QLYKJCMUNUWAGO-GAJHUEQPSA-N					removed another duplicate entry; compound annotation
0391_012643	DCPIB	C22H28Cl2O4	5.6123	10071166		CCCCC1(C2CCCC2)Cc2cc(OCCCC(=O)O)c(Cl)c(Cl)c2C1=O	InChI=1S/C22H28Cl2O4/c1-2-3-10-22(15-7-4-5-8-15)13-14-12-16(28-11-6-9-17(25)26)19(23)20(24)18(14)21(22)27/h12,15H,2-11,13H2,1H3,(H,25,26)	KHKGTPJPBOQECW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012645	Velpatasvir	C49H54N8O8	3.2561	67683363	C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC	COCC1CC(c2ncc(-c3cc4c(cc3)-c3c(cc5c(c3)ccc3c5nc(C5CCC(C)N5C(=O)C(NC(=O)OC)C(C)C)[nH]3)OC4)[nH]2)N(C(=O)C(NC(=O)OC)c2ccccc2)C1	InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1	FHCUMDQMBHQXKK-CDIODLITSA-N					compound annotation
0391_012646	Ledipasvir	C49H54F2N8O6	3.4348	67505836	CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC	COC(=O)NC(C(=O)N1CC2(CC2)CC1c1ncc(-c2cc3c(cc2)-c2c(cc(-c4cc5c(cc4)nc(C4C6CCC(C6)N4C(=O)C(NC(=O)OC)C(C)C)[nH]5)cc2)C3(F)F)[nH]1)C(C)C	InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1	VRTWBAAJJOHBQU-KMWAZVGDSA-N					doublet; compound annotation
0391_012647	cefditoren pivoxil	C25H28N6O7S3	3.5623	6437877	CC1=C(SC=N1)/C=C\C2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C	CON=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C=Cc3c(C)ncs3)CSC12)c1csc(N)n1	InChI=1S/C25H28N6O7S3/c1-12-15(41-10-27-12)7-6-13-8-39-21-17(29-19(32)16(30-36-5)14-9-40-24(26)28-14)20(33)31(21)18(13)22(34)37-11-38-23(35)25(2,3)4/h6-7,9-10,17,21H,8,11H2,1-5H3,(H2,26,28)(H,29,32)/b7-6-,30-16-/t17-,21-/m1/s1	AFZFFLVORLEPPO-UVYJNCLZSA-N					doublet; removed another duplicate entry; compound annotation
0391_012649	Doravirine	C17H11ClF3N5O3	3.5943	58460047		Cn1c(Cn2ccc(C(F)(F)F)c(Oc3cc(Cl)cc(C#N)c3)c2=O)n[nH]c1=O	InChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)	ZIAOVIPSKUPPQW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012651	cefditoren pivoxil	C25H28N6O7S3	3.7402	6437877	CC1=C(SC=N1)/C=C\C2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C	CON=C(C(=O)NC1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C=Cc3c(C)ncs3)CSC12)c1csc(N)n1	InChI=1S/C25H28N6O7S3/c1-12-15(41-10-27-12)7-6-13-8-39-21-17(29-19(32)16(30-36-5)14-9-40-24(26)28-14)20(33)31(21)18(13)22(34)37-11-38-23(35)25(2,3)4/h6-7,9-10,17,21H,8,11H2,1-5H3,(H2,26,28)(H,29,32)/b7-6-,30-16-/t17-,21-/m1/s1	AFZFFLVORLEPPO-UVYJNCLZSA-N					doublet; compound annotation
0391_012652	butenafine	C23H27N	3.7743	2484		CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12	InChI=1S/C23H27N/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20/h5-15H,16-17H2,1-4H3	ABJKWBDEJIDSJZ-UHFFFAOYSA-N					compound annotation
0391_012653	Pirozadil	C27H29NO10	4.4656	68711		COc1c(OC)c(OC)cc(C(=O)OCc2cccc(COC(=O)c3cc(OC)c(OC)c(OC)c3)n2)c1	InChI=1S/C27H29NO10/c1-31-20-10-16(11-21(32-2)24(20)35-5)26(29)37-14-18-8-7-9-19(28-18)15-38-27(30)17-12-22(33-3)25(36-6)23(13-17)34-4/h7-13H,14-15H2,1-6H3	DIIBXMIIOQXTHW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012655	Vonoprazan	C17H16FN3O2S	2.2959	15981397		CNCc1cn(S(=O)(=O)c2cnccc2)c(-c2ccccc2F)c1	InChI=1S/C17H16FN3O2S/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14/h2-9,11-12,19H,10H2,1H3	BFDBKMOZYNOTPK-UHFFFAOYSA-N					doublet; compound annotation
0391_012656	BEPHENIUM	C17H22NO+	2.4912	19667		C[N+](C)(CCOc1ccccc1)Cc1ccccc1	InChI=1S/C17H22NO/c1-18(2,15-16-9-5-3-6-10-16)13-14-19-17-11-7-4-8-12-17/h3-12H,13-15H2,1-2H3/q+1	AVWWVJUMXRXPNF-UHFFFAOYSA-N					compound annotation
0391_012657	cefuroxime axetil	C20H22N4O10S	2.9912	6321416	CC(OC(=O)C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CC=CO3)COC(=O)N	CON=C(C(=O)NC1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CSC12)c1ccco1	InChI=1S/C20H22N4O10S/c1-9(25)33-10(2)34-19(28)15-11(7-32-20(21)29)8-35-18-14(17(27)24(15)18)22-16(26)13(23-30-3)12-5-4-6-31-12/h4-6,10,14,18H,7-8H2,1-3H3,(H2,21,29)(H,22,26)/b23-13-/t10?,14-,18-/m1/s1	KEJCWVGMRLCZQQ-YJBYXUATSA-N					compound annotation
0391_012658	1245319-54-3	C22H22N8OS	3.0181	46916382		Cc1ccc(NC(=O)N2CCN(c3c4nc(-c5cnccc5)sc4nc(N)n3)CC2)cc1	InChI=1S/C22H22N8OS/c1-14-4-6-16(7-5-14)25-22(31)30-11-9-29(10-12-30)18-17-20(28-21(23)27-18)32-19(26-17)15-3-2-8-24-13-15/h2-8,13H,9-12H2,1H3,(H,25,31)(H2,23,27,28)	UWTRKIJAGTTXNM-UHFFFAOYSA-N					compound annotation
0391_012659	Nesbuvir	C22H23FN2O5S	3.2265	11561383		CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12	InChI=1S/C22H23FN2O5S/c1-24-22(27)20-17-11-16(13-3-4-13)18(25(9-10-26)31(2,28)29)12-19(17)30-21(20)14-5-7-15(23)8-6-14/h5-8,11-13,26H,3-4,9-10H2,1-2H3,(H,24,27)	WTDWVLJJJOTABN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012661	Revaprazan	C22H23FN4	3.8367	204104		Cc1c(C)c(N2CCc3ccccc3C2C)nc(Nc2ccc(F)cc2)n1	InChI=1S/C22H23FN4/c1-14-15(2)24-22(25-19-10-8-18(23)9-11-19)26-21(14)27-13-12-17-6-4-5-7-20(17)16(27)3/h4-11,16H,12-13H2,1-3H3,(H,24,25,26)	LECZXZOBEZITCL-UHFFFAOYSA-N					compound annotation
0391_012662	Ansamitocin P-3	C32H43ClN2O9	4.1183	5282049	C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O	COc1cc2cc(c1Cl)N(C)C(=O)CC(OC(=O)C(C)C)C1(C)OC1C(C)C1CC(O)(NC(=O)O1)C(OC)C=CC=C(C)C2	InChI=1S/C32H43ClN2O9/c1-17(2)29(37)43-25-15-26(36)35(6)21-13-20(14-22(40-7)27(21)33)12-18(3)10-9-11-24(41-8)32(39)16-23(42-30(38)34-32)19(4)28-31(25,5)44-28/h9-11,13-14,17,19,23-25,28,39H,12,15-16H2,1-8H3,(H,34,38)/b11-9+,18-10+/t19-,23+,24-,25+,28+,31+,32+/m1/s1	OPQNCARIZFLNLF-JBHFWYGFSA-N					removed another duplicate entry; compound annotation
0391_012664	BROMPHENIRAMINE	C16H19BrN2	2.2274	6834		CN(C)CCC(c1ccc(Br)cc1)c1ccccn1	InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3	ZDIGNSYAACHWNL-UHFFFAOYSA-N					compound annotation
0391_012665	doxapram	C24H30N2O2	2.2566	3156		CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O	InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3	XFDJYSQDBULQSI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012667	Azacyclonol	C18H21NO	2.3871	15723		OC(c1ccccc1)(c1ccccc1)C1CCNCC1	InChI=1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2	ZMISODWVFHHWNR-UHFFFAOYSA-N					compound annotation
0391_012668	6-Aminofluorescein	C20H13NO5	2.4485	103924		Nc1cc2c(cc1)C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2	InChI=1S/C20H13NO5/c21-10-1-4-13-16(7-10)20(26-19(13)24)14-5-2-11(22)8-17(14)25-18-9-12(23)3-6-15(18)20/h1-9,22-23H,21H2	YOAWSYSKQHLFPM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012670	dibucaine	C20H29N3O2	3.1682	3025		CCCCOc1nc2ccccc2c(C(=O)NCCN(CC)CC)c1	InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)	PUFQVTATUTYEAL-UHFFFAOYSA-N					doublet; compound annotation
0391_012671	dibucaine	C20H29N3O2	3.171	3025		CCCCOc1nc2ccccc2c(C(=O)NCCN(CC)CC)c1	InChI=1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24)	PUFQVTATUTYEAL-UHFFFAOYSA-N					doublet; compound annotation
0391_012672	Menbutone	C15H14O4	3.4572	71818		COc1ccc(C(=O)CCC(=O)O)c2ccccc12	InChI=1S/C15H14O4/c1-19-14-8-6-11(13(16)7-9-15(17)18)10-4-2-3-5-12(10)14/h2-6,8H,7,9H2,1H3,(H,17,18)	FHGJSJFIQNQBCK-UHFFFAOYSA-N					compound annotation
0391_012673	Clofentezine	C14H8Cl2N4	4.9774	73670		Clc1ccccc1-c1nnc(-c2ccccc2Cl)nn1	InChI=1S/C14H8Cl2N4/c15-11-7-3-1-5-9(11)13-17-19-14(20-18-13)10-6-2-4-8-12(10)16/h1-8H	UXADOQPNKNTIHB-UHFFFAOYSA-N					compound annotation
0391_012674	benzbromarone	C17H12Br2O3	5.301	2333		CCc1c(C(=O)c2cc(Br)c(O)c(Br)c2)c2ccccc2o1	InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3	WHQCHUCQKNIQEC-UHFFFAOYSA-N					compound annotation
0391_012675	Solvent Yellow 16	C16H14N4O	5.4714	107537		CC1=NN(c2ccccc2)C(=O)C1N=Nc1ccccc1	InChI=1S/C16H14N4O/c1-12-15(18-17-13-8-4-2-5-9-13)16(21)20(19-12)14-10-6-3-7-11-14/h2-11,15H,1H3	XCKGFJPFEHHHQA-UHFFFAOYSA-N					compound annotation
0391_012676	Sudan I	C16H12N2O	5.4984	13297		Oc1c(N=Nc2ccccc2)c2ccccc2cc1	InChI=1S/C16H12N2O/c19-15-11-10-12-6-4-5-9-14(12)16(15)18-17-13-7-2-1-3-8-13/h1-11,19H	MRQIXHXHHPWVIL-UHFFFAOYSA-N					compound annotation
0391_012677	Cordycepin	C10H13N5O3	0.4614	6303	C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO	Nc1c2ncn(C3OC(CO)CC3O)c2ncn1	InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1	OFEZSBMBBKLLBJ-BAJZRUMYSA-N					compound annotation
0391_012678	5-HYDROXYMETHYLFURFURAL	C6H6O3	0.6334	237332		O=Cc1ccc(CO)o1	InChI=1S/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H2	NOEGNKMFWQHSLB-UHFFFAOYSA-N					compound annotation
0391_012679	4199-09-1	C16H21NO2	2.5093	91536	CC(C)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O	CC(C)NCC(O)COc1cccc2ccccc12	InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/t14-/m0/s1	AQHHHDLHHXJYJD-AWEZNQCLSA-N					compound annotation
0391_012680	RPW-24	C15H13ClN4	2.5777	2227970		Cc1c(Cl)cc(Nc2nc3ccccc3c(N)n2)cc1	InChI=1S/C15H13ClN4/c1-9-6-7-10(8-12(9)16)18-15-19-13-5-3-2-4-11(13)14(17)20-15/h2-8H,1H3,(H3,17,18,19,20)	LFMFPKKYRXFHHZ-UHFFFAOYSA-N					compound annotation
0391_012681	methotrexate	C20H22N8O5	1.3481	126941	CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1	InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1	FBOZXECLQNJBKD-ZDUSSCGKSA-N					doublet; compound annotation
0391_012682	TPEN	C26H28N6	1.5126	5519		c1ccc(CN(CCN(Cc2ccccn2)Cc2ccccn2)Cc2ccccn2)nc1	InChI=1S/C26H28N6/c1-5-13-27-23(9-1)19-31(20-24-10-2-6-14-28-24)17-18-32(21-25-11-3-7-15-29-25)22-26-12-4-8-16-30-26/h1-16H,17-22H2	CVRXLMUYFMERMJ-UHFFFAOYSA-N					doublet; compound annotation
0391_012683	TPEN	C26H28N6	1.5156	5519		c1ccc(CN(CCN(Cc2ccccn2)Cc2ccccn2)Cc2ccccn2)nc1	InChI=1S/C26H28N6/c1-5-13-27-23(9-1)19-31(20-24-10-2-6-14-28-24)17-18-32(21-25-11-3-7-15-29-25)22-26-12-4-8-16-30-26/h1-16H,17-22H2	CVRXLMUYFMERMJ-UHFFFAOYSA-N					doublet; compound annotation
0391_012684	protopine	C20H19NO5	2.0868	4970		CN1CCc2cc3c(cc2C(=O)Cc2c(C1)c1c(cc2)OCO1)OCO3	InChI=1S/C20H19NO5/c1-21-5-4-13-7-18-19(25-10-24-18)8-14(13)16(22)6-12-2-3-17-20(15(12)9-21)26-11-23-17/h2-3,7-8H,4-6,9-11H2,1H3	GPTFURBXHJWNHR-UHFFFAOYSA-N					compound annotation
0391_012685	ROC-325	C28H27ClN4OS	2.4219	129626603		Cc1c2sc3ccccc3c(=O)c2c(NCCN(C)CCNc2ccnc3cc(Cl)ccc23)cc1	InChI=1S/C28H27ClN4OS/c1-18-7-10-23(26-27(34)21-5-3-4-6-25(21)35-28(18)26)32-14-16-33(2)15-13-31-22-11-12-30-24-17-19(29)8-9-20(22)24/h3-12,17,32H,13-16H2,1-2H3,(H,30,31)	HXUYKEGAEIYPKY-UHFFFAOYSA-N					compound annotation
0391_012686	Deapioplatycodin D	C52H84O24	2.7143	70698266	C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2OC(=O)[C@]34CCC(C[C@H]3C5=CC[C@H]6[C@]([C@@]5(C[C@H]4O)C)(CC[C@@H]7[C@@]6(C[C@@H]([C@@H](C7(CO)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)C)C)(C)C)O)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O	CC1OC(OC2C(OC(=O)C34CCC(C)(C)CC3C3=CCC5C6(C)CC(O)C(OC7OC(CO)C(O)C(O)C7O)C(CO)(CO)C6CCC5(C)C3(C)CC4O)OCC(O)C2O)C(O)C(O)C1OC1OCC(O)C(O)C1O	InChI=1S/C52H84O24/c1-21-39(73-42-36(65)31(60)25(57)17-69-42)35(64)38(67)43(71-21)74-40-32(61)26(58)18-70-45(40)76-46(68)52-12-11-47(2,3)13-23(52)22-7-8-28-48(4)14-24(56)41(75-44-37(66)34(63)33(62)27(16-53)72-44)51(19-54,20-55)29(48)9-10-49(28,5)50(22,6)15-30(52)59/h7,21,23-45,53-67H,8-20H2,1-6H3/t21-,23-,24-,25+,26-,27+,28+,29+,30+,31-,32-,33+,34-,35-,36+,37+,38+,39-,40+,41-,42-,43-,44-,45-,48+,49+,50+,52+/m0/s1	HCKUIVZXCXTBEH-PSRBGVDOSA-N					compound annotation
0391_012687	1271738-62-5	C18H25N5S2	2.8676	54765302		CCCc1cc2c(N3CCN(C4=NCC(C)(C)S4)CC3)ncnc2s1	InChI=1S/C18H25N5S2/c1-4-5-13-10-14-15(20-12-21-16(14)24-13)22-6-8-23(9-7-22)17-19-11-18(2,3)25-17/h10,12H,4-9,11H2,1-3H3	SRQYLNYQAPCPIR-UHFFFAOYSA-N					compound annotation
0391_012688	Tilbroquinol	C10H8BrNO	3.0696	65592		Cc1cc(Br)c(O)c2c1cccn2	InChI=1S/C10H8BrNO/c1-6-5-8(11)10(13)9-7(6)3-2-4-12-9/h2-5,13H,1H3	JMOVFFLYGIQXMM-UHFFFAOYSA-N					compound annotation
0391_012689	QS11	C36H33N5O2	5.7486	42623900	C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)N[C@@H](CC7=CC=CC=C7)CO	OCC(Cc1ccccc1)Nc1c2ncn(Cc3ccc(-c4ccccc4)cc3)c2nc(Oc2cc3c(cc2)CCC3)n1	InChI=1S/C36H33N5O2/c42-23-31(20-25-8-3-1-4-9-25)38-34-33-35(40-36(39-34)43-32-19-18-28-12-7-13-30(28)21-32)41(24-37-33)22-26-14-16-29(17-15-26)27-10-5-2-6-11-27/h1-6,8-11,14-19,21,24,31,42H,7,12-13,20,22-23H2,(H,38,39,40)/t31-/m0/s1	DOKZLKDGUQWMSX-HKBQPEDESA-N					removed another duplicate entry; compound annotation
0391_012691	FIACITABINE	C9H11FIN3O4	0.8563	50312	C1=C(C(=NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)N)I	Nc1nc(=O)n(C2OC(CO)C(O)C2F)cc1I	InChI=1S/C9H11FIN3O4/c10-5-6(16)4(2-15)18-8(5)14-1-3(11)7(12)13-9(14)17/h1,4-6,8,15-16H,2H2,(H2,12,13,17)/t4-,5+,6-,8-/m1/s1	GIMSJJHKKXRFGV-BYPJNBLXSA-N					removed another duplicate entry; compound annotation
0391_012693	HBX 19818	C25H28ClN3O	2.7251	73349008		CN(CCCNC(=O)c1cc2c(cc1)nc1CCCCc1c2Cl)Cc1ccccc1	InChI=1S/C25H28ClN3O/c1-29(17-18-8-3-2-4-9-18)15-7-14-27-25(30)19-12-13-23-21(16-19)24(26)20-10-5-6-11-22(20)28-23/h2-4,8-9,12-13,16H,5-7,10-11,14-15,17H2,1H3,(H,27,30)	ZCALMLVWZSQGGR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012695	INCB3344	C29H34F3N3O6	2.8296	10008367	CCO[C@H]1CN(C[C@@H]1NC(=O)CNC(=O)C2=CC(=CC=C2)C(F)(F)F)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O	CCOC1CN(C2CCC(O)(c3cc4c(cc3)OCO4)CC2)CC1NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1	InChI=1S/C29H34F3N3O6/c1-2-39-25-16-35(21-8-10-28(38,11-9-21)19-6-7-23-24(13-19)41-17-40-23)15-22(25)34-26(36)14-33-27(37)18-4-3-5-20(12-18)29(30,31)32/h3-7,12-13,21-22,25,38H,2,8-11,14-17H2,1H3,(H,33,37)(H,34,36)/t21?,22-,25-,28?/m0/s1	MZEOSVPWMSEFPW-XYCDVDSTSA-N					doublet; compound annotation
0391_012696	ML311	C23H24F3N3O	2.9411	3384730		CCN1CCN(C(c2ccc(C(F)(F)F)cc2)c2c(O)c3c(cccn3)cc2)CC1	InChI=1S/C23H24F3N3O/c1-2-28-12-14-29(15-13-28)21(17-5-8-18(9-6-17)23(24,25)26)19-10-7-16-4-3-11-27-20(16)22(19)30/h3-11,21,30H,2,12-15H2,1H3	NGAPBLRRJSKIRT-UHFFFAOYSA-N					compound annotation
0391_012697	INCB3344	C29H34F3N3O6	3.0009	10008367	CCO[C@H]1CN(C[C@@H]1NC(=O)CNC(=O)C2=CC(=CC=C2)C(F)(F)F)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O	CCOC1CN(C2CCC(O)(c3cc4c(cc3)OCO4)CC2)CC1NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1	InChI=1S/C29H34F3N3O6/c1-2-39-25-16-35(21-8-10-28(38,11-9-21)19-6-7-23-24(13-19)41-17-40-23)15-22(25)34-26(36)14-33-27(37)18-4-3-5-20(12-18)29(30,31)32/h3-7,12-13,21-22,25,38H,2,8-11,14-17H2,1H3,(H,33,37)(H,34,36)/t21?,22-,25-,28?/m0/s1	MZEOSVPWMSEFPW-XYCDVDSTSA-N					doublet; removed another duplicate entry; compound annotation
0391_012699	SAR405 R enantiomer	C19H21ClF3N5O2	3.2118	91933781	C[C@@H]1COCCN1C2=CC(=O)N3CC[C@@H](N(C3=N2)CC4=CC(=CN=C4)Cl)C(F)(F)F	CC1COCCN1c1cc(=O)n2CCC(C(F)(F)F)N(Cc3cc(Cl)cnc3)c2n1	InChI=1S/C19H21ClF3N5O2/c1-12-11-30-5-4-26(12)16-7-17(29)27-3-2-15(19(21,22)23)28(18(27)25-16)10-13-6-14(20)9-24-8-13/h6-9,12,15H,2-5,10-11H2,1H3/t12-,15-/m1/s1	SPDQRCUBFSRAFI-IUODEOHRSA-N					doublet; removed another duplicate entry; compound annotation
0391_012701	Sigma-1 receptor antagonist 2	C20H26ClN3O2	3.4107	118723361		COc1ccc(-c2nc(C)c(Cl)c(OCCCN3CCCCC3)n2)cc1	InChI=1S/C20H26ClN3O2/c1-15-18(21)20(26-14-6-13-24-11-4-3-5-12-24)23-19(22-15)16-7-9-17(25-2)10-8-16/h7-10H,3-6,11-14H2,1-2H3	FAEOHCOAHZFOEX-UHFFFAOYSA-N					compound annotation
0391_012702	SAR405 R enantiomer	C19H21ClF3N5O2	4.4653	91933781	C[C@@H]1COCCN1C2=CC(=O)N3CC[C@@H](N(C3=N2)CC4=CC(=CN=C4)Cl)C(F)(F)F	CC1COCCN1c1cc(=O)n2CCC(C(F)(F)F)N(Cc3cc(Cl)cnc3)c2n1	InChI=1S/C19H21ClF3N5O2/c1-12-11-30-5-4-26(12)16-7-17(29)27-3-2-15(19(21,22)23)28(18(27)25-16)10-13-6-14(20)9-24-8-13/h6-9,12,15H,2-5,10-11H2,1H3/t12-,15-/m1/s1	SPDQRCUBFSRAFI-IUODEOHRSA-N					doublet; compound annotation
0391_012703	AVN-492	C17H21N5O2S	4.6129	56655571		CNc1nn2c(C)c(N(C)C)c(C)nc2c1S(=O)(=O)c1ccccc1	InChI=1S/C17H21N5O2S/c1-11-14(21(4)5)12(2)22-17(19-11)15(16(18-3)20-22)25(23,24)13-9-7-6-8-10-13/h6-10H,1-5H3,(H,18,20)	SNPPEHMSSOEYDH-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012705	AVN-492	C17H21N5O2S	4.6157	56655571		CNc1nn2c(C)c(N(C)C)c(C)nc2c1S(=O)(=O)c1ccccc1	InChI=1S/C17H21N5O2S/c1-11-14(21(4)5)12(2)22-17(19-11)15(16(18-3)20-22)25(23,24)13-9-7-6-8-10-13/h6-10H,1-5H3,(H,18,20)	SNPPEHMSSOEYDH-UHFFFAOYSA-N					doublet; compound annotation
0391_012706	GPR120 modulator 1	C19H16ClNO4S	4.7063	25017320		Cc1c(OCC(=O)O)ccc(OCc2nc(-c3ccccc3Cl)cs2)c1	InChI=1S/C19H16ClNO4S/c1-12-8-13(6-7-17(12)25-10-19(22)23)24-9-18-21-16(11-26-18)14-4-2-3-5-15(14)20/h2-8,11H,9-10H2,1H3,(H,22,23)	FONSSTYHKIFEBM-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012708	GPR120 modulator 1	C19H16ClNO4S	4.8775	25017320		Cc1c(OCC(=O)O)ccc(OCc2nc(-c3ccccc3Cl)cs2)c1	InChI=1S/C19H16ClNO4S/c1-12-8-13(6-7-17(12)25-10-19(22)23)24-9-18-21-16(11-26-18)14-4-2-3-5-15(14)20/h2-8,11H,9-10H2,1H3,(H,22,23)	FONSSTYHKIFEBM-UHFFFAOYSA-N					doublet; compound annotation
0391_012709	SAR405 R enantiomer	C19H21ClF3N5O2	4.935	91933781	C[C@@H]1COCCN1C2=CC(=O)N3CC[C@@H](N(C3=N2)CC4=CC(=CN=C4)Cl)C(F)(F)F	CC1COCCN1c1cc(=O)n2CCC(C(F)(F)F)N(Cc3cc(Cl)cnc3)c2n1	InChI=1S/C19H21ClF3N5O2/c1-12-11-30-5-4-26(12)16-7-17(29)27-3-2-15(19(21,22)23)28(18(27)25-16)10-13-6-14(20)9-24-8-13/h6-9,12,15H,2-5,10-11H2,1H3/t12-,15-/m1/s1	SPDQRCUBFSRAFI-IUODEOHRSA-N					doublet; compound annotation
0391_012710	BI-3812	C26H32ClN7O5	2.4243	134691741		CNC(=O)COc1cc2cc(Nc3nc(N4CCC(C(=O)N(C)C)CC4)ncc3Cl)cc(OC)c2n(C)c1=O	InChI=1S/C26H32ClN7O5/c1-28-21(35)14-39-20-11-16-10-17(12-19(38-5)22(16)33(4)25(20)37)30-23-18(27)13-29-26(31-23)34-8-6-15(7-9-34)24(36)32(2)3/h10-13,15H,6-9,14H2,1-5H3,(H,28,35)(H,29,30,31)	XCGYXEVLQIIEJH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012711	AZ505	C29H38Cl2N4O4	2.4243	24961094		O=C1COc2c(CCNCCN(C(=O)CCNCCc3cc(Cl)c(Cl)cc3)C3CCCCC3)ccc(O)c2N1	InChI=1S/C29H38Cl2N4O4/c30-23-8-6-20(18-24(23)31)10-13-32-15-12-27(38)35(22-4-2-1-3-5-22)17-16-33-14-11-21-7-9-25(36)28-29(21)39-19-26(37)34-28/h6-9,18,22,32-33,36H,1-5,10-17,19H2,(H,34,37)	LIBVHXXKHSODII-UHFFFAOYSA-N					doublet; compound annotation
0391_012713	4-IBP	C19H21IN2O	2.6372	132995		O=C(NC1CCN(Cc2ccccc2)CC1)c1ccc(I)cc1	InChI=1S/C19H21IN2O/c20-17-8-6-16(7-9-17)19(23)21-18-10-12-22(13-11-18)14-15-4-2-1-3-5-15/h1-9,18H,10-14H2,(H,21,23)	HELCSESNNDZLFM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012715	Siramesine	C30H31FN2O	4.2656	9829526		Fc1ccc(-n2cc(CCCCN3CCC4(CC3)OCc3ccccc34)c3ccccc32)cc1	InChI=1S/C30H31FN2O/c31-25-12-14-26(15-13-25)33-21-23(27-9-2-4-11-29(27)33)7-5-6-18-32-19-16-30(17-20-32)28-10-3-1-8-24(28)22-34-30/h1-4,8-15,21H,5-7,16-20,22H2	XWAONOGAGZNUSF-UHFFFAOYSA-N					compound annotation
0391_012716	RP-54745	C13H12ClNOS2	4.5935	126203		CC1c2ccccc2CCN1c1c(Cl)c(=O)ss1	InChI=1S/C13H12ClNOS2/c1-8-10-5-3-2-4-9(10)6-7-15(8)12-11(14)13(16)18-17-12/h2-5,8H,6-7H2,1H3	BEJJGVDFQORITE-UHFFFAOYSA-N					compound annotation
0391_012717	Neurotoxin Inhibitor	C19H14N4OS	4.8153	135732862		O=C1CC(c2ccccc2)c2c(N1)n(-c1nc3ccccc3s1)nc2	InChI=1S/C19H14N4OS/c24-17-10-13(12-6-2-1-3-7-12)14-11-20-23(18(14)22-17)19-21-15-8-4-5-9-16(15)25-19/h1-9,11,13H,10H2,(H,22,24)	HLFQUUKVLVOMHH-UHFFFAOYSA-N					compound annotation
0391_012718	JNJ-40411813	C20H25ClN2O	4.8252	25195461		CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O	InChI=1S/C20H25ClN2O/c1-2-3-12-23-15-11-18(19(21)20(23)24)22-13-9-17(10-14-22)16-7-5-4-6-8-16/h4-8,11,15,17H,2-3,9-10,12-14H2,1H3	HYOGJHCDLQSAHX-UHFFFAOYSA-N					doublet; compound annotation
0391_012719	JNJ-40411813	C20H25ClN2O	4.8297	25195461		CCCCn1ccc(N2CCC(c3ccccc3)CC2)c(Cl)c1=O	InChI=1S/C20H25ClN2O/c1-2-3-12-23-15-11-18(19(21)20(23)24)22-13-9-17(10-14-22)16-7-5-4-6-8-16/h4-8,11,15,17H,2-3,9-10,12-14H2,1H3	HYOGJHCDLQSAHX-UHFFFAOYSA-N					doublet; compound annotation
0391_012720	RCM-1	C20H12N2OS4	5.3099	4273985		N#Cc1c(SCC(=O)c2cccs2)nc(-c2cccs2)cc1-c1cccs1	InChI=1S/C20H12N2OS4/c21-11-14-13(17-4-1-7-24-17)10-15(18-5-2-8-25-18)22-20(14)27-12-16(23)19-6-3-9-26-19/h1-10H,12H2	DCCYTKKDAZEVLY-UHFFFAOYSA-N					doublet; compound annotation
0391_012721	RCM-1	C20H12N2OS4	5.3132	4273985		N#Cc1c(SCC(=O)c2cccs2)nc(-c2cccs2)cc1-c1cccs1	InChI=1S/C20H12N2OS4/c21-11-14-13(17-4-1-7-24-17)10-15(18-5-2-8-25-18)22-20(14)27-12-16(23)19-6-3-9-26-19/h1-10H,12H2	DCCYTKKDAZEVLY-UHFFFAOYSA-N					doublet; compound annotation
0391_012722	Ribocil	C19H22N6OS	1.7652	136881500		CNc1ncc(CN2CCCC(c3nc(=O)cc(-c4cccs4)[nH]3)C2)cn1	InChI=1S/C19H22N6OS/c1-20-19-21-9-13(10-22-19)11-25-6-2-4-14(12-25)18-23-15(8-17(26)24-18)16-5-3-7-27-16/h3,5,7-10,14H,2,4,6,11-12H2,1H3,(H,20,21,22)(H,23,24,26)	ZSXCVAIJFUEGJR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012724	ABT-639	C20H20ClF2N3O3S	2.2031	46851313	C1C[C@@H]2CN(CCN2C1)C(=O)C3=CC(=C(C=C3Cl)F)S(=O)(=O)NC4=CC=CC=C4F	O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCCC2C1	InChI=1S/C20H20ClF2N3O3S/c21-15-11-17(23)19(30(28,29)24-18-6-2-1-5-16(18)22)10-14(15)20(27)26-9-8-25-7-3-4-13(25)12-26/h1-2,5-6,10-11,13,24H,3-4,7-9,12H2/t13-/m1/s1	AGPIHNZOZNKRGT-CYBMUJFWSA-N					compound annotation
0391_012725	BIBR 1087 SE	C32H37N7O5	2.8077	10290289	CCCCCCOC(=O)/N=C(/C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)O)C4=CC=CC=N4)\N	CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3c(ccc(C(=O)N(CCC(=O)O)c4ccccn4)c3)n2C)cc1	InChI=1S/C32H37N7O5/c1-3-4-5-8-19-44-32(43)37-30(33)22-10-13-24(14-11-22)35-21-28-36-25-20-23(12-15-26(25)38(28)2)31(42)39(18-16-29(40)41)27-9-6-7-17-34-27/h6-7,9-15,17,20,35H,3-5,8,16,18-19,21H2,1-2H3,(H,40,41)(H2,33,37,43)	UGEWTLXHMYKLCO-UHFFFAOYSA-N					compound annotation
0391_012726	GDP366	C20H17N5OS	3.406	6539985		Cc1cc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)ccc1	InChI=1S/C20H17N5OS/c1-12-3-2-4-15(9-12)25-20(26)24-14-7-5-13(6-8-14)16-10-27-19-17(16)18(21)22-11-23-19/h2-11H,1H3,(H2,21,22,23)(H2,24,25,26)	DZSUJUOJJJCWGG-UHFFFAOYSA-N					doublet; compound annotation
0391_012727	GDP366	C20H17N5OS	3.4092	6539985		Cc1cc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)ccc1	InChI=1S/C20H17N5OS/c1-12-3-2-4-15(9-12)25-20(26)24-14-7-5-13(6-8-14)16-10-27-19-17(16)18(21)22-11-23-19/h2-11H,1H3,(H2,21,22,23)(H2,24,25,26)	DZSUJUOJJJCWGG-UHFFFAOYSA-N					doublet; compound annotation
0391_012728	SCHEMBL19173743	C24H35NO2	3.9706	2882961		OC(COCCC12CC3CC(CC(C3)C1)C2)CN1CCc2ccccc2C1	InChI=1S/C24H35NO2/c26-23(16-25-7-5-21-3-1-2-4-22(21)15-25)17-27-8-6-24-12-18-9-19(13-24)11-20(10-18)14-24/h1-4,18-20,23,26H,5-17H2	MBCFSQHAVZFMOR-UHFFFAOYSA-N					compound annotation
0391_012729	ALLO-2	C18H12F3N5O	4.263	76848956		FC(F)(F)Oc1ccc(-c2nc(Nc3cc4c(cc3)[nH]nc4)ncc2)cc1	InChI=1S/C18H12F3N5O/c19-18(20,21)27-14-4-1-11(2-5-14)15-7-8-22-17(25-15)24-13-3-6-16-12(9-13)10-23-26-16/h1-10H,(H,23,26)(H,22,24,25)	QTYGEBIJNWMVCW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012731	939981-37-0	C40H49Cl2N5O4	4.2922	17754765	CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CC(=O)N4CCOCC4)(C)C5=CC=C(C=C5)Cl)(C)C6=CC=C(C=C6)Cl	CCOc1c(C2=NC(C)(c3ccc(Cl)cc3)C(C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CC(=O)N3CCOCC3)CC2)ccc(C(C)(C)C)c1	InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1	DJZBZZRLUQDRII-IOLBBIBUSA-N					doublet; removed another duplicate entry; compound annotation
0391_012733	163769-88-8	C22H21N3O2	4.5224	1103147		COc1c(OC)cc2c(c1)CC(C)(C)n1c-2cc2nc3ccccc3nc21	InChI=1S/C22H21N3O2/c1-22(2)12-13-9-19(26-3)20(27-4)10-14(13)18-11-17-21(25(18)22)24-16-8-6-5-7-15(16)23-17/h5-11H,12H2,1-4H3	HIXSPVQXXDULHS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012735	939981-37-0	C40H49Cl2N5O4	4.7425	17754765	CCOC1=C(C=CC(=C1)C(C)(C)C)C2=N[C@@]([C@@](N2C(=O)N3CCN(CC3)CC(=O)N4CCOCC4)(C)C5=CC=C(C=C5)Cl)(C)C6=CC=C(C=C6)Cl	CCOc1c(C2=NC(C)(c3ccc(Cl)cc3)C(C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CC(=O)N3CCOCC3)CC2)ccc(C(C)(C)C)c1	InChI=1S/C40H49Cl2N5O4/c1-7-51-34-26-30(38(2,3)4)12-17-33(34)36-43-39(5,28-8-13-31(41)14-9-28)40(6,29-10-15-32(42)16-11-29)47(36)37(49)46-20-18-44(19-21-46)27-35(48)45-22-24-50-25-23-45/h8-17,26H,7,18-25,27H2,1-6H3/t39-,40+/m0/s1	DJZBZZRLUQDRII-IOLBBIBUSA-N					doublet; compound annotation
0391_012736	ALLO-2	C18H12F3N5O	5.1035	76848956		FC(F)(F)Oc1ccc(-c2nc(Nc3cc4c(cc3)[nH]nc4)ncc2)cc1	InChI=1S/C18H12F3N5O/c19-18(20,21)27-14-4-1-11(2-5-14)15-7-8-22-17(25-15)24-13-3-6-16-12(9-13)10-23-26-16/h1-10H,(H,23,26)(H,22,24,25)	QTYGEBIJNWMVCW-UHFFFAOYSA-N					doublet; compound annotation
0391_012737	Linopirdine	C26H21N3O	1.4684	3932		O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1	InChI=1S/C26H21N3O/c30-25-26(18-20-10-14-27-15-11-20,19-21-12-16-28-17-13-21)23-8-4-5-9-24(23)29(25)22-6-2-1-3-7-22/h1-17H,18-19H2	YEJCDKJIEMIWRQ-UHFFFAOYSA-N					compound annotation
0391_012738	Propionylpromazine	C20H24N2OS	3.2077	24352		CCC(=O)c1cc2c(cc1)Sc1ccccc1N2CCCN(C)C	InChI=1S/C20H24N2OS/c1-4-18(23)15-10-11-20-17(14-15)22(13-7-12-21(2)3)16-8-5-6-9-19(16)24-20/h5-6,8-11,14H,4,7,12-13H2,1-3H3	ZQTVCQIJTREKSP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012740	RG-12525	C25H21N5O2	3.8765	129044		c1ccc(Cc2n[nH]nn2)c(COc2ccc(OCc3nc4ccccc4cc3)cc2)c1	InChI=1S/C25H21N5O2/c1-2-7-20(19(6-1)15-25-27-29-30-28-25)16-31-22-11-13-23(14-12-22)32-17-21-10-9-18-5-3-4-8-24(18)26-21/h1-14H,15-17H2,(H,27,28,29,30)	JELDFLOBXROBFH-UHFFFAOYSA-N					compound annotation
0391_012741	UNC0642	C29H44F2N6O2	1.4161	53315878		COc1c(OCCCN2CCCC2)cc2nc(N3CCC(F)(F)CC3)nc(NC3CCN(C(C)C)CC3)c2c1	InChI=1S/C29H44F2N6O2/c1-21(2)36-14-7-22(8-15-36)32-27-23-19-25(38-3)26(39-18-6-13-35-11-4-5-12-35)20-24(23)33-28(34-27)37-16-9-29(30,31)10-17-37/h19-22H,4-18H2,1-3H3,(H,32,33,34)	RNAMYOYQYRYFQY-UHFFFAOYSA-N					compound annotation
0391_012742	3,4,5-Trimethoxyphenol	C9H12O4	1.8009	69505		COc1cc(O)cc(OC)c1OC	InChI=1S/C9H12O4/c1-11-7-4-6(10)5-8(12-2)9(7)13-3/h4-5,10H,1-3H3	VTCDZPUMZAZMSB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012744	Sibofimloc	C35H39NO11	2.011	76684239	CC(=O)N1CCC2(CC1)C3=C(C=CC(=C3)C#C[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C5=C2C=C(C=C5)C#C[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O	CC(=O)N1CCC2(CC1)c1cc(C#CC3OC(CO)C(O)C(O)C3O)ccc1-c1c2cc(C#CC2OC(CO)C(O)C(O)C2O)cc1	InChI=1S/C35H39NO11/c1-18(39)36-12-10-35(11-13-36)23-14-19(4-8-25-29(40)33(44)31(42)27(16-37)46-25)2-6-21(23)22-7-3-20(15-24(22)35)5-9-26-30(41)34(45)32(43)28(17-38)47-26/h2-3,6-7,14-15,25-34,37-38,40-45H,10-13,16-17H2,1H3/t25-,26-,27-,28-,29-,30-,31-,32-,33-,34-/m1/s1	SFHMWDMKUYVSQJ-VECBPBMLSA-N					removed another duplicate entry; compound annotation
0391_012746	NSC 601980	C15H12N4	2.6017	121230984		Cc1nc2ccccc2nc1N=Nc1ccccc1	InChI=1S/C15H12N4/c1-11-15(19-18-12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11/h2-10H,1H3	HUXPPDSCOMVLMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012747	IDARUBICIN	C26H27NO9	2.976	42890	C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	CC(=O)C1(O)Cc2c(c(O)c3C(=O)c4ccccc4C(=O)c3c2O)C(OC2CC(N)C(O)C(C)O2)C1	InChI=1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1	XDXDZDZNSLXDNA-TZNDIEGXSA-N					compound annotation
0391_012748	BHPI	C21H17NO3	3.149	3860640		Cc1c2NC(=O)C(c3ccc(O)cc3)(c3ccc(O)cc3)c2ccc1	InChI=1S/C21H17NO3/c1-13-3-2-4-18-19(13)22-20(25)21(18,14-5-9-16(23)10-6-14)15-7-11-17(24)12-8-15/h2-12,23-24H,1H3,(H,22,25)	FABLAHMQSQFDHR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012751	NSC 601980	C15H12N4	4.1048	121230984		Cc1nc2ccccc2nc1N=Nc1ccccc1	InChI=1S/C15H12N4/c1-11-15(19-18-12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11/h2-10H,1H3	HUXPPDSCOMVLMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012752	sparsentan	C32H40N4O5S	4.1694	10257882		CCCCC1=NC2(CCCC2)C(=O)N1Cc1cc(COCC)c(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)cc1	InChI=1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35)	WRFHGDPIDHPWIQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012754	NSC 601980	C15H12N4	4.1802	121230984		Cc1nc2ccccc2nc1N=Nc1ccccc1	InChI=1S/C15H12N4/c1-11-15(19-18-12-7-3-2-4-8-12)17-14-10-6-5-9-13(14)16-11/h2-10H,1H3	HUXPPDSCOMVLMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012755	UT-155	C20H15F4N3O2	4.5816	122640156	C[C@](CN1C=CC2=C1C=CC(=C2)F)(C(=O)NC3=CC(=C(C=C3)C#N)C(F)(F)F)O	CC(O)(Cn1ccc2c1ccc(F)c2)C(=O)Nc1cc(C(F)(F)F)c(C#N)cc1	InChI=1S/C20H15F4N3O2/c1-19(29,11-27-7-6-12-8-14(21)3-5-17(12)27)18(28)26-15-4-2-13(10-25)16(9-15)20(22,23)24/h2-9,29H,11H2,1H3,(H,26,28)/t19-/m0/s1	CFSAYQVTXBMPRF-IBGZPJMESA-N					doublet; compound annotation
0391_012756	UT-155	C20H15F4N3O2	4.5854	122640156	C[C@](CN1C=CC2=C1C=CC(=C2)F)(C(=O)NC3=CC(=C(C=C3)C#N)C(F)(F)F)O	CC(O)(Cn1ccc2c1ccc(F)c2)C(=O)Nc1cc(C(F)(F)F)c(C#N)cc1	InChI=1S/C20H15F4N3O2/c1-19(29,11-27-7-6-12-8-14(21)3-5-17(12)27)18(28)26-15-4-2-13(10-25)16(9-15)20(22,23)24/h2-9,29H,11H2,1H3,(H,26,28)/t19-/m0/s1	CFSAYQVTXBMPRF-IBGZPJMESA-N					doublet; compound annotation
0391_012757	DO34	C26H28F3N5O4	5.8796	129188708		CC(C)(C)OC(=O)N1CCN(C(=O)n2cc(-c3ccc(OC(F)(F)F)cc3)nn2)C(Cc2ccccc2)C1	InChI=1S/C26H28F3N5O4/c1-25(2,3)38-24(36)32-13-14-33(20(16-32)15-18-7-5-4-6-8-18)23(35)34-17-22(30-31-34)19-9-11-21(12-10-19)37-26(27,28)29/h4-12,17,20H,13-16H2,1-3H3	CQGMWUWJVBKTRM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012759	Entecavir hydrate	C12H15N5O3	0.5156	135398508	C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N	C=C1C(CO)C(O)CC1n1cnc2c1[nH]c(N)nc2=O	InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1	QDGZDCVAUDNJFG-FXQIFTODSA-N					compound annotation
0391_012760	CEFORANIDE	C20H21N7O6S2	1.3083	43507	C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O	NCc1ccccc1CC(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CSC12	InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1	SLAYUXIURFNXPG-CRAIPNDOSA-N					doublet; compound annotation
0391_012761	CEFORANIDE	C20H21N7O6S2	1.3658	43507	C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O	NCc1ccccc1CC(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3nnnn3CC(=O)O)CSC12	InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1	SLAYUXIURFNXPG-CRAIPNDOSA-N					doublet; compound annotation
0391_012762	penicillin g	C16H18N2O4S	1.5835	5904	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C	CC1(C)SC2C(NC(=O)Cc3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	JGSARLDLIJGVTE-MBNYWOFBSA-N					doublet; compound annotation
0391_012763	Cefazedone	C18H15Cl2N5O5S3	1.9245	71736	CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)O	Cc1nnc(SCC2=C(C(=O)O)N3C(=O)C(NC(=O)Cn4cc(Cl)c(=O)c(Cl)c4)C3SC2)s1	InChI=1S/C18H15Cl2N5O5S3/c1-7-22-23-18(33-7)32-6-8-5-31-16-12(15(28)25(16)13(8)17(29)30)21-11(26)4-24-2-9(19)14(27)10(20)3-24/h2-3,12,16H,4-6H2,1H3,(H,21,26)(H,29,30)/t12-,16-/m1/s1	VTLCNEGVSVJLDN-MLGOLLRUSA-N					compound annotation
0391_012764	Bay 41-4109 racemate	C18H13ClF3N3O2	2.6867	9865484		COC(=O)C1=C(C)NC(c2c(F)cc(F)cn2)=NC1c1c(Cl)cc(F)cc1	InChI=1S/C18H13ClF3N3O2/c1-8-14(18(26)27-2)15(11-4-3-9(20)5-12(11)19)25-17(24-8)16-13(22)6-10(21)7-23-16/h3-7,15H,1-2H3,(H,24,25)	FVNJBPMQWSIGJK-UHFFFAOYSA-N					compound annotation
0391_012765	penicillin g	C16H18N2O4S	2.8438	5904	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C	CC1(C)SC2C(NC(=O)Cc3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1	JGSARLDLIJGVTE-MBNYWOFBSA-N					doublet; compound annotation
0391_012766	cefpodoxime proxetil	C21H27N5O9S2	3.4122	6526396	CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC	COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1	InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1	LTINZAODLRIQIX-FBXRGJNPSA-N					doublet; compound annotation
0391_012767	cefpodoxime proxetil	C21H27N5O9S2	3.4901	6526396	CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC	COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)C(NC(=O)C(=NOC)c3csc(N)n3)C2SC1	InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1	LTINZAODLRIQIX-FBXRGJNPSA-N					doublet; compound annotation
0391_012768	Butoconazole	C19H17Cl3N2S	4.0146	47472		Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1	InChI=1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2	SWLMUYACZKCSHZ-UHFFFAOYSA-N					compound annotation
0391_012769	citiolone	C6H9NO2S	0.5888	14520		CC(=O)NC1CCSC1=O	InChI=1S/C6H9NO2S/c1-4(8)7-5-2-3-10-6(5)9/h5H,2-3H2,1H3,(H,7,8)	NRFJZTXWLKPZAV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012771	(-)-Gallocatechin gallate	C22H18O11	1.5272	199472	C1[C@H]([C@@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O	O=C(OC1Cc2c(O)cc(O)cc2OC1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1	InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21+/m1/s1	WMBWREPUVVBILR-NQIIRXRSSA-N					compound annotation
0391_012772	LY2811376	C15H14F2N4S	1.8244	44251605	C[C@]1(CCSC(=N1)N)C2=C(C=C(C(=C2)C3=CN=CN=C3)F)F	CC1(c2c(F)cc(F)c(-c3cncnc3)c2)CCSC(N)=N1	InChI=1S/C15H14F2N4S/c1-15(2-3-22-14(18)21-15)11-4-10(12(16)5-13(11)17)9-6-19-8-20-7-9/h4-8H,2-3H2,1H3,(H2,18,21)/t15-/m0/s1	MJQMRGWYPNIERM-HNNXBMFYSA-N					compound annotation
0391_012773	Trilobatin	C21H24O10	2.4271	6451798	C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O	O=C(CCc1ccc(O)cc1)c1c(O)cc(OC2OC(CO)C(O)C(O)C2O)cc1O	InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-12-7-14(25)17(15(26)8-12)13(24)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-23,25-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1	GSTCPEBQYSOEHV-QNDFHXLGSA-N					compound annotation
0391_012774	Loxoprofen	C15H18O3	3.252	3965		CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1	InChI=1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)	YMBXTVYHTMGZDW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012776	AM-0902	C17H15ClN6O2	3.3206	73297271		Cn1cnc2c1c(=O)n(Cc1nc(CCc3ccc(Cl)cc3)no1)cn2	InChI=1S/C17H15ClN6O2/c1-23-9-19-16-15(23)17(25)24(10-20-16)8-14-21-13(22-26-14)7-4-11-2-5-12(18)6-3-11/h2-3,5-6,9-10H,4,7-8H2,1H3	AWJBWNUUODWOKQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012778	Bindarit	C19H20N2O3	4.0225	71354		CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(=O)O	InChI=1S/C19H20N2O3/c1-19(2,18(22)23)24-13-16-15-10-6-7-11-17(15)21(20-16)12-14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3,(H,22,23)	MTHORRSSURHQPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012780	Fasiglifam	C29H32O7S	4.565	24857286	CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)[C@@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C	Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2cc3c(cc2)C(CC(=O)O)CO3)c1	InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1	BZCALJIHZVNMGJ-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_012783	EC359	C36H38F2O2	6.0579	139600278	CC1=CC(=C(C(=C1)C)C2=CC=C(C=C2)[C@H]3C[C@]4([C@@H](CC[C@]4(C(C#C)(F)F)O)[C@H]5C3=C6CCC(=O)C=C6CC5)C)C	C#CC(F)(F)C1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(-c4c(C)cc(C)cc4C)cc3)CC21C	InChI=1S/C36H38F2O2/c1-6-36(37,38)35(40)16-15-31-29-13-11-26-19-27(39)12-14-28(26)33(29)30(20-34(31,35)5)24-7-9-25(10-8-24)32-22(3)17-21(2)18-23(32)4/h1,7-10,17-19,29-31,40H,11-16,20H2,2-5H3/t29-,30+,31-,34-,35-/m0/s1	AHHXLJGAODIDAX-WQQPUSSASA-N					removed another duplicate entry; compound annotation
0391_012786	63527-52-6	C16H17N5O7S2	1.5669	2632		CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(C)=O)CSC12)c1csc(N)n1	InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)	GPRBEKHLDVQUJE-UHFFFAOYSA-N					compound annotation
0391_012787	TOLIMIDONE	C11H10N2O2	2.3126	39065		Cc1cc(Oc2c[nH]c(=O)nc2)ccc1	InChI=1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14)	HJQILFPVRNHTIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012789	SKA-121	C12H10N2O	2.7753	91827362		Cc1cc2c(oc(N)n2)c2ccccc12	InChI=1S/C12H10N2O/c1-7-6-10-11(15-12(13)14-10)9-5-3-2-4-8(7)9/h2-6H,1H3,(H2,13,14)	JEGUERWMMMQFJV-UHFFFAOYSA-N					compound annotation
0391_012790	Thiophanate-methyl	C12H14N4O4S2	2.9067	3032791		COC(=O)N=C(S)Nc1ccccc1NC(S)=NC(=O)OC	InChI=1S/C12H14N4O4S2/c1-19-11(17)15-9(21)13-7-5-3-4-6-8(7)14-10(22)16-12(18)20-2/h3-6H,1-2H3,(H2,13,15,17,21)(H2,14,16,18,22)	QGHREAKMXXNCOA-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012792	Rhodamine B cation	C28H31N2O3+	4.0165	6695		CCN(CC)c1cc2c(cc1)c(-c1ccccc1C(=O)O)c1ccc(=[N+](CC)CC)cc-1o2	InChI=1S/C28H30N2O3/c1-5-29(6-2)19-13-15-23-25(17-19)33-26-18-20(30(7-3)8-4)14-16-24(26)27(23)21-11-9-10-12-22(21)28(31)32/h9-18H,5-8H2,1-4H3/p+1	CVAVMIODJQHEEH-UHFFFAOYSA-O					compound annotation
0391_012793	195513-96-3	C30H40N2O6	4.7414	35027274	CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC2=CC(=C(C=C2)OC)OC)C3=CC(=CC=C3)N	CCC(C)(C)C(=O)C(=O)N1CCCCC1C(=O)OC(CCc1cc(OC)c(OC)cc1)c1cc(N)ccc1	InChI=1S/C30H40N2O6/c1-6-30(2,3)27(33)28(34)32-17-8-7-12-23(32)29(35)38-24(21-10-9-11-22(31)19-21)15-13-20-14-16-25(36-4)26(18-20)37-5/h9-11,14,16,18-19,23-24H,6-8,12-13,15,17,31H2,1-5H3/t23-,24+/m0/s1	IIDSDBBDZNDWCN-BJKOFHAPSA-N					removed another duplicate entry; compound annotation
0391_012795	2098969-71-0	C26H28F3N5O4	5.8547	129201716		CC(C)(C)OC(=O)N1CCN(C(=O)n2ncc(-c3ccc(OC(F)(F)F)cc3)n2)C(Cc2ccccc2)C1	InChI=1S/C26H28F3N5O4/c1-25(2,3)38-24(36)32-13-14-33(20(17-32)15-18-7-5-4-6-8-18)23(35)34-30-16-22(31-34)19-9-11-21(12-10-19)37-26(27,28)29/h4-12,16,20H,13-15,17H2,1-3H3	ZCLTTXIIPQGUKN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012797	Itopride	C20H26N2O4	1.8014	3792		COc1c(OC)cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1	InChI=1S/C20H26N2O4/c1-22(2)11-12-26-17-8-5-15(6-9-17)14-21-20(23)16-7-10-18(24-3)19(13-16)25-4/h5-10,13H,11-12,14H2,1-4H3,(H,21,23)	QQQIECGTIMUVDS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012799	Tosufloxacin	C19H15F3N4O3	2.0877	5517		NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(-c4c(F)cc(F)cc4)c3n2)C1	InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29)	WUWFMDMBOJLQIV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012801	MK-8033	C25H21N5O3S	2.5355	45142457		Cn1cc(-c2cc3c(ccc4c(cc(CS(=O)(=O)NCc5ccccn5)cc4)c3=O)nc2)cn1	InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3	VMJFTOSOFDEKTM-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012803	nutlin-3A	C30H30Cl2N4O4	2.9457	11433190	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1	BDUHCSBCVGXTJM-WUFINQPMSA-N					doublet; compound annotation
0391_012804	nutlin-3A	C30H30Cl2N4O4	3.177	11433190	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1	BDUHCSBCVGXTJM-WUFINQPMSA-N					doublet; compound annotation
0391_012805	nutlin-3A	C30H30Cl2N4O4	3.6337	11433190	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1	BDUHCSBCVGXTJM-WUFINQPMSA-N					doublet; compound annotation
0391_012806	nutlin-3A	C30H30Cl2N4O4	3.6365	11433190	CC(C)OC1=C(C=CC(=C1)OC)C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl	COc1cc(OC(C)C)c(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)cc1	InChI=1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37)/t27-,28+/m0/s1	BDUHCSBCVGXTJM-WUFINQPMSA-N					doublet; compound annotation
0391_012807	Fexinidazole	C12H13N3O3S	3.8651	68792		CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1	InChI=1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3	MIWWSGDADVMLTG-UHFFFAOYSA-N					compound annotation
0391_012808	BAY-876	C24H16F4N6O2	3.8823	118191391		Cc1c(NC(=O)c2cc(C(N)=O)nc3c2ccc(F)c3)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1	InChI=1S/C24H16F4N6O2/c1-12-20(21(24(26,27)28)33-34(12)11-14-4-2-13(10-29)3-5-14)32-23(36)17-9-19(22(30)35)31-18-8-15(25)6-7-16(17)18/h2-9H,11H2,1H3,(H2,30,35)(H,32,36)	BKLJDIJJOOQUFG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012810	PYR6	C17H9F7N4O	4.5792	10598093		O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1c(F)cncc1	InChI=1S/C17H9F7N4O/c18-12-8-25-6-5-11(12)15(29)26-9-1-3-10(4-2-9)28-14(17(22,23)24)7-13(27-28)16(19,20)21/h1-8H,(H,26,29)	XZIQSOZOLJJMFN-UHFFFAOYSA-N					compound annotation
0391_012811	Treosulfan	C6H14O8S2	0.6064	9882105	CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O	CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O	InChI=1S/C6H14O8S2/c1-15(9,10)13-3-5(7)6(8)4-14-16(2,11)12/h5-8H,3-4H2,1-2H3/t5-,6-/m0/s1	YCPOZVAOBBQLRI-WDSKDSINSA-N					compound annotation
0391_012812	ChX710	C18H21N5O	1.3129	135397145		CC(CN(C)C)NC(=O)c1c2nc(-c3ccncc3)[nH]c2ccc1	InChI=1S/C18H21N5O/c1-12(11-23(2)3)20-18(24)14-5-4-6-15-16(14)22-17(21-15)13-7-9-19-10-8-13/h4-10,12H,11H2,1-3H3,(H,20,24)(H,21,22)	HCAALGAOSBFHFP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012814	PRX-08066	C19H17ClFN5S	2.5642	11502243		N#Cc1c(F)ccc(CN2CCC(Nc3c4cc(Cl)sc4ncn3)CC2)c1	InChI=1S/C19H17ClFN5S/c20-17-8-15-18(23-11-24-19(15)27-17)25-14-3-5-26(6-4-14)10-12-1-2-16(21)13(7-12)9-22/h1-2,7-8,11,14H,3-6,10H2,(H,23,24,25)	IENZFHBNCRQMNP-UHFFFAOYSA-N					compound annotation
0391_012815	ChX710	C18H21N5O	2.6763	135397145		CC(CN(C)C)NC(=O)c1c2nc(-c3ccncc3)[nH]c2ccc1	InChI=1S/C18H21N5O/c1-12(11-23(2)3)20-18(24)14-5-4-6-15-16(14)22-17(21-15)13-7-9-19-10-8-13/h4-10,12H,11H2,1-3H3,(H,20,24)(H,21,22)	HCAALGAOSBFHFP-UHFFFAOYSA-N					doublet; compound annotation
0391_012816	ChX710	C18H21N5O	2.6811	135397145		CC(CN(C)C)NC(=O)c1c2nc(-c3ccncc3)[nH]c2ccc1	InChI=1S/C18H21N5O/c1-12(11-23(2)3)20-18(24)14-5-4-6-15-16(14)22-17(21-15)13-7-9-19-10-8-13/h4-10,12H,11H2,1-3H3,(H,20,24)(H,21,22)	HCAALGAOSBFHFP-UHFFFAOYSA-N					doublet; compound annotation
0391_012817	NE 52-QQ57	C24H28N6O	2.6811	68379135		CCc1nn2c(C)cc(C)nc2c1Cc1ccc(-c2nnc(C3CCNCC3)o2)cc1	InChI=1S/C24H28N6O/c1-4-21-20(22-26-15(2)13-16(3)30(22)29-21)14-17-5-7-18(8-6-17)23-27-28-24(31-23)19-9-11-25-12-10-19/h5-8,13,19,25H,4,9-12,14H2,1-3H3	HXPQWNPLNIEJOW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012819	Pyridoclax	C29H22N4	2.7125	92042827	CC1=CC(=CN=C1C2=CN=CC=C2)C3=C(C=C(C=N3)C4=CN=CC=C4)/C=C/C5=CC=CC=C5	Cc1cc(-c2ncc(-c3cnccc3)cc2C=Cc2ccccc2)cnc1-c1cnccc1	InChI=1S/C29H22N4/c1-21-15-27(20-32-28(21)25-10-6-14-31-18-25)29-23(12-11-22-7-3-2-4-8-22)16-26(19-33-29)24-9-5-13-30-17-24/h2-20H,1H3/b12-11+	WGGSYXQFYRWBEC-VAWYXSNFSA-N					doublet; compound annotation
0391_012820	BENZOIN	C14H12O2	3.0697	8400		O=C(c1ccccc1)C(O)c1ccccc1	InChI=1S/C14H12O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13,15H	ISAOCJYIOMOJEB-UHFFFAOYSA-N					compound annotation
0391_012821	Pyridoclax	C29H22N4	3.0697	92042827	CC1=CC(=CN=C1C2=CN=CC=C2)C3=C(C=C(C=N3)C4=CN=CC=C4)/C=C/C5=CC=CC=C5	Cc1cc(-c2ncc(-c3cnccc3)cc2C=Cc2ccccc2)cnc1-c1cnccc1	InChI=1S/C29H22N4/c1-21-15-27(20-32-28(21)25-10-6-14-31-18-25)29-23(12-11-22-7-3-2-4-8-22)16-26(19-33-29)24-9-5-13-30-17-24/h2-20H,1H3/b12-11+	WGGSYXQFYRWBEC-VAWYXSNFSA-N					doublet; compound annotation
0391_012822	EMIXUSTAT	C16H25NO2	3.1354	25221720	C1CCC(CC1)COC2=CC=CC(=C2)[C@@H](CCN)O	NCCC(O)c1cc(OCC2CCCCC2)ccc1	InChI=1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2/t16-/m1/s1	WJIGGYYSZBWCGC-MRXNPFEDSA-N					doublet; compound annotation
0391_012823	CYPROTERONE ACETATE	C24H29ClO4	4.5181	9880	CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C	CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C	InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1	UWFYSQMTEOIJJG-FDTZYFLXSA-N					compound annotation
0391_012824	eIF4A3-IN-2	C25H19Br2ClN4O2	4.8185	131953885	C1CN([C@H](CN1C(=O)C2=C3C=CC(=CN3N=C2)Br)C4=CC=C(C=C4)Cl)C(=O)C5=CC=C(C=C5)Br	O=C(c1c2ccc(Br)cn2nc1)N1CCN(C(=O)c2ccc(Br)cc2)C(c2ccc(Cl)cc2)C1	InChI=1S/C25H19Br2ClN4O2/c26-18-5-1-17(2-6-18)24(33)31-12-11-30(15-23(31)16-3-8-20(28)9-4-16)25(34)21-13-29-32-14-19(27)7-10-22(21)32/h1-10,13-14,23H,11-12,15H2/t23-/m1/s1	WKKAVTNXNVPCCN-HSZRJFAPSA-N					removed another duplicate entry; compound annotation
0391_012826	Vorinostat	C14H20N2O3	2.1988	5311		O=C(CCCCCCC(=O)Nc1ccccc1)NO	InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)	WAEXFXRVDQXREF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012828	Coptisine	C19H14NO4+	2.2321	72322		c1c2CC[n+]3c(cc4ccc5c(OCO5)c4c3)-c2cc2c1OCO2	InChI=1S/C19H14NO4/c1-2-16-19(24-10-21-16)14-8-20-4-3-12-6-17-18(23-9-22-17)7-13(12)15(20)5-11(1)14/h1-2,5-8H,3-4,9-10H2/q+1	XYHOBCMEDLZUMP-UHFFFAOYSA-N					compound annotation
0391_012829	Valrocemide	C10H20N2O2	2.3063	6918293		CCCC(CCC)C(=O)NCC(N)=O	InChI=1S/C10H20N2O2/c1-3-5-8(6-4-2)10(14)12-7-9(11)13/h8H,3-7H2,1-2H3,(H2,11,13)(H,12,14)	RALGCAOVRLYSMA-UHFFFAOYSA-N					compound annotation
0391_012830	monastrol	C14H16N2O3S	2.6172	2987927		CCOC(=O)C1=C(C)NC(S)=NC1c1cc(O)ccc1	InChI=1S/C14H16N2O3S/c1-3-19-13(18)11-8(2)15-14(20)16-12(11)9-5-4-6-10(17)7-9/h4-7,12,17H,3H2,1-2H3,(H2,15,16,20)	LOBCDGHHHHGHFA-UHFFFAOYSA-N					compound annotation
0391_012831	Uniconazole	C15H18ClN3O	3.8603	6436604	CC(C)(C)C(/C(=C\C1=CC=C(C=C1)Cl)/N2C=NC=N2)O	CC(C)(C)C(O)C(=Cc1ccc(Cl)cc1)n1cncn1	InChI=1S/C15H18ClN3O/c1-15(2,3)14(20)13(19-10-17-9-18-19)8-11-4-6-12(16)7-5-11/h4-10,14,20H,1-3H3/b13-8+	YNWVFADWVLCOPU-MDWZMJQESA-N					doublet; compound annotation
0391_012832	Uniconazole	C15H18ClN3O	4.1367	6436604	CC(C)(C)C(/C(=C\C1=CC=C(C=C1)Cl)/N2C=NC=N2)O	CC(C)(C)C(O)C(=Cc1ccc(Cl)cc1)n1cncn1	InChI=1S/C15H18ClN3O/c1-15(2,3)14(20)13(19-10-17-9-18-19)8-11-4-6-12(16)7-5-11/h4-10,14,20H,1-3H3/b13-8+	YNWVFADWVLCOPU-MDWZMJQESA-N					doublet; compound annotation
0391_012833	Licofelone	C23H22ClNO2	5.5729	133021		CC1(C)Cc2c(-c3ccccc3)c(-c3ccc(Cl)cc3)c(CC(=O)O)n2C1	InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)	UAWXGRJVZSAUSZ-UHFFFAOYSA-N					compound annotation
0391_012834	KLH45	C24H25F3N4O2	6.3418	126970670		O=C(N(CCc1ccccc1)C1CCCCC1)n1ncc(-c2ccc(OC(F)(F)F)cc2)n1	InChI=1S/C24H25F3N4O2/c25-24(26,27)33-21-13-11-19(12-14-21)22-17-28-31(29-22)23(32)30(20-9-5-2-6-10-20)16-15-18-7-3-1-4-8-18/h1,3-4,7-8,11-14,17,20H,2,5-6,9-10,15-16H2	FYOYNRLSBYWAHL-UHFFFAOYSA-N					compound annotation
0391_012835	N-Acetyl-L-phenylalanine	C11H13NO3	1.8484	74839	CC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O	CC(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)/t10-/m0/s1	CBQJSKKFNMDLON-JTQLQIEISA-N					compound annotation
0391_012836	4-Methoxycinnamic acid	C10H10O3	2.7734	699414	COC1=CC=C(C=C1)/C=C/C(=O)O	COc1ccc(C=CC(=O)O)cc1	InChI=1S/C10H10O3/c1-13-9-5-2-8(3-6-9)4-7-10(11)12/h2-7H,1H3,(H,11,12)/b7-4+	AFDXODALSZRGIH-QPJJXVBHSA-N					doublet; compound annotation
0391_012837	benzamidine	C7H8N2	0.4587	2332		N=C(N)c1ccccc1	InChI=1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9)	PXXJHWLDUBFPOL-UHFFFAOYSA-N					compound annotation
0391_012838	4'-Hydroxyacetophenone	C8H8O2	1.6292	7469		CC(=O)c1ccc(O)cc1	InChI=1S/C8H8O2/c1-6(9)7-2-4-8(10)5-3-7/h2-5,10H,1H3	TXFPEBPIARQUIG-UHFFFAOYSA-N					compound annotation
0391_012839	Porcupine-IN-1	C25H19FN4O	2.889	132578555		Cc1nccc(-c2c(F)cc(CNC(=O)c3cc4c(cc3)c3ccccc3[nH]4)cn2)c1	InChI=1S/C25H19FN4O/c1-15-10-17(8-9-27-15)24-21(26)11-16(13-28-24)14-29-25(31)18-6-7-20-19-4-2-3-5-22(19)30-23(20)12-18/h2-13,30H,14H2,1H3,(H,29,31)	GOMFFTZBKYVUOE-UHFFFAOYSA-N					compound annotation
0391_012840	1-PHENYL-1,2-PROPANEDIONE	C9H8O2	3.1989	11363		CC(=O)C(=O)c1ccccc1	InChI=1S/C9H8O2/c1-7(10)9(11)8-5-3-2-4-6-8/h2-6H,1H3	BVQVLAIMHVDZEL-UHFFFAOYSA-N					compound annotation
0391_012841	Metronidazole benzoate	C13H13N3O4	3.1989	83213		Cc1ncc([N+](=O)[O-])n1CCOC(=O)c1ccccc1	InChI=1S/C13H13N3O4/c1-10-14-9-12(16(18)19)15(10)7-8-20-13(17)11-5-3-2-4-6-11/h2-6,9H,7-8H2,1H3	CUUCCLJJOWSASK-UHFFFAOYSA-N					compound annotation
0391_012842	XIPAMIDE	C15H15ClN2O4S	3.5439	26618		Cc1c(NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2O)c(C)ccc1	InChI=1S/C15H15ClN2O4S/c1-8-4-3-5-9(2)14(8)18-15(20)10-6-13(23(17,21)22)11(16)7-12(10)19/h3-7,19H,1-2H3,(H,18,20)(H2,17,21,22)	MTZBBNMLMNBNJL-UHFFFAOYSA-N					compound annotation
0391_012843	ML390	C21H21F3N2O3	4.1724	71768304	C1C[C@H](C2=CC=CC=C2C1)NC(=O)CCNC(=O)C3=CC=C(C=C3)OC(F)(F)F	O=C(CCNC(=O)c1ccc(OC(F)(F)F)cc1)NC1CCCc2ccccc21	InChI=1S/C21H21F3N2O3/c22-21(23,24)29-16-10-8-15(9-11-16)20(28)25-13-12-19(27)26-18-7-3-5-14-4-1-2-6-17(14)18/h1-2,4,6,8-11,18H,3,5,7,12-13H2,(H,25,28)(H,26,27)/t18-/m1/s1	SGNRHEDBLPGDDC-GOSISDBHSA-N					doublet; compound annotation
0391_012844	ML390	C21H21F3N2O3	4.1759	71768304	C1C[C@H](C2=CC=CC=C2C1)NC(=O)CCNC(=O)C3=CC=C(C=C3)OC(F)(F)F	O=C(CCNC(=O)c1ccc(OC(F)(F)F)cc1)NC1CCCc2ccccc21	InChI=1S/C21H21F3N2O3/c22-21(23,24)29-16-10-8-15(9-11-16)20(28)25-13-12-19(27)26-18-7-3-5-14-4-1-2-6-17(14)18/h1-2,4,6,8-11,18H,3,5,7,12-13H2,(H,25,28)(H,26,27)/t18-/m1/s1	SGNRHEDBLPGDDC-GOSISDBHSA-N					doublet; compound annotation
0391_012845	JSH-150	C24H33ClN6O2S	2.2273	134814484		COCCNC1CCC(Nc2ncc(Cl)c(-c3csc(NCC4(C#N)CCOCC4)n3)c2)CC1	InChI=1S/C24H33ClN6O2S/c1-32-11-8-27-17-2-4-18(5-3-17)30-22-12-19(20(25)13-28-22)21-14-34-23(31-21)29-16-24(15-26)6-9-33-10-7-24/h12-14,17-18,27H,2-11,16H2,1H3,(H,28,30)(H,29,31)	XSDZPPRQLIZLDG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012847	Fenobucarb	C12H17NO2	3.87	19588		CCC(C)c1ccccc1OC(=O)NC	InChI=1S/C12H17NO2/c1-4-9(2)10-7-5-6-8-11(10)15-12(14)13-3/h5-9H,4H2,1-3H3,(H,13,14)	DIRFUJHNVNOBMY-UHFFFAOYSA-N					compound annotation
0391_012848	TMB-PS	C19H26N2O3S	1.8622	21972361		Cc1cc(-c2cc(C)c(NCCCS(=O)(=O)O)c(C)c2)cc(C)c1N	InChI=1S/C19H26N2O3S/c1-12-8-16(9-13(2)18(12)20)17-10-14(3)19(15(4)11-17)21-6-5-7-25(22,23)24/h8-11,21H,5-7,20H2,1-4H3,(H,22,23,24)	GZNAFYJQMXPVSY-UHFFFAOYSA-N					compound annotation
0391_012849	Decernotinib	C18H19F3N6O	2.1538	59422203	CC[C@](C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3	CCC(C)(Nc1nc(-c2c[nH]c3c2cccn3)ncc1)C(=O)NCC(F)(F)F	InChI=1S/C18H19F3N6O/c1-3-17(2,16(28)25-10-18(19,20)21)27-13-6-8-23-15(26-13)12-9-24-14-11(12)5-4-7-22-14/h4-9H,3,10H2,1-2H3,(H,22,24)(H,25,28)(H,23,26,27)/t17-/m1/s1	ASUGUQWIHMTFJL-QGZVFWFLSA-N					compound annotation
0391_012850	AZD3229	C24H26FN7O3	2.4857	134814269		COCCOc1cc2c(c(F)c1)c(Nc1ccc(NC(=O)Cn3cc(C(C)C)nn3)cc1)ncn2	InChI=1S/C24H26FN7O3/c1-15(2)21-12-32(31-30-21)13-22(33)28-16-4-6-17(7-5-16)29-24-23-19(25)10-18(35-9-8-34-3)11-20(23)26-14-27-24/h4-7,10-12,14-15H,8-9,13H2,1-3H3,(H,28,33)(H,26,27,29)	FLJOFQUXYAWOPE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012852	1624117-53-8	C17H19N3O2	3.0728	78871801		O=C(NCC(=O)N1CCCC1)Nc1cc2ccccc2cc1	InChI=1S/C17H19N3O2/c21-16(20-9-3-4-10-20)12-18-17(22)19-15-8-7-13-5-1-2-6-14(13)11-15/h1-2,5-8,11H,3-4,9-10,12H2,(H2,18,19,22)	GSQHGSRPQHBTTP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012854	292053-42-0	C15H12N2O5S	3.1023	710526	COC(=O)/C(=C/C1=CC=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)/C#N	COC(=O)C(C#N)=Cc1ccc(-c2ccc(S(N)(=O)=O)cc2)o1	InChI=1S/C15H12N2O5S/c1-21-15(18)11(9-16)8-12-4-7-14(22-12)10-2-5-13(6-3-10)23(17,19)20/h2-8H,1H3,(H2,17,19,20)/b11-8+	VEXAKEBSBMAIOB-DHZHZOJOSA-N					compound annotation
0391_012855	7ACC2	C18H15NO4	3.9465	72696735		CN(Cc1ccccc1)c1cc2c(cc1)cc(C(=O)O)c(=O)o2	InChI=1S/C18H15NO4/c1-19(11-12-5-3-2-4-6-12)14-8-7-13-9-15(17(20)21)18(22)23-16(13)10-14/h2-10H,11H2,1H3,(H,20,21)	XTKDQPFUOFAMRL-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012858	Clofilium	C21H37ClN+	4.2777	2798		CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1	InChI=1S/C21H37ClN/c1-4-7-8-9-11-18-23(5-2,6-3)19-12-10-13-20-14-16-21(22)17-15-20/h14-17H,4-13,18-19H2,1-3H3/q+1	WPSYTTKBGAZSCX-UHFFFAOYSA-N					compound annotation
0391_012859	245075-84-7	C35H34Cl2N4O8	4.4954	10212249		CC(C)(Oc1ccc(NC(=O)Nc2c(Cl)cc(Cc3cc(Cl)c(NC(=O)Nc4ccc(OC(C)(C)C(=O)O)cc4)cc3)cc2)cc1)C(=O)O	InChI=1S/C35H34Cl2N4O8/c1-34(2,30(42)43)48-24-11-7-22(8-12-24)38-32(46)40-28-15-5-20(18-26(28)36)17-21-6-16-29(27(37)19-21)41-33(47)39-23-9-13-25(14-10-23)49-35(3,4)31(44)45/h5-16,18-19H,17H2,1-4H3,(H,42,43)(H,44,45)(H2,38,40,46)(H2,39,41,47)	WJDMCXSGUCNRPZ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012862	944261-79-4	C19H16ClNO4	4.9165	16038374		COc1cc(OC)cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)c1	InChI=1S/C19H16ClNO4/c1-23-15-9-14(10-16(11-15)24-2)21-19(22)18-8-7-17(25-18)12-3-5-13(20)6-4-12/h3-11H,1-2H3,(H,21,22)	VHKBTPQDHDSBSP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012865	4-Hydroxyquinazoline	C8H6N2O	1.2316	135408753		O=c1nc[nH]c2ccccc12	InChI=1S/C8H6N2O/c11-8-6-3-1-2-4-7(6)9-5-10-8/h1-5H,(H,9,10,11)	QMNUDYFKZYBWQX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012867	Tildipirosin	C41H71N3O8	1.3145	24860548	CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CCN3CCCCC3)C)\C)CN4CCCCC4	CCC1OC(=O)CC(O)C(C)C(OC2OC(C)C(O)C(N(C)C)C2O)C(CCN2CCCCC2)CC(C)C(=O)C=CC(C)=CC1CN1CCCCC1	InChI=1S/C41H71N3O8/c1-8-35-32(26-44-20-13-10-14-21-44)23-27(2)15-16-33(45)28(3)24-31(17-22-43-18-11-9-12-19-43)40(29(4)34(46)25-36(47)51-35)52-41-39(49)37(42(6)7)38(48)30(5)50-41/h15-16,23,28-32,34-35,37-41,46,48-49H,8-14,17-22,24-26H2,1-7H3/b16-15+,27-23+/t28-,29+,30-,31+,32-,34-,35-,37+,38-,39-,40-,41+/m1/s1	HNDXPZPJZGTJLJ-UEJFNEDBSA-N					compound annotation
0391_012868	Oxindole	C8H7NO	1.7065	321710		O=C1Cc2ccccc2N1	InChI=1S/C8H7NO/c10-8-5-6-3-1-2-4-7(6)9-8/h1-4H,5H2,(H,9,10)	JYGFTBXVXVMTGB-UHFFFAOYSA-N					compound annotation
0391_012869	(S)-quinacrine	C23H30ClN3O	1.9265	6603979	CCN(CC)CCC[C@H](C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC	CCN(CC)CCCC(C)Nc1c2cc(OC)ccc2nc2c1ccc(Cl)c2	InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)/t16-/m0/s1	GPKJTRJOBQGKQK-INIZCTEOSA-N					compound annotation
0391_012870	Lck inhibitor 2	C18H17N5O2	2.3801	25138012		Cc1c(Nc2nc(Nc3cccc(C(N)=O)c3)ncc2)cc(O)cc1	InChI=1S/C18H17N5O2/c1-11-5-6-14(24)10-15(11)22-16-7-8-20-18(23-16)21-13-4-2-3-12(9-13)17(19)25/h2-10,24H,1H3,(H2,19,25)(H2,20,21,22,23)	SFCBIFOAGRZJNX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012873	butacaine	C18H30N2O2	2.4846	2480		CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1	InChI=1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3	HQFWVSGBVLEQGA-UHFFFAOYSA-N					compound annotation
0391_012874	MAYTANSINOL	C28H37ClN2O8	3.6506	9915934	C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)O)C)\C)OC)(NC(=O)O2)O	COc1cc2cc(c1Cl)N(C)C(=O)CC(O)C1(C)OC1C(C)C1CC(O)(NC(=O)O1)C(OC)C=CC=C(C)C2	InChI=1S/C28H37ClN2O8/c1-15-8-7-9-22(37-6)28(35)14-20(38-26(34)30-28)16(2)25-27(3,39-25)21(32)13-23(33)31(4)18-11-17(10-15)12-19(36-5)24(18)29/h7-9,11-12,16,20-22,25,32,35H,10,13-14H2,1-6H3,(H,30,34)/b9-7+,15-8+/t16-,20+,21+,22-,25+,27+,28+/m1/s1	QWPXBEHQFHACTK-RZKXNLMUSA-N					removed another duplicate entry; compound annotation
0391_012876	azidonorleucine	C6H12N4O2	0.499	16666241	C(CCN=[N+]=[N-])C[C@@H](C(=O)O)N	[N-]=[N+]=NCCCCC(N)C(=O)O	InChI=1S/C6H12N4O2/c7-5(6(11)12)3-1-2-4-9-10-8/h5H,1-4,7H2,(H,11,12)/t5-/m0/s1	HTFFMYRVHHNNBE-YFKPBYRVSA-N					compound annotation
0391_012877	(+)-Dinotefuran	C7H15N4O3+	0.97	100958102		CN=C(NCC1CCOC1)N[N+](=O)O	InChI=1S/C7H15N4O3/c1-8-7(10-11(12)13)9-4-6-2-3-14-5-6/h6H,2-5H2,1H3,(H,12,13)(H2,8,9,10)/q+1	FYODOLZGKIRVSJ-UHFFFAOYSA-N					compound annotation
0391_012878	Nolatrexed dihydrochloride	C14H12N4OS	1.0155	135400184		Cc1c(Sc2ccncc2)c2c(cc1)[nH]c(N)nc2=O	InChI=1S/C14H12N4OS/c1-8-2-3-10-11(13(19)18-14(15)17-10)12(8)20-9-4-6-16-7-5-9/h2-7H,1H3,(H3,15,17,18,19)	XHWRWCSCBDLOLM-UHFFFAOYSA-N					compound annotation
0391_012879	261365-11-1	C11H15N2O4PS	1.5073	11289630		CC(C)Cc1c(-c2ccc(P(=O)(O)O)o2)nc(N)s1	InChI=1S/C11H15N2O4PS/c1-6(2)5-8-10(13-11(12)19-8)7-3-4-9(17-7)18(14,15)16/h3-4,6H,5H2,1-2H3,(H2,12,13)(H2,14,15,16)	XJMYIJPPDSZOPN-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012881	STAT5 Inhibitor	C16H11N3O3	2.0673	9566174	C1=CC=C2C(=C1)C(=O)C(=CO2)/C=N/NC(=O)C3=CN=CC=C3	O=C(NN=Cc1coc2ccccc2c1=O)c1cnccc1	InChI=1S/C16H11N3O3/c20-15-12(10-22-14-6-2-1-5-13(14)15)9-18-19-16(21)11-4-3-7-17-8-11/h1-10H,(H,19,21)/b18-9+	DAVIKTBRCQWOGT-GIJQJNRQSA-N					doublet; removed another duplicate entry; compound annotation
0391_012883	STAT5 Inhibitor	C16H11N3O3	2.3088	9566174	C1=CC=C2C(=C1)C(=O)C(=CO2)/C=N/NC(=O)C3=CN=CC=C3	O=C(NN=Cc1coc2ccccc2c1=O)c1cnccc1	InChI=1S/C16H11N3O3/c20-15-12(10-22-14-6-2-1-5-13(14)15)9-18-19-16(21)11-4-3-7-17-8-11/h1-10H,(H,19,21)/b18-9+	DAVIKTBRCQWOGT-GIJQJNRQSA-N					doublet; removed another duplicate entry; compound annotation
0391_012885	Amfenac	C15H13NO3	3.3843	2136		Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1	InChI=1S/C15H13NO3/c16-14-11(9-13(17)18)7-4-8-12(14)15(19)10-5-2-1-3-6-10/h1-8H,9,16H2,(H,17,18)	SOYCMDCMZDHQFP-UHFFFAOYSA-N					compound annotation
0391_012886	1426138-42-2	C14H9ClN2O4S2	3.8186	135886621		O=C(O)CCn1c(O)c(C2=c3cc(Cl)ccc3=NC2=O)sc1=S	InChI=1S/C14H9ClN2O4S2/c15-6-1-2-8-7(5-6)10(12(20)16-8)11-13(21)17(14(22)23-11)4-3-9(18)19/h1-2,5,21H,3-4H2,(H,18,19)	JYBGCTWNOMSQJY-UHFFFAOYSA-N					compound annotation
0391_012887	NB-598	C27H31NOS2	4.5065	6443223	CCN(C/C=C/C#CC(C)(C)C)CC1=CC(=CC=C1)OCC2=CC(=CS2)C3=CSC=C3	CCN(CC=CC#CC(C)(C)C)Cc1cc(OCc2cc(-c3cscc3)cs2)ccc1	InChI=1S/C27H31NOS2/c1-5-28(14-8-6-7-13-27(2,3)4)18-22-10-9-11-25(16-22)29-19-26-17-24(21-31-26)23-12-15-30-20-23/h6,8-12,15-17,20-21H,5,14,18-19H2,1-4H3/b8-6+	KIRGLCXNEVICOG-SOFGYWHQSA-N					compound annotation
0391_012888	LUSUTROMBOPAG	C29H32Cl2N2O5S	6.5164	49843517	CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl	CCCCCCOC(C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(C=C(C)C(=O)O)c(Cl)c3)n2)c1OC	InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1	NOZIJMHMKORZBA-KJCUYJGMSA-N					removed another duplicate entry; compound annotation
0391_012890	WST-8 Sodium	C20H15N6O11S2+	2.0396	9894948		COc1c(-[n+]2nc(-c3c(S(=O)(=O)O)cc(S(=O)(=O)O)cc3)nn2-c2ccc([N+](=O)[O-])cc2)ccc([N+](=O)[O-])c1	InChI=1S/C20H14N6O11S2/c1-37-18-10-14(26(29)30)6-9-17(18)24-22-20(21-23(24)12-2-4-13(5-3-12)25(27)28)16-8-7-15(38(31,32)33)11-19(16)39(34,35)36/h2-11H,1H3,(H-,31,32,33,34,35,36)/p+1	HXTJSSXEGZMAEH-UHFFFAOYSA-O					compound annotation
0391_012891	carbetapentane	C20H31NO3	3.1909	2562		CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1	InChI=1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3	CFJMRBQWBDQYMK-UHFFFAOYSA-N					compound annotation
0391_012892	150725-87-4	C23H27N3O6S	4.3204	122044		COc1cc(Oc2c(OCCO)ncnc2NS(=O)(=O)c2ccc(C(C)(C)C)cc2)ccc1	InChI=1S/C23H27N3O6S/c1-23(2,3)16-8-10-19(11-9-16)33(28,29)26-21-20(22(25-15-24-21)31-13-12-27)32-18-7-5-6-17(14-18)30-4/h5-11,14-15,27H,12-13H2,1-4H3,(H,24,25,26)	ZNXOKLWCOWOECF-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012894	GSK864	C30H31FN6O4	4.4169	91864701	CC1=CC(=CC(=C1OC)C)NC(=O)C2=NN(C3=C2CN(C[C@]3(C)C(=O)N)C(=O)C4=CC=CN4)CC5=CC=C(C=C5)F	COc1c(C)cc(NC(=O)c2nn(Cc3ccc(F)cc3)c3c2CN(C(=O)c2ccc[nH]2)CC3(C)C(N)=O)cc1C	InChI=1S/C30H31FN6O4/c1-17-12-21(13-18(2)25(17)41-4)34-27(38)24-22-15-36(28(39)23-6-5-11-33-23)16-30(3,29(32)40)26(22)37(35-24)14-19-7-9-20(31)10-8-19/h5-13,33H,14-16H2,1-4H3,(H2,32,40)(H,34,38)/t30-/m0/s1	DUCNNEYLFOQFSW-PMERELPUSA-N					doublet; removed another duplicate entry; compound annotation
0391_012896	GSK864	C30H31FN6O4	4.4197	91864701	CC1=CC(=CC(=C1OC)C)NC(=O)C2=NN(C3=C2CN(C[C@]3(C)C(=O)N)C(=O)C4=CC=CN4)CC5=CC=C(C=C5)F	COc1c(C)cc(NC(=O)c2nn(Cc3ccc(F)cc3)c3c2CN(C(=O)c2ccc[nH]2)CC3(C)C(N)=O)cc1C	InChI=1S/C30H31FN6O4/c1-17-12-21(13-18(2)25(17)41-4)34-27(38)24-22-15-36(28(39)23-6-5-11-33-23)16-30(3,29(32)40)26(22)37(35-24)14-19-7-9-20(31)10-8-19/h5-13,33H,14-16H2,1-4H3,(H2,32,40)(H,34,38)/t30-/m0/s1	DUCNNEYLFOQFSW-PMERELPUSA-N					doublet; compound annotation
0391_012897	Ciclesonide	C32H44O7	5.9269	6918155	CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6	CC(C)C(=O)OCC(=O)C12OC(C3CCCCC3)OC1CC1C3CCC4=CC(=O)C=CC4(C)C3C(O)CC12C	InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1	LUKZNWIVRBCLON-GXOBDPJESA-N					removed another duplicate entry; compound annotation
0391_012899	cinchonine	C19H22N2O	1.2851	90454	C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=CC=NC4=CC=CC=C34)O	C=CC1CN2CCC1CC2C(O)c1ccnc2ccccc12	InChI=1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2/t13-,14-,18+,19-/m0/s1	KMPWYEUPVWOPIM-QAMTZSDWSA-N					compound annotation
0391_012900	tubocurarine	C37H41N2O6+	1.6294	6000	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC	COc1c2cc3c(c1)CCN(C)C3Cc1ccc(cc1)Oc1c3c(cc(OC)c1O)CC[N+](C)(C)C3Cc1cc(c(O)cc1)O2	InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1	JFJZZMVDLULRGK-URLMMPGGSA-O					compound annotation
0391_012901	Coumarin-3-carboxylic acid	C10H6O4	1.9591	10752		O=C(O)c1cc2ccccc2oc1=O	InChI=1S/C10H6O4/c11-9(12)7-5-6-3-1-2-4-8(6)14-10(7)13/h1-5H,(H,11,12)	ACMLKANOGIVEPB-UHFFFAOYSA-N					compound annotation
0391_012902	CINNAMAMIDE	C9H9NO	2.0246	5273472	C1=CC=C(C=C1)/C=C/C(=O)N	NC(=O)C=Cc1ccccc1	InChI=1S/C9H9NO/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H2,10,11)/b7-6+	APEJMQOBVMLION-VOTSOKGWSA-N					compound annotation
0391_012903	1-(3,4-dichlorophenyl)-3-(dimethylamino)propan-1-one	C11H13Cl2NO	2.2118	432139		CN(C)CCC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C11H13Cl2NO/c1-14(2)6-5-11(15)8-3-4-9(12)10(13)7-8/h3-4,7H,5-6H2,1-2H3	LZXMNZWXKWSYMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012904	1-(3,4-dichlorophenyl)-3-(dimethylamino)propan-1-one	C11H13Cl2NO	3.5013	432139		CN(C)CCC(=O)c1cc(Cl)c(Cl)cc1	InChI=1S/C11H13Cl2NO/c1-14(2)6-5-11(15)8-3-4-9(12)10(13)7-8/h3-4,7H,5-6H2,1-2H3	LZXMNZWXKWSYMY-UHFFFAOYSA-N					doublet; compound annotation
0391_012905	Benzamide	C7H7NO	1.1786	2331		NC(=O)c1ccccc1	InChI=1S/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9)	KXDAEFPNCMNJSK-UHFFFAOYSA-N					compound annotation
0391_012906	Phenylacetylglutamine	C13H16N2O4	1.362	92258	C1=CC=C(C=C1)CC(=O)N[C@@H](CCC(=O)N)C(=O)O	NC(=O)CCC(NC(=O)Cc1ccccc1)C(=O)O	InChI=1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1	JFLIEFSWGNOPJJ-JTQLQIEISA-N					compound annotation
0391_012907	PHENOTHIAZINE	C12H9NS	2.3505	7108		c1ccc2Sc3ccccc3Nc2c1	InChI=1S/C12H9NS/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-8,13H	WJFKNYWRSNBZNX-UHFFFAOYSA-N					doublet; compound annotation
0391_012908	145888-79-5	C19H13Cl4NO	3.9424	5388806	C\1NC/C(=C\C2=CC(=C(C=C2)Cl)Cl)/C(=O)/C1=C/C3=CC(=C(C=C3)Cl)Cl	O=C1C(=Cc2cc(Cl)c(Cl)cc2)CNCC1=Cc1cc(Cl)c(Cl)cc1	InChI=1S/C19H13Cl4NO/c20-15-3-1-11(7-17(15)22)5-13-9-24-10-14(19(13)25)6-12-2-4-16(21)18(23)8-12/h1-8,24H,9-10H2/b13-5+,14-6+	GJPXGFGIFQWUOC-ACFHMISVSA-N					compound annotation
0391_012909	N-phenylanthranilic acid	C13H11NO2	4.1124	4386		O=C(O)c1ccccc1Nc1ccccc1	InChI=1S/C13H11NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9,14H,(H,15,16)	ZWJINEZUASEZBH-UHFFFAOYSA-N					compound annotation
0391_012910	PHENOTHIAZINE	C12H9NS	4.5233	7108		c1ccc2Sc3ccccc3Nc2c1	InChI=1S/C12H9NS/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-8,13H	WJFKNYWRSNBZNX-UHFFFAOYSA-N					doublet; compound annotation
0391_012911	Aegelin	C18H19NO3	3.1695	15558419	COC1=CC=C(C=C1)C(CNC(=O)/C=C/C2=CC=CC=C2)O	COc1ccc(C(O)CNC(=O)C=Cc2ccccc2)cc1	InChI=1S/C18H19NO3/c1-22-16-10-8-15(9-11-16)17(20)13-19-18(21)12-7-14-5-3-2-4-6-14/h2-12,17,20H,13H2,1H3,(H,19,21)/b12-7+	QRFDENJATPJOKG-KPKJPENVSA-N					compound annotation
0391_012912	1,3,5-Trimethoxybenzene	C9H12O3	3.3908	69301		COc1cc(OC)cc(OC)c1	InChI=1S/C9H12O3/c1-10-7-4-8(11-2)6-9(5-7)12-3/h4-6H,1-3H3	LKUDPHPHKOZXCD-UHFFFAOYSA-N					compound annotation
0391_012913	BENZIMIDAZOLE	C7H6N2	0.4983	5798		c1ccc2[nH]cnc2c1	InChI=1S/C7H6N2/c1-2-4-7-6(3-1)8-5-9-7/h1-5H,(H,8,9)	HYZJCKYKOHLVJF-UHFFFAOYSA-N					compound annotation
0391_012914	15356-74-8	C11H16O2	3.2902	27209		CC1(C)CCCC2(C)OC(=O)C=C12	InChI=1S/C11H16O2/c1-10(2)5-4-6-11(3)8(10)7-9(12)13-11/h7H,4-6H2,1-3H3	IMKHDCBNRDRUEB-UHFFFAOYSA-N					compound annotation
0391_012915	Bromfenac	C15H12BrNO3	4.0641	60726		Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1	InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N					doublet; compound annotation
0391_012916	8-Azaadenosine	C9H12N6O4	0.4946	96410	C1=NC(=C2C(=N1)N(N=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N	Nc1c2nnn(C3OC(CO)C(O)C3O)c2ncn1	InChI=1S/C9H12N6O4/c10-7-4-8(12-2-11-7)15(14-13-4)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H2,10,11,12)/t3-,5-,6-,9-/m1/s1	OAUKGFJQZRGECT-UUOKFMHZSA-N					compound annotation
0391_012917	188343-77-3	C21H22FN3	1.2201	500899		CN1CCC(c2cc(-c3ccncc3)c(-c3ccc(F)cc3)[nH]2)CC1	InChI=1S/C21H22FN3/c1-25-12-8-16(9-13-25)20-14-19(15-6-10-23-11-7-15)21(24-20)17-2-4-18(22)5-3-17/h2-7,10-11,14,16,24H,8-9,12-13H2,1H3	RBWNFHXBUDPAIO-UHFFFAOYSA-N					compound annotation
0391_012918	CHEMBL4747591	C18H21F2N7O	1.8382	135087198	CN1C=C(C=N1)NC2=NC=CC(=N2)N3CC4CCC(C3)N4C(=O)[C@@H]5CC5(F)F	Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)C3CC3(F)F)n2)cn1	InChI=1S/C18H21F2N7O/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24)/t12?,13?,14-/m0/s1	BUWBRTXGQRBBHG-RUXDESIVSA-N					doublet; removed another duplicate entry; compound annotation
0391_012920	CHEMBL4747591	C18H21F2N7O	1.8414	135087198	CN1C=C(C=N1)NC2=NC=CC(=N2)N3CC4CCC(C3)N4C(=O)[C@@H]5CC5(F)F	Cn1cc(Nc2nccc(N3CC4CCC(C3)N4C(=O)C3CC3(F)F)n2)cn1	InChI=1S/C18H21F2N7O/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24)/t12?,13?,14-/m0/s1	BUWBRTXGQRBBHG-RUXDESIVSA-N					doublet; compound annotation
0391_012921	Takinib	C18H18N4O2	3.3587	37750349		CCCn1c(NC(=O)c2cccc(C(N)=O)c2)nc2ccccc21	InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24)	UOZVVPXKJGOFIG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012923	Glutaminase-IN-1	C26H24F3N7O3Se	3.5005	137319720		O=C(Cc1cc(OC(F)(F)F)ccc1)Nc1nnc(CCCCc2nnc(NC(=O)Cc3ccccn3)[se]2)cc1	InChI=1S/C26H24F3N7O3Se/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38)	KWZUDGWKTNIKJY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012925	AM-2099	C19H13F3N4O3S2	3.7061	86687532		COc1c(-c2ncnc3c2ccc(S(=O)(=O)Nc2nccs2)c3)ccc(C(F)(F)F)c1	InChI=1S/C19H13F3N4O3S2/c1-29-16-8-11(19(20,21)22)2-4-14(16)17-13-5-3-12(9-15(13)24-10-25-17)31(27,28)26-18-23-6-7-30-18/h2-10H,1H3,(H,23,26)	VSUDRCZPHWUXEW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012927	Metaflumizone	C24H16F6N4O2	5.3646	9827529	C1=CC(=CC(=C1)C(F)(F)F)/C(=N\NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)/CC3=CC=C(C=C3)C#N	N#Cc1ccc(CC(=NNC(=O)Nc2ccc(OC(F)(F)F)cc2)c2cc(C(F)(F)F)ccc2)cc1	InChI=1S/C24H16F6N4O2/c25-23(26,27)18-3-1-2-17(13-18)21(12-15-4-6-16(14-31)7-5-15)33-34-22(35)32-19-8-10-20(11-9-19)36-24(28,29)30/h1-11,13H,12H2,(H2,32,34,35)/b33-21-	MIFOMMKAVSCNKQ-HWIUFGAZSA-N					doublet; compound annotation
0391_012928	Metaflumizone	C24H16F6N4O2	5.5126	9827529	C1=CC(=CC(=C1)C(F)(F)F)/C(=N\NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)/CC3=CC=C(C=C3)C#N	N#Cc1ccc(CC(=NNC(=O)Nc2ccc(OC(F)(F)F)cc2)c2cc(C(F)(F)F)ccc2)cc1	InChI=1S/C24H16F6N4O2/c25-23(26,27)18-3-1-2-17(13-18)21(12-15-4-6-16(14-31)7-5-15)33-34-22(35)32-19-8-10-20(11-9-19)36-24(28,29)30/h1-11,13H,12H2,(H2,32,34,35)/b33-21-	MIFOMMKAVSCNKQ-HWIUFGAZSA-N					doublet; compound annotation
0391_012929	Ogerin	C17H17N5O	2.6371	56707820		Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1	InChI=1S/C17H17N5O/c18-16-20-15(14-9-5-4-8-13(14)11-23)21-17(22-16)19-10-12-6-2-1-3-7-12/h1-9,23H,10-11H2,(H3,18,19,20,21,22)	MDGIEDNDSFMSLP-UHFFFAOYSA-N					doublet; compound annotation
0391_012930	Ogerin	C17H17N5O	2.64	56707820		Nc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1	InChI=1S/C17H17N5O/c18-16-20-15(14-9-5-4-8-13(14)11-23)21-17(22-16)19-10-12-6-2-1-3-7-12/h1-9,23H,10-11H2,(H3,18,19,20,21,22)	MDGIEDNDSFMSLP-UHFFFAOYSA-N					doublet; compound annotation
0391_012931	RTI-13951-33	C28H33N3O3	2.6547	134813902	C[C@H]([C@@H](CN(C1=CC=C(C=C1)C2=CC=C(C=C2)COC)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4)N)OC	COCc1ccc(-c2ccc(N(CC(N)C(C)OC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C28H33N3O3/c1-19(34-3)26(29)17-31(28(32)25-16-24(25)27-6-4-5-15-30-27)23-13-11-22(12-14-23)21-9-7-20(8-10-21)18-33-2/h4-15,19,24-26H,16-18,29H2,1-3H3/t19-,24-,25-,26-/m1/s1	XCHHIKJEGXHKLQ-UJTWYAIMSA-N					doublet; removed another duplicate entry; compound annotation
0391_012933	RTI-13951-33	C28H33N3O3	2.7384	134813902	C[C@H]([C@@H](CN(C1=CC=C(C=C1)C2=CC=C(C=C2)COC)C(=O)[C@@H]3C[C@H]3C4=CC=CC=N4)N)OC	COCc1ccc(-c2ccc(N(CC(N)C(C)OC)C(=O)C3CC3c3ccccn3)cc2)cc1	InChI=1S/C28H33N3O3/c1-19(34-3)26(29)17-31(28(32)25-16-24(25)27-6-4-5-15-30-27)23-13-11-22(12-14-23)21-9-7-20(8-10-21)18-33-2/h4-15,19,24-26H,16-18,29H2,1-3H3/t19-,24-,25-,26-/m1/s1	XCHHIKJEGXHKLQ-UJTWYAIMSA-N					doublet; removed another duplicate entry; compound annotation
0391_012935	Sildenafil citrate	C22H30N6O4S	2.7417	135398744		CCCc1nn(C)c2c1[nH]c(-c1c(OCC)ccc(S(=O)(=O)N3CCN(C)CC3)c1)nc2=O	InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)	BNRNXUUZRGQAQC-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_012937	Vicriviroc	C28H38F3N5O2	2.9225	3009355	C[C@H]1CN(CCN1[C@@H](COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C	COCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1C	InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1	CNPVJJQCETWNEU-CYFREDJKSA-N					doublet; compound annotation
0391_012938	Vicriviroc	C28H38F3N5O2	2.9733	3009355	C[C@H]1CN(CCN1[C@@H](COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C	COCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1C	InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1	CNPVJJQCETWNEU-CYFREDJKSA-N					doublet; removed another duplicate entry; compound annotation
0391_012940	Emricasan	C26H27F4N3O7	4.5641	12000240	C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C	CC(NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)NC(CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F	InChI=1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1	SCVHJVCATBPIHN-SJCJKPOMSA-N					removed another duplicate entry; compound annotation
0391_012942	BP-1-102	C29H27F5N2O6S	5.9739	53388144		CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1cc(O)c(C(=O)O)cc1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F	InChI=1S/C29H27F5N2O6S/c1-35(43(41,42)28-26(33)24(31)23(30)25(32)27(28)34)15-22(38)36(19-11-12-20(29(39)40)21(37)13-19)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h7-13,17,37H,2-6,14-15H2,1H3,(H,39,40)	WNVSFFVDMUSXSX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012944	PF 1022A	C52H76N4O12	6.4149	159590	C[C@@H]1C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O1)CC(C)C)C)CC2=CC=CC=C2)CC(C)C)C)C)CC(C)C)C)CC3=CC=CC=C3)CC(C)C)C	CC(C)CC1C(=O)OC(Cc2ccccc2)C(=O)N(C)C(CC(C)C)C(=O)OC(C)C(=O)N(C)C(CC(C)C)C(=O)OC(Cc2ccccc2)C(=O)N(C)C(CC(C)C)C(=O)OC(C)C(=O)N1C	InChI=1S/C52H76N4O12/c1-31(2)25-39-49(61)65-35(9)45(57)53(11)42(28-34(7)8)52(64)68-44(30-38-23-19-16-20-24-38)48(60)56(14)40(26-32(3)4)50(62)66-36(10)46(58)54(12)41(27-33(5)6)51(63)67-43(47(59)55(39)13)29-37-21-17-15-18-22-37/h15-24,31-36,39-44H,25-30H2,1-14H3/t35-,36-,39+,40+,41+,42+,43-,44-/m1/s1	YJNUXGPXJFAUQJ-LYWANRAQSA-N					removed another duplicate entry; compound annotation
0391_012946	brimonidine	C11H10BrN5	0.759	2435		Brc1c(NC2=NCCN2)ccc2nccnc12	InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)	XYLJNLCSTIOKRM-UHFFFAOYSA-N					doublet; compound annotation
0391_012947	Cl-amidine	C14H19ClN4O2	1.0848	24970878	C1=CC=C(C=C1)C(=O)N[C@@H](CCCN=C(CCl)N)C(=O)N	NC(=O)C(CCCN=C(N)CCl)NC(=O)c1ccccc1	InChI=1S/C14H19ClN4O2/c15-9-12(16)18-8-4-7-11(13(17)20)19-14(21)10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H2,16,18)(H2,17,20)(H,19,21)/t11-/m0/s1	BPWATVWOHQZVRP-NSHDSACASA-N					removed another duplicate entry; compound annotation
0391_012949	Histone Acetyltransferase Inhibitor II	C20H16Br2O3	4.4619	16203606	C1C/C(=C\C2=CC(=C(C=C2)O)Br)/C(=O)/C(=C/C3=CC(=C(C=C3)O)Br)/C1	O=C1C(=Cc2cc(Br)c(O)cc2)CCCC1=Cc1cc(Br)c(O)cc1	InChI=1S/C20H16Br2O3/c21-16-10-12(4-6-18(16)23)8-14-2-1-3-15(20(14)25)9-13-5-7-19(24)17(22)11-13/h4-11,23-24H,1-3H2/b14-8+,15-9+	YOLKEKNTCBWPSD-VOMDNODZSA-N					compound annotation
0391_012950	FENTICONAZOLE	C24H20Cl2N2OS	4.4697	51755		Clc1cc(Cl)c(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)cc1	InChI=1S/C24H20Cl2N2OS/c25-19-8-11-22(23(26)14-19)24(15-28-13-12-27-17-28)29-16-18-6-9-21(10-7-18)30-20-4-2-1-3-5-20/h1-14,17,24H,15-16H2	ZCJYUTQZBAIHBS-UHFFFAOYSA-N					compound annotation
0391_012951	4376-20-9	C16H22O4	4.8224	20393		CCCCC(CC)COC(=O)c1ccccc1C(=O)O	InChI=1S/C16H22O4/c1-3-5-8-12(4-2)11-20-16(19)14-10-7-6-9-13(14)15(17)18/h6-7,9-10,12H,3-5,8,11H2,1-2H3,(H,17,18)	DJDSLBVSSOQSLW-UHFFFAOYSA-N					compound annotation
0391_012952	paraxanthine	C7H8N4O2	0.9122	4687		Cn1c(=O)[nH]c2c(c1=O)n(C)cn2	InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)11(2)7(13)9-5/h3H,1-2H3,(H,9,13)	QUNWUDVFRNGTCO-UHFFFAOYSA-N					compound annotation
0391_012953	4-Methoxybenzaldehyde	C8H8O2	2.4431	31244		COc1ccc(C=O)cc1	InChI=1S/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H3	ZRSNZINYAWTAHE-UHFFFAOYSA-N					compound annotation
0391_012954	1,10-phenanthroline	C12H8N2	1.0609	1318		c1cc2c(nc1)c1c(cccn1)cc2	InChI=1S/C12H8N2/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1/h1-8H	DGEZNRSVGBDHLK-UHFFFAOYSA-N					doublet; compound annotation
0391_012955	2-PHENYLACETAMIDE	C8H9NO	1.4049	7680		NC(=O)Cc1ccccc1	InChI=1S/C8H9NO/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,9,10)	LSBDFXRDZJMBSC-UHFFFAOYSA-N					compound annotation
0391_012956	N4-Acetylcytidine	C11H15N3O6	0.5393	107461	CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	CC(=O)Nc1nc(=O)n(C2OC(CO)C(O)C2O)cc1	InChI=1S/C11H15N3O6/c1-5(16)12-7-2-3-14(11(19)13-7)10-9(18)8(17)6(4-15)20-10/h2-3,6,8-10,15,17-18H,4H2,1H3,(H,12,13,16,19)/t6-,8-,9-,10-/m1/s1	NIDVTARKFBZMOT-PEBGCTIMSA-N					removed another duplicate entry; compound annotation
0391_012958	2-Acetyl-3-ethylpyrazine	C8H10N2O	2.2756	61918		CCc1nccnc1C(C)=O	InChI=1S/C8H10N2O/c1-3-7-8(6(2)11)10-5-4-9-7/h4-5H,3H2,1-2H3	PPJSYGVFDJEMRP-UHFFFAOYSA-N					compound annotation
0391_012959	Pipequaline	C22H24N2	2.0833	71219		c1ccc(-c2nc3ccccc3c(CCC3CCNCC3)c2)cc1	InChI=1S/C22H24N2/c1-2-6-18(7-3-1)22-16-19(11-10-17-12-14-23-15-13-17)20-8-4-5-9-21(20)24-22/h1-9,16-17,23H,10-15H2	AMEWZCMTSIONOX-UHFFFAOYSA-N					compound annotation
0391_012960	KW-2449	C20H20N4O	2.2262	11427553	C1CN(CCN1)C(=O)C2=CC=C(C=C2)/C=C/C3=NNC4=CC=CC=C43	O=C(c1ccc(C=Cc2n[nH]c3ccccc23)cc1)N1CCNCC1	InChI=1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+	YYLKKYCXAOBSRM-JXMROGBWSA-N					removed another duplicate entry; compound annotation
0391_012962	Collagen proline hydroxylase inhibitor	C18H18N4O4	2.81	9928521		CCCN(CC)C(=O)c1cnc2c(c1)ccc1c2[nH]cc([N+](=O)[O-])c1=O	InChI=1S/C18H18N4O4/c1-3-7-21(4-2)18(24)12-8-11-5-6-13-16(15(11)19-9-12)20-10-14(17(13)23)22(25)26/h5-6,8-10H,3-4,7H2,1-2H3,(H,20,23)	XUARBCHSPWMKRC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012964	PROTAC BET-binding moiety 2	C20H17ClN4O4S	3.2958	67446188	CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C(=O)O	COC(=O)CC1N=C(c2ccc(Cl)cc2)c2c(sc(C(=O)O)c2C)-n2c(C)nnc12	InChI=1S/C20H17ClN4O4S/c1-9-15-16(11-4-6-12(21)7-5-11)22-13(8-14(26)29-3)18-24-23-10(2)25(18)19(15)30-17(9)20(27)28/h4-7,13H,8H2,1-3H3,(H,27,28)/t13-/m0/s1	LZXZWZXAVDJSIL-ZDUSSCGKSA-N					removed another duplicate entry; compound annotation
0391_012966	Ketohexokinase inhibitor 1	C16H19F3N4O2	4.1862	129278694	C[C@H]1CCN1C2=NC(=CC(=N2)N3C[C@@H]4[C@H](C3)C4CC(=O)O)C(F)(F)F	CC1CCN1c1nc(C(F)(F)F)cc(N2CC3C(CC(=O)O)C3C2)n1	InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9?,10-,11+/m0/s1	MDUYWDNWFXSMJJ-OFLUOSHYSA-N					doublet; compound annotation
0391_012967	Ketohexokinase inhibitor 1	C16H19F3N4O2	5.5938	129278694	C[C@H]1CCN1C2=NC(=CC(=N2)N3C[C@@H]4[C@H](C3)C4CC(=O)O)C(F)(F)F	CC1CCN1c1nc(C(F)(F)F)cc(N2CC3C(CC(=O)O)C3C2)n1	InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9?,10-,11+/m0/s1	MDUYWDNWFXSMJJ-OFLUOSHYSA-N					doublet; compound annotation
0391_012968	101328-85-2	C11H13N3O	1.0708	10465484	C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)N	CC1CC(=O)NN=C1c1ccc(N)cc1	InChI=1S/C11H13N3O/c1-7-6-10(15)13-14-11(7)8-2-4-9(12)5-3-8/h2-5,7H,6,12H2,1H3,(H,13,15)/t7-/m1/s1	GDMRFHZLKNYRRO-SSDOTTSWSA-N					removed another duplicate entry; compound annotation
0391_012971	4-isopropylbenzaldehyde	C10H12O	4.1497	326		CC(C)c1ccc(C=O)cc1	InChI=1S/C10H12O/c1-8(2)10-5-3-9(7-11)4-6-10/h3-8H,1-2H3	WTWBUQJHJGUZCY-UHFFFAOYSA-N					compound annotation
0391_012972	Spinacine	C7H9N3O2	4.2873	6990948	C1[C@H]([NH2+]CC2=C1N=CN2)C(=O)[O-]	O=C(O)C1Cc2c(CN1)[nH]cn2	InChI=1S/C7H9N3O2/c11-7(12)5-1-4-6(2-8-5)10-3-9-4/h3,5,8H,1-2H2,(H,9,10)(H,11,12)/t5-/m0/s1	YCFJXOFFQLPCHD-YFKPBYRVSA-N					compound annotation
0391_012973	149289-29-2	C14H21NO2	1.576	9859500		NCC(c1ccc(O)cc1)C1(O)CCCCC1	InChI=1S/C14H21NO2/c15-10-13(11-4-6-12(16)7-5-11)14(17)8-2-1-3-9-14/h4-7,13,16-17H,1-3,8-10,15H2	BHCUWXACHAFFSK-UHFFFAOYSA-N					compound annotation
0391_012974	Bifendate	C20H18O10	3.8028	108213		COC(=O)c1cc(OC)c2OCOc2c1-c1c2OCOc2c(OC)cc1C(=O)OC	InChI=1S/C20H18O10/c1-23-11-5-9(19(21)25-3)13(17-15(11)27-7-29-17)14-10(20(22)26-4)6-12(24-2)16-18(14)30-8-28-16/h5-6H,7-8H2,1-4H3	JMZOMFYRADAWOG-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012976	4651-67-6	C24H38O4	4.1156	444262	C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CC[C@H](C4)O)C)C	CC(CCC(=O)O)C1CCC2C3C(=O)CC4CC(O)CCC4(C)C3CCC12C	InChI=1S/C24H38O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-19,22,25H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,22+,23+,24-/m1/s1	DXOCDBGWDZAYRQ-AURDAFMXSA-N					compound annotation
0391_012977	dibutyl phthalate	C16H22O4	5.3824	3026		CCCCOC(=O)c1ccccc1C(=O)OCCCC	InChI=1S/C16H22O4/c1-3-5-11-19-15(17)13-9-7-8-10-14(13)16(18)20-12-6-4-2/h7-10H,3-6,11-12H2,1-2H3	DOIRQSBPFJWKBE-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012979	4-hydroxy-1H-indole-3-carbaldehyde	C9H7NO2	2.1581	9815282		O=Cc1c[nH]c2c1c(O)ccc2	InChI=1S/C9H7NO2/c11-5-6-4-10-7-2-1-3-8(12)9(6)7/h1-5,10,12H	QLBZIZLLMNWTHG-UHFFFAOYSA-N					compound annotation
0391_012980	Cyanidin 3-O-galactoside	C21H21O11+	0.8855	441699	C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O)O)O	OCC1OC(Oc2cc3c(O)cc(O)cc3[o+]c2-c2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C21H20O11/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26)/p+1/t16-,17+,18+,19-,21-/m1/s1	RKWHWFONKJEUEF-WVXKDWSHSA-O					doublet; compound annotation
0391_012981	Cyanidin 3-O-galactoside	C21H21O11+	1.1661	441699	C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O)O)O	OCC1OC(Oc2cc3c(O)cc(O)cc3[o+]c2-c2cc(O)c(O)cc2)C(O)C(O)C1O	InChI=1S/C21H20O11/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26)/p+1/t16-,17+,18+,19-,21-/m1/s1	RKWHWFONKJEUEF-WVXKDWSHSA-O					doublet; compound annotation
0391_012982	SIBA	C14H21N5O3S	2.1162	123674	CC(C)CSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O	CC(C)CSCC1OC(n2cnc3c(N)ncnc32)C(O)C1O	InChI=1S/C14H21N5O3S/c1-7(2)3-23-4-8-10(20)11(21)14(22-8)19-6-18-9-12(15)16-5-17-13(9)19/h5-8,10-11,14,20-21H,3-4H2,1-2H3,(H2,15,16,17)/t8-,10-,11-,14-/m1/s1	JDDUQGRUPLKDNT-IDTAVKCVSA-N					compound annotation
0391_012983	VARLITINIB	C22H19ClN6O2S	2.147	42642648	C[C@@H]1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl	CC1COC(Nc2cc3c(cc2)ncnc3Nc2cc(Cl)c(OCc3nccs3)cc2)=N1	InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1	UWXSAYUXVSFDBQ-CYBMUJFWSA-N					removed another duplicate entry; compound annotation
0391_012985	Vonoprazan	C17H16FN3O2S	2.2976	15981397		CNCc1cn(S(=O)(=O)c2cnccc2)c(-c2ccccc2F)c1	InChI=1S/C17H16FN3O2S/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14/h2-9,11-12,19H,10H2,1H3	BFDBKMOZYNOTPK-UHFFFAOYSA-N					doublet; compound annotation
0391_012986	CEP dipeptide 1	C18H27N3O6	2.3268	92044401	CC(=O)NCC(=O)N[C@@H](CCCCN1C=CC=C1CCC(=O)O)C(=O)OC	COC(=O)C(CCCCn1cccc1CCC(=O)O)NC(=O)CNC(C)=O	InChI=1S/C18H27N3O6/c1-13(22)19-12-16(23)20-15(18(26)27-2)7-3-4-10-21-11-5-6-14(21)8-9-17(24)25/h5-6,11,15H,3-4,7-10,12H2,1-2H3,(H,19,22)(H,20,23)(H,24,25)/t15-/m0/s1	VBZGZUAKQLIUCN-HNNXBMFYSA-N					compound annotation
0391_012987	SKF-96365 free base	C22H26N2O3	3.3956	104956		COc1ccc(CCCOC(Cn2ccnc2)c2ccc(OC)cc2)cc1	InChI=1S/C22H26N2O3/c1-25-20-9-5-18(6-10-20)4-3-15-27-22(16-24-14-13-23-17-24)19-7-11-21(26-2)12-8-19/h5-14,17,22H,3-4,15-16H2,1-2H3	HLMBXBGDBBCYII-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_012989	Escitalopram	C20H21FN2O	2.7648	146570	CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F	CN(C)CCCC1(c2ccc(F)cc2)OCc2c1ccc(C#N)c2	InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1	WSEQXVZVJXJVFP-FQEVSTJZSA-N					compound annotation
0391_012990	3-Chloro-L-tyrosine	C9H10ClNO3	0.5444	6951085	C1=CC(=C(C=C1C[C@@H](C(=O)[O-])[NH3+])Cl)O	NC(Cc1cc(Cl)c(O)cc1)C(=O)O	InChI=1S/C9H10ClNO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1	ACWBBAGYTKWBCD-ZETCQYMHSA-N					compound annotation
0391_012991	D-phenylalanine	C9H11NO2	0.5829	6919011	C1=CC=C(C=C1)C[C@H](C(=O)[O-])[NH3+]	NC(Cc1ccccc1)C(=O)O	InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m1/s1	COLNVLDHVKWLRT-MRVPVSSYSA-N					compound annotation
0391_012992	l-alanyl-l-leucine	C9H18N2O3	0.7605	96801	C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)N	CC(C)CC(NC(=O)C(C)N)C(=O)O	InChI=1S/C9H18N2O3/c1-5(2)4-7(9(13)14)11-8(12)6(3)10/h5-7H,4,10H2,1-3H3,(H,11,12)(H,13,14)/t6-,7-/m0/s1	RDIKFPRVLJLMER-BQBZGAKWSA-N					compound annotation
0391_012993	N-Acetyl-DL-methionine	C7H13NO3S	1.0728	6180		CSCCC(NC(C)=O)C(=O)O	InChI=1S/C7H13NO3S/c1-5(9)8-6(7(10)11)3-4-12-2/h6H,3-4H2,1-2H3,(H,8,9)(H,10,11)	XUYPXLNMDZIRQH-UHFFFAOYSA-N					compound annotation
0391_012994	Traxoprodil	C20H25NO3	1.6232	219101	C[C@@H]([C@H](C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O	CC(C(O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1	InChI=1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1	QEMSVZNTSXPFJA-HNAYVOBHSA-N					compound annotation
0391_012995	2',6'-Dihydroxyacetophenone	C8H8O3	2.0784	69687		CC(=O)c1c(O)cccc1O	InChI=1S/C8H8O3/c1-5(9)8-6(10)3-2-4-7(8)11/h2-4,10-11H,1H3	YPTJKHVBDCRKNF-UHFFFAOYSA-N					doublet; compound annotation
0391_012996	2',4'-DIHYDROXYACETOPHENONE	C8H8O3	2.0784	6990		CC(=O)c1c(O)cc(O)cc1	InChI=1S/C8H8O3/c1-5(9)7-3-2-6(10)4-8(7)11/h2-4,10-11H,1H3	SULYEHHGGXARJS-UHFFFAOYSA-N					doublet; compound annotation
0391_012997	3-Methyloxindole	C9H9NO	2.2182	150923		CC1C(=O)Nc2ccccc21	InChI=1S/C9H9NO/c1-6-7-4-2-3-5-8(7)10-9(6)11/h2-6H,1H3,(H,10,11)	BBZCPUCZKLTAJQ-UHFFFAOYSA-N					compound annotation
0391_012998	2',6'-Dihydroxyacetophenone	C8H8O3	2.4271	69687		CC(=O)c1c(O)cccc1O	InChI=1S/C8H8O3/c1-5(9)8-6(10)3-2-4-7(8)11/h2-4,10-11H,1H3	YPTJKHVBDCRKNF-UHFFFAOYSA-N					doublet; compound annotation
0391_012999	2',4'-DIHYDROXYACETOPHENONE	C8H8O3	2.4271	6990		CC(=O)c1c(O)cc(O)cc1	InChI=1S/C8H8O3/c1-5(9)7-3-2-6(10)4-8(7)11/h2-4,10-11H,1H3	SULYEHHGGXARJS-UHFFFAOYSA-N					doublet; compound annotation
0391_013000	4-(Diethylamino)benzaldehyde	C11H15NO	3.5624	67114		CCN(CC)c1ccc(C=O)cc1	InChI=1S/C11H15NO/c1-3-12(4-2)11-7-5-10(9-13)6-8-11/h5-9H,3-4H2,1-2H3	MNFZZNNFORDXSV-UHFFFAOYSA-N					compound annotation
0391_013001	cinnamyl alcohol	C9H10O	4.3205	5315892	C1=CC=C(C=C1)/C=C/CO	OCC=Cc1ccccc1	InChI=1S/C9H10O/c10-8-4-7-9-5-2-1-3-6-9/h1-7,10H,8H2/b7-4+	OOCCDEMITAIZTP-QPJJXVBHSA-N					compound annotation
0391_013002	benzocaine	C9H11NO2	2.5311	2337		CCOC(=O)c1ccc(N)cc1	InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3	BLFLLBZGZJTVJG-UHFFFAOYSA-N					compound annotation
0391_013003	2,4,6-TRIMETHYLBENZALDEHYDE	C10H12O	4.1463	10254		Cc1cc(C)c(C=O)c(C)c1	InChI=1S/C10H12O/c1-7-4-8(2)10(6-11)9(3)5-7/h4-6H,1-3H3	HIKRJHFHGKZKRI-UHFFFAOYSA-N					compound annotation
0391_013004	Biocytin	C16H28N4O4S	0.9573	7098660	C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)NCCCC[C@@H](C(=O)[O-])[NH3+])NC(=O)N2	NC(CCCCNC(=O)CCCCC1SCC2NC(=O)NC21)C(=O)O	InChI=1S/C16H28N4O4S/c17-10(15(22)23)5-3-4-8-18-13(21)7-2-1-6-12-14-11(9-25-12)19-16(24)20-14/h10-12,14H,1-9,17H2,(H,18,21)(H,22,23)(H2,19,20,24)/t10-,11-,12-,14-/m0/s1	BAQMYDQNMFBZNA-MNXVOIDGSA-N					removed another duplicate entry; compound annotation
0391_013006	dimethoate	C5H12NO3PS2	2.0122	3082		CNC(=O)CSP(=S)(OC)OC	InChI=1S/C5H12NO3PS2/c1-6-5(7)4-12-10(11,8-2)9-3/h4H2,1-3H3,(H,6,7)	MCWXGJITAZMZEV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013008	Phosphonoacetic acid	C2H5O5P	7.0593	546		O=C(O)CP(=O)(O)O	InChI=1S/C2H5O5P/c3-2(4)1-8(5,6)7/h1H2,(H,3,4)(H2,5,6,7)	XUYJLQHKOGNDPB-UHFFFAOYSA-N					compound annotation
0391_013009	ISOPHORONE	C9H14O	2.8485	6544		CC1=CC(=O)CC(C)(C)C1	InChI=1S/C9H14O/c1-7-4-8(10)6-9(2,3)5-7/h4H,5-6H2,1-3H3	HJOVHMDZYOCNQW-UHFFFAOYSA-N					compound annotation
0391_013010	DL-3-Phenyllactic acid	C9H10O3	4.2857	3848		O=C(O)C(O)Cc1ccccc1	InChI=1S/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)	VOXXWSYKYCBWHO-UHFFFAOYSA-N					compound annotation
0391_013011	Dehydronitrosonisoldipine	C20H22N2O5	4.6421	14823523		COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)C)c1-c1ccccc1N=O	InChI=1S/C20H22N2O5/c1-11(2)10-27-20(24)17-13(4)21-12(3)16(19(23)26-5)18(17)14-8-6-7-9-15(14)22-25/h6-9,11H,10H2,1-5H3	UNMSLPIJQICBKA-UHFFFAOYSA-N					doublet; compound annotation
0391_013012	Dehydronitrosonisoldipine	C20H22N2O5	4.6449	14823523		COC(=O)c1c(C)nc(C)c(C(=O)OCC(C)C)c1-c1ccccc1N=O	InChI=1S/C20H22N2O5/c1-11(2)10-27-20(24)17-13(4)21-12(3)16(19(23)26-5)18(17)14-8-6-7-9-15(14)22-25/h6-9,11H,10H2,1-5H3	UNMSLPIJQICBKA-UHFFFAOYSA-N					doublet; compound annotation
0391_013013	N-(2-Hydroxypropyl)methacrylamide	C7H13NO2	0.7706	38622		C=C(C)C(=O)NCC(C)O	InChI=1S/C7H13NO2/c1-5(2)7(10)8-4-6(3)9/h6,9H,1,4H2,2-3H3,(H,8,10)	OKPYIWASQZGASP-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013015	Butyrylcarnitine	C11H22NO4+	0.8553	213145	CCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C	CCCC(=O)OC(CC(=O)O)C[N+](C)(C)C	InChI=1S/C11H21NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h9H,5-8H2,1-4H3/p+1/t9-/m1/s1	QWYFHHGCZUCMBN-SECBINFHSA-O					compound annotation
0391_013016	Dermorphin	C40H50N8O10	2.0322	5485199	C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N	CC(NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(Cc1ccc(O)cc1)C(=O)N1CCCC1C(=O)NC(CO)C(N)=O	InChI=1S/C40H50N8O10/c1-23(44-37(55)29(41)18-25-9-13-27(50)14-10-25)36(54)46-30(19-24-6-3-2-4-7-24)38(56)43-21-34(52)45-31(20-26-11-15-28(51)16-12-26)40(58)48-17-5-8-33(48)39(57)47-32(22-49)35(42)53/h2-4,6-7,9-16,23,29-33,49-51H,5,8,17-22,41H2,1H3,(H2,42,53)(H,43,56)(H,44,55)(H,45,52)(H,46,54)(H,47,57)/t23-,29+,30+,31+,32+,33+/m1/s1	FHZPGIUBXYVUOY-VWGYHWLBSA-N					compound annotation
0391_013017	H-LEU-PHE-OH	C15H22N2O3	1.7848	6992309	CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)[O-])[NH3+]	CC(C)CC(N)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C15H22N2O3/c1-10(2)8-12(16)14(18)17-13(15(19)20)9-11-6-4-3-5-7-11/h3-7,10,12-13H,8-9,16H2,1-2H3,(H,17,18)(H,19,20)/t12-,13-/m0/s1	KFKWRHQBZQICHA-STQMWFEESA-N					removed another duplicate entry; compound annotation
0391_013019	L-phenylalanine	C9H11NO2	0.5892	6925665	C1=CC=C(C=C1)C[C@@H](C(=O)[O-])[NH3+]	NC(Cc1ccccc1)C(=O)O	InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1	COLNVLDHVKWLRT-QMMMGPOBSA-N					compound annotation
0391_013020	3-Iodo-L-tyrosine	C9H10INO3	0.9249	6918986	C1=CC(=C(C=C1C[C@@H](C(=O)[O-])[NH3+])I)O	NC(Cc1cc(I)c(O)cc1)C(=O)O	InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1	UQTZMGFTRHFAAM-ZETCQYMHSA-N					compound annotation
0391_013021	Cgp 36742	C7H18NO2P	0.5147	130021		CCCCP(=O)(O)CCCN	InChI=1S/C7H18NO2P/c1-2-3-6-11(9,10)7-4-5-8/h2-8H2,1H3,(H,9,10)	ONNMDRQRSGKZCN-UHFFFAOYSA-N					compound annotation
0391_013022	3-Nitro-L-tyrosine	C9H10N2O5	0.6799	65124	C1=CC(=C(C=C1C[C@@H](C(=O)O)N)[N+](=O)[O-])O	NC(Cc1cc([N+](=O)[O-])c(O)cc1)C(=O)O	InChI=1S/C9H10N2O5/c10-6(9(13)14)3-5-1-2-8(12)7(4-5)11(15)16/h1-2,4,6,12H,3,10H2,(H,13,14)/t6-/m0/s1	FBTSQILOGYXGMD-LURJTMIESA-N					compound annotation
0391_013023	Cefminox	C16H21N7O7S3	0.7755	71141	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSC[C@H](C(=O)O)N)OC)SC2)C(=O)O	COC1(NC(=O)CSCC(N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CSC21	InChI=1S/C16H21N7O7S3/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28)/t8-,14-,16+/m1/s1	JSDXOWVAHXDYCU-VXSYNFHWSA-N					compound annotation
0391_013024	cimetropium	C21H28NO4+	1.9609	20054871	C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)CC5CC5	C[N+]1(CC2CC2)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12	InChI=1S/C21H28NO4/c1-22(11-13-7-8-13)17-9-15(10-18(22)20-19(17)26-20)25-21(24)16(12-23)14-5-3-2-4-6-14/h2-6,13,15-20,23H,7-12H2,1H3/q+1/t15?,16-,17-,18+,19-,20+,22?/m1/s1	QVVOZYKELHAIPX-MWGADRMYSA-N					compound annotation
0391_013025	proglumide	C18H26N2O4	3.1538	4922		CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1	InChI=1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22)	DGMKFQYCZXERLX-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013027	CX-5461	C27H27N7O2S	2.4861	25257557		Cc1cnc(CNC(=O)c2c3sc4ccccc4n3c3c(ccc(N4CCCN(C)CC4)n3)c2=O)cn1	InChI=1S/C27H27N7O2S/c1-17-14-29-18(15-28-17)16-30-26(36)23-24(35)19-8-9-22(33-11-5-10-32(2)12-13-33)31-25(19)34-20-6-3-4-7-21(20)37-27(23)34/h3-4,6-9,14-15H,5,10-13,16H2,1-2H3,(H,30,36)	XGPBJCHFROADCK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013029	569-31-3	C10H10O4	2.0355	68437		COc1c(OC)c2c(cc1)COC2=O	InChI=1S/C10H10O4/c1-12-7-4-3-6-5-14-10(11)8(6)9(7)13-2/h3-4H,5H2,1-2H3	ORFFGRQMMWVHIB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013031	4-(DIMETHYLAMINO)BENZALDEHYDE	C9H11NO	2.6882	7479		CN(C)c1ccc(C=O)cc1	InChI=1S/C9H11NO/c1-10(2)9-5-3-8(7-11)4-6-9/h3-7H,1-2H3	BGNGWHSBYQYVRX-UHFFFAOYSA-N					compound annotation
0391_013032	Defensamide	C16H23NO4	3.0587	56652925	CCCCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)OC	CCCCCC(=O)NC(Cc1ccc(O)cc1)C(=O)OC	InChI=1S/C16H23NO4/c1-3-4-5-6-15(19)17-14(16(20)21-2)11-12-7-9-13(18)10-8-12/h7-10,14,18H,3-6,11H2,1-2H3,(H,17,19)/t14-/m0/s1	GBTVWZMJUZJPBU-AWEZNQCLSA-N					doublet; removed another duplicate entry; compound annotation
0391_013034	Defensamide	C16H23NO4	5.1739	56652925	CCCCCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)OC	CCCCCC(=O)NC(Cc1ccc(O)cc1)C(=O)OC	InChI=1S/C16H23NO4/c1-3-4-5-6-15(19)17-14(16(20)21-2)11-12-7-9-13(18)10-8-12/h7-10,14,18H,3-6,11H2,1-2H3,(H,17,19)/t14-/m0/s1	GBTVWZMJUZJPBU-AWEZNQCLSA-N					doublet; compound annotation
0391_013035	Gefitinib	C22H24ClFN4O3	1.9222	123631		COc1c(OCCCN2CCOCC2)cc2c(Nc3cc(Cl)c(F)cc3)ncnc2c1	InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)	XGALLCVXEZPNRQ-UHFFFAOYSA-N					doublet; compound annotation
0391_013036	DiZPK	C12H23N5O3	1.3622	53314876	CC1(N=N1)CCCNC(=O)NCCCC[C@@H](C(=O)O)N	CC1(CCCNC(=O)NCCCCC(N)C(=O)O)N=N1	InChI=1S/C12H23N5O3/c1-12(16-17-12)6-4-8-15-11(20)14-7-3-2-5-9(13)10(18)19/h9H,2-8,13H2,1H3,(H,18,19)(H2,14,15,20)/t9-/m0/s1	YGUIFRMUMYTGAV-VIFPVBQESA-N					doublet; removed another duplicate entry; compound annotation
0391_013038	188860-26-6	C27H28N6O2	1.6717	10174012		COc1c(OC)cc(-c2nc3c(cc(-c4nc5c(cc(N6CCN(C)CC6)cc5)[nH]4)cc3)[nH]2)cc1	InChI=1S/C27H28N6O2/c1-32-10-12-33(13-11-32)19-6-8-21-23(16-19)31-26(29-21)17-4-7-20-22(14-17)30-27(28-20)18-5-9-24(34-2)25(15-18)35-3/h4-9,14-16H,10-13H2,1-3H3,(H,28,30)(H,29,31)	BMRRDFCQNOZNNR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013040	(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl hydrogen phosphate	C25H53NO4P+	5.6841	148178		CCCCCCCCCCCCCCCCCCOP(=O)(O)OC1CC[N+](C)(C)CC1	InChI=1S/C25H52NO4P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-29-31(27,28)30-25-20-22-26(2,3)23-21-25/h25H,4-24H2,1-3H3/p+1	SZFPYBIJACMNJV-UHFFFAOYSA-O					compound annotation
0391_013041	acetylphosphate	C2H5O5P	7.0555	186		CC(=O)OP(=O)(O)O	InChI=1S/C2H5O5P/c1-2(3)7-8(4,5)6/h1H3,(H2,4,5,6)	LIPOUNRJVLNBCD-UHFFFAOYSA-N					compound annotation
0391_013042	2-Piperidone	C5H9NO	0.5804	12665		O=C1CCCCN1	InChI=1S/C5H9NO/c7-5-3-1-2-4-6-5/h1-4H2,(H,6,7)	XUWHAWMETYGRKB-UHFFFAOYSA-N					compound annotation
0391_013043	8-Aminooctanoic acid	C8H17NO2	0.8436	6994258		NCCCCCCCC(=O)O	InChI=1S/C8H17NO2/c9-7-5-3-1-2-4-6-8(10)11/h1-7,9H2,(H,10,11)	UQXNEWQGGVUVQA-UHFFFAOYSA-N					compound annotation
0391_013044	sulfadiazine	C10H10N4O2S	0.9985	5215		Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1	InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)	SEEPANYCNGTZFQ-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013046	5,6-Dimethylbenzimidazole	C9H10N2	1.4254	675		Cc1cc2c(cc1C)[nH]cn2	InChI=1S/C9H10N2/c1-6-3-8-9(4-7(6)2)11-5-10-8/h3-5H,1-2H3,(H,10,11)	LJUQGASMPRMWIW-UHFFFAOYSA-N					compound annotation
0391_013047	memantine	C12H21N	2.3002	4054		CC12CC3CC(C)(C1)CC(N)(C3)C2	InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3	BUGYDGFZZOZRHP-UHFFFAOYSA-N					compound annotation
0391_013048	diltiazem	C22H26N2O4S	2.8464	39186	CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC	COc1ccc(C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(C)=O)cc1	InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1	HSUGRBWQSSZJOP-RTWAWAEBSA-N					removed another duplicate entry; compound annotation
0391_013050	fosinopril	C30H46NO7P	5.3321	9601226	CCC(=O)O[C@H](C(C)C)O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3	CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C	InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30+,39-/m1/s1	BIDNLKIUORFRQP-XYGFDPSESA-N					compound annotation
0391_013051	TB500	C38H68N10O14	0.8391	62707662	C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)C)O	CC(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CCC(=O)O)C(=O)NC(C(=O)NC(CCC(N)=O)C(=O)O)C(C)O)C(C)O	InChI=1S/C38H68N10O14/c1-19(2)18-27(42-22(5)51)35(58)44-23(10-6-8-16-39)32(55)43-24(11-7-9-17-40)33(56)47-30(20(3)49)36(59)45-25(13-15-29(53)54)34(57)48-31(21(4)50)37(60)46-26(38(61)62)12-14-28(41)52/h19-21,23-27,30-31,49-50H,6-18,39-40H2,1-5H3,(H2,41,52)(H,42,51)(H,43,55)(H,44,58)(H,45,59)(H,46,60)(H,47,56)(H,48,57)(H,53,54)(H,61,62)/t20-,21-,23+,24+,25+,26+,27+,30+,31+/m1/s1	ADKDNDYYIZUVCZ-ZQNQAVPYSA-N					compound annotation
0391_013052	Vaborbactam	C12H16BNO5S	1.5331	56649692	B1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)CC2=CC=CS2)O	O=C(O)CC1CCC(NC(=O)Cc2cccs2)B(O)O1	InChI=1S/C12H16BNO5S/c15-11(7-9-2-1-5-20-9)14-10-4-3-8(6-12(16)17)19-13(10)18/h1-2,5,8,10,18H,3-4,6-7H2,(H,14,15)(H,16,17)/t8-,10-/m0/s1	IOOWNWLVCOUUEX-WPRPVWTQSA-N					compound annotation
0391_013053	Ethyl 3-aminobenzoate	C9H11NO2	1.9567	11400		CCOC(=O)c1cc(N)ccc1	InChI=1S/C9H11NO2/c1-2-12-9(11)7-4-3-5-8(10)6-7/h3-6H,2,10H2,1H3	ZMCBYSBVJIMENC-UHFFFAOYSA-N					compound annotation
0391_013054	hydralazine	C8H8N4	0.4901	3637		NNc1nncc2ccccc12	InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)	RPTUSVTUFVMDQK-UHFFFAOYSA-N					compound annotation
0391_013055	Leu-enkephalin	C28H37N5O7	2.1808	461776	CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N	CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccc(O)cc1)C(=O)O	InChI=1S/C28H37N5O7/c1-17(2)12-23(28(39)40)33-27(38)22(14-18-6-4-3-5-7-18)32-25(36)16-30-24(35)15-31-26(37)21(29)13-19-8-10-20(34)11-9-19/h3-11,17,21-23,34H,12-16,29H2,1-2H3,(H,30,35)(H,31,37)(H,32,36)(H,33,38)(H,39,40)/t21-,22-,23-/m0/s1	URLZCHNOLZSCCA-VABKMULXSA-N					compound annotation
0391_013056	Ala-phe	C12H16N2O3	1.0357	96814	C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N	CC(N)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C12H16N2O3/c1-8(13)11(15)14-10(12(16)17)7-9-5-3-2-4-6-9/h2-6,8,10H,7,13H2,1H3,(H,14,15)(H,16,17)/t8-,10-/m0/s1	OMNVYXHOSHNURL-WPRPVWTQSA-N					compound annotation
0391_013057	chloroquine	C18H26ClN3	1.2496	2719		CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2ncc1	InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)	WHTVZRBIWZFKQO-UHFFFAOYSA-N					doublet; compound annotation
0391_013058	ANGIOTENSIN II	C50H71N13O12	1.8916	172198	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N	CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C(N)CC(=O)O)C(C)C)C(=O)NC(Cc1cnc[nH]1)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1	CZGUSIXMZVURDU-JZXHSEFVSA-N					compound annotation
0391_013059	Peramivir	C15H28N4O4	1.4314	154234	CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C	CCC(CC)C(NC(C)=O)C1C(N=C(N)N)CC(C(=O)O)C1O	InChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1	XRQDFNLINLXZLB-CKIKVBCHSA-N					compound annotation
0391_013060	lomefloxacin	C17H19F2N3O3	1.6395	3948		CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21	InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)	ZEKZLJVOYLTDKK-UHFFFAOYSA-N					compound annotation
0391_013061	Clindamycin phosphate	C18H34ClN2O8PS	2.2213	443385	CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@H](C)Cl	CCCC1CC(C(=O)NC(C(C)Cl)C2OC(SC)C(OP(=O)(O)O)C(O)C2O)N(C)C1	InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1	UFUVLHLTWXBHGZ-MGZQPHGTSA-N					compound annotation
0391_013062	METYROSINE	C10H13NO3	0.4787	6918925	C[C@](CC1=CC=C(C=C1)O)(C(=O)[O-])[NH3+]	CC(N)(Cc1ccc(O)cc1)C(=O)O	InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1	NHTGHBARYWONDQ-JTQLQIEISA-N					compound annotation
0391_013063	Salbutamol	C13H21NO3	0.6662	2083		CC(C)(C)NCC(O)c1cc(CO)c(O)cc1	InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3	NDAUXUAQIAJITI-UHFFFAOYSA-N					compound annotation
0391_013064	Tandospirone	C21H29N5O2	2.1227	91273	C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5	O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ncccn2)CC1	InChI=1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18-	CEIJFEGBUDEYSX-FZDBZEDMSA-N					doublet; compound annotation
0391_013065	osimertinib	C28H33N7O2	2.366	71496458		C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C	InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)	DUYJMQONPNNFPI-UHFFFAOYSA-N					doublet; compound annotation
0391_013066	Fosbretabulin	C18H21O8P	2.6593	5351387	COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)O	COc1c(OP(=O)(O)O)cc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1	InChI=1S/C18H21O8P/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3/h5-11H,1-4H3,(H2,19,20,21)/b6-5-	WDOGQTQEKVLZIJ-WAYWQWQTSA-N					compound annotation
0391_013067	Jatrorrhizine	C20H20NO4+	2.254	72323		COc1c(O)cc2CC[n+]3c(cc4ccc(OC)c(OC)c4c3)-c2c1	InChI=1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1	MXTLAHSTUOXGQF-UHFFFAOYSA-O					doublet; compound annotation
0391_013068	phentolamine	C17H19N3O	2.3261	5775		Cc1ccc(N(CC2=NCCN2)c2cc(O)ccc2)cc1	InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)	MRBDMNSDAVCSSF-UHFFFAOYSA-N					compound annotation
0391_013069	Cevimeline	C10H17NOS	1.1586	25137844	CC1O[C@]2(CN3CCC2CC3)CS1	CC1OC2(CS1)CN1CCC2CC1	InChI=1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3/t8?,10-/m1/s1	WUTYZMFRCNBCHQ-LHIURRSHSA-N					compound annotation
0391_013070	69-53-4	C16H19N3O4S	1.214	7048611	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)[NH3+])C(=O)[O-])C	CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	AVKUERGKIZMTKX-NJBDSQKTSA-N					doublet; compound annotation
0391_013071	minocycline	C23H27N3O7	1.3585	54675783	CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C	CN(C)c1c2CC3CC4C(N(C)C)C(=O)C(C(N)=O)=C(O)C4(O)C(=O)C3=C(O)c2c(O)cc1	InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1	FFTVPQUHLQBXQZ-KVUCHLLUSA-N					removed another duplicate entry; compound annotation
0391_013073	69-53-4	C16H19N3O4S	1.43	7048611	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)[NH3+])C(=O)[O-])C	CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	AVKUERGKIZMTKX-NJBDSQKTSA-N					doublet; removed another duplicate entry; compound annotation
0391_013075	lisinopril	C21H31N3O5	1.3048	5362119	C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O	NCCCCC(NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O	InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1	RLAWWYSOJDYHDC-BZSNNMDCSA-N					compound annotation
0391_013076	Palosuran	C25H30N4O2	2.4773	10173280		Cc1nc2ccccc2c(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c1	InChI=1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30)	WYJCYXOCHXWTHG-UHFFFAOYSA-N					doublet; compound annotation
0391_013077	69-53-4	C16H19N3O4S	1.4255	7048611	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)[NH3+])C(=O)[O-])C	CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O	InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1	AVKUERGKIZMTKX-NJBDSQKTSA-N					doublet; compound annotation
0391_013078	Cilengitide	C27H40N8O7	2.1548	176873	CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N	CC(C)C1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(Cc2ccccc2)C(=O)N1C	InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1	AMLYAMJWYAIXIA-VWNVYAMZSA-N					doublet; compound annotation
0391_013079	H-PHE-PHE-OH	C18H20N2O3	1.8986	6993089	C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)[O-])[NH3+]	NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)O	InChI=1S/C18H20N2O3/c19-15(11-13-7-3-1-4-8-13)17(21)20-16(18(22)23)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H,20,21)(H,22,23)/t15-,16-/m0/s1	GKZIWHRNKRBEOH-HOTGVXAUSA-N					compound annotation
0391_013080	medrysone	C22H32O3	4.0917	247839	C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)C(=O)C	CC(=O)C1CCC2C3CC(C)C4=CC(=O)CCC4(C)C3C(O)CC12C	InChI=1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1	GZENKSODFLBBHQ-ILSZZQPISA-N					compound annotation
0391_013081	biperiden	C21H29NO	2.9461	2381		OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2	YSXKPIUOCJLQIE-UHFFFAOYSA-N					doublet; compound annotation
0391_013082	biperiden	C21H29NO	3.1478	2381		OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2	InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2	YSXKPIUOCJLQIE-UHFFFAOYSA-N					doublet; compound annotation
0391_013083	gabapentin	C9H17NO2	1.1253	3446		NCC1(CC(=O)O)CCCCC1	InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)	UGJMXCAKCUNAIE-UHFFFAOYSA-N					doublet; compound annotation
0391_013084	Copanlisib	C23H28N8O4	1.2172	135565596		COc1c(OCCCN2CCOCC2)ccc2c3NCCn3c(=NC(=O)c3cnc(N)nc3)nc12	InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27)	MWYDSXOGIBMAET-UHFFFAOYSA-N					compound annotation
0391_013085	69056-38-8	C9H15N5O3	1.2215	135398654	C[C@@H]([C@@H]([C@H]1CNC2=C(N1)C(=O)NC(=N2)N)O)O	CC(O)C(O)C1CNc2c(N1)c(=O)nc(N)[nH]2	InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1	FNKQXYHWGSIFBK-RPDRRWSUSA-N					compound annotation
0391_013086	DEXMEDETOMIDINE	C13H16N2	2.2926	5311068	CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C	Cc1c(C)c(C(C)c2cnc[nH]2)ccc1	InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1	CUHVIMMYOGQXCV-NSHDSACASA-N					compound annotation
0391_013087	penbutolol	C18H29NO2	3.3121	37464	CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O	CC(C)(C)NCC(O)COc1ccccc1C1CCCC1	InChI=1S/C18H29NO2/c1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14/h6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3/t15-/m0/s1	KQXKVJAGOJTNJS-HNNXBMFYSA-N					compound annotation
0391_013088	3-METHOXY-L-TYROSINE	C10H13NO4	0.4734	9307	COC1=C(C=CC(=C1)C[C@@H](C(=O)O)N)O	COc1c(O)ccc(CC(N)C(=O)O)c1	InChI=1S/C10H13NO4/c1-15-9-5-6(2-3-8(9)12)4-7(11)10(13)14/h2-3,5,7,12H,4,11H2,1H3,(H,13,14)/t7-/m0/s1	PFDUUKDQEHURQC-ZETCQYMHSA-N					compound annotation
0391_013089	hydroxychloroquine	C18H26ClN3O	1.18	3652		CCN(CCO)CCCC(C)Nc1c2ccc(Cl)cc2ncc1	InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)	XXSMGPRMXLTPCZ-UHFFFAOYSA-N					compound annotation
0391_013090	3,6-Diamino-10-methylacridinium	C14H14N3+	1.7309	2016		C[n+]1c2cc(N)ccc2cc2c1cc(N)cc2	InChI=1S/C14H13N3/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17/h2-8H,1H3,(H3,15,16)/p+1	XSIOKTWDEOJMGG-UHFFFAOYSA-O					doublet; compound annotation
0391_013091	3,6-Diamino-10-methylacridinium	C14H14N3+	1.9405	2016		C[n+]1c2cc(N)ccc2cc2c1cc(N)cc2	InChI=1S/C14H13N3/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17/h2-8H,1H3,(H3,15,16)/p+1	XSIOKTWDEOJMGG-UHFFFAOYSA-O					doublet; compound annotation
0391_013092	Levomilnacipran	C15H22N2O	2.234	6917779	CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2	CCN(CC)C(=O)C1(c2ccccc2)CC1CN	InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m0/s1	GJJFMKBJSRMPLA-DZGCQCFKSA-N					removed another duplicate entry; compound annotation
0391_013094	gabapentin	C9H17NO2	1.1263	3446		NCC1(CC(=O)O)CCCCC1	InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)	UGJMXCAKCUNAIE-UHFFFAOYSA-N					doublet; compound annotation
0391_013095	H-gamma-glu-phe-oh	C14H18N2O5	1.2575	111299	C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)N	NC(CCC(=O)NC(Cc1ccccc1)C(=O)O)C(=O)O	InChI=1S/C14H18N2O5/c15-10(13(18)19)6-7-12(17)16-11(14(20)21)8-9-4-2-1-3-5-9/h1-5,10-11H,6-8,15H2,(H,16,17)(H,18,19)(H,20,21)/t10-,11-/m0/s1	XHHOHZPNYFQJKL-QWRGUYRKSA-N					compound annotation
0391_013096	Tacrine	C13H14N2	1.5977	1935		Nc1c2CCCCc2nc2ccccc12	InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)	YLJREFDVOIBQDA-UHFFFAOYSA-N					doublet; compound annotation
0391_013097	lobeline	C22H27NO2	2.7255	101616	CN1[C@@H](CCC[C@@H]1CC(=O)C2=CC=CC=C2)C[C@@H](C3=CC=CC=C3)O	CN1C(CC(=O)c2ccccc2)CCCC1CC(O)c1ccccc1	InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1	MXYUKLILVYORSK-HBMCJLEFSA-N					doublet; compound annotation
0391_013098	lobeline	C22H27NO2	2.8001	101616	CN1[C@@H](CCC[C@@H]1CC(=O)C2=CC=CC=C2)C[C@@H](C3=CC=CC=C3)O	CN1C(CC(=O)c2ccccc2)CCCC1CC(O)c1ccccc1	InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1	MXYUKLILVYORSK-HBMCJLEFSA-N					doublet; compound annotation
0391_013099	Corynoxeine	C22H26N2O4	2.2023	44568160	CO/C=C(\[C@H]1C[C@H]2[C@@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	C=CC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	MUVGVMUWMAGNSY-KAXDATADSA-N					doublet; compound annotation
0391_013100	Corynoxeine	C22H26N2O4	2.205	44568160	CO/C=C(\[C@H]1C[C@H]2[C@@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	C=CC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	MUVGVMUWMAGNSY-KAXDATADSA-N					doublet; compound annotation
0391_013101	9-amino-5-imino-5h-benzo[a]phenoxazine	C16H11N3O	2.315	82687		N=c1cc2oc3c(ccc(N)c3)nc-2c2ccccc12	InChI=1S/C16H11N3O/c17-9-5-6-13-14(7-9)20-15-8-12(18)10-3-1-2-4-11(10)16(15)19-13/h1-8,18H,17H2	PNEZKPARQSZCID-UHFFFAOYSA-N					compound annotation
0391_013102	Corynoxeine	C22H26N2O4	2.3188	44568160	CO/C=C(\[C@H]1C[C@H]2[C@@]3(CCN2C[C@@H]1C=C)C4=CC=CC=C4NC3=O)/C(=O)OC	C=CC1CN2CCC3(C(=O)Nc4ccccc43)C2CC1C(=COC)C(=O)OC	InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22+/m0/s1	MUVGVMUWMAGNSY-KAXDATADSA-N					doublet; compound annotation
0391_013103	bmh-21	C21H20N4O2	2.7086	3508054		CN(C)CCNC(=O)c1cccn2c(=O)c3cc4ccccc4cc3nc12	InChI=1S/C21H20N4O2/c1-24(2)11-9-22-20(26)16-8-5-10-25-19(16)23-18-13-15-7-4-3-6-14(15)12-17(18)21(25)27/h3-8,10,12-13H,9,11H2,1-2H3,(H,22,26)	BXYDVWIAGDJBEC-UHFFFAOYSA-N					compound annotation
0391_013104	154447-35-5	C17H15NO3	3.0044	9860529		O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12	InChI=1S/C17H15NO3/c19-15-11-16(18-7-9-20-10-8-18)21-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2	KKTZALUTXUZPSN-UHFFFAOYSA-N					doublet; compound annotation
0391_013105	154447-35-5	C17H15NO3	3.0073	9860529		O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12	InChI=1S/C17H15NO3/c19-15-11-16(18-7-9-20-10-8-18)21-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2	KKTZALUTXUZPSN-UHFFFAOYSA-N					doublet; compound annotation
0391_013106	SM-164	C62H84N14O6	3.157	17756618	C[C@@H](C(=O)N[C@H]1CCCC[C@H]2CC[C@H](N2C1=O)C(=O)N[C@@H](C3=CC=CC=C3)C4=CN(N=N4)CCCCC5=CC=C(C=C5)CCCCN6C=C(N=N6)[C@H](C7=CC=CC=C7)NC(=O)[C@@H]8CC[C@H]9N8C(=O)[C@H](CCCC9)NC(=O)[C@H](C)NC)NC	CNC(C)C(=O)NC1CCCCC2CCC(C(=O)NC(c3ccccc3)c3cn(CCCCc4ccc(CCCCn5cc(C(NC(=O)C6CCC7CCCCC(NC(=O)C(C)NC)C(=O)N76)c6ccccc6)nn5)cc4)nn3)N2C1=O	InChI=1S/C62H84N14O6/c1-41(63-3)57(77)65-49-27-13-11-25-47-33-35-53(75(47)61(49)81)59(79)67-55(45-21-7-5-8-22-45)51-39-73(71-69-51)37-17-15-19-43-29-31-44(32-30-43)20-16-18-38-74-40-52(70-72-74)56(46-23-9-6-10-24-46)68-60(80)54-36-34-48-26-12-14-28-50(62(82)76(48)54)66-58(78)42(2)64-4/h5-10,21-24,29-32,39-42,47-50,53-56,63-64H,11-20,25-28,33-38H2,1-4H3,(H,65,77)(H,66,78)(H,67,79)(H,68,80)/t41-,42-,47-,48-,49-,50-,53-,54-,55-,56-/m0/s1	LGYDZXNSSLRFJS-IOQQVAQYSA-N					removed another duplicate entry; compound annotation
0391_013108	Elacridar	C34H33N3O5	3.2047	119373		COc1c(OC)cc2CN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(cccc4OC)c5=O)cc3)CCc2c1	InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)	OSFCMRGOZNQUSW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013110	E260	C24H34N6S	3.3307	46898309		CC(C)c1ccc(-c2cn3nc(N4CCC(CN5CCN(C)CC5)CC4)sc3n2)cc1	InChI=1S/C24H34N6S/c1-18(2)20-4-6-21(7-5-20)22-17-30-23(25-22)31-24(26-30)29-10-8-19(9-11-29)16-28-14-12-27(3)13-15-28/h4-7,17-19H,8-16H2,1-3H3	RFHSWNJYHRAOMP-UHFFFAOYSA-N					compound annotation
0391_013111	INO5042	C15H7NO3S	4.1028	10446437		O=C1c2ccccc2C(=O)c2c1nc(-c1ccco1)s2	InChI=1S/C15H7NO3S/c17-12-8-4-1-2-5-9(8)13(18)14-11(12)16-15(20-14)10-6-3-7-19-10/h1-7H	VJKZUTFFMNSTTD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013113	1233855-46-3	C16H20N4O2	2.5075	46831476		CN(C(=O)n1cnc(-c2c[n+]([O-])ccc2)c1)C1CCCCC1	InChI=1S/C16H20N4O2/c1-18(14-7-3-2-4-8-14)16(21)19-11-15(17-12-19)13-6-5-9-20(22)10-13/h5-6,9-12,14H,2-4,7-8H2,1H3	DOWVMJFBDGWVML-UHFFFAOYSA-N					compound annotation
0391_013114	374913-63-0	C16H17N5O2	2.5423	135444382		COc1cc2nc(Nc3nc(=O)c(C)c(C)[nH]3)nc(C)c2cc1	InChI=1S/C16H17N5O2/c1-8-9(2)17-16(20-14(8)22)21-15-18-10(3)12-6-5-11(23-4)7-13(12)19-15/h5-7H,1-4H3,(H2,17,18,19,20,21,22)	QQJIYKXTEMDJFM-UHFFFAOYSA-N					compound annotation
0391_013115	TAK-960	C27H34F3N7O3	2.9408	53357478		COc1c(Nc2ncc3c(n2)N(C2CCCC2)CC(F)(F)C(=O)N3C)cc(F)c(C(=O)NC2CCN(C)CC2)c1	InChI=1S/C27H34F3N7O3/c1-35-10-8-16(9-11-35)32-24(38)18-12-22(40-3)20(13-19(18)28)33-26-31-14-21-23(34-26)37(17-6-4-5-7-17)15-27(29,30)25(39)36(21)2/h12-14,16-17H,4-11,15H2,1-3H3,(H,32,38)(H,31,33,34)	GWRSATNRNFYMDI-UHFFFAOYSA-N					doublet; compound annotation
0391_013116	oxolinic acid	C13H11NO5	2.3095	4628		CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3	InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)	KYGZCKSPAKDVKC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013118	149385-65-9	C25H47N5O6S	2.3243	10816380	CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)O)N	CCC(C)C(N)C(=O)NC(C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)O)C(C)CC	InChI=1S/C25H47N5O6S/c1-8-15(5)20(26)23(33)30-21(16(6)9-2)24(34)27-13-19(31)28-18(12-14(3)4)22(32)29-17(25(35)36)10-11-37-7/h14-18,20-21H,8-13,26H2,1-7H3,(H,27,34)(H,28,31)(H,29,32)(H,30,33)(H,35,36)/t15-,16-,17-,18-,20-,21-/m0/s1	ZMDGLWRNBGRYQB-ZKHIMWLXSA-N					removed another duplicate entry; compound annotation
0391_013119	RGB-286638 free base	C29H35N7O4	2.3243	11285002		COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c-4cccc3NC(=O)NN3CCOCC3)cc2)CC1	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	XLSYZSRXVVCHLS-UHFFFAOYSA-N					doublet; compound annotation
0391_013121	RGB-286638 free base	C29H35N7O4	2.3276	11285002		COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c-4cccc3NC(=O)NN3CCOCC3)cc2)CC1	InChI=1S/C29H35N7O4/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38)	XLSYZSRXVVCHLS-UHFFFAOYSA-N					doublet; compound annotation
0391_013122	AMG-208	C22H17N5O2	2.5903	24864821		COc1cc2nccc(OCc3nnc4ccc(-c5ccccc5)nn34)c2cc1	InChI=1S/C22H17N5O2/c1-28-16-7-8-17-19(13-16)23-12-11-20(17)29-14-22-25-24-21-10-9-18(26-27(21)22)15-5-3-2-4-6-15/h2-13H,14H2,1H3	HEAIZQNMNCHNFD-UHFFFAOYSA-N					compound annotation
0391_013123	TH1020	C23H15N7S2	3.0251	124203921		c1ccc(Cn2c(Sc3ncnc4c3sc3c4cccn3)nnc2-c2ccncc2)cc1	InChI=1S/C23H15N7S2/c1-2-5-15(6-3-1)13-30-20(16-8-11-24-12-9-16)28-29-23(30)32-22-19-18(26-14-27-22)17-7-4-10-25-21(17)31-19/h1-12,14H,13H2	CBBXTGWSGPEJEE-UHFFFAOYSA-N					doublet; compound annotation
0391_013124	TH1020	C23H15N7S2	3.104	124203921		c1ccc(Cn2c(Sc3ncnc4c3sc3c4cccn3)nnc2-c2ccncc2)cc1	InChI=1S/C23H15N7S2/c1-2-5-15(6-3-1)13-30-20(16-8-11-24-12-9-16)28-29-23(30)32-22-19-18(26-14-27-22)17-7-4-10-25-21(17)31-19/h1-12,14H,13H2	CBBXTGWSGPEJEE-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013126	BIBB 515	C22H21ClN2O2	3.2843	501398		O=C(c1ccc(Cl)cc1)N1CCC(=Cc2ccc(C3=NCCO3)cc2)CC1	InChI=1S/C22H21ClN2O2/c23-20-7-5-19(6-8-20)22(26)25-12-9-17(10-13-25)15-16-1-3-18(4-2-16)21-24-11-14-27-21/h1-8,15H,9-14H2	JQNWPWUJMRAASQ-UHFFFAOYSA-N					compound annotation
0391_013127	Quetiapine Sulfoxide	C21H25N3O3S	2.0607	10431050	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3[S@@](=O)C4=CC=CC=C42	[O-][S+]1c2ccccc2N=C(N2CCN(CCOCCO)CC2)c2ccccc21	InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2/t28-/m0/s1	FXJNLPUSSHEDON-NDEPHWFRSA-N					doublet; compound annotation
0391_013128	Quetiapine Sulfoxide	C21H25N3O3S	2.1063	10431050	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3[S@@](=O)C4=CC=CC=C42	[O-][S+]1c2ccccc2N=C(N2CCN(CCOCCO)CC2)c2ccccc21	InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2/t28-/m0/s1	FXJNLPUSSHEDON-NDEPHWFRSA-N					doublet; compound annotation
0391_013129	Quetiapine Sulfoxide	C21H25N3O3S	2.11	10431050	C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3[S@@](=O)C4=CC=CC=C42	[O-][S+]1c2ccccc2N=C(N2CCN(CCOCCO)CC2)c2ccccc21	InChI=1S/C21H25N3O3S/c25-14-16-27-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)28(26)20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2/t28-/m0/s1	FXJNLPUSSHEDON-NDEPHWFRSA-N					doublet; compound annotation
0391_013130	diclofenac	C14H11Cl2NO2	4.3293	3033		O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl	InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)	DCOPUUMXTXDBNB-UHFFFAOYSA-N					doublet; compound annotation
0391_013131	34839-70-8	C9H16N4S2	0.7623	1548992		CN=C(S)NCCSCc1c(C)[nH]cn1	InChI=1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14)	FPBPLBWLMYGIQR-UHFFFAOYSA-N					compound annotation
0391_013132	JAK-IN-5	C27H31FN6O	1.6484	137226770		CCc1cc(O)c(F)cc1-c1cc2c(cc1)c(-c1nc3c(CN(C4CCN(C)CC4)CC3)[nH]1)n[nH]2	InChI=1S/C27H31FN6O/c1-3-16-13-25(35)21(28)14-20(16)17-4-5-19-23(12-17)31-32-26(19)27-29-22-8-11-34(15-24(22)30-27)18-6-9-33(2)10-7-18/h4-5,12-14,18,35H,3,6-11,15H2,1-2H3,(H,29,30)(H,31,32)	YEGFDJOAFMPJSE-UHFFFAOYSA-N					compound annotation
0391_013133	GNE-495	C22H20FN5O2	2.5029	89730041		Nc1ncc(C(=O)NC2CN(C(=O)C3CC3)C2)c2c1nc(-c1cc(F)ccc1)cc2	InChI=1S/C22H20FN5O2/c23-14-3-1-2-13(8-14)18-7-6-16-17(9-25-20(24)19(16)27-18)21(29)26-15-10-28(11-15)22(30)12-4-5-12/h1-3,6-9,12,15H,4-5,10-11H2,(H2,24,25)(H,26,29)	FYXCIBJXJYBWPX-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013135	Amicarbazone	C10H19N5O2	2.5667	153920		CC(C)c1nn(C(=O)NC(C)(C)C)c(=O)n1N	InChI=1S/C10H19N5O2/c1-6(2)7-13-15(9(17)14(7)11)8(16)12-10(3,4)5/h6H,11H2,1-5H3,(H,12,16)	ORFPWVRKFLOQHK-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013137	Thiazolyl Blue cation	C18H16N5S+	3.1077	64966		Cc1c(C)sc(-[n+]2nc(-c3ccccc3)nn2-c2ccccc2)n1	InChI=1S/C18H16N5S/c1-13-14(2)24-18(19-13)23-21-17(15-9-5-3-6-10-15)20-22(23)16-11-7-4-8-12-16/h3-12H,1-2H3/q+1	FTZIQBGFCYJWKA-UHFFFAOYSA-N					compound annotation
0391_013138	Rifalazil	C51H64N4O13	4.1627	135431094	C[C@H]1/C=C/C=C(\C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C([C@](O5)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)/C	COC1C=COC2(C)Oc3c(C)c(O)c4c(=O)c(c5oc6cc(N7CCN(CC(C)C)CC7)cc(=O)c6nc5c4c3=C2O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C	InChI=1S/C51H64N4O13/c1-24(2)23-54-16-18-55(19-17-54)32-21-33(57)39-35(22-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-20-15-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)25(3)13-12-14-26(4)50(63)53-41(48)45(37)61/h12-15,20-22,24-25,27-29,34,42-43,46,58-60,62H,16-19,23H2,1-11H3,(H,53,63)/b13-12+,20-15+,26-14-/t25-,27+,28+,29+,34-,42-,43+,46+,51-/m0/s1	IXSVOCGZBUJEPI-HTQYORAHSA-N					removed another duplicate entry; compound annotation
0391_013140	Notoginsenoside Ft1	C47H80O17	4.1659	91973814	CC(=CCC[C@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)C)O)C)O)C	CC(C)=CCCC(C)(O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4OC4OCC(O)C(O)C4O)C(C)(C)C3CCC12C	InChI=1S/C47H80O17/c1-22(2)10-9-14-47(8,58)23-11-16-46(7)31(23)24(50)18-29-44(5)15-13-30(43(3,4)28(44)12-17-45(29,46)6)62-41-38(35(55)33(53)26(19-48)60-41)64-42-39(36(56)34(54)27(20-49)61-42)63-40-37(57)32(52)25(51)21-59-40/h10,23-42,48-58H,9,11-21H2,1-8H3/t23-,24+,25+,26+,27+,28-,29+,30-,31-,32-,33+,34+,35-,36-,37+,38+,39+,40-,41-,42-,44-,45+,46+,47+/m0/s1	LLXVPTXOKTYXHU-UGGLCNOCSA-N					compound annotation
0391_013141	(R,S)-Ivosidenib	C28H22ClF3N6O3	4.1995	121230976	C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N	N#Cc1cc(N2C(=O)CCC2C(=O)N(c2cc(F)cnc2)C(C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)ncc1	InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25+/m0/s1	WIJZXSAJMHAVGX-WIOPSUGQSA-N					compound annotation
0391_013142	KKL-10	C14H10BrN3O2S	5.1208	16854524		Cc1ccc(-c2nnc(NC(=O)c3ccc(Br)s3)o2)cc1	InChI=1S/C14H10BrN3O2S/c1-8-2-4-9(5-3-8)13-17-18-14(20-13)16-12(19)10-6-7-11(15)21-10/h2-7H,1H3,(H,16,18,19)	QKSDWSBGDVYRKQ-UHFFFAOYSA-N					compound annotation
0391_013143	JERVINE	C27H39NO3	2.542	10098	C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5C(=O)C4=C3C)C)O)C)NC1	CC1=C2C(=O)C3C(CC=C4CC(O)CCC43C)C2CCC12OC1CC(C)CNC1C2C	InChI=1S/C27H39NO3/c1-14-11-21-24(28-13-14)16(3)27(31-21)10-8-19-20-6-5-17-12-18(29)7-9-26(17,4)23(20)25(30)22(19)15(27)2/h5,14,16,18-21,23-24,28-29H,6-13H2,1-4H3/t14-,16+,18-,19-,20-,21+,23+,24-,26-,27-/m0/s1	CLEXYFLHGFJONT-DNMILWOZSA-N					compound annotation
0391_013144	chlorprothixene	C18H18ClNS	3.3873	667467	CN(C)CC/C=C\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	CN(C)CCC=C1c2ccccc2Sc2c1cc(Cl)cc2	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	WSPOMRSOLSGNFJ-AUWJEWJLSA-N					doublet; compound annotation
0391_013145	chlorprothixene	C18H18ClNS	3.4517	667467	CN(C)CC/C=C\1/C2=CC=CC=C2SC3=C1C=C(C=C3)Cl	CN(C)CCC=C1c2ccccc2Sc2c1cc(Cl)cc2	InChI=1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7-	WSPOMRSOLSGNFJ-AUWJEWJLSA-N					doublet; compound annotation
0391_013146	hypocrellin b	C30H24O9	5.0572	1023768		COc1c(O)c2c3c(c4c(OC)cc(=O)c5c(O)c(OC)c6C(C(C)=O)=C(C)Cc1c3c6c54)c(OC)cc2=O	InChI=1S/C30H24O9/c1-10-7-12-18-23-19(27(34)29(12)38-5)13(32)8-15(36-3)21(23)22-16(37-4)9-14(33)20-25(22)24(18)26(17(10)11(2)31)30(39-6)28(20)35/h8-9,34-35H,7H2,1-6H3	SBMXTMAIKRQSQE-UHFFFAOYSA-N					compound annotation
0391_013147	Abt-418	C9H14N2O	0.4794	119380	CC1=NOC(=C1)[C@@H]2CCCN2C	Cc1noc(C2CCCN2C)c1	InChI=1S/C9H14N2O/c1-7-6-9(12-10-7)8-4-3-5-11(8)2/h6,8H,3-5H2,1-2H3/t8-/m0/s1	ILLGYRJAYAAAEW-QMMMGPOBSA-N					compound annotation
0391_013148	D-Kynurenine	C10H12N2O3	0.5711	6971244	C1=CC=C(C(=C1)C(=O)C[C@H](C(=O)[O-])[NH3+])N	Nc1ccccc1C(=O)CC(N)C(=O)O	InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m1/s1	YGPSJZOEDVAXAB-MRVPVSSYSA-N					compound annotation
0391_013149	(R)-Baclofen	C10H12ClNO2	1.3452	6918881	C1=CC(=CC=C1[C@@H](CC(=O)[O-])C[NH3+])Cl	NCC(CC(=O)O)c1ccc(Cl)cc1	InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1	KPYSYYIEGFHWSV-QMMMGPOBSA-N					compound annotation
0391_013150	Glycyrrhizic acid	C42H62O16	3.507	14982	C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O	CC1(C(=O)O)CCC2(C)CCC3(C)C(=CC(=O)C4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C)C5CCC43C)C2C1	InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1	LPLVUJXQOOQHMX-QWBHMCJMSA-N					doublet; compound annotation
0391_013151	cerivastatin	C26H34FNO5	3.9989	446156	CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)O)O)O	COCc1c(-c2ccc(F)cc2)c(C=CC(O)CC(O)CC(=O)O)c(C(C)C)nc1C(C)C	InChI=1S/C26H34FNO5/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32)/b11-10+/t19-,20-/m1/s1	SEERZIQQUAZTOL-ANMDKAQQSA-N					compound annotation
0391_013152	CLINAFLOXACIN	C17H17ClFN3O3	1.862	60063		NC1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1	InChI=1S/C17H17ClFN3O3/c18-13-14-10(5-12(19)15(13)21-4-3-8(20)6-21)16(23)11(17(24)25)7-22(14)9-1-2-9/h5,7-9H,1-4,6,20H2,(H,24,25)	QGPKADBNRMWEQR-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013154	171179-06-9	C14H12BrN5	2.7036	4707		CNc1ncc2ncnc(Nc3cc(Br)ccc3)c2c1	InChI=1S/C14H12BrN5/c1-16-13-6-11-12(7-17-13)18-8-19-14(11)20-10-4-2-3-9(15)5-10/h2-8H,1H3,(H,16,17)(H,18,19,20)	KFHMLBXBRCITHF-UHFFFAOYSA-N					compound annotation
0391_013155	1421227-52-2	C28H30F3N7O3	3.0208	72551586		CN1CCN(Cc2c(C(F)(F)F)cc(NC(=O)Nc3ccc(Oc4ncnc(NC(=O)C5CC5)c4)cc3)cc2)CC1	InChI=1S/C28H30F3N7O3/c1-37-10-12-38(13-11-37)16-19-4-5-21(14-23(19)28(29,30)31)35-27(40)34-20-6-8-22(9-7-20)41-25-15-24(32-17-33-25)36-26(39)18-2-3-18/h4-9,14-15,17-18H,2-3,10-13,16H2,1H3,(H2,34,35,40)(H,32,33,36,39)	KIKOYRNAERIVSJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013157	Elacridar	C34H33N3O5	3.206	119373		COc1c(OC)cc2CN(CCc3ccc(NC(=O)c4cccc5c4[nH]c4c(cccc4OC)c5=O)cc3)CCc2c1	InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)	OSFCMRGOZNQUSW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013159	RIPK3-IN-1	C29H25FN4O4	3.7332	138393291		Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2cc(NC(=O)C3CC3)ncc2)c1C	InChI=1S/C29H25FN4O4/c1-17-18(2)25(38-22-13-14-31-26(16-22)33-27(35)19-5-6-19)12-11-24(17)32-28(36)23-4-3-15-34(29(23)37)21-9-7-20(30)8-10-21/h3-4,7-16,19H,5-6H2,1-2H3,(H,32,36)(H,31,33,35)	PETCZXAONWLUFT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013161	IWP-L6	C25H20N4O2S2	4.5714	71601111		O=C(CSc1nc2c(SCC2)c(=O)n1-c1ccccc1)Nc1ncc(-c2ccccc2)cc1	InChI=1S/C25H20N4O2S2/c30-22(28-21-12-11-18(15-26-21)17-7-3-1-4-8-17)16-33-25-27-20-13-14-32-23(20)24(31)29(25)19-9-5-2-6-10-19/h1-12,15H,13-14,16H2,(H,26,28,30)	QESQGTFWEQMCMH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013163	Artefenomel	C28H39NO5	4.6188	24999143		c1c(OCCN2CCOCC2)ccc(C2CCC3(CC2)OOC2(O3)C3CC4CC(C3)CC2C4)c1	InChI=1S/C28H39NO5/c1-3-26(31-14-11-29-9-12-30-13-10-29)4-2-22(1)23-5-7-27(8-6-23)32-28(34-33-27)24-16-20-15-21(18-24)19-25(28)17-20/h1-4,20-21,23-25H,5-19H2	XLCNVWUKICLURR-UHFFFAOYSA-N					doublet; compound annotation
0391_013164	Artefenomel	C28H39NO5	4.7577	24999143		c1c(OCCN2CCOCC2)ccc(C2CCC3(CC2)OOC2(O3)C3CC4CC(C3)CC2C4)c1	InChI=1S/C28H39NO5/c1-3-26(31-14-11-29-9-12-30-13-10-29)4-2-22(1)23-5-7-27(8-6-23)32-28(34-33-27)24-16-20-15-21(18-24)19-25(28)17-20/h1-4,20-21,23-25H,5-19H2	XLCNVWUKICLURR-UHFFFAOYSA-N					doublet; compound annotation
0391_013165	rivastigmine	C14H22N2O2	1.8895	77991	CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C	CCN(C)C(=O)Oc1cccc(C(C)N(C)C)c1	InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1	XSVMFMHYUFZWBK-NSHDSACASA-N					doublet; compound annotation
0391_013166	Abrine	C12H14N2O2	1.021	6921653	C[NH2+][C@@H](CC1=CNC2=CC=CC=C21)C(=O)[O-]	CNC(Cc1c[nH]c2ccccc12)C(=O)O	InChI=1S/C12H14N2O2/c1-13-11(12(15)16)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,13-14H,6H2,1H3,(H,15,16)/t11-/m0/s1	CZCIKBSVHDNIDH-NSHDSACASA-N					compound annotation
0391_013167	TH1834	C33H40N6O3	2.316	91826512		O=C(O)Cn1nnc(-c2ccc(CN(CCCCOc3ccc(CN4CCCC4)cc3)CCc3ccccc3)cc2)n1	InChI=1S/C33H40N6O3/c40-32(41)26-39-35-33(34-36-39)30-14-10-28(11-15-30)25-38(22-18-27-8-2-1-3-9-27)21-6-7-23-42-31-16-12-29(13-17-31)24-37-19-4-5-20-37/h1-3,8-17H,4-7,18-26H2,(H,40,41)	XERATECPNBWJFP-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013169	enoxacin	C15H17FN4O3	1.4416	28230148		CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21	InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)	IDYZIJYBMGIQMJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013171	ciprofloxacin	C17H18FN3O3	1.5514	4011971		O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O	InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)	MYSWGUAQZAJSOK-UHFFFAOYSA-N					compound annotation
0391_013172	indole-3-acetamide	C10H10N2O	1.6145	397		NC(=O)Cc1c[nH]c2ccccc12	InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)	ZOAMBXDOGPRZLP-UHFFFAOYSA-N					doublet; compound annotation
0391_013173	indole-3-acetamide	C10H10N2O	1.6184	397		NC(=O)Cc1c[nH]c2ccccc12	InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)	ZOAMBXDOGPRZLP-UHFFFAOYSA-N					doublet; compound annotation
0391_013174	Enrofloxacin	C19H22FN3O3	1.7004	71188		CCN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2)CC1	InChI=1S/C19H22FN3O3/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12/h9-12H,2-8H2,1H3,(H,25,26)	SPFYMRJSYKOXGV-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013176	scopoletin	C10H8O4	1.8037	5280460		COc1c(O)cc2oc(=O)ccc2c1	InChI=1S/C10H8O4/c1-13-9-4-6-2-3-10(12)14-8(6)5-7(9)11/h2-5,11H,1H3	RODXRVNMMDRFIK-UHFFFAOYSA-N					compound annotation
0391_013177	rosiglitazone	C18H19N3O3S	1.9945	77999		CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1	InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)	YASAKCUCGLMORW-UHFFFAOYSA-N					doublet; compound annotation
0391_013178	Quinagolide	C20H33N3O3S	2.3534	3086401	CCCN1C[C@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)N(CC)CC	CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(cccc3O)CC21	InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1	GDFGTRDCCWFXTG-ZIFCJYIRSA-N					compound annotation
0391_013179	Schisandrin	C24H32O7	3.8835	23915		COc1c(OC)c(OC)c2c(c1)CC(C)C(C)(O)Cc1cc(OC)c(OC)c(OC)c1-2	InChI=1S/C24H32O7/c1-13-9-14-10-16(26-3)20(28-5)22(30-7)18(14)19-15(12-24(13,2)25)11-17(27-4)21(29-6)23(19)31-8/h10-11,13,25H,9,12H2,1-8H3	YEFOAORQXAOVJQ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013182	Buclizine	C28H33ClN2	4.5586	6729		CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1	InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3	MOYGZHXDRJNJEP-UHFFFAOYSA-N					compound annotation
0391_013183	2140-77-4	C11H15N5O5	0.4996	135501934	CNC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	CNc1nc(=O)c2c([nH]1)n(C1OC(CO)C(O)C1O)cn2	InChI=1S/C11H15N5O5/c1-12-11-14-8-5(9(20)15-11)13-3-16(8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15,20)/t4-,6-,7-,10-/m1/s1	SLEHROROQDYRAW-KQYNXXCUSA-N					compound annotation
0391_013184	baclofen	C10H12ClNO2	1.3244	2284		NCC(CC(=O)O)c1ccc(Cl)cc1	InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)	KPYSYYIEGFHWSV-UHFFFAOYSA-N					compound annotation
0391_013185	1516895-53-6	C21H19N7	2.0945	72709059	CC1=CN=C(C2=NC(=NN12)[C@@H]3C[C@H]3C4=C(N5C=CC6=C(C5=N4)C=CC=N6)C)C	Cc1ncc(C)n2nc(C3CC3c3c(C)n4ccc5c(cccn5)c4n3)nc12	InChI=1S/C21H19N7/c1-11-10-23-12(2)20-25-19(26-28(11)20)16-9-15(16)18-13(3)27-8-6-17-14(21(27)24-18)5-4-7-22-17/h4-8,10,15-16H,9H2,1-3H3/t15-,16-/m1/s1	ZLHNYULRKIEGAY-HZPDHXFCSA-N					compound annotation
0391_013186	Zofenopril	C22H23NO4S2	4.4634	92400	C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N2C[C@H](C[C@H]2C(=O)O)SC3=CC=CC=C3	CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O	InChI=1S/C22H23NO4S2/c1-15(14-28-22(27)16-8-4-2-5-9-16)20(24)23-13-18(12-19(23)21(25)26)29-17-10-6-3-7-11-17/h2-11,15,18-19H,12-14H2,1H3,(H,25,26)/t15-,18+,19+/m1/s1	IAIDUHCBNLFXEF-MNEFBYGVSA-N					doublet; compound annotation
0391_013187	Zofenopril	C22H23NO4S2	4.4671	92400	C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N2C[C@H](C[C@H]2C(=O)O)SC3=CC=CC=C3	CC(CSC(=O)c1ccccc1)C(=O)N1CC(Sc2ccccc2)CC1C(=O)O	InChI=1S/C22H23NO4S2/c1-15(14-28-22(27)16-8-4-2-5-9-16)20(24)23-13-18(12-19(23)21(25)26)29-17-10-6-3-7-11-17/h2-11,15,18-19H,12-14H2,1H3,(H,25,26)/t15-,18+,19+/m1/s1	IAIDUHCBNLFXEF-MNEFBYGVSA-N					doublet; compound annotation
0391_013188	Brigatinib	C29H39ClN7O2P	1.6936	68165256		COc1c(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)	AILRADAXUVEEIR-UHFFFAOYSA-N					doublet; compound annotation
0391_013189	Brigatinib	C29H39ClN7O2P	1.6966	68165256		COc1c(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc(N2CCC(N3CCN(C)CC3)CC2)c1	InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)	AILRADAXUVEEIR-UHFFFAOYSA-N					doublet; compound annotation
0391_013190	TAK-659	C17H21FN6O	1.8132	53252276	CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4N	Cn1cc(-c2nc(NC3CCCCC3N)c(F)c3c2C(=O)NC3)cn1	InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1	MJHOMTRKVMKCNE-NWDGAFQWSA-N					doublet; compound annotation
0391_013191	TAK-659	C17H21FN6O	1.8169	53252276	CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4N	Cn1cc(-c2nc(NC3CCCCC3N)c(F)c3c2C(=O)NC3)cn1	InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1	MJHOMTRKVMKCNE-NWDGAFQWSA-N					doublet; compound annotation
0391_013192	Gilteritinib	C29H44N8O3	2.0327	49803313		CCc1c(NC2CCOCC2)nc(Nc2cc(OC)c(N3CCC(N4CCN(C)CC4)CC3)cc2)c(C(N)=O)n1	InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)	GYQYAJJFPNQOOW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013194	TAK-901	C28H32N4O3S	2.3659	16124208		CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3c2c2c(ncc(C)c2)[nH]3)c1	InChI=1S/C28H32N4O3S/c1-5-36(34,35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8,13-16,20H,5,9-12H2,1-4H3,(H,29,31)(H,30,33)	WKDACQVEJIVHMZ-UHFFFAOYSA-N					compound annotation
0391_013195	CCT129202	C23H25ClN8OS	2.7169	16202152		CN(C)c1ccc(-c2nc3ncc(Cl)c(N4CCN(CC(=O)Nc5nccs5)CC4)c3[nH]2)cc1	InChI=1S/C23H25ClN8OS/c1-30(2)16-5-3-15(4-6-16)21-28-19-20(17(24)13-26-22(19)29-21)32-10-8-31(9-11-32)14-18(33)27-23-25-7-12-34-23/h3-7,12-13H,8-11,14H2,1-2H3,(H,25,27,33)(H,26,28,29)	QYKHWEFPFAGNEV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013198	PKI-402	C29H34N10O3	2.9184	44187953		CCn1nnc2c1nc(-c1ccc(NC(=O)Nc3ccc(C(=O)N4CCN(C)CC4)cc3)cc1)nc2N1CCOCC1	InChI=1S/C29H34N10O3/c1-3-39-27-24(34-35-39)26(37-16-18-42-19-17-37)32-25(33-27)20-4-8-22(9-5-20)30-29(41)31-23-10-6-21(7-11-23)28(40)38-14-12-36(2)13-15-38/h4-11H,3,12-19H2,1-2H3,(H2,30,31,41)	ZAXFYGBKZSQBIV-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013200	TAM-IN-2	C31H27F2N7O3	3.1974	130447757		CC(=O)N1CCC(c2cc(-c3c(F)cc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3)c3c(N)ncnn23)CC1	InChI=1S/C31H27F2N7O3/c1-18(41)38-13-10-19(11-14-38)27-16-25(28-29(34)35-17-36-40(27)28)23-9-6-21(15-26(23)33)37-30(42)24-3-2-12-39(31(24)43)22-7-4-20(32)5-8-22/h2-9,12,15-17,19H,10-11,13-14H2,1H3,(H,37,42)(H2,34,35,36)	PLCVJNJRUVNDEY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013202	CDK9-IN-8	C31H32FN7O3	3.8569	137628632		CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)nc2n1C1CCCC1	InChI=1S/C31H32FN7O3/c1-38(2)27(40)25-17-19-18-33-30(37-26(19)39(25)24-5-3-4-6-24)36-23-13-11-22(12-14-23)35-29(42)31(15-16-31)28(41)34-21-9-7-20(32)8-10-21/h7-14,17-18,24H,3-6,15-16H2,1-2H3,(H,34,41)(H,35,42)(H,33,36,37)	KXUNYNZTSOIXMY-UHFFFAOYSA-N					doublet; compound annotation
0391_013203	CDK9-IN-8	C31H32FN7O3	3.8599	137628632		CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)nc2n1C1CCCC1	InChI=1S/C31H32FN7O3/c1-38(2)27(40)25-17-19-18-33-30(37-26(19)39(25)24-5-3-4-6-24)36-23-13-11-22(12-14-23)35-29(42)31(15-16-31)28(41)34-21-9-7-20(32)8-10-21/h7-14,17-18,24H,3-6,15-16H2,1-2H3,(H,34,41)(H,35,42)(H,33,36,37)	KXUNYNZTSOIXMY-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013205	Dexrazoxane	C11H16N4O4	0.6859	71384	C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2	CC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1	InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1	BMKDZUISNHGIBY-ZETCQYMHSA-N					compound annotation
0391_013206	SCHEMBL3706	C26H45NO7S	3.0689	13020211	C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](CC4[C@@]3(CC[C@H](C4)O)C)O)O)C	CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C	InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16?,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1	WBWWGRHZICKQGZ-FBJWDKEHSA-N					removed another duplicate entry; compound annotation
0391_013208	IMIQUIMOD	C14H16N4	2.1338	57469		CC(C)Cn1cnc2c1c1ccccc1nc2N	InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)	DOUYETYNHWVLEO-UHFFFAOYSA-N					doublet; compound annotation
0391_013209	solasodine	C27H43NO2	3.3904	442985	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C27H43NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h5,16-17,19-24,28-29H,6-15H2,1-4H3/t16-,17+,19+,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1	KWVISVAMQJWJSZ-VKROHFNGSA-N					doublet; compound annotation
0391_013210	solasodine	C27H43NO2	3.4828	442985	C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CC=C5CC(O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C27H43NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h5,16-17,19-24,28-29H,6-15H2,1-4H3/t16-,17+,19+,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1	KWVISVAMQJWJSZ-VKROHFNGSA-N					doublet; compound annotation
0391_013211	Tomatidine	C27H45NO2	3.4858	65576	C[C@H]1CC[C@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)NC1	CC1CCC2(NC1)OC1CC3C4CCC5CC(O)CCC5(C)C4CCC3(C)C1C2C	InChI=1S/C27H45NO2/c1-16-7-12-27(28-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(29)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28-29H,5-15H2,1-4H3/t16-,17-,18-,19-,20+,21-,22-,23-,24-,25-,26-,27-/m0/s1	XYNPYHXGMWJBLV-VXPJTDKGSA-N					doublet; compound annotation
0391_013212	CHEMBL3140024	C24H21ClN3OS3+	4.0743	72547054	CCN1/C(=C/C2=[N+](C=CS2)CC3=CC=CC=C3)/S/C(=C/4\N(C5=C(S4)C=C(C=C5)Cl)C)/C1=O	CCn1c(=Cc2[n+](Cc3ccccc3)ccs2)sc(=C2Sc3c(ccc(Cl)c3)N2C)c1=O	InChI=1S/C24H21ClN3OS3/c1-3-28-21(14-20-27(11-12-30-20)15-16-7-5-4-6-8-16)32-22(23(28)29)24-26(2)18-10-9-17(25)13-19(18)31-24/h4-14H,3,15H2,1-2H3/q+1/b24-22+	QDZKRCPSFILNHR-ZNTNEXAZSA-N					compound annotation
0391_013213	itraconazole	C35H38Cl2N8O4	4.7246	55283	CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6c(Cl)cc(Cl)cc6)O5)cc4)CC3)cc2)c1=O	InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1	VHVPQPYKVGDNFY-ZPGVKDDISA-N					removed another duplicate entry; compound annotation
0391_013215	Tanshinone I	C18H12O3	4.8921	114917		Cc1coc2c1C(=O)C(=O)c1c-2ccc2c(C)cccc12	InChI=1S/C18H12O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-8H,1-2H3	AIGAZQPHXLWMOJ-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013217	2,3,5,6-Tetramethylpyrazine	C8H12N2	1.1537	14296		Cc1c(C)nc(C)c(C)n1	InChI=1S/C8H12N2/c1-5-6(2)10-8(4)7(3)9-5/h1-4H3	FINHMKGKINIASC-UHFFFAOYSA-N					compound annotation
0391_013218	RG7800	C24H28N6O	2.5773	89741565		CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12	InChI=1S/C24H28N6O/c1-5-19-22-11-21(27-30(22)13-16(3)25-19)20-12-23(31)29-14-18(10-15(2)24(29)26-20)17-6-8-28(4)9-7-17/h10-14,17H,5-9H2,1-4H3	GYFRQCMDLBNZSF-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013220	Securinine	C13H15NO2	0.4727	442872	C1CCN2[C@H](C1)[C@]34C[C@H]2C=CC3=CC(=O)O4	O=C1C=C2C=CC3CC2(O1)C1CCCCN31	InChI=1S/C13H15NO2/c15-12-7-9-4-5-10-8-13(9,16-12)11-3-1-2-6-14(10)11/h4-5,7,10-11H,1-3,6,8H2/t10-,11-,13+/m1/s1	SWZMSZQQJRKFBP-WZRBSPASSA-N					compound annotation
0391_013221	Naphthoquine	C24H28ClN3O	1.8985	9851775		CC(C)(C)NCc1cc(Nc2ccnc3cc(Cl)ccc23)c2CCCCc2c1O	InChI=1S/C24H28ClN3O/c1-24(2,3)27-14-15-12-22(17-6-4-5-7-18(17)23(15)29)28-20-10-11-26-21-13-16(25)8-9-19(20)21/h8-13,27,29H,4-7,14H2,1-3H3,(H,26,28)	VEVMYTDOWUQLGI-UHFFFAOYSA-N					compound annotation
0391_013222	Marmesin	C14H14O4	2.467	334704	CC(C)([C@@H]1CC2=C(O1)C=C3C(=C2)C=CC(=O)O3)O	CC(C)(O)C1Cc2c(cc3oc(=O)ccc3c2)O1	InChI=1S/C14H14O4/c1-14(2,16)12-6-9-5-8-3-4-13(15)18-10(8)7-11(9)17-12/h3-5,7,12,16H,6H2,1-2H3/t12-/m0/s1	FWYSBEAFFPBAQU-LBPRGKRZSA-N					compound annotation
0391_013223	Alectinib	C30H34N4O2	3.1227	49806720		CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1c(C2=O)c2c(cc(C#N)cc2)[nH]1	InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3	KDGFLJKFZUIJMX-UHFFFAOYSA-N					doublet; compound annotation
0391_013224	686772-17-8	C23H20N4O3S3	4.448	2155264		COc1ccccc1-n1c(SCC(=O)Nc2nc3c(cc(C)cc3)s2)nc2c(SCC2)c1=O	InChI=1S/C23H20N4O3S3/c1-13-7-8-14-18(11-13)33-22(24-14)26-19(28)12-32-23-25-15-9-10-31-20(15)21(29)27(23)16-5-3-4-6-17(16)30-2/h3-8,11H,9-10,12H2,1-2H3,(H,24,26,28)	RHUJMHOIQBDFQR-UHFFFAOYSA-N					compound annotation
0391_013225	Isoimperatorin	C16H14O4	4.5708	68081		CC(C)=CCOc1c2ccc(=O)oc2cc2c1cco2	InChI=1S/C16H14O4/c1-10(2)5-7-19-16-11-3-4-15(17)20-14(11)9-13-12(16)6-8-18-13/h3-6,8-9H,7H2,1-2H3	IGWDEVSBEKYORK-UHFFFAOYSA-N					compound annotation
0391_013226	NAV-2729	C25H17ClN4O3	4.7075	2257249		O=c1cc(-c2ccc([N+](=O)[O-])cc2)nc2c(-c3ccc(Cl)cc3)c(Cc3ccccc3)[nH]n12	InChI=1S/C25H17ClN4O3/c26-19-10-6-18(7-11-19)24-22(14-16-4-2-1-3-5-16)28-29-23(31)15-21(27-25(24)29)17-8-12-20(13-9-17)30(32)33/h1-13,15,28H,14H2	WHYGBVWGARJOCS-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013228	CU-CPT17e	C27H24N2O8	5.3343	132585194		O=[N+]([O-])c1ccc(COc2cc3c(cc2OCc2ccc([N+](=O)[O-])cc2)OC2(C=C3)CCOCC2)cc1	InChI=1S/C27H24N2O8/c30-28(31)22-5-1-19(2-6-22)17-35-25-15-21-9-10-27(11-13-34-14-12-27)37-24(21)16-26(25)36-18-20-3-7-23(8-4-20)29(32)33/h1-10,15-16H,11-14,17-18H2	LHTNFHWDTHQECR-UHFFFAOYSA-N					compound annotation
0391_013229	Lerociclib	C26H34N8O	1.6766	86269224		CC(C)N1CCN(c2cnc(Nc3ncc4cc5C(=O)NCC6(CCCCC6)n5c4n3)cc2)CC1	InChI=1S/C26H34N8O/c1-18(2)32-10-12-33(13-11-32)20-6-7-22(27-16-20)30-25-28-15-19-14-21-24(35)29-17-26(8-4-3-5-9-26)34(21)23(19)31-25/h6-7,14-16,18H,3-5,8-13,17H2,1-2H3,(H,29,35)(H,27,28,30,31)	YPJRHEKCFKOVRT-UHFFFAOYSA-N					compound annotation
0391_013230	Abemaciclib	C27H32F2N8	1.8954	46220502		CCN1CCN(Cc2cnc(Nc3ncc(F)c(-c4cc5c(nc(C)n5C(C)C)c(F)c4)n3)cc2)CC1	InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)	UZWDCWONPYILKI-UHFFFAOYSA-N					doublet; compound annotation
0391_013231	Toceranib	C22H25FN4O2	1.9383	5329106	CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCCN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-	SRSGVKWWVXWSJT-ATVHPVEESA-N					doublet; compound annotation
0391_013232	1579965-12-0	C21H23N4O7PS2	1.9759	73386708		CC(C)(C)S(=O)(=O)c1c(OCCOP(=O)(O)O)cc2ncnc(Nc3cc4c(cc3)scn4)c2c1	InChI=1S/C21H23N4O7PS2/c1-21(2,3)35(29,30)19-9-14-15(10-17(19)31-6-7-32-33(26,27)28)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-34-18/h4-5,8-12H,6-7H2,1-3H3,(H,22,23,25)(H2,26,27,28)	MJLYDVMFNHZMLV-UHFFFAOYSA-N					compound annotation
0391_013233	Toceranib	C22H25FN4O2	2.6345	5329106	CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCCN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-	SRSGVKWWVXWSJT-ATVHPVEESA-N					doublet; compound annotation
0391_013234	Dubermatinib	C24H30ClN7O2S	2.8368	56839178		CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1	InChI=1S/C24H30ClN7O2S/c1-30(2)35(33,34)22-7-5-4-6-21(22)28-23-20(25)16-26-24(29-23)27-19-10-8-18(9-11-19)17-32-14-12-31(3)13-15-32/h4-11,16H,12-15,17H2,1-3H3,(H2,26,27,28,29)	YUAALFPUEOYPNX-UHFFFAOYSA-N					compound annotation
0391_013235	GNF4877	C25H27FN6O4	3.043	139600315	CC(C)OC1=CC(=C(C=C1)F)C2=CN=C(C(=N2)C(=O)NC3=C(C=CN=C3)N4CCC[C@H](C4)C(=O)O)N	CC(C)Oc1cc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCCC(C(=O)O)C3)n2)c(F)cc1	InChI=1S/C25H27FN6O4/c1-14(2)36-16-5-6-18(26)17(10-16)19-12-29-23(27)22(30-19)24(33)31-20-11-28-8-7-21(20)32-9-3-4-15(13-32)25(34)35/h5-8,10-12,14-15H,3-4,9,13H2,1-2H3,(H2,27,29)(H,31,33)(H,34,35)/t15-/m1/s1	UZIATSFXNVOVFE-OAHLLOKOSA-N					compound annotation
0391_013236	UM-164	C30H31F3N8O3S	3.3144	11714353		Cc1nc(Nc2ncc(C(=O)Nc3c(C)ccc(NC(=O)c4cc(C(F)(F)F)ccc4)c3)s2)cc(N2CCN(CCO)CC2)n1	InChI=1S/C30H31F3N8O3S/c1-18-6-7-22(37-27(43)20-4-3-5-21(14-20)30(31,32)33)15-23(18)38-28(44)24-17-34-29(45-24)39-25-16-26(36-19(2)35-25)41-10-8-40(9-11-41)12-13-42/h3-7,14-17,42H,8-13H2,1-2H3,(H,37,43)(H,38,44)(H,34,35,36,39)	ANEBQUSWQAQFQB-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013238	CEP-40783	C31H26F2N4O6	3.7031	71576419		COc1c(OC)cc2c(Oc3c(F)cc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3)ccnc2c1	InChI=1S/C31H26F2N4O6/c1-17(2)36-16-22(30(39)37(31(36)40)20-8-5-18(32)6-9-20)29(38)35-19-7-10-26(23(33)13-19)43-25-11-12-34-24-15-28(42-4)27(41-3)14-21(24)25/h5-17H,1-4H3,(H,35,38)	FKCWHHYUMFGOPY-UHFFFAOYSA-N					compound annotation
0391_013239	882531-87-5	C18H14ClFN4O	3.8465	135398512		COc1c(F)cc2C(c3ccccc3Cl)=NC3=C(C)NNC3=Nc2c1	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	UOVCGJXDGOGOCZ-UHFFFAOYSA-N					doublet; compound annotation
0391_013240	ZSTK474	C19H21F2N7O2	4.1586	11647372		FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1	InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2	HGVNLRPZOWWDKD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013242	882531-87-5	C18H14ClFN4O	4.753	135398512		COc1c(F)cc2C(c3ccccc3Cl)=NC3=C(C)NNC3=Nc2c1	InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24)	UOVCGJXDGOGOCZ-UHFFFAOYSA-N					doublet; compound annotation
0391_013243	862896-30-8	C17H24N2O2	1.4738	11380684		NC(=O)c1ccc(OCCCN2CC3CCCC3C2)cc1	InChI=1S/C17H24N2O2/c18-17(20)13-5-7-16(8-6-13)21-10-2-9-19-11-14-3-1-4-15(14)12-19/h5-8,14-15H,1-4,9-12H2,(H2,18,20)	MRNMYWNBLVJWKG-UHFFFAOYSA-N					compound annotation
0391_013244	PIK-90	C18H17N5O3	1.7667	135398491		COc1c(OC)c2nc(=NC(=O)c3cnccc3)n3CCNc3c2cc1	InChI=1S/C18H17N5O3/c1-25-13-6-5-12-14(15(13)26-2)21-18(23-9-8-20-16(12)23)22-17(24)11-4-3-7-19-10-11/h3-7,10,20H,8-9H2,1-2H3	FCKJZIRDZMVDEM-UHFFFAOYSA-N					compound annotation
0391_013245	tetrandrine	C38H42N2O6	2.1317	73078	CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC	COc1c2cc(cc1)CC1c3c(Oc4c(OC)cc5CCN(C)C(Cc6ccc(cc6)O2)c5c4)c(OC)c(OC)cc3CCN1C	InChI=1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30-/m0/s1	WVTKBKWTSCPRNU-KYJUHHDHSA-N					removed another duplicate entry; compound annotation
0391_013247	BMS-986158	C30H33N5O2	3.4061	118196485	CC1=C(N(N=N1)C)C2=CC3=C(C4=C(N3[C@@H](C5CCOCC5)C6=CC=CC=C6)C=C(C=C4)C(C)(C)O)N=C2	Cc1c(-c2cc3c(nc2)c2c(cc(C(C)(C)O)cc2)n3C(c2ccccc2)C2CCOCC2)n(C)nn1	InChI=1S/C30H33N5O2/c1-19-28(34(4)33-32-19)22-16-26-27(31-18-22)24-11-10-23(30(2,3)36)17-25(24)35(26)29(20-8-6-5-7-9-20)21-12-14-37-15-13-21/h5-11,16-18,21,29,36H,12-15H2,1-4H3/t29-/m1/s1	KGERZPVQIRYWRK-GDLZYMKVSA-N					compound annotation
0391_013248	Torin 1	C35H28F3N5O2	3.8775	49836027		CCC(=O)N1CCN(c2c(C(F)(F)F)cc(-n3c(=O)ccc4cnc5ccc(-c6cc7ccccc7nc6)cc5c43)cc2)CC1	InChI=1S/C35H28F3N5O2/c1-2-32(44)42-15-13-41(14-16-42)31-11-9-26(19-28(31)35(36,37)38)43-33(45)12-8-24-20-40-30-10-7-22(18-27(30)34(24)43)25-17-23-5-3-4-6-29(23)39-21-25/h3-12,17-21H,2,13-16H2,1H3	AKCRNFFTGXBONI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013250	STAT3-IN-3	C27H26BrN3O6S	4.1753	138454793		CCN(CC)c1cc2c(cc1)cc(C(=O)N1CCN(C(=O)C3=Cc4c(cccc4Br)S3(=O)=O)CC1)c(=O)o2	InChI=1S/C27H26BrN3O6S/c1-3-29(4-2)18-9-8-17-14-20(27(34)37-22(17)15-18)25(32)30-10-12-31(13-11-30)26(33)24-16-19-21(28)6-5-7-23(19)38(24,35)36/h5-9,14-16H,3-4,10-13H2,1-2H3	LEVMMUZFAXTJOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_013251	STAT3-IN-3	C27H26BrN3O6S	4.1791	138454793		CCN(CC)c1cc2c(cc1)cc(C(=O)N1CCN(C(=O)C3=Cc4c(cccc4Br)S3(=O)=O)CC1)c(=O)o2	InChI=1S/C27H26BrN3O6S/c1-3-29(4-2)18-9-8-17-14-20(27(34)37-22(17)15-18)25(32)30-10-12-31(13-11-30)26(33)24-16-19-21(28)6-5-7-23(19)38(24,35)36/h5-9,14-16H,3-4,10-13H2,1-2H3	LEVMMUZFAXTJOJ-UHFFFAOYSA-N					doublet; compound annotation
0391_013252	Dihydrotanshinone I	C18H14O3	4.355	11425923	C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C=CC=C43)C	Cc1c2ccc3c(C(=O)C(=O)C4=C3OCC4C)c2ccc1	InChI=1S/C18H14O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-7,10H,8H2,1-2H3/t10-/m0/s1	HARGZZNYNSYSGJ-JTQLQIEISA-N					removed another duplicate entry; compound annotation
0391_013254	Palmitoylethanolamide	C18H37NO2	6.0085	4671		CCCCCCCCCCCCCCCC(=O)NCCO	InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)	HXYVTAGFYLMHSO-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013256	Gatifloxacin	C19H22FN3O4	1.8273	5379		COc1c2c(cc(F)c1N1CCNC(C)C1)c(=O)c(C(=O)O)cn2C1CC1	InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)	XUBOMFCQGDBHNK-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013258	Nitidine	C21H18NO4+	2.5925	4501		COc1c(OC)cc2c(c1)c[n+](C)c1c2ccc2cc3c(cc21)OCO3	InChI=1S/C21H18NO4/c1-22-10-13-7-17(23-2)18(24-3)8-15(13)14-5-4-12-6-19-20(26-11-25-19)9-16(12)21(14)22/h4-10H,11H2,1-3H3/q+1	KKMPSGJPCCJYRV-UHFFFAOYSA-N					doublet; compound annotation
0391_013259	Nitidine	C21H18NO4+	3.0274	4501		COc1c(OC)cc2c(c1)c[n+](C)c1c2ccc2cc3c(cc21)OCO3	InChI=1S/C21H18NO4/c1-22-10-13-7-17(23-2)18(24-3)8-15(13)14-5-4-12-6-19-20(26-11-25-19)9-16(12)21(14)22/h4-10H,11H2,1-3H3/q+1	KKMPSGJPCCJYRV-UHFFFAOYSA-N					doublet; compound annotation
0391_013260	4,7-Diphenyl-1,10-phenanthroline	C24H16N2	3.6484	72812		c1ccc(-c2ccnc3c4nccc(-c5ccccc5)c4ccc23)cc1	InChI=1S/C24H16N2/c1-3-7-17(8-4-1)19-13-15-25-23-21(19)11-12-22-20(14-16-26-24(22)23)18-9-5-2-6-10-18/h1-16H	DHDHJYNTEFLIHY-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013263	DRI-C21045	C32H24N2O7S	3.9028	129275747		COC(=O)c1ccc(C(=O)Nc2ccc(-c3ccc(C(=O)Nc4cccc5c4c(S(=O)(=O)O)ccc5)cc3)cc2)cc1	InChI=1S/C32H24N2O7S/c1-41-32(37)25-14-12-23(13-15-25)30(35)33-26-18-16-21(17-19-26)20-8-10-24(11-9-20)31(36)34-27-6-2-4-22-5-3-7-28(29(22)27)42(38,39)40/h2-19H,1H3,(H,33,35)(H,34,36)(H,38,39,40)	BZAWLSZPOBGURT-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013265	Carboxyamidotriazole	C17H12Cl3N5O2	4.0933	108144		NC(=O)c1c(N)n(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)nn1	InChI=1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27)	WNRZHQBJSXRYJK-UHFFFAOYSA-N					doublet; compound annotation
0391_013266	MAT2A inhibitor	C31H22N6OS	4.9484	137296045		Cc1nc2c(cc(-c3c(Nc4ccccn4)[nH]c4c(-c5ccccc5)c(-c5ccccc5)nn4c3=O)cc2)s1	InChI=1S/C31H22N6OS/c1-19-33-23-16-15-22(18-24(23)39-19)27-29(34-25-14-8-9-17-32-25)35-30-26(20-10-4-2-5-11-20)28(36-37(30)31(27)38)21-12-6-3-7-13-21/h2-18,35H,1H3,(H,32,34)	ZTNQNZDNHUAVEI-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013268	Lumefantrine	C30H32Cl3NO	5.1634	6437380	CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O	CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1c(cc(Cl)cc1)C2=Cc1ccc(Cl)cc1	InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-	DYLGFOYVTXJFJP-MYYYXRDXSA-N					compound annotation
0391_013269	BMT-145027	C23H14ClF3N4	5.2821	129012190		N#Cc1c(C2CC2)c2c(-c3cc(C(F)(F)F)c(Cl)cc3)[nH]nc2nc1-c1ccccc1	InChI=1S/C23H14ClF3N4/c24-17-9-8-14(10-16(17)23(25,26)27)21-19-18(12-6-7-12)15(11-28)20(29-22(19)31-30-21)13-4-2-1-3-5-13/h1-5,8-10,12H,6-7H2,(H,29,30,31)	UXLUNMKSQUMWLH-UHFFFAOYSA-N					compound annotation
0391_013270	ITX3	C22H17N3OS	5.5178	1362865	CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/3\C(=O)N4C5=CC=CC=C5N=C4S3	Cc1cc(C=c2sc3nc4ccccc4n3c2=O)c(C)n1-c1ccccc1	InChI=1S/C22H17N3OS/c1-14-12-16(15(2)24(14)17-8-4-3-5-9-17)13-20-21(26)25-19-11-7-6-10-18(19)23-22(25)27-20/h3-13H,1-2H3/b20-13+	SJMYMKPBODEZSH-DEDYPNTBSA-N					doublet; compound annotation
0391_013271	ITX3	C22H17N3OS	5.5855	1362865	CC1=CC(=C(N1C2=CC=CC=C2)C)/C=C/3\C(=O)N4C5=CC=CC=C5N=C4S3	Cc1cc(C=c2sc3nc4ccccc4n3c2=O)c(C)n1-c1ccccc1	InChI=1S/C22H17N3OS/c1-14-12-16(15(2)24(14)17-8-4-3-5-9-17)13-20-21(26)25-19-11-7-6-10-18(19)23-22(25)27-20/h3-13H,1-2H3/b20-13+	SJMYMKPBODEZSH-DEDYPNTBSA-N					doublet; compound annotation
0391_013272	Abemaciclib metabolite M20	C27H32F2N8O	1.8237	139600311		CCN1CCN(Cc2cnc(Nc3ncc(F)c(-c4cc5c(nc(CO)n5C(C)C)c(F)c4)n3)cc2)CC1	InChI=1S/C27H32F2N8O/c1-4-35-7-9-36(10-8-35)15-18-5-6-23(30-13-18)32-27-31-14-21(29)25(34-27)19-11-20(28)26-22(12-19)37(17(2)3)24(16-38)33-26/h5-6,11-14,17,38H,4,7-10,15-16H2,1-3H3,(H,30,31,32,34)	KUJBDJBMXOTNIT-UHFFFAOYSA-N					compound annotation
0391_013273	Toceranib	C22H25FN4O2	1.9515	5329106	CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCCN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-	SRSGVKWWVXWSJT-ATVHPVEESA-N					doublet; compound annotation
0391_013274	RO9021	C18H25N7O	2.0188	71626896	CC1=C(N=C(C=C1)NC2=CC(=NN=C2C(=O)N)N[C@@H]3CCCC[C@@H]3N)C	Cc1c(C)nc(Nc2cc(NC3CCCCC3N)nnc2C(N)=O)cc1	InChI=1S/C18H25N7O/c1-10-7-8-15(21-11(10)2)23-14-9-16(24-25-17(14)18(20)26)22-13-6-4-3-5-12(13)19/h7-9,12-13H,3-6,19H2,1-2H3,(H2,20,26)(H2,21,22,23,24)/t12-,13+/m0/s1	XJZVCDVZCRLIKN-QWHCGFSZSA-N					compound annotation
0391_013275	Gilteritinib	C29H44N8O3	2.0442	49803313		CCc1c(NC2CCOCC2)nc(Nc2cc(OC)c(N3CCC(N4CCN(C)CC4)CC3)cc2)c(C(N)=O)n1	InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)	GYQYAJJFPNQOOW-UHFFFAOYSA-N					doublet; removed another duplicate entry; compound annotation
0391_013277	IRAK-1-4 Inhibitor I	C20H21N5O4	2.3977	11983295		O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cc([N+](=O)[O-])ccc1	InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)	QTCFYQHZJIIHBS-UHFFFAOYSA-N					compound annotation
0391_013278	Toceranib	C22H25FN4O2	2.6403	5329106	CC1=C(NC(=C1C(=O)NCCN2CCCC2)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O	Cc1c(C(=O)NCCN2CCCC2)c(C)c(C=C2C(=O)Nc3ccc(F)cc23)[nH]1	InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-	SRSGVKWWVXWSJT-ATVHPVEESA-N					doublet; compound annotation
0391_013279	1392429-79-6	C28H33F2N7O2S	2.8729	60152613		CCCS(=O)(=O)Nc1c(F)c(-n2cc(-c3cncnc3)c3c2ccc(N(C)C2CCN(CC)CC2)n3)c(F)cc1	InChI=1S/C28H33F2N7O2S/c1-4-14-40(38,39)34-23-7-6-22(29)28(26(23)30)37-17-21(19-15-31-18-32-16-19)27-24(37)8-9-25(33-27)35(3)20-10-12-36(5-2)13-11-20/h6-9,15-18,20,34H,4-5,10-14H2,1-3H3	AEJACXAFHXBVHF-UHFFFAOYSA-N					compound annotation
0391_013280	STL127705	C22H20FN5O4	3.2952	53333307		COc1c(OC)cc(CCNc2ncc3c(=O)n(-c4cc(F)ccc4)c(=O)[nH]c3n2)cc1	InChI=1S/C22H20FN5O4/c1-31-17-7-6-13(10-18(17)32-2)8-9-24-21-25-12-16-19(26-21)27-22(30)28(20(16)29)15-5-3-4-14(23)11-15/h3-7,10-12H,8-9H2,1-2H3,(H2,24,25,26,27,30)	FPVFCXYTLUJPQJ-UHFFFAOYSA-N					compound annotation
0391_013281	NMS-P715	C35H39F3N8O3	3.9965	44556162		CCc1c(NC(=O)c2nn(C)c3c2CCc2cnc(Nc4c(OC(F)(F)F)cc(C(=O)NC5CCN(C)CC5)cc4)nc2-3)c(CC)ccc1	InChI=1S/C35H39F3N8O3/c1-5-20-8-7-9-21(6-2)28(20)42-33(48)30-25-12-10-23-19-39-34(43-29(23)31(25)46(4)44-30)41-26-13-11-22(18-27(26)49-35(36,37)38)32(47)40-24-14-16-45(3)17-15-24/h7-9,11,13,18-19,24H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,42,48)(H,39,41,43)	JFOAJUGFHDCBJJ-UHFFFAOYSA-N					doublet; compound annotation
0391_013282	NMS-P715	C35H39F3N8O3	3.9998	44556162		CCc1c(NC(=O)c2nn(C)c3c2CCc2cnc(Nc4c(OC(F)(F)F)cc(C(=O)NC5CCN(C)CC5)cc4)nc2-3)c(CC)ccc1	InChI=1S/C35H39F3N8O3/c1-5-20-8-7-9-21(6-2)28(20)42-33(48)30-25-12-10-23-19-39-34(43-29(23)31(25)46(4)44-30)41-26-13-11-22(18-27(26)49-35(36,37)38)32(47)40-24-14-16-45(3)17-15-24/h7-9,11,13,18-19,24H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,42,48)(H,39,41,43)	JFOAJUGFHDCBJJ-UHFFFAOYSA-N					doublet; compound annotation
0391_013283	867331-82-6	C33H30ClN5O3	4.5102	11973736		Cc1cc(-c2c(Cl)ccc(OC(=O)c3ccccc3)c2)cc2c1nc(Nc1ccc(OCCN3CCCC3)cc1)nn2	InChI=1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38)	JMGXJHWTVBGOKG-UHFFFAOYSA-N					compound annotation
0391_013284	LY2794193	C16H18N2O6	1.3024	60096231	COC1=CC=CC(=C1)C(=O)N[C@H]2C[C@]([C@H]3[C@@H]2[C@@H]3C(=O)O)(C(=O)O)N	COc1cccc(C(=O)NC2CC(N)(C(=O)O)C3C(C(=O)O)C23)c1	InChI=1S/C16H18N2O6/c1-24-8-4-2-3-7(5-8)13(19)18-9-6-16(17,15(22)23)12-10(9)11(12)14(20)21/h2-5,9-12H,6,17H2,1H3,(H,18,19)(H,20,21)(H,22,23)/t9-,10-,11-,12-,16-/m0/s1	UXNRHIJPZNNDDJ-VZAVHYRXSA-N					compound annotation
0391_013285	Leonurine	C14H21N3O5	1.6819	161464		COc1cc(C(=O)OCCCCN=C(N)N)cc(OC)c1O	InChI=1S/C14H21N3O5/c1-20-10-7-9(8-11(21-2)12(10)18)13(19)22-6-4-3-5-17-14(15)16/h7-8,18H,3-6H2,1-2H3,(H4,15,16,17)	WNGSUWLDMZFYNZ-UHFFFAOYSA-N					doublet; compound annotation
0391_013286	906805-42-3	C23H31Cl2N7O	1.8127	11995774	CC[C@H]1CN(CCN1C2CCN(CC2)CC3=CC=C(C=C3)Cl)C4=NC(=C(N=C4Cl)C(=O)N)N	CCC1CN(c2nc(N)c(C(N)=O)nc2Cl)CCN1C1CCN(Cc2ccc(Cl)cc2)CC1	InChI=1S/C23H31Cl2N7O/c1-2-17-14-31(23-20(25)28-19(22(27)33)21(26)29-23)11-12-32(17)18-7-9-30(10-8-18)13-15-3-5-16(24)6-4-15/h3-6,17-18H,2,7-14H2,1H3,(H2,26,29)(H2,27,33)/t17-/m0/s1	UYDYJFWSPRQEAX-KRWDZBQOSA-N					compound annotation
0391_013287	BEMESETRON	C15H17Cl2NO2	2.9262	671690	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CC(=CC(=C3)Cl)Cl	CN1C2CCC1CC(OC(=O)c1cc(Cl)cc(Cl)c1)C2	InChI=1S/C15H17Cl2NO2/c1-18-12-2-3-13(18)8-14(7-12)20-15(19)9-4-10(16)6-11(17)5-9/h4-6,12-14H,2-3,7-8H2,1H3/t12-,13+,14?	MNJNPLVXBISNSX-PBWFPOADSA-N					compound annotation
0391_013288	DiZPK	C12H23N5O3	1.358	53314876	CC1(N=N1)CCCNC(=O)NCCCC[C@@H](C(=O)O)N	CC1(CCCNC(=O)NCCCCC(N)C(=O)O)N=N1	InChI=1S/C12H23N5O3/c1-12(16-17-12)6-4-8-15-11(20)14-7-3-2-5-9(13)10(18)19/h9H,2-8,13H2,1H3,(H,18,19)(H2,14,15,20)/t9-/m0/s1	YGUIFRMUMYTGAV-VIFPVBQESA-N					doublet; compound annotation
0391_013289	Rufloxacin	C17H18FN3O3S	1.4071	4979271		CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4CCSc2c34)CC1	InChI=1S/C17H18FN3O3S/c1-19-2-4-20(5-3-19)14-12(18)8-10-13-16(14)25-7-6-21(13)9-11(15(10)22)17(23)24/h8-9H,2-7H2,1H3,(H,23,24)	NJCJBUHJQLFDSW-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013291	1-Methyl-D-tryptophan	C12H14N2O2	1.5231	6920151	CN1C=C(C2=CC=CC=C21)C[C@H](C(=O)[O-])[NH3+]	Cn1cc(CC(N)C(=O)O)c2ccccc21	InChI=1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)/t10-/m1/s1	ZADWXFSZEAPBJS-SNVBAGLBSA-N					compound annotation
0391_013292	Voreloxin	C18H19N5O4S	2.0556	9952884	CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O	CNC1CN(c2nc3c(cc2)c(=O)c(C(=O)O)cn3-c2nccs2)CC1OC	InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1	XZAFZXJXZHRNAQ-STQMWFEESA-N					removed another duplicate entry; compound annotation
0391_013294	Mezigdomide	C32H30FN5O4	2.6696	137379043	C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCN(CC5)C6=C(C=C(C=C6)C#N)F	N#Cc1cc(F)c(N2CCN(Cc3ccc(COc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)cc3)CC2)cc1	InChI=1S/C32H30FN5O4/c33-26-16-23(17-34)8-9-27(26)37-14-12-36(13-15-37)18-21-4-6-22(7-5-21)20-42-29-3-1-2-24-25(29)19-38(32(24)41)28-10-11-30(39)35-31(28)40/h1-9,16,28H,10-15,18-20H2,(H,35,39,40)/t28-/m0/s1	YTINZZFBHWSAGL-NDEPHWFRSA-N					removed another duplicate entry; compound annotation
0391_013296	Fosamprenavir	C25H36N3O9PS	2.9482	131536	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N	CC(C)CN(CC(OP(=O)(O)O)C(Cc1ccccc1)NC(=O)OC1CCOC1)S(=O)(=O)c1ccc(N)cc1	InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1	MLBVMOWEQCZNCC-OEMFJLHTSA-N					doublet; compound annotation
0391_013297	Netupitant	C30H32F6N4O	4.3186	6451149		Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1	InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3	WAXQNWCZJDTGBU-UHFFFAOYSA-N					compound annotation
0391_013298	Bisantrene	C22H22N8	1.6214	5351322	C1NC(=NC1)N/N=C/C2=C3C(=C(C4=CC=CC=C24)/C=N/NC5=NCCN5)C=CC=C3	C(=NNC1=NCCN1)c1c2ccccc2c(C=NNC2=NCCN2)c2ccccc12	InChI=1S/C22H22N8/c1-2-6-16-15(5-1)19(13-27-29-21-23-9-10-24-21)17-7-3-4-8-18(17)20(16)14-28-30-22-25-11-12-26-22/h1-8,13-14H,9-12H2,(H2,23,24,29)(H2,25,26,30)/b27-13+,28-14+	NJSMWLQOCQIOPE-OCHFTUDZSA-N					doublet; compound annotation
0391_013299	Bisantrene	C22H22N8	1.7079	5351322	C1NC(=NC1)N/N=C/C2=C3C(=C(C4=CC=CC=C24)/C=N/NC5=NCCN5)C=CC=C3	C(=NNC1=NCCN1)c1c2ccccc2c(C=NNC2=NCCN2)c2ccccc12	InChI=1S/C22H22N8/c1-2-6-16-15(5-1)19(13-27-29-21-23-9-10-24-21)17-7-3-4-8-18(17)20(16)14-28-30-22-25-11-12-26-22/h1-8,13-14H,9-12H2,(H2,23,24,29)(H2,25,26,30)/b27-13+,28-14+	NJSMWLQOCQIOPE-OCHFTUDZSA-N					doublet; compound annotation
0391_013300	Preladenant	C25H29N9O3	2.3872	10117987		COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1	InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7,14,17H,8-13,15-16H2,1H3,(H2,26,29)	DTYWJKSSUANMHD-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013303	CX-5461	C27H27N7O2S	2.479	25257557		Cc1cnc(CNC(=O)c2c3sc4ccccc4n3c3c(ccc(N4CCCN(C)CC4)n3)c2=O)cn1	InChI=1S/C27H27N7O2S/c1-17-14-29-18(15-28-17)16-30-26(36)23-24(35)19-8-9-22(33-11-5-10-32(2)12-13-33)31-25(19)34-20-6-3-4-7-21(20)37-27(23)34/h3-4,6-9,14-15H,5,10-13,16H2,1-2H3,(H,30,36)	XGPBJCHFROADCK-UHFFFAOYSA-N					doublet; compound annotation
0391_013304	RG7800	C24H28N6O	2.579	89741565		CCc1nc(C)cn2nc(-c3cc(=O)n4cc(C5CCN(C)CC5)cc(C)c4n3)cc12	InChI=1S/C24H28N6O/c1-5-19-22-11-21(27-30(22)13-16(3)25-19)20-12-23(31)29-14-18(10-15(2)24(29)26-20)17-6-8-28(4)9-7-17/h10-14,17H,5-9H2,1-4H3	GYFRQCMDLBNZSF-UHFFFAOYSA-N					doublet; compound annotation
0391_013305	1093403-33-8	C26H24N6O2S2	3.5427	25108829		Cc1c(C(=O)Nc2ccccc2-c2cn3c(CN4CCOCC4)csc3n2)sc(-c2cnccc2)n1	InChI=1S/C26H24N6O2S2/c1-17-23(36-25(28-17)18-5-4-8-27-13-18)24(33)29-21-7-3-2-6-20(21)22-15-32-19(16-35-26(32)30-22)14-31-9-11-34-12-10-31/h2-8,13,15-16H,9-12,14H2,1H3,(H,29,33)	LAMQVIQMVKWXOC-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013307	Oglemilast	C20H13Cl2F2N3O5S	3.7782	11387409		CS(=O)(=O)Nc1cc2c(cc1)oc1c(OC(F)F)ccc(C(=O)Nc3c(Cl)cncc3Cl)c12	InChI=1S/C20H13Cl2F2N3O5S/c1-33(29,30)27-9-2-4-14-11(6-9)16-10(3-5-15(18(16)31-14)32-20(23)24)19(28)26-17-12(21)7-25-8-13(17)22/h2-8,20,27H,1H3,(H,25,26,28)	OKFDRAHPFKMAJH-UHFFFAOYSA-N					removed another duplicate entry; compound annotation
0391_013309	DICHLORISONE ACETATE	C23H28Cl2O5	4.0296	5388959	CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)Cl)C)O	CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(Cl)CC21C	InChI=1S/C23H28Cl2O5/c1-13(26)30-12-19(28)22(29)9-7-16-17-5-4-14-10-15(27)6-8-20(14,2)23(17,25)18(24)11-21(16,22)3/h6,8,10,16-18,29H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20-,21-,22-,23-/m0/s1	YNNURTVKPVJVEI-GSLJADNHSA-N					compound annotation
0391_013310	Telratolimod	C36H59N5O2	6.1002	56833311		CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c1c1ccccc1nc2N	InChI=1S/C36H59N5O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-27-33(42)38-28-22-23-29-43-41-32(26-6-4-2)40-34-35(41)30-24-20-21-25-31(30)39-36(34)37/h20-21,24-25H,3-19,22-23,26-29H2,1-2H3,(H2,37,39)(H,38,42)	RRTPWQXEERTRRK-UHFFFAOYSA-N					compound annotation
